Citrus Sinensis ID: 039290

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------970-------980-------990------1000------1010------1020------1030------1040------105
Protein Sequence
NIGFMIITLVPLLHCLMLSSVMAAVTNVTTDQFALLALKEHIKHDPSNLLANNWSTTSSVCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSPKLQVSPCKTRSHPRSRTTVVLLIVLPLVSALTMIVVLTAKLVRRRRRRRRRQKGSTRPYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYIDV
Secondary Structure (PSIPRED)
cccHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHcccccccccccccccccccccccEEEEcccccccEEEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEccccccEEEccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccccccccEEEcccccccccccccccccccccEEEEEccccEEcccHHcccccccccccccccccEEcccHHHHcccccccEEcccccccccccHHHHccccccEEEcccccccccccHHHHcccccccEEEccccEEEEcccHHHHHcccccEEEccccEEEEcccccccccccccEEEccccccccccccccccccccccccccEEEcccccccccccHHHHcccccccEEEEcccEEEEcccccccccccccEEEcccccccccccHHHcccccccEEEcccccccccccHHHHcccccccEEcccccccccccccccccccccccccccccccccccHHHHcccccccEEcccccccccccHHHHcccccccEEcccccccccccHHHHccccccEEccccccccccccHHHcccccccEEEcccccccccccHHHHcccccccccccccccccccccccccccccHHcccccccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccHHHHHHHHcccccccEEEcccccEEEEEEcccccEEEEEEEccccccccHHHHHHHHHHccccccccccEEEEEEcccccEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHccccccccccEEccccccccccccccEEEEcccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHccccccccccccccHHHHHHHHcccccccEEEcccccccccccHHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHHHcccc
Secondary Structure Prediction (SSPRO)
cHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHcccccccccccccccccccccEEEEEEcccccEEEEEEcccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEcccccccccccHHHccccccEEEEcccccccccccHHHccccccEEEEEccccccccccHHHcccccHcccccccEEEcccccccccccHHHcccccccEEEEccccccccccHHHcccHHHHEEEcccccccccccHHHcccHHHHEEEEccccccccccHHHccccccEEEEcccccccccccHHHHHccHcccEEEEccccccccccHHHcccccccEEEcccccccccccHHHccccccEEEEEccccccccccccccHHHHccccccEEEEEccccccccccHHHHccccccEEEEEccccccccccccHcccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccHHHcccccccEEEcccccccccccHHHccccccEEEEccEccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccccEEcccHHHHHcccccEEEccccEEEEEccccccHHHccHHHcccccEEEcccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccEccHHHHHHHHHcccHHcEEEcccccEEEEEEcccccEEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHHccccccEEEEEEccccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHccccccEEEcccccccEEccccccHHHHHHcHHHHcccccccccccccccccccccccccEEEEcccccHEHHHHHHHHHHcccccccccccccccHHHHHHHHccccccHHHccHHHcccccccccHHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHcHHHHccc
Coil and Loop (DISEMBL)
NIGFMIITLVPLLHCLMLSSVMAAVTNVTTDQFALLALKEHikhdpsnllannwsttsSVCSWIGVTCGVRNRRVTALNISylgltgtippqlgnlSFLAVLAIRnnsffgslPEELShlrglkyfdfrfnnfhieipswfvsLPRLQHLLLKhnsfvgkipETIGYLSLLQEldlsdnqlsgtipssifnisscqnlpvlEGLFISYnqltgpiptnlwkcrELHVVSLAFNkfqggiprdignltSVRNLFlgnnsligeipneignlrnlevlgvqssnlaglipasifnistlkelavtdndllgslpssidlglpnlerlflgennfsgtipssltniselsvldfgfnsfsglipttfgnlrSLKLLSLAgnvltsptpdlsflssltscRNLEIiylsenpingilpssignfsISMKSLSMescnisggipkelgninnltvirlgnneltgtipVTLGRLQKLQGLYLqnnklegsipedlCHLYRLANlylgdnklsgrlpaclgnltslrdlslgsnaltsiipstlwNLKDILRFnlssnslngsllpdignLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNrlqgpipesfgglkslnfvdmsnnnlsgtipKSMEALSYLKHLNLSFnqlegeiptrgpfitfsaesflgnqalcgspklqvspcktrshprsrtTVVLLIVLPLVSALTMIVVLTAKLVRRRRRRRrrqkgstrpyydanmypqatwrRISYQDLLratdgfsenkllgmgsfgsvykgvlpdGMEIAAKVFHmefdgsleSFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMsngslekclysdnyFLDILQRLKIMIDVASALEYlhfgystpivhcdikpsnvllnesmvghlsdfgIAKILGKEESMRQTktlgtigymapeygregkvsrkcdvYSYGIMLMETftkkkptdeifagEMSLKRWVgdsllscsitevadanllnceendfsAREQCVSSIFSLAMdctvdlpekrisMKDVANRLVRIRETLSAYIDV
Flexible Loop (DISEMBL)
NIGFMIITLVPLLHCLMLSSVMAAVTNVTTDQFALLALKEHIKHDPSNLLANNWSTTSSVCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSPKLQvspcktrshprsrttvVLLIVLplvsaltmivvltaklvrrrrrrrrrqkgstrpyydanmypqatWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTlgtigymapeygregkvsrKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVdlpekrismkdvanRLVRIRETLSAYIDV
Low Complexity Region (SEG)
NIGFMIITLVPLLHCLMLSSVMAAVTNVTTDQFALLALKEHIKHDPSNLLANNWSTTSSVCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFnlssnslngsllPDIGNLKVVIEMDLSLNALSGVIPVTIgglqglqllslRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSPKLQVSPCKTRSHPRSRTTvvllivlplvSALTMIVVLTAKLVrrrrrrrrrQKGSTRPYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYIDV
Disordered region (IsUnstruct)
*IGFMIITLVPLLHCLMLSSVMAAVTNVTTDQFALLALKEHIKHDPSNLLANNWSTTSSVCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSPKLQ************RTTVVLLIVLPLVSALTMIVVLTAKLVRR*************PYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAY***
Disordered Region (DISOPRED)
NIGFMIITLVPLLHCLMLSSVMAAVTNVTTDQFALLALKEHIK**********WSTTSSVCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSP*********************LIVLPLVSALTMIVVLTAKLVRR**********************QATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI**********KTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS*YIDV
Disordered Region (DISEMBL)
NIGFMIITLVPLLHCLMLSSVMAAVTNVTTDQFALLALKEHIKHDPSNLLANNWSTTSSVCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSPK*************SRTTVVLLIVLPLVSALTMIVVLTAKLV***************PYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYIDV
Disordered Region (DISPRO)
NIGFMIITLVPLLHCLMLSSVMAAVTNVTTDQFALLALKEHIKHDPSNLLANNWSTTSSVCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSPKLQVSPCKTRSHPRSRTTVVLLIVLPLVSALTMIVVLTAKLVRRRRRRR**************MYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS*****
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
NIGFMIITLVPLLHCLMLSSVMAAVTNVTTDQFALLALKEHIKHDPSNLLANNWSTTSSVCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSPKLQVSPCKTRSHPRSRTTVVLLIVLPLVSALTMIVVLTAKLVRRRRRRRRRQKGSTRPYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYIDV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	1049	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.903	0.938	0.369	1e-171
C0LGT6	1031	LRR receptor-like serine/	no	no	0.896	0.911	0.356	1e-163
Q9SD62	1025	Putative receptor-like pr	no	no	0.928	0.950	0.365	1e-158
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.896	0.752	0.358	1e-151
Q9FL28	1173	LRR receptor-like serine/	no	no	0.944	0.844	0.328	1e-149
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.897	0.751	0.345	1e-145
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.934	0.889	0.336	1e-135
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.928	0.884	0.326	1e-132
P93194	1109	Receptor-like protein kin	N/A	no	0.933	0.882	0.324	1e-132
O49318	1124	Probable leucine-rich rep	no	no	0.957	0.893	0.316	1e-131

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  603 bits (1556), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 384/1040 (36%), Positives = 582/1040 (55%), Gaps = 92/1040 (8%)

Query: 30   TDQFALLALKEHIKHDPSNLLANNWSTTSSVCSWIGVTCGVRNRRVTALNISYLGLTGTI 89
            TD+ ALL  K  +  D   +L++ W+ +  +C+W GVTCG +N+RVT L +  L L G I
Sbjct: 24   TDRQALLQFKSQVSEDKRVVLSS-WNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGGVI 82

Query: 90   PPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQH 149
             P +GNLSFL  L +                         + NF                
Sbjct: 83   SPSIGNLSFLVSLDL-------------------------YENF---------------- 101

Query: 150  LLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYN 209
                   F G IP+ +G LS L+ LD+  N L G IP  ++N S   NL       +  N
Sbjct: 102  -------FGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLNLR------LDSN 148

Query: 210  QLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGN 269
            +L G +P+ L     L  ++L  N  +G +P  +GNLT +  L L +N+L GEIP+++  
Sbjct: 149  RLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIPSDVAQ 208

Query: 270  LRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGE 329
            L  +  L + ++N +G+ P +++N+S+LK L +  N   G L   + + LPNL    +G 
Sbjct: 209  LTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGG 268

Query: 330  NNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTP-DLS 388
            N F+G+IP++L+NIS L  L    N+ +G IPT FGN+ +LKLL L  N L S +  DL 
Sbjct: 269  NYFTGSIPTTLSNISTLERLGMNENNLTGSIPT-FGNVPNLKLLFLHTNSLGSDSSRDLE 327

Query: 389  FLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNL 448
            FL+SLT+C  LE + +  N + G LP SI N S  + +L +    ISG IP ++GN+ NL
Sbjct: 328  FLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINL 387

Query: 449  TVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSG 508
              + L  N L+G +P +LG+L  L+ L L +N+L G IP  + ++  L  L L +N   G
Sbjct: 388  QKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEG 447

Query: 509  RLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVV 568
             +P  LGN + L +L +G N L   IP  +  ++ +LR ++S NSL GSL  DIG L+ +
Sbjct: 448  IVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNL 507

Query: 569  IEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSG 628
              + L  N LSG +P T+G    ++ L L  N   G IP+   GL  +  VD+SNN+LSG
Sbjct: 508  GTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPD-LKGLVGVKEVDLSNNDLSG 566

Query: 629  TIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCG-------SPKLQ 681
            +IP+   + S L++LNLSFN LEG++P +G F   +  S +GN  LCG        P L 
Sbjct: 567  SIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLS 626

Query: 682  VSPCKTRSHPRSRTTVVLLIVLPLVSALTMIVVLTAKLVRRRRRRRRRQKGSTRPYYDAN 741
             +P   + H  SR   V++ V   ++ L ++ + +  L+  R+R++ ++  +  P     
Sbjct: 627  QAPSVVKKH-SSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEV 685

Query: 742  MYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKG-VLPDGMEIAAKVFHMEFDGS 800
            ++      +ISY DL  AT+GFS + ++G GSFG+VYK  +L +   +A KV +M+  G+
Sbjct: 686  LH-----EKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGA 740

Query: 801  LESFHAECKVMGSIRHRNLVKIISSCSN-----NDFKALVLEYMSNGSLEKCLYSDNY-- 853
            ++SF AEC+ +  IRHRNLVK++++CS+     N+F+AL+ E+M NGSL+  L+ +    
Sbjct: 741  MKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEE 800

Query: 854  ------FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGI 907
                   L +L+RL I IDVAS L+YLH     PI HCD+KPSNVLL++ +  H+SDFG+
Sbjct: 801  IHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGL 860

Query: 908  AKILGK--EES----MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
            A++L K  EES    +      GTIGY APEYG  G+ S   DVYS+GI+L+E FT K+P
Sbjct: 861  ARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRP 920

Query: 962  TDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVD 1021
            T+E+F G  +L  +   S L   I ++ D ++L+          +C++ +F + + C  +
Sbjct: 921  TNELFGGNFTLNSYT-KSALPERILDIVDESILHIGLRVGFPVVECLTMVFEVGLRCCEE 979

Query: 1022 LPEKRISMKDVANRLVRIRE 1041
             P  R++   V   L+ IRE
Sbjct: 980  SPMNRLATSIVVKELISIRE 999

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  577 bits (1486), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 370/1039 (35%), Positives = 556/1039 (53%), Gaps = 99/1039 (9%)

Query: 30   TDQFALLALKEHIKHDPSNLLANNWSTTSSVCSWIGVTCGVRNRRVTALNISYLGLTGTI 89
            TD  ALL  K  +  +    +  +W+ +S  C+WIGVTCG R  RV +LN+    LTG I
Sbjct: 30   TDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRRERVISLNLGGFKLTGVI 89

Query: 90   PPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQH 149
             P +GNLSFL +L                                               
Sbjct: 90   SPSIGNLSFLRLLN---------------------------------------------- 103

Query: 150  LLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYN 209
              L  NSF   IP+ +G L  LQ L++S N L G IPSS+   S+C  L  ++   +S N
Sbjct: 104  --LADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSL---SNCSRLSTVD---LSSN 155

Query: 210  QLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGN 269
             L   +P+ L    +L ++ L+ N   G  P  +GNLTS++ L    N + GEIP+E+  
Sbjct: 156  HLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVAR 215

Query: 270  LRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGE 329
            L  +    +  ++ +G  P +++NIS+L+ L++ DN   G+L +     LPNL RL LG 
Sbjct: 216  LTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGT 275

Query: 330  NNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSL-AGNVLTSPTPDLS 388
            N F+G IP +L NIS L   D   N  SG IP +FG LR+L  L +   ++  + +  L 
Sbjct: 276  NQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLE 335

Query: 389  FLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNL 448
            F+ ++ +C  LE + +  N + G LP+SI N S ++ SL +    ISG IP ++GN+ +L
Sbjct: 336  FIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSL 395

Query: 449  TVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSG 508
              + L  N L+G +PV+ G+L  LQ + L +N + G IP    ++ RL  L+L  N   G
Sbjct: 396  QELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHG 455

Query: 509  RLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVV 568
            R+P  LG    L DL + +N L   IP  +  +  +   +LS+N L G    ++G L+++
Sbjct: 456  RIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELL 515

Query: 569  IEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSG 628
            + +  S N LSG +P  IGG   ++ L ++ N   G IP+    L SL  VD SNNNLSG
Sbjct: 516  VGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSG 574

Query: 629  TIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSPK-LQVSPCKT 687
             IP+ + +L  L++LNLS N+ EG +PT G F   +A S  GN  +CG  + +Q+ PC  
Sbjct: 575  RIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIV 634

Query: 688  RSHPRS------RTTVVLLIVLPLVSALTMIVVLTAKLVRRRRRRRRRQKGSTRPYYDAN 741
            ++ PR       R  VV  I + + S L +I+V +     +R+++     G+        
Sbjct: 635  QASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLG 694

Query: 742  MYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGS 800
            M+ +    ++SY++L  AT  FS   L+G G+FG+V+KG+L P+   +A KV ++   G+
Sbjct: 695  MFHE----KVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGA 750

Query: 801  LESFHAECKVMGSIRHRNLVKIISSCSN-----NDFKALVLEYMSNGSLEKCLYSDNY-- 853
             +SF AEC+    IRHRNLVK+I+ CS+     NDF+ALV E+M  GSL+  L  ++   
Sbjct: 751  TKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLER 810

Query: 854  ------FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGI 907
                   L   ++L I IDVASALEYLH     P+ HCDIKPSN+LL++ +  H+SDFG+
Sbjct: 811  VNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGL 870

Query: 908  AKILGK---EESMRQTKTL---GTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
            A++L K   E  + Q  +    GTIGY APEYG  G+ S + DVYS+GI+L+E F+ KKP
Sbjct: 871  AQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKP 930

Query: 962  TDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVD 1021
            TDE FAG+ +L  +    L  C  T    +N          A ++ +  +  + + C+ +
Sbjct: 931  TDESFAGDYNLHSYTKSILSGC--TSSGGSN----------AIDEGLRLVLQVGIKCSEE 978

Query: 1022 LPEKRISMKDVANRLVRIR 1040
             P  R+   +    L+ IR
Sbjct: 979  YPRDRMRTDEAVRELISIR 997

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  561 bits (1445), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 387/1060 (36%), Positives = 569/1060 (53%), Gaps = 86/1060 (8%)

Query: 10   VPLLHCLMLSSVMAAVTNVTTDQFALLALKEHIKHDPSNLLANNWSTTSSVCSWIGVTCG 69
            V L H  M+ +    +T   TD+ ALL  K  +  + S ++  +W+ +  +CSW GV CG
Sbjct: 20   VSLEHSDMVCAQTIRLTE-ETDKQALLEFKSQVS-ETSRVVLGSWNDSLPLCSWTGVKCG 77

Query: 70   VRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFR 129
            +++RRVT +++  L LTG + P +GNLSFL                              
Sbjct: 78   LKHRRVTGVDLGGLKLTGVVSPFVGNLSFL------------------------------ 107

Query: 130  FNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSI 189
                              + L L  N F G IP  +G L  LQ L++S+N   G IP  +
Sbjct: 108  ------------------RSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVL 149

Query: 190  FNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSV 249
                   N   L  L +S N L   +P       +L ++SL  N   G  P  +GNLTS+
Sbjct: 150  ------SNCSSLSTLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSL 203

Query: 250  RNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLG 309
            + L    N + GEIP +I  L+ +    +  +   G+ P  I+N+S+L  L++T N   G
Sbjct: 204  QMLDFIYNQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSG 263

Query: 310  SLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRS 369
            +L       LPNL+ L++G N+F+GTIP +L+NIS L  LD   N  +G IP +FG L++
Sbjct: 264  TLRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQN 323

Query: 370  LKLLSLAGNVLTS-PTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLS 428
            L LL L  N L +  + DL FL +LT+C  L+ + +  N + G LP  I N S  +  LS
Sbjct: 324  LLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELS 383

Query: 429  MESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPE 488
            +    ISG IP  +GN+ +L  + LG N LTG +P +LG L +L+ + L +N L G IP 
Sbjct: 384  LGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPS 443

Query: 489  DLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFN 548
             L ++  L  LYL +N   G +P+ LG+ + L DL+LG+N L   IP  L  L  ++  N
Sbjct: 444  SLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLN 503

Query: 549  LSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPE 608
            +S N L G L  DIG LK ++ +D+S N LSG IP T+     L+ L L+ N   GPIP+
Sbjct: 504  VSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPD 563

Query: 609  SFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESF 668
               GL  L F+D+S NNLSGTIP+ M   S L++LNLS N  +G +PT G F   SA S 
Sbjct: 564  -IRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSV 622

Query: 669  LGNQALCGS-PKLQVSPCKT---RSHPRSRTTVVLLIVLPLVSALTMIVVLTAKLVRRRR 724
             GN  LCG  P LQ+ PC     R H   R  + + +   + + L + + +      + R
Sbjct: 623  FGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLR 682

Query: 725  RRRRRQKGSTRPYYDANMYP-QATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVL- 782
             +  R   +     D +  P ++ + +ISY +L + T GFS + L+G G+FG+V+KG L 
Sbjct: 683  VKSVRANNNEN---DRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLG 739

Query: 783  PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSN-----NDFKALVLE 837
                 +A KV ++   G+ +SF AEC+ +G IRHRNLVK+++ CS+     NDF+ALV E
Sbjct: 740  SKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYE 799

Query: 838  YMSNGSLEKCLYSD--------NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKP 889
            +M NG+L+  L+ D        +  L +  RL I IDVASAL YLH     PI HCDIKP
Sbjct: 800  FMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKP 859

Query: 890  SNVLLNESMVGHLSDFGIAKILGKEE------SMRQTKTLGTIGYMAPEYGREGKVSRKC 943
            SN+LL++ +  H+SDFG+A++L K +              GTIGY APEYG  G  S   
Sbjct: 860  SNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMG 919

Query: 944  DVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSA 1003
            DVYS+GI+L+E FT K+PT+++F   ++L  +   +L      ++ D  +L         
Sbjct: 920  DVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFN 979

Query: 1004 REQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043
              +C++ +F + + C+ + P  RISM +  ++LV IRE+ 
Sbjct: 980  MVECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIRESF 1019

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  536 bits (1380), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 373/1039 (35%), Positives = 536/1039 (51%), Gaps = 99/1039 (9%)

Query: 85   LTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSL 144
            L GTIP +LG L  L +L + NNS  G +P +L  +  L+Y     N     IP     L
Sbjct: 227  LNGTIPAELGRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADL 286

Query: 145  PRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGL 204
              LQ L L  N+  G+IPE    +S L +L L++N LSG++P SI     C N   LE L
Sbjct: 287  GNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSI-----CSNNTNLEQL 341

Query: 205  FISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPR----------------------- 241
             +S  QL+G IP  L KC+ L  + L+ N   G IP                        
Sbjct: 342  VLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLS 401

Query: 242  -DIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKEL 300
              I NLT+++ L L +N+L G++P EI  LR LEVL +  +  +G IP  I N ++LK +
Sbjct: 402  PSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMI 461

Query: 301  AVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLI 360
             +  N   G +P SI   L  L  L L +N   G +P+SL N  +L++LD   N  SG I
Sbjct: 462  DMFGNHFEGEIPPSIGR-LKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSI 520

Query: 361  PTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNF 420
            P++FG L+ L+ L L  N L    PD     SL S RNL  I LS N +NG +    G  
Sbjct: 521  PSSFGFLKGLEQLMLYNNSLQGNLPD-----SLISLRNLTRINLSHNRLNGTIHPLCG-- 573

Query: 421  SISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNN 480
            S S  S  + +      IP ELGN  NL  +RLG N+LTG IP TLG++++L  L + +N
Sbjct: 574  SSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSN 633

Query: 481  KLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWN 540
             L G+IP  L    +L ++ L +N LSG +P  LG L+ L +L L SN     +P+ L+N
Sbjct: 634  ALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFN 693

Query: 541  LKDILRFNLSSNSLNGSLLPDIGNLKV------------------------VIEMDLSLN 576
               +L  +L  NSLNGS+  +IGNL                          + E+ LS N
Sbjct: 694  CTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRN 753

Query: 577  ALSGVIPVTIGGLQGLQ-LLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSME 635
            +L+G IPV IG LQ LQ  L L YN   G IP + G L  L  +D+S+N L+G +P S+ 
Sbjct: 754  SLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVG 813

Query: 636  ALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSPKLQVSPC-KTRSHPR-- 692
             +  L +LN+SFN L G++  +  F  + A+SFLGN  LCGSP   +S C + RS+ +  
Sbjct: 814  DMKSLGYLNVSFNNLGGKLKKQ--FSRWPADSFLGNTGLCGSP---LSRCNRVRSNNKQQ 868

Query: 693  --SRTTVVLLIVLPLVSALTMIVVLTAKLVRRRRRRRRRQKGSTRPYYDANMYPQATWR- 749
              S  +VV++  +  ++A+ +++++ A   ++R    ++    +  Y  ++   QAT + 
Sbjct: 869  GLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKP 928

Query: 750  ---------RISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFD-G 799
                      I ++D++ AT   SE  ++G G  G VYK  L +G  +A K    + D  
Sbjct: 929  LFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLM 988

Query: 800  SLESFHAECKVMGSIRHRNLVKIISSCSNND--FKALVLEYMSNGSLEKCLYSD------ 851
            S +SF  E K +G IRHR+LVK++  CS+       L+ EYM NGS+   L+ D      
Sbjct: 989  SNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEK 1048

Query: 852  -NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI 910
                LD   RL+I + +A  +EYLH     PIVH DIK SNVLL+ +M  HL DFG+AK+
Sbjct: 1049 KKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKV 1108

Query: 911  LGKE---ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFA 967
            L +     +   T    + GY+APEY    K + K DVYS GI+LME  T K PTD +F 
Sbjct: 1109 LTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFG 1168

Query: 968  GEMSLKRWVGDSLLSCSITEVADANLLNCEEND-FSAREQCVSSIFSLAMDCTVDLPEKR 1026
             EM + RWV   L    +   A   L++ +        E     +  +A+ CT   P++R
Sbjct: 1169 AEMDMVRWVETHL---EVAGSARDKLIDPKLKPLLPFEEDAACQVLEIALQCTKTSPQER 1225

Query: 1027 ISMKDVANRLVRIRETLSA 1045
             S +   + L+ +    +A
Sbjct: 1226 PSSRQACDSLLHVYNNRTA 1244

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  530 bits (1365), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 379/1153 (32%), Positives = 595/1153 (51%), Gaps = 162/1153 (14%)

Query: 34   ALLALKEHIKHDPSNLLANNWSTTSSV--CSWIGVTCGVRNRRVTALNISYLGLTGTIPP 91
            AL + K  I +DP  +L++ W+   S+  C+W G+TC      V ++++    L G + P
Sbjct: 33   ALKSFKNGISNDPLGVLSD-WTIIGSLRHCNWTGITCD-STGHVVSVSLLEKQLEGVLSP 90

Query: 92   QLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLL 151
             + NL++L VL + +NSF G +P E+  L  L       N F   IPS    L  + +L 
Sbjct: 91   AIANLTYLQVLDLTSNSFTGKIPAEIGKLTELNQLILYLNYFSGSIPSGIWELKNIFYLD 150

Query: 152  LK------------------------HNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPS 187
            L+                        +N+  GKIPE +G L  LQ    + N L+G+IP 
Sbjct: 151  LRNNLLSGDVPEEICKTSSLVLIGFDYNNLTGKIPECLGDLVHLQMFVAAGNHLTGSIPV 210

Query: 188  SIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLT 247
            SI  +++  +L       +S NQLTG IP +      L  + L  N  +G IP +IGN +
Sbjct: 211  SIGTLANLTDLD------LSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNCS 264

Query: 248  SVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDL 307
            S+  L L +N L G+IP E+GNL  L+ L +  + L   IP+S+F ++ L  L +++N L
Sbjct: 265  SLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENHL 324

Query: 308  LGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNL 367
            +G +   I   L +LE L L  NNF+G  P S+TN+  L+VL  GFN+ SG +P   G L
Sbjct: 325  VGPISEEIGF-LESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGLL 383

Query: 368  RSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSIS---- 423
             +L+ LS   N+LT P P     SS+++C  L+++ LS N + G +P   G  +++    
Sbjct: 384  TNLRNLSAHDNLLTGPIP-----SSISNCTGLKLLDLSHNQMTGEIPRGFGRMNLTFISI 438

Query: 424  ------------------MKSLSMESCNISGG------------------------IPKE 441
                              +++LS+   N++G                         IP+E
Sbjct: 439  GRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPRE 498

Query: 442  LGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYL 501
            +GN+ +L ++ L +N  TG IP  +  L  LQGL + +N LEG IPE++  +  L+ L L
Sbjct: 499  IGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDL 558

Query: 502  GDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLK-----DI------------ 544
             +NK SG++PA    L SL  LSL  N     IP++L +L      DI            
Sbjct: 559  SNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGE 618

Query: 545  ---------LRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGG------- 588
                     L  N S+N L G++  ++G L++V E+DLS N  SG IP ++         
Sbjct: 619  LLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTL 678

Query: 589  ---------------LQGLQL---LSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTI 630
                            QG+ +   L+L  N   G IP+SFG +  L  +D+S+NNL+G I
Sbjct: 679  DFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEI 738

Query: 631  PKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSPKLQVSPC--KTR 688
            P+S+  LS LKHL L+ N L+G +P  G F   +A   +GN  LCGS K  + PC  K +
Sbjct: 739  PESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKPCTIKQK 797

Query: 689  SHPRSRTTVVLLIVL--PLVSALTMIVVLTAKLVRRRRRRRRRQKGSTRPYYDANMYPQA 746
            S   S+ T V+LI+L       L +++VL     +++ ++      S+ P  D+ +    
Sbjct: 798  SSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSAL---- 853

Query: 747  TWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHM-EFDGSLES-F 804
              +R   ++L +ATD F+   ++G  S  +VYKG L DG  IA KV ++ EF    +  F
Sbjct: 854  KLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWF 913

Query: 805  HAECKVMGSIRHRNLVKIIS-SCSNNDFKALVLEYMSNGSLEKCLYSDNYFL-DILQRLK 862
            + E K +  ++HRNLVKI+  +  +   KALVL +M NG+LE  ++     +  +L+++ 
Sbjct: 914  YTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKID 973

Query: 863  IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT 922
            + + +AS ++YLH GY  PIVHCD+KP+N+LL+   V H+SDFG A+ILG  E    T +
Sbjct: 974  LCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTAS 1033

Query: 923  L----GTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPT--DEIFAGEMSLKRWV 976
                 GTIGY+APE+    KV+ K DV+S+GI++ME  TK++PT  ++  + +M+L++ V
Sbjct: 1034 TSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLV 1093

Query: 977  GDSLLSCSITEVADANLLNCEENDFSA---REQCVSSIFSLAMDCTVDLPEKRISMKDVA 1033
              S+ +     V    +L+ E  D      +E+ +     L + CT   PE R  M ++ 
Sbjct: 1094 EKSIGNGRKGMV---RVLDMELGDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPDMNEIL 1150

Query: 1034 NRLVRIRETLSAY 1046
              L+++R   +++
Sbjct: 1151 THLMKLRGKANSF 1163

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  517 bits (1332), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 361/1046 (34%), Positives = 537/1046 (51%), Gaps = 105/1046 (10%)

Query: 85   LTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSL 144
            L G IP ++GN + LA+ A   N   GSLP EL+ L+ L+  +   N+F  EIPS    L
Sbjct: 204  LEGPIPAEIGNCTSLALFAAAFNRLNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDL 263

Query: 145  PRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISS---------- 194
              +Q+L L  N   G IP+ +  L+ LQ LDLS N L+G I    + ++           
Sbjct: 264  VSIQYLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNR 323

Query: 195  ---------CQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGN 245
                     C N   L+ LF+S  QL+G IP  +  C+ L ++ L+ N   G IP  +  
Sbjct: 324  LSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQ 383

Query: 246  LTSVRNLFLGNNSLIG------------------------EIPNEIGNLRNLEVLGVQSS 281
            L  + NL+L NNSL G                        ++P EIG L  LE++ +  +
Sbjct: 384  LVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYEN 443

Query: 282  NLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLT 341
              +G +P  I N + L+E+    N L G +PSSI   L +L RL L EN   G IP+SL 
Sbjct: 444  RFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGR-LKDLTRLHLRENELVGNIPASLG 502

Query: 342  NISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEI 401
            N  +++V+D   N  SG IP++FG L +L+L  +  N L    PD     SL + +NL  
Sbjct: 503  NCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPD-----SLINLKNLTR 557

Query: 402  IYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGT 461
            I  S N  NG +    G  S S  S  +      G IP ELG   NL  +RLG N+ TG 
Sbjct: 558  INFSSNKFNGSISPLCG--SSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGR 615

Query: 462  IPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLR 521
            IP T G++ +L  L +  N L G IP +L    +L ++ L +N LSG +P  LG L  L 
Sbjct: 616  IPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLG 675

Query: 522  DLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKV-------------- 567
            +L L SN     +P+ +++L +IL   L  NSLNGS+  +IGNL+               
Sbjct: 676  ELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGP 735

Query: 568  ----------VIEMDLSLNALSGVIPVTIGGLQGLQ-LLSLRYNRLQGPIPESFGGLKSL 616
                      + E+ LS NAL+G IPV IG LQ LQ  L L YN   G IP +   L  L
Sbjct: 736  LPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKL 795

Query: 617  NFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCG 676
              +D+S+N L G +P  +  +  L +LNLS+N LEG++  +  F  + A++F+GN  LCG
Sbjct: 796  ESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQ--FSRWQADAFVGNAGLCG 853

Query: 677  SPKLQVSPCKTRSHPRSRT----TVVLLIVLPLVSALTMIVVLTAKLVRRRRRRRRRQKG 732
            SP   +S C        R+    TVV++  +  ++A+ ++V++     ++     ++ +G
Sbjct: 854  SP---LSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRG 910

Query: 733  STRPYYDANMYPQA-------TWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDG 785
                +   +   QA           I + D++ AT   +E  ++G G  G VYK  L +G
Sbjct: 911  GNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNG 970

Query: 786  MEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSN--NDFKALVLEYMSNG 842
              IA K    + D  S +SF+ E K +G+IRHR+LVK++  CS+  +    L+ EYM+NG
Sbjct: 971  ETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANG 1030

Query: 843  SLEKCLYSD-----NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES 897
            S+   L+++        L    RLKI + +A  +EYLH+    PIVH DIK SNVLL+ +
Sbjct: 1031 SVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSN 1090

Query: 898  MVGHLSDFGIAKIL-GKEESMRQTKTL--GTIGYMAPEYGREGKVSRKCDVYSYGIMLME 954
            +  HL DFG+AKIL G  ++  ++ T+  G+ GY+APEY    K + K DVYS GI+LME
Sbjct: 1091 IEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLME 1150

Query: 955  TFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE-ENDFSAREQCVSSIFS 1013
              T K PT+ +F  E  + RWV +++L       A   L++ E ++     E+    +  
Sbjct: 1151 IVTGKMPTEAMFDEETDMVRWV-ETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLE 1209

Query: 1014 LAMDCTVDLPEKRISMKDVANRLVRI 1039
            +A+ CT   P++R S +  +  L+ +
Sbjct: 1210 IALQCTKSYPQERPSSRQASEYLLNV 1235

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  483 bits (1242), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 360/1071 (33%), Positives = 540/1071 (50%), Gaps = 91/1071 (8%)

Query: 35   LLALKEHIKHDPSNLLANNWSTTSSV-CSWIGVTCG--VRNRRVTALNISYLGLTGTIPP 91
            LL +K        NL   NW++  SV C W GV C     +  V +LN+S + L+G + P
Sbjct: 34   LLEIKSKFVDAKQNL--RNWNSNDSVPCGWTGVMCSNYSSDPEVLSLNLSSMVLSGKLSP 91

Query: 92   QLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLL 151
             +G L  L  L +  N   G +P+E+ +   L+      N F  EIP     L  L++L+
Sbjct: 92   SIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLI 151

Query: 152  LKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFN-------------------- 191
            + +N   G +P  IG L  L +L    N +SG +P SI N                    
Sbjct: 152  IYNNRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPS 211

Query: 192  -ISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVR 250
             I  C++L V+ GL  + NQL+G +P  +   ++L  V L  N+F G IPR+I N TS+ 
Sbjct: 212  EIGGCESL-VMLGL--AQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLE 268

Query: 251  NLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGS 310
             L L  N L+G IP E+G+L++LE L +  + L G IP  I N+S   E+  ++N L G 
Sbjct: 269  TLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGE 328

Query: 311  LPSSIDLG-LPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRS 369
            +P  ++LG +  LE L+L EN  +GTIP  L+ +  LS LD   N+ +G IP  F  LR 
Sbjct: 329  IP--LELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRG 386

Query: 370  LKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSM 429
            L +L L  N L+   P       L    +L ++ +S+N ++G +PS +   S +M  L++
Sbjct: 387  LFMLQLFQNSLSGTIP-----PKLGWYSDLWVLDMSDNHLSGRIPSYLCLHS-NMIILNL 440

Query: 430  ESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPED 489
             + N+SG IP  +     L  +RL  N L G  P  L +   +  + L  N+  GSIP +
Sbjct: 441  GTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPRE 500

Query: 490  LCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNL 549
            + +   L  L L DN  +G LP  +G L+ L  L++ SN LT  +PS ++N K + R ++
Sbjct: 501  VGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDM 560

Query: 550  SSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQ------------------- 590
              N+ +G+L  ++G+L  +  + LS N LSG IPV +G L                    
Sbjct: 561  CCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRE 620

Query: 591  -----GLQL-LSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLN 644
                 GLQ+ L+L YN+L G IP     L  L F+ ++NNNLSG IP S   LS L   N
Sbjct: 621  LGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYN 680

Query: 645  LSFNQLEGEIPTRGPFITFSAESFLGNQALCGSPKLQV------SPCKTRSHPRS-RTTV 697
             S+N L G IP        S  SF+GN+ LCG P  Q       +P ++   P   R++ 
Sbjct: 681  FSYNSLTGPIPL---LRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSK 737

Query: 698  VLLIVLPLVSALT-MIVVLTAKLVRRRRRRRRRQKGSTRP---YYDANMYPQATWRRISY 753
            ++ I   ++  ++ M++ L   L+RR  R         +P     D    P+  +   ++
Sbjct: 738  IIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGF---TF 794

Query: 754  QDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGS-----LESFHAEC 808
            QDL+ ATD F E+ ++G G+ G+VYK VLP G  +A K      +G        SF AE 
Sbjct: 795  QDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEI 854

Query: 809  KVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVA 868
              +G+IRHRN+VK+   C++     L+ EYM  GSL + L+  +  LD  +R KI +  A
Sbjct: 855  LTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSCNLDWSKRFKIALGAA 914

Query: 869  SALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGY 928
              L YLH      I H DIK +N+LL++    H+ DFG+AK++    S   +   G+ GY
Sbjct: 915  QGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGY 974

Query: 929  MAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITE- 987
            +APEY    KV+ K D+YSYG++L+E  T K P   I  G   +  WV   +   +++  
Sbjct: 975  IAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGG-DVVNWVRSYIRRDALSSG 1033

Query: 988  VADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVR 1038
            V DA L   +E   S     + ++  +A+ CT   P  R SM+ V   L+ 
Sbjct: 1034 VLDARLTLEDERIVSH----MLTVLKIALLCTSVSPVARPSMRQVVLMLIE 1080

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  473 bits (1218), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 359/1098 (32%), Positives = 537/1098 (48%), Gaps = 124/1098 (11%)

Query: 25   VTNVTTDQFALLALKEHIKHDPSNLLANNWSTTSSVCSWIGVTCGVRNRRVTALNISYLG 84
            V ++  +   LL  K  + +D +  LA+     S+ C+W G+ C    R VT+++++ + 
Sbjct: 21   VRSLNEEGRVLLEFKAFL-NDSNGYLASWNQLDSNPCNWTGIAC-THLRTVTSVDLNGMN 78

Query: 85   LTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSL 144
            L+GT+ P +  L  L  L +  N   G +P++LS  R L+  D   N FH          
Sbjct: 79   LSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFH---------- 128

Query: 145  PRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGL 204
                          G IP  +  +  L++L L +N L G+IP  I N+SS Q L      
Sbjct: 129  --------------GVIPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQEL------ 168

Query: 205  FISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIP 264
             I  N LTG IP ++ K R+L ++    N F G IP +I    S++ L L  N L G +P
Sbjct: 169  VIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAENLLEGSLP 228

Query: 265  NEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLER 324
             ++  L+NL  L +  + L+G IP S+ NIS L+ LA+ +N   GS+P  I   L  ++R
Sbjct: 229  KQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIG-KLTKMKR 287

Query: 325  LFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPT 384
            L+L  N  +G IP  + N+ + + +DF  N  +G IP  FG++ +LKLL L  N+L  P 
Sbjct: 288  LYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPI 347

Query: 385  P----DLSFLSSLTSCRN---------------LEIIYLSENPINGILPSSIGNFSISMK 425
            P    +L+ L  L    N               L  + L +N + G +P  IG +S +  
Sbjct: 348  PRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYS-NFS 406

Query: 426  SLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGS 485
             L M + ++SG IP        L ++ LG+N+L+G IP  L   + L  L L +N+L GS
Sbjct: 407  VLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGS 466

Query: 486  IPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDIL 545
            +P +L +L  L  L L  N LSG + A LG L +L  L L +N  T  IP  + NL  I+
Sbjct: 467  LPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIV 526

Query: 546  RFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGP 605
             FN+SSN L G +  ++G+   +  +DLS N  SG I   +G L  L++L L  NRL G 
Sbjct: 527  GFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGE 586

Query: 606  IPESFGGLKSLN-------------------------FVDMSNNNLSGTIPKSMEALSYL 640
            IP SFG L  L                           +++S+NNLSGTIP S+  L  L
Sbjct: 587  IPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQML 646

Query: 641  KHLNLSFNQLEGEIPTR------------------------GPFITFSAESFLGNQALCG 676
            + L L+ N+L GEIP                            F    + +F GN  LC 
Sbjct: 647  EILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCN 706

Query: 677  SPKLQVSPCKTRSHPR-------SRTTVVLLIVLPLVSALTMIVVL-TAKLVRRRRRRRR 728
            S +    P    S  +       S+   +L I   ++ ++ +I  L     ++RR     
Sbjct: 707  SQRSHCQPLVPHSDSKLNWLINGSQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFV 766

Query: 729  RQKGSTRP-YYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGME 787
              +  T+P   D+  +P+   +  +YQ L+ AT  FSE+ +LG G+ G+VYK  +  G  
Sbjct: 767  ALEDQTKPDVMDSYYFPK---KGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEV 823

Query: 788  IAAKVFHMEFDG--SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLE 845
            IA K  +   +G  S  SF AE   +G IRHRN+VK+   C + +   L+ EYMS GSL 
Sbjct: 824  IAVKKLNSRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLG 883

Query: 846  KCLY--SDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLS 903
            + L     N  LD   R +I +  A  L YLH      IVH DIK +N+LL+E    H+ 
Sbjct: 884  EQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVG 943

Query: 904  DFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTD 963
            DFG+AK++    S   +   G+ GY+APEY    KV+ KCD+YS+G++L+E  T K P  
Sbjct: 944  DFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQ 1003

Query: 964  EIFAGEMSLKRWVGDSLLSCSIT-EVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDL 1022
             +  G   L  WV  S+ +   T E+ DA L   + ND     + +S +  +A+ CT + 
Sbjct: 1004 PLEQGG-DLVNWVRRSIRNMIPTIEMFDARL---DTNDKRTVHE-MSLVLKIALFCTSNS 1058

Query: 1023 PEKRISMKDVANRLVRIR 1040
            P  R +M++V   +   R
Sbjct: 1059 PASRPTMREVVAMITEAR 1076

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P93194|RPK1_IPONI Receptor-like protein kinase OS=Ipomoea nil GN=INRPK1 PE=2 SV=2

 Score =  473 bits (1217), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 368/1134 (32%), Positives = 550/1134 (48%), Gaps = 155/1134 (13%)

Query: 12   LLHCLMLSSVMAAVTNVTTDQFALLALKEHIKHDPSNLLANNWSTTSSVCSWIGVTCGVR 71
            LL     SS+ AA   + +D  ALL+L  H    PS++  +  ++ S+ CSW+GV C  R
Sbjct: 9    LLFLCSTSSIYAAFA-LNSDGAALLSLTRHWTSIPSDITQSWNASDSTPCSWLGVECD-R 66

Query: 72   NRRVTALNISYLGLTG------------------------TIPPQLGNLSFLAVLAIRNN 107
             + V  LN+S  G++G                        +IP QLGN S L  + + +N
Sbjct: 67   RQFVDTLNLSSYGISGEFGPEISHLKHLKKVVLSGNGFFGSIPSQLGNCSLLEHIDLSSN 126

Query: 108  SFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGY 167
            SF G++P+ L  L+ L+     FN+     P   +S+P L+ +    N   G IP  IG 
Sbjct: 127  SFTGNIPDTLGALQNLRNLSLFFNSLIGPFPESLLSIPHLETVYFTGNGLNGSIPSNIGN 186

Query: 168  LSLLQELDLSDNQLSGTIPSSIFNISSCQN-----------LPV----LEGLF---ISYN 209
            +S L  L L DNQ SG +PSS+ NI++ Q            LPV    LE L    +  N
Sbjct: 187  MSELTTLWLDDNQFSGPVPSSLGNITTLQELYLNDNNLVGTLPVTLNNLENLVYLDVRNN 246

Query: 210  QLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVR------------------- 250
             L G IP +   C+++  +SL+ N+F GG+P  +GN TS+R                   
Sbjct: 247  SLVGAIPLDFVSCKQIDTISLSNNQFTGGLPPGLGNCTSLREFGAFSCALSGPIPSCFGQ 306

Query: 251  -----------------------------NLFLGNNSLIGEIPNEIGNLRNLEVLGVQSS 281
                                         +L L  N L GEIP E+G L  L+ L + ++
Sbjct: 307  LTKLDTLYLAGNHFSGRIPPELGKCKSMIDLQLQQNQLEGEIPGELGMLSQLQYLHLYTN 366

Query: 282  NLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLG-LPNLERLFLGENNFSGTIPSSL 340
            NL+G +P SI+ I +L+ L +  N+L G LP  +D+  L  L  L L EN+F+G IP  L
Sbjct: 367  NLSGEVPLSIWKIQSLQSLQLYQNNLSGELP--VDMTELKQLVSLALYENHFTGVIPQDL 424

Query: 341  TNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLE 400
               S L VLD   N F+G IP    + + LK L L  N L    P     S L  C  LE
Sbjct: 425  GANSSLEVLDLTRNMFTGHIPPNLCSQKKLKRLLLGYNYLEGSVP-----SDLGGCSTLE 479

Query: 401  IIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTG 460
             + L EN + G LP  +   ++    LS    N +G IP  LGN+ N+T I L +N+L+G
Sbjct: 480  RLILEENNLRGGLPDFVEKQNLLFFDLSGN--NFTGPIPPSLGNLKNVTAIYLSSNQLSG 537

Query: 461  TIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSL 520
            +IP  LG L KL+ L L +N L+G +P +L + ++L+ L    N L+G +P+ LG+LT L
Sbjct: 538  SIPPELGSLVKLEHLNLSHNILKGILPSELSNCHKLSELDASHNLLNGSIPSTLGSLTEL 597

Query: 521  RDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSG 580
              LSLG N+ +  IP++L+    +L   L  N L G  +P +G L+ +  ++LS N L+G
Sbjct: 598  TKLSLGENSFSGGIPTSLFQSNKLLNLQLGGNLLAGD-IPPVGALQALRSLNLSSNKLNG 656

Query: 581  VIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYL 640
             +P+ +G L+ L+ L + +N L G +      ++SL F+++S+N  SG +P S+      
Sbjct: 657  QLPIDLGKLKMLEELDVSHNNLSGTL-RVLSTIQSLTFINISHNLFSGPVPPSLTK---- 711

Query: 641  KHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALC--------GSPKLQV-SPCKTRSHP 691
                               F+  S  SF GN  LC          P+  +  PC  +S+ 
Sbjct: 712  -------------------FLNSSPTSFSGNSDLCINCPADGLACPESSILRPCNMQSNT 752

Query: 692  RSRTTVVLLIVLPLVSALTMIVVLTAKLVRRRRRRRR--RQKGSTRPYYDANMYPQATWR 749
                   L I + ++ AL  I+ L           ++  ++   +    D ++       
Sbjct: 753  GKGGLSTLGIAMIVLGALLFIICLFLFSAFLFLHCKKSVQEIAISAQEGDGSL------- 805

Query: 750  RISYQDLLRATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAEC 808
                  +L AT+  ++  ++G G+ G++YK  L PD +    K+          S   E 
Sbjct: 806  ---LNKVLEATENLNDKYVIGKGAHGTIYKATLSPDKVYAVKKLVFTGIKNGSVSMVREI 862

Query: 809  KVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDN--YFLDILQRLKIMID 866
            + +G +RHRNL+K+       ++  ++  YM NGSL   L+  N    LD   R  I + 
Sbjct: 863  ETIGKVRHRNLIKLEEFWLRKEYGLILYTYMENGSLHDILHETNPPKPLDWSTRHNIAVG 922

Query: 867  VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GT 925
             A  L YLHF     IVH DIKP N+LL+  +  H+SDFGIAK+L +  +   + T+ GT
Sbjct: 923  TAHGLAYLHFDCDPAIVHRDIKPMNILLDSDLEPHISDFGIAKLLDQSATSIPSNTVQGT 982

Query: 926  IGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSC-S 984
            IGYMAPE       SR+ DVYSYG++L+E  T+KK  D  F GE  +  WV         
Sbjct: 983  IGYMAPENAFTTVKSRESDVYSYGVVLLELITRKKALDPSFNGETDIVGWVRSVWTQTGE 1042

Query: 985  ITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVR 1038
            I ++ D +LL+ E  D S  EQ V+   SLA+ C     +KR +M+DV  +L R
Sbjct: 1043 IQKIVDPSLLD-ELIDSSVMEQ-VTEALSLALRCAEKEVDKRPTMRDVVKQLTR 1094

Possible role in short-day photoperiod floral induction.

Ipomoea nil (taxid: 35883)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1

 Score =  471 bits (1212), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 354/1118 (31%), Positives = 542/1118 (48%), Gaps = 114/1118 (10%)

Query: 16   LMLSSVMAAVTNVTTDQFALLALKEHIKHDPSNLLANNWSTTSSVCSWIGVTC------- 68
             +L+ ++    ++ +D   LL LK     D  N L N      + C+WIGV C       
Sbjct: 21   FLLTLLVWTSESLNSDGQFLLELKNRGFQDSLNRLHNWNGIDETPCNWIGVNCSSQGSSS 80

Query: 69   ------------------GVRNRRVTAL------NISYLGLTGTIPPQLGNLSFLAVLAI 104
                              G+ +  +  L      N++Y  LTG IP ++GN S L V+ +
Sbjct: 81   SSNSLVVTSLDLSSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFL 140

Query: 105  RNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPET 164
             NN F GS+P E++ L  L+ F+   N     +P     L  L+ L+   N+  G +P +
Sbjct: 141  NNNQFGGSIPVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRS 200

Query: 165  IGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRE 224
            +G L+ L       N  SG IP+ I     C NL +L    ++ N ++G +P  +    +
Sbjct: 201  LGNLNKLTTFRAGQNDFSGNIPTEI---GKCLNLKLLG---LAQNFISGELPKEIGMLVK 254

Query: 225  LHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLA 284
            L  V L  NKF G IP+DIGNLTS+  L L  NSL+G IP+EIGN+++L+ L +  + L 
Sbjct: 255  LQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLN 314

Query: 285  GLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNIS 344
            G IP  +  +S + E+  ++N L G +P  +   +  L  L+L +N  +G IP+ L+ + 
Sbjct: 315  GTIPKELGKLSKVMEIDFSENLLSGEIPVELS-KISELRLLYLFQNKLTGIIPNELSKLR 373

Query: 345  ELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYL 404
             L+ LD   NS +G IP  F NL S++ L L  N L+   P       L     L ++  
Sbjct: 374  NLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQ-----GLGLYSPLWVVDF 428

Query: 405  SENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPV 464
            SEN ++G +P  I   S ++  L++ S  I G IP  +    +L  +R+  N LTG  P 
Sbjct: 429  SENQLSGKIPPFICQQS-NLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPT 487

Query: 465  TLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLS 524
             L +L  L  + L  N+  G +P ++    +L  L+L  N+ S  LP  +  L++L   +
Sbjct: 488  ELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFN 547

Query: 525  LGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPD----------------------- 561
            + SN+LT  IPS + N K + R +LS NS  GSL P+                       
Sbjct: 548  VSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPF 607

Query: 562  -IGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQL-LSLRYNRLQGPIPESFGGLKSLNFV 619
             IGNL  + E+ +  N  SG IP  +G L  LQ+ ++L YN   G IP   G L  L ++
Sbjct: 608  TIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYL 667

Query: 620  DMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCG--- 676
             ++NN+LSG IP + E LS L   N S+N L G++P    F   +  SFLGN+ LCG   
Sbjct: 668  SLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHL 727

Query: 677  -------SPKLQVSPCKTRSHPRSRTTVV---------LLIVLPLVSALTMIVVLTAKLV 720
                   S    +S  K  S  R R  ++         LL++  +V  L   V  TA  V
Sbjct: 728  RSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYV 787

Query: 721  RRRRRRRRRQKGSTRPYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKG 780
              +            P++  +        R + +D+L AT GF ++ ++G G+ G+VYK 
Sbjct: 788  HDKE-----------PFFQESDIYFVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKA 836

Query: 781  VLPDGMEIAAKVFHMEFDGSLES-------FHAECKVMGSIRHRNLVKIISSCSNNDFKA 833
            V+P G  IA K      +G+  +       F AE   +G IRHRN+V++ S C +    +
Sbjct: 837  VMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNS 896

Query: 834  --LVLEYMSNGSLEKCLYS-DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPS 890
              L+ EYMS GSL + L+   ++ +D   R  I +  A  L YLH      I+H DIK +
Sbjct: 897  NLLLYEYMSRGSLGELLHGGKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSN 956

Query: 891  NVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGI 950
            N+L++E+   H+ DFG+AK++    S   +   G+ GY+APEY    KV+ KCD+YS+G+
Sbjct: 957  NILIDENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGV 1016

Query: 951  MLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSIT-EVADANLLNCEENDFSAREQCVS 1009
            +L+E  T K P   +  G   L  W  + +   S+T E+ D  L   E++        V+
Sbjct: 1017 VLLELLTGKAPVQPLEQGG-DLATWTRNHIRDHSLTSEILDPYLTKVEDDVILNHMITVT 1075

Query: 1010 SIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYI 1047
             I   A+ CT   P  R +M++V   L+   E     I
Sbjct: 1076 KI---AVLCTKSSPSDRPTMREVVLMLIESGERAGKVI 1110

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	1049
359483198	1087	PREDICTED: probable LRR receptor-like se	0.986	0.952	0.518	0.0
255572272	1089	serine-threonine protein kinase, plant-t	0.954	0.919	0.514	0.0
449465016	1092	PREDICTED: probable LRR receptor-like se	0.965	0.927	0.497	0.0
255578886	1043	serine-threonine protein kinase, plant-t	0.971	0.976	0.517	0.0
359483685	1046	PREDICTED: LRR receptor-like serine/thre	0.938	0.941	0.493	0.0
359497186	1140	PREDICTED: LRR receptor-like serine/thre	0.956	0.879	0.464	0.0
359483677	1229	PREDICTED: LRR receptor-like serine/thre	0.914	0.780	0.498	0.0
147776333	1205	hypothetical protein VITISV_000078 [Viti	0.911	0.793	0.509	0.0
224116832	1061	predicted protein [Populus trichocarpa]	0.899	0.889	0.497	0.0
224139658	1019	predicted protein [Populus trichocarpa]	0.951	0.979	0.486	0.0

>gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score = 1021 bits (2641), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 565/1090 (51%), Positives = 736/1090 (67%), Gaps = 55/1090 (5%)

Query: 4    FMIITLVPLLHCLMLSSVMAAVTNVTTDQFALLALKEHIKHDPSNLLANNWSTTSSVCSW 63
            F++ + +  +  +  S+ +A   +  TDQ +LLALK HI  DP ++LA NWST +S C W
Sbjct: 5    FLLSSTIISVFIVQFSACVAMSLSNFTDQSSLLALKAHITLDPHHVLAGNWSTKTSFCEW 64

Query: 64   IGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGL 123
            IGV+C  + +RV AL++S LGL GTIPP LGNLSFL  L + +N+F G +P E+  L  L
Sbjct: 65   IGVSCNAQQQRVIALDLSNLGLRGTIPPDLGNLSFLVSLDLSSNNFHGPVPVEVGQLTSL 124

Query: 124  KYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQEL--------- 174
               + ++N    +IP  F +L RLQ L L +NSF G IP +IG +S+L+ L         
Sbjct: 125  LSMNLQYNLLSGQIPPSFGNLNRLQSLFLGNNSFTGTIPPSIGNMSMLETLGLGGNHLQG 184

Query: 175  ---------------DLSDNQLSGTIPSSIFNISSCQN--------------------LP 199
                           D+  NQL G IPS+IFNISS Q                     L 
Sbjct: 185  NIPEEIGKLSTMKILDIQSNQLVGAIPSAIFNISSLQEIALTYNSLSGDLPSSMCNHELS 244

Query: 200  VLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSL 259
             L G+ +S N+ TGPIP+NL KC EL  + L+FNKF GGIPR I +LT +  L L  NSL
Sbjct: 245  ALRGIRLSANRFTGPIPSNLSKCGELQTLYLSFNKFTGGIPRSIDSLTKLTMLSLAANSL 304

Query: 260  IGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGL 319
             GE+P EIG+L  L VL ++ ++L G IP  IFNIS++   ++T N+L G+LP +    L
Sbjct: 305  SGEVPCEIGSLCTLNVLNIEDNSLTGHIPFQIFNISSMVSGSLTRNNLSGNLPPNFGSYL 364

Query: 320  PNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNV 379
            PNLE L L  N  SG IPSS+ N S+L  LDFG+N  +G IP   G+LR L+ L+L  N 
Sbjct: 365  PNLENLILEINWLSGIIPSSIGNASKLRSLDFGYNMLTGSIPHALGSLRFLERLNLGVNN 424

Query: 380  LT--SPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGG 437
            L   S   +LSFL+SLT+C+ L I+YLS NP+ GILP SIGN S S++     +C + G 
Sbjct: 425  LKGESYIQELSFLTSLTNCKRLRILYLSFNPLIGILPISIGNLSTSLQRFEANTCKLKGN 484

Query: 438  IPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLA 497
            IP E+GN++NL ++ L NN+LTGTIP ++G+LQKLQGLYL +NKL+GSIP D+C L  L 
Sbjct: 485  IPTEIGNLSNLYLLSLNNNDLTGTIPPSIGQLQKLQGLYLPSNKLQGSIPNDICQLRNLG 544

Query: 498  NLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGS 557
             L+L +N+LSG +PACLG LT LR L LGSN L S IPSTLW+L  IL  ++SSN L G 
Sbjct: 545  ELFLTNNQLSGSIPACLGELTFLRHLYLGSNKLNSTIPSTLWSLIHILSLDMSSNFLVGY 604

Query: 558  LLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLN 617
            L  D+GNLKV++++DLS N LSG IP  IGGLQ L  LSL +NR +GPI  SF  LKSL 
Sbjct: 605  LPSDMGNLKVLVKIDLSRNQLSGEIPSNIGGLQDLTSLSLAHNRFEGPILHSFSNLKSLE 664

Query: 618  FVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGS 677
            F+D+S+N L G IPKS+E L YLK+L++SFN L GEIP  GPF  FSAESF+ N+ALCGS
Sbjct: 665  FMDLSDNALFGEIPKSLEGLVYLKYLDVSFNGLYGEIPPEGPFANFSAESFMMNKALCGS 724

Query: 678  PKLQVSPCKTRSHPRSRTTVVLLIVLPLVSALTMIVVLTAKLVRRRRRRRRRQKGSTRPY 737
            P+L++ PC+T +  R  TT+  L++  ++ A+   ++  A +    R R+R    +  P 
Sbjct: 725  PRLKLPPCRTGT--RWSTTISWLLLKYILPAILSTLLFLALIFVWTRCRKRN---AVLPT 779

Query: 738  YDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEF 797
               ++   ATWRRISYQ++ +AT+GFS   LLG GS GSVY+G L DG   A KVF+++ 
Sbjct: 780  QSESLL-TATWRRISYQEIFQATNGFSAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQE 838

Query: 798  DGSLESFHAECKVMGSIRHRNLVKIISSCSNN--DFKALVLEYMSNGSLEKCLYSDNYFL 855
            + + +SF AEC+VM  IRHRNL+KI+SSCSN+  DFKALVLEY+ NGSLE+ LYS NY L
Sbjct: 839  EAAFKSFDAECEVMHHIRHRNLIKIVSSCSNSYIDFKALVLEYVPNGSLERWLYSHNYCL 898

Query: 856  DILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE 915
            DILQRL IMIDVA A+EYLH G STP+VHCD+KPSN+LL+E   GH+ DFGIAK+L +EE
Sbjct: 899  DILQRLNIMIDVALAMEYLHHGCSTPVVHCDLKPSNILLDEDFGGHVGDFGIAKLLREEE 958

Query: 916  SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRW 975
            S+R+T+TL TIGYMAP+Y   G V+   DVYSYGI+LMETFT+++PTDEIF+ EMS+K W
Sbjct: 959  SIRETQTLATIGYMAPKYVSNGIVTTSGDVYSYGIVLMETFTRRRPTDEIFSEEMSMKNW 1018

Query: 976  VGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035
            V D L   SITEV DANLL  E+  F A++QC+S I  LAMDC  D PE+RI MKDV   
Sbjct: 1019 VWDWLCG-SITEVVDANLLRGEDEQFMAKKQCISLILGLAMDCVADSPEERIKMKDVVTT 1077

Query: 1036 LVRIRETLSA 1045
            L +I+  +S+
Sbjct: 1078 LKKIKTHISS 1087

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score = 1011 bits (2615), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 545/1059 (51%), Positives = 718/1059 (67%), Gaps = 58/1059 (5%)

Query: 30   TDQFALLALKEHIKHDPSNLLANNWSTTSSVCSWIGVTCGVRNRRVTALNISYLGLTGTI 89
            TD  ALL LKEH   DP   ++ NWS+ +S C W GVTC  R+ RV AL +S +G+ G +
Sbjct: 30   TDLSALLVLKEHSNFDP--FMSKNWSSATSFCHWYGVTCSERHNRVVALTLSNMGIKGIV 87

Query: 90   PPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQH 149
            PP +GNLSFL  + + NNS+ G LP EL +L  LK+ +F  N+F  EIPS    LP+LQH
Sbjct: 88   PPHIGNLSFLVHIDMSNNSYSGHLPNELGNLHRLKFMNFSNNSFVGEIPSSLAMLPKLQH 147

Query: 150  LLLKHNSFV-----------------------GKIPETIG-YLSLLQELDLSDNQLSGTI 185
            LLL +NS                         G I + IG  LS LQ L++  NQLSG+ 
Sbjct: 148  LLLANNSLTAGRSSIFNITTLNTLDLNDNLLGGNILDNIGGNLSNLQVLNMGLNQLSGSF 207

Query: 186  PSSIFNISS-------------------CQNLPVLEGLFISYNQLTGPIPTNLWKCRELH 226
            P  I ++ S                   C     L+ L ++ NQL G IP++L+KC+EL 
Sbjct: 208  PPKILDLPSLKFIYLQVNNLSGNLKEILCNQNSKLQLLNLAGNQLYGQIPSDLYKCKELR 267

Query: 227  VVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGL 286
             ++L  NKF G IPR IGNLT ++ L LG N+L G IP EIGNL+NL+++ +  +NL G 
Sbjct: 268  SLALHANKFTGSIPRTIGNLTKLKWLSLGRNNLTGRIPLEIGNLQNLQIVHLSFNNLNGS 327

Query: 287  IPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISEL 346
            IP ++FNIST+K +A+T N+LLG+LP+S+ L LPNL  L+LG N  SG IPS ++N S+L
Sbjct: 328  IPHALFNISTMKWIAMTSNNLLGNLPTSLGLHLPNLIWLYLGINKLSGPIPSYISNASKL 387

Query: 347  SVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSP--TPDLSFLSSLTSCRNLEIIYL 404
            ++L+   NSF+G IP + G+LR+L+ L L  N+L+S   + +L+  SSL +C+NL+ ++L
Sbjct: 388  TILELPSNSFTGFIPDSLGDLRNLQTLKLGANLLSSKKTSQELTIFSSLKNCQNLKYLWL 447

Query: 405  SENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPV 464
            S NP++G LP S+GN S S++S       I G + + +GN+++LT + LGNN+LTG IP 
Sbjct: 448  SYNPLDGYLPHSVGNLSNSLESFLASDGLIKGSVHESIGNLSSLTRLNLGNNDLTGRIPT 507

Query: 465  TLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLS 524
            T+G L+ LQGLYL  N L+GSIP +LC L  L NL L  NKLSG +P C  NLTSLR+L 
Sbjct: 508  TIGTLKHLQGLYLHGNDLDGSIPSELCDLRTLYNLELTGNKLSGSIPTCFSNLTSLRNLF 567

Query: 525  LGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPV 584
            L SN   S I STLW LKDIL+ NL+SN L GSL  +I NL+ V  +++S N LSG IP+
Sbjct: 568  LASNRFVSTISSTLWTLKDILQVNLASNYLTGSLPSEIENLRAVYMINISKNQLSGEIPI 627

Query: 585  TIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLN 644
            +IGGLQ L  L L  N+LQGPIP+S G +KSL F+D+S+NNLSG IPKS++ L YLK+ N
Sbjct: 628  SIGGLQDLAQLYLSGNKLQGPIPQSVGDIKSLEFLDLSSNNLSGMIPKSLDNLLYLKYFN 687

Query: 645  LSFNQLEGEIPTRGPFITFSAESFLGNQALCGSPKLQVSPCK---TRSHPRSRTTVVLLI 701
            +SFN L+GEIP  G F  FSA+SF+GN+ALCGS +LQVSPCK   +R+     + +VL  
Sbjct: 688  VSFNYLQGEIPEGGSFSNFSAQSFIGNEALCGSARLQVSPCKDDNSRATETPGSKIVLRY 747

Query: 702  VLPLVSALTMIVVLTAKLVRRRRRRRRRQKGSTRPYYDANMYPQATWRRISYQDLLRATD 761
            VLP   A+   V + A ++  +R   R+ K S    + A      T RRISY +L  AT+
Sbjct: 748  VLP---AIVFAVFVLAFVIMLKRYCERKAKFSIEDDFLA----LTTIRRISYHELQLATN 800

Query: 762  GFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVK 821
            GF E+  LGMGSFGSVYKG L DG  IAAKVF+++ + + +SF  EC+V+ ++RHRNLVK
Sbjct: 801  GFQESNFLGMGSFGSVYKGTLSDGTVIAAKVFNLQLERAFKSFDTECEVLRNLRHRNLVK 860

Query: 822  IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
            II+SCS  +FKALVLE+M N SLEK LYSD+YFL+ LQRL IM+DVAS LEYLH GY+ P
Sbjct: 861  IITSCSGPNFKALVLEFMPNWSLEKWLYSDDYFLNNLQRLNIMLDVASVLEYLHHGYTIP 920

Query: 882  IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSR 941
            + HCDIKPSNVLLNE MV  L+DFGI+K+LG+E S+ QT TL TIGYMAPEYG EG VS 
Sbjct: 921  MAHCDIKPSNVLLNEDMVAFLADFGISKLLGEEGSVMQTMTLATIGYMAPEYGSEGIVSV 980

Query: 942  KCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDF 1001
            + DVYSYG++LMETFT+KKPTD++F  ++SLK WV  S LSC +T+V DANLL  EE+  
Sbjct: 981  RGDVYSYGVLLMETFTQKKPTDKMFTEQLSLKSWVEQS-LSCEVTQVIDANLLGIEEDHL 1039

Query: 1002 SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIR 1040
            +A++ C+ SI  LA+ C+ DLP  RI MK V   L +I+
Sbjct: 1040 AAKKDCIVSILKLALQCSADLPHDRIDMKHVVTTLQKIK 1078

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449465016|ref|XP_004150225.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus]

 Score =  999 bits (2583), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 548/1101 (49%), Positives = 729/1101 (66%), Gaps = 88/1101 (7%)

Query: 22   MAAVTNVTTDQFALLALKEHIKHDPSNLLANNWSTTSSVCSWIGVTCGVRNRRVTALNIS 81
            MA   N+TTDQ ALLAL+ HI  DP  +  NNWS T+SVC+W+G+ CGV+++RVT+LN S
Sbjct: 1    MAFAQNITTDQAALLALRAHITSDPFGITTNNWSATTSVCNWVGIICGVKHKRVTSLNFS 60

Query: 82   YLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWF 141
            ++GLTGT PP++G LSFL  + I+NNSF   LP EL++L  LK      NNF  EIP+W 
Sbjct: 61   FMGLTGTFPPEVGTLSFLTYVTIKNNSFHDPLPIELTNLPRLKMMSLGNNNFSGEIPTWI 120

Query: 142  VSLPRLQHLLLKHNSFVG------------------------KIPETIGYLSLLQELDLS 177
              LPR++ L L  N F G                         IP  IG L+LLQ+L L+
Sbjct: 121  GRLPRMEELYLYGNQFSGLIPTSLFNLTSLIMLNLQENQLSGSIPREIGNLTLLQDLYLN 180

Query: 178  DNQL-----------------------SGTIPSSIFNISS-------------------C 195
             NQL                       SG IP  IFN+SS                   C
Sbjct: 181  SNQLTEIPTEIGTLQSLRTLDIEFNLFSGPIPLFIFNLSSLVILGLSGNNFIGGLPDDIC 240

Query: 196  QNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLG 255
            ++LP L GL++SYNQL+G +P+ LWKC  L  V+LA+N+F G IPR++GNLT V+ +FLG
Sbjct: 241  EDLPSLGGLYLSYNQLSGQLPSTLWKCENLEDVALAYNQFTGSIPRNVGNLTRVKQIFLG 300

Query: 256  NNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSI 315
             N L GEIP E+G L+NLE L +Q +   G IP +IFN+S L  +A+  N L G+LP+ +
Sbjct: 301  VNYLSGEIPYELGYLQNLEYLAMQENFFNGTIPPTIFNLSKLNTIALVKNQLSGTLPADL 360

Query: 316  DLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSL 375
             +GLPNL +L LG N  +GTIP S+TN S L++ D G NSFSGLIP  FG   +L+ ++L
Sbjct: 361  GVGLPNLVQLMLGRNELTGTIPESITNSSMLTLFDVGDNSFSGLIPNVFGRFENLRWINL 420

Query: 376  AGNVLTSPTPD-----LSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSME 430
              N  T+ +P       SFL++LTS   LE   LS NP+N  LPSS  NFS S + LSM 
Sbjct: 421  ELNNFTTESPPSERGIFSFLTNLTSLVRLE---LSHNPLNIFLPSSFVNFSSSFQYLSMV 477

Query: 431  SCNISGGIPKELGN-INNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPED 489
            +  I G IPK++GN + +L V+ + +N++TGTIP ++G+L++LQGL+L NN LEG+IP +
Sbjct: 478  NTGIKGMIPKDIGNFLRSLIVLVMDDNQITGTIPTSIGKLKQLQGLHLSNNSLEGNIPAE 537

Query: 490  LCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNL 549
            +C L  L  LYL +NKLSG +P C  NL++LR LSLGSN L S +PS+LW+L  IL  NL
Sbjct: 538  ICQLENLDELYLANNKLSGAIPECFDNLSALRTLSLGSNNLNSTMPSSLWSLSYILHLNL 597

Query: 550  SSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPES 609
            SSNSL GSL  +IGNL+VV+++D+S N LSG IP +IGGL  L  LSL +N L+G IP+S
Sbjct: 598  SSNSLRGSLPVEIGNLEVVLDIDVSKNQLSGEIPSSIGGLINLVNLSLLHNELEGSIPDS 657

Query: 610  FGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFL 669
            FG L +L  +D+S+NNL+G IP+S+E LS+L+  N+SFNQLEGEIP  GPF  FSA+SF+
Sbjct: 658  FGNLVNLEILDLSSNNLTGVIPRSLEKLSHLEQFNVSFNQLEGEIPNGGPFSNFSAQSFI 717

Query: 670  GNQALC-GSPKLQVSPCKTR-SHPRSRTTVVLLIVLPLVSALTMIVVLTAKLVRRRRRRR 727
             N  LC  S + QV+PC T+ S    R T  L+ +LP +    + ++L    +  R R++
Sbjct: 718  SNIGLCSASSRFQVAPCTTKTSQGSGRKTNKLVYILPSILLAMLSLILLLLFMTYRHRKK 777

Query: 728  RRQKGSTR-PYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGM 786
             + +  T  PY       Q  WRR +YQ+L +ATDGFSE+ L+G GSFGSVYK  L DG 
Sbjct: 778  EQVREDTPLPY-------QPAWRRTTYQELSQATDGFSESNLIGRGSFGSVYKATLSDGT 830

Query: 787  EIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEK 846
              A K+F +    + +SF  EC+++ +IRHRNLVKII+SCS+ DFKAL+LEYM NG+L+ 
Sbjct: 831  IAAVKIFDLLTQDANKSFELECEILCNIRHRNLVKIITSCSSVDFKALILEYMPNGNLDM 890

Query: 847  CLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFG 906
             LY+ +  L++L+RL I+IDVA AL+YLH GY  PIVHCD+KP+N+LL+  MV HL+DFG
Sbjct: 891  WLYNHDCGLNMLERLDIVIDVALALDYLHNGYGKPIVHCDLKPNNILLDGDMVAHLTDFG 950

Query: 907  IAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIF 966
            I+K+LG  +S+ QT TL T+GYMAPE G +G VSRKCDVYSYGI+LMETFT+KKPTDE+F
Sbjct: 951  ISKLLGGGDSITQTITLATVGYMAPELGLDGIVSRKCDVYSYGILLMETFTRKKPTDEMF 1010

Query: 967  -AGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEK 1025
             AGEMSL+ WV  +    SI  V D +LLN ++  F+   +C+SSI  LA+ CT + PEK
Sbjct: 1011 SAGEMSLREWVAKA-YPHSINNVVDPDLLN-DDKSFNYASECLSSIMLLALTCTAESPEK 1068

Query: 1026 RISMKDVANRLVRIRETLSAY 1046
            R S KDV N L +I+  +  Y
Sbjct: 1069 RASSKDVLNSLNKIKAMILTY 1089

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255578886|ref|XP_002530297.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223530195|gb|EEF32104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  983 bits (2540), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 541/1045 (51%), Positives = 722/1045 (69%), Gaps = 26/1045 (2%)

Query: 1    NIGFMIITLVPLLHCLMLSSVMAAVTNVTTDQFALLALKEHIKHDPSNLLANNWSTTSSV 60
            N  ++I+ +  +L      S+   VTN+ +DQ ALLALK  I  DP+NLLA NWS T+SV
Sbjct: 4    NKTYLILCMKIILLYSFFVSIADGVTNIASDQDALLALKVRIIRDPNNLLAANWSITTSV 63

Query: 61   CSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHL 120
            C+W+GVTCG R+ RVTAL++S +GLTGTIPP LGNLSFLA ++  NN F GSLP+ELS L
Sbjct: 64   CTWVGVTCGARHGRVTALDLSDMGLTGTIPPHLGNLSFLAFISFYNNRFHGSLPDELSKL 123

Query: 121  RGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIG--YLSLLQELDLSD 178
            R +K F    N F  EIPSW  S  +LQ L L  N F G +P  +    +S L  LD   
Sbjct: 124  RRIKAFGMSTNYFSGEIPSWIGSFTQLQRLSLSSNKFTGLLPAILANNTISSLWLLDFGT 183

Query: 179  NQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGG 238
            N L+G +P +IF      +L  L  L+++ N   GPIP+ L  C++L +++L+FN F+G 
Sbjct: 184  NNLTGRLPPNIFT-----HLANLRALYLNSNLFNGPIPSTLMACQQLKLLALSFNHFEGS 238

Query: 239  IPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLK 298
            I +DIGNLT ++ L+LG N+  G IP+EIG+L +LE + +  + L+GL+P+ I+N S + 
Sbjct: 239  IHKDIGNLTMLQELYLGGNNFSGTIPDEIGDLAHLEEIILNVNGLSGLVPSGIYNASKMT 298

Query: 299  ELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSG 358
             + +  N L G LPSS +L  PNLE   + +NNF+G IP SL N S+L  +D G+NSF G
Sbjct: 299  AIGLALNQLSGYLPSSSNL--PNLEFFIIEDNNFTGPIPVSLFNASKLGNIDLGWNSFYG 356

Query: 359  LIPTTFGNLRSLKLLSLAGNVLT--SPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSS 416
             IP   GNL+SL++ S   N LT  S +  LS  SSLT C++L    LS NP+NG LP S
Sbjct: 357  PIPDELGNLKSLEVFSFWVNHLTVKSSSSGLSLFSSLTKCKHLRRFDLSNNPLNGNLPIS 416

Query: 417  IGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLY 476
            +GN S S++ + +  C I+G IPKE+GN+++L+ + LG N+L GTIP T+ +L KLQ L 
Sbjct: 417  VGNLSSSLEVVEIFDCGITGTIPKEIGNLSSLSWLDLGANDLRGTIPTTIRKLGKLQELK 476

Query: 477  LQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPS 536
            L  N+LEGS P +LC L  LA LYL  N LSG++P+CLGN+ SLR LS+G N  +S IPS
Sbjct: 477  LHYNRLEGSFPYELCDLQSLAYLYLEVNALSGQIPSCLGNVNSLRTLSMGMNKFSSTIPS 536

Query: 537  TLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLS 596
            TLW L DIL  NLSSNSL+GSL  DIGNLK V  +DLS N LSG IP +IGGL+ L  LS
Sbjct: 537  TLWRLADILELNLSSNSLSGSLAVDIGNLKAVTLIDLSGNQLSGHIPSSIGGLKTLLNLS 596

Query: 597  LRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPT 656
            L  NRL+G IP+ FG   SL  +D+SNNNLSG IPKS+E L YL + N+SFN+L+GEIP 
Sbjct: 597  LAVNRLEGSIPQLFGDAISLQLLDLSNNNLSGEIPKSLEELRYLTYFNVSFNELQGEIPN 656

Query: 657  RGPFITFSAESFLGNQALCGSPKLQVSPCKTRSHPRSRTTVVLLIVLPLVS-ALTMIVVL 715
               FI  SA+SF+GN+ LCG+ KLQV PC+T +H  S+    L +   L++  LT++ V 
Sbjct: 657  GRAFINLSAKSFMGNKGLCGAAKLQVQPCETSTHQGSKAASKLALRYGLMATGLTILAVA 716

Query: 716  TAKL--VRRRRRRRRRQKGSTRPYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGS 773
               +  +R R+R  R  +G         + P AT +RISY++L +ATD F+E  LLG GS
Sbjct: 717  AVAIIFIRSRKRNMRITEG---------LLPLATLKRISYRELEQATDKFNEMNLLGRGS 767

Query: 774  FGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS--NNDF 831
            FGSVYKG   DG  +A KVF+++ +G+ +SF  EC+V+  IRHRNLVKII+SCS  N DF
Sbjct: 768  FGSVYKGTFSDGSSVAVKVFNLQVEGAFKSFDVECEVLRMIRHRNLVKIITSCSDINIDF 827

Query: 832  KALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSN 891
            KALVLE+M N SLEK L S  +FL++L+RL IM+DVASA+EYLH GY+ PIVHCD+KPSN
Sbjct: 828  KALVLEFMPNYSLEKWLCSPKHFLELLERLNIMLDVASAVEYLHHGYAMPIVHCDLKPSN 887

Query: 892  VLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIM 951
            +LL+E+MV H++DFGIAK+LG E S  QT TL T+GYMAPEYG EG VS   D+YS+GI+
Sbjct: 888  ILLDENMVAHVTDFGIAKLLGDEHSFIQTITLATVGYMAPEYGSEGVVSTGGDIYSFGIL 947

Query: 952  LMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSI 1011
            LMETFT+KKPTD++F  E+S+K+WV +S +   +T++ D +LL  EE  FSA++ C+ S+
Sbjct: 948  LMETFTRKKPTDDMFNEEISMKQWVQES-VPGGVTQITDPDLLRIEEQHFSAKKDCILSV 1006

Query: 1012 FSLAMDCTVDLPEKRISMKDVANRL 1036
              +A+ C+ DLPE+R +++DV N L
Sbjct: 1007 MQVALQCSADLPEERPNIRDVLNTL 1031

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483685|ref|XP_002263372.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase EFR-like [Vitis vinifera]

 Score =  969 bits (2504), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 522/1058 (49%), Positives = 682/1058 (64%), Gaps = 73/1058 (6%)

Query: 31   DQFALLALKEHIKHDPSNLLANNWSTTSSVCSWIGVTCGVRNRRVTALNISYLGLTGTIP 90
            D+FAL+ALK HI +D   +LA NWST SS C+W G++C    +RV+A+N+S +GL GTI 
Sbjct: 9    DEFALIALKAHITYDSQGILATNWSTKSSYCNWYGISCNAPQQRVSAINLSNMGLEGTIA 68

Query: 91   PQLGNLSFLAVL------------------------AIRNNSFFGSLPEELSHLRGLKYF 126
            PQ+GNLSFL  L                        ++RNNS  G +P  LSH R L+  
Sbjct: 69   PQVGNLSFLVSLDLTYNDFTGSIPNGIGNLVELQRLSLRNNSLTGEIPSNLSHCRELRGL 128

Query: 127  DFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIP 186
                N F   IP    SL  L+ L L +N   G IP  IG LS L  L L  N +SG IP
Sbjct: 129  SLSINQFTGGIPQAIGSLSNLEELYLNYNKLTGGIPREIGNLSNLNILQLGSNGISGPIP 188

Query: 187  SSIFNISS-------------------CQNLPVLEGLFISYNQLTGPIPTNLWKCRELHV 227
            + IF +SS                   C++LP L+GL++S N L+G +PT L  CREL  
Sbjct: 189  AEIFTVSSLQRIIFANNSLSGSLPMDICKHLPNLQGLYLSQNHLSGQLPTTLSLCRELLS 248

Query: 228  VSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLI 287
            ++L  NKF G IPR+IGNL+ +  + L  NSLIG IP   GNL  L+ L           
Sbjct: 249  LALPMNKFTGSIPREIGNLSKLEEIDLSENSLIGSIPTSFGNLMTLKFLS---------- 298

Query: 288  PASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELS 347
                FNIS L+ L +  N L GSLPSSI   LP+LE L++G N FSGTIP S++N+S+L+
Sbjct: 299  ----FNISKLQTLGLVQNHLSGSLPSSIGTWLPDLEGLYIGINEFSGTIPMSISNMSKLT 354

Query: 348  VLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSP--TPDLSFLSSLTSCRNLEIIYLS 405
            VL    NSF+G +P    NL  L+ L LA N LT       + FL+SLT+C+ L  +++ 
Sbjct: 355  VLSLSDNSFTGNVPKDLCNLTKLQFLDLAYNQLTDEHLASGVGFLTSLTNCKFLRNLWIG 414

Query: 406  ENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVT 465
             NP+ G LP+S+GN  I+++     +C   G IP  +GN+ NL  + LG N+LTG+IP T
Sbjct: 415  YNPLTGTLPNSLGNLPIALEIFIASACQFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTT 474

Query: 466  LGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSL 525
            LG+LQKLQ L +  N++ GSIP DLCHL  L  L L  NKLSG +P+C G+L +LR+LSL
Sbjct: 475  LGQLQKLQALSIVGNRIRGSIPNDLCHLKNLGYLRLSYNKLSGSIPSCFGDLPALRELSL 534

Query: 526  GSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVT 585
             SN L   IP + W+L+D+L  NLSSN L G+L P++GN+K +  +DLS N +SG IP  
Sbjct: 535  DSNVLAFNIPMSFWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPSR 594

Query: 586  IGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNL 645
            +G LQ L  LSL  N+LQGPIP  FG L SL  +D+S NNLSGTIPK++EAL YLK+LN+
Sbjct: 595  MGKLQNLITLSLSQNKLQGPIPVEFGDLVSLESLDLSQNNLSGTIPKTLEALIYLKYLNV 654

Query: 646  SFNQLEGEIPTRGPFITFSAESFLGNQALCGSPKLQVSPCKTRSHPRSRTT---VVLLIV 702
            SFN+L+GEIP  GPF+ F+AESF+ N+ALCG+P  QV  C   +  +S  T   ++  I+
Sbjct: 655  SFNKLQGEIPNGGPFVKFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYIL 714

Query: 703  LPLVSALTMIVVLTAKLVRRRRRRRRRQKGSTRPYYDANMYPQATWRRISYQDLLRATDG 762
            LP+ S +T++V +   + RR          S  P          T  +IS+Q LL AT+ 
Sbjct: 715  LPVGSTVTLVVFIVLWIRRRDNMEIPTPIDSWLP---------GTHEKISHQQLLYATND 765

Query: 763  FSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKI 822
            F E+ L+G GS G VYKGVL +G+ +A KVF++EF G+L SF++EC+VM  IRHRNLV+I
Sbjct: 766  FGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFNSECEVMQGIRHRNLVRI 825

Query: 823  ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
            I+ CSN DFKALVL+YM NGSLEK LYS  YFLD++QRL IMIDVASALEYLH   S+ +
Sbjct: 826  ITCCSNLDFKALVLKYMPNGSLEKLLYSHYYFLDLIQRLNIMIDVASALEYLHHDCSSLV 885

Query: 883  VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRK 942
            VHCD+KPSNVLL++ MV H++DFGIAK+L + ESM+QTKTL TIGYMAPE+G  G VS K
Sbjct: 886  VHCDLKPSNVLLDDDMVAHVADFGIAKLLTETESMQQTKTLSTIGYMAPEHGSAGIVSTK 945

Query: 943  CDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFS 1002
             DVYSYGI+LME F +KKP DE+F G+++LK WV    LS S+ +V D NLL  E+ D +
Sbjct: 946  SDVYSYGILLMEVFARKKPMDEMFTGDLTLKTWVES--LSNSVIQVVDVNLLRREDEDLA 1003

Query: 1003 AREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIR 1040
             +  C+SSI +LA+ CT D PE+RI MKD    L + R
Sbjct: 1004 TKLSCLSSIMALALACTTDSPEERIDMKDAVVELKKSR 1041

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359497186|ref|XP_003635448.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  966 bits (2498), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 530/1142 (46%), Positives = 707/1142 (61%), Gaps = 139/1142 (12%)

Query: 30   TDQFALLALKEHIKHDPSNLLANNWSTTSSVCSWIGVTCGVRNRRVTALNISYLGLTGTI 89
             D+FAL+ALK HI +D   +LA NWST S  CSWIG++C    + V+A+N+S +GL GTI
Sbjct: 8    VDEFALIALKAHITYDSQGILATNWSTKSPHCSWIGISCNAPQQSVSAINLSNMGLEGTI 67

Query: 90   PPQLGN------------------------------------------------LSFLAV 101
             PQ+GN                                                LS L  
Sbjct: 68   APQVGNLSFLVSLDLSDNYFHGSLPKDIGKCKELQQLNLFNNKLVGGIPEAICNLSKLEE 127

Query: 102  LAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSL----------------- 144
            L + NN   G +P++++HL+ LK   F  NN    IP+   ++                 
Sbjct: 128  LYLGNNQLIGEIPKKMNHLQNLKVLSFPMNNLTGSIPATIFNISSLLNISLSNNNLSGSL 187

Query: 145  --------PRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPS--------- 187
                    P+L+ L L  N   GKIP  +G    LQ + L+ N  +G+IPS         
Sbjct: 188  PMDMCYANPKLKELNLSSNHLSGKIPTGLGQCIQLQVISLAYNDFTGSIPSGIDNLVELQ 247

Query: 188  ----------------------SIFNISS-------------------CQNLPVLEGLFI 206
                                   IFN+SS                   C++LP L+GL +
Sbjct: 248  RLSLQNNSFTAFKDISKALLFAEIFNVSSLQVIAFTDNSLSGSLPKDICKHLPNLQGLSL 307

Query: 207  SYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNE 266
            S N L+G +PT L  C EL  +SL+FNKF+G IP++IGNL+ +  ++LG NSLIG IP  
Sbjct: 308  SQNHLSGQLPTTLSLCGELLFLSLSFNKFRGSIPKEIGNLSKLEEIYLGTNSLIGSIPTS 367

Query: 267  IGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLF 326
             GNL+ L+ L +  +NL G +P +IFNIS L+ LA+  N L GSLPSSI   LP+LE LF
Sbjct: 368  FGNLKALKFLNLGINNLTGTVPEAIFNISKLQSLAMVKNHLSGSLPSSIGTWLPDLEGLF 427

Query: 327  LGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSP--T 384
            +  N FSG IP S++N+S+L+VL    NSF+G +P   GNL  LK+L LAGN LT     
Sbjct: 428  IAGNEFSGIIPMSISNMSKLTVLGLSANSFTGNVPKDLGNLTKLKVLDLAGNQLTDEHVA 487

Query: 385  PDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGN 444
             ++ FL+SLT+C+ L+ +++   P  G LP+S+GN  I+++S    +C   G IP  +GN
Sbjct: 488  SEVGFLTSLTNCKFLKNLWIGNIPFKGTLPNSLGNLPIALESFIASACQFRGTIPTGIGN 547

Query: 445  INNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDN 504
            + NL  + LG N+LTG+IP TLG+LQKLQ LY+  N++ GSIP DLCHL  L  L+L  N
Sbjct: 548  LTNLIRLDLGANDLTGSIPTTLGQLQKLQWLYIAGNRIRGSIPNDLCHLKDLGYLFLSSN 607

Query: 505  KLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGN 564
            KLSG +P+C G+L +L++L L SN L   IP++LW+L+D+L  NLSSN L G+L P++GN
Sbjct: 608  KLSGSIPSCFGDLLALQELFLDSNVLAFNIPTSLWSLRDLLALNLSSNFLTGNLPPEVGN 667

Query: 565  LKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNN 624
            +K +  +DLS N +SG IP  +G LQ L  LSL  NRLQGPIP  FG L SL  +D+S N
Sbjct: 668  MKSITTLDLSKNLVSGYIPSKMGKLQSLITLSLSQNRLQGPIPIEFGDLVSLESLDLSQN 727

Query: 625  NLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSPKLQVSP 684
            NLSGTIPKS+EAL YLK+LN+S N+L+GEIP  GPFI F+AESF+ N+ALCG+P  QV  
Sbjct: 728  NLSGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVMA 787

Query: 685  CKTRSHPRSRTT---VVLLIVLPLVSALTMIVVLTAKLVRRRRRRRRRQKGSTRPYYDAN 741
            C   +  +S  T   ++  I+LP+ S +T++V +   + RR          S  P     
Sbjct: 788  CDKNNRTQSWKTKSFILKYILLPVGSIVTLVVFIVLWIRRRDNMEIPTPIDSWLP----- 842

Query: 742  MYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL 801
                 T  +IS+Q LL AT+ F E+ L+G GS G VYKGVL +G+ +A KVF++EF G+L
Sbjct: 843  ----GTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGAL 898

Query: 802  ESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL 861
             SF +EC+VM  IRHRNLV+II+ CSN DFKALVLEYM NGSLEK LYS NYFLD++QRL
Sbjct: 899  RSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRL 958

Query: 862  KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK 921
             IMIDVASALEYLH   S+ +VHCD+KP+NVLL++ MV H++DFGI K+L K ESM+QTK
Sbjct: 959  NIMIDVASALEYLHHDCSSLVVHCDLKPNNVLLDDDMVAHVADFGITKLLTKTESMQQTK 1018

Query: 922  TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLL 981
            TLGTIGYMAPE+G +G VS K DVYSYGI+LME F++KKP DE+F G ++LK WV    L
Sbjct: 1019 TLGTIGYMAPEHGSDGIVSTKSDVYSYGILLMEVFSRKKPMDEMFTGGLTLKTWVES--L 1076

Query: 982  SCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041
            S S+ +V DANLL  E+ D + +  C+SSI +LA+ CT + PEKR++MKD    L + + 
Sbjct: 1077 SNSVIQVVDANLLRREDEDLATKLSCLSSIMALALACTTNSPEKRLNMKDAVVELKKSKM 1136

Query: 1042 TL 1043
             L
Sbjct: 1137 KL 1138

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  945 bits (2443), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 507/1018 (49%), Positives = 673/1018 (66%), Gaps = 59/1018 (5%)

Query: 74   RVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPE------------------ 115
            ++  ++++Y   TG+IP  +GNL  L  L+++NNSF G +P+                  
Sbjct: 221  QLQVISLAYNDFTGSIPSGIGNLVELQRLSLQNNSFTGEIPQLLFNISSLRFLNLAVNNL 280

Query: 116  ------ELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLS 169
                   LSH R L+     FN F   IP    SL  L+ L L HN   G IP  IG LS
Sbjct: 281  EGEIPSNLSHCRELRVLSLSFNQFTGGIPQAIGSLSNLEELYLSHNKLTGGIPREIGNLS 340

Query: 170  LLQELDLSDNQLSGTIPSSIFNISS-------------------CQNLPVLEGLFISYNQ 210
             L  L LS N +SG IP+ IFN+SS                   C++LP L+GL +S N 
Sbjct: 341  NLNILQLSSNGISGPIPAEIFNVSSLQVIAFTDNSLSGSLPKDICKHLPNLQGLSLSQNH 400

Query: 211  LTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNL 270
            L+G +PT L  C EL  +SL+FNKF+G IP++IGNL+ +  ++LG NSLIG IP   GNL
Sbjct: 401  LSGQLPTTLSLCGELLFLSLSFNKFRGSIPKEIGNLSKLEKIYLGTNSLIGSIPTSFGNL 460

Query: 271  RNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGEN 330
            + L+ L +  +NL G +P +IFNIS L+ LA+  N L GSLPSSI   L +LE LF+  N
Sbjct: 461  KALKFLNLGINNLTGTVPEAIFNISKLQSLAMVKNHLSGSLPSSIGTWLSDLEGLFIAGN 520

Query: 331  NFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSP--TPDLS 388
             FSG IP S++N+S+L+VL    NSF+G +P   GNL  LK+L LAGN LT      ++ 
Sbjct: 521  EFSGIIPMSISNMSKLTVLGLSANSFTGNVPKDLGNLTKLKVLDLAGNQLTDEHVASEVG 580

Query: 389  FLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNL 448
            FL+SLT+C+ L+ +++  NP  G LP+S+GN  I+++S    +C   G IP  +GN+ NL
Sbjct: 581  FLTSLTNCKFLKNLWIGNNPFKGTLPNSLGNLPIALESFIASACQFRGTIPTRIGNLTNL 640

Query: 449  TVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSG 508
              + LG N+LTG+IP TLGRL+KLQ L++  N+L GSIP DLCHL  L  L+L  NKLSG
Sbjct: 641  IWLDLGANDLTGSIPTTLGRLKKLQKLHIVGNRLRGSIPNDLCHLKNLGYLHLSSNKLSG 700

Query: 509  RLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVV 568
             +P+C G+L +L++L L SN L   IP++LW+L+D+L  NLSSN L G+L P++GN+K +
Sbjct: 701  SIPSCFGDLPALQELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSI 760

Query: 569  IEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSG 628
              +DLS N +SG IP  +G  Q L  LSL  N+LQGPIP  FG L SL  +D+S NNLSG
Sbjct: 761  TTLDLSKNLVSGHIPRKMGEQQNLAKLSLSQNKLQGPIPIEFGDLVSLESLDLSQNNLSG 820

Query: 629  TIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSPKLQVSPCKTR 688
            TIPKS+EAL YLK+LN+S N+L+GEIP  GPFI F+AESF+ N+ALCG+P  QV  C   
Sbjct: 821  TIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVMACDKN 880

Query: 689  SHPRSRTT---VVLLIVLPLVSALTMIVVLTAKLVRRRRRRRRRQKGSTRPYYDANMYPQ 745
            +  +S  T   ++  I+LP+ S +T++V +   + RR          S  P         
Sbjct: 881  NRTQSWKTKSFILKYILLPVGSIVTLVVFIVLWIRRRDNMEIPTPIDSWLP--------- 931

Query: 746  ATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFH 805
             T  +IS+Q LL AT+ F E+ L+G GS G VYKGVL +G+ +A KVF++EF G+L SF 
Sbjct: 932  GTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFD 991

Query: 806  AECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMI 865
            +EC+VM  IRHRNLV+II+ CSN DFKALVLEYM NGSLEK LYS NYFLD++QRL IMI
Sbjct: 992  SECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMI 1051

Query: 866  DVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT 925
            DVASALEYLH   S+ +VHCD+KP+NVLL++ MV H++DFGI K+L K ESM+QTKTLGT
Sbjct: 1052 DVASALEYLHHDCSSLVVHCDLKPNNVLLDDDMVAHVADFGITKLLTKTESMQQTKTLGT 1111

Query: 926  IGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSI 985
            IGYMAPE+G +G VS K DVYSYGI+LME F++KKP DE+F G+++LK WV    LS S+
Sbjct: 1112 IGYMAPEHGSDGIVSTKSDVYSYGILLMEVFSRKKPMDEMFTGDLTLKTWVES--LSNSV 1169

Query: 986  TEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043
             +V DANLL  E+ D + +  C+SSI +LA+ CT D PE+R++MKD    L + R  L
Sbjct: 1170 IQVVDANLLRREDEDLATKLSCLSSIMALALACTTDSPEERLNMKDAVVELKKSRMKL 1227

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147776333|emb|CAN72034.1| hypothetical protein VITISV_000078 [Vitis vinifera]

 Score =  943 bits (2437), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 505/991 (50%), Positives = 669/991 (67%), Gaps = 35/991 (3%)

Query: 74   RVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNF 133
            ++  ++++Y   TG+IP  +GNL  L  L++RNNS  G +P  LSH R L+     FN F
Sbjct: 221  KLQVISLAYNDFTGSIPNGIGNLVELQRLSLRNNSLTGEIPSNLSHCRELRVLSSSFNQF 280

Query: 134  HIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNIS 193
               IP    SL  L+ L L  N   G IP  IG LS L  L L  N +SG IP+ IFNIS
Sbjct: 281  TGGIPQAIGSLCNLEELYLAFNKLTGGIPREIGNLSNLNILQLGSNGISGPIPAEIFNIS 340

Query: 194  S-------------------CQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNK 234
            S                   C++LP L+GL+++ N L+G +PT L  C EL  +SL+FNK
Sbjct: 341  SLQVIDFTNNSLSGSLPMGICKHLPNLQGLYLAQNHLSGQLPTTLSLCGELLFLSLSFNK 400

Query: 235  FQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNI 294
            F+G IPR+IGNL+ + ++ L +NSL+G IP   GNL+ L+ L +  + L G +P +IFNI
Sbjct: 401  FRGSIPREIGNLSKLEHIDLRSNSLVGSIPTSFGNLKALKFLNLGINFLTGTVPEAIFNI 460

Query: 295  STLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFN 354
            S L+ LA+  N L GSLPSSI   LP+LE L++G N FSGTIP S++N+S+L+VL    N
Sbjct: 461  SELQNLALVQNHLSGSLPSSIGTWLPDLEGLYIGANEFSGTIPMSISNMSKLTVLSLSDN 520

Query: 355  SFSGLIPTTFGNLRSLKLLSLAGNVLTSP--TPDLSFLSSLTSCRNLEIIYLSENPINGI 412
            SF+G +P    NL  LK L+LA N LT       + FL+SLT+C+ L  +++  NP+ G 
Sbjct: 521  SFTGNVPKDLCNLTKLKFLNLAHNQLTDEHLASGVGFLTSLTNCKFLRYLWIGYNPLKGT 580

Query: 413  LPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKL 472
            LP+S+GN  I+++S +  +C   G IP  +GN+ NL  + LG N+LTG+IP TLGRLQKL
Sbjct: 581  LPNSLGNLPIALESFTAYACQFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTLGRLQKL 640

Query: 473  QGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTS 532
            Q L++  N++ GSIP DLCHL  L  L L  NKLSG  P+C G+L +LR+L L SNAL  
Sbjct: 641  QRLHIAGNRIRGSIPNDLCHLKNLGYLGLSSNKLSGSTPSCFGDLLALRELFLDSNALAF 700

Query: 533  IIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGL 592
             IP++LW+L+D+L  NLSSN L G+L P++GN+K +  +DLS N +SG IP  +G LQ L
Sbjct: 701  NIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPSRMGKLQYL 760

Query: 593  QLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEG 652
              LSL  NRLQGPI   FG L SL  +D+S+NNLSGTIPKS+EAL YLK+LN+SFN+L+G
Sbjct: 761  ITLSLSQNRLQGPIXVEFGDLVSLESLDLSHNNLSGTIPKSLEALIYLKYLNVSFNKLQG 820

Query: 653  EIPTRGPFITFSAESFLGNQALCGSPKLQVSPCKTRSHPRSRTT---VVLLIVLPLVSAL 709
            EIP  GPF+ F+AESF+ N+ALCG+P  QV  C   +  +S  T   ++  I+LP+ S +
Sbjct: 821  EIPNGGPFVKFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSTV 880

Query: 710  TMIVVLTAKLVRRRRRRRRRQKGSTRPYYDANMYPQATWRRISYQDLLRATDGFSENKLL 769
            T++V +   +      RRR       P    + +   T  +IS+Q LL AT+ F E+ L+
Sbjct: 881  TLVVFIVLWI------RRRDNMEIPTPI---DSWLLGTHEKISHQQLLYATNDFGEDNLI 931

Query: 770  GMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNN 829
            G GS G VYKGVL +G+ +A KVF++EF G+L SF +EC+VM  IRHRNLV+II+ CSN 
Sbjct: 932  GKGSQGMVYKGVLSNGLNVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCCSNL 991

Query: 830  DFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKP 889
            DFKALVLEYM NGSLEK LYS NYFLD++QRL IMIDVASALEYLH   S+ +VHCD+KP
Sbjct: 992  DFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKP 1051

Query: 890  SNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYG 949
            SNVLL++ MV H++DFGIAK+L + ESM+QTKTLGTIGYMAPE+G  G VS K DVYSYG
Sbjct: 1052 SNVLLDDDMVAHVADFGIAKLLTETESMQQTKTLGTIGYMAPEHGSAGIVSTKSDVYSYG 1111

Query: 950  IMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVS 1009
            I+LME F +KKP DE+F G+++LK WV    LS S+ +V D NLL  E+ D + +  C+S
Sbjct: 1112 ILLMEVFARKKPMDEMFTGDLTLKTWVES--LSNSVIQVVDVNLLRREDEDLATKLSCLS 1169

Query: 1010 SIFSLAMDCTVDLPEKRISMKDVANRLVRIR 1040
            SI +LA+ CT D P++RI MKD    L + R
Sbjct: 1170 SIMALALACTTDSPKERIDMKDAVVELKKSR 1200

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa]

 Score =  935 bits (2417), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 525/1056 (49%), Positives = 675/1056 (63%), Gaps = 112/1056 (10%)

Query: 85   LTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPS-WFVS 143
            L GT+PPQ+GNLSFL  + + NNSF G LP EL+HL  LK  +  +NNF  +IPS WF  
Sbjct: 3    LEGTLPPQVGNLSFLVSINLSNNSFHGYLPRELTHLHRLKDMNLAYNNFAGDIPSSWFAM 62

Query: 144  LPRLQHLLLKHNSFVGKIP------------------------ETIGYLSLLQELDLSDN 179
            LP+LQHL L +NS  G IP                        E I  LS L+ LDL  N
Sbjct: 63   LPQLQHLFLTNNSLAGSIPSSLFNVTALETLNLEGNFIEGNISEEIRNLSNLKILDLGHN 122

Query: 180  QLSGTIPSSIFNISSCQ--------------------NLP-VLEGLFISYNQLTGPIPTN 218
              SG I   +FN+ S +                    N+P  LE L + YNQL G IP+N
Sbjct: 123  HFSGVISPILFNMPSLRLINLRANSLSGILQVVMIMSNIPSTLEVLNLGYNQLHGRIPSN 182

Query: 219  LWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLG- 277
            L KC EL V+ L  N+F G IP++I  LT ++ L+LG N+L G+IP EI  L +LE LG 
Sbjct: 183  LHKCTELRVLDLESNRFTGSIPKEICTLTKLKELYLGKNNLTGQIPGEIARLVSLEKLGL 242

Query: 278  -----------------------VQSSNLAGLIPASIFNISTLKELAVTDNDLLGS---- 310
                                   V+++NL G+IP  + N+ TL+EL +  N++ GS    
Sbjct: 243  EVNGLNGNIPREIGNCTYLMEIHVENNNLTGVIPNEMGNLHTLQELDLGFNNITGSIPST 302

Query: 311  --------------------LPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLD 350
                                LPS+  LGLPNLE L+L +N  SG IP S+ N S+L VLD
Sbjct: 303  FFNFSILRRVNMAYNYLSGHLPSNTGLGLPNLEELYLEKNELSGPIPDSIGNASKLIVLD 362

Query: 351  FGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLT--SCRNLEIIYLSENP 408
              +NSFSG IP   GNLR+L+ L+LA N+LTS +         +  +CR+L  +  + NP
Sbjct: 363  LSYNSFSGRIPDLLGNLRNLQKLNLAENILTSKSLRSELSFLSSLSNCRSLAYLRFNGNP 422

Query: 409  INGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGR 468
            + G LP SIGN S S++ L    C I G IP+ +GN++NL  + L  NELTG IP  +GR
Sbjct: 423  LRGRLPVSIGNLSASLEELYAFDCRIIGNIPRGIGNLSNLIGLILQQNELTGAIPSEIGR 482

Query: 469  LQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSN 528
            L+ LQ   L +NKL+G IP ++CHL RL+ LYL +N  SG LPACL N+TSLR+L LGSN
Sbjct: 483  LKHLQDFSLASNKLQGHIPNEICHLERLSYLYLLENGFSGSLPACLSNITSLRELYLGSN 542

Query: 529  ALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGG 588
              TSI P+T W+LKD+L+ NLS NSL G+L  +IGNLKVV  +D S N LSG IP +I  
Sbjct: 543  RFTSI-PTTFWSLKDLLQINLSFNSLTGTLPLEIGNLKVVTVIDFSSNQLSGDIPTSIAD 601

Query: 589  LQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFN 648
            LQ L   SL  NR+QGPIP SFG L SL F+D+S N+LSG IPKS+E L +LK  N+SFN
Sbjct: 602  LQNLAHFSLSDNRMQGPIPSSFGDLVSLEFLDLSRNSLSGAIPKSLEKLVHLKTFNVSFN 661

Query: 649  QLEGEIPTRGPFITFSAESFLGNQALCGSPKLQVSPCKT----RSHPRSRTTVVLLIVLP 704
            +L+GEI   GPF  FS  SF+ N+ALCG  ++QV PCK+    R   R R  V+  IV P
Sbjct: 662  RLQGEILDGGPFANFSFRSFMDNEALCGPIRMQVPPCKSISTHRQSKRPREFVIRYIV-P 720

Query: 705  LVSALTMIVVLTAKLVRRRRRRRRRQKGSTRPYYDANMYPQATWRRISYQDLLRATDGFS 764
             ++ + +++ L   + RR  +R+   +         +  P ATWR+ISY +L RAT+GF+
Sbjct: 721  AIAFIILVLALAVIIFRRSHKRKLSTQ--------EDPLPPATWRKISYHELYRATEGFN 772

Query: 765  ENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
            E  LLG GS GSVYKG L DG+ IA KVFH++ +G L  F +EC+V+  +RHRNLVKIIS
Sbjct: 773  ETNLLGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMRFDSECEVLRMLRHRNLVKIIS 832

Query: 825  SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
            SC N DFKAL+LE++ +GSLEK LYS NY+LDILQRL IMIDVASALEYLH G + P+VH
Sbjct: 833  SCCNLDFKALILEFIPHGSLEKWLYSHNYYLDILQRLNIMIDVASALEYLHHGCTRPVVH 892

Query: 885  CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCD 944
            CD+KPSNVL+NE MV H+SDFGI+++LG+ +++ QT TL TIGYMAPEYG EG VS K D
Sbjct: 893  CDLKPSNVLINEDMVAHVSDFGISRLLGEGDAVTQTLTLATIGYMAPEYGLEGIVSVKGD 952

Query: 945  VYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAR 1004
            VYSYGI LMETFT+KKPTD++F GEMSLK WV  SL   +ITEV DANLL  EE  F A+
Sbjct: 953  VYSYGIFLMETFTRKKPTDDMFGGEMSLKNWVKQSLPK-AITEVIDANLL-IEEEHFVAK 1010

Query: 1005 EQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIR 1040
            + C++SI +LA++C+ DLP +RI M+DV   L +I+
Sbjct: 1011 KDCITSILNLALECSADLPGERICMRDVLPALEKIK 1046

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa]

 Score =  932 bits (2409), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 505/1039 (48%), Positives = 682/1039 (65%), Gaps = 41/1039 (3%)

Query: 6    IITLVPLLHCLMLSSVMAAVTNVTTDQFALLALKEHIKHDPSNLLANNWSTTSSVCSWIG 65
            I  LV +L   +    ++  T+  TDQ ALLA K+HI  DP N+L ++WS+ +S C+W+G
Sbjct: 6    ITILVSMLLMSLPKKCISIPTSNFTDQSALLAFKDHITFDPQNMLTHSWSSKTSFCNWMG 65

Query: 66   VTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKY 125
            V+C +R +RVTAL++S +GL GTIPPQLGNLSFL  L + NNSF G LP E+ +LR L+ 
Sbjct: 66   VSCSLRRQRVTALDLSSMGLLGTIPPQLGNLSFLQYLILYNNSFHGDLPSEIGNLRRLQV 125

Query: 126  FDFRFNNFHIEI-PSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGT 184
             D   N   + I P  F +L RL+ L    N+  G IP TI  +S L+ LDL  N L G+
Sbjct: 126  MDIGSNKLSLVIVPESFGNLHRLEELRFDGNNLTGTIPSTIFNISSLKVLDLMFNGLFGS 185

Query: 185  IPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIG 244
            +P ++     C +LP LE L +S NQL+G IP++L+KCREL ++ L +N F G       
Sbjct: 186  LPKNM-----CDHLPRLEMLLLSSNQLSGQIPSDLFKCRELQLLWLPYNNFTG------- 233

Query: 245  NLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTD 304
                              IP E+G L  LEVL +  + L+G +P SIFN+++L+ + +  
Sbjct: 234  -----------------VIPEELGFLPMLEVLNLGVNMLSGDLPRSIFNMTSLRTMQICC 276

Query: 305  NDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTF 364
            N+L GS+P    + LPNLE L L  N  +G++P  L N+S L +LD  +N  +G +   F
Sbjct: 277  NNLSGSIPQENSIDLPNLEELQLNLNGITGSMPRFLGNMSRLEILDLSYNKMTGNVLQEF 336

Query: 365  GNLRSLKLLSLAGNVLTS--PTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSI 422
            GNLR+L++LSL  N  T+   +  L+F++SLT+ R L+ +++ +NP++G+LP+S+GN S 
Sbjct: 337  GNLRALQVLSLQSNSFTNHPSSQTLNFITSLTNSRQLKELHIGDNPLDGMLPNSVGNLSS 396

Query: 423  SMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKL 482
             +    + +  + G IP E+GN++NL V+ L  N L G IP T+G L+K+Q LYL  N L
Sbjct: 397  FLTKFYVYASKLKGNIPGEIGNLSNLIVLSLEENSLMGPIPTTVGGLRKIQVLYLHKNNL 456

Query: 483  EGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLK 542
             GSIP D+C   RL ++ L +N LSG +P+C+GNLTSLR+L L  N L+S IP  LW+LK
Sbjct: 457  NGSIPSDICLARRLVDITLNNNVLSGEIPSCIGNLTSLRNLYLHFNILSSTIPMALWSLK 516

Query: 543  DILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRL 602
            D+L  NL SN L GSL   +G ++  I + LS N LSG IP TIG LQ L   SL  N  
Sbjct: 517  DLLILNLHSNFLYGSLPSQVGEMEAAIGIRLSSNQLSGNIPSTIGSLQNLIRFSLSKNSF 576

Query: 603  QGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFIT 662
            QG IPE+FGGL SL  +D+S NNLSG IPKS+EAL YL+  ++SFN L+GEIP  GPF  
Sbjct: 577  QGSIPEAFGGLVSLELLDLSQNNLSGEIPKSLEALRYLEFFSVSFNGLQGEIPRGGPFAN 636

Query: 663  FSAESFLGNQALCGSPKLQVSPCKTRSHPRSRTTVVLL-IVLPLVSALTMIVVLTAKLVR 721
            F+A SF+ N+ LCG  +LQV PC   S   S+T   LL   LP V+++ ++V     ++ 
Sbjct: 637  FTARSFIMNKGLCGPSRLQVPPCSIESRKDSKTKSRLLRFSLPTVASILLVVAFIFLVMG 696

Query: 722  RRRRRRRRQKGSTRPYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGV 781
             RRR R+       P         A  RRISY +LL AT+ F E+ LLG+GSFGSVY+G 
Sbjct: 697  CRRRYRKDPIPEALPV-------TAIQRRISYLELLHATNEFHESNLLGIGSFGSVYQGR 749

Query: 782  LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSN 841
            L DG+ +A K+F+++   +  SF  EC++M +IRHRNLVKII SCSN DFKALVLEYM  
Sbjct: 750  LRDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIRHRNLVKIICSCSNLDFKALVLEYMPK 809

Query: 842  GSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGH 901
            GSLEK LYS NY LDI+QR+ IMIDVASALEYLH GY +P+VHCD+KPSNVLL+E MV H
Sbjct: 810  GSLEKWLYSHNYCLDIIQRVNIMIDVASALEYLHHGYPSPVVHCDLKPSNVLLDEDMVAH 869

Query: 902  LSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
            + DFGIAK+LG+ ES  QT+TL TIGYMAPEYG +G VS K DVYS+GIMLME  T+K+P
Sbjct: 870  VCDFGIAKLLGENESFAQTRTLATIGYMAPEYGLDGLVSTKIDVYSFGIMLMEMLTRKRP 929

Query: 962  TDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVD 1021
            TDE+F GEMSLKR V +SL   S+ ++ D+N+LN  +     +E CV+SI  LA+ C  +
Sbjct: 930  TDEMFEGEMSLKRLVKESLPD-SVIDIVDSNMLNRGDGYSVKKEHCVTSIMELALQCVNE 988

Query: 1022 LPEKRISMKDVANRLVRIR 1040
             P +R++M ++  RL  I+
Sbjct: 989  SPGERMAMVEILARLKNIK 1007

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	1049
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.728	0.756	0.371	8e-168
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.842	0.862	0.385	6.2e-149
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.664	0.676	0.352	9.8e-146
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.908	0.812	0.335	1.4e-135
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.733	0.750	0.381	4.5e-130
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.763	0.641	0.323	1.2e-90
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.739	0.769	0.366	1.5e-122
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.730	0.757	0.348	2.2e-121
TAIR|locus:2085949	1141	AT3G24240 [Arabidopsis thalian	0.908	0.835	0.326	4.1e-120
UNIPROTKB|P93194	1109	INRPK1 "Receptor-like protein	0.919	0.870	0.321	1.8e-119

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 1240 (441.6 bits), Expect = 8.0e-168, Sum P(2) = 8.0e-168
 Identities = 295/794 (37%), Positives = 446/794 (56%)

Query:   143 SLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLE 202
             +L  L  L L  N F G IP+ +G LS L+ LD+  N L G IP  ++N S   NL    
Sbjct:    88 NLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLNLR--- 144

Query:   203 GLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGE 262
                +  N+L G +P+ L     L  ++L  N  +G +P  +GNLT +  L L +N+L GE
Sbjct:   145 ---LDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGE 201

Query:   263 IPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNL 322
             IP+++  L  +  L + ++N +G+ P +++N+S+LK L +  N   G L   + + LPNL
Sbjct:   202 IPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNL 261

Query:   323 ERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTS 382
                 +G N F+G+IP++L+NIS L  L    N+ +G IPT FGN+ +LKLL L  N L S
Sbjct:   262 LSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPT-FGNVPNLKLLFLHTNSLGS 320

Query:   383 PTP-DLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKE 441
              +  DL FL+SLT+C  LE + +  N + G LP SI N S  + +L +    ISG IP +
Sbjct:   321 DSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYD 380

Query:   442 LGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYL 501
             +GN+ NL  + L  N L+G +P +LG+L  L+ L L +N+L G IP  + ++  L  L L
Sbjct:   381 IGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDL 440

Query:   502 GDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFXXXXXXXXXXXXPD 561
              +N   G +P  LGN + L +L +G N L   IP  +  ++ +LR              D
Sbjct:   441 SNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQD 500

Query:   562 IGNLKVVIEMDLSLNALSGVIPVTIXXXXXXXXXXXRYNRLQGPIPESFGGLKSLNFVDM 621
             IG L+ +  + L  N LSG +P T+             N   G IP+   GL  +  VD+
Sbjct:   501 IGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPD-LKGLVGVKEVDL 559

Query:   622 SNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSPK-L 680
             SNN+LSG+IP+   + S L++LNLSFN LEG++P +G F   +  S +GN  LCG     
Sbjct:   560 SNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGF 619

Query:   681 QVSPCKTR--SHPRSRTTXXXXXXXXXXSALTMIVVLTAKLVXXXXXXXXXQKGSTRPYY 738
             Q+ PC ++  S  +  ++            +T++++L    V         +   T    
Sbjct:   620 QLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPT 679

Query:   739 DANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF 797
              + +  +    +ISY DL  AT+GFS + ++G GSFG+VYK +L  +   +A KV +M+ 
Sbjct:   680 PSTL--EVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQR 737

Query:   798 DGSLESFHAECKVMGSIRHRNLVKIISSCSN-----NDFKALVLEYMSNGSLEKCLYSDN 852
              G+++SF AEC+ +  IRHRNLVK++++CS+     N+F+AL+ E+M NGSL+  L+ + 
Sbjct:   738 RGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEE 797

Query:   853 Y--------FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSD 904
                       L +L+RL I IDVAS L+YLH     PI HCD+KPSNVLL++ +  H+SD
Sbjct:   798 VEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSD 857

Query:   905 FGIAKILGK--EES 916
             FG+A++L K  EES
Sbjct:   858 FGLARLLLKFDEES 871

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1454 (516.9 bits), Expect = 6.2e-149, P = 6.2e-149
 Identities = 362/940 (38%), Positives = 517/940 (55%)

Query:   143 SLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLE 202
             +L  L+ L L  N   G+IP  +  LS LQ L+LSDN + G+IP++I    +C  L  L+
Sbjct:   101 NLSFLRELDLGDNYLSGEIPPELSRLSRLQLLELSDNSIQGSIPAAI---GACTKLTSLD 157

Query:   203 GLFISYNQLTGPIPTNLW-KCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIG 261
                +S+NQL G IP  +    + L  + L  N   G IP  +GNLTS++   L  N L G
Sbjct:   158 ---LSHNQLRGMIPREIGASLKHLSNLYLYKNGLSGEIPSALGNLTSLQEFDLSFNRLSG 214

Query:   262 EIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPN 321
              IP+ +G L +L  + +  +NL+G+IP SI+N+S+L+  +V +N L G +P++    L  
Sbjct:   215 AIPSSLGQLSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFSVRENKLGGMIPTNAFKTLHL 274

Query:   322 LERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVL- 380
             LE + +G N F G IP+S+ N S L+V+    N FSG+I + FG LR+L  L L  N+  
Sbjct:   275 LEVIDMGTNRFHGKIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYLWRNLFQ 334

Query:   381 TSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPK 440
             T    D  F+S LT+C  L+ + L EN + G+LP+S  N S S+  L++E   I+G IPK
Sbjct:   335 TREQDDWGFISDLTNCSKLQTLNLGENNLGGVLPNSFSNLSTSLSFLALELNKITGSIPK 394

Query:   441 ELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLY 500
             ++GN+  L  + L NN   G++P +LGRL+ L  L    N L GSIP  + +L  L  L 
Sbjct:   395 DIGNLIGLQHLYLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTELNILL 454

Query:   501 LGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFXXXXXXXXXXXXP 560
             LG NK SG +P  L NLT+L  L L +N L+  IPS L+N++ +               P
Sbjct:   455 LGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIP 514

Query:   561 -DIGNLKVVIEMDLSLNALSGVIPVTIXXXXXXXXXXXRYNRLQGPIPESFGGLKSLNFV 619
              +IG+LK ++E     N LSG IP T+           + N L G IP + G LK L  +
Sbjct:   515 QEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETL 574

Query:   620 DMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGS-P 678
             D+S+NNLSG IP S+  ++ L  LNLSFN   GE+PT G F   S  S  GN  LCG  P
Sbjct:   575 DLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIP 634

Query:   679 KLQVSPC----KTRSH-PRSRTTXXXXXXXXXXSALTMIVVLTAKLVXXXXXXXXXQKGS 733
              L +  C    + R H P    +          S+L +++    K            KG 
Sbjct:   635 DLHLPRCCPLLENRKHFPVLPISVSLAAALAILSSLYLLITWH-KRTKKGAPSRTSMKG- 692

Query:   734 TRPYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVF 793
                      +P      +SY  L++ATDGF+   LLG GSFGSVYKG L     +A KV 
Sbjct:   693 ---------HPL-----VSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDHVAVKVL 738

Query:   794 HMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSN-----NDFKALVLEYMSNGSLEKCL 848
              +E   +L+SF AEC+ + ++RHRNLVKI++ CS+     NDFKA+V ++M NGSLE  +
Sbjct:   739 KLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWI 798

Query:   849 Y------SDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHL 902
             +      +D   L++ +R+ I++DVA AL+YLH     P+VHCDIK SNVLL+  MV H+
Sbjct:   799 HPETNDQADQRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHV 858

Query:   903 SDFGIAKILGKEESMRQTKT-----LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
              DFG+A+IL    S+ Q  T     +GTIGY APEYG     S   D+YSYGI+++E  T
Sbjct:   859 GDFGLARILVDGTSLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGILVLEIVT 918

Query:   958 KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL-------LNCEENDFSAR-EQCVS 1009
              K+PTD  F  ++ L+++V +  L   +T+V D  L       LN   N    R  +C+ 
Sbjct:   919 GKRPTDSTFRPDLGLRQYV-ELGLHGRVTDVVDTKLILDSENWLNSTNNSPCRRITECIV 977

Query:  1010 SIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYIDV 1049
              +  L + C+ +LP  R    D+ + L  I++ LS    V
Sbjct:   978 WLLRLGLSCSQELPSSRTPTGDIIDELNAIKQNLSGLFPV 1017

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 1068 (381.0 bits), Expect = 9.8e-146, Sum P(2) = 9.8e-146
 Identities = 253/718 (35%), Positives = 381/718 (53%)

Query:   143 SLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLE 202
             +L  L+ L L  NSF   IP+ +G L  LQ L++S N L G IPSS+   S+C  L  ++
Sbjct:    95 NLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSL---SNCSRLSTVD 151

Query:   203 GLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGE 262
                +S N L   +P+ L    +L ++ L+ N   G  P  +GNLTS++ L    N + GE
Sbjct:   152 ---LSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGE 208

Query:   263 IPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNL 322
             IP+E+  L  +    +  ++ +G  P +++NIS+L+ L++ DN   G+L +     LPNL
Sbjct:   209 IPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNL 268

Query:   323 ERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVL-T 381
              RL LG N F+G IP +L NIS L   D   N  SG IP +FG LR+L  L +  N L  
Sbjct:   269 RRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGN 328

Query:   382 SPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKE 441
             + +  L F+ ++ +C  LE + +  N + G LP+SI N S ++ SL +    ISG IP +
Sbjct:   329 NSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHD 388

Query:   442 LGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYL 501
             +GN+ +L  + L  N L+G +PV+ G+L  LQ + L +N + G IP    ++ RL  L+L
Sbjct:   389 IGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHL 448

Query:   502 GDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFXXXXXXXXXXXXPD 561
               N   GR+P  LG    L DL + +N L   IP  +  +  +                +
Sbjct:   449 NSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEE 508

Query:   562 IGNLKVVIEMDLSLNALSGVIPVTIXXXXXXXXXXXRYNRLQGPIPESFGGLKSLNFVDM 621
             +G L++++ +  S N LSG +P  I           + N   G IP+    L SL  VD 
Sbjct:   509 VGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDF 567

Query:   622 SNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSPK-L 680
             SNNNLSG IP+ + +L  L++LNLS N+ EG +PT G F   +A S  GN  +CG  + +
Sbjct:   568 SNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREM 627

Query:   681 QVSPCKTRSHPRSRTTXXXXXXXXXXSALTMIVVLTAKLVXXXXXXXXXQKGSTRPYYDA 740
             Q+ PC  ++ PR R              + +  +L   +V         +K +     D 
Sbjct:   628 QLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNAS--DG 685

Query:   741 NMYPQATW----RRISYQDLLRATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHM 795
             N     T      ++SY++L  AT  FS   L+G G+FG+V+KG+L P+   +A KV ++
Sbjct:   686 NPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNL 745

Query:   796 EFDGSLESFHAECKVMGSIRHRNLVKIISSCSN-----NDFKALVLEYMSNGSLEKCL 848
                G+ +SF AEC+    IRHRNLVK+I+ CS+     NDF+ALV E+M  GSL+  L
Sbjct:   746 LKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWL 803

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1328 (472.5 bits), Expect = 1.4e-135, P = 1.4e-135
 Identities = 338/1007 (33%), Positives = 519/1007 (51%)

Query:    78 LNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEI 137
             +   Y  LTG IP  LG+L  L +     N   GS+P  +  L  L   D   N    +I
Sbjct:   173 IGFDYNNLTGKIPECLGDLVHLQMFVAAGNHLTGSIPVSIGTLANLTDLDLSGNQLTGKI 232

Query:   138 PSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQN 197
             P  F +L  LQ L+L  N   G IP  IG  S L +L+L DNQL+G IP+ + N+   Q 
Sbjct:   233 PRDFGNLLNLQSLVLTENLLEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQLQA 292

Query:   198 LPVLEG---------LF---------ISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGI 239
             L + +          LF         +S N L GPI   +     L V++L  N F G  
Sbjct:   293 LRIYKNKLTSSIPSSLFRLTQLTHLGLSENHLVGPISEEIGFLESLEVLTLHSNNFTGEF 352

Query:   240 PRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKE 299
             P+ I NL ++  L +G N++ GE+P ++G L NL  L    + L G IP+SI N + LK 
Sbjct:   353 PQSITNLRNLTVLTVGFNNISGELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKL 412

Query:   300 LAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGL 359
             L ++ N + G +P     G  NL  + +G N+F+G IP  + N S L  L    N+ +G 
Sbjct:   413 LDLSHNQMTGEIPRGF--GRMNLTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGT 470

Query:   360 IPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGN 419
             +    G L+ L++L ++ N LT P P       + + ++L I+YL  N   G +P  + N
Sbjct:   471 LKPLIGKLQKLRILQVSYNSLTGPIP-----REIGNLKDLNILYLHSNGFTGRIPREMSN 525

Query:   420 FSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQN 479
              ++ ++ L M S ++ G IP+E+ ++  L+V+ L NN+ +G IP    +L+ L  L LQ 
Sbjct:   526 LTL-LQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQG 584

Query:   480 NKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSL----GSNALTSIIP 535
             NK  GSIP  L  L  L    + DN L+G +P  L  L SL+++ L     +N LT  IP
Sbjct:   585 NKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGEL--LASLKNMQLYLNFSNNLLTGTIP 642

Query:   536 STLWNLKDILRFXXXXXXXXXXXXPDIGNLKVVIEMDLSLNALSGVIPVTIXXXXXXXXX 595
               L  L+ +                 +   K V  +D S N LSG IP  +         
Sbjct:   643 KELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIIS 702

Query:   596 XX-RYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEI 654
                  N   G IP+SFG +  L  +D+S+NNL+G IP+S+  LS LKHL L+ N L+G +
Sbjct:   703 LNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHV 762

Query:   655 PTRGPFITFSAESFLGNQALCGSPKLQVSPC--KTRSHPRSRTTXXXXXXXXXXSALTMI 712
             P  G F   +A   +GN  LCGS K  + PC  K +S   S+ T          +AL ++
Sbjct:   763 PESGVFKNINASDLMGNTDLCGSKK-PLKPCTIKQKSSHFSKRTRVILIILGSAAALLLV 821

Query:   713 VVLTAKLVXXXXXXXXXQKGSTRPYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMG 772
             ++L   L          +  S     D +   +   +R   ++L +ATD F+   ++G  
Sbjct:   822 LLLVLILTCCKKKEKKIENSSESSLPDLDSALKL--KRFEPKELEQATDSFNSANIIGSS 879

Query:   773 SFGSVYKGVLPDGMEIAAKVFHM-EFDGSLES-FHAECKVMGSIRHRNLVKIIS-SCSNN 829
             S  +VYKG L DG  IA KV ++ EF    +  F+ E K +  ++HRNLVKI+  +  + 
Sbjct:   880 SLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESG 939

Query:   830 DFKALVLEYMSNGSLEKCLYSDNYFL-DILQRLKIMIDVASALEYLHFGYSTPIVHCDIK 888
               KALVL +M NG+LE  ++     +  +L+++ + + +AS ++YLH GY  PIVHCD+K
Sbjct:   940 KTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLK 999

Query:   889 PSNVLLNESMVGHLSDFGIAKILG-KEESMRQTKTL---GTIGYMAPEYGREGKVSRKCD 944
             P+N+LL+   V H+SDFG A+ILG +E+      T    GTIGY+APE+    KV+ K D
Sbjct:  1000 PANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKAD 1059

Query:   945 VYSYGIMLMETFTKKKPT--DEIFAGEMSLKRWVGDSLLSC--SITEVADANLLNCEEND 1000
             V+S+GI++ME  TK++PT  ++  + +M+L++ V  S+ +    +  V D  L    ++ 
Sbjct:  1060 VFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDMEL---GDSI 1116

Query:  1001 FSAR-EQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAY 1046
              S + E+ +     L + CT   PE R  M ++   L+++R   +++
Sbjct:  1117 VSLKQEEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLRGKANSF 1163

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1276 (454.2 bits), Expect = 4.5e-130, P = 4.5e-130
 Identities = 304/796 (38%), Positives = 440/796 (55%)

Query:   137 IPSWFV-SLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSC 195
             + S FV +L  L+ L L  N F G IP  +G L  LQ L++S+N   G IP  +   S+C
Sbjct:    96 VVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVL---SNC 152

Query:   196 QNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLG 255
              +L  L+   +S N L   +P       +L ++SL  N   G  P  +GNLTS++ L   
Sbjct:   153 SSLSTLD---LSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFI 209

Query:   256 NNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSI 315
              N + GEIP +I  L+ +    +  +   G+ P  I+N+S+L  L++T N   G+L    
Sbjct:   210 YNQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDF 269

Query:   316 DLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSL 375
                LPNL+ L++G N+F+GTIP +L+NIS L  LD   N  +G IP +FG L++L LL L
Sbjct:   270 GSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGL 329

Query:   376 AGNVLTS-PTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNI 434
               N L +  + DL FL +LT+C  L+ + +  N + G LP  I N S  +  LS+    I
Sbjct:   330 NNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLI 389

Query:   435 SGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLY 494
             SG IP  +GN+ +L  + LG N LTG +P +LG L +L+ + L +N L G IP  L ++ 
Sbjct:   390 SGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNIS 449

Query:   495 RLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFXXXXXXX 554
              L  LYL +N   G +P+ LG+ + L DL+LG+N L   IP  L  L  ++         
Sbjct:   450 GLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLL 509

Query:   555 XXXXXPDIGNLKVVIEMDLSLNALSGVIPVTIXXXXXXXXXXXRYNRLQGPIPESFGGLK 614
                   DIG LK ++ +D+S N LSG IP T+           + N   GPIP+   GL 
Sbjct:   510 VGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPD-IRGLT 568

Query:   615 SLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQAL 674
              L F+D+S NNLSGTIP+ M   S L++LNLS N  +G +PT G F   SA S  GN  L
Sbjct:   569 GLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINL 628

Query:   675 CGS-PKLQVSPCKTRSHPRSRTTXXXXXXXXXXSALTMIVVLTAKLVXXXXXXXXXQK-G 732
             CG  P LQ+ PC     PR  ++          + +  +++L   +V         +   
Sbjct:   629 CGGIPSLQLQPCSVEL-PRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVR 687

Query:   733 STRPYYDANMYP-QATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPD-GMEIAA 790
             +     D +  P ++ + +ISY +L + T GFS + L+G G+FG+V+KG L      +A 
Sbjct:   688 ANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAI 747

Query:   791 KVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSN-----NDFKALVLEYMSNGSLE 845
             KV ++   G+ +SF AEC+ +G IRHRNLVK+++ CS+     NDF+ALV E+M NG+L+
Sbjct:   748 KVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLD 807

Query:   846 KCLYSDNY--------FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES 897
               L+ D           L +  RL I IDVASAL YLH     PI HCDIKPSN+LL++ 
Sbjct:   808 MWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKD 867

Query:   898 MVGHLSDFGIAKILGK 913
             +  H+SDFG+A++L K
Sbjct:   868 LTAHVSDFGLAQLLLK 883

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 904 (323.3 bits), Expect = 1.2e-90, P = 1.2e-90
 Identities = 278/860 (32%), Positives = 414/860 (48%)

Query:    71 RNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRF 130
             R   +  LN++   LTG IP QLG +S L  L++  N   G +P+ L+ L  L+  D   
Sbjct:   237 RLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSA 296

Query:   131 NNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETI-GYLSLLQELDLSDNQLSGTIPSSI 189
             NN   EIP  F ++ +L  L+L +N   G +P++I    + L++L LS  QLSG IP  +
Sbjct:   297 NNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVEL 356

Query:   190 FNISSCQNLPV----LEG--------------LFISYNQLTGPIPTNLWKCRELHVVSLA 231
                 S + L +    L G              L++  N L G +  ++     L  + L 
Sbjct:   357 SKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLY 416

Query:   232 FNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASI 291
              N  +G +P++I  L  +  LFL  N   GEIP EIGN  +L+++ +  ++  G IP SI
Sbjct:   417 HNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSI 476

Query:   292 FNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDF 351
               +  L  L +  N+L+G LP+S+      L  L L +N  SG+IPSS   +  L  L  
Sbjct:   477 GRLKELNLLHLRQNELVGGLPASLG-NCHQLNILDLADNQLSGSIPSSFGFLKGLEQLML 535

Query:   352 GFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPING 411
               NS  G +P +  +LR+L  ++L+ N L      L   SS  S        ++ N    
Sbjct:   536 YNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLS------FDVTNNGFED 589

Query:   412 ILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQK 471
              +P  +GN S ++  L +    ++G IP  LG I  L+++ + +N LTGTIP+ L   +K
Sbjct:   590 EIPLELGN-SQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKK 648

Query:   472 LQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALT 531
             L  + L NN L G IP  L  L +L  L L  N+    LP  L N T L  LSL  N+L 
Sbjct:   649 LTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLN 708

Query:   532 SIIPSTLWNLKDILRFXXXXXXXXXXXXPD-IGNLKVVIEMDLSLNALSGVIPVTIXXXX 590
               IP  + NL   L              P  +G L  + E+ LS N+L+G IPV I    
Sbjct:   709 GSIPQEIGNL-GALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQ 767

Query:   591 XXXXXXX-RYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQ 649
                      YN   G IP + G L  L  +D+S+N L+G +P S+  +  L +LN+SFN 
Sbjct:   768 DLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNN 827

Query:   650 LEGEIPTRGPFITFSAESFLGNQALCGSPKLQVSPC-KTRSHPRSR-TTXXXXXXXXXXS 707
             L G++  +  F  + A+SFLGN  LCGSP   +S C + RS+ + +  +          S
Sbjct:   828 LGGKLKKQ--FSRWPADSFLGNTGLCGSP---LSRCNRVRSNNKQQGLSARSVVIISAIS 882

Query:   708 ALT----MIVVLTAKLVXXXXXXXXXQKGSTRPYYDANMYPQAT----WRR------ISY 753
             ALT    MI+V+                GST  Y  ++   QAT    +R       I +
Sbjct:   883 ALTAIGLMILVIALFFKQRHDFFKKVGHGSTA-YTSSSSSSQATHKPLFRNGASKSDIRW 941

Query:   754 QDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFD-GSLESFHAECKVMG 812
             +D++ AT   SE  ++G G  G VYK  L +G  +A K    + D  S +SF  E K +G
Sbjct:   942 EDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLG 1001

Query:   813 SIRHRNLVKIISSCSNND--FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASA 870
              IRHR+LVK++  CS+       L+ EYM NGS+   L+ D     +L++ K ++D  + 
Sbjct:  1002 RIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDK---PVLEKKKKLLDWEAR 1058

Query:   871 LEY-LHFGYSTPIVHCDIKP 889
             L   +        +H D  P
Sbjct:  1059 LRIAVGLAQGVEYLHHDCVP 1078

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 1205 (429.2 bits), Expect = 1.5e-122, P = 1.5e-122
 Identities = 295/804 (36%), Positives = 441/804 (54%)

Query:   143 SLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLE 202
             +L  L +L L +NSF G IP+ +G L  L+ L +  N L G IP+S+   S+C  L  L+
Sbjct:    88 NLSFLIYLDLSNNSFGGTIPQEMGNLFRLKYLAVGFNYLEGEIPASL---SNCSRLLYLD 144

Query:   203 GLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGE 262
              LF   N L   +P+ L   R+L  + L  N  +G  P  I NLTS+  L LG N L GE
Sbjct:   145 -LFS--NNLGDGVPSELGSLRKLLYLYLGLNDLKGKFPVFIRNLTSLIVLNLGYNHLEGE 201

Query:   263 IPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNL 322
             IP++I  L  +  L +  +N +G+ P + +N+S+L+ L +  N   G+L       LPN+
Sbjct:   202 IPDDIAMLSQMVSLTLTMNNFSGVFPPAFYNLSSLENLYLLGNGFSGNLKPDFGNLLPNI 261

Query:   323 ERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTS 382
               L L  N  +G IP++L NIS L +   G N  +G I   FG L +L  L LA N L S
Sbjct:   262 HELSLHGNFLTGAIPTTLANISTLEMFGIGKNRMTGSISPNFGKLENLHYLELANNSLGS 321

Query:   383 PT-PDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKE 441
              +  DL+FL +LT+C +L  + +S N + G LP+SI N S  +  L+++   I G IP +
Sbjct:   322 YSFGDLAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNMSTELTVLNLKGNLIYGSIPHD 381

Query:   442 LGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYL 501
             +GN+  L  + L +N LTG +P +LG L  L  L L +N+  G IP  + +L +L  LYL
Sbjct:   382 IGNLIGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNLTQLVKLYL 441

Query:   502 GDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFXXXXXXXXXXXXPD 561
              +N   G +P  LG+ + + DL +G N L   IP  +  +  ++               D
Sbjct:   442 SNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVHLNMESNSLSGSLPND 501

Query:   562 IGNLKVVIEMDLSLNALSGVIPVTIXXXXXXXXXXXRYNRLQGPIPESFGGLKSLNFVDM 621
             IG L+ ++E+ L  N LSG +P T+           + N   G IP+   GL  +  VD+
Sbjct:   502 IGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIPD-IKGLMGVKNVDL 560

Query:   622 SNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSPK-L 680
             SNNNLSG+I +  E  S L++LNLS N  EG +PT G F   +  S  GN+ LCGS K L
Sbjct:   561 SNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFGNKNLCGSIKEL 620

Query:   681 QVSPCKTRSHPRSRTTXXXXXXXXXXSALTMIVVLTAKLVXXXXXXXXXQKGSTRPYYDA 740
             ++ PC  ++ P    T            +++ + L   L          +K + +    A
Sbjct:   621 KLKPCIAQAPPVE--TRHPSLLKKVAIGVSVGIALLLLLFIVSLSWFKKRKNNQKINNSA 678

Query:   741 NMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDG 799
                 +    ++SY DL  ATDGFS + ++G GSFG+V+K +L  +   +A KV +M+  G
Sbjct:   679 PFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRG 738

Query:   800 SLESFHAECKVMGSIRHRNLVKIISSCSN-----NDFKALVLEYMSNGSLEKCLYSDNY- 853
             +++SF AEC+ +  IRHRNLVK++++C++     N+F+AL+ E+M NGSL+K L+ +   
Sbjct:   739 AMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVE 798

Query:   854 -------FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFG 906
                     L +L+RL I IDVAS L+YLH     PI HCD+KPSN+LL++ +  H+SDFG
Sbjct:   799 EIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFG 858

Query:   907 IAKILGK--EESM-RQTKTLGTIG 927
             +A++L K  +ES   Q  + G  G
Sbjct:   859 LARLLLKFDQESFFNQLSSAGVRG 882

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 1194 (425.4 bits), Expect = 2.2e-121, P = 2.2e-121
 Identities = 277/795 (34%), Positives = 438/795 (55%)

Query:   152 LKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQL 211
             L  N+F G IP  +G L  L+ L ++ N L G IP+++ N S   NL +        N L
Sbjct:    97 LSDNAFGGIIPREVGNLFRLEHLYMAFNSLEGGIPATLSNCSRLLNLDLYS------NPL 150

Query:   212 TGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLR 271
                +P+ L    +L ++ L  N  +G +PR +GNLTS+++L   +N++ GE+P+E+  L 
Sbjct:   151 RQGVPSELGSLTKLVILDLGRNNLKGKLPRSLGNLTSLKSLGFTDNNIEGEVPDELARLS 210

Query:   272 NLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENN 331
              +  LG+  +   G+ P +I+N+S L++L +  +   GSL       LPN+  L LGEN+
Sbjct:   211 QMVGLGLSMNKFFGVFPPAIYNLSALEDLFLFGSGFSGSLKPDFGNLLPNIRELNLGEND 270

Query:   332 FSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPT-PDLSFL 390
               G IP++L+NIS L       N  +G I   FG + SL+ L L+ N L S T  DL F+
Sbjct:   271 LVGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSLQYLDLSENPLGSYTFGDLEFI 330

Query:   391 SSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTV 450
              SLT+C +L+++ +    + G LP+SI N S  + SL++   +  G IP+++GN+  L  
Sbjct:   331 DSLTNCTHLQLLSVGYTRLGGALPTSIANMSTELISLNLIGNHFFGSIPQDIGNLIGLQR 390

Query:   451 IRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRL 510
             ++LG N LTG +P +LG+L +L  L L +N++ G IP  + +L +L  LYL +N   G +
Sbjct:   391 LQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLEILYLSNNSFEGIV 450

Query:   511 PACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFXXXXXXXXXXXXPDIGNLKVVIE 570
             P  LG  + + DL +G N L   IP  +  +  ++               DIG+L+ +++
Sbjct:   451 PPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVNLSMEGNSLSGSLPNDIGSLQNLVK 510

Query:   571 MDLSLNALSGVIPVTIXXXXXXXXXXXRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTI 630
             + L  N  SG +P T+           + N   G IP +  GL  +  VD+SNN+LSG+I
Sbjct:   511 LSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIP-NIRGLMGVRRVDLSNNDLSGSI 569

Query:   631 PKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSPK-LQVSPCKTRS 689
             P+     S L++LNLS N   G++P++G F   +     GN+ LCG  K L++ PC  + 
Sbjct:   570 PEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLCGGIKDLKLKPCLAQE 629

Query:   690 HPRSRTTXXXXXXXXXXSALTMIVVLTAKLVXXXXXXXXXQKGSTRPYYDANMYP---QA 746
              P    T            +++ + L   LV         +K       + N+ P   + 
Sbjct:   630 PPVE--TKHSSHLKKVAILVSIGIALLLLLVIASMVLCWFRKRRKNQQTN-NLVPSKLEI 686

Query:   747 TWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVFHMEFDGSLESFH 805
                +ISY DL  AT+GFS + ++G GSFG+V+K +LP   +I A KV +M+  G+++SF 
Sbjct:   687 FHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFM 746

Query:   806 AECKVMGSIRHRNLVKIISSCSN-----NDFKALVLEYMSNGSLEKCLYSDNY------- 853
             AEC+ +   RHRNLVK++++C++     N+F+AL+ EY+ NGS++  L+ +         
Sbjct:   747 AECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHPEEVEEIRRPP 806

Query:   854 -FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG 912
               L +L+RL I+IDVAS L+YLH     PI HCD+KPSNVLL + +  H+SDFG+A++L 
Sbjct:   807 RTLTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLL 866

Query:   913 KEESMRQTKTLGTIG 927
             K +       L + G
Sbjct:   867 KFDKESFLNQLSSAG 881

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)]

 Score = 1182 (421.1 bits), Expect = 4.1e-120, P = 4.1e-120
 Identities = 325/996 (32%), Positives = 494/996 (49%)

Query:    73 RRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNN 132
             R +  L IS   LTGT+P  LG+   L VL + +N   G +P  LS LR L+      N 
Sbjct:   105 RSLQKLTISGANLTGTLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNLETLILNSNQ 164

Query:   133 FHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDN-QLSGTIPSSIFN 191
                +IP       +L+ L+L  N   G IP  +G LS L+ + +  N ++SG IPS I  
Sbjct:   165 LTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEISGQIPSEI-- 222

Query:   192 ISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRN 251
                C NL VL GL  +   ++G +P++L K ++L  +S+      G IP D+GN + + +
Sbjct:   223 -GDCSNLTVL-GL--AETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSELVD 278

Query:   252 LFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSL 311
             LFL  NSL G IP EIG L  LE L +  ++L G IP  I N S LK + ++ N L GS+
Sbjct:   279 LFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSI 338

Query:   312 PSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLK 371
             PSSI   L  LE   + +N FSG+IP++++N S L  L    N  SGLIP+  G L  L 
Sbjct:   339 PSSIGR-LSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLT 397

Query:   372 LLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSI-SMKSLSME 430
             L     N L    P       L  C +L+ + LS N + G +PS  G F + ++  L + 
Sbjct:   398 LFFAWSNQLEGSIPP-----GLADCTDLQALDLSRNSLTGTIPS--GLFMLRNLTKLLLI 450

Query:   431 SCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDL 490
             S ++SG IP+E+GN ++L  +RLG N +TG IP  +G L+K+  L   +N+L G +P+++
Sbjct:   451 SNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEI 510

Query:   491 CHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFXXX 550
                  L  + L +N L G LP  + +L+ L+ L + +N  +  IP++L  L  + +    
Sbjct:   511 GSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILS 570

Query:   551 XXXXXXXXXPDIGNLKVVIEMDLSLNALSGVIPVTIXXXXXXXXXXX-RYNRLQGPIPES 609
                        +G    +  +DL  N LSG IP  +              NRL G IP  
Sbjct:   571 KNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSK 630

Query:   610 FGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFL 669
                L  L+ +D+S+N L G +   +  +  L  LN+S+N   G +P    F   S +   
Sbjct:   631 IASLNKLSILDLSHNMLEGDLAP-LANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLE 689

Query:   670 GNQALCGSPKLQVSPCKT-RSHPRSRTTXXXXXXXXXXSALTMIVVLTAKLVXXXXXXXX 728
             GN+ LC S   Q S   T R                    L +++ LT  L+        
Sbjct:   690 GNKKLCSST--QDSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVI 747

Query:   729 XQKGSTRPYYDANMYPQATWRRISYQDLLRATDGFS----ENKLLGMGSFGSVYKGVLPD 784
               + +     D+ +     W+   +Q L  + D       E  ++G G  G VY+  + +
Sbjct:   748 RARRNIDNERDSELGETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDN 807

Query:   785 GMEIAAKVF--------HMEFDGSL-ESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV 835
             G  IA K          H E   ++ +SF AE K +G+IRH+N+V+ +  C N + + L+
Sbjct:   808 GEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLM 867

Query:   836 LEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL 894
              +YM NGSL   L+      LD   R +I++  A  L YLH     PIVH DIK +N+L+
Sbjct:   868 YDYMPNGSLGSLLHERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILI 927

Query:   895 NESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGYMAPEYGREGKVSRKCDVYSYGIMLM 953
                   +++DFG+AK++ + +  R + T+ G+ GY+APEYG   K++ K DVYSYG++++
Sbjct:   928 GLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVL 987

Query:   954 ETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFS 1013
             E  T K+P D      + L  WV  +  S    EV D+ L +  E +  A E  +  +  
Sbjct:   988 EVLTGKQPIDPTVPEGIHLVDWVRQNRGSL---EVLDSTLRSRTEAE--ADE--MMQVLG 1040

Query:  1014 LAMDCTVDLPEKRISMKDVANRLVRIRETLSAYIDV 1049
              A+ C    P++R +MKDVA  L  I++    Y  V
Sbjct:  1041 TALLCVNSSPDERPTMKDVAAMLKEIKQEREEYAKV 1076

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010359 "regulation of anion channel activity" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

UNIPROTKB|P93194 INRPK1 "Receptor-like protein kinase" [Ipomoea nil (taxid:35883)]

 Score = 1176 (419.0 bits), Expect = 1.8e-119, P = 1.8e-119
 Identities = 334/1038 (32%), Positives = 505/1038 (48%)

Query:    41 HIKHDPSNLLANNWSTTSSVCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLA 100
             H+KH    +L+ N     S+ S +G  C +       +++S    TG IP  LG L  L 
Sbjct:    90 HLKHLKKVVLSGN-GFFGSIPSQLG-NCSLLEH----IDLSSNSFTGNIPDTLGALQNLR 143

Query:   101 VLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGK 160
              L++  NS  G  PE L  +  L+   F  N  +  IPS   ++  L  L L  N F G 
Sbjct:   144 NLSLFFNSLIGPFPESLLSIPHLETVYFTGNGLNGSIPSNIGNMSELTTLWLDDNQFSGP 203

Query:   161 IPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLW 220
             +P ++G ++ LQEL L+DN L GT+P ++ N+   +NL  L+   +  N L G IP +  
Sbjct:   204 VPSSLGNITTLQELYLNDNNLVGTLPVTLNNL---ENLVYLD---VRNNSLVGAIPLDFV 257

Query:   221 KCRELHVVSLAFNKFQGGIPRDIGNLTSVRN------------------------LFLGN 256
              C+++  +SL+ N+F GG+P  +GN TS+R                         L+L  
Sbjct:   258 SCKQIDTISLSNNQFTGGLPPGLGNCTSLREFGAFSCALSGPIPSCFGQLTKLDTLYLAG 317

Query:   257 NSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSID 316
             N   G IP E+G  +++  L +Q + L G IP  +  +S L+ L +  N+L G +P SI 
Sbjct:   318 NHFSGRIPPELGKCKSMIDLQLQQNQLEGEIPGELGMLSQLQYLHLYTNNLSGEVPLSI- 376

Query:   317 LGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLA 376
               + +L+ L L +NN SG +P  +T + +L  L    N F+G+IP   G   SL++L L 
Sbjct:   377 WKIQSLQSLQLYQNNLSGELPVDMTELKQLVSLALYENHFTGVIPQDLGANSSLEVLDLT 436

Query:   377 GNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISG 436
              N+ T   P      +L S + L+ + L  N + G +PS +G  S +++ L +E  N+ G
Sbjct:   437 RNMFTGHIPP-----NLCSQKKLKRLLLGYNYLEGSVPSDLGGCS-TLERLILEENNLRG 490

Query:   437 GIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRL 496
             G+P +     NL    L  N  TG IP +LG L+ +  +YL +N+L GSIP +L  L +L
Sbjct:   491 GLP-DFVEKQNLLFFDLSGNNFTGPIPPSLGNLKNVTAIYLSSNQLSGSIPPELGSLVKL 549

Query:   497 ANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFXXXXXXXXX 556
              +L L  N L G LP+ L N   L +L    N L   IPSTL +L ++ +          
Sbjct:   550 EHLNLSHNILKGILPSELSNCHKLSELDASHNLLNGSIPSTLGSLTELTKLSLGENSFSG 609

Query:   557 XXXPDIGNLKVVIEMDLSLNALSGVIPVTIXXXXXXXXXXXRYNRLQGPIPESFGGLKSL 616
                  +     ++ + L  N L+G IP  +             N+L G +P   G LK L
Sbjct:   610 GIPTSLFQSNKLLNLQLGGNLLAGDIP-PVGALQALRSLNLSSNKLNGQLPIDLGKLKML 668

Query:   617 NFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIP-TRGPFITFSAESFLGNQALC 675
               +D+S+NNLSGT+ + +  +  L  +N+S N   G +P +   F+  S  SF GN  LC
Sbjct:   669 EELDVSHNNLSGTL-RVLSTIQSLTFINISHNLFSGPVPPSLTKFLNSSPTSFSGNSDLC 727

Query:   676 --------GSPKLQV-SPCKTRSHPRSRTTXXXXXXXXXXSALTMIVVLTAKLVXXXXXX 726
                       P+  +  PC  +S+                 AL  I+ L    +      
Sbjct:   728 INCPADGLACPESSILRPCNMQSNTGKGGLSTLGIAMIVLGALLFIICL---FLFSAFLF 784

Query:   727 XXXQKGSTRPYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVL-PDG 785
                +K        A     +   ++     L AT+  ++  ++G G+ G++YK  L PD 
Sbjct:   785 LHCKKSVQEIAISAQEGDGSLLNKV-----LEATENLNDKYVIGKGAHGTIYKATLSPDK 839

Query:   786 MEIAAK-VFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSL 844
             +    K VF    +GS+ S   E + +G +RHRNL+K+       ++  ++  YM NGSL
Sbjct:   840 VYAVKKLVFTGIKNGSV-SMVREIETIGKVRHRNLIKLEEFWLRKEYGLILYTYMENGSL 898

Query:   845 EKCLYSDN--YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHL 902
                L+  N    LD   R  I +  A  L YLHF     IVH DIKP N+LL+  +  H+
Sbjct:   899 HDILHETNPPKPLDWSTRHNIAVGTAHGLAYLHFDCDPAIVHRDIKPMNILLDSDLEPHI 958

Query:   903 SDFGIAKILGKEESMRQTKTL-GTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
             SDFGIAK+L +  +   + T+ GTIGYMAPE       SR+ DVYSYG++L+E  T+KK 
Sbjct:   959 SDFGIAKLLDQSATSIPSNTVQGTIGYMAPENAFTTVKSRESDVYSYGVVLLELITRKKA 1018

Query:   962 TDEIFAGEMSLKRWVGDSLLSCS-ITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTV 1020
              D  F GE  +  WV         I ++ D +LL+ E  D S  EQ V+   SLA+ C  
Sbjct:  1019 LDPSFNGETDIVGWVRSVWTQTGEIQKIVDPSLLD-ELIDSSVMEQ-VTEALSLALRCAE 1076

Query:  1021 DLPEKRISMKDVANRLVR 1038
                +KR +M+DV  +L R
Sbjct:  1077 KEVDKRPTMRDVVKQLTR 1094

GO:0005524 "ATP binding" evidence=NAS

GO:0005576 "extracellular region" evidence=NAS

GO:0005886 "plasma membrane" evidence=NAS

GO:0006468 "protein phosphorylation" evidence=NAS

GO:0019199 "transmembrane receptor protein kinase activity" evidence=NAS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
C0LGP4	Y3475_ARATH	2, ., 7, ., 1, 1, ., 1	0.3692	0.9037	0.9386	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00025217001 SubName- Full=Chromosome chr9 scaffold_33, whole genome shotgun sequence; (2202 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	1049
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-125
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-47
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-44
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	9e-43
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-41
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-40
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-38
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-37
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-36
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-32
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-31
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-28
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	8e-28
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-27
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-27
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-27
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	7e-27
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	9e-27
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	9e-27
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-26
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-25
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-24
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-24
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-23
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-23
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-22
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-22
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-22
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-22
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-22
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-22
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-22
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-22
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	9e-22
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-21
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-21
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-21
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-20
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-20
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-20
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-20
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-20
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-19
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-19
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-19
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-19
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-19
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-19
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-19
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-18
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-18
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-18
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-18
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-18
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-18
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-18
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-17
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-17
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-17
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-17
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-17
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-16
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-16
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-16
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-16
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-16
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-16
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-16
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	6e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-16
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-16
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	9e-16
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-15
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-15
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-15
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-15
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	7e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-14
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-14
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-14
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-14
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-14
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-14
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-13
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-13
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-13
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-13
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-13
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-13
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-13
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-13
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-13
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-13
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-12
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-12
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-12
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-12
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-12
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-12
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-12
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-12
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	6e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	8e-12
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	8e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-12
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	9e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	9e-12
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-11
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-11
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-11
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	6e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	8e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-10
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-10
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-10
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	7e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	7e-10
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-09
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-09
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-09
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	7e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	7e-09
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	7e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-09
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-08
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	1e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-08
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-08
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-08
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-08
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-08
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-08
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-08
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	6e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	9e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-07
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-07
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-07
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-07
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	2e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-07
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-07
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	4e-07
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-07
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-07
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-07
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	8e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	9e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-06
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-06
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-06
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-06
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-06
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	7e-06
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	7e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	8e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	9e-06
PLN03210	1153	PLN03210, PLN03210, Resistant to P	9e-06
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	9e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-05
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-05
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-05
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	5e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-05
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	6e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	6e-05
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-05
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	9e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-04
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-04
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-04
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	5e-04
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-04
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-04
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	6e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	6e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	8e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.001
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	0.001
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.002
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  405 bits (1043), Expect = e-125
 Identities = 301/1011 (29%), Positives = 483/1011 (47%), Gaps = 105/1011 (10%)

Query: 35   LLALKEHIKHDPSNLLANNWSTTSSVCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLG 94
            LL+ K  I +DP   L+N W++++ VC W G+TC   + RV ++++S   ++G I   + 
Sbjct: 34   LLSFKSSI-NDPLKYLSN-WNSSADVCLWQGITCN-NSSRVVSIDLSGKNISGKISSAIF 90

Query: 95   NLSFLAVLAIRNNSFFGSLPEELSHL-RGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLK 153
             L ++  + + NN   G +P+++      L+Y +   NNF   IP     +P L+ L L 
Sbjct: 91   RLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGS--IPNLETLDLS 148

Query: 154  HNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTG 213
            +N   G+IP  IG  S L+ LDL  N L G IP+S+ N++S      LE L ++ NQL G
Sbjct: 149  NNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTS------LEFLTLASNQLVG 202

Query: 214  PIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNL 273
             IP  L + + L  + L +N   G IP +IG LTS+ +L L  N+L G IP+ +GNL+NL
Sbjct: 203  QIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNL 262

Query: 274  EVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFS 333
            + L +  + L+G IP SIF++  L  L ++DN L G +P  + + L NLE L L  NNF+
Sbjct: 263  QYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELV-IQLQNLEILHLFSNNFT 321

Query: 334  GTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSL 393
            G IP +LT++  L VL    N FSG IP   G                            
Sbjct: 322  GKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHN------------------------- 356

Query: 394  TSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRL 453
                NL ++ LS N                         N++G IP+ L +  NL  + L
Sbjct: 357  ----NLTVLDLSTN-------------------------NLTGEIPEGLCSSGNLFKLIL 387

Query: 454  GNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPAC 513
             +N L G IP +LG  + L+ + LQ+N   G +P +   L  +  L + +N L GR+ + 
Sbjct: 388  FSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSR 447

Query: 514  LGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDL 573
              ++ SL+ LSL  N     +P   +  K +   +LS N  +G++   +G+L  ++++ L
Sbjct: 448  KWDMPSLQMLSLARNKFFGGLPD-SFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKL 506

Query: 574  SLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKS 633
            S N LSG IP  +   + L  L L +N+L G IP SF  +  L+ +D+S N LSG IPK+
Sbjct: 507  SENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKN 566

Query: 634  MEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSPKLQ-VSPCKTRSHPR 692
            +  +  L  +N+S N L G +P+ G F+  +A +  GN  LCG      + PCK      
Sbjct: 567  LGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKR----V 622

Query: 693  SRTTVVLLIVLPLVSALTMIVVLTAKLVRRRRRR-----RRRQKGSTRPYYDANMYPQAT 747
             +T      +   + A  ++ ++    V  R R      R   +  T   ++   +    
Sbjct: 623  RKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGT---WELQFFDSKV 679

Query: 748  WRRISYQDLLRATDGFSENKLLGMGSFGSVYKG-VLPDGMEIAAKVFHMEFDGSLESFHA 806
             + I+  D+L +     E  ++  G  G+ YKG  + +GM+   K  + + +    S  A
Sbjct: 680  SKSITINDILSSL---KEENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIA 735

Query: 807  ECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMID 866
            +   MG ++H N+VK+I  C +     L+ EY+   +L + L +    L   +R KI I 
Sbjct: 736  D---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIG 788

Query: 867  VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM-RQTKTLGT 925
            +A AL +LH   S  +V  ++ P  ++++     HL        L     +   TK   +
Sbjct: 789  IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-------RLSLPGLLCTDTKCFIS 841

Query: 926  IGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSI 985
              Y+APE      ++ K D+Y +G++L+E  T K P D  F    S+  W       C +
Sbjct: 842  SAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHL 901

Query: 986  TEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036
                D ++      D S  +  +  + +LA+ CT   P  R    DV   L
Sbjct: 902  DMWIDPSI----RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  167 bits (425), Expect = 4e-47
 Identities = 66/191 (34%), Positives = 105/191 (54%), Gaps = 10/191 (5%)

Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFH-MEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
           LG G FG+VY       G ++A K+    +    LE    E +++  + H N+VK+    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
            + +   LV+EY   GSL+  L  +   L   + L+I++ +   LEYLH   S  I+H D
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117

Query: 887 IKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR-EGKVSRKC 943
           +KP N+LL+    G   L+DFG++K+L  ++S+ +T  +GT  YMAPE    +G  S K 
Sbjct: 118 LKPENILLDSD-NGKVKLADFGLSKLLTSDKSLLKTI-VGTPAYMAPEVLLGKGYYSEKS 175

Query: 944 DVYSYGIMLME 954
           D++S G++L E
Sbjct: 176 DIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  160 bits (406), Expect = 5e-44
 Identities = 77/268 (28%), Positives = 112/268 (41%), Gaps = 26/268 (9%)

Query: 767  KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIIS 824
            + LG GSFG VY       G  +A KV   +      E    E K++  ++H N+V++  
Sbjct: 5    EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 825  SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
               + D   LV+EY   G L   L      L   +    +  + SALEYLH   S  IVH
Sbjct: 65   VFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLH---SKGIVH 120

Query: 885  CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCD 944
             D+KP N+LL+E     L+DFG+A+ L   E +  T  +GT  YMAPE        +  D
Sbjct: 121  RDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGTPEYMAPEVLLGKGYGKAVD 178

Query: 945  VYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAR 1004
            ++S G++L E  T K P    F G+  L                    +   +       
Sbjct: 179  IWSLGVILYELLTGKPP----FPGDDQLLELF--------------KKIGKPKPPFPPPE 220

Query: 1005 EQCVSSIFSLAMDCTVDLPEKRISMKDV 1032
                     L     V  PEKR++ ++ 
Sbjct: 221  WDISPEAKDLIRKLLVKDPEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  156 bits (397), Expect = 9e-43
 Identities = 71/203 (34%), Positives = 103/203 (50%), Gaps = 9/203 (4%)

Query: 763 FSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLE--SFHAECKVMGSIRHRNL 819
           +   + LG GSFG+VYK      G  +A K+     + S +  +   E +++  + H N+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
           V++I +  + D   LV+EY   G L   L          +  KI + +   LEYLH   S
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPL-SEDEAKKIALQILRGLEYLH---S 116

Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGK- 938
             I+H D+KP N+LL+E+ V  ++DFG+AK L K  S   T   GT  YMAPE    G  
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNG 175

Query: 939 VSRKCDVYSYGIMLMETFTKKKP 961
              K DV+S G++L E  T K P
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  151 bits (385), Expect = 3e-41
 Identities = 79/278 (28%), Positives = 131/278 (47%), Gaps = 31/278 (11%)

Query: 766  NKLLGMGSFGSVYKGVL-----PDGMEIAAKVFHMEFDGS-LESFHAECKVMGSIRHRNL 819
             K LG G+FG VYKG L        +E+A K    +     +E F  E ++M  + H N+
Sbjct: 4    GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 820  VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            VK++  C+  +   +V+EYM  G L   L  +   L +   L   + +A  +EYL    S
Sbjct: 64   VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---S 120

Query: 880  TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKV 939
               +H D+   N L+ E++V  +SDFG+++ L  ++  R+      I +MAPE  +EGK 
Sbjct: 121  KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKF 180

Query: 940  SRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE 998
            + K DV+S+G++L E FT  ++P        MS +      +L      + +   L    
Sbjct: 181  TSKSDVWSFGVLLWEIFTLGEQP-----YPGMSNEE-----VLEY----LKNGYRLPQPP 226

Query: 999  NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036
            N       C   ++ L + C  + PE R +  ++   L
Sbjct: 227  N-------CPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  150 bits (380), Expect = 1e-40
 Identities = 78/279 (27%), Positives = 128/279 (45%), Gaps = 32/279 (11%)

Query: 766  NKLLGMGSFGSVYKGVL-----PDGMEIAAKVFHMEFDGS-LESFHAECKVMGSIRHRNL 819
             K LG G+FG VYKG L        +E+A K    +     +E F  E ++M  + H N+
Sbjct: 4    GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 820  VKIISSCSNNDFKALVLEYMSNGSLEKCL-YSDNYFLDILQRLKIMIDVASALEYLHFGY 878
            VK++  C+  +   +V+EYM  G L   L  +    L +   L   + +A  +EYL    
Sbjct: 64   VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--- 120

Query: 879  STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGK 938
            S   +H D+   N L+ E++V  +SDFG+++ L  ++  +       I +MAPE  +EGK
Sbjct: 121  SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180

Query: 939  VSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE 997
             + K DV+S+G++L E FT  ++P        MS        +L      +     L   
Sbjct: 181  FTSKSDVWSFGVLLWEIFTLGEEP-----YPGMSNAE-----VLEY----LKKGYRLPKP 226

Query: 998  ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036
             N       C   ++ L + C  + PE R +  ++   L
Sbjct: 227  PN-------CPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  144 bits (365), Expect = 2e-38
 Identities = 78/279 (27%), Positives = 126/279 (45%), Gaps = 32/279 (11%)

Query: 766  NKLLGMGSFGSVYKGVL-----PDGMEIAAKVFHMEFDGS-LESFHAECKVMGSIRHRNL 819
             K LG G+FG VYKG L         ++A K           E F  E  +M  + H N+
Sbjct: 4    GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63

Query: 820  VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            V+++  C+  +   +V EYM  G L   L      L +   L++ + +A  +EYL    S
Sbjct: 64   VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---S 120

Query: 880  TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ-TKTLGTIGYMAPEYGREGK 938
               VH D+   N L+ E++V  +SDFG+++ + +++  R+       I +MAPE  ++GK
Sbjct: 121  KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180

Query: 939  VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE 998
             + K DV+S+G++L E FT          GE        + +L      + D   L   E
Sbjct: 181  FTSKSDVWSFGVLLWEIFTL---------GEQPYPGMSNEEVLEL----LEDGYRLPRPE 227

Query: 999  NDFSAREQCVSSIFSLAMDC-TVDLPEKRISMKDVANRL 1036
            N       C   ++ L + C   D PE R +  ++   L
Sbjct: 228  N-------CPDELYELMLQCWAYD-PEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  140 bits (356), Expect = 3e-37
 Identities = 78/285 (27%), Positives = 123/285 (43%), Gaps = 39/285 (13%)

Query: 767  KLLGMGSFGSVYKGVLPDG----MEIAAKVF-HMEFDGSLESFHAECKVMGSIRHRNLVK 821
            K LG G+FG VYKG L        E+A K       +   + F  E +VM  + H N+V+
Sbjct: 1    KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 822  IISSCSNNDFKALVLEYMSNGSLEKCL--------YSDNYFLDILQRLKIMIDVASALEY 873
            ++  C+  +   LVLEYM  G L   L          +   L +   L   I +A  +EY
Sbjct: 61   LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 874  LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK-ILGKEESMRQTKTLGTIGYMAPE 932
            L    S   VH D+   N L+ E +V  +SDFG+++ +   +   ++T     I +MAPE
Sbjct: 121  LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 933  YGREGKVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA 991
              ++G  + K DV+S+G++L E FT    P   +   E+              +  +   
Sbjct: 178  SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV--------------LEYLRKG 223

Query: 992  NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036
              L   E        C   ++ L + C    PE R +  ++  RL
Sbjct: 224  YRLPKPEY-------CPDELYELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  138 bits (351), Expect = 1e-36
 Identities = 73/201 (36%), Positives = 105/201 (52%), Gaps = 10/201 (4%)

Query: 767 KLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGS--LESFHAECKVMGSIRHRNLVKII 823
           +LLG GSFGSVY  +  D G  +A K   +  D    LE+   E +++ S++H N+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 824 SSCSNNDFKAL--VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
            S  + +   L   LEY+S GSL   L       + + R K    +   L YLH   S  
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIR-KYTRQILEGLAYLH---SNG 121

Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGYMAPEYGREGKVS 940
           IVH DIK +N+L++   V  L+DFG AK LG  E+   T ++ GT  +MAPE  R  +  
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181

Query: 941 RKCDVYSYGIMLMETFTKKKP 961
           R  D++S G  ++E  T K P
Sbjct: 182 RAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  126 bits (320), Expect = 1e-32
 Identities = 65/194 (33%), Positives = 93/194 (47%), Gaps = 6/194 (3%)

Query: 769 LGMGSFGSVYKG-VLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           +G G FG VYK      G E+A KV  +E     E    E +++   +H N+VK   S  
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 828 NNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDI 887
             D   +V+E+ S GSL+  L S N  L   Q   +  ++   LEYLH   S  I+H DI
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDI 124

Query: 888 KPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYS 947
           K +N+LL       L DFG++  L   ++  +   +GT  +MAPE         K D++S
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMVGTPYWMAPEVINGKPYDYKADIWS 182

Query: 948 YGIMLMETFTKKKP 961
            GI  +E    K P
Sbjct: 183 LGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  123 bits (310), Expect = 3e-31
 Identities = 82/276 (29%), Positives = 125/276 (45%), Gaps = 36/276 (13%)

Query: 768  LLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
             +G G FG V  G    G ++A K    +   + ++F AE  VM ++RH NLV+++    
Sbjct: 13   TIGKGEFGDVMLGDY-RGQKVAVKCLKDD-STAAQAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 828  NNDFKALVLEYMSNGSLEKCLYS-DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
              +   +V EYM+ GSL   L S     + + Q+L   +DV   +EYL        VH D
Sbjct: 71   QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRD 127

Query: 887  IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
            +   NVL++E +V  +SDFG+A    KE S  Q      + + APE  RE K S K DV+
Sbjct: 128  LAARNVLVSEDLVAKVSDFGLA----KEASQGQDSGKLPVKWTAPEALREKKFSTKSDVW 183

Query: 947  SYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDF--SA 1003
            S+GI+L E ++  + P   I                   + +V         E  +   A
Sbjct: 184  SFGILLWEIYSFGRVPYPRI------------------PLKDVVPH-----VEKGYRMEA 220

Query: 1004 REQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039
             E C   ++ +  DC    P KR + K +  +L  I
Sbjct: 221  PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  115 bits (290), Expect = 1e-28
 Identities = 64/206 (31%), Positives = 97/206 (47%), Gaps = 26/206 (12%)

Query: 768 LLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIIS 824
           L+G G+FG VYKG+ L  G  +A K   +E     +L+S   E  ++ +++H N+VK I 
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 825 SCSNNDFKALVLEYMSNGSLEKCL---------YSDNYFLDILQRLKIMIDVASALEYLH 875
           S   +D   ++LEY  NGSL + +             Y   +LQ           L YLH
Sbjct: 67  SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQ----------GLAYLH 116

Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
                 ++H DIK +N+L  +  V  L+DFG+A  L        +  +GT  +MAPE   
Sbjct: 117 ---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS-VVGTPYWMAPEVIE 172

Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
               S   D++S G  ++E  T   P
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  113 bits (286), Expect = 8e-28
 Identities = 64/189 (33%), Positives = 93/189 (49%), Gaps = 10/189 (5%)

Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           +G G+ G VYK      G E+A K   +    + E    E  +M   +H N+V    S  
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYL 85

Query: 828 NNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDI 887
             D   +V+EYM  GSL   +  +   ++  Q   +  +V   LEYLH   S  ++H DI
Sbjct: 86  VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDI 142

Query: 888 KPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           K  N+LL+    G   L+DFG A  L KE+S R +  +GT  +MAPE  +      K D+
Sbjct: 143 KSDNILLS--KDGSVKLADFGFAAQLTKEKSKRNS-VVGTPYWMAPEVIKRKDYGPKVDI 199

Query: 946 YSYGIMLME 954
           +S GIM +E
Sbjct: 200 WSLGIMCIE 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  115 bits (288), Expect = 2e-27
 Identities = 86/280 (30%), Positives = 115/280 (41%), Gaps = 29/280 (10%)

Query: 767  KLLGMGSFGSVYKGVLPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRH-RNLVKI 822
            + LG GSFG VY     D   +A KV           +E F  E +++ S+ H  N+VK+
Sbjct: 6    RKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63

Query: 823  ISSCSNNDFKALVLEYMSNGSLEK--CLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
                 +     LV+EY+  GSLE           L   + L I+  + SALEYLH   S 
Sbjct: 64   YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SK 120

Query: 881  PIVHCDIKPSNVLLNE-SMVGHLSDFGIAKILGKEESMRQTKTL-----GTIGYMAPEY- 933
             I+H DIKP N+LL+    V  L DFG+AK+L    S      L     GT GYMAPE  
Sbjct: 121  GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180

Query: 934  --GREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA 991
                    S   D++S GI L E  T   P +         K     S     I E+   
Sbjct: 181  LGLSLAYASSSSDIWSLGITLYELLTGLPPFE-------GEKNSSATSQTLKIILELPTP 233

Query: 992  NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKD 1031
            +L +      S  E    +   L        P+ R+S   
Sbjct: 234  SLAS--PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS 271

Length = 384

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  110 bits (277), Expect = 5e-27
 Identities = 82/274 (29%), Positives = 135/274 (49%), Gaps = 38/274 (13%)

Query: 769  LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSN 828
            +G G FG+V +G    G ++A K   ++ D + ++F  E  VM  + H+NLV+++    +
Sbjct: 14   IGEGEFGAVLQGEYT-GQKVAVKN--IKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 829  NDFKALVLEYMSNGSLEKCLYSDNYFL-DILQRLKIMIDVASALEYLHFGYSTPIVHCDI 887
            N    +V+E MS G+L   L +    L  ++Q L+  +DVA  +EYL    S  +VH D+
Sbjct: 71   NGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDL 126

Query: 888  KPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYS 947
               N+L++E  V  +SDFG+A++     SM    +   + + APE  +  K S K DV+S
Sbjct: 127  AARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWS 182

Query: 948  YGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAR-- 1004
            YG++L E F+  + P       +MSLK             EV +     C E  +     
Sbjct: 183  YGVLLWEVFSYGRAPYP-----KMSLK-------------EVKE-----CVEKGYRMEPP 219

Query: 1005 EQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVR 1038
            E C + ++ L   C    P+KR S   +  +L +
Sbjct: 220  EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  111 bits (279), Expect = 5e-27
 Identities = 63/202 (31%), Positives = 93/202 (46%), Gaps = 12/202 (5%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGS--LESFHAECKVMGSIRHRNLVKII 823
           K +G GSFG VY      DG     K   +        E    E K++  + H N++K  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 824 SSCSNNDFKALVLEYMSNGSL----EKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            S        +V+EY   G L    +K       F +  Q L   + +  AL+YLH   S
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPE-EQILDWFVQLCLALKYLH---S 121

Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKV 939
             I+H DIKP N+ L  + +  L DFGI+K+L     + +T  +GT  Y++PE  +    
Sbjct: 122 RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-VVGTPYYLSPELCQNKPY 180

Query: 940 SRKCDVYSYGIMLMETFTKKKP 961
           + K D++S G +L E  T K P
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  110 bits (278), Expect = 7e-27
 Identities = 70/211 (33%), Positives = 101/211 (47%), Gaps = 34/211 (16%)

Query: 767 KLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLES-FHAECKVMGSIRHRNLVKIIS 824
           K+LG GS G VYK    P G   A K  H++ D         E K + S     +VK   
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK--- 63

Query: 825 SCSNNDFK----ALVLEYMSNGSLEKCLYSDNYFLDILQRLK---------IMIDVASAL 871
            C    +K    ++VLEYM  GSL           D+L+++          I   +   L
Sbjct: 64  -CYGAFYKEGEISIVLEYMDGGSLA----------DLLKKVGKIPEPVLAYIARQILKGL 112

Query: 872 EYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT-LGTIGYMA 930
           +YLH      I+H DIKPSN+L+N      ++DFGI+K+L  E ++ Q  T +GT+ YM+
Sbjct: 113 DYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMS 168

Query: 931 PEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           PE  +    S   D++S G+ L+E    K P
Sbjct: 169 PERIQGESYSYAADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  110 bits (277), Expect = 9e-27
 Identities = 62/197 (31%), Positives = 100/197 (50%), Gaps = 11/197 (5%)

Query: 766 NKLLGMGSFGSVYKGVLPDGMEIAAKVFH---MEFDGSLESFHAECKVMGSIRHRNLVKI 822
            + LG G FG V+ G      ++A K      M    S E+F  E ++M  +RH  LV++
Sbjct: 11  ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQL 66

Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTP 881
            + CS  +   +V EYMS GSL   L S     L + Q + +   +A  + YL    S  
Sbjct: 67  YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRN 123

Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSR 941
            +H D+   N+L+ E++V  ++DFG+A+++  +E   +      I + APE    G+ + 
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTI 183

Query: 942 KCDVYSYGIMLMETFTK 958
           K DV+S+GI+L E  T 
Sbjct: 184 KSDVWSFGILLTEIVTY 200

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  109 bits (275), Expect = 9e-27
 Identities = 78/282 (27%), Positives = 123/282 (43%), Gaps = 45/282 (15%)

Query: 767  KLLGMGSFGSVYKGVLPDGMEIAAKVFHME-FDGSLESFHAECKVMGSIRHRNLVKIISS 825
            + +G G+FG VYKGVL    E+A K             F  E +++    H N+VK+I  
Sbjct: 1    EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 826  CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
            C       +V+E +  GSL   L      L + + L++ +D A+ +EYL    S   +H 
Sbjct: 61   CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHR 117

Query: 886  DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT----IGYMAPEYGREGKVSR 941
            D+   N L+ E+ V  +SDFG+++   +EE    T + G     I + APE    G+ + 
Sbjct: 118  DLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174

Query: 942  KCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDF 1001
            + DV+SYGI+L ETF+                   GD+             + N +  + 
Sbjct: 175  ESDVWSYGILLWETFSL------------------GDTPYP---------GMSNQQTRER 207

Query: 1002 -------SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036
                    A + C   I+ L + C    PE R S  ++ N L
Sbjct: 208  IESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNEL 249

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  108 bits (272), Expect = 3e-26
 Identities = 69/203 (33%), Positives = 94/203 (46%), Gaps = 21/203 (10%)

Query: 769 LGMGSFGSVY----KGVLPDGMEIAAKV---FHMEFDGSLESFHAECKVMGSIRHRNLVK 821
           LG GSFG V     K     G   A KV     +     +E    E  ++  I H  +VK
Sbjct: 1   LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           +  +    +   LVLEY   G L   L  +  F +   R     ++  ALEYLH   S  
Sbjct: 58  LHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLH---SLG 113

Query: 882 IVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTL-GTIGYMAPEYGREGK 938
           I++ D+KP N+LL+    GH  L+DFG+AK L  E S  +T T  GT  Y+APE      
Sbjct: 114 IIYRDLKPENILLDAD--GHIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAPEVLLGKG 169

Query: 939 VSRKCDVYSYGIMLMETFTKKKP 961
             +  D +S G++L E  T K P
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  104 bits (262), Expect = 6e-25
 Identities = 66/205 (32%), Positives = 98/205 (47%), Gaps = 9/205 (4%)

Query: 763 FSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVK 821
           F   + LG GS+GSVYK +    G  +A KV  +  +  L+    E  ++       +VK
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKV--VPVEEDLQEIIKEISILKQCDSPYIVK 62

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
              S   N    +V+EY   GS+   +   N  L   +   I+      LEYLH   S  
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNK 119

Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGYMAPEYGREGKVS 940
            +H DIK  N+LLNE     L+DFG++  L   ++M +  T+ GT  +MAPE  +E   +
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQL--TDTMAKRNTVIGTPFWMAPEVIQEIGYN 177

Query: 941 RKCDVYSYGIMLMETFTKKKPTDEI 965
            K D++S GI  +E    K P  +I
Sbjct: 178 NKADIWSLGITAIEMAEGKPPYSDI 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  103 bits (258), Expect = 3e-24
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 15/205 (7%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKV--FHMEFDGSLESFHAECKVMGSIRHRNLVKII 823
             +G G+FG VY  V L  G  +A K          +++    E KV+  ++H NLVK  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 824 SSCSNNDFKALVLEYMSNGSLEK-CLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
               + +   + +EY S G+LE+   +       +++   + +     L YLH   S  I
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLH---SHGI 120

Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM---RQTKTLGTIGYMAPEYGREGKV 939
           VH DIKP+N+ L+ + V  L DFG A  L    +          GT  YMAPE    GK 
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180

Query: 940 S---RKCDVYSYGIMLMETFTKKKP 961
               R  D++S G +++E  T K+P
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  103 bits (258), Expect = 3e-24
 Identities = 64/207 (30%), Positives = 96/207 (46%), Gaps = 11/207 (5%)

Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES-FHAECKVMGSIRHRNLVKIISSC 826
           LG G+ G V K +  P G  +A K   +E + +++     E  ++       +V    + 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 827 SNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
            NN   ++ +EYM  GSL+K L          IL   KI + V   L YLH  +   I+H
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILG--KIAVAVLKGLTYLHEKHK--IIH 124

Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCD 944
            D+KPSN+L+N      L DFG++  L    S+ +T   GT  YMAPE  +    S K D
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTFV-GTSSYMAPERIQGNDYSVKSD 181

Query: 945 VYSYGIMLMETFTKKKPTDEIFAGEMS 971
           ++S G+ L+E  T + P          
Sbjct: 182 IWSLGLSLIELATGRFPYPPENDPPDG 208

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 99.3 bits (247), Expect = 6e-23
 Identities = 70/191 (36%), Positives = 98/191 (51%), Gaps = 12/191 (6%)

Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISS-CS 827
           +G G FG V  G    G ++A K   ++ D + ++F AE  VM  +RH NLV+++     
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 828 NNDFKALVLEYMSNGSLEKCLYS-DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
                 +V EYM+ GSL   L S     L     LK  +DV  A+EYL    +   VH D
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRD 127

Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   NVL++E  V  +SDFG    L KE S  Q      + + APE  RE K S K DV+
Sbjct: 128 LAARNVLVSEDNVAKVSDFG----LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVW 183

Query: 947 SYGIMLMETFT 957
           S+GI+L E ++
Sbjct: 184 SFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 99.8 bits (249), Expect = 6e-23
 Identities = 75/291 (25%), Positives = 134/291 (46%), Gaps = 46/291 (15%)

Query: 769  LGMGSFGSVYKG--VLPDGME----IAAKVFHMEFDGSL-ESFHAECKVMGSIRHRNLVK 821
            LG G+FG VYKG    P+       +A K      +  + + F  E ++M  ++H N+V 
Sbjct: 13   LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 822  IISSCSNNDFKALVLEYMSNGSLEKCL-----YSDNYF----------LDILQRLKIMID 866
            ++  C+      ++ EY+++G L + L     +SD             LD    L I I 
Sbjct: 73   LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 867  VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGT 925
            +A+ +EYL    S   VH D+   N L+ E +   +SDFG+++ +   +  R Q+K+L  
Sbjct: 133  IAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 926  IGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSI 985
            + +M PE    GK + + D++S+G++L E F+        F+ +  ++      LL C  
Sbjct: 190  VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCP- 248

Query: 986  TEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036
                               E C + +++L ++C  ++P +R   KD+  RL
Sbjct: 249  -------------------EDCPARVYALMIECWNEIPARRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 99.0 bits (247), Expect = 1e-22
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 12/213 (5%)

Query: 767 KLLGMGSFGSVYKGV-LPDG----MEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLV 820
           K+LG G+FG+VYKGV +P+G    + +A KV   E    + +    E  VM S+ H ++V
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
           +++  C ++    L+ + M  G L   + +    +     L   + +A  + YL      
Sbjct: 73  RLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EK 128

Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILG-KEESMRQTKTLGTIGYMAPEYGREGKV 939
            +VH D+   NVL+       ++DFG+AK+L   E+          I +MA E       
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIY 188

Query: 940 SRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
           + K DV+SYG+ + E  T   KP + I A E+ 
Sbjct: 189 THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP 221

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 98.3 bits (245), Expect = 1e-22
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 29/204 (14%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIIS 824
           + LG G FG V++G+  +   +A K       G++  + F AE ++M  +RH  L+++ +
Sbjct: 12  RKLGAGQFGEVWEGLWNNTTPVAVKTLK---PGTMDPKDFLAEAQIMKKLRHPKLIQLYA 68

Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQR-----LKI--MID----VASALEY 873
            C+  +   +V E M  GSL          L+ LQ      LK+  +ID    VAS + Y
Sbjct: 69  VCTLEEPIYIVTELMKYGSL----------LEYLQGGAGRALKLPQLIDMAAQVASGMAY 118

Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
           L    +   +H D+   NVL+ E+ +  ++DFG+A+++ ++    +      I + APE 
Sbjct: 119 LE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEA 175

Query: 934 GREGKVSRKCDVYSYGIMLMETFT 957
               + S K DV+S+GI+L E  T
Sbjct: 176 ALYNRFSIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 97.9 bits (244), Expect = 2e-22
 Identities = 55/190 (28%), Positives = 97/190 (51%), Gaps = 5/190 (2%)

Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSN 828
           LG G FG V++G+  + + +A K+   +     + F  E + +  +RH++L+ + + CS 
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73

Query: 829 NDFKALVLEYMSNGSLEKCLYS-DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDI 887
            +   ++ E M  GSL   L S +   L +   + +   VA  + YL        +H D+
Sbjct: 74  GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDL 130

Query: 888 KPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYS 947
              N+L+ E +V  ++DFG+A+++ KE+    +       + APE    G  S K DV+S
Sbjct: 131 AARNILVGEDLVCKVADFGLARLI-KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWS 189

Query: 948 YGIMLMETFT 957
           +GI+L E FT
Sbjct: 190 FGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 98.3 bits (245), Expect = 2e-22
 Identities = 81/294 (27%), Positives = 132/294 (44%), Gaps = 54/294 (18%)

Query: 769  LGMGSFGSVYKG----VLPDG--MEIAAKVFH-MEFDGSLESFHAECKVMGSIRHRNLVK 821
            LG G+FG V+ G    + P+     +A K       + + + F  E +++ + +H N+VK
Sbjct: 13   LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 822  IISSCSNNDFKALVLEYMSNGSLEKCLYS---DNYFLD----------ILQRLKIMIDVA 868
                C+  D   +V EYM +G L K L S   D  FL           + Q L+I + +A
Sbjct: 73   FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 869  SALEYL---HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLG 924
            S + YL   HF      VH D+   N L+   +V  + DFG+++ +   +  R    T+ 
Sbjct: 133  SGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186

Query: 925  TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSC 983
             I +M PE     K + + DV+S+G++L E FT  K+P             W G S  + 
Sbjct: 187  PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP-------------WYGLS--NE 231

Query: 984  SITEVADAN-LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036
             + E      LL            C S ++ + + C    P++RI++KD+  RL
Sbjct: 232  EVIECITQGRLLQRPRT-------CPSEVYDIMLGCWKRDPQQRINIKDIHERL 278

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 98.2 bits (245), Expect = 2e-22
 Identities = 72/286 (25%), Positives = 124/286 (43%), Gaps = 23/286 (8%)

Query: 767  KLLGMGSFGSVYKGVLP-----DGMEIAAKVF-HMEFDGSLESFHAECKVMGSIRHRNLV 820
            K LG G FG V            G ++A K   H   +     F  E +++ ++ H N+V
Sbjct: 10   KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 821  KIISSCSNNDFKA--LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
            K    C     ++  L++EY+ +GSL   L      +++ + L     +   ++YL    
Sbjct: 70   KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG--- 126

Query: 879  STPIVHCDIKPSNVLL-NESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGR 935
            S   +H D+   N+L+ +E +V  +SDFG+AK+L +++     K  G   I + APE  R
Sbjct: 127  SQRYIHRDLAARNILVESEDLV-KISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185

Query: 936  EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL-L 994
              K S   DV+S+G+ L E FT   P+    A  + +       ++   + E+      L
Sbjct: 186  TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERL 245

Query: 995  NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIR 1040
                +       C   ++ L   C    P+ R S  D+   + R+R
Sbjct: 246  PRPPS-------CPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 97.1 bits (242), Expect = 3e-22
 Identities = 70/262 (26%), Positives = 119/262 (45%), Gaps = 28/262 (10%)

Query: 767  KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIIS 824
            K LG G FG V+ G     +++A K+     +G++  + F  E KVM  + H NLV++  
Sbjct: 10   KELGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66

Query: 825  SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
             C+      +V EYM+NG L   L      L     L +  DV  A+EYL    S   +H
Sbjct: 67   VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIH 123

Query: 885  CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCD 944
             D+   N L+ E  V  +SDFG+A+ +  ++      T   + +  PE     + S K D
Sbjct: 124  RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183

Query: 945  VYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAR 1004
            V+S+G+++ E F++         G+M  +R+        S +EV ++             
Sbjct: 184  VWSFGVLMWEVFSE---------GKMPYERF--------SNSEVVESVSAGYR---LYRP 223

Query: 1005 EQCVSSIFSLAMDCTVDLPEKR 1026
            +   + ++++   C  + PE R
Sbjct: 224  KLAPTEVYTIMYSCWHEKPEDR 245

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 97.0 bits (242), Expect = 3e-22
 Identities = 80/283 (28%), Positives = 118/283 (41%), Gaps = 42/283 (14%)

Query: 769  LGMGSFGSVYKGV--LPDGMEI--AAKVFHMEFDGSLES-FHAECKVMGSIRHRNLVKII 823
            LG G+FGSV KGV  +  G E+  A K    E   + +  F  E  VM  + H  +V++I
Sbjct: 3    LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 824  SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL---HFGYST 880
              C       LV+E    G L K L      + +    ++   VA  + YL   HF    
Sbjct: 63   GVCKGEPL-MLVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGMAYLESKHF---- 116

Query: 881  PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREGK 938
              VH D+   NVLL       +SDFG+++ LG      +  T G   + + APE    GK
Sbjct: 117  --VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174

Query: 939  VSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL-LNC 996
             S K DV+SYG+ L E F+   KP  E+   E               +  + ++   L  
Sbjct: 175  FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---------------VIAMLESGERLPR 219

Query: 997  EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039
             E        C   I+S+ + C    PE R +  ++ +   R 
Sbjct: 220  PEE-------CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 96.2 bits (239), Expect = 5e-22
 Identities = 61/194 (31%), Positives = 100/194 (51%), Gaps = 8/194 (4%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLE-SFHAECKVMGSIRHRNLVKIISS 825
           +LLG G+FG V+KG L D   +A K    +    L+  F +E +++    H N+VK+I  
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
           C+      +V+E +  G     L      L   Q +K  +D A+ + YL    S   +H 
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHR 117

Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREGKVSRKC 943
           D+   N L+ E+ V  +SDFG+++   +++ +  +  L    I + APE    G+ S + 
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175

Query: 944 DVYSYGIMLMETFT 957
           DV+SYGI+L ETF+
Sbjct: 176 DVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 95.8 bits (238), Expect = 9e-22
 Identities = 56/192 (29%), Positives = 94/192 (48%), Gaps = 4/192 (2%)

Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSN 828
           +G G FG V+ G   +  ++A K    E   S E F  E +VM  + H  LV++   C+ 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 829 NDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIK 888
                LV E+M +G L   L +          L + +DV   + YL    S+ ++H D+ 
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLA 127

Query: 889 PSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSY 948
             N L+ E+ V  +SDFG+ + +  ++    T T   + + +PE     K S K DV+S+
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSF 187

Query: 949 GIMLMETFTKKK 960
           G+++ E F++ K
Sbjct: 188 GVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 19/203 (9%)

Query: 766 NKLLGMGSFGSVYKGVL--PDGMEI--AAKVFHMEFDGSLES----FHAECKVMGSIRHR 817
            K++G G FG V +G L  P   EI  A K       GS +     F  E  +MG   H 
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLK---AGSSDKQRLDFLTEASIMGQFDHP 65

Query: 818 NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL-HF 876
           N++++    + +    ++ EYM NGSL+K L  ++    + Q + ++  +AS ++YL   
Sbjct: 66  NIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM 125

Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIG--YMAPEYG 934
            Y    VH D+   N+L+N ++V  +SDFG+++ L   E+   TK  G I   + APE  
Sbjct: 126 NY----VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG-GKIPIRWTAPEAI 180

Query: 935 REGKVSRKCDVYSYGIMLMETFT 957
              K +   DV+S+GI++ E  +
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 94.5 bits (235), Expect = 3e-21
 Identities = 74/222 (33%), Positives = 102/222 (45%), Gaps = 33/222 (14%)

Query: 763 FSENK---LLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRN 818
           + EN    +LG G++G VY    L   + IA K         ++  H E  +   ++HRN
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYS------DN------YFLDILQRLKIMID 866
           +V+ + S S N F  + +E +  GSL   L S      DN      Y   IL+ LK    
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLK---- 122

Query: 867 VASALEYLHFGYSTPIVHCDIKPSNVLLNE-SMVGHLSDFGIAKILGKEESMRQTKTLGT 925
                 YLH      IVH DIK  NVL+N  S V  +SDFG +K L       +T T GT
Sbjct: 123 ------YLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT-GT 172

Query: 926 IGYMAPEYGREGK--VSRKCDVYSYGIMLMETFTKKKPTDEI 965
           + YMAPE   +G        D++S G  ++E  T K P  E+
Sbjct: 173 LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 93.9 bits (234), Expect = 4e-21
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 12/205 (5%)

Query: 762 GFSENKLLGMGSFGSVYKGVLPD-----GMEIAAKVFHMEFDGSLESFHAECKVMGSIRH 816
            F   +++G G+FG V      D      M+   K   +E  GS+ +   E +++  + H
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE-KGSVRNVLNERRILQELNH 59

Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LV +  S  + +   LV++ +  G L   L     F +   +   + ++  ALEYLH 
Sbjct: 60  PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-WICEIVLALEYLH- 117

Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  I+H DIKP N+LL+E    H++DF IA  +  +     T T GT GYMAPE    
Sbjct: 118 --SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT--TSTSGTPGYMAPEVLCR 173

Query: 937 GKVSRKCDVYSYGIMLMETFTKKKP 961
              S   D +S G+   E    K+P
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 93.5 bits (233), Expect = 5e-21
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 21/210 (10%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECKVMGSIRHRNLV 820
           + +G GSFG+V K     DG  +  K       G++     +   +E  ++  ++H N+V
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDY---GNMTEKEKQQLVSEVNILRELKHPNIV 62

Query: 821 KIISSCSNNDFKAL--VLEYMSNGSL----EKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           +      +   + L  V+EY   G L    +KC   +  +++     +I+  +  AL   
Sbjct: 63  RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKC-KKERKYIEEEFIWRILTQLLLALYEC 121

Query: 875 HFGY--STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT-LGTIGYMAP 931
           H        ++H D+KP+N+ L+ +    L DFG+AKILG + S    KT +GT  YM+P
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSP 179

Query: 932 EYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           E         K D++S G ++ E      P
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 62/202 (30%), Positives = 92/202 (45%), Gaps = 32/202 (15%)

Query: 769 LGMGSFGSVYKGVLPDGMEIAA-KVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           +G G++G VYK       E+ A KV  +E     E    E  ++   RH N+V    S  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 828 NNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK----------IMIDVASALEYLHFG 877
             D   +V+EY   GSL+          DI Q  +          +  +    L YLH  
Sbjct: 71  RRDKLWIVMEYCGGGSLQ----------DIYQVTRGPLSELQIAYVCRETLKGLAYLH-- 118

Query: 878 YSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG- 934
             T  +H DIK +N+LL E   G   L+DFG++  L    + R++  +GT  +MAPE   
Sbjct: 119 -ETGKIHRDIKGANILLTED--GDVKLADFGVSAQLTATIAKRKS-FIGTPYWMAPEVAA 174

Query: 935 --REGKVSRKCDVYSYGIMLME 954
             R+G    KCD+++ GI  +E
Sbjct: 175 VERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 92.4 bits (229), Expect = 1e-20
 Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 10/195 (5%)

Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISSC 826
           LG G FG V+ G       +A K       G++  E+F  E +VM  +RH  LV++ +  
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70

Query: 827 SNNDFKALVLEYMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
           S      +V EYMS GSL   L  +   +L + Q + +   +AS + Y+        VH 
Sbjct: 71  SEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126

Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L+ E++V  ++DFG+A+++   E   +      I + APE    G+ + K DV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 946 YSYGIMLMETFTKKK 960
           +S+GI+L E  TK +
Sbjct: 187 WSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 92.1 bits (229), Expect = 2e-20
 Identities = 67/205 (32%), Positives = 105/205 (51%), Gaps = 19/205 (9%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGS-----LESFHAECKVMGSIRHRNLV 820
           +LLG GSFGSVY+G+ L DG   A K   +  DG      ++    E  ++  ++H N+V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL---KIMIDVASALEYLHFG 877
           + + +    D   + LE +  GSL K L     F + + RL   +I+      LEYLH  
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL----LGLEYLH-- 119

Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY-GRE 936
                VH DIK +N+L++ + V  L+DFG+AK + +    +  K  G+  +MAPE   ++
Sbjct: 120 -DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK--GSPYWMAPEVIAQQ 176

Query: 937 GKVSRKCDVYSYGIMLMETFTKKKP 961
           G      D++S G  ++E  T K P
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 92.4 bits (229), Expect = 2e-20
 Identities = 71/297 (23%), Positives = 132/297 (44%), Gaps = 56/297 (18%)

Query: 769  LGMGSFGSVY----KGVLP--DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKI 822
            LG G+FG V+      +LP  D M +A K      + + + F  E +++  ++H+++V+ 
Sbjct: 13   LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 823  ISSCSNNDFKALVLEYMSNGSLEKCLYS---DNYFLD-----------ILQRLKIMIDVA 868
               C+      +V EYM +G L + L S   D   L            + Q L I   +A
Sbjct: 73   YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 869  SALEY---LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLG 924
            S + Y   LHF      VH D+   N L+ + +V  + DFG+++ +   +  R   +T+ 
Sbjct: 133  SGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186

Query: 925  TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSC 983
             I +M PE     K + + D++S+G++L E FT  K+P             W        
Sbjct: 187  PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP-------------WY------- 226

Query: 984  SITEVADANLLNC--EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVR 1038
               ++++   + C  +  +      C   ++++   C    P++R+ +KD+ +RL  
Sbjct: 227  ---QLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 91.5 bits (227), Expect = 2e-20
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 9/210 (4%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIIS 824
           K LG G FG V  G      ++A K   M  +GS+  + F  E KVM  + H  LV++  
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66

Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
            C+      +V EYMSNG L   L          Q L++  DV   + YL    S   +H
Sbjct: 67  VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIH 123

Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCD 944
            D+   N L+++     +SDFG+++ +  +E      +   + +  PE     K S K D
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183

Query: 945 VYSYGIMLMETFT-KKKPTDEIFAGEMSLK 973
           V+++G+++ E ++  K P +     E   K
Sbjct: 184 VWAFGVLMWEVYSLGKMPYERFNNSETVEK 213

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 91.2 bits (226), Expect = 3e-20
 Identities = 53/201 (26%), Positives = 104/201 (51%), Gaps = 10/201 (4%)

Query: 764 SENKLLGMGSFGSVYKGVL--PDGMEIAAKVFHME---FDGSLESFHAECKVMGSIRHRN 818
           ++ K++G G FG V++G+L  P   E+A  +  ++    +   + F +E  +MG   H N
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67

Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
           ++++    +      ++ EYM NG+L+K L   +      Q + ++  +A+ ++YL    
Sbjct: 68  IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS--- 124

Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIG--YMAPEYGRE 936
               VH D+   N+L+N ++   +SDFG++++L  +     T + G I   + APE    
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184

Query: 937 GKVSRKCDVYSYGIMLMETFT 957
            K +   DV+S+GI++ E  +
Sbjct: 185 RKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 89.5 bits (222), Expect = 1e-19
 Identities = 57/200 (28%), Positives = 101/200 (50%), Gaps = 7/200 (3%)

Query: 760 TDGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRN 818
           TD   ++KL G G +G VY+GV     + +A K    E    +E F  E  VM  I+H N
Sbjct: 6   TDITMKHKL-GGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPN 63

Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYS-DNYFLDILQRLKIMIDVASALEYLHFG 877
           LV+++  C+      ++ E+M+ G+L   L   +   ++ +  L +   ++SA+EYL   
Sbjct: 64  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 121

Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG 937
                +H D+   N L+ E+ +  ++DFG+++++  +           I + APE     
Sbjct: 122 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 180

Query: 938 KVSRKCDVYSYGIMLMETFT 957
           K S K DV+++G++L E  T
Sbjct: 181 KFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 89.6 bits (222), Expect = 2e-19
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 16/201 (7%)

Query: 767 KLLGMGSFGSVYKGVL--PDGMEIAA-----KVFHMEFDGSLESFHAECKVMGSIRHRNL 819
           K++G G FG V  G L  P   EI       K  + E       F +E  +MG   H N+
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE--KQRRDFLSEASIMGQFDHPNI 67

Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH-FGY 878
           + +    + +    +V EYM NGSL+  L   +    ++Q + ++  +AS ++YL   GY
Sbjct: 68  IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY 127

Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIG--YMAPEYGRE 936
               VH D+   N+L+N ++V  +SDFG++++L  +     T   G I   + APE    
Sbjct: 128 ----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183

Query: 937 GKVSRKCDVYSYGIMLMETFT 957
            K +   DV+SYGI++ E  +
Sbjct: 184 RKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 89.3 bits (221), Expect = 2e-19
 Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 10/197 (5%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIIS 824
           K LG G FG V+ G      ++A K       G++  ESF  E ++M  +RH  LV++ +
Sbjct: 12  KKLGNGQFGEVWMGTWNGNTKVAVKTLK---PGTMSPESFLEEAQIMKKLRHDKLVQLYA 68

Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYS-DNYFLDILQRLKIMIDVASALEYLHFGYSTPIV 883
             S      +V EYMS GSL   L   +   L +   + +   VA+ + Y+        +
Sbjct: 69  VVSEEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYI 124

Query: 884 HCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKC 943
           H D++ +N+L+ + +V  ++DFG+A+++   E   +      I + APE    G+ + K 
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 944 DVYSYGIMLMETFTKKK 960
           DV+S+GI+L E  TK +
Sbjct: 185 DVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 89.2 bits (221), Expect = 2e-19
 Identities = 73/275 (26%), Positives = 126/275 (45%), Gaps = 32/275 (11%)

Query: 769  LGMGSFGSVYKGVL---PDGMEIAAKVFHMEFDGSL-ESFHAECKVMGSIRHRNLVKIIS 824
            LG G+FG V KGV       +++A KV   E + S+ +    E ++M  + +  +V++I 
Sbjct: 3    LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 825  SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
             C       LV+E  S G L K L      + +   +++M  V+  ++YL        VH
Sbjct: 63   VCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVH 118

Query: 885  CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREGKVSRK 942
             D+   NVLL       +SDFG++K LG ++S  + ++ G   + + APE     K S +
Sbjct: 119  RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR 178

Query: 943  CDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDF 1001
             DV+SYGI + E F+  +KP  ++   E+              ++ +     L+C     
Sbjct: 179  SDVWSYGITMWEAFSYGQKPYKKMKGPEV--------------MSFIEQGKRLDCP---- 220

Query: 1002 SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036
                +C   +++L  DC +   E R +   V  R+
Sbjct: 221  ---AECPPEMYALMKDCWIYKWEDRPNFAKVEERM 252

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 88.2 bits (219), Expect = 4e-19
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 31/211 (14%)

Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHME-FDGSLESFHAECKVMGSIRHRNLVKIISSC 826
           +G+G+   VY  + LP+  ++A K   +E    S++    E + M    H N+VK  +S 
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQR------------LKIMIDVASALEYL 874
              D   LV+ Y+S GSL          LDI++               ++ +V   LEYL
Sbjct: 69  VVGDELWLVMPYLSGGSL----------LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118

Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL--GKEESMRQTKTL-GTIGYMAP 931
           H   S   +H DIK  N+LL E     ++DFG++  L  G + + +  KT  GT  +MAP
Sbjct: 119 H---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175

Query: 932 EYGREGK-VSRKCDVYSYGIMLMETFTKKKP 961
           E   +      K D++S+GI  +E  T   P
Sbjct: 176 EVMEQVHGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 88.2 bits (218), Expect = 4e-19
 Identities = 58/195 (29%), Positives = 104/195 (53%), Gaps = 5/195 (2%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
           K LG G FG V+ G   +  ++A K        S+++F  E  +M +++H  LV++ +  
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASAL-EYLHFGYSTPIVHC 885
           +  +   ++ EYM+ GSL   L SD     +L +L   ID ++ + E + +      +H 
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL---IDFSAQIAEGMAYIERKNYIHR 127

Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +NVL++ES++  ++DFG+A+++   E   +      I + APE    G  + K DV
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187

Query: 946 YSYGIMLMETFTKKK 960
           +S+GI+L E  T  K
Sbjct: 188 WSFGILLYEIVTYGK 202

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 88.1 bits (218), Expect = 5e-19
 Identities = 82/295 (27%), Positives = 131/295 (44%), Gaps = 54/295 (18%)

Query: 769  LGMGSFGSVYKG--VLPDGME----IAAKVFHMEFDGSLE--SFHAECKVMGSIRHRNLV 820
            LG  +FG +YKG   LP GM+    +A K    + +   +   F  E  +M  + H N+V
Sbjct: 13   LGECAFGKIYKGHLYLP-GMDHAQLVAIKTLK-DINNPQQWGEFQQEASLMAELHHPNIV 70

Query: 821  KIISSCSNNDFKALVLEYMSNGSLEKCL-----YSD-----------NYFLDILQRLKIM 864
             ++   +      ++ EY++ G L + L     +SD              LD    L I 
Sbjct: 71   CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 865  IDVASALEYL--HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTK 921
            I +A+ +EYL  HF      VH D+   N+L+ E +   +SD G+++ +   +  R Q K
Sbjct: 131  IQIAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185

Query: 922  TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLL 981
            +L  I +M PE    GK S   D++S+G++L E F+              L+ + G S  
Sbjct: 186  SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS------------FGLQPYYGFSNQ 233

Query: 982  SCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036
               I  V    LL C E+       C   ++SL  +C  + P +R   KD+  RL
Sbjct: 234  EV-IEMVRKRQLLPCSED-------CPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 87.9 bits (218), Expect = 6e-19
 Identities = 72/283 (25%), Positives = 118/283 (41%), Gaps = 31/283 (10%)

Query: 766  NKLLGMGSFGSVYKGVL----PDGMEIAAKVFHMEFDGSL-ESFHAECKVMGSIRHRNLV 820
             + +G G FG VY+GV      + + +A K        S+ E F  E  +M    H ++V
Sbjct: 11   GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 821  KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
            K+I   + N    +V+E    G L   L  + Y LD+   +     +++AL YL    S 
Sbjct: 71   KLIGVITENPV-WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SK 126

Query: 881  PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVS 940
              VH DI   NVL++      L DFG+++ L  E   + +K    I +MAPE     + +
Sbjct: 127  RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFT 186

Query: 941  RKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEN 999
               DV+ +G+ + E      KP    F         V ++ +   I  + +   L    N
Sbjct: 187  SASDVWMFGVCMWEILMLGVKP----FQ-------GVKNNDV---IGRIENGERLPMPPN 232

Query: 1000 DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042
                   C  +++SL   C    P KR    ++  +L  I + 
Sbjct: 233  -------CPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 87.4 bits (216), Expect = 6e-19
 Identities = 56/195 (28%), Positives = 99/195 (50%), Gaps = 10/195 (5%)

Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISSC 826
           LG G FG V+ G      ++A K       G++  E+F  E ++M  +RH  LV + +  
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLK---PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70

Query: 827 SNNDFKALVLEYMSNGSLEKCLYS-DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
           S      +V E+M  GSL   L   D  +L + Q + +   +A  + Y+        +H 
Sbjct: 71  SEEPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126

Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L+ +++V  ++DFG+A+++   E   +      I + APE    G+ + K DV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 946 YSYGIMLMETFTKKK 960
           +S+GI+L E  TK +
Sbjct: 187 WSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 88.0 bits (219), Expect = 6e-19
 Identities = 68/214 (31%), Positives = 97/214 (45%), Gaps = 28/214 (13%)

Query: 769 LGMGSFGSVYKGVLPDGMEIAA--KV-FHMEFDGSLESFHAECKVMGSIRHRNLVK---I 822
           +G G++G VYK       E+ A  K+    E +G   +   E K++  +RH N+V+   I
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
           ++S        +V EYM +  L   L S        Q    M  +   L+YLH   S  I
Sbjct: 67  VTSKGKGSI-YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGI 121

Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE-------YGR 935
           +H DIK SN+L+N   V  L+DFG+A+   K  S   T  + T+ Y  PE       YG 
Sbjct: 122 LHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGP 181

Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGE 969
           E       D++S G +L E F  K     IF G 
Sbjct: 182 E------VDMWSVGCILAELFLGKP----IFQGS 205

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 87.0 bits (215), Expect = 7e-19
 Identities = 68/283 (24%), Positives = 119/283 (42%), Gaps = 48/283 (16%)

Query: 769  LGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLES-FHAECKVMGSIRHRNLVKIISSC 826
            +G G+FG V+ G L  D   +A K         L++ F  E +++    H N+V++I  C
Sbjct: 3    IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 827  SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
            +      +V+E +  G     L ++   L + + ++++ + A+ +EYL    S   +H D
Sbjct: 63   TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRD 119

Query: 887  IKPSNVLLNESMVGHLSDFGIAK-----ILGKEESMRQTKTLGTIGYMAPEYGREGKVSR 941
            +   N L+ E  V  +SDFG+++     +      M+Q      + + APE    G+ S 
Sbjct: 120  LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP----VKWTAPEALNYGRYSS 175

Query: 942  KCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDF 1001
            + DV+S+GI+L E F                           S+  V  ANL N +  + 
Sbjct: 176  ESDVWSFGILLWEAF---------------------------SLGAVPYANLSNQQTREA 208

Query: 1002 SAR-------EQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037
              +       E C  +++ L   C    P +R S   V   L 
Sbjct: 209  IEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 87.1 bits (216), Expect = 1e-18
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 10/203 (4%)

Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G+FG VYK    + G+  AAK+  +E +  LE F  E  ++   +H N+V +  +  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 828 NNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDI 887
             +   +++E+   G+L+  +      L   Q   +   +  AL +LH   S  ++H D+
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129

Query: 888 KPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY-----GREGKVSRK 942
           K  N+LL       L+DFG++         R T  +GT  +MAPE       ++     K
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT-FIGTPYWMAPEVVACETFKDNPYDYK 188

Query: 943 CDVYSYGIMLMETFTKKKPTDEI 965
            D++S GI L+E    + P  E+
Sbjct: 189 ADIWSLGITLIELAQMEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 86.9 bits (216), Expect = 1e-18
 Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 24/209 (11%)

Query: 763 FSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHME-FDGSLESFHAECKVMGSIRHRNLV 820
           F+  + +G GSFG VYK +       +A KV  +E  +  +E    E + +   R   + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK--------IMIDVASALE 872
           K   S        +++EY   GS           LD+L+  K        I+ +V   LE
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSC----------LDLLKPGKLDETYIAFILREVLLGLE 112

Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE 932
           YLH       +H DIK +N+LL+E     L+DFG++  L    S R T  +GT  +MAPE
Sbjct: 113 YLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-FVGTPFWMAPE 168

Query: 933 YGREGKVSRKCDVYSYGIMLMETFTKKKP 961
             ++     K D++S GI  +E    + P
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 20/206 (9%)

Query: 769 LGMGSFGSVYKGVLPD------GMEIAAK-VFHMEFDGSLESFHAECKVMGSIRHRNLVK 821
           LG GSFG VY+G+            +A K V           F  E  VM      ++V+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYS------DNYFLDILQRLKIM---IDVASALE 872
           ++   S      +V+E M+ G L+  L S      +N  L      K +    ++A  + 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT-KTLGTIGYMAP 931
           YL    +   VH D+   N ++ E +   + DFG+ + + + +  R+  K L  + +MAP
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 932 EYGREGKVSRKCDVYSYGIMLMETFT 957
           E  ++G  + K DV+S+G++L E  T
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 86.4 bits (214), Expect = 1e-18
 Identities = 68/214 (31%), Positives = 109/214 (50%), Gaps = 29/214 (13%)

Query: 768 LLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGS-----------LESFHAECKVMGSIRH 816
           L+G GSFGSVY G+     E+ A V  +E               L++   E  ++  ++H
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMA-VKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65

Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNY--FLDILQRLKIMIDVASALEYL 874
            N+V+ + S  + D   + LEY+  GS+   L  +NY  F + L R   +  +   L YL
Sbjct: 66  ENIVQYLGSSLDADHLNIFLEYVPGGSVAALL--NNYGAFEETLVR-NFVRQILKGLNYL 122

Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT-------LGTIG 927
           H   +  I+H DIK +N+L++      +SDFGI+K L  E +   TKT        G++ 
Sbjct: 123 H---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL--EANSLSTKTNGARPSLQGSVF 177

Query: 928 YMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           +MAPE  ++   +RK D++S G +++E  T K P
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 18/208 (8%)

Query: 763 FSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRH---R 817
           +   +L+G G++G+VY+G  +P G  +A K+ +++  D  +     E  ++  +R     
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 818 NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYS---DNYFLDILQRLKIMIDVASALEYL 874
           N+ K   S        +++EY   GS+   + +      ++ +     I+ +V  AL+Y+
Sbjct: 63  NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-----IIREVLVALKYI 117

Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H      ++H DIK +N+L+  +    L DFG+A +L +  S R T   GT  +MAPE  
Sbjct: 118 H---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVI 173

Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKP 961
            EGK    K D++S GI + E  T   P
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 85.6 bits (212), Expect = 3e-18
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 21/214 (9%)

Query: 763 FSENKLLGMGSFGSVYKGVL--PDGMEIAAKVFHMEFDGS----LESFHAECKVMGSIRH 816
               K+LG G FGSV +G L   DG ++   V  M+ D      +E F +E   M    H
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 817 RNLVKIISSC----SNNDFKA--LVLEYMSNGSLEKCLYS----DNYFLDILQRL-KIMI 865
            N++K+I  C    S        ++L +M +G L   L             LQ L K M+
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120

Query: 866 DVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT 925
           D+A  +EYL    +   +H D+   N +L E M   ++DFG++K +   +  RQ +    
Sbjct: 121 DIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177

Query: 926 -IGYMAPEYGREGKVSRKCDVYSYGIMLMETFTK 958
            + ++A E   +   + K DV+++G+ + E  T+
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 85.3 bits (211), Expect = 4e-18
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 19/212 (8%)

Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL------ESFHAECKVMGSIRH 816
           +++ ++LG G++G+VY G+   G  IA K   ++    L      E    E  ++ S++H
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
            N+V+ + +C +++  ++ +E++  GS+   L       + +   K    +   + YLH 
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFC-KYTKQILDGVAYLH- 119

Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG-------KEESMRQTKTLGTIGYM 929
             +  +VH DIK +NV+L  + +  L DFG A+ L            ++     GT  +M
Sbjct: 120 --NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH--GTPYWM 175

Query: 930 APEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           APE   E    RK D++S G  + E  T K P
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 85.2 bits (211), Expect = 4e-18
 Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 16/221 (7%)

Query: 760 TDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAK---VFHMEFDGSLESFHAECKVMGSIR 815
              F   K +G G F  VYK + L DG  +A K   +F M    + +    E  ++  + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLE---KCLYSDNYFLDILQRLKIMIDVASALE 872
           H N++K ++S   N+   +VLE    G L    K        +      K  + + SALE
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE 932
           ++H   S  I+H DIKP+NV +  + V  L D G+ +    + +   +  +GT  YM+PE
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPE 176

Query: 933 YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGE-MSL 972
              E   + K D++S G +L E    + P    F G+ M+L
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNL 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 84.9 bits (210), Expect = 4e-18
 Identities = 54/192 (28%), Positives = 97/192 (50%), Gaps = 6/192 (3%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
           K LG G FG V+ G      ++A K    +   S E+F AE  +M  ++H  LV++ +  
Sbjct: 12  KKLGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70

Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
           +      ++ EYM NGSL   L +     L I + + +   +A  + ++        +H 
Sbjct: 71  TQEPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHR 126

Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L++E++   ++DFG+A+++   E   +      I + APE    G  + K DV
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186

Query: 946 YSYGIMLMETFT 957
           +S+GI+L E  T
Sbjct: 187 WSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 85.7 bits (212), Expect = 4e-18
 Identities = 73/302 (24%), Positives = 127/302 (42%), Gaps = 58/302 (19%)

Query: 769  LGMGSFGSVYK----GVLPDGMEIAAKVFHMEFDGSLE---SFHAECKVMGSIRHRNLVK 821
            +G G+FG V++    G+LP        V  ++ + S +    F  E  +M    H N+VK
Sbjct: 13   IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 822  IISSCSNNDFKALVLEYMSNGSLEKCL--------------------YSDNYF-LDILQR 860
            ++  C+      L+ EYM+ G L + L                       N   L   ++
Sbjct: 73   LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 861  LKIMIDVASALEYL---HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM 917
            L I   VA+ + YL    F      VH D+   N L+ E+MV  ++DFG+++ +   +  
Sbjct: 133  LCIAKQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186

Query: 918  RQTKT-LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWV 976
            + ++     I +M PE     + + + DV++YG++L E F+              ++ + 
Sbjct: 187  KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS------------YGMQPYY 234

Query: 977  GDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036
            G +     I  V D N+L+C +N       C   +++L   C   LP  R S   +   L
Sbjct: 235  GMAHEEV-IYYVRDGNVLSCPDN-------CPLELYNLMRLCWSKLPSDRPSFASINRIL 286

Query: 1037 VR 1038
             R
Sbjct: 287  QR 288

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 84.6 bits (210), Expect = 7e-18
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 28/219 (12%)

Query: 767 KLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSI-RHRNLVK 821
           K++G GSF +V          E A K+        +  ++    E +V+  +  H  ++K
Sbjct: 7   KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           +  +  + +    VLEY  NG L + +      LD         ++  ALEYLH   S  
Sbjct: 67  LYYTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALEYLH---SKG 122

Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILG-----------------KEESMRQTKT-- 922
           I+H D+KP N+LL++ M   ++DFG AK+L                  + E  R+     
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182

Query: 923 LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           +GT  Y++PE   E    +  D+++ G ++ +  T K P
Sbjct: 183 VGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 88.3 bits (219), Expect = 8e-18
 Identities = 55/178 (30%), Positives = 87/178 (48%), Gaps = 10/178 (5%)

Query: 567 VVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNL 626
            +  + L    L G IP  I  L+ LQ ++L  N ++G IP S G + SL  +D+S N+ 
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478

Query: 627 SGTIPKSMEALSYLKHLNLSFNQLEGEIPTR--GPFITFSAESFLGNQALCGSPKLQVSP 684
           +G+IP+S+  L+ L+ LNL+ N L G +P    G  +  ++ +F  N  LCG P L+   
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLR--A 536

Query: 685 CKTRSHPRSRTTVVLLIVLPLVSALTMIVVLTAKLVRRRRRRRRRQKGSTR--PYYDA 740
           C     P       + I   +  A   +V+      +RR+   R Q+ + R  PY  A
Sbjct: 537 CG----PHLSVGAKIGIAFGVSVAFLFLVICAMCWWKRRQNILRAQRIAAREAPYAKA 590

Length = 623

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 84.8 bits (210), Expect = 8e-18
 Identities = 62/207 (29%), Positives = 88/207 (42%), Gaps = 25/207 (12%)

Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAK--VFHMEFDGSLESFHAECKVMGSIRHRN 818
           +   E   LG G+ GSV K  L +   I A   +         +    E ++  S +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 819 LVKIISSCSNNDFK--ALVLEYMSNGSLEKCLYSDNYFLDILQR---------LKIMIDV 867
           +VK   +  +       + +EY   GSL      D+ +  + +R          KI   V
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSL------DSIYKKVKKRGGRIGEKVLGKIAESV 114

Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIG 927
              L YLH   S  I+H DIKPSN+LL       L DFG++  L    S+  T T GT  
Sbjct: 115 LKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NSLAGTFT-GTSF 168

Query: 928 YMAPEYGREGKVSRKCDVYSYGIMLME 954
           YMAPE  +    S   DV+S G+ L+E
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLE 195

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 83.7 bits (207), Expect = 1e-17
 Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 18/214 (8%)

Query: 769 LGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVKIISS 825
           +G GSFG V+K V   D    A K   +      E   A  E +V+  +    +++   S
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL------KIMIDVASALEYLHFGYS 879
             +     +V+EY  NG L K L          + L      +  I +   L +LH   S
Sbjct: 68  FLDKGKLNIVMEYAENGDLHKLLKMQRG-----RPLPEDQVWRFFIQILLGLAHLH---S 119

Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKV 939
             I+H DIK  N+ L+      + D G+AK+L    +   T  +GT  Y++PE   +   
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELCEDKPY 178

Query: 940 SRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
           + K DV++ G++L E  T K P D    G + LK
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 84.4 bits (209), Expect = 1e-17
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 26/211 (12%)

Query: 767 KLLGMGSFGSVYKGVL----PDGMEIAAKVFHMEFDGSLES---FHAECKVMGSIRHRNL 819
           + LG G+FG VY+G+      D +E+   V  +    S +    F  E  +M    H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCL-----YSDNYF-LDILQRLKIMIDVASALEY 873
           V++I        + ++LE M+ G L+  L       +    L +   L    DVA   +Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 874 L---HFGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAK-ILGKEESMRQTKTLGTI 926
           L   HF      +H DI   N LL       V  ++DFG+A+ I       +  + +  I
Sbjct: 132 LEENHF------IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185

Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
            +M PE   +G  + K DV+S+G++L E F+
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 80/288 (27%), Positives = 127/288 (44%), Gaps = 27/288 (9%)

Query: 767  KLLGMGSFGSVYK---GVLPD--GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVK 821
            + LG G+FGSV       L D  G  +A K         L  F  E +++ S++H N+VK
Sbjct: 10   QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 822  ---IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
               +  S    + + LV+EY+  GSL   L      LD  + L     +   +EYL    
Sbjct: 70   YKGVCYSAGRRNLR-LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG--- 125

Query: 879  STPIVHCDIKPSNVLL-NESMVGHLSDFGIAKIL--GKEESMRQTKTLGTIGYMAPEYGR 935
            S   VH D+   N+L+ +E+ V  + DFG+ K+L   KE    +      I + APE   
Sbjct: 126  SKRYVHRDLATRNILVESENRV-KIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184

Query: 936  EGKVSRKCDVYSYGIMLMETFT---KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN 992
            E K S   DV+S+G++L E FT   K       F   M   +     ++   + E+   N
Sbjct: 185  ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDK--QGQMIVYHLIELLKNN 242

Query: 993  LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIR 1040
                      A   C + I+++  +C  + P +R S  ++A ++  IR
Sbjct: 243  ------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 83.3 bits (206), Expect = 1e-17
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 16/205 (7%)

Query: 767 KLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGS-----LESFHAECKVMGSIRHRNLV 820
           KLLG G+FG VY     D G E+A K    + D       + +   E +++ +++H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
           +      +++  ++ +EYM  GS++  L +     + + R K    +   +EYLH   S 
Sbjct: 68  QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLH---SN 123

Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAK----ILGKEESMRQTKTLGTIGYMAPEYGRE 936
            IVH DIK +N+L + +    L DFG +K    I      M+     GT  +M+PE    
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS--VTGTPYWMSPEVISG 181

Query: 937 GKVSRKCDVYSYGIMLMETFTKKKP 961
               RK DV+S G  ++E  T+K P
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 83.4 bits (206), Expect = 2e-17
 Identities = 63/199 (31%), Positives = 95/199 (47%), Gaps = 17/199 (8%)

Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           +G G+ G+VY  + +  G E+A K  +++     E    E  VM   +H N+V  + S  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 828 NNDFKALVLEYMSNGSL-----EKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
             D   +V+EY++ GSL     E C+       D  Q   +  +   ALE+LH   S  +
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETCM-------DEGQIAAVCRECLQALEFLH---SNQV 136

Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRK 942
           +H DIK  N+LL       L+DFG    +  E+S R T  +GT  +MAPE         K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPK 195

Query: 943 CDVYSYGIMLMETFTKKKP 961
            D++S GIM +E    + P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 82.1 bits (203), Expect = 4e-17
 Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 14/219 (6%)

Query: 762 GFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRN 818
            F   K LG GS+GSVYK   L D    A K   +      E   A  E +++ S+ H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQR---LKIMIDVASALEYLH 875
           ++    +  + +   +V+EY   G L K +        ++      +I I +   L+ LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT-LGTIGYMAPEYG 934
                 I+H D+K +N+LL  + +  + D GI+K+L K       KT +GT  YMAPE  
Sbjct: 121 ---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKK----NMAKTQIGTPHYMAPEVW 173

Query: 935 REGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
           +    S K D++S G +L E  T   P +     ++  K
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK 212

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 82.2 bits (203), Expect = 4e-17
 Identities = 61/196 (31%), Positives = 94/196 (47%), Gaps = 8/196 (4%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
           K LG G FG V+ G     +++A K  + E   S E F  E KVM  + H  LV++   C
Sbjct: 10  KELGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFL--DILQRLKIMIDVASALEYLHFGYSTPIVH 884
           +      +V E+M NG L   L      L  D+L  L +  DV   +EYL        +H
Sbjct: 69  TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLE---RNSFIH 123

Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCD 944
            D+   N L++ + V  +SDFG+ + +  +E    +     + +  PE     K S K D
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183

Query: 945 VYSYGIMLMETFTKKK 960
           V+S+G+++ E FT+ K
Sbjct: 184 VWSFGVLMWEVFTEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 82.1 bits (203), Expect = 4e-17
 Identities = 57/199 (28%), Positives = 102/199 (51%), Gaps = 10/199 (5%)

Query: 767 KLLGMGSFGS--VYKGVLPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVKI 822
           ++LG G+FG   +Y+    D   +  K  ++      E   A  E  ++  ++H N++  
Sbjct: 6   RVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64

Query: 823 ISSCSNNDFKALVLEYMSNGSL-EKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
            +   +++   + +EY + G+L +K +       +    L  +  + SA+ Y+H      
Sbjct: 65  YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAG 121

Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSR 941
           I+H DIK  N+ L ++ +  L DFGI+KILG E SM +T  +GT  YM+PE  +  K + 
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKYNF 180

Query: 942 KCDVYSYGIMLMETFTKKK 960
           K D+++ G +L E  T K+
Sbjct: 181 KSDIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 82.4 bits (203), Expect = 6e-17
 Identities = 74/329 (22%), Positives = 138/329 (41%), Gaps = 71/329 (21%)

Query: 748  WRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVF----------HME 796
            W  I ++D++            G G+FG V + ++  DG+++ A +           H +
Sbjct: 1    WEDIKFEDVI------------GEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRD 48

Query: 797  FDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSL------EKCLYS 850
            F G LE     CK+     H N++ ++ +C N  +  + +EY   G+L       + L +
Sbjct: 49   FAGELEVL---CKLG---HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLET 102

Query: 851  DNYF---------LDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGH 901
            D  F         L   Q L+   DVA+ ++YL        +H D+   NVL+ E++   
Sbjct: 103  DPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASK 159

Query: 902  LSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKK 960
            ++DFG+++  G+E  +++T     + +MA E       + K DV+S+G++L E  +    
Sbjct: 160  IADFGLSR--GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGT 217

Query: 961  PTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTV 1020
            P   +   E+  K   G  +                          C   ++ L   C  
Sbjct: 218  PYCGMTCAELYEKLPQGYRM---------------------EKPRNCDDEVYELMRQCWR 256

Query: 1021 DLPEKRISMKDVANRLVRIRETLSAYIDV 1049
            D P +R     ++ +L R+ E   AY+++
Sbjct: 257  DRPYERPPFAQISVQLSRMLEARKAYVNM 285

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 27/203 (13%)

Query: 772 GSFGSVY---KGVLPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRHRNLVKIISS 825
           G++G V+   K    D    A KV     M     ++    E  ++   +   +VK+  S
Sbjct: 4   GAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYS 61

Query: 826 --CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIV 883
                N +  LV+EY+  G L   L +     + + R+ I  ++  ALEYLH   S  I+
Sbjct: 62  FQGKKNLY--LVMEYLPGGDLASLLENVGSLDEDVARIYIA-EIVLALEYLH---SNGII 115

Query: 884 HCDIKPSNVLLNESMVGH--LSDFGIAK-------ILGKEESMRQTKTLGTIGYMAPEYG 934
           H D+KP N+L++ +  GH  L+DFG++K       I   ++     + +GT  Y+APE  
Sbjct: 116 HRDLKPDNILIDSN--GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173

Query: 935 REGKVSRKCDVYSYGIMLMETFT 957
                S+  D +S G +L E   
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 80.7 bits (200), Expect = 1e-16
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 28/206 (13%)

Query: 769 LGMGSFGSVYK-GVLPDGMEIAAKVF--HMEFDGSLES-FHAECKVMGSIRHRNLVKIIS 824
           LG+G FG V    V       A K        +   +    +E +++    H  +VK+  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI--MIDVASALEYLHFGYSTPI 882
           +  +  +  +++EY   G L   L     F +   R  I  ++    A EYLH   +  I
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVV---LAFEYLH---NRGI 114

Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGYMAPE------YGR 935
           ++ D+KP N+LL+ +    L DFG AK L    S ++T T  GT  Y+APE      Y  
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLK---SGQKTWTFCGTPEYVAPEIILNKGYD- 170

Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
                   D +S GI+L E  T + P
Sbjct: 171 -----FSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 80.7 bits (199), Expect = 1e-16
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 29/214 (13%)

Query: 767 KLLGMGSFGSVYKG----VLPDGME---IAAKVFHM-EFDGSLESFHAECKVMGSIRHRN 818
             LG G+FG VY+G    +L  G     +A K       D   + F  E  +M +  H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNY------FLDILQRLKIMIDVASALE 872
           +VK++  C  N+ + +++E M  G L   L            L + + L I +DVA    
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 873 YL---HFGYSTPIVHCDIKPSNVLLNES-----MVGHLSDFGIAKILGKEESMR-QTKTL 923
           YL   HF      +H D+   N L++E       V  + DFG+A+ + K +  R + + L
Sbjct: 121 YLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174

Query: 924 GTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
             + +MAPE   +GK + + DV+S+G+++ E  T
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 82.2 bits (203), Expect = 2e-16
 Identities = 69/245 (28%), Positives = 114/245 (46%), Gaps = 39/245 (15%)

Query: 732 GSTRPYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAA 790
            S+     ++    A     S  +L R          +G G+ G+VYK +  P G   A 
Sbjct: 52  SSSSSSSSSSASGSAPSAAKSLSELERV-------NRIGSGAGGTVYKVIHRPTGRLYAL 104

Query: 791 KVFHMEFDGSLE-SFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLY 849
           KV +   + ++      E +++  + H N+VK      +N    ++LE+M  GSLE    
Sbjct: 105 KVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHI 164

Query: 850 SDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK 909
           +D  FL  + R      + S + YLH      IVH DIKPSN+L+N +    ++DFG+++
Sbjct: 165 ADEQFLADVAR-----QILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSR 216

Query: 910 ILGKEESMRQT-----KTLGTIGYMAPE-------YGR-EGKVSRKCDVYSYGIMLMETF 956
           IL       QT      ++GTI YM+PE       +G  +G      D++S G+ ++E +
Sbjct: 217 ILA------QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAG---DIWSLGVSILEFY 267

Query: 957 TKKKP 961
             + P
Sbjct: 268 LGRFP 272

Length = 353

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 80.3 bits (198), Expect = 2e-16
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 12/200 (6%)

Query: 767 KLLGMGSFGSVYKGVL--PDGMEI--AAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVK 821
           +++G G FG V +G L  P   EI  A K     + +     F +E  +MG   H N++ 
Sbjct: 10  EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           +    + +    ++ E+M NG+L+  L  ++    ++Q + ++  +A+ ++YL       
Sbjct: 70  LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMN 126

Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES-MRQTKTLG---TIGYMAPEYGREG 937
            VH D+   N+L+N ++V  +SDFG+++ L  + S    T +LG    I + APE     
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186

Query: 938 KVSRKCDVYSYGIMLMETFT 957
           K +   DV+SYGI++ E  +
Sbjct: 187 KFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 81.2 bits (200), Expect = 2e-16
 Identities = 82/333 (24%), Positives = 138/333 (41%), Gaps = 71/333 (21%)

Query: 743  YPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKG-VLPDGM----------EIAAK 791
            YP   W  I +QD++            G G+FG V K  +  DG+          E A+K
Sbjct: 1    YPVLEWNDIKFQDVI------------GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK 48

Query: 792  VFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSL------E 845
              H +F G LE     CK+     H N++ ++ +C +  +  L +EY  +G+L       
Sbjct: 49   DDHRDFAGELEVL---CKLG---HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKS 102

Query: 846  KCLYSDNYF---------LDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE 896
            + L +D  F         L   Q L    DVA  ++YL        +H D+   N+L+ E
Sbjct: 103  RVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGE 159

Query: 897  SMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETF 956
            + V  ++DFG+++  G+E  +++T     + +MA E       +   DV+SYG++L E  
Sbjct: 160  NYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217

Query: 957  T-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLA 1015
            +    P   +   E+  K   G  L             LNC++            ++ L 
Sbjct: 218  SLGGTPYCGMTCAELYEKLPQGYRL----------EKPLNCDD-----------EVYDLM 256

Query: 1016 MDCTVDLPEKRISMKDVANRLVRIRETLSAYID 1048
              C  + P +R S   +   L R+ E    Y++
Sbjct: 257  RQCWREKPYERPSFAQILVSLNRMLEERKTYVN 289

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 80.6 bits (199), Expect = 2e-16
 Identities = 74/225 (32%), Positives = 105/225 (46%), Gaps = 36/225 (16%)

Query: 758 RATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA--KVFHMEFDGSLESFHA----ECKVM 811
           R  D F     +G G++G VYK    D  E+ A  KV     D   E F      E K++
Sbjct: 4   RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV---RLDNEKEGFPITAIREIKIL 60

Query: 812 GSIRHRNLVK----IISSCSNNDFKA------LVLEYMSN---GSLEKCL--YSDNYFLD 856
             + HRN+V     +       DFK       LV EYM +   G LE  L  +S+++   
Sbjct: 61  RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120

Query: 857 ILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES 916
            +++L         LE L++ +    +H DIK SN+LLN      L+DFG+A++   EES
Sbjct: 121 FMKQL---------LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171

Query: 917 MRQTKTLGTIGYMAPE--YGREGKVSRKCDVYSYGIMLMETFTKK 959
              T  + T+ Y  PE   G E +     DV+S G +L E FTKK
Sbjct: 172 RPYTNKVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 79.9 bits (197), Expect = 3e-16
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 41/219 (18%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHM------EFDGSLESFHAECKVMGSIRHRNL 819
           + LG G+F S Y+   +  G  +A K          E +  +E+   E ++M  + H ++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLY---------SDNYFLDILQRLKIMIDVASA 870
           ++++ +   +    L +E+M+ GS+   L            NY   +L+           
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLR----------G 115

Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNESMVGH---LSDFGIA-----KILGKEESMRQTKT 922
           L YLH      I+H D+K +N+L++ +  G    ++DFG A     K  G  E   Q + 
Sbjct: 116 LSYLH---ENQIIHRDVKGANLLIDST--GQRLRIADFGAAARLAAKGTGAGEF--QGQL 168

Query: 923 LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           LGTI +MAPE  R  +  R CDV+S G +++E  T K P
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 80.4 bits (198), Expect = 3e-16
 Identities = 70/304 (23%), Positives = 130/304 (42%), Gaps = 49/304 (16%)

Query: 769  LGMGSFGSVY----KGVLP--DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKI 822
            LG G+FG V+      + P  D M +A K        + + F  E +++ +++H ++VK 
Sbjct: 13   LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 823  ISSCSNNDFKALVLEYMSNGSLEKCLYS---------------DNYFLDILQRLKIMIDV 867
               C + D   +V EYM +G L K L +                   L + Q L I   +
Sbjct: 73   YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 868  ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTI 926
            AS + YL    S   VH D+   N L+  +++  + DFG+++ +   +  R    T+  I
Sbjct: 133  ASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 927  GYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRW--VGDSLLSCS 984
             +M PE     K + + DV+S+G++L E FT  K            + W  + ++ +   
Sbjct: 190  RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK------------QPWFQLSNTEVIEC 237

Query: 985  ITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044
            IT          +         C   ++ + + C    P++R+++K++   L  + +   
Sbjct: 238  IT----------QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287

Query: 1045 AYID 1048
             Y+D
Sbjct: 288  IYLD 291

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 79.3 bits (196), Expect = 4e-16
 Identities = 69/282 (24%), Positives = 107/282 (37%), Gaps = 37/282 (13%)

Query: 767  KLLGMGSFGSVYKG----VLPDGMEIAAKVFHME-FDGSLESFHAECKVMGSIRHRNLVK 821
            K LG GSFG V +G         + +A K    +     ++ F  E  +M S+ H NL++
Sbjct: 1    KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 822  IISSCSNNDFKALVLEYMSNGSLEKCLYSDN---YFLDILQRLKIMIDVASALEYLHFGY 878
            +      +    +V E    GSL   L  D    + +  L    + I  A+ + YL    
Sbjct: 61   LYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI--ANGMRYLE--- 114

Query: 879  STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES---MRQTKTLGTIGYMAPEYGR 935
            S   +H D+   N+LL       + DFG+ + L + E    M +   +    + APE  R
Sbjct: 115  SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESLR 173

Query: 936  EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN 995
                S   DV+ +G+ L E FT          GE     W G  L    I +  D     
Sbjct: 174  TRTFSHASDVWMFGVTLWEMFT---------YGEEP---WAG--LSGSQILKKIDKEGER 219

Query: 996  CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037
             E       E C   I+++ + C    P  R +   +   L 
Sbjct: 220  LERP-----EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 79.5 bits (196), Expect = 4e-16
 Identities = 59/221 (26%), Positives = 108/221 (48%), Gaps = 28/221 (12%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFD------------GSLESFHAECKVMGSI 814
           +L+G G++G VY  +     E+ A V  +E                +++  +E + +  +
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMA-VKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
            H N+V+ +   +  ++ ++ LEY+  GS+  CL +   F + L R      V   L YL
Sbjct: 66  DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRF-FTEQVLEGLAYL 124

Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK----ILGKEESMRQTKTLGTIGYMA 930
           H   S  I+H D+K  N+L++   +  +SDFGI+K    I   +++M      G++ +MA
Sbjct: 125 H---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ---GSVFWMA 178

Query: 931 PE--YGREGKVSRKCDVYSYGIMLMETFTKKKP--TDEIFA 967
           PE  +      S K D++S G +++E F  ++P   +E  A
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 79.0 bits (194), Expect = 6e-16
 Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 8/205 (3%)

Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA-KVFHME-FDGSLESFHAECKVMGSIRHRNLV 820
           F++ + +G GSFG V+KG+     ++ A K+  +E  +  +E    E  V+       + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
           K   S   +    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   S 
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 120

Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVS 940
             +H DIK +NVLL+E     L+DFG+A  L  +  +++   +GT  +MAPE  ++    
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIKQSAYD 179

Query: 941 RKCDVYSYGIMLMETFTKKKPTDEI 965
            K D++S GI  +E    + P  E+
Sbjct: 180 SKADIWSLGITAIELAKGEPPHSEL 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 78.9 bits (194), Expect = 6e-16
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 8/205 (3%)

Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA-KVFHME-FDGSLESFHAECKVMGSIRHRNLV 820
           F++ + +G GSFG V+KG+     ++ A K+  +E  +  +E    E  V+       + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
           K   S        +++EY+  GS    L +  +  D  Q   ++ ++   L+YLH   S 
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH---SE 120

Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVS 940
             +H DIK +NVLL+E     L+DFG+A  L   +  R T  +GT  +MAPE  ++    
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIQQSAYD 179

Query: 941 RKCDVYSYGIMLMETFTKKKPTDEI 965
            K D++S GI  +E    + P  ++
Sbjct: 180 SKADIWSLGITAIELAKGEPPNSDM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 78.7 bits (194), Expect = 8e-16
 Identities = 66/199 (33%), Positives = 99/199 (49%), Gaps = 10/199 (5%)

Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-ESFHAECKVMGSIRHRNLVKIISSC 826
           LG G+ GSV K   +P G  +A KV H+    S+ +    E ++M   R   +V    + 
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYF-LDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
            N +   + +E+M  GSL++         ++IL   KI + V   L YL+      I+H 
Sbjct: 73  LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG--KIAVAVVEGLTYLY--NVHRIMHR 128

Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           DIKPSN+L+N      L DFG++  L    S+  T  +GT  YM+PE  + GK + K DV
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGEL--INSIADT-FVGTSTYMSPERIQGGKYTVKSDV 185

Query: 946 YSYGIMLMETFTKKKPTDE 964
           +S GI ++E    K P   
Sbjct: 186 WSLGISIIELALGKFPFAF 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 79.6 bits (196), Expect = 8e-16
 Identities = 69/230 (30%), Positives = 107/230 (46%), Gaps = 20/230 (8%)

Query: 767 KLLGMGSFGSVY---KGVLPD-----GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRN 818
           K+LG G++G V+   K    D      M++  K   ++   ++E    E  V+  +R   
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 819 LVKIISSCSNNDFKA-LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
            +  +      + K  L+L+Y+S G +   LY  + F +   R     ++  ALE+LH  
Sbjct: 66  FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALEHLH-- 122

Query: 878 YSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
               IV+ DIK  N+LL+    GH  L+DFG++K    EE  R     GTI YMAPE  R
Sbjct: 123 -KLGIVYRDIKLENILLDSE--GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIR 179

Query: 936 -EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCS 984
            +G   +  D +S GI++ E  T   P      GE + +  V   +L C 
Sbjct: 180 GKGGHGKAVDWWSLGILIFELLTGASPF--TLEGERNTQSEVSRRILKCD 227

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 78.5 bits (193), Expect = 9e-16
 Identities = 55/200 (27%), Positives = 98/200 (49%), Gaps = 15/200 (7%)

Query: 767 KLLGMGSFGSVYKGV-LPDG--MEIAAKVFHMEFDGSLESFHA---ECKVMGSIRHRNLV 820
           KLLG G FG+V+KG+ +P+G  ++I   +  ++     ++F         MGS+ H  +V
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
           +++  C     + LV +    GSL   +      LD  + L   + +A  + YL      
Sbjct: 73  RLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EH 128

Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKIL---GKEESMRQTKTLGTIGYMAPEYGREG 937
            +VH ++   N+LL    +  ++DFG+A +L    K+    + KT   I +MA E    G
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT--PIKWMALESILFG 186

Query: 938 KVSRKCDVYSYGIMLMETFT 957
           + + + DV+SYG+ + E  +
Sbjct: 187 RYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 78.6 bits (193), Expect = 1e-15
 Identities = 71/301 (23%), Positives = 130/301 (43%), Gaps = 46/301 (15%)

Query: 769  LGMGSFGSVY----KGVLP--DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKI 822
            LG G+FG V+      + P  D + +A K      D + + FH E +++ +++H ++VK 
Sbjct: 13   LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 823  ISSCSNNDFKALVLEYMSNGSLEKCLYSDN------------YFLDILQRLKIMIDVASA 870
               C   D   +V EYM +G L K L +                L   Q L I   +A+ 
Sbjct: 73   YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 871  LEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYM 929
            + YL    S   VH D+   N L+ E+++  + DFG+++ +   +  R    T+  I +M
Sbjct: 133  MVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 930  APEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA 989
             PE     K + + DV+S G++L E FT  K            + W           +++
Sbjct: 190  PPESIMYRKFTTESDVWSLGVVLWEIFTYGK------------QPWY----------QLS 227

Query: 990  DANLLNC--EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYI 1047
            +  ++ C  +         C   ++ L + C    P  R+++K++ + L  + +    Y+
Sbjct: 228  NNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASPVYL 287

Query: 1048 D 1048
            D
Sbjct: 288  D 288

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 12/204 (5%)

Query: 767 KLLGMGSFGSVYKGVL--PDGMEI--AAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVK 821
           +++G G FG VY G L   DG +I  A K  +   D   +E F  E  +M    H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 822 IISSCSNNDFKALV-LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
           ++  C  ++   LV L YM +G L   + S+ +   +   +   + VA  +EYL    S 
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SK 117

Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAK-ILGKEESMRQTKTLGT--IGYMAPEYGREG 937
             VH D+   N +L+ES    ++DFG+A+ I  KE       T     + +MA E  +  
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177

Query: 938 KVSRKCDVYSYGIMLMETFTKKKP 961
           K + K DV+S+G++L E  T+  P
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 77.8 bits (191), Expect = 2e-15
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 17/205 (8%)

Query: 763 FSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVK 821
           ++  + +G G+ G+V+  + +  G E+A K  +++     E    E  VM  +++ N+V 
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80

Query: 822 IISSCSNNDFKALVLEYMSNGSL-----EKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
            + S    D   +V+EY++ GSL     E C+       D  Q   +  +   ALE+LH 
Sbjct: 81  FLDSFLVGDELFVVMEYLAGGSLTDVVTETCM-------DEAQIAAVCRECLQALEFLH- 132

Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             +  ++H DIK  NVLL       L+DFG    +  E+S R T  +GT  +MAPE    
Sbjct: 133 --ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTR 189

Query: 937 GKVSRKCDVYSYGIMLMETFTKKKP 961
                K D++S GIM +E    + P
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 77.8 bits (191), Expect = 2e-15
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 20/208 (9%)

Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G+FG VYK    + G   AAKV   + +  LE +  E +++ +  H  +VK++ +  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 828 NNDFKALVLEYMSNGSLEKCLYSDNYFLDI-LQRLKIMIDVASALEYLHFGYSTPIVHCD 886
            +    +++E+   G+++  +      LD  L   +I +     LE L + +S  I+H D
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLE----LDRGLTEPQIQVICRQMLEALQYLHSMKIIHRD 135

Query: 887 IKPSNVLLNESMVGHLSDFGIA----KILGKEESMRQTKTLGTIGYMAPEY-----GREG 937
           +K  NVLL       L+DFG++    K L + +S      +GT  +MAPE       ++ 
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSF-----IGTPYWMAPEVVMCETMKDT 190

Query: 938 KVSRKCDVYSYGIMLMETFTKKKPTDEI 965
               K D++S GI L+E    + P  E+
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPPHHEL 218

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 77.4 bits (190), Expect = 2e-15
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 16/209 (7%)

Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA-KVFHME-FDGSLESFHAECKVMGSIRHRNLV 820
           F++ + +G GSFG VYKG+     E+ A K+  +E  +  +E    E  V+       + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 821 KIISSCSNNDFKALVLEYMSNGS----LEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
           +   S        +++EY+  GS    L+     + Y   IL+      ++   L+YLH 
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR------EILKGLDYLH- 118

Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S   +H DIK +NVLL+E     L+DFG+A  L   +  R T  +GT  +MAPE  ++
Sbjct: 119 --SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQ 175

Query: 937 GKVSRKCDVYSYGIMLMETFTKKKPTDEI 965
                K D++S GI  +E    + P  ++
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDL 204

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 60/193 (31%), Positives = 100/193 (51%), Gaps = 6/193 (3%)

Query: 766 NKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISS 825
            K LG G FG V+        ++A K        S+E+F AE  VM +++H  LVK+ + 
Sbjct: 11  EKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69

Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASAL-EYLHFGYSTPIVH 884
            +      ++ E+M+ GSL   L SD       Q L  +ID ++ + E + F      +H
Sbjct: 70  VTKEPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 125

Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCD 944
            D++ +N+L++ S+V  ++DFG+A+++   E   +      I + APE    G  + K D
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 185

Query: 945 VYSYGIMLMETFT 957
           V+S+GI+LME  T
Sbjct: 186 VWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 77.5 bits (191), Expect = 3e-15
 Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 28/212 (13%)

Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDG--SLESFH---AECKVMGSIRHR 817
           F++ + +G GSFG+VY        E+ A +  M + G  S E +     E + +  +RH 
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVA-IKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75

Query: 818 NLVKIISSCSNNDFKA-LVLEYMSNGSLEKCLYSDNYFLDI----LQRLKIMIDVASALE 872
           N ++    C   +  A LV+EY        CL S +  L++    LQ ++I      AL+
Sbjct: 76  NTIEY-KGCYLREHTAWLVMEY--------CLGSASDILEVHKKPLQEVEIAAICHGALQ 126

Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE 932
            L + +S   +H DIK  N+LL E     L+DFG A ++    S      +GT  +MAPE
Sbjct: 127 GLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF-----VGTPYWMAPE 181

Query: 933 Y---GREGKVSRKCDVYSYGIMLMETFTKKKP 961
                 EG+   K DV+S GI  +E   +K P
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 75.9 bits (186), Expect = 5e-15
 Identities = 68/232 (29%), Positives = 103/232 (44%), Gaps = 37/232 (15%)

Query: 747 TWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFD------- 798
            WRR                KLLG G+FG VY     D G E+AAK   ++FD       
Sbjct: 3   NWRR---------------GKLLGQGAFGRVYLCYDVDTGRELAAK--QVQFDPESPETS 45

Query: 799 GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV--LEYMSNGSLEKCLYSDNYFLD 856
             + +   E +++ +++H  +V+      +   K L   +EYM  GS++  L +     +
Sbjct: 46  KEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTE 105

Query: 857 ILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK----ILG 912
            + R K    +   + YLH   S  IVH DIK +N+L + +    L DFG +K    I  
Sbjct: 106 SVTR-KYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161

Query: 913 KEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDE 964
               +R     GT  +M+PE        RK DV+S G  ++E  T+K P  E
Sbjct: 162 SGTGIRSVT--GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 76.3 bits (187), Expect = 6e-15
 Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 17/199 (8%)

Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           +G G+ G+VY  + +  G E+A K  +++     E    E  VM   ++ N+V  + S  
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 828 NNDFKALVLEYMSNGSL-----EKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
             D   +V+EY++ GSL     E C+       D  Q   +  +   AL++LH   S  +
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETCM-------DEGQIAAVCRECLQALDFLH---SNQV 136

Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRK 942
           +H DIK  N+LL       L+DFG    +  E+S R T  +GT  +MAPE         K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPK 195

Query: 943 CDVYSYGIMLMETFTKKKP 961
            D++S GIM +E    + P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 76.0 bits (188), Expect = 7e-15
 Identities = 64/210 (30%), Positives = 92/210 (43%), Gaps = 48/210 (22%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEIAA-------KVFHMEFDGSLESFHAECKVMGSIRHRNL 819
           K LG GSFG V         +  A       K+  +     +E    E +++ SIRH  L
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKL---KQVEHVLNEKRILQSIRHPFL 63

Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMI------DVASALEY 873
           V +  S  ++    LV+EY+  G L          L    R    +       V  ALEY
Sbjct: 64  VNLYGSFQDDSNLYLVMEYVPGGEL-------FSHLRKSGRFPEPVARFYAAQVVLALEY 116

Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTL-GTIGYMA 930
           LH   S  IV+ D+KP N+LL+    G+  ++DFG AK +       +T TL GT  Y+A
Sbjct: 117 LH---SLDIVYRDLKPENLLLDSD--GYIKITDFGFAKRVKG-----RTYTLCGTPEYLA 166

Query: 931 PE------YGREGKVSRKCDVYSYGIMLME 954
           PE      YG      +  D ++ GI++ E
Sbjct: 167 PEIILSKGYG------KAVDWWALGILIYE 190

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 75.8 bits (186), Expect = 7e-15
 Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 20/209 (9%)

Query: 767 KLLGMGSFGSVYKGVLPDG---MEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVK 821
           K LG G FGSV +G L      +++A K   +       +E F +E   M    H N+++
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 822 IISSC----SNNDFKA--LVLEYMSNGSLEK-CLYS----DNYFLDILQRLKIMIDVASA 870
           +I  C     +  + +  ++L +M +G L    LYS       +L     +K M D+AS 
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-IGYM 929
           +EYL    S   +H D+   N +LNE+M   ++DFG++K +   +  RQ +     + ++
Sbjct: 125 MEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181

Query: 930 APEYGREGKVSRKCDVYSYGIMLMETFTK 958
           A E   +   + K DV+S+G+ + E  T+
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATR 210

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 75.9 bits (186), Expect = 8e-15
 Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 17/199 (8%)

Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           +G G+ G+VY  + +  G E+A +  +++     E    E  VM   ++ N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 828 NNDFKALVLEYMSNGSL-----EKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
             D   +V+EY++ GSL     E C+       D  Q   +  +   ALE+LH   S  +
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCM-------DEGQIAAVCRECLQALEFLH---SNQV 137

Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRK 942
           +H DIK  N+LL       L+DFG    +  E+S R +  +GT  +MAPE         K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKAYGPK 196

Query: 943 CDVYSYGIMLMETFTKKKP 961
            D++S GIM +E    + P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 75.0 bits (184), Expect = 1e-14
 Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 13/201 (6%)

Query: 769 LGMGSFGSVYKGVL---PDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKII 823
           LG G+FG+V KG+         +A K+   + +     +    E  VM  + +  +V++I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 824 SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIV 883
             C    +  LV+E    G L K L   N  +      +++  V+  ++YL     T  V
Sbjct: 63  GICEAESW-MLVMELAELGPLNKFL-QKNKHVTEKNITELVHQVSMGMKYLE---ETNFV 117

Query: 884 HCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREGKVSR 941
           H D+   NVLL       +SDFG++K LG +E+  + KT G   + + APE     K S 
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177

Query: 942 KCDVYSYGIMLMETFT-KKKP 961
           K DV+S+G+++ E F+  +KP
Sbjct: 178 KSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 75.1 bits (184), Expect = 1e-14
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 17/209 (8%)

Query: 763 FSENKLLGMGSFGSVYKGV-LPDGMEIAAK---VFHMEFDGSLESFHAECKVMGSIRHRN 818
           F   K +G G F  VY+   L D   +A K   +F M    + +    E  ++  + H N
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLD----ILQRL--KIMIDVASALE 872
           ++K + S   ++   +VLE    G L + +    YF      I +R   K  + + SA+E
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMI---KYFKKQKRLIPERTVWKYFVQLCSAVE 120

Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE 932
           ++H   S  ++H DIKP+NV +  + V  L D G+ +    + +   +  +GT  YM+PE
Sbjct: 121 HMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPE 176

Query: 933 YGREGKVSRKCDVYSYGIMLMETFTKKKP 961
              E   + K D++S G +L E    + P
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 75.5 bits (185), Expect = 1e-14
 Identities = 71/291 (24%), Positives = 129/291 (44%), Gaps = 46/291 (15%)

Query: 769  LGMGSFGSVYKGVL------PDGMEIAAKVFHMEFDGSL-ESFHAECKVMGSIRHRNLVK 821
            LG   FG VYKG L           +A K    + +G L E F  E  +   ++H N+V 
Sbjct: 13   LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 822  IISSCSNNDFKALVLEYMSNGSLEKCL-----YSDNYFLDILQRLK----------IMID 866
            ++   +     +++  Y S+  L + L     +SD    D  + +K          I+  
Sbjct: 73   LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132

Query: 867  VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK-ILGKEESMRQTKTLGT 925
            +A+ +E+L    S  +VH D+   NVL+ + +   +SD G+ + +   +       +L  
Sbjct: 133  IAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189

Query: 926  IGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSI 985
            I +M+PE    GK S   D++SYG++L E F+              L+ + G S     I
Sbjct: 190  IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS------------YGLQPYCGYSNQDV-I 236

Query: 986  TEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036
              + +  +L C ++       C + +++L ++C  + P +R   KD+ +RL
Sbjct: 237  EMIRNRQVLPCPDD-------CPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 1e-14
 Identities = 60/220 (27%), Positives = 92/220 (41%), Gaps = 31/220 (14%)

Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI 814
           L   T  F   +++G G++G VYK      G  +A K+  +  D   E    E  ++   
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKY 59

Query: 815 -RHRNLVK-----IISSCSNNDFKA-LVLEYMSNGSLEKCLYSD--NYFLDILQRLK--- 862
             H N+       I  +   ND +  LV+E    GS+     +D         +RLK   
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSV-----TDLVKGLRKKGKRLKEEW 114

Query: 863 ---IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ 919
              I+ +    L YLH      ++H DIK  N+LL ++    L DFG++  L      R 
Sbjct: 115 IAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN 171

Query: 920 TKTLGTIGYMAPE-----YGREGKVSRKCDVYSYGIMLME 954
           T  +GT  +MAPE        +     + DV+S GI  +E
Sbjct: 172 T-FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 74.5 bits (183), Expect = 2e-14
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 24/212 (11%)

Query: 768 LLGMGSFGSVYKGVLPDGME--IAAK---VFHMEF-------DGSLESFHAECKVMG-SI 814
            LG G+FG VYK    +  +  +A K   V +  F       D S+    +E  ++   +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYS----DNYFLDILQRL-KIMIDVAS 869
           RH N+V+   +   ND   +V++ +    L +   S       F +  +R+  I + +  
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTE--ERIWNIFVQMVL 124

Query: 870 ALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYM 929
           AL YLH      IVH D+ P+N++L E     ++DFG+AK    E  +  T  +GTI Y 
Sbjct: 125 ALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL--TSVVGTILYS 180

Query: 930 APEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
            PE  +      K DV+++G +L +  T + P
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 74.5 bits (184), Expect = 2e-14
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 28/203 (13%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEIAA--KVFHMEFDGSLESFHA----ECKVMGSIRHRNLV 820
           K LG G++  VYK    +   I A  K+   E   + +  +     E K++  ++H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFL---DILQRLKIMIDVASALEYLHFG 877
            ++    +     LV E+M    LEK +   +  L   DI      M+     LEYLH  
Sbjct: 66  GLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKS---YMLMTLRGLEYLHSN 121

Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE--YGR 935
           +   I+H D+KP+N+L+    V  L+DFG+A+  G   + + T  + T  Y APE  +G 
Sbjct: 122 W---ILHRDLKPNNLLIASDGVLKLADFGLARSFG-SPNRKMTHQVVTRWYRAPELLFG- 176

Query: 936 EGKVSRK----CDVYSYGIMLME 954
               +R      D++S G +  E
Sbjct: 177 ----ARHYGVGVDMWSVGCIFAE 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 74.3 bits (182), Expect = 3e-14
 Identities = 66/215 (30%), Positives = 109/215 (50%), Gaps = 18/215 (8%)

Query: 767 KLLGMGSFGSVYKGV-LPDG----MEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNL 819
           K+LG G+FG+VYKG+ +P+G    + +A K+ + E  G   +  F  E  +M S+ H +L
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMDHPHL 71

Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYS--DNYFLDILQRLKIMIDVASALEYLHFG 877
           V+++  C +   + LV + M +G L   ++   DN    +L  L   + +A  + YL   
Sbjct: 72  VRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLL--LNWCVQIAKGMMYLE-- 126

Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL-GKEESMRQTKTLGTIGYMAPEYGRE 936
               +VH D+   NVL+       ++DFG+A++L G E+          I +MA E    
Sbjct: 127 -ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185

Query: 937 GKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEM 970
            K + + DV+SYG+ + E  T   KP D I   E+
Sbjct: 186 RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 220

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 74.1 bits (182), Expect = 3e-14
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 19/208 (9%)

Query: 767 KLLGMGSFGSVY----KGVLPDGMEIAAKVFH----MEFDGSLESFHAECKVMGSIRHRN 818
           ++LG G++G V+     G    G   A KV      ++   + E    E +V+ ++R   
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65

Query: 819 LVKIISSCSNNDFKA-LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
            +  +      D K  L+L+Y++ G L   LY   +F +   R+ I  ++  AL++LH  
Sbjct: 66  FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLH-- 122

Query: 878 YSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMAPEY-- 933
               I++ DIK  N+LL+    GH  L+DFG++K    EE  R     GTI YMAPE   
Sbjct: 123 -QLGIIYRDIKLENILLDSE--GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179

Query: 934 GREGKVSRKCDVYSYGIMLMETFTKKKP 961
           G  G   +  D +S G++  E  T   P
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 73.5 bits (181), Expect = 5e-14
 Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 30/201 (14%)

Query: 769 LGMGSFGSVYK-GVLPDGMEIAAKVFHME--FDGSLESFHAECKVMGSIRHRNLVKII-- 823
           +G G+ G V+K      G  +A K   +     G       E K + + +H  +VK++  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 824 ----SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
               S         LV+EYM    L + L  +   L   Q    M  +   + Y+H   +
Sbjct: 68  FPHGSGFV------LVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---A 117

Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE--YGREG 937
             I+H D+KP+N+L++   V  ++DFG+A++  +EE    +  + T  Y APE  YG   
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG--- 174

Query: 938 KVSRK----CDVYSYGIMLME 954
             +RK     D+++ G +  E
Sbjct: 175 --ARKYDPGVDLWAVGCIFAE 193

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 73.2 bits (179), Expect = 5e-14
 Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 37/213 (17%)

Query: 768 LLGMGSFGSVYKGVLP-DGMEIAAKVF----------HMEFDGSLESFHAECKVMGSIRH 816
           ++G G+FG V K  +  DG+ + A +           H +F G LE     CK+     H
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVL---CKLG---HH 55

Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSL------EKCLYSDNYF---------LDILQRL 861
            N++ ++ +C +  +  L +EY  +G+L       + L +D  F         L   Q L
Sbjct: 56  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115

Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK 921
               DVA  ++YL        +H D+   N+L+ E+ V  ++DFG+++  G+E  +++T 
Sbjct: 116 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTM 170

Query: 922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLME 954
               + +MA E       +   DV+SYG++L E
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 203

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 72.8 bits (178), Expect = 7e-14
 Identities = 57/197 (28%), Positives = 95/197 (48%), Gaps = 9/197 (4%)

Query: 769 LGMGSFGSVYKGVLPDGMEIAA-KVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           +G G++G VYK    +  E+AA KV  +E          E  +M   +H N+V    S  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 828 NNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDI 887
             D   + +E+   GSL+  +Y     L   Q   +  +    L YLH   S   +H DI
Sbjct: 77  RRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDI 132

Query: 888 KPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG---REGKVSRKCD 944
           K +N+LL ++    L+DFG++  +    + R++  +GT  +MAPE     R+G  ++ CD
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITATIAKRKS-FIGTPYWMAPEVAAVERKGGYNQLCD 191

Query: 945 VYSYGIMLMETFTKKKP 961
           +++ GI  +E    + P
Sbjct: 192 IWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 73.5 bits (180), Expect = 7e-14
 Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 13/224 (5%)

Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+LG G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 3   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61

Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVAS 869
           VM S+ + ++ +++  C  +  + L+ + M  G L   +      +     L   + +A 
Sbjct: 62  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 120

Query: 870 ALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-IGY 928
            + YL       +VH D+   NVL+       ++DFG+AK+LG +E     +     I +
Sbjct: 121 GMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKW 177

Query: 929 MAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
           MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 221

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 73.2 bits (179), Expect = 1e-13
 Identities = 68/212 (32%), Positives = 101/212 (47%), Gaps = 28/212 (13%)

Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDG--SLESFH---AECKVMGSIRHR 817
           F++ + +G GSFG+VY        E+ A +  M + G  S E +     E K +  I+H 
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVA-IKKMSYSGKQSNEKWQDIIKEVKFLQRIKHP 85

Query: 818 NLVKIISSCSNNDFKA-LVLEYMSNGSLEKCLYSDNYFLDI----LQRLKIMIDVASALE 872
           N ++    C   +  A LV+EY        CL S +  L++    LQ ++I      AL+
Sbjct: 86  NSIEY-KGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQ 136

Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE 932
            L + +S  ++H DIK  N+LL E     L+DFG A I     S      +GT  +MAPE
Sbjct: 137 GLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF-----VGTPYWMAPE 191

Query: 933 Y---GREGKVSRKCDVYSYGIMLMETFTKKKP 961
                 EG+   K DV+S GI  +E   +K P
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKPP 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 72.5 bits (179), Expect = 1e-13
 Identities = 52/172 (30%), Positives = 79/172 (45%), Gaps = 18/172 (10%)

Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAEC----KVMGSIRHRNLVKII 823
           LG G++G VYK      G  +A K   ++ +   E   +       ++  ++H N+VK++
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEE--EGIPSTALREISLLKELKHPNIVKLL 64

Query: 824 SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL--KIMIDVASALEYLHFGYSTP 881
                     LV EY     L+K L  D     +   L   IM  +   L Y H   S  
Sbjct: 65  DVIHTERKLYLVFEYCDM-DLKKYL--DKRPGPLSPNLIKSIMYQLLRGLAYCH---SHR 118

Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ-TKTLGTIGYMAPE 932
           I+H D+KP N+L+N   V  L+DFG+A+  G    +R  T  + T+ Y APE
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGIP--LRTYTHEVVTLWYRAPE 168

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 73.3 bits (181), Expect = 1e-13
 Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 17/177 (9%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVK-- 821
           K +G G++G V   V    G ++A K     FD  +++     E K++  +RH N++   
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65

Query: 822 -IISSCSNNDFKAL--VLEYMSNGSLEKCLYSDNYFLDILQRLK-IMIDVASALEYLHFG 877
            I+   S  DF  +  V E M    L K + S     D    ++  +  +   L+YLH  
Sbjct: 66  DILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTD--DHIQYFLYQILRGLKYLH-- 120

Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT--LGTIGYMAPE 932
            S  ++H D+KPSN+L+N +    + DFG+A+ +  +E  +   T  + T  Y APE
Sbjct: 121 -SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPE 176

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 72.6 bits (178), Expect = 1e-13
 Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 15/205 (7%)

Query: 767 KLLGMGSFGSV----YKGVLPD-GMEIAAKVFHMEFDGSLES-FHAECKVMGSIRHRNLV 820
           ++LG G FG V    Y       G  +A K    E      S +  E  ++ ++ H N+V
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 821 KIISSCSNNDFKA--LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
           K    CS    K   L++EY+  GSL   L      L++ Q L     +   + YLH   
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH--- 124

Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGRE 936
           S   +H D+   NVLL+   +  + DFG+AK + +     + +  G   + + A E  +E
Sbjct: 125 SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184

Query: 937 GKVSRKCDVYSYGIMLMETFTKKKP 961
            K S   DV+S+G+ L E  T    
Sbjct: 185 NKFSYASDVWSFGVTLYELLTHCDS 209

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 72.8 bits (178), Expect = 1e-13
 Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 28/212 (13%)

Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGS-----LESFHAECKVMGSIRHR 817
           FS+ + +G GSFG+VY        E+ A +  M + G       +    E + +  +RH 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVA-IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75

Query: 818 NLVKIISSCSNNDFKA-LVLEYMSNGSLEKCLYSDNYFLDI----LQRLKIMIDVASALE 872
           N ++    C   +  A LV+EY        CL S +  L++    LQ ++I      AL+
Sbjct: 76  NTIQY-RGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQ 126

Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE 932
            L + +S  ++H D+K  N+LL+E  +  L DFG A I+           +GT  +MAPE
Sbjct: 127 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGTPYWMAPE 181

Query: 933 Y---GREGKVSRKCDVYSYGIMLMETFTKKKP 961
                 EG+   K DV+S GI  +E   +K P
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 72.5 bits (178), Expect = 1e-13
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 20/209 (9%)

Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGME-IAAKVFHMEFDGSL---ESFHAECKVMGSIRH 816
           D     K +G G+FG V+           A KV  +     L   +  H E +V+  + H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             ++++  +  +  F  +++EY+  G L   L +   F +         ++  ALEYLH 
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYLH- 118

Query: 877 GYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTL-GTIGYMAPE- 932
             S  IV+ D+KP N+LL++   GH  L+DFG AK     +   +T TL GT  Y+APE 
Sbjct: 119 --SKEIVYRDLKPENILLDKE--GHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPEV 169

Query: 933 YGREGKVSRKCDVYSYGIMLMETFTKKKP 961
              +G  ++  D ++ GI++ E      P
Sbjct: 170 IQSKGH-NKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 74.1 bits (182), Expect = 2e-13
 Identities = 41/113 (36%), Positives = 63/113 (55%), Gaps = 7/113 (6%)

Query: 523 LSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVI 582
           L L +  L   IP+ +  L+ +   NLS NS+ G++ P +G++  +  +DLS N+ +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 583 PVTIGGLQGLQLLSLRYNRLQGPIPESFGGL----KSLNFVDMSNNNLSGTIP 631
           P ++G L  L++L+L  N L G +P + GG      S NF D  N  L G IP
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTD--NAGLCG-IP 532

Length = 623

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 15/208 (7%)

Query: 763 FSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAEC----KVMGSIRHR 817
           F   K +G G F  VY+   L DG+ +A K   + FD       A+C     ++  + H 
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQI-FDLMDAKARADCIKEIDLLKQLNHP 62

Query: 818 NLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRL--KIMIDVASALEY 873
           N++K  +S   ++   +VLE    G L + +  +     L I ++   K  + + SALE+
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPEKTVWKYFVQLCSALEH 121

Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
           +H   S  ++H DIKP+NV +  + V  L D G+ +    + +   +  +GT  YM+PE 
Sbjct: 122 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPER 177

Query: 934 GREGKVSRKCDVYSYGIMLMETFTKKKP 961
             E   + K D++S G +L E    + P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 13/201 (6%)

Query: 767 KLLGMGSFGSVYK----GVLPDG--MEIAAKVFHMEFDGS-LESFHAECKVMGSI-RHRN 818
           K LG G+FG V +    G+      M++A K+       S  E+  +E K+M  +  H N
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100

Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNY-FLDILQRLKIMIDVASALEYLHFG 877
           +V ++ +C+      ++ EY   G L   L      FL +   L     VA  + +L   
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA-- 158

Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK-ILGKEESMRQTKTLGTIGYMAPEYGRE 936
            S   +H D+   NVLL    +  + DFG+A+ I+     + +      + +MAPE    
Sbjct: 159 -SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFN 217

Query: 937 GKVSRKCDVYSYGIMLMETFT 957
              + + DV+SYGI+L E F+
Sbjct: 218 CVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 72.4 bits (177), Expect = 2e-13
 Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 28/206 (13%)

Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGS-----LESFHAECKVMGSIRHRNLVKII 823
           +G GSFG+VY        E+ A V  M + G       +    E K +  ++H N ++  
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVA-VKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY- 86

Query: 824 SSCSNNDFKA-LVLEYMSNGSLEKCLYSDNYFLDI----LQRLKIMIDVASALEYLHFGY 878
             C   +  A LV+EY        CL S +  L++    LQ ++I      AL+ L + +
Sbjct: 87  KGCYLKEHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 138

Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY---GR 935
           S  ++H DIK  N+LL E     L+DFG A       S      +GT  +MAPE      
Sbjct: 139 SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF-----VGTPYWMAPEVILAMD 193

Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           EG+   K DV+S GI  +E   +K P
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERKPP 219

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 71.1 bits (174), Expect = 2e-13
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 21/206 (10%)

Query: 767 KLLGMGSFGSVY--KGVLPDGMEIAAKV-FHMEFDGSLESFHAECKVMGSIRHRNLVKII 823
           K +G GSFG +Y  K        +  ++          E+   E  ++  ++H N+V   
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 824 SSCSNNDFKALVLEYMSNGSLEK-------CLYSDNYFLDILQRLKIMIDVASALEYLHF 876
           +S   N    +V+EY   G L K        L+S++      Q L   + ++  L+++H 
Sbjct: 66  ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSED------QILSWFVQISLGLKHIH- 118

Query: 877 GYSTPIVHCDIKPSNVLLNES-MVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
                I+H DIK  N+ L+++ MV  L DFGIA+ L     +  T  +GT  Y++PE  +
Sbjct: 119 --DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSPEICQ 175

Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
               + K D++S G +L E  T K P
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 71.5 bits (175), Expect = 2e-13
 Identities = 72/298 (24%), Positives = 129/298 (43%), Gaps = 45/298 (15%)

Query: 763  FSENKLLGMGSFGSVYKGVLP----DGMEIAAKVFHMEFDGS--LESFHAECKVMGSIRH 816
            F+  ++LG G FGSV +  L        ++A K+   +   S  +E F  E   M    H
Sbjct: 1    FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 817  RNLVKIISSCSNNDFKA------LVLEYMSNGSLEKCLY----SDNYFLDILQRL-KIMI 865
             N++K+I     +  K       ++L +M +G L   L      +  F   LQ L + MI
Sbjct: 61   PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 866  DVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ-TKTLG 924
            D+AS +EYL    S   +H D+   N +LNE+M   ++DFG++K +   +  RQ   +  
Sbjct: 121  DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 925  TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCS 984
             + ++A E   +   +   DV+++G+ + E  T+ +     +AG                
Sbjct: 178  PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP---YAG---------------- 218

Query: 985  ITEVADANLLN--CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIR 1040
               V ++ + N   + N       C+  ++ L   C    P+ R S + + ++L  I 
Sbjct: 219  ---VENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 20/211 (9%)

Query: 767 KLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFD-GSLES------FHAECKVMGSIRHRN 818
           KLLG G+FG VY     D G E+A K   + FD  S E+         E +++ ++RH  
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVK--QVPFDPDSQETSKEVNALECEIQLLKNLRHDR 65

Query: 819 LVKIISSCSNNDFKALVL--EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
           +V+      + + K L +  EYM  GS++  L +     + + R +    +   + YLH 
Sbjct: 66  IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLH- 123

Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT---KTLGTIGYMAPEY 933
             S  IVH DIK +N+L + +    L DFG +K + +   M  T      GT  +M+PE 
Sbjct: 124 --SNMIVHRDIKGANILRDSAGNVKLGDFGASKRI-QTICMSGTGIKSVTGTPYWMSPEV 180

Query: 934 GREGKVSRKCDVYSYGIMLMETFTKKKPTDE 964
                  RK DV+S    ++E  T+K P  E
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 10/203 (4%)

Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G+FG VYK    + G+  AAKV   + +  LE +  E  ++ S  H N+VK++ +  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 828 NNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDI 887
             +   +++E+ + G+++  +      L   Q   +      AL YLH      I+H D+
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDL 129

Query: 888 KPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY-----GREGKVSRK 942
           K  N+L        L+DFG++         R+   +GT  +MAPE       ++     K
Sbjct: 130 KAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYK 188

Query: 943 CDVYSYGIMLMETFTKKKPTDEI 965
            DV+S GI L+E    + P  E+
Sbjct: 189 ADVWSLGITLIEMAQIEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 70.7 bits (173), Expect = 3e-13
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 10/202 (4%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLE--SFHAECKVMGSIRHRNLVKII 823
           +++G G+FG V+      D   +  K   +E     E  +   EC+V+  + H N+++  
Sbjct: 6   RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65

Query: 824 SSCSNNDFKALVLEYMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
            +   +    +V+EY   G+L + +    N  LD    L   + +  AL ++H   +  I
Sbjct: 66  ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLI 122

Query: 883 VHCDIKPSNVLLNE-SMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSR 941
           +H D+K  N+LL++  MV  + DFGI+KIL  +   +    +GT  Y++PE       ++
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--KAYTVVGTPCYISPELCEGKPYNQ 180

Query: 942 KCDVYSYGIMLMETFTKKKPTD 963
           K D+++ G +L E  + K+  +
Sbjct: 181 KSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 29/216 (13%)

Query: 767 KLLGMGSFGSVYKGVL------PDGMEIAAKVFHME-FDGSLESFHAECKVMGSI-RHRN 818
           K LG G+FG V K          +   +A K+   +  +  L    +E ++M  I +H+N
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77

Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSD-------NYFLDILQRLKIMI------ 865
           ++ ++  C+      +V+EY ++G+L   L +        +          +        
Sbjct: 78  IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 866 --DVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL 923
              VA  +E+L    S   +H D+   NVL+ E  V  ++DFG+A+ +   +  R+T T 
Sbjct: 138 AYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT-TN 193

Query: 924 G--TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           G   + +MAPE   +   + + DV+S+G++L E FT
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 71.0 bits (174), Expect = 3e-13
 Identities = 61/290 (21%), Positives = 116/290 (40%), Gaps = 37/290 (12%)

Query: 762  GFSENKLLGMGSFGSVYKGVLPDGME------IAAKVF-HMEFDGSLESFHAECKVMGSI 814
               E   LG G FG V+        E      +  K     + +     F  E  +   +
Sbjct: 6    NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 815  RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDIL--------QRLKIMID 866
             H+N+V+++  C   +   ++LEY   G L++ L +     + L        Q++ +   
Sbjct: 66   SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 867  VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTI 926
            +A  +++L    +   VH D+   N L++      +S   ++K +   E  +    L  +
Sbjct: 126  IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182

Query: 927  GYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSIT 986
             ++APE  +E   S K DV+S+G+++ E FT+         GE+       + +L     
Sbjct: 183  RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQ---------GELPFYGLSDEEVL----- 228

Query: 987  EVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036
                 N L   + +    E C S ++ L   C    P+ R S  ++ + L
Sbjct: 229  -----NRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 70.7 bits (173), Expect = 3e-13
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 24/201 (11%)

Query: 767 KLLGMGSFGSVYKGVL--PDGMEIAAKVFHMEFDGSLES----FHAECKVMGSIRHRNLV 820
           ++LG G FG + +G L  P   E+   + H    G  +     F AE   +G   H N+V
Sbjct: 11  RILGTGRFGELCRGCLKLPSKRELPVAI-HTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69

Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL-HFGYS 879
           ++    +  +   +V EYMSNG+L+  L      L   Q + ++  +AS ++YL   GY 
Sbjct: 70  RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY- 128

Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIG------YMAPEY 933
              VH  +    VL+N  +V  +S F       +E+      T  T+       + APE 
Sbjct: 129 ---VHKGLAAHKVLVNSDLVCKISGFR----RLQEDKSEAIYT--TMSGKSPVLWAAPEA 179

Query: 934 GREGKVSRKCDVYSYGIMLME 954
            +    S   DV+S+GI++ E
Sbjct: 180 IQYHHFSSASDVWSFGIVMWE 200

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 71.2 bits (175), Expect = 4e-13
 Identities = 55/230 (23%), Positives = 99/230 (43%), Gaps = 34/230 (14%)

Query: 767 KLLGMGSFGSVY------------KGVLPDGMEIAAKVFHMEF------DGSLESFHAEC 808
           + LG G FG V+            K    +    A  +  ++       D + E F  E 
Sbjct: 11  EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEV 70

Query: 809 KVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLY-------SDNYFLDIL--Q 859
           K++  +   N+ +++  C+ +    +++EYM NG L + L                L   
Sbjct: 71  KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130

Query: 860 RLKIMI-DVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR 918
            L  M   +AS + YL    S   VH D+   N L+ ++    ++DFG+++ L   +  R
Sbjct: 131 TLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYR 187

Query: 919 -QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT--KKKPTDEI 965
            Q +    I +MA E    GK + K DV+++G+ L E  T  +++P + +
Sbjct: 188 VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 70.5 bits (173), Expect = 5e-13
 Identities = 60/195 (30%), Positives = 92/195 (47%), Gaps = 11/195 (5%)

Query: 768 LLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVKIIS 824
           L+G GS+G V K    + G  +A K F    D  +    A  E +++  +RH NLV +I 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                    LV E++ +  L+      N  LD  +  K +  +   +E+ H   S  I+H
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNG-LDESRVRKYLFQILRGIEFCH---SHNIIH 123

Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKIL-GKEESMRQTKTLGTIGYMAPEY-GREGKVSRK 942
            DIKP N+L+++S V  L DFG A+ L    E    T  + T  Y APE    + K  R 
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATRWYRAPELLVGDTKYGRA 181

Query: 943 CDVYSYGIMLMETFT 957
            D+++ G ++ E  T
Sbjct: 182 VDIWAVGCLVTEMLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 70.6 bits (173), Expect = 8e-13
 Identities = 64/226 (28%), Positives = 110/226 (48%), Gaps = 28/226 (12%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEF-------DGSLESFH--AECKVMGSIRHR 817
           K+LG G +G V++     G +   K+F M+            ++ H  AE  ++ +++H 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGAD-TGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 818 NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
            +V +I +        L+LEY+S G L   L  +  F++       + +++ ALE+LH  
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACF-YLSEISLALEHLH-- 117

Query: 878 YSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
               I++ D+KP N+LL+    GH  L+DFG+ K    E ++  T   GTI YMAPE   
Sbjct: 118 -QQGIIYRDLKPENILLDAQ--GHVKLTDFGLCKESIHEGTVTHT-FCGTIEYMAPEILM 173

Query: 936 EGKVSRKCDVYSYGIMLMETFT---------KKKPTDEIFAGEMSL 972
                +  D +S G ++ +  T         +KK  D+I  G+++L
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 71.8 bits (176), Expect = 1e-12
 Identities = 41/113 (36%), Positives = 59/113 (52%), Gaps = 5/113 (4%)

Query: 406 ENPINGI---LPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTI 462
           ++P +G      S+ G + I    L +++  + G IP ++  + +L  I L  N + G I
Sbjct: 401 QHPWSGADCQFDSTKGKWFID--GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNI 458

Query: 463 PVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLG 515
           P +LG +  L+ L L  N   GSIPE L  L  L  L L  N LSGR+PA LG
Sbjct: 459 PPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 69.3 bits (170), Expect = 1e-12
 Identities = 58/200 (29%), Positives = 87/200 (43%), Gaps = 20/200 (10%)

Query: 768 LLGMGSFGSVYKG-VLPDGMEIAAKVFHMEFDG--SLESFHAECKVMGSIRHRNLVKIIS 824
           ++G G++G V K      G  +A K F    D     ++   E KV+  +RH N+V +  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
           +        LV EY+    LE  L +    L        +  +  A+ Y H   S  I+H
Sbjct: 68  AFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIH 123

Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE-------YGREG 937
            DIKP N+L++ES V  L DFG A+ L    +   T  + T  Y APE       YG+  
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKP- 182

Query: 938 KVSRKCDVYSYGIMLMETFT 957
                 DV++ G ++ E   
Sbjct: 183 -----VDVWAIGCIMAELLD 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 69.3 bits (170), Expect = 1e-12
 Identities = 38/104 (36%), Positives = 56/104 (53%), Gaps = 8/104 (7%)

Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK 921
           K+ + +  AL YL   +   ++H D+KPSN+LL+ S    L DFGI+  L   +S  +T+
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAKTR 173

Query: 922 TLGTIGYMAPEY----GREGKVSRKCDVYSYGIMLMETFTKKKP 961
           + G   YMAPE         K   + DV+S GI L+E  T + P
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 70.0 bits (171), Expect = 1e-12
 Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 25/222 (11%)

Query: 754 QDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLES--------FH 805
           +DL    + +   K++G G+FG V         +   KV+ M+     E         F 
Sbjct: 36  RDLRMKAEDYEVVKVIGRGAFGEVQLV----RHKSTRKVYAMKLLSKFEMIKRSDSAFFW 91

Query: 806 AECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK--I 863
            E  +M       +V++  +  ++ +  +V+EYM  G L   +   NY  D+ ++     
Sbjct: 92  EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNY--DVPEKWARFY 147

Query: 864 MIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL 923
             +V  AL+ +H   S   +H D+KP N+LL++S    L+DFG    + KE  +R    +
Sbjct: 148 TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 204

Query: 924 GTIGYMAPEY----GREGKVSRKCDVYSYGIMLMETFTKKKP 961
           GT  Y++PE     G +G   R+CD +S G+ L E      P
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 71.0 bits (174), Expect = 2e-12
 Identities = 33/92 (35%), Positives = 54/92 (58%)

Query: 98  FLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSF 157
           F+  L + N    G +P ++S LR L+  +   N+    IP    S+  L+ L L +NSF
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478

Query: 158 VGKIPETIGYLSLLQELDLSDNQLSGTIPSSI 189
            G IPE++G L+ L+ L+L+ N LSG +P+++
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 69.4 bits (170), Expect = 2e-12
 Identities = 79/319 (24%), Positives = 126/319 (39%), Gaps = 70/319 (21%)

Query: 766  NKLLGMGSFGSVYKGV-LPDGMEIA-AKVFHMEFDGSLESFHA-------------ECKV 810
               LG G++G V K      G  +A  KV  +E    +                  E K+
Sbjct: 14   GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 811  MGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASA 870
            M  I+H N++ ++      DF  LV++ M+   L+K +      L   Q   I++ + + 
Sbjct: 74   MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKK-VVDRKIRLTESQVKCILLQILNG 131

Query: 871  LEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG---------KEESM---- 917
            L  LH  Y    +H D+ P+N+ +N   +  ++DFG+A+  G         K+E+M    
Sbjct: 132  LNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188

Query: 918  RQTKTLGTIGYMAPE--YGREGKVSRKCDVYSYGIMLMETFTKKK---PTDEI------- 965
              T  + T+ Y APE   G E K     D++S G +  E  T K      +EI       
Sbjct: 189  EMTSKVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247

Query: 966  -FAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSARE-QCVSSIFSLAMDCTVDL- 1022
               G  +   W     L            L  E   F+ R+ + + +IF  A D  +DL 
Sbjct: 248  ELLGTPNEDNWPQAKKLP-----------LYTE---FTPRKPKDLKTIFPNASDDAIDLL 293

Query: 1023 -------PEKRISMKDVAN 1034
                   P +RIS K+   
Sbjct: 294  QSLLKLNPLERISAKEALK 312

Length = 335

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 23/210 (10%)

Query: 767 KLLGMGSFGSVY---------KGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHR 817
           K+LG G++G V+          G L   M++  K   ++   + E    E +V+  IR  
Sbjct: 6   KVLGTGAYGKVFLVRKVSGHDSGKLY-AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 64

Query: 818 NLVKIISSCSNNDFKA-LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMI-DVASALEYLH 875
             +  +      D K  L+L+Y++ G L   L     F +  Q ++I   ++  ALE+LH
Sbjct: 65  PFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE--QEVQIYSGEIVLALEHLH 122

Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
                 I++ DIK  N+LL+ +  GH  L+DFG++K   ++E  R     GTI YMAP+ 
Sbjct: 123 ---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177

Query: 934 --GREGKVSRKCDVYSYGIMLMETFTKKKP 961
             G +G   +  D +S G+++ E  T   P
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 76/315 (24%), Positives = 137/315 (43%), Gaps = 68/315 (21%)

Query: 763  FSENKL-----LGMGSFGSVY--------KGVLPDGMEIAAKVFHME-FDGSLESFHAEC 808
            FS +KL     LG G FG V         K    + + +A K+   +  +  L    +E 
Sbjct: 12   FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 71

Query: 809  KVMGSI-RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSD-----NYFLDILQ--- 859
            ++M  I +H+N++ ++ +C+ +    +++EY S G+L + L +       Y  DI +   
Sbjct: 72   EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPD 131

Query: 860  ---RLKIMID----VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG 912
                 K ++     VA  +EYL    S   +H D+   NVL+ E+ V  ++DFG+A+ + 
Sbjct: 132  EQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVN 188

Query: 913  KEESMRQTKTLG--TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT------KKKPTDE 964
              +  ++T T G   + +MAPE   +   + + DV+S+G+++ E FT         P +E
Sbjct: 189  NIDYYKKT-TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247

Query: 965  IFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPE 1024
            +F                          LL  E +       C + ++ +  DC   +P 
Sbjct: 248  LF-------------------------KLLK-EGHRMDKPANCTNELYMMMRDCWHAIPS 281

Query: 1025 KRISMKDVANRLVRI 1039
             R + K +   L RI
Sbjct: 282  HRPTFKQLVEDLDRI 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 68.8 bits (168), Expect = 2e-12
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 28/227 (12%)

Query: 769 LGMGSFGSVYKG-VLPDGMEIAAKVFHMEFDGSLE-SFHAECKVMGSIRHRNLVKIISSC 826
           LG G+ G+VYK   L     +A KV  ++    L+    +E +++       ++    + 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL------KIMIDVASALEYLHFGYST 880
              +  ++  E+M  GSL           D+ +++      +I + V   L YL   +S 
Sbjct: 69  FVENRISICTEFMDGGSL-----------DVYRKIPEHVLGRIAVAVVKGLTYL---WSL 114

Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVS 940
            I+H D+KPSN+L+N      L DFG++  L    S+ +T  +GT  YMAPE     +  
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL--VNSIAKT-YVGTNAYMAPERISGEQYG 171

Query: 941 RKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITE 987
              DV+S GI  ME    + P  +I   + SL   +   LL C + E
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSL---MPLQLLQCIVDE 215

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 47/154 (30%), Positives = 77/154 (50%), Gaps = 18/154 (11%)

Query: 807 ECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMID 866
           E  +M   +H N+V++ SS    D   +V+E++  G+L   +      ++  Q   + + 
Sbjct: 66  EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLA 123

Query: 867 VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTI 926
           V  AL +LH   +  ++H DIK  ++LL       LSDFG    + KE   R++  +GT 
Sbjct: 124 VLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS-LVGTP 179

Query: 927 GYMAPE------YGREGKVSRKCDVYSYGIMLME 954
            +MAPE      YG E       D++S GIM++E
Sbjct: 180 YWMAPEVISRLPYGTE------VDIWSLGIMVIE 207

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 70.0 bits (171), Expect = 2e-12
 Identities = 84/301 (27%), Positives = 128/301 (42%), Gaps = 50/301 (16%)

Query: 160 KIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNL 219
              E +  L  L  LDL+ N+L         NIS    L  L  L +  N +T       
Sbjct: 84  DGSENLLNLLPLPSLDLNLNRL-------RSNISELLELTNLTSLDLDNNNITD------ 130

Query: 220 WKCRELHVVSLAFNKFQGGIPRDIGNLTS-VRNLFLGNNSLIGEIPNEIGNLRNLEVLGV 278
                              IP  IG L S ++ L L +N  I  +P+ + NL NL+ L +
Sbjct: 131 -------------------IPPLIGLLKSNLKELDLSDNK-IESLPSPLRNLPNLKNLDL 170

Query: 279 QSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPS 338
             ++L+  +P  + N+S L  L ++ N +   LP  I+L L  LE L L  NN    + S
Sbjct: 171 SFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIEL-LSALEELDLS-NNSIIELLS 226

Query: 339 SLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRN 398
           SL+N+  LS L+   N     +P + GNL +L+ L L+ N ++S       +SSL S  N
Sbjct: 227 SLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISS-------ISSLGSLTN 278

Query: 399 LEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNEL 458
           L  + LS N ++  LP       +    L++           EL   + L    + +N  
Sbjct: 279 LRELDLSGNSLSNALPLIALLLLLLELLLNLLLTL----KALELKLNSILLNNNILSNGE 334

Query: 459 T 459
           T
Sbjct: 335 T 335

Length = 394

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 42/106 (39%), Positives = 58/106 (54%), Gaps = 8/106 (7%)

Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK 921
           KI + +  ALEYLH   S  ++H D+KPSNVL+N +    L DFGI+  L   +S+ +T 
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTI 162

Query: 922 TLGTIGYMAPEY----GREGKVSRKCDVYSYGIMLMETFTKKKPTD 963
             G   YMAPE       +     K DV+S GI ++E  T + P D
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 2e-12
 Identities = 54/191 (28%), Positives = 85/191 (44%), Gaps = 11/191 (5%)

Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVKIISS 825
           +G G++G VYK      G  +A K   + F+       A  E K++  + H N++K++  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
             +     LV E+M    L K +      L        +  +   L + H   S  I+H 
Sbjct: 67  FRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHR 122

Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE--YGREGKVSRKC 943
           D+KP N+L+N   V  L+DFG+A+  G       T  + T  Y APE   G +G  S   
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRP-YTHYVVTRWYRAPELLLGDKG-YSTPV 180

Query: 944 DVYSYGIMLME 954
           D++S G +  E
Sbjct: 181 DIWSVGCIFAE 191

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 28/220 (12%)

Query: 769 LGMGSFGSVYKGVLPDGMEIAA-KVFHMEFDGSL-ESFHA--ECKVMGSIRHRNLVKIIS 824
           +G G +G V+     D  EI A K         L E  H   E  ++ + +   LVK++ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH-FGYSTPIV 883
           +  ++++  L +EY+  G   + L ++   L        M ++  A++ LH  GY    +
Sbjct: 69  AFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY----I 123

Query: 884 HCDIKPSNVLLNESMVGH--LSDFGIAK-ILGKEESMRQTKTLGTIGYMAPEYGREGKVS 940
           H D+KP N L++ S  GH  L+DFG++K I+    S+     +G+  YMAPE  R     
Sbjct: 124 HRDLKPENFLIDAS--GHIKLTDFGLSKGIVTYANSV-----VGSPDYMAPEVLRGKGYD 176

Query: 941 RKCDVYSYGIMLMETFTKKKP-----TDEIFAGEMSLKRW 975
              D +S G ML E      P      +E +    +LK W
Sbjct: 177 FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYW 213

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 68.2 bits (167), Expect = 3e-12
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 23/211 (10%)

Query: 768 LLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDG-SLESFHAECK-VMGSIRHRNLVKIIS 824
            +G G+FG+V K +    G  +A K      D    +    +   VM S     +VK   
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70

Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL-------KIMIDVASALEYLHFG 877
           +        + +E M   SL+K  Y   Y  ++L+ +       KI +    AL YL   
Sbjct: 71  ALFREGDCWICMELMDI-SLDK-FYKYVY--EVLKSVIPEEILGKIAVATVKALNYLK-- 124

Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE----Y 933
               I+H D+KPSN+LL+ +    L DFGI+  L   +S+ +T+  G   YMAPE     
Sbjct: 125 EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMAPERIDPS 182

Query: 934 GREGKVSRKCDVYSYGIMLMETFTKKKPTDE 964
            R+G   R  DV+S GI L E  T K P  +
Sbjct: 183 ARDGYDVRS-DVWSLGITLYEVATGKFPYPK 212

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 69.8 bits (171), Expect = 4e-12
 Identities = 34/86 (39%), Positives = 48/86 (55%)

Query: 453 LGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPA 512
           L N  L G IP  + +L+ LQ + L  N + G+IP  L  +  L  L L  N  +G +P 
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484

Query: 513 CLGNLTSLRDLSLGSNALTSIIPSTL 538
            LG LTSLR L+L  N+L+  +P+ L
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 68.5 bits (167), Expect = 4e-12
 Identities = 62/216 (28%), Positives = 107/216 (49%), Gaps = 12/216 (5%)

Query: 761 DGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES-FHAECKVMGSIRHRN 818
           D F +   LG G+ G V+K    P G+ +A K+ H+E   ++ +    E +V+       
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL--KIMIDVASALEYLHF 876
           +V    +  ++   ++ +E+M  GSL++ L        I +++  K+ I V   L YL  
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE 121

Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
            +   I+H D+KPSN+L+N      L DFG++  L   +SM  +  +GT  YM+PE  + 
Sbjct: 122 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANS-FVGTRSYMSPERLQG 176

Query: 937 GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSL 972
              S + D++S G+ L+E    + P     A E+ L
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL 212

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 67.7 bits (165), Expect = 4e-12
 Identities = 65/307 (21%), Positives = 121/307 (39%), Gaps = 58/307 (18%)

Query: 766  NKLLGMGSFGSVYKGV------LPDGMEIAAKVFHMEFDGS-LESFHAECKVMGSIRHRN 818
             K LG G FG V K              +A K+       S L    +E  ++  + H +
Sbjct: 5    GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPH 64

Query: 819  LVKIISSCSNNDFKALVLEYMSNGSLEKCL-----------------------YSDNYFL 855
            ++K+  +CS +    L++EY   GSL   L                         D   L
Sbjct: 65   VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 856  DILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE 915
             +   +     ++  ++YL       +VH D+   NVL+ E     +SDFG+++ + +E+
Sbjct: 125  TMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181

Query: 916  S-MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
            S ++++K    + +MA E   +   + + DV+S+G++L E  T                 
Sbjct: 182  SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----------------- 224

Query: 975  WVGDSLLSCSITEVADANLLNCEENDFSAR--EQCVSSIFSLAMDCTVDLPEKRISMKDV 1032
                 L       +A   L N  +  +     E C   +++L + C    P+KR +  D+
Sbjct: 225  -----LGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279

Query: 1033 ANRLVRI 1039
            +  L ++
Sbjct: 280  SKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 69.8 bits (171), Expect = 5e-12
 Identities = 36/83 (43%), Positives = 51/83 (61%), Gaps = 2/83 (2%)

Query: 304 DND-LLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPT 362
           DN  L G +P+ I   L +L+ + L  N+  G IP SL +I+ L VLD  +NSF+G IP 
Sbjct: 426 DNQGLRGFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484

Query: 363 TFGNLRSLKLLSLAGNVLTSPTP 385
           + G L SL++L+L GN L+   P
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 69.1 bits (169), Expect = 6e-12
 Identities = 66/225 (29%), Positives = 100/225 (44%), Gaps = 42/225 (18%)

Query: 766 NKLLGMGSFGSV-YKGVLPDGMEIAAKVFHMEFDGSLESFHAECKV-------MGSIR-- 815
           +++LG G+ G+V     + DG   A KV  ME     +   A+ +V         SI   
Sbjct: 37  SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96

Query: 816 HRNLVKIISSCSNND----FKALVLEYMSNGSLEKCLYSDNYFLDILQRLK--------- 862
           H +  K       N       ALVL+Y + G L +         +I  R K         
Sbjct: 97  HEDFAK---KDPRNPENVLMIALVLDYANAGDLRQ---------EIKSRAKTNRTFREHE 144

Query: 863 ---IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ 919
              + I V  A+ ++H   S  ++H DIK +N+LL  + +  L DFG +K+     S   
Sbjct: 145 AGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV 201

Query: 920 TKTL-GTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTD 963
            +T  GT  Y+APE  R    S+K D++S G++L E  T K+P D
Sbjct: 202 GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 67.9 bits (166), Expect = 6e-12
 Identities = 67/199 (33%), Positives = 95/199 (47%), Gaps = 22/199 (11%)

Query: 767 KLLGMGSFGSVYKGVLP-DGMEIAAKVFHME-FDGSLESFH--AECKVM-GSIRHRNLVK 821
           K++G GSFG V       DG   A KV   +      E  H  AE  V+  +++H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           +  S    D    VL+Y++ G L   L  +  F +   R     ++ASAL YLH   S  
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SLN 116

Query: 882 IVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTL----GTIGYMAPEYGR 935
           I++ D+KP N+LL+    GH  L+DFG+ K     E +  +KT     GT  Y+APE  R
Sbjct: 117 IIYRDLKPENILLDSQ--GHVVLTDFGLCK-----EGIEHSKTTSTFCGTPEYLAPEVLR 169

Query: 936 EGKVSRKCDVYSYGIMLME 954
           +    R  D +  G +L E
Sbjct: 170 KQPYDRTVDWWCLGAVLYE 188

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 66.6 bits (162), Expect = 7e-12
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 9/197 (4%)

Query: 769 LGMGSFGSVYKGVLPDGMEIAA-KVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           +G G++G VYK       E+AA K+  +E          E  ++   +H N+V    S  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 828 NNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDI 887
           + +   + +EY   GSL+  +Y     L  LQ   +  +    L YLH   S   +H DI
Sbjct: 77  SREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDI 132

Query: 888 KPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG---REGKVSRKCD 944
           K +N+LL ++    L+DFG+A  +    + R++  +GT  +MAPE     + G  ++ CD
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKITATIAKRKS-FIGTPYWMAPEVAAVEKNGGYNQLCD 191

Query: 945 VYSYGIMLMETFTKKKP 961
           +++ GI  +E    + P
Sbjct: 192 IWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 66.6 bits (162), Expect = 8e-12
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 20/206 (9%)

Query: 769 LGMGSFGSVY----KGVLPDGMEIAAKVFHMEFDGSLES---FHAECKVMGSIRHRNLVK 821
           LG GSFG VY    KGV+ D  E    +  +    S+     F  E  VM      ++V+
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYS-----DNYFLDILQRLKIMI----DVASALE 872
           ++   S      +++E M+ G L+  L S     +N  +     LK MI    ++A  + 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT-KTLGTIGYMAP 931
           YL+   +   VH D+   N ++ E     + DFG+ + + + +  R+  K L  + +M+P
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Query: 932 EYGREGKVSRKCDVYSYGIMLMETFT 957
           E  ++G  +   DV+S+G++L E  T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 8e-12
 Identities = 62/238 (26%), Positives = 97/238 (40%), Gaps = 60/238 (25%)

Query: 761 DGFSENKLLGMGSFGSVY-------KGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGS 813
           D F   K++G G+FG V+         V    M++  K   ++ +       AE  ++  
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVY--AMKVLRKSDMIKRNQIA-HVRAERDILAD 57

Query: 814 IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
                +VK+  S  + +   LV+EYM  G L   L   + F +   R  I  ++  AL+ 
Sbjct: 58  ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA-ELVLALDS 116

Query: 874 LH-FGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKIL---GKEESMRQTK------ 921
           +H  G+    +H DIKP N+L++    GH  L+DFG+ K +      E            
Sbjct: 117 VHKLGF----IHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170

Query: 922 -------------------TLGTIGYMAPE------YGREGKVSRKCDVYSYGIMLME 954
                              T+GT  Y+APE      YG E      CD +S G++L E
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE------CDWWSLGVILYE 222

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 67.0 bits (163), Expect = 8e-12
 Identities = 72/309 (23%), Positives = 133/309 (43%), Gaps = 69/309 (22%)

Query: 767  KLLGMGSFGSVYKGVLPDGM-----------EIAAKVFHME-FDGSLESFHAECKVMGSI 814
            K LG G FG V   V+ + +           ++A K+   +  +  L    +E ++M  I
Sbjct: 24   KPLGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 80

Query: 815  -RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL-----------YSDNYFLDILQRLK 862
             +H+N++ ++ +C+ +    +++EY S G+L + L           Y+     +     K
Sbjct: 81   GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 863  IMID----VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR 918
             ++     VA  +EYL    S   +H D+   NVL+ E  V  ++DFG+A+ +   +  +
Sbjct: 141  DLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197

Query: 919  QTKTLG--TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT------KKKPTDEIFAGEM 970
            +T T G   + +MAPE   +   + + DV+S+G++L E FT         P +E+F    
Sbjct: 198  KT-TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF---- 252

Query: 971  SLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMK 1030
                                  LL  E +       C + ++ +  DC   +P +R + K
Sbjct: 253  ---------------------KLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 290

Query: 1031 DVANRLVRI 1039
             +   L RI
Sbjct: 291  QLVEDLDRI 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 67.3 bits (164), Expect = 9e-12
 Identities = 66/195 (33%), Positives = 94/195 (48%), Gaps = 14/195 (7%)

Query: 767 KLLGMGSFGSVYKGVLP-DGMEIAAKVFHME-FDGSLESFH--AECKVM-GSIRHRNLVK 821
           K++G GSFG V       DG   A KV   +      E  H  AE  V+  +++H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           +  S    +    VL+Y++ G L   L  +  FL+   R     +VASA+ YLH   S  
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SLN 116

Query: 882 IVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKV 939
           I++ D+KP N+LL+    GH  L+DFG+ K  G E     +   GT  Y+APE  R+   
Sbjct: 117 IIYRDLKPENILLDSQ--GHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPEVLRKEPY 173

Query: 940 SRKCDVYSYGIMLME 954
            R  D +  G +L E
Sbjct: 174 DRTVDWWCLGAVLYE 188

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 69.1 bits (169), Expect = 9e-12
 Identities = 53/188 (28%), Positives = 90/188 (47%), Gaps = 17/188 (9%)

Query: 785 GMEIAAKVF---HMEFDGSLESFHAECKVMGSIRHRNLVKIISS-CSNNDFKALVLEYMS 840
           G E+A K+      E +     F  E  +   + H N+V ++ S  +       V EY+ 
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 841 NGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVG 900
             +L + L +D   L   +  ++M+ V  AL   H   +  IVH D+KP N++++++ V 
Sbjct: 63  GRTLREVLAADGA-LPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVR 118

Query: 901 ---HLSDFGIAKIL-GKEESMRQTKT-----LGTIGYMAPEYGREGKVSRKCDVYSYGIM 951
               + DFGI  +L G  ++   T T     LGT  Y APE  R   V+   D+Y++G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178

Query: 952 LMETFTKK 959
            +E  T +
Sbjct: 179 FLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 66.5 bits (162), Expect = 1e-11
 Identities = 50/179 (27%), Positives = 92/179 (51%), Gaps = 21/179 (11%)

Query: 804 FHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL----------YSDNY 853
           F  E K+M  +++ N+++++  C ++D   ++ EYM NG L + L          +++N 
Sbjct: 64  FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123

Query: 854 -FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG 912
             + I   L + + +AS ++YL    S   VH D+   N L+       ++DFG+++ L 
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLY 180

Query: 913 KEESMR-QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT--KKKP----TDE 964
             +  R Q + +  I +MA E    GK +   DV+++G+ L E FT  K++P    +DE
Sbjct: 181 SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 65/220 (29%), Positives = 99/220 (45%), Gaps = 32/220 (14%)

Query: 767 KLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFD-------GSLESFHAECKVMGSIRHRN 818
           KLLG G+FG VY     D G E+A K   ++FD         + +   E +++ ++ H  
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVK--QVQFDPESPETSKEVNALECEIQLLKNLLHER 65

Query: 819 LVKIISSCSNNDFKAL--VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
           +V+      +   + L   +E+M  GS++  L S     + + R K    +   + YLH 
Sbjct: 66  IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTR-KYTRQILEGVSYLH- 123

Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL---------GTIG 927
             S  IVH DIK +N+L +      L DFG +K L       QT  L         GT  
Sbjct: 124 --SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL-------QTICLSGTGMKSVTGTPY 174

Query: 928 YMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFA 967
           +M+PE        RK D++S G  ++E  T+K P  E  A
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA 214

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 33/212 (15%)

Query: 767 KLLGMGSFGSVY---KGVLPD-GMEIAAKVFHMEFDGSLE-----SFHAECKVMGSIRHR 817
           K+LG GSFG V+   K   PD G   A KV       +L+         E  ++  + H 
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLK---KATLKVRDRVRTKMERDILAEVNHP 58

Query: 818 NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI-MIDVASALEYLHF 876
            +VK+  +        L+L+++  G L   L  +  F +  + +K  + ++A AL++LH 
Sbjct: 59  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE--EDVKFYLAELALALDHLH- 115

Query: 877 GYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKT----LGTIGYMA 930
             S  I++ D+KP N+LL+E   GH  L+DFG++K     ES+   K      GT+ YMA
Sbjct: 116 --SLGIIYRDLKPENILLDEE--GHIKLTDFGLSK-----ESIDHEKKAYSFCGTVEYMA 166

Query: 931 PE-YGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           PE   R G  ++  D +S+G+++ E  T   P
Sbjct: 167 PEVVNRRGH-TQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 25/214 (11%)

Query: 767 KLLGMGSFGSVY--KGVLPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRHR-NLV 820
           K +  G+FGSVY  K     G   A KV     M     + +  AE  +M        + 
Sbjct: 2   KPISKGAFGSVYLAKKRS-TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60

Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
           K+  S  + D+  LV+EY++ G     + +     +   + + + +V   +E LH     
Sbjct: 61  KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDLH---QR 116

Query: 881 PIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGK 938
            I+H DIKP N+L++++  GH  L+DFG+++       +   K +GT  Y+APE      
Sbjct: 117 GIIHRDIKPENLLIDQT--GHLKLTDFGLSRN-----GLENKKFVGTPDYLAPETILGVG 169

Query: 939 VSRKCDVYSYGIMLMETFTKKKP-----TDEIFA 967
             +  D +S G ++ E      P      D +F 
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFD 203

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 65.8 bits (160), Expect = 3e-11
 Identities = 72/316 (22%), Positives = 136/316 (43%), Gaps = 62/316 (19%)

Query: 767  KLLGMGSFGSVYK----GVLPDGME----IAAKVFHME-FDGSLESFHAECKVMGSI-RH 816
            K LG G FG V +    G+     +    +A K+      D  L    +E ++M  I +H
Sbjct: 18   KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77

Query: 817  RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSD-----NYFLDILQR----------L 861
            +N++ ++  C+      +++EY + G+L + L +      +Y  DI +           +
Sbjct: 78   KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 862  KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK 921
                 VA  +EYL    S   +H D+   NVL+ E  V  ++DFG+A+ +   +  ++T 
Sbjct: 138  SCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194

Query: 922  T-LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT------KKKPTDEIFAGEMSLKR 974
                 + +MAPE   +   + + DV+S+GI++ E FT         P +E+F        
Sbjct: 195  NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF-------- 246

Query: 975  WVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVAN 1034
                 LL        + + ++   N       C   ++ L  +C   +P +R + K +  
Sbjct: 247  ----KLLR-------EGHRMDKPSN-------CTHELYMLMRECWHAVPTQRPTFKQLVE 288

Query: 1035 RLVRIRETLS-AYIDV 1049
             L ++   +S  Y+D+
Sbjct: 289  ALDKVLAAVSEEYLDL 304

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 65.8 bits (160), Expect = 3e-11
 Identities = 61/205 (29%), Positives = 95/205 (46%), Gaps = 21/205 (10%)

Query: 767 KLLGMGSFGSVYKGVL----PDGMEIAAKVFHME-FDGSLESFHA--ECKVMGSIRHRNL 819
           KLLG G+FG V   +L      G   A K+   E      E  H   E +V+ + RH  L
Sbjct: 1   KLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 57

Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
             +  +   +D    V+EY + G L   L  +  F +   R     ++ SALEYLH   S
Sbjct: 58  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH---S 113

Query: 880 TPIVHCDIKPSNVLLNESMVGH--LSDFGIAKI-LGKEESMRQTKTLGTIGYMAPEYGRE 936
             +V+ DIK  N++L++   GH  ++DFG+ K  +    +M+     GT  Y+APE   +
Sbjct: 114 RDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEVLED 169

Query: 937 GKVSRKCDVYSYGIMLMETFTKKKP 961
               R  D +  G+++ E    + P
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 65.4 bits (159), Expect = 4e-11
 Identities = 63/233 (27%), Positives = 113/233 (48%), Gaps = 37/233 (15%)

Query: 767 KLLGMGSFGSVYK----GVLPD----GMEIAAKVFHME-FDGSLESFHAECKVMGSI-RH 816
           K LG G FG V      G+  D     + +A K+   +  D  L    +E ++M  I +H
Sbjct: 18  KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77

Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSD-----NYFLDILQ------RLKIMI 865
           +N++ ++ +C+ +    +++EY S G+L + L +      +Y  D  +        K ++
Sbjct: 78  KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137

Query: 866 D----VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK 921
                VA  +EYL    S   +H D+   NVL+ E  V  ++DFG+A+ +   +  ++T 
Sbjct: 138 SCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT- 193

Query: 922 TLG--TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKK------PTDEIF 966
           T G   + +MAPE   +   + + DV+S+G++L E FT         P +E+F
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 65.6 bits (160), Expect = 4e-11
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 29/217 (13%)

Query: 761 DGFSENKLLGMGSFGSVY-------KGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGS 813
           + F   K++G G+FG V        K V    M++ +K F M        F  E  +M  
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVY--AMKLLSK-FEMIKRSDSAFFWEERDIMAH 99

Query: 814 IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIM--IDVASAL 871
                +V++  +  ++ +  +V+EYM  G L   +   NY  DI ++       +V  AL
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DIPEKWARFYTAEVVLAL 155

Query: 872 EYLH-FGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGY 928
           + +H  G+    +H D+KP N+LL++S  GH  L+DFG    +     +R    +GT  Y
Sbjct: 156 DAIHSMGF----IHRDVKPDNMLLDKS--GHLKLADFGTCMKMDANGMVRCDTAVGTPDY 209

Query: 929 MAPEY----GREGKVSRKCDVYSYGIMLMETFTKKKP 961
           ++PE     G +G   R+CD +S G+ L E      P
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 64.6 bits (157), Expect = 4e-11
 Identities = 66/287 (22%), Positives = 119/287 (41%), Gaps = 45/287 (15%)

Query: 769  LGMGSFGSV----YKGVLPDG----MEIAAKVFHMEFDGS-LESFHAECKVMGSIRHRNL 819
            LG G FG V    Y    P+G     ++A K    E  G+ +     E +++ ++ H N+
Sbjct: 12   LGEGHFGKVELCRYD---PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68

Query: 820  VKIISSCSNNDFKA--LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
            VK    C+ +      L++E++ +GSL++ L  +   +++ Q+LK  + +   ++YL   
Sbjct: 69   VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG-- 126

Query: 878  YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT--LGTIGYMAPEYGR 935
             S   VH D+   NVL+       + DFG+ K +  ++     K      + + APE   
Sbjct: 127  -SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185

Query: 936  EGKVSRKCDVYSYGIMLMETFT----KKKPTDEIFA------GEMSLKRWVGDSLLSCSI 985
            + K     DV+S+G+ L E  T    +  P            G+M++ R V         
Sbjct: 186  QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV--------- 236

Query: 986  TEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDV 1032
                   +L  E         C   ++ L   C    P KR + +++
Sbjct: 237  ------RVLE-EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 66.4 bits (162), Expect = 5e-11
 Identities = 34/90 (37%), Positives = 48/90 (53%)

Query: 474 GLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSI 533
           GL L N  L G IP D+  L  L ++ L  N + G +P  LG++TSL  L L  N+    
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481

Query: 534 IPSTLWNLKDILRFNLSSNSLNGSLLPDIG 563
           IP +L  L  +   NL+ NSL+G +   +G
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 64.7 bits (157), Expect = 5e-11
 Identities = 49/177 (27%), Positives = 82/177 (46%), Gaps = 6/177 (3%)

Query: 785 GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSL 844
           G ++A K   +      E    E  +M    H N+V + +S    D   +V+E++  G+L
Sbjct: 47  GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106

Query: 845 EKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSD 904
              +      ++  Q   + + V  AL YLH   +  ++H DIK  ++LL       LSD
Sbjct: 107 TDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSD 161

Query: 905 FGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           FG    + KE   R++  +GT  +MAPE         + D++S GIM++E    + P
Sbjct: 162 FGFCAQVSKEVPKRKS-LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 64.1 bits (156), Expect = 5e-11
 Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 31/218 (14%)

Query: 767 KLLGMGSFGSVYKGVL----PDGMEIAAK---VFHMEFDGSLESFHAECKVMGSIRHRNL 819
           K +G GSFG   K +L     DG +   K   +  M      ES   E  V+ +++H N+
Sbjct: 6   KKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREES-RKEVAVLSNMKHPNI 61

Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEK-------CLYSDNYFLDILQRLKIMIDVASALE 872
           V+   S   N    +V++Y   G L K        L+ ++  LD        + +  AL+
Sbjct: 62  VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF------VQICLALK 115

Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE 932
           ++H      I+H DIK  N+ L +     L DFGIA++L     + +T  +GT  Y++PE
Sbjct: 116 HVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART-CIGTPYYLSPE 171

Query: 933 YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEM 970
                  + K D+++ G +L E  T K   +   AG M
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLKHAFE---AGNM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 64.6 bits (157), Expect = 5e-11
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 20/222 (9%)

Query: 769 LGMGSFGSVYKGVLPD----GMEIAAKVFHMEFDGSLES---FHAECKVMGSIRHRNLVK 821
           LG GSFG VY+G   D      E    V  +    SL     F  E  VM      ++V+
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 822 IISSCSNNDFKALVLEYMSNGSLE---KCLYSD--NYFLDILQRLKIMI----DVASALE 872
           ++   S      +V+E M++G L+   + L  +  N        L+ MI    ++A  + 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT-KTLGTIGYMAP 931
           YL+   +   VH D+   N ++       + DFG+ + + + +  R+  K L  + +MAP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 932 EYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
           E  ++G  +   D++S+G++L E  +  +   +  + E  LK
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 232

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 64.7 bits (157), Expect = 6e-11
 Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 15/202 (7%)

Query: 767 KLLGMGSFGSVYKGVL----PDGMEIAAKVFHME-FDGSLESFHA--ECKVMGSIRHRNL 819
           KLLG G+FG V   +L      G   A K+   E      E  H   E +V+ + RH  L
Sbjct: 1   KLLGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFL 57

Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
             +  S    D    V+EY++ G L   L  +  F +   R     ++ SAL+YLH G  
Sbjct: 58  TSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLHSG-- 114

Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKV 939
             IV+ D+K  N++L++     ++DFG+ K  G  ++       GT  Y+APE   +   
Sbjct: 115 -KIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEVLEDNDY 172

Query: 940 SRKCDVYSYGIMLMETFTKKKP 961
            R  D +  G+++ E    + P
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 64.3 bits (156), Expect = 8e-11
 Identities = 75/237 (31%), Positives = 106/237 (44%), Gaps = 25/237 (10%)

Query: 767 KLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD-GSLESFH--AECKVM-GSIRHRNLVK 821
           K++G GSFG V       DG   A KV   +      E  H  AE  V+  +++H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           +  S    +    VL++++ G L   L  +  F +   R     ++ASAL YLH   S  
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SIN 116

Query: 882 IVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKV 939
           IV+ D+KP N+LL+    GH  L+DFG+ K  G  +S   T   GT  Y+APE  R+   
Sbjct: 117 IVYRDLKPENILLDS--QGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPY 173

Query: 940 SRKCDVYSYGIMLMETFTKKKP---------TDEIFAGEMSLKRWVGDSLLSCSITE 987
               D +  G +L E      P          D I    + L+   G SL + SI E
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRP--GASLTAWSILE 228

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 65.2 bits (159), Expect = 1e-10
 Identities = 41/129 (31%), Positives = 56/129 (43%), Gaps = 35/129 (27%)

Query: 140 WFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLP 199
           WF+       L L +    G IP  I  L  LQ ++LS N + G IP S+ +I+S     
Sbjct: 418 WFID-----GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITS----- 467

Query: 200 VLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSL 259
                                    L V+ L++N F G IP  +G LTS+R L L  NSL
Sbjct: 468 -------------------------LEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSL 502

Query: 260 IGEIPNEIG 268
            G +P  +G
Sbjct: 503 SGRVPAALG 511

Length = 623

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 64.3 bits (156), Expect = 1e-10
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 37/215 (17%)

Query: 767 KLLGMGSFGSV----YKGVLPDGMEIAAKVFHMEFDGSLES--------FHAECKVMGSI 814
           K++G G+FG V    +K         + KV+ M+     E         F  E  +M   
Sbjct: 49  KVIGRGAFGEVQLVRHKS--------SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100

Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK--IMIDVASALE 872
               +V++  +  ++ +  +V+EYM  G L   +   NY  D+ ++       +V  AL+
Sbjct: 101 NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DVPEKWAKFYTAEVVLALD 156

Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMA 930
            +H   S  ++H D+KP N+LL++   GH  L+DFG    + +   +R    +GT  Y++
Sbjct: 157 AIH---SMGLIHRDVKPDNMLLDKH--GHLKLADFGTCMKMDETGMVRCDTAVGTPDYIS 211

Query: 931 PEY----GREGKVSRKCDVYSYGIMLMETFTKKKP 961
           PE     G +G   R+CD +S G+ L E      P
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 63.4 bits (154), Expect = 1e-10
 Identities = 46/178 (25%), Positives = 88/178 (49%), Gaps = 20/178 (11%)

Query: 804 FHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL----------YSDNY 853
           F  E K+M  ++  N++++++ C  +D   ++ EYM NG L + L           +D  
Sbjct: 66  FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125

Query: 854 FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK 913
            +     + +   +AS ++YL    S   VH D+   N L+ ++    ++DFG+++ L  
Sbjct: 126 TISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182

Query: 914 EESMR-QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT--KKKP----TDE 964
            +  R Q + +  I +M+ E    GK +   DV+++G+ L E  T  K++P    +DE
Sbjct: 183 GDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 63.6 bits (155), Expect = 1e-10
 Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 10/204 (4%)

Query: 761 DGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES-FHAECKVMGSIRHRN 818
           D F +   LG G+ G V K +  P G+ +A K+ H+E   ++ +    E KV+       
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60

Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYF-LDILQRLKIMIDVASALEYLHFG 877
           +V    +  ++   ++ +E+M  GSL++ L        +IL   KI I V   L YL   
Sbjct: 61  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG--KISIAVLRGLTYLREK 118

Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG 937
           +   I+H D+KPSN+L+N      L DFG++  L   +SM  +  +GT  YM+PE  +  
Sbjct: 119 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANS-FVGTRSYMSPERLQGT 173

Query: 938 KVSRKCDVYSYGIMLMETFTKKKP 961
             + + D++S G+ L+E    + P
Sbjct: 174 HYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 63.5 bits (154), Expect = 2e-10
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 10/204 (4%)

Query: 761 DGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGSLES-FHAECKVMGSIRHRN 818
           D F     LG G+ G V K    P G+ +A K+ H+E   ++ +    E +V+       
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYF-LDILQRLKIMIDVASALEYLHFG 877
           +V    +  ++   ++ +E+M  GSL++ L        +IL   K+ I V   L YL   
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG--KVSIAVLRGLAYLREK 122

Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG 937
           +   I+H D+KPSN+L+N      L DFG++  L   +SM  +  +GT  YM+PE  +  
Sbjct: 123 HQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANS-FVGTRSYMSPERLQGT 177

Query: 938 KVSRKCDVYSYGIMLMETFTKKKP 961
             S + D++S G+ L+E    + P
Sbjct: 178 HYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 25/215 (11%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMG-SIRHRNLVK 821
           K+LG GSFG V    L    E  A K    +    D  +E    E +V+  +  H  L  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           +  +    +    V+EY++ G L   + S   F +   R     ++   L++LH      
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF-YAAEIICGLQFLH---KKG 116

Query: 882 IVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKT---LGTIGYMAPEYGRE 936
           I++ D+K  NVLL++   GH  ++DFG+ K    E    + K     GT  Y+APE  + 
Sbjct: 117 IIYRDLKLDNVLLDKD--GHIKIADFGMCK----ENMNGEGKASTFCGTPDYIAPEILKG 170

Query: 937 GKVSRKCDVYSYGIMLMETFTKKKP-----TDEIF 966
            K +   D +S+G++L E    + P      DE+F
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 54/194 (27%), Positives = 89/194 (45%), Gaps = 7/194 (3%)

Query: 769 LGMGSFGSV-YKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           +G GS G V    V   G  +A K   +      E    E  +M   +H N+V++ +S  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 828 NNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDI 887
             D   +V+E++  G+L   +      ++  Q   + + V  AL  LH   +  ++H DI
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLH---AQGVIHRDI 142

Query: 888 KPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYS 947
           K  ++LL       LSDFG    + KE   R++  +GT  +MAPE         + D++S
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS-LVGTPYWMAPELISRLPYGPEVDIWS 201

Query: 948 YGIMLMETFTKKKP 961
            GIM++E    + P
Sbjct: 202 LGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 48/177 (27%), Positives = 84/177 (47%), Gaps = 6/177 (3%)

Query: 785 GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSL 844
           G ++A K+  +      E    E  +M   +H+N+V++  S    +   +++E++  G+L
Sbjct: 46  GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105

Query: 845 EKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSD 904
              +      L+  Q   +   V  AL YLH   S  ++H DIK  ++LL       LSD
Sbjct: 106 TDIVSQTR--LNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSD 160

Query: 905 FGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           FG    + K+   R++  +GT  +MAPE         + D++S GIM++E    + P
Sbjct: 161 FGFCAQISKDVPKRKS-LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 62.3 bits (152), Expect = 3e-10
 Identities = 51/184 (27%), Positives = 82/184 (44%), Gaps = 45/184 (24%)

Query: 807 ECKVMGSIRHRNLVKI--ISSCSNNDFKA--LVLEYMSNGSLEKCLYSD--------NYF 854
           E K++   +H N++ I  I      DFK   +V++ M +  L   ++SD         YF
Sbjct: 54  ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYF 112

Query: 855 LDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK- 913
           L  L R          L+Y+H   S  ++H D+KPSN+L+NE     + DFG+A+ L   
Sbjct: 113 LYQLLR---------GLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160

Query: 914 --EESMRQTKTLGTIGYMAPE-------YGREGKVSRKCDVYSYGIMLMETFTKKKPTDE 964
             E     T+ + T  Y APE       Y      +   D++S G +  E   ++    +
Sbjct: 161 PTEHKYFMTEYVATRWYRAPELLLSLPEY------TTAIDMWSVGCIFAEMLGRR----Q 210

Query: 965 IFAG 968
           +F G
Sbjct: 211 LFPG 214

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 63.3 bits (154), Expect = 4e-10
 Identities = 27/80 (33%), Positives = 50/80 (62%)

Query: 236 QGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNIS 295
           +G IP DI  L  ++++ L  NS+ G IP  +G++ +LEVL +  ++  G IP S+  ++
Sbjct: 431 RGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLT 490

Query: 296 TLKELAVTDNDLLGSLPSSI 315
           +L+ L +  N L G +P+++
Sbjct: 491 SLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 62.9 bits (153), Expect = 5e-10
 Identities = 33/89 (37%), Positives = 55/89 (61%), Gaps = 1/89 (1%)

Query: 252 LFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSL 311
           L L N  L G IPN+I  LR+L+ + +  +++ G IP S+ +I++L+ L ++ N   GS+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 312 PSSIDLGLPNLERLFLGENNFSGTIPSSL 340
           P S+   L +L  L L  N+ SG +P++L
Sbjct: 483 PESLGQ-LTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 62.1 bits (151), Expect = 5e-10
 Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 39/230 (16%)

Query: 769 LGMGSFGSV----YKGVLPDGMEIAAK------VFHMEFDGSLESFHAECKVMGSIRHRN 818
           LG GSFG V    +KG    G   A K      +  M+    ++    E  ++  + H  
Sbjct: 26  LGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMK---QVQHVAQEKSILMELSHPF 79

Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
           +V ++ S  + +    +LE++  G L   L     F + + +     ++  A EYLH   
Sbjct: 80  IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF-YHAELVLAFEYLH--- 135

Query: 879 STPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTL-GTIGYMAPEYGR 935
           S  I++ D+KP N+LL+    GH  ++DFG AK     +   +T TL GT  Y+APE  +
Sbjct: 136 SKDIIYRDLKPENLLLDNK--GHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAPEVIQ 188

Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP---------TDEIFAGEMSLKRWV 976
                +  D ++ G++L E      P          ++I AG +    W 
Sbjct: 189 SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWF 238

Length = 329

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 61.2 bits (148), Expect = 5e-10
 Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 33/289 (11%)

Query: 767  KLLGMGSFGSVYKGV-LPDG----MEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLV 820
            K+LG G+FG+VYKG+ +PDG    + +A KV        + +    E  VM  +    + 
Sbjct: 13   KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 821  KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
            +++  C  +  + LV + M  G L   +  +   +     L   + +A  + YL      
Sbjct: 73   RLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EV 128

Query: 881  PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-IGYMAPEYGREGKV 939
             +VH D+   NVL+       ++DFG+A++L  +E+          I +MA E     + 
Sbjct: 129  RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188

Query: 940  SRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE 998
            + + DV+SYG+ + E  T   KP D I A E+                     +LL   E
Sbjct: 189  THQSDVWSYGVTVWELMTFGAKPYDGIPAREIP--------------------DLLEKGE 228

Query: 999  NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYI 1047
                    C   ++ + + C +   E R   +++ +   R+    S ++
Sbjct: 229  R-LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSRFV 276

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 61.1 bits (149), Expect = 6e-10
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 26/216 (12%)

Query: 768 LLGMGSFGSVYKGV-LPDGMEIAAK--VFHMEFDGSLESFHAECKVMGSIR---HRNLVK 821
            +G G++G+VYK   L  G  +A K     +  +G   S   E  ++  +    H N+V+
Sbjct: 6   EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65

Query: 822 IISSCSNNDFK-----ALVLEYMS---NGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
           ++  C            LV E++       L KC       L       +M  +   +++
Sbjct: 66  LLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG---LPPETIKDLMRQLLRGVDF 122

Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
           LH   S  IVH D+KP N+L+       ++DFG+A+I   E  M  T  + T+ Y APE 
Sbjct: 123 LH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE--MALTSVVVTLWYRAPEV 177

Query: 934 GREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGE 969
             +   +   D++S G +  E F +++P   +F G 
Sbjct: 178 LLQSSYATPVDMWSVGCIFAELF-RRRP---LFRGT 209

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 62.3 bits (151), Expect = 7e-10
 Identities = 47/169 (27%), Positives = 77/169 (45%), Gaps = 25/169 (14%)

Query: 806 AECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK--- 862
           +E   + +  H  +VK      ++D   L++EY S G L K          I QRLK   
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNK---------QIKQRLKEHL 164

Query: 863 ---------IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK 913
                    +   +  AL+ +H   S  ++H D+K +N+ L  + +  L DFG +K    
Sbjct: 165 PFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221

Query: 914 EESMRQTKTL-GTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
             S+    +  GT  Y+APE     + S+K D++S G++L E  T  +P
Sbjct: 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 60.4 bits (146), Expect = 7e-10
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 15/201 (7%)

Query: 767 KLLGMGSFGSV----YKGVLPDGMEIAAKVFHMEFDGSLESFHAE--CKVMGSIRHRNLV 820
           +++G GS+G V    ++    DG +   K  ++      E   AE   +++  ++H N+V
Sbjct: 6   RVVGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV 62

Query: 821 KIISSCSNND-FKALVLEYMSNGSL-EKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
               S    D    +V+ +   G L  K        L   Q ++  + +A AL+YLH   
Sbjct: 63  AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH--- 119

Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGK 938
              I+H D+K  NV L  + +  + D GIA++L  +  M  T  +GT  YM+PE      
Sbjct: 120 EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELFSNKP 178

Query: 939 VSRKCDVYSYGIMLMETFTKK 959
            + K DV++ G  + E  T K
Sbjct: 179 YNYKSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 61.1 bits (148), Expect = 1e-09
 Identities = 81/255 (31%), Positives = 121/255 (47%), Gaps = 14/255 (5%)

Query: 405 SENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPV 464
             +    +LPSS+         L   S   S    + L N+  L  + L  N L   I  
Sbjct: 54  LSSNTLLLLPSSLSRLLS--LDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNIS- 110

Query: 465 TLGRLQKLQGLYLQNNKLEGSIPEDLCHL-YRLANLYLGDNKLSGRLPACLGNLTSLRDL 523
            L  L  L  L L NN +   IP  +  L   L  L L DNK+   LP+ L NL +L++L
Sbjct: 111 ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNL 168

Query: 524 SLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVI-EMDLSLNALSGVI 582
            L  N L+ +    L NL ++   +LS N +  S LP    L   + E+DLS N++   +
Sbjct: 169 DLSFNDLSDLPKL-LSNLSNLNNLDLSGNKI--SDLPPEIELLSALEELDLSNNSII-EL 224

Query: 583 PVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKH 642
             ++  L+ L  L L  N+L+  +PES G L +L  +D+SNN +S     S+ +L+ L+ 
Sbjct: 225 LSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRE 281

Query: 643 LNLSFNQLEGEIPTR 657
           L+LS N L   +P  
Sbjct: 282 LDLSGNSLSNALPLI 296

Length = 394

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 26/208 (12%)

Query: 767 KLLGMGSFGSVYKGVL----PDGMEIAAKVFHME-FDGSLESFHA--ECKVMGSIRHRNL 819
           KLLG G+FG V   +L      G   A K+   E      E  H   E +V+ + RH  L
Sbjct: 1   KLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 57

Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
             +  S   +D    V+EY + G L   L  +  F +   R     ++ SAL+YLH    
Sbjct: 58  TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH--SE 114

Query: 880 TPIVHCDIKPSNVLLNESMVGHL--SDFGIAKILGKEESMRQTKTL----GTIGYMAPEY 933
             +V+ D+K  N++L++   GH+  +DFG+ K     E ++   T+    GT  Y+APE 
Sbjct: 115 KNVVYRDLKLENLMLDKD--GHIKITDFGLCK-----EGIKDGATMKTFCGTPEYLAPEV 167

Query: 934 GREGKVSRKCDVYSYGIMLMETFTKKKP 961
             +    R  D +  G+++ E    + P
Sbjct: 168 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 59.7 bits (145), Expect = 2e-09
 Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 27/216 (12%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMG-SIRHRNLVK 821
           K+LG GSFG V    L    E+ A KV   +    D  +E    E +V+  + +H  L +
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           + S     D    V+EY++ G L   +     F +   R     ++   L++LH      
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF-YAAEIVLGLQFLH---ERG 116

Query: 882 IVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMR---QTKTL-GTIGYMAPEYGR 935
           I++ D+K  NVLL+    GH  ++DFG+ K     E +     T T  GT  Y+APE   
Sbjct: 117 IIYRDLKLDNVLLDSE--GHIKIADFGMCK-----EGILGGVTTSTFCGTPDYIAPEILS 169

Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP-----TDEIF 966
                   D ++ G++L E    + P      DE+F
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF 205

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 60.6 bits (147), Expect = 3e-09
 Identities = 32/92 (34%), Positives = 55/92 (59%)

Query: 200 VLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSL 259
            ++GL +    L G IP ++ K R L  ++L+ N  +G IP  +G++TS+  L L  NS 
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478

Query: 260 IGEIPNEIGNLRNLEVLGVQSSNLAGLIPASI 291
            G IP  +G L +L +L +  ++L+G +PA++
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 59.4 bits (144), Expect = 3e-09
 Identities = 77/302 (25%), Positives = 125/302 (41%), Gaps = 70/302 (23%)

Query: 769  LGMGSFGSVYKGV-LPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISS 825
            +G G++G VYKG     G  +A K   +E   +G   +   E  ++  ++H N+V +   
Sbjct: 8    IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 826  CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH-------FGY 878
                    L+ E++S   L+K       +LD L + + M D      YL+       F +
Sbjct: 68   LMQESRLYLIFEFLSM-DLKK-------YLDSLPKGQYM-DAELVKSYLYQILQGILFCH 118

Query: 879  STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE--YGRE 936
            S  ++H D+KP N+L++   V  L+DFG+A+  G    +  T  + T+ Y APE   G  
Sbjct: 119  SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV-YTHEVVTLWYRAPEVLLGSP 177

Query: 937  GKVSRKCDVYSYGIMLMETFTKK--------------------KPTDEIFAGEMSLK--- 973
             + S   D++S G +  E  TKK                     PT++++ G  SL    
Sbjct: 178  -RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236

Query: 974  ----RWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISM 1029
                +W   SL          + + N +E+     E+       L  D     P KRIS 
Sbjct: 237  NTFPKWKKGSL---------RSAVKNLDEDGLDLLEKM------LIYD-----PAKRISA 276

Query: 1030 KD 1031
            K 
Sbjct: 277  KK 278

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 59.1 bits (144), Expect = 3e-09
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 35/220 (15%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAEC---KVMGSIR----HRNL 819
           K LG G+FGSVY     +  E+ A +  M+      S+  EC   + + S+R    H N+
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVA-IKKMK--KKFYSWE-ECMNLREVKSLRKLNEHPNI 60

Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDN---YFLDILQRLKIMIDVASALEYLH- 875
           VK+      ND    V EYM  G+L + L  D     F + + R  I+  +   L ++H 
Sbjct: 61  VKLKEVFRENDELYFVFEYM-EGNLYQ-LMKDRKGKPFSESVIR-SIIYQILQGLAHIHK 117

Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ-TKTLGTIGYMAPE-Y 933
            G+     H D+KP N+L++   V  ++DFG+A+ +    S    T  + T  Y APE  
Sbjct: 118 HGF----FHRDLKPENLLVSGPEVVKIADFGLAREI---RSRPPYTDYVSTRWYRAPEIL 170

Query: 934 GREGKVSRKCDVYSYGIMLMETFTKKKP-------TDEIF 966
            R    S   D+++ G ++ E +T  +P        D+++
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYT-LRPLFPGSSEIDQLY 209

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 58.7 bits (142), Expect = 3e-09
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 27/207 (13%)

Query: 769 LGMGSFGSVYKGV---LPDG-----MEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLV 820
           LG G+F  ++KG+   + D       E+  KV         ESF     +M  + H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
                C   D   +V EY+  GSL+  L  +   ++I  +L++   +A AL +L      
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DK 119

Query: 881 PIVHCDIKPSNVLL---NESMVGH-----LSDFGIA-KILGKEESMRQTKTLGTIGYMAP 931
            + H ++   NVLL    +   G+     LSD GI+  +L KE        L  I ++ P
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE------ILLERIPWVPP 173

Query: 932 EYGREGK-VSRKCDVYSYGIMLMETFT 957
           E     + +S   D +S+G  L E F+
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFS 200

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 58.7 bits (142), Expect = 4e-09
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 35/206 (16%)

Query: 769 LGMGSFGSVYKGVL--PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
           LG G++GSVYK VL  P G+ +A K   +E D        E K    I   +++    S 
Sbjct: 9   LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELD--------ESKFNQIIMELDILHKAVSP 59

Query: 827 SNNDFKA---------LVLEYMSNGSLEKCLYSDNYFLDIL---QRLKIMIDVASALEYL 874
              DF           + +EYM  GSL+K LY+     + +      +I   V   L++L
Sbjct: 60  YIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFL 118

Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
              ++  I+H D+KP+NVL+N +    L DFG++  L    S+ +T  +G   YMAPE  
Sbjct: 119 KEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL--VASLAKT-NIGCQSYMAPERI 173

Query: 935 REGKVSR------KCDVYSYGIMLME 954
           + G  ++      + DV+S G+ ++E
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILE 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 58.8 bits (142), Expect = 4e-09
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 18/204 (8%)

Query: 767 KLLGMGSFGSVYKGVLP-DGMEIAAKVFHME---FDGSLESFHAECKVMG-SIRHRNLVK 821
           K+LG GSFG V+   L       A K    +    D  +E    E +V+  +  H  L  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           +  +    +    V+EY++ G L   + S + F D+ +      ++   L++LH   S  
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKF-DLPRATFYAAEIICGLQFLH---SKG 116

Query: 882 IVHCDIKPSNVLLNESMVGH--LSDFGIAK--ILGKEESMRQTKTLGTIGYMAPEYGREG 937
           IV+ D+K  N+LL+    GH  ++DFG+ K  +LG     +     GT  Y+APE     
Sbjct: 117 IVYRDLKLDNILLD--TDGHIKIADFGMCKENMLGDA---KTCTFCGTPDYIAPEILLGQ 171

Query: 938 KVSRKCDVYSYGIMLMETFTKKKP 961
           K +   D +S+G++L E    + P
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 57.9 bits (140), Expect = 6e-09
 Identities = 38/131 (29%), Positives = 61/131 (46%), Gaps = 10/131 (7%)

Query: 834 LVLEYMSNGSLEKCLYS-DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNV 892
           LV+  M+ G L+  +Y+         + +     +   LE+LH      IV+ D+KP NV
Sbjct: 70  LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENV 126

Query: 893 LLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGI 950
           LL++   G+  +SD G+A  L   + ++     GT GYMAPE  +        D ++ G 
Sbjct: 127 LLDDH--GNVRISDLGLAVELKGGKKIKGR--AGTPGYMAPEVLQGEVYDFSVDWFALGC 182

Query: 951 MLMETFTKKKP 961
            L E    + P
Sbjct: 183 TLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 58.3 bits (141), Expect = 7e-09
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 19/212 (8%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMG-SIRHRNLVK 821
           K+LG GSFG V    L    E+ A KV   +    D  ++    E +++  + +H  L  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           +       D    V+EY++ G L   +     F +   R     +V  AL +LH      
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLH---RHG 116

Query: 882 IVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKV 939
           +++ D+K  N+LL+    GH  L+DFG+ K  G    +  T   GT  Y+APE  +E + 
Sbjct: 117 VIYRDLKLDNILLDAE--GHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEILQELEY 173

Query: 940 SRKCDVYSYGIMLMETFTKKKP-----TDEIF 966
               D ++ G+++ E    + P      D++F
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEADNEDDLF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 59.8 bits (145), Expect = 7e-09
 Identities = 57/227 (25%), Positives = 90/227 (39%), Gaps = 36/227 (15%)

Query: 767 KLLGMGSFGSVYKGVLPD-GMEIAAKVFH---MEFDGSLESFHAECKVMGSIRHRNLVKI 822
           +L+G G  G VY    P     +A K       E     + F  E K+   + H  +V +
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQR-----------LKIMIDVASAL 871
            S CS+ D     + Y+   +L K L    +  + L +           L I   + + +
Sbjct: 68  YSICSDGDPVYYTMPYIEGYTL-KSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126

Query: 872 EYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE------SMRQT----- 920
           EY+H   S  ++H D+KP N+LL       + D+G A     EE       + +      
Sbjct: 127 EYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183

Query: 921 ------KTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
                 K +GT  YMAPE       S   D+Y+ G++L +  T   P
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 58.1 bits (140), Expect = 7e-09
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 16/207 (7%)

Query: 763 FSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEF----DGSLESFHAECKVMGSIRHR 817
           F + ++LG G FG V    V   G   A K    +      G   + + E +++  +  +
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN-EKQILEKVNSQ 60

Query: 818 NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYS-DNYFLDILQRLKIMIDVASALEYLHF 876
            +V +  +    D   LVL  M+ G L+  +Y+  N   +  + L    ++   LE LH 
Sbjct: 61  FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH- 119

Query: 877 GYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
                 V+ D+KP N+LL++   GH  +SD G+A  + + ES+R    +GT+GYMAPE  
Sbjct: 120 --RENTVYRDLKPENILLDDY--GHIRISDLGLAVKIPEGESIR--GRVGTVGYMAPEVL 173

Query: 935 REGKVSRKCDVYSYGIMLMETFTKKKP 961
              + +   D +  G ++ E    + P
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 7e-09
 Identities = 65/232 (28%), Positives = 94/232 (40%), Gaps = 58/232 (25%)

Query: 767 KLLGMGSFGSVY----KGVLPDGMEIAAKV---FHMEFDGSLESFHAECKVMGSIRHRNL 819
           KLLG G  G V+    KG    G   A KV     M     ++    E +++ ++ H  L
Sbjct: 7   KLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFL 63

Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDVASALEYLH-F 876
             + +S     +  LV++Y   G L + L         + + R     +V  ALEYLH  
Sbjct: 64  PTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLALEYLHLL 122

Query: 877 GYSTPIVHCDIKPSNVLLNESMVGH--LSDFG-----------IAKILGKEESMRQTKTL 923
           G    IV+ D+KP N+LL+ES  GH  LSDF            ++K L K        ++
Sbjct: 123 G----IVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176

Query: 924 -----------------GTIGYMAPE----YGREGKVSRKCDVYSYGIMLME 954
                            GT  Y+APE     G    V    D ++ GI+L E
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILLYE 224

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 58.1 bits (140), Expect = 8e-09
 Identities = 50/154 (32%), Positives = 75/154 (48%), Gaps = 9/154 (5%)

Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVAS 869
           ++ +++H  LV +  S    D    VL+Y++ G L   L  +  FL+   R     ++AS
Sbjct: 49  LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIAS 107

Query: 870 ALEYLHFGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIG 927
           AL YLH   S  IV+ D+KP N+LL+    GH  L+DFG+ K    E +   +   GT  
Sbjct: 108 ALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCK-ENIEHNGTTSTFCGTPE 161

Query: 928 YMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           Y+APE   +    R  D +  G +L E      P
Sbjct: 162 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 57.8 bits (140), Expect = 1e-08
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 19/201 (9%)

Query: 769 LGMGSFGSVYKGVLPDGMEIAA--KV-FHMEFDGSLESFHAECKVMGSIRHRNLVK---- 821
           +G G++G VY+       EI A  KV    E DG   S   E  ++ ++RH N+V+    
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           ++    ++ F  LV+EY     L   L +        Q   +M+ +   L+YLH  +   
Sbjct: 75  VVGKHLDSIF--LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--- 128

Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGK-EESMRQTKTLGTIGYMAPE--YGREGK 938
           I+H D+K SN+LL +     ++DFG+A+  G   + M  T  + T+ Y APE   G    
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TPKVVTLWYRAPELLLGCT-T 185

Query: 939 VSRKCDVYSYGIMLMETFTKK 959
            +   D+++ G +L E    K
Sbjct: 186 YTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 57.2 bits (139), Expect = 1e-08
 Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 10/159 (6%)

Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
           + N +K+  S +      L+++Y+ +G L   L  +   L   +  KI+  +  AL  LH
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQLVEALNDLH 126

Query: 876 FGYSTPIVHCDIKPSNVLLNESMVG-HLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
                 I+H DIK  NVL + +    +L D+G+ KI+G           GT+ Y +PE  
Sbjct: 127 ---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD-----GTLDYFSPEKI 178

Query: 935 REGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
           +        D ++ G++  E  T K P  E    E+ L+
Sbjct: 179 KGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE 217

Length = 267

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 62/207 (29%), Positives = 92/207 (44%), Gaps = 25/207 (12%)

Query: 767 KLLGMGSFGSVY-----KGVLPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNL 819
           KLLG G+FG V             M+I  K   +  D   E  H   E +V+ + RH  L
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKD---EVAHTLTESRVLQNTRHPFL 57

Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
             +  S   +D    V+EY + G L   L  +  F +   R     ++ SAL YLH   S
Sbjct: 58  TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALGYLH---S 113

Query: 880 TPIVHCDIKPSNVLLNESMVGHL--SDFGIAKILGKEE--SMRQTKTL-GTIGYMAPEYG 934
             +V+ D+K  N++L++   GH+  +DFG    L KE        KT  GT  Y+APE  
Sbjct: 114 CDVVYRDLKLENLMLDKD--GHIKITDFG----LCKEGISDGATMKTFCGTPEYLAPEVL 167

Query: 935 REGKVSRKCDVYSYGIMLMETFTKKKP 961
            +    R  D +  G+++ E    + P
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 36/224 (16%)

Query: 766 NKLLGMGSFGSVY----KGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVK 821
           +KL+G G FG VY            +  AK+ ++E     E+   E  V  +I   + + 
Sbjct: 17  DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLEN----ETIVMETLVYNNIYDIDKIA 72

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFL---------DILQRLK---------I 863
           +  +  N D   +   Y   GS ++C     + L         +I +R+K         I
Sbjct: 73  LWKNIHNIDHLGIPK-YYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNI 131

Query: 864 MIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK---ILGKE-ESMRQ 919
           M D+ + LEY+H      I H DIKP N++++ +  G++ D+GIA    I GK  E  ++
Sbjct: 132 MKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKE 188

Query: 920 TKTL--GTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
            K L  GT+ Y   +      V+R+ D+ S G  +++    K P
Sbjct: 189 QKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232

Length = 294

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 56.7 bits (137), Expect = 1e-08
 Identities = 70/290 (24%), Positives = 117/290 (40%), Gaps = 54/290 (18%)

Query: 769  LGMGSFGSVYKGVL---PDG--------MEIAAKVFHMEFDGSLESFHAECKVMGSIRHR 817
            LG G+F ++YKGVL    D         + +  KV   +   S  +F     +M  + H+
Sbjct: 3    LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDS-LAFFETASLMSQLSHK 61

Query: 818  NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
            +LVK+   C   D   +V EY+  G L+  L+ +   + +  +L +   +ASAL YL   
Sbjct: 62   HLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE-- 118

Query: 878  YSTPIVHCDIKPSNVLL-----NESMV--GHLSDFGIAKILGKEESMRQTKTLGTIGYMA 930
                +VH ++   N+L+     NE  V    LSD GI   +   E  R  +    I ++A
Sbjct: 119  -DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE-RVER----IPWIA 172

Query: 931  PEYGREG--KVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLLSCSITE 987
            PE  R G   ++   D +S+G  L+E  +  ++P   + + E                  
Sbjct: 173  PECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY------------- 219

Query: 988  VADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037
              D + L   +            + +L   C    P KR S + +   L 
Sbjct: 220  -QDQHRLPMPDCA---------ELANLINQCWTYDPTKRPSFRAILRDLN 259

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 57.1 bits (138), Expect = 1e-08
 Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 20/207 (9%)

Query: 763 FSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHM--EFDGSLESFHAECKVMGSIRHRNL 819
           F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  + H N+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASA-----LEYL 874
           VK++      +   LV E++ +  L+K       F+D      I + +  +     L+ L
Sbjct: 62  VKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASPLSGIPLPLIKSYLFQLLQGL 113

Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ-TKTLGTIGYMAPEY 933
            F +S  ++H D+KP N+L+N      L+DFG+A+  G    +R  T  + T+ Y APE 
Sbjct: 114 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTLWYRAPEI 171

Query: 934 GREGKV-SRKCDVYSYGIMLMETFTKK 959
               K  S   D++S G +  E  T++
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 16/207 (7%)

Query: 763 FSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEF----DGSLESFHAECKVMGSIRHR 817
           F + ++LG G FG V    V   G   A K    +      G   + + E +++  +  R
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN-EKQILEKVNSR 60

Query: 818 NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYS-DNYFLDILQRLKIMIDVASALEYLHF 876
            +V +  +    D   LVL  M+ G L+  +Y       +  + +    ++   LE LH 
Sbjct: 61  FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH- 119

Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHL--SDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
                IV+ D+KP N+LL++   GH+  SD G+A  + + ++++    +GT+GYMAPE  
Sbjct: 120 --QERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIK--GRVGTVGYMAPEVV 173

Query: 935 REGKVSRKCDVYSYGIMLMETFTKKKP 961
           +  + +   D ++ G +L E    + P
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 59/215 (27%), Positives = 104/215 (48%), Gaps = 26/215 (12%)

Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEF--DGSLESFHAECKVMGSIR---HRNLVKI 822
           +G+G++G+VYK   P  G  +A K   ++   DG   S   E  ++  +    H N+V++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 823 ISSC----SNNDFK-ALVLEYMSN---GSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           +  C    ++ + K  LV E++       L+K +       + ++ L  M      L++L
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDK-VPPPGLPAETIKDL--MRQFLRGLDFL 124

Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   +  IVH D+KP N+L+       L+DFG+A+I   +  M  T  + T+ Y APE  
Sbjct: 125 H---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ--MALTPVVVTLWYRAPEVL 179

Query: 935 REGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGE 969
            +   +   D++S G +  E F ++KP   +F G 
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMF-RRKP---LFCGN 210

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 57.2 bits (139), Expect = 1e-08
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 23/200 (11%)

Query: 772 GSFGSVYKGVLPDGMEIAA--KV-FHMEFDG----SLESFHAECKVMGSIRHRNLVKI-- 822
           G++G VY+       EI A  K+    E +G    SL     E  ++  ++H N+V +  
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR----EINILLKLQHPNIVTVKE 71

Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
           +   SN D   +V+EY+ +  L+  + +        +   +M+ + S + +LH  +   I
Sbjct: 72  VVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---I 127

Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ-TKTLGTIGYMAPE--YGREGKV 939
           +H D+K SN+LLN   +  + DFG+A+  G    ++  T+ + T+ Y APE   G   + 
Sbjct: 128 LHRDLKTSNLLLNNRGILKICDFGLAREYG--SPLKPYTQLVVTLWYRAPELLLG-AKEY 184

Query: 940 SRKCDVYSYGIMLMETFTKK 959
           S   D++S G +  E  TKK
Sbjct: 185 STAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 57.3 bits (138), Expect = 2e-08
 Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 19/212 (8%)

Query: 767 KLLGMGSFGSVYKGVLPDGME-IAAKVFHME---FDGSLESFHAECKVMG-SIRHRNLVK 821
           K+LG GSFG V    L    E  A K    +    D  +E    E +V+  +  +  L  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           +  +    +    V+E+++ G L   +     F D+ +      ++   L++LH   S  
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRF-DLYRATFYAAEIVCGLQFLH---SKG 116

Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAK--ILGKEESMRQTKTLGTIGYMAPEYGREGKV 939
           I++ D+K  NV+L+      ++DFG+ K  + G     R +   GT  Y+APE  +  K 
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN---RASTFCGTPDYIAPEILQGLKY 173

Query: 940 SRKCDVYSYGIMLMETFTKKKP-----TDEIF 966
           +   D +S+G++L E    + P      DE+F
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 26/222 (11%)

Query: 751 ISYQDLLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECK 809
           +  + L   TD +   + +G G++G VYK     DG   A K+     D   E   AE  
Sbjct: 12  LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYN 70

Query: 810 VMGSI-RHRNLVKIISSCSNNDFKA-----LVLEYMSNGSLEKCLYSDNYFLDILQRLK- 862
           ++ S+  H N+VK        D        LVLE  + GS+ + +      L   QRL  
Sbjct: 71  ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKG---LLICGQRLDE 127

Query: 863 -----IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM 917
                I+      L++LH   +  I+H D+K +N+LL       L DFG++  L     +
Sbjct: 128 AMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL-TSTRL 183

Query: 918 RQTKTLGTIGYMAPEY-----GREGKVSRKCDVYSYGIMLME 954
           R+  ++GT  +MAPE        +     +CDV+S GI  +E
Sbjct: 184 RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIE 225

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 57.1 bits (138), Expect = 2e-08
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 37/216 (17%)

Query: 760 TDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRH 816
           T+ + + + +GMG+FG V        G  +A K     F   + +     E K++  +RH
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 817 RNLV---KIISSCSNNDFKALVLEYMSN--------GSLEKCLYSDNYFL-DILQRLKIM 864
            N++    I  S   + +   V E +            LEK      YFL  IL+ LK  
Sbjct: 69  ENIISLSDIFISPLEDIY--FVTELLGTDLHRLLTSRPLEKQFI--QYFLYQILRGLK-- 122

Query: 865 IDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLG 924
                   Y+H   S  +VH D+KPSN+L+NE+    + DFG+A+I    +  + T  + 
Sbjct: 123 --------YVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVS 167

Query: 925 TIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKK 959
           T  Y APE      K   + D++S G +  E    K
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 56.5 bits (136), Expect = 2e-08
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 10/158 (6%)

Query: 807 ECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYS-DNYFLDILQRLKIMI 865
           E +++  +  R +V +  +    D   LVL  M+ G L+  +Y+  N   D  + +    
Sbjct: 50  EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109

Query: 866 DVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTL 923
           ++   LE L       IV+ D+KP N+LL++   GH  +SD G+A  + + E++R    +
Sbjct: 110 ELCCGLEDLQ---RERIVYRDLKPENILLDDR--GHIRISDLGLAVQIPEGETVR--GRV 162

Query: 924 GTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           GT+GYMAPE     K +   D +  G ++ E    + P
Sbjct: 163 GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 56.9 bits (137), Expect = 3e-08
 Identities = 91/353 (25%), Positives = 142/353 (40%), Gaps = 46/353 (13%)

Query: 205 FISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIP 264
            I+ N     + +       L++ S          P  +  L S+  L     S +    
Sbjct: 32  SINLNFPDSNLESVAVNRLALNLSSNTLLLL----PSSLSRLLSLDLLSPSGISSLDGSE 87

Query: 265 NEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLER 324
           N + NL  L  L +  + L   I   +  ++ L  L + +N++   +P  I L   NL+ 
Sbjct: 88  NLL-NLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKE 144

Query: 325 LFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPT 384
           L L +N    ++PS L N+  L  LD  FN  S  +P    NL +L  L L+GN ++   
Sbjct: 145 LDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKISDLP 202

Query: 385 PDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGN 444
           P++  LS       LE + LS N I  +L S                          L N
Sbjct: 203 PEIELLS------ALEELDLSNNSIIELLSS--------------------------LSN 230

Query: 445 INNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDN 504
           + NL+ + L NN+L   +P ++G L  L+ L L NN++  S    L  L  L  L L  N
Sbjct: 231 LKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQI--SSISSLGSLTNLRELDLSGN 287

Query: 505 KLSGRLP--ACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLN 555
            LS  LP  A L  L  L    L +     +  +++    +IL    +S+   
Sbjct: 288 SLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEA 340

Length = 394

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 56.7 bits (137), Expect = 3e-08
 Identities = 42/139 (30%), Positives = 62/139 (44%), Gaps = 13/139 (9%)

Query: 834 LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVL 893
           LV+EY   G L   L   N + D          +A  +  +H  +    VH DIKP NVL
Sbjct: 78  LVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVL 134

Query: 894 LNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMAPEY------GREGKVSRKCDV 945
           ++ +  GH  L+DFG A  L   + +     +GT  Y+APE         +G    +CD 
Sbjct: 135 IDRT--GHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDW 192

Query: 946 YSYGIMLMETFTKKKPTDE 964
           +S G++  E    + P  E
Sbjct: 193 WSLGVIAYEMIYGRSPFHE 211

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 56.6 bits (137), Expect = 3e-08
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 35/213 (16%)

Query: 769 LGMGSFGSVYKGVLPDGMEIAA-KVFHMEFDGSLESFHA----ECKVMGSIRHRNLVKII 823
           +G G+FG V+K       +I A K   ME     E F      E K++  ++H N+V +I
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLME--NEKEGFPITALREIKILQLLKHENVVNLI 77

Query: 824 SSCSN-----NDFKA---LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
             C       N +K    LV E+  +  L   L + N    + +  K+M  + + L Y+H
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136

Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK---ILGKEESMRQTKTLGTIGYMAPE 932
                 I+H D+K +N+L+ +  +  L+DFG+A+   +    +  R T  + T+ Y  PE
Sbjct: 137 ---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193

Query: 933 -------YGREGKVSRKCDVYSYGIMLMETFTK 958
                  YG         D++  G ++ E +T+
Sbjct: 194 LLLGERDYG------PPIDMWGAGCIMAEMWTR 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 56.6 bits (136), Expect = 3e-08
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 36/216 (16%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLE--------SFHAECKVMGSIRHRN 818
           K++G G+FG V    L +    A KVF M+     E         F  E  V+ +  ++ 
Sbjct: 7   KVIGRGAFGEVAVVKLKN----ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62

Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDI----LQRLKIMIDVASALE 872
           +  +  +  + +   LV++Y   G L   L  + D    D+    L  + I ID    L 
Sbjct: 63  ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122

Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMA 930
           Y         VH DIKP N+L++  M GH  L+DFG    L ++ +++ +  +GT  Y++
Sbjct: 123 Y---------VHRDIKPDNILMD--MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171

Query: 931 PEYGR-----EGKVSRKCDVYSYGIMLMETFTKKKP 961
           PE  +     +GK   +CD +S G+ + E    + P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 56.0 bits (135), Expect = 3e-08
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 10/158 (6%)

Query: 807 ECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYS-DNYFLDILQRLKIMI 865
           E +++  +  R +V +  +    D   LVL  M+ G L+  +Y+  N   D  + +    
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109

Query: 866 DVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTL 923
           ++   LE LH      IV+ D+KP N+LL++   GH  +SD G+A  + + E++R    +
Sbjct: 110 EITCGLEDLH---RERIVYRDLKPENILLDDY--GHIRISDLGLAVEIPEGETIR--GRV 162

Query: 924 GTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           GT+GYMAPE  +  + +   D +  G ++ E    K P
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 55.6 bits (134), Expect = 4e-08
 Identities = 43/161 (26%), Positives = 72/161 (44%), Gaps = 13/161 (8%)

Query: 807 ECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYS---DNYFLDILQRLKI 863
           E +++  +  R +V +  +        LV+  M+ G L   +Y+   +N      +    
Sbjct: 43  EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY 102

Query: 864 MIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT- 922
              + S LE+LH      I++ D+KP NVLL+      +SD G+A     E    Q+KT 
Sbjct: 103 TAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLA----VELKDGQSKTK 155

Query: 923 --LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
              GT G+MAPE  +  +     D ++ G+ L E    + P
Sbjct: 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 55.6 bits (134), Expect = 4e-08
 Identities = 53/196 (27%), Positives = 92/196 (46%), Gaps = 14/196 (7%)

Query: 769 LGMGSFGSVYKGVLPDGMEIAA-KVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSC 826
           LG G++ +VYKG      EI A K  H++ + G+  +   E  +M  ++H N+V++    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNY----FLDILQRLKIMIDVASALEYLHFGYSTPI 882
              +   LV EYM    L+K  Y D +     LD          +   + + H      +
Sbjct: 68  HTENKLMLVFEYMDK-DLKK--YMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRV 121

Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKV-SR 941
           +H D+KP N+L+N+     L+DFG+A+  G   +    + + T+ Y AP+     +  S 
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYST 180

Query: 942 KCDVYSYGIMLMETFT 957
             D++S G ++ E  T
Sbjct: 181 SIDIWSVGCIMAEMIT 196

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 56.2 bits (136), Expect = 4e-08
 Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 36/212 (16%)

Query: 768 LLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVKI-- 822
            +G G++G V      P G+++A K     F+          E K++   +H N++ I  
Sbjct: 12  YIGEGAYGMVCSATHKPTGVKVAIKKIS-PFEHQTFCQRTLREIKILRRFKHENIIGILD 70

Query: 823 ----ISSCSNNDFKALVLEYMSNGSLEKCLYSDN-------YFL-DILQRLKIMIDVASA 870
                S  S ND   +V E M    L K + + +       YFL  IL+ LK        
Sbjct: 71  IIRPPSFESFNDV-YIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLK-------- 120

Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE--SMRQTKTLGTIGY 928
             Y+H   S  ++H D+KPSN+LLN +    + DFG+A+I   E   +   T+ + T  Y
Sbjct: 121 --YIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWY 175

Query: 929 MAPEYGREGK-VSRKCDVYSYGIMLMETFTKK 959
            APE     K  ++  D++S G +L E  + +
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 56.7 bits (137), Expect = 5e-08
 Identities = 39/106 (36%), Positives = 55/106 (51%), Gaps = 9/106 (8%)

Query: 137 IPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQ 196
           IP+    L  LQ + L  NS  G IP ++G ++ L+ LDLS N  +G+IP S+  ++S  
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS-- 491

Query: 197 NLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQG--GIP 240
               L  L ++ N L+G +P  L   R LH  S  F    G  GIP
Sbjct: 492 ----LRILNLNGNSLSGRVPAAL-GGRLLHRASFNFTDNAGLCGIP 532

Length = 623

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 55.3 bits (133), Expect = 5e-08
 Identities = 49/187 (26%), Positives = 90/187 (48%), Gaps = 30/187 (16%)

Query: 804 FHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQR--- 860
           F  E K++  ++  N+++++  C + D   ++ EYM NG L + L S ++  D  +    
Sbjct: 66  FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL-SSHHLDDKEENGND 124

Query: 861 ----------------LKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSD 904
                           L + + +AS ++YL    S   VH D+   N L+ E++   ++D
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIAD 181

Query: 905 FGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT--KKKP 961
           FG+++ L   +  R Q + +  I +MA E    GK +   DV+++G+ L E     K++P
Sbjct: 182 FGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241

Query: 962 ----TDE 964
               TDE
Sbjct: 242 YGELTDE 248

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 55.0 bits (132), Expect = 6e-08
 Identities = 40/129 (31%), Positives = 66/129 (51%), Gaps = 6/129 (4%)

Query: 834 LVLEYMSNGSLEKCLYS-DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNV 892
           LV+  M+ G L+  +Y+     L++ + +     +   + +LH   S  IV+ D+KP NV
Sbjct: 70  LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENV 126

Query: 893 LLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIML 952
           LL++     LSD G+A  L   +++  T+  GT GYMAPE  +E   S   D ++ G  +
Sbjct: 127 LLDDQGNCRLSDLGLAVELKDGKTI--TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSI 184

Query: 953 METFTKKKP 961
            E    + P
Sbjct: 185 YEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 55.5 bits (133), Expect = 6e-08
 Identities = 44/157 (28%), Positives = 79/157 (50%), Gaps = 18/157 (11%)

Query: 761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM-EFDGSLESFHAECKVMGSIRHRN 818
           D + + + LG GS+ +VYKG    +G  +A KV  + E +G+  +   E  ++  ++H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKC------LYSDNYFLDILQRLKIMIDVASALE 872
           +V +       +   LV EY+     +        L+ +N  L + Q L+        L 
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR-------GLS 117

Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK 909
           Y+H  Y   I+H D+KP N+L++++    L+DFG+A+
Sbjct: 118 YIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.6 bits (134), Expect = 6e-08
 Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 38/223 (17%)

Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGMEI-AAKVFH---MEFDGSLESFHAECKVMGSIRH 816
           D F   K++G G+FG V    + +  ++ A K+ +   M        F  E  V+ +   
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL--KIMIDVAS----- 869
           R +  +  +  + +   LV++Y   G L          L +L +   ++  D+A      
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDL----------LTLLSKFEDRLPEDMARFYLAE 110

Query: 870 ---ALEYLH-FGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTL 923
              A++ +H  GY    VH DIKP NVLL+    GH  L+DFG    L  + +++    +
Sbjct: 111 MVLAIDSVHQLGY----VHRDIKPDNVLLD--KNGHIRLADFGSCLRLLADGTVQSNVAV 164

Query: 924 GTIGYMAPEYGR-----EGKVSRKCDVYSYGIMLMETFTKKKP 961
           GT  Y++PE  +     +G+   +CD +S G+ + E    + P
Sbjct: 165 GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 54.9 bits (132), Expect = 6e-08
 Identities = 51/197 (25%), Positives = 94/197 (47%), Gaps = 18/197 (9%)

Query: 769 LGMGSFGSVY-----KGVLPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVK 821
           LG GSFG+VY     K V  + +++  ++   E + + E+  A  E +++  + H  +VK
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPN-ETVQANQEAQLLSKLDHPAIVK 66

Query: 822 IISSCSNNDFKALVLEYMSNGSL----EKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
             +S    D   ++ EY     L    E+  ++     +  Q  +  I +   + Y+H  
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSEN-QVCEWFIQLLLGVHYMH-- 123

Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG 937
               I+H D+K  N+ L  +++  + DFG++++L     +  T T GT  YM+PE  +  
Sbjct: 124 -QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFT-GTPYYMSPEALKHQ 180

Query: 938 KVSRKCDVYSYGIMLME 954
               K D++S G +L E
Sbjct: 181 GYDSKSDIWSLGCILYE 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 54.6 bits (131), Expect = 9e-08
 Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 28/227 (12%)

Query: 747 TWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVL--PDGMEIAAKVFHMEFDGSLESF 804
           + + I +      +D +   + +G G++G V+K VL   +G + A K+     D   E  
Sbjct: 4   SGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDID-EEI 61

Query: 805 HAECKVMGSIR-HRNLVKIISSCSNNDFKA-----LVLEYMSNGSLEKCLYSDNYFLDIL 858
            AE  ++ ++  H N+VK        D K      LVLE  + GS+   +     FL   
Sbjct: 62  EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKG---FLKRG 118

Query: 859 QRLK------IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG 912
           +R++      I+ +    L++LH       +H D+K +N+LL       L DFG++  L 
Sbjct: 119 ERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175

Query: 913 KEESMRQTKTLGTIGYMAPEY-----GREGKVSRKCDVYSYGIMLME 954
                R T ++GT  +MAPE        +     +CDV+S GI  +E
Sbjct: 176 STRLRRNT-SVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIE 221

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 39/216 (18%)

Query: 763 FSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLV 820
           F   +++G G++G VYKG  +  G   A KV  +  D   E    E  ++     HRN+ 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIA 76

Query: 821 KII------SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK-----------I 863
                    S   ++D   LV+E+   GS+           D+++  K           I
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVT----------DLVKNTKGNALKEDWIAYI 126

Query: 864 MIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL 923
             ++   L +LH   +  ++H DIK  NVLL E+    L DFG++  L +    R T  +
Sbjct: 127 CREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FI 182

Query: 924 GTIGYMAPEY-----GREGKVSRKCDVYSYGIMLME 954
           GT  +MAPE        +     + D++S GI  +E
Sbjct: 183 GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIE 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 54.4 bits (131), Expect = 1e-07
 Identities = 42/147 (28%), Positives = 75/147 (51%), Gaps = 7/147 (4%)

Query: 769 LGMGSFGSVYKGVLPDGMEIAA-KVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISS 825
           +G G++G+V+K    +  EI A K   ++ D  G   S   E  ++  ++H+N+V++   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
             ++    LV EY  +  L+K   S N  +D       M  +   L + H   S  ++H 
Sbjct: 68  LHSDKKLTLVFEY-CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHR 123

Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILG 912
           D+KP N+L+N++    L+DFG+A+  G
Sbjct: 124 DLKPQNLLINKNGELKLADFGLARAFG 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 37/206 (17%)

Query: 769 LGMGSFGSVYKGVLPDGMEI-AAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           +G G+FG VY+    D   I A KV       S +   A+ +V  +I  RN++ + +   
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERNIL-VRTLLD 53

Query: 828 NNDFKA-------------LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMI-DVASALEY 873
            + F               LV +YMS G L   L  +  F +   R K  I ++  ALE+
Sbjct: 54  ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE--DRAKFYIAELVLALEH 111

Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKI-LGKEESMRQTKTL-GTIGYM 929
           LH      IV+ D+KP N+LL+ +  GH  L DFG++K  L   ++   T T  GT  Y+
Sbjct: 112 LH---KYDIVYRDLKPENILLDAT--GHIALCDFGLSKANLTDNKT---TNTFCGTTEYL 163

Query: 930 APEYGREGK-VSRKCDVYSYGIMLME 954
           APE   + K  ++  D +S G+++ E
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFE 189

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 54.2 bits (131), Expect = 1e-07
 Identities = 59/235 (25%), Positives = 94/235 (40%), Gaps = 54/235 (22%)

Query: 769 LGMGSFGSVYKGV-LPDGMEIAAK--VFHMEFDGSLESFHA----ECKVMGSIRHRNLVK 821
           LG G+FG VYK   +  G  +A K  + H E DG    F      E K++  ++H N+V 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG----FPITALREIKILKKLKHPNVVP 71

Query: 822 II------SSCSNNDFKA--LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
           +I         S     +  +V  YM +  L   L + +  L   Q    M+ +   + Y
Sbjct: 72  LIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINY 130

Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIG------ 927
           LH      I+H DIK +N+L++   +  ++DFG+A+    +      K  G  G      
Sbjct: 131 LH---ENHILHRDIKAANILIDNQGILKIADFGLARPY--DGPPPNPKGGGGGGTRKYTN 185

Query: 928 ------YMAPE-------YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGE 969
                 Y  PE       Y          D++  G +  E FT++     I  G+
Sbjct: 186 LVVTRWYRPPELLLGERRYTTA------VDIWGIGCVFAEMFTRRP----ILQGK 230

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 54.4 bits (131), Expect = 1e-07
 Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 35/227 (15%)

Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKII---- 823
           LG GS G V+  V  D    +A K   +    S++    E K++  + H N+VK+     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 824 --SSCSNNDFKAL--------VLEYMSNG---SLEKCLYSDNYFLDILQRLKIMIDVASA 870
              S    D  +L        V EYM       LE+   S+ +      RL  M  +   
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHA-----RL-FMYQLLRG 126

Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQ--TKTLGTIG 927
           L+Y+H   S  ++H D+KP+NV +N E +V  + DFG+A+I+    S +   ++ L T  
Sbjct: 127 LKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183

Query: 928 YMAPEYG-REGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
           Y +P         ++  D+++ G +  E  T K     +FAG   L+
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP----LFAGAHELE 226

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 48/211 (22%), Positives = 91/211 (43%), Gaps = 33/211 (15%)

Query: 767 KLLGMGSFGS--VYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
           +++G GSFG   + + V  D      ++   +   ++E    E  ++  ++H N+V    
Sbjct: 6   RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65

Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI--------------MIDVASA 870
           S   +    +V+EY   G             D++Q++K+               + +   
Sbjct: 66  SFEADGHLYIVMEYCDGG-------------DLMQKIKLQRGKLFPEDTILQWFVQMCLG 112

Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMA 930
           ++++H      ++H DIK  N+ L ++    L DFG A++L    +   T  +GT  Y+ 
Sbjct: 113 VQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT-YVGTPYYVP 168

Query: 931 PEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           PE       + K D++S G +L E  T K P
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 54.2 bits (130), Expect = 2e-07
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 20/217 (9%)

Query: 750 RISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDG--MEIAAKVFH---MEFDGSLESF 804
           ++ Y+D       F+  + LG GSFG V      +     +A K F    +     ++  
Sbjct: 26  KMKYED-------FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHV 78

Query: 805 HAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIM 864
            +E K++  I H   V +  S  +  +  LVLE++  G     L  +  F + +      
Sbjct: 79  FSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF-YA 137

Query: 865 IDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLG 924
             +    EYL    S  IV+ D+KP N+LL++     ++DFG AK++      R     G
Sbjct: 138 AQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV----DTRTYTLCG 190

Query: 925 TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           T  Y+APE        +  D ++ GI + E      P
Sbjct: 191 TPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 53.9 bits (129), Expect = 2e-07
 Identities = 38/129 (29%), Positives = 63/129 (48%), Gaps = 8/129 (6%)

Query: 834 LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVL 893
            +L+ M+ G L   L     F +   R     ++   LE++H  +   +V+ D+KP+N+L
Sbjct: 74  FILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMHNRF---VVYRDLKPANIL 129

Query: 894 LNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKV-SRKCDVYSYGIML 952
           L+E     +SD G+A    K+   +   ++GT GYMAPE  ++G       D +S G ML
Sbjct: 130 LDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCML 186

Query: 953 METFTKKKP 961
            +      P
Sbjct: 187 FKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 53.9 bits (129), Expect = 2e-07
 Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 24/216 (11%)

Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLE--------SFHAECKVMG 812
           D F   K++G G+FG V   V+   M+   +++ M+     E         F  E  V+ 
Sbjct: 1   DDFEIIKVIGRGAFGEV--AVVK--MKHTERIYAMKILNKWEMLKRAETACFREERNVLV 56

Query: 813 SIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALE 872
           +   + +  +  +  + ++  LV++Y   G L   L   + F D L        +A  + 
Sbjct: 57  NGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYIAEMVL 113

Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMA 930
            +H  +    VH DIKP NVLL+  M GH  L+DFG    + ++ +++ +  +GT  Y++
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLD--MNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYIS 171

Query: 931 PEYGRE-----GKVSRKCDVYSYGIMLMETFTKKKP 961
           PE  +      GK   +CD +S G+ + E    + P
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 48.1 bits (115), Expect = 2e-07
 Identities = 19/36 (52%), Positives = 24/36 (66%), Gaps = 2/36 (5%)

Query: 34 ALLALKEHIKHDPSNLLANNWSTTSSV-CSWIGVTC 68
          ALLA K  +  DPS  L++ W+ +SS  CSW GVTC
Sbjct: 7  ALLAFKSSLNGDPSGALSS-WNPSSSDPCSWTGVTC 41

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 54.2 bits (130), Expect = 2e-07
 Identities = 42/152 (27%), Positives = 67/152 (44%), Gaps = 7/152 (4%)

Query: 807 ECKVMGSIRHRNLVKIISSCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMI 865
           E  ++ +I H +++++  + + N F  L+L  Y ++     C  +    + I   L I  
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD---LYCYLAAKRNIAICDILAIER 189

Query: 866 DVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT 925
            V  A++YLH      I+H DIK  N+ +N      L DFG A       + +     GT
Sbjct: 190 SVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGT 246

Query: 926 IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           I   APE           D++S GI+L E  T
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278

Length = 391

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 54.3 bits (130), Expect = 2e-07
 Identities = 41/121 (33%), Positives = 60/121 (49%), Gaps = 6/121 (4%)

Query: 840 SNGSLEKCLYSDNYF--LDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES 897
           SN S  K L SD+    L  L  L     VA  +E+L    S   VH D+   NVLL + 
Sbjct: 217 SNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQG 273

Query: 898 MVGHLSDFGIAK-ILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETF 956
            +  + DFG+A+ I+     + +  T   + +MAPE   +   +   DV+SYGI+L E F
Sbjct: 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIF 333

Query: 957 T 957
           +
Sbjct: 334 S 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 20/178 (11%)

Query: 863  IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT 922
            +M  +   L++LH   S  +VH D+KP N+L+  S    L+DFG+A+I   +  M  T  
Sbjct: 115  MMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSV 169

Query: 923  LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLS 982
            + T+ Y APE   +   +   D++S G +  E F ++KP   +F G   + + +G  L  
Sbjct: 170  VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP---LFRGSSDVDQ-LGKILDV 224

Query: 983  CSITEVAD-ANLLNCEENDFSAR-----EQCVSSI----FSLAMDCTVDLPEKRISMK 1030
              +    D    +      F ++     E+ V+ I      L + C    P KRIS  
Sbjct: 225  IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 25/212 (11%)

Query: 768 LLGMGSFGSVYKGVLPDGMEIAA-KVFH--MEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
           ++G G++G V K    +  EI A K F    E +   E+   E K++ +++  N+V++  
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL-------KIMIDVASALEYLHFG 877
           +        LV EY+    LE           +L+ +       K+   +   ++ +H+ 
Sbjct: 68  AFRRRGKLYLVFEYVEKNMLE-----------LLEEMPNGVPPEKVRSYIYQLIKAIHWC 116

Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG 937
           +   IVH DIKP N+L++ + V  L DFG A+ L +  +   T+ + T  Y +PE     
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176

Query: 938 KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGE 969
              +  D++S G +L E  +  +P   +F GE
Sbjct: 177 PYGKAVDMWSVGCILGE-LSDGQP---LFPGE 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 54.1 bits (130), Expect = 3e-07
 Identities = 32/112 (28%), Positives = 50/112 (44%), Gaps = 4/112 (3%)

Query: 63  WIGVTCGVRNRR----VTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELS 118
           W G  C   + +    +  L +   GL G IP  +  L  L  + +  NS  G++P  L 
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463

Query: 119 HLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSL 170
            +  L+  D  +N+F+  IP     L  L+ L L  NS  G++P  +G   L
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLL 515

Length = 623

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 53.5 bits (128), Expect = 3e-07
 Identities = 60/227 (26%), Positives = 96/227 (42%), Gaps = 29/227 (12%)

Query: 760 TDGFSENKLLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMGSIR 815
              F    +LG GSFG V         E+ A K+   +    D  +E    E +V+    
Sbjct: 1   DFNFL--MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58

Query: 816 HRNLVKIISSCSNN-DFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
               +  + SC    D    V+EY++ G L   +     F +  Q +    +++  L +L
Sbjct: 59  KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP-QAVFYAAEISVGLFFL 117

Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHL--SDFGIAKILGKEESMRQ---TKTL-GTIGY 928
           H      I++ D+K  NV+L+    GH+  +DFG+ K     E M     T+T  GT  Y
Sbjct: 118 H---RRGIIYRDLKLDNVMLDSE--GHIKIADFGMCK-----EHMVDGVTTRTFCGTPDY 167

Query: 929 MAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP-----TDEIFAGEM 970
           +APE        +  D ++YG++L E    + P      DE+F   M
Sbjct: 168 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 53.5 bits (129), Expect = 3e-07
 Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 51/220 (23%)

Query: 767 KLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVK-- 821
           K +G G++G V      +   ++A K     FD  +++     E K++  + H N++   
Sbjct: 11  KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70

Query: 822 -IISSCSNNDFKA--LVLEYM---------SNGSL--EKCLYSDNYFLDILQRLKIMIDV 867
            I+       F    +V E M         S+ +L  + C     YFL  L R       
Sbjct: 71  DIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHC----QYFLYQLLR------- 119

Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI-LGKEESMRQTKTLGTI 926
              L+Y+H   S  ++H D+KPSN+LLN +    + DFG+A+    K + M  T+ + T 
Sbjct: 120 --GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM--TEYVVTR 172

Query: 927 GYMAPE-------YGREGKVSRKCDVYSYGIMLMETFTKK 959
            Y APE       Y          DV+S G +  E   +K
Sbjct: 173 WYRAPELLLNCSEYT------TAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 54.1 bits (130), Expect = 3e-07
 Identities = 31/79 (39%), Positives = 49/79 (62%), Gaps = 8/79 (10%)

Query: 834 LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVL 893
           LV+EY+  G ++  L+   YF D    +K + +VA AL+YLH      I+H D+KP N+L
Sbjct: 81  LVMEYLIGGDVKSLLHIYGYF-DEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNML 136

Query: 894 LNESMVGH--LSDFGIAKI 910
           ++    GH  L+DFG++K+
Sbjct: 137 ISNE--GHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 53.5 bits (128), Expect = 4e-07
 Identities = 38/160 (23%), Positives = 67/160 (41%), Gaps = 16/160 (10%)

Query: 807 ECKVMGSIRHRNLVKIISSCSNNDFKALVLE--------YMSNGSLEKCLYSDNYFLDIL 858
           E   +G + H N++KI     +     ++ +        +M + + +   + D   L   
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD---WKDRPLLK-- 267

Query: 859 QRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR 918
           Q   IM  +  A+EY+H      ++H DIK  N+ LN      L DFG A    KE    
Sbjct: 268 QTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF 324

Query: 919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTK 958
               +GT+   +PE           D++S G++L++  + 
Sbjct: 325 DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSH 364

Length = 501

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 53.1 bits (128), Expect = 4e-07
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 48/215 (22%)

Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA-----ECKVMGSIRHRNLVKI 822
           +G G++G V        G ++A K     F  S    HA     E +++  + H N++ +
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAI--HAKRTYRELRLLKHMDHENVIGL 79

Query: 823 IS----SCSNNDFKA--LVLEYMS---NGSLEKCLYSDNY--FLDILQRLKIMIDVASAL 871
           +     + S  DF+   LV   M    N  ++    SD++  FL + Q L+        L
Sbjct: 80  LDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFL-VYQILR-------GL 131

Query: 872 EYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAP 931
           +Y+H   S  I+H D+KPSN+ +NE     + DFG+A+    E  M  T  + T  Y AP
Sbjct: 132 KYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--M--TGYVATRWYRAP 184

Query: 932 E-------YGREGKVSRKCDVYSYGIMLMETFTKK 959
           E       Y      ++  D++S G ++ E  T K
Sbjct: 185 EIMLNWMHY------NQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 52.8 bits (127), Expect = 4e-07
 Identities = 61/220 (27%), Positives = 91/220 (41%), Gaps = 38/220 (17%)

Query: 769 LGMGSFGSV----YKGVLPDGMEIAAKVFHMEF---DGSLESFHAECKVM---GSIRHRN 818
           LG G FG V    YK     G   A K            +ES   E ++     S RH  
Sbjct: 7   LGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMI-DVASALEYLHFG 877
           LV + +     D    V+EY + G L   +++D +      R       V   L+YLH  
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF---SEPRAVFYAACVVLGLQYLH-- 118

Query: 878 YSTPIVHCDIKPSNVLLNESMVGHL--SDFGIAKILGKEESM---RQTKTL-GTIGYMAP 931
               IV+ D+K  N+LL+    G +  +DFG+ K     E M    +T T  GT  ++AP
Sbjct: 119 -ENKIVYRDLKLDNLLLDTE--GFVKIADFGLCK-----EGMGFGDRTSTFCGTPEFLAP 170

Query: 932 EYGREGKVSRKCDVYSYGIMLMETFTKKKP-----TDEIF 966
           E   E   +R  D +  G+++ E    + P      +E+F
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 52.6 bits (126), Expect = 4e-07
 Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 27/216 (12%)

Query: 767 KLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIR-HRNLVK 821
           ++LG GSFG V    L   G   A KV   +    D  +E    E +++   R H  L +
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           +       D    V+E+++ G L   +     F +   R     ++ SAL +LH      
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLH---DKG 116

Query: 882 IVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTL----GTIGYMAPEYGR 935
           I++ D+K  NVLL+    GH  L+DFG+ K     E +   KT     GT  Y+APE  +
Sbjct: 117 IIYRDLKLDNVLLDHE--GHCKLADFGMCK-----EGIFNGKTTSTFCGTPDYIAPEILQ 169

Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP-----TDEIF 966
           E       D ++ G++L E      P      D++F
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 52.0 bits (124), Expect = 6e-07
 Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 23/215 (10%)

Query: 763 FSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLV 820
           F   +L+G G++G VYKG  +  G   A KV  +  D   E    E  ++     HRN+ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66

Query: 821 KIISSC------SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQR---LKIMIDVASAL 871
               +         +D   LV+E+   GS+   +   N   + L+      I  ++   L
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGL 124

Query: 872 EYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAP 931
            +LH      ++H DIK  NVLL E+    L DFG++  L +    R T  +GT  +MAP
Sbjct: 125 SHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAP 180

Query: 932 EY-----GREGKVSRKCDVYSYGIMLMETFTKKKP 961
           E        +     K D++S GI  +E      P
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 52.2 bits (125), Expect = 7e-07
 Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 43/214 (20%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVKII 823
           K +G G++GSV   +    G ++A K     F   + +  A  E  ++  ++H N++ ++
Sbjct: 21  KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80

Query: 824 ----SSCSNNDFKA--LVLEYMSNGSLEKCL---YSDN--YFLDILQRLKIMIDVASALE 872
               S+ S ++F+   LV+ YM    L+K +    S++   +L + Q L         L+
Sbjct: 81  DVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQYL-VYQMLC-------GLK 131

Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE 932
           Y+H   S  I+H D+KP N+ +NE     + DFG+A+    E     T  + T  Y APE
Sbjct: 132 YIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPE 184

Query: 933 -------YGREGKVSRKCDVYSYGIMLMETFTKK 959
                  Y      ++  D++S G ++ E  T K
Sbjct: 185 VILNWMHY------NQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 52.3 bits (125), Expect = 8e-07
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 34/216 (15%)

Query: 761 DGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHR 817
           D + + K +G G++G+V   +    G ++A K  +  F   L +  A  E +++  ++H 
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74

Query: 818 N---LVKIISSCSN----NDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASA 870
           N   L+ + +   +    +DF  LV+ +M    L K +  +    D +Q L  +  +   
Sbjct: 75  NVIGLLDVFTPDLSLDRFHDF-YLVMPFMGT-DLGKLMKHEKLSEDRIQFL--VYQMLKG 130

Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMA 930
           L+Y+H   +  I+H D+KP N+ +NE     + DFG+A         RQT +  T GY+ 
Sbjct: 131 LKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA---------RQTDSEMT-GYVV 177

Query: 931 PEYGREGKV-------SRKCDVYSYGIMLMETFTKK 959
             + R  +V       ++  D++S G ++ E  T K
Sbjct: 178 TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 52.1 bits (125), Expect = 8e-07
 Identities = 60/230 (26%), Positives = 101/230 (43%), Gaps = 39/230 (16%)

Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMG-SIRHR 817
           F+   +LG GSFG V         E+ A K+   +    D  +E    E +V+    +  
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61

Query: 818 NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK------IMIDVASAL 871
            L ++ S     D    V+EY++ G L        Y +  + + K         ++A  L
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLM-------YHIQQVGKFKEPHAVFYAAEIAIGL 114

Query: 872 EYLHFGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESM---RQTKTL-GT 925
            +LH   S  I++ D+K  NV+L+    GH  ++DFG+ K     E++   + T+T  GT
Sbjct: 115 FFLH---SKGIIYRDLKLDNVMLDAE--GHIKIADFGMCK-----ENIFGGKTTRTFCGT 164

Query: 926 IGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP-----TDEIFAGEM 970
             Y+APE        +  D +++G++L E    + P      DE+F   M
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 52.1 bits (125), Expect = 8e-07
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 24/205 (11%)

Query: 769 LGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDG--SLESFHAECKVMGSIRHRN---LVKI 822
           +G G+FG V+    P DG  +A K     F    S +    E K++   +H N    + I
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67

Query: 823 ISSCSNNDFKAL-VLEYMSNGSLEKC------LYSDNYFLDILQRLKIMIDVASALEYLH 875
           +     + F+ + V+  +    L K       L SD+  + + Q L+        L+YLH
Sbjct: 68  LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILR-------GLKYLH 120

Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
              S  I+H DIKP N+L+N + V  + DFG+A++   +ES   T+ + T  Y APE   
Sbjct: 121 ---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILM 177

Query: 936 EGK-VSRKCDVYSYGIMLMETFTKK 959
             +  +   D++S G +  E   ++
Sbjct: 178 GSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 51.5 bits (123), Expect = 9e-07
 Identities = 38/130 (29%), Positives = 64/130 (49%), Gaps = 8/130 (6%)

Query: 833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNV 892
           + +L+ M+ G L   L     F +   R     ++   LE++H  +   +V+ D+KP+N+
Sbjct: 73  SFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIILGLEHMHNRF---VVYRDLKPANI 128

Query: 893 LLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIM 951
           LL+E     +SD G+A    K+   +   ++GT GYMAPE  ++G       D +S G M
Sbjct: 129 LLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCM 185

Query: 952 LMETFTKKKP 961
           L +      P
Sbjct: 186 LFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 52.1 bits (125), Expect = 1e-06
 Identities = 26/77 (33%), Positives = 47/77 (61%), Gaps = 1/77 (1%)

Query: 391 SSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTV 450
           + ++  R+L+ I LS N I G +P S+G+ + S++ L +   + +G IP+ LG + +L +
Sbjct: 436 NDISKLRHLQSINLSGNSIRGNIPPSLGSIT-SLEVLDLSYNSFNGSIPESLGQLTSLRI 494

Query: 451 IRLGNNELTGTIPVTLG 467
           + L  N L+G +P  LG
Sbjct: 495 LNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 51.2 bits (123), Expect = 1e-06
 Identities = 47/167 (28%), Positives = 73/167 (43%), Gaps = 8/167 (4%)

Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVKIISS 825
           +G GS+G V+K    + G  +A K F    D  +    A  E +++  ++H NLV +I  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
                   LV EY  +  L + L  +   +      KI+     A+ + H       +H 
Sbjct: 69  FRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHR 124

Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE 932
           D+KP N+L+ +     L DFG A+IL        T  + T  Y APE
Sbjct: 125 DVKPENILITKQGQIKLCDFGFARILTGPGDD-YTDYVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 51.4 bits (123), Expect = 1e-06
 Identities = 29/92 (31%), Positives = 54/92 (58%), Gaps = 4/92 (4%)

Query: 867 VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGT 925
           VA  +E+L    S   +H D+   N+LL+E+ V  + DFG+A+ + K+ + +R+      
Sbjct: 182 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 926 IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           + +MAPE   +   + + DV+S+G++L E F+
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 20/152 (13%)

Query: 767 KLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVKII 823
           + LG GS+ +VYKG+   +G  +A KV  M+ +  +  F A  E  ++  ++H N+V + 
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLH 69

Query: 824 SSCSNNDFKALVLEYMSNGSLEKC------LYSDNYFLDILQRLKIMIDVASALEYLHFG 877
                 +    V EYM     +        L+  N  L + Q L+        L Y+H  
Sbjct: 70  DIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR-------GLAYIHGQ 122

Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK 909
           +   I+H D+KP N+L++      L+DFG+A+
Sbjct: 123 H---ILHRDLKPQNLLISYLGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 63/223 (28%), Positives = 96/223 (43%), Gaps = 33/223 (14%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKI 822
            +LG GSFG V         E+ A K+   +    D  +E    E +V+        +  
Sbjct: 6   MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQ 65

Query: 823 ISSC-SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY---LHFGY 878
           + SC    D    V+EY++ G L        Y +  + R K    V  A E    L F +
Sbjct: 66  LHSCFQTMDRLYFVMEYVNGGDLM-------YQIQQVGRFKEPHAVFYAAEIAIGLFFLH 118

Query: 879 STPIVHCDIKPSNVLLNESMVGHL--SDFGIAKILGKEESMRQ---TKTL-GTIGYMAPE 932
           S  I++ D+K  NV+L+    GH+  +DFG+ K     E+M     TKT  GT  Y+APE
Sbjct: 119 SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCK-----ENMWDGVTTKTFCGTPDYIAPE 171

Query: 933 YGREGKVSRKCDVYSYGIMLMETFTKKKP-----TDEIFAGEM 970
                   +  D +++G++L E    + P      DE+F   M
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 50.6 bits (121), Expect = 2e-06
 Identities = 37/101 (36%), Positives = 52/101 (51%), Gaps = 21/101 (20%)

Query: 870 ALEYLHFGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKI-------------LGKE 914
           ALEYLH   +  IVH D+KP N+L+  SM GH  L+DFG++KI             + K+
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLIT-SM-GHIKLTDFGLSKIGLMSLTTNLYEGHIEKD 167

Query: 915 ESMRQTKTL-GTIGYMAPEYGREGKVSRKCDVYSYGIMLME 954
                 K + GT  Y+APE        +  D ++ GI+L E
Sbjct: 168 TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYE 208

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 50.8 bits (122), Expect = 2e-06
 Identities = 34/140 (24%), Positives = 59/140 (42%), Gaps = 13/140 (9%)

Query: 772 GSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESF---HAECKVMGSIRHRNLVKIISSCSN 828
                + K   P    +A K  +++   S E       E      ++H N++  ++S   
Sbjct: 13  LMIVHLAKHK-PTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIV 70

Query: 829 NDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI---MIDVASALEYLHFGYSTPIVHC 885
           +    +V   M+ GS E  L    +F + L  L I   + DV +AL+Y+H   S   +H 
Sbjct: 71  DSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHR 125

Query: 886 DIKPSNVLLNESMVGHLSDF 905
            +K S++LL+      LS  
Sbjct: 126 SVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.0 bits (122), Expect = 2e-06
 Identities = 35/119 (29%), Positives = 62/119 (52%), Gaps = 4/119 (3%)

Query: 840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMV 899
           S+ S ++    D++ LD+   L+    VA  +++L    S   +H D+   NVLL +  V
Sbjct: 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRV 250

Query: 900 GHLSDFGIAK-ILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
             + DFG+A+ I+     + +      + +MAPE   +   + + DV+SYGI+L E F+
Sbjct: 251 AKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 50.7 bits (122), Expect = 2e-06
 Identities = 43/125 (34%), Positives = 67/125 (53%), Gaps = 16/125 (12%)

Query: 816 HRNLVK---IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALE 872
           H N+VK   +I + ++ D   LV EYM    L   + ++   L+ + +  IM  +  AL+
Sbjct: 66  HPNIVKLLNVIKAENDKDI-YLVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALK 121

Query: 873 YLHFGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKTL----GTIG 927
           Y+H   S  ++H D+KPSN+LLN +  V  L+DFG+A+ L + E   +   L     T  
Sbjct: 122 YIH---SGNVIHRDLKPSNILLNSDCRV-KLADFGLARSLSELEENPENPVLTDYVATRW 177

Query: 928 YMAPE 932
           Y APE
Sbjct: 178 YRAPE 182

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 50.1 bits (120), Expect = 2e-06
 Identities = 59/233 (25%), Positives = 103/233 (44%), Gaps = 33/233 (14%)

Query: 761 DGFSENKLLGMGSFGSVYKGVLPD---GMEIAAKVFHMEFDGSLESFH---AECKVMGSI 814
           D  + + LL  G+FG ++ G+L D   G E    V  ++   S         E  ++  +
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65

Query: 815 RHRNLVKIISSCSNNDFKALVLE-YMSNGSL----EKCLYSDNYF---LDILQRLKIMID 866
            H+N++ I+  C  +     VL  YM+ G+L    ++C   +      L   Q + + I 
Sbjct: 66  SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125

Query: 867 VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK--------ILGKEESMR 918
           +A  + YLH      ++H DI   N +++E +   ++D  +++         LG  E+ R
Sbjct: 126 IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN-R 181

Query: 919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEM 970
             K      +MA E     + S   DV+S+G++L E  T  + P  EI   EM
Sbjct: 182 PVK------WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM 228

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 45.6 bits (109), Expect = 2e-06
 Identities = 21/60 (35%), Positives = 24/60 (40%)

Query: 447 NLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKL 506
           NL  + L NN LT         L  L+ L L  N L    PE    L  L +L L  N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 50.6 bits (121), Expect = 3e-06
 Identities = 48/188 (25%), Positives = 76/188 (40%), Gaps = 52/188 (27%)

Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH-FG 877
           +VK+  S  + D    V++Y+  G +   L     F + L R  I  ++  A+E +H  G
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVHKMG 121

Query: 878 YSTPIVHCDIKPSNVLLNESMVGH--LSDFGI---------AKILGKEESMRQ------- 919
           +    +H DIKP N+L++    GH  L+DFG+         +K   K +  RQ       
Sbjct: 122 F----IHRDIKPDNILIDRD--GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175

Query: 920 ---------TKTL-----------------GTIGYMAPEYGREGKVSRKCDVYSYGIMLM 953
                     K L                 GT  Y+APE       ++ CD +S G++L 
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235

Query: 954 ETFTKKKP 961
           E    + P
Sbjct: 236 EMLVGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 44.8 bits (107), Expect = 4e-06
 Identities = 23/60 (38%), Positives = 33/60 (55%)

Query: 591 GLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQL 650
            L+ L L  NRL      +F GL +L  +D+S NNL+   P++   L  L+ L+LS N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 50.0 bits (119), Expect = 4e-06
 Identities = 29/92 (31%), Positives = 54/92 (58%), Gaps = 4/92 (4%)

Query: 867 VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGT 925
           VA  +E+L    S   +H D+   N+LL+E+ V  + DFG+A+ + K+ + +R+      
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 926 IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           + +MAPE   +   + + DV+S+G++L E F+
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 49.4 bits (118), Expect = 4e-06
 Identities = 48/195 (24%), Positives = 86/195 (44%), Gaps = 17/195 (8%)

Query: 776 SVYKGVLPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRHRNLVKI----ISSCSN 828
           S+YKG+  +  E+  + F   H      ++    E K +  I   N++KI    I    +
Sbjct: 35  SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 829 NDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIK 888
               +L+LEY + G L + L  +   L    +L + ID    L  L+   + P  + ++ 
Sbjct: 94  LPRLSLILEYCTRGYLREVLDKEKD-LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150

Query: 889 PSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE--GKVSRKCDVY 946
             + L+ E+    +   G+ KIL    S    K +  + Y + +   +   + + K D+Y
Sbjct: 151 SVSFLVTENYKLKIICHGLEKIL----SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIY 206

Query: 947 SYGIMLMETFTKKKP 961
           S G++L E FT K P
Sbjct: 207 SLGVVLWEIFTGKIP 221

Length = 283

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 49.5 bits (118), Expect = 4e-06
 Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 13/199 (6%)

Query: 769 LGMGSFGSVYKGVLPDGMEIAA----KVFHMEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
           +G GSFG V +    D   I A    +  H+     +    AE  V+  +    +V +  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
           S  + +   LVL +++ G L   L  +  F     R     ++  ALE LH      +++
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA-ELLCALENLH---KFNVIY 116

Query: 885 CDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRK 942
            D+KP N+LL+    GH  L DFG+ K L  ++  +     GT  Y+APE       ++ 
Sbjct: 117 RDLKPENILLDYQ--GHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173

Query: 943 CDVYSYGIMLMETFTKKKP 961
            D ++ G++L E  T   P
Sbjct: 174 VDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.1 bits (120), Expect = 4e-06
 Identities = 63/244 (25%), Positives = 98/244 (40%), Gaps = 63/244 (25%)

Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGMEI-AAKVF---HMEFDGSLESFHAECKVMGSIRH 816
           D F   K++G G+FG V      D   I A K      M     +    AE  ++    +
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60

Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH- 875
             +VK+  S  + ++  L++EY+  G +   L   + F +   R  I  +   A++ +H 
Sbjct: 61  PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETILAIDSIHK 119

Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGK-------------------- 913
            GY    +H DIKP N+LL+    GH  LSDFG+   L K                    
Sbjct: 120 LGY----IHRDIKPDNLLLDAK--GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD 173

Query: 914 -----EESMRQTK------------TLGTIGYMAPE------YGREGKVSRKCDVYSYGI 950
                  S R+ +            T+GT  Y+APE      Y +E      CD +S G+
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE------CDWWSLGV 227

Query: 951 MLME 954
           ++ E
Sbjct: 228 IMYE 231

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 48.7 bits (116), Expect = 6e-06
 Identities = 52/208 (25%), Positives = 86/208 (41%), Gaps = 25/208 (12%)

Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLE-----SFHAECKVMGSIRHRNLVKII 823
           +G G FG V  G    GM  A +V   E   S        F  E +    + H N+++ +
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKA-RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 824 SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFL------DILQRLKIMIDVASALEYLHFG 877
             C  +    LVLE+   G L+  L S+   +      D+LQR+    +VAS L +LH  
Sbjct: 62  GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMA--CEVASGLLWLH-- 117

Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-IGYMAPEYGRE 936
                +H D+   N  L   +   + D+G+A     E+           + ++APE    
Sbjct: 118 -QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176

Query: 937 -------GKVSRKCDVYSYGIMLMETFT 957
                     ++K +++S G+ + E FT
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 49.2 bits (117), Expect = 7e-06
 Identities = 33/111 (29%), Positives = 56/111 (50%), Gaps = 4/111 (3%)

Query: 848 LYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGI 907
           L +++  L  +  +     VA+ +E+L    S   VH D+   NVL+ E  +  + DFG+
Sbjct: 229 LINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGKLVKICDFGL 285

Query: 908 AK-ILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           A+ I+     + +  T   + +MAPE       +   DV+S+GI+L E FT
Sbjct: 286 ARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 48.7 bits (116), Expect = 7e-06
 Identities = 52/198 (26%), Positives = 92/198 (46%), Gaps = 13/198 (6%)

Query: 769 LGMGSFGSVYKGVLPDGMEIAA--KV-FHMEFDGSLESFHAECKVMGSIRHRNLVKIISS 825
           +G G++G VYK       E  A  K+    E +G   +   E  ++  ++H N+V++   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI-MIDVASALEYLHFGYSTPIVH 884
             +     LV EY+ +  L+K + S   F    + +K  +  +   + Y H   S  ++H
Sbjct: 70  VHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLH 125

Query: 885 CDIKPSNVLLNESMVG-HLSDFGIAKILGKEESMRQ-TKTLGTIGYMAPEYGREGK-VSR 941
            D+KP N+L++       L+DFG+A+  G    +R  T  + T+ Y APE     +  S 
Sbjct: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGI--PVRTFTHEVVTLWYRAPEILLGSRHYST 183

Query: 942 KCDVYSYGIMLMETFTKK 959
             D++S G +  E   +K
Sbjct: 184 PVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 49.2 bits (117), Expect = 8e-06
 Identities = 62/252 (24%), Positives = 101/252 (40%), Gaps = 60/252 (23%)

Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFD----GSLESFHAECKVMGSIRHRN 818
           F + K LG+G+FG V      D   + A     + D      +    AE  ++    +  
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH-FG 877
           +VK+  S  + D    V++Y+  G +   L     F ++L R  I  ++  A+E +H  G
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVHKMG 121

Query: 878 YSTPIVHCDIKPSNVLLNESMVGH--LSDFGI---------AKILGKEESMRQT------ 920
           +    +H DIKP N+L++  + GH  L+DFG+         +K   K   +RQ       
Sbjct: 122 F----IHRDIKPDNILID--LDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSD 175

Query: 921 --------------KTL-----------------GTIGYMAPEYGREGKVSRKCDVYSYG 949
                         KTL                 GT  Y+APE       ++ CD +S G
Sbjct: 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235

Query: 950 IMLMETFTKKKP 961
           ++L E    + P
Sbjct: 236 VILFEMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 48.4 bits (115), Expect = 9e-06
 Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 21/207 (10%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLE-----SFHAECKVMGSIRHRNLVK 821
           K +G G FG V  G +  G    A+V   E   S        F  E +   S++H NL++
Sbjct: 1   KEIGNGWFGKVILGEVNSGYT-PAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQ 59

Query: 822 IISSCSNNDFKALVLEYMS----NGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
            +  C+      LV+E+       G L  C  ++    D     ++  ++A  L +LH  
Sbjct: 60  CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH-- 117

Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-IGYMAPEYGRE 936
                +H D+   N LL   +   + D+G++    KE+       L   + ++APE   E
Sbjct: 118 -KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176

Query: 937 --GKV-----SRKCDVYSYGIMLMETF 956
             G +     +++ +V+S G+ + E F
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|215633 PLN03210, PLN03210, Resistant to P

 Score = 49.5 bits (118), Expect = 9e-06
 Identities = 85/330 (25%), Positives = 131/330 (39%), Gaps = 56/330 (16%)

Query: 120 LRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDN 179
           L GL+  D R +    EIP   ++   L+ L L   S + ++P +I YL+ L++LD+S  
Sbjct: 633 LTGLRNIDLRGSKNLKEIPDLSMA-TNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRC 691

Query: 180 QLSGTIPSSI-------FNISSCQNLPVLEGLF--ISYNQLTGP----IPTNLWKCRELH 226
           +    +P+ I        N+S C  L     +   IS+  L        P+NL +   L 
Sbjct: 692 ENLEILPTGINLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIEEFPSNL-RLENLD 750

Query: 227 VVSLAFNKFQGGIPRDIGNLT--------SVRNLFLGNNSLIGEIPNEIGNLRNLEVLGV 278
            + L   K +    R +  LT        S+  LFL +   + E+P+ I NL  LE L  
Sbjct: 751 ELILCEMKSEKLWER-VQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLE- 808

Query: 279 QSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPS 338
                       I N   L+ L    N     L S   L L    RL         T P 
Sbjct: 809 ------------IENCINLETLPTGIN-----LESLESLDLSGCSRL--------RTFPD 843

Query: 339 SLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAG-NVLTSPTPDLSFLSSLTSCR 397
             TNIS+L++   G       +P       +L  L + G N L   + ++S L  L +  
Sbjct: 844 ISTNISDLNLSRTGIEE----VPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVD 899

Query: 398 NLEIIYLSENPINGILPSSIGNFSISMKSL 427
             +   L+E   NG  PS +   + ++ S 
Sbjct: 900 FSDCGALTEASWNGS-PSEVAMATDNIHSK 928

syringae 6; Provisional. Length = 1153

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 48.5 bits (116), Expect = 9e-06
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 26/214 (12%)

Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKI--I 823
           +G G++G VYK      G  +A K   +E +  G   +   E  ++  + H N+V++  +
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 824 SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI---MIDVASALEYLHFGYST 880
               N  +  LV E++ +  L+K  Y D+  L  L    I   +  +   + Y H   S 
Sbjct: 67  VHSENKLY--LVFEFL-DLDLKK--YMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SH 118

Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ-TKTLGTIGYMAPEYGREGK- 938
            ++H D+KP N+L++      L+DFG+A+  G    +R  T  + T+ Y APE     + 
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAFGV--PVRTYTHEVVTLWYRAPEILLGSRQ 176

Query: 939 VSRKCDVYSYGIMLMETFTKK------KPTDEIF 966
            S   D++S G +  E   ++         D++F
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 29/92 (31%), Positives = 54/92 (58%), Gaps = 4/92 (4%)

Query: 867 VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGT 925
           VA  +E+L    S   +H D+   N+LL+E+ V  + DFG+A+ + K+ + +R+      
Sbjct: 188 VAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 926 IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           + +MAPE   +   + + DV+S+G++L E F+
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 48.3 bits (115), Expect = 2e-05
 Identities = 30/94 (31%), Positives = 52/94 (55%), Gaps = 7/94 (7%)

Query: 327 LGENN--FSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPT 384
           LG +N    G IP+ ++ +  L  ++   NS  G IP + G++ SL++L L+ N      
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 385 PDLSFLSSLTSCRNLEIIYLSENPINGILPSSIG 418
           P+   L  LTS   L I+ L+ N ++G +P+++G
Sbjct: 483 PES--LGQLTS---LRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.9 bits (102), Expect = 2e-05
 Identities = 20/60 (33%), Positives = 29/60 (48%)

Query: 321 NLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVL 380
           NL+ L L  N  +     +   +  L VLD   N+ + + P  F  L SL+ L L+GN L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 47.7 bits (113), Expect = 2e-05
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)

Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 825 ---SCSNNDFKA--LVLEYMSN--GSLEKC--LYSDNYFLDILQRLKIMIDVASALEYLH 875
              + S  +F    LV   M     ++ KC  L  D+    I Q L+        L+Y+H
Sbjct: 85  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR-------GLKYIH 137

Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
              S  I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE   
Sbjct: 138 ---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIML 190

Query: 936 EG-KVSRKCDVYSYGIMLMETFTKK 959
                ++  D++S G ++ E  T +
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.1 bits (100), Expect = 3e-05
 Identities = 20/60 (33%), Positives = 29/60 (48%)

Query: 495 RLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSL 554
            L +L L +N+L+         L +L+ L L  N LTSI P     L  +   +LS N+L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 46.8 bits (111), Expect = 3e-05
 Identities = 46/180 (25%), Positives = 79/180 (43%), Gaps = 27/180 (15%)

Query: 803 SFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK 862
           +F     +M  + H +L  +   C       +V E++ +G L+ CL  +   + +  ++ 
Sbjct: 62  AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKIT 121

Query: 863 IMIDVASALEYLHFGYSTPIVHCDIKPSNVLL-------NESMVGHLSDFGIA-KILGKE 914
           +   +ASAL YL       +VH ++   N+LL         S    LSD G++   L +E
Sbjct: 122 VAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE 178

Query: 915 ESMRQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
           E + +      I ++APE    G  +S   D +S+G  L+E           F GE+ LK
Sbjct: 179 ERVER------IPWIAPECVPGGNSLSTAADKWSFGTTLLEI---------CFDGEVPLK 223

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 46.9 bits (111), Expect = 3e-05
 Identities = 44/146 (30%), Positives = 76/146 (52%), Gaps = 12/146 (8%)

Query: 769 LGMGSFGSVYKG--VLPDGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISS 825
           LG G++ +V+KG   L + + +A K   +E + G+  +   E  ++ +++H N+V +   
Sbjct: 13  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNY-FLDILQRLKI-MIDVASALEYLHFGYSTPIV 883
                   LV EY+ +  L++  Y DN   L  +  +KI M  +   L Y H      I+
Sbjct: 72  IHTERCLTLVFEYLDS-DLKQ--YLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKIL 125

Query: 884 HCDIKPSNVLLNESMVGHLSDFGIAK 909
           H D+KP N+L+NE     L+DFG+A+
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.1 bits (100), Expect = 4e-05
 Identities = 24/57 (42%), Positives = 32/57 (56%)

Query: 570 EMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNL 626
            +DLS N L+ +      GL  L++L L  N L    PE+F GL SL  +D+S NNL
Sbjct: 4   SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 46.6 bits (110), Expect = 4e-05
 Identities = 52/206 (25%), Positives = 86/206 (41%), Gaps = 18/206 (8%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKI 822
           +++G GS+  V    L     I A KV   E    D  ++    E  V     +   +  
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 823 ISSCSNNDFKAL-VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           + SC   + +   V+EY++ G L   +       +   R     +++ AL YLH      
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERG 116

Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL----GTIGYMAPEYGREG 937
           I++ D+K  NVLL+      L+D+G+ K     E +R   T     GT  Y+APE  R  
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAPEILRGE 171

Query: 938 KVSRKCDVYSYGIMLMETFTKKKPTD 963
                 D ++ G+++ E    + P D
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.8 bits (99), Expect = 5e-05
 Identities = 21/60 (35%), Positives = 25/60 (41%)

Query: 122 GLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQL 181
            LK  D   N   +     F  LP L+ L L  N+     PE    L  L+ LDLS N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 46.6 bits (110), Expect = 5e-05
 Identities = 56/241 (23%), Positives = 97/241 (40%), Gaps = 46/241 (19%)

Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-----GMEIAAKVFHMEFDGSLESFHAECKVMGSIR 815
           D F   K++G G+FG V      D      M+I  K   +E +  +    AE  ++    
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKE-QVAHIRAERDILVEAD 59

Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
              +VK+  S  +     L++E++  G +   L   +   +   +  I  +   A++ +H
Sbjct: 60  GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIH 118

Query: 876 -FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK--------------------- 913
             G+    +H DIKP N+LL+      LSDFG+   L K                     
Sbjct: 119 QLGF----IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174

Query: 914 -----------EESMRQT--KTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKK 960
                      +++ RQ    T+GT  Y+APE   +   ++ CD +S G+++ E      
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Query: 961 P 961
           P
Sbjct: 235 P 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 46.4 bits (110), Expect = 5e-05
 Identities = 39/156 (25%), Positives = 68/156 (43%), Gaps = 20/156 (12%)

Query: 807 ECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMID 866
           E  ++ ++ H +++++  +  +     +VL +  +  L   L   +  L I Q L I   
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ 165

Query: 867 VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI-------LGKEESMRQ 919
           +   L YLH   +  I+H D+K  N+ +N+     + D G A+        LG       
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG------- 215

Query: 920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMET 955
               GT+   APE     K + K D++S GI+L E 
Sbjct: 216 --LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 46.1 bits (109), Expect = 6e-05
 Identities = 39/144 (27%), Positives = 76/144 (52%), Gaps = 8/144 (5%)

Query: 769 LGMGSFGSVYKG--VLPDGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISS 825
           LG G++ +V+KG   L + + +A K   +E + G+  +   E  ++  ++H N+V +   
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
              +    LV EY+ +  L++  Y D+   +I+    + I +   L  L + +   ++H 
Sbjct: 73  VHTDKSLTLVFEYL-DKDLKQ--YMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128

Query: 886 DIKPSNVLLNESMVGHLSDFGIAK 909
           D+KP N+L+NE     L+DFG+A+
Sbjct: 129 DLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 46.2 bits (109), Expect = 6e-05
 Identities = 52/224 (23%), Positives = 101/224 (45%), Gaps = 26/224 (11%)

Query: 763 FSENKLLGMGSFG---SVYKGVLPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHR 817
           + + K +G G+ G   + +  VL  G+ +A K     F     +  A  E  ++  + H+
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 80

Query: 818 NLVKIIS----SCSNNDFKA--LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASAL 871
           N++ +++      S  +F+   LV+E M + +L + ++ +   LD  +   ++  +   +
Sbjct: 81  NIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHME---LDHERMSYLLYQMLCGI 136

Query: 872 EYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAP 931
           ++LH   S  I+H D+KPSN+++       + DFG+A+       M  T  + T  Y AP
Sbjct: 137 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM--TPYVVTRYYRAP 191

Query: 932 EYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRW 975
           E           D++S G ++ E          IF G   + +W
Sbjct: 192 EVILGMGYKENVDIWSVGCIMGELVKGSV----IFQGTDHIDQW 231

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 46.2 bits (109), Expect = 6e-05
 Identities = 54/210 (25%), Positives = 88/210 (41%), Gaps = 22/210 (10%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKI 822
           +++G GS+  V    L    +I A KV   E    D  ++    E  V         +  
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 823 ISSCSNNDFKA-LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           + SC     +  LV+EY++ G L   +       +   R     ++  AL +LH      
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLH---ERG 116

Query: 882 IVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTL----GTIGYMAPEYGR 935
           I++ D+K  NVLL+    GH  L+D+G+ K     E +    T     GT  Y+APE  R
Sbjct: 117 IIYRDLKLDNVLLDAD--GHIKLTDYGMCK-----EGLGPGDTTSTFCGTPNYIAPEILR 169

Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKPTDEI 965
             +     D ++ G+++ E    + P D I
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGRSPFDII 199

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 45.8 bits (108), Expect = 7e-05
 Identities = 41/147 (27%), Positives = 73/147 (49%), Gaps = 14/147 (9%)

Query: 769 LGMGSFGSVYKG--VLPDGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISS 825
           LG G++ +VYKG   L D + +A K   +E + G+  +   E  ++  ++H N+V +   
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 826 CSNNDFKALVLEYMSNG---SLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
                   LV EY+       L+ C  S N     +  +K+ +     L  L++ +   +
Sbjct: 73  IHTEKSLTLVFEYLDKDLKQYLDDCGNSIN-----MHNVKLFL--FQLLRGLNYCHRRKV 125

Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAK 909
           +H D+KP N+L+NE     L+DFG+A+
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 45.4 bits (108), Expect = 9e-05
 Identities = 62/295 (21%), Positives = 100/295 (33%), Gaps = 59/295 (20%)

Query: 319 LPNLERLFLGENNFSGT----IPSSLTNISELSVLDFGFN------SFSGLIPTTFGNLR 368
           L  L+ L L  N         + S+L     L  L    N           +        
Sbjct: 22  LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81

Query: 369 SLKLLSLAGNVLTSPTPDLS-FLSSLTSCRNLEIIYLSENPING----ILPSSIGNFSIS 423
            L+ L L+ N L    PD    L SL    +L+ + L+ N +      +L   + +   +
Sbjct: 82  GLQELDLSDNALG---PDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPA 138

Query: 424 MKSLSMESCNISGG----IPKELGNINNLTVIRLGNNELTG----TIPVTLGRLQKLQGL 475
           ++ L +    + G     + K L    +L  + L NN +       +   L     L+ L
Sbjct: 139 LEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVL 198

Query: 476 YLQNNKL--EGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSI 533
            L NN L  EG+    L                       L +L SL  L+LG N LT  
Sbjct: 199 DLNNNGLTDEGAS--ALAE--------------------TLASLKSLEVLNLGDNNLTDA 236

Query: 534 IPSTLWN-----LKDILRFNLSSNSLN----GSLLPDIGNLKVVIEMDLSLNALS 579
             + L +        +L  +LS N +       L   +   + ++E+DL  N   
Sbjct: 237 GAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 45.4 bits (107), Expect = 1e-04
 Identities = 58/267 (21%), Positives = 98/267 (36%), Gaps = 60/267 (22%)

Query: 763 FSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHME---FDGSLESFHAECKVMGSIRHRN 818
           F + K LG+G+FG V      D     A K    +       +    AE  ++    +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
           +V++  S  + D    V++Y+  G +   L     F + L R  I  ++  A+E +H   
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVH--- 118

Query: 879 STPIVHCDIKPSNVLLNESMVGH--LSDFGI---------AKILGKEESMRQTKT----- 922
               +H DIKP N+L++    GH  L+DFG+         +K     + +RQ        
Sbjct: 119 KMGFIHRDIKPDNILIDRD--GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176

Query: 923 --------------------------------LGTIGYMAPEYGREGKVSRKCDVYSYGI 950
                                           +GT  Y+APE       ++ CD +S G+
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236

Query: 951 MLMETFTKKKP--TDEIFAGEMSLKRW 975
           +L E    + P         +M +  W
Sbjct: 237 ILYEMLVGQPPFLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 45.1 bits (107), Expect = 1e-04
 Identities = 32/107 (29%), Positives = 53/107 (49%), Gaps = 17/107 (15%)

Query: 870 ALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK---ILGKEESMRQTKTLGTI 926
            L+Y+H   S  ++H D+KP N+L+N      + DFG+A+       E +   T+ + T 
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173

Query: 927 GYMAPE----YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGE 969
            Y APE    +      ++  DV+S G +L E    +KP   +F G+
Sbjct: 174 WYRAPEIMLSFQS---YTKAIDVWSVGCILAE-LLGRKP---VFKGK 213

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 45.2 bits (107), Expect = 1e-04
 Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 35/214 (16%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVK-- 821
           +++G GS+G V   +    G ++A K  +  F+   ++     E K++  +RH ++V+  
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65

Query: 822 -IISSCSNNDFKAL--VLEYM---------SNGSLEKCLYSDNYFLDILQRLKIMIDVAS 869
            I+   S  +FK +  V E M         +N  L    +   +FL  L R         
Sbjct: 66  HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHH--QFFLYQLLR--------- 114

Query: 870 ALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI--LGKEESMRQTKTLGTIG 927
           AL+Y+H   +  + H D+KP N+L N      + DFG+A++       ++  T  + T  
Sbjct: 115 ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171

Query: 928 YMAPEYGRE--GKVSRKCDVYSYGIMLMETFTKK 959
           Y APE       K +   D++S G +  E  T K
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 45.0 bits (106), Expect = 1e-04
 Identities = 55/241 (22%), Positives = 96/241 (39%), Gaps = 46/241 (19%)

Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-----GMEIAAKVFHMEFDGSLESFHAECKVMGSIR 815
           + F   K++G G+FG V      D      M+I  K   +E +  +    AE  ++    
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKE-QVGHIRAERDILVEAD 59

Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
              +VK+  S  +     L++E++  G +   L   +   +   +  I  +   A++ +H
Sbjct: 60  SLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIH 118

Query: 876 -FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK--------------------- 913
             G+    +H DIKP N+LL+      LSDFG+   L K                     
Sbjct: 119 QLGF----IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174

Query: 914 -----------EESMRQT--KTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKK 960
                      + + RQ    T+GT  Y+APE   +   ++ CD +S G+++ E      
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Query: 961 P 961
           P
Sbjct: 235 P 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 45.3 bits (107), Expect = 1e-04
 Identities = 31/108 (28%), Positives = 49/108 (45%), Gaps = 4/108 (3%)

Query: 851 DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK- 909
           D   LD    L     VA  + +L    S   +H D+   N+LL    +  + DFG+A+ 
Sbjct: 207 DELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARD 263

Query: 910 ILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           I      + +      + +MAPE       + + DV+SYGI+L E F+
Sbjct: 264 IRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 44.7 bits (105), Expect = 2e-04
 Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 26/220 (11%)

Query: 767 KLLGMGSFGSV---YKGVLPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVK 821
           K +G G+ G V   Y  VL     +A K     F     +  A  E  +M  + H+N++ 
Sbjct: 23  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80

Query: 822 IISSCSNN----DFKA--LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
           +++  +      +F+   LV+E M + +L + +  +   LD  +   ++  +   +++LH
Sbjct: 81  LLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKHLH 136

Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
              S  I+H D+KPSN+++       + DFG+A+  G   S   T  + T  Y APE   
Sbjct: 137 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVIL 191

Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRW 975
                   D++S G ++ E    K     +F G   + +W
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 227

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 44.7 bits (105), Expect = 2e-04
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 28/205 (13%)

Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV          ++A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 825 ---SCSNNDFKA--LVLEYMSN--GSLEKC--LYSDNYFLDILQRLKIMIDVASALEYLH 875
              + S  +F    LV   M     ++ KC  L  ++    I Q L+        L+Y+H
Sbjct: 83  FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR-------GLKYIH 135

Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
              S  I+H D+KPSNV +NE     + DFG+A+    E     T  + T  Y APE   
Sbjct: 136 ---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWYRAPEIML 188

Query: 936 EG-KVSRKCDVYSYGIMLMETFTKK 959
                ++  D++S G ++ E    K
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 55/228 (24%), Positives = 95/228 (41%), Gaps = 42/228 (18%)

Query: 769 LGMGSFGSVYKGVLPDG-------------MEIAAKVFHMEF-DGSLESFHAECKVMGSI 814
           LG G+   +Y G+L                +++  KV      D SL  F     +M  +
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFET-ASMMRQV 61

Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
            H+++V +   C  +    +V E++  G L+  ++  +  L    + K+   +ASAL YL
Sbjct: 62  SHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYL 121

Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVG-------HLSDFGIA-KILGKEESMRQTKTLGTI 926
                  +VH ++   N+LL    +         LSD GI   +L ++E + +      I
Sbjct: 122 E---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVER------I 172

Query: 927 GYMAPEYGREGKV-SRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
            ++APE   + K  S   D +S+G  L E           + GE+ LK
Sbjct: 173 PWIAPECVEDSKNLSIAADKWSFGTTLWEI---------CYNGEIPLK 211

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.1 bits (104), Expect = 3e-04
 Identities = 61/248 (24%), Positives = 97/248 (39%), Gaps = 62/248 (25%)

Query: 761 DGFSENKLLGMGSFGSVYKGV--LPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIR 815
           + F   K++G G+FG V + V     G   A K      M     L    AE  V+    
Sbjct: 1   EDFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD 59

Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
              +V +  S  +  +  L++E++  G L   L   + F + + R   M +   A+E +H
Sbjct: 60  SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMAECVLAIEAVH 118

Query: 876 -FGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIA-------------KIL-GKEESMR 918
             G+    +H DIKP N+L++    GH  LSDFG++             K+L GK    R
Sbjct: 119 KLGF----IHRDIKPDNILIDRG--GHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNR 172

Query: 919 QTK--------------------------------TLGTIGYMAPEYGREGKVSRKCDVY 946
                                              T+GT  Y+APE   +    ++CD +
Sbjct: 173 IDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232

Query: 947 SYGIMLME 954
           S G ++ E
Sbjct: 233 SLGAIMFE 240

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 44.3 bits (104), Expect = 4e-04
 Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 42/189 (22%)

Query: 807 ECKVMGSIRHRNLVKIISSCSN--NDFKALVLEYMSNGSL----EKCL-----YSDNYFL 855
           E  VM  ++H+N+V+ I    N  N    +++E+   G L    +KC        ++  +
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121

Query: 856 DILQRLKIMIDVASALEYLHFGYSTP----IVHCDIKPSNVL-----------------L 894
           DI ++L        AL Y H     P    ++H D+KP N+                  L
Sbjct: 122 DITRQL------LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175

Query: 895 NESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE--YGREGKVSRKCDVYSYGIML 952
           N   +  + DFG++K +G  ESM  +  +GT  Y +PE           K D+++ G ++
Sbjct: 176 NGRPIAKIGDFGLSKNIGI-ESMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWALGCII 233

Query: 953 METFTKKKP 961
            E  + K P
Sbjct: 234 YELCSGKTP 242

Length = 1021

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 43.7 bits (103), Expect = 4e-04
 Identities = 40/169 (23%), Positives = 64/169 (37%), Gaps = 32/169 (18%)

Query: 807 ECKVMGSIRHRNLVKIISSCSNNDFKALVL-----------EYMSNGSLEKCLYSDNYFL 855
           E  ++ +I HR ++ +I +        +V+           +      LE+ +       
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAIT------ 189

Query: 856 DILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE 915
            I +RL        AL YLH      I+H D+K  N+ L+E     L DFG A  L    
Sbjct: 190 -IQRRL------LEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD--A 237

Query: 916 SMRQTKTLGTIGYM---APEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
                +  G  G +   +PE         K D++S G++L E   K   
Sbjct: 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 43.6 bits (103), Expect = 4e-04
 Identities = 40/155 (25%), Positives = 77/155 (49%), Gaps = 17/155 (10%)

Query: 807 ECKVMGSIRHRNLVKIISSCSNN----DFKA--LVLEYMSNGSLEKCLYSDNYFLDILQR 860
           E  +M  + H+N++ +++  +      +F+   LV+E M + +L + +  D   LD  +R
Sbjct: 65  ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMD---LD-HER 119

Query: 861 LKIMI-DVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ 919
           +  ++  +   +++LH   S  I+H D+KPSN+++       + DFG+A+  G    M  
Sbjct: 120 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-- 174

Query: 920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLME 954
           T  + T  Y APE           D++S G ++ E
Sbjct: 175 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 209

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.1 bits (92), Expect = 5e-04
 Identities = 20/64 (31%), Positives = 32/64 (50%), Gaps = 5/64 (7%)

Query: 346 LSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLS 405
           L  LD   N  + +    F  L +LK+L L+GN LTS +P+     + +   +L  + LS
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPE-----AFSGLPSLRSLDLS 56

Query: 406 ENPI 409
            N +
Sbjct: 57  GNNL 60

Length = 60

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 43.0 bits (102), Expect = 5e-04
 Identities = 43/183 (23%), Positives = 82/183 (44%), Gaps = 26/183 (14%)

Query: 770 GMGSFGSVYKGVL---PDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRHRNLVKII 823
           G G++G VYK       DG E A K F     ++ G  +S   E  ++  ++H N+V ++
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68

Query: 824 SSCSNNDFKA--LVLEYMSNGSLEKCLYSDNYFLDILQR--LK-IMIDVASALEYLHFGY 878
                +  K+  L+ +Y  +   +   +        +    +K ++  + + + YLH   
Sbjct: 69  EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH--- 125

Query: 879 STPIVHCDIKPSNVLL----NESMVGHLSDFGIAKILGKEESMRQT-----KTLGTIGYM 929
           S  ++H D+KP+N+L+     E  V  + D G+A++     +  +        + TI Y 
Sbjct: 126 SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF---NAPLKPLADLDPVVVTIWYR 182

Query: 930 APE 932
           APE
Sbjct: 183 APE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 43.3 bits (102), Expect = 5e-04
 Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 13/96 (13%)

Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTL----GTIG 927
           L+F +   I++ D+K  NVLL+    GH  L+D+G+ K     E +R   T     GT  
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDAE--GHIKLTDYGMCK-----EGIRPGDTTSTFCGTPN 161

Query: 928 YMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTD 963
           Y+APE  R        D ++ G+++ E    + P D
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 43.0 bits (101), Expect = 6e-04
 Identities = 45/131 (34%), Positives = 66/131 (50%), Gaps = 11/131 (8%)

Query: 89  IPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQ 148
           +P  L NLS L  L +  N     LP E+  L  L+  D   NN  IE+ S   +L  L 
Sbjct: 178 LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS-NNSIIELLSSLSNLKNLS 235

Query: 149 HLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISY 208
            L L +N     +PE+IG LS L+ LDLS+NQ+S    SS+ ++++ + L       +S 
Sbjct: 236 GLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELD------LSG 286

Query: 209 NQLTGPIPTNL 219
           N L+  +P   
Sbjct: 287 NSLSNALPLIA 297

Length = 394

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 38.7 bits (91), Expect = 6e-04
 Identities = 19/60 (31%), Positives = 24/60 (40%), Gaps = 2/60 (3%)

Query: 99  LAVLAIRNNSFFGSLPEE-LSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSF 157
           L  L + NN     +P+     L  LK  D   NN     P  F  LP L+ L L  N+ 
Sbjct: 2   LKSLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 42.7 bits (100), Expect = 8e-04
 Identities = 52/220 (23%), Positives = 97/220 (44%), Gaps = 26/220 (11%)

Query: 767 KLLGMGSFGSV---YKGVLPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVK 821
           K +G G+ G V   Y  +L     +A K     F     +  A  E  +M  + H+N++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 87

Query: 822 IIS----SCSNNDFKAL--VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
           +++      S  +F+ +  V+E M + +L + +  +   LD  +   ++  +   +++LH
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKHLH 143

Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
              S  I+H D+KPSN+++       + DFG+A+  G   S   T  + T  Y APE   
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVIL 198

Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRW 975
                   D++S G ++ E          +F G   + +W
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGV----LFPGTDHIDQW 234

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.9 bits (89), Expect = 0.001
 Identities = 21/66 (31%), Positives = 27/66 (40%), Gaps = 6/66 (9%)

Query: 146 RLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLF 205
            L+ L L +N            L  L+ LDLS N L+ +I    F       LP L  L 
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAF-----SGLPSLRSLD 54

Query: 206 ISYNQL 211
           +S N L
Sbjct: 55  LSGNNL 60

Length = 60

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 42.0 bits (99), Expect = 0.001
 Identities = 43/151 (28%), Positives = 69/151 (45%), Gaps = 22/151 (14%)

Query: 769 LGMGSFGSVYKGV--LPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVKIIS 824
           LG GS+ +VYKG   L   + +A K   +E +     F A  E  ++  ++H N+V +  
Sbjct: 13  LGEGSYATVYKGRSKLTGQL-VALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTLHD 70

Query: 825 SCSNNDFKALVLEYMSNG---SLEKC---LYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
                    LV EY+       ++ C   L   N  L + Q L+        L Y H   
Sbjct: 71  IIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR-------GLAYCH--- 120

Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAK 909
              ++H D+KP N+L++E     L+DFG+A+
Sbjct: 121 QRRVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 41.4 bits (97), Expect = 0.002
 Identities = 30/102 (29%), Positives = 46/102 (45%), Gaps = 4/102 (3%)

Query: 855 LDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL-GK 913
           L + Q   +   + SA++Y+H      I+H DIK  NVL+N      L DFG A    G 
Sbjct: 257 LGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313

Query: 914 EESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMET 955
             +       GT+   APE       +   D++S G+++ E 
Sbjct: 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEA 355

Length = 461

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 40.3 bits (95), Expect = 0.004
 Identities = 48/196 (24%), Positives = 84/196 (42%), Gaps = 15/196 (7%)

Query: 769 LGMGSFGSVYKG-VLPDGMEIAAKVFHMEFDGSLESFH-AECKVMGSIR-HRNLVKIISS 825
           +G G+F  V K      G   A K     F    +  +  E + +  +  H N++++I  
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66

Query: 826 CSNNDFK--ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIV 883
             +      ALV E M + +L + +      L   +    M  +  +L+++H      I 
Sbjct: 67  LFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIF 122

Query: 884 HCDIKPSNVLLNESMVGHLSDFGIAK-ILGKEESMRQTKTLGTIGYMAPE-YGREGKVSR 941
           H DIKP N+L+ +  +  L+DFG  + I  K      T+ + T  Y APE    +G    
Sbjct: 123 HRDIKPENILIKDD-ILKLADFGSCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGP 178

Query: 942 KCDVYSYGIMLMETFT 957
           K D+++ G +  E  +
Sbjct: 179 KMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	1049
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
PTZ00284	467	protein kinase; Provisional	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.98
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.98
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.98
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.98
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.98
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.98
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.98
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.98
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.98
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.98
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.98
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.98
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.98
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.98
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.98
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.98
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.9
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.9
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.89
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.89
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.89
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.88
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.86
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.86
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.85
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.84
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.82
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.81
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.8
PRK12274	218	serine/threonine protein kinase; Provisional	99.79
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.79
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.78
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.77
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.77
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.76
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.76
PRK10345	210	hypothetical protein; Provisional	99.74
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.74
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.74
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.73
PRK14879	211	serine/threonine protein kinase; Provisional	99.71
smart00090	237	RIO RIO-like kinase.	99.69
PLN03150	623	hypothetical protein; Provisional	99.69
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.67
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.65
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.64
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.62
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.6
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.56
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.56
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.54
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.51
PLN03150	623	hypothetical protein; Provisional	99.51
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.48
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.48
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.4
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.39
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.38
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.33
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.32
KOG1243	690	consensus Protein kinase [General function predict	99.26
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.23
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.22
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.2
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.16
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.15
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.14
COG4248	637	Uncharacterized protein with protein kinase and he	99.14
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.14
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.12
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.08
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.07
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.06
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.06
KOG3087	229	consensus Serine/threonine protein kinase [General	99.05
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.05
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.04
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.02
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.97
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.96
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.94
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.94
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.87
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.82
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.82
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.8
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.79
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.78
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.77
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.76
PRK09902	216	hypothetical protein; Provisional	98.57
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.54
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.51
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.51
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.47
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.43

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=7e-118  Score=1144.70  Aligned_cols=923  Identities=32%  Similarity=0.548  Sum_probs=708.7

Q ss_pred             ChhhHHHHHHHHHhcccCCCCcccccCCCCCCCceeeeEEEcCCCCcEEEEEEeccccccccCCCCCCcchhhhhhcccC
Q 039290           28 VTTDQFALLALKEHIKHDPSNLLANNWSTTSSVCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNN  107 (1049)
Q Consensus        28 ~~~d~~all~~k~~~~~~~~~~l~~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n  107 (1049)
                      .+.|+.||++||+++. ||.+.+ .+|+.+.+||.|.||+|+. .++|+.|+|++++++|.+|+.+..+++|++|+|++|
T Consensus        27 ~~~~~~~l~~~~~~~~-~~~~~~-~~w~~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n  103 (968)
T PLN00113         27 HAEELELLLSFKSSIN-DPLKYL-SNWNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNN  103 (968)
T ss_pred             CHHHHHHHHHHHHhCC-CCcccC-CCCCCCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCC
Confidence            5689999999999994 787776 4898888999999999985 468999999999999999999999999999999999


Q ss_pred             ccccccCcccc-cccCCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccC
Q 039290          108 SFFGSLPEELS-HLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIP  186 (1049)
Q Consensus       108 ~~~g~~p~~~~-~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip  186 (1049)
                      ++.|.+|..+. ++++|++|||++|++++.+|.  +.+++|++|+|++|.+++.+|..++++++|++|||++|.+.+.+|
T Consensus       104 ~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p  181 (968)
T PLN00113        104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP  181 (968)
T ss_pred             ccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCC
Confidence            99999998876 899999999999999998886  568999999999999999999999999999999999999998899


Q ss_pred             CCcccccccCCCCccceEEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceEEeccccccccCccc
Q 039290          187 SSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNE  266 (1049)
Q Consensus       187 ~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  266 (1049)
                      ..++++      ++|++|+|++|++.+.+|..++++++|+.|+|++|++++.+|..|+++++|++|+|++|++++.+|..
T Consensus       182 ~~~~~l------~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~  255 (968)
T PLN00113        182 NSLTNL------TSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSS  255 (968)
T ss_pred             hhhhhC------cCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChh
Confidence            887654      45889999999998888888888888888888888888888888888888888888888888888888


Q ss_pred             cccccceEEEeeccccCCCccccccccccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCC
Q 039290          267 IGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISEL  346 (1049)
Q Consensus       267 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  346 (1049)
                      ++++++|+.|+|++|++.+.+|..+.++++|++|++++|++.+.+|..+. .+++|++|++++|.+++.+|..++.+++|
T Consensus       256 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~l~~n~~~~~~~~~~~~l~~L  334 (968)
T PLN00113        256 LGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI-QLQNLEILHLFSNNFTGKIPVALTSLPRL  334 (968)
T ss_pred             HhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHc-CCCCCcEEECCCCccCCcCChhHhcCCCC
Confidence            88888888888888888877777777777777777777766666655443 45666666666666666666666666666


Q ss_pred             ceeecccCccccCcccccccccccceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccE
Q 039290          347 SVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKS  426 (1049)
Q Consensus       347 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~  426 (1049)
                      +.|++++|.+.+.+|..++.+++|+.|++                             ++|+++                
T Consensus       335 ~~L~L~~n~l~~~~p~~l~~~~~L~~L~L-----------------------------s~n~l~----------------  369 (968)
T PLN00113        335 QVLQLWSNKFSGEIPKNLGKHNNLTVLDL-----------------------------STNNLT----------------  369 (968)
T ss_pred             CEEECcCCCCcCcCChHHhCCCCCcEEEC-----------------------------CCCeeE----------------
Confidence            66666666665555554444444333333                             333333                


Q ss_pred             EEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCccc
Q 039290          427 LSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKL  506 (1049)
Q Consensus       427 L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  506 (1049)
                               +.+|..+..+++|+.|++++|.+.+.+|..++.+++|+.|++++|++++.+|..+..++.|+.|++++|.+
T Consensus       370 ---------~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l  440 (968)
T PLN00113        370 ---------GEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNL  440 (968)
T ss_pred             ---------eeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcc
Confidence                     33444455555666666666666666666666666666666666666666666666667777777777777


Q ss_pred             CCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccc
Q 039290          507 SGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTI  586 (1049)
Q Consensus       507 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~  586 (1049)
                      ++.+|..+..+++|+.|++++|++.+.+|..+ ..++|+.|++++|++++..|..+..+++|++|+|++|++++.+|..+
T Consensus       441 ~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~  519 (968)
T PLN00113        441 QGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDEL  519 (968)
T ss_pred             cCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHH
Confidence            76666666677777777777777777666654 34778888888888888888888888999999999999999999999


Q ss_pred             cCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCcccccCCCCCCccccccc
Q 039290          587 GGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAE  666 (1049)
Q Consensus       587 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~  666 (1049)
                      +++++|+.|+|++|++++.+|..|.++++|+.|||++|++++.+|..+..+++|+.|++++|++.|.+|..++|.++...
T Consensus       520 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~  599 (968)
T PLN00113        520 SSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINAS  599 (968)
T ss_pred             cCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccCCCCc-cCCCCCCCCCCCCCceeeEeeehhHHHHHHHHHHHHHHHHHHHhhhhhcccCCCCCc--cCcCCC
Q 039290          667 SFLGNQALCGSPKL-QVSPCKTRSHPRSRTTVVLLIVLPLVSALTMIVVLTAKLVRRRRRRRRRQKGSTRPY--YDANMY  743 (1049)
Q Consensus       667 ~~~~n~~~cg~~~~-~~~~c~~~~~~~~~~~~~~~i~~~~v~~~~~~~~l~~~~~rrrrr~~~~~~~~~~~~--~~~~~~  743 (1049)
                      ++.||+.+||.+.. ..++|.....   ... .+++++.+++++++++++++.++++|++++.+.+......  .....+
T Consensus       600 ~~~~n~~lc~~~~~~~~~~c~~~~~---~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (968)
T PLN00113        600 AVAGNIDLCGGDTTSGLPPCKRVRK---TPS-WWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFF  675 (968)
T ss_pred             hhcCCccccCCccccCCCCCccccc---cce-eeeehhHHHHHHHHHHHHHHHHHHHHhhhccccccccccccccccccc
Confidence            99999999986532 3456754311   111 1222222222222222222222222222211111111000  000001


Q ss_pred             CccccccccHHHHHHHhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeE
Q 039290          744 PQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKI  822 (1049)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l  822 (1049)
                      .....+.++++++.   ..|...++||+|+||+||+|+. .++..||||+++....    ...+|++++++++|||||++
T Consensus       676 ~~~~~~~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~  748 (968)
T PLN00113        676 DSKVSKSITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKL  748 (968)
T ss_pred             ccccchhhhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceE
Confidence            11111233444443   4577888999999999999996 5889999999864322    22356889999999999999


Q ss_pred             EeeeecCCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEE
Q 039290          823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHL  902 (1049)
Q Consensus       823 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl  902 (1049)
                      ++++.+.+..++||||+++|+|.++++.    +++.++.+++.|+++|++|+|+.++++|+||||||+||+++.++.+++
T Consensus       749 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~  824 (968)
T PLN00113        749 IGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL  824 (968)
T ss_pred             EEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEE
Confidence            9999999999999999999999999863    789999999999999999999766789999999999999999888887


Q ss_pred             ecccCceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcccc
Q 039290          903 SDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLS  982 (1049)
Q Consensus       903 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  982 (1049)
                      . ||.+......     ....+++.|+|||++.+..++.++|||||||++|||+||+.||+...........|.......
T Consensus       825 ~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  898 (968)
T PLN00113        825 R-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD  898 (968)
T ss_pred             E-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCc
Confidence            5 6655433211     223678999999999999999999999999999999999999976555555666776654444


Q ss_pred             CCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHh
Q 039290          983 CSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042 (1049)
Q Consensus       983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~ 1042 (1049)
                      .....+.++.+..    ......+...++.+++.+||+.||++||||+|++++|+++.+.
T Consensus       899 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        899 CHLDMWIDPSIRG----DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             cchhheeCccccC----CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            4444444443322    1122345566789999999999999999999999999998764

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.1e-62  Score=633.16  Aligned_cols=517  Identities=36%  Similarity=0.536  Sum_probs=369.3

Q ss_pred             hhhhhhcccCccccccCcccccccCCcEeccccCCccccCccccc-ccCCccEEEeCCCCccCCCcccccCCCcccEEcC
Q 039290           98 FLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFV-SLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDL  176 (1049)
Q Consensus        98 ~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L  176 (1049)
                      .++.|+|++|.+.|.+|..+..+++|++|||++|+++|.+|..+. .+++|++|+|++|.++|.+|.  +.+++|++|||
T Consensus        70 ~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~L  147 (968)
T PLN00113         70 RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDL  147 (968)
T ss_pred             cEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEEC
Confidence            455566666666666665555666666666666655555554433 555555555555555555553  34555555555


Q ss_pred             CCccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceEEecc
Q 039290          177 SDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGN  256 (1049)
Q Consensus       177 s~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  256 (1049)
                      ++|.+++.+|..                              ++.+++|++|+|++|.+++.+|..|+++++|++|+|++
T Consensus       148 s~n~~~~~~p~~------------------------------~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~  197 (968)
T PLN00113        148 SNNMLSGEIPND------------------------------IGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLAS  197 (968)
T ss_pred             cCCcccccCChH------------------------------HhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccC
Confidence            555555555544                              44444444444444444444444444444455555555


Q ss_pred             ccccccCccccccccceEEEeeccccCCCccccccccccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCC
Q 039290          257 NSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTI  336 (1049)
Q Consensus       257 N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~  336 (1049)
                      |++++.+|..++++++|+.|+|++|++.+.+|..+.++++|++|++++|++.+.+|..+. .+++|++|+|++|++++.+
T Consensus       198 n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~  276 (968)
T PLN00113        198 NQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG-NLKNLQYLFLYQNKLSGPI  276 (968)
T ss_pred             CCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHh-CCCCCCEEECcCCeeeccC
Confidence            544444444455555555555555555444455555555555555555555544444433 4555555555555555556


Q ss_pred             CccccCCCCCceeecccCccccCcccccccccccceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCc
Q 039290          337 PSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSS  416 (1049)
Q Consensus       337 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~  416 (1049)
                      |..+.++++|++|++++|.+.+.+|..+.++++|+.|++++|.++...+.     .+..+++|+.|+             
T Consensus       277 p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~-----~~~~l~~L~~L~-------------  338 (968)
T PLN00113        277 PPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV-----ALTSLPRLQVLQ-------------  338 (968)
T ss_pred             chhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCCh-----hHhcCCCCCEEE-------------
Confidence            66666666666666666666666666666666666666555555432221     133333344444             


Q ss_pred             cccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCccccccccc
Q 039290          417 IGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRL  496 (1049)
Q Consensus       417 ~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  496 (1049)
                                  +++|.+.+.+|..++.+++|+.|+|++|++++.+|..+..+++|+.|++++|++.+.+|..+..+++|
T Consensus       339 ------------L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L  406 (968)
T PLN00113        339 ------------LWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSL  406 (968)
T ss_pred             ------------CcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCC
Confidence                        44444444566777888999999999999999999999999999999999999999999999999999


Q ss_pred             ceEEeeCcccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccc
Q 039290          497 ANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLN  576 (1049)
Q Consensus       497 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  576 (1049)
                      +.|++++|++++.+|..+.+++.|+.|++++|++++.+|..++.+++|+.|++++|++.+.+|..+ ...+|+.||+++|
T Consensus       407 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n  485 (968)
T PLN00113        407 RRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRN  485 (968)
T ss_pred             CEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCC
Confidence            999999999999999999999999999999999999999999999999999999999998888766 4589999999999


Q ss_pred             cccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCcccccCCC
Q 039290          577 ALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPT  656 (1049)
Q Consensus       577 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~  656 (1049)
                      ++++.+|..|.++++|+.|+|++|++++.+|..+.++++|++|+|++|++++.+|..+..+++|+.|+|++|++++.+|.
T Consensus       486 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  565 (968)
T PLN00113        486 QFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPK  565 (968)
T ss_pred             ccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCCh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999997


Q ss_pred             C-CCccccccccccCCccccCCC
Q 039290          657 R-GPFITFSAESFLGNQALCGSP  678 (1049)
Q Consensus       657 ~-~~~~~~~~~~~~~n~~~cg~~  678 (1049)
                      . ..+..+....+.+|+..+..|
T Consensus       566 ~l~~l~~L~~l~ls~N~l~~~~p  588 (968)
T PLN00113        566 NLGNVESLVQVNISHNHLHGSLP  588 (968)
T ss_pred             hHhcCcccCEEeccCCcceeeCC
Confidence            4 334456666777887665444

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-46  Score=416.10  Aligned_cols=290  Identities=40%  Similarity=0.664  Sum_probs=251.0

Q ss_pred             ccccccHHHHHHHhcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeee
Q 039290          747 TWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC  826 (1049)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~  826 (1049)
                      ..+.++++++..++++|.....||+|+||.||+|...+|+.||||++.........+|.+|++++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56789999999999999999999999999999999999999999988655432145699999999999999999999999


Q ss_pred             ecCC-eeEEEEeccCCCChhhhhhcCCC-ccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEec
Q 039290          827 SNND-FKALVLEYMSNGSLEKCLYSDNY-FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSD  904 (1049)
Q Consensus       827 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D  904 (1049)
                      .+.+ +.++||||+++|+|.+.++.... .++|.++.+||.++|+||+|||+.+.+.||||||||+|||+|+++++||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9988 59999999999999999998776 899999999999999999999987788899999999999999999999999


Q ss_pred             ccCceecCCCcccccccc-ccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccc-cccchHHHhhhhcccc
Q 039290          905 FGIAKILGKEESMRQTKT-LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIF-AGEMSLKRWVGDSLLS  982 (1049)
Q Consensus       905 fGla~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~-~~~~~~~~~~~~~~~~  982 (1049)
                      ||+|+....... ..... .||.+|+|||+...+..+.++||||||+++.|++||+.|.+... .++.....|.......
T Consensus       221 FGLa~~~~~~~~-~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~  299 (361)
T KOG1187|consen  221 FGLAKLGPEGDT-SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE  299 (361)
T ss_pred             ccCcccCCcccc-ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence            999965543111 11222 79999999999999999999999999999999999999887654 4455688998888888


Q ss_pred             CCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 039290          983 CSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041 (1049)
Q Consensus       983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~ 1041 (1049)
                      ..+.+++|+.+..   ..+.. ......+..++.+|++.+|.+||+|.||+++|+.+..
T Consensus       300 ~~~~eiiD~~l~~---~~~~~-~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  300 GKLREIVDPRLKE---GEYPD-EKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             cchhheeCCCccC---CCCCh-HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            8899999988753   11111 1466779999999999999999999999999966543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=397.74  Aligned_cols=257  Identities=30%  Similarity=0.465  Sum_probs=217.2

Q ss_pred             CCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCC--HHHHHHHHHHHhhcCCCceeeEEeeeecCC-eeEEEEeccC
Q 039290          764 SENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGS--LESFHAECKVMGSIRHRNLVKIISSCSNND-FKALVLEYMS  840 (1049)
Q Consensus       764 ~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~hpniv~l~~~~~~~~-~~~lv~e~~~  840 (1049)
                      ...+.+|+|+||+||+|.+.....||||++.......  .++|.+|+.++.+++|||||+++|+|.+.. ..++||||++
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            3445699999999999999666669999997654222  458999999999999999999999999887 7899999999


Q ss_pred             CCChhhhhhc-CCCccCHHHHHHHHHHHHHHHHHhHccCCCC-eEEcCCCCCCeeecCCC-ceEEecccCceecCCCccc
Q 039290          841 NGSLEKCLYS-DNYFLDILQRLKIMIDVASALEYLHFGYSTP-IVHCDIKPSNVLLNESM-VGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       841 ~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Dlkp~NIl~~~~~-~~kl~DfGla~~~~~~~~~  917 (1049)
                      +|+|.++++. ....+++..+.+++.|||+||+|||   +.+ ||||||||+|||++.++ ++||+|||+++...... .
T Consensus       124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~  199 (362)
T KOG0192|consen  124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T  199 (362)
T ss_pred             CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence            9999999988 4678999999999999999999999   888 99999999999999997 99999999998765432 2


Q ss_pred             cccccccccCcccccccC--CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          918 RQTKTLGTIGYMAPEYGR--EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                      ..+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||......+.......                   
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~-------------------  260 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVV-------------------  260 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-------------------
Confidence            334467999999999999  56899999999999999999999999987554222221111                   


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                       ...++..+..++..+..+|.+||+.||++||++.|++..|+.+.....
T Consensus       261 -~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  261 -GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             -cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence             112333344588899999999999999999999999999999987654

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-45  Score=380.91  Aligned_cols=251  Identities=27%  Similarity=0.305  Sum_probs=210.3

Q ss_pred             CCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCC-eeEEEEeccC
Q 039290          764 SENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNND-FKALVLEYMS  840 (1049)
Q Consensus       764 ~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~-~~~lv~e~~~  840 (1049)
                      +..+.||+|..|+||+++++ +++-+|+|++....+ ...+++.+|++++++.+||+||.++|+|...+ ...++||||+
T Consensus        82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD  161 (364)
T KOG0581|consen   82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD  161 (364)
T ss_pred             hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence            44578999999999999965 788899999965543 34578999999999999999999999999988 5999999999


Q ss_pred             CCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccccc
Q 039290          841 NGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT  920 (1049)
Q Consensus       841 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~  920 (1049)
                      +|+|++++...+ .+++....+|+.++++||.|||+  +++||||||||+|||++..|+|||||||.+......   ...
T Consensus       162 gGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~  235 (364)
T KOG0581|consen  162 GGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IAN  235 (364)
T ss_pred             CCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hcc
Confidence            999999988764 48999999999999999999993  399999999999999999999999999999877544   345


Q ss_pred             ccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccC
Q 039290          921 KTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEND 1000 (1049)
Q Consensus       921 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1049)
                      +.+||..|||||.+.+..|+.++||||||++++||.+|+.||...........             +.++......+   
T Consensus       236 tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~-------------~Ll~~Iv~~pp---  299 (364)
T KOG0581|consen  236 TFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIF-------------ELLCAIVDEPP---  299 (364)
T ss_pred             cccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHH-------------HHHHHHhcCCC---
Confidence            68999999999999999999999999999999999999999976412111111             12222221111   


Q ss_pred             chhhH-HHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290         1001 FSARE-QCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus      1001 ~~~~~-~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                      +..+. .++++++.|+..|++.||.+||+++|+++|-
T Consensus       300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp  336 (364)
T KOG0581|consen  300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP  336 (364)
T ss_pred             CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence            12223 4889999999999999999999999999984

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-44  Score=397.90  Aligned_cols=248  Identities=25%  Similarity=0.350  Sum_probs=218.3

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecc---cCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHME---FDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      .+|...+.||+|+|+.||+++. .+|+.||+|++.+.   .+...+++.+|+++.++++|||||+++++|++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4689999999999999999996 89999999999764   3556788999999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      |+|+.++|..+++ .++.+++.+++.++.||+.|+.|||   +++|+|||||..|+|++++.+|||+|||+|.....++.
T Consensus        98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            9999999999888 5667999999999999999999999   99999999999999999999999999999998865543


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                       +..+.+|||.|+|||++.....+..+||||+|||||-|++|++||+...-.+.....                      
T Consensus       174 -rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I----------------------  230 (592)
T KOG0575|consen  174 -RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI----------------------  230 (592)
T ss_pred             -ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH----------------------
Confidence             345678999999999999999999999999999999999999999863222222111                      


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ...++..|...+.+..++|.++++.+|.+|||+++|+.+
T Consensus       231 k~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  231 KLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             HhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            122334445677889999999999999999999999986

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=3e-49  Score=408.19  Aligned_cols=477  Identities=29%  Similarity=0.438  Sum_probs=300.9

Q ss_pred             EEEEEEeccccccccCCCCCCcchhhhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCC
Q 039290           75 VTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKH  154 (1049)
Q Consensus        75 v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~  154 (1049)
                      ...+.+++|.+. .+.+.+-+|..|++|++++|.+. ++|++++.+..++.|+.++|+++ ++|+.++++.+|.+|+.++
T Consensus        47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~  123 (565)
T KOG0472|consen   47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS  123 (565)
T ss_pred             hhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence            455666666666 55666667777777777777665 66667777777777777777666 6666666666666666666


Q ss_pred             CCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccceecccccc
Q 039290          155 NSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNK  234 (1049)
Q Consensus       155 n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~  234 (1049)
                      |.+. .+|++|+.+..|+.||..+|+++ ++|+.+++                              +.+|..+++.+|+
T Consensus       124 n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~------------------------------~~~l~~l~~~~n~  171 (565)
T KOG0472|consen  124 NELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVN------------------------------LSKLSKLDLEGNK  171 (565)
T ss_pred             ccee-ecCchHHHHhhhhhhhccccccc-cCchHHHH------------------------------HHHHHHhhccccc
Confidence            6666 56666666666666666666666 55555544                              4444444555555


Q ss_pred             cccccCCCCccccccceEEeccccccccCccccccccceEEEeeccccCCCccccccccccccceEEeccCccCCCCCCc
Q 039290          235 FQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSS  314 (1049)
Q Consensus       235 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~  314 (1049)
                      +. .+|+..-+++.|++||...|.+. .+|+.++.+.+|+.|+|..|++... | +|..++.|++|+++.|++. .+|+.
T Consensus       172 l~-~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~l-P-ef~gcs~L~Elh~g~N~i~-~lpae  246 (565)
T KOG0472|consen  172 LK-ALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFL-P-EFPGCSLLKELHVGENQIE-MLPAE  246 (565)
T ss_pred             hh-hCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccC-C-CCCccHHHHHHHhcccHHH-hhHHH
Confidence            54 23333333666777777777665 6677777777777777777777643 4 7778888888888888886 78888


Q ss_pred             ccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCcccccccccccceeecccccccCCCCCcccccccc
Q 039290          315 IDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLT  394 (1049)
Q Consensus       315 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~  394 (1049)
                      ...+++++..|||..|+++ ..|+.++.+.+|+.||+|+|.|++ +|.+++++ .|+.|-+.||.+.++..++-.-..  
T Consensus       247 ~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~-Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT--  321 (565)
T KOG0472|consen  247 HLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS-LPYSLGNL-HLKFLALEGNPLRTIRREIISKGT--  321 (565)
T ss_pred             Hhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc-CCcccccc-eeeehhhcCCchHHHHHHHHcccH--
Confidence            8888999999999999998 789999999999999999999996 57889999 999999999998765433200000  


Q ss_pred             cCCCCcEEE--ccCCccc---------cCCCCccc---cccccccEEEccCCccccCCCCCCCCCCC---ccEEEccCCc
Q 039290          395 SCRNLEIIY--LSENPIN---------GILPSSIG---NFSISMKSLSMESCNISGGIPKELGNINN---LTVIRLGNNE  457 (1049)
Q Consensus       395 ~l~~L~~L~--Ls~N~i~---------~~~p~~~~---~~~~~L~~L~L~~n~i~~~~p~~~~~l~~---L~~L~Ls~N~  457 (1049)
                       -.-|++|.  ...-.++         +..|.+.+   ....+.+.|+++.-+++ .+|++.+....   .+..+++.|+
T Consensus       322 -~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNq  399 (565)
T KOG0472|consen  322 -QEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQ  399 (565)
T ss_pred             -HHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccch
Confidence             00011110  0000111         11111111   11135666666666666 44544433333   6666777777


Q ss_pred             ccccCCccccCcCCCcc-eEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccccCc
Q 039290          458 LTGTIPVTLGRLQKLQG-LYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPS  536 (1049)
Q Consensus       458 l~~~~p~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  536 (1049)
                      +. .+|..+..++.+++ +.+++|++. .+|..++.+++|..|+|++|.+. .+|..++.+..|+.|+++.|++.. .|.
T Consensus       400 L~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~-lP~  475 (565)
T KOG0472|consen  400 LC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRM-LPE  475 (565)
T ss_pred             Hh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheeccccccccc-chH
Confidence            66 56666655555443 344444443 66666666666777777666665 566666666666666666666664 556


Q ss_pred             ccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCC
Q 039290          537 TLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSL  616 (1049)
Q Consensus       537 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  616 (1049)
                      .+..+..++.+-.++|++....+                        +.+.++.+|..|||.+|.|. .+|..+++|++|
T Consensus       476 ~~y~lq~lEtllas~nqi~~vd~------------------------~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL  530 (565)
T KOG0472|consen  476 CLYELQTLETLLASNNQIGSVDP------------------------SGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNL  530 (565)
T ss_pred             HHhhHHHHHHHHhccccccccCh------------------------HHhhhhhhcceeccCCCchh-hCChhhccccce
Confidence            66555555555555555554444                        44555555555555555555 455556666666


Q ss_pred             cEEeccCcccc
Q 039290          617 NFVDMSNNNLS  627 (1049)
Q Consensus       617 ~~L~Ls~N~l~  627 (1049)
                      ++|+|+||++.
T Consensus       531 ~hLeL~gNpfr  541 (565)
T KOG0472|consen  531 RHLELDGNPFR  541 (565)
T ss_pred             eEEEecCCccC
Confidence            66666666665

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=394.67  Aligned_cols=255  Identities=29%  Similarity=0.463  Sum_probs=221.8

Q ss_pred             CCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCCC
Q 039290          764 SENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGS  843 (1049)
Q Consensus       764 ~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~  843 (1049)
                      ...+.||+|.||+||.|.+.....||+|.++.. .-..++|.+|+++|++++|++||+++++|..++.++|||||++.|+
T Consensus       209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs  287 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS  287 (468)
T ss_pred             HHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence            345789999999999999988889999999765 4456889999999999999999999999999999999999999999


Q ss_pred             hhhhhhc-CCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccccccc
Q 039290          844 LEKCLYS-DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT  922 (1049)
Q Consensus       844 L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~~  922 (1049)
                      |.+++.. .+..+...+.+.++.|||+||+||+   ++++|||||.++||||+++..|||+|||+|+....+........
T Consensus       288 Ll~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~  364 (468)
T KOG0197|consen  288 LLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGG  364 (468)
T ss_pred             HHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCC
Confidence            9999987 5667899999999999999999999   99999999999999999999999999999996655555445555


Q ss_pred             ccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCc
Q 039290          923 LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDF 1001 (1049)
Q Consensus       923 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1049)
                      ..+..|+|||.+..+.++.|||||||||+||||+| |+.||..+...+....                     -....|.
T Consensus       365 kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~---------------------le~GyRl  423 (468)
T KOG0197|consen  365 KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL---------------------LERGYRL  423 (468)
T ss_pred             CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHH---------------------HhccCcC
Confidence            56789999999999999999999999999999999 8888876432221110                     0123356


Q ss_pred             hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhh
Q 039290         1002 SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043 (1049)
Q Consensus      1002 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~ 1043 (1049)
                      +.|..||.+++++|..||..+|++||||+.+...++++....
T Consensus       424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence            777889999999999999999999999999999999887643

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-44  Score=377.07  Aligned_cols=254  Identities=27%  Similarity=0.363  Sum_probs=210.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEE-eCCCcEEEEEEeecccC-C------CHHHHHHHHHHHhhcCCCceeeEEeeeecCCe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFD-G------SLESFHAECKVMGSIRHRNLVKIISSCSNNDF  831 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~-~~~~~~vavK~~~~~~~-~------~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~  831 (1049)
                      .+.|.+.+.||+|+||.|-+|. .++|+.||||++.+..- .      ....+.+|+++|++++|||||+++++++..+.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            3468888999999999999998 56899999999976431 1      22346799999999999999999999999999


Q ss_pred             eEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCC---CceEEecccCc
Q 039290          832 KALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES---MVGHLSDFGIA  908 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~---~~~kl~DfGla  908 (1049)
                      .||||||++||+|.+.+-.++. +.+..-+.+++|++.|+.|||   +.||+||||||+|||++.+   ..+||+|||+|
T Consensus       251 ~YmVlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             eEEEEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchh
Confidence            9999999999999999887665 677777899999999999999   9999999999999999754   78999999999


Q ss_pred             eecCCCccccccccccccCcccccccCCCCc---CcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCc
Q 039290          909 KILGKEESMRQTKTLGTIGYMAPEYGREGKV---SRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSI  985 (1049)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  985 (1049)
                      +..+.  ...+.+.+||+.|.|||++.++.+   ..++|+||+||++|-+++|.+||.+.........+.          
T Consensus       327 K~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI----------  394 (475)
T KOG0615|consen  327 KVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI----------  394 (475)
T ss_pred             hcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH----------
Confidence            98763  335567899999999999987543   357899999999999999999998744333222221          


Q ss_pred             chhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          986 TEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       986 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                             ........+..+...+++..++|.+|+..||++|||++|+++|-
T Consensus       395 -------~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp  438 (475)
T KOG0615|consen  395 -------LKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHP  438 (475)
T ss_pred             -------hcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence                   11122222344456788899999999999999999999999873

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-44  Score=372.77  Aligned_cols=205  Identities=31%  Similarity=0.504  Sum_probs=182.3

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      .++|...+.||+|+||+||+|+++ ++..||||.+....  ....+-+..|+++++.++|||||++++++.+++..|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            457888899999999999999954 78999999997663  334566789999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCC------CceEEecccCcee
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES------MVGHLSDFGIAKI  910 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~------~~~kl~DfGla~~  910 (1049)
                      |||.||+|.++++..+. +++.+++.++.|||.|+++||   +++||||||||+|||++..      -.+||+|||+|+.
T Consensus        89 EyC~gGDLs~yi~~~~~-l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGR-LPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EeCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            99999999999998764 899999999999999999999   9999999999999999754      5689999999998


Q ss_pred             cCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccc
Q 039290          911 LGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEM  970 (1049)
Q Consensus       911 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~  970 (1049)
                      ..+..  .....+|++.|||||++...+|+.|+|+||+|+|+|+|++|+.||+.....|.
T Consensus       165 L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL  222 (429)
T KOG0595|consen  165 LQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL  222 (429)
T ss_pred             CCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence            86433  23456899999999999999999999999999999999999999986444433

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=9.1e-44  Score=405.98  Aligned_cols=264  Identities=28%  Similarity=0.486  Sum_probs=225.3

Q ss_pred             CCCCCceecCCCcEEEEEEEeC------CCcEEEEEEeecccCC-CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEFDG-SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      +.+..+.||+|+||+||+|+..      +...||||.++...+. ..++|++|++++..++|||||+++|+|.+++.+++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            3455678999999999999842      3456999999887655 67899999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCC-------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceE
Q 039290          835 VLEYMSNGSLEKCLYSDN-------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGH  901 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~k  901 (1049)
                      |+|||..|||.+++....             .+++..+.+.||.|||.||+||.   ++.+|||||..+|+||.++..||
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VK  643 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVK  643 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEE
Confidence            999999999999986422             23888999999999999999999   99999999999999999999999


Q ss_pred             EecccCceecCCCcccccc-ccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhc
Q 039290          902 LSDFGIAKILGKEESMRQT-KTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDS  979 (1049)
Q Consensus       902 l~DfGla~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  979 (1049)
                      |+|||+++..-..+.++.. ...-+.+|||||.+..++++.+||||||||++||+++ |+.||.+....|.....     
T Consensus       644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i-----  718 (774)
T KOG1026|consen  644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI-----  718 (774)
T ss_pred             ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH-----
Confidence            9999999976555544433 4556789999999999999999999999999999999 99999875444332211     


Q ss_pred             cccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhccCC
Q 039290          980 LLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYIDV 1049 (1049)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~~~~ 1049 (1049)
                               .+..+       .+.+++||.+++++|.+||+..|++||+++||-..|++..+.-..|.|+
T Consensus       719 ---------~~g~l-------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~~~~  772 (774)
T KOG1026|consen  719 ---------RAGQL-------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKYSSL  772 (774)
T ss_pred             ---------HcCCc-------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcccccc
Confidence                     11111       3556789999999999999999999999999999999998887777653

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=2e-47  Score=394.67  Aligned_cols=488  Identities=26%  Similarity=0.368  Sum_probs=357.6

Q ss_pred             cccCCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCC
Q 039290          119 HLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNL  198 (1049)
Q Consensus       119 ~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l  198 (1049)
                      .=..|+.|++++|.+. .+-..+.+|..|.+|++++|+++ .+|.++|.+..++.|+.|+|+++ .+|+.+++      +
T Consensus        43 ~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s------~  113 (565)
T KOG0472|consen   43 EQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGS------L  113 (565)
T ss_pred             hhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhh------h
Confidence            3355777888888877 44556777888888888888887 77788888888888888888887 78877764      3


Q ss_pred             CccceEEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceEEeccccccccCccccccccceEEEee
Q 039290          199 PVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGV  278 (1049)
Q Consensus       199 ~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  278 (1049)
                      ++|..|+.++|.+. .+|+.++.+..|+.++..+|+++ .+|++++++.+|..|++.+|++... |+..-+++.|+.||.
T Consensus       114 ~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l-~~~~i~m~~L~~ld~  190 (565)
T KOG0472|consen  114 ISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKAL-PENHIAMKRLKHLDC  190 (565)
T ss_pred             hhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhC-CHHHHHHHHHHhccc
Confidence            45777888888887 67777888888888888888877 6777777888888888888887744 434334778888877


Q ss_pred             ccccCCCccccccccccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCcccc-CCCCCceeecccCccc
Q 039290          279 QSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLT-NISELSVLDFGFNSFS  357 (1049)
Q Consensus       279 ~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~  357 (1049)
                      .+|-+. .+|+.++.+.+|.-|||..|++. .+|+ + .++..|++|+++.|+|+ .+|+..+ ++.++.+|||..|++.
T Consensus       191 ~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lPe-f-~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk  265 (565)
T KOG0472|consen  191 NSNLLE-TLPPELGGLESLELLYLRRNKIR-FLPE-F-PGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK  265 (565)
T ss_pred             chhhhh-cCChhhcchhhhHHHHhhhcccc-cCCC-C-CccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc
Confidence            666554 45777777777777888887776 5662 2 25667777777777777 5555544 7777777777777777


Q ss_pred             cCcccccccccccceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCcccccc-ccccEEEc--cCCcc
Q 039290          358 GLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFS-ISMKSLSM--ESCNI  434 (1049)
Q Consensus       358 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~-~~L~~L~L--~~n~i  434 (1049)
                       ..|..++.+++|.+||+++|.|++++..      ++++ .|+.|.+.+|++..+-.+-+..-+ .-|++|.=  ..-++
T Consensus       266 -e~Pde~clLrsL~rLDlSNN~is~Lp~s------Lgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dgl  337 (565)
T KOG0472|consen  266 -EVPDEICLLRSLERLDLSNNDISSLPYS------LGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGL  337 (565)
T ss_pred             -cCchHHHHhhhhhhhcccCCccccCCcc------cccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCC
Confidence             4577777777777777777777777654      4555 677777777776533221111111 01222210  00011


Q ss_pred             ccCCCCCCCCCCCccEEEccCCccccc-CCc---cccCcCCCcceEeeccccCCCCCcccccccc---cceEEeeCcccC
Q 039290          435 SGGIPKELGNINNLTVIRLGNNELTGT-IPV---TLGRLQKLQGLYLQNNKLEGSIPEDLCHLYR---LANLYLGDNKLS  507 (1049)
Q Consensus       435 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~---~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~L~~N~l~  507 (1049)
                      +..        .       ++-.=++. .+.   ....+.+.+.|+++.-+++ .+|+......+   ....+++.|++.
T Consensus       338 S~s--------e-------~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~  401 (565)
T KOG0472|consen  338 SQS--------E-------GGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC  401 (565)
T ss_pred             CCC--------c-------ccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh
Confidence            100        0       00000011 111   2234567888999999998 67776665544   788999999998


Q ss_pred             CcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeeccccccccccccccc
Q 039290          508 GRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIG  587 (1049)
Q Consensus       508 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  587 (1049)
                       ++|..+..+..+.+.-+.+|+..+.+|..++.+++|..|+|++|.+.. +|..++.+..|+.||+|+|++. .+|..+.
T Consensus       402 -elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln~-LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y  478 (565)
T KOG0472|consen  402 -ELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLND-LPEEMGSLVRLQTLNLSFNRFR-MLPECLY  478 (565)
T ss_pred             -hhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhhh-cchhhhhhhhhheecccccccc-cchHHHh
Confidence             789888888776554444444555789999999999999999998875 7889999999999999999998 7899999


Q ss_pred             CCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCccc
Q 039290          588 GLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLE  651 (1049)
Q Consensus       588 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~  651 (1049)
                      .+..|+.+-.++|++....|..+.+|.+|..|||.+|.+. .+|+.+++|++|++|+++||+|+
T Consensus       479 ~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  479 ELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             hHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            9999999999999999888888999999999999999998 99999999999999999999998

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-44  Score=357.99  Aligned_cols=253  Identities=25%  Similarity=0.364  Sum_probs=206.6

Q ss_pred             CCCCCceecCCCcEEEEEEE-eCCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEe-eeecCCe-eEEEE
Q 039290          762 GFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIIS-SCSNNDF-KALVL  836 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~-~~~~~~~-~~lv~  836 (1049)
                      .|++.++||+|.||+||++. ..+|..+|.|.++...  ....++...|+.++++++|||||++++ .+.++.. ++|||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            46778899999999999999 5699999999987443  334567889999999999999999998 4555544 89999


Q ss_pred             eccCCCChhhhhhc---CCCccCHHHHHHHHHHHHHHHHHhHccCCCC--eEEcCCCCCCeeecCCCceEEecccCceec
Q 039290          837 EYMSNGSLEKCLYS---DNYFLDILQRLKIMIDVASALEYLHFGYSTP--IVHCDIKPSNVLLNESMVGHLSDFGIAKIL  911 (1049)
Q Consensus       837 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~  911 (1049)
                      |||.+|+|..++..   .++.+++.++|+++.|++.||.++|.-- +.  |+||||||.||+++..|.||++|||+++.+
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            99999999998864   4567999999999999999999999211 44  889999999999999999999999999988


Q ss_pred             CCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccc
Q 039290          912 GKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA  991 (1049)
Q Consensus       912 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  991 (1049)
                      ..... ...+.+|||.||+||.+.+.+|++++||||+||++|||+.-.+||.+..-  ..+.+.+               
T Consensus       179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~--~~L~~KI---------------  240 (375)
T KOG0591|consen  179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL--LSLCKKI---------------  240 (375)
T ss_pred             cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH--HHHHHHH---------------
Confidence            65544 34567999999999999999999999999999999999999999986411  1111111               


Q ss_pred             ccccccccCc-hhh-HHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 039290          992 NLLNCEENDF-SAR-EQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVR 1038 (1049)
Q Consensus       992 ~~~~~~~~~~-~~~-~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~ 1038 (1049)
                           ...++ +.| ..++.++.++|..|+.+||+.||+...++..+..
T Consensus       241 -----~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  241 -----EQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             -----HcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence                 11111 122 5678899999999999999999986555555443

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.6e-43  Score=352.40  Aligned_cols=270  Identities=21%  Similarity=0.223  Sum_probs=209.4

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      +.|+...++|+|+||+||+++.+ +|+-||||++....+  ...+-.++|++++++++|||+|.++++|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45778889999999999999965 799999999975443  234567899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      ||+. ++.+-+.......+...+.++++|++.|+.|+|   +++++||||||+||+++.+|.+|+||||+|+....++ .
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg-d  156 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG-D  156 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCc-c
Confidence            9988 555556666667999999999999999999999   9999999999999999999999999999999886422 2


Q ss_pred             cccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcc------
Q 039290          918 RQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD------  990 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  990 (1049)
                      ..+..+.|.+|+|||.+.+ .+|..++||||+||++.||++|.+-|.+..+-+..+.....-....+....++.      
T Consensus       157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~  236 (396)
T KOG0593|consen  157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH  236 (396)
T ss_pred             hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence            3456788999999998877 789999999999999999999999887644433322111110011111111111      


Q ss_pred             cccccccccC---chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          991 ANLLNCEEND---FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       991 ~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ....+.++..   ....+....-+.++++.|++.||.+|++-+|++.|
T Consensus       237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            1111111110   11112344568999999999999999999999976

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-42  Score=359.24  Aligned_cols=250  Identities=27%  Similarity=0.323  Sum_probs=207.1

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      .++|++.++||+|+||+||.++. ++++.||+|++++..   ....+..++|..++.+++||+||+++..|++.+.+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            45799999999999999999995 468889999997654   34567889999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      +||+.||.|...+.+.+. +++..+.-++.+|+.||.|||   ++||||||+||+|||+|++|+++|+|||+++......
T Consensus       104 ld~~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EeccCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence            999999999999987665 888889999999999999999   9999999999999999999999999999998543332


Q ss_pred             cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                      . .....+||+.|||||++.+..|+.++|.||+|+++|||++|.+||......     +++.......            
T Consensus       180 ~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~-----~~~~~I~~~k------------  241 (357)
T KOG0598|consen  180 D-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK-----KMYDKILKGK------------  241 (357)
T ss_pred             C-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH-----HHHHHHhcCc------------
Confidence            2 334478999999999999999999999999999999999999999763222     1111111000            


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCC----CHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRI----SMKDVANR 1035 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp----t~~ell~~ 1035 (1049)
                          ....+...+.+.++++.+.+..||++|.    .+.++.+|
T Consensus       242 ----~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H  281 (357)
T KOG0598|consen  242 ----LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH  281 (357)
T ss_pred             ----CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence                0111222456789999999999999996    45554443

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=6.9e-42  Score=337.03  Aligned_cols=270  Identities=23%  Similarity=0.301  Sum_probs=212.9

Q ss_pred             cCCCCCceecCCCcEEEEEEE-eCCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          761 DGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .+|...+++|+|.||.||+|+ ..+|+.||+|+++...  ++-.....+|++.++.++||||+.++++|...+.+.+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            467788999999999999999 5689999999997654  3345678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      |++. +|...+++....++..+++.++.++++|++|||   ++.|+|||+||.|++++++|.+||+|||+|+.++.....
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            9965 999999999999999999999999999999999   999999999999999999999999999999999876654


Q ss_pred             cccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhh-hccccCC---cchhcccc
Q 039290          918 RQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVG-DSLLSCS---ITEVADAN  992 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~  992 (1049)
                      . ...+.|.+|+|||.+.+ +.|+..+|+||.|||++||+-|.+-|.+..+-+.....+.. ....+..   +.++.|-.
T Consensus       158 ~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~  236 (318)
T KOG0659|consen  158 Q-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV  236 (318)
T ss_pred             c-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence            3 33478999999998876 57899999999999999999998766553322221111110 0001111   11111111


Q ss_pred             ccccccc--CchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          993 LLNCEEN--DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       993 ~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .....+.  ....-..++.+..+++.+|+..+|.+|+|++|+++|
T Consensus       237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            1110100  001123456677999999999999999999999876

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-43  Score=371.13  Aligned_cols=268  Identities=23%  Similarity=0.280  Sum_probs=213.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEE-eCCCcEEEEEEeecccCCCHH-HHHHHHHHHhhcC-CCceeeEEeeeecCC-eeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLE-SFHAECKVMGSIR-HRNLVKIISSCSNND-FKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~-~~~~~~vavK~~~~~~~~~~~-~~~~e~~~l~~l~-hpniv~l~~~~~~~~-~~~lv  835 (1049)
                      .++|...++||.|+||.||+|+ ..+|..||||+.+.....+.+ .=.+|+..++++. |||||++.+++.+.+ .+++|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            4678899999999999999999 557899999999877654322 2357999999998 999999999999988 99999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      ||||+. +|.++++++++.+++..++.|++||++||+|+|   .+|+.|||+||+|||+.....+||+|||+|+......
T Consensus        89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp  164 (538)
T KOG0661|consen   89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP  164 (538)
T ss_pred             HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccCC
Confidence            999976 999999999999999999999999999999999   9999999999999999999999999999999875443


Q ss_pred             cccccccccccCcccccccC-CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcc-ccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGR-EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD-ANL  993 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  993 (1049)
                        ..+..+.|.+|+|||++. .+-|+.+.|+||+|||++|+.+-++-|.+..+-+.  ...+-.+...+...++.. ..+
T Consensus       165 --PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq--i~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  165 --PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ--IYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             --CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH--HHHHHHHhCCCccccchhHHHH
Confidence              345678999999999765 57789999999999999999998877765322221  111223333332222222 011


Q ss_pred             cc--------ccccCc-hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          994 LN--------CEENDF-SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       994 ~~--------~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ..        ...... ..-..++.+..++|.+|+.|||.+||||+|++++
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            00        011110 1113477889999999999999999999999987

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-41  Score=363.42  Aligned_cols=269  Identities=24%  Similarity=0.288  Sum_probs=214.3

Q ss_pred             CCCCCceecCCCcEEEEEEE-eCCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecC--CeeEEEE
Q 039290          762 GFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNN--DFKALVL  836 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~lv~  836 (1049)
                      .|+..++||+|+||.||+|+ ..+|+.||+|+++.+.  ++......+|+.+++++.||||+++.+.+.+.  ..+|+|+
T Consensus       118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF  197 (560)
T KOG0600|consen  118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF  197 (560)
T ss_pred             HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence            46666899999999999999 5689999999998765  55567788999999999999999999988776  6899999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      |||+. +|.-++...+-.+++.+++.++.|+++||+|||   ++||+|||||..|||+|.+|.+||+|||+|+++.....
T Consensus       198 eYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~  273 (560)
T KOG0600|consen  198 EYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS  273 (560)
T ss_pred             ecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence            99988 898888887778999999999999999999999   99999999999999999999999999999999987777


Q ss_pred             ccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhh--ccccCCcc--hhccc
Q 039290          917 MRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGD--SLLSCSIT--EVADA  991 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~--~~~~~  991 (1049)
                      ...+..+-|.+|+|||.+.+ ..|+.++|+||.|||+.||++|++.|.+...-+.. ....+.  ...+..+.  ++...
T Consensus       274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl-~kIfklcGSP~e~~W~~~kLP~~  352 (560)
T KOG0600|consen  274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQL-HKIFKLCGSPTEDYWPVSKLPHA  352 (560)
T ss_pred             cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHH-HHHHHHhCCCChhccccccCCcc
Confidence            77788899999999998876 57999999999999999999999998763322221 111110  11111111  11110


Q ss_pred             cccc-cc--ccCc-hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          992 NLLN-CE--ENDF-SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       992 ~~~~-~~--~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .... ..  +.+. ..-...+....+++..++..||.+|.||.++++.
T Consensus       353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            1100 00  0000 1123456778999999999999999999998864

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=365.81  Aligned_cols=253  Identities=25%  Similarity=0.387  Sum_probs=215.6

Q ss_pred             HHHhcCCCCCceecCCCcEEEEEEE-eCCCcEEEEEEeeccc---CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCe
Q 039290          757 LRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF---DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDF  831 (1049)
Q Consensus       757 ~~~~~~~~~~~~lg~G~fg~Vy~a~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~  831 (1049)
                      .+...+|..++.||+|+|++||+|+ ..+++.||||++.+..   +...+.+..|-++|.+| .||.|++++..|.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            4556689999999999999999999 4579999999986543   34456788899999999 89999999999999999


Q ss_pred             eEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceec
Q 039290          832 KALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL  911 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~  911 (1049)
                      +|+|+||+++|+|.++|.+.+. +++.-++-++.+|+.|++|||   ++|||||||||+|||+|++|++||+|||.|+.+
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gs-fde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGS-FDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCc-chHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence            9999999999999999998765 899999999999999999999   999999999999999999999999999999987


Q ss_pred             CCCccc------------cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhc
Q 039290          912 GKEESM------------RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDS  979 (1049)
Q Consensus       912 ~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  979 (1049)
                      .+....            +....+||..|.+||++.++..++++|+|+||||+|+|+.|.+||.+.    .++..+.+  
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~----NeyliFqk--  298 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA----NEYLIFQK--  298 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc----cHHHHHHH--
Confidence            543211            124589999999999999999999999999999999999999999752    12222111  


Q ss_pred             cccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          980 LLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                              +        -.-.+..++.+++.+.+++++.+..||.+|+|+++|.+|
T Consensus       299 --------I--------~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  299 --------I--------QALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             --------H--------HHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence                    0        011234445667889999999999999999999999887

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=370.64  Aligned_cols=250  Identities=27%  Similarity=0.379  Sum_probs=218.1

Q ss_pred             cCCCCCceecCCCcEEEEEEE-eCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          761 DGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      ..|...++||+|+.|.||.|+ ..+++.||||++........+-+.+|+.+|+..+|+|||++++.|...+.+|+||||+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            457888999999999999999 5688899999998887777788999999999999999999999998889999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      +||+|.|.+....  +++.++..|++++++||+|||   .+||+|||||.+|||++.+|.+||+|||++..+..... ..
T Consensus       353 ~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR  426 (550)
T KOG0578|consen  353 EGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KR  426 (550)
T ss_pred             CCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cc
Confidence            9999999987665  899999999999999999999   99999999999999999999999999999988765554 45


Q ss_pred             cccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccccccc
Q 039290          920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEN  999 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1049)
                      .+.+||+.|||||+.....|++++||||||++++||+.|++||-.    |..+....               .++.....
T Consensus       427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln----E~PlrAly---------------LIa~ng~P  487 (550)
T KOG0578|consen  427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRALY---------------LIATNGTP  487 (550)
T ss_pred             ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC----CChHHHHH---------------HHhhcCCC
Confidence            668899999999999999999999999999999999999999864    11111100               01222233


Q ss_pred             CchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290         1000 DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus      1000 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      +...++..+..+++|+.+|++.||++||+|.|+++|
T Consensus       488 ~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  488 KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            445556778899999999999999999999999998

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-41  Score=359.90  Aligned_cols=257  Identities=31%  Similarity=0.416  Sum_probs=208.3

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCC--eeEEEEe
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNND--FKALVLE  837 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~--~~~lv~e  837 (1049)
                      .+|...+.||+|+||+||.+... +|+..|||.+........+.+.+|+.++++++|||||+++|.....+  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            35777889999999999999965 59999999997764333567899999999999999999999754444  6889999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC-CCceEEecccCceecCC--C
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE-SMVGHLSDFGIAKILGK--E  914 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-~~~~kl~DfGla~~~~~--~  914 (1049)
                      |+++|+|.+++...+..+++..+.++..||++||+|||   ++|||||||||+|||++. ++.+||+|||++.....  .
T Consensus        97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            99999999999987656999999999999999999999   999999999999999999 79999999999987653  2


Q ss_pred             ccccccccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          915 ESMRQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       915 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                      .........||+.|||||++..+ ...+++||||+||++.||+||+.||... .+.....-+++...             
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~~~~~~ig~~~-------------  239 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEAEALLLIGRED-------------  239 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cchHHHHHHHhccC-------------
Confidence            22233457899999999999853 3446999999999999999999999874 11111111111000             


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                           .-+..+...+.+..+|+.+|+..+|++||||+++++|....
T Consensus       240 -----~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~  280 (313)
T KOG0198|consen  240 -----SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK  280 (313)
T ss_pred             -----CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence                 01123344677899999999999999999999999987643

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-41  Score=376.93  Aligned_cols=257  Identities=24%  Similarity=0.442  Sum_probs=220.4

Q ss_pred             CCCCCceecCCCcEEEEEEEeC----CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP----DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ...+.++||.|.||+||+|+++    ....||+|.++... ++.+.+|..|+.||.++.||||+++.|++......+||+
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            3566789999999999999964    23469999998765 455778999999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      |||++|+|+.+++.+...+++.+...+.++||.|++||.   +.++|||||.++||||+.+-.+|++|||+++...++..
T Consensus       710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~  786 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  786 (996)
T ss_pred             hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence            999999999999998888999999999999999999999   99999999999999999999999999999997754332


Q ss_pred             ccccccc--cccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          917 MRQTKTL--GTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       917 ~~~~~~~--~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                      ...+...  -+.+|.|||.+...+++.++||||||++|||.++ |+.||-++...+.....                   
T Consensus       787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI-------------------  847 (996)
T KOG0196|consen  787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI-------------------  847 (996)
T ss_pred             ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH-------------------
Confidence            2222222  3568999999999999999999999999999888 99998764433221111                   


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHh
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~ 1042 (1049)
                        ...-|.+.|++|+..+.++|..||+.|-.+||+|++++..|.++...
T Consensus       848 --e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  848 --EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             --HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence              11235567789999999999999999999999999999999988763

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=362.51  Aligned_cols=266  Identities=25%  Similarity=0.423  Sum_probs=216.1

Q ss_pred             HHHHHhcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCee
Q 039290          755 DLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFK  832 (1049)
Q Consensus       755 ~~~~~~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~  832 (1049)
                      ++....+...+.+.||+|.||+||+|+|..  .||||++....  +...+.|+.|+.++++-+|.||+=+.|||..+.. 
T Consensus       386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-  462 (678)
T KOG0193|consen  386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-  462 (678)
T ss_pred             ccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence            333444556777899999999999999843  69999998765  3356789999999999999999999999998887 


Q ss_pred             EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecC
Q 039290          833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      .||+.+|+|.+|..+++..+..++..+...||+||++|+.|||   .++|||||+|..||++.+++.|||+|||++....
T Consensus       463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~  539 (678)
T KOG0193|consen  463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT  539 (678)
T ss_pred             eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence            9999999999999999988888999999999999999999999   9999999999999999999999999999997543


Q ss_pred             CC-ccccccccccccCcccccccCC---CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchh
Q 039290          913 KE-ESMRQTKTLGTIGYMAPEYGRE---GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEV  988 (1049)
Q Consensus       913 ~~-~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  988 (1049)
                      .- .........|...|||||++..   .+|++.+||||||+++|||++|..||.....+...+..  +.....      
T Consensus       540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV--GrG~l~------  611 (678)
T KOG0193|consen  540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV--GRGYLM------  611 (678)
T ss_pred             eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe--cccccC------
Confidence            21 1112223446789999998865   47899999999999999999999999732222221111  100000      


Q ss_pred             cccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhh
Q 039290          989 ADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043 (1049)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~ 1043 (1049)
                               +.......+|++++.+++..||..++++||++.+|+..|+++..++
T Consensus       612 ---------pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~  657 (678)
T KOG0193|consen  612 ---------PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL  657 (678)
T ss_pred             ---------ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence                     0112234678999999999999999999999999999999887754

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6.9e-40  Score=354.01  Aligned_cols=252  Identities=24%  Similarity=0.351  Sum_probs=208.6

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      ..++|+.+++||+|+||.||.|+. .+|..+|+|++++..   ..+.+.++.|-.+|....+|+||+++..|++.+.+|+
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            356799999999999999999994 579999999998764   4567889999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCC-
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK-  913 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~-  913 (1049)
                      ||||++||++..+|...+. +++..+..++.+++-|++.+|   +.|||||||||+|+|||..|++||+|||++..+.. 
T Consensus       219 iMEylPGGD~mTLL~~~~~-L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKDT-LTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEEecCCccHHHHHHhcCc-CchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            9999999999999987664 899999999999999999999   99999999999999999999999999999853211 


Q ss_pred             ---------------------Cc-c-----------------------ccccccccccCcccccccCCCCcCcccchHHH
Q 039290          914 ---------------------EE-S-----------------------MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSY  948 (1049)
Q Consensus       914 ---------------------~~-~-----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  948 (1049)
                                           .+ .                       ......+|||.|||||++.+..|+..+|.||+
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                 00 0                       00123689999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCccccccch--HHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCC
Q 039290          949 GIMLMETFTKKKPTDEIFAGEMS--LKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKR 1026 (1049)
Q Consensus       949 G~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 1026 (1049)
                      |||||||+.|.+||......+..  +..|.....                    ++....++.+..++|.+|+. ||++|
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~--------------------fP~~~~~s~eA~DLI~rll~-d~~~R  433 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK--------------------FPEEVDLSDEAKDLITRLLC-DPENR  433 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc--------------------CCCcCcccHHHHHHHHHHhc-CHHHh
Confidence            99999999999999764443332  122221111                    11123345788999999999 99999


Q ss_pred             CC---HHHHHHH
Q 039290         1027 IS---MKDVANR 1035 (1049)
Q Consensus      1027 pt---~~ell~~ 1035 (1049)
                      ..   ++||.+|
T Consensus       434 LG~~G~~EIK~H  445 (550)
T KOG0605|consen  434 LGSKGAEEIKKH  445 (550)
T ss_pred             cCcccHHHHhcC
Confidence            85   7777665

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=341.95  Aligned_cols=261  Identities=24%  Similarity=0.320  Sum_probs=217.6

Q ss_pred             hcCCCCCceecCCCcEEEEEEE-eCCCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .+.|+..++||.|.-++||+|+ .+.++.||||++..+.. ...+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            4578999999999999999999 56789999999987663 335889999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          838 YMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||.+|++.+.+... ...+++..+..|.+++++||.|||   .+|.||||||+.|||++++|.|||+|||.+-.+...+.
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            99999999998753 345899999999999999999999   99999999999999999999999999998876644331


Q ss_pred             ---ccccccccccCcccccccCC--CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccc
Q 039290          917 ---MRQTKTLGTIGYMAPEYGRE--GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA  991 (1049)
Q Consensus       917 ---~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  991 (1049)
                         .+....+||++|||||++..  ..|+.|+||||||++..|+.+|..||....+-+....+..+.......       
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t-------  254 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT-------  254 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccc-------
Confidence               12245689999999999543  579999999999999999999999999876666555554433221110       


Q ss_pred             ccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          992 NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                           ...+......+...+.+++..|++.||++|||+++++++
T Consensus       255 -----~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  255 -----SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             -----ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence                 011122334456689999999999999999999999987

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.7e-40  Score=356.89  Aligned_cols=247  Identities=29%  Similarity=0.406  Sum_probs=211.2

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      ++|.+.+.||+|+||.||+|+.+ +.+.||+|.+.+...  +..+.+++|++++++++|||||.++++|+...++++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888999999999999999954 788899999976543  335678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      |+.| +|..++..++. ++++++..|+.++..||.|||   +.+|.|||+||+||+++..|.+|+||||+|+.+.... .
T Consensus        82 ~a~g-~L~~il~~d~~-lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-~  155 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGK-LPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-S  155 (808)
T ss_pred             hhhh-hHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccCc-e
Confidence            9987 99999987765 899999999999999999999   9999999999999999999999999999999886543 3


Q ss_pred             cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccccc
Q 039290          918 RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE  997 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1049)
                      ..+...|||-|||||+..+++|+..+|.||+|||+|||++|++||...     .+.+.++....++              
T Consensus       156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d~--------------  216 (808)
T KOG0597|consen  156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKDP--------------  216 (808)
T ss_pred             eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcCC--------------
Confidence            345577999999999999999999999999999999999999998652     1122222111111              


Q ss_pred             ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          998 ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       998 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                         ...+...+..+.++++..+..||.+|.|..+++.|
T Consensus       217 ---v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  217 ---VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             ---CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence               11223567789999999999999999999999877

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-41  Score=363.99  Aligned_cols=398  Identities=24%  Similarity=0.256  Sum_probs=266.3

Q ss_pred             ceecccccccccccCCCCc-cc-cccceEEeccccccccCccccccccceEEEeeccccCCCccccccccccccceEEec
Q 039290          226 HVVSLAFNKFQGGIPRDIG-NL-TSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVT  303 (1049)
Q Consensus       226 ~~L~L~~N~l~~~~p~~~~-~l-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~  303 (1049)
                      +.||++.+++...--..+. -+ +.-+.||+++|++...-+..|.++++|+.+++..|.++. ||........|+.|+|.
T Consensus        55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~-IP~f~~~sghl~~L~L~  133 (873)
T KOG4194|consen   55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTR-IPRFGHESGHLEKLDLR  133 (873)
T ss_pred             eeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhhh-cccccccccceeEEeee
Confidence            4466666665432111111 11 234557777777776666667777777777776666653 34433344446666666


Q ss_pred             cCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCcccccccccccceeecccccccCC
Q 039290          304 DNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSP  383 (1049)
Q Consensus       304 ~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  383 (1049)
                      +|.+. ++...-...++.|+.||||.|.|+...-.+|..-.++++|+|++|+|+....+.|.++.+|..|.|+.|+|+.+
T Consensus       134 ~N~I~-sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittL  212 (873)
T KOG4194|consen  134 HNLIS-SVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTL  212 (873)
T ss_pred             ccccc-cccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccccc
Confidence            65554 33333333455555566666655543334454445555555555555555555555555555555555555555


Q ss_pred             CCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCC
Q 039290          384 TPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIP  463 (1049)
Q Consensus       384 ~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  463 (1049)
                      +..     +|+.+++|+.|+|..|+|.                         -.---.|.++++|+.|.|..|.+.....
T Consensus       213 p~r-----~Fk~L~~L~~LdLnrN~ir-------------------------ive~ltFqgL~Sl~nlklqrN~I~kL~D  262 (873)
T KOG4194|consen  213 PQR-----SFKRLPKLESLDLNRNRIR-------------------------IVEGLTFQGLPSLQNLKLQRNDISKLDD  262 (873)
T ss_pred             CHH-----Hhhhcchhhhhhcccccee-------------------------eehhhhhcCchhhhhhhhhhcCcccccC
Confidence            543     3555555555555555554                         2223446667777777777777776666


Q ss_pred             ccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccccCcccccccc
Q 039290          464 VTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKD  543 (1049)
Q Consensus       464 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  543 (1049)
                      +.|-.+.++++|+|+.|+++..-..++.+++.|+.|+||.|.|..+-+.+..-.++|++|+|++|+++...++.|..+..
T Consensus       263 G~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~  342 (873)
T KOG4194|consen  263 GAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQ  342 (873)
T ss_pred             cceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHH
Confidence            67777777777777777777666667777777777777777777666777777777777777777777777777777777


Q ss_pred             cccccccCCccCCCCccCcCCCcceeEeecccccccccccc---cccCCCcccEEEeecccccCCccccccCccCCcEEe
Q 039290          544 ILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPV---TIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVD  620 (1049)
Q Consensus       544 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  620 (1049)
                      |+.|+|++|.++..--..|..+++|++|||++|.|+..+.+   .|.++++|+.|.|.+|+|+.+.-.+|.++++|+.||
T Consensus       343 Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~Ld  422 (873)
T KOG4194|consen  343 LEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLD  422 (873)
T ss_pred             hhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceec
Confidence            77777777777766666777788888888888888766544   588899999999999999977778999999999999


Q ss_pred             ccCccccCCcccccccccccceeeccCCcccccCCC
Q 039290          621 MSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPT  656 (1049)
Q Consensus       621 Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~  656 (1049)
                      |.+|.|....|..|..+ .|+.|-+..-.|-|+|.-
T Consensus       423 L~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCql  457 (873)
T KOG4194|consen  423 LGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQL  457 (873)
T ss_pred             CCCCcceeecccccccc-hhhhhhhcccceEEeccH
Confidence            99999998889999999 899999988888888764

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-39  Score=359.90  Aligned_cols=250  Identities=26%  Similarity=0.346  Sum_probs=209.5

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecc----cC-CCHHHHHHHHHHHhhcC-CCceeeEEeeeecCCe
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHME----FD-GSLESFHAECKVMGSIR-HRNLVKIISSCSNNDF  831 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~  831 (1049)
                      ..++|...+.||+|+||+|+.|.. .+++.||+|++...    .. ...+.+.+|+.++++++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            356899999999999999999984 47899999977553    11 23456778999999998 9999999999999999


Q ss_pred             eEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCC-CceEEecccCcee
Q 039290          832 KALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES-MVGHLSDFGIAKI  910 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-~~~kl~DfGla~~  910 (1049)
                      .++||||+.||+|.+++.. ..++.+.++..+++|++.|++|||   ++||+||||||+||+++.+ +.+||+|||++..
T Consensus        95 ~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI  170 (370)
T ss_pred             EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence            9999999999999999998 556899999999999999999999   9999999999999999998 9999999999998


Q ss_pred             cCCCccccccccccccCcccccccCCCC-cC-cccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchh
Q 039290          911 LGKEESMRQTKTLGTIGYMAPEYGREGK-VS-RKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEV  988 (1049)
Q Consensus       911 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  988 (1049)
                      .. .........+|++.|+|||++.+.. |+ .++||||+||++|.|++|..||++.........               
T Consensus       171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k---------------  234 (370)
T KOG0583|consen  171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK---------------  234 (370)
T ss_pred             cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH---------------
Confidence            74 2223445678999999999999877 75 789999999999999999999987211111111               


Q ss_pred             cccccccccccCchhhHHH-HHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          989 ADANLLNCEENDFSAREQC-VSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                             .....+..+..+ +.++..++.+|+..+|.+|+|+.|++.+
T Consensus       235 -------i~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h  275 (370)
T KOG0583|consen  235 -------IRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH  275 (370)
T ss_pred             -------HhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence                   112223333344 7788999999999999999999999954

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.6e-39  Score=329.67  Aligned_cols=269  Identities=23%  Similarity=0.237  Sum_probs=208.3

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeec--CCeeEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSN--NDFKALV  835 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--~~~~~lv  835 (1049)
                      +.|+.+..|++|+||.||+|+. ++++.||+|+++.+.  .+-.-...+|+.++.+.+|||||.+-.++..  -+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            3477778999999999999995 478899999998765  3345677899999999999999999988754  4579999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      ||||+. +|..+++.-+.++...+++.++.|+++|++|||   .+.|+|||+|++|++++..|.+||+|||+|+.++.+.
T Consensus       156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            999987 999999988888999999999999999999999   9999999999999999999999999999999987653


Q ss_pred             cccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcc--cc
Q 039290          916 SMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD--AN  992 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  992 (1049)
                      . ..+..+-|.+|+|||.+.+ ..|+.+.|+||+|||+.||+++++-|.+...-+.....+.-.......+.+-+.  +.
T Consensus       232 k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~  310 (419)
T KOG0663|consen  232 K-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA  310 (419)
T ss_pred             c-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence            3 3456678999999998776 568999999999999999999998876533222211111111111111111100  00


Q ss_pred             c--cccc-------ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          993 L--LNCE-------ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       993 ~--~~~~-------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      +  ....       ..++.... .++.-.+++...+..||.+|.||+|.++|
T Consensus       311 ~k~~~f~~~pyn~lr~kF~~~~-lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  311 VKKMTFSEHPYNNLRKKFGALS-LSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             hhccccCCCCchhhhhhccccc-cchhHHHHHHHHhccCccccccHHHhhcc
Confidence            0  0000       11111111 34677899999999999999999999876

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=385.19  Aligned_cols=261  Identities=27%  Similarity=0.463  Sum_probs=221.3

Q ss_pred             CCCCCceecCCCcEEEEEEEeC--CCc----EEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP--DGM----EIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~--~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      .-+..+.||+|+||.||+|...  ++.    .||+|.++... .+...+|.+|..+|+.++|||||+++|++.+....+|
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            4556689999999999999954  343    48999887653 4557889999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcC------CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCc
Q 039290          835 VLEYMSNGSLEKCLYSD------NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA  908 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla  908 (1049)
                      ++|||++|+|..++++.      ...++..+...++.|||+|++||+   ++++|||||..+|+|+++...|||+|||+|
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA  849 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLA  849 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchh
Confidence            99999999999999987      567899999999999999999999   999999999999999999999999999999


Q ss_pred             eecCCCcccccccc-ccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcc
Q 039290          909 KILGKEESMRQTKT-LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSIT  986 (1049)
Q Consensus       909 ~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  986 (1049)
                      +.+-..+.++.... .-+..|||||.+.++.++.|+|||||||++||++| |..||.....-+.... +           
T Consensus       850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~-~-----------  917 (1025)
T KOG1095|consen  850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD-V-----------  917 (1025)
T ss_pred             HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH-H-----------
Confidence            96554444433333 45679999999999999999999999999999999 8899876332222111 0           


Q ss_pred             hhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhc
Q 039290          987 EVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAY 1046 (1049)
Q Consensus       987 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~ 1046 (1049)
                               ...+|.+.+..|+..++++|.+||+.+|++||++..+++.+..+......+
T Consensus       918 ---------~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~  968 (1025)
T KOG1095|consen  918 ---------LEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT  968 (1025)
T ss_pred             ---------HhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence                     112356667889999999999999999999999999999999998876544

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-40  Score=357.62  Aligned_cols=364  Identities=23%  Similarity=0.250  Sum_probs=206.4

Q ss_pred             cEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccce
Q 039290          148 QHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHV  227 (1049)
Q Consensus       148 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~  227 (1049)
                      +.||+|+|+++..-+..|.++++|+.+++.+|.++ .||...+..+      .|+.|+|.+|.++..-.+++..+..|+.
T Consensus        81 ~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sg------hl~~L~L~~N~I~sv~se~L~~l~alrs  153 (873)
T KOG4194|consen   81 QTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESG------HLEKLDLRHNLISSVTSEELSALPALRS  153 (873)
T ss_pred             eeeeccccccccCcHHHHhcCCcceeeeeccchhh-hccccccccc------ceeEEeeeccccccccHHHHHhHhhhhh
Confidence            44555555555555555555555555555555555 5554332211      2555555555555444455555555566


Q ss_pred             ecccccccccccCCCCccccccceEEeccccccccCccccccccceEEEeeccccCCCccccccccccccceEEeccCcc
Q 039290          228 VSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDL  307 (1049)
Q Consensus       228 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l  307 (1049)
                      ||||.|.|+..--..|..-.++++|+|++|+|+..--..|.++.+|..|.|+.|.++...+.+|.++++|+.|+|..|++
T Consensus       154 lDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~i  233 (873)
T KOG4194|consen  154 LDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRI  233 (873)
T ss_pred             hhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccce
Confidence            66666655533333455555666666666666655566666666666666666666666566666666666666666666


Q ss_pred             CCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCcccccccccccceeecccccccCCCCCc
Q 039290          308 LGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDL  387 (1049)
Q Consensus       308 ~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~  387 (1049)
                      . .+....|.+|++|+.|.|..|.|...-...|..+.++++|+|+.|++...-.+++.+|++|+.|+|++|.|..+..+ 
T Consensus       234 r-ive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d-  311 (873)
T KOG4194|consen  234 R-IVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHID-  311 (873)
T ss_pred             e-eehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecc-
Confidence            4 33344455677777777777777766666777777777777777777766666777777777777777777766543 


Q ss_pred             ccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCcccc
Q 039290          388 SFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLG  467 (1049)
Q Consensus       388 ~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  467 (1049)
                          +...+++|++|+|++|+|+...+.++                         ..+..|++|+|++|.+...-..+|.
T Consensus       312 ----~WsftqkL~~LdLs~N~i~~l~~~sf-------------------------~~L~~Le~LnLs~Nsi~~l~e~af~  362 (873)
T KOG4194|consen  312 ----SWSFTQKLKELDLSSNRITRLDEGSF-------------------------RVLSQLEELNLSHNSIDHLAEGAFV  362 (873)
T ss_pred             ----hhhhcccceeEeccccccccCChhHH-------------------------HHHHHhhhhcccccchHHHHhhHHH
Confidence                34455666666666666664444433                         3344444444444444433334444


Q ss_pred             CcCCCcceEeeccccCCCCCc---ccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccccCccccccccc
Q 039290          468 RLQKLQGLYLQNNKLEGSIPE---DLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDI  544 (1049)
Q Consensus       468 ~l~~L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  544 (1049)
                      .+++|++|||++|.|+..+.+   .|.+|+.|+.|+|.+|++..+.-.+|.++..|+.|||.+|.+..+-|.+|..+ .|
T Consensus       363 ~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~L  441 (873)
T KOG4194|consen  363 GLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-EL  441 (873)
T ss_pred             HhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hh
Confidence            444444444444444433222   23444445555555555443333445555555555555555555555555544 45


Q ss_pred             cccccc
Q 039290          545 LRFNLS  550 (1049)
Q Consensus       545 ~~L~Ls  550 (1049)
                      +.|.++
T Consensus       442 k~Lv~n  447 (873)
T KOG4194|consen  442 KELVMN  447 (873)
T ss_pred             hhhhhc
Confidence            554443

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-39  Score=321.14  Aligned_cols=236  Identities=27%  Similarity=0.314  Sum_probs=203.5

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|+..+.||.|+||.|..++.+ +|..+|+|++.+..   ..+.+...+|..+++.+.||+++++++.+.+.+.+|+||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            35778899999999999999954 78899999997653   334577889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||++||.|..++++.++ +++..++-+|.||+.|++|||   +.+|++||+||+|||+|.+|.+||+|||+|+....   
T Consensus       124 eyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---  196 (355)
T ss_pred             eccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecC---
Confidence            99999999999987665 899999999999999999999   99999999999999999999999999999997643   


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                       +..+.+|||.|+|||.+..+++..++|.|||||++|||+.|.+||.........-+              +        
T Consensus       197 -rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~K--------------I--------  253 (355)
T KOG0616|consen  197 -RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEK--------------I--------  253 (355)
T ss_pred             -cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHH--------------H--------
Confidence             34567899999999999999999999999999999999999999986433211111              1        


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCC
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKR 1026 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 1026 (1049)
                      ...+...|.....++++++...++.|-.+|
T Consensus       254 ~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  254 LEGKVKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HhCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence            122233445667789999999999999888

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=342.05  Aligned_cols=249  Identities=27%  Similarity=0.385  Sum_probs=211.3

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      ..|+..+.||+|+||.||+|.. ..++.||+|++..+. ....+++++|+.++.+.+++||.++++.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            3577778999999999999995 478899999997765 34567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      |.||++.+.+..... +++..+.-|+.++..|+.|+|   .++.+|||||+.||++..+|.||++|||.+..+......+
T Consensus        93 ~~gGsv~~lL~~~~~-~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr  168 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGNI-LDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR  168 (467)
T ss_pred             hcCcchhhhhccCCC-CccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence            999999998877653 488888889999999999999   9999999999999999999999999999998876554433


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                       .+.+||+.|||||++....|+.|+||||+|++.+||.+|.+|+......               .+...+...    .+
T Consensus       169 -~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm---------------rvlflIpk~----~P  228 (467)
T KOG0201|consen  169 -KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM---------------RVLFLIPKS----AP  228 (467)
T ss_pred             -ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc---------------eEEEeccCC----CC
Confidence             6789999999999999889999999999999999999999998763221               111111111    11


Q ss_pred             cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          999 NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       999 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ...+  .++++.+++|+..|+..+|+.||+|.++++|
T Consensus       229 P~L~--~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  229 PRLD--GDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             Cccc--cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            1111  2567789999999999999999999999987

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=341.80  Aligned_cols=263  Identities=23%  Similarity=0.398  Sum_probs=216.7

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCC-HHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGS-LESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      ....++++||+|.||+|..++...+..||||.++...... ..+|.+|+++|.+++|||||+++|+|..++.+++|+||+
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            3466779999999999999999888999999998776443 478999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcc-CHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc-
Q 039290          840 SNGSLEKCLYSDNYFL-DILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM-  917 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~-~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~-  917 (1049)
                      ++|+|.+++..+..+. ....-.+|+.||+.|++||.   +.++||||+.++|+|++.++++||+|||+++-.-..+.+ 
T Consensus       618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~  694 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR  694 (807)
T ss_pred             hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence            9999999998875433 56677889999999999999   999999999999999999999999999999855433332 


Q ss_pred             cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh--CCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          918 RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT--KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                      .....+-+.+|||||.+..++++.++|||+||+++||+++  .+.||.+..+.+.. .. .+.....+.           
T Consensus       695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv-en-~~~~~~~~~-----------  761 (807)
T KOG1094|consen  695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV-EN-AGEFFRDQG-----------  761 (807)
T ss_pred             eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH-Hh-hhhhcCCCC-----------
Confidence            3345667889999999999999999999999999999877  78898764433211 11 111111100           


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIR 1040 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~ 1040 (1049)
                       ...-...|.-|+.+++++|.+||..|-++||+++++..+|.+..
T Consensus       762 -~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  762 -RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             -cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence             01123445678999999999999999999999999999998643

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2e-38  Score=358.74  Aligned_cols=260  Identities=24%  Similarity=0.399  Sum_probs=205.6

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe------CCCcEEEEEEeecccC-CCHHHHHHHHHHHhhc-CCCceeeEEeeeecC-C
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL------PDGMEIAAKVFHMEFD-GSLESFHAECKVMGSI-RHRNLVKIISSCSNN-D  830 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~-~  830 (1049)
                      .++|++.++||+|+||.||+|.+      .+++.||+|+++.... ...+.+.+|++++.++ +||||+++++++... +
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            45799999999999999999974      2356799999875432 2345788999999999 899999999988764 4


Q ss_pred             eeEEEEeccCCCChhhhhhcCC----------------------------------------------------------
Q 039290          831 FKALVLEYMSNGSLEKCLYSDN----------------------------------------------------------  852 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  852 (1049)
                      ..++||||+++|+|.+++...+                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            6789999999999999886532                                                          


Q ss_pred             ---CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc-ccccccccccCc
Q 039290          853 ---YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES-MRQTKTLGTIGY  928 (1049)
Q Consensus       853 ---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y  928 (1049)
                         ..+++.++.+++.||++|++|||   ++||+||||||+||+++.++.+||+|||+++....... .......++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence               23777888999999999999999   99999999999999999999999999999986533221 122233456789


Q ss_pred             ccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCchhhHHH
Q 039290          929 MAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQC 1007 (1049)
Q Consensus       929 ~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1049)
                      +|||++.+..++.++|||||||++|||++ |..||......+.......             +..       ....+..+
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~-------------~~~-------~~~~~~~~  302 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK-------------DGT-------RMRAPENA  302 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHh-------------cCC-------CCCCCCCC
Confidence            99999988899999999999999999997 9999876332221111100             000       01112235


Q ss_pred             HHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHh
Q 039290         1008 VSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042 (1049)
Q Consensus      1008 ~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~ 1042 (1049)
                      +.++.+++.+||+.||++|||+.|+++.|+++.++
T Consensus       303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            56789999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-39  Score=358.45  Aligned_cols=261  Identities=28%  Similarity=0.420  Sum_probs=214.1

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC--CC---cEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCee
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP--DG---MEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFK  832 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~--~~---~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~  832 (1049)
                      ++-...++||+|+||.||+|++.  ++   ..||||..+...   .....++.+|+++|+.++|||||+++|++.....+
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence            34455589999999999999954  22   238999988533   34567899999999999999999999999999999


Q ss_pred             EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecC
Q 039290          833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      ++|||+|.||+|++++...+..++..+..+++.+.|+||+|||   +++++||||.++|+|++.++.+||+|||+++.-.
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~  313 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS  313 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence            9999999999999999998878999999999999999999999   9999999999999999999999999999987543


Q ss_pred             CCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccc
Q 039290          913 KEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA  991 (1049)
Q Consensus       913 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  991 (1049)
                       ..........-+..|+|||.+..+.+++++|||||||++||+++ |..||.+....+.  ..++..             
T Consensus       314 -~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v--~~kI~~-------------  377 (474)
T KOG0194|consen  314 -QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV--KAKIVK-------------  377 (474)
T ss_pred             -ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH--HHHHHh-------------
Confidence             11111112234679999999999999999999999999999999 8889987543322  222200             


Q ss_pred             ccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhh
Q 039290          992 NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSA 1045 (1049)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~ 1045 (1049)
                           ...+...+...+.++..++.+||..+|++||+|.++.+.++.+.+...+
T Consensus       378 -----~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  378 -----NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             -----cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence                 0111222234677899999999999999999999999999999887553

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.7e-39  Score=351.38  Aligned_cols=249  Identities=24%  Similarity=0.310  Sum_probs=213.4

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      +.|+.++.||.|+.|.|..|++ .+|+.+|||++.+..   +.....+.+|+-+|+-+.|||+++++++|++..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            4588899999999999999995 589999999997653   344678899999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+++|.|.+++...+. +++.++.+++.||+.|+.|+|   ..+|+|||+||+|+++|..+.+||+|||+|..-.++ .
T Consensus        92 Eyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-k  166 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-K  166 (786)
T ss_pred             EecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCC-c
Confidence            99999999999987765 888899999999999999999   999999999999999999999999999999864332 2


Q ss_pred             ccccccccccCcccccccCCCCcC-cccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVS-RKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                       --.+.+|++.|.|||++.+.+|. .++||||.|||+|.++||+.||++.--....                      .+
T Consensus       167 -lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LL----------------------lK  223 (786)
T KOG0588|consen  167 -LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLL----------------------LK  223 (786)
T ss_pred             -cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHH----------------------HH
Confidence             23346899999999999998884 7899999999999999999999852111111                      11


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                      ...+.+..|.+.+.+..+++.+|+.+||++|.|++||++|-.
T Consensus       224 V~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~  265 (786)
T KOG0588|consen  224 VQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF  265 (786)
T ss_pred             HHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence            123345555677888999999999999999999999999843

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.7e-38  Score=328.43  Aligned_cols=275  Identities=24%  Similarity=0.275  Sum_probs=209.6

Q ss_pred             CCCCCceecCCCcEEEEEEE-eCCCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCc-eeeEEeeeecCC------e
Q 039290          762 GFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRN-LVKIISSCSNND------F  831 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpn-iv~l~~~~~~~~------~  831 (1049)
                      .|...++||+|+||+||+|+ ..+|+.||+|++..+.+  +......+|+.++++++|+| ||++++++...+      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            45566789999999999999 45889999999987654  46678899999999999999 999999998776      7


Q ss_pred             eEEEEeccCCCChhhhhhcCC---CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCc
Q 039290          832 KALVLEYMSNGSLEKCLYSDN---YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA  908 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla  908 (1049)
                      .++|+||++. +|.+++....   ...+...++.+++||++|++|||   +++|+||||||+||+++++|.+||+|||+|
T Consensus        92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccchH
Confidence            8999999966 9999998766   35777899999999999999999   999999999999999999999999999999


Q ss_pred             eecCCCccccccccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhh-ccccCCcc
Q 039290          909 KILGKEESMRQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGD-SLLSCSIT  986 (1049)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~  986 (1049)
                      +.+.-+.. ..++.++|.+|+|||++.+. .|+...||||+|||++||++++.-|.+....+.....+... ...+..+.
T Consensus       168 ra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp  246 (323)
T KOG0594|consen  168 RAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP  246 (323)
T ss_pred             HHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence            97653332 24567789999999998775 78999999999999999999988887654432222211110 00001111


Q ss_pred             hhc---ccc-cccccccCchhh---HHHHHHHHHHHhhccccCCCCCCCHHHHHHH--HHHHHH
Q 039290          987 EVA---DAN-LLNCEENDFSAR---EQCVSSIFSLAMDCTVDLPEKRISMKDVANR--LVRIRE 1041 (1049)
Q Consensus       987 ~~~---~~~-~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~--L~~i~~ 1041 (1049)
                      .+.   +-. ............   ........+++.+|++.+|.+|.|++.++.|  +..+..
T Consensus       247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence            111   000 000010000001   1112478999999999999999999999998  655543

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-39  Score=345.86  Aligned_cols=251  Identities=24%  Similarity=0.405  Sum_probs=209.1

Q ss_pred             cccHHHHHHHhcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecC
Q 039290          750 RISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNN  829 (1049)
Q Consensus       750 ~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~  829 (1049)
                      .+.|+++.       .++-||.|+.|.||.|+. .++.||||+++.-       -..+++.+++++||||+.+.|+|...
T Consensus       120 eiPFe~Is-------ELeWlGSGaQGAVF~Grl-~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqs  184 (904)
T KOG4721|consen  120 EIPFEEIS-------ELEWLGSGAQGAVFLGRL-HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQS  184 (904)
T ss_pred             cCCHHHhh-------hhhhhccCcccceeeeec-cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCC
Confidence            45555553       346799999999999998 6789999998632       23578889999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCce
Q 039290          830 DFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK  909 (1049)
Q Consensus       830 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~  909 (1049)
                      ..++||||||..|-|..+++..+. ++..-...|..+||.|+.|||   .++|||||||.-||||+.+..|||+|||-++
T Consensus       185 PcyCIiMEfCa~GqL~~VLka~~~-itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~  260 (904)
T KOG4721|consen  185 PCYCIIMEFCAQGQLYEVLKAGRP-ITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSK  260 (904)
T ss_pred             ceeEEeeeccccccHHHHHhccCc-cCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchH
Confidence            999999999999999999987654 777888899999999999999   9999999999999999999999999999998


Q ss_pred             ecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhc
Q 039290          910 ILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA  989 (1049)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  989 (1049)
                      .....  .....+.||..|||||++...+.+.|+||||||||+|||+||..||.+.....+.+-     +          
T Consensus       261 e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG-----V----------  323 (904)
T KOG4721|consen  261 ELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG-----V----------  323 (904)
T ss_pred             hhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEe-----c----------
Confidence            65432  233457899999999999999999999999999999999999999976322211110     0          


Q ss_pred             ccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 039290          990 DANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041 (1049)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~ 1041 (1049)
                      .     ......+.+..|++.+.-++++||+-.|..||+|.+++.||+-...
T Consensus       324 G-----sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p  370 (904)
T KOG4721|consen  324 G-----SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP  370 (904)
T ss_pred             c-----CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence            0     0111234567789999999999999999999999999999975433

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-39  Score=331.11  Aligned_cols=273  Identities=23%  Similarity=0.283  Sum_probs=207.8

Q ss_pred             HHHHhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeec----
Q 039290          756 LLRATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSN----  828 (1049)
Q Consensus       756 ~~~~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~----  828 (1049)
                      .......|...+.||+|+||.|..|.. .+|+.||+|++...+  ....++..+|+++++.++|+||+.+.+++..    
T Consensus        17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~   96 (359)
T KOG0660|consen   17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD   96 (359)
T ss_pred             EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence            334455677788999999999999995 588999999997444  3446788999999999999999999998865    


Q ss_pred             -CCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccC
Q 039290          829 -NDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGI  907 (1049)
Q Consensus       829 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGl  907 (1049)
                       -+..|+|+|+| +.+|.+.++.... +++..+.-+++|+++|++|+|   +.+|+|||+||.|++++.++..||+|||+
T Consensus        97 ~f~DvYiV~elM-etDL~~iik~~~~-L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen   97 KFNDVYLVFELM-ETDLHQIIKSQQD-LTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             ccceeEEehhHH-hhHHHHHHHcCcc-ccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccc
Confidence             35789999999 5599999887654 899999999999999999999   99999999999999999999999999999


Q ss_pred             ceecCCC-ccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccC--
Q 039290          908 AKILGKE-ESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSC--  983 (1049)
Q Consensus       908 a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--  983 (1049)
                      |+..... .....+..+.|.+|+|||++.. ..|+.+.||||.|||++||++|++-|.+...  ....+.+-.....+  
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~--v~Ql~lI~~~lGtP~~  249 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY--VHQLQLILELLGTPSE  249 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch--HHHHHHHHHhcCCCCH
Confidence            9987542 1223456678999999997754 6899999999999999999999988765221  11111111111111  


Q ss_pred             -Ccchhccc----c---cccccccCc-hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          984 -SITEVADA----N---LLNCEENDF-SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       984 -~~~~~~~~----~---~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                       .+..+...    .   +...++..+ ..-+...+...+++.+|+..||.+|+|++|+++|
T Consensus       250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence             11111100    0   111111111 1113456778999999999999999999999987

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=331.02  Aligned_cols=272  Identities=24%  Similarity=0.356  Sum_probs=208.9

Q ss_pred             CCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhh--cCCCceeeEEeeeecCC----eeEEE
Q 039290          762 GFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGS--IRHRNLVKIISSCSNND----FKALV  835 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~hpniv~l~~~~~~~~----~~~lv  835 (1049)
                      .....+++|+|+||.||+|.+ +++.||||++...   ..+.|.+|.++++.  ++|+||++++++-...+    .+++|
T Consensus       211 pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             chhhHHHhhcCccceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            344557899999999999998 5599999999754   45778888888875  48999999999876665    78999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHc------cCCCCeEEcCCCCCCeeecCCCceEEecccCce
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF------GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK  909 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~------~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~  909 (1049)
                      +||++.|+|.+++..+-  ++|....+|+..+++||+|||+      .++.+|+|||||++||||.+++++.|+|||+|.
T Consensus       287 t~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl  364 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL  364 (534)
T ss_pred             eeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence            99999999999998754  8999999999999999999994      346789999999999999999999999999999


Q ss_pred             ecCCCccc-cccccccccCcccccccCCCC------cCcccchHHHHHHHHHHHhCCCCCC--ccccccchHHHhhhhcc
Q 039290          910 ILGKEESM-RQTKTLGTIGYMAPEYGREGK------VSRKCDVYSYGIMLMETFTKKKPTD--EIFAGEMSLKRWVGDSL  980 (1049)
Q Consensus       910 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~------~~~~~DvwslG~il~elltg~~p~~--~~~~~~~~~~~~~~~~~  980 (1049)
                      .+.+.... .....+||.+|||||++.+.-      .-.+.||||+|.|+|||+++..-++  ....-+..+..-++   
T Consensus       365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG---  441 (534)
T KOG3653|consen  365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG---  441 (534)
T ss_pred             EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc---
Confidence            88654432 223378999999999987632      1236899999999999999776543  22222223332222   


Q ss_pred             ccCCcchhcccccccccccCchh---hHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHh
Q 039290          981 LSCSITEVADANLLNCEENDFSA---REQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042 (1049)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~ 1042 (1049)
                      ..+.+.++.+-.+.+.....++.   ....+..+.+.+..||+.||+.|.|+.-+.+++.++...
T Consensus       442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~  506 (534)
T KOG3653|consen  442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML  506 (534)
T ss_pred             CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence            22333444333333222221111   124567799999999999999999999999999887653

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=343.25  Aligned_cols=256  Identities=24%  Similarity=0.417  Sum_probs=221.8

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC---CCc--EEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP---DGM--EIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~---~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      +.....++||+|-||.||+|.+.   .|.  .||||.-+.+- ....+.|..|+.+|+.++||||++++|+|.+. ..+|
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi  467 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI  467 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence            34556689999999999999953   233  48889887643 44578999999999999999999999999876 4699


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      |||.++.|.|..++..++..++......+++||+.||+|||   +..+|||||..+||+|.+..-||++|||+++.+..+
T Consensus       468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            99999999999999999999999999999999999999999   999999999999999999999999999999998777


Q ss_pred             ccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          915 ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       915 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                      ..+..+...-+..|||||.+.-.+++.++|||.|||.|||++. |..||.+....+..                     .
T Consensus       545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI---------------------~  603 (974)
T KOG4257|consen  545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI---------------------G  603 (974)
T ss_pred             chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE---------------------E
Confidence            7666665556789999999999999999999999999999998 99999874333221                     1


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~ 1041 (1049)
                      .-....|.+.|++|++.++.++.+||.+||.+||++.|+...|.++..
T Consensus       604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            112234667788999999999999999999999999999999999987

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-38  Score=310.14  Aligned_cols=250  Identities=24%  Similarity=0.333  Sum_probs=213.6

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      .++|++++.||+|.||.||.|+. +++--||+|++.+..   .+...++.+|+++.+.++||||++++++|.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            45789999999999999999994 577789999986653   34467899999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          836 LEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      +||..+|.+...+...+ ..+++...+.++.|+|.|+.|+|   .++|+||||||+|+|++.++..|++|||.+..-.  
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            99999999999888543 35899999999999999999999   9999999999999999999999999999998643  


Q ss_pred             ccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          915 ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       915 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                       .......+||..|.|||+..+..++..+|+|++|++.||++.|.+||+....++. +.+..+                 
T Consensus       176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et-YkrI~k-----------------  236 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET-YKRIRK-----------------  236 (281)
T ss_pred             -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH-HHHHHH-----------------
Confidence             2344557899999999999999999999999999999999999999987553332 222111                 


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                          -+...+...+....++|.+|+..+|.+|.+..|+++|-.
T Consensus       237 ----~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw  275 (281)
T KOG0580|consen  237 ----VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPW  275 (281)
T ss_pred             ----ccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence                112223456678899999999999999999999998854

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=378.33  Aligned_cols=505  Identities=26%  Similarity=0.336  Sum_probs=359.5

Q ss_pred             EEEeccccccccCCCCCCcchhhhhhcccCccccccCc-ccccccCCcEeccccCCccccCcccccccCCccEEEeCCCC
Q 039290           78 LNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPE-ELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNS  156 (1049)
Q Consensus        78 l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~-~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~  156 (1049)
                      +|+++..+. .||..+..-..++.|+++.|.+. ..|- .+.+.-+|+.||+++|++. ..|..+..+.+|+.|+++.|.
T Consensus         3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~   79 (1081)
T KOG0618|consen    3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNY   79 (1081)
T ss_pred             cccccccCc-ccchhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhh
Confidence            566666666 78888877777999999988765 4443 3345556999999988886 889999999999999999999


Q ss_pred             ccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccceecccccccc
Q 039290          157 FVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQ  236 (1049)
Q Consensus       157 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  236 (1049)
                      +. .+|.+++++.+|++|.|.+|++. ..|.++..      +.+|++|++|.|++. .+|..+..++.+..+..++|...
T Consensus        80 i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~------lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~  150 (1081)
T KOG0618|consen   80 IR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISE------LKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKI  150 (1081)
T ss_pred             Hh-hCchhhhhhhcchhheeccchhh-cCchhHHh------hhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhh
Confidence            98 88899999999999999999998 88887754      345889999999997 89999999999999999999332


Q ss_pred             cccCCCCccccccceEEeccccccccCccccccccceEEEeeccccCCCccccccccccccceEEeccCccCCCCCCccc
Q 039290          237 GGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSID  316 (1049)
Q Consensus       237 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~  316 (1049)
                      ..    ++... ++.++|..|.+.+.++.+++++++  .|+|++|++.   -..+.++.+|+.|.+..|++..     +.
T Consensus       151 ~~----lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~-----l~  215 (1081)
T KOG0618|consen  151 QR----LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSE-----LE  215 (1081)
T ss_pred             hh----hcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccce-----EE
Confidence            22    23333 888899999999999988888888  8999999887   2346778888888888888862     12


Q ss_pred             CCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCcccccccccccceeecccccccCCCCCcccccccccC
Q 039290          317 LGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSC  396 (1049)
Q Consensus       317 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l  396 (1049)
                      ...++|+.|+.++|.++...+. + .-.+|+++|+++|++++. |++++.+.+|+.+...+|+++.++..      +...
T Consensus       216 ~~g~~l~~L~a~~n~l~~~~~~-p-~p~nl~~~dis~n~l~~l-p~wi~~~~nle~l~~n~N~l~~lp~r------i~~~  286 (1081)
T KOG0618|consen  216 ISGPSLTALYADHNPLTTLDVH-P-VPLNLQYLDISHNNLSNL-PEWIGACANLEALNANHNRLVALPLR------ISRI  286 (1081)
T ss_pred             ecCcchheeeeccCcceeeccc-c-ccccceeeecchhhhhcc-hHHHHhcccceEecccchhHHhhHHH------Hhhh
Confidence            2457888999999988833322 2 235788899999998854 68888888888888888888765543      2333


Q ss_pred             CCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCC-Ccce
Q 039290          397 RNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQK-LQGL  475 (1049)
Q Consensus       397 ~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L  475 (1049)
                      .+|+.|+..+|.+.                          .+|+....++.|++|+|..|+|....+..+.-+.. |..|
T Consensus       287 ~~L~~l~~~~nel~--------------------------yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~l  340 (1081)
T KOG0618|consen  287 TSLVSLSAAYNELE--------------------------YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTL  340 (1081)
T ss_pred             hhHHHHHhhhhhhh--------------------------hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHH
Confidence            44444444444444                          44555556666666666666666333323333332 5666


Q ss_pred             EeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccC
Q 039290          476 YLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLN  555 (1049)
Q Consensus       476 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  555 (1049)
                      +.+.|++....--.=..++.|+.|++.+|.++...-..+.+..+|+.|+|++|+|..+....+.+++.|+.|+||+|+++
T Consensus       341 n~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~  420 (1081)
T KOG0618|consen  341 NVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT  420 (1081)
T ss_pred             hhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh
Confidence            66666665332222223556777777777776665556667777777777777777665566677777777777777776


Q ss_pred             CCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCC-ccccccCccCCcEEeccCccccCCccccc
Q 039290          556 GSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGP-IPESFGGLKSLNFVDMSNNNLSGTIPKSM  634 (1049)
Q Consensus       556 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~  634 (1049)
                      . +|..+..+..|+.|...+|+|. ..| ++..++.|+.+|+|.|+|+.. +|..... ++|++|||++|.-....-..+
T Consensus       421 ~-Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~~l~~d~~~l  496 (1081)
T KOG0618|consen  421 T-LPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNTRLVFDHKTL  496 (1081)
T ss_pred             h-hhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCC-cccceeeccCCcccccchhhh
Confidence            4 5667777777777777777776 455 777788888888888887753 3333322 788888888887433444556


Q ss_pred             ccccccceeeccCC
Q 039290          635 EALSYLKHLNLSFN  648 (1049)
Q Consensus       635 ~~l~~L~~l~l~~N  648 (1049)
                      ..++++...++.-|
T Consensus       497 ~~l~~l~~~~i~~~  510 (1081)
T KOG0618|consen  497 KVLKSLSQMDITLN  510 (1081)
T ss_pred             HHhhhhhheecccC
Confidence            66667777776666

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-38  Score=346.67  Aligned_cols=251  Identities=26%  Similarity=0.344  Sum_probs=215.2

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCe-eEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDF-KALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~-~~lv  835 (1049)
                      .++|...+++|+|+||.++.++++ ++..||+|.+....  .......++|+.++++++|||||.+.+.|.+++. .+||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            357889999999999999999854 77899999997654  3344578899999999999999999999999988 9999


Q ss_pred             EeccCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          836 LEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      |+||+||++.+.+.+.+ ..++++++.+++.|++.|+.|||   ++.|+|||||+.|||++.++.|||+|||+|+.+.++
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            99999999999998765 67999999999999999999999   999999999999999999999999999999998776


Q ss_pred             ccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          915 ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       915 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                      ... ..+.+||+.||+||.+.+.+|..|+||||+||++|||++-+++|............              ....  
T Consensus       160 ~~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki--------------~~~~--  222 (426)
T KOG0589|consen  160 DSL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKI--------------NRGL--  222 (426)
T ss_pred             hhh-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHH--------------hhcc--
Confidence            533 34578999999999999999999999999999999999999998763222221111              1111  


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                           -.+.+...+.++..+|..|++.+|+.||++.+++.+
T Consensus       223 -----~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 -----YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -----CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                 123344567889999999999999999999999988

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=315.46  Aligned_cols=252  Identities=24%  Similarity=0.363  Sum_probs=207.3

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      .+.|++.++||+|.|+.||++.+ .+|+.+|+|++....  ....+++.+|+++-+.++|||||++.+.+......|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            45678888999999999999984 589999999885432  446788999999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec---CCCceEEecccCceecCC
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~---~~~~~kl~DfGla~~~~~  913 (1049)
                      |+++|++|..-+-.+ ..+++..+-..++||++|+.|+|   .++|||||+||+|+++-   ....+|++|||+|.... 
T Consensus        90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-  164 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-  164 (355)
T ss_pred             ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence            999999997665544 45788889999999999999999   99999999999999995   45589999999999887 


Q ss_pred             CccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          914 EESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       914 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                       +.......+|||.|||||+....+|+..+|||+.|||+|-++.|.+||.+.....  +.+.                .+
T Consensus       165 -~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r--lye~----------------I~  225 (355)
T KOG0033|consen  165 -DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYEQ----------------IK  225 (355)
T ss_pred             -CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH--HHHH----------------Hh
Confidence             3333445789999999999999999999999999999999999999997622221  1111                11


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ........+.....+++.++++++|+..||.+|.|+.|.++|
T Consensus       226 ~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  226 AGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             ccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence            111111112234566788999999999999999999999876

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.2e-37  Score=337.96  Aligned_cols=247  Identities=23%  Similarity=0.327  Sum_probs=202.1

Q ss_pred             CceecCCCcEEEEEEEeCCCcEEEEEEeecccCCC---HHHHHHHHHHHhhcCCCceeeEEeeeec----CCeeEEEEec
Q 039290          766 NKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGS---LESFHAECKVMGSIRHRNLVKIISSCSN----NDFKALVLEY  838 (1049)
Q Consensus       766 ~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~----~~~~~lv~e~  838 (1049)
                      ...+|+|++|.||+|++ +|+.||+|+++......   .+.+.+|++++++++||||+++++++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36899999999999998 78999999997654333   4677899999999999999999999876    3467899999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCC-CCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS-TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      +++|+|.+++...+ .+++....+++.|++.|++|+|   + .+++||||||+||++++++.+||+|||++.......  
T Consensus       104 ~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        104 CTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            99999999997654 5889999999999999999999   6 489999999999999999999999999988653321  


Q ss_pred             cccccccccCcccccccCC--CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          918 RQTKTLGTIGYMAPEYGRE--GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                        ....++..|+|||++.+  ..++.++|||||||++|||++|+.||......+.. .....                 .
T Consensus       178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~-~~i~~-----------------~  237 (283)
T PHA02988        178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY-DLIIN-----------------K  237 (283)
T ss_pred             --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH-HHHHh-----------------c
Confidence              23467889999999876  68899999999999999999999999764222111 11100                 0


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~ 1041 (1049)
                        ..+...+..++.++.+++.+||+.||++|||++|+++.|+.+..
T Consensus       238 --~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        238 --NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             --CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence              00111222466789999999999999999999999999997753

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-38  Score=308.02  Aligned_cols=262  Identities=23%  Similarity=0.284  Sum_probs=210.3

Q ss_pred             HHhcCCCCCceecCCCcEEEEEEE-eCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecC-----Ce
Q 039290          758 RATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNN-----DF  831 (1049)
Q Consensus       758 ~~~~~~~~~~~lg~G~fg~Vy~a~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~-----~~  831 (1049)
                      ....+|++.+.+|+|+|+.||.++ ..+++.||+|++.-......+..++|++..++++|||+++++++...+     ..
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            345689999999999999999999 668899999999887767788999999999999999999999987443     35


Q ss_pred             eEEEEeccCCCChhhhhhc---CCCccCHHHHHHHHHHHHHHHHHhHccCCCC--eEEcCCCCCCeeecCCCceEEeccc
Q 039290          832 KALVLEYMSNGSLEKCLYS---DNYFLDILQRLKIMIDVASALEYLHFGYSTP--IVHCDIKPSNVLLNESMVGHLSDFG  906 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIl~~~~~~~kl~DfG  906 (1049)
                      .|++++|...|+|.+.+..   .+..+++.++.+|+.++++||++||   +..  ++||||||.||++++++.+++.|||
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCceEEEecc
Confidence            8999999999999998764   4457999999999999999999999   666  9999999999999999999999999


Q ss_pred             CceecCCCccc--------cccccccccCcccccccC---CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHh
Q 039290          907 IAKILGKEESM--------RQTKTLGTIGYMAPEYGR---EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRW  975 (1049)
Q Consensus       907 la~~~~~~~~~--------~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~  975 (1049)
                      .++...-.-..        .......|..|+|||.+.   +...+.++||||+||++|+|+.|..||+..........  
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla--  252 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA--  252 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE--
Confidence            99765321111        112234689999999874   34578999999999999999999999986432211110  


Q ss_pred             hhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 039290          976 VGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIR 1040 (1049)
Q Consensus       976 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~ 1040 (1049)
                                ..+..+.      ..++.....++.+.++++.|+++||.+||++.+++.++.++.
T Consensus       253 ----------LAv~n~q------~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  253 ----------LAVQNAQ------ISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ----------Eeeeccc------cccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                      0111111      111222236788999999999999999999999999988753

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.3e-37  Score=341.84  Aligned_cols=271  Identities=20%  Similarity=0.196  Sum_probs=204.8

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      ++|++.+.||+|+||+||+|+.. +++.||+|+++...  ....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36889999999999999999965 67889999987543  2335678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      |++++.+..+.. ....+++..++.++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++.........
T Consensus        81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          81 YVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence            999877665443 3445899999999999999999999   999999999999999999999999999999876433322


Q ss_pred             cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchH--HHhhhh--------ccccCCcch
Q 039290          918 RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSL--KRWVGD--------SLLSCSITE  987 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--~~~~~~--------~~~~~~~~~  987 (1049)
                      ......+++.|+|||++.+..++.++||||+||++|||++|+.||......+...  ....+.        .........
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07848         157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG  236 (287)
T ss_pred             cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence            2334568999999999988889999999999999999999999997532211110  000000        000000000


Q ss_pred             hcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          988 VADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       988 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ...+................+.++.+++.+|++.||++|||++|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            000000000000001112356779999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=330.36  Aligned_cols=257  Identities=28%  Similarity=0.366  Sum_probs=203.4

Q ss_pred             HHHhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC--------------CCHHHHHHHHHHHhhcCCCceee
Q 039290          757 LRATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD--------------GSLESFHAECKVMGSIRHRNLVK  821 (1049)
Q Consensus       757 ~~~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~hpniv~  821 (1049)
                      .+..++|++.+.||+|.||.|-+|+. .+++.||+|++.+..-              ...+++.+|+.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            34567899999999999999999995 4789999999965421              12368999999999999999999


Q ss_pred             EEeeeec--CCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCc
Q 039290          822 IISSCSN--NDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMV  899 (1049)
Q Consensus       822 l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~  899 (1049)
                      ++++..+  .+.+|||+|||..|.+...-.. ...+++.++++++.++..||+|||   .+|||||||||.|+|++++|+
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCc
Confidence            9999876  4689999999999988764222 223899999999999999999999   999999999999999999999


Q ss_pred             eEEecccCceecCCCc----cccccccccccCcccccccCCCC----cCcccchHHHHHHHHHHHhCCCCCCccccccch
Q 039290          900 GHLSDFGIAKILGKEE----SMRQTKTLGTIGYMAPEYGREGK----VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMS  971 (1049)
Q Consensus       900 ~kl~DfGla~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~p~~~~~~~~~~  971 (1049)
                      |||+|||.+.......    .......+|||.|+|||...++.    .+.+.||||+||++|.|+.|+.||-+.+.-+..
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~  328 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF  328 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence            9999999998763221    11123378999999999887632    357889999999999999999999763322221


Q ss_pred             HHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          972 LKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                      -+.              ....+      .++..++..+++.++|.+++..||++|.+..+|..|..
T Consensus       329 ~KI--------------vn~pL------~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw  374 (576)
T KOG0585|consen  329 DKI--------------VNDPL------EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW  374 (576)
T ss_pred             HHH--------------hcCcc------cCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence            111              11100      11222245677899999999999999999999988754

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3e-37  Score=336.61  Aligned_cols=255  Identities=23%  Similarity=0.370  Sum_probs=206.8

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC----CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP----DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      .+|++.+.||+|+||.||+|.+.    .+..||+|.++.... .....+.+|+.++++++||||+++++++..++..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46888899999999999999853    456899999876532 2345788999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++|+|.+++......+++.+++.++.|++.|++|||   +++++||||||+||+++.++.++++|||.+.......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~  161 (266)
T cd05064          85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA  161 (266)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence            9999999999999876667899999999999999999999   9999999999999999999999999999876543222


Q ss_pred             cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                      ........++..|+|||.+.+..++.++||||+||++||+++ |..||......+  ........               
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~~~~~~~~---------------  224 (266)
T cd05064         162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--VIKAVEDG---------------  224 (266)
T ss_pred             hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHHCC---------------
Confidence            111122334678999999988999999999999999999775 999997643221  11111000               


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                          ...+.+..++..+.+++.+||+.+|++||+++|+.+.|+++
T Consensus       225 ----~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 ----FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                01112234677899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=4.3e-37  Score=338.85  Aligned_cols=251  Identities=23%  Similarity=0.301  Sum_probs=203.1

Q ss_pred             CCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          762 GFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+....   ......+.+|++++++++|++|+++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            367789999999999999995 578999999986543   2223467889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          838 YMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      |+++|+|.+.+... ...+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||++........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence            99999999887643 335899999999999999999999   99999999999999999999999999999987543221


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                        .....|+..|+|||++.+..++.++||||+||++|||++|+.||......... ....              ....  
T Consensus       158 --~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~~~~--------------~~~~--  218 (285)
T cd05631         158 --VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR-EEVD--------------RRVK--  218 (285)
T ss_pred             --ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH-HHHH--------------HHhh--
Confidence              23456899999999999999999999999999999999999999753221111 0000              0000  


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRIS-----MKDVANR 1035 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~ell~~ 1035 (1049)
                       ......+...+.++.+++.+||+.||++||+     +++++++
T Consensus       219 -~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         219 -EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             -cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence             0001112235667899999999999999997     8898886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.3e-38  Score=325.74  Aligned_cols=262  Identities=25%  Similarity=0.299  Sum_probs=198.1

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecC---C--eeEEE
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNN---D--FKALV  835 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~---~--~~~lv  835 (1049)
                      .|...+++|+|+||.||+|... +++.||||+.-.+..    .--+|+++|+.++|||||++..+|...   +  ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4667799999999999999954 578999999864432    123689999999999999999988542   2  34589


Q ss_pred             EeccCCCChhhhhhc---CCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCC-CceEEecccCceec
Q 039290          836 LEYMSNGSLEKCLYS---DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES-MVGHLSDFGIAKIL  911 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-~~~kl~DfGla~~~  911 (1049)
                      |||++. +|.++++.   .+..++...++-+.+||++|++|||   +.||+||||||.|+|||.+ |.+||||||.|+..
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999976 99988874   2446888889999999999999999   9999999999999999954 99999999999988


Q ss_pred             CCCccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhc--cccCCcchh
Q 039290          912 GKEESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDS--LLSCSITEV  988 (1049)
Q Consensus       912 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~  988 (1049)
                      ......  .+...|..|+|||.+.+ ..|+.+.||||.|||++||+-|++-|.+... ..+++..++-.  .....+..+
T Consensus       177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~-~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS-VDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH-HHHHHHHHHHhCCCCHHHHhhc
Confidence            665543  34567999999998876 5799999999999999999999998876322 22333322211  111111111


Q ss_pred             -------cccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          989 -------ADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       989 -------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                             ..+.+....-.+ -.....+++..+++.++++.+|.+|.++.|++.|
T Consensus       254 n~~y~~~~~p~ik~~~~~~-~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHK-VFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             CcccccccCccccccccee-ecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence                   111111111111 1223456789999999999999999999999976

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.4e-37  Score=338.04  Aligned_cols=271  Identities=20%  Similarity=0.245  Sum_probs=204.9

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .++|+..+.||+|+||+||+|+.. +++.||+|+++... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            457999999999999999999954 78899999987543 2334577899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      |+++ +|.+++...+..+++..+..++.||+.||+|||   ++||+||||||+||+++.++.+||+|||++........ 
T Consensus        84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-  158 (288)
T cd07871          84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-  158 (288)
T ss_pred             CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence            9975 999988776666889999999999999999999   99999999999999999999999999999976533221 


Q ss_pred             cccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhh-ccccCCcchhc-----c
Q 039290          918 RQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGD-SLLSCSITEVA-----D  990 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~  990 (1049)
                      ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+.....+... ......+..+.     .
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR  238 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence            1233467899999998765 568999999999999999999999997543222111110000 00000000000     0


Q ss_pred             cccccccc--cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          991 ANLLNCEE--NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       991 ~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ....+...  .........+.+..+++.+|++.||.+|||++|+++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            00000000  0001112245678999999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-37  Score=343.02  Aligned_cols=242  Identities=24%  Similarity=0.316  Sum_probs=204.2

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~l  834 (1049)
                      .++|...++||+|.||+|+.|..+ +++.||||++++..   +...+..+.|.+++... +||.+++++..|.+.+++|+
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            457899999999999999999954 78899999998765   55678888999998877 59999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      ||||+.||++..+.+  ...+++..+.-++..++.||+|||   ++||||||+|.+||++|.+|.+||+|||+++.---.
T Consensus       447 vmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  447 VMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             EEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence            999999999544333  345899999999999999999999   999999999999999999999999999999854222


Q ss_pred             ccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          915 ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       915 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                       ....++..||+.|||||++.+..|+.++|.|||||+||||+.|..||.+...++.                  +|..+ 
T Consensus       522 -g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~------------------FdsI~-  581 (694)
T KOG0694|consen  522 -GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV------------------FDSIV-  581 (694)
T ss_pred             -CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH------------------HHHHh-
Confidence             2355678999999999999999999999999999999999999999986333322                  11111 


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISM 1029 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~ 1029 (1049)
                         ..+...|..++.+..+++++++..+|++|..+
T Consensus       582 ---~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  582 ---NDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ---cCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence               11223345577889999999999999999965

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-37  Score=341.83  Aligned_cols=245  Identities=24%  Similarity=0.300  Sum_probs=202.9

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999965 78899999986542   123456889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+++|+|.+++...+ .+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||++......  
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence            9999999999987654 4889999999999999999999   999999999999999999999999999999865322  


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                        .....|++.|+|||++.+..++.++||||+||++|||++|+.||......+.. .....                   
T Consensus       155 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~-~~i~~-------------------  212 (291)
T cd05612         155 --TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY-EKILA-------------------  212 (291)
T ss_pred             --cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHh-------------------
Confidence              12346899999999999888999999999999999999999999753221111 11000                   


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRIS-----MKDVANR 1035 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~ell~~ 1035 (1049)
                        .....+...+..+.+++.+|++.||.+||+     ++|+++|
T Consensus       213 --~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         213 --GKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             --CCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence              001111223567899999999999999995     9998877

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=7.2e-37  Score=349.55  Aligned_cols=256  Identities=24%  Similarity=0.385  Sum_probs=203.6

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe------CCCcEEEEEEeeccc-CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL------PDGMEIAAKVFHMEF-DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDF  831 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~  831 (1049)
                      .++|+..+.||+|+||.||+|++      .++..||||+++... ....+.+.+|++++..+ +||||+++++++.+.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            34688899999999999999973      245689999987543 23346788999999999 89999999999999999


Q ss_pred             eEEEEeccCCCChhhhhhcCC-----------------------------------------------------------
Q 039290          832 KALVLEYMSNGSLEKCLYSDN-----------------------------------------------------------  852 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  852 (1049)
                      .++||||+++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999998886422                                                           


Q ss_pred             ---------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          853 ---------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       853 ---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                                     ..+++..+.+++.||++|++|||   +++|+||||||+||+++.++.+||+|||++.........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                           14678889999999999999999   999999999999999999999999999999866433221


Q ss_pred             c-ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          918 R-QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       918 ~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                      . .....++..|+|||++.+..++.++|||||||++|||++ |..||........ ..++.....               
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-~~~~~~~~~---------------  334 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-FYKMIKEGY---------------  334 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-HHHHHHhCc---------------
Confidence            1 112234567999999999999999999999999999998 8888875432221 111111000               


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVR 1038 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~ 1038 (1049)
                          +...+...+.++.+++.+||+.||++||+++|+++.|++
T Consensus       335 ----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         335 ----RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             ----cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence                000111235678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.1e-36  Score=336.46  Aligned_cols=264  Identities=26%  Similarity=0.447  Sum_probs=215.0

Q ss_pred             cCCCCCceecCCCcEEEEEEEe------CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL------PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      .+|.+.+.||+|+||+||++..      .++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            4688889999999999999984      2345689999876544456679999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCC------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEE
Q 039290          835 VLEYMSNGSLEKCLYSDN------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHL  902 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl  902 (1049)
                      ||||+++++|.+++...+            ..+++.+++.++.|++.|++|||   ++|++||||||+||++++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence            999999999999986432            24899999999999999999999   999999999999999999999999


Q ss_pred             ecccCceecCCCcc-ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhcc
Q 039290          903 SDFGIAKILGKEES-MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSL  980 (1049)
Q Consensus       903 ~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  980 (1049)
                      +|||++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||......+.. .....   
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~-~~i~~---  237 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI-ECITQ---  237 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHc---
Confidence            99999986543221 11222345678999999988889999999999999999998 89998654322211 11100   


Q ss_pred             ccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhccC
Q 039290          981 LSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYID 1048 (1049)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~~~ 1048 (1049)
                        ..        .       ...+..++.++.+++.+||+.+|.+|||+.|+.+.|+++.++...|+|
T Consensus       238 --~~--------~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~~~~~  288 (288)
T cd05093         238 --GR--------V-------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASPVYLD  288 (288)
T ss_pred             --CC--------c-------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcccccC
Confidence              00        0       001112456789999999999999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.4e-37  Score=344.86  Aligned_cols=242  Identities=24%  Similarity=0.315  Sum_probs=198.3

Q ss_pred             ceecCCCcEEEEEEEe-CCCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCC
Q 039290          767 KLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNG  842 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  842 (1049)
                      +.||+|+||.||+|+. .+|+.||+|+++...   ......+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999995 478899999997643   223456788999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccccccc
Q 039290          843 SLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT  922 (1049)
Q Consensus       843 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~~  922 (1049)
                      +|.+++...+ .+++.++..++.||+.||+|||   +.||+||||||+||+++.++.+||+|||+++...... ......
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~  155 (323)
T cd05571          81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF  155 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccce
Confidence            9999887654 5899999999999999999999   9999999999999999999999999999987532221 122345


Q ss_pred             ccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCch
Q 039290          923 LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFS 1002 (1049)
Q Consensus       923 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1049)
                      .|++.|+|||++.+..++.++||||+||++|||++|+.||........  ...+   ..                 ....
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~--~~~~---~~-----------------~~~~  213 (323)
T cd05571         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FELI---LM-----------------EEIR  213 (323)
T ss_pred             ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH--HHHH---Hc-----------------CCCC
Confidence            689999999999998999999999999999999999999965221111  1100   00                 0011


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 039290         1003 AREQCVSSIFSLAMDCTVDLPEKRI-----SMKDVANR 1035 (1049)
Q Consensus      1003 ~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~~ 1035 (1049)
                      .+...+.++.+++.+|++.||++||     ++.++++|
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            1223456789999999999999999     89999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.4e-36  Score=329.46  Aligned_cols=251  Identities=25%  Similarity=0.377  Sum_probs=204.8

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccC
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMS  840 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  840 (1049)
                      ++|+..+.||+|+||.||+|.+.++..+|+|.+... ....+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            357788999999999999999888889999988643 3345788999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccccc
Q 039290          841 NGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT  920 (1049)
Q Consensus       841 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~  920 (1049)
                      +|+|.+++......+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+|++|||.+............
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS  159 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence            99999998765556899999999999999999999   999999999999999999999999999998865433322222


Q ss_pred             ccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccccccccc
Q 039290          921 KTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEN  999 (1049)
Q Consensus       921 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1049)
                      ...++..|+|||++.+..++.++||||+|+++|||++ |+.||......+.  ...+...   .                
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~--~~~i~~~---~----------------  218 (256)
T cd05114         160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV--VEMISRG---F----------------  218 (256)
T ss_pred             CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH--HHHHHCC---C----------------
Confidence            2335668999999988889999999999999999999 8999865322111  1111000   0                


Q ss_pred             CchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290         1000 DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus      1000 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                      +...+...+..+.+++.+||+.+|++||+++|+++.|
T Consensus       219 ~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         219 RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            0001112345789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.4e-37  Score=345.65  Aligned_cols=245  Identities=22%  Similarity=0.263  Sum_probs=202.6

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56888999999999999999965 68899999997542   233467889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||++....... 
T Consensus        98 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-  172 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-  172 (329)
T ss_pred             cCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence            9999999999987654 4788899999999999999999   9999999999999999999999999999998664322 


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                         ....|++.|+|||++.+..++.++||||+||++|||++|..||......+.  ...+            ..      
T Consensus       173 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~i------------~~------  229 (329)
T PTZ00263        173 ---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI--YEKI------------LA------  229 (329)
T ss_pred             ---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH--HHHH------------hc------
Confidence               234689999999999998999999999999999999999999965321111  1100            00      


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRIS-----MKDVANR 1035 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~ell~~ 1035 (1049)
                        .+...+...+.++.+++.+||+.||++||+     +++++.|
T Consensus       230 --~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        230 --GRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             --CCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence              001111123456889999999999999997     6888876

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=8.6e-37  Score=348.50  Aligned_cols=258  Identities=25%  Similarity=0.407  Sum_probs=204.5

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC------CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEF-DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDF  831 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~  831 (1049)
                      .++|++.+.||+|+||.||+|+..      ++..||+|+++... ....+.+.+|+++++.+ +||||+++++++.+.+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            447889999999999999999842      34579999997543 22345688999999999 89999999999999999


Q ss_pred             eEEEEeccCCCChhhhhhcCC-----------------------------------------------------------
Q 039290          832 KALVLEYMSNGSLEKCLYSDN-----------------------------------------------------------  852 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  852 (1049)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999999875421                                                           


Q ss_pred             ----------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc-cccc
Q 039290          853 ----------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM-RQTK  921 (1049)
Q Consensus       853 ----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~-~~~~  921 (1049)
                                ..+++.++++++.||++|++|||   ++||+||||||+||++++++.+||+|||+++........ ....
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                      24678889999999999999999   999999999999999999999999999999865432211 1112


Q ss_pred             cccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccccccccC
Q 039290          922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEND 1000 (1049)
Q Consensus       922 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1049)
                      ..++..|+|||++.+..++.++||||+||++|||++ |+.||......+..........                    +
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~--------------------~  333 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY--------------------Q  333 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc--------------------C
Confidence            234567999999988899999999999999999997 9999976433221111110000                    0


Q ss_pred             chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 039290         1001 FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIR 1040 (1049)
Q Consensus      1001 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~ 1040 (1049)
                      ...+...+.++.+++.+||+.||++|||++++++.|+++.
T Consensus       334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            0011123567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.2e-36  Score=338.65  Aligned_cols=271  Identities=20%  Similarity=0.275  Sum_probs=203.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .++|++.+.||+|+||+||+|+.. +++.||+|+++... ......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999965 78899999987543 2334567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      |++ +++.+++......+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||++........ 
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  158 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH-  158 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc-
Confidence            995 5888888766666899999999999999999999   99999999999999999999999999999875432221 


Q ss_pred             cccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhh--ccccCCcchh-----c
Q 039290          918 RQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGD--SLLSCSITEV-----A  989 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~-----~  989 (1049)
                      ......+++.|+|||++.+ ..++.++||||+||++|||++|..||................  ......+...     .
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T cd07869         159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF  238 (303)
T ss_pred             cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence            2233567899999998765 457889999999999999999999997643221111111100  0000000000     0


Q ss_pred             ccc-cccccccCch---hhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          990 DAN-LLNCEENDFS---AREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       990 ~~~-~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .+. ..........   .....+..+.+++.+|++.||++|||++|+++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            000 0000000000   001123568899999999999999999999976

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=339.73  Aligned_cols=245  Identities=29%  Similarity=0.386  Sum_probs=209.1

Q ss_pred             ceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCCChh
Q 039290          767 KLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLE  845 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~  845 (1049)
                      -++|+|+||+||-|++. +...+|||-+........+-+++|+...++++|.|||+++|.+.++++.-|.||-++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            37999999999999955 56689999998777777788999999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCcc--CHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec-CCCceEEecccCceecCCCcccccccc
Q 039290          846 KCLYSDNYFL--DILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKT  922 (1049)
Q Consensus       846 ~~l~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~-~~~~~kl~DfGla~~~~~~~~~~~~~~  922 (1049)
                      ++++..-.++  .+.++--+..||++||+|||   +..|||||||-+||+|+ -.|.+||+|||-+++...-.. -..+.
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TETF  736 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTETF  736 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCc-ccccc
Confidence            9998876666  67788889999999999999   99999999999999996 689999999999987753322 23346


Q ss_pred             ccccCcccccccCCC--CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccC
Q 039290          923 LGTIGYMAPEYGREG--KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEND 1000 (1049)
Q Consensus       923 ~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1049)
                      .||.-|||||++..+  .|..++|||||||++.||.||++||.+.........+ +                  ...+..
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk-V------------------GmyKvH  797 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK-V------------------GMYKVH  797 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh-h------------------cceecC
Confidence            799999999999764  5889999999999999999999999875444333222 1                  122334


Q ss_pred             chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 039290         1001 FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVAN 1034 (1049)
Q Consensus      1001 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~ 1034 (1049)
                      ++.|+..+.+...+|.+|+.+||.+||+|+++++
T Consensus       798 P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  798 PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            5667788899999999999999999999999875

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-37  Score=319.76  Aligned_cols=247  Identities=22%  Similarity=0.334  Sum_probs=208.5

Q ss_pred             cCCCCCceecCCCcEEEEEEE-eCCCcEEEEEEeecccCC---CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDG---SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      .+|++.+.||+|+||+|-+|. +..|+.||||.++++.-.   ..-.+++|+++|..++||||+.++.+|+..+...|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            467888899999999999998 578999999999776533   3446789999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||..+|.|.|++...+. +++.++..+++||..|+.|+|   .++|||||+|.+||++|.++.+||+|||++-.+.... 
T Consensus       133 EYaS~GeLYDYiSer~~-LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k-  207 (668)
T KOG0611|consen  133 EYASGGELYDYISERGS-LSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK-  207 (668)
T ss_pred             EecCCccHHHHHHHhcc-ccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcccc-
Confidence            99999999999987764 999999999999999999999   9999999999999999999999999999998875433 


Q ss_pred             ccccccccccCcccccccCCCCc-CcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKV-SRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                       ...+++|++-|.+||+..+.+| .+.+|-||+|+++|-+..|..||++...... ..+.......+             
T Consensus       208 -fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l-vrQIs~GaYrE-------------  272 (668)
T KOG0611|consen  208 -FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL-VRQISRGAYRE-------------  272 (668)
T ss_pred             -HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH-HHHhhcccccC-------------
Confidence             4456889999999999999888 4789999999999999999999987322111 11111111100             


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                               +..+.+...+|++|+.++|++|.|+.+|..|-
T Consensus       273 ---------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  273 ---------PETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             ---------CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence                     12344567899999999999999999998773

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.9e-36  Score=337.39  Aligned_cols=261  Identities=24%  Similarity=0.407  Sum_probs=202.2

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCC-----------------CcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceee
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPD-----------------GMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVK  821 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~  821 (1049)
                      .++|+..++||+|+||.||+|.+.+                 +..||+|.+..... ....++.+|++++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3578889999999999999997532                 33699999875432 23457899999999999999999


Q ss_pred             EEeeeecCCeeEEEEeccCCCChhhhhhcCC------------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeE
Q 039290          822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDN------------------YFLDILQRLKIMIDVASALEYLHFGYSTPIV  883 (1049)
Q Consensus       822 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iv  883 (1049)
                      +++++.+.+..++||||+++|+|.+++....                  ..+++.++.+++.||+.|++|||   +.||+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            9999999999999999999999999885422                  23677889999999999999999   99999


Q ss_pred             EcCCCCCCeeecCCCceEEecccCceecCCCcccc-ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh--CCC
Q 039290          884 HCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT--KKK  960 (1049)
Q Consensus       884 H~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~  960 (1049)
                      ||||||+||+++.++.+||+|||+++......... .....++..|+|||++..+.++.++|||||||++|||++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            99999999999999999999999998654333211 122345778999999988899999999999999999987  556


Q ss_pred             CCCccccccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          961 PTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       961 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                      ||......+  ....+........         .   ......+..++..+.+++.+||+.+|++|||++|+.+.|+
T Consensus       241 p~~~~~~~~--~~~~~~~~~~~~~---------~---~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTDEQ--VIENAGEFFRDQG---------R---QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCHHH--HHHHHHHHhhhcc---------c---cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            776532221  1111111110000         0   0001112245678999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3e-36  Score=339.37  Aligned_cols=267  Identities=25%  Similarity=0.334  Sum_probs=206.6

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .++|++.+.||+|+||.||+|+.. ++..||+|.+..... ...+++.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            357999999999999999999965 688899999876532 234678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCC-CeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST-PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      |+++++|.+++.... .+++..+..++.|++.|++|||   ++ +|+||||||+||+++.++.+||+|||++....... 
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  158 (331)
T cd06649          84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (331)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence            999999999987654 4889999999999999999999   65 69999999999999999999999999987653322 


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcc----------
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSIT----------  986 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------  986 (1049)
                        .....+++.|+|||++.+..++.++||||+||++|||++|+.||......+  .....+.........          
T Consensus       159 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             --cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCccccCcccc
Confidence              223468999999999998899999999999999999999999996532211  111111000000000          


Q ss_pred             --------------------hhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          987 --------------------EVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       987 --------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                                          +..+. +........ ....++.++.+++.+||+.||++|||++|+++|-.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~  303 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDY-IVNEPPPKL-PNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF  303 (331)
T ss_pred             cccccccccccccccchhHHHHHHH-HHhCCCcCC-CCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence                                00000 000000000 01124678999999999999999999999999853

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=334.78  Aligned_cols=263  Identities=24%  Similarity=0.400  Sum_probs=220.4

Q ss_pred             HHHHHHhcCCCCCceecCCCcEEEEEEEeCC-CcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCee
Q 039290          754 QDLLRATDGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFK  832 (1049)
Q Consensus       754 ~~~~~~~~~~~~~~~lg~G~fg~Vy~a~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~  832 (1049)
                      ++++....+.....+||-|.||.||.|.|+. .-.||||.++.+ .-..++|.+|+.+|+.++|||+|+++|+|.....+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            3444445566777899999999999999864 557999999754 45678999999999999999999999999999999


Q ss_pred             EEEEeccCCCChhhhhhcCCC-ccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceec
Q 039290          833 ALVLEYMSNGSLEKCLYSDNY-FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL  911 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~  911 (1049)
                      |||+|||..|+|.+++++..+ .++....+.++.||..|++||.   .+++||||+..+|+||.++..|||+|||+++.+
T Consensus       339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlM  415 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLM  415 (1157)
T ss_pred             EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence            999999999999999987544 4666677899999999999999   999999999999999999999999999999998


Q ss_pred             CCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcc
Q 039290          912 GKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD  990 (1049)
Q Consensus       912 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  990 (1049)
                      ..+.........-++.|.|||-+....++.|+|||+|||++||+.| |..||.++...     +.++          +++
T Consensus       416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-----qVY~----------LLE  480 (1157)
T KOG4278|consen  416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYG----------LLE  480 (1157)
T ss_pred             cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-----HHHH----------HHh
Confidence            6555444333445789999999999999999999999999999999 88888763222     1111          111


Q ss_pred             cccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 039290          991 ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041 (1049)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~ 1041 (1049)
                            ...++..++.|++..+++|+.||+|.|.+||++.|+-+.|+-...
T Consensus       481 ------kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  481 ------KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             ------ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence                  123556678899999999999999999999999999999886543

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-36  Score=343.07  Aligned_cols=251  Identities=23%  Similarity=0.304  Sum_probs=205.5

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++...   ......+.+|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36889999999999999999965 68899999997543   223457888999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+++|+|.+++.... .+++.++..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++.....   
T Consensus        81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            9999999999987654 4789999999999999999999   99999999999999999999999999999986533   


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchH--HHhhhhccccCCcchhcccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSL--KRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                       ......|++.|+|||++.+..++.++||||+||++|||++|..||......+...  ..|...          ...   
T Consensus       154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------~~~---  219 (333)
T cd05600         154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET----------LQR---  219 (333)
T ss_pred             -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc----------ccC---
Confidence             2234568999999999998899999999999999999999999997633222111  111100          000   


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                        +. ........+.++.+++.+|+..+|.+||+++|++++
T Consensus       220 --~~-~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         220 --PV-YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             --CC-CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence              00 000002346678999999999999999999999987

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-36  Score=315.00  Aligned_cols=266  Identities=23%  Similarity=0.393  Sum_probs=209.2

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhc--CCCceeeEEeeeecC----CeeE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI--RHRNLVKIISSCSNN----DFKA  833 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~hpniv~l~~~~~~~----~~~~  833 (1049)
                      ..+....+.||+|.||+||+|+| .|+.||||+|...   +.+.+.+|.+++..+  +|+||+.++++-..+    ..++
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             hheeEEEEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            34577789999999999999999 7899999999643   346677888888765  999999999876443    3678


Q ss_pred             EEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHc-----cCCCCeEEcCCCCCCeeecCCCceEEecccCc
Q 039290          834 LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF-----GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA  908 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~-----~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla  908 (1049)
                      +|++|++.|+|.|++..  ..++.....+++..+|.||+|||.     ...+.|.|||||++||||..++.+.|+|+|+|
T Consensus       286 LvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA  363 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  363 (513)
T ss_pred             EeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence            99999999999999987  458999999999999999999992     34678999999999999999999999999999


Q ss_pred             eecCCCc---cccccccccccCcccccccCCCC----c--CcccchHHHHHHHHHHHhCC----------CCCCcccccc
Q 039290          909 KILGKEE---SMRQTKTLGTIGYMAPEYGREGK----V--SRKCDVYSYGIMLMETFTKK----------KPTDEIFAGE  969 (1049)
Q Consensus       909 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~----~--~~~~DvwslG~il~elltg~----------~p~~~~~~~~  969 (1049)
                      .......   .......+||.+|||||++...-    +  -..+||||||.|+||+..+.          .||.+..+.+
T Consensus       364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D  443 (513)
T KOG2052|consen  364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD  443 (513)
T ss_pred             EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence            9876542   23456689999999999986531    1  23589999999999998743          5666655544


Q ss_pred             chHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 039290          970 MSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041 (1049)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~ 1041 (1049)
                      ..+.+-.+-+.         .+.+.+..++++.. ..+...+.++|+.||..+|.-|.|+--+.+.|.++.+
T Consensus       444 Ps~eeMrkVVC---------v~~~RP~ipnrW~s-~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  444 PSFEEMRKVVC---------VQKLRPNIPNRWKS-DPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCHHHHhccee---------ecccCCCCCccccc-CHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            44433221111         12233334444443 3456778999999999999999999999999988774

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3e-36  Score=326.77  Aligned_cols=252  Identities=25%  Similarity=0.389  Sum_probs=205.3

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccC
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMS  840 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  840 (1049)
                      ++|+..+.||+|+||+||.|++.++..||+|.++.. ....+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            357888999999999999999877778999998743 3345778999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccccc
Q 039290          841 NGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT  920 (1049)
Q Consensus       841 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~  920 (1049)
                      +|+|.+++......+++.++++++.|++.|++|||   +.|++|+||||+||+++.++.+||+|||.++...........
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV  159 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence            99999999876557899999999999999999999   999999999999999999999999999998866433222222


Q ss_pred             ccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccccccccc
Q 039290          921 KTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEN  999 (1049)
Q Consensus       921 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1049)
                      ...++..|+|||+..+..++.++|||||||++|||++ |..||......+.  ........                   
T Consensus       160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~--~~~~~~~~-------------------  218 (256)
T cd05113         160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET--VEKVSQGL-------------------  218 (256)
T ss_pred             CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH--HHHHhcCC-------------------
Confidence            2335568999999988889999999999999999999 9999875332211  11110000                   


Q ss_pred             CchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290         1000 DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus      1000 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                      +...+...+..+.+++.+||+.+|++||++.++++.++
T Consensus       219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         219 RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            00011123567899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.8e-36  Score=328.29  Aligned_cols=254  Identities=24%  Similarity=0.422  Sum_probs=208.0

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      .++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            35688899999999999999998888899999986532 34578899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          840 SNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       840 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      ++++|.+++... ....++.++..++.|+++|++|||   +.+++||||||+||+++.++.++++|||++..........
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA  160 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence            999999998653 345788899999999999999999   9999999999999999999999999999998764332222


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE  997 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1049)
                      .....++..|+|||++....++.++||||+||++|||++ |..||......+  ...+.....                 
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~~~-----------------  221 (261)
T cd05072         161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSALQRGY-----------------  221 (261)
T ss_pred             cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHHHHcCC-----------------
Confidence            222345678999999988889999999999999999998 999986532221  111111000                 


Q ss_pred             ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 039290          998 ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVR 1038 (1049)
Q Consensus       998 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~ 1038 (1049)
                        +.+....++.++.+++.+|++.+|++||+++++.+.|++
T Consensus       222 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         222 --RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence              001112345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.8e-36  Score=343.98  Aligned_cols=259  Identities=25%  Similarity=0.419  Sum_probs=207.1

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC------CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcC-CCceeeEEeeeecCCe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIR-HRNLVKIISSCSNNDF  831 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~  831 (1049)
                      .++|++.+.||+|+||.||+|+..      .+..||+|+++.... ...+.+.+|+++++++. ||||+++++++.+.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            567899999999999999999852      234699999975432 23467899999999996 9999999999999999


Q ss_pred             eEEEEeccCCCChhhhhhcCC-----------------------------------------------------------
Q 039290          832 KALVLEYMSNGSLEKCLYSDN-----------------------------------------------------------  852 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  852 (1049)
                      .++||||+++|+|.+++....                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999998875421                                                           


Q ss_pred             ------------------------------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC
Q 039290          853 ------------------------------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE  896 (1049)
Q Consensus       853 ------------------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~  896 (1049)
                                                          ..+++.++..++.|+++|++|||   +.+|+||||||+||+++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence                                                23677888999999999999999   999999999999999999


Q ss_pred             CCceEEecccCceecCCCcc-ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHH
Q 039290          897 SMVGHLSDFGIAKILGKEES-MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKR  974 (1049)
Q Consensus       897 ~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~  974 (1049)
                      ++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||......+.....
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~  352 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK  352 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence            99999999999986543222 11223446778999999988889999999999999999997 89998754322211111


Q ss_pred             hhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 039290          975 WVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041 (1049)
Q Consensus       975 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~ 1041 (1049)
                      ....                    .+...+..++.++.+++.+||+.+|++||++.++.+.|+++.+
T Consensus       353 ~~~~--------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         353 IKSG--------------------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HhcC--------------------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            0000                    0111223456789999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.3e-36  Score=342.39  Aligned_cols=246  Identities=22%  Similarity=0.268  Sum_probs=202.2

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCC--CcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPD--GMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~--~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      .++|++.+.||+|+||.||+|....  +..||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3468889999999999999998543  3689999986542   2345678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      ||||+++|+|.+++.... .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||++......
T Consensus       109 v~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            999999999999987654 4889999999999999999999   999999999999999999999999999999865432


Q ss_pred             ccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          915 ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       915 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                          .....||+.|+|||++.+..++.++||||+||++|||++|..||........ .....             ..   
T Consensus       185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-~~~i~-------------~~---  243 (340)
T PTZ00426        185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI-YQKIL-------------EG---  243 (340)
T ss_pred             ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH-HHHHh-------------cC---
Confidence                2335689999999999888899999999999999999999999975321111 11100             00   


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI-----SMKDVANR 1035 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~~ 1035 (1049)
                           ....+...+..+.+++.+|++.||++|+     +++|+++|
T Consensus       244 -----~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        244 -----IIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                 0011122345678999999999999995     89999887

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.1e-36  Score=332.37  Aligned_cols=264  Identities=25%  Similarity=0.441  Sum_probs=214.4

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC------CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      .+|...+.||+|+||.||+|+..      ++..+++|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            35777889999999999999842      355689999876544445678999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCC---------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCc
Q 039290          835 VLEYMSNGSLEKCLYSDN---------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMV  899 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~  899 (1049)
                      ||||+++++|.+++....               ..+++.+++.++.||+.|++|||   +++|+||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence            999999999999986532               24788999999999999999999   999999999999999999999


Q ss_pred             eEEecccCceecCCCcc-ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhh
Q 039290          900 GHLSDFGIAKILGKEES-MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVG  977 (1049)
Q Consensus       900 ~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  977 (1049)
                      ++|+|||++........ .......++..|+|||++.+..++.++||||+||++|||++ |..||......+.  .....
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~~~~~  239 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV--IECIT  239 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHh
Confidence            99999999976543221 11223446788999999988899999999999999999999 9999865332221  11100


Q ss_pred             hccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhccC
Q 039290          978 DSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYID 1048 (1049)
Q Consensus       978 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~~~ 1048 (1049)
                          ....               ...+..++..+.+++.+||+.+|++||+++++++.|+++.+.-..|+|
T Consensus       240 ----~~~~---------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~~~~~  291 (291)
T cd05094         240 ----QGRV---------------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATPIYLD  291 (291)
T ss_pred             ----CCCC---------------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcCcccC
Confidence                0000               001122456789999999999999999999999999999999888876

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=4e-39  Score=366.13  Aligned_cols=482  Identities=31%  Similarity=0.358  Sum_probs=378.4

Q ss_pred             eccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEE
Q 039290          126 FDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLF  205 (1049)
Q Consensus       126 L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~  205 (1049)
                      +|.+..++. .||..+..-..|+.|++++|.+....-+.+..--+|+.||+|+|+++ .+|..+..      ++.|+.|.
T Consensus         3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~------l~~L~~ln   74 (1081)
T KOG0618|consen    3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITL------LSHLRQLN   74 (1081)
T ss_pred             cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhh------HHHHhhcc
Confidence            566777776 67777766666999999999876322234445556999999999987 78876643      45688899


Q ss_pred             eeccccCCCCCCCcccccccceecccccccccccCCCCccccccceEEeccccccccCccccccccceEEEeeccccCCC
Q 039290          206 ISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAG  285 (1049)
Q Consensus       206 l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~  285 (1049)
                      ++.|-+. ..|.+..++++|+++.|..|+++ .+|.++..+.+|+.||++.|++. .+|..+..++.++.+..++|....
T Consensus        75 ~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~  151 (1081)
T KOG0618|consen   75 LSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQ  151 (1081)
T ss_pred             cchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhh
Confidence            9999888 67888888899999999988887 78888888999999999999887 888888888888888888883322


Q ss_pred             ccccccccccccceEEeccCccCCCCCCcccCCCCCccE-EEcCCCCCCCCCCccccCCCCCceeecccCccccCccccc
Q 039290          286 LIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLER-LFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTF  364 (1049)
Q Consensus       286 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  364 (1049)
                      .    ++... .+.+++..|.+.+.++..+.    +++. |+|++|.+.   -..+.++.+|+.|..+.|+++...    
T Consensus       152 ~----lg~~~-ik~~~l~~n~l~~~~~~~i~----~l~~~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----  215 (1081)
T KOG0618|consen  152 R----LGQTS-IKKLDLRLNVLGGSFLIDIY----NLTHQLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----  215 (1081)
T ss_pred             h----hcccc-chhhhhhhhhcccchhcchh----hhheeeecccchhh---hhhhhhccchhhhhhhhcccceEE----
Confidence            2    22222 78888888888887777654    3444 889998886   345677788888888888887542    


Q ss_pred             ccccccceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCC
Q 039290          365 GNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGN  444 (1049)
Q Consensus       365 ~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~  444 (1049)
                      -.-++|+.|+.++|.++.....       ..-.+|+++++++|++++. |+++.... +|+.++..+|++. .+|..+..
T Consensus       216 ~~g~~l~~L~a~~n~l~~~~~~-------p~p~nl~~~dis~n~l~~l-p~wi~~~~-nle~l~~n~N~l~-~lp~ri~~  285 (1081)
T KOG0618|consen  216 ISGPSLTALYADHNPLTTLDVH-------PVPLNLQYLDISHNNLSNL-PEWIGACA-NLEALNANHNRLV-ALPLRISR  285 (1081)
T ss_pred             ecCcchheeeeccCcceeeccc-------cccccceeeecchhhhhcc-hHHHHhcc-cceEecccchhHH-hhHHHHhh
Confidence            2346888888888888854332       2235788999999998854 47777776 8889999999885 78888888


Q ss_pred             CCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcc-cccccc-cceEEeeCcccCCcCc-hhccCcccCC
Q 039290          445 INNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPED-LCHLYR-LANLYLGDNKLSGRLP-ACLGNLTSLR  521 (1049)
Q Consensus       445 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~-L~~L~L~~N~l~~~~p-~~~~~l~~L~  521 (1049)
                      .++|+.|...+|.++ .+|....+++.|++|+|..|+|. ..|+. +.-+.. |..|+.+.|++. ..| ..=..+..|+
T Consensus       286 ~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq  362 (1081)
T KOG0618|consen  286 ITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQ  362 (1081)
T ss_pred             hhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHH
Confidence            889999999999988 67788888889999999999988 44543 333333 778888888887 344 2222456799


Q ss_pred             ceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeeccc
Q 039290          522 DLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNR  601 (1049)
Q Consensus       522 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  601 (1049)
                      .|++.+|++++..-..+.+...|+.|+|++|++.......+.+++.|++|+||+|+++ .+|+++..+..|++|...+|+
T Consensus       363 ~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~  441 (1081)
T KOG0618|consen  363 ELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQ  441 (1081)
T ss_pred             HHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCc
Confidence            9999999999877778889999999999999998877778899999999999999999 678999999999999999999


Q ss_pred             ccCCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCcc
Q 039290          602 LQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQL  650 (1049)
Q Consensus       602 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l  650 (1049)
                      |. ..| .+..++.|+.+|+|.|+|+...-......++|++|||+||.+
T Consensus       442 l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  442 LL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR  488 (1081)
T ss_pred             ee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence            99 677 888999999999999999854333333338999999999985

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-36  Score=326.78  Aligned_cols=255  Identities=25%  Similarity=0.437  Sum_probs=207.9

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCC----CcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPD----GMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      ++|+..+.||+|+||+||+|++..    ...||+|.++.... ....++.+|+.++++++||||+++++++.+.+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            468889999999999999999642    45799999875443 2346788999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++++|.+++......+++.++.+++.|++.|++|||   +++|+||||||+||++++++.++++|||++.......
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            9999999999999876667899999999999999999999   9999999999999999999999999999998775222


Q ss_pred             -cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          916 -SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       916 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                       ........++..|+|||.+.+..++.++||||+|+++|||++ |..||......+  .........             
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~-------------  225 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VIKAVEDGY-------------  225 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HHHHHHcCC-------------
Confidence             111122334678999999988899999999999999999998 999986532221  111110000             


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                            ..+.+..++..+.+++.+||+.+|++||+++|++++|.++
T Consensus       226 ------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         226 ------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                  0011123566789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.1e-36  Score=339.10  Aligned_cols=242  Identities=24%  Similarity=0.303  Sum_probs=197.7

Q ss_pred             ceecCCCcEEEEEEEe-CCCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCC
Q 039290          767 KLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNG  842 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  842 (1049)
                      +.||+|+||.||+|+. .+|+.||+|+++...   ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999995 478999999997643   223456778999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccccccc
Q 039290          843 SLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT  922 (1049)
Q Consensus       843 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~~  922 (1049)
                      +|.+++...+ .+++..++.++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++....... ......
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~  155 (323)
T cd05595          81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF  155 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccccc
Confidence            9998887654 5889999999999999999999   9999999999999999999999999999987532221 122335


Q ss_pred             ccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCch
Q 039290          923 LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFS 1002 (1049)
Q Consensus       923 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1049)
                      .|++.|+|||++.+..++.++||||+||++|||++|+.||......+.. .....                     ....
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~-~~~~~---------------------~~~~  213 (323)
T cd05595         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-ELILM---------------------EEIR  213 (323)
T ss_pred             cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH-HHHhc---------------------CCCC
Confidence            6899999999999889999999999999999999999999653221111 11000                     0001


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 039290         1003 AREQCVSSIFSLAMDCTVDLPEKRI-----SMKDVANR 1035 (1049)
Q Consensus      1003 ~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~~ 1035 (1049)
                      .+..++.++.+++.+||+.||++||     ++.+++++
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            1123456789999999999999998     89998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-36  Score=325.02  Aligned_cols=254  Identities=25%  Similarity=0.430  Sum_probs=207.6

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      .++|++.+.||+|+||.||+|...+++.||+|.++... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            35688899999999999999998788899999987543 34577899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          840 SNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       840 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      ++++|.+++.... ..+++.++..++.|++.|++|||   +.||+||||||+||++++++.+||+|||++..........
T Consensus        84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05068          84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA  160 (261)
T ss_pred             cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence            9999999987643 46899999999999999999999   9999999999999999999999999999998765322211


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE  997 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1049)
                      ......+..|+|||+..+..++.++||||+|+++|||++ |+.||......+. ........                  
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~------------------  221 (261)
T cd05068         161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV-LQQVDQGY------------------  221 (261)
T ss_pred             cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-HHHHHcCC------------------
Confidence            111223457999999988899999999999999999999 9999875322211 11110000                  


Q ss_pred             ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 039290          998 ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVR 1038 (1049)
Q Consensus       998 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~ 1038 (1049)
                        ....+..++..+.+++.+|++.+|++||+++++++.|++
T Consensus       222 --~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         222 --RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             --CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence              001112345678999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-36  Score=330.35  Aligned_cols=247  Identities=33%  Similarity=0.557  Sum_probs=194.7

Q ss_pred             CceecCCCcEEEEEEEeC-----CCcEEEEEEeecccCC-CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          766 NKLLGMGSFGSVYKGVLP-----DGMEIAAKVFHMEFDG-SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       766 ~~~lg~G~fg~Vy~a~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      .+.||+|+||.||+|++.     .+..|+||.++..... ..+.+.+|++.+++++||||++++|++...+..++||||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            478999999999999975     3567999999653322 3678999999999999999999999999888899999999


Q ss_pred             CCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc-c
Q 039290          840 SNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES-M  917 (1049)
Q Consensus       840 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~-~  917 (1049)
                      ++|+|.+++... ...+++.++.+|+.||++||+|||   +++++||||+++||++++++.+||+|||++........ .
T Consensus        84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~  160 (259)
T PF07714_consen   84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK  160 (259)
T ss_dssp             TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred             ccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccc
Confidence            999999999887 567899999999999999999999   89999999999999999999999999999987632221 2


Q ss_pred             cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          918 RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                      ..........|+|||.+....++.++||||||+++|||++ |+.||.+....+. ......                   
T Consensus       161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~-~~~~~~-------------------  220 (259)
T PF07714_consen  161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI-IEKLKQ-------------------  220 (259)
T ss_dssp             ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH-HHHHHT-------------------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccc-------------------
Confidence            2233456778999999988889999999999999999999 6788876422211 111100                   


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                       ..+...+..++..+.+++.+||+.+|++|||+.++++.|
T Consensus       221 -~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  221 -GQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -TEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -cccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence             001112234567799999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.2e-36  Score=337.25  Aligned_cols=262  Identities=24%  Similarity=0.404  Sum_probs=210.1

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCc----EEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGM----EIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      .+|+..+.||+|+||.||+|++. ++.    .||+|+++... ....+++.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46889999999999999999853 333    48999986443 23456788999999999999999999998775 4679


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      |+||+++|+|.+++......+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.....
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence            99999999999999887667899999999999999999999   999999999999999999999999999999876533


Q ss_pred             ccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccc
Q 039290          915 ESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       915 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      ... ......++..|+|||++.+..++.++|||||||++|||++ |..||++....+  ...+....             
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~~~~~~~-------------  227 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKG-------------  227 (316)
T ss_pred             CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHhCC-------------
Confidence            221 1112234668999999998899999999999999999998 999987532221  11111100             


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhcc
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYI 1047 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~~ 1047 (1049)
                            .+.+.+..++.++.+++.+||+.+|++||++.+++.++.++.+.-.+|.
T Consensus       228 ------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~~~  276 (316)
T cd05108         228 ------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYL  276 (316)
T ss_pred             ------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCchhe
Confidence                  0111112345678999999999999999999999999999988766553

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.3e-36  Score=341.72  Aligned_cols=265  Identities=21%  Similarity=0.211  Sum_probs=201.1

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      ..+|++.+.||+|+||.||+|.. .+++.||+|...      ...+.+|++++++++||||+++++++...+..++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            35799999999999999999995 478899999753      24578899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      +. ++|.+++.... .+++.+++.++.|+++||+|||   ++||+||||||+||+++.++.+||+|||+|..........
T Consensus       165 ~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~  239 (391)
T PHA03212        165 YK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK  239 (391)
T ss_pred             CC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence            95 68888876554 4789999999999999999999   9999999999999999999999999999997543322222


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCcccc--c----cchHHHhhhhcc---ccCC-----
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFA--G----EMSLKRWVGDSL---LSCS-----  984 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~--~----~~~~~~~~~~~~---~~~~-----  984 (1049)
                      .....||+.|+|||++.+..++.++||||+||++|||++|..||.....  +    +...........   .+..     
T Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~  319 (391)
T PHA03212        240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA  319 (391)
T ss_pred             cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence            3345789999999999988999999999999999999999988643211  1    111111111000   0000     


Q ss_pred             -cchhc---ccccccccccC--chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          985 -ITEVA---DANLLNCEEND--FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       985 -~~~~~---~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                       .....   .......+..+  +......+.++.+++.+|++.||++|||++|++++
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence             00000   00000001111  11223456789999999999999999999999976

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-37  Score=340.97  Aligned_cols=260  Identities=27%  Similarity=0.423  Sum_probs=220.7

Q ss_pred             CCCCceecCCCcEEEEEEEe-CCCc----EEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          763 FSENKLLGMGSFGSVYKGVL-PDGM----EIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~-~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      .+..++||+|+||+||+|.| ..|+    +||+|++.... .+..+++.+|+-+|.+++|||++++++++.... +.||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            34568999999999999995 3444    58889886443 445688999999999999999999999998776 78999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      +|++.|+|.++++.++..+.....+.|.+|||+||.|||   ++++|||||..+||||.+-..+||.|||+|+....+..
T Consensus       777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            999999999999999888999999999999999999999   99999999999999999999999999999998765442


Q ss_pred             c-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          917 M-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       917 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                      . ......-.+.|||-|.+....|+.++|||||||.+||++| |..|++.+...+..-.-                    
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll--------------------  913 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL--------------------  913 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH--------------------
Confidence            2 2222234678999999999999999999999999999999 99999886555442211                    


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhcc
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYI 1047 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~~ 1047 (1049)
                       ....|.+.++.|+.+++.++.+||..|+..||+|+++...+.+..+...+|+
T Consensus       914 -e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqryl  965 (1177)
T KOG1025|consen  914 -EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRYL  965 (1177)
T ss_pred             -hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceEe
Confidence             1122456667899999999999999999999999999999999988777775

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3e-36  Score=338.44  Aligned_cols=242  Identities=25%  Similarity=0.324  Sum_probs=198.1

Q ss_pred             ceecCCCcEEEEEEEe-CCCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCC
Q 039290          767 KLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNG  842 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  842 (1049)
                      +.||+|+||.||+|+. .+++.||+|++....   ......+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999995 478999999997543   223467788999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccccccc
Q 039290          843 SLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT  922 (1049)
Q Consensus       843 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~~  922 (1049)
                      +|.+++...+ .+++.++..++.||+.|++|||   +++|+||||||+||+++.++.+||+|||++....... ......
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~  155 (328)
T cd05593          81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTF  155 (328)
T ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccc
Confidence            9998887654 5889999999999999999999   9999999999999999999999999999987532221 122335


Q ss_pred             ccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCch
Q 039290          923 LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFS 1002 (1049)
Q Consensus       923 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1049)
                      .|++.|+|||++.+..++.++||||+||++|||++|+.||......+.....     ..                 ....
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~-----~~-----------------~~~~  213 (328)
T cd05593         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-----LM-----------------EDIK  213 (328)
T ss_pred             cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh-----cc-----------------CCcc
Confidence            6899999999999889999999999999999999999999653221111000     00                 0011


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 039290         1003 AREQCVSSIFSLAMDCTVDLPEKRI-----SMKDVANR 1035 (1049)
Q Consensus      1003 ~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~~ 1035 (1049)
                      .+...+.++.+++.+|++.||++||     ++.|+++|
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            1123456789999999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8.6e-37  Score=344.08  Aligned_cols=253  Identities=23%  Similarity=0.288  Sum_probs=205.1

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC---CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD---GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|.+.+.||+|+||+||+|+.. +++.||+|+++....   ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36888999999999999999954 788999999976432   23456888999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+++|+|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++........
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            999999999999877667899999999999999999999   99999999999999999999999999999987654433


Q ss_pred             ccccccccccCcccccccC------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcc
Q 039290          917 MRQTKTLGTIGYMAPEYGR------EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD  990 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  990 (1049)
                      .......||+.|+|||++.      ...++.++||||+||++|||++|+.||......+. ......    ...      
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-~~~i~~----~~~------  226 (330)
T cd05601         158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-YNNIMN----FQR------  226 (330)
T ss_pred             eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-HHHHHc----CCC------
Confidence            3333456899999999886      45678999999999999999999999975322111 111000    000      


Q ss_pred             cccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          991 ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                             ...++.....+.++.+++.+|++ +|.+|||++++++|
T Consensus       227 -------~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         227 -------FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             -------ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence                   00011112245678899999998 99999999999876

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.7e-36  Score=324.17  Aligned_cols=250  Identities=28%  Similarity=0.417  Sum_probs=204.3

Q ss_pred             CCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCC
Q 039290          762 GFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSN  841 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  841 (1049)
                      +|+..+.||+|+||.||+|.+.++..+|+|.+... ......+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            47788999999999999999877888999998643 23456788999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccc
Q 039290          842 GSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK  921 (1049)
Q Consensus       842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~  921 (1049)
                      ++|.+++......+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+|++|||.++............
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~  160 (256)
T cd05059          84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG  160 (256)
T ss_pred             CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence            9999999876667899999999999999999999   9999999999999999999999999999998654322221122


Q ss_pred             cccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccccccccC
Q 039290          922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEND 1000 (1049)
Q Consensus       922 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1049)
                      ..++..|+|||.+.+..++.++||||+|+++|||++ |..||......+..  ......                   .+
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~--~~~~~~-------------------~~  219 (256)
T cd05059         161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV--ESVSAG-------------------YR  219 (256)
T ss_pred             CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH--HHHHcC-------------------Cc
Confidence            223457999999988899999999999999999999 88998753222211  110000                   00


Q ss_pred             chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290         1001 FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus      1001 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                      ...+..++.++.+++.+||..+|++|||+.|+++.|
T Consensus       220 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            111123567899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.5e-36  Score=346.27  Aligned_cols=253  Identities=22%  Similarity=0.294  Sum_probs=203.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            457899999999999999999964 68899999996532   22345678899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++|+|.+++...  .+++..+..++.|++.||+|||   ++||+||||||+|||++.++.+||+|||++.......
T Consensus       122 ~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         122 MEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG  196 (370)
T ss_pred             EcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence            9999999999988654  3788889999999999999999   9999999999999999999999999999998765433


Q ss_pred             cccccccccccCcccccccCCC----CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREG----KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA  991 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  991 (1049)
                      ........||+.|+|||++.+.    .++.++||||+||++|||++|+.||......+ ......             ..
T Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~-------------~~  262 (370)
T cd05596         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIM-------------DH  262 (370)
T ss_pred             cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-HHHHHH-------------cC
Confidence            3333446789999999988653    47899999999999999999999997532211 111110             00


Q ss_pred             ccccccccCchhhHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 039290          992 NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEK--RISMKDVANR 1035 (1049)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~ell~~ 1035 (1049)
                          .....++.....+.++.+++.+|++.+|.+  ||+++|+++|
T Consensus       263 ----~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         263 ----KNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             ----CCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                000001111234677899999999999998  9999999887

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-36  Score=336.49  Aligned_cols=240  Identities=23%  Similarity=0.300  Sum_probs=195.5

Q ss_pred             ecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCCCh
Q 039290          769 LGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSL  844 (1049)
Q Consensus       769 lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  844 (1049)
                      ||+|+||.||+|+.. +++.||+|+++...   ......+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999965 68899999987542   23346678899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccccccccc
Q 039290          845 EKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLG  924 (1049)
Q Consensus       845 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  924 (1049)
                      .+++...+ .+++..+..++.|+++|++|||   +++|+||||||+||+++.++.+||+|||+++....... ......|
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~g  155 (312)
T cd05585          81 FHHLQREG-RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTFCG  155 (312)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccccC
Confidence            99987654 4889999999999999999999   99999999999999999999999999999875432221 2233568


Q ss_pred             ccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCchhh
Q 039290          925 TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAR 1004 (1049)
Q Consensus       925 ~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1049)
                      |+.|+|||++.+..++.++||||+||++|||++|+.||......+.     ......                 .....+
T Consensus       156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~-----~~~~~~-----------------~~~~~~  213 (312)
T cd05585         156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM-----YRKILQ-----------------EPLRFP  213 (312)
T ss_pred             CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH-----HHHHHc-----------------CCCCCC
Confidence            9999999999998999999999999999999999999975322111     100000                 011112


Q ss_pred             HHHHHHHHHHHhhccccCCCCCCC---HHHHHHH
Q 039290         1005 EQCVSSIFSLAMDCTVDLPEKRIS---MKDVANR 1035 (1049)
Q Consensus      1005 ~~~~~~l~~li~~cl~~dP~~Rpt---~~ell~~ 1035 (1049)
                      ...+.++.+++.+||+.||++||+   +.|++.|
T Consensus       214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            234567899999999999999984   6777665

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=6e-36  Score=325.95  Aligned_cols=254  Identities=24%  Similarity=0.416  Sum_probs=206.0

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      .+|+..+.||+|+||.||+|... .++.||+|.+... ....+++.+|++++++++||||+++++++..++..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            35778899999999999999964 5889999998744 334567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          840 SNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       840 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      ++++|.+++... ...+++..++.++.|+++|++|||   +++++||||||+||++++++.+||+|||++..........
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~  161 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  161 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence            999999998654 345889999999999999999999   9999999999999999999999999999998764432222


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE  997 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1049)
                      ......+..|+|||.+.+..++.++|||||||++|||++ |..||......+. ... ...             ..    
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~-~~~-------------~~----  222 (263)
T cd05052         162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YEL-LEK-------------GY----  222 (263)
T ss_pred             cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHH-HHC-------------CC----
Confidence            222234567999999988899999999999999999998 8899865322111 111 000             00    


Q ss_pred             ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290          998 ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus       998 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                        +...+..++.++.+++.+||+.+|++||++.++++.|+.+
T Consensus       223 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         223 --RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence              0111223567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.4e-36  Score=328.75  Aligned_cols=255  Identities=26%  Similarity=0.476  Sum_probs=210.9

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      ..+|+..++||+|+||.||+|...++..+|+|.+..........+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            45688889999999999999998889999999998765555678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          840 SNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       840 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      ++++|.+++... ...+++.++..++.|++.|++|||   ++||+||||||+||++++++.+||+|||.+........ .
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-~  160 (261)
T cd05148          85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-L  160 (261)
T ss_pred             ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc-c
Confidence            999999998763 345899999999999999999999   99999999999999999999999999999976643221 1


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE  997 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1049)
                      .....++..|+|||.+.+..++.++||||+|+++|+|++ |..||......+.  .......                  
T Consensus       161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~--~~~~~~~------------------  220 (261)
T cd05148         161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV--YDQITAG------------------  220 (261)
T ss_pred             ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH--HHHHHhC------------------
Confidence            223345678999999988889999999999999999998 8999865332211  1111000                  


Q ss_pred             ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290          998 ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus       998 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                       .+.+.+..++..+.+++.+||+.+|++|||++++++.|+.+
T Consensus       221 -~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         221 -YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             -CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence             00111233456789999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-36  Score=332.31  Aligned_cols=252  Identities=26%  Similarity=0.311  Sum_probs=213.7

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCC---CHHHHHHHHHHHhhcC-CCceeeEEeeeecCCeeEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDG---SLESFHAECKVMGSIR-HRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~l  834 (1049)
                      ...|+..+.||+|.||.||+++.+ +|+.+|+|++.+....   ..+.+.+|+.+|+++. |||||.+.++|++.+..++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            456888899999999999999965 5999999999776543   3468999999999998 9999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC----CCceEEecccCcee
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE----SMVGHLSDFGIAKI  910 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~----~~~~kl~DfGla~~  910 (1049)
                      |||+++||.|.+.+... . +++..+..++.|++.|++|||   +.||+|||+||+|+++..    ++.+|++|||+|..
T Consensus       114 vmEL~~GGeLfd~i~~~-~-~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~  188 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-H-YSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF  188 (382)
T ss_pred             EEEecCCchHHHHHHHc-c-CCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence            99999999999998876 3 899999999999999999999   999999999999999963    35899999999998


Q ss_pred             cCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcc
Q 039290          911 LGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD  990 (1049)
Q Consensus       911 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  990 (1049)
                      ...  .......+||+.|+|||++....|+.++||||+|+++|.|++|..||......+.......+.+           
T Consensus       189 ~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~-----------  255 (382)
T KOG0032|consen  189 IKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF-----------  255 (382)
T ss_pred             ccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC-----------
Confidence            866  3345568899999999999999999999999999999999999999987443333332211111           


Q ss_pred             cccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          991 ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                             .-........+..+.+++.+|+..||.+|+|+.++++|-
T Consensus       256 -------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~Hp  294 (382)
T KOG0032|consen  256 -------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHP  294 (382)
T ss_pred             -------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCc
Confidence                   111122244577899999999999999999999999973

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-38  Score=313.73  Aligned_cols=248  Identities=26%  Similarity=0.373  Sum_probs=215.6

Q ss_pred             CCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCC
Q 039290          763 FSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSN  841 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  841 (1049)
                      |.++++||+|+||.||+|.++ .|+.+|+|.+..+  ...+++.+|+.+|.+.+.|++|+++|.|-....+++|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            566789999999999999964 7999999998654  5678999999999999999999999998888889999999999


Q ss_pred             CChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccc
Q 039290          842 GSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK  921 (1049)
Q Consensus       842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~  921 (1049)
                      |+..+.++.+++++++.++..|..+.+.||+|||   ...-+|||||+.||+++-+|.+|++|||.|....... .....
T Consensus       113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKRNT  188 (502)
T KOG0574|consen  113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKRNT  188 (502)
T ss_pred             CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhH-HhhCc
Confidence            9999999999999999999999999999999999   7888999999999999999999999999997664322 23455


Q ss_pred             cccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCc
Q 039290          922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDF 1001 (1049)
Q Consensus       922 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1049)
                      ..||+.|||||+++.-.|..++||||+|+...||..|++||.+.-.....+                   .+...++.-+
T Consensus       189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF-------------------MIPT~PPPTF  249 (502)
T KOG0574|consen  189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF-------------------MIPTKPPPTF  249 (502)
T ss_pred             cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE-------------------eccCCCCCCC
Confidence            789999999999999999999999999999999999999998632221100                   0122344456


Q ss_pred             hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290         1002 SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus      1002 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ..++..+.++.+++++|+...|++|.|+.++++|
T Consensus       250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            6678889999999999999999999999999987

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.8e-36  Score=352.37  Aligned_cols=250  Identities=21%  Similarity=0.277  Sum_probs=203.3

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-C-CcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-D-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      .|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4888899999999999999854 3 6788888876554444567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhc---CCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          840 SNGSLEKCLYS---DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       840 ~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ++|+|.+++..   ....+++.++..++.|++.||+|+|   +++|+||||||+||+++.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            99999988754   2346889999999999999999999   99999999999999999999999999999987644322


Q ss_pred             c-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          917 M-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       917 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                      . ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+.......+              .   
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~--------------~---  287 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG--------------K---  287 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------C---
Confidence            1 123456899999999999889999999999999999999999999653221111100000              0   


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                          ....+..++.++.+++.+||+.+|++||++++++++
T Consensus       288 ----~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        288 ----YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             ----CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence                001112345678999999999999999999999764

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.8e-36  Score=329.96  Aligned_cols=254  Identities=28%  Similarity=0.512  Sum_probs=206.0

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCC------CcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPD------GMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKA  833 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~  833 (1049)
                      ++|++.+.||+|+||.||+|....      ...||+|.++.... .....+.+|++++++++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468888999999999999998532      25799999865432 23457889999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCC---------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC
Q 039290          834 LVLEYMSNGSLEKCLYSDN---------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM  898 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~  898 (1049)
                      ++|||+++++|.+++....               ..+++.++..++.|++.|++|||   +.+++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            9999999999999986532               34788899999999999999999   99999999999999999999


Q ss_pred             ceEEecccCceecCCCcc-ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhh
Q 039290          899 VGHLSDFGIAKILGKEES-MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWV  976 (1049)
Q Consensus       899 ~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  976 (1049)
                      .+||+|||++........ .......+++.|+|||++.+..++.++||||+||++|||++ |..||......+.  ..++
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~--~~~i  239 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV--IEMI  239 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH--HHHH
Confidence            999999999986543322 11223456788999999988899999999999999999998 9999875332211  1111


Q ss_pred             hhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 039290          977 GDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVR 1038 (1049)
Q Consensus       977 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~ 1038 (1049)
                      .            ..       .....+..++.++.+++.+||+.+|.+||+++|++++|++
T Consensus       240 ~------------~~-------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         240 R------------SR-------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             H------------cC-------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            0            00       0111234567889999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=7.5e-36  Score=336.74  Aligned_cols=252  Identities=26%  Similarity=0.289  Sum_probs=201.2

Q ss_pred             CCCCCceecCCCcEEEEEEEe----CCCcEEEEEEeeccc----CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCee
Q 039290          762 GFSENKLLGMGSFGSVYKGVL----PDGMEIAAKVFHMEF----DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFK  832 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~  832 (1049)
                      +|++.+.||+|+||+||+|+.    .+++.||+|++....    ....+.+.+|+++++.+ +||+|+++++++.+.+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478889999999999999985    367899999997532    22345678899999999 589999999999999999


Q ss_pred             EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecC
Q 039290          833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      ++||||+++|+|.+++.... .+++.++..++.||+.||+|||   ++||+||||||+|||++.++.+||+|||++..+.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            99999999999999887654 4889999999999999999999   9999999999999999999999999999998654


Q ss_pred             CCccccccccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccc
Q 039290          913 KEESMRQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA  991 (1049)
Q Consensus       913 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  991 (1049)
                      ...........||+.|+|||++.+. .++.++||||+||++|||++|+.||......... ........           
T Consensus       157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~-----------  224 (332)
T cd05614         157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ-SEVSRRIL-----------  224 (332)
T ss_pred             ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH-HHHHHHHh-----------
Confidence            4333333345789999999998764 4788999999999999999999999643222111 11100000           


Q ss_pred             ccccccccCchhhHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 039290          992 NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI-----SMKDVANR 1035 (1049)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~~ 1035 (1049)
                            ......+...+..+.+++.+|++.||++||     +++++++|
T Consensus       225 ------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         225 ------KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             ------cCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence                  000111123456789999999999999999     78888876

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-36  Score=346.98  Aligned_cols=259  Identities=24%  Similarity=0.306  Sum_probs=207.9

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCCC-cEEEEEEeecccCCCHHHHHHHHHHHhhcC-CCceeeEEee-eec------CCe
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPDG-MEIAAKVFHMEFDGSLESFHAECKVMGSIR-HRNLVKIISS-CSN------NDF  831 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~-~~~------~~~  831 (1049)
                      .++++.++|.+|+|+.||.|....+ ..||+|+.-.........+++|+++|+.++ |||||.+++. ...      ..+
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            3567789999999999999997655 999999998776667788999999999997 9999999993 211      236


Q ss_pred             eEEEEeccCCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCcee
Q 039290          832 KALVLEYMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI  910 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~  910 (1049)
                      +++.||||+||.|-|++..+ ...+++.++++|++|+++|+++|| .+...|||||||-+|||++.++..||||||.|.-
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt  195 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADGNYKLCDFGSATT  195 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence            78999999999999999743 234999999999999999999999 3467799999999999999999999999999974


Q ss_pred             cCCCc-cc-------cccccccccCccccccc---CCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhc
Q 039290          911 LGKEE-SM-------RQTKTLGTIGYMAPEYG---REGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDS  979 (1049)
Q Consensus       911 ~~~~~-~~-------~~~~~~~~~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  979 (1049)
                      ..... ..       .......|+-|+|||++   .+..++.|+|||++||++|-++....||++...  ..        
T Consensus       196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--la--------  265 (738)
T KOG1989|consen  196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--LA--------  265 (738)
T ss_pred             ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--ee--------
Confidence            32111 00       11124578999999976   567899999999999999999999999986211  11        


Q ss_pred             cccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          980 LLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                              +....      -.++....++..+.+||..||+++|.+||++-+++.++.++..+-.
T Consensus       266 --------Ilng~------Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~  316 (738)
T KOG1989|consen  266 --------ILNGN------YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC  316 (738)
T ss_pred             --------EEecc------ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence                    11100      0112224577889999999999999999999999999998876543

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.4e-35  Score=328.12  Aligned_cols=268  Identities=22%  Similarity=0.274  Sum_probs=198.1

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC--CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhc---CCCceeeEEeeee-----c
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP--DGMEIAAKVFHMEF--DGSLESFHAECKVMGSI---RHRNLVKIISSCS-----N  828 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~hpniv~l~~~~~-----~  828 (1049)
                      .+|++.+.||+|+||+||+|+..  +++.||+|+++...  ......+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36889999999999999999853  46789999987543  22344566777777766   6999999999885     2


Q ss_pred             CCeeEEEEeccCCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccC
Q 039290          829 NDFKALVLEYMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGI  907 (1049)
Q Consensus       829 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGl  907 (1049)
                      ....++||||++ ++|.+++... ...+++.+++.++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456899999996 5898888653 335889999999999999999999   99999999999999999999999999999


Q ss_pred             ceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcc--ccCCc
Q 039290          908 AKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSL--LSCSI  985 (1049)
Q Consensus       908 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~  985 (1049)
                      +.......  ......+++.|+|||++.+..++.++||||+||++|||++|+.||......+. .........  .....
T Consensus       157 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~-~~~i~~~~~~~~~~~~  233 (290)
T cd07862         157 ARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEEDW  233 (290)
T ss_pred             eEeccCCc--ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHHhCCCChhhc
Confidence            98764332  22345689999999999888899999999999999999999999976432211 111111000  00000


Q ss_pred             c-h--hcccccccccccCc-hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          986 T-E--VADANLLNCEENDF-SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       986 ~-~--~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      . +  .............. ....+.+..+.+++.+|++.||++|||+.|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            0 0  00000000000000 1112356678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-37  Score=335.35  Aligned_cols=251  Identities=25%  Similarity=0.412  Sum_probs=209.4

Q ss_pred             CCCCceecCCCcEEEEEEEeC--CCc--EEEEEEeecccCC-CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          763 FSENKLLGMGSFGSVYKGVLP--DGM--EIAAKVFHMEFDG-SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~~--~~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      ....++||+|.||+|++|.|.  +|+  .||||.++..... ...+|.+|+.+|.+++|||++++||++.+ ....+|||
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            345578999999999999975  343  5899999876644 56899999999999999999999999988 56789999


Q ss_pred             ccCCCChhhhhhc-CCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          838 YMSNGSLEKCLYS-DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       838 ~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      .++.|+|.+.+++ ....+-......++.|||.||.||.   +++.||||+..+|+++-....|||+|||+.+..+..+.
T Consensus       191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            9999999999988 4557888888999999999999999   99999999999999999999999999999998865443


Q ss_pred             cc-c-cccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          917 MR-Q-TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       917 ~~-~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                      +. + ....-...|.|||.+...+++.++|||+|||++|||+| |+.||-+......  .+             .+|   
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI--L~-------------~iD---  329 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI--LK-------------NID---  329 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH--HH-------------hcc---
Confidence            21 1 12234568999999999999999999999999999999 8889876322211  11             111   


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVR 1038 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~ 1038 (1049)
                         ...+...++.|++++++++++||...|++||||..+++.+-.
T Consensus       330 ---~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  330 ---AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             ---ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence               234566778899999999999999999999999999865543

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.2e-35  Score=334.41  Aligned_cols=267  Identities=23%  Similarity=0.302  Sum_probs=203.2

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .++|++.+.||+|+||.||+|... ++..+|+|.++.... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            367999999999999999999965 688899998875432 234678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCC-CeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST-PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      |+++|+|.+++.... .+++..+..++.|++.|++|||   +. +|+||||||+||++++++.+||+|||++....... 
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-  158 (333)
T cd06650          84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (333)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence            999999999987654 4788999999999999999999   64 79999999999999999999999999987553221 


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc-
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN-  995 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  995 (1049)
                        .....++..|+|||++.+..++.++||||+||++|||++|+.||......+..  ...+.............+.... 
T Consensus       159 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  234 (333)
T cd06650         159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE--LMFGCPVEGDPAESETSPRPRPP  234 (333)
T ss_pred             --cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH--HHhcCcccCCccccccCcccCCc
Confidence              12346789999999998888999999999999999999999999753221111  1000000000000000000000 


Q ss_pred             -------ccccC-----------------chh-hHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          996 -------CEEND-----------------FSA-REQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       996 -------~~~~~-----------------~~~-~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                             .+..+                 ... ....+.++.+++.+||+.||++|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                   00000                 000 01134678999999999999999999999877

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.3e-36  Score=342.92  Aligned_cols=254  Identities=21%  Similarity=0.301  Sum_probs=201.9

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3467999999999999999999965 68899999986432   2234567889999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      ||||+++|+|.+++...  .+++..+..++.||+.||+|||   +++|+||||||+|||+++++.+||+|||++......
T Consensus       121 v~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence            99999999999998654  3788999999999999999999   999999999999999999999999999999876543


Q ss_pred             ccccccccccccCcccccccCCC----CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcc
Q 039290          915 ESMRQTKTLGTIGYMAPEYGREG----KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD  990 (1049)
Q Consensus       915 ~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  990 (1049)
                      .........||+.|+|||++.+.    .++.++||||+||++|||++|+.||......+ ......             +
T Consensus       196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-~~~~i~-------------~  261 (370)
T cd05621         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-TYSKIM-------------D  261 (370)
T ss_pred             CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-HHHHHH-------------h
Confidence            33333456799999999998653    37889999999999999999999997532111 111110             0


Q ss_pred             cccccccccCchhhHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 039290          991 ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEK--RISMKDVANR 1035 (1049)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~ell~~ 1035 (1049)
                      ..    ....++.....+..+.+++.+|++.+|.+  |++++|+++|
T Consensus       262 ~~----~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         262 HK----NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CC----cccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            00    00001111234567888999999866554  8999999988

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.6e-35  Score=322.18  Aligned_cols=253  Identities=28%  Similarity=0.432  Sum_probs=205.6

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccC
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMS  840 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  840 (1049)
                      ++|++.++||+|+||.||+|+..++..||+|+++... ...+++.+|++++++++||||+++++++.+ +..++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence            5689999999999999999998777789999987533 345678999999999999999999998754 55799999999


Q ss_pred             CCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          841 NGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       841 ~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      +|+|.+++... ...+++..+..++.|+++|++|+|   +.+|+||||||+||++++++.++|+|||.+...........
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~  160 (262)
T cd05071          84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR  160 (262)
T ss_pred             CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence            99999999753 345789999999999999999999   99999999999999999999999999999987654332222


Q ss_pred             cccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccccccc
Q 039290          920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                      ....++..|+|||+..+..++.++||||+||++|||++ |..||......+.......              .       
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~--------------~-------  219 (262)
T cd05071         161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER--------------G-------  219 (262)
T ss_pred             cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc--------------C-------
Confidence            23345678999999988889999999999999999999 8888865432211110000              0       


Q ss_pred             cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290          999 NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus       999 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                      ........++..+.+++.+|++.+|++||+++++++.|++.
T Consensus       220 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         220 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            00111234567789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=7.8e-36  Score=336.00  Aligned_cols=259  Identities=25%  Similarity=0.417  Sum_probs=204.0

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC------CCcEEEEEEeecccC-CCHHHHHHHHHHHhhc-CCCceeeEEeeeec-CC
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEFD-GSLESFHAECKVMGSI-RHRNLVKIISSCSN-ND  830 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~-~~  830 (1049)
                      .++|++.+.||+|+||.||+|...      +++.||+|+++.... ...+.+.+|++++.++ +||||+++++++.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            347899999999999999999732      347899999875432 2235678899999999 79999999998764 45


Q ss_pred             eeEEEEeccCCCChhhhhhcCC----------------------------------------------------------
Q 039290          831 FKALVLEYMSNGSLEKCLYSDN----------------------------------------------------------  852 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  852 (1049)
                      ..+++|||+++++|.+++....                                                          
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            7889999999999999885421                                                          


Q ss_pred             --CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc-ccccccccccCcc
Q 039290          853 --YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES-MRQTKTLGTIGYM  929 (1049)
Q Consensus       853 --~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~  929 (1049)
                        ..+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||++..+..... .......++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence              25788999999999999999999   99999999999999999999999999999987643221 1222334567899


Q ss_pred             cccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCchhhHHHH
Q 039290          930 APEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCV 1008 (1049)
Q Consensus       930 aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1049)
                      |||++.+..++.++||||+||++|||++ |..||......+. .........                   +...+...+
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~-------------------~~~~~~~~~  302 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FCRRLKEGT-------------------RMRAPEYAT  302 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HHHHHhccC-------------------CCCCCccCC
Confidence            9999999999999999999999999998 9999875322221 111100000                   001112345


Q ss_pred             HHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 039290         1009 SSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041 (1049)
Q Consensus      1009 ~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~ 1041 (1049)
                      .++.+++.+||+.+|++||+++|++++|+++.+
T Consensus       303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            678999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.8e-35  Score=321.60  Aligned_cols=258  Identities=23%  Similarity=0.318  Sum_probs=208.0

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|++.+.||+|+||.||+|+. .+++.||+|.++...   ......+.+|++++++++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            4788999999999999999995 478999999876432   222456888999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhc---CCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          837 EYMSNGSLEKCLYS---DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       837 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      ||+++++|.+++..   ....+++..+..++.|++.|++|||   +++++||||||+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988753   2345788999999999999999999   99999999999999999999999999999887643


Q ss_pred             CccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          914 EESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       914 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                      ... ......+++.|+|||.+.+..++.++|+||+|+++|||++|+.||..................             
T Consensus       159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-------------  224 (267)
T cd08228         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD-------------  224 (267)
T ss_pred             hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC-------------
Confidence            222 122345788999999998888999999999999999999999998653222111111110000             


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIR 1040 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~ 1040 (1049)
                         .  ........+..+.+++.+||+.+|++||++.++++.+++++
T Consensus       225 ---~--~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         225 ---Y--PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             ---C--CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence               0  00111235577999999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7e-36  Score=335.11  Aligned_cols=242  Identities=24%  Similarity=0.328  Sum_probs=196.7

Q ss_pred             ceecCCCcEEEEEEEe----CCCcEEEEEEeeccc----CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          767 KLLGMGSFGSVYKGVL----PDGMEIAAKVFHMEF----DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      +.||+|+||.||+|+.    .+++.||+|+++...    ......+.+|+++++.++||||+++++++.+++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999985    357889999997532    22345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      +++++|.+++.... .+.+..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....... .
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  156 (323)
T cd05584          82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-V  156 (323)
T ss_pred             CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-c
Confidence            99999999887654 4788888999999999999999   99999999999999999999999999999875432222 1


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                      .....|++.|+|||++.+..++.++||||+||++|||++|+.||......+. ...    ..         .        
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~-~~~----~~---------~--------  214 (323)
T cd05584         157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT-IDK----IL---------K--------  214 (323)
T ss_pred             ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH-HHH----HH---------c--------
Confidence            2234689999999999888899999999999999999999999975321111 000    00         0        


Q ss_pred             cCchhhHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 039290          999 NDFSAREQCVSSIFSLAMDCTVDLPEKRI-----SMKDVANR 1035 (1049)
Q Consensus       999 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~~ 1035 (1049)
                      .....+...+.++.+++.+|++.+|++||     ++++++++
T Consensus       215 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         215 GKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            01111223456789999999999999999     88888875

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.4e-36  Score=339.31  Aligned_cols=267  Identities=20%  Similarity=0.231  Sum_probs=197.9

Q ss_pred             CCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecC-----CeeE
Q 039290          762 GFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNN-----DFKA  833 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~-----~~~~  833 (1049)
                      +|++.+.||+|+||.||+|+. .+++.||+|+++...  ......+.+|++++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            578889999999999999995 478999999987532  22345688999999999999999999987543     3579


Q ss_pred             EEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          834 LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      +||||++ ++|.+++.... .+++..+..++.|+++||+|||   +.||+||||||+||+++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            9999995 68998887654 4899999999999999999999   99999999999999999999999999999986432


Q ss_pred             Ccc--ccccccccccCcccccccCC--CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCC-----
Q 039290          914 EES--MRQTKTLGTIGYMAPEYGRE--GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCS-----  984 (1049)
Q Consensus       914 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----  984 (1049)
                      ...  .......+++.|+|||++.+  ..++.++||||+||++|||++|+.||.......  ....+........     
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH--QLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH--HHHHHHHHhCCCCHHHHH
Confidence            221  12234568999999998865  678999999999999999999999996532111  0011000000000     


Q ss_pred             ------cchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          985 ------ITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       985 ------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                            .......................+.++.+++.+||+.||++|||++|++++
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                  000000000000000000011245678899999999999999999999987

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-36  Score=344.48  Aligned_cols=252  Identities=25%  Similarity=0.372  Sum_probs=206.1

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|++.+.||+|+||+||+|+.. +++.||+|+++...   ......+.+|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36889999999999999999965 78999999997543   234567889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc-
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE-  915 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~-  915 (1049)
                      ||+++++|.+++... ..+++..++.++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++....... 
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            999999999998776 45899999999999999999999   9999999999999999999999999999998664332 


Q ss_pred             ---------------------------cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccc
Q 039290          916 ---------------------------SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAG  968 (1049)
Q Consensus       916 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~  968 (1049)
                                                 ........||+.|+|||++.+..++.++||||+||++|||++|+.||......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                       11223456899999999999999999999999999999999999999764322


Q ss_pred             cchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCC-HHHHHHH
Q 039290          969 EMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRIS-MKDVANR 1035 (1049)
Q Consensus       969 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-~~ell~~ 1035 (1049)
                      +.. ..... ..          ...      ..+.....++++.+++.+|+. +|.+||+ ++|++++
T Consensus       237 ~~~-~~i~~-~~----------~~~------~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         237 ETY-NKIIN-WK----------ESL------RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHH-HHHhc-cC----------Ccc------cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            111 11000 00          000      000011146778999999998 9999999 9999987

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=6.4e-36  Score=343.24  Aligned_cols=252  Identities=21%  Similarity=0.288  Sum_probs=198.6

Q ss_pred             CCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          762 GFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .|+..+.||+|+||+||+|+. .+++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            578889999999999999985 478899999997543   2234678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc-
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES-  916 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~-  916 (1049)
                      |+++|+|.+++.... .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||++..+..... 
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            999999999987654 4788999999999999999999   99999999999999999999999999999754311000 


Q ss_pred             ---------------------------------------------ccccccccccCcccccccCCCCcCcccchHHHHHH
Q 039290          917 ---------------------------------------------MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIM  951 (1049)
Q Consensus       917 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~i  951 (1049)
                                                                   ......+||+.|+|||++.+..++.++||||+||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                         00123468999999999988889999999999999


Q ss_pred             HHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhh--ccccCCCCCCCH
Q 039290          952 LMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMD--CTVDLPEKRISM 1029 (1049)
Q Consensus       952 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~Rpt~ 1029 (1049)
                      +|||++|..||......+........  .  .              ....+.....+.++.+++.+  |+..+|..||++
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~--~--~--------------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~  299 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLKVINW--E--N--------------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA  299 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHHHHcc--c--c--------------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence            99999999999763322211111000  0  0              00001111245677888888  555666679999


Q ss_pred             HHHHHH
Q 039290         1030 KDVANR 1035 (1049)
Q Consensus      1030 ~ell~~ 1035 (1049)
                      +|+++|
T Consensus       300 ~~~l~h  305 (381)
T cd05626         300 DDIKAH  305 (381)
T ss_pred             HHHhcC
Confidence            999987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-36  Score=344.10  Aligned_cols=252  Identities=23%  Similarity=0.332  Sum_probs=201.7

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++....   ......+.+|+++++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            36889999999999999999964 68899999997542   233456788999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||++..+.....
T Consensus        81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            9999999999987654 4899999999999999999999   99999999999999999999999999999875432110


Q ss_pred             c-------------------------------------cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCC
Q 039290          917 M-------------------------------------RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKK  959 (1049)
Q Consensus       917 ~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~  959 (1049)
                      .                                     .....+||+.|+|||++.+..++.++||||+||++|||++|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence            0                                     011246899999999999889999999999999999999999


Q ss_pred             CCCCccccccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCC---HHHHHHH
Q 039290          960 KPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRIS---MKDVANR 1035 (1049)
Q Consensus       960 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~ell~~ 1035 (1049)
                      .||......+.. .... ...  .        ..      ..+.....++++.+++.+|+. +|.+|++   ++|+++|
T Consensus       237 ~Pf~~~~~~~~~-~~i~-~~~--~--------~~------~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         237 PPFCSDNPQETY-RKII-NWK--E--------TL------QFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCHHHHH-HHHH-cCC--C--------cc------CCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            999753322111 1100 000  0        00      000011235678899999997 8999998   9999886

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.9e-36  Score=340.83  Aligned_cols=247  Identities=26%  Similarity=0.348  Sum_probs=195.1

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      +|+..+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+++++.++|+||+++++++.+.+..++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            4566789999999999999954 789999999865432 23467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      ++|+|.+.     ...++..+..++.||+.||+|||   +.+|+||||||+||++++++.+||+|||++........ ..
T Consensus       155 ~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~  225 (353)
T PLN00034        155 DGGSLEGT-----HIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PC  225 (353)
T ss_pred             CCCccccc-----ccCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-cc
Confidence            99998653     23567788899999999999999   99999999999999999999999999999987643221 12


Q ss_pred             cccccccCcccccccCC-----CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          920 TKTLGTIGYMAPEYGRE-----GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                      ....|+..|+|||++..     ...+.++|||||||++|||++|+.||.....++.  ........              
T Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~--------------  289 (353)
T PLN00034        226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW--ASLMCAIC--------------  289 (353)
T ss_pred             cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHHHHh--------------
Confidence            34578999999998743     2345689999999999999999999973222211  11000000              


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                        .......+..++.++.+++.+||+.||++|||++|+++|
T Consensus       290 --~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        290 --MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             --ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              000111123456779999999999999999999999987

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-36  Score=318.16  Aligned_cols=249  Identities=23%  Similarity=0.304  Sum_probs=215.7

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      .+-|...+.||+|.|++|-.|++ -+|.+||||++.+..  +.....+.+|++.|+-++|||||++|++......+|+|.
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            34588889999999999999994 589999999997665  334567899999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec-CCCceEEecccCceecCCCc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~-~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |.-++|+|.|||.++...+.+.-+.+++.||+.|+.|+|   +..|||||+||+||.+- .-|-||+.|||++-.+.+..
T Consensus        97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~  173 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK  173 (864)
T ss_pred             EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence            999999999999998888999999999999999999999   89999999999998775 67899999999998876655


Q ss_pred             cccccccccccCcccccccCCCCcC-cccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKVS-RKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                      .  ....+|+..|.|||++.+..|+ +++||||+|||+|-+.+|+.||++..+.|.....              +|    
T Consensus       174 k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI--------------mD----  233 (864)
T KOG4717|consen  174 K--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI--------------MD----  233 (864)
T ss_pred             h--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh--------------hc----
Confidence            3  4557899999999999988875 7899999999999999999999876555443221              11    


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                          =++..|...+.+.+++|..|+..||.+|.+.+||+.+
T Consensus       234 ----CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  234 ----CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             ----ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence                1345567788899999999999999999999999764

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.2e-35  Score=327.05  Aligned_cols=253  Identities=29%  Similarity=0.472  Sum_probs=204.7

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCC------CcEEEEEEeecccCC-CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPD------GMEIAAKVFHMEFDG-SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKA  833 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~  833 (1049)
                      ++|.+.+.||+|+||.||+|+..+      +..||+|.++..... ..+.+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            457788999999999999998633      478999998765433 3578999999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCC-------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCce
Q 039290          834 LVLEYMSNGSLEKCLYSDN-------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVG  900 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~  900 (1049)
                      +||||+++++|.+++...+             ..+++.++..++.|++.|++|+|   +++++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence            9999999999999987542             34788899999999999999999   9999999999999999999999


Q ss_pred             EEecccCceecCCCcc-ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhh
Q 039290          901 HLSDFGIAKILGKEES-MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGD  978 (1049)
Q Consensus       901 kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  978 (1049)
                      ||+|||++........ .......+++.|+|||++.+..++.++||||+||++|||++ |..||......+  ....+. 
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~~~~~-  238 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VIECIT-  238 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHH-
Confidence            9999999986533221 11223345778999999999999999999999999999998 999986532221  111110 


Q ss_pred             ccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          979 SLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       979 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                         ..        ..       ...+..++..+.+++.+||+.+|++||++.|+++.|+
T Consensus       239 ---~~--------~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         239 ---QG--------RL-------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             ---cC--------Cc-------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence               00        00       0011234567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=9.8e-36  Score=332.67  Aligned_cols=242  Identities=24%  Similarity=0.320  Sum_probs=192.8

Q ss_pred             ceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEEEeccCC
Q 039290          767 KLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALVLEYMSN  841 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  841 (1049)
                      +.||+|+||+||+|+.. +++.||+|+++...   ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999964 67889999997643   22344556677777654 899999999999999999999999999


Q ss_pred             CChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccc
Q 039290          842 GSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK  921 (1049)
Q Consensus       842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~  921 (1049)
                      |+|.+++.... .+++.++..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||++....... .....
T Consensus        81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~  155 (316)
T cd05592          81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST  155 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence            99999887654 4899999999999999999999   9999999999999999999999999999998643222 22234


Q ss_pred             cccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCc
Q 039290          922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDF 1001 (1049)
Q Consensus       922 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1049)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||......+.. .....                     ...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~-~~i~~---------------------~~~  213 (316)
T cd05592         156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF-DSILN---------------------DRP  213 (316)
T ss_pred             ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH-HHHHc---------------------CCC
Confidence            56899999999999888999999999999999999999999753221111 11000                     001


Q ss_pred             hhhHHHHHHHHHHHhhccccCCCCCCCHH-HHHHH
Q 039290         1002 SAREQCVSSIFSLAMDCTVDLPEKRISMK-DVANR 1035 (1049)
Q Consensus      1002 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~-ell~~ 1035 (1049)
                      ..+..++.++.+++.+||+.+|++||++. +++++
T Consensus       214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05592         214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH  248 (316)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence            11123456788999999999999999875 55543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.4e-36  Score=337.23  Aligned_cols=242  Identities=24%  Similarity=0.301  Sum_probs=197.1

Q ss_pred             ceecCCCcEEEEEEEe-CCCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCC
Q 039290          767 KLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNG  842 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  842 (1049)
                      +.||+|+||.||+|+. .+++.||+|+++...   ......+.+|++++..++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999995 478999999997643   223456778999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCC-CCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccc
Q 039290          843 SLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS-TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK  921 (1049)
Q Consensus       843 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~  921 (1049)
                      +|.+++...+ .+++.++..++.||+.||+|||   + .||+||||||+||+++.++.+||+|||++........ ....
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~  155 (325)
T cd05594          81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKT  155 (325)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cccc
Confidence            9998886654 4899999999999999999999   7 7999999999999999999999999999875432221 2223


Q ss_pred             cccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCc
Q 039290          922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDF 1001 (1049)
Q Consensus       922 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1049)
                      ..|++.|+|||++.+..++.++||||+||++|||++|+.||......+.....+.                      ...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~----------------------~~~  213 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM----------------------EEI  213 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc----------------------CCC
Confidence            5689999999999988999999999999999999999999965322111111000                      000


Q ss_pred             hhhHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 039290         1002 SAREQCVSSIFSLAMDCTVDLPEKRI-----SMKDVANR 1035 (1049)
Q Consensus      1002 ~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~~ 1035 (1049)
                      ..+...+.++.+++.+|++.||++|+     ++.++++|
T Consensus       214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            11122456789999999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=8.8e-36  Score=334.64  Aligned_cols=245  Identities=25%  Similarity=0.323  Sum_probs=196.0

Q ss_pred             CCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHH---hhcCCCceeeEEeeeecCCeeEEE
Q 039290          763 FSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVM---GSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      |++.+.||+|+||.||+|... +++.||+|+++...   ....+.+.+|++++   +.++||||+++++++.+.+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            667899999999999999954 78999999997543   22345566676655   566799999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++++|...+...  .+++.++..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||++.......
T Consensus        81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            9999999999887643  4899999999999999999999   9999999999999999999999999999987532222


Q ss_pred             cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                       .......|++.|+|||++.+..++.++||||+||++|||++|+.||......+.. .....                  
T Consensus       156 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~-~~i~~------------------  215 (324)
T cd05589         156 -DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF-DSIVN------------------  215 (324)
T ss_pred             -CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH-HHHHh------------------
Confidence             1223456899999999999889999999999999999999999999753221111 11000                  


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRI-----SMKDVANR 1035 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~~ 1035 (1049)
                         .....+...+..+.+++.+|++.||.+||     ++.+++++
T Consensus       216 ---~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         216 ---DEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence               00011123456789999999999999999     57777765

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.8e-35  Score=325.94  Aligned_cols=267  Identities=22%  Similarity=0.348  Sum_probs=203.7

Q ss_pred             CCCCceecCCCcEEEEEEEe-----CCCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecC--CeeEE
Q 039290          763 FSENKLLGMGSFGSVYKGVL-----PDGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNN--DFKAL  834 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~l  834 (1049)
                      |+..+.||+|+||+||.+..     .++..||+|.++.... ...+.+.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            38889999999999988652     3677899999875432 3456788999999999999999999987653  46789


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      ||||+++++|.+++...  .+++.+++.++.|++.|++|||   +++|+||||||+||++++++.+||+|||++......
T Consensus        86 v~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             EecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            99999999999998764  3899999999999999999999   999999999999999999999999999999866432


Q ss_pred             cccc--ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccc
Q 039290          915 ESMR--QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       915 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      ....  .....++..|+|||.+....++.++||||+|+++|||++|..||............+...........+..+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG  240 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence            2111  11223456799999998888999999999999999999999998653221111111100000000011111110


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIR 1040 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~ 1040 (1049)
                            ...+.+..++.++.+++.+||+.+|++|||++++++.|+++.
T Consensus       241 ------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         241 ------MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             ------CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence                  111223346678999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=9e-36  Score=339.88  Aligned_cols=253  Identities=21%  Similarity=0.278  Sum_probs=197.3

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|+..+.||+|+||+||+|+.. +++.||+|+++...   ......+.+|+.++.+++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46889999999999999999854 68899999997543   223456788999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+++|+|.+++...+ .+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++.......
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            9999999999987654 5899999999999999999999   99999999999999999999999999999875432110


Q ss_pred             ----------------------------------ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCC
Q 039290          917 ----------------------------------MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPT  962 (1049)
Q Consensus       917 ----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~  962 (1049)
                                                        ......+||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence                                              0012346899999999999889999999999999999999999999


Q ss_pred             CccccccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccc--cCCCCCCCHHHHHHH
Q 039290          963 DEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTV--DLPEKRISMKDVANR 1035 (1049)
Q Consensus       963 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~Rpt~~ell~~ 1035 (1049)
                      ......+..... . .....     .           .++.....+.++.+++.+++.  .++..||+++|+++|
T Consensus       237 ~~~~~~~~~~~i-~-~~~~~-----~-----------~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         237 CSETPQETYKKV-M-NWKET-----L-----------IFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCHHHHHHHH-H-cCcCc-----c-----------cCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            753222111111 0 00000     0           000001134566777777554  233456899999987

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.2e-35  Score=322.38  Aligned_cols=254  Identities=23%  Similarity=0.337  Sum_probs=203.3

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      .+|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++...+..++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            4689999999999999999995 578899999997654445567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      ++++|.+++.... .+++.++..++.|++.|++|||   +.+|+|||+||+||+++.++.+||+|||++........ ..
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~  163 (267)
T cd06646          89 GGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KR  163 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc-cc
Confidence            9999999886543 5789999999999999999999   99999999999999999999999999999986643221 12


Q ss_pred             cccccccCcccccccC---CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          920 TKTLGTIGYMAPEYGR---EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                      ....++..|+|||.+.   ...++.++||||+||++|||++|+.||......+.. ..+.....                
T Consensus       164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~~~~~~~~----------------  226 (267)
T cd06646         164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMSKSNF----------------  226 (267)
T ss_pred             CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-eeeecCCC----------------
Confidence            2345788999999874   345788999999999999999999998643211111 00000000                


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                      ...........+..+.+++.+||+.+|++|||++++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         227 QPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            0000111123456789999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.6e-35  Score=320.34  Aligned_cols=252  Identities=27%  Similarity=0.446  Sum_probs=204.7

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccC
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMS  840 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  840 (1049)
                      ++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|||++++++++.+ +..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence            4688899999999999999998888899999987543 345789999999999999999999998854 45789999999


Q ss_pred             CCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          841 NGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       841 ~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      +++|.+++... ...+++.++..++.|++.|++|||   +.+|+||||||+||++++++.++++|||.+..+........
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05070          84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence            99999998764 335899999999999999999999   99999999999999999999999999999987644332222


Q ss_pred             cccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccccccc
Q 039290          920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                      ....++..|+|||++.+..++.++||||||+++|||++ |..||......+. ...+...                    
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~-~~~~~~~--------------------  219 (260)
T cd05070         161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV-LEQVERG--------------------  219 (260)
T ss_pred             cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH-HHHHHcC--------------------
Confidence            22345668999999988889999999999999999999 8889865322211 1111000                    


Q ss_pred             cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 039290          999 NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVR 1038 (1049)
Q Consensus       999 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~ 1038 (1049)
                      ...+.+...+..+.+++.+|+..+|++|||+.++.+.|++
T Consensus       220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         220 YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            0011123345679999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1e-35  Score=333.19  Aligned_cols=242  Identities=23%  Similarity=0.300  Sum_probs=195.3

Q ss_pred             ceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEEEeccCC
Q 039290          767 KLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALVLEYMSN  841 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  841 (1049)
                      +.||+|+||+||+|+.. +++.||+|+++...   ....+.+..|.+++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999964 68899999997542   33456677888888876 699999999999999999999999999


Q ss_pred             CChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccc
Q 039290          842 GSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK  921 (1049)
Q Consensus       842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~  921 (1049)
                      |+|.+++...+ .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++........ ....
T Consensus        81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~~~  155 (320)
T cd05590          81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTST  155 (320)
T ss_pred             chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-cccc
Confidence            99999887654 4899999999999999999999   99999999999999999999999999999875432221 2233


Q ss_pred             cccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCc
Q 039290          922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDF 1001 (1049)
Q Consensus       922 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1049)
                      ..|++.|+|||++.+..++.++||||+||++|||++|+.||......+  ....+   .. .                ..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--~~~~i---~~-~----------------~~  213 (320)
T cd05590         156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD--LFEAI---LN-D----------------EV  213 (320)
T ss_pred             cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--HHHHH---hc-C----------------CC
Confidence            568999999999998899999999999999999999999997532211  11110   00 0                00


Q ss_pred             hhhHHHHHHHHHHHhhccccCCCCCCCH------HHHHHH
Q 039290         1002 SAREQCVSSIFSLAMDCTVDLPEKRISM------KDVANR 1035 (1049)
Q Consensus      1002 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~------~ell~~ 1035 (1049)
                      ..+...+.++.+++.+|++.||++||++      ++++.|
T Consensus       214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         214 VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence            1112245678999999999999999998      666654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=7.3e-36  Score=340.47  Aligned_cols=259  Identities=22%  Similarity=0.298  Sum_probs=204.5

Q ss_pred             HHHHHhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCC
Q 039290          755 DLLRATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNND  830 (1049)
Q Consensus       755 ~~~~~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~  830 (1049)
                      +.....++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+++
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            44445678999999999999999999965 68899999986432   223456788999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCcee
Q 039290          831 FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI  910 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~  910 (1049)
                      ..++||||+++|+|.+++...  .+++..+..++.||+.|++|||   ++||+||||||+||+++.++.+||+|||++..
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~  191 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence            999999999999999988654  3788889999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCccccccccccccCcccccccCCC----CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcc
Q 039290          911 LGKEESMRQTKTLGTIGYMAPEYGREG----KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSIT  986 (1049)
Q Consensus       911 ~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  986 (1049)
                      .............||+.|+|||++...    .++.++||||+||++|||++|+.||....... .......    ..   
T Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~----~~---  263 (371)
T cd05622         192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIMN----HK---  263 (371)
T ss_pred             cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-HHHHHHc----CC---
Confidence            654433333456799999999998653    37889999999999999999999997532211 1111100    00   


Q ss_pred             hhcccccccccccCchhhHHHHHHHHHHHhhccccCCCC--CCCHHHHHHHH
Q 039290          987 EVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEK--RISMKDVANRL 1036 (1049)
Q Consensus       987 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~ell~~L 1036 (1049)
                                ....++.....+..+.+++.+|++.++.+  |++++|+++|.
T Consensus       264 ----------~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         264 ----------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             ----------CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence                      00011111235667899999999854443  78999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.4e-36  Score=297.46  Aligned_cols=254  Identities=24%  Similarity=0.326  Sum_probs=208.4

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCC----C----HHHHHHHHHHHhhc-CCCceeeEEeeeec
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDG----S----LESFHAECKVMGSI-RHRNLVKIISSCSN  828 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~----~----~~~~~~e~~~l~~l-~hpniv~l~~~~~~  828 (1049)
                      ....|...+.+|.|..++|.++.+ .+|..+|+|++......    .    .+.-.+|+.+++++ .||+|+++.++|+.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            345677888999999999999884 57889999998654321    1    24456799999998 69999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCc
Q 039290          829 NDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA  908 (1049)
Q Consensus       829 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla  908 (1049)
                      +..+++|+|.|+.|.|.|++...- .+++.+..+|+.|+.+|++|||   .+.|||||+||+||+++++.++||+|||+|
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa  170 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFA  170 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEecccee
Confidence            999999999999999999998765 4889999999999999999999   999999999999999999999999999999


Q ss_pred             eecCCCccccccccccccCcccccccCC------CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcccc
Q 039290          909 KILGKEESMRQTKTLGTIGYMAPEYGRE------GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLS  982 (1049)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  982 (1049)
                      +...+...  ....+|||+|.|||.+.-      ..|+..+|+|+.|||||-++.|.+||...  .+....         
T Consensus       171 ~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--kQmlML---------  237 (411)
T KOG0599|consen  171 CQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR--KQMLML---------  237 (411)
T ss_pred             eccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--HHHHHH---------
Confidence            98876554  345689999999998742      46888999999999999999999998641  111111         


Q ss_pred             CCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          983 CSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                             ...+.....-+.+...+.+.+..++|.+|+++||++|.|++|+++|-
T Consensus       238 -------R~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp  284 (411)
T KOG0599|consen  238 -------RMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP  284 (411)
T ss_pred             -------HHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence                   11111122223344567788899999999999999999999999873

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.2e-35  Score=322.94  Aligned_cols=262  Identities=23%  Similarity=0.399  Sum_probs=206.8

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCc----EEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGM----EIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      ++|+..+.||+|+||+||+|.+. +++    .|++|.+..... ....++..|+.+++++.||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46788899999999999999963 444    477777753322 223567788889999999999999998764 45688


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      ++||+++|+|.+++......+++..+..++.|++.|++|+|   +++++||||||+||++++++.+||+|||+++.....
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            99999999999999877667899999999999999999999   999999999999999999999999999999866433


Q ss_pred             cc-ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccc
Q 039290          915 ES-MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       915 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      .. .......++..|+|||++.++.++.++|||||||++|||++ |..||.+....+  ...+.....            
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~~~------------  228 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VPDLLEKGE------------  228 (279)
T ss_pred             CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHCCC------------
Confidence            22 11223346678999999988899999999999999999998 999987532221  111111000            


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhcc
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYI 1047 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~~ 1047 (1049)
                             ....+..++..+.+++.+||..+|++|||+.|+++.|..+.+.-..|+
T Consensus       229 -------~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~~~~  276 (279)
T cd05111         229 -------RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPRYL  276 (279)
T ss_pred             -------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCccee
Confidence                   001111244567889999999999999999999999999887666664

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.5e-35  Score=326.95  Aligned_cols=261  Identities=24%  Similarity=0.444  Sum_probs=207.0

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCc--EEEEEEeeccc-CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGM--EIAAKVFHMEF-DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      ++|++.+.||+|+||.||+|... ++.  .+++|.++... ....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            46888999999999999999864 333  47888876432 22346788999999999 799999999999999999999


Q ss_pred             EeccCCCChhhhhhcCC---------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCce
Q 039290          836 LEYMSNGSLEKCLYSDN---------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVG  900 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~  900 (1049)
                      |||+++++|.+++....               ..+++.++..++.|++.|++|||   ++||+||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            99999999999986532               24788899999999999999999   9999999999999999999999


Q ss_pred             EEecccCceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhc
Q 039290          901 HLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDS  979 (1049)
Q Consensus       901 kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  979 (1049)
                      ||+|||++......  ........+..|+|||++.+..++.++|||||||++|||++ |..||......+. ......  
T Consensus       159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~-~~~~~~--  233 (297)
T cd05089         159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL-YEKLPQ--  233 (297)
T ss_pred             EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhc--
Confidence            99999998643211  11111223457999999988889999999999999999997 9999865322211 110000  


Q ss_pred             cccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhcc
Q 039290          980 LLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYI 1047 (1049)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~~ 1047 (1049)
                                  .      .....+..++..+.+++.+||+.+|.+||+++++++.|+++..+...++
T Consensus       234 ------------~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~  283 (297)
T cd05089         234 ------------G------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYV  283 (297)
T ss_pred             ------------C------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcccc
Confidence                        0      0011122355678999999999999999999999999999998877665

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.1e-35  Score=333.53  Aligned_cols=242  Identities=23%  Similarity=0.299  Sum_probs=196.1

Q ss_pred             ceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEEEeccCC
Q 039290          767 KLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALVLEYMSN  841 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  841 (1049)
                      ++||+|+||.||+|+.. +++.||+|+++...   ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999964 67899999997643   23345677888888866 799999999999999999999999999


Q ss_pred             CChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccc
Q 039290          842 GSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK  921 (1049)
Q Consensus       842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~  921 (1049)
                      |+|.+.+...+ .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||++........ ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~  155 (321)
T cd05591          81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTT  155 (321)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cccc
Confidence            99999887654 4889999999999999999999   99999999999999999999999999999875432222 2233


Q ss_pred             cccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCc
Q 039290          922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDF 1001 (1049)
Q Consensus       922 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1049)
                      ..|++.|+|||++.+..++.++||||+||++|||++|+.||......+.. .....                     ...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~-~~i~~---------------------~~~  213 (321)
T cd05591         156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF-ESILH---------------------DDV  213 (321)
T ss_pred             cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH-HHHHc---------------------CCC
Confidence            56899999999999889999999999999999999999999753322111 11000                     000


Q ss_pred             hhhHHHHHHHHHHHhhccccCCCCCC-------CHHHHHHH
Q 039290         1002 SAREQCVSSIFSLAMDCTVDLPEKRI-------SMKDVANR 1035 (1049)
Q Consensus      1002 ~~~~~~~~~l~~li~~cl~~dP~~Rp-------t~~ell~~ 1035 (1049)
                      ..+..++.++.+++.+|++.||++||       ++++++++
T Consensus       214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            11112456789999999999999999       88888876

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=9.3e-36  Score=334.86  Aligned_cols=248  Identities=22%  Similarity=0.301  Sum_probs=196.7

Q ss_pred             ceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEEEeccCC
Q 039290          767 KLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALVLEYMSN  841 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  841 (1049)
                      ++||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999964 68899999997643   22345678899999988 699999999999999999999999999


Q ss_pred             CChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccc
Q 039290          842 GSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK  921 (1049)
Q Consensus       842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~  921 (1049)
                      |+|.+++...+ .+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||++........ ....
T Consensus        81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~~~~  155 (329)
T cd05588          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-TTST  155 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC-cccc
Confidence            99998886554 5899999999999999999999   99999999999999999999999999999874322111 2234


Q ss_pred             cccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccc---hHHHhhhhccccCCcchhcccccccccc
Q 039290          922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEM---SLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       922 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||+.....+.   ....+......                .
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~----------------~  219 (329)
T cd05588         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL----------------E  219 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH----------------c
Confidence            5689999999999998999999999999999999999999974322110   01111100000                0


Q ss_pred             cCchhhHHHHHHHHHHHhhccccCCCCCCC------HHHHHHH
Q 039290          999 NDFSAREQCVSSIFSLAMDCTVDLPEKRIS------MKDVANR 1035 (1049)
Q Consensus       999 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt------~~ell~~ 1035 (1049)
                      .....+...+.++.+++.+|++.||.+||+      ++++++|
T Consensus       220 ~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         220 KQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            011112234567899999999999999997      6777765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.6e-35  Score=332.56  Aligned_cols=247  Identities=23%  Similarity=0.286  Sum_probs=198.1

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCC-CceeeEEeeeecCCeeEEEE
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRH-RNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-pniv~l~~~~~~~~~~~lv~  836 (1049)
                      +|++.+.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|.+++..++| ++|+++++++.+.+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788899999999999999965 67889999997543   2345677889999999876 56888999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+++|+|.+++.... .+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++........
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05587          81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK  156 (324)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence            9999999999887654 4789999999999999999999   99999999999999999999999999999875322221


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                       ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+..  ..+.            .      
T Consensus       157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~--~~i~------------~------  215 (324)
T cd05587         157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF--QSIM------------E------  215 (324)
T ss_pred             -ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH--HHHH------------c------
Confidence             223356899999999999989999999999999999999999999753222111  1000            0      


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCCH-----HHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRISM-----KDVANR 1035 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~ell~~ 1035 (1049)
                        .....+...+.++.+++.+|++.+|.+|++.     +++.+|
T Consensus       216 --~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         216 --HNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             --CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence              0011112345678899999999999999986     566654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.5e-35  Score=324.03  Aligned_cols=264  Identities=24%  Similarity=0.423  Sum_probs=211.5

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCc----EEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGM----EIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      .+|+..+.||+|+||+||+|++ .+++    .||+|+++.... .....+.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence            4688889999999999999985 3444    489999865432 2346788899999999999999999998754 4679


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      ++||+++|+|.+++......+++.++..++.|+++|++|||   +++|+||||||+||++++++.+||+|||+++.....
T Consensus        86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~  162 (279)
T cd05109          86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID  162 (279)
T ss_pred             EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence            99999999999999876667899999999999999999999   999999999999999999999999999999876432


Q ss_pred             ccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccc
Q 039290          915 ESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       915 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      ... ......++..|+|||...+..++.++|||||||++|||++ |..||+.....+  ...+....             
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~-------------  227 (279)
T cd05109         163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--IPDLLEKG-------------  227 (279)
T ss_pred             cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHCC-------------
Confidence            221 1112234678999999988889999999999999999998 889986532211  11111100             


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhccCC
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYIDV 1049 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~~~~ 1049 (1049)
                            .....+..++.++.+++.+||+.||++||++.|+++.|+++...-.+|.++
T Consensus       228 ------~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~~~~~~  278 (279)
T cd05109         228 ------ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSRFVVI  278 (279)
T ss_pred             ------CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCcCeEee
Confidence                  001111235567899999999999999999999999999998888887764

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.4e-35  Score=329.22  Aligned_cols=271  Identities=18%  Similarity=0.257  Sum_probs=204.1

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .++|...+.||+|+||.||+|+.. +++.||+|+++... ......+.+|++++++++||||+++++++..++..++|||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            357899999999999999999964 67889999987543 2334567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      |+++ ++.+++...+..+++.++..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||++........ 
T Consensus        85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  159 (309)
T cd07872          85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-  159 (309)
T ss_pred             CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence            9975 888888776666899999999999999999999   99999999999999999999999999999976533222 


Q ss_pred             cccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhh-hccccCCcchhccc----
Q 039290          918 RQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVG-DSLLSCSITEVADA----  991 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~----  991 (1049)
                      ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+........ .......+..+...    
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK  239 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence            1223457889999998764 56889999999999999999999999754322211100000 00000000000000    


Q ss_pred             --cccc-ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          992 --NLLN-CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       992 --~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                        .... ............+.++.+++.+|++.||.+|||++|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence              0000 0000001112356678999999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8.8e-36  Score=334.85  Aligned_cols=248  Identities=23%  Similarity=0.303  Sum_probs=195.8

Q ss_pred             ceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEEEeccCC
Q 039290          767 KLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALVLEYMSN  841 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  841 (1049)
                      +.||+|+||.||+|+.. +++.||+|+++...   ......+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999954 67899999997643   22345677888888877 799999999999999999999999999


Q ss_pred             CChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccc
Q 039290          842 GSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK  921 (1049)
Q Consensus       842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~  921 (1049)
                      |+|.+++...+ .+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+++....... ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~~  155 (329)
T cd05618          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTST  155 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cccc
Confidence            99998876654 4899999999999999999999   99999999999999999999999999999875322221 2233


Q ss_pred             cccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccc---hHHHhhhhccccCCcchhcccccccccc
Q 039290          922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEM---SLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       922 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||........   ....+......                .
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~----------------~  219 (329)
T cd05618         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL----------------E  219 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh----------------c
Confidence            5689999999999999999999999999999999999999964222111   11111100000                0


Q ss_pred             cCchhhHHHHHHHHHHHhhccccCCCCCCC------HHHHHHH
Q 039290          999 NDFSAREQCVSSIFSLAMDCTVDLPEKRIS------MKDVANR 1035 (1049)
Q Consensus       999 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt------~~ell~~ 1035 (1049)
                      .....+...+.++.+++.+|++.||++||+      ++++++|
T Consensus       220 ~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         220 KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            111122334567889999999999999998      4677665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=326.34  Aligned_cols=251  Identities=24%  Similarity=0.313  Sum_probs=202.4

Q ss_pred             CCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          762 GFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      +|+..+.||+|+||+||+|.. .+++.||+|++....   ......+.+|++++++++||||+++++++.+++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            478889999999999999995 478899999986532   1223457789999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          838 YMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      |+++|+|.+++... ...+++..+..++.|++.|++|||   +.+|+||||||+||++++++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET  157 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence            99999999887653 345899999999999999999999   99999999999999999999999999999987543221


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                        .....|+..|+|||++.+..++.++||||+||++|||++|+.||...... ......... ..               
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~~~~~-~~---------------  218 (285)
T cd05605         158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREEVERR-VK---------------  218 (285)
T ss_pred             --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHHHHHH-hh---------------
Confidence              22346889999999998888999999999999999999999999753211 111111000 00               


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRI-----SMKDVANR 1035 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~~ 1035 (1049)
                       ......+...+..+.+++.+||+.||++||     ++++++++
T Consensus       219 -~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         219 -EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             -hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence             000111223566789999999999999999     89999876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-36  Score=342.59  Aligned_cols=252  Identities=22%  Similarity=0.281  Sum_probs=198.6

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|++.+.||+|+||+||+|+. .+++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            3688999999999999999985 478899999986532   223457888999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            9999999999987654 4788999999999999999999   99999999999999999999999999999964321100


Q ss_pred             c----------------------------------------------cccccccccCcccccccCCCCcCcccchHHHHH
Q 039290          917 M----------------------------------------------RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGI  950 (1049)
Q Consensus       917 ~----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~  950 (1049)
                      .                                              .....+||+.|+|||++.+..++.++||||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence            0                                              001246899999999999889999999999999


Q ss_pred             HHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCC---C
Q 039290          951 MLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKR---I 1027 (1049)
Q Consensus       951 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---p 1027 (1049)
                      ++|||++|..||......+. ...... ....                ..++.....+.++.+++.+|+. +|.+|   +
T Consensus       237 il~elltG~~Pf~~~~~~~~-~~~i~~-~~~~----------------~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~  297 (377)
T cd05629         237 IMFECLIGWPPFCSENSHET-YRKIIN-WRET----------------LYFPDDIHLSVEAEDLIRRLIT-NAENRLGRG  297 (377)
T ss_pred             hhhhhhcCCCCCCCCCHHHH-HHHHHc-cCCc----------------cCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence            99999999999965322111 111000 0000                0000111234678899999998 66665   5


Q ss_pred             CHHHHHHH
Q 039290         1028 SMKDVANR 1035 (1049)
Q Consensus      1028 t~~ell~~ 1035 (1049)
                      ++.|++.|
T Consensus       298 ~~~~~l~h  305 (377)
T cd05629         298 GAHEIKSH  305 (377)
T ss_pred             CHHHHhcC
Confidence            99999987

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.3e-35  Score=319.18  Aligned_cols=247  Identities=24%  Similarity=0.414  Sum_probs=198.4

Q ss_pred             ceecCCCcEEEEEEEeC-CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCCCh
Q 039290          767 KLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSL  844 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  844 (1049)
                      +.||+|+||.||+|+.. +++.||+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999964 788999998864432 2346789999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc-ccccc
Q 039290          845 EKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTL  923 (1049)
Q Consensus       845 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~-~~~~~  923 (1049)
                      .+++......+++.+++.++.|+++|++|||   +.+|+||||||+||+++.++.+|++|||++.......... .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            9999776666899999999999999999999   9999999999999999999999999999987543221111 01112


Q ss_pred             cccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCch
Q 039290          924 GTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFS 1002 (1049)
Q Consensus       924 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1049)
                      .+..|+|||.+.++.++.++||||+||++|||++ |..||......+.  .....             ..      .+..
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~--~~~~~-------------~~------~~~~  216 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT--REAIE-------------QG------VRLP  216 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH--HHHHH-------------cC------CCCC
Confidence            3457999999988889999999999999999998 8888865322111  11000             00      0011


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290         1003 AREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus      1003 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                      .+..++..+.+++.+|++.+|++|||++|+++.|+
T Consensus       217 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            12234667899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.6e-35  Score=323.75  Aligned_cols=245  Identities=24%  Similarity=0.304  Sum_probs=196.4

Q ss_pred             ecCCCcEEEEEEEeC-CCcEEEEEEeecccC---CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCCCh
Q 039290          769 LGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD---GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSL  844 (1049)
Q Consensus       769 lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  844 (1049)
                      ||+|+||+||+|... +++.||+|.+.....   ...+.+..|+++++.++||||+++.+++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999954 788999999865432   2235677899999999999999999999999999999999999999


Q ss_pred             hhhhhc---CCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccc
Q 039290          845 EKCLYS---DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK  921 (1049)
Q Consensus       845 ~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~  921 (1049)
                      .+.+..   ....+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++........ ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence            987753   2345899999999999999999999   99999999999999999999999999999986643322 1223


Q ss_pred             cccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCc
Q 039290          922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDF 1001 (1049)
Q Consensus       922 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1049)
                      ..|++.|+|||++.+..++.++||||+||++|||++|+.||......... ........                 ....
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~-----------------~~~~  218 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQRIL-----------------NDSV  218 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH-HHHHHhhc-----------------ccCC
Confidence            46889999999999999999999999999999999999999753221111 11000000                 0001


Q ss_pred             hhhHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 039290         1002 SAREQCVSSIFSLAMDCTVDLPEKRI-----SMKDVANR 1035 (1049)
Q Consensus      1002 ~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~~ 1035 (1049)
                      ..+..++.++.+++.+|++.||++||     +++++++|
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            11233567789999999999999999     77888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.3e-35  Score=316.67  Aligned_cols=247  Identities=28%  Similarity=0.435  Sum_probs=200.4

Q ss_pred             ceecCCCcEEEEEEEeCCCcEEEEEEeecccCC-CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCCChh
Q 039290          767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDG-SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLE  845 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~  845 (1049)
                      ++||+|+||.||+|...++..||+|.++..... ....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            369999999999999888999999998755422 2346889999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccccccc
Q 039290          846 KCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT  925 (1049)
Q Consensus       846 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~  925 (1049)
                      +++......+++.++..++.|++.|+.|+|   ++|++||||||+||+++.++.+|++|||++...............++
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence            998776666899999999999999999999   99999999999999999999999999999875433221111222345


Q ss_pred             cCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCchhh
Q 039290          926 IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAR 1004 (1049)
Q Consensus       926 ~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1049)
                      ..|+|||++.+..++.++||||+|+++||+++ |..||......+....  ...    .               .+...+
T Consensus       158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~--~~~----~---------------~~~~~~  216 (250)
T cd05085         158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ--VEK----G---------------YRMSCP  216 (250)
T ss_pred             ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HHc----C---------------CCCCCC
Confidence            67999999988889999999999999999998 9999875422211111  000    0               000111


Q ss_pred             HHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290         1005 EQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus      1005 ~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                      ..++.++.+++.+|++.+|++||++.|+++.|.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            234567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.2e-35  Score=321.59  Aligned_cols=257  Identities=25%  Similarity=0.414  Sum_probs=207.6

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCC----CcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPD----GMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      .+|.+.+.||+|+||.||+|...+    ...||+|...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457888999999999999998543    3468999887554 2345678999999999999999999998876 456899


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++++|.+++......+++.++..++.|++.|++|+|   +.+++||||||+||+++.++.+|++|||++.......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            9999999999999876667899999999999999999999   9999999999999999999999999999998664432


Q ss_pred             cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                      ........++..|+|||.+....++.++||||+|+++|||++ |..||......+..  .+...                
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~--~~~~~----------------  223 (270)
T cd05056         162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI--GRIEN----------------  223 (270)
T ss_pred             ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHHc----------------
Confidence            222222334568999999888889999999999999999996 99999764332211  11100                


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHh
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~ 1042 (1049)
                         ..+...+..++..+.+++.+|+..+|++|||+.++++.|+++.++
T Consensus       224 ---~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         224 ---GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             ---CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence               001111234567899999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=327.33  Aligned_cols=245  Identities=26%  Similarity=0.340  Sum_probs=205.3

Q ss_pred             CCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC---CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          762 GFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD---GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .|...+.||+|+||.||-|+. .+.+.||+|+......   ..+.++..|++.+.+++|||++.+-|+|..+...|+|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            366778899999999999995 4778899999865543   346789999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      ||-| +-.|++.-.++++.+.++..|+.+.+.||+|||   +.+.||||||+.||++++.|.||++|||.|..+.+..  
T Consensus       107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn--  180 (948)
T KOG0577|consen  107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN--  180 (948)
T ss_pred             HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCchh--
Confidence            9954 888888888888999999999999999999999   9999999999999999999999999999998776543  


Q ss_pred             cccccccccCcccccccC---CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          918 RQTKTLGTIGYMAPEYGR---EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                         .++|||.|||||++.   .+.|+-++||||+|++..|+..+++|+-.+......+..-..+           .+.+ 
T Consensus       181 ---sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe-----------sPtL-  245 (948)
T KOG0577|consen  181 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-----------SPTL-  245 (948)
T ss_pred             ---cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC-----------CCCC-
Confidence               478999999999874   4789999999999999999999999976543222111110000           0000 


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                              ...+.+..+++|+..|++.-|.+|||.+++++|
T Consensus       246 --------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  246 --------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             --------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence                    123456779999999999999999999999887

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.6e-35  Score=318.40  Aligned_cols=253  Identities=25%  Similarity=0.424  Sum_probs=205.6

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      .++|++.++||+|+||.||+|...+++.||+|.+.... ...+++.+|+.++++++||||+++++++. .+..++||||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            35688899999999999999998889999999987543 34578999999999999999999999874 45689999999


Q ss_pred             CCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          840 SNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       840 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      ++++|.+++... +..+++.++..++.|++.|++|||   +.|++||||||+||++++++.++++|||++..........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05067          83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence            999999988653 346889999999999999999999   9999999999999999999999999999998765322222


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE  997 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1049)
                      .....++..|+|||++....++.++||||+|+++|||++ |+.||......+  .........                 
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~-----------------  220 (260)
T cd05067         160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQNLERGY-----------------  220 (260)
T ss_pred             ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHHHHHcCC-----------------
Confidence            223345678999999988889999999999999999999 999997533221  111110000                 


Q ss_pred             ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 039290          998 ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVR 1038 (1049)
Q Consensus       998 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~ 1038 (1049)
                        +...+...+.++.+++.+|++.+|++||++++++..|+.
T Consensus       221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         221 --RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence              001112245679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-35  Score=318.88  Aligned_cols=251  Identities=26%  Similarity=0.361  Sum_probs=203.5

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCC-----CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDG-----SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      ++|...+.||+|+||.||+|.. .+++.||+|.++.....     ..+.+.+|++++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4688999999999999999985 47899999998754321     23568889999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      |+||+++++|.+.+.... .+++..+.+++.|++.|++|||   +.||+||||+|+||++++++.++|+|||++......
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            999999999999887654 4788999999999999999999   999999999999999999999999999999765432


Q ss_pred             ccccc--cccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccc
Q 039290          915 ESMRQ--TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       915 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      .....  ....++..|+|||++.+..++.++||||+|+++|||++|+.||......+... . ....             
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~-~~~~-------------  222 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF-K-IATQ-------------  222 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH-H-Hhcc-------------
Confidence            21111  23457789999999998889999999999999999999999986531111111 0 0000             


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                           ......+..++..+.+++.+||..+|.+|||+.|++++
T Consensus       223 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         223 -----PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -----CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                 00111223355678999999999999999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.8e-35  Score=330.53  Aligned_cols=242  Identities=22%  Similarity=0.303  Sum_probs=193.4

Q ss_pred             ceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEEEeccCC
Q 039290          767 KLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALVLEYMSN  841 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  841 (1049)
                      +.||+|+||.||+|+.. +|+.||+|+++...   ....+.+..|.+++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999965 68899999997643   23345667788887754 899999999999999999999999999


Q ss_pred             CChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccc
Q 039290          842 GSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK  921 (1049)
Q Consensus       842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~  921 (1049)
                      |+|.+++.... .+++.++..++.|+++|++|||   ++||+||||||+||+++.++.+||+|||+++...... .....
T Consensus        81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~  155 (316)
T cd05620          81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAST  155 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cceec
Confidence            99999887654 4789999999999999999999   9999999999999999999999999999987532211 12234


Q ss_pred             cccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCc
Q 039290          922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDF 1001 (1049)
Q Consensus       922 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1049)
                      ..|++.|+|||++.+..++.++||||+||++|||++|+.||......  ...+.+..                    ...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~~~~~~--------------------~~~  213 (316)
T cd05620         156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELFESIRV--------------------DTP  213 (316)
T ss_pred             cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHh--------------------CCC
Confidence            56899999999999989999999999999999999999999753221  11111000                    000


Q ss_pred             hhhHHHHHHHHHHHhhccccCCCCCCCHH-HHHHH
Q 039290         1002 SAREQCVSSIFSLAMDCTVDLPEKRISMK-DVANR 1035 (1049)
Q Consensus      1002 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~-ell~~ 1035 (1049)
                      ..+...+.++.+++.+|++.||++||++. ++.+|
T Consensus       214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h  248 (316)
T cd05620         214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH  248 (316)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence            11112456788999999999999999984 66543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.3e-35  Score=317.80  Aligned_cols=247  Identities=28%  Similarity=0.483  Sum_probs=198.1

Q ss_pred             eecCCCcEEEEEEEeC---CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCCC
Q 039290          768 LLGMGSFGSVYKGVLP---DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGS  843 (1049)
Q Consensus       768 ~lg~G~fg~Vy~a~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~  843 (1049)
                      .||+|+||.||+|.+.   ++..||+|++..... ...+.+.+|+.++++++||||+++++++.. +..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999753   455799999875532 234678899999999999999999998864 56799999999999


Q ss_pred             hhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc--ccc
Q 039290          844 LEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR--QTK  921 (1049)
Q Consensus       844 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~--~~~  921 (1049)
                      |.+++......+++.++.+++.|++.|++|||   ++|++||||||+||+++.++.+||+|||++..........  ...
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            99999876667899999999999999999999   9999999999999999999999999999998654333211  111


Q ss_pred             cccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccccccccC
Q 039290          922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEND 1000 (1049)
Q Consensus       922 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1049)
                      ..++..|+|||++....++.++|||||||++||+++ |..||......+.  ...+...                   .+
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~~~-------------------~~  216 (257)
T cd05115         158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV--MSFIEQG-------------------KR  216 (257)
T ss_pred             CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH--HHHHHCC-------------------CC
Confidence            223568999999988889999999999999999996 9999976432221  1111000                   01


Q ss_pred             chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290         1001 FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus      1001 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                      ...+..++.++.+++.+||+.+|++||++.++.+.|+.+
T Consensus       217 ~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         217 LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            112234567899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.9e-35  Score=328.62  Aligned_cols=242  Identities=25%  Similarity=0.343  Sum_probs=193.6

Q ss_pred             ceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEEEeccCC
Q 039290          767 KLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALVLEYMSN  841 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  841 (1049)
                      +.||+|+||+||+|+.. +++.||+|+++...   ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 57899999997642   23345567788888764 899999999999999999999999999


Q ss_pred             CChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccc
Q 039290          842 GSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK  921 (1049)
Q Consensus       842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~  921 (1049)
                      |+|.+++.... .+++.++..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||++........ ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~  155 (316)
T cd05619          81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCT  155 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceee
Confidence            99999887643 4789999999999999999999   99999999999999999999999999999875422221 2233


Q ss_pred             cccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCc
Q 039290          922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDF 1001 (1049)
Q Consensus       922 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1049)
                      ..||+.|+|||++.+..++.++||||+||++|||++|..||......+  ..+.+...                    ..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~~~i~~~--------------------~~  213 (316)
T cd05619         156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE--LFQSIRMD--------------------NP  213 (316)
T ss_pred             ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhC--------------------CC
Confidence            568999999999998899999999999999999999999997532211  11111000                    00


Q ss_pred             hhhHHHHHHHHHHHhhccccCCCCCCCHH-HHHHH
Q 039290         1002 SAREQCVSSIFSLAMDCTVDLPEKRISMK-DVANR 1035 (1049)
Q Consensus      1002 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~-ell~~ 1035 (1049)
                      ..+...+.++.+++.+|++.+|++||++. ++.++
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05619         214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQH  248 (316)
T ss_pred             CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence            01122456788999999999999999997 66553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.9e-35  Score=350.62  Aligned_cols=260  Identities=24%  Similarity=0.327  Sum_probs=205.8

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCC---CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDG---SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|++.++||+|+||.||+|... +++.||+|+++.....   ..+++.+|++++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57999999999999999999964 6899999999754322   2457889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcC----------CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEeccc
Q 039290          837 EYMSNGSLEKCLYSD----------NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFG  906 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfG  906 (1049)
                      ||++||+|.+++...          ....++..+.+++.||++||+|||   +.||+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988642          123566778899999999999999   9999999999999999999999999999


Q ss_pred             CceecCCCcc-----------------ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCcccccc
Q 039290          907 IAKILGKEES-----------------MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGE  969 (1049)
Q Consensus       907 la~~~~~~~~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~  969 (1049)
                      ++........                 ......+||+.|+|||++.+..++.++||||+||++|||+||+.||......+
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986621110                 01122468999999999999999999999999999999999999997522211


Q ss_pred             chHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCC-CHHHHHHHHHHHHHh
Q 039290          970 MSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI-SMKDVANRLVRIRET 1042 (1049)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~ell~~L~~i~~~ 1042 (1049)
                      ......    .        .++       .......+.+..+.+++.+|++.||++|| +++++.+.|+...+.
T Consensus       239 i~~~~~----i--------~~P-------~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        239 ISYRDV----I--------LSP-------IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hhhhhh----c--------cCh-------hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            111100    0        000       00011123556789999999999999996 677788888877654

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.7e-35  Score=323.47  Aligned_cols=254  Identities=27%  Similarity=0.434  Sum_probs=202.5

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-----CCCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-----PDGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      ++|++.+.||+|+||.||+|..     .++..||+|.++.... .....+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4577889999999999999984     2567899999875332 234678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCC----------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDN----------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM  898 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~  898 (1049)
                      ||||+++++|.+++....                ..+++.++..++.|++.|++|||   +++|+||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            999999999999885321                24788889999999999999999   99999999999999999999


Q ss_pred             ceEEecccCceecCCCcc-ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhh
Q 039290          899 VGHLSDFGIAKILGKEES-MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWV  976 (1049)
Q Consensus       899 ~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  976 (1049)
                      .+|++|||+++....... .......++..|+|||++.+..++.++||||+||++|||++ |..||......  .....+
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--~~~~~~  239 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--EVIEMV  239 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH
Confidence            999999999986543321 11222345678999999988889999999999999999998 88898653211  111111


Q ss_pred             hhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 039290          977 GDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVR 1038 (1049)
Q Consensus       977 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~ 1038 (1049)
                      ..    .        .       ....+..++.++.+++.+||+.+|++||++.++.++|++
T Consensus       240 ~~----~--------~-------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         240 RK----R--------Q-------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             Hc----C--------C-------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            00    0        0       011122355678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.2e-35  Score=323.23  Aligned_cols=270  Identities=27%  Similarity=0.391  Sum_probs=205.5

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-----CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeec--CCeeE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-----PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSN--NDFKA  833 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--~~~~~  833 (1049)
                      .+|++.+.||+|+||.||+|..     .+++.||+|.++.......+.+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4688889999999999999974     3578999999876554456688999999999999999999998643  34688


Q ss_pred             EEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          834 LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      +||||+++++|.+++...+..+++..+..++.|++.|++|||   ++||+||||||+||++++++.+||+|||++.....
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            999999999999999876666899999999999999999999   99999999999999999999999999999987643


Q ss_pred             Cccccc--cccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccc-cCCcchhcc
Q 039290          914 EESMRQ--TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLL-SCSITEVAD  990 (1049)
Q Consensus       914 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  990 (1049)
                      ......  ....++..|+|||++.+..++.++||||+||++|||++|..|+.....   ......+.... ......+.+
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA---EFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch---hhhhhcccccccccchHHHHH
Confidence            322111  112234569999999888899999999999999999998776543211   11110000000 000000000


Q ss_pred             cccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290          991 ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                       .+.  ...+.+.+..++.++.+++.+||+.+|++|||+.|+++.|+++
T Consensus       238 -~~~--~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         238 -LLK--NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             -HHh--cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence             000  0111122234567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.1e-35  Score=336.21  Aligned_cols=259  Identities=23%  Similarity=0.376  Sum_probs=205.7

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEeC------CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcC-CCceeeEEeeeecCC
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIR-HRNLVKIISSCSNND  830 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~  830 (1049)
                      ..++|.+.+.||+|+||.||+|++.      .+..||+|+++.... ...+.+.+|++++.++. ||||+++++++...+
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3446788899999999999999853      346799999975432 23457889999999997 999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhhcCC----------------------------------------------------------
Q 039290          831 FKALVLEYMSNGSLEKCLYSDN----------------------------------------------------------  852 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  852 (1049)
                      ..++||||+++|+|.++++..+                                                          
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            9999999999999999986432                                                          


Q ss_pred             ---------------------------------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCee
Q 039290          853 ---------------------------------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVL  893 (1049)
Q Consensus       853 ---------------------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl  893 (1049)
                                                             ..+++.++..++.|++.|++|||   +.+|+||||||+||+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEE
Confidence                                                   13567778899999999999999   999999999999999


Q ss_pred             ecCCCceEEecccCceecCCCcc-ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccch
Q 039290          894 LNESMVGHLSDFGIAKILGKEES-MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS  971 (1049)
Q Consensus       894 ~~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~  971 (1049)
                      +++++.+|++|||+++....... .......++..|+|||.+.+..++.++||||+||++|||++ |..||......+..
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~  351 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF  351 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence            99999999999999986533221 11223356788999999988889999999999999999998 88898654322211


Q ss_pred             HHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 039290          972 LKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIR 1040 (1049)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~ 1040 (1049)
                      .......                    .+...+..++.++.+++.+||..+|++||+++|+++.|+++.
T Consensus       352 ~~~~~~~--------------------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         352 YNAIKRG--------------------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HHHHHcC--------------------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            1110000                    001112234578999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=8.9e-36  Score=342.03  Aligned_cols=251  Identities=21%  Similarity=0.270  Sum_probs=198.9

Q ss_pred             CCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          762 GFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .|++.+.||+|+||.||+|+. .+++.||+|++....   ......+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            688999999999999999995 468899999986432   2335678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc--
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE--  915 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~--  915 (1049)
                      |+++|+|.+++...+ .+++..+..++.||+.||+|||   +.||+||||||+||+++.++.+||+|||+|..+....  
T Consensus        82 ~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          82 YIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence            999999999987654 4788899999999999999999   9999999999999999999999999999975321000  


Q ss_pred             ----------------------------------------cccccccccccCcccccccCCCCcCcccchHHHHHHHHHH
Q 039290          916 ----------------------------------------SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMET  955 (1049)
Q Consensus       916 ----------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el  955 (1049)
                                                              .......+||+.|+|||++.+..++.++||||+||++|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence                                                    0001124689999999999998999999999999999999


Q ss_pred             HhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCC---CHHHH
Q 039290          956 FTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI---SMKDV 1032 (1049)
Q Consensus       956 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---t~~el 1032 (1049)
                      ++|+.||......+.......  ....                ...+.....+.++.+++.+|+ .+|.+|+   ++.|+
T Consensus       238 l~G~~Pf~~~~~~~~~~~i~~--~~~~----------------~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el  298 (376)
T cd05598         238 LVGQPPFLADTPAETQLKVIN--WETT----------------LHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI  298 (376)
T ss_pred             hhCCCCCCCCCHHHHHHHHhc--cCcc----------------ccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence            999999976432221111100  0000                000011123456778888876 5999999   89999


Q ss_pred             HHH
Q 039290         1033 ANR 1035 (1049)
Q Consensus      1033 l~~ 1035 (1049)
                      ++|
T Consensus       299 l~h  301 (376)
T cd05598         299 KAH  301 (376)
T ss_pred             hCC
Confidence            987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-35  Score=309.40  Aligned_cols=251  Identities=27%  Similarity=0.331  Sum_probs=205.8

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .|+..+.||+|.-|+||.|+.. ++..+|+|++.+..   .....++..|.+|++.+.||.++.+++.++.++..|+|||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            4666789999999999999965 45889999997654   3334567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCC---
Q 039290          838 YMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK---  913 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~---  913 (1049)
                      ||+||+|....++. .+.+++..++-++.+++-||+|||   -.|||+|||||+||||.++|++.|+||.++.....   
T Consensus       158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt  234 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT  234 (459)
T ss_pred             cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence            99999999988754 447899999999999999999999   99999999999999999999999999998743210   


Q ss_pred             ------------------------------C-c---------------------cccccccccccCcccccccCCCCcCc
Q 039290          914 ------------------------------E-E---------------------SMRQTKTLGTIGYMAPEYGREGKVSR  941 (1049)
Q Consensus       914 ------------------------------~-~---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~  941 (1049)
                                                    . .                     ..+....+||-.|.|||++.+...+.
T Consensus       235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs  314 (459)
T KOG0610|consen  235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS  314 (459)
T ss_pred             eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence                                          0 0                     01223468999999999999999999


Q ss_pred             ccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhcccc
Q 039290          942 KCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVD 1021 (1049)
Q Consensus       942 ~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 1021 (1049)
                      ++|.|+||+.+|||+.|..||.+....+... ..+...                   .+++..+..+..++++|++.+..
T Consensus       315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~-NIv~~~-------------------l~Fp~~~~vs~~akDLIr~LLvK  374 (459)
T KOG0610|consen  315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLR-NIVGQP-------------------LKFPEEPEVSSAAKDLIRKLLVK  374 (459)
T ss_pred             hhhHHHHHHHHHHHHhCCCCcCCCCchhhHH-HHhcCC-------------------CcCCCCCcchhHHHHHHHHHhcc
Confidence            9999999999999999999998744333322 211110                   11222235567889999999999


Q ss_pred             CCCCCCC----HHHHHHH
Q 039290         1022 LPEKRIS----MKDVANR 1035 (1049)
Q Consensus      1022 dP~~Rpt----~~ell~~ 1035 (1049)
                      ||++|..    |.||.+|
T Consensus       375 dP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  375 DPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             ChhhhhccccchHHhhcC
Confidence            9999998    8888776

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.6e-35  Score=323.66  Aligned_cols=255  Identities=24%  Similarity=0.416  Sum_probs=201.8

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEeC------CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCe
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDF  831 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~  831 (1049)
                      ..++|+..+.||+|+||.||+|...      .+..||+|++..... ....++.+|+.+++.++||||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567999999999999999999753      346799999864322 234568899999999999999999999999999


Q ss_pred             eEEEEeccCCCChhhhhhcCC---------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEE
Q 039290          832 KALVLEYMSNGSLEKCLYSDN---------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHL  902 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl  902 (1049)
                      .++||||+++++|.+++...+         ...++.++..++.|+++|++|||   +.+++||||||+||++++++.+++
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999986532         23577889999999999999999   999999999999999999999999


Q ss_pred             ecccCceecCCCcccc-ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhcc
Q 039290          903 SDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSL  980 (1049)
Q Consensus       903 ~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  980 (1049)
                      +|||++.......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......+  ....+.   
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~--~~~~~~---  235 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ--VLRFVM---  235 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHH---
Confidence            9999987654322211 112345678999999988889999999999999999999 788886532211  111110   


Q ss_pred             ccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          981 LSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                               ....       ...+..++..+.+++.+|++.+|++|||+.|++++|+
T Consensus       236 ---------~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         236 ---------EGGL-------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             ---------cCCc-------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence                     0000       0011234567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.5e-35  Score=329.94  Aligned_cols=242  Identities=24%  Similarity=0.317  Sum_probs=196.4

Q ss_pred             ceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEEEeccCC
Q 039290          767 KLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALVLEYMSN  841 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  841 (1049)
                      +.||+|+||+||+|+.. +++.||+|+++...   ......+.+|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 67899999997643   23455677888998887 699999999999999999999999999


Q ss_pred             CChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccc
Q 039290          842 GSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK  921 (1049)
Q Consensus       842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~  921 (1049)
                      |+|.+++.... .+++.++..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||++........ ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~  155 (318)
T cd05570          81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTST  155 (318)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccc
Confidence            99999887654 4899999999999999999999   99999999999999999999999999999875322221 2223


Q ss_pred             cccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCc
Q 039290          922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDF 1001 (1049)
Q Consensus       922 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1049)
                      ..|++.|+|||++.+..++.++||||+||++|||++|+.||......+.  ....   .         .        ...
T Consensus       156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~--~~~i---~---------~--------~~~  213 (318)
T cd05570         156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL--FQSI---L---------E--------DEV  213 (318)
T ss_pred             eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH--HHHH---H---------c--------CCC
Confidence            4689999999999999999999999999999999999999975322111  1100   0         0        000


Q ss_pred             hhhHHHHHHHHHHHhhccccCCCCCCCH-----HHHHHH
Q 039290         1002 SAREQCVSSIFSLAMDCTVDLPEKRISM-----KDVANR 1035 (1049)
Q Consensus      1002 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~ell~~ 1035 (1049)
                      ..+...+..+.+++.+||+.||.+||++     .+++++
T Consensus       214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            1112345678999999999999999999     888765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.7e-35  Score=317.43  Aligned_cols=254  Identities=28%  Similarity=0.471  Sum_probs=208.0

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      .++|++.++||+|+||.||+|..++++.||+|.+... ....+++.+|+.++++++||||+++++++.+....++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            4678999999999999999999888889999998754 334578999999999999999999999999988999999999


Q ss_pred             CCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          840 SNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       840 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      ++++|.+++.... ..+++.++..++.|++.|++|||   +.+++||||||+||++++++.+|++|||.+..........
T Consensus        84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  160 (261)
T cd05034          84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA  160 (261)
T ss_pred             CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence            9999999987643 46899999999999999999999   9999999999999999999999999999998765322211


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE  997 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1049)
                      ......+..|+|||.+.+..++.++||||+|+++|||++ |+.||....... .........                  
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~~~~~~~------------------  221 (261)
T cd05034         161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLEQVERGY------------------  221 (261)
T ss_pred             hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCC------------------
Confidence            122234568999999988889999999999999999999 999986532211 111111000                  


Q ss_pred             ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 039290          998 ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVR 1038 (1049)
Q Consensus       998 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~ 1038 (1049)
                        +...+..++.++.+++.+|++.+|++||+++++++.|+.
T Consensus       222 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         222 --RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence              001112235678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=7.5e-35  Score=316.69  Aligned_cols=252  Identities=25%  Similarity=0.433  Sum_probs=203.9

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccC
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMS  840 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  840 (1049)
                      ++|.+.+.||+|+||.||+|....+..+|+|.+.... ...+.+.+|++++++++|||++++++++.. +..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence            4688889999999999999998777789999886442 345678899999999999999999998754 56789999999


Q ss_pred             CCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          841 NGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       841 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      +++|.+++.... ..+++..+..++.|++.|++|||   +.|++||||||+||++++++.++|+|||.+...........
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence            999999987543 35789999999999999999999   99999999999999999999999999999987643322222


Q ss_pred             cccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccccccc
Q 039290          920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                      ....++..|+|||+..+..++.++||||+|+++|||++ |..||......+.  ..+.....                  
T Consensus       161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--~~~~~~~~------------------  220 (260)
T cd05069         161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV--LEQVERGY------------------  220 (260)
T ss_pred             CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHcCC------------------
Confidence            22345678999999988889999999999999999999 8999876332211  11111000                  


Q ss_pred             cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 039290          999 NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVR 1038 (1049)
Q Consensus       999 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~ 1038 (1049)
                       ....+...+..+.+++.+||..+|++||+++++++.|++
T Consensus       221 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         221 -RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             001122346779999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-35  Score=319.48  Aligned_cols=253  Identities=26%  Similarity=0.472  Sum_probs=201.0

Q ss_pred             CCCCceecCCCcEEEEEEEeCC----CcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCe-----
Q 039290          763 FSENKLLGMGSFGSVYKGVLPD----GMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNNDF-----  831 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~~~----~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~-----  831 (1049)
                      |++.+.||+|+||.||+|....    +..||+|+++....  .....+.+|++.++.++||||+++++++.+.+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998542    36799999875432  224578899999999999999999998866544     


Q ss_pred             -eEEEEeccCCCChhhhhhcC-----CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecc
Q 039290          832 -KALVLEYMSNGSLEKCLYSD-----NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDF  905 (1049)
Q Consensus       832 -~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df  905 (1049)
                       .++||||+++|+|.+++...     ...+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             78999999999999887542     235889999999999999999999   999999999999999999999999999


Q ss_pred             cCceecCCCccccc-cccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccC
Q 039290          906 GIAKILGKEESMRQ-TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSC  983 (1049)
Q Consensus       906 Gla~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  983 (1049)
                      |+++.+........ .....+..|+|||++.+..++.++||||+||++|||++ |..||......+  ...+....    
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--~~~~~~~~----  231 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--IYDYLRHG----  231 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC----
Confidence            99987644332211 11234668999999988889999999999999999999 888886533221  11111100    


Q ss_pred             CcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290          984 SITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus       984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                              .       ....+..++.++.+++.+||+.||++|||+.|++++|+++
T Consensus       232 --------~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         232 --------N-------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             --------C-------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                    0       0111223567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-35  Score=330.64  Aligned_cols=255  Identities=22%  Similarity=0.264  Sum_probs=200.9

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++....   ....+.+.+|..++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46889999999999999999954 68899999987532   233456888999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+++|+|.+++......+++..+..++.||+.|++|||   +++|+||||||+||+++.++.+||+|||++........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            999999999999775666899999999999999999999   99999999999999999999999999999987654333


Q ss_pred             ccccccccccCcccccccCC-----CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccc
Q 039290          917 MRQTKTLGTIGYMAPEYGRE-----GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA  991 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  991 (1049)
                      .......||+.|+|||++..     ..++.++||||+||++|||++|+.||......+.....     ....        
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i-----~~~~--------  224 (331)
T cd05597         158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI-----MNHK--------  224 (331)
T ss_pred             ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHH-----HcCC--------
Confidence            33333568999999999863     45788999999999999999999999753221111110     0000        


Q ss_pred             ccccccccCchhhHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 039290          992 NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEK--RISMKDVANR 1035 (1049)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~ell~~ 1035 (1049)
                      .....+    ......+..+.+++.+|+..++.+  ||+++++++|
T Consensus       225 ~~~~~~----~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         225 EHFQFP----PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CcccCC----CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            000000    001124567888999988654443  8899999988

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.9e-35  Score=316.84  Aligned_cols=250  Identities=30%  Similarity=0.388  Sum_probs=208.1

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      ++|+..+.||+|+||.||+|+.. +++.|++|.+.....  .+++.+|++++++++||||+++++++.+.+..++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            57888999999999999999976 478999999875533  678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      ++++|.+++......+++..+..++.|+++|++|||   +.+++||||+|+||+++.++.++|+|||++........ ..
T Consensus        81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~  156 (256)
T cd06612          81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KR  156 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-cc
Confidence            999999999876777899999999999999999999   99999999999999999999999999999987644321 22


Q ss_pred             cccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccccccc
Q 039290          920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEN  999 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1049)
                      ....++..|+|||++.+..++.++||||+|+++|+|++|+.||......+.....                   ......
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~-------------------~~~~~~  217 (256)
T cd06612         157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI-------------------PNKPPP  217 (256)
T ss_pred             ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-------------------ccCCCC
Confidence            3345788999999998889999999999999999999999998753222111000                   000011


Q ss_pred             CchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290         1000 DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus      1000 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ....+...+..+.+++.+||+.+|++|||++|++++
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            112233456778999999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.6e-35  Score=322.80  Aligned_cols=269  Identities=22%  Similarity=0.383  Sum_probs=204.5

Q ss_pred             CCCCCceecCCCcEEEEEEEe-----CCCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecC--CeeE
Q 039290          762 GFSENKLLGMGSFGSVYKGVL-----PDGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNN--DFKA  833 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~  833 (1049)
                      -|++.+.||+|+||.||.|+.     .++..||+|.++... ......+.+|+++++.++|||++++++++.+.  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            467889999999999999983     357889999987543 23346789999999999999999999998775  5688


Q ss_pred             EEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          834 LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      +||||+++++|.+++......+++.++..++.|++.|++|+|   ++||+||||||+||+++.++.+||+|||++.....
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            999999999999998776556899999999999999999999   99999999999999999999999999999986643


Q ss_pred             Cccc--cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccc
Q 039290          914 EESM--RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA  991 (1049)
Q Consensus       914 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  991 (1049)
                      ....  ......++..|+|||++.+..++.++||||+||++|||+++..|+......   .....+....+.........
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL---FLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch---hhhhcccccccccHHHHHHH
Confidence            3221  112234567899999998888999999999999999999987664321110   00000000000000000000


Q ss_pred             ccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290          992 NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                       +  ....+.+.+..++..+.+++.+|++.+|++|||++++++.++++
T Consensus       239 -~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 -L--EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             -H--HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence             0  00011112234567899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.8e-35  Score=337.18  Aligned_cols=267  Identities=25%  Similarity=0.321  Sum_probs=200.6

Q ss_pred             CCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecCC-----eeE
Q 039290          762 GFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNND-----FKA  833 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~-----~~~  833 (1049)
                      +|+..+.||+|+||.||+|.. .+++.||+|++.....  ...+++.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999995 4789999999865422  23467889999999999999999999998776     789


Q ss_pred             EEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          834 LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      +||||+. ++|.+.+.... .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9999996 58888776543 5899999999999999999999   99999999999999999999999999999986544


Q ss_pred             CccccccccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcc--
Q 039290          914 EESMRQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD--  990 (1049)
Q Consensus       914 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  990 (1049)
                      ..........+++.|+|||++.+. .++.++||||+||++|||++|+.||......+. ... +..........++..  
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~-i~~~~g~~~~~~~~~~~  233 (372)
T cd07853         156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ-LDL-ITDLLGTPSLEAMRSAC  233 (372)
T ss_pred             CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH-HHH-HHHHcCCCCHHHHHHhh
Confidence            333233345678899999988764 578999999999999999999999975332211 110 001111111000000  


Q ss_pred             ----cccccccc------cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          991 ----ANLLNCEE------NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       991 ----~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                          ..+.....      .........+.++.+++.+|++.||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                00000000      0001112235678999999999999999999999987

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.9e-35  Score=347.75  Aligned_cols=253  Identities=27%  Similarity=0.325  Sum_probs=203.0

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCC-----
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNND-----  830 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~-----  830 (1049)
                      ..++|++.+.||+|+||+||+|+. .+++.||+|++....  ......+.+|+.++..++|+|++++++.+...+     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            346899999999999999999984 578999999987543  223456788999999999999999988765432     


Q ss_pred             ---eeEEEEeccCCCChhhhhhcC---CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEec
Q 039290          831 ---FKALVLEYMSNGSLEKCLYSD---NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSD  904 (1049)
Q Consensus       831 ---~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D  904 (1049)
                         ..++||||+++|+|.+++...   ...+++..+..++.|++.||+|+|   +++|+||||||+||+++.++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEe
Confidence               367999999999999988653   346889999999999999999999   99999999999999999999999999


Q ss_pred             ccCceecCCCcc-ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccC
Q 039290          905 FGIAKILGKEES-MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSC  983 (1049)
Q Consensus       905 fGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  983 (1049)
                      ||+++.+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+     ......   
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~-----~~~~~~---  258 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE-----VMHKTL---  258 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHh---
Confidence            999987643221 12234568999999999999899999999999999999999999997532111     110000   


Q ss_pred             CcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          984 SITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                            ...       ....+..++.++.+++.+||+.+|.+||++.+++++
T Consensus       259 ------~~~-------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        259 ------AGR-------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             ------cCC-------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                  000       001123356779999999999999999999999876

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.8e-35  Score=339.98  Aligned_cols=251  Identities=21%  Similarity=0.285  Sum_probs=197.3

Q ss_pred             CCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          762 GFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      +|+..++||+|+||+||+|+. .+++.||+|++....   ......+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            588899999999999999995 478899999987542   2234578899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc--
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE--  915 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~--  915 (1049)
                      |+++|+|.+++...+ .+++..+..++.||+.|++|||   +.+|+||||||+|||++.++.+||+|||++..+....  
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            999999999987654 4788899999999999999999   9999999999999999999999999999975321000  


Q ss_pred             --------------------------------------------cccccccccccCcccccccCCCCcCcccchHHHHHH
Q 039290          916 --------------------------------------------SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIM  951 (1049)
Q Consensus       916 --------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~i  951 (1049)
                                                                  .......+||+.|+|||++.+..++.++||||+||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                        000112468999999999998899999999999999


Q ss_pred             HHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCC---
Q 039290          952 LMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRIS--- 1028 (1049)
Q Consensus       952 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt--- 1028 (1049)
                      +|||++|+.||......+.......  ..                .....+.....+++..+++.+|+ .+|++|++   
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~--~~----------------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~  298 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQMKVIN--WQ----------------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNG  298 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHc--cC----------------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCC
Confidence            9999999999975322211111100  00                00000111223456778888875 59999997   


Q ss_pred             HHHHHHH
Q 039290         1029 MKDVANR 1035 (1049)
Q Consensus      1029 ~~ell~~ 1035 (1049)
                      ++|+++|
T Consensus       299 ~~ei~~h  305 (382)
T cd05625         299 ADEIKAH  305 (382)
T ss_pred             HHHHhcC
Confidence            8888876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=6.9e-35  Score=323.04  Aligned_cols=250  Identities=26%  Similarity=0.335  Sum_probs=205.5

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      .+|+..+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|||++++++.+..++..++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            4688889999999999999995 478899999998765555678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      ++++|.+++...  .+++.++..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||++........ ..
T Consensus       100 ~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~  173 (296)
T cd06654         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR  173 (296)
T ss_pred             CCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-cc
Confidence            999999988653  3788999999999999999999   99999999999999999999999999999876543221 12


Q ss_pred             cccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccccccc
Q 039290          920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEN  999 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1049)
                      ....+++.|+|||.+.+..++.++|||||||++|+|++|+.||......+.....+..    .               ..
T Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~----~---------------~~  234 (296)
T cd06654         174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN----G---------------TP  234 (296)
T ss_pred             CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC----C---------------CC
Confidence            2346788999999998888999999999999999999999999653221111111000    0               00


Q ss_pred             CchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290         1000 DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus      1000 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ....+...+..+.+++.+||..+|++|||++|++++
T Consensus       235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            001122345678999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.5e-35  Score=330.26  Aligned_cols=194  Identities=26%  Similarity=0.367  Sum_probs=170.3

Q ss_pred             CCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcC-C-----CceeeEEeeeecCCeeEE
Q 039290          762 GFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR-H-----RNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----pniv~l~~~~~~~~~~~l  834 (1049)
                      +|.+.+.||+|+||.|.+|.. .+++.||||+++.. .....+...|+.+++.++ |     -|+|+++++|...++.||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            789999999999999999994 57999999999754 333456678999999996 4     389999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCC-ccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC--CCceEEecccCceec
Q 039290          835 VLEYMSNGSLEKCLYSDNY-FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE--SMVGHLSDFGIAKIL  911 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~--~~~~kl~DfGla~~~  911 (1049)
                      |+|.++. +|.++++.++. .++...++.|+.||+.||.+||   +.+|||+||||+|||+.+  ...+||+|||.|+..
T Consensus       266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            9999955 99999987654 6889999999999999999999   999999999999999973  458999999999976


Q ss_pred             CCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCc
Q 039290          912 GKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDE  964 (1049)
Q Consensus       912 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~  964 (1049)
                      ...-    ...+.+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+
T Consensus       342 ~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG  390 (586)
T KOG0667|consen  342 SQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG  390 (586)
T ss_pred             CCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence            4332    245678999999999999999999999999999999999876655

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.3e-35  Score=329.88  Aligned_cols=247  Identities=21%  Similarity=0.295  Sum_probs=197.7

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEEE
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      +|+..+.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|.+++..+ +||+|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788899999999999999965 67899999997643   22334567788888777 5899999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+++|+|.+.+.... .+++.++..++.|++.||+|||   +.||+||||||+||++++++.+||+|||++........
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~  156 (323)
T cd05616          81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV  156 (323)
T ss_pred             cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence            9999999999887654 4889999999999999999999   99999999999999999999999999999975432221


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                       ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ......                   
T Consensus       157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~-~~~i~~-------------------  215 (323)
T cd05616         157 -TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-FQSIME-------------------  215 (323)
T ss_pred             -ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH-HHHHHh-------------------
Confidence             22345689999999999999999999999999999999999999975322211 111100                   


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCCH-----HHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRISM-----KDVANR 1035 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~ell~~ 1035 (1049)
                        .....+...+.++.+++.+|++.+|++|++.     .++.++
T Consensus       216 --~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         216 --HNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             --CCCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence              0011112345678999999999999999985     566544

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=3.4e-38  Score=341.33  Aligned_cols=371  Identities=30%  Similarity=0.489  Sum_probs=251.7

Q ss_pred             CCcchhhhhhcccCcccc-ccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCccc
Q 039290           94 GNLSFLAVLAIRNNSFFG-SLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQ  172 (1049)
Q Consensus        94 ~~l~~L~~L~l~~n~~~g-~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~  172 (1049)
                      |-|++.+..|+++|.|+| ..|..+..+++++.|.|...++. .+|+.++.|.+|++|.+++|++. .+-..+..|+.|+
T Consensus         4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LR   81 (1255)
T KOG0444|consen    4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLR   81 (1255)
T ss_pred             cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhH
Confidence            335566666777777763 67777777777777777777776 67777777777777777777776 5566677777777


Q ss_pred             EEcCCCccCcc-ccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccceecccccccccccCC-CCccccccc
Q 039290          173 ELDLSDNQLSG-TIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPR-DIGNLTSVR  250 (1049)
Q Consensus       173 ~L~Ls~N~l~g-~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~  250 (1049)
                      .+++.+|++.. -||..++.+.      .|..||||+|++. +.|..+-.-+++-+|+||+|+|. .||. -|-+|+.|-
T Consensus        82 sv~~R~N~LKnsGiP~diF~l~------dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLL  153 (1255)
T KOG0444|consen   82 SVIVRDNNLKNSGIPTDIFRLK------DLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLL  153 (1255)
T ss_pred             HHhhhccccccCCCCchhcccc------cceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHh
Confidence            77777777753 4777776543      3677777777777 67777777777777888888777 4454 456788888


Q ss_pred             eEEeccccccccCccccccccceEEEeeccccCCCccccccccccccceEEeccCccCCCCCCcccCCCCCccEEEcCCC
Q 039290          251 NLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGEN  330 (1049)
Q Consensus       251 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N  330 (1049)
                      .||||+|++. .+|+.+..|.+|+.|+|++|.+.-.      ++.              .+|     .+++|+.|.+++.
T Consensus       154 fLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hf------QLr--------------QLP-----smtsL~vLhms~T  207 (1255)
T KOG0444|consen  154 FLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHF------QLR--------------QLP-----SMTSLSVLHMSNT  207 (1255)
T ss_pred             hhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHH------HHh--------------cCc-----cchhhhhhhcccc
Confidence            8888888887 6777778888888888877766421      111              122     2445566666655


Q ss_pred             CCC-CCCCccccCCCCCceeecccCccccCcccccccccccceeecccccccCCCCCcccccccccCCCCcEEEccCCcc
Q 039290          331 NFS-GTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPI  409 (1049)
Q Consensus       331 ~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i  409 (1049)
                      +-+ ..+|.++..+.+|..+|+|.|++. .+|+.+-++++|+.|+|++|.|+.+....      ....+|+.|+||.|++
T Consensus       208 qRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~------~~W~~lEtLNlSrNQL  280 (1255)
T KOG0444|consen  208 QRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTE------GEWENLETLNLSRNQL  280 (1255)
T ss_pred             cchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccH------HHHhhhhhhccccchh
Confidence            433 357788888888888888888888 67888888888888888888888765432      2234455555555555


Q ss_pred             ccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccc-cCCccccCcCCCcceEeeccccCCCCCc
Q 039290          410 NGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTG-TIPVTLGRLQKLQGLYLQNNKLEGSIPE  488 (1049)
Q Consensus       410 ~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~  488 (1049)
                      +                          .+|+++++++.|+.|.+.+|+++- -+|..++.+.+|+++..++|++. .+|+
T Consensus       281 t--------------------------~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPE  333 (1255)
T KOG0444|consen  281 T--------------------------VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPE  333 (1255)
T ss_pred             c--------------------------cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCch
Confidence            4                          456666666666666666666541 25666666666666666666666 6666


Q ss_pred             ccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccccC
Q 039290          489 DLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIP  535 (1049)
Q Consensus       489 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  535 (1049)
                      .+|.+..|+.|.|+.|++- .+|+++.-++.|+.||+..|.---.+|
T Consensus       334 glcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPP  379 (1255)
T KOG0444|consen  334 GLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPP  379 (1255)
T ss_pred             hhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCC
Confidence            6666666666666666665 566666666666666666665544444

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=5.8e-35  Score=316.98  Aligned_cols=246  Identities=26%  Similarity=0.435  Sum_probs=197.2

Q ss_pred             eecCCCcEEEEEEEe---CCCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCC
Q 039290          768 LLGMGSFGSVYKGVL---PDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNG  842 (1049)
Q Consensus       768 ~lg~G~fg~Vy~a~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  842 (1049)
                      .||+|+||+||+|.+   .++..||+|+++....  ...+++.+|+.+++.++||||+++++++.. +..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            589999999999974   3578899999865432  234678899999999999999999998864 4668999999999


Q ss_pred             ChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc--cc
Q 039290          843 SLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR--QT  920 (1049)
Q Consensus       843 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~--~~  920 (1049)
                      +|.+++.... .+++..+..++.|++.|++|+|   ++||+||||||+||+++.++.+||+|||++..........  ..
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            9999987554 5889999999999999999999   9999999999999999999999999999998765433211  11


Q ss_pred             ccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccccccccc
Q 039290          921 KTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEN  999 (1049)
Q Consensus       921 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1049)
                      ...++..|+|||.+....++.++|||||||++|||++ |..||......+  ....+...                   .
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~i~~~-------------------~  215 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE--VTQMIESG-------------------E  215 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHCC-------------------C
Confidence            2234578999999988889999999999999999998 999997643221  11111100                   0


Q ss_pred             CchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290         1000 DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus      1000 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                      ..+.+..++.++.++|.+||+.||++||++++|++.|+.+
T Consensus       216 ~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         216 RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            0111223567889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.1e-35  Score=333.04  Aligned_cols=238  Identities=25%  Similarity=0.317  Sum_probs=193.6

Q ss_pred             ceecCCCcEEEEEEEe----CCCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccC
Q 039290          767 KLLGMGSFGSVYKGVL----PDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMS  840 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  840 (1049)
                      +.||+|+||.||+++.    .+|+.||+|+++....  .....+.+|++++++++||||+++++++.+.+..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999974    3678999999976432  234567789999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccccc
Q 039290          841 NGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT  920 (1049)
Q Consensus       841 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~  920 (1049)
                      +|+|.+++.... .+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++........ ...
T Consensus        82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~  156 (318)
T cd05582          82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAY  156 (318)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-cee
Confidence            999999886654 4899999999999999999999   99999999999999999999999999999886543321 223


Q ss_pred             ccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccC
Q 039290          921 KTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEND 1000 (1049)
Q Consensus       921 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1049)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||......+.. .. +   .                 ...
T Consensus       157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~-~~-i---~-----------------~~~  214 (318)
T cd05582         157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM-TM-I---L-----------------KAK  214 (318)
T ss_pred             cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH-HH-H---H-----------------cCC
Confidence            456899999999998888999999999999999999999999753221111 00 0   0                 000


Q ss_pred             chhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 039290         1001 FSAREQCVSSIFSLAMDCTVDLPEKRISMKD 1031 (1049)
Q Consensus      1001 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~e 1031 (1049)
                      ...+...+.++.+++.+||+.||++||++.+
T Consensus       215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            1112234567899999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=9.1e-35  Score=318.91  Aligned_cols=245  Identities=23%  Similarity=0.321  Sum_probs=193.7

Q ss_pred             ecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCCCh
Q 039290          769 LGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSL  844 (1049)
Q Consensus       769 lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  844 (1049)
                      ||+|+||.||+|+.. +|+.||+|++....   ......+..|++++++++||||+++++++.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999954 68999999986432   12234556799999999999999999999999999999999999999


Q ss_pred             hhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccccc
Q 039290          845 EKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL  923 (1049)
Q Consensus       845 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~~~  923 (1049)
                      .+.+.... ..+++..+..++.|++.|++|||   +.||+||||||+||+++.++.++|+|||++.......  ......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~  155 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA  155 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence            98876433 35889999999999999999999   9999999999999999999999999999998764322  223346


Q ss_pred             cccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCchh
Q 039290          924 GTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSA 1003 (1049)
Q Consensus       924 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1049)
                      ++..|+|||++.+..++.++||||+||++|||++|+.||........ .........         ....    .  . .
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~~~---------~~~~----~--~-~  218 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRRTL---------EDEV----K--F-E  218 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHHhh---------cccc----c--c-c
Confidence            88999999999888899999999999999999999999875322111 111110000         0000    0  0 0


Q ss_pred             hHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290         1004 REQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus      1004 ~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ....+.++.+++.+||+.||++||++.|+++.
T Consensus       219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             cccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence            11345678999999999999999999766543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.5e-35  Score=317.25  Aligned_cols=239  Identities=22%  Similarity=0.342  Sum_probs=190.5

Q ss_pred             ceecCCCcEEEEEEEeCC-------------CcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeE
Q 039290          767 KLLGMGSFGSVYKGVLPD-------------GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKA  833 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~  833 (1049)
                      +.||+|+||.||+|+..+             ...|++|.+..........+.+|+.+++.++||||+++++++.+....+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998532             2358889886655555567888999999999999999999999998999


Q ss_pred             EEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCc-------eEEeccc
Q 039290          834 LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMV-------GHLSDFG  906 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~-------~kl~DfG  906 (1049)
                      +||||+++|+|..++......+++..+++++.||++|++|||   +++|+||||||+||+++.++.       ++++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999988766666899999999999999999999   999999999999999986553       8999999


Q ss_pred             CceecCCCccccccccccccCcccccccC-CCCcCcccchHHHHHHHHHHH-hCCCCCCccccccchHHHhhhhccccCC
Q 039290          907 IAKILGKEESMRQTKTLGTIGYMAPEYGR-EGKVSRKCDVYSYGIMLMETF-TKKKPTDEIFAGEMSLKRWVGDSLLSCS  984 (1049)
Q Consensus       907 la~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~  984 (1049)
                      ++......     ....++..|+|||.+. +..++.++||||+||++|||+ +|..||......+.  .......     
T Consensus       158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~~~~~-----  225 (262)
T cd05077         158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--ERFYEGQ-----  225 (262)
T ss_pred             CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--HHHHhcC-----
Confidence            98755322     2245678899999886 466899999999999999998 58888764321111  1100000     


Q ss_pred             cchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          985 ITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       985 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                                      .........++.+++.+||+.||.+||++.++++++
T Consensus       226 ----------------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         226 ----------------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             ----------------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence                            000011235689999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=8.8e-35  Score=315.50  Aligned_cols=249  Identities=25%  Similarity=0.318  Sum_probs=205.1

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      +|+..+.||+|+||.||+|... +++.|++|.+....  ....+.+.+|++++++++|||++++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677889999999999999964 78899999986542  33457788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          839 MSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       839 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      +++++|.+++... ...+++.+++.++.|++.|++|||   +.||+||||||+||++++++.++++|||++.........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            9999999998764 456899999999999999999999   999999999999999999999999999998876543322


Q ss_pred             cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccccc
Q 039290          918 RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE  997 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1049)
                       .....+++.|+|||+..+..++.++||||+||++|||++|+.||......+  .......    .        .     
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~----~--------~-----  217 (256)
T cd08529         158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--LILKIIR----G--------V-----  217 (256)
T ss_pred             -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHc----C--------C-----
Confidence             223457889999999998889999999999999999999999997533211  1111100    0        0     


Q ss_pred             ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          998 ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       998 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                        ....+...+..+.+++.+||+.+|++||++.+++++
T Consensus       218 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         218 --FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             --CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence              001112355678999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-34  Score=315.11  Aligned_cols=254  Identities=25%  Similarity=0.363  Sum_probs=207.9

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      ++|+..+.||+|+||.||+|... +++.+++|.+........+.+.+|++++++++||||+++++++.+.+..+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57889999999999999999964 67889999998765556788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      ++++|.+++......+++.++..++.|++.|++|||   +.+|+||||+|+||+++.++.+||+|||.+........ ..
T Consensus        83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~  158 (262)
T cd06613          83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KR  158 (262)
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhh-cc
Confidence            999999998876566899999999999999999999   99999999999999999999999999999876543221 22


Q ss_pred             cccccccCcccccccCCC---CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          920 TKTLGTIGYMAPEYGREG---KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                      ....++..|+|||.+...   .++.++||||+|+++|||++|+.||......+....... ..             .   
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~-~~-------------~---  221 (262)
T cd06613         159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK-SN-------------F---  221 (262)
T ss_pred             ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cc-------------C---
Confidence            334678899999998776   788999999999999999999999875332211111000 00             0   


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ...........+.++.+++.+||+.+|.+|||+++++.+
T Consensus       222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         222 PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000111123356679999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.8e-35  Score=322.07  Aligned_cols=259  Identities=22%  Similarity=0.361  Sum_probs=208.2

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCC-----CcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeec-CCee
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPD-----GMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSN-NDFK  832 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~-~~~~  832 (1049)
                      .++|++.+.||+|+||.||+|...+     +..|++|++.... ....+.+.+|+.++++++||||+++++++.+ +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4578889999999999999999765     6789999886432 2235668889999999999999999998765 5678


Q ss_pred             EEEEeccCCCChhhhhhcCC-------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecc
Q 039290          833 ALVLEYMSNGSLEKCLYSDN-------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDF  905 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df  905 (1049)
                      ++++||+++++|.+++....       ..+++.+++.++.|++.|++|||   +.+++||||||+||++++++.+|++||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence            99999999999999986532       35889999999999999999999   999999999999999999999999999


Q ss_pred             cCceecCCCccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccC
Q 039290          906 GIAKILGKEESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSC  983 (1049)
Q Consensus       906 Gla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  983 (1049)
                      |+++.+...... ......++..|+|||++.+..++.++||||+||++||+++ |+.||.....  .....+.....   
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~---  236 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKDGY---  236 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHcCC---
Confidence            999866433221 1122335668999999988889999999999999999999 9999875322  11222211100   


Q ss_pred             CcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHh
Q 039290          984 SITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042 (1049)
Q Consensus       984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~ 1042 (1049)
                                      +...+..++.++.+++.+||+.+|++|||+.|+++.|+++.++
T Consensus       237 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         237 ----------------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             ----------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence                            0111123456789999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=7.1e-38  Score=338.83  Aligned_cols=365  Identities=28%  Similarity=0.424  Sum_probs=227.4

Q ss_pred             CCcEeccccCCcc-ccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCc
Q 039290          122 GLKYFDFRFNNFH-IEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPV  200 (1049)
Q Consensus       122 ~L~~L~l~~n~~~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~  200 (1049)
                      --+-.|+++|.|+ +.+|.....+++++.|.|...++. .+|+.++.|.+|++|.+++|++. .+-.++      ..||.
T Consensus         8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGEL------s~Lp~   79 (1255)
T KOG0444|consen    8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGEL------SDLPR   79 (1255)
T ss_pred             eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhh------ccchh
Confidence            3455677788877 457777777777777777777776 77777777777777777777776 333322      23445


Q ss_pred             cceEEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceEEeccccccccCccccccccceEEEeecc
Q 039290          201 LEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQS  280 (1049)
Q Consensus       201 L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~  280 (1049)
                      |+.+++.+|++..                       ..||.++..+..|+.||||+|++. +.|..+..-+++-+|+||+
T Consensus        80 LRsv~~R~N~LKn-----------------------sGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~  135 (1255)
T KOG0444|consen   80 LRSVIVRDNNLKN-----------------------SGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSY  135 (1255)
T ss_pred             hHHHhhhcccccc-----------------------CCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEccc
Confidence            6666666666552                       247888888888888888888887 7777777777776766666


Q ss_pred             ccCCCccccccccccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCc
Q 039290          281 SNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLI  360 (1049)
Q Consensus       281 n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  360 (1049)
                      |++.                         .||..++.+|..|-.||||+|++. .+|..+..+.+|++|+|++|.+...-
T Consensus       136 N~Ie-------------------------tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQ  189 (1255)
T KOG0444|consen  136 NNIE-------------------------TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQ  189 (1255)
T ss_pred             Cccc-------------------------cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHH
Confidence            6554                         455555555666666777777766 56666666667777777776665321


Q ss_pred             ccccccccccceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCC
Q 039290          361 PTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPK  440 (1049)
Q Consensus       361 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~  440 (1049)
                      -..                             +.+++.|+.|.+++.+-+                              
T Consensus       190 LrQ-----------------------------LPsmtsL~vLhms~TqRT------------------------------  210 (1255)
T KOG0444|consen  190 LRQ-----------------------------LPSMTSLSVLHMSNTQRT------------------------------  210 (1255)
T ss_pred             Hhc-----------------------------Cccchhhhhhhcccccch------------------------------
Confidence            111                             112222333333332211                              


Q ss_pred             CCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccC
Q 039290          441 ELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSL  520 (1049)
Q Consensus       441 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  520 (1049)
                                       + .-+|.++..+.+|..+|||.|.+. .+|+.+.++.+|+.|+||+|+|+ .+..+.+...+|
T Consensus       211 -----------------l-~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~l  270 (1255)
T KOG0444|consen  211 -----------------L-DNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENL  270 (1255)
T ss_pred             -----------------h-hcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhh
Confidence                             0 123444444555555555555554 55555555555666666666655 455556666777


Q ss_pred             CceeecCcccccccCcccccccccccccccCCccCC-CCccCcCCCcceeEeecccccccccccccccCCCcccEEEeec
Q 039290          521 RDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNG-SLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRY  599 (1049)
Q Consensus       521 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  599 (1049)
                      ++|+||.|+++. .|+++++++.|+.|.+.+|+++- -+|+.++.+.+|+.+..++|.+. ..|..++.+.+|+.|.|+.
T Consensus       271 EtLNlSrNQLt~-LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~  348 (1255)
T KOG0444|consen  271 ETLNLSRNQLTV-LPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDH  348 (1255)
T ss_pred             hhhccccchhcc-chHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccc
Confidence            777777777774 67777777777777777777652 24555555555555555555555 5566666666666666666


Q ss_pred             ccccCCccccccCccCCcEEeccCccc
Q 039290          600 NRLQGPIPESFGGLKSLNFVDMSNNNL  626 (1049)
Q Consensus       600 N~l~~~~~~~~~~l~~L~~L~Ls~N~l  626 (1049)
                      |++. .+|+++.-|+.|+.|||.+|.=
T Consensus       349 NrLi-TLPeaIHlL~~l~vLDlreNpn  374 (1255)
T KOG0444|consen  349 NRLI-TLPEAIHLLPDLKVLDLRENPN  374 (1255)
T ss_pred             ccee-echhhhhhcCCcceeeccCCcC
Confidence            6665 4566666666666666666643

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=8.6e-35  Score=317.85  Aligned_cols=255  Identities=29%  Similarity=0.349  Sum_probs=202.8

Q ss_pred             HHhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          758 RATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       758 ~~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      .+++.+.....||+|+||.||+|+. .++..||+|.+........+.+.+|++++++++||||+++++++..++..++|+
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            4455666667999999999999995 467889999987665555678999999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCcc--CHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC-CCceEEecccCceecCC
Q 039290          837 EYMSNGSLEKCLYSDNYFL--DILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE-SMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-~~~~kl~DfGla~~~~~  913 (1049)
                      ||+++++|.+++......+  ++..+..++.|+++|++|||   +++|+||||||+||+++. ++.++|+|||.+.....
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            9999999999988654445  78888999999999999999   999999999999999986 67999999999876543


Q ss_pred             CccccccccccccCcccccccCCC--CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccc
Q 039290          914 EESMRQTKTLGTIGYMAPEYGREG--KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA  991 (1049)
Q Consensus       914 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  991 (1049)
                      ... ......++..|+|||++...  .++.++||||+|+++|+|++|..||.........  .+....            
T Consensus       162 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~--~~~~~~------------  226 (268)
T cd06624         162 INP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA--MFKVGM------------  226 (268)
T ss_pred             CCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh--Hhhhhh------------
Confidence            222 12234578899999998654  3788999999999999999999998653221111  110000            


Q ss_pred             ccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          992 NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                           .......+..+..++.+++.+||+.+|++|||+.|++++
T Consensus       227 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         227 -----FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             -----hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence                 000111223456678999999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6.2e-35  Score=321.49  Aligned_cols=250  Identities=24%  Similarity=0.338  Sum_probs=201.3

Q ss_pred             CCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCC
Q 039290          763 FSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSN  841 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  841 (1049)
                      |++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|||++++++++..++..++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            566788999999999999965 5778899998655444556788999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccc
Q 039290          842 GSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK  921 (1049)
Q Consensus       842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~  921 (1049)
                      ++|.+++......+++..+..++.|+++||+|||   +.||+||||||+||+++.++.+|++|||++....... .....
T Consensus        87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~  162 (282)
T cd06643          87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDS  162 (282)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc-ccccc
Confidence            9999988765567899999999999999999999   9999999999999999999999999999987653222 12233


Q ss_pred             cccccCcccccccC-----CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          922 TLGTIGYMAPEYGR-----EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       922 ~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                      ..++..|+|||++.     +..++.++||||+||++|||++|+.||......+.. .......                 
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~-~~~~~~~-----------------  224 (282)
T cd06643         163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL-LKIAKSE-----------------  224 (282)
T ss_pred             ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH-HHHhhcC-----------------
Confidence            46788999999874     345788999999999999999999998753222111 1110000                 


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                       ......+..++.++.+++.+||+.+|.+||++++++++
T Consensus       225 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         225 -PPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             -CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             00011112345678999999999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5.5e-35  Score=324.99  Aligned_cols=261  Identities=24%  Similarity=0.420  Sum_probs=204.9

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCc--EEEEEEeeccc-CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGM--EIAAKVFHMEF-DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      ++|++.+.||+|+||.||+|.+. ++.  .+|+|.++... ......+.+|++++.++ +||||+++++++.+++..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            46788899999999999999964 454  45777765432 22345788899999999 899999999999999999999


Q ss_pred             EeccCCCChhhhhhcCC---------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCce
Q 039290          836 LEYMSNGSLEKCLYSDN---------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVG  900 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~  900 (1049)
                      |||+++++|.+++...+               ..+++.+++.++.|++.|++|||   ++||+||||||+||++++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcE
Confidence            99999999999986532               25788999999999999999999   9999999999999999999999


Q ss_pred             EEecccCceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhc
Q 039290          901 HLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDS  979 (1049)
Q Consensus       901 kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  979 (1049)
                      ||+|||++.....  .........+..|+|||++.+..++.++||||+||++|||+| |..||......+  ....... 
T Consensus       164 kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~-  238 (303)
T cd05088         164 KIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKLPQ-  238 (303)
T ss_pred             EeCccccCcccch--hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--HHHHHhc-
Confidence            9999999864311  111111233567999999988889999999999999999998 999986532211  1111000 


Q ss_pred             cccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhcc
Q 039290          980 LLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYI 1047 (1049)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~~ 1047 (1049)
                         .               .....+..++..+.+++.+||+.+|++||+++++++++.++...-..|.
T Consensus       239 ---~---------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~  288 (303)
T cd05088         239 ---G---------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV  288 (303)
T ss_pred             ---C---------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhh
Confidence               0               0001112245678999999999999999999999999999887766554

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5.4e-35  Score=320.98  Aligned_cols=254  Identities=26%  Similarity=0.433  Sum_probs=201.7

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC------CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCee
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFK  832 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~  832 (1049)
                      .++|.+.+.||+|+||.||+|.+.      .+..||+|.+..... .....+.+|+.++++++||||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            456888999999999999999964      356789998864432 2345688999999999999999999999998999


Q ss_pred             EEEEeccCCCChhhhhhcCC------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC---ceEEe
Q 039290          833 ALVLEYMSNGSLEKCLYSDN------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM---VGHLS  903 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~---~~kl~  903 (1049)
                      ++||||+++++|.+++...+      ..+++.++.+++.||+.|++|||   +++++||||||+||+++.++   .+|++
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999987643      25889999999999999999999   99999999999999998654   69999


Q ss_pred             cccCceecCCCcccc-ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccc
Q 039290          904 DFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLL  981 (1049)
Q Consensus       904 DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  981 (1049)
                      |||+++......... ......+..|+|||++.+..++.++||||+||++|||++ |..||......+.  ...+.   .
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~--~~~~~---~  236 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV--MEFVT---G  236 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH--HHHHH---c
Confidence            999998663222111 112233568999999988899999999999999999997 9999875332211  11100   0


Q ss_pred             cCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          982 SCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                      .                .+...+..++..+.+++.+|++.+|++||++.+++++|.
T Consensus       237 ~----------------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         237 G----------------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             C----------------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            0                001112234567899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.5e-35  Score=324.58  Aligned_cols=257  Identities=26%  Similarity=0.452  Sum_probs=205.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC------CCcEEEEEEeecccC-CCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEFD-GSLESFHAECKVMGSI-RHRNLVKIISSCSNNDF  831 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~  831 (1049)
                      .++|+..+.||+|+||.||+|...      ....+|+|.+..... ....++.+|+++++++ +||||+++++++..++.
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   90 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP   90 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence            456888899999999999999853      235799999875432 2345688899999999 79999999999999999


Q ss_pred             eEEEEeccCCCChhhhhhcC---------------CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC
Q 039290          832 KALVLEYMSNGSLEKCLYSD---------------NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE  896 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~  896 (1049)
                      .++||||+++|+|.+++...               ...+++..+++++.|++.|++|||   +.+|+||||||+||+++.
T Consensus        91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~  167 (293)
T cd05053          91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTE  167 (293)
T ss_pred             eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcC
Confidence            99999999999999998642               246889999999999999999999   999999999999999999


Q ss_pred             CCceEEecccCceecCCCcccc-ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHH
Q 039290          897 SMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKR  974 (1049)
Q Consensus       897 ~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~  974 (1049)
                      ++.+|++|||+++.+....... .....++..|+|||++.+..++.++|||||||++|||++ |..||......+..  .
T Consensus       168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--~  245 (293)
T cd05053         168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF--K  245 (293)
T ss_pred             CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH--H
Confidence            9999999999998764432211 112234567999999988889999999999999999998 88888653222111  1


Q ss_pred             hhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 039290          975 WVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIR 1040 (1049)
Q Consensus       975 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~ 1040 (1049)
                      ....            .       .....+..++..+.+++.+||+.+|++|||+.|+++.|+++.
T Consensus       246 ~~~~------------~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         246 LLKE------------G-------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHc------------C-------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            0000            0       001112234567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.1e-34  Score=321.32  Aligned_cols=252  Identities=26%  Similarity=0.329  Sum_probs=203.6

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      +.|++.+.||+|+||.||+|+.. ++..||+|.+........+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56889999999999999999965 58899999997665555677889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      ++++|..++......+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||.+....... ...
T Consensus        92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~  167 (292)
T cd06644          92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRR  167 (292)
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc-ccc
Confidence            999999888766667899999999999999999999   9999999999999999999999999999987543221 112


Q ss_pred             cccccccCcccccccC-----CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          920 TKTLGTIGYMAPEYGR-----EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                      ....++..|+|||++.     ...++.++||||+||++|||++|..||......+ ....+...                
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~----------------  230 (292)
T cd06644         168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKS----------------  230 (292)
T ss_pred             ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-HHHHHhcC----------------
Confidence            2345788999999874     3456889999999999999999999986532111 11111100                


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                        .......+..++.++.+++.+||+.+|++||+++|++++
T Consensus       231 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         231 --EPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             --CCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence              000011122345678999999999999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.1e-35  Score=318.80  Aligned_cols=255  Identities=25%  Similarity=0.452  Sum_probs=205.5

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC----CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP----DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      ++|++.+.||+|+||.||+|...    .+..+|+|.++... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46888999999999999999853    23479999986543 22346788999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++++|.+++......+++.++..++.|++.|++|||   +.+++||||||+||+++.++.++++|||++.......
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            9999999999999876666899999999999999999999   9999999999999999999999999999998764332


Q ss_pred             cccc--cccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccc
Q 039290          916 SMRQ--TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       916 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      ....  ....++..|+|||++.+..++.++||||+||++||+++ |..||......+  .........            
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~~~~~~------------  226 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKAIEEGY------------  226 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHHHhCCC------------
Confidence            2111  11223467999999988889999999999999999887 999987532221  111111000            


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                             +.+.+..++..+.+++.+|++.+|++||++.++++.|+++
T Consensus       227 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         227 -------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                   0111123456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.7e-34  Score=313.80  Aligned_cols=258  Identities=25%  Similarity=0.359  Sum_probs=209.0

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|+..+.||+|+||.||+|... +|+.||+|.++...   ....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57889999999999999999965 88999999886432   223568899999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhc---CCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          837 EYMSNGSLEKCLYS---DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       837 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      ||+++++|.+++..   ....+++.+++.++.+++.|++|||   +.||+||||+|+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999998864   2345789999999999999999999   99999999999999999999999999999876543


Q ss_pred             CccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          914 EESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       914 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                      ... ......++..|+|||.+.+..++.++||||+||++|+|++|+.||.....   .......... ...        .
T Consensus       159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~-~~~--------~  225 (267)
T cd08224         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKIE-KCD--------Y  225 (267)
T ss_pred             CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc---cHHHHHhhhh-cCC--------C
Confidence            322 12234578899999999888899999999999999999999999864221   1111111000 000        0


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIR 1040 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~ 1040 (1049)
                            ........+..+.+++.+||..+|++|||+.++++.++++.
T Consensus       226 ------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         226 ------PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             ------CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                  00011245667899999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=8.9e-35  Score=317.76  Aligned_cols=255  Identities=25%  Similarity=0.479  Sum_probs=205.2

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CC---cEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DG---MEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      ++|+..+.||+|+||.||+|+.. ++   ..+|+|.++... ....+++.+|++++++++|||++++.+++.+.+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            46778899999999999999964 33   369999986543 23356788999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++++|.+++......+++.++..++.|++.|++|+|   +.+++||||||+||+++.++.+|++|||++.......
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  161 (268)
T cd05063          85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP  161 (268)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence            9999999999999776666899999999999999999999   9999999999999999999999999999998664322


Q ss_pred             ccccc--ccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccc
Q 039290          916 SMRQT--KTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       916 ~~~~~--~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      .....  ....+..|+|||++....++.++||||+||++|||++ |..||......+  ....+...             
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~--~~~~i~~~-------------  226 (268)
T cd05063         162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--VMKAINDG-------------  226 (268)
T ss_pred             ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHHHHhcC-------------
Confidence            11111  1123457999999988889999999999999999998 999986532211  11111000             


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                            .+.+...+++.++.+++.+||+.+|++||++.++++.|+++
T Consensus       227 ------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         227 ------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                  01111223567789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.2e-34  Score=316.70  Aligned_cols=257  Identities=25%  Similarity=0.338  Sum_probs=207.6

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC---CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD---GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|++.+.||+|+||.||+|.. .+++.||+|.+.....   ...+++.+|+++++.++||||+++++++.+++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688889999999999999995 5889999998865322   23457889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhc---CCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          837 EYMSNGSLEKCLYS---DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       837 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      ||+++++|.+++..   ....+++.+++.++.|++.|++|||   ++|++|+||||+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998763   2345889999999999999999999   99999999999999999999999999999876643


Q ss_pred             CccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          914 EESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       914 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                      ... ......++..|+|||++.+..++.++||||+|+++|+|++|..||.....+.........         ....   
T Consensus       159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------~~~~---  225 (267)
T cd08229         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE---------QCDY---  225 (267)
T ss_pred             CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhh---------cCCC---
Confidence            322 122345788999999998888999999999999999999999998643222111111100         0000   


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                            ....+...+.++.+++.+||+.+|++|||+.+|++.+++.
T Consensus       226 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         226 ------PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             ------CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence                  0001123567899999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=6.8e-35  Score=320.68  Aligned_cols=253  Identities=26%  Similarity=0.460  Sum_probs=203.6

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC------CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      .+|+..++||+|+||.||+|...      ++..+|+|.+........+.+.+|+++++.++||||+++++++.+.+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            35777899999999999999732      456799998876555556789999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCC--------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCce
Q 039290          835 VLEYMSNGSLEKCLYSDN--------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVG  900 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~  900 (1049)
                      ||||+++++|.+++....              ..+++.++..++.|++.|++|||   +.+|+||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence            999999999999987543              24788999999999999999999   9999999999999999999999


Q ss_pred             EEecccCceecCCCcccc-ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhh
Q 039290          901 HLSDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGD  978 (1049)
Q Consensus       901 kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  978 (1049)
                      ||+|||++.......... .....+++.|+|||++.+..++.++|||||||++|||++ |..||......+..  .... 
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--~~~~-  238 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI--ECIT-  238 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH--HHHH-
Confidence            999999997654322111 122335678999999988899999999999999999998 89998653222111  1000 


Q ss_pred             ccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          979 SLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       979 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                                 ..       .....+..++..+.+++.+||+.||++||+++|+++.|+
T Consensus       239 -----------~~-------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         239 -----------QG-------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             -----------cC-------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                       00       000111235567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.2e-34  Score=317.63  Aligned_cols=253  Identities=26%  Similarity=0.449  Sum_probs=197.5

Q ss_pred             CCCCceecCCCcEEEEEEEeCCC-c--EEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecC------Ce
Q 039290          763 FSENKLLGMGSFGSVYKGVLPDG-M--EIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNN------DF  831 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~~~~-~--~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~------~~  831 (1049)
                      |.+.+.||+|+||.||+|...+. .  .||+|.++...  ....+.+.+|+++++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            35678999999999999996543 2  68999886543  23356788999999999999999999987432      24


Q ss_pred             eEEEEeccCCCChhhhhhc-----CCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEeccc
Q 039290          832 KALVLEYMSNGSLEKCLYS-----DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFG  906 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfG  906 (1049)
                      .++||||+++|+|.+++..     ....+++..+..++.|++.|++|||   +++|+||||||+||++++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence            6899999999999988742     2235789999999999999999999   9999999999999999999999999999


Q ss_pred             CceecCCCcccc-ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCC
Q 039290          907 IAKILGKEESMR-QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCS  984 (1049)
Q Consensus       907 la~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  984 (1049)
                      +++.+....... .....+++.|+|||+..+..++.++||||+||++|||++ |+.||......+.  .....    ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~~~~----~~~  231 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI--YDYLR----QGN  231 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--HHHHH----cCC
Confidence            998764433211 122345678999999998899999999999999999999 7888865322211  11000    000


Q ss_pred             cchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290          985 ITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus       985 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                                     ....+..++..+.+++.+||+.+|++|||++|+++.|+++
T Consensus       232 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 ---------------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                           0011123456789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=8.9e-35  Score=321.60  Aligned_cols=257  Identities=24%  Similarity=0.408  Sum_probs=204.4

Q ss_pred             CCCCCceecCCCcEEEEEEEeC------CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      +|++.+.||+|+||.||+|...      ....+++|.+..... ....++.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            3778899999999999999852      235688888865432 234578899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCC-----------------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCC
Q 039290          835 VLEYMSNGSLEKCLYSDN-----------------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSN  891 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N  891 (1049)
                      |+||+.+++|.+++....                       ..+++.+++.++.|++.|++|||   +.+|+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            999999999999876421                       24788999999999999999999   9999999999999


Q ss_pred             eeecCCCceEEecccCceecCCCccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCcccccc
Q 039290          892 VLLNESMVGHLSDFGIAKILGKEESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGE  969 (1049)
Q Consensus       892 Il~~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~  969 (1049)
                      |++++++.+||+|||+++........ ......++..|+|||...+..++.++||||||+++|||++ |..||......+
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            99999999999999999865332221 1122345678999999988889999999999999999999 999986532211


Q ss_pred             chHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHh
Q 039290          970 MSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042 (1049)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~ 1042 (1049)
                        ...+.....                   +...+..++.++.+++.+||+.+|++||+++|+++.|+++..+
T Consensus       238 --~~~~~~~~~-------------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         238 --LFNLLKTGY-------------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             --HHHHHhCCC-------------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence              111111000                   0111223456789999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-34  Score=314.14  Aligned_cols=249  Identities=31%  Similarity=0.493  Sum_probs=205.7

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccC
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMS  840 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  840 (1049)
                      ++|+..+.||+|+||.||+|.. .|+.||+|.++.... ..+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            4688889999999999999987 478999999976543 46789999999999999999999999998999999999999


Q ss_pred             CCChhhhhhcCCC-ccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          841 NGSLEKCLYSDNY-FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       841 ~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      +++|.+++..... .+++..+..++.|++.|++|||   +++++||||||+||+++.++.+||+|||.+........   
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---  157 (256)
T cd05039          84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---  157 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence            9999999876542 5899999999999999999999   99999999999999999999999999999986632221   


Q ss_pred             cccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccccccc
Q 039290          920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                       ....+..|+|||++....++.++||||+|+++|||++ |..||......+.  ......    .               
T Consensus       158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~~~~----~---------------  215 (256)
T cd05039         158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPHVEK----G---------------  215 (256)
T ss_pred             -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH--HHHHhc----C---------------
Confidence             2334668999999988889999999999999999997 9999865322211  111000    0               


Q ss_pred             cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290          999 NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus       999 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                      .+...+..++.++.+++.+|+..+|++||+++|++++|+.+
T Consensus       216 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         216 YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            00111123467789999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=8.4e-35  Score=329.15  Aligned_cols=260  Identities=23%  Similarity=0.389  Sum_probs=202.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe------CCCcEEEEEEeecccC-CCHHHHHHHHHHHhhc-CCCceeeEEeeeecC-C
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL------PDGMEIAAKVFHMEFD-GSLESFHAECKVMGSI-RHRNLVKIISSCSNN-D  830 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~-~  830 (1049)
                      .++|++.+.||+|+||.||+|.+      .+++.||||+++.... .....+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            35799999999999999999973      3577899999975432 2345688999999999 689999999987654 5


Q ss_pred             eeEEEEeccCCCChhhhhhcCC----------------------------------------------------------
Q 039290          831 FKALVLEYMSNGSLEKCLYSDN----------------------------------------------------------  852 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  852 (1049)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999999886421                                                          


Q ss_pred             --------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc-ccccccc
Q 039290          853 --------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES-MRQTKTL  923 (1049)
Q Consensus       853 --------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~-~~~~~~~  923 (1049)
                              ..+++.++.+++.|+++|++|||   +++|+||||||+||++++++.+||+|||++........ .......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                    13577888999999999999999   99999999999999999999999999999986532221 1112233


Q ss_pred             cccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCch
Q 039290          924 GTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFS 1002 (1049)
Q Consensus       924 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1049)
                      ++..|+|||.+.+..++.++||||+|+++|||++ |..||......+.......     ..        .       +..
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-----~~--------~-------~~~  302 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK-----EG--------T-------RMR  302 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHh-----cc--------C-------CCC
Confidence            4667999999988889999999999999999997 8899865322211111100     00        0       000


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHh
Q 039290         1003 AREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042 (1049)
Q Consensus      1003 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~ 1042 (1049)
                      .+...+.++.+++.+||+.+|++|||+.|++++|+.+.+.
T Consensus       303 ~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            1112345689999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=9.4e-35  Score=324.06  Aligned_cols=260  Identities=26%  Similarity=0.434  Sum_probs=206.6

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC--------CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCC
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP--------DGMEIAAKVFHMEF-DGSLESFHAECKVMGSI-RHRNLVKIISSCSNND  830 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~  830 (1049)
                      ++|.+.+.||+|+||.||+|+..        +...||+|.++... .....++.+|+++++.+ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            56899999999999999999852        23569999987543 23345788899999999 7999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhhcCC---------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec
Q 039290          831 FKALVLEYMSNGSLEKCLYSDN---------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN  895 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~  895 (1049)
                      ..++||||+++|+|.+++...+               ..+++.++.+++.|++.|++|||   +.|++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence            9999999999999999987542               24788999999999999999999   99999999999999999


Q ss_pred             CCCceEEecccCceecCCCcccc-ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHH
Q 039290          896 ESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLK  973 (1049)
Q Consensus       896 ~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~  973 (1049)
                      .++.+||+|||.+.......... .....++..|+|||++.+..++.++||||+||++|||++ |..||......+  ..
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~--~~  252 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--LF  252 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--HH
Confidence            99999999999987654322111 111223468999999988889999999999999999998 888886432111  11


Q ss_pred             HhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          974 RWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       974 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                      ....    ..               .....+..++.++.+++.+||..+|++|||+.|+++.|+++...-.
T Consensus       253 ~~~~----~~---------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~  304 (307)
T cd05098         253 KLLK----EG---------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS  304 (307)
T ss_pred             HHHH----cC---------------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence            1000    00               0111223456788999999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4.7e-35  Score=340.51  Aligned_cols=264  Identities=20%  Similarity=0.262  Sum_probs=193.6

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecC--------C
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNN--------D  830 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--------~  830 (1049)
                      ..+|+..+.||+|+||.||+|.. .+++.||+|++....    ....+|+.+++.++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            45799999999999999999996 468899999885432    3345799999999999999998876331        2


Q ss_pred             eeEEEEeccCCCChhhhhhc---CCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCC-CceEEeccc
Q 039290          831 FKALVLEYMSNGSLEKCLYS---DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES-MVGHLSDFG  906 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-~~~kl~DfG  906 (1049)
                      ..++||||+++ ++.+++..   ....+++..++.++.||+.||+|||   +++|+||||||+||+++.+ +.+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence            46799999975 77666543   3446899999999999999999999   9999999999999999965 479999999


Q ss_pred             CceecCCCccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCc
Q 039290          907 IAKILGKEESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSI  985 (1049)
Q Consensus       907 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  985 (1049)
                      +|+.+....  ......+++.|+|||++.+ ..++.++||||+||++|||++|.+||.+....+.. ..... ....+..
T Consensus       217 la~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~-~~i~~-~~~~p~~  292 (440)
T PTZ00036        217 SAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL-VRIIQ-VLGTPTE  292 (440)
T ss_pred             cchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHH-HhCCCCH
Confidence            998664322  2233567999999998765 46899999999999999999999999764322111 11110 0000000


Q ss_pred             chh--cccccc-----ccc--ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          986 TEV--ADANLL-----NCE--ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       986 ~~~--~~~~~~-----~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ...  ..+...     ...  ..+...+...+.++.+++.+||+.||.+|||+.|+++|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            000  000000     000  00011122345689999999999999999999999977

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-35  Score=321.96  Aligned_cols=252  Identities=25%  Similarity=0.371  Sum_probs=206.0

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      ++|++.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            46888899999999999999964 68899999997665555678889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      ++++|.+++...+..+++.++..++.|++.|++|||   +.+|+||||||+||+++.++.++|+|||.+........ ..
T Consensus        85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~  160 (280)
T cd06611          85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KR  160 (280)
T ss_pred             CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc-cc
Confidence            999999998876667999999999999999999999   99999999999999999999999999999875432221 22


Q ss_pred             cccccccCcccccccC-----CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          920 TKTLGTIGYMAPEYGR-----EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                      ....+++.|+|||.+.     ...++.++||||+|+++|||++|+.||......+ ....+...                
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~----------------  223 (280)
T cd06611         161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VLLKILKS----------------  223 (280)
T ss_pred             ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HHHHHhcC----------------
Confidence            3346788999999874     3456789999999999999999999987532211 11111100                


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                        .......+..++.++.+++.+||+.+|++||++.+++++
T Consensus       224 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         224 --EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             --CCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence              000111123355678999999999999999999999987

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.3e-34  Score=314.19  Aligned_cols=251  Identities=26%  Similarity=0.414  Sum_probs=204.3

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccC
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMS  840 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  840 (1049)
                      .+|+..+.||+|+||.||+|.+.+++.+|+|.++... .....+.+|++++++++|||++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            3577889999999999999998778899999986442 335678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccccc
Q 039290          841 NGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT  920 (1049)
Q Consensus       841 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~  920 (1049)
                      +++|.+++......+++..++.++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.+............
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST  159 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence            99999998876666889999999999999999999   999999999999999999999999999998865433222122


Q ss_pred             ccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccccccccc
Q 039290          921 KTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEN  999 (1049)
Q Consensus       921 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1049)
                      ...++..|+|||++.++.++.++||||+|+++|||++ |..||......+.  .....    .         ..      
T Consensus       160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~----~---------~~------  218 (256)
T cd05112         160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV--VETIN----A---------GF------  218 (256)
T ss_pred             CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH--HHHHh----C---------CC------
Confidence            2334678999999988889999999999999999998 8999875322211  11000    0         00      


Q ss_pred             CchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290         1000 DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus      1000 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                      +...+...+..+.+++.+||+.+|++|||+.|++++|
T Consensus       219 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         219 RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            0000111346789999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.7e-35  Score=322.72  Aligned_cols=252  Identities=25%  Similarity=0.420  Sum_probs=201.3

Q ss_pred             CCCCCceecCCCcEEEEEEEeC------CCcEEEEEEeecccCC-CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEFDG-SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      +|++.+.||+|+||+||+|...      ++..||+|+++..... ..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4667789999999999999853      2578999999754322 24568899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcC---------------CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCc
Q 039290          835 VLEYMSNGSLEKCLYSD---------------NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMV  899 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~  899 (1049)
                      ++||+.+++|.+++...               +..+++..+.+++.|+++|++|+|   ++||+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence            99999999999988532               124788889999999999999999   999999999999999999999


Q ss_pred             eEEecccCceecCCCccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhh
Q 039290          900 GHLSDFGIAKILGKEESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVG  977 (1049)
Q Consensus       900 ~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  977 (1049)
                      +||+|||+++........ ......+++.|+|||++.+..++.++||||+||++|||++ |..||......+  ....+.
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~i~  240 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--VIEMIR  240 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHH
Confidence            999999998865433221 1223345778999999988889999999999999999998 888886532211  111110


Q ss_pred             hccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          978 DSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       978 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                                  +..       ....+.+++..+.+++.+||+.+|++||+++++++.|+
T Consensus       241 ------------~~~-------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         241 ------------NRQ-------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             ------------cCC-------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence                        000       01112346778999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1e-34  Score=314.76  Aligned_cols=249  Identities=22%  Similarity=0.287  Sum_probs=202.9

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      +|++.+.||+|+||.||++... ++..||+|.++... ....+.+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999954 78899999986533 334567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          840 SNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       840 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      ++++|.+++... ...+++..+..++.|++.|++|||   +.+|+|+||||+||++++++.++++|||.+........ .
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  156 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y  156 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence            999999987653 345789999999999999999999   99999999999999999999999999999986643322 1


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                      .....+++.|+|||++.+..++.++|+||+|+++|+|++|..||............. .     ..              
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-~-----~~--------------  216 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-Q-----GS--------------  216 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-c-----CC--------------
Confidence            223567889999999988889999999999999999999999997522111110000 0     00              


Q ss_pred             cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          999 NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       999 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                       ....+...+..+.+++.+||+.||++||++.|++..
T Consensus       217 -~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 -YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence             001112345578999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.3e-35  Score=328.93  Aligned_cols=237  Identities=27%  Similarity=0.316  Sum_probs=188.7

Q ss_pred             ceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHH-HHhhcCCCceeeEEeeeecCCeeEEEEeccCC
Q 039290          767 KLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECK-VMGSIRHRNLVKIISSCSNNDFKALVLEYMSN  841 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  841 (1049)
                      +.||+|+||+||+|+.. +|+.||+|++....   .....++.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999964 78999999997542   222344555554 46778999999999999999999999999999


Q ss_pred             CChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccc
Q 039290          842 GSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK  921 (1049)
Q Consensus       842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~  921 (1049)
                      |+|.+++.... .+++..+..++.||++||+|||   ++||+||||||+||+++.++.+||+|||++....... .....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~  155 (323)
T cd05575          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTST  155 (323)
T ss_pred             CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccccc
Confidence            99999887654 5889999999999999999999   9999999999999999999999999999987532222 12233


Q ss_pred             cccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCc
Q 039290          922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDF 1001 (1049)
Q Consensus       922 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1049)
                      ..|++.|+|||++.+..++.++||||+||++|||++|..||......+. .....             ..        ..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~i~-------------~~--------~~  213 (323)
T cd05575         156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM-YDNIL-------------NK--------PL  213 (323)
T ss_pred             ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH-HHHHH-------------cC--------CC
Confidence            5689999999999998999999999999999999999999975321111 11100             00        00


Q ss_pred             hhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 039290         1002 SAREQCVSSIFSLAMDCTVDLPEKRISMK 1030 (1049)
Q Consensus      1002 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ 1030 (1049)
                      ..+...+..+.+++.+|++.||++||++.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         214 RLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            11122356789999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.1e-35  Score=328.60  Aligned_cols=248  Identities=22%  Similarity=0.282  Sum_probs=196.0

Q ss_pred             ceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEEEeccCC
Q 039290          767 KLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALVLEYMSN  841 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  841 (1049)
                      +.||+|+||+||+|+.. +++.||+|+++...   ....+.+.+|+.++.++ +||+|+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999954 67899999997643   22345678899999888 699999999999999999999999999


Q ss_pred             CChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccc
Q 039290          842 GSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK  921 (1049)
Q Consensus       842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~  921 (1049)
                      |+|.+++...+ .+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||++........ ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~  155 (327)
T cd05617          81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TTST  155 (327)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-ceec
Confidence            99998886554 4899999999999999999999   99999999999999999999999999999875322221 2234


Q ss_pred             cccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccc-hHHHhhhhccccCCcchhcccccccccccC
Q 039290          922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEM-SLKRWVGDSLLSCSITEVADANLLNCEEND 1000 (1049)
Q Consensus       922 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1049)
                      ..||+.|+|||++.+..++.++||||+||++|||++|..||........ ....+.....             .   ...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~-------------~---~~~  219 (327)
T cd05617         156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI-------------L---EKP  219 (327)
T ss_pred             ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH-------------H---hCC
Confidence            5689999999999999999999999999999999999999964322111 1111110000             0   001


Q ss_pred             chhhHHHHHHHHHHHhhccccCCCCCCCH------HHHHHH
Q 039290         1001 FSAREQCVSSIFSLAMDCTVDLPEKRISM------KDVANR 1035 (1049)
Q Consensus      1001 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~------~ell~~ 1035 (1049)
                      ...+...+..+.+++.+|++.||++|+++      +++++|
T Consensus       220 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         220 IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            11222345678999999999999999985      566655

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6e-35  Score=332.94  Aligned_cols=265  Identities=20%  Similarity=0.222  Sum_probs=198.5

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCC-----
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNND-----  830 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~-----  830 (1049)
                      ..++|++.+.||+|+||.||+|+. .+|..||+|++....  ......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            356899999999999999999995 468899999986543  233567889999999999999999999886543     


Q ss_pred             -eeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCce
Q 039290          831 -FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK  909 (1049)
Q Consensus       831 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~  909 (1049)
                       ..++||||+++ ++.+.+..   .+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence             57999999976 56665532   3788899999999999999999   9999999999999999999999999999997


Q ss_pred             ecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhc----------
Q 039290          910 ILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDS----------  979 (1049)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~----------  979 (1049)
                      ......  ......+|+.|+|||++.+..++.++||||+||++|||++|+.||......+ .+.......          
T Consensus       172 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~  248 (359)
T cd07876         172 TACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQLGTPSAEFMNR  248 (359)
T ss_pred             ccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCcHHHHHH
Confidence            543222  2234568999999999999899999999999999999999999997532211 000000000          


Q ss_pred             --------cccC------CcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          980 --------LLSC------SITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       980 --------~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                              ....      ...+......   ...........+.++.+++.+|++.||++|||++|+++|-
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  316 (359)
T cd07876         249 LQPTVRNYVENRPQYPGISFEELFPDWI---FPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP  316 (359)
T ss_pred             HHHHHHHHHhhCCCCCCcchhhhccccc---cccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence                    0000      0000000000   0000011112356789999999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=9.1e-35  Score=317.83  Aligned_cols=255  Identities=24%  Similarity=0.449  Sum_probs=204.8

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CC---cEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DG---MEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      .+|++.+.||+|+||.||+|+.. ++   ..||+|.++... .....++..|+.+++.++||||+++++++.+++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            35778899999999999999964 33   369999987543 22356789999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++++|.+++......+++.+++.++.|++.|++|||   +.|++||||||+||+++.++.+|++|||++.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999999876667899999999999999999999   9999999999999999999999999999987654322


Q ss_pred             ccc-ccccc---cccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcc
Q 039290          916 SMR-QTKTL---GTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD  990 (1049)
Q Consensus       916 ~~~-~~~~~---~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  990 (1049)
                      ... .....   .+..|+|||++.+..++.++||||+||++|||++ |..||......  ....++...           
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~~~-----------  227 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIEQD-----------  227 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcC-----------
Confidence            111 11111   2357999999998899999999999999999887 99998653221  112221100           


Q ss_pred             cccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290          991 ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                              .+.+.+.+++..+.+++.+||+.+|.+||++.+++..|+++
T Consensus       228 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         228 --------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             --------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                    01111234567789999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.6e-34  Score=321.89  Aligned_cols=261  Identities=25%  Similarity=0.442  Sum_probs=207.7

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe--------CCCcEEEEEEeeccc-CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecC
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL--------PDGMEIAAKVFHMEF-DGSLESFHAECKVMGSI-RHRNLVKIISSCSNN  829 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~--------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~  829 (1049)
                      .++|.+.+.||+|+||.||+|+.        .++..||+|.++... .....++.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            45688889999999999999973        134579999986543 23356789999999999 899999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhhcCC---------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeee
Q 039290          830 DFKALVLEYMSNGSLEKCLYSDN---------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL  894 (1049)
Q Consensus       830 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~  894 (1049)
                      +..++||||+++|+|.+++...+               ..+++.++..++.|+++|++|||   ++||+||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence            99999999999999999987532               24678889999999999999999   9999999999999999


Q ss_pred             cCCCceEEecccCceecCCCcccc-ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchH
Q 039290          895 NESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSL  972 (1049)
Q Consensus       895 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~  972 (1049)
                      ++++.+||+|||.++......... .....++..|+|||++.+..++.++||||+|+++|||++ |..||......+.  
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--  248 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--  248 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH--
Confidence            999999999999998764332221 122335678999999988889999999999999999998 7788764322111  


Q ss_pred             HHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          973 KRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                      .....   ..                .+...+..++..+.+++.+||+.+|++|||+.|+++.|+++..--.
T Consensus       249 ~~~~~---~~----------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~  301 (304)
T cd05101         249 FKLLK---EG----------------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT  301 (304)
T ss_pred             HHHHH---cC----------------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence            11000   00                0011123456789999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=9.3e-35  Score=320.99  Aligned_cols=259  Identities=22%  Similarity=0.381  Sum_probs=203.5

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEeC------CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCe
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDF  831 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~  831 (1049)
                      ..++|++.+.||+|+||.||+|...      .+..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4568999999999999999999743      245799998864432 223467889999999999999999999999999


Q ss_pred             eEEEEeccCCCChhhhhhcCC---------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEE
Q 039290          832 KALVLEYMSNGSLEKCLYSDN---------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHL  902 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl  902 (1049)
                      .++||||+++|+|.+++....         ...+...+..++.|++.|++|||   +++|+||||||+||++++++.+++
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999986522         23466788899999999999999   999999999999999999999999


Q ss_pred             ecccCceecCCCcccc-ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhcc
Q 039290          903 SDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSL  980 (1049)
Q Consensus       903 ~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  980 (1049)
                      +|||+++......... .....++..|+|||.+.++.++.++||||+||++|||++ |..||......+  .....   .
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--~~~~~---~  235 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--VLKFV---M  235 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH---H
Confidence            9999988653322211 122345678999999988889999999999999999998 788886532221  11110   0


Q ss_pred             ccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 039290          981 LSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041 (1049)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~ 1041 (1049)
                               +..       ....+..++..+.+++.+|++.+|++|||+.++++.+++...
T Consensus       236 ---------~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  280 (288)
T cd05061         236 ---------DGG-------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH  280 (288)
T ss_pred             ---------cCC-------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence                     000       001112345689999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.3e-34  Score=320.77  Aligned_cols=250  Identities=26%  Similarity=0.346  Sum_probs=206.4

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      .+|+..+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            3588899999999999999985 578999999997665556678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      ++++|.+++...  .+++.++..++.|++.|++|||   +.|++||||||+||+++.++.+||+|||++........ ..
T Consensus        99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~  172 (296)
T cd06655          99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KR  172 (296)
T ss_pred             CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cC
Confidence            999999988654  4799999999999999999999   99999999999999999999999999999876543322 12


Q ss_pred             cccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccccccc
Q 039290          920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEN  999 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1049)
                      ....++..|+|||.+.+..++.++||||+||++|+|++|+.||......+.....+..                   ...
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-------------------~~~  233 (296)
T cd06655         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-------------------GTP  233 (296)
T ss_pred             CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------------CCc
Confidence            2345788999999998888999999999999999999999999753222111111000                   000


Q ss_pred             CchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290         1000 DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus      1000 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ....+..++..+.+++.+||..||++||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         234 ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            011122345678999999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=8.7e-35  Score=317.65  Aligned_cols=253  Identities=23%  Similarity=0.332  Sum_probs=201.9

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      ++|+..+.||+|+||.||+|+. .+++.||+|.++.........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            4677778999999999999985 468899999987665445567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      ++++|.+++...+ .+++.++..++.|++.|++|||   +.|++|+||||+||+++.++.++|+|||++........ ..
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-~~  163 (267)
T cd06645          89 GGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-KR  163 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-cc
Confidence            9999999887654 4899999999999999999999   99999999999999999999999999999876543221 22


Q ss_pred             cccccccCcccccccC---CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          920 TKTLGTIGYMAPEYGR---EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                      ....|+..|+|||++.   ...++.++||||+||++|||++|..||............ ........             
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~-~~~~~~~~-------------  229 (267)
T cd06645         164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-TKSNFQPP-------------  229 (267)
T ss_pred             ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh-hccCCCCC-------------
Confidence            3346889999999874   456888999999999999999999998653222111110 00000000             


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                         .......++..+.+++.+|++.+|++||++++++++
T Consensus       230 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         230 ---KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             ---cccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence               000011234568899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=8.3e-35  Score=327.77  Aligned_cols=255  Identities=20%  Similarity=0.243  Sum_probs=200.9

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|++.++||+|+||+||+|+.. +++.||+|++....   ......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36888999999999999999965 57789999986422   223455788999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+++|+|.+++......+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++........
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            999999999999876566899999999999999999999   99999999999999999999999999999976543333


Q ss_pred             ccccccccccCcccccccC-----CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccc
Q 039290          917 MRQTKTLGTIGYMAPEYGR-----EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA  991 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  991 (1049)
                      .......||+.|+|||++.     ...++.++||||+||++|||++|+.||......+.. ..    ......       
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~-~~----i~~~~~-------  225 (332)
T cd05623         158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-GK----IMNHKE-------  225 (332)
T ss_pred             ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH-HH----HhCCCc-------
Confidence            2333456899999999885     346789999999999999999999999753211111 11    000000       


Q ss_pred             ccccccccCchhhHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 039290          992 NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEK--RISMKDVANR 1035 (1049)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~ell~~ 1035 (1049)
                       ..    ........++.++.+++.+|+..++.+  |++++|+++|
T Consensus       226 -~~----~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         226 -RF----QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             -cc----cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence             00    000111235677899999988665544  7899999988

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=9.2e-35  Score=325.90  Aligned_cols=241  Identities=23%  Similarity=0.289  Sum_probs=194.1

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcC-CCceeeEEeeeecCCeeEEEE
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIR-HRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      +|+..+.||+|+||.||+|+.. +++.||+|++....   ....+.+..|.+++..+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3677899999999999999954 78899999997542   233456778888888885 578889999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+++|+|.+++.... .+++.++..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||++........
T Consensus        81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~  156 (323)
T cd05615          81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV  156 (323)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence            9999999999887654 4889999999999999999999   99999999999999999999999999999875432221


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                       ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+  ..+.+.            .      
T Consensus       157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~~~i~------------~------  215 (323)
T cd05615         157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE--LFQSIM------------E------  215 (323)
T ss_pred             -cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHHH------------h------
Confidence             2233468999999999998889999999999999999999999997532211  111100            0      


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCCH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRISM 1029 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~ 1029 (1049)
                        .....+...+.++.+++.+|++.+|.+|++.
T Consensus       216 --~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         216 --HNVSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             --CCCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence              0011112345678899999999999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.6e-34  Score=320.41  Aligned_cols=250  Identities=25%  Similarity=0.331  Sum_probs=205.9

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      .+|+..+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            5789999999999999999995 579999999997665555677889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      ++++|.+++...  .+++.++..++.|++.|++|||   +.+|+||||||+||+++.++.++|+|||++........ ..
T Consensus        99 ~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~  172 (297)
T cd06656          99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR  172 (297)
T ss_pred             CCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-Cc
Confidence            999999988653  3788999999999999999999   99999999999999999999999999999986543322 12


Q ss_pred             cccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccccccc
Q 039290          920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEN  999 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1049)
                      ....+++.|+|||.+.+..++.++||||+||++|+|++|..||............+.                   ....
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-------------------~~~~  233 (297)
T cd06656         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-------------------NGTP  233 (297)
T ss_pred             CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-------------------CCCC
Confidence            234678899999999888899999999999999999999999965221111100000                   0000


Q ss_pred             CchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290         1000 DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus      1000 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ....+...+..+.+++.+||+.+|++||++++++++
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         234 ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            011123345678899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.6e-34  Score=320.96  Aligned_cols=257  Identities=24%  Similarity=0.392  Sum_probs=204.9

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC------CCcEEEEEEeecccC-CCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEFD-GSLESFHAECKVMGSI-RHRNLVKIISSCSNNDF  831 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~  831 (1049)
                      .++|...+.||+|+||.||+|...      ++..||+|+++.... ...+.+.+|+++++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            346888999999999999999741      345799999875432 2346788999999999 79999999999999999


Q ss_pred             eEEEEeccCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCcee
Q 039290          832 KALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI  910 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~  910 (1049)
                      .++||||+.+|+|.+++.... ..+++.++..++.|++.|++|+|   +++|+|+||||+||+++.++.++++|||++..
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence            999999999999999987543 34799999999999999999999   99999999999999999999999999999986


Q ss_pred             cCCCccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchh
Q 039290          911 LGKEESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEV  988 (1049)
Q Consensus       911 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  988 (1049)
                      ....... ......++..|+|||.+.+..++.++||||+||++|||++ |..||......+.. ........        
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~-~~~~~~~~--------  261 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF-YKLIKEGY--------  261 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH-HHHHHcCC--------
Confidence            5433211 1112345678999999988889999999999999999998 99998754322211 11110000        


Q ss_pred             cccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290          989 ADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                                 +...+...+.++.+++.+|++.+|++|||+.|+++.|++.
T Consensus       262 -----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         262 -----------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             -----------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                       0001112345789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=7.1e-35  Score=327.98  Aligned_cols=255  Identities=21%  Similarity=0.254  Sum_probs=201.3

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++....   ......+.+|..++..++|++|+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46889999999999999999964 67889999986532   223455788999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+++|+|.+++......+++..+..++.|++.||+|+|   +++|+||||||+||+++.++.+||+|||++........
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            999999999999875556899999999999999999999   99999999999999999999999999999987654433


Q ss_pred             ccccccccccCcccccccCC-----CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccc
Q 039290          917 MRQTKTLGTIGYMAPEYGRE-----GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA  991 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  991 (1049)
                      .......|++.|+|||++.+     +.++.++||||+||++|||++|+.||......+.. .....   ....       
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~-~~i~~---~~~~-------  226 (331)
T cd05624         158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-GKIMN---HEER-------  226 (331)
T ss_pred             eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH-HHHHc---CCCc-------
Confidence            33333568999999998865     46788999999999999999999999753221111 11000   0000       


Q ss_pred             ccccccccCchhhHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 039290          992 NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEK--RISMKDVANR 1035 (1049)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~ell~~ 1035 (1049)
                        .+    ......+.++++.+++.+|+..++.+  |++++++++|
T Consensus       227 --~~----~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         227 --FQ----FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             --cc----CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence              00    00111234567889999999876654  5689998876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.8e-34  Score=318.91  Aligned_cols=267  Identities=24%  Similarity=0.275  Sum_probs=196.7

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhc---CCCceeeEEeeeec-----CC
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSI---RHRNLVKIISSCSN-----ND  830 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~hpniv~l~~~~~~-----~~  830 (1049)
                      +|++.+.||+|+||+||+|+.. +++.||+|.++...  ......+.+|+++++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4888899999999999999964 68899999987543  22334566777777665   69999999998754     34


Q ss_pred             eeEEEEeccCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCce
Q 039290          831 FKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK  909 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~  909 (1049)
                      ..++||||+.+ +|.+++.... ..+++..+..++.|++.|++|+|   +.||+||||||+||+++.++.+||+|||++.
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            57899999975 8888876543 35899999999999999999999   9999999999999999999999999999998


Q ss_pred             ecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcc--ccCCcch
Q 039290          910 ILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSL--LSCSITE  987 (1049)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~  987 (1049)
                      ......  ......++..|+|||++.+..++.++||||+||++|||++|.+||......+. .........  ....+..
T Consensus       157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~  233 (288)
T cd07863         157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LGKIFDLIGLPPEDDWPR  233 (288)
T ss_pred             cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH-HHHHHHHhCCCChhhCcc
Confidence            664322  22335678999999999888999999999999999999999999865322211 111111000  0000000


Q ss_pred             hc---cccccccc-ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          988 VA---DANLLNCE-ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       988 ~~---~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ..   ........ ..........+.++.+++.+|++.||++|||++|++.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            00   00000000 00001112356778999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.5e-34  Score=314.58  Aligned_cols=258  Identities=24%  Similarity=0.370  Sum_probs=210.7

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      .|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++++.||||+++++++.+++..++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4777789999999999999964 68899999987543 234567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      ++++|.+++...  .+++.++..++.|++.|++|+|   +.+++|+||+|+||+++.++.++++|||++........ ..
T Consensus        85 ~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~  158 (277)
T cd06640          85 GGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KR  158 (277)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-cc
Confidence            999999988653  4788999999999999999999   99999999999999999999999999999976643321 22


Q ss_pred             cccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccccccc
Q 039290          920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEN  999 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1049)
                      ....++..|+|||++.+..++.++|+|||||++|||++|..||......+.....               ..      ..
T Consensus       159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~---------------~~------~~  217 (277)
T cd06640         159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI---------------PK------NN  217 (277)
T ss_pred             ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh---------------hc------CC
Confidence            3345788999999998888999999999999999999999998753222111000               00      00


Q ss_pred             CchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH------------HHHHHHhhhhc
Q 039290         1000 DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR------------LVRIRETLSAY 1046 (1049)
Q Consensus      1000 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~------------L~~i~~~~~~~ 1046 (1049)
                      .......++..+.+++.+||+.+|++||++++++++            +....++...|
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~  276 (277)
T cd06640         218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLTELIDRFKRW  276 (277)
T ss_pred             CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchhhhHHHHHHHHHHhc
Confidence            112224467789999999999999999999999888            66666665554

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.1e-34  Score=313.16  Aligned_cols=253  Identities=26%  Similarity=0.444  Sum_probs=205.0

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      .++|++.+.||+|+||.||+|...++..+|+|.++.. ....+.+.+|++++++++|+||+++++++.+ +..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            4578899999999999999999878888999988643 2345678899999999999999999999887 7789999999


Q ss_pred             CCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          840 SNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       840 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      ++++|.+++... ....++.++..++.|++.|++|+|   +.|++||||||+||+++.++.+||+|||.+..........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  159 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA  159 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence            999999998763 345788899999999999999999   9999999999999999999999999999998664332222


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE  997 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1049)
                      .....++..|+|||++....++.++|+||+||++|++++ |..||......  ....+.....                 
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~-----------------  220 (260)
T cd05073         160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGY-----------------  220 (260)
T ss_pred             ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhCCC-----------------
Confidence            222345677999999988889999999999999999999 89998753221  1111111100                 


Q ss_pred             ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 039290          998 ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVR 1038 (1049)
Q Consensus       998 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~ 1038 (1049)
                        ..+.+...+.++.+++.+|++.+|++||++.++.+.|+.
T Consensus       221 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         221 --RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             --CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence              001112345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.9e-34  Score=320.78  Aligned_cols=269  Identities=20%  Similarity=0.268  Sum_probs=204.0

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .++|+..+.||+|+||.||+|+.. +++.||+|.++... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            457899999999999999999864 68899999987543 3334577889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      |++ ++|.+++......+++..+..++.|+++|++|||   +.+|+||||||+||++++++.+||+|||++........ 
T Consensus        85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-  159 (301)
T cd07873          85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-  159 (301)
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence            997 5899988776667899999999999999999999   99999999999999999999999999999976533221 


Q ss_pred             cccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcc---ccCCcchhccccc
Q 039290          918 RQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSL---LSCSITEVADANL  993 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  993 (1049)
                      ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+. .. ......   ....+..+.....
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-LH-FIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HH-HHHHHcCCCChhhchhhhcccc
Confidence            1223456889999998765 4578899999999999999999999975332211 10 000000   0011111111000


Q ss_pred             ccc---cccC----chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          994 LNC---EEND----FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       994 ~~~---~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ...   +...    .......+.++.+++.+|++.||.+|||++|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            000   0000    01112346678999999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-34  Score=312.08  Aligned_cols=247  Identities=30%  Similarity=0.472  Sum_probs=198.2

Q ss_pred             ceecCCCcEEEEEEEeC-C---CcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCC
Q 039290          767 KLLGMGSFGSVYKGVLP-D---GMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSN  841 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~-~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  841 (1049)
                      ++||+|+||.||+|++. .   +..||+|.+..... ...+++.+|+++++.+.||||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999843 2   26899999875543 24567889999999999999999999876 4567999999999


Q ss_pred             CChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccc
Q 039290          842 GSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK  921 (1049)
Q Consensus       842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~  921 (1049)
                      |+|.+++.... .+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.++............
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999998765 5899999999999999999999   9999999999999999999999999999998764433221111


Q ss_pred             --cccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccccccc
Q 039290          922 --TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       922 --~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                        ..++..|+|||...+..++.++|||||||++|||++ |..||......  ....++....                  
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--~~~~~~~~~~------------------  215 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--EVIAMLESGE------------------  215 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHcCC------------------
Confidence              123457999999988889999999999999999998 99998764221  1222111100                  


Q ss_pred             cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290          999 NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus       999 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                       ....+..++..+.+++.+||..+|++||++.++++.|+++
T Consensus       216 -~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         216 -RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             -cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence             0111223456789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=6e-35  Score=328.03  Aligned_cols=240  Identities=27%  Similarity=0.300  Sum_probs=189.5

Q ss_pred             ceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHH-HHhhcCCCceeeEEeeeecCCeeEEEEeccCC
Q 039290          767 KLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECK-VMGSIRHRNLVKIISSCSNNDFKALVLEYMSN  841 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  841 (1049)
                      +.||+|+||+||+|+.. +++.||+|++....   ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999965 67789999987542   122234444443 56778999999999999999999999999999


Q ss_pred             CChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccc
Q 039290          842 GSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK  921 (1049)
Q Consensus       842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~  921 (1049)
                      |+|.+++.... .+.+..+..++.||++||+|||   +.||+||||||+||+++.++.+||+|||+++....... ....
T Consensus        81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~~  155 (325)
T cd05602          81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTST  155 (325)
T ss_pred             CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cccc
Confidence            99999887654 4778888899999999999999   99999999999999999999999999999975432221 2234


Q ss_pred             cccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCc
Q 039290          922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDF 1001 (1049)
Q Consensus       922 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1049)
                      ..|++.|+|||++.+..++.++||||+||++|||++|..||......+.  ....   .         ..        ..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i---~---------~~--------~~  213 (325)
T cd05602         156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM--YDNI---L---------NK--------PL  213 (325)
T ss_pred             ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH--HHHH---H---------hC--------Cc
Confidence            5689999999999998999999999999999999999999975322111  1110   0         00        00


Q ss_pred             hhhHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 039290         1002 SAREQCVSSIFSLAMDCTVDLPEKRISMKDVA 1033 (1049)
Q Consensus      1002 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell 1033 (1049)
                      ..+...+..+.+++.+|++.+|.+||++.+.+
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            11123456789999999999999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-36  Score=324.91  Aligned_cols=248  Identities=26%  Similarity=0.359  Sum_probs=207.0

Q ss_pred             CCceecCCCcEEEEEEEeCC-CcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCCC
Q 039290          765 ENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGS  843 (1049)
Q Consensus       765 ~~~~lg~G~fg~Vy~a~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~  843 (1049)
                      +...||.|+||.||+|..++ +...|.|++........++|.-|++++....||+||+++++|...+.++|..|||.||-
T Consensus        36 IiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGA  115 (1187)
T KOG0579|consen   36 IIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGA  115 (1187)
T ss_pred             HHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCch
Confidence            34569999999999999664 44567799887777778999999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccccc
Q 039290          844 LEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL  923 (1049)
Q Consensus       844 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~~~  923 (1049)
                      .+..+-.-++.+++.++.-+++|++.||.|||   +.+|||||+|+.||+++-+|.++++|||.+..... .......++
T Consensus       116 VDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkRDsFI  191 (1187)
T KOG0579|consen  116 VDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKRDSFI  191 (1187)
T ss_pred             HhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchh-HHhhhcccc
Confidence            99998888888999999999999999999999   99999999999999999999999999999865432 223445688


Q ss_pred             cccCccccccc-----CCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccc
Q 039290          924 GTIGYMAPEYG-----REGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       924 ~~~~y~aPE~~-----~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                      |||+|||||+.     .+.+|+.++||||||+++.||..+.+|-.+.......+..                   ....+
T Consensus       192 GTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKi-------------------aKSeP  252 (1187)
T KOG0579|consen  192 GTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI-------------------AKSEP  252 (1187)
T ss_pred             CCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHH-------------------hhcCC
Confidence            99999999975     4578999999999999999999999997653322211111                   11111


Q ss_pred             cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          999 NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       999 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .-...|...+..+.+|+.+|+..+|..||+++++++|
T Consensus       253 PTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  253 PTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             CcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            1223345567789999999999999999999999987

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.1e-34  Score=317.79  Aligned_cols=252  Identities=24%  Similarity=0.308  Sum_probs=200.2

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhc-CCCceeeEEeeeecC------C
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLVKIISSCSNN------D  830 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~------~  830 (1049)
                      +.+.|+..+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++++ +||||+++++++...      +
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            4567888899999999999999954 68889999987543 3456788999999998 699999999998653      4


Q ss_pred             eeEEEEeccCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCce
Q 039290          831 FKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK  909 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~  909 (1049)
                      ..++||||+.+++|.+++.... ..+++..+..++.|++.|++|||   +++|+||||||+||++++++.++|+|||++.
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~  159 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  159 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence            6789999999999999987643 46889999999999999999999   9999999999999999999999999999998


Q ss_pred             ecCCCccccccccccccCcccccccC-----CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCC
Q 039290          910 ILGKEESMRQTKTLGTIGYMAPEYGR-----EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCS  984 (1049)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  984 (1049)
                      ....... ......|+..|+|||++.     +..++.++||||+||++|||++|+.||............+.     .  
T Consensus       160 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~-----~--  231 (272)
T cd06637         160 QLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-----N--  231 (272)
T ss_pred             ecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc-----C--
Confidence            6533221 223456888999999875     34578899999999999999999999865322111111000     0  


Q ss_pred             cchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          985 ITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       985 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                                   ..+......++.++.+++.+||+.+|.+|||++|++++
T Consensus       232 -------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         232 -------------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             -------------CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence                         00000111245678999999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-34  Score=312.83  Aligned_cols=247  Identities=31%  Similarity=0.530  Sum_probs=204.4

Q ss_pred             ceecCCCcEEEEEEEeCC----CcEEEEEEeecccCCC-HHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCC
Q 039290          767 KLLGMGSFGSVYKGVLPD----GMEIAAKVFHMEFDGS-LESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSN  841 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~~----~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  841 (1049)
                      +.||+|+||.||+|....    +..|++|.++...... .+.+.+|+++++.++|+|++++++++.+.+..++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999999653    7889999997654333 67889999999999999999999999999999999999999


Q ss_pred             CChhhhhhcC--------CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          842 GSLEKCLYSD--------NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       842 g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      ++|.+++...        ...+++.+++.++.|++.|++|||   +++|+||||||+||++++++.+|++|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999876        467899999999999999999999   99999999999999999999999999999987654


Q ss_pred             Ccc-ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccc
Q 039290          914 EES-MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA  991 (1049)
Q Consensus       914 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  991 (1049)
                      ... .......++..|+|||.+....++.++||||+|+++|||++ |..||......+  ......            . 
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~------------~-  222 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE--VLEYLR------------K-  222 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHH------------c-
Confidence            331 12233456889999999988889999999999999999999 699987642211  111110            0 


Q ss_pred             ccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          992 NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                            ..+...+..++.++.+++.+||+.+|++|||++|++++|+
T Consensus       223 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 ------GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ------CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  0111222345678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.7e-35  Score=333.75  Aligned_cols=252  Identities=23%  Similarity=0.311  Sum_probs=198.7

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|+..+.||+|+||.||+|+.. +++.||+|+++...   ......+.+|+.++..++||+|+++++++.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888999999999999999964 68899999997532   233567888999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+++|+|.+++...+ .+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||++........
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            9999999999987654 4889999999999999999999   99999999999999999999999999999875422110


Q ss_pred             ----------------------------------ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCC
Q 039290          917 ----------------------------------MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPT  962 (1049)
Q Consensus       917 ----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~  962 (1049)
                                                        ......+||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence                                              0012346899999999999999999999999999999999999999


Q ss_pred             CccccccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCC---HHHHHHH
Q 039290          963 DEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRIS---MKDVANR 1035 (1049)
Q Consensus       963 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~ell~~ 1035 (1049)
                      ......+.......  .  .       ..  .     .++.....+.++.+++.+++. +|.+|++   ++|+++|
T Consensus       237 ~~~~~~~~~~~i~~--~--~-------~~--~-----~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         237 CSETPQETYRKVMN--W--K-------ET--L-----VFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCHHHHHHHHHc--C--C-------Cc--e-----ecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            75332211111000  0  0       00  0     000001234567888888764 9999985   6787776

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-34  Score=316.40  Aligned_cols=262  Identities=26%  Similarity=0.415  Sum_probs=211.3

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCc----EEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGM----EIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      .+|+..+.||+|+||.||+|... +|.    .||+|....... ....++.+|+.++++++||||+++++++.. +..++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            46788899999999999999854 333    589998865532 234678899999999999999999999887 77899


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      ||||+++|+|.+++......+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||.++.....
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~  162 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD  162 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence            99999999999999887667899999999999999999999   999999999999999999999999999999876433


Q ss_pred             ccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccc
Q 039290          915 ESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       915 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      ... ......++..|+|||.+....++.++||||+|+++||+++ |+.||......+  .......    .         
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~----~---------  227 (279)
T cd05057         163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--IPDLLEK----G---------  227 (279)
T ss_pred             ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHhC----C---------
Confidence            221 1111223568999999988889999999999999999998 999987632221  1111110    0         


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhcc
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYI 1047 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~~ 1047 (1049)
                            .....+..++..+.+++.+||..+|.+||++.++++.|+++.+.-.+|+
T Consensus       228 ------~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~~  276 (279)
T cd05057         228 ------ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQRYL  276 (279)
T ss_pred             ------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCcceE
Confidence                  0011112244578899999999999999999999999999988877775

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.2e-35  Score=320.96  Aligned_cols=253  Identities=32%  Similarity=0.439  Sum_probs=199.4

Q ss_pred             CCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCC--HHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          763 FSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGS--LESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      |+..+.||+|+||+||+|+.. +++.||+|++.......  .....+|+.++++++||||+++++++.+.+..++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            567789999999999999965 56689999998664222  223456999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      ++++|.+++... ..+++.++..++.|+++||++||   +.+|+||||||+||++++++.++|+|||.+..... .....
T Consensus        81 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~~  155 (260)
T PF00069_consen   81 PGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNENF  155 (260)
T ss_dssp             TTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSEB
T ss_pred             cccccccccccc-ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-ccccc
Confidence            999999999833 34799999999999999999999   89999999999999999999999999999986522 22233


Q ss_pred             cccccccCcccccccC-CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccc
Q 039290          920 TKTLGTIGYMAPEYGR-EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                      ....++..|+|||+.. +..++.++||||+|+++|+|++|..||......+. ......          ......    .
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~-~~~~~~----------~~~~~~----~  220 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ-LEIIEK----------ILKRPL----P  220 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH-HHHHHH----------HHHTHH----H
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhh-hhhhhh----------cccccc----c
Confidence            4466789999999988 78899999999999999999999999986411111 000000          000000    0


Q ss_pred             cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          999 NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       999 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ...........++.+++.+|++.||++||++++++++
T Consensus       221 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  221 SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000001113789999999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.5e-34  Score=321.68  Aligned_cols=259  Identities=24%  Similarity=0.424  Sum_probs=205.0

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC--------CCcEEEEEEeecccC-CCHHHHHHHHHHHhhc-CCCceeeEEeeeecCC
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP--------DGMEIAAKVFHMEFD-GSLESFHAECKVMGSI-RHRNLVKIISSCSNND  830 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~  830 (1049)
                      ++|.+.+.||+|+||.||+|+..        ....||+|.++.... ....++.+|+++++++ +||||+++++++.+.+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            46888899999999999999742        245689999875432 2345788999999999 6999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhhcCC---------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec
Q 039290          831 FKALVLEYMSNGSLEKCLYSDN---------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN  895 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~  895 (1049)
                      ..++||||+++|+|.+++....               ..+++.++.+++.|++.|++|+|   ++||+||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEc
Confidence            9999999999999999986532               24788899999999999999999   99999999999999999


Q ss_pred             CCCceEEecccCceecCCCcccc-ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHH
Q 039290          896 ESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLK  973 (1049)
Q Consensus       896 ~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~  973 (1049)
                      +++.+||+|||.++......... .....++..|+|||++.+..++.++||||+||++|||++ |..||......+.  .
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~  246 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL--F  246 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH--H
Confidence            99999999999998654322111 111223467999999988889999999999999999999 8888865322111  1


Q ss_pred             HhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhh
Q 039290          974 RWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043 (1049)
Q Consensus       974 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~ 1043 (1049)
                      ....    ..               .....+..++.++.+++.+||+.+|++|||+.|+++.|+++....
T Consensus       247 ~~~~----~~---------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~  297 (314)
T cd05099         247 KLLR----EG---------------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV  297 (314)
T ss_pred             HHHH----cC---------------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence            1100    00               001112335567899999999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-36  Score=352.90  Aligned_cols=252  Identities=26%  Similarity=0.358  Sum_probs=207.6

Q ss_pred             hcCCCCCceecCCCcEEEEEEE-eCCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      +-+|+....||.|.||.||.|. ..+|+-.|+|-++...  ....+.+.+|+.++..++|||+|+++|+-.+.+..+|.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            3467888899999999999999 5678899999886543  344567889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc-
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE-  915 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~-  915 (1049)
                      |||++|+|.+.+...+ ..++.-...+..|++.|++|||   +.|||||||||.||+++.+|.+|++|||.|..+.... 
T Consensus      1314 EyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred             HHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence            9999999999887654 3666677778899999999999   9999999999999999999999999999999876543 


Q ss_pred             --cccccccccccCcccccccCCC---CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcc
Q 039290          916 --SMRQTKTLGTIGYMAPEYGREG---KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD  990 (1049)
Q Consensus       916 --~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  990 (1049)
                        .......+||+.|||||++.+.   ....++||||+|||+.||+||+.||.+. +.+......++.            
T Consensus      1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~-dne~aIMy~V~~------------ 1456 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAEL-DNEWAIMYHVAA------------ 1456 (1509)
T ss_pred             cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhc-cchhHHHhHHhc------------
Confidence              1223457899999999999763   4567999999999999999999999863 222222111110            


Q ss_pred             cccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          991 ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                             ...++.|+..+.+-.+|+.+|++.||++|+++.|++++
T Consensus      1457 -------gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 -------GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             -------cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                   11234445577888999999999999999999998876

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.4e-34  Score=318.59  Aligned_cols=266  Identities=24%  Similarity=0.317  Sum_probs=203.8

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      ++|++.+.||+|+||.||+|... ++..||+|.++.... ....++.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36889999999999999999954 678899998875432 2345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCC-CCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS-TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      +++++|.+++...+ .+++..+..++.|+++|++|||   + .+++||||||+||+++.++.+||+|||++.......  
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  154 (308)
T cd06615          81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  154 (308)
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence            99999999987653 4789999999999999999999   6 589999999999999999999999999987553221  


Q ss_pred             cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCc------------
Q 039290          918 RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSI------------  985 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------------  985 (1049)
                       .....++..|+|||++.+..++.++||||+||++|||++|+.||......  ....+..........            
T Consensus       155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCccccccccCCcccccCCCC
Confidence             12346788999999998888999999999999999999999998643211  111111110000000            


Q ss_pred             --------chhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          986 --------TEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       986 --------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                              .+..+........ .. ....++.++.+++.+||+.+|++|||++|++++--
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~  289 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEPPP-KL-PSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF  289 (308)
T ss_pred             CccchhhHHHHHHHHhcCCCc-cC-cCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence                    0000000000000 00 00124567999999999999999999999999843

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-34  Score=310.35  Aligned_cols=247  Identities=29%  Similarity=0.464  Sum_probs=200.8

Q ss_pred             ceecCCCcEEEEEEEeCCCcEEEEEEeecccCC-CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCCChh
Q 039290          767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDG-SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLE  845 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~  845 (1049)
                      ++||+|+||.||+|...+++.||+|.+...... ..+.+.+|++++++++||||+++++++.+.+..++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            469999999999999777999999998765433 4567899999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc-ccccc
Q 039290          846 KCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ-TKTLG  924 (1049)
Q Consensus       846 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~-~~~~~  924 (1049)
                      +++......+++..+..++.+++.|++|||   +.+++||||||+||+++.++.+||+|||.+........... .....
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            999776556889999999999999999999   99999999999999999999999999999976532111111 11223


Q ss_pred             ccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCchh
Q 039290          925 TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSA 1003 (1049)
Q Consensus       925 ~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1049)
                      +..|+|||.+.++.++.++||||+||++|||++ |..||........  .......                   .+...
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~--~~~~~~~-------------------~~~~~  216 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT--RERIESG-------------------YRMPA  216 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH--HHHHhcC-------------------CCCCC
Confidence            567999999988889999999999999999999 8888865332211  1111000                   00111


Q ss_pred             hHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290         1004 REQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus      1004 ~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                      +..++.++.+++.+|++.+|.+|||+.|+++.|+
T Consensus       217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            2234668999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2e-34  Score=317.58  Aligned_cols=250  Identities=22%  Similarity=0.278  Sum_probs=200.6

Q ss_pred             CCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          763 FSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      |+..+.||+|+||+||+|.. .+++.||+|.+....   ......+.+|++++++++|++|+++.+++.+++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            66778999999999999995 478899999986542   12234577899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          839 MSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      +++++|.+.+.... ..+++..+..++.|++.|++|||   +++|+||||||+||++++++.+||+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            99999998886533 36899999999999999999999   9999999999999999999999999999997653322  


Q ss_pred             cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccccc
Q 039290          918 RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE  997 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1049)
                      ......|+..|+|||++.+..++.++|+||+||++|||++|..||........ ...+..... .               
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~~~~-~---------------  219 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDRRVL-E---------------  219 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhh-c---------------
Confidence            12334689999999999888999999999999999999999999975322111 111110000 0               


Q ss_pred             ccCchhhHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 039290          998 ENDFSAREQCVSSIFSLAMDCTVDLPEKRIS-----MKDVANR 1035 (1049)
Q Consensus       998 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~ell~~ 1035 (1049)
                       .....+...+.++.+++.+|++.+|++||+     +++++++
T Consensus       220 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         220 -TEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             -cccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence             000111234567889999999999999999     7788776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.9e-35  Score=317.94  Aligned_cols=239  Identities=23%  Similarity=0.369  Sum_probs=188.7

Q ss_pred             eecCCCcEEEEEEEeCC-------------------------CcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeE
Q 039290          768 LLGMGSFGSVYKGVLPD-------------------------GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKI  822 (1049)
Q Consensus       768 ~lg~G~fg~Vy~a~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l  822 (1049)
                      .||+|+||.||+|....                         ...||+|++..........+.+|+++++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            59999999999997421                         13588898865544445678889999999999999999


Q ss_pred             EeeeecCCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC----
Q 039290          823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM----  898 (1049)
Q Consensus       823 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~----  898 (1049)
                      ++++.+.+..++||||+++|+|.+++......+++..+.+++.|+++|++|||   +++|+||||||+||+++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence            99999999999999999999999998776667899999999999999999999   99999999999999997543    


Q ss_pred             ---ceEEecccCceecCCCccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHH-hCCCCCCccccccchHH
Q 039290          899 ---VGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETF-TKKKPTDEIFAGEMSLK  973 (1049)
Q Consensus       899 ---~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~ell-tg~~p~~~~~~~~~~~~  973 (1049)
                         .+|++|||.+......     ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||......+.  .
T Consensus       159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~  231 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK--E  231 (274)
T ss_pred             ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--H
Confidence               4899999988644221     12356788999998865 56899999999999999995 68999875322211  1


Q ss_pred             HhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          974 RWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       974 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                      .+....                     ...+.....++.+++.+||+.+|++|||+.++++.|.
T Consensus       232 ~~~~~~---------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         232 RFYEKK---------------------HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHHhc---------------------cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            111000                     0000112346889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.3e-34  Score=312.10  Aligned_cols=248  Identities=30%  Similarity=0.443  Sum_probs=200.4

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeee-ecCCeeEEEEecc
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC-SNNDFKALVLEYM  839 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~-~~~~~~~lv~e~~  839 (1049)
                      .+|++.+.||+|+||.||+|.. .+..||+|.++..  ...+.+.+|+.++++++|||++++++++ .+++..++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            4688889999999999999987 4788999998643  3456789999999999999999999976 4556789999999


Q ss_pred             CCCChhhhhhcCCC-ccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          840 SNGSLEKCLYSDNY-FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      ++++|.+++..... .+++..+.+++.|++.|++|||   ++||+||||||+||++++++.+|++|||++.......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence            99999999876443 4789999999999999999999   9999999999999999999999999999987543222   


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE  997 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1049)
                       .....+..|+|||+..+..++.++||||+||++|||++ |+.||......+  ...+....                 .
T Consensus       157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~--~~~~~~~~-----------------~  216 (256)
T cd05082         157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKG-----------------Y  216 (256)
T ss_pred             -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHhcC-----------------C
Confidence             12234568999999988889999999999999999998 999986421111  11111000                 0


Q ss_pred             ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290          998 ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus       998 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                        ....+..++..+.+++.+|++.+|++|||++++++.|+++
T Consensus       217 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         217 --KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             --CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence              0011123567889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.8e-34  Score=318.76  Aligned_cols=261  Identities=23%  Similarity=0.375  Sum_probs=204.1

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCC-----------------CcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceee
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPD-----------------GMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVK  821 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~  821 (1049)
                      ..+|++.+.||+|+||.||+|...+                 +..||+|.+..... ...+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578999999999999999998542                 24589999875432 23567889999999999999999


Q ss_pred             EEeeeecCCeeEEEEeccCCCChhhhhhcCC----------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCC
Q 039290          822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDN----------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSN  891 (1049)
Q Consensus       822 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N  891 (1049)
                      +++++..++..++||||+++++|.+++....          ..+++..++.++.|++.|++|||   +.+|+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence            9999999999999999999999999987644          25889999999999999999999   9999999999999


Q ss_pred             eeecCCCceEEecccCceecCCCccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh--CCCCCCccccc
Q 039290          892 VLLNESMVGHLSDFGIAKILGKEESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT--KKKPTDEIFAG  968 (1049)
Q Consensus       892 Il~~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~~~~~  968 (1049)
                      |+++.++.++++|||++......... ......++..|+|||++.+..++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            99999999999999998865433211 1223445778999999988889999999999999999998  67777653221


Q ss_pred             cchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          969 EMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       969 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                      +  .............            .......+..++.++.+++.+|++.||++|||+.|+++.|+
T Consensus       241 ~--~~~~~~~~~~~~~------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 Q--VIENAGHFFRDDG------------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             H--HHHHHHhcccccc------------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            1  1111111100000            00001112234568999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.2e-34  Score=320.39  Aligned_cols=264  Identities=25%  Similarity=0.420  Sum_probs=208.6

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCc----EEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGM----EIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKA  833 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~  833 (1049)
                      .++|+..+.||+|+||.||+|.+. ++.    .||+|.+..... ....++.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            346788899999999999999853 444    478888765432 2234688999999999999999999998754 467


Q ss_pred             EEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          834 LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      +++||+++|+|.+++......+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus        85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccC
Confidence            899999999999999877667899999999999999999999   99999999999999999999999999999986643


Q ss_pred             Cccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccc
Q 039290          914 EESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA  991 (1049)
Q Consensus       914 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  991 (1049)
                      .... ......++..|+|||++.+..++.++|||||||++|||++ |+.||......+  ...+....            
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~------------  227 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--IPDLLEKG------------  227 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHCC------------
Confidence            2211 1122335678999999988889999999999999999997 889986532211  11111100            


Q ss_pred             ccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhccC
Q 039290          992 NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYID 1048 (1049)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~~~ 1048 (1049)
                             .....+..++..+.+++.+||..+|++||+++++++.|+++.+.-.++++
T Consensus       228 -------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~  277 (303)
T cd05110         228 -------ERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLV  277 (303)
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchhhhee
Confidence                   00011122455789999999999999999999999999999887766654

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.3e-34  Score=310.11  Aligned_cols=250  Identities=25%  Similarity=0.341  Sum_probs=205.4

Q ss_pred             CCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          762 GFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      +|+..+.||+|+||.||.++. .+++.+++|.+....  .....++.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            588899999999999999984 478899999986543  33456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          839 MSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       839 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      +++++|.+++... ...+++.++..++.|+++|++|||   +.+++||||+|+||++++++.+||+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999998765 446899999999999999999999   99999999999999999999999999999987644332 


Q ss_pred             cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccccc
Q 039290          918 RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE  997 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1049)
                      ......+++.|+|||+..+..++.++||||+|+++|||++|..||......+... ...    . .        .     
T Consensus       157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~-~~~----~-~--------~-----  217 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV-KIV----Q-G--------N-----  217 (256)
T ss_pred             cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH-HHH----c-C--------C-----
Confidence            2233567899999999988888999999999999999999999986532211110 000    0 0        0     


Q ss_pred             ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          998 ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       998 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                        .......++.++.+++.+||+.+|.+||+++|+++++
T Consensus       218 --~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         218 --YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             --CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence              0011123456789999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.8e-34  Score=318.54  Aligned_cols=262  Identities=24%  Similarity=0.329  Sum_probs=204.7

Q ss_pred             ccHHHHHHHhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhc-CCCceeeEEeeee-
Q 039290          751 ISYQDLLRATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLVKIISSCS-  827 (1049)
Q Consensus       751 ~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~-  827 (1049)
                      +.++.+....++|++.+.||+|+||.||+|+. .+++.||+|++... ......+.+|+.+++++ +||||+++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            44556666788999999999999999999985 46889999987643 22346788899999999 6999999999873 


Q ss_pred             ----cCCeeEEEEeccCCCChhhhhhc---CCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCce
Q 039290          828 ----NNDFKALVLEYMSNGSLEKCLYS---DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVG  900 (1049)
Q Consensus       828 ----~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~  900 (1049)
                          .++..++||||+++++|.+++..   ....+++..+..++.|+++|++|||   +.+|+||||||+||++++++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCE
Confidence                44678999999999999988753   2345788999999999999999999   9999999999999999999999


Q ss_pred             EEecccCceecCCCccccccccccccCcccccccCC-----CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHh
Q 039290          901 HLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE-----GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRW  975 (1049)
Q Consensus       901 kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~  975 (1049)
                      |++|||++....... .......+++.|+|||++..     ..++.++||||+||++|||++|+.||......+. ....
T Consensus       164 kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-~~~~  241 (286)
T cd06638         164 KLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-LFKI  241 (286)
T ss_pred             EEccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-Hhhc
Confidence            999999998664322 12233468899999998753     4578899999999999999999999875321111 1000


Q ss_pred             hhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          976 VGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       976 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                      ..     .             .......+..++.++.+++.+||+.+|++|||+.|++++.
T Consensus       242 ~~-----~-------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         242 PR-----N-------------PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             cc-----c-------------CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            00     0             0000001112345789999999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2e-34  Score=312.85  Aligned_cols=247  Identities=25%  Similarity=0.398  Sum_probs=200.3

Q ss_pred             ceecCCCcEEEEEEEeCC--C--cEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCC
Q 039290          767 KLLGMGSFGSVYKGVLPD--G--MEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSN  841 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  841 (1049)
                      ++||+|+||.||+|.+.+  +  ..||+|.+..... ...+++.+|++++++++||||+++++++.+ ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  3  3689999976654 456788999999999999999999999988 889999999999


Q ss_pred             CChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc--c
Q 039290          842 GSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM--R  918 (1049)
Q Consensus       842 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~--~  918 (1049)
                      ++|.+++.... ..+++..++.++.|+++|++|||   +++++||||||+||+++.++.+||+|||++.........  .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999997765 56899999999999999999999   999999999999999999999999999999876543221  1


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE  997 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1049)
                      .....++..|+|||++.+..++.++||||+||++|||++ |..||......+.. .....    .               
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~~----~---------------  216 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQIL-KKIDK----E---------------  216 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHh----c---------------
Confidence            112346778999999988899999999999999999999 99998653222211 11100    0               


Q ss_pred             ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          998 ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       998 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                      ......+...+..+.+++.+|++.+|++||++.|+++.|.
T Consensus       217 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         217 GERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            0001111234567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4e-34  Score=314.39  Aligned_cols=249  Identities=24%  Similarity=0.307  Sum_probs=199.0

Q ss_pred             CCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          762 GFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      +|+..++||+|+||.||+|.. .+++.||+|++.... .....++.+|++++++++||||+++++++...+..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            577889999999999999985 578899999986543 223457889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      ++++|..+.     .+++..+..++.|++.|++|||   +.||+|+||||+||+++.++.++|+|||++.......   .
T Consensus        82 ~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~  150 (279)
T cd06619          82 DGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---A  150 (279)
T ss_pred             CCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---c
Confidence            999987542     3678889999999999999999   9999999999999999999999999999998654322   2


Q ss_pred             cccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchH--HHhhhhccccCCcchhccccccccc
Q 039290          920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSL--KRWVGDSLLSCSITEVADANLLNCE  997 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1049)
                      ....++..|+|||++.+..++.++||||+||++|+|++|+.||......+...  ..+....         .+...    
T Consensus       151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------~~~~~----  217 (279)
T cd06619         151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI---------VDEDP----  217 (279)
T ss_pred             cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH---------hccCC----
Confidence            23568899999999998899999999999999999999999997643222111  0110000         00000    


Q ss_pred             ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          998 ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       998 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                       ... .....+.++.+++.+|++.+|++||+++|++++-
T Consensus       218 -~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~  254 (279)
T cd06619         218 -PVL-PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP  254 (279)
T ss_pred             -CCC-CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence             000 0012345689999999999999999999999873

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.1e-34  Score=330.48  Aligned_cols=267  Identities=21%  Similarity=0.200  Sum_probs=198.5

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecC------
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNN------  829 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~------  829 (1049)
                      ..++|+..+.||+|+||.||+|... .++.||+|++.....  .....+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4568999999999999999999854 688999999875432  2345778899999999999999999988543      


Q ss_pred             CeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCce
Q 039290          830 DFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK  909 (1049)
Q Consensus       830 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~  909 (1049)
                      ...++||||+++ ++.+.+..   .+++.++..++.|+++||+|||   ++||+||||||+||+++.++.+||+|||+++
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence            357999999976 66665543   3788899999999999999999   9999999999999999999999999999998


Q ss_pred             ecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcc---------
Q 039290          910 ILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSL---------  980 (1049)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~---------  980 (1049)
                      ......  ......+|+.|+|||++.+..++.++||||+||++|||++|+.||......+.. ........         
T Consensus       168 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~  244 (355)
T cd07874         168 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW-NKVIEQLGTPCPEFMKK  244 (355)
T ss_pred             cCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHHHh
Confidence            654322  223456899999999999889999999999999999999999999753221111 00000000         


Q ss_pred             ---------c-cCCcchhcccccccc--cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          981 ---------L-SCSITEVADANLLNC--EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       981 ---------~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                               . .........+.....  ...........+.++.+++.+|++.||++|||++|+++|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                     0 000000000000000  000001112234678999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.6e-34  Score=323.35  Aligned_cols=268  Identities=20%  Similarity=0.233  Sum_probs=197.2

Q ss_pred             CCceecCC--CcEEEEEEEe-CCCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          765 ENKLLGMG--SFGSVYKGVL-PDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       765 ~~~~lg~G--~fg~Vy~a~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      +.++||+|  +|++||+++. .+|+.||+|++.....  ...+.+.+|+++++.++||||+++++++.+++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35689999  7899999985 5789999999976532  23456778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc-
Q 039290          840 SNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM-  917 (1049)
Q Consensus       840 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~-  917 (1049)
                      ++|+|.+++... ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.++++|||.+......... 
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999998653 335889999999999999999999   999999999999999999999999999875433211110 


Q ss_pred             -----cccccccccCcccccccCC--CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcc----
Q 039290          918 -----RQTKTLGTIGYMAPEYGRE--GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSIT----  986 (1049)
Q Consensus       918 -----~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----  986 (1049)
                           ......++..|+|||++.+  ..++.++||||+||++|||++|+.||..............+.........    
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence                 0112346778999999875  45889999999999999999999999764332222111111100000000    


Q ss_pred             -hh--------cccccc-------c----ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          987 -EV--------ADANLL-------N----CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       987 -~~--------~~~~~~-------~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                       +.        .+....       .    ............+..+.+++.+||+.||++|||++|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence             00        000000       0    0000011122346689999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.1e-34  Score=312.39  Aligned_cols=251  Identities=25%  Similarity=0.438  Sum_probs=194.6

Q ss_pred             ceecCCCcEEEEEEEeC----CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeee-cCCeeEEEEeccC
Q 039290          767 KLLGMGSFGSVYKGVLP----DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCS-NNDFKALVLEYMS  840 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~-~~~~~~lv~e~~~  840 (1049)
                      +.||+|+||.||+|...    ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    24579999885432 223567888999999999999999999775 4556789999999


Q ss_pred             CCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc---c
Q 039290          841 NGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES---M  917 (1049)
Q Consensus       841 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~---~  917 (1049)
                      +|+|.+++.......++..+..++.|+++|++|||   +.+++||||||+||++++++.+||+|||+++.......   .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            99999999876656778888999999999999999   99999999999999999999999999999975532211   1


Q ss_pred             cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhC-CCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          918 RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                      ......++..|+|||++.+..++.++|||||||++|||++| .+||......+  ......   ..              
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~--~~~~~~---~~--------------  218 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD--ITVYLL---QG--------------  218 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHh---cC--------------
Confidence            11123456789999999888899999999999999999995 55554322111  111110   00              


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~ 1041 (1049)
                        .....+..++..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus       219 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         219 --RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             --CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence              0011112345678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=9.4e-35  Score=326.00  Aligned_cols=237  Identities=27%  Similarity=0.311  Sum_probs=187.3

Q ss_pred             ceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHH-HHhhcCCCceeeEEeeeecCCeeEEEEeccCC
Q 039290          767 KLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECK-VMGSIRHRNLVKIISSCSNNDFKALVLEYMSN  841 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  841 (1049)
                      ++||+|+||.||+|+.. +++.||+|++....   ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999964 68899999987542   122334555554 57888999999999999999999999999999


Q ss_pred             CChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccc
Q 039290          842 GSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK  921 (1049)
Q Consensus       842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~  921 (1049)
                      |+|.+.+.... .+++.++..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||++........ ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~  155 (321)
T cd05603          81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TTST  155 (321)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-cccc
Confidence            99988876543 4788899999999999999999   99999999999999999999999999999875322221 2233


Q ss_pred             cccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCc
Q 039290          922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDF 1001 (1049)
Q Consensus       922 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1049)
                      ..|++.|+|||++.+..++.++||||+||++|||++|..||......+. ...    ....                 ..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~----i~~~-----------------~~  213 (321)
T cd05603         156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM-YDN----ILHK-----------------PL  213 (321)
T ss_pred             ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH-HHH----HhcC-----------------CC
Confidence            5689999999999888899999999999999999999999975321111 110    0000                 00


Q ss_pred             hhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 039290         1002 SAREQCVSSIFSLAMDCTVDLPEKRISMK 1030 (1049)
Q Consensus      1002 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ 1030 (1049)
                      ..+...+.++.+++.+|++.+|.+||++.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            11122345688999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-34  Score=320.56  Aligned_cols=260  Identities=25%  Similarity=0.390  Sum_probs=200.2

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCC---------------CcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEe
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPD---------------GMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIIS  824 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~---------------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~  824 (1049)
                      .+|++.+.||+|+||.||+|...+               ...||+|.++.... .....+.+|++++++++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            478999999999999999987532               23489999875432 23457889999999999999999999


Q ss_pred             eeecCCeeEEEEeccCCCChhhhhhcCC-----------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCee
Q 039290          825 SCSNNDFKALVLEYMSNGSLEKCLYSDN-----------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVL  893 (1049)
Q Consensus       825 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl  893 (1049)
                      ++...+..++||||+++++|.+++....           ..+++.++.+++.|+++|++|||   +.+++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence            9999999999999999999999886432           13678899999999999999999   999999999999999


Q ss_pred             ecCCCceEEecccCceecCCCcccc-ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh--CCCCCCccccccc
Q 039290          894 LNESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT--KKKPTDEIFAGEM  970 (1049)
Q Consensus       894 ~~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~~~~~~~  970 (1049)
                      ++.++.+||+|||++.......... .....++..|+|||+..++.++.++|||||||++|||++  |..||......+.
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            9999999999999997653322111 122345678999999988889999999999999999998  5667765322211


Q ss_pred             hHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          971 SLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                       ..... ......         ...   .....+..++..+.+++.+||+.+|++||+++++++.|+
T Consensus       242 -~~~~~-~~~~~~---------~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         242 -IENTG-EFFRNQ---------GRQ---IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             -HHHHH-Hhhhhc---------ccc---ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence             11110 000000         000   000111224568999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.7e-34  Score=312.29  Aligned_cols=251  Identities=24%  Similarity=0.339  Sum_probs=202.0

Q ss_pred             CCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCC------CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          762 GFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDG------SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      +|+..+.||+|+||+||+|...+++.+|+|.++.....      ..+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            47888999999999999999888999999998654311      235688899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++++|.+++.... .+++..+..++.|++.|++|+|   +.+|+|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            99999999999987654 4789999999999999999999   9999999999999999999999999999987653211


Q ss_pred             -----cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcc
Q 039290          916 -----SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD  990 (1049)
Q Consensus       916 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  990 (1049)
                           ........++..|+|||++.+..++.++||||+||++|||++|..||......+. ......   ....      
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~~~~~~---~~~~------  226 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-MFYIGA---HRGL------  226 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-HHHhhh---ccCC------
Confidence                 1112234578899999999988899999999999999999999999975321111 111000   0000      


Q ss_pred             cccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          991 ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                               ....+..++.++.+++.+||+.+|++||++.|++.+
T Consensus       227 ---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         227 ---------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                     001112345678999999999999999999999864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-34  Score=316.76  Aligned_cols=254  Identities=24%  Similarity=0.399  Sum_probs=203.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC------CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCee
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFK  832 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~  832 (1049)
                      .++|++.+.||+|+||.||+|...      .+..||+|.+.... ......+.+|+.+++.++||||+++++++...+..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            357888999999999999999854      24689999986443 22345788999999999999999999999999999


Q ss_pred             EEEEeccCCCChhhhhhcCC---------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEe
Q 039290          833 ALVLEYMSNGSLEKCLYSDN---------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLS  903 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~  903 (1049)
                      ++||||+++|+|.+++....         ..+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence            99999999999999986432         23678899999999999999999   9999999999999999999999999


Q ss_pred             cccCceecCCCccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccc
Q 039290          904 DFGIAKILGKEESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLL  981 (1049)
Q Consensus       904 DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  981 (1049)
                      |||+++........ ......++..|+|||.+.++.++.++||||+||++||+++ |..||......+  ...+..    
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~~----  235 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--VLKFVI----  235 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH--HHHHHh----
Confidence            99999865433321 1223346778999999988889999999999999999998 888986532211  111111    


Q ss_pred             cCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          982 SCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                      ..               .....+..++.++.+++.+||+.+|++|||+.++++.|+
T Consensus       236 ~~---------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         236 DG---------------GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             cC---------------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            00               001111224678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=7.1e-35  Score=327.45  Aligned_cols=238  Identities=26%  Similarity=0.313  Sum_probs=188.5

Q ss_pred             ceecCCCcEEEEEEEe-CCCcEEEEEEeeccc---CCCHHHHHHHHH-HHhhcCCCceeeEEeeeecCCeeEEEEeccCC
Q 039290          767 KLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAECK-VMGSIRHRNLVKIISSCSNNDFKALVLEYMSN  841 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  841 (1049)
                      +.||+|+||+||+|+. .+|+.||+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999995 478999999997542   122344555554 46778999999999999999999999999999


Q ss_pred             CChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccc
Q 039290          842 GSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK  921 (1049)
Q Consensus       842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~  921 (1049)
                      |+|.+++.... .+++.++..++.||++|++|||   +.||+||||||+||+++.++.+||+|||++....... .....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~  155 (325)
T cd05604          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTT  155 (325)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCccc
Confidence            99998887544 5899999999999999999999   9999999999999999999999999999987532211 12234


Q ss_pred             cccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCc
Q 039290          922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDF 1001 (1049)
Q Consensus       922 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1049)
                      ..|++.|+|||++.+..++.++||||+||++|||++|..||......+.. ....             ...        .
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~-~~~~-------------~~~--------~  213 (325)
T cd05604         156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY-DNIL-------------HKP--------L  213 (325)
T ss_pred             ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH-HHHH-------------cCC--------c
Confidence            56899999999999989999999999999999999999999753211111 1100             000        0


Q ss_pred             hhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 039290         1002 SAREQCVSSIFSLAMDCTVDLPEKRISMKD 1031 (1049)
Q Consensus      1002 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~e 1031 (1049)
                      ..+...+..+.+++.+|++.+|++||++.+
T Consensus       214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         214 VLRPGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence            001123456889999999999999998853

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.5e-34  Score=312.94  Aligned_cols=249  Identities=24%  Similarity=0.370  Sum_probs=201.1

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCC---------HHHHHHHHHHHhhcCCCceeeEEeeeecCCe
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGS---------LESFHAECKVMGSIRHRNLVKIISSCSNNDF  831 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~---------~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~  831 (1049)
                      +|.+.+.||+|+||.||+|... +++.||+|.+.......         .+.+.+|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4778899999999999999854 68899999986543221         2567889999999999999999999999999


Q ss_pred             eEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceec
Q 039290          832 KALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL  911 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~  911 (1049)
                      .++||||+++++|.+++...+ .+++..+..++.|++.|++|+|   +.+++||||+|+||++++++.++|+|||.++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            999999999999999997654 4788899999999999999999   999999999999999999999999999999866


Q ss_pred             CCCcc-----ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcc
Q 039290          912 GKEES-----MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSIT  986 (1049)
Q Consensus       912 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  986 (1049)
                      .....     .......++..|+|||.+.+..++.++||||+||++|+|++|+.||....... ...... .        
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~-~--------  226 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AIFKIG-E--------  226 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HHHHHh-c--------
Confidence            42111     01112347889999999988889999999999999999999999997532111 111000 0        


Q ss_pred             hhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          987 EVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       987 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                                 ......+...+..+.+++.+||+.+|.+||++.|++++
T Consensus       227 -----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         227 -----------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             -----------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence                       00011122356778999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-34  Score=332.12  Aligned_cols=265  Identities=20%  Similarity=0.211  Sum_probs=198.5

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      .+|.+.+.||+|+||.||+|.+. .++.||+|...      ...+.+|++++++++|||||++++++..++..++|||++
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            46999999999999999999965 57889999643      234678999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc-c
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM-R  918 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~-~  918 (1049)
                      . ++|.+++......+++.+++.++.|+++||+|||   ++||+||||||+|||++.++.+||+|||+++........ .
T Consensus       243 ~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~  318 (461)
T PHA03211        243 R-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF  318 (461)
T ss_pred             C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence            5 6898888766667999999999999999999999   999999999999999999999999999999865432211 1


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccc------cchHHHhhhhcc-ccCCcchhccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAG------EMSLKRWVGDSL-LSCSITEVADA  991 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~------~~~~~~~~~~~~-~~~~~~~~~~~  991 (1049)
                      .....||..|+|||++.+..++.++|||||||++|||++|..|+......      .....+.+.... ...........
T Consensus       319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~  398 (461)
T PHA03211        319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS  398 (461)
T ss_pred             ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence            22356899999999999989999999999999999999987764322111      011111111100 00000000000


Q ss_pred             cc--------cc--c-c--ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          992 NL--------LN--C-E--ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       992 ~~--------~~--~-~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .+        ..  . .  ...+........++.+++.+|++.||.+|||+.|++++
T Consensus       399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00        00  0 0  00011111234578899999999999999999999987

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.1e-34  Score=317.82  Aligned_cols=270  Identities=25%  Similarity=0.390  Sum_probs=208.9

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-----CCcEEEEEEeecccCC-CHHHHHHHHHHHhhcCCCceeeEEeeeec--CCee
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-----DGMEIAAKVFHMEFDG-SLESFHAECKVMGSIRHRNLVKIISSCSN--NDFK  832 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~l~~~~~~--~~~~  832 (1049)
                      ..|+..+.||+|+||.||+|++.     ++..||+|+++..... ..+.+.+|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            35777799999999999999853     3678999999765443 45789999999999999999999999877  5578


Q ss_pred             EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecC
Q 039290          833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      ++||||+++++|.+++......+++.++..++.|++.|++|||   +.|++||||||+||+++.++.++++|||.+....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            9999999999999999877667899999999999999999999   9999999999999999999999999999998765


Q ss_pred             CCcccc--ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcc
Q 039290          913 KEESMR--QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD  990 (1049)
Q Consensus       913 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  990 (1049)
                      ......  .....++..|+|||...+..++.++||||+|+++|||++|..|+.........   +.+..........+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~  237 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGIAQGQMIVTRLLE  237 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccccccccccHHHHHH
Confidence            322211  11223456799999998888999999999999999999999997653222111   1000000000000000


Q ss_pred             cccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290          991 ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                       .+.  ...+...+..++.++.+++.+||+.+|++|||+.|++++|+++
T Consensus       238 -~~~--~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         238 -LLK--EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             -HHH--cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence             000  0111222334567899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-34  Score=312.88  Aligned_cols=248  Identities=24%  Similarity=0.419  Sum_probs=195.1

Q ss_pred             ceecCCCcEEEEEEEeC-CCc--EEEEEEeeccc-CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEEEeccCC
Q 039290          767 KLLGMGSFGSVYKGVLP-DGM--EIAAKVFHMEF-DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALVLEYMSN  841 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  841 (1049)
                      +.||+|+||.||+|+.. ++.  .+++|.++... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            36899999999999965 343  46888886433 23346788999999999 799999999999999999999999999


Q ss_pred             CChhhhhhcCC---------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEeccc
Q 039290          842 GSLEKCLYSDN---------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFG  906 (1049)
Q Consensus       842 g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfG  906 (1049)
                      |+|.+++...+               ..+++.++..++.|++.|++|||   +.|++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999986532               24788999999999999999999   9999999999999999999999999999


Q ss_pred             CceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCc
Q 039290          907 IAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSI  985 (1049)
Q Consensus       907 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  985 (1049)
                      ++.....  .........+..|+|||++....++.++|||||||++|||++ |..||......+.  .....   . .  
T Consensus       158 l~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--~~~~~---~-~--  227 (270)
T cd05047         158 LSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--YEKLP---Q-G--  227 (270)
T ss_pred             Cccccch--hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH--HHHHh---C-C--
Confidence            9863221  111111223567999999988889999999999999999997 9999865322111  11000   0 0  


Q ss_pred             chhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 039290          986 TEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIR 1040 (1049)
Q Consensus       986 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~ 1040 (1049)
                                   .+...+..++.++.+++.+||+.+|.+|||++|+++.|+++.
T Consensus       228 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         228 -------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             -------------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                         000111234567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.4e-34  Score=330.52  Aligned_cols=267  Identities=20%  Similarity=0.213  Sum_probs=198.6

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecC------
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNN------  829 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~------  829 (1049)
                      ..++|+..+.||+|+||.||+|... .++.||||++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3568999999999999999999954 68899999987543  23346788899999999999999999987543      


Q ss_pred             CeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCce
Q 039290          830 DFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK  909 (1049)
Q Consensus       830 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~  909 (1049)
                      ...++||||+++ ++.+.+..   .+++.++..++.|+++||+|||   ++||+||||||+||+++.++.+||+|||+++
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            357999999975 67776643   3788899999999999999999   9999999999999999999999999999998


Q ss_pred             ecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccC-Ccchh
Q 039290          910 ILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSC-SITEV  988 (1049)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~  988 (1049)
                      ......  ......++..|+|||++.+..++.++||||+||++|||++|+.||......+. ............ .....
T Consensus       175 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~  251 (364)
T cd07875         175 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMKK  251 (364)
T ss_pred             ccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHh
Confidence            654322  22345689999999999998999999999999999999999999975332211 111110000000 00000


Q ss_pred             cccc------------------cccc--cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          989 ADAN------------------LLNC--EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       989 ~~~~------------------~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ..+.                  ....  .............++.+++.+|++.||++|||++|+++|
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0000                  0000  000000111134568999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.2e-34  Score=314.72  Aligned_cols=254  Identities=23%  Similarity=0.376  Sum_probs=203.9

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC------CCcEEEEEEeecccCC-CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEFDG-SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKA  833 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~  833 (1049)
                      ++|+..+.||+|+||.||+|+.+      +.+.|++|.+...... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            46888899999999999999953      3457999988654333 3567999999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCC--------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecc
Q 039290          834 LVLEYMSNGSLEKCLYSDN--------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDF  905 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df  905 (1049)
                      +||||+++|+|.+++....        ..+++.++..++.|++.|++|||   +.+|+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999987544        15899999999999999999999   999999999999999999999999999


Q ss_pred             cCceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCC
Q 039290          906 GIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCS  984 (1049)
Q Consensus       906 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  984 (1049)
                      |++...............++..|+|||.+.+..++.++||||+|+++|+|++ |..||.......  .........    
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--~~~~~~~~~----  235 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--VLNRLQAGK----  235 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--HHHHHHcCC----
Confidence            9987543332222333456778999999988888999999999999999999 788886532221  111110000    


Q ss_pred             cchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          985 ITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       985 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                                    ..+..+..++..+.+++.+||+.+|++||++.|++++|.
T Consensus       236 --------------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         236 --------------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             --------------cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                          000111234567999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.4e-34  Score=319.11  Aligned_cols=260  Identities=23%  Similarity=0.397  Sum_probs=201.2

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-----------------CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-----------------DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKI  822 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l  822 (1049)
                      ++|++.+.||+|+||.||+|...                 ++..||+|+++... .....++.+|+++++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46889999999999999998632                 23468999987543 2234678999999999999999999


Q ss_pred             EeeeecCCeeEEEEeccCCCChhhhhhcCC----------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCe
Q 039290          823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDN----------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNV  892 (1049)
Q Consensus       823 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NI  892 (1049)
                      ++++...+..++||||+++++|.+++....          ..+++.++..++.|++.|++|||   +.+|+||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence            999999999999999999999999886532          23677889999999999999999   99999999999999


Q ss_pred             eecCCCceEEecccCceecCCCcccc-ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh--CCCCCCcccccc
Q 039290          893 LLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT--KKKPTDEIFAGE  969 (1049)
Q Consensus       893 l~~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~~~~~~  969 (1049)
                      +++.++.++++|||++..+....... .....++..|+|||+...+.++.++||||+||++|||++  |..||......+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            99999999999999998654332211 112334678999998888889999999999999999998  677886532221


Q ss_pred             chHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          970 MSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                      .  ............         .   ....+.+..++..+.+++.+||+.||.+||+++|+++.|+
T Consensus       242 ~--~~~~~~~~~~~~---------~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         242 V--IENTGEFFRDQG---------R---QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             H--HHHHHHHHhhcc---------c---cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            1  110100000000         0   0001111235577899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.9e-34  Score=315.82  Aligned_cols=268  Identities=24%  Similarity=0.289  Sum_probs=200.0

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      +|++.+.||+|+||.||+|+.. ++..||+|+++...  ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999964 78899999986543  22346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC--CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          839 MSNGSLEKCLYSDN--YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ++ ++|.+++....  ..+++.+++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            97 58888876432  46899999999999999999999   99999999999999999999999999999976543321


Q ss_pred             ccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcc--ccCCc---chh--
Q 039290          917 MRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSL--LSCSI---TEV--  988 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~---~~~--  988 (1049)
                       ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+..... .....  ....+   ...  
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRI-FRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-HHHhCCCChhhhhcchhhHH
Confidence             1223456889999998765 45788999999999999999999999753221111100 00000  00000   000  


Q ss_pred             cccccccccccC-chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          989 ADANLLNCEEND-FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       989 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ............ .......+.++.+++.+|++.||++|||+.+++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            000000000000 00112256778899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.5e-34  Score=315.59  Aligned_cols=250  Identities=22%  Similarity=0.304  Sum_probs=200.8

Q ss_pred             CCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCC---CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          763 FSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDG---SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      |+..+.||+|+||.||+|... +++.||+|.+......   ..+.+.+|+.++++++|++++++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677789999999999999954 7889999998654321   234577899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          839 MSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      +++++|.+++...+ ..+++.++..++.|++.|++|||   +.+|+||||||+||++++++.++|+|||++........ 
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  157 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-  157 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence            99999999886433 35889999999999999999999   99999999999999999999999999999876543222 


Q ss_pred             cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccccc
Q 039290          918 RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE  997 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1049)
                       .....|+..|+|||++.+..++.++||||+||++|||++|+.||........ ......          .... .    
T Consensus       158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~~~~~~----------~~~~-~----  220 (285)
T cd05630         158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVER----------LVKE-V----  220 (285)
T ss_pred             -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-HHHHHh----------hhhh-h----
Confidence             2234689999999999988999999999999999999999999975322110 001000          0000 0    


Q ss_pred             ccCchhhHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 039290          998 ENDFSAREQCVSSIFSLAMDCTVDLPEKRIS-----MKDVANR 1035 (1049)
Q Consensus       998 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~ell~~ 1035 (1049)
                        ....+..++.++.+++.+||+.||++|||     ++|+++|
T Consensus       221 --~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         221 --QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             --hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence              00111234567899999999999999999     8899885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-35  Score=294.84  Aligned_cols=272  Identities=22%  Similarity=0.313  Sum_probs=209.1

Q ss_pred             cHHHHHHHhcCCCCCceecCCCcEEEEEEE-eCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcC-CCceeeEEeeeecC
Q 039290          752 SYQDLLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR-HRNLVKIISSCSNN  829 (1049)
Q Consensus       752 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~a~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~  829 (1049)
                      .+++..+-++     +.||+|+|+.|--+. ..+|.+||||++.+.......++.+|++++.+.+ |+||++++++|+++
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            3566666655     689999999999998 6799999999998775566789999999999884 99999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCC---CceEEeccc
Q 039290          830 DFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES---MVGHLSDFG  906 (1049)
Q Consensus       830 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~---~~~kl~DfG  906 (1049)
                      +..|+|||.+.||.|...|.+... +++.++.++..+|+.||.|||   .+||.|||+||+||+-...   ..||||||.
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~~~-F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD  224 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKRKH-FNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFD  224 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHhhh-ccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccc
Confidence            999999999999999999987665 899999999999999999999   9999999999999998643   468999998


Q ss_pred             CceecCC------CccccccccccccCcccccccC-----CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHh
Q 039290          907 IAKILGK------EESMRQTKTLGTIGYMAPEYGR-----EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRW  975 (1049)
Q Consensus       907 la~~~~~------~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~  975 (1049)
                      ++.-..-      .......+.+|+..|||||+..     ...|+.++|.||+|||+|-|+.|.+||.+....+--+   
T Consensus       225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW---  301 (463)
T KOG0607|consen  225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW---  301 (463)
T ss_pred             cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc---
Confidence            8754321      1122334567899999999642     2468899999999999999999999998765433221   


Q ss_pred             hhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          976 VGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       976 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .....=..-...++...-....+-....+...+.+..+++...+..|+.+|.++.+++.+
T Consensus       302 drGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  302 DRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             cCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence            111000000001111110000111112235577888999999999999999999999874

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6e-34  Score=314.51  Aligned_cols=268  Identities=22%  Similarity=0.251  Sum_probs=202.8

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      ++|+..+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|++++++++|||++++++++.+.+..++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888999999999999999965 68999999986543  2234567899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      |++++.+..++.... .+++..+..++.|++.|++|||   +.+++||||||+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07847          81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-  155 (286)
T ss_pred             ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence            999988887765443 4899999999999999999999   99999999999999999999999999999987644321 


Q ss_pred             cccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHH--HhhhhccccCCcchhcc----
Q 039290          918 RQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK--RWVGDSLLSCSITEVAD----  990 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~----  990 (1049)
                      ......++..|+|||++.+ ..++.++||||+|+++|||++|+.||.+....+....  ...+....  ...+..+    
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  233 (286)
T cd07847         156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIP--RHQQIFSTNQF  233 (286)
T ss_pred             cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh--HHhhhcccccc
Confidence            1223456789999998865 5578999999999999999999999975433221111  00000000  0000000    


Q ss_pred             --cccccccccCc---hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          991 --ANLLNCEENDF---SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       991 --~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                        ....+......   ......+..+.+++.+||+.+|++||++.|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence              00000000000   0112345778999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-34  Score=313.48  Aligned_cols=248  Identities=26%  Similarity=0.336  Sum_probs=204.5

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      ++|+..+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|+++++.++|||++++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36888899999999999999954 68899999987553 33456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      +++++|.+++...  .+++.+++.++.|++.|++|+|   +.+++||||+|+||++++++.++++|||++........ .
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~  154 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-K  154 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-c
Confidence            9999999998765  5899999999999999999999   99999999999999999999999999999987754321 2


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                      .....+++.|+|||++.+..++.++||||+|+++|||++|..||......+......      ..         .    .
T Consensus       155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~------~~---------~----~  215 (274)
T cd06609         155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP------KN---------N----P  215 (274)
T ss_pred             cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh------hc---------C----C
Confidence            233467889999999988889999999999999999999999997532211110000      00         0    0


Q ss_pred             cCchhhHH-HHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          999 NDFSAREQ-CVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       999 ~~~~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                        ...... ++.++.+++.+||..+|++|||+++++++
T Consensus       216 --~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         216 --PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             --CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence              000011 45678999999999999999999999876

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.7e-34  Score=317.45  Aligned_cols=255  Identities=27%  Similarity=0.455  Sum_probs=202.8

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC------CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCee
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFK  832 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~  832 (1049)
                      .++|+..+.||+|+||.||+|...      ++..||+|+++.... ....++.+|+.++++++||||+++++++.+++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            457888999999999999999853      467899999875432 2346788999999999999999999999999999


Q ss_pred             EEEEeccCCCChhhhhhcCC---------------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCC
Q 039290          833 ALVLEYMSNGSLEKCLYSDN---------------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSN  891 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N  891 (1049)
                      ++||||+++|+|.+++....                     ..+++.+++.++.|++.|++|+|   +++++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence            99999999999999986422                     24678889999999999999999   9999999999999


Q ss_pred             eeecCCCceEEecccCceecCCCccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCcccccc
Q 039290          892 VLLNESMVGHLSDFGIAKILGKEESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGE  969 (1049)
Q Consensus       892 Il~~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~  969 (1049)
                      |++++++.++|+|||.+......... .......+..|+|||.+.+..++.++||||+||++|||++ |..||......+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999998765332211 1122234667999999988899999999999999999998 878886532221


Q ss_pred             chHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 039290          970 MSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVR 1038 (1049)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~ 1038 (1049)
                      .  .....            +...       ...+..++.++.+++.+|++.+|++|||+.|+++.|++
T Consensus       241 ~--~~~~~------------~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 V--IYYVR------------DGNV-------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             H--HHHHh------------cCCC-------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            1  11110            0000       01112345679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=8.6e-34  Score=318.06  Aligned_cols=193  Identities=21%  Similarity=0.301  Sum_probs=159.9

Q ss_pred             CceecCCCcEEEEEEEeC---CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeec--CCeeEEEEeccC
Q 039290          766 NKLLGMGSFGSVYKGVLP---DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSN--NDFKALVLEYMS  840 (1049)
Q Consensus       766 ~~~lg~G~fg~Vy~a~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~  840 (1049)
                      .++||+|+||+||+|+..   +++.||+|.+...  .....+.+|++++++++||||+++++++..  +...++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            368999999999999854   5678999998643  234567899999999999999999998854  456889999996


Q ss_pred             CCChhhhhhcC--------CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeee----cCCCceEEecccCc
Q 039290          841 NGSLEKCLYSD--------NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL----NESMVGHLSDFGIA  908 (1049)
Q Consensus       841 ~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~----~~~~~~kl~DfGla  908 (1049)
                      + +|.+++...        ...+++..++.++.|++.|++|||   +.||+||||||+||++    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 887776432        125888999999999999999999   9999999999999999    45679999999999


Q ss_pred             eecCCCcc--ccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCc
Q 039290          909 KILGKEES--MRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDE  964 (1049)
Q Consensus       909 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~  964 (1049)
                      +.......  .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            87643321  12234568999999998876 4589999999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4.8e-34  Score=315.29  Aligned_cols=268  Identities=23%  Similarity=0.281  Sum_probs=205.6

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      +|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788899999999999999964 78999999987654  33456889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      + +++|.+++......+++.+++.++.|+++|++|||   +.+++|+||||+||+++.++.++++|||.+..........
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  156 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL  156 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence            9 99999998776677999999999999999999999   9999999999999999999999999999998765433222


Q ss_pred             ccccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCC---cc---hhccc
Q 039290          919 QTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCS---IT---EVADA  991 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~---~~~~~  991 (1049)
                      .....++..|+|||++.+. .++.++||||+||+++||++|.+||......+. ...... ......   ..   +..+.
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ-LAIVFR-TLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH-HHHHHH-HcCCCChHHHhhccCcchh
Confidence            3345688899999987654 468999999999999999999888765332211 111111 000000   00   00000


Q ss_pred             ccccccccC---c-hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          992 NLLNCEEND---F-SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       992 ~~~~~~~~~---~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .........   . ....+.+.++.+++.+|++.+|++|||+++++.|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000000000   0 0112345789999999999999999999999876

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=9.8e-34  Score=309.62  Aligned_cols=251  Identities=22%  Similarity=0.315  Sum_probs=190.6

Q ss_pred             ceecCCCcEEEEEEEeCC---CcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCC
Q 039290          767 KLLGMGSFGSVYKGVLPD---GMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNG  842 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  842 (1049)
                      +.||+|+||.||+|...+   +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998643   45799998865442 23357888999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCC----CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc-
Q 039290          843 SLEKCLYSDN----YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM-  917 (1049)
Q Consensus       843 ~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~-  917 (1049)
                      +|.+++....    ...++..+..++.|+++|++|||   +++++||||||+||+++.++.+|++|||.+......... 
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999987532    24567788899999999999999   999999999999999999999999999998754332211 


Q ss_pred             cccccccccCcccccccCCC-------CcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhc
Q 039290          918 RQTKTLGTIGYMAPEYGREG-------KVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA  989 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~~-------~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  989 (1049)
                      ......++..|+|||++...       .++.++||||+|+++|||++ |+.||......+.....+.+...      ...
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------~~~  231 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL------KLP  231 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC------CCC
Confidence            11224467889999988642       35789999999999999996 99999754332221111110000      000


Q ss_pred             ccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          990 DANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                      .+          ......+..+.+++.+|| .+|++|||++||++.|+
T Consensus       232 ~~----------~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         232 KP----------RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CC----------ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            00          001123456788999999 58999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=8e-34  Score=308.18  Aligned_cols=249  Identities=23%  Similarity=0.342  Sum_probs=201.1

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeec-CCeeEEEEe
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSN-NDFKALVLE  837 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~-~~~~~lv~e  837 (1049)
                      +|++.+.||+|+||.||+|... +++.||+|.+....  ....+.+.+|++++++++|||++++++.+.. +...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4888999999999999999954 67889999986543  2335678899999999999999999998764 446789999


Q ss_pred             ccCCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          838 YMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      |+++++|.+++... ...+++.+++.++.|++.|++++|   +.||+||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            99999999988764 345899999999999999999999   99999999999999999999999999999987643322


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                       ......+++.|+|||++.+..++.++||||+|++++||++|+.||.......... ....     ...           
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~-~~~~-----~~~-----------  219 (257)
T cd08223         158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY-RIIE-----GKL-----------  219 (257)
T ss_pred             -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHh-----cCC-----------
Confidence             2233457889999999999899999999999999999999999986432111111 1100     000           


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                          ...+...+..+.+++.+|++.+|++||++.+++++
T Consensus       220 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         220 ----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                01112345678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.9e-34  Score=316.65  Aligned_cols=268  Identities=22%  Similarity=0.267  Sum_probs=200.8

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      +|+..+.||+|+||.||+|+.. +|+.||+|+++...  ......+.+|++++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999964 78899999987543  22345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      +++ +|.+++......+++..++.++.||++|++|||   +.+|+||||||+||+++.++.+||+|||++........ .
T Consensus        81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~  155 (284)
T cd07839          81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-C  155 (284)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-C
Confidence            974 888877765566899999999999999999999   99999999999999999999999999999986543221 1


Q ss_pred             ccccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCC---c---chhccc
Q 039290          919 QTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCS---I---TEVADA  991 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~---~~~~~~  991 (1049)
                      .....++..|+|||++.+. .++.++||||+||++|||++|..|+......+......... .....   +   ....+.
T Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL-LGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHH-hCCCChHHhHHhhhcccc
Confidence            2234568899999987664 46899999999999999999998864322222111111100 00000   0   000000


Q ss_pred             ccccccccC---chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          992 NLLNCEEND---FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       992 ~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .........   .+.....+.++.+++.+|++.||.+|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            000000000   01112356788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4e-34  Score=329.22  Aligned_cols=266  Identities=19%  Similarity=0.156  Sum_probs=200.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC---CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP---DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ..+|.+.+.||+|+||.||+|...   .+..||+|.+...     ....+|++++++++||||+++++++...+..++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            357999999999999999999743   4578999987643     34568999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      |++. ++|.+++.. ...+++.+++.++.|++.||+|||   ++||+||||||+||+++.++.++|+|||++........
T Consensus       166 e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        166 PKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             hhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            9996 588888843 345899999999999999999999   99999999999999999999999999999986643322


Q ss_pred             -ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCcccccc--chHHHhhhhccccCCcc-------
Q 039290          917 -MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGE--MSLKRWVGDSLLSCSIT-------  986 (1049)
Q Consensus       917 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~-------  986 (1049)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.....  ..+....... ......       
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~-~~~~~~~~~~~~~  319 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCM-QVHPLEFPQNGST  319 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHh-ccCccccCCccch
Confidence             22234578999999999998899999999999999999999999986533221  1111111100 000000       


Q ss_pred             ---hhccccccc-cc---ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          987 ---EVADANLLN-CE---ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       987 ---~~~~~~~~~-~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                         +........ ..   ..........+.++.+++.+|++.||++|||+.|++.+-
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p  376 (392)
T PHA03207        320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP  376 (392)
T ss_pred             hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence               000000000 00   000000112346788999999999999999999999873

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-34  Score=326.29  Aligned_cols=270  Identities=21%  Similarity=0.260  Sum_probs=199.5

Q ss_pred             HHHHHhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecC--
Q 039290          755 DLLRATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNN--  829 (1049)
Q Consensus       755 ~~~~~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--  829 (1049)
                      ..+...++|++.+.||+|+||.||+|.. .+++.||+|++.....  .....+.+|++++++++||||+++++++...  
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07878           9 TVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS   88 (343)
T ss_pred             HHhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence            3445567899999999999999999995 4788999999875432  2345677899999999999999999987543  


Q ss_pred             ----CeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecc
Q 039290          830 ----DFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDF  905 (1049)
Q Consensus       830 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df  905 (1049)
                          ...++++|++ +++|.+++...  .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          89 IENFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             ccccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCC
Confidence                3568999998 67998877543  4899999999999999999999   999999999999999999999999999


Q ss_pred             cCceecCCCccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccC-
Q 039290          906 GIAKILGKEESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSC-  983 (1049)
Q Consensus       906 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-  983 (1049)
                      |++......    .....+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ....+........ 
T Consensus       163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~  237 (343)
T cd07878         163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIMEVVGTPSP  237 (343)
T ss_pred             ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCCH
Confidence            999865432    223468999999999876 568899999999999999999999996532111 1111111000000 


Q ss_pred             -Ccchhcc-------cccccccccCc-hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          984 -SITEVAD-------ANLLNCEENDF-SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       984 -~~~~~~~-------~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                       ....+..       ..+...+.... .......+.+.+++.+|++.||.+|||++|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             0000000       00000000000 0001123457899999999999999999999987

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.3e-34  Score=323.45  Aligned_cols=265  Identities=22%  Similarity=0.240  Sum_probs=196.4

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      ...+|++.+.||+|+||.||+|+.. +++.||+|+....      ....|+.++++++||||+++++++.+.+..++|||
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3457999999999999999999965 5778999975422      33568999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      ++. ++|.+++......+++.++..++.||+.||+|||   ++||+||||||+||+++.++.+||+|||++.......  
T Consensus       138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--  211 (357)
T PHA03209        138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--  211 (357)
T ss_pred             ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence            995 5888888776677999999999999999999999   9999999999999999999999999999997532211  


Q ss_pred             cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCC-Cccccc-cc-------hHHHhhhhc-cccCCcc-
Q 039290          918 RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPT-DEIFAG-EM-------SLKRWVGDS-LLSCSIT-  986 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~-~~~~~~-~~-------~~~~~~~~~-~~~~~~~-  986 (1049)
                      ......||..|+|||++.+..++.++||||+||++|||+++..|+ ...... +.       ......... ....... 
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  291 (357)
T PHA03209        212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR  291 (357)
T ss_pred             ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence            223356899999999999989999999999999999999965554 322111 00       001100000 0000000 


Q ss_pred             ----hh----cc-cccccccccCch--hhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          987 ----EV----AD-ANLLNCEENDFS--AREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       987 ----~~----~~-~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                          ..    .+ ......+..++.  .....+.+..++|.+||+.||++|||+.|+++|
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence                00    00 000000000000  011334567789999999999999999999986

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.7e-34  Score=347.09  Aligned_cols=255  Identities=20%  Similarity=0.255  Sum_probs=197.1

Q ss_pred             HHhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeec--CCee
Q 039290          758 RATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSN--NDFK  832 (1049)
Q Consensus       758 ~~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--~~~~  832 (1049)
                      ...++|.+.+.||+|+||+||+|+.. ++..||+|++....  ......+..|+.+++.++|||||+++++|.+  ...+
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            34568999999999999999999964 57789999886543  2235678899999999999999999998854  4578


Q ss_pred             EEEEeccCCCChhhhhhcC---CCccCHHHHHHHHHHHHHHHHHhHccC----CCCeEEcCCCCCCeeecC---------
Q 039290          833 ALVLEYMSNGSLEKCLYSD---NYFLDILQRLKIMIDVASALEYLHFGY----STPIVHCDIKPSNVLLNE---------  896 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~----~~~ivH~Dlkp~NIl~~~---------  896 (1049)
                      |+||||+++|+|.+++...   ...+++..++.|+.||+.||+|||...    ..+||||||||+|||++.         
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            9999999999999988653   235899999999999999999999211    145999999999999964         


Q ss_pred             --------CCceEEecccCceecCCCccccccccccccCcccccccCC--CCcCcccchHHHHHHHHHHHhCCCCCCccc
Q 039290          897 --------SMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE--GKVSRKCDVYSYGIMLMETFTKKKPTDEIF  966 (1049)
Q Consensus       897 --------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~  966 (1049)
                              .+.+||+|||++.......  ......||+.|+|||++.+  ..++.++|||||||++|||++|..||....
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                    3458999999998654322  1234568999999998854  458899999999999999999999996422


Q ss_pred             cccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          967 AGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       967 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ..    ..+........              .  . .....+.++.++|.+||+.+|.+||++.|++.+
T Consensus       248 ~~----~qli~~lk~~p--------------~--l-pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        248 NF----SQLISELKRGP--------------D--L-PIKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             cH----HHHHHHHhcCC--------------C--C-CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            11    11111000000              0  0 001235678999999999999999999999965

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6.8e-34  Score=320.96  Aligned_cols=257  Identities=25%  Similarity=0.432  Sum_probs=204.1

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC--------CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCC
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP--------DGMEIAAKVFHMEF-DGSLESFHAECKVMGSI-RHRNLVKIISSCSNND  830 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~  830 (1049)
                      .+|++.+.||+|+||.||+|+..        .+..||+|.++... ....+++.+|+++++++ +||||+++++++...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46889999999999999999742        12368999887543 22356789999999999 7999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhhcCC---------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec
Q 039290          831 FKALVLEYMSNGSLEKCLYSDN---------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN  895 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~  895 (1049)
                      ..+++|||+++|+|.+++....               ..+++.++.+++.|++.|++|||   ++||+||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence            9999999999999999986532               24778899999999999999999   99999999999999999


Q ss_pred             CCCceEEecccCceecCCCcccc-ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHH
Q 039290          896 ESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLK  973 (1049)
Q Consensus       896 ~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~  973 (1049)
                      .++.+||+|||+++......... .....++..|+|||++.+..++.++||||+||++|||++ |..||......+.  .
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~  246 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL--F  246 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH--H
Confidence            99999999999998664322111 111223567999999998899999999999999999998 8888865322111  1


Q ss_pred             HhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 039290          974 RWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041 (1049)
Q Consensus       974 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~ 1041 (1049)
                      ....   ..                .....+..++.++.+++.+||+.+|++||++.|++++|+++..
T Consensus       247 ~~~~---~~----------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         247 KLLK---EG----------------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             HHHH---cC----------------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            1000   00                0011112345678999999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.1e-34  Score=314.89  Aligned_cols=239  Identities=26%  Similarity=0.376  Sum_probs=190.0

Q ss_pred             ceecCCCcEEEEEEEeCC--------CcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          767 KLLGMGSFGSVYKGVLPD--------GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      +.||+|+||.||+|....        ..+||+|.+........+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            369999999999998532        234888887655444456788999999999999999999999998899999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCc--------eEEecccCcee
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMV--------GHLSDFGIAKI  910 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~--------~kl~DfGla~~  910 (1049)
                      +++|+|.+++...+..+++..+..++.||+.|++|||   +++|+||||||+||+++.++.        ++++|||.+..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            9999999999877667899999999999999999999   999999999999999987654        69999999875


Q ss_pred             cCCCccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCC-CCCCccccccchHHHhhhhccccCCcchh
Q 039290          911 LGKEESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKK-KPTDEIFAGEMSLKRWVGDSLLSCSITEV  988 (1049)
Q Consensus       911 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  988 (1049)
                      ....     ....++..|+|||++.+ ..++.++||||+||++|||++|. .|+.......  .......          
T Consensus       158 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~----------  220 (258)
T cd05078         158 VLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--KLQFYED----------  220 (258)
T ss_pred             cCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--HHHHHHc----------
Confidence            5332     22456788999999876 45789999999999999999985 5554321111  0110000          


Q ss_pred             cccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          989 ADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                                 +...+.....++.+++.+||+.+|++|||++++++.|
T Consensus       221 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         221 -----------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             -----------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                       0001111235689999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-34  Score=311.75  Aligned_cols=252  Identities=23%  Similarity=0.331  Sum_probs=201.1

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcC-CCceeeEEeeeecCCeeEEEEe
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIR-HRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      ..|++.++||+|+-+.||++...+.+.||+|++....  .....-|..|+..+.+++ |.+||++++|-..++.+|+|||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            3588999999999999999998888899988775432  344678999999999995 8999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc-
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES-  916 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~-  916 (1049)
                      |=+. +|.+++.........-.++.+..|++.|+.++|   .+||||.||||.|+++-. |.+||+|||+|..+..+.. 
T Consensus       441 ~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTs  515 (677)
T KOG0596|consen  441 CGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTS  515 (677)
T ss_pred             cccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCccccc
Confidence            8754 999999887765554588889999999999999   999999999999999875 5899999999998865543 


Q ss_pred             ccccccccccCcccccccCCC-----------CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCc
Q 039290          917 MRQTKTLGTIGYMAPEYGREG-----------KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSI  985 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  985 (1049)
                      ......+||+.||+||.+...           +.++++||||+|||+|+|+.|+.||+....      .|.+       +
T Consensus       516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------~~aK-------l  582 (677)
T KOG0596|consen  516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------QIAK-------L  582 (677)
T ss_pred             eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------HHHH-------H
Confidence            344567899999999987542           256899999999999999999999986321      1222       1


Q ss_pred             chhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          986 TEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       986 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ..+.++...-..+.   .+.  ..++.++|+.|+.+||.+|||+.|+++|
T Consensus       583 ~aI~~P~~~Iefp~---~~~--~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  583 HAITDPNHEIEFPD---IPE--NDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             HhhcCCCccccccC---CCC--chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            22223221111111   011  1228999999999999999999999986

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=9.8e-34  Score=313.49  Aligned_cols=272  Identities=22%  Similarity=0.324  Sum_probs=201.1

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++.+|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+++++.++|+||+++++++.+++..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            456899999999999999999985 478899999987543 333456788999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+. +++.+++......+.+.++..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9996 6777776655556788889999999999999999   99999999999999999999999999999876433221


Q ss_pred             ccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHH-hhhhccccCC-------cch
Q 039290          917 MRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR-WVGDSLLSCS-------ITE  987 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~-------~~~  987 (1049)
                      . .....++..|+|||++.+ ..++.++||||+||++|||++|..||+........... |.........       ..+
T Consensus       159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07870         159 T-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN  237 (291)
T ss_pred             C-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence            1 223456889999998865 35788999999999999999999999754322111111 1100000000       000


Q ss_pred             hcccccccccccCchh---hHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          988 VADANLLNCEENDFSA---REQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       988 ~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ........+.......   ....+..+.+++.+|+..||++|||++|++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            0000000000000000   00124578899999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.3e-33  Score=308.40  Aligned_cols=256  Identities=27%  Similarity=0.338  Sum_probs=205.7

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      ++|++.+.||+|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|||++++++.+..++..++|||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46889999999999999999954 68899999986543 23457889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC--CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          839 MSNGSLEKCLYSDN--YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      +++++|.+++....  ..+++..+..++.|++.|++|||   +.||+||||+|+||++++++.++++|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            99999999987542  35899999999999999999999   99999999999999999999999999999876654322


Q ss_pred             c---cccccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccc
Q 039290          917 M---RQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       917 ~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      .   ......++..|+|||++... .++.++|+||+||++|||++|+.||......+.. ......  ....        
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~-~~~~~~--~~~~--------  226 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL-MLTLQN--DPPS--------  226 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH-HHHhcC--CCCC--------
Confidence            1   12334678899999998776 7899999999999999999999999764332211 111110  0000        


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .    . ........+..+.+++.+||+.+|++||++++++++
T Consensus       227 ~----~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         227 L----E-TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             c----C-CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            0    0 000012456778999999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.9e-34  Score=337.10  Aligned_cols=269  Identities=20%  Similarity=0.211  Sum_probs=194.0

Q ss_pred             HHHHhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCC------CceeeEEeeeec
Q 039290          756 LLRATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRH------RNLVKIISSCSN  828 (1049)
Q Consensus       756 ~~~~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------pniv~l~~~~~~  828 (1049)
                      +....++|++.++||+|+||+||+|... .++.||||+++... ....++..|+++++.++|      ++++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3344678999999999999999999954 67889999986432 223456667777777754      458889888865


Q ss_pred             C-CeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCC-CCeEEcCCCCCCeeecCCC--------
Q 039290          829 N-DFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS-TPIVHCDIKPSNVLLNESM--------  898 (1049)
Q Consensus       829 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~~--------  898 (1049)
                      . ++.++|||++ +++|.+++...+ .+++.++..|+.||+.||+|||   + .|||||||||+|||++.++        
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccc
Confidence            4 5789999998 668888887654 4899999999999999999999   7 5999999999999998665        


Q ss_pred             --------ceEEecccCceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccc
Q 039290          899 --------VGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEM  970 (1049)
Q Consensus       899 --------~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~  970 (1049)
                              .+||+|||.+.....    .....+||+.|+|||++.+..++.++||||+||++|||++|+.||......+.
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~  353 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH  353 (467)
T ss_pred             cccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                    499999998764321    22346789999999999999999999999999999999999999975332111


Q ss_pred             hH--H--------HhhhhccccCCcchhcccc--ccccc---------ccCchhhHHHHHHHHHHHhhccccCCCCCCCH
Q 039290          971 SL--K--------RWVGDSLLSCSITEVADAN--LLNCE---------ENDFSAREQCVSSIFSLAMDCTVDLPEKRISM 1029 (1049)
Q Consensus       971 ~~--~--------~~~~~~~~~~~~~~~~~~~--~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~ 1029 (1049)
                      ..  .        .|....... ...+..+..  +..+.         ..+..........+.+|+.+|+++||++|||+
T Consensus       354 ~~~i~~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta  432 (467)
T PTZ00284        354 LHLMEKTLGRLPSEWAGRCGTE-EARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA  432 (467)
T ss_pred             HHHHHHHcCCCCHHHHhhccch-hHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence            10  0        011000000 000000000  00000         00000001123567899999999999999999


Q ss_pred             HHHHHH
Q 039290         1030 KDVANR 1035 (1049)
Q Consensus      1030 ~ell~~ 1035 (1049)
                      +|+++|
T Consensus       433 ~e~L~H  438 (467)
T PTZ00284        433 RQMTTH  438 (467)
T ss_pred             HHHhcC
Confidence            999986

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.3e-33  Score=306.70  Aligned_cols=250  Identities=30%  Similarity=0.564  Sum_probs=202.4

Q ss_pred             CCCCceecCCCcEEEEEEEeCC-----CcEEEEEEeecccCC-CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          763 FSENKLLGMGSFGSVYKGVLPD-----GMEIAAKVFHMEFDG-SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      +++.+.||+|+||.||+|+..+     +..||+|+++..... ..+.+.+|+++++.++||||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3566889999999999999653     478999999765433 4678999999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCc-cCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          837 EYMSNGSLEKCLYSDNYF-LDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      ||+++++|.+++...... +++.++..++.|++.|++|||   +.+++||||||+||++++++.++++|||++.......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999998765544 899999999999999999999   9999999999999999999999999999998765443


Q ss_pred             cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                      ........++..|+|||...+..++.++||||+|++++||++ |..||......  ...+......              
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~--~~~~~~~~~~--------------  221 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE--EVLEYLKKGY--------------  221 (258)
T ss_pred             ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcCC--------------
Confidence            222212336789999999988889999999999999999998 78887652111  1111110000              


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                           ....+..++.++.+++.+|+..+|++|||+.|+++.|
T Consensus       222 -----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 -----RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -----CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                 0011122567799999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.2e-33  Score=308.49  Aligned_cols=250  Identities=25%  Similarity=0.332  Sum_probs=197.2

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC-----CCHHHHHHHHHHHhhcCCCceeeEEeeeec--CCee
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD-----GSLESFHAECKVMGSIRHRNLVKIISSCSN--NDFK  832 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--~~~~  832 (1049)
                      .+|+..+.||+|+||.||+|.. .++..||+|++.....     .....+.+|+.++++++||||+++++++.+  .+..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            3688999999999999999986 4688999999865431     123568889999999999999999998865  3577


Q ss_pred             EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecC
Q 039290          833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      ++++||+++++|.+++.... .+++..++.++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            89999999999999987654 3788999999999999999999   9999999999999999999999999999987653


Q ss_pred             CCcc--ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcc
Q 039290          913 KEES--MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD  990 (1049)
Q Consensus       913 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  990 (1049)
                      ....  .......++..|+|||++.+..++.++||||+||++|||++|+.||......+... .    ....        
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~-~----~~~~--------  224 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF-K----IATQ--------  224 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH-H----HhcC--------
Confidence            2111  11122457889999999988889999999999999999999999997532111110 0    0000        


Q ss_pred             cccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          991 ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                             ......+....+.+.+++ +||..+|++||+++|+++|
T Consensus       225 -------~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         225 -------PTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             -------CCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence                   001112233455677787 6888999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-33  Score=306.94  Aligned_cols=237  Identities=26%  Similarity=0.416  Sum_probs=190.3

Q ss_pred             ceecCCCcEEEEEEEeCCCc-----------EEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          767 KLLGMGSFGSVYKGVLPDGM-----------EIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      +.||+|+||.||+|...+..           .|++|.+...... ...+.+|+.+++.++||||+++++++.. +..++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999975433           5777877654333 6788999999999999999999999988 778999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC-------ceEEecccCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM-------VGHLSDFGIA  908 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-------~~kl~DfGla  908 (1049)
                      |||+++|+|.+++......+++..+..++.|++.|++|||   +++|+||||||+||+++.++       .+|++|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            9999999999999876656899999999999999999999   99999999999999999877       7999999999


Q ss_pred             eecCCCccccccccccccCcccccccCCC--CcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCc
Q 039290          909 KILGKEESMRQTKTLGTIGYMAPEYGREG--KVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSI  985 (1049)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  985 (1049)
                      .....     .....++..|+|||++...  .++.++||||+|+++|||++ |..||......  ....+..   ..   
T Consensus       156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~~~~~---~~---  222 (259)
T cd05037         156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EKERFYQ---DQ---  222 (259)
T ss_pred             ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hHHHHHh---cC---
Confidence            86543     1223467789999998776  78999999999999999999 57777653211  1111110   00   


Q ss_pred             chhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          986 TEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       986 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                            ...       ..  .....+.+++.+||..+|++|||+.|+++.|
T Consensus       223 ------~~~-------~~--~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         223 ------HRL-------PM--PDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             ------CCC-------CC--CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                  000       00  0115788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.5e-34  Score=310.97  Aligned_cols=252  Identities=25%  Similarity=0.297  Sum_probs=205.6

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      +|+..+.||+|+||.||+|... +++.||+|.+..... ...+++.+|++++++++||||+++++++...+..++|+||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5777889999999999999965 688999999876542 33467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCC-CCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS-TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      ++++|.+++......+++..+.+++.|+++|++|+|   + .+++||||||+||++++++.++|+|||.+......... 
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-  157 (265)
T cd06605          82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-  157 (265)
T ss_pred             CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-
Confidence            999999999876567899999999999999999999   8 99999999999999999999999999998765322211 


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                        ...++..|+|||++.+..++.++||||+|+++|+|++|+.||.....................               
T Consensus       158 --~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------  220 (265)
T cd06605         158 --TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP---------------  220 (265)
T ss_pred             --cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC---------------
Confidence              156788999999998889999999999999999999999998754322121111111111000               


Q ss_pred             cCchhhH-HHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          999 NDFSARE-QCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       999 ~~~~~~~-~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                       ....+. ..+.++.++|.+||..+|++|||+.|++.+
T Consensus       221 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         221 -PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             -CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence             001111 156779999999999999999999999876

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.1e-34  Score=308.29  Aligned_cols=248  Identities=25%  Similarity=0.319  Sum_probs=202.2

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC-----CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD-----GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      +|+..+.||+|+||.||+|... +++.|++|.+.....     ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4778899999999999999965 789999999865432     2346788999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      +||+++++|.+++.... .+++..+..++.|++.|++|||   +.||+|+||+|+||+++.++.+||+|||.+.......
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            99999999999987654 4789999999999999999999   9999999999999999999999999999988654332


Q ss_pred             cccccccccccCcccccccCCCC-cCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                        ......++..|+|||.+.... ++.++|+||+|+++|+|++|+.||......+.. ..+..    ..           
T Consensus       157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~----~~-----------  218 (258)
T cd06632         157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV-FKIGR----SK-----------  218 (258)
T ss_pred             --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH-HHHHh----cc-----------
Confidence              223355788999999887766 899999999999999999999998763311111 11000    00           


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                          .....+...+.++.+++.+||+.+|.+||++++++.+
T Consensus       219 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         219 ----ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             ----cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence                0011112345678999999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-33  Score=312.53  Aligned_cols=271  Identities=21%  Similarity=0.265  Sum_probs=200.6

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .++|+..+.||+|+||.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            467899999999999999999965 788999999875432 233567789999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      |+.+ +|.+++......+++..++.++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++....... 
T Consensus        84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-  158 (291)
T cd07844          84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-  158 (291)
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence            9975 999988776667899999999999999999999   99999999999999999999999999999875432211 


Q ss_pred             cccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcc--ccCCcchhccc-cc
Q 039290          918 RQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSL--LSCSITEVADA-NL  993 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-~~  993 (1049)
                      ......++..|+|||++.+ ..++.++||||+|+++|||++|+.||..................  ........... ..
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF  238 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence            1122346788999998765 45789999999999999999999999654321111111110000  00000000000 00


Q ss_pred             c----cccccCc--hh--hHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          994 L----NCEENDF--SA--REQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       994 ~----~~~~~~~--~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .    .......  ..  ......+..+++.+|++.+|++|||++|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            0    0000000  00  00112567899999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=8.8e-34  Score=307.62  Aligned_cols=249  Identities=23%  Similarity=0.327  Sum_probs=203.4

Q ss_pred             CCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          762 GFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      +|+..+.||+|+||.||+++. .+++.||+|.+....  ....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            478889999999999999995 478899999987542  23346789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          839 MSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      +.+++|.+++.... ..+++.++.+++.|++.|++|+|   +.+++|+||+|+||+++.++.++++|||++........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            99999999887643 35789999999999999999999   99999999999999999999999999999986643221 


Q ss_pred             cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccccc
Q 039290          918 RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE  997 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1049)
                      ......+++.|+|||+..+..++.++|+||+||++++|++|+.||......+. ...+..                 .. 
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~-~~~~~~-----------------~~-  217 (256)
T cd08218         157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL-VLKIIR-----------------GS-  217 (256)
T ss_pred             hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH-HHHHhc-----------------CC-
Confidence            12234578899999999888899999999999999999999999864211111 111100                 00 


Q ss_pred             ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          998 ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       998 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                        ....+..++.++.+++.+||+.+|++||++.|++++
T Consensus       218 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         218 --YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             --CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence              011123346679999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-35  Score=306.42  Aligned_cols=253  Identities=24%  Similarity=0.304  Sum_probs=208.3

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      .+.|+..++||+|+||.||-++. .+|+.||.|++.+..   .........|..++.+++.+.||.+-.+|++.+.+++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            35688889999999999999984 589999999885443   33345678899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          836 LEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      +..|.||+|.-.|+..+ ..+++..+.-++.+|+.||++||   .++||+||+||+|||+|+.|+++|+|.|+|..+...
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999998887654 46899999999999999999999   999999999999999999999999999999988654


Q ss_pred             ccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          915 ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       915 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                      ..  ....+||.+|||||++....|+...|.||+||++|||+.|+.||..-.....    |           +-+|+.+.
T Consensus       341 ~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk----~-----------eEvdrr~~  403 (591)
T KOG0986|consen  341 KP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK----R-----------EEVDRRTL  403 (591)
T ss_pred             Cc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh----H-----------HHHHHHHh
Confidence            43  3445899999999999999999999999999999999999999975221111    0           01111111


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI-----SMKDVANR 1035 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~~ 1035 (1049)
                      ..+   ...+..++++..++.+..++.||++|.     .++||.+|
T Consensus       404 ~~~---~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H  446 (591)
T KOG0986|consen  404 EDP---EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH  446 (591)
T ss_pred             cch---hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence            111   122355778899999999999999997     45566554

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=8.2e-34  Score=312.61  Aligned_cols=260  Identities=23%  Similarity=0.309  Sum_probs=203.5

Q ss_pred             ccHHHHHHHhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhc-CCCceeeEEeeeec
Q 039290          751 ISYQDLLRATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLVKIISSCSN  828 (1049)
Q Consensus       751 ~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~  828 (1049)
                      .+..+.....+.|++.+.+|+|+||.||+|+. .+++.||+|++.... ....++..|+.+++++ +||||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            34555556677899999999999999999996 468899999986543 2346788899999998 69999999998853


Q ss_pred             ------CCeeEEEEeccCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceE
Q 039290          829 ------NDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGH  901 (1049)
Q Consensus       829 ------~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~k  901 (1049)
                            .+..+++|||+++|+|.+++.... ..+++..+..++.|+++|++|||   +.+|+||||||+||++++++.++
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence                  467899999999999999887533 35788889999999999999999   99999999999999999999999


Q ss_pred             EecccCceecCCCccccccccccccCcccccccC-----CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhh
Q 039290          902 LSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR-----EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWV  976 (1049)
Q Consensus       902 l~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~  976 (1049)
                      |+|||++........ ......++..|+|||.+.     +..++.++||||+||++|||++|..||......+.....  
T Consensus       162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~--  238 (282)
T cd06636         162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI--  238 (282)
T ss_pred             EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH--
Confidence            999999875532221 223356788999999875     346788999999999999999999999653211111000  


Q ss_pred             hhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          977 GDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       977 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                                  ...      .........++.++.+++.+||+.||.+|||+.|++++
T Consensus       239 ------------~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         239 ------------PRN------PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             ------------hhC------CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence                        000      00000112356689999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.1e-33  Score=313.25  Aligned_cols=260  Identities=26%  Similarity=0.316  Sum_probs=203.4

Q ss_pred             cHHHHHHHhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhc-CCCceeeEEeeeecC
Q 039290          752 SYQDLLRATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLVKIISSCSNN  829 (1049)
Q Consensus       752 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~  829 (1049)
                      .++++..+.++|++.+.||+|+||.||+|.. .+++.+|+|++... ....+.+.+|+.+++++ +|||++++++++...
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            3445556678899999999999999999996 47889999998643 22346778899999999 799999999998653


Q ss_pred             -----CeeEEEEeccCCCChhhhhhc---CCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceE
Q 039290          830 -----DFKALVLEYMSNGSLEKCLYS---DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGH  901 (1049)
Q Consensus       830 -----~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~k  901 (1049)
                           +..++||||+++++|.+++..   ....+++..++.++.|++.|++|||   +.+++||||||+||+++.++.+|
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEE
Confidence                 358999999999999998753   3346889999999999999999999   99999999999999999999999


Q ss_pred             EecccCceecCCCccccccccccccCcccccccCCC-----CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhh
Q 039290          902 LSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-----KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWV  976 (1049)
Q Consensus       902 l~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~  976 (1049)
                      |+|||++........ ......++..|+|||++...     .++.++||||+||++|||++|+.||......+. ...+.
T Consensus       169 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-~~~~~  246 (291)
T cd06639         169 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-LFKIP  246 (291)
T ss_pred             Eeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-HHHHh
Confidence            999999886543221 12234678899999987543     368899999999999999999999875322111 11111


Q ss_pred             hhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          977 GDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       977 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ...                  ......+......+.+++.+||+.+|++||++.|++++
T Consensus       247 ~~~------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         247 RNP------------------PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             cCC------------------CCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            000                  00011112234568999999999999999999999876

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.2e-34  Score=314.29  Aligned_cols=251  Identities=23%  Similarity=0.350  Sum_probs=200.9

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      ++|++.+.||+|+||.||+|+.. ++..||+|.++.... .....+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36788899999999999999965 789999999875432 2346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC--CCccCHHHHHHHHHHHHHHHHHhHccCC-CCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          839 MSNGSLEKCLYSD--NYFLDILQRLKIMIDVASALEYLHFGYS-TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       839 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      +++++|.+++...  ...+++..+..++.|++.|++|||   + .+|+||||||+||+++.++.+||+|||.+.......
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK---EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            9999999988764  236899999999999999999999   6 599999999999999999999999999987653222


Q ss_pred             cccccccccccCcccccccCCC------CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREG------KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA  989 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  989 (1049)
                         .....++..|+|||.+.+.      .++.++||||+||++|||++|+.||......... ....          .+.
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~----------~~~  223 (286)
T cd06622         158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF-AQLS----------AIV  223 (286)
T ss_pred             ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH-HHHH----------HHh
Confidence               1224577899999988543      3478999999999999999999999653221110 0000          000


Q ss_pred             ccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          990 DANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      +       ......+..++.++.+++.+||+.+|++||++++++++
T Consensus       224 ~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         224 D-------GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             h-------cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            0       00111223466788999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-34  Score=324.56  Aligned_cols=241  Identities=22%  Similarity=0.251  Sum_probs=187.4

Q ss_pred             ecCCCcEEEEEEEeC-CCcEEEEEEeecccC---CCHHHHHHHHHHHhhc---CCCceeeEEeeeecCCeeEEEEeccCC
Q 039290          769 LGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD---GSLESFHAECKVMGSI---RHRNLVKIISSCSNNDFKALVLEYMSN  841 (1049)
Q Consensus       769 lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l---~hpniv~l~~~~~~~~~~~lv~e~~~~  841 (1049)
                      ||+|+||+||+|+.. +++.||+|++.....   .....+..|..++...   +||||+++++++.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999954 689999999865321   2233455566676655   699999999999999999999999999


Q ss_pred             CChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccc
Q 039290          842 GSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK  921 (1049)
Q Consensus       842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~  921 (1049)
                      |+|.+++.... .+++..+..++.||++|++|||   +++|+||||||+||+++.++.+||+|||++........ ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~  155 (330)
T cd05586          81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNT  155 (330)
T ss_pred             ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-CccC
Confidence            99999887654 4899999999999999999999   99999999999999999999999999999875432221 2234


Q ss_pred             cccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccC
Q 039290          922 TLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEND 1000 (1049)
Q Consensus       922 ~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1049)
                      ..||+.|+|||++.+. .++.++||||+||++|||++|+.||......+.. ....   ....                +
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~-~~i~---~~~~----------------~  215 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY-RNIA---FGKV----------------R  215 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHH-HHHH---cCCC----------------C
Confidence            5689999999988654 4789999999999999999999998653221111 1100   0000                0


Q ss_pred             chhhHHHHHHHHHHHhhccccCCCCCC----CHHHHHHH
Q 039290         1001 FSAREQCVSSIFSLAMDCTVDLPEKRI----SMKDVANR 1035 (1049)
Q Consensus      1001 ~~~~~~~~~~l~~li~~cl~~dP~~Rp----t~~ell~~ 1035 (1049)
                      .. ....+.++.+++.+||+.||.+||    ++.++++|
T Consensus       216 ~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         216 FP-KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             CC-CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence            00 012356678999999999999998    56777664

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.1e-33  Score=312.90  Aligned_cols=250  Identities=26%  Similarity=0.339  Sum_probs=205.3

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      ++|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++++++|||++++++++...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            5788999999999999999985 478899999987655555678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      ++++|.+++...  .+++.++..++.|++.|++|||   +.|++||||||+||+++.++.++|+|||++........ ..
T Consensus        99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~  172 (293)
T cd06647          99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR  172 (293)
T ss_pred             CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-cc
Confidence            999999988754  3688899999999999999999   99999999999999999999999999999876543332 22


Q ss_pred             cccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccccccc
Q 039290          920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEN  999 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1049)
                      ....+++.|+|||.+.+..++.++||||+|+++|++++|+.||......+.....+.                   ....
T Consensus       173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-------------------~~~~  233 (293)
T cd06647         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-------------------NGTP  233 (293)
T ss_pred             ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-------------------CCCC
Confidence            234578899999999888899999999999999999999999975322111100000                   0000


Q ss_pred             CchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290         1000 DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus      1000 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ....+...+..+.+++.+||+.+|++||++.+++.|
T Consensus       234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         234 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111122345678999999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.5e-34  Score=313.68  Aligned_cols=258  Identities=24%  Similarity=0.300  Sum_probs=204.2

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      ++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            46778899999999999999954 68899999886543 23457889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCC-CCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS-TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      +++++|.+++...+ .+++..+..++.+++.|++|||   + .+++||||||+||+++.++.++|+|||++.......  
T Consensus        85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--  158 (284)
T cd06620          85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLY---NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--  158 (284)
T ss_pred             CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---HhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence            99999999887644 4889999999999999999999   5 589999999999999999999999999987542221  


Q ss_pred             cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccch---HHHhhhhccccCCcchhcccccc
Q 039290          918 RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMS---LKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                       .....++..|+|||++.+..++.++||||+||++|||++|+.||......+..   ...+.          +.......
T Consensus       159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~----------~~~~~~~~  227 (284)
T cd06620         159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL----------DLLQQIVQ  227 (284)
T ss_pred             -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHH----------HHHHHHhh
Confidence             12346789999999998888999999999999999999999999754332110   00000          00000000


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                      . ..... ....++.++.+++.+|++.||++|||++|++++..
T Consensus       228 ~-~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~  268 (284)
T cd06620         228 E-PPPRL-PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP  268 (284)
T ss_pred             c-cCCCC-CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence            0 00000 01235677999999999999999999999998743

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.1e-34  Score=313.33  Aligned_cols=247  Identities=25%  Similarity=0.355  Sum_probs=200.9

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      .|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            3556678999999999999854 67889999987543 233567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      ++++|.+++...  .+++..+..++.|+++|++|||   +++++|+||+|+||++++++.++++|||++........ ..
T Consensus        85 ~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~  158 (277)
T cd06642          85 GGGSALDLLKPG--PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KR  158 (277)
T ss_pred             CCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch-hh
Confidence            999999988653  4789999999999999999999   99999999999999999999999999999976543221 22


Q ss_pred             cccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccccccc
Q 039290          920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEN  999 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1049)
                      ....++..|+|||++.+..++.++||||+||++|||++|..||......+..  .+..    ..         .      
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~----~~---------~------  217 (277)
T cd06642         159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL--FLIP----KN---------S------  217 (277)
T ss_pred             hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH--hhhh----cC---------C------
Confidence            2345788999999999888999999999999999999999998753222111  1000    00         0      


Q ss_pred             CchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290         1000 DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus      1000 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .......++..+.+++.+||+.+|++||++.+++++
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         218 PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            001112345678999999999999999999999986

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=9.7e-34  Score=309.76  Aligned_cols=247  Identities=28%  Similarity=0.502  Sum_probs=197.2

Q ss_pred             ceecCCCcEEEEEEEeCC-------CcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          767 KLLGMGSFGSVYKGVLPD-------GMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      +.||+|+||.||+|+..+       +..||+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998642       2578999886543 23456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC------CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC-----ceEEecccC
Q 039290          839 MSNGSLEKCLYSD------NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM-----VGHLSDFGI  907 (1049)
Q Consensus       839 ~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-----~~kl~DfGl  907 (1049)
                      +++++|.+++...      ...+++.++..++.|++.|++|+|   +.+++|+||||+||+++.++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999998642      234788999999999999999999   99999999999999999877     899999999


Q ss_pred             ceecCCCccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCc
Q 039290          908 AKILGKEESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSI  985 (1049)
Q Consensus       908 a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  985 (1049)
                      +......... ......++..|+|||++.++.++.++|||||||++|||++ |..||......+  ....+.    .   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--~~~~~~----~---  228 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--VLQHVT----A---  228 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--HHHHHh----c---
Confidence            8765432211 1122345678999999998899999999999999999998 999986532211  111110    0   


Q ss_pred             chhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          986 TEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       986 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                                  ......+...+..+.+++.+||+.+|++||+++++++.|+
T Consensus       229 ------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         229 ------------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             ------------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                        0011122345678899999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-34  Score=294.33  Aligned_cols=270  Identities=22%  Similarity=0.297  Sum_probs=222.6

Q ss_pred             HHHHHHhcCCCCCceecCCCcEEEEEEEeC------CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeee
Q 039290          754 QDLLRATDGFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSC  826 (1049)
Q Consensus       754 ~~~~~~~~~~~~~~~lg~G~fg~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~  826 (1049)
                      +++.....+++....+.+|.||.||+|.|.      +.+.|.||.++... +-+...+..|.-.+..+.|||+..+.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            455556778888899999999999999754      34457778776432 33456788899999999999999999988


Q ss_pred             ec-CCeeEEEEeccCCCChhhhhhc-------CCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC
Q 039290          827 SN-NDFKALVLEYMSNGSLEKCLYS-------DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM  898 (1049)
Q Consensus       827 ~~-~~~~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~  898 (1049)
                      .+ .+.+++++.+..-|+|..++.-       ....++..+...++.|++.|++|||   ++||||.||..+|.+||+.-
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhe
Confidence            55 5577889999999999999872       2235677788899999999999999   99999999999999999999


Q ss_pred             ceEEecccCceecCCCccccc-cccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhh
Q 039290          899 VGHLSDFGIAKILGKEESMRQ-TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWV  976 (1049)
Q Consensus       899 ~~kl~DfGla~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  976 (1049)
                      +||++|=.+++..-+.+..-. .....+..||+||.+....|+.++||||||+++|||+| |+.|+.++.+.|....-. 
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk-  512 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK-  512 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh-
Confidence            999999999998766543211 11234678999999999999999999999999999999 999998865554432221 


Q ss_pred             hhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhcc
Q 039290          977 GDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYI 1047 (1049)
Q Consensus       977 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~~ 1047 (1049)
                                          ...|...|.+||.+++.+|.-||..+|++||+++|++..|.++..++.+|+
T Consensus       513 --------------------dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt~YV  563 (563)
T KOG1024|consen  513 --------------------DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLTRYV  563 (563)
T ss_pred             --------------------ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHhhcC
Confidence                                122455667899999999999999999999999999999999999999985

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.4e-33  Score=308.40  Aligned_cols=250  Identities=21%  Similarity=0.304  Sum_probs=188.4

Q ss_pred             eecCCCcEEEEEEEeCC---CcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCCC
Q 039290          768 LLGMGSFGSVYKGVLPD---GMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGS  843 (1049)
Q Consensus       768 ~lg~G~fg~Vy~a~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~  843 (1049)
                      .||+|+||+||+|...+   ...+|+|.+..... .....+.+|+++++.++||||+++++++.+.+..++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            59999999999997543   34688887754432 224567889999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCC----ccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc-c
Q 039290          844 LEKCLYSDNY----FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM-R  918 (1049)
Q Consensus       844 L~~~l~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~-~  918 (1049)
                      |.+++.....    ..++..+..++.|++.|++|||   +++|+||||||+||++++++.+||+|||++......... .
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            9999876432    3467788899999999999999   999999999999999999999999999998754332211 1


Q ss_pred             ccccccccCcccccccCC-------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcc
Q 039290          919 QTKTLGTIGYMAPEYGRE-------GKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD  990 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  990 (1049)
                      .....++..|+|||+...       ..++.++||||+||++|||++ |..||......+. .........     .+.. 
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~~~-----~~~~-  231 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-LKQVVREQD-----IKLP-  231 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH-HHHHhhccC-----ccCC-
Confidence            122345678999998642       456889999999999999999 7788865322221 111110000     0000 


Q ss_pred             cccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          991 ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                               ....+..++..+.+++..|| .||++|||++||++.|.
T Consensus       232 ---------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         232 ---------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             ---------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence                     01112235567788999999 59999999999998763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.3e-33  Score=305.93  Aligned_cols=252  Identities=29%  Similarity=0.401  Sum_probs=203.3

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCC--CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDG--SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      +|...+.||+|+||.||+|... +++.||+|.++.....  ..+.+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5888899999999999999954 7889999999766443  567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      +++++|.+++.... .+++..+..++.|+++|++|||   +.+|+|+||+|+||++++++.+||+|||.+..........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            99999999987654 4788999999999999999999   9999999999999999999999999999998764433211


Q ss_pred             c---cccccccCcccccccCCCC---cCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccc
Q 039290          919 Q---TKTLGTIGYMAPEYGREGK---VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       919 ~---~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      .   ....++..|+|||++.+..   ++.++||||+|+++|||++|..||...... ......... .            
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~~~~~~~~~-~------------  222 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIMFHVGA-G------------  222 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-HHHHHHHhc-C------------
Confidence            1   1245788999999987765   889999999999999999999999753211 111111100 0            


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                          .....+....++..+.+++.+||+.+|++|||+.|++.+
T Consensus       223 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         223 ----HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             ----CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                000011112235678899999999999999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.2e-34  Score=314.36  Aligned_cols=268  Identities=25%  Similarity=0.301  Sum_probs=202.0

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCC--CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDG--SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      ++|+..+.||+|+||.||+|... +++.||+|++......  ..+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36888899999999999999975 6889999998654322  34678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      |++++++.++..... .+++.++..++.|+++|++|||   +.+++||||+|+||++++++.++|+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07846          81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-  155 (286)
T ss_pred             cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence            999998888765443 4899999999999999999999   99999999999999999999999999999886543321 


Q ss_pred             cccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHH--HhhhhccccCCcchhcc----
Q 039290          918 RQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK--RWVGDSLLSCSITEVAD----  990 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~----  990 (1049)
                      ......++..|+|||++.+ ..++.++||||+|+++|||++|+.||......+....  .+.+...  ....+..+    
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  233 (286)
T cd07846         156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLI--PRHQEIFQKNPL  233 (286)
T ss_pred             ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCc--hhhHHHhccchH
Confidence            2223457889999998765 4578899999999999999999998864322111100  0000000  00000000    


Q ss_pred             --ccccccccc---CchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          991 --ANLLNCEEN---DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       991 --~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                        .........   ........+..+.+++.+||+.+|++||++++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence              000000000   001112356789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-34  Score=339.71  Aligned_cols=264  Identities=27%  Similarity=0.445  Sum_probs=217.7

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC----C----CcEEEEEEeecccC-CCHHHHHHHHHHHhhc-CCCceeeEEeeeecCC
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP----D----GMEIAAKVFHMEFD-GSLESFHAECKVMGSI-RHRNLVKIISSCSNND  830 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~----~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~  830 (1049)
                      ++..+.+.+|+|+||.|++|...    .    ...||||.++.... ...+.+..|+++|+.+ +||||+.++|+|..++
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            34456679999999999999832    1    45799999986543 3567899999999999 6999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhhcCC---------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec
Q 039290          831 FKALVLEYMSNGSLEKCLYSDN---------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN  895 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~  895 (1049)
                      ..++|+||++.|+|.++++..+               ..++..+...++.|||.|++||+   +.++||||+..+||+++
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLIT  452 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEec
Confidence            9999999999999999998877               34888999999999999999999   99999999999999999


Q ss_pred             CCCceEEecccCceecCCCccccccccc--cccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchH
Q 039290          896 ESMVGHLSDFGIAKILGKEESMRQTKTL--GTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSL  972 (1049)
Q Consensus       896 ~~~~~kl~DfGla~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~  972 (1049)
                      ++..+||+|||+|+.......+......  -+..|||||.+....|+.++||||||+++||+++ |..||.+....+.. 
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l-  531 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL-  531 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH-
Confidence            9999999999999976655544433223  3557999999999999999999999999999999 88998763211111 


Q ss_pred             HHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhccC
Q 039290          973 KRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYID 1048 (1049)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~~~ 1048 (1049)
                      .++.                   ....+...|..|+.+++++|+.||+.+|++||++.|+++.|+..... ..|+|
T Consensus       532 ~~~l-------------------~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~-~~~~~  587 (609)
T KOG0200|consen  532 LEFL-------------------KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD-ELYLD  587 (609)
T ss_pred             HHHH-------------------hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH-hhhhh
Confidence            1111                   12234566678899999999999999999999999999999986543 34444

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.8e-33  Score=307.65  Aligned_cols=251  Identities=25%  Similarity=0.358  Sum_probs=199.9

Q ss_pred             CCCCCceecCCCcEEEEEEEeCC--CcEEEEEEeeccc----------CCCHHHHHHHHHHHhh-cCCCceeeEEeeeec
Q 039290          762 GFSENKLLGMGSFGSVYKGVLPD--GMEIAAKVFHMEF----------DGSLESFHAECKVMGS-IRHRNLVKIISSCSN  828 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~~--~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~hpniv~l~~~~~~  828 (1049)
                      +|++.+.||+|+||.||+|....  ++.+|+|.+....          .....++.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999999654  6789999885432          1223456778888765 699999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhhc---CCCccCHHHHHHHHHHHHHHHHHhHccCC-CCeEEcCCCCCCeeecCCCceEEec
Q 039290          829 NDFKALVLEYMSNGSLEKCLYS---DNYFLDILQRLKIMIDVASALEYLHFGYS-TPIVHCDIKPSNVLLNESMVGHLSD  904 (1049)
Q Consensus       829 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~~~~kl~D  904 (1049)
                      ++..++||||+++++|.+++..   ....+++..+++++.|++.|++|||   + .+++||||+|+||+++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999988743   3446899999999999999999999   6 6899999999999999999999999


Q ss_pred             ccCceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCC
Q 039290          905 FGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCS  984 (1049)
Q Consensus       905 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  984 (1049)
                      ||.+.......  ......++..|+|||+..+..++.++||||+|+++|||++|+.||.......  ......       
T Consensus       158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~--~~~~~~-------  226 (269)
T cd08528         158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS--LATKIV-------  226 (269)
T ss_pred             ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH--HHHHHh-------
Confidence            99998765433  2234567889999999988889999999999999999999999986421111  111000       


Q ss_pred             cchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          985 ITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       985 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                           +......      .....+.++.+++.+||+.||++||++.|+.++++
T Consensus       227 -----~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         227 -----EAVYEPL------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             -----hccCCcC------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                 0000000      01123567899999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.5e-34  Score=315.04  Aligned_cols=248  Identities=23%  Similarity=0.309  Sum_probs=199.8

Q ss_pred             CCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCC
Q 039290          763 FSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSN  841 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  841 (1049)
                      |.....||+|+||.||+|.. .++..||+|.+........+.+.+|+.+++.++||||+++++.+..++..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            33446799999999999995 46889999998765545566788999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccc
Q 039290          842 GSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK  921 (1049)
Q Consensus       842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~  921 (1049)
                      ++|.+++...  .+++.++..++.||+.|++|||   +++|+||||||+||++++++.++|+|||++........ ....
T Consensus       104 ~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~  177 (292)
T cd06658         104 GALTDIVTHT--RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKS  177 (292)
T ss_pred             CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCce
Confidence            9999987543  4789999999999999999999   99999999999999999999999999999875533221 2233


Q ss_pred             cccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCc
Q 039290          922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDF 1001 (1049)
Q Consensus       922 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1049)
                      ..++..|+|||+..+..++.++||||+|+++|||++|+.||......+ .......          ...        ...
T Consensus       178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~----------~~~--------~~~  238 (292)
T cd06658         178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-AMRRIRD----------NLP--------PRV  238 (292)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHh----------cCC--------Ccc
Confidence            467889999999988889999999999999999999999986422111 1111000          000        000


Q ss_pred             hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290         1002 SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus      1002 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ......+..+.+++.+|+..||++|||++|++++
T Consensus       239 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         239 KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1112245578899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-33  Score=311.99  Aligned_cols=271  Identities=23%  Similarity=0.254  Sum_probs=203.6

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      ++|+..+.||+|+||.||+|... +++.||+|+++...  ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999965 68899999987543  2335788999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      |++++.+..+... ...+++.+++.++.|++.|++|||   +.+++|||++|+||++++++.+||+|||.+.........
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence            9998777665544 345899999999999999999999   999999999999999999999999999999876544332


Q ss_pred             cccccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccchHH--HhhhhccccCCcchhcccccc
Q 039290          918 RQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK--RWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                      ......++..|+|||++.+. .++.++||||+|+++|+|++|..||......+....  ...+............+....
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA  236 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence            23345678899999999887 789999999999999999999999875322211110  000000000000000000000


Q ss_pred             -----ccccc---CchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          995 -----NCEEN---DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       995 -----~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                           .....   ....+..++.++.+++++||+.+|++||++++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence                 00000   000112246789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-33  Score=308.35  Aligned_cols=253  Identities=24%  Similarity=0.326  Sum_probs=201.6

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCC------
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLVKIISSCSNND------  830 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~------  830 (1049)
                      ..++|++.+.||+|+||.||+|... +++.|++|++..... ..+.+.+|+++++++ .||||+++++++.+..      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4578999999999999999999964 678999999875432 346789999999999 6999999999986544      


Q ss_pred             eeEEEEeccCCCChhhhhhcC---CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccC
Q 039290          831 FKALVLEYMSNGSLEKCLYSD---NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGI  907 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGl  907 (1049)
                      ..++||||+++++|.+++...   +..+++..+..++.|+++|++|||   +.+++||||+|+||++++++.+|++|||.
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence            489999999999999987653   356899999999999999999999   99999999999999999999999999999


Q ss_pred             ceecCCCccccccccccccCcccccccCC-----CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcccc
Q 039290          908 AKILGKEESMRQTKTLGTIGYMAPEYGRE-----GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLS  982 (1049)
Q Consensus       908 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  982 (1049)
                      +........ ......++..|+|||++..     ..++.++||||+||++|+|++|..||......+. ..+...     
T Consensus       160 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~-----  232 (275)
T cd06608         160 SAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-LFKIPR-----  232 (275)
T ss_pred             ceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH-HHHhhc-----
Confidence            886543222 2233557889999998753     3467899999999999999999999965322111 111100     


Q ss_pred             CCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          983 CSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                                   ........+...+.++.+++.+||+.||++|||++|++++
T Consensus       233 -------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         233 -------------NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             -------------cCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                         0000111223356789999999999999999999999874

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=9.3e-34  Score=314.05  Aligned_cols=245  Identities=24%  Similarity=0.329  Sum_probs=199.2

Q ss_pred             CceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCCCh
Q 039290          766 NKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSL  844 (1049)
Q Consensus       766 ~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  844 (1049)
                      ...||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++|||++++++++..++..++||||+++++|
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L  105 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence            357999999999999954 7899999999765555567788999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccccccccc
Q 039290          845 EKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLG  924 (1049)
Q Consensus       845 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  924 (1049)
                      .+++...  .+++.+++.++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++........ ......+
T Consensus       106 ~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~  179 (297)
T cd06659         106 TDIVSQT--RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVG  179 (297)
T ss_pred             HHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccceec
Confidence            9977553  4789999999999999999999   99999999999999999999999999999875533221 2233567


Q ss_pred             ccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCchhh
Q 039290          925 TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAR 1004 (1049)
Q Consensus       925 ~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1049)
                      +..|+|||++.+..++.++||||+||++|||++|+.||......+ .... .....                 .......
T Consensus       180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~-~~~~~-----------------~~~~~~~  240 (297)
T cd06659         180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-AMKR-LRDSP-----------------PPKLKNA  240 (297)
T ss_pred             CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HhccC-----------------CCCcccc
Confidence            899999999988889999999999999999999999986422111 1111 10000                 0000111


Q ss_pred             HHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290         1005 EQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus      1005 ~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ...+.++.+++.+|++.+|++||++++++++
T Consensus       241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         241 HKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            1234568899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.8e-33  Score=305.25  Aligned_cols=248  Identities=23%  Similarity=0.352  Sum_probs=201.7

Q ss_pred             CCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          762 GFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      +|+..+.||+|+||.||+|.. .+++.+|+|.+....  ......+.+|++++++++|||++++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            478889999999999999995 478899999987543  23356788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCC-CceEEecccCceecCCCcc
Q 039290          839 MSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES-MVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-~~~kl~DfGla~~~~~~~~  916 (1049)
                      +++++|.+++.... ..+++..+.+++.++++|++|+|   +++|+||||+|+||+++++ +.+|++|||.+....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence            99999999997643 45899999999999999999999   9999999999999999854 468999999998764332 


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                       ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||.......  .......            ..    
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~~~~~------------~~----  217 (256)
T cd08220         157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA--LVLKIMS------------GT----  217 (256)
T ss_pred             -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH--HHHHHHh------------cC----
Confidence             1223467889999999988889999999999999999999999986532211  1111100            00    


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                         ....+..++.++.+++.+||+.+|++|||+.|++++
T Consensus       218 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         218 ---FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             ---CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence               001112245678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.4e-33  Score=306.55  Aligned_cols=253  Identities=24%  Similarity=0.371  Sum_probs=202.2

Q ss_pred             CCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCC------CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          762 GFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDG------SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      +|+..+.||+|+||.||+|+. .+++.||+|++......      ..+.+.+|++++++++||||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999994 57899999998754321      24678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC-ceEEecccCceecCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM-VGHLSDFGIAKILGK  913 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-~~kl~DfGla~~~~~  913 (1049)
                      ||||+++++|.+++...+ .+++..+..++.|++.|++|||   +.|++||||+|+||+++.++ .+||+|||.+.....
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            999999999999987654 5789999999999999999999   99999999999999998765 699999999987653


Q ss_pred             Ccc---ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcc
Q 039290          914 EES---MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD  990 (1049)
Q Consensus       914 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  990 (1049)
                      ...   .......++..|+|||.+.+..++.++||||+|+++|+|++|..||......... ..+.. ...         
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~-~~~---------  225 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL-ALIFK-IAS---------  225 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH-HHHHH-Hhc---------
Confidence            321   1112245788999999998888999999999999999999999998642211111 11000 000         


Q ss_pred             cccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          991 ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                            .......+...+.++.+++.+|++.+|++||++.|++++
T Consensus       226 ------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         226 ------ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             ------cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence                  000112223456788999999999999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.8e-33  Score=311.01  Aligned_cols=245  Identities=27%  Similarity=0.301  Sum_probs=202.6

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|+..+.||+|+||.||+|... +++.||+|+++...   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36888899999999999999964 68999999986542   233567889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+++++|.+++.... .+++..+..++.|++.|++|||   +.||+||||+|+||+++.++.+||+|||++......  
T Consensus        81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            9999999999987664 5889999999999999999999   999999999999999999999999999999876433  


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                        .....+++.|+|||.+.+..++.++||||+|+++|+|++|..||......+ ......                    
T Consensus       155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~--------------------  211 (290)
T cd05580         155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ-IYEKIL--------------------  211 (290)
T ss_pred             --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHh--------------------
Confidence              223457889999999988888999999999999999999999987533111 111100                    


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRI-----SMKDVANR 1035 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~~ 1035 (1049)
                       ......+...+..+.+++.+||+.+|.+|+     +++|++++
T Consensus       212 -~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         212 -EGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             -cCCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence             000111122356789999999999999999     88888765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4e-33  Score=312.79  Aligned_cols=193  Identities=21%  Similarity=0.286  Sum_probs=159.0

Q ss_pred             CceecCCCcEEEEEEEeC---CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeec--CCeeEEEEeccC
Q 039290          766 NKLLGMGSFGSVYKGVLP---DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSN--NDFKALVLEYMS  840 (1049)
Q Consensus       766 ~~~lg~G~fg~Vy~a~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~  840 (1049)
                      ..+||+|+||+||+|+..   ++..||+|.+....  ....+.+|++++++++||||+++++++..  +...++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            368999999999999964   45789999886432  33567899999999999999999998843  567899999997


Q ss_pred             CCChhhhhhcC--------CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeee----cCCCceEEecccCc
Q 039290          841 NGSLEKCLYSD--------NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL----NESMVGHLSDFGIA  908 (1049)
Q Consensus       841 ~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~----~~~~~~kl~DfGla  908 (1049)
                      + +|.+++...        ...+++..++.++.|++.||+|||   +.+|+||||||+||++    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 777766421        225788999999999999999999   9999999999999999    46679999999999


Q ss_pred             eecCCCcc--ccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCc
Q 039290          909 KILGKEES--MRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDE  964 (1049)
Q Consensus       909 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~  964 (1049)
                      +.......  .......+|+.|+|||++.+ ..++.++||||+||++|||+||+.||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            87643321  12233567899999998876 4578999999999999999999999964

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.6e-33  Score=311.37  Aligned_cols=267  Identities=23%  Similarity=0.273  Sum_probs=201.7

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCC-----CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDG-----SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      +|+..+.||+|+||.||+|... +++.||+|.++.....     ....+..|++++++++||||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778889999999999999964 7899999999765422     245677899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+ +++|.+++......+++..+..++.|+++||+|||   +.||+||||||+||+++.++.++|+|||++.......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 88999999776546899999999999999999999   9999999999999999999999999999998765432


Q ss_pred             cccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcc------hh
Q 039290          916 SMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSIT------EV  988 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~  988 (1049)
                      . ......+++.|+|||.+.+ ..++.++||||+||++|||++|..||......+ ....... ........      ..
T Consensus       157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~  233 (298)
T cd07841         157 R-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFE-ALGTPTEENWPGVTSL  233 (298)
T ss_pred             c-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHH-HcCCCchhhhhhcccc
Confidence            2 1223356788999998754 467899999999999999999977776432211 1111110 00000000      00


Q ss_pred             ccccccc--ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          989 ADANLLN--CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       989 ~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .+.....  ............+.++.+++.+||+.+|++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0000000  0000001112346788999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.8e-33  Score=305.33  Aligned_cols=250  Identities=24%  Similarity=0.291  Sum_probs=197.4

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC-----CCHHHHHHHHHHHhhcCCCceeeEEeeeecC--Cee
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD-----GSLESFHAECKVMGSIRHRNLVKIISSCSNN--DFK  832 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~  832 (1049)
                      .+|++.+.||+|+||.||+|... +++.||+|.+.....     ...+.+.+|++++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46888999999999999999964 688999998864321     1235788899999999999999999988763  467


Q ss_pred             EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecC
Q 039290          833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      ++||||+++++|.+++.... .+++..+.+++.|++.|++|||   +.+|+|+||||+||+++.++.++|+|||++....
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            89999999999999987654 3788889999999999999999   9999999999999999999999999999987653


Q ss_pred             CCcc--ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcc
Q 039290          913 KEES--MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD  990 (1049)
Q Consensus       913 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  990 (1049)
                      ....  .......++..|+|||++.+..++.++|||||||++|||++|+.||........ ....    ...        
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~~~----~~~--------  224 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-IFKI----ATQ--------  224 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-HHHH----hcC--------
Confidence            2111  112234578899999999888899999999999999999999999875311111 1100    000        


Q ss_pred             cccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          991 ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                             ......+......+.+++.+|+. +|++||+++|++++
T Consensus       225 -------~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         225 -------PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             -------CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence                   00111223455678889999995 89999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-34  Score=317.84  Aligned_cols=243  Identities=24%  Similarity=0.434  Sum_probs=194.7

Q ss_pred             ceecCCCcEEEEEEEeC-CCcEEEEEEee---cc-cCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCe--eEEEEecc
Q 039290          767 KLLGMGSFGSVYKGVLP-DGMEIAAKVFH---ME-FDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDF--KALVLEYM  839 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~-~~~~vavK~~~---~~-~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~--~~lv~e~~  839 (1049)
                      .+||+|+|-+||+|.+. +|..||=-.++   .. .+...++|..|+.+++.|+||||++++++|.+.+.  ..+|+|.+
T Consensus        46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~  125 (632)
T KOG0584|consen   46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF  125 (632)
T ss_pred             hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence            56999999999999964 56677632221   11 13345889999999999999999999999987654  77899999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec-CCCceEEecccCceecCCCcccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~-~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      ..|+|..|..+.++ .+...++.|++||++||.||| ...++|+|||||-+||||+ ..|.|||+|.|+|.......   
T Consensus       126 TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLH-s~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~---  200 (632)
T KOG0584|consen  126 TSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLH-SQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH---  200 (632)
T ss_pred             cCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhh-cCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc---
Confidence            99999999988765 788899999999999999999 4478999999999999998 56899999999999775433   


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                      ....+|||.|||||++. ..|+..+||||||++|+||.|+..||.+-...- .+.+.+-....+.....+.|        
T Consensus       201 aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A-QIYKKV~SGiKP~sl~kV~d--------  270 (632)
T KOG0584|consen  201 AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA-QIYKKVTSGIKPAALSKVKD--------  270 (632)
T ss_pred             cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH-HHHHHHHcCCCHHHhhccCC--------
Confidence            23478999999999997 689999999999999999999999997633332 22222222222222222222        


Q ss_pred             cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          999 NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       999 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                                +++++||.+|+.. .++|||+.|++++
T Consensus       271 ----------Pevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  271 ----------PEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             ----------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence                      4578999999999 9999999999875

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.8e-33  Score=307.92  Aligned_cols=252  Identities=29%  Similarity=0.364  Sum_probs=206.8

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      .+.|+..+.+|+|+||.||+|... ++..|++|++..... ..+.+.+|+++++.++|+|++++++++...+..++|+||
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   96 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY   96 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence            456888889999999999999976 788999999976544 467788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      +++++|.+++......+++..+..++.|++.|++|||   +.|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus        97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~  172 (286)
T cd06614          97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-K  172 (286)
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-h
Confidence            9999999999876656899999999999999999999   99999999999999999999999999999875543221 1


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                      .....++..|+|||++.+..++.++||||+|+++|+|++|..||....... ....+...                  ..
T Consensus       173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-~~~~~~~~------------------~~  233 (286)
T cd06614         173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-ALFLITTK------------------GI  233 (286)
T ss_pred             hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhc------------------CC
Confidence            223457789999999988889999999999999999999999986532211 11111000                  00


Q ss_pred             cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          999 NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       999 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ........++..+.+++.+|++.+|.+||++.+++++
T Consensus       234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         234 PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            0111122356779999999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=4.9e-33  Score=300.83  Aligned_cols=250  Identities=30%  Similarity=0.389  Sum_probs=206.6

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccC
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMS  840 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  840 (1049)
                      .|+..+.||+|++|.||+|... ++..+++|++........+.+.+|+++++.++||+++++++++..++..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3778899999999999999975 788999999977655456789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccccc
Q 039290          841 NGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT  920 (1049)
Q Consensus       841 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~  920 (1049)
                      +++|.+++......+++..+..++.|+++|+++||   +.+++||||+|+||+++.++.++|+|||.+........  ..
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~  155 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN  155 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence            99999998876566899999999999999999999   99999999999999999999999999999987654332  23


Q ss_pred             ccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccC
Q 039290          921 KTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEND 1000 (1049)
Q Consensus       921 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1049)
                      ...++..|+|||.+....++.++||||+|+++++|++|+.||......+.....  ..    .             ....
T Consensus       156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~----~-------------~~~~  216 (253)
T cd05122         156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI--AT----N-------------GPPG  216 (253)
T ss_pred             ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH--Hh----c-------------CCCC
Confidence            356788999999998888999999999999999999999998753211111100  00    0             0000


Q ss_pred             chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290         1001 FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus      1001 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .......+..+.+++.+||+.||++|||+.|++++
T Consensus       217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         217 LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             cCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            01111235678999999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.7e-33  Score=307.55  Aligned_cols=249  Identities=25%  Similarity=0.318  Sum_probs=201.1

Q ss_pred             CCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccC
Q 039290          762 GFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMS  840 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  840 (1049)
                      .|...+.||+|++|.||+|.. .+++.|++|++........+.+.+|+.+++.++|||++++++++...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            355567999999999999995 4788999999875544455678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccccc
Q 039290          841 NGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT  920 (1049)
Q Consensus       841 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~  920 (1049)
                      +++|.+++..  ..+++.++..++.|++.|++|+|   +.|++||||+|+||+++.++.++++|||.+........ ...
T Consensus       100 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~  173 (285)
T cd06648         100 GGALTDIVTH--TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRK  173 (285)
T ss_pred             CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccc
Confidence            9999998876  34789999999999999999999   99999999999999999999999999998875533222 122


Q ss_pred             ccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccC
Q 039290          921 KTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEND 1000 (1049)
Q Consensus       921 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1049)
                      ...++..|+|||...+..++.++||||+|+++|||++|+.||......+. ..... ..                 ....
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~-~~~~~-~~-----------------~~~~  234 (285)
T cd06648         174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA-MKRIR-DN-----------------LPPK  234 (285)
T ss_pred             cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH-HHHHH-hc-----------------CCCC
Confidence            34578899999999888899999999999999999999999865221111 00000 00                 0000


Q ss_pred             chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290         1001 FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus      1001 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .......+..+.+++.+||+.+|++||++.+++++
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         235 LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             CcccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            01111245679999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3e-33  Score=303.05  Aligned_cols=246  Identities=30%  Similarity=0.519  Sum_probs=199.0

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccC
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMS  840 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  840 (1049)
                      .+|++.+.||+|+||.||+|.. +++.||+|.++..  ...+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4588899999999999999975 7788999998643  2346789999999999999999999998765 4699999999


Q ss_pred             CCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          841 NGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       841 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      +++|.+++.... ..+++..+..++.|++.|++|+|   +.|++||||||+||+++.++.+||+|||.+.......    
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----  154 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----  154 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence            999999987643 35789999999999999999999   9999999999999999999999999999987643221    


Q ss_pred             cccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccccccc
Q 039290          920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                      .....+..|+|||++.+..++.++|+||+||++|||++ |..||......+.  ......             ..     
T Consensus       155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~~-------------~~-----  214 (254)
T cd05083         155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV--KECVEK-------------GY-----  214 (254)
T ss_pred             CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH--HHHHhC-------------CC-----
Confidence            11233567999999988889999999999999999998 9999875332211  111100             00     


Q ss_pred             cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 039290          999 NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVR 1038 (1049)
Q Consensus       999 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~ 1038 (1049)
                       +...+..++..+.+++.+||+.+|++||+++++++.|++
T Consensus       215 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         215 -RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence             011112345778999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.7e-33  Score=304.78  Aligned_cols=250  Identities=19%  Similarity=0.297  Sum_probs=185.8

Q ss_pred             eecCCCcEEEEEEEeCCCc---EEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCCC
Q 039290          768 LLGMGSFGSVYKGVLPDGM---EIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGS  843 (1049)
Q Consensus       768 ~lg~G~fg~Vy~a~~~~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~  843 (1049)
                      .||+|+||+||+|+..++.   .+++|.+.... ....+.+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            5999999999999854433   45666665433 2345688999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCC---CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc-ccc
Q 039290          844 LEKCLYSDN---YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES-MRQ  919 (1049)
Q Consensus       844 L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~-~~~  919 (1049)
                      |.+++....   ...++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||++........ ...
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999987532   24566778899999999999999   99999999999999999999999999999864322111 112


Q ss_pred             cccccccCcccccccCC-------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccc
Q 039290          920 TKTLGTIGYMAPEYGRE-------GKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA  991 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  991 (1049)
                      ....++..|+|||++..       ..++.++|||||||++|||++ |..||......+.....+.     ... ....++
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~-----~~~-~~~~~~  232 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK-----DQQ-VKLFKP  232 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-----hcc-cccCCC
Confidence            23457889999998753       245789999999999999997 5667754222111111110     000 001111


Q ss_pred             ccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          992 NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                      .          ........+.+++.+|| .+|++||+++|+++.|.
T Consensus       233 ~----------~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         233 Q----------LELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             c----------cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            1          11124456888999999 67999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5e-33  Score=303.22  Aligned_cols=250  Identities=28%  Similarity=0.322  Sum_probs=207.4

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      +|+..+.||+|++|.||+|+.. +++.||+|++..... .....+.+|++++.+++|||++++++++...+..++||||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            6888899999999999999965 589999999876543 34678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCC-CCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS-TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      ++++|.+++... ..+++..++.++.|+++|++|+|   + .+++||||+|+||+++.++.++|+|||.+......... 
T Consensus        82 ~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-  156 (264)
T cd06623          82 DGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-  156 (264)
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence            999999998765 45899999999999999999999   8 99999999999999999999999999999876433322 


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCcccccc-chHHHhhhhccccCCcchhccccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGE-MSLKRWVGDSLLSCSITEVADANLLNCE  997 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1049)
                      .....++..|+|||.+.+..++.++||||||+++|+|++|..||......+ .....+..   ..         .     
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~~---------~-----  219 (264)
T cd06623         157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---DG---------P-----  219 (264)
T ss_pred             ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---cC---------C-----
Confidence            123457889999999988889999999999999999999999997643211 11111110   00         0     


Q ss_pred             ccCchhhHH-HHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          998 ENDFSAREQ-CVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       998 ~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                        ....+.. ++..+.+++.+|++.+|++||++.|++++
T Consensus       220 --~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         220 --PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             --CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence              0111122 56789999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.4e-33  Score=305.06  Aligned_cols=254  Identities=22%  Similarity=0.353  Sum_probs=199.0

Q ss_pred             CCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC---C-------CHHHHHHHHHHHhhcCCCceeeEEeeeecCC
Q 039290          762 GFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD---G-------SLESFHAECKVMGSIRHRNLVKIISSCSNND  830 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~---~-------~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~  830 (1049)
                      +|...+.||+|+||.||+|.. .+++.||+|.++....   .       ..+.+.+|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            477789999999999999985 4788999998864321   1       1246788999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCcee
Q 039290          831 FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI  910 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~  910 (1049)
                      ..++||||+++++|.+++.... .+++..+..++.|++.|+.|+|   +.+++||||+|+||+++.++.++++|||++..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            9999999999999999987764 5889999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCccc-cccccccccCcccccccCCCC--cCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcch
Q 039290          911 LGKEESM-RQTKTLGTIGYMAPEYGREGK--VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITE  987 (1049)
Q Consensus       911 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  987 (1049)
                      ....... ......++..|+|||.+....  ++.++|+||+|+++||+++|..||......+.. ...... ....   .
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~-~~~~---~  232 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM-FKLGNK-RSAP---P  232 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH-HHhhcc-ccCC---c
Confidence            5322111 122345788999999887654  789999999999999999999998642111111 100000 0000   0


Q ss_pred             hcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          988 VADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       988 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .           .......++.++.+++.+||..+|++||++++++++
T Consensus       233 ~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         233 I-----------PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             C-----------CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            0           001112356789999999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.7e-33  Score=309.18  Aligned_cols=269  Identities=23%  Similarity=0.241  Sum_probs=200.9

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecC--CeeEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNN--DFKALV  835 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~lv  835 (1049)
                      ++|+..+.||+|+||.||+|+.. +++.+|+|.++...  +.....+.+|++++++++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888899999999999999965 68899999997543  22334677899999999999999999998777  889999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++ +|.+++......+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......
T Consensus        85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            999975 999988776667899999999999999999999   9999999999999999999999999999998765432


Q ss_pred             cccccccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccc--cCCcchhcc--
Q 039290          916 SMRQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLL--SCSITEVAD--  990 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~--  990 (1049)
                      . ......++..|+|||.+.+. .++.++|+||+|+++|||++|..||......+. ..........  ...+....+  
T Consensus       161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         161 K-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             c-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchHHHHHhhccc
Confidence            1 12234568899999988654 468899999999999999999999875322111 1100000000  000000000  


Q ss_pred             ----cccccccc--cCchhhHH-HHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          991 ----ANLLNCEE--NDFSAREQ-CVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       991 ----~~~~~~~~--~~~~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                          ........  .....+.. .++.+.+++.+|++.+|++|||++|++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence                00000000  00001111 36678999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-33  Score=312.52  Aligned_cols=251  Identities=27%  Similarity=0.334  Sum_probs=202.6

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCC---CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDG---SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      +|+..+.||+|+||.||+|... +++.||+|.+......   ..+.+.+|+++++.++||||+++++.+.+.+..++|||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            6888899999999999999965 5899999999765322   34678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          838 YMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      |+.+++|.+++... ...+++..+..++.|++.|++|||   +.||+||||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence            99999999998754 346899999999999999999999   99999999999999999999999999999875432111


Q ss_pred             ----------------------------ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccc
Q 039290          917 ----------------------------MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAG  968 (1049)
Q Consensus       917 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~  968 (1049)
                                                  .......|+..|+|||++.+..++.++||||+|+++|+|++|..||......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~  238 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD  238 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence                                        0111235788999999998888999999999999999999999999753222


Q ss_pred             cchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCC----HHHHHHH
Q 039290          969 EMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRIS----MKDVANR 1035 (1049)
Q Consensus       969 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt----~~ell~~ 1035 (1049)
                      +.....+              ....      ........+.++.+++.+|++.+|++|||    ++|++++
T Consensus       239 ~~~~~~~--------------~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         239 ETFSNIL--------------KKEV------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             HHHHHHh--------------cCCc------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            1111100              0000      00111114678999999999999999999    8888775

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-35  Score=286.88  Aligned_cols=271  Identities=21%  Similarity=0.305  Sum_probs=204.3

Q ss_pred             CCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecc--cCCCHHHHHHHHHHHhhcCCCceeeEEeeeec--------CC
Q 039290          762 GFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHME--FDGSLESFHAECKVMGSIRHRNLVKIISSCSN--------ND  830 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--------~~  830 (1049)
                      .|....++|+|.||+||+|+. ++|++||+|++-.+  ..+......+|++++..++|+|++.++++|..        ..
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            455667899999999999994 46888999876543  35567788999999999999999999988743        23


Q ss_pred             eeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCcee
Q 039290          831 FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI  910 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~  910 (1049)
                      ..|+||++|+. +|.-.+......++..++.+++.++..||.|+|   +..|+|||+||.||+|+.+|.+||+|||+++.
T Consensus        98 t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar~  173 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLARA  173 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence            57999999987 898888877677999999999999999999999   99999999999999999999999999999976


Q ss_pred             cCCCc---cccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccc--hHHHhhhhc----c
Q 039290          911 LGKEE---SMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEM--SLKRWVGDS----L  980 (1049)
Q Consensus       911 ~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--~~~~~~~~~----~  980 (1049)
                      +....   ..+.+..+-|.+|++||.+.+ ..|+++.|||+.|||+.||+||.+-+.+......  ......+..    +
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW  253 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW  253 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence            64332   334556778999999997765 6799999999999999999999988765332211  111111111    1


Q ss_pred             ccCCcchhcccc-cccccccCchhhHHHH------HHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          981 LSCSITEVADAN-LLNCEENDFSAREQCV------SSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       981 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~------~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                      ....-.++.... +.+.+++....-++..      .+..+++.+++..||.+|+++++++.|-
T Consensus       254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence            111111111111 0111222222222322      3678999999999999999999998873

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4.3e-33  Score=305.41  Aligned_cols=253  Identities=25%  Similarity=0.450  Sum_probs=197.9

Q ss_pred             CCCCceecCCCcEEEEEEEeC----CCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecCC------
Q 039290          763 FSENKLLGMGSFGSVYKGVLP----DGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNND------  830 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~~----~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~------  830 (1049)
                      |.+.+.||+|+||.||+|.+.    +++.||+|+++....  ...+++.+|++++++++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999853    467899999875432  23567889999999999999999999886532      


Q ss_pred             eeEEEEeccCCCChhhhhhcC-----CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecc
Q 039290          831 FKALVLEYMSNGSLEKCLYSD-----NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDF  905 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df  905 (1049)
                      ..++++||+.+|+|.+++...     ...+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            247889999999998876432     225788899999999999999999   999999999999999999999999999


Q ss_pred             cCceecCCCccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccC
Q 039290          906 GIAKILGKEESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSC  983 (1049)
Q Consensus       906 Gla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  983 (1049)
                      |.++........ ......++..|++||.+....++.++||||+||++|||++ |..||......+  ...+....   .
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~~---~  232 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE--IYNYLIKG---N  232 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH--HHHHHHcC---C
Confidence            999866433211 1122345678999999988889999999999999999999 888886532221  11111100   0


Q ss_pred             CcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290          984 SITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus       984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                                      ....+..++..+.+++.+||+.+|++||++.|+++.|+++
T Consensus       233 ----------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         233 ----------------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ----------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                            0001122456799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=6.3e-33  Score=305.79  Aligned_cols=250  Identities=26%  Similarity=0.305  Sum_probs=194.1

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC-CCHHHHHHHHHH-HhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD-GSLESFHAECKV-MGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|+++.... ....++..|+.. ++..+||||+++++++..++..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36888899999999999999965 799999999876532 223455556665 566689999999999999999999999


Q ss_pred             ccCCCChhhhhhc---CCCccCHHHHHHHHHHHHHHHHHhHccCCC-CeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          838 YMSNGSLEKCLYS---DNYFLDILQRLKIMIDVASALEYLHFGYST-PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       838 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      |++ |+|.+++..   ....+++..++.++.|++.|++|||   ++ +++||||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 588777654   2346899999999999999999999   87 999999999999999999999999999986533


Q ss_pred             CccccccccccccCcccccccCC----CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhc
Q 039290          914 EESMRQTKTLGTIGYMAPEYGRE----GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA  989 (1049)
Q Consensus       914 ~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  989 (1049)
                      ..  ......++..|+|||.+.+    ..++.++|+||+||++|||++|+.||.................          
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------  224 (283)
T cd06617         157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP----------  224 (283)
T ss_pred             cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC----------
Confidence            21  1223457889999998764    4568899999999999999999999864222111111111000          


Q ss_pred             ccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          990 DANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                         ..     .. ....++.++.+++.+||..+|++||++++++++
T Consensus       225 ---~~-----~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         225 ---SP-----QL-PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             ---CC-----CC-CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               00     00 001245678999999999999999999999985

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=7.4e-33  Score=304.02  Aligned_cols=247  Identities=26%  Similarity=0.378  Sum_probs=201.5

Q ss_pred             CCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          762 GFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      -|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            367788999999999999985 478899999986433 233467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      ++++|.+++...  .+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.++++|||++........ ..
T Consensus        85 ~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~  158 (277)
T cd06641          85 GGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KR  158 (277)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-hh
Confidence            999999988653  4789999999999999999999   99999999999999999999999999999876543221 22


Q ss_pred             cccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccccccc
Q 039290          920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEN  999 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1049)
                      ....++..|+|||.+.+..++.++|+||+||++|+|++|..||.......  ....+.    ..               .
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~----~~---------------~  217 (277)
T cd06641         159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--VLFLIP----KN---------------N  217 (277)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--HHHHHh----cC---------------C
Confidence            23457889999999988889999999999999999999999986532211  111000    00               0


Q ss_pred             CchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290         1000 DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus      1000 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .......++.++.+++.+||+.+|.+||++++++++
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         218 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            001112345678999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=315.31  Aligned_cols=276  Identities=26%  Similarity=0.331  Sum_probs=209.0

Q ss_pred             CCCCceecCCCcEEEEEEE-eCCCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCC------eeEE
Q 039290          763 FSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNND------FKAL  834 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~------~~~l  834 (1049)
                      |...+.||+|+||.||+|+ ..+|+.||||.+.... ....+...+|++++++++|||||+++++-++..      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            4455789999999999999 5689999999997654 345678899999999999999999999865543      5689


Q ss_pred             EEeccCCCChhhhhhcC--CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec--CCC--ceEEecccCc
Q 039290          835 VLEYMSNGSLEKCLYSD--NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN--ESM--VGHLSDFGIA  908 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~--~~~--~~kl~DfGla  908 (1049)
                      |||||.||+|...+.+.  ...+++.+.+.+..+++.||.|||   ++|||||||||.||++-  ++|  ..||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            99999999999999763  347999999999999999999999   99999999999999984  333  5799999999


Q ss_pred             eecCCCccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchH-HHhhhhccccCCcc
Q 039290          909 KILGKEESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSL-KRWVGDSLLSCSIT  986 (1049)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~  986 (1049)
                      +......  ...+.+||..|.+||+... +.|+..+|.|||||++|++.||..||.......... ..|.........+.
T Consensus       172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~  249 (732)
T KOG4250|consen  172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA  249 (732)
T ss_pred             ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence            9875443  5567899999999999985 788999999999999999999999997644332111 11211111111111


Q ss_pred             hhccccccc--ccccCchhh----HHHHHHHHHHHhhccccCCCCCC--CHHHHHHHHHHHHHhh
Q 039290          987 EVADANLLN--CEENDFSAR----EQCVSSIFSLAMDCTVDLPEKRI--SMKDVANRLVRIRETL 1043 (1049)
Q Consensus       987 ~~~~~~~~~--~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rp--t~~ell~~L~~i~~~~ 1043 (1049)
                      ....+..-.  .+....+.+    ......+...+..++.++|++|.  .+.+..+.+.+|+..-
T Consensus       250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~  314 (732)
T KOG4250|consen  250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK  314 (732)
T ss_pred             EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence            111110000  000111111    23345577788889999999999  8899988888887643

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5.2e-33  Score=309.73  Aligned_cols=252  Identities=23%  Similarity=0.285  Sum_probs=198.0

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|+..+.||+|+||.||+|... +++.||+|.+....   ....+.+.+|+++++.++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888999999999999999964 67899999987543   223457889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc-
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE-  915 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~-  915 (1049)
                      ||+++++|.+++...+ .+++..+..++.|++.|++|+|   +.+++||||||+||+++.++.+|++|||+++...... 
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            9999999999997654 4889999999999999999999   9999999999999999999999999999986421100 


Q ss_pred             -------------cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcccc
Q 039290          916 -------------SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLS  982 (1049)
Q Consensus       916 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  982 (1049)
                                   ........++..|+|||.+....++.++||||+||++|||++|..||.+....+. .........  
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~-~~~~~~~~~--  233 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-FGQVISDDI--  233 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccc--
Confidence                         0001123467889999999888899999999999999999999999865322211 111110000  


Q ss_pred             CCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCH---HHHHHH
Q 039290          983 CSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISM---KDVANR 1035 (1049)
Q Consensus       983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~---~ell~~ 1035 (1049)
                                      ........++.++.+++.+||+.+|++||++   .+++++
T Consensus       234 ----------------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         234 ----------------EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             ----------------CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence                            0000011345678999999999999999985   555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-33  Score=304.99  Aligned_cols=248  Identities=25%  Similarity=0.405  Sum_probs=200.1

Q ss_pred             CCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcC---CCceeeEEeeeecCCeeEEEE
Q 039290          762 GFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF-DGSLESFHAECKVMGSIR---HRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+++.+|+.++++++   |||++++++++.+++..++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            467788999999999999995 578999999987543 334567889999999996   999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+++++|.+++...  .+++..+..++.|+++|++|||   +.||+||||+|+||++++++.++++|||.+........
T Consensus        82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            999999999988654  5889999999999999999999   99999999999999999999999999999987754332


Q ss_pred             ccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                       ......++..|+|||.+.+ ..++.++||||+||++|+|++|..||.......     +..... ..     ..+.+  
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~~~~~-~~-----~~~~~--  222 (277)
T cd06917         157 -KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----AMMLIP-KS-----KPPRL--  222 (277)
T ss_pred             -ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----hhhccc-cC-----CCCCC--
Confidence             2233468889999998765 456899999999999999999999997532111     110000 00     00000  


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                       .      ....+.++.+++.+||+.||++||++.|++++
T Consensus       223 -~------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         223 -E------DNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             -C------cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence             0      01145678999999999999999999999875

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5.8e-33  Score=310.04  Aligned_cols=270  Identities=23%  Similarity=0.255  Sum_probs=201.1

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecC--CeeEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNN--DFKAL  834 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~l  834 (1049)
                      .++|+..+.||+|+||.||+|... +|+.||+|+++....  .....+.+|++++++++||||+++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            457899999999999999999964 689999999875432  2234567899999999999999999998754  56899


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      ||||+++ +|.+++......+++.++..++.|++.|++|||   +.|++||||||+||+++.++.+||+|||.+......
T Consensus        86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            9999975 888888766667899999999999999999999   999999999999999999999999999999876543


Q ss_pred             ccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcccc---CCcchh--
Q 039290          915 ESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLS---CSITEV--  988 (1049)
Q Consensus       915 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~--  988 (1049)
                      .. ......++..|+|||.+.+ ..++.++||||+||++|||++|..||......+. ...... ....   ......  
T Consensus       162 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~  238 (309)
T cd07845         162 AK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ-LDLIIQ-LLGTPNESIWPGFSD  238 (309)
T ss_pred             cC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-hcCCCChhhchhhhc
Confidence            21 1223345788999998865 5578999999999999999999999975322211 111100 0000   000000  


Q ss_pred             -cccccccccccCch----hhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          989 -ADANLLNCEENDFS----AREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       989 -~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                       ..............    .....++++.+++.+|+++||++|||++|+++|-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~  291 (309)
T cd07845         239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS  291 (309)
T ss_pred             ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence             00000000000000    0112356788999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.2e-33  Score=304.93  Aligned_cols=248  Identities=27%  Similarity=0.319  Sum_probs=203.4

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC---CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD---GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      +|++.+.||+|+||.||+|... ++..||+|++.....   ...+.+.+|++++++++||||+++++++.+++..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788899999999999999965 689999999975432   345788999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      |+++++|.+++... ..+++.++..++.|+++|++|||   +.+++|+||+|+||++++++.++|+|||.+.......  
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            99999999998765 45899999999999999999999   9999999999999999999999999999988664432  


Q ss_pred             cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccccc
Q 039290          918 RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE  997 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1049)
                      ......++..|+|||++.+..++.++|+||+|+++|+|++|..||......  .......... .               
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~-~---------------  216 (258)
T cd05578         155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQE-T---------------  216 (258)
T ss_pred             cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhc-c---------------
Confidence            123345788999999998888999999999999999999999999764321  1111110000 0               


Q ss_pred             ccCchhhHHHHHHHHHHHhhccccCCCCCCCH--HHHHH
Q 039290          998 ENDFSAREQCVSSIFSLAMDCTVDLPEKRISM--KDVAN 1034 (1049)
Q Consensus       998 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~--~ell~ 1034 (1049)
                       .....+...+..+.+++.+||+.||.+||++  +|+++
T Consensus       217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence             0111223345788999999999999999999  66654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.4e-34  Score=288.73  Aligned_cols=273  Identities=21%  Similarity=0.238  Sum_probs=200.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC---C--CcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeec-CCe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP---D--GMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSN-NDF  831 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~---~--~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~-~~~  831 (1049)
                      ...|+..+.||+|+||.||+|...   +  ...+|+|+++.+.+  +......+|+..++.++|||++.+..++.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            446888999999999999999632   2  33799999987653  335678899999999999999999999877 778


Q ss_pred             eEEEEeccCCCChhhhhhcC----CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCC----CceEEe
Q 039290          832 KALVLEYMSNGSLEKCLYSD----NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES----MVGHLS  903 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~----~~~kl~  903 (1049)
                      .++++||.+. +|.+.++-.    .+.++...++.|+.||+.|+.|||   +.-|+|||+||.||||..+    |.|||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEee
Confidence            9999999988 888887643    246888999999999999999999   9999999999999999866    999999


Q ss_pred             cccCceecCCCccc--cccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCcccccc-----chHHHh
Q 039290          904 DFGIAKILGKEESM--RQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGE-----MSLKRW  975 (1049)
Q Consensus       904 DfGla~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~-----~~~~~~  975 (1049)
                      |+|+++.+...-..  .....+-|.+|+|||.+.+ ..|+++.|||+.|||+.||+|-++-|.+....-     ....+.
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            99999988654422  2334677999999998876 568999999999999999999887775432110     011110


Q ss_pred             --hhhccccCCcchhccccccccc-------c-cC---------chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          976 --VGDSLLSCSITEVADANLLNCE-------E-ND---------FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       976 --~~~~~~~~~~~~~~~~~~~~~~-------~-~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                        +=.....+...++.+-.-.+..       + ..         +......++..++++.++++.||.+|.|+++.+++.
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence              0011111111111110000000       0 00         000011223378999999999999999999999874

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=8.1e-33  Score=308.46  Aligned_cols=246  Identities=26%  Similarity=0.329  Sum_probs=197.6

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCC---CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDG---SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      .+|+..+.||+|+||.||+|+.. +++.||+|++......   ..+++.+|+++++.++||||+++++++.+++..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888899999999999999964 6889999998644322   2356889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||++ |++.+.+......+++..+..++.|++.|++|||   +.+|+||||+|+||+++.++.++|+|||++......  
T Consensus        95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--  168 (307)
T cd06607          95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--  168 (307)
T ss_pred             HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence            9997 5777777655556899999999999999999999   999999999999999999999999999998765332  


Q ss_pred             ccccccccccCcccccccC---CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGR---EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                         ....++..|+|||++.   ...++.++||||||+++|||++|..||.......... . ..   ...          
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~-~-~~---~~~----------  230 (307)
T cd06607         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-H-IA---QND----------  230 (307)
T ss_pred             ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH-H-Hh---cCC----------
Confidence               2245788999999874   3568899999999999999999999986532111110 0 00   000          


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                          . .......++..+.+++.+||+.+|++||++.+++.+
T Consensus       231 ----~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         231 ----S-PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             ----C-CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                0 000112356679999999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.6e-33  Score=316.65  Aligned_cols=265  Identities=23%  Similarity=0.243  Sum_probs=199.0

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecC------
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNN------  829 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~------  829 (1049)
                      ..++|+..+.||+|+||.||+|.. .+++.||+|++....  .....++.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            456899999999999999999995 478999999986432  22345677899999999999999999988543      


Q ss_pred             CeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCce
Q 039290          830 DFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK  909 (1049)
Q Consensus       830 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~  909 (1049)
                      ...++||||+.+ +|.+.+...   +++.++..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||++.
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence            357999999965 888877543   788999999999999999999   9999999999999999999999999999998


Q ss_pred             ecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccc--------
Q 039290          910 ILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLL--------  981 (1049)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--------  981 (1049)
                      .......  .....++..|+|||.+.+..++.++||||+||++|+|++|+.||......+ ...........        
T Consensus       167 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~  243 (353)
T cd07850         167 TAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID-QWNKIIEQLGTPSDEFMSR  243 (353)
T ss_pred             eCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHH
Confidence            7643321  233457889999999999899999999999999999999999986532111 00000000000        


Q ss_pred             ----------cC------CcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          982 ----------SC------SITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       982 ----------~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                                ..      ...+.........  .........+..+.+++.+|++.||++|||++|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPP--DSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             hhhhhhHHhhcCCCCCCcchhhhCcccccCc--ccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                      00      0000000000000  0000012345678999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=6.9e-33  Score=302.21  Aligned_cols=252  Identities=23%  Similarity=0.318  Sum_probs=202.2

Q ss_pred             CCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeec--CCeeEEEE
Q 039290          762 GFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSN--NDFKALVL  836 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--~~~~~lv~  836 (1049)
                      +|++.+.||.|+||.||+|.. .++..||+|++....  ....+++.+|++++++++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477889999999999999985 478899999987543  2234568889999999999999999997754  45678999


Q ss_pred             eccCCCChhhhhhcC---CCccCHHHHHHHHHHHHHHHHHhHccC--CCCeEEcCCCCCCeeecCCCceEEecccCceec
Q 039290          837 EYMSNGSLEKCLYSD---NYFLDILQRLKIMIDVASALEYLHFGY--STPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL  911 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~  911 (1049)
                      ||+++++|.+++...   ...+++..++.++.|++.|++|+|..+  +.+++||||+|+||+++.++.+|++|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998653   446899999999999999999999443  678999999999999999999999999999876


Q ss_pred             CCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccc
Q 039290          912 GKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA  991 (1049)
Q Consensus       912 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  991 (1049)
                      ...... .....+++.|+|||++.+..++.++||||+|+++|+|++|..||......  ...+.+.    ...       
T Consensus       161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~----~~~-------  226 (265)
T cd08217         161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL--QLASKIK----EGK-------  226 (265)
T ss_pred             cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH--HHHHHHh----cCC-------
Confidence            543321 22346789999999998888999999999999999999999999753211  1111110    000       


Q ss_pred             ccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          992 NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                       .       ...+...+..+.+++.+|++.+|++||++++++++
T Consensus       227 -~-------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         227 -F-------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             -C-------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence             0       01122345678999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=8.8e-34  Score=331.52  Aligned_cols=255  Identities=27%  Similarity=0.354  Sum_probs=192.7

Q ss_pred             HHhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecC------
Q 039290          758 RATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNN------  829 (1049)
Q Consensus       758 ~~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~------  829 (1049)
                      +...+|+..+.||+|+||.||+++.+ ||+.||||++.... +.....+.+|+.++++++|||||+++.+|.+.      
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            44566788899999999999999965 99999999997664 33456788999999999999999998322100      


Q ss_pred             --------------------------------------------------------------------------------
Q 039290          830 --------------------------------------------------------------------------------  829 (1049)
Q Consensus       830 --------------------------------------------------------------------------------  829 (1049)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------------CeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHc
Q 039290          830 ---------------------------------DFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF  876 (1049)
Q Consensus       830 ---------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~  876 (1049)
                                                       -.+||-||||+...++++++.+...-.....|+++++|++|++|+| 
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH-  714 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH-  714 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH-
Confidence                                             1357889999998888888776543357788999999999999999 


Q ss_pred             cCCCCeEEcCCCCCCeeecCCCceEEecccCceecC-----------------CCccccccccccccCcccccccCCC--
Q 039290          877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG-----------------KEESMRQTKTLGTIGYMAPEYGREG--  937 (1049)
Q Consensus       877 ~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~-----------------~~~~~~~~~~~~~~~y~aPE~~~~~--  937 (1049)
                        +.|||||||||.|||+++++.|||+|||+|....                 .......+..+||.-|+|||++.+.  
T Consensus       715 --~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~  792 (1351)
T KOG1035|consen  715 --DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS  792 (1351)
T ss_pred             --hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence              9999999999999999999999999999998721                 0112244567899999999998764  


Q ss_pred             -CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHh
Q 039290          938 -KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAM 1016 (1049)
Q Consensus       938 -~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 1016 (1049)
                       .|+.|+|+||+|+|++||+.   ||......-..+....     .+.+...            .....+..+.-..+|+
T Consensus       793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR-----~g~iP~~------------~~f~~~~~~~e~slI~  852 (1351)
T KOG1035|consen  793 NKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR-----KGSIPEP------------ADFFDPEHPEEASLIR  852 (1351)
T ss_pred             ccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc-----cCCCCCC------------cccccccchHHHHHHH
Confidence             49999999999999999985   5654222211111111     1111110            0001112233467999


Q ss_pred             hccccCCCCCCCHHHHHHH
Q 039290         1017 DCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus      1017 ~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      +|++.||.+||||.|++..
T Consensus       853 ~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  853 WLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             HHhcCCCccCCCHHHHhhc
Confidence            9999999999999999863

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1e-32  Score=304.47  Aligned_cols=256  Identities=26%  Similarity=0.285  Sum_probs=200.7

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeec--CCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSN--NDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--~~~~~lv~  836 (1049)
                      ++|+..+.||.|++|.||+|... +++.||+|.+..... ....++.+|++++++++||||+++++++.+  .+..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36788899999999999999964 688999999875432 345678999999999999999999998855  34789999


Q ss_pred             eccCCCChhhhhhc---CCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          837 EYMSNGSLEKCLYS---DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       837 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      ||+++++|.+++..   ....+++..+..++.|+++|++|||   +.+++|+||+|+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999887653   3345788999999999999999999   99999999999999999999999999999875532


Q ss_pred             CccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCcccc---ccchHHHhhhhccccCCcchhcc
Q 039290          914 EESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFA---GEMSLKRWVGDSLLSCSITEVAD  990 (1049)
Q Consensus       914 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  990 (1049)
                      ...   ....++..|+|||.+.+..++.++||||+||++|+|++|+.||.....   .......+.....    .     
T Consensus       158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~-----  225 (287)
T cd06621         158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP----N-----  225 (287)
T ss_pred             ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC----c-----
Confidence            221   123467889999999888999999999999999999999999976422   1111222211100    0     


Q ss_pred             cccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          991 ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ..+...    .......++.+.+++.+||+.+|++|||+.|++++
T Consensus       226 ~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         226 PELKDE----PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             hhhccC----CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            000000    01011245678999999999999999999999985

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3e-33  Score=308.02  Aligned_cols=249  Identities=25%  Similarity=0.300  Sum_probs=210.7

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ...|.+.+.||+|.|++|..|++ .++..||+|.+++..-  .....+.+|+++|+.++|||||+++.+.+....+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            45789999999999999999995 4799999999987653  23456899999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+.+|.+.+++..+++ ..+..+..++.|+.+|++|||   ++.|||||||++||+++.+..+||+|||++.++.... 
T Consensus       135 eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~-  209 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL-  209 (596)
T ss_pred             EeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecccc-
Confidence            99999999999998877 445889999999999999999   9999999999999999999999999999999886333 


Q ss_pred             ccccccccccCcccccccCCCCc-CcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKV-SRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                       ...+..|++.|.|||++.+.+| .+++|+||+|+++|-|+.|..||++..-.+                  ..++.+. 
T Consensus       210 -~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~------------------Lr~rvl~-  269 (596)
T KOG0586|consen  210 -MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE------------------LRPRVLR-  269 (596)
T ss_pred             -cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc------------------ccchhee-
Confidence             3445789999999999998776 589999999999999999999998632222                  2222222 


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                         +++..+...+.+..+++++++..+|.+|++.++++++-
T Consensus       270 ---gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~  307 (596)
T KOG0586|consen  270 ---GKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR  307 (596)
T ss_pred             ---eeecccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence               22233333455678999999999999999999998873

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.8e-33  Score=306.25  Aligned_cols=268  Identities=23%  Similarity=0.283  Sum_probs=199.1

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      +|+..+.||+|+||.||+|+.. +++.||+|+++...  ......+.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999864 78899999987543  22346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          839 MSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       839 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      +. ++|.+++... ...+++..+..++.|+++|++|||   +.+++||||+|+||+++.++.+|++|||++........ 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            96 5888887653 345889999999999999999999   99999999999999999999999999999876543221 


Q ss_pred             cccccccccCcccccccCCCC-cCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcc-ccCCcchhcc-----
Q 039290          918 RQTKTLGTIGYMAPEYGREGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSL-LSCSITEVAD-----  990 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----  990 (1049)
                      ......++..|+|||++.+.. ++.++||||+|+++|||+||+.||......+. ..+...... ..........     
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChhhhhhhhHHHHH
Confidence            122335678899999876644 58899999999999999999999865322111 111111000 0000000000     


Q ss_pred             -cccccccccCc-hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          991 -ANLLNCEENDF-SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       991 -~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                       ........... ......+.++.+++.+|++.||++|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence             00000000000 0112245678899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.7e-32  Score=298.99  Aligned_cols=250  Identities=22%  Similarity=0.278  Sum_probs=196.4

Q ss_pred             HHHHHHhcCCCCCcee--cCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhc-CCCceeeEEeeeecC
Q 039290          754 QDLLRATDGFSENKLL--GMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLVKIISSCSNN  829 (1049)
Q Consensus       754 ~~~~~~~~~~~~~~~l--g~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~  829 (1049)
                      .+.....+.|++.+.+  |+|+||.||++.. .++..+|+|.+........     |......+ +||||+++++++...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence            3444455677777776  9999999999995 4788899999875422111     22222222 799999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC-ceEEecccCc
Q 039290          830 DFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM-VGHLSDFGIA  908 (1049)
Q Consensus       830 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-~~kl~DfGla  908 (1049)
                      +..++||||+++++|.+++.... .+++.++..++.|+++|++|+|   +.+++||||||+||+++.++ .++++|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~  157 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLC  157 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence            99999999999999999987764 6899999999999999999999   99999999999999999888 9999999998


Q ss_pred             eecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchh
Q 039290          909 KILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEV  988 (1049)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  988 (1049)
                      .......     ...++..|+|||++.+..++.++||||+|+++|||++|+.||......+.....+.....        
T Consensus       158 ~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------  224 (267)
T PHA03390        158 KIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ--------  224 (267)
T ss_pred             eecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc--------
Confidence            8654322     235788999999999888999999999999999999999999754333322232221110        


Q ss_pred             cccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCC-HHHHHHH
Q 039290          989 ADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRIS-MKDVANR 1035 (1049)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-~~ell~~ 1035 (1049)
                                .........+..+.+++.+|++.+|++||+ ++|+++|
T Consensus       225 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        225 ----------KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             ----------ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence                      011111245677899999999999999996 6998864

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=333.37  Aligned_cols=260  Identities=25%  Similarity=0.304  Sum_probs=216.1

Q ss_pred             HHHHHHhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeec---ccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecC
Q 039290          754 QDLLRATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM---EFDGSLESFHAECKVMGSIRHRNLVKIISSCSNN  829 (1049)
Q Consensus       754 ~~~~~~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~  829 (1049)
                      .+++-..++|.+.++||+|+||.|..++++ +++.||.|++.+   -.....+-|..|-++|..-..+-|++++.+|.+.
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            344555678999999999999999999964 678899999865   2345567899999999988899999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCce
Q 039290          830 DFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK  909 (1049)
Q Consensus       830 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~  909 (1049)
                      +++|+||||++||+|-.++.+.. .+++..++-++..|.-||.-+|   +.|+|||||||+|||+|..|++||+|||.+.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsCl  223 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCL  223 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHH
Confidence            99999999999999999998887 6899999999999999999999   9999999999999999999999999999999


Q ss_pred             ecCCCccccccccccccCcccccccCC-----CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCC
Q 039290          910 ILGKEESMRQTKTLGTIGYMAPEYGRE-----GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCS  984 (1049)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  984 (1049)
                      .+..++.......+|||.|++||++..     +.|++.+|.||+||++|||+.|..||....-.+..-..          
T Consensus       224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KI----------  293 (1317)
T KOG0612|consen  224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKI----------  293 (1317)
T ss_pred             hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHH----------
Confidence            998888888888999999999998753     57899999999999999999999999863222211111          


Q ss_pred             cchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCC---HHHHHHHH
Q 039290          985 ITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRIS---MKDVANRL 1036 (1049)
Q Consensus       985 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~ell~~L 1036 (1049)
                          .+-    ...-.++...+.+++..++|.+.+. +|+.|..   ++++..|-
T Consensus       294 ----m~h----k~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp  339 (1317)
T KOG0612|consen  294 ----MNH----KESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP  339 (1317)
T ss_pred             ----hch----hhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence                100    0001122224467888999988776 4888887   88888773

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-32  Score=304.11  Aligned_cols=267  Identities=28%  Similarity=0.312  Sum_probs=202.2

Q ss_pred             CCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecC--CeeEEEEe
Q 039290          763 FSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNN--DFKALVLE  837 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~lv~e  837 (1049)
                      |++.+.||+|+||.||+|+.. +++.||+|+++...  ......+.+|+++++.++|||++++++++.+.  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999965 58899999998663  33456788999999999999999999999887  88999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      |+++ +|.+++......+++.+++.++.|+++|++|||   +.+++|+||+|+||++++++.+|++|||.+.........
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence            9975 898888766557899999999999999999999   999999999999999999999999999999877544322


Q ss_pred             cccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCC---cchhcc---
Q 039290          918 RQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCS---ITEVAD---  990 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~---  990 (1049)
                      ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ......+ ......   .....+   
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE-QLEKIFE-LCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHH-HhCCCchhhccccccchh
Confidence            2333456788999997654 457899999999999999999999987533211 1111111 000000   000000   


Q ss_pred             -cccccccc--cCc-hhhHH-HHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          991 -ANLLNCEE--NDF-SAREQ-CVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       991 -~~~~~~~~--~~~-~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                       ........  ... ..... ++.++.+++.+||+.+|++||++++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence             00000000  000 00111 36789999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.6e-33  Score=328.71  Aligned_cols=273  Identities=17%  Similarity=0.159  Sum_probs=190.9

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEeCC--CcEEEEEEe--------------ec---ccCCCHHHHHHHHHHHhhcCCCce
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVLPD--GMEIAAKVF--------------HM---EFDGSLESFHAECKVMGSIRHRNL  819 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~~~--~~~vavK~~--------------~~---~~~~~~~~~~~e~~~l~~l~hpni  819 (1049)
                      ..++|++.+.||+|+||+||+|..+.  +..++.|.+              .+   ........+.+|++++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            35689999999999999999987432  222222211              10   011124567899999999999999


Q ss_pred             eeEEeeeecCCeeEEEEeccCCCChhhhhhcCC----CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec
Q 039290          820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDN----YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN  895 (1049)
Q Consensus       820 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~  895 (1049)
                      +++++++.+.+..|+|+|++.+ ++.+++....    ......++..++.|++.||+|||   ++|||||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence            9999999999999999999954 7777665422    12345667889999999999999   99999999999999999


Q ss_pred             CCCceEEecccCceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCC-CCcccccc-chHH
Q 039290          896 ESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP-TDEIFAGE-MSLK  973 (1049)
Q Consensus       896 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p-~~~~~~~~-~~~~  973 (1049)
                      .++.+||+|||++..+............|+..|+|||++.+..++.++||||+||++|||++|..+ |....... ....
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            999999999999987754443333446789999999999998999999999999999999998754 43321111 1111


Q ss_pred             Hhhhhcc-ccCCc----chhcc---cccccccccC---chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          974 RWVGDSL-LSCSI----TEVAD---ANLLNCEEND---FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       974 ~~~~~~~-~~~~~----~~~~~---~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      +...... .....    .+..+   ..........   .......+.++.+++.+|++.||.+|||+.|++++
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            1111000 00000    00000   0000000000   00111234567889999999999999999999986

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-33  Score=304.23  Aligned_cols=267  Identities=22%  Similarity=0.294  Sum_probs=199.2

Q ss_pred             CCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          763 FSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      |+..+.||+|++|.||+|... +|..||+|++....  ......+.+|++++++++|||++++++++.+++..++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            667889999999999999954 79999999987554  223467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          840 SNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       840 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      + ++|.+++.... ..+++..+..++.|+++|++|||   +++++||||+|+||+++.++.++|+|||.+........ .
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~  155 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-T  155 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-c
Confidence            5 68999887654 35899999999999999999999   99999999999999999999999999999976543221 1


Q ss_pred             ccccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccC--C---cchhcc--
Q 039290          919 QTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSC--S---ITEVAD--  990 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~---~~~~~~--  990 (1049)
                      .....++..|+|||++.+. .++.++||||+|+++|+|++|+.||......+... ..........  .   ...+.+  
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF-RIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCCChHHhhhhhhchhhh
Confidence            1223567899999987654 56889999999999999999999986532211111 1110000000  0   000000  


Q ss_pred             ccccccc-ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          991 ANLLNCE-ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       991 ~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ....... ..........+.++.+++.+|++.+|++|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0000000 00001112344678999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=284.52  Aligned_cols=249  Identities=24%  Similarity=0.279  Sum_probs=204.1

Q ss_pred             hcCCCCCceecCCCcEEEEEEE-eCCCcEEEEEEeecccCC---CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDG---SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      .++|...++||+|.||+|..++ ..+++.||+|+++++.-.   ..+.-..|-++++.-+||.+..+-..|+..+++|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            4678889999999999999998 558999999999877533   344556789999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+.||.|.-.+...+ .+++...+-+..+|..||.|||   +++||.||+|.+|.|+|.+|++||+|||+++.--. .
T Consensus       247 MeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-~  321 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-Y  321 (516)
T ss_pred             EEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccc-c
Confidence            99999999988877654 4788888889999999999999   99999999999999999999999999999874322 2


Q ss_pred             cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                      .......+|||.|.|||++....|.+++|.|.+||+||||++|+.||.....+...-....                   
T Consensus       322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~-------------------  382 (516)
T KOG0690|consen  322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM-------------------  382 (516)
T ss_pred             cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh-------------------
Confidence            2334567899999999999999999999999999999999999999976332221111111                   


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRI-----SMKDVANR 1035 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~~ 1035 (1049)
                         .+...|...+++...++...+..||.+|.     .+.||.++
T Consensus       383 ---ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  383 ---EDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             ---hhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence               01122334566788999999999999998     45555544

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-33  Score=258.30  Aligned_cols=268  Identities=22%  Similarity=0.253  Sum_probs=203.8

Q ss_pred             CCCCCceecCCCcEEEEEEE-eCCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          762 GFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      .|...++||+|.||+||+|+ +.+++.||+|+++.+.  ++......+|+-+++.++|.|||+++++...++.+.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            45566889999999999999 5578889999987654  45577889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      |.. +|.++...-...++.+.++.++.|+++|+.|+|   ++++.|||+||.|.+++.+|+.|++|||+|+.++.+.. -
T Consensus        83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvr-c  157 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-C  157 (292)
T ss_pred             hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE-e
Confidence            965 999998887777999999999999999999999   99999999999999999999999999999998765432 1


Q ss_pred             ccccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCC-CCccccccchHHHh--hhhccccCCc---chhccc
Q 039290          919 QTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKP-TDEIFAGEMSLKRW--VGDSLLSCSI---TEVADA  991 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p-~~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~  991 (1049)
                      ....+-|.+|++|.++.+. -|+...|+||.|||+.|+.....| |.+..-. .+..+.  .-....+..+   ....|-
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd-dqlkrif~~lg~p~ed~wps~t~lpdy  236 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEDQWPSMTKLPDY  236 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH-HHHHHHHHHhCCCccccCCccccCCCC
Confidence            2345679999999998875 478899999999999999984444 4432222 222221  1111111111   112221


Q ss_pred             ccccccccCc---hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          992 NLLNCEENDF---SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       992 ~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ...+..+.-.   +.-+.....=++++++.+.-+|.+|.++++.+++
T Consensus       237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            1111111111   1112233445789999999999999999998876

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.5e-32  Score=305.71  Aligned_cols=246  Identities=26%  Similarity=0.331  Sum_probs=198.0

Q ss_pred             CCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC---CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          763 FSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD---GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      |+..+.||+|+||.||+|+. .++..||+|++.....   .....+.+|++++++++|||++++++++.+++..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            66778999999999999995 4788999999865422   2245688899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      +.+ ++.+.+......+++.++..++.|++.|++|||   +.+|+||||+|+||+++.++.++|+|||++......    
T Consensus       107 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~----  178 (317)
T cd06635         107 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----  178 (317)
T ss_pred             CCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence            975 788877665667899999999999999999999   999999999999999999999999999998754322    


Q ss_pred             ccccccccCcccccccC---CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          919 QTKTLGTIGYMAPEYGR---EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                       ....++..|+|||++.   .+.++.++||||+||++|||++|+.||......+. ...+.....               
T Consensus       179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~~~---------------  241 (317)
T cd06635         179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNES---------------  241 (317)
T ss_pred             -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHhccC---------------
Confidence             2245788999999873   45688999999999999999999999865321111 111111000               


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                          ........+..+.+++.+||+.+|.+||++.+++++..
T Consensus       242 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         242 ----PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             ----CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence                00011234567899999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=282.51  Aligned_cols=252  Identities=23%  Similarity=0.261  Sum_probs=199.2

Q ss_pred             hcCCCCC-ceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhc-CCCceeeEEeeeec----CCee
Q 039290          760 TDGFSEN-KLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLVKIISSCSN----NDFK  832 (1049)
Q Consensus       760 ~~~~~~~-~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~----~~~~  832 (1049)
                      +++|++. ++||-|-.|.|..+.. .+++++|+|++...     ...++|++..-.. .|||||+++++|+.    ...+
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            3455544 5799999999999985 47899999998633     5678888876554 69999999999864    4577


Q ss_pred             EEEEeccCCCChhhhhhcCCC-ccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec---CCCceEEecccCc
Q 039290          833 ALVLEYMSNGSLEKCLYSDNY-FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIA  908 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~---~~~~~kl~DfGla  908 (1049)
                      .+|||.++||.|.+.+.+++. .+++.++..|+.||+.|+.|||   +.+|.|||+||+|+|.+   .+..+|++|||+|
T Consensus       135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA  211 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA  211 (400)
T ss_pred             EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccc
Confidence            899999999999999987554 6999999999999999999999   99999999999999996   4668999999999


Q ss_pred             eecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchh
Q 039290          909 KILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEV  988 (1049)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  988 (1049)
                      +.....  ....+...|+.|.|||++...+|+..+|+||+||+||-|++|.+||...-.-...-              .+
T Consensus       212 K~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aisp--------------gM  275 (400)
T KOG0604|consen  212 KETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--------------GM  275 (400)
T ss_pred             cccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCCh--------------hH
Confidence            875432  23445667999999999999999999999999999999999999997632211100              00


Q ss_pred             cccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          989 ADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ..+.......-..+.+...+++.+++|+.++..+|++|.|++|++++
T Consensus       276 k~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  276 KRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             HhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            00000000111112335678889999999999999999999999886

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.5e-32  Score=301.54  Aligned_cols=242  Identities=22%  Similarity=0.262  Sum_probs=189.1

Q ss_pred             eecCCCcEEEEEEEeC-CCcEEEEEEeecccC---CCHHHHHHHHHHHhh---cCCCceeeEEeeeecCCeeEEEEeccC
Q 039290          768 LLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD---GSLESFHAECKVMGS---IRHRNLVKIISSCSNNDFKALVLEYMS  840 (1049)
Q Consensus       768 ~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~---l~hpniv~l~~~~~~~~~~~lv~e~~~  840 (1049)
                      .||+|+||.||+|... +++.||+|.+.....   .....+.+|..+++.   .+||+|+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999964 688999999865432   112334445444333   479999999999999999999999999


Q ss_pred             CCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccccc
Q 039290          841 NGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT  920 (1049)
Q Consensus       841 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~  920 (1049)
                      +++|.+++.... .+++..+..++.|++.|++|||   +.+|+||||||+||++++++.++++|||++.......   ..
T Consensus        81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~  153 (279)
T cd05633          81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH  153 (279)
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---cc
Confidence            999999887654 4899999999999999999999   9999999999999999999999999999987653322   12


Q ss_pred             ccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccccccc
Q 039290          921 KTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEN  999 (1049)
Q Consensus       921 ~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1049)
                      ...++..|+|||.+.+ ..++.++||||+||++|||++|..||..............   ..                ..
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---~~----------------~~  214 (279)
T cd05633         154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TL----------------TV  214 (279)
T ss_pred             CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH---hh----------------cC
Confidence            3468999999998864 5688999999999999999999999975432221111100   00                00


Q ss_pred             CchhhHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 039290         1000 DFSAREQCVSSIFSLAMDCTVDLPEKRI-----SMKDVANR 1035 (1049)
Q Consensus      1000 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~~ 1035 (1049)
                      ....+...+.++.+++.+|++.||++||     +++|+++|
T Consensus       215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            1112233567889999999999999999     69999987

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.5e-32  Score=296.61  Aligned_cols=251  Identities=30%  Similarity=0.384  Sum_probs=206.7

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecC--CeeEEEE
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNN--DFKALVL  836 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~lv~  836 (1049)
                      +|+..+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|++++++++||||+++++.+.+.  +..++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999965 788999999876542  3467889999999999999999999999888  8899999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+++++|.+++.... .+++.+++.++.|+++|++|||   +.+++|+|++|+||+++.++.++|+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            9999999999988765 6899999999999999999999   99999999999999999999999999999987754432


Q ss_pred             c-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          917 M-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       917 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                      . ......++..|+|||...+..++.++||||+|+++++|++|..||......  ....+.  ..         .     
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~--~~---------~-----  218 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP--MAALYK--IG---------S-----  218 (260)
T ss_pred             cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHHHHh--cc---------c-----
Confidence            1 123356788999999998888999999999999999999999999764311  100000  00         0     


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                       .......+...+..+.+++.+|++.+|++||++.|++++
T Consensus       219 -~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         219 -SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             -cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence             001111223346789999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.1e-32  Score=301.50  Aligned_cols=264  Identities=20%  Similarity=0.216  Sum_probs=196.0

Q ss_pred             CCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC-CCHHHHHHHHHHHhhcC-CCceeeEEeeeecC--CeeEEEEe
Q 039290          763 FSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD-GSLESFHAECKVMGSIR-HRNLVKIISSCSNN--DFKALVLE  837 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~--~~~~lv~e  837 (1049)
                      |++.+.||+|+||.||+|+. .+++.||+|+++.... .......+|+.++.++. |||++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            56788999999999999995 4788999999875432 22334457888888885 99999999999887  88999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      |+++ ++.+.+......+++.++..++.|++.||+|||   +.+++||||+|+||+++. +.+||+|||++.........
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~  155 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY  155 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence            9974 888887765567899999999999999999999   999999999999999999 99999999999866433221


Q ss_pred             cccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCc--chhc-----
Q 039290          918 RQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSI--TEVA-----  989 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-----  989 (1049)
                        ....++..|+|||++.. ..++.++||||+||++|||++|..||......+  ...+..........  ....     
T Consensus       156 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         156 --TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             --CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcCCCCHHHHHhhccccc
Confidence              22457889999997644 557889999999999999999999996532211  11111111100000  0000     


Q ss_pred             -cccccccc-ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          990 -DANLLNCE-ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       990 -~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                       +....... ..-.......+.++.+++.+|++.+|++||++++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence             00000000 00001123457889999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-32  Score=307.47  Aligned_cols=270  Identities=21%  Similarity=0.261  Sum_probs=198.2

Q ss_pred             CCCCCceecCCCcEEEEEEEeC---CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecC--CeeE
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP---DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNN--DFKA  833 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~  833 (1049)
                      +|++.+.||+|+||.||+|...   ++..||+|.+....   ....+.+.+|+.++++++||||+++++++.+.  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788899999999999999964   47899999998643   44456788999999999999999999999888  8899


Q ss_pred             EEEeccCCCChhhhhhcC----CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC----CCceEEecc
Q 039290          834 LVLEYMSNGSLEKCLYSD----NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE----SMVGHLSDF  905 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~----~~~~kl~Df  905 (1049)
                      +||||+++ ++.+.+...    ...+++..++.++.|++.|++|||   +.+|+||||||+||+++.    ++.+|++||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 666655422    225889999999999999999999   999999999999999998    999999999


Q ss_pred             cCceecCCCcc--ccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccc--------hHHH
Q 039290          906 GIAKILGKEES--MRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEM--------SLKR  974 (1049)
Q Consensus       906 Gla~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--------~~~~  974 (1049)
                      |++........  .......++..|+|||++.+ ..++.++||||+||+++||++|..||........        ....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99986643222  12223457889999998765 4578999999999999999999999975433220        0111


Q ss_pred             hhhhcccc-----------CCcchhcccccccccc-cCc----hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          975 WVGDSLLS-----------CSITEVADANLLNCEE-NDF----SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       975 ~~~~~~~~-----------~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ........           .......+........ ...    ......+.++.+++.+|+++||++|||++|++++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            10000000           0000000000000000 000    0001345678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.1e-32  Score=304.65  Aligned_cols=245  Identities=24%  Similarity=0.319  Sum_probs=197.8

Q ss_pred             CceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCCCh
Q 039290          766 NKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSL  844 (1049)
Q Consensus       766 ~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  844 (1049)
                      ..+||+|+||.||+|.. .+++.||+|++..........+.+|+.+++.++|||++++++++...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            36799999999999986 47899999998655444566789999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccccccccc
Q 039290          845 EKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLG  924 (1049)
Q Consensus       845 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  924 (1049)
                      .+++...  .+++..+..++.|++.|++|||   +.|++||||+|+||++++++.++++|||.+........ ......+
T Consensus       105 ~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~  178 (292)
T cd06657         105 TDIVTHT--RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVG  178 (292)
T ss_pred             HHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccccc
Confidence            9987543  4788999999999999999999   99999999999999999999999999999876543221 1223457


Q ss_pred             ccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCchhh
Q 039290          925 TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAR 1004 (1049)
Q Consensus       925 ~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1049)
                      +..|+|||.+.+..++.++|+||+|+++|||++|..||......  ........             ..    .......
T Consensus       179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~~~-------------~~----~~~~~~~  239 (292)
T cd06657         179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRD-------------NL----PPKLKNL  239 (292)
T ss_pred             CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh-------------hC----CcccCCc
Confidence            88999999998888999999999999999999999998642111  11110000             00    0001111


Q ss_pred             HHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290         1005 EQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus      1005 ~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ...+..+.+++.+||+.+|.+||++.+++++
T Consensus       240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             ccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            2245568899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.2e-32  Score=301.64  Aligned_cols=268  Identities=22%  Similarity=0.288  Sum_probs=200.9

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      +|+..+.||+|++|.||+|+.. +|..||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788899999999999999965 68899999987653 334567788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCC--CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          840 SNGSLEKCLYSDN--YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       840 ~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      ++ +|.+++....  ..+++..+..++.|+++|++|||   +.+++||||||+||++++++.++++|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 8888876543  45899999999999999999999   99999999999999999999999999999975533221 


Q ss_pred             cccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhc--cccCCcchhcc----
Q 039290          918 RQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDS--LLSCSITEVAD----  990 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~----  990 (1049)
                      ......++..|+|||++.+ ..++.++||||+||++|||++|+.||......+.. .......  ........+..    
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQL-LKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHHHhCCCChhhHHHHhcCchh
Confidence            1223456888999998765 45688999999999999999999998754322111 1100000  00000000000    


Q ss_pred             -cccccccc-cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          991 -ANLLNCEE-NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       991 -~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                       ........ ......+..+.++.+++.+|++.+|.+||+++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence             00000000 0001112346778999999999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.8e-32  Score=305.17  Aligned_cols=273  Identities=26%  Similarity=0.277  Sum_probs=201.8

Q ss_pred             HHhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCC----
Q 039290          758 RATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNND----  830 (1049)
Q Consensus       758 ~~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~----  830 (1049)
                      ...++|++.+.||+|+||.||+|..+ +++.||+|+++...  ......+.+|++++++++|||++++++++.+.+    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34567999999999999999999965 68899999997543  233456788999999999999999999887654    


Q ss_pred             ------eeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEec
Q 039290          831 ------FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSD  904 (1049)
Q Consensus       831 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D  904 (1049)
                            ..++|+||+++ ++.+.+......+++.++..++.|++.|++|||   +.+|+||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence                  78999999976 777777665556899999999999999999999   99999999999999999999999999


Q ss_pred             ccCceecCCCccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccc--
Q 039290          905 FGIAKILGKEESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLL--  981 (1049)
Q Consensus       905 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--  981 (1049)
                      ||.+...............++..|+|||.+.+ ..++.++||||+||++|||++|+.||...... ............  
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~  238 (302)
T cd07864         160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQLELISRLCGSPC  238 (302)
T ss_pred             ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCC
Confidence            99998764433222222345778999998764 45788999999999999999999999753211 111111111000  


Q ss_pred             cCCcchhccccccc----cc---ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          982 SCSITEVADANLLN----CE---ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       982 ~~~~~~~~~~~~~~----~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .....++.......    ..   ..........+..+.+++.+||+.+|++||++++++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00000000000000    00   00000111246779999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.9e-32  Score=297.42  Aligned_cols=249  Identities=28%  Similarity=0.365  Sum_probs=205.5

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      +|+..+.||+|+||.||+|... ++..||+|++.....  ...+.+.+|+++++.++|||++++.+.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4788899999999999999965 688999999976543  4456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC---CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          839 MSNGSLEKCLYSD---NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       839 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      +++++|.+++...   ...+++.++..++.+++.|++|||   +.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999998765   367899999999999999999999   9999999999999999999999999999998764433


Q ss_pred             cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                      . ......+++.|+|||...+..++.++|+||+|+++++|++|..||......+.. ...    .. ...          
T Consensus       158 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-~~~----~~-~~~----------  220 (258)
T cd08215         158 D-LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA-LKI----LK-GQY----------  220 (258)
T ss_pred             c-eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHH-HHH----hc-CCC----------
Confidence            1 223346788999999998888999999999999999999999998653211111 110    00 000          


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                           ...+..++.++.+++.+||..+|++|||+.|++++
T Consensus       221 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         221 -----PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                 00111345678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1e-32  Score=299.39  Aligned_cols=249  Identities=25%  Similarity=0.340  Sum_probs=201.1

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      +|+..+.||+|+||.||+|... +|..||+|.+....  ....+.+.+|+++++.++||||+++++++.+.+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788899999999999999964 68899999986542  23456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC-ceEEecccCceecCCCcc
Q 039290          839 MSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM-VGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-~~kl~DfGla~~~~~~~~  916 (1049)
                      +++++|.+++.... ..+++..+..++.|+++|++|||   +.+++|+||||+||++++++ .+|++|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999886643 35789999999999999999999   99999999999999999875 569999999986643322


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                       ......+++.|+|||+..+..++.++|+||+|+++|||++|..||......+     +....... ...          
T Consensus       158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~-~~~----------  220 (257)
T cd08225         158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ-----LVLKICQG-YFA----------  220 (257)
T ss_pred             -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-----HHHHHhcc-cCC----------
Confidence             1223457889999999988889999999999999999999999986532211     11111100 000          


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                           ......+.++.+++.+||+.+|++|||++|++++
T Consensus       221 -----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         221 -----PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             -----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                 0011234578999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2e-32  Score=301.74  Aligned_cols=267  Identities=22%  Similarity=0.260  Sum_probs=204.0

Q ss_pred             CCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          763 FSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      |+..+.||+|++|.||+|... +++.+++|++.....  .....+.+|++++++++||||+++++++.+++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999964 788999999875532  24567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      ++ ++.+.+......+++.++..++.|+++|++|||   +.+|+|+||||+||+++.++.++|+|||.+....... ...
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~  155 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPY  155 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccc
Confidence            75 888888776567899999999999999999999   9999999999999999999999999999998765433 122


Q ss_pred             cccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccc--cCCcchhcc---ccc
Q 039290          920 TKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLL--SCSITEVAD---ANL  993 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~---~~~  993 (1049)
                      ....++..|+|||.+.+. .++.++||||+|+++|+|++|+.||......+. ..........  ........+   ...
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ-LFKIFRTLGTPDPEVWPKFTSLARNYK  234 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCchHhcccchhhhhhhh
Confidence            234578889999988776 789999999999999999999999865322111 1110000000  000000000   000


Q ss_pred             ccccc----cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          994 LNCEE----NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       994 ~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .....    .........+.++.+++.+||++||.+||++.+++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            00000    0011224567889999999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=301.26  Aligned_cols=247  Identities=25%  Similarity=0.347  Sum_probs=202.0

Q ss_pred             CceecCCCcEEEEEEEe-CCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCC
Q 039290          766 NKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNG  842 (1049)
Q Consensus       766 ~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  842 (1049)
                      .++||.|.||+||-|++ ++|+.||||++.+..  ......+++|+.++..++||.||.+...|++.+..++|||.+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            37899999999999995 589999999997643  344578999999999999999999999999999999999999663


Q ss_pred             ChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCC---CceEEecccCceecCCCccccc
Q 039290          843 SLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES---MVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       843 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~---~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      =|.-.+.....++++...+-+..||+.||.|||   .++|||+|+||+||++.+.   .++||||||+|++.+..  ...
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--sFR  723 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--SFR  723 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchh--hhh
Confidence            344445555667899888889999999999999   9999999999999999643   48999999999998643  344


Q ss_pred             cccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccccccc
Q 039290          920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEN  999 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1049)
                      ...+||+.|.|||++..+.|.+.-|+||.|||+|--+.|..||.+..+-..+...-          ..++.         
T Consensus       724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNA----------aFMyP---------  784 (888)
T KOG4236|consen  724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNA----------AFMYP---------  784 (888)
T ss_pred             hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcc----------ccccC---------
Confidence            56899999999999999999999999999999999999999998632221111110          00110         


Q ss_pred             CchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290         1000 DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus      1000 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                       ...+.+.+.+..++|...+++.-++|.+.++.+.|..
T Consensus       785 -p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W  821 (888)
T KOG4236|consen  785 -PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW  821 (888)
T ss_pred             -CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence             1122456677899999999999999999998887743

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.3e-32  Score=297.68  Aligned_cols=243  Identities=26%  Similarity=0.330  Sum_probs=197.6

Q ss_pred             ecCCCcEEEEEEEeC-CCcEEEEEEeecccC---CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCCCh
Q 039290          769 LGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD---GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSL  844 (1049)
Q Consensus       769 lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  844 (1049)
                      ||.|+||.||+|+.. +++.||+|++.....   ...+.+.+|+++++.++||||+++++++.+++..++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999965 588999999875432   3346789999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccccccccc
Q 039290          845 EKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLG  924 (1049)
Q Consensus       845 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  924 (1049)
                      .+++.... .+++..+..++.|++.|++|+|   +++++|+||+|+||+++.++.++++|||.+.......  ......+
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~  154 (262)
T cd05572          81 WTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG  154 (262)
T ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence            99987654 4889999999999999999999   9999999999999999999999999999998764432  2233467


Q ss_pred             ccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCchhh
Q 039290          925 TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAR 1004 (1049)
Q Consensus       925 ~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1049)
                      +..|+|||.+.+..++.++|+||+|+++|||++|..||.............   .         ..      .......+
T Consensus       155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~---------~~------~~~~~~~~  216 (262)
T cd05572         155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND---I---------LK------GNGKLEFP  216 (262)
T ss_pred             CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHH---H---------hc------cCCCCCCC
Confidence            889999999988889999999999999999999999997643211111110   0         00      00011112


Q ss_pred             HHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 039290         1005 EQCVSSIFSLAMDCTVDLPEKRIS-----MKDVANR 1035 (1049)
Q Consensus      1005 ~~~~~~l~~li~~cl~~dP~~Rpt-----~~ell~~ 1035 (1049)
                      ...+.++.+++.+||+.+|++||+     ++|++++
T Consensus       217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence            223568999999999999999999     7888774

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3e-32  Score=306.67  Aligned_cols=273  Identities=20%  Similarity=0.277  Sum_probs=198.6

Q ss_pred             ceecCC--CcEEEEEEEe-CCCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCC
Q 039290          767 KLLGMG--SFGSVYKGVL-PDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSN  841 (1049)
Q Consensus       767 ~~lg~G--~fg~Vy~a~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  841 (1049)
                      +.||+|  +||+||+|+. .+|+.||+|++.....  ...+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  9999999996 4799999999875432  2346788899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc--
Q 039290          842 GSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR--  918 (1049)
Q Consensus       842 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~--  918 (1049)
                      +++.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++++||+.+..........  
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            99999887643 35889999999999999999999   9999999999999999999999999998654332111100  


Q ss_pred             ----ccccccccCcccccccCC--CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCC-------c
Q 039290          919 ----QTKTLGTIGYMAPEYGRE--GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCS-------I  985 (1049)
Q Consensus       919 ----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------~  985 (1049)
                          .....++..|+|||++.+  ..++.++||||+||++|||++|..||......+...............       .
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence                011234567999999876  347899999999999999999999997643322211111100000000       0


Q ss_pred             ch-----------hcccccc-------cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--HHHHHHh
Q 039290          986 TE-----------VADANLL-------NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR--LVRIRET 1042 (1049)
Q Consensus       986 ~~-----------~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~--L~~i~~~ 1042 (1049)
                      ..           +.+....       .....+......++..+.+++.+||+.||++|||++|++++  ++.+.++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~  317 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ  317 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence            00           0000000       00011222334577889999999999999999999999876  4444443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.5e-32  Score=302.98  Aligned_cols=268  Identities=21%  Similarity=0.239  Sum_probs=197.2

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC--CCHHHHHHHHHHHhhcC-CCceeeEEeeeecCCe-----
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD--GSLESFHAECKVMGSIR-HRNLVKIISSCSNNDF-----  831 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~-----  831 (1049)
                      ++|+..+.||+|+||.||+|+.. +++.||+|+++....  .....+.+|+.++++++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36888999999999999999964 789999999865432  23467888999999995 6999999999877655     


Q ss_pred             eEEEEeccCCCChhhhhhcC----CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC-CCceEEeccc
Q 039290          832 KALVLEYMSNGSLEKCLYSD----NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE-SMVGHLSDFG  906 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-~~~~kl~DfG  906 (1049)
                      .++||||+++ ++.+++...    ...+++..++.++.||++||+|||   +++|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999986 888887643    235799999999999999999999   999999999999999998 8899999999


Q ss_pred             CceecCCCccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCC-
Q 039290          907 IAKILGKEESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCS-  984 (1049)
Q Consensus       907 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-  984 (1049)
                      ++..+..... ......+++.|+|||++.+ ..++.++||||+|+++|+|++|..||......+..... .. ....+. 
T Consensus       157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~-~~-~~~~~~~  233 (295)
T cd07837         157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI-FK-LLGTPTE  233 (295)
T ss_pred             cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-HH-HhCCCCh
Confidence            9986543221 1223356788999998755 45789999999999999999999998753221111110 00 000000 


Q ss_pred             --cchhcc-cccccccccCc----hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          985 --ITEVAD-ANLLNCEENDF----SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       985 --~~~~~~-~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                        ...... ......+....    ......+.++.+++.+|++.+|++||+++|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence              000000 00000000000    0112356778999999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.8e-32  Score=300.98  Aligned_cols=244  Identities=25%  Similarity=0.291  Sum_probs=194.6

Q ss_pred             ecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCCCh
Q 039290          769 LGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSL  844 (1049)
Q Consensus       769 lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  844 (1049)
                      ||+|+||+||+|... +|+.||+|.+....   ......+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999854 78899999986532   22345667899999999999999999999999999999999999999


Q ss_pred             hhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccccc
Q 039290          845 EKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL  923 (1049)
Q Consensus       845 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~~~  923 (1049)
                      .+++.... ..+++.++..++.|++.|++|||   +.|++||||+|+||++++++.++|+|||.+.......  ......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~  155 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA  155 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence            99987654 35899999999999999999999   9999999999999999999999999999987654321  222345


Q ss_pred             cccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCchh
Q 039290          924 GTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSA 1003 (1049)
Q Consensus       924 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1049)
                      ++..|+|||++.+..++.++||||+|+++|+|++|+.||........ .........                 ......
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~-----------------~~~~~~  217 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEELKRRTL-----------------EMAVEY  217 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHHHHhccc-----------------cccccC
Confidence            67899999999888899999999999999999999999965322111 111000000                 001111


Q ss_pred             hHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 039290         1004 REQCVSSIFSLAMDCTVDLPEKRI-----SMKDVANR 1035 (1049)
Q Consensus      1004 ~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~~ 1035 (1049)
                      +...+..+.+++.+||+.+|++||     ++.+++.+
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence            223466789999999999999999     77777764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-32  Score=295.88  Aligned_cols=248  Identities=27%  Similarity=0.361  Sum_probs=204.2

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      +|+..+.||+|++|.||+|+.. +++.|++|.+.....  ...+.+.+|++++++++|||++++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999865 678999999976643  3457889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      +++++|.+++... ..+++..+..++.|++.|++|+|   +.||+||||+|+||+++.++.++|+|||.+......... 
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-  155 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence            9999999998765 45899999999999999999999   999999999999999999999999999999876543321 


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                      .....++..|+|||...+..++.++|||++|+++|+|++|..||.......   ..|.....                  
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~------------------  214 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA---ALFRIVQD------------------  214 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHhcc------------------
Confidence            223457889999999888788999999999999999999999987532111   11110000                  


Q ss_pred             cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          999 NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       999 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .....+...+..+.+++.+|++.+|++|||+.+++.+
T Consensus       215 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         215 DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence            0011112345678999999999999999999999854

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-32  Score=296.57  Aligned_cols=250  Identities=24%  Similarity=0.293  Sum_probs=198.7

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc-----CCCHHHHHHHHHHHhhcCCCceeeEEeeeecC--Cee
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF-----DGSLESFHAECKVMGSIRHRNLVKIISSCSNN--DFK  832 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~  832 (1049)
                      .+|++.+.||+|+||.||+|+. .++..||+|.+....     ......+.+|++++++++||||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4688999999999999999995 468899999875432     12345788999999999999999999998664  467


Q ss_pred             EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecC
Q 039290          833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      ++|+||+++++|.+++.... .+++..+.+++.|++.|++|||   +.+|+|+||||+||+++.++.++|+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            89999999999999987654 3788999999999999999999   9999999999999999999999999999998653


Q ss_pred             CCc--cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcc
Q 039290          913 KEE--SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD  990 (1049)
Q Consensus       913 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  990 (1049)
                      ...  ........++..|+|||++.+..++.++|+||+||++|||++|+.||......+.. .+..   .          
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~---~----------  223 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI-FKIA---T----------  223 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH-HHHH---c----------
Confidence            211  11112345788999999998888999999999999999999999999753211111 1100   0          


Q ss_pred             cccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          991 ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                            ...+...+...+.++.+++.+|++. |.+||++.+++.|
T Consensus       224 ------~~~~~~~p~~~~~~~~~~i~~~l~~-~~~r~~~~~~~~~  261 (264)
T cd06653         224 ------QPTKPMLPDGVSDACRDFLKQIFVE-EKRRPTAEFLLRH  261 (264)
T ss_pred             ------CCCCCCCCcccCHHHHHHHHHHhcC-cccCccHHHHhcC
Confidence                  0001122334567799999999994 7999999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.2e-32  Score=301.22  Aligned_cols=257  Identities=20%  Similarity=0.240  Sum_probs=185.5

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCC----CcEEEEEEeecccCCCH-----------HHHHHHHHHHhhcCCCceeeEEee
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPD----GMEIAAKVFHMEFDGSL-----------ESFHAECKVMGSIRHRNLVKIISS  825 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~----~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~hpniv~l~~~  825 (1049)
                      .+|.+.++||+|+||+||+|...+    +..+|+|+.........           .....+...+..+.|+++++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            579999999999999999999654    34566665433322110           112233344556789999999987


Q ss_pred             eecCC----eeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceE
Q 039290          826 CSNND----FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGH  901 (1049)
Q Consensus       826 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~k  901 (1049)
                      +....    ..++++|++.. ++.+.+.... ..++..+..++.|+++|++|+|   +++|+||||||+||+++.++.++
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~  166 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGY  166 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEE
Confidence            65443    34678888744 6666655432 3577888999999999999999   99999999999999999999999


Q ss_pred             EecccCceecCCCccc------cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHh
Q 039290          902 LSDFGIAKILGKEESM------RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRW  975 (1049)
Q Consensus       902 l~DfGla~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~  975 (1049)
                      |+|||+|+.+......      ......||+.|+|||+..+..++.++||||+||++|||++|+.||.............
T Consensus       167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~  246 (294)
T PHA02882        167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA  246 (294)
T ss_pred             EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence            9999999876432211      1122468999999999999999999999999999999999999998653222111110


Q ss_pred             hhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          976 VGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       976 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                      .....     ..+..        .. .....+++.+.+++..|++.+|++||+++++++.|
T Consensus       247 ~~~~~-----~~~~~--------~~-~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        247 KCDFI-----KRLHE--------GK-IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHH-----HHhhh--------hh-hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            00000     00000        00 01123467899999999999999999999999876

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.5e-32  Score=303.28  Aligned_cols=272  Identities=22%  Similarity=0.296  Sum_probs=196.6

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCC------
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNND------  830 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~------  830 (1049)
                      .++|+..+.||+|+||.||+|+.. +++.||+|.+....  ......+.+|++++++++||||+++++++...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            457999999999999999999964 78899999986543  222345678999999999999999999886644      


Q ss_pred             --eeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCc
Q 039290          831 --FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA  908 (1049)
Q Consensus       831 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla  908 (1049)
                        ..++||||+.+ ++.+.+......+++.+++.++.|++.|++|||   +++++|+||||+||+++.++.+||+|||++
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence              45999999965 888887766556899999999999999999999   999999999999999999999999999999


Q ss_pred             eecCCCccc---cccccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccc-hHHHhhhhccccC
Q 039290          909 KILGKEESM---RQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEM-SLKRWVGDSLLSC  983 (1049)
Q Consensus       909 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~  983 (1049)
                      ..+......   ......++..|+|||.+.+. .++.++||||+|+++|||++|..||........ .............
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE  246 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            866432211   11234567889999987654 468899999999999999999999865322111 0000000000000


Q ss_pred             Ccchhccccc---ccccccCc-hh-----hHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          984 SITEVADANL---LNCEENDF-SA-----REQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       984 ~~~~~~~~~~---~~~~~~~~-~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ..........   ...+.... ..     .......+.+++.+||+.||++|||++|++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            0000000000   00000000 00     00123467899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.3e-32  Score=296.55  Aligned_cols=247  Identities=25%  Similarity=0.327  Sum_probs=203.1

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      +|++.+.||+|+||.||+|+.. +++.+|+|.+....  .....++.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788899999999999999854 78899999987543  23345778899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC---CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          839 MSNGSLEKCLYSD---NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       839 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      +++++|.+++...   ...+++..++.++.|+++|++|||   +.|++||||+|+||++++++.+|++|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999988652   345889999999999999999999   999999999999999999999999999999876543 


Q ss_pred             cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                        ......++..|+|||...+..++.++|+||+|+++|||++|+.||......+.  ...+.    ...           
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~--~~~~~----~~~-----------  217 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL--RYKVQ----RGK-----------  217 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHh----cCC-----------
Confidence              12234578899999999888899999999999999999999999975322111  11110    000           


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                          ....+...+.++.+++.+|++.+|++||++.|++++
T Consensus       218 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         218 ----YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             ----CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                011112456779999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-33  Score=276.78  Aligned_cols=249  Identities=25%  Similarity=0.266  Sum_probs=196.4

Q ss_pred             CCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC-CCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEEEeccC
Q 039290          764 SENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD-GSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALVLEYMS  840 (1049)
Q Consensus       764 ~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~  840 (1049)
                      +....+|.|+-|.|++++.. +|...|||....... ...+++...++++..- .+|+||+.+|+|..+...++.||.|.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs  174 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS  174 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence            34467999999999999954 688999999876542 2345666666666544 37999999999999999999999994


Q ss_pred             CCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccccc
Q 039290          841 NGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT  920 (1049)
Q Consensus       841 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~  920 (1049)
                      . ..+.++..-..++++..+-++...+..||.||.+  .++|+|||+||+||++|+.|.+|+||||++.++....  ..+
T Consensus       175 ~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--Aht  249 (391)
T KOG0983|consen  175 T-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--AHT  249 (391)
T ss_pred             H-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc--ccc
Confidence            3 6777777766778898888999999999999995  7899999999999999999999999999998775433  344


Q ss_pred             ccccccCcccccccCC---CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccccc
Q 039290          921 KTLGTIGYMAPEYGRE---GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE  997 (1049)
Q Consensus       921 ~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1049)
                      ...|-+.|||||.+.-   ..|+-++||||||+.++|+.||+.||..-.. +......            +.+     ..
T Consensus       250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t-dFe~ltk------------vln-----~e  311 (391)
T KOG0983|consen  250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT-DFEVLTK------------VLN-----EE  311 (391)
T ss_pred             cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc-cHHHHHH------------HHh-----cC
Confidence            5678899999998864   4688899999999999999999999976322 2222211            111     11


Q ss_pred             ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          998 ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       998 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      +...+....++..+.+++..|++.|+.+||...++++|
T Consensus       312 PP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  312 PPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             CCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            11122223367889999999999999999999999987

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1e-32  Score=304.90  Aligned_cols=252  Identities=25%  Similarity=0.298  Sum_probs=193.6

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcC-CCceeeEEeeeecCCeeEEEEec
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIR-HRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      +|...+.||+|+||.||++... +++.||+|.+..... .....+.+|+.++.++. ||||+++++++.+++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4555678999999999999954 689999999875432 23457888999999996 99999999999998899999999


Q ss_pred             cCCCChhhhh---hc-CCCccCHHHHHHHHHHHHHHHHHhHccCC-CCeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          839 MSNGSLEKCL---YS-DNYFLDILQRLKIMIDVASALEYLHFGYS-TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       839 ~~~g~L~~~l---~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      +.. ++.++.   .. ....+++..+..++.|++.|++|||   + .+|+||||||+||+++.++.+||+|||++.....
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK---EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            864 555432   22 2346899999999999999999999   5 5999999999999999999999999999976543


Q ss_pred             CccccccccccccCcccccccCCC---CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcc
Q 039290          914 EESMRQTKTLGTIGYMAPEYGREG---KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD  990 (1049)
Q Consensus       914 ~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  990 (1049)
                      ..  ......++..|+|||++.+.   .++.++||||+||++|||++|+.||.....   .... ........      .
T Consensus       161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~-~~~~~~~~------~  228 (288)
T cd06616         161 SI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS---VFDQ-LTQVVKGD------P  228 (288)
T ss_pred             CC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch---HHHH-HhhhcCCC------C
Confidence            22  12234578899999998765   688999999999999999999999875321   1010 00000000      0


Q ss_pred             cccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          991 ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      +..      .......++.++.+++.+||+.+|++|||+++++++
T Consensus       229 ~~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         229 PIL------SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CcC------CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000      001112356789999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.9e-32  Score=303.49  Aligned_cols=266  Identities=21%  Similarity=0.215  Sum_probs=195.5

Q ss_pred             CCceecCCCcEEEEEEEeCCCcEEEEEEeecc--cCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCC
Q 039290          765 ENKLLGMGSFGSVYKGVLPDGMEIAAKVFHME--FDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNG  842 (1049)
Q Consensus       765 ~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  842 (1049)
                      +.+.+|.|+++.||+++. +++.||+|++...  .....+.+.+|+++++.++||||+++++++.+.+..+++|||+++|
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344455556655555555 7899999998765  2334578999999999999999999999999999999999999999


Q ss_pred             ChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc-----
Q 039290          843 SLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES-----  916 (1049)
Q Consensus       843 ~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~-----  916 (1049)
                      +|.+++... ...+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+|++|||.+........     
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            999998753 345889999999999999999999   99999999999999999999999999999875532211     


Q ss_pred             -ccccccccccCcccccccCC--CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcc---ccCCcchhcc
Q 039290          917 -MRQTKTLGTIGYMAPEYGRE--GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSL---LSCSITEVAD  990 (1049)
Q Consensus       917 -~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  990 (1049)
                       .......++..|+|||++..  ..++.++||||+||++|||++|..||..............+...   ..... ....
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  240 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTY-PLYE  240 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCch-hhhc
Confidence             01122346778999999865  35789999999999999999999999764322221111111000   00000 0000


Q ss_pred             cccc----------cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          991 ANLL----------NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       991 ~~~~----------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ..+.          ...............++.+++.+||+.+|++|||++|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence            0000          00001112223456788999999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.3e-32  Score=300.88  Aligned_cols=269  Identities=22%  Similarity=0.291  Sum_probs=197.6

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      ++|+..+.||+|++|+||+|+.. +++.||+|.+....  ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888999999999999999965 78899999986543  2334678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC-CCceEEecccCceecCCCc
Q 039290          838 YMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE-SMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-~~~~kl~DfGla~~~~~~~  915 (1049)
                      |++ +++.+.+.... ...++..+..++.||+.|++|||   +++++||||+|+||+++. ++.+||+|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            996 47877765433 34678888999999999999999   999999999999999985 5679999999997654321


Q ss_pred             cccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHh--hhhccccCCcch---hc
Q 039290          916 SMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRW--VGDSLLSCSITE---VA  989 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~---~~  989 (1049)
                      . ......+++.|+|||++.+ ..++.++||||+||++|+|++|..||......+......  .+... ...+..   ..
T Consensus       158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  235 (294)
T PLN00009        158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPN-EETWPGVTSLP  235 (294)
T ss_pred             c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC-hhhccccccch
Confidence            1 1223456889999998765 457899999999999999999999997532211111100  00000 000000   00


Q ss_pred             cc-ccccc-cccC-chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          990 DA-NLLNC-EEND-FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       990 ~~-~~~~~-~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      +. ..... .... .......+.++.+++.+|++.+|++||++.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00 00000 0000 00112345678999999999999999999999975

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-32  Score=308.37  Aligned_cols=268  Identities=21%  Similarity=0.265  Sum_probs=197.7

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecC-----Cee
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNN-----DFK  832 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~-----~~~  832 (1049)
                      .++|++.+.||+|+||.||+|+. .+|+.||+|++.... .....++.+|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46799999999999999999985 478999999986432 23446788899999999999999999887543     357


Q ss_pred             EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecC
Q 039290          833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      ++|+||+++ ++.+.+...  .+++..++.++.|+++|++|||   +.||+||||||+||+++.++.+||+|||++....
T Consensus        84 ~lv~e~~~~-~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          84 YIVQELMET-DLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEehhccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            999999965 888777543  4899999999999999999999   9999999999999999999999999999998654


Q ss_pred             CCccc--cccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCC---cc
Q 039290          913 KEESM--RQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCS---IT  986 (1049)
Q Consensus       913 ~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~  986 (1049)
                      .....  ......++..|+|||.+.+ ..++.++||||+||++|+|++|+.||...... .....+. .....+.   ..
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~-~~~~~~~-~~~~~~~~~~~~  235 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL-HQLNLIL-GVLGTPSQEDLN  235 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH-HHcCCCCHHHHH
Confidence            32211  1123467889999998654 56889999999999999999999999652211 1111110 1111000   00


Q ss_pred             hhcccccc----ccc---ccCc-hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          987 EVADANLL----NCE---ENDF-SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       987 ~~~~~~~~----~~~---~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .+.+....    ...   .... ......+.++.+++.+||+.+|++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00000000    000   0000 0112345678999999999999999999999998

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.2e-32  Score=301.08  Aligned_cols=253  Identities=24%  Similarity=0.273  Sum_probs=197.1

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCC-CcEEEEEEeecccC-CCHHHHHHHHHHHhhcC-CCceeeEEeeeecCCeeEEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFD-GSLESFHAECKVMGSIR-HRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~-~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      .++|+..+.||+|+||.||+|.+.+ ++.||||+++.... ....++.+|+.++.+.. ||||+++++++.++...++||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3568888999999999999999764 88999999975432 23455666777666664 999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCC-CCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS-TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      ||+. +++.+++......+++..+..++.|++.|++|||   + .+|+||||+|+||++++++.+||+|||++..+....
T Consensus        94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            9985 4788777665557899999999999999999999   7 599999999999999999999999999987654322


Q ss_pred             cccccccccccCcccccccCCCC----cCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGK----VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA  991 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  991 (1049)
                      .  .....++..|+|||.+.+..    ++.++||||||+++|||++|+.||............+....            
T Consensus       170 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------------  235 (296)
T cd06618         170 A--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE------------  235 (296)
T ss_pred             c--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC------------
Confidence            2  22235678999999987543    78899999999999999999999865322211111111100            


Q ss_pred             ccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          992 NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                       ..     ..+....++.++.+++.+||+.+|++||++++++++-
T Consensus       236 -~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         236 -PP-----SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             -CC-----CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence             00     0001112456789999999999999999999998874

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.2e-32  Score=299.52  Aligned_cols=252  Identities=25%  Similarity=0.297  Sum_probs=199.0

Q ss_pred             CCCCCceecCCCcEEEEEEEe----CCCcEEEEEEeeccc----CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCee
Q 039290          762 GFSENKLLGMGSFGSVYKGVL----PDGMEIAAKVFHMEF----DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFK  832 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~  832 (1049)
                      +|++.+.||+|+||.||+|+.    .+|..||+|+++...    ....+.+.+|+++++++ +||||+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999985    378899999987532    22346778899999999 589999999999999999


Q ss_pred             EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecC
Q 039290          833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      ++||||+++++|.+++.... .+++..+..++.|+++|++|||   +.+++||||+|+||+++.++.+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            99999999999999987654 4788999999999999999999   9999999999999999999999999999998664


Q ss_pred             CCccccccccccccCcccccccCCC--CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcc
Q 039290          913 KEESMRQTKTLGTIGYMAPEYGREG--KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD  990 (1049)
Q Consensus       913 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  990 (1049)
                      ...........++..|+|||.+...  .++.++||||+|+++|+|++|..||...... .....+......         
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~---------  226 (290)
T cd05613         157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEISRRILK---------  226 (290)
T ss_pred             cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHHHHhhc---------
Confidence            4332223345678899999988653  4678999999999999999999998642111 111111111000         


Q ss_pred             cccccccccCchhhHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 039290          991 ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI-----SMKDVANR 1035 (1049)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~~ 1035 (1049)
                              .....+..++..+.+++.+||+.+|++||     ++++++.+
T Consensus       227 --------~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         227 --------SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             --------cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence                    00011223456789999999999999997     77888765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-32  Score=307.90  Aligned_cols=273  Identities=23%  Similarity=0.272  Sum_probs=206.8

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCC-----eeE
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNND-----FKA  833 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~-----~~~  833 (1049)
                      +|++.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|+++++.++||||+++++++.+.+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5788899999999999999965 58999999987654  334568899999999999999999999987765     789


Q ss_pred             EEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          834 LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      +||||++ ++|.+++.... .+++..+..++.|+++|++|||   +.||+||||||+||+++.++.++|+|||++.....
T Consensus        81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            9999997 48988887654 6899999999999999999999   99999999999999999999999999999987654


Q ss_pred             Ccc--ccccccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcch---
Q 039290          914 EES--MRQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITE---  987 (1049)
Q Consensus       914 ~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  987 (1049)
                      ...  .......++..|+|||++.+. .++.++||||+|+++|+|++|..||......+.. .. +...........   
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~-~~-i~~~~~~~~~~~~~~  233 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL-NL-IVEVLGTPSEEDLKF  233 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH-HH-HHHhcCCCChhHhhh
Confidence            321  122334578899999999887 7899999999999999999999999764322111 10 000000000000   


Q ss_pred             hcccc-------cccccccC-chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--HHHHHH
Q 039290          988 VADAN-------LLNCEEND-FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR--LVRIRE 1041 (1049)
Q Consensus       988 ~~~~~-------~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~--L~~i~~ 1041 (1049)
                      .....       ........ .......+.++.+++.+||+.+|.+|||+++++.+  ++++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence            00000       00000000 01112246778999999999999999999999997  555544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.98  E-value=2e-32  Score=308.97  Aligned_cols=270  Identities=20%  Similarity=0.259  Sum_probs=200.1

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeec----CCeeE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSN----NDFKA  833 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~----~~~~~  833 (1049)
                      ++|++.+.||+|+||.||+|.. .+++.||+|++.....  .....+.+|+.++++++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            5788999999999999999995 4799999999875432  345677889999999999999999988753    35689


Q ss_pred             EEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          834 LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      +||||+. ++|.+++.... .+++..++.++.|+++||+|||   +.+|+||||||+||++++++.+||+|||++.....
T Consensus        85 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  159 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS  159 (334)
T ss_pred             EEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence            9999996 58988886654 4899999999999999999999   99999999999999999999999999999976543


Q ss_pred             Cccc---cccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcc--ccCCcch
Q 039290          914 EESM---RQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSL--LSCSITE  987 (1049)
Q Consensus       914 ~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~  987 (1049)
                      ....   ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||........ .........  .......
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~-~~~~~~~~g~~~~~~~~~  238 (334)
T cd07855         160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ-LKLILSVLGSPSEEVLNR  238 (334)
T ss_pred             cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH-HHHHHHHhCCChhHhhhh
Confidence            2211   1123467889999998765 4688999999999999999999999965322111 000000000  0000000


Q ss_pred             hcccccc---cccccC----c-hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          988 VADANLL---NCEEND----F-SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       988 ~~~~~~~---~~~~~~----~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                      .......   ......    + ......+.++.+++.+|++.+|++||++++++.+-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  295 (334)
T cd07855         239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP  295 (334)
T ss_pred             hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence            0000000   000000    0 01123467899999999999999999999999863

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.98  E-value=3.1e-32  Score=307.70  Aligned_cols=272  Identities=22%  Similarity=0.241  Sum_probs=201.9

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecC-----Ce
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNN-----DF  831 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~-----~~  831 (1049)
                      ..+|.+.+.||+|+||+||+|+. .+++.||+|.++...  ......+.+|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            35789999999999999999995 478999999987542  23345678899999999999999999987644     35


Q ss_pred             eEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceec
Q 039290          832 KALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL  911 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~  911 (1049)
                      .++|+||+. ++|.+++...+ .+++..+..++.|++.|++|||   +++++||||||+||+++.++.+||+|||++...
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            799999996 68988887654 5899999999999999999999   999999999999999999999999999999866


Q ss_pred             CCCccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcccc---CCcch
Q 039290          912 GKEESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLS---CSITE  987 (1049)
Q Consensus       912 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~  987 (1049)
                      ..... ......++..|+|||.+.. ..++.++||||+||++|+|++|+.||......+ ...... .....   .....
T Consensus       159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~-~~~~~~~~~~~~~  235 (337)
T cd07858         159 SEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-QLKLIT-ELLGSPSEEDLGF  235 (337)
T ss_pred             CCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHH-HHhCCCChHHhhh
Confidence            43321 2223457889999998764 468899999999999999999999996532111 000000 00000   00000


Q ss_pred             hccccc-------ccccccC-chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--HHHH
Q 039290          988 VADANL-------LNCEEND-FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR--LVRI 1039 (1049)
Q Consensus       988 ~~~~~~-------~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~--L~~i 1039 (1049)
                      +.+...       ....... ......++.++.+++.+|++.+|++|||++|++++  ++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            000000       0000000 01113456788999999999999999999999998  5544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.98  E-value=3.7e-32  Score=307.33  Aligned_cols=270  Identities=23%  Similarity=0.268  Sum_probs=198.8

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecC--CeeE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSI-RHRNLVKIISSCSNN--DFKA  833 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~--~~~~  833 (1049)
                      .++|+..+.||+|+||.||+|... +++.||+|++....  ......+.+|+.+++++ +||||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            457888899999999999999965 68899999885432  22345677899999999 999999999988653  3689


Q ss_pred             EEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          834 LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      +||||++ ++|.+++...  .+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||++.....
T Consensus        86 lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE  159 (337)
T ss_pred             EEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence            9999997 5999888765  5788999999999999999999   99999999999999999999999999999986643


Q ss_pred             Ccc----ccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhh-hcccc-----
Q 039290          914 EES----MRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVG-DSLLS-----  982 (1049)
Q Consensus       914 ~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-~~~~~-----  982 (1049)
                      ...    .......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||......+........ .....     
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07852         160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES  239 (337)
T ss_pred             ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            321    12223457889999998754 45788999999999999999999998653222111100000 00000     


Q ss_pred             ---CCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          983 ---CSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       983 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                         .......+.................+.++.+++.+||+.+|++|||+.+++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence               00000000000000000001112246789999999999999999999999987

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.98  E-value=2.9e-32  Score=297.25  Aligned_cols=240  Identities=25%  Similarity=0.347  Sum_probs=193.7

Q ss_pred             ecCCCcEEEEEEEeC-CCcEEEEEEeecccC---CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCCCh
Q 039290          769 LGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD---GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSL  844 (1049)
Q Consensus       769 lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  844 (1049)
                      ||+|+||.||+|+.. +++.|++|++.....   ...+.+.+|++++++++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999976 589999999865432   3456788999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc-------c
Q 039290          845 EKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES-------M  917 (1049)
Q Consensus       845 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~-------~  917 (1049)
                      .+++...+ .+++..+..++.|+++||+|||   +.+++||||+|+||++++++.++|+|||++........       .
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            99987655 5899999999999999999999   99999999999999999999999999999875432211       1


Q ss_pred             cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccccc
Q 039290          918 RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE  997 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1049)
                      ......++..|+|||......++.++||||+|+++||+++|..||......+. ......                    
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~~~~~~--------------------  215 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI-FQNILN--------------------  215 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhc--------------------
Confidence            22334578899999999888899999999999999999999999875322111 111000                    


Q ss_pred             ccCchhhHH--HHHHHHHHHhhccccCCCCCCCHHHHHH
Q 039290          998 ENDFSAREQ--CVSSIFSLAMDCTVDLPEKRISMKDVAN 1034 (1049)
Q Consensus       998 ~~~~~~~~~--~~~~l~~li~~cl~~dP~~Rpt~~ell~ 1034 (1049)
                       .....+..  .+..+.+++.+||+.+|++|||+.++.+
T Consensus       216 -~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~  253 (265)
T cd05579         216 -GKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEE  253 (265)
T ss_pred             -CCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHH
Confidence             00001111  3677899999999999999999944443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.98  E-value=2.2e-33  Score=269.94  Aligned_cols=280  Identities=18%  Similarity=0.268  Sum_probs=212.2

Q ss_pred             CCccccccccHHHHHHHhcCCCCCceecCCCcEEEEEEE-eCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcC-CCcee
Q 039290          743 YPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR-HRNLV  820 (1049)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~a~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv  820 (1049)
                      .|.+.|...++..-+...++|++.+++|+|.|++||.|. ..+.++++||+++..   ..+.+.+|+.++..++ ||||+
T Consensus        20 rp~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi   96 (338)
T KOG0668|consen   20 RPREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNII   96 (338)
T ss_pred             CchhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCee
Confidence            345566666666666778899999999999999999999 567889999999743   4578999999999997 99999


Q ss_pred             eEEeeeecC--CeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec-CC
Q 039290          821 KIISSCSNN--DFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN-ES  897 (1049)
Q Consensus       821 ~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~-~~  897 (1049)
                      ++++++.+.  ..+.+|+||+++.+......    .++...+...+.+++.||.|+|   +.||+|||+||.|||+| +.
T Consensus        97 ~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~  169 (338)
T KOG0668|consen   97 KLLDIVKDPESKTPSLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHEL  169 (338)
T ss_pred             ehhhhhcCccccCchhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhh
Confidence            999999775  46789999999988766533    3677788899999999999999   99999999999999999 45


Q ss_pred             CceEEecccCceecCCCccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhh
Q 039290          898 MVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWV  976 (1049)
Q Consensus       898 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~  976 (1049)
                      ...+++|+|+|.++.+....  .-.+.+..|..||.+.. ..|+..-|+|||||++++|+..+.||-.-.....++++.+
T Consensus       170 rkLrlIDWGLAEFYHp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIa  247 (338)
T KOG0668|consen  170 RKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIA  247 (338)
T ss_pred             ceeeeeecchHhhcCCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHH
Confidence            68999999999999765533  34567888999998876 5688999999999999999999999853222222222211


Q ss_pred             h------------h--ccccCCcchhcccccccccccCch---hhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          977 G------------D--SLLSCSITEVADANLLNCEENDFS---AREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       977 ~------------~--~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      +            .  ...++....+........+. ++.   ...-..++..+++.+.+..|.++|+|++|.++|
T Consensus       248 kVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~-~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  248 KVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWS-RFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHhChHHHHHHHHHHccCCChhHhhHhhccccccHH-HhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence            1            0  01112222222211111110 000   011234788999999999999999999999987

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.98  E-value=4.1e-32  Score=303.76  Aligned_cols=271  Identities=21%  Similarity=0.228  Sum_probs=197.3

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecC-------
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNN-------  829 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~-------  829 (1049)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.....  .....+.+|++++++++||||+++++++.+.       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999954 688999999865432  2235678899999999999999999987543       


Q ss_pred             -CeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCc
Q 039290          830 -DFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA  908 (1049)
Q Consensus       830 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla  908 (1049)
                       ...++||||+.+ ++...+......+++.++..++.|+++|++|||   +.||+||||||+||++++++.++++|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence             346999999965 777777665567999999999999999999999   999999999999999999999999999999


Q ss_pred             eecCCCccc----------cccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhh
Q 039290          909 KILGKEESM----------RQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVG  977 (1049)
Q Consensus       909 ~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  977 (1049)
                      .........          ......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......... .....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~-~~~~~  241 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL-HLIFK  241 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHH
Confidence            765432211          1123356788999998765 45789999999999999999999998653222111 11110


Q ss_pred             hcc--ccCCc------chhcccccccccccC-chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          978 DSL--LSCSI------TEVADANLLNCEEND-FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       978 ~~~--~~~~~------~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ...  .+...      ....+.......... ..........+.+++.+|++.+|++|||+.|++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            000  00000      000000000000000 00111233678999999999999999999999865

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=5.6e-32  Score=294.20  Aligned_cols=242  Identities=24%  Similarity=0.284  Sum_probs=187.8

Q ss_pred             ceecCCCcEEEEEEEe-CCCcEEEEEEeecccCC---CHHHHHHHHHHH-hhcCCCceeeEEeeeecCCeeEEEEeccCC
Q 039290          767 KLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDG---SLESFHAECKVM-GSIRHRNLVKIISSCSNNDFKALVLEYMSN  841 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l-~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  841 (1049)
                      +.||+|+||.||+|.. .+++.||+|+++.....   ....+..|..++ ...+|||++++++++..++..++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5699999999999996 46889999998654311   122344454444 445899999999999999999999999999


Q ss_pred             CChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccc
Q 039290          842 GSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK  921 (1049)
Q Consensus       842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~  921 (1049)
                      ++|.+++.... .+++..+.+++.|++.||+|+|   +.+++||||+|+||++++++.++|+|||++.....     ...
T Consensus        82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~  152 (260)
T cd05611          82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK  152 (260)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence            99999987654 4789999999999999999999   99999999999999999999999999999875432     123


Q ss_pred             cccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCc
Q 039290          922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDF 1001 (1049)
Q Consensus       922 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1049)
                      ..++..|+|||.+.+..++.++||||+|+++|||++|..||......+. ........                 .....
T Consensus       153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~-----------------~~~~~  214 (260)
T cd05611         153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-FDNILSRR-----------------INWPE  214 (260)
T ss_pred             CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhcc-----------------cCCCC
Confidence            4578899999999888889999999999999999999999975322211 11100000                 00000


Q ss_pred             hhhHHHHHHHHHHHhhccccCCCCCCCHH---HHHHH
Q 039290         1002 SAREQCVSSIFSLAMDCTVDLPEKRISMK---DVANR 1035 (1049)
Q Consensus      1002 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~---ell~~ 1035 (1049)
                      .....++..+.+++.+||+.+|++||++.   |++.+
T Consensus       215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence            11123567899999999999999999664   55544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.98  E-value=1.7e-31  Score=295.13  Aligned_cols=266  Identities=23%  Similarity=0.287  Sum_probs=198.2

Q ss_pred             CCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC--CCHHHHHHHHHHHhhc---CCCceeeEEeeeecCCe-----
Q 039290          763 FSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD--GSLESFHAECKVMGSI---RHRNLVKIISSCSNNDF-----  831 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~hpniv~l~~~~~~~~~-----  831 (1049)
                      |++.+.||+|+||.||+|+.. +++.||+|+++....  .....+.+|+.+++++   +|||++++++++.+.+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567789999999999999976 589999999975432  2234566788777666   59999999999988776     


Q ss_pred             eEEEEeccCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCcee
Q 039290          832 KALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI  910 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~  910 (1049)
                      .+++|||+.+ +|.+++.... ..+++.+++.++.|+++|++|||   +.+++|+||+|+||+++.++.+||+|||.+..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            8999999975 8988876543 35899999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcc
Q 039290          911 LGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD  990 (1049)
Q Consensus       911 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  990 (1049)
                      ......  .....++..|+|||++.+..++.++||||+||++|||++|..||......+ ....+...............
T Consensus       157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07838         157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIFDVIGLPSEEEWPRN  233 (287)
T ss_pred             ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHHHHHHcCCCChHhcCCC
Confidence            643322  123346888999999988889999999999999999999999987533221 12222111110000000000


Q ss_pred             c-----ccccccccC-chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          991 A-----NLLNCEEND-FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       991 ~-----~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .     ......... .......+..+.+++.+||+.||++||+++|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            0     000000000 11123456778999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.98  E-value=1.4e-31  Score=298.92  Aligned_cols=244  Identities=26%  Similarity=0.324  Sum_probs=194.8

Q ss_pred             CCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCC---CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          763 FSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDG---SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      |...+.||+|+||+||+|+. .+++.|++|++......   ..+.+.+|+++++.++|||++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            66667899999999999995 47889999998754322   235678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      +. |++.+++......+++.++..++.|++.|++|||   +.||+||||+|+||+++.++.+||+|||++.....     
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----  173 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----  173 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence            96 5788877766667899999999999999999999   99999999999999999999999999999864322     


Q ss_pred             ccccccccCcccccccC---CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          919 QTKTLGTIGYMAPEYGR---EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                      .....++..|+|||++.   ...++.++||||+||++|||++|..||...........  ....   .         .  
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~--~~~~---~---------~--  237 (313)
T cd06633         174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH--IAQN---D---------S--  237 (313)
T ss_pred             CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH--HHhc---C---------C--
Confidence            12346788999999874   35688899999999999999999999865322111111  0000   0         0  


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                       +.   ......+..+.+++.+||+.+|.+||++.+++.+
T Consensus       238 -~~---~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         238 -PT---LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             -CC---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             00   0011234568899999999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.98  E-value=9.3e-32  Score=299.84  Aligned_cols=247  Identities=25%  Similarity=0.319  Sum_probs=196.9

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .|+..+.||+|+||.||+|+.. ++..||+|.+....   .....++.+|+++++.++|||++++++++...+..++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            3666788999999999999954 67889999986432   2234567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      |+. |++.+.+......+++.++..++.|++.|++|||   +.+++||||+|+||+++.++.++++|||++......   
T Consensus        96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---  168 (308)
T cd06634          96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (308)
T ss_pred             ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence            996 5888877655566899999999999999999999   999999999999999999999999999998765432   


Q ss_pred             cccccccccCcccccccC---CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          918 RQTKTLGTIGYMAPEYGR---EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                        ....++..|+|||.+.   ...++.++||||+||++|||++|..||......+.. ..+.....              
T Consensus       169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~--------------  231 (308)
T cd06634         169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQNES--------------  231 (308)
T ss_pred             --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH-HHHhhcCC--------------
Confidence              2245788999999874   356788999999999999999999998653211111 11110000              


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                           ........+..+.+++.+||+.+|++||++++++++..
T Consensus       232 -----~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         232 -----PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             -----CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence                 00011234567899999999999999999999998744

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.98  E-value=4.8e-32  Score=298.24  Aligned_cols=249  Identities=26%  Similarity=0.366  Sum_probs=203.3

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcC-CCceeeEEeeeecCCeeEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIR-HRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv  835 (1049)
                      ++|...+.||+|+||.||+|+.. ++..||+|++....   ....+.+.+|++++++++ ||||+++++++.+++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36888999999999999999964 78999999987532   223467888999999998 99999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++++|.+++...+ .+++..++.++.|++.|++|||   +.|++|+||+|+||+++.++.++++|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            99999999999987764 5899999999999999999999   9999999999999999999999999999998664332


Q ss_pred             c-------------------ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhh
Q 039290          916 S-------------------MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWV  976 (1049)
Q Consensus       916 ~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~  976 (1049)
                      .                   .......++..|+|||......++.++||||+|++++++++|..||......  ...+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~  234 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY--LTFQKI  234 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH--HHHHHH
Confidence            1                   1222345788999999988888999999999999999999999998753211  111100


Q ss_pred             hhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCH----HHHHHH
Q 039290          977 GDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISM----KDVANR 1035 (1049)
Q Consensus       977 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~----~ell~~ 1035 (1049)
                      .                    ......+...++.+.+++.+||+.+|++||++    ++++++
T Consensus       235 ~--------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         235 L--------------------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             H--------------------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            0                    00111112235678999999999999999999    787764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.98  E-value=1.2e-31  Score=296.21  Aligned_cols=254  Identities=25%  Similarity=0.291  Sum_probs=198.9

Q ss_pred             CCCCCceecCCCcEEEEEEEe----CCCcEEEEEEeeccc----CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCee
Q 039290          762 GFSENKLLGMGSFGSVYKGVL----PDGMEIAAKVFHMEF----DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFK  832 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~  832 (1049)
                      +|++.+.||+|+||.||+|+.    .+++.||+|+++...    ....+.+.+|++++.++ +||||+++++++..++..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            377789999999999999984    357889999987432    22345678899999999 599999999999999999


Q ss_pred             EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecC
Q 039290          833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      ++||||+++++|.+++.... .+++..+..++.|+++|++|||   +.+++||||+|+||+++.++.++++|||++....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            99999999999999887543 4788999999999999999999   9999999999999999999999999999988654


Q ss_pred             CCccccccccccccCcccccccCCCC--cCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcc
Q 039290          913 KEESMRQTKTLGTIGYMAPEYGREGK--VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD  990 (1049)
Q Consensus       913 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  990 (1049)
                      ...........++..|+|||...+..  .+.++||||+|+++|||++|..||...... ............         
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~---------  226 (288)
T cd05583         157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRRILK---------  226 (288)
T ss_pred             cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHHHHHHc---------
Confidence            43332223345788999999987654  788999999999999999999998642111 111111110000         


Q ss_pred             cccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          991 ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                              .....+..++..+.+++.+||+.+|++|||+.++.+.++
T Consensus       227 --------~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         227 --------SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             --------cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence                    001112234567899999999999999999877765544

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.98  E-value=1.4e-31  Score=293.76  Aligned_cols=242  Identities=21%  Similarity=0.261  Sum_probs=188.3

Q ss_pred             eecCCCcEEEEEEEe-CCCcEEEEEEeecccCC---CHHHHHHHHH---HHhhcCCCceeeEEeeeecCCeeEEEEeccC
Q 039290          768 LLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDG---SLESFHAECK---VMGSIRHRNLVKIISSCSNNDFKALVLEYMS  840 (1049)
Q Consensus       768 ~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~---~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  840 (1049)
                      .||+|+||.||+|.. .+++.||+|.+......   ....+..|..   .++...||+|+++++++.+.+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999985 46889999998654311   1122334433   3444579999999999999999999999999


Q ss_pred             CCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccccc
Q 039290          841 NGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT  920 (1049)
Q Consensus       841 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~  920 (1049)
                      +++|.+++.... .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||++.......   ..
T Consensus        81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~  153 (278)
T cd05606          81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH  153 (278)
T ss_pred             CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---Cc
Confidence            999999886544 5899999999999999999999   9999999999999999999999999999987653322   12


Q ss_pred             ccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccccccc
Q 039290          921 KTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEN  999 (1049)
Q Consensus       921 ~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1049)
                      ...|+..|+|||++.++ .++.++||||+||++|||++|+.||................                   ..
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------~~  214 (278)
T cd05606         154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-------------------TM  214 (278)
T ss_pred             CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh-------------------cc
Confidence            34688999999998754 68899999999999999999999997632221111100000                   00


Q ss_pred             CchhhHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 039290         1000 DFSAREQCVSSIFSLAMDCTVDLPEKRI-----SMKDVANR 1035 (1049)
Q Consensus      1000 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~~ 1035 (1049)
                      ....+...+.++.+++.+|+..+|.+||     ++.+++++
T Consensus       215 ~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         215 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            1111223456789999999999999999     99999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.98  E-value=1.1e-31  Score=303.31  Aligned_cols=268  Identities=22%  Similarity=0.256  Sum_probs=197.1

Q ss_pred             cCCCC-CceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCC--------------HHHHHHHHHHHhhcCCCceeeEEe
Q 039290          761 DGFSE-NKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGS--------------LESFHAECKVMGSIRHRNLVKIIS  824 (1049)
Q Consensus       761 ~~~~~-~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~hpniv~l~~  824 (1049)
                      ++|.. .+.||+|+||+||+|... +++.||+|+++......              ...+.+|++++++++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            45653 477999999999999954 78999999986543211              125778999999999999999999


Q ss_pred             eeecCCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEec
Q 039290          825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSD  904 (1049)
Q Consensus       825 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D  904 (1049)
                      ++...+..++||||+. |+|.+++.... .+++..+..++.|++.|++|||   +.||+||||+|+||+++.++.++++|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~d  162 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIAD  162 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECC
Confidence            9999999999999997 58998886543 4889999999999999999999   99999999999999999999999999


Q ss_pred             ccCceecCCCc-------------cccccccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccc
Q 039290          905 FGIAKILGKEE-------------SMRQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEM  970 (1049)
Q Consensus       905 fGla~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~  970 (1049)
                      ||.+.......             ........++..|+|||.+.+. .++.++||||+||++|||++|..||......+.
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~  242 (335)
T PTZ00024        163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ  242 (335)
T ss_pred             ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99998664111             1111223467889999988664 468999999999999999999999975432211


Q ss_pred             hHHHhhhhccccCC---cchhc-----ccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          971 SLKRWVGDSLLSCS---ITEVA-----DANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       971 ~~~~~~~~~~~~~~---~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                       ...... ......   +....     .+.....+.........++.++.+++.+|++.+|++|||++|++.+
T Consensus       243 -~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        243 -LGRIFE-LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             -HHHHHH-HhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence             111110 000000   00000     0000000000001112345778999999999999999999999975

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=1.2e-31  Score=295.71  Aligned_cols=263  Identities=22%  Similarity=0.283  Sum_probs=197.6

Q ss_pred             CCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCC-CHHHHHHHHHHHhhcC-CCceeeEEeeeecCCeeEEEEecc
Q 039290          763 FSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDG-SLESFHAECKVMGSIR-HRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      |++.+.||+|+||+||+|+.. +++.||+|++...... ......+|+..+++++ |||++++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567789999999999999975 5788999998755332 2234567899999998 999999999999999999999999


Q ss_pred             CCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          840 SNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       840 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                       +|+|.+.+.... ..+++.++..++.|+++|++|||   +.+++|+||+|+||++++++.++|+|||.+........  
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence             779988887654 46899999999999999999999   99999999999999999999999999999986643222  


Q ss_pred             ccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchH-----------HHhhhhccccCCcc
Q 039290          919 QTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSL-----------KRWVGDSLLSCSIT  986 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~-----------~~~~~~~~~~~~~~  986 (1049)
                      .....++..|+|||++.+ ..++.++|+||||++++||++|+.||......+...           ..|.......... 
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  233 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL-  233 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc-
Confidence            223457889999998744 557899999999999999999999986532211111           0111110000000 


Q ss_pred             hhcccccccccccCc-hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          987 EVADANLLNCEENDF-SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       987 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                         +........... ......+.++.+++.+||+.+|++|||++|++.+
T Consensus       234 ---~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         234 ---GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ---cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence               000000000000 0011224678999999999999999999999865

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.98  E-value=7.1e-32  Score=305.51  Aligned_cols=274  Identities=20%  Similarity=0.266  Sum_probs=202.1

Q ss_pred             ccHHHHHHHhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeee
Q 039290          751 ISYQDLLRATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCS  827 (1049)
Q Consensus       751 ~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~  827 (1049)
                      ....+++...++|.+.+.||+|+||.||+|.. .+++.||+|++.....  ...+.+.+|++++++++||||+++++++.
T Consensus         7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~   86 (345)
T cd07877           7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   86 (345)
T ss_pred             hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence            34456777889999999999999999999984 5788999999875432  22456788999999999999999999875


Q ss_pred             cC------CeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceE
Q 039290          828 NN------DFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGH  901 (1049)
Q Consensus       828 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~k  901 (1049)
                      ..      ...+++++++ +++|.+++...  .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+|
T Consensus        87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ecccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEE
Confidence            43      3467888887 77998877653  4889999999999999999999   99999999999999999999999


Q ss_pred             EecccCceecCCCccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhh-c
Q 039290          902 LSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGD-S  979 (1049)
Q Consensus       902 l~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~  979 (1049)
                      |+|||++......    .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||....... ........ .
T Consensus       161 l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~  235 (345)
T cd07877         161 ILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVG  235 (345)
T ss_pred             Eeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC
Confidence            9999998764322    123457889999998765 567889999999999999999999986432211 11110000 0


Q ss_pred             cccCCc-chhccc-------ccccccccCch-hhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          980 LLSCSI-TEVADA-------NLLNCEENDFS-AREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       980 ~~~~~~-~~~~~~-------~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ...... ..+.+.       .+...+...+. .....+.++.+++.+|++.||.+||++.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            000000 000000       00000000000 001235678999999999999999999999987

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=7.3e-32  Score=305.17  Aligned_cols=272  Identities=21%  Similarity=0.263  Sum_probs=198.2

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecC------
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNN------  829 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~------  829 (1049)
                      ...+|...+.||+|+||.||+|+. .+++.||+|+++...  ......+.+|+++++.++||||+++++++...      
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            357899999999999999999995 478999999987543  22345688999999999999999999988654      


Q ss_pred             CeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCce
Q 039290          830 DFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK  909 (1049)
Q Consensus       830 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~  909 (1049)
                      ...++|+||+.. ++.++..   ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+|++|||++.
T Consensus        93 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          93 QDFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             ceEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            346899999964 7776542   24789999999999999999999   9999999999999999999999999999987


Q ss_pred             ecCCCccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchh
Q 039290          910 ILGKEESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEV  988 (1049)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  988 (1049)
                      .....    .....++..|+|||++.+ ..++.++||||+||++|||++|+.||............+.......+...+.
T Consensus       166 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07879         166 HADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK  241 (342)
T ss_pred             CCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            64322    123456888999998866 4688999999999999999999999975321111111110000000000000


Q ss_pred             c-cc-------ccccccccCc-hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--HHHHHH
Q 039290          989 A-DA-------NLLNCEENDF-SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR--LVRIRE 1041 (1049)
Q Consensus       989 ~-~~-------~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~--L~~i~~ 1041 (1049)
                      . +.       .......... ......+.++.+++.+||+.||++||+++|++.|  ++++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            0 00       0000000000 0011245678999999999999999999999977  665543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=6.7e-32  Score=305.46  Aligned_cols=268  Identities=21%  Similarity=0.260  Sum_probs=196.5

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecC----------
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNN----------  829 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~----------  829 (1049)
                      .+|+..+.||+|+||.||+|.. .+++.||+|++........+.+.+|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            5789999999999999999995 46889999999776555667889999999999999999999876543          


Q ss_pred             ----CeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec-CCCceEEec
Q 039290          830 ----DFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN-ESMVGHLSD  904 (1049)
Q Consensus       830 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~-~~~~~kl~D  904 (1049)
                          ...++||||++ ++|.+++...  .+++..++.++.||++|++|||   +.||+||||||+||+++ +++.+|++|
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECC
Confidence                35789999997 5898877643  4789999999999999999999   99999999999999997 456789999


Q ss_pred             ccCceecCCCccc--cccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccc
Q 039290          905 FGIAKILGKEESM--RQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLL  981 (1049)
Q Consensus       905 fGla~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  981 (1049)
                      ||.+.........  ......++..|+|||.+.. ..++.++||||+||++|||++|+.||.....-+.. ....+....
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~-~~~~~~~~~  237 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM-QLILESVPV  237 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhcCC
Confidence            9999865432211  1122357889999997644 56788999999999999999999999653221111 111100000


Q ss_pred             cC--Ccchh---cccccc-cccccCc---hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          982 SC--SITEV---ADANLL-NCEENDF---SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       982 ~~--~~~~~---~~~~~~-~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ..  ...+.   ...... .....+.   ......+.++.+++.+|++.||++|||++|++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            00  00000   000000 0000000   0112345678999999999999999999999875

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=1.2e-31  Score=301.16  Aligned_cols=267  Identities=24%  Similarity=0.280  Sum_probs=199.8

Q ss_pred             HHHHhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeec-CCe
Q 039290          756 LLRATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSN-NDF  831 (1049)
Q Consensus       756 ~~~~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~-~~~  831 (1049)
                      +....++|+..+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+++++.++||||+++.+++.. .+.
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            3456788999999999999999999854 78999999886432  2345678899999999999999999998865 567


Q ss_pred             eEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceec
Q 039290          832 KALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL  911 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~  911 (1049)
                      .++|+||+ +++|.+++...  .+++..+..++.|+++|++|||   +.+|+||||+|+||++++++.++++|||.+...
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            89999999 56898887643  3688888899999999999999   999999999999999999999999999998754


Q ss_pred             CCCccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhh-----------hhc
Q 039290          912 GKEESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWV-----------GDS  979 (1049)
Q Consensus       912 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~-----------~~~  979 (1049)
                      ...    .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||....... ....+.           ...
T Consensus       159 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd07856         159 DPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN-QFSIITDLLGTPPDDVINTI  233 (328)
T ss_pred             CCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHhc
Confidence            322    122456888999998765 568999999999999999999999986532211 111110           000


Q ss_pred             cccCCcchhcccccccccccCc-hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          980 LLSCSITEVADANLLNCEENDF-SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .... ..+.... ......... .....++.++.+++.+|++.+|++|||+++++.+
T Consensus       234 ~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         234 CSEN-TLRFVQS-LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             cchh-hHHHHhh-ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000 0000000 000000000 0112245789999999999999999999999887

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=1.7e-31  Score=294.33  Aligned_cols=266  Identities=26%  Similarity=0.303  Sum_probs=201.6

Q ss_pred             CCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          763 FSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      |+..+.||+|+||.||+|+.. +++.||+|++....  +...+.+..|++++++++|||++++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566788999999999999965 58999999997653  334567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      + ++|.+++......+++.++.+++.|++.|++|||   +.||+||||+|+||++++++.++|+|||.+........ ..
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~  155 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TY  155 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-cc
Confidence            7 5899999876556899999999999999999999   99999999999999999999999999999986643322 22


Q ss_pred             cccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccC---Ccchh-----cc
Q 039290          920 TKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSC---SITEV-----AD  990 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~-----~~  990 (1049)
                      ....++..|+|||.+.+. .++.++||||+||++|||++|..||......+. ..+ ........   .+..+     .+
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ-LFK-IFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHH-HHHHhCCCcHHHHHhhccccccc
Confidence            233457789999988766 789999999999999999999999865322111 000 00000000   00000     00


Q ss_pred             cccccccccCc-hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          991 ANLLNCEENDF-SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       991 ~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ........... ......+..+.+++.+||+.+|++||++++++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            00000000000 1111235679999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=7.9e-32  Score=304.84  Aligned_cols=270  Identities=20%  Similarity=0.232  Sum_probs=200.1

Q ss_pred             HHHHHhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecCC-
Q 039290          755 DLLRATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNND-  830 (1049)
Q Consensus       755 ~~~~~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~-  830 (1049)
                      .++...++|++.+.||+|+||.||+|.. .++..||+|++.....  .....+.+|++++++++||||+++++++...+ 
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07880           9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS   88 (343)
T ss_pred             hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence            4455678899999999999999999984 5789999999865332  23456889999999999999999999887653 


Q ss_pred             -----eeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecc
Q 039290          831 -----FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDF  905 (1049)
Q Consensus       831 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df  905 (1049)
                           ..++||||+ +++|.+++...  .+++..+..++.|+++|++|||   +.||+||||||+||+++.++.+|++||
T Consensus        89 ~~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~df  162 (343)
T cd07880          89 LDRFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDF  162 (343)
T ss_pred             ccccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeec
Confidence                 458999999 67998887643  4889999999999999999999   999999999999999999999999999


Q ss_pred             cCceecCCCccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccC-
Q 039290          906 GIAKILGKEESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSC-  983 (1049)
Q Consensus       906 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-  983 (1049)
                      |++.......    ....+++.|+|||.+.+ ..++.++|+||+|+++|++++|..||........ ............ 
T Consensus       163 g~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~  237 (343)
T cd07880         163 GLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ-LMEIMKVTGTPSK  237 (343)
T ss_pred             ccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCH
Confidence            9998653321    22356889999998865 4588999999999999999999999975322111 111000000000 


Q ss_pred             Ccchhcc-----cccccccccC----chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          984 SITEVAD-----ANLLNCEEND----FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       984 ~~~~~~~-----~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ...+...     ......+...    ......++.++.+++.+|++.||++|||+.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000000     0000000000    01112455678999999999999999999999965

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=1.5e-31  Score=290.76  Aligned_cols=248  Identities=23%  Similarity=0.261  Sum_probs=194.6

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc-----CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF-----DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      +|.+.+.||+|+||.||+|+.. .+..+++|+.+...     .....++.+|+.++++++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            5788899999999999999864 34456666654321     22334577899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhc---CCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecC
Q 039290          836 LEYMSNGSLEKCLYS---DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      |||+++++|.+++..   ....+++.+++.++.|+++|++|||   +.|++|+||+|+||++++ +.++++|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999988864   3346899999999999999999999   999999999999999985 569999999987664


Q ss_pred             CCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccc
Q 039290          913 KEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       913 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      .... ......+++.|+|||...+..++.++|+||+|+++|+|++|..||......+.. ....             .  
T Consensus       157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~-~~~~-------------~--  219 (260)
T cd08222         157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV-LRIV-------------E--  219 (260)
T ss_pred             CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH-HHHH-------------c--
Confidence            3322 122345788999999988888899999999999999999999998642111100 0000             0  


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                           ......+..++.++.+++.+||+.+|++||++.|++++
T Consensus       220 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         220 -----GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             -----CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence                 00111123456788999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.7e-32  Score=298.26  Aligned_cols=241  Identities=24%  Similarity=0.286  Sum_probs=196.5

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEEEe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      ++.|.....+|.|+|++|-.+.. .+++..+||++....    .+..+|+.++... .||||+++.+++.++.+.|+|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            45677778899999999999884 578899999997552    3345667666555 69999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeee-cCCCceEEecccCceecCCCcc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL-NESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~-~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ++.|+-+.+.+...+.  ....+..|+.+|+.|+.|||   ++||||||+||+|||+ ++.++++|+|||.++...+.  
T Consensus       397 ~l~g~ell~ri~~~~~--~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKPE--FCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             hccccHHHHHHHhcch--hHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            9999988887766554  22677789999999999999   9999999999999999 58999999999999876544  


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                        ..+..-|..|.|||+.....|++++|+||+|+++|+|++|+.||.....+ ......++                   
T Consensus       470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i~-------------------  527 (612)
T KOG0603|consen  470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRIQ-------------------  527 (612)
T ss_pred             --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhhc-------------------
Confidence              22335588999999999999999999999999999999999999875555 22221111                   


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                         ........+...++++.+|++.||.+||+++++..|=
T Consensus       528 ---~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~  564 (612)
T KOG0603|consen  528 ---MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHP  564 (612)
T ss_pred             ---CCccccccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence               0011144567889999999999999999999998763

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.5e-32  Score=282.38  Aligned_cols=267  Identities=22%  Similarity=0.259  Sum_probs=201.0

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcC--CC----ceeeEEeeeecCCee
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIR--HR----NLVKIISSCSNNDFK  832 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--hp----niv~l~~~~~~~~~~  832 (1049)
                      +++|.++..+|+|+||.|.++... .+..||+|+++. .....+..+-|++++.++.  .|    -+|++.+||...++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            678999999999999999999854 578999999864 3445567788999999993  23    378888899999999


Q ss_pred             EEEEeccCCCChhhhhhcCCC-ccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC---------------
Q 039290          833 ALVLEYMSNGSLEKCLYSDNY-FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE---------------  896 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---------------  896 (1049)
                      ++|+|.+ |-++.+++..+.. +++..++..|++|++++++|||   +.+++|-|+||+||++.+               
T Consensus       167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~  242 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF  242 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccce
Confidence            9999999 5699999987544 7899999999999999999999   999999999999999831               


Q ss_pred             -----CCceEEecccCceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccc-
Q 039290          897 -----SMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEM-  970 (1049)
Q Consensus       897 -----~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-  970 (1049)
                           ...+||+|||.|++.....    +..+.|..|+|||++.+-.++.++||||+|||++|++||..-|..-..-|. 
T Consensus       243 ~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL  318 (415)
T KOG0671|consen  243 IRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL  318 (415)
T ss_pred             eccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence                 2468999999998754333    456789999999999999999999999999999999999988765332221 


Q ss_pred             hHHHhhhhccccCCcchh-------------cc-------ccccccccc---CchhhHHHHHHHHHHHhhccccCCCCCC
Q 039290          971 SLKRWVGDSLLSCSITEV-------------AD-------ANLLNCEEN---DFSAREQCVSSIFSLAMDCTVDLPEKRI 1027 (1049)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~-------------~~-------~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rp 1027 (1049)
                      ...+.+-+......+...             .+       ..+.+.+..   ..........++.+++++|+..||.+|+
T Consensus       319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri  398 (415)
T KOG0671|consen  319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI  398 (415)
T ss_pred             HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence            111111000000000000             00       000000000   0111123446699999999999999999


Q ss_pred             CHHHHHHH
Q 039290         1028 SMKDVANR 1035 (1049)
Q Consensus      1028 t~~ell~~ 1035 (1049)
                      |+.|++.|
T Consensus       399 Tl~EAL~H  406 (415)
T KOG0671|consen  399 TLREALSH  406 (415)
T ss_pred             cHHHHhcC
Confidence            99999986

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-31  Score=299.77  Aligned_cols=258  Identities=24%  Similarity=0.315  Sum_probs=212.7

Q ss_pred             HHHHHHhcCCCCCceecCCCcEEEEEEE-eCCCcEEEEEEeecccCCCHHHHHHHHHHHhhc-CCCceeeEEeeeec---
Q 039290          754 QDLLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLVKIISSCSN---  828 (1049)
Q Consensus       754 ~~~~~~~~~~~~~~~lg~G~fg~Vy~a~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~---  828 (1049)
                      +.+...++-|.+.+.||.|.+|.||+++ .++++.+|+|+.....+. .+++..|.++++.. .|||++.++|++..   
T Consensus        12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~   90 (953)
T KOG0587|consen   12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDP   90 (953)
T ss_pred             hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence            3333345668888999999999999999 568899999998776544 36788899999988 59999999998843   


Q ss_pred             --CCeeEEEEeccCCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecc
Q 039290          829 --NDFKALVLEYMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDF  905 (1049)
Q Consensus       829 --~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df  905 (1049)
                        ++.+|+|||||.+|+..|+++.. +..+.|+.+..|++.++.|+.+||   ...++|||||-.||+++.++.||++||
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDF  167 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDF  167 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeee
Confidence              57899999999999999988653 456899999999999999999999   999999999999999999999999999


Q ss_pred             cCceecCCCccccccccccccCcccccccCC-----CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcc
Q 039290          906 GIAKILGKEESMRQTKTLGTIGYMAPEYGRE-----GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSL  980 (1049)
Q Consensus       906 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  980 (1049)
                      |.+....... .+..+.+||+.|||||++.-     ..|+..+|+||+|++..||.-|.+|+.++-+....+.       
T Consensus       168 GvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~-------  239 (953)
T KOG0587|consen  168 GVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-------  239 (953)
T ss_pred             eeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc-------
Confidence            9998775433 34556889999999998853     3577889999999999999999999876422211110       


Q ss_pred             ccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          981 LSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                                  +.+.++.+...+....+++.++|..|+..|-++||++.++++|
T Consensus       240 ------------IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  240 ------------IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             ------------CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                        1223444455667788999999999999999999999999876

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=6.8e-31  Score=283.88  Aligned_cols=239  Identities=28%  Similarity=0.322  Sum_probs=194.8

Q ss_pred             ecCCCcEEEEEEEeC-CCcEEEEEEeecccCC---CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCCCh
Q 039290          769 LGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDG---SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSL  844 (1049)
Q Consensus       769 lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  844 (1049)
                      ||+|+||.||+|... +++.||+|++......   ..+.+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999965 5889999998764322   345788999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccccccccc
Q 039290          845 EKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLG  924 (1049)
Q Consensus       845 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  924 (1049)
                      .+++.... .+++..+..++.|+++|+.|+|   +.+++|+||+|+||+++.++.++++|||.+....... .......+
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~  155 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCG  155 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcC
Confidence            99987664 4899999999999999999999   9999999999999999999999999999998764332 12233457


Q ss_pred             ccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCchhh
Q 039290          925 TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAR 1004 (1049)
Q Consensus       925 ~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1049)
                      +..|+|||...+..++.++|+||+|+++||+++|..||.....  .......   ..                 .....+
T Consensus       156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~---~~-----------------~~~~~~  213 (250)
T cd05123         156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEKI---LK-----------------DPLRFP  213 (250)
T ss_pred             CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHH---hc-----------------CCCCCC
Confidence            8899999999888889999999999999999999999965322  1111111   00                 011112


Q ss_pred             HHHHHHHHHHHhhccccCCCCCCCH---HHHHH
Q 039290         1005 EQCVSSIFSLAMDCTVDLPEKRISM---KDVAN 1034 (1049)
Q Consensus      1005 ~~~~~~l~~li~~cl~~dP~~Rpt~---~ell~ 1034 (1049)
                      ...+.++.+++.+||..||++||++   +++..
T Consensus       214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~  246 (250)
T cd05123         214 EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA  246 (250)
T ss_pred             CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence            2235678999999999999999999   55544

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.9e-31  Score=301.89  Aligned_cols=265  Identities=23%  Similarity=0.285  Sum_probs=198.6

Q ss_pred             HHhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCe---
Q 039290          758 RATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDF---  831 (1049)
Q Consensus       758 ~~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~---  831 (1049)
                      ...++|+..+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|+.+++.++|||++++.+++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34668999999999999999999965 68899999986532  2234567789999999999999999998766554   


Q ss_pred             ---eEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCc
Q 039290          832 ---KALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA  908 (1049)
Q Consensus       832 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla  908 (1049)
                         .++|+||+ +++|.+++...  .+++.++..++.|+++|++|||   +.||+||||||+||++++++.++|+|||++
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence               89999999 56999988753  4899999999999999999999   999999999999999999999999999999


Q ss_pred             eecCCCccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcch
Q 039290          909 KILGKEESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITE  987 (1049)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  987 (1049)
                      ......    .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+ ........ .... ...
T Consensus       166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~~-~~~~-~~~  238 (343)
T cd07851         166 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMNL-VGTP-DEE  238 (343)
T ss_pred             cccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHh-cCCC-CHH
Confidence            865432    223456888999998755 467899999999999999999999996432211 11111100 0000 000


Q ss_pred             hccc-----------ccccccccCch-hhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          988 VADA-----------NLLNCEENDFS-AREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       988 ~~~~-----------~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      +...           .+......++. .....+.++.+++.+|++.+|++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            0000           00000000111 111236789999999999999999999999876

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=278.27  Aligned_cols=242  Identities=23%  Similarity=0.288  Sum_probs=196.2

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~l  834 (1049)
                      ..+|....+||+|+||+|-.|..+ +.+.||||+++++.   +...+--+.|-+++.-- +-|.+++++.++++-+++|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            346888999999999999999865 56679999998765   33334445677777655 57899999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      ||||+.||+|--.+..-++ +.+..+.-+|.+||-||=|||   ++||++||+|.+|||++.+|++||+|||+++.---+
T Consensus       428 VMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             EEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence            9999999999888877655 677788889999999999999   999999999999999999999999999998743222


Q ss_pred             ccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          915 ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       915 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                      + ....+..||+.|+|||++...+|+.++|.||+||++|||+.|++||++....  .+.+-            +.+    
T Consensus       504 ~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~--elF~a------------I~e----  564 (683)
T KOG0696|consen  504 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQA------------IME----  564 (683)
T ss_pred             C-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHH------------HHH----
Confidence            2 2334578999999999999999999999999999999999999999873322  22211            111    


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCC
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRIS 1028 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt 1028 (1049)
                          .....+...+.+...++...+...|.+|..
T Consensus       565 ----hnvsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  565 ----HNVSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             ----ccCcCcccccHHHHHHHHHHhhcCCccccC
Confidence                112334556778888999999999999973

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=1.2e-30  Score=317.52  Aligned_cols=146  Identities=29%  Similarity=0.412  Sum_probs=131.2

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC---CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD---GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      .++|.+.++||+|+||.||+|... +++.||+|+++....   .....+.+|+.+++.++||||+++++++...+..|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            357899999999999999999965 788999999975432   1236788899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCce
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK  909 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~  909 (1049)
                      |||+.+++|.+++...+ .+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999987654 4788999999999999999999   8999999999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=8.7e-31  Score=295.38  Aligned_cols=268  Identities=21%  Similarity=0.233  Sum_probs=193.5

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-C--CcEEEEEEeecccC--CCHHHHHHHHHHHhhc-CCCceeeEEeeeec----CCe
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-D--GMEIAAKVFHMEFD--GSLESFHAECKVMGSI-RHRNLVKIISSCSN----NDF  831 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~--~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~----~~~  831 (1049)
                      +|++.+.||+|+||.||+|+.. +  +..||+|++.....  ...+.+.+|+++++++ +||||+++++++..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999999954 4  77899999865332  2345788899999999 59999999987533    245


Q ss_pred             eEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceec
Q 039290          832 KALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL  911 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~  911 (1049)
                      .++++||+. ++|.+++.... .+++..++.++.|++.||+|||   +.||+||||||+||+++.++.+||+|||++...
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            788999986 58988886544 5899999999999999999999   999999999999999999999999999999865


Q ss_pred             CCCcc---ccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhc--cccCCc
Q 039290          912 GKEES---MRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDS--LLSCSI  985 (1049)
Q Consensus       912 ~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~~  985 (1049)
                      .....   .......++..|+|||+..+ ..++.++||||+||++|+|++|+.||....... .........  ......
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGTPDEETL  234 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence            43221   11223467899999998765 468899999999999999999999987532111 010000000  000000


Q ss_pred             chhccc-------ccccccccCch-hhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          986 TEVADA-------NLLNCEENDFS-AREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       986 ~~~~~~-------~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ..+..+       .........+. .....+..+.+++.+|++.+|++|||++|++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            000000       00000000000 011235678999999999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=1.2e-30  Score=279.06  Aligned_cols=219  Identities=20%  Similarity=0.150  Sum_probs=176.4

Q ss_pred             CCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCCChhhhhhc
Q 039290          772 GSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYS  850 (1049)
Q Consensus       772 G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  850 (1049)
                      |.||.||+|+. .+++.||+|+++...     .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            89999999995 478899999997542     233455555556799999999999999999999999999999998876


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccccccccCccc
Q 039290          851 DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMA  930 (1049)
Q Consensus       851 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~a  930 (1049)
                      .. .+++..+..++.|+++|++|+|   +++|+||||||+||+++.++.++++|||.+.......    ....++..|+|
T Consensus        79 ~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~a  150 (237)
T cd05576          79 FL-NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYCA  150 (237)
T ss_pred             hc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccccC
Confidence            54 4899999999999999999999   9999999999999999999999999999876554321    12345678999


Q ss_pred             ccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHH
Q 039290          931 PEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSS 1010 (1049)
Q Consensus       931 PE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1049)
                      ||...+..++.++||||+|+++|||++|..|+........                .          ......+...+..
T Consensus       151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----------------~----------~~~~~~~~~~~~~  204 (237)
T cd05576         151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN----------------T----------HTTLNIPEWVSEE  204 (237)
T ss_pred             CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----------------c----------ccccCCcccCCHH
Confidence            9999888899999999999999999999988653211000                0          0000111234567


Q ss_pred             HHHHHhhccccCCCCCCCH
Q 039290         1011 IFSLAMDCTVDLPEKRISM 1029 (1049)
Q Consensus      1011 l~~li~~cl~~dP~~Rpt~ 1029 (1049)
                      +.+++.+|++.||++||++
T Consensus       205 ~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         205 ARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHHHHccCCHHHhcCC
Confidence            8999999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-32  Score=268.65  Aligned_cols=251  Identities=25%  Similarity=0.238  Sum_probs=192.5

Q ss_pred             CCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC-CCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEEEeccCC
Q 039290          765 ENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD-GSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALVLEYMSN  841 (1049)
Q Consensus       765 ~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  841 (1049)
                      ....||.|+||+|++-.+ +.|+..|||+++.... ...+++..|.+...+- +.||||+++|++-.++.-|+.||.|.-
T Consensus        68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~  147 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI  147 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh
Confidence            346799999999999985 4799999999987654 4567788888875544 689999999998887888999999954


Q ss_pred             CChhhhhhc----CCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          842 GSLEKCLYS----DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       842 g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                       +++.+...    ....+++...-.|......||.||-.  ..+|+|||+||+|||++..|.+|+||||++....  ++.
T Consensus       148 -SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv--~Si  222 (361)
T KOG1006|consen  148 -SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV--DSI  222 (361)
T ss_pred             -hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHH--HHH
Confidence             77665321    23458888888999999999999994  6789999999999999999999999999987653  334


Q ss_pred             cccccccccCcccccccCC--CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          918 RQTKTLGTIGYMAPEYGRE--GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                      ..+..+|-..|||||.+..  ..|+-++||||+|++++|+.||..||.....--.+..+.+.   ..++       .+..
T Consensus       223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~---gdpp-------~l~~  292 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI---GDPP-------ILLF  292 (361)
T ss_pred             HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc---CCCC-------eecC
Confidence            5556678889999998864  35889999999999999999999998763221111111110   0000       0000


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .     ....+.+..+..++..|+..|-.+||..+++.++
T Consensus       293 ~-----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  293 D-----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             c-----ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            0     0112356678999999999999999999998765

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=2.1e-30  Score=306.98  Aligned_cols=260  Identities=23%  Similarity=0.233  Sum_probs=172.2

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEeC-C----CcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEee------ee
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVLP-D----GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISS------CS  827 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~------~~  827 (1049)
                      ..++|+..+.||+|+||.||+|+.. +    +..||+|++.....  .+....|  .+....+.+++.++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4568999999999999999999965 4    68999998764321  1111111  1122222233222221      24


Q ss_pred             cCCeeEEEEeccCCCChhhhhhcCCCcc-------------------CHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCC
Q 039290          828 NNDFKALVLEYMSNGSLEKCLYSDNYFL-------------------DILQRLKIMIDVASALEYLHFGYSTPIVHCDIK  888 (1049)
Q Consensus       828 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------------------~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk  888 (1049)
                      +++..++||||+.+++|.+++.......                   ....+..++.|+++||+|||   +++|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence            5667899999999999999887543211                   12345689999999999999   9999999999


Q ss_pred             CCCeeecC-CCceEEecccCceecCCCccccccccccccCcccccccCCC----------------------CcCcccch
Q 039290          889 PSNVLLNE-SMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG----------------------KVSRKCDV  945 (1049)
Q Consensus       889 p~NIl~~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Dv  945 (1049)
                      |+|||++. ++.+||+|||+|+..............+++.|+|||.+...                      .++.++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999985 57999999999986644433334456789999999965322                      23446799


Q ss_pred             HHHHHHHHHHHhCCCCCCccccc--------cchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhh
Q 039290          946 YSYGIMLMETFTKKKPTDEIFAG--------EMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMD 1017 (1049)
Q Consensus       946 wslG~il~elltg~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 1017 (1049)
                      ||+||++|||+++..|++.....        ......|....          ...........+...........+++.+
T Consensus       363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~d~~~~~~~dLi~~  432 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLV----------EPRASPDLRRGFEVLDLDGGAGWELLKS  432 (566)
T ss_pred             HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhh----------ccccchhhhhhhhhccccchHHHHHHHH
Confidence            99999999999977665431100        00111121110          0000000000001111112345689999


Q ss_pred             ccccCCCCCCCHHHHHHH
Q 039290         1018 CTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus      1018 cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      |++.||++|||++|+++|
T Consensus       433 mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        433 MMRFKGRQRISAKAALAH  450 (566)
T ss_pred             HccCCcccCCCHHHHhCC
Confidence            999999999999999987

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.6e-31  Score=275.79  Aligned_cols=256  Identities=27%  Similarity=0.428  Sum_probs=198.5

Q ss_pred             cCCCCCceecCCCcEEEEEEE-eCCCcEEEEEEeecccC-------CCHHHHHHHHHHHhhcCCCceeeEEeeee-cCCe
Q 039290          761 DGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFD-------GSLESFHAECKVMGSIRHRNLVKIISSCS-NNDF  831 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~-~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~hpniv~l~~~~~-~~~~  831 (1049)
                      ++|-....||+|+|+.||+|. ....+.||||+-.....       ...+...+|.++.+.+.||.||++++++. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            457778899999999999999 45677889988654321       12345678999999999999999999985 5567


Q ss_pred             eEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec---CCCceEEecccCc
Q 039290          832 KALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIA  908 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~---~~~~~kl~DfGla  908 (1049)
                      +|-|+|||+|.+|+-++..++ .+++.++..|+.||+.||.||. .-+.+|||-|+||.||++.   .-|.+||+|||++
T Consensus       543 FCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLN-EikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLN-EIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHh-ccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            899999999999999998765 4899999999999999999999 4467899999999999995   4579999999999


Q ss_pred             eecCCCccc------cccccccccCcccccccCCC----CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhh
Q 039290          909 KILGKEESM------RQTKTLGTIGYMAPEYGREG----KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGD  978 (1049)
Q Consensus       909 ~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  978 (1049)
                      +.+..+...      -.....||.+|.+||.+.-+    +.+.++||||+|||+|+++.|+.||+........+.     
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq-----  695 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ-----  695 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh-----
Confidence            988543211      12235699999999977543    467899999999999999999999976322211110     


Q ss_pred             ccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 039290          979 SLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVAN 1034 (1049)
Q Consensus       979 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~ 1034 (1049)
                         ..        .+....+-.++..+..+.+...||++|+++.-++|....++..
T Consensus       696 ---eN--------TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  696 ---EN--------TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             ---hh--------chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence               11        1111112223333456678899999999999999998887754

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=284.12  Aligned_cols=248  Identities=23%  Similarity=0.300  Sum_probs=203.7

Q ss_pred             CCCCCceecCCCcEEEEEEEeCCCc-EEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          762 GFSENKLLGMGSFGSVYKGVLPDGM-EIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~~~~-~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      ++.....||-|+||.|=.++.+... .+|+|++++..   ..+.+.+..|-++|...+.|.||+++..|.+.++.|+.||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            3445567999999999988865433 48888776543   4556788899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      -|-||.++..+++++. +++.+..-++..+++|++|||   ++|||+||+||+|.+++.+|-+||.|||+|+..+...  
T Consensus       501 aClGGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~--  574 (732)
T KOG0614|consen  501 ACLGGELWTILRDRGS-FDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR--  574 (732)
T ss_pred             hhcCchhhhhhhhcCC-cccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCC--
Confidence            9999999999987765 788888889999999999999   9999999999999999999999999999999886544  


Q ss_pred             cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccccc
Q 039290          918 RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE  997 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1049)
                      ..++.+||+.|.|||++.++..+.++|.||+|+++||+++|.+||.+...........                  ....
T Consensus       575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL------------------kGid  636 (732)
T KOG0614|consen  575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL------------------KGID  636 (732)
T ss_pred             ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH------------------hhhh
Confidence            4567899999999999999999999999999999999999999997632221111111                  0001


Q ss_pred             ccCchhhHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 039290          998 ENDFSAREQCVSSIFSLAMDCTVDLPEKRIS-----MKDVANR 1035 (1049)
Q Consensus       998 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~ell~~ 1035 (1049)
                        .+..|...++...++|++....+|.+|..     +.++.+|
T Consensus       637 --~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  637 --KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             --hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence              12223445667889999999999999985     6666665

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=1.3e-29  Score=291.84  Aligned_cols=258  Identities=22%  Similarity=0.272  Sum_probs=183.3

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEe-----------------CCCcEEEEEEeecccCCCHHH--------------HHHH
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVL-----------------PDGMEIAAKVFHMEFDGSLES--------------FHAE  807 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~e  807 (1049)
                      ..++|++.++||+|+||+||+|..                 .+++.||||++........++              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            366899999999999999999963                 245679999987544332223              3346


Q ss_pred             HHHHhhcCCCc-----eeeEEeeeec--------CCeeEEEEeccCCCChhhhhhcCC----------------------
Q 039290          808 CKVMGSIRHRN-----LVKIISSCSN--------NDFKALVLEYMSNGSLEKCLYSDN----------------------  852 (1049)
Q Consensus       808 ~~~l~~l~hpn-----iv~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~----------------------  852 (1049)
                      +.++.+++|.+     +++++++|..        .+..++||||+++++|.++++...                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            67777776654     4677777643        356799999999999999886421                      


Q ss_pred             -CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccccccccCcccc
Q 039290          853 -YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAP  931 (1049)
Q Consensus       853 -~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aP  931 (1049)
                       ...++..++.++.|+++|++|+|   +.+|+||||||+||+++.++.+||+|||++...............+++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence             12356778899999999999999   99999999999999999999999999999976543322222223457899999


Q ss_pred             cccCCCC----------------------cCcccchHHHHHHHHHHHhCCC-CCCccccccchH-------HHhhhhccc
Q 039290          932 EYGREGK----------------------VSRKCDVYSYGIMLMETFTKKK-PTDEIFAGEMSL-------KRWVGDSLL  981 (1049)
Q Consensus       932 E~~~~~~----------------------~~~~~DvwslG~il~elltg~~-p~~~~~~~~~~~-------~~~~~~~~~  981 (1049)
                      |.+....                      ...+.||||+||+++||++|.. |+..........       ..|...   
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~---  456 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY---  456 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh---
Confidence            9875422                      1234799999999999999875 665321111111       111110   


Q ss_pred             cCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCC---CCCCCHHHHHHH
Q 039290          982 SCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLP---EKRISMKDVANR 1035 (1049)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~Rpt~~ell~~ 1035 (1049)
                                   ......++..........+++.+++..+|   .+|+|++|+++|
T Consensus       457 -------------~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        457 -------------KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             -------------cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence                         00011122223345678999999999766   689999999987

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-30  Score=294.73  Aligned_cols=244  Identities=28%  Similarity=0.435  Sum_probs=191.9

Q ss_pred             CCCCceecCCCcEE-EEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEEEeccC
Q 039290          763 FSENKLLGMGSFGS-VYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALVLEYMS  840 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~-Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~  840 (1049)
                      |...+++|.|+-|+ ||+|.. +|+.||||++-.+   ..+...+|+..++.- +|||||++++.-.+....||+.|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            55567899998874 699998 8889999998654   335678999999887 69999999999999999999999996


Q ss_pred             CCChhhhhhcCCC---ccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC---C--CceEEecccCceecC
Q 039290          841 NGSLEKCLYSDNY---FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE---S--MVGHLSDFGIAKILG  912 (1049)
Q Consensus       841 ~g~L~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~--~~~kl~DfGla~~~~  912 (1049)
                      . +|+++++....   .......+.+..|+++|+++||   +.+|||||+||.||||+.   +  ..++|+|||+++...
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            5 99999987421   1111445789999999999999   999999999999999974   2  588999999999886


Q ss_pred             CCccc--cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhC-CCCCCccccccchHHHhhhhccccCCcchhc
Q 039290          913 KEESM--RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLLSCSITEVA  989 (1049)
Q Consensus       913 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  989 (1049)
                      .....  +.....||-+|+|||++.....+.++||||+||++|+.++| ..||++....+..+..-..      ...   
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~------~L~---  733 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNY------TLV---  733 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCcc------cee---
Confidence            54422  23456789999999999998888999999999999999995 8999874433332221100      000   


Q ss_pred             ccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          990 DANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                                ......++  +..++|.+|+.++|..||+|.+|+.|
T Consensus       734 ----------~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  734 ----------HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             ----------eeccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence                      00111223  78899999999999999999999876

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=4.1e-30  Score=244.13  Aligned_cols=213  Identities=26%  Similarity=0.296  Sum_probs=171.4

Q ss_pred             HHhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC-CCHHHHHHHHHHHhh-cCCCceeeEEeeeecCCeeEE
Q 039290          758 RATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD-GSLESFHAECKVMGS-IRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       758 ~~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~-l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      ...+.......||+|+||.|=+-++ .+|...|+|+++.... +..++..+|+++..+ ..+|.+|.++|...+....++
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI  122 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI  122 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence            3344455567899999999988884 5899999999987653 334567778877544 479999999999999999999


Q ss_pred             EEeccCCCChhhhhh---cCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceec
Q 039290          835 VLEYMSNGSLEKCLY---SDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL  911 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~  911 (1049)
                      .||.|.. +|+.+-.   +.+...++..+-+|+..+.+||.|||+  ...|+|||+||+|||++.+|+||+||||.+-..
T Consensus       123 cME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L  199 (282)
T KOG0984|consen  123 CMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYL  199 (282)
T ss_pred             eHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence            9999954 7876643   345568899999999999999999994  568999999999999999999999999999876


Q ss_pred             CCCccccccccccccCcccccccCC----CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHh
Q 039290          912 GKEESMRQTKTLGTIGYMAPEYGRE----GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRW  975 (1049)
Q Consensus       912 ~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~  975 (1049)
                      ..  +...+...|-..|||||.+..    ..|+-++||||+|+.+.||.+++.||+..+..-..+.+.
T Consensus       200 ~d--SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv  265 (282)
T KOG0984|consen  200 VD--SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV  265 (282)
T ss_pred             hh--hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence            43  333344567778999998754    478999999999999999999999998755544444443

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=5e-30  Score=278.93  Aligned_cols=210  Identities=24%  Similarity=0.349  Sum_probs=178.3

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      ..-|...+.||-|+||+|..++.. +...||.|.+++..   ......+++|-+|+.....+-||+++..|.+++.+|+|
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV  707 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV  707 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence            445888899999999999999854 45568999987653   34567889999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceec----
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL----  911 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~----  911 (1049)
                      |||++||++-.++..-+- +.+.-++-++.++.+|+++.|   ..|+|||||||+|||||.+|++||+|||++.-+    
T Consensus       708 MdYIPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH  783 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  783 (1034)
T ss_pred             EeccCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceecc
Confidence            999999999998876653 667777778889999999999   999999999999999999999999999998532    


Q ss_pred             -----CCCc-----cc---------------------------cccccccccCcccccccCCCCcCcccchHHHHHHHHH
Q 039290          912 -----GKEE-----SM---------------------------RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLME  954 (1049)
Q Consensus       912 -----~~~~-----~~---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~e  954 (1049)
                           ...+     .+                           .....+||+.|+|||++....|+..+|.||.|||+||
T Consensus       784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e  863 (1034)
T KOG0608|consen  784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE  863 (1034)
T ss_pred             ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence                 1100     00                           0012469999999999999999999999999999999


Q ss_pred             HHhCCCCCCccccccchHH
Q 039290          955 TFTKKKPTDEIFAGEMSLK  973 (1049)
Q Consensus       955 lltg~~p~~~~~~~~~~~~  973 (1049)
                      |+.|+.||.....++....
T Consensus       864 m~~g~~pf~~~tp~~tq~k  882 (1034)
T KOG0608|consen  864 MLVGQPPFLADTPGETQYK  882 (1034)
T ss_pred             HhhCCCCccCCCCCcceee
Confidence            9999999988777766544

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=6.3e-29  Score=266.84  Aligned_cols=239  Identities=30%  Similarity=0.349  Sum_probs=194.8

Q ss_pred             CcEEEEEEEeC-CCcEEEEEEeecccCCC-HHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCCChhhhhhc
Q 039290          773 SFGSVYKGVLP-DGMEIAAKVFHMEFDGS-LESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYS  850 (1049)
Q Consensus       773 ~fg~Vy~a~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  850 (1049)
                      +||.||+|+.. +++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999976 58999999997665444 68899999999999999999999999998999999999999999999876


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccccccccCccc
Q 039290          851 DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMA  930 (1049)
Q Consensus       851 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~a  930 (1049)
                      ... +++.+++.++.++++++++||   +.+++|+||+|+||+++.++.++++|||.+.......  ......++..|+|
T Consensus        81 ~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~  154 (244)
T smart00220       81 RGR-LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA  154 (244)
T ss_pred             ccC-CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence            554 789999999999999999999   9999999999999999999999999999998765432  2234557889999


Q ss_pred             ccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHH
Q 039290          931 PEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSS 1010 (1049)
Q Consensus       931 PE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1049)
                      ||......++.++|||++|++++++++|..||......+ ...++......                . .......++.+
T Consensus       155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-~~~~~~~~~~~----------------~-~~~~~~~~~~~  216 (244)
T smart00220      155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-ELFKKIGKPKP----------------P-FPPPEWKISPE  216 (244)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHhccCC----------------C-CccccccCCHH
Confidence            999988888999999999999999999999986531111 11111110000                0 00000014567


Q ss_pred             HHHHHhhccccCCCCCCCHHHHHHH
Q 039290         1011 IFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus      1011 l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      +.+++.+|+..+|++||++.+++++
T Consensus       217 ~~~~i~~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      217 AKDLIRKLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             HHHHHHHHccCCchhccCHHHHhhC
Confidence            8999999999999999999999873

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.8e-31  Score=259.82  Aligned_cols=266  Identities=23%  Similarity=0.313  Sum_probs=199.2

Q ss_pred             CCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecC-----CeeEEEE
Q 039290          765 ENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNN-----DFKALVL  836 (1049)
Q Consensus       765 ~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~-----~~~~lv~  836 (1049)
                      ..+.||-|+||+||.+++ ++|+.||.|++....+  ...+++.+|.+++..++|.|++..+++..-.     .+.|+++
T Consensus        57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T  136 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT  136 (449)
T ss_pred             CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence            346799999999999995 4899999999865443  2357889999999999999999988876543     2567889


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      |.+.. +|.+.+.... .++...++-+.+||++||+|||   +.+|.||||||.|.+|+++...||||||+|+....++.
T Consensus       137 ELmQS-DLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  137 ELMQS-DLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHHh-hhhheeccCC-CCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence            99954 8888876654 4788889999999999999999   99999999999999999999999999999998776666


Q ss_pred             ccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccc----
Q 039290          917 MRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA----  991 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  991 (1049)
                      ..++..+-|..|+|||.+.+ ..|+.+.||||.|||+.|++.++.-|.....  ....+.+.+....+...++...    
T Consensus       212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P--iqQL~lItdLLGTPs~EaMr~ACEGA  289 (449)
T KOG0664|consen  212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP--IEQLQMIIDLLGTPSQEAMKYACEGA  289 (449)
T ss_pred             hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh--HHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence            66666778999999999877 5689999999999999999998887765322  1222222222222222211110    


Q ss_pred             --ccccccccC--------chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          992 --NLLNCEEND--------FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       992 --~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                        .+.......        ...+.+...+...+..+++..||.+|.+.++.+.+.-
T Consensus       290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence              000000000        0111123345677888999999999999999887753

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-29  Score=255.70  Aligned_cols=247  Identities=21%  Similarity=0.265  Sum_probs=197.5

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc---CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~l  834 (1049)
                      ..+|+..++||+|+|++|..+++ ++.+.||+|+++++-   +...+.++.|..++.+. +||.+|.+..+|.+...+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            35689999999999999999995 467789999997653   45567788888888877 69999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      |.||++||+|--.+...++ ++++.++-+..+|.-||.|||   ++||+.||+|.+||++|..|++|++|+|+.+.--.+
T Consensus       329 vieyv~ggdlmfhmqrqrk-lpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             EEEEecCcceeeehhhhhc-CcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence            9999999999877766554 899999999999999999999   999999999999999999999999999998754332


Q ss_pred             ccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCcccccc--chHHHhhhhccccCCcchhcccc
Q 039290          915 ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGE--MSLKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       915 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      +. ..++..|||.|+|||.+.+..|...+|.|++|++|+||+.|+.||+-.....  .....+             +.+.
T Consensus       405 gd-~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedy-------------lfqv  470 (593)
T KOG0695|consen  405 GD-TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDY-------------LFQV  470 (593)
T ss_pred             Cc-ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHH-------------HHHH
Confidence            22 3456789999999999999999999999999999999999999997543221  111111             0011


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCC
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI 1027 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 1027 (1049)
                      +   .+.....+...+-....+++.-+..||.+|.
T Consensus       471 i---lekqiriprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  471 I---LEKQIRIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             H---hhhcccccceeehhhHHHHHHhhcCCcHHhc
Confidence            0   0111112223344566788888999999986

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-29  Score=255.94  Aligned_cols=261  Identities=23%  Similarity=0.245  Sum_probs=201.3

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecC------Ce
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNN------DF  831 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~------~~  831 (1049)
                      .+|...+.+|.|+- .|..|.+. .+++||+|+...+.  ....++..+|..++..+.|+||++++.++.-.      ..
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            46777889999998 66666643 78899999886554  23457788999999999999999999998543      35


Q ss_pred             eEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceec
Q 039290          832 KALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL  911 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~  911 (1049)
                      .|+|||++.. +|...+..   .++..++..+.+|++.|++|+|   +.||+|||+||+||++..++.+||.|||+|+.-
T Consensus        96 ~y~v~e~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   96 VYLVMELMDA-NLCQVILM---ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE  168 (369)
T ss_pred             HHHHHHhhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhccc
Confidence            6899999954 88887763   3688899999999999999999   999999999999999999999999999999865


Q ss_pred             CCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccc
Q 039290          912 GKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA  991 (1049)
Q Consensus       912 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  991 (1049)
                      ...  ...+..+.+..|.|||++.+..+...+||||.||++.||++|+.-|.    |+....+|.+....-+...+-+-.
T Consensus       169 ~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~----g~d~idQ~~ki~~~lgtpd~~F~~  242 (369)
T KOG0665|consen  169 DTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP----GKDHIDQWNKIIEQLGTPDPSFMK  242 (369)
T ss_pred             Ccc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec----CchHHHHHHHHHHHhcCCCHHHHH
Confidence            433  45677788999999999999889999999999999999999998664    566666665543322221111111


Q ss_pred             ccccc--------c------------c----cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          992 NLLNC--------E------------E----NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       992 ~~~~~--------~------------~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .+.+.        +            .    .......-......+++.+|+..+|++|.+++++++|
T Consensus       243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            11000        0            0    0000111123457899999999999999999999987

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.2e-28  Score=257.69  Aligned_cols=267  Identities=21%  Similarity=0.223  Sum_probs=196.1

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcC-----C---CceeeEEeeeec---
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR-----H---RNLVKIISSCSN---  828 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---pniv~l~~~~~~---  828 (1049)
                      .+|.+.++||.|.|++||.|.+ .+.+.||+|+.+.. ....+....|++++++++     |   .+||++++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            6899999999999999999984 56778999998754 445677889999999984     3   479999999864   


Q ss_pred             -CCeeEEEEeccCCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCC---------
Q 039290          829 -NDFKALVLEYMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES---------  897 (1049)
Q Consensus       829 -~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~---------  897 (1049)
                       +.+++||+|++ |.+|..+|... -+.++...+++|++|++.||.|||.  +.||||-||||+|||+...         
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~~~e~~~~~~~~  233 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLCSTEIDPAKDAR  233 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeeeccccchhhhhh
Confidence             45899999999 55888877653 3468999999999999999999995  5699999999999998210         


Q ss_pred             --------------------------------------------------------------------------------
Q 039290          898 --------------------------------------------------------------------------------  897 (1049)
Q Consensus       898 --------------------------------------------------------------------------------  897 (1049)
                                                                                                      
T Consensus       234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~  313 (590)
T KOG1290|consen  234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE  313 (590)
T ss_pred             hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence                                                                                            


Q ss_pred             -----------------------------------------------------------------------------Cce
Q 039290          898 -----------------------------------------------------------------------------MVG  900 (1049)
Q Consensus       898 -----------------------------------------------------------------------------~~~  900 (1049)
                                                                                                   ..|
T Consensus       314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v  393 (590)
T KOG1290|consen  314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV  393 (590)
T ss_pred             cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence                                                                                         013


Q ss_pred             EEecccCceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCcccc-----ccchHHHh
Q 039290          901 HLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFA-----GEMSLKRW  975 (1049)
Q Consensus       901 kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~-----~~~~~~~~  975 (1049)
                      ||+|||.|+.+....    +..+.|..|+|||++.+..|+..+||||++|++||+.||..-|+....     ++..++..
T Consensus       394 KIaDlGNACW~~khF----T~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i  469 (590)
T KOG1290|consen  394 KIADLGNACWVHKHF----TEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI  469 (590)
T ss_pred             EEeeccchhhhhhhh----chhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence            444555544432211    224568899999999999999999999999999999999988865322     23333222


Q ss_pred             hhhcc-------ccCCc-chhccc-------------ccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 039290          976 VGDSL-------LSCSI-TEVADA-------------NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVAN 1034 (1049)
Q Consensus       976 ~~~~~-------~~~~~-~~~~~~-------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~ 1034 (1049)
                      +.-..       ..++. .+.+++             .+......++..+.+...++.+|+.-|++.+|++||||.++++
T Consensus       470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~  549 (590)
T KOG1290|consen  470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK  549 (590)
T ss_pred             HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence            21110       00000 011110             0111111234556778889999999999999999999999997


Q ss_pred             H
Q 039290         1035 R 1035 (1049)
Q Consensus      1035 ~ 1035 (1049)
                      |
T Consensus       550 h  550 (590)
T KOG1290|consen  550 H  550 (590)
T ss_pred             C
Confidence            6

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=2.1e-28  Score=264.90  Aligned_cols=200  Identities=25%  Similarity=0.368  Sum_probs=171.3

Q ss_pred             HHhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--------CCCHHHHHHHHHHHhhcC---CCceeeEEee
Q 039290          758 RATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--------DGSLESFHAECKVMGSIR---HRNLVKIISS  825 (1049)
Q Consensus       758 ~~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---hpniv~l~~~  825 (1049)
                      .....|...+.+|+|+||.|+.|.++ +...|++|.+.++.        +...-.+-.|+.+|++++   |+||++++++
T Consensus       558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence            34567999999999999999999976 45678999987653        112234566999999997   9999999999


Q ss_pred             eecCCeeEEEEeccC-CCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEec
Q 039290          826 CSNNDFKALVLEYMS-NGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSD  904 (1049)
Q Consensus       826 ~~~~~~~~lv~e~~~-~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D  904 (1049)
                      |++++.+|++||-.. +.+|.+++..+.+ +++.++..|+.|++.|+++||   +.||||||||-+||.++.+|-+|++|
T Consensus       638 FEddd~yyl~te~hg~gIDLFd~IE~kp~-m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  638 FEDDDYYYLETEVHGEGIDLFDFIEFKPR-MDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             eecCCeeEEEecCCCCCcchhhhhhccCc-cchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEee
Confidence            999999999999875 4489999987654 899999999999999999999   99999999999999999999999999


Q ss_pred             ccCceecCCCccccccccccccCcccccccCCCCc-CcccchHHHHHHHHHHHhCCCCCCc
Q 039290          905 FGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKV-SRKCDVYSYGIMLMETFTKKKPTDE  964 (1049)
Q Consensus       905 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~  964 (1049)
                      ||.|..... +  .....+||..|.|||++.+.+| ...-|||++|+++|-+...+.||..
T Consensus       714 fgsaa~~ks-g--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  714 FGSAAYTKS-G--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             ccchhhhcC-C--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            999876532 2  2345789999999999999887 4668999999999999999999864

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=6.4e-28  Score=238.34  Aligned_cols=251  Identities=20%  Similarity=0.258  Sum_probs=192.5

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhc-CCCceeeEEe-eeecCCeeEEEEe
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLVKIIS-SCSNNDFKALVLE  837 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~-~~~~~~~~~lv~e  837 (1049)
                      +.|.+.+.+|+|.||.+-.|+++ +.+.+|+|.++.+. ...++|.+|...--.+ .|.||+.-++ +|+..+.+.+++|
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            45888999999999999999965 67789999987653 3568899998876666 5899998776 4678888899999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec--CCCceEEecccCceecCCCc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN--ESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~--~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |++.|+|.+-+...+  +.+...++++.|+++|+.|+|   ++++||||||.+||||-  +...+|+||||..+..+..-
T Consensus       103 ~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV  177 (378)
T KOG1345|consen  103 FAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV  177 (378)
T ss_pred             cCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence            999999999877654  788889999999999999999   99999999999999994  34589999999998664332


Q ss_pred             cccccccccccCcccccccCCC-----CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREG-----KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD  990 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  990 (1049)
                      ...    .-+..|.|||.....     ...+.+|||.||++++.++||..||+.....+..+.+|..-.....  .    
T Consensus       178 ~~~----~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~--~----  247 (378)
T KOG1345|consen  178 KYL----EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN--P----  247 (378)
T ss_pred             hhh----hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC--c----
Confidence            221    235679999976442     3567899999999999999999999976666666655543111111  0    


Q ss_pred             cccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          991 ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                       .+.+       .-..+++.+..+.++-+.++|++|-...++.++
T Consensus       248 -~~P~-------~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  248 -ALPK-------KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             -cCch-------hhcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence             0100       001245667889999999999999544444443

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=2.2e-26  Score=241.14  Aligned_cols=211  Identities=34%  Similarity=0.520  Sum_probs=184.9

Q ss_pred             ecCCCcEEEEEEEeC-CCcEEEEEEeecccCC-CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCCChhh
Q 039290          769 LGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDG-SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEK  846 (1049)
Q Consensus       769 lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~  846 (1049)
                      ||+|++|.||++... +++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999975 4899999999765432 35789999999999999999999999999899999999999999999


Q ss_pred             hhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC-CCceEEecccCceecCCCccccccccccc
Q 039290          847 CLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE-SMVGHLSDFGIAKILGKEESMRQTKTLGT  925 (1049)
Q Consensus       847 ~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~~  925 (1049)
                      ++......+++..++.++.+++++++++|   +.+++|+||+|.||+++. ++.++++|||.+........ ......+.
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~  156 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT  156 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence            98876445899999999999999999999   999999999999999998 89999999999987654321 12234567


Q ss_pred             cCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCchhh
Q 039290          926 IGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAR 1004 (1049)
Q Consensus       926 ~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1049)
                      ..|++||..... .++.++|+|++|+++++|                                                 
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------------  187 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------------  187 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence            889999998776 888999999999999998                                                 


Q ss_pred             HHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290         1005 EQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus      1005 ~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                          ..+.+++.+|++.+|++||++.++++++
T Consensus       188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                3578899999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=4.7e-28  Score=266.66  Aligned_cols=254  Identities=24%  Similarity=0.354  Sum_probs=205.5

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      .++|.....+|.|+||.||+|+. ..++..|+|+++.+.....+-+.+|+-+++.-+|||||.+++.+...+..+++|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            45788899999999999999994 57899999999988777778889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      |.+|+|++.-+..+ ++++.++..++++..+|++|+|   +.|-+|||||-.||++++.|.+|++|||.+..++..-. .
T Consensus        94 cgggslQdiy~~Tg-plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~-K  168 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA-K  168 (829)
T ss_pred             cCCCcccceeeecc-cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhhh-h
Confidence            99999999766554 5899999999999999999999   99999999999999999999999999999877654332 3


Q ss_pred             ccccccccCccccccc---CCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          919 QTKTLGTIGYMAPEYG---REGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                      .....||+.|||||+.   ..+.|...+|||+.|+...|+-.-++|....-.....+.  .        ....+++-   
T Consensus       169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L--m--------TkS~~qpp---  235 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL--M--------TKSGFQPP---  235 (829)
T ss_pred             hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH--h--------hccCCCCC---
Confidence            4557899999999975   346789999999999999999887777433111111000  0        00011111   


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                          ....+....+.+-+|++.|+..+|.+|||++.++.|
T Consensus       236 ----~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  236 ----TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             ----cccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence                011112345678999999999999999999988765

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=6.8e-27  Score=246.95  Aligned_cols=271  Identities=24%  Similarity=0.319  Sum_probs=201.2

Q ss_pred             HHHHhcCCCCCceecCCCcEEEEEEEeC----CCcEEEEEEeecccCCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCC
Q 039290          756 LLRATDGFSENKLLGMGSFGSVYKGVLP----DGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLVKIISSCSNND  830 (1049)
Q Consensus       756 ~~~~~~~~~~~~~lg~G~fg~Vy~a~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~  830 (1049)
                      +....+.|...++||+|+|++||+|+..    ..+.||+|.+....  ...++.+|++++..+ .+.||+++.+++...+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3344567999999999999999999843    46789999987553  457899999999999 4899999999999999


Q ss_pred             eeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec-CCCceEEecccCce
Q 039290          831 FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAK  909 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~-~~~~~kl~DfGla~  909 (1049)
                      ...+|+||++.....++...    ++..++..+++.++.||+++|   ..|||||||||.|++.+ ..+.-.|+|||+|.
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             eeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHH
Confidence            99999999999888887764    567889999999999999999   99999999999999998 45678999999997


Q ss_pred             ecC-----------------C----------------Cc----------cccccccccccCcccccccCC-CCcCcccch
Q 039290          910 ILG-----------------K----------------EE----------SMRQTKTLGTIGYMAPEYGRE-GKVSRKCDV  945 (1049)
Q Consensus       910 ~~~-----------------~----------------~~----------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv  945 (1049)
                      .+.                 +                +.          ........||++|+|||++.. ...+.+.||
T Consensus       182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi  261 (418)
T KOG1167|consen  182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI  261 (418)
T ss_pred             HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence            221                 0                00          001123569999999998865 567889999


Q ss_pred             HHHHHHHHHHHhCCCCCCccccccchHHHhhh---------hccccCC-----------cchhc---ccc-cccccc---
Q 039290          946 YSYGIMLMETFTKKKPTDEIFAGEMSLKRWVG---------DSLLSCS-----------ITEVA---DAN-LLNCEE---  998 (1049)
Q Consensus       946 wslG~il~elltg~~p~~~~~~~~~~~~~~~~---------~~~~~~~-----------~~~~~---~~~-~~~~~~---  998 (1049)
                      ||.|+|+..++++..||-....+-....+.+.         .....+.           +.+..   +.. ...+.+   
T Consensus       262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q  341 (418)
T KOG1167|consen  262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ  341 (418)
T ss_pred             eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence            99999999999999998654444333222111         0001111           00000   000 001111   


Q ss_pred             ---cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          999 ---NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       999 ---~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                         .+.......+..+++++.+|+..+|.+|.|++|.++|
T Consensus       342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence               0111112234578999999999999999999999987

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=1.3e-25  Score=238.25  Aligned_cols=199  Identities=31%  Similarity=0.434  Sum_probs=174.0

Q ss_pred             CCCCceecCCCcEEEEEEEeCC-CcEEEEEEeecccCC-CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccC
Q 039290          763 FSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDG-SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMS  840 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  840 (1049)
                      |+..+.||+|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++...+..++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5667899999999999999764 889999999866544 56789999999999999999999999999899999999999


Q ss_pred             CCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccccc
Q 039290          841 NGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT  920 (1049)
Q Consensus       841 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~  920 (1049)
                      +++|.+++......+++..+..++.+++++++++|   +.+++|+|++|+||+++.++.++++|||.+............
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK  157 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence            99999998765543789999999999999999999   899999999999999999999999999999877543211223


Q ss_pred             ccccccCccccccc-CCCCcCcccchHHHHHHHHHHHhCCCCCCc
Q 039290          921 KTLGTIGYMAPEYG-REGKVSRKCDVYSYGIMLMETFTKKKPTDE  964 (1049)
Q Consensus       921 ~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg~~p~~~  964 (1049)
                      ...++..|++||.. ....++.++|||++|++++||++|+.||..
T Consensus       158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            34567889999988 666788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=3.3e-27  Score=252.24  Aligned_cols=269  Identities=22%  Similarity=0.234  Sum_probs=201.0

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCC------CceeeEEeeeecCCe
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRH------RNLVKIISSCSNNDF  831 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------pniv~l~~~~~~~~~  831 (1049)
                      --.+|.+....|+|-|++|.+|... .|..||||++.... ...+.=.+|+++++++..      -++++++-.|...++
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            3468999999999999999999954 67899999997542 223445679999999952      489999999999999


Q ss_pred             eEEEEeccCCCChhhhhhcCCC--ccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCC-CceEEecccCc
Q 039290          832 KALVLEYMSNGSLEKCLYSDNY--FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES-MVGHLSDFGIA  908 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-~~~kl~DfGla  908 (1049)
                      +|+|+|-+.- +|.+++...+.  .+....+..+++|+.-||..|-   ..||+|.||||+||||++. ..+||||||.|
T Consensus       509 LClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  509 LCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             eEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCccc
Confidence            9999999854 99999987654  4667788999999999999999   9999999999999999965 57899999999


Q ss_pred             eecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccc-----------hHHHhhh
Q 039290          909 KILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEM-----------SLKRWVG  977 (1049)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-----------~~~~~~~  977 (1049)
                      .+.+...   .++..-+..|.|||++.+.+|+...|+||+||++||+.||+.-|.+.....+           ...-..+
T Consensus       585 ~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK  661 (752)
T KOG0670|consen  585 SFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK  661 (752)
T ss_pred             ccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence            8775443   2334457789999999999999999999999999999999987765332211           1111111


Q ss_pred             hccccCC-----------cchhccccc----ccc-c-----------ccCchhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 039290          978 DSLLSCS-----------ITEVADANL----LNC-E-----------ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMK 1030 (1049)
Q Consensus       978 ~~~~~~~-----------~~~~~~~~~----~~~-~-----------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ 1030 (1049)
                      ..+....           ...+.....    ... +           +......+.....+.+++.+|+..||++|.|..
T Consensus       662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n  741 (752)
T KOG0670|consen  662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN  741 (752)
T ss_pred             cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence            1110000           000000000    000 0           001112234567799999999999999999999


Q ss_pred             HHHHH
Q 039290         1031 DVANR 1035 (1049)
Q Consensus      1031 ell~~ 1035 (1049)
                      ++++|
T Consensus       742 qAL~H  746 (752)
T KOG0670|consen  742 QALKH  746 (752)
T ss_pred             HHhcC
Confidence            99887

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.93  E-value=1.1e-27  Score=248.93  Aligned_cols=401  Identities=22%  Similarity=0.265  Sum_probs=263.8

Q ss_pred             cEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCC-ccCccccCCCcccccccCCCCccc
Q 039290          124 KYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSD-NQLSGTIPSSIFNISSCQNLPVLE  202 (1049)
Q Consensus       124 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~-N~l~g~ip~~~~~l~~l~~l~~L~  202 (1049)
                      ..++|..|+++...|..|+.+++|+.||||+|.|+.+-|+.|..|.+|..|-+.+ |+|+ .+|+..+     .+|..|+
T Consensus        70 veirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F-----~gL~slq  143 (498)
T KOG4237|consen   70 VEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAF-----GGLSSLQ  143 (498)
T ss_pred             eEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHh-----hhHHHHH
Confidence            4567777777766677888888888888888888877788888887777665554 8887 7777654     3566678


Q ss_pred             eEEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceEEecccc------------ccccCccccccc
Q 039290          203 GLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNS------------LIGEIPNEIGNL  270 (1049)
Q Consensus       203 ~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~------------l~~~~p~~l~~l  270 (1049)
                      .|.+.-|++.-...+.|+.+++|..|.+.+|.+...--..|..+.+++.+.+..|.            ..-..|.+++..
T Consensus       144 rLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsga  223 (498)
T KOG4237|consen  144 RLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGA  223 (498)
T ss_pred             HHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccc
Confidence            88888888886666778888888888888888884333478888888888888888            333456666776


Q ss_pred             cceEEEeeccccCCCcccccccc-ccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCcee
Q 039290          271 RNLEVLGVQSSNLAGLIPASIFN-ISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVL  349 (1049)
Q Consensus       271 ~~L~~L~L~~n~l~~~~p~~~~~-l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  349 (1049)
                      ....-..+.++++..+-+..|.. +.++..-..+.+...+.-|...+..|++|+.|+|++|+|+++-+.+|..+.++++|
T Consensus       224 rc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL  303 (498)
T KOG4237|consen  224 RCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQEL  303 (498)
T ss_pred             eecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhh
Confidence            66666667677666655544433 22343334445556667788888899999999999999999999999999999999


Q ss_pred             ecccCccccCcccccccccccceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCC-CccccccccccEEE
Q 039290          350 DFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILP-SSIGNFSISMKSLS  428 (1049)
Q Consensus       350 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p-~~~~~~~~~L~~L~  428 (1049)
                      .|..|+|...-...|.++..|+.|+|.+|+|+.+.+.     +|..+..|..|.|-.|++...-- .+++.+        
T Consensus       304 ~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~-----aF~~~~~l~~l~l~~Np~~CnC~l~wl~~W--------  370 (498)
T KOG4237|consen  304 YLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPG-----AFQTLFSLSTLNLLSNPFNCNCRLAWLGEW--------  370 (498)
T ss_pred             hcCcchHHHHHHHhhhccccceeeeecCCeeEEEecc-----cccccceeeeeehccCcccCccchHHHHHH--------
Confidence            9999999887778899999999999999999987765     47788888999988888753210 111111        


Q ss_pred             ccCCccccCCCCCCCCCCCccEEEccCCccccc---CCcccc---------CcCCCcc-eEeeccccCCCCCcccccccc
Q 039290          429 MESCNISGGIPKELGNINNLTVIRLGNNELTGT---IPVTLG---------RLQKLQG-LYLQNNKLEGSIPEDLCHLYR  495 (1049)
Q Consensus       429 L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~---------~l~~L~~-L~L~~N~l~~~~~~~~~~l~~  495 (1049)
                      |..+...|..|  -.+-..++.+.++++.+...   .|+..+         ..+-+.+ ...|++.++ .+|..+..  .
T Consensus       371 lr~~~~~~~~~--Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP~--d  445 (498)
T KOG4237|consen  371 LRKKSVVGNPR--CQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIPV--D  445 (498)
T ss_pred             HhhCCCCCCCC--CCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCCc--h
Confidence            11111111111  11112233444444333211   111111         1111222 223333333 34433322  3


Q ss_pred             cceEEeeCcccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCC
Q 039290          496 LANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSN  552 (1049)
Q Consensus       496 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N  552 (1049)
                      -.+|++.+|.++ .+|..  .+.+| .+|+++|++....-..|.++++|.+|-||.|
T Consensus       446 ~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  446 VTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             hHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence            455666666666 45554  45556 6677777776666666666776666666654

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.92  E-value=1.8e-27  Score=247.31  Aligned_cols=392  Identities=24%  Similarity=0.256  Sum_probs=222.5

Q ss_pred             ceEEeccccccccCccccccccceEEEeeccccCCCccccccccccccceEEecc-CccCCCCCCcccCCCCCccEEEcC
Q 039290          250 RNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTD-NDLLGSLPSSIDLGLPNLERLFLG  328 (1049)
Q Consensus       250 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~~l~~L~~L~L~  328 (1049)
                      ..++|..|+|+...|.+|+.+++|++|||++|+++.+-|++|..+.+|.+|.+.+ |+++ .+|...+.+|..|+.|.+.
T Consensus        70 veirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLllN  148 (498)
T KOG4237|consen   70 VEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLLN  148 (498)
T ss_pred             eEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHHHhcC
Confidence            3444444555444444445555555555555555544455555554444444444 3333 4555555555555555555


Q ss_pred             CCCCCCCCCccccCCCCCceeecccCccccCcccccccccccceeecccccccCC------CCCcc-cccccccCCCCcE
Q 039290          329 ENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSP------TPDLS-FLSSLTSCRNLEI  401 (1049)
Q Consensus       329 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~------~~~~~-~l~~l~~l~~L~~  401 (1049)
                      -|++.-.....|..+++|..|.+..|.+..+-...|..+.+++.+.+..|.+...      ..+.. ....++..+-..-
T Consensus       149 an~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p  228 (498)
T KOG4237|consen  149 ANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSP  228 (498)
T ss_pred             hhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecch
Confidence            5555544445555555555555555555533333555555555555555542110      00000 0001222222333


Q ss_pred             EEccCCccccCCCCccccccccccEEEccCCccccCCC-CCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeecc
Q 039290          402 IYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIP-KELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNN  480 (1049)
Q Consensus       402 L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  480 (1049)
                      ..+.++++..+-+..+.....++.+--.+.+...+..| ..|..+++|+.|+|++|+|+++-+.+|.++..+++|+|..|
T Consensus       229 ~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N  308 (498)
T KOG4237|consen  229 YRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRN  308 (498)
T ss_pred             HHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcc
Confidence            33444444444443333322222222233444444444 35888889999999999998888888888889999999999


Q ss_pred             ccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccc-----cCccc-----------cccccc
Q 039290          481 KLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSI-----IPSTL-----------WNLKDI  544 (1049)
Q Consensus       481 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-----~p~~~-----------~~l~~L  544 (1049)
                      +|...-...|.++..|+.|+|.+|+|+...|.+|..+.+|.+|+|-.|.+.--     ..+|+           ..-..+
T Consensus       309 ~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~~  388 (498)
T KOG4237|consen  309 KLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGFV  388 (498)
T ss_pred             hHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCCCCCchh
Confidence            88866667788888888899999998888888888888888888888766310     00111           111234


Q ss_pred             ccccccCCccCCC---CccCc---------CCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccC
Q 039290          545 LRFNLSSNSLNGS---LLPDI---------GNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGG  612 (1049)
Q Consensus       545 ~~L~Ls~N~l~~~---~~~~~---------~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  612 (1049)
                      +.+.++++.+...   .|+..         ..++-+.+.-=-.|+....+|..+.  ..-.+|++.+|.++ .+|..  .
T Consensus       389 ~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk~lp~~iP--~d~telyl~gn~~~-~vp~~--~  463 (498)
T KOG4237|consen  389 RQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLKLLPRGIP--VDVTELYLDGNAIT-SVPDE--L  463 (498)
T ss_pred             ccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchhhcCCCCC--chhHHHhcccchhc-ccCHH--H
Confidence            5556665544321   12111         1122233222222333334554443  34678889999998 56665  6


Q ss_pred             ccCCcEEeccCccccCCcccccccccccceeeccCC
Q 039290          613 LKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFN  648 (1049)
Q Consensus       613 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N  648 (1049)
                      +.+| .+||++|+++-.---.|.++++|.+|-||+|
T Consensus       464 ~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  464 LRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             Hhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence            6778 8999999998666667888999999988887

>PLN03210 Resistant to P

Probab=99.92  E-value=7e-24  Score=272.93  Aligned_cols=344  Identities=22%  Similarity=0.291  Sum_probs=196.0

Q ss_pred             cccccCCccEEEeCCCC------ccCCCcccccCCC-cccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccC
Q 039290          140 WFVSLPRLQHLLLKHNS------FVGKIPETIGYLS-LLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLT  212 (1049)
Q Consensus       140 ~~~~l~~L~~L~L~~n~------l~~~~p~~~~~l~-~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~  212 (1049)
                      .|.+|++|+.|.+..+.      +...+|+.+..++ +|+.|++++|.++ .+|..+.       ..+|+.|++++|++.
T Consensus       553 aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f~-------~~~L~~L~L~~s~l~  624 (1153)
T PLN03210        553 AFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNFR-------PENLVKLQMQGSKLE  624 (1153)
T ss_pred             HHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcCC-------ccCCcEEECcCcccc
Confidence            45556666666664432      2223455554443 3555555555554 5554431       123445555555544


Q ss_pred             CCCCCCcccccccceecccccccccccCCCCccccccceEEeccccccccCccccccccceEEEeeccccCCCccccccc
Q 039290          213 GPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIF  292 (1049)
Q Consensus       213 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~  292 (1049)
                                               .+|..+..+++|+.|+|++|...+.+|. ++.+++|+.|+|++|.....+|..+.
T Consensus       625 -------------------------~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~  678 (1153)
T PLN03210        625 -------------------------KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQ  678 (1153)
T ss_pred             -------------------------ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhh
Confidence                                     3444444555555555554433334442 45555555555555544445555555


Q ss_pred             cccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCcccccccccccce
Q 039290          293 NISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKL  372 (1049)
Q Consensus       293 ~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  372 (1049)
                      ++++|+.|++++|...+.+|..+  .+++|+.|++++|...+.+|..   ..+|+.|++++|.+.. +|..+ .+++|++
T Consensus       679 ~L~~L~~L~L~~c~~L~~Lp~~i--~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~-lP~~~-~l~~L~~  751 (1153)
T PLN03210        679 YLNKLEDLDMSRCENLEILPTGI--NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEE-FPSNL-RLENLDE  751 (1153)
T ss_pred             ccCCCCEEeCCCCCCcCccCCcC--CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCcccc-ccccc-ccccccc
Confidence            55555555555554444555543  3556666666666544444432   2456667777776653 34443 4566666


Q ss_pred             eecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEE
Q 039290          373 LSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIR  452 (1049)
Q Consensus       373 L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~  452 (1049)
                      |++.++....+....      ..                 ++........+|+.|+|++|...+.+|..++++++|+.|+
T Consensus       752 L~l~~~~~~~l~~~~------~~-----------------l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~  808 (1153)
T PLN03210        752 LILCEMKSEKLWERV------QP-----------------LTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLE  808 (1153)
T ss_pred             ccccccchhhccccc------cc-----------------cchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEE
Confidence            666554322211100      00                 0001111223566677777666666777777888888888


Q ss_pred             ccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecC-cccc
Q 039290          453 LGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGS-NALT  531 (1049)
Q Consensus       453 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~  531 (1049)
                      |++|..-+.+|..+ .+++|+.|+|++|..-..+|..   ..+|+.|+|++|.++ .+|..+..+++|+.|+|++ |++.
T Consensus       809 Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~  883 (1153)
T PLN03210        809 IENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ  883 (1153)
T ss_pred             CCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC
Confidence            88765444666655 6778888888877654455543   357788888888887 6788888888888888887 4444


Q ss_pred             cccCcccccccccccccccCCc
Q 039290          532 SIIPSTLWNLKDILRFNLSSNS  553 (1049)
Q Consensus       532 ~~~p~~~~~l~~L~~L~Ls~N~  553 (1049)
                      . +|..+..++.|+.+++++|.
T Consensus       884 ~-l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        884 R-VSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             c-cCcccccccCCCeeecCCCc
Confidence            4 66677788888888887763

syringae 6; Provisional

>PLN03210 Resistant to P

Probab=99.91  E-value=1.3e-23  Score=270.40  Aligned_cols=324  Identities=19%  Similarity=0.239  Sum_probs=257.5

Q ss_pred             CCCCCcccc-cccceecccccccccccCCCCccccccceEEeccccccccCccccccccceEEEeeccccCCCccccccc
Q 039290          214 PIPTNLWKC-RELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIF  292 (1049)
Q Consensus       214 ~~p~~l~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~  292 (1049)
                      .+|..+..+ .+|+.|++.+|.+. .+|..| ...+|++|+|++|++. .+|..+..+++|+.|+|++++..+.+|. +.
T Consensus       579 ~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls  654 (1153)
T PLN03210        579 HLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LS  654 (1153)
T ss_pred             ecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cc
Confidence            345555443 45777777777765 677777 5689999999999998 7888999999999999999877777774 88


Q ss_pred             cccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCcccccccccccce
Q 039290          293 NISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKL  372 (1049)
Q Consensus       293 ~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  372 (1049)
                      .+++|+.|++++|.....+|..+. .+++|+.|++++|...+.+|..+ ++++|+.|++++|.....+|..   ..+|+.
T Consensus       655 ~l~~Le~L~L~~c~~L~~lp~si~-~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~  729 (1153)
T PLN03210        655 MATNLETLKLSDCSSLVELPSSIQ-YLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISW  729 (1153)
T ss_pred             cCCcccEEEecCCCCccccchhhh-ccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCe
Confidence            899999999999988888998875 78999999999986666788766 7899999999999766566643   468899


Q ss_pred             eecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEE
Q 039290          373 LSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIR  452 (1049)
Q Consensus       373 L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~  452 (1049)
                      |++++|.++.++...       .+++|+.|++.++..... +.                 .+....+..+...++|+.|+
T Consensus       730 L~L~~n~i~~lP~~~-------~l~~L~~L~l~~~~~~~l-~~-----------------~~~~l~~~~~~~~~sL~~L~  784 (1153)
T PLN03210        730 LDLDETAIEEFPSNL-------RLENLDELILCEMKSEKL-WE-----------------RVQPLTPLMTMLSPSLTRLF  784 (1153)
T ss_pred             eecCCCccccccccc-------cccccccccccccchhhc-cc-----------------cccccchhhhhccccchhee
Confidence            999999998776532       467778887776553311 11                 11112222334467899999


Q ss_pred             ccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCccccc
Q 039290          453 LGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTS  532 (1049)
Q Consensus       453 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  532 (1049)
                      |++|...+.+|..++++++|+.|++++|..-+.+|..+ .+++|+.|++++|.....+|..   .++|+.|+|++|.++.
T Consensus       785 Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~~  860 (1153)
T PLN03210        785 LSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIEE  860 (1153)
T ss_pred             CCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCcc
Confidence            99998887899999999999999999986555778766 7899999999998765566653   3689999999999986


Q ss_pred             ccCcccccccccccccccCC-ccCCCCccCcCCCcceeEeeccccc
Q 039290          533 IIPSTLWNLKDILRFNLSSN-SLNGSLLPDIGNLKVVIEMDLSLNA  577 (1049)
Q Consensus       533 ~~p~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~  577 (1049)
                       +|.++..+++|+.|++++| +++ .+|..+..++.|+.+++++|.
T Consensus       861 -iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        861 -VPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             -ChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence             7889999999999999995 455 477788889999999998873

syringae 6; Provisional

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=8.2e-24  Score=215.04  Aligned_cols=170  Identities=22%  Similarity=0.193  Sum_probs=132.0

Q ss_pred             CChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccc
Q 039290          842 GSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK  921 (1049)
Q Consensus       842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~  921 (1049)
                      |+|.+++...+..+++.+++.++.|+++||+|||   +.+      ||+||+++.++.+|+  ||.+.......      
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc------
Confidence            6899999876667999999999999999999999   776      999999999999999  99998764322      


Q ss_pred             cccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCc
Q 039290          922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDF 1001 (1049)
Q Consensus       922 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1049)
                      ..|++.|+|||++.+..++.++||||+||++|||++|+.||............+........             ... .
T Consensus        64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------------~~~-~  129 (176)
T smart00750       64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD-------------PRD-R  129 (176)
T ss_pred             CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC-------------ccc-c
Confidence            25789999999999999999999999999999999999998754322222222221111000             000 0


Q ss_pred             hhhHHHHH--HHHHHHhhccccCCCCCCCHHHHHHHHHHHHHh
Q 039290         1002 SAREQCVS--SIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042 (1049)
Q Consensus      1002 ~~~~~~~~--~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~ 1042 (1049)
                      ........  ++.+++.+||+.+|.+||++.|+++++..+..+
T Consensus       130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence            11122333  699999999999999999999999999877654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.90  E-value=1.7e-24  Score=270.89  Aligned_cols=195  Identities=17%  Similarity=0.211  Sum_probs=140.3

Q ss_pred             cCC-CceeeEEeee-------ecCCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEc
Q 039290          814 IRH-RNLVKIISSC-------SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC  885 (1049)
Q Consensus       814 l~h-pniv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~  885 (1049)
                      ++| +||+++++++       .+.+.++.++||+ +++|.+++......+++.+++.++.||++||+|||   ++||+||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvHr  104 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVVH  104 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence            345 5788888877       2334567788988 55999999876667999999999999999999999   9999999


Q ss_pred             CCCCCCeeecC-------------------CCceEEecccCceecCCCc---------------cccccccccccCcccc
Q 039290          886 DIKPSNVLLNE-------------------SMVGHLSDFGIAKILGKEE---------------SMRQTKTLGTIGYMAP  931 (1049)
Q Consensus       886 Dlkp~NIl~~~-------------------~~~~kl~DfGla~~~~~~~---------------~~~~~~~~~~~~y~aP  931 (1049)
                      ||||+|||++.                   ++.+|++|||+++......               .......+||+.||||
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            99999999954                   4456666667665321100               0011123578899999


Q ss_pred             cccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHH
Q 039290          932 EYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSI 1011 (1049)
Q Consensus       932 E~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1011 (1049)
                      |++.+..++.++|||||||++|||++|..|+.....   ....+....         ..           ........+.
T Consensus       185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~~---------~~-----------~~~~~~~~~~  241 (793)
T PLN00181        185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHRV---------LP-----------PQILLNWPKE  241 (793)
T ss_pred             hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHhh---------cC-----------hhhhhcCHHH
Confidence            999999999999999999999999998887653110   111110000         00           0000112335


Q ss_pred             HHHHhhccccCCCCCCCHHHHHHH
Q 039290         1012 FSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus      1012 ~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .+++.+||+++|.+||++.|++++
T Consensus       242 ~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        242 ASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHHHhCCCChhhCcChHHHhhc
Confidence            678899999999999999999876

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=7.6e-23  Score=208.36  Aligned_cols=263  Identities=19%  Similarity=0.211  Sum_probs=212.7

Q ss_pred             cCCCCCceecCCCcEEEEEEE-eCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcC-CCceeeEEeeeecCCeeEEEEec
Q 039290          761 DGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR-HRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      ..|+++++||+|.||+++.|+ .-+++.||+|.-...+  ...+++.|.+..+.+. .++|..++.+..++.+-.+|+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            369999999999999999999 5689999999865543  4478889999999885 69999999999999888999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC-----CCceEEecccCceecCC
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE-----SMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-----~~~~kl~DfGla~~~~~  913 (1049)
                      + |.+|+|+..-.++.++..++..||.|++.-++|+|   ++..|.|||||+|+||..     ...+.++|||+|+.+..
T Consensus       106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            9 67999999888888999999999999999999999   999999999999999963     35789999999998865


Q ss_pred             Cccc------cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccc-hHHHhhhhccccCCcc
Q 039290          914 EESM------RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEM-SLKRWVGDSLLSCSIT  986 (1049)
Q Consensus       914 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~  986 (1049)
                      ....      ....-.||.+||+-....+.+.+++.|.-|+|-++.+.+.|..||.+...... ...+.+++....-++.
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~  261 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE  261 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH
Confidence            4421      12234699999999999999999999999999999999999999998655432 1222222221111111


Q ss_pred             hhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          987 EVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       987 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                      +               .-+.+|.++..-+.-.-..+-.+-|..+-+..-+.++.+.+.
T Consensus       262 ~---------------Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g  304 (449)
T KOG1165|consen  262 V---------------LCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG  304 (449)
T ss_pred             H---------------HHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence            1               113356777777887888888999999988888888887654

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.89  E-value=7.6e-23  Score=245.39  Aligned_cols=315  Identities=22%  Similarity=0.350  Sum_probs=163.4

Q ss_pred             ccCChhhHHHHHHHHHhcccCCCCccccc----CCCCCCCceeee----------------EEEcCCCCcEEEEEEeccc
Q 039290           25 VTNVTTDQFALLALKEHIKHDPSNLLANN----WSTTSSVCSWIG----------------VTCGVRNRRVTALNISYLG   84 (1049)
Q Consensus        25 ~~~~~~d~~all~~k~~~~~~~~~~l~~~----w~~~~~~c~w~g----------------v~c~~~~~~v~~l~l~~~~   84 (1049)
                      .+..+.|.++++++.+.+. -| +++ ++    |+.++++|-=..                |.|.  ++.|+.+...+..
T Consensus        58 ~~~~~~~~~~~~~~~~~l~-~p-~~~-~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~--~~~vt~l~~~g~~  132 (754)
T PRK15370         58 ETASPEEIKSKFECLRMLA-FP-AYA-DNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGG--GKSVTYTRVTESE  132 (754)
T ss_pred             CCCCHHHHHHHHHHHHHhc-CC-chh-hccccccCCCCcccccCCcchhhheeeecCCceEEecC--CCccccccccccc
Confidence            3446789999999999994 33 333 35    999999996544                6674  3456666665533


Q ss_pred             cccccCCCCCCcchhhhhhc-ccCccccccC---ccc-----ccccCCcEeccccCCccccCcccccccCCccEEEeCCC
Q 039290           85 LTGTIPPQLGNLSFLAVLAI-RNNSFFGSLP---EEL-----SHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHN  155 (1049)
Q Consensus        85 l~g~~~~~~~~l~~L~~L~l-~~n~~~g~~p---~~~-----~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n  155 (1049)
                      ....-..+-..-.+....+= ..+.-.+.-+   ..+     +--.+.+.|++++++++ .+|..+.  +.|+.|+|++|
T Consensus       133 ~~~~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N  209 (754)
T PRK15370        133 QASSASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACIP--EQITTLILDNN  209 (754)
T ss_pred             ccccCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcccc--cCCcEEEecCC
Confidence            22221111010001000000 0011000000   000     11134567777777776 4665543  46777777777


Q ss_pred             CccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccceeccccccc
Q 039290          156 SFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKF  235 (1049)
Q Consensus       156 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l  235 (1049)
                      +++ .+|..+.  ++|++|+|++|+|+ .+|..+.        +.|+.|+|++|++. .+|..+.  ++|+.|++++|++
T Consensus       210 ~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--------~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L  274 (754)
T PRK15370        210 ELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--------DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKI  274 (754)
T ss_pred             CCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--------ccccEEECcCCccC-cCChhHh--CCCCEEECcCCcc
Confidence            777 5666554  46777777777776 5665442        23667777777776 5565543  3566666666666


Q ss_pred             ccccCCCCccccccceEEeccccccccCccccccccceEEEeeccccCCCccccccccccccceEEeccCccCCCCCCcc
Q 039290          236 QGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSI  315 (1049)
Q Consensus       236 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~  315 (1049)
                      + .+|..+.  .+|+.|+|++|+++ .+|..+.  ++|+.|++++|+++.                         +|..+
T Consensus       275 ~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~-------------------------LP~~l  323 (754)
T PRK15370        275 S-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTA-------------------------LPETL  323 (754)
T ss_pred             C-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCcccc-------------------------CCccc
Confidence            5 3454443  35566666666555 2343322  234444444444443                         33322


Q ss_pred             cCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCcccccccccccceeecccccccCCCCCccccccccc
Q 039290          316 DLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTS  395 (1049)
Q Consensus       316 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~  395 (1049)
                      .   ++|+.|++++|.+++ +|..+.  ++|+.|++++|+|+. +|..+.  ++|+.|++++|.|+.+++.+.       
T Consensus       324 ~---~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~-LP~~lp--~~L~~LdLs~N~Lt~LP~~l~-------  387 (754)
T PRK15370        324 P---PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITV-LPETLP--PTITTLDVSRNALTNLPENLP-------  387 (754)
T ss_pred             c---ccceeccccCCcccc-CChhhc--CcccEEECCCCCCCc-CChhhc--CCcCEEECCCCcCCCCCHhHH-------
Confidence            2   345555555555552 444332  455555555555552 343332  455566666666555544320       


Q ss_pred             CCCCcEEEccCCccc
Q 039290          396 CRNLEIIYLSENPIN  410 (1049)
Q Consensus       396 l~~L~~L~Ls~N~i~  410 (1049)
                       ..|+.|++++|++.
T Consensus       388 -~sL~~LdLs~N~L~  401 (754)
T PRK15370        388 -AALQIMQASRNNLV  401 (754)
T ss_pred             -HHHHHHhhccCCcc
Confidence             23555555665554

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.89  E-value=6.7e-23  Score=243.80  Aligned_cols=80  Identities=29%  Similarity=0.293  Sum_probs=43.4

Q ss_pred             ceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCcccccccccccceeecc
Q 039290          567 VVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLS  646 (1049)
Q Consensus       567 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~  646 (1049)
                      +|+.|++++|+|++ +|..   .++|+.|++++|+|++ +|..+   .+|+.|+|++|+|+ .+|..+..+++|+.|+|+
T Consensus       383 ~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs  453 (788)
T PRK15387        383 GLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE  453 (788)
T ss_pred             ccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence            34455555555553 2322   2345566666666653 44322   34555666666665 556666666666666666


Q ss_pred             CCcccccCC
Q 039290          647 FNQLEGEIP  655 (1049)
Q Consensus       647 ~N~l~~~~p  655 (1049)
                      +|+|++.+|
T Consensus       454 ~N~Ls~~~~  462 (788)
T PRK15387        454 GNPLSERTL  462 (788)
T ss_pred             CCCCCchHH
Confidence            666665544

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.89  E-value=1e-22  Score=242.13  Aligned_cols=54  Identities=28%  Similarity=0.409  Sum_probs=29.9

Q ss_pred             CccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccC
Q 039290          146 RLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLT  212 (1049)
Q Consensus       146 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~  212 (1049)
                      .-..|+|+.|.++ .+|..+.  ++|+.|++++|+++ .+|..         +++|++|++++|+|+
T Consensus       202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---------p~~Lk~LdLs~N~Lt  255 (788)
T PRK15387        202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---------PPELRTLEVSGNQLT  255 (788)
T ss_pred             CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---------CCCCcEEEecCCccC
Confidence            3455666666665 5565554  25666666666666 45532         234555555555555

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=1e-21  Score=218.88  Aligned_cols=260  Identities=22%  Similarity=0.249  Sum_probs=199.1

Q ss_pred             CCCCCceecCCCcEEEEEEEeCCC--cEEEEEEeecccCCCHHHHHHHHHHHhhcCC----CceeeEEeee-ecCCeeEE
Q 039290          762 GFSENKLLGMGSFGSVYKGVLPDG--MEIAAKVFHMEFDGSLESFHAECKVMGSIRH----RNLVKIISSC-SNNDFKAL  834 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----pniv~l~~~~-~~~~~~~l  834 (1049)
                      +|.+.+.||+|+||.||.|...+.  ..+|+|............+..|+.++..+..    +++.++++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999996543  5788888876543333378889999988862    6899999988 57778899


Q ss_pred             EEeccCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCC-----CceEEecccCc
Q 039290          835 VLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES-----MVGHLSDFGIA  908 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-----~~~kl~DfGla  908 (1049)
                      ||+.+ |.+|.++..... ..++..++.+|+.|++.+|+++|   +.|++||||||.|+++...     ..+.+.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99999 679999875554 67999999999999999999999   9999999999999999754     47999999999


Q ss_pred             e--ecCCCcc-----cc--ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhc
Q 039290          909 K--ILGKEES-----MR--QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDS  979 (1049)
Q Consensus       909 ~--~~~~~~~-----~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  979 (1049)
                      +  .+.....     .+  .....||..|.++.+..+.+.+++.|+||++.++.|+..|..||......... .... ..
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~-~~~~-~~  252 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK-SKFE-KD  252 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH-HHHH-HH
Confidence            8  4322211     11  12345999999999999999999999999999999999999999764332211 1000 00


Q ss_pred             cccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHh
Q 039290          980 LLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042 (1049)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~ 1042 (1049)
                      ...    .....           .....+.++.++...+-..+...+|....+...+++...+
T Consensus       253 ~~~----~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  253 PRK----LLTDR-----------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             hhh----hcccc-----------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            000    00000           0112345677777777779999999999999998887665

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=2.5e-22  Score=221.78  Aligned_cols=164  Identities=20%  Similarity=0.220  Sum_probs=128.1

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEeC--CCcEEEEEEeeccc-----CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCe
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVLP--DGMEIAAKVFHMEF-----DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDF  831 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~~--~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~  831 (1049)
                      ..++|+..+.||+|+||+||+|.+.  +++.||||++....     ....+.+.+|++++++++|+|+++.+..+   +.
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~~   92 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---GK   92 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---CC
Confidence            3567999999999999999999864  57778999875331     12245689999999999999998533322   45


Q ss_pred             eEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCC-CCCCeeecCCCceEEecccCcee
Q 039290          832 KALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDI-KPSNVLLNESMVGHLSDFGIAKI  910 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-kp~NIl~~~~~~~kl~DfGla~~  910 (1049)
                      .++||||++|++|... ...    .   ...++.++++|++|+|   ++||+|||| ||+||+++.++.+||+|||+|+.
T Consensus        93 ~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~  161 (365)
T PRK09188         93 DGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV  161 (365)
T ss_pred             cEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence            7999999999999732 111    1   1467889999999999   999999999 99999999999999999999997


Q ss_pred             cCCCccc-------cccccccccCcccccccCC
Q 039290          911 LGKEESM-------RQTKTLGTIGYMAPEYGRE  936 (1049)
Q Consensus       911 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~  936 (1049)
                      +......       ......+++.|+|||++..
T Consensus       162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             cccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            7543311       1134567888999998854

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.7e-23  Score=206.76  Aligned_cols=246  Identities=20%  Similarity=0.310  Sum_probs=191.0

Q ss_pred             CCCceecCCCcEEEEEEEeCCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCC
Q 039290          764 SENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSN  841 (1049)
Q Consensus       764 ~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  841 (1049)
                      ....+|.+...|+.|+|+|+ |..+++|++....  .....+|..|+-.++-+.||||+.++++|.....+.++..|++.
T Consensus       193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            34457889999999999994 5566677775443  23346789999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCC-ccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEe--cccCceecCCCcccc
Q 039290          842 GSLEKCLYSDNY-FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLS--DFGIAKILGKEESMR  918 (1049)
Q Consensus       842 g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~--DfGla~~~~~~~~~~  918 (1049)
                      |+|...++.... ..+..++.+++.++|+|++|||. .++-|..--+.++.|++|++.+++|+  |--++.        .
T Consensus       272 gslynvlhe~t~vvvd~sqav~faldiargmaflhs-lep~ipr~~lns~hvmidedltarismad~kfsf--------q  342 (448)
T KOG0195|consen  272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHS-LEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--------Q  342 (448)
T ss_pred             hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhh-cchhhhhhhcccceEEecchhhhheecccceeee--------e
Confidence            999999987543 67788999999999999999993 23334455689999999999888874  322221        1


Q ss_pred             ccccccccCcccccccCCCCcC---cccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVS---RKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~---~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                      .......+.||+||.++.++.+   +++|+|||++++||+-|++.||.+....|...+.-                    
T Consensus       343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia--------------------  402 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA--------------------  402 (448)
T ss_pred             ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh--------------------
Confidence            1223447899999999876543   57999999999999999999998865554433221                    


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                      ....+...++..+..+..+|.-|+..||.+||.++.++-.|++.
T Consensus       403 leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  403 LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            11223344455677889999999999999999999999888864

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=6e-22  Score=193.05  Aligned_cols=267  Identities=21%  Similarity=0.220  Sum_probs=207.8

Q ss_pred             hcCCCCCceecCCCcEEEEEEE-eCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCC-CceeeEEeeeecCCeeEEEEe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRH-RNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-pniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .+.|.+.++||.|+||.+|.|. ..+|.+||+|+-....  .-.++..|.++.+.+++ ..|..+..+..+.++-.+|||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            4579999999999999999999 6789999999965432  23567789999999975 788888888889999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec---CCCceEEecccCceecCCC
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~---~~~~~kl~DfGla~~~~~~  914 (1049)
                      .. |.+|+++..-..+.++..+++..+-|++.-++|+|   .++++||||||+|.++.   ....+.++|||+|+.+-..
T Consensus        92 LL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~  167 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI  167 (341)
T ss_pred             cc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence            99 67999998877778999999999999999999999   99999999999999996   3457899999999877432


Q ss_pred             cc-----c-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchh
Q 039290          915 ES-----M-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEV  988 (1049)
Q Consensus       915 ~~-----~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  988 (1049)
                      ..     + ......||..|.+-....+...+++.|+-|+|.++.++-.|..||++.......  +..         ..+
T Consensus       168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~--QKy---------EkI  236 (341)
T KOG1163|consen  168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK--QKY---------EKI  236 (341)
T ss_pred             cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH--HHH---------HHH
Confidence            21     1 223456899998888777778899999999999999999999999986443211  100         111


Q ss_pred             cccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhc
Q 039290          989 ADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAY 1046 (1049)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~ 1046 (1049)
                      .+..+....   ...=...|.++...+.-|-..--++-|...-+.+.++-+...+..-
T Consensus       237 ~EkK~s~~i---e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~  291 (341)
T KOG1163|consen  237 SEKKMSTPI---EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQ  291 (341)
T ss_pred             HHhhcCCCH---HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcccc
Confidence            111110000   0000224677888889999999999999998888888777766543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.5e-22  Score=238.62  Aligned_cols=253  Identities=21%  Similarity=0.243  Sum_probs=193.8

Q ss_pred             CCceecCCCcEEEEEEEe-CCCcEEEEEEeec---ccC---CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          765 ENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHM---EFD---GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       765 ~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~---~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      ..+++|.|++|.|+.+.. .....++.|.+..   ...   .....+..|+.+-.+++|||++..+..+.+.+..+-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            346899999998887773 3444455554432   111   112236678888899999999988888877776666799


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc-
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES-  916 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~-  916 (1049)
                      ||++ +|..++.... .+...++..++.|+..|++|+|   +.||.|||+|++|++++.+|.+||+|||.+..+..+.. 
T Consensus       402 ~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             cccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            9999 9999887763 4788899999999999999999   99999999999999999999999999999987654332 


Q ss_pred             --ccccccccccCcccccccCCCCcCc-ccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          917 --MRQTKTLGTIGYMAPEYGREGKVSR-KCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       917 --~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                        ......+|+..|+|||++.+..|++ ..||||.|+++..|.+|+.||......+..+.             +.....-
T Consensus       477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-------------~~~~~~~  543 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-------------TNNYSDQ  543 (601)
T ss_pred             hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh-------------hhccccc
Confidence              3445678999999999999999875 58999999999999999999976444433220             0111111


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .....+........+...+.+|.+|++++|.+|.|+++|++-
T Consensus       544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            122223334446677888999999999999999999999863

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.86  E-value=5e-22  Score=238.41  Aligned_cols=234  Identities=27%  Similarity=0.416  Sum_probs=145.7

Q ss_pred             ceeeeEEEcCCCCcEEEEEEeccccccccCCCCCCcchhhhhhcccCccccccCcccccccCCcEeccccCCccccCccc
Q 039290           61 CSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSW  140 (1049)
Q Consensus        61 c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~  140 (1049)
                      +.|.-..|-.  ..++.|++++++++ .+|..+.  +.|+.|+|++|.++ .+|..+.  .+|++|++++|+++ .+|..
T Consensus       168 a~~r~~~Cl~--~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~  238 (754)
T PRK15370        168 AVQRMRDCLK--NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPAT  238 (754)
T ss_pred             HHHHHHhhcc--cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChh
Confidence            4455556732  35688999998888 6777664  46888888888887 6777664  47888888888887 56765


Q ss_pred             ccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcc
Q 039290          141 FVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLW  220 (1049)
Q Consensus       141 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~  220 (1049)
                      +.  ++|+.|+|++|.+. .+|..+.  ++|+.|+|++|+++ .+|..+.        ++|+.|++++|+|++ +|..+.
T Consensus       239 l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--------~sL~~L~Ls~N~Lt~-LP~~lp  303 (754)
T PRK15370        239 LP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--------EELRYLSVYDNSIRT-LPAHLP  303 (754)
T ss_pred             hh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--------CCCcEEECCCCcccc-Ccccch
Confidence            53  36888888888887 6777664  47888888888887 6776553        247778888887773 555442


Q ss_pred             cccccceecccccccccccCCCCccccccceEEeccccccccCccccccccceEEEeeccccCCCccccccccccccceE
Q 039290          221 KCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKEL  300 (1049)
Q Consensus       221 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  300 (1049)
                        ++|+.|++++|++++ +|..+.  ++|+.|++++|.+++ +|..+.  ++|+.|++++|++.. +|..+.  ++|+.|
T Consensus       304 --~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~-LP~~lp--~~L~~L  372 (754)
T PRK15370        304 --SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITV-LPETLP--PTITTL  372 (754)
T ss_pred             --hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCCc-CChhhc--CCcCEE
Confidence              356667777776663 444332  456666666666663 454442  455555555555542 333321  344555


Q ss_pred             EeccCccCCCCCCcccCCCCCccEEEcCCCCCC
Q 039290          301 AVTDNDLLGSLPSSIDLGLPNLERLFLGENNFS  333 (1049)
Q Consensus       301 ~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~  333 (1049)
                      ++++|+++ .+|..+.   ..|+.|++++|+++
T Consensus       373 dLs~N~Lt-~LP~~l~---~sL~~LdLs~N~L~  401 (754)
T PRK15370        373 DVSRNALT-NLPENLP---AALQIMQASRNNLV  401 (754)
T ss_pred             ECCCCcCC-CCCHhHH---HHHHHHhhccCCcc
Confidence            55555444 3343332   23444444444444

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.85  E-value=2.3e-22  Score=233.48  Aligned_cols=250  Identities=21%  Similarity=0.231  Sum_probs=182.3

Q ss_pred             CCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccC-CCHHHHHHHHHH--HhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          762 GFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFD-GSLESFHAECKV--MGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~--l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      .|...+.+|.+.|=+|.+|+++.|. |+||++-+..+ -....|.++++-  ...++|||++++..+-......|+|-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5778899999999999999998887 99999966553 223344333322  4455899999999888888888999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceec-CCCc-c
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL-GKEE-S  916 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~-~~~~-~  916 (1049)
                      +.. +|.|.+..+. .+...+.+.|+.|++.|+..+|   ..||+|||||.+||||+.-..+.|+||..-+.. -+++ .
T Consensus       103 vkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP  177 (1431)
T KOG1240|consen  103 VKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP  177 (1431)
T ss_pred             Hhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence            966 9999887655 4788888999999999999999   999999999999999999999999999765422 1222 1


Q ss_pred             cc----ccccccccCcccccccCCC----------C-cCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhcc
Q 039290          917 MR----QTKTLGTIGYMAPEYGREG----------K-VSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSL  980 (1049)
Q Consensus       917 ~~----~~~~~~~~~y~aPE~~~~~----------~-~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  980 (1049)
                      ..    ..+...-.+|.|||.+...          . .+++.||||+||+++|+++ |++||.-.     ++..+.... 
T Consensus       178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~~-  251 (1431)
T KOG1240|consen  178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSGN-  251 (1431)
T ss_pred             ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhccC-
Confidence            11    1122234589999976441          1 5789999999999999999 68887531     111110000 


Q ss_pred             ccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 039290          981 LSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVR 1038 (1049)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~ 1038 (1049)
                           .......+...+          ...+++++..|++.||++|.++++.++.-+.
T Consensus       252 -----~~~~e~~Le~Ie----------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  252 -----ADDPEQLLEKIE----------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             -----ccCHHHHHHhCc----------CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence                 000000010000          1247899999999999999999999988443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.84  E-value=1.8e-19  Score=203.90  Aligned_cols=257  Identities=31%  Similarity=0.392  Sum_probs=199.1

Q ss_pred             CCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCC---CHHHHHHHHHHHhhcCCC-ceeeEEeeeecCCeeEEEEec
Q 039290          763 FSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDG---SLESFHAECKVMGSIRHR-NLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hp-niv~l~~~~~~~~~~~lv~e~  838 (1049)
                      |...+.+|.|+||.||++...  ..+++|.+......   ....+.+|..+++.+.|+ +++++.+++......++++|+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667789999999999999986  78999998766543   367899999999999988 799999999877778999999


Q ss_pred             cCCCChhhhhhcCC--CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC-ceEEecccCceecCCCc
Q 039290          839 MSNGSLEKCLYSDN--YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM-VGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-~~kl~DfGla~~~~~~~  915 (1049)
                      +.++++.+++....  ..+.......++.|++.+++|+|   +.+++|||+||+||+++..+ .++++|||.+.......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997776654  25889999999999999999999   99999999999999999888 79999999998654433


Q ss_pred             cc-----cccccccccCcccccccCC---CCcCcccchHHHHHHHHHHHhCCCCCCccccc--cchHHHhhhhccccCCc
Q 039290          916 SM-----RQTKTLGTIGYMAPEYGRE---GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAG--EMSLKRWVGDSLLSCSI  985 (1049)
Q Consensus       916 ~~-----~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~  985 (1049)
                      ..     ......++..|+|||....   ..+....|+|++|++++++++|..||......  ..............   
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP---  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence            21     2355679999999999887   57889999999999999999999996653321  11111111111100   


Q ss_pred             chhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          986 TEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       986 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                            ...........  ......+.+++.+|+..+|..|.+..+...+
T Consensus       234 ------~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 ------SLASPLSPSNP--ELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ------ccccccCcccc--chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence                  00000000000  2234568899999999999999999987775

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.82  E-value=1.9e-20  Score=191.64  Aligned_cols=170  Identities=13%  Similarity=0.092  Sum_probs=133.6

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHH---------HHHHHHHHhhcCCCceeeEEeeeecC-
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLES---------FHAECKVMGSIRHRNLVKIISSCSNN-  829 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~hpniv~l~~~~~~~-  829 (1049)
                      .++|+..+++|.|+||.||.+.. ++..+|+|+++.........         +.+|++.+.++.||+|..+.+++... 
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            56899999999999999999766 67789999997655433322         68899999999999999999886533 


Q ss_pred             -------CeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEE
Q 039290          830 -------DFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHL  902 (1049)
Q Consensus       830 -------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl  902 (1049)
                             +..++||||++|.+|.++..     .++    ....+++.+++.+|   +.|++|||+||+||+++.++ +++
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~l  175 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LRI  175 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EEE
Confidence                   35789999999999988632     222    24569999999999   99999999999999999888 999


Q ss_pred             ecccCceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHH
Q 039290          903 SDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETF  956 (1049)
Q Consensus       903 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ell  956 (1049)
                      +|||............             .+.....+..++|+|++|+.+....
T Consensus       176 iDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        176 IDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHH
Confidence            9999887542221111             0223345667899999999887654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.81  E-value=7.7e-20  Score=186.16  Aligned_cols=139  Identities=16%  Similarity=0.160  Sum_probs=109.1

Q ss_pred             CceecCCCcEEEEEEEeCCCcEEEEEEeecccCC--C-------H-----------------HHHHHHHHHHhhcCCCce
Q 039290          766 NKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDG--S-------L-----------------ESFHAECKVMGSIRHRNL  819 (1049)
Q Consensus       766 ~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~hpni  819 (1049)
                      ...||+|+||.||+|...+|+.||+|+++.....  .       .                 .....|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3579999999999999879999999999754311  1       1                 122349999999988776


Q ss_pred             eeEEeeeecCCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHh-HccCCCCeEEcCCCCCCeeecCCC
Q 039290          820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL-HFGYSTPIVHCDIKPSNVLLNESM  898 (1049)
Q Consensus       820 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dlkp~NIl~~~~~  898 (1049)
                      .....+...  ..++||||++++++....... ..++..++.+++.|++.+++++ |   +.||+||||||+||+++ ++
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~  154 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence            443332222  238999999988776543332 3578899999999999999999 7   88999999999999998 47


Q ss_pred             ceEEecccCceec
Q 039290          899 VGHLSDFGIAKIL  911 (1049)
Q Consensus       899 ~~kl~DfGla~~~  911 (1049)
                      .++++|||+|...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            8999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.80  E-value=2.7e-21  Score=178.69  Aligned_cols=166  Identities=31%  Similarity=0.534  Sum_probs=112.7

Q ss_pred             CCCcchhhhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCccc
Q 039290           93 LGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQ  172 (1049)
Q Consensus        93 ~~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~  172 (1049)
                      +.+++..+.|.||+|.++ .+|+.|..|.+|+.|++++|++. .+|.++++|++|+.|+++-|++. .+|..||.++.|+
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le  105 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE  105 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence            445566666667777666 56666666666666666666665 56666666666666666666665 5666666666666


Q ss_pred             EEcCCCccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceE
Q 039290          173 ELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNL  252 (1049)
Q Consensus       173 ~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  252 (1049)
                      +|||++|+++.                             ..+|..|+.++.|+.|+|++|.|. .+|.+++++++|+.|
T Consensus       106 vldltynnl~e-----------------------------~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil  155 (264)
T KOG0617|consen  106 VLDLTYNNLNE-----------------------------NSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQIL  155 (264)
T ss_pred             hhhcccccccc-----------------------------ccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEE
Confidence            66666666542                             245666667777777777777776 677778888888888


Q ss_pred             EeccccccccCccccccccceEEEeeccccCCCcccccccc
Q 039290          253 FLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFN  293 (1049)
Q Consensus       253 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~  293 (1049)
                      .+.+|.+. .+|.+++.++.|+.|++.+|+++- +|+.+++
T Consensus       156 ~lrdndll-~lpkeig~lt~lrelhiqgnrl~v-lppel~~  194 (264)
T KOG0617|consen  156 SLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTV-LPPELAN  194 (264)
T ss_pred             eeccCchh-hCcHHHHHHHHHHHHhcccceeee-cChhhhh
Confidence            88888777 777888888888888887777764 3545544

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=8e-19  Score=175.27  Aligned_cols=189  Identities=15%  Similarity=0.093  Sum_probs=140.1

Q ss_pred             CCCceecCCCcEEEEEEEeCCCcEEEEEEeecccC----CCHHHHHHHHHHHhhcC-CCceeeEEeeeecCCeeEEEEec
Q 039290          764 SENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFD----GSLESFHAECKVMGSIR-HRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       764 ~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      .+...|++|+||+||.+.. .+.+++.+.+.....    .....+.+|+++++++. |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3557899999999997766 778888777754321    01225789999999995 5889999886    346899999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCC-CCCCeeecCCCceEEecccCceecCCCccc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDI-KPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-kp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      +.|.+|.+....        ....++.|++++++++|   +.||+|||| ||+||+++.++.++|+|||+|.........
T Consensus        80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             ecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            999998764321        12357789999999999   999999999 799999999999999999999865433310


Q ss_pred             ----c--------ccccccccCcccccccCC-CCcC-cccchHHHHHHHHHHHhCCCCCCccccc
Q 039290          918 ----R--------QTKTLGTIGYMAPEYGRE-GKVS-RKCDVYSYGIMLMETFTKKKPTDEIFAG  968 (1049)
Q Consensus       918 ----~--------~~~~~~~~~y~aPE~~~~-~~~~-~~~DvwslG~il~elltg~~p~~~~~~~  968 (1049)
                          .        ......++.|++|+...- ...+ .+.+.++-|+.+|.++|+..|..+...|
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~  213 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEG  213 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCC
Confidence                0        011235667777764322 1233 5678889999999999999886554333

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.79  E-value=9.8e-19  Score=179.11  Aligned_cols=140  Identities=18%  Similarity=0.198  Sum_probs=111.7

Q ss_pred             CceecCCCcEEEEEEEeCCCcEEEEEEeecccCC---------------------C-----HHHHHHHHHHHhhcCCCce
Q 039290          766 NKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDG---------------------S-----LESFHAECKVMGSIRHRNL  819 (1049)
Q Consensus       766 ~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~e~~~l~~l~hpni  819 (1049)
                      .+.||+|+||.||+|+..+|+.||||+++.....                     .     ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999999778999999999765321                     0     1223578999999999987


Q ss_pred             eeEEeeeecCCeeEEEEeccCCCChhhh-hhcCCCccCHHHHHHHHHHHHHHHHHhHccCC-CCeEEcCCCCCCeeecCC
Q 039290          820 VKIISSCSNNDFKALVLEYMSNGSLEKC-LYSDNYFLDILQRLKIMIDVASALEYLHFGYS-TPIVHCDIKPSNVLLNES  897 (1049)
Q Consensus       820 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~  897 (1049)
                      .....+....  .++||||++|+++... +..  ..++..++.+++.|++.++.++|   + .||+||||||+||+++ +
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-C
Confidence            5554443332  4899999998855433 332  34678899999999999999999   8 9999999999999999 7


Q ss_pred             CceEEecccCceecCC
Q 039290          898 MVGHLSDFGIAKILGK  913 (1049)
Q Consensus       898 ~~~kl~DfGla~~~~~  913 (1049)
                      +.++|+|||++.....
T Consensus       154 ~~~~liDFG~a~~~~~  169 (190)
T cd05145         154 GKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCEEEEEcccceecCC
Confidence            8999999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.78  E-value=3.2e-20  Score=206.74  Aligned_cols=225  Identities=25%  Similarity=0.282  Sum_probs=182.1

Q ss_pred             eecCCCcEEEEEEEe----CCCcEEEEEEeecccCC--CHHHHHHHHHHHhhcC-CCceeeEEeeeecCCeeEEEEeccC
Q 039290          768 LLGMGSFGSVYKGVL----PDGMEIAAKVFHMEFDG--SLESFHAECKVMGSIR-HRNLVKIISSCSNNDFKALVLEYMS  840 (1049)
Q Consensus       768 ~lg~G~fg~Vy~a~~----~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~  840 (1049)
                      .+|+|+||.|+.++.    ..+.-+|.|+.++....  .......|..++...+ ||.+|++...++.+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999998763    34667898888765422  1225566888888886 9999999999999999999999999


Q ss_pred             CCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccccc
Q 039290          841 NGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT  920 (1049)
Q Consensus       841 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~  920 (1049)
                      +|++...+..... +++.........++-+++++|   +.+|+|||+|++||+++.+|++++.|||+++..-....    
T Consensus        81 gg~lft~l~~~~~-f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----  152 (612)
T KOG0603|consen   81 GGDLFTRLSKEVM-FDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----  152 (612)
T ss_pred             cchhhhccccCCc-hHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence            9999888776554 667777778889999999999   99999999999999999999999999999986543332    


Q ss_pred             ccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccC
Q 039290          921 KTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEND 1000 (1049)
Q Consensus       921 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1049)
                       .+||..|||||+..  ....++|.||||++++||+||..||..    +. .                     .......
T Consensus       153 -~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~-~---------------------~~Il~~~  203 (612)
T KOG0603|consen  153 -ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DT-M---------------------KRILKAE  203 (612)
T ss_pred             -cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HH-H---------------------HHHhhhc
Confidence             27899999999987  678899999999999999999999875    11 0                     1111223


Q ss_pred             chhhHHHHHHHHHHHhhccccCCCCCCCH
Q 039290         1001 FSAREQCVSSIFSLAMDCTVDLPEKRISM 1029 (1049)
Q Consensus      1001 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~ 1029 (1049)
                      ...+......+.+++.++...+|..|.-.
T Consensus       204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  204 LEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            34456677788899999999999999855

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.77  E-value=2.2e-18  Score=181.83  Aligned_cols=230  Identities=20%  Similarity=0.263  Sum_probs=146.4

Q ss_pred             CCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC---CCHHHHHHHHHHHhhcCC----------CceeeEEeee--
Q 039290          763 FSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD---GSLESFHAECKVMGSIRH----------RNLVKIISSC--  826 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h----------pniv~l~~~~--  826 (1049)
                      +...+.||.|+++.||.+++. +++++|+|++....+   ...+++++|.-....+.+          -.++-.++..  
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            344578999999999999975 689999999976542   234566666655544322          1222222221  


Q ss_pred             -------ec---CCe-----eEEEEeccCCCChhhhhhc---CCC---ccCHHHHHHHHHHHHHHHHHhHccCCCCeEEc
Q 039290          827 -------SN---NDF-----KALVLEYMSNGSLEKCLYS---DNY---FLDILQRLKIMIDVASALEYLHFGYSTPIVHC  885 (1049)
Q Consensus       827 -------~~---~~~-----~~lv~e~~~~g~L~~~l~~---~~~---~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~  885 (1049)
                             ..   ...     .+++|+-+. ++|.+++..   ...   ......+..+..|+++.++++|   +.|+||+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEec
Confidence                   11   112     256788884 488887542   211   2333445567789999999999   9999999


Q ss_pred             CCCCCCeeecCCCceEEecccCceecCCCccccccccccccCcccccccCC--------CCcCcccchHHHHHHHHHHHh
Q 039290          886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE--------GKVSRKCDVYSYGIMLMETFT  957 (1049)
Q Consensus       886 Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~ellt  957 (1049)
                      ||+|+|++++.+|.++|+||+.....+.....    ...+..|.+||....        -.++.+.|.|++|+++|.|++
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            99999999999999999999988765432221    234578999996633        257889999999999999999


Q ss_pred             CCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCC
Q 039290          958 KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKR 1026 (1049)
Q Consensus       958 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 1026 (1049)
                      +..||+..........                  ....       .. +.++.+..+|..+++++|.+|
T Consensus       246 ~~lPf~~~~~~~~~~~------------------~f~~-------C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADPEW------------------DFSR-------CR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTSGG------------------GGTT-------SS----HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCccccccc------------------cchh-------cC-CcCHHHHHHHHHHccCCcccC
Confidence            9999985322211100                  1111       11 467789999999999999998

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.77  E-value=8.2e-21  Score=175.50  Aligned_cols=168  Identities=32%  Similarity=0.520  Sum_probs=125.4

Q ss_pred             CCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCC
Q 039290          442 LGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLR  521 (1049)
Q Consensus       442 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  521 (1049)
                      +.++.+++.|.||+|+++ .+|..++.+.+|+.|++++|+|+ .+|..++.+++|+.|+++-|++. ..|..|+.++.|+
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le  105 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE  105 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence            456677788888888887 67777788888888888888887 66777777777777777777776 6777777777777


Q ss_pred             ceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeeccc
Q 039290          522 DLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNR  601 (1049)
Q Consensus       522 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  601 (1049)
                      .|||.+|++.+-                       ..|..|-.++.|.-|+|++|.+. .+|..++++++|+.|.+..|.
T Consensus       106 vldltynnl~e~-----------------------~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdnd  161 (264)
T KOG0617|consen  106 VLDLTYNNLNEN-----------------------SLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDND  161 (264)
T ss_pred             hhhccccccccc-----------------------cCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCc
Confidence            777777777541                       23444445555555555555555 677888888888888888888


Q ss_pred             ccCCccccccCccCCcEEeccCccccCCccccccccc
Q 039290          602 LQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALS  638 (1049)
Q Consensus       602 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  638 (1049)
                      +- ..|..++.++.|++|++.+|+++ .+|+.++.+.
T Consensus       162 ll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~  196 (264)
T KOG0617|consen  162 LL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANLD  196 (264)
T ss_pred             hh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhhh
Confidence            87 68888889999999999999998 7777776653

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.76  E-value=1.9e-18  Score=193.70  Aligned_cols=216  Identities=26%  Similarity=0.418  Sum_probs=165.3

Q ss_pred             HhhcCCCceeeEEeeeecCCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCe-EEcCCCC
Q 039290          811 MGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI-VHCDIKP  889 (1049)
Q Consensus       811 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i-vH~Dlkp  889 (1049)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+......+++.....+..+|+.|++|+|   ...| .|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeecc
Confidence            35678999999999999999999999999999999999987778999999999999999999999   5555 8999999


Q ss_pred             CCeeecCCCceEEecccCceecCCCc-cccccccccccCcccccccCCC-------CcCcccchHHHHHHHHHHHhCCCC
Q 039290          890 SNVLLNESMVGHLSDFGIAKILGKEE-SMRQTKTLGTIGYMAPEYGREG-------KVSRKCDVYSYGIMLMETFTKKKP  961 (1049)
Q Consensus       890 ~NIl~~~~~~~kl~DfGla~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~DvwslG~il~elltg~~p  961 (1049)
                      .|.++|....+|++|||+........ ........-..-|.|||.+...       ..+.+.||||+|++++|+++++.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            99999999999999999987664211 1111112235579999988663       146779999999999999999999


Q ss_pred             CCccccccch--HHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290          962 TDEIFAGEMS--LKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus       962 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                      |+.....+..  ...++...     ......+.+        ....+..+++..++.+||..+|++||+++++...++.+
T Consensus       158 ~~~~~~~~~~~eii~~~~~~-----~~~~~rP~i--------~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKKG-----GSNPFRPSI--------ELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             cccccccCChHHHHHHHHhc-----CCCCcCcch--------hhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            9874433332  22111110     000001111        10113455789999999999999999999999998877


Q ss_pred             HHh
Q 039290         1040 RET 1042 (1049)
Q Consensus      1040 ~~~ 1042 (1049)
                      .+.
T Consensus       225 ~~~  227 (484)
T KOG1023|consen  225 NKG  227 (484)
T ss_pred             ccc
Confidence            764

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.76  E-value=2e-20  Score=210.03  Aligned_cols=180  Identities=23%  Similarity=0.259  Sum_probs=93.4

Q ss_pred             hhcccCccc-cccCcccccccCCcEeccccCCccc----cCcccccccCCccEEEeCCCCccC------CCcccccCCCc
Q 039290          102 LAIRNNSFF-GSLPEELSHLRGLKYFDFRFNNFHI----EIPSWFVSLPRLQHLLLKHNSFVG------KIPETIGYLSL  170 (1049)
Q Consensus       102 L~l~~n~~~-g~~p~~~~~L~~L~~L~l~~n~~~~----~~p~~~~~l~~L~~L~L~~n~l~~------~~p~~~~~l~~  170 (1049)
                      |+|.++.++ +..+..+..+.+|++|+++++.++.    .++..+...+.|++|++++|.+.+      .++..++.+++
T Consensus         3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~   82 (319)
T cd00116           3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG   82 (319)
T ss_pred             cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence            445555554 2444445555666666666666632    245555566667777777666652      23445666667


Q ss_pred             ccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCC----CCCCCcccc-cccceecccccccccc----cCC
Q 039290          171 LQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTG----PIPTNLWKC-RELHVVSLAFNKFQGG----IPR  241 (1049)
Q Consensus       171 L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~----~~p~~l~~l-~~L~~L~L~~N~l~~~----~p~  241 (1049)
                      |+.|++++|.+.+..+..+..+..  . ++|++|++++|++++    .+...+..+ ++|+.|++++|.+++.    ++.
T Consensus        83 L~~L~l~~~~~~~~~~~~~~~l~~--~-~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~  159 (319)
T cd00116          83 LQELDLSDNALGPDGCGVLESLLR--S-SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK  159 (319)
T ss_pred             eeEEEccCCCCChhHHHHHHHHhc--c-CcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence            777777777776544444433322  2 446667777666652    122223333 4555555555555422    222


Q ss_pred             CCccccccceEEecccccccc----CccccccccceEEEeeccccCC
Q 039290          242 DIGNLTSVRNLFLGNNSLIGE----IPNEIGNLRNLEVLGVQSSNLA  284 (1049)
Q Consensus       242 ~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~n~l~  284 (1049)
                      .+..+++|++|+|++|.+++.    ++..+..+++|+.|++++|.+.
T Consensus       160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~  206 (319)
T cd00116         160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLT  206 (319)
T ss_pred             HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccC
Confidence            333444555555555555421    2222333345555555555444

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PRK10345 hypothetical protein; Provisional

Probab=99.74  E-value=1.9e-17  Score=169.75  Aligned_cols=136  Identities=17%  Similarity=0.247  Sum_probs=106.9

Q ss_pred             CCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhc-----CCCceeeEEeeeecCC---eeE-E
Q 039290          764 SENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-----RHRNLVKIISSCSNND---FKA-L  834 (1049)
Q Consensus       764 ~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~hpniv~l~~~~~~~~---~~~-l  834 (1049)
                      ...+.||+|+||.||.  +++....+||++........+.+.+|+++++.+     .||||++++|+++++.   ..+ +
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            4457899999999996  443333479988765455567899999999999     5799999999998863   333 7


Q ss_pred             EEec--cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHH-HHhHccCCCCeEEcCCCCCCeeecC----CCceEEecccC
Q 039290          835 VLEY--MSNGSLEKCLYSDNYFLDILQRLKIMIDVASAL-EYLHFGYSTPIVHCDIKPSNVLLNE----SMVGHLSDFGI  907 (1049)
Q Consensus       835 v~e~--~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~Dlkp~NIl~~~----~~~~kl~DfGl  907 (1049)
                      |+||  +.+++|.+++....  +++.  ..++.+++.++ +|||   +.+|+||||||+||+++.    ++.++|+||+.
T Consensus        83 I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            8999  55799999997643  4544  35677888777 9999   999999999999999973    34899999543


Q ss_pred             c
Q 039290          908 A  908 (1049)
Q Consensus       908 a  908 (1049)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            3

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.74  E-value=5.2e-20  Score=206.64  Aligned_cols=137  Identities=20%  Similarity=0.261  Sum_probs=78.2

Q ss_pred             ccCcccCCceeecCcccccc----cCcccccccccccccccCCccCCC----CccCcCCCcceeEeeccccccccccccc
Q 039290          514 LGNLTSLRDLSLGSNALTSI----IPSTLWNLKDILRFNLSSNSLNGS----LLPDIGNLKVVIEMDLSLNALSGVIPVT  585 (1049)
Q Consensus       514 ~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  585 (1049)
                      +..+++|+.|++++|.+++.    ++..+...++|++|++++|.+++.    +...+..+++|++|++++|.+++.....
T Consensus       161 ~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~  240 (319)
T cd00116         161 LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAA  240 (319)
T ss_pred             HHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHH
Confidence            33344444455544444421    122223334455555555544422    1223445566667777777666432222


Q ss_pred             cc-----CCCcccEEEeecccccC----CccccccCccCCcEEeccCccccCC----cccccccc-cccceeeccCCcc
Q 039290          586 IG-----GLQGLQLLSLRYNRLQG----PIPESFGGLKSLNFVDMSNNNLSGT----IPKSMEAL-SYLKHLNLSFNQL  650 (1049)
Q Consensus       586 ~~-----~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~l~l~~N~l  650 (1049)
                      +.     ..+.|+.|++++|.+++    .+...+..+++|+++|+++|.++..    ....+... +.|+.+++.+|+|
T Consensus       241 l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         241 LASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             HHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence            22     23678888888888862    3345566667888888888888854    44445555 6788888888875

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.74  E-value=1.1e-17  Score=174.72  Aligned_cols=195  Identities=23%  Similarity=0.293  Sum_probs=142.3

Q ss_pred             CCCceeeEEeeeec---------------------------CCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHH
Q 039290          815 RHRNLVKIISSCSN---------------------------NDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDV  867 (1049)
Q Consensus       815 ~hpniv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i  867 (1049)
                      +|||||++.++|.+                           ...+|+||..++. +|.+++..+.  .+.....-+..|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence            59999999887643                           2467899988865 8999887654  3555666789999


Q ss_pred             HHHHHHhHccCCCCeEEcCCCCCCeeec--CC--CceEEecccCceecCCCc-----cccccccccccCcccccccCCCC
Q 039290          868 ASALEYLHFGYSTPIVHCDIKPSNVLLN--ES--MVGHLSDFGIAKILGKEE-----SMRQTKTLGTIGYMAPEYGREGK  938 (1049)
Q Consensus       868 ~~~l~~LH~~~~~~ivH~Dlkp~NIl~~--~~--~~~kl~DfGla~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~  938 (1049)
                      ++|+.|||   .+||.|||+|++||++.  ++  ....|+|||++-.....+     ........|...-||||+....+
T Consensus       351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            99999999   99999999999999994  33  367899999875433211     11223345778899999875432


Q ss_pred             ------cCcccchHHHHHHHHHHHhCCCCCCccccccchH--HHhhhhccccCCcchhcccccccccccCchhhHHHHHH
Q 039290          939 ------VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSL--KRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSS 1010 (1049)
Q Consensus       939 ------~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1049)
                            .-.++|.|+.|.+.||+++...||..  .|+..+  ..+..                    .+-+..+..++..
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~--rGem~L~~r~Yqe--------------------~qLPalp~~vpp~  485 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYK--RGEMLLDTRTYQE--------------------SQLPALPSRVPPV  485 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccc--cchheechhhhhh--------------------hhCCCCcccCChH
Confidence                  13589999999999999999999986  333322  11110                    0112334557788


Q ss_pred             HHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290         1011 IFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus      1011 l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                      +.+++...++.||++|+++.-....+.
T Consensus       486 ~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  486 ARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHHHHHhcCCccccCCccHHHhHHH
Confidence            999999999999999999875555443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=1.5e-17  Score=199.04  Aligned_cols=195  Identities=24%  Similarity=0.259  Sum_probs=158.4

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcC---CCceeeEEeeeecCCeeEEE
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR---HRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---hpniv~l~~~~~~~~~~~lv  835 (1049)
                      ..+.|.+.+.+|+|+||+||+|...+|+.||+|+-+....   .+|.-=.+++.+|+   -+-|..+..++.-.+.-++|
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv  772 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV  772 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence            3456888899999999999999988899999999765432   23333334555555   24555566666667778899


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec-------CCCceEEecccCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN-------ESMVGHLSDFGIA  908 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~-------~~~~~kl~DfGla  908 (1049)
                      +||.+.|+|.+++.. .+..++.-+.-+..|+++.+++||   ..+||||||||+|.|+.       ....++|+|||.+
T Consensus       773 ~ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s  848 (974)
T KOG1166|consen  773 SEYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS  848 (974)
T ss_pred             eeccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence            999999999999984 445899999999999999999999   99999999999999994       2346899999999


Q ss_pred             eecCC-CccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCC
Q 039290          909 KILGK-EESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKK  960 (1049)
Q Consensus       909 ~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~  960 (1049)
                      ..+.- .+.......++|-.+-.+|+..+..+++..|.|.++.+++-|+.|+.
T Consensus       849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            87642 22234455678889999999999999999999999999999999875

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.71  E-value=1.8e-16  Score=166.18  Aligned_cols=134  Identities=23%  Similarity=0.325  Sum_probs=113.9

Q ss_pred             ceecCCCcEEEEEEEeCCCcEEEEEEeecccCCC--------HHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGS--------LESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~--------~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      +.||+|++|.||+|.. .|..|++|+........        ..++.+|++++..++|+++.....++.+.+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999988 77889999865432211        24577899999999999988777777777788999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCcee
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI  910 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~  910 (1049)
                      ++|++|.+++....    . ++..++.+++.+++++|   +.+++|||++|+||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999886532    2 78899999999999999   99999999999999999 78999999998764

>smart00090 RIO RIO-like kinase

Probab=99.69  E-value=1.1e-16  Score=168.80  Aligned_cols=142  Identities=17%  Similarity=0.147  Sum_probs=111.8

Q ss_pred             CCCCCceecCCCcEEEEEEE--eCCCcEEEEEEeecccCC------------------------CHHHHHHHHHHHhhcC
Q 039290          762 GFSENKLLGMGSFGSVYKGV--LPDGMEIAAKVFHMEFDG------------------------SLESFHAECKVMGSIR  815 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~  815 (1049)
                      .|++.+.||+|+||.||+|.  ..+|+.||+|+++.....                        ....+.+|++.+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            58888999999999999998  568999999998754210                        0123568999999997


Q ss_pred             CC--ceeeEEeeeecCCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCC-eEEcCCCCCCe
Q 039290          816 HR--NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP-IVHCDIKPSNV  892 (1049)
Q Consensus       816 hp--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Dlkp~NI  892 (1049)
                      +.  .+.+++++   . ..++||||++++++........ .....++..++.|++.+++++|   +.| |+||||||+||
T Consensus       109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NI  180 (237)
T smart00090      109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNI  180 (237)
T ss_pred             hcCCCCCeeeEe---c-CceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhE
Confidence            53  34444443   2 3489999999988876543322 3566677899999999999999   999 99999999999


Q ss_pred             eecCCCceEEecccCceecC
Q 039290          893 LLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       893 l~~~~~~~kl~DfGla~~~~  912 (1049)
                      +++ ++.++++|||.+...+
T Consensus       181 li~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEE-CCCEEEEEChhhhccC
Confidence            999 8899999999987543

>PLN03150 hypothetical protein; Provisional

Probab=99.69  E-value=3.4e-17  Score=196.81  Aligned_cols=136  Identities=27%  Similarity=0.528  Sum_probs=76.4

Q ss_pred             cCChhhHHHHHHHHHhcccCCCCcccccCCCCCCCc----eeeeEEEcCC--C--CcEEEEEEeccccccccCCCCCCcc
Q 039290           26 TNVTTDQFALLALKEHIKHDPSNLLANNWSTTSSVC----SWIGVTCGVR--N--RRVTALNISYLGLTGTIPPQLGNLS   97 (1049)
Q Consensus        26 ~~~~~d~~all~~k~~~~~~~~~~l~~~w~~~~~~c----~w~gv~c~~~--~--~~v~~l~l~~~~l~g~~~~~~~~l~   97 (1049)
                      +..+.|.+||++||+++. +|..   .+|+. ..||    .|.||+|+..  .  .+|+.|+|+++++.|.+|+.++.++
T Consensus       368 ~t~~~~~~aL~~~k~~~~-~~~~---~~W~g-~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~  442 (623)
T PLN03150        368 KTLLEEVSALQTLKSSLG-LPLR---FGWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLR  442 (623)
T ss_pred             ccCchHHHHHHHHHHhcC-Cccc---CCCCC-CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCC
Confidence            456789999999999995 5543   37864 3442    7999999532  1  2466666666666655555555555


Q ss_pred             hhhhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCccccc
Q 039290           98 FLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIG  166 (1049)
Q Consensus        98 ~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~  166 (1049)
                      +|+.|+|++|.+.|.+|.++++|++|++|||++|+++|.+|..+++|++|++|+|++|.++|.+|..++
T Consensus       443 ~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~  511 (623)
T PLN03150        443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG  511 (623)
T ss_pred             CCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHh
Confidence            555555554444444444444444444444444444444444444444444444444444444444443

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.67  E-value=3.8e-16  Score=161.49  Aligned_cols=145  Identities=18%  Similarity=0.202  Sum_probs=113.8

Q ss_pred             HHHHHHhcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCC----------------------CHHHHHHHHHHH
Q 039290          754 QDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDG----------------------SLESFHAECKVM  811 (1049)
Q Consensus       754 ~~~~~~~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l  811 (1049)
                      +++......|.+.+.||+|+||.||+|...+|+.||||+++.....                      ....+..|+.++
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            3444444458888999999999999999888999999987643211                      112356788889


Q ss_pred             hhcCCC--ceeeEEeeeecCCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCC
Q 039290          812 GSIRHR--NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKP  889 (1049)
Q Consensus       812 ~~l~hp--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp  889 (1049)
                      ..+.|+  .+++.++.    ...++||||+++++|.+....       .....++.+++.++.++|   +.||+||||||
T Consensus        88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p  153 (198)
T cd05144          88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSE  153 (198)
T ss_pred             HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCc
Confidence            888777  44444432    345899999999998775321       345678999999999999   89999999999


Q ss_pred             CCeeecCCCceEEecccCceecC
Q 039290          890 SNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       890 ~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      +||++++++.++|+|||.+....
T Consensus       154 ~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         154 FNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             ccEEEcCCCcEEEEECCccccCC
Confidence            99999999999999999997554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.65  E-value=5.6e-16  Score=160.76  Aligned_cols=131  Identities=22%  Similarity=0.318  Sum_probs=107.1

Q ss_pred             eecCCCcEEEEEEEeCCCcEEEEEEeecccC-C-------CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          768 LLGMGSFGSVYKGVLPDGMEIAAKVFHMEFD-G-------SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       768 ~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~-~-------~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      .||+|+||.||+|.+ ++..|++|+...... .       ...++.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999995 678899998654321 1       1256778999999999887665555555666778999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceec
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL  911 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~  911 (1049)
                      +|++|.+.+.....        .++.+++.+++++|   +.|++|||++|+||+++ ++.++++|||++...
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999987654321        78999999999999   99999999999999999 789999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.64  E-value=6.7e-17  Score=177.08  Aligned_cols=241  Identities=22%  Similarity=0.270  Sum_probs=158.6

Q ss_pred             CCCCCceecCCCcEEEEEEEeCCC----cEEEEEEeecccCCCHHHHHHHHHHHhhc-CCCceeeEE------eee----
Q 039290          762 GFSENKLLGMGSFGSVYKGVLPDG----MEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLVKII------SSC----  826 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~~~----~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~------~~~----  826 (1049)
                      .+++.+..+..+++.++..+...+    ..++.|..+...........+++-.+... .|+..+..-      ..+    
T Consensus       245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~  324 (516)
T KOG1033|consen  245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNK  324 (516)
T ss_pred             cccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhccccc
Confidence            344556677777777766653322    33444444433312222333334444333 344433221      011    


Q ss_pred             -ecCCeeEEEEeccCCCChhhhhhc--CCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEe
Q 039290          827 -SNNDFKALVLEYMSNGSLEKCLYS--DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLS  903 (1049)
Q Consensus       827 -~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~  903 (1049)
                       ....++||.|++|+..+|.+++..  .....++.....++.|++.|++|      ++.+|+|+||.||+...+.++||.
T Consensus       325 v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIg  398 (516)
T KOG1033|consen  325 VGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIG  398 (516)
T ss_pred             cccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhh
Confidence             112367899999999999999964  33467788889999999999988      689999999999999999999999


Q ss_pred             cccCceecCCCc-----cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhh
Q 039290          904 DFGIAKILGKEE-----SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVG  977 (1049)
Q Consensus       904 DfGla~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  977 (1049)
                      |||+........     ....+..+||..||+||.+.+..|+.++||||+|++++|+++ =..+++..    .       
T Consensus       399 DFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----~-------  467 (516)
T KOG1033|consen  399 DFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----A-------  467 (516)
T ss_pred             hhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----H-------
Confidence            999998765433     234556789999999999999999999999999999999997 22222210    0       


Q ss_pred             hccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 039290          978 DSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDV 1032 (1049)
Q Consensus       978 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~el 1032 (1049)
                            ...++.+..+.+      ....+.+ +-+.++.+++.+.|.+||++.+.
T Consensus       468 ------t~~d~r~g~ip~------~~~~d~p-~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  468 ------TLTDIRDGIIPP------EFLQDYP-EEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             ------hhhhhhcCCCCh------HHhhcCc-HHHHHHHHhcCCCcccCchHHHH
Confidence                  011111111110      0111222 23679999999999999955544

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.62  E-value=1.8e-15  Score=180.58  Aligned_cols=137  Identities=22%  Similarity=0.291  Sum_probs=111.8

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEe-ecccC-------CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVF-HMEFD-------GSLESFHAECKVMGSIRHRNLVKIISSCSNNDF  831 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~-~~~~~-------~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~  831 (1049)
                      ...|...+.||+|+||+||+|.+.+. .+++|+. .....       ...+++.+|+++++.++|++++....++.+.+.
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            44567789999999999999987544 3444432 22111       113568899999999999999988877777777


Q ss_pred             eEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCcee
Q 039290          832 KALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI  910 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~  910 (1049)
                      .++||||+++++|.+++.         ....++.+++++++++|   +.+++|||+||+||++ .++.++|+|||+++.
T Consensus       411 ~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             CEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            899999999999998775         35679999999999999   9999999999999999 577999999999875

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.60  E-value=6.1e-16  Score=180.89  Aligned_cols=211  Identities=24%  Similarity=0.260  Sum_probs=143.2

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      ..+|...|.+..|+||.||.++++ ..+++|.|+=+..      .+.+  .++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------lilR--nilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILR--NILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccc------hhhh--ccccccCCccee------------------
Confidence            357889999999999999999976 4567777432211      1111  022222333333                  


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc---
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE---  915 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~---  915 (1049)
                         |+-.+.+..-+. ++..        ++.+++|+|   +.||||||+||+|.+|+.-|++|+.|||+++......   
T Consensus       136 ---gDc~tllk~~g~-lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  136 ---GDCATLLKNIGP-LPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             ---chhhhhcccCCC-Ccch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence               333333333222 2222        277999999   9999999999999999999999999999986432111   


Q ss_pred             -----------cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCC
Q 039290          916 -----------SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCS  984 (1049)
Q Consensus       916 -----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  984 (1049)
                                 .......+||+.|+|||++..+.|...+|.|++|+|+||.+.|+.||.+....+. +.+.+...+.   
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel-fg~visd~i~---  276 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-FGQVISDDIE---  276 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH-Hhhhhhhhcc---
Confidence                       0111224799999999999999999999999999999999999999987533322 2222221110   


Q ss_pred             cchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 039290          985 ITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMK 1030 (1049)
Q Consensus       985 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ 1030 (1049)
                                     .++.....+.+..+++.+.++.+|..|--..
T Consensus       277 ---------------wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~  307 (1205)
T KOG0606|consen  277 ---------------WPEEDEALPPEAQDLIEQLLRQNPLCRLGTG  307 (1205)
T ss_pred             ---------------ccccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence                           0011123456788999999999999997433

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.56  E-value=1.6e-14  Score=148.17  Aligned_cols=136  Identities=18%  Similarity=0.220  Sum_probs=98.6

Q ss_pred             CceecCCCcEEEEEEEeCCCcEEEEEEeecccCCC--HHH----------------------HHHHHHHHhhcCCC--ce
Q 039290          766 NKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGS--LES----------------------FHAECKVMGSIRHR--NL  819 (1049)
Q Consensus       766 ~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~e~~~l~~l~hp--ni  819 (1049)
                      .+.||+|+||.||+|...+++.||||+++......  ...                      ...|.+.+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999998889999999987542111  111                      13456666666433  24


Q ss_pred             eeEEeeeecCCeeEEEEeccCCCChhh-hhhcCCCccCHHHHHHHHHHHHHHHHHhHccCC-CCeEEcCCCCCCeeecCC
Q 039290          820 VKIISSCSNNDFKALVLEYMSNGSLEK-CLYSDNYFLDILQRLKIMIDVASALEYLHFGYS-TPIVHCDIKPSNVLLNES  897 (1049)
Q Consensus       820 v~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~  897 (1049)
                      .+++++    ...++||||++++.+.. .+....  . ..++..++.+++.++.++|   . .+|+||||||+||+++ +
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence            444443    23589999999854321 111111  1 1567889999999999999   8 9999999999999999 8


Q ss_pred             CceEEecccCceecC
Q 039290          898 MVGHLSDFGIAKILG  912 (1049)
Q Consensus       898 ~~~kl~DfGla~~~~  912 (1049)
                      +.++++|||.+....
T Consensus       151 ~~~~liDfg~a~~~~  165 (187)
T cd05119         151 GKVYIIDVPQAVEID  165 (187)
T ss_pred             CcEEEEECccccccc
Confidence            899999999997553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.56  E-value=3.4e-14  Score=140.29  Aligned_cols=135  Identities=19%  Similarity=0.230  Sum_probs=114.6

Q ss_pred             CCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCC--CceeeEEeeeecCCeeEEEEeccCCC
Q 039290          765 ENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRH--RNLVKIISSCSNNDFKALVLEYMSNG  842 (1049)
Q Consensus       765 ~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--pniv~l~~~~~~~~~~~lv~e~~~~g  842 (1049)
                      +.+.+|+|.++.||++...+ ..+++|.......  ...+.+|+.+++.++|  +++++++++....+..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999999854 7899999865433  5678999999999976  58999999888888899999999987


Q ss_pred             ChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCcee
Q 039290          843 SLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI  910 (1049)
Q Consensus       843 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~  910 (1049)
                      .+..+        +......++.+++++++++|.....+++|||++|+||+++..+.++++|||.+..
T Consensus        79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77653        5566778899999999999943335899999999999999989999999998874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.54  E-value=9.5e-16  Score=181.30  Aligned_cols=255  Identities=24%  Similarity=0.273  Sum_probs=195.1

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCC--CcEEEEEEeeccc--CCCHHHHHHHHHHHhhcC-CCceeeEEeeeecCCeeEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPD--GMEIAAKVFHMEF--DGSLESFHAECKVMGSIR-HRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv  835 (1049)
                      ..|...+.||+|+|+.|-.+....  ...+|+|.+....  .........|..+-+.+. |+|++++++...+.+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            357777889999999998887533  3456666665443  222344555777777776 99999999999999999999


Q ss_pred             EeccCCCChhhhh-hcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC-ceEEecccCceecCC
Q 039290          836 LEYMSNGSLEKCL-YSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM-VGHLSDFGIAKILGK  913 (1049)
Q Consensus       836 ~e~~~~g~L~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-~~kl~DfGla~~~~~  913 (1049)
                      +||..++++.+-+ .......+......+..|+..++.|+|.  ..++.|||+||+|.+++..+ ..+++|||+|..+..
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            9999999999988 5444356777788899999999999994  67899999999999999999 999999999998766


Q ss_pred             -Cc-ccccccccc-ccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhc
Q 039290          914 -EE-SMRQTKTLG-TIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA  989 (1049)
Q Consensus       914 -~~-~~~~~~~~~-~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  989 (1049)
                       .+ ........| ++.|+|||...+. ...+..|+||.|+++..+++|..||+........+..|.+.....       
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------  250 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRF-------  250 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccccc-------
Confidence             22 233344567 9999999998874 446789999999999999999999987666655555554322110       


Q ss_pred             ccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 039290          990 DANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVAN 1034 (1049)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~ 1034 (1049)
                                .............++..+++..+|+.|.+.+++..
T Consensus       251 ----------~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  251 ----------TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ----------ccCccccCChhhhhcccccccCCchhccccccccc
Confidence                      00111122344677888899999999999888754

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.51  E-value=1.1e-13  Score=146.36  Aligned_cols=135  Identities=15%  Similarity=0.181  Sum_probs=105.4

Q ss_pred             ceec-CCCcEEEEEEEeCCCcEEEEEEeeccc-------------CCCHHHHHHHHHHHhhcCCCce--eeEEeeeecCC
Q 039290          767 KLLG-MGSFGSVYKGVLPDGMEIAAKVFHMEF-------------DGSLESFHAECKVMGSIRHRNL--VKIISSCSNND  830 (1049)
Q Consensus       767 ~~lg-~G~fg~Vy~a~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~hpni--v~l~~~~~~~~  830 (1049)
                      ..|| .|+.|+||.+.. .+..+++|.+....             .....++.+|++++.+++|+++  ++.+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            5687 899999999987 47789999885321             0123567889999999998775  67777644322


Q ss_pred             ----eeEEEEeccCC-CChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecc
Q 039290          831 ----FKALVLEYMSN-GSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDF  905 (1049)
Q Consensus       831 ----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df  905 (1049)
                          ..++|||+++| .+|.+++...  .+++.    .+.+++.+++++|   +.||+||||||+|||++.++.++|+||
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LIDf  186 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLIDF  186 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEEC
Confidence                23599999997 6898887653  24443    3568999999999   999999999999999998889999999


Q ss_pred             cCceec
Q 039290          906 GIAKIL  911 (1049)
Q Consensus       906 Gla~~~  911 (1049)
                      |.+...
T Consensus       187 g~~~~~  192 (239)
T PRK01723        187 DRGELR  192 (239)
T ss_pred             CCcccC
Confidence            988753

>PLN03150 hypothetical protein; Provisional

Probab=99.51  E-value=4.4e-14  Score=170.05  Aligned_cols=118  Identities=36%  Similarity=0.642  Sum_probs=98.8

Q ss_pred             ceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCcccccccccccceeecc
Q 039290          567 VVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLS  646 (1049)
Q Consensus       567 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~  646 (1049)
                      .++.|+|++|.+++.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..+..+++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            47788999999998899999999999999999999998899889999999999999999999999999999999999999


Q ss_pred             CCcccccCCCC--CCccccccccccCCccccCCCCccCCCCC
Q 039290          647 FNQLEGEIPTR--GPFITFSAESFLGNQALCGSPKLQVSPCK  686 (1049)
Q Consensus       647 ~N~l~~~~p~~--~~~~~~~~~~~~~n~~~cg~~~~~~~~c~  686 (1049)
                      +|+++|.+|..  ..+.......+.+|+.+||.|..  ..|.
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l--~~C~  538 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGL--RACG  538 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCCC--CCCc
Confidence            99999998863  22233345678899999998743  4674

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.48  E-value=2.2e-15  Score=164.72  Aligned_cols=182  Identities=32%  Similarity=0.495  Sum_probs=134.5

Q ss_pred             cccCCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCC
Q 039290          119 HLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNL  198 (1049)
Q Consensus       119 ~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l  198 (1049)
                      .|+.-...||+.|++. ++|..+..+..|+.|.|.+|.+. .||..+++|..|++|||+.|+++ .+|..++.+.     
T Consensus        73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-----  144 (722)
T KOG0532|consen   73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-----  144 (722)
T ss_pred             cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-----
Confidence            4455566677777776 67777777777777888888877 77888888888888888888887 7777776653     


Q ss_pred             CccceEEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceEEeccccccccCccccccccceEEEee
Q 039290          199 PVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGV  278 (1049)
Q Consensus       199 ~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  278 (1049)
                        |+.|-+++|+++ .+|+.++....|..||.+.|.+. .+|..++.+.+|+.|.+..|++. .+|.+++.| .|..||+
T Consensus       145 --Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDf  218 (722)
T KOG0532|consen  145 --LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDF  218 (722)
T ss_pred             --ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeec
Confidence              778888888887 67777777777778888888777 67777778888888888888777 667777744 3777777


Q ss_pred             ccccCCCccccccccccccceEEeccCccCCCCCCccc
Q 039290          279 QSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSID  316 (1049)
Q Consensus       279 ~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~  316 (1049)
                      +.|+++ .+|-.|.+|+.|++|-|.+|-+. +-|..+.
T Consensus       219 ScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC  254 (722)
T KOG0532|consen  219 SCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQIC  254 (722)
T ss_pred             ccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHH
Confidence            777776 35777777777777777777766 4555443

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.48  E-value=2.7e-15  Score=164.03  Aligned_cols=212  Identities=25%  Similarity=0.367  Sum_probs=162.3

Q ss_pred             EEEeccccccccC--CCCCCcchhhhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCCC
Q 039290           78 LNISYLGLTGTIP--PQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHN  155 (1049)
Q Consensus        78 l~l~~~~l~g~~~--~~~~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n  155 (1049)
                      |.|++..|. ..|  ..=-.|+.-...||+.|++. .+|.+...+..|+.|.|+.|.+. .||..+.+|..|.+|||+.|
T Consensus        55 l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~N  131 (722)
T KOG0532|consen   55 LLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSN  131 (722)
T ss_pred             cccccchhh-cCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccc
Confidence            455555554 233  22245667777888888886 78888888888888888888887 78888888888888888888


Q ss_pred             CccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccceeccccccc
Q 039290          156 SFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKF  235 (1049)
Q Consensus       156 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l  235 (1049)
                      +++ .+|..++.|+ |+.|-+++|+++ .+|..++.      ++.|..||.+.|++. .+|..++.+.+|+.|.+..|++
T Consensus       132 qlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~------~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l  201 (722)
T KOG0532|consen  132 QLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGL------LPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHL  201 (722)
T ss_pred             hhh-cCChhhhcCc-ceeEEEecCccc-cCCccccc------chhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhh
Confidence            888 7888888776 888888888887 88888762      455788888888888 6888888888888888888888


Q ss_pred             ccccCCCCccccccceEEeccccccccCccccccccceEEEeeccccCCCcccccccccc---ccceEEeccCc
Q 039290          236 QGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNIS---TLKELAVTDND  306 (1049)
Q Consensus       236 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~---~L~~L~l~~N~  306 (1049)
                      . .+|++++.| .|..||+|+|+++ .+|-+|.+|+.|++|-|.+|.+.. .|..+....   =.|+|+...++
T Consensus       202 ~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS-PPAqIC~kGkVHIFKyL~~qA~q  271 (722)
T KOG0532|consen  202 E-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS-PPAQICEKGKVHIFKYLSTQACQ  271 (722)
T ss_pred             h-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCC-ChHHHHhccceeeeeeecchhcc
Confidence            7 677777744 5888999999988 888899999999999998888875 355554332   34566666664

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.40  E-value=1.8e-13  Score=158.03  Aligned_cols=179  Identities=31%  Similarity=0.461  Sum_probs=86.1

Q ss_pred             cccccCCcEeccccCCccccCcccccccC-CccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCccccccc
Q 039290          117 LSHLRGLKYFDFRFNNFHIEIPSWFVSLP-RLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSC  195 (1049)
Q Consensus       117 ~~~L~~L~~L~l~~n~~~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l  195 (1049)
                      +..++.++.|++..|+++ .+|...+.+. +|++|++++|++. .+|..++.+++|+.|++++|+++ .+|...+.    
T Consensus       112 ~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~----  184 (394)
T COG4886         112 LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSN----  184 (394)
T ss_pred             hhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhh----
Confidence            333445555555555554 4444444443 5555555555554 44445555555555555555555 44443321    


Q ss_pred             CCCCccceEEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceEEeccccccccCccccccccceEE
Q 039290          196 QNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEV  275 (1049)
Q Consensus       196 ~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~  275 (1049)
                        ++.|+.|++++|+++ .+|..+..+..|+.+++++|++. .++..+.++.++..|.+.+|++. .++..++.+++++.
T Consensus       185 --~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~  259 (394)
T COG4886         185 --LSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLET  259 (394)
T ss_pred             --hhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccce
Confidence              233555555555555 44444444444555555555322 33444455555555555555544 23444455555555


Q ss_pred             EeeccccCCCccccccccccccceEEeccCccCC
Q 039290          276 LGVQSSNLAGLIPASIFNISTLKELAVTDNDLLG  309 (1049)
Q Consensus       276 L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~  309 (1049)
                      |++++|.++...+  ++.+.+|+.|++++|.+..
T Consensus       260 L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~  291 (394)
T COG4886         260 LDLSNNQISSISS--LGSLTNLRELDLSGNSLSN  291 (394)
T ss_pred             ecccccccccccc--ccccCccCEEeccCccccc
Confidence            5555544443322  4444444444444444443

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.39  E-value=9.8e-13  Score=151.30  Aligned_cols=141  Identities=21%  Similarity=0.256  Sum_probs=101.9

Q ss_pred             CceecCCCcEEEEEEEeCCCcEEEEEEeecccCCC----------------------------------------HHHHH
Q 039290          766 NKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGS----------------------------------------LESFH  805 (1049)
Q Consensus       766 ~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~  805 (1049)
                      .+.||.|++|.||+|+..+|+.||||+.+......                                        .-+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36899999999999999999999999986542110                                        01245


Q ss_pred             HHHHHHhhcC-----CCceeeEEeee-ecCCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHH-HHHHhHccC
Q 039290          806 AECKVMGSIR-----HRNLVKIISSC-SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVAS-ALEYLHFGY  878 (1049)
Q Consensus       806 ~e~~~l~~l~-----hpniv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~-~l~~LH~~~  878 (1049)
                      +|++.+.+++     ++++ .+-.++ ......++||||++|+++.++........   ...+++..+++ .+..+|   
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~---  274 (437)
T TIGR01982       202 REAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL---  274 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH---
Confidence            5666665552     3433 332222 33445689999999999988765322212   23456666666 467889   


Q ss_pred             CCCeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       879 ~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      ..|++|+|++|.||+++.++.++++|||++..+.+
T Consensus       275 ~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       275 RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            89999999999999999999999999999987754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.38  E-value=2.3e-13  Score=157.20  Aligned_cols=216  Identities=30%  Similarity=0.444  Sum_probs=179.7

Q ss_pred             ceeeeEEEcCCCCcEE---EEEEeccccccccCCCCCCcchhhhhhcccCccccccCccccccc-CCcEeccccCCcccc
Q 039290           61 CSWIGVTCGVRNRRVT---ALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLR-GLKYFDFRFNNFHIE  136 (1049)
Q Consensus        61 c~w~gv~c~~~~~~v~---~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~~~~~L~-~L~~L~l~~n~~~~~  136 (1049)
                      +.+.+..+....  +.   .+++..+.+... +..+..++.++.|++.+|.++ .||.....++ +|++|++++|++. .
T Consensus        80 ~~~l~~~~~~~~--~~~~~~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~  154 (394)
T COG4886          80 ISSLDGSENLLN--LLPLPSLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-S  154 (394)
T ss_pred             cccccccccccC--CCCCceeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-h
Confidence            556666664332  23   477777766432 334566688999999999998 8999999996 9999999999998 7


Q ss_pred             CcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCCCCC
Q 039290          137 IPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIP  216 (1049)
Q Consensus       137 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p  216 (1049)
                      +|..++.+++|+.|++++|+++ .+|...+.+++|+.|++++|+++ .+|..+..      ...|++|++++|++. .++
T Consensus       155 l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~------~~~L~~l~~~~N~~~-~~~  225 (394)
T COG4886         155 LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIEL------LSALEELDLSNNSII-ELL  225 (394)
T ss_pred             hhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhh------hhhhhhhhhcCCcce-ecc
Confidence            8888999999999999999999 88888889999999999999999 88886532      234999999999655 578


Q ss_pred             CCcccccccceecccccccccccCCCCccccccceEEeccccccccCccccccccceEEEeeccccCCCcccccccc
Q 039290          217 TNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFN  293 (1049)
Q Consensus       217 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~  293 (1049)
                      ..+..+.++..+.++.|++. .++..++.+++++.|++++|+++ .++. ++.+.+|+.|++++|.+....|.....
T Consensus       226 ~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~~~~  299 (394)
T COG4886         226 SSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLIALL  299 (394)
T ss_pred             hhhhhcccccccccCCceee-eccchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchhhhcc
Confidence            88999999999999999987 44788999999999999999998 5555 999999999999999999887765543

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.33  E-value=1.3e-12  Score=146.97  Aligned_cols=248  Identities=22%  Similarity=0.199  Sum_probs=186.3

Q ss_pred             CCCCCceecC--CCcEEEEEEEe---CCCcEEEEEEeecccC--CCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeE
Q 039290          762 GFSENKLLGM--GSFGSVYKGVL---PDGMEIAAKVFHMEFD--GSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKA  833 (1049)
Q Consensus       762 ~~~~~~~lg~--G~fg~Vy~a~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~  833 (1049)
                      .|...+.+|.  |.+|.||.+..   .++..+|+|+-+....  ....+=.+|+...+.+ .|++.++.+..++..+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4666788999  99999999985   4788899998655443  3333445677777777 4999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHH----HHHHhHccCCCCeEEcCCCCCCeeecCC-CceEEecccCc
Q 039290          834 LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVAS----ALEYLHFGYSTPIVHCDIKPSNVLLNES-MVGHLSDFGIA  908 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-~~~kl~DfGla  908 (1049)
                      +-+|++. .++.++.+.....+++...+.+..+..+    |+.++|   +.+++|-|+||.||+...+ ..++++|||+.
T Consensus       195 iqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             eeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCccee
Confidence            9999995 6888888776667888899999999999    999999   9999999999999999988 89999999999


Q ss_pred             eecCCCccccc----cccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCC
Q 039290          909 KILGKEESMRQ----TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCS  984 (1049)
Q Consensus       909 ~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  984 (1049)
                      ..++...-...    ....+...|++||...+ -++.+.|+|++|.++.+..++..+....  .   ...|...    ..
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g--~---~~~W~~~----r~  340 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVG--K---NSSWSQL----RQ  340 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCC--C---CCCcccc----cc
Confidence            88865442111    11257788999999864 7888999999999999999987654320  0   0111100    00


Q ss_pred             cchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          985 ITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       985 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .. +.+           ..-.....++...+.+|++.+|..|++++.+.++
T Consensus       341 ~~-ip~-----------e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  341 GY-IPL-----------EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             cc-Cch-----------hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence            00 000           0001123345558999999999999999877654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.32  E-value=2.4e-12  Score=132.17  Aligned_cols=209  Identities=20%  Similarity=0.249  Sum_probs=144.2

Q ss_pred             HHHHHHHHHHhhcCCCceeeEEeeeecCC-----eeEEEEeccCCCChhhhhhcC---CCccCHHHHHHHHHHHHHHHHH
Q 039290          802 ESFHAECKVMGSIRHRNLVKIISSCSNND-----FKALVLEYMSNGSLEKCLYSD---NYFLDILQRLKIMIDVASALEY  873 (1049)
Q Consensus       802 ~~~~~e~~~l~~l~hpniv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~  873 (1049)
                      +....-+..+-.+-|.|+|+++.||.+.+     +..+++||+..|++..++++.   ...+......+|+.||..||.|
T Consensus       112 ek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~y  191 (458)
T KOG1266|consen  112 EKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSY  191 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhh
Confidence            33344445556667999999999986643     467899999999999998753   3467778889999999999999


Q ss_pred             hHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc----cccccccccccCcccccccCCCCcCcccchHHHH
Q 039290          874 LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE----SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYG  949 (1049)
Q Consensus       874 LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG  949 (1049)
                      || .++..|+|+++.-+-|++..+|-+|+.--- -....+..    ........+-++|.|||+-.....+.++|||+||
T Consensus       192 Lh-s~~PpiihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fg  269 (458)
T KOG1266|consen  192 LH-SCDPPIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFG  269 (458)
T ss_pred             hh-ccCCccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhh
Confidence            99 668999999999999999999988874211 11111100    0111112356789999998877888899999999


Q ss_pred             HHHHHHHhCCCCCCc-cccccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCC
Q 039290          950 IMLMETFTKKKPTDE-IFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRIS 1028 (1049)
Q Consensus       950 ~il~elltg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt 1028 (1049)
                      +...||..+..--.. ....+..               +-..........+          --++++.+|++..|..||+
T Consensus       270 mcAlemailEiq~tnseS~~~~e---------------e~ia~~i~~len~----------lqr~~i~kcl~~eP~~rp~  324 (458)
T KOG1266|consen  270 MCALEMAILEIQSTNSESKVEVE---------------ENIANVIIGLENG----------LQRGSITKCLEGEPNGRPD  324 (458)
T ss_pred             HHHHHHHHheeccCCCcceeehh---------------hhhhhheeeccCc----------cccCcCcccccCCCCCCcc
Confidence            999999987653211 1000000               0000011110000          0135788999999999999


Q ss_pred             HHHHHHHHH
Q 039290         1029 MKDVANRLV 1037 (1049)
Q Consensus      1029 ~~ell~~L~ 1037 (1049)
                      |.+++.|.-
T Consensus       325 ar~llfHpl  333 (458)
T KOG1266|consen  325 ARLLLFHPL  333 (458)
T ss_pred             hhhhhcCce
Confidence            999987743

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.26  E-value=3.9e-11  Score=135.89  Aligned_cols=169  Identities=18%  Similarity=0.203  Sum_probs=130.2

Q ss_pred             EeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCCChhhhhhcCCCccCHHHH
Q 039290          781 VLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQR  860 (1049)
Q Consensus       781 ~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~  860 (1049)
                      +..++.+|.|+.++.......+...+.++.++.++||||+++++.++.+++.|+|+|-+.  .|..++..    +....+
T Consensus        33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----l~~~~v  106 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----LGKEEV  106 (690)
T ss_pred             eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----hHHHHH
Confidence            355888999998876655445667888999999999999999999999999999999996  46666654    336677


Q ss_pred             HHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccccccccCcccccccCCCCcC
Q 039290          861 LKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVS  940 (1049)
Q Consensus       861 ~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  940 (1049)
                      ...++||+.||.|||+  +.+++|+++.-..|+|++.|..||++|-++........ .......--.|..|+.+....  
T Consensus       107 ~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--  181 (690)
T KOG1243|consen  107 CLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--  181 (690)
T ss_pred             HHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--
Confidence            7789999999999984  67899999999999999999999999988765432221 011111222456666543322  


Q ss_pred             cccchHHHHHHHHHHHhCCC
Q 039290          941 RKCDVYSYGIMLMETFTKKK  960 (1049)
Q Consensus       941 ~~~DvwslG~il~elltg~~  960 (1049)
                      -..|.|.|||+++|++.|..
T Consensus       182 ~s~D~~~Lg~li~el~ng~~  201 (690)
T KOG1243|consen  182 WSIDSWGLGCLIEELFNGSL  201 (690)
T ss_pred             cchhhhhHHHHHHHHhCccc
Confidence            34699999999999999943

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.23  E-value=1.5e-11  Score=142.52  Aligned_cols=148  Identities=20%  Similarity=0.188  Sum_probs=96.2

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCC-CcEEEEEEeecccCC--------------------------C--------H---
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDG--------------------------S--------L---  801 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~-~~~vavK~~~~~~~~--------------------------~--------~---  801 (1049)
                      ...|+. +.+|+|++|.||+|+.++ |+.||||+.+.....                          .        .   
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345666 799999999999999877 999999999754210                          0        0   


Q ss_pred             ---HHHHHHHHHHhhcC----CCceeeEEeeeec-CCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHH-HHH
Q 039290          802 ---ESFHAECKVMGSIR----HRNLVKIISSCSN-NDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVAS-ALE  872 (1049)
Q Consensus       802 ---~~~~~e~~~l~~l~----hpniv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~-~l~  872 (1049)
                         -++.+|+..+.+++    +...+.+-.++.+ ....++||||++|+.+.+.-.-.....+..   .++...++ -+.
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~---~la~~~v~~~~~  274 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMK---LLAERGVEVFFT  274 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHH---HHHHHHHHHHHH
Confidence               12344555554442    3333433333322 445689999999999987422111111211   12222222 223


Q ss_pred             HhHccCCCCeEEcCCCCCCeeecCCC----ceEEecccCceecCCC
Q 039290          873 YLHFGYSTPIVHCDIKPSNVLLNESM----VGHLSDFGIAKILGKE  914 (1049)
Q Consensus       873 ~LH~~~~~~ivH~Dlkp~NIl~~~~~----~~kl~DfGla~~~~~~  914 (1049)
                      .++   ..|++|+|++|.||+++.++    .++++|||++....+.
T Consensus       275 Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        275 QVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             HHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence            344   78999999999999999887    9999999999877543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.22  E-value=3.9e-11  Score=120.89  Aligned_cols=128  Identities=19%  Similarity=0.168  Sum_probs=96.4

Q ss_pred             CceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCcee-eEEeeeecCCeeEEEEeccCCCCh
Q 039290          766 NKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLV-KIISSCSNNDFKALVLEYMSNGSL  844 (1049)
Q Consensus       766 ~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv-~l~~~~~~~~~~~lv~e~~~~g~L  844 (1049)
                      .+.++.|.++.||+++.. +..|++|....... ....+.+|+++++.+.+.+++ +++++..  +..++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            357899999999999874 77899999865432 234567899999988654443 4554433  334799999999887


Q ss_pred             hhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCC-----eEEcCCCCCCeeecCCCceEEecccCcee
Q 039290          845 EKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP-----IVHCDIKPSNVLLNESMVGHLSDFGIAKI  910 (1049)
Q Consensus       845 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~Dlkp~NIl~~~~~~~kl~DfGla~~  910 (1049)
                      .+.         ......++.+++++++.||   +.+     ++|||++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~---------~~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTE---------DFSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc---------cccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            653         0112346678999999999   666     59999999999999 66899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.20  E-value=2.4e-10  Score=114.91  Aligned_cols=136  Identities=15%  Similarity=0.147  Sum_probs=99.8

Q ss_pred             ceecCCCcEEEEEEEeCC-------CcEEEEEEeecccC----------------------CCHHHH----HHHHHHHhh
Q 039290          767 KLLGMGSFGSVYKGVLPD-------GMEIAAKVFHMEFD----------------------GSLESF----HAECKVMGS  813 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~~-------~~~vavK~~~~~~~----------------------~~~~~~----~~e~~~l~~  813 (1049)
                      ..||.|.-+.||.|...+       +..+|||+.+....                      ...+.+    .+|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            579999999999998543       47999999864320                      001223    379999999


Q ss_pred             cCC--CceeeEEeeeecCCeeEEEEeccCCCChhh-hhhcCCCccCHHHHHHHHHHHHHHHHHh-HccCCCCeEEcCCCC
Q 039290          814 IRH--RNLVKIISSCSNNDFKALVLEYMSNGSLEK-CLYSDNYFLDILQRLKIMIDVASALEYL-HFGYSTPIVHCDIKP  889 (1049)
Q Consensus       814 l~h--pniv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dlkp  889 (1049)
                      +..  -++.+++++    ..-++||||+.++.+.. .+.+  ..++..+...+..+++.++..+ |   +.|+||||+++
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~  153 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSE  153 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence            853  456666654    34589999997754422 2222  1245566778889999999999 8   89999999999


Q ss_pred             CCeeecCCCceEEecccCceecC
Q 039290          890 SNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       890 ~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      .||+++ ++.++++|||.+....
T Consensus       154 ~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         154 YNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHEEEE-CCcEEEEECCCceeCC
Confidence            999997 4679999999887653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.16  E-value=7.1e-12  Score=126.81  Aligned_cols=207  Identities=22%  Similarity=0.228  Sum_probs=134.5

Q ss_pred             CCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCc-ccCCcCchhccCccc
Q 039290          441 ELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDN-KLSGRLPACLGNLTS  519 (1049)
Q Consensus       441 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~  519 (1049)
                      .+.-+.+|..+.++.+.-.. +-+....-+.|+++...+..++. .| .+-.+..+....-+.- -.+|..-..+..+..
T Consensus       209 ~l~~f~~l~~~~~s~~~~~~-i~~~~~~kptl~t~~v~~s~~~~-~~-~l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq~  285 (490)
T KOG1259|consen  209 NLNAFRNLKTLKFSALSTEN-IVDIELLKPTLQTICVHNTTIQD-VP-SLLPETILADPSGSEPSTSNGSALVSADTWQE  285 (490)
T ss_pred             chHHhhhhheeeeeccchhh-eeceeecCchhheeeeecccccc-cc-cccchhhhcCccCCCCCccCCceEEecchHhh
Confidence            34445566666666654332 22222233567777776665542 11 2222222222222111 122333334445567


Q ss_pred             CCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeec
Q 039290          520 LRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRY  599 (1049)
Q Consensus       520 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  599 (1049)
                      |+++|||+|.++. +.+...-+|.++.|++|+|.|...  ..+..+.+|++||||+|.++ .+..+-..+.+.+.|.|++
T Consensus       286 LtelDLS~N~I~~-iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~  361 (490)
T KOG1259|consen  286 LTELDLSGNLITQ-IDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQ  361 (490)
T ss_pred             hhhccccccchhh-hhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhh
Confidence            8888888888886 556777788888888888888743  34778888999999999888 3445556778889999999


Q ss_pred             ccccCCccccccCccCCcEEeccCccccCCc-ccccccccccceeeccCCcccccCCC
Q 039290          600 NRLQGPIPESFGGLKSLNFVDMSNNNLSGTI-PKSMEALSYLKHLNLSFNQLEGEIPT  656 (1049)
Q Consensus       600 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~l~l~~N~l~~~~p~  656 (1049)
                      |.|..  -..+..+-+|..||+++|+|.... ...+++++-|+.+.|.+||+.+.+-.
T Consensus       362 N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vdY  417 (490)
T KOG1259|consen  362 NKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVDY  417 (490)
T ss_pred             hhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccchH
Confidence            98873  245677788999999999997322 24588899999999999999875543

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.15  E-value=5.5e-12  Score=134.67  Aligned_cols=214  Identities=24%  Similarity=0.292  Sum_probs=130.7

Q ss_pred             ccCCccEEEeCCCCccCCCc--ccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcc
Q 039290          143 SLPRLQHLLLKHNSFVGKIP--ETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLW  220 (1049)
Q Consensus       143 ~l~~L~~L~L~~n~l~~~~p--~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~  220 (1049)
                      ++.+|++..|.+.... .++  +....+++++.||||+|-|..-.|    -++-++.||+|+.|+|+.|++.-.+...  
T Consensus       119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~----v~~i~eqLp~Le~LNls~Nrl~~~~~s~--  191 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFP----VLKIAEQLPSLENLNLSSNRLSNFISSN--  191 (505)
T ss_pred             hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHH----HHHHHHhcccchhcccccccccCCcccc--
Confidence            5667777777776654 333  355667778888888877662111    1112345666777777777766322111  


Q ss_pred             cccccceecccccccccccCCCCccccccceEEeccccccc-cCccccccccceEEEeeccccCCCccccccccccccce
Q 039290          221 KCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIG-EIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKE  299 (1049)
Q Consensus       221 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~  299 (1049)
                                    .+       ..+++|+.|.|+.|.++- .+-..+..+++|+.|+|.+|+...........+..|++
T Consensus       192 --------------~~-------~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~  250 (505)
T KOG3207|consen  192 --------------TT-------LLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQE  250 (505)
T ss_pred             --------------ch-------hhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhh
Confidence                          11       145677777777777762 22333556778888888888644333344455677888


Q ss_pred             EEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCC-CCcc-----ccCCCCCceeecccCccccCc-ccccccccccce
Q 039290          300 LAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGT-IPSS-----LTNISELSVLDFGFNSFSGLI-PTTFGNLRSLKL  372 (1049)
Q Consensus       300 L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~-~p~~-----~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~  372 (1049)
                      |+|++|++...-.......+|.|+.|+++.+.+... .|+.     ...+++|++|+++.|+|...- -..+..+.+|+.
T Consensus       251 LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~  330 (505)
T KOG3207|consen  251 LDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKH  330 (505)
T ss_pred             ccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhh
Confidence            888888876332222334678888888888887743 2332     245678888888888885320 123455667777


Q ss_pred             eecccccccCCC
Q 039290          373 LSLAGNVLTSPT  384 (1049)
Q Consensus       373 L~L~~N~l~~~~  384 (1049)
                      |.+..|.++...
T Consensus       331 l~~~~n~ln~e~  342 (505)
T KOG3207|consen  331 LRITLNYLNKET  342 (505)
T ss_pred             hhcccccccccc
Confidence            777777776544

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.14  E-value=3.9e-10  Score=108.54  Aligned_cols=131  Identities=22%  Similarity=0.301  Sum_probs=101.0

Q ss_pred             ceecCCCcEEEEEEEeCCCcEEEEEEeeccc-C-C------CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEF-D-G------SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~-~-~------~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      ..+++|+-+.+|.+.+. |.++++|.-..+. . .      ...+-.+|++++.+++--.|...+=+..+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35889999999999774 4446666432221 1 1      134567799999998766665555566677777899999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCcee
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI  910 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~  910 (1049)
                      ++|..|.+.+...        ...++..+-+-+.-||   ..||||+|+.++||++..++ +.++|||++.+
T Consensus        81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888765        2457778888889999   99999999999999998775 99999999874

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.14  E-value=1.4e-09  Score=115.92  Aligned_cols=270  Identities=13%  Similarity=0.094  Sum_probs=173.1

Q ss_pred             CCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhc-CCCceeeEEeee-------ecCCeeEEE
Q 039290          764 SENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLVKIISSC-------SNNDFKALV  835 (1049)
Q Consensus       764 ~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~-------~~~~~~~lv  835 (1049)
                      ...+.||+|+-+.+|-.-  .-...+.|+++........+   .+..|... .||-+-.-+.+-       ..+....+.
T Consensus        14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            345789999999999653  22334568887654332222   23333333 466443312211       122336788


Q ss_pred             EeccCCC-Chhhhhhc-----CCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCce
Q 039290          836 LEYMSNG-SLEKCLYS-----DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK  909 (1049)
Q Consensus       836 ~e~~~~g-~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~  909 (1049)
                      |..+.+- ....+...     .-...+|....++++.++.+.+.+|   ..|.+-||+.++|+||++++.|.+.|-..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEccccee
Confidence            8888764 22222221     1125788999999999999999999   9999999999999999999999999876554


Q ss_pred             ecCCCccccccccccccCcccccccC-----CCCcCcccchHHHHHHHHHHHhC-CCCCCccccccc---hHHHhhhhcc
Q 039290          910 ILGKEESMRQTKTLGTIGYMAPEYGR-----EGKVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEM---SLKRWVGDSL  980 (1049)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~---~~~~~~~~~~  980 (1049)
                      ...  ........+|...|.+||...     +..-+...|.|.+|+++++++.| +.||.++.....   ....-+    
T Consensus       166 i~~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I----  239 (637)
T COG4248         166 INA--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI----  239 (637)
T ss_pred             ecc--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh----
Confidence            432  222334567899999999654     34556789999999999999986 999987543211   111000    


Q ss_pred             ccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccC--CCCCCCHHHHHHHHHHHHHhhhhcc
Q 039290          981 LSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDL--PEKRISMKDVANRLVRIRETLSAYI 1047 (1049)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d--P~~Rpt~~ell~~L~~i~~~~~~~~ 1047 (1049)
                      .......-.++.....+..+.....-.+..+..+..+|+...  |.-|||++..+..|.++.+++..+.
T Consensus       240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~  308 (637)
T COG4248         240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCT  308 (637)
T ss_pred             hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhh
Confidence            001111111111111111122222345667788888998765  5789999999999999999987653

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.14  E-value=3.3e-11  Score=135.70  Aligned_cols=251  Identities=21%  Similarity=0.177  Sum_probs=180.1

Q ss_pred             HHhcCCCCCceecCCCcEEEEEEEe--CCCcEEEEEEeecccCCCHHHH--HHHHHHHhhc-CCCceeeEEeeeecCCee
Q 039290          758 RATDGFSENKLLGMGSFGSVYKGVL--PDGMEIAAKVFHMEFDGSLESF--HAECKVMGSI-RHRNLVKIISSCSNNDFK  832 (1049)
Q Consensus       758 ~~~~~~~~~~~lg~G~fg~Vy~a~~--~~~~~vavK~~~~~~~~~~~~~--~~e~~~l~~l-~hpniv~l~~~~~~~~~~  832 (1049)
                      ....+|..+..||.|.|+.||....  .++..|++|...........++  ..|+-+...+ .|.++++....|...+..
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            4466899999999999999999874  3677899998866544333332  3455555555 589999988888888888


Q ss_pred             EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCC-CceEEecccCceec
Q 039290          833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES-MVGHLSDFGIAKIL  911 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-~~~kl~DfGla~~~  911 (1049)
                      |+--|||++++....... ...+++..++++..|++.++.++|   +..++|+|+||+||++..+ +..+++|||....+
T Consensus       342 ~ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             cCchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccccc
Confidence            899999999987765522 224677788999999999999999   9999999999999999875 78899999998753


Q ss_pred             CCCccccccccccccCcc--cccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhc
Q 039290          912 GKEESMRQTKTLGTIGYM--APEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA  989 (1049)
Q Consensus       912 ~~~~~~~~~~~~~~~~y~--aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  989 (1049)
                      ....    .......+++  +|+......+..+.|+|++|.-+.|..++..--..   +    .+|.             
T Consensus       418 ~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~---~----~~~~-------------  473 (524)
T KOG0601|consen  418 AFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES---G----VQSL-------------  473 (524)
T ss_pred             ceec----ccccccccccccchhhccccccccccccccccccccccccCcccCcc---c----ccce-------------
Confidence            2211    1112233344  56666677888999999999999999987642111   0    1110             


Q ss_pred             ccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 039290          990 DANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041 (1049)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~ 1041 (1049)
                           ....+...........+..+.+.+...++..||.+.++..+.+..+.
T Consensus       474 -----~i~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  474 -----TIRSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             -----eeecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence                 00011111112223567788889999999999999998887665443

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.12  E-value=1.2e-11  Score=142.96  Aligned_cols=200  Identities=28%  Similarity=0.314  Sum_probs=102.7

Q ss_pred             CCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCc-hhccCcccC
Q 039290          442 LGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLP-ACLGNLTSL  520 (1049)
Q Consensus       442 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L  520 (1049)
                      +..+++|++|+|++|.|+.+  ..+..++.|+.|++++|.|+..  ..+..+..|+.+++++|++...-+ . ...+.++
T Consensus       114 l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l  188 (414)
T KOG0531|consen  114 LSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISL  188 (414)
T ss_pred             hhhhhcchheeccccccccc--cchhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccch
Confidence            44456666666666666643  2344455566666666666522  334446666666666666663322 1 4556666


Q ss_pred             CceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCc--ceeEeecccccccccccccccCCCcccEEEee
Q 039290          521 RDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLK--VVIEMDLSLNALSGVIPVTIGGLQGLQLLSLR  598 (1049)
Q Consensus       521 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  598 (1049)
                      +.+++++|.+..+  ..+..+..+..+++..|.++..-+  +..+.  .|+++++++|++.. .+..+..+..+..|+++
T Consensus       189 ~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~  263 (414)
T KOG0531|consen  189 EELDLGGNSIREI--EGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLS  263 (414)
T ss_pred             HHHhccCCchhcc--cchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCcccc-ccccccccccccccchh
Confidence            6666666666532  333344444455666666553211  11222  25566666666652 22445555566666666


Q ss_pred             cccccCCccccccCccCCcEEeccCccccCC---cccc-cccccccceeeccCCccccc
Q 039290          599 YNRLQGPIPESFGGLKSLNFVDMSNNNLSGT---IPKS-MEALSYLKHLNLSFNQLEGE  653 (1049)
Q Consensus       599 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~p~~-~~~l~~L~~l~l~~N~l~~~  653 (1049)
                      +|++...  ..+.....+..+.++.|.+...   .... ....+.+..+++.+|+....
T Consensus       264 ~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
T KOG0531|consen  264 SNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKI  320 (414)
T ss_pred             hcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccc
Confidence            6665532  1233344455555555555411   1111 33344555555555555443

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.08  E-value=1.9e-11  Score=123.72  Aligned_cols=134  Identities=28%  Similarity=0.364  Sum_probs=78.6

Q ss_pred             CCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCC
Q 039290          442 LGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLR  521 (1049)
Q Consensus       442 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  521 (1049)
                      +..++.|+++|||+|.|+ .+.++..-+++++.|++|+|.|.. + ..+..+++|+.||||+|.++ .+..+-..+.+.+
T Consensus       280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIK  355 (490)
T KOG1259|consen  280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIK  355 (490)
T ss_pred             cchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhH-hhhhhHhhhcCEe
Confidence            334455666666666666 455555556666666666666652 2 22555555555555555554 3333334444445


Q ss_pred             ceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccc-cccccCCCcccEEEeecc
Q 039290          522 DLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVI-PVTIGGLQGLQLLSLRYN  600 (1049)
Q Consensus       522 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N  600 (1049)
                      .|.|++|.+..                          .+.++.+-+|..||+++|+|.... -..+++++-|+.|.|.+|
T Consensus       356 tL~La~N~iE~--------------------------LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~N  409 (490)
T KOG1259|consen  356 TLKLAQNKIET--------------------------LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGN  409 (490)
T ss_pred             eeehhhhhHhh--------------------------hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCC
Confidence            55555554443                          233455556666666666665332 256889999999999999


Q ss_pred             cccCC
Q 039290          601 RLQGP  605 (1049)
Q Consensus       601 ~l~~~  605 (1049)
                      .|.+.
T Consensus       410 Pl~~~  414 (490)
T KOG1259|consen  410 PLAGS  414 (490)
T ss_pred             Ccccc
Confidence            99954

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.07  E-value=3.7e-12  Score=132.59  Aligned_cols=114  Identities=19%  Similarity=0.233  Sum_probs=52.7

Q ss_pred             ccccceEEEeeccccCCCc----cccccccccccceEEeccCccCCCCCCc---ccCCCCCccEEEcCCCCCCCCCCcc-
Q 039290          268 GNLRNLEVLGVQSSNLAGL----IPASIFNISTLKELAVTDNDLLGSLPSS---IDLGLPNLERLFLGENNFSGTIPSS-  339 (1049)
Q Consensus       268 ~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~---~~~~l~~L~~L~L~~N~l~~~~p~~-  339 (1049)
                      ...+.|+.+.+++|.+...    +...+..+++|+.|+|.+|.++..-...   ....+++|+.|++++|.++..-... 
T Consensus       182 ~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~  261 (382)
T KOG1909|consen  182 QSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAF  261 (382)
T ss_pred             HhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHH
Confidence            3344444444444443311    2223344455555555555443211100   0113445555555555554221111 


Q ss_pred             ---c-cCCCCCceeecccCcccc----Ccccccccccccceeeccccccc
Q 039290          340 ---L-TNISELSVLDFGFNSFSG----LIPTTFGNLRSLKLLSLAGNVLT  381 (1049)
Q Consensus       340 ---~-~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~  381 (1049)
                         + ...++|++|.+.+|.|+.    .+.......+.|+.|+|++|.+.
T Consensus       262 ~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  262 VDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             HHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence               1 124566777777776652    12223445677777777777773

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.06  E-value=2.4e-11  Score=140.37  Aligned_cols=249  Identities=28%  Similarity=0.322  Sum_probs=145.7

Q ss_pred             ccccCCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCC
Q 039290          118 SHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQN  197 (1049)
Q Consensus       118 ~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~  197 (1049)
                      ..+..++.++++.|.+.- +-..+..+++|+.|++..|++. .+...+..+++|++||||+|+|+. +       ..+..
T Consensus        69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~-i-------~~l~~  138 (414)
T KOG0531|consen   69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITK-L-------EGLST  138 (414)
T ss_pred             HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccc-c-------cchhh
Confidence            345566666677777662 3344667788888888888887 444447778888888888888873 2       22344


Q ss_pred             CCccceEEeeccccCCCCCCCcccccccceecccccccccccC-CCCccccccceEEeccccccccCccccccccceEEE
Q 039290          198 LPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIP-RDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVL  276 (1049)
Q Consensus       198 l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  276 (1049)
                      ++.|+.|++++|.++.  ...+..+..|+.+++++|++...-+ . ...+.+++.+++.+|.+.  ....+..+..+..+
T Consensus       139 l~~L~~L~l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~  213 (414)
T KOG0531|consen  139 LTLLKELNLSGNLISD--ISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR--EIEGLDLLKKLVLL  213 (414)
T ss_pred             ccchhhheeccCcchh--ccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh--cccchHHHHHHHHh
Confidence            5567888888888773  2334446666666666666663322 1 355566666666666654  22233333334444


Q ss_pred             eeccccCCCccccccccccccceEEeccCccCCCCCCcccCCCC--CccEEEcCCCCCCCCCCccccCCCCCceeecccC
Q 039290          277 GVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLP--NLERLFLGENNFSGTIPSSLTNISELSVLDFGFN  354 (1049)
Q Consensus       277 ~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~--~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N  354 (1049)
                      ++..|.++..-+-  .                         .+.  .|+.+++++|++. ..+..+..+.++..|++++|
T Consensus       214 ~l~~n~i~~~~~l--~-------------------------~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n  265 (414)
T KOG0531|consen  214 SLLDNKISKLEGL--N-------------------------ELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSN  265 (414)
T ss_pred             hcccccceeccCc--c-------------------------cchhHHHHHHhcccCccc-cccccccccccccccchhhc
Confidence            4444444322110  0                         111  2566677777766 33355666777788888888


Q ss_pred             ccccCcccccccccccceeecccccccCCCCCcccccccccCCCCcEEEccCCccccC
Q 039290          355 SFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGI  412 (1049)
Q Consensus       355 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~  412 (1049)
                      ++...  ..+.....+..+.+..|.+....... .-......+.++.+++..|.+...
T Consensus       266 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
T KOG0531|consen  266 RISNL--EGLERLPKLSELWLNDNKLALSEAIS-QEYITSAAPTLVTLTLELNPIRKI  320 (414)
T ss_pred             ccccc--ccccccchHHHhccCcchhcchhhhh-ccccccccccccccccccCccccc
Confidence            77754  33555666777777777766432211 001134455666666666666543

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.06  E-value=8.7e-11  Score=115.75  Aligned_cols=122  Identities=25%  Similarity=0.330  Sum_probs=32.8

Q ss_pred             cccCCceeecCcccccccCcccc-cccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccc-cCCCcccE
Q 039290          517 LTSLRDLSLGSNALTSIIPSTLW-NLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTI-GGLQGLQL  594 (1049)
Q Consensus       517 l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~  594 (1049)
                      ..++++|+|++|+|+.+  +.+. .+.+|+.|+|++|.|+..  +.+..++.|++|++++|+|+... ..+ ..+++|+.
T Consensus        18 ~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~-~~l~~~lp~L~~   92 (175)
T PF14580_consen   18 PVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSIS-EGLDKNLPNLQE   92 (175)
T ss_dssp             --------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-C-HHHHHH-TT--E
T ss_pred             ccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccc-cchHHhCCcCCE
Confidence            33455555555555542  1232 244455555555555432  23444555566666666665332 222 34566666


Q ss_pred             EEeecccccCCc-cccccCccCCcEEeccCccccCCcc----cccccccccceee
Q 039290          595 LSLRYNRLQGPI-PESFGGLKSLNFVDMSNNNLSGTIP----KSMEALSYLKHLN  644 (1049)
Q Consensus       595 L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~l~  644 (1049)
                      |+|++|+|...- -..++.+++|++|+|.+|+++.. +    ..+..+|+|+.||
T Consensus        93 L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD  146 (175)
T PF14580_consen   93 LYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLD  146 (175)
T ss_dssp             EE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEET
T ss_pred             EECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeC
Confidence            666666665421 13445566666666666666522 2    1244455555554

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.05  E-value=1.8e-09  Score=103.12  Aligned_cols=142  Identities=16%  Similarity=0.201  Sum_probs=104.0

Q ss_pred             CCceecCCCcEEEEEEEeCCCcEEEEEEeeccc-CC-------CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          765 ENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEF-DG-------SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       765 ~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~-~~-------~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ....+-||+-+.|+++.+ .|+.+.||.-.... ..       ...+..+|++.+.+.+--.|.-..-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            557899999999999988 67777776532221 11       2456778999998886545554444555555567999


Q ss_pred             eccCC-CChhhhhhcCCC-ccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC---ceEEecccCcee
Q 039290          837 EYMSN-GSLEKCLYSDNY-FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM---VGHLSDFGIAKI  910 (1049)
Q Consensus       837 e~~~~-g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~---~~kl~DfGla~~  910 (1049)
                      ||++| .++.+++...-. ..+......++..|-+.+.-||   ..+|+|||+..+||++..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 477887765332 2233333788999999999999   99999999999999996543   458999999864

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.05  E-value=1.7e-09  Score=114.27  Aligned_cols=142  Identities=20%  Similarity=0.192  Sum_probs=111.6

Q ss_pred             ceecCCCcEEEEEEEeCCCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCC--CceeeEEeeeecC---CeeEEEEeccC
Q 039290          767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRH--RNLVKIISSCSNN---DFKALVLEYMS  840 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--pniv~l~~~~~~~---~~~~lv~e~~~  840 (1049)
                      +.++.|.++.||+++..+|+.+++|....... ....++..|+++++.+++  ..+.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            67899999999999987778999999765432 135678899999999975  4467777776654   35689999999


Q ss_pred             CCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHcc-------------------------------------------
Q 039290          841 NGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG-------------------------------------------  877 (1049)
Q Consensus       841 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-------------------------------------------  877 (1049)
                      |.++.+.+..  ..++..+...++.++++++++||..                                           
T Consensus        84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            9888775532  2367778888899999999999831                                           


Q ss_pred             ----------CCCCeEEcCCCCCCeeecC--CCceEEecccCcee
Q 039290          878 ----------YSTPIVHCDIKPSNVLLNE--SMVGHLSDFGIAKI  910 (1049)
Q Consensus       878 ----------~~~~ivH~Dlkp~NIl~~~--~~~~kl~DfGla~~  910 (1049)
                                ....++|+|+.|.||+++.  ++.+.++||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                      1256799999999999998  66789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.04  E-value=4.9e-12  Score=131.68  Aligned_cols=90  Identities=19%  Similarity=0.232  Sum_probs=50.4

Q ss_pred             cCCCcceeEeecccccccc----cccccccCCCcccEEEeecccccCCcccc----c-cCccCCcEEeccCccccCC---
Q 039290          562 IGNLKVVIEMDLSLNALSG----VIPVTIGGLQGLQLLSLRYNRLQGPIPES----F-GGLKSLNFVDMSNNNLSGT---  629 (1049)
Q Consensus       562 ~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~----~-~~l~~L~~L~Ls~N~l~~~---  629 (1049)
                      +..+++|+.|||.+|-++.    .+...++.++.|+.|++++|.++..-..+    + ...++|++|+|.+|.++..   
T Consensus       209 l~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~  288 (382)
T KOG1909|consen  209 LEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAAL  288 (382)
T ss_pred             HHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHH
Confidence            3444444445555554442    12334555666666666666666432222    2 2256777777777777631   


Q ss_pred             -cccccccccccceeeccCCccc
Q 039290          630 -IPKSMEALSYLKHLNLSFNQLE  651 (1049)
Q Consensus       630 -~p~~~~~l~~L~~l~l~~N~l~  651 (1049)
                       +...+...+.|..|+|++|.+.
T Consensus       289 ~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  289 ALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             HHHHHHhcchhhHHhcCCccccc
Confidence             2233455677888888888773

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.02  E-value=6.5e-11  Score=126.59  Aligned_cols=137  Identities=26%  Similarity=0.264  Sum_probs=60.6

Q ss_pred             cccccceecccccccccccC--CCCccccccceEEeccccccccCc--cccccccceEEEeeccccCCCccccccccccc
Q 039290          221 KCRELHVVSLAFNKFQGGIP--RDIGNLTSVRNLFLGNNSLIGEIP--NEIGNLRNLEVLGVQSSNLAGLIPASIFNIST  296 (1049)
Q Consensus       221 ~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p--~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~  296 (1049)
                      ++.+|+.+.|.+.... .++  .....+++++.|||++|-+....|  .....|++|+.|+|+.|++.            
T Consensus       119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~------------  185 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLS------------  185 (505)
T ss_pred             hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhccccccccc------------
Confidence            3455555555555443 222  133445555555555555542211  12333444444444444443            


Q ss_pred             cceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCC-CCccccCCCCCceeecccCccccCcccccccccccceeec
Q 039290          297 LKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGT-IPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSL  375 (1049)
Q Consensus       297 L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  375 (1049)
                                  -.........++.|+.|.|+.|.++-. +......+++|+.|+|.+|..-..-......+..|+.|+|
T Consensus       186 ------------~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdL  253 (505)
T KOG3207|consen  186 ------------NFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDL  253 (505)
T ss_pred             ------------CCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccc
Confidence                        222222222344555555555555411 1122233455556666655422222233334445555555


Q ss_pred             ccccccC
Q 039290          376 AGNVLTS  382 (1049)
Q Consensus       376 ~~N~l~~  382 (1049)
                      ++|++-.
T Consensus       254 s~N~li~  260 (505)
T KOG3207|consen  254 SNNNLID  260 (505)
T ss_pred             cCCcccc
Confidence            5555443

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.97  E-value=4.3e-10  Score=110.86  Aligned_cols=111  Identities=25%  Similarity=0.293  Sum_probs=43.6

Q ss_pred             cccccccccccccCCccCCCCccCcC-CCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCC
Q 039290          538 LWNLKDILRFNLSSNSLNGSLLPDIG-NLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSL  616 (1049)
Q Consensus       538 ~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  616 (1049)
                      +.+...++.|+|++|.|+..  +.++ .+.+|+.||||+|.|+..  +.+..++.|+.|++++|+|+...+.....+++|
T Consensus        15 ~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L   90 (175)
T PF14580_consen   15 YNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNL   90 (175)
T ss_dssp             -----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT-
T ss_pred             cccccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcC
Confidence            44556789999999999863  4566 588999999999999965  368889999999999999995433333568999


Q ss_pred             cEEeccCccccCCcc-cccccccccceeeccCCcccc
Q 039290          617 NFVDMSNNNLSGTIP-KSMEALSYLKHLNLSFNQLEG  652 (1049)
Q Consensus       617 ~~L~Ls~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~~  652 (1049)
                      ++|+|++|+|...-. ..+..+++|+.|++.+||++.
T Consensus        91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~  127 (175)
T PF14580_consen   91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE  127 (175)
T ss_dssp             -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred             CEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence            999999999975322 457789999999999999864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.96  E-value=1.9e-10  Score=135.75  Aligned_cols=249  Identities=24%  Similarity=0.296  Sum_probs=175.0

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecc---cCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHME---FDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      ..+.+.+.+-+-.|+++.++.++-. .|...+.|+....   .....+....+-.+.-..++|.+++...-+.-....++
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            3456777788999999999988743 4444444433221   11123334444444444567888877776666778899


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCC-
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK-  913 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~-  913 (1049)
                      |++|..++++...++..+. .+.+-.......+..+.++||   +..+.|+|++|.|.+...++..++.|||.....+- 
T Consensus       882 ~~~~~~~~~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSGC-LSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             hhHHhccCCchhhhhcCCC-cccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccc
Confidence            9999999999998877653 455555667778889999999   88899999999999999999999999984332210 


Q ss_pred             --------------------Cc---------cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCc
Q 039290          914 --------------------EE---------SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDE  964 (1049)
Q Consensus       914 --------------------~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~  964 (1049)
                                          ..         .......++|+.|.+||...+.....++|.|+.|++++|.++|..||..
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence                                00         0112345789999999999999999999999999999999999999976


Q ss_pred             cccccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 039290          965 IFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMK 1030 (1049)
Q Consensus       965 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ 1030 (1049)
                      ....... .                  .+..........+...+.+..+++.+.+..+|.+|-.+.
T Consensus      1038 ~tpq~~f-~------------------ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQQIF-E------------------NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             cchhhhh-h------------------ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            4332211 0                  001111111122234456678889999999999998776

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.94  E-value=5.2e-10  Score=82.68  Aligned_cols=40  Identities=48%  Similarity=0.984  Sum_probs=30.4

Q ss_pred             hhhHHHHHHHHHhcccCCCCcccccCCCC--CCCceeeeEEEc
Q 039290           29 TTDQFALLALKEHIKHDPSNLLANNWSTT--SSVCSWIGVTCG   69 (1049)
Q Consensus        29 ~~d~~all~~k~~~~~~~~~~l~~~w~~~--~~~c~w~gv~c~   69 (1049)
                      ++|++||++||+++..||.+.+ .+|+.+  ++||+|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l-~~W~~~~~~~~C~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVL-SSWNPSSDSDPCSWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCC-TT--TT--S-CCCSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCccc-ccCCCcCCCCCeeeccEEeC
Confidence            5799999999999987787776 499987  799999999996

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.94  E-value=4e-10  Score=138.47  Aligned_cols=268  Identities=23%  Similarity=0.272  Sum_probs=126.9

Q ss_pred             hhhhhhcccCcc-ccccCcc-cccccCCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEc
Q 039290           98 FLAVLAIRNNSF-FGSLPEE-LSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELD  175 (1049)
Q Consensus        98 ~L~~L~l~~n~~-~g~~p~~-~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  175 (1049)
                      .|++|-+..|.- ...++.. +..++.|++|||++|.--+.+|.++++|-+|++|+|++..++ .+|..+++|.+|.+||
T Consensus       546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln  624 (889)
T KOG4658|consen  546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN  624 (889)
T ss_pred             ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence            344555555531 1233332 444555666666655555556666666666666666665555 5566666666666666


Q ss_pred             CCCccCccccCCCcccccccCCCCccceEEeeccccC--CCCCCCcccccccceecccccccccccCCCCcccccc----
Q 039290          176 LSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLT--GPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSV----  249 (1049)
Q Consensus       176 Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~--~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L----  249 (1049)
                      +..+.-...+|.-..      .+++|++|.+..-...  +..-.++..+..|+.+.......  .+-..+..++.|    
T Consensus       625 l~~~~~l~~~~~i~~------~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~  696 (889)
T KOG4658|consen  625 LEVTGRLESIPGILL------ELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLL  696 (889)
T ss_pred             cccccccccccchhh------hcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHh
Confidence            655544323322211      1333555555443311  11112233334444443322221  011111122222    


Q ss_pred             ceEEeccccccccCccccccccceEEEeeccccCCCcccccccc------ccccceEEeccCccCCCCCCcccCCCCCcc
Q 039290          250 RNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFN------ISTLKELAVTDNDLLGSLPSSIDLGLPNLE  323 (1049)
Q Consensus       250 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~------l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~  323 (1049)
                      +.+.+.++... ..+..++.+.+|+.|.+..+............      ++++..+...++... ..+.+. .-.|+|+
T Consensus       697 ~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~-~f~~~L~  773 (889)
T KOG4658|consen  697 QSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWL-LFAPHLT  773 (889)
T ss_pred             Hhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccc-cccchh-hccCccc
Confidence            22232222322 34445666666666666666665332211111      112222222222211 111111 1257889


Q ss_pred             EEEcCCCCCCCCCCccccCCCCCceeecccCccccC-cccccccccccceeeccc
Q 039290          324 RLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGL-IPTTFGNLRSLKLLSLAG  377 (1049)
Q Consensus       324 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~  377 (1049)
                      .|.+..+.....+.+....+..+..+-+..+.+.+. .-...+.++++..+.+.+
T Consensus       774 ~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l~~  828 (889)
T KOG4658|consen  774 SLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPLSF  828 (889)
T ss_pred             EEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEecccCc
Confidence            999988887766666677777777777777777765 234455555555554443

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.87  E-value=1.5e-08  Score=101.76  Aligned_cols=126  Identities=23%  Similarity=0.312  Sum_probs=83.7

Q ss_pred             EEEEEEeCCCcEEEEEEeecccCC--------------------------CHHHHHHHHHHHhhcCCC--ceeeEEeeee
Q 039290          776 SVYKGVLPDGMEIAAKVFHMEFDG--------------------------SLESFHAECKVMGSIRHR--NLVKIISSCS  827 (1049)
Q Consensus       776 ~Vy~a~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~hp--niv~l~~~~~  827 (1049)
                      .||.|...+|..+|+|..+.....                          ......+|++.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            389999999999999998543110                          023567899999999754  466666542 


Q ss_pred             cCCeeEEEEeccC--CCChhhhhhcCCCccCHHHHHHHHHHHHHHHHH-hHccCCCCeEEcCCCCCCeeecCCCceEEec
Q 039290          828 NNDFKALVLEYMS--NGSLEKCLYSDNYFLDILQRLKIMIDVASALEY-LHFGYSTPIVHCDIKPSNVLLNESMVGHLSD  904 (1049)
Q Consensus       828 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D  904 (1049)
                         .-.+||||++  |..+..+....   ++......++.++++.+.. +|   ..||+|||+.+.||+++++ .+.++|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence               2379999998  54454432221   1133456677788885555 58   9999999999999999988 999999


Q ss_pred             ccCceecC
Q 039290          905 FGIAKILG  912 (1049)
Q Consensus       905 fGla~~~~  912 (1049)
                      ||.+....
T Consensus       150 f~qav~~~  157 (188)
T PF01163_consen  150 FGQAVDSS  157 (188)
T ss_dssp             GTTEEETT
T ss_pred             cCcceecC
Confidence            99887543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.82  E-value=1.2e-07  Score=104.43  Aligned_cols=213  Identities=16%  Similarity=0.142  Sum_probs=151.5

Q ss_pred             cEEEEEEE-eCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeec----CCeeEEEEeccCCC-Chhhh
Q 039290          774 FGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSN----NDFKALVLEYMSNG-SLEKC  847 (1049)
Q Consensus       774 fg~Vy~a~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~----~~~~~lv~e~~~~g-~L~~~  847 (1049)
                      -.+.|++. ..||..|++|+++.........-..-+++++++.|+|+|++.+++..    +..+++||+|+++. +|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            35789998 45899999999976655444455667899999999999999998863    34678999999864 67665


Q ss_pred             hhc--------------CCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          848 LYS--------------DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       848 l~~--------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      ...              .+...+++..|.++.|+..||.++|   +.|..-+-+.+++|+++.+.+++|+..|.......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            432              1224678899999999999999999   99999999999999999999999988887654432


Q ss_pred             CccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCC-CCccccccchHHHhhhhccccCCcchhcccc
Q 039290          914 EESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP-TDEIFAGEMSLKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       914 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      +.             .  |.+   .--.+-|.=.+|.+++.+.||..- +......+...                    
T Consensus       446 d~-------------~--~~l---e~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~--------------------  487 (655)
T KOG3741|consen  446 DP-------------T--EPL---ESQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHL--------------------  487 (655)
T ss_pred             CC-------------C--cch---hHHhhhhHHHHHHHHHHHhhcccccccccchHHHHH--------------------
Confidence            21             0  111   112456888999999999998653 11100000000                    


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                              .......+.++++++.-.....+++ -++.+++.++
T Consensus       488 --------~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  488 --------TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             --------HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence                    0112345566777777777777776 6677776654

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.82  E-value=3.5e-09  Score=130.25  Aligned_cols=131  Identities=30%  Similarity=0.373  Sum_probs=88.3

Q ss_pred             cccccceEEeccccccccCccccccccceEEEeecccc--CCCccccccccccccceEEeccCccCCCCCCcccCCCCCc
Q 039290          245 NLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSN--LAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNL  322 (1049)
Q Consensus       245 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~--l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L  322 (1049)
                      +....+...+-+|++. .++....+- .|+.|-+..|.  +....++.|..++.|+.|||++|.-.+.+|..+. .|-+|
T Consensus       521 ~~~~~rr~s~~~~~~~-~~~~~~~~~-~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~-~Li~L  597 (889)
T KOG4658|consen  521 SWNSVRRMSLMNNKIE-HIAGSSENP-KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIG-ELVHL  597 (889)
T ss_pred             chhheeEEEEeccchh-hccCCCCCC-ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHh-hhhhh
Confidence            3355666666666665 344333332 56666666665  3333333455577777777777766667777776 57777


Q ss_pred             cEEEcCCCCCCCCCCccccCCCCCceeecccCccccCcccccccccccceeeccccc
Q 039290          323 ERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNV  379 (1049)
Q Consensus       323 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  379 (1049)
                      ++|+|++..++ .+|..+.++.+|.+||+.++.-...+|.....|++|++|.+..-.
T Consensus       598 ryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~  653 (889)
T KOG4658|consen  598 RYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA  653 (889)
T ss_pred             hcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence            78888888877 778888888888888888777665667777778888888777655

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.80  E-value=1.5e-10  Score=130.44  Aligned_cols=129  Identities=33%  Similarity=0.309  Sum_probs=97.3

Q ss_pred             cCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEee
Q 039290          519 SLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLR  598 (1049)
Q Consensus       519 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  598 (1049)
                      .|...+.++|++.- ....+.-++.|+.|||++|+++...  .+..+..|++|||+.|+++.+.--...++. |+.|+++
T Consensus       165 ~L~~a~fsyN~L~~-mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr  240 (1096)
T KOG1859|consen  165 KLATASFSYNRLVL-MDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR  240 (1096)
T ss_pred             hHhhhhcchhhHHh-HHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence            46677778888774 4566777788888888888887644  677788888888888888854333444444 9999999


Q ss_pred             cccccCCccccccCccCCcEEeccCccccCCcc-cccccccccceeeccCCccccc
Q 039290          599 YNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIP-KSMEALSYLKHLNLSFNQLEGE  653 (1049)
Q Consensus       599 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~~~  653 (1049)
                      +|.++..  ..+.+|++|+.|||+.|-|++.-. ..++.|..|+.|+|.|||+.|.
T Consensus       241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~  294 (1096)
T KOG1859|consen  241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA  294 (1096)
T ss_pred             ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence            9988843  346788899999999998886433 2367788899999999999874

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.79  E-value=3.7e-09  Score=85.60  Aligned_cols=59  Identities=36%  Similarity=0.560  Sum_probs=31.1

Q ss_pred             ceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCcc
Q 039290          567 VVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNN  625 (1049)
Q Consensus       567 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  625 (1049)
                      +|++|++++|+|+...+..|.++++|++|++++|+|+...|..|.++++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            34455555555554444455555555555555555554444555555555555555554

...

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.78  E-value=3.5e-08  Score=100.99  Aligned_cols=134  Identities=22%  Similarity=0.261  Sum_probs=101.8

Q ss_pred             CCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccC-----------------C-----CHHHHHHHHHHHhhcCCC--c
Q 039290          763 FSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFD-----------------G-----SLESFHAECKVMGSIRHR--N  818 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~-----------------~-----~~~~~~~e~~~l~~l~hp--n  818 (1049)
                      +.+..+||-|.-+.||.|..+.|.++|||.=+....                 .     .....++|+++|.++...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            456689999999999999999999999986422110                 0     124567899999998654  6


Q ss_pred             eeeEEeeeecCCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC
Q 039290          819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM  898 (1049)
Q Consensus       819 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~  898 (1049)
                      +.+.+++    +.-.+||||++|-.|...-      ++.+....++..|++-++..-   ..||||||+.+-||+++++|
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCC
Confidence            7777654    4558999999996665421      234555566667777777666   78999999999999999999


Q ss_pred             ceEEecccCce
Q 039290          899 VGHLSDFGIAK  909 (1049)
Q Consensus       899 ~~kl~DfGla~  909 (1049)
                      .+.++||--+.
T Consensus       240 ~~~vIDwPQ~v  250 (304)
T COG0478         240 DIVVIDWPQAV  250 (304)
T ss_pred             CEEEEeCcccc
Confidence            99999997554

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.77  E-value=8.5e-08  Score=102.47  Aligned_cols=140  Identities=14%  Similarity=0.030  Sum_probs=100.5

Q ss_pred             ceecCCCcEEEEEEEeCCCcEEEEEEeecccC-----------CCHHHHHHHHHHHhhcCCC--ceeeEEeeeec-----
Q 039290          767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFD-----------GSLESFHAECKVMGSIRHR--NLVKIISSCSN-----  828 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~hp--niv~l~~~~~~-----  828 (1049)
                      +.+-+.....|++... +|+.|.||+.....-           .....+.+|++.+.++..-  ..++++++.+.     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4555455555777766 678899997743220           0112477899998888432  23344555433     


Q ss_pred             CCeeEEEEeccCCC-ChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC-------CCc
Q 039290          829 NDFKALVLEYMSNG-SLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE-------SMV  899 (1049)
Q Consensus       829 ~~~~~lv~e~~~~g-~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-------~~~  899 (1049)
                      ...-++|||++++. +|.+++... ....+......++.+++..++.||   ..||+|+|++++|||++.       ++.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence            23468999999886 898887532 223456677889999999999999   999999999999999974       468


Q ss_pred             eEEecccCcee
Q 039290          900 GHLSDFGIAKI  910 (1049)
Q Consensus       900 ~kl~DfGla~~  910 (1049)
                      +.++||+.++.
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998764

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.76  E-value=5.1e-09  Score=84.80  Aligned_cols=61  Identities=39%  Similarity=0.569  Sum_probs=57.2

Q ss_pred             CcccEEEeecccccCCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCcc
Q 039290          590 QGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQL  650 (1049)
Q Consensus       590 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l  650 (1049)
                      ++|+.|++++|+|+...+..|.++++|++|++++|+++...|..|..+++|++|++++|++
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            5799999999999988788999999999999999999977778999999999999999985

...

>PRK09902 hypothetical protein; Provisional

Probab=98.57  E-value=1.2e-06  Score=88.33  Aligned_cols=154  Identities=14%  Similarity=0.062  Sum_probs=112.8

Q ss_pred             cHHHHHHHhcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeeccc------CCCHHHHHHHHHHHhhcCC--CceeeEE
Q 039290          752 SYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEF------DGSLESFHAECKVMGSIRH--RNLVKII  823 (1049)
Q Consensus       752 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h--pniv~l~  823 (1049)
                      +++.++.....+...---|+|+-+.|++... +|..+-+|+-....      +-....|.+|+..+.++..  -.+.+++
T Consensus         9 ~f~~~w~~~~~wve~pN~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv   87 (216)
T PRK09902          9 EFNHWWATEGDWVEEPNYRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV   87 (216)
T ss_pred             hHHHHHhCCCceecCCCcCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc
Confidence            4556666666666556678899999999877 44478888864111      2345789999999999853  2255555


Q ss_pred             eeeec----CCeeEEEEeccCC-CChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCC
Q 039290          824 SSCSN----NDFKALVLEYMSN-GSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES  897 (1049)
Q Consensus       824 ~~~~~----~~~~~lv~e~~~~-g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~  897 (1049)
                      .+...    .-..+||+|-+++ .+|.+++.... .+.+..+...+..+++.+++-||   +.|+.|+|+.++||+++.+
T Consensus        88 f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~  164 (216)
T PRK09902         88 FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTE  164 (216)
T ss_pred             eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCC
Confidence            22211    1245799998864 48888875532 24677888899999999999999   9999999999999999866


Q ss_pred             Cc--eEEecccCce
Q 039290          898 MV--GHLSDFGIAK  909 (1049)
Q Consensus       898 ~~--~kl~DfGla~  909 (1049)
                      +.  ++++||--++
T Consensus       165 g~~~v~lIDlEk~r  178 (216)
T PRK09902        165 GKAEAGFLDLEKSR  178 (216)
T ss_pred             CCeeEEEEEhhccc
Confidence            66  9999998665

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.54  E-value=3.6e-09  Score=95.50  Aligned_cols=134  Identities=22%  Similarity=0.261  Sum_probs=84.9

Q ss_pred             CCceeecCcccccccCccc---ccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEE
Q 039290          520 LRDLSLGSNALTSIIPSTL---WNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLS  596 (1049)
Q Consensus       520 L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  596 (1049)
                      +..++|++|++-. +++..   .....|+..+|++|.+....+..-...+.++.|+|++|.|+ .+|.++..++.|+.|+
T Consensus        29 ~h~ldLssc~lm~-i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN  106 (177)
T KOG4579|consen   29 LHFLDLSSCQLMY-IADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN  106 (177)
T ss_pred             hhhcccccchhhH-HHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence            3445555555542 22222   22334444566666665433333333446666777777777 4577788888888888


Q ss_pred             eecccccCCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCcccccCCCC
Q 039290          597 LRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTR  657 (1049)
Q Consensus       597 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~  657 (1049)
                      ++.|.+. ..|..+..|.+|-.||..+|.+. .+|-.+-.-+.....++.+++|.+.+|-.
T Consensus       107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~k  165 (177)
T KOG4579|consen  107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKK  165 (177)
T ss_pred             cccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccc
Confidence            8888888 67777777888888888888887 55554444444555667778888777753

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.51  E-value=4.8e-07  Score=104.64  Aligned_cols=141  Identities=20%  Similarity=0.201  Sum_probs=99.0

Q ss_pred             ceecCCCcEEEEEEEeCCCcEEEEEEeecccCCC----------------------------------------HHHHHH
Q 039290          767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGS----------------------------------------LESFHA  806 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~~  806 (1049)
                      +.++.++-|.||+|++++|+.||||+.+......                                        .-++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            6899999999999999999999999986543210                                        113555


Q ss_pred             HHHHHhhcC-----CCceeeEEeeeecCCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHH-HHHhHccCCC
Q 039290          807 ECKVMGSIR-----HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASA-LEYLHFGYST  880 (1049)
Q Consensus       807 e~~~l~~l~-----hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~-l~~LH~~~~~  880 (1049)
                      |+..+.+++     .|.+.-..=|++-.....++|||++|..+.+...-.....+...   ++..++++ +..+-   ..
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~---~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLL---RD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHH---hc
Confidence            666666653     35544333344555667899999999988887433223344333   33333332 23333   57


Q ss_pred             CeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       881 ~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      |++|.|..|.||+++.+|.+.+.|||+.....+
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            999999999999999999999999999987654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.51  E-value=7.5e-07  Score=92.30  Aligned_cols=107  Identities=21%  Similarity=0.208  Sum_probs=84.3

Q ss_pred             HHHHHHHHHHHhhcCC--CceeeEEeeeecC----CeeEEEEeccCCC-ChhhhhhcCCCccCHHHHHHHHHHHHHHHHH
Q 039290          801 LESFHAECKVMGSIRH--RNLVKIISSCSNN----DFKALVLEYMSNG-SLEKCLYSDNYFLDILQRLKIMIDVASALEY  873 (1049)
Q Consensus       801 ~~~~~~e~~~l~~l~h--pniv~l~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~  873 (1049)
                      ..+..+|++.+..+..  =...+++++.+..    ...++|+|++++. +|.+++..... .+......++.++++.++-
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence            4567888888888743  2345556665542    2458999999884 79998876333 5667788999999999999


Q ss_pred             hHccCCCCeEEcCCCCCCeeecCCC---ceEEecccCceec
Q 039290          874 LHFGYSTPIVHCDIKPSNVLLNESM---VGHLSDFGIAKIL  911 (1049)
Q Consensus       874 LH~~~~~~ivH~Dlkp~NIl~~~~~---~~kl~DfGla~~~  911 (1049)
                      ||   +.||+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       134 lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  134 LH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99   99999999999999999776   8999999987753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.47  E-value=2.4e-09  Score=120.92  Aligned_cols=127  Identities=28%  Similarity=0.309  Sum_probs=85.3

Q ss_pred             ccceEEeeCcccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecc
Q 039290          495 RLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLS  574 (1049)
Q Consensus       495 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  574 (1049)
                      .|...+.+.|.+. ....++.-++.|+.|+|++|+++..  +.+..++.|++|||+.|+++...--....+. |+.|.++
T Consensus       165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr  240 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR  240 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence            4666777777776 5566677777777777777777754  3666777777777777777643322233333 7777777


Q ss_pred             cccccccccccccCCCcccEEEeecccccCCc-cccccCccCCcEEeccCcccc
Q 039290          575 LNALSGVIPVTIGGLQGLQLLSLRYNRLQGPI-PESFGGLKSLNFVDMSNNNLS  627 (1049)
Q Consensus       575 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~  627 (1049)
                      +|.++..  ..+.+|.+|+.|||++|-|.+-- -..++.|..|+.|+|.||.+-
T Consensus       241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            7777643  44667777888888888776521 233556677788888888775

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.43  E-value=1e-07  Score=109.16  Aligned_cols=150  Identities=19%  Similarity=0.224  Sum_probs=103.7

Q ss_pred             HHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc--c------ccccccCcccccccCCC
Q 039290          866 DVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ--T------KTLGTIGYMAPEYGREG  937 (1049)
Q Consensus       866 ~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~--~------~~~~~~~y~aPE~~~~~  937 (1049)
                      +.+.|+.|+|.  +.++||+.|.|++|.++..+..|++.|+.+........+..  +      -......|.|||++...
T Consensus       107 ~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            44589999995  78999999999999999999999999998865433111110  0      11235689999999988


Q ss_pred             CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhh
Q 039290          938 KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMD 1017 (1049)
Q Consensus       938 ~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 1017 (1049)
                      ..+.++|+||+|+++|-+..|..+.-....+...+..-..               .  ..-+.+....+.+.++++=+.+
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~---------------~--~~~~~~~~s~~~p~el~~~l~k  247 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN---------------L--LNAGAFGYSNNLPSELRESLKK  247 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc---------------c--cccccccccccCcHHHHHHHHH
Confidence            8899999999999999999554442221222111111000               0  0001112224567889999999


Q ss_pred             ccccCCCCCCCHHHHHH
Q 039290         1018 CTVDLPEKRISMKDVAN 1034 (1049)
Q Consensus      1018 cl~~dP~~Rpt~~ell~ 1034 (1049)
                      ++..++..||++.++..
T Consensus       248 ~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  248 LLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             HhcCCcccCcchhhhhc
Confidence            99999999998877654

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	1049
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-55
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		3e-16
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		7e-44
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		9e-42
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-36
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-35
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		7e-34
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		8e-34
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-24
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-24
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-24
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-22
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-21
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-21
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-20
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-20
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-20
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-19
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-19
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-19
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-19
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-19
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		5e-19
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-19
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-19
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-19
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-19
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		8e-19
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		8e-19
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-19
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-18
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-18
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-18
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-18
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-18
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-18
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-18
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-18
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		7e-18
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		8e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-17
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-17
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-17
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-17
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-17
3iok_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-17
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-17
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-17
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-17
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-17
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-17
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		8e-17
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-16
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-16
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-16
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-16
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-16
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-16
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-16
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-16
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-16
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-16
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-16
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-16
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-16
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-16
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-16
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-16
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-16
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-16
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-16
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-16
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-16
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-16
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-16
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-16
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-16
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-16
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-16
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		7e-16
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		9e-16
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-15
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-15
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-15
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-15
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-15
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-15
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-15
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-15
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-15
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-15
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-15
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-15
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-15
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-15
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-15
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-15
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-15
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		6e-15
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-15
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		6e-15
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		7e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		8e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		8e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		8e-15
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-15
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		8e-15
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		8e-15
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		8e-15
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		8e-15
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		8e-15
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		8e-15
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		8e-15
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-15
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-15
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		8e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		9e-15
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		9e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-14
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-14
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-14
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-14
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-14
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-14
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-14
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-14
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-14
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-14
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-14
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-14
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-14
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-14
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-14
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-14
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-14
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-14
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-14
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-14
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-14
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-14
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		7e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		8e-14
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		9e-14
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		9e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-13
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-13
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-13
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-13
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-13
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		7e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		7e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-13
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		8e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-12
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-12
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-12
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-12
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-12
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-12
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-12
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-12
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-12
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-12
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-12
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-12
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-12
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-12
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-12
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-12
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-12
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-12
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-12
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-12
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-12
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-12
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-12
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-12
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-12
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-12
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-12
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-12
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-12
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-12
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-12
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-12
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		7e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		7e-12
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		7e-12
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		7e-12
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		7e-12
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		7e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		7e-12
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		8e-12
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		9e-12
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-12
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		9e-12
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-11
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-11
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-11
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-11
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		7e-11
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		8e-11
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		8e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		8e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		8e-11
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		9e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-10
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-10
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-10
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-10
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-10
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-10
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-10
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		6e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-10
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		9e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		9e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-09
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-09
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-09
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-09
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-09
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-09
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-09
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-09
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-09
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-09
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		5e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-09
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-09
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-09
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-09
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-09
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-09
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-09
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-09
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-09
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-09
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-09
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-09
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-09
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		6e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		7e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		7e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		7e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		7e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		7e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		7e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		7e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		7e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		7e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		7e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		8e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		8e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		8e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		8e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		8e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		8e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		9e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		9e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		9e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-08
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-08
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		1e-08
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		1e-04
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-08
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-08
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-08
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-08
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-08
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		3e-08
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		1e-04
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-08
3soa_A	444	Full-Length Human Camkii Length = 444		3e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-08
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		3e-08
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		4e-04
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-08
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-08
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-08
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		6e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		6e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-08
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		6e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-08
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		7e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		7e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-08
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		7e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		8e-08
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		8e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		8e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		8e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		9e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		9e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		9e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		9e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		9e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		9e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-07
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-07
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-07
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-07
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		7e-07
2id5_A	477	Crystal Structure Of The Lingo-1 Ectodomain Length		7e-07
2id5_A	477	Crystal Structure Of The Lingo-1 Ectodomain Length		6e-05
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		8e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		8e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		8e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		9e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-06
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-06
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-06
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-06
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-06
3cig_A	697	Crystal Structure Of Mouse Tlr3 Ectodomain Length =		3e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		5e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-06
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		6e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-06
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		7e-06
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		7e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		7e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-06
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		7e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		7e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		8e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		8e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		8e-06
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		9e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		9e-06
3rfj_A	279	Design Of A Binding Scaffold Based On Variable Lymp		9e-06
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		9e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		9e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		9e-06
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-05
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-05
3j0a_A	844	Homology Model Of Human Toll-Like Receptor 5 Fitted		1e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-05
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-05
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-05
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-05
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-05
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-05
3ulu_A	694	Structure Of Quaternary Complex Of Human Tlr3ecd Wi		2e-05
3kj4_A	286	Structure Of Rat Nogo Receptor Bound To 1d9 Antagon		2e-05
3kj4_A	286	Structure Of Rat Nogo Receptor Bound To 1d9 Antagon		1e-04
1p8t_A	285	Crystal Structure Of Nogo-66 Receptor Length = 285		2e-05
1p8t_A	285	Crystal Structure Of Nogo-66 Receptor Length = 285		4e-04
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-05
1ozn_A	285	1.5a Crystal Structure Of The Nogo Receptor Ligand		2e-05
1ozn_A	285	1.5a Crystal Structure Of The Nogo Receptor Ligand		4e-04
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-05
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-05
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-05
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-05
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-05
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-05
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-05
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		3e-05
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-05
4fmz_A	347	Crystal Structure Of An Internalin (Inlf) From List		4e-05
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-05
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-05
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-05
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		4e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-05
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-05
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-05
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-05
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-05
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-05
1xcd_A	329	Dimeric Bovine Tissue-Extracted Decorin, Crystal Fo		4e-05
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-05
1xku_A	330	Crystal Structure Of The Dimeric Protein Core Of De		4e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-05
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-05
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		7e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-05
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		7e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		7e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		8e-05
2a0z_A	705	The Molecular Structure Of Toll-like Receptor 3 Lig		8e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-05
1ziw_A	680	Human Toll-Like Receptor 3 Extracellular Domain Str		8e-05
2ft3_A	332	Crystal Structure Of The Biglycan Dimer Core Protei		8e-05
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		9e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		9e-05
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		9e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		9e-05
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-04
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-04
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-04
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		2e-04
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-04
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-04
4fho_A	231	Crystal Structure Of An Internalin C2 (Inlc2) From		2e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-04
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-04
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-04
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-04
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-04
3e6j_A	229	Crystal Structure Of Variable Lymphocyte Receptor (		3e-04
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-04

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  215 bits (548), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 188/604 (31%), Positives = 283/604 (46%), Gaps = 39/604 (6%)
Query: 99  LAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFV 158
           L  LAI  N   G +  ++S    L++ D   NNF   IP +      LQHL +  N   
Sbjct: 180 LKHLAISGNKISGDV--DVSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLS 236
Query: 159 GKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPV--LEGLFISYNQLTGPIP 216
           G     I   + L+ L++S NQ  G IP           LP+  L+ L ++ N+ TG IP
Sbjct: 237 GDFSRAISTCTELKLLNISSNQFVGPIPP----------LPLKSLQYLSLAENKFTGEIP 286
Query: 217 TNL-WKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIP-NEIGNLRNLE 274
             L   C  L  + L+ N F G +P   G+ + + +L L +N+  GE+P + +  +R L+
Sbjct: 287 DFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLK 346
Query: 275 VLGVQSSNLAGLIPASIFNIS-TLKELAVTDNDLLGS-LPSSIDLGLPNLERLFLGENNF 332
           VL +  +  +G +P S+ N+S +L  L ++ N+  G  LP+        L+ L+L  N F
Sbjct: 347 VLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGF 406
Query: 333 SGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSS 392
           +G IP +L+N SEL  L   FN  SG IP++ G+L  L+ L L  N+L    P       
Sbjct: 407 TGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQ-----E 461
Query: 393 LTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIR 452
           L   + LE + L  N + G +PS + N + ++  +S+ +  ++G IPK +G + NL +++
Sbjct: 462 LMYVKTLETLILDFNDLTGEIPSGLSNCT-NLNWISLSNNRLTGEIPKWIGRLENLAILK 520
Query: 453 LGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYR--LANLYLGDN----KL 506
           L NN  +G IP  LG  + L  L L  N   G+IP  +        AN   G      K 
Sbjct: 521 LSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKN 580
Query: 507 SGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFXXXXXXXXXXXXPDIGNLK 566
            G    C G    L    + S  L  +      N+   +              P   N  
Sbjct: 581 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVY--------GGHTSPTFDNNG 632
Query: 567 VVIEMDLSLNALSGVIPVTIXXXXXXXXXXXRYNRLQGPIPESFGGLKSLNFVDMSNNNL 626
            ++ +D+S N LSG IP  I            +N + G IP+  G L+ LN +D+S+N L
Sbjct: 633 SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKL 692
Query: 627 SGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSPKLQVSPCK 686
            G IP++M AL+ L  ++LS N L G IP  G F TF    FL N  LCG P  +  P  
Sbjct: 693 DGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSN 752
Query: 687 TRSH 690
              +
Sbjct: 753 ADGY 756

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 127/468 (27%), Positives = 194/468 (41%), Gaps = 104/468 (22%)
Query: 205 FISYNQLTGPIPTNLWKCR-ELHVVSLAFNKFQGGIPR--DIGNLTSVRNLFLGNNSLIG 261
           F+S + + G +    +KC   L  + L+ N   G +     +G+ + ++ L + +N+L  
Sbjct: 83  FLSNSHINGSVSG--FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTL-- 138
Query: 262 EIPNEIG---NLRNLEVLGVQSSNLAGLIPASIFN------ISTLKELAVTDNDLLGSLP 312
           + P ++     L +LEVL + +++++G   A++           LK LA++ N + G + 
Sbjct: 139 DFPGKVSGGLKLNSLEVLDLSANSISG---ANVVGWVLSDGCGELKHLAISGNKISGDVD 195
Query: 313 SSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKL 372
            S  +   NLE L +  NNFS  IP  L + S L  LD   N  SG           LKL
Sbjct: 196 VSRCV---NLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKL 251
Query: 373 LSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESC 432
           L+++ N    P P L         ++L+ + L+EN   G +P  +               
Sbjct: 252 LNISSNQFVGPIPPLPL-------KSLQYLSLAENKFTGEIPDFLS-------------- 290
Query: 433 NISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPED-LC 491
                     G  + LT + L  N   G +P   G    L+ L L +N   G +P D L 
Sbjct: 291 ----------GACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLL 340
Query: 492 HLYRLANLYLGDNKLSGRLPACLGNLT-SLRDLSLGSNALTS-IIPSTLWNLKDILRFXX 549
            +  L  L L  N+ SG LP  L NL+ SL  L L SN  +  I+P+   N K+ L+   
Sbjct: 341 KMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQ--- 397
Query: 550 XXXXXXXXXXPDIGNLKVVIEMDLSLNALSGVIPVTIXXXXXXXXXXXRYNRLQGPIPES 609
                               E+ L  N  +G IP T+                       
Sbjct: 398 --------------------ELYLQNNGFTGKIPPTLS---------------------- 415
Query: 610 FGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTR 657
                 L  + +S N LSGTIP S+ +LS L+ L L  N LEGEIP  
Sbjct: 416 --NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQE 461

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  176 bits (445), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 161/503 (32%), Positives = 247/503 (49%), Gaps = 53/503 (10%)
Query: 48  NLLANNWSTTSSVCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNN 107
           N L+ ++S   S C+            +  LNIS     G IPP    L  L  L++  N
Sbjct: 230 NKLSGDFSRAISTCT-----------ELKLLNISSNQFVGPIPPL--PLKSLQYLSLAEN 276
Query: 108 SFFGSLPEELS-HLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIP-ETI 165
            F G +P+ LS     L   D   N+F+  +P +F S   L+ L L  N+F G++P +T+
Sbjct: 277 KFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTL 336
Query: 166 GYLSLLQELDLSDNQLSGTIPSSIFNISS--------------------CQNLP-VLEGL 204
             +  L+ LDLS N+ SG +P S+ N+S+                    CQN    L+ L
Sbjct: 337 LKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQEL 396
Query: 205 FISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIP 264
           ++  N  TG IP  L  C EL  + L+FN   G IP  +G+L+ +R+L L  N L GEIP
Sbjct: 397 YLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIP 456
Query: 265 NEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLER 324
            E+  ++ LE L +  ++L G IP+ + N + L  +++++N L G +P  I   L NL  
Sbjct: 457 QELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR-LENLAI 515
Query: 325 LFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGN---------LRSLKLLSL 375
           L L  N+FSG IP+ L +   L  LD   N F+G IP              +   + + +
Sbjct: 516 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYI 575
Query: 376 AGNVLTSPTPDLSFLSSLTSCRNLEIIYLS-ENPIN------GILPSSIGNFSISMKSLS 428
             + +         L      R+ ++  LS  NP N      G   S   + + SM  L 
Sbjct: 576 KNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD 635
Query: 429 MESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPE 488
           M    +SG IPKE+G++  L ++ LG+N+++G+IP  +G L+ L  L L +NKL+G IP+
Sbjct: 636 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQ 695
Query: 489 DLCHLYRLANLYLGDNKLSGRLP 511
            +  L  L  + L +N LSG +P
Sbjct: 696 AMSALTMLTEIDLSNNNLSGPIP 718

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  169 bits (427), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 206/767 (26%), Positives = 323/767 (42%), Gaps = 146/767 (19%)
Query: 46  PSNLLANNWSTTSSVCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLA-- 103
           P   L  +WS+  + C++ GVTC  R+ +VT++++S   L         N+ F AV +  
Sbjct: 22  PDKNLLPDWSSNKNPCTFDGVTC--RDDKVTSIDLSSKPL---------NVGFSAVSSSL 70
Query: 104 ----------IRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSW--FVSLPRLQHLL 151
                     + N+   GS+         L   D   N+    + +     S   L+ L 
Sbjct: 71  LSLTGLESLFLSNSHINGSV-SGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLN 129
Query: 152 LKHNS--FVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYN 209
           +  N+  F GK+   +  L+ L+ LDLS N +SG           C  L   + L IS N
Sbjct: 130 VSSNTLDFPGKVSGGL-KLNSLEVLDLSANSISGANVVGWVLSDGCGEL---KHLAISGN 185
Query: 210 QLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGN 269
           +++G +  ++ +C  L  + ++ N F  GIP  +G+ +++++L +  N L G+    I  
Sbjct: 186 KISGDV--DVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAIST 242
Query: 270 LRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGE 329
              L++L + S+   G IP     + +L+ L++ +N   G +P  +      L  L L  
Sbjct: 243 CTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSG 300
Query: 330 NNFSGTIPSSLTNISELSVLDFGFNSFSGLIP-TTFGNLRSLKLLSLAGNVLTSPTPDLS 388
           N+F G +P    + S L  L    N+FSG +P  T   +R LK+L L+ N  +   P+  
Sbjct: 301 NHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPE-- 358
Query: 389 FLSSLTS-CRNLEIIYLSENPING-ILPSSIGNFSISMKSLSMESCNISGGIPKELGNIN 446
              SLT+   +L  + LS N  +G ILP+   N   +++ L +++   +G IP  L N +
Sbjct: 359 ---SLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCS 415
Query: 447 NLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKL 506
            L  + L  N L+GTIP +LG L KL+ L L  N LEG IP++L ++  L  L L  N L
Sbjct: 416 ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 475
Query: 507 SGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFXXXXXXXXXXXXPDIGNLK 566
           +G +P+ L N T+L  +SL +N LT  IP  +  L+++                ++G+ +
Sbjct: 476 TGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCR 535
Query: 567 VVIEMDLSLNALSGVIPVTIXXXXXXXXXX----XRY----------------------- 599
            +I +DL+ N  +G IP  +               RY                       
Sbjct: 536 SLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQG 595
Query: 600 ------NRLQ-------------GPIPESFGGLKSLNFVDMSNNNLSGTIPKSM------ 634
                 NRL              G    +F    S+ F+DMS N LSG IPK +      
Sbjct: 596 IRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYL 655
Query: 635 ------------------------------------------EALSYLKHLNLSFNQLEG 652
                                                      AL+ L  ++LS N L G
Sbjct: 656 FILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSG 715
Query: 653 EIPTRGPFITFSAESFLGNQALCGSPKLQVSPCKT-------RSHPR 692
            IP  G F TF    FL N  LCG P  +  P          RSH R
Sbjct: 716 PIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHHQRSHGR 762

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  152 bits (384), Expect = 1e-36,   Method: Composition-based stats.
 Identities = 98/295 (33%), Positives = 147/295 (49%), Gaps = 13/295 (4%)
Query: 749  RRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHME-FDGSLESFHAE 807
            +R S ++L  A+D FS   +LG G FG VYKG L DG  +A K    E   G    F  E
Sbjct: 26   KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 808  CKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYS---DNYFLDILQRLKIM 864
             +++    HRNL+++   C     + LV  YM+NGS+  CL         LD  +R +I 
Sbjct: 86   VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 865  IDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLG 924
            +  A  L YLH      I+H D+K +N+LL+E     + DFG+AK++  ++        G
Sbjct: 146  LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRG 205
Query: 925  TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAG---EMSLKRWVGDSLL 981
            TIG++APEY   GK S K DV+ YG+ML+E  T ++  D        ++ L  WV   L 
Sbjct: 206  TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 265
Query: 982  SCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036
               +  + D +L    + ++   E  V  +  +A+ CT   P +R  M +V   L
Sbjct: 266  EKKLEALVDVDL----QGNYKDEE--VEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  148 bits (373), Expect = 2e-35,   Method: Composition-based stats.
 Identities = 96/295 (32%), Positives = 145/295 (49%), Gaps = 13/295 (4%)
Query: 749  RRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHME-FDGSLESFHAE 807
            +R S ++L  A+D F    +LG G FG VYKG L DG  +A K    E   G    F  E
Sbjct: 18   KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 808  CKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYS---DNYFLDILQRLKIM 864
             +++    HRNL+++   C     + LV  YM+NGS+  CL         LD  +R +I 
Sbjct: 78   VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 865  IDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLG 924
            +  A  L YLH      I+H D+K +N+LL+E     + DFG+AK++  ++        G
Sbjct: 138  LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRG 197
Query: 925  TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAG---EMSLKRWVGDSLL 981
             IG++APEY   GK S K DV+ YG+ML+E  T ++  D        ++ L  WV   L 
Sbjct: 198  XIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 982  SCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036
               +  + D +L    + ++   E  V  +  +A+ CT   P +R  M +V   L
Sbjct: 258  EKKLEALVDVDL----QGNYKDEE--VEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  142 bits (359), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 102/305 (33%), Positives = 158/305 (51%), Gaps = 23/305 (7%)
Query: 750  RISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECK 809
            R+   DL  AT+ F    L+G G FG VYKGVL DG ++A K    E    +E F  E +
Sbjct: 28   RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 810  VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDN---YFLDILQRLKIMID 866
             +   RH +LV +I  C   +   L+ +YM NG+L++ LY  +     +   QRL+I I 
Sbjct: 88   TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 867  VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK----T 922
             A  L YLH   +  I+H D+K  N+LL+E+ V  ++DFGI+K   K   + QT      
Sbjct: 148  AARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK---KGTELDQTHLXXVV 201
Query: 923  LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEM-SLKRWVGDSLL 981
             GT+GY+ PEY  +G+++ K DVYS+G++L E    +    +    EM +L  W  +S  
Sbjct: 202  KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 982  SCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL---VR 1038
            +  + ++ D NL +        R + +      A+ C     E R SM DV  +L   +R
Sbjct: 262  NGQLEQIVDPNLAD------KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315
Query: 1039 IRETL 1043
            ++E++
Sbjct: 316  LQESV 320

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  142 bits (359), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 102/305 (33%), Positives = 158/305 (51%), Gaps = 23/305 (7%)
Query: 750  RISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECK 809
            R+   DL  AT+ F    L+G G FG VYKGVL DG ++A K    E    +E F  E +
Sbjct: 28   RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 810  VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDN---YFLDILQRLKIMID 866
             +   RH +LV +I  C   +   L+ +YM NG+L++ LY  +     +   QRL+I I 
Sbjct: 88   TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 867  VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK----T 922
             A  L YLH   +  I+H D+K  N+LL+E+ V  ++DFGI+K   K   + QT      
Sbjct: 148  AARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK---KGTELGQTHLXXVV 201
Query: 923  LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEM-SLKRWVGDSLL 981
             GT+GY+ PEY  +G+++ K DVYS+G++L E    +    +    EM +L  W  +S  
Sbjct: 202  KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 982  SCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL---VR 1038
            +  + ++ D NL +        R + +      A+ C     E R SM DV  +L   +R
Sbjct: 262  NGQLEQIVDPNLAD------KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315
Query: 1039 IRETL 1043
            ++E++
Sbjct: 316  LQESV 320

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 93/303 (30%), Positives = 145/303 (47%), Gaps = 27/303 (8%)
Query: 748  WRRISYQDLLRATDGFSENKL------LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL 801
            +   S+ +L   T+ F E  +      +G G FG VYKG + +   +A K      D + 
Sbjct: 12   FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 70
Query: 802  E----SFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEK---CLYSDNYF 854
            E     F  E KVM   +H NLV+++   S+ D   LV  YM NGSL     CL      
Sbjct: 71   EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPP 129
Query: 855  LDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK- 913
            L    R KI    A+ + +LH  +    +H DIK +N+LL+E+    +SDFG+A+   K 
Sbjct: 130  LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 914  EESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
             +++  ++ +GT  YMAPE  R G+++ K D+YS+G++L+E  T     DE    ++ L 
Sbjct: 187  AQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245
Query: 974  RWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVA 1033
                      +I +  D  +     ND  A    V +++S+A  C  +   KR  +K V 
Sbjct: 246  IKEEIEDEEKTIEDYIDKKM-----ND--ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 298
Query: 1034 NRL 1036
              L
Sbjct: 299  QLL 301

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 93/303 (30%), Positives = 144/303 (47%), Gaps = 27/303 (8%)
Query: 748  WRRISYQDLLRATDGFSENKL------LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL 801
            +   S+ +L   T+ F E  +      +G G FG VYKG + +   +A K      D + 
Sbjct: 12   FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 70
Query: 802  E----SFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEK---CLYSDNYF 854
            E     F  E KVM   +H NLV+++   S+ D   LV  YM NGSL     CL      
Sbjct: 71   EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPP 129
Query: 855  LDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK- 913
            L    R KI    A+ + +LH  +    +H DIK +N+LL+E+    +SDFG+A+   K 
Sbjct: 130  LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 914  EESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
             +++   + +GT  YMAPE  R G+++ K D+YS+G++L+E  T     DE    ++ L 
Sbjct: 187  AQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245
Query: 974  RWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVA 1033
                      +I +  D  +     ND  A    V +++S+A  C  +   KR  +K V 
Sbjct: 246  IKEEIEDEEKTIEDYIDKKM-----ND--ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 298
Query: 1034 NRL 1036
              L
Sbjct: 299  QLL 301

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  110 bits (275), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 93/303 (30%), Positives = 143/303 (47%), Gaps = 27/303 (8%)
Query: 748  WRRISYQDLLRATDGFSENKL------LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL 801
            +   S+ +L   T+ F E  +      +G G FG VYKG + +   +A K      D + 
Sbjct: 6    FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 64
Query: 802  E----SFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEK---CLYSDNYF 854
            E     F  E KVM   +H NLV+++   S+ D   LV  YM NGSL     CL      
Sbjct: 65   EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPP 123
Query: 855  LDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK- 913
            L    R KI    A+ + +LH  +    +H DIK +N+LL+E+    +SDFG+A+   K 
Sbjct: 124  LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 180
Query: 914  EESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
             + +   + +GT  YMAPE  R G+++ K D+YS+G++L+E  T     DE    ++ L 
Sbjct: 181  AQXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 239
Query: 974  RWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVA 1033
                      +I +  D  +     ND  A    V +++S+A  C  +   KR  +K V 
Sbjct: 240  IKEEIEDEEKTIEDYIDKKM-----ND--ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 292
Query: 1034 NRL 1036
              L
Sbjct: 293  QLL 295

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  105 bits (261), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 107/198 (54%), Gaps = 9/198 (4%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLE---SFHAECKVMGSIRHRNLVKIISS 825
           +G GSFG+V++     G ++A K+  ME D   E    F  E  +M  +RH N+V  + +
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKIL-MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNYF--LDILQRLKIMIDVASALEYLHFGYSTPIV 883
            +     ++V EY+S GSL + L+       LD  +RL +  DVA  + YLH   + PIV
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIV 161
Query: 884 HCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKC 943
           H D+K  N+L+++     + DFG+++ L     +      GT  +MAPE  R+   + K 
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSR-LKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKS 220
Query: 944 DVYSYGIMLMETFTKKKP 961
           DVYS+G++L E  T ++P
Sbjct: 221 DVYSFGVILWELATLQQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  103 bits (256), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 111/199 (55%), Gaps = 11/199 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLE---SFHAECKVMGSIRHRNLVKIISS 825
           +G GSFG+V++     G ++A K+  ME D   E    F  E  +M  +RH N+V  + +
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKIL-MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNYF--LDILQRLKIMIDVASALEYLHFGYSTPIV 883
            +     ++V EY+S GSL + L+       LD  +RL +  DVA  + YLH   + PIV
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIV 161
Query: 884 HCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGYMAPEYGREGKVSRK 942
           H ++K  N+L+++     + DFG++++  K  +   +K+  GT  +MAPE  R+   + K
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEK 219
Query: 943 CDVYSYGIMLMETFTKKKP 961
            DVYS+G++L E  T ++P
Sbjct: 220 SDVYSFGVILWELATLQQP 238

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 74/243 (30%), Positives = 112/243 (46%), Gaps = 4/243 (1%)
Query: 438 IPKELGNINNLTVIRLGN-NELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRL 496
           IP  L N+  L  + +G  N L G IP  + +L +L  LY+ +  + G+IP+ L  +  L
Sbjct: 68  IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 497 ANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDIL-RFXXXXXXXX 555
             L    N LSG LP  + +L +L  ++   N ++  IP +  +   +            
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 556 XXXXPDIGNLKVVIEMDLSLNALSGVIPVTIXXXXXXXXXXXRYNRLQGPIPESFGGLKS 615
               P   NL +   +DLS N L G   V               N L   + +  G  K+
Sbjct: 188 GKIPPTFANLNLAF-VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKN 245
Query: 616 LNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALC 675
           LN +D+ NN + GT+P+ +  L +L  LN+SFN L GEIP  G    F   ++  N+ LC
Sbjct: 246 LNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLC 305
Query: 676 GSP 678
           GSP
Sbjct: 306 GSP 308

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 90/303 (29%), Positives = 139/303 (45%), Gaps = 27/303 (8%)
Query: 748  WRRISYQDLLRATDGFSENKL------LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL 801
            +   S+ +L   T+ F E  +       G G FG VYKG + +   +A K      D + 
Sbjct: 3    FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 61
Query: 802  E----SFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEK---CLYSDNYF 854
            E     F  E KV    +H NLV+++   S+ D   LV  Y  NGSL     CL      
Sbjct: 62   EELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCL-DGTPP 120
Query: 855  LDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK- 913
            L    R KI    A+ + +LH  +    +H DIK +N+LL+E+    +SDFG+A+   K 
Sbjct: 121  LSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 177
Query: 914  EESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
             + +  ++ +GT  Y APE  R G+++ K D+YS+G++L+E  T     DE    ++ L 
Sbjct: 178  AQXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 236
Query: 974  RWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVA 1033
                      +I +  D      + ND  A    V + +S+A  C  +   KR  +K V 
Sbjct: 237  IKEEIEDEEKTIEDYIDK-----KXND--ADSTSVEAXYSVASQCLHEKKNKRPDIKKVQ 289
Query: 1034 NRL 1036
              L
Sbjct: 290  QLL 292

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 135/298 (45%), Gaps = 38/298 (12%)
Query: 764  SENKLLGMGSFGSVYKGVLPDG-----MEIAAKVFHMEF-DGSLESFHAECKVMGSIRHR 817
            +  K++G G FG VYKG+L        + +A K     + +     F  E  +MG   H 
Sbjct: 47   TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 818  NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
            N++++    S      ++ EYM NG+L+K L   +    +LQ + ++  +A+ ++YL   
Sbjct: 107  NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA-- 164
Query: 878  YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGR 935
             +   VH D+   N+L+N ++V  +SDFG++++L  +     T + G   I + APE   
Sbjct: 165  -NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 936  EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN 995
              K +   DV+S+GI++ E  T          GE     W           E+++  ++ 
Sbjct: 224  YRKFTSASDVWSFGIVMWEVMT---------YGERPY--W-----------ELSNHEVMK 261
Query: 996  CEENDFS--AREQCVSSIFSLAMDCTVDLPEKRISMKDVA---NRLVRIRETLSAYID 1048
               + F       C S+I+ L M C      +R    D+    ++L+R  ++L    D
Sbjct: 262  AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLAD 319

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 96.7 bits (239), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 114/231 (49%), Gaps = 13/231 (5%)
Query: 735 RPYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKG--VLPDGMEIAAKV 792
           R Y D + Y   T     +   L AT+  S +K++G G FG V  G   LP   EI+  +
Sbjct: 18  RTYVDPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAI 76
Query: 793 FHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLY 849
             ++    +     F  E  +MG   H N++++    + +    +V EYM NGSL+  L 
Sbjct: 77  KTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 136
Query: 850 SDNYFLDILQRLKIMIDVASALEYL-HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA 908
             +    ++Q + ++  +AS ++YL   GY    VH D+   N+L+N ++V  +SDFG++
Sbjct: 137 KHDAQFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLS 192
Query: 909 KILGKEESMRQTKTLGT--IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           ++L  +     T   G   I + +PE     K +   DV+SYGI+L E  +
Sbjct: 193 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 114/231 (49%), Gaps = 13/231 (5%)
Query: 735 RPYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKG--VLPDGMEIAAKV 792
           R Y D + Y   T     +   L AT+  S +K++G G FG V  G   LP   EI+  +
Sbjct: 20  RTYVDPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAI 78
Query: 793 FHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLY 849
             ++    +     F  E  +MG   H N++++    + +    +V EYM NGSL+  L 
Sbjct: 79  KTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 850 SDNYFLDILQRLKIMIDVASALEYL-HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA 908
             +    ++Q + ++  +AS ++YL   GY    VH D+   N+L+N ++V  +SDFG++
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLS 194
Query: 909 KILGKEESMRQTKTLGT--IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           ++L  +     T   G   I + +PE     K +   DV+SYGI+L E  +
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 22/210 (10%)
Query: 766 NKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFD----GSLESFHAECKVMGSIRHRNLVK 821
            +++G+G FG VY+     G E+A K    + D     ++E+   E K+   ++H N++ 
Sbjct: 12  EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           +   C       LV+E+   G L + L       DIL  +   + +A  + YLH     P
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLHDEAIVP 128
Query: 882 IVHCDIKPSNVLLNESM--------VGHLSDFGIAKILGKEESMRQTK--TLGTIGYMAP 931
           I+H D+K SN+L+ + +        +  ++DFG+A+     E  R TK    G   +MAP
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAAGAYAWMAP 183
Query: 932 EYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           E  R    S+  DV+SYG++L E  T + P
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 114/231 (49%), Gaps = 13/231 (5%)
Query: 735 RPYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKG--VLPDGMEIAAKV 792
           R + D + Y   T     +   L AT+  S +K++G G FG V  G   LP   EI+  +
Sbjct: 20  RTFVDPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAI 78
Query: 793 FHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLY 849
             ++    +     F  E  +MG   H N++++    + +    +V EYM NGSL+  L 
Sbjct: 79  KTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 850 SDNYFLDILQRLKIMIDVASALEYL-HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA 908
             +    ++Q + ++  +AS ++YL   GY    VH D+   N+L+N ++V  +SDFG++
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLS 194
Query: 909 KILGKEESMRQTKTLGT--IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           ++L  +     T   G   I + +PE     K +   DV+SYGI+L E  +
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 114/231 (49%), Gaps = 13/231 (5%)
Query: 735 RPYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKG--VLPDGMEIAAKV 792
           R Y D + +   T     +   L AT+  S +K++G G FG V  G   LP   EI+  +
Sbjct: 20  RTYVDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAI 78
Query: 793 FHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLY 849
             ++    +     F  E  +MG   H N++++    + +    +V EYM NGSL+  L 
Sbjct: 79  KTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 850 SDNYFLDILQRLKIMIDVASALEYL-HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA 908
             +    ++Q + ++  +AS ++YL   GY    VH D+   N+L+N ++V  +SDFG++
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLS 194
Query: 909 KILGKEESMRQTKTLGT--IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           ++L  +     T   G   I + +PE     K +   DV+SYGI+L E  +
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 114/231 (49%), Gaps = 13/231 (5%)
Query: 735 RPYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKG--VLPDGMEIAAKV 792
           R + D + +   T     +   L AT+  S +K++G G FG V  G   LP   EI+  +
Sbjct: 20  RTFVDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAI 78
Query: 793 FHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLY 849
             ++    +     F  E  +MG   H N++++    + +    +V EYM NGSL+  L 
Sbjct: 79  KTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 850 SDNYFLDILQRLKIMIDVASALEYL-HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA 908
             +    ++Q + ++  +AS ++YL   GY    VH D+   N+L+N ++V  +SDFG+A
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLA 194
Query: 909 KILGKEESMRQTKTLGT--IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           ++L  +     T   G   I + +PE     K +   DV+SYGI+L E  +
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 114/231 (49%), Gaps = 13/231 (5%)
Query: 735 RPYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKG--VLPDGMEIAAKV 792
           R + D + +   T     +   L AT+  S +K++G G FG V  G   LP   EI+  +
Sbjct: 20  RTFVDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAI 78
Query: 793 FHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLY 849
             ++    +     F  E  +MG   H N++++    + +    +V EYM NGSL+  L 
Sbjct: 79  KTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 850 SDNYFLDILQRLKIMIDVASALEYL-HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA 908
             +    ++Q + ++  +AS ++YL   GY    VH D+   N+L+N ++V  +SDFG++
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLS 194
Query: 909 KILGKEESMRQTKTLGT--IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           ++L  +     T   G   I + +PE     K +   DV+SYGI+L E  +
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 10/195 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISSC 826
           LG G FG V+ G       +A K       G++  E+F  E +VM  +RH  LV++ +  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
           S      +V EYMS GSL   L  +   +L + Q + +   +AS + Y+        VH 
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L+ E++V  ++DFG+A+++   E   +      I + APE    G+ + K DV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 946 YSYGIMLMETFTKKK 960
           +S+GI+L E  TK +
Sbjct: 365 WSFGILLTELTTKGR 379

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 735 RPYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKG--VLPDGMEIAAKV 792
           R Y D + Y   T     +   L AT+  S +K++G G FG V  G   LP   EI+  +
Sbjct: 20  RTYVDPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAI 78
Query: 793 FHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLY 849
             ++    +     F  E  +MG   H N++++    + +    +V E M NGSL+  L 
Sbjct: 79  KTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR 138
Query: 850 SDNYFLDILQRLKIMIDVASALEYL-HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA 908
             +    ++Q + ++  +AS ++YL   GY    VH D+   N+L+N ++V  +SDFG++
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLS 194
Query: 909 KILGKEESMRQTKTLGT--IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           ++L  +     T   G   I + +PE     K +   DV+SYGI+L E  +
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 10/195 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISSC 826
           LG G FG V+ G       +A K       G++  E+F  E +VM  +RH  LV++ +  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
           S      +V EYMS GSL   L  +   +L + Q + +   +AS + Y+        VH 
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L+ E++V  ++DFG+A+++   E   +      I + APE    G+ + K DV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 946 YSYGIMLMETFTKKK 960
           +S+GI+L E  TK +
Sbjct: 365 WSFGILLTELTTKGR 379

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 735 RPYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKG--VLPDGMEIAAKV 792
           R + D + +   T     +   L AT+  S +K++G G FG V  G   LP   EI+  +
Sbjct: 20  RTFVDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAI 78
Query: 793 FHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLY 849
             ++    +     F  E  +MG   H N++++    + +    +V EYM NGSL+  L 
Sbjct: 79  KTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 850 SDNYFLDILQRLKIMIDVASALEYL-HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA 908
             +    ++Q + ++  +AS ++YL   GY    VH D+   N+L+N ++V  +SDFG+ 
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLG 194
Query: 909 KILGKEESMRQTKTLGT--IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           ++L  +     T   G   I + +PE     K +   DV+SYGI+L E  +
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Composition-based stats.
 Identities = 61/195 (31%), Positives = 102/195 (52%), Gaps = 10/195 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISSC 826
           LG G FG V+ G       +A K       G++  E+F  E +VM  +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
           S      +V+EYMS GSL   L  +   +L + Q + +   +AS + Y+        VH 
Sbjct: 83  SEEPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L+ E++V  ++DFG+A+++   E   +      I + APE    G+ + K DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 946 YSYGIMLMETFTKKK 960
           +S+GI+L E  TK +
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 93.2 bits (230), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 10/195 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISSC 826
           LG G FG V+ G       +A K       G++  E+F  E +VM  +RH  LV++ +  
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
           S      +V EYMS GSL   L  +   +L + Q + +   +AS + Y+        VH 
Sbjct: 332 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L+ E++V  ++DFG+A+++   E   +      I + APE    G+ + K DV
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 946 YSYGIMLMETFTKKK 960
           +S+GI+L E  TK +
Sbjct: 448 WSFGILLTELTTKGR 462

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Composition-based stats.
 Identities = 61/195 (31%), Positives = 102/195 (52%), Gaps = 10/195 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISSC 826
           LG G FG V+ G       +A K       G++  E+F  E +VM  +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
           S      +V+EYMS GSL   L  +   +L + Q + +   +AS + Y+        VH 
Sbjct: 83  SEEPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L+ E++V  ++DFG+A+++   E   +      I + APE    G+ + K DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 946 YSYGIMLMETFTKKK 960
           +S+GI+L E  TK +
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Composition-based stats.
 Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 10/195 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISSC 826
           LG G FG V+ G       +A K       G++  E+F  E +VM  +RH  LV++ +  
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 72
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
           S      +V EYMS GSL   L  +   +L + Q + +   +AS + Y+        VH 
Sbjct: 73  SEEPI-XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 128
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L+ E++V  ++DFG+A+++   E   +      I + APE    G+ + K DV
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 188
Query: 946 YSYGIMLMETFTKKK 960
           +S+GI+L E  TK +
Sbjct: 189 WSFGILLTELTTKGR 203

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 9e-19,   Method: Composition-based stats.
 Identities = 62/195 (31%), Positives = 101/195 (51%), Gaps = 10/195 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISSC 826
           LG G FG V+ G       +A K       G++  E+F  E +VM  IRH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKIRHEKLVQLYAVV 82
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
           S      +V EYMS GSL   L  +   +L + Q + +   +AS + Y+        VH 
Sbjct: 83  SEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L+ E++V  ++DFG+A+++   E   +      I + APE    G+ + K DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 946 YSYGIMLMETFTKKK 960
           +S+GI+L E  TK +
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 10/195 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISSC 826
           LG G FG V+ G       +A K       G++  E+F  E +VM  +RH  LV++ +  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
           S      +V EYMS GSL   L  +   +L + Q + +   +AS + Y+        VH 
Sbjct: 249 SEEPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L+ E++V  ++DFG+A+++   E   +      I + APE    G+ + K DV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 946 YSYGIMLMETFTKKK 960
           +S+GI+L E  TK +
Sbjct: 365 WSFGILLTELTTKGR 379

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 114/231 (49%), Gaps = 13/231 (5%)
Query: 735 RPYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKG--VLPDGMEIAAKV 792
           R + D + +   T     +   L AT+  S +K++G G FG V  G   LP   EI+  +
Sbjct: 20  RTFVDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAI 78
Query: 793 FHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLY 849
             ++    +     F  E  +MG   H N++++    + +    +V EYM NGSL+  L 
Sbjct: 79  KTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 850 SDNYFLDILQRLKIMIDVASALEYL-HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA 908
             +    ++Q + ++  +AS ++YL   G+    VH D+   N+L+N ++V  +SDFG++
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGF----VHRDLAARNILINSNLVCKVSDFGLS 194
Query: 909 KILGKEESMRQTKTLGT--IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           ++L  +     T   G   I + +PE     K +   DV+SYGI+L E  +
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 99/193 (51%), Gaps = 6/193 (3%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSN 828
           LG G FG V+ G       +A K      + S E+F  E +VM  +RH  LV++ +  S 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 251
Query: 829 NDFKALVLEYMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDI 887
                +V EYMS GSL   L  +   +L + Q + +   +AS + Y+        VH D+
Sbjct: 252 EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 307
Query: 888 KPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYS 947
           + +N+L+ E++V  ++DFG+ +++   E   +      I + APE    G+ + K DV+S
Sbjct: 308 RAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 367
Query: 948 YGIMLMETFTKKK 960
           +GI+L E  TK +
Sbjct: 368 FGILLTELTTKGR 380

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 10/195 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISSC 826
           LG G FG V+ G       +A K       G++  E+F  E +VM  +RH  LV++ +  
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 75
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
           S      +V EYMS GSL   L  +   +L + Q + +   +AS + Y+        VH 
Sbjct: 76  SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 131
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L+ E++V  ++DFG+A+++   E   +      I + APE    G+ + K DV
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 191
Query: 946 YSYGIMLMETFTKKK 960
           +S+GI+L E  TK +
Sbjct: 192 WSFGILLTELTTKGR 206

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 71/195 (36%), Positives = 100/195 (51%), Gaps = 16/195 (8%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISS- 825
           + +G G FG V  G    G ++A K   ++ D + ++F AE  VM  +RH NLV+++   
Sbjct: 12  QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNYFL---DILQRLKIMIDVASALEYLHFGYSTPI 882
                   +V EYM+ GSL   L S    +   D L  LK  +DV  A+EYL        
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LKFSLDVCEAMEYLE---GNNF 123
Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRK 942
           VH D+   NVL++E  V  +SDFG    L KE S  Q      + + APE  RE K S K
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFG----LTKEASSTQDTGKLPVKWTAPEALREKKFSTK 179
Query: 943 CDVYSYGIMLMETFT 957
            DV+S+GI+L E ++
Sbjct: 180 SDVWSFGILLWEIYS 194

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 71/195 (36%), Positives = 100/195 (51%), Gaps = 16/195 (8%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISS- 825
           + +G G FG V  G    G ++A K   ++ D + ++F AE  VM  +RH NLV+++   
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNYFL---DILQRLKIMIDVASALEYLHFGYSTPI 882
                   +V EYM+ GSL   L S    +   D L  LK  +DV  A+EYL        
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LKFSLDVCEAMEYLE---GNNF 138
Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRK 942
           VH D+   NVL++E  V  +SDFG    L KE S  Q      + + APE  RE K S K
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFG----LTKEASSTQDTGKLPVKWTAPEALREKKFSTK 194
Query: 943 CDVYSYGIMLMETFT 957
            DV+S+GI+L E ++
Sbjct: 195 SDVWSFGILLWEIYS 209

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 10/195 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISSC 826
           LG G FG V+ G       +A K       G++  E+F  E +VM  +RH  LV++ +  
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 71
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
           S      +V EYMS GSL   L  +   +L + Q + +   +AS + Y+        VH 
Sbjct: 72  SEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 127
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L+ E++V  ++DFG+A+++   E   +      I + APE    G+ + K DV
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 187
Query: 946 YSYGIMLMETFTKKK 960
           +S+GI+L E  TK +
Sbjct: 188 WSFGILLTELTTKGR 202

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 10/195 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISSC 826
           LG G FG V+ G       +A K       G++  E+F  E +VM  +RH  LV++ +  
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 73
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
           S      +V EYMS GSL   L  +   +L + Q + +   +AS + Y+        VH 
Sbjct: 74  SEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 129
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L+ E++V  ++DFG+A+++   E   +      I + APE    G+ + K DV
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 946 YSYGIMLMETFTKKK 960
           +S+GI+L E  TK +
Sbjct: 190 WSFGILLTELTTKGR 204

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 10/195 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISSC 826
           LG G FG V+ G       +A K       G++  E+F  E +VM  +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
           S      +V EYMS GSL   L  +   +L + Q + +   +AS + Y+        VH 
Sbjct: 83  SEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L+ E++V  ++DFG+A+++   E   +      I + APE    G+ + K DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 946 YSYGIMLMETFTKKK 960
           +S+GI+L E  TK +
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 10/195 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISSC 826
           LG G FG V+ G       +A K       G++  E+F  E +VM  +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
           S      +V EYMS GSL   L  +   +L + Q + +   +AS + Y+        VH 
Sbjct: 83  SEEPI-YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L+ E++V  ++DFG+A+++   E   +      I + APE    G+ + K DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 946 YSYGIMLMETFTKKK 960
           +S+GI+L E  TK +
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 766 NKLLGMGSFGSVYKG--VLPDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLV 820
           +K++G G FG V  G   LP   EI+  +  ++    +     F  E  +MG   H N++
Sbjct: 38  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 97
Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL-HFGYS 879
           ++    + +    +V EYM NGSL+  L   +    ++Q + ++  +AS ++YL   GY 
Sbjct: 98  RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY- 156
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREG 937
              VH D+   N+L+N ++V  +SDFG++++L  +     T   G   I + +PE     
Sbjct: 157 ---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 213
Query: 938 KVSRKCDVYSYGIMLMETFT 957
           K +   DV+SYGI+L E  +
Sbjct: 214 KFTSASDVWSYGIVLWEVMS 233

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 766 NKLLGMGSFGSVYKG--VLPDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLV 820
           +K++G G FG V  G   LP   EI+  +  ++    +     F  E  +MG   H N++
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL-HFGYS 879
           ++    + +    +V EYM NGSL+  L   +    ++Q + ++  +AS ++YL   GY 
Sbjct: 81  RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY- 139
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREG 937
              VH D+   N+L+N ++V  +SDFG++++L  +     T   G   I + +PE     
Sbjct: 140 ---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 196
Query: 938 KVSRKCDVYSYGIMLMETFT 957
           K +   DV+SYGI+L E  +
Sbjct: 197 KFTSASDVWSYGIVLWEVMS 216

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 60/195 (30%), Positives = 101/195 (51%), Gaps = 10/195 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISSC 826
           LG G FG V+ G       +A K       G++  E+F  E +VM  +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
           S      +V+EYMS G L   L  +   +L + Q + +   +AS + Y+        VH 
Sbjct: 83  SEEPI-YIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L+ E++V  ++DFG+A+++   E   +      I + APE    G+ + K DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 946 YSYGIMLMETFTKKK 960
           +S+GI+L E  TK +
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 75/276 (27%), Positives = 120/276 (43%), Gaps = 26/276 (9%)
Query: 767  KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
            K LG G FG V  G      ++A K+   E   S + F  E + M  + H  LVK    C
Sbjct: 14   KELGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 827  SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
            S      +V EY+SNG L   L S    L+  Q L++  DV   + +L    S   +H D
Sbjct: 73   SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRD 129
Query: 887  IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
            +   N L++  +   +SDFG+ + +  ++ +    T   + + APE     K S K DV+
Sbjct: 130  LAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVW 189
Query: 947  SYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSARE 1005
            ++GI++ E F+  K P D     E+ LK   G  L    +                    
Sbjct: 190  AFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLAS------------------ 231
Query: 1006 QCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041
                +I+ +   C  +LPEKR + + + + +  +RE
Sbjct: 232  ---DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRHRNLVKIISS 825
           +G GSFG+VYKG      ++A K+  +  D + E F A   E  V+   RH N++  +  
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKILKV-VDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
            + ++  A+V ++    SL K L+       + Q + I    A  ++YLH   +  I+H 
Sbjct: 101 MTKDNL-AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHR 156
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT-LGTIGYMAPEYGR---EGKVSR 941
           D+K +N+ L+E +   + DFG+A +  +    +Q +   G++ +MAPE  R       S 
Sbjct: 157 DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSF 216
Query: 942 KCDVYSYGIMLMETFTKKKPTDEI 965
           + DVYSYGI+L E  T + P   I
Sbjct: 217 QSDVYSYGIVLYELMTGELPYSHI 240

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 71/195 (36%), Positives = 100/195 (51%), Gaps = 16/195 (8%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISS- 825
           + +G G FG V  G    G ++A K   ++ D + ++F AE  VM  +RH NLV+++   
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNYFL---DILQRLKIMIDVASALEYLHFGYSTPI 882
                   +V EYM+ GSL   L S    +   D L  LK  +DV  A+EYL        
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LKFSLDVCEAMEYLE---GNNF 310
Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRK 942
           VH D+   NVL++E  V  +SDFG    L KE S  Q      + + APE  RE K S K
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFG----LTKEASSTQDTGKLPVKWTAPEALREKKFSTK 366
Query: 943 CDVYSYGIMLMETFT 957
            DV+S+GI+L E ++
Sbjct: 367 SDVWSFGILLWEIYS 381

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Composition-based stats.
 Identities = 61/195 (31%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISSC 826
           LG G FG V+ G       +A K       G++  E+F  E +VM  +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
           S      +V EYMS GSL   L  +   +L + Q + +   +AS + Y+        VH 
Sbjct: 83  SEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D+  +N+L+ E++V  ++DFG+A+++   E   +      I + APE    G+ + K DV
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 946 YSYGIMLMETFTKKK 960
           +S+GI+L E  TK +
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 90.5 bits (223), Expect = 5e-18,   Method: Composition-based stats.
 Identities = 70/195 (35%), Positives = 99/195 (50%), Gaps = 16/195 (8%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISS- 825
           + +G G FG V  G    G ++A K   ++ D + ++F AE  VM  +RH NLV+++   
Sbjct: 18  QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNYFL---DILQRLKIMIDVASALEYLHFGYSTPI 882
                   +V EYM+ GSL   L S    +   D L  LK  +DV  A+EYL        
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LKFSLDVCEAMEYLE---GNNF 129
Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRK 942
           VH D+   NVL++E  V  +SDFG    L KE S  Q      + + APE  RE   S K
Sbjct: 130 VHRDLAARNVLVSEDNVAKVSDFG----LTKEASSTQDTGKLPVKWTAPEALREAAFSTK 185
Query: 943 CDVYSYGIMLMETFT 957
            DV+S+GI+L E ++
Sbjct: 186 SDVWSFGILLWEIYS 200

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Composition-based stats.
 Identities = 60/195 (30%), Positives = 101/195 (51%), Gaps = 10/195 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISSC 826
           LG G FG V+ G       +A K       G++  E+F  E +VM  +RH  LV++ +  
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 79
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
           S      +V EYM+ GSL   L  +   +L + Q + +   +AS + Y+        VH 
Sbjct: 80  SEEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHR 135
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L+ E++V  ++DFG+A+++   E   +      I + APE    G+ + K DV
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 946 YSYGIMLMETFTKKK 960
           +S+GI+L E  TK +
Sbjct: 196 WSFGILLTELTTKGR 210

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 60/195 (30%), Positives = 101/195 (51%), Gaps = 10/195 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISSC 826
           LG G FG V+ G       +A K       G++  E+F  E +VM  +RH  LV++ +  
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 79
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
           S      +V EYM+ GSL   L  +   +L + Q + +   +AS + Y+        VH 
Sbjct: 80  SEEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHR 135
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L+ E++V  ++DFG+A+++   E   +      I + APE    G+ + K DV
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 946 YSYGIMLMETFTKKK 960
           +S+GI+L E  TK +
Sbjct: 196 WSFGILLTELTTKGR 210

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 60/195 (30%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISSC 826
           LG G FG V+ G       +A K       G++  E+F  E +VM  +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
           S      +V EYMS G L   L  +   +L + Q + +   +AS + Y+        VH 
Sbjct: 83  SEEPI-YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L+ E++V  ++DFG+A+++   E   +      I + APE    G+ + K DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 946 YSYGIMLMETFTKKK 960
           +S+GI+L E  TK +
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 89.7 bits (221), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 108/215 (50%), Gaps = 9/215 (4%)
Query: 744 PQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLES 803
           PQ  W + +++      +     K LG G FG V+        ++A K        S+E+
Sbjct: 174 PQKPWEKDAWEI---PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEA 229
Query: 804 FHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI 863
           F AE  VM +++H  LVK+ +  +      ++ E+M+ GSL   L SD       Q L  
Sbjct: 230 FLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPK 285
Query: 864 MIDVASAL-EYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT 922
           +ID ++ + E + F      +H D++ +N+L++ S+V  ++DFG+A+++   E   +   
Sbjct: 286 LIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA 345
Query: 923 LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
              I + APE    G  + K DV+S+GI+LME  T
Sbjct: 346 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 12/202 (5%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
           +++G G+FG V K       ++A K   +E +   ++F  E + +  + H N+VK+  +C
Sbjct: 15  EVVGRGAFGVVCKAKW-RAKDVAIK--QIESESERKAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNY--FLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
            N     LV+EY   GSL   L+      +      +   +  +  + YLH      ++H
Sbjct: 72  LNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 129
Query: 885 CDIKPSNVLL-NESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKC 943
            D+KP N+LL     V  + DFG A  +        T   G+  +MAPE       S KC
Sbjct: 130 RDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAWMAPEVFEGSNYSEKC 185
Query: 944 DVYSYGIMLMETFTKKKPTDEI 965
           DV+S+GI+L E  T++KP DEI
Sbjct: 186 DVFSWGIILWEVITRRKPFDEI 207

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 12/202 (5%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
           +++G G+FG V K       ++A K   +E +   ++F  E + +  + H N+VK+  +C
Sbjct: 14  EVVGRGAFGVVCKAKW-RAKDVAIK--QIESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNY--FLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
            N     LV+EY   GSL   L+      +      +   +  +  + YLH      ++H
Sbjct: 71  LNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 885 CDIKPSNVLL-NESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKC 943
            D+KP N+LL     V  + DFG A  +        T   G+  +MAPE       S KC
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAWMAPEVFEGSNYSEKC 184
Query: 944 DVYSYGIMLMETFTKKKPTDEI 965
           DV+S+GI+L E  T++KP DEI
Sbjct: 185 DVFSWGIILWEVITRRKPFDEI 206

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 111/230 (48%), Gaps = 11/230 (4%)
Query: 735 RPYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKG--VLPDGMEIAAKV 792
           R + D + +   T     +   L AT+  S +K++G G FG V  G   LP   EI+  +
Sbjct: 20  RTFVDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAI 78
Query: 793 FHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLY 849
             ++    +     F  E  +MG   H N++++    + +    +V E M NGSL+  L 
Sbjct: 79  KTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR 138
Query: 850 SDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK 909
             +    ++Q + ++  +AS ++YL        VH D+   N+L+N ++V  +SDFG+++
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLS---DMGAVHRDLAARNILINSNLVCKVSDFGLSR 195
Query: 910 ILGKEESMRQTKTLGT--IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           +L  +     T   G   I + +PE     K +   DV+SYGI+L E  +
Sbjct: 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 101/200 (50%), Gaps = 12/200 (6%)
Query: 766 NKLLGMGSFGSVYKG--VLPDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLV 820
           +K++G G FG V  G   LP   EI+  +  ++    +     F  E  +MG   H N++
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL-HFGYS 879
           ++    + +    +V E M NGSL+  L   +    ++Q + ++  +AS ++YL   GY 
Sbjct: 81  RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY- 139
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREG 937
              VH D+   N+L+N ++V  +SDFG++++L  +     T   G   I + +PE     
Sbjct: 140 ---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 196
Query: 938 KVSRKCDVYSYGIMLMETFT 957
           K +   DV+SYGI+L E  +
Sbjct: 197 KFTSASDVWSYGIVLWEVMS 216

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 74/307 (24%), Positives = 136/307 (44%), Gaps = 54/307 (17%)
Query: 769  LGMGSFGSVY----KGVLP--DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKI 822
            LG G+FG V+      +LP  D M +A K      + + + F  E +++  ++H+++V+ 
Sbjct: 26   LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 823  ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDIL--------------QRLKIMIDVA 868
               C+      +V EYM +G L + L S      +L              Q L +   VA
Sbjct: 86   FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 869  SALEY---LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLG 924
            + + Y   LHF      VH D+   N L+ + +V  + DFG+++ +   +  R   +T+ 
Sbjct: 146  AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 199
Query: 925  TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCS 984
             I +M PE     K + + DV+S+G++L E FT  K            + W         
Sbjct: 200  PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK------------QPWY-------- 239
Query: 985  ITEVADANLLNC--EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042
              ++++   ++C  +  +      C   ++++   C    P++R S+KDV  RL  + + 
Sbjct: 240  --QLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 297
Query: 1043 LSAYIDV 1049
               Y+DV
Sbjct: 298  PPVYLDV 304

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 74/307 (24%), Positives = 136/307 (44%), Gaps = 54/307 (17%)
Query: 769  LGMGSFGSVY----KGVLP--DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKI 822
            LG G+FG V+      +LP  D M +A K      + + + F  E +++  ++H+++V+ 
Sbjct: 20   LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 823  ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDIL--------------QRLKIMIDVA 868
               C+      +V EYM +G L + L S      +L              Q L +   VA
Sbjct: 80   FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 869  SALEY---LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLG 924
            + + Y   LHF      VH D+   N L+ + +V  + DFG+++ +   +  R   +T+ 
Sbjct: 140  AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 925  TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCS 984
             I +M PE     K + + DV+S+G++L E FT  K            + W         
Sbjct: 194  PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK------------QPWY-------- 233
Query: 985  ITEVADANLLNC--EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042
              ++++   ++C  +  +      C   ++++   C    P++R S+KDV  RL  + + 
Sbjct: 234  --QLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 291
Query: 1043 LSAYIDV 1049
               Y+DV
Sbjct: 292  PPVYLDV 298

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 74/307 (24%), Positives = 136/307 (44%), Gaps = 54/307 (17%)
Query: 769  LGMGSFGSVY----KGVLP--DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKI 822
            LG G+FG V+      +LP  D M +A K      + + + F  E +++  ++H+++V+ 
Sbjct: 49   LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 823  ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDIL--------------QRLKIMIDVA 868
               C+      +V EYM +G L + L S      +L              Q L +   VA
Sbjct: 109  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 869  SALEY---LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLG 924
            + + Y   LHF      VH D+   N L+ + +V  + DFG+++ +   +  R   +T+ 
Sbjct: 169  AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 925  TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCS 984
             I +M PE     K + + DV+S+G++L E FT  K            + W         
Sbjct: 223  PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK------------QPWY-------- 262
Query: 985  ITEVADANLLNC--EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042
              ++++   ++C  +  +      C   ++++   C    P++R S+KDV  RL  + + 
Sbjct: 263  --QLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320
Query: 1043 LSAYIDV 1049
               Y+DV
Sbjct: 321  PPVYLDV 327

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 139/309 (44%), Gaps = 34/309 (11%)
Query: 757  LRATDGFSENKL-----LGMGSFGSV----YKGVLPD-GMEIAAKVFHMEFDGSLESFHA 806
            +R    F E  L     LG G+FGSV    Y  +  + G  +A K      +  L  F  
Sbjct: 1    MRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 807  ECKVMGSIRHRNLVKIISSCSNNDFK--ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIM 864
            E +++ S++H N+VK    C +   +   L++EY+  GSL   L      +D ++ L+  
Sbjct: 61   EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 865  IDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLG 924
              +   +EYL    +   +H D+   N+L+       + DFG+ K+L +++   + K  G
Sbjct: 121  SQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 177
Query: 925  T--IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT----KKKPTDEIFAGEMSLKRWVGD 978
               I + APE   E K S   DV+S+G++L E FT     K P  E         R +G+
Sbjct: 178  ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGN 230
Query: 979  SLLSCSITEVADANLLNCEEND--FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036
                  I      +L+   +N+      + C   I+ +  +C  +   +R S +D+A R+
Sbjct: 231  DKQGQMIV----FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286
Query: 1037 VRIRETLSA 1045
             +IR+ ++ 
Sbjct: 287  DQIRDNMAG 295

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 81/317 (25%), Positives = 144/317 (45%), Gaps = 36/317 (11%)
Query: 751  ISYQDLLRATDGFSENKL-----LGMGSFGSV----YKGVLPD-GMEIAAKVFHMEFDGS 800
            ++++D  R    F E  L     LG G+FGSV    Y  +  + G  +A K      +  
Sbjct: 1    MAFED--RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH 58
Query: 801  LESFHAECKVMGSIRHRNLVKIISSCSNNDFK--ALVLEYMSNGSLEKCLYSDNYFLDIL 858
            L  F  E +++ S++H N+VK    C +   +   L++EY+  GSL   L      +D +
Sbjct: 59   LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 118
Query: 859  QRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR 918
            + L+    +   +EYL    +   +H D+   N+L+       + DFG+ K+L +++   
Sbjct: 119  KLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 175
Query: 919  QTKTLGT--IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT----KKKPTDEIFAGEMSL 972
            + K  G   I + APE   E K S   DV+S+G++L E FT     K P  E        
Sbjct: 176  KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM------ 229
Query: 973  KRWVGDSLLSCSITEVADANLLNCEEND--FSAREQCVSSIFSLAMDCTVDLPEKRISMK 1030
             R +G+      I      +L+   +N+      + C   I+ +  +C  +   +R S +
Sbjct: 230  -RMIGNDKQGQMIV----FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFR 284
Query: 1031 DVANRLVRIRETLSAYI 1047
            D+A R+ +IR+ ++  +
Sbjct: 285  DLALRVDQIRDNMAGLV 301

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 134/292 (45%), Gaps = 29/292 (9%)
Query: 769  LGMGSFGSV----YKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKII 823
            LG G+FGSV    Y  +  + G  +A K      +  L  F  E +++ S++H N+VK  
Sbjct: 49   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 824  SSCSNNDFK--ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
              C +   +   L++EY+  GSL   L      +D ++ L+    +   +EYL    +  
Sbjct: 109  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 165
Query: 882  IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREGKV 939
             +H D+   N+L+       + DFG+ K+L +++   + K  G   I + APE   E K 
Sbjct: 166  YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 225
Query: 940  SRKCDVYSYGIMLMETFT----KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN 995
            S   DV+S+G++L E FT     K P  E         R +G+      I      +L+ 
Sbjct: 226  SVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGNDKQGQMIV----FHLIE 274
Query: 996  CEEND--FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSA 1045
              +N+      + C   I+ +  +C  +   +R S +D+A R+ +IR+ ++ 
Sbjct: 275  LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMAG 326

>pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 134/292 (45%), Gaps = 29/292 (9%)
Query: 769  LGMGSFGSV----YKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKII 823
            LG G+FGSV    Y  +  + G  +A K      +  L  F  E +++ S++H N+VK  
Sbjct: 36   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 824  SSCSNNDFK--ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
              C +   +   L++EY+  GSL   L      +D ++ L+    +   +EYL    +  
Sbjct: 96   GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 152
Query: 882  IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREGKV 939
             +H D+   N+L+       + DFG+ K+L +++   + K  G   I + APE   E K 
Sbjct: 153  YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 212
Query: 940  SRKCDVYSYGIMLMETFT----KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN 995
            S   DV+S+G++L E FT     K P  E         R +G+      I      +L+ 
Sbjct: 213  SVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGNDKQGQMIV----FHLIE 261
Query: 996  CEEND--FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSA 1045
              +N+      + C   I+ +  +C  +   +R S +D+A R+ +IR+ ++ 
Sbjct: 262  LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 313

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 134/292 (45%), Gaps = 29/292 (9%)
Query: 769  LGMGSFGSV----YKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKII 823
            LG G+FGSV    Y  +  + G  +A K      +  L  F  E +++ S++H N+VK  
Sbjct: 18   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 824  SSCSNNDFK--ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
              C +   +   L++EY+  GSL   L      +D ++ L+    +   +EYL    +  
Sbjct: 78   GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134
Query: 882  IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREGKV 939
             +H D+   N+L+       + DFG+ K+L +++   + K  G   I + APE   E K 
Sbjct: 135  YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 194
Query: 940  SRKCDVYSYGIMLMETFT----KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN 995
            S   DV+S+G++L E FT     K P  E         R +G+      I      +L+ 
Sbjct: 195  SVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGNDKQGQMIV----FHLIE 243
Query: 996  CEEND--FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSA 1045
              +N+      + C   I+ +  +C  +   +R S +D+A R+ +IR+ ++ 
Sbjct: 244  LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 295

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 4/200 (2%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
           K LG G FG V  G      ++A K+   E   S + F  E KVM ++ H  LV++   C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
           +      ++ EYM+NG L   L    +     Q L++  DV  A+EYL    S   +H D
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 145
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+N+  V  +SDFG+++ +  +E      +   + +  PE     K S K D++
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 947 SYGIMLMETFTKKKPTDEIF 966
           ++G+++ E ++  K   E F
Sbjct: 206 AFGVLMWEIYSLGKMPYERF 225

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 134/292 (45%), Gaps = 29/292 (9%)
Query: 769  LGMGSFGSV----YKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKII 823
            LG G+FGSV    Y  +  + G  +A K      +  L  F  E +++ S++H N+VK  
Sbjct: 16   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 824  SSCSNNDFK--ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
              C +   +   L++EY+  GSL   L      +D ++ L+    +   +EYL    +  
Sbjct: 76   GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 132
Query: 882  IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREGKV 939
             +H D+   N+L+       + DFG+ K+L +++   + K  G   I + APE   E K 
Sbjct: 133  YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 192
Query: 940  SRKCDVYSYGIMLMETFT----KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN 995
            S   DV+S+G++L E FT     K P  E         R +G+      I      +L+ 
Sbjct: 193  SVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGNDKQGQMIV----FHLIE 241
Query: 996  CEEND--FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSA 1045
              +N+      + C   I+ +  +C  +   +R S +D+A R+ +IR+ ++ 
Sbjct: 242  LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMAG 293

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 134/292 (45%), Gaps = 29/292 (9%)
Query: 769  LGMGSFGSV----YKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKII 823
            LG G+FGSV    Y  +  + G  +A K      +  L  F  E +++ S++H N+VK  
Sbjct: 25   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 824  SSCSNNDFK--ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
              C +   +   L++EY+  GSL   L      +D ++ L+    +   +EYL    +  
Sbjct: 85   GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 141
Query: 882  IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREGKV 939
             +H D+   N+L+       + DFG+ K+L +++   + K  G   I + APE   E K 
Sbjct: 142  YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 201
Query: 940  SRKCDVYSYGIMLMETFT----KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN 995
            S   DV+S+G++L E FT     K P  E         R +G+      I      +L+ 
Sbjct: 202  SVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGNDKQGQMIV----FHLIE 250
Query: 996  CEEND--FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSA 1045
              +N+      + C   I+ +  +C  +   +R S +D+A R+ +IR+ ++ 
Sbjct: 251  LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 302

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 135/292 (46%), Gaps = 29/292 (9%)
Query: 769  LGMGSFGSV----YKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKII 823
            LG G+FGSV    Y  +  + G  +A K      +  L  F  E +++ S++H N+VK  
Sbjct: 21   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 824  SSCSNNDFK--ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
              C +   +   L++EY+  GSL   L +    +D ++ L+    +   +EYL    +  
Sbjct: 81   GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLG---TKR 137
Query: 882  IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREGKV 939
             +H D+   N+L+       + DFG+ K+L +++   + K  G   I + APE   E K 
Sbjct: 138  YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 197
Query: 940  SRKCDVYSYGIMLMETFT----KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN 995
            S   DV+S+G++L E FT     K P  E         R +G+      I      +L+ 
Sbjct: 198  SVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGNDKQGQMIV----FHLIE 246
Query: 996  CEEND--FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSA 1045
              +N+      + C   I+ +  +C  +   +R S +D+A R+ +IR+ ++ 
Sbjct: 247  LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 298

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Composition-based stats.
 Identities = 60/192 (31%), Positives = 100/192 (52%), Gaps = 6/192 (3%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
           K LG G FG V+        ++A K        S+E+F AE  VM +++H  LVK+ +  
Sbjct: 21  KKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 79
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASAL-EYLHFGYSTPIVHC 885
           +      ++ E+M+ GSL   L SD       Q L  +ID ++ + E + F      +H 
Sbjct: 80  TKEPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 135
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L++ S+V  ++DFG+A+++   E   +      I + APE    G  + K DV
Sbjct: 136 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 195
Query: 946 YSYGIMLMETFT 957
           +S+GI+LME  T
Sbjct: 196 WSFGILLMEIVT 207

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 134/292 (45%), Gaps = 29/292 (9%)
Query: 769  LGMGSFGSV----YKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKII 823
            LG G+FGSV    Y  +  + G  +A K      +  L  F  E +++ S++H N+VK  
Sbjct: 18   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 824  SSCSNNDFK--ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
              C +   +   L++EY+  GSL   L      +D ++ L+    +   +EYL    +  
Sbjct: 78   GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134
Query: 882  IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREGKV 939
             +H D+   N+L+       + DFG+ K+L +++   + K  G   I + APE   E K 
Sbjct: 135  YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194
Query: 940  SRKCDVYSYGIMLMETFT----KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN 995
            S   DV+S+G++L E FT     K P  E         R +G+      I      +L+ 
Sbjct: 195  SVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGNDKQGQMIV----FHLIE 243
Query: 996  CEEND--FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSA 1045
              +N+      + C   I+ +  +C  +   +R S +D+A R+ +IR+ ++ 
Sbjct: 244  LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 295

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Composition-based stats.
 Identities = 57/195 (29%), Positives = 101/195 (51%), Gaps = 5/195 (2%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
           K LG G FG V+ G   +  ++A K        S+++F  E  +M +++H  LV++ +  
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL-KIMIDVASALEYLHFGYSTPIVHC 885
           +  +   ++ EYM+ GSL   L SD     +L +L      +A  + Y+        +H 
Sbjct: 78  TREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHR 134
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +NVL++ES++  ++DFG+A+++   E   +      I + APE    G  + K DV
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDV 194
Query: 946 YSYGIMLMETFTKKK 960
           +S+GI+L E  T  K
Sbjct: 195 WSFGILLYEIVTYGK 209

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 134/292 (45%), Gaps = 29/292 (9%)
Query: 769  LGMGSFGSV----YKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKII 823
            LG G+FGSV    Y  +  + G  +A K      +  L  F  E +++ S++H N+VK  
Sbjct: 23   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 824  SSCSNNDFK--ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
              C +   +   L++EY+  GSL   L      +D ++ L+    +   +EYL    +  
Sbjct: 83   GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 139
Query: 882  IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREGKV 939
             +H D+   N+L+       + DFG+ K+L +++   + K  G   I + APE   E K 
Sbjct: 140  YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 199
Query: 940  SRKCDVYSYGIMLMETFT----KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN 995
            S   DV+S+G++L E FT     K P  E         R +G+      I      +L+ 
Sbjct: 200  SVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGNDKQGQMIV----FHLIE 248
Query: 996  CEEND--FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSA 1045
              +N+      + C   I+ +  +C  +   +R S +D+A R+ +IR+ ++ 
Sbjct: 249  LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 300

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 134/291 (46%), Gaps = 29/291 (9%)
Query: 769  LGMGSFGSV----YKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKII 823
            LG G+FGSV    Y  +  + G  +A K      +  L  F  E +++ S++H N+VK  
Sbjct: 17   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 824  SSCSNNDFK--ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
              C +   +   L++EY+  GSL   L      +D ++ L+    +   +EYL    +  
Sbjct: 77   GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 133
Query: 882  IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREGKV 939
             +H D+   N+L+       + DFG+ K+L +++   + K  G   I + APE   E K 
Sbjct: 134  YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 193
Query: 940  SRKCDVYSYGIMLMETFT----KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN 995
            S   DV+S+G++L E FT     K P  E         R +G+      I      +L+ 
Sbjct: 194  SVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGNDKQGQMIV----FHLIE 242
Query: 996  CEEND--FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044
              +N+      + C   I+ +  +C  +   +R S +D+A R+ +IR+ ++
Sbjct: 243  LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 293

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 134/292 (45%), Gaps = 29/292 (9%)
Query: 769  LGMGSFGSV----YKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKII 823
            LG G+FGSV    Y  +  + G  +A K      +  L  F  E +++ S++H N+VK  
Sbjct: 21   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 824  SSCSNNDFK--ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
              C +   +   L++EY+  GSL   L      +D ++ L+    +   +EYL    +  
Sbjct: 81   GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 137
Query: 882  IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREGKV 939
             +H D+   N+L+       + DFG+ K+L +++   + K  G   I + APE   E K 
Sbjct: 138  YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 197
Query: 940  SRKCDVYSYGIMLMETFT----KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN 995
            S   DV+S+G++L E FT     K P  E         R +G+      I      +L+ 
Sbjct: 198  SVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGNDKQGQMIV----FHLIE 246
Query: 996  CEEND--FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSA 1045
              +N+      + C   I+ +  +C  +   +R S +D+A R+ +IR+ ++ 
Sbjct: 247  LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 298

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 81/315 (25%), Positives = 143/315 (45%), Gaps = 36/315 (11%)
Query: 751  ISYQDLLRATDGFSENKL-----LGMGSFGSV----YKGVLPD-GMEIAAKVFHMEFDGS 800
            ++++D  R    F E  L     LG G+FGSV    Y  +  + G  +A K      +  
Sbjct: 3    MAFED--RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH 60
Query: 801  LESFHAECKVMGSIRHRNLVKIISSCSNNDFK--ALVLEYMSNGSLEKCLYSDNYFLDIL 858
            L  F  E +++ S++H N+VK    C +   +   L++EY+  GSL   L      +D +
Sbjct: 61   LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 120
Query: 859  QRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR 918
            + L+    +   +EYL    +   +H D+   N+L+       + DFG+ K+L +++   
Sbjct: 121  KLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 177
Query: 919  QTKTLGT--IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT----KKKPTDEIFAGEMSL 972
            + K  G   I + APE   E K S   DV+S+G++L E FT     K P  E        
Sbjct: 178  KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM------ 231
Query: 973  KRWVGDSLLSCSITEVADANLLNCEEND--FSAREQCVSSIFSLAMDCTVDLPEKRISMK 1030
             R +G+      I      +L+   +N+      + C   I+ +  +C  +   +R S +
Sbjct: 232  -RMIGNDKQGQMIV----FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFR 286
Query: 1031 DVANRLVRIRETLSA 1045
            D+A R+ +IR+ ++ 
Sbjct: 287  DLALRVDQIRDNMAG 301

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Composition-based stats.
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 4/200 (2%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
           K LG G FG V  G      ++A K+   E   S + F  E KVM ++ H  LV++   C
Sbjct: 21  KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
           +      ++ EYM+NG L   L    +     Q L++  DV  A+EYL    S   +H D
Sbjct: 80  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 136
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+N+  V  +SDFG+++ +  +E      +   + +  PE     K S K D++
Sbjct: 137 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 196
Query: 947 SYGIMLMETFTKKKPTDEIF 966
           ++G+++ E ++  K   E F
Sbjct: 197 AFGVLMWEIYSLGKMPYERF 216

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Composition-based stats.
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 4/200 (2%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
           K LG G FG V  G      ++A K+   E   S + F  E KVM ++ H  LV++   C
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
           +      ++ EYM+NG L   L    +     Q L++  DV  A+EYL    S   +H D
Sbjct: 73  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 129
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+N+  V  +SDFG+++ +  +E      +   + +  PE     K S K D++
Sbjct: 130 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 189
Query: 947 SYGIMLMETFTKKKPTDEIF 966
           ++G+++ E ++  K   E F
Sbjct: 190 AFGVLMWEIYSLGKMPYERF 209

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Composition-based stats.
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 4/200 (2%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
           K LG G FG V  G      ++A K+   E   S + F  E KVM ++ H  LV++   C
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
           +      ++ EYM+NG L   L    +     Q L++  DV  A+EYL    S   +H D
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 130
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+N+  V  +SDFG+++ +  +E      +   + +  PE     K S K D++
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 190
Query: 947 SYGIMLMETFTKKKPTDEIF 966
           ++G+++ E ++  K   E F
Sbjct: 191 AFGVLMWEIYSLGKMPYERF 210

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Composition-based stats.
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 4/200 (2%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
           K LG G FG V  G      ++A K+   E   S + F  E KVM ++ H  LV++   C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
           +      ++ EYM+NG L   L    +     Q L++  DV  A+EYL    S   +H D
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 125
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+N+  V  +SDFG+++ +  +E      +   + +  PE     K S K D++
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 185
Query: 947 SYGIMLMETFTKKKPTDEIF 966
           ++G+++ E ++  K   E F
Sbjct: 186 AFGVLMWEIYSLGKMPYERF 205

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 133/290 (45%), Gaps = 29/290 (10%)
Query: 769  LGMGSFGSV----YKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKII 823
            LG G+FGSV    Y  +  + G  +A K      +  L  F  E +++ S++H N+VK  
Sbjct: 36   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 824  SSCSNNDFK--ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
              C +   +   L++EY+  GSL   L      +D ++ L+    +   +EYL    +  
Sbjct: 96   GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 152
Query: 882  IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREGKV 939
             +H D+   N+L+       + DFG+ K+L +++   + K  G   I + APE   E K 
Sbjct: 153  YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 212
Query: 940  SRKCDVYSYGIMLMETFT----KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN 995
            S   DV+S+G++L E FT     K P  E         R +G+      I      +L+ 
Sbjct: 213  SVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGNDKQGQMIV----FHLIE 261
Query: 996  CEEND--FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043
              +N+      + C   I+ +  +C  +   +R S +D+A R+ +IR+ +
Sbjct: 262  LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 311

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 4/200 (2%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
           K LG G FG V  G      ++A K+   E   S + F  E KVM ++ H  LV++   C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
           +      ++ EYM+NG L   L    +     Q L++  DV  A+EYL    S   +H D
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 145
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+N+  V  +SDFG+++ +  +E      +   + +  PE     K S K D++
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 947 SYGIMLMETFTKKKPTDEIF 966
           ++G+++ E ++  K   E F
Sbjct: 206 AFGVLMWEIYSLGKMPYERF 225

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Composition-based stats.
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 4/200 (2%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
           K LG G FG V  G      ++A K+   E   S + F  E KVM ++ H  LV++   C
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
           +      ++ EYM+NG L   L    +     Q L++  DV  A+EYL    S   +H D
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 130
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+N+  V  +SDFG+++ +  +E      +   + +  PE     K S K D++
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIW 190
Query: 947 SYGIMLMETFTKKKPTDEIF 966
           ++G+++ E ++  K   E F
Sbjct: 191 AFGVLMWEIYSLGKMPYERF 210

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 136/294 (46%), Gaps = 29/294 (9%)
Query: 767  KLLGMGSFGSV----YKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVK 821
            + LG G+FGSV    Y  +  + G  +A K      +  L  F  E +++ S++H N+VK
Sbjct: 19   RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 822  IISSCSNNDFK--ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
                C +   +   L++E++  GSL + L      +D ++ L+    +   +EYL    +
Sbjct: 79   YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLG---T 135
Query: 880  TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREG 937
               +H D+   N+L+       + DFG+ K+L +++   + K  G   I + APE   E 
Sbjct: 136  KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 938  KVSRKCDVYSYGIMLMETFT----KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL 993
            K S   DV+S+G++L E FT     K P  E         R +G+      I      +L
Sbjct: 196  KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGNDKQGQMIV----FHL 244
Query: 994  LNCEEND--FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSA 1045
            +   +N+      + C   I+ +  +C  +   +R S +D+A R+ +IR+ ++ 
Sbjct: 245  IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 298

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 60/223 (26%), Positives = 110/223 (49%), Gaps = 21/223 (9%)
Query: 752 SYQDLLRATDGFSEN---------KLLGMGSFGSVYKG--VLPDGMEIAAKVFHMEF--- 797
           +Y+D  RA   F++          +++G G FG V  G   LP   ++A  +  ++    
Sbjct: 25  TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT 84
Query: 798 DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDI 857
           +     F  E  +MG   H N+V +    +      +V+E+M NG+L+  L   +    +
Sbjct: 85  EKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV 144
Query: 858 LQRLKIMIDVASALEYL-HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES 916
           +Q + ++  +A+ + YL   GY    VH D+   N+L+N ++V  +SDFG+++++  +  
Sbjct: 145 IQLVGMLRGIAAGMRYLADMGY----VHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPE 200
Query: 917 MRQTKTLGTIG--YMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
              T T G I   + APE  +  K +   DV+SYGI++ E  +
Sbjct: 201 AVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 10/199 (5%)
Query: 766 NKLLGMGSFGSVYKGVL--PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLV 820
            K++G+G FG V  G L  P   EI   +  ++    D     F +E  +MG   H N++
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
            +    +      ++ EYM NGSL+  L  ++    ++Q + ++  + S ++YL      
Sbjct: 94  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DM 150
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREGK 938
             VH D+   N+L+N ++V  +SDFG++++L  +     T   G   I + APE     K
Sbjct: 151 SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 210
Query: 939 VSRKCDVYSYGIMLMETFT 957
            +   DV+SYGI++ E  +
Sbjct: 211 FTSASDVWSYGIVMWEVMS 229

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 121/287 (42%), Gaps = 48/287 (16%)
Query: 769  LGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLES-FHAECKVMGSIRHRNLVKIISSC 826
            +G G+FG V+ G L  D   +A K         L++ F  E +++    H N+V++I  C
Sbjct: 122  IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 827  SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
            +      +V+E +  G     L ++   L +   L+++ D A+ +EYL    S   +H D
Sbjct: 182  TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 887  IKPSNVLLNESMVGHLSDFGIAK-----ILGKEESMRQTKTLGTIGYMAPEYGREGKVSR 941
            +   N L+ E  V  +SDFG+++     +      +RQ      + + APE    G+ S 
Sbjct: 239  LAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQV----PVKWTAPEALNYGRYSS 294
Query: 942  KCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDF 1001
            + DV+S+GI+L ETF                           S+      NL N +  +F
Sbjct: 295  ESDVWSFGILLWETF---------------------------SLGASPYPNLSNQQTREF 327
Query: 1002 SAR-------EQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041
              +       E C  ++F L   C    P +R S   +   L  IR+
Sbjct: 328  VEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 121/287 (42%), Gaps = 48/287 (16%)
Query: 769  LGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLES-FHAECKVMGSIRHRNLVKIISSC 826
            +G G+FG V+ G L  D   +A K         L++ F  E +++    H N+V++I  C
Sbjct: 122  IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 827  SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
            +      +V+E +  G     L ++   L +   L+++ D A+ +EYL    S   +H D
Sbjct: 182  TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 887  IKPSNVLLNESMVGHLSDFGIAK-----ILGKEESMRQTKTLGTIGYMAPEYGREGKVSR 941
            +   N L+ E  V  +SDFG+++     +      +RQ      + + APE    G+ S 
Sbjct: 239  LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV----PVKWTAPEALNYGRYSS 294
Query: 942  KCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDF 1001
            + DV+S+GI+L ETF                           S+      NL N +  +F
Sbjct: 295  ESDVWSFGILLWETF---------------------------SLGASPYPNLSNQQTREF 327
Query: 1002 SAR-------EQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041
              +       E C  ++F L   C    P +R S   +   L  IR+
Sbjct: 328  VEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 10/199 (5%)
Query: 766 NKLLGMGSFGSVYKGVL--PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLV 820
            K++G+G FG V  G L  P   EI   +  ++    D     F +E  +MG   H N++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
            +    +      ++ EYM NGSL+  L  ++    ++Q + ++  + S ++YL      
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DM 135
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREGK 938
             VH D+   N+L+N ++V  +SDFG++++L  +     T   G   I + APE     K
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 195
Query: 939 VSRKCDVYSYGIMLMETFT 957
            +   DV+SYGI++ E  +
Sbjct: 196 FTSASDVWSYGIVMWEVMS 214

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 10/199 (5%)
Query: 766 NKLLGMGSFGSVYKGVL--PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLV 820
            K++G+G FG V  G L  P   EI   +  ++    D     F +E  +MG   H N++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
            +    +      ++ EYM NGSL+  L  ++    ++Q + ++  + S ++YL      
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DM 129
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREGK 938
             VH D+   N+L+N ++V  +SDFG++++L  +     T   G   I + APE     K
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 189
Query: 939 VSRKCDVYSYGIMLMETFT 957
            +   DV+SYGI++ E  +
Sbjct: 190 FTSASDVWSYGIVMWEVMS 208

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 9/206 (4%)
Query: 761 DGFSENKLLGMGSFGSVYKG-VLPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRH 816
           + F   K+LG GSF +V     L    E A K+    H+  +  +     E  VM  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
              VK+  +  +++     L Y  NG L K +     F +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGTIGYMAPEYGR 935
                I+H D+KP N+LLNE M   ++DFG AK+L  E +  R    +GT  Y++PE   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 207
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           E   S+  D+++ G ++ +      P
Sbjct: 208 EKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 134/292 (45%), Gaps = 29/292 (9%)
Query: 769  LGMGSFGSV----YKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKII 823
            LG G+FGSV    Y  +  + G  +A K      +  L  F  E +++ S++H N+VK  
Sbjct: 19   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 824  SSCSNNDFK--ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
              C +   +   L++EY+  GSL   L      +D ++ L+    +   +EYL    +  
Sbjct: 79   GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 135
Query: 882  IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREGKV 939
             +H ++   N+L+       + DFG+ K+L +++   + K  G   I + APE   E K 
Sbjct: 136  YIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF 195
Query: 940  SRKCDVYSYGIMLMETFT----KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN 995
            S   DV+S+G++L E FT     K P  E         R +G+      I      +L+ 
Sbjct: 196  SVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGNDKQGQMIV----FHLIE 244
Query: 996  CEEND--FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSA 1045
              +N+      + C   I+ +  +C  +   +R S +D+A R+ +IR+ ++ 
Sbjct: 245  LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 296

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 110/223 (49%), Gaps = 12/223 (5%)
Query: 749 RRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFD--GSLESFHA 806
           RR S  D        +  + +G GSFG+VYKG      ++A K+ ++       L++F  
Sbjct: 24  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN 81
Query: 807 ECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMID 866
           E  V+   RH N++  +   +     A+V ++    SL   L+      ++++ + I   
Sbjct: 82  EVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 140
Query: 867 VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GT 925
            A  ++YLH   +  I+H D+K +N+ L+E +   + DFG+A +  +     Q + L G+
Sbjct: 141 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 197
Query: 926 IGYMAPEYGR---EGKVSRKCDVYSYGIMLMETFTKKKPTDEI 965
           I +MAPE  R   +   S + DVY++GI+L E  T + P   I
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 240

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/307 (23%), Positives = 138/307 (44%), Gaps = 45/307 (14%)
Query: 752  SYQDLLRATDGFSEN---------KLLGMGSFGSVYKG--VLPDGME--IAAKVFHMEF- 797
            +Y+D  +A   F++          +++G G FG V  G   LP   E  +A K   + + 
Sbjct: 4    TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 798  DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDI 857
            +     F  E  +MG   H N++ +    + +    +V EYM NGSL+  L  ++    +
Sbjct: 64   EKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV 123
Query: 858  LQRLKIMIDVASALEYL-HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES 916
            +Q + ++  +++ ++YL   GY    VH D+   N+L+N ++V  +SDFG++++L  +  
Sbjct: 124  IQLVGMLRGISAGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 179
Query: 917  MRQTKTLGT--IGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
               T   G   I + APE     K +   DV+SYGI++ E  +          GE     
Sbjct: 180  AAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVS---------YGERPY-- 228
Query: 975  WVGDSLLSCSITEVADANLLNCEENDFS--AREQCVSSIFSLAMDCTVDLPEKRISMKDV 1032
            W           E+ + +++   E  +   +   C ++++ L +DC       R    ++
Sbjct: 229  W-----------EMTNQDVIKAVEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEI 277
Query: 1033 ANRLVRI 1039
             N L ++
Sbjct: 278  VNMLDKL 284

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 744 PQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLES 803
           PQ  W + +++      +     K LG G FG V+        ++A K        S+E+
Sbjct: 168 PQKPWEKDAWE---IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEA 223
Query: 804 FHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI 863
           F AE  VM +++H  LVK+ +  +      ++ E+M+ GSL   L SD       Q L  
Sbjct: 224 FLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPK 279
Query: 864 MIDVASAL-EYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT 922
           +ID ++ + E + F      +H D++ +N+L++ S+V  ++DFG+A++  K         
Sbjct: 280 LIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAK--------- 330
Query: 923 LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
              I + APE    G  + K DV+S+GI+LME  T
Sbjct: 331 -FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 364

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 104/203 (51%), Gaps = 12/203 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSC 826
           +G GSFG+VYKG      ++A K+ ++       L++F  E  V+   RH N++  +   
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
           +     A+V ++    SL   L+      ++++ + I    A  ++YLH   +  I+H D
Sbjct: 74  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGYMAPEYGR---EGKVSRK 942
           +K +N+ L+E +   + DFG+A +  +     Q + L G+I +MAPE  R   +   S +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 943 CDVYSYGIMLMETFTKKKPTDEI 965
            DVY++GI+L E  T + P   I
Sbjct: 190 SDVYAFGIVLYELMTGQLPYSNI 212

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 110/223 (49%), Gaps = 12/223 (5%)
Query: 749 RRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFD--GSLESFHA 806
           RR S  D        +  + +G GSFG+VYKG      ++A K+ ++       L++F  
Sbjct: 23  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN 80
Query: 807 ECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMID 866
           E  V+   RH N++  +   +     A+V ++    SL   L+      ++++ + I   
Sbjct: 81  EVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 139
Query: 867 VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GT 925
            A  ++YLH   +  I+H D+K +N+ L+E +   + DFG+A +  +     Q + L G+
Sbjct: 140 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 196
Query: 926 IGYMAPEYGR---EGKVSRKCDVYSYGIMLMETFTKKKPTDEI 965
           I +MAPE  R   +   S + DVY++GI+L E  T + P   I
Sbjct: 197 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 239

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 9/226 (3%)
Query: 741 NMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKG-VLPDGMEIAAKVF---HME 796
           N+Y Q    +   Q   +  + F   K+LG GSF +V     L    E A K+    H+ 
Sbjct: 9   NLYFQGQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII 68
Query: 797 FDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLD 856
            +  +     E  VM  + H   VK+  +  +++     L Y  NG L K +     F +
Sbjct: 69  KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE 128
Query: 857 ILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-E 915
              R     ++ SALEYLH      I+H D+KP N+LLNE M   ++DFG AK+L  E +
Sbjct: 129 TCTRF-YTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 184
Query: 916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
             R    +GT  Y++PE   E    +  D+++ G ++ +      P
Sbjct: 185 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 84.3 bits (207), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 104/203 (51%), Gaps = 12/203 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSC 826
           +G GSFG+VYKG      ++A K+ ++       L++F  E  V+   RH N++  +   
Sbjct: 18  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
           +     A+V ++    SL   L+      ++++ + I    A  ++YLH   +  I+H D
Sbjct: 76  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 131
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGYMAPEYGR---EGKVSRK 942
           +K +N+ L+E +   + DFG+A +  +     Q + L G+I +MAPE  R   +   S +
Sbjct: 132 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 191
Query: 943 CDVYSYGIMLMETFTKKKPTDEI 965
            DVY++GI+L E  T + P   I
Sbjct: 192 SDVYAFGIVLYELMTGQLPYSNI 214

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 104/203 (51%), Gaps = 12/203 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSC 826
           +G GSFG+VYKG      ++A K+ ++       L++F  E  V+   RH N++  +   
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
           +     A+V ++    SL   L+      ++++ + I    A  ++YLH   +  I+H D
Sbjct: 79  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 134
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGYMAPEYGR---EGKVSRK 942
           +K +N+ L+E +   + DFG+A +  +     Q + L G+I +MAPE  R   +   S +
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 194
Query: 943 CDVYSYGIMLMETFTKKKPTDEI 965
            DVY++GI+L E  T + P   I
Sbjct: 195 SDVYAFGIVLYELMTGQLPYSNI 217

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 104/203 (51%), Gaps = 12/203 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSC 826
           +G GSFG+VYKG      ++A K+ ++       L++F  E  V+   RH N++  +   
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
           +     A+V ++    SL   L+      ++++ + I    A  ++YLH   +  I+H D
Sbjct: 79  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 134
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGYMAPEYGR---EGKVSRK 942
           +K +N+ L+E +   + DFG+A +  +     Q + L G+I +MAPE  R   +   S +
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 194
Query: 943 CDVYSYGIMLMETFTKKKPTDEI 965
            DVY++GI+L E  T + P   I
Sbjct: 195 SDVYAFGIVLYELMTGQLPYSNI 217

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 9/226 (3%)
Query: 741 NMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKG-VLPDGMEIAAKVF---HME 796
           N+Y Q    +   Q   +  + F   K+LG GSF +V     L    E A K+    H+ 
Sbjct: 9   NLYFQGQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII 68
Query: 797 FDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLD 856
            +  +     E  VM  + H   VK+  +  +++     L Y  NG L K +     F +
Sbjct: 69  KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE 128
Query: 857 ILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-E 915
              R     ++ SALEYLH      I+H D+KP N+LLNE M   ++DFG AK+L  E +
Sbjct: 129 TCTRF-YTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 184
Query: 916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
             R    +GT  Y++PE   E    +  D+++ G ++ +      P
Sbjct: 185 QARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 104/203 (51%), Gaps = 12/203 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSC 826
           +G GSFG+VYKG      ++A K+ ++       L++F  E  V+   RH N++  +   
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
           +     A+V ++    SL   L+      ++++ + I    A  ++YLH   +  I+H D
Sbjct: 74  TAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGYMAPEYGR---EGKVSRK 942
           +K +N+ L+E +   + DFG+A +  +     Q + L G+I +MAPE  R   +   S +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 943 CDVYSYGIMLMETFTKKKPTDEI 965
            DVY++GI+L E  T + P   I
Sbjct: 190 SDVYAFGIVLYELMTGQLPYSNI 212

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 5e-16,   Method: Composition-based stats.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIIS 824
           K LG G FG V+ G      ++A K       G++  ESF  E ++M  ++H  LV++ +
Sbjct: 15  KRLGNGQFGEVWMGTWNGNTKVAIKTLK---PGTMSPESFLEEAQIMKKLKHDKLVQLYA 71
Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYS-DNYFLDILQRLKIMIDVASALEYLHFGYSTPIV 883
             S      +V EYM+ GSL   L   +   L +   + +   VA+ + Y+        +
Sbjct: 72  VVSEEPI-YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYI 127
Query: 884 HCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKC 943
           H D++ +N+L+   ++  ++DFG+A+++   E   +      I + APE    G+ + K 
Sbjct: 128 HRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 944 DVYSYGIMLMETFTKKK 960
           DV+S+GI+L E  TK +
Sbjct: 188 DVWSFGILLTELVTKGR 204

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Composition-based stats.
 Identities = 55/195 (28%), Positives = 101/195 (51%), Gaps = 5/195 (2%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
           K LG G FG V+ G   +  ++A K        S+++F  E  +M +++H  LV++ +  
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL-KIMIDVASALEYLHFGYSTPIVHC 885
           +  +   ++ E+M+ GSL   L SD     +L +L      +A  + Y+        +H 
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHR 133
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +NVL++ES++  ++DFG+A+++   E   +      I + APE    G  + K +V
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNV 193
Query: 946 YSYGIMLMETFTKKK 960
           +S+GI+L E  T  K
Sbjct: 194 WSFGILLYEIVTYGK 208

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 83.6 bits (205), Expect = 6e-16,   Method: Composition-based stats.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 761 DGFSENKLLGMGSFGSVYKG-VLPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRH 816
           + F   K+LG GSF +V     L    E A K+    H+  +  +     E  VM  + H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
              VK+  +  +++     L Y  NG L K +     F +   R     ++ SALEYLH 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 150
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGTIGYMAPEYGR 935
                I+H D+KP N+LLNE M   ++DFG AK+L  E +  R    +GT  Y++PE   
Sbjct: 151 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 208
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           E    +  D+++ G ++ +      P
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 6e-16,   Method: Composition-based stats.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 761 DGFSENKLLGMGSFGSVYKG-VLPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRH 816
           + F   K+LG GSF +V     L    E A K+    H+  +  +     E  VM  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
              VK+  +  +++     L Y  NG L K +     F +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGTIGYMAPEYGR 935
                I+H D+KP N+LLNE M   ++DFG AK+L  E +  R    +GT  Y++PE   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           E    +  D+++ G ++ +      P
Sbjct: 208 EKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Composition-based stats.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 761 DGFSENKLLGMGSFGSVYKG-VLPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRH 816
           + F   K+LG GSF +V     L    E A K+    H+  +  +     E  VM  + H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
              VK+  +  +++     L Y  NG L K +     F +   R     ++ SALEYLH 
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 126
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGTIGYMAPEYGR 935
                I+H D+KP N+LLNE M   ++DFG AK+L  E +  R    +GT  Y++PE   
Sbjct: 127 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 184
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           E    +  D+++ G ++ +      P
Sbjct: 185 EKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Composition-based stats.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 761 DGFSENKLLGMGSFGSVYKG-VLPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRH 816
           + F   K+LG GSF +V     L    E A K+    H+  +  +     E  VM  + H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
              VK+  +  +++     L Y  NG L K +     F +   R     ++ SALEYLH 
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 127
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGTIGYMAPEYGR 935
                I+H D+KP N+LLNE M   ++DFG AK+L  E +  R    +GT  Y++PE   
Sbjct: 128 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 185
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           E    +  D+++ G ++ +      P
Sbjct: 186 EKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Composition-based stats.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 761 DGFSENKLLGMGSFGSVYKG-VLPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRH 816
           + F   K+LG GSF +V     L    E A K+    H+  +  +     E  VM  + H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
              VK+  +  +++     L Y  NG L K +     F +   R     ++ SALEYLH 
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 125
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGTIGYMAPEYGR 935
                I+H D+KP N+LLNE M   ++DFG AK+L  E +  R    +GT  Y++PE   
Sbjct: 126 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 183
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           E    +  D+++ G ++ +      P
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Composition-based stats.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 761 DGFSENKLLGMGSFGSVYKG-VLPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRH 816
           + F   K+LG GSF +V     L    E A K+    H+  +  +     E  VM  + H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
              VK+  +  +++     L Y  NG L K +     F +   R     ++ SALEYLH 
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 124
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGTIGYMAPEYGR 935
                I+H D+KP N+LLNE M   ++DFG AK+L  E +  R    +GT  Y++PE   
Sbjct: 125 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 182
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           E    +  D+++ G ++ +      P
Sbjct: 183 EKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Composition-based stats.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 761 DGFSENKLLGMGSFGSVYKG-VLPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRH 816
           + F   K+LG GSF +V     L    E A K+    H+  +  +     E  VM  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
              VK+  +  +++     L Y  NG L K +     F +   R     ++ SALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGTIGYMAPEYGR 935
                I+H D+KP N+LLNE M   ++DFG AK+L  E +  R    +GT  Y++PE   
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           E    +  D+++ G ++ +      P
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Composition-based stats.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 761 DGFSENKLLGMGSFGSVYKG-VLPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRH 816
           + F   K+LG GSF +V     L    E A K+    H+  +  +     E  VM  + H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
              VK+  +  +++     L Y  NG L K +     F +   R     ++ SALEYLH 
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 131
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGTIGYMAPEYGR 935
                I+H D+KP N+LLNE M   ++DFG AK+L  E +  R    +GT  Y++PE   
Sbjct: 132 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 189
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           E    +  D+++ G ++ +      P
Sbjct: 190 EKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Composition-based stats.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 761 DGFSENKLLGMGSFGSVYKG-VLPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRH 816
           + F   K+LG GSF +V     L    E A K+    H+  +  +     E  VM  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
              VK+  +  +++     L Y  NG L K +     F +   R     ++ SALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGTIGYMAPEYGR 935
                I+H D+KP N+LLNE M   ++DFG AK+L  E +  R    +GT  Y++PE   
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           E    +  D+++ G ++ +      P
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Composition-based stats.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 761 DGFSENKLLGMGSFGSVYKG-VLPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRH 816
           + F   K+LG GSF +V     L    E A K+    H+  +  +     E  VM  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
              VK+  +  +++     L Y  NG L K +     F +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGTIGYMAPEYGR 935
                I+H D+KP N+LLNE M   ++DFG AK+L  E +  R    +GT  Y++PE   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           E    +  D+++ G ++ +      P
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Composition-based stats.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 761 DGFSENKLLGMGSFGSVYKG-VLPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRH 816
           + F   K+LG GSF +V     L    E A K+    H+  +  +     E  VM  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
              VK+  +  +++     L Y  NG L K +     F +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGTIGYMAPEYGR 935
                I+H D+KP N+LLNE M   ++DFG AK+L  E +  R    +GT  Y++PE   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           E    +  D+++ G ++ +      P
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Composition-based stats.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 761 DGFSENKLLGMGSFGSVYKG-VLPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRH 816
           + F   K+LG GSF +V     L    E A K+    H+  +  +     E  VM  + H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
              VK+  +  +++     L Y  NG L K +     F +   R     ++ SALEYLH 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 150
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGTIGYMAPEYGR 935
                I+H D+KP N+LLNE M   ++DFG AK+L  E +  R    +GT  Y++PE   
Sbjct: 151 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 208
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           E    +  D+++ G ++ +      P
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Composition-based stats.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 761 DGFSENKLLGMGSFGSVYKG-VLPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRH 816
           + F   K+LG GSF +V     L    E A K+    H+  +  +     E  VM  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
              VK+  +  +++     L Y  NG L K +     F +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGTIGYMAPEYGR 935
                I+H D+KP N+LLNE M   ++DFG AK+L  E +  R    +GT  Y++PE   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           E    +  D+++ G ++ +      P
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Composition-based stats.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 761 DGFSENKLLGMGSFGSVYKG-VLPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRH 816
           + F   K+LG GSF +V     L    E A K+    H+  +  +     E  VM  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
              VK+  +  +++     L Y  NG L K +     F +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGTIGYMAPEYGR 935
                I+H D+KP N+LLNE M   ++DFG AK+L  E +  R    +GT  Y++PE   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           E    +  D+++ G ++ +      P
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Composition-based stats.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 761 DGFSENKLLGMGSFGSVYKG-VLPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRH 816
           + F   K+LG GSF +V     L    E A K+    H+  +  +     E  VM  + H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
              VK+  +  +++     L Y  NG L K +     F +   R     ++ SALEYLH 
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 152
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGTIGYMAPEYGR 935
                I+H D+KP N+LLNE M   ++DFG AK+L  E +  R    +GT  Y++PE   
Sbjct: 153 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 210
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           E    +  D+++ G ++ +      P
Sbjct: 211 EKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Composition-based stats.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 761 DGFSENKLLGMGSFGSVYKG-VLPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRH 816
           + F   K+LG GSF +V     L    E A K+    H+  +  +     E  VM  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
              VK+  +  +++     L Y  NG L K +     F +   R     ++ SALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGTIGYMAPEYGR 935
                I+H D+KP N+LLNE M   ++DFG AK+L  E +  R    +GT  Y++PE   
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLT 205
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           E    +  D+++ G ++ +      P
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-16,   Method: Composition-based stats.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 761 DGFSENKLLGMGSFGS-VYKGVLPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRH 816
           + F   K+LG GSF + V    L    E A K+    H+  +  +     E  VM  + H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
              VK+  +  +++     L Y  NG L K +     F +   R     ++ SALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGTIGYMAPEYGR 935
                I+H D+KP N+LLNE M   ++DFG AK+L  E +  R    +GT  Y++PE   
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           E    +  D+++ G ++ +      P
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 4/192 (2%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSN 828
           +G G FG V+ G   +  ++A K    E   S E F  E +VM  + H  LV++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 829 NDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIK 888
                LV E+M +G L   L +          L + +DV   + YL       ++H D+ 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EASVIHRDLA 130
Query: 889 PSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSY 948
             N L+ E+ V  +SDFG+ + +  ++    T T   + + +PE     + S K DV+S+
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 190
Query: 949 GIMLMETFTKKK 960
           G+++ E F++ K
Sbjct: 191 GVLMWEVFSEGK 202

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 761 DGFSENKLLGMGSFGSVYKG-VLPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRH 816
           + F   K+LG GSF +V     L    E A K+    H+  +  +     E  VM  + H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
              VK+     +++     L Y  NG L K +     F +   R     ++ SALEYLH 
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 154
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGTIGYMAPEYGR 935
                I+H D+KP N+LLNE M   ++DFG AK+L  E +  R    +GT  Y++PE   
Sbjct: 155 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 212
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           E    +  D+++ G ++ +      P
Sbjct: 213 EKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 109/223 (48%), Gaps = 12/223 (5%)
Query: 749 RRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFD--GSLESFHA 806
           RR S  D        +  + +G GSFG+VYKG      ++A K+ ++       L++F  
Sbjct: 16  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN 73
Query: 807 ECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMID 866
           E  V+   RH N++  +   +     A+V ++    SL   L+      ++++ + I   
Sbjct: 74  EVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 132
Query: 867 VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GT 925
            A  ++YLH   +  I+H D+K +N+ L+E +   + DFG+A    +     Q + L G+
Sbjct: 133 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 189
Query: 926 IGYMAPEYGR---EGKVSRKCDVYSYGIMLMETFTKKKPTDEI 965
           I +MAPE  R   +   S + DVY++GI+L E  T + P   I
Sbjct: 190 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 232

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 109/223 (48%), Gaps = 12/223 (5%)
Query: 749 RRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFD--GSLESFHA 806
           RR S  D        +  + +G GSFG+VYKG      ++A K+ ++       L++F  
Sbjct: 24  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN 81
Query: 807 ECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMID 866
           E  V+   RH N++  +   +     A+V ++    SL   L+      ++++ + I   
Sbjct: 82  EVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 140
Query: 867 VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GT 925
            A  ++YLH   +  I+H D+K +N+ L+E +   + DFG+A    +     Q + L G+
Sbjct: 141 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 197
Query: 926 IGYMAPEYGR---EGKVSRKCDVYSYGIMLMETFTKKKPTDEI 965
           I +MAPE  R   +   S + DVY++GI+L E  T + P   I
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 240

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 12/203 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSC 826
           +G GSFG+VYKG      ++A K+ ++       L++F  E  V+   RH N++  +   
Sbjct: 20  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
           +     A+V ++    SL   L++     ++ + + I    A  ++YLH   +  I+H D
Sbjct: 78  TKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 133
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGYMAPEYGR---EGKVSRK 942
           +K +N+ L+E     + DFG+A +  +     Q + L G+I +MAPE  R       S +
Sbjct: 134 LKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 193
Query: 943 CDVYSYGIMLMETFTKKKPTDEI 965
            DVY++GI+L E  T + P   I
Sbjct: 194 SDVYAFGIVLYELMTGQLPYSNI 216

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 4/192 (2%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSN 828
           +G G FG V+ G   +  ++A K    E   S E F  E +VM  + H  LV++   C  
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 829 NDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIK 888
                LV E+M +G L   L +          L + +DV   + YL       ++H D+ 
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 128
Query: 889 PSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSY 948
             N L+ E+ V  +SDFG+ + +  ++    T T   + + +PE     + S K DV+S+
Sbjct: 129 ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 188
Query: 949 GIMLMETFTKKK 960
           G+++ E F++ K
Sbjct: 189 GVLMWEVFSEGK 200

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 4/192 (2%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSN 828
           +G G FG V+ G   +  ++A K    E   S E F  E +VM  + H  LV++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 829 NDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIK 888
                LV E+M +G L   L +          L + +DV   + YL       ++H D+ 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 130
Query: 889 PSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSY 948
             N L+ E+ V  +SDFG+ + +  ++    T T   + + +PE     + S K DV+S+
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 190
Query: 949 GIMLMETFTKKK 960
           G+++ E F++ K
Sbjct: 191 GVLMWEVFSEGK 202

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 12/203 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSC 826
           +G GSFG+VYKG      ++A K+ ++       L++F  E  V+   RH N++  +   
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
           +     A+V ++    SL   L+      ++++ + I    A  ++YLH   +  I+H D
Sbjct: 74  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGYMAPEYGR---EGKVSRK 942
           +K +N+ L+E +   + DFG+A    +     Q + L G+I +MAPE  R   +   S +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 943 CDVYSYGIMLMETFTKKKPTDEI 965
            DVY++GI+L E  T + P   I
Sbjct: 190 SDVYAFGIVLYELMTGQLPYSNI 212

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 112/255 (43%), Gaps = 22/255 (8%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVF-------HMEFDGSLESFHAECKV 810
           A +     K +G G FG V+KG L  D   +A K           E     + F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 811 MGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASA 870
           M ++ H N+VK+     N     +V+E++  G L   L    + +    +L++M+D+A  
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 871 LEYLHFGYSTPIVHCDIKPSNVLL-----NESMVGHLSDFGIAKILGKEESMRQTKTLGT 925
           +EY+    + PIVH D++  N+ L     N  +   ++DFG    L ++     +  LG 
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG----LSQQSVHSVSGLLGN 189
Query: 926 IGYMAPEY--GREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSC 983
             +MAPE     E   + K D YS+ ++L    T + P DE   G++     + +  L  
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249
Query: 984 SITEVADANLLNCEE 998
           +I E     L N  E
Sbjct: 250 TIPEDCPPRLRNVIE 264

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 4/192 (2%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSN 828
           +G G FG V+ G   +  ++A K    E   S E F  E +VM  + H  LV++   C  
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 829 NDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIK 888
                LV E+M +G L   L +          L + +DV   + YL       ++H D+ 
Sbjct: 77  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 133
Query: 889 PSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSY 948
             N L+ E+ V  +SDFG+ + +  ++    T T   + + +PE     + S K DV+S+
Sbjct: 134 ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 193
Query: 949 GIMLMETFTKKK 960
           G+++ E F++ K
Sbjct: 194 GVLMWEVFSEGK 205

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 125/264 (47%), Gaps = 36/264 (13%)
Query: 766  NKLLGMGSFGSVYKGVL--PDGME--IAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLV 820
             +++G G FG V +G L  P   E  +A K     + +     F +E  +MG   H N++
Sbjct: 21   EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 821  KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
            ++    +N+    ++ E+M NG+L+  L  ++    ++Q + ++  +AS + YL      
Sbjct: 81   RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA---EM 137
Query: 881  PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES-MRQTKTLG---TIGYMAPEYGRE 936
              VH D+   N+L+N ++V  +SDFG+++ L +  S   +T +LG    I + APE    
Sbjct: 138  SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAF 197
Query: 937  GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC 996
             K +   D +SYGI++ E  +          GE     W           ++++ +++N 
Sbjct: 198  RKFTSASDAWSYGIVMWEVMS---------FGERPY--W-----------DMSNQDVINA 235
Query: 997  EENDFS--AREQCVSSIFSLAMDC 1018
             E D+       C +S+  L +DC
Sbjct: 236  IEQDYRLPPPPDCPTSLHQLMLDC 259

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 83/338 (24%), Positives = 140/338 (41%), Gaps = 71/338 (21%)
Query: 739  DANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKG-VLPDGM----------E 787
            D  +YP   W  I +QD++            G G+FG V K  +  DG+          E
Sbjct: 5    DPTIYPVLDWNDIKFQDVI------------GEGNFGQVLKARIKKDGLRMDAAIKRMKE 52
Query: 788  IAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSL--- 844
             A+K  H +F G LE     CK+     H N++ ++ +C +  +  L +EY  +G+L   
Sbjct: 53   YASKDDHRDFAGELEVL---CKLG---HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 106
Query: 845  ---EKCLYSDNYF---------LDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNV 892
                + L +D  F         L   Q L    DVA  ++YL        +H D+   N+
Sbjct: 107  LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNI 163
Query: 893  LLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIML 952
            L+ E+ V  ++DFG+++  G+E  +++T     + +MA E       +   DV+SYG++L
Sbjct: 164  LVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 221
Query: 953  METFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSI 1011
             E  +    P   +   E+  K   G  L             LNC++            +
Sbjct: 222  WEIVSLGGTPYCGMTCAELYEKLPQGYRL----------EKPLNCDD-----------EV 260
Query: 1012 FSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYIDV 1049
            + L   C  + P +R S   +   L R+ E    Y++ 
Sbjct: 261  YDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNT 298

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 123/263 (46%), Gaps = 18/263 (6%)
Query: 755  DLLRATDGFSENK---LLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKV 810
            DLL     + EN    +LG G++G VY G  L + + IA K          +  H E  +
Sbjct: 13   DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIAL 72
Query: 811  MGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSD-NYFLDILQRLKIMI-DVA 868
               ++H+N+V+ + S S N F  + +E +  GSL   L S      D  Q +      + 
Sbjct: 73   HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 132
Query: 869  SALEYLHFGYSTPIVHCDIKPSNVLLNE-SMVGHLSDFGIAKILGKEESMRQTKTLGTIG 927
              L+YLH      IVH DIK  NVL+N  S V  +SDFG +K L       +T T GT+ 
Sbjct: 133  EGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQ 188
Query: 928  YMAPEYGREGK--VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVG----DSLL 981
            YMAPE   +G     +  D++S G  ++E  T K P  E+   + ++ + VG       +
Sbjct: 189  YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK-VGMFKVHPEI 247
Query: 982  SCSITEVADANLLNCEENDFSAR 1004
              S++  A A +L C E D   R
Sbjct: 248  PESMSAEAKAFILKCFEPDPDKR 270

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 128/285 (44%), Gaps = 36/285 (12%)
Query: 766  NKLLGMGSFGSVYKG--VLPDGMEI--AAKVFHMEF-DGSLESFHAECKVMGSIRHRNLV 820
             +++G G FG V  G   LP   EI  A K     + +     F +E  +MG   H N++
Sbjct: 38   EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 821  KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
             +    + +    ++ E+M NGSL+  L  ++    ++Q + ++  +A+ ++YL      
Sbjct: 98   HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DM 154
Query: 881  PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES-MRQTKTLG---TIGYMAPEYGRE 936
              VH D+   N+L+N ++V  +SDFG+++ L  + S    T  LG    I + APE  + 
Sbjct: 155  NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 214
Query: 937  GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC 996
             K +   DV+SYGI++ E  +          GE     W           ++ + +++N 
Sbjct: 215  RKFTSASDVWSYGIVMWEVMS---------YGERPY--W-----------DMTNQDVINA 252
Query: 997  EENDFS--AREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039
             E D+       C S++  L +DC       R     + N L ++
Sbjct: 253  IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 297

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 55/191 (28%), Positives = 97/191 (50%), Gaps = 6/191 (3%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G +G VY+GV     + +A K    E    +E F  E  VM  I+H NLV+++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
                 +++E+M+ G+L   L   N   ++ +  L +   ++SA+EYL        +H D
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 137
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+ E+ +  ++DFG+++++  +           I + APE     K S K DV+
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 197
Query: 947 SYGIMLMETFT 957
           ++G++L E  T
Sbjct: 198 AFGVLLWEIAT 208

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 77/287 (26%), Positives = 130/287 (45%), Gaps = 54/287 (18%)
Query: 769  LGMGSFGSVYKG---VLPDGMEIAAKVFHM---EFDGSLESFHAECKVMGSIRHRNLVKI 822
            LG G   +VY     +L   +++A K   +   E + +L+ F  E      + H+N+V +
Sbjct: 19   LGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 823  ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
            I     +D   LV+EY+   +L + + S    L +   +     +   +++ H      I
Sbjct: 77   IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKHAH---DMRI 132
Query: 883  VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK-TLGTIGYMAPEYGREGKVSR 941
            VH DIKP N+L++ +    + DFGIAK L  E S+ QT   LGT+ Y +PE  + G+ + 
Sbjct: 133  VHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSPEQAK-GEATD 190
Query: 942  KC-DVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEND 1000
            +C D+YS GI+L E    + P +             G++ +S +I  + D          
Sbjct: 191  ECTDIYSIGIVLYEMLVGEPPFN-------------GETAVSIAIKHIQD---------- 227
Query: 1001 FSAREQCVSSIFSLAMDCTVDLPEK------RISMKDVANRLVRIRE 1041
                     S+ ++  D   D+P+       R + KD ANR   I+E
Sbjct: 228  ---------SVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQE 265

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 83/338 (24%), Positives = 140/338 (41%), Gaps = 71/338 (21%)
Query: 739  DANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKG-VLPDGM----------E 787
            D  +YP   W  I +QD++            G G+FG V K  +  DG+          E
Sbjct: 15   DPTIYPVLDWNDIKFQDVI------------GEGNFGQVLKARIKKDGLRMDAAIKRMKE 62
Query: 788  IAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSL--- 844
             A+K  H +F G LE     CK+     H N++ ++ +C +  +  L +EY  +G+L   
Sbjct: 63   YASKDDHRDFAGELEVL---CKLG---HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 116
Query: 845  ---EKCLYSDNYF---------LDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNV 892
                + L +D  F         L   Q L    DVA  ++YL        +H D+   N+
Sbjct: 117  LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNI 173
Query: 893  LLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIML 952
            L+ E+ V  ++DFG+++  G+E  +++T     + +MA E       +   DV+SYG++L
Sbjct: 174  LVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 231
Query: 953  METFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSI 1011
             E  +    P   +   E+  K   G  L             LNC++            +
Sbjct: 232  WEIVSLGGTPYCGMTCAELYEKLPQGYRL----------EKPLNCDD-----------EV 270
Query: 1012 FSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYIDV 1049
            + L   C  + P +R S   +   L R+ E    Y++ 
Sbjct: 271  YDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNT 308

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 4/192 (2%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSN 828
           +G G FG V+ G   +  ++A K    E   S E F  E +VM  + H  LV++   C  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 829 NDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIK 888
                LV E+M +G L   L +          L + +DV   + YL       ++H D+ 
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 131
Query: 889 PSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSY 948
             N L+ E+ V  +SDFG+ + +  ++    T T   + + +PE     + S K DV+S+
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 191
Query: 949 GIMLMETFTKKK 960
           G+++ E F++ K
Sbjct: 192 GVLMWEVFSEGK 203

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 60/217 (27%), Positives = 110/217 (50%), Gaps = 13/217 (5%)
Query: 744 PQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL-- 801
           PQ  W    ++ + R T    E   LG G FG V+ G      ++A K       GS+  
Sbjct: 7   PQKPWWEDEWE-VPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSP 60
Query: 802 ESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL 861
           ++F AE  +M  ++H+ LV++ +  +      ++ EYM NGSL   L + +    I   +
Sbjct: 61  DAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTI 116
Query: 862 KIMIDVASAL-EYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT 920
             ++D+A+ + E + F      +H D++ +N+L+++++   ++DFG+A+++   E   + 
Sbjct: 117 NKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE 176
Query: 921 KTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
                I + APE    G  + K DV+S+GI+L E  T
Sbjct: 177 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 213

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 60/217 (27%), Positives = 110/217 (50%), Gaps = 13/217 (5%)
Query: 744 PQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL-- 801
           PQ  W    ++ + R T    E   LG G FG V+ G      ++A K       GS+  
Sbjct: 5   PQKPWWEDEWE-VPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSP 58
Query: 802 ESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL 861
           ++F AE  +M  ++H+ LV++ +  +      ++ EYM NGSL   L + +    I   +
Sbjct: 59  DAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTI 114
Query: 862 KIMIDVASAL-EYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT 920
             ++D+A+ + E + F      +H D++ +N+L+++++   ++DFG+A+++   E   + 
Sbjct: 115 NKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE 174
Query: 921 KTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
                I + APE    G  + K DV+S+GI+L E  T
Sbjct: 175 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 60/217 (27%), Positives = 110/217 (50%), Gaps = 13/217 (5%)
Query: 744 PQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL-- 801
           PQ  W    ++ + R T    E   LG G FG V+ G      ++A K       GS+  
Sbjct: 1   PQKPWWEDEWE-VPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSP 54
Query: 802 ESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL 861
           ++F AE  +M  ++H+ LV++ +  +      ++ EYM NGSL   L + +    I   +
Sbjct: 55  DAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTI 110
Query: 862 KIMIDVASAL-EYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT 920
             ++D+A+ + E + F      +H D++ +N+L+++++   ++DFG+A+++   E   + 
Sbjct: 111 NKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE 170
Query: 921 KTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
                I + APE    G  + K DV+S+GI+L E  T
Sbjct: 171 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 207

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 60/217 (27%), Positives = 110/217 (50%), Gaps = 13/217 (5%)
Query: 744 PQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL-- 801
           PQ  W    ++ + R T    E   LG G FG V+ G      ++A K       GS+  
Sbjct: 8   PQKPWWEDEWE-VPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSP 61
Query: 802 ESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL 861
           ++F AE  +M  ++H+ LV++ +  +      ++ EYM NGSL   L + +    I   +
Sbjct: 62  DAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTI 117
Query: 862 KIMIDVASAL-EYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT 920
             ++D+A+ + E + F      +H D++ +N+L+++++   ++DFG+A+++   E   + 
Sbjct: 118 NKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE 177
Query: 921 KTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
                I + APE    G  + K DV+S+GI+L E  T
Sbjct: 178 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 214

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 56/191 (29%), Positives = 95/191 (49%), Gaps = 6/191 (3%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G FG VY+GV     + +A K    E    +E F  E  VM  I+H NLV+++  C+
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
                 ++ E+M+ G+L   L   N   +  +  L +   ++SA+EYL        +H D
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+ E+ +  ++DFG+++++  +           I + APE     K S K DV+
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 194
Query: 947 SYGIMLMETFT 957
           ++G++L E  T
Sbjct: 195 AFGVLLWEIAT 205

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 55/191 (28%), Positives = 97/191 (50%), Gaps = 6/191 (3%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G +G VY+GV     + +A K    E    +E F  E  VM  I+H NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
                 +++E+M+ G+L   L   N   ++ +  L +   ++SA+EYL        +H D
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+ E+ +  ++DFG+++++  +           I + APE     K S K DV+
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 201
Query: 947 SYGIMLMETFT 957
           ++G++L E  T
Sbjct: 202 AFGVLLWEIAT 212

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 91/192 (47%), Gaps = 4/192 (2%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSN 828
           +G G FG V+ G   +  ++A K    E   S + F  E +VM  + H  LV++   C  
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 829 NDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIK 888
                LV E+M +G L   L +          L + +DV   + YL       ++H D+ 
Sbjct: 94  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 150
Query: 889 PSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSY 948
             N L+ E+ V  +SDFG+ + +  ++    T T   + + +PE     + S K DV+S+
Sbjct: 151 ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 210
Query: 949 GIMLMETFTKKK 960
           G+++ E F++ K
Sbjct: 211 GVLMWEVFSEGK 222

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 55/191 (28%), Positives = 96/191 (50%), Gaps = 6/191 (3%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G +G VY+GV     + +A K    E    +E F  E  VM  I+H NLV+++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
                 +++E+M+ G+L   L   N   +  +  L +   ++SA+EYL        +H D
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+ E+ +  ++DFG+++++  +           I + APE     K S K DV+
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 194
Query: 947 SYGIMLMETFT 957
           ++G++L E  T
Sbjct: 195 AFGVLLWEIAT 205

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 61/197 (30%), Positives = 93/197 (47%), Gaps = 5/197 (2%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSN 828
           LG GS+GSVYK +  +  +I A +  +  +  L+    E  +M      ++VK   S   
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVA-IKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFK 95
Query: 829 NDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIK 888
           N    +V+EY   GS+   +   N  L   +   I+      LEYLHF      +H DIK
Sbjct: 96  NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK---IHRDIK 152
Query: 889 PSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSY 948
             N+LLN      L+DFG+A  L  +   ++   +GT  +MAPE  +E   +   D++S 
Sbjct: 153 AGNILLNTEGHAKLADFGVAGQL-TDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSL 211
Query: 949 GIMLMETFTKKKPTDEI 965
           GI  +E    K P  +I
Sbjct: 212 GITAIEMAEGKPPYADI 228

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 112/255 (43%), Gaps = 22/255 (8%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVF-------HMEFDGSLESFHAECKV 810
           A +     K +G G FG V+KG L  D   +A K           E     + F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 811 MGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASA 870
           M ++ H N+VK+     N     +V+E++  G L   L    + +    +L++M+D+A  
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 871 LEYLHFGYSTPIVHCDIKPSNVLL-----NESMVGHLSDFGIAKILGKEESMRQTKTLGT 925
           +EY+    + PIVH D++  N+ L     N  +   ++DFG ++    +     +  LG 
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ----QSVHSVSGLLGN 189
Query: 926 IGYMAPEY--GREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSC 983
             +MAPE     E   + K D YS+ ++L    T + P DE   G++     + +  L  
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249
Query: 984 SITEVADANLLNCEE 998
           +I E     L N  E
Sbjct: 250 TIPEDCPPRLRNVIE 264

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 26/210 (12%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKI---- 822
           LG G FG V + +  D G ++A K    E    + E +  E ++M  + H N+V      
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 823 --ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK------IMIDVASALEYL 874
             +   + ND   L +EY   G L K L   N F +    LK      ++ D++SAL YL
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYL---NQFENCCG-LKEGPIRTLLSDISSALRYL 138
Query: 875 HFGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAP 931
           H      I+H D+KP N++L    + ++  + D G AK L + E    T+ +GT+ Y+AP
Sbjct: 139 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--TEFVGTLQYLAP 193
Query: 932 EYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           E   + K +   D +S+G +  E  T  +P
Sbjct: 194 ELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 78/247 (31%), Positives = 117/247 (47%), Gaps = 15/247 (6%)
Query: 768  LLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
            +LG G++G VY G  L + + IA K          +  H E  +   ++H+N+V+ + S 
Sbjct: 15   VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 827  SNNDFKALVLEYMSNGSLEKCLYSD-NYFLDILQRLKIMI-DVASALEYLHFGYSTPIVH 884
            S N F  + +E +  GSL   L S      D  Q +      +   L+YLH      IVH
Sbjct: 75   SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 131
Query: 885  CDIKPSNVLLNE-SMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGK--VSR 941
             DIK  NVL+N  S V  +SDFG +K L       +T T GT+ YMAPE   +G     +
Sbjct: 132  RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYMAPEIIDKGPRGYGK 190
Query: 942  KCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVG----DSLLSCSITEVADANLLNCE 997
              D++S G  ++E  T K P  E+   + ++ + VG       +  S++  A A +L C 
Sbjct: 191  AADIWSLGCTIIEMATGKPPFYELGEPQAAMFK-VGMFKVHPEIPESMSAEAKAFILKCF 249
Query: 998  ENDFSAR 1004
            E D   R
Sbjct: 250  EPDPDKR 256

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 766 NKLLGMGSFGSVYKGVL--PDGMEI--AAKVFHMEFD-GSLESFHAECKVMGSIRHRNLV 820
           N+++G G FG VY G L   DG +I  A K  +   D G +  F  E  +M    H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 821 KIISSCSNNDFKALV-LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            ++  C  ++   LV L YM +G L   + ++ +   +   +   + VA  ++YL    S
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 150
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT---IGYMAPEYGRE 936
              VH D+   N +L+E     ++DFG+A+ +  +E        G    + +MA E  + 
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 937 GKVSRKCDVYSYGIMLMETFTKKKP 961
            K + K DV+S+G++L E  T+  P
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-15,   Method: Composition-based stats.
 Identities = 60/217 (27%), Positives = 110/217 (50%), Gaps = 13/217 (5%)
Query: 744 PQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL-- 801
           PQ  W    ++ + R T    E   LG G FG V+ G      ++A K       GS+  
Sbjct: 5   PQKPWWEDEWE-VPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSP 58
Query: 802 ESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL 861
           ++F AE  +M  ++H+ LV++ +  +      ++ EYM NGSL   L + +    I   +
Sbjct: 59  DAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTI 114
Query: 862 KIMIDVASAL-EYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT 920
             ++D+A+ + E + F      +H D++ +N+L+++++   ++DFG+A+++   E   + 
Sbjct: 115 NKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 174
Query: 921 KTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
                I + APE    G  + K DV+S+GI+L E  T
Sbjct: 175 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-15,   Method: Composition-based stats.
 Identities = 60/217 (27%), Positives = 110/217 (50%), Gaps = 13/217 (5%)
Query: 744 PQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL-- 801
           PQ  W    ++ + R T    E   LG G FG V+ G      ++A K       GS+  
Sbjct: 9   PQKPWWEDEWE-VPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSP 62
Query: 802 ESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL 861
           ++F AE  +M  ++H+ LV++ +  +      ++ EYM NGSL   L + +    I   +
Sbjct: 63  DAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTI 118
Query: 862 KIMIDVASAL-EYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT 920
             ++D+A+ + E + F      +H D++ +N+L+++++   ++DFG+A+++   E   + 
Sbjct: 119 NKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 178
Query: 921 KTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
                I + APE    G  + K DV+S+GI+L E  T
Sbjct: 179 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 215

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-15,   Method: Composition-based stats.
 Identities = 60/217 (27%), Positives = 110/217 (50%), Gaps = 13/217 (5%)
Query: 744 PQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL-- 801
           PQ  W    ++ + R T    E   LG G FG V+ G      ++A K       GS+  
Sbjct: 4   PQKPWWEDEWE-VPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSP 57
Query: 802 ESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL 861
           ++F AE  +M  ++H+ LV++ +  +      ++ EYM NGSL   L + +    I   +
Sbjct: 58  DAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTI 113
Query: 862 KIMIDVASAL-EYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT 920
             ++D+A+ + E + F      +H D++ +N+L+++++   ++DFG+A+++   E   + 
Sbjct: 114 NKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 173
Query: 921 KTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
                I + APE    G  + K DV+S+GI+L E  T
Sbjct: 174 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 210

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 26/210 (12%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKI---- 822
           LG G FG V + +  D G ++A K    E    + E +  E ++M  + H N+V      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 823 --ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK------IMIDVASALEYL 874
             +   + ND   L +EY   G L K L   N F +    LK      ++ D++SAL YL
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYL---NQFENCCG-LKEGPIRTLLSDISSALRYL 137
Query: 875 HFGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAP 931
           H      I+H D+KP N++L    + ++  + D G AK L + E    T+ +GT+ Y+AP
Sbjct: 138 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--TEFVGTLQYLAP 192
Query: 932 EYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           E   + K +   D +S+G +  E  T  +P
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 54/192 (28%), Positives = 101/192 (52%), Gaps = 10/192 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISSC 826
           LG G FG V+ G      ++A K       GS+  ++F AE  +M  ++H+ LV++ +  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASAL-EYLHFGYSTPIVHC 885
           +      ++ EYM NGSL   L + +    I   +  ++D+A+ + E + F      +H 
Sbjct: 78  TQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L+++++   ++DFG+A+++   E   +      I + APE    G  + K DV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 946 YSYGIMLMETFT 957
           +S+GI+L E  T
Sbjct: 194 WSFGILLTEIVT 205

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 54/192 (28%), Positives = 101/192 (52%), Gaps = 10/192 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISSC 826
           LG G FG V+ G      ++A K       GS+  ++F AE  +M  ++H+ LV++ +  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASAL-EYLHFGYSTPIVHC 885
           +      ++ EYM NGSL   L + +    I   +  ++D+A+ + E + F      +H 
Sbjct: 78  TQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L+++++   ++DFG+A+++   E   +      I + APE    G  + K DV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 946 YSYGIMLMETFT 957
           +S+GI+L E  T
Sbjct: 194 WSFGILLTEIVT 205

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 55/191 (28%), Positives = 96/191 (50%), Gaps = 6/191 (3%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G +G VY+GV     + +A K    E    +E F  E  VM  I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
                 +++E+M+ G+L   L   N   +  +  L +   ++SA+EYL        +H D
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+ E+ +  ++DFG+++++  +           I + APE     K S K DV+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 947 SYGIMLMETFT 957
           ++G++L E  T
Sbjct: 197 AFGVLLWEIAT 207

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 54/192 (28%), Positives = 101/192 (52%), Gaps = 10/192 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISSC 826
           LG G FG V+ G      ++A K       GS+  ++F AE  +M  ++H+ LV++ +  
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 78
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASAL-EYLHFGYSTPIVHC 885
           +      ++ EYM NGSL   L + +    I   +  ++D+A+ + E + F      +H 
Sbjct: 79  TQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHR 134
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L+++++   ++DFG+A+++   E   +      I + APE    G  + K DV
Sbjct: 135 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 194
Query: 946 YSYGIMLMETFT 957
           +S+GI+L E  T
Sbjct: 195 WSFGILLTEIVT 206

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 55/191 (28%), Positives = 96/191 (50%), Gaps = 6/191 (3%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G +G VY+GV     + +A K    E    +E F  E  VM  I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
                 +++E+M+ G+L   L   N   +  +  L +   ++SA+EYL        +H D
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+ E+ +  ++DFG+++++  +           I + APE     K S K DV+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 947 SYGIMLMETFT 957
           ++G++L E  T
Sbjct: 197 AFGVLLWEIAT 207

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 55/191 (28%), Positives = 96/191 (50%), Gaps = 6/191 (3%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G +G VY+GV     + +A K    E    +E F  E  VM  I+H NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
                 ++ E+M+ G+L   L   N   ++ +  L +   ++SA+EYL        +H D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+ E+ +  ++DFG+++++  +           I + APE     K S K DV+
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 201
Query: 947 SYGIMLMETFT 957
           ++G++L E  T
Sbjct: 202 AFGVLLWEIAT 212

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 766 NKLLGMGSFGSVYKGVL--PDGMEI--AAKVFHMEFD-GSLESFHAECKVMGSIRHRNLV 820
           N+++G G FG VY G L   DG +I  A K  +   D G +  F  E  +M    H N++
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 821 KIISSCSNNDFKALV-LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            ++  C  ++   LV L YM +G L   + ++ +   +   +   + VA  ++YL    S
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 169
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT---IGYMAPEYGRE 936
              VH D+   N +L+E     ++DFG+A+ +  +E        G    + +MA E  + 
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 229
Query: 937 GKVSRKCDVYSYGIMLMETFTKKKP 961
            K + K DV+S+G++L E  T+  P
Sbjct: 230 QKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 80.1 bits (196), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 766 NKLLGMGSFGSVYKGVL--PDGMEI--AAKVFHMEFD-GSLESFHAECKVMGSIRHRNLV 820
           N+++G G FG VY G L   DG +I  A K  +   D G +  F  E  +M    H N++
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 821 KIISSCSNNDFKALV-LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            ++  C  ++   LV L YM +G L   + ++ +   +   +   + VA  ++YL    S
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 170
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT---IGYMAPEYGRE 936
              VH D+   N +L+E     ++DFG+A+ +  +E        G    + +MA E  + 
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 230
Query: 937 GKVSRKCDVYSYGIMLMETFTKKKP 961
            K + K DV+S+G++L E  T+  P
Sbjct: 231 QKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 124/264 (46%), Gaps = 36/264 (13%)
Query: 766  NKLLGMGSFGSVYKGVL--PDGME--IAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLV 820
             +++G G FG V +G L  P   E  +A K     + +     F +E  +MG   H N++
Sbjct: 19   EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 821  KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
            ++    +N+    ++ E+M NG+L+  L  ++    ++Q + ++  +AS + YL      
Sbjct: 79   RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA---EM 135
Query: 881  PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES-MRQTKTLG---TIGYMAPEYGRE 936
              VH D+   N+L+N ++V  +SDFG+++ L +  S    T +LG    I + APE    
Sbjct: 136  SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAF 195
Query: 937  GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC 996
             K +   D +SYGI++ E  +          GE     W           ++++ +++N 
Sbjct: 196  RKFTSASDAWSYGIVMWEVMS---------FGERPY--W-----------DMSNQDVINA 233
Query: 997  EENDFS--AREQCVSSIFSLAMDC 1018
             E D+       C +S+  L +DC
Sbjct: 234  IEQDYRLPPPPDCPTSLHQLMLDC 257

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 82/338 (24%), Positives = 140/338 (41%), Gaps = 71/338 (21%)
Query: 739  DANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKG-VLPDGM----------E 787
            D  +YP   W  I +QD++            G G+FG V K  +  DG+          E
Sbjct: 12   DPTIYPVLDWNDIKFQDVI------------GEGNFGQVLKARIKKDGLRMDAAIKRMKE 59
Query: 788  IAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSL--- 844
             A+K  H +F G LE     CK+     H N++ ++ +C +  +  L +EY  +G+L   
Sbjct: 60   YASKDDHRDFAGELEVL---CKLG---HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 113
Query: 845  ---EKCLYSDNYF---------LDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNV 892
                + L +D  F         L   Q L    DVA  ++YL        +H ++   N+
Sbjct: 114  LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRNLAARNI 170
Query: 893  LLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIML 952
            L+ E+ V  ++DFG+++  G+E  +++T     + +MA E       +   DV+SYG++L
Sbjct: 171  LVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 228
Query: 953  METFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSI 1011
             E  +    P   +   E+  K   G  L             LNC++            +
Sbjct: 229  WEIVSLGGTPYCGMTCAELYEKLPQGYRL----------EKPLNCDD-----------EV 267
Query: 1012 FSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYIDV 1049
            + L   C  + P +R S   +   L R+ E    Y++ 
Sbjct: 268  YDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNT 305

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-15,   Method: Composition-based stats.
 Identities = 54/192 (28%), Positives = 101/192 (52%), Gaps = 10/192 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISSC 826
           LG G FG V+ G      ++A K       GS+  ++F AE  +M  ++H+ LV++ +  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASAL-EYLHFGYSTPIVHC 885
           +      ++ EYM NGSL   L + +    I   +  ++D+A+ + E + F      +H 
Sbjct: 78  TQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L+++++   ++DFG+A+++   E   +      I + APE    G  + K DV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 946 YSYGIMLMETFT 957
           +S+GI+L E  T
Sbjct: 194 WSFGILLTEIVT 205

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-15,   Method: Composition-based stats.
 Identities = 54/192 (28%), Positives = 101/192 (52%), Gaps = 10/192 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISSC 826
           LG G FG V+ G      ++A K       GS+  ++F AE  +M  ++H+ LV++ +  
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 72
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASAL-EYLHFGYSTPIVHC 885
           +      ++ EYM NGSL   L + +    I   +  ++D+A+ + E + F      +H 
Sbjct: 73  TQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHR 128
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L+++++   ++DFG+A+++   E   +      I + APE    G  + K DV
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 188
Query: 946 YSYGIMLMETFT 957
           +S+GI+L E  T
Sbjct: 189 WSFGILLTEIVT 200

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 766 NKLLGMGSFGSVYKGVL--PDGMEI--AAKVFHMEFD-GSLESFHAECKVMGSIRHRNLV 820
           N+++G G FG VY G L   DG +I  A K  +   D G +  F  E  +M    H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 821 KIISSCSNNDFKALV-LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            ++  C  ++   LV L YM +G L   + ++ +   +   +   + VA  ++YL    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 151
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT---IGYMAPEYGRE 936
              VH D+   N +L+E     ++DFG+A+ +  +E        G    + +MA E  + 
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 937 GKVSRKCDVYSYGIMLMETFTKKKP 961
            K + K DV+S+G++L E  T+  P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-15,   Method: Composition-based stats.
 Identities = 55/191 (28%), Positives = 96/191 (50%), Gaps = 6/191 (3%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G +G VY+GV     + +A K    E    +E F  E  VM  I+H NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
                 ++ E+M+ G+L   L   N   ++ +  L +   ++SA+EYL        +H D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+ E+ +  ++DFG+++++  +           I + APE     K S K DV+
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 201
Query: 947 SYGIMLMETFT 957
           ++G++L E  T
Sbjct: 202 AFGVLLWEIAT 212

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-15,   Method: Composition-based stats.
 Identities = 55/191 (28%), Positives = 96/191 (50%), Gaps = 6/191 (3%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G +G VY+GV     + +A K    E    +E F  E  VM  I+H NLV+++  C+
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
                 ++ E+M+ G+L   L   N   ++ +  L +   ++SA+EYL        +H D
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 149
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+ E+ +  ++DFG+++++  +           I + APE     K S K DV+
Sbjct: 150 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 209
Query: 947 SYGIMLMETFT 957
           ++G++L E  T
Sbjct: 210 AFGVLLWEIAT 220

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-15,   Method: Composition-based stats.
 Identities = 55/191 (28%), Positives = 96/191 (50%), Gaps = 6/191 (3%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G +G VY+GV     + +A K    E    +E F  E  VM  I+H NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
                 ++ E+M+ G+L   L   N   ++ +  L +   ++SA+EYL        +H D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+ E+ +  ++DFG+++++  +           I + APE     K S K DV+
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 201
Query: 947 SYGIMLMETFT 957
           ++G++L E  T
Sbjct: 202 AFGVLLWEIAT 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-15,   Method: Composition-based stats.
 Identities = 55/191 (28%), Positives = 96/191 (50%), Gaps = 6/191 (3%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G +G VY+GV     + +A K    E    +E F  E  VM  I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
                 ++ E+M+ G+L   L   N   ++ +  L +   ++SA+EYL        +H D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+ E+ +  ++DFG+++++  +           I + APE     K S K DV+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 947 SYGIMLMETFT 957
           ++G++L E  T
Sbjct: 197 AFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-15,   Method: Composition-based stats.
 Identities = 55/191 (28%), Positives = 96/191 (50%), Gaps = 6/191 (3%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G +G VY+GV     + +A K    E    +E F  E  VM  I+H NLV+++  C+
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
                 ++ E+M+ G+L   L   N   ++ +  L +   ++SA+EYL        +H D
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 140
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+ E+ +  ++DFG+++++  +           I + APE     K S K DV+
Sbjct: 141 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 200
Query: 947 SYGIMLMETFT 957
           ++G++L E  T
Sbjct: 201 AFGVLLWEIAT 211

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-15,   Method: Composition-based stats.
 Identities = 55/191 (28%), Positives = 96/191 (50%), Gaps = 6/191 (3%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G +G VY+GV     + +A K    E    +E F  E  VM  I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
                 ++ E+M+ G+L   L   N   ++ +  L +   ++SA+EYL        +H D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+ E+ +  ++DFG+++++  +           I + APE     K S K DV+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 947 SYGIMLMETFT 957
           ++G++L E  T
Sbjct: 197 AFGVLLWEIAT 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-15,   Method: Composition-based stats.
 Identities = 55/191 (28%), Positives = 96/191 (50%), Gaps = 6/191 (3%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G +G VY+GV     + +A K    E    +E F  E  VM  I+H NLV+++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
                 ++ E+M+ G+L   L   N   ++ +  L +   ++SA+EYL        +H D
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+ E+ +  ++DFG+++++  +           I + APE     K S K DV+
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 198
Query: 947 SYGIMLMETFT 957
           ++G++L E  T
Sbjct: 199 AFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-15,   Method: Composition-based stats.
 Identities = 55/191 (28%), Positives = 96/191 (50%), Gaps = 6/191 (3%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G +G VY+GV     + +A K    E    +E F  E  VM  I+H NLV+++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
                 ++ E+M+ G+L   L   N   ++ +  L +   ++SA+EYL        +H D
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+ E+ +  ++DFG+++++  +           I + APE     K S K DV+
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 198
Query: 947 SYGIMLMETFT 957
           ++G++L E  T
Sbjct: 199 AFGVLLWEIAT 209

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 12/205 (5%)
Query: 766 NKLLGMGSFGSVYKGVL--PDGMEI--AAKVFHMEFD-GSLESFHAECKVMGSIRHRNLV 820
           N+++G G FG VY G L   DG +I  A K  +   D G +  F  E  +M    H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 821 KIISSCSNNDFKALV-LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            ++  C  ++   LV L YM +G L   + ++ +   +   +   + VA  +++L    S
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 152
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAK-ILGKEESMRQTKTLGT--IGYMAPEYGRE 936
              VH D+   N +L+E     ++DFG+A+ +L KE      KT     + +MA E  + 
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 937 GKVSRKCDVYSYGIMLMETFTKKKP 961
            K + K DV+S+G++L E  T+  P
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 766 NKLLGMGSFGSVYKGVL--PDGMEI--AAKVFHMEFD-GSLESFHAECKVMGSIRHRNLV 820
           N+++G G FG VY G L   DG +I  A K  +   D G +  F  E  +M    H N++
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 821 KIISSCSNNDFKALV-LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            ++  C  ++   LV L YM +G L   + ++ +   +   +   + VA  ++YL    S
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 143
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT---IGYMAPEYGRE 936
              VH D+   N +L+E     ++DFG+A+ +  +E        G    + +MA E  + 
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 203
Query: 937 GKVSRKCDVYSYGIMLMETFTKKKP 961
            K + K DV+S+G++L E  T+  P
Sbjct: 204 QKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 79.7 bits (195), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 75/306 (24%), Positives = 125/306 (40%), Gaps = 37/306 (12%)
Query: 756  LLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLE-SFHAECKVMGSI 814
            + R +D     ++LG G FG   K    +  E+      + FD   + +F  E KVM  +
Sbjct: 6    IFRPSD-LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64
Query: 815  RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
             H N++K I     +     + EY+  G+L   + S +      QR+    D+AS + YL
Sbjct: 65   EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 875  HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI-------------LGKEESMRQTK 921
            H   S  I+H D+   N L+ E+    ++DFG+A++             L K +  ++  
Sbjct: 125  H---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 922  TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLL 981
             +G   +MAPE         K DV+S+GI+L E   +     +     M           
Sbjct: 182  VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD---------F 232
Query: 982  SCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041
              ++    D     C  N       C  S F + + C    PEKR S   + + L  +R 
Sbjct: 233  GLNVRGFLDR---YCPPN-------CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282
Query: 1042 TLSAYI 1047
             L+ ++
Sbjct: 283  HLAGHL 288

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 766 NKLLGMGSFGSVYKGVL--PDGMEI--AAKVFHMEFD-GSLESFHAECKVMGSIRHRNLV 820
           N+++G G FG VY G L   DG +I  A K  +   D G +  F  E  +M    H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 821 KIISSCSNNDFKALV-LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            ++  C  ++   LV L YM +G L   + ++ +   +   +   + VA  ++YL    S
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 150
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT---IGYMAPEYGRE 936
              VH D+   N +L+E     ++DFG+A+ +  +E        G    + +MA E  + 
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 210
Query: 937 GKVSRKCDVYSYGIMLMETFTKKKP 961
            K + K DV+S+G++L E  T+  P
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 766 NKLLGMGSFGSVYKGVL--PDGMEI--AAKVFHMEFD-GSLESFHAECKVMGSIRHRNLV 820
           N+++G G FG VY G L   DG +I  A K  +   D G +  F  E  +M    H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 821 KIISSCSNNDFKALV-LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            ++  C  ++   LV L YM +G L   + ++ +   +   +   + VA  ++YL    S
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 148
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT---IGYMAPEYGRE 936
              VH D+   N +L+E     ++DFG+A+ +  +E        G    + +MA E  + 
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 208
Query: 937 GKVSRKCDVYSYGIMLMETFTKKKP 961
            K + K DV+S+G++L E  T+  P
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 766 NKLLGMGSFGSVYKGVL--PDGMEI--AAKVFHMEFD-GSLESFHAECKVMGSIRHRNLV 820
           N+++G G FG VY G L   DG +I  A K  +   D G +  F  E  +M    H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 821 KIISSCSNNDFKALV-LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            ++  C  ++   LV L YM +G L   + ++ +   +   +   + VA  ++YL    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 151
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT---IGYMAPEYGRE 936
              VH D+   N +L+E     ++DFG+A+ +  +E        G    + +MA E  + 
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 937 GKVSRKCDVYSYGIMLMETFTKKKP 961
            K + K DV+S+G++L E  T+  P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 12/203 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSC 826
           +G GSFG+VYKG      ++A K+ ++       L++F  E  V+   RH N++  +   
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
           +     A+V ++    SL   L++     ++ + + I    A  ++YLH   +  I+H D
Sbjct: 90  TKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGYMAPEYGR---EGKVSRK 942
           +K +N+ L+E     + DFG+A    +     Q + L G+I +MAPE  R       S +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 943 CDVYSYGIMLMETFTKKKPTDEI 965
            DVY++GI+L E  T + P   I
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNI 228

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 111/255 (43%), Gaps = 22/255 (8%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVF-------HMEFDGSLESFHAECKV 810
           A +     K +G G FG V+KG L  D   +A K           E     + F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 811 MGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASA 870
           M ++ H N+VK+     N     +V+E++  G L   L    + +    +L++M+D+A  
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 871 LEYLHFGYSTPIVHCDIKPSNVLL-----NESMVGHLSDFGIAKILGKEESMRQTKTLGT 925
           +EY+    + PIVH D++  N+ L     N  +   ++DF     L ++     +  LG 
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFS----LSQQSVHSVSGLLGN 189
Query: 926 IGYMAPEY--GREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSC 983
             +MAPE     E   + K D YS+ ++L    T + P DE   G++     + +  L  
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249
Query: 984 SITEVADANLLNCEE 998
           +I E     L N  E
Sbjct: 250 TIPEDCPPRLRNVIE 264

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 766 NKLLGMGSFGSVYKGVL--PDGMEI--AAKVFHMEFD-GSLESFHAECKVMGSIRHRNLV 820
           N+++G G FG VY G L   DG +I  A K  +   D G +  F  E  +M    H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 821 KIISSCSNNDFKALV-LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            ++  C  ++   LV L YM +G L   + ++ +   +   +   + VA  ++YL    S
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 149
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT---IGYMAPEYGRE 936
              VH D+   N +L+E     ++DFG+A+ +  +E        G    + +MA E  + 
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 209
Query: 937 GKVSRKCDVYSYGIMLMETFTKKKP 961
            K + K DV+S+G++L E  T+  P
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 766 NKLLGMGSFGSVYKGVL--PDGMEI--AAKVFHMEFD-GSLESFHAECKVMGSIRHRNLV 820
           N+++G G FG VY G L   DG +I  A K  +   D G +  F  E  +M    H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 821 KIISSCSNNDFKALV-LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            ++  C  ++   LV L YM +G L   + ++ +   +   +   + VA  ++YL    S
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 146
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT---IGYMAPEYGRE 936
              VH D+   N +L+E     ++DFG+A+ +  +E        G    + +MA E  + 
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 937 GKVSRKCDVYSYGIMLMETFTKKKP 961
            K + K DV+S+G++L E  T+  P
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 102/195 (52%), Gaps = 10/195 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISSC 826
           LG G FG V+ G      ++A K       GS+  ++F AE  +M  ++H+ LV++ +  
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 73
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASAL-EYLHFGYSTPIVHC 885
           +      ++ EYM NGSL   L + +    I   +  ++D+A+ + E + F      +H 
Sbjct: 74  TQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHR 129
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           +++ +N+L+++++   ++DFG+A+++   E   +      I + APE    G  + K DV
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 189
Query: 946 YSYGIMLMETFTKKK 960
           +S+GI+L E  T  +
Sbjct: 190 WSFGILLTEIVTHGR 204

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 21/230 (9%)
Query: 744 PQATWRRISYQDLLRATDGFSEN---------KLLGMGSFGSVYKGVL----PDGMEIAA 790
           PQ      +Y++  RA   F+           K++G G  G V  G L       + +A 
Sbjct: 23  PQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAI 82
Query: 791 KVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLY 849
           K     + +     F +E  +MG   H N++++    +      +V EYM NGSL+  L 
Sbjct: 83  KALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR 142
Query: 850 SDNYFLDILQRLKIMIDVASALEYLH-FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA 908
           + +    I+Q + ++  V + + YL   GY    VH D+   NVL++ ++V  +SDFG++
Sbjct: 143 THDGQFTIMQLVGMLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLS 198
Query: 909 KILGKEESMRQTKTLGTIG--YMAPEYGREGKVSRKCDVYSYGIMLMETF 956
           ++L  +     T T G I   + APE       S   DV+S+G+++ E  
Sbjct: 199 RVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 7/200 (3%)
Query: 763 FSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVK 821
           ++  + +G G+ G+VY  + +  G E+A +  +++     E    E  VM   ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
            + S    D   +V+EY++ GSL   +      +D  Q   +  +   ALE+LH   S  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQ 136
Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSR 941
           ++H DIK  N+LL       L+DFG    +  E+S R T  +GT  +MAPE         
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGP 195
Query: 942 KCDVYSYGIMLMETFTKKKP 961
           K D++S GIM +E    + P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 55/191 (28%), Positives = 95/191 (49%), Gaps = 6/191 (3%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G +G VY+GV     + +A K    E    +E F  E  VM  I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
                 ++ E+M+ G+L   L   N   +  +  L +   ++SA+EYL        +H D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+ E+ +  ++DFG+++++  +           I + APE     K S K DV+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 947 SYGIMLMETFT 957
           ++G++L E  T
Sbjct: 197 AFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 55/191 (28%), Positives = 95/191 (49%), Gaps = 6/191 (3%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G +G VY+GV     + +A K    E    +E F  E  VM  I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
                 ++ E+M+ G+L   L   N   +  +  L +   ++SA+EYL        +H D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+ E+ +  ++DFG+++++  +           I + APE     K S K DV+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 947 SYGIMLMETFT 957
           ++G++L E  T
Sbjct: 197 AFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 55/191 (28%), Positives = 95/191 (49%), Gaps = 6/191 (3%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G +G VY+GV     + +A K    E    +E F  E  VM  I+H NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
                 ++ E+M+ G+L   L   N   +  +  L +   ++SA+EYL        +H D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+ E+ +  ++DFG+++++  +           I + APE     K S K DV+
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 201
Query: 947 SYGIMLMETFT 957
           ++G++L E  T
Sbjct: 202 AFGVLLWEIAT 212

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 55/191 (28%), Positives = 96/191 (50%), Gaps = 6/191 (3%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G +G VY+GV     + +A K    E    +E F  E  VM  I+H NLV+++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
                 ++ E+M+ G+L   L   N   ++ +  L +   ++SA+EYL        +H D
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 137
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+ E+ +  ++DFG+++++  +           I + APE     K S K DV+
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVW 197
Query: 947 SYGIMLMETFT 957
           ++G++L E  T
Sbjct: 198 AFGVLLWEIAT 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 55/191 (28%), Positives = 96/191 (50%), Gaps = 6/191 (3%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G +G VY+GV     + +A K    E    +E F  E  VM  I+H NLV+++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
                 ++ E+M+ G+L   L   N   ++ +  L +   ++SA+EYL        +H D
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+ E+ +  ++DFG+++++  +           I + APE     K S K DV+
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVW 198
Query: 947 SYGIMLMETFT 957
           ++G++L E  T
Sbjct: 199 AFGVLLWEIAT 209

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 21/230 (9%)
Query: 744 PQATWRRISYQDLLRATDGFSEN---------KLLGMGSFGSVYKGVL----PDGMEIAA 790
           PQ      +Y++  RA   F+           K++G G  G V  G L       + +A 
Sbjct: 23  PQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAI 82
Query: 791 KVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLY 849
           K     + +     F +E  +MG   H N++++    +      +V EYM NGSL+  L 
Sbjct: 83  KALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR 142
Query: 850 SDNYFLDILQRLKIMIDVASALEYLH-FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA 908
           + +    I+Q + ++  V + + YL   GY    VH D+   NVL++ ++V  +SDFG++
Sbjct: 143 THDGQFTIMQLVGMLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLS 198
Query: 909 KILGKEESMRQTKTLGTIG--YMAPEYGREGKVSRKCDVYSYGIMLMETF 956
           ++L  +     T T G I   + APE       S   DV+S+G+++ E  
Sbjct: 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 55/191 (28%), Positives = 95/191 (49%), Gaps = 6/191 (3%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G +G VY+GV     + +A K    E    +E F  E  VM  I+H NLV+++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
                 ++ E+M+ G+L   L   N   +  +  L +   ++SA+EYL        +H D
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+ E+ +  ++DFG+++++  +           I + APE     K S K DV+
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 194
Query: 947 SYGIMLMETFT 957
           ++G++L E  T
Sbjct: 195 AFGVLLWEIAT 205

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 12/203 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSC 826
           +G GSFG+VYKG      ++A K+ ++       L++F  E  V+   RH N++  +   
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
           +     A+V ++    SL   L++     ++ + + I    A  ++YLH   +  I+H D
Sbjct: 90  TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGYMAPEYGR---EGKVSRK 942
           +K +N+ L+E     + DFG+A    +     Q + L G+I +MAPE  R       S +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 943 CDVYSYGIMLMETFTKKKPTDEI 965
            DVY++GI+L E  T + P   I
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNI 228

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 71/302 (23%), Positives = 128/302 (42%), Gaps = 46/302 (15%)
Query: 769  LGMGSFGSVYKG----VLP--DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKI 822
            LG G+FG V+      + P  D + +A K      D + + FH E +++ +++H ++VK 
Sbjct: 21   LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 823  ISSCSNNDFKALVLEYMSNGSLEKCLYSDN------------YFLDILQRLKIMIDVASA 870
               C   D   +V EYM +G L K L +                L   Q L I   +A+ 
Sbjct: 81   YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 871  LEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYM 929
            + YL    S   VH D+   N L+ E+++  + DFG+++ +   +  R    T+  I +M
Sbjct: 141  MVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 930  APEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA 989
             PE     K + + DV+S G++L E FT  K            + W           +++
Sbjct: 198  PPESIMYRKFTTESDVWSLGVVLWEIFTYGK------------QPWY----------QLS 235
Query: 990  DANLLNC--EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYI 1047
            +  ++ C  +         C   ++ L + C    P  R ++K +   L  + +    Y+
Sbjct: 236  NNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPVYL 295
Query: 1048 DV 1049
            D+
Sbjct: 296  DI 297

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 7/200 (3%)
Query: 763 FSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVK 821
           ++  + +G G+ G+VY  + +  G E+A +  +++     E    E  VM   ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
            + S    D   +V+EY++ GSL   +      +D  Q   +  +   ALE+LH   S  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQ 136
Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSR 941
           ++H DIK  N+LL       L+DFG    +  E+S R ++ +GT  +MAPE         
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-SEMVGTPYWMAPEVVTRKAYGP 195
Query: 942 KCDVYSYGIMLMETFTKKKP 961
           K D++S GIM +E    + P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 127/284 (44%), Gaps = 36/284 (12%)
Query: 767  KLLGMGSFGSVYKG--VLPDGMEI--AAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVK 821
            +++G G FG V  G   LP   EI  A K     + +     F +E  +MG   H N++ 
Sbjct: 13   QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 822  IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
            +    + +    ++ E+M NGSL+  L  ++    ++Q + ++  +A+ ++YL       
Sbjct: 73   LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMN 129
Query: 882  IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES-MRQTKTLG---TIGYMAPEYGREG 937
             VH  +   N+L+N ++V  +SDFG+++ L  + S    T  LG    I + APE  +  
Sbjct: 130  YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 189
Query: 938  KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE 997
            K +   DV+SYGI++ E  +          GE     W           ++ + +++N  
Sbjct: 190  KFTSASDVWSYGIVMWEVMS---------YGERPY--W-----------DMTNQDVINAI 227
Query: 998  ENDFS--AREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039
            E D+       C S++  L +DC       R     + N L ++
Sbjct: 228  EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 271

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 766 NKLLGMGSFGSVYKGVL--PDGMEI--AAKVFHMEFD-GSLESFHAECKVMGSIRHRNLV 820
           N+++G G FG VY G L   DG +I  A K  +   D G +  F  E  +M    H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 821 KIISSCSNNDFKALV-LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            ++  C  ++   LV L YM +G L   + ++ +   +   +   + VA  +++L    S
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 210
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAK-ILGKEESMRQTKTLGT--IGYMAPEYGRE 936
              VH D+   N +L+E     ++DFG+A+ +  KE      KT     + +MA E  + 
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 937 GKVSRKCDVYSYGIMLMETFTKKKP 961
            K + K DV+S+G++L E  T+  P
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 766 NKLLGMGSFGSVYKGVL--PDGMEI--AAKVFHMEFD-GSLESFHAECKVMGSIRHRNLV 820
           N+++G G FG VY G L   DG +I  A K  +   D G +  F  E  +M    H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 821 KIISSCSNNDFKALV-LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            ++  C  ++   LV L YM +G L   + ++ +   +   +   + VA  +++L    S
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 152
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAK-ILGKEESMRQTKTLGT--IGYMAPEYGRE 936
              VH D+   N +L+E     ++DFG+A+ +  KE      KT     + +MA E  + 
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 937 GKVSRKCDVYSYGIMLMETFTKKKP 961
            K + K DV+S+G++L E  T+  P
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 766 NKLLGMGSFGSVYKGVL--PDGMEI--AAKVFHMEFD-GSLESFHAECKVMGSIRHRNLV 820
           N+++G G FG VY G L   DG +I  A K  +   D G +  F  E  +M    H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 821 KIISSCSNNDFKALV-LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            ++  C  ++   LV L YM +G L   + ++ +   +   +   + VA  +++L    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 151
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAK-ILGKEESMRQTKTLGT--IGYMAPEYGRE 936
              VH D+   N +L+E     ++DFG+A+ +  KE      KT     + +MA E  + 
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 937 GKVSRKCDVYSYGIMLMETFTKKKP 961
            K + K DV+S+G++L E  T+  P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 766 NKLLGMGSFGSVYKGVL--PDGMEI--AAKVFHMEFD-GSLESFHAECKVMGSIRHRNLV 820
           N+++G G FG VY G L   DG +I  A K  +   D G +  F  E  +M    H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 821 KIISSCSNNDFKALV-LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            ++  C  ++   LV L YM +G L   + ++ +   +   +   + VA  +++L    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 151
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAK-ILGKEESMRQTKTLGT--IGYMAPEYGRE 936
              VH D+   N +L+E     ++DFG+A+ +  KE      KT     + +MA E  + 
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 937 GKVSRKCDVYSYGIMLMETFTKKKP 961
            K + K DV+S+G++L E  T+  P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 7/200 (3%)
Query: 763 FSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVK 821
           ++  + +G G+ G+VY  + +  G E+A +  +++     E    E  VM   ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
            + S    D   +V+EY++ GSL   +      +D  Q   +  +   ALE+LH   S  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQ 136
Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSR 941
           ++H DIK  N+LL       L+DFG    +  E+S R +  +GT  +MAPE         
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-SXMVGTPYWMAPEVVTRKAYGP 195
Query: 942 KCDVYSYGIMLMETFTKKKP 961
           K D++S GIM +E    + P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 80/319 (25%), Positives = 141/319 (44%), Gaps = 53/319 (16%)
Query: 741  NMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVL------PDGMEIAAKVFH 794
            N + QA  + IS    L A     E   LG   FG VYKG L           +A K   
Sbjct: 13   NQHKQAKLKEIS----LSAVRFMEE---LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK 65
Query: 795  MEFDGSL-ESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL----- 848
             + +G L E F  E  +   ++H N+V ++   + +   +++  Y S+G L + L     
Sbjct: 66   DKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSP 125
Query: 849  YSDNYFLDILQRLK----------IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM 898
            +SD    D  + +K          ++  +A+ +EYL    S  +VH D+   NVL+ + +
Sbjct: 126  HSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL 182
Query: 899  VGHLSDFGIAK-ILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
               +SD G+ + +   +       +L  I +MAPE    GK S   D++SYG++L E F+
Sbjct: 183  NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242
Query: 958  KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMD 1017
                          L+ + G S     +  + +  +L C ++       C + +++L ++
Sbjct: 243  ------------YGLQPYCGYSNQDV-VEMIRNRQVLPCPDD-------CPAWVYALMIE 282
Query: 1018 CTVDLPEKRISMKDVANRL 1036
            C  + P +R   KD+ +RL
Sbjct: 283  CWNEFPSRRPRFKDIHSRL 301

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 766 NKLLGMGSFGSVYKGVL--PDGMEI--AAKVFHMEFD-GSLESFHAECKVMGSIRHRNLV 820
           N+++G G FG VY G L   DG +I  A K  +   D G +  F  E  +M    H N++
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 821 KIISSCSNNDFKALV-LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            ++  C  ++   LV L YM +G L   + ++ +   +   +   + VA  +++L    S
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 156
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAK-ILGKEESMRQTKTLGT--IGYMAPEYGRE 936
              VH D+   N +L+E     ++DFG+A+ +  KE      KT     + +MA E  + 
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 216
Query: 937 GKVSRKCDVYSYGIMLMETFTKKKP 961
            K + K DV+S+G++L E  T+  P
Sbjct: 217 QKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 766 NKLLGMGSFGSVYKGVL--PDGMEI--AAKVFHMEFD-GSLESFHAECKVMGSIRHRNLV 820
           N+++G G FG VY G L   DG +I  A K  +   D G +  F  E  +M    H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 821 KIISSCSNNDFKALV-LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            ++  C  ++   LV L YM +G L   + ++ +   +   +   + VA  +++L    S
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 149
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAK-ILGKEESMRQTKTLGT--IGYMAPEYGRE 936
              VH D+   N +L+E     ++DFG+A+ +  KE      KT     + +MA E  + 
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 937 GKVSRKCDVYSYGIMLMETFTKKKP 961
            K + K DV+S+G++L E  T+  P
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 96/191 (50%), Gaps = 6/191 (3%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G +G VY+GV     + +A K    E    +E F  E  VM  I+H NLV+++  C+
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
                 ++ E+M+ G+L   L   N   ++ +  L +   ++SA+EYL        +H +
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRN 382
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+ E+ +  ++DFG+++++  +           I + APE     K S K DV+
Sbjct: 383 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 442
Query: 947 SYGIMLMETFT 957
           ++G++L E  T
Sbjct: 443 AFGVLLWEIAT 453

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 7/200 (3%)
Query: 763 FSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVK 821
           ++  + +G G+ G+VY  + +  G E+A +  +++     E    E  VM   ++ N+V 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
            + S    D   +V+EY++ GSL   +      +D  Q   +  +   ALE+LH   S  
Sbjct: 83  YLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQ 137
Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSR 941
           ++H DIK  N+LL       L+DFG    +  E+S R +  +GT  +MAPE         
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-SXMVGTPYWMAPEVVTRKAYGP 196
Query: 942 KCDVYSYGIMLMETFTKKKP 961
           K D++S GIM +E    + P
Sbjct: 197 KVDIWSLGIMAIEMIEGEPP 216

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 95/191 (49%), Gaps = 6/191 (3%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G +G VY+GV     + +A K    E    +E F  E  VM  I+H NLV+++  C+
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
                 ++ E+M+ G+L   L   N   +  +  L +   ++SA+EYL        +H +
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRN 343
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+ E+ +  ++DFG+++++  +           I + APE     K S K DV+
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 403
Query: 947 SYGIMLMETFT 957
           ++G++L E  T
Sbjct: 404 AFGVLLWEIAT 414

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 7/200 (3%)
Query: 763 FSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVK 821
           ++  + +G G+ G+VY  + +  G E+A +  +++     E    E  VM   ++ N+V 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
            + S    D   +V+EY++ GSL   +      +D  Q   +  +   ALE+LH   S  
Sbjct: 83  YLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQ 137
Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSR 941
           ++H +IK  N+LL       L+DFG    +  E+S R T  +GT  +MAPE         
Sbjct: 138 VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGP 196
Query: 942 KCDVYSYGIMLMETFTKKKP 961
           K D++S GIM +E    + P
Sbjct: 197 KVDIWSLGIMAIEMIEGEPP 216

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 53/192 (27%), Positives = 100/192 (52%), Gaps = 10/192 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISSC 826
           LG G  G V+ G      ++A K       GS+  ++F AE  +M  ++H+ LV++ +  
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASAL-EYLHFGYSTPIVHC 885
           +      ++ EYM NGSL   L + +    I   +  ++D+A+ + E + F      +H 
Sbjct: 78  TQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L+++++   ++DFG+A+++   E   +      I + APE    G  + K DV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 946 YSYGIMLMETFT 957
           +S+GI+L E  T
Sbjct: 194 WSFGILLTEIVT 205

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Composition-based stats.
 Identities = 57/191 (29%), Positives = 92/191 (48%), Gaps = 6/191 (3%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G +G VY GV     + +A K    E    +E F  E  VM  I+H NLV+++  C+
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDNYF-LDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
                 +V EYM  G+L   L   N   +  +  L +   ++SA+EYL        +H D
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE---KKNFIHRD 155
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVY 946
           +   N L+ E+ V  ++DFG+++++  +           I + APE       S K DV+
Sbjct: 156 LAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVW 215
Query: 947 SYGIMLMETFT 957
           ++G++L E  T
Sbjct: 216 AFGVLLWEIAT 226

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 72/291 (24%), Positives = 131/291 (45%), Gaps = 46/291 (15%)
Query: 769  LGMGSFGSVYKGVL------PDGMEIAAKVFHMEFDGSL-ESFHAECKVMGSIRHRNLVK 821
            LG   FG VYKG L           +A K    + +G L E F  E  +   ++H N+V 
Sbjct: 17   LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 822  IISSCSNNDFKALVLEYMSNGSLEKCL-----YSDNYFLDILQRLK----------IMID 866
            ++   + +   +++  Y S+G L + L     +SD    D  + +K          ++  
Sbjct: 77   LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 867  VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK-ILGKEESMRQTKTLGT 925
            +A+ +EYL    S  +VH D+   NVL+ + +   +SD G+ + +   +       +L  
Sbjct: 137  IAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 926  IGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSI 985
            I +MAPE    GK S   D++SYG++L E F+              L+ + G S     +
Sbjct: 194  IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS------------YGLQPYCGYSNQDV-V 240
Query: 986  TEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036
              + +  +L C ++       C + +++L ++C  + P +R   KD+ +RL
Sbjct: 241  EMIRNRQVLPCPDD-------CPAWVYALMIECWNEFPSRRPRFKDIHSRL 284

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/286 (23%), Positives = 123/286 (43%), Gaps = 30/286 (10%)
Query: 769  LGMGSFGSVYKGVL---PDGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIIS 824
            LG G+FGSV +GV       +++A KV     +    E    E ++M  + +  +V++I 
Sbjct: 344  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 825  SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
             C       LV+E    G L K L      + +    +++  V+  ++YL        VH
Sbjct: 404  VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVH 459
Query: 885  CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREGKVSRK 942
             ++   NVLL       +SDFG++K LG ++S    ++ G   + + APE     K S +
Sbjct: 460  RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 519
Query: 943  CDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFS 1002
             DV+SYG+ + E  +          G+   K+  G  +++     +     + C      
Sbjct: 520  SDVWSYGVTMWEALS---------YGQKPYKKMKGPEVMAF----IEQGKRMECP----- 561
Query: 1003 AREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYID 1048
               +C   +++L  DC +   E R     V  R+     +L++ ++
Sbjct: 562  --PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 605

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 34/227 (14%)
Query: 757 LRATDGFSENKLLGMGSFGSVYKG--VLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI 814
           LR    F E  +LG G+FG V K    L        K+ H E    L +  +E  ++ S+
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASL 59
Query: 815 RH-------------RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL 861
            H             RN VK +++        + +EY  NG+L   ++S+N      +  
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ-- 919
           ++   +  AL Y+H   S  I+H D+KP N+ ++ES    + DFG+AK + +   + +  
Sbjct: 120 RLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 920 -----------TKTLGTIGYMAPEY-GREGKVSRKCDVYSYGIMLME 954
                      T  +GT  Y+A E     G  + K D+YS GI+  E
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 112/226 (49%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+LG G+FG+VYKG+ +P+G ++   V  ME   +      +    E  
Sbjct: 45  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAY 103
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+ + M  G L   +  + DN     L  L   + +
Sbjct: 104 VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 160
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG+AK+LG EE     +     I
Sbjct: 161 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 217
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 218 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 263

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 94/191 (49%), Gaps = 8/191 (4%)
Query: 764 SENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKI 822
           S+ ++LG G FG V+K      G+++AAK+         E    E  VM  + H NL+++
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
             +  + +   LV+EY+  G L   +  ++Y L  L  +  M  +   + ++H  Y   I
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---I 208
Query: 883 VHCDIKPSNVLL--NESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVS 940
           +H D+KP N+L    ++    + DFG+A+     E ++     GT  ++APE      VS
Sbjct: 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV--NFGTPEFLAPEVVNYDFVS 266
Query: 941 RKCDVYSYGIM 951
              D++S G++
Sbjct: 267 FPTDMWSVGVI 277

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 68/286 (23%), Positives = 123/286 (43%), Gaps = 30/286 (10%)
Query: 769  LGMGSFGSVYKGVL---PDGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIIS 824
            LG G+FGSV +GV       +++A KV     +    E    E ++M  + +  +V++I 
Sbjct: 18   LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 825  SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
             C       LV+E    G L K L      + +    +++  V+  ++YL        VH
Sbjct: 78   VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVH 133
Query: 885  CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREGKVSRK 942
             D+   NVLL       +SDFG++K LG ++S    ++ G   + + APE     K S +
Sbjct: 134  RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 193
Query: 943  CDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFS 1002
             DV+SYG+ + E  +          G+   K+  G  +++     +     + C      
Sbjct: 194  SDVWSYGVTMWEALS---------YGQKPYKKMKGPEVMAF----IEQGKRMECP----- 235
Query: 1003 AREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYID 1048
               +C   +++L  DC +   E R     V  R+     +L++ ++
Sbjct: 236  --PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 67/288 (23%), Positives = 125/288 (43%), Gaps = 49/288 (17%)
Query: 769  LGMGSFGSVYKG----VLP--DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKI 822
            LG G+FG V+      + P  D M +A K        + + F  E +++ +++H ++VK 
Sbjct: 23   LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 823  ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDIL---------------QRLKIMIDV 867
               C + D   +V EYM +G L K L +      IL               Q L I   +
Sbjct: 83   YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 868  ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTI 926
            AS + YL    S   VH D+   N L+  +++  + DFG+++ +   +  R    T+  I
Sbjct: 143  ASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 927  GYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSIT 986
             +M PE     K + + DV+S+G++L E FT  K            + W           
Sbjct: 200  RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK------------QPWF---------- 237
Query: 987  EVADANLLNC--EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDV 1032
            ++++  ++ C  +         C   ++ + + C    P++R+++K++
Sbjct: 238  QLSNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEI 285

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 763 FSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAEC----KVMGSIRHR 817
           F   K +G G F  VY+   L DG+ +A K   + FD       A+C     ++  + H 
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQI-FDLMDAKARADCIKEIDLLKQLNHP 92
Query: 818 NLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRL--KIMIDVASALEY 873
           N++K  +S   ++   +VLE    G L + +  +     L I +R   K  + + SALE+
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPERTVWKYFVQLCSALEH 151
Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
           +H   S  ++H DIKP+NV +  + V  L D G+ +    + +   +  +GT  YM+PE 
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPER 207
Query: 934 GREGKVSRKCDVYSYGIMLMETFTKKKP 961
             E   + K D++S G +L E    + P
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSP 235

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 13/208 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G + K L   + F D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKF-DEQRTATYITELANALSYC 129
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    ++DFG +       S R+T   GT+ Y+ PE  
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMI 183
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKP 961
            EG++   K D++S G++  E    K P
Sbjct: 184 -EGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 14/212 (6%)
Query: 760 TDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF--DGSLE-SFHAECKVMGSIR 815
           +D +   ++LG G    V+    L D  ++A KV   +   D S    F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 816 HRNLVKIISS----CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASAL 871
           H  +V +  +            +V+EY+   +L   ++++     +  +  I + +A A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 872 EYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQT-KTLGTIGYM 929
           + L+F +   I+H D+KP+N+L++ +    + DFGIA+ +     S+ QT   +GT  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYL 186
Query: 930 APEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           +PE  R   V  + DVYS G +L E  T + P
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 66/215 (30%), Positives = 110/215 (51%), Gaps = 18/215 (8%)
Query: 767 KLLGMGSFGSVYKGV-LPDG----MEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNL 819
           K+LG G+FG+VYKG+ +P+G    + +A K+ + E  G   +  F  E  +M S+ H +L
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMDHPHL 102
Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYS--DNYFLDILQRLKIMIDVASALEYLHFG 877
           V+++  C +   + LV + M +G L + ++   DN    +L  L   + +A  + YL   
Sbjct: 103 VRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLL--LNWCVQIAKGMMYLE-- 157
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL-GKEESMRQTKTLGTIGYMAPEYGRE 936
               +VH D+   NVL+       ++DFG+A++L G E+          I +MA E    
Sbjct: 158 -ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 216
Query: 937 GKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEM 970
            K + + DV+SYG+ + E  T   KP D I   E+
Sbjct: 217 RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 251

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 66/215 (30%), Positives = 110/215 (51%), Gaps = 18/215 (8%)
Query: 767 KLLGMGSFGSVYKGV-LPDG----MEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNL 819
           K+LG G+FG+VYKG+ +P+G    + +A K+ + E  G   +  F  E  +M S+ H +L
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMDHPHL 79
Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYS--DNYFLDILQRLKIMIDVASALEYLHFG 877
           V+++  C +   + LV + M +G L + ++   DN    +L  L   + +A  + YL   
Sbjct: 80  VRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLL--LNWCVQIAKGMMYLE-- 134
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL-GKEESMRQTKTLGTIGYMAPEYGRE 936
               +VH D+   NVL+       ++DFG+A++L G E+          I +MA E    
Sbjct: 135 -ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 193
Query: 937 GKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEM 970
            K + + DV+SYG+ + E  T   KP D I   E+
Sbjct: 194 RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 228

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGS-----LESFHAECKVMGSIRHR 817
           FS+ + +G GSFG+VY        E+ A +  M + G       +    E + +  +RH 
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVA-IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 818 NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDI----LQRLKIMIDVASALEY 873
           N ++            LV+EY        CL S +  L++    LQ ++I      AL+ 
Sbjct: 115 NTIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQG 166
Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
           L + +S  ++H D+K  N+LL+E  +  L DFG A I+           +GT  +MAPE 
Sbjct: 167 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGTPYWMAPEV 221
Query: 934 ---GREGKVSRKCDVYSYGIMLMETFTKKKP 961
                EG+   K DV+S GI  +E   +K P
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 13/208 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYC 124
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    ++DFG +       S R+T+  GT+ Y+ PE  
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTELCGTLDYLPPEMI 178
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKP 961
            EG++   K D++S G++  E    K P
Sbjct: 179 -EGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 55/212 (25%), Positives = 102/212 (48%), Gaps = 14/212 (6%)
Query: 760 TDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF--DGSLE-SFHAECKVMGSIR 815
           +D +   ++LG G    V+    L D  ++A KV   +   D S    F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 816 HRNLVKIISS----CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASAL 871
           H  +V +  +            +V+EY+   +L   ++++     +  +  I + +A A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 872 EYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQT-KTLGTIGYM 929
           + L+F +   I+H D+KP+N++++ +    + DFGIA+ +     S+ QT   +GT  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 930 APEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           +PE  R   V  + DVYS G +L E  T + P
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 55/212 (25%), Positives = 102/212 (48%), Gaps = 14/212 (6%)
Query: 760 TDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF--DGSLE-SFHAECKVMGSIR 815
           +D +   ++LG G    V+    L D  ++A KV   +   D S    F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 816 HRNLVKIISS----CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASAL 871
           H  +V +  +            +V+EY+   +L   ++++     +  +  I + +A A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 872 EYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQT-KTLGTIGYM 929
           + L+F +   I+H D+KP+N++++ +    + DFGIA+ +     S+ QT   +GT  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 930 APEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           +PE  R   V  + DVYS G +L E  T + P
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 19/219 (8%)
Query: 754 QDLLRATDGFSENKLLGMGSFGSV----YKGVLP-DGMEIAAKVFHMEFDGSLESFHAEC 808
           +DL    + +   K++G G+FG V    +K       M++ +K F M        F  E 
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSK-FEMIKRSDSAFFWEER 120
Query: 809 KVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK--IMID 866
            +M       +V++  +  ++ +  +V+EYM  G L   +   NY  D+ ++       +
Sbjct: 121 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNY--DVPEKWARFYTAE 176
Query: 867 VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTI 926
           V  AL+ +H   S   +H D+KP N+LL++S    L+DFG    + KE  +R    +GT 
Sbjct: 177 VVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 233
Query: 927 GYMAPE----YGREGKVSRKCDVYSYGIMLMETFTKKKP 961
            Y++PE     G +G   R+CD +S G+ L E      P
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 66/226 (29%), Positives = 112/226 (49%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+LG G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 12  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+++ M  G L   +  + DN     L  L   + +
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYL--LNWCVQI 127
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG+AK+LG EE     +     I
Sbjct: 128 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 230

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 99/227 (43%), Gaps = 34/227 (14%)
Query: 757 LRATDGFSENKLLGMGSFGSVYKG--VLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI 814
           LR    F E  +LG G+FG V K    L        K+ H E    L +  +E  ++ S+
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASL 59
Query: 815 RH-------------RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL 861
            H             RN VK +++        + +EY  N +L   ++S+N      +  
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ-- 919
           ++   +  AL Y+H   S  I+H D+KP N+ ++ES    + DFG+AK + +   + +  
Sbjct: 120 RLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 920 -----------TKTLGTIGYMAPEY-GREGKVSRKCDVYSYGIMLME 954
                      T  +GT  Y+A E     G  + K D+YS GI+  E
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 19/219 (8%)
Query: 754 QDLLRATDGFSENKLLGMGSFGSV----YKGVLP-DGMEIAAKVFHMEFDGSLESFHAEC 808
           +DL    + +   K++G G+FG V    +K       M++ +K F M        F  E 
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSK-FEMIKRSDSAFFWEER 125
Query: 809 KVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK--IMID 866
            +M       +V++  +  ++ +  +V+EYM  G L   +   NY  D+ ++       +
Sbjct: 126 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNY--DVPEKWARFYTAE 181
Query: 867 VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTI 926
           V  AL+ +H   S   +H D+KP N+LL++S    L+DFG    + KE  +R    +GT 
Sbjct: 182 VVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 238
Query: 927 GYMAPE----YGREGKVSRKCDVYSYGIMLMETFTKKKP 961
            Y++PE     G +G   R+CD +S G+ L E      P
Sbjct: 239 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 66/226 (29%), Positives = 112/226 (49%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+LG G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+++ M  G L   +  + DN     L  L   + +
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 128
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG+AK+LG EE     +     I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 66/226 (29%), Positives = 112/226 (49%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+LG G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+++ M  G L   +  + DN     L  L   + +
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 129
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG+AK+LG EE     +     I
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 66/226 (29%), Positives = 112/226 (49%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+LG G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 15  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+++ M  G L   +  + DN     L  L   + +
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 130
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG+AK+LG EE     +     I
Sbjct: 131 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 187
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 233

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 66/226 (29%), Positives = 112/226 (49%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+LG G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 12  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+++ M  G L   +  + DN     L  L   + +
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 127
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG+AK+LG EE     +     I
Sbjct: 128 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 230

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 66/226 (29%), Positives = 112/226 (49%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+LG G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+++ M  G L   +  + DN     L  L   + +
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 126
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG+AK+LG EE     +     I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 19/219 (8%)
Query: 754 QDLLRATDGFSENKLLGMGSFGSV----YKGVLP-DGMEIAAKVFHMEFDGSLESFHAEC 808
           +DL    + +   K++G G+FG V    +K       M++ +K F M        F  E 
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSK-FEMIKRSDSAFFWEER 125
Query: 809 KVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK--IMID 866
            +M       +V++  +  ++ +  +V+EYM  G L   +   NY  D+ ++       +
Sbjct: 126 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNY--DVPEKWARFYTAE 181
Query: 867 VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTI 926
           V  AL+ +H   S   +H D+KP N+LL++S    L+DFG    + KE  +R    +GT 
Sbjct: 182 VVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 238
Query: 927 GYMAPE----YGREGKVSRKCDVYSYGIMLMETFTKKKP 961
            Y++PE     G +G   R+CD +S G+ L E      P
Sbjct: 239 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYC 124
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    ++DFG +       S R+T   GT+ Y+ PE  
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMI 178
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKP 961
            EG++   K D++S G++  E    K P
Sbjct: 179 -EGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 8/205 (3%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA-KVFHMEFDGSLESF-HAECKVMGSIRHRNLV 820
           F++ + +G GSFG V+KG+     ++ A K+  +E           E  V+       + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
           K   S   +    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   S 
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 143
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVS 940
             +H DIK +NVLL+E     L+DFG+A  L   +  R T  +GT  +MAPE  ++    
Sbjct: 144 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQSAYD 202
Query: 941 RKCDVYSYGIMLMETFTKKKPTDEI 965
            K D++S GI  +E    + P  E+
Sbjct: 203 SKADIWSLGITAIELARGEPPHSEL 227

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYC 128
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    ++DFG +       S R+T   GT+ Y+ PE  
Sbjct: 129 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMI 182
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKP 961
            EG++   K D++S G++  E    K P
Sbjct: 183 -EGRMHDEKVDLWSLGVLCYEFLVGKPP 209

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYC 124
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    ++DFG +       S R+T   GT+ Y+ PE  
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMI 178
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKP 961
            EG++   K D++S G++  E    K P
Sbjct: 179 -EGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYC 124
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    ++DFG +       S R+T   GT+ Y+ PE  
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMI 178
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKP 961
            EG++   K D++S G++  E    K P
Sbjct: 179 -EGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDG--SLESFH---AECKVMGSIRHR 817
           FS+ + +G GSFG+VY        E+ A +  M + G  S E +     E + +  +RH 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVA-IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 818 NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDI----LQRLKIMIDVASALEY 873
           N ++            LV+EY        CL S +  L++    LQ ++I      AL+ 
Sbjct: 76  NTIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQG 127
Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
           L + +S  ++H D+K  N+LL+E  +  L DFG A I+           +GT  +MAPE 
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGTPYWMAPEV 182
Query: 934 ---GREGKVSRKCDVYSYGIMLMETFTKKKP 961
                EG+   K DV+S GI  +E   +K P
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYC 150
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    ++DFG +       S R+T   GT+ Y+ PE  
Sbjct: 151 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMI 204
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKP 961
            EG++   K D++S G++  E    K P
Sbjct: 205 -EGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 8/205 (3%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA-KVFHMEFDGSLESF-HAECKVMGSIRHRNLV 820
           F++ + +G GSFG V+KG+     ++ A K+  +E           E  V+       + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
           K   S        +++EY+  GS    L +  +  D  Q   ++ ++   L+YLH   S 
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH---SE 139
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVS 940
             +H DIK +NVLL+E     L+DFG+A  L   +  R T  +GT  +MAPE  ++    
Sbjct: 140 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIQQSAYD 198
Query: 941 RKCDVYSYGIMLMETFTKKKPTDEI 965
            K D++S GI  +E    + P  ++
Sbjct: 199 SKADIWSLGITAIELAKGEPPNSDM 223

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYC 125
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    ++DFG +       S R+T   GT+ Y+ PE  
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMI 179
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKP 961
            EG++   K D++S G++  E    K P
Sbjct: 180 -EGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 111/226 (49%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+LG G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 36  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 94
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+ + M  G L   +  + DN     L  L   + +
Sbjct: 95  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 151
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG+AK+LG EE     +     I
Sbjct: 152 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 208
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 209 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 254

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYC 124
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    ++DFG +       S R+T   GT+ Y+ PE  
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTXLCGTLDYLPPEM- 177
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKP 961
            EG++   K D++S G++  E    K P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 13/208 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY     +   I A KV     +E  G       E ++   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     ++    L+LEY   G++ + L   + F D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYC 124
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    ++DFG +       S R+    GT+ Y+ PE  
Sbjct: 125 H---SKKVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRAALCGTLDYLPPEMI 178
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKP 961
            EG++   K D++S G++  E    K P
Sbjct: 179 -EGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 77/289 (26%), Positives = 134/289 (46%), Gaps = 33/289 (11%)
Query: 767  KLLGMGSFGSVYKGV-LPDG--MEIAAKVFHMEFDGSLESFHAECKVM---GSIRHRNLV 820
            K+LG G FG+V+KGV +P+G  ++I   +  +E     +SF A    M   GS+ H ++V
Sbjct: 37   KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 821  KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
            +++  C  +  + LV +Y+  GSL   +      L     L   + +A  + YL      
Sbjct: 97   RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EH 152
Query: 881  PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE-SMRQTKTLGTIGYMAPEYGREGKV 939
             +VH ++   NVLL       ++DFG+A +L  ++  +  ++    I +MA E    GK 
Sbjct: 153  GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 212
Query: 940  SRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEN 999
            + + DV+SYG+ + E  T      E +AG                + EV D  LL  E+ 
Sbjct: 213  THQSDVWSYGVTVWELMTFGA---EPYAG--------------LRLAEVPD--LL--EKG 251
Query: 1000 DFSAREQ-CVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYI 1047
            +  A+ Q C   ++ + + C +     R + K++AN   R+      Y+
Sbjct: 252  ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYL 300

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 77/289 (26%), Positives = 134/289 (46%), Gaps = 33/289 (11%)
Query: 767  KLLGMGSFGSVYKGV-LPDG--MEIAAKVFHMEFDGSLESFHAECKVM---GSIRHRNLV 820
            K+LG G FG+V+KGV +P+G  ++I   +  +E     +SF A    M   GS+ H ++V
Sbjct: 19   KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 821  KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
            +++  C  +  + LV +Y+  GSL   +      L     L   + +A  + YL      
Sbjct: 79   RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EH 134
Query: 881  PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE-SMRQTKTLGTIGYMAPEYGREGKV 939
             +VH ++   NVLL       ++DFG+A +L  ++  +  ++    I +MA E    GK 
Sbjct: 135  GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194
Query: 940  SRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEN 999
            + + DV+SYG+ + E  T      E +AG                + EV D  LL  E+ 
Sbjct: 195  THQSDVWSYGVTVWELMTFGA---EPYAG--------------LRLAEVPD--LL--EKG 233
Query: 1000 DFSAREQ-CVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYI 1047
            +  A+ Q C   ++ + + C +     R + K++AN   R+      Y+
Sbjct: 234  ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYL 282

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYC 123
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    ++DFG +       S R+T   GT+ Y+ PE  
Sbjct: 124 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEM- 176
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKP 961
            EG++   K D++S G++  E    K P
Sbjct: 177 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 204

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYC 127
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    ++DFG +       S R+T   GT+ Y+ PE  
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEM- 180
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKP 961
            EG++   K D++S G++  E    K P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYC 129
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    ++DFG +       S R+T   GT+ Y+ PE  
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMI 183
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKP 961
            EG++   K D++S G++  E    K P
Sbjct: 184 -EGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYC 127
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    ++DFG +       S R+T   GT+ Y+ PE  
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMI 181
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKP 961
            EG++   K D++S G++  E    K P
Sbjct: 182 -EGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYC 129
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    ++DFG +       S R+T   GT+ Y+ PE  
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMI 183
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKP 961
            EG++   K D++S G++  E    K P
Sbjct: 184 -EGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYC 129
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    ++DFG +       S R+T   GT+ Y+ PE  
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEXI 183
Query: 935 REGKVSRKCDVYSYGIMLMETFTKKKP 961
                  K D++S G++  E    K P
Sbjct: 184 EGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G+FG VYK    + G   AAKV   + +  LE +  E +++ +  H  +VK++ +  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDNYFLDI-LQRLKIMIDVASALEYLHFGYSTPIVHCD 886
           ++    +++E+   G+++  +      LD  L   +I +     LE L+F +S  I+H D
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLE----LDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRD 134
Query: 887 IKPSNVLLNESMVGHLSDFGIA----KILGKEESMRQTKTLGTIGYMAPEY-----GREG 937
           +K  NVL+       L+DFG++    K L K +S      +GT  +MAPE       ++ 
Sbjct: 135 LKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF-----IGTPYWMAPEVVMCETMKDT 189
Query: 938 KVSRKCDVYSYGIMLMETFTKKKPTDEI 965
               K D++S GI L+E    + P  E+
Sbjct: 190 PYDYKADIWSLGITLIEMAQIEPPHHEL 217

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G+FG VYK    + G   AAKV   + +  LE +  E +++ +  H  +VK++ +  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDNYFLDI-LQRLKIMIDVASALEYLHFGYSTPIVHCD 886
           ++    +++E+   G+++  +      LD  L   +I +     LE L+F +S  I+H D
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLE----LDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRD 142
Query: 887 IKPSNVLLNESMVGHLSDFGIA----KILGKEESMRQTKTLGTIGYMAPEY-----GREG 937
           +K  NVL+       L+DFG++    K L K +S      +GT  +MAPE       ++ 
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF-----IGTPYWMAPEVVMCETMKDT 197
Query: 938 KVSRKCDVYSYGIMLMETFTKKKPTDEI 965
               K D++S GI L+E    + P  E+
Sbjct: 198 PYDYKADIWSLGITLIEMAQIEPPHHEL 225

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 20/206 (9%)
Query: 769 LGMGSFGSVYKGVL------PDGMEIAAKVFHMEFDGSLE-SFHAECKVMGSIRHRNLVK 821
           LG G+FG VY+G +      P  +++A K     +    E  F  E  ++    H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLY------SDNYFLDILQRLKIMIDVASALEYLH 875
            I     +  + ++LE M+ G L+  L       S    L +L  L +  D+A   +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 876 FGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGKEESMRQTK-TLGTIGYMAP 931
             +    +H DI   N LL       V  + DFG+A+ + +    R+    +  + +M P
Sbjct: 173 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 932 EYGREGKVSRKCDVYSYGIMLMETFT 957
           E   EG  + K D +S+G++L E F+
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYC 125
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    ++DFG +       S R+T   GT+ Y+ PE  
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS---CHAPSSRRTTLSGTLDYLPPEMI 179
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKP 961
            EG++   K D++S G++  E    K P
Sbjct: 180 -EGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 24/201 (11%)
Query: 769 LGMGSFGSVYKGVLPDGM-EIAAKVFHM-EFDG--------SLESFHAEC----KVMGSI 814
           LG G++G V      +G  E A KV    +FD         ++E FH E      ++ S+
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
            H N++K+     +  +  LV E+   G L + + + + F D      IM  + S + YL
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF-DECDAANIMKQILSGICYL 162
Query: 875 HFGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAP 931
           H      IVH DIKP N+LL   N  +   + DFG++    K+  +R    LGT  Y+AP
Sbjct: 163 H---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD--RLGTAYYIAP 217
Query: 932 EYGREGKVSRKCDVYSYGIML 952
           E  ++ K + KCDV+S G+++
Sbjct: 218 EVLKK-KYNEKCDVWSCGVIM 237

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 8/205 (3%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA-KVFHMEFDGSLESF-HAECKVMGSIRHRNLV 820
           F++ + +G GSFG V+KG+     ++ A K+  +E           E  V+       + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
           K   S   +    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   S 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 123
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVS 940
             +H DIK +NVLL+E     L+DFG+A  L   +  R T  +GT  +MAPE  ++    
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQSAYD 182
Query: 941 RKCDVYSYGIMLMETFTKKKPTDEI 965
            K D++S GI  +E    + P  E+
Sbjct: 183 SKADIWSLGITAIELARGEPPHSEL 207

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 20/213 (9%)
Query: 761 DGFSENKLLGMGSFGSVYKG-VLPDGMEIAAKVFH---MEFDGSLESFHAECKVMGSIRH 816
           + F    LLG GSF  VY+   +  G+E+A K+     M   G ++    E K+   ++H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCL------YSDNYFLDILQRLKIMIDVASA 870
            +++++ +   ++++  LVLE   NG + + L      +S+N      +    M  + + 
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSEN------EARHFMHQIITG 124
Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMA 930
           + YLH   S  I+H D+  SN+LL  +M   ++DFG+A  L K    +     GT  Y++
Sbjct: 125 MLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQL-KMPHEKHYTLCGTPNYIS 180
Query: 931 PEYGREGKVSRKCDVYSYGIMLMETFTKKKPTD 963
           PE         + DV+S G M       + P D
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 66/226 (29%), Positives = 111/226 (49%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+LG G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+ + M  G L   +  + DN     L  L   + +
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYL--LNWCVQI 126
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG+AK+LG EE     +     I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G + K L   + F D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKF-DEQRTATYITELANALSYC 129
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    ++DFG +       S R+    GT+ Y+ PE  
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLXGTLDYLPPEM- 182
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKP 961
            EG++   K D++S G++  E    K P
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 66/226 (29%), Positives = 111/226 (49%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+LG G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 8   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 66
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+ + M  G L   +  + DN     L  L   + +
Sbjct: 67  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 123
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG+AK+LG EE     +     I
Sbjct: 124 AEGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 180
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 181 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 226

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 66/226 (29%), Positives = 111/226 (49%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+LG G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+ + M  G L   +  + DN     L  L   + +
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 128
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG+AK+LG EE     +     I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 77/312 (24%), Positives = 129/312 (41%), Gaps = 54/312 (17%)
Query: 769  LGMGSFGSVYK----GVLP--DGMEIAAKVFHMEFDGSLES-FHAECKVMGSIRHRNLVK 821
            +G G+FG V++    G+LP      +A K+   E    +++ F  E  +M    + N+VK
Sbjct: 55   IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 822  IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYF-----------------------LDIL 858
            ++  C+      L+ EYM+ G L + L S +                         L   
Sbjct: 115  LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 859  QRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK-ILGKEESM 917
            ++L I   VA+ + YL        VH D+   N L+ E+MV  ++DFG+++ I   +   
Sbjct: 175  EQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 918  RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVG 977
                    I +M PE     + + + DV++YG++L E F+              L+ + G
Sbjct: 232  ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS------------YGLQPYYG 279
Query: 978  DSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037
             +     I  V D N+L C EN       C   +++L   C   LP  R S   +   L 
Sbjct: 280  MAHEEV-IYYVRDGNILACPEN-------CPLELYNLMRLCWSKLPADRPSFCSIHRILQ 331
Query: 1038 RIRETLSAYIDV 1049
            R+ E     + V
Sbjct: 332  RMCERAEGTVGV 343

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 66/226 (29%), Positives = 111/226 (49%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+LG G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 17  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 75
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+ + M  G L   +  + DN     L  L   + +
Sbjct: 76  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 132
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG+AK+LG EE     +     I
Sbjct: 133 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 189
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 190 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 235

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 66/226 (29%), Positives = 111/226 (49%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+LG G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 21  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 79
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+ + M  G L   +  + DN     L  L   + +
Sbjct: 80  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 136
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG+AK+LG EE     +     I
Sbjct: 137 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 193
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 194 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 239

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 66/226 (29%), Positives = 111/226 (49%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+LG G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+ + M  G L   +  + DN     L  L   + +
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 129
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG+AK+LG EE     +     I
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 66/226 (29%), Positives = 111/226 (49%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+LG G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 18  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+ + M  G L   +  + DN     L  L   + +
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 133
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG+AK+LG EE     +     I
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 66/226 (29%), Positives = 111/226 (49%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+LG G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+ + M  G L   +  + DN     L  L   + +
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 126
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG+AK+LG EE     +     I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 66/226 (29%), Positives = 111/226 (49%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+LG G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 5   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+ + M  G L   +  + DN     L  L   + +
Sbjct: 64  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 120
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG+AK+LG EE     +     I
Sbjct: 121 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 66/226 (29%), Positives = 111/226 (49%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+LG G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+ + M  G L   +  + DN     L  L   + +
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 126
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG+AK+LG EE     +     I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 66/226 (29%), Positives = 111/226 (49%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+LG G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+ + M  G L   +  + DN     L  L   + +
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 129
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG+AK+LG EE     +     I
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 66/226 (29%), Positives = 111/226 (49%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+LG G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+ + M  G L   +  + DN     L  L   + +
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 129
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG+AK+LG EE     +     I
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYC 141
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    ++DFG +       S R+T   GT+ Y+ PE  
Sbjct: 142 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMI 195
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKP 961
            EG++   K D++S G++  E    K P
Sbjct: 196 -EGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 8/205 (3%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA-KVFHMEFDGSLESF-HAECKVMGSIRHRNLV 820
           F++ + +G GSFG V+KG+     ++ A K+  +E           E  V+       + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
           K   S   +    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   S 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 138
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVS 940
             +H DIK +NVLL+E     L+DFG+A  L  +  +++   +GT  +MAPE  ++    
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNXFVGTPFWMAPEVIKQSAYD 197
Query: 941 RKCDVYSYGIMLMETFTKKKPTDEI 965
            K D++S GI  +E    + P  E+
Sbjct: 198 SKADIWSLGITAIELARGEPPHSEL 222

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYC 121
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    ++DFG +       S R+T   GT+ Y+ PE  
Sbjct: 122 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEM- 174
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKP 961
            EG++   K D++S G++  E    K P
Sbjct: 175 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 202

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 66/226 (29%), Positives = 111/226 (49%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+LG G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+++ M  G L   +  + DN     L  L   + +
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 128
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG AK+LG EE     +     I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 66/226 (29%), Positives = 111/226 (49%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+LG G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+++ M  G L   +  + DN     L  L   + +
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 128
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG AK+LG EE     +     I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 66/226 (29%), Positives = 111/226 (49%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+LG G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 15  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+++ M  G L   +  + DN     L  L   + +
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 130
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG AK+LG EE     +     I
Sbjct: 131 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 187
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 233

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 8/205 (3%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA-KVFHMEFDGSLESF-HAECKVMGSIRHRNLV 820
           F++ + +G GSFG V+KG+     ++ A K+  +E           E  V+       + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
           K   S   +    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   S 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 123
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVS 940
             +H DIK +NVLL+E     L+DFG+A  L  +  +++   +GT  +MAPE  ++    
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNXFVGTPFWMAPEVIKQSAYD 182
Query: 941 RKCDVYSYGIMLMETFTKKKPTDEI 965
            K D++S GI  +E    + P  E+
Sbjct: 183 SKADIWSLGITAIELARGEPPHSEL 207

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 20/209 (9%)
Query: 767 KLLGMGSFGSVYKGVLP--DGMEIAAKVFHMEFDGS----LESFHAECKVMGSIRHRNLV 820
           K+LG G FGSV +G L   DG  +   V  M+ D S    +E F +E   M    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 821 KIISSCSNNDFKAL-----VLEYMSNGSLEK-CLYSD----NYFLDILQRLKIMIDVASA 870
           +++  C     + +     +L +M  G L    LYS        + +   LK M+D+A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-IGYM 929
           +EYL    +   +H D+   N +L + M   ++DFG++K +   +  RQ +     + ++
Sbjct: 160 MEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 930 APEYGREGKVSRKCDVYSYGIMLMETFTK 958
           A E   +   + K DV+++G+ + E  T+
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATR 245

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 20/206 (9%)
Query: 769 LGMGSFGSVYKGVL------PDGMEIAAKVFHMEFDGSLE-SFHAECKVMGSIRHRNLVK 821
           LG G+FG VY+G +      P  +++A K          E  F  E  ++  + H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLY------SDNYFLDILQRLKIMIDVASALEYLH 875
            I     +  + ++LE M+ G L+  L       S    L +L  L +  D+A   +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 876 FGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGKEESMRQTK-TLGTIGYMAP 931
             +    +H DI   N LL       V  + DFG+A+ + +    R+    +  + +M P
Sbjct: 159 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 932 EYGREGKVSRKCDVYSYGIMLMETFT 957
           E   EG  + K D +S+G++L E F+
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYC 127
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    ++DFG +       S R+    GT+ Y+ PE  
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRAALCGTLDYLPPEMI 181
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKPTD 963
            EG++   K D++S G++  E    K P +
Sbjct: 182 -EGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 765 ENKLLGMGSFGSVYKG---VLPDGMEIAAKVFHMEF-DGSL-ESFHAECKVMGSIRHRNL 819
           E+K LG G+FG+V KG   +      +A K+   E  D +L +   AE  VM  + +  +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
           V++I  C    +  LV+E    G L K L  + +  D    ++++  V+  ++YL     
Sbjct: 75  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLE---E 129
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREG 937
           +  VH D+   NVLL       +SDFG++K L  +E+  + +T G   + + APE     
Sbjct: 130 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYY 189
Query: 938 KVSRKCDVYSYGIMLMETFT-KKKP 961
           K S K DV+S+G+++ E F+  +KP
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 765 ENKLLGMGSFGSVYKG---VLPDGMEIAAKVFHMEF-DGSL-ESFHAECKVMGSIRHRNL 819
           E+K LG G+FG+V KG   +      +A K+   E  D +L +   AE  VM  + +  +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
           V++I  C    +  LV+E    G L K L  + +  D    ++++  V+  ++YL     
Sbjct: 81  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLE---E 135
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREG 937
           +  VH D+   NVLL       +SDFG++K L  +E+  + +T G   + + APE     
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 938 KVSRKCDVYSYGIMLMETFT-KKKP 961
           K S K DV+S+G+++ E F+  +KP
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 765 ENKLLGMGSFGSVYKG---VLPDGMEIAAKVFHMEF-DGSL-ESFHAECKVMGSIRHRNL 819
           E+K LG G+FG+V KG   +      +A K+   E  D +L +   AE  VM  + +  +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
           V++I  C    +  LV+E    G L K L  + +  D    ++++  V+  ++YL     
Sbjct: 91  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLE---E 145
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREG 937
           +  VH D+   NVLL       +SDFG++K L  +E+  + +T G   + + APE     
Sbjct: 146 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 205
Query: 938 KVSRKCDVYSYGIMLMETFT-KKKP 961
           K S K DV+S+G+++ E F+  +KP
Sbjct: 206 KFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 765 ENKLLGMGSFGSVYKG---VLPDGMEIAAKVFHMEF-DGSL-ESFHAECKVMGSIRHRNL 819
           E+K LG G+FG+V KG   +      +A K+   E  D +L +   AE  VM  + +  +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
           V++I  C    +  LV+E    G L K L  + +  D    ++++  V+  ++YL     
Sbjct: 91  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLE---E 145
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREG 937
           +  VH D+   NVLL       +SDFG++K L  +E+  + +T G   + + APE     
Sbjct: 146 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 205
Query: 938 KVSRKCDVYSYGIMLMETFT-KKKP 961
           K S K DV+S+G+++ E F+  +KP
Sbjct: 206 KFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 10/203 (4%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G+FG VYK    +  +  AAKV   + +  LE +  E  ++ S  H N+VK++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDI 887
             +   +++E+ + G+++  +      L   Q   +      AL YLH      I+H D+
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 888 KPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY-----GREGKVSRK 942
           K  N+L        L+DFG++         R+   +GT  +MAPE       ++     K
Sbjct: 162 KAGNILFTLDGDIKLADFGVSA-KNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYK 220
Query: 943 CDVYSYGIMLMETFTKKKPTDEI 965
            DV+S GI L+E    + P  E+
Sbjct: 221 ADVWSLGITLIEMAEIEPPHHEL 243

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 65/226 (28%), Positives = 111/226 (49%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+L  G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 18  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+++ M  G L   +  + DN     L  L   + +
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 133
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG+AK+LG EE     +     I
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 765 ENKLLGMGSFGSVYKG---VLPDGMEIAAKVFHMEF-DGSL-ESFHAECKVMGSIRHRNL 819
           E+K LG G+FG+V KG   +      +A K+   E  D +L +   AE  VM  + +  +
Sbjct: 29  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 88
Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
           V++I  C    +  LV+E    G L K L  + +  D    ++++  V+  ++YL     
Sbjct: 89  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLE---E 143
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREG 937
           +  VH D+   NVLL       +SDFG++K L  +E+  + +T G   + + APE     
Sbjct: 144 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 203
Query: 938 KVSRKCDVYSYGIMLMETFT-KKKP 961
           K S K DV+S+G+++ E F+  +KP
Sbjct: 204 KFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 20/206 (9%)
Query: 769 LGMGSFGSVYKGVL------PDGMEIAAKVFHMEFDGSLE-SFHAECKVMGSIRHRNLVK 821
           LG G+FG VY+G +      P  +++A K          E  F  E  ++  + H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLY------SDNYFLDILQRLKIMIDVASALEYLH 875
            I     +  + ++LE M+ G L+  L       S    L +L  L +  D+A   +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 876 FGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGKEESMRQTK-TLGTIGYMAP 931
             +    +H DI   N LL       V  + DFG+A+ + +    R+    +  + +M P
Sbjct: 173 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 932 EYGREGKVSRKCDVYSYGIMLMETFT 957
           E   EG  + K D +S+G++L E F+
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 13/210 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYC 127
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    +++FG +       S R+T   GT+ Y+ PE  
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIANFGWS---VHAPSSRRTTLCGTLDYLPPEMI 181
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKPTD 963
            EG++   K D++S G++  E    K P +
Sbjct: 182 -EGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 765 ENKLLGMGSFGSVYKG---VLPDGMEIAAKVFHMEF-DGSL-ESFHAECKVMGSIRHRNL 819
           E+K LG G+FG+V KG   +      +A K+   E  D +L +   AE  VM  + +  +
Sbjct: 9   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 68
Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
           V++I  C    +  LV+E    G L K L  + +  D    ++++  V+  ++YL     
Sbjct: 69  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLE---E 123
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREG 937
           +  VH D+   NVLL       +SDFG++K L  +E+  + +T G   + + APE     
Sbjct: 124 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 183
Query: 938 KVSRKCDVYSYGIMLMETFT-KKKP 961
           K S K DV+S+G+++ E F+  +KP
Sbjct: 184 KFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 74/309 (23%), Positives = 134/309 (43%), Gaps = 69/309 (22%)
Query: 767  KLLGMGSFGSVYKGVLPDGM-----------EIAAKVFHMEF-DGSLESFHAECKVMGSI 814
            K LG G+FG V   VL + +           ++A K+   +  +  L    +E ++M  I
Sbjct: 75   KPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131
Query: 815  -RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL---------YSDNYFLDILQRL--- 861
             +H+N++ ++ +C+ +    +++EY S G+L + L         YS N   +  ++L   
Sbjct: 132  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 862  ---KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR 918
                    VA  +EYL    S   +H D+   NVL+ E  V  ++DFG+A+ +   +  +
Sbjct: 192  DLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248
Query: 919  QTKTLGT--IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT------KKKPTDEIFAGEM 970
            +T T G   + +MAPE   +   + + DV+S+G++L E FT         P +E+F    
Sbjct: 249  KT-TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK--- 304
Query: 971  SLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMK 1030
                                   L  E +       C + ++ +  DC   +P +R + K
Sbjct: 305  -----------------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 341
Query: 1031 DVANRLVRI 1039
             +   L RI
Sbjct: 342  QLVEDLDRI 350

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 765 ENKLLGMGSFGSVYKG---VLPDGMEIAAKVFHMEF-DGSL-ESFHAECKVMGSIRHRNL 819
           E+K LG G+FG+V KG   +      +A K+   E  D +L +   AE  VM  + +  +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
           V++I  C    +  LV+E    G L K L  + +  D    ++++  V+  ++YL     
Sbjct: 75  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLE---E 129
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREG 937
           +  VH D+   NVLL       +SDFG++K L  +E+  + +T G   + + APE     
Sbjct: 130 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 189
Query: 938 KVSRKCDVYSYGIMLMETFT-KKKP 961
           K S K DV+S+G+++ E F+  +KP
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 765 ENKLLGMGSFGSVYKG---VLPDGMEIAAKVFHMEF-DGSL-ESFHAECKVMGSIRHRNL 819
           E+K LG G+FG+V KG   +      +A K+   E  D +L +   AE  VM  + +  +
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 432
Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
           V++I  C    +  LV+E    G L K L  + +  D    ++++  V+  ++YL     
Sbjct: 433 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---E 487
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREG 937
           +  VH D+   NVLL       +SDFG++K L  +E+  + +T G   + + APE     
Sbjct: 488 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 547
Query: 938 KVSRKCDVYSYGIMLMETFT 957
           K S K DV+S+G+++ E F+
Sbjct: 548 KFSSKSDVWSFGVLMWEAFS 567

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 765 ENKLLGMGSFGSVYKG---VLPDGMEIAAKVFHMEF-DGSL-ESFHAECKVMGSIRHRNL 819
           E+K LG G+FG+V KG   +      +A K+   E  D +L +   AE  VM  + +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
           V++I  C    +  LV+E    G L K L  + +  D    ++++  V+  ++YL     
Sbjct: 71  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLE---E 125
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREG 937
           +  VH D+   NVLL       +SDFG++K L  +E+  + +T G   + + APE     
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 938 KVSRKCDVYSYGIMLMETFT-KKKP 961
           K S K DV+S+G+++ E F+  +KP
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 10/203 (4%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G+FG VYK    +  +  AAKV   + +  LE +  E  ++ S  H N+VK++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDI 887
             +   +++E+ + G+++  +      L   Q   +      AL YLH      I+H D+
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 888 KPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY-----GREGKVSRK 942
           K  N+L        L+DFG++         R+   +GT  +MAPE       ++     K
Sbjct: 162 KAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYK 220
Query: 943 CDVYSYGIMLMETFTKKKPTDEI 965
            DV+S GI L+E    + P  E+
Sbjct: 221 ADVWSLGITLIEMAEIEPPHHEL 243

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 26/212 (12%)
Query: 756 LLRATDGFSEN----KLLGMGSFGSVYKGVLPD-GMEIAAKVFHME--FDGSLESFHAEC 808
           ++ A+  FS+N    + LG G+F  V + V    G+E AAK+ + +       +    E 
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 809 KVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVA 868
           ++   ++H N+V++  S     F  LV + ++ G L         F DI+ R       A
Sbjct: 80  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---------FEDIVAREFYSEADA 130
Query: 869 SA-----LEYLHFGYSTPIVHCDIKPSNVLLNESMVG---HLSDFGIAKILGKEESMRQT 920
           S      LE + + +S  IVH ++KP N+LL     G    L+DFG+A  +   E+    
Sbjct: 131 SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH-- 188
Query: 921 KTLGTIGYMAPEYGREGKVSRKCDVYSYGIML 952
              GT GY++PE  ++   S+  D+++ G++L
Sbjct: 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 10/203 (4%)
Query: 769 LGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           LG G+FG VYK    +  +  AAKV   + +  LE +  E  ++ S  H N+VK++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDI 887
             +   +++E+ + G+++  +      L   Q   +      AL YLH      I+H D+
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 888 KPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY-----GREGKVSRK 942
           K  N+L        L+DFG++         R+   +GT  +MAPE       ++     K
Sbjct: 162 KAGNILFTLDGDIKLADFGVSA-KNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYK 220
Query: 943 CDVYSYGIMLMETFTKKKPTDEI 965
            DV+S GI L+E    + P  E+
Sbjct: 221 ADVWSLGITLIEMAEIEPPHHEL 243

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 769 LGMGSFGSVYKGVL------PDGMEIAAKVFHMEFDGSLE-SFHAECKVMGSIRHRNLVK 821
           LG G+FG VY+G +      P  +++A K          E  F  E  ++    H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLY------SDNYFLDILQRLKIMIDVASALEYLH 875
            I     +  + ++LE M+ G L+  L       S    L +L  L +  D+A   +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 876 FGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGKEESMRQTK-TLGTIGYMAP 931
             +    +H DI   N LL       V  + DFG+A+ + +    R+    +  + +M P
Sbjct: 159 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 932 EYGREGKVSRKCDVYSYGIMLMETFT 957
           E   EG  + K D +S+G++L E F+
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 13/208 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSIRH 816
           D F   + LG G FG+VY         I A KV     +E +G       E ++   +RH
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
            N++++ +   +     L+LE+   G L K L     F D  +    M ++A AL Y H 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF-DEQRSATFMEELADALHYCH- 132
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
                ++H DIKP N+L+       ++DFG +       S+R+    GT+ Y+ PE   E
Sbjct: 133 --ERKVIHRDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRXMCGTLDYLPPEM-IE 186
Query: 937 GKV-SRKCDVYSYGIMLMETFTKKKPTD 963
           GK    K D++  G++  E      P D
Sbjct: 187 GKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 769 LGMGSFGSVYKGVL------PDGMEIAAKVFHMEFDGSLE-SFHAECKVMGSIRHRNLVK 821
           LG G+FG VY+G +      P  +++A K          E  F  E  ++    H+N+V+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLY------SDNYFLDILQRLKIMIDVASALEYLH 875
            I     +  + ++LE M+ G L+  L       S    L +L  L +  D+A   +YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 876 FGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGKEESMRQTK-TLGTIGYMAP 931
             +    +H DI   N LL       V  + DFG+A+ + +    R+    +  + +M P
Sbjct: 150 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 932 EYGREGKVSRKCDVYSYGIMLMETFT 957
           E   EG  + K D +S+G++L E F+
Sbjct: 207 EAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 765 ENKLLGMGSFGSVYKG---VLPDGMEIAAKVFHMEF-DGSL-ESFHAECKVMGSIRHRNL 819
           E+K LG G+FG+V KG   +      +A K+   E  D +L +   AE  VM  + +  +
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 433
Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
           V++I  C    +  LV+E    G L K L  + +  D    ++++  V+  ++YL     
Sbjct: 434 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLE---E 488
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREG 937
           +  VH D+   NVLL       +SDFG++K L  +E+  + +T G   + + APE     
Sbjct: 489 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 548
Query: 938 KVSRKCDVYSYGIMLMETFT 957
           K S K DV+S+G+++ E F+
Sbjct: 549 KFSSKSDVWSFGVLMWEAFS 568

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 760 TDGFSENKLLGMGSFGSVYKGVLPD---GMEIAAKVF---HMEFDGSLESFHAECKVMGS 813
           +D +   ++LG GSFG V   +  D   G E A KV     ++     ES   E +++  
Sbjct: 48  SDRYKGQRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 105
Query: 814 IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
           + H N++K+     +  +  LV E  + G L   + S   F ++    +I+  V S + Y
Sbjct: 106 LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITY 164
Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVG---HLSDFGIAKILGKEESMRQTKTLGTIGYMA 930
           +H      IVH D+KP N+LL          + DFG++     E S +    +GT  Y+A
Sbjct: 165 MH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIA 219
Query: 931 PEYGREGKVSRKCDVYSYGIML 952
           PE    G    KCDV+S G++L
Sbjct: 220 PEV-LHGTYDEKCDVWSTGVIL 240

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 16/201 (7%)
Query: 760 TDGFSENKLLGMGSFGSVY--KGVLPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSI 814
           +D +   ++LG GSFG V   K  +  G E A KV     ++     ES   E +++  +
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
            H N++K+     +  +  LV E  + G L   + S   F ++    +I+  V S + Y+
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 142
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVG---HLSDFGIAKILGKEESMRQTKTLGTIGYMAP 931
           H      IVH D+KP N+LL          + DFG++     E S +    +GT  Y+AP
Sbjct: 143 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIAP 197
Query: 932 EYGREGKVSRKCDVYSYGIML 952
           E    G    KCDV+S G++L
Sbjct: 198 EV-LHGTYDEKCDVWSTGVIL 217

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 769 LGMGSFGSVYKGVL------PDGMEIAAKVFHMEFDGSLE-SFHAECKVMGSIRHRNLVK 821
           LG G+FG VY+G +      P  +++A K          E  F  E  ++    H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLY------SDNYFLDILQRLKIMIDVASALEYLH 875
            I     +  + ++LE M+ G L+  L       S    L +L  L +  D+A   +YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 876 FGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGKEESMRQTK-TLGTIGYMAP 931
             +    +H DI   N LL       V  + DFG+A+ + +    R+    +  + +M P
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 932 EYGREGKVSRKCDVYSYGIMLMETFT 957
           E   EG  + K D +S+G++L E F+
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 13/208 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYC 124
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    ++DFG +       S R+    GT+ Y+ PE  
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRAALCGTLDYLPPEM- 177
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKP 961
            EG++   K D++S G++  E    K P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYC 126
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    +++FG +       S R+T   GT+ Y+ PE  
Sbjct: 127 H---SKRVIHRDIKPENLLLGSAGELKIANFGWS---VHAPSSRRTTLCGTLDYLPPEMI 180
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKP 961
            EG++   K D++S G++  E    K P
Sbjct: 181 -EGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 13/208 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYC 126
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    ++DFG +       S R+    GT+ Y+ PE  
Sbjct: 127 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPPEMI 180
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKP 961
            EG++   K D++S G++  E    K P
Sbjct: 181 -EGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 13/212 (6%)
Query: 743 YPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL 801
           YPQ     I +  +L   D +  ++ LG G+FG V++      G   AAK      +   
Sbjct: 144 YPQPV--EIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK 198
Query: 802 ESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL 861
           E+   E + M  +RH  LV +  +  +++   ++ E+MS G L + +  ++  +   + +
Sbjct: 199 ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV 258
Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLS--DFGIAKILGKEESMRQ 919
           + M  V   L ++H       VH D+KP N++        L   DFG+   L  ++S++ 
Sbjct: 259 EYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV 315
Query: 920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIM 951
             T GT  + APE      V    D++S G++
Sbjct: 316 --TTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 345

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 760 TDGFSENKLLGMGSFGSVYKGVLPD---GMEIAAKVF---HMEFDGSLESFHAECKVMGS 813
           +D +   ++LG GSFG V   +  D   G E A KV     ++     ES   E +++  
Sbjct: 49  SDRYKGQRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 106
Query: 814 IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
           + H N++K+     +  +  LV E  + G L   + S   F ++    +I+  V S + Y
Sbjct: 107 LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITY 165
Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVG---HLSDFGIAKILGKEESMRQTKTLGTIGYMA 930
           +H      IVH D+KP N+LL          + DFG++     E S +    +GT  Y+A
Sbjct: 166 MH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIA 220
Query: 931 PEYGREGKVSRKCDVYSYGIML 952
           PE    G    KCDV+S G++L
Sbjct: 221 PEV-LHGTYDEKCDVWSTGVIL 241

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 769 LGMGSFGSVYKGVL------PDGMEIAAKVFHMEFDGSLE-SFHAECKVMGSIRHRNLVK 821
           LG G+FG VY+G +      P  +++A K          E  F  E  ++    H+N+V+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLY------SDNYFLDILQRLKIMIDVASALEYLH 875
            I     +  + ++LE M+ G L+  L       S    L +L  L +  D+A   +YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 876 FGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGKEESMRQTK-TLGTIGYMAP 931
             +    +H DI   N LL       V  + DFG+A+ + +    R+    +  + +M P
Sbjct: 165 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 932 EYGREGKVSRKCDVYSYGIMLMETFT 957
           E   EG  + K D +S+G++L E F+
Sbjct: 222 EAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 760 TDGFSENKLLGMGSFGSVYKGVLPD---GMEIAAKVF---HMEFDGSLESFHAECKVMGS 813
           +D +   ++LG GSFG V   +  D   G E A KV     ++     ES   E +++  
Sbjct: 31  SDRYKGQRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 88
Query: 814 IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
           + H N++K+     +  +  LV E  + G L   + S   F ++    +I+  V S + Y
Sbjct: 89  LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITY 147
Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVG---HLSDFGIAKILGKEESMRQTKTLGTIGYMA 930
           +H      IVH D+KP N+LL          + DFG++     E S +    +GT  Y+A
Sbjct: 148 MH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIA 202
Query: 931 PEYGREGKVSRKCDVYSYGIML 952
           PE    G    KCDV+S G++L
Sbjct: 203 PEV-LHGTYDEKCDVWSTGVIL 223

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 769 LGMGSFGSVYKGVL------PDGMEIAAKVFHMEFDGSLE-SFHAECKVMGSIRHRNLVK 821
           LG G+FG VY+G +      P  +++A K          E  F  E  ++    H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLY------SDNYFLDILQRLKIMIDVASALEYLH 875
            I     +  + ++LE M+ G L+  L       S    L +L  L +  D+A   +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 876 FGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGKEESMRQTK-TLGTIGYMAP 931
             +    +H DI   N LL       V  + DFG+A+ + +    R+    +  + +M P
Sbjct: 159 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 932 EYGREGKVSRKCDVYSYGIMLMETFT 957
           E   EG  + K D +S+G++L E F+
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 13/208 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYC 127
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    ++DFG +       S R+    GT+ Y+ PE  
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLCGTLDYLPPEM- 180
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKP 961
            EG++   K D++S G++  E    K P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 13/208 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYC 125
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    ++DFG +       S R+    GT+ Y+ PE  
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRDTLCGTLDYLPPEMI 179
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKP 961
            EG++   K D++S G++  E    K P
Sbjct: 180 -EGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 13/208 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYC 124
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    ++DFG +       S R+    GT+ Y+ PE  
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLCGTLDYLPPEM- 177
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKP 961
            EG++   K D++S G++  E    K P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 13/206 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSIRH 816
           D F   + LG G FG+VY         I A KV     +E +G       E ++   + H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
            N++++ +   +     L+LEY   G L K L     F D  +   IM ++A AL Y H 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTF-DEQRTATIMEELADALMYCH- 140
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
                ++H DIKP N+LL       ++DFG +       S+R+    GT+ Y+ PE   E
Sbjct: 141 --GKKVIHRDIKPENLLLGLKGELKIADFGWS---VHAPSLRRKTMCGTLDYLPPEMI-E 194
Query: 937 GKV-SRKCDVYSYGIMLMETFTKKKP 961
           G++ + K D++  G++  E      P
Sbjct: 195 GRMHNEKVDLWCIGVLCYELLVGNPP 220

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 769 LGMGSFGSVYKGVL------PDGMEIAAKVFHMEFDGSLE-SFHAECKVMGSIRHRNLVK 821
           LG G+FG VY+G +      P  +++A K          E  F  E  ++    H+N+V+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLY------SDNYFLDILQRLKIMIDVASALEYLH 875
            I     +  + ++LE M+ G L+  L       S    L +L  L +  D+A   +YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 876 FGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGKEESMRQTK-TLGTIGYMAP 931
             +    +H DI   N LL       V  + DFG+A+ + +    R+    +  + +M P
Sbjct: 175 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 231
Query: 932 EYGREGKVSRKCDVYSYGIMLMETFT 957
           E   EG  + K D +S+G++L E F+
Sbjct: 232 EAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 13/208 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYC 150
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    ++DFG +       S R+    GT+ Y+ PE  
Sbjct: 151 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRDDLCGTLDYLPPEM- 203
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKP 961
            EG++   K D++S G++  E    K P
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 54/212 (25%), Positives = 102/212 (48%), Gaps = 14/212 (6%)
Query: 760 TDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF--DGSLE-SFHAECKVMGSIR 815
           +D +   ++LG G    V+    L    ++A KV   +   D S    F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 816 HRNLVKIISS----CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASAL 871
           H  +V + ++            +V+EY+   +L   ++++     +  +  I + +A A 
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 872 EYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQT-KTLGTIGYM 929
           + L+F +   I+H D+KP+N++++ +    + DFGIA+ +     S+ QT   +GT  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 930 APEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           +PE  R   V  + DVYS G +L E  T + P
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 72/312 (23%), Positives = 134/312 (42%), Gaps = 63/312 (20%)
Query: 761  DGFSENKLLGMGSFGSVY--------KGVLPDGMEIAAKVFHMEF-DGSLESFHAECKVM 811
            D  +  K LG G FG V         K    + + +A K+   +  +  L    +E ++M
Sbjct: 81   DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 812  GSI-RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL-----------YSDNYFLDILQ 859
              I +H+N++ ++ +C+ +    +++EY S G+L + L           Y  N   +   
Sbjct: 141  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 860  RLKIMI----DVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE 915
              K ++     +A  +EYL    S   +H D+   NVL+ E+ V  ++DFG+A+ +   +
Sbjct: 201  TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 916  SMRQTKTLGT--IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT------KKKPTDEIFA 967
              ++T T G   + +MAPE   +   + + DV+S+G+++ E FT         P +E+F 
Sbjct: 258  YYKKT-TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF- 315
Query: 968  GEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI 1027
                        LL               E +       C + ++ +  DC   +P +R 
Sbjct: 316  -----------KLLK--------------EGHRMDKPANCTNELYMMMRDCWHAVPSQRP 350
Query: 1028 SMKDVANRLVRI 1039
            + K +   L RI
Sbjct: 351  TFKQLVEDLDRI 362

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 13/212 (6%)
Query: 743 YPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL 801
           YPQ     I +  +L   D +  ++ LG G+FG V++      G   AAK      +   
Sbjct: 38  YPQPV--EIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK 92
Query: 802 ESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL 861
           E+   E + M  +RH  LV +  +  +++   ++ E+MS G L + +  ++  +   + +
Sbjct: 93  ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV 152
Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLS--DFGIAKILGKEESMRQ 919
           + M  V   L ++H       VH D+KP N++        L   DFG+   L  ++S++ 
Sbjct: 153 EYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV 209
Query: 920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIM 951
             T GT  + APE      V    D++S G++
Sbjct: 210 --TTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 239

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+LG G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+ + M  G L   +  + DN     L  L   + +
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 128
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG AK+LG EE     +     I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+LG G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 18  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+ + M  G L   +  + DN     L  L   + +
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 133
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG AK+LG EE     +     I
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 190
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+LG G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+ + M  G L   +  + DN     L  L   + +
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 126
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG AK+LG EE     +     I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 183
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 13/208 (6%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSI 814
           A + F   + LG G FG+VY         I A KV     +E  G       E ++   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           RH N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYC 127
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  ++H DIKP N+LL  +    ++DFG +       S R+    GT+ Y+ PE  
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRDDLCGTLDYLPPEM- 180
Query: 935 REGKV-SRKCDVYSYGIMLMETFTKKKP 961
            EG++   K D++S G++  E    K P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 761 DGFSENKLLGMGSFGSVY-KGVLPDGMEIAAKVFHMEFDG-SLESFHAECKVMGSIRHRN 818
           D F   + LG G+FG V+       G+E   K  + +     +E   AE +V+ S+ H N
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQR---LKIMIDVASALEYLH 875
           ++KI     +     +V+E    G L + + S       L      ++M  + +AL Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 876 FGYSTPIVHCDIKPSNVLLNESMVG---HLSDFGIAKILGKEESMRQTKTLGTIGYMAPE 932
              S  +VH D+KP N+L  ++       + DFG+A++   +E    T   GT  YMAPE
Sbjct: 142 ---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALYMAPE 196
Query: 933 YGREGKVSRKCDVYSYGIML 952
             +   V+ KCD++S G+++
Sbjct: 197 VFKR-DVTFKCDIWSAGVVM 215

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 72/312 (23%), Positives = 135/312 (43%), Gaps = 63/312 (20%)
Query: 761  DGFSENKLLGMGSFGSVY--------KGVLPDGMEIAAKVFHME-FDGSLESFHAECKVM 811
            D  +  K LG G+FG V         K    + + +A K+   +  +  L    +E ++M
Sbjct: 35   DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 812  GSI-RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL-----------YSDNYFLDILQ 859
              I +H+N++ ++ +C+ +    +++EY S G+L + L           Y  N   +   
Sbjct: 95   KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 860  RLKIMID----VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE 915
              K ++     +A  +EYL    S   +H D+   NVL+ E+ V  ++DFG+A+ +   +
Sbjct: 155  TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 916  SMRQTKTLG--TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT------KKKPTDEIFA 967
              ++T T G   + +MAPE   +   + + DV+S+G+++ E FT         P +E+F 
Sbjct: 212  XXKKT-TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF- 269
Query: 968  GEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI 1027
                                     LL  E +       C + ++ +  DC   +P +R 
Sbjct: 270  ------------------------KLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRP 304
Query: 1028 SMKDVANRLVRI 1039
            + K +   L RI
Sbjct: 305  TFKQLVEDLDRI 316

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 72/312 (23%), Positives = 135/312 (43%), Gaps = 63/312 (20%)
Query: 761  DGFSENKLLGMGSFGSVY--------KGVLPDGMEIAAKVFHME-FDGSLESFHAECKVM 811
            D  +  K LG G+FG V         K    + + +A K+   +  +  L    +E ++M
Sbjct: 35   DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 812  GSI-RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL-----------YSDNYFLDILQ 859
              I +H+N++ ++ +C+ +    +++EY S G+L + L           Y  N   +   
Sbjct: 95   KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 860  RLKIMID----VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE 915
              K ++     +A  +EYL    S   +H D+   NVL+ E+ V  ++DFG+A+ +   +
Sbjct: 155  TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 916  SMRQTKTLG--TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT------KKKPTDEIFA 967
              ++T T G   + +MAPE   +   + + DV+S+G+++ E FT         P +E+F 
Sbjct: 212  XXKKT-TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF- 269
Query: 968  GEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI 1027
                                     LL  E +       C + ++ +  DC   +P +R 
Sbjct: 270  ------------------------KLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRP 304
Query: 1028 SMKDVANRLVRI 1039
            + K +   L RI
Sbjct: 305  TFKQLVEDLDRI 316

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 769 LGMGSFGSVYKGVL------PDGMEIAAKVFHMEFDGSLE-SFHAECKVMGSIRHRNLVK 821
           LG G+FG VY+G +      P  +++A K          E  F  E  ++    H+N+V+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLY------SDNYFLDILQRLKIMIDVASALEYLH 875
            I     +  + ++LE M+ G L+  L       S    L +L  L +  D+A   +YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 876 FGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGKEESMRQTK-TLGTIGYMAP 931
             +    +H DI   N LL       V  + DFG+A+ + +    R+    +  + +M P
Sbjct: 185 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 932 EYGREGKVSRKCDVYSYGIMLMETFT 957
           E   EG  + K D +S+G++L E F+
Sbjct: 242 EAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 106/228 (46%), Gaps = 21/228 (9%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEF-------DGSLESFH--AECKVMGSIRHR 817
           ++LG G +G V++     G     K+F M+          + ++ H  AE  ++  ++H 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGAN-TGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 818 NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
            +V +I +        L+LEY+S G L   L  +  F++       + +++ AL +LH  
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLH-- 138
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG 937
               I++ D+KP N++LN      L+DFG+ K    + ++  T   GTI YMAPE     
Sbjct: 139 -QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYMAPEILMRS 196
Query: 938 KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSI 985
             +R  D +S G ++ +  T   P    F GE   K    D +L C +
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGAPP----FTGENRKK--TIDKILKCKL 238

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 93/189 (49%), Gaps = 13/189 (6%)
Query: 769 LGMGSFGSVYKGVLPDGMEI--AAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
           +G GS+G V K  +  G  I  AAK     F   ++ F  E ++M S+ H N++++  + 
Sbjct: 17  IGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
            +N    LV+E  + G L + +     F +     +IM DV SA+ Y H      + H D
Sbjct: 76  EDNTDIYLVMELCTGGELFERVVHKRVFRES-DAARIMKDVLSAVAYCH---KLNVAHRD 131
Query: 887 IKPSNVL-LNESMVGHLS--DFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKC 943
           +KP N L L +S    L   DFG+A      + MR    +GT  Y++P+   EG    +C
Sbjct: 132 LKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT--KVGTPYYVSPQV-LEGLYGPEC 188
Query: 944 DVYSYGIML 952
           D +S G+M+
Sbjct: 189 DEWSAGVMM 197

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 769 LGMGSFGSVYKGVL------PDGMEIAAKVFHMEFDGSLE-SFHAECKVMGSIRHRNLVK 821
           LG G+FG VY+G +      P  +++A K          E  F  E  ++    H+N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLY------SDNYFLDILQRLKIMIDVASALEYLH 875
            I     +  + ++LE M+ G L+  L       S    L +L  L +  D+A   +YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 876 FGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGKEESMRQTK-TLGTIGYMAP 931
             +    +H DI   N LL       V  + DFG+A+ + +    R+    +  + +M P
Sbjct: 199 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 932 EYGREGKVSRKCDVYSYGIMLMETFT 957
           E   EG  + K D +S+G++L E F+
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 769 LGMGSFGSVYKGVL------PDGMEIAAKVFHMEFDGSLE-SFHAECKVMGSIRHRNLVK 821
           LG G+FG VY+G +      P  +++A K          E  F  E  ++    H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLY------SDNYFLDILQRLKIMIDVASALEYLH 875
            I     +  + +++E M+ G L+  L       S    L +L  L +  D+A   +YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 876 FGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGKEESMRQTK-TLGTIGYMAP 931
             +    +H DI   N LL       V  + DFG+A+ + +    R+    +  + +M P
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 932 EYGREGKVSRKCDVYSYGIMLMETFT 957
           E   EG  + K D +S+G++L E F+
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 769 LGMGSFGSVYKGVL------PDGMEIAAKVFHMEFDGSLE-SFHAECKVMGSIRHRNLVK 821
           LG G+FG VY+G +      P  +++A K          E  F  E  ++    H+N+V+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLY------SDNYFLDILQRLKIMIDVASALEYLH 875
            I     +  + ++LE M+ G L+  L       S    L +L  L +  D+A   +YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 876 FGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGKEESMRQTK-TLGTIGYMAP 931
             +    +H DI   N LL       V  + DFG+A+ + +    R+    +  + +M P
Sbjct: 176 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 932 EYGREGKVSRKCDVYSYGIMLMETFT 957
           E   EG  + K D +S+G++L E F+
Sbjct: 233 EAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 13/208 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSIRH 816
           D F   + LG G FG+VY         I A KV     +E +G       E ++   +RH
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
            N++++ +   +     L+LE+   G L K L     F D  +    M ++A AL Y H 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF-DEQRSATFMEELADALHYCH- 131
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
                ++H DIKP N+L+       ++DFG +       S+R+    GT+ Y+ PE   E
Sbjct: 132 --ERKVIHRDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRXMCGTLDYLPPEM-IE 185
Query: 937 GKV-SRKCDVYSYGIMLMETFTKKKPTD 963
           GK    K D++  G++  E      P D
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 72/312 (23%), Positives = 135/312 (43%), Gaps = 63/312 (20%)
Query: 761  DGFSENKLLGMGSFGSVY--------KGVLPDGMEIAAKVFHME-FDGSLESFHAECKVM 811
            D  +  K LG G+FG V         K    + + +A K+   +  +  L    +E ++M
Sbjct: 35   DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 812  GSI-RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL-----------YSDNYFLDILQ 859
              I +H+N++ ++ +C+ +    +++EY S G+L + L           Y  N   +   
Sbjct: 95   KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 860  RLKIMID----VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE 915
              K ++     +A  +EYL    S   +H D+   NVL+ E+ V  ++DFG+A+ +   +
Sbjct: 155  TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMRIADFGLARDINNID 211
Query: 916  SMRQTKTLG--TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT------KKKPTDEIFA 967
              ++T T G   + +MAPE   +   + + DV+S+G+++ E FT         P +E+F 
Sbjct: 212  YYKKT-TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF- 269
Query: 968  GEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI 1027
                                     LL  E +       C + ++ +  DC   +P +R 
Sbjct: 270  ------------------------KLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRP 304
Query: 1028 SMKDVANRLVRI 1039
            + K +   L RI
Sbjct: 305  TFKQLVEDLDRI 316

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 54/212 (25%), Positives = 101/212 (47%), Gaps = 14/212 (6%)
Query: 760 TDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF--DGSLE-SFHAECKVMGSIR 815
           +D +   ++LG G    V+    L    ++A KV   +   D S    F  E +   ++ 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 816 HRNLVKIISS----CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASAL 871
           H  +V +  +            +V+EY+   +L   ++++     +  +  I + +A A 
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 143
Query: 872 EYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQT-KTLGTIGYM 929
           + L+F +   I+H D+KP+N++++ +    + DFGIA+ +     S+ QT   +GT  Y+
Sbjct: 144 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 203
Query: 930 APEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           +PE  R   V  + DVYS G +L E  T + P
Sbjct: 204 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 54/212 (25%), Positives = 101/212 (47%), Gaps = 14/212 (6%)
Query: 760 TDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF--DGSLE-SFHAECKVMGSIR 815
           +D +   ++LG G    V+    L    ++A KV   +   D S    F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 816 HRNLVKIISS----CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASAL 871
           H  +V +  +            +V+EY+   +L   ++++     +  +  I + +A A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 872 EYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQT-KTLGTIGYM 929
           + L+F +   I+H D+KP+N++++ +    + DFGIA+ +     S+ QT   +GT  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 930 APEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           +PE  R   V  + DVYS G +L E  T + P
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 68/231 (29%), Positives = 105/231 (45%), Gaps = 38/231 (16%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKV--MGSIRHRNLVKII- 823
           +L+G G +G+VYKG L D   +A KVF      + ++F  E  +  +  + H N+ + I 
Sbjct: 19  ELIGRGRYGAVYKGSL-DERPVAVKVFSF---ANRQNFINEKNIYRVPLMEHDNIARFIV 74
Query: 824 ----SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF--- 876
                +        LV+EY  NGSL K  Y   +  D +   ++   V   L YLH    
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXK--YLSLHTSDWVSSCRLAHSVTRGLAYLHTELP 132
Query: 877 ---GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA-KILGK------EESMRQTKTLGTI 926
               Y   I H D+   NVL+       +SDFG++ ++ G       EE       +GTI
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTI 192
Query: 927 GYMAPEYGREGKVS--------RKCDVYSYGIMLMETFTKKKPTDEIFAGE 969
            YMAPE   EG V+        ++ D+Y+ G++  E F +     ++F GE
Sbjct: 193 RYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMR---CTDLFPGE 239

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 65/226 (28%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+L  G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 18  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+ + M  G L   +  + DN     L  L   + +
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 133
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG+AK+LG EE     +     I
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 65/226 (28%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL-----ESFHAECK 809
           +L+ T+ F + K+L  G+FG+VYKG+ +P+G ++   V   E   +      +    E  
Sbjct: 11  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 810 VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDV 867
           VM S+ + ++ +++  C  +  + L+ + M  G L   +  + DN     L  L   + +
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI 126
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-I 926
           A  + YL       +VH D+   NVL+       ++DFG+AK+LG EE     +     I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMS 971
            +MA E       + + DV+SYG+ + E  T   KP D I A E+S
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 767 KLLGMGSFGSVY---KGVLPD-GMEIAAKVFH---MEFDGSLESFHAECKVMGSIRHRNL 819
           K+LG GSFG V+   K   PD G   A KV     ++    + +   E  ++  + H  +
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRT-KMERDILADVNHPFV 92
Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI-MIDVASALEYLHFGY 878
           VK+  +        L+L+++  G L   L  +  F +  + +K  + ++A  L++LH   
Sbjct: 93  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE--EDVKFYLAELALGLDHLH--- 147
Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGK 938
           S  I++ D+KP N+LL+E     L+DFG++K     E  +     GT+ YMAPE      
Sbjct: 148 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEK-KAYSFCGTVEYMAPEVVNRQG 206
Query: 939 VSRKCDVYSYGIMLMETFTKKKP 961
            S   D +SYG+++ E  T   P
Sbjct: 207 HSHSADWWSYGVLMFEMLTGSLP 229

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 769 LGMGSFGSVYKGVL------PDGMEIAAKVFHMEFDGSLE-SFHAECKVMGSIRHRNLVK 821
           LG G+FG VY+G +      P  +++A K          E  F  E  ++    H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLY------SDNYFLDILQRLKIMIDVASALEYLH 875
            I     +  + +++E M+ G L+  L       S    L +L  L +  D+A   +YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 876 FGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGKEESMRQTK-TLGTIGYMAP 931
             +    +H DI   N LL       V  + DFG+A+ + +    R+    +  + +M P
Sbjct: 173 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 932 EYGREGKVSRKCDVYSYGIMLMETFT 957
           E   EG  + K D +S+G++L E F+
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/189 (32%), Positives = 95/189 (50%), Gaps = 13/189 (6%)
Query: 769 LGMGSFGSVYKGVLPDGMEI--AAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
           +G GS+G V K  +  G  I  AAK     F   ++ F  E ++M S+ H N++++  + 
Sbjct: 34  IGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 92
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
            +N    LV+E  + G L + +     F +     +IM DV SA+ Y H      + H D
Sbjct: 93  EDNTDIYLVMELCTGGELFERVVHKRVFRES-DAARIMKDVLSAVAYCH---KLNVAHRD 148
Query: 887 IKPSNVL-LNESMVGHLS--DFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKC 943
           +KP N L L +S    L   DFG+A      + MR TK +GT  Y++P+   EG    +C
Sbjct: 149 LKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR-TK-VGTPYYVSPQV-LEGLYGPEC 205
Query: 944 DVYSYGIML 952
           D +S G+M+
Sbjct: 206 DEWSAGVMM 214

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 760 TDGFSENKLLGMGSFGSVY--KGVLPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSI 814
           +D +   ++LG GSFG V   K  +  G E A KV     ++     ES   E +++  +
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
            H N+ K+     +  +  LV E  + G L   + S   F ++    +I+  V S + Y 
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYX 142
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVG---HLSDFGIAKILGKEESMRQTKTLGTIGYMAP 931
           H      IVH D+KP N+LL          + DFG++     E S +    +GT  Y+AP
Sbjct: 143 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKXKDKIGTAYYIAP 197
Query: 932 EYGREGKVSRKCDVYSYGIML 952
           E    G    KCDV+S G++L
Sbjct: 198 EV-LHGTYDEKCDVWSTGVIL 217

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 72/312 (23%), Positives = 135/312 (43%), Gaps = 63/312 (20%)
Query: 761  DGFSENKLLGMGSFGSVY--------KGVLPDGMEIAAKVFHME-FDGSLESFHAECKVM 811
            D  +  K LG G+FG V         K    + + +A K+   +  +  L    +E ++M
Sbjct: 35   DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 812  GSI-RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL-----------YSDNYFLDILQ 859
              I +H+N++ ++ +C+ +    +++EY S G+L + L           Y  N   +   
Sbjct: 95   KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 860  RLKIMID----VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE 915
              K ++     +A  +EYL    S   +H D+   NVL+ E+ V  ++DFG+A+ +   +
Sbjct: 155  TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 916  SMRQTKTLG--TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT------KKKPTDEIFA 967
              ++T T G   + +MAPE   +   + + DV+S+G+++ E FT         P +E+F 
Sbjct: 212  YYKKT-TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF- 269
Query: 968  GEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI 1027
                                     LL  E +       C + ++ +  DC   +P +R 
Sbjct: 270  ------------------------KLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRP 304
Query: 1028 SMKDVANRLVRI 1039
            + K +   L RI
Sbjct: 305  TFKQLVEDLDRI 316

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 72/312 (23%), Positives = 135/312 (43%), Gaps = 63/312 (20%)
Query: 761  DGFSENKLLGMGSFGSVY--------KGVLPDGMEIAAKVFHME-FDGSLESFHAECKVM 811
            D  +  K LG G+FG V         K    + + +A K+   +  +  L    +E ++M
Sbjct: 35   DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 812  GSI-RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL-----------YSDNYFLDILQ 859
              I +H+N++ ++ +C+ +    +++EY S G+L + L           Y  N   +   
Sbjct: 95   KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 860  RLKIMID----VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE 915
              K ++     +A  +EYL    S   +H D+   NVL+ E+ V  ++DFG+A+ +   +
Sbjct: 155  TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 916  SMRQTKTLG--TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT------KKKPTDEIFA 967
              ++T T G   + +MAPE   +   + + DV+S+G+++ E FT         P +E+F 
Sbjct: 212  YYKKT-TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF- 269
Query: 968  GEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI 1027
                                     LL  E +       C + ++ +  DC   +P +R 
Sbjct: 270  ------------------------KLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRP 304
Query: 1028 SMKDVANRLVRI 1039
            + K +   L RI
Sbjct: 305  TFKQLVEDLDRI 316

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 16/209 (7%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA-KVFHMEFDGSLESF-HAECKVMGSIRHRNLV 820
           F++   +G GSFG VYKG+     E+ A K+  +E           E  V+       + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 821 KIISSCSNNDFKALVLEYMSNGS----LEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
           +   S   +    +++EY+  GS    L+     + Y   IL+      ++   L+YLH 
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR------EILKGLDYLH- 133
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S   +H DIK +NVLL+E     L+DFG+A  L  +  +++   +GT  +MAPE  ++
Sbjct: 134 --SERKIHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNXFVGTPFWMAPEVIKQ 190
Query: 937 GKVSRKCDVYSYGIMLMETFTKKKPTDEI 965
                K D++S GI  +E    + P  ++
Sbjct: 191 SAYDFKADIWSLGITAIELAKGEPPNSDL 219

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 72/312 (23%), Positives = 135/312 (43%), Gaps = 63/312 (20%)
Query: 761  DGFSENKLLGMGSFGSVY--------KGVLPDGMEIAAKVFHME-FDGSLESFHAECKVM 811
            D  +  K LG G+FG V         K    + + +A K+   +  +  L    +E ++M
Sbjct: 35   DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 812  GSI-RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL-----------YSDNYFLDILQ 859
              I +H+N++ ++ +C+ +    +++EY S G+L + L           Y  N   +   
Sbjct: 95   KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 860  RLKIMID----VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE 915
              K ++     +A  +EYL    S   +H D+   NVL+ E+ V  ++DFG+A+ +   +
Sbjct: 155  TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 916  SMRQTKTLG--TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT------KKKPTDEIFA 967
              ++T T G   + +MAPE   +   + + DV+S+G+++ E FT         P +E+F 
Sbjct: 212  YYKKT-TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF- 269
Query: 968  GEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI 1027
                                     LL  E +       C + ++ +  DC   +P +R 
Sbjct: 270  ------------------------KLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRP 304
Query: 1028 SMKDVANRLVRI 1039
            + K +   L RI
Sbjct: 305  TFKQLVEDLDRI 316

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSIRH 816
           + F   + LG G FG+VY         I A KV     +E  G       E ++   +RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
            N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y H 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRF-DEQRTATYITELANALSYCH- 129
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  ++H DIKP N+LL  +    ++DFG +       S R+T   GT+ Y+ PE   E
Sbjct: 130 --SKRVIHRDIKPENLLLGSNGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMI-E 183
Query: 937 GKV-SRKCDVYSYGIMLME 954
           G++   K D++S G++  E
Sbjct: 184 GRMHDEKVDLWSLGVLCYE 202

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 8/214 (3%)
Query: 761 DGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGSLE-SFHAECKVMGSIRHRN 818
           D F +   LG G+ G V+K    P G+ +A K+ H+E   ++      E +V+       
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
           +V    +  ++   ++ +E+M  GSL++ L       + +   K+ I V   L YL   +
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLREKH 186
Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGK 938
              I+H D+KPSN+L+N      L DFG++  L   +SM  +  +GT  YM+PE  +   
Sbjct: 187 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANS-FVGTRSYMSPERLQGTH 241
Query: 939 VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSL 972
            S + D++S G+ L+E    + P     A E+ L
Sbjct: 242 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 275

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 21/212 (9%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEF--------DGSLESFHAECKVMG 812
           D F   + +G GSFG V      D      K++ M++           + +   E ++M 
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKND----TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQ 70
Query: 813 SIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALE 872
            + H  LV +  S  + +   +V++ +  G L   L  + +F +   +L  + ++  AL+
Sbjct: 71  GLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL-FICELVMALD 129
Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE 932
           YL    +  I+H D+KP N+LL+E    H++DF IA +L +E  +  T   GT  YMAPE
Sbjct: 130 YLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI--TTMAGTKPYMAPE 184
Query: 933 Y--GREGK-VSRKCDVYSYGIMLMETFTKKKP 961
               R+G   S   D +S G+   E    ++P
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 34/222 (15%)
Query: 767 KLLGMGSFGSVYK----GVLPDG--MEIAAKVFHMEFDGS-LESFHAECKVMGSI-RHRN 818
           K+LG G+FG V      G+   G  +++A K+   + D S  E+  +E K+M  +  H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 819 LVKIISSCSNNDFKALVLEYMSNGSL-------------EKCLYSDNYFLDILQRLKIM- 864
           +V ++ +C+ +    L+ EY   G L             ++  Y +   L+  + L ++ 
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 865 --------IDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK-ILGKEE 915
                     VA  +E+L F      VH D+   NVL+    V  + DFG+A+ I+    
Sbjct: 171 FEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
            + +      + +MAPE   EG  + K DV+SYGI+L E F+
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 34/227 (14%)
Query: 757 LRATDGFSENKLLGMGSFGSVYKG--VLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI 814
           LR    F E  +LG G+FG V K    L        K+ H E    L +  +E  ++ S+
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVXLLASL 59
Query: 815 RH-------------RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL 861
            H             RN VK  ++        +  EY  N +L   ++S+N      +  
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE------- 914
           ++   +  AL Y+H   S  I+H ++KP N+ ++ES    + DFG+AK + +        
Sbjct: 120 RLFRQILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 915 ------ESMRQTKTLGTIGYMAPE-YGREGKVSRKCDVYSYGIMLME 954
                  S   T  +GT  Y+A E     G  + K D YS GI+  E
Sbjct: 177 SQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 72/312 (23%), Positives = 134/312 (42%), Gaps = 63/312 (20%)
Query: 761  DGFSENKLLGMGSFGSVY--------KGVLPDGMEIAAKVFHME-FDGSLESFHAECKVM 811
            D  +  K LG G+FG V         K    + + +A K+   +  +  L    +E ++M
Sbjct: 35   DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 812  GSI-RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL-----------YSDNYFLDILQ 859
              I +H+N++ ++ +C+ +    +++EY S G+L + L           Y  N   +   
Sbjct: 95   KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 860  RLKIMID----VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE 915
              K ++     +A  +EYL    S   +H D+   NVL+ E+ V  ++DFG+A+ +   +
Sbjct: 155  TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 916  SMRQTKTLG--TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT------KKKPTDEIFA 967
              + T T G   + +MAPE   +   + + DV+S+G+++ E FT         P +E+F 
Sbjct: 212  YYKNT-TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF- 269
Query: 968  GEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI 1027
                                     LL  E +       C + ++ +  DC   +P +R 
Sbjct: 270  ------------------------KLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRP 304
Query: 1028 SMKDVANRLVRI 1039
            + K +   L RI
Sbjct: 305  TFKQLVEDLDRI 316

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 760 TDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRH 816
           TD +   + LG G+F  V + + +P G E AAK+ + +   +   +    E ++   ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
            N+V++  S S   F  LV + ++ G L + + +  Y+ +      I       LE ++ 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ----QILESVNH 118
Query: 877 GYSTPIVHCDIKPSNVLLNESMVG---HLSDFGIA-KILGKEESMRQTKTLGTIGYMAPE 932
            +   IVH D+KP N+LL     G    L+DFG+A ++ G +++       GT GY++PE
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAW--FGFAGTPGYLSPE 176
Query: 933 YGREGKVSRKCDVYSYGIML 952
             R+    +  D+++ G++L
Sbjct: 177 VLRKDPYGKPVDMWACGVIL 196

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 9/193 (4%)
Query: 767 KLLGMGSFGSVYKGVL--PD--GMEIAAKVF-HMEFDGSLESFHAECKVMGSIRHRNLVK 821
           + +G G FG V++G+   P+   M +A K   +   D   E F  E   M    H ++VK
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           +I   + N    +++E  + G L   L    Y LD+   +     +++AL YL    S  
Sbjct: 76  LIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKR 131
Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSR 941
            VH DI   NVL++ +    L DFG+++ +      + +K    I +MAPE     + + 
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 942 KCDVYSYGIMLME 954
             DV+ +G+ + E
Sbjct: 192 ASDVWMFGVCMWE 204

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 72/312 (23%), Positives = 134/312 (42%), Gaps = 63/312 (20%)
Query: 761  DGFSENKLLGMGSFGSVY--------KGVLPDGMEIAAKVFHME-FDGSLESFHAECKVM 811
            D  +  K LG G FG V         K    + + +A K+   +  +  L    +E ++M
Sbjct: 22   DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 812  GSI-RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL-----------YSDNYFLDILQ 859
              I +H+N++ ++ +C+ +    +++EY S G+L + L           Y  N   +   
Sbjct: 82   KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 860  RLKIMID----VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE 915
              K ++     +A  +EYL    S   +H D+   NVL+ E+ V  ++DFG+A+ +   +
Sbjct: 142  TFKDLVSCTYQLARGMEYLA---SQKCIHRDLTARNVLVTENNVMKIADFGLARDINNID 198
Query: 916  SMRQTKTLG--TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT------KKKPTDEIFA 967
              ++T T G   + +MAPE   +   + + DV+S+G+++ E FT         P +E+F 
Sbjct: 199  YYKKT-TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF- 256
Query: 968  GEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI 1027
                                     LL  E +       C + ++ +  DC   +P +R 
Sbjct: 257  ------------------------KLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRP 291
Query: 1028 SMKDVANRLVRI 1039
            + K +   L RI
Sbjct: 292  TFKQLVEDLDRI 303

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 760 TDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGS--LESFHAECKVMGSIRH 816
           +D +   + LG G+F  V + V    G+E AAK+ + +   +   +    E ++   ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVAS-----AL 871
            N+V++  S     F  LV + ++ G L         F DI+ R       AS      L
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGEL---------FEDIVAREFYSEADASHCIQQIL 115
Query: 872 EYLHFGYSTPIVHCDIKPSNVLLNESMVG---HLSDFGIAKILGKEESMRQTKTLGTIGY 928
           E + + +S  IVH ++KP N+LL     G    L+DFG+A  +   E+       GT GY
Sbjct: 116 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGY 173
Query: 929 MAPEYGREGKVSRKCDVYSYGIML 952
           ++PE  ++   S+  D+++ G++L
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVIL 197

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 760 TDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGS--LESFHAECKVMGSIRH 816
           +D +   + LG G+F  V + V    G+E AAK+ + +   +   +    E ++   ++H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVAS-----AL 871
            N+V++  S     F  LV + ++ G L         F DI+ R       AS      L
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGEL---------FEDIVAREFYSEADASHCIQQIL 114
Query: 872 EYLHFGYSTPIVHCDIKPSNVLLNESMVG---HLSDFGIAKILGKEESMRQTKTLGTIGY 928
           E + + +S  IVH ++KP N+LL     G    L+DFG+A  +   E+       GT GY
Sbjct: 115 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGY 172
Query: 929 MAPEYGREGKVSRKCDVYSYGIML 952
           ++PE  ++   S+  D+++ G++L
Sbjct: 173 LSPEVLKKDPYSKPVDIWACGVIL 196

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 760 TDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGS--LESFHAECKVMGSIRH 816
           +D +   + LG G+F  V + V    G+E AAK+ + +   +   +    E ++   ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVAS-----AL 871
            N+V++  S     F  LV + ++ G L         F DI+ R       AS      L
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGEL---------FEDIVAREFYSEADASHCIQQIL 115
Query: 872 EYLHFGYSTPIVHCDIKPSNVLLNESMVG---HLSDFGIAKILGKEESMRQTKTLGTIGY 928
           E + + +S  IVH ++KP N+LL     G    L+DFG+A  +   E+       GT GY
Sbjct: 116 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGY 173
Query: 929 MAPEYGREGKVSRKCDVYSYGIML 952
           ++PE  ++   S+  D+++ G++L
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVIL 197

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 72/312 (23%), Positives = 134/312 (42%), Gaps = 63/312 (20%)
Query: 761  DGFSENKLLGMGSFGSVY--------KGVLPDGMEIAAKVFHME-FDGSLESFHAECKVM 811
            D  +  K LG G FG V         K    + + +A K+   +  +  L    +E ++M
Sbjct: 27   DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 812  GSI-RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL-----------YSDNYFLDILQ 859
              I +H+N++ ++ +C+ +    +++EY S G+L + L           Y  N   +   
Sbjct: 87   KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 860  RLKIMID----VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE 915
              K ++     +A  +EYL    S   +H D+   NVL+ E+ V  ++DFG+A+ +   +
Sbjct: 147  TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 203
Query: 916  SMRQTKTLG--TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT------KKKPTDEIFA 967
              ++T T G   + +MAPE   +   + + DV+S+G+++ E FT         P +E+F 
Sbjct: 204  YYKKT-TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF- 261
Query: 968  GEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI 1027
                                     LL  E +       C + ++ +  DC   +P +R 
Sbjct: 262  ------------------------KLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRP 296
Query: 1028 SMKDVANRLVRI 1039
            + K +   L RI
Sbjct: 297  TFKQLVEDLDRI 308

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 58/194 (29%), Positives = 95/194 (48%), Gaps = 11/194 (5%)
Query: 768 LLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVKIIS 824
           L+G GS+G V K    D G  +A K F    D  +    A  E K++  +RH NLV ++ 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 825 SCSNNDFKALVLEYMSNGSLEKC-LYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIV 883
            C       LV E++ +  L+   L+ +     ++Q  K +  + + + + H   S  I+
Sbjct: 92  VCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQ--KYLFQIINGIGFCH---SHNII 146
Query: 884 HCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE-YGREGKVSRK 942
           H DIKP N+L+++S V  L DFG A+ L     +   + + T  Y APE    + K  + 
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE-VATRWYRAPELLVGDVKYGKA 205
Query: 943 CDVYSYGIMLMETF 956
            DV++ G ++ E F
Sbjct: 206 VDVWAIGCLVTEMF 219

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 72/312 (23%), Positives = 134/312 (42%), Gaps = 63/312 (20%)
Query: 761  DGFSENKLLGMGSFGSVY--------KGVLPDGMEIAAKVFHME-FDGSLESFHAECKVM 811
            D  +  K LG G FG V         K    + + +A K+   +  +  L    +E ++M
Sbjct: 24   DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 812  GSI-RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL-----------YSDNYFLDILQ 859
              I +H+N++ ++ +C+ +    +++EY S G+L + L           Y  N   +   
Sbjct: 84   KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 860  RLKIMID----VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE 915
              K ++     +A  +EYL    S   +H D+   NVL+ E+ V  ++DFG+A+ +   +
Sbjct: 144  TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 200
Query: 916  SMRQTKTLG--TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT------KKKPTDEIFA 967
              ++T T G   + +MAPE   +   + + DV+S+G+++ E FT         P +E+F 
Sbjct: 201  YYKKT-TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF- 258
Query: 968  GEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI 1027
                                     LL  E +       C + ++ +  DC   +P +R 
Sbjct: 259  ------------------------KLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRP 293
Query: 1028 SMKDVANRLVRI 1039
            + K +   L RI
Sbjct: 294  TFKQLVEDLDRI 305

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/309 (22%), Positives = 131/309 (42%), Gaps = 69/309 (22%)
Query: 767  KLLGMGSFGSVYKGVLPDGM-----------EIAAKVFHMEF-DGSLESFHAECKVMGSI 814
            K LG G+FG V   VL + +           ++A K+   +  +  L    +E ++M  I
Sbjct: 34   KPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 90
Query: 815  -RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL---------------YSDNYFLDIL 858
             +H+N++ ++ +C+ +    +++EY S G+L + L               ++    L   
Sbjct: 91   GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSK 150
Query: 859  QRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR 918
              +     VA  +EYL    S   +H D+   NVL+ E  V  ++DFG+A+ +   +  +
Sbjct: 151  DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXK 207
Query: 919  QTKTLGT--IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT------KKKPTDEIFAGEM 970
            +T T G   + +MAPE   +   + + DV+S+G++L E FT         P +E+F    
Sbjct: 208  KT-TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK--- 263
Query: 971  SLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMK 1030
                                   L  E +       C + ++ +  DC   +P +R + K
Sbjct: 264  -----------------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 300
Query: 1031 DVANRLVRI 1039
             +   L RI
Sbjct: 301  QLVEDLDRI 309

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 75/309 (24%), Positives = 135/309 (43%), Gaps = 69/309 (22%)
Query: 767  KLLGMGSFGSVYKGVLPDGM-----------EIAAKVFHME-FDGSLESFHAECKVMGSI 814
            K LG G+FG V   VL + +           ++A K+   +  +  L    +E ++M  I
Sbjct: 26   KPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 82
Query: 815  -RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL---------YSDNYFLDILQRL--- 861
             +H+N++ ++ +C+ +    +++EY S G+L + L         YS N   +  ++L   
Sbjct: 83   GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 142
Query: 862  ---KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR 918
                    VA  +EYL    S   +H D+   NVL+ E  V  ++DFG+A+ +   +  +
Sbjct: 143  DLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 199
Query: 919  QTKTLG--TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT------KKKPTDEIFAGEM 970
            +T T G   + +MAPE   +   + + DV+S+G++L E FT         P +E+F    
Sbjct: 200  KT-TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF---- 254
Query: 971  SLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMK 1030
                                  LL  E +       C + ++ +  DC   +P +R + K
Sbjct: 255  ---------------------KLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 292
Query: 1031 DVANRLVRI 1039
             +   L RI
Sbjct: 293  QLVEDLDRI 301

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 75/309 (24%), Positives = 135/309 (43%), Gaps = 69/309 (22%)
Query: 767  KLLGMGSFGSVYKGVLPDGM-----------EIAAKVFHME-FDGSLESFHAECKVMGSI 814
            K LG G+FG V   VL + +           ++A K+   +  +  L    +E ++M  I
Sbjct: 23   KPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 79
Query: 815  -RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL---------YSDNYFLDILQRL--- 861
             +H+N++ ++ +C+ +    +++EY S G+L + L         YS N   +  ++L   
Sbjct: 80   GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 139
Query: 862  ---KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR 918
                    VA  +EYL    S   +H D+   NVL+ E  V  ++DFG+A+ +   +  +
Sbjct: 140  DLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 196
Query: 919  QTKTLG--TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT------KKKPTDEIFAGEM 970
            +T T G   + +MAPE   +   + + DV+S+G++L E FT         P +E+F    
Sbjct: 197  KT-TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF---- 251
Query: 971  SLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMK 1030
                                  LL  E +       C + ++ +  DC   +P +R + K
Sbjct: 252  ---------------------KLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 289
Query: 1031 DVANRLVRI 1039
             +   L RI
Sbjct: 290  QLVEDLDRI 298

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 75/309 (24%), Positives = 135/309 (43%), Gaps = 69/309 (22%)
Query: 767  KLLGMGSFGSVYKGVLPDGM-----------EIAAKVFHME-FDGSLESFHAECKVMGSI 814
            K LG G+FG V   VL + +           ++A K+   +  +  L    +E ++M  I
Sbjct: 34   KPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 90
Query: 815  -RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL---------YSDNYFLDILQRL--- 861
             +H+N++ ++ +C+ +    +++EY S G+L + L         YS N   +  ++L   
Sbjct: 91   GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSK 150
Query: 862  ---KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR 918
                    VA  +EYL    S   +H D+   NVL+ E  V  ++DFG+A+ +   +  +
Sbjct: 151  DLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 919  QTKTLG--TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT------KKKPTDEIFAGEM 970
            +T T G   + +MAPE   +   + + DV+S+G++L E FT         P +E+F    
Sbjct: 208  KT-TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF---- 262
Query: 971  SLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMK 1030
                                  LL  E +       C + ++ +  DC   +P +R + K
Sbjct: 263  ---------------------KLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 300
Query: 1031 DVANRLVRI 1039
             +   L RI
Sbjct: 301  QLVEDLDRI 309

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 75/309 (24%), Positives = 135/309 (43%), Gaps = 69/309 (22%)
Query: 767  KLLGMGSFGSVYKGVLPDGM-----------EIAAKVFHME-FDGSLESFHAECKVMGSI 814
            K LG G+FG V   VL + +           ++A K+   +  +  L    +E ++M  I
Sbjct: 34   KPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 90
Query: 815  -RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL---------YSDNYFLDILQRL--- 861
             +H+N++ ++ +C+ +    +++EY S G+L + L         YS N   +  ++L   
Sbjct: 91   GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 150
Query: 862  ---KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR 918
                    VA  +EYL    S   +H D+   NVL+ E  V  ++DFG+A+ +   +  +
Sbjct: 151  DLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 919  QTKTLG--TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT------KKKPTDEIFAGEM 970
            +T T G   + +MAPE   +   + + DV+S+G++L E FT         P +E+F    
Sbjct: 208  KT-TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF---- 262
Query: 971  SLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMK 1030
                                  LL  E +       C + ++ +  DC   +P +R + K
Sbjct: 263  ---------------------KLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 300
Query: 1031 DVANRLVRI 1039
             +   L RI
Sbjct: 301  QLVEDLDRI 309

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 75/309 (24%), Positives = 135/309 (43%), Gaps = 69/309 (22%)
Query: 767  KLLGMGSFGSVYKGVLPDGM-----------EIAAKVFHME-FDGSLESFHAECKVMGSI 814
            K LG G+FG V   VL + +           ++A K+   +  +  L    +E ++M  I
Sbjct: 27   KPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 83
Query: 815  -RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL---------YSDNYFLDILQRL--- 861
             +H+N++ ++ +C+ +    +++EY S G+L + L         YS N   +  ++L   
Sbjct: 84   GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 143
Query: 862  ---KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR 918
                    VA  +EYL    S   +H D+   NVL+ E  V  ++DFG+A+ +   +  +
Sbjct: 144  DLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 200
Query: 919  QTKTLG--TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT------KKKPTDEIFAGEM 970
            +T T G   + +MAPE   +   + + DV+S+G++L E FT         P +E+F    
Sbjct: 201  KT-TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF---- 255
Query: 971  SLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMK 1030
                                  LL  E +       C + ++ +  DC   +P +R + K
Sbjct: 256  ---------------------KLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 293
Query: 1031 DVANRLVRI 1039
             +   L RI
Sbjct: 294  QLVEDLDRI 302

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 25/213 (11%)
Query: 767 KLLGMGSFGSVYKG----------VLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-R 815
           K LG G+FG V +           VL   +++     H +     E+  +E K+M  + +
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD---EKEALMSELKIMSHLGQ 108
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
           H N+V ++ +C++     ++ EY   G L   L   +  L+      I    AS  + LH
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 876 FG----------YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK-ILGKEESMRQTKTLG 924
           F            S   +H D+   NVLL    V  + DFG+A+ I+     + +     
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 925 TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
            + +MAPE   +   + + DV+SYGI+L E F+
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 8/203 (3%)
Query: 761 DGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGSLE-SFHAECKVMGSIRHRN 818
           D F +   LG G+ G V+K    P G+ +A K+ H+E   ++      E +V+       
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
           +V    +  ++   ++ +E+M  GSL++ L       + +   K+ I V   L YL   +
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLREKH 127
Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGK 938
              I+H D+KPSN+L+N      L DFG++  L  E +    + +GT  YM+PE  +   
Sbjct: 128 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMA---NEFVGTRSYMSPERLQGTH 182
Query: 939 VSRKCDVYSYGIMLMETFTKKKP 961
            S + D++S G+ L+E    + P
Sbjct: 183 YSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 90/193 (46%), Gaps = 9/193 (4%)
Query: 767 KLLGMGSFGSVYKGVL--PD--GMEIAAKVF-HMEFDGSLESFHAECKVMGSIRHRNLVK 821
           + +G G FG V++G+   P+   M +A K   +   D   E F  E   M    H ++VK
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           +I   + N    +++E  + G L   L    + LD+   +     +++AL YL    S  
Sbjct: 76  LIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKR 131
Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSR 941
            VH DI   NVL++ +    L DFG+++ +      + +K    I +MAPE     + + 
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFTS 191
Query: 942 KCDVYSYGIMLME 954
             DV+ +G+ + E
Sbjct: 192 ASDVWMFGVCMWE 204

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 8/214 (3%)
Query: 761 DGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGSLE-SFHAECKVMGSIRHRN 818
           D F +   LG G+ G V+K    P G+ +A K+ H+E   ++      E +V+       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
           +V    +  ++   ++ +E+M  GSL++ L       + +   K+ I V   L YL   +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLREKH 124
Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGK 938
              I+H D+KPSN+L+N      L DFG++  L   +SM  +  +GT  YM+PE  +   
Sbjct: 125 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANS-FVGTRSYMSPERLQGTH 179
Query: 939 VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSL 972
            S + D++S G+ L+E    + P     A E+ L
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 105/232 (45%), Gaps = 29/232 (12%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEF-------DGSLESFH--AECKVMGSIRHR 817
           ++LG G +G V++     G     K+F M+          + ++ H  AE  ++  ++H 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGAN-TGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 818 NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
            +V +I +        L+LEY+S G L   L  +  F++       + +++ AL +LH  
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLH-- 138
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT----LGTIGYMAPEY 933
               I++ D+KP N++LN      L+DFG+ K     ES+          GTI YMAPE 
Sbjct: 139 -QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-----ESIHDGTVTHXFCGTIEYMAPEI 192
Query: 934 GREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSI 985
                 +R  D +S G ++ +  T   P    F GE   K    D +L C +
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAPP----FTGENRKK--TIDKILKCKL 238

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 107/223 (47%), Gaps = 21/223 (9%)
Query: 754 QDLLRATDGFSENKLLGMGSFGSVYKGVLP--DG--MEIAAKVFHMEFDGS--LESFHAE 807
           +D+L     F+  ++LG G FGSV +  L   DG  +++A K+   +   S  +E F  E
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 808 CKVMGSIRHRNLVKIISSCSNNDFKA------LVLEYMSNGSLEKCLYS----DNYFLDI 857
              M    H ++ K++     +  K       ++L +M +G L   L +    +N F   
Sbjct: 76  AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 858 LQRL-KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES 916
           LQ L + M+D+A  +EYL    S   +H D+   N +L E M   ++DFG+++ +   + 
Sbjct: 136 LQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192
Query: 917 MRQ-TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTK 958
            RQ   +   + ++A E   +   +   DV+++G+ + E  T+
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR 235

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 8/214 (3%)
Query: 761 DGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGSLE-SFHAECKVMGSIRHRN 818
           D F +   LG G+ G V+K    P G+ +A K+ H+E   ++      E +V+       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
           +V    +  ++   ++ +E+M  GSL++ L       + +   K+ I V   L YL   +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLREKH 124
Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGK 938
              I+H D+KPSN+L+N      L DFG++  L   +SM  +  +GT  YM+PE  +   
Sbjct: 125 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANS-FVGTRSYMSPERLQGTH 179
Query: 939 VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSL 972
            S + D++S G+ L+E    + P     A E+ L
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 89/193 (46%), Gaps = 9/193 (4%)
Query: 767 KLLGMGSFGSVYKGVL--PDGMEIAAKVFHME---FDGSLESFHAECKVMGSIRHRNLVK 821
           + +G G FG V++G+   P+   +A  +   +    D   E F  E   M    H ++VK
Sbjct: 44  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           +I   + N    +++E  + G L   L    Y LD+   +     +++AL YL    S  
Sbjct: 104 LIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKR 159
Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSR 941
            VH DI   NVL++ +    L DFG+++ +      + +K    I +MAPE     + + 
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 219
Query: 942 KCDVYSYGIMLME 954
             DV+ +G+ + E
Sbjct: 220 ASDVWMFGVCMWE 232

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 769 LGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLE---SFHAECKVMGSIRHRNLVKIIS 824
           LG+G+FG V  G     G ++A K+ + +   SL+       E + +   RH +++K+  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
             S      +V+EY+S G L   +       ++  R ++   + SA++Y H      +VH
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCH---RHMVVH 134
Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY--GREGKVSRK 942
            D+KP NVLL+  M   ++DFG++ ++   E +R   + G+  Y APE   GR      +
Sbjct: 135 RDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRD--SCGSPNYAAPEVISGRL-YAGPE 191
Query: 943 CDVYSYGIMLMETFTKKKPTDE 964
            D++S G++L        P D+
Sbjct: 192 VDIWSCGVILYALLCGTLPFDD 213

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 89/193 (46%), Gaps = 9/193 (4%)
Query: 767 KLLGMGSFGSVYKGVL--PDGMEIAAKVFHME---FDGSLESFHAECKVMGSIRHRNLVK 821
           + +G G FG V++G+   P+   +A  +   +    D   E F  E   M    H ++VK
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           +I   + N    +++E  + G L   L    Y LD+   +     +++AL YL    S  
Sbjct: 76  LIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKR 131
Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSR 941
            VH DI   NVL++ +    L DFG+++ +      + +K    I +MAPE     + + 
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 942 KCDVYSYGIMLME 954
             DV+ +G+ + E
Sbjct: 192 ASDVWMFGVCMWE 204

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 769 LGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLE---SFHAECKVMGSIRHRNLVKIIS 824
           LG+G+FG V  G     G ++A K+ + +   SL+       E + +   RH +++K+  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
             S      +V+EY+S G L   +       ++  R ++   + SA++Y H      +VH
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCH---RHMVVH 134
Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY--GREGKVSRK 942
            D+KP NVLL+  M   ++DFG++ ++   E +R   + G+  Y APE   GR      +
Sbjct: 135 RDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR--TSCGSPNYAAPEVISGRL-YAGPE 191
Query: 943 CDVYSYGIMLMETFTKKKPTDE 964
            D++S G++L        P D+
Sbjct: 192 VDIWSCGVILYALLCGTLPFDD 213

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 90/193 (46%), Gaps = 9/193 (4%)
Query: 767 KLLGMGSFGSVYKGVL--PD--GMEIAAKVF-HMEFDGSLESFHAECKVMGSIRHRNLVK 821
           + +G G FG V++G+   P+   M +A K   +   D   E F  E   M    H ++VK
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           +I   + N    +++E  + G L   L    + LD+   +     +++AL YL    S  
Sbjct: 76  LIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKR 131
Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSR 941
            VH DI   NVL++ +    L DFG+++ +      + +K    I +MAPE     + + 
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 942 KCDVYSYGIMLME 954
             DV+ +G+ + E
Sbjct: 192 ASDVWMFGVCMWE 204

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 769 LGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLE---SFHAECKVMGSIRHRNLVKIIS 824
           LG+G+FG V  G     G ++A K+ + +   SL+       E + +   RH +++K+  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
             S      +V+EY+S G L   +   N  LD  +  ++   + S ++Y H      +VH
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCH---RHMVVH 139
Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY--GREGKVSRK 942
            D+KP NVLL+  M   ++DFG++ ++   E +R   + G+  Y APE   GR      +
Sbjct: 140 RDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRX--SCGSPNYAAPEVISGR-LYAGPE 196
Query: 943 CDVYSYGIMLMETFTKKKPTDE 964
            D++S G++L        P D+
Sbjct: 197 VDIWSSGVILYALLCGTLPFDD 218

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 89/193 (46%), Gaps = 9/193 (4%)
Query: 767 KLLGMGSFGSVYKGVL--PDGMEIAAKVFHME---FDGSLESFHAECKVMGSIRHRNLVK 821
           + +G G FG V++G+   P+   +A  +   +    D   E F  E   M    H ++VK
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           +I   + N    +++E  + G L   L    Y LD+   +     +++AL YL    S  
Sbjct: 81  LIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKR 136
Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSR 941
            VH DI   NVL++ +    L DFG+++ +      + +K    I +MAPE     + + 
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 196
Query: 942 KCDVYSYGIMLME 954
             DV+ +G+ + E
Sbjct: 197 ASDVWMFGVCMWE 209

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 89/193 (46%), Gaps = 9/193 (4%)
Query: 767 KLLGMGSFGSVYKGVL--PDGMEIAAKVFHME---FDGSLESFHAECKVMGSIRHRNLVK 821
           + +G G FG V++G+   P+   +A  +   +    D   E F  E   M    H ++VK
Sbjct: 19  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           +I   + N    +++E  + G L   L    Y LD+   +     +++AL YL    S  
Sbjct: 79  LIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKR 134
Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSR 941
            VH DI   NVL++ +    L DFG+++ +      + +K    I +MAPE     + + 
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 194
Query: 942 KCDVYSYGIMLME 954
             DV+ +G+ + E
Sbjct: 195 ASDVWMFGVCMWE 207

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 89/193 (46%), Gaps = 9/193 (4%)
Query: 767 KLLGMGSFGSVYKGVL--PDGMEIAAKVFHME---FDGSLESFHAECKVMGSIRHRNLVK 821
           + +G G FG V++G+   P+   +A  +   +    D   E F  E   M    H ++VK
Sbjct: 18  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           +I   + N    +++E  + G L   L    Y LD+   +     +++AL YL    S  
Sbjct: 78  LIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKR 133
Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSR 941
            VH DI   NVL++ +    L DFG+++ +      + +K    I +MAPE     + + 
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 193
Query: 942 KCDVYSYGIMLME 954
             DV+ +G+ + E
Sbjct: 194 ASDVWMFGVCMWE 206

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 8/214 (3%)
Query: 761 DGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGSLE-SFHAECKVMGSIRHRN 818
           D F +   LG G+ G V+K    P G+ +A K+ H+E   ++      E +V+       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
           +V    +  ++   ++ +E+M  GSL++ L       + +   K+ I V   L YL   +
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLREKH 151
Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGK 938
              I+H D+KPSN+L+N      L DFG++  L   +SM  +  +GT  YM+PE  +   
Sbjct: 152 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANS-FVGTRSYMSPERLQGTH 206
Query: 939 VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSL 972
            S + D++S G+ L+E    + P     A E+ L
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 240

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 8/214 (3%)
Query: 761 DGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGSLE-SFHAECKVMGSIRHRN 818
           D F +   LG G+ G V+K    P G+ +A K+ H+E   ++      E +V+       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
           +V    +  ++   ++ +E+M  GSL++ L       + +   K+ I V   L YL   +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLREKH 124
Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGK 938
              I+H D+KPSN+L+N      L DFG++  L   +SM  +  +GT  YM+PE  +   
Sbjct: 125 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANS-FVGTRSYMSPERLQGTH 179
Query: 939 VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSL 972
            S + D++S G+ L+E    + P     A E+ L
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 8/214 (3%)
Query: 761 DGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGSLE-SFHAECKVMGSIRHRN 818
           D F +   LG G+ G V+K    P G+ +A K+ H+E   ++      E +V+       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
           +V    +  ++   ++ +E+M  GSL++ L       + +   K+ I V   L YL   +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLREKH 124
Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGK 938
              I+H D+KPSN+L+N      L DFG++  L   +SM  +  +GT  YM+PE  +   
Sbjct: 125 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANS-FVGTRSYMSPERLQGTH 179
Query: 939 VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSL 972
            S + D++S G+ L+E    + P     A E+ L
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 89/193 (46%), Gaps = 9/193 (4%)
Query: 767 KLLGMGSFGSVYKGVL--PDGMEIAAKVFHME---FDGSLESFHAECKVMGSIRHRNLVK 821
           + +G G FG V++G+   P+   +A  +   +    D   E F  E   M    H ++VK
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           +I   + N    +++E  + G L   L    Y LD+   +     +++AL YL    S  
Sbjct: 73  LIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKR 128
Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSR 941
            VH DI   NVL++ +    L DFG+++ +      + +K    I +MAPE     + + 
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 942 KCDVYSYGIMLME 954
             DV+ +G+ + E
Sbjct: 189 ASDVWMFGVCMWE 201

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 761 DGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGSLE-SFHAECKVMGSIRHRN 818
           D F +   LG G+ G V+K    P G+ +A K+ H+E   ++      E +V+       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
           +V    +  ++   ++ +E+M  GSL++ L       + +   K+ I V   L YL   +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLREKH 124
Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGK 938
              I+H D+KPSN+L+N      L DFG++  L   +SM  +  +GT  YM+PE  +   
Sbjct: 125 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANS-FVGTRSYMSPERLQGTH 179
Query: 939 VSRKCDVYSYGIMLMETFTKKKP 961
            S + D++S G+ L+E    + P
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 54/200 (27%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 760 TDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRH 816
           TD +   + LG G+F  V + + +P G E AAK+ + +   +   +    E ++   ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
            N+V++  S S   F  LV + ++ G L + + +  Y+ +      I       LE ++ 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ----QILESVNH 118
Query: 877 GYSTPIVHCDIKPSNVLLNESMVG---HLSDFGIA-KILGKEESMRQTKTLGTIGYMAPE 932
            +   IVH D+KP N+LL     G    L+DFG+A ++ G +++       GT GY++PE
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAW--FGFAGTPGYLSPE 176
Query: 933 YGREGKVSRKCDVYSYGIML 952
             R+    +  D+++ G++L
Sbjct: 177 VLRKDPYGKPVDMWACGVIL 196

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 93/197 (47%), Gaps = 9/197 (4%)
Query: 766 NKLLGMGSFGSVYKGVLPD--GMEIAAKVFHMEFDGSL---ESFHAECKVMGSIRHRNLV 820
           N++LG G FG VY+GV  +  G +I   V   + D +L   E F +E  +M ++ H ++V
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
           K+I          +++E    G L   L  +   L +L  +   + +  A+ YL    S 
Sbjct: 89  KLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 144
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVS 940
             VH DI   N+L+       L DFG+++ +  E+  + + T   I +M+PE     + +
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 204
Query: 941 RKCDVYSYGIMLMETFT 957
              DV+ + + + E  +
Sbjct: 205 TASDVWMFAVCMWEILS 221

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 71/312 (22%), Positives = 134/312 (42%), Gaps = 63/312 (20%)
Query: 761  DGFSENKLLGMGSFGSVY--------KGVLPDGMEIAAKVFHME-FDGSLESFHAECKVM 811
            D  +  K LG G+FG V         K    + + +A K+   +  +  L    +E ++M
Sbjct: 35   DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 812  GSI-RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL-----------YSDNYFLDILQ 859
              I +H+N++ ++ +C+ +    +++ Y S G+L + L           Y  N   +   
Sbjct: 95   KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 860  RLKIMID----VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE 915
              K ++     +A  +EYL    S   +H D+   NVL+ E+ V  ++DFG+A+ +   +
Sbjct: 155  TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 916  SMRQTKTLG--TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT------KKKPTDEIFA 967
              ++T T G   + +MAPE   +   + + DV+S+G+++ E FT         P +E+F 
Sbjct: 212  YYKKT-TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF- 269
Query: 968  GEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI 1027
                                     LL  E +       C + ++ +  DC   +P +R 
Sbjct: 270  ------------------------KLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRP 304
Query: 1028 SMKDVANRLVRI 1039
            + K +   L RI
Sbjct: 305  TFKQLVEDLDRI 316

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 10/202 (4%)
Query: 766 NKLLGMGSFGSVYKGVLPD--GMEIAAKVFHMEFDGSL---ESFHAECKVMGSIRHRNLV 820
           N++LG G FG VY+GV  +  G +I   V   + D +L   E F +E  +M ++ H ++V
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
           K+I          +++E    G L   L  +   L +L  +   + +  A+ YL    S 
Sbjct: 73  KLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 128
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVS 940
             VH DI   N+L+       L DFG+++ +  E+  + + T   I +M+PE     + +
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 188
Query: 941 RKCDVYSYGIMLMETFT-KKKP 961
              DV+ + + + E  +  K+P
Sbjct: 189 TASDVWMFAVCMWEILSFGKQP 210

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 56/232 (24%), Positives = 109/232 (46%), Gaps = 20/232 (8%)
Query: 759 ATDGFSENKLLGMGSFGSVY----KGVLPDGMEIAAKVFHMEFDGSLES---FHAECKVM 811
           A +  + ++ LG GSFG VY    KGV+ D  E    +  +    S+     F  E  VM
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 812 GSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYS------DNYFL---DILQRLK 862
                 ++V+++   S      +++E M+ G L+  L S      +N  L    + + ++
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 863 IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT-K 921
           +  ++A  + YL+   +   VH D+   N ++ E     + DFG+ + + + +  R+  K
Sbjct: 137 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGK 193
Query: 922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
            L  + +M+PE  ++G  +   DV+S+G++L E  T  +   +  + E  L+
Sbjct: 194 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 245

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHM------EFDGSLESFHAECKVMGSIRHRNL 819
           K LG GSFG V        G ++A K+ +       +  G +E    E   +  +RH ++
Sbjct: 19  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIER---EISYLRLLRHPHI 75
Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
           +K+     + D   +V+EY  N   +  +  D   +   +  +    + SA+EY H    
Sbjct: 76  IKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDK--MSEQEARRFFQQIISAVEYCH---R 130
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKV 939
             IVH D+KP N+LL+E +   ++DFG++ I+     ++   + G+  Y APE    GK+
Sbjct: 131 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT--SCGSPNYAAPEV-ISGKL 187
Query: 940 SR--KCDVYSYGIMLMETFTKKKPTDE 964
               + DV+S G++L     ++ P D+
Sbjct: 188 YAGPEVDVWSCGVILYVMLCRRLPFDD 214

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 56/232 (24%), Positives = 109/232 (46%), Gaps = 20/232 (8%)
Query: 759 ATDGFSENKLLGMGSFGSVY----KGVLPDGMEIAAKVFHMEFDGSLES---FHAECKVM 811
           A +  + ++ LG GSFG VY    KGV+ D  E    +  +    S+     F  E  VM
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 812 GSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYS------DNYFL---DILQRLK 862
                 ++V+++   S      +++E M+ G L+  L S      +N  L    + + ++
Sbjct: 68  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 127
Query: 863 IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT-K 921
           +  ++A  + YL+   +   VH D+   N ++ E     + DFG+ + + + +  R+  K
Sbjct: 128 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGK 184
Query: 922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
            L  + +M+PE  ++G  +   DV+S+G++L E  T  +   +  + E  L+
Sbjct: 185 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 236

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHM------EFDGSLESFHAECKVMGSIRHRNL 819
           K LG GSFG V        G ++A K+ +       +  G +E    E   +  +RH ++
Sbjct: 14  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIER---EISYLRLLRHPHI 70
Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
           +K+     + D   +V+EY  N   +  +  D   +   +  +    + SA+EY H    
Sbjct: 71  IKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDK--MSEQEARRFFQQIISAVEYCH---R 125
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKV 939
             IVH D+KP N+LL+E +   ++DFG++ I+     ++   + G+  Y APE    GK+
Sbjct: 126 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT--SCGSPNYAAPEV-ISGKL 182
Query: 940 SR--KCDVYSYGIMLMETFTKKKPTDE 964
               + DV+S G++L     ++ P D+
Sbjct: 183 YAGPEVDVWSCGVILYVMLCRRLPFDD 209

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 90/193 (46%), Gaps = 9/193 (4%)
Query: 767 KLLGMGSFGSVYKGVL--PD--GMEIAAKVF-HMEFDGSLESFHAECKVMGSIRHRNLVK 821
           + +G G FG V++G+   P+   M +A K   +   D   E F  E   M    H ++VK
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           +I   + N    +++E  + G L   L    + LD+   +     +++AL YL    S  
Sbjct: 456 LIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKR 511
Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSR 941
            VH DI   NVL++ +    L DFG+++ +      + +K    I +MAPE     + + 
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 942 KCDVYSYGIMLME 954
             DV+ +G+ + E
Sbjct: 572 ASDVWMFGVCMWE 584

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 93/197 (47%), Gaps = 9/197 (4%)
Query: 766 NKLLGMGSFGSVYKGVLPD--GMEIAAKVFHMEFDGSL---ESFHAECKVMGSIRHRNLV 820
           N++LG G FG VY+GV  +  G +I   V   + D +L   E F +E  +M ++ H ++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
           K+I          +++E    G L   L  +   L +L  +   + +  A+ YL    S 
Sbjct: 77  KLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 132
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVS 940
             VH DI   N+L+       L DFG+++ +  E+  + + T   I +M+PE     + +
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 192
Query: 941 RKCDVYSYGIMLMETFT 957
              DV+ + + + E  +
Sbjct: 193 TASDVWMFAVCMWEILS 209

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHM------EFDGSLESFHAECKVMGSIRHRNL 819
           K LG GSFG V        G ++A K+ +       +  G +E    E   +  +RH ++
Sbjct: 10  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIER---EISYLRLLRHPHI 66
Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
           +K+     + D   +V+EY  N   +  +  D   +   +  +    + SA+EY H    
Sbjct: 67  IKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDK--MSEQEARRFFQQIISAVEYCH---R 121
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKV 939
             IVH D+KP N+LL+E +   ++DFG++ I+     ++   + G+  Y APE    GK+
Sbjct: 122 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT--SCGSPNYAAPEV-ISGKL 178
Query: 940 SR--KCDVYSYGIMLMETFTKKKPTDE 964
               + DV+S G++L     ++ P D+
Sbjct: 179 YAGPEVDVWSCGVILYVMLCRRLPFDD 205

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 13/199 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAA-KVF---HMEFDGSLESFHAECKVMGSIRH 816
           + F   + LG G FG+VY         I A KV     +E  G       E ++   +RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
            N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y H 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRF-DEQRTATYITELANALSYCH- 129
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  ++H DIKP N+LL  +    ++DFG +       S R+    GT+ Y+ PE   E
Sbjct: 130 --SKRVIHRDIKPENLLLGSNGELKIADFGWSV---HAPSSRRDTLCGTLDYLPPEMI-E 183
Query: 937 GKV-SRKCDVYSYGIMLME 954
           G++   K D++S G++  E
Sbjct: 184 GRMHDEKVDLWSLGVLCYE 202

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 76/321 (23%), Positives = 141/321 (43%), Gaps = 71/321 (22%)
Query: 767  KLLGMGSFGSVYKGVLPDGM-----------EIAAKVFHME-FDGSLESFHAECKVMGSI 814
            K LG G+FG V   VL + +           ++A K+   +  +  L    +E ++M  I
Sbjct: 34   KPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 90
Query: 815  -RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL-----------YSDNYFLDILQRLK 862
             +H+N++ ++ +C+ +    +++EY S G+L + L           Y+ ++  +     K
Sbjct: 91   GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 150
Query: 863  IMID----VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR 918
             ++     VA  +EYL    S   +H D+   NVL+ E  V  ++DFG+A+ +   +  +
Sbjct: 151  DLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 919  QTKTLG--TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT------KKKPTDEIFAGEM 970
            +T T G   + +MAPE   +   + + DV+S+G++L E FT         P +E+F    
Sbjct: 208  KT-TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF---- 262
Query: 971  SLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMK 1030
                                  LL  E +       C + ++ +  DC   +P +R + K
Sbjct: 263  ---------------------KLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 300
Query: 1031 DVANRLVRIRETLS--AYIDV 1049
             +   L RI    S   Y+D+
Sbjct: 301  QLVEDLDRIVALTSNQEYLDL 321

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 73/309 (23%), Positives = 136/309 (44%), Gaps = 69/309 (22%)
Query: 767  KLLGMGSFGSVYKGVLPDGM-----------EIAAKVFHME-FDGSLESFHAECKVMGSI 814
            K LG G+FG V   VL + +           ++A K+   +  +  L    +E ++M  I
Sbjct: 19   KPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 75
Query: 815  -RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL-----------YSDNYFLDILQRLK 862
             +H+N++ ++ +C+ +    +++EY S G+L + L           Y+ ++  +     K
Sbjct: 76   GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 135
Query: 863  IMID----VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR 918
             ++     VA  +EYL    S   +H D+   NVL+ E  V  ++DFG+A+ +   +  +
Sbjct: 136  DLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 919  QTKTLG--TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT------KKKPTDEIFAGEM 970
            +T T G   + +MAPE   +   + + DV+S+G++L E FT         P +E+F    
Sbjct: 193  KT-TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF---- 247
Query: 971  SLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMK 1030
                                  LL  E +       C + ++ +  DC   +P +R + K
Sbjct: 248  ---------------------KLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 285
Query: 1031 DVANRLVRI 1039
             +   L RI
Sbjct: 286  QLVEDLDRI 294

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHM------EFDGSLESFHAECKVMGSIRHRNL 819
           K LG GSFG V        G ++A K+ +       +  G +E    E   +  +RH ++
Sbjct: 20  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIER---EISYLRLLRHPHI 76
Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
           +K+     + D   +V+EY  N   +  +  D   +   +  +    + SA+EY H    
Sbjct: 77  IKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDK--MSEQEARRFFQQIISAVEYCH---R 131
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKV 939
             IVH D+KP N+LL+E +   ++DFG++ I+     ++   + G+  Y APE    GK+
Sbjct: 132 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT--SCGSPNYAAPEV-ISGKL 188
Query: 940 SR--KCDVYSYGIMLMETFTKKKPTDE 964
               + DV+S G++L     ++ P D+
Sbjct: 189 YAGPEVDVWSCGVILYVMLCRRLPFDD 215

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 71/312 (22%), Positives = 134/312 (42%), Gaps = 63/312 (20%)
Query: 761  DGFSENKLLGMGSFGSVY--------KGVLPDGMEIAAKVFHME-FDGSLESFHAECKVM 811
            D  +  K LG G+FG V         K    + + +A K+   +  +  L    +E ++M
Sbjct: 35   DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 812  GSI-RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL-----------YSDNYFLDILQ 859
              I +H+N++ ++ +C+ +    +++ Y S G+L + L           Y  N   +   
Sbjct: 95   KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 860  RLKIMID----VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE 915
              K ++     +A  +EYL    S   +H D+   NVL+ E+ V  ++DFG+A+ +   +
Sbjct: 155  TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 916  SMRQTKTLG--TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT------KKKPTDEIFA 967
              ++T T G   + +MAPE   +   + + DV+S+G+++ E FT         P +E+F 
Sbjct: 212  YYKKT-TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF- 269
Query: 968  GEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI 1027
                                     LL  E +       C + ++ +  DC   +P +R 
Sbjct: 270  ------------------------KLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRP 304
Query: 1028 SMKDVANRLVRI 1039
            + K +   L RI
Sbjct: 305  TFKQLVEDLDRI 316

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 769 LGMGSFGSVYKGVL-PDG----MEIAAKVFHMEFDGS-LESFHAECKVMGSIRHRNLVKI 822
           LG G FG V      P+G     ++A K    E  G+ +     E +++ ++ H N+VK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 823 ISSCSNNDFKA--LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              C+ +      L++E++ +GSL++ L  +   +++ Q+LK  + +   ++YL    S 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKIL--GKEESMRQTKTLGTIGYMAPEYGREGK 938
             VH D+   NVL+       + DFG+ K +   KE    +      + + APE   + K
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 205
Query: 939 VSRKCDVYSYGIMLMETFT 957
                DV+S+G+ L E  T
Sbjct: 206 FYIASDVWSFGVTLHELLT 224

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 90/193 (46%), Gaps = 9/193 (4%)
Query: 767 KLLGMGSFGSVYKGVL--PD--GMEIAAKVF-HMEFDGSLESFHAECKVMGSIRHRNLVK 821
           + +G G FG V++G+   P+   M +A K   +   D   E F  E   M    H ++VK
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           +I   + N    +++E  + G L   L    + LD+   +     +++AL YL    S  
Sbjct: 456 LIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKR 511
Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSR 941
            VH DI   NVL++ +    L DFG+++ +      + +K    I +MAPE     + + 
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 942 KCDVYSYGIMLME 954
             DV+ +G+ + E
Sbjct: 572 ASDVWMFGVCMWE 584

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 769 LGMGSFGSVYKGVL-PDG----MEIAAKVFHMEFDGS-LESFHAECKVMGSIRHRNLVKI 822
           LG G FG V      P+G     ++A K    E  G+ +     E +++ ++ H N+VK 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 823 ISSCSNNDFKA--LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              C+ +      L++E++ +GSL++ L  +   +++ Q+LK  + +   ++YL    S 
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 133
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKIL--GKEESMRQTKTLGTIGYMAPEYGREGK 938
             VH D+   NVL+       + DFG+ K +   KE    +      + + APE   + K
Sbjct: 134 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 193
Query: 939 VSRKCDVYSYGIMLMETFT 957
                DV+S+G+ L E  T
Sbjct: 194 FYIASDVWSFGVTLHELLT 212

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 25/213 (11%)
Query: 767 KLLGMGSFGSVYKG----------VLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-R 815
           K LG G+FG V +           VL   +++     H +     E+  +E K+M  + +
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD---EKEALMSELKIMSHLGQ 108
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
           H N+V ++ +C++     ++ EY   G L   L   +  L+      I     S  + LH
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLH 168
Query: 876 FG----------YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK-ILGKEESMRQTKTLG 924
           F            S   +H D+   NVLL    V  + DFG+A+ I+     + +     
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 925 TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
            + +MAPE   +   + + DV+SYGI+L E F+
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 761 DGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGSLE-SFHAECKVMGSIRHRN 818
           D F +   LG G+ G V+K    P G+ +A K+ H+E   ++      E +V+       
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
           +V    +  ++   ++ +E+M  GSL++ L       + +   K+ I V   L YL   +
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLREKH 143
Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGK 938
              I+H D+KPSN+L+N      L DFG++  L   +SM  +  +GT  YM+PE  +   
Sbjct: 144 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANS-FVGTRSYMSPERLQGTH 198
Query: 939 VSRKCDVYSYGIMLMETFTKKKP 961
            S + D++S G+ L+E    + P
Sbjct: 199 YSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 10/214 (4%)
Query: 761 DGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGSLE-SFHAECKVMGSIRHRN 818
           D F     LG G+ G V K    P G+ +A K+ H+E   ++      E +V+       
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYF-LDILQRLKIMIDVASALEYLHFG 877
           +V    +  ++   ++ +E+M  GSL++ L        +IL   K+ I V   L YL   
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG--KVSIAVLRGLAYLREK 133
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG 937
           +   I+H D+KPSN+L+N      L DFG++  L   +SM  +  +GT  YMAPE  +  
Sbjct: 134 HQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANS-FVGTRSYMAPERLQGT 188
Query: 938 KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMS 971
             S + D++S G+ L+E    + P     A E+ 
Sbjct: 189 HYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELE 222

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 767 KLLGMGSFGSVY---------KGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHR 817
           K+LG G++G V+          G L   M++  K   ++   + E    E +V+  IR  
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLY-AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 118
Query: 818 NLVKIISSCSNNDFK-ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMI-DVASALEYLH 875
             +  +      + K  L+L+Y++ G L   L     F +    ++I + ++  ALE+LH
Sbjct: 119 PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE--HEVQIYVGEIVLALEHLH 176
Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
                 I++ DIK  N+LL+ +  GH  L+DFG++K    +E+ R     GTI YMAP+ 
Sbjct: 177 ---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 231
Query: 934 GREGKV--SRKCDVYSYGIMLMETFTKKKP 961
            R G     +  D +S G+++ E  T   P
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 56/232 (24%), Positives = 109/232 (46%), Gaps = 20/232 (8%)
Query: 759 ATDGFSENKLLGMGSFGSVY----KGVLPDGMEIAAKVFHMEFDGSLES---FHAECKVM 811
           A +  + ++ LG GSFG VY    KGV+ D  E    +  +    S+     F  E  VM
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 812 GSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYS------DNYFL---DILQRLK 862
                 ++V+++   S      +++E M+ G L+  L S      +N  L    + + ++
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 863 IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT-K 921
           +  ++A  + YL+   +   VH D+   N ++ E     + DFG+ + + + +  R+  K
Sbjct: 143 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
            L  + +M+PE  ++G  +   DV+S+G++L E  T  +   +  + E  L+
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 112/271 (41%), Gaps = 34/271 (12%)
Query: 769  LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
            LG G+FG V++ V    G    AK  +  +     +   E  +M  + H  L+ +  +  
Sbjct: 59   LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 828  NNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDI 887
            +     L+LE++S G L   + +++Y +   + +  M      L+++H      IVH DI
Sbjct: 119  DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDI 175
Query: 888  KPSNVLLNESMVGHLS--DFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
            KP N++        +   DFG+A  L  +E ++   T  T  + APE      V    D+
Sbjct: 176  KPENIMCETKKASSVKIIDFGLATKLNPDEIVKV--TTATAEFAAPEIVDREPVGFYTDM 233
Query: 946  YSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSARE 1005
            ++ G++     +   P    FAGE  L+                   L N +  D+   E
Sbjct: 234  WAIGVLGYVLLSGLSP----FAGEDDLE------------------TLQNVKRCDWEFDE 271
Query: 1006 QCVSSIFSLAMDCTVDL----PEKRISMKDV 1032
               SS+   A D   +L    P KR+++ D 
Sbjct: 272  DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 302

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 56/232 (24%), Positives = 109/232 (46%), Gaps = 20/232 (8%)
Query: 759 ATDGFSENKLLGMGSFGSVY----KGVLPDGMEIAAKVFHMEFDGSLES---FHAECKVM 811
           A +  + ++ LG GSFG VY    KGV+ D  E    +  +    S+     F  E  VM
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 73
Query: 812 GSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYS------DNYFL---DILQRLK 862
                 ++V+++   S      +++E M+ G L+  L S      +N  L    + + ++
Sbjct: 74  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 133
Query: 863 IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT-K 921
           +  ++A  + YL+   +   VH D+   N ++ E     + DFG+ + + + +  R+  K
Sbjct: 134 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 190
Query: 922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
            L  + +M+PE  ++G  +   DV+S+G++L E  T  +   +  + E  L+
Sbjct: 191 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 242

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 56/232 (24%), Positives = 109/232 (46%), Gaps = 20/232 (8%)
Query: 759 ATDGFSENKLLGMGSFGSVY----KGVLPDGMEIAAKVFHMEFDGSLES---FHAECKVM 811
           A +  + ++ LG GSFG VY    KGV+ D  E    +  +    S+     F  E  VM
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 812 GSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYS------DNYFL---DILQRLK 862
                 ++V+++   S      +++E M+ G L+  L S      +N  L    + + ++
Sbjct: 73  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 132
Query: 863 IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT-K 921
           +  ++A  + YL+   +   VH D+   N ++ E     + DFG+ + + + +  R+  K
Sbjct: 133 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 189
Query: 922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
            L  + +M+PE  ++G  +   DV+S+G++L E  T  +   +  + E  L+
Sbjct: 190 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 241

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 56/232 (24%), Positives = 109/232 (46%), Gaps = 20/232 (8%)
Query: 759 ATDGFSENKLLGMGSFGSVY----KGVLPDGMEIAAKVFHMEFDGSLES---FHAECKVM 811
           A +  + ++ LG GSFG VY    KGV+ D  E    +  +    S+     F  E  VM
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 812 GSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYS------DNYFL---DILQRLK 862
                 ++V+++   S      +++E M+ G L+  L S      +N  L    + + ++
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 863 IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT-K 921
           +  ++A  + YL+   +   VH D+   N ++ E     + DFG+ + + + +  R+  K
Sbjct: 136 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 192
Query: 922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
            L  + +M+PE  ++G  +   DV+S+G++L E  T  +   +  + E  L+
Sbjct: 193 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 244

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 56/232 (24%), Positives = 109/232 (46%), Gaps = 20/232 (8%)
Query: 759 ATDGFSENKLLGMGSFGSVY----KGVLPDGMEIAAKVFHMEFDGSLES---FHAECKVM 811
           A +  + ++ LG GSFG VY    KGV+ D  E    +  +    S+     F  E  VM
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 812 GSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYS------DNYFL---DILQRLK 862
                 ++V+++   S      +++E M+ G L+  L S      +N  L    + + ++
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 863 IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT-K 921
           +  ++A  + YL+   +   VH D+   N ++ E     + DFG+ + + + +  R+  K
Sbjct: 137 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 193
Query: 922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
            L  + +M+PE  ++G  +   DV+S+G++L E  T  +   +  + E  L+
Sbjct: 194 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 245

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 56/232 (24%), Positives = 109/232 (46%), Gaps = 20/232 (8%)
Query: 759 ATDGFSENKLLGMGSFGSVY----KGVLPDGMEIAAKVFHMEFDGSLES---FHAECKVM 811
           A +  + ++ LG GSFG VY    KGV+ D  E    +  +    S+     F  E  VM
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 812 GSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYS------DNYFL---DILQRLK 862
                 ++V+++   S      +++E M+ G L+  L S      +N  L    + + ++
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 863 IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT-K 921
           +  ++A  + YL+   +   VH D+   N ++ E     + DFG+ + + + +  R+  K
Sbjct: 130 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 186
Query: 922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
            L  + +M+PE  ++G  +   DV+S+G++L E  T  +   +  + E  L+
Sbjct: 187 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 238

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 56/232 (24%), Positives = 109/232 (46%), Gaps = 20/232 (8%)
Query: 759 ATDGFSENKLLGMGSFGSVY----KGVLPDGMEIAAKVFHMEFDGSLES---FHAECKVM 811
           A +  + ++ LG GSFG VY    KGV+ D  E    +  +    S+     F  E  VM
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 812 GSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYS------DNYFL---DILQRLK 862
                 ++V+++   S      +++E M+ G L+  L S      +N  L    + + ++
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 142
Query: 863 IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT-K 921
           +  ++A  + YL+   +   VH D+   N ++ E     + DFG+ + + + +  R+  K
Sbjct: 143 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
            L  + +M+PE  ++G  +   DV+S+G++L E  T  +   +  + E  L+
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 26/204 (12%)
Query: 769 LGMGSFGSVYKGVL----PDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVKI 822
           +G GSFG   K +L     DG +   K  ++    S E   +  E  V+ +++H N+V+ 
Sbjct: 32  IGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 823 ISSCSNNDFKALVLEYMSNGSLEK-------CLYSDNYFLDILQRLKIMIDVASALEYLH 875
             S   N    +V++Y   G L K        L+ ++  LD        + +  AL+++H
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF------VQICLALKHVH 142
Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
                 I+H DIK  N+ L +     L DFGIA++L     + +   +GT  Y++PE   
Sbjct: 143 ---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-CIGTPYYLSPEICE 198
Query: 936 EGKVSRKCDVYSYGIMLMETFTKK 959
               + K D+++ G +L E  T K
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLK 222

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 56/232 (24%), Positives = 109/232 (46%), Gaps = 20/232 (8%)
Query: 759 ATDGFSENKLLGMGSFGSVY----KGVLPDGMEIAAKVFHMEFDGSLES---FHAECKVM 811
           A +  + ++ LG GSFG VY    KGV+ D  E    +  +    S+     F  E  VM
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 812 GSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYS------DNYFL---DILQRLK 862
                 ++V+++   S      +++E M+ G L+  L S      +N  L    + + ++
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 863 IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT-K 921
           +  ++A  + YL+   +   VH D+   N ++ E     + DFG+ + + + +  R+  K
Sbjct: 136 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 192
Query: 922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
            L  + +M+PE  ++G  +   DV+S+G++L E  T  +   +  + E  L+
Sbjct: 193 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 244

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 56/232 (24%), Positives = 109/232 (46%), Gaps = 20/232 (8%)
Query: 759 ATDGFSENKLLGMGSFGSVY----KGVLPDGMEIAAKVFHMEFDGSLES---FHAECKVM 811
           A +  + ++ LG GSFG VY    KGV+ D  E    +  +    S+     F  E  VM
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 104
Query: 812 GSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYS------DNYFL---DILQRLK 862
                 ++V+++   S      +++E M+ G L+  L S      +N  L    + + ++
Sbjct: 105 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 164
Query: 863 IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT-K 921
           +  ++A  + YL+   +   VH D+   N ++ E     + DFG+ + + + +  R+  K
Sbjct: 165 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 221
Query: 922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
            L  + +M+PE  ++G  +   DV+S+G++L E  T  +   +  + E  L+
Sbjct: 222 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 273

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 50/177 (28%), Positives = 81/177 (45%), Gaps = 6/177 (3%)
Query: 785 GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSL 844
           G ++A K   +      E    E  +M    H N+V + SS    D   +V+E++  G+L
Sbjct: 70  GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGAL 129
Query: 845 EKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSD 904
              +      ++  Q   + + V  AL YLH   +  ++H DIK  ++LL       LSD
Sbjct: 130 TDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSD 184
Query: 905 FGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           FG    + KE   R+   +GT  +MAPE         + D++S GIM++E    + P
Sbjct: 185 FGFCAQVSKEVPKRKX-LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 240

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 29/203 (14%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHME------FDGSLESFHAECKVMGSIRH 816
           F   + LG G+F  V   VL +  +   K+F ++        G   S   E  V+  I+H
Sbjct: 24  FEFKETLGTGAFSEV---VLAE-EKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKH 79
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSL-----EKCLYSDNYFLDILQRLKIMIDVASAL 871
            N+V +     + +   LV++ +S G L     EK  Y++     ++++      V  A+
Sbjct: 80  ENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQ------VLDAV 133
Query: 872 EYLHFGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKILGKEESMRQTKTLGTIGY 928
            YLH      IVH D+KP N+L    +E     +SDFG++K+ GK + M  +   GT GY
Sbjct: 134 YYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVM--STACGTPGY 188
Query: 929 MAPEYGREGKVSRKCDVYSYGIM 951
           +APE   +   S+  D +S G++
Sbjct: 189 VAPEVLAQKPYSKAVDCWSIGVI 211

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 23/207 (11%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEF--DGSLE-----SFHAECKVMGSIRHRNL 819
           K+LG GSFG V+      G + A +++ M+     +L+         E  ++  + H  +
Sbjct: 31  KVLGQGSFGKVFLVKKISGSD-ARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 89
Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI-MIDVASALEYLHFGY 878
           VK+  +        L+L+++  G L   L  +  F +  + +K  + ++A AL++LH   
Sbjct: 90  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE--EDVKFYLAELALALDHLH--- 144
Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT----LGTIGYMAPEYG 934
           S  I++ D+KP N+LL+E     L+DFG++K     ES+   K      GT+ YMAPE  
Sbjct: 145 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-----ESIDHEKKAYSFCGTVEYMAPEVV 199
Query: 935 REGKVSRKCDVYSYGIMLMETFTKKKP 961
                ++  D +S+G+++ E  T   P
Sbjct: 200 NRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 23/207 (11%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEF--DGSLE-----SFHAECKVMGSIRHRNL 819
           K+LG GSFG V+      G + A +++ M+     +L+         E  ++  + H  +
Sbjct: 30  KVLGQGSFGKVFLVKKISGSD-ARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 88
Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI-MIDVASALEYLHFGY 878
           VK+  +        L+L+++  G L   L  +  F +  + +K  + ++A AL++LH   
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE--EDVKFYLAELALALDHLH--- 143
Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT----LGTIGYMAPEYG 934
           S  I++ D+KP N+LL+E     L+DFG++K     ES+   K      GT+ YMAPE  
Sbjct: 144 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-----ESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 935 REGKVSRKCDVYSYGIMLMETFTKKKP 961
                ++  D +S+G+++ E  T   P
Sbjct: 199 NRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 23/207 (11%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEF--DGSLE-----SFHAECKVMGSIRHRNL 819
           K+LG GSFG V+      G + A +++ M+     +L+         E  ++  + H  +
Sbjct: 30  KVLGQGSFGKVFLVKKISGSD-ARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 88
Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI-MIDVASALEYLHFGY 878
           VK+  +        L+L+++  G L   L  +  F +  + +K  + ++A AL++LH   
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE--EDVKFYLAELALALDHLH--- 143
Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT----LGTIGYMAPEYG 934
           S  I++ D+KP N+LL+E     L+DFG++K     ES+   K      GT+ YMAPE  
Sbjct: 144 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-----ESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 935 REGKVSRKCDVYSYGIMLMETFTKKKP 961
                ++  D +S+G+++ E  T   P
Sbjct: 199 NRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 106/213 (49%), Gaps = 17/213 (7%)
Query: 757 LRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFD-GSLESFHAECKVMGSI 814
           + ++  F + + LG G++ +VYKG+    G+ +A K   ++ + G+  +   E  +M  +
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNY-------FLDILQRLKIMIDV 867
           +H N+V++       +   LV E+M N  L+K + S           L++++  +  +  
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQL-- 117
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIG 927
              L+ L F +   I+H D+KP N+L+N+     L DFG+A+  G   +   ++ + T+ 
Sbjct: 118 ---LQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLW 173
Query: 928 YMAPEYGREGKV-SRKCDVYSYGIMLMETFTKK 959
           Y AP+     +  S   D++S G +L E  T K
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 34/223 (15%)
Query: 757 LRATDGFSENKLLGMGSFGSV----YKGVLPDGMEIAAKVFHMEFDGSLES--------F 804
           ++A D +   K++G G+FG V    +K         + KV+ M+     E         F
Sbjct: 72  MKAED-YDVVKVIGRGAFGEVQLVRHKA--------SQKVYAMKLLSKFEMIKRSDSAFF 122
Query: 805 HAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK-- 862
             E  +M       +V++  +  ++ +  +V+EYM  G L   +   NY  D+ ++    
Sbjct: 123 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DVPEKWAKF 178
Query: 863 IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT 922
              +V  AL+ +H   S  ++H D+KP N+LL++     L+DFG    + +   +     
Sbjct: 179 YTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA 235
Query: 923 LGTIGYMAPE----YGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           +GT  Y++PE     G +G   R+CD +S G+ L E      P
Sbjct: 236 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 17/216 (7%)
Query: 753 YQDLLRATDGFSENKLLGMGSFGSVYKGVLPDG--MEIAAKVFHMEFDGSLESFHAECKV 810
           +++ ++ TDG+   + +G+GS+ SV K  +     ME A K+     D S      E ++
Sbjct: 14  HRNSIQFTDGYEVKEDIGVGSY-SVCKRCIHKATNMEFAVKII----DKSKRDPTEEIEI 68
Query: 811 MGSI-RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVAS 869
           +    +H N++ +     +  +  +V E M  G L   +    +F +  +   ++  +  
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE-REASAVLFTITK 127
Query: 870 ALEYLHFGYSTPIVHCDIKPSNVL-LNES---MVGHLSDFGIAKILGKEESMRQTKTLGT 925
            +EYLH   +  +VH D+KPSN+L ++ES       + DFG AK L  E  +  T    T
Sbjct: 128 TVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY-T 183
Query: 926 IGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
             ++APE          CD++S G++L    T   P
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDG--SLESFHAECKVMGSIRHRNLVKIIS 824
           +L+G G FG VY G      E+A ++  +E D    L++F  E       RH N+V  + 
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
           +C +    A++       +L   +      LD+ +  +I  ++   + YLH   +  I+H
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153
Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL----GTIGYMAPEYGR----- 935
            D+K  NV  +   V  ++DFG+  I G  ++ R+   L    G + ++APE  R     
Sbjct: 154 KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 936 --EGKV--SRKCDVYSYGIMLMETFTKKKP 961
             E K+  S+  DV++ G +  E   ++ P
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 56/232 (24%), Positives = 108/232 (46%), Gaps = 20/232 (8%)
Query: 759 ATDGFSENKLLGMGSFGSVY----KGVLPDGMEIAAKVFHMEFDGSLES---FHAECKVM 811
           A +  + ++ LG GSFG VY    KGV+ D  E    +  +    S+     F  E  VM
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 812 GSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYS------DNYFL---DILQRLK 862
                 ++V+++   S      +++E M+ G L+  L S      +N  L    + + ++
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 863 IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT-K 921
           +  ++A  + YL+   +   VH D+   N  + E     + DFG+ + + + +  R+  K
Sbjct: 130 MAGEIADGMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGK 186
Query: 922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
            L  + +M+PE  ++G  +   DV+S+G++L E  T  +   +  + E  L+
Sbjct: 187 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 238

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 27/210 (12%)
Query: 763 FSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVK 821
           F E +L+G G FG V+K     DG     K   ++++   E    E K +  + H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIK--RVKYNN--EKAEREVKALAKLDHVNIVH 68
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYF-----------------LDILQRLKIM 864
                   D+        S+ S  KCL+    F                 LD +  L++ 
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 865 IDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLG 924
             +   ++Y+H   S  +++ D+KPSN+ L ++    + DFG+   L  +    ++K  G
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSK--G 183
Query: 925 TIGYMAPEYGREGKVSRKCDVYSYGIMLME 954
           T+ YM+PE        ++ D+Y+ G++L E
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAE 213

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 105/238 (44%), Gaps = 33/238 (13%)
Query: 749 RRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHA-- 806
           +RI Y      +  F    LLG G++G V         EI A      FD  L +     
Sbjct: 3   KRIVYN----ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR 58
Query: 807 ECKVMGSIRHRNLVKIISSCSNNDFK----ALVLEYMSNGSLEKCLYSDNYFLDILQRLK 862
           E K++   +H N++ I +    + F+      +++ +    L + + +     D +Q   
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF- 117
Query: 863 IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL----------- 911
            +     A++ LH    + ++H D+KPSN+L+N +    + DFG+A+I+           
Sbjct: 118 -IYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 912 GKEESMRQTKTLGTIGYMAPEYG-REGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAG 968
           G++  M  T+ + T  Y APE      K SR  DV+S G +L E F ++     IF G
Sbjct: 174 GQQSGM--TEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP----IFPG 225

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 763 FSENKLLGMGSFGSVYKGVL----PDGMEIAAKVFHME-FDGSLESFHA--ECKVMGSIR 815
           F   KLLG G+FG V   +L      G   A K+   E      E  H   E +V+ + R
Sbjct: 10  FDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 66
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
           H  L  +  +   +D    V+EY + G L   L  +  F +   R     ++ SALEYLH
Sbjct: 67  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH 125
Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
              S  +V+ DIK  N++L++     ++DFG+ K  G  +        GT  Y+APE   
Sbjct: 126 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLE 181
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           +    R  D +  G+++ E    + P
Sbjct: 182 DNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 763 FSENKLLGMGSFGSVYKGVL----PDGMEIAAKVFHME-FDGSLESFHA--ECKVMGSIR 815
           F   KLLG G+FG V   +L      G   A K+   E      E  H   E +V+ + R
Sbjct: 7   FDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
           H  L  +  +   +D    V+EY + G L   L  +  F +   R     ++ SALEYLH
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH 122
Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
              S  +V+ DIK  N++L++     ++DFG+ K  G  +        GT  Y+APE   
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLE 178
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           +    R  D +  G+++ E    + P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 763 FSENKLLGMGSFGSVYKGVL----PDGMEIAAKVFHME-FDGSLESFHA--ECKVMGSIR 815
           F   KLLG G+FG V   +L      G   A K+   E      E  H   E +V+ + R
Sbjct: 7   FDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
           H  L  +  +   +D    V+EY + G L   L  +  F +   R     ++ SALEYLH
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH 122
Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
              S  +V+ DIK  N++L++     ++DFG+ K  G  +        GT  Y+APE   
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLE 178
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           +    R  D +  G+++ E    + P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 763 FSENKLLGMGSFGSVYKGVL----PDGMEIAAKVFHME-FDGSLESFHA--ECKVMGSIR 815
           F   KLLG G+FG V   +L      G   A K+   E      E  H   E +V+ + R
Sbjct: 7   FDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
           H  L  +  +   +D    V+EY + G L   L  +  F +   R     ++ SALEYLH
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH 122
Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
              S  +V+ DIK  N++L++     ++DFG+ K  G  +        GT  Y+APE   
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYLAPEVLE 178
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           +    R  D +  G+++ E    + P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 763 FSENKLLGMGSFGSVYKGVL----PDGMEIAAKVFHME-FDGSLESFHA--ECKVMGSIR 815
           F   KLLG G+FG V   +L      G   A K+   E      E  H   E +V+ + R
Sbjct: 7   FDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
           H  L  +  +   +D    V+EY + G L   L  +  F +   R     ++ SALEYLH
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH 122
Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
              S  +V+ DIK  N++L++     ++DFG+ K  G  +        GT  Y+APE   
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYLAPEVLE 178
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           +    R  D +  G+++ E    + P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 763 FSENKLLGMGSFGSVYKGVL----PDGMEIAAKVFHME-FDGSLESFHA--ECKVMGSIR 815
           F   KLLG G+FG V   +L      G   A K+   E      E  H   E +V+ + R
Sbjct: 7   FDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
           H  L  +  +   +D    V+EY + G L   L  +  F +   R     ++ SALEYLH
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH 122
Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
              S  +V+ DIK  N++L++     ++DFG+ K  G  +        GT  Y+APE   
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYLAPEVLE 178
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           +    R  D +  G+++ E    + P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 763 FSENKLLGMGSFGSVYKGVL----PDGMEIAAKVFHME-FDGSLESFHA--ECKVMGSIR 815
           F   KLLG G+FG V   +L      G   A K+   E      E  H   E +V+ + R
Sbjct: 12  FDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 68
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
           H  L  +  +   +D    V+EY + G L   L  +  F +   R     ++ SALEYLH
Sbjct: 69  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH 127
Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
              S  +V+ DIK  N++L++     ++DFG+ K  G  +        GT  Y+APE   
Sbjct: 128 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYLAPEVLE 183
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           +    R  D +  G+++ E    + P
Sbjct: 184 DNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 53/200 (26%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 760 TDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRH 816
           TD +   + +G G+F  V + V L  G E AAK+ + +   +   +    E ++   ++H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
            N+V++  S S   F  LV + ++ G L + + +  Y+ +      I   + + L     
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 122
Query: 877 GYSTPIVHCDIKPSNVLLNESMVG---HLSDFGIA-KILGKEESMRQTKTLGTIGYMAPE 932
           G    +VH D+KP N+LL     G    L+DFG+A ++ G +++       GT GY++PE
Sbjct: 123 G----VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAW--FGFAGTPGYLSPE 176
Query: 933 YGREGKVSRKCDVYSYGIML 952
             R+    +  D+++ G++L
Sbjct: 177 VLRKEAYGKPVDIWACGVIL 196

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 26/157 (16%)
Query: 807 ECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK---- 862
           E  V+  + H N++K+     +     LV+E    G L         F +I+ R+K    
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL---------FDEIIHRMKFNEV 136
Query: 863 ----IMIDVASALEYLHFGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKILGKEE 915
               I+  V S + YLH      IVH D+KP N+LL    +  +  + DFG++ +   ++
Sbjct: 137 DAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193
Query: 916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIML 952
            M++   LGT  Y+APE  R+ K   KCDV+S G++L
Sbjct: 194 KMKE--RLGTAYYIAPEVLRK-KYDEKCDVWSIGVIL 227

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 105/238 (44%), Gaps = 33/238 (13%)
Query: 749 RRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHA-- 806
           +RI Y      +  F    LLG G++G V         EI A      FD  L +     
Sbjct: 3   KRIVYN----ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR 58
Query: 807 ECKVMGSIRHRNLVKIISSCSNNDFK----ALVLEYMSNGSLEKCLYSDNYFLDILQRLK 862
           E K++   +H N++ I +    + F+      +++ +    L + + +     D +Q   
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF- 117
Query: 863 IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL----------- 911
            +     A++ LH    + ++H D+KPSN+L+N +    + DFG+A+I+           
Sbjct: 118 -IYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 912 GKEESMRQTKTLGTIGYMAPEYG-REGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAG 968
           G++  M  T+ + T  Y APE      K SR  DV+S G +L E F ++     IF G
Sbjct: 174 GQQSGM--TEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP----IFPG 225

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 54/208 (25%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 766 NKLLGMGSFGSVYKGVLPD--------GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHR 817
           ++++G G FG VY G   D         ++  +++  M+    +E+F  E  +M  + H 
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ---QVEAFLREGLLMRGLNHP 82
Query: 818 NLVKIIS-SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
           N++ +I           ++L YM +G L + + S      +   +   + VA  +EYL  
Sbjct: 83  NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA- 141
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK-ILGKE-ESMRQTKTLG-TIGYMAPEY 933
                 VH D+   N +L+ES    ++DFG+A+ IL +E  S++Q +     + + A E 
Sbjct: 142 --EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 934 GREGKVSRKCDVYSYGIMLMETFTKKKP 961
            +  + + K DV+S+G++L E  T+  P
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 767 KLLGMGSFGSVYKG----------VLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-R 815
           K LG G+FG V +           VL   +++     H +     E+  +E K+M  + +
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD---EKEALMSELKIMSHLGQ 100
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLY---------SDNYFLDILQRLKIMID 866
           H N+V ++ +C++     ++ EY   G L   L           D   L++   L     
Sbjct: 101 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 160
Query: 867 VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK-ILGKEESMRQTKTLGT 925
           VA  + +L    S   +H D+   NVLL    V  + DFG+A+ I+     + +      
Sbjct: 161 VAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 217
Query: 926 IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           + +MAPE   +   + + DV+SYGI+L E F+
Sbjct: 218 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA----KVFHME--FDGSLESFHAECKVMGSIRH 816
           + +   LG G F +VYK    +  +I A    K+ H     DG   +   E K++  + H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
            N++ ++ +  +    +LV ++M    LE  +  ++  L        M+     LEYLH 
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 130
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
            +   I+H D+KP+N+LL+E+ V  L+DFG+AK  G        + + T  Y APE    
Sbjct: 131 HW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV-TRWYRAPELLFG 186
Query: 937 GKV-SRKCDVYSYGIMLME 954
            ++     D+++ G +L E
Sbjct: 187 ARMYGVGVDMWAVGCILAE 205

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 56/198 (28%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 769 LGMGSFGSV----YKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKI- 822
           LG G+FGSV    Y  +  + G  +A K            F  E +++ ++    +VK  
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 823 -ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
            +S         LV+EY+ +G L   L      LD  + L     +   +EYL    S  
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 134
Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREGKV 939
            VH D+   N+L+       ++DFG+AK+L  ++     +  G   I + APE   +   
Sbjct: 135 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 194
Query: 940 SRKCDVYSYGIMLMETFT 957
           SR+ DV+S+G++L E FT
Sbjct: 195 SRQSDVWSFGVVLYELFT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 56/198 (28%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 769 LGMGSFGSV----YKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKI- 822
           LG G+FGSV    Y  +  + G  +A K            F  E +++ ++    +VK  
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 823 -ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
            +S         LV+EY+ +G L   L      LD  + L     +   +EYL    S  
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 135
Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREGKV 939
            VH D+   N+L+       ++DFG+AK+L  ++     +  G   I + APE   +   
Sbjct: 136 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 195
Query: 940 SRKCDVYSYGIMLMETFT 957
           SR+ DV+S+G++L E FT
Sbjct: 196 SRQSDVWSFGVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 56/198 (28%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 769 LGMGSFGSV----YKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKI- 822
           LG G+FGSV    Y  +  + G  +A K            F  E +++ ++    +VK  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 823 -ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
            +S         LV+EY+ +G L   L      LD  + L     +   +EYL    S  
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 147
Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREGKV 939
            VH D+   N+L+       ++DFG+AK+L  ++     +  G   I + APE   +   
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207
Query: 940 SRKCDVYSYGIMLMETFT 957
           SR+ DV+S+G++L E FT
Sbjct: 208 SRQSDVWSFGVVLYELFT 225

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 26/181 (14%)
Query: 786 MEIAAKVFHME-FDGSLESFHAECKVMGSIR-HRNLVKIISSCSNNDFKALVLEYMSNGS 843
           ME+ A+    E  +   E+   E  ++  +  H +++ +I S  ++ F  LV + M  G 
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE 186
Query: 844 LEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLS 903
           L   L ++   L   +   IM  +  A+ +LH   +  IVH D+KP N+LL+++M   LS
Sbjct: 187 LFDYL-TEKVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLS 242
Query: 904 DFGIAKILGKEESMRQTKTLGTIGYMAPE------------YGREGKVSRKCDVYSYGIM 951
           DFG +  L   E +R+    GT GY+APE            YG+E       D+++ G++
Sbjct: 243 DFGFSCHLEPGEKLRE--LCGTPGYLAPEILKCSMDETHPGYGKE------VDLWACGVI 294
Query: 952 L 952
           L
Sbjct: 295 L 295

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 767 KLLGMGSFGSVYKG----------VLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-R 815
           K LG G+FG V +           VL   +++     H +     E+  +E K+M  + +
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD---EKEALMSELKIMSHLGQ 108
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLY---------SDNYFLDILQRLKIMID 866
           H N+V ++ +C++     ++ EY   G L   L           D   L++   L     
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 168
Query: 867 VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK-ILGKEESMRQTKTLGT 925
           VA  + +L    S   +H D+   NVLL    V  + DFG+A+ I+     + +      
Sbjct: 169 VAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 225
Query: 926 IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           + +MAPE   +   + + DV+SYGI+L E F+
Sbjct: 226 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 54/202 (26%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 758 RATDGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSL--ESFHAECKVMGSI 814
           R TD +   + LG G+F  V + V      E AAK+ + +   +   +    E ++   +
Sbjct: 28  RFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLL 87
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           +H N+V++  S S   F  LV + ++ G L + + +  Y+ +      I       LE +
Sbjct: 88  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIH----QILESV 143
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVG---HLSDFGIA-KILGKEESMRQTKTLGTIGYMA 930
           +  +   IVH D+KP N+LL     G    L+DFG+A ++ G++++       GT GY++
Sbjct: 144 NHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAW--FGFAGTPGYLS 201
Query: 931 PEYGREGKVSRKCDVYSYGIML 952
           PE  R+    +  D+++ G++L
Sbjct: 202 PEVLRKDPYGKPVDIWACGVIL 223

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 56/198 (28%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 769 LGMGSFGSV----YKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKI- 822
           LG G+FGSV    Y  +  + G  +A K            F  E +++ ++    +VK  
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 823 -ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
            +S         LV+EY+ +G L   L      LD  + L     +   +EYL    S  
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 131
Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREGKV 939
            VH D+   N+L+       ++DFG+AK+L  ++     +  G   I + APE   +   
Sbjct: 132 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIF 191
Query: 940 SRKCDVYSYGIMLMETFT 957
           SR+ DV+S+G++L E FT
Sbjct: 192 SRQSDVWSFGVVLYELFT 209

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 88/194 (45%), Gaps = 7/194 (3%)
Query: 769 LGMGSFGSV-YKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           +G GS G V    V   G  +A K   +      E    E  +M   +H N+V++ +S  
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDI 887
             D   +V+E++  G+L   +      ++  Q   + + V  AL  LH   +  ++H DI
Sbjct: 219 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 273
Query: 888 KPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYS 947
           K  ++LL       LSDFG    + KE   R+   +GT  +MAPE         + D++S
Sbjct: 274 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX-LVGTPYWMAPELISRLPYGPEVDIWS 332
Query: 948 YGIMLMETFTKKKP 961
            GIM++E    + P
Sbjct: 333 LGIMVIEMVDGEPP 346

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 12/212 (5%)
Query: 767 KLLGMGSFGSVYKGV-LPDG----MEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLV 820
           K+LG G+FG+VYKG+ +PDG    + +A KV        + +    E  VM  +    + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
           +++  C  +  + LV + M  G L   +  +   L     L   + +A  + YL      
Sbjct: 83  RLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLE---DV 138
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT-IGYMAPEYGREGKV 939
            +VH D+   NVL+       ++DFG+A++L  +E+          I +MA E     + 
Sbjct: 139 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRF 198
Query: 940 SRKCDVYSYGIMLMETFT-KKKPTDEIFAGEM 970
           + + DV+SYG+ + E  T   KP D I A E+
Sbjct: 199 THQSDVWSYGVTVWELMTFGAKPYDGIPAREI 230

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 15/225 (6%)
Query: 744 PQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEI-AAKVFHME---FDG 799
           P+    R S Q  L+  D F  +K+LG GSFG V+        +  A K    +    D 
Sbjct: 2   PELNKERPSLQIKLKIED-FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD 60
Query: 800 SLESFHAECKVMG-SIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDIL 858
            +E    E +V+  +  H  L  +  +    +    V+EY++ G L   + S + F D+ 
Sbjct: 61  DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-DLS 119
Query: 859 QRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK--ILGKEES 916
           +      ++   L++LH   S  IV+ D+K  N+LL++     ++DFG+ K  +LG    
Sbjct: 120 RATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG---D 173
Query: 917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
            +  +  GT  Y+APE     K +   D +S+G++L E    + P
Sbjct: 174 AKTNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 15/199 (7%)
Query: 760 TDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHR 817
           +DG+   + +G+GS+    + V     ME A KV     D S      E +++    +H 
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVI----DKSKRDPSEEIEILLRYGQHP 81
Query: 818 NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
           N++ +     +     LV E M  G L   +    +F +      ++  +   +EYLH  
Sbjct: 82  NIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-VLHTIGKTVEYLH-- 138
Query: 878 YSTPIVHCDIKPSNVL-LNES---MVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
            S  +VH D+KPSN+L ++ES       + DFG AK L  E  +  T    T  ++APE 
Sbjct: 139 -SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANFVAPEV 196
Query: 934 GREGKVSRKCDVYSYGIML 952
            +       CD++S GI+L
Sbjct: 197 LKRQGYDEGCDIWSLGILL 215

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 89/202 (44%), Gaps = 8/202 (3%)
Query: 767 KLLGMGSFGSVYKGVLPDGME-IAAKVFHMEFDGSL-ESFHAECKVMGSIRHRNLVKIIS 824
           + LG G++G V   V     E +A K+  M+      E+   E  +   + H N+VK   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                + + L LEY S G L   +  D   +      +    + + + YLH      I H
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITH 127
Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPE-YGREGKVSRK 942
            DIKP N+LL+E     +SDFG+A +       R   K  GT+ Y+APE   R    +  
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 943 CDVYSYGIMLMETFTKKKPTDE 964
            DV+S GI+L      + P D+
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 17/226 (7%)
Query: 744 PQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEI-AAKVFHME---FDG 799
           P+    R S Q  L+  D F  +K+LG GSFG V+        +  A K    +    D 
Sbjct: 1   PELNKERPSLQIKLKIED-FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD 59
Query: 800 SLESFHAECKVMG-SIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDIL 858
            +E    E +V+  +  H  L  +  +    +    V+EY++ G L   + S + F D+ 
Sbjct: 60  DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-DLS 118
Query: 859 QRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR 918
           +      ++   L++LH   S  IV+ D+K  N+LL++     ++DFG+     KE  + 
Sbjct: 119 RATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMC----KENMLG 171
Query: 919 QTKT---LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
             KT    GT  Y+APE     K +   D +S+G++L E    + P
Sbjct: 172 DAKTNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 89/202 (44%), Gaps = 8/202 (3%)
Query: 767 KLLGMGSFGSVYKGVLPDGME-IAAKVFHMEFDGSL-ESFHAECKVMGSIRHRNLVKIIS 824
           + LG G++G V   V     E +A K+  M+      E+   E  +   + H N+VK   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                + + L LEY S G L   +  D   +      +    + + + YLH      I H
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITH 128
Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPE-YGREGKVSRK 942
            DIKP N+LL+E     +SDFG+A +       R   K  GT+ Y+APE   R    +  
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 943 CDVYSYGIMLMETFTKKKPTDE 964
            DV+S GI+L      + P D+
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 82/167 (49%), Gaps = 27/167 (16%)
Query: 799 GSLESFHAECKVMGSIRHRNLVKIISSCS--NNDFKALVLEYMSNGSLE-----KCLYSD 851
           G +E  + E  ++  + H N+VK++      N D   +V E ++ G +      K L  D
Sbjct: 78  GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED 137
Query: 852 N---YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA 908
               YF D+++           +EYLH+     I+H DIKPSN+L+ E     ++DFG++
Sbjct: 138 QARFYFQDLIK----------GIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 909 KILGKEESMRQTKTLGTIGYMAPEYGREGKV---SRKCDVYSYGIML 952
                 +++  + T+GT  +MAPE   E +     +  DV++ G+ L
Sbjct: 185 NEFKGSDALL-SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 37/225 (16%)
Query: 761 DGFSENKLLGMGSFGSVYKG-VLPDGMEIAAKVFHME-FDGSLESFHAECKVMGSIRHRN 818
           D +   +++G G+   V      P   ++A K  ++E    S++    E + M    H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL----------------- 861
           +V   +S    D   LV++ +S GS+          LDI++ +                 
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSV----------LDIIKHIVAKGEHKSGVLDESTIA 119
Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK 921
            I+ +V   LEYLH       +H D+K  N+LL E     ++DFG++  L     + + K
Sbjct: 120 TILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 176
Query: 922 T----LGTIGYMAPEYGREGK-VSRKCDVYSYGIMLMETFTKKKP 961
                +GT  +MAPE   + +    K D++S+GI  +E  T   P
Sbjct: 177 VRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 37/225 (16%)
Query: 761 DGFSENKLLGMGSFGSVYKG-VLPDGMEIAAKVFHME-FDGSLESFHAECKVMGSIRHRN 818
           D +   +++G G+   V      P   ++A K  ++E    S++    E + M    H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL----------------- 861
           +V   +S    D   LV++ +S GS+          LDI++ +                 
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSV----------LDIIKHIVAKGEHKSGVLDESTIA 124
Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK 921
            I+ +V   LEYLH       +H D+K  N+LL E     ++DFG++  L     + + K
Sbjct: 125 TILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 181
Query: 922 T----LGTIGYMAPEYGREGK-VSRKCDVYSYGIMLMETFTKKKP 961
                +GT  +MAPE   + +    K D++S+GI  +E  T   P
Sbjct: 182 VRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 15/199 (7%)
Query: 760 TDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHR 817
           +DG+   + +G+GS+    + V     ME A KV     D S      E +++    +H 
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVI----DKSKRDPSEEIEILLRYGQHP 81
Query: 818 NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
           N++ +     +     LV E M  G L   +    +F +      ++  +   +EYLH  
Sbjct: 82  NIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-VLHTIGKTVEYLH-- 138
Query: 878 YSTPIVHCDIKPSNVL-LNES---MVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
            S  +VH D+KPSN+L ++ES       + DFG AK L  E  +  T    T  ++APE 
Sbjct: 139 -SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANFVAPEV 196
Query: 934 GREGKVSRKCDVYSYGIML 952
            +       CD++S GI+L
Sbjct: 197 LKRQGYDEGCDIWSLGILL 215

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 8/202 (3%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHM--EFDGSLESFHAECKVMGSIRHRN 818
           + + + + +G G++G VYK     G  +A K   +  E +G   +   E  ++  + H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
           +V +I    +     LV E+M    L+K L  +   L   Q  +I I +   L  +   +
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCH 136
Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY-GREG 937
              I+H D+KP N+L+N      L+DFG+A+  G       T  + T+ Y AP+      
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 938 KVSRKCDVYSYGIMLMETFTKK 959
           K S   D++S G +  E  T K
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGK 217

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 94/198 (47%), Gaps = 20/198 (10%)
Query: 767 KLLGMGSFGSV----YKGVLPDGMEIAAKVFHME-FDGSLESFHAECK---VMGSIRHRN 818
           K++G GSFG V    +K    + +  A KV   +      E  H   +   ++ +++H  
Sbjct: 44  KVIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
           LV +  S    D    VL+Y++ G L   L  +  FL+   R     ++ASAL YLH   
Sbjct: 101 LVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH--- 156
Query: 879 STPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
           S  IV+ D+KP N+LL+    GH  L+DFG+ K   +  S   T   GT  Y+APE   +
Sbjct: 157 SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNSTTST-FCGTPEYLAPEVLHK 213
Query: 937 GKVSRKCDVYSYGIMLME 954
               R  D +  G +L E
Sbjct: 214 QPYDRTVDWWCLGAVLYE 231

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 767 KLLGMGSFGSVYKG----VLPDGMEIAAKVFHMEFDGSLES---FHAECKVMGSIRHRNL 819
           + LG GSFG VY+G    ++    E    V  +    SL     F  E  VM      ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLD---------ILQRLKIMIDVASA 870
           V+++   S      +V+E M++G L+  L S     +         + + +++  ++A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT-KTLGTIGYM 929
           + YL+   +   VH D+   N ++       + DFG+ + + + +  R+  K L  + +M
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 930 APEYGREGKVSRKCDVYSYGIMLME 954
           APE  ++G  +   D++S+G++L E
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWE 224

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 8/202 (3%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHM--EFDGSLESFHAECKVMGSIRHRN 818
           + + + + +G G++G VYK     G  +A K   +  E +G   +   E  ++  + H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
           +V +I    +     LV E+M    L+K L  +   L   Q  +I I +   L  +   +
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCH 136
Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY-GREG 937
              I+H D+KP N+L+N      L+DFG+A+  G       T  + T+ Y AP+      
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 938 KVSRKCDVYSYGIMLMETFTKK 959
           K S   D++S G +  E  T K
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGK 217

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 54/194 (27%), Positives = 88/194 (45%), Gaps = 7/194 (3%)
Query: 769 LGMGSFGSV-YKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           +G GS G V    V   G  +A K   +      E    E  +M   +H N+V++ +S  
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDI 887
             D   +V+E++  G+L   +      ++  Q   + + V  AL  LH   +  ++H DI
Sbjct: 142 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 196
Query: 888 KPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYS 947
           K  ++LL       LSDFG    + KE   R+   +GT  +MAPE         + D++S
Sbjct: 197 KSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKXLVGTPYWMAPELISRLPYGPEVDIWS 255
Query: 948 YGIMLMETFTKKKP 961
            GIM++E    + P
Sbjct: 256 LGIMVIEMVDGEPP 269

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 54/194 (27%), Positives = 88/194 (45%), Gaps = 7/194 (3%)
Query: 769 LGMGSFGSV-YKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           +G GS G V    V   G  +A K   +      E    E  +M   +H N+V++ +S  
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDI 887
             D   +V+E++  G+L   +      ++  Q   + + V  AL  LH   +  ++H DI
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 146
Query: 888 KPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYS 947
           K  ++LL       LSDFG    + KE   R+   +GT  +MAPE         + D++S
Sbjct: 147 KSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKXLVGTPYWMAPELISRLPYGPEVDIWS 205
Query: 948 YGIMLMETFTKKKP 961
            GIM++E    + P
Sbjct: 206 LGIMVIEMVDGEPP 219

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 54/194 (27%), Positives = 88/194 (45%), Gaps = 7/194 (3%)
Query: 769 LGMGSFGSV-YKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           +G GS G V    V   G  +A K   +      E    E  +M   +H N+V++ +S  
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDI 887
             D   +V+E++  G+L   +      ++  Q   + + V  AL  LH   +  ++H DI
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 153
Query: 888 KPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYS 947
           K  ++LL       LSDFG    + KE   R+   +GT  +MAPE         + D++S
Sbjct: 154 KSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKXLVGTPYWMAPELISRLPYGPEVDIWS 212
Query: 948 YGIMLMETFTKKKP 961
            GIM++E    + P
Sbjct: 213 LGIMVIEMVDGEPP 226

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 54/194 (27%), Positives = 88/194 (45%), Gaps = 7/194 (3%)
Query: 769 LGMGSFGSV-YKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           +G GS G V    V   G  +A K   +      E    E  +M   +H N+V++ +S  
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDI 887
             D   +V+E++  G+L   +      ++  Q   + + V  AL  LH   +  ++H DI
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 142
Query: 888 KPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYS 947
           K  ++LL       LSDFG    + KE   R+   +GT  +MAPE         + D++S
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKXLVGTPYWMAPELISRLPYGPEVDIWS 201
Query: 948 YGIMLMETFTKKKP 961
            GIM++E    + P
Sbjct: 202 LGIMVIEMVDGEPP 215

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 54/194 (27%), Positives = 88/194 (45%), Gaps = 7/194 (3%)
Query: 769 LGMGSFGSV-YKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS 827
           +G GS G V    V   G  +A K   +      E    E  +M   +H N+V++ +S  
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDI 887
             D   +V+E++  G+L   +      ++  Q   + + V  AL  LH   +  ++H DI
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 151
Query: 888 KPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYS 947
           K  ++LL       LSDFG    + KE   R+   +GT  +MAPE         + D++S
Sbjct: 152 KSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKXLVGTPYWMAPELISRLPYGPEVDIWS 210
Query: 948 YGIMLMETFTKKKP 961
            GIM++E    + P
Sbjct: 211 LGIMVIEMVDGEPP 224

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 106/236 (44%), Gaps = 29/236 (12%)
Query: 749 RRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHA-- 806
           +RI Y      +  F    LLG G++G V         EI A      FD  L +     
Sbjct: 3   KRIVYN----ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR 58
Query: 807 ECKVMGSIRHRNLVKIISSCSNNDFK----ALVLEYMSNGSLEKCLYSDNYFLDILQRLK 862
           E K++   +H N++ I +    + F+      +++ +    L + + +     D +Q   
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF- 117
Query: 863 IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK------EES 916
            +     A++ LH    + ++H D+KPSN+L+N +    + DFG+A+I+ +      E +
Sbjct: 118 -IYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 917 MRQT---KTLGTIGYMAPEYG-REGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAG 968
            +Q+   + + T  Y APE      K SR  DV+S G +L E F ++     IF G
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP----IFPG 225

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 8/202 (3%)
Query: 767 KLLGMGSFGSVYKGVLPDGME-IAAKVFHMEFDGSL-ESFHAECKVMGSIRHRNLVKIIS 824
           + LG G++G V   V     E +A K+  M+      E+   E  +   + H N+VK   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                + + L LEY S G L   +  D    +   + +    + + + YLH      I H
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLH---GIGITH 127
Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKV-SRK 942
            DIKP N+LL+E     +SDFG+A +       R   K  GT+ Y+APE  +  +  +  
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 943 CDVYSYGIMLMETFTKKKPTDE 964
            DV+S GI+L      + P D+
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 8/202 (3%)
Query: 767 KLLGMGSFGSVYKGVLPDGME-IAAKVFHMEFDGSL-ESFHAECKVMGSIRHRNLVKIIS 824
           + LG G++G V   V     E +A K+  M+      E+   E  +   + H N+VK   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 72
Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                + + L LEY S G L   +  D    +   + +    + + + YLH      I H
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLH---GIGITH 128
Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKV-SRK 942
            DIKP N+LL+E     +SDFG+A +       R   K  GT+ Y+APE  +  +  +  
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 188
Query: 943 CDVYSYGIMLMETFTKKKPTDE 964
            DV+S GI+L      + P D+
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 8/202 (3%)
Query: 767 KLLGMGSFGSVYKGVLPDGME-IAAKVFHMEFDGSL-ESFHAECKVMGSIRHRNLVKIIS 824
           + LG G++G V   V     E +A K+  M+      E+   E  +   + H N+VK   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                + + L LEY S G L   +  D    +   + +    + + + YLH      I H
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLH---GIGITH 127
Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKV-SRK 942
            DIKP N+LL+E     +SDFG+A +       R   K  GT+ Y+APE  +  +  +  
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 943 CDVYSYGIMLMETFTKKKPTDE 964
            DV+S GI+L      + P D+
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 102/227 (44%), Gaps = 49/227 (21%)
Query: 758 RATDGFSEN----KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL------ESFHA 806
            +T GF EN    ++LG G    V + +  P   E A K+  +   GS       E   A
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 807 ECKVMGSIR----HRNLVKIISSCSNNDFKALVLEYMSNGSL-----EKCLYSDNYFLDI 857
             K +  +R    H N++++  +   N F  LV + M  G L     EK   S+     I
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129
Query: 858 LQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM 917
           ++ L   ++V  AL  L+      IVH D+KP N+LL++ M   L+DFG +  L   E +
Sbjct: 130 MRAL---LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL 180
Query: 918 RQTKTLGTIGYMAPE------------YGREGKVSRKCDVYSYGIML 952
           R+    GT  Y+APE            YG+E       D++S G+++
Sbjct: 181 RE--VCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 219

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 12/158 (7%)
Query: 806 AECKVMGSIRHRNLVKIISSC--SNNDFKALVLEYMSNGSLEKCLYS---DNYFLDILQR 860
           +E  ++  ++H N+V+         N    +V+EY   G L   +     +  +LD    
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 861 LKIMIDVASALEYLHF----GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES 916
           L++M  +  AL+  H     G++  ++H D+KP+NV L+      L DFG+A+IL  + S
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHT--VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171
Query: 917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLME 954
             +T  +GT  YM+PE       + K D++S G +L E
Sbjct: 172 FAKT-FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 27/204 (13%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGME----IAAKVFHME-FDGSLESFHAECKVMGSIR 815
           D +    +LG G+F  V   +L +       +A K    E  +G   S   E  V+  I+
Sbjct: 18  DIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIK 74
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSL-----EKCLYSDNYFLDILQRLKIMIDVASA 870
           H N+V +     +     L+++ +S G L     EK  Y++          +++  V  A
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASRLIFQVLDA 128
Query: 871 LEYLHFGYSTPIVHCDIKPSNVL---LNESMVGHLSDFGIAKILGKEESMRQTKTLGTIG 927
           ++YLH      IVH D+KP N+L   L+E     +SDFG++K+  ++     +   GT G
Sbjct: 129 VKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPG 183
Query: 928 YMAPEYGREGKVSRKCDVYSYGIM 951
           Y+APE   +   S+  D +S G++
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 27/204 (13%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGME----IAAKVFHME-FDGSLESFHAECKVMGSIR 815
           D +    +LG G+F  V   +L +       +A K    E  +G   S   E  V+  I+
Sbjct: 18  DIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIK 74
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSL-----EKCLYSDNYFLDILQRLKIMIDVASA 870
           H N+V +     +     L+++ +S G L     EK  Y++          +++  V  A
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASRLIFQVLDA 128
Query: 871 LEYLHFGYSTPIVHCDIKPSNVL---LNESMVGHLSDFGIAKILGKEESMRQTKTLGTIG 927
           ++YLH      IVH D+KP N+L   L+E     +SDFG++K+  ++     +   GT G
Sbjct: 129 VKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPG 183
Query: 928 YMAPEYGREGKVSRKCDVYSYGIM 951
           Y+APE   +   S+  D +S G++
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 27/204 (13%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGME----IAAKVFHME-FDGSLESFHAECKVMGSIR 815
           D +    +LG G+F  V   +L +       +A K    E  +G   S   E  V+  I+
Sbjct: 18  DIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIK 74
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSL-----EKCLYSDNYFLDILQRLKIMIDVASA 870
           H N+V +     +     L+++ +S G L     EK  Y++          +++  V  A
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASRLIFQVLDA 128
Query: 871 LEYLHFGYSTPIVHCDIKPSNVL---LNESMVGHLSDFGIAKILGKEESMRQTKTLGTIG 927
           ++YLH      IVH D+KP N+L   L+E     +SDFG++K+  ++     +   GT G
Sbjct: 129 VKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPG 183
Query: 928 YMAPEYGREGKVSRKCDVYSYGIM 951
           Y+APE   +   S+  D +S G++
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 8/202 (3%)
Query: 767 KLLGMGSFGSVYKGVLPDGME-IAAKVFHMEFDGSL-ESFHAECKVMGSIRHRNLVKIIS 824
           + LG G++G V   V     E +A K+  M+      E+   E  +   + H N+VK   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYG 72
Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                + + L LEY S G L   +  D    +   + +    + + + YLH      I H
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLH---GIGITH 128
Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKV-SRK 942
            DIKP N+LL+E     +SDFG+A +       R   K  GT+ Y+APE  +  +  +  
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 943 CDVYSYGIMLMETFTKKKPTDE 964
            DV+S GI+L      + P D+
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 69/278 (24%), Positives = 116/278 (41%), Gaps = 41/278 (14%)
Query: 769  LGMGSFGSVYKGV--LPDGMEIAAKVFHMEFD-----GSLESFHAECKVMGSIRHRNLVK 821
            LG GSFG V +G    P G  ++  V  ++ D      +++ F  E   M S+ HRNL++
Sbjct: 20   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 822  IISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            +         K +V E    GSL   L  +  ++ L  L R    + VA  + YL    S
Sbjct: 80   LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYA--VQVAEGMGYLE---S 133
Query: 880  TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES---MRQTKTLGTIGYMAPEYGRE 936
               +H D+   N+LL    +  + DFG+ + L + +    M++ + +    + APE  + 
Sbjct: 134  KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESLKT 192
Query: 937  GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC 996
               S   D + +G+ L E FT  +            + W+G  L    I    D      
Sbjct: 193  RTFSHASDTWMFGVTLWEMFTYGQ------------EPWIG--LNGSQILHKIDK----- 233
Query: 997  EENDFSAREQCVSSIFSLAMDCTVDLPEKR---ISMKD 1031
            E       E C   I+++ + C    PE R   ++++D
Sbjct: 234  EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 271

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 69/278 (24%), Positives = 116/278 (41%), Gaps = 41/278 (14%)
Query: 769  LGMGSFGSVYKGV--LPDGMEIAAKVFHMEFD-----GSLESFHAECKVMGSIRHRNLVK 821
            LG GSFG V +G    P G  ++  V  ++ D      +++ F  E   M S+ HRNL++
Sbjct: 20   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 822  IISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            +         K +V E    GSL   L  +  ++ L  L R    + VA  + YL    S
Sbjct: 80   LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYA--VQVAEGMGYLE---S 133
Query: 880  TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES---MRQTKTLGTIGYMAPEYGRE 936
               +H D+   N+LL    +  + DFG+ + L + +    M++ + +    + APE  + 
Sbjct: 134  KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESLKT 192
Query: 937  GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC 996
               S   D + +G+ L E FT  +            + W+G  L    I    D      
Sbjct: 193  RTFSHASDTWMFGVTLWEMFTYGQ------------EPWIG--LNGSQILHKIDK----- 233
Query: 997  EENDFSAREQCVSSIFSLAMDCTVDLPEKR---ISMKD 1031
            E       E C   I+++ + C    PE R   ++++D
Sbjct: 234  EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 271

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 69/278 (24%), Positives = 116/278 (41%), Gaps = 41/278 (14%)
Query: 769  LGMGSFGSVYKGV--LPDGMEIAAKVFHMEFD-----GSLESFHAECKVMGSIRHRNLVK 821
            LG GSFG V +G    P G  ++  V  ++ D      +++ F  E   M S+ HRNL++
Sbjct: 16   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 822  IISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            +         K +V E    GSL   L  +  ++ L  L R    + VA  + YL    S
Sbjct: 76   LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYA--VQVAEGMGYLE---S 129
Query: 880  TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES---MRQTKTLGTIGYMAPEYGRE 936
               +H D+   N+LL    +  + DFG+ + L + +    M++ + +    + APE  + 
Sbjct: 130  KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESLKT 188
Query: 937  GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC 996
               S   D + +G+ L E FT  +            + W+G  L    I    D      
Sbjct: 189  RTFSHASDTWMFGVTLWEMFTYGQ------------EPWIG--LNGSQILHKIDK----- 229
Query: 997  EENDFSAREQCVSSIFSLAMDCTVDLPEKR---ISMKD 1031
            E       E C   I+++ + C    PE R   ++++D
Sbjct: 230  EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 69/278 (24%), Positives = 116/278 (41%), Gaps = 41/278 (14%)
Query: 769  LGMGSFGSVYKGV--LPDGMEIAAKVFHMEFD-----GSLESFHAECKVMGSIRHRNLVK 821
            LG GSFG V +G    P G  ++  V  ++ D      +++ F  E   M S+ HRNL++
Sbjct: 26   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 822  IISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            +         K +V E    GSL   L  +  ++ L  L R    + VA  + YL    S
Sbjct: 86   LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYA--VQVAEGMGYLE---S 139
Query: 880  TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES---MRQTKTLGTIGYMAPEYGRE 936
               +H D+   N+LL    +  + DFG+ + L + +    M++ + +    + APE  + 
Sbjct: 140  KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESLKT 198
Query: 937  GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC 996
               S   D + +G+ L E FT  +            + W+G  L    I    D      
Sbjct: 199  RTFSHASDTWMFGVTLWEMFTYGQ------------EPWIG--LNGSQILHKIDK----- 239
Query: 997  EENDFSAREQCVSSIFSLAMDCTVDLPEKR---ISMKD 1031
            E       E C   I+++ + C    PE R   ++++D
Sbjct: 240  EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 69/278 (24%), Positives = 116/278 (41%), Gaps = 41/278 (14%)
Query: 769  LGMGSFGSVYKGV--LPDGMEIAAKVFHMEFD-----GSLESFHAECKVMGSIRHRNLVK 821
            LG GSFG V +G    P G  ++  V  ++ D      +++ F  E   M S+ HRNL++
Sbjct: 26   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 822  IISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            +         K +V E    GSL   L  +  ++ L  L R    + VA  + YL    S
Sbjct: 86   LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYA--VQVAEGMGYLE---S 139
Query: 880  TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES---MRQTKTLGTIGYMAPEYGRE 936
               +H D+   N+LL    +  + DFG+ + L + +    M++ + +    + APE  + 
Sbjct: 140  KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAPESLKT 198
Query: 937  GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC 996
               S   D + +G+ L E FT  +            + W+G  L    I    D      
Sbjct: 199  RTFSHASDTWMFGVTLWEMFTYGQ------------EPWIG--LNGSQILHKIDK----- 239
Query: 997  EENDFSAREQCVSSIFSLAMDCTVDLPEKR---ISMKD 1031
            E       E C   I+++ + C    PE R   ++++D
Sbjct: 240  EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 69/278 (24%), Positives = 116/278 (41%), Gaps = 41/278 (14%)
Query: 769  LGMGSFGSVYKGV--LPDGMEIAAKVFHMEFD-----GSLESFHAECKVMGSIRHRNLVK 821
            LG GSFG V +G    P G  ++  V  ++ D      +++ F  E   M S+ HRNL++
Sbjct: 16   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 822  IISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            +         K +V E    GSL   L  +  ++ L  L R    + VA  + YL    S
Sbjct: 76   LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYA--VQVAEGMGYLE---S 129
Query: 880  TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES---MRQTKTLGTIGYMAPEYGRE 936
               +H D+   N+LL    +  + DFG+ + L + +    M++ + +    + APE  + 
Sbjct: 130  KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAPESLKT 188
Query: 937  GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC 996
               S   D + +G+ L E FT  +            + W+G  L    I    D      
Sbjct: 189  RTFSHASDTWMFGVTLWEMFTYGQ------------EPWIG--LNGSQILHKIDK----- 229
Query: 997  EENDFSAREQCVSSIFSLAMDCTVDLPEKR---ISMKD 1031
            E       E C   I+++ + C    PE R   ++++D
Sbjct: 230  EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 12/202 (5%)
Query: 767 KLLGMGSFGSVY--KGVLPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKI 822
           K +G G+F  V   + +L  G E+A K+         SL+    E ++M  + H N+VK+
Sbjct: 13  KTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 71
Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
                      LV+EY S G +   L +  +  +   R K    + SA++Y H  +   I
Sbjct: 72  FEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQYCHQKF---I 127
Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVS-R 941
           VH D+K  N+LL+  M   ++DFG +        +      G+  Y APE  +  K    
Sbjct: 128 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL--DTFCGSPPYAAPELFQGKKYDGP 185
Query: 942 KCDVYSYGIMLMETFTKKKPTD 963
           + DV+S G++L    +   P D
Sbjct: 186 EVDVWSLGVILYTLVSGSLPFD 207

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 69/278 (24%), Positives = 116/278 (41%), Gaps = 41/278 (14%)
Query: 769  LGMGSFGSVYKGV--LPDGMEIAAKVFHMEFD-----GSLESFHAECKVMGSIRHRNLVK 821
            LG GSFG V +G    P G  ++  V  ++ D      +++ F  E   M S+ HRNL++
Sbjct: 16   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 822  IISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            +         K +V E    GSL   L  +  ++ L  L R    + VA  + YL    S
Sbjct: 76   LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYA--VQVAEGMGYLE---S 129
Query: 880  TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES---MRQTKTLGTIGYMAPEYGRE 936
               +H D+   N+LL    +  + DFG+ + L + +    M++ + +    + APE  + 
Sbjct: 130  KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESLKT 188
Query: 937  GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC 996
               S   D + +G+ L E FT  +            + W+G  L    I    D      
Sbjct: 189  RTFSHASDTWMFGVTLWEMFTYGQ------------EPWIG--LNGSQILHKIDK----- 229
Query: 997  EENDFSAREQCVSSIFSLAMDCTVDLPEKR---ISMKD 1031
            E       E C   I+++ + C    PE R   ++++D
Sbjct: 230  EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 12/202 (5%)
Query: 767 KLLGMGSFGSV--YKGVLPDGMEIAAKVFHME--FDGSLESFHAECKVMGSIRHRNLVKI 822
           K +G G+F  V   + VL  G E+A K+         SL+    E ++M  + H N+VK+
Sbjct: 21  KTIGKGNFAKVKLARHVL-TGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
                      LV+EY S G +   L +     +   R K    + SA++Y H  Y   I
Sbjct: 80  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKY---I 135
Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVS-R 941
           VH D+K  N+LL+  M   ++DFG +        +      G+  Y APE  +  K    
Sbjct: 136 VHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKL--DTFCGSPPYAAPELFQGKKYDGP 193
Query: 942 KCDVYSYGIMLMETFTKKKPTD 963
           + DV+S G++L    +   P D
Sbjct: 194 EVDVWSLGVILYTLVSGSLPFD 215

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 26/219 (11%)
Query: 761 DGFSENKLLGMGSFGSVYK----GVLPDGMEIAAKVFHMEFDGSLESFH----AECKVMG 812
           D  +  K LG G+FG V +    G+          V  M  +G+  S H    +E K++ 
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAV-KMLKEGATHSEHRALMSELKILI 85
Query: 813 SIRHR-NLVKIISSCSNNDFKALVL-EYMSNGSLEKCL---------YSDNY--FLDILQ 859
            I H  N+V ++ +C+      +V+ E+   G+L   L         Y D Y  FL +  
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEH 145
Query: 860 RLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMR 918
            +     VA  +E+L    S   +H D+   N+LL+E  V  + DFG+A+ + K+ + +R
Sbjct: 146 LIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVR 202
Query: 919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           +      + +MAPE   +   + + DV+S+G++L E F+
Sbjct: 203 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 12/158 (7%)
Query: 806 AECKVMGSIRHRNLVKIISSC--SNNDFKALVLEYMSNGSLEKCLYS---DNYFLDILQR 860
           +E  ++  ++H N+V+         N    +V+EY   G L   +     +  +LD    
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 861 LKIMIDVASALEYLHF----GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES 916
           L++M  +  AL+  H     G++  ++H D+KP+NV L+      L DFG+A+IL  +E 
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHT--VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED 171
Query: 917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLME 954
             + + +GT  YM+PE       + K D++S G +L E
Sbjct: 172 FAK-EFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 39/234 (16%)
Query: 748 WRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHME----------- 796
           W+ +  Q +    D F + ++LG G FG V+       M+   K++  +           
Sbjct: 174 WKWLEAQPM--GEDWFLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRK 227
Query: 797 -FDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLY---SDN 852
            + G++     E K++  +  R +V +  +        LV+  M+ G +   +Y    DN
Sbjct: 228 GYQGAM----VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283
Query: 853 YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG 912
                 + +     + S LE+LH      I++ D+KP NVLL++     +SD G+A  L 
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL- 339
Query: 913 KEESMRQTKT---LGTIGYMAPE--YGREGKVSRKCDVYSYGIMLMETFTKKKP 961
                 QTKT    GT G+MAPE   G E   S   D ++ G+ L E    + P
Sbjct: 340 ---KAGQTKTKGYAGTPGFMAPELLLGEEYDFS--VDYFALGVTLYEMIAARGP 388

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 8/202 (3%)
Query: 767 KLLGMGSFGSVYKGVLPDGME-IAAKVFHMEFDGSL-ESFHAECKVMGSIRHRNLVKIIS 824
           + LG G++G V   V     E +A K+  M+      E+   E  +   + H N+VK   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                + + L LEY S G L   +  D    +   + +    + + + YLH      I H
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLH---GIGITH 127
Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKV-SRK 942
            DIKP N+LL+E     +SDFG+A +       R   K  GT+ Y+APE  +  +  +  
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 943 CDVYSYGIMLMETFTKKKPTDE 964
            DV+S GI+L      + P D+
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 101/208 (48%), Gaps = 26/208 (12%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI--RHRNLVKIIS 824
           + +G G +G V++G    G  +A K+F    +   +S+  E ++  ++  RH N++  I+
Sbjct: 43  ECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIA 98
Query: 825 SCSNNDFKA----LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH---FG 877
           S   +   +    L+  Y   GSL    Y     LD +  L+I++ +AS L +LH   FG
Sbjct: 99  SDMTSRHSSTQLWLITHYHEMGSLYD--YLQLTTLDTVSCLRIVLSIASGLAHLHIEIFG 156
Query: 878 YS--TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK---EESMRQTKTLGTIGYMAPE 932
                 I H D+K  N+L+ ++    ++D G+A +  +   +  +     +GT  YMAPE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 216
Query: 933 YGREG------KVSRKCDVYSYGIMLME 954
              E          ++ D++++G++L E
Sbjct: 217 VLDETIQVDCFDSYKRVDIWAFGLVLWE 244

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 8/202 (3%)
Query: 767 KLLGMGSFGSVYKGVLPDGME-IAAKVFHMEFDGSL-ESFHAECKVMGSIRHRNLVKIIS 824
           + LG G++G V   V     E +A K+  M+      E+   E  +   + H N+VK   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                + + L LEY S G L   +  D    +   + +    + + + YLH      I H
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLH---GIGITH 127
Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKV-SRK 942
            DIKP N+LL+E     +SDFG+A +       R   K  GT+ Y+APE  +  +  +  
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 943 CDVYSYGIMLMETFTKKKPTDE 964
            DV+S GI+L      + P D+
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 8/202 (3%)
Query: 767 KLLGMGSFGSVYKGVLPDGME-IAAKVFHMEFDGSL-ESFHAECKVMGSIRHRNLVKIIS 824
           + LG G++G V   V     E +A K+  M+      E+   E  +   + H N+VK   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                + + L LEY S G L   +  D    +   + +    + + + YLH      I H
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLH---GIGITH 127
Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKV-SRK 942
            DIKP N+LL+E     +SDFG+A +       R   K  GT+ Y+APE  +  +  +  
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 943 CDVYSYGIMLMETFTKKKPTDE 964
            DV+S GI+L      + P D+
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 8/202 (3%)
Query: 767 KLLGMGSFGSVYKGVLPDGME-IAAKVFHMEFDGSL-ESFHAECKVMGSIRHRNLVKIIS 824
           + LG G++G V   V     E +A K+  M+      E+   E  +   + H N+VK   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                + + L LEY S G L   +  D    +   + +    + + + YLH      I H
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLH---GIGITH 128
Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKV-SRK 942
            DIKP N+LL+E     +SDFG+A +       R   K  GT+ Y+APE  +  +  +  
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 943 CDVYSYGIMLMETFTKKKPTDE 964
            DV+S GI+L      + P D+
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 8/202 (3%)
Query: 767 KLLGMGSFGSVYKGVLPDGME-IAAKVFHMEFDGSL-ESFHAECKVMGSIRHRNLVKIIS 824
           + LG G++G V   V     E +A K+  M+      E+   E  +   + H N+VK   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                + + L LEY S G L   +  D    +   + +    + + + YLH      I H
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLH---GIGITH 128
Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKV-SRK 942
            DIKP N+LL+E     +SDFG+A +       R   K  GT+ Y+APE  +  +  +  
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 943 CDVYSYGIMLMETFTKKKPTDE 964
            DV+S GI+L      + P D+
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 8/202 (3%)
Query: 767 KLLGMGSFGSVYKGVLPDGME-IAAKVFHMEFDGSL-ESFHAECKVMGSIRHRNLVKIIS 824
           + LG G++G V   V     E +A K+  M+      E+   E  +   + H N+VK   
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                + + L LEY S G L   +  D    +   + +    + + + YLH      I H
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLH---GIGITH 126
Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKV-SRK 942
            DIKP N+LL+E     +SDFG+A +       R   K  GT+ Y+APE  +  +  +  
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186
Query: 943 CDVYSYGIMLMETFTKKKPTDE 964
            DV+S GI+L      + P D+
Sbjct: 187 VDVWSCGIVLTAMLAGELPWDQ 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 8/202 (3%)
Query: 767 KLLGMGSFGSVYKGVLPDGME-IAAKVFHMEFDGSL-ESFHAECKVMGSIRHRNLVKIIS 824
           + LG G++G V   V     E +A K+  M+      E+   E  +   + H N+VK   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                + + L LEY S G L   +  D    +   + +    + + + YLH      I H
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLH---GIGITH 127
Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKV-SRK 942
            DIKP N+LL+E     +SDFG+A +       R   K  GT+ Y+APE  +  +  +  
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 943 CDVYSYGIMLMETFTKKKPTDE 964
            DV+S GI+L      + P D+
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 8/202 (3%)
Query: 767 KLLGMGSFGSVYKGVLPDGME-IAAKVFHMEFDGSL-ESFHAECKVMGSIRHRNLVKIIS 824
           + LG G++G V   V     E +A K+  M+      E+   E  +   + H N+VK   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                + + L LEY S G L   +  D    +   + +    + + + YLH      I H
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLH---GIGITH 127
Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKV-SRK 942
            DIKP N+LL+E     +SDFG+A +       R   K  GT+ Y+APE  +  +  +  
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 943 CDVYSYGIMLMETFTKKKPTDE 964
            DV+S GI+L      + P D+
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 8/202 (3%)
Query: 767 KLLGMGSFGSVYKGVLPDGME-IAAKVFHMEFDGSL-ESFHAECKVMGSIRHRNLVKIIS 824
           + LG G++G V   V     E +A K+  M+      E+   E  +   + H N+VK   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                + + L LEY S G L   +  D    +   + +    + + + YLH      I H
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLH---GIGITH 128
Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKV-SRK 942
            DIKP N+LL+E     +SDFG+A +       R   K  GT+ Y+APE  +  +  +  
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 943 CDVYSYGIMLMETFTKKKPTDE 964
            DV+S GI+L      + P D+
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 8/202 (3%)
Query: 767 KLLGMGSFGSVYKGVLPDGME-IAAKVFHMEFDGSL-ESFHAECKVMGSIRHRNLVKIIS 824
           + LG G++G V   V     E +A K+  M+      E+   E  +   + H N+VK   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                + + L LEY S G L   +  D    +   + +    + + + YLH      I H
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLH---GIGITH 127
Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKV-SRK 942
            DIKP N+LL+E     +SDFG+A +       R   K  GT+ Y+APE  +  +  +  
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 943 CDVYSYGIMLMETFTKKKPTDE 964
            DV+S GI+L      + P D+
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 8/202 (3%)
Query: 767 KLLGMGSFGSVYKGVLPDGME-IAAKVFHMEFDGSL-ESFHAECKVMGSIRHRNLVKIIS 824
           + LG G++G V   V     E +A K+  M+      E+   E  +   + H N+VK   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                + + L LEY S G L   +  D    +   + +    + + + YLH      I H
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLH---GIGITH 127
Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKV-SRK 942
            DIKP N+LL+E     +SDFG+A +       R   K  GT+ Y+APE  +  +  +  
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 943 CDVYSYGIMLMETFTKKKPTDE 964
            DV+S GI+L      + P D+
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 8/202 (3%)
Query: 767 KLLGMGSFGSVYKGVLPDGME-IAAKVFHMEFDGSL-ESFHAECKVMGSIRHRNLVKIIS 824
           + LG G++G V   V     E +A K+  M+      E+   E  +   + H N+VK   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                + + L LEY S G L   +  D    +   + +    + + + YLH      I H
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLH---GIGITH 127
Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKV-SRK 942
            DIKP N+LL+E     +SDFG+A +       R   K  GT+ Y+APE  +  +  +  
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 943 CDVYSYGIMLMETFTKKKPTDE 964
            DV+S GI+L      + P D+
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 8/202 (3%)
Query: 767 KLLGMGSFGSVYKGVLPDGME-IAAKVFHMEFDGSL-ESFHAECKVMGSIRHRNLVKIIS 824
           + LG G++G V   V     E +A K+  M+      E+   E  +   + H N+VK   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                + + L LEY S G L   +  D    +   + +    + + + YLH      I H
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLH---GIGITH 128
Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKV-SRK 942
            DIKP N+LL+E     +SDFG+A +       R   K  GT+ Y+APE  +  +  +  
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 943 CDVYSYGIMLMETFTKKKPTDE 964
            DV+S GI+L      + P D+
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 8/202 (3%)
Query: 767 KLLGMGSFGSVYKGVLPDGME-IAAKVFHMEFDGSL-ESFHAECKVMGSIRHRNLVKIIS 824
           + LG G++G V   V     E +A K+  M+      E+   E  +   + H N+VK   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                + + L LEY S G L   +  D    +   + +    + + + YLH      I H
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLH---GIGITH 128
Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKV-SRK 942
            DIKP N+LL+E     +SDFG+A +       R   K  GT+ Y+APE  +  +  +  
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 943 CDVYSYGIMLMETFTKKKPTDE 964
            DV+S GI+L      + P D+
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 767 KLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGSL---ESFHAECKVMGSIRHRNLVKI 822
           + LG GSFG V+      +G   A KV   E    L   E  + E  ++  + H  ++++
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
             +  +     ++++Y+  G L   L     F + + +     +V  ALEYLH   S  I
Sbjct: 72  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLH---SKDI 127
Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRK 942
           ++ D+KP N+LL+++    ++DFG AK +            GT  Y+APE       ++ 
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYXLCGTPDYIAPEVVSTKPYNKS 183
Query: 943 CDVYSYGIMLMETFTKKKP 961
            D +S+GI++ E      P
Sbjct: 184 IDWWSFGILIYEMLAGYTP 202

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 52/222 (23%), Positives = 101/222 (45%), Gaps = 20/222 (9%)
Query: 769 LGMGSFGSVYKG----VLPDGMEIAAKVFHMEFDGSLES---FHAECKVMGSIRHRNLVK 821
           LG GSFG VY+G    ++    E    V  +    SL     F  E  VM      ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLD---------ILQRLKIMIDVASALE 872
           ++   S      +V+E M++G L+  L S     +         + + +++  ++A  + 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT-KTLGTIGYMAP 931
           YL+   +   VH D+   N ++       + DFG+ + + + +  R+  K L  + +MAP
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 932 EYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
           E  ++G  +   D++S+G++L E  +  +   +  + E  LK
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 240

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 55/229 (24%), Positives = 97/229 (42%), Gaps = 52/229 (22%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRHRNL 819
           F E +L+G G FG V+K        I  K +    ++++   E    E K +  + H N+
Sbjct: 14  FKEIELIGSGGFGQVFKA----KHRIDGKTYVIRRVKYNN--EKAEREVKALAKLDHVNI 67
Query: 820 VKIISSCSNNDFKALVLEYMSNGSLE-----------------KCLYSDNYF-------- 854
           V         D+        S+ SLE                 KCL+    F        
Sbjct: 68  VHYNGCWDGFDYDP----ETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQ 123
Query: 855 ---------LDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDF 905
                    LD +  L++   +   ++Y+H   S  ++H D+KPSN+ L ++    + DF
Sbjct: 124 WIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDF 180
Query: 906 GIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLME 954
           G+   L  +   ++T++ GT+ YM+PE        ++ D+Y+ G++L E
Sbjct: 181 GLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 227

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 39/234 (16%)
Query: 748 WRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHME----------- 796
           W+ +  Q +    D F + ++LG G FG V+       M+   K++  +           
Sbjct: 174 WKWLEAQPM--GEDWFLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRK 227
Query: 797 -FDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLY---SDN 852
            + G++     E K++  +  R +V +  +        LV+  M+ G +   +Y    DN
Sbjct: 228 GYQGAM----VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283
Query: 853 YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG 912
                 + +     + S LE+LH      I++ D+KP NVLL++     +SD G+A  L 
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL- 339
Query: 913 KEESMRQTKT---LGTIGYMAPE--YGREGKVSRKCDVYSYGIMLMETFTKKKP 961
                 QTKT    GT G+MAPE   G E   S   D ++ G+ L E    + P
Sbjct: 340 ---KAGQTKTKGYAGTPGFMAPELLLGEEYDFS--VDYFALGVTLYEMIAARGP 388

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 52/222 (23%), Positives = 101/222 (45%), Gaps = 20/222 (9%)
Query: 769 LGMGSFGSVYKG----VLPDGMEIAAKVFHMEFDGSLES---FHAECKVMGSIRHRNLVK 821
           LG GSFG VY+G    ++    E    V  +    SL     F  E  VM      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLD---------ILQRLKIMIDVASALE 872
           ++   S      +V+E M++G L+  L S     +         + + +++  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT-KTLGTIGYMAP 931
           YL+   +   VH D+   N ++       + DFG+ + + + +  R+  K L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 932 EYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
           E  ++G  +   D++S+G++L E  +  +   +  + E  LK
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 37/211 (17%)
Query: 757 LRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEF--------DGSLESFHAEC 808
           +R T  F E  +LG G+F  V+         +  K+F ++         D SLE+   E 
Sbjct: 7   IRKTFIFME--VLGSGAFSEVFLV----KQRLTGKLFALKCIKKSPAFRDSSLEN---EI 57
Query: 809 KVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSL-----EKCLYSDNYFLDILQRLKI 863
            V+  I+H N+V +     +     LV++ +S G L     E+ +Y++     ++Q+   
Sbjct: 58  AVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ--- 114
Query: 864 MIDVASALEYLHFGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKILGKEESMRQT 920
              V SA++YLH      IVH D+KP N+L     E+    ++DFG++K+   E++   +
Sbjct: 115 ---VLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMS 165
Query: 921 KTLGTIGYMAPEYGREGKVSRKCDVYSYGIM 951
              GT GY+APE   +   S+  D +S G++
Sbjct: 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 196

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 39/234 (16%)
Query: 748 WRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHME----------- 796
           W+ +  Q +    D F + ++LG G FG V+       M+   K++  +           
Sbjct: 174 WKWLEAQPM--GEDWFLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRK 227
Query: 797 -FDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLY---SDN 852
            + G++     E K++  +  R +V +  +        LV+  M+ G +   +Y    DN
Sbjct: 228 GYQGAM----VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283
Query: 853 YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG 912
                 + +     + S LE+LH      I++ D+KP NVLL++     +SD G+A  L 
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL- 339
Query: 913 KEESMRQTKT---LGTIGYMAPE--YGREGKVSRKCDVYSYGIMLMETFTKKKP 961
                 QTKT    GT G+MAPE   G E   S   D ++ G+ L E    + P
Sbjct: 340 ---KAGQTKTKGYAGTPGFMAPELLLGEEYDFS--VDYFALGVTLYEMIAARGP 388

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 101/227 (44%), Gaps = 49/227 (21%)
Query: 758 RATDGFSEN----KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL------ESFHA 806
            +T GF EN    ++LG G    V + +  P   E A K+  +   GS       E   A
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 807 ECKVMGSIR----HRNLVKIISSCSNNDFKALVLEYMSNGSL-----EKCLYSDNYFLDI 857
             K +  +R    H N++++  +   N F  LV + M  G L     EK   S+     I
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129
Query: 858 LQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM 917
           ++ L   ++V  AL  L+      IVH D+KP N+LL++ M   L+DFG +  L   E +
Sbjct: 130 MRAL---LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL 180
Query: 918 RQTKTLGTIGYMAPE------------YGREGKVSRKCDVYSYGIML 952
           R     GT  Y+APE            YG+E       D++S G+++
Sbjct: 181 RS--VCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 219

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 34/210 (16%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA--KVFHMEFDGSLESFHAECKVMGSIRHRNLV 820
           +++ K++G GSFG VY+  L D  E+ A  KV     D   +  + E ++M  + H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFK--NRELQIMRKLDHCNIV 110
Query: 821 KI----ISSCSNND--FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI------MIDVA 868
           ++     SS    D  +  LVL+Y+     E       ++    Q L +      M  + 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 869 SALEYLH-FGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKTLGTI 926
            +L Y+H FG    I H DIKP N+LL+ ++ V  L DFG AK L + E       + + 
Sbjct: 167 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSR 220
Query: 927 GYMAPE--YGREGKVSRKCDVYSYGIMLME 954
            Y APE  +G     S   DV+S G +L E
Sbjct: 221 YYRAPELIFGATDYTS-SIDVWSAGCVLAE 249

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 39/234 (16%)
Query: 748 WRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHME----------- 796
           W+ +  Q +    D F + ++LG G FG V+       M+   K++  +           
Sbjct: 174 WKWLEAQPM--GEDWFLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRK 227
Query: 797 -FDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLY---SDN 852
            + G++     E K++  +  R +V +  +        LV+  M+ G +   +Y    DN
Sbjct: 228 GYQGAM----VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283
Query: 853 YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG 912
                 + +     + S LE+LH      I++ D+KP NVLL++     +SD G+A  L 
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL- 339
Query: 913 KEESMRQTKT---LGTIGYMAPE--YGREGKVSRKCDVYSYGIMLMETFTKKKP 961
                 QTKT    GT G+MAPE   G E   S   D ++ G+ L E    + P
Sbjct: 340 ---KAGQTKTKGYAGTPGFMAPELLLGEEYDFS--VDYFALGVTLYEMIAARGP 388

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 47/162 (29%), Positives = 82/162 (50%), Gaps = 22/162 (13%)
Query: 798 DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSL-----EKCLYSDN 852
           +GS+E+   E  V+  I+H N+V +     +     L+++ +S G L     EK  Y++ 
Sbjct: 60  EGSMEN---EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER 116
Query: 853 YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVL---LNESMVGHLSDFGIAK 909
                    +++  V  A++YLH      IVH D+KP N+L   L+E     +SDFG++K
Sbjct: 117 ------DASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 167
Query: 910 ILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIM 951
           +  ++     +   GT GY+APE   +   S+  D +S G++
Sbjct: 168 M--EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 34/210 (16%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA--KVFHMEFDGSLESFHAECKVMGSIRHRNLV 820
           +++ K++G GSFG VY+  L D  E+ A  KV     D   +  + E ++M  + H N+V
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFK--NRELQIMRKLDHCNIV 84
Query: 821 KI----ISSCSNND--FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI------MIDVA 868
           ++     SS    D  +  LVL+Y+     E       ++    Q L +      M  + 
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 140
Query: 869 SALEYLH-FGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKTLGTI 926
            +L Y+H FG    I H DIKP N+LL+ ++ V  L DFG AK L + E       + + 
Sbjct: 141 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSR 194
Query: 927 GYMAPE--YGREGKVSRKCDVYSYGIMLME 954
            Y APE  +G     S   DV+S G +L E
Sbjct: 195 YYRAPELIFGATDYTS-SIDVWSAGCVLAE 223

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 34/210 (16%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA--KVFHMEFDGSLESFHAECKVMGSIRHRNLV 820
           +++ K++G GSFG VY+  L D  E+ A  KV     D   +  + E ++M  + H N+V
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFK--NRELQIMRKLDHCNIV 95
Query: 821 KI----ISSCSNND--FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI------MIDVA 868
           ++     SS    D  +  LVL+Y+     E       ++    Q L +      M  + 
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 151
Query: 869 SALEYLH-FGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKTLGTI 926
            +L Y+H FG    I H DIKP N+LL+ ++ V  L DFG AK L + E       + + 
Sbjct: 152 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSR 205
Query: 927 GYMAPE--YGREGKVSRKCDVYSYGIMLME 954
            Y APE  +G     S   DV+S G +L E
Sbjct: 206 YYRAPELIFGATDYTS-SIDVWSAGCVLAE 234

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 29/199 (14%)
Query: 768 LLGMGSFGSVYK-GVLPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIIS 824
           +LG GSFG V K        E A KV +     +    +   E +++  + H N++K+  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQR--------LKIMIDVASALEYLHF 876
              ++    +V E  + G L         F +I++R         +I+  V S + Y+H 
Sbjct: 89  ILEDSSSFYIVGELYTGGEL---------FDEIIKRKRFSEHDAARIIKQVFSGITYMH- 138
Query: 877 GYSTPIVHCDIKPSNVLLNESMVG---HLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
                IVH D+KP N+LL          + DFG++    +   M+    +GT  Y+APE 
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPEV 194
Query: 934 GREGKVSRKCDVYSYGIML 952
            R G    KCDV+S G++L
Sbjct: 195 LR-GTYDEKCDVWSAGVIL 212

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 34/210 (16%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA--KVFHMEFDGSLESFHAECKVMGSIRHRNLV 820
           +++ K++G GSFG VY+  L D  E+ A  KV     D   +  + E ++M  + H N+V
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFK--NRELQIMRKLDHCNIV 88
Query: 821 KI----ISSCSNND--FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI------MIDVA 868
           ++     SS    D  +  LVL+Y+     E       ++    Q L +      M  + 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 869 SALEYLH-FGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKTLGTI 926
            +L Y+H FG    I H DIKP N+LL+ ++ V  L DFG AK L + E       + + 
Sbjct: 145 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSR 198
Query: 927 GYMAPE--YGREGKVSRKCDVYSYGIMLME 954
            Y APE  +G     S   DV+S G +L E
Sbjct: 199 YYRAPELIFGATDYTS-SIDVWSAGCVLAE 227

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 34/210 (16%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA--KVFHMEFDGSLESFHAECKVMGSIRHRNLV 820
           +++ K++G GSFG VY+  L D  E+ A  KV     D   ++   E ++M  + H N+V
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNIV 77
Query: 821 KI----ISSCSNND--FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI------MIDVA 868
           ++     SS    D  +  LVL+Y+     E       ++    Q L +      M  + 
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 133
Query: 869 SALEYLH-FGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKTLGTI 926
            +L Y+H FG    I H DIKP N+LL+ ++ V  L DFG AK L + E       + + 
Sbjct: 134 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSR 187
Query: 927 GYMAPE--YGREGKVSRKCDVYSYGIMLME 954
            Y APE  +G     S   DV+S G +L E
Sbjct: 188 YYRAPELIFGATDYTS-SIDVWSAGCVLAE 216

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 34/210 (16%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA--KVFHMEFDGSLESFHAECKVMGSIRHRNLV 820
           +++ K++G GSFG VY+  L D  E+ A  KV     D   +  + E ++M  + H N+V
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFK--NRELQIMRKLDHCNIV 81
Query: 821 KI----ISSCSNND--FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI------MIDVA 868
           ++     SS    D  +  LVL+Y+     E       ++    Q L +      M  + 
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 137
Query: 869 SALEYLH-FGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKTLGTI 926
            +L Y+H FG    I H DIKP N+LL+ ++ V  L DFG AK L + E       + + 
Sbjct: 138 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSR 191
Query: 927 GYMAPE--YGREGKVSRKCDVYSYGIMLME 954
            Y APE  +G     S   DV+S G +L E
Sbjct: 192 YYRAPELIFGATDYTS-SIDVWSAGCVLAE 220

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 34/210 (16%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA--KVFHMEFDGSLESFHAECKVMGSIRHRNLV 820
           +++ K++G GSFG VY+  L D  E+ A  KV     D   +  + E ++M  + H N+V
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFK--NRELQIMRKLDHCNIV 104
Query: 821 KI----ISSCSNND--FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI------MIDVA 868
           ++     SS    D  +  LVL+Y+     E       ++    Q L +      M  + 
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 160
Query: 869 SALEYLH-FGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKTLGTI 926
            +L Y+H FG    I H DIKP N+LL+ ++ V  L DFG AK L + E       + + 
Sbjct: 161 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSR 214
Query: 927 GYMAPE--YGREGKVSRKCDVYSYGIMLME 954
            Y APE  +G     S   DV+S G +L E
Sbjct: 215 YYRAPELIFGATDYTS-SIDVWSAGCVLAE 243

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 34/210 (16%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA--KVFHMEFDGSLESFHAECKVMGSIRHRNLV 820
           +++ K++G GSFG VY+  L D  E+ A  KV     D   ++   E ++M  + H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNIV 76
Query: 821 KI----ISSCSNND--FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI------MIDVA 868
           ++     SS    D  +  LVL+Y+     E       ++    Q L +      M  + 
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 869 SALEYLH-FGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKTLGTI 926
            +L Y+H FG    I H DIKP N+LL+ ++ V  L DFG AK L + E       + + 
Sbjct: 133 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSR 186
Query: 927 GYMAPE--YGREGKVSRKCDVYSYGIMLME 954
            Y APE  +G     S   DV+S G +L E
Sbjct: 187 YYRAPELIFGATDYTS-SIDVWSAGCVLAE 215

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 99/209 (47%), Gaps = 32/209 (15%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI--RHRNLVKIISSC 826
           +G G FG V++G    G E+A K+F    +    S+  E ++  ++  RH N++  I++ 
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 827 SNNDFKA----LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY---- 878
           + ++       LV +Y  +GSL    Y + Y + +   +K+ +  AS L +LH       
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 879 -STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT------KTLGTIGYMAP 931
               I H D+K  N+L+ ++    ++D G+A    + +S   T        +GT  YMAP
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAV---RHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 932 EY------GREGKVSRKCDVYSYGIMLME 954
           E        +  +  ++ D+Y+ G++  E
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWE 249

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 100/206 (48%), Gaps = 26/206 (12%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI--RHRNLVKIISSC 826
           +G G +G V++G    G  +A K+F    +   +S+  E ++  ++  RH N++  I+S 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASD 71
Query: 827 SNNDFKA----LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH---FGYS 879
             +   +    L+  Y   GSL    Y     LD +  L+I++ +AS L +LH   FG  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYD--YLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 880 --TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK---EESMRQTKTLGTIGYMAPEYG 934
               I H D+K  N+L+ ++    ++D G+A +  +   +  +     +GT  YMAPE  
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 935 REG------KVSRKCDVYSYGIMLME 954
            E          ++ D++++G++L E
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWE 215

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 34/210 (16%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA--KVFHMEFDGSLESFHAECKVMGSIRHRNLV 820
           +++ K++G GSFG VY+  L D  E+ A  KV     D   ++   E ++M  + H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNIV 76
Query: 821 KI----ISSCSNND--FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI------MIDVA 868
           ++     SS    D  +  LVL+Y+     E       ++    Q L +      M  + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 869 SALEYLH-FGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKTLGTI 926
            +L Y+H FG    I H DIKP N+LL+ ++ V  L DFG AK L + E       + + 
Sbjct: 133 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSR 186
Query: 927 GYMAPE--YGREGKVSRKCDVYSYGIMLME 954
            Y APE  +G     S   DV+S G +L E
Sbjct: 187 YYRAPELIFGATDYTS-SIDVWSAGCVLAE 215

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 34/210 (16%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA--KVFHMEFDGSLESFHAECKVMGSIRHRNLV 820
           +++ K++G GSFG VY+  L D  E+ A  KV     D   +  + E ++M  + H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFK--NRELQIMRKLDHCNIV 110
Query: 821 KI----ISSCSNND--FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI------MIDVA 868
           ++     SS    D  +  LVL+Y+     E       ++    Q L +      M  + 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 869 SALEYLH-FGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKTLGTI 926
            +L Y+H FG    I H DIKP N+LL+ ++ V  L DFG AK L + E       + + 
Sbjct: 167 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSR 220
Query: 927 GYMAPE--YGREGKVSRKCDVYSYGIMLME 954
            Y APE  +G     S   DV+S G +L E
Sbjct: 221 YYRAPELIFGATDYTS-SIDVWSAGCVLAE 249

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 100/206 (48%), Gaps = 26/206 (12%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI--RHRNLVKIISSC 826
           +G G +G V++G    G  +A K+F    +   +S+  E ++  ++  RH N++  I+S 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASD 71
Query: 827 SNNDFKA----LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH---FGYS 879
             +   +    L+  Y   GSL    Y     LD +  L+I++ +AS L +LH   FG  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYD--YLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 880 --TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK---EESMRQTKTLGTIGYMAPEYG 934
               I H D+K  N+L+ ++    ++D G+A +  +   +  +     +GT  YMAPE  
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 935 REG------KVSRKCDVYSYGIMLME 954
            E          ++ D++++G++L E
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWE 215

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 40/225 (17%)
Query: 767 KLLGMGSFGSVYKG----------VLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-R 815
           K LG G+FG V +           VL   +++     H +     E+  +E K+M  + +
Sbjct: 37  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD---EKEALMSELKIMSHLGQ 93
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSL----------------------EKCLYSDNY 853
           H N+V ++ +C++     ++ EY   G L                      E     D  
Sbjct: 94  HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGR 153
Query: 854 FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK-ILG 912
            L++   L     VA  + +L    S   +H D+   NVLL    V  + DFG+A+ I+ 
Sbjct: 154 PLELRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 210
Query: 913 KEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
               + +      + +MAPE   +   + + DV+SYGI+L E F+
Sbjct: 211 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 34/210 (16%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA--KVFHMEFDGSLESFHAECKVMGSIRHRNLV 820
           +++ K++G GSFG VY+  L D  E+ A  KV     D   +  + E ++M  + H N+V
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFK--NRELQIMRKLDHCNIV 114
Query: 821 KI----ISSCSNND--FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI------MIDVA 868
           ++     SS    D  +  LVL+Y+     E       ++    Q L +      M  + 
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 170
Query: 869 SALEYLH-FGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKTLGTI 926
            +L Y+H FG    I H DIKP N+LL+ ++ V  L DFG AK L + E       + + 
Sbjct: 171 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSR 224
Query: 927 GYMAPE--YGREGKVSRKCDVYSYGIMLME 954
            Y APE  +G     S   DV+S G +L E
Sbjct: 225 YYRAPELIFGATDYTS-SIDVWSAGCVLAE 253

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 34/210 (16%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA--KVFHMEFDGSLESFHAECKVMGSIRHRNLV 820
           +++ K++G GSFG VY+  L D  E+ A  KV     D   +  + E ++M  + H N+V
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFK--NRELQIMRKLDHCNIV 88
Query: 821 KI----ISSCSNND--FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI------MIDVA 868
           ++     SS    D  +  LVL+Y+     E       ++    Q L +      M  + 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 869 SALEYLH-FGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKTLGTI 926
            +L Y+H FG    I H DIKP N+LL+ ++ V  L DFG AK L + E       + + 
Sbjct: 145 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSR 198
Query: 927 GYMAPE--YGREGKVSRKCDVYSYGIMLME 954
            Y APE  +G     S   DV+S G +L E
Sbjct: 199 YYRAPELIFGATDYTS-SIDVWSAGCVLAE 227

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 34/210 (16%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA--KVFHMEFDGSLESFHAECKVMGSIRHRNLV 820
           +++ K++G GSFG VY+  L D  E+ A  KV     D   ++   E ++M  + H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNIV 76
Query: 821 KI----ISSCSNND--FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI------MIDVA 868
           ++     SS    D  +  LVL+Y+     E       ++    Q L +      M  + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 869 SALEYLH-FGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKTLGTI 926
            +L Y+H FG    I H DIKP N+LL+ ++ V  L DFG AK L + E       + + 
Sbjct: 133 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSR 186
Query: 927 GYMAPE--YGREGKVSRKCDVYSYGIMLME 954
            Y APE  +G     S   DV+S G +L E
Sbjct: 187 YYRAPELIFGATDYTS-SIDVWSAGCVLAE 215

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 34/105 (32%), Positives = 53/105 (50%), Gaps = 14/105 (13%)
Query: 861 LKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES---- 916
           L I + +A A+E+LH   S  ++H D+KPSN+      V  + DFG+   + ++E     
Sbjct: 121 LHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 917 -------MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLME 954
                   R T  +GT  YM+PE       S K D++S G++L E
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 99/209 (47%), Gaps = 32/209 (15%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI--RHRNLVKIISSC 826
           +G G FG V++G    G E+A K+F    +    S+  E ++  ++  RH N++  I++ 
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAAD 92
Query: 827 SNNDFKA----LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY---- 878
           + ++       LV +Y  +GSL    Y + Y + +   +K+ +  AS L +LH       
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 150
Query: 879 -STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT------KTLGTIGYMAP 931
               I H D+K  N+L+ ++    ++D G+A    + +S   T        +GT  YMAP
Sbjct: 151 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAV---RHDSATDTIDIAPNHRVGTKRYMAP 207
Query: 932 EY------GREGKVSRKCDVYSYGIMLME 954
           E        +  +  ++ D+Y+ G++  E
Sbjct: 208 EVLDDSINMKHFESFKRADIYAMGLVFWE 236

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 34/210 (16%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA--KVFHMEFDGSLESFHAECKVMGSIRHRNLV 820
           +++ K++G GSFG VY+  L D  E+ A  KV     D   ++   E ++M  + H N+V
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNIV 80
Query: 821 KI----ISSCSNND--FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI------MIDVA 868
           ++     SS    D  +  LVL+Y+     E       ++    Q L +      M  + 
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 136
Query: 869 SALEYLH-FGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKTLGTI 926
            +L Y+H FG    I H DIKP N+LL+ ++ V  L DFG AK L + E       + + 
Sbjct: 137 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSR 190
Query: 927 GYMAPE--YGREGKVSRKCDVYSYGIMLME 954
            Y APE  +G     S   DV+S G +L E
Sbjct: 191 YYRAPELIFGATDYTS-SIDVWSAGCVLAE 219

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 33/210 (15%)
Query: 768 LLGMGSFGSVYKGVLPDGM---EIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKI 822
           +LG GSFG V K    D +   E A KV +     +    +   E +++  + H N++K+
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQR--------LKIMIDVASALEYL 874
                ++    +V E  + G L         F +I++R         +I+  V S + Y+
Sbjct: 87  FEILEDSSSFYIVGELYTGGEL---------FDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVG---HLSDFGIAKILGKEESMRQTKTLGTIGYMAP 931
           H      IVH D+KP N+LL          + DFG++    +   M+    +GT  Y+AP
Sbjct: 138 H---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAP 192
Query: 932 EYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           E  R G    KCDV+S G++L    +   P
Sbjct: 193 EVLR-GTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 33/210 (15%)
Query: 768 LLGMGSFGSVYKGVLPDGM---EIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKI 822
           +LG GSFG V K    D +   E A KV +     +    +   E +++  + H N++K+
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQR--------LKIMIDVASALEYL 874
                ++    +V E  + G L         F +I++R         +I+  V S + Y+
Sbjct: 87  FEILEDSSSFYIVGELYTGGEL---------FDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVG---HLSDFGIAKILGKEESMRQTKTLGTIGYMAP 931
           H      IVH D+KP N+LL          + DFG++    +   M+    +GT  Y+AP
Sbjct: 138 H---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAP 192
Query: 932 EYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           E  R G    KCDV+S G++L    +   P
Sbjct: 193 EVLR-GTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 34/210 (16%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA--KVFHMEFDGSLESFHAECKVMGSIRHRNLV 820
           +++ K++G GSFG VY+  L D  E+ A  KV     D   +  + E ++M  + H N+V
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFK--NRELQIMRKLDHCNIV 89
Query: 821 KI----ISSCSNND--FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI------MIDVA 868
           ++     SS    D  +  LVL+Y+     E       ++    Q L +      M  + 
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 145
Query: 869 SALEYLH-FGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKTLGTI 926
            +L Y+H FG    I H DIKP N+LL+ ++ V  L DFG AK L + E       + + 
Sbjct: 146 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSR 199
Query: 927 GYMAPE--YGREGKVSRKCDVYSYGIMLME 954
            Y APE  +G     S   DV+S G +L E
Sbjct: 200 YYRAPELIFGATDYTS-SIDVWSAGCVLAE 228

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 34/210 (16%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA--KVFHMEFDGSLESFHAECKVMGSIRHRNLV 820
           +++ K++G GSFG VY+  L D  E+ A  KV     D   +  + E ++M  + H N+V
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFK--NRELQIMRKLDHCNIV 112
Query: 821 KI----ISSCSNND--FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI------MIDVA 868
           ++     SS    D  +  LVL+Y+     E       ++    Q L +      M  + 
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 168
Query: 869 SALEYLH-FGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKTLGTI 926
            +L Y+H FG    I H DIKP N+LL+ ++ V  L DFG AK L + E       + + 
Sbjct: 169 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSR 222
Query: 927 GYMAPE--YGREGKVSRKCDVYSYGIMLME 954
            Y APE  +G     S   DV+S G +L E
Sbjct: 223 YYRAPELIFGATDYTS-SIDVWSAGCVLAE 251

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 49/223 (21%)
Query: 762 GFSEN----KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL------ESFHAECKV 810
           GF EN    ++LG G    V + +  P   E A K+  +   GS       E   A  K 
Sbjct: 1   GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 60
Query: 811 MGSIR----HRNLVKIISSCSNNDFKALVLEYMSNGSL-----EKCLYSDNYFLDILQRL 861
           +  +R    H N++++  +   N F  LV + M  G L     EK   S+     I++ L
Sbjct: 61  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 120
Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK 921
              ++V  AL  L+      IVH D+KP N+LL++ M   L+DFG +  L   E +R+  
Sbjct: 121 ---LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-- 169
Query: 922 TLGTIGYMAPE------------YGREGKVSRKCDVYSYGIML 952
             GT  Y+APE            YG+E       D++S G+++
Sbjct: 170 VCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 206

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 26/219 (11%)
Query: 761 DGFSENKLLGMGSFGSVYK----GVLPDGMEIAAKVFHMEFDGSLESFH----AECKVMG 812
           D  +  K LG G+FG V +    G+          V  M  +G+  S H    +E K++ 
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAV-KMLKEGATHSEHRALMSELKILI 85
Query: 813 SIRHR-NLVKIISSCSNNDFKALVL-EYMSNGSLEKCL---------YSDNY--FLDILQ 859
            I H  N+V ++ +C+      +V+ E+   G+L   L         Y D Y  FL +  
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEH 145
Query: 860 RLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMR 918
            +     VA  +E+L    S   +H D+   N+LL+E  V  + DFG+A+ + K+ + +R
Sbjct: 146 LICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 202
Query: 919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           +      + +MAPE   +   + + DV+S+G++L E F+
Sbjct: 203 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 34/210 (16%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA--KVFHMEFDGSLESFHAECKVMGSIRHRNLV 820
           +++ K++G GSFG VY+  L D  E+ A  KV     D   +  + E ++M  + H N+V
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFK--NRELQIMRKLDHCNIV 155
Query: 821 KI----ISSCSNND--FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI------MIDVA 868
           ++     SS    D  +  LVL+Y+     E       ++    Q L +      M  + 
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 211
Query: 869 SALEYLH-FGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKTLGTI 926
            +L Y+H FG    I H DIKP N+LL+ ++ V  L DFG AK L + E       + + 
Sbjct: 212 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSR 265
Query: 927 GYMAPE--YGREGKVSRKCDVYSYGIMLME 954
            Y APE  +G     S   DV+S G +L E
Sbjct: 266 YYRAPELIFGATDYTS-SIDVWSAGCVLAE 294

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 64/209 (30%), Positives = 94/209 (44%), Gaps = 32/209 (15%)
Query: 760 TDGFSENKLLGMGSFGSVY--KGVLPDGMEIAAKVFHMEFDGSLESFHA---ECKVMGSI 814
           +D +   K LG G++G V   K  L  G E A K+       +  +  A   E  V+  +
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK--------IMID 866
            H N++K+     +     LV+E    G L         F +I+ R K        IM  
Sbjct: 79  DHPNIMKLYEFFEDKRNYYLVMEVYRGGEL---------FDEIILRQKFSEVDAAVIMKQ 129
Query: 867 VASALEYLHFGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKILGKEESMRQTKTL 923
           V S   YLH      IVH D+KP N+LL   +   +  + DFG++     E   +  + L
Sbjct: 130 VLSGTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGKMKERL 184
Query: 924 GTIGYMAPEYGREGKVSRKCDVYSYGIML 952
           GT  Y+APE  R+ K   KCDV+S G++L
Sbjct: 185 GTAYYIAPEVLRK-KYDEKCDVWSCGVIL 212

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 47/177 (26%), Positives = 83/177 (46%), Gaps = 6/177 (3%)
Query: 785 GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSL 844
           G ++A K+  +      E    E  +M   +H N+V++  S    +   +++E++  G+L
Sbjct: 70  GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGAL 129
Query: 845 EKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSD 904
              +      L+  Q   +   V  AL YLH   +  ++H DIK  ++LL       LSD
Sbjct: 130 TDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSD 184
Query: 905 FGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           FG    + K+   R+   +GT  +MAPE       + + D++S GIM++E    + P
Sbjct: 185 FGFCAQISKDVPKRKX-LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 12/158 (7%)
Query: 806 AECKVMGSIRHRNLVKIISSC--SNNDFKALVLEYMSNGSLEKCLYS---DNYFLDILQR 860
           +E  ++  ++H N+V+         N    +V+EY   G L   +     +  +LD    
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 861 LKIMIDVASALEYLHF----GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES 916
           L++M  +  AL+  H     G++  ++H D+KP+NV L+      L DFG+A+IL  + S
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHT--VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171
Query: 917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLME 954
             +   +GT  YM+PE       + K D++S G +L E
Sbjct: 172 FAKA-FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 12/202 (5%)
Query: 767 KLLGMGSFGSVY--KGVLPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKI 822
           K +G G+F  V   + +L  G E+A K+         SL+    E ++M  + H N+VK+
Sbjct: 20  KTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
                      LV+EY S G +   L +     +   R K    + SA++Y H  +   I
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---I 134
Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVS-R 941
           VH D+K  N+LL+  M   ++DFG +        +      G+  Y APE  +  K    
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL--DTFCGSPPYAAPELFQGKKYDGP 192
Query: 942 KCDVYSYGIMLMETFTKKKPTD 963
           + DV+S G++L    +   P D
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFD 214

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 49/191 (25%), Positives = 96/191 (50%), Gaps = 13/191 (6%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISS 825
           LG G+F  V + V +  G E AAK+ + +   +   +    E ++   ++H N+V++  S
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
            S      L+ + ++ G L + + +  Y+ +      I   + + L     G    +VH 
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG----VVHR 145
Query: 886 DIKPSNVLLNESMVG---HLSDFGIA-KILGKEESMRQTKTLGTIGYMAPEYGREGKVSR 941
           D+KP N+LL   + G    L+DFG+A ++ G++++       GT GY++PE  R+    +
Sbjct: 146 DLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW--FGFAGTPGYLSPEVLRKDPYGK 203
Query: 942 KCDVYSYGIML 952
             D+++ G++L
Sbjct: 204 PVDLWACGVIL 214

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 12/202 (5%)
Query: 767 KLLGMGSFGSVY--KGVLPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKI 822
           K +G G+F  V   + +L  G E+A K+         SL+    E ++M  + H N+VK+
Sbjct: 20  KTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
                      LV+EY S G +   L +     +   R K    + SA++Y H  +   I
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---I 134
Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVS-R 941
           VH D+K  N+LL+  M   ++DFG +        +      G+  Y APE  +  K    
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL--DTFCGSPPYAAPELFQGKKYDGP 192
Query: 942 KCDVYSYGIMLMETFTKKKPTD 963
           + DV+S G++L    +   P D
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFD 214

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 12/202 (5%)
Query: 767 KLLGMGSFGSVY--KGVLPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKI 822
           K +G G+F  V   + +L  G E+A ++         SL+    E ++M  + H N+VK+
Sbjct: 20  KTIGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
                      LV+EY S G +   L +     +   R K    + SA++Y H  +   I
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---I 134
Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVS-R 941
           VH D+K  N+LL+  M   ++DFG +        + +    G+  Y APE  +  K    
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDE--FCGSPPYAAPELFQGKKYDGP 192
Query: 942 KCDVYSYGIMLMETFTKKKPTD 963
           + DV+S G++L    +   P D
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFD 214

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 52/222 (23%), Positives = 101/222 (45%), Gaps = 20/222 (9%)
Query: 769 LGMGSFGSVYKG----VLPDGMEIAAKVFHMEFDGSLES---FHAECKVMGSIRHRNLVK 821
           LG GSFG VY+G    ++    E    V  +    SL     F  E  VM      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLD---------ILQRLKIMIDVASALE 872
           ++   S      +V+E M++G L+  L S     +         + + +++  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT-KTLGTIGYMAP 931
           YL+   +   VH D+   N ++       + DFG+ + + + +  R+  K L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 932 EYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
           E  ++G  +   D++S+G++L E  +  +   +  + E  LK
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 52/222 (23%), Positives = 101/222 (45%), Gaps = 20/222 (9%)
Query: 769 LGMGSFGSVYKG----VLPDGMEIAAKVFHMEFDGSLES---FHAECKVMGSIRHRNLVK 821
           LG GSFG VY+G    ++    E    V  +    SL     F  E  VM      ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLD---------ILQRLKIMIDVASALE 872
           ++   S      +V+E M++G L+  L S     +         + + +++  ++A  + 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT-KTLGTIGYMAP 931
           YL+   +   VH D+   N ++       + DFG+ + + + +  R+  K L  + +MAP
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 932 EYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
           E  ++G  +   D++S+G++L E  +  +   +  + E  LK
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 242

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 34/210 (16%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA--KVFHMEFDGSLESFHAECKVMGSIRHRNLV 820
           +++ K++G GSFG VY+  L D  E+ A  KV     D   ++   E ++M  + H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNIV 76
Query: 821 KI----ISSCSNND--FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI------MIDVA 868
           ++     SS    D  +  LVL+Y+     E       ++    Q L +      M  + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 869 SALEYLH-FGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKTLGTI 926
            +L Y+H FG    I H DIKP N+LL+ ++ V  L DFG AK L + E       + + 
Sbjct: 133 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSR 186
Query: 927 GYMAPE--YGREGKVSRKCDVYSYGIMLME 954
            Y APE  +G     S   DV+S G +L E
Sbjct: 187 YYRAPELIFGATDYTS-SIDVWSAGCVLAE 215

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVY-KGVLPDGMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V     +  G   A K+   +    L+       E +++ ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY+  G +   L     F +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 213
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 214 KGYNKAVDWWALGVLIYE 231

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVY-KGVLPDGMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V     +  G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY+  G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVY-KGVLPDGMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V     +  G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY+  G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 89/202 (44%), Gaps = 12/202 (5%)
Query: 767 KLLGMGSFGSVY--KGVLPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKI 822
           K +G G+F  V   + +L  G E+A K+         SL+    E ++M  + H N+VK+
Sbjct: 20  KTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
                      LV+EY S G +   L +     +   R K    + SA++Y H  +   I
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---I 134
Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVS-R 941
           VH D+K  N+LL+  M   ++DFG +        +      G   Y APE  +  K    
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL--DAFCGAPPYAAPELFQGKKYDGP 192
Query: 942 KCDVYSYGIMLMETFTKKKPTD 963
           + DV+S G++L    +   P D
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFD 214

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 56/218 (25%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 753 YQDLLRATDGFSENKLLGMGSFGSVYKGVL--PDGMEIAAKVFHMEFDGSLESFHAECKV 810
           +++ ++ TDG+   + +G+GS+ SV K  +      E A K+     D S      E ++
Sbjct: 14  HRNSIQFTDGYEVKEDIGVGSY-SVCKRCIHKATNXEFAVKII----DKSKRDPTEEIEI 68
Query: 811 MGSI-RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVAS 869
           +    +H N++ +     +  +  +V E    G L   +    +F +  +   ++  +  
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSE-REASAVLFTITK 127
Query: 870 ALEYLHFGYSTPIVHCDIKPSNVL-LNESMVGH-----LSDFGIAKILGKEESMRQTKTL 923
            +EYLH   +  +VH D+KPSN+L ++ES  G+     + DFG AK L  E  +  T   
Sbjct: 128 TVEYLH---AQGVVHRDLKPSNILYVDES--GNPESIRICDFGFAKQLRAENGLLXTPCY 182
Query: 924 GTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
            T  ++APE          CD++S G++L    T   P
Sbjct: 183 -TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVY-KGVLPDGMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V     +  G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY++ G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 94/209 (44%), Gaps = 32/209 (15%)
Query: 760 TDGFSENKLLGMGSFGSVY--KGVLPDGMEIAAKVFHMEFDGSLESFHA---ECKVMGSI 814
           +D +   K LG G++G V   K  L  G E A K+       +  +  A   E  V+  +
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK--------IMID 866
            H N++K+     +     LV+E    G L         F +I+ R K        IM  
Sbjct: 62  DHPNIMKLYEFFEDKRNYYLVMEVYRGGEL---------FDEIILRQKFSEVDAAVIMKQ 112
Query: 867 VASALEYLHFGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKILGKEESMRQTKTL 923
           V S   YLH      IVH D+KP N+LL   +   +  + DFG++     E   +  + L
Sbjct: 113 VLSGTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGKMKERL 167
Query: 924 GTIGYMAPEYGREGKVSRKCDVYSYGIML 952
           GT  Y+APE  R+ K   KCDV+S G++L
Sbjct: 168 GTAYYIAPEVLRK-KYDEKCDVWSCGVIL 195

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V      + G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY++ G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 9/155 (5%)
Query: 807 ECKVMGSIRHRNLVKIISSCSNNDFKAL--VLEYMSNGSLEKCLYSDNYFLDILQRLKIM 864
           E  ++ ++ H +++K    C +   K+L  V+EY+  GSL    Y   + + + Q L   
Sbjct: 66  EIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRD--YLPRHSIGLAQLLLFA 123
Query: 865 IDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLG 924
             +   + YLH   S   +H ++   NVLL+   +  + DFG+AK + +     + +  G
Sbjct: 124 QQICEGMAYLH---SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 180
Query: 925 T--IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
              + + APE  +E K     DV+S+G+ L E  T
Sbjct: 181 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 112/252 (44%), Gaps = 14/252 (5%)
Query: 761  DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGSIRHR 817
            + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  + H 
Sbjct: 10   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 818  NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
            N+VK++      +   LV E++    L+K  + D   L  +    I   +   L+ L F 
Sbjct: 70   NIVKLLDVIHTENKLYLVFEFLHQ-DLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 878  YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG 937
            +S  ++H D+KP N+L+N      L+DFG+A+  G       T  + T+ Y APE     
Sbjct: 127  HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGX 185
Query: 938  K-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEVAD-- 990
            K  S   D++S G +  E  T++   P D        + R +G  D ++   +T + D  
Sbjct: 186  KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 245
Query: 991  ANLLNCEENDFS 1002
             +       DFS
Sbjct: 246  PSFPKWARQDFS 257

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V      + G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY++ G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V      + G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY++ G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 763 FSENKLLGMGSFGSVYKGVL----PDGMEIAAKVFHME-FDGSLESFHA--ECKVMGSIR 815
           F   KLLG G+FG V   +L      G   A K+   E      E  H   E +V+ + R
Sbjct: 10  FEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 66
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
           H  L  +  S   +D    V+EY + G L   L  +  F +   R     ++ SAL+YLH
Sbjct: 67  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH 125
Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
                 +V+ D+K  N++L++     ++DFG+ K  G ++        GT  Y+APE   
Sbjct: 126 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYLAPEVLE 182
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           +    R  D +  G+++ E    + P
Sbjct: 183 DNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 763 FSENKLLGMGSFGSVYKGVL----PDGMEIAAKVFHME-FDGSLESFHA--ECKVMGSIR 815
           F   KLLG G+FG V   +L      G   A K+   E      E  H   E +V+ + R
Sbjct: 11  FEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 67
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
           H  L  +  S   +D    V+EY + G L   L  +  F +   R     ++ SAL+YLH
Sbjct: 68  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH 126
Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
                 +V+ D+K  N++L++     ++DFG+ K  G ++        GT  Y+APE   
Sbjct: 127 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYLAPEVLE 183
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           +    R  D +  G+++ E    + P
Sbjct: 184 DNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 763 FSENKLLGMGSFGSVYKGVL----PDGMEIAAKVFHME-FDGSLESFHA--ECKVMGSIR 815
           F   KLLG G+FG V   +L      G   A K+   E      E  H   E +V+ + R
Sbjct: 12  FEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 68
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
           H  L  +  S   +D    V+EY + G L   L  +  F +   R     ++ SAL+YLH
Sbjct: 69  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH 127
Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
                 +V+ D+K  N++L++     ++DFG+ K  G ++        GT  Y+APE   
Sbjct: 128 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYLAPEVLE 184
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           +    R  D +  G+++ E    + P
Sbjct: 185 DNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 105/400 (26%), Positives = 166/400 (41%), Gaps = 99/400 (24%)
Query: 165 IGYLSLLQELDLSDNQLSGTIP--------------SSIFNISSCQNLPVLEGLFISYNQ 210
           + YL+ L +++ S+NQL+   P              + I +I+   NL  L GL +  NQ
Sbjct: 59  VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQ 118
Query: 211 LTGPIP-TNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGN 269
           +T   P  NL     L + S   +         +  LTS++ L   +N +    P  + N
Sbjct: 119 ITDIDPLKNLTNLNRLELSSNTISDISA-----LSGLTSLQQLSFSSNQVTDLKP--LAN 171
Query: 270 LRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGE 329
           L  LE L + S+ ++ +  + +  ++ L+ L  T+N +    P  I   L NL+ L L  
Sbjct: 172 LTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITPLGI---LTNLDELSLNG 226
Query: 330 NNFS--GTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDL 387
           N     GT+ +SLTN+++L   D   N  S L P     L  L  L L  N +++ +P  
Sbjct: 227 NQLKDIGTL-ASLTNLTDL---DLANNQISNLAP--LSGLTKLTELKLGANQISNISP-- 278
Query: 388 SFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINN 447
             L+ LT+  NLE   L+EN +  I P                           + N+ N
Sbjct: 279 --LAGLTALTNLE---LNENQLEDISP---------------------------ISNLKN 306
Query: 448 LTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLS 507
           LT + L  N ++   PV+   L KLQ L+  NNK+                         
Sbjct: 307 LTYLTLYFNNISDISPVS--SLTKLQRLFFSNNKVSDV---------------------- 342
Query: 508 GRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRF 547
               + L NLT++  LS G N ++ + P  L NL  I + 
Sbjct: 343 ----SSLANLTNINWLSAGHNQISDLTP--LANLTRITQL 376

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 95/235 (40%), Gaps = 36/235 (15%)
Query: 445 INNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDN 504
           +NNLT I   NN+LT   P  L  L KL  + + NN++    P  L +L  L  L L +N
Sbjct: 62  LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNN 117
Query: 505 KLSGRLP--------------------ACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDI 544
           +++   P                    + L  LTSL+ LS  SN +T + P  L NL  +
Sbjct: 118 QITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFSSNQVTDLKP--LANLTTL 175
Query: 545 LRFXXXXXXXXXXXX-PDIGNLKVVIEMDLSLNALSGVIPVTIXXXXXXXXXXXRYNRLQ 603
            R                + NL+ +I  +   N +S + P+ I              +  
Sbjct: 176 ERLDISSNKVSDISVLAKLTNLESLIATN---NQISDITPLGILTNLDELSLNGNQLKDI 232
Query: 604 GPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRG 658
           G    +   L +L  +D++NN +S   P  +  L+ L  L L  NQ+    P  G
Sbjct: 233 G----TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAG 281

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVY-KGVLPDGMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K +G GSFG V     +  G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EYM  G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVY-KGVLPDGMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K +G GSFG V     +  G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EYM  G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V      + G   A K+   +    L+       E +++ ++  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY++ G +   L     F +   R      +    EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 179
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 233
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 234 KGYNKAVDWWALGVLIYE 251

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 12/202 (5%)
Query: 767 KLLGMGSFGSVY--KGVLPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKI 822
           K +G G+F  V   + +L  G E+A ++         SL+    E ++M  + H N+VK+
Sbjct: 20  KTIGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
                      LV+EY S G +   L +     +   R K    + SA++Y H  +   I
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---I 134
Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVS-R 941
           VH D+K  N+LL+  M   ++DFG +        +      G+  Y APE  +  K    
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL--DTFCGSPPYAAPELFQGKKYDGP 192
Query: 942 KCDVYSYGIMLMETFTKKKPTD 963
           + DV+S G++L    +   P D
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFD 214

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V      + G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY++ G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 767 KLLGMGSFGSVY--KGVLPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKI 822
           K +G G+F  V   + +L  G E+A K+         SL+    E ++M  + H N+VK+
Sbjct: 18  KTIGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 76
Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
                      L++EY S G +   L +     +   R K    + SA++Y H      I
Sbjct: 77  FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKRI 132
Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAK---ILGKEESMRQTKTLGTIGYMAPEYGREGKV 939
           VH D+K  N+LL+  M   ++DFG +    + GK ++       G+  Y APE  +  K 
Sbjct: 133 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTF-----CGSPPYAAPELFQGKKY 187
Query: 940 SR-KCDVYSYGIMLMETFTKKKPTD 963
              + DV+S G++L    +   P D
Sbjct: 188 DGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 17/178 (9%)
Query: 758 RATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSI-- 814
           R T  F E + +G G FGSV+K V   DG   A K       GS++  +A  +V      
Sbjct: 4   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 63
Query: 815 -RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNY----FLDILQRLKIMIDVAS 869
            +H ++V+  S+ + +D   +  EY + GSL   + S+NY    +    +   +++ V  
Sbjct: 64  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVGR 122
Query: 870 ALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIG 927
            L Y+H   S  +VH DIKPSN+ ++ + +        A   G E+     K +  IG
Sbjct: 123 GLRYIH---SMSLVHMDIKPSNIFISRTSIP-----NAASEEGDEDDWASNKVMFKIG 172

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 28/211 (13%)
Query: 761 DGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHM-EFDGS----LESFHAECKVMGSI 814
           D +   +++G G+F  V + +    G + A K+  + +F  S     E    E  +   +
Sbjct: 24  DVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASA---- 870
           +H ++V+++ + S++    +V E+M    L  C        +I++R       + A    
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADL--CF-------EIVKRADAGFVYSEAVASH 134
Query: 871 -----LEYLHFGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKILGKEESMRQTKT 922
                LE L + +   I+H D+KP NVLL     S    L DFG+A  LG E  +     
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG-ESGLVAGGR 193
Query: 923 LGTIGYMAPEYGREGKVSRKCDVYSYGIMLM 953
           +GT  +MAPE  +     +  DV+  G++L 
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVILF 224

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 28/221 (12%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAK----VFHMEFDGSLESFH----AECKVMG 812
           D     K LG G+FG V +     G++  A        M  +G+  S H    +E K++ 
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADA-FGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILI 87
Query: 813 SIRHR-NLVKIISSCSNNDFKALVL-EYMSNGSLEKCLYS-----------DNY--FLDI 857
            I H  N+V ++ +C+      +V+ E+   G+L   L S           D Y  FL +
Sbjct: 88  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTL 147
Query: 858 LQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ES 916
              +     VA  +E+L    S   +H D+   N+LL+E  V  + DFG+A+ + K+ + 
Sbjct: 148 EHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           +R+      + +MAPE   +   + + DV+S+G++L E F+
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVY-KGVLPDGMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V     +  G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY+  G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 8/199 (4%)
Query: 767 KLLGMGSFGSVY-KGVLPDGMEIAAKVFHME-FDGSLESFHA--ECKVMGSIRHRNLVKI 822
           KLLG G+FG V        G   A K+   E      E  H   E +V+ + RH  L  +
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
             S   +D    V+EY + G L   L  +  F +   R     ++ SAL+YLH      +
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH--SEKNV 270
Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRK 942
           V+ D+K  N++L++     ++DFG+ K   K+ +  +T   GT  Y+APE   +    R 
Sbjct: 271 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRA 329
Query: 943 CDVYSYGIMLMETFTKKKP 961
            D +  G+++ E    + P
Sbjct: 330 VDWWGLGVVMYEMMCGRLP 348

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 112/252 (44%), Gaps = 14/252 (5%)
Query: 761  DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGSIRHR 817
            + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  + H 
Sbjct: 10   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 818  NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
            N+VK++      +   LV E++    L+K  + D   L  +    I   +   L+ L F 
Sbjct: 70   NIVKLLDVIHTENKLYLVFEFLHQ-DLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 878  YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG 937
            +S  ++H D+KP N+L+N      L+DFG+A+  G       T  + T+ Y APE     
Sbjct: 127  HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGC 185
Query: 938  K-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEVAD-- 990
            K  S   D++S G +  E  T++   P D        + R +G  D ++   +T + D  
Sbjct: 186  KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 245
Query: 991  ANLLNCEENDFS 1002
             +       DFS
Sbjct: 246  PSFPKWARQDFS 257

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 113/252 (44%), Gaps = 14/252 (5%)
Query: 761  DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGSIRHR 817
            + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  + H 
Sbjct: 2    ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 818  NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
            N+VK++      +   LV E++ +  L+K  + D   L  +    I   +   L+ L F 
Sbjct: 62   NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 878  YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG 937
            +S  ++H D+KP N+L+N      L+DFG+A+  G       T  + T+ Y APE     
Sbjct: 119  HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGC 177
Query: 938  K-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEVAD-- 990
            K  S   D++S G +  E  T++   P D        + R +G  D ++   +T + D  
Sbjct: 178  KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 991  ANLLNCEENDFS 1002
             +       DFS
Sbjct: 238  PSFPKWARQDFS 249

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 17/178 (9%)
Query: 758 RATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSI-- 814
           R T  F E + +G G FGSV+K V   DG   A K       GS++  +A  +V      
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 65
Query: 815 -RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNY----FLDILQRLKIMIDVAS 869
            +H ++V+  S+ + +D   +  EY + GSL   + S+NY    +    +   +++ V  
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVGR 124
Query: 870 ALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIG 927
            L Y+H   S  +VH DIKPSN+ ++ + +        A   G E+     K +  IG
Sbjct: 125 GLRYIH---SMSLVHMDIKPSNIFISRTSIP-----NAASEEGDEDDWASNKVMFKIG 174

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVY-KGVLPDGMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V     +  G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY+  G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 17/178 (9%)
Query: 758 RATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSI-- 814
           R T  F E + +G G FGSV+K V   DG   A K       GS++  +A  +V      
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 65
Query: 815 -RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNY----FLDILQRLKIMIDVAS 869
            +H ++V+  S+ + +D   +  EY + GSL   + S+NY    +    +   +++ V  
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVGR 124
Query: 870 ALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIG 927
            L Y+H   S  +VH DIKPSN+ ++ + +        A   G E+     K +  IG
Sbjct: 125 GLRYIH---SMSLVHMDIKPSNIFISRTSIP-----NAASEEGDEDDWASNKVMFKIG 174

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 767 KLLGMGSFGSVYKG----VLPDGMEIAAKVFHMEFDGSLES---FHAECKVMGSIRHRNL 819
           + LG GSFG VY+G    ++    E    V  +    SL     F  E  VM      ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLD---------ILQRLKIMIDVASA 870
           V+++   S      +V+E M++G L+  L S     +         + + +++  ++A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT-KTLGTIGYM 929
           + YL+   +   VH ++   N ++       + DFG+ + + + +  R+  K L  + +M
Sbjct: 143 MAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 199
Query: 930 APEYGREGKVSRKCDVYSYGIMLME 954
           APE  ++G  +   D++S+G++L E
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWE 224

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 8/199 (4%)
Query: 767 KLLGMGSFGSVY-KGVLPDGMEIAAKVFHME-FDGSLESFHA--ECKVMGSIRHRNLVKI 822
           KLLG G+FG V        G   A K+   E      E  H   E +V+ + RH  L  +
Sbjct: 157 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 216
Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
             S   +D    V+EY + G L   L  +  F +   R     ++ SAL+YLH      +
Sbjct: 217 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH--SEKNV 273
Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRK 942
           V+ D+K  N++L++     ++DFG+ K   K+ +  +T   GT  Y+APE   +    R 
Sbjct: 274 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRA 332
Query: 943 CDVYSYGIMLMETFTKKKP 961
            D +  G+++ E    + P
Sbjct: 333 VDWWGLGVVMYEMMCGRLP 351

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V      + G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY++ G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLXGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 113/252 (44%), Gaps = 14/252 (5%)
Query: 761  DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGSIRHR 817
            + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  + H 
Sbjct: 3    ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 818  NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
            N+VK++      +   LV E++ +  L+K  + D   L  +    I   +   L+ L F 
Sbjct: 63   NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 878  YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG 937
            +S  ++H D+KP N+L+N      L+DFG+A+  G       T  + T+ Y APE     
Sbjct: 120  HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGC 178
Query: 938  K-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEVAD-- 990
            K  S   D++S G +  E  T++   P D        + R +G  D ++   +T + D  
Sbjct: 179  KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 991  ANLLNCEENDFS 1002
             +       DFS
Sbjct: 239  PSFPKWARQDFS 250

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVY-KGVLPDGMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V     +  G   A K+   +    L+       E +++ ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY+  G +   L     F +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 213
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 214 KGYNKAVDWWALGVLIYE 231

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 767 KLLGMGSFGSVYKG----VLPDGMEIAAKVFHMEFDGSLES---FHAECKVMGSIRHRNL 819
           + LG GSFG VY+G    ++    E    V  +    SL     F  E  VM      ++
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 83
Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLD---------ILQRLKIMIDVASA 870
           V+++   S      +V+E M++G L+  L S     +         + + +++  ++A  
Sbjct: 84  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT-KTLGTIGYM 929
           + YL+   +   VH ++   N ++       + DFG+ + + + +  R+  K L  + +M
Sbjct: 144 MAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 200
Query: 930 APEYGREGKVSRKCDVYSYGIMLME 954
           APE  ++G  +   D++S+G++L E
Sbjct: 201 APESLKDGVFTTSSDMWSFGVVLWE 225

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 84/178 (47%), Gaps = 17/178 (9%)
Query: 758 RATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSI-- 814
           R T  F E + +G G FGSV+K V   DG   A K       GS++  +A  +V      
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 815 -RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNY----FLDILQRLKIMIDVAS 869
            +H ++V+  S+ + +D   +  EY + GSL   + S+NY    +    +   +++ V  
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVGR 126
Query: 870 ALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIG 927
            L Y+H   S  +VH DIKPSN+ ++ + + +      A   G E+     K +  IG
Sbjct: 127 GLRYIH---SMSLVHMDIKPSNIFISRTSIPN-----AASEEGDEDDWASNKVMFKIG 176

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 96/230 (41%), Gaps = 57/230 (24%)
Query: 767 KLLGMGSFGSVYKG----------VLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-R 815
           K LG G+FG V +           VL   +++     H +     E+  +E K+M  + +
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD---EKEALMSELKIMSHLGQ 108
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY-- 873
           H N+V ++ +C++     ++ EY        C Y D   L+ L+R +        LEY  
Sbjct: 109 HENIVNLLGACTHGGPVLVITEY--------CCYGD--LLNFLRRKR-----PPGLEYSY 153
Query: 874 ---------------LHFG----------YSTPIVHCDIKPSNVLLNESMVGHLSDFGIA 908
                          LHF            S   +H D+   NVLL    V  + DFG+A
Sbjct: 154 NPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 213
Query: 909 K-ILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           + I+     + +      + +MAPE   +   + + DV+SYGI+L E F+
Sbjct: 214 RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 52/222 (23%), Positives = 100/222 (45%), Gaps = 20/222 (9%)
Query: 769 LGMGSFGSVYKG----VLPDGMEIAAKVFHMEFDGSLES---FHAECKVMGSIRHRNLVK 821
           LG GSFG VY+G    ++    E    V  +    SL     F  E  VM      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLD---------ILQRLKIMIDVASALE 872
           ++   S      +V+E M++G L+  L S     +         + + +++  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT-KTLGTIGYMAP 931
           YL+   +   VH D+   N ++       + DFG+ + + +    R+  K L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 932 EYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
           E  ++G  +   D++S+G++L E  +  +   +  + E  LK
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 113/252 (44%), Gaps = 14/252 (5%)
Query: 761  DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGSIRHR 817
            + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  + H 
Sbjct: 3    ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 818  NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
            N+VK++      +   LV E++ +  L+K  + D   L  +    I   +   L+ L F 
Sbjct: 63   NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 878  YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG 937
            +S  ++H D+KP N+L+N      L+DFG+A+  G       T  + T+ Y APE     
Sbjct: 120  HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGC 178
Query: 938  K-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEVAD-- 990
            K  S   D++S G +  E  T++   P D        + R +G  D ++   +T + D  
Sbjct: 179  KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 991  ANLLNCEENDFS 1002
             +       DFS
Sbjct: 239  PSFPKWARQDFS 250

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 112/252 (44%), Gaps = 14/252 (5%)
Query: 761  DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGSIRHR 817
            + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  + H 
Sbjct: 3    ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 818  NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
            N+VK++      +   LV E++    L+K  + D   L  +    I   +   L+ L F 
Sbjct: 63   NIVKLLDVIHTENKLYLVFEFLHQ-DLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 878  YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG 937
            +S  ++H D+KP N+L+N      L+DFG+A+  G       T  + T+ Y APE     
Sbjct: 120  HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGC 178
Query: 938  K-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEVAD-- 990
            K  S   D++S G +  E  T++   P D        + R +G  D ++   +T + D  
Sbjct: 179  KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 991  ANLLNCEENDFS 1002
             +       DFS
Sbjct: 239  PSFPKWARQDFS 250

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 113/252 (44%), Gaps = 14/252 (5%)
Query: 761  DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGSIRHR 817
            + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  + H 
Sbjct: 2    ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 818  NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
            N+VK++      +   LV E++ +  L+K  + D   L  +    I   +   L+ L F 
Sbjct: 62   NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 878  YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG 937
            +S  ++H D+KP N+L+N      L+DFG+A+  G       T  + T+ Y APE     
Sbjct: 119  HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGC 177
Query: 938  K-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEVAD-- 990
            K  S   D++S G +  E  T++   P D        + R +G  D ++   +T + D  
Sbjct: 178  KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 991  ANLLNCEENDFS 1002
             +       DFS
Sbjct: 238  PSFPKWARQDFS 249

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V      + G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY++ G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLAGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 115/256 (44%), Gaps = 14/256 (5%)
Query: 757  LRATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGS 813
            L + + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  
Sbjct: 2    LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 814  IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
            + H N+VK++      +   LV E++S   L+K  + D   L  +    I   +   L+ 
Sbjct: 62   LNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKK--FMDASALTGIPLPLIKSYLFQLLQG 118
Query: 874  LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
            L F +S  ++H D+KP N+L+N      L+DFG+A+  G        + + T+ Y APE 
Sbjct: 119  LAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEI 177
Query: 934  GREGK-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEV 988
                K  S   D++S G +  E  T++   P D        + R +G  D ++   +T +
Sbjct: 178  LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 989  AD--ANLLNCEENDFS 1002
             D   +       DFS
Sbjct: 238  PDYKPSFPKWARQDFS 253

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 107/230 (46%), Gaps = 33/230 (14%)
Query: 762 GFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVK 821
            ++  K++G GSFG V++  L +  E+A K      D   ++   E ++M  ++H N+V 
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ--DKRFKN--RELQIMRIVKHPNVVD 96
Query: 822 IIS-SCSNND-----FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI------MIDVAS 869
           + +   SN D     F  LVLEY+     E    +  ++  + Q + +      M  +  
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 870 ALEYLHFGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKTLGTIGY 928
           +L Y+H   S  I H DIKP N+LL+  S V  L DFG AKIL   E       + +  Y
Sbjct: 153 SLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP--NVSXICSRYY 207
Query: 929 MAPE--YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWV 976
            APE  +G     +   D++S G ++ E    +     +F GE  + + V
Sbjct: 208 RAPELIFGATNYTT-NIDIWSTGCVMAELMQGQP----LFPGESGIDQLV 252

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 44/217 (20%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI--RHRNLVKIIS 824
           + +G G +G V++G L  G  +A K+F    +   +S+  E ++  ++  RH N++  I+
Sbjct: 14  ECVGKGRYGEVWRG-LWHGESVAVKIFSSRDE---QSWFRETEIYNTVLLRHDNILGFIA 69
Query: 825 S--CSNNDFKALVL--EYMSNGSLEKCLYSDNYFLDILQR--------LKIMIDVASALE 872
           S   S N    L L   Y  +GSL           D LQR        L++ +  A  L 
Sbjct: 70  SDMTSRNSSTQLWLITHYHEHGSL----------YDFLQRQTLEPHLALRLAVSAACGLA 119
Query: 873 YLH---FGYS--TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE---SMRQTKTLG 924
           +LH   FG      I H D K  NVL+  ++   ++D G+A +  +      +     +G
Sbjct: 120 HLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVG 179
Query: 925 TIGYMAPEYGREGKVSRKC-------DVYSYGIMLME 954
           T  YMAPE   E ++   C       D++++G++L E
Sbjct: 180 TKRYMAPEVLDE-QIRTDCFESYKWTDIWAFGLVLWE 215

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 8/202 (3%)
Query: 767 KLLGMGSFGSVYKGVLPDGME-IAAKVFHMEFDGSL-ESFHAECKVMGSIRHRNLVKIIS 824
           + LG G+ G V   V     E +A K+  M+      E+   E  +   + H N+VK   
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                + + L LEY S G L   +  D    +   + +    + + + YLH      I H
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLH---GIGITH 127
Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKV-SRK 942
            DIKP N+LL+E     +SDFG+A +       R   K  GT+ Y+APE  +  +  +  
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 943 CDVYSYGIMLMETFTKKKPTDE 964
            DV+S GI+L      + P D+
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 36/211 (17%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA--KVFHMEFDGSLESF-HAECKVMGSIRHRNL 819
           +++ K++G GSFG VY+  L D  E+ A  KV         ++F + E ++M  + H N+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG------KAFKNRELQIMRKLDHCNI 75
Query: 820 VKI----ISSCSNND--FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI------MIDV 867
           V++     SS    D  +  LVL+Y+     E       ++    Q L +      M  +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 868 ASALEYLH-FGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKTLGT 925
             +L Y+H FG    I H DIKP N+LL+ ++ V  L DFG AK L + E       + +
Sbjct: 132 FRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICS 185
Query: 926 IGYMAPE--YGREGKVSRKCDVYSYGIMLME 954
             Y APE  +G     S   DV+S G +L E
Sbjct: 186 RYYRAPELIFGATDYTS-SIDVWSAGCVLAE 215

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVY-KGVLPDGMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V     +  G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY+  G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 767 KLLGMGSFGSVY--KGVLPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKI 822
           K +G G+F  V   + +L  G E+A K+         SL+    E ++M  + H N+VK+
Sbjct: 21  KTIGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
                      L++EY S G +   L +     +   R K    + SA++Y H      I
Sbjct: 80  FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKRI 135
Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAK---ILGKEESMRQTKTLGTIGYMAPEYGREGKV 939
           VH D+K  N+LL+  M   ++DFG +    + GK ++       G   Y APE  +  K 
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF-----CGAPPYAAPELFQGKKY 190
Query: 940 SR-KCDVYSYGIMLMETFTKKKPTD 963
              + DV+S G++L    +   P D
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V      + G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY++ G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVY-KGVLPDGMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V     +  G   A K+   +    L+       E +++ ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY+  G +   L     F +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWTLCGTPEYLAPEIILS 213
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 214 KGYNKAVDWWALGVLIYE 231

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 113/252 (44%), Gaps = 14/252 (5%)
Query: 761  DGFSENKLLGMGSFGSVYKGVLPDGMEIAA--KV-FHMEFDGSLESFHAECKVMGSIRHR 817
            + F + + +G G++G VYK       E+ A  K+    E +G   +   E  ++  + H 
Sbjct: 3    ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 818  NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
            N+VK++      +   LV E++ +  L+K  + D   L  +    I   +   L+ L F 
Sbjct: 63   NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 878  YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG 937
            +S  ++H D+KP N+L+N      L+DFG+A+  G       T  + T+ Y APE     
Sbjct: 120  HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGC 178
Query: 938  K-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEVAD-- 990
            K  S   D++S G +  E  T++   P D        + R +G  D ++   +T + D  
Sbjct: 179  KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 991  ANLLNCEENDFS 1002
             +       DFS
Sbjct: 239  PSFPKWARQDFS 250

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 113/252 (44%), Gaps = 14/252 (5%)
Query: 761  DGFSENKLLGMGSFGSVYKGVLPDGMEIAA--KV-FHMEFDGSLESFHAECKVMGSIRHR 817
            + F + + +G G++G VYK       E+ A  K+    E +G   +   E  ++  + H 
Sbjct: 2    ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 818  NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
            N+VK++      +   LV E++ +  L+K  + D   L  +    I   +   L+ L F 
Sbjct: 62   NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 878  YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG 937
            +S  ++H D+KP N+L+N      L+DFG+A+  G       T  + T+ Y APE     
Sbjct: 119  HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGC 177
Query: 938  K-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEVAD-- 990
            K  S   D++S G +  E  T++   P D        + R +G  D ++   +T + D  
Sbjct: 178  KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 991  ANLLNCEENDFS 1002
             +       DFS
Sbjct: 238  PSFPKWARQDFS 249

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 113/254 (44%), Gaps = 14/254 (5%)
Query: 759  ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGSIR 815
            + + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  + 
Sbjct: 2    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 816  HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
            H N+VK++      +   LV E++    L+K  + D   L  +    I   +   L+ L 
Sbjct: 62   HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 876  FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
            F +S  ++H D+KP N+L+N      L+DFG+A+  G       T  + T+ Y APE   
Sbjct: 119  FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILL 177
Query: 936  EGK-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEVAD 990
              K  S   D++S G +  E  T++   P D        + R +G  D ++   +T + D
Sbjct: 178  GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 237
Query: 991  --ANLLNCEENDFS 1002
               +       DFS
Sbjct: 238  YKPSFPKWARQDFS 251

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 769 LGMGSFG---SVYKGVLPDGMEIA-AKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
           +G G++G   S Y  V  + + +A  K+   E     +    E K++ + RH N++ I  
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGI-- 88
Query: 825 SCSNNDFKALVLEYMSNGSL-EKCLYSDNYFLDILQRLK------IMIDVASALEYLHFG 877
              N+  +A  +E M +  + +  + +D Y L   Q L        +  +   L+Y+H  
Sbjct: 89  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 143
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ--TKTLGTIGYMAPEYGR 935
            S  ++H D+KPSN+LLN +    + DFG+A++   +       T+ + T  Y APE   
Sbjct: 144 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 936 EGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
             K  ++  D++S G +L E  + +     IF G+  L +
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V      + G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY++ G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V      + G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY++ G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 36/211 (17%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA--KVFHMEFDGSLESF-HAECKVMGSIRHRNL 819
           +++ K++G GSFG VY+  L D  E+ A  KV         ++F + E ++M  + H N+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG------KAFKNRELQIMRKLDHCNI 75
Query: 820 VKI----ISSCSNND--FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKI------MIDV 867
           V++     SS    D  +  LVL+Y+     E       ++    Q L +      M  +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 868 ASALEYLH-FGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKTLGT 925
             +L Y+H FG    I H DIKP N+LL+ ++ V  L DFG AK L + E       + +
Sbjct: 132 FRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICS 185
Query: 926 IGYMAPE--YGREGKVSRKCDVYSYGIMLME 954
             Y APE  +G     S   DV+S G +L E
Sbjct: 186 RYYRAPELIFGATDYTS-SIDVWSAGCVLAE 215

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V      + G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY++ G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V      + G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY++ G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V      + G   A K+   +    L+       E +++ ++  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY++ G +   L     F +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 213
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 214 KGYNKAVDWWALGVLIYE 231

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 105/400 (26%), Positives = 166/400 (41%), Gaps = 99/400 (24%)
Query: 165 IGYLSLLQELDLSDNQLSGTIP--------------SSIFNISSCQNLPVLEGLFISYNQ 210
           + YL+ L +++ S+NQL+   P              + I +I+   NL  L GL +  NQ
Sbjct: 59  VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQ 118
Query: 211 LTGPIP-TNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGN 269
           +T   P  NL     L + S   +         +  LTS++ L   +N +    P  + N
Sbjct: 119 ITDIDPLKNLTNLNRLELSSNTISDISA-----LSGLTSLQQLSFSSNQVTDLKP--LAN 171
Query: 270 LRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGE 329
           L  LE L + S+ ++ +  + +  ++ L+ L  T+N +    P  I   L NL+ L L  
Sbjct: 172 LTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITPLGI---LTNLDELSLNG 226
Query: 330 NNFS--GTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDL 387
           N     GT+ +SLTN+++L   D   N  S L P     L  L  L L  N +++ +P  
Sbjct: 227 NQLKDIGTL-ASLTNLTDL---DLANNQISNLAP--LSGLTKLTELKLGANQISNISP-- 278
Query: 388 SFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINN 447
             L+ LT+  NLE   L+EN +  I P                           + N+ N
Sbjct: 279 --LAGLTALTNLE---LNENQLEDISP---------------------------ISNLKN 306
Query: 448 LTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLS 507
           LT + L  N ++   PV+   L KLQ L+  NNK+                         
Sbjct: 307 LTYLTLYFNNISDISPVS--SLTKLQRLFFYNNKVSDV---------------------- 342
Query: 508 GRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRF 547
               + L NLT++  LS G N ++ + P  L NL  I + 
Sbjct: 343 ----SSLANLTNINWLSAGHNQISDLTP--LANLTRITQL 376

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 95/235 (40%), Gaps = 36/235 (15%)
Query: 445 INNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDN 504
           +NNLT I   NN+LT   P  L  L KL  + + NN++    P  L +L  L  L L +N
Sbjct: 62  LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNN 117
Query: 505 KLSGRLP--------------------ACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDI 544
           +++   P                    + L  LTSL+ LS  SN +T + P  L NL  +
Sbjct: 118 QITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFSSNQVTDLKP--LANLTTL 175
Query: 545 LRFXXXXXXXXXXXX-PDIGNLKVVIEMDLSLNALSGVIPVTIXXXXXXXXXXXRYNRLQ 603
            R                + NL+ +I  +   N +S + P+ I              +  
Sbjct: 176 ERLDISSNKVSDISVLAKLTNLESLIATN---NQISDITPLGILTNLDELSLNGNQLKDI 232
Query: 604 GPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRG 658
           G    +   L +L  +D++NN +S   P  +  L+ L  L L  NQ+    P  G
Sbjct: 233 G----TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAG 281

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V      + G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY+  G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V      + G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY+  G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 114/256 (44%), Gaps = 14/256 (5%)
Query: 757  LRATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGS 813
            L + + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  
Sbjct: 3    LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 814  IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
            + H N+VK++      +   LV E++    L+K  + D   L  +    I   +   L+ 
Sbjct: 63   LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKK--FMDASALTGIPLPLIKSYLFQLLQG 119
Query: 874  LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
            L F +S  ++H D+KP N+L+N      L+DFG+A+  G        + + T+ Y APE 
Sbjct: 120  LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEI 178
Query: 934  GREGK-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEV 988
                K  S   D++S G +  E  T++   P D        + R +G  D ++   +T +
Sbjct: 179  LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 238
Query: 989  AD--ANLLNCEENDFS 1002
             D   +       DFS
Sbjct: 239  PDYKPSFPKWARQDFS 254

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 102/242 (42%), Gaps = 11/242 (4%)
Query: 768  LLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKII 823
             LG G F   ++    D  E+ A K+            E    E  +  S+ H+++V   
Sbjct: 28   FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 824  SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIV 883
                +NDF  +VLE     SL + L+     L   +    +  +    +YLH      ++
Sbjct: 88   GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 143
Query: 884  HCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGYMAPEYGREGKVSRK 942
            H D+K  N+ LNE +   + DFG+A  +  E    + KTL GT  Y+APE   +   S +
Sbjct: 144  HRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKTLCGTPNYIAPEVLSKKGHSFE 201
Query: 943  CDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFS 1002
             DV+S G ++      K P +     E  L+    +  +   I  VA + +    + D +
Sbjct: 202  VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPT 261
Query: 1003 AR 1004
            AR
Sbjct: 262  AR 263

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 34/105 (32%), Positives = 53/105 (50%), Gaps = 14/105 (13%)
Query: 861 LKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT 920
           L I I +A A+E+LH   S  ++H D+KPSN+      V  + DFG+   + ++E  +  
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 921 KT-----------LGTIGYMAPEYGREGKVSRKCDVYSYGIMLME 954
            T           +GT  YM+PE       S K D++S G++L E
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 769 LGMGSFG---SVYKGVLPDGMEIA-AKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
           +G G++G   S Y  V  + + +A  K+   E     +    E K++   RH N++ I  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-- 86
Query: 825 SCSNNDFKALVLEYMSNGSL-EKCLYSDNYFLDILQRLK------IMIDVASALEYLHFG 877
              N+  +A  +E M +  + +  + +D Y L   Q L        +  +   L+Y+H  
Sbjct: 87  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 141
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ--TKTLGTIGYMAPEYGR 935
            S  ++H D+KPSN+LLN +    + DFG+A++   +       T+ + T  Y APE   
Sbjct: 142 -SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 936 EGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
             K  ++  D++S G +L E  + +     IF G+  L +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 236

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 758 RATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSI 814
           R T+ +   + LG G+F  V + V +  G E AA + + +   +   +    E ++   +
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           +H N+V++  S S      L+ + ++ G L + + +  Y+ +      I   + + L   
Sbjct: 68  KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 127
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVG---HLSDFGIA-KILGKEESMRQTKTLGTIGYMA 930
             G    +VH ++KP N+LL   + G    L+DFG+A ++ G++++       GT GY++
Sbjct: 128 QMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW--FGFAGTPGYLS 181
Query: 931 PEYGREGKVSRKCDVYSYGIML 952
           PE  R+    +  D+++ G++L
Sbjct: 182 PEVLRKDPYGKPVDLWACGVIL 203

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 28/207 (13%)
Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA--KVFHMEFDGSLESF-HAECKVMGSIRHRNL 819
           +++ K++G GSFG VY+  L D  E+ A  KV         ++F + E ++M  + H N+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG------KAFKNRELQIMRKLDHCNI 75
Query: 820 VKI----ISSCSNND--FKALVLEYMSNG--SLEKCLYSDNYFLDILQRLKIMIDVASAL 871
           V++     SS    D  +  LVL+Y+      + +        L ++     M  +  +L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 872 EYLH-FGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYM 929
            Y+H FG    I H DIKP N+LL+ ++ V  L DFG AK L + E       + +  Y 
Sbjct: 136 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYYR 189
Query: 930 APE--YGREGKVSRKCDVYSYGIMLME 954
           APE  +G     S   DV+S G +L E
Sbjct: 190 APELIFGATDYTS-SIDVWSAGCVLAE 215

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 769 LGMGSFG---SVYKGVLPDGMEIA-AKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
           +G G++G   S Y  V  + + +A  K+   E     +    E K++ + RH N++ I  
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGI-- 88
Query: 825 SCSNNDFKALVLEYMSNGSL-EKCLYSDNYFLDILQRLK------IMIDVASALEYLHFG 877
              N+  +A  +E M +  + +  + +D Y L   Q L        +  +   L+Y+H  
Sbjct: 89  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 143
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ--TKTLGTIGYMAPEYGR 935
            S  ++H D+KPSN+LLN +    + DFG+A++   +       T+ + T  Y APE   
Sbjct: 144 -SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 936 EGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
             K  ++  D++S G +L E  + +     IF G+  L +
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 238

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 102/242 (42%), Gaps = 11/242 (4%)
Query: 768  LLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKII 823
             LG G F   ++    D  E+ A K+            E    E  +  S+ H+++V   
Sbjct: 24   FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 824  SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIV 883
                +NDF  +VLE     SL + L+     L   +    +  +    +YLH      ++
Sbjct: 84   GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 139
Query: 884  HCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGYMAPEYGREGKVSRK 942
            H D+K  N+ LNE +   + DFG+A  +  E    + KTL GT  Y+APE   +   S +
Sbjct: 140  HRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKTLCGTPNYIAPEVLSKKGHSFE 197
Query: 943  CDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFS 1002
             DV+S G ++      K P +     E  L+    +  +   I  VA + +    + D +
Sbjct: 198  VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPT 257
Query: 1003 AR 1004
            AR
Sbjct: 258  AR 259

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 29/222 (13%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAK----VFHMEFDGSLESFH----AECKVMG 812
           D  +  K LG G+FG V +     G++  A        M  +G+  S H    +E K++ 
Sbjct: 28  DRLNLGKPLGRGAFGQVIEAD-AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 86
Query: 813 SI-RHRNLVKIISSCSNNDFKALVL-EYMSNGSLEKCLYS------------DNY--FLD 856
            I  H N+V ++ +C+      +V+ E+   G+L   L S            D Y  FL 
Sbjct: 87  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLT 146
Query: 857 ILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-E 915
           +   +     VA  +E+L    S   +H D+   N+LL+E  V  + DFG+A+ + K+ +
Sbjct: 147 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 203
Query: 916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
            +R+      + +MAPE   +   + + DV+S+G++L E F+
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 114/256 (44%), Gaps = 14/256 (5%)
Query: 757  LRATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGS 813
            L + + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  
Sbjct: 2    LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 814  IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
            + H N+VK++      +   LV E++S   ++   + D   L  +    I   +   L+ 
Sbjct: 62   LNHPNIVKLLDVIHTENKLYLVFEFLS---MDLKDFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 874  LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
            L F +S  ++H D+KP N+L+N      L+DFG+A+  G        + + T+ Y APE 
Sbjct: 119  LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEI 177
Query: 934  GREGK-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEV 988
                K  S   D++S G +  E  T++   P D        + R +G  D ++   +T +
Sbjct: 178  LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 989  AD--ANLLNCEENDFS 1002
             D   +       DFS
Sbjct: 238  PDYKPSFPKWARQDFS 253

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 102/242 (42%), Gaps = 11/242 (4%)
Query: 768  LLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKII 823
             LG G F   ++    D  E+ A K+            E    E  +  S+ H+++V   
Sbjct: 24   FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 824  SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIV 883
                +NDF  +VLE     SL + L+     L   +    +  +    +YLH      ++
Sbjct: 84   GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 139
Query: 884  HCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGYMAPEYGREGKVSRK 942
            H D+K  N+ LNE +   + DFG+A  +  E    + KTL GT  Y+APE   +   S +
Sbjct: 140  HRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKTLCGTPNYIAPEVLSKKGHSFE 197
Query: 943  CDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFS 1002
             DV+S G ++      K P +     E  L+    +  +   I  VA + +    + D +
Sbjct: 198  VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPT 257
Query: 1003 AR 1004
            AR
Sbjct: 258  AR 259

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V      + G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY+  G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 9/155 (5%)
Query: 807 ECKVMGSIRHRNLVKIISSCSNNDFKAL--VLEYMSNGSLEKCLYSDNYFLDILQRLKIM 864
           E  ++ ++ H +++K    C +   K+L  V+EY+  GSL    Y   + + + Q L   
Sbjct: 66  EIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRD--YLPRHSIGLAQLLLFA 123
Query: 865 IDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLG 924
             +   + YLH   +   +H ++   NVLL+   +  + DFG+AK + +     + +  G
Sbjct: 124 QQICEGMAYLH---AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 180
Query: 925 T--IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
              + + APE  +E K     DV+S+G+ L E  T
Sbjct: 181 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 114/254 (44%), Gaps = 14/254 (5%)
Query: 759  ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGSIR 815
            + + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  + 
Sbjct: 2    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 816  HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
            H N+VK++      +   LV E++S   L+K  + D   L  +    I   +   L+ L 
Sbjct: 62   HPNIVKLLDVIHTENKLYLVFEFLSM-DLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 876  FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
            F +S  ++H D+KP N+L+N      L+DFG+A+  G        + + T+ Y APE   
Sbjct: 119  FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 177
Query: 936  EGK-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEVAD 990
              K  S   D++S G +  E  T++   P D        + R +G  D ++   +T + D
Sbjct: 178  GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 237
Query: 991  --ANLLNCEENDFS 1002
               +       DFS
Sbjct: 238  YKPSFPKWARQDFS 251

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 114/256 (44%), Gaps = 14/256 (5%)
Query: 757  LRATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGS 813
            L + + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  
Sbjct: 2    LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 814  IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
            + H N+VK++      +   LV E++    L+K  + D   L  +    I   +   L+ 
Sbjct: 62   LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKK--FMDASALTGIPLPLIKSYLFQLLQG 118
Query: 874  LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
            L F +S  ++H D+KP N+L+N      L+DFG+A+  G        + + T+ Y APE 
Sbjct: 119  LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEI 177
Query: 934  GREGK-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEV 988
                K  S   D++S G +  E  T++   P D        + R +G  D ++   +T +
Sbjct: 178  LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 989  AD--ANLLNCEENDFS 1002
             D   +       DFS
Sbjct: 238  PDYKPSFPKWARQDFS 253

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 769 LGMGSFG---SVYKGVLPDGMEIA-AKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
           +G G++G   S Y  V  + + +A  K+   E     +    E K++   RH N++ I  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-- 86
Query: 825 SCSNNDFKALVLEYMSNGSL-EKCLYSDNYFLDILQRLK------IMIDVASALEYLHFG 877
              N+  +A  +E M +  + +  + +D Y L   Q L        +  +   L+Y+H  
Sbjct: 87  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 141
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ--TKTLGTIGYMAPEYGR 935
            S  ++H D+KPSN+LLN +    + DFG+A++   +       T+ + T  Y APE   
Sbjct: 142 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 936 EGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
             K  ++  D++S G +L E  + +     IF G+  L +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 236

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 769 LGMGSFG---SVYKGVLPDGMEIA-AKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
           +G G++G   S Y  V  + + +A  K+   E     +    E K++   RH N++ I  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-- 86
Query: 825 SCSNNDFKALVLEYMSNGSL-EKCLYSDNYFLDILQRLK------IMIDVASALEYLHFG 877
              N+  +A  +E M +  + +  + +D Y L   Q L        +  +   L+Y+H  
Sbjct: 87  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 141
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ--TKTLGTIGYMAPEYGR 935
            S  ++H D+KPSN+LLN +    + DFG+A++   +       T+ + T  Y APE   
Sbjct: 142 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 936 EGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
             K  ++  D++S G +L E  + +     IF G+  L +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 236

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 105/400 (26%), Positives = 166/400 (41%), Gaps = 99/400 (24%)
Query: 165 IGYLSLLQELDLSDNQLSGTIP--------------SSIFNISSCQNLPVLEGLFISYNQ 210
           + YL+ L +++ S+NQL+   P              + I +I+   NL  L GL +  NQ
Sbjct: 59  VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQ 118
Query: 211 LTGPIP-TNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGN 269
           +T   P  NL     L + S   +         +  LTS++ L   +N +    P  + N
Sbjct: 119 ITDIDPLKNLTNLNRLELSSNTISDISA-----LSGLTSLQQLNFSSNQVTDLKP--LAN 171
Query: 270 LRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGE 329
           L  LE L + S+ ++ +  + +  ++ L+ L  T+N +    P  I   L NL+ L L  
Sbjct: 172 LTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITPLGI---LTNLDELSLNG 226
Query: 330 NNFS--GTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDL 387
           N     GT+ +SLTN+++L   D   N  S L P     L  L  L L  N +++ +P  
Sbjct: 227 NQLKDIGTL-ASLTNLTDL---DLANNQISNLAP--LSGLTKLTELKLGANQISNISP-- 278
Query: 388 SFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINN 447
             L+ LT+  NLE   L+EN +  I P                           + N+ N
Sbjct: 279 --LAGLTALTNLE---LNENQLEDISP---------------------------ISNLKN 306
Query: 448 LTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLS 507
           LT + L  N ++   PV+   L KLQ L+  NNK+                         
Sbjct: 307 LTYLTLYFNNISDISPVS--SLTKLQRLFFYNNKVSDV---------------------- 342
Query: 508 GRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRF 547
               + L NLT++  LS G N ++ + P  L NL  I + 
Sbjct: 343 ----SSLANLTNINWLSAGHNQISDLTP--LANLTRITQL 376

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 95/235 (40%), Gaps = 36/235 (15%)
Query: 445 INNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDN 504
           +NNLT I   NN+LT   P  L  L KL  + + NN++    P  L +L  L  L L +N
Sbjct: 62  LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNN 117
Query: 505 KLSGRLP--------------------ACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDI 544
           +++   P                    + L  LTSL+ L+  SN +T + P  L NL  +
Sbjct: 118 QITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTL 175
Query: 545 LRFXXXXXXXXXXXX-PDIGNLKVVIEMDLSLNALSGVIPVTIXXXXXXXXXXXRYNRLQ 603
            R                + NL+ +I  +   N +S + P+ I              +  
Sbjct: 176 ERLDISSNKVSDISVLAKLTNLESLIATN---NQISDITPLGILTNLDELSLNGNQLKDI 232
Query: 604 GPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRG 658
           G    +   L +L  +D++NN +S   P  +  L+ L  L L  NQ+    P  G
Sbjct: 233 G----TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAG 281

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 9/155 (5%)
Query: 807 ECKVMGSIRHRNLVKIISSCSNNDFKA--LVLEYMSNGSLEKCLYSDNYFLDILQRLKIM 864
           E +++ ++ H ++VK    C +   K+  LV+EY+  GSL    Y   + + + Q L   
Sbjct: 60  EIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRD--YLPRHCVGLAQLLLFA 117
Query: 865 IDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLG 924
             +   + YLH   +   +H  +   NVLL+   +  + DFG+AK + +     + +  G
Sbjct: 118 QQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 174
Query: 925 T--IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
              + + APE  +E K     DV+S+G+ L E  T
Sbjct: 175 DSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 9/155 (5%)
Query: 807 ECKVMGSIRHRNLVKIISSCSNNDFKA--LVLEYMSNGSLEKCLYSDNYFLDILQRLKIM 864
           E +++ ++ H ++VK    C +   K+  LV+EY+  GSL    Y   + + + Q L   
Sbjct: 61  EIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRD--YLPRHCVGLAQLLLFA 118
Query: 865 IDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLG 924
             +   + YLH   +   +H  +   NVLL+   +  + DFG+AK + +     + +  G
Sbjct: 119 QQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 175
Query: 925 T--IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
              + + APE  +E K     DV+S+G+ L E  T
Sbjct: 176 DSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 47/151 (31%), Positives = 79/151 (52%), Gaps = 18/151 (11%)
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
           HRN++++I      D   LV E M  GS+   ++   +F + L+   ++ DVASAL++LH
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNE-LEASVVVQDVASALDFLH 128
Query: 876 FGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIA---KILGKEESMRQTKTL---GTI 926
              +  I H D+KP N+L    N+     + DFG+    K+ G    +   + L   G+ 
Sbjct: 129 ---NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 927 GYMAPE----YGREGKV-SRKCDVYSYGIML 952
            YMAPE    +  E  +  ++CD++S G++L
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 102/224 (45%), Gaps = 24/224 (10%)
Query: 763 FSENKLLGMGSFG---SVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNL 819
           +++ + +G G++G   S Y  V    + I  K+   E     +    E +++   RH N+
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIK-KISPFEHQTYCQRTLREIQILLRFRHENV 103
Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK------IMIDVASALEY 873
           + I      +  +A+   Y+    +E    +D Y L   Q+L        +  +   L+Y
Sbjct: 104 IGIRDILRASTLEAMRDVYIVQDLME----TDLYKLLKSQQLSNDHICYFLYQILRGLKY 159
Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ--TKTLGTIGYMAP 931
           +H   S  ++H D+KPSN+L+N +    + DFG+A+I   E       T+ + T  Y AP
Sbjct: 160 IH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAP 216
Query: 932 EYGREGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
           E     K  ++  D++S G +L E  + +     IF G+  L +
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 256

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 113/254 (44%), Gaps = 14/254 (5%)
Query: 759  ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGSIR 815
            + + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  + 
Sbjct: 3    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 816  HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
            H N+VK++      +   LV E++    L+K  + D   L  +    I   +   L+ L 
Sbjct: 63   HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 876  FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
            F +S  ++H D+KP N+L+N      L+DFG+A+  G        + + T+ Y APE   
Sbjct: 120  FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 178
Query: 936  EGK-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEVAD 990
              K  S   D++S G +  E  T++   P D        + R +G  D ++   +T + D
Sbjct: 179  GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 238
Query: 991  --ANLLNCEENDFS 1002
               +       DFS
Sbjct: 239  YKPSFPKWARQDFS 252

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 769 LGMGSFG---SVYKGVLPDGMEIA-AKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
           +G G++G   S Y  V  + + +A  K+   E     +    E K++   RH N++ I  
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-- 88
Query: 825 SCSNNDFKALVLEYMSNGSL-EKCLYSDNYFLDILQRLK------IMIDVASALEYLHFG 877
              N+  +A  +E M +  + +  + +D Y L   Q L        +  +   L+Y+H  
Sbjct: 89  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 143
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ--TKTLGTIGYMAPEYGR 935
            S  ++H D+KPSN+LLN +    + DFG+A++   +       T+ + T  Y APE   
Sbjct: 144 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 936 EGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
             K  ++  D++S G +L E  + +     IF G+  L +
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 238

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 113/254 (44%), Gaps = 14/254 (5%)
Query: 759  ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGSIR 815
            + + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  + 
Sbjct: 4    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 816  HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
            H N+VK++      +   LV E++    L+K  + D   L  +    I   +   L+ L 
Sbjct: 64   HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 876  FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
            F +S  ++H D+KP N+L+N      L+DFG+A+  G        + + T+ Y APE   
Sbjct: 121  FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 179
Query: 936  EGK-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEVAD 990
              K  S   D++S G +  E  T++   P D        + R +G  D ++   +T + D
Sbjct: 180  GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 239
Query: 991  --ANLLNCEENDFS 1002
               +       DFS
Sbjct: 240  YKPSFPKWARQDFS 253

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 762 GFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVK 821
            FSE  ++ M   G VY       M+I  K + M   G +  F  E  V+ +   R + +
Sbjct: 73  AFSEVAVVKMKQTGQVY------AMKIMNK-WDMLKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH-FGYST 880
           +  +  + ++  LV+EY   G L   L      +        + ++  A++ +H  GY  
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGY-- 183
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE-------Y 933
             VH DIKP N+LL+      L+DFG    L  + ++R    +GT  Y++PE        
Sbjct: 184 --VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG 241
Query: 934 GREGKVSRKCDVYSYGIMLMETFTKKKP 961
              G    +CD ++ G+   E F  + P
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTP 269

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 113/254 (44%), Gaps = 14/254 (5%)
Query: 759  ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGSIR 815
            + + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  + 
Sbjct: 3    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 816  HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
            H N+VK++      +   LV E++    L+K  + D   L  +    I   +   L+ L 
Sbjct: 63   HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 876  FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
            F +S  ++H D+KP N+L+N      L+DFG+A+  G        + + T+ Y APE   
Sbjct: 120  FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 178
Query: 936  EGK-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEVAD 990
              K  S   D++S G +  E  T++   P D        + R +G  D ++   +T + D
Sbjct: 179  GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 238
Query: 991  --ANLLNCEENDFS 1002
               +       DFS
Sbjct: 239  YKPSFPKWARQDFS 252

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 10/190 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSC 826
           +G G++G VYK     G   A K   +E +  G   +   E  ++  ++H N+VK+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
                  LV E++    L+K L      L+ +     ++ + + + Y H      ++H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE--YGREGKVSRKCD 944
           +KP N+L+N      ++DFG+A+  G     + T  + T+ Y AP+   G + K S   D
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIVTLWYRAPDVLMGSK-KYSTTID 183
Query: 945 VYSYGIMLME 954
           ++S G +  E
Sbjct: 184 IWSVGCIFAE 193

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 24/213 (11%)
Query: 748 WRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGME-IAAKVFHMEFDGSLESFHA 806
           W   S +D L  +D F     LG G+   VY+       +  A KV     D  +     
Sbjct: 42  WIDGSNRDAL--SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI--VRT 97
Query: 807 ECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSL-----EKCLYSDNYFLDILQRL 861
           E  V+  + H N++K+          +LVLE ++ G L     EK  YS+    D +++ 
Sbjct: 98  EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ- 156
Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVG---HLSDFGIAKILGKEESMR 918
                +  A+ YLH      IVH D+KP N+L           ++DFG++KI+  E  + 
Sbjct: 157 -----ILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVL 206
Query: 919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIM 951
                GT GY APE  R      + D++S GI+
Sbjct: 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGII 239

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 114/256 (44%), Gaps = 14/256 (5%)
Query: 757  LRATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGS 813
            L + + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  
Sbjct: 1    LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 60
Query: 814  IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
            + H N+VK++      +   LV E++S   ++   + D   L  +    I   +   L+ 
Sbjct: 61   LNHPNIVKLLDVIHTENKLYLVFEFLS---MDLKDFMDASALTGIPLPLIKSYLFQLLQG 117
Query: 874  LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
            L F +S  ++H D+KP N+L+N      L+DFG+A+  G        + + T+ Y APE 
Sbjct: 118  LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEI 176
Query: 934  GREGK-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEV 988
                K  S   D++S G +  E  T++   P D        + R +G  D ++   +T +
Sbjct: 177  LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 236
Query: 989  AD--ANLLNCEENDFS 1002
             D   +       DFS
Sbjct: 237  PDYKPSFPKWARQDFS 252

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 99/219 (45%), Gaps = 12/219 (5%)
Query: 748 WRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHA- 806
           W+ +  Q + + T  F + ++LG G FG V    +    ++ A     +         A 
Sbjct: 173 WKWLERQPVTKNT--FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM 230
Query: 807 ---ECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYS-DNYFLDILQRLK 862
              E +++  +  R +V +  +    D   LVL  M+ G L+  +Y          + + 
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290
Query: 863 IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT 922
              ++   LE LH      IV+ D+KP N+LL++     +SD G+A  + + ++++    
Sbjct: 291 YAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GR 345
Query: 923 LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           +GT+GYMAPE  +  + +   D ++ G +L E    + P
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVY-KGVLPDGMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V     +  G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY   G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+++++     ++DFG+AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRV----KGRTWXLCGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 114/254 (44%), Gaps = 14/254 (5%)
Query: 759  ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGSIR 815
            + + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  + 
Sbjct: 1    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 816  HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
            H N+VK++      +   LV E++ +  L+K  + D   L  +    I   +   L+ L 
Sbjct: 61   HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 876  FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
            F +S  ++H D+KP N+L+N      L+DFG+A+  G        + + T+ Y APE   
Sbjct: 118  FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 176
Query: 936  EGK-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEVAD 990
              K  S   D++S G +  E  T++   P D        + R +G  D ++   +T + D
Sbjct: 177  GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 236
Query: 991  --ANLLNCEENDFS 1002
               +       DFS
Sbjct: 237  YKPSFPKWARQDFS 250

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 807 ECKVMGSIRHRNLVKIISSCSNNDFKAL--VLEYMSNGSLEKCLYSDNYFLDILQRLKIM 864
           E  ++ ++ H +++K    C +    +L  V+EY+  GSL    Y   + + + Q L   
Sbjct: 83  EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRD--YLPRHSIGLAQLLLFA 140
Query: 865 IDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLG 924
             +   + YLH   +   +H D+   NVLL+   +  + DFG+AK + +     + +  G
Sbjct: 141 QQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDG 197
Query: 925 T--IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
              + + APE  +E K     DV+S+G+ L E  T
Sbjct: 198 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 769 LGMGSFG---SVYKGVLPDGMEIA-AKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
           +G G++G   S Y  V  + + +A  K+   E     +    E K++   RH N++ I  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-- 86
Query: 825 SCSNNDFKALVLEYMSNGSL-EKCLYSDNYFLDILQRLK------IMIDVASALEYLHFG 877
              N+  +A  +E M +  + +  + +D Y L   Q L        +  +   L+Y+H  
Sbjct: 87  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 141
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ--TKTLGTIGYMAPEYGR 935
            S  ++H D+KPSN+LLN +    + DFG+A++   +       T+ + T  Y APE   
Sbjct: 142 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 936 EGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
             K  ++  D++S G +L E  + +     IF G+  L +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 236

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 769 LGMGSFG---SVYKGVLPDGMEIA-AKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
           +G G++G   S Y  V  + + +A  K+   E     +    E K++   RH N++ I  
Sbjct: 39  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-- 94
Query: 825 SCSNNDFKALVLEYMSNGSL-EKCLYSDNYFLDILQRLK------IMIDVASALEYLHFG 877
              N+  +A  +E M +  + +  + +D Y L   Q L        +  +   L+Y+H  
Sbjct: 95  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 149
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ--TKTLGTIGYMAPEYGR 935
            S  ++H D+KPSN+LLN +    + DFG+A++   +       T+ + T  Y APE   
Sbjct: 150 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 936 EGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
             K  ++  D++S G +L E  + +     IF G+  L +
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 244

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 769 LGMGSFG---SVYKGVLPDGMEIA-AKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
           +G G++G   S Y  V  + + +A  K+   E     +    E K++   RH N++ I  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-- 86
Query: 825 SCSNNDFKALVLEYMSNGSL-EKCLYSDNYFLDILQRLK------IMIDVASALEYLHFG 877
              N+  +A  +E M +  + +  + +D Y L   Q L        +  +   L+Y+H  
Sbjct: 87  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 141
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ--TKTLGTIGYMAPEYGR 935
            S  ++H D+KPSN+LLN +    + DFG+A++   +       T+ + T  Y APE   
Sbjct: 142 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 936 EGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
             K  ++  D++S G +L E  + +     IF G+  L +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 236

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 113/252 (44%), Gaps = 14/252 (5%)
Query: 761  DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGSIRHR 817
            + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  + H 
Sbjct: 2    ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 818  NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
            N+VK++      +   LV E++ +  L+K  + D   L  +    I   +   L+ L F 
Sbjct: 62   NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 878  YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG 937
            +S  ++H D+KP N+L+N      L+DFG+A+  G        + + T+ Y APE     
Sbjct: 119  HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 177
Query: 938  K-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEVAD-- 990
            K  S   D++S G +  E  T++   P D        + R +G  D ++   +T + D  
Sbjct: 178  KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 991  ANLLNCEENDFS 1002
             +       DFS
Sbjct: 238  PSFPKWARQDFS 249

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 113/254 (44%), Gaps = 14/254 (5%)
Query: 759  ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGSIR 815
            + + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  + 
Sbjct: 2    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 816  HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
            H N+VK++      +   LV E++    L+K  + D   L  +    I   +   L+ L 
Sbjct: 62   HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 876  FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
            F +S  ++H D+KP N+L+N      L+DFG+A+  G        + + T+ Y APE   
Sbjct: 119  FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 177
Query: 936  EGK-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEVAD 990
              K  S   D++S G +  E  T++   P D        + R +G  D ++   +T + D
Sbjct: 178  GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 237
Query: 991  --ANLLNCEENDFS 1002
               +       DFS
Sbjct: 238  YKPSFPKWARQDFS 251

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 769 LGMGSFG---SVYKGVLPDGMEIA-AKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
           +G G++G   S Y  V  + + +A  K+   E     +    E K++   RH N++ I  
Sbjct: 51  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-- 106
Query: 825 SCSNNDFKALVLEYMSNGSL-EKCLYSDNYFLDILQRLK------IMIDVASALEYLHFG 877
              N+  +A  +E M +  + +  + +D Y L   Q L        +  +   L+Y+H  
Sbjct: 107 ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 161
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ--TKTLGTIGYMAPEYGR 935
            S  ++H D+KPSN+LLN +    + DFG+A++   +       T+ + T  Y APE   
Sbjct: 162 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 936 EGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
             K  ++  D++S G +L E  + +     IF G+  L +
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 256

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 114/254 (44%), Gaps = 14/254 (5%)
Query: 759  ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGSIR 815
            + + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  + 
Sbjct: 1    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 816  HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
            H N+VK++      +   LV E++ +  L+K  + D   L  +    I   +   L+ L 
Sbjct: 61   HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 876  FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
            F +S  ++H D+KP N+L+N      L+DFG+A+  G        + + T+ Y APE   
Sbjct: 118  FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 176
Query: 936  EGK-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEVAD 990
              K  S   D++S G +  E  T++   P D        + R +G  D ++   +T + D
Sbjct: 177  GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 236
Query: 991  --ANLLNCEENDFS 1002
               +       DFS
Sbjct: 237  YKPSFPKWARQDFS 250

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V      + G   A K+   +    L+       E +++ ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY+  G +   L     F +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 213
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 214 KGYNKAVDWWALGVLIYE 231

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 761 DGFSENKLLGMGSFGSV----YKGVLPDGMEIAAKVFHMEFDGSLESFH---AECKVMGS 813
           D F   K LG GSFG V    +K     G   A K+   +    L+       E +++ +
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 84
Query: 814 IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
           +    LVK+  S  +N    +V+EY++ G +   L     F +   R      +    EY
Sbjct: 85  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 143
Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
           LH   S  +++ D+KP N+L++E     ++DFG AK +      R     GT  Y+APE 
Sbjct: 144 LH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEI 196
Query: 934 GREGKVSRKCDVYSYGIMLMETFTKKKP 961
                 ++  D ++ G+++ E      P
Sbjct: 197 ILSKGYNKAVDWWALGVLIYEMAAGYPP 224

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V      + G   A K+   +    L+       E +++ ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY+  G +   L     F +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 213
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 214 KGYNKAVDWWALGVLIYE 231

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V      + G   A K+   +    L+       E +++ ++  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY+  G +   L     F +   R      +    EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 179
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 233
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 234 KGYNKAVDWWALGVLIYE 251

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V      + G   A K+   +    L+       E +++ ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY+  G +   L     F +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 213
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 214 KGYNKAVDWWALGVLIYE 231

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 113/254 (44%), Gaps = 14/254 (5%)
Query: 759  ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGSIR 815
            + + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  + 
Sbjct: 3    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 816  HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
            H N+VK++      +   LV E++    L+K  + D   L  +    I   +   L+ L 
Sbjct: 63   HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 876  FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
            F +S  ++H D+KP N+L+N      L+DFG+A+  G        + + T+ Y APE   
Sbjct: 120  FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 178
Query: 936  EGK-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEVAD 990
              K  S   D++S G +  E  T++   P D        + R +G  D ++   +T + D
Sbjct: 179  GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 238
Query: 991  --ANLLNCEENDFS 1002
               +       DFS
Sbjct: 239  YKPSFPKWARQDFS 252

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 30/223 (13%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAK----VFHMEFDGSLESFH----AECKVMG 812
           D     K LG G+FG V +     G++  A        M  +G+  S H    +E K++ 
Sbjct: 18  DRLKLGKPLGRGAFGQVIEAD-AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 76
Query: 813 SI-RHRNLVKIISSCSNNDFKALVL-EYMSNGSLEKCLYS-------------DNY--FL 855
            I  H N+V ++ +C+      +V+ E+   G+L   L S             D Y  FL
Sbjct: 77  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 136
Query: 856 DILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE- 914
            +   +     VA  +E+L    S   +H D+   N+LL+E  V  + DFG+A+ + K+ 
Sbjct: 137 TLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 193
Query: 915 ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           + +R+      + +MAPE   +   + + DV+S+G++L E F+
Sbjct: 194 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 30/223 (13%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAK----VFHMEFDGSLESFH----AECKVMG 812
           D     K LG G+FG V +     G++  A        M  +G+  S H    +E K++ 
Sbjct: 18  DRLKLGKPLGRGAFGQVIEAD-AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 76
Query: 813 SI-RHRNLVKIISSCSNNDFKALVL-EYMSNGSLEKCLYS-------------DNY--FL 855
            I  H N+V ++ +C+      +V+ E+   G+L   L S             D Y  FL
Sbjct: 77  HIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 136
Query: 856 DILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE- 914
            +   +     VA  +E+L    S   +H D+   N+LL+E  V  + DFG+A+ + K+ 
Sbjct: 137 TLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 193
Query: 915 ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           + +R+      + +MAPE   +   + + DV+S+G++L E F+
Sbjct: 194 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 113/252 (44%), Gaps = 14/252 (5%)
Query: 761  DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGSIRHR 817
            + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  + H 
Sbjct: 2    ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 818  NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
            N+VK++      +   LV E++ +  L+K  + D   L  +    I   +   L+ L F 
Sbjct: 62   NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 878  YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG 937
            +S  ++H D+KP N+L+N      L+DFG+A+  G        + + T+ Y APE     
Sbjct: 119  HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 177
Query: 938  K-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEVAD-- 990
            K  S   D++S G +  E  T++   P D        + R +G  D ++   +T + D  
Sbjct: 178  KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 991  ANLLNCEENDFS 1002
             +       DFS
Sbjct: 238  PSFPKWARQDFS 249

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 30/223 (13%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAK----VFHMEFDGSLESFH----AECKVMG 812
           D     K LG G+FG V +     G++  A        M  +G+  S H    +E K++ 
Sbjct: 27  DRLKLGKPLGRGAFGQVIEAD-AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 85
Query: 813 SI-RHRNLVKIISSCSNNDFKALVL-EYMSNGSLEKCLYS-------------DNY--FL 855
            I  H N+V ++ +C+      +V+ E+   G+L   L S             D Y  FL
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 856 DILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE- 914
            +   +     VA  +E+L    S   +H D+   N+LL+E  V  + DFG+A+ + K+ 
Sbjct: 146 TLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 202
Query: 915 ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           + +R+      + +MAPE   +   + + DV+S+G++L E F+
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 114/254 (44%), Gaps = 14/254 (5%)
Query: 759  ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGSIR 815
            + + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  + 
Sbjct: 1    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 816  HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
            H N+VK++      +   LV E++ +  L+K  + D   L  +    I   +   L+ L 
Sbjct: 61   HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 876  FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
            F +S  ++H D+KP N+L+N      L+DFG+A+  G        + + T+ Y APE   
Sbjct: 118  FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 176
Query: 936  EGK-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEVAD 990
              K  S   D++S G +  E  T++   P D        + R +G  D ++   +T + D
Sbjct: 177  GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 236
Query: 991  --ANLLNCEENDFS 1002
               +       DFS
Sbjct: 237  YKPSFPKWARQDFS 250

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 10/190 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSC 826
           +G G++G VYK     G   A K   +E +  G   +   E  ++  ++H N+VK+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
                  LV E++    L+K L      L+ +     ++ + + + Y H      ++H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE--YGREGKVSRKCD 944
           +KP N+L+N      ++DFG+A+  G     + T  + T+ Y AP+   G + K S   D
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEVVTLWYRAPDVLMGSK-KYSTTID 183
Query: 945 VYSYGIMLME 954
           ++S G +  E
Sbjct: 184 IWSVGCIFAE 193

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 87/198 (43%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVY-KGVLPDGMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V     +  G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY   G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+++++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 112/252 (44%), Gaps = 14/252 (5%)
Query: 761  DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGSIRHR 817
            + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  + H 
Sbjct: 4    ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 818  NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
            N+VK++      +   LV E++    L+K  + D   L  +    I   +   L+ L F 
Sbjct: 64   NIVKLLDVIHTENKLYLVFEFLHQ-DLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 878  YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG 937
            +S  ++H D+KP N+L+N      L+DFG+A+  G        + + T+ Y APE     
Sbjct: 121  HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 179
Query: 938  K-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEVAD-- 990
            K  S   D++S G +  E  T++   P D        + R +G  D ++   +T + D  
Sbjct: 180  KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 239
Query: 991  ANLLNCEENDFS 1002
             +       DFS
Sbjct: 240  PSFPKWARQDFS 251

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 99/219 (45%), Gaps = 12/219 (5%)
Query: 748 WRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHA- 806
           W+ +  Q + + T  F + ++LG G FG V    +    ++ A     +         A 
Sbjct: 173 WKWLERQPVTKNT--FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM 230
Query: 807 ---ECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYS-DNYFLDILQRLK 862
              E +++  +  R +V +  +    D   LVL  M+ G L+  +Y          + + 
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290
Query: 863 IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT 922
              ++   LE LH      IV+ D+KP N+LL++     +SD G+A  + + ++++    
Sbjct: 291 YAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GR 345
Query: 923 LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           +GT+GYMAPE  +  + +   D ++ G +L E    + P
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 128/301 (42%), Gaps = 36/301 (11%)
Query: 767  KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI--RHRNLVKIIS 824
            K +G G +G V+ G    G ++A KVF   F     S+  E ++  ++  RH N++  I+
Sbjct: 43   KQIGKGRYGEVWMGKW-RGEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 825  SCSNNDFKA--------LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
            +    D K         L+ +Y  NGSL   L S    LD    LK+     S L +LH 
Sbjct: 99   A----DIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHT 152
Query: 877  G-YST----PIVHCDIKPSNVLLNESMVGHLSDFGIA-KILGK--EESMRQTKTLGTIGY 928
              +ST     I H D+K  N+L+ ++    ++D G+A K +    E  +     +GT  Y
Sbjct: 153  EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 929  MAPEYGREGKVSRK-------CDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLL 981
            M PE   E  ++R         D+YS+G++L E   +      +   ++     V     
Sbjct: 213  MPPEVLDES-LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271
Query: 982  SCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041
               + E+     L     +  + ++C+  +  L  +C    P  R++   V   L ++ E
Sbjct: 272  YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331
Query: 1042 T 1042
            +
Sbjct: 332  S 332

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 101/241 (41%), Gaps = 9/241 (3%)
Query: 768  LLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKII 823
             LG G F   ++    D  E+ A K+            E    E  +  S+ H+++V   
Sbjct: 48   FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 824  SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIV 883
                +NDF  +VLE     SL + L+     L   +    +  +    +YLH      ++
Sbjct: 108  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 163
Query: 884  HCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKC 943
            H D+K  N+ LNE +   + DFG+A  + + +  R+    GT  Y+APE   +   S + 
Sbjct: 164  HRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 222
Query: 944  DVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSA 1003
            DV+S G ++      K P +     E  L+    +  +   I  VA + +    + D +A
Sbjct: 223  DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTA 282
Query: 1004 R 1004
            R
Sbjct: 283  R 283

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 8/203 (3%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAA--KV-FHMEFDGSLESFHAECKVMGSIRHR 817
           + F + + +G G++G VYK       E+ A  K+    E +G   +   E  ++  + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 818 NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
           N+VK++      +   LV E++    L+K  + D   L  +    I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG 937
           +S  ++H D+KP N+L+N      L+DFG+A+  G       T  + T+ Y APE     
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGX 178
Query: 938 K-VSRKCDVYSYGIMLMETFTKK 959
           K  S   D++S G +  E  T++
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V      + G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY++ G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ +
Sbjct: 213 KGYNKAVDWWALGVLIYQ 230

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 8/203 (3%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAA--KV-FHMEFDGSLESFHAECKVMGSIRHR 817
           + F + + +G G++G VYK       E+ A  K+    E +G   +   E  ++  + H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 818 NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
           N+VK++      +   LV E++    L+K  + D   L  +    I   +   L+ L F 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQ-DLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG 937
           +S  ++H D+KP N+L+N      L+DFG+A+  G       T  + T+ Y APE     
Sbjct: 124 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGC 182
Query: 938 K-VSRKCDVYSYGIMLMETFTKK 959
           K  S   D++S G +  E  T++
Sbjct: 183 KYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 113/254 (44%), Gaps = 14/254 (5%)
Query: 759  ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGSIR 815
            + + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  + 
Sbjct: 2    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 816  HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
            H N+VK++      +   LV E++    L+K  + D   L  +    I   +   L+ L 
Sbjct: 62   HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 876  FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
            F +S  ++H D+KP N+L+N      L+DFG+A+  G        + + T+ Y APE   
Sbjct: 119  FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 177
Query: 936  EGK-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEVAD 990
              K  S   D++S G +  E  T++   P D        + R +G  D ++   +T + D
Sbjct: 178  GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 237
Query: 991  --ANLLNCEENDFS 1002
               +       DFS
Sbjct: 238  YKPSFPKWARQDFS 251

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 10/190 (5%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSC 826
           +G G++G VYK     G   A K   +E +  G   +   E  ++  ++H N+VK+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCD 886
                  LV E++    L+K L      L+ +     ++ + + + Y H      ++H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 887 IKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE--YGREGKVSRKCD 944
           +KP N+L+N      ++DFG+A+  G     + T  + T+ Y AP+   G + K S   D
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEVVTLWYRAPDVLMGSK-KYSTTID 183
Query: 945 VYSYGIMLME 954
           ++S G +  E
Sbjct: 184 IWSVGCIFAE 193

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 769 LGMGSFG---SVYKGVLPDGMEIA-AKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
           +G G++G   S Y  V  + + +A  K+   E     +    E K++   RH N++ I  
Sbjct: 51  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-- 106
Query: 825 SCSNNDFKALVLEYMSNGSLEKCLY-SDNYFLDILQRLK------IMIDVASALEYLHFG 877
              N+  +A  +E M +  L   L  +D Y L   Q L        +  +   L+Y+H  
Sbjct: 107 ---NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 161
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ--TKTLGTIGYMAPEYGR 935
            S  ++H D+KPSN+LLN +    + DFG+A++   +       T+ + T  Y APE   
Sbjct: 162 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 936 EGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
             K  ++  D++S G +L E  + +     IF G+  L +
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 256

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVY-KGVLPDGMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K +G GSFG V     +  G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY+  G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/310 (20%), Positives = 120/310 (38%), Gaps = 66/310 (21%)
Query: 767  KLLGMGSFGSVYKGVL------PDGMEIAAKVFHMEFDGS-LESFHAECKVMGSIRHRNL 819
            K LG G FG V K              +A K+       S L    +E  V+  + H ++
Sbjct: 29   KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 820  VKIISSCSNNDFKALVLEYMSNGSLEKCL-----------------------YSDNYFLD 856
            +K+  +CS +    L++EY   GSL   L                       + D   L 
Sbjct: 89   IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 857  ILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES 916
            +   +     ++  ++YL       +VH D+   N+L+ E     +SDFG+++ + +E+S
Sbjct: 149  MGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 917  -MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT------KKKPTDEIFAGE 969
             +++++    + +MA E   +   + + DV+S+G++L E  T         P + +F   
Sbjct: 206  XVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF--- 262
Query: 970  MSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISM 1029
                                  NLL          + C   ++ L + C    P+KR   
Sbjct: 263  ----------------------NLLKTGHR-MERPDNCSEEMYRLMLQCWKQEPDKRPVF 299
Query: 1030 KDVANRLVRI 1039
             D++  L ++
Sbjct: 300  ADISKDLEKM 309

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 87/198 (43%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVY-KGVLPDGMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V     +  G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY   G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+++++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V      + G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY++ G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+++++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIIS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI--RHRNLVKIISSC 826
           +G G FG V++G    G E+A K+F    +    S+  E ++  ++  RH N++  I++ 
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA- 66
Query: 827 SNNDFKA-----LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY--- 878
            N D        LV +Y  +GSL    Y + Y + +   +K+ +  AS L +LH      
Sbjct: 67  DNKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 124
Query: 879 --STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT------KTLGTIGYMA 930
                I H D+K  N+L+ ++    ++D G+A    + +S   T        +GT  YMA
Sbjct: 125 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV---RHDSATDTIDIAPNHRVGTKRYMA 181
Query: 931 PEY------GREGKVSRKCDVYSYGIMLME 954
           PE        +  +  ++ D+Y+ G++  E
Sbjct: 182 PEVLDDSINMKHFESFKRADIYAMGLVFWE 211

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI--RHRNLVKIISSC 826
           +G G FG V++G    G E+A K+F    +    S+  E ++  ++  RH N++  I++ 
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA- 65
Query: 827 SNNDFKA-----LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY--- 878
            N D        LV +Y  +GSL    Y + Y + +   +K+ +  AS L +LH      
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 879 --STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT------KTLGTIGYMA 930
                I H D+K  N+L+ ++    ++D G+A    + +S   T        +GT  YMA
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV---RHDSATDTIDIAPNHRVGTKRYMA 180
Query: 931 PEY------GREGKVSRKCDVYSYGIMLME 954
           PE        +  +  ++ D+Y+ G++  E
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWE 210

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI--RHRNLVKIISSC 826
           +G G FG V++G    G E+A K+F    +    S+  E ++  ++  RH N++  I++ 
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA- 71
Query: 827 SNNDFKA-----LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY--- 878
            N D        LV +Y  +GSL    Y + Y + +   +K+ +  AS L +LH      
Sbjct: 72  DNKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 129
Query: 879 --STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT------KTLGTIGYMA 930
                I H D+K  N+L+ ++    ++D G+A    + +S   T        +GT  YMA
Sbjct: 130 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV---RHDSATDTIDIAPNHRVGTKRYMA 186
Query: 931 PEY------GREGKVSRKCDVYSYGIMLME 954
           PE        +  +  ++ D+Y+ G++  E
Sbjct: 187 PEVLDDSINMKHFESFKRADIYAMGLVFWE 216

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI--RHRNLVKIISSC 826
           +G G FG V++G    G E+A K+F    +    S+  E ++  ++  RH N++  I++ 
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA- 68
Query: 827 SNNDFKA-----LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY--- 878
            N D        LV +Y  +GSL    Y + Y + +   +K+ +  AS L +LH      
Sbjct: 69  DNKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 126
Query: 879 --STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT------KTLGTIGYMA 930
                I H D+K  N+L+ ++    ++D G+A    + +S   T        +GT  YMA
Sbjct: 127 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV---RHDSATDTIDIAPNHRVGTKRYMA 183
Query: 931 PEY------GREGKVSRKCDVYSYGIMLME 954
           PE        +  +  ++ D+Y+ G++  E
Sbjct: 184 PEVLDDSINMKHFESFKRADIYAMGLVFWE 213

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/310 (20%), Positives = 120/310 (38%), Gaps = 66/310 (21%)
Query: 767  KLLGMGSFGSVYKGVL------PDGMEIAAKVFHMEFDGS-LESFHAECKVMGSIRHRNL 819
            K LG G FG V K              +A K+       S L    +E  V+  + H ++
Sbjct: 29   KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 820  VKIISSCSNNDFKALVLEYMSNGSLEKCL-----------------------YSDNYFLD 856
            +K+  +CS +    L++EY   GSL   L                       + D   L 
Sbjct: 89   IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 857  ILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES 916
            +   +     ++  ++YL       +VH D+   N+L+ E     +SDFG+++ + +E+S
Sbjct: 149  MGDLISFAWQISQGMQYLA---EMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 917  -MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT------KKKPTDEIFAGE 969
             +++++    + +MA E   +   + + DV+S+G++L E  T         P + +F   
Sbjct: 206  XVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF--- 262
Query: 970  MSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISM 1029
                                  NLL          + C   ++ L + C    P+KR   
Sbjct: 263  ----------------------NLLKTGHR-MERPDNCSEEMYRLMLQCWKQEPDKRPVF 299
Query: 1030 KDVANRLVRI 1039
             D++  L ++
Sbjct: 300  ADISKDLEKM 309

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/310 (20%), Positives = 120/310 (38%), Gaps = 66/310 (21%)
Query: 767  KLLGMGSFGSVYKGVL------PDGMEIAAKVFHMEFDGS-LESFHAECKVMGSIRHRNL 819
            K LG G FG V K              +A K+       S L    +E  V+  + H ++
Sbjct: 29   KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 820  VKIISSCSNNDFKALVLEYMSNGSLEKCL-----------------------YSDNYFLD 856
            +K+  +CS +    L++EY   GSL   L                       + D   L 
Sbjct: 89   IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 857  ILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES 916
            +   +     ++  ++YL       +VH D+   N+L+ E     +SDFG+++ + +E+S
Sbjct: 149  MGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 917  -MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT------KKKPTDEIFAGE 969
             +++++    + +MA E   +   + + DV+S+G++L E  T         P + +F   
Sbjct: 206  YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF--- 262
Query: 970  MSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISM 1029
                                  NLL          + C   ++ L + C    P+KR   
Sbjct: 263  ----------------------NLLKTGHR-MERPDNCSEEMYRLMLQCWKQEPDKRPVF 299
Query: 1030 KDVANRLVRI 1039
             D++  L ++
Sbjct: 300  ADISKDLEKM 309

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVY-KGVLPDGMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V     +  G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY   G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+++++     ++DFG+AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRV----KGRTWXLCGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 766 NKLLGMGSFGSVYKGVLPD--------GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHR 817
           N+ LG G+F  ++KGV  +          E+  KV         ESF     +M  + H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 818 NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
           +LV     C   D   LV E++  GSL+  L  +   ++IL +L++   +A+A   +HF 
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA---MHFL 129
Query: 878 YSTPIVHCDIKPSNVLL---NESMVGH-----LSDFGIAKILGKEESMRQTKTLGTIGYM 929
               ++H ++   N+LL    +   G+     LSD GI+  +  ++ +++      I ++
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQE-----RIPWV 184
Query: 930 APEYGREGK-VSRKCDVYSYGIMLME 954
            PE     K ++   D +S+G  L E
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWE 210

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V      + G   A K+   +    L+       E +++ ++  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY++ G +   L     F +   R      +    EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 179
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGYMAPEYGR 935
             S  +++ D+KP N+L+++     ++DFG AK +        T TL GT  Y+APE   
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----ATWTLCGTPEYLAPEIIL 232
Query: 936 EGKVSRKCDVYSYGIMLME 954
               ++  D ++ G+++ E
Sbjct: 233 SKGYNKAVDWWALGVLIYE 251

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 107/232 (46%), Gaps = 38/232 (16%)
Query: 739 DANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGME------IAAKV 792
           D ++YP+A          LR  D +  +K LG G+ G V         +      I+ + 
Sbjct: 139 DQSVYPKA----------LR--DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRK 186
Query: 793 FHM----EFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL 848
           F +    E D +L +   E +++  + H  ++KI +     D+  +VLE M  G L   +
Sbjct: 187 FAIGSAREADPAL-NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKV 244
Query: 849 YSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN---ESMVGHLSDF 905
             +    +   +L     +  A++YLH      I+H D+KP NVLL+   E  +  ++DF
Sbjct: 245 VGNKRLKEATCKL-YFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF 300
Query: 906 GIAKILGKEESMRQTKTLGTIGYMAPE----YGREGKVSRKCDVYSYGIMLM 953
           G +KILG+   MR     GT  Y+APE     G  G  +R  D +S G++L 
Sbjct: 301 GHSKILGETSLMRT--LCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILF 349

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 105/400 (26%), Positives = 167/400 (41%), Gaps = 100/400 (25%)
Query: 165 IGYLSLLQELDLSDNQLSGTIP--------------SSIFNISSCQNLPVLEGLFISYNQ 210
           + YL+ L +++ S+NQL+   P              + I +I+   NL  L GL +  NQ
Sbjct: 59  VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQ 118
Query: 211 LTGPIP-TNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGN 269
           +T   P  NL     L + S   +         +  LTS++ L  GN   + ++   + N
Sbjct: 119 ITDIDPLKNLTNLNRLELSSNTISDISA-----LSGLTSLQQLNFGNQ--VTDLK-PLAN 170
Query: 270 LRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGE 329
           L  LE L + S+ ++ +  + +  ++ L+ L  T+N +    P  I   L NL+ L L  
Sbjct: 171 LTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITPLGI---LTNLDELSLNG 225
Query: 330 NNFS--GTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDL 387
           N     GT+ +SLTN+++L   D   N  S L P     L  L  L L  N +++ +P  
Sbjct: 226 NQLKDIGTL-ASLTNLTDL---DLANNQISNLAP--LSGLTKLTELKLGANQISNISP-- 277
Query: 388 SFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINN 447
             L+ LT+  NLE   L+EN +  I P                           + N+ N
Sbjct: 278 --LAGLTALTNLE---LNENQLEDISP---------------------------ISNLKN 305
Query: 448 LTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLS 507
           LT + L  N ++   PV+   L KLQ L+  NNK+                         
Sbjct: 306 LTYLTLYFNNISDISPVS--SLTKLQRLFFSNNKVSDV---------------------- 341
Query: 508 GRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRF 547
               + L NLT++  LS G N ++ + P  L NL  I + 
Sbjct: 342 ----SSLANLTNINWLSAGHNQISDLTP--LANLTRITQL 375

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 101/241 (41%), Gaps = 9/241 (3%)
Query: 768  LLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKII 823
             LG G F   ++    D  E+ A K+            E    E  +  S+ H+++V   
Sbjct: 46   FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 824  SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIV 883
                +NDF  +VLE     SL + L+     L   +    +  +    +YLH      ++
Sbjct: 106  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 161
Query: 884  HCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKC 943
            H D+K  N+ LNE +   + DFG+A  + + +  R+    GT  Y+APE   +   S + 
Sbjct: 162  HRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 220
Query: 944  DVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSA 1003
            DV+S G ++      K P +     E  L+    +  +   I  VA + +    + D +A
Sbjct: 221  DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTA 280
Query: 1004 R 1004
            R
Sbjct: 281  R 281

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 113/254 (44%), Gaps = 14/254 (5%)
Query: 759  ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGSIR 815
            + + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  + 
Sbjct: 4    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 816  HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
            H N+VK++      +   LV E++    L+K  + D   L  +    I   +   L+ L 
Sbjct: 64   HPNIVKLLDVIHTENKLYLVFEHVDQ-DLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 876  FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
            F +S  ++H D+KP N+L+N      L+DFG+A+  G        + + T+ Y APE   
Sbjct: 121  FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 179
Query: 936  EGK-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEVAD 990
              K  S   D++S G +  E  T++   P D        + R +G  D ++   +T + D
Sbjct: 180  GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 239
Query: 991  --ANLLNCEENDFS 1002
               +       DFS
Sbjct: 240  YKPSFPKWARQDFS 253

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 105/400 (26%), Positives = 167/400 (41%), Gaps = 100/400 (25%)
Query: 165 IGYLSLLQELDLSDNQLSGTIP--------------SSIFNISSCQNLPVLEGLFISYNQ 210
           + YL+ L +++ S+NQL+   P              + I +I+   NL  L GL +  NQ
Sbjct: 63  VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQ 122
Query: 211 LTGPIP-TNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGN 269
           +T   P  NL     L + S   +         +  LTS++ L  GN   + ++   + N
Sbjct: 123 ITDIDPLKNLTNLNRLELSSNTISDISA-----LSGLTSLQQLSFGNQ--VTDLK-PLAN 174
Query: 270 LRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGE 329
           L  LE L + S+ ++ +  + +  ++ L+ L  T+N +    P  I   L NL+ L L  
Sbjct: 175 LTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITPLGI---LTNLDELSLNG 229
Query: 330 NNFS--GTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDL 387
           N     GT+ +SLTN+++L   D   N  S L P     L  L  L L  N +++ +P  
Sbjct: 230 NQLKDIGTL-ASLTNLTDL---DLANNQISNLAP--LSGLTKLTELKLGANQISNISP-- 281
Query: 388 SFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINN 447
             L+ LT+  NLE   L+EN +  I P                           + N+ N
Sbjct: 282 --LAGLTALTNLE---LNENQLEDISP---------------------------ISNLKN 309
Query: 448 LTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLS 507
           LT + L  N ++   PV+   L KLQ L+  NNK+                         
Sbjct: 310 LTYLTLYFNNISDISPVS--SLTKLQRLFFANNKVSDV---------------------- 345
Query: 508 GRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRF 547
               + L NLT++  LS G N ++ + P  L NL  I + 
Sbjct: 346 ----SSLANLTNINWLSAGHNQISDLTP--LANLTRITQL 379

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 114/254 (44%), Gaps = 14/254 (5%)
Query: 759  ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGSIR 815
            + + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  + 
Sbjct: 1    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 816  HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
            H N+VK++      +   LV E++ +  L+K  + D   L  +    I   +   L+ L 
Sbjct: 61   HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 876  FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
            F +S  ++H D+KP N+L+N      L+DFG+A+  G        + + T+ Y APE   
Sbjct: 118  FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 176
Query: 936  EGK-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEVAD 990
              K  S   D++S G +  E  T++   P D        + R +G  D ++   +T + D
Sbjct: 177  GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 236
Query: 991  --ANLLNCEENDFS 1002
               +       DFS
Sbjct: 237  YKPSFPKWARQDFS 250

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/107 (37%), Positives = 59/107 (55%), Gaps = 10/107 (9%)
Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK 921
           KI + +  ALE+LH   S  ++H D+KPSNVL+N      + DFGI+  L   +S+ +T 
Sbjct: 157 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL--VDSVAKTI 212
Query: 922 TLGTIGYMAPEY-----GREGKVSRKCDVYSYGIMLMETFTKKKPTD 963
             G   YMAPE       ++G  S K D++S GI ++E    + P D
Sbjct: 213 DAGCKPYMAPERINPELNQKG-YSVKSDIWSLGITMIELAILRFPYD 258

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 107/232 (46%), Gaps = 38/232 (16%)
Query: 739 DANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGME------IAAKV 792
           D ++YP+A          LR  D +  +K LG G+ G V         +      I+ + 
Sbjct: 125 DQSVYPKA----------LR--DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRK 172
Query: 793 FHM----EFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL 848
           F +    E D +L +   E +++  + H  ++KI +     D+  +VLE M  G L   +
Sbjct: 173 FAIGSAREADPAL-NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKV 230
Query: 849 YSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN---ESMVGHLSDF 905
             +    +   +L     +  A++YLH      I+H D+KP NVLL+   E  +  ++DF
Sbjct: 231 VGNKRLKEATCKL-YFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF 286
Query: 906 GIAKILGKEESMRQTKTLGTIGYMAPE----YGREGKVSRKCDVYSYGIMLM 953
           G +KILG+   MR     GT  Y+APE     G  G  +R  D +S G++L 
Sbjct: 287 GHSKILGETSLMRT--LCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILF 335

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 30/223 (13%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAK----VFHMEFDGSLESFH----AECKVMG 812
           D     K LG G+FG V +     G++  A        M  +G+  S H    +E K++ 
Sbjct: 27  DRLKLGKPLGRGAFGQVIEAD-AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 85
Query: 813 SI-RHRNLVKIISSCSNNDFKALVL-EYMSNGSLEKCLYS-------------DNY--FL 855
            I  H N+V ++ +C+      +V+ E+   G+L   L S             D Y  FL
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 856 DILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE- 914
            +   +     VA  +E+L    S   +H D+   N+LL+E  V  + DFG+A+ + K+ 
Sbjct: 146 TLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202
Query: 915 ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           + +R+      + +MAPE   +   + + DV+S+G++L E F+
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 105/400 (26%), Positives = 167/400 (41%), Gaps = 100/400 (25%)
Query: 165 IGYLSLLQELDLSDNQLSGTIP--------------SSIFNISSCQNLPVLEGLFISYNQ 210
           + YL+ L +++ S+NQL+   P              + I +I+   NL  L GL +  NQ
Sbjct: 64  VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQ 123
Query: 211 LTGPIP-TNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGN 269
           +T   P  NL     L + S   +         +  LTS++ L  GN   + ++   + N
Sbjct: 124 ITDIDPLKNLTNLNRLELSSNTISDISA-----LSGLTSLQQLSFGNQ--VTDLK-PLAN 175
Query: 270 LRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGE 329
           L  LE L + S+ ++ +  + +  ++ L+ L  T+N +    P  I   L NL+ L L  
Sbjct: 176 LTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITPLGI---LTNLDELSLNG 230
Query: 330 NNFS--GTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDL 387
           N     GT+ +SLTN+++L   D   N  S L P     L  L  L L  N +++ +P  
Sbjct: 231 NQLKDIGTL-ASLTNLTDL---DLANNQISNLAP--LSGLTKLTELKLGANQISNISP-- 282
Query: 388 SFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINN 447
             L+ LT+  NLE   L+EN +  I P                           + N+ N
Sbjct: 283 --LAGLTALTNLE---LNENQLEDISP---------------------------ISNLKN 310
Query: 448 LTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLS 507
           LT + L  N ++   PV+   L KLQ L+  NNK+                         
Sbjct: 311 LTYLTLYFNNISDISPVS--SLTKLQRLFFYNNKVSDV---------------------- 346
Query: 508 GRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRF 547
               + L NLT++  LS G N ++ + P  L NL  I + 
Sbjct: 347 ----SSLANLTNINWLSAGHNQISDLTP--LANLTRITQL 380

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 761 DGFSENKLLGMGSFGSV----YKGVLPDGMEIAAKVFHMEFDGSLESFH---AECKVMGS 813
           D F   K LG GSFG V    +K     G   A K+   +    L+       E +++ +
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 92
Query: 814 IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
           +    LVK+  S  +N    +V+EY++ G +   L     F +   R      +    EY
Sbjct: 93  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEY 151
Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
           LH   S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE 
Sbjct: 152 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEI 204
Query: 934 GREGKVSRKCDVYSYGIMLMETFTKKKP 961
                 ++  D ++ G+++ E      P
Sbjct: 205 ILSKGYNKAVDWWALGVLIYEMAAGYPP 232

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 87/198 (43%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVY-KGVLPDGMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V     +  G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY   G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+++++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 105/400 (26%), Positives = 167/400 (41%), Gaps = 100/400 (25%)
Query: 165 IGYLSLLQELDLSDNQLSGTIP--------------SSIFNISSCQNLPVLEGLFISYNQ 210
           + YL+ L +++ S+NQL+   P              + I +I+   NL  L GL +  NQ
Sbjct: 59  VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQ 118
Query: 211 LTGPIP-TNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGN 269
           +T   P  NL     L + S   +         +  LTS++ L  GN   + ++   + N
Sbjct: 119 ITDIDPLKNLTNLNRLELSSNTISDISA-----LSGLTSLQQLNFGNQ--VTDLK-PLAN 170
Query: 270 LRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGE 329
           L  LE L + S+ ++ +  + +  ++ L+ L  T+N +    P  I   L NL+ L L  
Sbjct: 171 LTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITPLGI---LTNLDELSLNG 225
Query: 330 NNFS--GTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDL 387
           N     GT+ +SLTN+++L   D   N  S L P     L  L  L L  N +++ +P  
Sbjct: 226 NQLKDIGTL-ASLTNLTDL---DLANNQISNLAP--LSGLTKLTELKLGANQISNISP-- 277
Query: 388 SFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINN 447
             L+ LT+  NLE   L+EN +  I P                           + N+ N
Sbjct: 278 --LAGLTALTNLE---LNENQLEDISP---------------------------ISNLKN 305
Query: 448 LTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLS 507
           LT + L  N ++   PV+   L KLQ L+  NNK+                         
Sbjct: 306 LTYLTLYFNNISDISPVS--SLTKLQRLFFYNNKVSDV---------------------- 341
Query: 508 GRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRF 547
               + L NLT++  LS G N ++ + P  L NL  I + 
Sbjct: 342 ----SSLANLTNINWLSAGHNQISDLTP--LANLTRITQL 375

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 769 LGMGSFG---SVYKGVLPDGMEIA-AKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
           +G G++G   S Y  +  + + +A  K+   E     +    E K++   RH N++ I  
Sbjct: 35  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGI-- 90
Query: 825 SCSNNDFKALVLEYMSNGSL-EKCLYSDNYFLDILQRLK------IMIDVASALEYLHFG 877
              N+  +A  +E M +  + +  + +D Y L   Q L        +  +   L+Y+H  
Sbjct: 91  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 145
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ--TKTLGTIGYMAPEYGR 935
            S  ++H D+KPSN+LLN +    + DFG+A++   +       T+ + T  Y APE   
Sbjct: 146 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 936 EGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
             K  ++  D++S G +L E  + +     IF G+  L +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 240

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 10/206 (4%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEF---DGSLESFHAECKVMGSIR- 815
           D F   ++LG GSFG V    + + G   A KV   +    D  +E    E +++   R 
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
           H  L ++       D    V+E+++ G L   +     F +   R     ++ SAL +LH
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISALMFLH 141
Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
                 I++ D+K  NVLL+      L+DFG+ K  G    +      GT  Y+APE  +
Sbjct: 142 ---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYIAPEILQ 197
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
           E       D ++ G++L E      P
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAP 223

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 101/241 (41%), Gaps = 9/241 (3%)
Query: 768  LLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKII 823
             LG G F   ++    D  E+ A K+            E    E  +  S+ H+++V   
Sbjct: 22   FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 824  SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIV 883
                +NDF  +VLE     SL + L+     L   +    +  +    +YLH      ++
Sbjct: 82   GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 137
Query: 884  HCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKC 943
            H D+K  N+ LNE +   + DFG+A  + + +  R+    GT  Y+APE   +   S + 
Sbjct: 138  HRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 196
Query: 944  DVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSA 1003
            DV+S G ++      K P +     E  L+    +  +   I  VA + +    + D +A
Sbjct: 197  DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTA 256
Query: 1004 R 1004
            R
Sbjct: 257  R 257

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 769 LGMGSFG---SVYKGVLPDGMEIA-AKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
           +G G++G   S Y  +  + + +A  K+   E     +    E K++   RH N++ I  
Sbjct: 35  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-- 90
Query: 825 SCSNNDFKALVLEYMSNGSL-EKCLYSDNYFLDILQRLK------IMIDVASALEYLHFG 877
              N+  +A  +E M +  + +  + +D Y L   Q L        +  +   L+Y+H  
Sbjct: 91  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 145
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ--TKTLGTIGYMAPEYGR 935
            S  ++H D+KPSN+LLN +    + DFG+A++   +       T+ + T  Y APE   
Sbjct: 146 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 936 EGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
             K  ++  D++S G +L E  + +     IF G+  L +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 240

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 761 DGFSENKLLGMGSFGSVY-KGVLPDGMEIAAKVFHMEFDGSLESFH---AECKVMGSIRH 816
           D F   K LG GSFG V     +  G   A K+   +    L+       E +++ ++  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY+  G +   L     F +   R      +    EYLH 
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 144
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK-ILGKEESMRQTKTLGTIGYMAPEYGR 935
             S  +++ D+KP N+L+++     ++DFG AK + G+  ++      GT  Y+APE   
Sbjct: 145 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL-----CGTPEYLAPEIIL 197
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP 961
               ++  D ++ G+++ E      P
Sbjct: 198 SKGYNKAVDWWALGVLIYEMAAGYPP 223

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 111/254 (43%), Gaps = 14/254 (5%)
Query: 759  ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGSIR 815
            + + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  + 
Sbjct: 4    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 816  HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
            H N+VK++      +   LV E++     +   + D   L  +    I   +   L+ L 
Sbjct: 64   HPNIVKLLDVIHTENKLYLVFEFLHQ---DLKTFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 876  FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
            F +S  ++H D+KP N+L+N      L+DFG+A+  G        + + T+ Y APE   
Sbjct: 121  FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 179
Query: 936  EGK-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEVAD 990
              K  S   D++S G +  E  T++   P D        + R +G  D ++   +T + D
Sbjct: 180  GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 239
Query: 991  --ANLLNCEENDFS 1002
               +       DFS
Sbjct: 240  YKPSFPKWARQDFS 253

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 769 LGMGSFG---SVYKGVLPDGMEIA-AKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
           +G G++G   S Y  +  + + +A  K+   E     +    E K++   RH N++ I  
Sbjct: 35  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-- 90
Query: 825 SCSNNDFKALVLEYMSNGSL-EKCLYSDNYFLDILQRLK------IMIDVASALEYLHFG 877
              N+  +A  +E M +  + +  + +D Y L   Q L        +  +   L+Y+H  
Sbjct: 91  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIH-- 145
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ--TKTLGTIGYMAPEYGR 935
            S  ++H D+KPSN+LLN +    + DFG+A++   +       T+ + T  Y APE   
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 936 EGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
             K  ++  D++S G +L E  + +     IF G+  L +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 240

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 36/216 (16%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLE--------SFHAECKVMGSIRHRN 818
           K++G G+FG V    L +    A KVF M+     E         F  E  V+ +   + 
Sbjct: 80  KVIGRGAFGEVAVVKLKN----ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDI----LQRLKIMIDVASALE 872
           +  +  +  +++   LV++Y   G L   L  + D    ++    L  + I ID    L 
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMA 930
           Y         VH DIKP N+L++  M GH  L+DFG    L ++ +++ +  +GT  Y++
Sbjct: 196 Y---------VHRDIKPDNILMD--MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 931 PEY-----GREGKVSRKCDVYSYGIMLMETFTKKKP 961
           PE      G +G+   +CD +S G+ + E    + P
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 23/222 (10%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGME-IAAKVFHMEFD--GSLESFHAECKVMGSIRHR 817
           D +     LG G++G VYK +     E +A K   +E +  G   +   E  ++  ++HR
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 818 NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
           N++++ S   +N    L+ EY  N  L+K +  +    D+  R+ I   +   +  ++F 
Sbjct: 94  NIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP---DVSMRV-IKSFLYQLINGVNFC 148
Query: 878 YSTPIVHCDIKPSNVLL-----NESMVGHLSDFGIAKILGKEESMRQ-TKTLGTIGYMAP 931
           +S   +H D+KP N+LL     +E+ V  + DFG+A+  G    +RQ T  + T+ Y  P
Sbjct: 149 HSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI--PIRQFTHEIITLWYRPP 206
Query: 932 EYGREGK-VSRKCDVYS----YGIMLMET--FTKKKPTDEIF 966
           E     +  S   D++S    +  MLM+T  F      D++F
Sbjct: 207 EILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF 248

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 30/223 (13%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAK----VFHMEFDGSLESFH----AECKVMG 812
           D     K LG G+FG V +     G++  A        M  +G+  S H    +E K++ 
Sbjct: 29  DRLKLGKPLGRGAFGQVIEAD-AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 87
Query: 813 SI-RHRNLVKIISSCSNNDFKALVL-EYMSNGSLEKCLYS-------------DNY--FL 855
            I  H N+V ++ +C+      +V+ E+   G+L   L S             D Y  FL
Sbjct: 88  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFL 147
Query: 856 DILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE- 914
            +   +     VA  +E+L    S   +H D+   N+LL+E  V  + DFG+A+ + K+ 
Sbjct: 148 TLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 204
Query: 915 ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           + +R+      + +MAPE   +   + + DV+S+G++L E F+
Sbjct: 205 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 30/223 (13%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAK----VFHMEFDGSLESFH----AECKVMG 812
           D     K LG G+FG V +     G++  A        M  +G+  S H    +E K++ 
Sbjct: 18  DRLKLGKPLGRGAFGQVIEAD-AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 76
Query: 813 SI-RHRNLVKIISSCSNNDFKALVL-EYMSNGSLEKCLYS-------------DNY--FL 855
            I  H N+V ++ +C+      +V+ E+   G+L   L S             D Y  FL
Sbjct: 77  HIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 136
Query: 856 DILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE- 914
            +   +     VA  +E+L    S   +H D+   N+LL+E  V  + DFG+A+ + K+ 
Sbjct: 137 TLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 193
Query: 915 ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           + +R+      + +MAPE   +   + + DV+S+G++L E F+
Sbjct: 194 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 30/223 (13%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAK----VFHMEFDGSLESFH----AECKVMG 812
           D     K LG G+FG V +     G++  A        M  +G+  S H    +E K++ 
Sbjct: 27  DRLKLGKPLGRGAFGQVIEAD-AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 85
Query: 813 SI-RHRNLVKIISSCSNNDFKALVL-EYMSNGSLEKCLYS-------------DNY--FL 855
            I  H N+V ++ +C+      +V+ E+   G+L   L S             D Y  FL
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 856 DILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE- 914
            +   +     VA  +E+L    S   +H D+   N+LL+E  V  + DFG+A+ + K+ 
Sbjct: 146 TLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202
Query: 915 ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           + +R+      + +MAPE   +   + + DV+S+G++L E F+
Sbjct: 203 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 30/223 (13%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAK----VFHMEFDGSLESFH----AECKVMG 812
           D     K LG G+FG V +     G++  A        M  +G+  S H    +E K++ 
Sbjct: 18  DRLKLGKPLGRGAFGQVIEAD-AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 76
Query: 813 SI-RHRNLVKIISSCSNNDFKALVL-EYMSNGSLEKCLYS-------------DNY--FL 855
            I  H N+V ++ +C+      +V+ E+   G+L   L S             D Y  FL
Sbjct: 77  HIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 136
Query: 856 DILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE- 914
            +   +     VA  +E+L    S   +H D+   N+LL+E  V  + DFG+A+ + K+ 
Sbjct: 137 TLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 193
Query: 915 ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           + +R+      + +MAPE   +   + + DV+S+G++L E F+
Sbjct: 194 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 769 LGMGSFG---SVYKGVLPDGMEIA-AKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
           +G G++G   S Y  +  + + +A  K+   E     +    E K++   RH N++ I  
Sbjct: 36  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-- 91
Query: 825 SCSNNDFKALVLEYMSNGSL-EKCLYSDNYFLDILQRLK------IMIDVASALEYLHFG 877
              N+  +A  +E M +  + +  + +D Y L   Q L        +  +   L+Y+H  
Sbjct: 92  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 146
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ--TKTLGTIGYMAPEYGR 935
            S  ++H D+KPSN+LLN +    + DFG+A++   +       T+ + T  Y APE   
Sbjct: 147 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 936 EGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
             K  ++  D++S G +L E  + +     IF G+  L +
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 241

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 769 LGMGSFG---SVYKGVLPDGMEIA-AKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
           +G G++G   S Y  +  + + +A  K+   E     +    E K++   RH N++ I  
Sbjct: 37  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-- 92
Query: 825 SCSNNDFKALVLEYMSNGSL-EKCLYSDNYFLDILQRLK------IMIDVASALEYLHFG 877
              N+  +A  +E M +  + +  + +D Y L   Q L        +  +   L+Y+H  
Sbjct: 93  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 147
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ--TKTLGTIGYMAPEYGR 935
            S  ++H D+KPSN+LLN +    + DFG+A++   +       T+ + T  Y APE   
Sbjct: 148 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 936 EGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
             K  ++  D++S G +L E  + +     IF G+  L +
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 242

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 769 LGMGSFG---SVYKGVLPDGMEIA-AKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
           +G G++G   S Y  +  + + +A  K+   E     +    E K++   RH N++ I  
Sbjct: 28  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-- 83
Query: 825 SCSNNDFKALVLEYMSNGSL-EKCLYSDNYFLDILQRLK------IMIDVASALEYLHFG 877
              N+  +A  +E M +  + +  + +D Y L   Q L        +  +   L+Y+H  
Sbjct: 84  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 138
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ--TKTLGTIGYMAPEYGR 935
            S  ++H D+KPSN+LLN +    + DFG+A++   +       T+ + T  Y APE   
Sbjct: 139 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 936 EGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
             K  ++  D++S G +L E  + +     IF G+  L +
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 233

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 769 LGMGSFG---SVYKGVLPDGMEIA-AKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
           +G G++G   S Y  +  + + +A  K+   E     +    E K++   RH N++ I  
Sbjct: 35  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-- 90
Query: 825 SCSNNDFKALVLEYMSNGSL-EKCLYSDNYFLDILQRLK------IMIDVASALEYLHFG 877
              N+  +A  +E M +  + +  + +D Y L   Q L        +  +   L+Y+H  
Sbjct: 91  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 145
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ--TKTLGTIGYMAPEYGR 935
            S  ++H D+KPSN+LLN +    + DFG+A++   +       T+ + T  Y APE   
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 936 EGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
             K  ++  D++S G +L E  + +     IF G+  L +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 240

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 111/254 (43%), Gaps = 14/254 (5%)
Query: 759  ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGSIR 815
            + + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  + 
Sbjct: 1    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 816  HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
            H N+VK++      +   LV E++     +   + D   L  +    I   +   L+ L 
Sbjct: 61   HPNIVKLLDVIHTENKLYLVFEFLHQDLKD---FMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 876  FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
            F +S  ++H D+KP N+L+N      L+DFG+A+  G        + + T+ Y APE   
Sbjct: 118  FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 176
Query: 936  EGK-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEVAD 990
              K  S   D++S G +  E  T++   P D        + R +G  D ++   +T + D
Sbjct: 177  GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 236
Query: 991  --ANLLNCEENDFS 1002
               +       DFS
Sbjct: 237  YKPSFPKWARQDFS 250

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 30/223 (13%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAK----VFHMEFDGSLESFH----AECKVMG 812
           D     K LG G+FG V +     G++  A        M  +G+  S H    +E K++ 
Sbjct: 64  DRLKLGKPLGRGAFGQVIEAD-AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 122
Query: 813 SIRHR-NLVKIISSCSNNDFKALVL-EYMSNGSLEKCLYS-------------DNY--FL 855
            I H  N+V ++ +C+      +V+ E+   G+L   L S             D Y  FL
Sbjct: 123 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 182
Query: 856 DILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE- 914
            +   +     VA  +E+L    S   +H D+   N+LL+E  V  + DFG+A+ + K+ 
Sbjct: 183 TLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 239
Query: 915 ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           + +R+      + +MAPE   +   + + DV+S+G++L E F+
Sbjct: 240 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 23/212 (10%)
Query: 768 LLGMGSFGSVYKGVLPD-GMEIAAKVFH-MEFDGSLESFHAECKVMGSIRHRNLVKI--I 823
           +LG G+  +V++G     G   A KVF+ + F   ++    E +V+  + H+N+VK+  I
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 824 SSCSNNDFKALVLEYMSNGSLEKCLY--SDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
              +    K L++E+   GSL   L   S+ Y L   + L ++ DV   + +L       
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132
Query: 882 IVHCDIKPSNVLL----NESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE-YGR- 935
           IVH +IKP N++     +   V  L+DFG A+ L  +E        GT  Y+ P+ Y R 
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VXLYGTEEYLHPDMYERA 190
Query: 936 ------EGKVSRKCDVYSYGIMLMETFTKKKP 961
                 + K     D++S G+      T   P
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 110/252 (43%), Gaps = 14/252 (5%)
Query: 761  DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--EFDGSLESFHAECKVMGSIRHR 817
            + F + + +G G++G VYK      G  +A K   +  E +G   +   E  ++  + H 
Sbjct: 2    ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 818  NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
            N+VK++      +   LV E++     +   + D   L  +    I   +   L+ L F 
Sbjct: 62   NIVKLLDVIHTENKLYLVFEHVHQ---DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 878  YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG 937
            +S  ++H D+KP N+L+N      L+DFG+A+  G       T  + T+ Y APE     
Sbjct: 119  HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGC 177
Query: 938  K-VSRKCDVYSYGIMLMETFTKKK--PTDEIFAGEMSLKRWVG--DSLLSCSITEVAD-- 990
            K  S   D++S G +  E  T++   P D        + R +G  D ++   +T + D  
Sbjct: 178  KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 991  ANLLNCEENDFS 1002
             +       DFS
Sbjct: 238  PSFPKWARQDFS 249

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 23/212 (10%)
Query: 768 LLGMGSFGSVYKGVLPD-GMEIAAKVFH-MEFDGSLESFHAECKVMGSIRHRNLVKI--I 823
           +LG G+  +V++G     G   A KVF+ + F   ++    E +V+  + H+N+VK+  I
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 824 SSCSNNDFKALVLEYMSNGSLEKCLY--SDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
              +    K L++E+   GSL   L   S+ Y L   + L ++ DV   + +L       
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132
Query: 882 IVHCDIKPSNVLL----NESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE-YGR- 935
           IVH +IKP N++     +   V  L+DFG A+ L  +E        GT  Y+ P+ Y R 
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLHPDMYERA 190
Query: 936 ------EGKVSRKCDVYSYGIMLMETFTKKKP 961
                 + K     D++S G+      T   P
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 769 LGMGSFG---SVYKGVLPDGMEIA-AKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
           +G G++G   S Y  +  + + +A  K+   E     +    E K++   RH N++ I  
Sbjct: 35  IGEGAYGMVCSAYDNL--NKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGI-- 90
Query: 825 SCSNNDFKALVLEYMSNGSL-EKCLYSDNYFLDILQRLK------IMIDVASALEYLHFG 877
              N+  +A  +E M +  + +  + +D Y L   Q L        +  +   L+Y+H  
Sbjct: 91  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 145
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ--TKTLGTIGYMAPEYGR 935
            S  ++H D+KPSN+LLN +    + DFG+A++   +       T+ + T  Y APE   
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 936 EGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
             K  ++  D++S G +L E  + +     IF G+  L +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 240

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 769 LGMGSFG---SVYKGVLPDGMEIA-AKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
           +G G++G   S Y  +  + + +A  K+   E     +    E K++   RH N++ I  
Sbjct: 29  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-- 84
Query: 825 SCSNNDFKALVLEYMSNGSL-EKCLYSDNYFLDILQRLK------IMIDVASALEYLHFG 877
              N+  +A  +E M +  + +  + +D Y L   Q L        +  +   L+Y+H  
Sbjct: 85  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 139
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ--TKTLGTIGYMAPEYGR 935
            S  ++H D+KPSN+LLN +    + DFG+A++   +       T+ + T  Y APE   
Sbjct: 140 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 936 EGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
             K  ++  D++S G +L E  + +     IF G+  L +
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 234

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 769 LGMGSFG---SVYKGVLPDGMEIA-AKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
           +G G++G   S Y  +  + + +A  K+   E     +    E K++   RH N++ I  
Sbjct: 29  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-- 84
Query: 825 SCSNNDFKALVLEYMSNGSL-EKCLYSDNYFLDILQRLK------IMIDVASALEYLHFG 877
              N+  +A  +E M +  + +  + +D Y L   Q L        +  +   L+Y+H  
Sbjct: 85  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 139
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ--TKTLGTIGYMAPEYGR 935
            S  ++H D+KPSN+LLN +    + DFG+A++   +       T+ + T  Y APE   
Sbjct: 140 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 936 EGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
             K  ++  D++S G +L E  + +     IF G+  L +
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 234

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 15/156 (9%)
Query: 805 HAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIM 864
             E +++  + H  ++KI +     D+  +VLE M  G L   +  +    +   +L   
Sbjct: 62  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YF 119
Query: 865 IDVASALEYLHFGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGKEESMRQTK 921
             +  A++YLH      I+H D+KP NVLL+   E  +  ++DFG +KILG+   MR   
Sbjct: 120 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-- 174
Query: 922 TLGTIGYMAPE----YGREGKVSRKCDVYSYGIMLM 953
             GT  Y+APE     G  G  +R  D +S G++L 
Sbjct: 175 LCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILF 209

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V      + G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY++ G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+AP     
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPAIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 28/213 (13%)
Query: 772 GSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGS--IRHRNLVKIISS---C 826
           G FG V+K  L +   +A K+F ++     +S+ +E ++  +  ++H NL++ I++    
Sbjct: 26  GRFGCVWKAQLMNDF-VAVKIFPLQ---DKQSWQSEREIFSTPGMKHENLLQFIAAEKRG 81
Query: 827 SNNDFKA-LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF--------G 877
           SN + +  L+  +   GSL    Y     +   +   +   ++  L YLH         G
Sbjct: 82  SNLEVELWLITAFHDKGSLTD--YLKGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEG 139
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK-TLGTIGYMAPEYGRE 936
           +   I H D K  NVLL   +   L+DFG+A      +    T   +GT  YMAPE   E
Sbjct: 140 HKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEV-LE 198
Query: 937 GKVS------RKCDVYSYGIMLMETFTKKKPTD 963
           G ++       + D+Y+ G++L E  ++ K  D
Sbjct: 199 GAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 82/165 (49%), Gaps = 16/165 (9%)
Query: 796 EFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFL 855
           E D +L +   E +++  + H  ++KI +     D+  +VLE M  G L   +  +    
Sbjct: 61  EADPAL-NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLK 118
Query: 856 DILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILG 912
           +   +L     +  A++YLH      I+H D+KP NVLL+   E  +  ++DFG +KILG
Sbjct: 119 EATCKL-YFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 174
Query: 913 KEESMRQTKTLGTIGYMAPE----YGREGKVSRKCDVYSYGIMLM 953
           +   MR     GT  Y+APE     G  G  +R  D +S G++L 
Sbjct: 175 ETSLMRT--LCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILF 216

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 82/165 (49%), Gaps = 16/165 (9%)
Query: 796 EFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFL 855
           E D +L +   E +++  + H  ++KI +     D+  +VLE M  G L   +  +    
Sbjct: 55  EADPAL-NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLK 112
Query: 856 DILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILG 912
           +   +L     +  A++YLH      I+H D+KP NVLL+   E  +  ++DFG +KILG
Sbjct: 113 EATCKL-YFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168
Query: 913 KEESMRQTKTLGTIGYMAPE----YGREGKVSRKCDVYSYGIMLM 953
           +   MR     GT  Y+APE     G  G  +R  D +S G++L 
Sbjct: 169 ETSLMRT--LCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILF 210

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 15/156 (9%)
Query: 805 HAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIM 864
             E +++  + H  ++KI +     D+  +VLE M  G L   +  +    +   +L   
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YF 120
Query: 865 IDVASALEYLHFGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGKEESMRQTK 921
             +  A++YLH      I+H D+KP NVLL+   E  +  ++DFG +KILG+   MR   
Sbjct: 121 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-- 175
Query: 922 TLGTIGYMAPE----YGREGKVSRKCDVYSYGIMLM 953
             GT  Y+APE     G  G  +R  D +S G++L 
Sbjct: 176 LCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILF 210

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 12/205 (5%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFH---AECKVMGSIRH 816
           D F   K LG GSFG V      + G   A K+   +    L+       E +++ ++  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY+  G +   L     F +   R      +    EYLH 
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 151
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 205
Query: 937 GKVSRKCDVYSYGIMLMETFTKKKP 961
              ++  D ++ G+++ E      P
Sbjct: 206 KGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 15/156 (9%)
Query: 805 HAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIM 864
             E +++  + H  ++KI +     D+  +VLE M  G L   +  +    +   +L   
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YF 120
Query: 865 IDVASALEYLHFGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGKEESMRQTK 921
             +  A++YLH      I+H D+KP NVLL+   E  +  ++DFG +KILG+   MR   
Sbjct: 121 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-- 175
Query: 922 TLGTIGYMAPE----YGREGKVSRKCDVYSYGIMLM 953
             GT  Y+APE     G  G  +R  D +S G++L 
Sbjct: 176 LCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILF 210

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 766 NKLLGMGSFGSVYKGVLPD--------GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHR 817
           N+ LG G+F  ++KGV  +          E+  KV         ESF     +M  + H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 818 NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
           +LV     C   D   LV E++  GSL+  L  +   ++IL +L++   +A A   +HF 
Sbjct: 73  HLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWA---MHFL 129
Query: 878 YSTPIVHCDIKPSNVLL---NESMVGH-----LSDFGIAKILGKEESMRQTKTLGTIGYM 929
               ++H ++   N+LL    +   G+     LSD GI+  +  ++ +++      I ++
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQE-----RIPWV 184
Query: 930 APEYGREGK-VSRKCDVYSYGIMLME 954
            PE     K ++   D +S+G  L E
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWE 210

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVY-KGVLPDGMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V     +  G   A K+   +    L+       E +++ ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             L K+  S  +N    +V+EY   G +   L     F +   R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+++++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 213
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 214 KGYNKAVDWWALGVLIYE 231

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 27/78 (34%), Positives = 41/78 (52%)
Query: 884 HCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKC 943
           H D+KP N+L++     +L DFGIA     E+  +   T+GT+ Y APE   E   + + 
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRA 216
Query: 944 DVYSYGIMLMETFTKKKP 961
           D+Y+   +L E  T   P
Sbjct: 217 DIYALTCVLYECLTGSPP 234

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 118/275 (42%), Gaps = 34/275 (12%)
Query: 765  ENKLLGMGSFGSVYKGVLPDGME-IAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKII 823
            ++K LG GSF    K V     +  A K+     + + +      K+     H N+VK+ 
Sbjct: 15   KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG--HPNIVKLH 72
Query: 824  SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIV 883
                +     LV+E ++ G L + +    +F +  +   IM  + SA+ ++H      +V
Sbjct: 73   EVFHDQLHTFLVMELLNGGELFERIKKKKHFSET-EASYIMRKLVSAVSHMH---DVGVV 128
Query: 884  HCDIKPSNVLL---NESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVS 940
            H D+KP N+L    N+++   + DFG A++   +    +T    T+ Y APE   +    
Sbjct: 129  HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF-TLHYAAPELLNQNGYD 187
Query: 941  RKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSC-SITEVADANLLNCEEN 999
              CD++S G++L    + + P                D  L+C S  E+    +   ++ 
Sbjct: 188  ESCDLWSLGVILYTMLSGQVPFQS------------HDRSLTCTSAVEI----MKKIKKG 231
Query: 1000 DFSAREQCVSSIFSLAMD-----CTVDLPEKRISM 1029
            DFS   +   ++   A D      TVD P KR+ M
Sbjct: 232  DFSFEGEAWKNVSQEAKDLIQGLLTVD-PNKRLKM 265

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 86/198 (43%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   + LG GSFG V      + G   A K+   +    L+       E ++  ++  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +VLEY   G +   L     F +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPEIILS 213
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 214 KGYNKAVDWWALGVLIYE 231

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 863 IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT 922
           +M  +   L++LH   S  +VH D+KP N+L+  S    L+DFG+A+I   +  M  T  
Sbjct: 125 MMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSV 179
Query: 923 LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKK 959
           + T+ Y APE   +   +   D++S G +  E F +K
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 87/198 (43%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V      + G   A K+   +    L+       E +++ ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY   G +   L     F +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+++++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 213
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 214 KGYNKAVDWWALGVLIYE 231

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 863 IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT 922
           +M  +   L++LH   S  +VH D+KP N+L+  S    L+DFG+A+I   +  M  T  
Sbjct: 125 MMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSV 179
Query: 923 LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKK 959
           + T+ Y APE   +   +   D++S G +  E F +K
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 863 IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT 922
           +M  +   L++LH   S  +VH D+KP N+L+  S    L+DFG+A+I   +  M  T  
Sbjct: 125 MMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSV 179
Query: 923 LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKK 959
           + T+ Y APE   +   +   D++S G +  E F +K
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 12/205 (5%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFH---AECKVMGSIRH 816
           D F   K LG GSFG V      + G   A K+   +    L+       E +++ ++  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY+  G +   L     F +   R      +    EYLH 
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 151
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 205
Query: 937 GKVSRKCDVYSYGIMLMETFTKKKP 961
              ++  D ++ G+++ E      P
Sbjct: 206 KGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 93/223 (41%), Gaps = 39/223 (17%)
Query: 769 LGMGSFGSVYKGVLPD---GMEIAAKVFHMEFDGSLESFHAE----CKVMGSIRHRNLVK 821
           LG GSFG V++  + D   G + A K         LE F AE    C  + S R   +V 
Sbjct: 82  LGRGSFGEVHR--MEDKQTGFQCAVKKV------RLEVFRAEELMACAGLTSPR---IVP 130
Query: 822 IISSCSNNDFKALVLEYMSNGSL------EKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
           +  +     +  + +E +  GSL      + CL  D     + Q L+        LEYLH
Sbjct: 131 LYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALE-------GLEYLH 183
Query: 876 FGYSTPIVHCDIKPSNVLL-NESMVGHLSDFGIAKILGKEESMRQTKT----LGTIGYMA 930
              S  I+H D+K  NVLL ++     L DFG A  L  +   +   T     GT  +MA
Sbjct: 184 ---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMA 240
Query: 931 PEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
           PE         K DV+S   M++       P  + F G + LK
Sbjct: 241 PEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 283

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAA-KVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISS 825
           +G G++G+V+K    +  EI A K   ++ D  G   S   E  ++  ++H+N+V++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNYFLD--ILQRLKIMIDVASALEYLHFGYSTPIV 883
             ++    LV E+  +  L+K   S N  LD  I++     +     L+ L F +S  ++
Sbjct: 70  LHSDKKLTLVFEF-CDQDLKKYFDSCNGDLDPEIVKSFLFQL-----LKGLGFCHSRNVL 123
Query: 884 HCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKV-SRK 942
           H D+KP N+L+N +    L+DFG+A+  G        + + T+ Y  P+     K+ S  
Sbjct: 124 HRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTS 182
Query: 943 CDVYSYGIMLMETFTKKKP 961
            D++S G +  E     +P
Sbjct: 183 IDMWSAGCIFAELANAARP 201

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVY-KGVLPDGMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V     +  G   A K+   +    L+       E +++ ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             L K+  S  +N    +V+EY   G +   L     F +   R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+++++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 213
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 214 KGYNKAVDWWALGVLIYE 231

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 90/221 (40%), Gaps = 35/221 (15%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDG-SLESFHAE----CKVMGSIRHRNLVKII 823
           LG GSFG V++      ME     F        LE F AE    C  + S R   +V + 
Sbjct: 101 LGRGSFGEVHR------MEDKQTGFQCAVKKVRLEVFRAEELMACAGLTSPR---IVPLY 151
Query: 824 SSCSNNDFKALVLEYMSNGSL------EKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
            +     +  + +E +  GSL      + CL  D     + Q L+        LEYLH  
Sbjct: 152 GAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALE-------GLEYLH-- 202
Query: 878 YSTPIVHCDIKPSNVLL-NESMVGHLSDFGIAKILGKEESMRQTKT----LGTIGYMAPE 932
            S  I+H D+K  NVLL ++     L DFG A  L  +   +   T     GT  +MAPE
Sbjct: 203 -SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPE 261
Query: 933 YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
                    K DV+S   M++       P  + F G + LK
Sbjct: 262 VVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 302

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 68/148 (45%), Gaps = 24/148 (16%)
Query: 862  KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK 921
            KI +    AL   H   +  I+H DIKPSN+LL+ S    L DFGI+  L   +S+ +T+
Sbjct: 129  KITLATVKALN--HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIAKTR 184
Query: 922  TLGTIGYMAPEY-----GREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRW- 975
              G   YMAPE       R+G   R  DV+S GI L E  T          G     +W 
Sbjct: 185  DAGCRPYMAPERIDPSASRQGYDVRS-DVWSLGITLYELAT----------GRFPYPKWN 233
Query: 976  -VGDSLLSCSITEVADANLLNCEENDFS 1002
             V D L    + +     L N EE +FS
Sbjct: 234  SVFDQL--TQVVKGDPPQLSNSEEREFS 259

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 54/217 (24%), Positives = 102/217 (47%), Gaps = 27/217 (12%)
Query: 753 YQDLLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVM 811
           ++D+ + T     ++LLG G++  V   V L +G E A K+   +   S      E + +
Sbjct: 10  FEDMYKLT-----SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETL 64
Query: 812 GSIR-HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASA 870
              + ++N++++I    ++    LV E +  GS+   +    +F +  +  +++ DVA+A
Sbjct: 65  YQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNE-REASRVVRDVAAA 123
Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNE----SMVGHLSDFGIAKILGKEESMRQTKT---- 922
           L++LH   +  I H D+KP N+L       S V  + DF +   +    S     T    
Sbjct: 124 LDFLH---TKGIAHRDLKPENILCESPEKVSPV-KICDFDLGSGMKLNNSCTPITTPELT 179
Query: 923 --LGTIGYMAPEY-----GREGKVSRKCDVYSYGIML 952
              G+  YMAPE       +     ++CD++S G++L
Sbjct: 180 TPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVL 216

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVY-KGVLPDGMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V     +  G   A K+   +    L+       E +++ ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             L K+  S  +N    +V+EY   G +   L     F +   R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+++++     ++DFG AK +      R     GT  Y+APE    
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 213
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 214 KGYNKAVDWWALGVLIYE 231

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHA---ECKVMGSIRH 816
           D F   K LG GSFG V      + G   A K+   +    L+       E +++ ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             LVK+  S  +N    +V+EY++ G +   L     F +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +++ D+KP N+L+++     ++DFG AK +      R     GT   +APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEALAPEIILS 212
Query: 937 GKVSRKCDVYSYGIMLME 954
              ++  D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 772 GSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISS----CS 827
           G FG V+K  L +   +A K+F ++   S ++ + E   +  ++H N+++ I +     S
Sbjct: 35  GRFGCVWKAQLLNEY-VAVKIFPIQDKQSWQNEY-EVYSLPGMKHENILQFIGAEKRGTS 92
Query: 828 NNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF-------GYST 880
            +    L+  +   GSL   L ++    + L    I   +A  L YLH        G+  
Sbjct: 93  VDVDLWLITAFHEKGSLSDFLKANVVSWNEL--CHIAETMARGLAYLHEDIPGLKDGHKP 150
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK-TLGTIGYMAPEYGREGKV 939
            I H DIK  NVLL  ++   ++DFG+A      +S   T   +GT  YMAPE   EG +
Sbjct: 151 AISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV-LEGAI 209
Query: 940 S------RKCDVYSYGIMLMETFTK----KKPTDE 964
           +       + D+Y+ G++L E  ++      P DE
Sbjct: 210 NFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 46/151 (30%), Positives = 78/151 (51%), Gaps = 18/151 (11%)
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
           HRN++++I      D   LV E M  GS+   ++   +F + L+   ++ DVASAL++LH
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNE-LEASVVVQDVASALDFLH 128
Query: 876 FGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIA---KILGKEESMRQTKTL---GTI 926
              +  I H D+KP N+L    N+     + DF +    K+ G    +   + L   G+ 
Sbjct: 129 ---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 927 GYMAPE----YGREGKV-SRKCDVYSYGIML 952
            YMAPE    +  E  +  ++CD++S G++L
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 117/281 (41%), Gaps = 55/281 (19%)
Query: 766  NKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHR-NLVKII 823
            +K LG G F  V + +    G E AAK       G       +C+    I H   ++++ 
Sbjct: 34   SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ------DCR--AEILHEIAVLELA 85
Query: 824  SSC----------SNNDFKALVLEYMSNGSL-EKCLYSDNYFLDILQRLKIMIDVASALE 872
             SC           N     L+LEY + G +   CL       +++    ++  +   LE
Sbjct: 86   KSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPE---LAEMVSENDVIRLIKQILE 142
Query: 873  YLHFGYSTPIVHCDIKPSNVLLNESM-VGHLS--DFGIAKILGKEESMRQTKTLGTIGYM 929
             +++ +   IVH D+KP N+LL+    +G +   DFG+++ +G    +R+   +GT  Y+
Sbjct: 143  GVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IMGTPEYL 200
Query: 930  APEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA 989
            APE      ++   D+++ GI+     T   P    F GE + + +              
Sbjct: 201  APEILNYDPITTATDMWNIGIIAYMLLTHTSP----FVGEDNQETY-------------- 242
Query: 990  DANLLNCEENDFSAREQCVSSIFSLAMDCTVDL----PEKR 1026
                LN  + +    E+  SS+  LA D    L    PEKR
Sbjct: 243  ----LNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKR 279

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 38/107 (35%), Positives = 57/107 (53%), Gaps = 10/107 (9%)
Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK 921
           KI + +  ALE+LH   S  ++H D+KPSNVL+N      + DFGI+  L   + + +  
Sbjct: 113 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDI 168
Query: 922 TLGTIGYMA-----PEYGREGKVSRKCDVYSYGIMLMETFTKKKPTD 963
             G   YMA     PE  ++G  S K D++S GI ++E    + P D
Sbjct: 169 DAGCKPYMAPERINPELNQKG-YSVKSDIWSLGITMIELAILRFPYD 214

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 4/92 (4%)
Query: 867 VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK-ILGKEESMRQTKTLGT 925
           VA  +E+L    S   +H D+   N+LL+E+ V  + DFG+A+ I    + +R+  T   
Sbjct: 208 VARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 926 IGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           + +MAPE   +   S K DV+SYG++L E F+
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 769 LGMGSFG---SVYKGVLPDGMEIA-AKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
           +G G++G   S Y  +  + + +A  K+   E     +    E K++   RH N++ I  
Sbjct: 35  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-- 90
Query: 825 SCSNNDFKALVLEYMSNGSL-EKCLYSDNYFLDILQRLK------IMIDVASALEYLHFG 877
              N+  +A  +E M +  + +  + +D Y L   Q L        +  +   L+Y+H  
Sbjct: 91  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 145
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ--TKTLGTIGYMAPEYGR 935
            S  ++H D+KPSN+LLN +    + DFG+A++   +        + + T  Y APE   
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 204
Query: 936 EGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
             K  ++  D++S G +L E  + +     IF G+  L +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 240

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 769 LGMGSFG---SVYKGVLPDGMEIA-AKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
           +G G++G   S Y  +  + + +A  K+   E     +    E K++   RH N++ I  
Sbjct: 36  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-- 91
Query: 825 SCSNNDFKALVLEYMSNGSL-EKCLYSDNYFLDILQRLK------IMIDVASALEYLHFG 877
              N+  +A  +E M +  + +  + +D Y L   Q L        +  +   L+Y+H  
Sbjct: 92  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 146
Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ--TKTLGTIGYMAPEYGR 935
            S  ++H D+KPSN+LLN +    + DFG+A++   +        + + T  Y APE   
Sbjct: 147 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 205
Query: 936 EGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
             K  ++  D++S G +L E  + +     IF G+  L +
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 241

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 118/243 (48%), Gaps = 42/243 (17%)
Query: 767 KLLGMGSFGSV-YKGVLPDGMEIAAKVFHMEF-DGSLESFHAECKVMG-SIRHRNLVKII 823
           K+LG GS G+V ++G    G  +A K   ++F D +L     E K++  S  H N+++  
Sbjct: 21  KILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIAL----MEIKLLTESDDHPNVIRYY 75
Query: 824 SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK------IMIDVASALEYLHFG 877
            S + + F  + LE + N +L+  + S N   + L+  K      ++  +AS + +LH  
Sbjct: 76  CSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-- 132
Query: 878 YSTPIVHCDIKPSNVLLN-------------ESMVGHLSDFGIAKILGKEESMRQT---K 921
            S  I+H D+KP N+L++             E++   +SDFG+ K L   +S  +T    
Sbjct: 133 -SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 922 TLGTIGYMAPEYGREG-------KVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLK 973
             GT G+ APE   E        +++R  D++S G +     +K K P  + ++ E ++ 
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 251
Query: 974 RWV 976
           R +
Sbjct: 252 RGI 254

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 102/227 (44%), Gaps = 26/227 (11%)
Query: 748 WRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAE 807
           W+ +     L   D FS ++++G G FG VY     D      K++ M+          +
Sbjct: 177 WKNVELNIHLTMND-FSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQ 231
Query: 808 CKVMGSIRHRNLVKIISS-------CSNNDFK-----ALVLEYMSNGSLEKCLYSDNYFL 855
            + + ++  R ++ ++S+       C +  F      + +L+ M+ G L   L     F 
Sbjct: 232 GETL-ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS 290
Query: 856 DILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE 915
           +   R     ++   LE++H  +   +V+ D+KP+N+LL+E     +SD G+A    K+ 
Sbjct: 291 EADMRF-YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 345
Query: 916 SMRQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKP 961
             +   ++GT GYMAPE  ++G       D +S G ML +      P
Sbjct: 346 --KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 102/227 (44%), Gaps = 26/227 (11%)
Query: 748 WRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAE 807
           W+ +     L   D FS ++++G G FG VY     D      K++ M+          +
Sbjct: 177 WKNVELNIHLTMND-FSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQ 231
Query: 808 CKVMGSIRHRNLVKIISS-------CSNNDFK-----ALVLEYMSNGSLEKCLYSDNYFL 855
            + + ++  R ++ ++S+       C +  F      + +L+ M+ G L   L     F 
Sbjct: 232 GETL-ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS 290
Query: 856 DILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE 915
           +   R     ++   LE++H  +   +V+ D+KP+N+LL+E     +SD G+A    K+ 
Sbjct: 291 EADMRF-YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 345
Query: 916 SMRQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKP 961
             +   ++GT GYMAPE  ++G       D +S G ML +      P
Sbjct: 346 --KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 102/227 (44%), Gaps = 26/227 (11%)
Query: 748 WRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAE 807
           W+ +     L   D FS ++++G G FG VY     D      K++ M+          +
Sbjct: 177 WKNVELNIHLTMND-FSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQ 231
Query: 808 CKVMGSIRHRNLVKIISS-------CSNNDFK-----ALVLEYMSNGSLEKCLYSDNYFL 855
            + + ++  R ++ ++S+       C +  F      + +L+ M+ G L   L     F 
Sbjct: 232 GETL-ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS 290
Query: 856 DILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE 915
           +   R     ++   LE++H  +   +V+ D+KP+N+LL+E     +SD G+A    K+ 
Sbjct: 291 EADMRF-YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 345
Query: 916 SMRQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKP 961
             +   ++GT GYMAPE  ++G       D +S G ML +      P
Sbjct: 346 --KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 102/227 (44%), Gaps = 26/227 (11%)
Query: 748 WRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAE 807
           W+ +     L   D FS ++++G G FG VY     D      K++ M+          +
Sbjct: 176 WKNVELNIHLTMND-FSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQ 230
Query: 808 CKVMGSIRHRNLVKIISS-------CSNNDFK-----ALVLEYMSNGSLEKCLYSDNYFL 855
            + + ++  R ++ ++S+       C +  F      + +L+ M+ G L   L     F 
Sbjct: 231 GETL-ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS 289
Query: 856 DILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE 915
           +   R     ++   LE++H  +   +V+ D+KP+N+LL+E     +SD G+A    K+ 
Sbjct: 290 EADMRF-YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 344
Query: 916 SMRQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKP 961
             +   ++GT GYMAPE  ++G       D +S G ML +      P
Sbjct: 345 --KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 16/212 (7%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA----KVFHMEFDGSLESFH--AECKVMG 812
           AT  +     +G+G++G+VYK   P      A    +V + E    + +    A  + + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 813 SIRHRNLVKIISSC----SNNDFK-ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDV 867
           +  H N+V+++  C    ++ + K  LV E++     +   Y D      L    I   +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ---DLRTYLDKAPPPGLPAETIKDLM 118
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIG 927
              L  L F ++  IVH D+KP N+L+       L+DFG+A+I   +  M     + T+ 
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALAPVVVTLW 176
Query: 928 YMAPEYGREGKVSRKCDVYSYGIMLMETFTKK 959
           Y APE   +   +   D++S G +  E F +K
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 19/215 (8%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHM--------EFDGSLESFHAECK 809
           AT  +     +G+G++G+VYK   P  G  +A K   +            S     A  +
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 810 VMGSIRHRNLVKIISSC----SNNDFK-ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIM 864
            + +  H N+V+++  C    ++ + K  LV E++     +   Y D      L    I 
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ---DLRTYLDKAPPPGLPAETIK 123
Query: 865 IDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLG 924
             +   L  L F ++  IVH D+KP N+L+       L+DFG+A+I   +  M  T  + 
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALTPVVV 181
Query: 925 TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKK 959
           T+ Y APE   +   +   D++S G +  E F +K
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 769 LGMGSFGSV-----YKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKII 823
           LG GSFG V     YK      ++  ++    + D  +     E   +  +RH +++K+ 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHM-RVEREISYLKLLRHPHIIKLY 75
Query: 824 SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIV 883
              +      +V+EY + G L   +       +   R +    +  A+EY H      IV
Sbjct: 76  DVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGR-RFFQQIICAIEYCH---RHKIV 130
Query: 884 HCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSR-- 941
           H D+KP N+LL++++   ++DFG++ I+     ++   + G+  Y APE    GK+    
Sbjct: 131 HRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT--SCGSPNYAAPEVI-NGKLYAGP 187
Query: 942 KCDVYSYGIMLMETFTKKKPTDEIF 966
           + DV+S GI+L      + P D+ F
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFDDEF 212

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF------DGSLESFHAECKVMGS 813
           D +   + LG G F  V K      G E AAK              S E    E  ++  
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 814 IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFL--DILQRLKIMIDVASAL 871
           IRH N++ +     N     L+LE +S G L   L         +  Q LK ++D    +
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GV 121
Query: 872 EYLHFGYSTPIVHCDIKPSNVLLNESMVGH----LSDFGIAKILGKEESMRQTKTL-GTI 926
            YLH   S  I H D+KP N++L +  V +    L DFGIA    K E+  + K + GT 
Sbjct: 122 HYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH---KIEAGNEFKNIFGTP 175
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIM 951
            ++APE      +  + D++S G++
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVI 200

>pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 133/314 (42%), Gaps = 29/314 (9%)
Query: 238 GIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTL 297
           GIP      T  R L LG N +     +E  +  +LE L +  + ++ + P +  N+  L
Sbjct: 29  GIP------TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82
Query: 298 KELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFS 357
           + L +  N L   +P  +  GL NL +L + EN     +     ++  L  L+ G N   
Sbjct: 83  RTLGLRSNRL-KLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV 141
Query: 358 GLIPTTFGNLRSLKLLSLAGNVLTS-PTPDLSFLSSLTSCR------------------N 398
            +    F  L SL+ L+L    LTS PT  LS L  L   R                   
Sbjct: 142 YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYR 201
Query: 399 LEIIYLSENP-INGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNE 457
           L+++ +S  P ++ + P+ +  + +++ SLS+  CN++      + ++  L  + L  N 
Sbjct: 202 LKVLEISHWPYLDTMTPNCL--YGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNP 259
Query: 458 LTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNL 517
           ++      L  L +LQ + L   +L    P     L  L  L +  N+L+    +   ++
Sbjct: 260 ISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSV 319
Query: 518 TSLRDLSLGSNALT 531
            +L  L L SN L 
Sbjct: 320 GNLETLILDSNPLA 333

>pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 16/228 (7%)
Query: 319 LPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPT-TFGNLRSLKLLSLAG 377
            P+LE L L EN  S   P +  N+  L  L    N    LIP   F  L +L  L ++ 
Sbjct: 55  FPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISE 113
Query: 378 N----VLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCN 433
           N    +L     DL  L SL    N +++Y+S    +G+          S++ L++E CN
Sbjct: 114 NKIVILLDYMFQDLYNLKSLEVGDN-DLVYISHRAFSGL---------NSLEQLTLEKCN 163
Query: 434 ISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHL 493
           ++    + L +++ L V+RL +  +      +  RL +L+ L + +     ++  +  + 
Sbjct: 164 LTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYG 223
Query: 494 YRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNL 541
             L +L +    L+      + +L  LR L+L  N +++I  S L  L
Sbjct: 224 LNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHEL 271

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 16/212 (7%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA----KVFHMEFDGSLESFH--AECKVMG 812
           AT  +     +G+G++G+VYK   P      A    +V + E    + +    A  + + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 813 SIRHRNLVKIISSC----SNNDFK-ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDV 867
           +  H N+V+++  C    ++ + K  LV E++     +   Y D      L    I   +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ---DLRTYLDKAPPPGLPAETIKDLM 118
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIG 927
              L  L F ++  IVH D+KP N+L+       L+DFG+A+I   +  M     + T+ 
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALDPVVVTLW 176
Query: 928 YMAPEYGREGKVSRKCDVYSYGIMLMETFTKK 959
           Y APE   +   +   D++S G +  E F +K
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 32/213 (15%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFD------GSLESFHAECKVMGSIRHRNLVKI 822
           +G GSF +VYKG+     E   +V   E           + F  E + +  ++H N+V+ 
Sbjct: 34  IGRGSFKTVYKGL---DTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRF 90
Query: 823 I----SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMI------DVASALE 872
                S+        LV E  ++G+L+        +L   +  KI +       +   L+
Sbjct: 91  YDSWESTVKGKKCIVLVTELXTSGTLKT-------YLKRFKVXKIKVLRSWCRQILKGLQ 143
Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVG-HLSDFGIAKILGKEESMRQTKTLGTIGYMAP 931
           +LH   + PI+H D+K  N+ +        + D G+A +  K  S  +   +GT  + AP
Sbjct: 144 FLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL--KRASFAKA-VIGTPEFXAP 199
Query: 932 EYGREGKVSRKCDVYSYGIMLMETFTKKKPTDE 964
           E   E K     DVY++G   +E  T + P  E
Sbjct: 200 EXYEE-KYDESVDVYAFGXCXLEXATSEYPYSE 231

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF------DGSLESFHAECKVMGS 813
           D +   + LG G F  V K      G E AAK              S E    E  ++  
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 814 IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFL--DILQRLKIMIDVASAL 871
           IRH N++ +     N     L+LE +S G L   L         +  Q LK ++D    +
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GV 128
Query: 872 EYLHFGYSTPIVHCDIKPSNVLLNESMVGH----LSDFGIAKILGKEESMRQTKTL-GTI 926
            YLH   S  I H D+KP N++L +  V +    L DFGIA    K E+  + K + GT 
Sbjct: 129 HYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH---KIEAGNEFKNIFGTP 182
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIM 951
            ++APE      +  + D++S G++
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF------DGSLESFHAECKVMGS 813
           D +   + LG G F  V K      G E AAK              S E    E  ++  
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 814 IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFL--DILQRLKIMIDVASAL 871
           IRH N++ +     N     L+LE +S G L   L         +  Q LK ++D    +
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GV 142
Query: 872 EYLHFGYSTPIVHCDIKPSNVLLNESMVGH----LSDFGIAKILGKEESMRQTKTL-GTI 926
            YLH   S  I H D+KP N++L +  V +    L DFGIA    K E+  + K + GT 
Sbjct: 143 HYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH---KIEAGNEFKNIFGTP 196
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIM 951
            ++APE      +  + D++S G++
Sbjct: 197 EFVAPEIVNYEPLGLEADMWSIGVI 221

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 131/284 (46%), Gaps = 42/284 (14%)
Query: 763  FSENKLLGMGSFGS-VYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVM-GSIRHRNLV 820
            F    +LG G+ G+ VY+G+  D  ++A K    E          E +++  S  H N++
Sbjct: 26   FCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVI 81
Query: 821  KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
            +   +  +  F+ + +E +   +L++ +   ++    L+ + ++    S L +LH   S 
Sbjct: 82   RYFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SL 137
Query: 881  PIVHCDIKPSNVLL-----NESMVGHLSDFGIAKIL--GKEESMRQTKTLGTIGYMAPEY 933
             IVH D+KP N+L+     +  +   +SDFG+ K L  G+    R++   GT G++APE 
Sbjct: 138  NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 934  GREG---KVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLLSCSITEVA 989
              E      +   D++S G +     ++   P  +      SL+R     L +CS+    
Sbjct: 198  LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK------SLQRQANILLGACSL---- 247
Query: 990  DANLLNCEEN-DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDV 1032
              + L+ E++ D  ARE     I   AMD     P+KR S K V
Sbjct: 248  --DCLHPEKHEDVIARELIEKMI---AMD-----PQKRPSAKHV 281

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 54/202 (26%), Positives = 86/202 (42%), Gaps = 12/202 (5%)
Query: 767 KLLGMGSFGSV--YKGVLPDGMEIAAKVFHME--FDGSLESFHAECKVMGSIRHRNLVKI 822
           K +G G+F  V   + +L  G E+A K+         SL+    E ++   + H N+VK+
Sbjct: 20  KTIGKGNFAKVKLARHIL-TGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKL 78
Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
                      LV EY S G +   L +     +   R K    + SA++Y H  +   I
Sbjct: 79  FEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAVQYCHQKF---I 134
Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVS-R 941
           VH D+K  N+LL+      ++DFG +        +      G   Y APE  +  K    
Sbjct: 135 VHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKL--DAFCGAPPYAAPELFQGKKYDGP 192
Query: 942 KCDVYSYGIMLMETFTKKKPTD 963
           + DV+S G++L    +   P D
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFD 214

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 16/212 (7%)
Query: 759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAA----KVFHMEFDGSLESFH--AECKVMG 812
           AT  +     +G+G++G+VYK   P      A    +V + E    + +    A  + + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 813 SIRHRNLVKIISSC----SNNDFK-ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDV 867
           +  H N+V+++  C    ++ + K  LV E++     +   Y D      L    I   +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ---DLRTYLDKAPPPGLPAETIKDLM 118
Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIG 927
              L  L F ++  IVH D+KP N+L+       L+DFG+A+I   +  M     + T+ 
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALFPVVVTLW 176
Query: 928 YMAPEYGREGKVSRKCDVYSYGIMLMETFTKK 959
           Y APE   +   +   D++S G +  E F +K
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 35/105 (33%), Positives = 57/105 (54%), Gaps = 9/105 (8%)
Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK 921
           K+ + +  AL YL   +   ++H D+KPSN+LL+E     L DFGI+  L  +++  + +
Sbjct: 128 KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA--KDR 183
Query: 922 TLGTIGYMAPEYGREGKVSR-----KCDVYSYGIMLMETFTKKKP 961
           + G   YMAPE       ++     + DV+S GI L+E  T + P
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAA-KVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISS 825
           +G G++G+V+K    +  EI A K   ++ D  G   S   E  ++  ++H+N+V++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNYFLD--ILQRLKIMIDVASALEYLHFGYSTPIV 883
             ++    LV E+  +  L+K   S N  LD  I++     +     L+ L F +S  ++
Sbjct: 70  LHSDKKLTLVFEF-CDQDLKKYFDSCNGDLDPEIVKSFLFQL-----LKGLGFCHSRNVL 123
Query: 884 HCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKV-SRK 942
           H D+KP N+L+N +    L++FG+A+  G        + + T+ Y  P+     K+ S  
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTS 182
Query: 943 CDVYSYGIMLMETFTKKKP 961
            D++S G +  E     +P
Sbjct: 183 IDMWSAGCIFAELANAGRP 201

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 11/209 (5%)
Query: 758 RATDGFSENKLLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMGS 813
           R    +   + LG G F   Y+    D  E+ A KV            E    E  +  S
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 814 IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
           + + ++V       ++DF  +VLE     SL + L+     +   +    M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGYMAPE 932
           LH   +  ++H D+K  N+ LN+ M   + DFG+A  +  E    + KTL GT  Y+APE
Sbjct: 158 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKTLCGTPNYIAPE 212
Query: 933 YGREGKVSRKCDVYSYGIMLMETFTKKKP 961
              +   S + D++S G +L      K P
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 9/208 (4%)
Query: 758 RATDGFSENKLLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMGS 813
           R    +   + LG G F   Y+    D  E+ A KV            E    E  +  S
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 814 IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
           + + ++V       ++DF  +VLE     SL + L+     +   +    M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
           LH   +  ++H D+K  N+ LN+ M   + DFG+A  + + +  R+    GT  Y+APE 
Sbjct: 158 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI-EFDGERKKXLCGTPNYIAPEV 213
Query: 934 GREGKVSRKCDVYSYGIMLMETFTKKKP 961
             +   S + D++S G +L      K P
Sbjct: 214 LCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 9/208 (4%)
Query: 758 RATDGFSENKLLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMGS 813
           R    +   + LG G F   Y+    D  E+ A KV            E    E  +  S
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 814 IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
           + + ++V       ++DF  +VLE     SL + L+     +   +    M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
           LH   +  ++H D+K  N+ LN+ M   + DFG+A  + + +  R+    GT  Y+APE 
Sbjct: 158 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI-EFDGERKKDLCGTPNYIAPEV 213
Query: 934 GREGKVSRKCDVYSYGIMLMETFTKKKP 961
             +   S + D++S G +L      K P
Sbjct: 214 LCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 9/208 (4%)
Query: 758 RATDGFSENKLLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMGS 813
           R    +   + LG G F   Y+    D  E+ A KV            E    E  +  S
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 814 IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
           + + ++V       ++DF  +VLE     SL + L+     +   +    M      ++Y
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 141
Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
           LH   +  ++H D+K  N+ LN+ M   + DFG+A  + + +  R+    GT  Y+APE 
Sbjct: 142 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI-EFDGERKKDLCGTPNYIAPEV 197
Query: 934 GREGKVSRKCDVYSYGIMLMETFTKKKP 961
             +   S + D++S G +L      K P
Sbjct: 198 LCKKGHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 91/215 (42%), Gaps = 19/215 (8%)
Query: 763 FSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEF--------DGSLESFHAECKVMGS 813
           +S    LG G+FG V+  V  +   E+  K    E         D  L     E  ++  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 814 IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNY-FLDILQRLKIMIDVASALE 872
           + H N++K++    N  F  LV+E   +G L+   + D +  LD      I   + SA+ 
Sbjct: 86  VEHANIIKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE 932
           YL       I+H DIK  N+++ E     L DFG A  L  E         GTI Y APE
Sbjct: 145 YLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYTFCGTIEYCAPE 199
Query: 933 YGREGKVSR--KCDVYSYGIMLMETFTKKKPTDEI 965
               G   R  + +++S G+ L     ++ P  E+
Sbjct: 200 V-LMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 34/221 (15%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHR 817
           D +   + +G G++G V        G ++A K     FD    +     E K++   +H 
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 114
Query: 818 NLVKIIS----SCSNNDFKAL--VLEYMSNGSLEKCLYSDN--------YFLDILQRLKI 863
           N++ I      +    +FK++  VL+ M +  L + ++S          YFL  L R   
Sbjct: 115 NIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLR--- 170
Query: 864 MIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ---T 920
                  L+Y+H   S  ++H D+KPSN+L+NE+    + DFG+A+ L    +  Q   T
Sbjct: 171 ------GLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMT 221
Query: 921 KTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKK 960
           + + T  Y APE      + ++  D++S G +  E   +++
Sbjct: 222 EYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 91/237 (38%), Gaps = 57/237 (24%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAA-------KVFHMEFDGSLESFHAECKVMGSIRHRNLVK 821
           +G GS+G V   +      I A       K+  +     +E    E ++M  + H N+ +
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQIN-PKDVERIKTEVRLMKKLHHPNIAR 92
Query: 822 IISSCSNNDFKALVLEYMSNGSL------------EKC---------------------- 847
           +     +  +  LV+E    G L             KC                      
Sbjct: 93  LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 848 -LYSDNYFLDILQRLK----IMIDVASALEYLHFGYSTPIVHCDIKPSNVLL--NESMVG 900
            ++     LD +QR K    IM  + SAL YLH   +  I H DIKP N L   N+S   
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEI 209
Query: 901 HLSDFGIAK---ILGKEESMRQTKTLGTIGYMAPEYGREGKVSR--KCDVYSYGIML 952
            L DFG++K    L   E    T   GT  ++APE       S   KCD +S G++L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 34/221 (15%)
Query: 761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHR 817
           D +   + +G G++G V        G ++A K     FD    +     E K++   +H 
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 113
Query: 818 NLVKIIS----SCSNNDFKAL--VLEYMSNGSLEKCLYSDN--------YFLDILQRLKI 863
           N++ I      +    +FK++  VL+ M +  L + ++S          YFL  L R   
Sbjct: 114 NIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLR--- 169
Query: 864 MIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ---T 920
                  L+Y+H   S  ++H D+KPSN+L+NE+    + DFG+A+ L    +  Q   T
Sbjct: 170 ------GLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMT 220
Query: 921 KTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKK 960
           + + T  Y APE      + ++  D++S G +  E   +++
Sbjct: 221 EYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 59/212 (27%), Positives = 89/212 (41%), Gaps = 17/212 (8%)
Query: 763 FSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLV 820
           F   +L+G G++G VYKG  +  G   A KV  +  D   E    E  ++     HRN+ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 84
Query: 821 KIISSC------SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
               +         +D   LV+E+   GS+   +   N   + L+   I       L  L
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGL 142
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY- 933
              +   ++H DIK  NVLL E+    L DFG++  L +    R T  +GT  +MAPE  
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVI 201
Query: 934 ----GREGKVSRKCDVYSYGIMLMETFTKKKP 961
                 +     K D++S GI  +E      P
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 6/111 (5%)
Query: 848 LYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGI 907
           LY D  FL +   +     VA  +E+L    S   +H D+   N+LL+E  V  + DFG+
Sbjct: 185 LYKD--FLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGL 239
Query: 908 AKILGKE-ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           A+ + K+ + +R+      + +MAPE   +   + + DV+S+G++L E F+
Sbjct: 240 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 28/211 (13%)
Query: 761 DGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHM-EFDGS----LESFHAECKVMGSI 814
           D +   +++G G F  V + +    G + A K+  + +F  S     E    E  +   +
Sbjct: 26  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 85
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASA---- 870
           +H ++V+++ + S++    +V E+M    L  C        +I++R       + A    
Sbjct: 86  KHPHIVELLETYSSDGMLYMVFEFMDGADL--C-------FEIVKRADAGFVYSEAVASH 136
Query: 871 -----LEYLHFGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKILGKEESMRQTKT 922
                LE L + +   I+H D+KP  VLL     S    L  FG+A  LG E  +     
Sbjct: 137 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG-ESGLVAGGR 195
Query: 923 LGTIGYMAPEYGREGKVSRKCDVYSYGIMLM 953
           +GT  +MAPE  +     +  DV+  G++L 
Sbjct: 196 VGTPHFMAPEVVKREPYGKPVDVWGCGVILF 226

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 116/239 (48%), Gaps = 38/239 (15%)
Query: 767 KLLGMGSFGSV-YKGVLPDGMEIAAKVFHMEF-DGSLESFHAECKVMG-SIRHRNLVKII 823
           K+LG GS G+V ++G    G  +A K   ++F D +L     E K++  S  H N+++  
Sbjct: 39  KILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIAL----MEIKLLTESDDHPNVIRYY 93
Query: 824 SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK------IMIDVASALEYLHFG 877
            S + + F  + LE + N +L+  + S N   + L+  K      ++  +AS + +LH  
Sbjct: 94  CSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-- 150
Query: 878 YSTPIVHCDIKPSNVLLN-------------ESMVGHLSDFGIAKILGKEESMRQ---TK 921
            S  I+H D+KP N+L++             E++   +SDFG+ K L   +   +     
Sbjct: 151 -SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 209
Query: 922 TLGTIGYMAPEYGREG---KVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWV 976
             GT G+ APE   E    +++R  D++S G +     +K K P  + ++ E ++ R +
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGI 268

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 20/170 (11%)
Query: 799 GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDI- 857
              + F  E +++  I++   +      +N D   ++ EYM N S+   L  D YF  + 
Sbjct: 85  SKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSI---LKFDEYFFVLD 141
Query: 858 --------LQRLKIMID-VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA 908
                   +Q +K +I  V ++  Y+H      I H D+KPSN+L++++    LSDFG +
Sbjct: 142 KNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGES 199
Query: 909 KILGKEESMRQTKTLGTIGYMAPEY--GREGKVSRKCDVYSYGIMLMETF 956
           + +  ++ ++ ++  GT  +M PE+          K D++S GI L   F
Sbjct: 200 EYMV-DKKIKGSR--GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF 246

>pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 96/393 (24%), Positives = 150/393 (38%), Gaps = 91/393 (23%)
Query: 292 FNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDF 351
           +N++    L +T   +   LPS+I +       L L  N      P++ T  S+L++LD 
Sbjct: 6   YNVADCSHLKLTH--IPDDLPSNITV-------LNLTHNQLRRLPPTNFTRYSQLAILDA 56
Query: 352 GFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPING 411
           GFNS S L P     L  LK+L+L  N L S   D +F+     C NL  + L  N I+ 
Sbjct: 57  GFNSISKLEPELCQILPLLKVLNLQHNEL-SQISDQTFV----FCTNLTELDLMSNSIHK 111
Query: 412 ILPSSIGN----FSISMKSLSMESCNISGGI-------------------PKELGNINN- 447
           I  +   N      + +    + S  +  G+                    +EL  + N 
Sbjct: 112 IKSNPFKNQKNLIKLDLSHNGLSSTKLGTGVQLENLQELLLAKNKILALRSEELEFLGNS 171
Query: 448 -LTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKL 506
            L  + L +N L    P     + KL  L L N +L   + E LC  + L+N        
Sbjct: 172 SLRKLDLSSNPLKEFSPGCFQTIGKLFALLLNNAQLNPHLTEKLC--WELSN-------- 221
Query: 507 SGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFXXXXXXXXXXXXPDIGNLK 566
                      TS+++LSL +N L +   ST   LK                        
Sbjct: 222 -----------TSIQNLSLANNQLLATSESTFSGLK----------------------WT 248
Query: 567 VVIEMDLSLNALSGVIPVTIXXXXXXXXXXXRYNRLQGPIPESFGGLKSLNFVDMSNNNL 626
            + ++DLS N L  V   +             YN +Q   P SF GL +L ++ +     
Sbjct: 249 NLTQLDLSYNNLHDVGNGSFSYLPSLRYLSLEYNNIQRLSPRSFYGLSNLRYLSLKRAFT 308
Query: 627 SGTI-----PK----SMEALSYLKHLNLSFNQL 650
             ++     P     S + L YL++LN+  N +
Sbjct: 309 KQSVSLASHPNIDDFSFQWLKYLEYLNMDDNNI 341

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 6/111 (5%)
Query: 848 LYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGI 907
           LY D  FL +   +     VA  +E+L    S   +H D+   N+LL+E  V  + DFG+
Sbjct: 183 LYKD--FLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGL 237
Query: 908 AKILGKE-ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           A+ + K+ + +R+      + +MAPE   +   + + DV+S+G++L E F+
Sbjct: 238 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 28/211 (13%)
Query: 761 DGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHM-EFDGS----LESFHAECKVMGSI 814
           D +   +++G G F  V + +    G + A K+  + +F  S     E    E  +   +
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASA---- 870
           +H ++V+++ + S++    +V E+M    L  C        +I++R       + A    
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADL--C-------FEIVKRADAGFVYSEAVASH 134
Query: 871 -----LEYLHFGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKILGKEESMRQTKT 922
                LE L + +   I+H D+KP  VLL     S    L  FG+A  LG E  +     
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG-ESGLVAGGR 193
Query: 923 LGTIGYMAPEYGREGKVSRKCDVYSYGIMLM 953
           +GT  +MAPE  +     +  DV+  G++L 
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVILF 224

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 73/158 (46%), Gaps = 12/158 (7%)
Query: 807 ECKVMGSIRHRNLVKIISSCSNNDFKAL--VLEYMSNGSLEKCLYSDNYFLDILQRLKIM 864
           E +++  +RH+N+++++    N + + +  V+EY   G  E           + Q     
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF 115
Query: 865 IDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL---GKEESMRQTK 921
             +   LEYLH   S  IVH DIKP N+LL       +S  G+A+ L     +++ R ++
Sbjct: 116 CQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 922 TLGTIGYMAPEY--GREGKVSRKCDVYSYGIMLMETFT 957
             G+  +  PE   G +     K D++S G+ L    T
Sbjct: 173 --GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT 208

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 6/111 (5%)
Query: 848 LYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGI 907
           LY D  FL +   +     VA  +E+L    S   +H D+   N+LL+E  V  + DFG+
Sbjct: 190 LYKD--FLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGL 244
Query: 908 AKILGKE-ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           A+ + K+ + +R+      + +MAPE   +   + + DV+S+G++L E F+
Sbjct: 245 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 94/223 (42%), Gaps = 39/223 (17%)
Query: 769 LGMGSFGSVYKGVLPD---GMEIAAKVFHMEFDGSLESFHAE----CKVMGSIRHRNLVK 821
           LG GSFG V++  + D   G + A K         LE F  E    C  + S R   +V 
Sbjct: 80  LGRGSFGEVHR--MKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPR---IVP 128
Query: 822 IISSCSNNDFKALVLEYMSNGSLEK------CLYSDNYFLDILQRLKIMIDVASALEYLH 875
           +  +     +  + +E +  GSL +      CL  D     + Q L+        LEYLH
Sbjct: 129 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALE-------GLEYLH 181
Query: 876 FGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKIL---GKEESMRQTKTL-GTIGYMA 930
              +  I+H D+K  NVLL+ +     L DFG A  L   G  +S+     + GT  +MA
Sbjct: 182 ---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 238
Query: 931 PEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
           PE         K D++S   M++       P  + F G + LK
Sbjct: 239 PEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 281

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 6/111 (5%)
Query: 848 LYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGI 907
           LY D  FL +   +     VA  +E+L    S   +H D+   N+LL+E  V  + DFG+
Sbjct: 192 LYKD--FLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGL 246
Query: 908 AKILGKE-ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           A+ + K+ + +R+      + +MAPE   +   + + DV+S+G++L E F+
Sbjct: 247 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 116/239 (48%), Gaps = 38/239 (15%)
Query: 767 KLLGMGSFGSV-YKGVLPDGMEIAAKVFHMEF-DGSLESFHAECKVMG-SIRHRNLVKII 823
           K+LG GS G+V ++G    G  +A K   ++F D +L     E K++  S  H N+++  
Sbjct: 39  KILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIAL----MEIKLLTESDDHPNVIRYY 93
Query: 824 SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK------IMIDVASALEYLHFG 877
            S + + F  + LE + N +L+  + S N   + L+  K      ++  +AS + +LH  
Sbjct: 94  CSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-- 150
Query: 878 YSTPIVHCDIKPSNVLLN-------------ESMVGHLSDFGIAKILGKEESMRQ---TK 921
            S  I+H D+KP N+L++             E++   +SDFG+ K L   +   +     
Sbjct: 151 -SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 209
Query: 922 TLGTIGYMAPEYGREG---KVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWV 976
             GT G+ APE   E    +++R  D++S G +     +K K P  + ++ E ++ R +
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGI 268

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 769 LGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKIISS 825
           +G G++G+V   V    G ++A K  +  F   L  +  + E +++  +RH N++ ++  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 826 CSNN----DFKA--LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            + +    DF    LV+ +M    L K +  +    D +Q L  +  +   L Y+H   +
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFL--VYQMLKGLRYIH---A 146
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-K 938
             I+H D+KP N+ +NE     + DFG+A+    E        + T  Y APE      +
Sbjct: 147 AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MXGXVVTRWYRAPEVILNWMR 202
Query: 939 VSRKCDVYSYGIMLMETFTKK 959
            ++  D++S G ++ E  T K
Sbjct: 203 YTQTVDIWSVGCIMAEMITGK 223

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 145 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 200
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 149
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 150 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 205
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 206 NQTVDIWSVGCIMAELLTGR 225

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGXVATRWYRAPEIMLNWMHY 200
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 27/209 (12%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVKIISS 825
           +G G+FG V+K      G ++A K   ME +       A  E K++  ++H N+V +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 826 CSN-----NDFKA---LVLEYMSN---GSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           C       N  KA   LV ++  +   G L   L    + L  ++R+  M+     L  L
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQML-----LNGL 138
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK---ILGKEESMRQTKTLGTIGYMAP 931
           ++ +   I+H D+K +NVL+    V  L+DFG+A+   +    +  R    + T+ Y  P
Sbjct: 139 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 932 E--YGREGKVSRKCDVYSYGIMLMETFTK 958
           E   G E       D++  G ++ E +T+
Sbjct: 199 ELLLG-ERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 18/207 (8%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAA----KVFHMEFDGSLESFHAECKVMGSIRHRNLVKI 822
           K++G G+FG V    + +   I A      + M        F  E  V+ +   + +  +
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITAL 139
Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYS-DNYFLDILQRLKI--MIDVASALEYLHFGYS 879
             +  + +   LV++Y   G L   L   ++   + + R  I  M+    ++  LH+   
Sbjct: 140 HYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY--- 196
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE--- 936
              VH DIKP NVLL+ +    L+DFG    +  + +++ +  +GT  Y++PE  +    
Sbjct: 197 ---VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 253
Query: 937 --GKVSRKCDVYSYGIMLMETFTKKKP 961
             GK   +CD +S G+ + E    + P
Sbjct: 254 GMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 151
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWYRAPEIMLNWMHY 207
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 208 NQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 151
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWYRAPEIMLNWMHY 207
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 208 NQTVDIWSVGCIMAELLTGR 227

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 151
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWYRAPEIMLNWMHY 207
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 208 NQTVDIWSVGCIMAELLTGR 227

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 149
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 150 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 205
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 206 NQTVDIWSVGCIMAELLTGR 225

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 116/243 (47%), Gaps = 42/243 (17%)
Query: 767 KLLGMGSFGSV-YKGVLPDGMEIAAKVFHMEF-DGSLESFHAECKVMG-SIRHRNLVKII 823
           K+LG GS G+V ++G    G  +A K   ++F D +L     E K++  S  H N+++  
Sbjct: 21  KILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIAL----MEIKLLTESDDHPNVIRYY 75
Query: 824 SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK------IMIDVASALEYLHFG 877
            S + + F  + LE + N +L+  + S N   + L+  K      ++  +AS + +LH  
Sbjct: 76  CSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-- 132
Query: 878 YSTPIVHCDIKPSNVLLN-------------ESMVGHLSDFGIAKILGKEESMRQ---TK 921
            S  I+H D+KP N+L++             E++   +SDFG+ K L   +   +     
Sbjct: 133 -SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 191
Query: 922 TLGTIGYMAPEYGREG-------KVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLK 973
             GT G+ APE   E        +++R  D++S G +     +K K P  + ++ E ++ 
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 251
Query: 974 RWV 976
           R +
Sbjct: 252 RGI 254

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 140
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 196
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 197 NQTVDIWSVGCIMAELLTGR 216

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 17/200 (8%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHM----EFDGSLESF-HAECKVMGSIRHRNLVKII 823
           LG G FG V++ V     E ++K  +M    +  G+ +     E  ++   RHRN++ + 
Sbjct: 13  LGRGEFGIVHRCV-----ETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 824 SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIV 883
            S  + +   ++ E++S   + + + +  + L+  + +  +  V  AL++LH   S  I 
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIG 124
Query: 884 HCDIKPSNVLLN--ESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSR 941
           H DI+P N++     S    + +FG A+ L   ++ R   T     Y APE  +   VS 
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE--YYAPEVHQHDVVST 182
Query: 942 KCDVYSYGIMLMETFTKKKP 961
             D++S G ++    +   P
Sbjct: 183 ATDMWSLGTLVYVLLSGINP 202

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNAMHY 200
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 18/207 (8%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAA----KVFHMEFDGSLESFHAECKVMGSIRHRNLVKI 822
           K++G G+FG V    + +   I A      + M        F  E  V+ +   + +  +
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITAL 155
Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYS-DNYFLDILQRLKI--MIDVASALEYLHFGYS 879
             +  + +   LV++Y   G L   L   ++   + + R  I  M+    ++  LH+   
Sbjct: 156 HYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY--- 212
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE--- 936
              VH DIKP NVLL+ +    L+DFG    +  + +++ +  +GT  Y++PE  +    
Sbjct: 213 ---VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 269
Query: 937 --GKVSRKCDVYSYGIMLMETFTKKKP 961
             GK   +CD +S G+ + E    + P
Sbjct: 270 GMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 141
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 142 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 197
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 198 NQTVDIWSVGCIMAELLTGR 217

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 141
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 142 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 197
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 198 NQTVDIWSVGCIMAELLTGR 217

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 88  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 142
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 143 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 198
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 199 NQTVDIWSVGCIMAELLTGR 218

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 200
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 200
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 155
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 156 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 211
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 212 NQTVDIWSVGCIMAELLTGR 231

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 63/223 (28%), Positives = 94/223 (42%), Gaps = 39/223 (17%)
Query: 769 LGMGSFGSVYKGVLPD---GMEIAAKVFHMEFDGSLESFHAE----CKVMGSIRHRNLVK 821
           +G GSFG V++  + D   G + A K         LE F  E    C  + S R   +V 
Sbjct: 66  VGRGSFGEVHR--MKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPR---IVP 114
Query: 822 IISSCSNNDFKALVLEYMSNGSLEK------CLYSDNYFLDILQRLKIMIDVASALEYLH 875
           +  +     +  + +E +  GSL +      CL  D     + Q L+        LEYLH
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALE-------GLEYLH 167
Query: 876 FGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKIL---GKEESMRQTKTL-GTIGYMA 930
              +  I+H D+K  NVLL+ +     L DFG A  L   G  +S+     + GT  +MA
Sbjct: 168 ---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224
Query: 931 PEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
           PE         K D++S   M++       P  + F G + LK
Sbjct: 225 PEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 267

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 149
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 150 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 205
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 206 NQTVDIWSVGCIMAELLTGR 225

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV     +  G++IA K     F   + +   + E +++  ++H N++ ++  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 119 FTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 173
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 174 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 229
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           +   D++S G ++ E  T +
Sbjct: 230 NMTVDIWSVGCIMAELLTGR 249

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 8/94 (8%)
Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES---MVGHLSDFGIAKILGKEESMR 918
           +IM  +  A++YLH   S  I H D+KP N+L        +  L+DFG AK      S+ 
Sbjct: 119 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL- 174
Query: 919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIML 952
            T+   T  Y+APE     K  + CD++S G+++
Sbjct: 175 -TEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 207

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 48/207 (23%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 775 GSVYKGVLPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIISSCSN--ND 830
           G ++KG    G +I  KV  +    + +S  F+ EC  +    H N++ ++ +C +    
Sbjct: 24  GELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 831 FKALVLEYMSNGSLEKCLYS-DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKP 889
              L+  +M  GSL   L+   N+ +D  Q +K  +D+A  + +LH      I    +  
Sbjct: 83  HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNS 141
Query: 890 SNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR---EGKVSRKCDVY 946
            +V+++E M   +S   +A +   + S +    +    ++APE  +   E    R  D++
Sbjct: 142 RSVMIDEDMTARIS---MADV---KFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMW 195
Query: 947 SYGIMLMETFTKKKPTDEIFAGEMSLK 973
           S+ ++L E  T++ P  ++   E+ +K
Sbjct: 196 SFAVLLWELVTREVPFADLSNMEIGMK 222

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 200
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 200
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 200
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 200
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 146
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 147 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 202
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 203 NQTVDIWSVGCIMAELLTGR 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 200
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   + S     D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+ +    E     T  + T  Y APE        
Sbjct: 145 DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE----MTGYVATRWYRAPEIMLNWMHY 200
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 146
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 147 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 202
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 203 NQTVDIWSVGCIMAELLTGR 222

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 39/124 (31%), Positives = 64/124 (51%), Gaps = 12/124 (9%)
Query: 834 LVLEYMSNGSLEKCLYS--DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSN 891
           +++E M  G L   +    D  F +  +  +IM D+ +A+++LH   S  I H D+KP N
Sbjct: 84  IIMECMEGGELFSRIQERGDQAFTE-REAAEIMRDIGTAIQFLH---SHNIAHRDVKPEN 139
Query: 892 VLLN---ESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSY 948
           +L     +  V  L+DFG AK     ++  QT    T  Y+APE     K  + CD++S 
Sbjct: 140 LLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCY-TPYYVAPEVLGPEKYDKSCDMWSL 196
Query: 949 GIML 952
           G+++
Sbjct: 197 GVIM 200

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 39/124 (31%), Positives = 64/124 (51%), Gaps = 12/124 (9%)
Query: 834 LVLEYMSNGSLEKCLYS--DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSN 891
           +++E M  G L   +    D  F +  +  +IM D+ +A+++LH   S  I H D+KP N
Sbjct: 103 IIMECMEGGELFSRIQERGDQAFTE-REAAEIMRDIGTAIQFLH---SHNIAHRDVKPEN 158
Query: 892 VLLN---ESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSY 948
           +L     +  V  L+DFG AK     ++  QT    T  Y+APE     K  + CD++S 
Sbjct: 159 LLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCY-TPYYVAPEVLGPEKYDKSCDMWSL 215
Query: 949 GIML 952
           G+++
Sbjct: 216 GVIM 219

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 146
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 147 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 202
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 203 NQTVDIWSVGCIMAELLTGR 222

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 163
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 164 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 219
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 220 NQTVDIWSVGCIMAELLTGR 239

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 200
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 23/220 (10%)
Query: 755 DLLRATDGFSENKLLGMGSFGSVYKGVLPD--GME--IAAKVFHMEF---DGSLESFHAE 807
           D ++ TD F+   +LG GSFG V   +L D  G E   A K+   +    D  +E    E
Sbjct: 14  DRVKLTD-FNFLMVLGKGSFGKV---MLADRKGTEELYAIKILKKDVVIQDDDVECTMVE 69
Query: 808 CKVMGSIRHRNLVKIISSCSNN-DFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMID 866
            +V+  +     +  + SC    D    V+EY++ G L   +     F +  Q +    +
Sbjct: 70  KRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP-QAVFYAAE 128
Query: 867 VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT---L 923
           ++  L +LH      I++ D+K  NV+L+      ++DFG+ K    E  M    T    
Sbjct: 129 ISIGLFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCK----EHMMDGVTTREFC 181
Query: 924 GTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTD 963
           GT  Y+APE        +  D ++YG++L E    + P D
Sbjct: 182 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 149
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 150 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 205
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 206 NQTVDIWSVGCIMAELLTGR 225

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 156
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 157 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 212
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 213 NQTVDIWSVGCIMAELLTGR 232

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 164
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 165 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 220
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 221 NQTVDIWSVGCIMAELLTGR 240

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 89  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 143
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 144 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 199
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 200 NQTVDIWSVGCIMAELLTGR 219

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 167
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 168 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 223
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 224 NQTVDIWSVGCIMAELLTGR 243

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 151
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 207
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 208 NQTVDIWSVGCIMAELLTGR 227

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 156
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 157 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 212
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 213 NQTVDIWSVGCIMAELLTGR 232

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 150
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 151 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 206
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 207 NQTVDIWSVGCIMAELLTGR 226

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 41/146 (28%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 769 LGMGSFGSVYKGVLPDGMEIAA--KVFHMEFDGSLESFH-AECKVMGSIRHRNLVKIISS 825
           +G GS+G V+K    D  +I A  K    E D  ++     E +++  ++H NLV ++  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
                   LV EY  +  L +    D Y   + + L   I     L+ ++F +    +H 
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHEL---DRYQRGVPEHLVKSI-TWQTLQAVNFCHKHNCIHR 126
Query: 886 DIKPSNVLLNESMVGHLSDFGIAKIL 911
           D+KP N+L+ +  V  L DFG A++L
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARLL 152

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 146
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 147 DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 202
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 203 NQTVDIWSVGCIMAELLTGR 222

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 156
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 157 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 212
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 213 NQTVDIWSVGCIMAELLTGR 232

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 150
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 151 DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 206
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 207 NQTVDIWSVGCIMAELLTGR 226

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 94/223 (42%), Gaps = 39/223 (17%)
Query: 769 LGMGSFGSVYKGVLPD---GMEIAAKVFHMEFDGSLESFHAE----CKVMGSIRHRNLVK 821
           +G GSFG V++  + D   G + A K         LE F  E    C  + S R   +V 
Sbjct: 82  VGRGSFGEVHR--MKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPR---IVP 130
Query: 822 IISSCSNNDFKALVLEYMSNGSLEK------CLYSDNYFLDILQRLKIMIDVASALEYLH 875
           +  +     +  + +E +  GSL +      CL  D     + Q L+        LEYLH
Sbjct: 131 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALE-------GLEYLH 183
Query: 876 FGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKIL---GKEESMRQTKTL-GTIGYMA 930
              +  I+H D+K  NVLL+ +     L DFG A  L   G  +S+     + GT  +MA
Sbjct: 184 ---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 240
Query: 931 PEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
           PE         K D++S   M++       P  + F G + LK
Sbjct: 241 PEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 283

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 155
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 156 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 211
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 212 NQTVDIWSVGCIMAELLTGR 231

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES---MVGHLSDFGIAKILGKEESMR 918
           +IM  +  A++YLH   S  I H D+KP N+L        +  L+DFG AK      S+ 
Sbjct: 125 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL- 180
Query: 919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIML 952
            T    T  Y+APE     K  + CD++S G+++
Sbjct: 181 -TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 213

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES---MVGHLSDFGIAKILGKEESMR 918
           +IM  +  A++YLH   S  I H D+KP N+L        +  L+DFG AK      S+ 
Sbjct: 126 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL- 181
Query: 919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIML 952
            T    T  Y+APE     K  + CD++S G+++
Sbjct: 182 -TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 214

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES---MVGHLSDFGIAKILGKEESMR 918
           +IM  +  A++YLH   S  I H D+KP N+L        +  L+DFG AK      S+ 
Sbjct: 127 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL- 182
Query: 919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIML 952
            T    T  Y+APE     K  + CD++S G+++
Sbjct: 183 -TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 215

>pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 61/178 (34%), Positives = 80/178 (44%), Gaps = 21/178 (11%)
Query: 243 IGNLTSVRNLFLGNNSL--IGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFN-ISTLKE 299
           I  L +VR L LG N L  I  +  E+ NL  L + G Q  +L    P  +F+ ++ LKE
Sbjct: 59  IQYLPNVRYLALGGNKLHDISAL-KELTNLTYLILTGNQLQSL----PNGVFDKLTNLKE 113
Query: 300 LAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGL 359
           L + +N L  SLP  +   L NL  L+L  N            ++ L+ LD   N    L
Sbjct: 114 LVLVENQL-QSLPDGVFDKLTNLTYLYLYHNQLQSLPKGVFDKLTNLTRLDLDNNQLQSL 172
Query: 360 IPTTFGNLRSLKLLSLAGNVLTSPTPDLSF--LSSLT---------SCRNLEIIYLSE 406
               F  L  LK LSL  N L S  PD  F  L+SLT          C   +I+YLS 
Sbjct: 173 PEGVFDKLTQLKQLSLNDNQLKS-VPDGVFDRLTSLTHIWLLNNPWDCACSDILYLSR 229

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES---MVGHLSDFGIAKILGKEESMR 918
           +IM  +  A++YLH   S  I H D+KP N+L        +  L+DFG AK      S+ 
Sbjct: 120 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL- 175
Query: 919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIML 952
            T    T  Y+APE     K  + CD++S G+++
Sbjct: 176 -TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 208

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 27/209 (12%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVKIISS 825
           +G G+FG V+K      G ++A K   ME +       A  E K++  ++H N+V +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 826 CSN-----NDFKA---LVLEYMSN---GSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           C       N  K    LV ++  +   G L   L    + L  ++R+  M+     L  L
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQML-----LNGL 138
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK---ILGKEESMRQTKTLGTIGYMAP 931
           ++ +   I+H D+K +NVL+    V  L+DFG+A+   +    +  R    + T+ Y  P
Sbjct: 139 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 932 E--YGREGKVSRKCDVYSYGIMLMETFTK 958
           E   G E       D++  G ++ E +T+
Sbjct: 199 ELLLG-ERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 71/144 (49%), Gaps = 8/144 (5%)
Query: 769 LGMGSFGSVYKGV--LPDGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISS 825
           LG G++ +VYKG   L D + +A K   +E + G+  +   E  ++  ++H N+V +   
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
                   LV EY+ +  L++ L      +++      +  +   L Y H      ++H 
Sbjct: 69  IHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHR 124
Query: 886 DIKPSNVLLNESMVGHLSDFGIAK 909
           D+KP N+L+NE     L+DFG+A+
Sbjct: 125 DLKPQNLLINERGELKLADFGLAR 148

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES---MVGHLSDFGIAKILGKEESMR 918
           +IM  +  A++YLH   S  I H D+KP N+L        +  L+DFG AK      S+ 
Sbjct: 119 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL- 174
Query: 919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIML 952
            T    T  Y+APE     K  + CD++S G+++
Sbjct: 175 -TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 207

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES---MVGHLSDFGIAKILGKEESMR 918
           +IM  +  A++YLH   S  I H D+KP N+L        +  L+DFG AK      S+ 
Sbjct: 165 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL- 220
Query: 919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIML 952
            T    T  Y+APE     K  + CD++S G+++
Sbjct: 221 -TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 150
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 151 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 206
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 207 NQTVDIWSVGCIMAELLTGR 226

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES---MVGHLSDFGIAKILGKEESMR 918
           +IM  +  A++YLH   S  I H D+KP N+L        +  L+DFG AK      S+ 
Sbjct: 135 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL- 190
Query: 919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIML 952
            T    T  Y+APE     K  + CD++S G+++
Sbjct: 191 -TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 223

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 13/107 (12%)
Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGTIGYM 929
           LE +H  +   IVH D+KP+N L+ + M+  L DFGIA  +  +  S+ +   +GT+ YM
Sbjct: 117 LEAVHTIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYM 175
Query: 930 APEYGREGKVSRK-----------CDVYSYGIMLMETFTKKKPTDEI 965
            PE  ++   SR+            DV+S G +L      K P  +I
Sbjct: 176 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 222

>pdb|3J0A|A Chain A, Homology Model Of Human Toll-Like Receptor 5 Fitted Into An Electron Microscopy Single Particle Reconstruction Length = 844

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 125/291 (42%), Gaps = 45/291 (15%)
Query: 247 TSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDND 306
           +SVR+L L +  +          L++L+VL +  + +  +   + + +  L+ L ++ N 
Sbjct: 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYN- 324
Query: 307 LLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGN 366
           LLG L SS   GLP +  + L +N+ +     +   + +L  LD   N+      TT   
Sbjct: 325 LLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHF 379
Query: 367 LRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKS 426
           + S+  + L+GN L +  P ++  ++L        I+LSEN +  +              
Sbjct: 380 IPSIPDIFLSGNKLVT-LPKINLTANL--------IHLSENRLENL-------------- 416
Query: 427 LSMESCNISGGIPKELGNINNLTVIRLGNNELTG-TIPVTLGRLQKLQGLYLQNNKLEGS 485
                      I   L  + +L ++ L  N  +  +   T      L+ L+L  N L+ +
Sbjct: 417 ----------DILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLA 466
Query: 486 IPEDLCH-----LYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALT 531
              +LC      L  L  LYL  N L+   P    +LT+LR LSL SN LT
Sbjct: 467 WETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT 517

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES---MVGHLSDFGIAKILGKEESMR 918
           +IM  +  A++YLH   S  I H D+KP N+L        +  L+DFG AK      S+ 
Sbjct: 121 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL- 176
Query: 919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIML 952
            T    T  Y+APE     K  + CD++S G+++
Sbjct: 177 -TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 209

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 13/107 (12%)
Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGTIGYM 929
           LE +H  +   IVH D+KP+N L+ + M+  L DFGIA  +  +  S+ +   +GT+ YM
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 930 APEYGREGKVSRK-----------CDVYSYGIMLMETFTKKKPTDEI 965
            PE  ++   SR+            DV+S G +L      K P  +I
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 13/107 (12%)
Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGTIGYM 929
           LE +H  +   IVH D+KP+N L+ + M+  L DFGIA  +  +  S+ +   +GT+ YM
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 930 APEYGREGKVSRK-----------CDVYSYGIMLMETFTKKKPTDEI 965
            PE  ++   SR+            DV+S G +L      K P  +I
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES---MVGHLSDFGIAKILGKEESMR 918
           +IM  +  A++YLH   S  I H D+KP N+L        +  L+DFG AK      S+ 
Sbjct: 171 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL- 226
Query: 919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIML 952
            T    T  Y+APE     K  + CD++S G+++
Sbjct: 227 -TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 259

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES---MVGHLSDFGIAKILGKEESMR 918
           +IM  +  A++YLH   S  I H D+KP N+L        +  L+DFG AK      S+ 
Sbjct: 121 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL- 176
Query: 919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIML 952
            T    T  Y+APE     K  + CD++S G+++
Sbjct: 177 -TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 209

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 13/107 (12%)
Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGTIGYM 929
           LE +H  +   IVH D+KP+N L+ + M+  L DFGIA  +  +  S+ +   +GT+ YM
Sbjct: 121 LEAVHTIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYM 179
Query: 930 APEYGREGKVSRK-----------CDVYSYGIMLMETFTKKKPTDEI 965
            PE  ++   SR+            DV+S G +L      K P  +I
Sbjct: 180 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 226

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 37/107 (34%), Positives = 54/107 (50%), Gaps = 10/107 (9%)
Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK 921
           KI + +  ALE+LH   S  ++H D+KPSNVL+N        DFGI+  L   + + +  
Sbjct: 140 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYL--VDDVAKDI 195
Query: 922 TLGTIGYMA-----PEYGREGKVSRKCDVYSYGIMLMETFTKKKPTD 963
             G   Y A     PE  ++G  S K D++S GI  +E    + P D
Sbjct: 196 DAGCKPYXAPERINPELNQKG-YSVKSDIWSLGITXIELAILRFPYD 241

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 13/107 (12%)
Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGTIGYM 929
           LE +H  +   IVH D+KP+N L+ + M+  L DFGIA  +  +  S+ +   +GT+ YM
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 930 APEYGREGKVSRK-----------CDVYSYGIMLMETFTKKKPTDEI 965
            PE  ++   SR+            DV+S G +L      K P  +I
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G  +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 140
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 196
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 197 NQTVDIWSVGCIMAELLTGR 216

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 27/209 (12%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVKIISS 825
           +G G+FG V+K      G ++A K   ME +       A  E K++  ++H N+V +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 826 CSN-----NDFKA---LVLEYMSN---GSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           C       N  K    LV ++  +   G L   L    + L  ++R+  M+     L  L
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQML-----LNGL 138
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK---ILGKEESMRQTKTLGTIGYMAP 931
           ++ +   I+H D+K +NVL+    V  L+DFG+A+   +    +  R    + T+ Y  P
Sbjct: 139 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 932 E--YGREGKVSRKCDVYSYGIMLMETFTK 958
           E   G E       D++  G ++ E +T+
Sbjct: 199 ELLLG-ERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 29/227 (12%)
Query: 767 KLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKI--- 822
           K LG G  G V+  V  D    +A K   +    S++    E K++  + H N+VK+   
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 823 -----------ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASAL 871
                      + S +  +   +V EYM    L   L      L+   RL  M  +   L
Sbjct: 77  LGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL-EQGPLLEEHARL-FMYQLLRGL 133
Query: 872 EYLHFGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQ--TKTLGTIGY 928
           +Y+H   S  ++H D+KP+N+ +N E +V  + DFG+A+I+    S +   ++ L T  Y
Sbjct: 134 KYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWY 190
Query: 929 MAPE-YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
            +P         ++  D+++ G +  E  T K     +FAG   L++
Sbjct: 191 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT----LFAGAHELEQ 233

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 27/209 (12%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVKIISS 825
           +G G+FG V+K      G ++A K   ME +       A  E K++  ++H N+V +I  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 826 CSN-----NDFKA---LVLEYMSN---GSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
           C       N  K    LV ++  +   G L   L    + L  ++R+  M+     L  L
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQML-----LNGL 137
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK---ILGKEESMRQTKTLGTIGYMAP 931
           ++ +   I+H D+K +NVL+    V  L+DFG+A+   +    +  R    + T+ Y  P
Sbjct: 138 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 197
Query: 932 E--YGREGKVSRKCDVYSYGIMLMETFTK 958
           E   G E       D++  G ++ E +T+
Sbjct: 198 ELLLG-ERDYGPPIDLWGAGCIMAEMWTR 225

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 85/205 (41%), Gaps = 17/205 (8%)
Query: 758 RATDGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDG------SLESFHAECKV 810
           +  D +   + LG G F  V K      G+E AAK              S E    E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 811 MGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASA 870
           +  + H N++ +     N     L+LE +S G L   L +    L   +    +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDG 127
Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNESMVG----HLSDFGIAKILGKEESMRQTKTLGTI 926
           + YLH   +  I H D+KP N++L +  +      L DFG+A  +  E+ +      GT 
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTP 182
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIM 951
            ++APE      +  + D++S G++
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G  +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 163
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 164 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 219
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 220 NQTVDIWSVGCIMAELLTGR 239

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G  +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 100 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 154
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 155 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 210
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 211 NQTVDIWSVGCIMAELLTGR 230

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + D+G+A+    E     T  + T  Y APE        
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 200
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G  +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 200
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G  +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 164
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 165 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 220
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 221 NQTVDIWSVGCIMAELLTGR 240

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 85/205 (41%), Gaps = 17/205 (8%)
Query: 758 RATDGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDG------SLESFHAECKV 810
           +  D +   + LG G F  V K      G+E AAK              S E    E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 811 MGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASA 870
           +  + H N++ +     N     L+LE +S G L   L +    L   +    +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDG 127
Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNESMVG----HLSDFGIAKILGKEESMRQTKTLGTI 926
           + YLH   +  I H D+KP N++L +  +      L DFG+A  +  E+ +      GT 
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTP 182
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIM 951
            ++APE      +  + D++S G++
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 769 LGMGSFGSV---YKGVLPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKII 823
           +G G++GSV   Y   L    ++A K     F   + +   + E +++  ++H N++ ++
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 824 S----SCSNNDFKALVLEYMSNGS----LEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
                + S  DF  + L     G+    + KC    +  +  L     +  +   L+Y+H
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFL-----VYQLLRGLKYIH 148
Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
              S  I+H D+KPSNV +NE     + DFG+A+   +E     T  + T  Y APE   
Sbjct: 149 ---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE----MTGYVATRWYRAPEIML 201
Query: 936 EG-KVSRKCDVYSYGIMLMETFTKK 959
                ++  D++S G ++ E    K
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3ULU|A Chain A, Structure Of Quaternary Complex Of Human Tlr3ecd With Three Fabs (Form1) Length = 694

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 102/411 (24%), Positives = 157/411 (38%), Gaps = 94/411 (22%)
Query: 276 LGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGT 335
           LG  SS     +   + + S LK   V D+     LP++I +       L L  N     
Sbjct: 3   LGSASSTTKCTVSHEVADCSHLKLTQVPDD-----LPTNITV-------LNLTHNQLRRL 50
Query: 336 IPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTS 395
             ++ T  S+L+ LD GFN+ S L P     L  LK+L+L  N L S   D +F      
Sbjct: 51  PAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL-SQLSDKTF----AF 105
Query: 396 CRNLEIIYLSENPI---------------------NGILPSSIGNFSISMKSLSMESCN- 433
           C NL  ++L  N I                     NG+  + +G          +   N 
Sbjct: 106 CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 165
Query: 434 -ISGGIPKELGNINN--LTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDL 490
            I     +EL    N  L  + L +N++    P     + +L GL+L N +L  S+ E L
Sbjct: 166 KIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL 225
Query: 491 CHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFXXX 550
           C    LAN                   TS+R+LSL ++ L++   +T   LK        
Sbjct: 226 C--LELAN-------------------TSIRNLSLSNSQLSTTSNTTFLGLK-------- 256
Query: 551 XXXXXXXXXPDIGNLKVVIEMDLSLNALSGVIPVTIXXXXXXXXXXXRYNRLQGPIPESF 610
                        NL +   +DLS N L+ V   +             YN +Q     S 
Sbjct: 257 -----------WTNLTM---LDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL 302
Query: 611 GGLKSLNFVDMSNNNLSGTI-----PK----SMEALSYLKHLNLSFNQLEG 652
            GL ++ ++++  +    +I     PK    S + L  L+HLN+  N + G
Sbjct: 303 HGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG 353

>pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 12/219 (5%)
Query: 238 GIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTL 297
           GIP       S + +FL  N +         + RNL +L + S+ LAG+  A+   ++ L
Sbjct: 28  GIP------ASSQRIFLHGNRISYVPAASFQSCRNLTILWLHSNALAGIDAAAFTGLTLL 81
Query: 298 KELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFS 357
           ++L ++DN  L  +  +   GL +L  L L         P     ++ L  L    N+  
Sbjct: 82  EQLDLSDNAQLRVVDPTTFRGLGHLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNNLQ 141
Query: 358 GLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSI 417
            L   TF +L +L  L L GN + S  P+ +F        +L+ + L +N +  + P + 
Sbjct: 142 ALPDNTFRDLGNLTHLFLHGNRIPS-VPEHAF----RGLHSLDRLLLHQNHVARVHPHAF 196
Query: 418 GNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNN 456
            +    M +L + + N+S    + L  + +L  +RL +N
Sbjct: 197 RDLGRLM-TLYLFANNLSMLPAEVLVPLRSLQYLRLNDN 234

>pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 42/158 (26%), Positives = 70/158 (44%), Gaps = 6/158 (3%)
Query: 391 SSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIP---KELGNINN 447
           +S  SCRNL I++L  N + GI  ++    ++  +    ++  +    P   + LG+++ 
Sbjct: 49  ASFQSCRNLTILWLHSNALAGIDAAAFTGLTLLEQLDLSDNAQLRVVDPTTFRGLGHLHT 108
Query: 448 LTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLS 507
           L + R G  EL    P     L  LQ LYLQ+N L+         L  L +L+L  N++ 
Sbjct: 109 LHLDRCGLQELG---PGLFRGLAALQYLYLQDNNLQALPDNTFRDLGNLTHLFLHGNRIP 165
Query: 508 GRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDIL 545
                    L SL  L L  N +  + P    +L  ++
Sbjct: 166 SVPEHAFRGLHSLDRLLLHQNHVARVHPHAFRDLGRLM 203

>pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 6/186 (3%)
Query: 271 RNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGEN 330
           RNL +L + S+ LA +  A+   ++ L++L ++DN  L S+  +   GL  L  L L   
Sbjct: 55  RNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRC 114
Query: 331 NFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFL 390
                 P     ++ L  L    N+   L   TF +L +L  L L GN ++S  P+ +F 
Sbjct: 115 GLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS-VPERAF- 172
Query: 391 SSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTV 450
                  +L+ + L +N +  + P +  +    M +L + + N+S    + L  +  L  
Sbjct: 173 ---RGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM-TLYLFANNLSALPTEALAPLRALQY 228
Query: 451 IRLGNN 456
           +RL +N
Sbjct: 229 LRLNDN 234

>pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 391 SSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKE---LGNINN 447
           +S  +CRNL I++L  N +  I  ++    ++  +    ++  +    P     LG ++ 
Sbjct: 49  ASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHT 108
Query: 448 LTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCH-LYRLANLYLGDNKL 506
           L + R G  EL    P     L  LQ LYLQ+N L+ ++P+D    L  L +L+L  N++
Sbjct: 109 LHLDRCGLQELG---PGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRI 164
Query: 507 SGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDIL 545
           S         L SL  L L  N +  + P    +L  ++
Sbjct: 165 SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM 203

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G  +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 825 ---SCSNNDFKALVLEYMSNGS----LEKC--LYSDNYFLDILQRLKIMIDVASALEYLH 875
              + S  +F  + L     G+    + KC  L  D+    I Q L+        L+Y+H
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILR-------GLKYIH 138
Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
              S  I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE   
Sbjct: 139 ---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIML 191
Query: 936 EG-KVSRKCDVYSYGIMLMETFTKK 959
                ++  D++S G ++ E  T +
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 6/186 (3%)
Query: 271 RNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGEN 330
           RNL +L + S+ LA +  A+   ++ L++L ++DN  L S+  +   GL  L  L L   
Sbjct: 56  RNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRC 115
Query: 331 NFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFL 390
                 P     ++ L  L    N+   L   TF +L +L  L L GN ++S  P+ +F 
Sbjct: 116 GLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS-VPERAF- 173
Query: 391 SSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTV 450
                  +L+ + L +N +  + P +  +    M +L + + N+S    + L  +  L  
Sbjct: 174 ---RGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM-TLYLFANNLSALPTEALAPLRALQY 229
Query: 451 IRLGNN 456
           +RL +N
Sbjct: 230 LRLNDN 235

>pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 391 SSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKE---LGNINN 447
           +S  +CRNL I++L  N +  I  ++    ++  +    ++  +    P     LG ++ 
Sbjct: 50  ASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHT 109
Query: 448 LTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCH-LYRLANLYLGDNKL 506
           L + R G  EL    P     L  LQ LYLQ+N L+ ++P+D    L  L +L+L  N++
Sbjct: 110 LHLDRCGLQELG---PGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRI 165
Query: 507 SGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDIL 545
           S         L SL  L L  N +  + P    +L  ++
Sbjct: 166 SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM 204

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 71/149 (47%), Gaps = 18/149 (12%)
Query: 809 KVMGSIRHRNLVKIISSCSNNDFKA-----LVLEYMSNGSLEKCLYSDNYFLDILQRLKI 863
           + +  + H ++V+I +   + D        +V+EY+   SL++   S    L + + +  
Sbjct: 131 QFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKR---SKGQKLPVAEAIAY 187
Query: 864 MIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL 923
           ++++  AL YLH   S  +V+ D+KP N++L E  +  L D G    +     +      
Sbjct: 188 LLEILPALSYLH---SIGLVYNDLKPENIMLTEEQL-KLIDLGAVSRINSFGYL-----Y 238
Query: 924 GTIGYMAPEYGREGKVSRKCDVYSYGIML 952
           GT G+ APE  R G  +   D+Y+ G  L
Sbjct: 239 GTPGFQAPEIVRTGP-TVATDIYTVGRTL 266

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 76/150 (50%), Gaps = 14/150 (9%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEIAA--KVFHMEFDGSLESFHAECKVMGSIR---HRNLVK 821
           K LG G++G V+K +     E+ A  K+F   F  S ++     ++M       H N+V 
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVN 73
Query: 822 IIS--SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
           +++     N+    LV +YM    L   + ++   L+ + +  ++  +   ++YLH G  
Sbjct: 74  LLNVLRADNDRDVYLVFDYMET-DLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSG-- 128
Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAK 909
             ++H D+KPSN+LLN      ++DFG+++
Sbjct: 129 -GLLHRDMKPSNILLNAECHVKVADFGLSR 157

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 51/215 (23%), Positives = 87/215 (40%), Gaps = 17/215 (7%)
Query: 758 RATDGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDG------SLESFHAECKV 810
           +  D +   + LG G F  V K      G+E AAK              S E    E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 811 MGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASA 870
           +  + H N++ +     N     L+LE +S G L   L +    L   +    +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDG 127
Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNESMVG----HLSDFGIAKILGKEESMRQTKTLGTI 926
           + YLH   +  I H D+KP N++L +  +      L DFG+A  +  E+ +      GT 
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTP 182
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
            ++APE      +  + D++S G++     +   P
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 51/215 (23%), Positives = 87/215 (40%), Gaps = 17/215 (7%)
Query: 758 RATDGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDG------SLESFHAECKV 810
           +  D +   + LG G F  V K      G+E AAK              S E    E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 811 MGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASA 870
           +  + H N++ +     N     L+LE +S G L   L +    L   +    +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDG 127
Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNESMVG----HLSDFGIAKILGKEESMRQTKTLGTI 926
           + YLH   +  I H D+KP N++L +  +      L DFG+A  +  E+ +      GT 
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTP 182
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
            ++APE      +  + D++S G++     +   P
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 51/215 (23%), Positives = 87/215 (40%), Gaps = 17/215 (7%)
Query: 758 RATDGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDG------SLESFHAECKV 810
           +  D +   + LG G F  V K      G+E AAK              S E    E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 811 MGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASA 870
           +  + H N++ +     N     L+LE +S G L   L +    L   +    +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDG 127
Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNESMVG----HLSDFGIAKILGKEESMRQTKTLGTI 926
           + YLH   +  I H D+KP N++L +  +      L DFG+A  +  E+ +      GT 
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTP 182
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
            ++APE      +  + D++S G++     +   P
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 92/206 (44%), Gaps = 30/206 (14%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 167
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKV- 939
            I+H D+KPSN+ +NE     + DFG+A+    E            GY+A  + R  ++ 
Sbjct: 168 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MXGYVATRWYRAPEIM 217
Query: 940 ------SRKCDVYSYGIMLMETFTKK 959
                 ++  D++S G ++ E  T +
Sbjct: 218 LNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G  +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 150
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E     T  + T  Y APE        
Sbjct: 151 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 206
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 207 NQTVDIWSVGCIMAELLTGR 226

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 96/230 (41%), Gaps = 49/230 (21%)
Query: 764 SENKLLGMGSFGSVYK----GVLPDGMEIAAKVFHMEFDGSL---ESFHAECKVMGSI-R 815
           S  K LG G+FG V +    G++     +   V  ++    L   E+  +E KV+  +  
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK-----------IM 864
           H N+V ++ +C+      ++ EY        C Y D   L+ L+R +           IM
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEY--------CCYGD--LLNFLRRKRDSFICSKTSPAIM 135
Query: 865 ----------------IDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA 908
                             VA  + +L    S   +H D+   N+LL    +  + DFG+A
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLA 192
Query: 909 KILGKEES-MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           + +  + + + +      + +MAPE       + + DV+SYGI L E F+
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 95/227 (41%), Gaps = 49/227 (21%)
Query: 767 KLLGMGSFGSVYK----GVLPDGMEIAAKVFHMEFDGSL---ESFHAECKVMGSI-RHRN 818
           K LG G+FG V +    G++     +   V  ++    L   E+  +E KV+  +  H N
Sbjct: 45  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 104
Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK-----------IM--- 864
           +V ++ +C+      ++ EY        C Y D   L+ L+R +           IM   
Sbjct: 105 IVNLLGACTIGGPTLVITEY--------CCYGD--LLNFLRRKRDSFICSKTSPAIMEDD 154
Query: 865 -------------IDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL 911
                          VA  + +L    S   +H D+   N+LL    +  + DFG+A+ +
Sbjct: 155 ELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDI 211
Query: 912 GKEES-MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
             + + + +      + +MAPE       + + DV+SYGI L E F+
Sbjct: 212 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 63/286 (22%), Positives = 115/286 (40%), Gaps = 43/286 (15%)
Query: 761  DGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGS------LESFHAECKVMGS 813
            D +   + LG G F  V K      G++ AAK        S       E    E  ++  
Sbjct: 11   DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 814  IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
            I+H N++ +     N     L+LE ++ G L   L ++   L   +  + +  + + + Y
Sbjct: 71   IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 874  LHFGYSTPIVHCDIKPSNVLLNESMVG----HLSDFGIAKILGKEESMRQTKTLGTIGYM 929
            LH   S  I H D+KP N++L +  V      + DFG+A  +      +     GT  ++
Sbjct: 130  LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPAFV 184
Query: 930  APEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA 989
            APE      +  + D++S G++     +   P             ++GD+          
Sbjct: 185  APEIVNYEPLGLEADMWSIGVITYILLSGASP-------------FLGDT---------K 222
Query: 990  DANLLNCEENDFSAREQCVSSIFSLAMDCT----VDLPEKRISMKD 1031
               L N    ++   ++  S+  +LA D      V  P+KR++++D
Sbjct: 223  QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 86/206 (41%), Gaps = 18/206 (8%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKI 822
           +++G GS+  V    L     I A KV   E    D  ++    E  V     +   +  
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 823 ISSCSNNDFKAL-VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           + SC   + +   V+EY++ G L   +       +   R     +++ AL YLH      
Sbjct: 75  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERG 130
Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL----GTIGYMAPEYGREG 937
           I++ D+K  NVLL+      L+D+G+ K     E +R   T     GT  Y+APE  R  
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSXFCGTPNYIAPEILRGE 185
Query: 938 KVSRKCDVYSYGIMLMETFTKKKPTD 963
                 D ++ G+++ E    + P D
Sbjct: 186 DYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 86/206 (41%), Gaps = 18/206 (8%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKI 822
           +++G GS+  V    L     I A KV   E    D  ++    E  V     +   +  
Sbjct: 11  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 70
Query: 823 ISSCSNNDFKAL-VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           + SC   + +   V+EY++ G L   +       +   R     +++ AL YLH      
Sbjct: 71  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERG 126
Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL----GTIGYMAPEYGREG 937
           I++ D+K  NVLL+      L+D+G+ K     E +R   T     GT  Y+APE  R  
Sbjct: 127 IIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSXFCGTPNYIAPEILRGE 181
Query: 938 KVSRKCDVYSYGIMLMETFTKKKPTD 963
                 D ++ G+++ E    + P D
Sbjct: 182 DYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 63/286 (22%), Positives = 115/286 (40%), Gaps = 43/286 (15%)
Query: 761  DGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGS------LESFHAECKVMGS 813
            D +   + LG G F  V K      G++ AAK        S       E    E  ++  
Sbjct: 11   DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 814  IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
            I+H N++ +     N     L+LE ++ G L   L ++   L   +  + +  + + + Y
Sbjct: 71   IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 874  LHFGYSTPIVHCDIKPSNVLLNESMVG----HLSDFGIAKILGKEESMRQTKTLGTIGYM 929
            LH   S  I H D+KP N++L +  V      + DFG+A  +      +     GT  ++
Sbjct: 130  LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFV 184
Query: 930  APEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA 989
            APE      +  + D++S G++     +   P             ++GD+          
Sbjct: 185  APEIVNYEPLGLEADMWSIGVITYILLSGASP-------------FLGDT---------K 222
Query: 990  DANLLNCEENDFSAREQCVSSIFSLAMDCT----VDLPEKRISMKD 1031
               L N    ++   ++  S+  +LA D      V  P+KR++++D
Sbjct: 223  QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 17/208 (8%)
Query: 757 LRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR 815
           LR  + +   + +G GSFG +Y G  +  G E+A K+  ++        H E K+   ++
Sbjct: 5   LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQ 62
Query: 816 HRNLVKIISSC-SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
               +  I  C +  D+  +V+E +   SLE      +    +   L +   + S +EY+
Sbjct: 63  GGVGIPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLS---DFGIAKILGKEES-----MRQTKTL-GT 925
           H   S   +H D+KP N L+     G+L    DFG+AK      +      R+ K L GT
Sbjct: 122 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 178
Query: 926 IGYMAPEYGREGKVSRKCDVYSYGIMLM 953
             Y +       + SR+ D+ S G +LM
Sbjct: 179 ARYASINTHLGIEQSRRDDLESLGYVLM 206

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 63/286 (22%), Positives = 115/286 (40%), Gaps = 43/286 (15%)
Query: 761  DGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGS------LESFHAECKVMGS 813
            D +   + LG G F  V K      G++ AAK        S       E    E  ++  
Sbjct: 11   DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 814  IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
            I+H N++ +     N     L+LE ++ G L   L ++   L   +  + +  + + + Y
Sbjct: 71   IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 874  LHFGYSTPIVHCDIKPSNVLLNESMVG----HLSDFGIAKILGKEESMRQTKTLGTIGYM 929
            LH   S  I H D+KP N++L +  V      + DFG+A  +      +     GT  ++
Sbjct: 130  LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFV 184
Query: 930  APEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA 989
            APE      +  + D++S G++     +   P             ++GD+          
Sbjct: 185  APEIVNYEPLGLEADMWSIGVITYILLSGASP-------------FLGDT---------K 222
Query: 990  DANLLNCEENDFSAREQCVSSIFSLAMDCT----VDLPEKRISMKD 1031
               L N    ++   ++  S+  +LA D      V  P+KR++++D
Sbjct: 223  QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268

>pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 132/291 (45%), Gaps = 52/291 (17%)
Query: 270 LRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDL--LGSLPSSIDLGLPNLERLFL 327
           L NLE L +  + +  + P S  N+  L  L +  N +  + +L +     L NL  L+L
Sbjct: 65  LTNLEYLNLNGNQITDISPLS--NLVKLTNLYIGTNKITDISALQN-----LTNLRELYL 117
Query: 328 GENNFSGTIPSSLTNISELSVLDFGFN-SFSGLIP--------------------TTFGN 366
            E+N S   P  L N+++   L+ G N + S L P                    T   N
Sbjct: 118 NEDNISDISP--LANLTKXYSLNLGANHNLSDLSPLSNXTGLNYLTVTESKVKDVTPIAN 175
Query: 367 LRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSE--NPINGILPSSIGNFSISM 424
           L  L  LSL  N +     D+S L+SLTS       Y +   N I  I P  + N +  +
Sbjct: 176 LTDLYSLSLNYNQI----EDISPLASLTSLH-----YFTAYVNQITDITP--VANXT-RL 223
Query: 425 KSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEG 484
            SL + +  I+   P  L N++ LT + +G N+++    V    L KL+ L + +N++  
Sbjct: 224 NSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINAV--KDLTKLKXLNVGSNQI-- 277
Query: 485 SIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIP 535
           S    L +L +L +L+L +N+L       +G LT+L  L L  N +T I P
Sbjct: 278 SDISVLNNLSQLNSLFLNNNQLGNEDXEVIGGLTNLTTLFLSQNHITDIRP 328

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 96/230 (41%), Gaps = 49/230 (21%)
Query: 764 SENKLLGMGSFGSVYK----GVLPDGMEIAAKVFHMEFDGSL---ESFHAECKVMGSI-R 815
           S  K LG G+FG V +    G++     +   V  ++    L   E+  +E KV+  +  
Sbjct: 44  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 103
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK-----------IM 864
           H N+V ++ +C+      ++ EY        C Y D   L+ L+R +           IM
Sbjct: 104 HMNIVNLLGACTIGGPTLVITEY--------CCYGD--LLNFLRRKRDSFICSKTSPAIM 153
Query: 865 ----------------IDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA 908
                             VA  + +L    S   +H D+   N+LL    +  + DFG+A
Sbjct: 154 EDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLA 210
Query: 909 KILGKEES-MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           + +  + + + +      + +MAPE       + + DV+SYGI L E F+
Sbjct: 211 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 96/230 (41%), Gaps = 49/230 (21%)
Query: 764 SENKLLGMGSFGSVYK----GVLPDGMEIAAKVFHMEFDGSL---ESFHAECKVMGSI-R 815
           S  K LG G+FG V +    G++     +   V  ++    L   E+  +E KV+  +  
Sbjct: 49  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK-----------IM 864
           H N+V ++ +C+      ++ EY        C Y D   L+ L+R +           IM
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEY--------CCYGD--LLNFLRRKRDSFICSKTSPAIM 158
Query: 865 ----------------IDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA 908
                             VA  + +L    S   +H D+   N+LL    +  + DFG+A
Sbjct: 159 EDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLA 215
Query: 909 KILGKEES-MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           + +  + + + +      + +MAPE       + + DV+SYGI L E F+
Sbjct: 216 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 63/286 (22%), Positives = 115/286 (40%), Gaps = 43/286 (15%)
Query: 761  DGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGS------LESFHAECKVMGS 813
            D +   + LG G F  V K      G++ AAK        S       E    E  ++  
Sbjct: 11   DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 814  IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
            I+H N++ +     N     L+LE ++ G L   L ++   L   +  + +  + + + Y
Sbjct: 71   IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 874  LHFGYSTPIVHCDIKPSNVLLNESMVG----HLSDFGIAKILGKEESMRQTKTLGTIGYM 929
            LH   S  I H D+KP N++L +  V      + DFG+A  +      +     GT  ++
Sbjct: 130  LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFV 184
Query: 930  APEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA 989
            APE      +  + D++S G++     +   P             ++GD+          
Sbjct: 185  APEIVNYEPLGLEADMWSIGVITYILLSGASP-------------FLGDT---------K 222
Query: 990  DANLLNCEENDFSAREQCVSSIFSLAMDCT----VDLPEKRISMKD 1031
               L N    ++   ++  S+  +LA D      V  P+KR++++D
Sbjct: 223  QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 17/208 (8%)
Query: 757 LRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR 815
           LR  + +   + +G GSFG +Y G  +  G E+A K+  ++        H E K+   ++
Sbjct: 3   LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQ 60
Query: 816 HRNLVKIISSC-SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
               +  I  C +  D+  +V+E +   SLE      +    +   L +   + S +EY+
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLS---DFGIAKILGKEES-----MRQTKTL-GT 925
           H   S   +H D+KP N L+     G+L    DFG+AK      +      R+ K L GT
Sbjct: 120 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 926 IGYMAPEYGREGKVSRKCDVYSYGIMLM 953
             Y +       + SR+ D+ S G +LM
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLM 204

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 34/107 (31%), Positives = 53/107 (49%), Gaps = 13/107 (12%)
Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGTIGYM 929
           LE +H  +   IVH D+KP+N L+ + M+  L DFGIA  +  +   + +   +GT+ YM
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDXXXVVKDSQVGTVNYM 195
Query: 930 APEYGREGKVSRK-----------CDVYSYGIMLMETFTKKKPTDEI 965
            PE  ++   SR+            DV+S G +L      K P  +I
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 63/286 (22%), Positives = 115/286 (40%), Gaps = 43/286 (15%)
Query: 761  DGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGS------LESFHAECKVMGS 813
            D +   + LG G F  V K      G++ AAK        S       E    E  ++  
Sbjct: 11   DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 814  IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
            I+H N++ +     N     L+LE ++ G L   L ++   L   +  + +  + + + Y
Sbjct: 71   IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 874  LHFGYSTPIVHCDIKPSNVLLNESMVG----HLSDFGIAKILGKEESMRQTKTLGTIGYM 929
            LH   S  I H D+KP N++L +  V      + DFG+A  +      +     GT  ++
Sbjct: 130  LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFV 184
Query: 930  APEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA 989
            APE      +  + D++S G++     +   P             ++GD+          
Sbjct: 185  APEIVNYEPLGLEADMWSIGVITYILLSGASP-------------FLGDT---------K 222
Query: 990  DANLLNCEENDFSAREQCVSSIFSLAMD----CTVDLPEKRISMKD 1031
               L N    ++   ++  S+  +LA D      V  P+KR++++D
Sbjct: 223  QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 63/286 (22%), Positives = 115/286 (40%), Gaps = 43/286 (15%)
Query: 761  DGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGS------LESFHAECKVMGS 813
            D +   + LG G F  V K      G++ AAK        S       E    E  ++  
Sbjct: 10   DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 814  IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
            I+H N++ +     N     L+LE ++ G L   L ++   L   +  + +  + + + Y
Sbjct: 70   IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 128
Query: 874  LHFGYSTPIVHCDIKPSNVLLNESMVG----HLSDFGIAKILGKEESMRQTKTLGTIGYM 929
            LH   S  I H D+KP N++L +  V      + DFG+A  +      +     GT  ++
Sbjct: 129  LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFV 183
Query: 930  APEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA 989
            APE      +  + D++S G++     +   P             ++GD+          
Sbjct: 184  APEIVNYEPLGLEADMWSIGVITYILLSGASP-------------FLGDT---------K 221
Query: 990  DANLLNCEENDFSAREQCVSSIFSLAMD----CTVDLPEKRISMKD 1031
               L N    ++   ++  S+  +LA D      V  P+KR++++D
Sbjct: 222  QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 267

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 63/286 (22%), Positives = 115/286 (40%), Gaps = 43/286 (15%)
Query: 761  DGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGS------LESFHAECKVMGS 813
            D +   + LG G F  V K      G++ AAK        S       E    E  ++  
Sbjct: 10   DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 814  IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
            I+H N++ +     N     L+LE ++ G L   L ++   L   +  + +  + + + Y
Sbjct: 70   IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 128
Query: 874  LHFGYSTPIVHCDIKPSNVLLNESMVG----HLSDFGIAKILGKEESMRQTKTLGTIGYM 929
            LH   S  I H D+KP N++L +  V      + DFG+A  +      +     GT  ++
Sbjct: 129  LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFV 183
Query: 930  APEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA 989
            APE      +  + D++S G++     +   P             ++GD+          
Sbjct: 184  APEIVNYEPLGLEADMWSIGVITYILLSGASP-------------FLGDT---------K 221
Query: 990  DANLLNCEENDFSAREQCVSSIFSLAMD----CTVDLPEKRISMKD 1031
               L N    ++   ++  S+  +LA D      V  P+KR++++D
Sbjct: 222  QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 267

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 63/286 (22%), Positives = 115/286 (40%), Gaps = 43/286 (15%)
Query: 761  DGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGS------LESFHAECKVMGS 813
            D +   + LG G F  V K      G++ AAK        S       E    E  ++  
Sbjct: 11   DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 814  IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
            I+H N++ +     N     L+LE ++ G L   L ++   L   +  + +  + + + Y
Sbjct: 71   IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 874  LHFGYSTPIVHCDIKPSNVLLNESMVG----HLSDFGIAKILGKEESMRQTKTLGTIGYM 929
            LH   S  I H D+KP N++L +  V      + DFG+A  +      +     GT  ++
Sbjct: 130  LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFV 184
Query: 930  APEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA 989
            APE      +  + D++S G++     +   P             ++GD+          
Sbjct: 185  APEIVNYEPLGLEADMWSIGVITYILLSGASP-------------FLGDT---------K 222
Query: 990  DANLLNCEENDFSAREQCVSSIFSLAMD----CTVDLPEKRISMKD 1031
               L N    ++   ++  S+  +LA D      V  P+KR++++D
Sbjct: 223  QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 63/286 (22%), Positives = 115/286 (40%), Gaps = 43/286 (15%)
Query: 761  DGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGS------LESFHAECKVMGS 813
            D +   + LG G F  V K      G++ AAK        S       E    E  ++  
Sbjct: 11   DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 814  IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
            I+H N++ +     N     L+LE ++ G L   L ++   L   +  + +  + + + Y
Sbjct: 71   IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 874  LHFGYSTPIVHCDIKPSNVLLNESMVG----HLSDFGIAKILGKEESMRQTKTLGTIGYM 929
            LH   S  I H D+KP N++L +  V      + DFG+A  +      +     GT  ++
Sbjct: 130  LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFV 184
Query: 930  APEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA 989
            APE      +  + D++S G++     +   P             ++GD+          
Sbjct: 185  APEIVNYEPLGLEADMWSIGVITYILLSGASP-------------FLGDT---------K 222
Query: 990  DANLLNCEENDFSAREQCVSSIFSLAMD----CTVDLPEKRISMKD 1031
               L N    ++   ++  S+  +LA D      V  P+KR++++D
Sbjct: 223  QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 25/208 (12%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGVLPDGM--EIAAKVFHMEFDGSL-ESFHAECKVMG 812
           ++  +D +   K +G G+FG     ++ D +  E+ A V ++E   ++ E+   E     
Sbjct: 15  IMHDSDRYDFVKDIGSGNFGVA--RLMRDKLTKELVA-VKYIERGAAIDENVQREIINHR 71
Query: 813 SIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALE 872
           S+RH N+V+           A+++EY S G L + + +   F +   R      + S + 
Sbjct: 72  SLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARF-FFQQLLSGVS 130
Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGHLS--DFGIAK--ILGKEESMRQTKTLGTIGY 928
           Y H   S  I H D+K  N LL+ S    L   DFG +K  +L  +       T+GT  Y
Sbjct: 131 YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAY 183
Query: 929 MAPE----YGREGKVSRKCDVYSYGIML 952
           +APE       +GK++   DV+S G+ L
Sbjct: 184 IAPEVLLRQEYDGKIA---DVWSCGVTL 208

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 769 LGMGSFGSV---YKGVLPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKII 823
           +G G++GSV   Y   L    ++A K     F   + +   + E +++  ++H N++ ++
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 824 S----SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
                + S  DF  + L   +    L   + S     + +Q L  +  +   L+Y+H   
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFL--VYQLLRGLKYIH--- 148
Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG- 937
           S  I+H D+KPSNV +NE     + DFG+A+   +E     T  + T  Y APE      
Sbjct: 149 SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE----MTGYVATRWYRAPEIMLNWM 204
Query: 938 KVSRKCDVYSYGIMLMETFTKK 959
             ++  D++S G ++ E    K
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGK 226

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 63/286 (22%), Positives = 115/286 (40%), Gaps = 43/286 (15%)
Query: 761  DGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGS------LESFHAECKVMGS 813
            D +   + LG G F  V K      G++ AAK        S       E    E  ++  
Sbjct: 11   DYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 814  IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
            I+H N++ +     N     L+LE ++ G L   L ++   L   +  + +  + + + Y
Sbjct: 71   IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 874  LHFGYSTPIVHCDIKPSNVLLNESMVG----HLSDFGIAKILGKEESMRQTKTLGTIGYM 929
            LH   S  I H D+KP N++L +  V      + DFG+A  +      +     GT  ++
Sbjct: 130  LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFV 184
Query: 930  APEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA 989
            APE      +  + D++S G++     +   P             ++GD+          
Sbjct: 185  APEIVNYEPLGLEADMWSIGVITYILLSGASP-------------FLGDT---------K 222
Query: 990  DANLLNCEENDFSAREQCVSSIFSLAMD----CTVDLPEKRISMKD 1031
               L N    ++   ++  S+  +LA D      V  P+KR++++D
Sbjct: 223  QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 86/206 (41%), Gaps = 18/206 (8%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKI 822
           +++G GS+  V    L     I A KV   E    D  ++    E  V     +   +  
Sbjct: 26  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 85
Query: 823 ISSCSNNDFKAL-VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           + SC   + +   V+EY++ G L   +       +   R     +++ AL YLH      
Sbjct: 86  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERG 141
Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL----GTIGYMAPEYGREG 937
           I++ D+K  NVLL+      L+D+G+ K     E +R   T     GT  Y+APE  R  
Sbjct: 142 IIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSXFCGTPNYIAPEILRGE 196
Query: 938 KVSRKCDVYSYGIMLMETFTKKKPTD 963
                 D ++ G+++ E    + P D
Sbjct: 197 DYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|1XCD|A Chain A, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 1 Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 117/257 (45%), Gaps = 22/257 (8%)
Query: 239 IPRDIGNLTSVRNLFLGNNSLIGEIPN-EIGNLRNLEVLGVQSSNLAGLIPASIFNISTL 297
           +P+D+   T++ +L    N+ I EI + +  NL+NL  L + ++ ++ + P +   +  L
Sbjct: 46  VPKDLPPDTALLDL---QNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102
Query: 298 KELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSF- 356
           + L ++ N L   LP  +      L+ L + EN  +    S    ++++ V++ G N   
Sbjct: 103 ERLYLSKNQL-KELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK 158
Query: 357 -SGLIPTTFGNLRSLKLLSLAG-NVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILP 414
            SG+    F  ++ L  + +A  N+ T P        SLT       ++L  N I  +  
Sbjct: 159 SSGIENGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTE------LHLDGNKITKVDA 209
Query: 415 SSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQG 474
           +S+   + ++  L +   +IS      L N  +L  + L NN+L   +P  L   + +Q 
Sbjct: 210 ASLKGLN-NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQV 267
Query: 475 LYLQNNKLEGSIPEDLC 491
           +YL NN +      D C
Sbjct: 268 VYLHNNNISAIGSNDFC 284

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 96/230 (41%), Gaps = 49/230 (21%)
Query: 764 SENKLLGMGSFGSVYK----GVLPDGMEIAAKVFHMEFDGSL---ESFHAECKVMGSI-R 815
           S  K LG G+FG V +    G++     +   V  ++    L   E+  +E KV+  +  
Sbjct: 49  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK-----------IM 864
           H N+V ++ +C+      ++ EY        C Y D   L+ L+R +           IM
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEY--------CCYGD--LLNFLRRKRDSFICSKTSPAIM 158
Query: 865 ----------------IDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA 908
                             VA  + +L    S   +H D+   N+LL    +  + DFG+A
Sbjct: 159 EDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLA 215
Query: 909 KILGKEES-MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           + +  + + + +      + +MAPE       + + DV+SYGI L E F+
Sbjct: 216 RHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1XKU|A Chain A, Crystal Structure Of The Dimeric Protein Core Of Decorin, The Archetypal Small Leucine-Rich Repeat Proteoglycan Length = 330

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 117/257 (45%), Gaps = 22/257 (8%)
Query: 239 IPRDIGNLTSVRNLFLGNNSLIGEIPN-EIGNLRNLEVLGVQSSNLAGLIPASIFNISTL 297
           +P+D+   T++ +L    N+ I EI + +  NL+NL  L + ++ ++ + P +   +  L
Sbjct: 46  VPKDLPPDTALLDL---QNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102
Query: 298 KELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSF- 356
           + L ++ N L   LP  +      L+ L + EN  +    S    ++++ V++ G N   
Sbjct: 103 ERLYLSKNQL-KELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK 158
Query: 357 -SGLIPTTFGNLRSLKLLSLAG-NVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILP 414
            SG+    F  ++ L  + +A  N+ T P        SLT       ++L  N I  +  
Sbjct: 159 SSGIENGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTE------LHLDGNKITKVDA 209
Query: 415 SSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQG 474
           +S+   + ++  L +   +IS      L N  +L  + L NN+L   +P  L   + +Q 
Sbjct: 210 ASLKGLN-NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQV 267
Query: 475 LYLQNNKLEGSIPEDLC 491
           +YL NN +      D C
Sbjct: 268 VYLHNNNISAIGSNDFC 284

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 63/286 (22%), Positives = 115/286 (40%), Gaps = 43/286 (15%)
Query: 761  DGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGS------LESFHAECKVMGS 813
            D +   + LG G F  V K      G++ AAK        S       E    E  ++  
Sbjct: 11   DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 814  IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
            I+H N++ +     N     L+LE ++ G L   L ++   L   +  + +  + + + Y
Sbjct: 71   IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 874  LHFGYSTPIVHCDIKPSNVLLNESMVG----HLSDFGIAKILGKEESMRQTKTLGTIGYM 929
            LH   S  I H D+KP N++L +  V      + DFG+A  +      +     GT  ++
Sbjct: 130  LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFV 184
Query: 930  APEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA 989
            APE      +  + D++S G++     +   P             ++GD+          
Sbjct: 185  APEIVNYEPLGLEADMWSIGVITYILLSGASP-------------FLGDT---------K 222
Query: 990  DANLLNCEENDFSAREQCVSSIFSLAMDCT----VDLPEKRISMKD 1031
               L N    ++   ++  S+  +LA D      V  P+KR++++D
Sbjct: 223  QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G  +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 164
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E        + T  Y APE        
Sbjct: 165 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MXGXVATRWYRAPEIMLNWMHY 220
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 221 NQTVDIWSVGCIMAELLTGR 240

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G  +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 140
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E        + T  Y APE        
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MAGFVATRWYRAPEIMLNWMHY 196
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 197 NQTVDIWSVGCIMAELLTGR 216

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 30/206 (14%)
Query: 769 LGMGSFGSV---YKGVLPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKII 823
           +G G++GSV   Y   L    ++A K     F   + +   + E +++  ++H N++ ++
Sbjct: 28  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 824 S----SCSNNDFKALVLEYMSNGS----LEKC-LYSDNYFLDILQRLKIMIDVASALEYL 874
                + S  DF  + L     G+    + KC   SD +   ++ +L         L+Y+
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQL------LRGLKYI 139
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
           H   S  I+H D+KPSNV +NE     + DFG+A+   +E     T  + T  Y APE  
Sbjct: 140 H---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEE----MTGYVATRWYRAPEIM 192
Query: 935 REG-KVSRKCDVYSYGIMLMETFTKK 959
                 ++  D++S G ++ E    K
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 63/286 (22%), Positives = 115/286 (40%), Gaps = 43/286 (15%)
Query: 761  DGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGS------LESFHAECKVMGS 813
            D +   + LG G F  V K      G++ AAK        S       E    E  ++  
Sbjct: 11   DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 814  IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
            I+H N++ +     N     L+LE ++ G L   L ++   L   +  + +  + + + Y
Sbjct: 71   IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 874  LHFGYSTPIVHCDIKPSNVLLNESMVG----HLSDFGIAKILGKEESMRQTKTLGTIGYM 929
            LH   S  I H D+KP N++L +  V      + DFG+A  +      +     GT  ++
Sbjct: 130  LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFV 184
Query: 930  APEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA 989
            APE      +  + D++S G++     +   P             ++GD+          
Sbjct: 185  APEIVNYEPLGLEADMWSIGVITYILLSGASP-------------FLGDT---------K 222
Query: 990  DANLLNCEENDFSAREQCVSSIFSLAMDCT----VDLPEKRISMKD 1031
               L N    ++   ++  S+  +LA D      V  P+KR++++D
Sbjct: 223  QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 63/286 (22%), Positives = 115/286 (40%), Gaps = 43/286 (15%)
Query: 761  DGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGS------LESFHAECKVMGS 813
            D +   + LG G F  V K      G++ AAK        S       E    E  ++  
Sbjct: 11   DYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 814  IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
            I+H N++ +     N     L+LE ++ G L   L ++   L   +  + +  + + + Y
Sbjct: 71   IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 874  LHFGYSTPIVHCDIKPSNVLLNESMVG----HLSDFGIAKILGKEESMRQTKTLGTIGYM 929
            LH   S  I H D+KP N++L +  V      + DFG+A  +      +     GT  ++
Sbjct: 130  LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFV 184
Query: 930  APEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA 989
            APE      +  + D++S G++     +   P             ++GD+          
Sbjct: 185  APEIVNYEPLGLEADMWSIGVITYILLSGASP-------------FLGDT---------K 222
Query: 990  DANLLNCEENDFSAREQCVSSIFSLAMD----CTVDLPEKRISMKD 1031
               L N    ++   ++  S+  +LA D      V  P+KR++++D
Sbjct: 223  QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     +  FG+A+    E     T  + T  Y APE        
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 200
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G  +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E        + T  Y APE        
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MAGFVATRWYRAPEIMLNWMHY 200
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 13/108 (12%)
Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGTIGYM 929
           LE +H  +   IVH D+KP+N L+ + M+  L DFGIA  +  +  S+ +   +GT+ YM
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 930 APEYGREGKVSRK-----------CDVYSYGIMLMETFTKKKPTDEIF 966
            PE  ++   SR+            DV+S G +L      K P  +I 
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G  +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DFG+A+    E        + T  Y APE        
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MAGFVATRWYRAPEIMLNWMHY 200
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + D G+A+    E     T  + T  Y APE        
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 200
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 17/208 (8%)
Query: 757 LRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR 815
           LR  + +   + +G GSFG +Y G  +  G E+A K+  ++        H E K    ++
Sbjct: 5   LRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVK--TKHPQLHIESKFYKMMQ 62
Query: 816 HRNLVKIISSC-SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
               +  I  C +  D+  +V+E +   SLE      +    +   L +   + S +EY+
Sbjct: 63  GGVGIPSIKWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLS---DFGIAKILGKEES-----MRQTKTL-GT 925
           H   S   +H D+KP N L+     G+L    DFG+AK      +      R+ K L GT
Sbjct: 122 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 178
Query: 926 IGYMAPEYGREGKVSRKCDVYSYGIMLM 953
             Y +       + SR+ D+ S G +LM
Sbjct: 179 ARYASINTHLGIEQSRRDDLESLGYVLM 206

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 85/205 (41%), Gaps = 17/205 (8%)
Query: 758 RATDGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGS------LESFHAECKV 810
           +  D +   + LG G F  V K      G+E AAK        +       E    E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 811 MGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASA 870
           +  + H N++ +     N     L+LE +S G L   L +    L   +    +  +   
Sbjct: 69  LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDG 127
Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNESMVG----HLSDFGIAKILGKEESMRQTKTLGTI 926
           + YLH   +  I H D+KP N++L +  +      L DFG+A  +  E+ +      GT 
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTP 182
Query: 927 GYMAPEYGREGKVSRKCDVYSYGIM 951
            ++APE      +  + D++S G++
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 86/206 (41%), Gaps = 18/206 (8%)
Query: 767 KLLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKI 822
           +++G GS+  V    L     I A +V   E    D  ++    E  V     +   +  
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 823 ISSCSNNDFKAL-VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           + SC   + +   V+EY++ G L   +       +   R     +++ AL YLH      
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERG 173
Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL----GTIGYMAPEYGREG 937
           I++ D+K  NVLL+      L+D+G+ K     E +R   T     GT  Y+APE  R  
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAPEILRGE 228
Query: 938 KVSRKCDVYSYGIMLMETFTKKKPTD 963
                 D ++ G+++ E    + P D
Sbjct: 229 DYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|2A0Z|A Chain A, The Molecular Structure Of Toll-like Receptor 3 Ligand Binding Domain Length = 705

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 91/366 (24%), Positives = 140/366 (38%), Gaps = 82/366 (22%)
Query: 321 NLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVL 380
           N+  L L  N       ++ T  S+L+ LD GFN+ S L P     L  LK+L+L  N L
Sbjct: 31  NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL 90
Query: 381 TSPTPDLSFLSSLTSCRNLEIIYLSENPI---------------------NGILPSSIGN 419
            S   D +F      C NL  ++L  N I                     NG+  + +G 
Sbjct: 91  -SQLSDKTF----AFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGT 145
Query: 420 FSISMKSLSMESCN--ISGGIPKELGNINN--LTVIRLGNNELTGTIPVTLGRLQKLQGL 475
                    +   N  I     +EL    N  L  + L +N++    P     + +L GL
Sbjct: 146 QVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGL 205
Query: 476 YLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIP 535
           +L N +L  S+ E LC    LAN                   TS+R+LSL ++ L++   
Sbjct: 206 FLNNVQLGPSLTEKLC--LELAN-------------------TSIRNLSLSNSQLSTTSN 244
Query: 536 STLWNLKDILRFXXXXXXXXXXXXPDIGNLKVVIEMDLSLNALSGVIPVTIXXXXXXXXX 595
           +T   LK                     NL +   +DLS N L+ V   +          
Sbjct: 245 TTFLGLK-------------------WTNLTM---LDLSYNNLNVVGNDSFAWLPQLEYF 282
Query: 596 XXRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTI-----PK----SMEALSYLKHLNLS 646
              YN +Q     S  GL ++ ++++  +    +I     PK    S + L  L+HLN+ 
Sbjct: 283 FLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNME 342
Query: 647 FNQLEG 652
            N + G
Sbjct: 343 DNDIPG 348

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + D G+A+    E     T  + T  Y APE        
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 200
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|1ZIW|A Chain A, Human Toll-Like Receptor 3 Extracellular Domain Structure Length = 680

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 91/366 (24%), Positives = 140/366 (38%), Gaps = 82/366 (22%)
Query: 321 NLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVL 380
           N+  L L  N       ++ T  S+L+ LD GFN+ S L P     L  LK+L+L  N L
Sbjct: 26  NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL 85
Query: 381 TSPTPDLSFLSSLTSCRNLEIIYLSENPI---------------------NGILPSSIGN 419
            S   D +F      C NL  ++L  N I                     NG+  + +G 
Sbjct: 86  -SQLSDKTF----AFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGT 140
Query: 420 FSISMKSLSMESCN--ISGGIPKELGNINN--LTVIRLGNNELTGTIPVTLGRLQKLQGL 475
                    +   N  I     +EL    N  L  + L +N++    P     + +L GL
Sbjct: 141 QVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGL 200
Query: 476 YLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIP 535
           +L N +L  S+ E LC    LAN                   TS+R+LSL ++ L++   
Sbjct: 201 FLNNVQLGPSLTEKLC--LELAN-------------------TSIRNLSLSNSQLSTTSN 239
Query: 536 STLWNLKDILRFXXXXXXXXXXXXPDIGNLKVVIEMDLSLNALSGVIPVTIXXXXXXXXX 595
           +T   LK                     NL +   +DLS N L+ V   +          
Sbjct: 240 TTFLGLK-------------------WTNLTM---LDLSYNNLNVVGNDSFAWLPQLEYF 277
Query: 596 XXRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTI-----PK----SMEALSYLKHLNLS 646
              YN +Q     S  GL ++ ++++  +    +I     PK    S + L  L+HLN+ 
Sbjct: 278 FLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNME 337
Query: 647 FNQLEG 652
            N + G
Sbjct: 338 DNDIPG 343

>pdb|2FT3|A Chain A, Crystal Structure Of The Biglycan Dimer Core Protein Length = 332

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 102/242 (42%), Gaps = 29/242 (11%)
Query: 308 LGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNL 367
           L ++P  I    P+   L L  N+ S         +  L  L    N  S +    F  L
Sbjct: 45  LKAVPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPL 101
Query: 368 RSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSL 427
           R L+ L ++ N L    P+L   SSL   R      + +N I  + P  + +   +M  +
Sbjct: 102 RKLQKLYISKNHLVEIPPNLP--SSLVELR------IHDNRIRKV-PKGVFSGLRNMNCI 152
Query: 428 SMESCNISGGIPKELGNIN-------NLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNN 480
            M      GG P E             L  +R+   +LTG IP  L   + L  L+L +N
Sbjct: 153 EM------GGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPKDLP--ETLNELHLDHN 203
Query: 481 KLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWN 540
           K++    EDL    +L  L LG N++       L  L +LR+L L +N L S +P+ L +
Sbjct: 204 KIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL-SRVPAGLPD 262
Query: 541 LK 542
           LK
Sbjct: 263 LK 264

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 35/212 (16%)
Query: 763 FSENKLLGMGSFGSV----------YKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMG 812
           F   K +G G+FG +          Y  +  + M+  A   H+E+      F+   K +G
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEY-----RFY---KQLG 62
Query: 813 SIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALE 872
           S      V     C    + A+VLE +   SLE      +    +   L I I + S +E
Sbjct: 63  SGDGIPQVYYFGPCGK--YNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRME 119
Query: 873 YLHFGYSTPIVHCDIKPSNVLLNE-----SMVGHLSDFGIAKILGKEES-----MRQTKT 922
           Y+H   S  +++ D+KP N L+         V H+ DFG+AK     E+      R+ K+
Sbjct: 120 YVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFGLAKEYIDPETKKHIPYREHKS 176
Query: 923 L-GTIGYMAPEYGREGKVSRKCDVYSYGIMLM 953
           L GT  YM+       + SR+ D+ + G M M
Sbjct: 177 LTGTARYMSINTHLGKEQSRRDDLEALGHMFM 208

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 767 KLLGMGSFGSV---YKGVLPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVK 821
           K +G G+ G V   Y  VL     +A K     F     +  A  E  +M  + H+N++ 
Sbjct: 23  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 822 IISSCSNN----DFK--ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
           +++  +      +F+   LV+E M + +L + +  +   LD  +   ++  +   +++LH
Sbjct: 81  LLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME---LDHERMSYLLYQMLXGIKHLH 136
Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
              S  I+H D+KPSN+++       + DFG+A+  G   S   T  + T  Y APE   
Sbjct: 137 ---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVIL 191
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRW 975
                   D++S G ++ E    K     +F G   + +W
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 227

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 89/205 (43%), Gaps = 19/205 (9%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR 815
           ++  +D +   K +G G+FG           E+ A  +    +   E+   E     S+R
Sbjct: 13  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLR 72
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
           H N+V+           A+V+EY S G L + + +   F +   R      + S + Y H
Sbjct: 73  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF-FFQQLISGVSYCH 131
Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLS--DFGIAK--ILGKEESMRQTKTLGTIGYMAP 931
              +  + H D+K  N LL+ S    L   DFG +K  +L  +       T+GT  Y+AP
Sbjct: 132 ---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIAP 184
Query: 932 EY----GREGKVSRKCDVYSYGIML 952
           E       +GKV+   DV+S G+ L
Sbjct: 185 EVLLKKEYDGKVA---DVWSCGVTL 206

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 767 KLLGMGSFGSV---YKGVLPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVK 821
           K +G G+ G V   Y  VL     +A K     F     +  A  E  +M  + H+N++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIIS 87
Query: 822 IISSCSNN----DFK--ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
           +++  +      +F+   LV+E M + +L + +  +   LD  +   ++  +   +++LH
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME---LDHERMSYLLYQMLXGIKHLH 143
Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
              S  I+H D+KPSN+++       + DFG+A+  G   S   T  + T  Y APE   
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVIL 198
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRW 975
                   D++S G ++ E    K     +F G   + +W
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 103/233 (44%), Gaps = 34/233 (14%)
Query: 758 RATDGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSI-- 814
           +  D F   ++ G G+FG+V  G     GM +A K    +        + E ++M  +  
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK----KVIQDPRFRNRELQIMQDLAV 75
Query: 815 -RHRNLVKIIS---SCSNNDFKAL----VLEYMSNGSLEKCLYSDNYFLDILQRLKIMID 866
             H N+V++ S   +    D + +    V+EY+ + +L +C    NY+   +    I+I 
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRC--CRNYYRRQVAPPPILIK 132
Query: 867 V-----ASALEYLHFGYSTPIVHCDIKPSNVLLNESM-VGHLSDFGIAKILGKEESMRQT 920
           V       ++  LH   S  + H DIKP NVL+NE+     L DFG AK L   E     
Sbjct: 133 VFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP--NV 189
Query: 921 KTLGTIGYMAPE--YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMS 971
             + +  Y APE  +G +   +   D++S G +  E        + IF G+ S
Sbjct: 190 AYICSRYYRAPELIFGNQHYTT-AVDIWSVGCIFAEMML----GEPIFRGDNS 237

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G+ +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + D G+A+    E     T  + T  Y APE        
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 200
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 767 KLLGMGSFGSV---YKGVLPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVK 821
           K +G G+ G V   Y  VL     +A K     F     +  A  E  +M  + H+N++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 87
Query: 822 IISSCSNN----DFK--ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
           +++  +      +F+   LV+E M + +L + +  +   LD  +   ++  +   +++LH
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME---LDHERMSYLLYQMLXGIKHLH 143
Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
              S  I+H D+KPSN+++       + DFG+A+  G   S   T  + T  Y APE   
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVIL 198
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRW 975
                   D++S G ++ E    K     +F G   + +W
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 45/93 (48%), Gaps = 8/93 (8%)
Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES---MVGHLSDFGIAKILGKEESMR 918
           +I   +  A++YLH   S  I H D+KP N+L        +  L+DFG AK      S+ 
Sbjct: 165 EIXKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL- 220
Query: 919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIM 951
            T    T  Y+APE     K  + CD +S G++
Sbjct: 221 -TTPCYTPYYVAPEVLGPEKYDKSCDXWSLGVI 252

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 97/231 (41%), Gaps = 22/231 (9%)
Query: 754 QDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECK 809
           +D ++ TD F+   +LG GSFG V         E+ A K+   +    D  +E    E +
Sbjct: 14  RDRMKLTD-FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 72
Query: 810 VMGSIRHRNLVKIISSCSNN-DFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVA 868
           V+        +  + SC    D    V+EY++ G L        Y +  + R K    V 
Sbjct: 73  VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL-------MYHIQQVGRFKEPHAVF 125
Query: 869 SALEY---LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT 925
            A E    L F  S  I++ D+K  NV+L+      ++DFG+ K     + +      GT
Sbjct: 126 YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKXFCGT 184
Query: 926 IGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP-----TDEIFAGEMS 971
             Y+APE        +  D +++G++L E    + P      DE+F   M 
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 235

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 767 KLLGMGSFGSV---YKGVLPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVK 821
           K +G G+ G V   Y  VL     +A K     F     +  A  E  +M  + H+N++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIIS 87
Query: 822 IISSCSNN----DFK--ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
           +++  +      +F+   LV+E M + +L + +  +   LD  +   ++  +   +++LH
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME---LDHERMSYLLYQMLCGIKHLH 143
Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
              S  I+H D+KPSN+++       + DFG+A+  G   S   T  + T  Y APE   
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVIL 198
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRW 975
                   D++S G ++ E    K     +F G   + +W
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 78/205 (38%), Gaps = 31/205 (15%)
Query: 276 LGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGT 335
           L +QS+ L+ L   +   ++ L+ L + DN L  +LP+ I   L NLE L++ +N     
Sbjct: 42  LDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQAL 100
Query: 336 IPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTS 395
                  +  L+ L    N    L P  F +L  L  LSL  N L S             
Sbjct: 101 PIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQS------------- 147
Query: 396 CRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGN 455
                            LP  + +   S+K L + +  +          +  L  ++L N
Sbjct: 148 -----------------LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDN 190
Query: 456 NELTGTIPVTLGRLQKLQGLYLQNN 480
           N+L          L+KL+ L LQ N
Sbjct: 191 NQLKRVPEGAFDSLEKLKMLQLQEN 215

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 18/200 (9%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES--FHAECKVMGSIRHRNLVKIIS- 824
           +G G++GSV        G  +A K     F   + +   + E +++  ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 825 ---SCSNNDFKALVL-EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
              + S  +F  + L  ++    L   +       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KV 939
            I+H D+KPSN+ +NE     + DF +A+    E     T  + T  Y APE        
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 200
Query: 940 SRKCDVYSYGIMLMETFTKK 959
           ++  D++S G ++ E  T +
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 97/231 (41%), Gaps = 22/231 (9%)
Query: 754 QDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECK 809
           +D ++ TD F+   +LG GSFG V         E+ A K+   +    D  +E    E +
Sbjct: 335 RDRMKLTD-FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 393
Query: 810 VMGSIRHRNLVKIISSCSNN-DFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVA 868
           V+        +  + SC    D    V+EY++ G L        Y +  + R K    V 
Sbjct: 394 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL-------MYHIQQVGRFKEPHAVF 446
Query: 869 SALEY---LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT 925
            A E    L F  S  I++ D+K  NV+L+      ++DFG+ K     + +      GT
Sbjct: 447 YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKXFCGT 505
Query: 926 IGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP-----TDEIFAGEMS 971
             Y+APE        +  D +++G++L E    + P      DE+F   M 
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 556

>pdb|4FHO|A Chain A, Crystal Structure Of An Internalin C2 (Inlc2) From Listeria Monocytogenes Str. 4b F2365 At 1.90 A Resolution Length = 231

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 84/202 (41%), Gaps = 44/202 (21%)
Query: 319 LPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGN 378
           L NL  L L +N  +   P  L N+++++ L+   N    +  +    L+S+K L L   
Sbjct: 68  LNNLIGLELKDNQITDLTP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTST 123
Query: 379 VLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGI 438
            +T  TP       L    NL+++YL  N I  I P                        
Sbjct: 124 QITDVTP-------LAGLSNLQVLYLDLNQITNISP------------------------ 152
Query: 439 PKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLAN 498
              L  + NL  + +GNN++    P  L  L KL  L   +NK+    P  L  L  L  
Sbjct: 153 ---LAGLTNLQYLSIGNNQVNDLTP--LANLSKLTTLRADDNKISDISP--LASLPNLIE 205
Query: 499 LYLGDNKLSGRLPACLGNLTSL 520
           ++L DN++S   P  L NL++L
Sbjct: 206 VHLKDNQISDVSP--LANLSNL 225

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 31/89 (34%), Positives = 44/89 (49%), Gaps = 6/89 (6%)
Query: 866 DVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT 925
           D   AL +LH   S  +VH D+KP+N+ L       L DFG+   LG   +    +  G 
Sbjct: 165 DTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--GD 219
Query: 926 IGYMAPEYGREGKVSRKCDVYSYGIMLME 954
             YMAPE   +G      DV+S G+ ++E
Sbjct: 220 PRYMAPEL-LQGSYGTAADVFSLGLTILE 247

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 23/202 (11%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKII-- 823
           +G G++GSV   +    G ++A K     F   +  +  + E  ++  ++H N++ ++  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 824 ----SSCSN-NDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
               SS  N  DF  LV+ +M    L+K +  +          KI   V   L+ L + +
Sbjct: 110 FTPASSLRNFYDF-YLVMPFMQT-DLQKIMGME------FSEEKIQYLVYQMLKGLKYIH 161
Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG- 937
           S  +VH D+KP N+ +NE     + DFG+A+    E     T  + T  Y APE      
Sbjct: 162 SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWM 217
Query: 938 KVSRKCDVYSYGIMLMETFTKK 959
             ++  D++S G ++ E  T K
Sbjct: 218 HYNQTVDIWSVGCIMAEMLTGK 239

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 57/236 (24%), Positives = 111/236 (47%), Gaps = 23/236 (9%)
Query: 735 RPYYDANMY-PQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKV 792
           R Y D N + P+  W   S+       D +   + LG G +  V++ + + +  ++  K+
Sbjct: 10  RVYTDVNTHRPREYWDYASHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI 69
Query: 793 FHMEFDGSLESFHAECKVMGSIRH-RNLVKIISSCSN--NDFKALVLEYMSNGSLEKCLY 849
                   ++    E K++ ++R   N++ +     +  +   ALV E+++N   ++ LY
Sbjct: 70  LKPVKKNKIKR---EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LY 125
Query: 850 SDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIA 908
                 DI  R   M ++  AL+Y H   S  I+H D+KP NV+++ E     L D+G+A
Sbjct: 126 QTLTDYDI--RF-YMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 179
Query: 909 KIL--GKEESMRQTKTLGTIGYMAPEYGREGKV-SRKCDVYSYGIMLMETFTKKKP 961
           +    G+E ++R    + +  +  PE   + ++     D++S G ML     +K+P
Sbjct: 180 EFYHPGQEYNVR----VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 231

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 19/205 (9%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR 815
           ++  +D +   K +G G+FG           E+ A  +    +    +   E     S+R
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLR 73
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
           H N+V+           A+V+EY S G L + + +   F +   R      + S + Y H
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF-FFQQLISGVSYCH 132
Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLS--DFGIAK--ILGKEESMRQTKTLGTIGYMAP 931
              +  + H D+K  N LL+ S    L   DFG +K  +L  +       T+GT  Y+AP
Sbjct: 133 ---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIAP 185
Query: 932 EY----GREGKVSRKCDVYSYGIML 952
           E       +GKV+   DV+S G+ L
Sbjct: 186 EVLLKKEYDGKVA---DVWSCGVTL 207

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 29/205 (14%)
Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL--ESFHAECKVMGSIRHRNLVKII-- 823
           +G G++GSV   +    G ++A K     F   +  +  + E  ++  ++H N++ ++  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 824 ----SSCSN-NDFKALVLEYMSNGSLEKCL---YSDNYFLDILQRLKIMIDVASALEYLH 875
               SS  N  DF  LV+ +M    L+K +   +S+          KI   V   L+ L 
Sbjct: 92  FTPASSLRNFYDF-YLVMPFMQT-DLQKIMGLKFSEE---------KIQYLVYQMLKGLK 140
Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
           + +S  +VH D+KP N+ +NE     + DFG+A+    E     T  + T  Y APE   
Sbjct: 141 YIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVIL 196
Query: 936 EG-KVSRKCDVYSYGIMLMETFTKK 959
                ++  D++S G ++ E  T K
Sbjct: 197 SWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 13/108 (12%)
Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE-ESMRQTKTLGTIGYM 929
           LE +H  +   IVH D+KP+N L+ + M+  L DFGIA  +  +  S+ +   +G + YM
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 930 APEYGREGKVSRK-----------CDVYSYGIMLMETFTKKKPTDEIF 966
            PE  ++   SR+            DV+S G +L      K P  +I 
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 15/215 (6%)
Query: 756 LLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR 815
           ++  +D +   K +G G+FG           E+ A  +    +   E+   E     S+R
Sbjct: 14  IMHDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLR 73
Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
           H N+V+           A+V+EY S G L + + +   F +   R      + S + Y H
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF-FFQQLISGVSYAH 132
Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHL--SDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
              +  + H D+K  N LL+ S    L  +DFG +K        +    +GT  Y+APE 
Sbjct: 133 ---AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSK--ASVLHSQPKSAVGTPAYIAPEV 187
Query: 934 ----GREGKVSRKCDVYSYGIMLMETFTKKKPTDE 964
                 +GKV+   DV+S G+ L        P ++
Sbjct: 188 LLKKEYDGKVA---DVWSCGVTLYVMLVGAYPFED 219

>pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 63/132 (47%), Gaps = 4/132 (3%)
Query: 398 NLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKEL-GNINNLTVIRLGNN 456
           N +I+YL +N I  + P    +  I++K L + S N  G +P  +  ++  LTV+ LG N
Sbjct: 41  NAQILYLHDNQITKLEPGVFDSL-INLKELYLGS-NQLGALPVGVFDSLTQLTVLDLGTN 98
Query: 457 ELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGN 516
           +LT        RL  L+ L++  NKL   +P  +  L  L +L L  N+L          
Sbjct: 99  QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDR 157
Query: 517 LTSLRDLSLGSN 528
           L+SL    L  N
Sbjct: 158 LSSLTHAYLFGN 169

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 62/286 (21%), Positives = 114/286 (39%), Gaps = 43/286 (15%)
Query: 761  DGFSENKLLGMGSFGSVYK-GVLPDGMEIAAKVFHMEFDGS------LESFHAECKVMGS 813
            D +   + LG G F  V K      G++ AAK        S       E    E  ++  
Sbjct: 11   DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 814  IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
            I+H N++ +     N     L+ E ++ G L   L ++   L   +  + +  + + + Y
Sbjct: 71   IQHPNVITLHEVYENKTDVILIGELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 874  LHFGYSTPIVHCDIKPSNVLLNESMVG----HLSDFGIAKILGKEESMRQTKTLGTIGYM 929
            LH   S  I H D+KP N++L +  V      + DFG+A  +      +     GT  ++
Sbjct: 130  LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFV 184
Query: 930  APEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA 989
            APE      +  + D++S G++     +   P             ++GD+          
Sbjct: 185  APEIVNYEPLGLEADMWSIGVITYILLSGASP-------------FLGDT---------K 222
Query: 990  DANLLNCEENDFSAREQCVSSIFSLAMD----CTVDLPEKRISMKD 1031
               L N    ++   ++  S+  +LA D      V  P+KR++++D
Sbjct: 223  QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 767 KLLGMGSFGSV---YKGVLPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVK 821
           K +G G+ G V   Y  VL     +A K     F     +  A  E  +M  + H+N++ 
Sbjct: 24  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 81
Query: 822 IISSCSNN----DFK--ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
           +++  +      +F+   LV+E M + +L + +  +   LD  +   ++  +   +++LH
Sbjct: 82  LLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKHLH 137
Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
              S  I+H D+KPSN+++       + DFG+A+  G   S   T  + T  Y APE   
Sbjct: 138 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVIL 192
Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRW 975
                   D++S G ++ E    K     +F G   + +W
Sbjct: 193 GMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 228
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	1049
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	0.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-169
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-66
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-114
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-96
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-36
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-113
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-109
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-48
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-45
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-41
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-07
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-91
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-77
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-50
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-43
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-11
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-91
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-67
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-87
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-32
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-31
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-26
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-10
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-06
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	9e-85
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	9e-78
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-66
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-81
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-75
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-65
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-62
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-38
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	7e-79
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-77
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	8e-66
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-63
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-61
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-42
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	8e-41
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-29
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-27
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-11
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-59
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-57
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-50
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-39
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-58
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-58
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-56
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-56
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-55
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-48
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-29
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-54
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-54
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-52
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-51
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-51
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-48
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-48
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-46
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-43
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-50
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-50
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-50
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-50
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-49
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-49
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-35
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-04
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-50
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-49
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-48
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-48
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-44
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-42
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-48
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-47
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-46
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-45
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-44
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-44
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-42
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	9e-39
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	8e-36
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-43
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-42
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-42
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-42
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-38
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-36
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-30
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	9e-43
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	9e-39
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	9e-33
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-14
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-40
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	8e-38
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-37
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-37
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-23
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-39
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-37
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-32
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-14
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-37
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-36
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-34
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-32
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-29
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-28
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-37
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-37
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-36
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-36
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-36
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-36
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	7e-36
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-35
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-35
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-35
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-32
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	9e-27
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-16
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-10
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-35
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-35
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-35
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-34
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-32
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-31
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-24
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-11
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-35
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-35
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-35
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-35
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-35
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-35
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	7e-35
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-33
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-29
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	7e-27
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-20
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-18
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-13
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	7e-08
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	8e-35
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	8e-35
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-34
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-34
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-34
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-34
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-34
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-34
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	8e-32
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-31
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-31
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-29
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-28
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	6e-28
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-10
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-34
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-30
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-29
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-18
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-34
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-34
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-34
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-34
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	7e-34
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-33
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-33
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-33
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-33
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-32
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-32
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-32
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-22
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-08
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-33
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	6e-33
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-30
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-27
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-33
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	8e-33
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-32
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-32
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-32
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-32
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-32
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-32
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-32
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-32
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	7e-32
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-32
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-31
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-28
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-26
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-16
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	9e-15
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-31
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-31
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-31
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-31
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-26
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-21
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-19
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-12
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-31
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-31
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-30
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-30
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-30
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-30
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-30
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-30
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-30
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-29
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-29
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-29
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-29
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	6e-27
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-20
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	6e-08
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-29
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-29
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-29
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-29
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-28
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	9e-27
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-24
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-21
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-15
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-29
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-29
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-28
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-27
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-24
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-22
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-15
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-10
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-29
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-29
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-28
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-28
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-28
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-28
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-28
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-28
3fme_A	290	Dual specificity mitogen-activated protein kinase;	8e-28
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	8e-28
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	8e-28
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-27
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-27
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-27
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-25
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-25
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	5e-24
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-23
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-20
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	9e-14
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-27
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-27
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-22
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-19
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-15
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-15
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-27
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-27
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-27
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-27
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-27
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	8e-27
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-26
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	9e-25
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-19
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-19
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-14
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-26
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-26
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-26
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-26
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-26
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	6e-26
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	7e-26
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	7e-26
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	7e-26
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-25
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-25
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-25
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-25
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-25
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-25
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-25
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-25
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-25
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-25
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-25
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-25
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-25
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-25
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-25
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-25
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-25
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-25
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	6e-25
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-25
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	7e-25
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	8e-25
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	9e-25
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-24
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-24
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-24
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-24
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-23
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-23
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-23
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-23
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	8e-23
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-21
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-21
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-04
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-22
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-22
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-22
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-04
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-22
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-22
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-21
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-17
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-16
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-13
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-21
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-21
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-21
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-11
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-20
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-17
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-15
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-11
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-05
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-20
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	8e-20
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	5e-17
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	8e-17
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-13
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-19
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-18
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-18
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-16
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-16
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-11
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-19
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-19
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-17
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	8e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-12
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-19
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-18
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-18
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-18
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-18
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-18
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-17
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-17
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-16
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-14
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-14
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-13
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-09
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-08
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-17
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-17
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-17
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	9e-17
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-16
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	8e-16
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-12
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	5e-10
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-16
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-16
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-16
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	9e-16
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	7e-14
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	8e-14
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-09
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-07
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-15
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-10
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-15
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-15
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	6e-15
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	7e-15
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-15
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	9e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	7e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-05
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-14
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-14
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-14
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	7e-14
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	7e-14
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-14
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-14
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-13
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-07
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-13
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-13
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	7e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	9e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-07
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-04
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-13
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-13
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-13
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-07
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-13
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	9e-13
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-10
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-08
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-12
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-12
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-06
3m19_A	251	Variable lymphocyte receptor A diversity region; a	7e-05
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-12
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-12
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	6e-12
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-12
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	7e-12
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-11
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-04
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-11
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-11
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-08
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	5e-05
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	4e-04
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-11
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-11
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-11
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-11
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	7e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-11
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-10
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-10
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	4e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-10
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	7e-10
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-09
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-09
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	5e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	8e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-04
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-09
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	5e-09
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-04
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	6e-04
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	9e-04
3e6j_A	229	Variable lymphocyte receptor diversity region; var	6e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	5e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-05
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-04
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	9e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	8e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-08
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	9e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	5e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	9e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	6e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-04
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	6e-08
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	8e-05
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	1e-07
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	3e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-07
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	3e-06
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-07
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	9e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-04
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	5e-05
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	2e-04
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	6e-05
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	8e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	8e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  554 bits (1429), Expect = 0.0
 Identities = 191/628 (30%), Positives = 297/628 (47%), Gaps = 30/628 (4%)

Query: 76  TALNISYLGLTGTIPPQL---GNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNN 132
             L++S   ++G              L  LAI  N   G +   +S    L++ D   NN
Sbjct: 154 EVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNN 211

Query: 133 FHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNI 192
           F   IP        LQHL +  N   G     I   + L+ L++S NQ  G IP      
Sbjct: 212 FSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL---- 266

Query: 193 SSCQNLPVLEGLFISYNQLTGPIPTNLW-KCRELHVVSLAFNKFQGGIPRDIGNLTSVRN 251
                L  L+ L ++ N+ TG IP  L   C  L  + L+ N F G +P   G+ + + +
Sbjct: 267 ----PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLES 322

Query: 252 LFLGNNSLIGEIPNE-IGNLRNLEVLGVQSSNLAGLIPASIFNIST-LKELAVTDNDLLG 309
           L L +N+  GE+P + +  +R L+VL +  +  +G +P S+ N+S  L  L ++ N+  G
Sbjct: 323 LALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSG 382

Query: 310 SLPSSI-DLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLR 368
            +  ++       L+ L+L  N F+G IP +L+N SEL  L   FN  SG IP++ G+L 
Sbjct: 383 PILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS 442

Query: 369 SLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLS 428
            L+ L L  N+L    P       L   + LE + L  N + G +PS + N + ++  +S
Sbjct: 443 KLRDLKLWLNMLEGEIP-----QELMYVKTLETLILDFNDLTGEIPSGLSNCT-NLNWIS 496

Query: 429 MESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPE 488
           + +  ++G IPK +G + NL +++L NN  +G IP  LG  + L  L L  N   G+IP 
Sbjct: 497 LSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556

Query: 489 DLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNA--LTSIIPSTLWNLKDILR 546
            +          +  N ++G+    + N    ++     N      I    L  L     
Sbjct: 557 AMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNP 612

Query: 547 FNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPI 606
            N++S    G   P   N   ++ +D+S N LSG IP  IG +  L +L+L +N + G I
Sbjct: 613 CNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSI 672

Query: 607 PESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAE 666
           P+  G L+ LN +D+S+N L G IP++M AL+ L  ++LS N L G IP  G F TF   
Sbjct: 673 PDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPA 732

Query: 667 SFLGNQALCGSPKLQVSPCKTRSHPRSR 694
            FL N  LCG P  +  P     +   +
Sbjct: 733 KFLNNPGLCGYPLPRCDPSNADGYAHHQ 760

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  513 bits (1324), Expect = e-169
 Identities = 172/648 (26%), Positives = 303/648 (46%), Gaps = 32/648 (4%)

Query: 19  SSVMAAVTNVTTDQFALLALKEHIKHDPSNLLANNWSTTSSVCSWIGVTCGVRNRRVTAL 78
           S   +   ++  +   L++ K+ +     NLL + WS+  + C++ GVTC  R+ +VT++
Sbjct: 1   SFQASPSQSLYREIHQLISFKDVL--PDKNLLPD-WSSNKNPCTFDGVTC--RDDKVTSI 55

Query: 79  NISYLGLT---GTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHI 135
           ++S   L      +   L +L+ L  L + N+   GS+         L   D   N+   
Sbjct: 56  DLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSG 114

Query: 136 EIPS--WFVSLPRLQHLLLKHNSFVGKIPETIGY-LSLLQELDLSDNQLSGTIPSSIFNI 192
            + +     S   L+ L +  N+       + G  L+ L+ LDLS N +SG         
Sbjct: 115 PVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLS 174

Query: 193 SSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNL 252
             C     L+ L IS N+++G +   + +C  L  + ++ N F  GIP  +G+ +++++L
Sbjct: 175 DGCGE---LKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHL 228

Query: 253 FLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLP 312
            +  N L G+    I     L++L + S+   G IP     + +L+ L++ +N   G +P
Sbjct: 229 DISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIP 286

Query: 313 SSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPT-TFGNLRSLK 371
             +      L  L L  N+F G +P    + S L  L    N+FSG +P  T   +R LK
Sbjct: 287 DFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLK 346

Query: 372 LLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSI-SMKSLSME 430
           +L L+ N  +   P    L++L++  +L  + LS N  +G +  ++      +++ L ++
Sbjct: 347 VLDLSFNEFSGELP--ESLTNLSA--SLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQ 402

Query: 431 SCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDL 490
           +   +G IP  L N + L  + L  N L+GTIP +LG L KL+ L L  N LEG IP++L
Sbjct: 403 NNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 462

Query: 491 CHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLS 550
            ++  L  L L  N L+G +P+ L N T+L  +SL +N LT  IP  +  L+++    LS
Sbjct: 463 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLS 522

Query: 551 SNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESF 610
           +NS +G++  ++G+ + +I +DL+ N  +G IP  +    G     +  N + G      
Sbjct: 523 NNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYI 578

Query: 611 GGLKSLNFVDMSNN--NLSGTIPKSMEALSYLKHLNLSFNQLEGEIPT 656
                      + N     G   + +  LS     N++     G    
Sbjct: 579 KNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSP 626

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  238 bits (609), Expect = 2e-66
 Identities = 92/325 (28%), Positives = 145/325 (44%), Gaps = 13/325 (4%)

Query: 73  RRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNN 132
             + +L++S+  L+GTIP  LG+LS L  L +  N   G +P+EL +++ L+     FN+
Sbjct: 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477

Query: 133 FHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNI 192
              EIPS   +   L  + L +N   G+IP+ IG L  L  L LS+N  SG IP+ + + 
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDC 537

Query: 193 SSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNL 252
            S      L  L ++ N   G IP  ++K        +A N   G     I N    +  
Sbjct: 538 RS------LIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKEC 587

Query: 253 FLGNN--SLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGS 310
               N     G    ++  L       + S    G    +  N  ++  L ++ N L G 
Sbjct: 588 HGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGY 647

Query: 311 LPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSL 370
           +P  I   +P L  L LG N+ SG+IP  + ++  L++LD   N   G IP     L  L
Sbjct: 648 IPKEI-GSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTML 706

Query: 371 KLLSLAGNVLTSPTPDLSFLSSLTS 395
             + L+ N L+ P P++    +   
Sbjct: 707 TEIDLSNNNLSGPIPEMGQFETFPP 731

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  365 bits (939), Expect = e-114
 Identities = 93/667 (13%), Positives = 208/667 (31%), Gaps = 93/667 (13%)

Query: 18  LSSVMAAVTNVTTDQFALLALKEHIK------HDPSNLLANNWSTTSSVCSW---IGVTC 68
           +   ++       D  AL  + + +                NW+    +  W    GV+ 
Sbjct: 18  VPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSL 77

Query: 69  GVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFG----SLPEELSHLRGLK 124
              N RVT L++   G +G +P  +G L+ L VLA+ ++          P+ +S     +
Sbjct: 78  N-SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136

Query: 125 YFDFRFNNFHIEIPSW--FVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLS 182
                  ++      +        L    +  +     I ++        ++    N ++
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196

Query: 183 GTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRD 242
             +  ++  ++       L   ++  +          W+       +  + +        
Sbjct: 197 F-VSKAVMRLTK------LRQFYMGNSPFVAENICEAWENE-----NSEYAQQYKTEDLK 244

Query: 243 IGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGL--------IPASIFNI 294
             NL  + ++ + N   + ++P  +  L  ++++ V  +               A     
Sbjct: 245 WDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVG 304

Query: 295 STLKELAVTDNDLL-GSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGF 353
             ++ + +  N+L    + +S+   +  L  L    N   G +P +  +  +L+ L+  +
Sbjct: 305 EKIQIIYIGYNNLKTFPVETSL-QKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAY 362

Query: 354 NSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGIL 413
           N  + +     G    ++ LS A N L      +  +    S   +  I  S N I  + 
Sbjct: 363 NQITEIPANFCGFTEQVENLSFAHNKLKY----IPNIFDAKSVSVMSAIDFSYNEIGSV- 417

Query: 414 PSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQ 473
                                   +        N++ I L NN+++            L 
Sbjct: 418 -----------------DGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLS 460

Query: 474 GLYLQNNKLEG-------SIPEDLCHLYRLANLYLGDNKLSGRLPA--CLGNLTSLRDLS 524
            + L  N L            E+  + Y L ++ L  NKL+  L        L  L  + 
Sbjct: 461 SINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGID 519

Query: 525 LGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPV 584
           L  N+ +   P+   N   +  F + +                    D   N      P 
Sbjct: 520 LSYNSFSK-FPTQPLNSSTLKGFGIRNQ------------------RDAQGNRTLREWPE 560

Query: 585 TIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLN 644
            I     L  L +  N ++  + E      +++ +D+ +N         +          
Sbjct: 561 GITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYM 617

Query: 645 LSFNQLE 651
           L +++ +
Sbjct: 618 LFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  317 bits (814), Expect = 5e-96
 Identities = 82/583 (14%), Positives = 180/583 (30%), Gaps = 58/583 (9%)

Query: 126 FDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTI 185
           F+   + +  +      S  R+  L L+     G++P+ IG L+ L+ L L  +      
Sbjct: 62  FNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKV-- 119

Query: 186 PSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAF--NKFQGGIPRDI 243
              +F           E                  +     ++      +  Q  I +  
Sbjct: 120 NERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS 179

Query: 244 GNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVT 303
                   +   +N++   +   +  L  L    + +S          +           
Sbjct: 180 RITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS-----E 233

Query: 304 DNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGL---- 359
                 +     D  L +L  + +        +P+ L  + E+ +++   N         
Sbjct: 234 YAQQYKTEDLKWD-NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLK 292

Query: 360 ----IPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPS 415
                         ++++ +  N L +        +SL   + L ++    N + G LP 
Sbjct: 293 DDWQALADAPVGEKIQIIYIGYNNLKT----FPVETSLQKMKKLGMLECLYNQLEGKLP- 347

Query: 416 SIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIP--VTLGRLQKLQ 473
           + G+    + SL++    I+       G    +  +   +N+L   IP       +  + 
Sbjct: 348 AFGSEI-KLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMS 405

Query: 474 GLYLQNNKLEG-------SIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLG 526
            +    N++          +         ++++ L +N++S          + L  ++L 
Sbjct: 406 AIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLM 465

Query: 527 SNALTSI-------IPSTLWNLKDILRFNLSSNSLNGSLLPD---IGNLKVVIEMDLSLN 576
            N LT I             N   +   +L  N L    L D      L  ++ +DLS N
Sbjct: 466 GNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK--LSDDFRATTLPYLVGIDLSYN 523

Query: 577 ALSGVIPVTIGGLQGLQLLSLR------YNRLQGPIPESFGGLKSLNFVDMSNNNLSGTI 630
           + S   P        L+   +R       NR     PE      SL  + + +N++   +
Sbjct: 524 SFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KV 581

Query: 631 PKSMEALSYLKHLNLSFNQLEGEIPTR-GPFITFSAESFLGNQ 672
            + +     +  L++  N       +   P+I         ++
Sbjct: 582 NEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  147 bits (372), Expect = 1e-36
 Identities = 29/252 (11%), Positives = 77/252 (30%), Gaps = 12/252 (4%)

Query: 426 SLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEG- 484
           + + E           L +   +T + L     +G +P  +G+L +L+ L L ++  +  
Sbjct: 61  NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120

Query: 485 ---SIPEDLCHLYRLANLYLGDNKLSGRLPACLG--NLTSLRDLSLGSNALTSIIPSTLW 539
                P+ +                           + + L    + S+     I  +  
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180

Query: 540 NLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRY 599
                 +    SN++   +   +  L  + +  +  +                +  +  Y
Sbjct: 181 ITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEA-----WENENSEY 234

Query: 600 NRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGP 659
            +        +  LK L  V++ N      +P  ++AL  ++ +N++ N+       +  
Sbjct: 235 AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDD 294

Query: 660 FITFSAESFLGN 671
           +   +       
Sbjct: 295 WQALADAPVGEK 306

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  365 bits (938), Expect = e-113
 Identities = 129/642 (20%), Positives = 224/642 (34%), Gaps = 48/642 (7%)

Query: 73  RRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNN 132
             +T LN+++  L           S L  L +  N+     PE    L  LK  + + N 
Sbjct: 25  TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84

Query: 133 FHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNI 192
                   F     L  L L  NS              L  LDLS N LS T   +    
Sbjct: 85  LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGT---- 140

Query: 193 SSCQNLPVLEGLFISYNQLTGPIPTNL--WKCRELHVVSLAFNKFQGGIPRDIGNLTSVR 250
                L  L+ L +S N++       L  +    L  + L+ N+ +   P     +  + 
Sbjct: 141 --QVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLF 198

Query: 251 NLFLGNNSLIGEIPNEIG---NLRNLEVLGVQSSNLAGLIPASIFN--ISTLKELAVTDN 305
            LFL N  L   +  ++       ++  L + +S L+     +      + L  L ++ N
Sbjct: 199 GLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYN 258

Query: 306 DLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLD---------FGFNSF 356
           +L      S    LP LE  FL  NN       SL  +  +  L+             S 
Sbjct: 259 NLNVVGNDSFA-WLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASL 317

Query: 357 SGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSS 416
             +   +F  L+ L+ L++  N +     +       T   NL+ + LS +  +    ++
Sbjct: 318 PKIDDFSFQWLKCLEHLNMEDNDIPGIKSN-----MFTGLINLKYLSLSNSFTSLRTLTN 372

Query: 417 ---IGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPV-TLGRLQKL 472
              +      +  L++    IS         + +L V+ LG NE+   +       L+ +
Sbjct: 373 ETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENI 432

Query: 473 QGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSG--RLPACLGNLTSLRDLSLGSNAL 530
             +YL  NK           +  L  L L    L      P+    L +L  L L +N +
Sbjct: 433 FEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNI 492

Query: 531 TSIIPSTLWNLKDILRFNLSSNSLN--------GSLLPDIGNLKVVIEMDLSLNALSGVI 582
            +I    L  L+ +   +L  N+L         G  +  +  L  +  ++L  N    + 
Sbjct: 493 ANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIP 552

Query: 583 PVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSME-ALSYLK 641
                 L  L+++ L  N L       F    SL  +++  N ++    K    A   L 
Sbjct: 553 VEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLT 612

Query: 642 HLNLSFNQLEGEIPTRGPFITFSAES-----FLGNQALCGSP 678
            L++ FN  +    +   F+ +  E+      L +  LC +P
Sbjct: 613 ELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTP 654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  353 bits (909), Expect = e-109
 Identities = 124/604 (20%), Positives = 224/604 (37%), Gaps = 35/604 (5%)

Query: 78  LNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEI 137
            + S+L LT  +P  L   + + VL + +N          +    L   D  FN      
Sbjct: 9   ADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLE 65

Query: 138 PSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQN 197
           P     LP L+ L L+HN       +T  + + L EL L  N +     +          
Sbjct: 66  PELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF------VK 119

Query: 198 LPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIG--NLTSVRNLFLG 255
              L  L +S+N L+        +   L  + L+ NK Q     ++     +S++ L L 
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179

Query: 256 NNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIF---NISTLKELAVTDNDLLGSLP 312
           +N +    P     +  L  L + +  L   +   +      ++++ L+++++ L  +  
Sbjct: 180 SNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN 239

Query: 313 SSID-LGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLK 371
           ++   L   NL  L L  NN +     S   + +L      +N+   L   +   L +++
Sbjct: 240 TTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVR 299

Query: 372 LLSLAGNVLTSPTPDLSF----LSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSL 427
            L+L  +         S       S    + LE + + +N I GI  +       ++K L
Sbjct: 300 YLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLI-NLKYL 358

Query: 428 SMESCNISGGIPKELG----NINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLE 483
           S+ +   S              + L ++ L  N+++         L  L+ L L  N++ 
Sbjct: 359 SLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIG 418

Query: 484 GSIPED-LCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSI--IPSTLWN 540
             +       L  +  +YL  NK           + SL+ L L   AL ++   PS    
Sbjct: 419 QELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP 478

Query: 541 LKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALS--------GVIPVTIGGLQGL 592
           L+++   +LS+N++       +  L+ +  +DL  N L+        G     + GL  L
Sbjct: 479 LRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHL 538

Query: 593 QLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEG 652
            +L+L  N       E F  L  L  +D+  NNL+            LK LNL  N +  
Sbjct: 539 HILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITS 598

Query: 653 EIPT 656
               
Sbjct: 599 VEKK 602

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  181 bits (461), Expect = 7e-48
 Identities = 75/376 (19%), Positives = 127/376 (33%), Gaps = 24/376 (6%)

Query: 78  LNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIE- 136
            +IS   L          L  L  L + +N   G      + L  LKY     +   +  
Sbjct: 310 QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRT 369

Query: 137 -IPSWFVSLP--RLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNIS 193
                FVSL    L  L L  N       +   +L  L+ LDL  N++   +    +   
Sbjct: 370 LTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEW--- 426

Query: 194 SCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQG--GIPRDIGNLTSVRN 251
             + L  +  +++SYN+       +      L  + L     +     P     L ++  
Sbjct: 427 --RGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTI 484

Query: 252 LFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNL--------AGLIPASIFNISTLKELAVT 303
           L L NN++     + +  L  LE+L +Q +NL         G     +  +S L  L + 
Sbjct: 485 LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLE 544

Query: 304 DNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTT 363
            N             L  L+ + LG NN +    S   N   L  L+   N  + +    
Sbjct: 545 SNGFDEIPVEVFK-DLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKV 603

Query: 364 FG-NLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSI 422
           FG   R+L  L +  N        +++  +  +  +  I  LS + +    P   G    
Sbjct: 604 FGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHG---F 660

Query: 423 SMKSLSMESCNISGGI 438
            ++     SC  S   
Sbjct: 661 PVRLFDTSSCKDSAHH 676

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  172 bits (439), Expect = 5e-45
 Identities = 53/265 (20%), Positives = 99/265 (37%), Gaps = 11/265 (4%)

Query: 398 NLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNE 457
           + E+   S   +  + P  +     ++  L++    +           + LT + +G N 
Sbjct: 5   SHEVADCSHLKLTQV-PDDLPT---NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60

Query: 458 LTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNL 517
           ++   P    +L  L+ L LQ+N+L     +       L  L+L  N +           
Sbjct: 61  ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120

Query: 518 TSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVV--IEMDLSL 575
            +L  L L  N L+S    T   L+++    LS+N +      ++         +++LS 
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180

Query: 576 NALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFG---GLKSLNFVDMSNNNLSGTIPK 632
           N +    P     +  L  L L   +L   + E         S+  + +SN+ LS T   
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240

Query: 633 SMEALSY--LKHLNLSFNQLEGEIP 655
           +   L +  L  L+LS+N L     
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGN 265

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  162 bits (412), Expect = 2e-41
 Identities = 56/241 (23%), Positives = 106/241 (43%), Gaps = 8/241 (3%)

Query: 421 SISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNN 480
           ++S +        ++  +P +L    N+TV+ L +N+L         R  +L  L +  N
Sbjct: 3   TVSHEVADCSHLKLTQ-VPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN 59

Query: 481 KLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWN 540
            +    PE    L  L  L L  N+LS          T+L +L L SN++  I  +    
Sbjct: 60  TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119

Query: 541 LKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQG--LQLLSLR 598
            K+++  +LS N L+ + L     L+ + E+ LS N +  +    +       L+ L L 
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179

Query: 599 YNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSM---EALSYLKHLNLSFNQLEGEIP 655
            N+++   P  F  +  L  + ++N  L  ++ + +    A + +++L+LS +QL     
Sbjct: 180 SNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN 239

Query: 656 T 656
           T
Sbjct: 240 T 240

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 54.2 bits (131), Expect = 2e-07
 Identities = 24/136 (17%), Positives = 47/136 (34%), Gaps = 12/136 (8%)

Query: 73  RRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNN 132
             +  LN+   G          +L  L ++ +  N+         ++   LK  + + N 
Sbjct: 536 SHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNL 595

Query: 133 FHIEIPSWF-VSLPRLQHLLLKHNSFVGKIPETIGYLSLLQE-----LDLSDNQLSGTIP 186
                   F  +   L  L ++ N F         +++ + E      +LS + L  T P
Sbjct: 596 ITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPP 655

Query: 187 S------SIFNISSCQ 196
                   +F+ SSC+
Sbjct: 656 HYHGFPVRLFDTSSCK 671

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  304 bits (781), Expect = 1e-91
 Identities = 107/568 (18%), Positives = 195/568 (34%), Gaps = 53/568 (9%)

Query: 126 FDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTI 185
           +     NF+ +IP         ++L L  N        +      LQ LDLS  ++    
Sbjct: 12  YQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE 68

Query: 186 PSSIFNISS------------------CQNLPVLEGLFISYNQLTGPIPTNLWKCRELHV 227
             +  ++S                      L  L+ L      L       +   + L  
Sbjct: 69  DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128

Query: 228 VSLAFNKFQGG-IPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQ---SSNL 283
           +++A N  Q   +P    NLT++ +L L +N +      ++  L  + +L +    S N 
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188

Query: 284 AGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERL------FLGENNFSGTIP 337
              I    F    L +L + +N    ++  +   GL  LE        F  E N      
Sbjct: 189 MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248

Query: 338 SSLTNISELSVLDFGFNS---FSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLT 394
           S+L  +  L++ +F       +   I   F  L ++   SL    +     D S+     
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV-KDFSYNFGWQ 307

Query: 395 SCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLG 454
                  + L            + +    +K L+    +  GG      ++ +L  + L 
Sbjct: 308 H------LELVNCKFGQFPTLKLKS----LKRLTF--TSNKGGNAFSEVDLPSLEFLDLS 355

Query: 455 NNELT--GTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPA 512
            N L+  G    +      L+ L L  N +   +  +   L +L +L    + L      
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEF 414

Query: 513 -CLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDI-GNLKVVIE 570
               +L +L  L +               L  +    ++ NS   + LPDI   L+ +  
Sbjct: 415 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 474

Query: 571 MDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTI 630
           +DLS   L  + P     L  LQ+L++ +N         +  L SL  +D S N++  + 
Sbjct: 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK 534

Query: 631 PKSMEAL-SYLKHLNLSFNQLEGEIPTR 657
            + ++   S L  LNL+ N        +
Sbjct: 535 KQELQHFPSSLAFLNLTQNDFACTCEHQ 562

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  264 bits (678), Expect = 3e-77
 Identities = 97/561 (17%), Positives = 191/561 (34%), Gaps = 33/561 (5%)

Query: 78  LNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEI 137
           L++S   +         +LS L+ L +  N          S L  L+       N     
Sbjct: 57  LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 116

Query: 138 PSWFVSLPRLQHLLLKHNSFVG-KIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQ 196
                 L  L+ L + HN     K+PE    L+ L+ LDLS N++     + +  +    
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176

Query: 197 NLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGN-------LTSV 249
            L +   L +S N +    P    + R LH ++L  N     + +              V
Sbjct: 177 LLNLS--LDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLV 233

Query: 250 RNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNL---AGLIPASIFNISTLKELAVTDND 306
              F    +L     + +  L NL +   + + L      I      ++ +   ++    
Sbjct: 234 LGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT 293

Query: 307 LLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGN 366
           +      S        + L L    F       L ++  L+     F S  G    +  +
Sbjct: 294 IERVKDFS---YNFGWQHLELVNCKFGQFPTLKLKSLKRLT-----FTSNKGGNAFSEVD 345

Query: 367 LRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKS 426
           L SL+ L L+ N L+            T   +L+ + LS N +  +  S+       ++ 
Sbjct: 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTT---SLKYLDLSFNGVITM-SSNFLGLE-QLEH 400

Query: 427 LSMESCNISGGIPKE-LGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGS 485
           L  +  N+          ++ NL  + + +             L  L+ L +  N  + +
Sbjct: 401 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 460

Query: 486 IPED-LCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDI 544
              D    L  L  L L   +L    P    +L+SL+ L++  N   S+       L  +
Sbjct: 461 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL 520

Query: 545 LRFNLSSNSLNGSLLPDIGNLKVVIEM-DLSLNALSGVIPVT--IGGLQGLQLLSLRYNR 601
              + S N +  S   ++ +    +   +L+ N  +        +  ++  + L +   R
Sbjct: 521 QVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVER 580

Query: 602 LQGPIPESFGGLKSLNFVDMS 622
           ++   P    G   +  ++++
Sbjct: 581 MECATPSDKQG-MPVLSLNIT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  186 bits (475), Expect = 5e-50
 Identities = 72/430 (16%), Positives = 138/430 (32%), Gaps = 48/430 (11%)

Query: 71  RNRRVTALNISYLGLTGTIPPQ-LGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFR 129
           +  R+  L +     +  +    +  L+ L V  +    F                    
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN------------------ 239

Query: 130 FNNFHIEIPSWFVSLPRLQHLLLKHNS---FVGKIPETIGYLSLLQELDLSDNQLSGTIP 186
             N      S    L  L     +      ++  I +    L+ +    L    +     
Sbjct: 240 EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299

Query: 187 SSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNL 246
            S             + L +   +        L   + L      F   +GG      +L
Sbjct: 300 FS--------YNFGWQHLELVNCKFGQFPTLKLKSLKRLT-----FTSNKGGNAFSEVDL 346

Query: 247 TSVRNLFLGNNSL--IGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTD 304
            S+  L L  N L   G          +L+ L +  + +   + ++   +  L+ L    
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQH 405

Query: 305 NDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLI-PTT 363
           ++L      S+ L L NL  L +   +           +S L VL    NSF     P  
Sbjct: 406 SNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465

Query: 364 FGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSIS 423
           F  LR+L  L L+   L   +P      +  S  +L+++ +S N    +        + S
Sbjct: 466 FTELRNLTFLDLSQCQLEQLSPT-----AFNSLSSLQVLNMSHNNFFSLDTFPYKCLN-S 519

Query: 424 MKSLSMESCNISGGIPKELGNI-NNLTVIRLGNNELTGTIPVT--LGRLQKLQGLYLQNN 480
           ++ L     +I     +EL +  ++L  + L  N+   T      L  ++  + L ++  
Sbjct: 520 LQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVE 579

Query: 481 KLEGSIPEDL 490
           ++E + P D 
Sbjct: 580 RMECATPSDK 589

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  167 bits (424), Expect = 2e-43
 Identities = 68/374 (18%), Positives = 130/374 (34%), Gaps = 39/374 (10%)

Query: 319 LPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGN 378
           +PN+      E NF   IP +L        LD  FN    L   +F +   L++L L+  
Sbjct: 7   VPNIT-YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC 62

Query: 379 VLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGI 438
            + +         +  S  +L  + L+ NPI  +   +    S S++ L     N++   
Sbjct: 63  EIQTIEDG-----AYQSLSHLSTLILTGNPIQSLALGAFSGLS-SLQKLVAVETNLASLE 116

Query: 439 PKELGNINNLTVIRLGNNELTGT-IPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHL---- 493
              +G++  L  + + +N +    +P     L  L+ L L +NK++     DL  L    
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176

Query: 494 YRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALT-SIIPSTLWNLKDILRFNLSSN 552
               +L L  N ++   P     +  L  L+L +N  + +++ + +  L  +    L   
Sbjct: 177 LLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLG 235

Query: 553 SLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRL---QGPIPES 609
                                    L       + GL  L +   R   L      I + 
Sbjct: 236 EFRNE------------------GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDL 277

Query: 610 FGGLKSLNFVDMSNNNLSGTIPKS-MEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESF 668
           F  L +++   + +  +      S      +L+ +N  F Q           +TF++   
Sbjct: 278 FNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKG 337

Query: 669 LGNQALCGSPKLQV 682
               +    P L+ 
Sbjct: 338 GNAFSEVDLPSLEF 351

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 65.4 bits (160), Expect = 6e-11
 Identities = 29/133 (21%), Positives = 49/133 (36%), Gaps = 9/133 (6%)

Query: 73  RRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNN 132
           R +T L++S   L    P    +LS L VL + +N+FF         L  L+  D+  N+
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529

Query: 133 FHIEIPSWFVSLPR-LQHLLLKHNSFVGKIPET--IGYLSLLQELDLSDNQLSGTIPSSI 189
                       P  L  L L  N F         + ++   ++L +   ++    PS  
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 589

Query: 190 FNIS------SCQ 196
             +       +CQ
Sbjct: 590 QGMPVLSLNITCQ 602

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  311 bits (798), Expect = 1e-91
 Identities = 109/692 (15%), Positives = 211/692 (30%), Gaps = 123/692 (17%)

Query: 30  TDQFALLALKEHIKHDPSNLLAN---------NWSTTSSVCSW---IGVTCGVRNRRVTA 77
            D  AL A+ E +        +          NW+    +  W    GV     N RVT 
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLD-NNGRVTG 327

Query: 78  LNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEI 137
           L+++  G  G +P  +G L+ L VL+   +S   S              + R +   +  
Sbjct: 328 LSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHY 387

Query: 138 PSWFVS-LPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSG------TIPSSIF 190
              F+    RL    L  ++   + PE +  +     + L D Q+         I  +I 
Sbjct: 388 KKMFLDYDQRLNLSDLLQDAIN-RNPE-MKPIKKDSRISLKDTQIGNLTNRITFISKAIQ 445

Query: 191 NISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVR 250
            ++       L+ ++ + +  T           +    +  + K          NL  + 
Sbjct: 446 RLTK------LQIIYFANSPFTYDNI-----AVDWEDANSDYAKQYENEELSWSNLKDLT 494

Query: 251 NLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGL---------IPASIFNISTLKELA 301
           ++ L N   + ++P+ + +L  L+ L +  +              +         ++   
Sbjct: 495 DVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFY 554

Query: 302 VTDNDLLGSLPSSIDLG-LPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLI 360
           +  N+ L   P+S  L  +  L  L    N        +     +L+ L   +N    + 
Sbjct: 555 MGYNN-LEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEEIP 611

Query: 361 PTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNF 420
                    ++ L  + N L    P++    S+     +  +  S N I           
Sbjct: 612 EDFCAFTDQVEGLGFSHNKLKYI-PNIFNAKSVY---VMGSVDFSYNKIGSEGR------ 661

Query: 421 SISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNN 480
                         +     +     N + + L  NE+             +  + L NN
Sbjct: 662 --------------NISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNN 707

Query: 481 KLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWN 540
            +  SIPE+                          N   L  + L  N LTS+       
Sbjct: 708 LMT-SIPENSL----------------KPKDGNYKNTYLLTTIDLRFNKLTSLSDDFR-- 748

Query: 541 LKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRY- 599
                                   L  +  MD+S N  S   P        L+   +R+ 
Sbjct: 749 ---------------------ATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQ 786

Query: 600 -----NRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQL-EGE 653
                NR+    P       SL  + + +N++   + + +     L  L+++ N     +
Sbjct: 787 RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISID 843

Query: 654 IPTRGPFITFSAESFLGN--QALCGSPKLQVS 683
           + +  P+I       L +  Q + G   L + 
Sbjct: 844 VTSVCPYIEAGMYVLLYDKTQDIRGCDALGIE 875

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  243 bits (622), Expect = 1e-67
 Identities = 81/544 (14%), Positives = 161/544 (29%), Gaps = 55/544 (10%)

Query: 146 RLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLF 205
           ++        S + +       +   +   + DN+L+      I    + + +   + L 
Sbjct: 217 QVVAYTTYSQSGIKRSELETQSVRG-ESFTVIDNKLTKDANVPIQLKETAEYIKDYKALK 275

Query: 206 ISYNQLTGP---IPTNLWKCRELHV---VSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSL 259
             +  L G      +         +    +   + +      D+ N   V  L L     
Sbjct: 276 AIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGA 335

Query: 260 IGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGL 319
            G +P+ IG L  L+VL   + +             T        + +            
Sbjct: 336 KGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYD 395

Query: 320 PNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGL------IPTTFGNLRSLKLL 373
             L    L ++  +      +  I + S +         L      I      L  L+++
Sbjct: 396 QRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQII 453

Query: 374 SLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCN 433
             A +  T     + +  +                       S  N    +  + + +C 
Sbjct: 454 YFANSPFTYDNIAVDWEDAN----------SDYAKQYENEELSWSNLK-DLTDVELYNCP 502

Query: 434 ISGGIPKELGNINNLTVIRLGNNELTG---------TIPVTLGRLQKLQGLYLQNNKLEG 484
               +P  L ++  L  + +  N              +        K+Q  Y+  N LE 
Sbjct: 503 NMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE 562

Query: 485 SIPE-DLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKD 543
                 L  + +L  L    NK+   L A  G    L DL L  N +  I          
Sbjct: 563 FPASASLQKMVKLGLLDCVHNKVRH-LEA-FGTNVKLTDLKLDYNQIEEIPEDFCAFTDQ 620

Query: 544 ILRFNLSSNSLNGSLLPD---IGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQL-----L 595
           +     S N L    +P+     ++ V+  +D S N +          +   +      +
Sbjct: 621 VEGLGFSHNKLKY--IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTV 678

Query: 596 SLRYNRLQGPIPESFGGLKSLNFVDMSNNNLS-------GTIPKSMEALSYLKHLNLSFN 648
           +L YN +Q    E F     ++ + +SNN ++            + +    L  ++L FN
Sbjct: 679 TLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFN 738

Query: 649 QLEG 652
           +L  
Sbjct: 739 KLTS 742

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  291 bits (748), Expect = 4e-87
 Identities = 118/585 (20%), Positives = 201/585 (34%), Gaps = 50/585 (8%)

Query: 78  LNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEI 137
            N   LGL   IP  L   +    L    N          S L  L + D      +   
Sbjct: 17  YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73

Query: 138 PSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQN 197
              F S  RL  L+L  N  +      +     L+ L      +S      +       N
Sbjct: 74  EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPL------HN 127

Query: 198 LPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNN 257
              LE L++  N ++       +   +L V+    N        D+ +L    NL L  N
Sbjct: 128 QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLN 187

Query: 258 SLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSID- 316
                  N+I                   I    F+ +  + L       L  +   +  
Sbjct: 188 G------NDIAG-----------------IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKN 224

Query: 317 LGLPNLERLFLGENNFSGTIPSSLTNISELSV--LDFGFNSFSGLIPTTFGNLRSLKLLS 374
             + +L      + +     P+    + E+SV  ++   + F  +   TF     L+ L 
Sbjct: 225 STIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELD 284

Query: 375 LAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNI 434
           L    L+     L  LS       L+ + LS N    +   S  NF  S+  LS++    
Sbjct: 285 LTATHLSELPSGLVGLS------TLKKLVLSANKFENLCQISASNFP-SLTHLSIKGNTK 337

Query: 435 SGGIPKE-LGNINNLTVIRLGNNELT--GTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLC 491
              +    L N+ NL  + L ++++       + L  L  LQ L L  N+      E   
Sbjct: 338 RLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFK 397

Query: 492 HLYRLANLYLGDNKLSGRLP-ACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLS 550
              +L  L L   +L  +   +   NL  L+ L+L  + L          L  +   NL 
Sbjct: 398 ECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQ 457

Query: 551 SNSL---NGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIP 607
            N     N      +  L  +  + LS   LS +       L+ +  + L +NRL     
Sbjct: 458 GNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI 517

Query: 608 ESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEG 652
           E+   LK + ++++++N++S  +P  +  LS  + +NL  N L+ 
Sbjct: 518 EALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  133 bits (337), Expect = 1e-32
 Identities = 47/262 (17%), Positives = 92/262 (35%), Gaps = 11/262 (4%)

Query: 400 EIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELT 459
           +        +N I P ++ N   S + L      +          + NLT + L   ++ 
Sbjct: 15  KTYNCENLGLNEI-PGTLPN---STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY 70

Query: 460 GTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTS 519
                T     +L  L L  N L       L     L +L+     +S      L N  +
Sbjct: 71  WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130

Query: 520 LRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLK--VVIEMDLSLNA 577
           L  L LGSN ++SI     +  + +   +  +N+++     D+ +L+    + ++L+ N 
Sbjct: 131 LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND 190

Query: 578 LSGVIPVTIGGLQGLQLLSLRYNRLQGPIPE--SFGGLKSLNFVDMSNNNLSGTIPKSME 635
           ++G I          Q L+    +    I +      ++SL      + +     P   E
Sbjct: 191 IAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFE 249

Query: 636 ALS--YLKHLNLSFNQLEGEIP 655
            L    ++ +NL  +       
Sbjct: 250 GLCEMSVESINLQKHYFFNISS 271

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  130 bits (328), Expect = 2e-31
 Identities = 48/235 (20%), Positives = 77/235 (32%), Gaps = 6/235 (2%)

Query: 425 KSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEG 484
           K+ + E+  ++  IP  L N  +   +    N L      T  RL  L  L L   ++  
Sbjct: 15  KTYNCENLGLNE-IPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71

Query: 485 SIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDI 544
              +     +RL  L L  N L       L    +L+ L      ++SI    L N K +
Sbjct: 72  IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131

Query: 545 LRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQ- 603
               L SN ++   LP     + +  +D   NA+  +    +  LQ    LSL  N    
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191

Query: 604 GPIPESFGGLKSLNFVDMSNNNLSGTIPKSME--ALSYLKHLNLSFNQLEGEIPT 656
             I            ++         I K ++   +  L          E   P 
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPA 246

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  115 bits (290), Expect = 1e-26
 Identities = 45/232 (19%), Positives = 70/232 (30%), Gaps = 29/232 (12%)

Query: 450 VIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGR 509
                N  L   IP TL      + L    N L          L  L  L L   ++   
Sbjct: 16  TYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72

Query: 510 LPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVI 569
                 +   L  L L +N L  +  + L   K                      LK + 
Sbjct: 73  HEDTFQSQHRLDTLVLTANPLIFMAETALSGPK---------------------ALKHL- 110

Query: 570 EMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGT 629
                   +S +  + +   + L+ L L  N +           + L  +D  NN +   
Sbjct: 111 --FFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYL 168

Query: 630 IPKSMEALSYLKH--LNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSPK 679
             + M +L    +  LNL+ N + G  P       F + +F G Q L    K
Sbjct: 169 SKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFK 220

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 62.7 bits (153), Expect = 4e-10
 Identities = 28/152 (18%), Positives = 49/152 (32%), Gaps = 18/152 (11%)

Query: 78  LNISYLGLTGTI---PPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFH 134
           LN+               L  L  L +L +             + L+ + + D   N   
Sbjct: 454 LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT 513

Query: 135 IEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIF---- 190
                    L  + +L L  N     +P  +  LS  + ++L  N L  T  +  F    
Sbjct: 514 SSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEWY 572

Query: 191 ----------NISSCQNLPVLEGLFISYNQLT 212
                       + C+N P+L G+ +S   L+
Sbjct: 573 KENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 48.9 bits (117), Expect = 8e-06
 Identities = 29/130 (22%), Positives = 52/130 (40%), Gaps = 21/130 (16%)

Query: 73  RRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNN 132
            R+  L +S+  L+        +L  +  + + +N    S  E LSHL+G+ Y +   N+
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNH 534

Query: 133 FHIEIPSWFVSLPRLQHLLLKHNSF-------------------VGKIPETI-GYLSLLQ 172
             I +PS    L + + + L+ N                     +    +T+     LL+
Sbjct: 535 ISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEWYKENMQKLEDTEDTLCENPPLLR 594

Query: 173 ELDLSDNQLS 182
            + LSD  LS
Sbjct: 595 GVRLSDVTLS 604

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  275 bits (706), Expect = 9e-85
 Identities = 92/355 (25%), Positives = 143/355 (40%), Gaps = 61/355 (17%)

Query: 336 IPSSLTNISELS----VLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLS 391
           I   L N + LS      D    ++ G++  T      +  L L+G  L  P P      
Sbjct: 14  IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP------ 67

Query: 392 SLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCN-ISGGIPKELGNINNLTV 450
                                +PSS+ N    +  L +   N + G IP  +  +  L  
Sbjct: 68  ---------------------IPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQLHY 105

Query: 451 IRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRL 510
           + + +  ++G IP  L +++ L  L    N L G++P  +  L  L  +    N++SG +
Sbjct: 106 LYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165

Query: 511 PACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIE 570
           P   G+ + L                            +S N L G + P   NL +   
Sbjct: 166 PDSYGSFSKL-----------------------FTSMTISRNRLTGKIPPTFANLNLA-F 201

Query: 571 MDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTI 630
           +DLS N L G   V  G  +  Q + L  N L   +    G  K+LN +D+ NN + GT+
Sbjct: 202 VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTL 260

Query: 631 PKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSPKLQVSPC 685
           P+ +  L +L  LN+SFN L GEIP  G    F   ++  N+ LCGSP   +  C
Sbjct: 261 PQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  256 bits (657), Expect = 9e-78
 Identities = 93/356 (26%), Positives = 143/356 (40%), Gaps = 67/356 (18%)

Query: 30  TDQFALLALKEHIKHDPSNLLANNWSTTSSVC--SWIGVTCGVRNR--RVTALNISYLGL 85
            D+ ALL +K+ +  +P+ L  ++W  T+  C  +W+GV C    +  RV  L++S L L
Sbjct: 6   QDKQALLQIKKDL-GNPTTL--SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62

Query: 86  TGT--IPPQLGNLSFLAVLAIRN-NSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFV 142
                IP  L NL +L  L I   N+  G +P  ++ L  L Y      N    IP +  
Sbjct: 63  PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122

Query: 143 SLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLE 202
            +  L  L   +N+  G +P +I  L  L  +    N++SG IP S  + S      +  
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSK-----LFT 177

Query: 203 GLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGE 262
            + IS N+LTG IP        L  V L+ N  +G      G+  + + + L  NSL  +
Sbjct: 178 SMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD 236

Query: 263 IPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNL 322
           +  ++G  +NL                                                 
Sbjct: 237 LG-KVGLSKNLNG----------------------------------------------- 248

Query: 323 ERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGN 378
             L L  N   GT+P  LT +  L  L+  FN+  G IP   GNL+   + + A N
Sbjct: 249 --LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANN 301

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  225 bits (576), Expect = 1e-66
 Identities = 81/341 (23%), Positives = 128/341 (37%), Gaps = 66/341 (19%)

Query: 154 HNSFVGKIPETIGYLSLLQELDLSDNQLSGT--IPSSIFNISSCQNLPVLEGLFIS-YNQ 210
           + +++G + +T      +  LDLS   L     IPSS+ N      LP L  L+I   N 
Sbjct: 35  NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLAN------LPYLNFLYIGGINN 88

Query: 211 LTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNL 270
           L GPIP  + K  +LH + +      G IP  +  + ++  L    N+L G +P  I +L
Sbjct: 89  LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL 148

Query: 271 RNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGEN 330
            NL  +    + ++G IP S  + S L                           + +  N
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKL------------------------FTSMTISRN 184

Query: 331 NFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFL 390
             +G IP +  N++ L+ +D   N   G     FG+ ++ + + LA N L      +   
Sbjct: 185 RLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLS 243

Query: 391 SSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTV 450
                 +NL  + L  N                          I G +P+ L  +  L  
Sbjct: 244 ------KNLNGLDLRNN-------------------------RIYGTLPQGLTQLKFLHS 272

Query: 451 IRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLC 491
           + +  N L G IP   G LQ+       NNK     P   C
Sbjct: 273 LNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLPAC 312

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  277 bits (710), Expect = 1e-81
 Identities = 106/580 (18%), Positives = 196/580 (33%), Gaps = 40/580 (6%)

Query: 87  GTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPR 146
           G++ P +  +  +    +        +P+++      K  D  FN   I     F +   
Sbjct: 2   GSLNPCIEVVPNITYQCMDQK--LSKVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57

Query: 147 LQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFI 206
           LQ L L          +    L  L  L L+ N +    P S         L  LE L  
Sbjct: 58  LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSF------SGLTSLENLVA 111

Query: 207 SYNQLTGPIPTNLWKCRELHVVSLAFNKFQG-GIPRDIGNLTSVRNLFLGNNSLIGEIPN 265
              +L       + +   L  +++A N      +P    NLT++ ++ L  N +     N
Sbjct: 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN 171

Query: 266 EIGNLRNLEVLGVQ---SSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNL 322
           ++  LR    + +    S N    I    F    L EL +  N    ++  +    L  L
Sbjct: 172 DLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGL 231

Query: 323 ERL------FLGENNFSGTIPSSLTNISELSV--LDFGFNSFSGLIPTTFGNLRSLKLLS 374
                    F  E N     PS +  + ++++      + +        F  L ++  +S
Sbjct: 232 HVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMS 291

Query: 375 LAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNI 434
           LAG         + +L  +      + + +    +       +      +KSL++     
Sbjct: 292 LAGV-------SIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPF----LKSLTLTMNKG 340

Query: 435 SGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQ--KLQGLYLQNNKLEGSIPEDLCH 492
           S  I  +   + +L+ + L  N L+ +   +   L    L+ L L  N     +  +   
Sbjct: 341 S--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMG 397

Query: 493 LYRLANLYLGDNKLSGRLPA-CLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSS 551
           L  L +L    + L          +L  L  L +               L  +    ++ 
Sbjct: 398 LEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAG 457

Query: 552 NSLNGSLLPDI-GNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESF 610
           NS   + L ++  N   +  +DLS   L  +       L  LQLL++ +N L       +
Sbjct: 458 NSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHY 517

Query: 611 GGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQL 650
             L SL+ +D S N +  +          L   NL+ N +
Sbjct: 518 NQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  259 bits (665), Expect = 2e-75
 Identities = 99/568 (17%), Positives = 171/568 (30%), Gaps = 58/568 (10%)

Query: 75  VTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFH 134
              +++S+  L         N S L  L +          +    L  L       N   
Sbjct: 34  TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93

Query: 135 IEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISS 194
              P  F  L  L++L+             IG L  L++L+++ N +      + F    
Sbjct: 94  SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYF---- 149

Query: 195 CQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVV----SLAFNKFQGGIPRDIGNLTSVR 250
             NL  L  + +SYN +      +L   RE   V     ++ N     I         + 
Sbjct: 150 -SNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLH 207

Query: 251 NLFLGNNSLIGEIPNE-IGNLRNLEVLGVQSSNLAGLIPASIFNIST---LKELAVTDND 306
            L L  N     I    + NL  L V  +            IF  S    L ++ + +  
Sbjct: 208 ELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFR 267

Query: 307 LLGSLPSSIDL----GLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPT 362
           L  +   S D+     L N+  + L   +        +    +   L             
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQF--- 322

Query: 363 TFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFS- 421
              +L  LK L+L  N         S      +  +L  + LS N ++     S  +   
Sbjct: 323 PTLDLPFLKSLTLTMN-------KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGT 375

Query: 422 ISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPV-TLGRLQKLQGLYLQNN 480
            S++ L +        +      +  L  +   ++ L           L+KL  L +   
Sbjct: 376 NSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434

Query: 481 KLEGSIPEDLCHLYRLANLYLGDNKLSGRLPAC-LGNLTSLRDLSLGSNALTSIIPSTLW 539
             +         L  L  L +  N       +    N T+L  L L    L  I      
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFD 494

Query: 540 NLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRY 599
            L                       L+    +++S N L  +       L  L  L   +
Sbjct: 495 TLH---------------------RLQ---LLNMSHNNLLFLDSSHYNQLYSLSTLDCSF 530

Query: 600 NRLQGPIPESFGGLKSLNFVDMSNNNLS 627
           NR++          KSL F +++NN+++
Sbjct: 531 NRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  230 bits (589), Expect = 4e-65
 Identities = 105/493 (21%), Positives = 173/493 (35%), Gaps = 29/493 (5%)

Query: 174 LDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFN 233
               D +LS  +P  I            + + +S+N L      +     EL  + L+  
Sbjct: 16  YQCMDQKLS-KVPDDIP--------SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRC 66

Query: 234 KFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFN 293
           + +    +    L  + NL L  N +    P     L +LE L    + LA L    I  
Sbjct: 67  EIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQ 126

Query: 294 ISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELS----VL 349
           + TLK+L V  N +      +    L NL  + L  N       + L  + E       L
Sbjct: 127 LITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSL 186

Query: 350 DFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSF--LSSLTSCRNLEIIYLSEN 407
           D   N    +    F  +  L  L+L GN  +S         L+ L   R +   +  E 
Sbjct: 187 DMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDER 245

Query: 408 PINGILPSSIGNF-SISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTL 466
            +    PS +     +++    +   N       +   + N++ + L    +       +
Sbjct: 246 NLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDV 303

Query: 467 GRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLG 526
            +  K Q L +   +L+     DL  L     L L  NK S         L SL  L L 
Sbjct: 304 PKHFKWQSLSIIRCQLKQFPTLDLPFLKS---LTLTMNKGSISFK--KVALPSLSYLDLS 358

Query: 527 SNALTSIIPSTLWNLK--DILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPV 584
            NAL+     +  +L    +   +LS N     +  +   L+ +  +D   + L  V   
Sbjct: 359 RNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEF 417

Query: 585 -TIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEA-LSYLKH 642
                L+ L  L + Y   +      F GL SLN + M+ N+       ++ A  + L  
Sbjct: 418 SAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTF 477

Query: 643 LNLSFNQLEGEIP 655
           L+LS  QLE    
Sbjct: 478 LDLSKCQLEQISW 490

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  222 bits (567), Expect = 4e-62
 Identities = 94/552 (17%), Positives = 174/552 (31%), Gaps = 43/552 (7%)

Query: 78  LNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEI 137
           L++S   +          L  L+ L +  N      P   S L  L+             
Sbjct: 61  LDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLE 120

Query: 138 PSWFVSLPRLQHLLLKHNSFVG-KIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQ 196
                 L  L+ L + HN     K+P     L+ L  +DLS N +     + +  +    
Sbjct: 121 SFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENP 180

Query: 197 NLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGN-------LTSV 249
            +     L +S N +   I    ++  +LH ++L  N     I +              +
Sbjct: 181 QV--NLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLI 237

Query: 250 RNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSS--NLAGLIPASIFNISTLKELAVTDNDL 307
              F    +L    P+ +  L ++ +   + +  N           ++ +  +++    +
Sbjct: 238 LGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI 297

Query: 308 --LGSLPSSIDL----------------GLPNLERLFLGENNFSGTIPSSLTNISELSVL 349
             L  +P                      LP L+ L L  N   G+I      +  LS L
Sbjct: 298 KYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNK--GSISFKKVALPSLSYL 355

Query: 350 DFGFNSFSGLIPTTFGNL--RSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSEN 407
           D   N+ S     ++ +L   SL+ L L+ N     + +   L        L+ +    +
Sbjct: 356 DLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLE------ELQHLDFQHS 409

Query: 408 PINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPV-TL 466
            +  +   S       +  L +   N           + +L  +++  N           
Sbjct: 410 TLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVF 469

Query: 467 GRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLG 526
                L  L L   +LE         L+RL  L +  N L     +    L SL  L   
Sbjct: 470 ANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCS 529

Query: 527 SNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTI 586
            N + +         K +  FNL++NS+   +      L+ V E    L  +  +   T 
Sbjct: 530 FNRIETSKGILQHFPKSLAFFNLTNNSVA-CICEHQKFLQWVKEQKQFLVNVEQMTCATP 588

Query: 587 GGLQGLQLLSLR 598
             +    +L   
Sbjct: 589 VEMNTSLVLDFN 600

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  151 bits (383), Expect = 3e-38
 Identities = 57/340 (16%), Positives = 113/340 (33%), Gaps = 16/340 (4%)

Query: 69  GVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDF 128
           G+ +  +    ++Y         +   L+ ++ +++   S      E++      +    
Sbjct: 257 GLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSI 314

Query: 129 RFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSS 188
                  + P   + LP L+ L L  N   G I      L  L  LDLS N LS +   S
Sbjct: 315 IRCQLK-QFP--TLDLPFLKSLTLTMNK--GSISFKKVALPSLSYLDLSRNALSFSGCCS 369

Query: 189 IFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRD-IGNLT 247
             ++        L  L +S+N     +  N     EL  +    +  +         +L 
Sbjct: 370 YSDL----GTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLE 424

Query: 248 SVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIF-NISTLKELAVTDND 306
            +  L +   +   +       L +L  L +  ++      +++F N + L  L ++   
Sbjct: 425 KLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQ 484

Query: 307 LLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGN 366
            L  +   +   L  L+ L +  NN      S    +  LS LD  FN            
Sbjct: 485 -LEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHF 543

Query: 367 LRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSE 406
            +SL   +L  N +     +          +   ++ + +
Sbjct: 544 PKSLAFFNLTNNSVAC-ICEHQKFLQWVKEQKQFLVNVEQ 582

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  260 bits (666), Expect = 7e-79
 Identities = 97/292 (33%), Positives = 146/292 (50%), Gaps = 13/292 (4%)

Query: 748  WRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKV-FHMEFDGSLESFHA 806
             +R S ++L  A+D FS   +LG G FG VYKG L DG  +A K        G    F  
Sbjct: 17   LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 807  ECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLY---SDNYFLDILQRLKI 863
            E +++    HRNL+++   C     + LV  YM+NGS+  CL         LD  +R +I
Sbjct: 77   EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 864  MIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL 923
             +  A  L YLH      I+H D+K +N+LL+E     + DFG+AK++  +++   T   
Sbjct: 137  ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196

Query: 924  GTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGE---MSLKRWVGDSL 980
            GTIG++APEY   GK S K DV+ YG+ML+E  T ++  D         + L  WV   L
Sbjct: 197  GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256

Query: 981  LSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDV 1032
                +  + D +L    + ++   E  V  +  +A+ CT   P +R  M +V
Sbjct: 257  KEKKLEALVDVDL----QGNYKDEE--VEQLIQVALLCTQSSPMERPKMSEV 302

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  255 bits (654), Expect = 2e-77
 Identities = 98/315 (31%), Positives = 148/315 (46%), Gaps = 18/315 (5%)

Query: 725  RRRRRQKGSTRPYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPD 784
             +  +   S      ++        R+   DL  AT+ F    L+G G FG VYKGVL D
Sbjct: 3    SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62

Query: 785  GMEIAAKVFHME-FDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGS 843
            G ++A K    E   G  E F  E + +   RH +LV +I  C   +   L+ +YM NG+
Sbjct: 63   GAKVALKRRTPESSQGIEE-FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121

Query: 844  LEKCLY---SDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVG 900
            L++ LY        +   QRL+I I  A  L YLH      I+H D+K  N+LL+E+ V 
Sbjct: 122  LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVP 178

Query: 901  HLSDFGIAKILGKEESMRQ--TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTK 958
             ++DFGI+K  G E       T   GT+GY+ PEY  +G+++ K DVYS+G++L E    
Sbjct: 179  KITDFGISK-KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237

Query: 959  KKPTDEIF-AGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMD 1017
            +    +      ++L  W  +S  +  + ++ D NL     +        +      A+ 
Sbjct: 238  RSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL----ADKIRPE--SLRKFGDTAVK 291

Query: 1018 CTVDLPEKRISMKDV 1032
            C     E R SM DV
Sbjct: 292  CLALSSEDRPSMGDV 306

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  223 bits (570), Expect = 8e-66
 Identities = 90/303 (29%), Positives = 139/303 (45%), Gaps = 29/303 (9%)

Query: 749  RRISYQDLLRATDGFSENK------LLGMGSFGSVYKGVLPDGMEIAAKVFHMEFD---- 798
               S+ +L   T+ F E         +G G FG VYKG + +   +A K      D    
Sbjct: 13   HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71

Query: 799  -GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYF--L 855
                + F  E KVM   +H NLV+++   S+ D   LV  YM NGSL   L   +    L
Sbjct: 72   ELKQQ-FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130

Query: 856  DILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE 915
                R KI    A+ + +LH       +H DIK +N+LL+E+    +SDFG+A+   K  
Sbjct: 131  SWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187

Query: 916  -SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
             ++  ++ +GT  YMAPE  R G+++ K D+YS+G++L+E  T     DE       L  
Sbjct: 188  QTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH-REPQLLLD 245

Query: 975  WVGDSLLSC-SITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVA 1033
               +      +I +  D  +     ND  +    V +++S+A  C  +   KR  +K V 
Sbjct: 246  IKEEIEDEEKTIEDYIDKKM-----NDADSTS--VEAMYSVASQCLHEKKNKRPDIKKVQ 298

Query: 1034 NRL 1036
              L
Sbjct: 299  QLL 301

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  224 bits (574), Expect = 2e-63
 Identities = 108/555 (19%), Positives = 187/555 (33%), Gaps = 61/555 (10%)

Query: 112 SLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLL 171
            +P+ L      K  D  FN         F S P LQ L L               LS L
Sbjct: 21  KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 172 QELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLA 231
             L L+ N +  ++    F       L  L+ L      L       +   + L  +++A
Sbjct: 79  STLILTGNPIQ-SLALGAF-----SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132

Query: 232 FNKFQ-GGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQ---SSNLAGLI 287
            N  Q   +P    NLT++ +L L +N +      ++  L  + +L +    S N    I
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI 192

Query: 288 PASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERL------FLGENNFSGTIPSSLT 341
               F    L +L + +N    ++  +   GL  LE        F  E N      S+L 
Sbjct: 193 QPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALE 252

Query: 342 NISELSVLDF---GFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRN 398
            +  L++ +F     + +   I   F  L ++   SL    +     D S+         
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQH--- 308

Query: 399 LEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNEL 458
              + L            + +     K L+  + N  G    E+ ++ +L  + L  N L
Sbjct: 309 ---LELVNCKFGQFPTLKLKSL----KRLTF-TSNKGGNAFSEV-DLPSLEFLDLSRNGL 359

Query: 459 T--GTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPAC-LG 515
           +  G    +      L+ L L  N +  ++  +   L +L +L    + L          
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418

Query: 516 NLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSL 575
           +L +L  L +               L  +    ++ NS   + LPDI             
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI------------- 465

Query: 576 NALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSME 635
                        L+ L  L L   +L+   P +F  L SL  ++M++N L        +
Sbjct: 466 ----------FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFD 515

Query: 636 ALSYLKHLNLSFNQL 650
            L+ L+ + L  N  
Sbjct: 516 RLTSLQKIWLHTNPW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  218 bits (556), Expect = 5e-61
 Identities = 107/581 (18%), Positives = 190/581 (32%), Gaps = 65/581 (11%)

Query: 67  TCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYF 126
              V N          L     IP  L        L +  N               L+  
Sbjct: 4   VEVVPNITY---QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVL 57

Query: 127 DFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIP 186
           D             + SL  L  L+L  N            LS LQ+L   +  L+ ++ 
Sbjct: 58  DLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLE 116

Query: 187 SSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNL 246
           +         +L  L+ L +++N +                           +P    NL
Sbjct: 117 NFPI-----GHLKTLKELNVAHNLIQ-----------------------SFKLPEYFSNL 148

Query: 247 TSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQ---SSNLAGLIPASIFNISTLKELAVT 303
           T++ +L L +N +      ++  L  + +L +    S N    I    F    L +L + 
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 208

Query: 304 DNDLLGSLPSSIDLGLPNLERL------FLGENNFSGTIPSSLTNISELSVLDF---GFN 354
           +N    ++  +   GL  LE        F  E N      S+L  +  L++ +F     +
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268

Query: 355 SFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILP 414
            +   I   F  L ++   SL    +     D S+            + L          
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQH------LELVNCKFGQFPT 321

Query: 415 SSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELT--GTIPVTLGRLQKL 472
             + +     K L+  + N  G    E+ ++ +L  + L  N L+  G    +      L
Sbjct: 322 LKLKSL----KRLTF-TSNKGGNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375

Query: 473 QGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPAC-LGNLTSLRDLSLGSNALT 531
           + L L  N +  ++  +   L +L +L    + L          +L +L  L +      
Sbjct: 376 KYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434

Query: 532 SIIPSTLWNLKDILRFNLSSNSLNGSLLPDI-GNLKVVIEMDLSLNALSGVIPVTIGGLQ 590
                    L  +    ++ NS   + LPDI   L+ +  +DLS   L  + P     L 
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 494

Query: 591 GLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIP 631
            LQ+L++  N+L+      F  L SL  + +  N    + P
Sbjct: 495 SLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  162 bits (412), Expect = 3e-42
 Identities = 81/414 (19%), Positives = 151/414 (36%), Gaps = 32/414 (7%)

Query: 262 EIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPN 321
           +IP+ +    + + L +  + L  L   S F+   L+ L ++  ++  ++       L +
Sbjct: 21  KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77

Query: 322 LERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLT 381
           L  L L  N        + + +S L  L     + + L     G+L++LK L++A N++ 
Sbjct: 78  LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137

Query: 382 SPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFS---ISMKSLSMESCNISGGI 438
           S           ++  NLE + LS N I  I  + +       +   SL +    ++  I
Sbjct: 138 S----FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FI 192

Query: 439 PKELGNINNLTVIRLGNNELTGTIP-VTLGRLQKLQGLYLQNNKLEG---------SIPE 488
                    L  + L NN  +  +    +  L  L+   L   +            S  E
Sbjct: 193 QPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALE 252

Query: 489 DLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFN 548
            LC+L          +     +      LT++   SL S  +  +   +       L   
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHL--E 310

Query: 549 LSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQ--GPI 606
           L +        P +  LK +  +  + N            L  L+ L L  N L   G  
Sbjct: 311 LVNCKFGQ--FPTL-KLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCC 365

Query: 607 PESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPF 660
            +S  G  SL ++D+S N +  T+  +   L  L+HL+   + L+ ++     F
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVF 417

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  158 bits (401), Expect = 8e-41
 Identities = 94/480 (19%), Positives = 162/480 (33%), Gaps = 39/480 (8%)

Query: 78  LNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNF-HIE 136
           L ++   +          LS L  L     +        + HL+ LK  +   N     +
Sbjct: 81  LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK 140

Query: 137 IPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQ----ELDLSDNQLSGTIPSSIFNI 192
           +P +F +L  L+HL L  N         +  L  +      LDLS N ++  I    F  
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFK- 198

Query: 193 SSCQNLPVLEGLFISYNQLTGPIPTN-LWKCRELHVVSLAFNKFQGG---IPRDIGNLTS 248
                   L  L +  N  +  +    +     L V  L   +F+        D   L  
Sbjct: 199 -----EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEG 253

Query: 249 VRNLFLGNNSL------IGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAV 302
           + NL +    L      + +I +    L N+    + S  +  +   S       + L +
Sbjct: 254 LCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN--FGWQHLEL 311

Query: 303 TDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFN--SFSGLI 360
            +    G  P+   L L +L+RL    N        S  ++  L  LD   N  SF G  
Sbjct: 312 VNCKF-GQFPT---LKLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCC 365

Query: 361 PTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNF 420
             +     SLK L L+ N + + + +   L        LE +    + +  +   S+   
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVITMSSNFLGLE------QLEHLDFQHSNLKQMSEFSVFLS 419

Query: 421 SISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTI-PVTLGRLQKLQGLYLQN 479
             ++  L +   +           +++L V+++  N       P     L+ L  L L  
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479

Query: 480 NKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLW 539
            +LE   P     L  L  L +  N+L          LTSL+ + L +N      P   +
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 539

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  123 bits (310), Expect = 3e-29
 Identities = 66/357 (18%), Positives = 131/357 (36%), Gaps = 41/357 (11%)

Query: 336 IPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTS 395
           +P S         LD  FN    L   +F +   L++L L+   + +         +  S
Sbjct: 26  LPFSTK------NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG-----AYQS 74

Query: 396 CRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGN 455
             +L  + L+ NPI  +   +    S S++ L     N++      +G++  L  + + +
Sbjct: 75  LSHLSTLILTGNPIQSLALGAFSGLS-SLQKLVAVETNLASLENFPIGHLKTLKELNVAH 133

Query: 456 NELT-GTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRL----ANLYLGDNKLSGRL 510
           N +    +P     L  L+ L L +NK++     DL  L+++     +L L  N ++  +
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FI 192

Query: 511 PACLGNLTSLRDLSLGSNALT-SIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVI 569
                    L  L+L +N  + +++ + +  L       L  + L      + GNL+   
Sbjct: 193 QPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLA-----GLEVHRLVLGEFRNEGNLE--- 244

Query: 570 EMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQG---PIPESFGGLKSLNFVDMSNNNL 626
                 +AL G        L  L +   R   L      I + F  L +++   + +  +
Sbjct: 245 --KFDKSALEG--------LCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI 294

Query: 627 SGTIPKS-MEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSPKLQV 682
                 S      +L+ +N  F Q           +TF++       +    P L+ 
Sbjct: 295 ERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEF 351

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  118 bits (297), Expect = 1e-27
 Identities = 61/304 (20%), Positives = 112/304 (36%), Gaps = 21/304 (6%)

Query: 93  LGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNF-HIEIPSWFVSLPRLQHLL 151
           L NL+         + +   + +  + L  +  F         ++  S+      L+ + 
Sbjct: 254 LCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVN 313

Query: 152 LKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQL 211
            K   F          L  L+ L  + N+          N  S  +LP LE L +S N L
Sbjct: 314 CKFGQF------PTLKLKSLKRLTFTSNKGG--------NAFSEVDLPSLEFLDLSRNGL 359

Query: 212 T--GPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEI-- 267
           +  G    + +    L  + L+FN     +  +   L  + +L   +++L  ++      
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVF 417

Query: 268 GNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFL 327
            +LRNL  L +  ++           +S+L+ L +  N    +    I   L NL  L L
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477

Query: 328 GENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDL 387
            +       P++  ++S L VL+   N    +    F  L SL+ + L  N      P +
Sbjct: 478 SQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537

Query: 388 SFLS 391
            +LS
Sbjct: 538 DYLS 541

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 65.1 bits (159), Expect = 6e-11
 Identities = 19/112 (16%), Positives = 40/112 (35%), Gaps = 5/112 (4%)

Query: 545 LRFNLSSNSLNGSLLPDI-GNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQ 603
           + +     +    +  ++  + K    +DLS N L  +   +      LQ+L L    +Q
Sbjct: 10  ITYQCMELNFY-KIPDNLPFSTK---NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ 65

Query: 604 GPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIP 655
                ++  L  L+ + ++ N +      +   LS L+ L      L     
Sbjct: 66  TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN 117

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  209 bits (533), Expect = 6e-59
 Identities = 108/484 (22%), Positives = 191/484 (39%), Gaps = 52/484 (10%)

Query: 169 SLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIP-TNLWKCRELHV 227
            L       D  ++      IF  +    L       +    +T  +  T+L +   L  
Sbjct: 2   PLGSATITQDTPIN-----QIFTDT---ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQA 53

Query: 228 VSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLI 287
             L      G     +  L ++  +   NN L    P  + NL  L  + + ++ +A + 
Sbjct: 54  DRLGIKSIDG-----VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT 106

Query: 288 PASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELS 347
           P  + N++ L  L + +N +    P      L NL RL L  N  S    S+L+ ++ L 
Sbjct: 107 P--LANLTNLTGLTLFNNQITDIDPLK---NLTNLNRLELSSNTISD--ISALSGLTSLQ 159

Query: 348 VLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSEN 407
            L FG N  + L P    NL +L+ L ++ N ++        +S L    NLE +  + N
Sbjct: 160 QLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD-------ISVLAKLTNLESLIATNN 209

Query: 408 PINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLG 467
            I+ I  + +G  + ++  LS+    +       L ++ NLT + L NN+++   P  L 
Sbjct: 210 QISDI--TPLGILT-NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LS 262

Query: 468 RLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGS 527
            L KL  L L  N++    P  L  L  L NL L +N+L    P  + NL +L  L+L  
Sbjct: 263 GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYF 318

Query: 528 NALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIG 587
           N ++ I P  + +L  + R    +N ++   +  + NL  +  +    N +S + P  + 
Sbjct: 319 NNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LA 372

Query: 588 GLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSF 647
            L  +  L L               +   N V      L    P ++         ++++
Sbjct: 373 NLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITW 430

Query: 648 NQLE 651
           N   
Sbjct: 431 NLPS 434

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  204 bits (521), Expect = 3e-57
 Identities = 116/522 (22%), Positives = 203/522 (38%), Gaps = 73/522 (13%)

Query: 115 EELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQEL 174
              + L           N    +      L ++  L         K  + + YL+ L ++
Sbjct: 18  FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQI 73

Query: 175 DLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNK 234
           + S+NQL+        +I+  +NL  L  + ++ NQ+    P                  
Sbjct: 74  NFSNNQLT--------DITPLKNLTKLVDILMNNNQIADITP------------------ 107

Query: 235 FQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNI 294
                   + NLT++  L L NN +    P  + NL NL  L + S+ ++ +    +  +
Sbjct: 108 --------LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISA--LSGL 155

Query: 295 STLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFN 354
           ++L++L+   N +    P +    L  LERL +  N  S    S L  ++ L  L    N
Sbjct: 156 TSLQQLSF-GNQVTDLKPLA---NLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNN 209

Query: 355 SFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILP 414
             S + P   G L +L  LSL GN L         + +L S  NL  + L+ N I+ + P
Sbjct: 210 QISDITP--LGILTNLDELSLNGNQLKD-------IGTLASLTNLTDLDLANNQISNLAP 260

Query: 415 SSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQG 474
             +   +  +  L + +  IS      L  +  LT + L  N+L    P  +  L+ L  
Sbjct: 261 --LSGLT-KLTELKLGANQISN--ISPLAGLTALTNLELNENQLEDISP--ISNLKNLTY 313

Query: 475 LYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSII 534
           L L  N +    P  +  L +L  L+  +NK+S    + L NLT++  LS G N ++ + 
Sbjct: 314 LTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLT 369

Query: 535 PSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQL 594
           P  L NL  I +  L+  +   + +    N+ +   +     AL  + P TI        
Sbjct: 370 P--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTE 425

Query: 595 LSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEA 636
             + +N       E          +       SGT+ + ++A
Sbjct: 426 PDITWNLPSY-TNEVSYTFSQPVTIGKGTTTFSGTVTQPLKA 466

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  183 bits (467), Expect = 5e-50
 Identities = 89/408 (21%), Positives = 169/408 (41%), Gaps = 39/408 (9%)

Query: 248 SVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDL 307
            + +  +  ++ I +I      L       +  +N+   +     ++  +  L      +
Sbjct: 2   PLGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58

Query: 308 LGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNL 367
                  ++  L NL ++    N  +   P  L N+++L  +    N  + + P    NL
Sbjct: 59  --KSIDGVE-YLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANL 111

Query: 368 RSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSL 427
            +L  L+L  N +T        +  L +  NL  + LS N I+ I  S++   + S++ L
Sbjct: 112 TNLTGLTLFNNQITD-------IDPLKNLTNLNRLELSSNTISDI--SALSGLT-SLQQL 161

Query: 428 SMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIP 487
           S     ++   P  L N+  L  + + +N+++      L +L  L+ L   NN++    P
Sbjct: 162 SF-GNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP 216

Query: 488 EDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRF 547
             L  L  L  L L  N+L       L +LT+L DL L +N ++++ P  L  L  +   
Sbjct: 217 --LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 270

Query: 548 NLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIP 607
            L +N ++   +  +  L  +  ++L+ N L  + P  I  L+ L  L+L +N +    P
Sbjct: 271 KLGANQISN--ISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326

Query: 608 ESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIP 655
                L  L  +   NN +S     S+  L+ +  L+   NQ+    P
Sbjct: 327 --VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP 370

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  150 bits (381), Expect = 7e-39
 Identities = 92/451 (20%), Positives = 157/451 (34%), Gaps = 75/451 (16%)

Query: 76  TALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHI 135
           T +N S   LT   P  L NL+ L  + + NN    +    L++L  L       N   I
Sbjct: 71  TQINFSNNQLTDITP--LKNLTKLVDILMNNNQI--ADITPLANLTNLTGLTLFNNQ--I 124

Query: 136 EIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSC 195
                  +L  L  L L  N+        +  L+ LQ+L   +          + ++   
Sbjct: 125 TDIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQ---------VTDLKPL 173

Query: 196 QNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLG 255
            NL  LE L IS N+++    + L K   L  +    N+     P  +G LT++  L L 
Sbjct: 174 ANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLN 229

Query: 256 NNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSI 315
            N L       + +L NL  L + ++ ++ L P  +  ++ L EL +  N +    P + 
Sbjct: 230 GNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLA- 284

Query: 316 DLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSL 375
             GL  L  L L EN      P  ++N+  L+ L   FN+ S + P    +L  L+ L  
Sbjct: 285 --GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFF 338

Query: 376 AGNVLTSPTP---------------DLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNF 420
             N ++  +                 +S L+ L +   +  + L++        +   N 
Sbjct: 339 YNNKVSDVSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTNAPVNYKANV 398

Query: 421 SISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNN 480
           S                IP  + N+    +            P T+          +  N
Sbjct: 399 S----------------IPNTVKNVTGALI-----------APATISDGGSYTEPDITWN 431

Query: 481 KLEGSIPEDLCHLYRLANLYLGDNKLSGRLP 511
                  E      +   +  G    SG + 
Sbjct: 432 LPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  202 bits (516), Expect = 3e-58
 Identities = 64/310 (20%), Positives = 116/310 (37%), Gaps = 22/310 (7%)

Query: 751  ISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKV 810
            +  ++L   +      ++   G FG V+K        +A K+F ++   S +    E   
Sbjct: 14   LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQ-NEYEVYS 71

Query: 811  MGSIRHRNLVKIISSCSNNDFKA----LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMID 866
            +  ++H N+++ I +            L+  +   GSL   L      +   +   I   
Sbjct: 72   LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK--ANVVSWNELCHIAET 129

Query: 867  VASALEYLH------FGYSTP-IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ 919
            +A  L YLH           P I H DIK  NVLL  ++   ++DFG+A      +S   
Sbjct: 130  MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189

Query: 920  TKTL-GTIGYMAPEYGREG-----KVSRKCDVYSYGIMLMETFTKKKPTDEIF-AGEMSL 972
            T    GT  YMAPE              + D+Y+ G++L E  ++    D       +  
Sbjct: 190  THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249

Query: 973  KRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDV 1032
            +  +G       + EV           D+  +   ++ +     +C     E R+S   V
Sbjct: 250  EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309

Query: 1033 ANRLVRIRET 1042
              R+ +++  
Sbjct: 310  GERITQMQRL 319

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  200 bits (511), Expect = 5e-58
 Identities = 69/312 (22%), Positives = 128/312 (41%), Gaps = 47/312 (15%)

Query: 743  YPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFH------- 794
            +P++    ++  ++          K +G G FG V+KG  + D   +A K          
Sbjct: 8    FPKSRLPTLADNEI-------EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE 60

Query: 795  MEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYF 854
             E     + F  E  +M ++ H N+VK+     N     +V+E++  G L   L    + 
Sbjct: 61   TEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP 118

Query: 855  LDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES-----MVGHLSDFGIAK 909
            +    +L++M+D+A  +EY+    + PIVH D++  N+ L        +   ++DFG+++
Sbjct: 119  IKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177

Query: 910  ILGKEESMRQTKTLGTIGYMAPE--YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFA 967
                  S+  +  LG   +MAPE     E   + K D YS+ ++L    T + P DE   
Sbjct: 178  Q--SVHSV--SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233

Query: 968  GEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI 1027
            G++     + +  L  +I                   E C   + ++   C    P+KR 
Sbjct: 234  GKIKFINMIREEGLRPTIP------------------EDCPPRLRNVIELCWSGDPKKRP 275

Query: 1028 SMKDVANRLVRI 1039
                +   L  +
Sbjct: 276  HFSYIVKELSEL 287

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  197 bits (502), Expect = 2e-56
 Identities = 75/302 (24%), Positives = 120/302 (39%), Gaps = 46/302 (15%)

Query: 751  ISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKV 810
            I Y+++          +++G G+FG V K       ++A K    E +   ++F  E + 
Sbjct: 5    IDYKEI-------EVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQ 54

Query: 811  MGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDN--YFLDILQRLKIMIDVA 868
            +  + H N+VK+  +C N     LV+EY   GSL   L+      +      +   +  +
Sbjct: 55   LSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112

Query: 869  SALEYLHFGYSTPIVHCDIKPSNVLLNESM-VGHLSDFGIAKILGKEESMRQTKTLGTIG 927
              + YLH      ++H D+KP N+LL     V  + DFG A     +  M  T   G+  
Sbjct: 113  QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD--IQTHM--TNNKGSAA 168

Query: 928  YMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITE 987
            +MAPE       S KCDV+S+GI+L E  T++KP DEI                   I  
Sbjct: 169  WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-------------RIMW 215

Query: 988  VADANLLNCEENDFSAR----EQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043
                            R    +     I SL   C    P +R SM+++   +  +    
Sbjct: 216  AVHNGT----------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265

Query: 1044 SA 1045
              
Sbjct: 266  PG 267

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  208 bits (531), Expect = 5e-56
 Identities = 104/535 (19%), Positives = 188/535 (35%), Gaps = 39/535 (7%)

Query: 127 DFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIP 186
            +RF N   ++P     L   + LLL  N        +  +L  LQ L+L       TI 
Sbjct: 10  FYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTID 65

Query: 187 SSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGI--PRDIG 244
              F     +NLP L  L +  +++    P        L  + L F      +       
Sbjct: 66  KEAF-----RNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFR 120

Query: 245 NLTSVRNLFLGNNSLIG-EIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNIS--TLKELA 301
           NL ++  L L  N +    +    G L +L+ +   S+ +  +    +  +   TL   +
Sbjct: 121 NLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFS 180

Query: 302 VTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIP 361
           +  N L   +       +     + L   + SG       N   + +     N+ S    
Sbjct: 181 LAANSLYSRVSVDWGKCMNPFRNMVLEILDVSG-------NGWTVDITGNFSNAISKSQA 233

Query: 362 TTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFS 421
            +      +       + +  P  +    + L    ++  + LS   +  +         
Sbjct: 234 FSLILAHHIMGAGFGFHNIKDPDQNT--FAGLAR-SSVRHLDLSHGFVFSLNSRVFETLK 290

Query: 422 ISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNK 481
             +K L++    I+    +    ++NL V+ L  N L          L K+  + LQ N 
Sbjct: 291 -DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNH 349

Query: 482 LEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNL 541
           +     +    L +L  L L DN L+      +  + S+ D+ L  N L ++    L   
Sbjct: 350 IAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTAN 404

Query: 542 KDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIP-VTIGGLQGLQLLSLRYN 600
              L  N   N      L  + +L+++    L+ N  S      T      L+ L L  N
Sbjct: 405 LIHLSENRLENLDILYFLLRVPHLQIL---ILNQNRFSSCSGDQTPSENPSLEQLFLGEN 461

Query: 601 RLQGPI-----PESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQL 650
            LQ         + F GL  L  + +++N L+   P     L+ L+ L+L+ N+L
Sbjct: 462 MLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL 516

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  206 bits (526), Expect = 2e-55
 Identities = 125/708 (17%), Positives = 228/708 (32%), Gaps = 96/708 (13%)

Query: 73  RRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEE-LSHLRGLKYFDFRFN 131
                L +S+  +          L  L +L + +     ++ +E   +L  L+  D   +
Sbjct: 24  NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83

Query: 132 NFHIEIPSWFVSLPRLQHLLLKHNSFVGKI--PETIGYLSLLQELDLSDNQLSGTIPSSI 189
             +   P  F  L  L  L L        +        L  L  LDLS NQ+        
Sbjct: 84  KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPS 143

Query: 190 FNISSCQNLPVLEGLFISYNQLTGPIPTNLW--KCRELHVVSLAFNKFQGGIPRDIGNLT 247
           F       L  L+ +  S NQ+       L   + + L   SLA N     +  D G   
Sbjct: 144 F-----GKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCM 198

Query: 248 SV-RNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDND 306
           +  RN+ L    +        GN   +++ G  S+ ++     S+     +       ++
Sbjct: 199 NPFRNMVLEILDV-------SGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN 251

Query: 307 LLGSLPSSID-LGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFG 365
           +     ++   L   ++  L L               + +L VL+  +N  + +    F 
Sbjct: 252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFY 311

Query: 366 NLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMK 425
            L +L++L+L+ N+L           +      +  I L +N I  I   +         
Sbjct: 312 GLDNLQVLNLSYNLLGELYSS-----NFYGLPKVAYIDLQKNHIAIIQDQTFKFLE---- 362

Query: 426 SLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGS 485
                                 L  + L +N LT     T+  +  +  ++L  NKL   
Sbjct: 363 ---------------------KLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTL 396

Query: 486 IPEDLCHLYRLANLYLGDNKLSG-RLPACLGNLTSLRDLSLGSNALTSIIPS-TLWNLKD 543
              +L        ++L +N+L    +   L  +  L+ L L  N  +S     T      
Sbjct: 397 PKINLTANL----IHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPS 452

Query: 544 ILRFNLSSNSLNGSLLPDI-----GNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLR 598
           + +  L  N L  +   ++       L  +  + L+ N L+ + P     L  L+ LSL 
Sbjct: 453 LEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLN 512

Query: 599 YNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRG 658
            NRL            +L  +D+S N L       +     L  L+++ N+   E     
Sbjct: 513 SNRLTVLSHNDL--PANLEILDISRNQLL-APNPDV--FVSLSVLDITHNKFICECELS- 566

Query: 659 PFITFSAESF-----LGNQALCGSP---------KLQVSPCKTRSHPRSRTTVVLLIVLP 704
            FI +   +            C  P          L    C      +S    + ++   
Sbjct: 567 TFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTV 626

Query: 705 LVSALTMIVV----------LTAKLVRRRRRRRRRQKGSTRPY-YDAN 741
            ++   M ++          +  K  +R   +   Q      Y YDA 
Sbjct: 627 TLTLFLMTILTVTKFRGFCFICYKTAQRLVFKDHPQGTEPDMYKYDAY 674

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  184 bits (468), Expect = 4e-48
 Identities = 102/480 (21%), Positives = 169/480 (35%), Gaps = 36/480 (7%)

Query: 207 SYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNE 266
            +  LT  +P  L        + L+FN  +         L  ++ L LG+      I  E
Sbjct: 12  RFCNLTQ-VPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKE 67

Query: 267 I-GNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDL-LGSLPSSIDLGLPNLER 324
              NL NL +L + SS +  L P +   +  L EL +    L    L       L  L R
Sbjct: 68  AFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127

Query: 325 LFLGENNFSG-TIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLR--SLKLLSLAGNVLT 381
           L L +N      +  S   ++ L  +DF  N    +       L+  +L   SLA N L 
Sbjct: 128 LDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLY 187

Query: 382 SPTPDLSFLSSLTSCRN--LEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIP 439
           S    + +   +   RN  LEI+ +S N     +  +  N     ++ S+   +   G  
Sbjct: 188 S-RVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAG 246

Query: 440 KELGNI-------------NNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSI 486
               NI             +++  + L +  +          L+ L+ L L  NK+    
Sbjct: 247 FGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIA 306

Query: 487 PEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILR 546
            E    L  L  L L  N L     +    L  +  + L  N +  I   T   L+ +  
Sbjct: 307 DEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQT 366

Query: 547 FNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQG-P 605
            +L  N+L       I  +  + ++ LS N L  +  + +       L+ L  NRL+   
Sbjct: 367 LDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSENRLENLD 417

Query: 606 IPESFGGLKSLNFVDMSNNNLSGTIPKSMEA-LSYLKHLNLSFNQLEGEIPTRGPFITFS 664
           I      +  L  + ++ N  S        +    L+ L L  N L+    T   +  F 
Sbjct: 418 ILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFE 477

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  123 bits (311), Expect = 6e-29
 Identities = 81/391 (20%), Positives = 143/391 (36%), Gaps = 34/391 (8%)

Query: 69  GVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDF 128
           G+    V  L++S+  +          L  L VL +  N       E    L  L+  + 
Sbjct: 262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNL 321

Query: 129 RFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSS 188
            +N       S F  LP++ ++ L+ N       +T  +L  LQ LDL DN         
Sbjct: 322 SYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNA-------- 373

Query: 189 IFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQG-GIPRDIGNLT 247
              +++   +P +  +F+S N+L   +P        +H   L+ N+ +   I   +  + 
Sbjct: 374 ---LTTIHFIPSIPDIFLSGNKLVT-LPKINLTANLIH---LSENRLENLDILYFLLRVP 426

Query: 248 SVRNLFLGNNSLIGEIPNE--IGNLRNLEVLGVQSSNLAGL----IPASIF-NISTLKEL 300
            ++ L L  N        +       +LE L +  + L       +   +F  +S L+ L
Sbjct: 427 HLQILILNQNR-FSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVL 485

Query: 301 AVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLI 360
            +  N L  SLP  +   L  L  L L  N  +    + L   + L +LD   N      
Sbjct: 486 YLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPN 542

Query: 361 PTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNF 420
           P  F +L  L +     N         +F++ L +  N+ I     +       S  G  
Sbjct: 543 PDVFVSLSVLDIT---HNKFICECELSTFINWL-NHTNVTIAGPPADIYCVYPDSFSGV- 597

Query: 421 SISMKSLSMESCNISGGIPKELGNINNLTVI 451
             S+ SLS E C+    +     ++  +  +
Sbjct: 598 --SLFSLSTEGCDEEEVLKSLKFSLFIVCTV 626

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  191 bits (487), Expect = 2e-54
 Identities = 75/334 (22%), Positives = 137/334 (41%), Gaps = 43/334 (12%)

Query: 718  KLVRRRRRRRRRQKGSTRPYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSV 777
            K              +T   Y            I + DL       +  + +G GSFG+V
Sbjct: 2    KHHHHHHPMSDYDIPTTENLYFQGAMDGDDMD-IPWCDL-------NIKEKIGAGSFGTV 53

Query: 778  YKGVLPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV 835
            ++     G ++A K+   +      +  F  E  +M  +RH N+V  + + +     ++V
Sbjct: 54   HRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112

Query: 836  LEYMSNGSLEKCLYSDN--YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVL 893
             EY+S GSL + L+       LD  +RL +  DVA  + YLH   + PIVH ++K  N+L
Sbjct: 113  TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLL 171

Query: 894  LNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLM 953
            +++     + DFG++++        ++   GT  +MAPE  R+   + K DVYS+G++L 
Sbjct: 172  VDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAPEVLRDEPSNEKSDVYSFGVILW 230

Query: 954  ETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAR----EQCVS 1009
            E  T ++P   +   ++              +  V               R         
Sbjct: 231  ELATLQQPWGNLNPAQV--------------VAAVGFKCK----------RLEIPRNLNP 266

Query: 1010 SIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043
             + ++   C  + P KR S   + + L  + ++ 
Sbjct: 267  QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  189 bits (483), Expect = 2e-54
 Identities = 69/289 (23%), Positives = 115/289 (39%), Gaps = 46/289 (15%)

Query: 767  KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFD----GSLESFHAECKVMGSIRHRNLVKI 822
            +++G+G FG VY+     G E+A K    + D     ++E+   E K+   ++H N++ +
Sbjct: 13   EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 823  ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
               C       LV+E+   G L + L      +     +   + +A  + YLH     PI
Sbjct: 72   RGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPI 129

Query: 883  VHCDIKPSNVLLNESMVGH--------LSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG 934
            +H D+K SN+L+ + +           ++DFG+A+   +   M      G   +MAPE  
Sbjct: 130  IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA---GAYAWMAPEVI 186

Query: 935  REGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL 994
            R    S+  DV+SYG++L E  T + P   I    +                 VA   L 
Sbjct: 187  RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV--------------AYGVAMNKL- 231

Query: 995  NCEENDFSAR----EQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039
                            C      L  DC    P  R S  ++ ++L  I
Sbjct: 232  ---------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  184 bits (470), Expect = 1e-52
 Identities = 59/303 (19%), Positives = 114/303 (37%), Gaps = 51/303 (16%)

Query: 751  ISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGS--LESFHAEC 808
            I ++ L       +    L     G ++KG    G +I  KV  +    +     F+ EC
Sbjct: 7    IDFKQL-------NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEEC 58

Query: 809  KVMGSIRHRNLVKIISSCSNNDFK--ALVLEYMSNGSLEKCLYSD-NYFLDILQRLKIMI 865
              +    H N++ ++ +C +       L+  +M  GSL   L+   N+ +D  Q +K  +
Sbjct: 59   PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118

Query: 866  DVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT 925
            D+A  + +LH      I    +   +V+++E M   +S   +        S +    +  
Sbjct: 119  DMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYA 171

Query: 926  IGYMAPE---YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLS 982
              ++APE      E    R  D++S+ ++L E  T++ P  ++   E+ +K         
Sbjct: 172  PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK--------- 222

Query: 983  CSITEVADANLLNCEENDFSAR----EQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVR 1038
                 VA   L          R          +  L   C  + P KR     +   L +
Sbjct: 223  -----VALEGL----------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEK 267

Query: 1039 IRE 1041
            +++
Sbjct: 268  MQD 270

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  182 bits (464), Expect = 1e-51
 Identities = 65/279 (23%), Positives = 119/279 (42%), Gaps = 28/279 (10%)

Query: 767  KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIIS 824
            + +G GSFG+VYKG      ++A K+ ++       L++F  E  V+   RH N++  + 
Sbjct: 30   QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 825  SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
              +     A+V ++    SL   L++     ++ + + I    A  ++YLH   +  I+H
Sbjct: 88   YSTAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIH 143

Query: 885  CDIKPSNVLLNESMVGHLSDFGIAKILGK-EESMRQTKTLGTIGYMAPE---YGREGKVS 940
             D+K +N+ L+E     + DFG+A    +   S +  +  G+I +MAPE          S
Sbjct: 144  RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203

Query: 941  RKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEND 1000
             + DVY++GI+L E  T + P             +   +     I  V   +L       
Sbjct: 204  FQSDVYAFGIVLYELMTGQLP-------------YSNINNRDQIIEMVGRGSLSPDLSK- 249

Query: 1001 FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039
               R  C   +  L  +C     ++R S   +   +  +
Sbjct: 250  --VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  183 bits (466), Expect = 4e-51
 Identities = 76/372 (20%), Positives = 153/372 (41%), Gaps = 38/372 (10%)

Query: 286 LIPASIFNIST------LKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSS 339
            +PA I  I             +    +   +       L ++ +L +            
Sbjct: 7   TLPAPINQIFPDADLAEGIRAVLQKASVTDVVTQE---ELESITKLVVAGEKV--ASIQG 61

Query: 340 LTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNL 399
           +  ++ L  L+   N  + + P    NL  L  L +  N +T        +S+L +  NL
Sbjct: 62  IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-------ISALQNLTNL 112

Query: 400 EIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELT 459
             +YL+E+ I+ I  S + N +  M SL++ + +        L N+  L  + +  +++ 
Sbjct: 113 RELYLNEDNISDI--SPLANLT-KMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVK 168

Query: 460 GTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTS 519
              P  +  L  L  L L  N++E   P  L  L  L       N+++  +   + N+T 
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD-ITP-VANMTR 222

Query: 520 LRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALS 579
           L  L +G+N +T + P  L NL  +    + +N ++   +  + +L  +  +++  N +S
Sbjct: 223 LNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQIS 278

Query: 580 GVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSY 639
            +    +  L  L  L L  N+L     E  GGL +L  + +S N+++   P  + +LS 
Sbjct: 279 DISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSK 334

Query: 640 LKHLNLSFNQLE 651
           +   + +   ++
Sbjct: 335 MDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  175 bits (446), Expect = 1e-48
 Identities = 78/353 (22%), Positives = 150/353 (42%), Gaps = 34/353 (9%)

Query: 308 LGSLPSSI-----DLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPT 362
           L +LP+ I     D  L    R  L + + +  +      +  ++ L       + +   
Sbjct: 5   LATLPAPINQIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASIQG- 61

Query: 363 TFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSI 422
               L +L+ L+L GN +T        +S L++   L  +Y+  N I  I  S++ N + 
Sbjct: 62  -IEYLTNLEYLNLNGNQITD-------ISPLSNLVKLTNLYIGTNKITDI--SALQNLT- 110

Query: 423 SMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKL 482
           +++ L +   NIS   P  L N+  +  + LG N     +   L  +  L  L +  +K+
Sbjct: 111 NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKV 167

Query: 483 EGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLK 542
           +   P  + +L  L +L L  N++   +   L +LTSL   +   N +T I P  + N+ 
Sbjct: 168 KDVTP--IANLTDLYSLSLNYNQIED-ISP-LASLTSLHYFTAYVNQITDITP--VANMT 221

Query: 543 DILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRL 602
            +    + +N +    L  + NL  +  +++  N +S +    +  L  L++L++  N++
Sbjct: 222 RLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQI 277

Query: 603 QGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIP 655
                     L  LN + ++NN L     + +  L+ L  L LS N +    P
Sbjct: 278 SDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  174 bits (444), Expect = 3e-48
 Identities = 91/457 (19%), Positives = 158/457 (34%), Gaps = 112/457 (24%)

Query: 171 LQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSL 230
              L              I  I    +L       +    +T  +               
Sbjct: 2   AATLATLPAP--------INQIFPDADLAEGIRAVLQKASVTDVVT-------------- 39

Query: 231 AFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPAS 290
                          L S+  L +     +  I   I  L NLE L +  + +  + P S
Sbjct: 40  ------------QEELESITKLVVAGEK-VASIQ-GIEYLTNLEYLNLNGNQITDISPLS 85

Query: 291 IFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLD 350
                                       L  L  L++G N    T  S+L N++ L  L 
Sbjct: 86  ---------------------------NLVKLTNLYIGTNKI--TDISALQNLTNLRELY 116

Query: 351 FGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPIN 410
              ++ S + P    NL  +  L+L  N   S   DLS LS++T    L  + ++E+ + 
Sbjct: 117 LNEDNISDISP--LANLTKMYSLNLGANHNLS---DLSPLSNMT---GLNYLTVTESKVK 168

Query: 411 GILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQ 470
            + P                           + N+ +L  + L  N++    P  L  L 
Sbjct: 169 DVTP---------------------------IANLTDLYSLSLNYNQIEDISP--LASLT 199

Query: 471 KLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNAL 530
            L       N++    P  + ++ RL +L +G+NK++   P  L NL+ L  L +G+N +
Sbjct: 200 SLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI 255

Query: 531 TSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQ 590
           + I  + + +L  +   N+ SN ++   +  + NL  +  + L+ N L       IGGL 
Sbjct: 256 SDI--NAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLT 311

Query: 591 GLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLS 627
            L  L L  N +    P     L  ++  D +N  + 
Sbjct: 312 NLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  169 bits (430), Expect = 2e-46
 Identities = 70/369 (18%), Positives = 145/369 (39%), Gaps = 38/369 (10%)

Query: 163 ETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKC 222
                L+      L    ++  +            L  +  L ++  ++       +   
Sbjct: 16  FPDADLAEGIRAVLQKASVTDVVTQE--------ELESITKLVVAGEKVAS--IQGIEYL 65

Query: 223 RELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSN 282
             L  ++L  N+     P  + NL  + NL++G N +     + + NL NL  L +   N
Sbjct: 66  TNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDN 121

Query: 283 LAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTN 342
           ++ + P  + N++ +  L +  N  L S  S +   +  L  L + E+      P  + N
Sbjct: 122 ISDISP--LANLTKMYSLNLGANHNL-SDLSPLS-NMTGLNYLTVTESKVKDVTP--IAN 175

Query: 343 ISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEII 402
           +++L  L   +N    + P    +L SL   +   N +T        ++ + +   L  +
Sbjct: 176 LTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD-------ITPVANMTRLNSL 226

Query: 403 YLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTI 462
            +  N I  +  S + N S  +  L + +  IS      + ++  L ++ +G+N+++   
Sbjct: 227 KIGNNKITDL--SPLANLS-QLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDIS 281

Query: 463 PVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRD 522
              L  L +L  L+L NN+L     E +  L  L  L+L  N ++   P  L +L+ +  
Sbjct: 282 V--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDS 337

Query: 523 LSLGSNALT 531
               +  + 
Sbjct: 338 ADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  159 bits (404), Expect = 7e-43
 Identities = 74/411 (18%), Positives = 142/411 (34%), Gaps = 86/411 (20%)

Query: 73  RRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNN 132
                  +    +T  +      L  +  L +       +  + + +L  L+Y +   N 
Sbjct: 22  AEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV--ASIQGIEYLTNLEYLNLNGNQ 77

Query: 133 FHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNI 192
             I   S   +L +L +L +  N         +  L+ L+EL L+++ +S         I
Sbjct: 78  --ITDISPLSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISD--------I 125

Query: 193 SSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNL 252
           S   NL  +  L +  N                                 + N+T +  L
Sbjct: 126 SPLANLTKMYSLNLGANHNL-------------------------SDLSPLSNMTGLNYL 160

Query: 253 FLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLP 312
            +  +  + ++   I NL +L  L + + N           I  +  LA           
Sbjct: 161 TVTESK-VKDVTP-IANLTDLYSLSL-NYN----------QIEDISPLA----------- 196

Query: 313 SSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKL 372
                 L +L       N  +   P  + N++ L+ L  G N  + L P    NL  L  
Sbjct: 197 -----SLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTW 247

Query: 373 LSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESC 432
           L +  N ++        ++++     L+++ +  N I+ I  S + N S  + SL + + 
Sbjct: 248 LEIGTNQISD-------INAVKDLTKLKMLNVGSNQISDI--SVLNNLS-QLNSLFLNNN 297

Query: 433 NISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLE 483
            +     + +G + NLT + L  N +T   P  L  L K+      N  ++
Sbjct: 298 QLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  181 bits (460), Expect = 1e-50
 Identities = 74/324 (22%), Positives = 122/324 (37%), Gaps = 37/324 (11%)

Query: 751  ISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKV 810
             +  +     D     +L+G G +G+VYKG L D   +A KVF      + ++F  E  +
Sbjct: 3    AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNI 58

Query: 811  --MGSIRHRNLVKIISSCSNNDFKA-----LVLEYMSNGSLEKCLYSDNYFLDILQRLKI 863
              +  + H N+ + I               LV+EY  NGSL K L       D +   ++
Sbjct: 59   YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRL 116

Query: 864  MIDVASALEYLH------FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM 917
               V   L YLH        Y   I H D+   NVL+       +SDFG++  L     +
Sbjct: 117  AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

Query: 918  RQ-------TKTLGTIGYMAPEYGRE-------GKVSRKCDVYSYGIMLMETFTKKK--- 960
            R           +GTI YMAPE               ++ D+Y+ G++  E F +     
Sbjct: 177  RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236

Query: 961  PTDEIFAGEMSLKRWVGDSLLSCSITE-VADANLLNCEENDFSAREQCVSSIFSLAMDCT 1019
            P + +   +M+ +  VG+      +   V+           +      V S+     DC 
Sbjct: 237  PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296

Query: 1020 VDLPEKRISMKDVANRLVRIRETL 1043
                E R++ +    R+  +    
Sbjct: 297  DQDAEARLTAQXAEERMAELMMIW 320

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  186 bits (475), Expect = 2e-50
 Identities = 97/554 (17%), Positives = 185/554 (33%), Gaps = 59/554 (10%)

Query: 78  LNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEI 137
            +      T +IP  L   + +  L +  N        +L     L+    + +  +   
Sbjct: 10  CDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIE 66

Query: 138 PSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQN 197
              F SL  L+HL L  N          G LS L+ L+L  N       +S+F      N
Sbjct: 67  GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLF-----PN 121

Query: 198 LPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNN 257
           L  L+ L I   +    I                          D   LTS+  L +   
Sbjct: 122 LTNLQTLRIGNVETFSEIR-----------------------RIDFAGLTSLNELEIKAL 158

Query: 258 SLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDL 317
           SL       + ++R++  L +  S  A L+      +S+++ L + D + L     S   
Sbjct: 159 SLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTN-LARFQFSPLP 217

Query: 318 GLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAG 377
                  +       S     S   + +L            L    F +     L     
Sbjct: 218 VDEVSSPMKKLAFRGSVLTDESFNELLKL------LRYILELSEVEFDDCTLNGLGDFNP 271

Query: 378 NVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGG 437
           +     + +L  + ++     +  +++ +  +   L +        +K +++E+  +   
Sbjct: 272 SESDVVS-ELGKVETV----TIRRLHIPQFYLFYDLSTVYSLLE-KVKRITVENSKVFLV 325

Query: 438 IPKELGNINNLTVIRLGNNELTGTIPVT---LGRLQKLQGLYLQNNKLE--GSIPEDLCH 492
                 ++ +L  + L  N +           G    LQ L L  N L       E L  
Sbjct: 326 PCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLT 385

Query: 493 LYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSN 552
           L  L +L +  N     +P        +R L+L S  +  +       L+ +   ++S+N
Sbjct: 386 LKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVL---DVSNN 441

Query: 553 SLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGG 612
           +L+ S    +  L+   E+ +S N L  +   ++     L ++ +  N+L+      F  
Sbjct: 442 NLD-SFSLFLPRLQ---ELYISRNKLKTLPDASL--FPVLLVMKISRNQLKSVPDGIFDR 495

Query: 613 LKSLNFVDMSNNNL 626
           L SL  + +  N  
Sbjct: 496 LTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  184 bits (469), Expect = 9e-50
 Identities = 99/497 (19%), Positives = 192/497 (38%), Gaps = 39/497 (7%)

Query: 174 LDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFN 233
            D      + +IPS +           ++ L +S+N++T     +L  C  L V+ L  +
Sbjct: 10  CDGRSRSFT-SIPSGLT--------AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60

Query: 234 KFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIF- 292
           +          +L S+ +L L +N L     +  G L +L+ L +  +    L   S+F 
Sbjct: 61  RINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFP 120

Query: 293 NISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFG 352
           N++ L+ L + + +    +      GL +L  L +   +       SL +I ++  L   
Sbjct: 121 NLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLH 180

Query: 353 FNSFSGLIPTTFGNLRSLKLLSLAGNVLTS------PTPDLSFLSSLTSCRNLEIIYLSE 406
            +  + L+      L S++ L L    L        P  ++S      + R   +   S 
Sbjct: 181 LSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF 240

Query: 407 NPINGILPSSIGNFSISMKSLSMES----CNISGGIPKELGNIN--NLTVIRLGNNELTG 460
           N +  +L   +    +     ++            +  ELG +    +  + +    L  
Sbjct: 241 NELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFY 300

Query: 461 TIPVTLGRLQKLQGLYLQNNKLEGSIPEDLC-HLYRLANLYLGDNKLS---GRLPACLGN 516
            +      L+K++ + ++N+K+   +P     HL  L  L L +N +     +  AC G 
Sbjct: 301 DLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGA 359

Query: 517 LTSLRDLSLGSNALTSI--IPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLS 574
             SL+ L L  N L S+      L  LK++   ++S N+ +  +       + +  ++LS
Sbjct: 360 WPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLS 418

Query: 575 LNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSM 634
              +     V     Q L++L +  N L          L  L  + +S N L  T+P + 
Sbjct: 419 STGIRV---VKTCIPQTLEVLDVSNNNLD----SFSLFLPRLQELYISRNKLK-TLPDAS 470

Query: 635 EALSYLKHLNLSFNQLE 651
                L  + +S NQL+
Sbjct: 471 -LFPVLLVMKISRNQLK 486

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  183 bits (465), Expect = 4e-49
 Identities = 99/546 (18%), Positives = 183/546 (33%), Gaps = 62/546 (11%)

Query: 112 SLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLL 171
           S+P  L+    +K  D  FN           +   LQ L+LK +       +    L  L
Sbjct: 19  SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76

Query: 172 QELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTG-PIPTNLWKCRELHVVSL 230
           + LDLSDN LS ++ SS F       L  L+ L +  N      + +       L  + +
Sbjct: 77  EHLDLSDNHLS-SLSSSWF-----GPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRI 130

Query: 231 AFNKFQGGIPR-DIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPA 289
              +    I R D   LTS+  L +   SL       + ++R++  L +  S  A L+  
Sbjct: 131 GNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEI 190

Query: 290 SIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVL 349
               +S+++ L + D +L      S          +       S     S   + +L   
Sbjct: 191 FADILSSVRYLELRDTNL-ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKL--- 246

Query: 350 DFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPI 409
                    L    F +     L     +     + +L  + ++     +  +++ +  +
Sbjct: 247 ---LRYILELSEVEFDDCTLNGLGDFNPSESDVVS-ELGKVETV----TIRRLHIPQFYL 298

Query: 410 NGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVT---L 466
              L +        +K +++E+  +         ++ +L  + L  N +           
Sbjct: 299 FYDLSTVYSLLE-KVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACK 357

Query: 467 GRLQKLQGLYLQNNKLE--GSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLS 524
           G    LQ L L  N L       E L  L  L +L +  N     +P        +R L+
Sbjct: 358 GAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLN 416

Query: 525 LGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPV 584
           L S  +  +       L+ +   ++S+N+L+                            +
Sbjct: 417 LSSTGIRVVKTCIPQTLEVL---DVSNNNLD-------------------------SFSL 448

Query: 585 TIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLN 644
               L  LQ L +  N+L+     S      L  + +S N L        + L+ L+ + 
Sbjct: 449 ---FLPRLQELYISRNKLKTLPDASL--FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIW 503

Query: 645 LSFNQL 650
           L  N  
Sbjct: 504 LHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  182 bits (463), Expect = 6e-49
 Identities = 90/502 (17%), Positives = 182/502 (36%), Gaps = 40/502 (7%)

Query: 75  VTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEE-LSHLRGLKYFDFRFNNF 133
           + +L++S+  +T      L   + L VL ++++    ++  +    L  L++ D   N+ 
Sbjct: 28  MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI-NTIEGDAFYSLGSLEHLDLSDNHL 86

Query: 134 HIEIPSWFVSLPRLQHLLLKHNSFVG-KIPETIGYLSLLQELDLSDNQLSGTIPSSIFNI 192
                SWF  L  L++L L  N +    +      L+ LQ L + + +    I    F  
Sbjct: 87  SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDF-- 144

Query: 193 SSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNL 252
                L  L  L I    L      +L   R++H ++L  ++    +      L+SVR L
Sbjct: 145 ---AGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYL 201

Query: 253 FLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNIST-------LKELAVTDN 305
            L + +L     + +        +   +   + L   S   +         L E+   D 
Sbjct: 202 ELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDC 261

Query: 306 DLLG----------SLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNS 355
            L G           +     +    + RL + +      + +  + + ++  +    + 
Sbjct: 262 TLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSK 321

Query: 356 FSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPS 415
              +  +   +L+SL+ L L+ N++       S  +   +  +L+ + LS+N +   +  
Sbjct: 322 VFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNS--ACKGAWPSLQTLVLSQNHLR-SMQK 378

Query: 416 SIGNFS--ISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQ 473
           +        ++ SL +        +P        +  + L +  +     V     Q L+
Sbjct: 379 TGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIRV---VKTCIPQTLE 434

Query: 474 GLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSI 533
            L + NN L+ S       L RL  LY+  NKL   LP        L  + +  N L S+
Sbjct: 435 VLDVSNNNLD-SFSL---FLPRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSV 488

Query: 534 IPSTLWNLKDILRFNLSSNSLN 555
                  L  + +  L +N  +
Sbjct: 489 PDGIFDRLTSLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  139 bits (353), Expect = 9e-35
 Identities = 69/373 (18%), Positives = 122/373 (32%), Gaps = 51/373 (13%)

Query: 308 LGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNL 367
             S+PS +      ++ L L  N  +      L   + L VL    +  + +    F +L
Sbjct: 17  FTSIPSGL---TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSL 73

Query: 368 RSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSL 427
            SL+ L L+ N L+S +             +L+ + L  NP   +               
Sbjct: 74  GSLEHLDLSDNHLSSLSSSW-----FGPLSSLKYLNLMGNPYQTL--------------- 113

Query: 428 SMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPV-TLGRLQKLQGLYLQNNKLEGSI 486
                    G+     N+ NL  +R+GN E    I       L  L  L ++   L    
Sbjct: 114 ---------GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQ 164

Query: 487 PEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILR 546
            + L  +  + +L L  ++ +  L      L+S+R L L    L     S L   +    
Sbjct: 165 SQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSP 224

Query: 547 FNLSSNSLNG----------SLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQG----- 591
               +   +            LL  I  L  V   D +LN L    P     +       
Sbjct: 225 MKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVE 284

Query: 592 ---LQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFN 648
              ++ L +    L   +   +  L+ +  + + N+ +        + L  L+ L+LS N
Sbjct: 285 TVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSEN 344

Query: 649 QLEGEIPTRGPFI 661
            +  E        
Sbjct: 345 LMVEEYLKNSACK 357

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 42.4 bits (100), Expect = 7e-04
 Identities = 23/113 (20%), Positives = 37/113 (32%), Gaps = 9/113 (7%)

Query: 78  LNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEI 137
           LN+S  G+   +         L VL + NN+   S    L  L+ L       N      
Sbjct: 415 LNLSSTGIR-VVKT--CIPQTLEVLDVSNNNL-DSFSLFLPRLQEL---YISRNKLKTLP 467

Query: 138 PSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIF 190
            +     P L  + +  N            L+ LQ++ L  N    + P   +
Sbjct: 468 DASL--FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 518

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  178 bits (454), Expect = 5e-50
 Identities = 71/298 (23%), Positives = 119/298 (39%), Gaps = 38/298 (12%)

Query: 767  KLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISS 825
            ++LG G FG   K      G  +  K      + +  +F  E KVM  + H N++K I  
Sbjct: 16   EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 826  CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
               +     + EY+  G+L   + S +      QR+    D+AS + YLH   S  I+H 
Sbjct: 76   LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHR 132

Query: 886  DIKPSNVLLNESMVGHLSDFGIAKILGKEESM-------------RQTKTLGTIGYMAPE 932
            D+   N L+ E+    ++DFG+A+++  E++              ++   +G   +MAPE
Sbjct: 133  DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192

Query: 933  YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN 992
                     K DV+S+GI+L E   +     +     M                      
Sbjct: 193  MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM-------------DFGLNVRGF 239

Query: 993  L-LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYIDV 1049
            L   C  N       C  S F + + C    PEKR S   + + L  +R  L+ ++ +
Sbjct: 240  LDRYCPPN-------CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPL 290

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  177 bits (452), Expect = 1e-49
 Identities = 59/288 (20%), Positives = 114/288 (39%), Gaps = 41/288 (14%)

Query: 767  KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGS--LESFHAECKVMGSIRHRNLVKIIS 824
            +L+G G FG VY G      E+A ++  +E D    L++F  E       RH N+V  + 
Sbjct: 39   ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 825  SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
            +C +    A++       +L   +      LD+ +  +I  ++   + YLH   +  I+H
Sbjct: 97   ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153

Query: 885  CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL----GTIGYMAPE-------- 932
             D+K  NV  +   V  ++DFG+  I G  ++ R+   L    G + ++APE        
Sbjct: 154  KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212

Query: 933  -YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA 991
                +   S+  DV++ G +  E   ++ P    F      +          +I      
Sbjct: 213  TEEDKLPFSKHSDVFALGTIWYELHAREWP----FKT-QPAE----------AIIWQMGT 257

Query: 992  NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039
             +         ++      I  + + C     E+R +   + + L ++
Sbjct: 258  GMKPNL-----SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  179 bits (455), Expect = 1e-48
 Identities = 96/502 (19%), Positives = 167/502 (33%), Gaps = 88/502 (17%)

Query: 161 IPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLW 220
           I       + LQE     + L+  +P    N+ S          + ++++     P    
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKS------KTEYYNAWSEWERNAPPGNG 55

Query: 221 KCRELHVVSLAFNKFQG------------GIPRDIGNLTSVRNLFLGNNSLIGEIPNEIG 268
           + RE+ V  L     +              +P    +L S   L    NSL  E+P    
Sbjct: 56  EQREMAVSRLRDCLDRQAHELELNNLGLSSLPELPPHLES---LVASCNSLT-ELPELPQ 111

Query: 269 NLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLG 328
           +L++L V       L+ L P        L+ L V++N L   LP         L+ + + 
Sbjct: 112 SLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQL-EKLPEL--QNSSFLKIIDVD 161

Query: 329 ENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLS 388
            N+    +P    +   L  +  G N    L      NL  L  +    N L        
Sbjct: 162 NNSLK-KLPDLPPS---LEFIAAGNNQLEELPE--LQNLPFLTAIYADNNSLKKLPDLPL 215

Query: 389 FLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNL 448
                    +LE I    N +       + N    + ++  ++  +   +P    +   L
Sbjct: 216 ---------SLESIVAGNNILE--ELPELQNLP-FLTTIYADNNLLKT-LPDLPPS---L 259

Query: 449 TVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSG 508
             + + +N LT  +P     L  L       + L    P        L  L    N++  
Sbjct: 260 EALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPN-------LYYLNASSNEIR- 310

Query: 509 RLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVV 568
            L        SL +L++ +N L  + P+    L+   R   S N L   +     NLK  
Sbjct: 311 SLC---DLPPSLEELNVSNNKLIEL-PALPPRLE---RLIASFNHLA-EVPELPQNLK-- 360

Query: 569 IEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSG 628
            ++ +  N L    P     ++      LR N     +PE    LK L    +  N L  
Sbjct: 361 -QLHVEYNPLR-EFPDIPESVE-----DLRMNSHLAEVPELPQNLKQL---HVETNPLR- 409

Query: 629 TIPKSMEALSYLKHLNLSFNQL 650
             P   E+   ++ L ++  ++
Sbjct: 410 EFPDIPES---VEDLRMNSERV 428

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  178 bits (453), Expect = 2e-48
 Identities = 102/540 (18%), Positives = 191/540 (35%), Gaps = 90/540 (16%)

Query: 89  IPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQ 148
           I P+  + +FL      +++    +P E  +++    +   ++ +    P        + 
Sbjct: 3   INPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 149 HLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISY 208
              L+                   EL+L++  LS ++P    +         LE L  S 
Sbjct: 62  VSRLRDCL-----------DRQAHELELNNLGLS-SLPELPPH---------LESLVASC 100

Query: 209 NQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIG 268
           N LT  +P      + L V +         +      L     L + NN L  ++P E+ 
Sbjct: 101 NSLT-ELPELPQSLKSLLVDNNNLKA----LSDLPPLLEY---LGVSNNQLE-KLP-ELQ 150

Query: 269 NLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLG-LPNLERLFL 327
           N   L+++ V +++L  L         +L+ +A  +N  L  LP   +L  LP L  ++ 
Sbjct: 151 NSSFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQ-LEELP---ELQNLPFLTAIYA 202

Query: 328 GENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDL 387
             N+    +P    +   L  +  G N           NL  L  +    N+L +  PD 
Sbjct: 203 DNNSLK-KLPDLPLS---LESIVAGNNILE--ELPELQNLPFLTTIYADNNLLKT-LPD- 254

Query: 388 SFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINN 447
                     +LE + + +N +   LP    +    +  L +     S G+ +   N+  
Sbjct: 255 -------LPPSLEALNVRDNYLTD-LPELPQS----LTFLDVSENIFS-GLSELPPNLYY 301

Query: 448 LTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLS 507
           L      +NE+  ++      L++   L + NNKL   +P       RL  L    N L+
Sbjct: 302 LN---ASSNEIR-SLCDLPPSLEE---LNVSNNKLI-ELPALPP---RLERLIASFNHLA 350

Query: 508 GRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKV 567
             +P    NL     L +  N L    P    +++     +L  NS    +     NLK 
Sbjct: 351 -EVPELPQNLKQ---LHVEYNPLRE-FPDIPESVE-----DLRMNSHLAEVPELPQNLK- 399

Query: 568 VIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLS 627
             ++ +  N L    P     ++ L++      R+  P   +      L      +++  
Sbjct: 400 --QLHVETNPLR-EFPDIPESVEDLRMN---SERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  165 bits (420), Expect = 5e-44
 Identities = 91/424 (21%), Positives = 161/424 (37%), Gaps = 70/424 (16%)

Query: 240 PRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKE 299
           PR++ N T ++     +++L  E+P E  N+++        S      P        +  
Sbjct: 5   PRNVSN-TFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62

Query: 300 LAVTDNDL------------LGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELS 347
             + D               L SLP       P+LE L    N+ +  +P    ++  L 
Sbjct: 63  SRLRDCLDRQAHELELNNLGLSSLPELP----PHLESLVASCNSLT-ELPELPQSLKSLL 117

Query: 348 VLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSEN 407
           V +    + S L P        L+ L ++ N L         L  L +   L+II +  N
Sbjct: 118 VDNNNLKALSDLPP-------LLEYLGVSNNQLEK-------LPELQNSSFLKIIDVDNN 163

Query: 408 PINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLG 467
            +   LP    +    ++ ++  +  +      EL N+  LT I   NN L   +P    
Sbjct: 164 SLK-KLPDLPPS----LEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK-KLPDLPL 215

Query: 468 RLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGS 527
            L+ +      NN L      +L +L  L  +Y  +N L   LP    +L +L   ++  
Sbjct: 216 SLESI---VAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEAL---NVRD 266

Query: 528 NALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIG 587
           N LT + P    +L  +   ++S N  +  L     NL     ++ S N +  +      
Sbjct: 267 NYLTDL-PELPQSLTFL---DVSENIFS-GLSELPPNLY---YLNASSNEIRSLC----D 314

Query: 588 GLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSF 647
               L+ L++  N+L   +P     L+ L     S N+L+  +P+       LK L++ +
Sbjct: 315 LPPSLEELNVSNNKLIE-LPALPPRLERL---IASFNHLA-EVPEL---PQNLKQLHVEY 366

Query: 648 NQLE 651
           N L 
Sbjct: 367 NPLR 370

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  161 bits (410), Expect = 1e-42
 Identities = 85/489 (17%), Positives = 172/489 (35%), Gaps = 81/489 (16%)

Query: 76  TALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHI 135
           T    ++       PP  G    +AV  +R+              R     +        
Sbjct: 37  TEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL-----------DRQAHELELNNLGLS- 84

Query: 136 EIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPS-------- 187
            +P      P L+ L+   NS   ++PE    L  L   + +   LS   P         
Sbjct: 85  SLPE---LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSN 140

Query: 188 -SIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNL 246
             +  +   QN   L+ + +  N L   +P        +       N+ +  +P ++ NL
Sbjct: 141 NQLEKLPELQNSSFLKIIDVDNNSLKK-LPDLPPSLEFIA---AGNNQLE-ELP-ELQNL 194

Query: 247 TSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDND 306
             +  ++  NNSL  ++P+   +L ++       +N+   +P  + N+  L  +   +N 
Sbjct: 195 PFLTAIYADNNSLK-KLPDLPLSLESIVA----GNNILEELP-ELQNLPFLTTIYADNNL 248

Query: 307 LLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGN 366
           L      ++    P+LE L + +N  +  +P    +++ L V +  F+  S L P     
Sbjct: 249 L-----KTLPDLPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP----- 297

Query: 367 LRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKS 426
             +L  L+ + N + S               +LE + +S N +   LP+        ++ 
Sbjct: 298 --NLYYLNASSNEIRSLCDLPP---------SLEELNVSNNKLI-ELPALPPR----LER 341

Query: 427 LSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSI 486
           L     +++  +P+      NL  + +  N L    P     ++ L+     N+ L   +
Sbjct: 342 LIASFNHLA-EVPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLR----MNSHLA-EV 391

Query: 487 PEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILR 546
           PE   +L +   L++  N L    P    ++  LR   + S  +             +  
Sbjct: 392 PELPQNLKQ---LHVETNPLR-EFPDIPESVEDLR---MNSERVVDPYEFAHETTDKLED 444

Query: 547 FNLSSNSLN 555
                +  +
Sbjct: 445 DVFEHHHHH 453

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  173 bits (440), Expect = 8e-48
 Identities = 65/304 (21%), Positives = 117/304 (38%), Gaps = 38/304 (12%)

Query: 767  KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKV--MGSIRHRNLVKIIS 824
            K +G G +G V+ G    G ++A KVF         S+  E ++     +RH N++  I+
Sbjct: 43   KQIGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIA 98

Query: 825  SCSNNDFK----ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH----- 875
            +            L+ +Y  NGSL   L   +  LD    LK+     S L +LH     
Sbjct: 99   ADIKGTGSWTQLYLITDYHENGSLYDYLK--STTLDAKSMLKLAYSSVSGLCHLHTEIFS 156

Query: 876  FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL---GKEESMRQTKTLGTIGYMAPE 932
                  I H D+K  N+L+ ++    ++D G+A        E  +     +GT  YM PE
Sbjct: 157  TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216

Query: 933  ------YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSIT 986
                       +     D+YS+G++L E   +      +   ++     V        + 
Sbjct: 217  VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276

Query: 987  EVADANLLNCEEN------DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIR 1040
            E+       C +       +  + ++C+  +  L  +C    P  R++   V   L ++ 
Sbjct: 277  EIV------CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330

Query: 1041 ETLS 1044
            E+  
Sbjct: 331  ESQD 334

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  170 bits (433), Expect = 2e-47
 Identities = 61/299 (20%), Positives = 122/299 (40%), Gaps = 38/299 (12%)

Query: 767  KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKV--MGSIRHRNLVKIIS 824
            + +G G +G V++G    G  +A K+F        +S+  E ++     +RH N++  I+
Sbjct: 14   ECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIA 69

Query: 825  SCSNNDFKA----LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH----- 875
            S   +   +    L+  Y   GSL   L      LD +  L+I++ +AS L +LH     
Sbjct: 70   SDMTSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 876  FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM---RQTKTLGTIGYMAPE 932
                  I H D+K  N+L+ ++    ++D G+A +  +  +         +GT  YMAPE
Sbjct: 128  TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187

Query: 933  ------YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSIT 986
                          ++ D++++G++L E   +      +   +      V +      + 
Sbjct: 188  VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247

Query: 987  EVADANLLNCEEN------DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039
            +V       C +       +    +  ++S+  L  +C    P  R++   +   L +I
Sbjct: 248  KVV------CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  167 bits (424), Expect = 1e-45
 Identities = 58/302 (19%), Positives = 119/302 (39%), Gaps = 38/302 (12%)

Query: 767  KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKV--MGSIRHRNLVKIIS 824
            + +G G FG V++G    G E+A K+F         S+  E ++     +RH N++  I+
Sbjct: 48   ESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIA 103

Query: 825  SCSNNDFKA----LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH----- 875
            + + ++       LV +Y  +GSL   L  + Y + +   +K+ +  AS L +LH     
Sbjct: 104  ADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 161

Query: 876  FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR---QTKTLGTIGYMAPE 932
                  I H D+K  N+L+ ++    ++D G+A                 +GT  YMAPE
Sbjct: 162  TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221

Query: 933  ------YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSIT 986
                    +  +  ++ D+Y+ G++  E   +          ++     V        + 
Sbjct: 222  VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 281

Query: 987  EVADANLLNCEEN------DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIR 1040
            +V       CE+       +     + +  +  +  +C       R++   +   L ++ 
Sbjct: 282  KVV------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335

Query: 1041 ET 1042
            + 
Sbjct: 336  QQ 337

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  162 bits (412), Expect = 4e-44
 Identities = 58/346 (16%), Positives = 110/346 (31%), Gaps = 36/346 (10%)

Query: 237 GGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNIST 296
           G       + +   NL+   ++ +    + +   +          +      A     S 
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNA-----DRNRWHSAWRQANSN 56

Query: 297 LKELAVTDNDLLGSLPSSI-DLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNS 355
             ++       L +    + D   P    L L         P     +S L  +      
Sbjct: 57  NPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115

Query: 356 FSGLIPTTFGNLRSLKLLSLAGNVLTS-PTPDLSFLSSLTSCRNLEIIYLSENPINGILP 414
              L P T      L+ L+LA N L + P       +S+ S   L  + +   P    LP
Sbjct: 116 LMEL-PDTMQQFAGLETLTLARNPLRALP-------ASIASLNRLRELSIRACPELTELP 167

Query: 415 SSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQG 474
             + +                     E   + NL  +RL    +  ++P ++  LQ L+ 
Sbjct: 168 EPLASTDA----------------SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKS 210

Query: 475 LYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSL-GSNALTSI 533
           L ++N+ L  ++   + HL +L  L L         P   G    L+ L L   + L + 
Sbjct: 211 LKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT- 268

Query: 534 IPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALS 579
           +P  +  L  + + +L        L   I  L     + +  +  +
Sbjct: 269 LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  162 bits (411), Expect = 4e-44
 Identities = 53/334 (15%), Positives = 112/334 (33%), Gaps = 31/334 (9%)

Query: 319 LPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGN 378
               E L+   +         L+        D               N  + ++ +  G 
Sbjct: 11  SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGR 66

Query: 379 VLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGI 438
            L +    L   +          + L   P+    P      S  ++ +++++  +   +
Sbjct: 67  ALKATADLLEDATQP----GRVALELRSVPLP-QFPDQAFRLS-HLQHMTIDAAGLME-L 119

Query: 439 PKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLAN 498
           P  +     L  + L  N L   +P ++  L +L+ L ++       +PE L        
Sbjct: 120 PDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST----- 173

Query: 499 LYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSL 558
                             L +L+ L L    + S+ P+++ NL+++    + ++ L+ +L
Sbjct: 174 ----------DASGEHQGLVNLQSLRLEWTGIRSL-PASIANLQNLKSLKIRNSPLS-AL 221

Query: 559 LPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLR-YNRLQGPIPESFGGLKSLN 617
            P I +L  + E+DL         P   GG   L+ L L+  + L   +P     L  L 
Sbjct: 222 GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLE 280

Query: 618 FVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLE 651
            +D+        +P  +  L     + +  +   
Sbjct: 281 KLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  157 bits (400), Expect = 1e-42
 Identities = 55/384 (14%), Positives = 113/384 (29%), Gaps = 60/384 (15%)

Query: 110 FGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLS 169
            GS      H  G +   F+ +              R  +          +        +
Sbjct: 1   MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN----SN 56

Query: 170 LLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVS 229
             Q    +   L       + + +     P    L +    L                  
Sbjct: 57  NPQIETRTGRALK-ATADLLEDATQ----PGRVALELRSVPLP----------------- 94

Query: 230 LAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPA 289
                     P     L+ ++++ +    L+ E+P+ +     LE L +  + L  L PA
Sbjct: 95  --------QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRAL-PA 144

Query: 290 SIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVL 349
           SI +++ L+EL++     L  LP  +                 S         +  L  L
Sbjct: 145 SIASLNRLRELSIRACPELTELPEPL----------------ASTDASGEHQGLVNLQSL 188

Query: 350 DFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPI 409
              +     L P +  NL++LK L +  + L+      +   ++     LE + L     
Sbjct: 189 RLEWTGIRSL-PASIANLQNLKSLKIRNSPLS------ALGPAIHHLPKLEELDLRGCTA 241

Query: 410 NGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRL 469
               P   G  +  +K L ++ C+    +P ++  +  L  + L        +P  + +L
Sbjct: 242 LRNYPPIFGGRA-PLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQL 300

Query: 470 QKLQGLYLQNNKLEGSIPEDLCHL 493
                + +  +             
Sbjct: 301 PANCIILVPPHLQAQLDQHRPVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  146 bits (371), Expect = 9e-39
 Identities = 51/318 (16%), Positives = 110/318 (34%), Gaps = 28/318 (8%)

Query: 88  TIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPS-WFVSLPR 146
                L                        ++    +                   + P 
Sbjct: 27  PYHDVLSQWQRHYNADRNRWH----SAWRQANSNNPQIETRTGRALKATADLLEDATQPG 82

Query: 147 LQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFI 206
              L L+      + P+    LS LQ + +    L   +P ++   +       LE L +
Sbjct: 83  RVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAG------LETLTL 134

Query: 207 SYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGN---------LTSVRNLFLGNN 257
           + N L   +P ++     L  +S+        +P  + +         L ++++L L   
Sbjct: 135 ARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWT 193

Query: 258 SLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDL 317
            +   +P  I NL+NL+ L +++S L+ L   +I ++  L+EL +     L + P     
Sbjct: 194 GIR-SLPASIANLQNLKSLKIRNSPLSAL-GPAIHHLPKLEELDLRGCTALRNYPPIF-G 250

Query: 318 GLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAG 377
           G   L+RL L + +   T+P  +  +++L  LD         +P+    L +  ++ +  
Sbjct: 251 GRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPP 310

Query: 378 NVLTSPTPDLSFLSSLTS 395
           ++            +  +
Sbjct: 311 HLQAQLDQHR--PVARPA 326

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  138 bits (349), Expect = 8e-36
 Identities = 53/274 (19%), Positives = 96/274 (35%), Gaps = 46/274 (16%)

Query: 76  TALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHI 135
            AL +  + L    P Q   LS L  + I        LP+ +    GL+      N    
Sbjct: 84  VALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG-LMELPDTMQQFAGLETLTLARNPLR- 140

Query: 136 EIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSL---------LQELDLSDNQLSGTIP 186
            +P+   SL RL+ L ++    + ++PE +              LQ L L    +  ++P
Sbjct: 141 ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLP 199

Query: 187 SSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNL 246
           +SI N+ +      L+ L I  + L+                          +   I +L
Sbjct: 200 ASIANLQN------LKSLKIRNSPLS-------------------------ALGPAIHHL 228

Query: 247 TSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDND 306
             +  L L   + +   P   G    L+ L ++  +    +P  I  ++ L++L +    
Sbjct: 229 PKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCV 288

Query: 307 LLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSL 340
            L  LPS I   LP    + +   +    +    
Sbjct: 289 NLSRLPSLIA-QLPANCIILV-PPHLQAQLDQHR 320

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  163 bits (413), Expect = 6e-43
 Identities = 56/502 (11%), Positives = 135/502 (26%), Gaps = 33/502 (6%)

Query: 112 SLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLL 171
           ++ E   +    K      ++    + S   S   ++ L L  N         +   + L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 172 QELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLA 231
           + L+LS N L              ++L  L  L ++ N +       L     +  +  A
Sbjct: 61  ELLNLSSNVLY--------ETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAA 107

Query: 232 FNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASI 291
            N     +          +N++L NN +      + G    ++ L ++ + +  +  A +
Sbjct: 108 NNNIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164

Query: 292 F-NISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLD 350
             +  TL+ L +  N  +  +   +      L+ L L  N  +  +     + + ++ + 
Sbjct: 165 AASSDTLEHLNLQYNF-IYDVKGQV--VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWIS 220

Query: 351 FGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPIN 410
              N     I       ++L+   L GN     T    F       +N  +  +++  + 
Sbjct: 221 LRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFS------KNQRVQTVAKQTVK 273

Query: 411 GILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTG----TIPVTL 466
             L                 +             +  L           G     +    
Sbjct: 274 K-LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECER 332

Query: 467 GRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLG 526
               + + +     +    I +          L      L  ++         L      
Sbjct: 333 ENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQ 392

Query: 527 SNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTI 586
           +     +  +T       L   +        +         + + D+  +  + +     
Sbjct: 393 AVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENA 452

Query: 587 GGLQGLQLLSLRYNRLQGPIPE 608
              +      L        + E
Sbjct: 453 RLKKLNGEADLALASANATLQE 474

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  161 bits (409), Expect = 2e-42
 Identities = 68/505 (13%), Positives = 152/505 (30%), Gaps = 31/505 (6%)

Query: 141 FVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPV 200
             +  R +   +  +S    +         ++ELDLS N LS  I ++            
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADL-----APFTK 59

Query: 201 LEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLI 260
           LE L +S N L   +   L     L  + L  N  Q     ++    S+  L   NN+ I
Sbjct: 60  LELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNN-I 111

Query: 261 GEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLP 320
             +       +  + + + ++ +  L        S ++ L +  N++     + +     
Sbjct: 112 SRVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169

Query: 321 NLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVL 380
            LE L L  N     +   +   ++L  LD   N  +  +   F +   +  +SL  N L
Sbjct: 170 TLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKL 226

Query: 381 TSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPK 440
                 L F  +L          L  N  +        + +  +++++ ++     G  +
Sbjct: 227 VLIEKALRFSQNLEH------FDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE 280

Query: 441 ELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGS----IPEDLCHLYRL 496
           E       T+   G             RL  L+         +GS    +  +  +  R 
Sbjct: 281 E--ECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQ 338

Query: 497 ANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNG 556
             +     +    +        +   L     AL   + +      ++      +     
Sbjct: 339 REIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIE 398

Query: 557 SLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSL 616
                     + +   +        +         ++   +  ++      E+    K  
Sbjct: 399 LQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLN 458

Query: 617 NFVDMSNNNLSGTIPKSMEALSYLK 641
              D++  + + T+ + +     L 
Sbjct: 459 GEADLALASANATLQELVVREQNLA 483

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  160 bits (407), Expect = 4e-42
 Identities = 63/370 (17%), Positives = 127/370 (34%), Gaps = 27/370 (7%)

Query: 287 IPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISEL 346
           I     N +  K   VTD+ L     +S+     N++ L L  N  S    + L   ++L
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSL-KQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 347 SVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSE 406
            +L+   N     +     +L +L+ L L  N          ++  L    ++E ++ + 
Sbjct: 61  ELLNLSSNVLYETLD--LESLSTLRTLDLNNN----------YVQELLVGPSIETLHAAN 108

Query: 407 NPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTG-TIPVT 465
           N I+ +   S G      K++ + +  I+     + G  + +  + L  NE+        
Sbjct: 109 NNISRV-SCSRGQ---GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164

Query: 466 LGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSL 525
                 L+ L LQ N +   +   +    +L  L L  NKL+  +     +   +  +SL
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISL 221

Query: 526 GSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVT 585
            +N L  I    L   +++  F+L  N  +   L D    K      ++   +  +    
Sbjct: 222 RNNKLVLI-EKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQN 279

Query: 586 IGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSG----TIPKSMEALSYLK 641
                   L        +         L +L   + +  +  G     +    E  +  +
Sbjct: 280 EEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQR 339

Query: 642 HLNLSFNQLE 651
            ++    Q  
Sbjct: 340 EIDALKEQYR 349

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  160 bits (407), Expect = 4e-42
 Identities = 58/418 (13%), Positives = 134/418 (32%), Gaps = 27/418 (6%)

Query: 238 GIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTL 297
            I     N    +   + ++SL   + +   +  N++ L +  + L+ +  A +   + L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 298 KELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFS 357
           + L ++ N L  +L       L  L  L L  N         L     +  L    N+ S
Sbjct: 61  ELLNLSSNVLYETLDLE---SLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112

Query: 358 GLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSI 417
            +  +     +++    LA N +T    DL           ++ + L  N I+ +  + +
Sbjct: 113 RVSCSRGQGKKNI---YLANNKITM-LRDLDE----GCRSRVQYLDLKLNEIDTVNFAEL 164

Query: 418 GNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYL 477
              S +++ L+++   I   +  ++     L  + L +N+L   +         +  + L
Sbjct: 165 AASSDTLEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISL 221

Query: 478 QNNKLEGSIPEDLCHLYRLANLYLGDNKLS-GRLPACLGNLTSLRDLSLGSNALTSIIPS 536
           +NNKL   I + L     L +  L  N    G L         ++ ++     +  +   
Sbjct: 222 RNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQ 278

Query: 537 TLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSG----VIPVTIGGLQGL 592
                      +  +        P    L  +   + +L +  G     +          
Sbjct: 279 NEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQ 338

Query: 593 QLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQL 650
           + +     + +  I +     ++   ++     L   +     A + L          
Sbjct: 339 REIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ 396

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  150 bits (381), Expect = 1e-38
 Identities = 62/499 (12%), Positives = 148/499 (29%), Gaps = 63/499 (12%)

Query: 161 IPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLW 220
           I E     +  +   ++D+ L     +S+      Q+   ++ L +S N L+     +L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLK-QALASLR-----QSAWNVKELDLSGNPLSQISAADLA 55

Query: 221 KCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQS 280
              +L +++L+ N        D+ +L+++R L L NN +      E+    ++E L   +
Sbjct: 56  PFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHA-A 107

Query: 281 SNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSL 340
           +N    +  S                                + ++L  N  +       
Sbjct: 108 NNNISRVSCSRG---------------------------QGKKNIYLANNKITMLRDLDE 140

Query: 341 TNISELSVLDFGFNSFSGL-IPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNL 399
              S +  LD   N    +       +  +L+ L+L  N +         +        L
Sbjct: 141 GCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-------VKGQVVFAKL 193

Query: 400 EIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELT 459
           + + LS N +  +      + +  +  +S+ +  +   I K L    NL    L  N   
Sbjct: 194 KTLDLSSNKLAFM-GPEFQSAA-GVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250

Query: 460 GTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTS 519
               +     +  +   +    ++    ++          + G              L +
Sbjct: 251 -CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIA 309

Query: 520 LRDLSLGSNALT----SIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSL 575
           L+       +        +     N       +         +       +  I ++   
Sbjct: 310 LKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKK 369

Query: 576 NALSGVIPVT---IGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPK 632
            AL   +         L G    ++    LQ    E    L+ L  +      +   + +
Sbjct: 370 KALDEQVSNGRRAHAELDGTLQQAVGQIELQHA-TEEQSPLQLLRAIVKRYEEMY--VEQ 426

Query: 633 SMEALSYLKHLNLSFNQLE 651
                + ++  ++  ++  
Sbjct: 427 QSVQNNAIRDWDMYQHKET 445

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  143 bits (361), Expect = 4e-36
 Identities = 62/490 (12%), Positives = 146/490 (29%), Gaps = 33/490 (6%)

Query: 74  RVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNF 133
           R     ++   L   +     +   +  L +  N        +L+    L+  +   N  
Sbjct: 11  RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70

Query: 134 HIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNIS 193
           + E      SL  L+ L L +N       + +     ++ L  ++N +S  +  S     
Sbjct: 71  Y-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSRG--- 119

Query: 194 SCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQG-GIPRDIGNLTSVRNL 252
                   + ++++ N++T     +      +  + L  N+           +  ++ +L
Sbjct: 120 -----QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174

Query: 253 FLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLP 312
            L  N +  ++  ++     L+ L + S+ LA  +     + + +  +++ +N  L  + 
Sbjct: 175 NLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNK-LVLIE 230

Query: 313 SSIDLGLPNLERLFLGENNFS-GTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLK 371
            ++     NLE   L  N F  GT+    +    +  +     +   L            
Sbjct: 231 KALR-FSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVA--KQTVKKLTGQNEEECTVPT 287

Query: 372 LLSLAGNVLTS-PTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSME 430
           L           P P    L +L    +  ++    +    +            + +   
Sbjct: 288 LGHYGAYCCEDLPAPFADRLIALKRKEH-ALLSGQGSETERLECERENQ--ARQREIDAL 344

Query: 431 SCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEG--SIPE 488
                  I +          +      L   +        +L G   Q           E
Sbjct: 345 KEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATE 404

Query: 489 DLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFN 548
           +   L  L  +     ++            ++RD  +  +  T +        K     +
Sbjct: 405 EQSPLQLLRAIVKRYEEMYVEQQ--SVQNNAIRDWDMYQHKETQLAEENARLKKLNGEAD 462

Query: 549 LSSNSLNGSL 558
           L+  S N +L
Sbjct: 463 LALASANATL 472

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  125 bits (316), Expect = 2e-30
 Identities = 41/216 (18%), Positives = 86/216 (39%), Gaps = 13/216 (6%)

Query: 437 GIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRL 496
            I +   N N   + ++ ++ L   +         ++ L L  N L      DL    +L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 497 ANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNG 556
             L L  N L       L +L++LR L L +N +  +      +++ +   + ++N+++ 
Sbjct: 61  ELLNLSSNVLYE-TLD-LESLSTLRTLDLNNNYVQEL--LVGPSIETL---HAANNNISR 113

Query: 557 SLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQG-PIPESFGGLKS 615
                    K    + L+ N ++ +  +  G    +Q L L+ N +      E      +
Sbjct: 114 VSCSRGQGKK---NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 616 LNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLE 651
           L  +++  N +   +   +   + LK L+LS N+L 
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA 204

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  160 bits (406), Expect = 9e-43
 Identities = 75/440 (17%), Positives = 147/440 (33%), Gaps = 74/440 (16%)

Query: 239 IPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLK 298
           I  ++       ++ +   +       E   L N +++  ++S +  L  A + +   ++
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72

Query: 299 ELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSG 358
            L + D   +  + +        +++L++G N      P    N+  L+VL    N  S 
Sbjct: 73  LLNLNDL-QIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131

Query: 359 LIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIG 418
           L    F N   L  LS++ N L     D        +  +L+ + LS N +  +      
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLERIEDDT-----FQATTSLQNLQLSSNRLTHV------ 180

Query: 419 NFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQ 478
                                 +L  I +L    +  N L+     TL     ++ L   
Sbjct: 181 ----------------------DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDAS 213

Query: 479 NNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTL 538
           +N +   +   +     L  L L  N L+      L N   L ++ L  N L  I+    
Sbjct: 214 HNSIN-VVRGPV--NVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPF 268

Query: 539 WNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLR 598
             ++ + R  +S+N L                           + +    +  L++L L 
Sbjct: 269 VKMQRLERLYISNNRLV-------------------------ALNLYGQPIPTLKVLDLS 303

Query: 599 YNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRG 658
           +N L   +  +      L  + + +N++  T+  S      LK+L LS N  +     R 
Sbjct: 304 HNHLLH-VERNQPQFDRLENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDWD-CNSLRA 358

Query: 659 PFITFSAESFLGNQALCGSP 678
            F   +  +       C   
Sbjct: 359 LFRNVARPAVDDADQHCKID 378

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  148 bits (375), Expect = 9e-39
 Identities = 74/423 (17%), Positives = 143/423 (33%), Gaps = 65/423 (15%)

Query: 137 IPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQ 196
           I S          + +   +           L+  + +   ++ +   +P+++       
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALL-----D 66

Query: 197 NLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDI-GNLTSVRNLFLG 255
           +   +E L ++  Q+             +  + + FN  +  +P  +  N+  +  L L 
Sbjct: 67  SFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLE 125

Query: 256 NNSLIGEIPNEI-GNLRNLEVLGVQSSNLAGLIPASIF-NISTLKELAVTDNDLLGSLPS 313
            N  +  +P  I  N   L  L + S+N    I    F   ++L+ L ++ N L     +
Sbjct: 126 RND-LSSLPRGIFHNTPKLTTLSM-SNNNLERIEDDTFQATTSLQNLQLSSNRL-----T 178

Query: 314 SIDLG-LPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKL 372
            +DL  +P+L    +  N       S+L     +  LD   NS + +       L     
Sbjct: 179 HVDLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINVVRGPVNVELTI--- 230

Query: 373 LSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESC 432
           L L  N LT         + L +   L  + LS N +  I+                   
Sbjct: 231 LKLQHNNLTD-------TAWLLNYPGLVEVDLSYNELEKIMYHP---------------- 267

Query: 433 NISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCH 492
                       +  L  + + NN L   + +    +  L+ L L +N L   +  +   
Sbjct: 268 ---------FVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 316

Query: 493 LYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSN 552
             RL NLYL  N +   L   L    +L++L+L  N         L   +++ R  +   
Sbjct: 317 FDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDA 371

Query: 553 SLN 555
             +
Sbjct: 372 DQH 374

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  130 bits (329), Expect = 9e-33
 Identities = 64/320 (20%), Positives = 118/320 (36%), Gaps = 33/320 (10%)

Query: 353 FNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGI 412
           +N           +             +   T D+ F     +  N +I+    + +  +
Sbjct: 1   YNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKL 60

Query: 413 LPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKL 472
             + + +F   ++ L++    I           + +  + +G N +    P     +  L
Sbjct: 61  PAALLDSFR-QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLL 119

Query: 473 QGLYLQNNKLEGSIPEDL-CHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALT 531
             L L+ N L  S+P  +  +  +L  L + +N L           TSL++L L SN LT
Sbjct: 120 TVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 178

Query: 532 SIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGV---------- 581
            +  S + +L      N+S N L  S L     ++   E+D S N+++ V          
Sbjct: 179 HVDLSLIPSLFHA---NVSYNLL--STLAIPIAVE---ELDASHNSINVVRGPVNVELTI 230

Query: 582 ----------IPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIP 631
                         +    GL  + L YN L+  +   F  ++ L  + +SNN L   + 
Sbjct: 231 LKLQHNNLTDTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALN 288

Query: 632 KSMEALSYLKHLNLSFNQLE 651
              + +  LK L+LS N L 
Sbjct: 289 LYGQPIPTLKVLDLSHNHLL 308

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 73.9 bits (182), Expect = 5e-14
 Identities = 36/187 (19%), Positives = 70/187 (37%), Gaps = 21/187 (11%)

Query: 73  RRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNN 132
             +   N+SY  L+      L     +  L   +NS    +   +     L     + NN
Sbjct: 186 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSI-NVVRGPV--NVELTILKLQHNN 237

Query: 133 FHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNI 192
             +   +W ++ P L  + L +N     +      +  L+ L +S+N+L   +       
Sbjct: 238 --LTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYG--- 291

Query: 193 SSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNL 252
              Q +P L+ L +S+N L   +  N  +   L  + L  N     +   +    +++NL
Sbjct: 292 ---QPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNL 344

Query: 253 FLGNNSL 259
            L +N  
Sbjct: 345 TLSHNDW 351

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  155 bits (393), Expect = 2e-40
 Identities = 76/347 (21%), Positives = 132/347 (38%), Gaps = 41/347 (11%)

Query: 308 LGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNL 367
             ++P  I         L LG+N           +   L  L+   N  S + P  F NL
Sbjct: 23  FVAVPEGIP---TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNL 79

Query: 368 RSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSL 427
            +L+ L L  N L      +      T   NL  + +SEN I  +L              
Sbjct: 80  FNLRTLGLRSNRLKLIPLGV-----FTGLSNLTKLDISENKIVILLDYM----------- 123

Query: 428 SMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIP 487
                           ++ NL  + +G+N+L          L  L+ L L+   L  SIP
Sbjct: 124 --------------FQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIP 168

Query: 488 ED-LCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILR 546
            + L HL+ L  L L    ++         L  L+ L +        +        ++  
Sbjct: 169 TEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTS 228

Query: 547 FNLSSNSLNGSLLPD--IGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQG 604
            +++  +L  + +P   + +L  +  ++LS N +S +    +  L  LQ + L   +L  
Sbjct: 229 LSITHCNL--TAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAV 286

Query: 605 PIPESFGGLKSLNFVDMSNNNLSGTIPKSM-EALSYLKHLNLSFNQL 650
             P +F GL  L  +++S N L+ T+ +S+  ++  L+ L L  N L
Sbjct: 287 VEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  147 bits (373), Expect = 8e-38
 Identities = 63/318 (19%), Positives = 114/318 (35%), Gaps = 34/318 (10%)

Query: 335 TIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLT 394
            +P  +   +E  +LD G N    L    F +   L+ L L  N++++  P      +  
Sbjct: 25  AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPG-----AFN 77

Query: 395 SCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLG 454
           +  NL  + L  N +  I                                ++NLT + + 
Sbjct: 78  NLFNLRTLGLRSNRLKLIPLGV-------------------------FTGLSNLTKLDIS 112

Query: 455 NNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPED-LCHLYRLANLYLGDNKLSGRLPAC 513
            N++   +      L  L+ L + +N L   I       L  L  L L    L+      
Sbjct: 113 ENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEA 171

Query: 514 LGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDL 573
           L +L  L  L L    + +I   +   L  +    +S      ++ P+      +  + +
Sbjct: 172 LSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSI 231

Query: 574 SLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKS 633
           +   L+ V  + +  L  L+ L+L YN +          L  L  + +    L+   P +
Sbjct: 232 THCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYA 291

Query: 634 MEALSYLKHLNLSFNQLE 651
              L+YL+ LN+S NQL 
Sbjct: 292 FRGLNYLRVLNVSGNQLT 309

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  145 bits (368), Expect = 4e-37
 Identities = 78/318 (24%), Positives = 130/318 (40%), Gaps = 11/318 (3%)

Query: 239 IPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLK 298
           +P  I   T  R L LG N +     +E  +  +LE L +  + ++ + P +  N+  L+
Sbjct: 26  VPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLR 83

Query: 299 ELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSG 358
            L +  N  L  +P  +  GL NL +L + EN     +     ++  L  L+ G N    
Sbjct: 84  TLGLRSN-RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVY 142

Query: 359 LIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIG 418
           +    F  L SL+ L+L    LTS   +     +L+    L ++ L    IN I   S  
Sbjct: 143 ISHRAFSGLNSLEQLTLEKCNLTSIPTE-----ALSHLHGLIVLRLRHLNINAIRDYSFK 197

Query: 419 NFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQ 478
                +K L +        +        NLT + + +  LT    + +  L  L+ L L 
Sbjct: 198 RLY-RLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLS 256

Query: 479 NNKLEGSIPED-LCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPST 537
            N +  +I    L  L RL  + L   +L+   P     L  LR L++  N LT++  S 
Sbjct: 257 YNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESV 315

Query: 538 LWNLKDILRFNLSSNSLN 555
             ++ ++    L SN L 
Sbjct: 316 FHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  145 bits (368), Expect = 4e-37
 Identities = 71/345 (20%), Positives = 125/345 (36%), Gaps = 20/345 (5%)

Query: 67  TCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYF 126
            C  ++R V             +P  +   +   +L +  N       +E +    L+  
Sbjct: 8   ECSAQDRAV---LCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEEL 61

Query: 127 DFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIP 186
           +   N      P  F +L  L+ L L+ N            LS L +LD+S+N++   + 
Sbjct: 62  ELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILL 120

Query: 187 SSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNL 246
             +F     Q+L  L+ L +  N L             L  ++L            + +L
Sbjct: 121 DYMF-----QDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHL 175

Query: 247 TSVRNLFLGNNSLIGEIPNEI-GNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDN 305
             +  L L + + I  I +     L  L+VL +        +  +      L  L++T  
Sbjct: 176 HGLIVLRLRHLN-INAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHC 234

Query: 306 DLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFG 365
           +L  ++P      L  L  L L  N  S    S L  +  L  +       + + P  F 
Sbjct: 235 NL-TAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFR 293

Query: 366 NLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPIN 410
            L  L++L+++GN LT+    +       S  NLE + L  NP+ 
Sbjct: 294 GLNYLRVLNVSGNQLTTLEESV-----FHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  104 bits (261), Expect = 2e-23
 Identities = 44/208 (21%), Positives = 81/208 (38%), Gaps = 5/208 (2%)

Query: 449 TVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSG 508
             +          +P  +    + + L L  N+++    ++      L  L L +N +S 
Sbjct: 14  RAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA 70

Query: 509 RLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDI-GNLKV 567
             P    NL +LR L L SN L  I       L ++ + ++S N +   LL  +  +L  
Sbjct: 71  VEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYN 129

Query: 568 VIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLS 627
           +  +++  N L  +      GL  L+ L+L    L     E+   L  L  + + + N++
Sbjct: 130 LKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN 189

Query: 628 GTIPKSMEALSYLKHLNLSFNQLEGEIP 655
                S + L  LK L +S       + 
Sbjct: 190 AIRDYSFKRLYRLKVLEISHWPYLDTMT 217

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  155 bits (394), Expect = 1e-39
 Identities = 72/443 (16%), Positives = 147/443 (33%), Gaps = 50/443 (11%)

Query: 260 IGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGL 319
              I + +        + +               ++  K +   ++ +   LP+++    
Sbjct: 16  YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAALLDSF 74

Query: 320 PNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNV 379
             +E L L +         +      +  L  GFN+   L P  F N+  L +L L  N 
Sbjct: 75  RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 134

Query: 380 LTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIP 439
           L+S    +       +   L  + +S N +  I   +    + S+++L + S  ++  + 
Sbjct: 135 LSSLPRGI-----FHNTPKLTTLSMSNNNLERIEDDTFQATT-SLQNLQLSSNRLT-HVD 187

Query: 440 KELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANL 499
             L  I +L    +  N L+     TL     ++ L   +N +   +   +     L  L
Sbjct: 188 --LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVN--VELTIL 237

Query: 500 YLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLL 559
            L  N L+      L N   L ++ L  N L  I+      ++ + R  +S+N L     
Sbjct: 238 KLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV---- 291

Query: 560 PDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFV 619
                                 + +    +  L++L L +N L   +  +      L  +
Sbjct: 292 ---------------------ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENL 329

Query: 620 DMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSPK 679
            + +N++  T+  S      LK+L LS N  +     R  F   +  +       C    
Sbjct: 330 YLDHNSIV-TLKLS--THHTLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHCKIDY 385

Query: 680 LQVSPCKTRSHPRSRTTVVLLIV 702
                   +   +     +L  +
Sbjct: 386 QLEHGLCCKESDKPYLDRLLQYI 408

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  149 bits (377), Expect = 1e-37
 Identities = 85/517 (16%), Positives = 169/517 (32%), Gaps = 48/517 (9%)

Query: 134 HIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNIS 193
           +  I S          + +   +           L+  + +   ++ +   +P+++    
Sbjct: 16  YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALL--- 71

Query: 194 SCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDI-GNLTSVRNL 252
              +   +E L ++  Q+             +  + + FN  +  +P  +  N+  +  L
Sbjct: 72  --DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVL 128

Query: 253 FLGNNSLIGEIPNEI-GNLRNLEVLGVQSSNLAGLIPASIF-NISTLKELAVTDNDLLGS 310
            L  N  +  +P  I  N   L  L + S+N    I    F   ++L+ L ++ N L   
Sbjct: 129 VLERND-LSSLPRGIFHNTPKLTTLSM-SNNNLERIEDDTFQATTSLQNLQLSSNRL--- 183

Query: 311 LPSSIDLG-LPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRS 369
             + +DL  +P+L    +  N       S+L     +  LD   NS + +       L  
Sbjct: 184 --THVDLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINVVRGPVNVELTI 236

Query: 370 LKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSM 429
              L L  N LT         + L +   L  + LS N +  I+          ++ L +
Sbjct: 237 ---LKLQHNNLTD-------TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ-RLERLYI 285

Query: 430 ESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPED 489
            +  +   +      I  L V+ L +N L   +     +  +L+ LYL +N +  ++   
Sbjct: 286 SNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLS 342

Query: 490 LCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNL 549
               + L NL L  N        C       R+++  +           + L+  L    
Sbjct: 343 --THHTLKNLTLSHNDWD-----CNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKE 395

Query: 550 SSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPES 609
           S       LL  I    VV ++  +    S    +         +       LQG     
Sbjct: 396 SDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQ-- 453

Query: 610 FGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLS 646
                 +N +      L+    +  + L  L     +
Sbjct: 454 --LEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDT 488

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  133 bits (336), Expect = 2e-32
 Identities = 102/580 (17%), Positives = 184/580 (31%), Gaps = 93/580 (16%)

Query: 78  LNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEE-LSHLRGLKYFDFRFNNFHIE 136
           ++I           +   L+   ++  +N++    LP   L   R ++  +         
Sbjct: 32  VHIDMQTQDVYFGFEDITLNNQKIVTFKNST-MRKLPAALLDSFRQVELLNLNDLQIEEI 90

Query: 137 IPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQ 196
               F     +Q L +  N+     P     + LL  L L  N LS ++P  IF      
Sbjct: 91  DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIF-----H 144

Query: 197 NLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGN 256
           N P L  L +S N L                  +  + FQ          TS++NL L +
Sbjct: 145 NTPKLTTLSMSNNNLE----------------RIEDDTFQA--------TTSLQNLQLSS 180

Query: 257 NSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSID 316
           N  +  +   +  + +L    V S NL   +   I     ++EL  + N  +  +   + 
Sbjct: 181 NR-LTHVD--LSLIPSLFHANV-SYNLLSTLAIPIA----VEELDASHNS-INVVRGPV- 230

Query: 317 LGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLA 376
                L  L L  NN   T  + L N   L  +D  +N    ++   F  ++ L+ L ++
Sbjct: 231 --NVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS 286

Query: 377 GNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISG 436
            N L +       +        L+++ LS N +                           
Sbjct: 287 NNRLVALNLYGQPIP------TLKVLDLSHNHLL-------------------------- 314

Query: 437 GIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRL 496
            + +     + L  + L +N +  T+   L     L+ L L +N  + +    L     +
Sbjct: 315 HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNV 369

Query: 497 ANLYLGDNKLSGRLP-------ACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNL 549
           A   + D     ++         C  +     D  L   ALTS++             + 
Sbjct: 370 ARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATD- 428

Query: 550 SSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPES 609
           + NS+            V ++ +  L A    +   +  L   Q+       LQG   E 
Sbjct: 429 TINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQE--QLLQGLHAEI 486

Query: 610 FGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQ 649
              L+            S  + K    L   +   L   Q
Sbjct: 487 DTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQ 526

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 75.3 bits (185), Expect = 5e-14
 Identities = 63/438 (14%), Positives = 136/438 (31%), Gaps = 63/438 (14%)

Query: 73  RRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNN 132
             +   N+SY  L+      L     +  L   +NS    +   +     L     + NN
Sbjct: 192 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSI-NVVRGPV--NVELTILKLQHNN 243

Query: 133 FHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNI 192
             +   +W ++ P L  + L +N     +      +  L+ L +S+N+L   +       
Sbjct: 244 --LTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYG--- 297

Query: 193 SSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNL 252
              Q +P L+ L +S+N L                           + R+      + NL
Sbjct: 298 ---QPIPTLKVLDLSHNHLL-------------------------HVERNQPQFDRLENL 329

Query: 253 FLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLP 312
           +L +NS I  +   +     L+ L +  ++       ++F    +   AV D D    + 
Sbjct: 330 YLDHNS-IVTLK--LSTHHTLKNLTLSHNDWDCNSLRALF--RNVARPAVDDADQHCKID 384

Query: 313 SSIDLGL-------PNLERL--FLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTT 363
             ++ GL       P L+RL  ++   +    +  +    S    ++   +    +    
Sbjct: 385 YQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQG 444

Query: 364 FGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSIS 423
              L+  + L    N L +    L+    +   + L+ ++   +                
Sbjct: 445 GVPLQGNEQLEAEVNELRAEVQQLTN-EQIQQEQLLQGLHAEIDTNL----RRYRLPKDG 499

Query: 424 MKSLSMESCNISGGIPKELGNINNLTVIRLGN--NELTGTIPVTLGRLQKLQGLYLQNNK 481
           +   S     +   + +        T  R      +   T  +    +   + L  +  K
Sbjct: 500 LARSSDNLNKVFTHLKERQAFKLRETQARRTEADAKQKETEDLEQENIALEKQLDNKRAK 559

Query: 482 LEGSIPEDLCHLYRLANL 499
                 E      ++  L
Sbjct: 560 QAELRQETSLKRQKVKQL 577

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  142 bits (359), Expect = 3e-37
 Identities = 60/342 (17%), Positives = 120/342 (35%), Gaps = 28/342 (8%)

Query: 287 IPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISEL 346
           I     N +  K   VTD+ L     +S+     N++ L L  N  S    + L   ++L
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSL-KQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 347 SVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSE 406
            +L+   N     +     +L +L+ L L  N          ++  L    ++E ++ + 
Sbjct: 61  ELLNLSSNVLYETLD--LESLSTLRTLDLNNN----------YVQELLVGPSIETLHAAN 108

Query: 407 NPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTG-TIPVT 465
           N I+ +   S G      K++ + +  I+     + G  + +  + L  NE+        
Sbjct: 109 NNISRV-SCSRGQ---GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164

Query: 466 LGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSL 525
                 L+ L LQ N +   +   +    +L  L L  NKL+  +     +   +  +SL
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISL 221

Query: 526 GSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVT 585
            +N L   I   L   +++  F+L  N  +   L D    K      ++   +  +    
Sbjct: 222 RNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQN 279

Query: 586 IGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLS 627
                   L        +   P  F        + + +++  
Sbjct: 280 EEECTVPTLGHYGAYCCEDL-PAPFA----DRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  138 bits (351), Expect = 2e-36
 Identities = 55/328 (16%), Positives = 109/328 (33%), Gaps = 46/328 (14%)

Query: 360 IPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGN 419
           I     N    K+  +  + L      L       S  N++ + LS NP++ I  + +  
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASL-----RQSAWNVKELDLSGNPLSQISAADLAP 56

Query: 420 FSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQN 479
           F+                          L ++ L +N L       L  L  L+ L L N
Sbjct: 57  FT-------------------------KLELLNLSSNVLY-ETL-DLESLSTLRTLDLNN 89

Query: 480 NKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLW 539
           N ++     +L     +  L+  +N +S R+          +++ L +N +T +      
Sbjct: 90  NYVQ-----ELLVGPSIETLHAANNNIS-RVSC--SRGQGKKNIYLANNKITMLRDLDEG 141

Query: 540 NLKDILRFNLSSNSLNGSLLPD-IGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLR 598
               +   +L  N ++     +   +   +  ++L  N +   +   +     L+ L L 
Sbjct: 142 CRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLS 199

Query: 599 YNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRG 658
            N+L   +   F     + ++ + NN L   I K++     L+H +L  N        R 
Sbjct: 200 SNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRD 256

Query: 659 PFITFSAESFLGNQALCGSPKLQVSPCK 686
            F        +  Q +          C 
Sbjct: 257 FFSKNQRVQTVAKQTVKKLTGQNEEECT 284

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  133 bits (336), Expect = 3e-34
 Identities = 43/302 (14%), Positives = 99/302 (32%), Gaps = 28/302 (9%)

Query: 112 SLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLL 171
           ++ E   +    K      ++    + S   S   ++ L L  N         +   + L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 172 QELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLA 231
           + L+LS N L              ++L  L  L ++ N +       L     +  +  A
Sbjct: 61  ELLNLSSNVLY--------ETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAA 107

Query: 232 FNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGL-IPAS 290
            N     +          +N++L NN +      + G    ++ L ++ + +  +     
Sbjct: 108 NNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164

Query: 291 IFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLD 350
             +  TL+ L +  N +   +   +      L+ L L  N  +  +     + + ++ + 
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQV--VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWIS 220

Query: 351 FGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPIN 410
              N     I       ++L+   L GN     T    F       +N  +  +++  + 
Sbjct: 221 LRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFS------KNQRVQTVAKQTVK 273

Query: 411 GI 412
            +
Sbjct: 274 KL 275

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  127 bits (320), Expect = 3e-32
 Identities = 42/217 (19%), Positives = 88/217 (40%), Gaps = 15/217 (6%)

Query: 437 GIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRL 496
            I +   N N   + ++ ++ L   +         ++ L L  N L      DL    +L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 497 ANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNG 556
             L L  N L       L +L++LR L L +N +  +      +++ +   + ++N+++ 
Sbjct: 61  ELLNLSSNVLYE-TLD-LESLSTLRTLDLNNNYVQEL--LVGPSIETL---HAANNNIS- 112

Query: 557 SLLPDIG-NLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQG-PIPESFGGLK 614
            +    G   K    + L+ N ++ +  +  G    +Q L L+ N +      E      
Sbjct: 113 RVSCSRGQGKK---NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169

Query: 615 SLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLE 651
           +L  +++  N +   +   +   + LK L+LS N+L 
Sbjct: 170 TLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA 204

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  118 bits (299), Expect = 2e-29
 Identities = 51/315 (16%), Positives = 105/315 (33%), Gaps = 23/315 (7%)

Query: 95  NLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKH 154
           N +   +  + ++S   +L         +K  D   N       +      +L+ L L  
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67

Query: 155 NSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGP 214
           N    +  + +  LS L+ LDL++N +   +             P +E L  + N ++  
Sbjct: 68  NVLY-ETLD-LESLSTLRTLDLNNNYVQ-ELL----------VGPSIETLHAANNNISR- 113

Query: 215 IPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIG-EIPNEIGNLRNL 273
           +  +    +    + LA NK       D G  + V+ L L  N +          +   L
Sbjct: 114 VSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171

Query: 274 EVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFS 333
           E L +Q + +   +   +   + LK L ++ N L   +          +  + L  N   
Sbjct: 172 EHLNLQYNFIYD-VKGQVV-FAKLKTLDLSSNKLA-FMGPEFQ-SAAGVTWISLRNNKLV 227

Query: 334 GTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSL 393
             I  +L     L   D   N F           ++ ++ ++A   +   T       ++
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285

Query: 394 TSCRNLEIIYLSENP 408
            +  +       + P
Sbjct: 286 PTLGHYGAYCCEDLP 300

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  114 bits (288), Expect = 7e-28
 Identities = 43/313 (13%), Positives = 103/313 (32%), Gaps = 25/313 (7%)

Query: 73  RRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNN 132
            R     ++   L   +     +   +  L +  N        +L+    L+  +   N 
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 133 FHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNI 192
            + E      SL  L+ L L +N       + +     ++ L  ++N +S  +  S    
Sbjct: 70  LY-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSRG-- 119

Query: 193 SSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQG-GIPRDIGNLTSVRN 251
              Q     + ++++ N++T     +      +  + L  N+           +  ++ +
Sbjct: 120 ---QG---KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEH 173

Query: 252 LFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSL 311
           L L  N +  ++  ++     L+ L + S+ LA  +     + + +  +++ +N  L  +
Sbjct: 174 LNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNK-LVLI 229

Query: 312 PSSIDLGLPNLERLFLGENNFS-GTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSL 370
             ++     NLE   L  N F  GT+    +    +  +     +   L           
Sbjct: 230 EKALR-FSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVA--KQTVKKLTGQNEEECTVP 286

Query: 371 KLLSLAGNVLTSP 383
            L           
Sbjct: 287 TLGHYGAYCCEDL 299

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  142 bits (361), Expect = 5e-37
 Identities = 69/279 (24%), Positives = 117/279 (41%), Gaps = 28/279 (10%)

Query: 767  KLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIIS 824
            + +G G+FG V+ G L  D   +A K             F  E +++    H N+V++I 
Sbjct: 120  EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179

Query: 825  SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
             C+      +V+E +  G     L ++   L +   L+++ D A+ +EYL    S   +H
Sbjct: 180  VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIH 236

Query: 885  CDIKPSNVLLNESMVGHLSDFGIAKILGKEE-SMRQTKTLGTIGYMAPEYGREGKVSRKC 943
             D+   N L+ E  V  +SDFG+++       +         + + APE    G+ S + 
Sbjct: 237  RDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSES 296

Query: 944  DVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFS 1002
            DV+S+GI+L ETF+    P    +   +S ++             V     L C E    
Sbjct: 297  DVWSFGILLWETFSLGASP----YPN-LSNQQ-T--------REFVEKGGRLPCPEL--- 339

Query: 1003 AREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041
                C  ++F L   C    P +R S   +   L  IR+
Sbjct: 340  ----CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  139 bits (353), Expect = 8e-37
 Identities = 60/252 (23%), Positives = 104/252 (41%), Gaps = 21/252 (8%)

Query: 766  NKLLGMGSFGSVYKGV-LPDGMEIAAKVFHME--FDGSLESFHAECKVMGSIRHRNLVKI 822
            +  +G GSF +VYKG+     +E+A              + F  E +++  ++H N+V+ 
Sbjct: 31   DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 823  ISSCSNNDFKA----LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
              S  +         LV E M++G+L K        + I         +   L++LH   
Sbjct: 91   YDSWESTVKGKKCIVLVTELMTSGTL-KTYLKRFKVMKIKVLRSWCRQILKGLQFLH-TR 148

Query: 879  STPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
            + PI+H D+K  N+ +     G   + D G+A +     S  +   +GT  +MAPE   E
Sbjct: 149  TPPIIHRDLKCDNIFIT-GPTGSVKIGDLGLATLK--RASFAKA-VIGTPEFMAPEMYEE 204

Query: 937  GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN---- 992
                   DVY++G+ ++E  T + P  E       + R V   +   S  +VA       
Sbjct: 205  K-YDESVDVYAFGMCMLEMATSEYPYSE-CQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 262

Query: 993  LLNCEENDFSAR 1004
            +  C   +   R
Sbjct: 263  IEGCIRQNKDER 274

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  138 bits (349), Expect = 1e-36
 Identities = 64/280 (22%), Positives = 116/280 (41%), Gaps = 32/280 (11%)

Query: 767  KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
            + +G G FG V+ G   +  ++A K    E   S E F  E +VM  + H  LV++   C
Sbjct: 14   QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 827  SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL---HFGYSTPIV 883
                   LV E+M +G L   L +          L + +DV   + YL           +
Sbjct: 73   LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV------I 126

Query: 884  HCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKC 943
            H D+   N L+ E+ V  +SDFG+ + +  ++    T T   + + +PE     + S K 
Sbjct: 127  HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186

Query: 944  DVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFS 1002
            DV+S+G+++ E F++ K P +     E+              + +++    L        
Sbjct: 187  DVWSFGVLMWEVFSEGKIPYENRSNSEV--------------VEDISTGFRLYKPRL--- 229

Query: 1003 AREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042
                  + ++ +   C  + PE R +   +  +L  I E+
Sbjct: 230  ----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  142 bits (359), Expect = 3e-36
 Identities = 61/193 (31%), Positives = 97/193 (50%), Gaps = 6/193 (3%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
             LG G FG V+ G       +A K        S E+F  E +VM  +RH  LV++ +  
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 827 SNNDFKALVLEYMSNGSLEKCLYS-DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
           S      +V EYMS GSL   L      +L + Q + +   +AS + Y+        VH 
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304

Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L+ E++V  ++DFG+A+++   E   +      I + APE    G+ + K DV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364

Query: 946 YSYGIMLMETFTK 958
           +S+GI+L E  TK
Sbjct: 365 WSFGILLTELTTK 377

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  142 bits (359), Expect = 4e-36
 Identities = 54/193 (27%), Positives = 97/193 (50%), Gaps = 6/193 (3%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
           K LG G FG V+        ++A K        S+E+F AE  VM +++H  LVK+ +  
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 827 SNNDFKALVLEYMSNGSLEKCLYS-DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
           +      ++ E+M+ GSL   L S +     + + +     +A  + ++        +H 
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 308

Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L++ S+V  ++DFG+A+++   E   +      I + APE    G  + K DV
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 368

Query: 946 YSYGIMLMETFTK 958
           +S+GI+LME  T 
Sbjct: 369 WSFGILLMEIVTY 381

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  137 bits (347), Expect = 6e-36
 Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 12/202 (5%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISS 825
            +LG G++G VY G  L + + IA K          +  H E  +   ++H+N+V+ + S
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL--KIMIDVASALEYLHFGYSTPIV 883
            S N F  + +E +  GSL   L S    L   ++        +   L+YLH      IV
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIV 144

Query: 884 HCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMAPE--YGREGKV 939
           H DIK  NVL+N    G   +SDFG +K L       +T T GT+ YMAPE         
Sbjct: 145 HRDIKGDNVLINTYS-GVLKISDFGTSKRLAGINPCTETFT-GTLQYMAPEIIDKGPRGY 202

Query: 940 SRKCDVYSYGIMLMETFTKKKP 961
            +  D++S G  ++E  T K P
Sbjct: 203 GKAADIWSLGCTIIEMATGKPP 224

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  136 bits (345), Expect = 7e-36
 Identities = 60/199 (30%), Positives = 93/199 (46%), Gaps = 11/199 (5%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
           K LG G FG V  G      ++A K+   E   S + F  E + M  + H  LVK    C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL---HFGYSTPIV 883
           S      +V EY+SNG L   L S    L+  Q L++  DV   + +L    F      +
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF------I 126

Query: 884 HCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKC 943
           H D+   N L++  +   +SDFG+ + +  ++ +    T   + + APE     K S K 
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186

Query: 944 DVYSYGIMLMETFTK-KKP 961
           DV+++GI++ E F+  K P
Sbjct: 187 DVWAFGILMWEVFSLGKMP 205

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  136 bits (345), Expect = 1e-35
 Identities = 73/293 (24%), Positives = 128/293 (43%), Gaps = 27/293 (9%)

Query: 767  KLLGMGSFGSVYKGV---LPDGMEI--AAKVFHMEFDGSLESFHAECKVMGSIRHRNLVK 821
            + LG G+FGSV       L D      A K      +  L  F  E +++ S++H N+VK
Sbjct: 16   QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 822  IISSCSNNDFKA--LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
                C +   +   L++EY+  GSL   L      +D ++ L+    +   +EYL    +
Sbjct: 76   YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---T 132

Query: 880  TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREG 937
               +H D+   N+L+       + DFG+ K+L +++   + K  G   I + APE   E 
Sbjct: 133  KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192

Query: 938  KVSRKCDVYSYGIMLMETFT---KKKPTDEIFAGEMSLKRWVGDSLLSCS--ITEVADAN 992
            K S   DV+S+G++L E FT   K K     F   +   +      +     I  + +  
Sbjct: 193  KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ---MIVFHLIELLKNNG 249

Query: 993  LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSA 1045
             L   +        C   I+ +  +C  +   +R S +D+A R+ +IR+ ++ 
Sbjct: 250  RLPRPDG-------CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 295

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  143 bits (362), Expect = 1e-35
 Identities = 77/399 (19%), Positives = 128/399 (32%), Gaps = 84/399 (21%)

Query: 167 YLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELH 226
             +    L++ ++ L+ T+P  +           +  L I  N LT              
Sbjct: 38  LNNGNAVLNVGESGLT-TLPDCLPAH--------ITTLVIPDNNLTS------------- 75

Query: 227 VVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGL 286
                       +P     L   R L +  N L   +P     L  L +     ++L  L
Sbjct: 76  ------------LPALPPEL---RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPAL 119

Query: 287 IPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISEL 346
                     L +L +  N L  SLP       P L+ L + +N  + ++P+  + + +L
Sbjct: 120 PSG-------LCKLWIFGNQL-TSLPVLP----PGLQELSVSDNQLA-SLPALPSELCKL 166

Query: 347 SVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSE 406
              +   N  + L P     L+ L   S++ N L S     S          L  ++   
Sbjct: 167 WAYN---NQLTSL-PMLPSGLQEL---SVSDNQLASLPTLPS---------ELYKLWAYN 210

Query: 407 NPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTL 466
           N +   LP+        +K L +    ++  +P        L  + +  N LT ++P+  
Sbjct: 211 NRLTS-LPALPSG----LKELIVSGNRLTS-LPVLPSE---LKELMVSGNRLT-SLPMLP 260

Query: 467 GRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLG 526
             L  L    +  N+L   +PE L HL     + L  N LS R    L  +TS    S  
Sbjct: 261 SGLLSL---SVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGP 316

Query: 527 SNALTSIIPSTL---WNLKDILRFNLSSNSLNGSLLPDI 562
                    S       L       L           D 
Sbjct: 317 IIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADR 355

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  141 bits (356), Expect = 7e-35
 Identities = 73/366 (19%), Positives = 133/366 (36%), Gaps = 54/366 (14%)

Query: 295 STLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFN 354
           +    L V ++ L  +LP  +     ++  L + +NN + ++P+       L  L+   N
Sbjct: 40  NGNAVLNVGESGL-TTLPDCL---PAHITTLVIPDNNLT-SLPALPPE---LRTLEVSGN 91

Query: 355 SFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILP 414
             + L P     L  L + S     L                  L  +++  N +   LP
Sbjct: 92  QLTSL-PVLPPGLLELSIFSNPLTHLP------------ALPSGLCKLWIFGNQLTS-LP 137

Query: 415 SSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQG 474
                    ++ LS+    ++  +P     +  L      NN+LT ++P+    LQ+L  
Sbjct: 138 VLPPG----LQELSVSDNQLAS-LPALPSELCKLW---AYNNQLT-SLPMLPSGLQEL-- 186

Query: 475 LYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSII 534
             + +N+L  S+P     L     L+  +N+L+  LPA    L  L    +  N LTS+ 
Sbjct: 187 -SVSDNQLA-SLPTLPSEL---YKLWAYNNRLT-SLPALPSGLKEL---IVSGNRLTSL- 236

Query: 535 PSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQL 594
           P     LK++    +S N L  SL      L     + +  N L+  +P ++  L     
Sbjct: 237 PVLPSELKEL---MVSGNRLT-SLPMLPSGLL---SLSVYRNQLT-RLPESLIHLSSETT 288

Query: 595 LSLRYNRLQGPIPESFGGLKSLNFVDM---SNNNLSGTIPKSMEALSYLKHLNLSFNQLE 651
           ++L  N L     ++   + S           +    + P+   AL       L   +  
Sbjct: 289 VNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREG 348

Query: 652 GEIPTR 657
              P  
Sbjct: 349 EPAPAD 354

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  132 bits (333), Expect = 5e-32
 Identities = 79/409 (19%), Positives = 133/409 (32%), Gaps = 54/409 (13%)

Query: 99  LAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFV 158
            AVL +  +    +LP+ L     +       NN    +P+     P L+ L +  N   
Sbjct: 42  NAVLNVGESGL-TTLPDCL--PAHITTLVIPDNNL-TSLPA---LPPELRTLEVSGNQLT 94

Query: 159 GKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQN--------LPVLEGLFISYNQ 210
             +P     L  L         L   +PS +  +    N         P L+ L +S NQ
Sbjct: 95  -SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQ 152

Query: 211 LTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNL 270
           L   +P    +  +L       N+    +P     L     L + +N L   +P     L
Sbjct: 153 LAS-LPALPSELCKLW---AYNNQLT-SLPMLPSGLQE---LSVSDNQLA-SLPTLPSEL 203

Query: 271 RNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGEN 330
             L     + ++L    PA       LKEL V+ N  L SLP         L+ L +  N
Sbjct: 204 YKLWAYNNRLTSL----PALPSG---LKELIVSGN-RLTSLPVLP----SELKELMVSGN 251

Query: 331 NFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFL 390
             + ++P   +    L  L    N  + L P +  +L S   ++L GN L+  T      
Sbjct: 252 RLT-SLPMLPSG---LLSLSVYRNQLTRL-PESLIHLSSETTVNLEGNPLSERTLQA--- 303

Query: 391 SSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTV 450
                 R +        PI     +       +       +  +      E    +    
Sbjct: 304 -----LREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWH- 357

Query: 451 IRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANL 499
              G  +      + L RL + +  ++++   +  I   L  L     L
Sbjct: 358 -MFGQEDNADAFSLFLDRLSETEN-FIKDAGFKAQISSWLAQLAEDEAL 404

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  116 bits (291), Expect = 9e-27
 Identities = 67/325 (20%), Positives = 107/325 (32%), Gaps = 45/325 (13%)

Query: 76  TALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHI 135
             L +S   LT ++P     L  L++ +         LP   S L  L       N    
Sbjct: 84  RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLT----HLPALPSGLCKL---WIFGNQLT- 134

Query: 136 EIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSC 195
            +P      P LQ L +  N     +P        L +L   +NQL+ ++P         
Sbjct: 135 SLPV---LPPGLQELSVSDNQL-ASLPALPSE---LCKLWAYNNQLT-SLPMLPSG---- 182

Query: 196 QNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLG 255
                L+ L +S NQL   +PT   +  +L   +         +P     L     L + 
Sbjct: 183 -----LQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTS----LPALPSGLKE---LIVS 229

Query: 256 NNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSI 315
            N L   +P     L+ L V    S N    +P      S L  L+V  N  L  LP S+
Sbjct: 230 GNRL-TSLPVLPSELKELMV----SGNRLTSLPML---PSGLLSLSVYRNQ-LTRLPESL 280

Query: 316 DLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSL 375
            + L +   + L  N  S     +L  I+           F     +     R+L L   
Sbjct: 281 -IHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLA-A 338

Query: 376 AGNVLTSPTPDLSFLSSLTSCRNLE 400
           A  ++ +   + +           +
Sbjct: 339 ADWLVPAREGEPAPADRWHMFGQED 363

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 82.2 bits (203), Expect = 3e-16
 Identities = 44/179 (24%), Positives = 68/179 (37%), Gaps = 24/179 (13%)

Query: 478 QNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPST 537
              +         C     A L +G++ L+  LP CL     +  L +  N LTS +P+ 
Sbjct: 24  SRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPAL 79

Query: 538 LWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSL 597
              L+ +    +S N L  SL      L  +      L  L  +         GL  L +
Sbjct: 80  PPELRTL---EVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWI 128

Query: 598 RYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPT 656
             N+L   +P    GL+ L    +S+N L+ ++P      S L  L    NQL   +P 
Sbjct: 129 FGNQLTS-LPVLPPGLQEL---SVSDNQLA-SLPAL---PSELCKLWAYNNQLT-SLPM 178

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 63.0 bits (153), Expect = 4e-10
 Identities = 36/188 (19%), Positives = 56/188 (29%), Gaps = 20/188 (10%)

Query: 76  TALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHI 135
             L      LT ++P     L  L V    + +   SLP   S L+ L        N   
Sbjct: 204 YKLWAYNNRLT-SLPALPSGLKELIV----SGNRLTSLPVLPSELKEL---MVS-GNRLT 254

Query: 136 EIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSC 195
            +P        L  L +  N    ++PE++ +LS    ++L  N LS             
Sbjct: 255 SLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALR--EI 307

Query: 196 QNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRD----IGNLTSVRN 251
            + P   G  I ++      P             L   +     P D     G   +   
Sbjct: 308 TSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADA 367

Query: 252 LFLGNNSL 259
             L  + L
Sbjct: 368 FSLFLDRL 375

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  136 bits (344), Expect = 1e-35
 Identities = 64/282 (22%), Positives = 119/282 (42%), Gaps = 32/282 (11%)

Query: 767  KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
            K LG G FG V  G      ++A K+   E   S + F  E KVM ++ H  LV++   C
Sbjct: 30   KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 827  SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL---HFGYSTPIV 883
            +      ++ EYM+NG L   L    +     Q L++  DV  A+EYL    F      +
Sbjct: 89   TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF------L 142

Query: 884  HCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKC 943
            H D+   N L+N+  V  +SDFG+++ +  +E      +   + +  PE     K S K 
Sbjct: 143  HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 202

Query: 944  DVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFS 1002
            D++++G+++ E ++  K P    +    +                +A    L        
Sbjct: 203  DIWAFGVLMWEIYSLGKMP----YER-FTNSE-T--------AEHIAQGLRLYRPHL--- 245

Query: 1003 AREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044
                    ++++   C  +  ++R + K + + ++ + +  S
Sbjct: 246  ----ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES 283

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  141 bits (358), Expect = 1e-35
 Identities = 61/193 (31%), Positives = 97/193 (50%), Gaps = 6/193 (3%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
             LG G FG V+ G       +A K        S E+F  E +VM  +RH  LV++ +  
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 827 SNNDFKALVLEYMSNGSLEKCLYS-DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
           S      +V EYMS GSL   L      +L + Q + +   +AS + Y+        VH 
Sbjct: 332 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387

Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L+ E++V  ++DFG+A+++   E   +      I + APE    G+ + K DV
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447

Query: 946 YSYGIMLMETFTK 958
           +S+GI+L E  TK
Sbjct: 448 WSFGILLTELTTK 460

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  141 bits (357), Expect = 2e-35
 Identities = 87/511 (17%), Positives = 180/511 (35%), Gaps = 56/511 (10%)

Query: 145 PRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGL 204
            +   L +  N         I  LS L+ L +S N++   +  S+F     +    LE L
Sbjct: 21  QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVF-----KFNQELEYL 74

Query: 205 FISYNQLTGPIPTNLWKCRELHVVSLAFNKFQG-GIPRDIGNLTSVRNLFLGNNSLIGEI 263
            +S+N+L           + L    L+FN F    I ++ GN++ ++ L L    L    
Sbjct: 75  DLSHNKLVKISCHPTVNLKHLD---LSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSS 131

Query: 264 PNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLE 323
              I +L   +VL V                   + L +                  N E
Sbjct: 132 VLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVF--------------PTNKE 177

Query: 324 RLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSP 383
             F+ + +        L+NI  +   +      S L         + KL +L  N + + 
Sbjct: 178 FHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSIL----AKLQTNPKLSNLTLNNIETT 233

Query: 384 TPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELG 443
                 +  L     +    +S   + G L     ++S +                    
Sbjct: 234 WNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGT-------------------- 273

Query: 444 NINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGD 503
           ++  L++ ++ ++               +       +            +    +L   +
Sbjct: 274 SLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSN 333

Query: 504 NKLSGRLPACLGNLTSLRDLSLGSNALTSI--IPSTLWNLKDILRFNLSSNSLNGSLLPD 561
           N L+  +    G+LT L  L L  N L  +  I      +K + + ++S NS++      
Sbjct: 334 NLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKG 393

Query: 562 I-GNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVD 620
                K ++ +++S N L+  I   +     +++L L  N+++  IP+    L++L  ++
Sbjct: 394 DCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKS-IPKQVVKLEALQELN 450

Query: 621 MSNNNLSGTIPKSM-EALSYLKHLNLSFNQL 650
           +++N L  ++P  + + L+ L+ + L  N  
Sbjct: 451 VASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  137 bits (346), Expect = 5e-34
 Identities = 90/509 (17%), Positives = 167/509 (32%), Gaps = 56/509 (11%)

Query: 123 LKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLS 182
               +   N       S  +SL +L+ L++ HN           +   L+ LDLS N+L 
Sbjct: 23  TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82

Query: 183 GTIPSSIFNISSCQNLPVLEGLFISYNQLTG-PIPTNLWKCRELHVVSLAFNKFQGGIPR 241
             I         C     L+ L +S+N     PI        +L  + L+    +     
Sbjct: 83  -KIS--------CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVL 133

Query: 242 DIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELA 301
            I +L   + L +   +   +   +   L++     +            I ++S      
Sbjct: 134 PIAHLNISKVLLVLGETYGEKE--DPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVAN 191

Query: 302 VTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIP 361
           +  +++           +    +     +  +    +   +   L+ ++  +NSF  ++ 
Sbjct: 192 LELSNI---------KCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRIL- 241

Query: 362 TTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFS 421
                  ++   S++   L        F  S TS + L I  +  +       S I    
Sbjct: 242 -QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG-FPQSYIYEIF 299

Query: 422 ISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNK 481
            +M   +                I+    +   NN LT T+    G L +L+ L LQ N+
Sbjct: 300 SNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQ 359

Query: 482 LEGSIPED---LCHLYRLANLYLGDNKLSGRLPACL-GNLTSLRDLSLGSNALTSIIPST 537
           L+  + +       +  L  L +  N +S            SL  L++ SN LT  I   
Sbjct: 360 LK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRC 418

Query: 538 LWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSL 597
           L     +L  +L SN +                           IP  +  L+ LQ L++
Sbjct: 419 LPPRIKVL--DLHSNKIK-------------------------SIPKQVVKLEALQELNV 451

Query: 598 RYNRLQGPIPESFGGLKSLNFVDMSNNNL 626
             N+L+      F  L SL  + +  N  
Sbjct: 452 ASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  131 bits (331), Expect = 4e-32
 Identities = 83/500 (16%), Positives = 158/500 (31%), Gaps = 41/500 (8%)

Query: 76  TALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHI 135
             ++ S  GL   +P  L       +L I  N        ++  L  L+      N    
Sbjct: 3   FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY 59

Query: 136 EIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSC 195
              S F     L++L L HN    KI         L+ LDLS N          F     
Sbjct: 60  LDISVFKFNQELEYLDLSHNKL-VKIS--CHPTVNLKHLDLSFNAFDALPICKEF----- 111

Query: 196 QNLPVLEGLFISYNQLTG---------PIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNL 246
            N+  L+ L +S   L            I   L    E +         Q      +  +
Sbjct: 112 GNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIV 171

Query: 247 TSVRNLFLG-----NNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELA 301
                 F         ++     + I  +          S LA L      +  TL  + 
Sbjct: 172 FPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIE 231

Query: 302 VTDNDLLG--SLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGL 359
            T N  +    L     +   ++  + L           S T++  LS+     + F   
Sbjct: 232 TTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFP 291

Query: 360 IPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGN 419
               +    ++ + +   +        L      +       +  S N +   +  + G+
Sbjct: 292 QSYIYEIFSNMNIKNFTVSGTRM-VHMLCP----SKISPFLHLDFSNNLLTDTVFENCGH 346

Query: 420 FSISMKSLSMESCNISGGIPKELG---NINNLTVIRLGNNELTGTIP-VTLGRLQKLQGL 475
            +  +++L ++   +   + K       + +L  + +  N ++           + L  L
Sbjct: 347 LT-ELETLILQMNQLKE-LSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSL 404

Query: 476 YLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIP 535
            + +N L  +I   L    R+  L L  NK+   +P  +  L +L++L++ SN L S+  
Sbjct: 405 NMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPD 461

Query: 536 STLWNLKDILRFNLSSNSLN 555
                L  + +  L +N  +
Sbjct: 462 GIFDRLTSLQKIWLHTNPWD 481

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  129 bits (327), Expect = 1e-31
 Identities = 99/490 (20%), Positives = 171/490 (34%), Gaps = 70/490 (14%)

Query: 75  VTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEE-LSHLRGLKYFDFRFNNF 133
            T LNIS   ++      + +LS L +L I +N     L        + L+Y D   N  
Sbjct: 23  TTILNISQNYISELWTSDILSLSKLRILIISHNRI-QYLDISVFKFNQELEYLDLSHNKL 81

Query: 134 HIEIPSWFVSLPRLQHLLLKHNSF-VGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNI 192
             +I         L+HL L  N+F    I +  G +S L+ L LS   L  +    I ++
Sbjct: 82  V-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHL 138

Query: 193 SSCQNLPVLEGLFISY----------------NQLTGPIPTNLWKCRELHVVSLAFNKFQ 236
           +  + L VL   +                      T      +       V +L  +  +
Sbjct: 139 NISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIK 198

Query: 237 GGIPRD-----------IGNLTSVRNLFLGNNSLIGEIPNEIGNL---RNLEVLGVQSSN 282
             +  +           +     + NL L N          I  L     +    + +  
Sbjct: 199 CVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVK 258

Query: 283 LAGLIPASIFNIST--LKELAVTD--NDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPS 338
           L G +    F+ S   LK L++    +D+ G   S I     N+       +        
Sbjct: 259 LQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHML 318

Query: 339 SLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRN 398
             + IS    LDF  N  +  +    G+L  L+ L L  N L   +      + +    +
Sbjct: 319 CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMK---S 375

Query: 399 LEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNEL 458
           L+ + +S+N ++       G+ S                         +L  + + +N L
Sbjct: 376 LQQLDISQNSVSYDEKK--GDCS----------------------WTKSLLSLNMSSNIL 411

Query: 459 TGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLT 518
           T TI   L    +++ L L +NK++ SIP+ +  L  L  L +  N+L          LT
Sbjct: 412 TDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLT 468

Query: 519 SLRDLSLGSN 528
           SL+ + L +N
Sbjct: 469 SLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  106 bits (265), Expect = 7e-24
 Identities = 58/370 (15%), Positives = 123/370 (33%), Gaps = 28/370 (7%)

Query: 287 IPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISEL 346
           +P  +        L ++ N  +  L +S  L L  L  L +  N       S      EL
Sbjct: 15  VPKDLS--QKTTILNISQN-YISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71

Query: 347 SVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSE 406
             LD   N    +   +     +LK L L+ N   +  P      +++    L+ + LS 
Sbjct: 72  EYLDLSHNKLVKI---SCHPTVNLKHLDLSFNAFDA-LPICKEFGNMS---QLKFLGLST 124

Query: 407 NPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTL 466
             +       I + +IS   L +          ++   + +     L     T      +
Sbjct: 125 THLEKSSVLPIAHLNISKVLLVLGETYGE---KEDPEGLQDFNTESLHIVFPTNKEFHFI 181

Query: 467 GRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLG 526
             +       L+ + ++  + ++ C  +         + L+        +  +L ++   
Sbjct: 182 LDVSVKTVANLELSNIKCVLEDNKCSYFL--------SILAKLQTNPKLSNLTLNNIETT 233

Query: 527 SNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIG-----NLKVVIEMDLSLNALSGV 581
            N+   I+   L     +  F++S+  L G L          +LK +    +  +     
Sbjct: 234 WNSFIRIL--QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFP 291

Query: 582 IPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLK 641
                     + + +   +  +         +     +D SNN L+ T+ ++   L+ L+
Sbjct: 292 QSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELE 351

Query: 642 HLNLSFNQLE 651
            L L  NQL+
Sbjct: 352 TLILQMNQLK 361

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 65.7 bits (160), Expect = 4e-11
 Identities = 33/180 (18%), Positives = 63/180 (35%), Gaps = 31/180 (17%)

Query: 477 LQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPS 536
              N L   +P+DL    +   L +  N +S    + + +L+ LR L +  N +  +  S
Sbjct: 7   RSKNGLI-HVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS 63

Query: 537 TLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLS 596
                +++   +LS N L                             ++      L+ L 
Sbjct: 64  VFKFNQELEYLDLSHNKLVK---------------------------ISCHPTVNLKHLD 96

Query: 597 LRYNRLQG-PIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIP 655
           L +N     PI + FG +  L F+ +S  +L  +    +  L+  K L +       +  
Sbjct: 97  LSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED 156

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  137 bits (346), Expect = 2e-35
 Identities = 72/293 (24%), Positives = 128/293 (43%), Gaps = 27/293 (9%)

Query: 767  KLLGMGSFGSVYKGVLP-----DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVK 821
            + LG G+FGSV            G  +A K      +  L  F  E +++ S++H N+VK
Sbjct: 47   QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 822  IISSCSNNDFKA--LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
                C +   +   L++EY+  GSL   L      +D ++ L+    +   +EYL    +
Sbjct: 107  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---T 163

Query: 880  TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREG 937
               +H D+   N+L+       + DFG+ K+L +++   + K  G   I + APE   E 
Sbjct: 164  KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES 223

Query: 938  KVSRKCDVYSYGIMLMETFT---KKKPTDEIFAGEMSLKRWVGDSLLSCS--ITEVADAN 992
            K S   DV+S+G++L E FT   K K     F   +   +      +     I  + +  
Sbjct: 224  KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ---MIVFHLIELLKNNG 280

Query: 993  LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSA 1045
             L   +        C   I+ +  +C  +   +R S +D+A R+ +IR+ ++ 
Sbjct: 281  RLPRPDG-------CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMAG 326

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  138 bits (349), Expect = 2e-35
 Identities = 80/389 (20%), Positives = 154/389 (39%), Gaps = 48/389 (12%)

Query: 682  VSPCK--TRSHPRSRTTVVLLIVLPLVSA----LTMIVVLTAKLVRRRRRRRRRQKGSTR 735
            + P       H R R +V   I++P  S     +  I  L+  L ++        +G+  
Sbjct: 4    IDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANT 63

Query: 736  PYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDG----MEIAAK 791
             + D +       + + +  +  ++     N+++G G FG VY G L D     +  A K
Sbjct: 64   VHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 123

Query: 792  VFHMEFDGS-LESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL-VLEYMSNGSLEKCLY 849
              +   D   +  F  E  +M    H N++ ++  C  ++   L VL YM +G L   + 
Sbjct: 124  SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 183

Query: 850  SDNYFLDILQRLKIMIDVASALEYL---HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFG 906
            ++ +   +   +   + VA  +++L    F      VH D+   N +L+E     ++DFG
Sbjct: 184  NETHNPTVKDLIGFGLQVAKGMKFLASKKF------VHRDLAARNCMLDEKFTVKVADFG 237

Query: 907  IAKILGKEESMRQTKTLGT---IGYMAPEYGREGKVSRKCDVYSYGIMLMETFTK-KKPT 962
            +A+ +  +E        G    + +MA E  +  K + K DV+S+G++L E  T+   P 
Sbjct: 238  LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 297

Query: 963  DEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDL 1022
             ++   ++                 +     L   E        C   ++ + + C    
Sbjct: 298  PDVNTFDI--------------TVYLLQGRRLLQPEY-------CPDPLYEVMLKCWHPK 336

Query: 1023 PEKRISMKDVANRLVRIRETLSA--YIDV 1049
             E R S  ++ +R+  I  T     Y+ V
Sbjct: 337  AEMRPSFSELVSRISAIFSTFIGEHYVHV 365

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  140 bits (355), Expect = 2e-35
 Identities = 66/286 (23%), Positives = 119/286 (41%), Gaps = 28/286 (9%)

Query: 767  KLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISS 825
              LG G +G VY+GV     + +A K    E    +E F  E  VM  I+H NLV+++  
Sbjct: 226  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 826  CSNNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
            C+      ++ E+M+ G+L   L   N   +  +  L +   ++SA+EYL        +H
Sbjct: 285  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 341

Query: 885  CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCD 944
             ++   N L+ E+ +  ++DFG+++++  +           I + APE     K S K D
Sbjct: 342  RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401

Query: 945  VYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSA 1003
            V+++G++L E  T    P    + G + L +             +     +   E     
Sbjct: 402  VWAFGVLLWEIATYGMSP----YPG-IDLSQ---------VYELLEKDYRMERPEG---- 443

Query: 1004 REQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYIDV 1049
               C   ++ L   C    P  R S  ++      + +  S   +V
Sbjct: 444  ---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 486

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  135 bits (342), Expect = 4e-35
 Identities = 60/284 (21%), Positives = 115/284 (40%), Gaps = 21/284 (7%)

Query: 767  KLLGMGSFGSVYKGVLP-----DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLV 820
            + LG G FG V            G ++A K    E     +     E +++ ++ H N+V
Sbjct: 27   RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 821  KIISSCSNNDFKA--LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
            K    C+ +      L++E++ +GSL++ L  +   +++ Q+LK  + +   ++YL    
Sbjct: 87   KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG--- 143

Query: 879  STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGRE 936
            S   VH D+   NVL+       + DFG+ K +  ++     K      + + APE   +
Sbjct: 144  SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203

Query: 937  GKVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN 995
             K     DV+S+G+ L E  T     +  +      +    G   ++  +  + +   L 
Sbjct: 204  SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLP 263

Query: 996  CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039
            C  N       C   ++ L   C    P  R S +++      +
Sbjct: 264  CPPN-------CPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  134 bits (340), Expect = 4e-35
 Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 22/209 (10%)

Query: 767 KLLGMGSFGSVYKGVL--PDGMEI--AAKVF---HMEFDGSLESFHAECKVMGSIRHRNL 819
           + LG GSFG V +G    P G  +  A K      +    +++ F  E   M S+ HRNL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83

Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL---HF 876
           +++         K +V E    GSL   L        +    +  + VA  + YL    F
Sbjct: 84  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 142

Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT---IGYMAPEY 933
                 +H D+   N+LL    +  + DFG+ + L + +               + APE 
Sbjct: 143 ------IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD-HYVMQEHRKVPFAWCAPES 195

Query: 934 GREGKVSRKCDVYSYGIMLMETFTK-KKP 961
            +    S   D + +G+ L E FT  ++P
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  135 bits (342), Expect = 6e-35
 Identities = 67/318 (21%), Positives = 121/318 (38%), Gaps = 50/318 (15%)

Query: 745  QATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGME-----IAAKVFHMEF-D 798
            QA  R +   +  +        K+LG G+FG+VYKG+     E     +A K        
Sbjct: 6    QALLRILKETEFKKI-------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP 58

Query: 799  GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDIL 858
             + +    E  VM S+ + ++ +++  C  +  + L+ + M  G L   +      +   
Sbjct: 59   KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ 117

Query: 859  QRLKIMIDVASALEYL---HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE 915
              L   + +A  + YL           VH D+   NVL+       ++DFG+AK+LG EE
Sbjct: 118  YLLNWCVQIAKGMNYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171

Query: 916  SMRQTKTLGT---IGYMAPEYGREGKVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMS 971
               +    G    I +MA E       + + DV+SYG+ + E  T   KP D I A E+ 
Sbjct: 172  K--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI- 228

Query: 972  LKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKD 1031
                          + +     L            C   ++ +   C +   + R   ++
Sbjct: 229  -------------SSILEKGERLPQPPI-------CTIDVYMIMRKCWMIDADSRPKFRE 268

Query: 1032 VANRLVRIRETLSAYIDV 1049
            +     ++      Y+ +
Sbjct: 269  LIIEFSKMARDPQRYLVI 286

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  138 bits (349), Expect = 7e-35
 Identities = 71/398 (17%), Positives = 147/398 (36%), Gaps = 40/398 (10%)

Query: 272 NLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENN 331
           ++  + +  +++A L   S   +  L+ L V        + ++   GL +L  L L  N 
Sbjct: 31  HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90

Query: 332 FSGTIPSSLTNISELSVLDFGFNSFSGLI--PTTFGNLRSLKLLSLAGNVLTSPTPDLSF 389
           F      +   ++ L VL     +  G +     F  L SL++L L  N +    P   F
Sbjct: 91  FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150

Query: 390 LSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLT 449
             ++       ++ L+ N +  I    + NF                G    L  ++++T
Sbjct: 151 -LNMR---RFHVLDLTFNKVKSICEEDLLNFQ---------------GKHFTLLRLSSIT 191

Query: 450 VIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLA-----NLYLGDN 504
           +  +    L         +   +  L L  N  + S+ +               L    N
Sbjct: 192 LQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYN 251

Query: 505 KLSGRLPACLGNL----------TSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSL 554
             S        +           + ++   L  + + +++ S   +  D+ +  L+ N +
Sbjct: 252 MGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEI 311

Query: 555 NGSLLPDI-GNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGL 613
           N  +  +    L  +++++LS N L  +       L  L++L L YN ++    +SF GL
Sbjct: 312 N-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGL 370

Query: 614 KSLNFVDMSNNNLSGTIPKSM-EALSYLKHLNLSFNQL 650
            +L  + +  N L  ++P  + + L+ L+ + L  N  
Sbjct: 371 PNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  133 bits (337), Expect = 3e-33
 Identities = 83/427 (19%), Positives = 146/427 (34%), Gaps = 64/427 (14%)

Query: 145 PRLQHLLLKHNSFVGKIPET-IGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEG 203
             + ++ L  NS   ++ ET    L  LQ L +        I ++ F     + L  L  
Sbjct: 30  AHVNYVDLSLNSI-AELNETSFSRLQDLQFLKVEQQTPGLVIRNNTF-----RGLSSLII 83

Query: 204 LFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIG-E 262
           L + YNQ                   L    F G        L ++  L L   +L G  
Sbjct: 84  LKLDYNQFL----------------QLETGAFNG--------LANLEVLTLTQCNLDGAV 119

Query: 263 IPNEI-GNLRNLEVLGVQSSNLAGLIPASIF-NISTLKELAVTDN-------DLLGSLPS 313
           +       L +LE+L ++ +N+  + PAS F N+     L +T N       + L +   
Sbjct: 120 LSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQG 179

Query: 314 S--IDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSL- 370
                L L ++    + E         +    + ++ LD   N F   +   F +  +  
Sbjct: 180 KHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGT 239

Query: 371 KLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSME 430
           K+ SL  +         +  +  +S  +            G+  S +    +S   +   
Sbjct: 240 KIQSLILS---------NSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-- 288

Query: 431 SCNISGGIPKELGNINNLTVIRLGNNELTGTIPV-TLGRLQKLQGLYLQNNKLEGSIPED 489
              +   +        +L  + L  NE+   I       L  L  L L  N L GSI   
Sbjct: 289 --ALLKSVFSHF---TDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL-GSIDSR 341

Query: 490 LCH-LYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFN 548
           +   L +L  L L  N +          L +L++L+L +N L S+       L  + +  
Sbjct: 342 MFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIW 401

Query: 549 LSSNSLN 555
           L +N  +
Sbjct: 402 LHTNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  120 bits (303), Expect = 6e-29
 Identities = 81/415 (19%), Positives = 142/415 (34%), Gaps = 42/415 (10%)

Query: 207 SYNQLTG--PIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIP 264
               L     +P ++     +    L+ N            L  ++ L +   +    I 
Sbjct: 18  INRGLHQVPELPAHV---NYVD---LSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIR 71

Query: 265 NEI-GNLRNLEVLGVQSSNLAGLIPASIF-NISTLKELAVTDNDLLGS-LPSSIDLGLPN 321
           N     L +L +L +  +    L     F  ++ L+ L +T  +L G+ L  +    L +
Sbjct: 72  NNTFRGLSSLIILKLDYNQFLQL-ETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTS 130

Query: 322 LERLFLGENNFSGTIPSSL-TNISELSVLDFGFNSFSGLIPTTFGNLRSLKL--LSLAGN 378
           LE L L +NN     P+S   N+    VLD  FN    +      N +      L L+  
Sbjct: 131 LEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSI 190

Query: 379 VLTSPTP---DLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNIS 435
            L              +     ++  + LS N     +      F  ++    ++S  + 
Sbjct: 191 TLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMA---KRFFDAIAGTKIQSLIL- 246

Query: 436 GGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQ--KLQGLYLQNNKLEGSIPEDLC-H 492
                   + +       G+         T   L+   ++   L  +K+  ++ + +  H
Sbjct: 247 --------SNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSH 297

Query: 493 LYRLANLYLGDNKLSGRLPA-CLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSS 551
              L  L L  N+++ ++       LT L  L+L  N L SI      NL  +   +LS 
Sbjct: 298 FTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSY 356

Query: 552 N---SLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQ 603
           N   +L       + NLK   E+ L  N L  V       L  LQ + L  N   
Sbjct: 357 NHIRALGDQSFLGLPNLK---ELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  114 bits (287), Expect = 7e-27
 Identities = 70/437 (16%), Positives = 140/437 (32%), Gaps = 70/437 (16%)

Query: 75  VTALNISYLGLTGTIPPQ-LGNLSFLAVLAIRNNSFFGSLPEEL-SHLRGLKYFDFRFNN 132
           V  +++S   +   +       L  L  L +   +    +       L  L      +N 
Sbjct: 32  VNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90

Query: 133 FHIEIPSW-FVSLPRLQHLLLKHNSF-VGKIPETI-GYLSLLQELDLSDNQLSGTIPSSI 189
           F  ++ +  F  L  L+ L L   +     +       L+ L+ L L DN +    P+S 
Sbjct: 91  FL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149

Query: 190 FNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSV 249
           F      N+     L +++N++               +       FQG     +  L+S+
Sbjct: 150 F-----LNMRRFHVLDLTFNKVK-------------SICEEDLLNFQGKHFTLL-RLSSI 190

Query: 250 RNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLG 309
               +    L  E         ++  L +  +     +    F+     ++      L+ 
Sbjct: 191 TLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKI----QSLIL 246

Query: 310 SLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRS 369
           S   ++     +          F G   S +         D   +    L+ + F +   
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFTFKGLEASGVK------TCDLSKSKIFALLKSVFSHFTD 300

Query: 370 LKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSM 429
           L+ L+LA N +     +     +     +L  + LS+N +                    
Sbjct: 301 LEQLTLAQNEINKIDDN-----AFWGLTHLLKLNLSQNFLG------------------- 336

Query: 430 ESCNISGGIPKELGNINNLTVIRLGNNELTGTIPV-TLGRLQKLQGLYLQNNKLEGSIPE 488
              +I   + + L     L V+ L  N +   +   +   L  L+ L L  N+L+ S+P+
Sbjct: 337 ---SIDSRMFENLD---KLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPD 388

Query: 489 D-LCHLYRLANLYLGDN 504
                L  L  ++L  N
Sbjct: 389 GIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 94.8 bits (236), Expect = 2e-20
 Identities = 57/285 (20%), Positives = 101/285 (35%), Gaps = 34/285 (11%)

Query: 398 NLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKEL-GNINNLTVIRLGNN 456
           ++  + LS N I  +  +S       ++ L +E       I       +++L +++L  N
Sbjct: 31  HVNYVDLSLNSIAELNETSFSRLQ-DLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 457 ELTGTIPV-TLGRLQKLQGLYLQNNKLEGS-IPEDL-CHLYRLANLYLGDNKLSGRLPAC 513
           +    +       L  L+ L L    L+G+ +  +    L  L  L L DN +    PA 
Sbjct: 90  QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148

Query: 514 L-GNLTSLRDLSLGSNALTSIIPSTLWNL--KDILRFNLSSNSL-----NGSLLPDIGN- 564
              N+     L L  N + SI    L N   K      LSS +L             GN 
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208

Query: 565 --LKVVIEMDLSLNALSGVIPVTIGGLQGLQLL-------------SLRYNRLQGPIPES 609
                +  +DLS N     +            +             S  +   + P   +
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFT 268

Query: 610 FGGLK--SLNFVDMSNNNLSGTIPKSM-EALSYLKHLNLSFNQLE 651
           F GL+   +   D+S + +   + KS+    + L+ L L+ N++ 
Sbjct: 269 FKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN 312

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 87.5 bits (217), Expect = 4e-18
 Identities = 68/344 (19%), Positives = 111/344 (32%), Gaps = 33/344 (9%)

Query: 76  TALNISYLGLTGTIPPQ-LGNLSFLAVLAIRNNSFFGS-LPEEL-SHLRGLKYFDFRFNN 132
             L + Y      +       L+ L VL +   +  G+ L       L  L+    R NN
Sbjct: 82  IILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140

Query: 133 FH-IEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGY---LSLLQELDLSDNQLSGTIPSS 188
              I+  S+F+++ R   L L  N     I E             L LS   L   +   
Sbjct: 141 IKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQ-DMNEY 198

Query: 189 IFNISSCQN---LPVLEGLFISYNQLTGPIPTNLWK-------------CRELHVVSLAF 232
                 C N      +  L +S N     +    +                     S   
Sbjct: 199 WLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGH 258

Query: 233 NKFQGGIPRDIGNL--TSVRNLFLGNNSLIGEIPNEI-GNLRNLEVLGVQSSNLAGLIPA 289
             F+         L  + V+   L  +  I  +   +  +  +LE L +  + +   I  
Sbjct: 259 TNFKDPDNFTFKGLEASGVKTCDLSKSK-IFALLKSVFSHFTDLEQLTLAQNEINK-IDD 316

Query: 290 SIF-NISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSV 348
           + F  ++ L +L ++ N  LGS+ S +   L  LE L L  N+       S   +  L  
Sbjct: 317 NAFWGLTHLLKLNLSQN-FLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKE 375

Query: 349 LDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSS 392
           L    N    +    F  L SL+ + L  N      P + +LS 
Sbjct: 376 LALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSR 419

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 72.5 bits (178), Expect = 3e-13
 Identities = 27/137 (19%), Positives = 56/137 (40%), Gaps = 4/137 (2%)

Query: 518 TSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDI-GNLKVVIEMDLSLN 576
             +  + L  N++  +  ++   L+D+    +   +    +  +    L  +I + L  N
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 577 ALSGVIPVTIGGLQGLQLLSLRYNRLQGPI--PESFGGLKSLNFVDMSNNNLSGTIPKSM 634
               +      GL  L++L+L    L G +     F  L SL  + + +NN+    P S 
Sbjct: 90  QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149

Query: 635 -EALSYLKHLNLSFNQL 650
              +     L+L+FN++
Sbjct: 150 FLNMRRFHVLDLTFNKV 166

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 55.1 bits (133), Expect = 7e-08
 Identities = 24/91 (26%), Positives = 40/91 (43%), Gaps = 3/91 (3%)

Query: 572 DLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPE-SFGGLKSLNFVDMSNNNLSGTI 630
           DLSLN+++ +   +   LQ LQ L +        I   +F GL SL  + +  N     +
Sbjct: 36  DLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QL 94

Query: 631 PKSM-EALSYLKHLNLSFNQLEGEIPTRGPF 660
                  L+ L+ L L+   L+G + +   F
Sbjct: 95  ETGAFNGLANLEVLTLTQCNLDGAVLSGNFF 125

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  133 bits (338), Expect = 8e-35
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 19/208 (9%)

Query: 765 ENKLLGMGSFGSVYKGVLPDG---MEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNL 819
           E+K LG G+FG+V KG          +A K+   E +     +   AE  VM  + +  +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80

Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL---HF 876
           V++I  C    +  LV+E    G L K L   N  +     ++++  V+  ++YL   +F
Sbjct: 81  VRMIGICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESNF 138

Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYG 934
                 VH D+   NVLL       +SDFG++K L  +E+  + +T G   + + APE  
Sbjct: 139 ------VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192

Query: 935 REGKVSRKCDVYSYGIMLMETFTK-KKP 961
              K S K DV+S+G+++ E F+  +KP
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  133 bits (338), Expect = 8e-35
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 17/203 (8%)

Query: 769 LGMGSFGSVYKGVLPDG---MEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIIS 824
           LG G+FGSV +GV       +++A KV          E    E ++M  + +  +V++I 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL---HFGYSTP 881
            C       LV+E    G L K L      + +    +++  V+  ++YL   +F     
Sbjct: 78  VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 131

Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREGKV 939
            VH D+   NVLL       +SDFG++K LG ++S    ++ G   + + APE     K 
Sbjct: 132 -VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190

Query: 940 SRKCDVYSYGIMLMETFTK-KKP 961
           S + DV+SYG+ + E  +  +KP
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKP 213

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  134 bits (340), Expect = 1e-34
 Identities = 53/254 (20%), Positives = 91/254 (35%), Gaps = 22/254 (8%)

Query: 716 TAKLVRRRRRRRRRQKGSTRPYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFG 775
            AK       + +R    T       +  +       Y++ +      +    +G GSFG
Sbjct: 16  LAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVH---WMTHQPRVGRGSFG 72

Query: 776 SVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL 834
            V++      G + A K   +  +        E      +    +V +  +     +  +
Sbjct: 73  EVHRMKDKQTGFQCAVK--KVRLEVFRVE---ELVACAGLSSPRIVPLYGAVREGPWVNI 127

Query: 835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL 894
            +E +  GSL + +       +       +      LEYLH   +  I+H D+K  NVLL
Sbjct: 128 FMELLEGGSLGQLIKQMGCLPEDRAL-YYLGQALEGLEYLH---TRRILHGDVKADNVLL 183

Query: 895 NESMVGH---LSDFGIAKIL---GKEESMRQTKTL-GTIGYMAPEYGREGKVSRKCDVYS 947
           +    G    L DFG A  L   G  +S+     + GT  +MAPE         K D++S
Sbjct: 184 SSD--GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWS 241

Query: 948 YGIMLMETFTKKKP 961
              M++       P
Sbjct: 242 SCCMMLHMLNGCHP 255

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  133 bits (338), Expect = 1e-34
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 11/208 (5%)

Query: 761 DGFSENKLLGMGSFGSVYKGV-LPDGMEIAAK---VFHMEFDGSLESFHAECKVMGSIRH 816
             F   K +G G F  VY+   L DG+ +A K   +F +    +      E  ++  + H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLE---KCLYSDNYFLDILQRLKIMIDVASALEY 873
            N++K  +S   ++   +VLE    G L    K        +      K  + + SALE+
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
           +H   S  ++H DIKP+NV +  + V  L D G+ +    + +   +   GT  YM+PE 
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207

Query: 934 GREGKVSRKCDVYSYGIMLMETFTKKKP 961
             E   + K D++S G +L E    + P
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSP 235

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  133 bits (336), Expect = 1e-34
 Identities = 67/286 (23%), Positives = 119/286 (41%), Gaps = 28/286 (9%)

Query: 767  KLLGMGSFGSVYKGVLPDG-MEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISS 825
              LG G +G VY+GV     + +A K    E    +E F  E  VM  I+H NLV+++  
Sbjct: 19   HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 826  CSNNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
            C+      ++ E+M+ G+L   L   N   +  +  L +   ++SA+EYL        +H
Sbjct: 78   CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134

Query: 885  CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCD 944
             D+   N L+ E+ +  ++DFG+++++  +           I + APE     K S K D
Sbjct: 135  RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194

Query: 945  VYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSA 1003
            V+++G++L E  T    P    + G + L +             +     +   E     
Sbjct: 195  VWAFGVLLWEIATYGMSP----YPG-IDLSQ---------VYELLEKDYRMERPEG---- 236

Query: 1004 REQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYIDV 1049
               C   ++ L   C    P  R S  ++      + +  S   +V
Sbjct: 237  ---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 279

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  134 bits (338), Expect = 2e-34
 Identities = 67/290 (23%), Positives = 112/290 (38%), Gaps = 28/290 (9%)

Query: 767  KLLGMGSFGSVYKGVLP-----DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVK 821
              LG G+FGSV            G  +A K            F  E +++ ++    +VK
Sbjct: 29   SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 822  IISSCSNNDFKA--LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
                      ++  LV+EY+ +G L   L      LD  + L     +   +EYL    S
Sbjct: 89   YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---S 145

Query: 880  TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREG 937
               VH D+   N+L+       ++DFG+AK+L  ++     +  G   I + APE   + 
Sbjct: 146  RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205

Query: 938  KVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC 996
              SR+ DV+S+G++L E FT   K      +      R +G      +++ +     L  
Sbjct: 206  IFSRQSDVWSFGVVLYELFTYCDKS----CSPSAEFLRMMGCERDVPALSRL-----LEL 256

Query: 997  EENDFSAR----EQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042
             E     R      C + +  L   C    P+ R S   +  +L  +   
Sbjct: 257  LEEGQ--RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  132 bits (335), Expect = 2e-34
 Identities = 52/193 (26%), Positives = 98/193 (50%), Gaps = 6/193 (3%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
           + LG G FG V+ G      ++A K    +   S ++F AE  +M  ++H+ LV++ +  
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 827 SNNDFKALVLEYMSNGSLEKCLYS-DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
           +      ++ EYM NGSL   L +     L I + L +   +A  + ++        +H 
Sbjct: 78  TQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133

Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
           D++ +N+L+++++   ++DFG+A+++   E   +      I + APE    G  + K DV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193

Query: 946 YSYGIMLMETFTK 958
           +S+GI+L E  T 
Sbjct: 194 WSFGILLTEIVTH 206

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  139 bits (351), Expect = 2e-34
 Identities = 69/325 (21%), Positives = 119/325 (36%), Gaps = 25/325 (7%)

Query: 654 IPTRGPFITFSAESFLGNQALCGSPKLQVSPCKTRSHPRSRTTVVLL-------IVLPLV 706
           IP    F T             G        C   S   +              +  P  
Sbjct: 223 IPEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQR 282

Query: 707 SALTMIVVLTAKLVRRRRRRRRRQKGSTRPYYDANMYPQATWRRISYQDLLRATDGFSEN 766
              T+          R     + +          + +      +     L R     ++ 
Sbjct: 283 RIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADI 342

Query: 767 KLLGMGSFGSVYKGVLPDG---MEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKI 822
           +L G G+FGSV +GV       +++A KV          E    E ++M  + +  +V++
Sbjct: 343 EL-GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401

Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL---HFGYS 879
           I  C       LV+E    G L K L      + +    +++  V+  ++YL   +F   
Sbjct: 402 IGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF--- 457

Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGREG 937
              VH ++   NVLL       +SDFG++K LG ++S    ++ G   + + APE     
Sbjct: 458 ---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514

Query: 938 KVSRKCDVYSYGIMLMETFTK-KKP 961
           K S + DV+SYG+ + E  +  +KP
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQKP 539

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  133 bits (337), Expect = 3e-34
 Identities = 72/324 (22%), Positives = 116/324 (35%), Gaps = 44/324 (13%)

Query: 308 LGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNL 367
           L  +P  +    P+   L L  N  +        N+  L  L    N  S + P  F  L
Sbjct: 43  LEKVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPL 99

Query: 368 RSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFS--ISMK 425
             L+ L L+ N L      +         + L+ + + EN I  +       F+    M 
Sbjct: 100 VKLERLYLSKNQLKELPEKM-P-------KTLQELRVHENEITKVRK---SVFNGLNQMI 148

Query: 426 SLSMESCNI-SGGIPKE-LGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLE 483
            + + +  + S GI       +  L+ IR+ +  +T TIP  L     L  L+L  NK+ 
Sbjct: 149 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT 205

Query: 484 GSIPED-LCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLK 542
             +    L  L  LA L L  N +S      L N   LR+L L +N L  + P  L + K
Sbjct: 206 -KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHK 263

Query: 543 DILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRL 602
            I    L +N+++                  ++ +     P           +SL  N +
Sbjct: 264 YIQVVYLHNNNIS------------------AIGSNDFCPPGYNTKKASYSGVSLFSNPV 305

Query: 603 QGPI--PESFGGLKSLNFVDMSNN 624
           Q     P +F  +     V + N 
Sbjct: 306 QYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  121 bits (305), Expect = 5e-30
 Identities = 56/291 (19%), Positives = 114/291 (39%), Gaps = 24/291 (8%)

Query: 395 SCR-NLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRL 453
            C+ +L ++  S+  +  + P  +         L +++  I+     +  N+ NL  + L
Sbjct: 28  RCQCHLRVVQCSDLGLEKV-PKDL---PPDTALLDLQNNKITEIKDGDFKNLKNLHTLIL 83

Query: 454 GNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPAC 513
            NN+++   P     L KL+ LYL  N+L+  +PE +     L  L + +N+++    + 
Sbjct: 84  INNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSV 140

Query: 514 LGNLTSLRDLSLGSNALTS--IIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEM 571
              L  +  + LG+N L S  I       +K +    ++  ++  + +P  G    + E+
Sbjct: 141 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI--TTIPQ-GLPPSLTEL 197

Query: 572 DLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIP 631
            L  N ++ V   ++ GL  L  L L +N +      S      L  + ++NN L   +P
Sbjct: 198 HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVP 256

Query: 632 KSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSPKLQV 682
             +    Y++ + L  N +              +  F              
Sbjct: 257 GGLADHKYIQVVYLHNNNIS----------AIGSNDFCPPGYNTKKASYSG 297

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  118 bits (298), Expect = 3e-29
 Identities = 69/345 (20%), Positives = 116/345 (33%), Gaps = 74/345 (21%)

Query: 145 PRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGL 204
           P    L L++N            L  L  L L +N++S  I    F       L  LE L
Sbjct: 52  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAF-----APLVKLERL 105

Query: 205 FISYNQLT---GPIPTNLWKCRELHVVSLAFNKFQGGIPRDI-GNLTSVRNLFLGNNSL- 259
           ++S NQL      +P  L   +EL    +  N+    + + +   L  +  + LG N L 
Sbjct: 106 YLSKNQLKELPEKMPKTL---QELR---VHENEITK-VRKSVFNGLNQMIVVELGTNPLK 158

Query: 260 IGEIPNEI-GNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLG 318
              I N     ++ L  + +  +N+   IP  +                           
Sbjct: 159 SSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP-------------------------- 191

Query: 319 LPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGN 378
            P+L  L L  N  +    +SL  ++ L+ L   FNS S +   +  N   L+ L L  N
Sbjct: 192 -PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN 250

Query: 379 VLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGI 438
            L      L+        + ++++YL  N I+ I  +                       
Sbjct: 251 KLVKVPGGLADH------KYIQVVYLHNNNISAIGSNDFCP------------------- 285

Query: 439 PKELGNINNLTVIRLGNNELTGTI--PVTLGRLQKLQGLYLQNNK 481
           P       + + + L +N +      P T   +     + L N K
Sbjct: 286 PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 86.6 bits (215), Expect = 2e-18
 Identities = 59/318 (18%), Positives = 106/318 (33%), Gaps = 76/318 (23%)

Query: 73  RRVTALNISYLGLTGTIPPQ-LGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFN 131
           + +  L +    ++  I P     L  L  L +  N     LPE++   + L+      N
Sbjct: 76  KNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQL-KELPEKM--PKTLQELRVHEN 131

Query: 132 NFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQL-SGTIPSSIF 190
                  S F  L ++  +                        +L  N L S  I +  F
Sbjct: 132 EITKVRKSVFNGLNQMIVV------------------------ELGTNPLKSSGIENGAF 167

Query: 191 NISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVR 250
                Q +  L  + I+   +T  IP  L                            S+ 
Sbjct: 168 -----QGMKKLSYIRIADTNITT-IPQGL--------------------------PPSLT 195

Query: 251 NLFLGNNSLIGEIPNEI-GNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLG 309
            L L  N  I ++       L NL  LG+  ++++ +   S+ N   L+EL + +N L+ 
Sbjct: 196 ELHLDGNK-ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV- 253

Query: 310 SLPSSIDLGLPNLERLFLGENNFSGTIPSS-------LTNISELSVLDFGFN--SFSGLI 360
            +P  +      ++ ++L  NN S  I S+        T  +  S +    N   +  + 
Sbjct: 254 KVPGGLA-DHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 311

Query: 361 PTTFGNLRSLKLLSLAGN 378
           P+TF  +     + L   
Sbjct: 312 PSTFRCVYVRAAVQLGNY 329

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  131 bits (333), Expect = 3e-34
 Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 16/204 (7%)

Query: 767 KLLGMGSFGSVYKGVL--PDGMEI--AAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVK 821
           ++LG G FG VY+GV     G +I  A K    +    + E F +E  +M ++ H ++VK
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL---HFGY 878
           +I          +++E    G L   L  +   L +L  +   + +  A+ YL   +   
Sbjct: 78  LIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC-- 134

Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGK 938
               VH DI   N+L+       L DFG+++ +  E+  + + T   I +M+PE     +
Sbjct: 135 ----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR 190

Query: 939 VSRKCDVYSYGIMLMETFTK-KKP 961
            +   DV+ + + + E  +  K+P
Sbjct: 191 FTTASDVWMFAVCMWEILSFGKQP 214

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  131 bits (332), Expect = 4e-34
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 16/204 (7%)

Query: 767 KLLGMGSFGSVYKGVL--PDGMEI--AAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVK 821
           + +G G FG V++G+   P+   +  A K       D   E F  E   M    H ++VK
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL---HFGY 878
           +I   + N    +++E  + G L   L    Y LD+   +     +++AL YL    F  
Sbjct: 81  LIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF-- 137

Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGK 938
               VH DI   NVL++ +    L DFG+++ +      + +K    I +MAPE     +
Sbjct: 138 ----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 193

Query: 939 VSRKCDVYSYGIMLMETFTK-KKP 961
            +   DV+ +G+ + E      KP
Sbjct: 194 FTSASDVWMFGVCMWEILMHGVKP 217

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  132 bits (333), Expect = 4e-34
 Identities = 65/291 (22%), Positives = 119/291 (40%), Gaps = 40/291 (13%)

Query: 767  KLLGMGSFGSVYKGVLPDG----MEIAAKVFHMEFDGS-LESFHAECKVMGSIRHRNLVK 821
            +++G G FG VY G L D     +  A K  +   D   +  F  E  +M    H N++ 
Sbjct: 31   EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 822  IISSCSNNDFKAL-VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL---HFG 877
            ++  C  ++   L VL YM +G L   + ++ +   +   +   + VA  ++YL    F 
Sbjct: 91   LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF- 149

Query: 878  YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT---IGYMAPEYG 934
                 VH D+   N +L+E     ++DFG+A+ +  +E        G    + +MA E  
Sbjct: 150  -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204

Query: 935  REGKVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL 993
            +  K + K DV+S+G++L E  T+   P  ++   ++                 +     
Sbjct: 205  QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--------------TVYLLQGRR 250

Query: 994  LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044
            L   E        C   ++ + + C     E R S  ++ +R+  I  T  
Sbjct: 251  LLQPEY-------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  131 bits (332), Expect = 5e-34
 Identities = 64/300 (21%), Positives = 119/300 (39%), Gaps = 42/300 (14%)

Query: 765  ENKLLGMGSFGSVYKGVLPDG----MEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNL 819
             ++++G G FG VY G   D     ++ A K          +E+F  E  +M  + H N+
Sbjct: 25   SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 820  VKIISSCSNND-FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL---H 875
            + +I      +    ++L YM +G L + + S      +   +   + VA  +EYL    
Sbjct: 85   LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK 144

Query: 876  FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT---IGYMAPE 932
            F      VH D+   N +L+ES    ++DFG+A+ +   E     +       + + A E
Sbjct: 145  F------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198

Query: 933  YGREGKVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA 991
              +  + + K DV+S+G++L E  T+   P   I   ++                 +A  
Sbjct: 199  SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL--------------THFLAQG 244

Query: 992  NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSA--YIDV 1049
              L   E        C  S++ +   C    P  R + + +   + +I   L    Y+ +
Sbjct: 245  RRLPQPEY-------CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHYVQL 297

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  132 bits (335), Expect = 7e-34
 Identities = 51/199 (25%), Positives = 86/199 (43%), Gaps = 8/199 (4%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKII 823
           + +G GSFG         DG +   K  ++        E    E  V+ +++H N+V+  
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89

Query: 824 SSCSNNDFKALVLEYMSNGSL-EKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
            S   N    +V++Y   G L ++            Q L   + +  AL+++H      I
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKI 146

Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRK 942
           +H DIK  N+ L +     L DFGIA++L     + +    GT  Y++PE       + K
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPYNNK 205

Query: 943 CDVYSYGIMLMETFTKKKP 961
            D+++ G +L E  T K  
Sbjct: 206 SDIWALGCVLYELCTLKHA 224

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  130 bits (329), Expect = 1e-33
 Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 11/211 (5%)

Query: 761 DGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHR 817
           + +     +G GS+G   K     DG  +  K        +   +   +E  ++  ++H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 818 NLVKIISSCSNNDFKAL--VLEYMSNGSLE---KCLYSDNYFLDILQRLKIMIDVASALE 872
           N+V+      +     L  V+EY   G L         +  +LD    L++M  +  AL+
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 873 YLH--FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMA 930
             H        ++H D+KP+NV L+      L DFG+A+IL  + S  +T  +GT  YM+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF-VGTPYYMS 184

Query: 931 PEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           PE       + K D++S G +L E      P
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  130 bits (329), Expect = 2e-33
 Identities = 66/293 (22%), Positives = 119/293 (40%), Gaps = 37/293 (12%)

Query: 767  KLLGMGSFGSVYKGVLPDGME-----IAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLV 820
            K+LG G FG+V+KGV     E     +  KV   +    S ++       +GS+ H ++V
Sbjct: 19   KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 821  KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
            +++  C  +  + LV +Y+  GSL   +      L     L   + +A  + YL      
Sbjct: 79   RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EH 134

Query: 881  PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT---IGYMAPEYGREG 937
             +VH ++   NVLL       ++DFG+A +L  ++   Q         I +MA E    G
Sbjct: 135  GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK--QLLYSEAKTPIKWMALESIHFG 192

Query: 938  KVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC 996
            K + + DV+SYG+ + E  T   +P   +   E+                 +     L  
Sbjct: 193  KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV--------------PDLLEKGERLAQ 238

Query: 997  EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYIDV 1049
             +        C   ++ + + C +     R + K++AN   R+      Y+ +
Sbjct: 239  PQI-------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVI 284

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  129 bits (327), Expect = 3e-33
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 18/210 (8%)

Query: 767 KLLGMGSFGSVYKGVLPD---GMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLV 820
             LG G   +VY     D    +++A K   +     + +L+ F  E      + H+N+V
Sbjct: 17  DKLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74

Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
            +I     +D   LV+EY+   +L       +  L +   +     +   +++ H     
Sbjct: 75  SMIDVDEEDDCYYLVMEYIEGPTL-SEYIESHGPLSVDTAINFTNQILDGIKHAH---DM 130

Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT-LGTIGYMAPEYGREGKV 939
            IVH DIKP N+L++ +    + DFGIAK L  E S+ QT   LGT+ Y +PE  +    
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEAT 189

Query: 940 SRKCDVYSYGIMLMETFTKKKPTDEIFAGE 969
               D+YS GI+L E    + P    F GE
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPP----FNGE 215

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  130 bits (328), Expect = 3e-33
 Identities = 60/290 (20%), Positives = 112/290 (38%), Gaps = 23/290 (7%)

Query: 767  KLLGMGSFGSVYKGVL-----PDGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLV 820
            + LG G FG V            G  +A K    +        +  E  ++ ++ H +++
Sbjct: 37   RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 821  KIISSCSNNDFKA--LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
            K    C +    +  LV+EY+  GSL   L   +  + + Q L     +   + YLH   
Sbjct: 97   KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH--- 151

Query: 879  STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGRE 936
            +   +H D+   NVLL+   +  + DFG+AK + +     + +  G   + + APE  +E
Sbjct: 152  AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 211

Query: 937  GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITE-VADANLLN 995
             K     DV+S+G+ L E  T    +       + L       +    +TE +     L 
Sbjct: 212  YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLP 271

Query: 996  CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSA 1045
              +        C + ++ L  +C       R + +++   L  + E    
Sbjct: 272  RPDK-------CPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  133 bits (336), Expect = 4e-33
 Identities = 69/418 (16%), Positives = 143/418 (34%), Gaps = 56/418 (13%)

Query: 144 LPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEG 203
           L  L  L   ++S    +   I  L+ L +L  + N ++        ++S   NL     
Sbjct: 41  LATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNITT------LDLSQNTNL---TY 89

Query: 204 LFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEI 263
           L    N+LT     ++    +L  ++   NK       D+     +  L    N+L  EI
Sbjct: 90  LACDSNKLTN---LDVTPLTKLTYLNCDTNKLTKL---DVSQNPLLTYLNCARNTLT-EI 142

Query: 264 PNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLG-LPNL 322
              + +   L  L    +     +   +   + L  L  + N +     + +D+     L
Sbjct: 143 D--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKI-----TELDVSQNKLL 193

Query: 323 ERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTS 382
            RL    NN +    +       L+ LD   N  + +       L  L     + N LT 
Sbjct: 194 NRLNCDTNNITKLDLNQNIQ---LTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLTE 247

Query: 383 PTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKEL 442
                     +++   L  ++  +  +  I    + + +  +     E C     +  ++
Sbjct: 248 L--------DVSTLSKLTTLHCIQTDLLEI---DLTHNT-QLIYFQAEGCRKIKEL--DV 293

Query: 443 GNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLG 502
            +   L ++      +T  +   L +  KL  LYL N +L   +  D+ H  +L +L   
Sbjct: 294 THNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-EL--DVSHNTKLKSLSCV 347

Query: 503 DNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLP 560
           +  +     + +G + +L +         ++   TL N    +  +       G+ + 
Sbjct: 348 NAHIQD-FSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN 403

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  131 bits (331), Expect = 1e-32
 Identities = 70/434 (16%), Positives = 138/434 (31%), Gaps = 54/434 (12%)

Query: 147 LQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFI 206
               +            +   L+ L  LD  ++ ++        +++  + L  L  L  
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT--------DMTGIEKLTGLTKLIC 71

Query: 207 SYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNE 266
           + N +T     +L +   L  ++   NK       D+  LT +  L    N L  ++   
Sbjct: 72  TSNNITTL---DLSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLT-KLD-- 122

Query: 267 IGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLF 326
           +     L  L    + L  +    + + + L EL    N  +  L  +       L  L 
Sbjct: 123 VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLDVT---PQTQLTTLD 176

Query: 327 LGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPD 386
              N  +    S       L+ L+   N+ + L          L  L  + N LT     
Sbjct: 177 CSFNKITELDVSQNKL---LNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE---- 226

Query: 387 LSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNIN 446
                 +T    L     S NP+  +    +   S  + +L     ++      E+   +
Sbjct: 227 ----IDVTPLTQLTYFDCSVNPLTEL---DVSTLS-KLTTLHCIQTDLL-----EIDLTH 273

Query: 447 NLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKL 506
           N  +I            + +    +L  L  Q   +   +  DL    +L  LYL + +L
Sbjct: 274 NTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-EL--DLSQNPKLVYLYLNNTEL 330

Query: 507 SGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLK 566
           +  L   + + T L+ LS  +  +     S++  +  +     +           + N  
Sbjct: 331 T-ELD--VSHNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTITMPKETLTNNS 385

Query: 567 VVIEMDLSLNALSG 580
           + I +   L    G
Sbjct: 386 LTIAVSPDLLDQFG 399

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  130 bits (330), Expect = 2e-32
 Identities = 65/402 (16%), Positives = 124/402 (30%), Gaps = 50/402 (12%)

Query: 250 RNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLG 309
            +       +          L  L  L   +S++  +    I  ++ L +L  T N++  
Sbjct: 21  ASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTG--IEKLTGLTKLICTSNNI-- 76

Query: 310 SLPSSIDL-GLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLR 368
              +++DL    NL  L    N  +    + LT    L+ L+   N  + L         
Sbjct: 77  ---TTLDLSQNTNLTYLACDSNKLTNLDVTPLTK---LTYLNCDTNKLTKL---DVSQNP 127

Query: 369 SLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLS 428
            L  L+ A N LT           ++    L  +    N     L   +   +  + +L 
Sbjct: 128 LLTYLNCARNTLTEI--------DVSHNTQLTELDCHLNKKITKLD--VTPQT-QLTTLD 176

Query: 429 MESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPE 488
                I+     ++     L  +    N +T    + L +  +L  L   +NKL   I  
Sbjct: 177 CSFNKITEL---DVSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT-EI-- 227

Query: 489 DLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFN 548
           D+  L +L       N L+  L   +  L+ L  L      L  I  +    L       
Sbjct: 228 DVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLEIDLTHNTQLI-----Y 279

Query: 549 LSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPE 608
             +         D+ +   +  +D     ++    + +     L  L L    L   +  
Sbjct: 280 FQAEGCRKIKELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELTE-LD- 334

Query: 609 SFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQL 650
                  L  +   N ++      S+  +  L +   +  Q 
Sbjct: 335 -VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQT 373

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  129 bits (325), Expect = 9e-32
 Identities = 64/382 (16%), Positives = 124/382 (32%), Gaps = 50/382 (13%)

Query: 272 NLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDL--GLPNLERLFLGE 329
           N       +  +      S   ++TL  L   ++ +     + +     L  L +L    
Sbjct: 19  NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI-----TDMTGIEKLTGLTKLICTS 73

Query: 330 NNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSF 389
           NN +    S  TN   L+ L    N  + L       L  L  L+   N LT        
Sbjct: 74  NNITTLDLSQNTN---LTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLTK------- 120

Query: 390 LSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLT 449
              ++    L  +  + N +  I    + + +  +  L             ++     LT
Sbjct: 121 -LDVSQNPLLTYLNCARNTLTEI---DVSHNT-QLTELDCHLNKKIT--KLDVTPQTQLT 173

Query: 450 VIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGR 509
            +    N++T    + + + + L  L    N +   +  DL    +L  L    NKL+  
Sbjct: 174 TLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KL--DLNQNIQLTFLDCSSNKLT-E 226

Query: 510 LPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVI 569
           +   +  LT L       N LT +  STL  L  +   +     L   +  D+ +   +I
Sbjct: 227 ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTL---HCIQTDLL-EI--DLTHNTQLI 278

Query: 570 EMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGT 629
                      +  + +     L LL  +   +             L ++ ++N  L+  
Sbjct: 279 Y--FQAEGCRKIKELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-E 332

Query: 630 IPKSMEALSYLKHLNLSFNQLE 651
           +  S    + LK L+     ++
Sbjct: 333 LDVS--HNTKLKSLSCVNAHIQ 352

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 99.0 bits (247), Expect = 9e-22
 Identities = 60/394 (15%), Positives = 125/394 (31%), Gaps = 43/394 (10%)

Query: 72  NRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFN 131
             ++T LN     LT  +   +     L  L    N+    +   +SH   L   D   N
Sbjct: 105 LTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTL-TEID--VSHNTQLTELDCHLN 158

Query: 132 NFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFN 191
               ++        +L  L    N         +    LL  L+   N ++  +  +   
Sbjct: 159 KKITKLD--VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLDLN--- 209

Query: 192 ISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRN 251
                    L  L  S N+LT     ++    +L     + N        D+  L+ +  
Sbjct: 210 -----QNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLT---ELDVSTLSKLTT 258

Query: 252 LFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSL 311
           L      L+ EI   + +   L     +      +    + + + L  L      +    
Sbjct: 259 LHCIQTDLL-EID--LTHNTQLIYFQAEGCRK--IKELDVTHNTQLYLLDCQAAGI---- 309

Query: 312 PSSIDLG-LPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSL 370
            + +DL   P L  L+L     +  +   +++ ++L  L            ++ G + +L
Sbjct: 310 -TELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQDF--SSVGKIPAL 363

Query: 371 KLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSME 430
                A     +   +    +SLT   + +++    NP+N I P   G +  +  +++ E
Sbjct: 364 NNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN-IEPGDGGVYDQATNTITWE 422

Query: 431 SCNISGGIPKELGNINNLTVIRLGNNELTGTIPV 464
           + +             N  ++           P+
Sbjct: 423 NLSTDNPAVTYTFTSENGAIVGTVTTPFEAPQPI 456

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 57.4 bits (139), Expect = 1e-08
 Identities = 24/160 (15%), Positives = 58/160 (36%), Gaps = 14/160 (8%)

Query: 496 LANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLN 555
            A+      ++          L +L  L   ++++T +  + +  L  + +   +SN++ 
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT 77

Query: 556 GSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKS 615
                D+     +  +    N L+ +    +  L  L  L+   N+L             
Sbjct: 78  T---LDLSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLT---KLDVSQNPL 128

Query: 616 LNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIP 655
           L +++ + N L+  I  S    + L  L+   N+   ++ 
Sbjct: 129 LTYLNCARNTLT-EIDVSH--NTQLTELDCHLNKKITKLD 165

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  129 bits (326), Expect = 6e-33
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 17/206 (8%)

Query: 767 KLLGMGSFGSVYKGVL--PDGMEI--AAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVK 821
           K++G G  G V  G L  P   ++  A K     + +     F +E  +MG   H N+++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL---HFGY 878
           +    +      +V EYM NGSL+  L + +    I+Q + ++  V + + YL    +  
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY-- 172

Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGRE 936
               VH D+   NVL++ ++V  +SDFG++++L  +     T T G   I + APE    
Sbjct: 173 ----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228

Query: 937 GKVSRKCDVYSYGIMLMETFTK-KKP 961
              S   DV+S+G+++ E     ++P
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGERP 254

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  129 bits (327), Expect = 6e-33
 Identities = 69/321 (21%), Positives = 119/321 (37%), Gaps = 39/321 (12%)

Query: 308 LGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNL 367
           L ++P  I    P+   L L  N+ S         +  L  L    N  S +    F  L
Sbjct: 45  LKAVPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPL 101

Query: 368 RSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSL 427
           R L+ L ++ N L    P+L          +L  + + +N I  +          +M  +
Sbjct: 102 RKLQKLYISKNHLVEIPPNLP--------SSLVELRIHDNRIRKVPKGVFSGLR-NMNCI 152

Query: 428 SMESCNI-SGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSI 486
            M    + + G      +   L  +R+   +LT  IP  L   + L  L+L +NK++ +I
Sbjct: 153 EMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AI 208

Query: 487 PE-DLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDIL 545
              DL    +L  L LG N++       L  L +LR+L L +N L+  +P+ L +LK + 
Sbjct: 209 ELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQ 267

Query: 546 RFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGP 605
              L +N++                  + +N    V             +SL  N +   
Sbjct: 268 VVYLHTNNIT----------------KVGVNDFCPVGFGV--KRAYYNGISLFNNPVPYW 309

Query: 606 I--PESFGGLKSLNFVDMSNN 624
              P +F  +     +   N 
Sbjct: 310 EVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  121 bits (305), Expect = 4e-30
 Identities = 67/315 (21%), Positives = 117/315 (37%), Gaps = 33/315 (10%)

Query: 377 GNVLTSPTPDLSFLSSLTS------CR-NLEIIYLSENPINGILPSSIGNFSISMKSLSM 429
           G   TS  PDL  L    S      C  +L ++  S+  +  + P  I   S     L +
Sbjct: 6   GAETTSGIPDLDSLPPTYSAMCPFGCHCHLRVVQCSDLGLKAV-PKEI---SPDTTLLDL 61

Query: 430 ESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPED 489
           ++ +IS     +   + +L  + L NN+++         L+KLQ LY+  N L   IP +
Sbjct: 62  QNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPN 120

Query: 490 LCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTS--IIPSTLWNLKDILRF 547
           L     L  L + DN++          L ++  + +G N L +    P     LK  L +
Sbjct: 121 L--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK--LNY 176

Query: 548 -NLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPI 606
             +S   L  + +P     + + E+ L  N +  +    +     L  L L +N+++   
Sbjct: 177 LRISEAKL--TGIPK-DLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIE 233

Query: 607 PESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAE 666
             S   L +L  + + NN LS  +P  +  L  L+ + L  N +                
Sbjct: 234 NGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT----------KVGVN 282

Query: 667 SFLGNQALCGSPKLQ 681
            F             
Sbjct: 283 DFCPVGFGVKRAYYN 297

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  113 bits (284), Expect = 2e-27
 Identities = 71/342 (20%), Positives = 111/342 (32%), Gaps = 69/342 (20%)

Query: 145 PRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGL 204
           P    L L++N       +    L  L  L L +N++S  I    F       L  L+ L
Sbjct: 54  PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAF-----SPLRKLQKL 107

Query: 205 FISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIP 264
           +IS N L   IP NL                           +S+  L + +N  I ++P
Sbjct: 108 YISKNHLVE-IPPNL--------------------------PSSLVELRIHDNR-IRKVP 139

Query: 265 NEI-GNLRNLEVLGVQSSNLAGL-IPASIFNISTLKELAVTDNDLLGSLPSSIDLGLP-N 321
             +   LRN+  + +  + L         F+   L  L +++  L     + I   LP  
Sbjct: 140 KGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKL-----TGIPKDLPET 194

Query: 322 LERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLT 381
           L  L L  N         L   S+L  L  G N    +   +   L +L+ L L  N L+
Sbjct: 195 LNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS 254

Query: 382 SPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKE 441
                L  L      + L+++YL  N I  +  +        +K                
Sbjct: 255 RVPAGLPDL------KLLQVVYLHTNNITKVGVNDFCPVGFGVKRAY------------- 295

Query: 442 LGNINNLTVIRLGNNELTGTI--PVTLGRLQKLQGLYLQNNK 481
                    I L NN +      P T   +     +   N K
Sbjct: 296 ------YNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  129 bits (326), Expect = 7e-33
 Identities = 67/318 (21%), Positives = 122/318 (38%), Gaps = 50/318 (15%)

Query: 745  QATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGME-----IAAKVFHMEF-D 798
            QA  R +   +  +        K+LG G+FG+VYKG+     E     +A K        
Sbjct: 6    QALLRILKETEFKKI-------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP 58

Query: 799  GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDIL 858
             + +    E  VM S+ + ++ +++  C  +  + L+ + M  G L   +      +   
Sbjct: 59   KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ 117

Query: 859  QRLKIMIDVASALEYL---HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE 915
              L   + +A  + YL           VH D+   NVL+       ++DFG+AK+LG EE
Sbjct: 118  YLLNWCVQIAKGMNYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171

Query: 916  SMRQTKTLGT---IGYMAPEYGREGKVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMS 971
               +    G    I +MA E       + + DV+SYG+ + E  T   KP D I A E+ 
Sbjct: 172  K--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI- 228

Query: 972  LKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKD 1031
                          + +     L            C   ++ + + C +   + R   ++
Sbjct: 229  -------------SSILEKGERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRE 268

Query: 1032 VANRLVRIRETLSAYIDV 1049
            +     ++      Y+ +
Sbjct: 269  LIIEFSKMARDPQRYLVI 286

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  128 bits (325), Expect = 8e-33
 Identities = 59/245 (24%), Positives = 90/245 (36%), Gaps = 18/245 (7%)

Query: 721 RRRRRRRRRQKGSTRPYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKG 780
            + + RR   +G       +  Y  +       Q        F     LG GS+G V+K 
Sbjct: 24  HQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQS-------FQRLSRLGHGSYGEVFKV 76

Query: 781 V-LPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSI-RHRNLVKIISSCSNNDFKALVL 836
               DG   A K     F G  +      E      + +H   V++  +        L  
Sbjct: 77  RSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136

Query: 837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE 896
           E     SL++   +    L   Q    + D   AL +LH   S  +VH D+KP+N+ L  
Sbjct: 137 EL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGP 192

Query: 897 SMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETF 956
                L DFG+   LG   +    +  G   YMAPE   +G      DV+S G+ ++E  
Sbjct: 193 RGRCKLGDFGLLVELGTAGAGEVQE--GDPRYMAPEL-LQGSYGTAADVFSLGLTILEVA 249

Query: 957 TKKKP 961
              + 
Sbjct: 250 CNMEL 254

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  131 bits (330), Expect = 2e-32
 Identities = 46/210 (21%), Positives = 95/210 (45%), Gaps = 18/210 (8%)

Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVM-GSIRHRNLVK 821
           F    +LG G+ G++    + D  ++A K    E     +    E +++  S  H N+++
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVIR 82

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
              +  +  F+ + +E  +  +L++ +   ++    L+ + ++    S L +LH   S  
Sbjct: 83  YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLN 138

Query: 882 IVHCDIKPSNVLL-----NESMVGHLSDFGIAKILGKEE-SMRQTKTL-GTIGYMAPEY- 933
           IVH D+KP N+L+     +  +   +SDFG+ K L     S  +   + GT G++APE  
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198

Query: 934 --GREGKVSRKCDVYSYGIMLMETFTKKKP 961
               +   +   D++S G +     ++   
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  127 bits (322), Expect = 2e-32
 Identities = 50/211 (23%), Positives = 90/211 (42%), Gaps = 22/211 (10%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNL--VKI 822
           K +G G    V++ +       A K  ++E   + +L+S+  E   +  ++  +   +++
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
                 + +  +V+E   N  L   L       D  +R     ++  A+  +H      I
Sbjct: 94  YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIH---QHGI 148

Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGYMAPE--------- 932
           VH D+KP+N L+ + M+  L DFGIA  +  + +     +  GT+ YM PE         
Sbjct: 149 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207

Query: 933 --YGREGKVSRKCDVYSYGIMLMETFTKKKP 961
                + K+S K DV+S G +L      K P
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  133 bits (337), Expect = 2e-32
 Identities = 53/204 (25%), Positives = 90/204 (44%), Gaps = 16/204 (7%)

Query: 767 KLLGMGSFGSVYKGVL--PDGMEI--AAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVK 821
           + +G G FG V++G+   P+   +  A K       D   E F  E   M    H ++VK
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL---HFGY 878
           +I   + N    +++E  + G L   L    + LD+   +     +++AL YL    F  
Sbjct: 456 LIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF-- 512

Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGK 938
               VH DI   NVL++ +    L DFG+++ +      + +K    I +MAPE     +
Sbjct: 513 ----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 568

Query: 939 VSRKCDVYSYGIMLMETFTK-KKP 961
            +   DV+ +G+ + E      KP
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKP 592

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  129 bits (325), Expect = 3e-32
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 17/206 (8%)

Query: 767 KLLGMGSFGSVYKGVL--PDGMEI--AAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVK 821
           K++G G FG V  G L  P   EI  A K   + + +     F  E  +MG   H N+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL---HFGY 878
           +    + +    +V EYM NGSL+  L   +    ++Q + ++  +AS ++YL    +  
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY-- 168

Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGRE 936
               VH D+   N+L+N ++V  +SDFG+ ++L  +     T   G   I + +PE    
Sbjct: 169 ----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224

Query: 937 GKVSRKCDVYSYGIMLMETFTK-KKP 961
            K +   DV+SYGI+L E  +  ++P
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERP 250

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  126 bits (318), Expect = 3e-32
 Identities = 52/222 (23%), Positives = 92/222 (41%), Gaps = 27/222 (12%)

Query: 758 RATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRH 816
           R    F E +L+G G FG V+K     DG     K          E    E K +  + H
Sbjct: 8   RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDH 63

Query: 817 RNLVKIISSCSNNDFKA----------------LVLEYMSNGSLEKCLYSDN-YFLDILQ 859
            N+V         D+                  + +E+   G+LE+ +       LD + 
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123

Query: 860 RLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ 919
            L++   +   ++Y+H   S  +++ D+KPSN+ L ++    + DFG+   L  +     
Sbjct: 124 ALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-- 178

Query: 920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           T++ GT+ YM+PE        ++ D+Y+ G++L E       
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  127 bits (321), Expect = 4e-32
 Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 18/207 (8%)

Query: 767 KLLGMGSFGSVYKGVL-----PDGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLV 820
           K++G G FG VYKG+L        + +A K     + +     F  E  +MG   H N++
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109

Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL---HFG 877
           ++    S      ++ EYM NG+L+K L   +    +LQ + ++  +A+ ++YL   ++ 
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY- 168

Query: 878 YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT--IGYMAPEYGR 935
                VH D+   N+L+N ++V  +SDFG++++L  +     T + G   I + APE   
Sbjct: 169 -----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223

Query: 936 EGKVSRKCDVYSYGIMLMETFTK-KKP 961
             K +   DV+S+GI++ E  T  ++P
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERP 250

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  126 bits (319), Expect = 4e-32
 Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 18/210 (8%)

Query: 767 KLLGMGSFGSVYKG---VLPDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLV 820
           +L+G G  G VY+    V      +A K+                 E +  G ++  ++V
Sbjct: 40  RLVGRGGMGDVYEAEDTVRER--IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97

Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
            I      +    + +  ++   L   L      L   + + I+  + SAL+  H   + 
Sbjct: 98  PIHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAH---AA 153

Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT-LGTIGYMAPEYGREGKV 939
              H D+KP N+L++     +L DFGIA     +E + Q    +GT+ YMAPE   E   
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSESHA 212

Query: 940 SRKCDVYSYGIMLMETFTKKKPTDEIFAGE 969
           + + D+Y+   +L E  T   P    + G+
Sbjct: 213 TYRADIYALTCVLYECLTGSPP----YQGD 238

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  129 bits (327), Expect = 5e-32
 Identities = 69/194 (35%), Positives = 98/194 (50%), Gaps = 12/194 (6%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
           + +G G FG V  G    G ++A K   ++ D + ++F AE  VM  +RH NLV+++   
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 827 SNNDFKA-LVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                   +V EYM+ GSL   L S     L     LK  +DV  A+EYL        VH
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 312

Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCD 944
            D+   NVL++E  V  +SDFG+ K    E S  Q      + + APE  RE K S K D
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 368

Query: 945 VYSYGIMLMETFTK 958
           V+S+GI+L E ++ 
Sbjct: 369 VWSFGILLWEIYSF 382

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  126 bits (319), Expect = 7e-32
 Identities = 50/211 (23%), Positives = 90/211 (42%), Gaps = 22/211 (10%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNL--VKI 822
           K +G G    V++ +       A K  ++E   + +L+S+  E   +  ++  +   +++
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
                 + +  +V+E   N  L   L       D  +R     ++  A+  +H      I
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIH---QHGI 129

Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGYMAPE--------- 932
           VH D+KP+N L+ + M+  L DFGIA  +  + +     +  GT+ YM PE         
Sbjct: 130 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188

Query: 933 --YGREGKVSRKCDVYSYGIMLMETFTKKKP 961
                + K+S K DV+S G +L      K P
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  126 bits (318), Expect = 7e-32
 Identities = 63/300 (21%), Positives = 123/300 (41%), Gaps = 48/300 (16%)

Query: 766  NKLLGMGSFGSVYKGVLPDG----MEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNL 819
             K+LG G FGSV +G L       +++A K   ++      +E F +E   M    H N+
Sbjct: 39   GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 820  VKIISSCSNNDFKA-----LVLEYMSNGSL-----EKCLYSDNYFLDILQRLKIMIDVAS 869
            ++++  C     +      ++L +M  G L        L +    + +   LK M+D+A 
Sbjct: 99   IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 870  ALEYL---HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK-ILGKEESMRQTKTLGT 925
             +EYL   +F      +H D+   N +L + M   ++DFG++K I   +   +       
Sbjct: 159  GMEYLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212

Query: 926  IGYMAPEYGREGKVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLLSCS 984
            + ++A E   +   + K DV+++G+ + E  T+   P   +   EM              
Sbjct: 213  VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM-------------- 258

Query: 985  ITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044
               +   + L   E+       C+  ++ +   C    P  R +   +  +L ++ E+L 
Sbjct: 259  YDYLLHGHRLKQPED-------CLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  125 bits (316), Expect = 1e-31
 Identities = 53/239 (22%), Positives = 90/239 (37%), Gaps = 10/239 (4%)

Query: 419 NFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELT--GTIPVTLGRLQKLQGLY 476
               S   L +ES  +          +  LT + L +N L+  G    +      L+ L 
Sbjct: 25  GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84

Query: 477 LQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPAC--LGNLTSLRDLSLGSNALTSII 534
           L  N +  ++  +   L +L +L    + L  ++       +L +L  L +         
Sbjct: 85  LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAF 142

Query: 535 PSTLWNLKDILRFNLSSNSLNGSLLPDI-GNLKVVIEMDLSLNALSGVIPVTIGGLQGLQ 593
                 L  +    ++ NS   + LPDI   L+ +  +DLS   L  + P     L  LQ
Sbjct: 143 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 202

Query: 594 LLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSM--EALSYLKHLNLSFNQL 650
           +L++ +N         +  L SL  +D S N++  T  K       S L  LNL+ N  
Sbjct: 203 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  115 bits (289), Expect = 3e-28
 Identities = 55/254 (21%), Positives = 103/254 (40%), Gaps = 18/254 (7%)

Query: 161 IPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLT--GPIPTN 218
           +P  I   S    L+L  N+L  ++P  +F       L  L  L +S N L+  G    +
Sbjct: 22  VPTGI--PSSATRLELESNKLQ-SLPHGVF-----DKLTQLTKLSLSSNGLSFKGCCSQS 73

Query: 219 LWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNE--IGNLRNLEVL 276
            +    L  + L+FN     +  +   L  + +L   +++ + ++       +LRNL  L
Sbjct: 74  DFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSN-LKQMSEFSVFLSLRNLIYL 131

Query: 277 GVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTI 336
            +  ++           +S+L+ L +  N    +    I   L NL  L L +       
Sbjct: 132 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 191

Query: 337 PSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSC 396
           P++  ++S L VL+   N+F  L    +  L SL++L  + N + +       L    S 
Sbjct: 192 PTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE--LQHFPS- 248

Query: 397 RNLEIIYLSENPIN 410
            +L  + L++N   
Sbjct: 249 -SLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  108 bits (273), Expect = 4e-26
 Identities = 51/323 (15%), Positives = 95/323 (29%), Gaps = 83/323 (25%)

Query: 308 LGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFN--SFSGLIPTTFG 365
           L S+P+ I     +  RL L  N            +++L+ L    N  SF G    +  
Sbjct: 19  LTSVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDF 75

Query: 366 NLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMK 425
              SLK L L+ N + + + +   L        LE +    + +  +   S+        
Sbjct: 76  GTTSLKYLDLSFNGVITMSSNFLGLE------QLEHLDFQHSNLKQMSEFSV-------- 121

Query: 426 SLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGS 485
                             ++ NL  + + +             L  L+ L +  N  + +
Sbjct: 122 ----------------FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 165

Query: 486 IPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDIL 545
              D+                          L +L  L L    L  + P+   +L  + 
Sbjct: 166 FLPDI-----------------------FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 202

Query: 546 RFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGP 605
             N+S N+                   L               L  LQ+L    N +   
Sbjct: 203 VLNMSHNNFF----------------SLDTFPYKC--------LNSLQVLDYSLNHIMTS 238

Query: 606 IPESFGGL-KSLNFVDMSNNNLS 627
             +       SL F++++ N+ +
Sbjct: 239 KKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 79.7 bits (197), Expect = 3e-16
 Identities = 42/192 (21%), Positives = 68/192 (35%), Gaps = 14/192 (7%)

Query: 73  RRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEE--LSHLRGLKYFDFRF 130
             +  L++S+ G+  T+      L  L  L  ++++    + E      LR L Y D   
Sbjct: 78  TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLSLRNLIYLDISH 135

Query: 131 NNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETI-GYLSLLQELDLSDNQLSGTIPSSI 189
            +  +     F  L  L+ L +  NSF       I   L  L  LDLS  QL   +  + 
Sbjct: 136 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTA 194

Query: 190 FNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDI--GNLT 247
           F      +L  L+ L +S+N               L V+  + N       +       +
Sbjct: 195 F-----NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPS 248

Query: 248 SVRNLFLGNNSL 259
           S+  L L  N  
Sbjct: 249 SLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 75.4 bits (186), Expect = 9e-15
 Identities = 36/185 (19%), Positives = 65/185 (35%), Gaps = 33/185 (17%)

Query: 475 LYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALT--S 532
           +   +  L  S+P  +        L L  NKL          LT L  LSL SN L+   
Sbjct: 12  IRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68

Query: 533 IIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGL 592
               + +    +   +LS N +                           +     GL+ L
Sbjct: 69  CCSQSDFGTTSLKYLDLSFNGVI-------------------------TMSSNFLGLEQL 103

Query: 593 QLLSLRYNRLQGPIPES-FGGLKSLNFVDMSNNNLSGTIPKSM-EALSYLKHLNLSFNQL 650
           + L  +++ L+     S F  L++L ++D+S+ +        +   LS L+ L ++ N  
Sbjct: 104 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSF 162

Query: 651 EGEIP 655
           +    
Sbjct: 163 QENFL 167

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  127 bits (321), Expect = 1e-31
 Identities = 49/211 (23%), Positives = 89/211 (42%), Gaps = 22/211 (10%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNL--VKI 822
           K +G G    V++ +       A K  ++E   + +L+S+  E   +  ++  +   +++
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
                 + +  +V+E   N  L   L       D  +R     ++  A+  +H      I
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIH---QHGI 176

Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGYMAPE--------- 932
           VH D+KP+N L+ + M+  L DFGIA  +  + +     +  G + YM PE         
Sbjct: 177 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR 235

Query: 933 --YGREGKVSRKCDVYSYGIMLMETFTKKKP 961
                + K+S K DV+S G +L      K P
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  125 bits (316), Expect = 1e-31
 Identities = 62/306 (20%), Positives = 120/306 (39%), Gaps = 49/306 (16%)

Query: 766  NKLLGMGSFGSVYKGVLPDG----MEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNL 819
             ++LG G FGSV +  L       +++A K+   +      +E F  E   M    H ++
Sbjct: 28   GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 820  VKIISSCSNNDFKA------LVLEYMSNGSL-----EKCLYSDNYFLDILQRLKIMIDVA 868
             K++     +  K       ++L +M +G L        +  + + L +   ++ M+D+A
Sbjct: 88   AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 869  SALEYL---HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA-KILGKEESMRQTKTLG 924
              +EYL   +F      +H D+   N +L E M   ++DFG++ KI   +   +   +  
Sbjct: 148  CGMEYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201

Query: 925  TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLLSC 983
             + ++A E   +   +   DV+++G+ + E  T+ + P   I   E+             
Sbjct: 202  PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI------------- 248

Query: 984  SITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043
                +   N L            C+  ++ L   C    P++R S   +   L  I   L
Sbjct: 249  -YNYLIGGNRLKQPPE-------CMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300

Query: 1044 SAYIDV 1049
            S     
Sbjct: 301  SVLSTS 306

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  124 bits (313), Expect = 2e-31
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 32/226 (14%)

Query: 757 LRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR 815
           LR    F E  +LG G+FG V K     D    A K      +  L +  +E  ++ S+ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLN 60

Query: 816 HRNLVKIISSCSNNDFKA-------------LVLEYMSNGSLEKCLYSDNYFLDILQRLK 862
           H+ +V+  ++                     + +EY  NG+L   ++S+N      +  +
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120

Query: 863 IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ--- 919
           +   +  AL Y+H   S  I+H D+KP N+ ++ES    + DFG+AK + +   + +   
Sbjct: 121 LFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 920 ----------TKTLGTIGYMAPE-YGREGKVSRKCDVYSYGIMLME 954
                     T  +GT  Y+A E     G  + K D+YS GI+  E
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  129 bits (326), Expect = 2e-31
 Identities = 103/496 (20%), Positives = 182/496 (36%), Gaps = 54/496 (10%)

Query: 145 PRLQHLLLKHNSFVGKIPET-IGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEG 203
           PR + L L  NS   ++    I +LS L+ L LS N++  ++   +F          LE 
Sbjct: 52  PRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVF-----LFNQDLEY 104

Query: 204 LFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEI 263
           L +S+N+L                 +++              + S+R+L L  N     +
Sbjct: 105 LDVSHNRLQ----------------NISC-----------CPMASLRHLDLSFNDFD-VL 136

Query: 264 P--NEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLL--GSLPSSIDLGL 319
           P   E GNL  L  LG+ ++    L    + ++     L    +  +  G   S      
Sbjct: 137 PVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNT 196

Query: 320 PNLERLFLGENNFSGTIPSSLTNISELSV--LDFGFNSFSGLIPTTFGNLRSLKLLSLAG 377
             L  +F   + FS  +  S+  +  L +  +     +   L+       R   LL++  
Sbjct: 197 TVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTL 256

Query: 378 NVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFS-ISMKSLSMESCNISG 436
             + +       L      R +E + +    I   +      +S  ++KSL +E      
Sbjct: 257 QHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQV 316

Query: 437 GIPKELG---NINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHL 493
            +  +         + +  L  ++      V          L    N    S+ +    L
Sbjct: 317 FLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTL 376

Query: 494 YRLANLYLGDNKLS--GRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRF-NLS 550
            RL  L L  N L    ++     N++SL  L +  N+L S          + +   NLS
Sbjct: 377 KRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLS 436

Query: 551 SNSLNGSLLPDI-GNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPES 609
           SN L GS+   +   +KV   +DL  N +   IP  +  LQ LQ L++  N+L+      
Sbjct: 437 SNMLTGSVFRCLPPKVKV---LDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGV 492

Query: 610 FGGLKSLNFVDMSNNN 625
           F  L SL ++ + +N 
Sbjct: 493 FDRLTSLQYIWLHDNP 508

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  113 bits (283), Expect = 5e-26
 Identities = 84/513 (16%), Positives = 165/513 (32%), Gaps = 41/513 (7%)

Query: 59  SVCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELS 118
           ++   +G      N   + ++ S   LT  +P           L++  NS       ++S
Sbjct: 17  ALALIVGSMTPFSNELESMVDYSNRNLT-HVPK--DLPPRTKALSLSQNSISELRMPDIS 73

Query: 119 HLRGLKYFDFRFNNFHIEIPSW-FVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLS 177
            L  L+      N     +    F+    L++L + HN     I      ++ L+ LDLS
Sbjct: 74  FLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NIS--CCPMASLRHLDLS 129

Query: 178 DNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLT-GPIPTNLWKCRELHVVSLAFNKFQ 236
            N          F      NL  L  L +S  +     +           ++ L     +
Sbjct: 130 FNDFDVLPVCKEF-----GNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIK 184

Query: 237 GGIPRDIGNL-TSVRNLFLGNNSLIGEIPNEIGN------LRNLEVLGVQSSNLAGLIPA 289
           GG    +    T+V +L    NSL     N   N      L N+++       L   +  
Sbjct: 185 GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSE 244

Query: 290 SIFNIS----TLKELAVTDNDLLGSLPSSIDLGLP--NLERLFLGENNFSGTIPSSLTNI 343
                +    TL+ +  T    +          +   N+  L + E         S T +
Sbjct: 245 LTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETAL 304

Query: 344 SELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIY 403
             L +       F       +     + +  L+ +                S  +   + 
Sbjct: 305 KSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPP-----SPSSFTFLN 359

Query: 404 LSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELT---- 459
            ++N     +          +++L ++   +     K      N++ +   +  L     
Sbjct: 360 FTQNVFTDSVFQGCSTLK-RLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNS 417

Query: 460 GTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTS 519
                T    + +  L L +N L GS+   L    ++  L L +N++   +P  + +L +
Sbjct: 418 HAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQA 474

Query: 520 LRDLSLGSNALTSIIPSTLWNLKDILRFNLSSN 552
           L++L++ SN L S+       L  +    L  N
Sbjct: 475 LQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 97.6 bits (243), Expect = 4e-21
 Identities = 65/401 (16%), Positives = 132/401 (32%), Gaps = 17/401 (4%)

Query: 272 NLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENN 331
             + L +  ++++ L    I  +S L+ L ++ N  + SL   + L   +LE L +  N 
Sbjct: 53  RTKALSLSQNSISELRMPDISFLSELRVLRLSHN-RIRSLDFHVFLFNQDLEYLDVSHNR 111

Query: 332 FSGTIPSSLTNISELSVLDFGFNSFSGL-IPTTFGNLRSLKLLSLAGNVLTS-PTPDLSF 389
                   + +   L  LD  FN F  L +   FGNL  L  L L+           ++ 
Sbjct: 112 LQNISCCPMAS---LRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAH 168

Query: 390 LSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGI-PKELGNINNL 448
           L       +L   ++       +   +     +     S+ S  ++  +       ++N+
Sbjct: 169 LHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNI 228

Query: 449 TVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLY--RLANLYLGDNKL 506
            +       L   +         L               +     +   +  L + +  +
Sbjct: 229 KLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTI 288

Query: 507 SGR-----LPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPD 561
           + R            L SL    + +        +      ++    LS +      +  
Sbjct: 289 TERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVC 348

Query: 562 IGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQ--GPIPESFGGLKSLNFV 619
             +      ++ + N  +  +      L+ LQ L L+ N L+    +      + SL  +
Sbjct: 349 PPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETL 408

Query: 620 DMSNNNL-SGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGP 659
           D+S N+L S    ++      +  LNLS N L G +    P
Sbjct: 409 DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP 449

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 91.5 bits (227), Expect = 4e-19
 Identities = 57/366 (15%), Positives = 114/366 (31%), Gaps = 36/366 (9%)

Query: 295 STLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSS----LTNISELSVLD 350
              K L+++ N  +  L       L  L  L L  N    ++         +   L  LD
Sbjct: 52  PRTKALSLSQN-SISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQD---LEYLD 106

Query: 351 FGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPIN 410
              N    +   +   + SL+ L L+ N      P      +LT    L  + LS     
Sbjct: 107 VSHNRLQNI---SCCPMASLRHLDLSFNDFDV-LPVCKEFGNLT---KLTFLGLSAAKFR 159

Query: 411 GILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQ 470
            +    + +  +S   L + S +I GG  + L   N   +  + +     ++ V +  + 
Sbjct: 160 QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMS-VN 218

Query: 471 KLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNAL 530
            L  L L N KL         +  RL        +    L        +L+ +       
Sbjct: 219 ALGHLQLSNIKLNDE------NCQRLMTFLSELTRGPTLLN------VTLQHIETTWKCS 266

Query: 531 TSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGN-----LKVVIEMDLSLNALSGVIPVT 585
             +     W  + +   N+ + ++   +  +        LK ++   +            
Sbjct: 267 VKLF-QFFWP-RPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEAL 324

Query: 586 IGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNL 645
                 + +  L  +              S  F++ + N  + ++ +    L  L+ L L
Sbjct: 325 YSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLIL 384

Query: 646 SFNQLE 651
             N L+
Sbjct: 385 QRNGLK 390

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 69.5 bits (170), Expect = 3e-12
 Identities = 46/321 (14%), Positives = 95/321 (29%), Gaps = 48/321 (14%)

Query: 47  SNLLANNWSTTSSVCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRN 106
           SN+  N+ +    +     +T G     VT  +I           Q      +  L I N
Sbjct: 226 SNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYN 285

Query: 107 NSFFGSLPEEL-----SHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKI 161
            +    +  E      + L+ L     +   F     + +     +   +L  +     I
Sbjct: 286 LTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISD-TPFI 344

Query: 162 PETI-GYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLW 220
                   S    L+ + N  +        +      L  L+ L +  N L         
Sbjct: 345 HMVCPPSPSSFTFLNFTQNVFT-DSVFQGCS-----TLKRLQTLILQRNGLKN------- 391

Query: 221 KCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSL----IGEIPNEIGNLRNLEVL 276
                               +      ++ +L   + SL                ++ VL
Sbjct: 392 ------------------FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVL 433

Query: 277 GVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTI 336
            + S+ L G +   +     +K L + +N ++ S+P  +   L  L+ L +  N    ++
Sbjct: 434 NLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVT-HLQALQELNVASNQLK-SV 488

Query: 337 P-SSLTNISELSVLDFGFNSF 356
           P      ++ L  +    N +
Sbjct: 489 PDGVFDRLTSLQYIWLHDNPW 509

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  123 bits (310), Expect = 4e-31
 Identities = 52/216 (24%), Positives = 91/216 (42%), Gaps = 32/216 (14%)

Query: 767 KLLGMGSFGSVYKGVL--------PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRN 818
           + LG G+F  ++KGV             E+  KV         ESF     +M  + H++
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73

Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL---H 875
           LV     C   D   LV E++  GSL+  L  +   ++IL +L++   +A+A+ +L    
Sbjct: 74  LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT 133

Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGH--------LSDFGIAKILGKEESMRQTKTLGTIG 927
                  +H ++   N+LL               LSD GI+  +  ++ +++      I 
Sbjct: 134 L------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQE-----RIP 182

Query: 928 YMAPEYGREGKV-SRKCDVYSYGIMLMETFTK-KKP 961
           ++ PE     K  +   D +S+G  L E  +   KP
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  122 bits (309), Expect = 6e-31
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 23/201 (11%)

Query: 763 FSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVK 821
           ++  + +G G+ G+VY  + +  G E+A +  +++     E    E  VM   ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK--------IMIDVASALEY 873
            + S    D   +V+EY++ GSL           D++            +  +   ALE+
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSL----------TDVVTETCMDEGQIAAVCRECLQALEF 131

Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
           LH   S  ++H DIK  N+LL       L+DFG    +  E+S R T  +GT  +MAPE 
Sbjct: 132 LH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEV 187

Query: 934 GREGKVSRKCDVYSYGIMLME 954
                   K D++S GIM +E
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIE 208

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  122 bits (309), Expect = 1e-30
 Identities = 61/299 (20%), Positives = 108/299 (36%), Gaps = 34/299 (11%)

Query: 761  DGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHME-FDGSLESFHAECKVMGSIRHRN 818
              +  + +LG G+  +V++G     G   A KVF+   F   ++    E +V+  + H+N
Sbjct: 9    HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 819  LVKI--ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQR--LKIMIDVASALEYL 874
            +VK+  I   +    K L++E+   GSL   L   +    + +   L ++ DV   + +L
Sbjct: 69   IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 875  HFGYSTPIVHCDIKPSNVLLNESMVGH----LSDFGIAKILGKEESMRQTKTL-GTIGYM 929
                   IVH +IKP N++      G     L+DFG A+ L  +E      +L GT  Y+
Sbjct: 129  R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLYGTEEYL 182

Query: 930  APE--------YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLL 981
             P+           + K     D++S G+      T   P           K  +   + 
Sbjct: 183  HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR-RNKEVMYKIIT 241

Query: 982  SCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDL--------PEKRISMKDV 1032
                  ++          D+S       S+          +         EK       
Sbjct: 242  GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  122 bits (309), Expect = 1e-30
 Identities = 51/201 (25%), Positives = 90/201 (44%), Gaps = 23/201 (11%)

Query: 763 FSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVK 821
                 +G GS G V        G ++A K+  +      E    E  +M   +H N+V+
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK--------IMIDVASALEY 873
           +  S    +   +++E++  G+L           DI+ +++        +   V  AL Y
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGAL----------TDIVSQVRLNEEQIATVCEAVLQALAY 156

Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
           LH   +  ++H DIK  ++LL       LSDFG    + K+   R++  +GT  +MAPE 
Sbjct: 157 LH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-LVGTPYWMAPEV 212

Query: 934 GREGKVSRKCDVYSYGIMLME 954
                 + + D++S GIM++E
Sbjct: 213 ISRSLYATEVDIWSLGIMVIE 233

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  121 bits (306), Expect = 1e-30
 Identities = 69/193 (35%), Positives = 96/193 (49%), Gaps = 12/193 (6%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
           + +G G FG V  G    G ++A K      D + ++F AE  VM  +RH NLV+++   
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 827 SNNDFKA-LVLEYMSNGSLEKCLYS-DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                   +V EYM+ GSL   L S     L     LK  +DV  A+EYL        VH
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 140

Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCD 944
            D+   NVL++E  V  +SDFG+ K    E S  Q      + + APE  RE K S K D
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 196

Query: 945 VYSYGIMLMETFT 957
           V+S+GI+L E ++
Sbjct: 197 VWSFGILLWEIYS 209

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  123 bits (310), Expect = 1e-30
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 8/203 (3%)

Query: 761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGS-LESFHAECKVMGSIRHRN 818
           D F +   LG G+ G V+K    P G+ +A K+ H+E   +       E +V+       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
           +V    +  ++   ++ +E+M  GSL++ +      +      K+ I V   L YL   +
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREKH 151

Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGK 938
              I+H D+KPSN+L+N      L DFG++  L   +SM  +   GT  YM+PE  +   
Sbjct: 152 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTH 206

Query: 939 VSRKCDVYSYGIMLMETFTKKKP 961
            S + D++S G+ L+E    + P
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYP 229

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  128 bits (322), Expect = 2e-30
 Identities = 46/211 (21%), Positives = 83/211 (39%), Gaps = 27/211 (12%)

Query: 768 LLGMGSFGSVYKG---VLPDGMEIAAKVFHMEFDGS-LESFHAECKVMGSIRHRNLVKII 823
            +  G  G +Y      + +G  +  K      D        AE + +  + H ++V+I 
Sbjct: 87  CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 824 SSCSNNDFKA-----LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
           +   + D        +V+EY+   SL++        L + + +  ++++  AL YLH   
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH--- 199

Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGK 938
           S  +V+ D+KP N++L E  +  L D G    +     +      GT G+ APE  R   
Sbjct: 200 SIGLVYNDLKPENIMLTEEQL-KLIDLGAVSRINSFGYL-----YGTPGFQAPEIVR-TG 252

Query: 939 VSRKCDVYSYGIMLMETFTKKKPTDEIFAGE 969
            +   D+Y+ G  L               G 
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPT----RNGR 279

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  122 bits (307), Expect = 2e-30
 Identities = 51/228 (22%), Positives = 81/228 (35%), Gaps = 24/228 (10%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISS 825
           + LG G F  V     L DG   A K          E    E  +     H N++++++ 
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94

Query: 826 CSNNDFKA----LVLEYMSNGSLEKCLY---SDNYFLDILQRLKIMIDVASALEYLHFGY 878
           C           L+L +   G+L   +        FL   Q L +++ +   LE +H   
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--- 151

Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL--------GTIGYMA 930
           +    H D+KP+N+LL +     L D G            +             TI Y A
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211

Query: 931 PE----YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
           PE          +  + DV+S G +L      + P D +F    S+  
Sbjct: 212 PELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  124 bits (312), Expect = 3e-30
 Identities = 69/305 (22%), Positives = 121/305 (39%), Gaps = 63/305 (20%)

Query: 763  FSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMG-SIRHRNLVK 821
                K+LG GS G+V       G  +A K   ++F    +    E K++  S  H N+++
Sbjct: 17   VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIR 73

Query: 822  IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL------KIMIDVASALEYLH 875
               S + + F  + LE   N +L+  + S N   + L+         ++  +AS + +LH
Sbjct: 74   YYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132

Query: 876  FGYSTPIVHCDIKPSNVLLNESMVGH-------------LSDFGIAKILGKEESMRQTKT 922
               S  I+H D+KP N+L++ S                 +SDFG+ K L   +S  +T  
Sbjct: 133  ---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 923  ---LGTIGYMAPE-------YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSL 972
                GT G+ APE          + +++R  D++S G +     +K K     F  + S 
Sbjct: 190  NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP---FGDKYS- 245

Query: 973  KRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDC-----TVDLPEKRI 1027
                             ++N++    +    +     S+ + A D        D P KR 
Sbjct: 246  ----------------RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHD-PLKRP 288

Query: 1028 SMKDV 1032
            +   V
Sbjct: 289  TAMKV 293

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  121 bits (306), Expect = 1e-29
 Identities = 61/305 (20%), Positives = 107/305 (35%), Gaps = 32/305 (10%)

Query: 761  DGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHME-FDGSLESFHAECKVMGSIRHRN 818
              +  + +LG G+  +V++G     G   A KVF+   F   ++    E +V+  + H+N
Sbjct: 9    HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 819  LVKI--ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQR--LKIMIDVASALEYL 874
            +VK+  I   +    K L++E+   GSL   L   +    + +   L ++ DV   + +L
Sbjct: 69   IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 875  HFGYSTPIVHCDIKPSNVLLNESMVGH----LSDFGIAKILGKEESMRQTKTLGTIGYMA 930
                   IVH +IKP N++      G     L+DFG A+ L  +E        GT  Y+ 
Sbjct: 129  R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLH 183

Query: 931  PE--------YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLS 982
            P+           + K     D++S G+      T   P           K  +   +  
Sbjct: 184  PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR-RNKEVMYKIITG 242

Query: 983  CSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDL--------PEKRISMKDVAN 1034
                 ++          D+S       S+          +         EK         
Sbjct: 243  KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302

Query: 1035 RLVRI 1039
                I
Sbjct: 303  ETSDI 307

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  120 bits (302), Expect = 1e-29
 Identities = 71/308 (23%), Positives = 127/308 (41%), Gaps = 52/308 (16%)

Query: 767  KLLGMGSFGSVYKGVLPDG------MEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLV 820
              LG G+FG V+     +       M +A K      + + + F  E +++  ++H+++V
Sbjct: 47   WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 821  KIISSCSNNDFKALVLEYMSNGSL--------------EKCLYSDNYFLDILQRLKIMID 866
            +    C+      +V EYM +G L                        L + Q L +   
Sbjct: 107  RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 867  VASALEYL---HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKT 922
            VA+ + YL   HF      VH D+   N L+ + +V  + DFG+++ +   +  R   +T
Sbjct: 167  VAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220

Query: 923  LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLL 981
            +  I +M PE     K + + DV+S+G++L E FT  K+P  ++   E            
Sbjct: 221  MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA----------- 269

Query: 982  SCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041
               I  +     L            C   ++++   C    P++R S+KDV  RL  + +
Sbjct: 270  ---IDCITQGRELERPRA-------CPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319

Query: 1042 TLSAYIDV 1049
                Y+DV
Sbjct: 320  APPVYLDV 327

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  124 bits (312), Expect = 1e-29
 Identities = 65/347 (18%), Positives = 117/347 (33%), Gaps = 42/347 (12%)

Query: 239 IPRDIGNLTSVRNLFLGNN--SLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNIST 296
           I   I N  S+      N       +  +         + G   +    L+   + N   
Sbjct: 3   IMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLIN--Q 60

Query: 297 LKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSF 356
             EL +   +L  SLP ++    P +  L + +N    ++P    +   L  LD   N  
Sbjct: 61  FSELQLNRLNL-SSLPDNL---PPQITVLEITQNALI-SLPELPAS---LEYLDACDNRL 112

Query: 357 SGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSS 416
           S L P    +L+ L +     N LT   P+L           LE I    N +   LP  
Sbjct: 113 STL-PELPASLKHLDV---DNNQLTM-LPEL--------PALLEYINADNNQLTM-LPEL 158

Query: 417 IGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQ--- 473
             +    ++ LS+ +  ++  +P+   +   L  + +  N L  ++P    R    +   
Sbjct: 159 PTS----LEVLSVRNNQLTF-LPELPES---LEALDVSTNLLE-SLPAVPVRNHHSEETE 209

Query: 474 -GLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTS 532
                + N++   IPE++  L     + L DN LS R+   L   T+  D        + 
Sbjct: 210 IFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSM 268

Query: 533 IIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALS 579
                  N       +  +     +   D+  +    E +   N  S
Sbjct: 269 SDGQ--QNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS 313

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  116 bits (291), Expect = 6e-27
 Identities = 62/333 (18%), Positives = 116/333 (34%), Gaps = 65/333 (19%)

Query: 335 TIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLT 394
           +I   + N   LS   F +N+ SG     F      +  +L G            +S L 
Sbjct: 2   SIMLPINNNFSLSQNSF-YNTISGTYADYFSAWDKWEKQALPGENRNE------AVSLLK 54

Query: 395 SC--RNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIR 452
            C       + L+   ++  LP ++                              +TV+ 
Sbjct: 55  ECLINQFSELQLNRLNLS-SLPDNLPP---------------------------QITVLE 86

Query: 453 LGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPA 512
           +  N L  ++P     L+ L      +N+L  ++PE    L    +L + +N+L+  LP 
Sbjct: 87  ITQNALI-SLPELPASLEYL---DACDNRLS-TLPELPASL---KHLDVDNNQLT-MLPE 137

Query: 513 CLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPD-IGNLKVVIEM 571
               L  +   +  +N LT + P    +L+     ++ +N L    LP+   +L+    +
Sbjct: 138 LPALLEYI---NADNNQLTML-PELPTSLE---VLSVRNNQLTF--LPELPESLE---AL 185

Query: 572 DLSLNALSGVIPVTIGGLQGLQ----LLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLS 627
           D+S N L   +P         +        R NR+   IPE+   L     + + +N LS
Sbjct: 186 DVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLS 243

Query: 628 GTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPF 660
             I +S+   +     +            +   
Sbjct: 244 SRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTL 276

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 95.4 bits (237), Expect = 2e-20
 Identities = 50/239 (20%), Positives = 87/239 (36%), Gaps = 35/239 (14%)

Query: 73  RRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNN 132
            + + L ++ L L+ ++P  L     + VL I  N+   SLPE  + L  L   D   N 
Sbjct: 59  NQFSELQLNRLNLS-SLPDNLPPQ--ITVLEITQNAL-ISLPELPASLEYL---DACDNR 111

Query: 133 FHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNI 192
               +P        L+HL + +N     +PE      LL+ ++  +NQL+  +P    + 
Sbjct: 112 L-STLPE---LPASLKHLDVDNNQLT-MLPELPA---LLEYINADNNQLT-MLPELPTS- 161

Query: 193 SSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRN- 251
                   LE L +  NQLT  +P        L    ++ N  +  +P            
Sbjct: 162 --------LEVLSVRNNQLTF-LPELPESLEALD---VSTNLLE-SLPAVPVRNHHSEET 208

Query: 252 ---LFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDL 307
                   N  I  IP  I +L     + ++ + L+  I  S+   +   +        
Sbjct: 209 EIFFRCRENR-ITHIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 55.7 bits (134), Expect = 6e-08
 Identities = 39/163 (23%), Positives = 55/163 (33%), Gaps = 17/163 (10%)

Query: 76  TALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHI 135
             +N     LT  +P    +L    VL++RNN     LPE    L  L   D   N    
Sbjct: 143 EYINADNNQLT-MLPELPTSLE---VLSVRNNQL-TFLPELPESLEAL---DVSTNLLE- 193

Query: 136 EIPSWFVSLPRLQ----HLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFN 191
            +P+  V     +        + N     IPE I  L     + L DN LS  I  S+  
Sbjct: 194 SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQ 252

Query: 192 ISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNK 234
            ++    P   G  I ++   G   T      +        NK
Sbjct: 253 QTA---QPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENK 292

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  118 bits (299), Expect = 2e-29
 Identities = 54/215 (25%), Positives = 98/215 (45%), Gaps = 22/215 (10%)

Query: 767 KLLGMGSFGSVYKGVLPD---GMEIAAKVFHMEF--DGS-LESFHAECKVMGSIRHRNLV 820
           ++LG G    V+     D     ++A KV   +   D S    F  E +   ++ H  +V
Sbjct: 18  EILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75

Query: 821 KIISSCSNNDFKA----LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
            +  +            +V+EY+   +L + +      +   + ++++ D   AL + H 
Sbjct: 76  AVYDTGEAETPAGPLPYIVMEYVDGVTL-RDIVHTEGPMTPKRAIEVIADACQALNFSH- 133

Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE-SMRQTKT-LGTIGYMAPEYG 934
                I+H D+KP+N++++ +    + DFGIA+ +     S+ QT   +GT  Y++PE  
Sbjct: 134 --QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191

Query: 935 REGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGE 969
           R   V  + DVYS G +L E  T + P    F G+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  118 bits (298), Expect = 2e-29
 Identities = 50/224 (22%), Positives = 89/224 (39%), Gaps = 30/224 (13%)

Query: 758 RATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF-DGSLESFHAECKVMGSIR 815
           R    F   + LG G FG V++     D    A K   +   + + E    E K +  + 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61

Query: 816 HRNLVKIISSCSNNDFKA------------LVLEYMSNGSLEKCL--YSDNYFLDILQRL 861
           H  +V+  ++    +               + ++     +L+  +         +    L
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK 921
            I + +A A+E+LH   S  ++H D+KPSN+      V  + DFG+   + ++E  +   
Sbjct: 122 HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 922 TL-----------GTIGYMAPEYGREGKVSRKCDVYSYGIMLME 954
           T            GT  YM+PE       S K D++S G++L E
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  118 bits (298), Expect = 2e-29
 Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 10/198 (5%)

Query: 763 FSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVK 821
           +     LG G+FG VYK      G   AAKV   + +  LE +  E +++ +  H  +VK
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           ++ +  ++    +++E+   G+++  +   +  L   Q   +   +  AL +LH   S  
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKR 137

Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE-----YGRE 936
           I+H D+K  NVL+       L+DFG++    K    R +  +GT  +MAPE       ++
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVMCETMKD 196

Query: 937 GKVSRKCDVYSYGIMLME 954
                K D++S GI L+E
Sbjct: 197 TPYDYKADIWSLGITLIE 214

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  121 bits (305), Expect = 3e-29
 Identities = 61/249 (24%), Positives = 92/249 (36%), Gaps = 12/249 (4%)

Query: 308 LGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNL 367
           L  +P  I     N   L L EN       +S  ++  L +L    N    +    F  L
Sbjct: 55  LREVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGL 111

Query: 368 RSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSL 427
            +L  L L  N LT+          L+    L+ ++L  NPI  I   +      S++ L
Sbjct: 112 ANLNTLELFDNRLTTIPNGA--FVYLS---KLKELWLRNNPIESIPSYAFNRIP-SLRRL 165

Query: 428 SMESCNISGGIPKE-LGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSI 486
            +        I +     ++NL  + L    L   IP  L  L KL  L L  N L    
Sbjct: 166 DLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIR 223

Query: 487 PEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILR 546
           P     L  L  L++  +++         NL SL +++L  N LT +       L  + R
Sbjct: 224 PGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLER 283

Query: 547 FNLSSNSLN 555
            +L  N  N
Sbjct: 284 IHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  118 bits (297), Expect = 3e-28
 Identities = 58/234 (24%), Positives = 106/234 (45%), Gaps = 5/234 (2%)

Query: 419 NFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQ 478
             S + + L++    I         ++ +L +++L  N +          L  L  L L 
Sbjct: 61  GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120

Query: 479 NNKLEGSIPED-LCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGS-NALTSIIPS 536
           +N+L  +IP     +L +L  L+L +N +          + SLR L LG    L+ I   
Sbjct: 121 DNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEG 179

Query: 537 TLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLS 596
               L ++   NL+  +L    +P++  L  + E+DLS N LS + P +  GL  LQ L 
Sbjct: 180 AFEGLSNLRYLNLAMCNL--REIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLW 237

Query: 597 LRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQL 650
           +  +++Q     +F  L+SL  +++++NNL+         L +L+ ++L  N  
Sbjct: 238 MIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  113 bits (285), Expect = 9e-27
 Identities = 49/207 (23%), Positives = 82/207 (39%), Gaps = 5/207 (2%)

Query: 447 NLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPED-LCHLYRLANLYLGDNK 505
           N  ++ L  N++      +   L+ L+ L L  N +  +I       L  L  L L DN+
Sbjct: 65  NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNR 123

Query: 506 LSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDI-GN 564
           L+         L+ L++L L +N + SI       +  + R +L        +       
Sbjct: 124 LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183

Query: 565 LKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNN 624
           L  +  ++L++  L   IP  +  L  L  L L  N L    P SF GL  L  + M  +
Sbjct: 184 LSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQS 241

Query: 625 NLSGTIPKSMEALSYLKHLNLSFNQLE 651
            +      + + L  L  +NL+ N L 
Sbjct: 242 QIQVIERNAFDNLQSLVEINLAHNNLT 268

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  108 bits (272), Expect = 5e-25
 Identities = 57/268 (21%), Positives = 103/268 (38%), Gaps = 36/268 (13%)

Query: 112 SLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLL 171
            +P+ +S     +  +   N   I   + F  L  L+ L L  N            L+ L
Sbjct: 57  EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114

Query: 172 QELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLA 231
             L+L DN+L+ TIP+  F       L  L+ L++  N +   IP+  +           
Sbjct: 115 NTLELFDNRLT-TIPNGAF-----VYLSKLKELWLRNNPIES-IPSYAFN---------- 157

Query: 232 FNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEI-GNLRNLEVLGVQSSNLAGLIPAS 290
                         + S+R L LG    +  I       L NL  L +   NL  +   +
Sbjct: 158 -------------RIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI--PN 202

Query: 291 IFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLD 350
           +  +  L EL ++ N  L ++      GL +L++L++ ++       ++  N+  L  ++
Sbjct: 203 LTPLIKLDELDLSGNH-LSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEIN 261

Query: 351 FGFNSFSGLIPTTFGNLRSLKLLSLAGN 378
              N+ + L    F  L  L+ + L  N
Sbjct: 262 LAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  106 bits (267), Expect = 2e-24
 Identities = 56/288 (19%), Positives = 106/288 (36%), Gaps = 42/288 (14%)

Query: 320 PNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNV 379
               ++     N    +P  ++  +   +L+   N    +   +F +LR L++L L+ N 
Sbjct: 43  NQFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99

Query: 380 LTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIP 439
           + +         +     NL  + L +N +  I   +    S                  
Sbjct: 100 IRTIEIG-----AFNGLANLNTLELFDNRLTTIPNGAFVYLS------------------ 136

Query: 440 KELGNINNLTVIRLGNNELTGTIPV-TLGRLQKLQGLYLQ-NNKLEGSIPED-LCHLYRL 496
                   L  + L NN +  +IP     R+  L+ L L    +L   I E     L  L
Sbjct: 137 -------KLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNL 187

Query: 497 ANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNG 556
             L L    L   +P  L  L  L +L L  N L++I P +   L  + +  +  + +  
Sbjct: 188 RYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ- 244

Query: 557 SLLPD-IGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQ 603
            +  +   NL+ ++E++L+ N L+ +       L  L+ + L +N   
Sbjct: 245 VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 98.3 bits (245), Expect = 1e-21
 Identities = 62/296 (20%), Positives = 114/296 (38%), Gaps = 45/296 (15%)

Query: 138 PSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQN 197
           PS      +   ++    +   ++P+ I   +  + L+L +NQ+   I  + F     ++
Sbjct: 36  PSVCSCSNQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQ-IIKVNSF-----KH 86

Query: 198 LPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNN 257
           L  LE L +S N +               +   AFN            L ++  L L +N
Sbjct: 87  LRHLEILQLSRNHIR-------------TIEIGAFN-----------GLANLNTLELFDN 122

Query: 258 SLIGEIPNEI-GNLRNLEVLGVQSSNLAGLIPASIF-NISTLKELAVTDNDLLGSLPSSI 315
             +  IPN     L  L+ L +  +N    IP+  F  I +L+ L + +   L  +    
Sbjct: 123 R-LTTIPNGAFVYLSKLKELWL-RNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGA 180

Query: 316 DLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSL 375
             GL NL  L L   N    IP +LT + +L  LD   N  S + P +F  L  L+ L +
Sbjct: 181 FEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWM 238

Query: 376 AGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMES 431
             + +     +     +  + ++L  I L+ N +  +           ++ + +  
Sbjct: 239 IQSQIQVIERN-----AFDNLQSLVEINLAHNNLTLLPHDLFTPLH-HLERIHLHH 288

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 78.3 bits (193), Expect = 4e-15
 Identities = 44/192 (22%), Positives = 72/192 (37%), Gaps = 12/192 (6%)

Query: 88  TIPPQ-LGNLSFLAVLAIRNNSFFGSLPEE-LSHLRGLKYFDFRFNNFHIEIPSWFVSLP 145
           TI       L+ L  L + +N    ++P     +L  LK    R N         F  +P
Sbjct: 102 TIEIGAFNGLANLNTLELFDNRL-TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIP 160

Query: 146 RLQHLLLKHNSFVGKIPETI-GYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGL 204
            L+ L L     +  I E     LS L+ L+L+   L          I +   L  L+ L
Sbjct: 161 SLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR--------EIPNLTPLIKLDEL 212

Query: 205 FISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIP 264
            +S N L+   P +      L  + +  ++ Q        NL S+  + L +N+L     
Sbjct: 213 DLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPH 272

Query: 265 NEIGNLRNLEVL 276
           +    L +LE +
Sbjct: 273 DLFTPLHHLERI 284

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  118 bits (299), Expect = 3e-29
 Identities = 61/200 (30%), Positives = 88/200 (44%), Gaps = 22/200 (11%)

Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGS-LESFHAECKV-MGSIRHRNLVKIISS 825
           +G G++GSV K V  P G  +A K      D    +    +  V M S     +V+   +
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNYFL-------DILQRLKIMIDVASALEYLHFGY 878
                   + +E M + S +K  Y   Y +       +IL   KI +    AL +L    
Sbjct: 90  LFREGDCWICMELM-STSFDK-FYKYVYSVLDDVIPEEILG--KITLATVKALNHLKENL 145

Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE----YG 934
              I+H DIKPSN+LL+ S    L DFGI+  L   +S+ +T+  G   YMAPE      
Sbjct: 146 K--IIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMAPERIDPSA 201

Query: 935 REGKVSRKCDVYSYGIMLME 954
                  + DV+S GI L E
Sbjct: 202 SRQGYDVRSDVWSLGITLYE 221

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  121 bits (305), Expect = 3e-29
 Identities = 61/249 (24%), Positives = 93/249 (37%), Gaps = 12/249 (4%)

Query: 308 LGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNL 367
           L  +P  I     N   L L ENN       +  ++  L VL  G NS   +    F  L
Sbjct: 66  LSEVPQGIP---SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGL 122

Query: 368 RSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSL 427
            SL  L L  N LT           L+    L  ++L  NPI  I   +      S+  L
Sbjct: 123 ASLNTLELFDNWLTVIPSGA--FEYLS---KLRELWLRNNPIESIPSYAFNRVP-SLMRL 176

Query: 428 SMESCNISGGIPKE-LGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSI 486
            +        I +     + NL  + LG   +   +P  L  L  L+ L +  N      
Sbjct: 177 DLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIR 234

Query: 487 PEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILR 546
           P     L  L  L++ ++++S         L SL +L+L  N L+S+       L+ ++ 
Sbjct: 235 PGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVE 294

Query: 547 FNLSSNSLN 555
            +L  N  N
Sbjct: 295 LHLHHNPWN 303

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  119 bits (299), Expect = 2e-28
 Identities = 59/236 (25%), Positives = 105/236 (44%), Gaps = 9/236 (3%)

Query: 419 NFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPV-TLGRLQKLQGLYL 477
               + + L++   NI         ++++L V++LG N +   I V     L  L  L L
Sbjct: 72  GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLEL 130

Query: 478 QNNKLEGSIPED-LCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGS-NALTSIIP 535
            +N L   IP     +L +L  L+L +N +          + SL  L LG    L  I  
Sbjct: 131 FDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISE 189

Query: 536 STLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLL 595
                L ++   NL   ++    +P++  L  + E+++S N    + P +  GL  L+ L
Sbjct: 190 GAFEGLFNLKYLNLGMCNI--KDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKL 247

Query: 596 SLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSM-EALSYLKHLNLSFNQL 650
            +  +++      +F GL SL  +++++NNLS ++P  +   L YL  L+L  N  
Sbjct: 248 WVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  116 bits (293), Expect = 1e-27
 Identities = 53/210 (25%), Positives = 85/210 (40%), Gaps = 11/210 (5%)

Query: 447 NLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPED-LCHLYRLANLYLGDNK 505
           N   + L  N +      T   L  L+ L L  N +   I       L  L  L L DN 
Sbjct: 76  NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNW 134

Query: 506 LSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSN----SLNGSLLPD 561
           L+         L+ LR+L L +N + SI       +  ++R +L        ++      
Sbjct: 135 LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194

Query: 562 IGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDM 621
           + NLK    ++L +  +   +P  +  L GL+ L +  N      P SF GL SL  + +
Sbjct: 195 LFNLK---YLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWV 249

Query: 622 SNNNLSGTIPKSMEALSYLKHLNLSFNQLE 651
            N+ +S     + + L+ L  LNL+ N L 
Sbjct: 250 MNSQVSLIERNAFDGLASLVELNLAHNNLS 279

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  107 bits (269), Expect = 1e-24
 Identities = 60/269 (22%), Positives = 104/269 (38%), Gaps = 38/269 (14%)

Query: 112 SLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPE-TIGYLSL 170
            +P+ +      +Y +   NN  +     F  L  L+ L L  NS + +I       L+ 
Sbjct: 68  EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS-IRQIEVGAFNGLAS 124

Query: 171 LQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSL 230
           L  L+L DN L+  IPS  F     + L  L  L++  N +   IP+  +          
Sbjct: 125 LNTLELFDNWLT-VIPSGAF-----EYLSKLRELWLRNNPIES-IPSYAFN--------- 168

Query: 231 AFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEI-GNLRNLEVLGVQSSNLAGLIPA 289
                          + S+  L LG    +  I       L NL+ L +   N+  +   
Sbjct: 169 --------------RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM--P 212

Query: 290 SIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVL 349
           ++  +  L+EL ++ N     +      GL +L++L++  +  S    ++   ++ L  L
Sbjct: 213 NLTPLVGLEELEMSGNH-FPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVEL 271

Query: 350 DFGFNSFSGLIPTTFGNLRSLKLLSLAGN 378
           +   N+ S L    F  LR L  L L  N
Sbjct: 272 NLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 99.8 bits (249), Expect = 4e-22
 Identities = 58/269 (21%), Positives = 94/269 (34%), Gaps = 63/269 (23%)

Query: 145 PRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGL 204
              ++L L  N+      +T  +L  L+ L L  N +   I    F       L  L  L
Sbjct: 75  SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAF-----NGLASLNTL 128

Query: 205 FISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIP 264
            +  N LT  IP+                 F+         L+ +R L+L NN  I  IP
Sbjct: 129 ELFDNWLTV-IPSGA---------------FEY--------LSKLRELWLRNNP-IESIP 163

Query: 265 NEI-GNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLE 323
           +     + +L  L +        I    F                         GL NL+
Sbjct: 164 SYAFNRVPSLMRLDLGELKKLEYISEGAFE------------------------GLFNLK 199

Query: 324 RLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSP 383
            L LG  N    +P +LT +  L  L+   N F  + P +F  L SLK L +  + ++  
Sbjct: 200 YLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLI 257

Query: 384 TPDLSFLSSLTSCRNLEIIYLSENPINGI 412
             +     +     +L  + L+ N ++ +
Sbjct: 258 ERN-----AFDGLASLVELNLAHNNLSSL 281

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 77.5 bits (191), Expect = 6e-15
 Identities = 40/207 (19%), Positives = 67/207 (32%), Gaps = 13/207 (6%)

Query: 73  RRVTALNISYLGLTGTIPPQ-LGNLSFLAVLAIRNNSFFGSLPEE-LSHLRGLKYFDFRF 130
             +  L +    +   I       L+ L  L + +N     +P     +L  L+    R 
Sbjct: 99  HHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWL-TVIPSGAFEYLSKLRELWLRN 156

Query: 131 NNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETI-GYLSLLQELDLSDNQLSGTIPSSI 189
           N         F  +P L  L L     +  I E     L  L+ L+L    +        
Sbjct: 157 NPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK------- 209

Query: 190 FNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSV 249
            ++ +   L  LE L +S N      P +      L  + +  ++           L S+
Sbjct: 210 -DMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASL 268

Query: 250 RNLFLGNNSLIGEIPNEIGNLRNLEVL 276
             L L +N+L     +    LR L  L
Sbjct: 269 VELNLAHNNLSSLPHDLFTPLRYLVEL 295

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 63.6 bits (155), Expect = 1e-10
 Identities = 37/174 (21%), Positives = 62/174 (35%), Gaps = 34/174 (19%)

Query: 88  TIPPQ-LGNLSFLAVLAIRNNSFFGSLPEE-LSHLRGLKYFDFRFNNFHIEIPSWFVSLP 145
           +IP      +  L  L +        + E     L  LKY +    N   ++P+    L 
Sbjct: 161 SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLV 218

Query: 146 RLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLF 205
            L+ L +  N F    P +   LS L++L + ++Q+S  I  + F       L  L  L 
Sbjct: 219 GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAF-----DGLASLVELN 272

Query: 206 ISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSL 259
           +++N L+                SL  + F          L  +  L L +N  
Sbjct: 273 LAHNNLS----------------SLPHDLFTP--------LRYLVELHLHHNPW 302

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  118 bits (297), Expect = 4e-29
 Identities = 63/301 (20%), Positives = 123/301 (40%), Gaps = 42/301 (13%)

Query: 766  NKLLGMGSFGSVYKGVLPDG------MEIAAKVFHMEFDGS-LESFHAECKVMGSIRHRN 818
            ++ LG GSFG VY+GV            +A K  +          F  E  VM      +
Sbjct: 30   SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89

Query: 819  LVKIISSCSNNDFKALVLEYMSNGSL---------EKCLYSDNYFLDILQRLKIMIDVAS 869
            +V+++   S      +++E M+ G L                     + + +++  ++A 
Sbjct: 90   VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 870  ALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGY 928
             + YL+   +   VH D+   N ++ E     + DFG+ + + + +  R   K L  + +
Sbjct: 150  GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206

Query: 929  MAPEYGREGKVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLLSCSITE 987
            M+PE  ++G  +   DV+S+G++L E  T  ++P    + G +S ++ V        +  
Sbjct: 207  MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----YQG-LSNEQ-V--------LRF 252

Query: 988  VADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYI 1047
            V +  LL+  +N       C   +F L   C    P+ R S  ++ + +    E     +
Sbjct: 253  VMEGGLLDKPDN-------CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 305

Query: 1048 D 1048
             
Sbjct: 306  S 306

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  117 bits (296), Expect = 5e-29
 Identities = 61/193 (31%), Positives = 89/193 (46%), Gaps = 7/193 (3%)

Query: 763 FSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVK 821
           F   + LG GS+GSVYK +    G  +A K   +  +  L+    E  +M      ++VK
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ--VPVESDLQEIIKEISIMQQCDSPHVVK 88

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
              S   N    +V+EY   GS+   +   N  L   +   I+      LEYLH      
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMR 145

Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSR 941
            +H DIK  N+LLN      L+DFG+A  L    + R T  +GT  +MAPE  +E   + 
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYNC 204

Query: 942 KCDVYSYGIMLME 954
             D++S GI  +E
Sbjct: 205 VADIWSLGITAIE 217

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  116 bits (292), Expect = 1e-28
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 24/202 (11%)

Query: 763 FSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHME-FDGSLESFHAECKVMGSIRHRNLV 820
           F++ + +G GSFG V+KG+       +A K+  +E  +  +E    E  V+       + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK--------IMIDVASALE 872
           K   S   +    +++EY+  GS           LD+L+           I+ ++   L+
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSA----------LDLLEPGPLDETQIATILREILKGLD 133

Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE 932
           YLH   S   +H DIK +NVLL+E     L+DFG+A  L   +  R T  +GT  +MAPE
Sbjct: 134 YLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPE 189

Query: 933 YGREGKVSRKCDVYSYGIMLME 954
             ++     K D++S GI  +E
Sbjct: 190 VIKQSAYDSKADIWSLGITAIE 211

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  121 bits (305), Expect = 2e-28
 Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 18/199 (9%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHME-FDGSLESFHAECKVMGSIRHRNLVKII- 823
           + LG G FG V + +    G ++A K    E    + E +  E ++M  + H N+V    
Sbjct: 20  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79

Query: 824 -----SSCSNNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDVASALEYLHF 876
                   + ND   L +EY   G L K L  + +   L       ++ D++SAL YLH 
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH- 138

Query: 877 GYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
                I+H D+KP N++L    + ++  + D G AK L + E    T+ +GT+ Y+APE 
Sbjct: 139 --ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--TEFVGTLQYLAPEL 194

Query: 934 GREGKVSRKCDVYSYGIML 952
             + K +   D +S+G + 
Sbjct: 195 LEQKKYTVTVDYWSFGTLA 213

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  116 bits (292), Expect = 2e-28
 Identities = 70/306 (22%), Positives = 122/306 (39%), Gaps = 53/306 (17%)

Query: 767  KLLGMGSFGSVYKGVL------PDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRHR 817
            + LG G+FG VY+G +      P  +++A K       E D     F  E  ++    H+
Sbjct: 36   RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD--ELDFLMEALIISKFNHQ 93

Query: 818  NLVKIISSCSNNDFKALVLEYMSNGSLEKCL------YSDNYFLDILQRLKIMIDVASAL 871
            N+V+ I     +  + +++E M+ G L+  L       S    L +L  L +  D+A   
Sbjct: 94   NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153

Query: 872  EYL---HFGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGKEESMR-QTKTLG 924
            +YL   HF      +H DI   N LL       V  + DFG+A+ + +    R     + 
Sbjct: 154  QYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 207

Query: 925  TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLLSC 983
             + +M PE   EG  + K D +S+G++L E F+    P    +    S +  V       
Sbjct: 208  PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP----YPS-KSNQE-V------- 254

Query: 984  SITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043
             +  V     ++  +N       C   ++ +   C    PE R +   +  R+    +  
Sbjct: 255  -LEFVTSGGRMDPPKN-------CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD- 305

Query: 1044 SAYIDV 1049
               I+ 
Sbjct: 306  PDVINT 311

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  114 bits (288), Expect = 3e-28
 Identities = 49/231 (21%), Positives = 92/231 (39%), Gaps = 35/231 (15%)

Query: 758 RATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGS--LESFHAECKVMGSI 814
           R T  F E + +G G FGSV+K V   DG   A K       GS   ++   E      +
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67

Query: 815 -RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDIL---QRLKIMIDVASA 870
            +H ++V+  S+ + +D   +  EY + GSL   +  +   +      +   +++ V   
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNESMVGH-------------------LSDFGIAKIL 911
           L Y+H   S  +VH DIKPSN+ ++ + + +                   + D G    +
Sbjct: 128 LRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184

Query: 912 GKEESMRQTKTLGTIGYMAPEYGREGKV-SRKCDVYSYGIMLMETFTKKKP 961
              +        G   ++A E  +E      K D+++  + ++     +  
Sbjct: 185 SSPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  115 bits (289), Expect = 3e-28
 Identities = 67/302 (22%), Positives = 126/302 (41%), Gaps = 53/302 (17%)

Query: 767  KLLGMGSFGSVYKGVLPDG------MEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLV 820
            + LG G+FG V+     +       M +A K        + + F  E +++ +++H ++V
Sbjct: 21   RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 821  KIISSCSNNDFKALVLEYMSNGSL---------------EKCLYSDNYFLDILQRLKIMI 865
            K    C + D   +V EYM +G L               +         L + Q L I  
Sbjct: 81   KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 866  DVASALEYL---HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTK 921
             +AS + YL   HF      VH D+   N L+  +++  + DFG+++ +   +  R    
Sbjct: 141  QIASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194

Query: 922  TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSL 980
            T+  I +M PE     K + + DV+S+G++L E FT  K+P    +   +S    V    
Sbjct: 195  TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP----WFQ-LSNTE-V---- 244

Query: 981  LSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIR 1040
                I  +    +L            C   ++ + + C    P++R+++K++   L  + 
Sbjct: 245  ----IECITQGRVLERPRV-------CPKEVYDVMLGCWQREPQQRLNIKEIYKILHALG 293

Query: 1041 ET 1042
            + 
Sbjct: 294  KA 295

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  116 bits (292), Expect = 5e-28
 Identities = 68/304 (22%), Positives = 120/304 (39%), Gaps = 49/304 (16%)

Query: 767  KLLGMGSFGSVYKGVLPDG------MEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNL 819
            + LG G+FG VY+G +         +++A K       +     F  E  ++    H+N+
Sbjct: 77   RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 820  VKIISSCSNNDFKALVLEYMSNGSLEKCL------YSDNYFLDILQRLKIMIDVASALEY 873
            V+ I     +  + ++LE M+ G L+  L       S    L +L  L +  D+A   +Y
Sbjct: 137  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 874  L---HFGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGKEESMR-QTKTLGTI 926
            L   HF      +H DI   N LL       V  + DFG+A+ + +    R     +  +
Sbjct: 197  LEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 250

Query: 927  GYMAPEYGREGKVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLLSCSI 985
             +M PE   EG  + K D +S+G++L E F+    P    +    S +  V        +
Sbjct: 251  KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP----YPS-KSNQE-V--------L 296

Query: 986  TEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSA 1045
              V     ++  +N       C   ++ +   C    PE R +   +  R+    +    
Sbjct: 297  EFVTSGGRMDPPKN-------CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD-PD 348

Query: 1046 YIDV 1049
             I+ 
Sbjct: 349  VINT 352

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  113 bits (285), Expect = 8e-28
 Identities = 56/199 (28%), Positives = 88/199 (44%), Gaps = 21/199 (10%)

Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGS-LESFHAECKV-MGSIRHRNLVKIISS 825
           LG G++G V K   +P G  +A K      +    +    +  + M ++     V    +
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNYFL------DILQRLKIMIDVASALEYLHFGYS 879
                   + +E M + SL+K  Y            DIL   KI + +  ALE+LH   S
Sbjct: 75  LFREGDVWICMELM-DTSLDK-FYKQVIDKGQTIPEDILG--KIAVSIVKALEHLHSKLS 130

Query: 880 TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE----YGR 935
             ++H D+KPSNVL+N      + DFGI+  L   + + +    G   YMAPE       
Sbjct: 131 --VIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCKPYMAPERINPELN 186

Query: 936 EGKVSRKCDVYSYGIMLME 954
           +   S K D++S GI ++E
Sbjct: 187 QKGYSVKSDIWSLGITMIE 205

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  115 bits (289), Expect = 8e-28
 Identities = 70/323 (21%), Positives = 118/323 (36%), Gaps = 72/323 (22%)

Query: 767  KLLGMGSFGSVYKGVLPDGMEIAA---------KVFHMEFDGSLESFHAECKVMGSIRHR 817
            + +G G+FG V++   P  +             K            F  E  +M    + 
Sbjct: 53   RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALMAEFDNP 110

Query: 818  NLVKIISSCSNNDFKALVLEYMSNGSL-----------------------EKCLYSDNYF 854
            N+VK++  C+      L+ EYM+ G L                        +        
Sbjct: 111  NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170

Query: 855  LDILQRLKIMIDVASALEYL---HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA-KI 910
            L   ++L I   VA+ + YL    F      VH D+   N L+ E+MV  ++DFG++  I
Sbjct: 171  LSCAEQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNI 224

Query: 911  LGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAG-- 968
               +           I +M PE     + + + DV++YG++L E F+        +    
Sbjct: 225  YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS--------YGLQP 276

Query: 969  --EMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKR 1026
               M+ +      ++      V D N+L C EN       C   +++L   C   LP  R
Sbjct: 277  YYGMAHEE-----VIYY----VRDGNILACPEN-------CPLELYNLMRLCWSKLPADR 320

Query: 1027 ISMKDVANRLVRIRETLSAYIDV 1049
             S   +   L R+ E     + V
Sbjct: 321  PSFCSIHRILQRMCERAEGTVGV 343

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  114 bits (288), Expect = 8e-28
 Identities = 67/306 (21%), Positives = 123/306 (40%), Gaps = 51/306 (16%)

Query: 767  KLLGMGSFGSVYKGVL-PDGMEIAA-----KVFHMEFDGSLESFHAECKVMGSI-RHRNL 819
             ++G G+FG V K  +  DG+ + A     K +  + D     F  E +V+  +  H N+
Sbjct: 31   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKLGHHPNI 88

Query: 820  VKIISSCSNNDFKALVLEYMSNGSL---------------EKCLYSDNYFLDILQRLKIM 864
            + ++ +C +  +  L +EY  +G+L                    S    L   Q L   
Sbjct: 89   INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 865  IDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLG 924
             DVA  ++YL        +H D+   N+L+ E+ V  ++DFG+++  G+E  +++T    
Sbjct: 149  ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRL 203

Query: 925  TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLLSC 983
             + +MA E       +   DV+SYG++L E  +    P   +   E+             
Sbjct: 204  PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------------- 250

Query: 984  SITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043
               ++     L    N       C   ++ L   C  + P +R S   +   L R+ E  
Sbjct: 251  -YEKLPQGYRLEKPLN-------CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302

Query: 1044 SAYIDV 1049
              Y++ 
Sbjct: 303  KTYVNT 308

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  113 bits (284), Expect = 1e-27
 Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 43/224 (19%)

Query: 758 RATDGFSEN----KLLGMGSFGSVYKGV-LPDGMEIAAKVF---------HMEFDGSLES 803
            +T GF EN    ++LG G    V + +  P   E A K+            E     E+
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 804 FHAECKVMGSI-RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK 862
              E  ++  +  H N++++  +   N F  LV + M  G L         F  + +++ 
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL---------FDYLTEKVT 120

Query: 863 --------IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE 914
                   IM  +   +  LH      IVH D+KP N+LL++ M   L+DFG +  L   
Sbjct: 121 LSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177

Query: 915 ESMRQTKTLGTIGYMAPE------YGREGKVSRKCDVYSYGIML 952
           E +   +  GT  Y+APE              ++ D++S G+++
Sbjct: 178 EKL--REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  113 bits (285), Expect = 1e-27
 Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 29/199 (14%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISS 825
           ++LG G+F  V+       G   A K           S   E  V+  I+H N+V +   
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74

Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK--------IMIDVASALEYLHFG 877
             +     LV++ +S G L         F  IL+R          ++  V SA++YLH  
Sbjct: 75  YESTTHYYLVMQLVSGGEL---------FDRILERGVYTEKDASLVIQQVLSAVKYLH-- 123

Query: 878 YSTPIVHCDIKPSNVLL----NESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
               IVH D+KP N+L       S +  ++DFG++K+  +   M  +   GT GY+APE 
Sbjct: 124 -ENGIVHRDLKPENLLYLTPEENSKI-MITDFGLSKME-QNGIM--STACGTPGYVAPEV 178

Query: 934 GREGKVSRKCDVYSYGIML 952
             +   S+  D +S G++ 
Sbjct: 179 LAQKPYSKAVDCWSIGVIT 197

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  113 bits (285), Expect = 3e-27
 Identities = 61/321 (19%), Positives = 115/321 (35%), Gaps = 52/321 (16%)

Query: 308 LGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNL 367
           L S+PS +      ++ L L  N  +    S L     L  L    N  + +   +F +L
Sbjct: 43  LNSIPSGLT---EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSL 99

Query: 368 RSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSL 427
            SL+ L L+ N L++ +        L+   +L  + L  NP   +  +S+          
Sbjct: 100 GSLEHLDLSYNYLSNLSSSW--FKPLS---SLTFLNLLGNPYKTLGETSL---------- 144

Query: 428 SMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPV-TLGRLQKLQGLYLQNNKLEGSI 486
                           ++  L ++R+GN +    I       L  L+ L +  + L+   
Sbjct: 145 --------------FSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYE 190

Query: 487 PEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILR 546
           P+ L  +  +++L L   +    L   +   +S+  L L    L +   S L        
Sbjct: 191 PKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSEL-------- 242

Query: 547 FNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPI 606
               +NSL                + ++  +L   +   +  + GL  L    N+L+  +
Sbjct: 243 STGETNSL--------IKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-V 292

Query: 607 PES-FGGLKSLNFVDMSNNNL 626
           P+  F  L SL  + +  N  
Sbjct: 293 PDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  108 bits (271), Expect = 2e-25
 Identities = 58/280 (20%), Positives = 117/280 (41%), Gaps = 22/280 (7%)

Query: 287 IPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPS-SLTNISE 345
           IP+ +     +K L +++N +   + +S      NL+ L L  N  + TI   S +++  
Sbjct: 46  IPSGLT--EAVKSLDLSNNRI-TYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGS 101

Query: 346 LSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLS 405
           L  LD  +N  S L  + F  L SL  L+L GN   +   + S  S LT    L+I+ + 
Sbjct: 102 LEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLT---KLQILRVG 157

Query: 406 ENPINGILPSSIGNFS--ISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIP 463
                  +     +F+    ++ L +++ ++    PK L +I N++ + L   +    + 
Sbjct: 158 NMDTFTKIQR--KDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLE 215

Query: 464 VTLGRLQKLQGLYLQNNKLEG----SIPED----LCHLYRLANLYLGDNKLSGRLPACLG 515
           + +     ++ L L++  L+      +       L   +   N+ + D  L  ++   L 
Sbjct: 216 IFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLN 274

Query: 516 NLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLN 555
            ++ L +L    N L S+       L  + +  L +N  +
Sbjct: 275 QISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  107 bits (268), Expect = 4e-25
 Identities = 58/318 (18%), Positives = 109/318 (34%), Gaps = 64/318 (20%)

Query: 171 LQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSL 230
           ++ LDLS+N+++  I +S       Q    L+ L ++ N +   I  +            
Sbjct: 54  VKSLDLSNNRIT-YISNSDL-----QRCVNLQALVLTSNGINT-IEED------------ 94

Query: 231 AFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEI-GNLRNLEVLGVQSSNLAGLIPA 289
           +F+           +L S+ +L L  N  +  + +     L +L  L +  +    L   
Sbjct: 95  SFS-----------SLGSLEHLDLSYN-YLSNLSSSWFKPLSSLTFLNLLGNPYKTLGET 142

Query: 290 SIF-NISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSV 348
           S+F +++ L+ L V + D    +      GL  LE L +  ++     P SL +I  +S 
Sbjct: 143 SLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSH 202

Query: 349 LDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPT----PDLSFLSSLTSCRNLEIIYL 404
           L         L+        S++ L L    L +            +SL        + +
Sbjct: 203 LILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGET-NSLIKKFTFRNVKI 261

Query: 405 SENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPV 464
           ++  +                            + K L  I+ L  +    N+L      
Sbjct: 262 TDESLF--------------------------QVMKLLNQISGLLELEFSRNQLKSVPDG 295

Query: 465 TLGRLQKLQGLYLQNNKL 482
              RL  LQ ++L  N  
Sbjct: 296 IFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  104 bits (260), Expect = 5e-24
 Identities = 70/310 (22%), Positives = 105/310 (33%), Gaps = 47/310 (15%)

Query: 110 FGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLS 169
             S+P  L+    +K  D   N       S       LQ L+L  N       ++   L 
Sbjct: 43  LNSIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLG 100

Query: 170 LLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVS 229
            L+ LDLS N LS  + SS F     + L  L  L +  N       T+L          
Sbjct: 101 SLEHLDLSYNYLS-NLSSSWF-----KPLSSLTFLNLLGNPYKTLGETSL---------- 144

Query: 230 LAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEI-GNLRNLEVLGVQSSNLAGLIP 288
                F          LT ++ L +GN     +I  +    L  LE L + +S+L    P
Sbjct: 145 -----FSH--------LTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEP 191

Query: 289 ASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNIS---- 344
            S+ +I  +  L +        L         ++E L L + +      S L+       
Sbjct: 192 KSLKSIQNVSHLILHMKQ-HILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSL 250

Query: 345 ----ELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLE 400
                   +     S    +      +  L  L  + N L S  PD  F   LTS   L+
Sbjct: 251 IKKFTFRNVKITDESLFQ-VMKLLNQISGLLELEFSRNQLKS-VPDGIF-DRLTS---LQ 304

Query: 401 IIYLSENPIN 410
            I+L  NP +
Sbjct: 305 KIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  101 bits (253), Expect = 4e-23
 Identities = 57/287 (19%), Positives = 101/287 (35%), Gaps = 51/287 (17%)

Query: 369 SLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLS 428
           ++K L L+ N +T  +        L  C NL+ + L+ N IN                  
Sbjct: 53  AVKSLDLSNNRITYISNS-----DLQRCVNLQALVLTSNGIN------------------ 89

Query: 429 MESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPE 488
                I       LG+   L  + L  N L+         L  L  L L  N  + ++ E
Sbjct: 90  ----TIEEDSFSSLGS---LEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGE 141

Query: 489 D--LCHLYRLANLYLGDNKLSGRLPA-CLGNLTSLRDLSLGSNALTSIIPSTLWNLKDIL 545
                HL +L  L +G+     ++       LT L +L + ++ L S  P +L +++++ 
Sbjct: 142 TSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVS 201

Query: 546 RFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGP 605
              L        LL +                +     V    L+   L +  ++ L   
Sbjct: 202 HLILHMKQH--ILLLE--------------IFVDVTSSVECLELRDTDLDTFHFSELSTG 245

Query: 606 IPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEG 652
              S     +   V +++ +L   + K +  +S L  L  S NQL+ 
Sbjct: 246 ETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS 291

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 92.9 bits (231), Expect = 3e-20
 Identities = 37/197 (18%), Positives = 75/197 (38%), Gaps = 4/197 (2%)

Query: 472 LQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALT 531
           ++ L L NN++      DL     L  L L  N ++        +L SL  L L  N L+
Sbjct: 54  VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS 113

Query: 532 SIIPSTLWNLKDILRFNLSSNSLNGSLLPDI---GNLKVVIEMDLSLNALSGVIPVTIGG 588
           ++  S    L  +   NL  N    +L          K+ I    +++  + +      G
Sbjct: 114 NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAG 172

Query: 589 LQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFN 648
           L  L+ L +  + LQ   P+S   +++++ + +        +   ++  S ++ L L   
Sbjct: 173 LTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDT 232

Query: 649 QLEGEIPTRGPFITFSA 665
            L+    +       ++
Sbjct: 233 DLDTFHFSELSTGETNS 249

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 72.8 bits (179), Expect = 9e-14
 Identities = 32/178 (17%), Positives = 67/178 (37%), Gaps = 8/178 (4%)

Query: 88  TIPPQ--LGNLSFLAVLAIRNNSFFGSLPEE-LSHLRGLKYFDFRFNNFHIEIPSWFVSL 144
           T+       +L+ L +L + N   F  +  +  + L  L+  +   ++     P    S+
Sbjct: 138 TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSI 197

Query: 145 PRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNIS--SCQNLPVLE 202
             + HL+L     +  +   +   S ++ L+L D  L     S +      S        
Sbjct: 198 QNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFR 257

Query: 203 GLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDI-GNLTSVRNLFLGNNSL 259
            + I+   L   +   L +   L  +  + N+ +  +P  I   LTS++ ++L  N  
Sbjct: 258 NVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  112 bits (281), Expect = 3e-27
 Identities = 52/208 (25%), Positives = 75/208 (36%), Gaps = 7/208 (3%)

Query: 447 NLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKL 506
               I L  N ++     +    + L  L+L +N L          L  L  L L DN  
Sbjct: 33  ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92

Query: 507 SGRLPA-CLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLN---GSLLPDI 562
              +       L  L  L L    L  + P     L  +    L  N+L         D+
Sbjct: 93  LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL 152

Query: 563 GNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMS 622
           GNL     + L  N +S V      GL  L  L L  NR+    P +F  L  L  + + 
Sbjct: 153 GNLT---HLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF 209

Query: 623 NNNLSGTIPKSMEALSYLKHLNLSFNQL 650
            NNLS    +++  L  L++L L+ N  
Sbjct: 210 ANNLSALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  110 bits (278), Expect = 7e-27
 Identities = 53/252 (21%), Positives = 90/252 (35%), Gaps = 40/252 (15%)

Query: 308 LGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNL 367
           L ++P  I       +R+FL  N  S    +S      L++L    N  + +    F  L
Sbjct: 23  LQAVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGL 79

Query: 368 RSLKLLSLAGNVLTSPTPDLSFLSS--LTSCRNLEIIYLSENPINGILPSSIGNFSISMK 425
             L+ L L+ N        L  +          L  ++L    +                
Sbjct: 80  ALLEQLDLSDN------AQLRSVDPATFHGLGRLHTLHLDRCGLQ--------------- 118

Query: 426 SLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPV-TLGRLQKLQGLYLQNNKLEG 484
                   +  G+ + L     L  + L +N L   +P  T   L  L  L+L  N++  
Sbjct: 119 -------ELGPGLFRGLAA---LQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS- 166

Query: 485 SIPED-LCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKD 543
           S+PE     L+ L  L L  N+++   P    +L  L  L L +N L+++    L  L+ 
Sbjct: 167 SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA 226

Query: 544 ILRFNLSSNSLN 555
           +    L+ N   
Sbjct: 227 LQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 96.2 bits (240), Expect = 6e-22
 Identities = 58/267 (21%), Positives = 93/267 (34%), Gaps = 58/267 (21%)

Query: 239 IPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLK 298
           +P  I    + + +FL  N +           RNL +L + S+ LA +  A+   ++ L+
Sbjct: 26  VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 299 ELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSG 358
           +L ++DN  L S+  +   GL  L  L L        +                      
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELG--------------------- 121

Query: 359 LIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIG 418
             P  F  L +L+ L L  N L +   D           NL  ++L  N I+ +      
Sbjct: 122 --PGLFRGLAALQYLYLQDNALQALPDDT-----FRDLGNLTHLFLHGNRISSVPE---R 171

Query: 419 NFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQ 478
            F                        +++L  + L  N +    P     L +L  LYL 
Sbjct: 172 AFR----------------------GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF 209

Query: 479 NNKLEGSIPED-LCHLYRLANLYLGDN 504
            N L  ++P + L  L  L  L L DN
Sbjct: 210 ANNLS-ALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 56/299 (18%), Positives = 89/299 (29%), Gaps = 85/299 (28%)

Query: 112 SLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLL 171
           ++P  +      +      N       + F +   L  L L  N            L+LL
Sbjct: 25  AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 172 QELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLA 231
           ++LDLSDN    ++  + F       L  L  L +    L                  L 
Sbjct: 83  EQLDLSDNAQLRSVDPATF-----HGLGRLHTLHLDRCGLQ----------------ELG 121

Query: 232 FNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASI 291
              F+G        L +++ L+L +N+L                           +P   
Sbjct: 122 PGLFRG--------LAALQYLYLQDNAL-------------------------QALPDDT 148

Query: 292 FNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDF 351
           F                          L NL  LFL  N  S     +   +  L  L  
Sbjct: 149 FR------------------------DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184

Query: 352 GFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPIN 410
             N  + + P  F +L  L  L L  N L++   +      L   R L+ + L++NP  
Sbjct: 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEA-----LAPLRALQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 42/178 (23%), Positives = 63/178 (35%), Gaps = 28/178 (15%)

Query: 475 LYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSII 534
                  L+ ++P  +        ++L  N++S    A      +L  L L SN L  I 
Sbjct: 16  TSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72

Query: 535 PSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQL 594
            +    L  + + +LS N                         L  V P T  GL  L  
Sbjct: 73  AAAFTGLALLEQLDLSDN-----------------------AQLRSVDPATFHGLGRLHT 109

Query: 595 LSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSM-EALSYLKHLNLSFNQLE 651
           L L    LQ   P  F GL +L ++ + +N L   +P      L  L HL L  N++ 
Sbjct: 110 LHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS 166

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 75.8 bits (187), Expect = 5e-15
 Identities = 41/193 (21%), Positives = 72/193 (37%), Gaps = 17/193 (8%)

Query: 73  RRVTALNISYLGLTGTIPPQ-LGNLSFLAVLAIRNNSFFGSLPEE-LSHLRGLKYFDFRF 130
           R +T L +    L   I       L+ L  L + +N+   S+       L  L       
Sbjct: 56  RNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDR 114

Query: 131 NNFHIEIPS-WFVSLPRLQHLLLKHNSFVGKIPETI-GYLSLLQELDLSDNQLSGTIPSS 188
                E+    F  L  LQ+L L+ N+    +P+     L  L  L L  N++S ++P  
Sbjct: 115 CGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPER 171

Query: 189 IFNISSCQNLPVLEGLFISYNQLTGPIPTN-LWKCRELHVVSLAFNKFQGGIPRDI-GNL 246
            F     + L  L+ L +  N++   +  +       L  + L  N     +P +    L
Sbjct: 172 AF-----RGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFANNLSA-LPTEALAPL 224

Query: 247 TSVRNLFLGNNSL 259
            +++ L L +N  
Sbjct: 225 RALQYLRLNDNPW 237

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  112 bits (282), Expect = 3e-27
 Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 13/194 (6%)

Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGS-LESFHAECKV-MGSIRHRNLVKIISS 825
           +G G+ G V+K      G  IA K      +    +    +  V + S     +V+   +
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92

Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
              N    + +E M     EK        +      K+ + +  AL YL   +   ++H 
Sbjct: 93  FITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHR 149

Query: 886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE-----YGREGKVS 940
           D+KPSN+LL+E     L DFGI+  L   +   + ++ G   YMAPE        +    
Sbjct: 150 DVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYD 207

Query: 941 RKCDVYSYGIMLME 954
            + DV+S GI L+E
Sbjct: 208 IRADVWSLGISLVE 221

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  111 bits (280), Expect = 4e-27
 Identities = 67/299 (22%), Positives = 125/299 (41%), Gaps = 58/299 (19%)

Query: 767  KLLGMGSFGSVYKGVLPDG------MEIAAKVF---HMEFDGSLESFHAECKVMGSIRHR 817
            + LG   FG VYKG L           +A K             E F  E  +   ++H 
Sbjct: 15   EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL--REEFRHEAMLRARLQHP 72

Query: 818  NLVKIISSCSNNDFKALVLEYMSNGSL---------------EKCLYSDNYFLDILQRLK 862
            N+V ++   + +   +++  Y S+G L                    +    L+    + 
Sbjct: 73   NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132

Query: 863  IMIDVASALEYL---HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR- 918
            ++  +A+ +EYL   H       VH D+   NVL+ + +   +SD G+ + +   +  + 
Sbjct: 133  LVAQIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKL 186

Query: 919  QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVG 977
               +L  I +MAPE    GK S   D++SYG++L E F+   +P    + G  S +  V 
Sbjct: 187  LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP----YCG-YSNQD-V- 239

Query: 978  DSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036
                   +  + +  +L C ++       C + +++L ++C  + P +R   KD+ +RL
Sbjct: 240  -------VEMIRNRQVLPCPDD-------CPAWVYALMIECWNEFPSRRPRFKDIHSRL 284

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  112 bits (282), Expect = 5e-27
 Identities = 68/361 (18%), Positives = 126/361 (34%), Gaps = 65/361 (18%)

Query: 721  RRRRRRRRRQKGSTRPYYDANMYPQATWRRISYQDLLRATDGFSENKL-----LGMGSFG 775
            + +++ + + +      Y+ N Y      ++ Y +       F  N L     LG G+FG
Sbjct: 5    KYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWE----FPRNNLQFGKTLGAGAFG 60

Query: 776  SVYKGVLPDGMEIAA---------KVFHMEFDGSLESFHAECKVMGSI-RHRNLVKIISS 825
             V +       +  A         K      +   E+  +E K+M  + +H N+V ++ +
Sbjct: 61   KVVEATAFGLGKEDAVLKVAVKMLKSTAHADE--KEALMSELKIMSHLGQHENIVNLLGA 118

Query: 826  CSNNDFKALVLEYMSNGSL-------------EKCLYSDNYFLDILQRLKIMIDVASALE 872
            C++     ++ EY   G L             +      N        L     VA  + 
Sbjct: 119  CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMA 178

Query: 873  YL---HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKTLGTIGY 928
            +L   +       +H D+   NVLL    V  + DFG+A+ +  + +   +      + +
Sbjct: 179  FLASKNC------IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 232

Query: 929  MAPEYGREGKVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLLSCSITE 987
            MAPE   +   + + DV+SYGI+L E F+    P   I       K              
Sbjct: 233  MAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL------------- 279

Query: 988  VADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYI 1047
            V D   +               +I+S+   C    P  R + + + + L    +      
Sbjct: 280  VKDGYQMAQPAF-------APKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRER 332

Query: 1048 D 1048
            D
Sbjct: 333  D 333

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  112 bits (283), Expect = 7e-27
 Identities = 59/258 (22%), Positives = 106/258 (41%), Gaps = 43/258 (16%)

Query: 723 RRRRRRRQKGSTRPYYDANMYPQATWRRISYQDLLRATDGFSEN----KLLGMGSFGSVY 778
                 ++    +P    N+Y Q+        D   A   F +      ++G G    V 
Sbjct: 53  NLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDW-AAAKEFYQKYDPKDVIGRGVSSVVR 111

Query: 779 KGV-LPDGMEIAAKVF--------HMEFDGSLESFHAECKVMGSIR-HRNLVKIISSCSN 828
           + V    G E A K+           + +   E+   E  ++  +  H +++ +I S  +
Sbjct: 112 RCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171

Query: 829 NDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK--------IMIDVASALEYLHFGYST 880
           + F  LV + M  G L         F  + +++         IM  +  A+ +LH   + 
Sbjct: 172 SSFMFLVFDLMRKGEL---------FDYLTEKVALSEKETRSIMRSLLEAVSFLH---AN 219

Query: 881 PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE------YG 934
            IVH D+KP N+LL+++M   LSDFG +  L   E +   +  GT GY+APE        
Sbjct: 220 NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL--RELCGTPGYLAPEILKCSMDE 277

Query: 935 REGKVSRKCDVYSYGIML 952
                 ++ D+++ G++L
Sbjct: 278 THPGYGKEVDLWACGVIL 295

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  112 bits (282), Expect = 7e-27
 Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 46/213 (21%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKV-----FHMEFDGSLESFHAECKVMGSIRHRNLV 820
           +++G G F  V + +    G + A K+     F      S E    E  +   ++H ++V
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89

Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK------------IMIDVA 868
           +++ + S++    +V E+M    L           +I++R               M  + 
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADL---------CFEIVKRADAGFVYSEAVASHYMRQIL 140

Query: 869 SALEYLHFGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKILGKEESMRQTKTLGT 925
            AL Y H      I+H D+KP  VLL     S    L  FG+A  LG+   +   + +GT
Sbjct: 141 EALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR-VGT 196

Query: 926 IGYMAPE------YGREGKVSRKCDVYSYGIML 952
             +MAPE      YG+        DV+  G++L
Sbjct: 197 PHFMAPEVVKREPYGKP------VDVWGCGVIL 223

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  112 bits (281), Expect = 8e-27
 Identities = 37/238 (15%), Positives = 68/238 (28%), Gaps = 27/238 (11%)

Query: 760 TDGFSENKLLGMGSFGSVYKGV------LPDGMEIAAKVFHMEFDGSLESFHAECKVMGS 813
           +     + LLG G+F  VY+          +  +   KV                + +  
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 814 IRHRNLVKIISSCSNNDFKALVLEYMSNGSL----EKCLYSDNYFLDILQRLKIMIDVAS 869
                 +K  S+    +   LV E  S G+L         +    +     +   + +  
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183

Query: 870 ALEYLHFGYSTPIVHCDIKPSNVLLNESMVGH-----------LSDFGIAKILGKEESMR 918
            +E +H      I+H DIKP N +L    +             L D G +  +       
Sbjct: 184 MIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 919 QTKTL-GTIGYMAPEYGREGKV-SRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
                  T G+   E     K  + + D +     +           +   GE   + 
Sbjct: 241 IFTAKCETSGFQCVEM-LSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEG 297

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  110 bits (276), Expect = 2e-26
 Identities = 59/314 (18%), Positives = 115/314 (36%), Gaps = 50/314 (15%)

Query: 338 SSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCR 397
                ++    +  G ++ +  +     +L  +  LS  G  +T+       +  +    
Sbjct: 13  FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-------IEGVQYLN 63

Query: 398 NLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNE 457
           NL  + L +N I  + P                           L N+  +T + L  N 
Sbjct: 64  NLIGLELKDNQITDLAP---------------------------LKNLTKITELELSGNP 96

Query: 458 LTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNL 517
           L       +  LQ ++ L L + ++  +    L  L  L  LYL  N+++  +   L  L
Sbjct: 97  LKNVSA--IAGLQSIKTLDLTSTQI--TDVTPLAGLSNLQVLYLDLNQIT-NISP-LAGL 150

Query: 518 TSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNA 577
           T+L+ LS+G+  ++ + P  L NL  +       N +  S +  + +L  +IE+ L  N 
Sbjct: 151 TNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKI--SDISPLASLPNLIEVHLKNNQ 206

Query: 578 LSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEAL 637
           +S V P  +     L +++L    +          L   N V     + +   P ++   
Sbjct: 207 ISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVV--KGPSGAPIAPATISDN 262

Query: 638 SYLKHLNLSFNQLE 651
                 NL++N   
Sbjct: 263 GTYASPNLTWNLTS 276

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  105 bits (263), Expect = 9e-25
 Identities = 75/346 (21%), Positives = 134/346 (38%), Gaps = 63/346 (18%)

Query: 316 DLGLPNLERLFLGENNFSGTIP-SSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLS 374
           D  L N  ++  G++N + T+  + L  I+ LS    G  +  G+       L +L  L 
Sbjct: 15  DPALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEGV-----QYLNNLIGLE 69

Query: 375 LAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNI 434
           L  N +T    DL+ L +LT    +  + LS NP+  +                      
Sbjct: 70  LKDNQIT----DLAPLKNLT---KITELELSGNPLKNV---------------------- 100

Query: 435 SGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLY 494
                  +  + ++  + L + ++T   P  L  L  LQ LYL  N++  +I   L  L 
Sbjct: 101 -----SAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NI-SPLAGLT 151

Query: 495 RLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSL 554
            L  L +G+ ++S  L   L NL+ L  L    N ++ I  S L +L +++  +L +N +
Sbjct: 152 NLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQI 207

Query: 555 NGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLK 614
             S +  + N   +  + L+   ++         L    ++         P   S  G  
Sbjct: 208 --SDVSPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNG-- 263

Query: 615 SLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPF 660
                  ++ NL+  +   +  +SY      +FNQ      T  PF
Sbjct: 264 -----TYASPNLTWNLTSFINNVSY------TFNQSVTFKNTTVPF 298

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 65/335 (19%), Positives = 110/335 (32%), Gaps = 78/335 (23%)

Query: 117 LSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDL 176
              L          +N  +        L  +  L       V  I E + YL+ L  L+L
Sbjct: 15  DPALANAIKIAAGKSN--VTDTVTQADLDGITTLSAFGTG-VTTI-EGVQYLNNLIGLEL 70

Query: 177 SDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQ 236
            DNQ++        +++  +NL  +  L +S N L                         
Sbjct: 71  KDNQIT--------DLAPLKNLTKITELELSGNPLKNVSA-------------------- 102

Query: 237 GGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNIST 296
                 I  L S++ L L +   I ++   +  L NL+VL +   N           I+ 
Sbjct: 103 ------IAGLQSIKTLDLTSTQ-ITDVTP-LAGLSNLQVLYL-DLN----------QITN 143

Query: 297 LKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSF 356
           +  LA                GL NL+ L +G    S    + L N+S+L+ L    N  
Sbjct: 144 ISPLA----------------GLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKI 185

Query: 357 SGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSS 416
           S + P    +L +L  + L  N ++        +S L +  NL I+ L+   I       
Sbjct: 186 SDISP--LASLPNLIEVHLKNNQISD-------VSPLANTSNLFIVTLTNQTITNQPVFY 236

Query: 417 IGNFSISMKSLSMESCNISGGIPKELGNINNLTVI 451
             N  +           I+     + G   +  + 
Sbjct: 237 NNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLT 271

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 88.6 bits (220), Expect = 4e-19
 Identities = 59/370 (15%), Positives = 116/370 (31%), Gaps = 99/370 (26%)

Query: 186 PSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGN 245
           P++I  I     L     +    + +T  +                             +
Sbjct: 6   PTAINVIFPDPALANAIKIAAGKSNVTDTVT--------------------------QAD 39

Query: 246 LTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDN 305
           L  +  L       +  I   +  L NL  L +   N           I+ L  L     
Sbjct: 40  LDGITTLSAFGT-GVTTIEG-VQYLNNLIGLEL-KDN----------QITDLAPLK---- 82

Query: 306 DLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFG 365
                        L  +  L L  N       S++  +  +  LD      + + P    
Sbjct: 83  ------------NLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP--LA 126

Query: 366 NLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMK 425
            L +L++L L  N +T+       +S L    NL+ + +    ++ + P           
Sbjct: 127 GLSNLQVLYLDLNQITN-------ISPLAGLTNLQYLSIGNAQVSDLTP----------- 168

Query: 426 SLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGS 485
                           L N++ LT ++  +N+++   P  L  L  L  ++L+NN++   
Sbjct: 169 ----------------LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDV 210

Query: 486 IPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDIL 545
            P  L +   L  + L +  ++ +      NL       +   +   I P+T+ +     
Sbjct: 211 SP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVP--NVVKGPSGAPIAPATISDNGTYA 266

Query: 546 RFNLSSNSLN 555
             NL+ N  +
Sbjct: 267 SPNLTWNLTS 276

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 59/338 (17%), Positives = 113/338 (33%), Gaps = 77/338 (22%)

Query: 75  VTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFH 134
              +      +T T+     +L  +  L+        ++ E + +L  L   + + N   
Sbjct: 21  AIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV-TTI-EGVQYLNNLIGLELKDNQ-- 74

Query: 135 IEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISS 194
           I   +   +L ++  L L  N    K    I  L  ++ LDL+  Q++        +++ 
Sbjct: 75  ITDLAPLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQIT--------DVTP 124

Query: 195 CQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFL 254
              L  L+ L++  NQ+T   P                          +  LT+++ L +
Sbjct: 125 LAGLSNLQVLYLDLNQITNISP--------------------------LAGLTNLQYLSI 158

Query: 255 GNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSS 314
           GN   + ++   + NL  L  L     N           IS +  LA             
Sbjct: 159 GNAQ-VSDLTP-LANLSKLTTLKA-DDN----------KISDISPLA------------- 192

Query: 315 IDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLS 374
               LPNL  + L  N  S    S L N S L ++     + +        NL    ++ 
Sbjct: 193 ---SLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVK 247

Query: 375 LAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGI 412
                  +P    + +S   +  +  + +   + IN +
Sbjct: 248 GPSGAPIAP----ATISDNGTYASPNLTWNLTSFINNV 281

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  112 bits (281), Expect = 2e-26
 Identities = 51/235 (21%), Positives = 99/235 (42%), Gaps = 14/235 (5%)

Query: 726 RRRRQKGSTRPYYDANMYPQATWRRISYQDLLRATDGFSEN----KLLGMGSFGSVYKGV 781
            + R K       D + + +  W++   Q +        +     + LG G+FG V++ V
Sbjct: 12  SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV 71

Query: 782 -LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMS 840
               G    AK  +  +     +   E  +M  + H  L+ +  +  +     L+LE++S
Sbjct: 72  EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131

Query: 841 NGSL-EKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMV 899
            G L ++   +++Y +   + +  M      L+++H      IVH DIKP N++      
Sbjct: 132 GGELFDRIA-AEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKA 187

Query: 900 GHL--SDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIML 952
             +   DFG+A  L  +E ++   T  T  + APE      V    D+++ G++ 
Sbjct: 188 SSVKIIDFGLATKLNPDEIVKV--TTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  109 bits (274), Expect = 2e-26
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 42/207 (20%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGS--LESFHAECKVMGSIRHRNLVKII 823
           + LG G+F  V + V    G+E AAK+ + +   +   +    E ++   ++H N+V++ 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71

Query: 824 SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK--------IMIDVASALEYLH 875
            S     F  LV + ++ G L         F DI+ R           +  +  ++ Y H
Sbjct: 72  DSIQEESFHYLVFDLVTGGEL---------FEDIVAREFYSEADASHCIQQILESIAYCH 122

Query: 876 FGYSTPIVHCDIKPSNVLL----NESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAP 931
              S  IVH ++KP N+LL      + V  L+DFG+A  +   E+       GT GY++P
Sbjct: 123 ---SNGIVHRNLKPENLLLASKAKGAAV-KLADFGLAIEVNDSEAW--HGFAGTPGYLSP 176

Query: 932 E------YGREGKVSRKCDVYSYGIML 952
           E      Y +        D+++ G++L
Sbjct: 177 EVLKKDPYSKP------VDIWACGVIL 197

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  111 bits (279), Expect = 3e-26
 Identities = 37/207 (17%), Positives = 73/207 (35%), Gaps = 35/207 (16%)

Query: 770 GMGSFGSVYKGV-LPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSC 826
           G     +V      P G  +  +  ++E   +  +     E  V     H N+V   ++ 
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 827 SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK-----------IMIDVASALEYLH 875
             ++   +V  +M+ GS            D++               I+  V  AL+Y+H
Sbjct: 96  IADNELWVVTSFMAYGSA----------KDLICTHFMDGMNELAIAYILQGVLKALDYIH 145

Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL------GTIGYM 929
                  VH  +K S++L++     +LS       +      ++            + ++
Sbjct: 146 ---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202

Query: 930 APEYGREGKV--SRKCDVYSYGIMLME 954
           +PE  ++       K D+YS GI   E
Sbjct: 203 SPEVLQQNLQGYDAKSDIYSVGITACE 229

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  110 bits (277), Expect = 3e-26
 Identities = 59/201 (29%), Positives = 87/201 (43%), Gaps = 20/201 (9%)

Query: 763 FSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGS---LESFHAECKVMGSIRHRN 818
           FS+ + +G GSFG+VY    + +   +A K        S    +    E + +  +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
            ++            LV+EY   GS    L      L  ++   +       L YLH   
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--- 171

Query: 879 STPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMAPE---Y 933
           S  ++H D+K  N+LL+E   G   L DFG A I+    S      +GT  +MAPE    
Sbjct: 172 SHNMIHRDVKAGNILLSEP--GLVKLGDFGSASIMAPANSF-----VGTPYWMAPEVILA 224

Query: 934 GREGKVSRKCDVYSYGIMLME 954
             EG+   K DV+S GI  +E
Sbjct: 225 MDEGQYDGKVDVWSLGITCIE 245

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  109 bits (275), Expect = 3e-26
 Identities = 61/310 (19%), Positives = 113/310 (36%), Gaps = 54/310 (17%)

Query: 767  KLLGMGSFGSVYKGVLPD------GMEIAAKV---FHMEFDGSLESFHAECKVMGSI-RH 816
            K LG G+FG V +            M +A K+        +   E+  +E KV+  +  H
Sbjct: 29   KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--REALMSELKVLSYLGNH 86

Query: 817  RNLVKIISSCSNNDFKALVLEYMSNGSL-----------------EKCLYSDNYFLDILQ 859
             N+V ++ +C+      ++ EY   G L                    +  D   LD+  
Sbjct: 87   MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 860  RLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR- 918
             L     VA  + +L    S   +H D+   N+LL    +  + DFG+A+ +  + +   
Sbjct: 147  LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 919  QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVG 977
            +      + +MAPE       + + DV+SYGI L E F+    P   +       K    
Sbjct: 204  KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM--- 260

Query: 978  DSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037
                      + +   +   E+         + ++ +   C    P KR + K +   + 
Sbjct: 261  ----------IKEGFRMLSPEH-------APAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303

Query: 1038 RIRETLSAYI 1047
            +     + +I
Sbjct: 304  KQISESTNHI 313

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  109 bits (275), Expect = 4e-26
 Identities = 64/239 (26%), Positives = 98/239 (41%), Gaps = 39/239 (16%)

Query: 740 ANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFD 798
           A+  P  +   I    L      F   +L+G G++G VYKG  +  G   A KV  +  D
Sbjct: 3   ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD 62

Query: 799 GSLESFHAECKVMGSI-RHRNLVK-----IISSCSNNDFKA-LVLEYMSNGSLEKCLYSD 851
              E    E  ++     HRN+       I  +    D +  LV+E+   GS+       
Sbjct: 63  -EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV------- 114

Query: 852 NYFLDILQRLK-----------IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVG 900
               D+++  K           I  ++   L +LH      ++H DIK  NVLL E+   
Sbjct: 115 ---TDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEV 168

Query: 901 HLSDFGIAKILGKEESMRQTKTLGTIGYMAPE-----YGREGKVSRKCDVYSYGIMLME 954
            L DFG++  L +    R T  +GT  +MAPE        +     K D++S GI  +E
Sbjct: 169 KLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  108 bits (272), Expect = 5e-26
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 39/205 (19%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFH--MEFDGSLESFHAECKVMGSIRHRNLVKII 823
            +LG GSFG V K        E A KV +     +    +   E +++  + H N++K+ 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 824 SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQR--------LKIMIDVASALEYLH 875
               ++    +V E  + G L         F +I++R         +I+  V S + Y+H
Sbjct: 88  EILEDSSSFYIVGELYTGGEL---------FDEIIKRKRFSEHDAARIIKQVFSGITYMH 138

Query: 876 FGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE 932
                 IVH D+KP N+LL    +     + DFG++    +   M     +GT  Y+APE
Sbjct: 139 ---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPE 193

Query: 933 -----YGREGKVSRKCDVYSYGIML 952
                Y  +      CDV+S G++L
Sbjct: 194 VLRGTYDEK------CDVWSAGVIL 212

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  107 bits (270), Expect = 6e-26
 Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 37/203 (18%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISS 825
             +G GS+G V   V     +  AAK     F   ++ F  E ++M S+ H N++++  +
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74

Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQR--------LKIMIDVASALEYLHFG 877
             +N    LV+E  + G L         F  ++ +         +IM DV SA+ Y H  
Sbjct: 75  FEDNTDIYLVMELCTGGEL---------FERVVHKRVFRESDAARIMKDVLSAVAYCH-- 123

Query: 878 YSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE-- 932
               + H D+KP N L    +      L DFG+A      + M     +GT  Y++P+  
Sbjct: 124 -KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQVL 180

Query: 933 ---YGREGKVSRKCDVYSYGIML 952
              YG E      CD +S G+M+
Sbjct: 181 EGLYGPE------CDEWSAGVMM 197

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  109 bits (274), Expect = 6e-26
 Identities = 65/314 (20%), Positives = 125/314 (39%), Gaps = 57/314 (18%)

Query: 767  KLLGMGSFGSVYKGVLPDGMEIAA-----------KVFHMEFDGSLESFHAECKVMGSI- 814
            K LG G+FG V         +              K    E D  L    +E ++M  I 
Sbjct: 41   KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIG 98

Query: 815  RHRNLVKIISSCSNNDFKALVLEYMSNGSL---------------EKCLYSDNYFLDILQ 859
            +H+N++ ++ +C+ +    +++EY S G+L                         +    
Sbjct: 99   KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158

Query: 860  RLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR- 918
             +     +A  +EYL    S   +H D+   NVL+ E+ V  ++DFG+A+ +   +  + 
Sbjct: 159  LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215

Query: 919  QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVG 977
             T     + +MAPE   +   + + DV+S+G+++ E FT    P   I   E+       
Sbjct: 216  TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 268

Query: 978  DSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037
                      + + + ++   N       C + ++ +  DC   +P +R + K +   L 
Sbjct: 269  -------FKLLKEGHRMDKPAN-------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314

Query: 1038 RIRETLS--AYIDV 1049
            RI    +   Y+D+
Sbjct: 315  RILTLTTNEEYLDL 328

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  108 bits (273), Expect = 7e-26
 Identities = 50/229 (21%), Positives = 89/229 (38%), Gaps = 30/229 (13%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFH---MEFDGSLESFHAECKVMGSIRHRNLVKI 822
           + LG G F   ++          A K+     +      E    E  +  S+ H+++V  
Sbjct: 47  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106

Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
                +NDF  +VLE     SL +         +   R   +  +    +YLH      +
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRV 162

Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRK 942
           +H D+K  N+ LNE +   + DFG+A  +  +   ++    GT  Y+APE   +   S +
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFE 221

Query: 943 CDVYSYGIML---------------METFTKKKPTDEIFAGEMSLKRWV 976
            DV+S G ++                ET+ +      I   E S+ + +
Sbjct: 222 VDVWSIGCIMYTLLVGKPPFETSCLKETYLR------IKKNEYSIPKHI 264

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  109 bits (275), Expect = 7e-26
 Identities = 47/205 (22%), Positives = 79/205 (38%), Gaps = 33/205 (16%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFH------MEFDGSLESFHAECKVMGSIRHRNL 819
           + LG G F  V K      G+E AAK                E    E  ++  + H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77

Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQR--------LKIMIDVASAL 871
           + +     N     L+LE +S G L         F  + Q+           +  +   +
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGEL---------FDFLAQKESLSEEEATSFIKQILDGV 128

Query: 872 EYLHFGYSTPIVHCDIKPSNVLLNESMVGH----LSDFGIAKILGKEESMRQTKTLGTIG 927
            YLH   +  I H D+KP N++L +  +      L DFG+A  +      +     GT  
Sbjct: 129 NYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPE 183

Query: 928 YMAPEYGREGKVSRKCDVYSYGIML 952
           ++APE      +  + D++S G++ 
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVIT 208

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  109 bits (275), Expect = 7e-26
 Identities = 62/305 (20%), Positives = 118/305 (38%), Gaps = 61/305 (20%)

Query: 767  KLLGMGSFGSVYKGVLPDGMEIAA-----------KVFHMEFDGSLESFHAECKVMGSI- 814
            K LG G FG V         +              K    E D  L    +E ++M  I 
Sbjct: 87   KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIG 144

Query: 815  RHRNLVKIISSCSNNDFKALVLEYMSNGSL---------------EKCLYSDNYFLDILQ 859
            +H+N++ ++ +C+ +    +++EY S G+L                         +    
Sbjct: 145  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 860  RLKIMIDVASALEYL---HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES 916
             +     +A  +EYL           +H D+   NVL+ E+ V  ++DFG+A+ +   + 
Sbjct: 205  LVSCTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDY 258

Query: 917  MR-QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKR 974
             +  T     + +MAPE   +   + + DV+S+G+++ E FT    P   I   E+    
Sbjct: 259  YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL---- 314

Query: 975  WVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVAN 1034
                         + + + ++   N       C + ++ +  DC   +P +R + K +  
Sbjct: 315  ----------FKLLKEGHRMDKPAN-------CTNELYMMMRDCWHAVPSQRPTFKQLVE 357

Query: 1035 RLVRI 1039
             L RI
Sbjct: 358  DLDRI 362

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  109 bits (274), Expect = 1e-25
 Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 48/223 (21%)

Query: 756 LLRATDGFSEN----KLLGMGSFGSVYKGV-LPDGMEIAAKVFH---MEFDGSLESFHAE 807
           ++ A+  FS+N    + LG G+F  V + V    G+E AAK+ +   +      +    E
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLERE 78

Query: 808 CKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK----- 862
            ++   ++H N+V++  S     F  LV + ++ G L         F DI+ R       
Sbjct: 79  ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---------FEDIVAREFYSEAD 129

Query: 863 ---IMIDVASALEYLHFGYSTPIVHCDIKPSNVLL----NESMVGHLSDFGIAKILGKEE 915
               +  +  ++ Y H   S  IVH ++KP N+LL      + V  L+DFG+A  +   E
Sbjct: 130 ASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAV-KLADFGLAIEVNDSE 185

Query: 916 SMRQTKTLGTIGYMAPE------YGREGKVSRKCDVYSYGIML 952
           +       GT GY++PE      Y +        D+++ G++L
Sbjct: 186 AW--HGFAGTPGYLSPEVLKKDPYSKP------VDIWACGVIL 220

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  107 bits (269), Expect = 1e-25
 Identities = 50/229 (21%), Positives = 89/229 (38%), Gaps = 30/229 (13%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRHRNLVKI 822
           + LG G F   ++          A K+     +      E    E  +  S+ H+++V  
Sbjct: 21  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80

Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
                +NDF  +VLE     SL +         +   R   +  +    +YLH      +
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRV 136

Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRK 942
           +H D+K  N+ LNE +   + DFG+A  +  +   ++    GT  Y+APE   +   S +
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFE 195

Query: 943 CDVYSYGIML---------------METFTKKKPTDEIFAGEMSLKRWV 976
            DV+S G ++                ET+ +      I   E S+ + +
Sbjct: 196 VDVWSIGCIMYTLLVGKPPFETSCLKETYLR------IKKNEYSIPKHI 238

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  108 bits (272), Expect = 1e-25
 Identities = 70/368 (19%), Positives = 119/368 (32%), Gaps = 68/368 (18%)

Query: 721  RRRRRRRRRQKGSTRPYYDANMYPQATWRRISYQDLLRATDGFSENKL-----LGMGSFG 775
            +++ R   + +         N Y    +R   Y         F    L     LG G+FG
Sbjct: 4    KKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWE----FPRENLEFGKVLGSGAFG 59

Query: 776  SVYKGVLPD--GMEIAAKV-------FHMEFDGSLESFHAECKVMGSI-RHRNLVKIISS 825
             V            ++ +V            +   E+  +E K+M  +  H N+V ++ +
Sbjct: 60   KVMNATAYGISKTGVSIQVAVKMLKEKADSSE--REALMSELKMMTQLGSHENIVNLLGA 117

Query: 826  CSNNDFKALVLEYMSNGSL----------------------EKCLYSDNYFLDILQRLKI 863
            C+ +    L+ EY   G L                            D   L     L  
Sbjct: 118  CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCF 177

Query: 864  MIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-QTKT 922
               VA  +E+L        VH D+   NVL+    V  + DFG+A+ +  + +   +   
Sbjct: 178  AYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNA 234

Query: 923  LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLL 981
               + +MAPE   EG  + K DV+SYGI+L E F+    P   I       K        
Sbjct: 235  RLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL------- 287

Query: 982  SCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041
                  + +   ++               I+ +   C      KR S  ++ + L     
Sbjct: 288  ------IQNGFKMDQPFY-------ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334

Query: 1042 TLSAYIDV 1049
                 +  
Sbjct: 335  DAEEAMYQ 342

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  107 bits (270), Expect = 1e-25
 Identities = 49/224 (21%), Positives = 91/224 (40%), Gaps = 38/224 (16%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEIAA---------KVFHMEFDGSLESFHAECKVMGSIRHR 817
           K LG G FG V K         A          K      +  L    +E  V+  + H 
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE--LRDLLSEFNVLKQVNHP 86

Query: 818 NLVKIISSCSNNDFKALVLEYMSNGSL-----------------------EKCLYSDNYF 854
           +++K+  +CS +    L++EY   GSL                           + D   
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146

Query: 855 LDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE 914
           L +   +     ++  ++YL       +VH D+   N+L+ E     +SDFG+++ + +E
Sbjct: 147 LTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203

Query: 915 ESMR-QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
           +S   +++    + +MA E   +   + + DV+S+G++L E  T
Sbjct: 204 DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  107 bits (270), Expect = 2e-25
 Identities = 57/303 (18%), Positives = 113/303 (37%), Gaps = 53/303 (17%)

Query: 767  KLLGMGSFGSVYKGVLP--DGMEIAAKV-------FHMEFDGSLESFHAECKVMGSI-RH 816
            K LG G+FG V +      D       V            +    +  +E K++  I  H
Sbjct: 33   KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIHIGHH 90

Query: 817  RNLVKIISSCSNNDFKALV-LEYMSNGSL---------------EKCLYSDNYFLDILQR 860
             N+V ++ +C+      +V +E+   G+L                        FL +   
Sbjct: 91   LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 861  LKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR-Q 919
            +     VA  +E+L    S   +H D+   N+LL+E  V  + DFG+A+ + K+     +
Sbjct: 151  ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207

Query: 920  TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGD 978
                  + +MAPE   +   + + DV+S+G++L E F+    P    + G + +      
Sbjct: 208  GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YPG-VKIDEEF-- 260

Query: 979  SLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVR 1038
                     + +   +   +            ++   +DC    P +R +  ++   L  
Sbjct: 261  ------CRRLKEGTRMRAPDY-------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307

Query: 1039 IRE 1041
            + +
Sbjct: 308  LLQ 310

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  107 bits (270), Expect = 2e-25
 Identities = 48/205 (23%), Positives = 80/205 (39%), Gaps = 33/205 (16%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFH------MEFDGSLESFHAECKVMGSIRHRNL 819
           + LG G F  V K      G+E AAK              S E    E  ++  + H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77

Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQR--------LKIMIDVASAL 871
           + +     N     L+LE +S G L         F  + Q+           +  +   +
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGEL---------FDFLAQKESLSEEEATSFIKQILDGV 128

Query: 872 EYLHFGYSTPIVHCDIKPSNVLLNESMVGH----LSDFGIAKILGKEESMRQTKTLGTIG 927
            YLH   +  I H D+KP N++L +  +      L DFG+A  +      +     GT  
Sbjct: 129 NYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPE 183

Query: 928 YMAPEYGREGKVSRKCDVYSYGIML 952
           ++APE      +  + D++S G++ 
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVIT 208

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  108 bits (273), Expect = 2e-25
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 33/220 (15%)

Query: 766 NKLLGMGSFGSVYKGVL----PDGMEIAAKV-------FHMEFDGSLESFHAECKVMGSI 814
            K LG G+FG V          D      KV          E D  L    +E ++M  I
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMI 131

Query: 815 -RHRNLVKIISSCSNNDFKALVLEYMSNGSL---------------EKCLYSDNYFLDIL 858
            +H+N++ ++ +C+ +    +++EY S G+L                   ++    L   
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 859 QRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR 918
             +     VA  +EYL    S   +H D+   NVL+ E  V  ++DFG+A+ +   +  +
Sbjct: 192 DLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248

Query: 919 -QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT 957
             T     + +MAPE   +   + + DV+S+G++L E FT
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  110 bits (277), Expect = 2e-25
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 30/201 (14%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRHRNLVKI 822
           ++LG GSFG V        G E A KV     ++     ES   E +++  + H N++K+
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91

Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQR--------LKIMIDVASALEYL 874
                +  +  LV E  + G L         F +I+ R         +I+  V S + Y+
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGEL---------FDEIISRKRFSEVDAARIIRQVLSGITYM 142

Query: 875 HFGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAP 931
           H      IVH D+KP N+LL   ++     + DFG++      + M     +GT  Y+AP
Sbjct: 143 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGTAYYIAP 197

Query: 932 EYGREGKVSRKCDVYSYGIML 952
           E    G    KCDV+S G++L
Sbjct: 198 EVLH-GTYDEKCDVWSTGVIL 217

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  109 bits (275), Expect = 2e-25
 Identities = 50/207 (24%), Positives = 89/207 (42%), Gaps = 41/207 (19%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVF--HMEFDGSLESFHAECKVMGSIRHRNLVKII 823
           + LG G+F  V + V +  G E AA +           +    E ++   ++H N+V++ 
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76

Query: 824 SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK--------IMIDVASALEYLH 875
            S S      L+ + ++ G L         F DI+ R           +  +  A+ + H
Sbjct: 77  DSISEEGHHYLIFDLVTGGEL---------FEDIVAREYYSEADASHCIQQILEAVLHCH 127

Query: 876 FGYSTPIVHCDIKPSNVLL----NESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAP 931
                 +VH ++KP N+LL      + V  L+DFG+A  + + E        GT GY++P
Sbjct: 128 ---QMGVVHRNLKPENLLLASKLKGAAV-KLADFGLAIEV-EGEQQAWFGFAGTPGYLSP 182

Query: 932 E------YGREGKVSRKCDVYSYGIML 952
           E      YG+        D+++ G++L
Sbjct: 183 EVLRKDPYGKP------VDLWACGVIL 203

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  111 bits (278), Expect = 2e-25
 Identities = 56/238 (23%), Positives = 100/238 (42%), Gaps = 18/238 (7%)

Query: 725 RRRRRQKGSTRPYYDANMYPQATWRRISYQDLLRATDGFSE----NKLLGMGSFGSVYKG 780
            + +  +G      + + Y    W++   Q +    D   +    ++ LG G+FG V++ 
Sbjct: 117 EQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV 176

Query: 781 V-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM 839
                G   AAK      +   E+   E + M  +RH  LV +  +  +++   ++ E+M
Sbjct: 177 TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236

Query: 840 SNGSL-EKCLYSDNYF--LDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE 896
           S G L EK     N     +    ++ M  V   L ++H       VH D+KP N++   
Sbjct: 237 SGGELFEKVADEHNKMSEDEA---VEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTT 290

Query: 897 SMVGHL--SDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIML 952
                L   DFG+   L  ++S++   T GT  + APE      V    D++S G++ 
Sbjct: 291 KRSNELKLIDFGLTAHLDPKQSVKV--TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  110 bits (276), Expect = 3e-25
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 40/211 (18%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKV-------------FHMEFDGSLESFHAECKVMG 812
           + LG G++G V          E A KV              +   +   E  + E  ++ 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 813 SIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQR--------LKIM 864
           S+ H N++K+     +  +  LV E+   G L         F  I+ R          IM
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL---------FEQIINRHKFDECDAANIM 152

Query: 865 IDVASALEYLHFGYSTPIVHCDIKPSNVLL-NESMVGHL--SDFGIAKILGKEESMRQTK 921
             + S + YLH      IVH DIKP N+LL N++ + ++   DFG++    K+  +    
Sbjct: 153 KQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL--RD 207

Query: 922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIML 952
            LGT  Y+APE  +  K + KCDV+S G+++
Sbjct: 208 RLGTAYYIAPEVLK-KKYNEKCDVWSCGVIM 237

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  108 bits (270), Expect = 3e-25
 Identities = 37/282 (13%), Positives = 69/282 (24%), Gaps = 46/282 (16%)

Query: 717 AKLVRRRRRRRRRQKGSTRPYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGS 776
             +   R    +                 A     S   L +        + L +G    
Sbjct: 20  ELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDS--LLSQGERKLKLVEPLRVGDRSV 77

Query: 777 VYKGV-LPDGMEIAAKVFHMEFDGS---LESFHAECKVMGSIRHRNLVKIISSC------ 826
           V+    +    + A KVF M  + S   LE  H        +   +  +           
Sbjct: 78  VFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS 137

Query: 827 ----------------SNNDFKA----LVLEYMS-----NGSLEKCLYSDNYFLDILQRL 861
                             +D+      L++   S       S    +Y       IL   
Sbjct: 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALH 197

Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK 921
            +   +      L    S  +VH    P N+ +       L D      +G     R   
Sbjct: 198 ILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPA 250

Query: 922 TLGTIGYMAPEY--GREGKVSRKCDVYSYGIMLMETFTKKKP 961
           +   + Y   E+        +   + +  G+ +   +    P
Sbjct: 251 SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  105 bits (265), Expect = 3e-25
 Identities = 57/235 (24%), Positives = 100/235 (42%), Gaps = 41/235 (17%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFH---MEFDGSLESFHAECKVMGSIRHRNLVKI 822
            LLG GSF  VY+   +  G+E+A K+     M   G ++    E K+   ++H +++++
Sbjct: 17  NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76

Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
            +   ++++  LVLE   NG + + L +        +    M  + + + YLH   S  I
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGI 133

Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE------YGRE 936
           +H D+  SN+LL  +M   ++DFG+A  L        T   GT  Y++PE      +G E
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHGLE 192

Query: 937 GKVSRKCDVYSYGIML---------------METFTKKKPTDEIFAGEMSLKRWV 976
                  DV+S G M                  T  K      +   +  +  ++
Sbjct: 193 ------SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK------VVLADYEMPSFL 235

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  106 bits (268), Expect = 3e-25
 Identities = 53/209 (25%), Positives = 85/209 (40%), Gaps = 38/209 (18%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFH--------MEFDGSLESFHAECKVMGSIRHR 817
           K LG G+ G V          ++A K+                  +   E +++  + H 
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75

Query: 818 NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK--------IMIDVAS 869
            ++KI +     D+  +VLE M  G L         F  ++   +            +  
Sbjct: 76  CIIKIKNFFDAEDY-YIVLELMEGGEL---------FDKVVGNKRLKEATCKLYFYQMLL 125

Query: 870 ALEYLHFGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKILGKEESMRQTKTLGTI 926
           A++YLH      I+H D+KP NVLL    E  +  ++DFG +KILG+   M      GT 
Sbjct: 126 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGTP 180

Query: 927 GYMAPE---YGREGKVSRKCDVYSYGIML 952
            Y+APE          +R  D +S G++L
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  109 bits (274), Expect = 4e-25
 Identities = 62/243 (25%), Positives = 96/243 (39%), Gaps = 31/243 (12%)

Query: 724 RRRRRRQKGSTRPYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGV-L 782
                   G    Y+  ++         S +  L   + +   K LG G++G V      
Sbjct: 2   HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLS--EMYQRVKKLGSGAYGEVLLCRDK 59

Query: 783 PDGMEIAAKVF--HMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMS 840
              +E A K+         S      E  V+  + H N++K+     +     LV+E   
Sbjct: 60  VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK 119

Query: 841 NGSLEKCLYSDNYFLDILQR--------LKIMIDVASALEYLHFGYSTPIVHCDIKPSNV 892
            G L         F +I+ R          I+  V S + YLH      IVH D+KP N+
Sbjct: 120 GGEL---------FDEIIHRMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENL 167

Query: 893 LLNESMVGH---LSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYG 949
           LL          + DFG++ +   ++ M   + LGT  Y+APE  R  K   KCDV+S G
Sbjct: 168 LLESKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYIAPEVLR-KKYDEKCDVWSIG 224

Query: 950 IML 952
           ++L
Sbjct: 225 VIL 227

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  105 bits (264), Expect = 4e-25
 Identities = 52/205 (25%), Positives = 82/205 (40%), Gaps = 33/205 (16%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFH------MEFDGSLESFHAECKVMGSIRHRNL 819
           + LG G F  V K      G E AAK              S E    E  ++  IRH N+
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70

Query: 820 VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQR--------LKIMIDVASAL 871
           + +     N     L+LE +S G L         F  + ++         + +  +   +
Sbjct: 71  ITLHDIFENKTDVVLILELVSGGEL---------FDFLAEKESLTEDEATQFLKQILDGV 121

Query: 872 EYLHFGYSTPIVHCDIKPSNVLLNESMVGH----LSDFGIAKILGKEESMRQTKTLGTIG 927
            YLH   S  I H D+KP N++L +  V +    L DFGIA  +      +     GT  
Sbjct: 122 HYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPE 176

Query: 928 YMAPEYGREGKVSRKCDVYSYGIML 952
           ++APE      +  + D++S G++ 
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVIT 201

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  107 bits (268), Expect = 5e-25
 Identities = 52/199 (26%), Positives = 84/199 (42%), Gaps = 30/199 (15%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISS 825
             LG G+   VY+          A KV     D   +    E  V+  + H N++K+   
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPNIIKLKEI 116

Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK--------IMIDVASALEYLHFG 877
                  +LVLE ++ G L         F  I+++           +  +  A+ YLH  
Sbjct: 117 FETPTEISLVLELVTGGEL---------FDRIVEKGYYSERDAADAVKQILEAVAYLH-- 165

Query: 878 YSTPIVHCDIKPSNVLL----NESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
               IVH D+KP N+L      ++ +  ++DFG++KI+  +  M      GT GY APE 
Sbjct: 166 -ENGIVHRDLKPENLLYATPAPDAPL-KIADFGLSKIVEHQVLM--KTVCGTPGYCAPEI 221

Query: 934 GREGKVSRKCDVYSYGIML 952
            R      + D++S GI+ 
Sbjct: 222 LRGCAYGPEVDMWSVGIIT 240

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  108 bits (271), Expect = 5e-25
 Identities = 53/231 (22%), Positives = 89/231 (38%), Gaps = 42/231 (18%)

Query: 749 RRISYQDLLRATDGFSEN----KLLGMGSFGSVYKGV-LPDGMEIAAKVFH--------M 795
             ++  D         +     K LG G+ G V          ++A ++           
Sbjct: 119 FDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSA 178

Query: 796 EFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFL 855
                  +   E +++  + H  ++KI +     D+  +VLE M  G L         F 
Sbjct: 179 READPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGEL---------FD 228

Query: 856 DILQRLK--------IMIDVASALEYLHFGYSTPIVHCDIKPSNVLL---NESMVGHLSD 904
            ++   +            +  A++YLH      I+H D+KP NVLL    E  +  ++D
Sbjct: 229 KVVGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITD 285

Query: 905 FGIAKILGKEESMRQTKTLGTIGYMAPE---YGREGKVSRKCDVYSYGIML 952
           FG +KILG+   M      GT  Y+APE          +R  D +S G++L
Sbjct: 286 FGHSKILGETSLM--RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  105 bits (264), Expect = 6e-25
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 17/208 (8%)

Query: 761 DGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHME-FDGSLESFHAECKVMGSIRHRN 818
           D +   +++G G+   V      P   ++A K  ++E    S++    E + M    H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 819 LVKIISSCSNNDFKALVLEYMSNGSL-------EKCLYSDNYFLDILQRLKIMIDVASAL 871
           +V   +S    D   LV++ +S GS+              +  LD      I+ +V   L
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 872 EYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL---GKEESMRQTKTL-GTIG 927
           EYLH       +H D+K  N+LL E     ++DFG++  L   G     +  KT  GT  
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 928 YMAPEYGREGKV-SRKCDVYSYGIMLME 954
           +MAPE   + +    K D++S+GI  +E
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIE 219

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  107 bits (268), Expect = 6e-25
 Identities = 53/194 (27%), Positives = 94/194 (48%), Gaps = 10/194 (5%)

Query: 763 FSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVK 821
            S+ ++LG G FG V+K      G+++AAK+         E    E  VM  + H NL++
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150

Query: 822 IISSCSNNDFKALVLEYMSNGSL-EKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
           +  +  + +   LV+EY+  G L ++ +  ++Y L  L  +  M  +   + ++H  Y  
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRII-DESYNLTELDTILFMKQICEGIRHMHQMY-- 207

Query: 881 PIVHCDIKPSNVLLNESMVGHL--SDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGK 938
            I+H D+KP N+L        +   DFG+A+     E ++     GT  ++APE      
Sbjct: 208 -ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV--NFGTPEFLAPEVVNYDF 264

Query: 939 VSRKCDVYSYGIML 952
           VS   D++S G++ 
Sbjct: 265 VSFPTDMWSVGVIA 278

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  105 bits (263), Expect = 6e-25
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 32/203 (15%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFH-MEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
           + LG G+FG V+       G+E   K  +       +E   AE +V+ S+ H N++KI  
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87

Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL------------KIMIDVASALE 872
              +     +V+E    G L            I+               ++M  + +AL 
Sbjct: 88  VFEDYHNMYIVMETCEGGEL---------LERIVSAQARGKALSEGYVAELMKQMMNALA 138

Query: 873 YLHFGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYM 929
           Y H   S  +VH D+KP N+L    +      + DFG+A++   +E    T   GT  YM
Sbjct: 139 YFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYM 193

Query: 930 APEYGREGKVSRKCDVYSYGIML 952
           APE  +   V+ KCD++S G+++
Sbjct: 194 APEVFK-RDVTFKCDIWSAGVVM 215

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  108 bits (272), Expect = 7e-25
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 29/200 (14%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVF--HMEFDGSLESFHAECKVMGSIRHRNLVKII 823
            +LG GSFG V K        E A KV       +    +   E +++  + H N++K+ 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 824 SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQR--------LKIMIDVASALEYLH 875
               ++    +V E  + G L         F +I++R         +I+  V S + Y+H
Sbjct: 88  EILEDSSSFYIVGELYTGGEL---------FDEIIKRKRFSEHDAARIIKQVFSGITYMH 138

Query: 876 FGYSTPIVHCDIKPSNVLL-NESMVGHL--SDFGIAKILGKEESMRQTKTLGTIGYMAPE 932
                 IVH D+KP N+LL ++     +   DFG++    +   M     +GT  Y+APE
Sbjct: 139 ---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPE 193

Query: 933 YGREGKVSRKCDVYSYGIML 952
             R G    KCDV+S G++L
Sbjct: 194 VLR-GTYDEKCDVWSAGVIL 212

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  104 bits (262), Expect = 8e-25
 Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 32/229 (13%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFH---MEFDGSLESFHAECKVMGSIRHRNLVKI 822
           + LG G FG+VY          +A KV     +E  G       E ++   +RH N++++
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
                +     L+LEY   G++ + L   + F +       + ++A+AL Y H   S  +
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCH---SKRV 130

Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRK 942
           +H DIKP N+LL  +    ++DFG +       S R+T   GT+ Y+ PE         K
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTDLCGTLDYLPPEMIEGRMHDEK 187

Query: 943 CDVYSYGIML---------------METFTKKKPTDEIFAGEMSLKRWV 976
            D++S G++                 ET+ +      I   E +   +V
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEANTYQETYKR------ISRVEFTFPDFV 230

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  105 bits (264), Expect = 9e-25
 Identities = 47/212 (22%), Positives = 86/212 (40%), Gaps = 33/212 (15%)

Query: 760 TDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFH------MEFDGSLESFHAECKVMG 812
            D +   + LG G F  V K      G++ AAK              S E    E  ++ 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 813 SIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQR--------LKIM 864
            I+H N++ +     N     L+LE ++ G L         F  + ++         + +
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGEL---------FDFLAEKESLTEEEATEFL 120

Query: 865 IDVASALEYLHFGYSTPIVHCDIKPSNVLL-NESMVGH---LSDFGIAKILGKEESMRQT 920
             + + + YLH   S  I H D+KP N++L + ++      + DFG+A  +      +  
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN- 176

Query: 921 KTLGTIGYMAPEYGREGKVSRKCDVYSYGIML 952
              GT  ++APE      +  + D++S G++ 
Sbjct: 177 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  104 bits (262), Expect = 2e-24
 Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 49/224 (21%)

Query: 754 QDLLRATDGFSEN----KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAEC 808
           Q L R +  F++     + +G+GS+    + +     ME A K+     D S      E 
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII----DKSKRDPTEEI 66

Query: 809 KVMG-SIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLK----- 862
           +++    +H N++ +     +  +  +V E M  G L            IL++       
Sbjct: 67  EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL---------LDKILRQKFFSERE 117

Query: 863 ---IMIDVASALEYLHFGYSTPIVHCDIKPSNVLL-----NESMVGHLSDFGIAKILGKE 914
              ++  +   +EYLH   +  +VH D+KPSN+L      N   +  + DFG AK L  E
Sbjct: 118 ASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESI-RICDFGFAKQLRAE 173

Query: 915 ESMRQTKTLGTIGYMAPE------YGREGKVSRKCDVYSYGIML 952
             +  T    T  ++APE      Y         CD++S G++L
Sbjct: 174 NGLLMTP-CYTANFVAPEVLERQGYDAA------CDIWSLGVLL 210

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  105 bits (263), Expect = 4e-24
 Identities = 29/244 (11%), Positives = 64/244 (26%), Gaps = 48/244 (19%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGS---LESFHAECKVMGSIR------- 815
            +LG     +  +      G      V +         ++    E   +  +R       
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 816 ---------------HRNLVKII-------SSCSNNDFKALVLEYMSNGSLEKCLYSD-- 851
                               K+I            + F        +  +  + L S   
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 852 -NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI 910
            +  L    RL++ + V   L  LH      +VH  ++P +++L++     L+ F     
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 911 LGKEESMRQTKTLGTIGYMAPE-----YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEI 965
            G        +        A             ++   D ++ G+ +   +    P    
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP---- 316

Query: 966 FAGE 969
              +
Sbjct: 317 NTDD 320

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  103 bits (259), Expect = 6e-24
 Identities = 55/238 (23%), Positives = 81/238 (34%), Gaps = 55/238 (23%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVF-----HMEFDGSLESFHAECKVMGSIRHRNLV 820
             +G GS+G V   +        A K+             +E    E ++M  + H N+ 
Sbjct: 32  GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91

Query: 821 KIISSCSNNDFKALVLEYMSNGSL-----EKCLYSDNYFLDILQRL-------------- 861
           ++     +  +  LV+E    G L          S       + +               
Sbjct: 92  RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151

Query: 862 --------------------KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL--NESMV 899
                                IM  + SAL YLH   +  I H DIKP N L   N+S  
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFE 208

Query: 900 GHLSDFGIAKILGK---EESMRQTKTLGTIGYMAPE--YGREGKVSRKCDVYSYGIML 952
             L DFG++K   K    E    T   GT  ++APE           KCD +S G++L
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  103 bits (258), Expect = 6e-24
 Identities = 50/200 (25%), Positives = 83/200 (41%), Gaps = 29/200 (14%)

Query: 766 NKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR-HRNLVKII 823
           +K LG GSF    K V        A K+          +   E   +     H N+VK+ 
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLH 72

Query: 824 SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL--------KIMIDVASALEYLH 875
               +     LV+E ++ G L         F  I ++          IM  + SA+ ++H
Sbjct: 73  EVFHDQLHTFLVMELLNGGEL---------FERIKKKKHFSETEASYIMRKLVSAVSHMH 123

Query: 876 FGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE 932
                 +VH D+KP N+L    N+++   + DFG A++   +    +T    T+ Y APE
Sbjct: 124 ---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP-CFTLHYAAPE 179

Query: 933 YGREGKVSRKCDVYSYGIML 952
              +      CD++S G++L
Sbjct: 180 LLNQNGYDESCDLWSLGVIL 199

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  102 bits (257), Expect = 1e-23
 Identities = 57/303 (18%), Positives = 103/303 (33%), Gaps = 52/303 (17%)

Query: 767  KLLGMGSFGSVYKGVLPDGMEIAAKVFH-----------------MEFDGSLESFHAECK 809
            + L  G F  +      D    A K +                  +      + F  E +
Sbjct: 37   RTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95

Query: 810  VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL-------K 862
            ++  I++   +      +N D   ++ EYM N S+ K                       
Sbjct: 96   IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155

Query: 863  IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT 922
            I+  V ++  Y+H      I H D+KPSN+L++++    LSDFG ++ +   +   +  +
Sbjct: 156  IIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM--VDKKIKG-S 210

Query: 923  LGTIGYMAPE--YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSL 980
             GT  +M PE           K D++S GI L   F    P    F+ ++SL        
Sbjct: 211  RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISLVE------ 260

Query: 981  LSCSITEVA----DANLLNCEENDFSAREQCVSSIFSLAMD-----CTVDLPEKRISMKD 1031
            L  +I                           + + +  +D        + P +RI+ +D
Sbjct: 261  LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKN-PAERITSED 319

Query: 1032 VAN 1034
               
Sbjct: 320  ALK 322

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  101 bits (253), Expect = 2e-23
 Identities = 46/193 (23%), Positives = 83/193 (43%), Gaps = 17/193 (8%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISS 825
           + LG G FG V++ V         AK   ++          E  ++   RHRN++ +  S
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHES 69

Query: 826 CSNNDFKALVLEYMSNGSL-EKCLYSDNYF--LDILQRLKIMIDVASALEYLHFGYSTPI 882
             + +   ++ E++S   + E+   S       +I   +  +  V  AL++LH      I
Sbjct: 70  FESMEELVMIFEFISGLDIFERINTSAFELNEREI---VSYVHQVCEALQFLHSHN---I 123

Query: 883 VHCDIKPSNVLL---NESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKV 939
            H DI+P N++      S +  + +FG A+ L   ++ R         Y APE  +   V
Sbjct: 124 GHFDIRPENIIYQTRRSSTI-KIIEFGQARQLKPGDNFRL--LFTAPEYYAPEVHQHDVV 180

Query: 940 SRKCDVYSYGIML 952
           S   D++S G ++
Sbjct: 181 STATDMWSLGTLV 193

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  100 bits (252), Expect = 4e-23
 Identities = 52/233 (22%), Positives = 84/233 (36%), Gaps = 32/233 (13%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR-HRNLVKIIS 824
           ++L  G F  VY+   +  G E A K      +    +   E   M  +  H N+V+  S
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 825 SCS-------NNDFKALVLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDVASALEYLH 875
           + S           + L+L  +  G L + L        L     LKI      A++++H
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153

Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-----------G 924
                PI+H D+K  N+LL+      L DFG A  +        +               
Sbjct: 154 -RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212

Query: 925 TIGYMAPE----YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
           T  Y  PE    Y     +  K D+++ G +L     ++ P    F     L+
Sbjct: 213 TPMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQHP----FEDGAKLR 260

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  100 bits (251), Expect = 5e-23
 Identities = 49/203 (24%), Positives = 82/203 (40%), Gaps = 31/203 (15%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGS--LESFHAECKVMGSIRHR-NLVKI 822
           K LG G F  V + +    G E AAK       G         E  V+   +    ++ +
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94

Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL----------KIMIDVASALE 872
                N     L+LEY + G +         F   L  L          +++  +   + 
Sbjct: 95  HEVYENTSEIILILEYAAGGEI---------FSLCLPELAEMVSENDVIRLIKQILEGVY 145

Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGH---LSDFGIAKILGKEESMRQTKTLGTIGYM 929
           YLH      IVH D+KP N+LL+         + DFG+++ +G    +R+   +GT  Y+
Sbjct: 146 YLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI--MGTPEYL 200

Query: 930 APEYGREGKVSRKCDVYSYGIML 952
           APE      ++   D+++ GI+ 
Sbjct: 201 APEILNYDPITTATDMWNIGIIA 223

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  103 bits (258), Expect = 8e-23
 Identities = 61/315 (19%), Positives = 111/315 (35%), Gaps = 53/315 (16%)

Query: 338 SSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCR 397
                 +E    +    S +  +      L S+  +    + +      +  +  L    
Sbjct: 15  FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK----SVQGIQYLP--- 65

Query: 398 NLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNE 457
           N+  ++L+ N +  I P                           L N+ NL  + L  N+
Sbjct: 66  NVTKLFLNGNKLTDIKP---------------------------LTNLKNLGWLFLDENK 98

Query: 458 LTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNL 517
           +       L  L+KL+ L L++N +   I   L HL +L +LYLG+NK++      L  L
Sbjct: 99  IKDLSS--LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD--ITVLSRL 152

Query: 518 TSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNA 577
           T L  LSL  N ++ I    L  L  +    LS N +  S L  +  LK +  ++L    
Sbjct: 153 TKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQE 208

Query: 578 LSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEAL 637
                      L     +      L  P   S       +  D    N+   +P+    +
Sbjct: 209 CLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS-------DDGDYEKPNVKWHLPEFTNEV 261

Query: 638 SYLKHLNLSFNQLEG 652
           S++ +  ++  + + 
Sbjct: 262 SFIFYQPVTIGKAKA 276

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 98.3 bits (244), Expect = 3e-21
 Identities = 57/323 (17%), Positives = 109/323 (33%), Gaps = 33/323 (10%)

Query: 250 RNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLG 309
                 +   I +I              ++  ++   +  +   ++++ ++   ++D+  
Sbjct: 2   GETITVSTP-IKQIFP-DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDI-- 55

Query: 310 SLPSSID--LGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNL 367
               S+     LPN+ +LFL  N  +      LTN+  L  L    N    L      +L
Sbjct: 56  ---KSVQGIQYLPNVTKLFLNGNKLTDI--KPLTNLKNLGWLFLDENKIKDLSS--LKDL 108

Query: 368 RSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSL 427
           + LK LSL  N ++        ++ L     LE +YL  N I  I  + +   +  + +L
Sbjct: 109 KKLKSLSLEHNGISD-------INGLVHLPQLESLYLGNNKITDI--TVLSRLT-KLDTL 158

Query: 428 SMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIP 487
           S+E   IS  I   L  +  L  + L  N ++      L  L+ L  L L + +      
Sbjct: 159 SLEDNQISD-IV-PLAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPI 214

Query: 488 EDLCHLYRLANLYLGDNKLSGRL----PACLGNLTSLRDLSLGSNALTSIIPSTLWNLKD 543
               +L     +   D  L                    L   +N ++ I    +   K 
Sbjct: 215 NHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKA 274

Query: 544 ILRFNLSSNSLNGSLLPDIGNLK 566
             RF+         +     ++ 
Sbjct: 275 KARFHGRVTQPLKEVYTVSYDVD 297

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 97.5 bits (242), Expect = 5e-21
 Identities = 44/216 (20%), Positives = 87/216 (40%), Gaps = 16/216 (7%)

Query: 442 LGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYL 501
                      L    +T  +      L  +  +   N+ ++ S+ + + +L  +  L+L
Sbjct: 17  DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 72

Query: 502 GDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPD 561
             NKL+   P  L NL +L  L L  N +  +  S+L +LK +   +L  N +  S +  
Sbjct: 73  NGNKLTDIKP--LTNLKNLGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGI--SDING 126

Query: 562 IGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDM 621
           + +L  +  + L  N ++ +    +  L  L  LSL  N++         GL  L  + +
Sbjct: 127 LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYL 182

Query: 622 SNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTR 657
           S N++  +  +++  L  L  L L   +   +    
Sbjct: 183 SKNHI--SDLRALAGLKNLDVLELFSQECLNKPINH 216

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 88.6 bits (219), Expect = 4e-18
 Identities = 59/381 (15%), Positives = 118/381 (30%), Gaps = 58/381 (15%)

Query: 115 EELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQEL 174
                       + +  +  +        L  +  ++  ++  +  + + I YL  + +L
Sbjct: 15  FPDDAFAETIKDNLKKKS--VTDAVTQNELNSIDQIIANNSD-IKSV-QGIQYLPNVTKL 70

Query: 175 DLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNK 234
            L+ N+L     + I  ++   NL  L  LF+  N++     ++L   ++L  +SL  N 
Sbjct: 71  FLNGNKL-----TDIKPLT---NLKNLGWLFLDENKIK--DLSSLKDLKKLKSLSLEHNG 120

Query: 235 FQGGIPRDI---GNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASI 291
                  DI    +L  + +L+LGNN  I +I   +  L  L+ L +   N         
Sbjct: 121 I-----SDINGLVHLPQLESLYLGNNK-ITDITV-LSRLTKLDTLSL-EDN--------- 163

Query: 292 FNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDF 351
             IS +  LA                GL  L+ L+L +N+   +   +L  +  L VL+ 
Sbjct: 164 -QISDIVPLA----------------GLTKLQNLYLSKNHI--SDLRALAGLKNLDVLEL 204

Query: 352 GFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTP--DLSFLSSLTSCRNLEIIYLSEN-- 407
                         NL     +      L +P    D           +L       +  
Sbjct: 205 FSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFI 264

Query: 408 -PINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTL 466
                 +  +   F   +     E   +S  +   +         R+   +         
Sbjct: 265 FYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGTRITAPKPPTKQGYVF 324

Query: 467 GRLQKLQGLYLQNNKLEGSIP 487
                 +    + N     + 
Sbjct: 325 KGWYTEKNGGHEWNFNTDYMS 345

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 44.3 bits (104), Expect = 2e-04
 Identities = 28/138 (20%), Positives = 49/138 (35%), Gaps = 12/138 (8%)

Query: 76  TALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHI 135
            +L++ + G++  I   L +L  L  L + NN    +    LS L  L       N   I
Sbjct: 112 KSLSLEHNGIS-DING-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQ--I 165

Query: 136 EIPSWFVSLPRLQHLLLKHNSFVGKIP--ETIGYLSLLQELDLSDNQLSGTIPSSIFNIS 193
                   L +LQ+L L  N     I     +  L  L  L+L   +      +   N+ 
Sbjct: 166 SDIVPLAGLTKLQNLYLSKN----HISDLRALAGLKNLDVLELFSQECLNKPINHQSNLV 221

Query: 194 SCQNLPVLEGLFISYNQL 211
               +   +G  ++   +
Sbjct: 222 VPNTVKNTDGSLVTPEII 239

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 98.4 bits (246), Expect = 1e-22
 Identities = 53/229 (23%), Positives = 92/229 (40%), Gaps = 32/229 (13%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRHRNLVKI 822
           + LG G FG+VY      +   +A KV     +E +G       E ++   +RH N++++
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79

Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
            +   +     L+LE+   G L K L     F +       M ++A AL Y H      +
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-TFMEELADALHYCH---ERKV 135

Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRK 942
           +H DIKP N+L+       ++DFG +         R+T   GT+ Y+ PE         K
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRT-MCGTLDYLPPEMIEGKTHDEK 192

Query: 943 CDVYSYGIML---------------METFTKKKPTDEIFAGEMSLKRWV 976
            D++  G++                 ET  +      I   ++    ++
Sbjct: 193 VDLWCAGVLCYEFLVGMPPFDSPSHTETHRR------IVNVDLKFPPFL 235

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 98.8 bits (247), Expect = 1e-22
 Identities = 59/228 (25%), Positives = 94/228 (41%), Gaps = 38/228 (16%)

Query: 743 YPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEI-AAKVF---HMEFD 798
            P    R+   +D       F   K+LG GSF +V            A K+    H+  +
Sbjct: 19  QPPPQPRKKRPED-------FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE 71

Query: 799 GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDIL 858
             +     E  VM  + H   VK+  +  +++     L Y  NG L          L  +
Sbjct: 72  NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL----------LKYI 121

Query: 859 QRL-KIMIDVA--------SALEYLHFGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGI 907
           +++                SALEYLH      I+H D+KP N+LLNE    H  ++DFG 
Sbjct: 122 RKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNED--MHIQITDFGT 176

Query: 908 AKILGKEESMRQTKTL-GTIGYMAPEYGREGKVSRKCDVYSYGIMLME 954
           AK+L  E    +  +  GT  Y++PE   E    +  D+++ G ++ +
Sbjct: 177 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 224

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  100 bits (249), Expect = 2e-22
 Identities = 28/233 (12%), Positives = 67/233 (28%), Gaps = 55/233 (23%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLES---------------------- 803
            +LG     +  +      G      V +        +                      
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 804 ------FHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM-SNGSLEKCL------YS 850
                 F     ++   + + ++++     +    +    Y     +L+          S
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 851 DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI 910
            +  L    RL++ + V   L  LH      +VH  ++P +++L++     L+ F     
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255

Query: 911 LGKEESMRQTKTLGTIGYMAPEY-----------GREGKVSRKCDVYSYGIML 952
            G            + G+  PE             R   ++   D ++ G+++
Sbjct: 256 DGARVVSS-----VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 98.5 bits (246), Expect = 2e-22
 Identities = 58/227 (25%), Positives = 93/227 (40%), Gaps = 45/227 (19%)

Query: 759 ATDGFSEN---------KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAEC 808
           +TD FS            +LG G+   V   + L    E A K+   +          E 
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61

Query: 809 KVMGSIR-HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL------ 861
           +++   + HRN++++I      D   LV E M  GS+            I +R       
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI---------LSHIHKRRHFNELE 112

Query: 862 --KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKIL--GKE 914
              ++ DVASAL++LH   +  I H D+KP N+L    N+     + DF +   +    +
Sbjct: 113 ASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169

Query: 915 ESMRQTKTL----GTIGYMAPE-----YGREGKVSRKCDVYSYGIML 952
            S   T  L    G+  YMAPE             ++CD++S G++L
Sbjct: 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 98.4 bits (245), Expect = 2e-22
 Identities = 40/183 (21%), Positives = 74/183 (40%), Gaps = 16/183 (8%)

Query: 795 MEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNY- 853
           +     +++   + + M     +N V  +   S   +  + ++     +L+  +      
Sbjct: 99  LSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158

Query: 854 -FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG 912
              +    L I I +A A+E+LH   S  ++H D+KPSN+      V  + DFG+   + 
Sbjct: 159 EDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 215

Query: 913 KEESMRQTKTL-----------GTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP 961
           ++E  +   T            GT  YM+PE       S K D++S G++L E       
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275

Query: 962 TDE 964
             E
Sbjct: 276 QME 278

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 43.3 bits (102), Expect = 3e-04
 Identities = 16/96 (16%), Positives = 32/96 (33%), Gaps = 2/96 (2%)

Query: 758 RATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAK-VFHMEFDGSLESFHAECKVMGSIR 815
           R    F   + +G G FG V++     D    A K +     + + E    E K +  + 
Sbjct: 3   RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62

Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSD 851
           H  +V+  ++      +    E       ++     
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWP 98

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 99.8 bits (249), Expect = 2e-22
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 35/207 (16%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEI-AAKV---FHMEFDGSLESFHAECKVMGSIRHRNLVKI 822
           K++G G+FG V         ++ A K+   F M        F  E  +M       +V++
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134

Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVA--------SALEYL 874
             +  ++ +  +V+EYM  G L          ++++    +    A         AL+ +
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKWARFYTAEVVLALDAI 184

Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTL-GTIGYMAP 931
           H   S   +H D+KP N+LL++S  GH  L+DFG    + KE  +R   T  GT  Y++P
Sbjct: 185 H---SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVR-CDTAVGTPDYISP 238

Query: 932 E----YGREGKVSRKCDVYSYGIMLME 954
           E     G +G   R+CD +S G+ L E
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYE 265

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 96.9 bits (241), Expect = 5e-22
 Identities = 57/324 (17%), Positives = 97/324 (29%), Gaps = 37/324 (11%)

Query: 292 FNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIP-SSLTNISELSVLD 350
            N S  K    +  + LG+    +  G  +LE L    +  +     + +     L  L 
Sbjct: 15  CNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLT 74

Query: 351 FGFNSFSGLIPTT---FGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSEN 407
                    I         +  L+ L+L    +T   P     ++      L +  +S  
Sbjct: 75  VRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWA 134

Query: 408 PINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVT-- 465
             +  L          +K LS+   +      +++     L+ + L +N   G   +   
Sbjct: 135 TRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194

Query: 466 --LGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDL 523
               +   LQ L L+N  +                        SG   A       L+ L
Sbjct: 195 LCPLKFPTLQVLALRNAGM---------------------ETPSGVCSALAAARVQLQGL 233

Query: 524 SLGSNALTSIIPSTLWNLKDILRF-NLSSNSLNGSLLPDIG-NLKVVIEMDLSLNALSGV 581
            L  N+L     +   +    L   NLS   L   +   +   L V+   DLS N L   
Sbjct: 234 DLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLSVL---DLSYNRLDRN 289

Query: 582 IPVTIGGLQGLQLLSLRYNRLQGP 605
                  L  +  LSL+ N     
Sbjct: 290 PS--PDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 96.1 bits (239), Expect = 1e-21
 Identities = 61/336 (18%), Positives = 103/336 (30%), Gaps = 55/336 (16%)

Query: 331 NFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFL 390
           NFS   P   +  + L   D             +G  RSL+ L    +           +
Sbjct: 16  NFSDPKPDWSSAFNCLGAADVEL----------YGGGRSLEYLLKRVDTEADLGQFTDII 65

Query: 391 SSLTSCRNLEIIYLSENPINGILPSSIGNF--SISMKSLSMESCNISGGIPKELGNI--N 446
            SL+    L+ + +    I   +            ++ L++E+  ++G  P  L      
Sbjct: 66  KSLS----LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGP 121

Query: 447 NLTVIRLGNNELTGTIPVTLGRLQ-----KLQGLYLQNNKLEGSIPEDLCHLYRLANLYL 501
           +L ++ L N          L  LQ      L+ L +          E +     L+ L L
Sbjct: 122 DLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDL 180

Query: 502 GDNKLSGRLP----ACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGS 557
            DN   G        C     +L+ L+L +  +                      + +G 
Sbjct: 181 SDNPELGERGLISALCPLKFPTLQVLALRNAGM---------------------ETPSGV 219

Query: 558 LLPDIGNLKVVIEMDLSLNALSGVIPVTI-GGLQGLQLLSLRYNRLQGPIPESFGGLKSL 616
                     +  +DLS N+L              L  L+L +  L+         L  L
Sbjct: 220 CSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVL 279

Query: 617 NFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEG 652
              D+S N L    P   E L  + +L+L  N    
Sbjct: 280 ---DLSYNRLD-RNPSPDE-LPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 84.2 bits (208), Expect = 1e-17
 Identities = 51/304 (16%), Positives = 89/304 (29%), Gaps = 43/304 (14%)

Query: 92  QLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSW---FVSLPRLQ 148
             G  S   +L   +         ++     LK    R       I       + +  LQ
Sbjct: 39  YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98

Query: 149 HLLLKHNSFVGKIPETIGYLSL--LQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFI 206
            L L++    G  P  +   +   L  L+L +   +    + +  +      P L+ L I
Sbjct: 99  ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQW-LKPGLKVLSI 156

Query: 207 SYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEI--- 263
           +                                        ++  L L +N  +GE    
Sbjct: 157 AQAHSLN-FSCEQV-----------------------RVFPALSTLDLSDNPELGERGLI 192

Query: 264 ----PNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGL 319
               P +   L+ L +        +G+  A       L+ L ++ N L  +  +      
Sbjct: 193 SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP 252

Query: 320 PNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNV 379
             L  L L        +P  L   ++LSVLD  +N        +   L  +  LSL GN 
Sbjct: 253 SQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNP 307

Query: 380 LTSP 383
               
Sbjct: 308 FLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 79.2 bits (195), Expect = 5e-16
 Identities = 50/293 (17%), Positives = 85/293 (29%), Gaps = 36/293 (12%)

Query: 49  LLANNWSTTSSVCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNS 108
            L     T + +  +  +   +  +R+T               ++  +S L  L + N  
Sbjct: 47  YLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLE 106

Query: 109 FFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVS------LPRLQHLLLKHNSFVGKIP 162
             G+ P  L    G         N        +++       P L+ L +     +    
Sbjct: 107 VTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSC 166

Query: 163 ETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKC 222
           E +     L  LDLSDN   G     + +       P L+ L +    +           
Sbjct: 167 EQVRVFPALSTLDLSDNPELGERG--LISALCPLKFPTLQVLALRNAGM----------- 213

Query: 223 RELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEI-GNLRNLEVLGVQSS 281
                         G           ++ L L +NSL              L  L +  +
Sbjct: 214 ----------ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFT 263

Query: 282 NLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSG 334
            L  + P  +   + L  L ++ N  L   PS     LP +  L L  N F  
Sbjct: 264 GLKQV-PKGLP--AKLSVLDLSYNR-LDRNPSP--DELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 70.7 bits (173), Expect = 3e-13
 Identities = 30/175 (17%), Positives = 51/175 (29%), Gaps = 23/175 (13%)

Query: 62  SWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSL-------P 114
           +W+          +  L+I+          Q+     L+ L + +N   G         P
Sbjct: 138 AWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP 197

Query: 115 EELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETI-GYLSLLQE 173
            +   L+ L   +           +   +  +LQ L L HNS           + S L  
Sbjct: 198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNS 257

Query: 174 LDLSDNQLSGTIPSSIF--------------NISSCQNLPVLEGLFISYNQLTGP 214
           L+LS   L   +P  +                  S   LP +  L +  N     
Sbjct: 258 LNLSFTGLK-QVPKGLPAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPFLDS 311

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 97.5 bits (243), Expect = 2e-21
 Identities = 49/210 (23%), Positives = 94/210 (44%), Gaps = 38/210 (18%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEI-AAKV---FHMEFDGSLESFHAECKVMGSIRHRNLVKI 822
           K++G G+FG V    L +  ++ A K+   + M        F  E  V+ +   + +  +
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139

Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMID----------VASALE 872
             +  +++   LV++Y   G L          L  L + +  +           +  A++
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDL--------LTL--LSKFEDRLPEEMARFYLAEMVIAID 189

Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTL-GTIGYM 929
            +H       VH DIKP N+L++ +  GH  L+DFG    L ++ +++ +    GT  Y+
Sbjct: 190 SVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQ-SSVAVGTPDYI 243

Query: 930 APE-----YGREGKVSRKCDVYSYGIMLME 954
           +PE      G +G+   +CD +S G+ + E
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYE 273

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 96.3 bits (240), Expect = 4e-21
 Identities = 57/248 (22%), Positives = 99/248 (39%), Gaps = 47/248 (18%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEI-AAKV---FHMEFDGSLESFHAECKVMGSIRHRNLVKI 822
           K++G G+F  V    +    ++ A K+   + M   G +  F  E  V+ +   R + ++
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126

Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMID----------VASALE 872
             +  + ++  LV+EY   G L          L  L +    I           +  A++
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDL--------LTL--LSKFGERIPAEMARFYLAEIVMAID 176

Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMA 930
            +H       VH DIKP N+LL+    GH  L+DFG    L  + ++R    +GT  Y++
Sbjct: 177 SVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLS 231

Query: 931 PE-------YGREGKVSRKCDVYSYGIMLMETFTKKKP-----TDEIFA----GEMSLKR 974
           PE           G    +CD ++ G+   E F  + P     T E +      +  L  
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL 291

Query: 975 WVGDSLLS 982
            + D  + 
Sbjct: 292 PLVDEGVP 299

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 95.6 bits (238), Expect = 6e-21
 Identities = 49/205 (23%), Positives = 84/205 (40%), Gaps = 38/205 (18%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLVKII- 823
           ++LG+G  G V +        + A K+              E ++     +  ++V+I+ 
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVD 122

Query: 824 ---SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL----------KIMIDVASA 870
              +  +      +V+E +  G L         F  I  R           +IM  +  A
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGEL---------FSRIQDRGDQAFTEREASEIMKSIGEA 173

Query: 871 LEYLHFGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKILGKEESMRQTKTLGTIG 927
           ++YLH   S  I H D+KP N+L      + +  L+DFG AK      S+  T    T  
Sbjct: 174 IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTPCYTPY 228

Query: 928 YMAPEYGREGKVSRKCDVYSYGIML 952
           Y+APE     K  + CD++S G+++
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIM 253

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 94.3 bits (235), Expect = 6e-21
 Identities = 51/205 (24%), Positives = 86/205 (41%), Gaps = 37/205 (18%)

Query: 766 NKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIIS 824
            ++LG+G  G V +      G + A K+ +       E      +  G     ++V I+ 
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE-VDHHWQASG---GPHIVCILD 89

Query: 825 SCSNNDFKA----LVLEYMSNGSLEKCLYSDNYFLDILQRL----------KIMIDVASA 870
              N         +++E M  G L         F  I +R           +IM D+ +A
Sbjct: 90  VYENMHHGKRCLLIIMECMEGGEL---------FSRIQERGDQAFTEREAAEIMRDIGTA 140

Query: 871 LEYLHFGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKILGKEESMRQTKTLGTIG 927
           +++LH   S  I H D+KP N+L     +  V  L+DFG AK    + ++       T  
Sbjct: 141 IQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET-TQNAL--QTPCYTPY 194

Query: 928 YMAPEYGREGKVSRKCDVYSYGIML 952
           Y+APE     K  + CD++S G+++
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGVIM 219

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 89.6 bits (223), Expect = 2e-20
 Identities = 28/193 (14%), Positives = 71/193 (36%), Gaps = 16/193 (8%)

Query: 316 DLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSL 375
           D          LG+++ +    + + +++ +++ +      +G+         ++K L++
Sbjct: 19  DSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTGI-----EYAHNIKDLTI 73

Query: 376 AGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNIS 435
                T    + + +S L+   NLE + +    +      ++   + S+  L +      
Sbjct: 74  NNIHAT----NYNPISGLS---NLERLRIMGKDVTSDKIPNLSGLT-SLTLLDISHSAHD 125

Query: 436 GGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYR 495
             I  ++  +  +  I L  N     I   L  L +L+ L +Q + +       +    +
Sbjct: 126 DSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPK 182

Query: 496 LANLYLGDNKLSG 508
           L  LY     + G
Sbjct: 183 LNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 81.2 bits (201), Expect = 1e-17
 Identities = 29/170 (17%), Positives = 65/170 (38%), Gaps = 13/170 (7%)

Query: 243 IGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAV 302
              + S+  + L N + + ++   I    N++ L + + +     P  I  +S L+ L +
Sbjct: 40  EAQMNSLTYITLANIN-VTDLTG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRI 95

Query: 303 TDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPT 362
              D+      ++  GL +L  L +  +    +I + +  + +++ +D  +N     I  
Sbjct: 96  MGKDVTSDKIPNLS-GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-M 153

Query: 363 TFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGI 412
               L  LK L++  + +     D   +        L  +Y     I G 
Sbjct: 154 PLKTLPELKSLNIQFDGVH----DYRGIEDFP---KLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 80.8 bits (200), Expect = 2e-17
 Identities = 23/185 (12%), Positives = 64/185 (34%), Gaps = 11/185 (5%)

Query: 397 RNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNN 456
           +      L ++    I  + + +    +  +++ + N++      +   +N+  + + N 
Sbjct: 23  KAYLNGLLGQSSTANITEAQMNS----LTYITLANINVTD--LTGIEYAHNIKDLTINNI 76

Query: 457 ELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGN 516
             T   P  +  L  L+ L +    +      +L  L  L  L +  +     +   +  
Sbjct: 77  HATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134

Query: 517 LTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLN 576
           L  +  + L  N   + I   L  L ++   N+  + ++      I +   + ++     
Sbjct: 135 LPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQ 191

Query: 577 ALSGV 581
            + G 
Sbjct: 192 TIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 39/192 (20%), Positives = 76/192 (39%), Gaps = 17/192 (8%)

Query: 245 NLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTD 304
              +  N  LG +S    I      + +L  + + + N+  L    I     +K+L + +
Sbjct: 21  TFKAYLNGLLGQSS-TANI--TEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75

Query: 305 NDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTF 364
                  P S   GL NLERL +   + +     +L+ ++ L++LD   ++    I T  
Sbjct: 76  IHATNYNPIS---GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132

Query: 365 GNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISM 424
             L  +  + L+ N   +   D+  L +L     L+ + +  + ++      I +F   +
Sbjct: 133 NTLPKVNSIDLSYNGAIT---DIMPLKTLP---ELKSLNIQFDGVHDY--RGIEDFP-KL 183

Query: 425 KSLSMESCNISG 436
             L   S  I G
Sbjct: 184 NQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 77.7 bits (192), Expect = 3e-16
 Identities = 28/188 (14%), Positives = 65/188 (34%), Gaps = 16/188 (8%)

Query: 469 LQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNK---LSGRLPACLGNLTSLRDLSL 525
            +      L  +         +  L     + L +     L+G     +    +++DL++
Sbjct: 22  FKAYLNGLLGQSSTANITEAQMNSLT---YITLANINVTDLTG-----IEYAHNIKDLTI 73

Query: 526 GSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVT 585
            +   T+   + +  L ++ R  +    +    +P++  L  +  +D+S +A    I   
Sbjct: 74  NNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131

Query: 586 IGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNL 645
           I  L  +  + L YN     I      L  L  +++  + +       +E    L  L  
Sbjct: 132 INTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYA 188

Query: 646 SFNQLEGE 653
               + G+
Sbjct: 189 FSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 75.4 bits (186), Expect = 1e-15
 Identities = 31/162 (19%), Positives = 60/162 (37%), Gaps = 13/162 (8%)

Query: 144 LPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEG 203
           +  L ++ L + + V  +   I Y   +++L +++   +        N +    L  LE 
Sbjct: 43  MNSLTYITLANIN-VTDL-TGIEYAHNIKDLTINNIHAT--------NYNPISGLSNLER 92

Query: 204 LFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEI 263
           L I    +T     NL     L ++ ++ +     I   I  L  V ++ L  N  I +I
Sbjct: 93  LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI 152

Query: 264 PNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDN 305
              +  L  L+ L +Q   +       I +   L +L     
Sbjct: 153 MP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 68.4 bits (168), Expect = 4e-13
 Identities = 25/135 (18%), Positives = 57/135 (42%), Gaps = 7/135 (5%)

Query: 516 NLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSL 575
              +  +  LG ++  +I  + + +L  I    L++ ++    L  I     + ++ ++ 
Sbjct: 21  TFKAYLNGLLGQSSTANITEAQMNSLTYI---TLANINVTD--LTGIEYAHNIKDLTINN 75

Query: 576 NALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSME 635
              +   P  I GL  L+ L +    +      +  GL SL  +D+S++    +I   + 
Sbjct: 76  IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

Query: 636 ALSYLKHLNLSFNQL 650
            L  +  ++LS+N  
Sbjct: 134 TLPKVNSIDLSYNGA 148

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 61.5 bits (150), Expect = 8e-11
 Identities = 27/160 (16%), Positives = 55/160 (34%), Gaps = 13/160 (8%)

Query: 75  VTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFH 134
           +T + ++ + +T      +     +  L I N     +    +S L  L+       +  
Sbjct: 46  LTYITLANINVTDLTG--IEYAHNIKDLTINNIHA--TNYNPISGLSNLERLRIMGKDVT 101

Query: 135 IEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISS 194
            +       L  L  L + H++    I   I  L  +  +DLS N         I +I  
Sbjct: 102 SDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA-------ITDIMP 154

Query: 195 CQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNK 234
            + LP L+ L I ++ +       +    +L+ +      
Sbjct: 155 LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQT 192

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 46/221 (20%), Positives = 84/221 (38%), Gaps = 20/221 (9%)

Query: 437 GIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLC-HLYR 495
            +P       +   + L  N L      +     +LQ L L   +++ +I +     L  
Sbjct: 25  NLP------FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77

Query: 496 LANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLN 555
           L+ L L  N +          L+SL+ L      L S+    + +LK +   N++ N + 
Sbjct: 78  LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137

Query: 556 GSLLPDI----GNLKVVIEMDLSLNALSGVIPVTIGGLQGLQL----LSLRYNRLQGPIP 607
              LP+      NL+    +DLS N +  +    +  L  + L    L L  N +    P
Sbjct: 138 SFKLPEYFSNLTNLE---HLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP 194

Query: 608 ESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFN 648
            +F  ++ L  + +  N L        + L+ L+ + L  N
Sbjct: 195 GAFKEIR-LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 82.3 bits (204), Expect = 3e-17
 Identities = 64/246 (26%), Positives = 92/246 (37%), Gaps = 48/246 (19%)

Query: 171 LQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSL 230
            + LDLS N L   + S  F      + P L+ L +S  ++   I               
Sbjct: 30  TKNLDLSFNPLR-HLGSYSF-----FSFPELQVLDLSRCEIQT-IEDG------------ 70

Query: 231 AFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEI-GNLRNLEVLGVQSSNLAGLIPA 289
           A+            +L+ +  L L  N +   +       L +L+ L    +NLA L   
Sbjct: 71  AYQ-----------SLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASL-EN 117

Query: 290 SIFNI-STLKELAVTDNDLLGSLPSSIDL-GLPNLERLFLGENNFSGTIP----SSLTNI 343
                  TLKEL V  N +  S         L NLE L L  N    +I       L  +
Sbjct: 118 FPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQM 175

Query: 344 SELSV-LDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEII 402
             L++ LD   N  + + P  F  +R LK L+L  N L S    +     LTS   L+ I
Sbjct: 176 PLLNLSLDLSLNPMNFIQPGAFKEIR-LKELALDTNQLKSVPDGI--FDRLTS---LQKI 229

Query: 403 YLSENP 408
           +L  NP
Sbjct: 230 WLHTNP 235

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 53/239 (22%), Positives = 97/239 (40%), Gaps = 39/239 (16%)

Query: 272 NLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGEN- 330
           + + L +  + L  L   S F+   L+ L ++  ++  ++       L +L  L L  N 
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNP 87

Query: 331 --NFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTS-PTPDL 387
             + +    S L++   L  L     + + L     G+L++LK L++A N++ S   P+ 
Sbjct: 88  IQSLALGAFSGLSS---LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

Query: 388 SFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINN 447
              S+LT   NLE + LS N I                       +I     + L  +  
Sbjct: 145 --FSNLT---NLEHLDLSSNKIQ----------------------SIYCTDLRVLHQMPL 177

Query: 448 LTV-IRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPED-LCHLYRLANLYLGDN 504
           L + + L  N +   I     +  +L+ L L  N+L+ S+P+     L  L  ++L  N
Sbjct: 178 LNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 33/154 (21%), Positives = 57/154 (37%), Gaps = 25/154 (16%)

Query: 498 NLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGS 557
           NL L  N L         +   L+ L L    + +I      +L                
Sbjct: 32  NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLS--------------- 76

Query: 558 LLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLN 617
                 +L     + L+ N +  +      GL  LQ L      L        G LK+L 
Sbjct: 77  ------HLS---TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK 127

Query: 618 FVDMSNNNL-SGTIPKSMEALSYLKHLNLSFNQL 650
            +++++N + S  +P+    L+ L+HL+LS N++
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 44/188 (23%), Positives = 74/188 (39%), Gaps = 39/188 (20%)

Query: 79  NISYLGLTG----TIPPQL-GNLSFLAVLAIRNNSFFGSLPEEL-SHLRGLKYFDFRFNN 132
           ++S L LTG    ++       LS L  L     +   SL      HL+ LK  +   N 
Sbjct: 77  HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNL 135

Query: 133 FH-IEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFN 191
               ++P +F +L  L+H                        LDLS N++  +I  +   
Sbjct: 136 IQSFKLPEYFSNLTNLEH------------------------LDLSSNKIQ-SIYCTDL- 169

Query: 192 ISSCQNLPVLEG-LFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDI-GNLTSV 249
                 +P+L   L +S N +   I    +K   L  ++L  N+ +  +P  I   LTS+
Sbjct: 170 -RVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSL 226

Query: 250 RNLFLGNN 257
           + ++L  N
Sbjct: 227 QKIWLHTN 234

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 92.3 bits (230), Expect = 2e-20
 Identities = 52/226 (23%), Positives = 89/226 (39%), Gaps = 54/226 (23%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVF--------------------------HMEFDG 799
             +G GS+G V       D    A KV                            ++  G
Sbjct: 19  DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78

Query: 800 SLESFHAECKVMGSIRHRNLVKIIS--SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDI 857
            +E  + E  ++  + H N+VK++      N D   +V E ++ G +          +++
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----------MEV 128

Query: 858 LQRLKIMIDVA--------SALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK 909
                +  D A          +EYLH      I+H DIKPSN+L+ E     ++DFG++ 
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185

Query: 910 ILGKEESMRQTKTLGTIGYMAPE--YGREGKVS-RKCDVYSYGIML 952
                +++    T+GT  +MAPE         S +  DV++ G+ L
Sbjct: 186 EFKGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 90.2 bits (224), Expect = 8e-20
 Identities = 54/215 (25%), Positives = 77/215 (35%), Gaps = 34/215 (15%)

Query: 434 ISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHL 493
           +   +PK      + T++ L  N L      TL    +L  L L   +L   +  D   L
Sbjct: 25  LPPDLPK------DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDG-TL 76

Query: 494 YRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNS 553
             L  L L  N+L   LP     L +L  L +  N LTS+    L  L ++    L  N 
Sbjct: 77  PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE 135

Query: 554 LNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGL 613
           L    LP                   G++         L+ LSL  N L         GL
Sbjct: 136 L--KTLPP------------------GLL----TPTPKLEKLSLANNNLTELPAGLLNGL 171

Query: 614 KSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFN 648
           ++L+ + +  N+L  TIPK       L    L  N
Sbjct: 172 ENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 82.1 bits (203), Expect = 5e-17
 Identities = 52/209 (24%), Positives = 71/209 (33%), Gaps = 38/209 (18%)

Query: 447 NLTVIRLGNNELT---GTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGD 503
           +   +      LT     +P           L+L  N L       L    RL  L L  
Sbjct: 11  SHLEVNCDKRNLTALPPDLPKDT------TILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 504 NKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIG 563
            +L+ +L    G L  L  L L  N L S+ P     L  +   ++S N L         
Sbjct: 65  AELT-KLQV-DGTLPVLGTLDLSHNQLQSL-PLLGQTLPALTVLDVSFNRLT-------- 113

Query: 564 NLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSN 623
                    L L AL G        L  LQ L L+ N L+   P        L  + ++N
Sbjct: 114 --------SLPLGALRG--------LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLAN 157

Query: 624 NNLSGTIPKSM-EALSYLKHLNLSFNQLE 651
           NNL+  +P  +   L  L  L L  N L 
Sbjct: 158 NNLT-ELPAGLLNGLENLDTLLLQENSLY 185

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 81.3 bits (201), Expect = 8e-17
 Identities = 52/213 (24%), Positives = 80/213 (37%), Gaps = 33/213 (15%)

Query: 413 LPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKL 472
           LP  +         L +    +       L     LT + L   ELT  + V  G L  L
Sbjct: 25  LPPDL---PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVL 79

Query: 473 QGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTS 532
             L L +N+L+ S+P     L  L  L +  N+L+      L  L  L++L L  N L +
Sbjct: 80  GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138

Query: 533 IIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTI-GGLQG 591
           + P  L     + + +L++N+L                           +P  +  GL+ 
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLT-------------------------ELPAGLLNGLEN 173

Query: 592 LQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNN 624
           L  L L+ N L   IP+ F G   L F  +  N
Sbjct: 174 LDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 51/219 (23%), Positives = 73/219 (33%), Gaps = 21/219 (9%)

Query: 194 SCQNLPVLEGLFISYNQLTG-P--IPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVR 250
               +     +      LT  P  +P +      LH   L+ N         +   T + 
Sbjct: 5   EVSKVASHLEVNCDKRNLTALPPDLPKDT---TILH---LSENLLYTFSLATLMPYTRLT 58

Query: 251 NLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGS 310
            L L    L  ++    G L  L  L +  + L  L P     +  L  L V+ N  L S
Sbjct: 59  QLNLDRAEL-TKLQ-VDGTLPVLGTLDLSHNQLQSL-PLLGQTLPALTVLDVSFN-RLTS 114

Query: 311 LPSSIDLGLPNLERLFLGENNFSGTIPSSL-TNISELSVLDFGFNSFSGLIPTTFGNLRS 369
           LP     GL  L+ L+L  N    T+P  L T   +L  L    N+ + L       L +
Sbjct: 115 LPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLEN 173

Query: 370 LKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENP 408
           L  L L  N L +          L         +L  NP
Sbjct: 174 LDTLLLQENSLYTIPKGFFGSHLLPF------AFLHGNP 206

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 50/231 (21%), Positives = 78/231 (33%), Gaps = 39/231 (16%)

Query: 76  TALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHI 135
             +N     LT  +PP L       +L +  N  +      L     L   +       +
Sbjct: 13  LEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA--EL 67

Query: 136 EIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSC 195
                  +LP L  L L HN     +P     L  L  LD+S N+L+ ++P         
Sbjct: 68  TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALR---- 121

Query: 196 QNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLG 255
             L  L+ L++  N+L   +P                                +  L L 
Sbjct: 122 -GLGELQELYLKGNELKT-LPPG------------LLTP-----------TPKLEKLSLA 156

Query: 256 NNSLIGEIPNEI-GNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDN 305
           NN+L  E+P  +   L NL+ L +Q ++L   IP   F    L    +  N
Sbjct: 157 NNNL-TELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 93.4 bits (232), Expect = 1e-19
 Identities = 58/242 (23%), Positives = 100/242 (41%), Gaps = 32/242 (13%)

Query: 745 QATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEI-AAKVF---HMEFDGS 800
              W+ +     L   D FS ++++G G FG VY     D  ++ A K      ++    
Sbjct: 174 FCQWKNVELNIHLTMND-FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG 232

Query: 801 LESFHAECKV---MGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDI 857
                 E  +   + +     +V +  +    D  + +L+ M+ G L   L     F + 
Sbjct: 233 ETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE- 291

Query: 858 LQRLKIMI-DVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKE 914
              ++    ++   LE++H   +  +V+ D+KP+N+LL+E   GH  +SD G+A     +
Sbjct: 292 -ADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEH--GHVRISDLGLAC----D 341

Query: 915 ESMRQTKTL-GTIGYMAPE-YGREGKVSRKCDVYSYGIMLMETFT--------KKKPTDE 964
            S ++     GT GYMAPE   +        D +S G ML +           K K   E
Sbjct: 342 FSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 401

Query: 965 IF 966
           I 
Sbjct: 402 ID 403

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 92.5 bits (230), Expect = 2e-19
 Identities = 55/221 (24%), Positives = 95/221 (42%), Gaps = 25/221 (11%)

Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEI-AAKVF---HMEFDGSLESFHAECKVMGSIRHRN 818
           F + ++LG G FG V    +    ++ A K      ++          E +++  +  R 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245

Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMI-DVASALEYLHFG 877
           +V +  +    D   LVL  M+ G L+  +Y          R      ++   LE LH  
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH-- 303

Query: 878 YSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTL-GTIGYMAPEYG 934
               IV+ D+KP N+LL++   GH  +SD G+A  + + ++    K   GT+GYMAPE  
Sbjct: 304 -RERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVV 357

Query: 935 REGKVSRKCDVYSYGIMLMETFT---------KKKPTDEIF 966
           +  + +   D ++ G +L E            KK   +E+ 
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 90.3 bits (224), Expect = 2e-19
 Identities = 32/204 (15%), Positives = 69/204 (33%), Gaps = 4/204 (1%)

Query: 447 NLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPED-LCHLYRLANLYL-GDN 504
           N   +R    +L             L+ + +  N +   I  D   +L +L  + +   N
Sbjct: 31  NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90

Query: 505 KLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDI-- 562
            L    P    NL +L+ L + +  +  +      +    +  ++  N    ++  +   
Sbjct: 91  NLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 150

Query: 563 GNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMS 622
           G     + + L+ N +  +      G Q  +L     N L+    + F G      +D+S
Sbjct: 151 GLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDIS 210

Query: 623 NNNLSGTIPKSMEALSYLKHLNLS 646
              +       +E L  L+  +  
Sbjct: 211 RTRIHSLPSYGLENLKKLRARSTY 234

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 88.0 bits (218), Expect = 1e-18
 Identities = 48/272 (17%), Positives = 89/272 (32%), Gaps = 43/272 (15%)

Query: 287 IPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIP----SSLTN 342
           IP+ +       EL       L  +      G  +LE++ + +N+    I     S+L  
Sbjct: 24  IPSDLP--RNAIELRFVLT-KLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80

Query: 343 ISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEII 402
           + E+ +     N+   + P  F NL +L+ L ++   +    PD+  + SL       ++
Sbjct: 81  LHEIRIEKA--NNLLYINPEAFQNLPNLQYLLISNTGIKHL-PDVHKIHSL----QKVLL 133

Query: 403 YLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTI 462
            + +N     +     +F                      G      ++ L  N +    
Sbjct: 134 DIQDNINIHTIER--NSFV---------------------GLSFESVILWLNKNGIQEIH 170

Query: 463 PVTLGRLQKLQGLYLQNNKLEGSIPED-LCHLYRLANLYLGDNKLSGRLPACLGNLTSLR 521
                  Q  +     NN LE  +P D          L +   ++       L NL  LR
Sbjct: 171 NSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLR 229

Query: 522 DLSLGSNALTSIIPSTLWNLKDILRFNLSSNS 553
             S     L  +    L  L  ++  +L+  S
Sbjct: 230 ARST--YNLKKLPT--LEKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 86.0 bits (213), Expect = 5e-18
 Identities = 51/248 (20%), Positives = 83/248 (33%), Gaps = 19/248 (7%)

Query: 136 EIPSWFVSLPR-LQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISS 194
           EIPS    LPR    L                    L+++++S N +   I + +F    
Sbjct: 23  EIPS---DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF---- 75

Query: 195 CQNLPVLEGLFIS-YNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDI-GNLTSVRNL 252
             NLP L  + I   N L    P        L  + ++    +  +P     +      L
Sbjct: 76  -SNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH-LPDVHKIHSLQKVLL 133

Query: 253 FLGNNSLIGEIPNEI--GNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGS 310
            + +N  I  I      G      +L +  + +   I  S FN + L EL ++DN+ L  
Sbjct: 134 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEE 192

Query: 311 LPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSL 370
           LP+ +  G      L +            L N+ +L        +   L       L +L
Sbjct: 193 LPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARS--TYNLKKLPT--LEKLVAL 248

Query: 371 KLLSLAGN 378
              SL   
Sbjct: 249 MEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 81.0 bits (200), Expect = 2e-16
 Identities = 43/212 (20%), Positives = 76/212 (35%), Gaps = 13/212 (6%)

Query: 447 NLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPED-LCHLYRLANLYLGDNK 505
           +  V     +++T  IP  L   +    L     KL   I +        L  + +  N 
Sbjct: 10  SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQND 65

Query: 506 LSGRLPA-CLGNLTSLRDLSL-GSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDI- 562
           +   + A    NL  L ++ +  +N L  I P    NL ++    +S+  +    LPD+ 
Sbjct: 66  VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI--KHLPDVH 123

Query: 563 -GNLKVVIEMDLSLNALSGVIPV-TIGGLQG-LQLLSLRYNRLQGPIPESFGGLKSLNFV 619
             +    + +D+  N     I   +  GL     +L L  N +Q     +F G +     
Sbjct: 124 KIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELN 183

Query: 620 DMSNNNLSGTIPKSMEALSYLKHLNLSFNQLE 651
              NNNL           S    L++S  ++ 
Sbjct: 184 LSDNNNLEELPNDVFHGASGPVILDISRTRIH 215

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 81.0 bits (200), Expect = 2e-16
 Identities = 44/257 (17%), Positives = 79/257 (30%), Gaps = 35/257 (13%)

Query: 161 IPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLW 220
           IP  +       EL     +L   I    F          LE + IS N +   I  +  
Sbjct: 24  IPSDL--PRNAIELRFVLTKLR-VIQKGAF-----SGFGDLEKIEISQNDVLEVIEAD-- 73

Query: 221 KCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEI-GNLRNLEVLGVQ 279
                      F+           NL  +  + +   + +  I  E   NL NL+ L + 
Sbjct: 74  ----------VFS-----------NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLIS 112

Query: 280 SSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLP-NLERLFLGENNFSGTIPS 338
           ++ +  L      +      L + DN  + ++  +  +GL      L+L +N       S
Sbjct: 113 NTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNS 172

Query: 339 SLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRN 398
           +        +     N+   L    F       +L ++   + S       L +L   R 
Sbjct: 173 AFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG--LENLKKLRA 230

Query: 399 LEIIYLSENPINGILPS 415
                L + P    L +
Sbjct: 231 RSTYNLKKLPTLEKLVA 247

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 65.2 bits (159), Expect = 3e-11
 Identities = 35/211 (16%), Positives = 65/211 (30%), Gaps = 20/211 (9%)

Query: 73  RRVTALNISYLGLTGTIPPQ-LGNLSFLAVLAIRNNSFFGSLPEE-LSHLRGLKYFDFRF 130
             +  + IS   +   I      NL  L  + I   +    +  E   +L  L+Y     
Sbjct: 54  GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 113

Query: 131 NNFHIEIPS-WFVSLPRLQHLLLKHNSFVGKIPETI--GYLSLLQELDLSDNQLSGTIPS 187
                 +P    +   +   L ++ N  +  I      G       L L+ N +   I +
Sbjct: 114 TGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHN 171

Query: 188 SIFNISSCQNLPVLEGLFISYNQLTGPIPTN-LWKCRELHVVSLAFNKFQGGIPRDI-GN 245
           S FN        + E      N L   +P +         ++ ++  +    +P     N
Sbjct: 172 SAFN-----GTQLDELNLSDNNNLEE-LPNDVFHGASGPVILDISRTRIH-SLPSYGLEN 224

Query: 246 LTSVRNLFLGNNSLIGEIPNEIGNLRNLEVL 276
           L  +R     N     ++P  +  L  L   
Sbjct: 225 LKKLRARSTYNLK---KLPT-LEKLVALMEA 251

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 61/293 (20%), Positives = 102/293 (34%), Gaps = 46/293 (15%)

Query: 338 SSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCR 397
            S    +E    +    S +  +      L S+  +    + +      +  +  L    
Sbjct: 18  FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK----SVQGIQYLP--- 68

Query: 398 NLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNE 457
           N+  ++L+ N +  I P                           L N+ NL  + L  N+
Sbjct: 69  NVTKLFLNGNKLTDIKP---------------------------LANLKNLGWLFLDENK 101

Query: 458 LTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNL 517
           +       L  L+KL+ L L++N +   I   L HL +L +LYLG+NK++      L  L
Sbjct: 102 VKDLSS--LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDITV--LSRL 155

Query: 518 TSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNA 577
           T L  LSL  N ++ I+P  L  L  +    LS N +  S L  +  LK +  ++L    
Sbjct: 156 TKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQE 211

Query: 578 LSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTI 630
                      L     +      L  P   S  G      V       +  +
Sbjct: 212 CLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 264

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 87.8 bits (218), Expect = 5e-19
 Identities = 45/221 (20%), Positives = 88/221 (39%), Gaps = 16/221 (7%)

Query: 442 LGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYL 501
                      L    +T  +      L  +  +   N+ ++ S+ + + +L  +  L+L
Sbjct: 20  DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 75

Query: 502 GDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPD 561
             NKL+   P  L NL +L  L L  N +  +  S+L +LK +   +L  N +  S +  
Sbjct: 76  NGNKLTDIKP--LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGI--SDING 129

Query: 562 IGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDM 621
           + +L  +  + L  N ++ +    +  L  L  LSL  N++         GL  L  + +
Sbjct: 130 LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYL 185

Query: 622 SNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFIT 662
           S N++S    +++  L  L  L L   +   +       + 
Sbjct: 186 SKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLV 224

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 82.4 bits (204), Expect = 3e-17
 Identities = 51/285 (17%), Positives = 101/285 (35%), Gaps = 31/285 (10%)

Query: 251 NLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGS 310
                    I +I +            ++  ++   +  +   ++++ ++   ++D+   
Sbjct: 6   ETITVPTP-IKQIFS-DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDI--- 58

Query: 311 LPSSID--LGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLR 368
              S+     LPN+ +LFL  N  +      L N+  L  L    N    L      +L+
Sbjct: 59  --KSVQGIQYLPNVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKVKDLSS--LKDLK 112

Query: 369 SLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLS 428
            LK LSL  N ++        ++ L     LE +YL  N I  I  + +   +  + +LS
Sbjct: 113 KLKSLSLEHNGISD-------INGLVHLPQLESLYLGNNKITDI--TVLSRLT-KLDTLS 162

Query: 429 MESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPE 488
           +E   IS  +P  L  +  L  + L  N ++      L  L+ L  L L + +       
Sbjct: 163 LEDNQISDIVP--LAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPIN 218

Query: 489 DLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSI 533
              +L     +   D  L    P  + +       ++  +     
Sbjct: 219 HQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPEFT 261

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 75.1 bits (185), Expect = 8e-15
 Identities = 58/317 (18%), Positives = 109/317 (34%), Gaps = 62/317 (19%)

Query: 115 EELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQEL 174
                       + +  +  +        L  +  ++  ++  +  + + I YL  + +L
Sbjct: 18  FSDDAFAETIKDNLKKKS--VTDAVTQNELNSIDQIIANNSD-IKSV-QGIQYLPNVTKL 73

Query: 175 DLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNK 234
            L+ N+L+        +I    NL  L  LF+  N++     ++L   ++L  +SL  N 
Sbjct: 74  FLNGNKLT--------DIKPLANLKNLGWLFLDENKVK--DLSSLKDLKKLKSLSLEHNG 123

Query: 235 FQGGIPRDI---GNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASI 291
                  DI    +L  + +L+LGNN  I +I   +  L  L+ L +   N         
Sbjct: 124 I-----SDINGLVHLPQLESLYLGNNK-ITDITV-LSRLTKLDTLSL-EDN--------- 166

Query: 292 FNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDF 351
             IS +  LA                GL  L+ L+L +N+ S     +L  +  L VL+ 
Sbjct: 167 -QISDIVPLA----------------GLTKLQNLYLSKNHISDL--RALAGLKNLDVLEL 207

Query: 352 GFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTP--DLSFLSSLTSCRNL-----EIIYL 404
                         NL     +      L +P    D           +L     E+ ++
Sbjct: 208 FSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFI 267

Query: 405 SENPINGILPSSIGNFS 421
              P+   +  +   F 
Sbjct: 268 FYQPVT--IGKAKARFH 282

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 67.0 bits (164), Expect = 4e-12
 Identities = 31/177 (17%), Positives = 65/177 (36%), Gaps = 14/177 (7%)

Query: 475 LYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSII 534
                  ++  I              L    ++         L S+  +   ++ + S+ 
Sbjct: 7   TITVPTPIK-QI-FSDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSV- 61

Query: 535 PSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQL 594
              +  L ++ +  L+ N L  + +  + NLK +  + L  N +  +    +  L+ L+ 
Sbjct: 62  -QGIQYLPNVTKLFLNGNKL--TDIKPLANLKNLGWLFLDENKVKDLSS--LKDLKKLKS 116

Query: 595 LSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLE 651
           LSL +N +          L  L  + + NN +  T    +  L+ L  L+L  NQ+ 
Sbjct: 117 LSLEHNGIS--DINGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS 169

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 90.6 bits (225), Expect = 7e-19
 Identities = 54/225 (24%), Positives = 96/225 (42%), Gaps = 26/225 (11%)

Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGMEI-AAKVF---HMEFDGSLESFHAECKVMGSIRH 816
           D F + ++LG G FG V+   +    ++ A K      ++     +    E K++  +  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDIL--QRLKIMI-DVASALEY 873
           R +V +  +        LV+  M+ G +   +Y+ +         R       + S LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304

Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTL-GTIGYMA 930
           LH      I++ D+KP NVLL++   G+  +SD G+A  L   ++  +TK   GT G+MA
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQT--KTKGYAGTPGFMA 357

Query: 931 PEYGREGKVSRKCDVYSYGIMLMETFT---------KKKPTDEIF 966
           PE     +     D ++ G+ L E            +K    E+ 
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 87.9 bits (218), Expect = 1e-18
 Identities = 59/229 (25%), Positives = 92/229 (40%), Gaps = 30/229 (13%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKV--------FHMEFDGSLESFHAECKVMGSIRHR 817
             LG G+FG V+  V      E+  K              D  L     E  ++  + H 
Sbjct: 30  SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89

Query: 818 NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL------KIMIDVASAL 871
           N++K++    N  F  LV+E   +G L+  L++   F+D   RL       I   + SA+
Sbjct: 90  NIIKVLDIFENQGFFQLVMEKHGSG-LD--LFA---FIDRHPRLDEPLASYIFRQLVSAV 143

Query: 872 EYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAP 931
            YL       I+H DIK  N+++ E     L DFG A  L +   +  T   GTI Y AP
Sbjct: 144 GYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL-ERGKLFYT-FCGTIEYCAP 198

Query: 932 E-YGREGKVSRKCDVYSYGIMLMETFTKKKP---TDEIFAGEMSLKRWV 976
           E          + +++S G+ L     ++ P    +E     +     V
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLV 247

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 86.9 bits (216), Expect = 1e-18
 Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 31/205 (15%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFH----MEFDGSLESFHAECKVMGSIRHRNLVK 821
            LLG GS+G V + +        A K+              +   E +++  +RH+N+++
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 822 ---IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVA--------SA 870
              ++ +        +V+EY   G  E         LD +   +  +  A          
Sbjct: 71  LVDVLYNEEKQKM-YMVMEYCVCGMQE--------MLDSVPEKRFPVCQAHGYFCQLIDG 121

Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGYM 929
           LEYLH   S  IVH DIKP N+LL       +S  G+A+ L    +    +T  G+  + 
Sbjct: 122 LEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178

Query: 930 APE--YGREGKVSRKCDVYSYGIML 952
            PE   G +     K D++S G+ L
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTL 203

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 88.1 bits (219), Expect = 1e-18
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 21/199 (10%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKI 822
           + +G GSFG V      D  ++ A K  + +       + +   E ++M  + H  LV +
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80

Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMI-DVASALEYLHFGYSTP 881
             S  + +   +V++ +  G L   L  + +F +  + +K+ I ++  AL+YL    +  
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKE--ETVKLFICELVMALDYLQ---NQR 135

Query: 882 IVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTL-GTIGYMAPE-YGREG 937
           I+H D+KP N+LL+E   GH  ++DF IA +L +E       T+ GT  YMAPE +    
Sbjct: 136 IIHRDMKPDNILLDEH--GHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRK 190

Query: 938 KV--SRKCDVYSYGIMLME 954
               S   D +S G+   E
Sbjct: 191 GAGYSFAVDWWSLGVTAYE 209

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 85.3 bits (212), Expect = 3e-18
 Identities = 57/198 (28%), Positives = 84/198 (42%), Gaps = 24/198 (12%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHME-FDGSLESFHAECKVMGSIRHRNLVKIIS 824
           + LG G++G V   V       +A K+  M+      E+   E  +   + H N+VK   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVA--------SALEYLHF 876
                + + L LEY S G L         F  I   + +    A        + + YLH 
Sbjct: 73  HRREGNIQYLFLEYCSGGEL---------FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH- 122

Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGYMAPE-YG 934
                I H DIKP N+LL+E     +SDFG+A +       R    + GT+ Y+APE   
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180

Query: 935 REGKVSRKCDVYSYGIML 952
           R    +   DV+S GI+L
Sbjct: 181 RREFHAEPVDVWSCGIVL 198

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 85.8 bits (213), Expect = 6e-18
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 32/208 (15%)

Query: 761 DGFSENKLLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMGSIRH 816
           D F   K LG GSFG V      +     A K+   +       +E    E +++ ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMI-DVASALEYLH 875
             LVK+  S  +N    +V+EY++ G +   L     F +     +     +    EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE--PHARFYAAQIVLTFEYLH 158

Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTL-GTIGYMAPE 932
              S  +++ D+KP N+L+++   G+  ++DFG AK +       +T TL GT   +APE
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQ--GYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPE 208

Query: 933 ------YGREGKVSRKCDVYSYGIMLME 954
                 Y +        D ++ G+++ E
Sbjct: 209 IILSKGYNKA------VDWWALGVLIYE 230

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 84.7 bits (210), Expect = 1e-17
 Identities = 57/198 (28%), Positives = 84/198 (42%), Gaps = 24/198 (12%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHME-FDGSLESFHAECKVMGSIRHRNLVKIIS 824
           + LG G++G V   V       +A K+  M+      E+   E  +   + H N+VK   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVA--------SALEYLHF 876
                + + L LEY S G L         F  I   + +    A        + + YLH 
Sbjct: 73  HRREGNIQYLFLEYCSGGEL---------FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH- 122

Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGYMAPE-YG 934
                I H DIKP N+LL+E     +SDFG+A +       R    + GT+ Y+APE   
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180

Query: 935 REGKVSRKCDVYSYGIML 952
           R    +   DV+S GI+L
Sbjct: 181 RREFHAEPVDVWSCGIVL 198

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 84.1 bits (209), Expect = 1e-17
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 30/218 (13%)

Query: 767 KLLGMGSFGSVY---KGVLPDGMEI-AAKVFHMEFDGSLESFH--AECKVMGSIRHRNLV 820
           K+LG GSFG V+   K    D  ++ A KV         +      E  ++  + H  +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89

Query: 821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMI-DVASALEYLHFGYS 879
           K+  +        L+L+++  G L   L  +  F    + +K  + ++A AL++LH   S
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT--EEDVKFYLAELALALDHLH---S 144

Query: 880 TPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQ---TKTL-GTIGYMAPEY 933
             I++ D+KP N+LL+E   GH  L+DFG++K     ES+       +  GT+ YMAPE 
Sbjct: 145 LGIIYRDLKPENILLDEE--GHIKLTDFGLSK-----ESIDHEKKAYSFCGTVEYMAPEV 197

Query: 934 GREGKVSRKCDVYSYGIMLMETFTKKKP-----TDEIF 966
                 ++  D +S+G+++ E  T   P       E  
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 235

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 52/223 (23%), Positives = 87/223 (39%), Gaps = 37/223 (16%)

Query: 308 LGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNL 367
           L ++PS+I     + ++L L  N  S     +   +++L +L    N    L    F  L
Sbjct: 28  LTAIPSNI---PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKEL 84

Query: 368 RSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSL 427
           ++L+ L +  N L +    +     L    NL  + L  N +                  
Sbjct: 85  KNLETLWVTDNKLQALPIGV--FDQLV---NLAELRLDRNQLK----------------- 122

Query: 428 SMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTL-GRLQKLQGLYLQNNKLEGSI 486
                ++   +   L     LT + LG NEL  ++P  +  +L  L+ L L NN+L+  +
Sbjct: 123 -----SLPPRVFDSLT---KLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RV 172

Query: 487 PEDLCH-LYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSN 528
           PE     L  L  L L +N+L         +L  L+ L L  N
Sbjct: 173 PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 59/214 (27%), Positives = 88/214 (41%), Gaps = 34/214 (15%)

Query: 437 GIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCH-LYR 495
            IP       +   + L +N+L+        RL KL+ LYL +NKL+ ++P  +   L  
Sbjct: 34  NIP------ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86

Query: 496 LANLYLGDNKLSGRLPACL-GNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSL 554
           L  L++ DNKL   LP  +   L +L +L L  N L S+ P    +L  +   +L  N L
Sbjct: 87  LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNEL 145

Query: 555 NGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLK 614
               LP                   GV       L  L+ L L  N+L+     +F  L 
Sbjct: 146 --QSLPK------------------GVF----DKLTSLKELRLYNNQLKRVPEGAFDKLT 181

Query: 615 SLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFN 648
            L  + + NN L      + ++L  LK L L  N
Sbjct: 182 ELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 61/202 (30%), Positives = 84/202 (41%), Gaps = 38/202 (18%)

Query: 462 IPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACL-GNLTSL 520
           IP         + L LQ+NKL     +    L +L  LYL DNKL   LPA +   L +L
Sbjct: 35  IPADT------KKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNL 87

Query: 521 RDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSG 580
             L +  N L ++       L ++    L  N L  SL P + +                
Sbjct: 88  ETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFD---------------- 130

Query: 581 VIPVTIGGLQGLQLLSLRYNRLQGPIPE-SFGGLKSLNFVDMSNNNLSGTIPKSM-EALS 638
                   L  L  LSL YN LQ  +P+  F  L SL  + + NN L   +P+   + L+
Sbjct: 131 -------SLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLT 181

Query: 639 YLKHLNLSFNQLEGEIPTRGPF 660
            LK L L  NQL+  +P  G F
Sbjct: 182 ELKTLKLDNNQLK-RVP-EGAF 201

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 72.7 bits (179), Expect = 4e-14
 Identities = 58/240 (24%), Positives = 91/240 (37%), Gaps = 64/240 (26%)

Query: 171 LQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSL 230
            ++LDL  N+LS ++PS  F       L  L  L+++ N+L   +P              
Sbjct: 39  TKKLDLQSNKLS-SLPSKAF-----HRLTKLRLLYLNDNKLQT-LPAG------------ 79

Query: 231 AFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPAS 290
            F +           L ++  L++ +N L                   Q+      +P  
Sbjct: 80  IFKE-----------LKNLETLWVTDNKL-------------------QA------LPIG 103

Query: 291 IF-NISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSL-TNISELSV 348
           +F  +  L EL +  N  L SLP  +   L  L  L LG N    ++P  +   ++ L  
Sbjct: 104 VFDQLVNLAELRLDRNQ-LKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKE 161

Query: 349 LDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENP 408
           L    N    +    F  L  LK L L  N L    P+ +F  SL     L+++ L ENP
Sbjct: 162 LRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKR-VPEGAF-DSLEK---LKMLQLQENP 216

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 51/188 (27%), Positives = 88/188 (46%), Gaps = 15/188 (7%)

Query: 147 LQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFI 206
            + L L+ N       +    L+ L+ L L+DN+L  T+P+ IF       L  LE L++
Sbjct: 39  TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFK-----ELKNLETLWV 92

Query: 207 SYNQLTGPIPTNL-WKCRELHVVSLAFNKFQGGIPRDI-GNLTSVRNLFLGNNSLIGEIP 264
           + N+L   +P  +  +   L  + L  N+ +  +P  +  +LT +  L LG N L   +P
Sbjct: 93  TDNKLQA-LPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNEL-QSLP 149

Query: 265 NEI-GNLRNLEVLGVQSSNLAGLIPASIF-NISTLKELAVTDNDLLGSLPSSIDLGLPNL 322
             +   L +L+ L + ++ L   +P   F  ++ LK L + +N L   +P      L  L
Sbjct: 150 KGVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKL 207

Query: 323 ERLFLGEN 330
           + L L EN
Sbjct: 208 KMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 48/192 (25%), Positives = 76/192 (39%), Gaps = 38/192 (19%)

Query: 118 SHLRGLKYFDFRFNNFHIEIPSW-FVSLPRLQHLLLKHNSFVGKIPETI-GYLSLLQELD 175
             L  L+      N     +P+  F  L  L+ L +  N     +P  +   L  L EL 
Sbjct: 58  HRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELR 115

Query: 176 LSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKF 235
           L  NQL  ++P  +F+     +L  L  L + YN+L   +P               F+K 
Sbjct: 116 LDRNQLK-SLPPRVFD-----SLTKLTYLSLGYNELQS-LPKG------------VFDK- 155

Query: 236 QGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEI-GNLRNLEVLGVQSSNLAGLIPASIF-N 293
                     LTS++ L L NN L   +P      L  L+ L + ++ L   +P   F +
Sbjct: 156 ----------LTSLKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLKR-VPEGAFDS 203

Query: 294 ISTLKELAVTDN 305
           +  LK L + +N
Sbjct: 204 LEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 38/143 (26%), Positives = 64/143 (44%), Gaps = 16/143 (11%)

Query: 513 CLGNLTSLRDLSLGSNALTSI---IPSTLWNLKDILRFNLSSNSLNGSLLPDI-GNLKVV 568
           C  N  S+      S  LT+I   IP+    L      +L SN L+ SL       L  +
Sbjct: 14  CNNNKNSV---DCSSKKLTAIPSNIPADTKKL------DLQSNKLS-SLPSKAFHRLTKL 63

Query: 569 IEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSG 628
             + L+ N L  +       L+ L+ L +  N+LQ      F  L +L  + +  N L  
Sbjct: 64  RLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK- 122

Query: 629 TIPKSM-EALSYLKHLNLSFNQL 650
           ++P  + ++L+ L +L+L +N+L
Sbjct: 123 SLPPRVFDSLTKLTYLSLGYNEL 145

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 27/203 (13%), Positives = 58/203 (28%), Gaps = 42/203 (20%)

Query: 768 LLGMGSFGSVYKGVLPD---GMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVK 821
             G       ++ +  D     ++A      +    D  L+   +    +  I    + +
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
           ++          +V E++  GSL++   +       +  ++ M  +A+A +  H      
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAG 149

Query: 882 IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSR 941
           +      PS V         +S  G                L     M          + 
Sbjct: 150 VALSIDHPSRVR--------VSIDGDVV-------------LAYPATMPD-------ANP 181

Query: 942 KCDVYSYGIMLMETFTKKKPTDE 964
           + D+   G  L      + P  E
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPE 204

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 83.4 bits (207), Expect = 3e-17
 Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 26/217 (11%)

Query: 767 KLLGMGSFGSVY---KGVLPDGMEI-AAKVFH----MEFDGSLESFHAECKVMGSIRHRN 818
           ++LG G +G V+   K    +  +I A KV      +          AE  ++  ++H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82

Query: 819 LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMI-DVASALEYLHFG 877
           +V +I +        L+LEY+S G L   L  +  F+         + +++ AL +LH  
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFM--EDTACFYLAEISMALGHLH-- 138

Query: 878 YSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTL-GTIGYMAPEYG 934
               I++ D+KP N++LN    GH  L+DFG+ K    + ++  T T  GTI YMAPE  
Sbjct: 139 -QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTV--THTFCGTIEYMAPEIL 193

Query: 935 REGKVSRKCDVYSYGIMLMETFTKKKP-----TDEIF 966
                +R  D +S G ++ +  T   P       +  
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI 230

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 83.6 bits (207), Expect = 3e-17
 Identities = 54/198 (27%), Positives = 78/198 (39%), Gaps = 27/198 (13%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISS 825
           K +G G+FG             +A K          E+   E     S+RH N+V+    
Sbjct: 26  KDIGSGNFGVARLMRDKLTKELVAVKYIERG-AAIDENVQREIINHRSLRHPNIVRFKEV 84

Query: 826 CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVA--------SALEYLHFG 877
                  A+++EY S G L         +  I    +   D A        S + Y H  
Sbjct: 85  ILTPTHLAIIMEYASGGEL---------YERICNAGRFSEDEARFFFQQLLSGVSYCH-- 133

Query: 878 YSTPIVHCDIKPSNVLLNESMVGHL--SDFGIAKILGKEESMRQTKTLGTIGYMAPE-YG 934
            S  I H D+K  N LL+ S    L   DFG +K      S  ++ T+GT  Y+APE   
Sbjct: 134 -SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKS-TVGTPAYIAPEVLL 190

Query: 935 REGKVSRKCDVYSYGIML 952
           R+    +  DV+S G+ L
Sbjct: 191 RQEYDGKIADVWSCGVTL 208

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 82.6 bits (205), Expect = 4e-17
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 32/202 (15%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKI 822
           + LG GSFG V+           A KV   E       +E  + E  ++  + H  ++++
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71

Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMI-DVASALEYLHFGYSTP 881
             +  +     ++++Y+  G L   L     F +     K    +V  ALEYLH   S  
Sbjct: 72  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPN--PVAKFYAAEVCLALEYLH---SKD 126

Query: 882 IVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTL-GTIGYMAPE------ 932
           I++ D+KP N+LL+++  GH  ++DFG AK +        T TL GT  Y+APE      
Sbjct: 127 IIYRDLKPENILLDKN--GHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKP 179

Query: 933 YGREGKVSRKCDVYSYGIMLME 954
           Y +        D +S+GI++ E
Sbjct: 180 YNKS------IDWWSFGILIYE 195

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 84.0 bits (208), Expect = 5e-17
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 27/216 (12%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEI-AAKVF---HMEFDGSLESFHAECKVMGSIRHRNLVKI 822
           KLLG G+FG V            A K+     +     +     E +V+ + RH  L  +
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213

Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMI-DVASALEYLHFGYSTP 881
             S   +D    V+EY + G L   L  +  F +   R +    ++ SAL+YLH   +  
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE--DRARFYGAEIVSALDYLHSEKN-- 269

Query: 882 IVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQ---TKTL-GTIGYMAPEYGR 935
           +V+ D+K  N++L++   GH  ++DFG+ K     E ++     KT  GT  Y+APE   
Sbjct: 270 VVYRDLKLENLMLDKD--GHIKITDFGLCK-----EGIKDGATMKTFCGTPEYLAPEVLE 322

Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP-----TDEIF 966
           +    R  D +  G+++ E    + P      +++F
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 358

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 82.3 bits (204), Expect = 8e-17
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 39/211 (18%)

Query: 767 KLLGMGSFGSVY---KGVLPDGMEI-AAKVFH----MEFDGSLESFHAECKVMGSIRHRN 818
           K+LG G++G V+   K    D  ++ A KV      ++   + E    E +V+  IR   
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119

Query: 819 -LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVA--------S 869
            LV +  +        L+L+Y++ G L         F  + QR +               
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGEL---------FTHLSQRERFTEHEVQIYVGEIVL 170

Query: 870 ALEYLHFGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTL-GTI 926
           ALE+LH      I++ DIK  N+LL+ +  GH  L+DFG++K    +E+ R      GTI
Sbjct: 171 ALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETER-AYDFCGTI 224

Query: 927 GYMAPE---YGREGKVSRKCDVYSYGIMLME 954
            YMAP+    G  G   +  D +S G+++ E
Sbjct: 225 EYMAPDIVRGGDSGH-DKAVDWWSLGVLMYE 254

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 81.9 bits (203), Expect = 9e-17
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 28/216 (12%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKI 822
           KLLG G+FG V            A K+   E       +     E +V+ + RH  L  +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMI-DVASALEYLHFGYSTP 881
             +   +D    V+EY + G L   L  +  F    +R +    ++ SALEYLH   S  
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFT--EERARFYGAEIVSALEYLH---SRD 125

Query: 882 IVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQ---TKTL-GTIGYMAPEYGR 935
           +V+ DIK  N++L++   GH  ++DFG+ K     E +      KT  GT  Y+APE   
Sbjct: 126 VVYRDIKLENLMLDKD--GHIKITDFGLCK-----EGISDGATMKTFCGTPEYLAPEVLE 178

Query: 936 EGKVSRKCDVYSYGIMLMETFTKKKP-----TDEIF 966
           +    R  D +  G+++ E    + P      + +F
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 48/242 (19%), Positives = 88/242 (36%), Gaps = 23/242 (9%)

Query: 314 SIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLL 373
             D GL N  +  LG+ +   T   S   +S +   +   ++   L         +LK L
Sbjct: 13  FPDPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQSLAG--MQFFTNLKEL 68

Query: 374 SLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCN 433
            L+ N ++    DLS L  LT    LE + ++ N +  +        S  +  L +++  
Sbjct: 69  HLSHNQIS----DLSPLKDLT---KLEELSVNRNRLKNLNGIP----SACLSRLFLDNNE 117

Query: 434 ISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHL 493
           +       L ++ NL ++ + NN+L   +   LG L KL+ L L  N++  +    L  L
Sbjct: 118 LRD--TDSLIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEIT-NT-GGLTRL 171

Query: 494 YRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNS 553
            ++  + L   K           L     +        S  P  + N    +   +    
Sbjct: 172 KKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWEL 229

Query: 554 LN 555
             
Sbjct: 230 PV 231

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 77.8 bits (192), Expect = 8e-16
 Identities = 43/205 (20%), Positives = 81/205 (39%), Gaps = 21/205 (10%)

Query: 442 LGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYL 501
              + N     LG   +T  +      L  +Q     N+ ++ S+   +     L  L+L
Sbjct: 15  DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHL 70

Query: 502 GDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPD 561
             N++S  L   L +LT L +LS+  N L ++       L  +    L +N L       
Sbjct: 71  SHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIPSACLSRL---FLDNNEL--RDTDS 123

Query: 562 IGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDM 621
           + +LK +  + +  N L  ++   +G L  L++L L  N +          LK +N++D+
Sbjct: 124 LIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEITN--TGGLTRLKKVNWIDL 179

Query: 622 SNNNLSGTIPKSMEALSYLKHLNLS 646
           +            E + Y   L ++
Sbjct: 180 TGQKC------VNEPVKYQPELYIT 198

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 41/267 (15%), Positives = 77/267 (28%), Gaps = 52/267 (19%)

Query: 243 IGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAV 302
              L +     LG  S + ++ +    L  ++     +SN+  L    +   + LKEL +
Sbjct: 15  DPGLANAVKQNLGKQS-VTDLVS-QKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHL 70

Query: 303 TDNDLLGSLPSSID--LGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLI 360
           + N +     S +     L  LE L +  N               LS L    N      
Sbjct: 71  SHNQI-----SDLSPLKDLTKLEELSVNRNRLKNLNGIPSAC---LSRLFLDNNELRDTD 122

Query: 361 PTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNF 420
                +L++L++LS+  N L      +  L  L+    LE++ L  N I           
Sbjct: 123 S--LIHLKNLEILSIRNNKLK----SIVMLGFLS---KLEVLDLHGNEITNT-------- 165

Query: 421 SISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNN 480
                                L  +  +  I L   +           L     +   + 
Sbjct: 166 -------------------GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDG 206

Query: 481 KLEGSIPEDLCHLYRLANLYLGDNKLS 507
           +     P  + +     +  +      
Sbjct: 207 RW--ISPYYISNGGSYVDGCVLWELPV 231

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 43/262 (16%), Positives = 93/262 (35%), Gaps = 54/262 (20%)

Query: 143 SLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLE 202
            L       L   S V  +  +   LS +Q  +  ++ +         +++  Q    L+
Sbjct: 17  GLANAVKQNLGKQS-VTDL-VSQKELSGVQNFNGDNSNIQ--------SLAGMQFFTNLK 66

Query: 203 GLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNL--TSVRNLFLGNNSLI 260
            L +S+NQ++    + L    +L  +S+  N+      +++  +    +  LFL NN  +
Sbjct: 67  ELHLSHNQISD--LSPLKDLTKLEELSVNRNRL-----KNLNGIPSACLSRLFLDNNE-L 118

Query: 261 GEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLP 320
            +  + + +L+NLE+L +  +N           + ++  L                  L 
Sbjct: 119 RDTDS-LIHLKNLEILSI-RNN----------KLKSIVMLG----------------FLS 150

Query: 321 NLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVL 380
            LE L L  N  +      LT + +++ +D                L     +       
Sbjct: 151 KLEVLDLHGNEITN--TGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208

Query: 381 TSPTPDLSFLSSLTSCRNLEII 402
            SP     ++S+  S  +  ++
Sbjct: 209 ISP----YYISNGGSYVDGCVL 226

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 63.1 bits (154), Expect = 6e-11
 Identities = 46/289 (15%), Positives = 87/289 (30%), Gaps = 75/289 (25%)

Query: 163 ETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKC 222
                L+   + +L    ++        ++ S + L  ++      + +           
Sbjct: 13  FPDPGLANAVKQNLGKQSVT--------DLVSQKELSGVQNFNGDNSNIQ---------- 54

Query: 223 RELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSN 282
                         G     +   T+++ L L +N  I ++   + +L  LE L V + N
Sbjct: 55  -----------SLAG-----MQFFTNLKELHLSHNQ-ISDLSP-LKDLTKLEELSV-NRN 95

Query: 283 LAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTN 342
                      +  L  +                     L RLFL  N    T   SL +
Sbjct: 96  ----------RLKNLNGIP-----------------SACLSRLFLDNNELRDT--DSLIH 126

Query: 343 ISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEII 402
           +  L +L    N    ++    G L  L++L L GN +T+          LT  + +  I
Sbjct: 127 LKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEITN-------TGGLTRLKKVNWI 177

Query: 403 YLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVI 451
            L+                I+      +   IS       G+  +  V+
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVL 226

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 60.4 bits (147), Expect = 5e-10
 Identities = 45/263 (17%), Positives = 81/263 (30%), Gaps = 27/263 (10%)

Query: 93  LGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLL 152
              L+      +   S   +       L G++ F+   +N  I+  +       L+ L L
Sbjct: 15  DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSN--IQSLAGMQFFTNLKELHL 70

Query: 153 KHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSS-------------IFNISSCQNLP 199
            HN  +  +   +  L+ L+EL ++ N+L                    + +  S  +L 
Sbjct: 71  SHNQ-ISDL-SPLKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNNELRDTDSLIHLK 128

Query: 200 VLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSL 259
            LE L I  N+L       L    +L V+ L  N+        +  L  V  + L     
Sbjct: 129 NLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEITN--TGGLTRLKKVNWIDLTGQKC 184

Query: 260 IGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGL 319
           + E       L     +         + P  I N  +  +  V            +    
Sbjct: 185 VNEPVKYQPELYITNTVKDPDGRW--ISPYYISNGGSYVDGCVLWELP--VYTDEVSYKF 240

Query: 320 PNLERLFLGENNFSGTIPSSLTN 342
                +   E  F GT+   + N
Sbjct: 241 SEYINVGETEAIFDGTVTQPIKN 263

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 78.8 bits (195), Expect = 4e-16
 Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 27/199 (13%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVF---HMEFDGSLESFHAECKVMGSIRHRNLVKI 822
             LG+G+FG V  G     G ++A K+     +     +     E + +   RH +++K+
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVA--------SALEYL 874
               S      +V+EY+S G L         F  I +  ++    A        SA++Y 
Sbjct: 77  YQVISTPTDFFMVMEYVSGGEL---------FDYICKHGRVEEMEARRLFQQILSAVDYC 127

Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE-Y 933
           H      +VH D+KP NVLL+  M   ++DFG++ ++  +    +T + G+  Y APE  
Sbjct: 128 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRT-SCGSPNYAAPEVI 182

Query: 934 GREGKVSRKCDVYSYGIML 952
                   + D++S G++L
Sbjct: 183 SGRLYAGPEVDIWSCGVIL 201

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 79.7 bits (197), Expect = 4e-16
 Identities = 53/233 (22%), Positives = 89/233 (38%), Gaps = 36/233 (15%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAK------VFHMEFDGSLESFHAECKVMGSIR---- 815
            LLG G FG+V+ G  L D +++A K      V          +   E  ++  +     
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 816 HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL------KIMIDVAS 869
           H  +++++      +   LVLE       +  L+    ++     L           V +
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQ-D--LFD---YITEKGPLGEGPSRCFFGQVVA 150

Query: 870 ALEYLHFGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIG 927
           A+++ H   S  +VH DIK  N+L++    G   L DFG   +L   +        GT  
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILIDLRR-GCAKLIDFGSGALL--HDEPYTD-FDGTRV 203

Query: 928 YMAPEYGREGK-VSRKCDVYSYGIMLMETFTKKKP---TDEIFAGEMSLKRWV 976
           Y  PE+    +  +    V+S GI+L +      P     EI   E+     V
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHV 256

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 79.3 bits (196), Expect = 6e-16
 Identities = 52/230 (22%), Positives = 93/230 (40%), Gaps = 32/230 (13%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAK------VFHMEFDGSLESFHAECKVMGSIRHR-- 817
            LLG G FGSVY G+ + D + +A K      +       +      E  ++  +     
Sbjct: 49  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108

Query: 818 NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL------KIMIDVASAL 871
            +++++      D   L+LE       +  L+    F+     L           V  A+
Sbjct: 109 GVIRLLDWFERPDSFVLILERPE-PVQD--LFD---FITERGALQEELARSFFWQVLEAV 162

Query: 872 EYLHFGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMA 930
            + H   +  ++H DIK  N+L++       L DFG   +L  ++++      GT  Y  
Sbjct: 163 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTD-FDGTRVYSP 216

Query: 931 PEYGREGK-VSRKCDVYSYGIMLMETFTKKKP---TDEIFAGEMSLKRWV 976
           PE+ R  +   R   V+S GI+L +      P    +EI  G++  ++ V
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 266

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 77.0 bits (190), Expect = 9e-16
 Identities = 36/207 (17%), Positives = 77/207 (37%), Gaps = 10/207 (4%)

Query: 447 NLTVIRLGNNELTGTIPV-TLGRLQKLQGLYL-QNNKLEGSIPEDL-CHLYRLANLYLGD 503
           +   ++L    L  TIP      L  +  +Y+  +  L+  +      +L ++ ++ + +
Sbjct: 32  STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRN 89

Query: 504 NKLSGRLPA-CLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILR-FNLSSNSLNGSLLPD 561
            +    +    L  L  L+ L + +  L      T     DI     ++ N    S+  +
Sbjct: 90  TRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149

Query: 562 I--GNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKS-LNF 618
              G     + + L  N  + V      G +   +   +   L     ++FGG+ S  + 
Sbjct: 150 AFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSL 209

Query: 619 VDMSNNNLSGTIPKSMEALSYLKHLNL 645
           +D+S  +++    K +E L  L   N 
Sbjct: 210 LDVSQTSVTALPSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 46/259 (17%), Positives = 83/259 (32%), Gaps = 55/259 (21%)

Query: 270 LRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGE 329
             + + L +  ++L  +   +  N+  +  + V+ +  L  L S     L  +  + +  
Sbjct: 30  PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89

Query: 330 NNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSF 389
                    +LT I                 P     L  LK L +    L    PDL+ 
Sbjct: 90  TR-------NLTYID----------------PDALKELPLLKFLGIFNTGLKM-FPDLTK 125

Query: 390 LSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLT 449
           + S        I+ +++NP    +P     F                      G  N   
Sbjct: 126 VYSTDI---FFILEITDNPYMTSIPV--NAFQ---------------------GLCNETL 159

Query: 450 VIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCH--LYRLANLYLGDNKLS 507
            ++L NN  T ++        KL  +YL  NK    I +D         + L +    ++
Sbjct: 160 TLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218

Query: 508 GRLPA-CLGNLTSLRDLSL 525
             LP+  L +L  L   + 
Sbjct: 219 -ALPSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 71.6 bits (176), Expect = 7e-14
 Identities = 40/245 (16%), Positives = 81/245 (33%), Gaps = 43/245 (17%)

Query: 112 SLPEELSHLRGLKYFDFRFNNFHIEIPSW-FVSLPRLQHLLLKHNSFVGKIPETI-GYLS 169
           SLP     L           +    IPS  F +LP +  + +  +  + ++       LS
Sbjct: 28  SLPPSTQTL------KLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLS 80

Query: 170 LLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVS 229
            +  +++ + +    I          + LP+L+ L I    L                  
Sbjct: 81  KVTHIEIRNTRNLTYIDPDAL-----KELPLLKFLGIFNTGLK-------------MFPD 122

Query: 230 LAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIP-NEIGNLRN-LEVLGVQSSNLAGLI 287
           L            + +      L + +N  +  IP N    L N    L + ++     +
Sbjct: 123 LTK----------VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-V 171

Query: 288 PASIFNISTLKELAVTDNDLLGSLPSSIDLGLPN-LERLFLGENNFSGTIPS-SLTNISE 345
               FN + L  + +  N  L  +      G+ +    L + + + +  +PS  L ++ E
Sbjct: 172 QGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKE 230

Query: 346 LSVLD 350
           L   +
Sbjct: 231 LIARN 235

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 71.2 bits (175), Expect = 8e-14
 Identities = 45/223 (20%), Positives = 84/223 (37%), Gaps = 19/223 (8%)

Query: 446 NNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPED-LCHLYRLANLYLGDN 504
           +     R+   ++   IP         Q L L    L  +IP     +L  ++ +Y+  +
Sbjct: 11  HQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSID 65

Query: 505 KLSGRLPA-CLGNLTSLRDLSLGSN-ALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPD- 561
               +L +    NL+ +  + + +   LT I P  L  L  +    + +  L   + PD 
Sbjct: 66  VTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL--KMFPDL 123

Query: 562 --IGNLKVVIEMDLSLNALSGVIPV-TIGGLQG-LQLLSLRYNRLQGPIPESFGGLKSLN 617
             + +  +   ++++ N     IPV    GL      L L  N        +F G K L+
Sbjct: 124 TKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTK-LD 182

Query: 618 FVDMSNNNLSGTIPKSM--EALSYLKHLNLSFNQLEGEIPTRG 658
            V ++ N     I K       S    L++S   +   +P++G
Sbjct: 183 AVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG 224

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 30/174 (17%), Positives = 59/174 (33%), Gaps = 10/174 (5%)

Query: 487 PEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILR 546
               C  ++  +  +    +  R+P       S + L L    L +I      NL +I R
Sbjct: 4   SSPPCECHQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISR 59

Query: 547 FNLSSNSLNGSLLPDI-GNLKVVIEMDLSLN-ALSGVIPVTIGGLQGLQLLSLRYNRLQG 604
             +S +     L      NL  V  +++     L+ + P  +  L  L+ L +    L+ 
Sbjct: 60  IYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM 119

Query: 605 -PIPESFGGLKSLNFVDMSNNNLSGTIPKSMEA--LSYLKHLNLSFNQLEGEIP 655
            P             +++++N    +IP +      +    L L  N     + 
Sbjct: 120 FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQ 172

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 51.5 bits (124), Expect = 3e-07
 Identities = 26/135 (19%), Positives = 47/135 (34%), Gaps = 14/135 (10%)

Query: 73  RRVTALNISYLGLTGTIPPQ--LGNLSFLAVLAIRNNSFFGSLPEE-LSHLRG-LKYFDF 128
             +  L I   GL    P    + +     +L I +N +  S+P      L         
Sbjct: 105 PLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKL 163

Query: 129 RFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETI--GYLSLLQELDLSDNQLSGTIP 186
             N F   +  +  +  +L  + L  N ++  I +    G  S    LD+S   ++  +P
Sbjct: 164 YNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALP 221

Query: 187 SSIFNISSCQNLPVL 201
           S        ++L  L
Sbjct: 222 SKGL-----EHLKEL 231

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 80.2 bits (197), Expect = 1e-15
 Identities = 47/220 (21%), Positives = 87/220 (39%), Gaps = 15/220 (6%)

Query: 335 TIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLT 394
               S+   + L            L P     L ++ LL  A + L      L + S+L 
Sbjct: 353 RCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLK 412

Query: 395 SCRNLEIIYLSENPINGILPSSI-GNFSISMKSLSMESCNISGGIPKELGNINNLTVIRL 453
           +   +   YL +     +L +S+       ++ L +   +++  +   L  +  +T + L
Sbjct: 413 AVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDL 470

Query: 454 GNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPA- 512
            +N L   +P  L  L+ L+ L   +N LE ++   + +L RL  L L +N+L     A 
Sbjct: 471 SHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQ-SAAI 526

Query: 513 -CLGNLTSLRDLSLGSNALTSI------IPSTLWNLKDIL 545
             L +   L  L+L  N+L         +   L ++  IL
Sbjct: 527 QPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 76.7 bits (188), Expect = 2e-14
 Identities = 48/267 (17%), Positives = 86/267 (32%), Gaps = 17/267 (6%)

Query: 390 LSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGI---PKELGNIN 446
                   ++ +  L    +N  LP        +      E   +        ++     
Sbjct: 290 PDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDE 349

Query: 447 NLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKL 506
            L    L   + T  +   L   ++LQ L  +N     +I   +  L  L          
Sbjct: 350 QLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYF 408

Query: 507 SGRLPACLGNLTSLRDLSLG--SNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGN 564
           S      L  +  +R   L    +              D+   +L+   L  ++L  +  
Sbjct: 409 ST-----LKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQ 461

Query: 565 LKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNN 624
           L +V  +DLS N L   +P  +  L+ L++L    N L+    +    L  L  + + NN
Sbjct: 462 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE--NVDGVANLPRLQELLLCNN 518

Query: 625 NLSG-TIPKSMEALSYLKHLNLSFNQL 650
            L      + + +   L  LNL  N L
Sbjct: 519 RLQQSAAIQPLVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 74.0 bits (181), Expect = 1e-13
 Identities = 57/333 (17%), Positives = 102/333 (30%), Gaps = 21/333 (6%)

Query: 320 PNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNV 379
                +   E   S      LT  S +  L    +     +     + R+        ++
Sbjct: 245 LCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDL 304

Query: 380 LTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSME-SCNISGGI 438
             +   D     +                +         + +   +    E S   S  +
Sbjct: 305 PAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVL 364

Query: 439 PKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGL---YLQNNKLEGSIPEDLCHLYR 495
             EL +   L  +   N     TI + +  L  L          + L+   P    +L  
Sbjct: 365 QSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDD 424

Query: 496 LANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIP-STLWNLKDILRFNLSSNSL 554
           L + +L +N +             +R L L    LT +     L  +  +   +LS N L
Sbjct: 425 LRSKFLLENSVL------KMEYADVRVLHLAHKDLTVLCHLEQLLLVTHL---DLSHNRL 475

Query: 555 NGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQG-PIPESFGGL 613
             +L P +  L+ +  +  S NAL  V    +  L  LQ L L  NRLQ     +     
Sbjct: 476 R-ALPPALAALRCLEVLQASDNALENVDG--VANLPRLQELLLCNNRLQQSAAIQPLVSC 532

Query: 614 KSLNFVDMSNNNLSGT---IPKSMEALSYLKHL 643
             L  +++  N+L        +  E L  +  +
Sbjct: 533 PRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 64.8 bits (157), Expect = 1e-10
 Identities = 31/196 (15%), Positives = 61/196 (31%), Gaps = 9/196 (4%)

Query: 456 NELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLG 515
            +            ++L    L   K    +  +L     L  L   +      L   + 
Sbjct: 335 KDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENK---WCLLTIIL 390

Query: 516 NLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSL 575
            + +L  L      L         +       +   +               V  + L+ 
Sbjct: 391 LMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAH 450

Query: 576 NALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSME 635
             L+ +    +  L  +  L L +NRL+  +P +   L+ L  +  S+N L   +   + 
Sbjct: 451 KDLTVLCH--LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVD-GVA 505

Query: 636 ALSYLKHLNLSFNQLE 651
            L  L+ L L  N+L+
Sbjct: 506 NLPRLQELLLCNNRLQ 521

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 63.6 bits (154), Expect = 2e-10
 Identities = 52/357 (14%), Positives = 94/357 (26%), Gaps = 73/357 (20%)

Query: 44  HDPSNLLANNWSTTSSVCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLA 103
                 L            W       R   V   ++    L   +P     + +    +
Sbjct: 268 GSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDS 327

Query: 104 IRN----NSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVG 159
            +              + +    L   +       + + S   S   LQ L  ++   + 
Sbjct: 328 QKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTV-LQSELESCKELQELEPENKWCLL 386

Query: 160 KI---PETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIP 216
            I      +  L   +E     + L    P     +   ++            +      
Sbjct: 387 TIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRS------------KFLLENS 434

Query: 217 TNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVL 276
               +  ++ V+ LA       +   +  L  V +L L +N L   +P  +  LR LEVL
Sbjct: 435 VLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVL 491

Query: 277 GVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTI 336
              S N           +  +  +A                 LP L+ L L  N      
Sbjct: 492 QA-SDN----------ALENVDGVA----------------NLPRLQELLLCNNR----- 519

Query: 337 PSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSL 393
              L   + +  L                +   L LL+L GN L         L+ +
Sbjct: 520 ---LQQSAAIQPL---------------VSCPRLVLLNLQGNSLCQEEGIQERLAEM 558

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 63.6 bits (154), Expect = 2e-10
 Identities = 45/355 (12%), Positives = 94/355 (26%), Gaps = 59/355 (16%)

Query: 125 YFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGT 184
           Y  +             V + R +  L    S    +   +G L L+ +      +    
Sbjct: 231 YHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTP 290

Query: 185 IPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIG 244
              +  +     +LP               I T     +E  ++      +     RD  
Sbjct: 291 DGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECW----CRDSA 346

Query: 245 NLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSS----------NLAGLIPASIFNI 294
               +    L        + +E+ + + L+ L  ++                +      +
Sbjct: 347 TDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETL 405

Query: 295 STLKELAVTDNDLLGSLPSSIDLGLPN----------LERLFLGENNFSGTIPSSLTNIS 344
                L   D      L       L            +  L L   +   T+   L  + 
Sbjct: 406 QYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLL 463

Query: 345 ELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYL 404
            ++ LD   N     +P     LR L++L  + N L +       +  + +   L+ + L
Sbjct: 464 LVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALEN-------VDGVANLPRLQELLL 515

Query: 405 SENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELT 459
             N +                ++            + L +   L ++ L  N L 
Sbjct: 516 CNNRLQ------------QSAAI------------QPLVSCPRLVLLNLQGNSLC 546

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 79.7 bits (196), Expect = 3e-15
 Identities = 64/262 (24%), Positives = 111/262 (42%), Gaps = 30/262 (11%)

Query: 722 RRRRRRRRQKGSTRPYYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGV 781
           R++  R +    T+   +      + +     +D ++ TD F+   +LG GSFG V    
Sbjct: 303 RQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTD-FNFLMVLGKGSFGKVMLSE 361

Query: 782 LPDGMEI-AAKVFHMEF---DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALVL 836
                E+ A K+   +    D  +E    E +V+    +   L ++ S     D    V+
Sbjct: 362 RKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 421

Query: 837 EYMSNGSLEKCLYSDNYFLDILQRLKIMI-DVASALEYLHFGYSTPIVHCDIKPSNVLLN 895
           EY++ G L   +     F            ++A  L +L    S  I++ D+K  NV+L+
Sbjct: 422 EYVNGGDLMYHIQQVGRFK--EPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLD 476

Query: 896 ESMVGH--LSDFGIAKILGKEESM---RQTKTL-GTIGYMAPEYGREGKVSRKCDVYSYG 949
               GH  ++DFG+ K     E++     TKT  GT  Y+APE        +  D +++G
Sbjct: 477 SE--GHIKIADFGMCK-----ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFG 529

Query: 950 IMLMETFTKKKP-----TDEIF 966
           ++L E    + P      DE+F
Sbjct: 530 VLLYEMLAGQAPFEGEDEDELF 551

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 77.6 bits (192), Expect = 3e-15
 Identities = 68/240 (28%), Positives = 109/240 (45%), Gaps = 30/240 (12%)

Query: 744 PQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEI-AAKVF---HMEFDG 799
           P+    R S Q  L+  D F  +K+LG GSFG V+        +  A K      +  D 
Sbjct: 1   PELNKERPSLQIKLKIED-FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD 59

Query: 800 SLESFHAECKVMG-SIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDIL 858
            +E    E +V+  +  H  L  +  +    +    V+EY++ G L   + S + F   L
Sbjct: 60  DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD--L 117

Query: 859 QRLKIMI-DVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEE 915
            R      ++   L++LH   S  IV+ D+K  N+LL++   GH  ++DFG+ K     E
Sbjct: 118 SRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCK-----E 167

Query: 916 SMRQ---TKTL-GTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP-----TDEIF 966
           +M     T T  GT  Y+APE     K +   D +S+G++L E    + P      +E+F
Sbjct: 168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 78.3 bits (193), Expect = 4e-15
 Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 35/203 (17%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFH---MEFDGSLESFHAECKVMGSIRHRNLVKI 822
             LG+G+FG V  G     G ++A K+ +   +     +     E + +   RH +++K+
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVA--------SALEYL 874
               S      +V+EY+S G L         F  I +  ++    +        S ++Y 
Sbjct: 82  YQVISTPSDIFMVMEYVSGGEL---------FDYICKNGRLDEKESRRLFQQILSGVDYC 132

Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL----GTIGYMA 930
           H      +VH D+KP NVLL+  M   ++DFG++ +      M   + L    G+  Y A
Sbjct: 133 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM------MSDGEFLRTSCGSPNYAA 183

Query: 931 PE-YGREGKVSRKCDVYSYGIML 952
           PE          + D++S G++L
Sbjct: 184 PEVISGRLYAGPEVDIWSSGVIL 206

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 76.9 bits (190), Expect = 5e-15
 Identities = 57/231 (24%), Positives = 92/231 (39%), Gaps = 38/231 (16%)

Query: 760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAA--KVFHMEFDGSLESFHAECKVMGSIRHR 817
            D F   ++ G G+FG+V  G         A  KV       + E      + +  + H 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE--LQIMQDLAVLHHP 79

Query: 818 NLVK---IISSCSNNDFK----ALVLEYMSNGSLEKCLYSDNYFLDILQRLKI---MIDV 867
           N+V+      +    D +     +V+EY+ + +L +C  +          + I   +  +
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQL 138

Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLS--DFGIAKILGKEESMRQTKTLGT 925
             ++  LH   S  + H DIKP NVL+NE+  G L   DFG AK L   E       + +
Sbjct: 139 IRSIGCLH-LPSVNVCHRDIKPHNVLVNEAD-GTLKLCDFGSAKKLSPSEPN--VAYICS 194

Query: 926 IGYMAPE-------YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGE 969
             Y APE       Y      +   D++S G +  E     +P   IF G+
Sbjct: 195 RYYRAPELIFGNQHY------TTAVDIWSVGCIFAEMML-GEP---IFRGD 235

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 76.9 bits (190), Expect = 6e-15
 Identities = 66/217 (30%), Positives = 97/217 (44%), Gaps = 29/217 (13%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMG-SIRHRNLVK 821
           K++G GSFG V            A KV   +        +   +E  V+  +++H  LV 
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMI-DVASALEYLHFGYST 880
           +  S    D    VL+Y++ G L   L  +  FL    R +    ++ASAL YLH   S 
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFL--EPRARFYAAEIASALGYLH---SL 158

Query: 881 PIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQ---TKTL-GTIGYMAPEYG 934
            IV+ D+KP N+LL+    GH  L+DFG+ K     E++     T T  GT  Y+APE  
Sbjct: 159 NIVYRDLKPENILLDSQ--GHIVLTDFGLCK-----ENIEHNSTTSTFCGTPEYLAPEVL 211

Query: 935 REGKVSRKCDVYSYGIMLMETFTKKKP-----TDEIF 966
            +    R  D +  G +L E      P     T E++
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 248

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 76.6 bits (189), Expect = 7e-15
 Identities = 44/223 (19%), Positives = 80/223 (35%), Gaps = 49/223 (21%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLES------FHA-----ECKVMGSIR 815
           + +  GS+G+V  GV  +G+ +A K                  F       E +++    
Sbjct: 28  RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87

Query: 816 HRNLVK---IISSCSNNDFKA--LVLEYMSNGSLEKCLYSDNYFLD-------ILQRLKI 863
           H N++    I             LV E M    L + ++     +        +   L  
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILL- 145

Query: 864 MIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL 923
                  L  LH      +VH D+ P N+LL ++    + DF +A+    + +   T  +
Sbjct: 146 ------GLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK--THYV 194

Query: 924 GTIGYMAPE-------YGREGKVSRKCDVYSYGIMLMETFTKK 959
               Y APE       +      ++  D++S G ++ E F +K
Sbjct: 195 THRWYRAPELVMQFKGF------TKLVDMWSAGCVMAEMFNRK 231

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 76.3 bits (188), Expect = 8e-15
 Identities = 49/212 (23%), Positives = 85/212 (40%), Gaps = 30/212 (14%)

Query: 763 FSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNL 819
           +   K +G G+ G V           +A K     F     +  A  E  +M  + H+N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86

Query: 820 VKI----ISSCSNNDFKA--LVLEYMSNGSLEKCLYSD------NYFLDILQRLKIMIDV 867
           + +        S  +F+   +V+E M   +L + +  +      +Y L   Q L      
Sbjct: 87  IGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLL--YQMLC----- 138

Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIG 927
              +++LH   S  I+H D+KPSN+++       + DFG+A+  G    M  T  + T  
Sbjct: 139 --GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY 191

Query: 928 YMAPEYGREGKVSRKCDVYSYGIMLMETFTKK 959
           Y APE           D++S G ++ E     
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 76.6 bits (189), Expect = 1e-14
 Identities = 66/241 (27%), Positives = 100/241 (41%), Gaps = 53/241 (21%)

Query: 749 RRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAK--VFHMEFDGSLESFHA 806
           R I+Y +           K++G GSFG V++  L +  E+A K  +    F         
Sbjct: 38  REIAYTNC----------KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR------ 81

Query: 807 ECKVMGSIRHRNLVK----IISSCSNNDFKA--LVLEYMSNGSLEKCLYSDNYFLDILQR 860
           E ++M  ++H N+V       S+    D     LVLEY+   ++ +           +  
Sbjct: 82  ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPM 140

Query: 861 LKI---MIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHL--SDFGIAKILGKEE 915
           L I   M  +  +L Y+H   S  I H DIKP N+LL+    G L   DFG AKIL   E
Sbjct: 141 LLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPS-GVLKLIDFGSAKILIAGE 196

Query: 916 SMRQTKTLGTIGYMAPE-------YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAG 968
                  + +  Y APE       Y      +   D++S G ++ E     +P   +F G
Sbjct: 197 PN--VSYICSRYYRAPELIFGATNY------TTNIDIWSTGCVMAELMQ-GQP---LFPG 244

Query: 969 E 969
           E
Sbjct: 245 E 245

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 75.7 bits (187), Expect = 1e-14
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 29/217 (13%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMGSI-RHRNLVK 821
           ++LG GSFG V    + +  ++ A KV   +    D  +E    E +++     H  L +
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMI-DVASALEYLHFGYST 880
           +       D    V+E+++ G L   +     F     R +    ++ SAL +LH     
Sbjct: 89  LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD--EARARFYAAEIISALMFLH---DK 143

Query: 881 PIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQ---TKTL-GTIGYMAPEYG 934
            I++ D+K  NVLL+    GH  L+DFG+ K     E +     T T  GT  Y+APE  
Sbjct: 144 GIIYRDLKLDNVLLDHE--GHCKLADFGMCK-----EGICNGVTTATFCGTPDYIAPEIL 196

Query: 935 REGKVSRKCDVYSYGIMLMETFTKKKP-----TDEIF 966
           +E       D ++ G++L E      P      D++F
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF 233

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 75.7 bits (186), Expect = 1e-14
 Identities = 39/195 (20%), Positives = 66/195 (33%), Gaps = 34/195 (17%)

Query: 437 GIPKELGNINNLTVIRLGNNELTGTIP-VTLGRLQKLQGLYLQNNKLEGSIPED-LCHLY 494
            +P      +   ++ L +N L+      T  RL  L  L L +N L   I  +    + 
Sbjct: 36  SLP------SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88

Query: 495 RLANLYLGDNKLSGRLPA-CLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNS 553
            L  L L  N L   L      +L +L  L L +N +  +  +   ++  + +  LS N 
Sbjct: 89  NLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQ 147

Query: 554 LNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGL 613
           +                    +  +          L  L LL L  N+L+         L
Sbjct: 148 I----------------SRFPVELIKDG-----NKLPKLMLLDLSSNKLKKLPLTDLQKL 186

Query: 614 KSL--NFVDMSNNNL 626
            +   N + + NN L
Sbjct: 187 PAWVKNGLYLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 75.3 bits (185), Expect = 2e-14
 Identities = 47/189 (24%), Positives = 70/189 (37%), Gaps = 38/189 (20%)

Query: 368 RSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSL 427
               LL L+ N L+    + +  + LT   NL  + LS N +N I   S   F       
Sbjct: 39  SYTALLDLSHNNLSRLRAEWTP-TRLT---NLHSLLLSHNHLNFI---SSEAFV------ 85

Query: 428 SMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPV-TLGRLQKLQGLYLQNNKLEGSI 486
                            + NL  + L +N L  T+       LQ L+ L L NN +   +
Sbjct: 86  ----------------PVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VV 127

Query: 487 PED-LCHLYRLANLYLGDNKLSGRLPA----CLGNLTSLRDLSLGSNALTSIIPSTLWNL 541
             +    + +L  LYL  N++S R P         L  L  L L SN L  +  + L  L
Sbjct: 128 DRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKL 186

Query: 542 KDILRFNLS 550
              ++  L 
Sbjct: 187 PAWVKNGLY 195

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 73.7 bits (181), Expect = 6e-14
 Identities = 48/196 (24%), Positives = 67/196 (34%), Gaps = 39/196 (19%)

Query: 485 SIPEDLCHLYRLANLYLGDNKLSGRLPA--CLGNLTSLRDLSLGSNALTSIIPSTLWNLK 542
           ++P+ L      A L L  N LS RL A      LT+L  L L  N L  I       + 
Sbjct: 32  NVPQSL--PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVP 88

Query: 543 DILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRL 602
                                NL+    +DLS N L  +       LQ L++L L  N +
Sbjct: 89  ---------------------NLR---YLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHI 124

Query: 603 QGPIPESFGGLKSLNFVDMSNNNLSGTIP----KSMEALSYLKHLNLSFNQLEGEIPTRG 658
                 +F  +  L  + +S N +S   P    K    L  L  L+LS N+L      + 
Sbjct: 125 VVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKL-----KKL 178

Query: 659 PFITFSAESFLGNQAL 674
           P              L
Sbjct: 179 PLTDLQKLPAWVKNGL 194

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 73.3 bits (180), Expect = 9e-14
 Identities = 42/179 (23%), Positives = 72/179 (40%), Gaps = 16/179 (8%)

Query: 239 IPRDIGNLTSVRNLFLGNNSLIGEIPNEI--GNLRNLEVLGVQSSNLAGLIPASIF-NIS 295
           +P+ +   +    L L +N+ +  +  E     L NL  L +  ++L   I +  F  + 
Sbjct: 33  VPQSL--PSYTALLDLSHNN-LSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88

Query: 296 TLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNS 355
            L+ L ++ N  L +L   +   L  LE L L  N+      ++  ++++L  L    N 
Sbjct: 89  NLRYLDLSSN-HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQ 147

Query: 356 FSGLIPTTFGN---LRSLKLLSLAGNVLTS-PTPDLSFLSSLTSCRNLEIIYLSENPIN 410
            S        +   L  L LL L+ N L   P  DL  L +         +YL  NP+ 
Sbjct: 148 ISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWV----KNGLYLHNNPLE 202

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 67.6 bits (165), Expect = 5e-12
 Identities = 52/223 (23%), Positives = 85/223 (38%), Gaps = 40/223 (17%)

Query: 287 IPASIFNISTLKELAVTDNDLLGSLPSSIDL-GLPNLERLFLGENNFSGTIPS-SLTNIS 344
           +P S+   S    L ++ N+L   L +      L NL  L L  N+ +  I S +   + 
Sbjct: 33  VPQSLP--SYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88

Query: 345 ELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYL 404
            L  LD   N    L    F +L++L++L L  N +       +F   +     L+ +YL
Sbjct: 89  NLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVV-VDRNAF-EDMA---QLQKLYL 143

Query: 405 SENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPV 464
           S+N I+      I + +                       +  L ++ L +N+L      
Sbjct: 144 SQNQISRFPVELIKDGN----------------------KLPKLMLLDLSSNKLKKLPLT 181

Query: 465 TLGRLQKL--QGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNK 505
            L +L      GLYL NN LE       C LY+L + +     
Sbjct: 182 DLQKLPAWVKNGLYLHNNPLECD-----CKLYQLFSHWQYRQL 219

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 67.2 bits (164), Expect = 7e-12
 Identities = 41/174 (23%), Positives = 65/174 (37%), Gaps = 16/174 (9%)

Query: 112 SLPEELSHLRGLKYFDFRFNNFHIEIPSW-FVSLPRLQHLLLKHNSFVGKIPE-TIGYLS 169
           ++P+ L         D   NN       W    L  L  LLL HN  +  I       + 
Sbjct: 32  NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNH-LNFISSEAFVPVP 88

Query: 170 LLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLW-KCRELHVV 228
            L+ LDLS N L  T+   +F      +L  LE L +  N +   +  N +    +L  +
Sbjct: 89  NLRYLDLSSNHLH-TLDEFLF-----SDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKL 141

Query: 229 SLAFNK---FQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQ 279
            L+ N+   F   + +D   L  +  L L +N L      ++  L      G+ 
Sbjct: 142 YLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 37/144 (25%), Positives = 61/144 (42%), Gaps = 10/144 (6%)

Query: 73  RRVTALNISYLGLTGTIPPQ--LGNLSFLAVLAIRNNSFFGSLPEE-LSHLRGLKYFDFR 129
                L++S+  L+  +  +     L+ L  L + +N     +  E    +  L+Y D  
Sbjct: 39  SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLS 96

Query: 130 FNNFHIEIPSW-FVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSS 188
            N+ H  +  + F  L  L+ LLL +N  V         ++ LQ+L LS NQ+S   P  
Sbjct: 97  SNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVE 154

Query: 189 IFNISSCQNLPVLEGLFISYNQLT 212
           +        LP L  L +S N+L 
Sbjct: 155 LI--KDGNKLPKLMLLDLSSNKLK 176

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 45.6 bits (108), Expect = 6e-05
 Identities = 34/156 (21%), Positives = 57/156 (36%), Gaps = 22/156 (14%)

Query: 73  RRVTALNISYLGLTGTIPPQ-LGNLSFLAVLAIRNNSFFGSLPEE-LSHLRGLKYFDFRF 130
             + +L +S+  L   I  +    +  L  L + +N    +L E   S L+ L+      
Sbjct: 64  TNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYN 121

Query: 131 NNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPE----TIGYLSLLQELDLSDNQLSGTIP 186
           N+  +   + F  + +LQ L L  N    + P         L  L  LDLS N+L   +P
Sbjct: 122 NHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLP 179

Query: 187 SSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKC 222
            +       Q LP      +  +        N  +C
Sbjct: 180 LTDL-----QKLPAWVKNGLYLH-------NNPLEC 203

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 74.1 bits (183), Expect = 2e-14
 Identities = 50/209 (23%), Positives = 96/209 (45%), Gaps = 20/209 (9%)

Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA----ECKVMGSIRHRNLVKII 823
           +G G++G+V+K         +A K   ++ D   E   +    E  ++  ++H+N+V++ 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELKHKNIVRLH 67

Query: 824 SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIV 883
               ++    LV E+     L+K   S N  LD       +  +   L + H   S  ++
Sbjct: 68  DVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVL 123

Query: 884 HCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ-TKTLGTIGYMAPE--YGREGKVS 940
           H D+KP N+L+N +    L++FG+A+  G    +R  +  + T+ Y  P+  +G +   S
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAK-LYS 180

Query: 941 RKCDVYSYGIMLMETFTKKKPTDEIFAGE 969
              D++S G +  E     +P   +F G 
Sbjct: 181 TSIDMWSAGCIFAELANAGRP---LFPGN 206

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 43/205 (20%), Positives = 77/205 (37%), Gaps = 59/205 (28%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLVKII- 823
           ++LG+G  G V +        + A K+              E ++     +  ++V+I+ 
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVD 78

Query: 824 ---SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL----------KIMIDVASA 870
              +  +      +V+E +  G L         F  I  R           +IM  +  A
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGEL---------FSRIQDRGDQAFTEREASEIMKSIGEA 129

Query: 871 LEYLHFGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKILGKEESMRQTKTLGTIG 927
           ++YLH   S  I H D+KP N+L      + +  L+DFG AK    E             
Sbjct: 130 IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE------------- 173

Query: 928 YMAPEYGREGKVSRKCDVYSYGIML 952
               +Y +       CD++S G+++
Sbjct: 174 ----KYDKS------CDMWSLGVIM 188

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 75.0 bits (185), Expect = 2e-14
 Identities = 58/224 (25%), Positives = 92/224 (41%), Gaps = 43/224 (19%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMGSI-RHRNLVK 821
            +LG GSFG V         E+ A K+   +    D  +E    E +V+    +   L +
Sbjct: 26  MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVA--------SALEY 873
           + S     D    V+EY++ G L            I Q  +     A          L +
Sbjct: 86  LHSCFQTMDRLYFVMEYVNGGDL---------MYHIQQVGRFKEPHAVFYAAEIAIGLFF 136

Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMR---QTKTL-GTIG 927
           L    S  I++ D+K  NV+L+    GH  ++DFG+ K     E++     TKT  GT  
Sbjct: 137 LQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCK-----ENIWDGVTTKTFCGTPD 186

Query: 928 YMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP-----TDEIF 966
           Y+APE        +  D +++G++L E    + P      DE+F
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 230

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 73.8 bits (182), Expect = 4e-14
 Identities = 54/200 (27%), Positives = 84/200 (42%), Gaps = 24/200 (12%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMGSI-RHRNLVK 821
           +++G GS+  V    L     I A KV   E    D  ++    E  V      H  LV 
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMI-DVASALEYLHFGYST 880
           + S          V+EY++ G L   +          +  +    +++ AL YLH     
Sbjct: 75  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP--EEHARFYSAEISLALNYLH---ER 129

Query: 881 PIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQ---TKTL-GTIGYMAPEYG 934
            I++ D+K  NVLL+    GH  L+D+G+ K     E +R    T T  GT  Y+APE  
Sbjct: 130 GIIYRDLKLDNVLLDSE--GHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAPEIL 182

Query: 935 REGKVSRKCDVYSYGIMLME 954
           R        D ++ G+++ E
Sbjct: 183 RGEDYGFSVDWWALGVLMFE 202

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 73.9 bits (182), Expect = 4e-14
 Identities = 52/203 (25%), Positives = 82/203 (40%), Gaps = 36/203 (17%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHME--FDGSLESFHAECKVMGSIRHRNLVKII 823
           K +G G+F  V     +  G E+A K+         SL+    E ++M  + H N+VK+ 
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80

Query: 824 SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDIL---QRL------KIMIDVASALEYL 874
                     L++EY S G +           D L    R+           + SA++Y 
Sbjct: 81  EVIETEKTLYLIMEYASGGEV----------FDYLVAHGRMKEKEARSKFRQIVSAVQYC 130

Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL----GTIGYMA 930
           H      IVH D+K  N+LL+  M   ++DFG +              L    G   Y A
Sbjct: 131 H---QKRIVHRDLKAENLLLDADMNIKIADFGFSNE------FTVGGKLDAFCGAPPYAA 181

Query: 931 PE-YGREGKVSRKCDVYSYGIML 952
           PE +  +     + DV+S G++L
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVIL 204

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 74.3 bits (183), Expect = 5e-14
 Identities = 53/200 (26%), Positives = 84/200 (42%), Gaps = 24/200 (12%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEI-AAKVFHMEF---DGSLESFHAECKVMGSI-RHRNLVK 821
           +++G GS+  V    L     I A +V   E    D  ++    E  V      H  LV 
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117

Query: 822 IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMI-DVASALEYLHFGYST 880
           + S          V+EY++ G L   +          +  +    +++ AL YLH     
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP--EEHARFYSAEISLALNYLH---ER 172

Query: 881 PIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQ---TKTL-GTIGYMAPEYG 934
            I++ D+K  NVLL+    GH  L+D+G+ K     E +R    T T  GT  Y+APE  
Sbjct: 173 GIIYRDLKLDNVLLDSE--GHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAPEIL 225

Query: 935 REGKVSRKCDVYSYGIMLME 954
           R        D ++ G+++ E
Sbjct: 226 RGEDYGFSVDWWALGVLMFE 245

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 73.2 bits (180), Expect = 7e-14
 Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 23/203 (11%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRH-RNLVKIIS 824
           K +G G+FG +  G  L     +A K+  M+        H E +    +     + ++  
Sbjct: 15  KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP--QLHLEYRFYKQLGSGDGIPQVYY 72

Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                 + A+VLE +   SLE      +    +   L I I + S +EY+H   S  +++
Sbjct: 73  FGPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIY 128

Query: 885 CDIKPSNVLL-----NESMVGHLSDFGIAKI-----LGKEESMRQTKTL-GTIGYM--AP 931
            D+KP N L+         V H+ DF +AK        K    R+ K+L GT  YM    
Sbjct: 129 RDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINT 188

Query: 932 EYGREGKVSRKCDVYSYGIMLME 954
             G+E   SR+ D+ + G M M 
Sbjct: 189 HLGKEQ--SRRDDLEALGHMFMY 209

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 74.0 bits (182), Expect = 7e-14
 Identities = 66/227 (29%), Positives = 101/227 (44%), Gaps = 42/227 (18%)

Query: 763 FSENKLLGMGSFGSVYKGVLPDGMEIAA--KVF-HMEFDGSLESFHAECKVMGSIRHRNL 819
           +++ K++G GSFG VY+  L D  E+ A  KV     F         E ++M  + H N+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNI 109

Query: 820 VK----IISSCSNNDFKAL--VLEYMSNGSLEKCLYSDNYFLDILQRLKI---MIDVASA 870
           V+      SS    D   L  VL+Y+   ++ +     +     L  + +   M  +  +
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168

Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYM 929
           L Y+H   S  I H DIKP N+LL+ ++ V  L DFG AK L + E       + +  Y 
Sbjct: 169 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRYYR 223

Query: 930 APE-------YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGE 969
           APE       Y      +   DV+S G +L E     +P   IF G+
Sbjct: 224 APELIFGATDY------TSSIDVWSAGCVLAELLL-GQP---IFPGD 260

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 72.6 bits (179), Expect = 7e-14
 Identities = 57/294 (19%), Positives = 99/294 (33%), Gaps = 54/294 (18%)

Query: 769  LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVKIISS 825
            +G GS+G V+K      G  +A K F    D  +    A  E +++  ++H NLV ++  
Sbjct: 11   IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 826  CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
                    LV EY  + ++   L      +       I      A+ + H       +H 
Sbjct: 71   FRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHR 126

Query: 886  DIKPSNVLLNESMVGHLSDFGIAKILG-KEESMRQTKTLGTIGYMAPE-------YGREG 937
            D+KP N+L+ +  V  L DFG A++L    +       + T  Y +PE       YG   
Sbjct: 127  DVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVATRWYRSPELLVGDTQYGPP- 183

Query: 938  KVSRKCDVYSYGIMLMETFTKK--------------------KPTDEIFAGEMSLKRWVG 977
                  DV++ G +  E  +                                 + + + G
Sbjct: 184  -----VDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238

Query: 978  DSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKD 1031
              +      E  +    N         + C      L MD     P +R++ + 
Sbjct: 239  VKIPDPEDMEPLELKFPNISYPALGLLKGC------LHMD-----PTERLTCEQ 281

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 72.4 bits (178), Expect = 8e-14
 Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 21/201 (10%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRH-RNLVKIIS 824
           + +G GSFG +Y G  +  G E+A K+  ++        H E K+   ++    +  I  
Sbjct: 15  RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQGGVGIPTIRW 72

Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
             +  D+  +V+E +   SLE      +    +   L +   + S +EY+H   S   +H
Sbjct: 73  CGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIH 128

Query: 885 CDIKPSNVLL---NESMVGHLSDFGIAK-----ILGKEESMRQTKTL-GTIGYM--APEY 933
            D+KP N L+    +  + ++ DFG+AK        +    R+ K L GT  Y       
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 188

Query: 934 GREGKVSRKCDVYSYGIMLME 954
           G E   SR+ D+ S G +LM 
Sbjct: 189 GIEQ--SRRDDLESLGYVLMY 207

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 36/136 (26%), Positives = 57/136 (41%), Gaps = 4/136 (2%)

Query: 419 NFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPV-TLGRLQKLQGLYL 477
           N   ++  + +E   I    P        L  I L NN+++  +       L+ L  L L
Sbjct: 29  NLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVL 87

Query: 478 QNNKLEGSIPEDL-CHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPS 536
             NK+   +P+ L   L+ L  L L  NK++        +L +L  LSL  N L +I   
Sbjct: 88  YGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKG 146

Query: 537 TLWNLKDILRFNLSSN 552
           T   L+ I   +L+ N
Sbjct: 147 TFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 63.1 bits (154), Expect = 3e-11
 Identities = 32/135 (23%), Positives = 61/135 (45%), Gaps = 8/135 (5%)

Query: 518 TSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDI----GNLKVVIEMDL 573
            ++ ++ L  N +  I P      K + R +LS+N ++  L PD      +L     + L
Sbjct: 32  ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLN---SLVL 87

Query: 574 SLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKS 633
             N ++ +      GL  LQLL L  N++     ++F  L +LN + + +N L      +
Sbjct: 88  YGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGT 147

Query: 634 MEALSYLKHLNLSFN 648
              L  ++ ++L+ N
Sbjct: 148 FSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 29/142 (20%), Positives = 60/142 (42%), Gaps = 9/142 (6%)

Query: 238 GIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFN-IST 296
            +P       ++  + L  N++    P      + L  + + ++ ++ L     F  + +
Sbjct: 29  NLP------ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISEL-APDAFQGLRS 81

Query: 297 LKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSF 356
           L  L +  N +   LP S+  GL +L+ L L  N  +     +  ++  L++L    N  
Sbjct: 82  LNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKL 140

Query: 357 SGLIPTTFGNLRSLKLLSLAGN 378
             +   TF  LR+++ + LA N
Sbjct: 141 QTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 57.4 bits (139), Expect = 4e-09
 Identities = 39/174 (22%), Positives = 70/174 (40%), Gaps = 41/174 (23%)

Query: 161 IPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLW 220
           +PETI       E+ L  N +   IP   F          L  + +S NQ++        
Sbjct: 30  LPETI------TEIRLEQNTIK-VIPPGAF-----SPYKKLRRIDLSNNQIS-------- 69

Query: 221 KCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEI-GNLRNLEVLGVQ 279
                    LA + FQG        L S+ +L L  N +  E+P  +   L +L++L + 
Sbjct: 70  --------ELAPDAFQG--------LRSLNSLVLYGNKI-TELPKSLFEGLFSLQLLLLN 112

Query: 280 SSNLAGLIPASIF-NISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNF 332
           ++ +   +    F ++  L  L++ DN L  ++       L  ++ + L +N F
Sbjct: 113 ANKINC-LRVDAFQDLHNLNLLSLYDNKL-QTIAKGTFSPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 29/135 (21%), Positives = 58/135 (42%), Gaps = 14/135 (10%)

Query: 127 DFRFNNFHIEIPSW-FVSLPRLQHLLLKHNSFVGKIPETI-GYLSLLQELDLSDNQLSGT 184
               N     IP   F    +L+ + L +N  + ++       L  L  L L  N+++  
Sbjct: 38  RLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQ-ISELAPDAFQGLRSLNSLVLYGNKIT-E 94

Query: 185 IPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLW-KCRELHVVSLAFNKFQGGIPRDI 243
           +P S+F     + L  L+ L ++ N++   +  + +     L+++SL  NK Q  I +  
Sbjct: 95  LPKSLF-----EGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQ-TIAKGT 147

Query: 244 -GNLTSVRNLFLGNN 257
              L +++ + L  N
Sbjct: 148 FSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 54.3 bits (131), Expect = 4e-08
 Identities = 33/133 (24%), Positives = 57/133 (42%), Gaps = 14/133 (10%)

Query: 148 QHLLLKHNSFVGKIPETI-GYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFI 206
             + L+ N+    IP         L+ +DLS+NQ+S  +    F     Q L  L  L +
Sbjct: 35  TEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAF-----QGLRSLNSLVL 87

Query: 207 SYNQLTGPIPTNLW-KCRELHVVSLAFNKFQGGIPRDI-GNLTSVRNLFLGNNSLIGEIP 264
             N++T  +P +L+     L ++ L  NK    +  D   +L ++  L L +N L   I 
Sbjct: 88  YGNKITE-LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL-QTIA 144

Query: 265 NEI-GNLRNLEVL 276
                 LR ++ +
Sbjct: 145 KGTFSPLRAIQTM 157

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 25/92 (27%), Positives = 47/92 (51%), Gaps = 4/92 (4%)

Query: 570 EMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGT 629
           E+ L  N +  + P      + L+ + L  N++    P++F GL+SLN + +  N ++  
Sbjct: 36  EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-E 94

Query: 630 IPKSM-EALSYLKHLNLSFNQLEGEIPTRGPF 660
           +PKS+ E L  L+ L L+ N++   +     F
Sbjct: 95  LPKSLFEGLFSLQLLLLNANKIN-CLR-VDAF 124

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 72.3 bits (178), Expect = 1e-13
 Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 36/203 (17%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFH---MEFDGSLESFHAECKVMGSIRHRNLVKI 822
           + LG GSFG V          ++A K      ++          E   +  +RH +++K+
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVA--------SALEYL 874
               +      +V+EY + G L         F  I+++ ++  D           A+EY 
Sbjct: 75  YDVITTPTDIVMVIEY-AGGEL---------FDYIVEKKRMTEDEGRRFFQQIICAIEYC 124

Query: 875 HFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL----GTIGYMA 930
           H      IVH D+KP N+LL++++   ++DFG++ I      M     L    G+  Y A
Sbjct: 125 H---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI------MTDGNFLKTSCGSPNYAA 175

Query: 931 PE-YGREGKVSRKCDVYSYGIML 952
           PE    +     + DV+S GI+L
Sbjct: 176 PEVINGKLYAGPEVDVWSCGIVL 198

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 29/115 (25%), Positives = 50/115 (43%), Gaps = 6/115 (5%)

Query: 444 NINNLTVIRLGNNELTGTIPV-TLGRLQKLQGLYLQNNKLEGSIPEDLC-HLYRLANLYL 501
            +  L  I   NN++T  I          +  + L +N+LE ++   +   L  L  L L
Sbjct: 55  KLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLML 112

Query: 502 GDNKLSGRLPA-CLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLN 555
             N+++  +       L+S+R LSL  N +T++ P     L  +   NL +N  N
Sbjct: 113 RSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 59.3 bits (144), Expect = 7e-10
 Identities = 34/155 (21%), Positives = 57/155 (36%), Gaps = 27/155 (17%)

Query: 498 NLYLGDNKLSGRLP-ACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNG 556
            L L +N+ +          L  LR ++  +N +T I          +    L+SN L  
Sbjct: 36  ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRL-- 93

Query: 557 SLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSL 616
             +                     +      GL+ L+ L LR NR+     +SF GL S+
Sbjct: 94  ENVQ------------------HKMF----KGLESLKTLMLRSNRITCVGNDSFIGLSSV 131

Query: 617 NFVDMSNNNLSGTIPKSM-EALSYLKHLNLSFNQL 650
             + + +N ++ T+     + L  L  LNL  N  
Sbjct: 132 RLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 58.9 bits (143), Expect = 9e-10
 Identities = 39/174 (22%), Positives = 62/174 (35%), Gaps = 35/174 (20%)

Query: 239 IPRDIGNLTSVRNLFLGNNSLIGEIPNEI-GNLRNLEVLGVQSSNLAGLIPASIFN-IST 296
           IP  I        L L NN         I   L  L  +   ++ +  +     F   S 
Sbjct: 26  IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDI-EEGAFEGASG 82

Query: 297 LKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSF 356
           + E+ +T N  L ++   +  GL +L+ L L  N  +  +                    
Sbjct: 83  VNEILLTSN-RLENVQHKMFKGLESLKTLMLRSNRIT-CVG------------------- 121

Query: 357 SGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPIN 410
                 +F  L S++LLSL  N +T+     +F  +L S   L  + L  NP N
Sbjct: 122 ----NDSFIGLSSVRLLSLYDNQITT-VAPGAF-DTLHS---LSTLNLLANPFN 166

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 56.6 bits (137), Expect = 6e-09
 Identities = 29/135 (21%), Positives = 55/135 (40%), Gaps = 13/135 (9%)

Query: 127 DFRFNNF-HIEIPSWFVSLPRLQHLLLKHNSFVGKIPETI-GYLSLLQELDLSDNQLSGT 184
               N F  +E    F  LP+L+ +   +N  +  I E      S + E+ L+ N+L   
Sbjct: 38  RLNNNEFTVLEATGIFKKLPQLRKINFSNNK-ITDIEEGAFEGASGVNEILLTSNRLE-N 95

Query: 185 IPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLW-KCRELHVVSLAFNKFQGGIPRDI 243
           +   +F     + L  L+ L +  N++T  +  + +     + ++SL  N+    +    
Sbjct: 96  VQHKMF-----KGLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLSLYDNQIT-TVAPGA 148

Query: 244 -GNLTSVRNLFLGNN 257
              L S+  L L  N
Sbjct: 149 FDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 30/131 (22%), Positives = 57/131 (43%), Gaps = 16/131 (12%)

Query: 527 SNALTSI---IPSTLWNLKDILRFNLSSNSLNGSLLPDIG---NLKVVIEMDLSLNALSG 580
           +  L  I   IP     L       L++N    ++L   G    L  + +++ S N ++ 
Sbjct: 20  NQKLNKIPEHIPQYTAEL------RLNNNEF--TVLEATGIFKKLPQLRKINFSNNKITD 71

Query: 581 VIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSM-EALSY 639
           +      G  G+  + L  NRL+    + F GL+SL  + + +N ++  +       LS 
Sbjct: 72  IEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSS 130

Query: 640 LKHLNLSFNQL 650
           ++ L+L  NQ+
Sbjct: 131 VRLLSLYDNQI 141

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 33/163 (20%), Positives = 68/163 (41%), Gaps = 34/163 (20%)

Query: 172 QELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLA 231
            EL L++N+ +    + IF     + LP L  +  S N++T                 + 
Sbjct: 35  AELRLNNNEFTVLEATGIF-----KKLPQLRKINFSNNKIT----------------DIE 73

Query: 232 FNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEI-GNLRNLEVLGVQSSNLAGLIPAS 290
              F+G         + V  + L +N L   + +++   L +L+ L ++S+ +  +    
Sbjct: 74  EGAFEG--------ASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCV-GND 123

Query: 291 IF-NISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNF 332
            F  +S+++ L++ DN  + ++       L +L  L L  N F
Sbjct: 124 SFIGLSSVRLLSLYDNQ-ITTVAPGAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 34/143 (23%), Positives = 57/143 (39%), Gaps = 11/143 (7%)

Query: 287 IPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISEL 346
           IP  I       EL + +N+      + I   LP L ++    N  +     +    S +
Sbjct: 26  IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83

Query: 347 SVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSE 406
           + +    N    +    F  L SLK L L  N +T    + SF   L+   ++ ++ L +
Sbjct: 84  NEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITC-VGNDSF-IGLS---SVRLLSLYD 138

Query: 407 NPINGILPSSIGNFSISMKSLSM 429
           N I  + P   G F  ++ SLS 
Sbjct: 139 NQITTVAP---GAFD-TLHSLST 157

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 19/84 (22%), Positives = 38/84 (45%), Gaps = 3/84 (3%)

Query: 570 EMDLSLNALSGVIPVTI-GGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSG 628
           E+ L+ N  + +    I   L  L+ ++   N++      +F G   +N + +++N L  
Sbjct: 36  ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE- 94

Query: 629 TIPKSM-EALSYLKHLNLSFNQLE 651
            +   M + L  LK L L  N++ 
Sbjct: 95  NVQHKMFKGLESLKTLMLRSNRIT 118

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 41.9 bits (99), Expect = 5e-04
 Identities = 15/60 (25%), Positives = 24/60 (40%), Gaps = 1/60 (1%)

Query: 593 QLLSLRYNRLQG-PIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLE 651
             L L  N          F  L  L  ++ SNN ++     + E  S +  + L+ N+LE
Sbjct: 35  AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 72.3 bits (178), Expect = 2e-13
 Identities = 54/226 (23%), Positives = 96/226 (42%), Gaps = 43/226 (19%)

Query: 769 LGMGSFGSVYKGVLPDGMEIAA--KV-FHMEFDG----SLESFHAECKVMGSIRHRNLVK 821
           +G G+FG V+K       +  A  KV    E +G    +L     E K++  ++H N+V 
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKILQLLKHENVVN 80

Query: 822 ---IISSCSNNDFKA-----LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
              I  + ++   +      LV ++  +  L   L +      + +  ++M  + + L Y
Sbjct: 81  LIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 139

Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG---KEESMRQTKTLGTIGYMA 930
           +H      I+H D+K +NVL+    V  L+DFG+A+        +  R T  + T+ Y  
Sbjct: 140 IH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 196

Query: 931 PE-------YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGE 969
           PE       YG         D++  G ++ E +T + P   I  G 
Sbjct: 197 PELLLGERDYGPP------IDLWGAGCIMAEMWT-RSP---IMQGN 232

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 71.9 bits (177), Expect = 2e-13
 Identities = 67/294 (22%), Positives = 106/294 (36%), Gaps = 54/294 (18%)

Query: 769  LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVKIISS 825
            +G GS+G V K      G  +A K F    D  +    A  E K++  +RH NLV ++  
Sbjct: 33   VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92

Query: 826  CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
            C       LV E++ + ++   L      LD     K +  + + + + H   S  I+H 
Sbjct: 93   CKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHR 148

Query: 886  DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ-TKTLGTIGYMAPE-------YGREG 937
            DIKP N+L+++S V  L DFG A+ L            + T  Y APE       YG+  
Sbjct: 149  DIKPENILVSQSGVVKLCDFGFARTLAAP--GEVYDDEVATRWYRAPELLVGDVKYGKA- 205

Query: 938  KVSRKCDVYSYGIMLMETFTKK--------------------KPTDEIFAGEMSLKRWVG 977
                  DV++ G ++ E F  +                                   + G
Sbjct: 206  -----VDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260

Query: 978  DSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKD 1031
              L      E  +       E      ++C      L +D     P+KR    +
Sbjct: 261  VRLPEIKEREPLERRYPKLSEVVIDLAKKC------LHID-----PDKRPFCAE 303

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 71.4 bits (176), Expect = 2e-13
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 20/208 (9%)

Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHA----ECKVMGSIRHRNLVKIIS 824
           +G G++G VYK     G  +A K   ++ +   E   +    E  ++  + H N+V +I 
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAED--EGIPSTAIREISLLKELHHPNIVSLID 86

Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
              +     LV E+M    L+K L  +   L   Q    +  +   + + H      I+H
Sbjct: 87  VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILH 142

Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ-TKTLGTIGYMAPE--YGREGKVSR 941
            D+KP N+L+N      L+DFG+A+  G    +R  T  + T+ Y AP+   G + K S 
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIP--VRSYTHEVVTLWYRAPDVLMGSK-KYST 199

Query: 942 KCDVYSYGIMLMETFTKKKPTDEIFAGE 969
             D++S G +  E  T  KP   +F G 
Sbjct: 200 SVDIWSIGCIFAEMIT-GKP---LFPGV 223

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 46/204 (22%), Positives = 81/204 (39%), Gaps = 25/204 (12%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRH-RNLVKIIS 824
           + +G GSFG +++G  L +  ++A K      D        E +    +     +  +  
Sbjct: 16  RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP--QLRDEYRTYKLLAGCTGIPNVYY 73

Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                    LV++ +   SLE  L        +         + + ++ +H      +V+
Sbjct: 74  FGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVY 129

Query: 885 CDIKPSNVLL------NESMVGHLSDFGIAKI-----LGKEESMRQTKTL-GTIGYM--A 930
            DIKP N L+      N +M+ ++ DFG+ K        +    R+ K L GT  YM   
Sbjct: 130 RDIKPDNFLIGRPNSKNANMI-YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 188

Query: 931 PEYGREGKVSRKCDVYSYGIMLME 954
              GRE   SR+ D+ + G + M 
Sbjct: 189 THLGREQ--SRRDDLEALGHVFMY 210

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 71.1 bits (174), Expect = 4e-13
 Identities = 35/146 (23%), Positives = 62/146 (42%), Gaps = 4/146 (2%)

Query: 813 SIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALE 872
            ++ R      S  S +               E        FL +   +     VA  +E
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207

Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK-ILGKEESMRQTKTLGTIGYMAP 931
           +L    S   +H D+   N+LL+E  V  + DFG+A+ I    + +R+      + +MAP
Sbjct: 208 FLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 264

Query: 932 EYGREGKVSRKCDVYSYGIMLMETFT 957
           E   +   + + DV+S+G++L E F+
Sbjct: 265 ETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 51.5 bits (123), Expect = 9e-07
 Identities = 21/87 (24%), Positives = 38/87 (43%), Gaps = 9/87 (10%)

Query: 767 KLLGMGSFGSVYKGVL------PDGMEIAAKVFHMEFDGS-LESFHAECKVMGSI-RHRN 818
           K LG G+FG V +              +A K+       S   +  +E K++  I  H N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 819 LVKIISSCSNNDFKALV-LEYMSNGSL 844
           +V ++ +C+      +V +E+   G+L
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNL 114

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 71.9 bits (177), Expect = 4e-13
 Identities = 70/400 (17%), Positives = 131/400 (32%), Gaps = 87/400 (21%)

Query: 295 STLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGT----IPSSLTNISELSVLD 350
             ++ L +   +L  +  + +   L   + + L +   +      I S+L     L+ L+
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 351 FGFNSFSG-----LIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSS-LTSCRNLEIIYL 404
              N         ++         ++ LSL    LT        LSS L +   L+ ++L
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA--GCGVLSSTLRTLPTLQELHL 120

Query: 405 SENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGT--- 461
           S+N         +G+  + +    +                  L  ++L    L+     
Sbjct: 121 SDN--------LLGDAGLQLLCEGLLDPQ------------CRLEKLQLEYCSLSAASCE 160

Query: 462 -IPVTLGRLQKLQGLYLQNNKLEGSIPEDLC-----HLYRLANLYLGDNKLSGR----LP 511
            +   L      + L + NN +  +    LC        +L  L L    ++      L 
Sbjct: 161 PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLC 220

Query: 512 ACLGNLTSLRDLSLGSNALT-----SIIPSTLWNLKDILRFNLSSNSLN----GSLLPDI 562
             + +  SLR+L+LGSN L       + P  L     +    +    +     G L   +
Sbjct: 221 GIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVL 280

Query: 563 GNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLS--LRYNRLQGPIPESFGGLKSLNFVD 620
              + + E+ L+ N L         G +G +LL   L     Q         L+SL    
Sbjct: 281 RAKESLKELSLAGNEL---------GDEGARLLCETLLEPGCQ---------LESL---W 319

Query: 621 MSNNNLSGTIPKSMEALSY-------LKHLNLSFNQLEGE 653
           + + + +          S        L  L +S N+LE  
Sbjct: 320 VKSCSFT---AACCSHFSSVLAQNRFLLELQISNNRLEDA 356

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 70.8 bits (174), Expect = 9e-13
 Identities = 87/465 (18%), Positives = 164/465 (35%), Gaps = 83/465 (17%)

Query: 247 TSVRNLFLGNNSLIGEIPNEIG-NLRNLEVLGVQSSNL----AGLIPASIFNISTLKELA 301
             +++L +    L      E+   L+  +V+ +    L       I +++     L EL 
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 302 VTDNDLLGSLPSSIDLGL----PNLERLFLGENNFSGT----IPSSLTNISELSVLDFGF 353
           +  N+L       +  GL      +++L L     +G     + S+L  +  L  L    
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122

Query: 354 NSFSG-----LIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSS-LTSCRNLEIIYLSEN 407
           N         L          L+ L L    L++       L+S L +  + + + +S N
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAA--SCEPLASVLRAKPDFKELTVSNN 180

Query: 408 PING----ILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIP 463
            IN     +L   + +    +++L +ESC ++    ++L  I                  
Sbjct: 181 DINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI------------------ 222

Query: 464 VTLGRLQKLQGLYLQNNKLEGSIPEDLC-----HLYRLANLYLGDNKLSGR----LPACL 514
             +     L+ L L +NKL      +LC        RL  L++ +  ++ +    L   L
Sbjct: 223 --VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVL 280

Query: 515 GNLTSLRDLSLGSNALT-----SIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNL---- 565
               SL++LSL  N L       +  + L     +    + S S   +      ++    
Sbjct: 281 RAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQN 340

Query: 566 KVVIEMDLSLNAL--SGVIPVTIGGLQG---LQLLSLRYNRLQ----GPIPESFGGLKSL 616
           + ++E+ +S N L  +GV  +  G  Q    L++L L    +       +  +     SL
Sbjct: 341 RFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSL 400

Query: 617 NFVDMSNNNLSGTIPKSMEALS--------YLKHLNLSFNQLEGE 653
             +D+SNN L       +  L          L+ L L       E
Sbjct: 401 RELDLSNNCLG---DAGILQLVESVRQPGCLLEQLVLYDIYWSEE 442

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 64.2 bits (157), Expect = 1e-10
 Identities = 79/433 (18%), Positives = 151/433 (34%), Gaps = 76/433 (17%)

Query: 171 LQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSL 230
           +Q LD+   +LS    + +        L   + + +    LT           E     +
Sbjct: 5   IQSLDIQCEELSDARWAEL-----LPLLQQCQVVRLDDCGLT-----------EARCKDI 48

Query: 231 AFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNL-----RNLEVLGVQSSNL-- 283
           +           +    ++  L L +N L     + +          ++ L +Q+  L  
Sbjct: 49  SSA---------LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTG 99

Query: 284 --AGLIPASIFNISTLKELAVTDNDL----LGSLPSSIDLGLPNLERLFLGENNFSGT-- 335
              G++ +++  + TL+EL ++DN L    L  L   +      LE+L L   + S    
Sbjct: 100 AGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASC 159

Query: 336 --IPSSLTNISELSVLDFGFNSFSG-----LIPTTFGNLRSLKLLSLAGNVLTSPTPDLS 388
             + S L    +   L    N  +      L      +   L+ L L    +TS   +  
Sbjct: 160 EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTS--DNCR 217

Query: 389 FLSS-LTSCRNLEIIYLSENPINGI----LPSSIGNFSISMKSLSMESCNIS----GGIP 439
            L   + S  +L  + L  N +  +    L   + + S  +++L +  C I+    G + 
Sbjct: 218 DLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLC 277

Query: 440 KELGNINNLTVIRLGNNELTGTIPVTLGRL-----QKLQGLYLQNNKL--EG--SIPEDL 490
           + L    +L  + L  NEL       L         +L+ L++++              L
Sbjct: 278 RVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVL 337

Query: 491 CHLYRLANLYLGDNKLSG----RLPACLG-NLTSLRDLSLGSNALTSI----IPSTLWNL 541
                L  L + +N+L       L   LG   + LR L L    ++      + +TL   
Sbjct: 338 AQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLAN 397

Query: 542 KDILRFNLSSNSL 554
             +   +LS+N L
Sbjct: 398 HSLRELDLSNNCL 410

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 57.7 bits (140), Expect = 1e-08
 Identities = 48/265 (18%), Positives = 93/265 (35%), Gaps = 56/265 (21%)

Query: 421 SISMKSLSMESCNIS-GGIPKELGNINNLTVIRLGNNELTGT----IPVTLGRLQKLQGL 475
           S+ ++SL ++   +S     + L  +    V+RL +  LT      I   L     L  L
Sbjct: 2   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61

Query: 476 YLQNNKLEGSIPEDLCHL-----YRLANLYLGDNKLSGR----LPACLGNLTSLRDLSLG 526
            L++N+L       +         ++  L L +  L+G     L + L  L +L++L L 
Sbjct: 62  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121

Query: 527 SNALT-----SIIPSTLWNLKDILRFNLSSNSLNGSLLPDIG----NLKVVIEMDLSLNA 577
            N L       +    L     + +  L   SL+ +    +           E+ +S N 
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 181

Query: 578 LSGVIPVTIGGLQGLQLLS--LRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSME 635
           +            G+++L   L+ +  Q         L++L    + +  ++     +  
Sbjct: 182 I---------NEAGVRVLCQGLKDSPCQ---------LEALK---LESCGVT---SDNCR 217

Query: 636 ALSY-------LKHLNLSFNQLEGE 653
            L         L+ L L  N+L   
Sbjct: 218 DLCGIVASKASLRELALGSNKLGDV 242

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 71.0 bits (174), Expect = 7e-13
 Identities = 37/184 (20%), Positives = 77/184 (41%), Gaps = 13/184 (7%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVK-- 821
            L+G GS+G V +     +   +A K     F+  ++      E  ++  + H ++VK  
Sbjct: 59  HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL 118

Query: 822 -IISSCSNNDFKA--LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
            I+       F    +VLE   +   +K   +  Y  ++  +  ++ ++   ++Y+H   
Sbjct: 119 DIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVH--- 173

Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGK 938
           S  I+H D+KP+N L+N+     + DFG+A+ +   E+      +               
Sbjct: 174 SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHT 233

Query: 939 VSRK 942
            + K
Sbjct: 234 KNLK 237

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 70.3 bits (172), Expect = 1e-12
 Identities = 50/215 (23%), Positives = 88/215 (40%), Gaps = 30/215 (13%)

Query: 760 TDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRH 816
              +   K +G G+ G V           +A K     F     +  A  E  +M  + H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120

Query: 817 RNLVKII----SSCSNNDFKA--LVLEYMSNGSLEKCLYSD------NYFLDILQRLKIM 864
           +N++ ++       +  +F+   LV+E M + +L + +  +      +Y L   Q L   
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLL--YQMLC-- 175

Query: 865 IDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLG 924
                 +++LH   S  I+H D+KPSN+++       + DFG+A+  G    M  T  + 
Sbjct: 176 -----GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVV 225

Query: 925 TIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKK 959
           T  Y APE           D++S G ++ E    K
Sbjct: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 68.7 bits (169), Expect = 1e-12
 Identities = 51/213 (23%), Positives = 91/213 (42%), Gaps = 30/213 (14%)

Query: 769 LGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHA----ECKVMGSIRHRNLVKIIS 824
           +G G++G VYK     G   A K   +E +   E   +    E  ++  ++H N+VK+  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKED--EGIPSTTIREISILKELKHSNIVKLYD 67

Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                    LV E++    L+K L      L+ +     ++ + + + Y H      ++H
Sbjct: 68  VIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123

Query: 885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ-TKTLGTIGYMAPE-------YGRE 936
            D+KP N+L+N      ++DFG+A+  G    +R+ T  + T+ Y AP+       Y   
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTLWYRAPDVLMGSKKYSTT 181

Query: 937 GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGE 969
                  D++S G +  E      P   +F G 
Sbjct: 182 ------IDIWSVGCIFAEMVN-GTP---LFPGV 204

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 69.3 bits (170), Expect = 2e-12
 Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 34/210 (16%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVKI- 822
             +G G++GSV        G+ +A K     F   + +     E +++  ++H N++ + 
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94

Query: 823 ---ISSCSNNDFKA--LVLEYMSNGSLEKCLYSDN-------YFLDILQRLKIMIDVASA 870
                + S  +F    LV   M    L   +           +   I Q L+        
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL--IYQILR-------G 144

Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMA 930
           L+Y+H   S  I+H D+KPSN+ +NE     + DFG+A+     + M  T  + T  Y A
Sbjct: 145 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEM--TGYVATRWYRA 197

Query: 931 PE-YGREGKVSRKCDVYSYGIMLMETFTKK 959
           PE        ++  D++S G ++ E  T +
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 68.0 bits (167), Expect = 3e-12
 Identities = 49/209 (23%), Positives = 87/209 (41%), Gaps = 22/209 (10%)

Query: 769 LGMGSFGSVYKGVLPDGMEIAA-KVFHMEFDGSLESFHA----ECKVMGSIRHRNLVKII 823
           LG G++ +VYKG       + A K   +E +   E        E  ++  ++H N+V + 
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLH 66

Query: 824 SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIV 883
                     LV EY+    L++ L      +++      +  +   L Y H      ++
Sbjct: 67  DIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVL 122

Query: 884 HCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ-TKTLGTIGYMAPE--YGREGKVS 940
           H D+KP N+L+NE     L+DFG+A+        +     + T+ Y  P+   G     S
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLARAKSIP--TKTYDNEVVTLWYRPPDILLGST-DYS 179

Query: 941 RKCDVYSYGIMLMETFTKKKPTDEIFAGE 969
            + D++  G +  E  T  +P   +F G 
Sbjct: 180 TQIDMWGVGCIFYEMAT-GRP---LFPGS 204

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 66.3 bits (162), Expect = 4e-12
 Identities = 53/185 (28%), Positives = 76/185 (41%), Gaps = 29/185 (15%)

Query: 238 GIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFN-IST 296
           GIP D         L L +  L          L  L  L +  + L  L  A +F+ ++ 
Sbjct: 32  GIPAD------TEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTL-SAGVFDDLTE 84

Query: 297 LKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPS----SLTNISELSVLDFG 352
           L  L + +N  L SLP  +   L  L++L+LG N    ++PS     LT    L  L   
Sbjct: 85  LGTLGLANNQ-LASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTK---LKELRLN 139

Query: 353 FNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSF--LSSLTS---------CRNLEI 401
            N    +    F  L +L+ LSL+ N L S  P  +F  L  L +         C   EI
Sbjct: 140 TNQLQSIPAGAFDKLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLFGNQFDCSRCEI 198

Query: 402 IYLSE 406
           +YLS+
Sbjct: 199 LYLSQ 203

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 53/225 (23%), Positives = 76/225 (33%), Gaps = 65/225 (28%)

Query: 308 LGSLPSSIDLGLP-NLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGN 366
           L S+PS I    P + E+L L     +    ++   +++L+ L+  +N    L    F +
Sbjct: 26  LDSVPSGI----PADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDD 81

Query: 367 LRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKS 426
           L  L  L LA N L S                              LP            
Sbjct: 82  LTELGTLGLANNQLAS------------------------------LPL----------- 100

Query: 427 LSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSI 486
                     G+   L     L  + LG N+L         RL KL+ L L  N+L+ SI
Sbjct: 101 ----------GVFDHL---TQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SI 146

Query: 487 PE---DLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSN 528
           P    D   L  L  L L  N+L          L  L+ ++L  N
Sbjct: 147 PAGAFD--KLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 45/158 (28%), Positives = 63/158 (39%), Gaps = 12/158 (7%)

Query: 473 QGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPA-CLGNLTSLRDLSLGSNALT 531
           + L LQ+  L          L +L  L L  N+L   L A    +LT L  L L +N L 
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96

Query: 532 SIIPSTLWNLKDILRFNLSSNSLNGSLLPD-----IGNLKVVIEMDLSLNALSGVIPVTI 586
           S+      +L  + +  L  N L    LP      +  LK   E+ L+ N L  +     
Sbjct: 97  SLPLGVFDHLTQLDKLYLGGNQLKS--LPSGVFDRLTKLK---ELRLNTNQLQSIPAGAF 151

Query: 587 GGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNN 624
             L  LQ LSL  N+LQ     +F  L  L  + +  N
Sbjct: 152 DKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 41/154 (26%), Positives = 65/154 (42%), Gaps = 4/154 (2%)

Query: 498 NLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGS 557
            L L    L+    A    LT L  L+L  N L ++      +L ++    L++N L  S
Sbjct: 39  KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-S 97

Query: 558 LLPDI-GNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPES-FGGLKS 615
           L   +  +L  + ++ L  N L  +       L  L+ L L  N+LQ  IP   F  L +
Sbjct: 98  LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTN 156

Query: 616 LNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQ 649
           L  + +S N L      + + L  L+ + L  NQ
Sbjct: 157 LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQ 190

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 41/164 (25%), Positives = 71/164 (43%), Gaps = 18/164 (10%)

Query: 148 QHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFIS 207
           + L L+          T   L+ L  L+L  NQL  T+ + +F      +L  L  L ++
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVF-----DDLTELGTLGLA 91

Query: 208 YNQLTG-P--IPTNLWKCRELHVVSLAFNKFQGGIPRDI-GNLTSVRNLFLGNNSLIGEI 263
            NQL   P  +  +L +  +L+   L  N+ +  +P  +   LT ++ L L  N L   I
Sbjct: 92  NNQLASLPLGVFDHLTQLDKLY---LGGNQLK-SLPSGVFDRLTKLKELRLNTNQL-QSI 146

Query: 264 PNEI-GNLRNLEVLGVQSSNLAGLIPASIF-NISTLKELAVTDN 305
           P      L NL+ L + ++ L   +P   F  +  L+ + +  N
Sbjct: 147 PAGAFDKLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 47/159 (29%), Positives = 65/159 (40%), Gaps = 18/159 (11%)

Query: 274 EVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFS 333
           E L +QS+ LA L  A+   ++ L  L +  N L  +L + +   L  L  L L  N  +
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA 96

Query: 334 GTIPS----SLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSF 389
            ++P      LT    L  L  G N    L    F  L  LK L L  N L S  P  +F
Sbjct: 97  -SLPLGVFDHLTQ---LDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQS-IPAGAF 151

Query: 390 LSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLS 428
              LT   NL+ + LS N +  +     G F   +  L 
Sbjct: 152 -DKLT---NLQTLSLSTNQLQSV---PHGAFD-RLGKLQ 182

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 44.7 bits (106), Expect = 7e-05
 Identities = 31/127 (24%), Positives = 45/127 (35%), Gaps = 9/127 (7%)

Query: 527 SNALTSI---IPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIP 583
             +L S+   IP+    L       L S  L          L  +  ++L  N L  +  
Sbjct: 23  GKSLDSVPSGIPADTEKLD------LQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA 76

Query: 584 VTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHL 643
                L  L  L L  N+L       F  L  L+ + +  N L        + L+ LK L
Sbjct: 77  GVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKEL 136

Query: 644 NLSFNQL 650
            L+ NQL
Sbjct: 137 RLNTNQL 143

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 67.6 bits (166), Expect = 4e-12
 Identities = 43/164 (26%), Positives = 76/164 (46%), Gaps = 10/164 (6%)

Query: 755 DLLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHME-FDGSLESFHA----EC 808
           D+      + +   LG G F +VYK         +A K   +     + +  +     E 
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query: 809 KVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVA 868
           K++  + H N++ ++ +  +    +LV ++M    LE  +  ++  L        M+   
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL 122

Query: 869 SALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG 912
             LEYLH      I+H D+KP+N+LL+E+ V  L+DFG+AK  G
Sbjct: 123 QGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 67.7 bits (166), Expect = 5e-12
 Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 33/216 (15%)

Query: 760 TDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRH 816
              +     +G G++GSV   +    G ++A K     F   + +  A  E  ++  ++H
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82

Query: 817 RNLVKI----ISSCSNNDFKA--LVLEYMSNGSLEKCLYSD------NYFLDILQRLKIM 864
            N++ +      + S  +F    LV+ +M    L+K +          Y   + Q LK  
Sbjct: 83  ENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKFSEEKIQYL--VYQMLK-- 137

Query: 865 IDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLG 924
                 L+Y+H   S  +VH D+KP N+ +NE     + DFG+A+    +  M  T  + 
Sbjct: 138 -----GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEM--TGYVV 185

Query: 925 TIGYMAPE-YGREGKVSRKCDVYSYGIMLMETFTKK 959
           T  Y APE        ++  D++S G ++ E  T K
Sbjct: 186 TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 67.4 bits (165), Expect = 6e-12
 Identities = 50/221 (22%), Positives = 85/221 (38%), Gaps = 44/221 (19%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKI- 822
           K +G G FG +Y         + A  V  +E+   G L S   E K    +  ++ +K  
Sbjct: 43  KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS---ELKFYQRVAKKDCIKKW 99

Query: 823 ------------------ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIM 864
                             ++      ++ +V+E +    L+K +   N        L++ 
Sbjct: 100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQK-ISGQNGTFKKSTVLQLG 157

Query: 865 IDVASALEYLHFGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKI-----LGKEES 916
           I +   LEY+H       VH DIK +N+LL   N   V +L+D+G++         K+  
Sbjct: 158 IRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSYRYCPNGNHKQYQ 213

Query: 917 MRQTKTL-GTIGYM--APEYGREGKVSRKCDVYSYGIMLME 954
               K   GTI +       G    +SR+ DV   G  ++ 
Sbjct: 214 ENPRKGHNGTIEFTSLDAHKGVA--LSRRSDVEILGYCMLR 252

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 68.1 bits (166), Expect = 6e-12
 Identities = 50/201 (24%), Positives = 87/201 (43%), Gaps = 21/201 (10%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLV-KIIS 824
           + +G GSFG +Y G  +    E+A K+ +++          E K+   ++    +  +  
Sbjct: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP--QLLYESKIYRILQGGTGIPNVRW 70

Query: 825 SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                D+  LV++ +   SLE      +  L +   L +   + + +E++H   S   +H
Sbjct: 71  FGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLH 126

Query: 885 CDIKPSNVLL---NESMVGHLSDFGIAK-----ILGKEESMRQTKTL-GTIGYM--APEY 933
            DIKP N L+     +   ++ DFG+AK        +    R+ K L GT  Y       
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHL 186

Query: 934 GREGKVSRKCDVYSYGIMLME 954
           G E   SR+ D+ S G +LM 
Sbjct: 187 GIEQ--SRRDDLESLGYVLMY 205

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 67.5 bits (165), Expect = 7e-12
 Identities = 49/246 (19%), Positives = 87/246 (35%), Gaps = 49/246 (19%)

Query: 754 QDLLRATDGFS-ENKLLGMGSFGSVYKGV---LPDGMEIAAKVFHMEFDGSLESFHAECK 809
            +  R  D F  E   +G G++G VYK       D  + A K    E  G   S   E  
Sbjct: 13  SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--EGTGISMSACREIA 70

Query: 810 VMGSIRHRNLVK---IISSCSNNDFKALVLEYMS-------NGSLEKCLYSDNYFLDILQ 859
           ++  ++H N++    +  S ++     L+ +Y                       L    
Sbjct: 71  LLRELKHPNVISLQKVFLSHADRKV-WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGM 129

Query: 860 RLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGH----LSDFGIAKILGKEE 915
              ++  +   + YLH   +  ++H D+KP+N+L+           ++D G A++     
Sbjct: 130 VKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN--- 183

Query: 916 SMRQTKTLG-----TIGYMAPE-------YGREGKVSRKCDVYSYGIMLMETFTKKKPTD 963
           S  +          T  Y APE       Y +        D+++ G +  E  T  +P  
Sbjct: 184 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKA------IDIWAIGCIFAELLT-SEP-- 234

Query: 964 EIFAGE 969
            IF   
Sbjct: 235 -IFHCR 239

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 66.5 bits (163), Expect = 1e-11
 Identities = 55/255 (21%), Positives = 104/255 (40%), Gaps = 48/255 (18%)

Query: 735 RPYYDANMY-PQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKV 792
           R Y D N + P+  W   S+       D +   + LG G +  V++ + + +  ++  K+
Sbjct: 9   RVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI 68

Query: 793 FHMEFDGSLESFHAECKVMGSIR-HRNLVKII----SSCSNNDFKALVLEYMSNGSLEKC 847
                    +    E K++ ++R   N++ +        S     ALV E+++N   ++ 
Sbjct: 69  LKPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTP--ALVFEHVNNTDFKQL 123

Query: 848 LY--SDN---YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN-ESMVGH 901
               +D    ++  + + LK       AL+Y H   S  I+H D+KP NV+++ E     
Sbjct: 124 YQTLTDYDIRFY--MYEILK-------ALDYCH---SMGIMHRDVKPHNVMIDHEHRKLR 171

Query: 902 LSDFGIAKILGKEESMRQTKTLGTIGYMAPE-------YGREGKVSRKCDVYSYGIMLME 954
           L D+G+A+     +       + +  +  PE       Y          D++S G ML  
Sbjct: 172 LIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMY------DYSLDMWSLGCMLAS 223

Query: 955 TFTKKKPTDEIFAGE 969
              +K+P    F G 
Sbjct: 224 MIFRKEP---FFHGH 235

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 66.7 bits (163), Expect = 1e-11
 Identities = 37/186 (19%), Positives = 71/186 (38%), Gaps = 25/186 (13%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVK-- 821
            L+G GS+G VY          +A K  +  F+  ++      E  ++  ++   +++  
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91

Query: 822 -IISSCSNNDFKA--LVLEYMSNGSLEKCLYSDNYFLD------ILQRLKIMIDVASALE 872
            +I       F    +VLE   +  L+K   +  +  +      +   L           
Sbjct: 92  DLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLL-------GEN 143

Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE 932
           ++H    + I+H D+KP+N LLN+     + DFG+A+ +  E+       L       P 
Sbjct: 144 FIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200

Query: 933 YGREGK 938
                K
Sbjct: 201 NKNLKK 206

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 67.6 bits (164), Expect = 2e-11
 Identities = 93/609 (15%), Positives = 175/609 (28%), Gaps = 189/609 (31%)

Query: 384 TPDLSFLSSLTSCRNLEIIYLSENPINGIL---------PSSI----------GNFSISM 424
             D     S+ S   ++ I +S++ ++G L            +           N+   M
Sbjct: 38  VQD--MPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLM 95

Query: 425 KSLSMESCNISGGIPKELGNINNLTVIRLGN-NELTGTIPVTLGRLQKLQGLYLQNNKLE 483
             +  E       + +      +    RL N N++     V+  RLQ    L      L 
Sbjct: 96  SPIKTE-QRQPSMMTRMYIEQRD----RLYNDNQVFAKYNVS--RLQPYLKL---RQALL 145

Query: 484 GSIPEDLCHLY--------RLANLYLGDNKLSGRLP---------------ACLGNLTSL 520
              P     +          +A       K+  ++                  L  L  L
Sbjct: 146 ELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL 205

Query: 521 R---DLSLGSNALTSI-IPSTLWNLKDILRFNLSSNSLNGSL--LPDIGNLKVVIEMDLS 574
               D +  S +  S  I   + +++  LR  L S      L  L ++ N K     +LS
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLS 265

Query: 575 ------------LNALSGVIPVTI------GGL---QGLQLLS---------LRYNRLQG 604
                        + LS      I        L   +   LL          L    L  
Sbjct: 266 CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT 325

Query: 605 -P-----IPESFGGLKSL--NFVDMSNNNLSGTIPKSMEALS--YLKHLNLSFNQL---- 650
            P     I ES     +   N+  ++ + L+  I  S+  L     + +   F++L    
Sbjct: 326 NPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM---FDRLSVFP 382

Query: 651 EG-EIPTRGPFITFSAESFLGNQALC--------GSPKLQVSPCKTRS----HPRSRTTV 697
               IPT                 L             + V+     S     P+  T  
Sbjct: 383 PSAHIPT---------------ILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTIS 427

Query: 698 VLLIVLPLVSALTMIVVLTAKLVRRRRRRRRRQKGSTRP-----YY---------DANMY 743
           +  I L L   L     L   +V      +        P     Y+         +    
Sbjct: 428 IPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHP 487

Query: 744 PQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVF-------HME 796
            + T  R+ + D       F E K+    +  +    +L    ++  K +         +
Sbjct: 488 ERMTLFRMVFLDF-----RFLEQKIRHDSTAWNASGSILNTLQQL--KFYKPYICDNDPK 540

Query: 797 FD---GSLESF--HAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSD 851
           ++    ++  F    E  ++ S ++ +L++I          AL+ E       ++ ++ +
Sbjct: 541 YERLVNAILDFLPKIEENLICS-KYTDLLRI----------ALMAE-------DEAIFEE 582

Query: 852 NYFLDILQR 860
            +    +QR
Sbjct: 583 AH--KQVQR 589

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 52.9 bits (126), Expect = 5e-07
 Identities = 76/481 (15%), Positives = 141/481 (29%), Gaps = 116/481 (24%)

Query: 27  NVTTDQFALLALKEHIKH-DPSNLL-------ANNWSTTSSVCSWIGVTCGVRNRRVTAL 78
           NV+  Q   L L++ +    P+  +       +        VC    V C   + ++  L
Sbjct: 130 NVSRLQ-PYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQC-KMDFKIFWL 187

Query: 79  NISYLGLTGTIPPQLGNLSFLAV--LAIRNNSF------FGSLPEELSHL-------RGL 123
           N+       T+   L  L +        R++          S+  EL  L         L
Sbjct: 188 NLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL 247

Query: 124 ------------KYFDF--------RFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPE 163
                         F+         RF        + F+S     H+ L H+S      E
Sbjct: 248 LVLLNVQNAKAWNAFNLSCKILLTTRFKQV-----TDFLSAATTTHISLDHHSMTLTPDE 302

Query: 164 TIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCR 223
               L    +    D      +P  +         P    + I+ +   G    + WK  
Sbjct: 303 VKSLLLKYLDCRPQD------LPREV-----LTTNPRRLSI-IAESIRDGLATWDNWK-- 348

Query: 224 ELHVVSLAFNKFQGGIPRDIGNLTS--VRNLF--LG---NNSLIGEIPNEIGNLRNLEVL 276
             HV     +K    I   +  L     R +F  L     ++    IP  +     L ++
Sbjct: 349 --HV---NCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAH---IPTIL-----LSLI 395

Query: 277 -GVQSSNLAGLIPASIFNISTL----KELAVTDNDLLGSLPSSIDLGLPNLERLFLGENN 331
                 +   ++   +   S +    KE  ++   +   L   ++     L R  +   N
Sbjct: 396 WFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLE-NEYALHRSIVDHYN 454

Query: 332 FSGTIPSSLTNISELSVLDFG-FNSFSG-------------LIPTTFGNLRSLKL-LSLA 376
               IP +  +   +       F S  G             L    F + R L+  +   
Sbjct: 455 ----IPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHD 510

Query: 377 GNVLTSPTPDLSFLSSLTSCRNLEIIYLSEN-PINGILPSSIGNF--SISMKSLSMESCN 433
                +    L+ L  L   +     Y+ +N P    L ++I +F   I    +  +  +
Sbjct: 511 STAWNASGSILNTLQQLKFYKP----YICDNDPKYERLVNAILDFLPKIEENLICSKYTD 566

Query: 434 I 434
           +
Sbjct: 567 L 567

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.9 bits (100), Expect = 6e-04
 Identities = 35/213 (16%), Positives = 64/213 (30%), Gaps = 73/213 (34%)

Query: 35  LLALKEHIKHDPS--NLLANNWSTTSSVCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQ 92
            L LK  ++++ +    + ++++   +  S                          IPP 
Sbjct: 432 YLELKVKLENEYALHRSIVDHYNIPKTFDSD-----------------------DLIPPY 468

Query: 93  LGNLSFLAVLAIRNNSFFG------SLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPR 146
           L    +         S  G        PE ++  R + + DFRF                
Sbjct: 469 LDQYFY---------SHIGHHLKNIEHPERMTLFRMV-FLDFRF---------------- 502

Query: 147 LQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFI 206
           L+  + +H+S       +I  L+ LQ+L      +             C N P  E L  
Sbjct: 503 LEQKI-RHDSTAWNASGSI--LNTLQQLKFYKPYI-------------CDNDPKYERLVN 546

Query: 207 SYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGI 239
           +       I  NL   +   ++ +A       I
Sbjct: 547 AILDFLPKIEENLICSKYTDLLRIALMAEDEAI 579

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 65.8 bits (161), Expect = 2e-11
 Identities = 53/210 (25%), Positives = 96/210 (45%), Gaps = 34/210 (16%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVKII 823
           + +G G++G+V   V    G ++A K  +  F   L +  A  E +++  +RH N++ ++
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90

Query: 824 ----SSCSNNDFKA--LVLEYMSNGSLEKCLYSDN-------YFLDILQRLKIMIDVASA 870
                  + +DF    LV+ +M    L K +  +        +   + Q LK        
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFL--VYQMLK-------G 140

Query: 871 LEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMA 930
           L Y+H   +  I+H D+KP N+ +NE     + DFG+A+    +  M  T  + T  Y A
Sbjct: 141 LRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEM--TGYVVTRWYRA 193

Query: 931 PEY-GREGKVSRKCDVYSYGIMLMETFTKK 959
           PE      + ++  D++S G ++ E  T K
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 65.9 bits (161), Expect = 2e-11
 Identities = 42/224 (18%), Positives = 78/224 (34%), Gaps = 47/224 (20%)

Query: 767 KLLGMGSFGSVYKGV------LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLV 820
             +G G FG +Y         +        KV   + +G L     E K          +
Sbjct: 41  LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD-NGPL---FTELKFYQRAAKPEQI 96

Query: 821 KIISS-------------------CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL 861
           +                        +   ++ ++++   +  L+K   ++         L
Sbjct: 97  QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRKTVL 155

Query: 862 KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKI-----LGK 913
           ++ + +   LEY+H       VH DIK SN+LL   N   V +L D+G+A       + K
Sbjct: 156 QLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAYRYCPEGVHK 211

Query: 914 EESMRQTKTL-GTIGYM--APEYGREGKVSRKCDVYSYGIMLME 954
             +    +   GTI +       G     SR+ D+   G  +++
Sbjct: 212 AYAADPKRCHDGTIEFTSIDAHNGVAP--SRRGDLEILGYCMIQ 253

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 64.3 bits (157), Expect = 3e-11
 Identities = 55/213 (25%), Positives = 82/213 (38%), Gaps = 34/213 (15%)

Query: 449 TVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSG 508
               L    +T         L  +  +   N+ ++        +L  +  L LG NKL  
Sbjct: 22  IKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSVQGIQ--YLPNVRYLALGGNKLH- 76

Query: 509 RLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVV 568
            + A L  LT+L  L L  N L S+       L ++    L  N L    LP        
Sbjct: 77  DISA-LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQL--QSLP-------- 125

Query: 569 IEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSG 628
                      GV       L  L  L+L +N+LQ      F  L +L  +D+S N L  
Sbjct: 126 ----------DGV----FDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ- 170

Query: 629 TIPKSM-EALSYLKHLNLSFNQLEGEIPTRGPF 660
           ++P+ + + L+ LK L L  NQL+  +P  G F
Sbjct: 171 SLPEGVFDKLTQLKDLRLYQNQLKS-VP-DGVF 201

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 61/239 (25%), Positives = 93/239 (38%), Gaps = 53/239 (22%)

Query: 274 EVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFS 333
               ++  ++   +     N     +  + +N  + S+   I   LPN+  L LG N   
Sbjct: 22  IKANLKKKSVTDAVT---QNELNSIDQIIANNSDIKSVQG-IQ-YLPNVRYLALGGNKLH 76

Query: 334 GTIPS--SLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLS 391
             I +   LTN   L+ L    N    L    F  L +LK L L  N L S    +    
Sbjct: 77  -DISALKELTN---LTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGV--FD 130

Query: 392 SLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVI 451
            LT   NL  + L+ N +   LP   G F      L+                  NLT +
Sbjct: 131 KLT---NLTYLNLAHNQLQS-LPK--GVF----DKLT------------------NLTEL 162

Query: 452 RLGNNELTGTIPVTLG---RLQKLQGLYLQNNKLEGSIPE---DLCHLYRLANLYLGDN 504
            L  N+L  ++P   G   +L +L+ L L  N+L+ S+P+   D   L  L  ++L DN
Sbjct: 163 DLSYNQLQ-SLPE--GVFDKLTQLKDLRLYQNQLK-SVPDGVFD--RLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 45.0 bits (107), Expect = 5e-05
 Identities = 67/278 (24%), Positives = 93/278 (33%), Gaps = 97/278 (34%)

Query: 141 FVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPV 200
              L  +  ++  ++    K  + I YL  ++ L L  N+L         +IS+ + L  
Sbjct: 37  QNELNSIDQIIANNSDI--KSVQGIQYLPNVRYLALGGNKLH--------DISALKELTN 86

Query: 201 LEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLI 260
           L  L ++ NQL                 SL    F          LT+++ L L  N L 
Sbjct: 87  LTYLILTGNQLQ----------------SLPNGVFDK--------LTNLKELVLVENQL- 121

Query: 261 GEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFN-ISTLKELAVTDNDLLGSLPSSIDLGL 319
                             QS      +P  +F+ ++ L  L +  N  L SLP  +   L
Sbjct: 122 ------------------QS------LPDGVFDKLTNLTYLNLAHNQ-LQSLPKGVFDKL 156

Query: 320 PNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNV 379
            NL  L L  N              +L  L  G           F  L  LK L L  N 
Sbjct: 157 TNLTELDLSYN--------------QLQSLPEG----------VFDKLTQLKDLRLYQNQ 192

Query: 380 LTSPTPDLSF--LSSLTS---------CRNLEIIYLSE 406
           L S  PD  F  L+SL           C    I YLSE
Sbjct: 193 LKS-VPDGVFDRLTSLQYIWLHDNPWDCTCPGIRYLSE 229

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 42.7 bits (101), Expect = 4e-04
 Identities = 24/128 (18%), Positives = 47/128 (36%), Gaps = 15/128 (11%)

Query: 527 SNALTSI---IPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIP 583
           +           +           NL   S+  +       L  + ++  + + +  V  
Sbjct: 7   TPIKQIFPDDAFAETIKA------NLKKKSV--TDAVTQNELNSIDQIIANNSDIKSVQG 58

Query: 584 VTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHL 643
             I  L  ++ L+L  N+L   I  +   L +L ++ ++ N L        + L+ LK L
Sbjct: 59  --IQYLPNVRYLALGGNKLH-DIS-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKEL 114

Query: 644 NLSFNQLE 651
            L  NQL+
Sbjct: 115 VLVENQLQ 122

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 65.0 bits (159), Expect = 4e-11
 Identities = 57/230 (24%), Positives = 97/230 (42%), Gaps = 48/230 (20%)

Query: 763 FSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNL 819
           ++    +G G++G V       + + +A K     F+          E K++   RH N+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENI 87

Query: 820 VK---IISSCSNNDFKA--LVLEYMSNGSLEKCLYSDN-------YFLDILQRLKIMIDV 867
           +    II + +    K   +V + M    L K L + +       YFL   Q L+     
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFL--YQILR----- 139

Query: 868 ASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT--LGT 925
              L+Y+H   S  ++H D+KPSN+LLN +    + DFG+A++   +       T  + T
Sbjct: 140 --GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194

Query: 926 IGYMAPE-------YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAG 968
             Y APE       Y      ++  D++S G +L E  + +     IF G
Sbjct: 195 RWYRAPEIMLNSKGY------TKSIDIWSVGCILAEMLSNR----PIFPG 234

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 64.5 bits (158), Expect = 4e-11
 Identities = 57/233 (24%), Positives = 98/233 (42%), Gaps = 39/233 (16%)

Query: 758 RATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAA--KV-FHMEFDG---------SLESF 804
           RA   +     +G G++G V+K   L +G    A  +V      +G         ++   
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV--- 64

Query: 805 HAECKVMGSIRHRNLVK----IISSCSNNDFKA-LVLEYMSNGSLEKCLYS-DNYFLDIL 858
               + + +  H N+V+       S ++ + K  LV E++    L   L       +   
Sbjct: 65  ---LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE 120

Query: 859 QRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR 918
               +M  +   L++LH   S  +VH D+KP N+L+  S    L+DFG+A+I   +  M 
Sbjct: 121 TIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MA 175

Query: 919 QTKTLGTIGYMAPE--YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGE 969
            T  + T+ Y APE         +   D++S G +  E F  +KP   +F G 
Sbjct: 176 LTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFR-RKP---LFRGS 222

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 64.2 bits (157), Expect = 5e-11
 Identities = 53/219 (24%), Positives = 94/219 (42%), Gaps = 37/219 (16%)

Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA----ECKVMGSIRHRNLVKII 823
           LG G++G VYK +       +A K   +E +   E        E  ++  ++HRN++++ 
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE--EGVPGTAIREVSLLKELQHRNIIELK 99

Query: 824 SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIV 883
           S   +N    L+ EY  N  L+K +  +      + +   +  + + + + H   S   +
Sbjct: 100 SVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIK-SFLYQLINGVNFCH---SRRCL 154

Query: 884 HCDIKPSNVLLNESMVGH-----LSDFGIAKILGKEESMRQ-TKTLGTIGYMAPE----- 932
           H D+KP N+LL+ S         + DFG+A+  G    +RQ T  + T+ Y  PE     
Sbjct: 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP--IRQFTHEIITLWYRPPEILLGS 212

Query: 933 --YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGE 969
             Y          D++S   +  E    K P   +F G+
Sbjct: 213 RHYSTS------VDIWSIACIWAEMLM-KTP---LFPGD 241

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 64.1 bits (157), Expect = 5e-11
 Identities = 55/229 (24%), Positives = 93/229 (40%), Gaps = 29/229 (12%)

Query: 758 RATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHME-FDGSLESFHAEC------- 808
            AT  +     +G+G++G+VYK      G  +A K   +    G                
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 809 KVMGSIRHRNLVK---IISSCSNNDFKA--LVLEYMSNGSLEKCLYSDN-YFLDILQRLK 862
           + + +  H N+V+   + ++   +      LV E++    L   L       L       
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124

Query: 863 IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT 922
           +M      L++LH   +  IVH D+KP N+L+       L+DFG+A+I   +  M  T  
Sbjct: 125 LMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALTPV 179

Query: 923 LGTIGYMAPE--YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGE 969
           + T+ Y APE         +   D++S G +  E F  +KP   +F G 
Sbjct: 180 VVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFR-RKP---LFCGN 222

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 63.8 bits (156), Expect = 7e-11
 Identities = 54/228 (23%), Positives = 88/228 (38%), Gaps = 57/228 (25%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVKII 823
           K LG G  G V+  V       +A K   +         HA  E K++  + H N+VK+ 
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIK--KIVLTDPQSVKHALREIKIIRRLDHDNIVKVF 74

Query: 824 ------------SSCSNNDFKA--LVLEYMSNGSLEKCLYSDN-------YFLDILQRLK 862
                          S  +  +  +V EYM    L   L            F  + Q L+
Sbjct: 75  EILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLF--MYQLLR 131

Query: 863 IMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLS--DFGIAKILGKEESMRQT 920
                   L+Y+H   S  ++H D+KP+N+ +N +    L   DFG+A+I+    S +  
Sbjct: 132 -------GLKYIH---SANVLHRDLKPANLFIN-TEDLVLKIGDFGLARIMDPHYSHKGH 180

Query: 921 KT--LGTIGYMAPE-------YGREGKVSRKCDVYSYGIMLMETFTKK 959
            +  L T  Y +P        Y      ++  D+++ G +  E  T K
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNY------TKAIDMWAAGCIFAEMLTGK 222

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 63.8 bits (156), Expect = 8e-11
 Identities = 62/240 (25%), Positives = 97/240 (40%), Gaps = 67/240 (27%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAK---VFHMEFDGSLESFHA-----ECKVMGSIRHR 817
            LLG G++G V      P G  +A K    F        +   A     E K++   +H 
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-------KPLFALRTLREIKILKHFKHE 69

Query: 818 NLVK---IISSCSNNDFKA--LVLEYMSNGSLEKCLYSDN-------YFLDILQRLKIMI 865
           N++    I    S  +F    ++ E M    L + + +         YF  I Q L+   
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYF--IYQTLR--- 123

Query: 866 DVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT 925
               A++ LH    + ++H D+KPSN+L+N +    + DFG+A+I+ +  +     T   
Sbjct: 124 ----AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176

Query: 926 IG---------YMAPE-------YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGE 969
            G         Y APE       Y      SR  DV+S G +L E F ++     IF G 
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKY------SRAMDVWSCGCILAELFLRRP----IFPGR 226

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 62.6 bits (153), Expect = 2e-10
 Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 37/219 (16%)

Query: 769 LGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA----ECKVMGSIRHRNLVKII 823
           LG G++ +VYKG+    G+ +A K   ++ +   E   +    E  +M  ++H N+V++ 
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISLMKELKHENIVRLY 69

Query: 824 SSCSNNDFKALVLEYMSNGSLEKCLYSDNYF-----LDILQRLKIMIDVASALEYLHFGY 878
                 +   LV E+M N  L+K + S         L++         +   L + H   
Sbjct: 70  DVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK 128

Query: 879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ-TKTLGTIGYMAPE----- 932
              I+H D+KP N+L+N+     L DFG+A+  G    +   +  + T+ Y AP+     
Sbjct: 129 ---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP--VNTFSSEVVTLWYRAPDVLMGS 183

Query: 933 --YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGE 969
             Y          D++S G +L E  T  KP   +F G 
Sbjct: 184 RTYSTS------IDIWSCGCILAEMIT-GKP---LFPGT 212

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 59.6 bits (145), Expect = 3e-10
 Identities = 33/122 (27%), Positives = 53/122 (43%), Gaps = 11/122 (9%)

Query: 437 GIPKELGNINNLTVIRLGNNELTGTIPV-TLGRLQKLQGLYLQNNKLEGSIPEDLC-HLY 494
            IP       + T + L +NEL         GRL  L  L L+ N+L   I  +      
Sbjct: 26  DIP------LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGAS 78

Query: 495 RLANLYLGDNKLSGRLPA-CLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNS 553
            +  L LG+NK+   +       L  L+ L+L  N ++ ++P +  +L  +   NL+SN 
Sbjct: 79  HIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNP 137

Query: 554 LN 555
            N
Sbjct: 138 FN 139

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 35/128 (27%), Positives = 51/128 (39%), Gaps = 19/128 (14%)

Query: 287 IPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPS----SLTN 342
           IP  I       EL + DN+L       +   LP+L +L L  N  +  I        ++
Sbjct: 23  IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASH 79

Query: 343 ISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSF--LSSLTSCRNLE 400
              +  L  G N    +    F  L  LK L+L  N ++      SF  L+SLTS     
Sbjct: 80  ---IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTS----- 130

Query: 401 IIYLSENP 408
            + L+ NP
Sbjct: 131 -LNLASNP 137

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 28/93 (30%), Positives = 41/93 (44%), Gaps = 5/93 (5%)

Query: 570 EMDLSLNALSGVIPVTI-GGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSG 628
           E+ L+ N L  +    + G L  L  L L+ N+L G  P +F G   +  + +  N +  
Sbjct: 33  ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK- 91

Query: 629 TIPKSM-EALSYLKHLNLSFNQLEGEIPTRGPF 660
            I   M   L  LK LNL  NQ+   +   G F
Sbjct: 92  EISNKMFLGLHQLKTLNLYDNQISC-VM-PGSF 122

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 30/129 (23%), Positives = 46/129 (35%), Gaps = 27/129 (20%)

Query: 498 NLYLGDNKLSGRLP-ACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNG 556
            L L DN+L         G L  L  L L  N LT I P+       I    L  N +  
Sbjct: 33  ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI-- 90

Query: 557 SLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPE-SFGGLKS 615
             +                   + +      GL  L+ L+L  N++   +   SF  L S
Sbjct: 91  KEIS------------------NKMF----LGLHQLKTLNLYDNQISC-VMPGSFEHLNS 127

Query: 616 LNFVDMSNN 624
           L  +++++N
Sbjct: 128 LTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 25/113 (22%), Positives = 48/113 (42%), Gaps = 11/113 (9%)

Query: 148 QHLLLKHNSFVGKIPETI-GYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFI 206
             LLL  N       + + G L  L +L+L  NQL+  I  + F     +    ++ L +
Sbjct: 32  TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAF-----EGASHIQELQL 85

Query: 207 SYNQLTGPIPTNLW-KCRELHVVSLAFNKFQGGIPRDI-GNLTSVRNLFLGNN 257
             N++   I   ++    +L  ++L  N+    +      +L S+ +L L +N
Sbjct: 86  GENKIKE-ISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASN 136

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 61.7 bits (150), Expect = 5e-10
 Identities = 37/221 (16%), Positives = 77/221 (34%), Gaps = 41/221 (18%)

Query: 767 KLLGMGSFGSVYKGV---------LPDGMEIAAKVFHMEFDGSLES-----------FHA 806
                 + G +Y+            P   + + K+   +     E             + 
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107

Query: 807 ECKVMGSIRHRNLVKIISSCSN-NDFKALVLEYMSNGSLEKCL-YSDNYFLDILQRLKIM 864
             K+        +   +    + + ++ LVL  +   SL+  L  S  + L     L++ 
Sbjct: 108 WKKLYS-TPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVA 165

Query: 865 IDVASALEYLHFGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAK---ILGKEESMR 918
             +  ALE+LH       VH ++   N+ +   ++S V  L+ +G A      GK  +  
Sbjct: 166 CRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAFRYCPSGKHVAYV 221

Query: 919 QTKTL---GTIGYM--APEYGREGKVSRKCDVYSYGIMLME 954
           +       G + ++      G     SR+ D+ S G  +++
Sbjct: 222 EGSRSPHEGDLEFISMDLHKGCGP--SRRSDLQSLGYCMLK 260

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 61.3 bits (149), Expect = 7e-10
 Identities = 46/317 (14%), Positives = 96/317 (30%), Gaps = 65/317 (20%)

Query: 322 LERLFLGENNFSG----TIPSSLTNISELSVLDFGFNSFSG----LIPTTFGNLRSLKLL 373
           +E   L  +  +     ++ + L     +  +    N+        +     + + L++ 
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 374 SLAGNVLTSPTPDL-----SFLSSLTSCRNLEIIYLSENPINGILPSSIGNF---SISMK 425
             +         ++       L +L  C  L  + LS+N         + +F      ++
Sbjct: 66  EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125

Query: 426 SLSMESCNIS-------------GGIPKELGNINNLTVIRLGNNELT--GTIPV--TLGR 468
            L + +  +                + K+  N   L  I  G N L          T   
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185

Query: 469 LQKLQGLYLQNNKL-----EGSIPEDLCHLYRLANLYLGDNKLSGR----LPACLGNLTS 519
            + L  + +  N +     E  + E L +   L  L L DN  +      L   L +  +
Sbjct: 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 245

Query: 520 LRDLSLGSN------------ALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIG---- 563
           LR+L L               A + +    L  L       L  N +    +  +     
Sbjct: 246 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTL------RLQYNEIELDAVRTLKTVID 299

Query: 564 -NLKVVIEMDLSLNALS 579
             +  ++ ++L+ N  S
Sbjct: 300 EKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 60.9 bits (148), Expect = 1e-09
 Identities = 48/296 (16%), Positives = 91/296 (30%), Gaps = 66/296 (22%)

Query: 417 IGNFSISMKSLSMESCNISG--GIPKELGNINNLTVIRLGNNELTGT----IPVTLGRLQ 470
           +  FSI  KSL +++        +   L   +++  I L  N +       +   +   +
Sbjct: 1   MARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK 60

Query: 471 KLQGLYLQNNKLE----------GSIPEDLCHLYRLANLYLGDNKLSGR----LPACLGN 516
            L+     +                + + L    +L  + L DN         L   L  
Sbjct: 61  DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 120

Query: 517 LTSLRDLSLGSN------------ALTSIIPSTLWNLKDILR-FNLSSNSLN-------G 556
            T L  L L +N            AL  +  +        LR      N L         
Sbjct: 121 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA 180

Query: 557 SLLPDIGNLKVVIEMDLSLNALS--GVIPVTIGGLQG---LQLLSLRYNRLQGP-----I 606
                   L  V    +  N +   G+  + + GL     L++L L+ N          +
Sbjct: 181 KTFQSHRLLHTV---KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF-THLGSSAL 236

Query: 607 PESFGGLKSLNFVDMSNNNLSGTIPKSMEALS---------YLKHLNLSFNQLEGE 653
             +     +L  + +++  LS    +   A+           L+ L L +N++E +
Sbjct: 237 AIALKSWPNLRELGLNDCLLS---ARGAAAVVDAFSKLENIGLQTLRLQYNEIELD 289

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 53.6 bits (129), Expect = 2e-07
 Identities = 41/314 (13%), Positives = 96/314 (30%), Gaps = 58/314 (18%)

Query: 201 LEGLFISYNQLTG----PIPTNLWKCRELHVVSLAFNKF--QGG--IPRDIGNLTSVRNL 252
           +EG  +  + +T      +   L +   +  + L+ N    +    +  +I +   +   
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 253 FLGNNSLIGEIPNEIG-----------NLRNLEVLGVQSSNL----AGLIPASIFNISTL 297
              +    G + +EI                L  + +  +         +   +   + L
Sbjct: 66  EFSDIF-TGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124

Query: 298 KELAVTDND------------LLGSLPSSIDLGLPNLERLFLGENNFSG----TIPSSLT 341
           + L + +N             L     +      P L  +  G N            +  
Sbjct: 125 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 184

Query: 342 NISELSVLDFGFNSF-----SGLIPTTFGNLRSLKLLSLAGNVLTSP-TPDLSFLSSLTS 395
           +   L  +    N         L+       + LK+L L  N  T   +  L+   +L S
Sbjct: 185 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA--IALKS 242

Query: 396 CRNLEIIYLSENPI-----NGILPSSIGNFSISMKSLSMESCNISGGIPKELG-----NI 445
             NL  + L++  +       ++ +     +I +++L ++   I     + L       +
Sbjct: 243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 302

Query: 446 NNLTVIRLGNNELT 459
            +L  + L  N  +
Sbjct: 303 PDLLFLELNGNRFS 316

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 29/117 (24%), Positives = 52/117 (44%), Gaps = 9/117 (7%)

Query: 437 GIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLC-HLYR 495
           GIP+      ++T + L  N+ T  +P  L   + L  + L NN++  ++      ++ +
Sbjct: 28  GIPR------DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQ 79

Query: 496 LANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSN 552
           L  L L  N+L    P     L SLR LSL  N ++ +      +L  +    + +N
Sbjct: 80  LLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 51.1 bits (123), Expect = 3e-07
 Identities = 31/112 (27%), Positives = 55/112 (49%), Gaps = 11/112 (9%)

Query: 148 QHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFIS 207
             L L  N F   +P+ +     L  +DLS+N++S T+ +  F+     N+  L  L +S
Sbjct: 34  TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFS-----NMTQLLTLILS 86

Query: 208 YNQLTGPIPTNLW-KCRELHVVSLAFNKFQGGIPRDI-GNLTSVRNLFLGNN 257
           YN+L   IP   +   + L ++SL  N     +P     +L+++ +L +G N
Sbjct: 87  YNRLRC-IPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 25/85 (29%), Positives = 38/85 (44%), Gaps = 7/85 (8%)

Query: 473 QGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLG---NLTSLRDLSLGSNA 529
             LYL  N+    +P++L +   L  + L +N++S  L        N+T L  L L  N 
Sbjct: 34  TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSN--QSFSNMTQLLTLILSYNR 89

Query: 530 LTSIIPSTLWNLKDILRFNLSSNSL 554
           L  I P T   LK +   +L  N +
Sbjct: 90  LRCIPPRTFDGLKSLRLLSLHGNDI 114

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 46.9 bits (112), Expect = 8e-06
 Identities = 31/128 (24%), Positives = 53/128 (41%), Gaps = 27/128 (21%)

Query: 498 NLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGS 557
            LYL  N+ +  +P  L N   L  + L +N ++++   +  N+  +L   LS N L   
Sbjct: 35  ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL--R 91

Query: 558 LLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPE-SFGGLKSL 616
            +P                           GL+ L+LLSL  N +   +PE +F  L +L
Sbjct: 92  CIPP------------------RT----FDGLKSLRLLSLHGNDISV-VPEGAFNDLSAL 128

Query: 617 NFVDMSNN 624
           + + +  N
Sbjct: 129 SHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 32/122 (26%), Positives = 48/122 (39%), Gaps = 27/122 (22%)

Query: 308 LGSLPSSIDLGLP-NLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGN 366
           L  LP     G+P ++  L+L  N F+  +P  L+N   L+++D   N  S L   +F N
Sbjct: 22  LKVLPK----GIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSN 76

Query: 367 LRSLKLLSLAGNVLTSPTPDLSF--LSSLT------------------SCRNLEIIYLSE 406
           +  L  L L+ N L    P  +F  L SL                       L  + +  
Sbjct: 77  MTQLLTLILSYNRLRC-IPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGA 135

Query: 407 NP 408
           NP
Sbjct: 136 NP 137

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 37/128 (28%), Positives = 59/128 (46%), Gaps = 12/128 (9%)

Query: 527 SNALTSI---IPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIP 583
           +  L  +   IP  +  L       L  N     +  ++ N K +  +DLS N +S +  
Sbjct: 19  NKGLKVLPKGIPRDVTEL------YLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSN 71

Query: 584 VTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPK-SMEALSYLKH 642
            +   +  L  L L YNRL+   P +F GLKSL  + +  N++S  +P+ +   LS L H
Sbjct: 72  QSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSH 130

Query: 643 LNLSFNQL 650
           L +  N L
Sbjct: 131 LAIGANPL 138

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 60.1 bits (146), Expect = 2e-09
 Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 26/184 (14%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIR-HRNLVKI 822
           K LG G++G V+K +    G  +A K     F  S ++     E  ++  +  H N+V +
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74

Query: 823 ISSCSNNDFKA--LVLEYMSNGSLEKCLYSDN-------YFLDILQRLKIMIDVASALEY 873
           ++    ++ +   LV +YM    L   + ++        Y   + Q +K        ++Y
Sbjct: 75  LNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYV--VYQLIK-------VIKY 124

Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
           LH   S  ++H D+KPSN+LLN      ++DFG+++       +     L          
Sbjct: 125 LH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181

Query: 934 GREG 937
             + 
Sbjct: 182 DDQP 185

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 58.7 bits (141), Expect = 4e-09
 Identities = 37/253 (14%), Positives = 73/253 (28%), Gaps = 67/253 (26%)

Query: 757 LRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFD--------GSLESFHAEC 808
              T+     + +G G FG V++ +  D   +A K+  +E           + E    E 
Sbjct: 16  CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74

Query: 809 KVM---------GSIRHRNLVKIISSC----------------------SNNDFKA---- 833
            +             R    + + S                        S ND       
Sbjct: 75  IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134

Query: 834 ----LVLEYMSNG-SLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIK 888
               +VLE+   G  LE+          +     I+  + ++L            H D+ 
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLR--FEHRDLH 189

Query: 889 PSNVLLNESMVGHLSDFGIAK----------ILGKEESMRQTKTLGTIGYMAPEYGRE-- 936
             NVLL ++ +  L      K          +   + ++ + +  G + +       +  
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLF 249

Query: 937 -GKVSRKCDVYSY 948
            G    + D+Y  
Sbjct: 250 TGDGDYQFDIYRL 262

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 56.6 bits (137), Expect = 5e-09
 Identities = 38/143 (26%), Positives = 59/143 (41%), Gaps = 6/143 (4%)

Query: 413 LPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTL-GRLQK 471
             S           L +E+ ++          + +LT + LG N+L  ++P  +  +L  
Sbjct: 19  RTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77

Query: 472 LQGLYLQNNKLEGSIPEDLC-HLYRLANLYLGDNKLSGRLPA-CLGNLTSLRDLSLGSNA 529
           L  L L  N+L+ S+P  +   L +L  L L  N+L   LP      LT L+DL L  N 
Sbjct: 78  LTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQ 135

Query: 530 LTSIIPSTLWNLKDILRFNLSSN 552
           L S+       L  +    L  N
Sbjct: 136 LKSVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 52/181 (28%), Positives = 66/181 (36%), Gaps = 45/181 (24%)

Query: 238 GIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFN-IST 296
           GIP           L L  NSL          L +L  L +  + L  L P  +FN +++
Sbjct: 25  GIP------AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSL-PNGVFNKLTS 77

Query: 297 LKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSF 356
           L  L ++ N  L SLP+ +   L  L+ L L  N              +L  L  G    
Sbjct: 78  LTYLNLSTNQ-LQSLPNGVFDKLTQLKELALNTN--------------QLQSLPDG---- 118

Query: 357 SGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSF--LSSLTS---------CRNLEIIYLS 405
                  F  L  LK L L  N L S  PD  F  L+SL           C    I YLS
Sbjct: 119 ------VFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCTCPGIRYLS 171

Query: 406 E 406
           E
Sbjct: 172 E 172

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 42.4 bits (100), Expect = 3e-04
 Identities = 40/132 (30%), Positives = 56/132 (42%), Gaps = 10/132 (7%)

Query: 498 NLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGS 557
            L L  N L          LTSL  L LG N L S+       L  +   NLS+N L  S
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-S 90

Query: 558 LLPDI----GNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPE-SFGG 612
           L   +      LK   E+ L+ N L  +       L  L+ L L  N+L+  +P+  F  
Sbjct: 91  LPNGVFDKLTQLK---ELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDR 146

Query: 613 LKSLNFVDMSNN 624
           L SL ++ + +N
Sbjct: 147 LTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 41.2 bits (97), Expect = 6e-04
 Identities = 33/114 (28%), Positives = 55/114 (48%), Gaps = 10/114 (8%)

Query: 148 QHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFIS 207
            +L L+ NS           L+ L +L L  N+L  ++P+ +FN      L  L  L +S
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFN-----KLTSLTYLNLS 84

Query: 208 YNQLTGPIPTNLW-KCRELHVVSLAFNKFQGGIPRDI-GNLTSVRNLFLGNNSL 259
            NQL   +P  ++ K  +L  ++L  N+ Q  +P  +   LT +++L L  N L
Sbjct: 85  TNQLQS-LPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL 136

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 40.8 bits (96), Expect = 9e-04
 Identities = 42/149 (28%), Positives = 63/149 (42%), Gaps = 20/149 (13%)

Query: 336 IPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTS 395
           IP+  T       LD   NS   L    F  L SL  L L GN L S    +   + LT 
Sbjct: 26  IPAQTTY------LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGV--FNKLT- 76

Query: 396 CRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCN----ISGGIPKELGNINNLTVI 451
             +L  + LS N +   LP+ + +    +K L++ + N    +  G+  +L     L  +
Sbjct: 77  --SLTYLNLSTNQLQS-LPNGVFDKLTQLKELAL-NTNQLQSLPDGVFDKLTQ---LKDL 129

Query: 452 RLGNNELTGTIPVTLGRLQKLQGLYLQNN 480
           RL  N+L         RL  LQ ++L +N
Sbjct: 130 RLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 56.6 bits (137), Expect = 6e-09
 Identities = 36/122 (29%), Positives = 57/122 (46%), Gaps = 15/122 (12%)

Query: 437 GIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLC-HLYR 495
           GIP       N  ++ L +N++T   P     L  L+ LYL +N+L  ++P  +   L +
Sbjct: 37  GIP------TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQ 89

Query: 496 LANLYLGDNKLSGRLPACLG---NLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSN 552
           L  L LG N+L+  LP+       L  L++L +  N LT  +P  +  L  +    L  N
Sbjct: 90  LTVLDLGTNQLT-VLPS--AVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQN 145

Query: 553 SL 554
            L
Sbjct: 146 QL 147

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 38/134 (28%), Positives = 62/134 (46%), Gaps = 15/134 (11%)

Query: 498 NLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSI---IPSTLWNLKDILRFNLSSNSL 554
            LYL DN+++   P    +L +L++L LGSN L ++   +  +L  L      +L +N L
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLT---VLDLGTNQL 100

Query: 555 NGSLLPDI----GNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESF 610
              L   +     +LK   E+ +  N L+  +P  I  L  L  L+L  N+L+     +F
Sbjct: 101 T-VLPSAVFDRLVHLK---ELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAF 155

Query: 611 GGLKSLNFVDMSNN 624
             L SL    +  N
Sbjct: 156 DRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 35/113 (30%), Positives = 51/113 (45%), Gaps = 9/113 (7%)

Query: 148 QHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFIS 207
           Q L L  N      P     L  L+EL L  NQL   +P  +F+     +L  L  L + 
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFD-----SLTQLTVLDLG 96

Query: 208 YNQLTGPIPTNLW-KCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSL 259
            NQLT  +P+ ++ +   L  + +  NK    +PR I  LT + +L L  N L
Sbjct: 97  TNQLTV-LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 43/141 (30%), Positives = 60/141 (42%), Gaps = 19/141 (13%)

Query: 274 EVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFS 333
           ++L +  + +  L P    ++  LKEL +  N L G+LP  +   L  L  L LG N  +
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLT 101

Query: 334 GTIPS----SLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSF 389
             +PS     L +   L  L    N  +  +P     L  L  L+L  N L S  P  +F
Sbjct: 102 -VLPSAVFDRLVH---LKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKS-IPHGAF 155

Query: 390 --LSSLTSCRNLEIIYLSENP 408
             LSSLT        YL  NP
Sbjct: 156 DRLSSLTH------AYLFGNP 170

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 38/173 (21%), Positives = 61/173 (35%), Gaps = 34/173 (19%)

Query: 308 LGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNL 367
             S+P+ I     N + L+L +N  +   P    ++  L  L  G N    L    F +L
Sbjct: 31  HASVPAGIP---TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSL 87

Query: 368 RSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSL 427
             L +L L  N LT   P   F   L    +L+ +++  N                +   
Sbjct: 88  TQLTVLDLGTNQLTV-LPSAVF-DRLV---HLKELFMCCN---------------KLTE- 126

Query: 428 SMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNN 480
                     +P+ +  + +LT + L  N+L         RL  L   YL  N
Sbjct: 127 ----------LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 41/143 (28%), Positives = 58/143 (40%), Gaps = 27/143 (18%)

Query: 518 TSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNA 577
           T+ + L L  N +T + P    +L ++    L SN L    LP                 
Sbjct: 40  TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL--GALP----------------- 80

Query: 578 LSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEAL 637
             GV       L  L +L L  N+L       F  L  L  + M  N L+  +P+ +E L
Sbjct: 81  -VGVF----DSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERL 134

Query: 638 SYLKHLNLSFNQLEGEIPTRGPF 660
           ++L HL L  NQL+  IP  G F
Sbjct: 135 THLTHLALDQNQLKS-IP-HGAF 155

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 58.2 bits (140), Expect = 6e-09
 Identities = 27/111 (24%), Positives = 43/111 (38%), Gaps = 3/111 (2%)

Query: 446 NNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIP-EDLCHLYRLANLYLGDN 504
           +  + +R   +         L   + L  LY++N +    +   DL  L  L NL +  +
Sbjct: 8   HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66

Query: 505 KLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLN 555
            L    P        L  L+L  NAL S+   T+  L  +    LS N L+
Sbjct: 67  GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 55.1 bits (132), Expect = 6e-08
 Identities = 18/102 (17%), Positives = 30/102 (29%), Gaps = 8/102 (7%)

Query: 112 SLPEELSHLRGLKYFDFRFNNFHIEIPSW-FVSLPRLQHLLLKHNSFVGKIPETIGYLSL 170
                L     L             +       L  L++L +  +      P+   +   
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 171 LQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLT 212
           L  L+LS N L  ++        S      L+ L +S N L 
Sbjct: 82  LSRLNLSFNALE-SLSWKTVQGLS------LQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 54.0 bits (129), Expect = 1e-07
 Identities = 19/101 (18%), Positives = 41/101 (40%), Gaps = 2/101 (1%)

Query: 551 SNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIP-VTIGGLQGLQLLSLRYNRLQGPIPES 609
           +       L  +   + + E+ +        +    + GL  L+ L++  + L+   P++
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75

Query: 610 FGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQL 650
           F     L+ +++S N L  ++         L+ L LS N L
Sbjct: 76  FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 53.6 bits (128), Expect = 2e-07
 Identities = 24/96 (25%), Positives = 36/96 (37%), Gaps = 4/96 (4%)

Query: 438 IPKELGNINNLTVIRLGNNELTGTIP-VTLGRLQKLQGLYLQNNKLEGSIPED-LCHLYR 495
               L    NLT + + N +    +    L  L +L+ L +  + L   +  D      R
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81

Query: 496 LANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALT 531
           L+ L L  N L   L        SL++L L  N L 
Sbjct: 82  LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 50.5 bits (120), Expect = 2e-06
 Identities = 25/95 (26%), Positives = 36/95 (37%), Gaps = 1/95 (1%)

Query: 287 IPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISEL 346
               +     L EL + +   L  L      GL  L  L + ++      P +      L
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82

Query: 347 SVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLT 381
           S L+  FN+   L   T   L SL+ L L+GN L 
Sbjct: 83  SRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.4 bits (112), Expect = 2e-05
 Identities = 18/96 (18%), Positives = 33/96 (34%), Gaps = 5/96 (5%)

Query: 239 IPRDIGNLTSVRNLFLGNNSLIGEIPNE-IGNLRNLEVLGVQSSNLAGLIPASIF-NIST 296
               +    ++  L++ N   +  +    +  L  L  L +  S L   +    F     
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81

Query: 297 LKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNF 332
           L  L ++ N L  SL     +   +L+ L L  N  
Sbjct: 82  LSRLNLSFNALE-SLSWKT-VQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 16/120 (13%), Positives = 31/120 (25%), Gaps = 29/120 (24%)

Query: 305 NDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTF 364
            D        +  G  NL  L++        +                            
Sbjct: 17  RDGALDSLHHLP-GAENLTELYIENQQHLQHLELR-----------------------DL 52

Query: 365 GNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISM 424
             L  L+ L++  + L    PD     +      L  + LS N +  +   ++   S+  
Sbjct: 53  RGLGELRNLTIVKSGLRFVAPD-----AFHFTPRLSRLNLSFNALESLSWKTVQGLSLQE 107

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.8 bits (100), Expect = 4e-04
 Identities = 18/83 (21%), Positives = 27/83 (32%), Gaps = 2/83 (2%)

Query: 425 KSLSMESCNISGGIPKE-LGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLE 483
             L +E+      +    L  +  L  + +  + L    P       +L  L L  N LE
Sbjct: 34  TELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE 93

Query: 484 GSIPEDLCHLYRLANLYLGDNKL 506
            S+         L  L L  N L
Sbjct: 94  -SLSWKTVQGLSLQELVLSGNPL 115

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 58.2 bits (141), Expect = 6e-09
 Identities = 56/249 (22%), Positives = 84/249 (33%), Gaps = 62/249 (24%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAK-----------------------------VFHME 796
           K LG GSFG V +   +  G   A K                              F+  
Sbjct: 13  KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTT 72

Query: 797 FDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKA-----LVLEYMSNGSLEKCLYSD 851
            D   +               N V         +        +++EY+ + +L K L S 
Sbjct: 73  GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSF 131

Query: 852 NYFLDILQRLKI---MIDVASALEYLHFGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGI 907
                 +    I   +  +  A+ ++H   S  I H DIKP N+L+N +     L DFG 
Sbjct: 132 IRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGS 188

Query: 908 AKILGKEESMRQTKTLGTIGYMAPE-------YGREGKVSRKCDVYSYGIMLMETFTKKK 960
           AK L   E       + +  Y APE       Y      +   D++S G +  E     K
Sbjct: 189 AKKLIPSEPS--VAYICSRFYRAPELMLGATEY------TPSIDLWSIGCVFGELIL-GK 239

Query: 961 PTDEIFAGE 969
           P   +F+GE
Sbjct: 240 P---LFSGE 245

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 25/129 (19%), Positives = 50/129 (38%), Gaps = 10/129 (7%)

Query: 440 KELGNINNLTVIRLGN--NELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLA 497
           ++         + L      +   +  TL  L+  + L L  N +E  I   L  +  L 
Sbjct: 17  RKSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLR 73

Query: 498 NLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGS 557
            L LG N +  ++        +L +L +  N + S+  S +  L ++    +S+N +  +
Sbjct: 74  ILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKI--T 128

Query: 558 LLPDIGNLK 566
              +I  L 
Sbjct: 129 NWGEIDKLA 137

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 31/146 (21%), Positives = 55/146 (37%), Gaps = 31/146 (21%)

Query: 391 SSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTV 450
           ++L++ +  + + LS N I       I +                      L  + NL +
Sbjct: 42  ATLSTLKACKHLALSTNNI-----EKISS----------------------LSGMENLRI 74

Query: 451 IRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRL 510
           + LG N +   I         L+ L++  N++  S+   +  L  L  LY+ +NK++   
Sbjct: 75  LSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWG 131

Query: 511 P-ACLGNLTSLRDLSLGSNALTSIIP 535
               L  L  L DL L  N L +   
Sbjct: 132 EIDKLAALDKLEDLLLAGNPLYNDYK 157

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 37/160 (23%), Positives = 66/160 (41%), Gaps = 15/160 (9%)

Query: 339 SLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRN 398
             T   ++  L          +  T   L++ K L+L+ N +         +SSL+   N
Sbjct: 21  VATEAEKVE-LHGMIPPIEK-MDATLSTLKACKHLALSTNNIEK-------ISSLSGMEN 71

Query: 399 LEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNEL 458
           L I+ L  N I  I   ++   + +++ L +    I+      +  + NL V+ + NN++
Sbjct: 72  LRILSLGRNLIKKI--ENLDAVADTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNKI 127

Query: 459 TGTIPV-TLGRLQKLQGLYLQNNKLEGSIPEDLCH-LYRL 496
           T    +  L  L KL+ L L  N L     E+     YR+
Sbjct: 128 TNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRI 167

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.8 bits (127), Expect = 9e-08
 Identities = 31/158 (19%), Positives = 65/158 (41%), Gaps = 15/158 (9%)

Query: 499 LYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSL 558
           L+     +  ++ A L  L + + L+L +N +  I  S+L  ++++   +L  N     L
Sbjct: 30  LHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRN-----L 81

Query: 559 LPDIGNLKVVI----EMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIP-ESFGGL 613
           +  I NL  V     E+ +S N ++ +    I  L  L++L +  N++      +    L
Sbjct: 82  IKKIENLDAVADTLEELWISYNQIASLSG--IEKLVNLRVLYMSNNKITNWGEIDKLAAL 139

Query: 614 KSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLE 651
             L  + ++ N L     ++     Y   +      L+
Sbjct: 140 DKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLK 177

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 34/166 (20%), Positives = 60/166 (36%), Gaps = 35/166 (21%)

Query: 245 NLTSVRNLFLGNN-SLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVT 303
             T    + L      I ++   +  L+  + L + S+N        I  IS+L      
Sbjct: 21  VATEAEKVELHGMIPPIEKMDATLSTLKACKHLAL-STNN-------IEKISSLS----- 67

Query: 304 DNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTT 363
                         G+ NL  L LG N     I +       L  L   +N  + L  + 
Sbjct: 68  --------------GMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SG 110

Query: 364 FGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPI 409
              L +L++L ++ N +T    +   +  L +   LE + L+ NP+
Sbjct: 111 IEKLVNLRVLYMSNNKIT----NWGEIDKLAALDKLEDLLLAGNPL 152

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 27/130 (20%), Positives = 48/130 (36%), Gaps = 10/130 (7%)

Query: 89  IPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQ 148
           +   L  L     LA+  N+        LS +  L+      N    +I +       L+
Sbjct: 40  MDATLSTLKACKHLALSTNNI--EKISSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96

Query: 149 HLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISY 208
            L + +N  +  +   I  L  L+ L +S+N+++     +   I     L  LE L ++ 
Sbjct: 97  ELWISYN-QIASL-SGIEKLVNLRVLYMSNNKIT-----NWGEIDKLAALDKLEDLLLAG 149

Query: 209 NQLTGPIPTN 218
           N L      N
Sbjct: 150 NPLYNDYKEN 159

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 37/153 (24%), Positives = 65/153 (42%), Gaps = 24/153 (15%)

Query: 136 EIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSC 195
           ++ +   +L   +HL L  N+   KI  ++  +  L+ L L  N +       I N+ + 
Sbjct: 39  KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLI-----KKIENLDAV 91

Query: 196 QNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQ--GGIPRDIGNLTSVRNLF 253
            +   LE L+ISYNQ+     + + K   L V+ ++ NK    G I + +  L  + +L 
Sbjct: 92  ADT--LEELWISYNQIA--SLSGIEKLVNLRVLYMSNNKITNWGEIDK-LAALDKLEDLL 146

Query: 254 LGNNSLIGEIPNE----------IGNLRNLEVL 276
           L  N L  +              +  L NL+ L
Sbjct: 147 LAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 30/130 (23%), Positives = 49/130 (37%), Gaps = 18/130 (13%)

Query: 149 HLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISY 208
            L         K+  T+  L   + L LS N +       I ++S  +N   L  L +  
Sbjct: 29  ELHGMIPPIE-KMDATLSTLKACKHLALSTNNI-----EKISSLSGMEN---LRILSLGR 79

Query: 209 NQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPR--DIGNLTSVRNLFLGNNSLIGEIPNE 266
           N +   I         L  + +++N+    I     I  L ++R L++ NN  I     E
Sbjct: 80  NLIKK-IENLDAVADTLEELWISYNQ----IASLSGIEKLVNLRVLYMSNN-KITNW-GE 132

Query: 267 IGNLRNLEVL 276
           I  L  L+ L
Sbjct: 133 IDKLAALDKL 142

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 45.4 bits (108), Expect = 3e-05
 Identities = 26/92 (28%), Positives = 39/92 (42%), Gaps = 10/92 (10%)

Query: 319 LPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGN 378
           L   + L L  NN    I SSL+ +  L +L  G N     I        +L+ L ++ N
Sbjct: 47  LKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYN 103

Query: 379 VLTSPTPDLSFLSSLTSCRNLEIIYLSENPIN 410
            + S       LS +    NL ++Y+S N I 
Sbjct: 104 QIAS-------LSGIEKLVNLRVLYMSNNKIT 128

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 43.9 bits (104), Expect = 8e-05
 Identities = 33/125 (26%), Positives = 51/125 (40%), Gaps = 12/125 (9%)

Query: 113 LPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQ 172
           +   LS L+  K+     NN  IE  S    +  L+ L L  N    KI         L+
Sbjct: 40  MDATLSTLKACKHLALSTNN--IEKISSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96

Query: 173 ELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIP-TNLWKCRELHVVSLA 231
           EL +S NQ++        ++S  + L  L  L++S N++T       L    +L  + LA
Sbjct: 97  ELWISYNQIA--------SLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLA 148

Query: 232 FNKFQ 236
            N   
Sbjct: 149 GNPLY 153

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 36/120 (30%), Positives = 59/120 (49%), Gaps = 14/120 (11%)

Query: 437 GIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLC-HLYR 495
           GIP      ++ T + L +N+L         +L +L  L L  N+++ S+P+ +   L +
Sbjct: 25  GIP------SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK 77

Query: 496 LANLYLGDNKLSGRLPACLG---NLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSN 552
           L  LYL +NKL   LP   G    LT L++L+L +N L S+       L  + +  L +N
Sbjct: 78  LTILYLHENKLQ-SLPN--GVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 40.3 bits (95), Expect = 9e-04
 Identities = 29/112 (25%), Positives = 53/112 (47%), Gaps = 10/112 (8%)

Query: 148 QHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFIS 207
             L L+ N            L+ L +L LS NQ+  ++P  +F+      L  L  L++ 
Sbjct: 31  TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFD-----KLTKLTILYLH 84

Query: 208 YNQLTGPIPTNLW-KCRELHVVSLAFNKFQGGIPRDI-GNLTSVRNLFLGNN 257
            N+L   +P  ++ K  +L  ++L  N+ +  +P  I   LTS++ ++L  N
Sbjct: 85  ENKLQS-LPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 56.3 bits (136), Expect = 3e-08
 Identities = 46/207 (22%), Positives = 89/207 (42%), Gaps = 31/207 (14%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA----ECKVMGSIRHR---- 817
           K++G GSFG V K         +A K+       + + FH     E +++  +R +    
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVR-----NEKRFHRQAAEEIRILEHLRKQDKDN 157

Query: 818 --NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYF---LDILQRLKIMIDVASALE 872
             N++ ++ + +  +   +  E +S  +L + +  + +    L +++  K    +   L+
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVR--KFAHSILQCLD 214

Query: 873 YLHFGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMA 930
            LH      I+HCD+KP N+LL +       + DFG +    +    R    + +  Y A
Sbjct: 215 ALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ----RVYTYIQSRFYRA 267

Query: 931 PEYGREGKVSRKCDVYSYGIMLMETFT 957
           PE     +     D++S G +L E  T
Sbjct: 268 PEVILGARYGMPIDMWSLGCILAELLT 294

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 53.5 bits (129), Expect = 3e-08
 Identities = 16/93 (17%), Positives = 35/93 (37%), Gaps = 3/93 (3%)

Query: 441 ELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLY 500
           +  N      + L   ++   I      L +   +   +N++   + +    L RL  L 
Sbjct: 14  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLL 70

Query: 501 LGDNKLSGRLPACLGNLTSLRDLSLGSNALTSI 533
           + +N++          L  L +L L +N+L  +
Sbjct: 71  VNNNRICRIGEGLDQALPDLTELILTNNSLVEL 103

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 52.7 bits (127), Expect = 5e-08
 Identities = 22/120 (18%), Positives = 38/120 (31%), Gaps = 14/120 (11%)

Query: 293 NISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNIS---ELSVL 349
           N    +EL +    +   +  ++   L   + +   +N         L        L  L
Sbjct: 17  NAVRDRELDLRGYKI--PVIENLGATLDQFDAIDFSDNEIR-----KLDGFPLLRRLKTL 69

Query: 350 DFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPI 409
               N    +       L  L  L L  N L     +L  L  L S ++L  + +  NP+
Sbjct: 70  LVNNNRICRIGEGLDQALPDLTELILTNNSLV----ELGDLDPLASLKSLTYLCILRNPV 125

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 49.3 bits (118), Expect = 9e-07
 Identities = 24/118 (20%), Positives = 43/118 (36%), Gaps = 14/118 (11%)

Query: 366 NLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSI--S 423
           N    + L L G  +      +  L +  +    + I  S+N I       +  F +   
Sbjct: 17  NAVRDRELDLRGYKIPV----IENLGA--TLDQFDAIDFSDNEI-----RKLDGFPLLRR 65

Query: 424 MKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVT-LGRLQKLQGLYLQNN 480
           +K+L + +  I          + +LT + L NN L     +  L  L+ L  L +  N
Sbjct: 66  LKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 22/101 (21%), Positives = 39/101 (38%), Gaps = 5/101 (4%)

Query: 466 LGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSL 525
                + + L L+  K+   I      L +   +   DN++  +L      L  L+ L +
Sbjct: 15  YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLV 71

Query: 526 GSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLK 566
            +N +  I       L D+    L++NSL    L D+  L 
Sbjct: 72  NNNRICRIGEGLDQALPDLTELILTNNSL--VELGDLDPLA 110

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 26/144 (18%), Positives = 45/144 (31%), Gaps = 29/144 (20%)

Query: 391 SSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTV 450
           +  T+      + L    I       I N   ++                          
Sbjct: 13  AQYTNAVRDRELDLRGYKI-----PVIENLGATLD---------------------QFDA 46

Query: 451 IRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSG-R 509
           I   +NE+   +      L++L+ L + NN++          L  L  L L +N L    
Sbjct: 47  IDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELG 104

Query: 510 LPACLGNLTSLRDLSLGSNALTSI 533
               L +L SL  L +  N +T+ 
Sbjct: 105 DLDPLASLKSLTYLCILRNPVTNK 128

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 23/111 (20%), Positives = 45/111 (40%), Gaps = 12/111 (10%)

Query: 168 LSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHV 227
               +ELDL   ++       I N+ +   L   + +  S N++   +       R L  
Sbjct: 18  AVRDRELDLRGYKIP-----VIENLGA--TLDQFDAIDFSDNEIR-KL-DGFPLLRRLKT 68

Query: 228 VSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSL--IGEIPNEIGNLRNLEVL 276
           + +  N+           L  +  L L NNSL  +G++ + + +L++L  L
Sbjct: 69  LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYL 118

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 30/124 (24%), Positives = 43/124 (34%), Gaps = 12/124 (9%)

Query: 91  PQLGNLSFLAVLAIRNN--SFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQ 148
            Q  N      L +R        +L   L     +   DF  N   I     F  L RL+
Sbjct: 13  AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAI---DFSDNE--IRKLDGFPLLRRLK 67

Query: 149 HLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISY 208
            LL+ +N            L  L EL L++N L       + ++    +L  L  L I  
Sbjct: 68  TLLVNNNRICRIGEGLDQALPDLTELILTNNSL-----VELGDLDPLASLKSLTYLCILR 122

Query: 209 NQLT 212
           N +T
Sbjct: 123 NPVT 126

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 52.8 bits (127), Expect = 3e-08
 Identities = 27/100 (27%), Positives = 45/100 (45%), Gaps = 5/100 (5%)

Query: 444 NINNLTVIRLGNNELT-GTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLG 502
             +++  + L N+    G +       ++L+ L   N  L  SI  +L  L +L  L L 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72

Query: 503 DNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLK 542
           DN++SG L        +L  L+L  N +  +  ST+  LK
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDL--STIEPLK 110

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 52.8 bits (127), Expect = 4e-08
 Identities = 26/117 (22%), Positives = 48/117 (41%), Gaps = 6/117 (5%)

Query: 293 NISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFG 352
             S +KEL + ++         +      LE L       + +I ++L  +++L  L+  
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72

Query: 353 FNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPI 409
            N  SG +        +L  L+L+GN +     DLS +  L    NL+ + L    +
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIK----DLSTIEPLKKLENLKSLDLFNCEV 125

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 48.5 bits (116), Expect = 1e-06
 Identities = 24/118 (20%), Positives = 40/118 (33%), Gaps = 12/118 (10%)

Query: 366 NLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFS--IS 423
               +K L L  +                    LE +      +     +SI N      
Sbjct: 15  TPSDVKELVLDNSRSNEG----KLEGLTDEFEELEFLSTINVGL-----TSIANLPKLNK 65

Query: 424 MKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVT-LGRLQKLQGLYLQNN 480
           +K L +    +SGG+        NLT + L  N++     +  L +L+ L+ L L N 
Sbjct: 66  LKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 46.2 bits (110), Expect = 6e-06
 Identities = 27/113 (23%), Positives = 49/113 (43%), Gaps = 4/113 (3%)

Query: 423 SMKSLSMESCNIS-GGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNK 481
            +K L +++   + G +         L  +   N  LT +I   L +L KL+ L L +N+
Sbjct: 18  DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNR 75

Query: 482 LEGSIPEDLCHLYRLANLYLGDNKLSG-RLPACLGNLTSLRDLSLGSNALTSI 533
           + G +         L +L L  NK+        L  L +L+ L L +  +T++
Sbjct: 76  VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNL 128

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.1 bits (107), Expect = 1e-05
 Identities = 24/108 (22%), Positives = 46/108 (42%), Gaps = 9/108 (8%)

Query: 151 LLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQ 210
           L    S  GK+         L+ L   +  L+        +I++   L  L+ L +S N+
Sbjct: 24  LDNSRSNEGKLEGLTDEFEELEFLSTINVGLT--------SIANLPKLNKLKKLELSDNR 75

Query: 211 LTGPIPTNLWKCRELHVVSLAFNKFQG-GIPRDIGNLTSVRNLFLGNN 257
           ++G +     KC  L  ++L+ NK +       +  L ++++L L N 
Sbjct: 76  VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 23/100 (23%), Positives = 38/100 (38%), Gaps = 5/100 (5%)

Query: 468 RLQKLQGLYLQNNKL-EGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLG 526
               ++ L L N++  EG +         L  L   +  L+  + A L  L  L+ L L 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72

Query: 527 SNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLK 566
            N ++  +        ++   NLS N +    L  I  LK
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLK 110

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 19/111 (17%), Positives = 49/111 (44%), Gaps = 4/111 (3%)

Query: 516 NLTSLRDLSLGSNALTSI-IPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLS 574
             + +++L L ++      +       +++   +  +  L  + + ++  L  + +++LS
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL--TSIANLPKLNKLKKLELS 72

Query: 575 LNALSGVIPVTIGGLQGLQLLSLRYNRLQGP-IPESFGGLKSLNFVDMSNN 624
            N +SG + V       L  L+L  N+++     E    L++L  +D+ N 
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 52.4 bits (126), Expect = 6e-08
 Identities = 30/101 (29%), Positives = 42/101 (41%), Gaps = 5/101 (4%)

Query: 444 NINNLTVIRLGNNELT-GTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLG 502
               +  + L N +   G I         L+ L L N  L  S+  +L  L +L  L L 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79

Query: 503 DNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKD 543
           +N++ G L      L +L  L+L  N L  I  STL  LK 
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDI--STLEPLKK 118

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 52.4 bits (126), Expect = 7e-08
 Identities = 26/117 (22%), Positives = 46/117 (39%), Gaps = 6/117 (5%)

Query: 293 NISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFG 352
             + ++EL + +          +     NLE L L       ++ S+L  + +L  L+  
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79

Query: 353 FNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPI 409
            N   G +      L +L  L+L+GN L     D+S L  L     L+ + L    +
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLK----DISTLEPLKKLECLKSLDLFNCEV 132

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 30/114 (26%), Positives = 52/114 (45%), Gaps = 6/114 (5%)

Query: 423 SMKSLSMESCNIS-GGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNK 481
           +++ L +++C  + G I        NL  + L N  L  ++   L +L KL+ L L  N+
Sbjct: 25  AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENR 82

Query: 482 LEGSIPEDLCHLYRLANLYLGDNKLSGRLP--ACLGNLTSLRDLSLGSNALTSI 533
           + G +      L  L +L L  NKL   +     L  L  L+ L L +  +T++
Sbjct: 83  IFGGLDMLAEKLPNLTHLNLSGNKLK-DISTLEPLKKLECLKSLDLFNCEVTNL 135

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 29/131 (22%), Positives = 50/131 (38%), Gaps = 14/131 (10%)

Query: 151 LLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQ 210
           L    S  GKI         L+ L L +  L         ++S+   LP L+ L +S N+
Sbjct: 31  LDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--------SVSNLPKLPKLKKLELSENR 82

Query: 211 LTGPIPTNLWKCRELHVVSLAFNKFQG-GIPRDIGNLTSVRNLFLGNNSLIGEIPN---- 265
           + G +     K   L  ++L+ NK +       +  L  +++L L N   +  + +    
Sbjct: 83  IFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCE-VTNLNDYRES 141

Query: 266 EIGNLRNLEVL 276
               L  L  L
Sbjct: 142 VFKLLPQLTYL 152

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.6 bits (103), Expect = 7e-05
 Identities = 26/140 (18%), Positives = 41/140 (29%), Gaps = 32/140 (22%)

Query: 366 NLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMK 425
              +++ L L                      NLE + L    +      S+ N      
Sbjct: 22  TPAAVRELVLDNCKSNDG----KIEGLTAEFVNLEFLSLINVGL-----ISVSNLP---- 68

Query: 426 SLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEG- 484
                              +  L  + L  N + G + +   +L  L  L L  NKL+  
Sbjct: 69  ------------------KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDI 110

Query: 485 SIPEDLCHLYRLANLYLGDN 504
           S  E L  L  L +L L + 
Sbjct: 111 STLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 41.3 bits (97), Expect = 4e-04
 Identities = 24/100 (24%), Positives = 37/100 (37%), Gaps = 5/100 (5%)

Query: 468 RLQKLQGLYLQNNKL-EGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLG 526
               ++ L L N K  +G I         L  L L +  L   + + L  L  L+ L L 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79

Query: 527 SNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLK 566
            N +   +      L ++   NLS N L    +  +  LK
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKL--KDISTLEPLK 117

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 41.3 bits (97), Expect = 4e-04
 Identities = 22/111 (19%), Positives = 46/111 (41%), Gaps = 4/111 (3%)

Query: 516 NLTSLRDLSLGSNALTSI-IPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLS 574
              ++R+L L +       I        ++   +L +  L    + ++  L  + +++LS
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL--ISVSNLPKLPKLKKLELS 79

Query: 575 LNALSGVIPVTIGGLQGLQLLSLRYNRLQGP-IPESFGGLKSLNFVDMSNN 624
            N + G + +    L  L  L+L  N+L+     E    L+ L  +D+ N 
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 40.5 bits (95), Expect = 7e-04
 Identities = 22/102 (21%), Positives = 38/102 (37%), Gaps = 7/102 (6%)

Query: 111 GSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSL 170
           G +    +    L++         +   S    LP+L+ L L  N   G +      L  
Sbjct: 39  GKIEGLTAEFVNLEFLSLINVG--LISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPN 96

Query: 171 LQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLT 212
           L  L+LS N+L       I  +   + L  L+ L +   ++T
Sbjct: 97  LTHLNLSGNKL-----KDISTLEPLKKLECLKSLDLFNCEVT 133

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 55.7 bits (134), Expect = 6e-08
 Identities = 57/394 (14%), Positives = 129/394 (32%), Gaps = 43/394 (10%)

Query: 95  NLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKH 154
           +L    V  +  +      P+  + L  L             +       P L+ L L  
Sbjct: 162 DLRESDVDDVSGHWL-SHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNR 220

Query: 155 NSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGP 214
              + K+   +     L+EL                   +      L  L   ++ +   
Sbjct: 221 AVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAY 280

Query: 215 IPTNLWKCRELHVVSLAFNKFQG-GIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNL 273
           +P     C  L  ++L++   Q   + + +     ++ L++ +          I +   L
Sbjct: 281 LPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY---------IED-AGL 330

Query: 274 EVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFS 333
           EVL     +L  L             +A+T+  L+     S+ +G P LE +        
Sbjct: 331 EVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLV-----SVSMGCPKLESVL------- 378

Query: 334 GTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTP---DLSFL 390
                    ++  +++    N           N+   +L  +        T    D+ F 
Sbjct: 379 ----YFCRQMTNAALITIARN---------RPNMTRFRLCIIEPKAPDYLTLEPLDIGFG 425

Query: 391 SSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISG-GIPKELGNINNLT 449
           + +  C++L  + LS    + +    IG ++  M+ LS+     S  G+   L   ++L 
Sbjct: 426 AIVEHCKDLRRLSLSGLLTDKVF-EYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLR 484

Query: 450 VIRLGNNELTG-TIPVTLGRLQKLQGLYLQNNKL 482
            + + +       +     +L+ ++ L++ +  +
Sbjct: 485 KLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 45.7 bits (108), Expect = 8e-05
 Identities = 51/331 (15%), Positives = 105/331 (31%), Gaps = 53/331 (16%)

Query: 293 NISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFG 352
           + +    +       +     ++      LE +                 +  + V D  
Sbjct: 78  HFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEI----------------RLKRMVVTDDC 121

Query: 353 FNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGI 412
               +     +F N + L L S  G   +         +   +CRNL+ + L E+ ++ +
Sbjct: 122 LELIA----KSFKNFKVLVLSSCEG--FS----TDGLAAIAATCRNLKELDLRESDVDDV 171

Query: 413 LPSSIGNFSISMKSLSMESCNISG--------GIPKELGNINNLTVIRLGNNELTGTIPV 464
               + +F  +  SL   S NIS          + + +    NL  ++L        +  
Sbjct: 172 SGHWLSHFPDTYTSL--VSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLAT 229

Query: 465 TLGRLQKLQGLYLQ------NNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLT 518
            L R  +L+ L            +   +   L     L  L    + +   LPA     +
Sbjct: 230 LLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCS 289

Query: 519 SLRDLSL-----GSNALTSIIPSTLWNLKDI-LRFNLSSNSLNGSLLPDIGNLKVVIEMD 572
            L  L+L      S  L  ++      L+ + +   +    L   L     +L+ +    
Sbjct: 290 RLTTLNLSYATVQSYDLVKLL-CQCPKLQRLWVLDYIEDAGLE-VLASTCKDLRELRVFP 347

Query: 573 LSLNALSGVIPVTIGGLQGLQLLSLRYNRLQ 603
                +   + +T    QGL  +S+   +L+
Sbjct: 348 SEPFVMEPNVALT---EQGLVSVSMGCPKLE 375

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 73/485 (15%), Positives = 145/485 (29%), Gaps = 58/485 (11%)

Query: 16  LMLSSVMAAVTNVTTDQFALLALKEHIKHDPSNLLANNWSTTSSVCSWIGVTCGVRNRRV 75
                +     N+ +     L LK   +    NL+  NW       +          R++
Sbjct: 63  ATPDRLSRRFPNLRS-----LKLKGKPRAAMFNLIPENWG---GYVTPWVTEISNNLRQL 114

Query: 76  TALNISYLGLTGTIPPQL--GNLSFLAVLAIRNNSFFG--SLPEELSHLRGLKYFDFRFN 131
            +++   + ++     +L       L  L +   S F    L   ++H R +K      +
Sbjct: 115 KSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEES 174

Query: 132 NFHIEIPSWFVSL----PRLQHLLLKHNSFVGKIPETIGYL----SLLQELDLSDNQLSG 183
           +F  +   W   L      L+ L      F    P+ +  +      L  + + D ++  
Sbjct: 175 SFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEIL- 233

Query: 184 TIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDI 243
                +    +  NL    G  ++ +        NL   R+L  + L        +P   
Sbjct: 234 ---ELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGL-SYMGPNEMPILF 289

Query: 244 GNLTSVRNLFLGNNSLIGEIPNE-IGNLRNLEVLGVQSS-NLAGLIPASIFNISTLKELA 301
                +R L L    L  E     I    NLEVL  ++     GL          LK L 
Sbjct: 290 PFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLE-VLAQYCKQLKRLR 348

Query: 302 VTDNDLLGSLPS-----------SIDLGLPNLERLFLGENNFS----GTIPSSLTNISEL 346
           +        +             ++  G   LE + +  ++ +     +I + L N+ + 
Sbjct: 349 IERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDF 408

Query: 347 SVL---------DFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCR 397
            ++         D   ++    +      LR        G +      DL          
Sbjct: 409 RLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGL-----TDLGLSYIGQYSP 463

Query: 398 NLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNIS-GGIPKELGNINNLTVIRLGNN 456
           N+  + L     +            +++ L M  C  S   I   +  + +L  + +   
Sbjct: 464 NVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGY 523

Query: 457 ELTGT 461
             + T
Sbjct: 524 RASMT 528

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 43.8 bits (103), Expect = 3e-04
 Identities = 60/369 (16%), Positives = 123/369 (33%), Gaps = 39/369 (10%)

Query: 301 AVTDNDLLGSLPS--SIDL-GLPNLERLFLGENNFSGTIPSSLTNISE----LSVLDFGF 353
             T + L    P+  S+ L G P      L   N+ G +   +T IS     L  + F  
Sbjct: 62  TATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRR 121

Query: 354 NSFS--GLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPING 411
              S   L          L+ L L      +       LS +T CR ++ + + E+  + 
Sbjct: 122 MIVSDLDLDRLAKARADDLETLKLDKCSGFT---TDGLLSIVTHCRKIKTLLMEESSFSE 178

Query: 412 ILPSSIGNFSISMKSLSMESCNISG-------GIPKELGNINNLTVIRLGNNELT--GTI 462
                +   +    SL + +  ++         +     N  +L  +++G+ E+      
Sbjct: 179 KDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGF 238

Query: 463 PVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANL---YLGDNKLSGRLPACLGNLTS 519
                 L++  G  L  +        +L    +L  L   Y+G N++    P     +  
Sbjct: 239 FKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFA-AQIRK 297

Query: 520 LRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALS 579
           L DL   +   T    + +    ++      +   +  L       K +  + +   A  
Sbjct: 298 L-DLL-YALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADE 355

Query: 580 GVIPVTIGGL--QGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEAL 637
             +    G +  +GL  L+     L+           ++   D++N +L  +I   ++ L
Sbjct: 356 QGMEDEEGLVSQRGLIALAQGCQELE---------YMAVYVSDITNESLE-SIGTYLKNL 405

Query: 638 SYLKHLNLS 646
              + + L 
Sbjct: 406 CDFRLVLLD 414

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 51/369 (13%), Positives = 105/369 (28%), Gaps = 72/369 (19%)

Query: 320 PNLERLFLGENNFSGTIPSSL-----TNISELSVLDFGFNSFS-----GLIPTTFGNLRS 369
             +  L L  NN        L        + ++ L+   NS        L+        +
Sbjct: 22  HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81

Query: 370 LKLLSLAGNVLTSPTPDLSFLSSL--TSCRNLEIIYLSENPING----ILPSSIGNFSIS 423
           +  L+L+GN L+        L          + ++ L  N  +         +  N   S
Sbjct: 82  VTSLNLSGNFLSYK--SSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPAS 139

Query: 424 MKSLSMESCNISG----GIPKELGNIN-NLTVIRLGNNELTGTIPVTLGRL-----QKLQ 473
           + SL++   ++       + + L  I  N+  + L  N L       L +        + 
Sbjct: 140 ITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVT 199

Query: 474 GLYLQNNKLEGSIPEDLCHL-----YRLANLYLGDNKLSG----RLPACLGNLTSLRDLS 524
            L L  N L      +L ++       + +L L  N L G     L     +L  L+ + 
Sbjct: 200 SLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVY 259

Query: 525 LGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPV 584
           L  + + ++       L                      N++ +I +D +   +      
Sbjct: 260 LDYDIVKNMSKEQCKALGAAFP-----------------NIQKIILVDKNGKEI------ 296

Query: 585 TIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEA--LSYLKH 642
                     +S   N ++       G     + ++              +      L+ 
Sbjct: 297 ---HPSHSIPIS---NLIRELS----GKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRE 346

Query: 643 LNLSFNQLE 651
              +   L 
Sbjct: 347 SIQTCKPLL 355

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 49.7 bits (119), Expect = 3e-06
 Identities = 52/308 (16%), Positives = 99/308 (32%), Gaps = 73/308 (23%)

Query: 393 LTSCRNLEIIYLSENPINGI----LPSSIGNFSISMKSLSMESCNIS----GGIPKELGN 444
            +    +  + LS N +  I    L  +  N   S+ SL++   ++       + + L  
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77

Query: 445 IN-NLTVIRLGNNELTGTIPVTLGRL-----QKLQGLYLQNNKLEGSIPEDLCHLYRLAN 498
           I  N+T + L  N L+      L +        +  L L  N        +    +    
Sbjct: 78  IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137

Query: 499 -----LYLGDNKLSGR----LPACLGNL-TSLRDLSLGSNALTSI-----------IPST 537
                L L  N L  +    L   L  +  ++  L+L  N L S            IP++
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS 197

Query: 538 LWNLKDILRFNLSSNSLNGSLLPDIG-----NLKVVIEMDLSLNALSGVIPVTIGGLQGL 592
           + +L      +LS+N L      ++          V+ ++L LN L G           L
Sbjct: 198 VTSL------DLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHG---------PSL 242

Query: 593 QLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEAL-------SYLKHLNL 645
           + L                 LK L  V +  + +     +  +AL         +  ++ 
Sbjct: 243 ENLK-----------LLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDK 291

Query: 646 SFNQLEGE 653
           +  ++   
Sbjct: 292 NGKEIHPS 299

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 52.8 bits (127), Expect = 4e-07
 Identities = 47/251 (18%), Positives = 91/251 (36%), Gaps = 48/251 (19%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA----ECKVMGSIRHRNLVK 821
           + LG G F +V+    + +   +A K+         + +      E K++  +   +  K
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVR-----GDKVYTEAAEDEIKLLQRVNDADNTK 79

Query: 822 IISSCSNN--------DFKA-------LVLEYMSNGSLEKCLYSDNYF---LDILQRLKI 863
             S  +N+        + K        +V E +   +L   +    +    L  ++  +I
Sbjct: 80  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVK--QI 136

Query: 864 MIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGH------LSDFGIAKILGKEESM 917
              +   L+Y+H      I+H DIKP NVL+             ++D G A    +    
Sbjct: 137 SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--- 191

Query: 918 RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVG 977
             T ++ T  Y +PE           D++S   ++ E  T     D +F  +        
Sbjct: 192 -YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT----GDFLFEPDEGHSYTKD 246

Query: 978 DSLLSCSITEV 988
           D  ++  I E+
Sbjct: 247 DDHIAQ-IIEL 256

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 48.6 bits (116), Expect = 7e-06
 Identities = 46/206 (22%), Positives = 84/206 (40%), Gaps = 25/206 (12%)

Query: 766 NKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA----ECKVMGSIRHR--- 817
           + L+G GSFG V K     +   +A K+       + ++F      E +++  +      
Sbjct: 59  DSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-----NKKAFLNQAQIEVRLLELMNKHDTE 113

Query: 818 ---NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYF-LDILQRLKIMIDVASALEY 873
               +V +       +   LV E +S  +L   L + N+  + +    K    + +AL +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172

Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMAP 931
           L     + I+HCD+KP N+LL         + DFG +         R  + + +  Y +P
Sbjct: 173 LATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----LGQRIYQYIQSRFYRSP 227

Query: 932 EYGREGKVSRKCDVYSYGIMLMETFT 957
           E           D++S G +L+E  T
Sbjct: 228 EVLLGMPYDLAIDMWSLGCILVEMHT 253

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 48.1 bits (115), Expect = 9e-06
 Identities = 47/238 (19%), Positives = 85/238 (35%), Gaps = 71/238 (29%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHA----ECKVMGSIRHR---- 817
           + +G G+FG V     + +    A KV       +++ +      E  ++  I++     
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVVR-----NIKKYTRSAKIEADILKKIQNDDINN 95

Query: 818 -NLVKIISSCSNNDFKA---LVLEYMSNGSLEKCLYS---DNYF----LDILQRLKIMID 866
            N+VK         +     L+ E      L   LY     N +    ++ ++     I+
Sbjct: 96  NNIVKYHGKF---MYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIK--LYCIE 145

Query: 867 VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTK----- 921
           +  AL YL       + H D+KP N+LL++               GK+  + +TK     
Sbjct: 146 ILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202

Query: 922 ------------TLGTI----GYMAPE------YGREGKVSRKCDVYSYGIMLMETFT 957
                         G+I     Y APE      +          D++S+G +L E +T
Sbjct: 203 LIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAELYT 254

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 48.0 bits (113), Expect = 1e-05
 Identities = 34/162 (20%), Positives = 58/162 (35%), Gaps = 21/162 (12%)

Query: 510 LPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIG------ 563
           L   L  +  L +L +      SI      NLK      + S  L  S++ DI       
Sbjct: 164 LSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLK---SLEIISGGLPDSVVEDILGSDLPN 220

Query: 564 ----NLKVVIEMDLSLNALSGVIPVTIGG-LQGLQLLSLRYNRLQGPIPESFGG---LKS 615
                L V +E       ++   P+        L+ L +     Q  + E F     L  
Sbjct: 221 LEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQ 280

Query: 616 LNFVDMSNNNLSGT----IPKSMEALSYLKHLNLSFNQLEGE 653
           L  +D+S   L+      +   ++ + +LK +N+ +N L  E
Sbjct: 281 LETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 44.2 bits (103), Expect = 1e-04
 Identities = 27/194 (13%), Positives = 65/194 (33%), Gaps = 24/194 (12%)

Query: 319 LPNLERLFLGENNFS---------GTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRS 369
             + E LF G+ +F            +   L  +  L+ L     +   +      NL+S
Sbjct: 138 FAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKS 197

Query: 370 LKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSI-----GNFSISM 424
           L+++S     L     +    S L +   L +    E+       +        +   ++
Sbjct: 198 LEIIS---GGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNL 254

Query: 425 KSLSMESCNISGGIPKELGN---INNLTVIRLGNNELTGT----IPVTLGRLQKLQGLYL 477
           K L +        + +       +  L  + +    LT      +   + +++ L+ + +
Sbjct: 255 KWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINM 314

Query: 478 QNNKLEGSIPEDLC 491
           + N L   + ++L 
Sbjct: 315 KYNYLSDEMKKELQ 328

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 44.2 bits (105), Expect = 5e-05
 Identities = 32/97 (32%), Positives = 40/97 (41%), Gaps = 18/97 (18%)

Query: 462 IPVTLGRLQKLQGLYLQNNKLEGSIPE---DLCHLYRLANLYLGDNKLSGRLPACLG--- 515
           IP         Q L+L NN++   +     D  HL  L  LY   NKL+  +P   G   
Sbjct: 31  IPTDK------QRLWLNNNQIT-KLEPGVFD--HLVNLQQLYFNSNKLT-AIPT--GVFD 78

Query: 516 NLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSN 552
            LT L  L L  N L SI      NLK +    L +N
Sbjct: 79  KLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 42.6 bits (101), Expect = 2e-04
 Identities = 34/98 (34%), Positives = 44/98 (44%), Gaps = 18/98 (18%)

Query: 437 GIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPE---DLCHL 493
           GIP       +   + L NN++T   P     L  LQ LY  +NKL  +IP    D   L
Sbjct: 30  GIP------TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFD--KL 80

Query: 494 YRLANLYLGDNKLSGRLPACLG---NLTSLRDLSLGSN 528
            +L  L L DN L   +P   G   NL SL  + L +N
Sbjct: 81  TQLTQLDLNDNHLK-SIPR--GAFDNLKSLTHIYLYNN 115

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 43.8 bits (104), Expect = 6e-05
 Identities = 34/97 (35%), Positives = 44/97 (45%), Gaps = 18/97 (18%)

Query: 462 IPVTLGRLQKLQGLYLQNNKLEGSIPE---DLCHLYRLANLYLGDNKLSGRLPACLG--- 515
           IP T       Q LYL +N++   +     D   L +L  L L +N+L+  LPA  G   
Sbjct: 28  IPTTT------QVLYLYDNQIT-KLEPGVFD--RLTQLTRLDLDNNQLT-VLPA--GVFD 75

Query: 516 NLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSN 552
            LT L  LSL  N L SI      NLK +    L +N
Sbjct: 76  KLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 43.4 bits (103), Expect = 8e-05
 Identities = 31/95 (32%), Positives = 42/95 (44%), Gaps = 12/95 (12%)

Query: 437 GIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPE---DLCHL 493
           GIP          V+ L +N++T   P    RL +L  L L NN+L   +P    D   L
Sbjct: 27  GIP------TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFD--KL 77

Query: 494 YRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSN 528
            +L  L L DN+L         NL SL  + L +N
Sbjct: 78  TQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNN 112

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 43.1 bits (102), Expect = 3e-04
 Identities = 43/234 (18%), Positives = 79/234 (33%), Gaps = 67/234 (28%)

Query: 767 KLLGMGSFGSVYKGV--LPDGMEIAAKVFHMEFDGSLESFHA----ECKVMGSIRHR--- 817
             LG G+FG V + +       ++A K+       ++  +      E  V+  I+ +   
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKIIR-----NVGKYREAARLEINVLKKIKEKDKE 79

Query: 818 ---NLVKIISSCSNNDFKA---LVLEYMSNGSLEKCLYS---DNYF----LDILQRLKIM 864
                V +       +F     +  E      L K  +    +N F    L  ++   + 
Sbjct: 80  NKFLCVLMSDWF---NFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHVR--HMA 129

Query: 865 IDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR------ 918
             +  AL +LH      + H D+KP N+L   S    L +   +      ++        
Sbjct: 130 YQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186

Query: 919 -----QTKTLGTI----GYMAPE------YGREGKVSRKCDVYSYGIMLMETFT 957
                  +   TI     Y  PE      +      ++ CDV+S G +L E + 
Sbjct: 187 GSATFDHEHHTTIVATRHYRPPEVILELGW------AQPCDVWSIGCILFEYYR 234

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 41.9 bits (99), Expect = 8e-04
 Identities = 24/109 (22%), Positives = 42/109 (38%), Gaps = 30/109 (27%)

Query: 870 ALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR----------- 918
           ++ +LH   S  + H D+KP N+L  +S      +  I +      +             
Sbjct: 130 SVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY 186

Query: 919 QTKTLGTI----GYMAPE------YGREGKVSRKCDVYSYGIMLMETFT 957
             +   T+     Y APE      +      S+ CDV+S G +L+E + 
Sbjct: 187 DDEHHSTLVSTRHYRAPEVILALGW------SQPCDVWSIGCILIEYYL 229

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	1049
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.98
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.98
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.97
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.96
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.95
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.94
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.94
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.94
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.94
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.93
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.93
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.93
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.93
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.93
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.92
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.92
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.9
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.9
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.89
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.89
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.89
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.89
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.89
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.88
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.88
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.88
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.88
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.88
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.88
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.87
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.87
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.87
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.87
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.86
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.86
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.86
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.83
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.82
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.82
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.82
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.82
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.81
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.81
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.79
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.79
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.78
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.78
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.78
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.78
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.78
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.78
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.77
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.75
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.74
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.73
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.73
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.73
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.72
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.72
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.71
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.7
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.67
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.66
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.62
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.62
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.62
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.61
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.6
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.58
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.58
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.58
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.58
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.56
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.55
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.54
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.53
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.52
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.49
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.48
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.48
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.44
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.42
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.37
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.29
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.29
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.26
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.26
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.25
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.24
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.23
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	99.12
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.92
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.91
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.91
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.87
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.84
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.78
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.47
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.42
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.38
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.32
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.32
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.31
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.27
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.24
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.17
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.8
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.8
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.76
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.72
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.69
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.67
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.67
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.32
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.28
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.13
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.05
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.01
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.0
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.99
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.97
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.93
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.65
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.6
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.5
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.37
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.35
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.09
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.42
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.45

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=3.4e-90  Score=864.74  Aligned_cols=649  Identities=30%  Similarity=0.490  Sum_probs=466.4

Q ss_pred             hhccCChhhHHHHHHHHHhcccCCCCcccccCCCCCCCceeeeEEEcCCCCcEEEEEEeccccccc---cCCCCCCcchh
Q 039290           23 AAVTNVTTDQFALLALKEHIKHDPSNLLANNWSTTSSVCSWIGVTCGVRNRRVTALNISYLGLTGT---IPPQLGNLSFL   99 (1049)
Q Consensus        23 ~~~~~~~~d~~all~~k~~~~~~~~~~l~~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~---~~~~~~~l~~L   99 (1049)
                      +++.+.++|++|||+||+++. ||. .+ ++|+.+++||+|+||+|+  ++||++|+|++.++.|.   +|+++++|++|
T Consensus         5 ~~~~~~~~~~~all~~k~~~~-~~~-~l-~~W~~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L   79 (768)
T 3rgz_A            5 SPSQSLYREIHQLISFKDVLP-DKN-LL-PDWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGL   79 (768)
T ss_dssp             ---CCHHHHHHHHHHHHTTCS-CTT-SS-TTCCTTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTC
T ss_pred             ccccCCHHHHHHHHHHHhhCC-Ccc-cc-cCCCCCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcc
Confidence            344456899999999999996 887 66 599988999999999998  68999999999999998   77666666555


Q ss_pred             hhhhcccCccccccCcccccccCCcEeccccCCccccCcc--cccccCCccEEEeCCCCccCCCcccc-cCCCcccEEcC
Q 039290          100 AVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPS--WFVSLPRLQHLLLKHNSFVGKIPETI-GYLSLLQELDL  176 (1049)
Q Consensus       100 ~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~--~~~~l~~L~~L~L~~n~l~~~~p~~~-~~l~~L~~L~L  176 (1049)
                      +.++++.|.+. .+|+.++++++|++|||++|++.|.+|.  .++++++|++|+|++|.+++.+|..+ +++++|++|||
T Consensus        80 ~~l~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L  158 (768)
T 3rgz_A           80 ESLFLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL  158 (768)
T ss_dssp             CEEECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEEC
T ss_pred             cccCCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEEC
Confidence            55555555443 3446666666666666666666666666  66666666666666666666666554 56666666666


Q ss_pred             CCccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceEEecc
Q 039290          177 SDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGN  256 (1049)
Q Consensus       177 s~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  256 (1049)
                      ++|++++.+|..+..   +.++++|++|++++|++++.+|.  ..+++|++|+|++|++++.+|. ++++++|++|+|++
T Consensus       159 s~n~l~~~~~~~~~~---~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~  232 (768)
T 3rgz_A          159 SANSISGANVVGWVL---SDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISG  232 (768)
T ss_dssp             CSSCCEEETHHHHHH---TTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCS
T ss_pred             CCCccCCcCChhhhh---hccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcC
Confidence            666666555443110   11233455555555555544332  4445555555555555544444 55555555555555


Q ss_pred             ccccccCccccccccceEEEeeccccCCCccccccccccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCC
Q 039290          257 NSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTI  336 (1049)
Q Consensus       257 N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~  336 (1049)
                      |++++.+|..++++++|++|+|++|++.+.+|..  .+++|++|++++|++.+.+|..++..+++|++|+|++|++++.+
T Consensus       233 n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~  310 (768)
T 3rgz_A          233 NKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAV  310 (768)
T ss_dssp             SCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECC
T ss_pred             CcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCcc
Confidence            5555555555555555555555555555444433  44455555555555554555444433345555555555555445


Q ss_pred             CccccCCCCCceeecccCccccCcccc-cccccccceeecccccccC-CCCCccc-------------------cccccc
Q 039290          337 PSSLTNISELSVLDFGFNSFSGLIPTT-FGNLRSLKLLSLAGNVLTS-PTPDLSF-------------------LSSLTS  395 (1049)
Q Consensus       337 p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~-~~~~~~~-------------------l~~l~~  395 (1049)
                      |..|+++++|++|++++|++.+.+|.. |+++++|++|++++|.+++ ++..+..                   ...+..
T Consensus       311 p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~  390 (768)
T 3rgz_A          311 PPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQ  390 (768)
T ss_dssp             CGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTC
T ss_pred             chHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhh
Confidence            555555555555555555554444433 4444455555555544442 1211100                   011222


Q ss_pred             --CCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCc
Q 039290          396 --CRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQ  473 (1049)
Q Consensus       396 --l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  473 (1049)
                        +++|++|++++|.+++.+|..+..+. +|++|+|++|++++.+|..++++++|++|+|++|.+++.+|..+..+++|+
T Consensus       391 ~~~~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~  469 (768)
T 3rgz_A          391 NPKNTLQELYLQNNGFTGKIPPTLSNCS-ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLE  469 (768)
T ss_dssp             STTCCCCEEECCSSEEEEECCGGGGGCT-TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCC
T ss_pred             cccCCccEEECCCCccccccCHHHhcCC-CCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCce
Confidence              56788888888888888888887775 888889998888888888888888999999999998888888888889999


Q ss_pred             ceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCc
Q 039290          474 GLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNS  553 (1049)
Q Consensus       474 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~  553 (1049)
                      +|+|++|++++.+|..+..+++|++|++++|++++.+|..++++++|++|+|++|++++.+|..+..+++|+.|++++|+
T Consensus       470 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~  549 (768)
T 3rgz_A          470 TLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNL  549 (768)
T ss_dssp             EEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSE
T ss_pred             EEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCc
Confidence            99999999988888888899999999999999988889889999999999999999998889999999999999999988


Q ss_pred             cCCCCccC----------------------------------------------------------------------cC
Q 039290          554 LNGSLLPD----------------------------------------------------------------------IG  563 (1049)
Q Consensus       554 l~~~~~~~----------------------------------------------------------------------~~  563 (1049)
                      +++.+|..                                                                      ++
T Consensus       550 l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~  629 (768)
T 3rgz_A          550 FNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFD  629 (768)
T ss_dssp             EESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCS
T ss_pred             cCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhh
Confidence            88766643                                                                      44


Q ss_pred             CCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCccccccccccccee
Q 039290          564 NLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHL  643 (1049)
Q Consensus       564 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l  643 (1049)
                      .+++|+.|||++|+++|.+|.+|+++++|+.|+|++|+++|.+|..|+++++|++|||++|+++|.+|..+..+++|++|
T Consensus       630 ~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L  709 (768)
T 3rgz_A          630 NNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEI  709 (768)
T ss_dssp             SSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEE
T ss_pred             ccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEE
Confidence            46789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eccCCcccccCCCCCCccccccccccCCccccCCCCccCCCCCCCC
Q 039290          644 NLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSPKLQVSPCKTRS  689 (1049)
Q Consensus       644 ~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~cg~~~~~~~~c~~~~  689 (1049)
                      |+++|+++|.+|..++|.++...+|.||+++||.|.   ++|....
T Consensus       710 ~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l---~~C~~~~  752 (768)
T 3rgz_A          710 DLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPL---PRCDPSN  752 (768)
T ss_dssp             ECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTS---CCCCSCC
T ss_pred             ECcCCcccccCCCchhhccCCHHHhcCCchhcCCCC---cCCCCCc
Confidence            999999999999999999999999999999999984   3786543

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=4.3e-72  Score=701.05  Aligned_cols=563  Identities=33%  Similarity=0.465  Sum_probs=414.2

Q ss_pred             EEEEEEeccccccccCC--CCCCcchhhhhhcccCccccccCccc-ccccCCcEeccccCCccccCccc---ccccCCcc
Q 039290           75 VTALNISYLGLTGTIPP--QLGNLSFLAVLAIRNNSFFGSLPEEL-SHLRGLKYFDFRFNNFHIEIPSW---FVSLPRLQ  148 (1049)
Q Consensus        75 v~~l~l~~~~l~g~~~~--~~~~l~~L~~L~l~~n~~~g~~p~~~-~~L~~L~~L~l~~n~~~~~~p~~---~~~l~~L~  148 (1049)
                      ++.|||+++.+.|.+|.  .++++++|++|+|++|.+.|.+|..+ +++++|++|||++|++++.+|..   +.++++|+
T Consensus       102 L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~  181 (768)
T 3rgz_A          102 LTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELK  181 (768)
T ss_dssp             CCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCC
T ss_pred             CCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCC
Confidence            34444444444444444  44444444444444444444444433 34444444444444444444433   34444444


Q ss_pred             EEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCccccccccee
Q 039290          149 HLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVV  228 (1049)
Q Consensus       149 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L  228 (1049)
                      +|+|++|.+++.+|.  +.+++|++|+|++|++++.+|. ++      ++++|++|++++|++++.+|..+..+++|++|
T Consensus       182 ~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~------~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L  252 (768)
T 3rgz_A          182 HLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LG------DCSALQHLDISGNKLSGDFSRAISTCTELKLL  252 (768)
T ss_dssp             EEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CT------TCCSCCEEECCSSCCCSCHHHHTTTCSSCCEE
T ss_pred             EEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cc------cCCCCCEEECcCCcCCCcccHHHhcCCCCCEE
Confidence            444444444443332  4455555555555555544443 32      23446666666666666666666666666666


Q ss_pred             cccccccccccCCCCccccccceEEeccccccccCccccccc-cceEEEeeccccCCCccccccccccccceEEeccCcc
Q 039290          229 SLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNL-RNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDL  307 (1049)
Q Consensus       229 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l  307 (1049)
                      +|++|+++|.+|..  .+++|++|+|++|++++.+|..+..+ ++|++|+|++|++.+.+|..+.++++|++|++++|++
T Consensus       253 ~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l  330 (768)
T 3rgz_A          253 NISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNF  330 (768)
T ss_dssp             ECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEE
T ss_pred             ECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcc
Confidence            66666666665554  56666666666666666777766664 7777777777777777777777777777777777777


Q ss_pred             CCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCC-CCceeecccCccccCccccccc--ccccceeecccccccCCC
Q 039290          308 LGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNIS-ELSVLDFGFNSFSGLIPTTFGN--LRSLKLLSLAGNVLTSPT  384 (1049)
Q Consensus       308 ~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~--l~~L~~L~L~~N~l~~~~  384 (1049)
                      .|.+|...+..+++|++|++++|++++.+|..+.+++ +|++|++++|++++.+|..+..  +++|++|++++|.+++..
T Consensus       331 ~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~  410 (768)
T 3rgz_A          331 SGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKI  410 (768)
T ss_dssp             EEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEEC
T ss_pred             cCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCcccccc
Confidence            7777766555677777777777777777777777766 7777777777777766666665  667777777777776543


Q ss_pred             CCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCc
Q 039290          385 PDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPV  464 (1049)
Q Consensus       385 ~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  464 (1049)
                      +     ..+..+++|++|++++|++++..|..+..+. +|+.|++++|.+++.+|..+..+++|++|+|++|++++.+|.
T Consensus       411 p-----~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  484 (768)
T 3rgz_A          411 P-----PTLSNCSELVSLHLSFNYLSGTIPSSLGSLS-KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS  484 (768)
T ss_dssp             C-----GGGGGCTTCCEEECCSSEEESCCCGGGGGCT-TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCG
T ss_pred             C-----HHHhcCCCCCEEECcCCcccCcccHHHhcCC-CCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCH
Confidence            3     2477888899999999999888888888776 899999999999988898898999999999999999988888


Q ss_pred             cccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccccCccc------
Q 039290          465 TLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTL------  538 (1049)
Q Consensus       465 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~------  538 (1049)
                      .++.+++|++|+|++|++++.+|.+++.+++|++|++++|++++.+|..++++++|++|++++|++++.+|..+      
T Consensus       485 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~  564 (768)
T 3rgz_A          485 GLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK  564 (768)
T ss_dssp             GGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTC
T ss_pred             HHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccch
Confidence            89999999999999999988889999999999999999999988889899999999999999998887666543      


Q ss_pred             ----------------------------------------------------------------ccccccccccccCCcc
Q 039290          539 ----------------------------------------------------------------WNLKDILRFNLSSNSL  554 (1049)
Q Consensus       539 ----------------------------------------------------------------~~l~~L~~L~Ls~N~l  554 (1049)
                                                                                      ..+++|+.|+|++|++
T Consensus       565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l  644 (768)
T 3rgz_A          565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNML  644 (768)
T ss_dssp             BCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCC
T ss_pred             hhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcc
Confidence                                                                            3457789999999999


Q ss_pred             CCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCccccc
Q 039290          555 NGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSM  634 (1049)
Q Consensus       555 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~  634 (1049)
                      +|.+|..++.++.|+.|+|++|+++|.+|..|+++++|+.|+|++|+++|.+|..|+++++|++|||++|+++|.+|.. 
T Consensus       645 ~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-  723 (768)
T 3rgz_A          645 SGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-  723 (768)
T ss_dssp             BSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-
T ss_pred             cccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999999964 


Q ss_pred             ccccccceeeccCCcccccCC
Q 039290          635 EALSYLKHLNLSFNQLEGEIP  655 (1049)
Q Consensus       635 ~~l~~L~~l~l~~N~l~~~~p  655 (1049)
                      ..+.++....+.+|+.-|-.|
T Consensus       724 ~~~~~~~~~~~~gN~~Lcg~~  744 (768)
T 3rgz_A          724 GQFETFPPAKFLNNPGLCGYP  744 (768)
T ss_dssp             SSGGGSCGGGGCSCTEEESTT
T ss_pred             hhhccCCHHHhcCCchhcCCC
Confidence            455666777788998555333

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=5.1e-64  Score=622.72  Aligned_cols=572  Identities=21%  Similarity=0.226  Sum_probs=424.4

Q ss_pred             CcEEEEEEeccccccccCCCCCCcchhhhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEe
Q 039290           73 RRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLL  152 (1049)
Q Consensus        73 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L  152 (1049)
                      .+++.|+|+++.+++..+..+++++.|++|+|++|.+++..|..++++++|++|+|++|++++..+..|+++++|++|+|
T Consensus        25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L  104 (680)
T 1ziw_A           25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL  104 (680)
T ss_dssp             TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred             CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence            35666777777666544455666777777777777766666666667777777777777666444445666777777777


Q ss_pred             CCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcc--cccccceecc
Q 039290          153 KHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLW--KCRELHVVSL  230 (1049)
Q Consensus       153 ~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~--~l~~L~~L~L  230 (1049)
                      ++|++++..|..|+.+++|++|||++|++++..|..+.+      +++|++|++++|++++..|..+.  .+++|+.|++
T Consensus       105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~------l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L  178 (680)
T 1ziw_A          105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ------LENLQELLLSNNKIQALKSEELDIFANSSLKKLEL  178 (680)
T ss_dssp             CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSC------CTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEEC
T ss_pred             CCCccCccChhHccccCCCCEEECCCCcccccCchhhcc------cccCCEEEccCCcccccCHHHhhccccccccEEEC
Confidence            777766555566677777777777777766555554433      34466677777776655554433  3466777777


Q ss_pred             cccccccccCCCCccccccceEEeccccccccCccccc---cccceEEEeeccccCCCccccccccccc--cceEEeccC
Q 039290          231 AFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIG---NLRNLEVLGVQSSNLAGLIPASIFNIST--LKELAVTDN  305 (1049)
Q Consensus       231 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~---~l~~L~~L~L~~n~l~~~~p~~~~~l~~--L~~L~l~~N  305 (1049)
                      ++|++++..|..++.+.+|+.|++++|.+.+.....+.   ..++|+.|++++|++.+..|..+.+++.  |++|++++|
T Consensus       179 ~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n  258 (680)
T 1ziw_A          179 SSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYN  258 (680)
T ss_dssp             TTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTS
T ss_pred             CCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCC
Confidence            77777666666666666777777766665533222221   2367888888888888888888887765  888888888


Q ss_pred             ccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCcccc-----Ccc----cccccccccceeecc
Q 039290          306 DLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSG-----LIP----TTFGNLRSLKLLSLA  376 (1049)
Q Consensus       306 ~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-----~~p----~~~~~l~~L~~L~L~  376 (1049)
                      ++.+..|..+ ..+++|++|++++|++++..|..|..+++|++|++++|...+     .+|    ..|..+++|++|+++
T Consensus       259 ~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~  337 (680)
T 1ziw_A          259 NLNVVGNDSF-AWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNME  337 (680)
T ss_dssp             CCCEECTTTT-TTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECC
T ss_pred             CcCccCcccc-cCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECC
Confidence            8876555544 468888888888888888888888888888888888776543     223    267788888888888


Q ss_pred             cccccCCCCCcccccccccCCCCcEEEccCCccccC--CCCcccccc-ccccEEEccCCccccCCCCCCCCCCCccEEEc
Q 039290          377 GNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGI--LPSSIGNFS-ISMKSLSMESCNISGGIPKELGNINNLTVIRL  453 (1049)
Q Consensus       377 ~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~--~p~~~~~~~-~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L  453 (1049)
                      +|.++++++.     .+..+++|++|++++|.+...  .+..+.... .+|+.|++++|++++..|..|..+++|++|+|
T Consensus       338 ~n~l~~~~~~-----~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  412 (680)
T 1ziw_A          338 DNDIPGIKSN-----MFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDL  412 (680)
T ss_dssp             SCCBCCCCTT-----TTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCccCCCChh-----HhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeC
Confidence            8888877654     367788888888888875422  222232222 37888888888888888888888888999999


Q ss_pred             cCCcccccCC-ccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccC--CcCchhccCcccCCceeecCccc
Q 039290          454 GNNELTGTIP-VTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLS--GRLPACLGNLTSLRDLSLGSNAL  530 (1049)
Q Consensus       454 s~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l  530 (1049)
                      ++|.+++.+| ..|.++++|++|++++|++.+..+..|..+++|+.|++++|.+.  +.+|..++++++|+.|++++|++
T Consensus       413 ~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l  492 (680)
T 1ziw_A          413 GLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNI  492 (680)
T ss_dssp             CSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCC
T ss_pred             CCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCC
Confidence            9888887665 67888888889999988888888888888888899999888876  56788888888899999999988


Q ss_pred             ccccCcccccccccccccccCCccCCCCc--------cCcCCCcceeEeecccccccccccccccCCCcccEEEeecccc
Q 039290          531 TSIIPSTLWNLKDILRFNLSSNSLNGSLL--------PDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRL  602 (1049)
Q Consensus       531 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  602 (1049)
                      +++.|..+..+++|++|++++|++++..+        ..+..+++|++|+|++|+++.+.+..|.++++|+.|+|++|+|
T Consensus       493 ~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l  572 (680)
T 1ziw_A          493 ANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNL  572 (680)
T ss_dssp             CCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             CcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCC
Confidence            88888888888888899999888876422        2367888888899999988866556788888899999999988


Q ss_pred             cCCccccccCccCCcEEeccCccccCCcccccc-cccccceeeccCCcccccCCC
Q 039290          603 QGPIPESFGGLKSLNFVDMSNNNLSGTIPKSME-ALSYLKHLNLSFNQLEGEIPT  656 (1049)
Q Consensus       603 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~l~l~~N~l~~~~p~  656 (1049)
                      ++..+..|.++++|++|+|++|++++..|..+. .+++|+.+++++|+|.|.|+.
T Consensus       573 ~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          573 NTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             CCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             CcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence            877777888888899999999988877777776 788888899999998888875

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=2.8e-63  Score=616.03  Aligned_cols=591  Identities=22%  Similarity=0.250  Sum_probs=512.6

Q ss_pred             EEEeccccccccCCCCCCcchhhhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCCCCc
Q 039290           78 LNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSF  157 (1049)
Q Consensus        78 l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l  157 (1049)
                      ++.++++++ .+|..+.  +.+++|+|++|.+++..|..++++++|++|||++|++.+..|..|+++++|++|+|++|.+
T Consensus         9 ~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l   85 (680)
T 1ziw_A            9 ADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL   85 (680)
T ss_dssp             EECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCC
T ss_pred             eECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCcc
Confidence            555666776 7888776  7899999999999987777899999999999999999999999999999999999999999


Q ss_pred             cCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccceeccccccccc
Q 039290          158 VGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQG  237 (1049)
Q Consensus       158 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  237 (1049)
                      ++..+..|+.+++|++|+|++|++++..|..+.      ++++|++|++++|++++..|..+.++++|++|++++|++++
T Consensus        86 ~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~------~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~  159 (680)
T 1ziw_A           86 SQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFV------KQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA  159 (680)
T ss_dssp             CCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTT------TCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCC
T ss_pred             CccChhhhccCCCCCEEECCCCccCccChhHcc------ccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccc
Confidence            965555799999999999999999855555554      45679999999999999999999999999999999999998


Q ss_pred             ccCCCCc--cccccceEEeccccccccCccccccccceEEEeeccccCCCccccccc---cccccceEEeccCccCCCCC
Q 039290          238 GIPRDIG--NLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIF---NISTLKELAVTDNDLLGSLP  312 (1049)
Q Consensus       238 ~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~---~l~~L~~L~l~~N~l~~~~p  312 (1049)
                      ..|..++  .+++|++|+|++|++++..|..++.+.+|+.|++++|.+.......+.   ..++|++|++++|++.+..|
T Consensus       160 ~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~  239 (680)
T 1ziw_A          160 LKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN  239 (680)
T ss_dssp             BCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECT
T ss_pred             cCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccCh
Confidence            8777665  558999999999999999999999999999999999988754333222   34789999999999998777


Q ss_pred             CcccCCC--CCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCcccccccccccceeecccccccCCCC--Ccc
Q 039290          313 SSIDLGL--PNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTP--DLS  388 (1049)
Q Consensus       313 ~~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~--~~~  388 (1049)
                      ..+. .+  ++|++|+|++|++++..|..|+.+++|++|++++|++.+..|..|.++++|+.|++++|.......  .+.
T Consensus       240 ~~~~-~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp  318 (680)
T 1ziw_A          240 TTFL-GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLP  318 (680)
T ss_dssp             TTTG-GGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CC
T ss_pred             hHhh-ccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhccccccccc
Confidence            6654 44  459999999999998889999999999999999999999999999999999999999886542111  000


Q ss_pred             cc--cccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCcccc--CCCCCCCCC--CCccEEEccCCcccccC
Q 039290          389 FL--SSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISG--GIPKELGNI--NNLTVIRLGNNELTGTI  462 (1049)
Q Consensus       389 ~l--~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~--~~p~~~~~l--~~L~~L~Ls~N~l~~~~  462 (1049)
                      .+  ..+..+++|++|++++|.+++..+..+..+. +|++|++++|.++.  ..+..|..+  ++|+.|++++|++++..
T Consensus       319 ~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~  397 (680)
T 1ziw_A          319 KIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLI-NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIE  397 (680)
T ss_dssp             EECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCT-TCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEEC
T ss_pred             ccChhhcccCCCCCEEECCCCccCCCChhHhcccc-CCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEC
Confidence            00  1477899999999999999998888888776 99999999998543  223344443  58999999999999999


Q ss_pred             CccccCcCCCcceEeeccccCCCCC-cccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccc--cccCcccc
Q 039290          463 PVTLGRLQKLQGLYLQNNKLEGSIP-EDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALT--SIIPSTLW  539 (1049)
Q Consensus       463 p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~  539 (1049)
                      |..|..+++|++|+|++|++++.+| ..+..+++|++|++++|++.+..+..|..+++|+.|++++|.++  +.+|..+.
T Consensus       398 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~  477 (680)
T 1ziw_A          398 SDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ  477 (680)
T ss_dssp             TTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTT
T ss_pred             hhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccc
Confidence            9999999999999999999987666 68999999999999999999888999999999999999999997  56899999


Q ss_pred             cccccccccccCCccCCCCccCcCCCcceeEeeccccccccccc--------ccccCCCcccEEEeecccccCCcccccc
Q 039290          540 NLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIP--------VTIGGLQGLQLLSLRYNRLQGPIPESFG  611 (1049)
Q Consensus       540 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  611 (1049)
                      .+++|+.|++++|++++..+..+..+++|++|+|++|++++..+        ..|.++++|+.|+|++|+|+...+..|.
T Consensus       478 ~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~  557 (680)
T 1ziw_A          478 PLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFK  557 (680)
T ss_dssp             TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred             cCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcc
Confidence            99999999999999999888889999999999999999996532        2488999999999999999976667899


Q ss_pred             CccCCcEEeccCccccCCcccccccccccceeeccCCcccccCCCC-C-CccccccccccCCccccCCCC
Q 039290          612 GLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTR-G-PFITFSAESFLGNQALCGSPK  679 (1049)
Q Consensus       612 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~-~~~~~~~~~~~~n~~~cg~~~  679 (1049)
                      ++++|++|||++|++++..+..|..+++|+.|++++|++++..|.. . .+..+....+.+||+.|+|+.
T Consensus       558 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          558 DLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             cccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence            9999999999999999777777899999999999999999877642 1 355667788999999998873

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1.5e-59  Score=574.67  Aligned_cols=534  Identities=21%  Similarity=0.234  Sum_probs=399.4

Q ss_pred             EEEeccccccccCCCCCCcchhhhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCCCCc
Q 039290           78 LNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSF  157 (1049)
Q Consensus        78 l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l  157 (1049)
                      ++.++.+++ .+|..+..  .+++|+|++|.+++..|..++++++|++|||++|++.+..|..|+++++|++|+|++|.+
T Consensus        17 ~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l   93 (606)
T 3t6q_A           17 YNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL   93 (606)
T ss_dssp             EECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             EECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence            444556666 78877764  689999999999988788999999999999999999988899999999999999999999


Q ss_pred             cCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccceeccccccccc
Q 039290          158 VGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQG  237 (1049)
Q Consensus       158 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  237 (1049)
                      ++..|..|+.+++|++|+|++|++++..|..+.      ++++|++|++++|++++..++.+..+++|++|++++|++++
T Consensus        94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~------~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~  167 (606)
T 3t6q_A           94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLH------NQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY  167 (606)
T ss_dssp             SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCT------TCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCE
T ss_pred             cccChhhhcccccccEeeccccCcccCCcchhc------cCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccc
Confidence            988899999999999999999999954455554      45679999999999997444445558999999999999998


Q ss_pred             ccCCCCccccccc--eEEeccccccccCccccccccceEEEeeccccCCCccccccccccccceEEeccCccCC----CC
Q 039290          238 GIPRDIGNLTSVR--NLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLG----SL  311 (1049)
Q Consensus       238 ~~p~~~~~l~~L~--~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~----~~  311 (1049)
                      ..|..|+.+++|+  .|++++|++++..|..+.. .+|+.|++++|.   .++..+..+..++...+.-+.+..    .+
T Consensus       168 ~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i  243 (606)
T 3t6q_A          168 LSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFEDMDDEDI  243 (606)
T ss_dssp             ECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTTSCCCCC
T ss_pred             cChhhhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCch---hHHHHhhhccccchhheechhhcccccccc
Confidence            8888888888888  8899999998777766655 689999998886   345555555555444443332221    12


Q ss_pred             CCcccCCCC--CccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCcccccccccccceeecccccccCCCCCccc
Q 039290          312 PSSIDLGLP--NLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSF  389 (1049)
Q Consensus       312 p~~~~~~l~--~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~  389 (1049)
                      +...+.++.  +|+.|++++|++++..+..|..+++|++|++++|+++ .+|..+..+++                    
T Consensus       244 ~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~--------------------  302 (606)
T 3t6q_A          244 SPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLST--------------------  302 (606)
T ss_dssp             CGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTT--------------------
T ss_pred             ChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhccccc--------------------
Confidence            222221111  3445555555555444444555555555555555554 23444444444                    


Q ss_pred             ccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCC-CCCCCCCccEEEccCCcccccC--Cccc
Q 039290          390 LSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPK-ELGNINNLTVIRLGNNELTGTI--PVTL  466 (1049)
Q Consensus       390 l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~--p~~~  466 (1049)
                               |++|++++|.+.+..|..+..++ +|++|++++|.+.+.+|. .+..+++|++|++++|.+++..  |..+
T Consensus       303 ---------L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  372 (606)
T 3t6q_A          303 ---------LKKLVLSANKFENLCQISASNFP-SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQL  372 (606)
T ss_dssp             ---------CCEEECTTCCCSBGGGGCGGGCT-TCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTT
T ss_pred             ---------CCEEECccCCcCcCchhhhhccC-cCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhc
Confidence                     45555555554444444444443 555555555555544443 3677777777777777777655  6677


Q ss_pred             cCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCch-hccCcccCCceeecCcccccccCcccccccccc
Q 039290          467 GRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPA-CLGNLTSLRDLSLGSNALTSIIPSTLWNLKDIL  545 (1049)
Q Consensus       467 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  545 (1049)
                      ..+++|++|++++|++.+..|..+..+++|++|++++|++++..|. .+.++++|++|++++|++++..|..+..+++|+
T Consensus       373 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  452 (606)
T 3t6q_A          373 RNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQ  452 (606)
T ss_dssp             TTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCC
T ss_pred             ccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCC
Confidence            7777777788877777777777777777888888888877766543 377788888888888888877777888888888


Q ss_pred             cccccCCccCCC---CccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEecc
Q 039290          546 RFNLSSNSLNGS---LLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMS  622 (1049)
Q Consensus       546 ~L~Ls~N~l~~~---~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  622 (1049)
                      +|++++|++++.   .+..+..+++|++|++++|++++..|..|+++++|+.|+|++|++++.+|..|.++++| +|+|+
T Consensus       453 ~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~  531 (606)
T 3t6q_A          453 HLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLA  531 (606)
T ss_dssp             EEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECC
T ss_pred             EEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECc
Confidence            888888887762   23568888999999999999999889999999999999999999999999999999999 99999


Q ss_pred             CccccCCcccccccccccceeeccCCcccccCCC
Q 039290          623 NNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPT  656 (1049)
Q Consensus       623 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~  656 (1049)
                      +|++++.+|..+..+++|+.|++++|+|.|.++.
T Consensus       532 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~  565 (606)
T 3t6q_A          532 SNHISIILPSLLPILSQQRTINLRQNPLDCTCSN  565 (606)
T ss_dssp             SSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred             CCcccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence            9999988888899999999999999999998874

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=3.9e-58  Score=580.70  Aligned_cols=537  Identities=21%  Similarity=0.221  Sum_probs=409.4

Q ss_pred             EEEEeccccccccCCCCCCcchhhhhhcccCccccccCcccccccCCcEeccccCCccccC-cccccccCCccEEEeCCC
Q 039290           77 ALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEI-PSWFVSLPRLQHLLLKHN  155 (1049)
Q Consensus        77 ~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~-p~~~~~l~~L~~L~L~~n  155 (1049)
                      ..|.++++++ .+|.   -.+.|++|+|++|.+++..|..++++++|++|||++|+..+.+ |..|+++++|++|+|++|
T Consensus         8 ~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N   83 (844)
T 3j0a_A            8 IAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS   83 (844)
T ss_dssp             EEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred             EEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence            3456677777 6776   4568889999999998888888999999999999998777777 778899999999999999


Q ss_pred             CccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCCCCC-CCcccccccceecccccc
Q 039290          156 SFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIP-TNLWKCRELHVVSLAFNK  234 (1049)
Q Consensus       156 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~L~~L~L~~N~  234 (1049)
                      .+++..|+.|+.+++|++|+|++|++++.+|...    .+.++++|++|+|++|++++..| ..+.++++|++|+|++|+
T Consensus        84 ~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~----~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~  159 (844)
T 3j0a_A           84 KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDG----YFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQ  159 (844)
T ss_dssp             CCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTC----CCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSC
T ss_pred             cCcccCHhHccCCcccCEeeCcCCCCCcccccCc----cccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCc
Confidence            9988889999999999999999999987777651    12346678899999999887655 467888888888888888


Q ss_pred             cccccCCCCccc--cccceEEeccccccccCccccccccc------eEEEeeccccCCCccccccccc---cccceEEec
Q 039290          235 FQGGIPRDIGNL--TSVRNLFLGNNSLIGEIPNEIGNLRN------LEVLGVQSSNLAGLIPASIFNI---STLKELAVT  303 (1049)
Q Consensus       235 l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~l~~l~~------L~~L~L~~n~l~~~~p~~~~~l---~~L~~L~l~  303 (1049)
                      +++..|..++.+  ++|+.|+|++|.+.+..|..++.+.+      |+.|++++|.+.+.+|..+...   ++++.|.++
T Consensus       160 i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~  239 (844)
T 3j0a_A          160 IFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILA  239 (844)
T ss_dssp             CCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECC
T ss_pred             CCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecc
Confidence            888888888877  78888888888888888877777665      8888888888777777666543   456666666


Q ss_pred             cCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCC--CCCceeecccCccccCcccccccccccceeeccccccc
Q 039290          304 DNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNI--SELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLT  381 (1049)
Q Consensus       304 ~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  381 (1049)
                      .+....                .++.|.+.+..+..|..+  ++|+.|++++|.+.+..|..|..+++|+.|+|++|.++
T Consensus       240 ~~~~~~----------------~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~  303 (844)
T 3j0a_A          240 HHIMGA----------------GFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN  303 (844)
T ss_dssp             SSCCBC----------------SSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCC
T ss_pred             cccccc----------------cccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCC
Confidence            433221                011233333333333333  45666666666666555556666666666666666665


Q ss_pred             CCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCccccc
Q 039290          382 SPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGT  461 (1049)
Q Consensus       382 ~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~  461 (1049)
                      .+.+.     .|.++++|++|+|++|.+++..|..+..++ +|+.|++++|++.+..+..|..+++|++|+|++|.+++.
T Consensus       304 ~~~~~-----~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i  377 (844)
T 3j0a_A          304 KIADE-----AFYGLDNLQVLNLSYNLLGELYSSNFYGLP-KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI  377 (844)
T ss_dssp             EECTT-----TTTTCSSCCEEEEESCCCSCCCSCSCSSCT-TCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC
T ss_pred             CCChH-----HhcCCCCCCEEECCCCCCCccCHHHhcCCC-CCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc
Confidence            54433     255556666666666666666566665554 677777777777766777788888899999999988742


Q ss_pred             CCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcC-chhccCcccCCceeecCcccccccCc-ccc
Q 039290          462 IPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRL-PACLGNLTSLRDLSLGSNALTSIIPS-TLW  539 (1049)
Q Consensus       462 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~  539 (1049)
                       +    .+++|+.|++++|+++ .+|..   ..+++.|++++|++++.. +..+.++++|+.|+|++|++++..+. .+.
T Consensus       378 -~----~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  448 (844)
T 3j0a_A          378 -H----FIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPS  448 (844)
T ss_dssp             -S----SCCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSC
T ss_pred             -c----CCCCcchhccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccc
Confidence             2    3778889999999988 45543   457888999999988542 33466889999999999999876543 456


Q ss_pred             cccccccccccCCccC-----CCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCcc
Q 039290          540 NLKDILRFNLSSNSLN-----GSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLK  614 (1049)
Q Consensus       540 ~l~~L~~L~Ls~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  614 (1049)
                      .+++|+.|++++|.++     +..+..|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++.+|..+.  +
T Consensus       449 ~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~  526 (844)
T 3j0a_A          449 ENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--A  526 (844)
T ss_dssp             SCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--S
T ss_pred             cCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--c
Confidence            6889999999999987     44456788999999999999999999999999999999999999999988887776  8


Q ss_pred             CCcEEeccCccccCCcccccccccccceeeccCCcccccCCCC
Q 039290          615 SLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTR  657 (1049)
Q Consensus       615 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~  657 (1049)
                      +|++|||++|+|++.+|..+   .+|+.+++++|+|.|.|+..
T Consensus       527 ~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~c~~~  566 (844)
T 3j0a_A          527 NLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECELS  566 (844)
T ss_dssp             CCCEEEEEEECCCCCCSCCC---SSCCEEEEEEECCCCSSSCC
T ss_pred             cccEEECCCCcCCCCChhHh---CCcCEEEecCCCcccccccH
Confidence            99999999999999888765   47899999999999999853

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=2e-60  Score=581.59  Aligned_cols=482  Identities=19%  Similarity=0.317  Sum_probs=367.6

Q ss_pred             hhhHHHHHHHHHhcccCCCCcc------cccCCCCCCCcee---eeEEEcCCCCcEEEEEEeccccccccCCCCCCcchh
Q 039290           29 TTDQFALLALKEHIKHDPSNLL------ANNWSTTSSVCSW---IGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFL   99 (1049)
Q Consensus        29 ~~d~~all~~k~~~~~~~~~~l------~~~w~~~~~~c~w---~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L   99 (1049)
                      ..|++||.+||+++..+.+..-      ..+|+.+++||.|   .||+|+.. +||++|+|++++++|++|+++++|++|
T Consensus        29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L~~L  107 (636)
T 4eco_A           29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLTEL  107 (636)
T ss_dssp             HHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGCTTC
T ss_pred             HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcCccc
Confidence            4699999999999865444321      1279999999999   99999865 899999999999999999999999999


Q ss_pred             hhhhcccCcc------cc------ccCcccccccCCcEeccccCCccccCccccccc-CCccEEEeC-------------
Q 039290          100 AVLAIRNNSF------FG------SLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSL-PRLQHLLLK-------------  153 (1049)
Q Consensus       100 ~~L~l~~n~~------~g------~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l-~~L~~L~L~-------------  153 (1049)
                      ++|+|++|.+      .|      .+|.+.  +..|+ ++++.|.+.+.+|..+..+ ..+..+++.             
T Consensus       108 ~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~  184 (636)
T 4eco_A          108 EVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLK  184 (636)
T ss_dssp             CEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCC
T ss_pred             eEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchh
Confidence            9999999977      45      677766  67788 9999999999998887732 223333333             


Q ss_pred             -------CCCccCCCcccccCCCcccEEcCCCccCccc-----------------cCCCcc--cccccCCCCccceEEee
Q 039290          154 -------HNSFVGKIPETIGYLSLLQELDLSDNQLSGT-----------------IPSSIF--NISSCQNLPVLEGLFIS  207 (1049)
Q Consensus       154 -------~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~-----------------ip~~~~--~l~~l~~l~~L~~L~l~  207 (1049)
                             .|+++| ||++|+++++|++|||++|+++|.                 +|++++  +      +++|++|+|+
T Consensus       185 ~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~------l~~L~~L~L~  257 (636)
T 4eco_A          185 DTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDN------LKDLTDVEVY  257 (636)
T ss_dssp             TTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGG------CTTCCEEEEE
T ss_pred             hhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcc------cCCCCEEEec
Confidence                   688888 899999999999999999999986                 888876  5      4558899999


Q ss_pred             ccccCCCCCCCcccccccceecccccc-ccc-ccCCCCccc------cccceEEeccccccccCcc--ccccccceEEEe
Q 039290          208 YNQLTGPIPTNLWKCRELHVVSLAFNK-FQG-GIPRDIGNL------TSVRNLFLGNNSLIGEIPN--EIGNLRNLEVLG  277 (1049)
Q Consensus       208 ~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~~-~~p~~~~~l------~~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~  277 (1049)
                      +|++.|.+|..++++++|++|+|++|+ ++| .+|..++++      ++|++|+|++|+++ .+|.  .++++++|+.|+
T Consensus       258 ~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~  336 (636)
T 4eco_A          258 NCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLE  336 (636)
T ss_dssp             CCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEE
T ss_pred             CCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEe
Confidence            999999999999999999999999998 888 899888887      89999999999998 8888  899999999999


Q ss_pred             eccccCCCccccccccccccceEEeccCccCCCCCCcccCCCCC-ccEEEcCCCCCCCCCCccccCCC--CCceeecccC
Q 039290          278 VQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPN-LERLFLGENNFSGTIPSSLTNIS--ELSVLDFGFN  354 (1049)
Q Consensus       278 L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~Ls~N  354 (1049)
                      +++|++.|.+| .+..+++|++|++++|++. .+|..+. .+++ |++|++++|+++ .+|..+..++  +|++|++++|
T Consensus       337 L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~-~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N  412 (636)
T 4eco_A          337 CLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFC-GFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYN  412 (636)
T ss_dssp             CCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSE-EECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSS
T ss_pred             CcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhh-hhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCC
Confidence            99999998888 8889999999999999988 7887755 6778 999999999998 7888887755  8999999999


Q ss_pred             ccccCcccccc-------cccccceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccc-----
Q 039290          355 SFSGLIPTTFG-------NLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSI-----  422 (1049)
Q Consensus       355 ~l~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~-----  422 (1049)
                      .+.+.+|..|.       .+++|++|++++|.++.++...     +..+++|++|+|++|+++ .+|..+.....     
T Consensus       413 ~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~-----~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~  486 (636)
T 4eco_A          413 EIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKEL-----FSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKN  486 (636)
T ss_dssp             CTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHH-----HHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTT
T ss_pred             cCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHH-----HccCCCCCEEECCCCCCC-CcCHHHhccccccccc
Confidence            99988888888       7788999999999888766542     556788888888888888 44544433221     


Q ss_pred             --cccEEEccCCccccCCCCCCC--CCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccce
Q 039290          423 --SMKSLSMESCNISGGIPKELG--NINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLAN  498 (1049)
Q Consensus       423 --~L~~L~L~~n~i~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  498 (1049)
                        +|++|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+..+++|++|+|++|+                 
T Consensus       487 l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~-----------------  547 (636)
T 4eco_A          487 TYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR-----------------  547 (636)
T ss_dssp             GGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCB-----------------
T ss_pred             cCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCc-----------------
Confidence              4555555555555 3444444  55555555555555554 45555555555555553221                 


Q ss_pred             EEeeCcccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccC
Q 039290          499 LYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLN  555 (1049)
Q Consensus       499 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  555 (1049)
                       ++++|++.+.+|..++++++|++|+|++|+++ .+|..+.  ++|+.|++++|++.
T Consensus       548 -~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~  600 (636)
T 4eco_A          548 -DAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKIT--PNISVLDIKDNPNI  600 (636)
T ss_dssp             -CTTCCBCCCCCCTTGGGCSSCCEEECCSSCCC-BCCSCCC--TTCCEEECCSCTTC
T ss_pred             -ccccCcccccChHHHhcCCCCCEEECCCCcCC-ccCHhHh--CcCCEEECcCCCCc
Confidence             01345555555555555556666666666653 3444443  45666666666554

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=2.9e-58  Score=563.30  Aligned_cols=537  Identities=18%  Similarity=0.176  Sum_probs=445.5

Q ss_pred             EEEEeccccccccCCCCCCcchhhhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCCCC
Q 039290           77 ALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNS  156 (1049)
Q Consensus        77 ~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~  156 (1049)
                      .++.++++++ .+|..+.  +.|++|+|++|.+++..|..++++++|++|||++|++++..|..|+++++|++|+|++|.
T Consensus        15 ~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~   91 (606)
T 3vq2_A           15 TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP   91 (606)
T ss_dssp             EEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             ceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCc
Confidence            4667777887 8888776  789999999999998888899999999999999999998889999999999999999999


Q ss_pred             ccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCC-CCCCCcccccccceeccccccc
Q 039290          157 FVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTG-PIPTNLWKCRELHVVSLAFNKF  235 (1049)
Q Consensus       157 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l  235 (1049)
                      +++..|..|+++++|++|+|++|++++..|..++      ++++|++|++++|++++ .+|..+.++++|++|++++|++
T Consensus        92 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~------~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l  165 (606)
T 3vq2_A           92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIG------QLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYI  165 (606)
T ss_dssp             CCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCT------TCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCC
T ss_pred             ccccChhhcCCcccCCEEEccCCccccccccccC------CCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcc
Confidence            9988899999999999999999999955556654      45679999999999986 6899999999999999999999


Q ss_pred             ccccCCCCccccccc----eEEeccccccccCccccccccceEEEeeccccCC-CccccccccccccceEEeccCccCCC
Q 039290          236 QGGIPRDIGNLTSVR----NLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLA-GLIPASIFNISTLKELAVTDNDLLGS  310 (1049)
Q Consensus       236 ~~~~p~~~~~l~~L~----~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~  310 (1049)
                      ++..|..|+.+++|+    +|++++|.+++..+..+... +|+.|++++|.+. +.+|..+.++++|+.+++..+.+.+.
T Consensus       166 ~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~  244 (606)
T 3vq2_A          166 QTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDE  244 (606)
T ss_dssp             CEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTS
T ss_pred             eecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccC
Confidence            998899999888776    79999999996666666555 8999999999987 56778889999999998877665421


Q ss_pred             CCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeec-ccCccccCcccccccccccceeecccccccCCCCCccc
Q 039290          311 LPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDF-GFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSF  389 (1049)
Q Consensus       311 ~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L-s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~  389 (1049)
                      .         .+.       .+.+..+..+..+ .++.+++ ..|.+.+.+|. +..+++|+.|++++|.++.++     
T Consensus       245 ~---------~l~-------~~~~~~~~~l~~l-~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l~-----  301 (606)
T 3vq2_A          245 R---------NLE-------IFEPSIMEGLCDV-TIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKYLE-----  301 (606)
T ss_dssp             C---------CCS-------CCCGGGGTTGGGS-EEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCCCC-----
T ss_pred             C---------ccc-------ccChHHhhhhhhc-cHhheeccccccccccccc-cccCCCCCEEEecCccchhhh-----
Confidence            1         111       0111122222222 3555555 55566665555 666666666666666665544     


Q ss_pred             ccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCccccc--CCcccc
Q 039290          390 LSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGT--IPVTLG  467 (1049)
Q Consensus       390 l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~  467 (1049)
                        .+..+++|+.|++++|.+ +.+|. + .+ .+|++|++++|...+..  .+..+++|++|++++|.+++.  .|..+.
T Consensus       302 --~l~~~~~L~~L~l~~n~l-~~lp~-~-~l-~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~  373 (606)
T 3vq2_A          302 --DVPKHFKWQSLSIIRCQL-KQFPT-L-DL-PFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDL  373 (606)
T ss_dssp             --CCCTTCCCSEEEEESCCC-SSCCC-C-CC-SSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHH
T ss_pred             --hccccccCCEEEcccccC-ccccc-C-CC-CccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhc
Confidence              245566667777777766 44552 3 33 36777777777544333  567889999999999999876  388899


Q ss_pred             CcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCc-hhccCcccCCceeecCcccccccCccccccccccc
Q 039290          468 RLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLP-ACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILR  546 (1049)
Q Consensus       468 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  546 (1049)
                      .+++|++|++++|++++ +|..+..+++|+.|++++|++.+..| ..+.++++|++|++++|++++..|..+..+++|++
T Consensus       374 ~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  452 (606)
T 3vq2_A          374 GTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNT  452 (606)
T ss_dssp             CCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCE
T ss_pred             cCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCE
Confidence            99999999999999984 66889999999999999999998777 68999999999999999999999999999999999


Q ss_pred             ccccCCccCC-CCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCcc
Q 039290          547 FNLSSNSLNG-SLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNN  625 (1049)
Q Consensus       547 L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  625 (1049)
                      |++++|++++ .+|..++.+++|++|+|++|++++..|..|+++++|+.|+|++|++++.+|..|+++++|++|||++|+
T Consensus       453 L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~  532 (606)
T 3vq2_A          453 LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR  532 (606)
T ss_dssp             EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSC
T ss_pred             EECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCc
Confidence            9999999998 478889999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCccccccccc-ccceeeccCCcccccCCC
Q 039290          626 LSGTIPKSMEALS-YLKHLNLSFNQLEGEIPT  656 (1049)
Q Consensus       626 l~~~~p~~~~~l~-~L~~l~l~~N~l~~~~p~  656 (1049)
                      ++ .+|..+..++ +|++|++++|+|.|.++.
T Consensus       533 l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~  563 (606)
T 3vq2_A          533 IE-TSKGILQHFPKSLAFFNLTNNSVACICEH  563 (606)
T ss_dssp             CC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred             Cc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence            99 7888899997 599999999999999986

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=5.2e-58  Score=567.65  Aligned_cols=478  Identities=18%  Similarity=0.259  Sum_probs=363.9

Q ss_pred             CChhhHHHHHHHHHhcccCCCCcccccCCCCC-----CC--cee------------eeEEEcCCCCcEEEEEEecccccc
Q 039290           27 NVTTDQFALLALKEHIKHDPSNLLANNWSTTS-----SV--CSW------------IGVTCGVRNRRVTALNISYLGLTG   87 (1049)
Q Consensus        27 ~~~~d~~all~~k~~~~~~~~~~l~~~w~~~~-----~~--c~w------------~gv~c~~~~~~v~~l~l~~~~l~g   87 (1049)
                      +..+|++||++||+++. ||      +|+.+.     +|  |.|            .||+|+. ++||+.|+|++++|+|
T Consensus       266 ~~~~d~~ALl~~k~~l~-~~------~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G  337 (876)
T 4ecn_A          266 EYIKDYKALKAIWEALD-GK------NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKG  337 (876)
T ss_dssp             HHHHHHHHHHHHHHHTT-GG------GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEE
T ss_pred             cchHHHHHHHHHHHHcC-CC------CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCC
Confidence            34679999999999994 55      565443     55  999            9999986 6899999999999999


Q ss_pred             ccCCCCCCcchhhhhhc-ccCccccccCccc-------------------------------------------------
Q 039290           88 TIPPQLGNLSFLAVLAI-RNNSFFGSLPEEL-------------------------------------------------  117 (1049)
Q Consensus        88 ~~~~~~~~l~~L~~L~l-~~n~~~g~~p~~~-------------------------------------------------  117 (1049)
                      .+|+++++|++|++|+| ++|.+.|..|-..                                                 
T Consensus       338 ~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i  417 (876)
T 4ecn_A          338 RVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPI  417 (876)
T ss_dssp             EECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCC
T ss_pred             cCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccc
Confidence            99999999999999999 9999988755321                                                 


Q ss_pred             --ccccCCcEecccc--CCccccCcccccccCCccEEEeCCCCccC-----------------CCccccc--CCCcccEE
Q 039290          118 --SHLRGLKYFDFRF--NNFHIEIPSWFVSLPRLQHLLLKHNSFVG-----------------KIPETIG--YLSLLQEL  174 (1049)
Q Consensus       118 --~~L~~L~~L~l~~--n~~~~~~p~~~~~l~~L~~L~L~~n~l~~-----------------~~p~~~~--~l~~L~~L  174 (1049)
                        .....++.+.+..  |++++ ||..|++|++|++|+|++|.++|                 .+|+.++  ++++|++|
T Consensus       418 ~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L  496 (876)
T 4ecn_A          418 KKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDV  496 (876)
T ss_dssp             CCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEE
T ss_pred             ccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEE
Confidence              1112344444443  88888 99999999999999999999998                 3999988  99999999


Q ss_pred             cCCCccCccccCCCcccccccCCCCccceEEeeccc-cCC-CCCCCccccc-------ccceecccccccccccCC--CC
Q 039290          175 DLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQ-LTG-PIPTNLWKCR-------ELHVVSLAFNKFQGGIPR--DI  243 (1049)
Q Consensus       175 ~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~-l~~-~~p~~l~~l~-------~L~~L~L~~N~l~~~~p~--~~  243 (1049)
                      +|++|++.|.+|..+++      +++|++|+|++|+ ++| .+|..+..++       +|+.|+|++|+++ .+|.  .|
T Consensus       497 ~Ls~N~l~~~iP~~l~~------L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l  569 (876)
T 4ecn_A          497 ELYNCPNMTQLPDFLYD------LPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASL  569 (876)
T ss_dssp             EEESCTTCCSCCGGGGG------CSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHH
T ss_pred             ECcCCCCCccChHHHhC------CCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhh
Confidence            99999999999988765      4569999999998 998 8998887776       9999999999999 8998  89


Q ss_pred             ccccccceEEeccccccccCccccccccceEEEeeccccCCCccccccccccc-cceEEeccCccCCCCCCcccC-CCCC
Q 039290          244 GNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNIST-LKELAVTDNDLLGSLPSSIDL-GLPN  321 (1049)
Q Consensus       244 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~-L~~L~l~~N~l~~~~p~~~~~-~l~~  321 (1049)
                      +++++|+.|+|++|+++ .+| .|+++++|+.|+|++|++. .+|..+.++++ |++|++++|++. .+|..+.. ..++
T Consensus       570 ~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~  645 (876)
T 4ecn_A          570 QKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYV  645 (876)
T ss_dssp             TTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSC
T ss_pred             hcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCC
Confidence            99999999999999999 888 9999999999999999999 78888999998 999999999998 78866542 2345


Q ss_pred             ccEEEcCCCCCCCCCCccc---c--CCCCCceeecccCccccCcccccccccccceeecccccccCCCCCccccc--ccc
Q 039290          322 LERLFLGENNFSGTIPSSL---T--NISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLS--SLT  394 (1049)
Q Consensus       322 L~~L~L~~N~l~~~~p~~~---~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~--~l~  394 (1049)
                      |+.|+|++|++++.+|...   .  .+++|+.|+|++|++....+..+..+++|+.|+|++|.|+.++.......  .+.
T Consensus       646 L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~  725 (876)
T 4ecn_A          646 MGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYK  725 (876)
T ss_dssp             EEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCT
T ss_pred             CCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhcccccccc
Confidence            9999999999998766432   2  33478899999999885433445578888888888888887665431110  122


Q ss_pred             cCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCC--CCCCccEEEccCCcccccCCccccCcCCC
Q 039290          395 SCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELG--NINNLTVIRLGNNELTGTIPVTLGRLQKL  472 (1049)
Q Consensus       395 ~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  472 (1049)
                      +|++|+.|+|++|+++                          .+|..+.  .+++|+.|+|++|++++ +|..+..+++|
T Consensus       726 nl~~L~~L~Ls~N~L~--------------------------~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L  778 (876)
T 4ecn_A          726 NTYLLTTIDLRFNKLT--------------------------SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQL  778 (876)
T ss_dssp             TGGGCCEEECCSSCCC--------------------------CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTC
T ss_pred             ccCCccEEECCCCCCc--------------------------cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCC
Confidence            3445666666666555                          3444444  56666666666666664 56666666666


Q ss_pred             cceEeec------cccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccccCccccccccccc
Q 039290          473 QGLYLQN------NKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILR  546 (1049)
Q Consensus       473 ~~L~L~~------N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  546 (1049)
                      +.|+|++      |++.+.+|..+..+++|+.|+|++|++ +.+|..+.  ++|+.|+|++|++..+.+..+.....+..
T Consensus       779 ~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~  855 (876)
T 4ecn_A          779 KAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGM  855 (876)
T ss_dssp             CEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTC
T ss_pred             CEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchh
Confidence            6666655      666666666666666666666666666 45665544  46666666666666665555555555555


Q ss_pred             ccccCCcc
Q 039290          547 FNLSSNSL  554 (1049)
Q Consensus       547 L~Ls~N~l  554 (1049)
                      +.|.+|++
T Consensus       856 ~~L~~n~~  863 (876)
T 4ecn_A          856 YVLLYDKT  863 (876)
T ss_dssp             CEEECCTT
T ss_pred             eeecCCCc
Confidence            55555543

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=3.4e-56  Score=545.03  Aligned_cols=528  Identities=19%  Similarity=0.189  Sum_probs=442.3

Q ss_pred             eeeEEEcCC---------CCcEEEEEEeccccccccCCCCCCcchhhhhhcccCccccccCcccccccCCcEeccccCCc
Q 039290           63 WIGVTCGVR---------NRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNF  133 (1049)
Q Consensus        63 w~gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~  133 (1049)
                      +.-|.|...         ...++.|+|+++.+++..|..++++++|++|+|++|.+.+..|..++++++|++|+|++|++
T Consensus        14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l   93 (606)
T 3t6q_A           14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL   93 (606)
T ss_dssp             TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence            455788642         24789999999999988888999999999999999999988899999999999999999999


Q ss_pred             cccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCC
Q 039290          134 HIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTG  213 (1049)
Q Consensus       134 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~  213 (1049)
                      .+..|..|+++++|++|+|++|.+++..|..++.+++|++|+|++|++++.-++.+.      .+++|++|++++|++++
T Consensus        94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~------~l~~L~~L~L~~n~l~~  167 (606)
T 3t6q_A           94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGF------PTEKLKVLDFQNNAIHY  167 (606)
T ss_dssp             SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTC------CCTTCCEEECCSSCCCE
T ss_pred             cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCccccc------CCcccCEEEcccCcccc
Confidence            999999999999999999999999977788999999999999999999963223332      25679999999999998


Q ss_pred             CCCCCcccccccc--eecccccccccccCCCCccccccceEEeccccccccCccccccccceEEEeeccccCCC-----c
Q 039290          214 PIPTNLWKCRELH--VVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAG-----L  286 (1049)
Q Consensus       214 ~~p~~l~~l~~L~--~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~-----~  286 (1049)
                      ..|..+..+++|+  .|++++|++++..|..+.. .+|+.|++++|.   .++..+..+.++....+..+.+.+     .
T Consensus       168 ~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i  243 (606)
T 3t6q_A          168 LSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFEDMDDEDI  243 (606)
T ss_dssp             ECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTTSCCCCC
T ss_pred             cChhhhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCch---hHHHHhhhccccchhheechhhcccccccc
Confidence            8888899999999  8999999999877777655 689999999997   456667777766655554433322     2


Q ss_pred             ccccccccc--ccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCccccc
Q 039290          287 IPASIFNIS--TLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTF  364 (1049)
Q Consensus       287 ~p~~~~~l~--~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  364 (1049)
                      .+..+..+.  +|++|++++|.+.+ ++...+..+++|++|++++|+++ .+|..+..+++|++|++++|.+.+..|..+
T Consensus       244 ~~~~~~~l~~~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~  321 (606)
T 3t6q_A          244 SPAVFEGLCEMSVESINLQKHYFFN-ISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISA  321 (606)
T ss_dssp             CGGGGGGGGGSEEEEEECTTCCCSS-CCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCG
T ss_pred             ChhHhchhhcCceeEEEeecCccCc-cCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhh
Confidence            233444444  79999999999984 55555668999999999999999 789999999999999999999999888899


Q ss_pred             ccccccceeecccccccC-CCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCC
Q 039290          365 GNLRSLKLLSLAGNVLTS-PTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELG  443 (1049)
Q Consensus       365 ~~l~~L~~L~L~~N~l~~-~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~  443 (1049)
                      ..+++|++|++++|.+.. ++..     .+..+++|++|++++|.+++..                       ..|..+.
T Consensus       322 ~~l~~L~~L~l~~n~~~~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~-----------------------~~~~~~~  373 (606)
T 3t6q_A          322 SNFPSLTHLSIKGNTKRLELGTG-----CLENLENLRELDLSHDDIETSD-----------------------CCNLQLR  373 (606)
T ss_dssp             GGCTTCSEEECCSCSSCCBCCSS-----TTTTCTTCCEEECCSSCCCEEE-----------------------ESTTTTT
T ss_pred             hccCcCCEEECCCCCcccccchh-----hhhccCcCCEEECCCCcccccc-----------------------Ccchhcc
Confidence            999999999999998773 3322     3566777777777777765432                       1255677


Q ss_pred             CCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCc-ccccccccceEEeeCcccCCcCchhccCcccCCc
Q 039290          444 NINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPE-DLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRD  522 (1049)
Q Consensus       444 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  522 (1049)
                      .+++|++|++++|.+++..|..|..+++|++|++++|++++..+. .+..+++|++|++++|.+++..|..++++++|++
T Consensus       374 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  453 (606)
T 3t6q_A          374 NLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQH  453 (606)
T ss_dssp             TCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCE
T ss_pred             cCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCE
Confidence            778888888888888877778888888888888888888766554 3778888888888888888777888888888888


Q ss_pred             eeecCcccccc---cCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeec
Q 039290          523 LSLGSNALTSI---IPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRY  599 (1049)
Q Consensus       523 L~L~~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  599 (1049)
                      |++++|++++.   .+..+..+++|++|++++|++++..|..|..+++|++|+|++|++++..|..|.++++| .|+|++
T Consensus       454 L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~  532 (606)
T 3t6q_A          454 LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLAS  532 (606)
T ss_dssp             EECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCS
T ss_pred             EECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcC
Confidence            88888888763   33568888999999999999988888889999999999999999999999999999999 999999


Q ss_pred             ccccCCccccccCccCCcEEeccCccccCCcc
Q 039290          600 NRLQGPIPESFGGLKSLNFVDMSNNNLSGTIP  631 (1049)
Q Consensus       600 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  631 (1049)
                      |++++.+|..|..+++|++|++++|++++..+
T Consensus       533 N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  564 (606)
T 3t6q_A          533 NHISIILPSLLPILSQQRTINLRQNPLDCTCS  564 (606)
T ss_dssp             SCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred             CcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence            99999999999999999999999999997655

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-55  Score=558.46  Aligned_cols=527  Identities=20%  Similarity=0.213  Sum_probs=407.3

Q ss_pred             ceeeeEEEcCCCCcEEEEEEeccccccccCCCCCCcchhhhhhcccCcccccc-CcccccccCCcEeccccCCccccCcc
Q 039290           61 CSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSL-PEELSHLRGLKYFDFRFNNFHIEIPS  139 (1049)
Q Consensus        61 c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~-p~~~~~L~~L~~L~l~~n~~~~~~p~  139 (1049)
                      |.|.+|.+  ...+++.|||++|.+++..|..+++++.|++|+|++|...+.+ |..+++|++|++|+|++|++.+..|.
T Consensus        14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~   91 (844)
T 3j0a_A           14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD   91 (844)
T ss_dssp             CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred             CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence            57888887  4468999999999999888999999999999999999888888 77899999999999999999999999


Q ss_pred             cccccCCccEEEeCCCCccCCCccc--ccCCCcccEEcCCCccCccccCC-CcccccccCCCCccceEEeeccccCCCCC
Q 039290          140 WFVSLPRLQHLLLKHNSFVGKIPET--IGYLSLLQELDLSDNQLSGTIPS-SIFNISSCQNLPVLEGLFISYNQLTGPIP  216 (1049)
Q Consensus       140 ~~~~l~~L~~L~L~~n~l~~~~p~~--~~~l~~L~~L~Ls~N~l~g~ip~-~~~~l~~l~~l~~L~~L~l~~N~l~~~~p  216 (1049)
                      .|+++++|++|+|++|.+++.+|..  ++++++|++|||++|++++..|. .+.      ++++|++|+|++|++++..|
T Consensus        92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~------~L~~L~~L~Ls~N~i~~~~~  165 (844)
T 3j0a_A           92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFG------KLNSLKSIDFSSNQIFLVCE  165 (844)
T ss_dssp             SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGG------TCSSCCEEEEESSCCCCCCS
T ss_pred             HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHh------hCCCCCEEECCCCcCCeeCH
Confidence            9999999999999999999878776  99999999999999999976553 443      46679999999999999999


Q ss_pred             CCcccc--cccceecccccccccccCCCCccccc------cceEEeccccccccCccccccc---cceEEEeeccccCCC
Q 039290          217 TNLWKC--RELHVVSLAFNKFQGGIPRDIGNLTS------VRNLFLGNNSLIGEIPNEIGNL---RNLEVLGVQSSNLAG  285 (1049)
Q Consensus       217 ~~l~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~------L~~L~L~~N~l~~~~p~~l~~l---~~L~~L~L~~n~l~~  285 (1049)
                      ..+..+  ++|+.|+|+.|.+++..|..++.+.+      |+.|+|++|.+++.+|..+...   .+++.|.++.+....
T Consensus       166 ~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~  245 (844)
T 3j0a_A          166 HELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGA  245 (844)
T ss_dssp             GGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBC
T ss_pred             HHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccc
Confidence            999988  89999999999999999998887776      9999999999999998887764   567888877443321


Q ss_pred             ccccccccccccceEEeccCccCCCCCCcccCC--CCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCcccc
Q 039290          286 LIPASIFNISTLKELAVTDNDLLGSLPSSIDLG--LPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTT  363 (1049)
Q Consensus       286 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~--l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  363 (1049)
                      .               ...+++.+.. ...+.+  .++|+.|+|++|.+++..|..|..+++|+.|+|++|++.+..|..
T Consensus       246 ~---------------~~~~~l~~~~-~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~  309 (844)
T 3j0a_A          246 G---------------FGFHNIKDPD-QNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEA  309 (844)
T ss_dssp             S---------------SSCSSSTTGG-GTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTT
T ss_pred             c---------------ccccccCCCC-hhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHH
Confidence            1               1111111111 111111  245666666666666555666666666666666666666666666


Q ss_pred             cccccccceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCC
Q 039290          364 FGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELG  443 (1049)
Q Consensus       364 ~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~  443 (1049)
                      |..+++|++|+|++|.++.+.+.     .+..+++|+.|++++|.+.++.+..+..+. +|+.|+|++|.+++     +.
T Consensus       310 ~~~l~~L~~L~Ls~N~l~~~~~~-----~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~-~L~~L~Ls~N~l~~-----i~  378 (844)
T 3j0a_A          310 FYGLDNLQVLNLSYNLLGELYSS-----NFYGLPKVAYIDLQKNHIAIIQDQTFKFLE-KLQTLDLRDNALTT-----IH  378 (844)
T ss_dssp             TTTCSSCCEEEEESCCCSCCCSC-----SCSSCTTCCEEECCSCCCCCCCSSCSCSCC-CCCEEEEETCCSCC-----CS
T ss_pred             hcCCCCCCEEECCCCCCCccCHH-----HhcCCCCCCEEECCCCCCCccChhhhcCCC-CCCEEECCCCCCCc-----cc
Confidence            66666666666666666555432     255566666666666666655555555443 66666666666653     22


Q ss_pred             CCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCC-CcccccccccceEEeeCcccCCcCch-hccCcccCC
Q 039290          444 NINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSI-PEDLCHLYRLANLYLGDNKLSGRLPA-CLGNLTSLR  521 (1049)
Q Consensus       444 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~  521 (1049)
                      .+++|+.|++++|+++ .+|..   ..+++.|++++|++++.. +..+..+++|+.|+|++|++++..+. .+..+++|+
T Consensus       379 ~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~  454 (844)
T 3j0a_A          379 FIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLE  454 (844)
T ss_dssp             SCCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCC
T ss_pred             CCCCcchhccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccc
Confidence            3677888888888887 44443   456788888888887532 22355778888888888888754432 355678888


Q ss_pred             ceeecCcccc-----cccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEE
Q 039290          522 DLSLGSNALT-----SIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLS  596 (1049)
Q Consensus       522 ~L~L~~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  596 (1049)
                      .|+|++|.++     +..+..|..+++|+.|+|++|++++..+..|..+++|++|+|++|+|++..|..+.  ++|+.|+
T Consensus       455 ~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~  532 (844)
T 3j0a_A          455 QLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILD  532 (844)
T ss_dssp             BCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEE
T ss_pred             cccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEE
Confidence            9999998887     44556788899999999999999998888899999999999999999988777776  8999999


Q ss_pred             eecccccCCccccccCccCCcEEeccCccccCCcc
Q 039290          597 LRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIP  631 (1049)
Q Consensus       597 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  631 (1049)
                      |++|+|++.+|..|.   +|+.|++++|++.+.-+
T Consensus       533 Ls~N~l~~~~~~~~~---~L~~l~l~~Np~~C~c~  564 (844)
T 3j0a_A          533 ISRNQLLAPNPDVFV---SLSVLDITHNKFICECE  564 (844)
T ss_dssp             EEEECCCCCCSCCCS---SCCEEEEEEECCCCSSS
T ss_pred             CCCCcCCCCChhHhC---CcCEEEecCCCcccccc
Confidence            999999999998764   78999999999987544

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=2.9e-55  Score=536.76  Aligned_cols=529  Identities=20%  Similarity=0.209  Sum_probs=392.7

Q ss_pred             hhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCc
Q 039290          100 AVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDN  179 (1049)
Q Consensus       100 ~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N  179 (1049)
                      .+++.++++++ .+|..+.  ++|++|||++|++++..|..|.++++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus        14 ~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n   90 (606)
T 3vq2_A           14 ITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN   90 (606)
T ss_dssp             TEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred             CceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCC
Confidence            35667777776 6776554  56777777777777666667777777777777777777666667777777777777777


Q ss_pred             cCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccceeccccccccc-ccCCCCccccccceEEecccc
Q 039290          180 QLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQG-GIPRDIGNLTSVRNLFLGNNS  258 (1049)
Q Consensus       180 ~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~  258 (1049)
                      ++++..|..+.+      +++|++|++++|++++..|..+.++++|++|+|++|++++ .+|..|+++++|++|+|++|+
T Consensus        91 ~l~~~~p~~~~~------l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~  164 (606)
T 3vq2_A           91 PIQSFSPGSFSG------LTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNY  164 (606)
T ss_dssp             CCCCCCTTSSTT------CTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSC
T ss_pred             cccccChhhcCC------cccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCc
Confidence            777555655543      3446666666666665544555556666666666665554 345555555555555555555


Q ss_pred             ccccCccccccccceE----EEeeccccCCCccccccccccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCC-
Q 039290          259 LIGEIPNEIGNLRNLE----VLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFS-  333 (1049)
Q Consensus       259 l~~~~p~~l~~l~~L~----~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~-  333 (1049)
                      +++..|..|+.+++|+    .|++++|++.+..+..+..                          .+|++|++++|.++ 
T Consensus       165 l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~--------------------------~~L~~L~L~~n~~~~  218 (606)
T 3vq2_A          165 IQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQG--------------------------IKLHELTLRGNFNSS  218 (606)
T ss_dssp             CCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTT--------------------------CEEEEEEEESCCSCH
T ss_pred             ceecChhhhhhhhccccccceeeccCCCcceeCcccccC--------------------------ceeeeeeccCCccch
Confidence            5555555555554443    4555555544333322222                          24555555555554 


Q ss_pred             CCCCccccCCCCCceeecccCcccc------Cccccccccc--ccceeec-ccccccCCCCCcccccccccCCCCcEEEc
Q 039290          334 GTIPSSLTNISELSVLDFGFNSFSG------LIPTTFGNLR--SLKLLSL-AGNVLTSPTPDLSFLSSLTSCRNLEIIYL  404 (1049)
Q Consensus       334 ~~~p~~~~~l~~L~~L~Ls~N~l~~------~~p~~~~~l~--~L~~L~L-~~N~l~~~~~~~~~l~~l~~l~~L~~L~L  404 (1049)
                      +..|..+.++++|+.+++..+.+.+      ..+..+..+.  +++.+++ ..|.+.+..+      .+..+++|+.|++
T Consensus       219 ~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~------~~~~l~~L~~L~l  292 (606)
T 3vq2_A          219 NIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIV------KFHCLANVSAMSL  292 (606)
T ss_dssp             HHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGG------SCGGGTTCSEEEE
T ss_pred             hHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheecccccccccccc------ccccCCCCCEEEe
Confidence            2345555556666665554443332      1122222222  4566666 5555555333      2778899999999


Q ss_pred             cCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCC
Q 039290          405 SENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEG  484 (1049)
Q Consensus       405 s~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  484 (1049)
                      ++|.+... | .+..+. +|++|++++|.+ +.+| .+ .+++|+.|++++|...+..  .+..+++|++|++++|++++
T Consensus       293 ~~~~~~~l-~-~l~~~~-~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~  364 (606)
T 3vq2_A          293 AGVSIKYL-E-DVPKHF-KWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSF  364 (606)
T ss_dssp             ESCCCCCC-C-CCCTTC-CCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEE
T ss_pred             cCccchhh-h-hccccc-cCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCC
Confidence            99999754 4 565554 899999999999 6788 45 9999999999999665443  67899999999999999986


Q ss_pred             C--CCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccccC-cccccccccccccccCCccCCCCccC
Q 039290          485 S--IPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIP-STLWNLKDILRFNLSSNSLNGSLLPD  561 (1049)
Q Consensus       485 ~--~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~  561 (1049)
                      .  +|..+..+++|++|++++|.++ .+|..+.++++|+.|++++|++++..| ..+..+++|++|++++|.+++..|..
T Consensus       365 ~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~  443 (606)
T 3vq2_A          365 SGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGI  443 (606)
T ss_dssp             EEECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTT
T ss_pred             CcchhhhhccCCcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhh
Confidence            6  4888999999999999999998 477899999999999999999999888 78999999999999999999999999


Q ss_pred             cCCCcceeEeecccccccc-cccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCccccccccccc
Q 039290          562 IGNLKVVIEMDLSLNALSG-VIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYL  640 (1049)
Q Consensus       562 ~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  640 (1049)
                      +..+++|++|++++|++++ .+|..|+.+++|+.|+|++|++++.+|..|+++++|++|+|++|++++.+|..+..+++|
T Consensus       444 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  523 (606)
T 3vq2_A          444 FLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSL  523 (606)
T ss_dssp             TTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTC
T ss_pred             hcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcC
Confidence            9999999999999999998 579999999999999999999999999999999999999999999999889999999999


Q ss_pred             ceeeccCCcccccCCCC-CCcc-ccccccccCCccccCCCC
Q 039290          641 KHLNLSFNQLEGEIPTR-GPFI-TFSAESFLGNQALCGSPK  679 (1049)
Q Consensus       641 ~~l~l~~N~l~~~~p~~-~~~~-~~~~~~~~~n~~~cg~~~  679 (1049)
                      ++|++++|+++. +|.. ..+. .+....+.+|++.|+++.
T Consensus       524 ~~L~l~~N~l~~-~p~~~~~l~~~L~~l~l~~N~~~c~c~~  563 (606)
T 3vq2_A          524 STLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVACICEH  563 (606)
T ss_dssp             CEEECTTSCCCC-EESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred             CEEECCCCcCcc-cCHhHhhhcccCcEEEccCCCcccCCcc
Confidence            999999999994 5543 2332 355678999999998874

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-52  Score=507.69  Aligned_cols=534  Identities=18%  Similarity=0.192  Sum_probs=385.7

Q ss_pred             EEEeccccccccCCCCCCcchhhhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCCCCc
Q 039290           78 LNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSF  157 (1049)
Q Consensus        78 l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l  157 (1049)
                      ++.++.+++ .+|..+.  +.+++|+|++|++++..|..++++++|++|||++|++++..|..|+++++|++|+|++|.+
T Consensus        12 ~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l   88 (570)
T 2z63_A           12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI   88 (570)
T ss_dssp             EECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             EEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcC
Confidence            444555666 6777654  4688999999999877777889999999999999999887788899999999999999999


Q ss_pred             cCCCcccccCCCcccEEcCCCccCccccCC-CcccccccCCCCccceEEeeccccCC-CCCCCcccccccceeccccccc
Q 039290          158 VGKIPETIGYLSLLQELDLSDNQLSGTIPS-SIFNISSCQNLPVLEGLFISYNQLTG-PIPTNLWKCRELHVVSLAFNKF  235 (1049)
Q Consensus       158 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~-~~~~l~~l~~l~~L~~L~l~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l  235 (1049)
                      ++..|..|+.+++|++|+|++|+++ .+|. .++      ++++|++|++++|++++ .+|..+.++++|+.|++++|++
T Consensus        89 ~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~------~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l  161 (570)
T 2z63_A           89 QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIG------HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI  161 (570)
T ss_dssp             CEECTTTTTTCTTCCEEECTTSCCC-CSTTCSCT------TCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCC
T ss_pred             CccCHhhhcCccccccccccccccc-cCCCcccc------ccccccEEecCCCccceecChhhhcccCCCCEEeCcCCcc
Confidence            8777788999999999999999998 4443 343      45668899999999887 5788888888999999999988


Q ss_pred             ccccCCCCcccccc----ceEEeccccccccCccccccccceEEEeeccccCCC-ccccccccccccceEEeccCccCCC
Q 039290          236 QGGIPRDIGNLTSV----RNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAG-LIPASIFNISTLKELAVTDNDLLGS  310 (1049)
Q Consensus       236 ~~~~p~~~~~l~~L----~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~  310 (1049)
                      ++..|..++.+++|    +.|++++|.+++..|..+..+ +|+.|++++|.... .+|..+..++.++.+.+..+.+.. 
T Consensus       162 ~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~-  239 (570)
T 2z63_A          162 QSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN-  239 (570)
T ss_dssp             CEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCC-
T ss_pred             ceecHHHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccC-
Confidence            88778888888888    788888888887777777766 78888888774432 355666677777766665443321 


Q ss_pred             CCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccC-ccccCcccccccccccceeecccccccCCCCCccc
Q 039290          311 LPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFN-SFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSF  389 (1049)
Q Consensus       311 ~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~  389 (1049)
                              ..+++  .+....+.     .+..+ .++.+++++| .+.+..|..|..+++|+.|++++|.++.++..   
T Consensus       240 --------~~~l~--~~~~~~~~-----~l~~l-~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~~---  300 (570)
T 2z63_A          240 --------EGNLE--KFDKSALE-----GLCNL-TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF---  300 (570)
T ss_dssp             --------CSSCE--ECCTTTTG-----GGGGS-EEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEECSCCBC---
T ss_pred             --------chhhh--hcchhhhc-----ccccc-chhhhhhhcchhhhhhchhhhcCcCcccEEEecCccchhhhhh---
Confidence                    11111  11111111     12222 3556666666 56666666677777777777777766654432   


Q ss_pred             ccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCc
Q 039290          390 LSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRL  469 (1049)
Q Consensus       390 l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  469 (1049)
                         +..+ +|+.|++++|.+.                          .+|.  ..+++|+.|++++|.+.+..+.  ..+
T Consensus       301 ---~~~~-~L~~L~l~~n~~~--------------------------~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~  346 (570)
T 2z63_A          301 ---SYNF-GWQHLELVNCKFG--------------------------QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDL  346 (570)
T ss_dssp             ---CSCC-CCSEEEEESCBCS--------------------------SCCB--CBCSSCCEEEEESCBSCCBCCC--CBC
T ss_pred             ---hccC-CccEEeeccCccc--------------------------ccCc--ccccccCEEeCcCCcccccccc--ccC
Confidence               2333 5555665555554                          1222  2345566666666665544433  456


Q ss_pred             CCCcceEeeccccCCCC--CcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccccC-ccccccccccc
Q 039290          470 QKLQGLYLQNNKLEGSI--PEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIP-STLWNLKDILR  546 (1049)
Q Consensus       470 ~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~  546 (1049)
                      ++|++|++++|++++..  |..+..+++|++|++++|.+++. |..+..+++|++|++++|++++..| ..+..+++|++
T Consensus       347 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~  425 (570)
T 2z63_A          347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY  425 (570)
T ss_dssp             TTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEE-EEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCE
T ss_pred             CCCCEEeCcCCccCccccccccccccCccCEEECCCCccccc-cccccccCCCCEEEccCCccccccchhhhhcCCCCCE
Confidence            66666666666665432  45566667777777777777643 3337777777777777777777655 46777788888


Q ss_pred             ccccCCccCCCCccCcCCCcceeEeeccccccc-ccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCcc
Q 039290          547 FNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALS-GVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNN  625 (1049)
Q Consensus       547 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  625 (1049)
                      |++++|.+++..+..+..+++|++|++++|.++ +.+|..|..+++|+.|+|++|++++..|..|.++++|++|+|++|+
T Consensus       426 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~  505 (570)
T 2z63_A          426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQ  505 (570)
T ss_dssp             EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             EeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCc
Confidence            888888887777778888888888889998887 5788999999999999999999998889999999999999999999


Q ss_pred             ccCCcccccccccccceeeccCCcccccCCCCCCc---cccccccccCCccccCCC
Q 039290          626 LSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPF---ITFSAESFLGNQALCGSP  678 (1049)
Q Consensus       626 l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~---~~~~~~~~~~n~~~cg~~  678 (1049)
                      +++..|..+..+++|+.|++++|+++|.+|....+   ..-....+.+.+ .|..|
T Consensus       506 l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~wl~~~~~~~~~~~-~C~~~  560 (570)
T 2z63_A          506 LKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSA-KCSGS  560 (570)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHHHHTGGGEESCC-BBTTT
T ss_pred             CCCCCHHHhhcccCCcEEEecCCcccCCCcchHHHHHHHHhccccCCCch-hhCCC
Confidence            99888888999999999999999999999874322   111122344444 67665

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.8e-52  Score=505.80  Aligned_cols=499  Identities=22%  Similarity=0.212  Sum_probs=323.1

Q ss_pred             CceeeeEEEcCCCCcEEEEEEeccccccccCCCCCCcchhhhhhcccCccccccCcccccccCCcEeccccCCccccCcc
Q 039290           60 VCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPS  139 (1049)
Q Consensus        60 ~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~  139 (1049)
                      .|.|.|| |+..          +++++ .+|+.+.  +.|++|+|++|.+++..|..++++++|++|+|++|++.+..|.
T Consensus         3 ~C~~~~~-c~~~----------~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~   68 (549)
T 2z81_A            3 SCDASGV-CDGR----------SRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD   68 (549)
T ss_dssp             EECTTSE-EECT----------TSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTT
T ss_pred             cCCCCce-EECC----------CCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChh
Confidence            4999999 9643          44555 7787665  6788888888888877778888888888888888888877778


Q ss_pred             cccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCcc-ccCCCcccccccCCCCccceEEeeccccCCCCCCC
Q 039290          140 WFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSG-TIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTN  218 (1049)
Q Consensus       140 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~  218 (1049)
                      .|+++++|++|+|++|.+++..|..|+.+++|++|||++|++++ .+|..+.      ++++|++|++++|++.+.+|. 
T Consensus        69 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~------~l~~L~~L~L~~n~~~~~~~~-  141 (549)
T 2z81_A           69 AFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFP------NLTNLQTLRIGNVETFSEIRR-  141 (549)
T ss_dssp             TTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCT------TCTTCCEEEEEESSSCCEECT-
T ss_pred             hccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhh------ccCCccEEECCCCccccccCH-
Confidence            88888888888888888887777778888888888888888874 3444443      344566666666664433331 


Q ss_pred             cccccccceecccccccccccCCCCccccccceEEeccccccccCccccccccceEEEeeccccCCCccccccccccccc
Q 039290          219 LWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLK  298 (1049)
Q Consensus       219 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~  298 (1049)
                                            ..|+++++|++|+|++|++++.+|..++++++|+.|+++.|.+....+..+..+++|+
T Consensus       142 ----------------------~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~  199 (549)
T 2z81_A          142 ----------------------IDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVR  199 (549)
T ss_dssp             ----------------------TTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBS
T ss_pred             ----------------------hhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhccccc
Confidence                                  2344445555555555555544555555555555555554444322111223344555


Q ss_pred             eEEeccCccCCCC--CCcccCCCCCccEEEcCCCCCCCCCC----ccccCCCCCceeecccCccccCcccccccccccce
Q 039290          299 ELAVTDNDLLGSL--PSSIDLGLPNLERLFLGENNFSGTIP----SSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKL  372 (1049)
Q Consensus       299 ~L~l~~N~l~~~~--p~~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  372 (1049)
                      +|++++|++.+..  |..+...+++|+.|++++|.+++..+    ..+..+++|+.|++++|.+.+              
T Consensus       200 ~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~--------------  265 (549)
T 2z81_A          200 YLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNG--------------  265 (549)
T ss_dssp             EEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEEC--------------
T ss_pred             EEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccc--------------
Confidence            5555555544321  11222234455555555555443222    222334444555555444443              


Q ss_pred             eecccccccCCCCCc-ccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEE
Q 039290          373 LSLAGNVLTSPTPDL-SFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVI  451 (1049)
Q Consensus       373 L~L~~N~l~~~~~~~-~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L  451 (1049)
                                +..-. .....+..+.+|+.|+++++.+.....  +.                  .++..+...++|+.|
T Consensus       266 ----------~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~--~~------------------~l~~~~~~~~~L~~L  315 (549)
T 2z81_A          266 ----------LGDFNPSESDVVSELGKVETVTIRRLHIPQFYL--FY------------------DLSTVYSLLEKVKRI  315 (549)
T ss_dssp             ----------CSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGG--SC------------------CCCHHHHHSTTCCEE
T ss_pred             ----------cccccccchhhhhhhcccccccccccccchhhh--cc------------------cchhhhhhcccceEE
Confidence                      21100 001123445666666666665542100  00                  011112224567777


Q ss_pred             EccCCcccccCCccc-cCcCCCcceEeeccccCCCCC---cccccccccceEEeeCcccCCcCc--hhccCcccCCceee
Q 039290          452 RLGNNELTGTIPVTL-GRLQKLQGLYLQNNKLEGSIP---EDLCHLYRLANLYLGDNKLSGRLP--ACLGNLTSLRDLSL  525 (1049)
Q Consensus       452 ~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L  525 (1049)
                      ++++|+++ .+|..+ ..+++|++|+|++|++++.+|   ..+..+++|++|++++|++++..+  ..++.+++|++|++
T Consensus       316 ~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~L  394 (549)
T 2z81_A          316 TVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDI  394 (549)
T ss_dssp             EEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEEC
T ss_pred             EeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEEC
Confidence            77777776 455544 467777777777777776553   236667777788888887775432  45777888888888


Q ss_pred             cCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCC
Q 039290          526 GSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGP  605 (1049)
Q Consensus       526 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  605 (1049)
                      ++|++++ +|..+..+++|++|++++|+++.. +..+  .++|++|||++|+|++.+    ..+++|++|+|++|+|+ .
T Consensus       395 s~N~l~~-lp~~~~~~~~L~~L~Ls~N~l~~l-~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~  465 (549)
T 2z81_A          395 SRNTFHP-MPDSCQWPEKMRFLNLSSTGIRVV-KTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-T  465 (549)
T ss_dssp             TTCCCCC-CCSCCCCCTTCCEEECTTSCCSCC-CTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-S
T ss_pred             CCCCCcc-CChhhcccccccEEECCCCCcccc-cchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-c
Confidence            8888874 677777788888888888887753 3322  257889999999998653    57899999999999999 5


Q ss_pred             ccccccCccCCcEEeccCccccCCcccccccccccceeeccCCcccccCCC
Q 039290          606 IPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPT  656 (1049)
Q Consensus       606 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~  656 (1049)
                      +|. ...+++|++|||++|++++.+|..+..+++|+.|++++|+|.|.+|.
T Consensus       466 ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  515 (549)
T 2z81_A          466 LPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  515 (549)
T ss_dssp             CCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred             CCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence            665 46789999999999999988888899999999999999999999884

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.1e-51  Score=496.42  Aligned_cols=496  Identities=19%  Similarity=0.172  Sum_probs=404.0

Q ss_pred             CcEEEEEEeccccccccCCCCCCcchhhhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEe
Q 039290           73 RRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLL  152 (1049)
Q Consensus        73 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L  152 (1049)
                      .++..|+|+++.+++..+..+++++.|++|+|++|++++..|..++++++|++|+|++|++.+..|..|+++++|++|+|
T Consensus        28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  107 (570)
T 2z63_A           28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  107 (570)
T ss_dssp             SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred             ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence            46899999999999877889999999999999999999877788999999999999999999888899999999999999


Q ss_pred             CCCCccCCCcccccCCCcccEEcCCCccCcc-ccCCCcccccccCCCCccceEEeeccccCCCCCCCccccccc----ce
Q 039290          153 KHNSFVGKIPETIGYLSLLQELDLSDNQLSG-TIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCREL----HV  227 (1049)
Q Consensus       153 ~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L----~~  227 (1049)
                      ++|.+++..+..++.+++|++|+|++|++++ .+|..+.+      +++|++|++++|++++..|..+..+++|    +.
T Consensus       108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~------l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~  181 (570)
T 2z63_A          108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN------LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS  181 (570)
T ss_dssp             TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGG------CTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCE
T ss_pred             cccccccCCCccccccccccEEecCCCccceecChhhhcc------cCCCCEEeCcCCccceecHHHccchhccchhhhh
Confidence            9999996655679999999999999999986 57887765      4569999999999998888899999999    89


Q ss_pred             ecccccccccccCCCCccccccceEEecccccc-ccCccccccccceEEEeeccccCCCccccccccccccceEEeccCc
Q 039290          228 VSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLI-GEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDND  306 (1049)
Q Consensus       228 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~  306 (1049)
                      +++++|.+++..|..+..+ +|+.|++++|... ..+|..++.+++++.+.+..+.+...        ..++.       
T Consensus       182 L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~--------~~l~~-------  245 (570)
T 2z63_A          182 LDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE--------GNLEK-------  245 (570)
T ss_dssp             EECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCC--------SSCEE-------
T ss_pred             cccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCc--------hhhhh-------
Confidence            9999999998888888766 8999999998544 25677788999998887765433221        11111       


Q ss_pred             cCCCCCCcccCCCC--CccEEEcCCC-CCCCCCCccccCCCCCceeecccCccccCcccccccccccceeecccccccCC
Q 039290          307 LLGSLPSSIDLGLP--NLERLFLGEN-NFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSP  383 (1049)
Q Consensus       307 l~~~~p~~~~~~l~--~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  383 (1049)
                          ++...+.+++  .++.+++++| .+.+..|..+..+++|++|++++|.+.+ +|..+..+ +|++|++++|.++.+
T Consensus       246 ----~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~-l~~~~~~~-~L~~L~l~~n~~~~l  319 (570)
T 2z63_A          246 ----FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNF-GWQHLELVNCKFGQF  319 (570)
T ss_dssp             ----CCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEECS-CCBCCSCC-CCSEEEEESCBCSSC
T ss_pred             ----cchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccchh-hhhhhccC-CccEEeeccCccccc
Confidence                1111111111  3567777777 6777788888888999999999998884 67778888 999999999988865


Q ss_pred             CCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccC-
Q 039290          384 TPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTI-  462 (1049)
Q Consensus       384 ~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-  462 (1049)
                      +.        ..+++|+.|++++|.+.+..+                         .  ..+++|++|++++|.+++.. 
T Consensus       320 ~~--------~~l~~L~~L~l~~n~~~~~~~-------------------------~--~~~~~L~~L~l~~n~l~~~~~  364 (570)
T 2z63_A          320 PT--------LKLKSLKRLTFTSNKGGNAFS-------------------------E--VDLPSLEFLDLSRNGLSFKGC  364 (570)
T ss_dssp             CB--------CBCSSCCEEEEESCBSCCBCC-------------------------C--CBCTTCCEEECCSSCCBEEEE
T ss_pred             Cc--------ccccccCEEeCcCCccccccc-------------------------c--ccCCCCCEEeCcCCccCcccc
Confidence            43        245667777777776553322                         2  45667777777777777543 


Q ss_pred             -CccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCc-hhccCcccCCceeecCcccccccCccccc
Q 039290          463 -PVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLP-ACLGNLTSLRDLSLGSNALTSIIPSTLWN  540 (1049)
Q Consensus       463 -p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  540 (1049)
                       |..+..+++|++|++++|++.+. +..+..+++|++|++++|.+++..| ..+.++++|++|++++|++++..|..+..
T Consensus       365 ~~~~~~~~~~L~~L~l~~n~l~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  443 (570)
T 2z63_A          365 CSQSDFGTTSLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG  443 (570)
T ss_dssp             EEHHHHTCSCCCEEECCSCSEEEE-EEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTT
T ss_pred             ccccccccCccCEEECCCCccccc-cccccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhc
Confidence             56677778888888888887744 3347788888888888888876655 46788888888888888888888888888


Q ss_pred             ccccccccccCCccC-CCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEE
Q 039290          541 LKDILRFNLSSNSLN-GSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFV  619 (1049)
Q Consensus       541 l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  619 (1049)
                      +++|++|++++|.++ +.+|..+..+++|++|++++|++++..|..|+.+++|+.|+|++|++++.+|..|.++++|++|
T Consensus       444 l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  523 (570)
T 2z63_A          444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKI  523 (570)
T ss_dssp             CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred             CCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEE
Confidence            888888888888887 5678888999999999999999998889999999999999999999999888899999999999


Q ss_pred             eccCccccCCccc
Q 039290          620 DMSNNNLSGTIPK  632 (1049)
Q Consensus       620 ~Ls~N~l~~~~p~  632 (1049)
                      ++++|++++..|.
T Consensus       524 ~l~~N~~~~~~~~  536 (570)
T 2z63_A          524 WLHTNPWDCSCPR  536 (570)
T ss_dssp             ECCSSCBCCCTTT
T ss_pred             EecCCcccCCCcc
Confidence            9999999988774

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.3e-52  Score=456.03  Aligned_cols=265  Identities=26%  Similarity=0.450  Sum_probs=222.9

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC------CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      ++|.+.+.||+|+||+||+|++.      ++..||||+++.......++|.+|++++++++|||||+++|+|.+++..++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            45778899999999999999863      477899999986655556789999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCC------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEE
Q 039290          835 VLEYMSNGSLEKCLYSDN------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHL  902 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl  902 (1049)
                      |||||++|+|.+++...+            ..+++.++.+|+.||++||+|||   +++||||||||+|||+++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence            999999999999997642            46899999999999999999999   999999999999999999999999


Q ss_pred             ecccCceecCCCcccc-ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhcc
Q 039290          903 SDFGIAKILGKEESMR-QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSL  980 (1049)
Q Consensus       903 ~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  980 (1049)
                      +|||+|+......... .....||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+..  ..+..  
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~--~~i~~--  245 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI--ECITQ--  245 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH--HHHHH--
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH--HHHHc--
Confidence            9999998765443322 233568999999999999999999999999999999999 89999864332211  11100  


Q ss_pred             ccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhccCC
Q 039290          981 LSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYIDV 1049 (1049)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~~~~ 1049 (1049)
                                       ..+.+.+..+++++.+++.+||+.||++||||+|+++.|+++.+.-..|+|+
T Consensus       246 -----------------~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p~~ldi  297 (299)
T 4asz_A          246 -----------------GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPVYLDI  297 (299)
T ss_dssp             -----------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCCCSCC
T ss_pred             -----------------CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCCccccC
Confidence                             0011223456788999999999999999999999999999999999999986

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=1.5e-51  Score=503.17  Aligned_cols=507  Identities=18%  Similarity=0.235  Sum_probs=286.5

Q ss_pred             ChhhHHHHHHHHHhcccCCCCcccccCCCCCC----Cceeee-EEEcCC--CCcEEEEEEeccccccccCCCCCCcchhh
Q 039290           28 VTTDQFALLALKEHIKHDPSNLLANNWSTTSS----VCSWIG-VTCGVR--NRRVTALNISYLGLTGTIPPQLGNLSFLA  100 (1049)
Q Consensus        28 ~~~d~~all~~k~~~~~~~~~~l~~~w~~~~~----~c~w~g-v~c~~~--~~~v~~l~l~~~~l~g~~~~~~~~l~~L~  100 (1049)
                      ...+.+.-.++++-+..- .+   ..|....+    .|.|.. ..|..-  ..-|+.   ..         .    .+++
T Consensus        25 ~~~~~~d~~aL~~~~~~~-~~---~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C---~~---------~----~~V~   84 (636)
T 4eco_A           25 TAEYIKDYLALKEIWDAL-NG---KNWSQQGFGTQPGANWNFNKELDMWGAQPGVSL---NS---------N----GRVT   84 (636)
T ss_dssp             CCHHHHHHHHHHHHHHHT-TG---GGCCCCC------CCCCCSSCGGGTTCCTTEEE---CT---------T----CCEE
T ss_pred             hhhHHHHHHHHHHHHHHc-CC---CCcccCCcCCccCCCCCCCCCcccccCCCCeEE---cC---------C----CCEE
Confidence            346777888888766432 22   36874432    247962 222211  012321   10         0    3567


Q ss_pred             hhhcccCccccccCcccccccCCcEeccccCCc------cc------cCcccccccCCccEEEeCCCCccCCCcccccC-
Q 039290          101 VLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNF------HI------EIPSWFVSLPRLQHLLLKHNSFVGKIPETIGY-  167 (1049)
Q Consensus       101 ~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~------~~------~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~-  167 (1049)
                      .|+|++|++.|.+|+++++|++|++|||++|++      .|      .+|...  +..|+ +++++|.+.+.+|..++. 
T Consensus        85 ~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~  161 (636)
T 4eco_A           85 GLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDL  161 (636)
T ss_dssp             EEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHH
T ss_pred             EEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHH
Confidence            888999999999999999999999999988876      23      444433  45566 677777777666666653 


Q ss_pred             CCcccEEcCCCccCccccCCCcccccccCCCCccceEE--eeccccCCCCCCCcccccccceecccccccccc-------
Q 039290          168 LSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLF--ISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGG-------  238 (1049)
Q Consensus       168 l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~--l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-------  238 (1049)
                      +..+..+++....+...            ....++.++  ..+|+++| ||..++++++|++|+|++|+++|.       
T Consensus       162 ~~~l~~~~l~~~~~~~~------------~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~  228 (636)
T 4eco_A          162 IKDCINSDPQQKSIKKS------------SRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWE  228 (636)
T ss_dssp             HHHHHHHCTTSCCCCCC------------CCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCS
T ss_pred             HHHHhhcCccccccccc------------cccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcccccccccccc
Confidence            23444444443333210            000111111  22455555 566666666666666666666654       


Q ss_pred             ----------cCCCCc--cccccceEEeccccccccCccccccccceEEEeecccc-CCC-ccccccccc------cccc
Q 039290          239 ----------IPRDIG--NLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSN-LAG-LIPASIFNI------STLK  298 (1049)
Q Consensus       239 ----------~p~~~~--~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~-l~~-~~p~~~~~l------~~L~  298 (1049)
                                +|..++  ++++|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..++++      ++|+
T Consensus       229 ~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~  308 (636)
T 4eco_A          229 NENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQ  308 (636)
T ss_dssp             CTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCC
T ss_pred             ccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCC
Confidence                      666666  66666666666666666666666666666666666666 665 566666554      4555


Q ss_pred             eEEeccCccCCCCCC-cccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCcccccccccccceeeccc
Q 039290          299 ELAVTDNDLLGSLPS-SIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAG  377 (1049)
Q Consensus       299 ~L~l~~N~l~~~~p~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  377 (1049)
                      +|++++|+++ .+|. .                        .++++++|++|++++|++.|.+| .|+.+++|++|++++
T Consensus       309 ~L~L~~n~l~-~ip~~~------------------------~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~  362 (636)
T 4eco_A          309 IIYIGYNNLK-TFPVET------------------------SLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAY  362 (636)
T ss_dssp             EEECCSSCCS-SCCCHH------------------------HHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCS
T ss_pred             EEECCCCcCC-ccCchh------------------------hhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCC
Confidence            5555555544 4444 0                        44444444444444444444444 444444444444444


Q ss_pred             ccccCCCCCcccccccccCCC-CcEEEccCCccccCCCCcccccc-ccccEEEccCCccccCCCCCCC-------CCCCc
Q 039290          378 NVLTSPTPDLSFLSSLTSCRN-LEIIYLSENPINGILPSSIGNFS-ISMKSLSMESCNISGGIPKELG-------NINNL  448 (1049)
Q Consensus       378 N~l~~~~~~~~~l~~l~~l~~-L~~L~Ls~N~i~~~~p~~~~~~~-~~L~~L~L~~n~i~~~~p~~~~-------~l~~L  448 (1049)
                      |.++.++..      +..+++ |++|++++|.++ .+|..+.... .+|+.|++++|.+++.+|..|.       .+++|
T Consensus       363 N~l~~lp~~------l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L  435 (636)
T 4eco_A          363 NQITEIPAN------FCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV  435 (636)
T ss_dssp             SEEEECCTT------SEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCE
T ss_pred             CccccccHh------hhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCC
Confidence            444433321      333444 444444444444 3333333221 1455555555555555555555       66778


Q ss_pred             cEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCccccc-c-------cccceEEeeCcccCCcCchhcc--Ccc
Q 039290          449 TVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCH-L-------YRLANLYLGDNKLSGRLPACLG--NLT  518 (1049)
Q Consensus       449 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l-------~~L~~L~L~~N~l~~~~p~~~~--~l~  518 (1049)
                      ++|+|++|++++..+..+..+++|++|+|++|+++ .+|..+.. .       ++|++|+|++|+++ .+|..+.  .++
T Consensus       436 ~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~  513 (636)
T 4eco_A          436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLP  513 (636)
T ss_dssp             EEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCT
T ss_pred             CEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCC
Confidence            88888888887443444556778888888888887 45544332 2       26666666666666 4555554  666


Q ss_pred             cCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEee
Q 039290          519 SLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLR  598 (1049)
Q Consensus       519 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  598 (1049)
                      +|+.|+|++|++++ +|..+..+++|+.|+|++|+                  ++++|++.+.+|..|+.+++|+.|+|+
T Consensus       514 ~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~------------------~ls~N~l~~~~p~~l~~l~~L~~L~Ls  574 (636)
T 4eco_A          514 YLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR------------------DAQGNRTLREWPEGITLCPSLTQLQIG  574 (636)
T ss_dssp             TCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECC
T ss_pred             CcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCc------------------ccccCcccccChHHHhcCCCCCEEECC
Confidence            66666666666665 55556566666666665554                  345566666666666666666666666


Q ss_pred             cccccCCccccccCccCCcEEeccCcccc
Q 039290          599 YNRLQGPIPESFGGLKSLNFVDMSNNNLS  627 (1049)
Q Consensus       599 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  627 (1049)
                      +|+|+ .+|..+.  ++|++|||++|++.
T Consensus       575 ~N~l~-~ip~~~~--~~L~~L~Ls~N~l~  600 (636)
T 4eco_A          575 SNDIR-KVNEKIT--PNISVLDIKDNPNI  600 (636)
T ss_dssp             SSCCC-BCCSCCC--TTCCEEECCSCTTC
T ss_pred             CCcCC-ccCHhHh--CcCCEEECcCCCCc
Confidence            66663 4454444  45666666666554

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.8e-51  Score=455.45  Aligned_cols=264  Identities=26%  Similarity=0.448  Sum_probs=211.6

Q ss_pred             CCCCCceecCCCcEEEEEEEeC------CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      +|...++||+|+||+||+|++.      +++.||||+++.......++|.+|++++++++|||||+++|+|.+.+..++|
T Consensus        42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV  121 (329)
T 4aoj_A           42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV  121 (329)
T ss_dssp             GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            4667789999999999999864      4788999999866555567899999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCC--------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceE
Q 039290          836 LEYMSNGSLEKCLYSDN--------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGH  901 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~k  901 (1049)
                      ||||++|+|.++++..+              ..+++.++.+|+.||++||+|||   +++||||||||+|||+++++.+|
T Consensus       122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~K  198 (329)
T 4aoj_A          122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVK  198 (329)
T ss_dssp             EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEE
T ss_pred             EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcEE
Confidence            99999999999987542              35899999999999999999999   99999999999999999999999


Q ss_pred             EecccCceecCCCccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhc
Q 039290          902 LSDFGIAKILGKEESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDS  979 (1049)
Q Consensus       902 l~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  979 (1049)
                      |+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||.+....+.  ...+.. 
T Consensus       199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~--~~~i~~-  275 (329)
T 4aoj_A          199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA--IDCITQ-  275 (329)
T ss_dssp             ECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH--HHHHHH-
T ss_pred             EcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH--HHHHHc-
Confidence            9999999876443322 2334678999999999999999999999999999999999 8999976432221  111100 


Q ss_pred             cccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhccCC
Q 039290          980 LLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYIDV 1049 (1049)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~~~~ 1049 (1049)
                                        ..+...+..+++++.+++.+||+.||++||||+||+++|+.+.+.-..|+|+
T Consensus       276 ------------------g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp~~ld~  327 (329)
T 4aoj_A          276 ------------------GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDV  327 (329)
T ss_dssp             ------------------TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC-----
T ss_pred             ------------------CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCcccccC
Confidence                              0112223456788999999999999999999999999999999988889885

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-50  Score=440.16  Aligned_cols=262  Identities=27%  Similarity=0.440  Sum_probs=208.9

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .++++..++||+|+||+||+|++.+  .||||+++....  ...+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            4567888999999999999999743  699999875432  235679999999999999999999998865 56899999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc-c
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE-S  916 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~-~  916 (1049)
                      ||++|+|.+++...+..+++.++.+|+.|||+||+|||   +++||||||||+|||+++++.+||+|||+|+...... .
T Consensus       112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            99999999999887777999999999999999999999   9999999999999999999999999999998764332 2


Q ss_pred             ccccccccccCcccccccCC---CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGRE---GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                      ......+||+.|||||++.+   ..|+.++|||||||++|||+||+.||.+....+..... +......+          
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~-~~~~~~~p----------  257 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM-VGRGYASP----------  257 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH-HHTTCCCC----------
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH-HhcCCCCC----------
Confidence            23345679999999999853   46899999999999999999999999764322221111 11110000          


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhh
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~ 1043 (1049)
                           .....+.++++++.+++.+||+.||++||||+||+++|+.+...+
T Consensus       258 -----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          258 -----DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             -----CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             -----CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence                 001122456788999999999999999999999999999887654

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=8.9e-50  Score=494.08  Aligned_cols=383  Identities=21%  Similarity=0.295  Sum_probs=267.6

Q ss_pred             cccccccCCCCccccccceEEeccccccc-----------------cCccccc--cccceEEEeeccccCCCcccccccc
Q 039290          233 NKFQGGIPRDIGNLTSVRNLFLGNNSLIG-----------------EIPNEIG--NLRNLEVLGVQSSNLAGLIPASIFN  293 (1049)
Q Consensus       233 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-----------------~~p~~l~--~l~~L~~L~L~~n~l~~~~p~~~~~  293 (1049)
                      |+++| +|..|+++++|++|+|++|++++                 .+|+.++  ++++|++|+|++|++.+.+|..+.+
T Consensus       435 N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~  513 (876)
T 4ecn_A          435 NRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYD  513 (876)
T ss_dssp             CEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGG
T ss_pred             Ccccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhC
Confidence            55555 55555556666666666666555                 2566555  6666666666666666666666666


Q ss_pred             ccccceEEeccCc-cCC-CCCCccc------CCCCCccEEEcCCCCCCCCCCc--cccCCCCCceeecccCccccCcccc
Q 039290          294 ISTLKELAVTDND-LLG-SLPSSID------LGLPNLERLFLGENNFSGTIPS--SLTNISELSVLDFGFNSFSGLIPTT  363 (1049)
Q Consensus       294 l~~L~~L~l~~N~-l~~-~~p~~~~------~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~  363 (1049)
                      +++|++|++++|+ ++| .+|..+.      ..+++|++|+|++|+++ .+|.  .++++++|+.|+|++|+++ .+| .
T Consensus       514 L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~  590 (876)
T 4ecn_A          514 LPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-A  590 (876)
T ss_dssp             CSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-C
T ss_pred             CCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-h
Confidence            6666666666665 555 4554332      23456777777777777 6666  6777777777777777776 555 6


Q ss_pred             cccccccceeecccccccCCCCCcccccccccCCC-CcEEEccCCccccCCCCcccccc-ccccEEEccCCccccCCCCC
Q 039290          364 FGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRN-LEIIYLSENPINGILPSSIGNFS-ISMKSLSMESCNISGGIPKE  441 (1049)
Q Consensus       364 ~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~-L~~L~Ls~N~i~~~~p~~~~~~~-~~L~~L~L~~n~i~~~~p~~  441 (1049)
                      |+.+++|+.|+|++|.++.++..      +..+++ |+.|+|++|+++ .+|..+.... .+|+.|+|++|++.+.+|..
T Consensus       591 ~~~L~~L~~L~Ls~N~l~~lp~~------l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l  663 (876)
T 4ecn_A          591 FGTNVKLTDLKLDYNQIEEIPED------FCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNI  663 (876)
T ss_dssp             CCTTSEESEEECCSSCCSCCCTT------SCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSC
T ss_pred             hcCCCcceEEECcCCccccchHH------HhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccc
Confidence            77777777777777777654432      455666 777777777776 4555554443 23777777777777655532


Q ss_pred             ---CC--CCCCccEEEccCCcccccCCcc-ccCcCCCcceEeeccccCCCCCccccc--------ccccceEEeeCcccC
Q 039290          442 ---LG--NINNLTVIRLGNNELTGTIPVT-LGRLQKLQGLYLQNNKLEGSIPEDLCH--------LYRLANLYLGDNKLS  507 (1049)
Q Consensus       442 ---~~--~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~--------l~~L~~L~L~~N~l~  507 (1049)
                         +.  .+++|+.|+|++|.++ .+|.. +..+++|+.|+|++|+|+ .+|..+..        +++|+.|+|++|+++
T Consensus       664 ~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~  741 (876)
T 4ecn_A          664 SCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT  741 (876)
T ss_dssp             SSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC
T ss_pred             hhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc
Confidence               22  3458899999999998 45554 457888999999999988 56655443        237888888888888


Q ss_pred             CcCchhcc--CcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeeccccccccccccc
Q 039290          508 GRLPACLG--NLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVT  585 (1049)
Q Consensus       508 ~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  585 (1049)
                       .+|..+.  .+++|+.|+|++|++++ +|..+..+++|+.|+|++|+                  ++++|++.+.+|..
T Consensus       742 -~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~------------------~ls~N~l~~~ip~~  801 (876)
T 4ecn_A          742 -SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR------------------DAEGNRILRQWPTG  801 (876)
T ss_dssp             -CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB------------------CTTCCBCCCCCCTT
T ss_pred             -cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC------------------CcccccccccChHH
Confidence             6777776  88888888888888887 67778888888888888775                  56778888888999


Q ss_pred             ccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCccc
Q 039290          586 IGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLE  651 (1049)
Q Consensus       586 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~  651 (1049)
                      |.++++|+.|+|++|+| +.+|..+.  ++|+.|||++|++....+..+.....+..+.|++|++.
T Consensus       802 l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~  864 (876)
T 4ecn_A          802 ITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ  864 (876)
T ss_dssp             GGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTS
T ss_pred             HhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCcc
Confidence            99999999999999999 57777765  58999999999988666666666666777778777664

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=6.5e-49  Score=483.77  Aligned_cols=535  Identities=19%  Similarity=0.157  Sum_probs=405.0

Q ss_pred             EEeccccccccCCCCCCcchhhhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCCCCcc
Q 039290           79 NISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFV  158 (1049)
Q Consensus        79 ~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~  158 (1049)
                      +-++.+|+ .||+.+.  +.+++|||++|++++..|..|++|++|++|||++|++++..|..|.+|++|++|+|++|+++
T Consensus        37 ~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~  113 (635)
T 4g8a_A           37 QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ  113 (635)
T ss_dssp             ECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred             ECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC
Confidence            45566777 7887654  47888999999998655678889999999999999998777788999999999999999998


Q ss_pred             CCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCC-CCCCCcccccccceeccccccccc
Q 039290          159 GKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTG-PIPTNLWKCRELHVVSLAFNKFQG  237 (1049)
Q Consensus       159 ~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~  237 (1049)
                      +..|..|+++++|++|+|++|++++..|..++      ++++|++|+|++|++++ .+|..+..+++|+.|+|++|++++
T Consensus       114 ~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~------~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~  187 (635)
T 4g8a_A          114 SLALGAFSGLSSLQKLVAVETNLASLENFPIG------HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS  187 (635)
T ss_dssp             EECGGGGTTCTTCCEEECTTSCCCCSTTCCCT------TCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCE
T ss_pred             CCCHHHhcCCCCCCEEECCCCcCCCCChhhhh------cCcccCeeccccCccccCCCchhhccchhhhhhcccCccccc
Confidence            76667789999999999999999843333343      45668889999998875 467777888888888888888888


Q ss_pred             ccCCCCccccccc----eEEeccccccccCccccccccceEEEeeccccCCCc-cccccccccccceEEeccCccCCCCC
Q 039290          238 GIPRDIGNLTSVR----NLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGL-IPASIFNISTLKELAVTDNDLLGSLP  312 (1049)
Q Consensus       238 ~~p~~~~~l~~L~----~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p  312 (1049)
                      ..|..|..+.+++    .++++.|.++...+. ......++.+++.+|..... .+..+..+..++...+..+....   
T Consensus       188 ~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~-~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~---  263 (635)
T 4g8a_A          188 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG-AFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN---  263 (635)
T ss_dssp             ECGGGGHHHHTCTTCCCEEECTTCCCCEECTT-TTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTT---
T ss_pred             cccccccchhhhhhhhhhhhcccCcccccCcc-cccchhhhhhhhhcccccccccchhhcCCccccccccccccccc---
Confidence            7787777766544    577888888744443 33444567777777765533 23445566666655554433221   


Q ss_pred             CcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCcccc---CcccccccccccceeecccccccCCCCCccc
Q 039290          313 SSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSG---LIPTTFGNLRSLKLLSLAGNVLTSPTPDLSF  389 (1049)
Q Consensus       313 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~---~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~  389 (1049)
                                      ...+.......+..+..+..+++..+....   ..+..+..+.+++.+.+.+|.+..+.     
T Consensus       264 ----------------~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~-----  322 (635)
T 4g8a_A          264 ----------------EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK-----  322 (635)
T ss_dssp             ----------------SCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG-----
T ss_pred             ----------------ccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccccc-----
Confidence                            011122223334444455555554443322   12334555666777777776665432     


Q ss_pred             ccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccc--cCCcccc
Q 039290          390 LSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTG--TIPVTLG  467 (1049)
Q Consensus       390 l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~  467 (1049)
                        .+.....|+.|++++|.+.+..+..+    ..|+.+++..|.+...  .....+++|+.|++++|.+..  ..+..+.
T Consensus       323 --~~~~~~~L~~L~l~~~~~~~~~~~~l----~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~  394 (635)
T 4g8a_A          323 --DFSYNFGWQHLELVNCKFGQFPTLKL----KSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDF  394 (635)
T ss_dssp             --GGGSCCCCSEEEEESCEESSCCCCBC----TTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHH
T ss_pred             --ccccchhhhhhhcccccccCcCcccc----hhhhhcccccccCCCC--cccccccccccchhhccccccccccccchh
Confidence              24445667777777777765544322    2567777777776533  234578899999999998863  4566777


Q ss_pred             CcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCc-hhccCcccCCceeecCcccccccCccccccccccc
Q 039290          468 RLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLP-ACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILR  546 (1049)
Q Consensus       468 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  546 (1049)
                      .+.+|+.|+++.|.+. ..+..+..+++|+.++++.|......+ ..+..+++++.++++.|++.+..|..+..++.++.
T Consensus       395 ~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~  473 (635)
T 4g8a_A          395 GTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV  473 (635)
T ss_dssp             SCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCE
T ss_pred             hhhhhhhhhccccccc-cccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhh
Confidence            8889999999999987 456678889999999999888765544 56888999999999999999999999999999999


Q ss_pred             ccccCCcc-CCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCcc
Q 039290          547 FNLSSNSL-NGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNN  625 (1049)
Q Consensus       547 L~Ls~N~l-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  625 (1049)
                      |++++|.+ .+..|..|..+++|++|||++|+|++..|..|+++++|+.|+|++|+|++.+|..|.++++|++|||++|+
T Consensus       474 L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~  553 (635)
T 4g8a_A          474 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH  553 (635)
T ss_dssp             EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSC
T ss_pred             hhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCc
Confidence            99999974 44577889999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCcccccccc-cccceeeccCCcccccCCC
Q 039290          626 LSGTIPKSMEAL-SYLKHLNLSFNQLEGEIPT  656 (1049)
Q Consensus       626 l~~~~p~~~~~l-~~L~~l~l~~N~l~~~~p~  656 (1049)
                      |++..|..+..+ ++|++|+|++|+|.|.|..
T Consensus       554 l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~  585 (635)
T 4g8a_A          554 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEH  585 (635)
T ss_dssp             CCBCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred             CCCCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence            999999999988 6899999999999999874

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.6e-50  Score=443.35  Aligned_cols=250  Identities=23%  Similarity=0.298  Sum_probs=213.2

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      ..|+..++||+|+||+||+|++. +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            45999999999999999999964 79999999998776667788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      +||+|.+++...  .+++.+++.++.||+.||+|||   ++|||||||||+|||++.+|.+||+|||+|+.+..... ..
T Consensus       154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~  227 (346)
T 4fih_A          154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR  227 (346)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CB
T ss_pred             CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-cc
Confidence            999999998764  4899999999999999999999   99999999999999999999999999999998754433 23


Q ss_pred             cccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccccccc
Q 039290          920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEN  999 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1049)
                      ...+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+  ....+...                 ...
T Consensus       228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~~i~~~-----------------~~~  288 (346)
T 4fih_A          228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKMIRDN-----------------LPP  288 (346)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHS-----------------SCC
T ss_pred             cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHHHHcC-----------------CCC
Confidence            45789999999999999999999999999999999999999997532211  11111000                 001


Q ss_pred             CchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290         1000 DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus      1000 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .......+++++.+++.+||+.||++|||++|+++|
T Consensus       289 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          289 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            112223456788999999999999999999999886

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.8e-50  Score=441.53  Aligned_cols=254  Identities=25%  Similarity=0.413  Sum_probs=210.4

Q ss_pred             CCCCCceecCCCcEEEEEEEeC------CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      +++..++||+|+||+||+|++.      +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            3556789999999999999863      56789999997554 3346789999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCC---------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCc
Q 039290          835 VLEYMSNGSLEKCLYSDN---------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMV  899 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~  899 (1049)
                      |||||++|+|.+++....               ..+++.++.+|+.|||+||+|||   +++||||||||+|||+++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCC
Confidence            999999999999996432               35899999999999999999999   999999999999999999999


Q ss_pred             eEEecccCceecCCCcc-ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhh
Q 039290          900 GHLSDFGIAKILGKEES-MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVG  977 (1049)
Q Consensus       900 ~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  977 (1049)
                      +||+|||+|+....... .......||+.|||||++.++.++.++|||||||++|||+| |..||.+....+  ....+.
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~--~~~~i~  261 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--VVEMIR  261 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH--HHHHHH
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH
Confidence            99999999987644332 22344678999999999999999999999999999999999 899997643222  111111


Q ss_pred             hccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290          978 DSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus       978 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                      .                   ..+.+.+.+++.++.++|.+||+.||++||||+||+++|++.
T Consensus       262 ~-------------------~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          262 N-------------------RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             T-------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             c-------------------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            0                   011223345778899999999999999999999999998753

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.5e-49  Score=476.62  Aligned_cols=457  Identities=18%  Similarity=0.247  Sum_probs=303.4

Q ss_pred             hhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCcc
Q 039290          101 VLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQ  180 (1049)
Q Consensus       101 ~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~  180 (1049)
                      +|++++|+++ .+|..+.  ++|++|||++|++.+..|..|.++++|++|+|++|++++..|+.|+.+++|++|||++|+
T Consensus         4 ~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~   80 (520)
T 2z7x_B            4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK   80 (520)
T ss_dssp             EEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSC
T ss_pred             eEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCc
Confidence            5677777777 5776665  677777777777776666777777777777777777776667777777777777777777


Q ss_pred             CccccCCCcccccccCCCCccceEEeeccccCC-CCCCCcccccccceecccccccccccCCCCccccccceEEeccccc
Q 039290          181 LSGTIPSSIFNISSCQNLPVLEGLFISYNQLTG-PIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSL  259 (1049)
Q Consensus       181 l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  259 (1049)
                      ++ .+|..        .+++|++|+|++|++++ .+|..+                        +++++|++|+|++|++
T Consensus        81 l~-~lp~~--------~l~~L~~L~L~~N~l~~~~~p~~~------------------------~~l~~L~~L~L~~n~l  127 (520)
T 2z7x_B           81 LV-KISCH--------PTVNLKHLDLSFNAFDALPICKEF------------------------GNMSQLKFLGLSTTHL  127 (520)
T ss_dssp             CC-EEECC--------CCCCCSEEECCSSCCSSCCCCGGG------------------------GGCTTCCEEEEEESSC
T ss_pred             ee-ecCcc--------ccCCccEEeccCCccccccchhhh------------------------ccCCcceEEEecCccc
Confidence            76 56654        13446666666666654 344444                        4444444444444444


Q ss_pred             cccCccccccccce--EEEeeccccC--CCcccccccccc-ccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCC
Q 039290          260 IGEIPNEIGNLRNL--EVLGVQSSNL--AGLIPASIFNIS-TLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSG  334 (1049)
Q Consensus       260 ~~~~p~~l~~l~~L--~~L~L~~n~l--~~~~p~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~  334 (1049)
                      ++   ..++.+++|  +.|++++|++  .+..|..+..+. +...+++++|++.+.++..                    
T Consensus       128 ~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~--------------------  184 (520)
T 2z7x_B          128 EK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDV--------------------  184 (520)
T ss_dssp             CG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCC--------------------
T ss_pred             ch---hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhh--------------------
Confidence            43   233334444  5555555544  444444443332 1222334444444333333                    


Q ss_pred             CCCccccCCCCCceeecccCc-------cccCcccccccccccceeecccccccCCCCCcccccccccCCCCcEEEccCC
Q 039290          335 TIPSSLTNISELSVLDFGFNS-------FSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSEN  407 (1049)
Q Consensus       335 ~~p~~~~~l~~L~~L~Ls~N~-------l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N  407 (1049)
                          .+.++++|+.|++++|.       +.+.+| .++.+++|+.|++++|.++.....  .+.....+++|++|++++|
T Consensus       185 ----~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~--~~~~~~~~~~L~~L~l~~n  257 (520)
T 2z7x_B          185 ----SVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFI--RILQLVWHTTVWYFSISNV  257 (520)
T ss_dssp             ----CCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHH--HHHHHHHTSSCSEEEEEEE
T ss_pred             ----hhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccCHHHHH--HHHHHhhhCcccEEEeecc
Confidence                34445555555555554       444433 455556666666655554321000  0000001224444444444


Q ss_pred             ccccCCCCccccccccccEEEccCCccccCCCCCC-----CCCCCccEEEccCCcccccCC-ccccCc---CCCcceEee
Q 039290          408 PINGILPSSIGNFSISMKSLSMESCNISGGIPKEL-----GNINNLTVIRLGNNELTGTIP-VTLGRL---QKLQGLYLQ  478 (1049)
Q Consensus       408 ~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~~p-~~~~~l---~~L~~L~L~  478 (1049)
                      ++                         ++.+|..+     .++++|+.+++++|.+  .+| ..+..+   .+|+.|+++
T Consensus       258 ~l-------------------------~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~  310 (520)
T 2z7x_B          258 KL-------------------------QGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVS  310 (520)
T ss_dssp             EE-------------------------ESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEE
T ss_pred             cc-------------------------cCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcC
Confidence            44                         44445444     6778888888888888  344 455544   678888888


Q ss_pred             ccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCccccc--ccCcccccccccccccccCCccCC
Q 039290          479 NNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTS--IIPSTLWNLKDILRFNLSSNSLNG  556 (1049)
Q Consensus       479 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~  556 (1049)
                      +|.+....  .+..+++|++|++++|++++.+|..++++++|++|++++|++++  .+|..+..+++|++|++++|.+++
T Consensus       311 ~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~  388 (520)
T 2z7x_B          311 GTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSY  388 (520)
T ss_dssp             SSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBC
T ss_pred             CCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCc
Confidence            88876432  12577888888888888888788888888888888888888886  456778888888889999988888


Q ss_pred             CCcc-CcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCcccc-c
Q 039290          557 SLLP-DIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKS-M  634 (1049)
Q Consensus       557 ~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-~  634 (1049)
                      .+|. .+..+++|++|++++|++++..|..+.  ++|+.|+|++|+|+ .+|..+..+++|++|+|++|+++ .+|.. +
T Consensus       389 ~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~  464 (520)
T 2z7x_B          389 DEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIF  464 (520)
T ss_dssp             CGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTT
T ss_pred             ccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHh
Confidence            4554 578889999999999999888887765  78999999999999 77887779999999999999999 56665 8


Q ss_pred             ccccccceeeccCCcccccCCC
Q 039290          635 EALSYLKHLNLSFNQLEGEIPT  656 (1049)
Q Consensus       635 ~~l~~L~~l~l~~N~l~~~~p~  656 (1049)
                      ..+++|++|++++|+++|.++.
T Consensus       465 ~~l~~L~~L~l~~N~~~c~c~~  486 (520)
T 2z7x_B          465 DRLTSLQKIWLHTNPWDCSCPR  486 (520)
T ss_dssp             TTCTTCCEEECCSSCBCCCHHH
T ss_pred             ccCCcccEEECcCCCCcccCCc
Confidence            9999999999999999998874

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=6.6e-50  Score=441.99  Aligned_cols=251  Identities=24%  Similarity=0.332  Sum_probs=204.9

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++.....  ...+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            36899999999999999999995 4799999999976532  23567899999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          837 EYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+||+|.+++...+ ..+++.+++.|+.||+.||+|||   ++|||||||||+|||+++++.+||+|||+|+......
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            9999999999997644 45789999999999999999999   9999999999999999999999999999998764322


Q ss_pred             cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                      . .....+||+.|||||++.+..|+.++||||+||++|||++|+.||......+.......+.              .  
T Consensus       180 ~-~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--------------~--  242 (350)
T 4b9d_A          180 E-LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS--------------F--  242 (350)
T ss_dssp             H-HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--------------C--
T ss_pred             c-cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC--------------C--
Confidence            2 2334679999999999999999999999999999999999999997632222111111000              0  


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                           ...+..++.++.+++.+||+.||++|||++|+++|
T Consensus       243 -----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          243 -----PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 01112356778999999999999999999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.7e-49  Score=435.26  Aligned_cols=257  Identities=22%  Similarity=0.256  Sum_probs=212.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      .+.|+..++||+|+||+||+|++ .+|+.||||+++....     ..+|++++++++|||||++++++.+++..|+||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            34577888999999999999996 4799999999976432     24799999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC-ceEEecccCceecCCCccc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM-VGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-~~kl~DfGla~~~~~~~~~  917 (1049)
                      |+||+|.+++...+ .+++.++..++.||+.||+|||   +++||||||||+|||++.+| .+||+|||+|+........
T Consensus       132 ~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          132 LEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            99999999998654 4899999999999999999999   99999999999999999887 6999999999977543321


Q ss_pred             ----cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          918 ----RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       918 ----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                          .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+.......+.               
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~---------------  272 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP---------------  272 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC---------------
T ss_pred             cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC---------------
Confidence                1223579999999999999999999999999999999999999998654443322211100               


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                          ......+..+++++.+++.+||+.||++|||++|+++++.....+..
T Consensus       273 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~  319 (336)
T 4g3f_A          273 ----PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG  319 (336)
T ss_dssp             ----CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             ----CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence                00011223467789999999999999999999999999998887654

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.7e-48  Score=470.90  Aligned_cols=465  Identities=19%  Similarity=0.238  Sum_probs=327.3

Q ss_pred             cceEEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceEEeccccccccCccccccccceEEEeecc
Q 039290          201 LEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQS  280 (1049)
Q Consensus       201 L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~  280 (1049)
                      |++|++++|++++..|..+..+++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++
T Consensus        28 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~  107 (549)
T 2z81_A           28 MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMG  107 (549)
T ss_dssp             CCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTT
T ss_pred             ccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCC
Confidence            44444444444444444455555555555555555555555566666666666666666655555566666666666666


Q ss_pred             ccCCCc-cccccccccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccC
Q 039290          281 SNLAGL-IPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGL  359 (1049)
Q Consensus       281 n~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  359 (1049)
                      |++++. +|..+.++++|++|++++|++.+.+|...+..+++|++|++++|++++..|..++.+++|++|++++|.+...
T Consensus       108 n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~  187 (549)
T 2z81_A          108 NPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL  187 (549)
T ss_dssp             CCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTH
T ss_pred             CcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCccccc
Confidence            666542 4455666666666666666655555544444666677777777777666677777777777777777776543


Q ss_pred             cccccccccccceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCcccc---ccccccEEEccCCcccc
Q 039290          360 IPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGN---FSISMKSLSMESCNISG  436 (1049)
Q Consensus       360 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~---~~~~L~~L~L~~n~i~~  436 (1049)
                      .+..+..+++|++|++++|.+++.+...  ......+++|+.|++++|.+++..+..+..   ...+|+.+++++|.+.+
T Consensus       188 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~--~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~  265 (549)
T 2z81_A          188 LEIFADILSSVRYLELRDTNLARFQFSP--LPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNG  265 (549)
T ss_dssp             HHHHHHSTTTBSEEEEESCBCTTCCCCC--CSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEEC
T ss_pred             chhhHhhcccccEEEccCCccccccccc--cchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccc
Confidence            2223345677777777777776643111  112334566777777777766543332211   12367777777777664


Q ss_pred             CC------CCCCCCCCCccEEEccCCccccc-----CCccccCcCCCcceEeeccccCCCCCccc-ccccccceEEeeCc
Q 039290          437 GI------PKELGNINNLTVIRLGNNELTGT-----IPVTLGRLQKLQGLYLQNNKLEGSIPEDL-CHLYRLANLYLGDN  504 (1049)
Q Consensus       437 ~~------p~~~~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N  504 (1049)
                      ..      ...+..+++|+.|++.++.+...     ++..+...++|+.|++++|+++ .+|..+ ..+++|++|++++|
T Consensus       266 ~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N  344 (549)
T 2z81_A          266 LGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSEN  344 (549)
T ss_dssp             CSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSS
T ss_pred             cccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCC
Confidence            31      23456788999999999987632     1222344678999999999998 677766 57999999999999


Q ss_pred             ccCCcCch---hccCcccCCceeecCcccccccC--cccccccccccccccCCccCCCCccCcCCCcceeEeeccccccc
Q 039290          505 KLSGRLPA---CLGNLTSLRDLSLGSNALTSIIP--STLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALS  579 (1049)
Q Consensus       505 ~l~~~~p~---~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  579 (1049)
                      ++++.+|.   .++.+++|++|++++|++++..+  ..+..+++|++|++++|+++. +|..+..+++|++|++++|+++
T Consensus       345 ~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~~~~L~~L~Ls~N~l~  423 (549)
T 2z81_A          345 LMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIR  423 (549)
T ss_dssp             CCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCC-CCSCCCCCTTCCEEECTTSCCS
T ss_pred             ccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCcc-CChhhcccccccEEECCCCCcc
Confidence            99987653   47889999999999999998653  568899999999999999994 7888999999999999999998


Q ss_pred             ccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCcccccCCCC-C
Q 039290          580 GVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTR-G  658 (1049)
Q Consensus       580 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~  658 (1049)
                      + +|..+.  ++|+.|+|++|+|++.+    ..+++|++|||++|+|+ .+|. ...+++|++|++++|++++.+|.. .
T Consensus       424 ~-l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~  494 (549)
T 2z81_A          424 V-VKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFD  494 (549)
T ss_dssp             C-CCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGG
T ss_pred             c-ccchhc--CCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHh
Confidence            4 444432  68999999999999753    57899999999999998 7776 567999999999999999988762 4


Q ss_pred             CccccccccccCCccccCCC
Q 039290          659 PFITFSAESFLGNQALCGSP  678 (1049)
Q Consensus       659 ~~~~~~~~~~~~n~~~cg~~  678 (1049)
                      .+..+....+.+|++.|+++
T Consensus       495 ~l~~L~~L~l~~N~~~~~~~  514 (549)
T 2z81_A          495 RLTSLQKIWLHTNPWDCSCP  514 (549)
T ss_dssp             GCTTCCEEECCSSCBCCCHH
T ss_pred             cCcccCEEEecCCCccCCCc
Confidence            55667778899999998766

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.7e-49  Score=431.22  Aligned_cols=249  Identities=26%  Similarity=0.368  Sum_probs=210.5

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecc---cCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHME---FDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|++.+.||+|+||+||+|+. .+|+.||+|++.+.   .....+.+.+|++++++++|||||++++++++++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4699999999999999999995 47999999999754   2455678999999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      |||+||+|.+++...+ .+++.+++.++.||+.||+|||   ++||+||||||+|||++.++.+||+|||+|+.+.....
T Consensus       112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            9999999999998654 4899999999999999999999   99999999999999999999999999999998754332


Q ss_pred             -ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          917 -MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       917 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                       ......+||+.|||||++.+..|+.++||||+||++|||++|+.||......+.. .....                  
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~-~~i~~------------------  248 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIF-AKIIK------------------  248 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHH------------------
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHc------------------
Confidence             2344578999999999999999999999999999999999999999753222111 11110                  


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                         ..+..+...++++.+++.+|++.||++|||++|+..+
T Consensus       249 ---~~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          249 ---LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             ---TCCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             ---CCCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence               0011122345678999999999999999999987543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=7e-49  Score=443.78  Aligned_cols=250  Identities=23%  Similarity=0.299  Sum_probs=212.8

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      +.|+..++||+|+||+||+|++. +|+.||||++........+.+.+|++++++++|||||++++++.+++.+|+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            46999999999999999999964 79999999998776667788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      +||+|.+++...  .+++.++..++.||+.||+|||   ++|||||||||+|||++.+|.+||+|||+|+.+..... ..
T Consensus       231 ~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~  304 (423)
T 4fie_A          231 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR  304 (423)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CB
T ss_pred             CCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-cc
Confidence            999999998764  3899999999999999999999   99999999999999999999999999999998754433 23


Q ss_pred             cccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccccccc
Q 039290          920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEN  999 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1049)
                      ...+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+.  ...+...                 ...
T Consensus       305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--~~~i~~~-----------------~~~  365 (423)
T 4fie_A          305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--MKMIRDN-----------------LPP  365 (423)
T ss_dssp             CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHS-----------------CCC
T ss_pred             cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--HHHHHcC-----------------CCC
Confidence            457899999999999999999999999999999999999999975322111  1111000                 000


Q ss_pred             CchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290         1000 DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus      1000 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .......++.++.+|+.+||+.||++|||++|+++|
T Consensus       366 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          366 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            111122356778999999999999999999999886

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.8e-48  Score=467.25  Aligned_cols=452  Identities=19%  Similarity=0.206  Sum_probs=348.0

Q ss_pred             EEEEeccccccccCCCCCCcchhhhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCCCC
Q 039290           77 ALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNS  156 (1049)
Q Consensus        77 ~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~  156 (1049)
                      .||+++++++ .+|..+.  +.|++|+|++|.+++..|..++++++|++|+|++|++++..|..|+++++|++|+|++|+
T Consensus         4 ~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~   80 (520)
T 2z7x_B            4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK   80 (520)
T ss_dssp             EEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSC
T ss_pred             eEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCc
Confidence            6899999999 7998887  899999999999998888899999999999999999999889999999999999999999


Q ss_pred             ccCCCcccccCCCcccEEcCCCccCcc-ccCCCcccccccCCCCccceEEeeccccCCCCCCCccccccc--ceeccccc
Q 039290          157 FVGKIPETIGYLSLLQELDLSDNQLSG-TIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCREL--HVVSLAFN  233 (1049)
Q Consensus       157 l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L--~~L~L~~N  233 (1049)
                      ++ .+|..  .+++|++|||++|++++ .+|..+++      +++|++|++++|++++   ..+..+++|  +.|++++|
T Consensus        81 l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~------l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n  148 (520)
T 2z7x_B           81 LV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGN------MSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLG  148 (520)
T ss_dssp             CC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGG------CTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEEC
T ss_pred             ee-ecCcc--ccCCccEEeccCCccccccchhhhcc------CCcceEEEecCcccch---hhccccccceeeEEEeecc
Confidence            99 68877  89999999999999997 57877765      4569999999999986   467778888  99999999


Q ss_pred             cc--ccccCCCCcccc-ccceEEeccccccccCcc-ccccccceEEEeecccc-------CCCccccccccccccceEEe
Q 039290          234 KF--QGGIPRDIGNLT-SVRNLFLGNNSLIGEIPN-EIGNLRNLEVLGVQSSN-------LAGLIPASIFNISTLKELAV  302 (1049)
Q Consensus       234 ~l--~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~L~~n~-------l~~~~p~~~~~l~~L~~L~l  302 (1049)
                      ++  .+..|..+..+. ....+++++|.+.+.+++ .+.++++|+.|++++|.       +.+.+| .+..+++|++|++
T Consensus       149 ~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l  227 (520)
T 2z7x_B          149 ETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTL  227 (520)
T ss_dssp             TTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEE
T ss_pred             cccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccc
Confidence            99  888999998876 455678899998876665 58889999999999997       777666 7888899999999


Q ss_pred             ccCccCCCCCCcccC--CCCCccEEEcCCCCCCCCCCccc-----cCCCCCceeecccCccccCcc-cccccc---cccc
Q 039290          303 TDNDLLGSLPSSIDL--GLPNLERLFLGENNFSGTIPSSL-----TNISELSVLDFGFNSFSGLIP-TTFGNL---RSLK  371 (1049)
Q Consensus       303 ~~N~l~~~~p~~~~~--~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~~p-~~~~~l---~~L~  371 (1049)
                      ++|++.+..+..+..  ..++|++|++++|+++|.+|..+     +.+++|+.+++++|.+  .+| ..+..+   .+|+
T Consensus       228 ~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~  305 (520)
T 2z7x_B          228 NNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIK  305 (520)
T ss_dssp             EEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCS
T ss_pred             cccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCcee
Confidence            988876432222110  13477778888887777777777     6777777777777777  234 344444   4566


Q ss_pred             eeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEE
Q 039290          372 LLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVI  451 (1049)
Q Consensus       372 ~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L  451 (1049)
                      .|++++|.+.....       ...++                         +|++|++++|++++.+|..++++++|++|
T Consensus       306 ~L~l~~n~l~~~~~-------~~~l~-------------------------~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L  353 (520)
T 2z7x_B          306 NFTVSGTRMVHMLC-------PSKIS-------------------------PFLHLDFSNNLLTDTVFENCGHLTELETL  353 (520)
T ss_dssp             EEEEESSCCCCCCC-------CSSCC-------------------------CCCEEECCSSCCCTTTTTTCCCCSSCCEE
T ss_pred             EEEcCCCccccccc-------hhhCC-------------------------cccEEEeECCccChhhhhhhccCCCCCEE
Confidence            66666666544321       12334                         45555555555555566667777777777


Q ss_pred             EccCCcccc--cCCccccCcCCCcceEeeccccCCCCCc-ccccccccceEEeeCcccCCcCchhccCcccCCceeecCc
Q 039290          452 RLGNNELTG--TIPVTLGRLQKLQGLYLQNNKLEGSIPE-DLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSN  528 (1049)
Q Consensus       452 ~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  528 (1049)
                      +|++|++++  .+|..++.+++|++|+|++|++++.+|. .+..+++|++|++++|++++..|..+.  ++|+.|++++|
T Consensus       354 ~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N  431 (520)
T 2z7x_B          354 ILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSN  431 (520)
T ss_dssp             ECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSS
T ss_pred             EccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCC
Confidence            777777775  4456677777788888888877764554 366777788888888887766666554  67888888888


Q ss_pred             ccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeeccccccccc
Q 039290          529 ALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGV  581 (1049)
Q Consensus       529 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  581 (1049)
                      +++ .+|..+..+++|++|++++|+++...+..+..+++|++|++++|.++..
T Consensus       432 ~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~  483 (520)
T 2z7x_B          432 KIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  483 (520)
T ss_dssp             CCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             ccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCccc
Confidence            887 4666666788888888888888754444477888888888888888754

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.6e-48  Score=418.18  Aligned_cols=248  Identities=23%  Similarity=0.357  Sum_probs=193.9

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      .++|++.+.||+|+||+||+|+. .+|+.||+|++....   ....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            36899999999999999999995 479999999997543   33456899999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+ +|+|.+++...+ .+++.++..++.||+.|++|||   ++||+||||||+|||+++++.+||+|||+|+......
T Consensus        92 mEy~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             EECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             EeCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            9999 679999987765 4999999999999999999999   9999999999999999999999999999998764332


Q ss_pred             cccccccccccCcccccccCCCCc-CcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKV-SRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                        .....+||+.|||||++.+..+ +.++||||+||++|||++|+.||.+....+. ......                 
T Consensus       167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~-~~~i~~-----------------  226 (275)
T 3hyh_A          167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL-FKNISN-----------------  226 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHH-----------------
T ss_pred             --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHc-----------------
Confidence              2345689999999999988776 5799999999999999999999975322111 111100                 


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                          ..+..+...++++.+++.+|++.||++|||++|+++|=
T Consensus       227 ----~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp  264 (275)
T 3hyh_A          227 ----GVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDD  264 (275)
T ss_dssp             ----TCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCH
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCc
Confidence                00111123456789999999999999999999999873

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.5e-48  Score=429.35  Aligned_cols=273  Identities=21%  Similarity=0.289  Sum_probs=202.6

Q ss_pred             CCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCC----eeEEEEe
Q 039290          762 GFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNND----FKALVLE  837 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~----~~~lv~e  837 (1049)
                      +|.+.++||+|+||+||+|++ +|+.||||+++.... ......+|+..+.+++|||||++++++.+++    .+++|||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            467788999999999999998 689999999965421 1122334566667889999999999997653    5799999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHcc-----CCCCeEEcCCCCCCeeecCCCceEEecccCceecC
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG-----YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      ||++|+|.++++..  .+++.++.+++.|+++||+|||..     ++++||||||||+|||++.++.+||+|||+|+...
T Consensus        82 y~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  159 (303)
T 3hmm_A           82 YHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  159 (303)
T ss_dssp             CCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             CCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence            99999999999865  489999999999999999999921     12399999999999999999999999999998764


Q ss_pred             CCccc---cccccccccCcccccccCCC------CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccC
Q 039290          913 KEESM---RQTKTLGTIGYMAPEYGREG------KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSC  983 (1049)
Q Consensus       913 ~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  983 (1049)
                      .....   .....+||+.|||||++.+.      .++.++|||||||++|||+||..||......+..+..+..   ...
T Consensus       160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~---~~~  236 (303)
T 3hmm_A          160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP---SDP  236 (303)
T ss_dssp             TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC---SSC
T ss_pred             CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc---ccc
Confidence            43321   22345799999999998654      4678999999999999999998887654333322221110   000


Q ss_pred             Ccchhc----ccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHh
Q 039290          984 SITEVA----DANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042 (1049)
Q Consensus       984 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~ 1042 (1049)
                      ....+.    +....+..+. .....+++..+.+++.+||+.||++||||+||+++|+++.++
T Consensus       237 ~~~~~~~~~~~~~~rp~~p~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          237 SVEEMRKVVCEQKLRPNIPN-RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCG-GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hHHHHHHHHhcccCCCCCCc-cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            011111    1111111111 111235677899999999999999999999999999998765

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=8.7e-49  Score=437.22  Aligned_cols=267  Identities=23%  Similarity=0.370  Sum_probs=218.6

Q ss_pred             HHHHHHhcCCCCCceecCCCcEEEEEEEeC------CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCC-CceeeEEee
Q 039290          754 QDLLRATDGFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRH-RNLVKIISS  825 (1049)
Q Consensus       754 ~~~~~~~~~~~~~~~lg~G~fg~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h-pniv~l~~~  825 (1049)
                      ++++...++|++.+.||+|+||+||+|++.      .++.||||+++.... ...+.+.+|++++.+++| ||||+++|+
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            344455678999999999999999999853      235799999975432 234678999999999965 999999999


Q ss_pred             eec-CCeeEEEEeccCCCChhhhhhcCC---------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCC
Q 039290          826 CSN-NDFKALVLEYMSNGSLEKCLYSDN---------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKP  889 (1049)
Q Consensus       826 ~~~-~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp  889 (1049)
                      |.+ ++..++|||||++|+|.++++..+               ..+++.++..++.|||+||+|||   +++||||||||
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~  213 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAA  213 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCc
Confidence            866 457899999999999999997532               35899999999999999999999   99999999999


Q ss_pred             CCeeecCCCceEEecccCceecCCCcc-ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCcccc
Q 039290          890 SNVLLNESMVGHLSDFGIAKILGKEES-MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFA  967 (1049)
Q Consensus       890 ~NIl~~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~  967 (1049)
                      +|||+++++.+||+|||+|+....... .......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+...
T Consensus       214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~  293 (353)
T 4ase_A          214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  293 (353)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987654332 23345678999999999999999999999999999999998 8999976433


Q ss_pred             ccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhh
Q 039290          968 GEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043 (1049)
Q Consensus       968 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~ 1043 (1049)
                      .+.........                    .++..+..+++++.++|.+||+.||++||||+|++++|+++.++-
T Consensus       294 ~~~~~~~i~~g--------------------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          294 DEEFCRRLKEG--------------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             SHHHHHHHHHT--------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHcC--------------------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence            32222111110                    112223446778999999999999999999999999999998754

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.2e-48  Score=419.86  Aligned_cols=245  Identities=24%  Similarity=0.379  Sum_probs=198.0

Q ss_pred             CCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeec----CCeeEEEE
Q 039290          764 SENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSN----NDFKALVL  836 (1049)
Q Consensus       764 ~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~----~~~~~lv~  836 (1049)
                      +..++||+|+||+||+|++. +++.||+|++.....  ...+.+.+|++++++++|||||++++++.+    ++.+|+||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            45678999999999999964 688999999975432  235679999999999999999999999865    35689999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCC--eEEcCCCCCCeeec-CCCceEEecccCceecCC
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP--IVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIl~~-~~~~~kl~DfGla~~~~~  913 (1049)
                      |||++|+|.+++...+ .+++..+..++.||+.||+|||   +++  ||||||||+|||++ .++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999999997654 5899999999999999999999   887  99999999999998 478999999999985432


Q ss_pred             CccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          914 EESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       914 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                      .   .....+||+.|||||++.+ +|+.++||||+||++|||+||+.||.+............. ..             
T Consensus       185 ~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~-~~-------------  246 (290)
T 3fpq_A          185 S---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GV-------------  246 (290)
T ss_dssp             T---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TC-------------
T ss_pred             C---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc-CC-------------
Confidence            2   2345689999999998865 6999999999999999999999999753222111111110 00             


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                           .....+..+++++.+++.+||+.||++|||++|+++|
T Consensus       247 -----~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          247 -----KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             -----CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -----CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 0011112244678999999999999999999999876

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.5e-48  Score=424.34  Aligned_cols=248  Identities=24%  Similarity=0.284  Sum_probs=199.2

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC----CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP----DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      ++|++.+.||+|+||+||+|+..    +++.||+|+++...  .....++.+|++++++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            46999999999999999999852    47789999997543  2234578899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      |||||+||+|.+++...+ .+++.++..++.||+.||+|||   ++||+||||||+|||++.++.+||+|||+|+.....
T Consensus       104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            999999999999998754 4899999999999999999999   999999999999999999999999999999865433


Q ss_pred             ccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          915 ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       915 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                      .. .....+||+.|||||++.+..|+.++||||+||++|||+||+.||.+....+..... ..                 
T Consensus       180 ~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i-~~-----------------  240 (304)
T 3ubd_A          180 EK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI-LK-----------------  240 (304)
T ss_dssp             -C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HH-----------------
T ss_pred             Cc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH-Hc-----------------
Confidence            22 234568999999999999999999999999999999999999999763222211111 00                 


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCH-----HHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISM-----KDVANR 1035 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~ell~~ 1035 (1049)
                          .....+..+++++.+++.+||+.||++|||+     +|+++|
T Consensus       241 ----~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          241 ----AKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             ----CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             ----CCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence                0111123356778999999999999999984     677765

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=4e-46  Score=450.60  Aligned_cols=469  Identities=18%  Similarity=0.193  Sum_probs=295.6

Q ss_pred             hhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCc
Q 039290          100 AVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDN  179 (1049)
Q Consensus       100 ~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N  179 (1049)
                      +++++++|+++ .+|..+.  ++|++|||++|++.+..|..|.++++|++|+|++|++++..|+.|+.+++|++|||++|
T Consensus        34 ~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  110 (562)
T 3a79_B           34 SMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN  110 (562)
T ss_dssp             CEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             cEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence            67788888777 4777664  67777888887777766677777777777888777777766777777777777777777


Q ss_pred             cCccccCCCcccccccCCCCccceEEeeccccCC-CCCCCcccccccceecccccccccccCCCCcccccc--ceEEecc
Q 039290          180 QLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTG-PIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSV--RNLFLGN  256 (1049)
Q Consensus       180 ~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~L~~  256 (1049)
                      +++ .+|..        .+++|++|+|++|++++ .+|..+.++++|++|+|++|++++   ..+..+++|  ++|+|++
T Consensus       111 ~l~-~lp~~--------~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~L~~  178 (562)
T 3a79_B          111 RLQ-NISCC--------PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPVAHLHLSCILLDL  178 (562)
T ss_dssp             CCC-EECSC--------CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT---TTTGGGTTSCEEEEEEEE
T ss_pred             cCC-ccCcc--------ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCcccc---CchhhhhhceeeEEEeec
Confidence            777 66654        24456677777777664 234455555555555555555443   123333333  4444444


Q ss_pred             ccc--cccCccccccccceEEEeeccccCCCccccccccccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCC
Q 039290          257 NSL--IGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSG  334 (1049)
Q Consensus       257 N~l--~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~  334 (1049)
                      |++  ++..|..+..+.. +                     .+ .+++++|.+.+.++......+++|+.|++++|+..-
T Consensus       179 n~l~~~~~~~~~l~~l~~-~---------------------~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~  235 (562)
T 3a79_B          179 VSYHIKGGETESLQIPNT-T---------------------VL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENC  235 (562)
T ss_dssp             SSCCCCSSSCCEEEECCE-E---------------------EE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTH
T ss_pred             ccccccccCcccccccCc-c---------------------eE-EEEecCccchhhhhhhcccccceEEEeccccccccc
Confidence            444  4444444333320 0                     11 234444444443333333333444444444442100


Q ss_pred             CCCccccCCCCCceeecccCccccCcccccccccccceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCC
Q 039290          335 TIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILP  414 (1049)
Q Consensus       335 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p  414 (1049)
                      .                   .+.+. ...+..+++|+.|+++++.+......  ........++|++|++++|.+++.+|
T Consensus       236 ~-------------------~l~~~-~~~l~~l~~L~~L~L~~~~l~~~~~~--~~~~~~~~~~L~~L~l~~n~l~~~ip  293 (562)
T 3a79_B          236 Q-------------------RLMTF-LSELTRGPTLLNVTLQHIETTWKCSV--KLFQFFWPRPVEYLNIYNLTITERID  293 (562)
T ss_dssp             H-------------------HHHHH-HHHHHSCSSCEEEEEEEEEECHHHHH--HHHHHHTTSSEEEEEEEEEEECSCCC
T ss_pred             c-------------------hHHHH-HHHHhccCcceEEEecCCcCcHHHHH--HHHHhhhcccccEEEEeccEeecccc
Confidence            0                   01111 12234444444444444433210000  00000111244444444444443333


Q ss_pred             CccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCC-ccccCc---CCCcceEeeccccCCCCCccc
Q 039290          415 SSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIP-VTLGRL---QKLQGLYLQNNKLEGSIPEDL  490 (1049)
Q Consensus       415 ~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l---~~L~~L~L~~N~l~~~~~~~~  490 (1049)
                      ..++...                    ..+++.|+.++++.|.+  .+| ..+..+   .+|++|++++|.+....  ..
T Consensus       294 ~~~~~~~--------------------~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~  349 (562)
T 3a79_B          294 REEFTYS--------------------ETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CP  349 (562)
T ss_dssp             CCCCCCC--------------------SCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CC
T ss_pred             chhhhcc--------------------cccchheehhhccccee--ecChhhhhhhhccCcceEEEccCCCccccc--Cc
Confidence            3221110                    15566677777777766  334 233222   56888888888875322  12


Q ss_pred             ccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccc--cCcccccccccccccccCCccCCCCc-cCcCCCcc
Q 039290          491 CHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSI--IPSTLWNLKDILRFNLSSNSLNGSLL-PDIGNLKV  567 (1049)
Q Consensus       491 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~  567 (1049)
                      ..+++|++|++++|++++.+|..++++++|++|++++|+++++  +|..+..+++|++|++++|++++.+| ..+..+++
T Consensus       350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~  429 (562)
T 3a79_B          350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES  429 (562)
T ss_dssp             SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred             cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence            5778888888888888877888888888888888888888873  35678888888888888888887444 45888899


Q ss_pred             eeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCcccc-cccccccceeecc
Q 039290          568 VIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKS-MEALSYLKHLNLS  646 (1049)
Q Consensus       568 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~l~l~  646 (1049)
                      |++|++++|++++..|..+.  ++|+.|+|++|+|+ .+|..+.++++|++|+|++|+++ .+|.. +..+++|+.|+++
T Consensus       430 L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~  505 (562)
T 3a79_B          430 ILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLH  505 (562)
T ss_dssp             CCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECC
T ss_pred             CCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEec
Confidence            99999999999887777665  78999999999999 67776779999999999999999 56665 9999999999999


Q ss_pred             CCcccccCCC
Q 039290          647 FNQLEGEIPT  656 (1049)
Q Consensus       647 ~N~l~~~~p~  656 (1049)
                      +|+|.|.||.
T Consensus       506 ~N~~~c~c~~  515 (562)
T 3a79_B          506 DNPWDCTCPG  515 (562)
T ss_dssp             SCCBCCCHHH
T ss_pred             CCCcCCCcch
Confidence            9999999885

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=2.4e-45  Score=451.99  Aligned_cols=514  Identities=19%  Similarity=0.169  Sum_probs=379.7

Q ss_pred             CcEEEEEEeccccccccCCCCCCcchhhhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEe
Q 039290           73 RRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLL  152 (1049)
Q Consensus        73 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L  152 (1049)
                      ..++.|||++|.|++..|.++.++++|++|+|++|++++..|..|++|++|++|+|++|++++..|..|.++++|++|+|
T Consensus        52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L  131 (635)
T 4g8a_A           52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  131 (635)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred             cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence            36899999999999655668999999999999999999766678999999999999999999877889999999999999


Q ss_pred             CCCCccCCCcccccCCCcccEEcCCCccCcc-ccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccc----e
Q 039290          153 KHNSFVGKIPETIGYLSLLQELDLSDNQLSG-TIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELH----V  227 (1049)
Q Consensus       153 ~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~----~  227 (1049)
                      ++|++++..|..|+++++|++|+|++|++++ .+|..+.+      ++.|++|++++|++++..|..+..+.+++    .
T Consensus       132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~------l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~  205 (635)
T 4g8a_A          132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN------LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS  205 (635)
T ss_dssp             TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGG------CTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCE
T ss_pred             CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhcc------chhhhhhcccCccccccccccccchhhhhhhhhh
Confidence            9999997777789999999999999999985 35665544      56699999999999998888888777655    5


Q ss_pred             ecccccccccccCCCCccccccceEEeccccccc-cCccccccccceEEEeeccccCC------CccccccccccccceE
Q 039290          228 VSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIG-EIPNEIGNLRNLEVLGVQSSNLA------GLIPASIFNISTLKEL  300 (1049)
Q Consensus       228 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~n~l~------~~~p~~~~~l~~L~~L  300 (1049)
                      ++++.|.++...| .......++.+++++|.... ..+..+..+..++...+..+...      ...+..+..+..+...
T Consensus       206 ~~ls~n~l~~i~~-~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~  284 (635)
T 4g8a_A          206 LDLSLNPMNFIQP-GAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE  284 (635)
T ss_dssp             EECTTCCCCEECT-TTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEE
T ss_pred             hhcccCcccccCc-ccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhh
Confidence            7889999985544 44455678899999987654 34456888888888877544332      2233444455555555


Q ss_pred             EeccCccCCCCCC--cccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCcccccccccccceeecccc
Q 039290          301 AVTDNDLLGSLPS--SIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGN  378 (1049)
Q Consensus       301 ~l~~N~l~~~~p~--~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  378 (1049)
                      .+..+........  ..+..+.+++.+++.+|.+.+..  .+.....|+.|++++|.+.+..+   ..+..|+.+++.+|
T Consensus       285 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~---~~l~~L~~l~l~~n  359 (635)
T 4g8a_A          285 EFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSN  359 (635)
T ss_dssp             EEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCCCSEEEEESCEESSCCC---CBCTTCCEEEEESC
T ss_pred             hhhhhhhcccccchhhhhhhhccccccccccccccccc--ccccchhhhhhhcccccccCcCc---ccchhhhhcccccc
Confidence            5544432211110  01112345555555555544221  23334455555555555543322   22344555555555


Q ss_pred             cccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcc
Q 039290          379 VLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNEL  458 (1049)
Q Consensus       379 ~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l  458 (1049)
                      .+.....       ...+++|+.|++++|.+...                       +..+..+..+.+|+.++++.|.+
T Consensus       360 ~~~~~~~-------~~~l~~L~~L~ls~n~l~~~-----------------------~~~~~~~~~~~~L~~L~~~~~~~  409 (635)
T 4g8a_A          360 KGGNAFS-------EVDLPSLEFLDLSRNGLSFK-----------------------GCCSQSDFGTISLKYLDLSFNGV  409 (635)
T ss_dssp             CSCCBCC-------CCBCTTCCEEECCSSCCBEE-----------------------EECCHHHHSCSCCCEEECCSCSE
T ss_pred             cCCCCcc-------cccccccccchhhccccccc-----------------------cccccchhhhhhhhhhhcccccc
Confidence            4433221       22344455555555444321                       22344455667788888888877


Q ss_pred             cccCCccccCcCCCcceEeeccccCCCCC-cccccccccceEEeeCcccCCcCchhccCcccCCceeecCccc-ccccCc
Q 039290          459 TGTIPVTLGRLQKLQGLYLQNNKLEGSIP-EDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNAL-TSIIPS  536 (1049)
Q Consensus       459 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l-~~~~p~  536 (1049)
                      . ..+..+..+++|+.+++++|......+ ..+..+.+++.++++.|.+.+..+..+..++.|+.|++++|++ .+..|.
T Consensus       410 ~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~  488 (635)
T 4g8a_A          410 I-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD  488 (635)
T ss_dssp             E-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECS
T ss_pred             c-cccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCch
Confidence            7 355667778888888888777665443 4577788888888888888888888888888888899988874 456788


Q ss_pred             ccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCc-cC
Q 039290          537 TLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGL-KS  615 (1049)
Q Consensus       537 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~  615 (1049)
                      .|..+++|++|+|++|++++..|..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|+|++.+|..|..+ ++
T Consensus       489 ~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~  568 (635)
T 4g8a_A          489 IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS  568 (635)
T ss_dssp             CCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTT
T ss_pred             hhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCc
Confidence            88889999999999999998888889999999999999999999889999999999999999999999999999998 68


Q ss_pred             CcEEeccCccccCC
Q 039290          616 LNFVDMSNNNLSGT  629 (1049)
Q Consensus       616 L~~L~Ls~N~l~~~  629 (1049)
                      |++|+|++|++++.
T Consensus       569 L~~L~L~~Np~~C~  582 (635)
T 4g8a_A          569 LAFLNLTQNDFACT  582 (635)
T ss_dssp             CCEEECTTCCBCCS
T ss_pred             CCEEEeeCCCCccc
Confidence            99999999999864

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.2e-46  Score=409.66  Aligned_cols=249  Identities=22%  Similarity=0.353  Sum_probs=190.3

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCC--------
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNND--------  830 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~--------  830 (1049)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|++++++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            4588999999999999999996 4799999999976543 23467899999999999999999999986543        


Q ss_pred             ----eeEEEEeccCCCChhhhhhcCCC--ccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEec
Q 039290          831 ----FKALVLEYMSNGSLEKCLYSDNY--FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSD  904 (1049)
Q Consensus       831 ----~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D  904 (1049)
                          ..|+|||||++|+|.+++.....  ..++..++.++.||++||+|||   ++||+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence                36899999999999999976543  3456778899999999999999   99999999999999999999999999


Q ss_pred             ccCceecCCCcc-----------ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHH
Q 039290          905 FGIAKILGKEES-----------MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK  973 (1049)
Q Consensus       905 fGla~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~  973 (1049)
                      ||+|+.......           ......+||+.|||||++.+..|+.++||||+||++|||++   ||......   ..
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~---~~  235 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER---VR  235 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH---HH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH---HH
Confidence            999987654321           12234579999999999999999999999999999999996   77542111   11


Q ss_pred             HhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          974 RWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       974 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ....          +..       ...++......+...+++.+||+.||++|||+.|+++|
T Consensus       236 ~~~~----------~~~-------~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          236 TLTD----------VRN-------LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HHHH----------HHT-------TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHH----------Hhc-------CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1000          000       00112223445567889999999999999999999875

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=6.8e-45  Score=439.76  Aligned_cols=453  Identities=19%  Similarity=0.205  Sum_probs=328.1

Q ss_pred             EEEEEeccccccccCCCCCCcchhhhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCCC
Q 039290           76 TALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHN  155 (1049)
Q Consensus        76 ~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n  155 (1049)
                      ..+|+++++++ .+|..+.  +.|++|+|++|.+++..|..++++++|++|+|++|++++..|..|+++++|++|||++|
T Consensus        34 ~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  110 (562)
T 3a79_B           34 SMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN  110 (562)
T ss_dssp             CEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             cEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence            67899999999 5998775  79999999999999877789999999999999999999999999999999999999999


Q ss_pred             CccCCCcccccCCCcccEEcCCCccCcc-ccCCCcccccccCCCCccceEEeeccccCCCCCCCccccccc--ceecccc
Q 039290          156 SFVGKIPETIGYLSLLQELDLSDNQLSG-TIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCREL--HVVSLAF  232 (1049)
Q Consensus       156 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L--~~L~L~~  232 (1049)
                      .++ .+|..  .+++|++|||++|++++ .+|..+.+      +++|++|++++|++++   ..+..+++|  +.|++++
T Consensus       111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~------l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~L~~  178 (562)
T 3a79_B          111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGN------LTKLTFLGLSAAKFRQ---LDLLPVAHLHLSCILLDL  178 (562)
T ss_dssp             CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGG------CTTCCEEEEECSBCCT---TTTGGGTTSCEEEEEEEE
T ss_pred             cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcc------cCcccEEecCCCcccc---CchhhhhhceeeEEEeec
Confidence            999 78877  89999999999999995 44566654      5569999999999986   345566666  9999999


Q ss_pred             ccc--ccccCCCCcccc-ccceEEeccccccccCcc-ccccccceEEEeeccccC-----CCccccccccccccceEEec
Q 039290          233 NKF--QGGIPRDIGNLT-SVRNLFLGNNSLIGEIPN-EIGNLRNLEVLGVQSSNL-----AGLIPASIFNISTLKELAVT  303 (1049)
Q Consensus       233 N~l--~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~L~~n~l-----~~~~p~~~~~l~~L~~L~l~  303 (1049)
                      |++  ++..|..+..+. ..-.+++++|.+.+.+++ .+.++++|+.|++++|+.     .+. +..+..+++|+.|+++
T Consensus       179 n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~-~~~l~~l~~L~~L~L~  257 (562)
T 3a79_B          179 VSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF-LSELTRGPTLLNVTLQ  257 (562)
T ss_dssp             SSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHH-HHHHHSCSSCEEEEEE
T ss_pred             ccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHH-HHHHhccCcceEEEec
Confidence            999  889999988865 233668999999887765 477899999999999852     222 3456777888888888


Q ss_pred             cCccCCC----CCCcccCCCCCccEEEcCCCCCCCCCCccc-----cCCCCCceeecccCccccCcc-cccccc---ccc
Q 039290          304 DNDLLGS----LPSSIDLGLPNLERLFLGENNFSGTIPSSL-----TNISELSVLDFGFNSFSGLIP-TTFGNL---RSL  370 (1049)
Q Consensus       304 ~N~l~~~----~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~~p-~~~~~l---~~L  370 (1049)
                      ++.+.+.    ++...  ..++|++|++++|+++|.+|..+     .+++.|+.++++.|.+  .+| ..+..+   .+|
T Consensus       258 ~~~l~~~~~~~~~~~~--~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L  333 (562)
T 3a79_B          258 HIETTWKCSVKLFQFF--WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNI  333 (562)
T ss_dssp             EEEECHHHHHHHHHHH--TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCC
T ss_pred             CCcCcHHHHHHHHHhh--hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcc
Confidence            7766532    11111  12467777777777777677665     5566666666666655  223 222222   345


Q ss_pred             ceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccE
Q 039290          371 KLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTV  450 (1049)
Q Consensus       371 ~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~  450 (1049)
                      ++|++++|.+.....       ...++                         +|++|++++|++++.+|..+.++++|++
T Consensus       334 ~~L~l~~n~~~~~~~-------~~~l~-------------------------~L~~L~l~~n~l~~~~~~~~~~l~~L~~  381 (562)
T 3a79_B          334 KMLSISDTPFIHMVC-------PPSPS-------------------------SFTFLNFTQNVFTDSVFQGCSTLKRLQT  381 (562)
T ss_dssp             SEEEEESSCCCCCCC-------CSSCC-------------------------CCCEEECCSSCCCTTTTTTCCSCSSCCE
T ss_pred             eEEEccCCCcccccC-------ccCCC-------------------------CceEEECCCCccccchhhhhcccCCCCE
Confidence            555555555433210       12233                         5555555556665566666777777777


Q ss_pred             EEccCCccccc--CCccccCcCCCcceEeeccccCCCCCc-ccccccccceEEeeCcccCCcCchhccCcccCCceeecC
Q 039290          451 IRLGNNELTGT--IPVTLGRLQKLQGLYLQNNKLEGSIPE-DLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGS  527 (1049)
Q Consensus       451 L~Ls~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  527 (1049)
                      |+|++|++++.  +|..++.+++|++|+|++|++++.+|. .+..+++|++|++++|++++.+|..+.  ++|++|+|++
T Consensus       382 L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~  459 (562)
T 3a79_B          382 LILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHN  459 (562)
T ss_dssp             EECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCS
T ss_pred             EECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCC
Confidence            77777777752  235567777777777777777764444 466677777777777777766655443  5777777777


Q ss_pred             cccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeeccccccccccc
Q 039290          528 NALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIP  583 (1049)
Q Consensus       528 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  583 (1049)
                      |+++. +|..+..+++|++|+|++|+++...+..+..+++|++|++++|.+.+..+
T Consensus       460 N~l~~-ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~  514 (562)
T 3a79_B          460 NRIMS-IPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP  514 (562)
T ss_dssp             SCCCC-CCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred             CcCcc-cChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence            77774 55555577777777777777775333347777788888888887775433

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=5.9e-45  Score=405.08  Aligned_cols=277  Identities=30%  Similarity=0.532  Sum_probs=225.4

Q ss_pred             cCChhhHHHHHHHHHhcccCCCCcccccCCCCCCCce--eeeEEEcCCC--CcEEEEEEecccccc--ccCCCCCCcchh
Q 039290           26 TNVTTDQFALLALKEHIKHDPSNLLANNWSTTSSVCS--WIGVTCGVRN--RRVTALNISYLGLTG--TIPPQLGNLSFL   99 (1049)
Q Consensus        26 ~~~~~d~~all~~k~~~~~~~~~~l~~~w~~~~~~c~--w~gv~c~~~~--~~v~~l~l~~~~l~g--~~~~~~~~l~~L   99 (1049)
                      .|.++|++||++||+++. ||. .+ ++|..+++||.  |.||+|+..+  ++|+.|+|+++++.|  .+|+.++++++|
T Consensus         2 ~c~~~~~~aL~~~k~~~~-~~~-~l-~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L   78 (313)
T 1ogq_A            2 LCNPQDKQALLQIKKDLG-NPT-TL-SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL   78 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTT-CCG-GG-TTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred             CCCHHHHHHHHHHHHhcC-Ccc-cc-cCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence            589999999999999994 776 45 58988889998  9999998655  899999999999999  899999999999


Q ss_pred             hhhhccc-CccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCC
Q 039290          100 AVLAIRN-NSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSD  178 (1049)
Q Consensus       100 ~~L~l~~-n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~  178 (1049)
                      ++|+|++ |.+.|.+|..++++++|++|+|++|++++.+|..|.++++|++|+|++|.+++.+|..++.+++|++|+|++
T Consensus        79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  158 (313)
T 1ogq_A           79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG  158 (313)
T ss_dssp             SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred             CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcC
Confidence            9999994 999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceEEecccc
Q 039290          179 NQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNS  258 (1049)
Q Consensus       179 N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  258 (1049)
                      |+++|.+|..++++.     +.|++|++++|++++.+|..+..++ |++|++++|++++.+|..|+.+++|++|+|++|+
T Consensus       159 N~l~~~~p~~l~~l~-----~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  232 (313)
T 1ogq_A          159 NRISGAIPDSYGSFS-----KLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNS  232 (313)
T ss_dssp             SCCEEECCGGGGCCC-----TTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSE
T ss_pred             CcccCcCCHHHhhhh-----hcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCc
Confidence            999988998876543     1578888888888887887777776 7777777777777777777777777777777777


Q ss_pred             ccccCccccccccceEEEeeccccCCCccccccccccccceEEeccCccCCCCC
Q 039290          259 LIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLP  312 (1049)
Q Consensus       259 l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  312 (1049)
                      +++.+|. +..+++|++|+|++|++++.+|..+..+++|++|++++|+++|.+|
T Consensus       233 l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip  285 (313)
T 1ogq_A          233 LAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP  285 (313)
T ss_dssp             ECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC
T ss_pred             eeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCC
Confidence            7655554 6666666666666666666666555555555555555554444444

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=411.04  Aligned_cols=270  Identities=21%  Similarity=0.241  Sum_probs=203.0

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCC--CHHHHHHHHHHHhhcCCCceeeEEeeeec------CCe
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDG--SLESFHAECKVMGSIRHRNLVKIISSCSN------NDF  831 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~------~~~  831 (1049)
                      ++|++.+.||+|+||+||+|++ .+|+.||||+++.....  ..+.+.+|++++++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5799999999999999999996 47999999999754422  34678899999999999999999998753      367


Q ss_pred             eEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceec
Q 039290          832 KALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL  911 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~  911 (1049)
                      .|+|||||+ |+|.+++...+ .+++.++..++.||+.||+|||   ++|||||||||+|||++.++.+||+|||+|+.+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             EEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence            899999996 68999987654 5999999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCc---cccccccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCC-cc
Q 039290          912 GKEE---SMRQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCS-IT  986 (1049)
Q Consensus       912 ~~~~---~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~  986 (1049)
                      ....   .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+....+............... ..
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~  288 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ  288 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            4322   2233457899999999998764 56999999999999999999999997633222111111000000000 00


Q ss_pred             hhccc----cccccccc---Cc-hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          987 EVADA----NLLNCEEN---DF-SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       987 ~~~~~----~~~~~~~~---~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .....    .....+..   .+ ......+.++.+|+.+||+.||++|||++|+++|
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            00000    00000000   00 0112345678999999999999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.7e-44  Score=402.25  Aligned_cols=269  Identities=20%  Similarity=0.264  Sum_probs=201.2

Q ss_pred             HHhcCCCCCceecCCCcEEEEEEEeC----CCcEEEEEEeecccCCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCee
Q 039290          758 RATDGFSENKLLGMGSFGSVYKGVLP----DGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFK  832 (1049)
Q Consensus       758 ~~~~~~~~~~~lg~G~fg~Vy~a~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~  832 (1049)
                      ...++|++.++||+|+||+||+|+.+    +++.||+|++...  ....++.+|+++++.+ +|||||++++++.+.++.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            34578999999999999999999842    4678999998654  3456788999999998 699999999999999999


Q ss_pred             EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCC-CceEEecccCceec
Q 039290          833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES-MVGHLSDFGIAKIL  911 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-~~~kl~DfGla~~~  911 (1049)
                      |+||||+++|+|.+++.    .+++.+++.++.|++.||+|||   ++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus        96 ~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~  168 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT  168 (361)
T ss_dssp             EEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence            99999999999999884    3889999999999999999999   9999999999999999876 79999999999865


Q ss_pred             CCCcc---------------------------ccccccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCC
Q 039290          912 GKEES---------------------------MRQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTD  963 (1049)
Q Consensus       912 ~~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~  963 (1049)
                      .....                           ......+||+.|||||++.+. .++.++||||+||++|||++|+.||.
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence            43211                           112345799999999998775 58999999999999999999999996


Q ss_pred             ccccccchHHHhhh------------hcc----cc-----CCcchhccc---------cccccc---ccCchhhHHHHHH
Q 039290          964 EIFAGEMSLKRWVG------------DSL----LS-----CSITEVADA---------NLLNCE---ENDFSAREQCVSS 1010 (1049)
Q Consensus       964 ~~~~~~~~~~~~~~------------~~~----~~-----~~~~~~~~~---------~~~~~~---~~~~~~~~~~~~~ 1010 (1049)
                      ..............            ...    ..     .........         ......   ..........+++
T Consensus       249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~  328 (361)
T 4f9c_A          249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE  328 (361)
T ss_dssp             CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred             CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence            43322111111100            000    00     000000000         000000   0000111234567


Q ss_pred             HHHHHhhccccCCCCCCCHHHHHHH
Q 039290         1011 IFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus      1011 l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      +.+|+.+|++.||++|||++|+++|
T Consensus       329 a~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          329 AYDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHHCcCChhHCcCHHHHhcC
Confidence            8999999999999999999999986

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=7.4e-43  Score=407.53  Aligned_cols=424  Identities=20%  Similarity=0.265  Sum_probs=245.9

Q ss_pred             CcEEEEEEeccccccccCCCCCCcchhhhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEe
Q 039290           73 RRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLL  152 (1049)
Q Consensus        73 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L  152 (1049)
                      .++..|+++++.+ |++|++++++++|++|++++|.+.|.+|.+++++++|+.++++.+..           .+|++|++
T Consensus        11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L~l   78 (454)
T 1jl5_A           11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHELEL   78 (454)
T ss_dssp             ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEEEC
T ss_pred             ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEEEe
Confidence            4567777777777 67887788888888888888887777888777777775555554421           34677788


Q ss_pred             CCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccceecccc
Q 039290          153 KHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAF  232 (1049)
Q Consensus       153 ~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~  232 (1049)
                      ++|.+++ +|..   .++|++|++++|++++ +|..+         ++|++|++++|++++ +|..   .++|++|++++
T Consensus        79 ~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~~---------~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~  140 (454)
T 1jl5_A           79 NNLGLSS-LPEL---PPHLESLVASCNSLTE-LPELP---------QSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSN  140 (454)
T ss_dssp             TTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCCC---------TTCCEEECCSSCCSC-CCSC---CTTCCEEECCS
T ss_pred             cCCcccc-CCCC---cCCCCEEEccCCcCCc-ccccc---------CCCcEEECCCCccCc-ccCC---CCCCCEEECcC
Confidence            8777774 4442   3677788888887775 66432         347777888887774 3332   15777888888


Q ss_pred             cccccccCCCCccccccceEEeccccccccCccccccccceEEEeeccccCCCccccccccccccceEEeccCccCCCCC
Q 039290          233 NKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLP  312 (1049)
Q Consensus       233 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  312 (1049)
                      |++++ +| +|+++++|++|++++|++++ +|..+   .+|++|++++|++.+ +| .+.++++|++|++++|++.+ +|
T Consensus       141 n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~  211 (454)
T 1jl5_A          141 NQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LP  211 (454)
T ss_dssp             SCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CC
T ss_pred             CCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CC
Confidence            88775 66 57788888888888888774 55543   477888888888777 45 57778888888888888774 55


Q ss_pred             CcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCcccccccccccceeecccccccCCCCCcccccc
Q 039290          313 SSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSS  392 (1049)
Q Consensus       313 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~  392 (1049)
                      ..    .++|++|++++|+++ .+|. ++.+++|++|++++|++++ +|..   +++|+.|++++|.+++++..      
T Consensus       212 ~~----~~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~l~~~------  275 (454)
T 1jl5_A          212 DL----PLSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTDLPEL------  275 (454)
T ss_dssp             CC----CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSCCCCC------
T ss_pred             CC----cCcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccccCcc------
Confidence            42    247888888888887 5663 7788888888888888876 3432   36788888888888775532      


Q ss_pred             cccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCC-CCccEEEccCCcccccCCccccCcCC
Q 039290          393 LTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNI-NNLTVIRLGNNELTGTIPVTLGRLQK  471 (1049)
Q Consensus       393 l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~  471 (1049)
                         +++|+.|++++|++++..     ..+.+|+.|++++|++++ ++    .+ ++|++|++++|++++ +|..   +++
T Consensus       276 ---~~~L~~L~ls~N~l~~l~-----~~~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~  338 (454)
T 1jl5_A          276 ---PQSLTFLDVSENIFSGLS-----ELPPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPR  338 (454)
T ss_dssp             ---CTTCCEEECCSSCCSEES-----CCCTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTT
T ss_pred             ---cCcCCEEECcCCccCccc-----CcCCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCc
Confidence               267888888888887631     122478888888888875 22    22 478888888888885 5544   477


Q ss_pred             CcceEeeccccCCCCCcccccccccceEEeeCcccCC--cCchhccCcccCCceeecCcccccccCcccccccccccccc
Q 039290          472 LQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSG--RLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNL  549 (1049)
Q Consensus       472 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  549 (1049)
                      |++|++++|+++ .+|.   .+++|++|++++|++++  .+|..++.        |+.|.+.+.+|..   +++|+.|++
T Consensus       339 L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L~l  403 (454)
T 1jl5_A          339 LERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL---PQNLKQLHV  403 (454)
T ss_dssp             CCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC--------------------
T ss_pred             CCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc---cCcCCEEEC
Confidence            888888888888 4555   46788888888888887  56655543        2346666666653   467888888


Q ss_pred             cCCccCC--CCccCcCCCcceeEeecccccccccccccccCC
Q 039290          550 SSNSLNG--SLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGL  589 (1049)
Q Consensus       550 s~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  589 (1049)
                      ++|++++  .+|.      .++.|.+++|.+.+..+.+....
T Consensus       404 s~N~l~~~~~iP~------sl~~L~~~~~~~~~~~~~~~~~~  439 (454)
T 1jl5_A          404 ETNPLREFPDIPE------SVEDLRMNSERVVDPYEFAHETT  439 (454)
T ss_dssp             ------------------------------------------
T ss_pred             CCCcCCccccchh------hHhheeCcCcccCCccccCHHHh
Confidence            8888886  4443      45667788888877666554443

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=2.9e-42  Score=402.50  Aligned_cols=400  Identities=23%  Similarity=0.317  Sum_probs=287.7

Q ss_pred             cEEEEEEeccccccccCCCCCCcchhhhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeC
Q 039290           74 RVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLK  153 (1049)
Q Consensus        74 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~  153 (1049)
                      ++..|+++++.+.|.+|++++++..|+.++++.+..           .+|++|++++|++++ +|..   .++|++|+++
T Consensus        35 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~   99 (454)
T 1jl5_A           35 SKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHELELNNLGLSS-LPEL---PPHLESLVAS   99 (454)
T ss_dssp             CHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEEECTTSCCSC-CCSC---CTTCSEEECC
T ss_pred             chhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEEEecCCcccc-CCCC---cCCCCEEEcc
Confidence            566788999999999999999999999999887753           568999999999985 5552   3789999999


Q ss_pred             CCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccceeccccc
Q 039290          154 HNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFN  233 (1049)
Q Consensus       154 ~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N  233 (1049)
                      +|.+++ +|+.   +++|++|++++|+++ .+|...         ++|++|++++|++++ +| .+..+++|++|++++|
T Consensus       100 ~n~l~~-lp~~---~~~L~~L~l~~n~l~-~l~~~~---------~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N  163 (454)
T 1jl5_A          100 CNSLTE-LPEL---PQSLKSLLVDNNNLK-ALSDLP---------PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNN  163 (454)
T ss_dssp             SSCCSS-CCCC---CTTCCEEECCSSCCS-CCCSCC---------TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSS
T ss_pred             CCcCCc-cccc---cCCCcEEECCCCccC-cccCCC---------CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCC
Confidence            999996 7764   478999999999998 455321         468999999999996 88 5999999999999999


Q ss_pred             ccccccCCCCccccccceEEeccccccccCccccccccceEEEeeccccCCCccccccccccccceEEeccCccCCCCCC
Q 039290          234 KFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPS  313 (1049)
Q Consensus       234 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  313 (1049)
                      ++++ +|..+   .+|++|++++|++++ +| .++++++|+.|++++|++++ +|...   ++|++|++++|++. .+|.
T Consensus       164 ~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~  232 (454)
T 1jl5_A          164 SLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELPE  232 (454)
T ss_dssp             CCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCCC
T ss_pred             cCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-cccc
Confidence            9986 67654   489999999999996 66 69999999999999999987 34432   58999999999998 7885


Q ss_pred             cccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCcccccccccccceeecccccccCCCCCccccccc
Q 039290          314 SIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSL  393 (1049)
Q Consensus       314 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l  393 (1049)
                        +..+++|++|++++|++++ +|..   +++|+.|++++|++++ +|..   +++|++|++++|.+++++..       
T Consensus       233 --~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~~~-------  295 (454)
T 1jl5_A          233 --LQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLSEL-------  295 (454)
T ss_dssp             --CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEESCC-------
T ss_pred             --cCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcccCc-------
Confidence              4479999999999999985 5543   4789999999999997 4543   37899999999999875421       


Q ss_pred             ccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCc
Q 039290          394 TSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQ  473 (1049)
Q Consensus       394 ~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  473 (1049)
                        .++|+.|++++|+++++     ...+.+|++|++++|++++ +|..   +++|++|++++|++++ +|.   .+++|+
T Consensus       296 --~~~L~~L~l~~N~l~~i-----~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~  360 (454)
T 1jl5_A          296 --PPNLYYLNASSNEIRSL-----CDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLK  360 (454)
T ss_dssp             --CTTCCEEECCSSCCSEE-----CCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCC
T ss_pred             --CCcCCEEECcCCcCCcc-----cCCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhcc
Confidence              26899999999999863     2333589999999999996 6654   5899999999999994 666   478999


Q ss_pred             ceEeeccccCC--CCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCccccc--ccCcccccccccccccc
Q 039290          474 GLYLQNNKLEG--SIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTS--IIPSTLWNLKDILRFNL  549 (1049)
Q Consensus       474 ~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L  549 (1049)
                      +|++++|++++  .+|..+..        ++.|.+.+.+|..   +++|+.|++++|++++  .+|.      +++.|.+
T Consensus       361 ~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~------sl~~L~~  423 (454)
T 1jl5_A          361 QLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPE------SVEDLRM  423 (454)
T ss_dssp             EEECCSSCCSSCCCCCTTCCE--------EECCC----------------------------------------------
T ss_pred             EEECCCCCCCcCCCChHHHHh--------hhhcccccccccc---cCcCCEEECCCCcCCccccchh------hHhheeC
Confidence            99999999998  67776654        3457777777763   5789999999999987  4554      3566778


Q ss_pred             cCCccCCCCccCcCC
Q 039290          550 SSNSLNGSLLPDIGN  564 (1049)
Q Consensus       550 s~N~l~~~~~~~~~~  564 (1049)
                      ++|.+.+..+.....
T Consensus       424 ~~~~~~~~~~~~~~~  438 (454)
T 1jl5_A          424 NSERVVDPYEFAHET  438 (454)
T ss_dssp             ---------------
T ss_pred             cCcccCCccccCHHH
Confidence            888887766554443

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.6e-43  Score=420.63  Aligned_cols=253  Identities=23%  Similarity=0.296  Sum_probs=212.9

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      .++|++.+.||+|+||+||+|+. .+|+.||+|++........+.+.+|+++|+.++|||||++++++.+.+.+|+||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            36799999999999999999996 47999999999776555567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC--CCceEEecccCceecCCCcc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE--SMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~--~~~~kl~DfGla~~~~~~~~  916 (1049)
                      |+||+|.+++......+++.++..++.||+.||+|||   +++|+||||||+|||++.  .+.+||+|||+|+.+.....
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~  312 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  312 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence            9999999999776667999999999999999999999   999999999999999985  48999999999998754432


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                        ....+||+.|||||++.+..|+.++||||+||++|||++|..||.+....+..........                 
T Consensus       313 --~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~-----------------  373 (573)
T 3uto_A          313 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW-----------------  373 (573)
T ss_dssp             --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC-----------------
T ss_pred             --eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCC-----------------
Confidence              3446799999999999999999999999999999999999999976332222111100000                 


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                       .........++.++.+||.+||+.||++|||++|+++|
T Consensus       374 -~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          374 -NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             -CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             00011122346678999999999999999999999986

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.1e-43  Score=414.55  Aligned_cols=249  Identities=22%  Similarity=0.284  Sum_probs=203.5

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHH---HHHHhhcCCCceeeEEeeeecCCee
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAE---CKVMGSIRHRNLVKIISSCSNNDFK  832 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e---~~~l~~l~hpniv~l~~~~~~~~~~  832 (1049)
                      .++|++.++||+|+||+||+|+.. +|+.||+|++.+..   ......+.+|   +.+++.++|||||++++++.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            357999999999999999999964 79999999997542   2333344444   5666777999999999999999999


Q ss_pred             EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecC
Q 039290          833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      |+|||||+||+|.+++...+ .+++..++.++.||+.||+|||   ++|||||||||+|||++.+|.+||+|||+|+.+.
T Consensus       268 ylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            99999999999999998754 4899999999999999999999   9999999999999999999999999999998775


Q ss_pred             CCccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccch-HHHhhhhccccCCcchhcc
Q 039290          913 KEESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMS-LKRWVGDSLLSCSITEVAD  990 (1049)
Q Consensus       913 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  990 (1049)
                      ...   ....+||+.|||||++.+ ..|+.++||||+||++|||++|..||.+....+.. ....+.             
T Consensus       344 ~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~-------------  407 (689)
T 3v5w_A          344 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-------------  407 (689)
T ss_dssp             SCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH-------------
T ss_pred             CCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc-------------
Confidence            432   345689999999999965 57999999999999999999999999763322211 111100             


Q ss_pred             cccccccccCchhhHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 039290          991 ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRIS-----MKDVANR 1035 (1049)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~ell~~ 1035 (1049)
                             ......+...++++.+++.+|++.||++|++     ++|+++|
T Consensus       408 -------~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          408 -------TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             -------HCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             -------CCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence                   0011112335677899999999999999998     7888876

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=7e-42  Score=402.85  Aligned_cols=389  Identities=22%  Similarity=0.283  Sum_probs=280.6

Q ss_pred             CCCceeee--EEEcCCCCcEEEEEEeccccccccCCCCCCcchhhhhhcccCccccccCcccccccCCcEeccccCCccc
Q 039290           58 SSVCSWIG--VTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHI  135 (1049)
Q Consensus        58 ~~~c~w~g--v~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~  135 (1049)
                      ...|.|.+  |.|+.            .+++ .+|. +.  ++|++|+|++|.+++..|..++++++|++|++++|.+.+
T Consensus         5 ~~~c~~~~~~~~c~~------------~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~   68 (455)
T 3v47_A            5 TSECSVIGYNAICIN------------RGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGL   68 (455)
T ss_dssp             --CCEEETTEEECCS------------SCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTC
T ss_pred             cceeEEEccccCcCC------------CCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccc
Confidence            44577776  67753            3344 6666 32  689999999999998889999999999999999999987


Q ss_pred             cC-cccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCCC
Q 039290          136 EI-PSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGP  214 (1049)
Q Consensus       136 ~~-p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~  214 (1049)
                      .+ |..|.++++|++|+|++|.+++..|..|+.+++|++|+|++|++++.+|..-    .+..+++|++|+|++|++++.
T Consensus        69 ~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~----~~~~l~~L~~L~L~~n~l~~~  144 (455)
T 3v47_A           69 VIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGN----FFKPLTSLEMLVLRDNNIKKI  144 (455)
T ss_dssp             EECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSS----TTTTCTTCCEEECCSSBCCSC
T ss_pred             eECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcc----cccCcccCCEEECCCCccCcc
Confidence            66 5679999999999999999998889999999999999999999998666541    124567799999999999988


Q ss_pred             CCCC-cccccccceecccccccccccCCCCccc--cccceEEeccccccccCcccc--------ccccceEEEeeccccC
Q 039290          215 IPTN-LWKCRELHVVSLAFNKFQGGIPRDIGNL--TSVRNLFLGNNSLIGEIPNEI--------GNLRNLEVLGVQSSNL  283 (1049)
Q Consensus       215 ~p~~-l~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~l--------~~l~~L~~L~L~~n~l  283 (1049)
                      .|.. +..+++|++|++++|++++..|..+.++  .+|+.|++++|.+.+..+..+        ..+++|+.|++++|++
T Consensus       145 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l  224 (455)
T 3v47_A          145 QPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGF  224 (455)
T ss_dssp             CCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCC
T ss_pred             CcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcc
Confidence            7876 7889999999999999999999999887  789999999999986655443        3668899999999999


Q ss_pred             CCccccccccc---cccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCC--CCCceeecccCcccc
Q 039290          284 AGLIPASIFNI---STLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNI--SELSVLDFGFNSFSG  358 (1049)
Q Consensus       284 ~~~~p~~~~~l---~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~  358 (1049)
                      .+.+|..+...   ++|+.|++++|.+.+...               ..+.+.+..+..+..+  ++|++|++++|.+.+
T Consensus       225 ~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~  289 (455)
T 3v47_A          225 KESMAKRFFDAIAGTKIQSLILSNSYNMGSSF---------------GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFA  289 (455)
T ss_dssp             CHHHHHHHHHHTTTCCEEEEECTTCTTTSCCT---------------TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCE
T ss_pred             cccchhhhhccccccceeeEeecccccccccc---------------chhhhccCcccccccccccCceEEEecCccccc
Confidence            98888877665   788888888887654211               1222222222233322  466667777777666


Q ss_pred             CcccccccccccceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCC
Q 039290          359 LIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGI  438 (1049)
Q Consensus       359 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~  438 (1049)
                      ..|..|+.+++|++|++++|.++++++.     .+..+++|++|+|++|.++                         +..
T Consensus       290 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-----~~~~l~~L~~L~Ls~N~l~-------------------------~~~  339 (455)
T 3v47_A          290 LLKSVFSHFTDLEQLTLAQNEINKIDDN-----AFWGLTHLLKLNLSQNFLG-------------------------SID  339 (455)
T ss_dssp             ECTTTTTTCTTCCEEECTTSCCCEECTT-----TTTTCTTCCEEECCSSCCC-------------------------EEC
T ss_pred             cchhhcccCCCCCEEECCCCcccccChh-----HhcCcccCCEEECCCCccC-------------------------CcC
Confidence            6666666666666666666666554332     2444455555555555444                         334


Q ss_pred             CCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCc
Q 039290          439 PKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLP  511 (1049)
Q Consensus       439 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  511 (1049)
                      |..|.++++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..+..+++|++|++++|++++..|
T Consensus       340 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          340 SRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             GGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             hhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence            4455556666666666666666666666666666666666666665555556666667777777776665544

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=5.7e-42  Score=403.63  Aligned_cols=385  Identities=19%  Similarity=0.248  Sum_probs=258.4

Q ss_pred             eecccccccccccCCCCccccccceEEeccccccccCccccccccceEEEeeccccCCCcc-ccccccccccceEEeccC
Q 039290          227 VVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLI-PASIFNISTLKELAVTDN  305 (1049)
Q Consensus       227 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~l~~N  305 (1049)
                      .++.+++.++ .+|. +.  ++|++|+|++|++++..|..|+++++|++|+|++|.+.+.+ |..|.++++|++|++++|
T Consensus        14 ~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n   89 (455)
T 3v47_A           14 NAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN   89 (455)
T ss_dssp             EEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTC
T ss_pred             ccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCC
Confidence            4555566555 4454 22  56666666666666655666666666666666666655443 234455555555555555


Q ss_pred             ccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCcccc--cccccccceeecccccccCC
Q 039290          306 DLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTT--FGNLRSLKLLSLAGNVLTSP  383 (1049)
Q Consensus       306 ~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~  383 (1049)
                      ++                         ++..|..|+++++|++|++++|++++..+..  |+.+++|++|+|++|.++.+
T Consensus        90 ~l-------------------------~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~  144 (455)
T 3v47_A           90 QF-------------------------LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKI  144 (455)
T ss_dssp             TT-------------------------CEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSC
T ss_pred             cc-------------------------CccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCcc
Confidence            54                         4444444444455555555555544422222  44445555555555554443


Q ss_pred             CCCcccccccccCCCCcEEEccCCccccCCCCcccccc-ccccEEEccCCccccCCCCC--------CCCCCCccEEEcc
Q 039290          384 TPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFS-ISMKSLSMESCNISGGIPKE--------LGNINNLTVIRLG  454 (1049)
Q Consensus       384 ~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~-~~L~~L~L~~n~i~~~~p~~--------~~~l~~L~~L~Ls  454 (1049)
                      .+..    .+..+++|++|++++|++++..+..+..+. .+++.|++++|.+.+..+..        +..+++|++|+++
T Consensus       145 ~~~~----~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls  220 (455)
T 3v47_A          145 QPAS----FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLS  220 (455)
T ss_dssp             CCCG----GGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECT
T ss_pred             Cccc----ccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecC
Confidence            2210    134444555555555555544444444332 24555555555555443332        3456788888888


Q ss_pred             CCcccccCCccccCc---CCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCc--ccCCceeecCcc
Q 039290          455 NNELTGTIPVTLGRL---QKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNL--TSLRDLSLGSNA  529 (1049)
Q Consensus       455 ~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~L~~N~  529 (1049)
                      +|++++..|..+...   ++|+.|++++|.+.+...              ..+.+....+..+..+  ++|++|++++|+
T Consensus       221 ~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~  286 (455)
T 3v47_A          221 GNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF--------------GHTNFKDPDNFTFKGLEASGVKTCDLSKSK  286 (455)
T ss_dssp             TSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCT--------------TCCSSCCCCTTTTGGGTTSCCCEEECCSSC
T ss_pred             CCcccccchhhhhccccccceeeEeecccccccccc--------------chhhhccCcccccccccccCceEEEecCcc
Confidence            888887777766554   778888888887654311              1222222333333333  678999999999


Q ss_pred             cccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCcccc
Q 039290          530 LTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPES  609 (1049)
Q Consensus       530 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~  609 (1049)
                      +++.+|..+..+++|++|++++|++++..+..|..+++|++|+|++|++++..|..|+++++|+.|+|++|++++..|..
T Consensus       287 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  366 (455)
T 3v47_A          287 IFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQS  366 (455)
T ss_dssp             CCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTT
T ss_pred             ccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhh
Confidence            99888888999999999999999999888888999999999999999999888999999999999999999999888999


Q ss_pred             ccCccCCcEEeccCccccCCcccccccccccceeeccCCcccccCCCCC
Q 039290          610 FGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRG  658 (1049)
Q Consensus       610 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~  658 (1049)
                      |.++++|++|+|++|++++..+..+..+++|++|++++|+++|.+|...
T Consensus       367 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~  415 (455)
T 3v47_A          367 FLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID  415 (455)
T ss_dssp             TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred             ccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcch
Confidence            9999999999999999997777778999999999999999999999643

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.2e-42  Score=385.63  Aligned_cols=288  Identities=34%  Similarity=0.549  Sum_probs=234.8

Q ss_pred             cccHHHHHHHhcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecC
Q 039290          750 RISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNN  829 (1049)
Q Consensus       750 ~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~  829 (1049)
                      ++++.++....++|+..+.||+|+||.||+|++.+++.||+|++........+.+.+|+++++.++||||+++++++.+.
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            34445556678899999999999999999999888999999998876666678899999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhhcCC---CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEeccc
Q 039290          830 DFKALVLEYMSNGSLEKCLYSDN---YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFG  906 (1049)
Q Consensus       830 ~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfG  906 (1049)
                      +..++||||+++|+|.+++....   ..+++.+++.++.|+++|++|||   ++||+||||||+||+++.++.+||+|||
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg  184 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFG  184 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCT
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecc
Confidence            99999999999999999987543   25899999999999999999999   9999999999999999999999999999


Q ss_pred             CceecCCCcc-ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccc-hHHHhhhhccccCC
Q 039290          907 IAKILGKEES-MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEM-SLKRWVGDSLLSCS  984 (1049)
Q Consensus       907 la~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~  984 (1049)
                      +++....... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ....|.........
T Consensus       185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
T 2qkw_B          185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ  264 (321)
T ss_dssp             TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred             cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence            9987543222 222334589999999999888999999999999999999999999976443322 23334332222222


Q ss_pred             cchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhc
Q 039290          985 ITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAY 1046 (1049)
Q Consensus       985 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~ 1046 (1049)
                      .....++..      .......++..+.+++.+||+.||++|||++|++++|+.+.+.....
T Consensus       265 ~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~~~  320 (321)
T 2qkw_B          265 LEQIVDPNL------ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQESV  320 (321)
T ss_dssp             CCSSSSSSC------TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSCCC
T ss_pred             HHHhcChhh------ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcccCc
Confidence            222222221      12233567889999999999999999999999999999998765443

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.6e-42  Score=384.68  Aligned_cols=283  Identities=35%  Similarity=0.564  Sum_probs=237.3

Q ss_pred             ccccccHHHHHHHhcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEee
Q 039290          747 TWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISS  825 (1049)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~  825 (1049)
                      ..+.++++++....++|+..+.||+|+||.||+|+..+++.||+|++.... ......+.+|+++++.++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            456788999999999999999999999999999998889999999997654 2234478999999999999999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhhcCC---CccCHHHHHHHHHHHHHHHHHhHccCCC---CeEEcCCCCCCeeecCCCc
Q 039290          826 CSNNDFKALVLEYMSNGSLEKCLYSDN---YFLDILQRLKIMIDVASALEYLHFGYST---PIVHCDIKPSNVLLNESMV  899 (1049)
Q Consensus       826 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~---~ivH~Dlkp~NIl~~~~~~  899 (1049)
                      +.+.+..++||||+++|+|.+++....   ..+++..+..++.|++.||+|||   +.   ||+||||||+||+++.++.
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~ivH~Dlkp~Nil~~~~~~  172 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH---DHCDPKIIHRDVKAANILLDEEFE  172 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH---HSSSSCEECCCCSGGGEEECTTCC
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCeEeCCCchhhEEECCCCC
Confidence            999999999999999999999997643   25899999999999999999999   66   9999999999999999999


Q ss_pred             eEEecccCceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccc---cccchHHHhh
Q 039290          900 GHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIF---AGEMSLKRWV  976 (1049)
Q Consensus       900 ~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~---~~~~~~~~~~  976 (1049)
                      +||+|||++...............||+.|+|||++.+..++.++||||+||++|||++|+.||+...   ..+.....|.
T Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  252 (326)
T 3uim_A          173 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV  252 (326)
T ss_dssp             EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred             EEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence            9999999999876554444455668999999999988889999999999999999999999996422   2333455565


Q ss_pred             hhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 039290          977 GDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVR 1038 (1049)
Q Consensus       977 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~ 1038 (1049)
                      .............+....      .......+..+.+++.+||+.||++|||++|++++|++
T Consensus       253 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          253 KGLLKEKKLEALVDVDLQ------GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TTTTSSCCSTTSSCTTCT------TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HHHhhchhhhhhcChhhc------cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            555544444444443321      22335678899999999999999999999999999975

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=376.92  Aligned_cols=265  Identities=26%  Similarity=0.394  Sum_probs=218.6

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      .++|...+.||+|+||+||+|++. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            356888999999999999999964 6899999998655445567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      +++|+|.+++......+++.++..++.|+++||+|||   +.||+||||||+||+++.++.+||+|||++..........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            9999999999887777999999999999999999999   9999999999999999999999999999998764333211


Q ss_pred             -------------ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCc
Q 039290          919 -------------QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSI  985 (1049)
Q Consensus       919 -------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  985 (1049)
                                   .....||+.|+|||++.+..++.++||||+|+++|||++|..|+..............         
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~---------  236 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV---------  236 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH---------
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh---------
Confidence                         1145789999999999999999999999999999999999999865332221111000         


Q ss_pred             chhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhc
Q 039290          986 TEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAY 1046 (1049)
Q Consensus       986 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~ 1046 (1049)
                      ....+          ...+..++..+.+++.+||+.||++|||++|+++.|+++.+.+...
T Consensus       237 ~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~  287 (310)
T 3s95_A          237 RGFLD----------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH  287 (310)
T ss_dssp             HHHHH----------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHC
T ss_pred             hcccc----------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCc
Confidence            00000          0011234567899999999999999999999999999999877643

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.5e-41  Score=371.31  Aligned_cols=251  Identities=25%  Similarity=0.333  Sum_probs=212.7

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      .++|+..+.||+|+||+||+|+. .+++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            45799999999999999999995 57899999999877777778899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      +++|+|.+++...  .+++.+++.++.|++.|++|||   ++||+||||||+||+++.++.+||+|||++........ .
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  172 (297)
T 3fxz_A           99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K  172 (297)
T ss_dssp             CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred             CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-c
Confidence            9999999998765  4899999999999999999999   99999999999999999999999999999987654432 2


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||......+........                   ..
T Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-------------------~~  233 (297)
T 3fxz_A          173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-------------------GT  233 (297)
T ss_dssp             BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH-------------------CS
T ss_pred             cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------CC
Confidence            34467899999999999999999999999999999999999999753222111111000                   00


Q ss_pred             cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          999 NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       999 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .....+..++..+.+++.+||+.||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          234 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            0111223456778999999999999999999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.2e-41  Score=365.52  Aligned_cols=260  Identities=28%  Similarity=0.407  Sum_probs=217.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      .++|++.+.||+|+||.||+|+..++..||+|+++... ...+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            45788999999999999999999888899999997543 34578999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      ++++|.+++...+..+++.+++.++.|++.|++|||   +.||+||||||+||+++.++.+||+|||++...........
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  162 (268)
T 3sxs_A           86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS  162 (268)
T ss_dssp             TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence            999999999887667999999999999999999999   99999999999999999999999999999987765544334


Q ss_pred             cccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccccccc
Q 039290          920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                      ....+++.|+|||++.+..++.++||||+|+++|||++ |+.||......+.......+.                    
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--------------------  222 (268)
T 3sxs_A          163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH--------------------  222 (268)
T ss_dssp             CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC--------------------
T ss_pred             cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC--------------------
Confidence            44556778999999988899999999999999999999 999997543322211110000                    


Q ss_pred             cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          999 NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       999 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                       ....+..++..+.+++.+||+.||++|||++|++++|+++.++..
T Consensus       223 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~k  267 (268)
T 3sxs_A          223 -RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK  267 (268)
T ss_dssp             -CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC---
T ss_pred             -CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhccC
Confidence             001112234578999999999999999999999999998876643

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.3e-41  Score=365.63  Aligned_cols=258  Identities=24%  Similarity=0.380  Sum_probs=217.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      .++|+..+.||+|+||+||+|++.+++.||+|++.... ...+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            35688899999999999999999889999999997543 34578999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      ++++|.+++......+++..++.++.|+++|++|||   +.||+||||||+||+++.++.+||+|||++...........
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  164 (269)
T 4hcu_A           88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  164 (269)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred             CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence            999999999887777999999999999999999999   99999999999999999999999999999987654443333


Q ss_pred             cccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccccccc
Q 039290          920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                      ....+++.|+|||++.+..++.++||||+|+++|||++ |..||......+.. .......                   
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~-~~~~~~~-------------------  224 (269)
T 4hcu_A          165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-EDISTGF-------------------  224 (269)
T ss_dssp             TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-HHHHTTC-------------------
T ss_pred             cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH-HHHhcCc-------------------
Confidence            44556788999999988899999999999999999999 99999763322211 1110000                   


Q ss_pred             cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHh
Q 039290          999 NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042 (1049)
Q Consensus       999 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~ 1042 (1049)
                       +...+...+..+.+++.+||+.||++|||++|++++|+++.++
T Consensus       225 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          225 -RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence             0011122356789999999999999999999999999998764

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=9e-41  Score=373.64  Aligned_cols=274  Identities=22%  Similarity=0.306  Sum_probs=211.1

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCC----eeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNND----FKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~----~~~lv  835 (1049)
                      .++|++.+.||+|+||+||+|++. ++.||||+++... .......+|+.++++++||||+++++++.+..    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            457899999999999999999974 7899999996542 23345667899999999999999999997744    46999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCC----------CeEEcCCCCCCeeecCCCceEEecc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST----------PIVHCDIKPSNVLLNESMVGHLSDF  905 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~----------~ivH~Dlkp~NIl~~~~~~~kl~Df  905 (1049)
                      |||+++|+|.+++....  +++.+++.++.|+++|++|||   +.          +|+||||||+||+++.++.+||+||
T Consensus       101 ~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          101 TAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            99999999999997654  899999999999999999999   88          9999999999999999999999999


Q ss_pred             cCceecCCCccc-cccccccccCcccccccCC-----CCcCcccchHHHHHHHHHHHhCCCCCCccccccc-hHHHhhhh
Q 039290          906 GIAKILGKEESM-RQTKTLGTIGYMAPEYGRE-----GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEM-SLKRWVGD  978 (1049)
Q Consensus       906 Gla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-~~~~~~~~  978 (1049)
                      |+++........ ......||+.|+|||++.+     ..++.++||||+||++|||++|+.||........ ......  
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~--  253 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI--  253 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH--
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh--
Confidence            999876543322 2233578999999999876     3567789999999999999999999976433211 111110  


Q ss_pred             ccccCCcchhcccccccccc---cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhh
Q 039290          979 SLLSCSITEVADANLLNCEE---NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043 (1049)
Q Consensus       979 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~ 1043 (1049)
                       .......++.+........   ........++.++.+++.+||+.||++|||++|+++.|+++.+..
T Consensus       254 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          254 -GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             -CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             -ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence             0011111111111000000   011122346678999999999999999999999999999987653

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=1.3e-39  Score=380.45  Aligned_cols=377  Identities=17%  Similarity=0.162  Sum_probs=239.8

Q ss_pred             hhhhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCC
Q 039290           98 FLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLS  177 (1049)
Q Consensus        98 ~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls  177 (1049)
                      .++..........+..|.+++++++|++||+++|++++ +| .++.+++|++|+|++|.+++ +|  ++.+++|++|+|+
T Consensus        19 ~l~~~~~~~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls   93 (457)
T 3bz5_A           19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACD   93 (457)
T ss_dssp             HHHHHHHHHTTCCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECC
T ss_pred             HHHHHHHHhcCcCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECc
Confidence            34444444555556667788888889999999888885 45 68888888999998888886 44  8888888888888


Q ss_pred             CccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceEEeccc
Q 039290          178 DNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNN  257 (1049)
Q Consensus       178 ~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  257 (1049)
                      +|++++ +|  +      ..+++|++|++++|++++ +|  +..+++|++|++++|++++. |  ++++++|++|++++|
T Consensus        94 ~N~l~~-~~--~------~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n  158 (457)
T 3bz5_A           94 SNKLTN-LD--V------TPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLN  158 (457)
T ss_dssp             SSCCSC-CC--C------TTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTC
T ss_pred             CCCCce-ee--c------CCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCC
Confidence            888885 33  3      345668888888888875 43  66667777777777776652 2  666666666666666


Q ss_pred             cccccCccccccccceEEEeeccccCCCccccccccccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCC
Q 039290          258 SLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIP  337 (1049)
Q Consensus       258 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p  337 (1049)
                      +..+.+  .++.+++|+.|++++|++++. |  +..+                         ++|+.|++++|++++.  
T Consensus       159 ~~~~~~--~~~~l~~L~~L~ls~n~l~~l-~--l~~l-------------------------~~L~~L~l~~N~l~~~--  206 (457)
T 3bz5_A          159 KKITKL--DVTPQTQLTTLDCSFNKITEL-D--VSQN-------------------------KLLNRLNCDTNNITKL--  206 (457)
T ss_dssp             SCCCCC--CCTTCTTCCEEECCSSCCCCC-C--CTTC-------------------------TTCCEEECCSSCCSCC--
T ss_pred             Cccccc--ccccCCcCCEEECCCCcccee-c--cccC-------------------------CCCCEEECcCCcCCee--
Confidence            544444  355556666666665555542 2  4444                         4455555555555432  


Q ss_pred             ccccCCCCCceeecccCccccCcccccccccccceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCcc
Q 039290          338 SSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSI  417 (1049)
Q Consensus       338 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~  417 (1049)
                       .++.+++|++|++++|++++ +|  ++.+++|+.|++++|++++++        ...+++|+.|++++|+         
T Consensus       207 -~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~--------~~~l~~L~~L~l~~n~---------  265 (457)
T 3bz5_A          207 -DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD--------VSTLSKLTTLHCIQTD---------  265 (457)
T ss_dssp             -CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC--------CTTCTTCCEEECTTCC---------
T ss_pred             -ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC--------HHHCCCCCEEeccCCC---------
Confidence             24455555555555555554 23  455555555555555555543        1234555556555542         


Q ss_pred             ccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccc
Q 039290          418 GNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLA  497 (1049)
Q Consensus       418 ~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  497 (1049)
                            |+.|++++|.+.+.+|  ++.+++|+.|+|++|...+.+|.   ...+|+.|++++|             ++|+
T Consensus       266 ------L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~  321 (457)
T 3bz5_A          266 ------LLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLV  321 (457)
T ss_dssp             ------CSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCC
T ss_pred             ------CCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCC
Confidence                  3345566666555555  45667777777777776666553   3345555555544             4677


Q ss_pred             eEEeeCcccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeeccccc
Q 039290          498 NLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNA  577 (1049)
Q Consensus       498 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  577 (1049)
                      +|++++|++++. +  ++++++|+.|++++|++++        ++.|..|++++|.+.|.     +.+..|..+++++|+
T Consensus       322 ~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~  385 (457)
T 3bz5_A          322 YLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNS  385 (457)
T ss_dssp             EEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTB
T ss_pred             EEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCc
Confidence            777777777763 3  6777777777777777775        24566667777777653     344556667777777


Q ss_pred             cccccccccc
Q 039290          578 LSGVIPVTIG  587 (1049)
Q Consensus       578 l~~~~p~~~~  587 (1049)
                      ++|.+|..+.
T Consensus       386 l~g~ip~~~~  395 (457)
T 3bz5_A          386 LTIAVSPDLL  395 (457)
T ss_dssp             EEEECCTTCB
T ss_pred             EEEEcChhHh
Confidence            7777765543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.3e-40  Score=377.13  Aligned_cols=261  Identities=24%  Similarity=0.445  Sum_probs=214.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe--------CCCcEEEEEEeecccC-CCHHHHHHHHHHHhhc-CCCceeeEEeeeecC
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL--------PDGMEIAAKVFHMEFD-GSLESFHAECKVMGSI-RHRNLVKIISSCSNN  829 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~--------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~  829 (1049)
                      .++|++.+.||+|+||.||+|++        .++..||+|+++.... ...+++.+|+++++++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            35788999999999999999985        2456799999975532 2346789999999999 899999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhhcCC---------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeee
Q 039290          830 DFKALVLEYMSNGSLEKCLYSDN---------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL  894 (1049)
Q Consensus       830 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~  894 (1049)
                      +..++||||+++|+|.+++...+               ..+++.+++.++.||++||+|||   ++||+||||||+||++
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence            99999999999999999997653               24789999999999999999999   9999999999999999


Q ss_pred             cCCCceEEecccCceecCCCccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchH
Q 039290          895 NESMVGHLSDFGIAKILGKEESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSL  972 (1049)
Q Consensus       895 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~  972 (1049)
                      +.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+.. 
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~-  315 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF-  315 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-
Confidence            99999999999999876543322 2233456789999999998899999999999999999999 99999764322211 


Q ss_pred             HHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          973 KRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                       ......                   .+...+..++.++.+++.+||+.||++|||++|++++|+++.....
T Consensus       316 -~~~~~~-------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          316 -KLLKEG-------------------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             -HHHHTT-------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             -HHHhcC-------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence             111000                   0111223456789999999999999999999999999999987554

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.6e-40  Score=368.84  Aligned_cols=260  Identities=26%  Similarity=0.410  Sum_probs=205.6

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCC--CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDG--SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ..++|++.+.||+|+||+||+|+. +++.||||++......  ..+++.+|++++++++||||+++++++.+.+..++||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            356789999999999999999987 6889999998755322  2457889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCC--ccCHHHHHHHHHHHHHHHHHhHccCCCC--eEEcCCCCCCeeecCCCceEEecccCceecC
Q 039290          837 EYMSNGSLEKCLYSDNY--FLDILQRLKIMIDVASALEYLHFGYSTP--IVHCDIKPSNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      ||+++|+|.+++.....  .+++.+++.++.|+++||+|||   +.|  |+||||||+||+++.++.+||+|||+++...
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            99999999999986543  4899999999999999999999   899  9999999999999999999999999998654


Q ss_pred             CCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccc
Q 039290          913 KEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       913 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      ... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+...  .....             
T Consensus       191 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~--~~~~~-------------  254 (309)
T 3p86_A          191 STF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA--AVGFK-------------  254 (309)
T ss_dssp             ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH--HHHHS-------------
T ss_pred             ccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhc-------------
Confidence            322 22334578999999999999999999999999999999999999997643222111  11000             


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhh
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~ 1043 (1049)
                           ..+...+..++.++.+++.+||+.||++|||++|+++.|+++.++.
T Consensus       255 -----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          255 -----CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             -----CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             -----CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence                 0011122335667899999999999999999999999999988754

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=6e-40  Score=366.46  Aligned_cols=262  Identities=22%  Similarity=0.293  Sum_probs=216.5

Q ss_pred             ccccHHHHHHHhcC----------CCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCC
Q 039290          749 RRISYQDLLRATDG----------FSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHR  817 (1049)
Q Consensus       749 ~~~~~~~~~~~~~~----------~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hp  817 (1049)
                      ..++++++..+++.          |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            34677777776653          667789999999999999965 7999999999877666778899999999999999


Q ss_pred             ceeeEEeeeecCCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCC
Q 039290          818 NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES  897 (1049)
Q Consensus       818 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~  897 (1049)
                      ||+++++++...+..++||||+++++|.+++...  .+++.++..++.|+++||+|||   +.||+||||||+||+++.+
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~  177 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLD  177 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTT
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCC
Confidence            9999999999999999999999999999988754  4899999999999999999999   9999999999999999999


Q ss_pred             CceEEecccCceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhh
Q 039290          898 MVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVG  977 (1049)
Q Consensus       898 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  977 (1049)
                      +.+||+|||++........ ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+  ......
T Consensus       178 ~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~--~~~~~~  254 (321)
T 2c30_A          178 GRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMKRLR  254 (321)
T ss_dssp             CCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHH
T ss_pred             CcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHh
Confidence            9999999999987654332 2334678999999999999899999999999999999999999997532211  111110


Q ss_pred             hccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          978 DSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       978 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ..                 ...........+..+.+++.+||+.||++|||++|++++
T Consensus       255 ~~-----------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          255 DS-----------------PPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HS-----------------SCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cC-----------------CCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00                 000111122345678999999999999999999999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.1e-40  Score=363.86  Aligned_cols=259  Identities=24%  Similarity=0.381  Sum_probs=214.8

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      .++|++.+.||+|+||+||+|++.++..||+|+++... ...+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            45788899999999999999999888899999997543 34578999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      ++++|.+++......+++.+++.++.|++.|++|||   ++||+||||||+||+++.++.+||+|||++...........
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  178 (283)
T 3gen_A          102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS  178 (283)
T ss_dssp             TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred             CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence            999999999876667999999999999999999999   99999999999999999999999999999987654433333


Q ss_pred             cccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccccccc
Q 039290          920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                      ....+|+.|+|||++.+..++.++||||+|+++|||++ |+.||......+..... ... .                  
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~~-~------------------  238 (283)
T 3gen_A          179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQG-L------------------  238 (283)
T ss_dssp             TSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HTT-C------------------
T ss_pred             cCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH-hcc-c------------------
Confidence            34456788999999988899999999999999999998 99999764322211111 000 0                  


Q ss_pred             cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhh
Q 039290          999 NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043 (1049)
Q Consensus       999 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~ 1043 (1049)
                       +...+..++..+.+++.+||+.+|++|||++|++++|+++.++-
T Consensus       239 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e  282 (283)
T 3gen_A          239 -RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE  282 (283)
T ss_dssp             -CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             -CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence             00111223467899999999999999999999999999998763

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.2e-39  Score=360.34  Aligned_cols=282  Identities=30%  Similarity=0.465  Sum_probs=227.1

Q ss_pred             ccccccHHHHHHHhcCCCCC------ceecCCCcEEEEEEEeCCCcEEEEEEeeccc----CCCHHHHHHHHHHHhhcCC
Q 039290          747 TWRRISYQDLLRATDGFSEN------KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEF----DGSLESFHAECKVMGSIRH  816 (1049)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h  816 (1049)
                      ....+++.++..++++|...      +.||+|+||.||+|+. +++.||+|++....    ....+.+.+|++++++++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            34668899999999988877      9999999999999987 68899999986543    2335778999999999999


Q ss_pred             CceeeEEeeeecCCeeEEEEeccCCCChhhhhhcC--CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeee
Q 039290          817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSD--NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL  894 (1049)
Q Consensus       817 pniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~  894 (1049)
                      |||+++++++.+.+..++||||+++++|.+++...  ...+++..++.++.|++.||+|||   +.||+||||||+||++
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEE
Confidence            99999999999999999999999999999998643  345899999999999999999999   9999999999999999


Q ss_pred             cCCCceEEecccCceecCCCccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHH
Q 039290          895 NESMVGHLSDFGIAKILGKEESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK  973 (1049)
Q Consensus       895 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~  973 (1049)
                      +.++.+||+|||++......... ......|++.|+|||.+.+ .++.++||||+|+++|||++|..||......+.. .
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~  244 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL-L  244 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT-T
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH-H
Confidence            99999999999999876543221 2233568999999998865 6899999999999999999999999864433221 1


Q ss_pred             Hhhhhcc-ccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 039290          974 RWVGDSL-LSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041 (1049)
Q Consensus       974 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~ 1041 (1049)
                      .+..... ....+.+..+..+       ...+..++..+.+++.+||+.||++|||++|++++|+++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          245 DIKEEIEDEEKTIEDYIDKKM-------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHHHTTSCCHHHHSCSSC-------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHHhhhhhhhhhhhccccc-------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            1211111 1111222222211       12235677889999999999999999999999999998754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=371.48  Aligned_cols=261  Identities=23%  Similarity=0.399  Sum_probs=213.2

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC----CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP----DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      .++|++.+.||+|+||+||+|++.    .+..||||+++... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            356888999999999999999964    34569999997543 2235678999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      ||||+++|+|.+++......+++.+++.++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+++.....
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            99999999999999877667999999999999999999999   999999999999999999999999999999877543


Q ss_pred             ccc--cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccc
Q 039290          915 ESM--RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA  991 (1049)
Q Consensus       915 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  991 (1049)
                      ...  ......+|+.|+|||++.+..++.++||||+||++|||++ |..||......+..... ...             
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-~~~-------------  270 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV-EEG-------------  270 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH-HTT-------------
T ss_pred             ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-HcC-------------
Confidence            221  2223345778999999988899999999999999999999 99999764332211111 000             


Q ss_pred             ccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          992 NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                             .+...+..++.++.+++.+||+.||++|||++|+++.|+++.+...
T Consensus       271 -------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          271 -------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             -------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence                   0111123456789999999999999999999999999999987543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.2e-40  Score=372.27  Aligned_cols=249  Identities=23%  Similarity=0.308  Sum_probs=208.1

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      ..++|++.+.||+|+||.||+|++ .+|+.||+|++.....  ...+++.+|+++++.++||||+++++++.+.+..++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            356899999999999999999996 5899999999976532  2346788999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++|+|.+++...+ .+++.+++.++.|+++|++|||   ++||+||||||+||+++.++.+||+|||++.......
T Consensus        93 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             ECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             EECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            99999999999987654 4899999999999999999999   9999999999999999999999999999998765433


Q ss_pred             cccccccccccCcccccccCCCCcC-cccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKVS-RKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                        ......||+.|+|||++.+..++ .++||||+||++|||++|+.||......+.......                  
T Consensus       169 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~------------------  228 (328)
T 3fe3_A          169 --KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR------------------  228 (328)
T ss_dssp             --GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------------------
T ss_pred             --ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------------
Confidence              23456799999999999887765 799999999999999999999976322211111100                  


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                          .....+...+.++.+++.+||+.||.+|||++|+++|
T Consensus       229 ----~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          229 ----GKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             ----CCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                0111112345678999999999999999999999876

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=7.5e-41  Score=382.56  Aligned_cols=260  Identities=25%  Similarity=0.424  Sum_probs=215.0

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .++|.+.+.||+|+||.||+|++. +++.||||+++.... ...+++.+|++++++++||||+++++++.+.+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            457888999999999999999975 789999999875432 223568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      |+++|+|.+++...+..+++.++..++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+++........
T Consensus       193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~  269 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA  269 (377)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence            99999999999877667899999999999999999999   999999999999999999999999999999865432211


Q ss_pred             c-ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          918 R-QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       918 ~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                      . .....+++.|+|||++.+..++.++|||||||++|||++ |..||......+.  ...+..                 
T Consensus       270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~--~~~~~~-----------------  330 (377)
T 3cbl_A          270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT--REFVEK-----------------  330 (377)
T ss_dssp             CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH--HHHHHT-----------------
T ss_pred             ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHc-----------------
Confidence            1 112235778999999988899999999999999999998 9999976432211  111110                 


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhh
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~ 1043 (1049)
                        ..+.+.+..++.++.+++.+||+.||++|||++++++.|+++.++.
T Consensus       331 --~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~  376 (377)
T 3cbl_A          331 --GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH  376 (377)
T ss_dssp             --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             --CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence              0011122345678999999999999999999999999999998764

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1e-40  Score=368.61  Aligned_cols=276  Identities=25%  Similarity=0.409  Sum_probs=212.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-----CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeec--CCee
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-----PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSN--NDFK  832 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--~~~~  832 (1049)
                      .++|++.+.||+|+||+||+|++     .+++.||+|++........+.+.+|++++++++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            35788999999999999999984     3688999999976554456788999999999999999999999854  3568


Q ss_pred             EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecC
Q 039290          833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      ++||||+++|+|.+++...+..+++.+++.++.|++.||+|||   +.||+||||||+||+++.++.+||+|||++....
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            9999999999999999887777999999999999999999999   9999999999999999999999999999998765


Q ss_pred             CCcc--ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCc-chhc
Q 039290          913 KEES--MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSI-TEVA  989 (1049)
Q Consensus       913 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  989 (1049)
                      ....  .......++..|+|||++.+..++.++||||+|+++|||++|..||......   .....+........ ....
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHHCTTCCTHHHHHHHH
T ss_pred             CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhhcCccccchhHHHHH
Confidence            4332  1222345677899999999889999999999999999999999998653211   11110000000000 0000


Q ss_pred             ccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          990 DANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                      . .+  ....+...+..++.++.+++.+||+.||++|||++|++++|+++++++.
T Consensus       243 ~-~~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~  294 (295)
T 3ugc_A          243 E-LL--KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA  294 (295)
T ss_dssp             H-HH--HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             H-HH--hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence            0 00  0111222334567889999999999999999999999999999988753

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.3e-40  Score=365.27  Aligned_cols=265  Identities=23%  Similarity=0.360  Sum_probs=210.9

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCC---HHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGS---LESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++.......   .+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            35799999999999999999995 478999999986544322   46788999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++++|.+++...+ .+++.+++.++.|+++|++|||   ++||+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            99999999999987654 4899999999999999999999   9999999999999999999999999999998765443


Q ss_pred             cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                      ........||+.|+|||.+.+..++.++||||+|+++|||++|+.||......+..........                
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~----------------  229 (294)
T 4eqm_A          166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV----------------  229 (294)
T ss_dssp             ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC----------------
T ss_pred             ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC----------------
Confidence            3334446789999999999998999999999999999999999999976432222111111000                


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCC-CHHHHHHHHHHHHHhhhh
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRI-SMKDVANRLVRIRETLSA 1045 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~ell~~L~~i~~~~~~ 1045 (1049)
                       +........+++..+.+++.+|++.||++|| +++++.+.|+++..+...
T Consensus       230 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~  279 (294)
T 4eqm_A          230 -PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA  279 (294)
T ss_dssp             -CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred             -CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence             0000111133567899999999999999999 999999999887665443

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-40  Score=367.57  Aligned_cols=253  Identities=19%  Similarity=0.260  Sum_probs=210.6

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      .++|++.+.||+|+||+||+|+.. +++.||+|.++.. ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            467999999999999999999965 6889999998754 23456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC--CCceEEecccCceecCCCcc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE--SMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~--~~~~kl~DfGla~~~~~~~~  916 (1049)
                      +++|+|.+++......+++.+++.++.|+++|++|||   +.||+||||||+||+++.  ++.+||+|||++........
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~  159 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence            9999999999877667999999999999999999999   999999999999999986  78999999999988754332


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                        .....+|+.|+|||++.+..++.++||||+||++|||++|..||......+.. ......                 .
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~i~~~-----------------~  219 (321)
T 1tki_A          160 --FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII-ENIMNA-----------------E  219 (321)
T ss_dssp             --EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHHHHT-----------------C
T ss_pred             --cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHH-HHHHcC-----------------C
Confidence              33457899999999999888999999999999999999999999763222111 111100                 0


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                      ...........+.++.+++.+|++.||++|||++|+++|-
T Consensus       220 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          220 YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             CCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence            0001111224567899999999999999999999999874

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1e-39  Score=369.00  Aligned_cols=252  Identities=22%  Similarity=0.276  Sum_probs=208.6

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCC------CHHHHHHHHHHHhhcCCCceeeEEeeeecCCee
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDG------SLESFHAECKVMGSIRHRNLVKIISSCSNNDFK  832 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~  832 (1049)
                      .++|++.+.||+|+||+||+|+.. +|+.||+|+++.....      ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            457899999999999999999965 7899999999765422      357899999999999999999999999999999


Q ss_pred             EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC----ceEEecccCc
Q 039290          833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM----VGHLSDFGIA  908 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~----~~kl~DfGla  908 (1049)
                      ++||||+++|+|.+++.... .+++.++..++.||+.|++|||   +.||+||||||+||+++.++    .+||+|||++
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            99999999999999997654 5899999999999999999999   99999999999999998776    7999999999


Q ss_pred             eecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchh
Q 039290          909 KILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEV  988 (1049)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  988 (1049)
                      .......  ......||+.|+|||++.+..++.++||||+||++|+|++|..||......+.. ......          
T Consensus       167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~-~~i~~~----------  233 (361)
T 2yab_A          167 HEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-ANITAV----------  233 (361)
T ss_dssp             EECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-HHHHTT----------
T ss_pred             eEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhc----------
Confidence            8765432  233457999999999999889999999999999999999999999753222111 111000          


Q ss_pred             cccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          989 ADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                             ............+.++.+++.+|++.||++|||++|+++|
T Consensus       234 -------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          234 -------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             -------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -------CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                   0000111223356778999999999999999999999875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.3e-39  Score=362.20  Aligned_cols=271  Identities=24%  Similarity=0.288  Sum_probs=208.5

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .++|++.+.||+|+||+||+|+..+++.||+|++.....  ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            467999999999999999999998899999999975432  234678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      |+++ +|.+++......+++.+++.++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+++....... 
T Consensus       100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-  174 (311)
T 3niz_A          100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-  174 (311)
T ss_dssp             CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred             CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence            9975 888888877777999999999999999999999   99999999999999999999999999999987653322 


Q ss_pred             cccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhc-cccCCcchhcc-----
Q 039290          918 RQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDS-LLSCSITEVAD-----  990 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----  990 (1049)
                      ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+.......... .....+....+     
T Consensus       175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  254 (311)
T 3niz_A          175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK  254 (311)
T ss_dssp             ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred             cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence            2334578999999998876 5689999999999999999999999976544332211111000 00000000000     


Q ss_pred             -ccccccccc-CchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          991 -ANLLNCEEN-DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       991 -~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                       ......... .......++.++.+++.+|++.||++|||++|+++|
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence             000000000 011122345678999999999999999999999985

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.1e-39  Score=365.56  Aligned_cols=249  Identities=24%  Similarity=0.293  Sum_probs=208.2

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecc---cCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHME---FDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      .++|+..+.||+|+||+||+|+.. +|+.||+|+++..   .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            357889999999999999999965 7899999999764   244567889999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++|+|.+++...+ .+++.+++.++.||+.||+|||   ++||+||||||+||+++.++.+||+|||+++......
T Consensus        84 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence            99999999999887654 4899999999999999999999   9999999999999999999999999999998643222


Q ss_pred             cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+.  ...+.            ..    
T Consensus       160 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~i~------------~~----  220 (337)
T 1o6l_A          160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--FELIL------------ME----  220 (337)
T ss_dssp             -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH------------HC----
T ss_pred             -CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH--HHHHH------------cC----
Confidence             223446799999999999999999999999999999999999999975322111  11000            00    


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRI-----SMKDVANR 1035 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~~ 1035 (1049)
                          ....+...+.++.+++.+||+.||++||     +++|+++|
T Consensus       221 ----~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          221 ----EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ----CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence                0011123456789999999999999999     89999887

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.5e-40  Score=355.70  Aligned_cols=258  Identities=24%  Similarity=0.383  Sum_probs=216.1

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      .++|+..+.||+|+||.||+|+..+++.||+|+++... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            35788899999999999999999889999999997653 34578999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      ++++|.+++......+++.+++.++.|+++|++|||   ++||+||||||+||+++.++.+||+|||++...........
T Consensus        86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  162 (267)
T 3t9t_A           86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  162 (267)
T ss_dssp             TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred             CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence            999999999887777899999999999999999999   99999999999999999999999999999987654332233


Q ss_pred             cccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccccccc
Q 039290          920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                      ....+++.|+|||++.+..++.++||||+|+++|||++ |..||......+.  ...+....                  
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~i~~~~------------------  222 (267)
T 3t9t_A          163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--VEDISTGF------------------  222 (267)
T ss_dssp             TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHHHTTC------------------
T ss_pred             ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH--HHHHhcCC------------------
Confidence            34456788999999988889999999999999999999 8999875322211  11110000                  


Q ss_pred             cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHh
Q 039290          999 NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042 (1049)
Q Consensus       999 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~ 1042 (1049)
                       +...+..++..+.+++.+||+.||++|||++|++++|+++.++
T Consensus       223 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          223 -RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence             0001122456789999999999999999999999999998764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=6.8e-40  Score=373.36  Aligned_cols=260  Identities=25%  Similarity=0.458  Sum_probs=203.2

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC----CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP----DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      .++|++.+.||+|+||.||+|+..    ++..||||+++.... ...+++.+|++++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357999999999999999999864    577899999976432 234678999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      ||||+++|+|.+++...+..+++.+++.++.|+++||+|||   +.||+||||||+||+++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            99999999999999887777999999999999999999999   999999999999999999999999999999876543


Q ss_pred             cccc--ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccc
Q 039290          915 ESMR--QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA  991 (1049)
Q Consensus       915 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  991 (1049)
                      ....  .....+++.|+|||++.+..++.++|||||||++|||++ |+.||......+.  ...+...            
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~--~~~i~~~------------  266 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV--IKAVDEG------------  266 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH--HHHHHTT------------
T ss_pred             CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHcC------------
Confidence            2211  112235678999999998899999999999999999998 9999975432211  1111000            


Q ss_pred             ccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhh
Q 039290          992 NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043 (1049)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~ 1043 (1049)
                       .      +...+..++.++.+++.+||+.||++||+++|+++.|+++.+..
T Consensus       267 -~------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          267 -Y------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             -E------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             -C------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence             0      01112245677999999999999999999999999999997754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-39  Score=359.48  Aligned_cols=275  Identities=22%  Similarity=0.245  Sum_probs=214.2

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCC--eeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNND--FKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~--~~~lv~  836 (1049)
                      ++|++.+.||+|+||+||+|+.. +++.||+|+++... ....+.+.+|++++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            46889999999999999999965 58999999997543 345678889999999999999999999987655  779999


Q ss_pred             eccCCCChhhhhhcCCC--ccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeee----cCCCceEEecccCcee
Q 039290          837 EYMSNGSLEKCLYSDNY--FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL----NESMVGHLSDFGIAKI  910 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~----~~~~~~kl~DfGla~~  910 (1049)
                      ||+++++|.+++.....  .+++.+++.++.|+++||+|||   +.||+||||||+||++    +.++.+||+|||+++.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            99999999999976443  3899999999999999999999   9999999999999999    7788899999999987


Q ss_pred             cCCCccccccccccccCcccccccC--------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhc--c
Q 039290          911 LGKEESMRQTKTLGTIGYMAPEYGR--------EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDS--L  980 (1049)
Q Consensus       911 ~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~--~  980 (1049)
                      ......  .....||+.|+|||++.        +..++.++||||+||++|||++|+.||.................  .
T Consensus       166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (319)
T 4euu_A          166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (319)
T ss_dssp             CCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred             cCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence            754432  23456899999999875        46789999999999999999999999975433222211111100  0


Q ss_pred             ccCCcchhccc---c--cccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 039290          981 LSCSITEVADA---N--LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIR 1040 (1049)
Q Consensus       981 ~~~~~~~~~~~---~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~ 1040 (1049)
                      ....+..+...   .  ...............+..+.+++.+||+.||++|||++|++++..+..
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            11111110000   0  000111112334677888999999999999999999999999988653

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.4e-39  Score=363.66  Aligned_cols=253  Identities=25%  Similarity=0.372  Sum_probs=207.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .++|++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            467999999999999999999965 78999999996543 2234678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc-c
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE-S  916 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~-~  916 (1049)
                      |+++|+|.+++.... .+++.+++.++.|++.||+|||   +.||+||||||+||+++.++.+||+|||++..+.... .
T Consensus        86 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            999999999987654 4899999999999999999999   9999999999999999999999999999998664322 1


Q ss_pred             ccccccccccCcccccccCCCCc-CcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKV-SRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                      .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||............|......              
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------  227 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------------  227 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT--------------
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc--------------
Confidence            22334678999999999987665 788999999999999999999998654443444433321110              


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                           ......++.++.+++.+||+.||++|||++|++++
T Consensus       228 -----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          228 -----LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             -----STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -----CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                 01112345678899999999999999999999876

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.8e-40  Score=377.88  Aligned_cols=259  Identities=22%  Similarity=0.284  Sum_probs=211.7

Q ss_pred             HHHHHHhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecC
Q 039290          754 QDLLRATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNN  829 (1049)
Q Consensus       754 ~~~~~~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~  829 (1049)
                      .++....++|++.++||+|+||+||+|+.. +++.||+|+++...   ....+.+.+|+++++.++||||+++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            344445678999999999999999999965 68899999997532   33445688999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCce
Q 039290          830 DFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK  909 (1049)
Q Consensus       830 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~  909 (1049)
                      +..|+||||+++|+|.+++...  .+++..++.++.||+.||+|||   ++||+||||||+||+++.++.+||+|||+++
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~  216 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  216 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence            9999999999999999998764  4899999999999999999999   9999999999999999999999999999998


Q ss_pred             ecCCCccccccccccccCcccccccCCCC----cCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCc
Q 039290          910 ILGKEESMRQTKTLGTIGYMAPEYGREGK----VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSI  985 (1049)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  985 (1049)
                      .............+||+.|+|||++.+..    ++.++||||+||++|||++|+.||......+.......+..      
T Consensus       217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~------  290 (410)
T 3v8s_A          217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN------  290 (410)
T ss_dssp             ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH------
T ss_pred             eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc------
Confidence            87655444445678999999999987655    78999999999999999999999975322211111100000      


Q ss_pred             chhcccccccccccCchhhHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 039290          986 TEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEK--RISMKDVANR 1035 (1049)
Q Consensus       986 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~ell~~ 1035 (1049)
                                  ...++.....+.++.+++.+|++.+|.+  ||+++|+++|
T Consensus       291 ------------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          291 ------------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             ------------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             ------------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence                        0001111234567899999999999999  9999999987

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=9.3e-40  Score=358.19  Aligned_cols=260  Identities=23%  Similarity=0.384  Sum_probs=201.8

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCC----CcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPD----GMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      .++|++.+.||+|+||.||+|+...    +..||+|+++.... ...+.+.+|+.++++++||||+++++++. ++..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4578899999999999999999643    45699999865432 23567899999999999999999999985 456799


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      ||||+++++|.+++......+++.+++.++.|+++||+|||   +.||+||||||+||+++.++.+||+|||++......
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  169 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence            99999999999999877767999999999999999999999   999999999999999999999999999999876544


Q ss_pred             ccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          915 ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       915 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                      .........+++.|+|||++.+..++.++||||+||++|||++ |..||......+..  ..+...              
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~--~~i~~~--------------  233 (281)
T 1mp8_A          170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI--GRIENG--------------  233 (281)
T ss_dssp             ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH--HHHHTT--------------
T ss_pred             cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH--HHHHcC--------------
Confidence            3333334456789999999988899999999999999999997 99999764332211  111000              


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                           .+...+..++..+.+++.+||+.||++|||++|++++|+++.++..
T Consensus       234 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  279 (281)
T 1mp8_A          234 -----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK  279 (281)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence                 0011123456788999999999999999999999999999987643

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-39  Score=361.76  Aligned_cols=251  Identities=22%  Similarity=0.281  Sum_probs=207.6

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCC------CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDG------SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKA  833 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~  833 (1049)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++.....      ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45889999999999999999965 6899999999765321      3578999999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC----ceEEecccCce
Q 039290          834 LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM----VGHLSDFGIAK  909 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~----~~kl~DfGla~  909 (1049)
                      +||||+++++|.+++.... .+++.+++.++.|++.||+|||   +.||+||||||+||+++.++    .+||+|||++.
T Consensus        91 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            9999999999999987654 5899999999999999999999   99999999999999998877    89999999998


Q ss_pred             ecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhc
Q 039290          910 ILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA  989 (1049)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  989 (1049)
                      .......  .....||+.|+|||++.+..++.++||||+||++|||++|..||......+.. ......           
T Consensus       167 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~-----------  232 (326)
T 2y0a_A          167 KIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAV-----------  232 (326)
T ss_dssp             ECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-HHHHHT-----------
T ss_pred             ECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH-HHHHhc-----------
Confidence            7753332  23457899999999999889999999999999999999999999753222111 110000           


Q ss_pred             ccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          990 DANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                            ...........++..+.+++.+||+.||++|||++|+++|
T Consensus       233 ------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          233 ------NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             ------CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ------CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                  0000111123356778999999999999999999999986

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=8.2e-40  Score=372.39  Aligned_cols=269  Identities=23%  Similarity=0.373  Sum_probs=216.8

Q ss_pred             cHHHHHHHhcCCCCCceecCCCcEEEEEEEe------CCCcEEEEEEeecccC-CCHHHHHHHHHHHhhc-CCCceeeEE
Q 039290          752 SYQDLLRATDGFSENKLLGMGSFGSVYKGVL------PDGMEIAAKVFHMEFD-GSLESFHAECKVMGSI-RHRNLVKII  823 (1049)
Q Consensus       752 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~a~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~l~  823 (1049)
                      ...++....++|++.+.||+|+||.||+|++      .+++.||||+++.... ...+.+.+|++++.++ +||||++++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            3445555678899999999999999999973      3567899999975432 2346789999999999 799999999


Q ss_pred             eeeecCC-eeEEEEeccCCCChhhhhhcCCC-------------------------------------------------
Q 039290          824 SSCSNND-FKALVLEYMSNGSLEKCLYSDNY-------------------------------------------------  853 (1049)
Q Consensus       824 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------  853 (1049)
                      +++.+.+ ..++||||+++|+|.+++.....                                                 
T Consensus        93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (359)
T 3vhe_A           93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS  172 (359)
T ss_dssp             EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred             eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence            9988755 48999999999999999876432                                                 


Q ss_pred             ----------------ccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc-
Q 039290          854 ----------------FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES-  916 (1049)
Q Consensus       854 ----------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~-  916 (1049)
                                      .+++..++.++.|+++||+|||   ++||+||||||+||+++.++.+||+|||+++....... 
T Consensus       173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  249 (359)
T 3vhe_A          173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY  249 (359)
T ss_dssp             -----------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred             cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence                            2889999999999999999999   99999999999999999999999999999986643322 


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                      .......+|+.|+|||++.+..++.++||||+||++|||++ |..||......+..........                
T Consensus       250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~----------------  313 (359)
T 3vhe_A          250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT----------------  313 (359)
T ss_dssp             EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC----------------
T ss_pred             hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC----------------
Confidence            23344568889999999988899999999999999999998 9999976433322222111100                


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhh
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~ 1043 (1049)
                          ....+..++.++.+++.+||+.||++|||++|++++|+++.++.
T Consensus       314 ----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          314 ----RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence                01111234567899999999999999999999999999998764

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.9e-39  Score=356.38  Aligned_cols=264  Identities=23%  Similarity=0.391  Sum_probs=205.8

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhh--cCCCceeeEEeeeec----CCeeE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGS--IRHRNLVKIISSCSN----NDFKA  833 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~hpniv~l~~~~~~----~~~~~  833 (1049)
                      .++|++.+.||+|+||+||+|+. +++.||||++...   ....+.+|.+++..  ++||||+++++++.+    .+..+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            45799999999999999999998 7899999998654   34566677777776  789999999998644    35689


Q ss_pred             EEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHcc-----CCCCeEEcCCCCCCeeecCCCceEEecccCc
Q 039290          834 LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG-----YSTPIVHCDIKPSNVLLNESMVGHLSDFGIA  908 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla  908 (1049)
                      +||||+++|+|.+++...  .+++..+++++.|+++|++|||..     ++++|+||||||+||+++.++.+||+|||++
T Consensus        83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             EEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            999999999999999643  589999999999999999999932     2679999999999999999999999999999


Q ss_pred             eecCCCccc---cccccccccCcccccccCCC------CcCcccchHHHHHHHHHHHhC----------CCCCCcccccc
Q 039290          909 KILGKEESM---RQTKTLGTIGYMAPEYGREG------KVSRKCDVYSYGIMLMETFTK----------KKPTDEIFAGE  969 (1049)
Q Consensus       909 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg----------~~p~~~~~~~~  969 (1049)
                      +........   ......||+.|+|||++.+.      .++.++||||+||++|||++|          ..||.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            866433321   12334789999999998776      556799999999999999999          77776644443


Q ss_pred             chHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290          970 MSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                      ..................          .........++.++.+++.+||+.||++|||++|+++.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          241 PSFEDMRKVVCVDQQRPN----------IPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCHHHHHHHHTTSCCCCC----------CCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhhhhHHHhccCCCCC----------CChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            333222211111100000          000112235678899999999999999999999999999876

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6.2e-39  Score=355.03  Aligned_cols=266  Identities=16%  Similarity=0.169  Sum_probs=217.3

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEEEe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++....  ..+.+.+|+++++.+ +|++++++++++.+.+..++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            35799999999999999999995 578999999986543  335688999999999 79999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCc-----eEEecccCceecC
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMV-----GHLSDFGIAKILG  912 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~-----~kl~DfGla~~~~  912 (1049)
                      |+ +++|.+++...+..+++.+++.++.|+++|++|||   ++||+||||||+||+++.++.     +||+|||+++...
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            99 99999999887767999999999999999999999   999999999999999987765     9999999998765


Q ss_pred             CCccc------cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchH-HHhhhhccccCCc
Q 039290          913 KEESM------RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSL-KRWVGDSLLSCSI  985 (1049)
Q Consensus       913 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~  985 (1049)
                      .....      ......||+.|+|||++.+..++.++||||+||++|||++|+.||.......... ...........  
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--  240 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST--  240 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS--
T ss_pred             cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc--
Confidence            43221      2234568999999999999899999999999999999999999998643222111 11000000000  


Q ss_pred             chhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhc
Q 039290          986 TEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAY 1046 (1049)
Q Consensus       986 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~ 1046 (1049)
                                   ........+++++.+++.+||+.||++||+++++++.|+++.+++...
T Consensus       241 -------------~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~  288 (298)
T 1csn_A          241 -------------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT  288 (298)
T ss_dssp             -------------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             -------------cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence                         000111235678999999999999999999999999999999887654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.2e-39  Score=364.64  Aligned_cols=248  Identities=22%  Similarity=0.341  Sum_probs=205.9

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      .++|.+.+.||+|+||+||+|+. .+++.||+|++....   ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            46799999999999999999996 578999999986542   33456889999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+ +|+|.+++...+ .+++.+++.++.|++.|++|||   +.||+||||||+||+++.++.+||+|||++.......
T Consensus        88 ~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            9999 678988887654 4899999999999999999999   9999999999999999999999999999998764433


Q ss_pred             cccccccccccCcccccccCCCCc-CcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKV-SRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                        ......||+.|+|||++.+..+ ++++||||+||++|+|++|+.||......+...                  .   
T Consensus       163 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~------------------~---  219 (336)
T 3h4j_B          163 --FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK------------------K---  219 (336)
T ss_dssp             --TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC------------------C---
T ss_pred             --ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH------------------H---
Confidence              2334578999999999988776 689999999999999999999997532221100                  0   


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                       ........+...+.++.+++.+||+.||.+|||++|++++-
T Consensus       220 -i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  260 (336)
T 3h4j_B          220 -VNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP  260 (336)
T ss_dssp             -CCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred             -HHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence             00011112223456789999999999999999999999873

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.5e-39  Score=360.68  Aligned_cols=272  Identities=22%  Similarity=0.383  Sum_probs=211.3

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-----CCCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecC--Cee
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-----PDGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNN--DFK  832 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~  832 (1049)
                      .+|+..+.||+|+||.||+|++     .+++.||+|+++... ....+.+.+|++++++++||||+++++++.+.  +..
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            3588889999999999999983     468899999997543 34567899999999999999999999999876  668


Q ss_pred             EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecC
Q 039290          833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      ++||||+++|+|.+++......+++.+++.++.|++.|++|||   ++||+||||||+||+++.++.+||+|||++....
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence            9999999999999999776667999999999999999999999   9999999999999999999999999999998775


Q ss_pred             CCcc--ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcc
Q 039290          913 KEES--MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD  990 (1049)
Q Consensus       913 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  990 (1049)
                      ....  .......+|..|+|||++.+..++.++||||+|+++|||++|..|+......   ...................
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL---FLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---HHHHHCSCCGGGHHHHHHH
T ss_pred             CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH---HhhccCCcccccCHHHHHH
Confidence            4432  2223456788899999998889999999999999999999999986532111   0000000000000000000


Q ss_pred             cccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 039290          991 ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041 (1049)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~ 1041 (1049)
                       .+  ....+...+..++.++.+++.+||+.||++|||++|+++.|+++.+
T Consensus       255 -~~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~  302 (302)
T 4e5w_A          255 -TL--KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK  302 (302)
T ss_dssp             -HH--HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             -HH--hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence             00  0011122233466789999999999999999999999999998763

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.8e-39  Score=362.06  Aligned_cols=263  Identities=20%  Similarity=0.210  Sum_probs=214.3

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEEEec
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      ++|++.+.||+|+||+||+|+. .+++.||||++....  ..+.+.+|+++++++ +||||+++++++.+.+..++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~   86 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL   86 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence            5789999999999999999995 578999999987543  235688999999999 899999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCc-----eEEecccCceecCC
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMV-----GHLSDFGIAKILGK  913 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~-----~kl~DfGla~~~~~  913 (1049)
                      + +++|.+++...+..+++.+++.++.|+++||+|||   +.||+||||||+||+++.++.     +||+|||+++.+..
T Consensus        87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~  162 (330)
T 2izr_A           87 L-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID  162 (330)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred             C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence            9 89999999876667999999999999999999999   999999999999999998876     99999999987643


Q ss_pred             Cccc------cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchH-HHhhhhccccCCcc
Q 039290          914 EESM------RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSL-KRWVGDSLLSCSIT  986 (1049)
Q Consensus       914 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~  986 (1049)
                      ....      ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+... ...+.......   
T Consensus       163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~---  239 (330)
T 2izr_A          163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT---  239 (330)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS---
T ss_pred             CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC---
Confidence            3221      1234678999999999999999999999999999999999999998643222211 11100000000   


Q ss_pred             hhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhh
Q 039290          987 EVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSA 1045 (1049)
Q Consensus       987 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~ 1045 (1049)
                                +  .......++ ++.+++.+||+.||.+||+++++++.|+++.++...
T Consensus       240 ----------~--~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~  285 (330)
T 2izr_A          240 ----------P--IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY  285 (330)
T ss_dssp             ----------C--HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             ----------C--HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence                      0  000001234 899999999999999999999999999999887654

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.1e-39  Score=360.81  Aligned_cols=267  Identities=25%  Similarity=0.391  Sum_probs=206.8

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhc--CCCceeeEEeeeecC----Cee
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI--RHRNLVKIISSCSNN----DFK  832 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~hpniv~l~~~~~~~----~~~  832 (1049)
                      ..++|++.+.||+|+||.||+|+.. ++.||||++...   ....+.+|.+++...  +||||+++++++.+.    +..
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  110 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL  110 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence            3568999999999999999999984 899999998643   234556666666654  899999999999876    788


Q ss_pred             EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCC--------CeEEcCCCCCCeeecCCCceEEec
Q 039290          833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST--------PIVHCDIKPSNVLLNESMVGHLSD  904 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~--------~ivH~Dlkp~NIl~~~~~~~kl~D  904 (1049)
                      ++||||+++|+|.+++...  .+++.+++.++.|++.||+|||   +.        ||+||||||+||+++.++.+||+|
T Consensus       111 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D  185 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD  185 (337)
T ss_dssp             EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             EEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence            9999999999999999765  4899999999999999999999   77        999999999999999999999999


Q ss_pred             ccCceecCCCccc---cccccccccCcccccccCCCCcCcc------cchHHHHHHHHHHHhC----------CCCCCcc
Q 039290          905 FGIAKILGKEESM---RQTKTLGTIGYMAPEYGREGKVSRK------CDVYSYGIMLMETFTK----------KKPTDEI  965 (1049)
Q Consensus       905 fGla~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~------~DvwslG~il~elltg----------~~p~~~~  965 (1049)
                      ||++.........   ......||+.|+|||++.+...+.+      +||||+||++|||++|          ..||...
T Consensus       186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL  265 (337)
T ss_dssp             CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence            9999876543321   1224578999999999987666554      9999999999999999          5555543


Q ss_pred             ccccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          966 FAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       966 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                      .........+.......         ....... .......++.++.+++.+||+.||++|||++|++++|+++.++..
T Consensus       266 ~~~~~~~~~~~~~~~~~---------~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  334 (337)
T 3mdy_A          266 VPSDPSYEDMREIVCIK---------KLRPSFP-NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD  334 (337)
T ss_dssp             SCSSCCHHHHHHHHTTS---------CCCCCCC-GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred             cCCCCchhhhHHHHhhh---------ccCcccc-ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence            33332222221111000         0000001 111224678899999999999999999999999999999988654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.7e-39  Score=357.52  Aligned_cols=270  Identities=22%  Similarity=0.271  Sum_probs=205.4

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      ++|++.+.||+|+||+||+|+..+++.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            5788999999999999999999889999999996543  23357788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      +++ +|.+++......+++.+++.++.|+++||+|||   ++||+||||||+||+++.++.+||+|||++........ .
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  156 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K  156 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-c
Confidence            976 999998877667999999999999999999999   99999999999999999999999999999986643221 2


Q ss_pred             ccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhc-cccCCcchh-----ccc
Q 039290          919 QTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDS-LLSCSITEV-----ADA  991 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~  991 (1049)
                      .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+.....+.... .....+...     .++
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T 1ob3_A          157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (288)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence            234568999999999865 4589999999999999999999999976433222111111000 000000000     000


Q ss_pred             cccccccc-CchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          992 NLLNCEEN-DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       992 ~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ........ ........+.++.+++.+||+.||++|||++|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            00000000 001112346778999999999999999999999875

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-39  Score=370.10  Aligned_cols=253  Identities=23%  Similarity=0.301  Sum_probs=209.8

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      .++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            457999999999999999999964 7889999999765444456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC--CCceEEecccCceecCCCcc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE--SMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~--~~~~kl~DfGla~~~~~~~~  916 (1049)
                      +++|+|.+++......+++.+++.++.||+.||+|||   +.||+||||||+||+++.  .+.+||+|||+++.......
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence            9999999999877667999999999999999999999   999999999999999974  57899999999997754332


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                        .....||+.|+|||++.+..++.++||||+||++|||++|..||......+. .........                
T Consensus       207 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-~~~i~~~~~----------------  267 (387)
T 1kob_A          207 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-LQNVKRCDW----------------  267 (387)
T ss_dssp             --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHHCCC----------------
T ss_pred             --eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCC----------------
Confidence              2335689999999999998999999999999999999999999976322111 111100000                


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                       .........++.++.+++.+||+.||++|||++|++++
T Consensus       268 -~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          268 -EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             -CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence             00001112345678999999999999999999999986

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=9.2e-40  Score=377.55  Aligned_cols=263  Identities=19%  Similarity=0.241  Sum_probs=214.0

Q ss_pred             HHHHHHHhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeec
Q 039290          753 YQDLLRATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSN  828 (1049)
Q Consensus       753 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~  828 (1049)
                      +.++....++|++.++||+|+||+||+|+.. +++.||+|+++...   ....+.+.+|+.++..++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            3445555788999999999999999999965 57889999997532   2334558899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCc
Q 039290          829 NDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA  908 (1049)
Q Consensus       829 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla  908 (1049)
                      .+..++||||+++|+|.+++......+++..++.++.|++.||+|||   +.||+||||||+|||++.++.+||+|||+|
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla  222 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSC  222 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence            99999999999999999999876667999999999999999999999   999999999999999999999999999999


Q ss_pred             eecCCCccccccccccccCcccccccC-----CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccC
Q 039290          909 KILGKEESMRQTKTLGTIGYMAPEYGR-----EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSC  983 (1049)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  983 (1049)
                      +.............+||+.|+|||++.     ...++.++||||+||++|||++|+.||......+...........   
T Consensus       223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---  299 (437)
T 4aw2_A          223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER---  299 (437)
T ss_dssp             EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH---
T ss_pred             hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc---
Confidence            877655444445568999999999986     567899999999999999999999999763322221111000000   


Q ss_pred             CcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 039290          984 SITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEK--RISMKDVANR 1035 (1049)
Q Consensus       984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~ell~~ 1035 (1049)
                                ...+    ......++++.+++.+|+..+|++  ||+++|+++|
T Consensus       300 ----------~~~p----~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          300 ----------FQFP----TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             ----------CCCC----SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             ----------ccCC----cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence                      0000    000124567899999999999988  9999999886

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.6e-39  Score=354.80  Aligned_cols=270  Identities=21%  Similarity=0.243  Sum_probs=206.6

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      ++|++.+.||+|+||+||+|+.. +++.||+|+++....  ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57889999999999999999964 689999999976543  234778899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      |+++ ++.+.+......+++.+++.++.|++.|++|||   ++||+||||||+||+++.++.+||+|||++........ 
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  156 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-
Confidence            9976 666666665667999999999999999999999   99999999999999999999999999999987653322 


Q ss_pred             cccccccccCcccccccCCCC-cCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccc--cCCcchhcc---c
Q 039290          918 RQTKTLGTIGYMAPEYGREGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLL--SCSITEVAD---A  991 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~---~  991 (1049)
                      ......+|+.|+|||++.+.. ++.++||||+||++|||++|..||...................  ...+.....   .
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (292)
T 3o0g_A          157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence            233457899999999987765 7999999999999999999888864322222222221111100  000000000   0


Q ss_pred             ---ccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          992 ---NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       992 ---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                         ................+.++.+++.+|++.||++|||++|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence               00000001111223456778999999999999999999999876

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.7e-39  Score=367.42  Aligned_cols=252  Identities=21%  Similarity=0.307  Sum_probs=205.9

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc-----CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF-----DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      ++|++.+.||+|+||+||+|+. .+++.||+|++....     ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            4689999999999999999996 478999999986432     2246789999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcC---CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCc---eEEecccCc
Q 039290          835 VLEYMSNGSLEKCLYSD---NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMV---GHLSDFGIA  908 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~---~kl~DfGla  908 (1049)
                      ||||+++++|.+.+...   ...+++..++.++.||++||+|||   +++|+||||||+||+++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            99999999998877543   335899999999999999999999   999999999999999986554   999999999


Q ss_pred             eecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchh
Q 039290          909 KILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEV  988 (1049)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  988 (1049)
                      ........ ......||+.|+|||++.+..++.++||||+||++|||++|..||.....  .........          
T Consensus       181 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~i~~~----------  247 (351)
T 3c0i_A          181 IQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIKG----------  247 (351)
T ss_dssp             EECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHHHHHHT----------
T ss_pred             eEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHHHHHcC----------
Confidence            87754332 23345789999999999988999999999999999999999999976311  111111100          


Q ss_pred             cccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          989 ADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                             ............+.++.+++.+||+.||++|||+.|+++|
T Consensus       248 -------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          248 -------KYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             -------CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -------CCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                   0000111122356789999999999999999999999976

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=376.90  Aligned_cols=347  Identities=22%  Similarity=0.252  Sum_probs=234.8

Q ss_pred             ceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCcccccccccccceeeccc
Q 039290          298 KELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAG  377 (1049)
Q Consensus       298 ~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  377 (1049)
                      +.++.+++++. .+|..+.   ++++.|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++
T Consensus        14 ~~v~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~   89 (477)
T 2id5_A           14 RAVLCHRKRFV-AVPEGIP---TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS   89 (477)
T ss_dssp             TEEECCSCCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcC-cCCCCCC---CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCC
Confidence            46777777776 6777654   5788999999999887788899999999999999999988888899999999999999


Q ss_pred             ccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCc
Q 039290          378 NVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNE  457 (1049)
Q Consensus       378 N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~  457 (1049)
                      |.++.++..     .|.++++|++|+|++|++.+..+                         ..|.++++|+.|+|++|.
T Consensus        90 n~l~~~~~~-----~~~~l~~L~~L~Ls~n~i~~~~~-------------------------~~~~~l~~L~~L~l~~n~  139 (477)
T 2id5_A           90 NRLKLIPLG-----VFTGLSNLTKLDISENKIVILLD-------------------------YMFQDLYNLKSLEVGDND  139 (477)
T ss_dssp             SCCCSCCTT-----SSTTCTTCCEEECTTSCCCEECT-------------------------TTTTTCTTCCEEEECCTT
T ss_pred             CcCCccCcc-----cccCCCCCCEEECCCCccccCCh-------------------------hHccccccCCEEECCCCc
Confidence            888877654     25667777777777777665444                         445555555566666665


Q ss_pred             ccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccccCcc
Q 039290          458 LTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPST  537 (1049)
Q Consensus       458 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  537 (1049)
                      +++..|..|.++++|++|+|++|++++..+..+..+++|+.|++++|.+.+..+..|..+++|+.|++++|.+.+.+|..
T Consensus       140 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~  219 (477)
T 2id5_A          140 LVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPN  219 (477)
T ss_dssp             CCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTT
T ss_pred             cceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcc
Confidence            55555555556666666666666665444445555666666666666665555555666666666666666555555555


Q ss_pred             cccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCc
Q 039290          538 LWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLN  617 (1049)
Q Consensus       538 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  617 (1049)
                      .....+|+.|++++|+++...+..+..+++|++|+|++|.+++..+..|.++++|+.|+|++|++++..|..|.++++|+
T Consensus       220 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  299 (477)
T 2id5_A          220 CLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLR  299 (477)
T ss_dssp             TTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCC
T ss_pred             cccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCC
Confidence            55555666666666666654445566666777777777777766666677777777777777777776677777777777


Q ss_pred             EEeccCccccCCcccccccccccceeeccCCcccccCCCCCCccccccccccCCccccCCC
Q 039290          618 FVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSP  678 (1049)
Q Consensus       618 ~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~cg~~  678 (1049)
                      +|+|++|++++..+..|..+++|+.|++++|+|.|.++..+.+.......+.++...|+.|
T Consensus       300 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p  360 (477)
T 2id5_A          300 VLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATP  360 (477)
T ss_dssp             EEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEES
T ss_pred             EEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCc
Confidence            7777777777655566677777777777777777766542222222223455566666555

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.2e-39  Score=363.20  Aligned_cols=261  Identities=25%  Similarity=0.410  Sum_probs=207.1

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcE----EEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGME----IAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      ++|+..+.||+|+||+||+|++. +++.    ||+|.++... ....+++.+|+.++++++||||+++++++.+.+ .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            46888999999999999999954 4443    5788775433 345678999999999999999999999998765 689


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      |+||+.+|+|.+++......+++..++.++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+++.....
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  170 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence            99999999999999887778999999999999999999999   999999999999999999999999999999876543


Q ss_pred             ccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccc
Q 039290          915 ESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       915 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      ... ......+|+.|+|||++.+..++.++||||+||++|||++ |+.||......+..  ......             
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~~~~~-------------  235 (327)
T 3poz_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--SILEKG-------------  235 (327)
T ss_dssp             CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH--HHHHTT-------------
T ss_pred             cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH--HHHHcC-------------
Confidence            322 2223456789999999999999999999999999999999 99999764333221  111100             


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhc
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAY 1046 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~ 1046 (1049)
                            .+...+..++.++.+++.+||+.||++|||+.|++++|+++.+....+
T Consensus       236 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~  283 (327)
T 3poz_A          236 ------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY  283 (327)
T ss_dssp             ------CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSHHHH
T ss_pred             ------CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhhhhh
Confidence                  001112235567899999999999999999999999999988755444

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.9e-39  Score=369.95  Aligned_cols=258  Identities=21%  Similarity=0.256  Sum_probs=204.1

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~l  834 (1049)
                      .++|++.++||+|+||+||+|+.. +++.||+|+++...   ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            457899999999999999999965 67889999997653   22345688899999887 89999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      ||||+++|+|.+++...+ .+++..++.++.||+.||+|||   ++||+||||||+||+++.++.+||+|||+++.....
T Consensus       131 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            999999999999987654 4899999999999999999999   999999999999999999999999999999863322


Q ss_pred             ccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          915 ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       915 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                      . ......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+......         ...+....  
T Consensus       207 ~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~---------~~~~~~~i--  274 (396)
T 4dc2_A          207 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT---------EDYLFQVI--  274 (396)
T ss_dssp             T-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CC---------HHHHHHHH--
T ss_pred             C-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhh---------HHHHHHHH--
Confidence            2 22345679999999999999999999999999999999999999996532221110000         00000000  


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCH------HHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISM------KDVANR 1035 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~------~ell~~ 1035 (1049)
                        .......+...+.++.+++.+||+.||++||++      +|+++|
T Consensus       275 --~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          275 --LEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             --HHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             --hccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence              001111223356778999999999999999995      577665

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=368.01  Aligned_cols=249  Identities=22%  Similarity=0.291  Sum_probs=202.8

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~l  834 (1049)
                      .++|++.+.||+|+||+||+|+.. +++.||+|+++...   ....+.+.+|.++++.+ +||||+++++++.+.+..|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            468999999999999999999964 68999999997542   34557788999999988 69999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      ||||+++|+|.+++...+ .+++.+++.++.||+.||+|||   ++||+||||||+||+++.++.+||+|||+++.....
T Consensus       102 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence            999999999999987654 4899999999999999999999   999999999999999999999999999999854322


Q ss_pred             ccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          915 ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       915 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                      . .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+..... ..                 
T Consensus       178 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i-~~-----------------  238 (353)
T 3txo_A          178 G-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI-LN-----------------  238 (353)
T ss_dssp             ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HH-----------------
T ss_pred             C-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH-Hc-----------------
Confidence            2 2334467999999999998888999999999999999999999999763322211111 00                 


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCH------HHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISM------KDVANR 1035 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~------~ell~~ 1035 (1049)
                          .....+...+.++.+++.+|++.||++||++      +|+++|
T Consensus       239 ----~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          239 ----DEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             ----CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence                0011112245678999999999999999998      778765

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.8e-39  Score=375.04  Aligned_cols=253  Identities=20%  Similarity=0.295  Sum_probs=205.8

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      .++|++.+.||+|+||+||+|.. .+|+.||+|++.....  ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            45799999999999999999985 4789999999975432  23467889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec---CCCceEEecccCceecCC
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~---~~~~~kl~DfGla~~~~~  913 (1049)
                      ||+++|+|.+.+.... .+++.++..++.||++|++|||   ++||+||||||+||+++   .++.+||+|||++.....
T Consensus        90 E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~  165 (444)
T 3soa_A           90 DLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG  165 (444)
T ss_dssp             CCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred             EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence            9999999999987765 4899999999999999999999   99999999999999998   467899999999987654


Q ss_pred             CccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          914 EESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       914 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                      ... ......||+.|+|||++.+..++.++||||+||++|+|++|..||......+.. ........             
T Consensus       166 ~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~-~~i~~~~~-------------  230 (444)
T 3soa_A          166 EQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY-QQIKAGAY-------------  230 (444)
T ss_dssp             TCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHTCC-------------
T ss_pred             CCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHH-HHHHhCCC-------------
Confidence            332 223467999999999999889999999999999999999999999753222111 11110000             


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                          ....+....+++++.+++.+|++.||++|||++|+++|
T Consensus       231 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          231 ----DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             ----CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ----CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                00001112345678999999999999999999999986

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-39  Score=368.36  Aligned_cols=266  Identities=26%  Similarity=0.423  Sum_probs=213.4

Q ss_pred             HHhcCCCCCceecCCCcEEEEEEEeC------CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCC
Q 039290          758 RATDGFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNND  830 (1049)
Q Consensus       758 ~~~~~~~~~~~lg~G~fg~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~  830 (1049)
                      ...++|++.+.||+|+||.||+|+..      +++.||+|+++.... ...+.+.+|++++++++||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            34578999999999999999999964      347899999975432 23567899999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhhcCC-----------------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCC
Q 039290          831 FKALVLEYMSNGSLEKCLYSDN-----------------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDI  887 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl  887 (1049)
                      ..++||||+++|+|.+++....                       ..+++.+++.++.|+++||+|||   ++||+||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dl  200 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDL  200 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence            9999999999999999987642                       46899999999999999999999   999999999


Q ss_pred             CCCCeeecCCCceEEecccCceecCCCcc-ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCcc
Q 039290          888 KPSNVLLNESMVGHLSDFGIAKILGKEES-MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEI  965 (1049)
Q Consensus       888 kp~NIl~~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~  965 (1049)
                      ||+||+++.++.+||+|||++........ .......+++.|+|||++.+..++.++||||+||++|||++ |..||...
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            99999999999999999999986643322 12234567889999999988899999999999999999999 99999763


Q ss_pred             ccccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhh
Q 039290          966 FAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSA 1045 (1049)
Q Consensus       966 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~ 1045 (1049)
                      ...+..  ..+.            +...       ...+..++.++.+++.+||+.||++|||++|++++|+++.++...
T Consensus       281 ~~~~~~--~~~~------------~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~  339 (343)
T 1luf_A          281 AHEEVI--YYVR------------DGNI-------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEG  339 (343)
T ss_dssp             CHHHHH--HHHH------------TTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC----
T ss_pred             ChHHHH--HHHh------------CCCc-------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhh
Confidence            322211  1110            0000       011123566799999999999999999999999999999887654


Q ss_pred             cc
Q 039290         1046 YI 1047 (1049)
Q Consensus      1046 ~~ 1047 (1049)
                      -+
T Consensus       340 ~~  341 (343)
T 1luf_A          340 TV  341 (343)
T ss_dssp             --
T ss_pred             hc
Confidence            43

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-39  Score=369.81  Aligned_cols=261  Identities=25%  Similarity=0.427  Sum_probs=213.8

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe--------CCCcEEEEEEeecccC-CCHHHHHHHHHHHhhc-CCCceeeEEeeeecC
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL--------PDGMEIAAKVFHMEFD-GSLESFHAECKVMGSI-RHRNLVKIISSCSNN  829 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~--------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~  829 (1049)
                      .++|.+.+.||+|+||+||+|+.        .++..||+|+++.... ...+++.+|+++++++ +||||+++++++.+.
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            35788999999999999999985        2345799999975532 2346788999999999 899999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhhcCC---------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeee
Q 039290          830 DFKALVLEYMSNGSLEKCLYSDN---------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL  894 (1049)
Q Consensus       830 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~  894 (1049)
                      +..++||||+++|+|.+++....               ..+++.+++.++.|+++||+|||   +.||+||||||+||++
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence            99999999999999999997654               35899999999999999999999   9999999999999999


Q ss_pred             cCCCceEEecccCceecCCCcc-ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchH
Q 039290          895 NESMVGHLSDFGIAKILGKEES-MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSL  972 (1049)
Q Consensus       895 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~  972 (1049)
                      +.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||+||++|||++ |..||......+.  
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~--  302 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL--  302 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH--
Confidence            9999999999999987654332 22233456889999999999999999999999999999999 9999875332211  


Q ss_pred             HHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          973 KRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                      ...+....                   +...+..++.++.+++.+||+.||++|||++|++++|+++.....
T Consensus       303 ~~~~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          303 FKLLKEGH-------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             HHHHHTTC-------------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             HHHHHcCC-------------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            11111000                   011112355679999999999999999999999999999987543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.1e-38  Score=350.89  Aligned_cols=252  Identities=25%  Similarity=0.421  Sum_probs=207.1

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCC-------HHHHHHHHHHHhhcCCCceeeEEeeeecCCee
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGS-------LESFHAECKVMGSIRHRNLVKIISSCSNNDFK  832 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~  832 (1049)
                      ++|++.+.||+|+||+||+|+. .+++.||+|++.......       .+.+.+|++++++++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            5788899999999999999996 478999999986544222       267899999999999999999999997665  


Q ss_pred             EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCC--eEEcCCCCCCeeecCCCc-----eEEecc
Q 039290          833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP--IVHCDIKPSNVLLNESMV-----GHLSDF  905 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIl~~~~~~-----~kl~Df  905 (1049)
                      ++||||+++|+|.+++......+++..++.++.|++.|++|||   +.+  |+||||||+||+++.++.     +||+||
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            6999999999999999887778999999999999999999999   889  999999999999987776     999999


Q ss_pred             cCceecCCCccccccccccccCccccccc--CCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccC
Q 039290          906 GIAKILGKEESMRQTKTLGTIGYMAPEYG--REGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSC  983 (1049)
Q Consensus       906 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  983 (1049)
                      |+++....    ......+|+.|+|||++  ....++.++||||+||++|||++|+.||......+...........   
T Consensus       174 g~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~---  246 (287)
T 4f0f_A          174 GLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG---  246 (287)
T ss_dssp             TTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC---
T ss_pred             Cccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC---
Confidence            99985433    22345689999999998  4456789999999999999999999999765444332222211110   


Q ss_pred             CcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290          984 SITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus       984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                                     .+...+..++.++.+++.+||+.||++|||++|+++.|+++
T Consensus       247 ---------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          247 ---------------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             ---------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ---------------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                           01111234567899999999999999999999999999853

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.7e-39  Score=380.59  Aligned_cols=257  Identities=26%  Similarity=0.436  Sum_probs=213.3

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      .++|++.+.||+|+||+||+|++.++..||||+++... ...+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~  264 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM  264 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence            45688889999999999999999889999999997543 45788999999999999999999999987 56789999999


Q ss_pred             CCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          840 SNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       840 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      ++|+|.+++.... ..+++.++..++.||++||+|||   +++|+||||||+||+++.++.+||+|||+++.........
T Consensus       265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~  341 (454)
T 1qcf_A          265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA  341 (454)
T ss_dssp             TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec
Confidence            9999999997543 35788999999999999999999   9999999999999999999999999999998764433222


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE  997 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1049)
                      .....++..|+|||++....++.++|||||||++|||++ |+.||......+..  ..+...                  
T Consensus       342 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~--~~i~~~------------------  401 (454)
T 1qcf_A          342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI--RALERG------------------  401 (454)
T ss_dssp             TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH--HHHHHT------------------
T ss_pred             cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH--HHHHcC------------------
Confidence            233446788999999988899999999999999999999 99999764322211  111000                  


Q ss_pred             ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHh
Q 039290          998 ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042 (1049)
Q Consensus       998 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~ 1042 (1049)
                       .+.+.+..++.++.++|.+||+.||++|||++++++.|+++..+
T Consensus       402 -~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          402 -YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             -CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence             01112234677899999999999999999999999999987654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=373.35  Aligned_cols=262  Identities=23%  Similarity=0.279  Sum_probs=211.8

Q ss_pred             HHHHHHHhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeec
Q 039290          753 YQDLLRATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSN  828 (1049)
Q Consensus       753 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~  828 (1049)
                      +.+.....++|++.+.||+|+||+||+|+.. +++.||+|+++...   ....+.+.+|.+++..++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            3444455688999999999999999999964 79999999997532   2234568899999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCc
Q 039290          829 NDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA  908 (1049)
Q Consensus       829 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla  908 (1049)
                      .+..|+||||+++|+|.+++...+..+++..++.++.||+.||+|||   +.||+||||||+||+++.++.+||+|||++
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla  209 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSC  209 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhh
Confidence            99999999999999999999876667999999999999999999999   999999999999999999999999999999


Q ss_pred             eecCCCccccccccccccCcccccccC-------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccc
Q 039290          909 KILGKEESMRQTKTLGTIGYMAPEYGR-------EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLL  981 (1049)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  981 (1049)
                      +.............+||+.|+|||++.       ...++.++||||+||++|||++|+.||......+... ....... 
T Consensus       210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~-~i~~~~~-  287 (412)
T 2vd5_A          210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG-KIVHYKE-  287 (412)
T ss_dssp             EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-HHHTHHH-
T ss_pred             eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHH-HHHhccc-
Confidence            887654443444568999999999986       4578999999999999999999999997633222111 1110000 


Q ss_pred             cCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCC---CCHHHHHHH
Q 039290          982 SCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKR---ISMKDVANR 1035 (1049)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---pt~~ell~~ 1035 (1049)
                               .  .    ........++.++.+++.+|+. +|++|   |+++|+++|
T Consensus       288 ---------~--~----~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          288 ---------H--L----SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             ---------H--C----CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             ---------C--c----CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence                     0  0    0001112356789999999999 99998   599999876

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-39  Score=367.06  Aligned_cols=262  Identities=25%  Similarity=0.367  Sum_probs=211.0

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEe------CCCcEEEEEEeeccc-CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCC
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVL------PDGMEIAAKVFHMEF-DGSLESFHAECKVMGSI-RHRNLVKIISSCSNND  830 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~  830 (1049)
                      ..++|++.+.||+|+||.||+|+.      .++..||+|+++... ....+.+.+|+++++++ +||||+++++++.+.+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            456899999999999999999995      245689999997543 33457899999999999 8999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhhcCCC----------------------ccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCC
Q 039290          831 FKALVLEYMSNGSLEKCLYSDNY----------------------FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIK  888 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk  888 (1049)
                      ..++||||+++|+|.+++.....                      .+++.+++.++.|+++||+|||   ++||+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence            99999999999999999976543                      3789999999999999999999   9999999999


Q ss_pred             CCCeeecCCCceEEecccCceecCCCccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccc
Q 039290          889 PSNVLLNESMVGHLSDFGIAKILGKEESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIF  966 (1049)
Q Consensus       889 p~NIl~~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~  966 (1049)
                      |+||+++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||+||++|||++ |..||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            99999999999999999999866433321 2234557889999999988899999999999999999998 999997643


Q ss_pred             cccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhh
Q 039290          967 AGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043 (1049)
Q Consensus       967 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~ 1043 (1049)
                      ..+... .......                   ....+..++.++.+++.+||+.||.+|||++|++++|+.+.+..
T Consensus       280 ~~~~~~-~~~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          280 VDANFY-KLIQNGF-------------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             CSHHHH-HHHHTTC-------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             cHHHHH-HHHhcCC-------------------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            322211 1111000                   01111234567999999999999999999999999999887654

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-39  Score=356.73  Aligned_cols=246  Identities=24%  Similarity=0.313  Sum_probs=207.2

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      .++|++.+.||+|+||+||+|+.. +|+.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            357889999999999999999964 78999999997542   34567888999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++|+|.+++.... .+++..++.++.||+.||+|||   ++||+||||||+||+++.++.+||+|||+++..... 
T Consensus        85 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-  159 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  159 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence            99999999999998754 4899999999999999999999   999999999999999999999999999999876432 


Q ss_pred             cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                         .....||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ......             .    
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~-------------~----  218 (318)
T 1fot_A          160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-YEKILN-------------A----  218 (318)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHH-------------C----
T ss_pred             ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHHh-------------C----
Confidence               2345789999999999999999999999999999999999999975322111 111100             0    


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRI-----SMKDVANR 1035 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~~ 1035 (1049)
                          ....+...+.++.+++.+|++.||++||     +++|+++|
T Consensus       219 ----~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          219 ----ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ----CCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence                0011123456789999999999999999     89999876

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=6.7e-39  Score=374.87  Aligned_cols=252  Identities=30%  Similarity=0.446  Sum_probs=209.8

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCC-eeEEEEec
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNND-FKALVLEY  838 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~-~~~lv~e~  838 (1049)
                      .++|++.+.||+|+||.||+|++. ++.||||+++...  ..+.+.+|++++++++||||+++++++.+.+ ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            457888999999999999999984 7899999997543  4578999999999999999999999987655 78999999


Q ss_pred             cCCCChhhhhhcCCC-ccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          839 MSNGSLEKCLYSDNY-FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      +++|+|.+++...+. .+++..++.++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+++......  
T Consensus       269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--  343 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  343 (450)
T ss_dssp             CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--
Confidence            999999999987544 4689999999999999999999   9999999999999999999999999999998653221  


Q ss_pred             cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          918 RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                        ....+++.|+|||++.+..++.++|||||||++|||++ |+.||......+... . +..                  
T Consensus       344 --~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~-~-i~~------------------  401 (450)
T 1k9a_A          344 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-R-VEK------------------  401 (450)
T ss_dssp             -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH-H-HHT------------------
T ss_pred             --cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-H-HHc------------------
Confidence              22356889999999999999999999999999999998 999997643322211 1 100                  


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHh
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~ 1042 (1049)
                       ..+...+..++.++.++|.+||+.||++|||+.++++.|+++...
T Consensus       402 -~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          402 -GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence             001122234677899999999999999999999999999998764

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.7e-39  Score=364.54  Aligned_cols=275  Identities=23%  Similarity=0.305  Sum_probs=213.7

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-----CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeee--cCCeeE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-----PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS--NNDFKA  833 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~--~~~~~~  833 (1049)
                      ++|++.+.||+|+||.||+|++     .+++.||+|++........+.+.+|++++++++||||+++++++.  +.+..+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            4688899999999999999983     468899999997665555677999999999999999999999886  456789


Q ss_pred             EEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          834 LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      +||||+++++|.+++...+..+++.+++.++.|++.||+|||   +.||+||||||+||+++.++.+||+|||++.....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL  179 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred             EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence            999999999999999876667999999999999999999999   99999999999999999999999999999987754


Q ss_pred             Cccc--cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccc
Q 039290          914 EESM--RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA  991 (1049)
Q Consensus       914 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  991 (1049)
                      ....  ......+++.|+|||++.+..++.++||||+||++|||++|+.||............+..   .......+.+.
T Consensus       180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~  256 (327)
T 3lxl_A          180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER---DVPALSRLLEL  256 (327)
T ss_dssp             TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-------CCHHHHHHHH
T ss_pred             CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccc---ccccHHHHHHH
Confidence            3321  223345788899999998888999999999999999999999998653221111000000   00000000000


Q ss_pred             ccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          992 NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                       +  ....+...+..++.++.+++.+||+.||++|||++|++++|+++.....
T Consensus       257 -~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  306 (327)
T 3lxl_A          257 -L--EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR  306 (327)
T ss_dssp             -H--HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred             -h--hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence             0  0011122234567789999999999999999999999999998876544

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.7e-39  Score=367.09  Aligned_cols=247  Identities=23%  Similarity=0.326  Sum_probs=200.9

Q ss_pred             CceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCCCh
Q 039290          766 NKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSL  844 (1049)
Q Consensus       766 ~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  844 (1049)
                      .+.||+|+||.||+|+. .+|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            56899999999999995 47899999999865544567899999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeee--cCCCceEEecccCceecCCCcccccccc
Q 039290          845 EKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL--NESMVGHLSDFGIAKILGKEESMRQTKT  922 (1049)
Q Consensus       845 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~--~~~~~~kl~DfGla~~~~~~~~~~~~~~  922 (1049)
                      .+++......+++.+++.++.||++||+|||   +.+|+||||||+||++  +.++.+||+|||+++.......  ....
T Consensus       174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~~  248 (373)
T 2x4f_A          174 FDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVN  248 (373)
T ss_dssp             HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCCC
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cccc
Confidence            9998877667999999999999999999999   9999999999999999  5678999999999997754332  2335


Q ss_pred             ccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCch
Q 039290          923 LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFS 1002 (1049)
Q Consensus       923 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1049)
                      .||+.|+|||++.+..++.++||||+||++|||++|..||......+. .........                 .....
T Consensus       249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~i~~~~~-----------------~~~~~  310 (373)
T 2x4f_A          249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET-LNNILACRW-----------------DLEDE  310 (373)
T ss_dssp             CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHTCC-----------------CSCSG
T ss_pred             cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccC-----------------CCChh
Confidence            689999999999988999999999999999999999999976332211 111111000                 00011


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290         1003 AREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus      1003 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ....+++++.+++.+|++.||++|||++|++++
T Consensus       311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          311 EFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            112346778999999999999999999999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.5e-39  Score=358.86  Aligned_cols=264  Identities=23%  Similarity=0.364  Sum_probs=216.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe------CCCcEEEEEEeecccC-CCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL------PDGMEIAAKVFHMEFD-GSLESFHAECKVMGSI-RHRNLVKIISSCSNNDF  831 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~  831 (1049)
                      .++|+..+.||+|+||.||+|++      .+++.||+|+++.... ...+.+.+|+++++++ +||||+++++++.+.+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            45788999999999999999984      3567899999975432 2356789999999999 89999999999999999


Q ss_pred             eEEEEeccCCCChhhhhhcCCC-----------------ccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeee
Q 039290          832 KALVLEYMSNGSLEKCLYSDNY-----------------FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL  894 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~  894 (1049)
                      .++||||+++|+|.+++.....                 .+++.+++.++.|+++|++|||   ++||+||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence            9999999999999999976543                 4899999999999999999999   9999999999999999


Q ss_pred             cCCCceEEecccCceecCCCccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchH
Q 039290          895 NESMVGHLSDFGIAKILGKEESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSL  972 (1049)
Q Consensus       895 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~  972 (1049)
                      +.++.+||+|||++......... ......+++.|+|||++.+..++.++||||+||++|||++ |..||..........
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  258 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY  258 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence            99999999999999876544322 2233456789999999988899999999999999999999 999997643322211


Q ss_pred             HHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhc
Q 039290          973 KRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAY 1046 (1049)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~ 1046 (1049)
                      .... ...                   +...+..++.++.+++.+||+.||++|||++|++++|+++..+..+.
T Consensus       259 ~~~~-~~~-------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~  312 (313)
T 1t46_A          259 KMIK-EGF-------------------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTNH  312 (313)
T ss_dssp             HHHH-HTC-------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC-
T ss_pred             HHhc-cCC-------------------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhcC
Confidence            1111 000                   00111234567899999999999999999999999999998876553

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.3e-39  Score=359.20  Aligned_cols=259  Identities=23%  Similarity=0.398  Sum_probs=213.3

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe------CCCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCee
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL------PDGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFK  832 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~  832 (1049)
                      .++|.+.+.||+|+||.||+|+.      .+++.||+|+++.... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            45788899999999999999985      3457899999975432 2346788999999999999999999999999999


Q ss_pred             EEEEeccCCCChhhhhhcCC-----------------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCC
Q 039290          833 ALVLEYMSNGSLEKCLYSDN-----------------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKP  889 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp  889 (1049)
                      ++||||+++++|.+++....                       ..+++.+++.++.|+++|++|||   ++||+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence            99999999999999997643                       24899999999999999999999   99999999999


Q ss_pred             CCeeecCCCceEEecccCceecCCCccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCcccc
Q 039290          890 SNVLLNESMVGHLSDFGIAKILGKEESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFA  967 (1049)
Q Consensus       890 ~NIl~~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~  967 (1049)
                      +||+++.++.+||+|||++......... ......+++.|+|||++.+..++.++||||+||++|||++ |..||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999876543322 2233456788999999988889999999999999999999 9999976433


Q ss_pred             ccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHh
Q 039290          968 GEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042 (1049)
Q Consensus       968 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~ 1042 (1049)
                      .+..  .......                   ....+..++.++.+++.+||+.||++|||++|++++|+++.++
T Consensus       259 ~~~~--~~~~~~~-------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          259 ERLF--NLLKTGH-------------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             GGHH--HHHHTTC-------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHH--HHhhcCC-------------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            2211  1111000                   0111123567799999999999999999999999999998875

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=4.2e-38  Score=367.64  Aligned_cols=352  Identities=19%  Similarity=0.184  Sum_probs=223.0

Q ss_pred             CccceEEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceEEeccccccccCccccccccceEEEee
Q 039290          199 PVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGV  278 (1049)
Q Consensus       199 ~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  278 (1049)
                      +.|++|++++|++++ +| .+..+++|++|+|++|++++. |  ++.+++|++|+|++|++++. |  ++++++|++|++
T Consensus        42 ~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L  113 (457)
T 3bz5_A           42 ATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNC  113 (457)
T ss_dssp             TTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEEC
T ss_pred             CCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEEC
Confidence            446666666666664 33 455666666666666666542 2  55666666666666666542 2  555566666666


Q ss_pred             ccccCCCccccccccccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCcccc
Q 039290          279 QSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSG  358 (1049)
Q Consensus       279 ~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  358 (1049)
                      ++|++++. |  +..+++|++|++++|++++ ++   ...+++|++|++++|+..+.+  .+..+++|++|++++|++++
T Consensus       114 ~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~-l~---l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~  184 (457)
T 3bz5_A          114 DTNKLTKL-D--VSQNPLLTYLNCARNTLTE-ID---VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE  184 (457)
T ss_dssp             CSSCCSCC-C--CTTCTTCCEEECTTSCCSC-CC---CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC
T ss_pred             CCCcCCee-c--CCCCCcCCEEECCCCccce-ec---cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce
Confidence            65555543 2  4455555555555555543 22   123445555555555333333  24444445555555554443


Q ss_pred             CcccccccccccceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCC
Q 039290          359 LIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGI  438 (1049)
Q Consensus       359 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~  438 (1049)
                      . |  ++.+++|+.|++++|.+++++        +..++                         +|++|++++|++++ +
T Consensus       185 l-~--l~~l~~L~~L~l~~N~l~~~~--------l~~l~-------------------------~L~~L~Ls~N~l~~-i  227 (457)
T 3bz5_A          185 L-D--VSQNKLLNRLNCDTNNITKLD--------LNQNI-------------------------QLTFLDCSSNKLTE-I  227 (457)
T ss_dssp             C-C--CTTCTTCCEEECCSSCCSCCC--------CTTCT-------------------------TCSEEECCSSCCSC-C
T ss_pred             e-c--cccCCCCCEEECcCCcCCeec--------cccCC-------------------------CCCEEECcCCcccc-c
Confidence            2 2  444444444444444444321        22333                         45555555555554 3


Q ss_pred             CCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcc
Q 039290          439 PKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLT  518 (1049)
Q Consensus       439 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  518 (1049)
                      |  ++.+++|+.|++++|++++..   ++.+++|+.|++++|+              |+.|++++|.+.+.+|  ++.++
T Consensus       228 p--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~--~~~l~  286 (457)
T 3bz5_A          228 D--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQ--AEGCR  286 (457)
T ss_dssp             C--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTCC--------------CSCCCCTTCTTCCEEE--CTTCT
T ss_pred             C--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCCC--------------CCEEECCCCccCCccc--ccccc
Confidence            3  666777788888888777643   4456677777776653              4567788888777776  56788


Q ss_pred             cCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEee
Q 039290          519 SLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLR  598 (1049)
Q Consensus       519 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  598 (1049)
                      +|+.|++++|+..+.+|.   ..++|+.|++++|             ++|++|++++|+|++. +  ++.+++|+.|+++
T Consensus       287 ~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~  347 (457)
T 3bz5_A          287 KIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCV  347 (457)
T ss_dssp             TCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECC
T ss_pred             cCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEEECC
Confidence            899999999988777764   3456666666655             5789999999999985 3  8999999999999


Q ss_pred             cccccCCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCcccccCCCC
Q 039290          599 YNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTR  657 (1049)
Q Consensus       599 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~  657 (1049)
                      +|+|++        ++.|..|++++|.++|.     ..+..|..+++++|+++|.+|..
T Consensus       348 ~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~  393 (457)
T 3bz5_A          348 NAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPD  393 (457)
T ss_dssp             SSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTT
T ss_pred             CCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChh
Confidence            999996        35677788999999976     35667889999999999999963

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=6.4e-39  Score=364.40  Aligned_cols=249  Identities=25%  Similarity=0.324  Sum_probs=205.5

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            57889999999999999999964 68899999996542   445678899999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+.+|+|.+++.... .+++..++.++.||+.||+|||   +.||+||||||+||+++.++.+||+|||++....... 
T Consensus        95 e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-  169 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-  169 (384)
T ss_dssp             CCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred             ecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC-
Confidence            9999999999987654 4899999999999999999999   9999999999999999999999999999998765432 


Q ss_pred             ccccccccccCcccccccCC---CCcCcccchHHHHHHHHHHHhCCCCCCccccccch-HHHhhhhccccCCcchhcccc
Q 039290          917 MRQTKTLGTIGYMAPEYGRE---GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMS-LKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                       ......||+.|+|||++..   ..++.++||||+||++|||++|+.||......... .......              
T Consensus       170 -~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--------------  234 (384)
T 4fr4_A          170 -QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET--------------  234 (384)
T ss_dssp             -CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH--------------
T ss_pred             -ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh--------------
Confidence             2345679999999999864   45899999999999999999999999753222111 1111000              


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCCC-HHHHHHH
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRIS-MKDVANR 1035 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-~~ell~~ 1035 (1049)
                            .....+..++.++.+++.+||+.||++||+ ++++.+|
T Consensus       235 ------~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h  272 (384)
T 4fr4_A          235 ------TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF  272 (384)
T ss_dssp             ------CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred             ------cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence                  001112234577899999999999999998 7777653

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.5e-39  Score=365.88  Aligned_cols=252  Identities=23%  Similarity=0.357  Sum_probs=206.3

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      .++|++.+.||+|+||.||+|... +++.||+|++.....  ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457999999999999999999964 789999999976532  23467889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCC---CceEEecccCceecCC
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES---MVGHLSDFGIAKILGK  913 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~---~~~kl~DfGla~~~~~  913 (1049)
                      ||+++|+|.+.+.... .+++.++..++.||++|++|||   ++||+||||||+||+++.+   +.+||+|||++.....
T Consensus       108 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~  183 (362)
T 2bdw_A          108 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  183 (362)
T ss_dssp             CCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence            9999999999887654 5899999999999999999999   9999999999999999854   4699999999987653


Q ss_pred             CccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          914 EESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       914 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                      ..  ......||+.|+|||++.+..++.++||||+||++|||++|..||......+.  ...+....             
T Consensus       184 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--~~~i~~~~-------------  246 (362)
T 2bdw_A          184 SE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL--YAQIKAGA-------------  246 (362)
T ss_dssp             CC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHTC-------------
T ss_pred             Cc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHhCC-------------
Confidence            32  22345789999999999988999999999999999999999999975322111  11110000             


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                         ..........++.++.+++.+||+.||++|||+.|+++|
T Consensus       247 ---~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          247 ---YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             ---CCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ---CCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               000001112345678999999999999999999999887

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=9.4e-39  Score=356.44  Aligned_cols=270  Identities=23%  Similarity=0.315  Sum_probs=193.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .++|++.+.||+|+||+||+|+.. +++.||+|+++... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            457999999999999999999954 78999999997654 3345788999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCC-----CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecC
Q 039290          838 YMSNGSLEKCLYSDN-----YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      |++ |+|.+++....     ..+++..+..++.|+++||+|||   +.||+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 59999886532     35899999999999999999999   9999999999999999999999999999998765


Q ss_pred             CCccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhc--cccCCcchh-
Q 039290          913 KEESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDS--LLSCSITEV-  988 (1049)
Q Consensus       913 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~-  988 (1049)
                      .... ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+.. .......  .....+..+ 
T Consensus       160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL-KLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCSCCTTTCGGGG
T ss_pred             CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCChhHhhhhh
Confidence            3322 2234568999999999876 46899999999999999999999999764332221 1111100  000000000 


Q ss_pred             ----cccccccccccC------chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          989 ----ADANLLNCEEND------FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       989 ----~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                          ..+.........      .......+.++.+++.+||+.||++|||++|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence                000000000000      00111345679999999999999999999999876

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-39  Score=370.81  Aligned_cols=259  Identities=25%  Similarity=0.420  Sum_probs=200.3

Q ss_pred             CCCCCceecCCCcEEEEEEEeC--CC--cEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeec-CCeeEEE
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP--DG--MEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSN-NDFKALV  835 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~--~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~-~~~~~lv  835 (1049)
                      .|+..+.||+|+||+||+|++.  ++  ..||+|.++... ....+++.+|+.++++++||||+++++++.+ ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4667789999999999999853  32  358999986543 2345789999999999999999999998654 5678999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++|+|.+++......+++.+++.++.|+++||+|||   ++||+||||||+||+++.++.+||+|||+++......
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            9999999999999887777899999999999999999999   9999999999999999999999999999998664332


Q ss_pred             cc---cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccc
Q 039290          916 SM---RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA  991 (1049)
Q Consensus       916 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  991 (1049)
                      ..   ......+++.|+|||++.+..++.++||||+||++|||++ |.+||......+.......+              
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~--------------  312 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--------------  312 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT--------------
T ss_pred             cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC--------------
Confidence            11   1223456788999999998899999999999999999999 67777653332221111000              


Q ss_pred             ccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          992 NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                             .+...+..++..+.+++.+||+.||++|||++|++++|+++..++.
T Consensus       313 -------~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          313 -------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence                   0011122356779999999999999999999999999999988654

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.5e-39  Score=361.39  Aligned_cols=272  Identities=21%  Similarity=0.358  Sum_probs=212.7

Q ss_pred             CCCCceecCCCcEEEEEEEeC-----CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeec--CCeeEE
Q 039290          763 FSENKLLGMGSFGSVYKGVLP-----DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSN--NDFKAL  834 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--~~~~~l  834 (1049)
                      |++.+.||+|+||+||+|.+.     +++.||+|+++.... ...+.+.+|++++++++||||+++++++.+  ....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488899999999999998642     688899999976532 235678999999999999999999999987  467899


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      ||||+++|+|.+++....  +++.+++.++.|++.|++|||   +.||+||||||+||+++.++.+||+|||++......
T Consensus       113 v~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             EEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            999999999999997654  899999999999999999999   999999999999999999999999999999887543


Q ss_pred             ccc--cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccc
Q 039290          915 ESM--RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       915 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      ...  ......++..|+|||++.+..++.++||||+||++|||++|..||............+...........+.... 
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  266 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER-  266 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT-
T ss_pred             ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc-
Confidence            321  22334578889999999988999999999999999999999999875322211111100000000000000000 


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhh
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSA 1045 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~ 1045 (1049)
                           ......+..++.++.+++.+||+.||++|||++|+++.|+++.+++..
T Consensus       267 -----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~  314 (318)
T 3lxp_A          267 -----GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG  314 (318)
T ss_dssp             -----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred             -----ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence                 111222344667899999999999999999999999999999988754

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.6e-39  Score=350.76  Aligned_cols=251  Identities=25%  Similarity=0.452  Sum_probs=196.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccC----CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFD----GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      .++|+..+.||+|+||.||+|++ .++.||+|+++....    ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            35788899999999999999997 488999999875432    2357789999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCC---eEEcCCCCCCeeecC--------CCceEEec
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP---IVHCDIKPSNVLLNE--------SMVGHLSD  904 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~---ivH~Dlkp~NIl~~~--------~~~~kl~D  904 (1049)
                      |||+++++|.+++...  .+++..++.++.|+++|++|||   +++   |+||||||+||+++.        ++.+||+|
T Consensus        85 ~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            9999999999988643  5899999999999999999999   887   999999999999985        77899999


Q ss_pred             ccCceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCC
Q 039290          905 FGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCS  984 (1049)
Q Consensus       905 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  984 (1049)
                      ||++........   ....|++.|+|||++.+..++.++||||+|+++|||++|+.||................      
T Consensus       160 fg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------  230 (271)
T 3dtc_A          160 FGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK------  230 (271)
T ss_dssp             CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC------
T ss_pred             CCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC------
Confidence            999986643322   23568999999999988889999999999999999999999997633222211111000      


Q ss_pred             cchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290          985 ITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus       985 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                                    .....+..++..+.+++.+||+.||++|||++|++++|+++
T Consensus       231 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          231 --------------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             --------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             --------------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                          00111233556799999999999999999999999999854

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=369.64  Aligned_cols=259  Identities=24%  Similarity=0.400  Sum_probs=209.7

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC------CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKA  833 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~  833 (1049)
                      ++|++.+.||+|+||+||+|++.      +++.||||+++... .....++.+|+.++++++||||+++++++.+.+..+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            46888999999999999999943      46689999996442 223457889999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCC------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC---ceEEec
Q 039290          834 LVLEYMSNGSLEKCLYSDN------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM---VGHLSD  904 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~---~~kl~D  904 (1049)
                      +||||+++|+|.+++...+      ..+++.+++.++.|+++||+|||   ++||+||||||+||+++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECC
Confidence            9999999999999997643      35899999999999999999999   99999999999999999544   599999


Q ss_pred             ccCceecCCCcc-ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhcccc
Q 039290          905 FGIAKILGKEES-MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLS  982 (1049)
Q Consensus       905 fGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  982 (1049)
                      ||+++....... .......+|+.|+|||++.+..++.++||||+||++|||++ |..||......+.  ...+...   
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~--~~~i~~~---  302 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--LEFVTSG---  302 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--HHHHHTT---
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHcC---
Confidence            999975532221 22234567889999999988899999999999999999998 9999976322211  1111000   


Q ss_pred             CCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhh
Q 039290          983 CSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043 (1049)
Q Consensus       983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~ 1043 (1049)
                                      .+...+..++..+.+++.+||+.||++|||++|++++|+.+.+..
T Consensus       303 ----------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          303 ----------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             ----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             ----------------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence                            001112335667899999999999999999999999999887654

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.4e-39  Score=381.52  Aligned_cols=257  Identities=24%  Similarity=0.402  Sum_probs=214.5

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      ..+|+..+.||+|+||.||+|++. ++..||||+++.. ....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            346888899999999999999976 4889999999754 34568899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          839 MSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       839 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      +++|+|.+++... ...+++..++.++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+++........
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  374 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT  374 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence            9999999999764 346899999999999999999999   999999999999999999999999999999876543333


Q ss_pred             cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          918 RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                      ......++..|+|||++.+..++.++|||||||++|||++ |..||......+.  ...+..                  
T Consensus       375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~--~~~~~~------------------  434 (495)
T 1opk_A          375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--YELLEK------------------  434 (495)
T ss_dssp             CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HHHHHT------------------
T ss_pred             ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHc------------------
Confidence            3333456788999999988899999999999999999999 9999876432221  111100                  


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~ 1041 (1049)
                       ..+...+..++.++.++|.+||+.||++|||++|+++.|+++.+
T Consensus       435 -~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          435 -DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             -CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence             00112223466789999999999999999999999999987643

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.2e-39  Score=353.94  Aligned_cols=250  Identities=24%  Similarity=0.333  Sum_probs=198.2

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC--------------------------CCHHHHHHHHHHHh
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD--------------------------GSLESFHAECKVMG  812 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~  812 (1049)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            46799999999999999999995 4788999999865431                          12356889999999


Q ss_pred             hcCCCceeeEEeeeec--CCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCC
Q 039290          813 SIRHRNLVKIISSCSN--NDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPS  890 (1049)
Q Consensus       813 ~l~hpniv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~  890 (1049)
                      +++||||+++++++.+  .+..++||||+++++|.+++..  ..+++.+++.++.|+++||+|||   +.||+||||||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~  166 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPS  166 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence            9999999999999986  5688999999999999886543  35899999999999999999999   999999999999


Q ss_pred             CeeecCCCceEEecccCceecCCCccccccccccccCcccccccCCCC---cCcccchHHHHHHHHHHHhCCCCCCcccc
Q 039290          891 NVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGK---VSRKCDVYSYGIMLMETFTKKKPTDEIFA  967 (1049)
Q Consensus       891 NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~p~~~~~~  967 (1049)
                      ||+++.++.+||+|||++........ ......||+.|+|||++.+..   ++.++||||+||++|||++|+.||.....
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  245 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI  245 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             HEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence            99999999999999999987654332 223457899999999987654   47889999999999999999999975321


Q ss_pred             ccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          968 GEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       968 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ..  ....+....            .      .++....++.++.+++.+||+.||++|||++|+++|
T Consensus       246 ~~--~~~~~~~~~------------~------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          246 MC--LHSKIKSQA------------L------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             HH--HHHHHHHCC------------C------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             HH--HHHHHhccc------------C------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            11  111000000            0      000112245678999999999999999999999876

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.1e-38  Score=349.49  Aligned_cols=258  Identities=24%  Similarity=0.409  Sum_probs=213.5

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      .++|++.+.||+|+||.||+|+..++..||+|+++... ...+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence            45788999999999999999998888899999997543 356789999999999999999999999874 4579999999


Q ss_pred             CCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          840 SNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       840 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      ++++|.+++.... ..+++.++..++.|+++|++|||   +.||+||||||+||++++++.+||+|||++..........
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  166 (279)
T 1qpc_A           90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA  166 (279)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred             CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence            9999999987543 25899999999999999999999   9999999999999999999999999999998775544333


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE  997 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1049)
                      .....++..|+|||++.+..++.++||||+|+++|||++ |..||......+.  ........                 
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~~~~~~~-----------------  227 (279)
T 1qpc_A          167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV--IQNLERGY-----------------  227 (279)
T ss_dssp             CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HHHHHTTC-----------------
T ss_pred             ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH--HHHHhccc-----------------
Confidence            334456789999999988889999999999999999999 8999875332211  11110000                 


Q ss_pred             ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhh
Q 039290          998 ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043 (1049)
Q Consensus       998 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~ 1043 (1049)
                        +...+..++.++.+++.+|++.||++|||++++++.|+++..+.
T Consensus       228 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          228 --RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             --CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence              00111234568999999999999999999999999999987764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=9.5e-39  Score=359.41  Aligned_cols=250  Identities=22%  Similarity=0.314  Sum_probs=200.3

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCC-------
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNND-------  830 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~-------  830 (1049)
                      .++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            457889999999999999999975 89999999997644 334578999999999999999999999985543       


Q ss_pred             --------------------------------------------------eeEEEEeccCCCChhhhhhcCCC--ccCHH
Q 039290          831 --------------------------------------------------FKALVLEYMSNGSLEKCLYSDNY--FLDIL  858 (1049)
Q Consensus       831 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~--~~~~~  858 (1049)
                                                                        ..++||||+++++|.+++.....  ..++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              37999999999999999976543  45667


Q ss_pred             HHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc-----------ccccccccccC
Q 039290          859 QRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES-----------MRQTKTLGTIG  927 (1049)
Q Consensus       859 ~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~~~~~  927 (1049)
                      .++.++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++.......           .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            78999999999999999   99999999999999999999999999999987754321           12233568999


Q ss_pred             cccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCchhhHHH
Q 039290          928 YMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQC 1007 (1049)
Q Consensus       928 y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1049)
                      |+|||++.+..++.++||||+||++|||++|..|+....    ......            .       ...........
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~----~~~~~~------------~-------~~~~~~~~~~~  298 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV----RIITDV------------R-------NLKFPLLFTQK  298 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH----HHHHHH------------H-------TTCCCHHHHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH----HHHHHh------------h-------ccCCCcccccC
Confidence            999999999899999999999999999999877643210    000000            0       00111223445


Q ss_pred             HHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290         1008 VSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus      1008 ~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      +.++.+++.+||+.||++|||++|++++
T Consensus       299 ~~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          299 YPQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             CHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             ChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            5678999999999999999999999975

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.9e-39  Score=364.01  Aligned_cols=271  Identities=16%  Similarity=0.186  Sum_probs=209.8

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCC------CcEEEEEEeecccCC-----------CHHHHHHHHHHHhhcCCCceeeE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPD------GMEIAAKVFHMEFDG-----------SLESFHAECKVMGSIRHRNLVKI  822 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~------~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~hpniv~l  822 (1049)
                      .++|++.+.||+|+||+||+|.+..      ++.||+|++......           ....+..|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4579999999999999999999754      478999998654311           11233445666777789999999


Q ss_pred             EeeeecC----CeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec--C
Q 039290          823 ISSCSNN----DFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN--E  896 (1049)
Q Consensus       823 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~--~  896 (1049)
                      ++++...    ...++||||+ +++|.+++......+++.+++.++.|++.||+|||   +.||+||||||+||+++  .
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSC
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCC
Confidence            9998764    4589999999 99999999887677999999999999999999999   99999999999999999  8


Q ss_pred             CCceEEecccCceecCCCccc------cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccc
Q 039290          897 SMVGHLSDFGIAKILGKEESM------RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEM  970 (1049)
Q Consensus       897 ~~~~kl~DfGla~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~  970 (1049)
                      ++.+||+|||+++.+......      ......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~  269 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK  269 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence            899999999999876543221      11234589999999999998999999999999999999999999986433322


Q ss_pred             hHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhh
Q 039290          971 SLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSA 1045 (1049)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~ 1045 (1049)
                      ... +..... ...+.++.+..+.         ...++.++.+++.+||+.+|++||+++++++.|+++.++...
T Consensus       270 ~~~-~~~~~~-~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~  333 (364)
T 3op5_A          270 YVR-DSKIRY-RENIASLMDKCFP---------AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS  333 (364)
T ss_dssp             HHH-HHHHHH-HHCHHHHHHHHSC---------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             HHH-HHHHHh-hhhHHHHHHHhcc---------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence            111 111000 0111111111110         023467899999999999999999999999999999987643

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.8e-39  Score=363.03  Aligned_cols=251  Identities=24%  Similarity=0.322  Sum_probs=206.6

Q ss_pred             HHhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCee
Q 039290          758 RATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFK  832 (1049)
Q Consensus       758 ~~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~  832 (1049)
                      ...++|++.+.||+|+||+||+|+.. +++.||+|+++...   ....+.+..|.+++..+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            34578999999999999999999965 68899999997642   44567788999999887 899999999999999999


Q ss_pred             EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecC
Q 039290          833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      |+||||+++|+|.+++...+ .+++.++..++.||+.||+|||   ++||+||||||+||+++.++.+||+|||+++...
T Consensus        94 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            99999999999999987654 4899999999999999999999   9999999999999999999999999999998643


Q ss_pred             CCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccc
Q 039290          913 KEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       913 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      ... .......||+.|+|||++.+..++.++||||+||++|||++|..||......+.  ...+..  .           
T Consensus       170 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~i~~--~-----------  233 (345)
T 1xjd_A          170 LGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL--FHSIRM--D-----------  233 (345)
T ss_dssp             CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH--C-----------
T ss_pred             cCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH--HHHHHh--C-----------
Confidence            222 123456799999999999999999999999999999999999999975322211  111000  0           


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHH-HHHHH
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMK-DVANR 1035 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~-ell~~ 1035 (1049)
                             ....+...+.++.+++.+||+.||++||++. |+++|
T Consensus       234 -------~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          234 -------NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             -------CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence                   0011122456789999999999999999997 77654

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.4e-39  Score=361.51  Aligned_cols=261  Identities=25%  Similarity=0.398  Sum_probs=208.4

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcE----EEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGME----IAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      ++|+..+.||+|+||+||+|++. +++.    ||+|.+.... ......+.+|+.++++++||||+++++++.+ +..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEE
Confidence            46888999999999999999954 4443    7788775433 3334667889999999999999999999874 56789


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      ||||+.+|+|.+++...+..+++..++.++.|+++||+|||   +.||+||||||+||+++.++.+||+|||+++.....
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            99999999999999877667899999999999999999999   999999999999999999999999999999877544


Q ss_pred             ccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccc
Q 039290          915 ESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       915 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      ... ......++..|+|||++.+..++.++||||+||++|||++ |..||......+....  .....            
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~--~~~~~------------  234 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL--LEKGE------------  234 (325)
T ss_dssp             TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH--HHTTC------------
T ss_pred             cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH--HHcCC------------
Confidence            322 2234567789999999998899999999999999999999 9999986433222111  11000            


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhc
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAY 1046 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~ 1046 (1049)
                             +...+..++.++.+++.+||+.||++|||++|++++|+++.+.-..+
T Consensus       235 -------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~~~  281 (325)
T 3kex_A          235 -------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRY  281 (325)
T ss_dssp             -------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHHHH
T ss_pred             -------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence                   00111123456789999999999999999999999999987655444

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.1e-39  Score=356.80  Aligned_cols=261  Identities=24%  Similarity=0.397  Sum_probs=218.0

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      ..++|++.+.||+|+||.||+|.+. ++..||+|+++.. ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            4567889999999999999999965 5889999999754 3456789999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          838 YMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      |+++++|.+++... ...+++..++.++.|++.|++|||   +.||+||||||+||+++.++.+||+|||++........
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence            99999999999763 345899999999999999999999   99999999999999999999999999999987765444


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                      .......+++.|+|||++.+..++.++||||+|+++|+|++ |..||......+.  .......                
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~--~~~~~~~----------------  228 (288)
T 3kfa_A          167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--YELLEKD----------------  228 (288)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HHHHHTT----------------
T ss_pred             ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHhcc----------------
Confidence            44444567889999999988899999999999999999999 9999876332221  1111000                


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                         .+...+..++.++.+++.+|++.||++|||++|+++.|+++..+..
T Consensus       229 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~  274 (288)
T 3kfa_A          229 ---YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS  274 (288)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence               0111123356779999999999999999999999999999887643

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=7.9e-39  Score=360.73  Aligned_cols=245  Identities=23%  Similarity=0.269  Sum_probs=207.0

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57889999999999999999965 78999999996542   345678899999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+++|+|.+++...+ .+++.+++.++.||+.||+|||   ++||+||||||+||+++.++.+||+|||+++.....  
T Consensus       121 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence            9999999999997654 4899999999999999999999   999999999999999999999999999999876432  


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                        .....||+.|+|||++.+..++.++||||+||++|||++|..||......+. .......                  
T Consensus       195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~i~~~------------------  253 (350)
T 1rdq_E          195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-YEKIVSG------------------  253 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHC------------------
T ss_pred             --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH-HHHHHcC------------------
Confidence              2345789999999999999999999999999999999999999975322111 1111100                  


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRIS-----MKDVANR 1035 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~ell~~ 1035 (1049)
                         ....+..++.++.+++.+||+.||++||+     ++|+++|
T Consensus       254 ---~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          254 ---KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ---CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence               00111234567899999999999999998     8888876

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=6.9e-39  Score=358.97  Aligned_cols=261  Identities=23%  Similarity=0.435  Sum_probs=197.2

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEeCCC----cEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCee
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVLPDG----MEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFK  832 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~~~~----~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~  832 (1049)
                      ..++|++.+.||+|+||+||+|+....    ..||+|+++...  ....+.+.+|++++++++||||+++++++.+.+..
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            346799999999999999999996533    279999997653  33457899999999999999999999999877655


Q ss_pred             ------EEEEeccCCCChhhhhhcCC-----CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceE
Q 039290          833 ------ALVLEYMSNGSLEKCLYSDN-----YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGH  901 (1049)
Q Consensus       833 ------~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~k  901 (1049)
                            ++||||+++|+|.+++....     ..+++.+++.++.|+++|++|||   ++||+||||||+||+++.++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEE
Confidence                  89999999999999986432     25899999999999999999999   99999999999999999999999


Q ss_pred             EecccCceecCCCccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhc
Q 039290          902 LSDFGIAKILGKEESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDS  979 (1049)
Q Consensus       902 l~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  979 (1049)
                      |+|||+++........ ......+++.|+|||.+.+..++.++||||+||++|||++ |..||......+..... ....
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-~~~~  256 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL-IGGN  256 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-HTTC
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH-hcCC
Confidence            9999999876443321 2223456788999999998899999999999999999999 99999764333221111 1000


Q ss_pred             cccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhh
Q 039290          980 LLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043 (1049)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~ 1043 (1049)
                                          ....+..++.++.+++.+||+.||++|||++|+++.|+++....
T Consensus       257 --------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          257 --------------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             --------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             --------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                                01112234567999999999999999999999999999988743

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=359.27  Aligned_cols=276  Identities=24%  Similarity=0.339  Sum_probs=202.9

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHH--HhhcCCCceeeEEeeee-----cCCee
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKV--MGSIRHRNLVKIISSCS-----NNDFK  832 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~hpniv~l~~~~~-----~~~~~  832 (1049)
                      .++|++.+.||+|+||+||+|+. +++.||||++....   ...+..|.++  +..++||||+++++++.     .....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            46789999999999999999987 78999999997542   3445555555  44589999999998543     23467


Q ss_pred             EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCC---------CeEEcCCCCCCeeecCCCceEEe
Q 039290          833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST---------PIVHCDIKPSNVLLNESMVGHLS  903 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~---------~ivH~Dlkp~NIl~~~~~~~kl~  903 (1049)
                      ++||||+++|+|.+++....  .++..++.++.|+++||+|||   +.         ||+||||||+||+++.++.+||+
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             EEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEe
Confidence            89999999999999997655  488999999999999999999   88         99999999999999999999999


Q ss_pred             cccCceecCCCc-------cccccccccccCcccccccCC-------CCcCcccchHHHHHHHHHHHhCCCCCCcccccc
Q 039290          904 DFGIAKILGKEE-------SMRQTKTLGTIGYMAPEYGRE-------GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGE  969 (1049)
Q Consensus       904 DfGla~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~  969 (1049)
                      |||+++.+....       ........||+.|+|||++.+       ..++.++||||+||++|||++|..||.......
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  242 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP  242 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence            999998764322       112234568999999999876       456789999999999999999977764322211


Q ss_pred             chHHHhhhhccccCCcchh----cccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          970 MSLKRWVGDSLLSCSITEV----ADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                      .....+...........++    ..................++.++.+++.+||+.||++|||++|+++.|+++...+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~  321 (336)
T 3g2f_A          243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE  321 (336)
T ss_dssp             CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred             HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence            1111110000000000000    00000111111122234567789999999999999999999999999999987654

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=7e-39  Score=351.25  Aligned_cols=259  Identities=22%  Similarity=0.363  Sum_probs=207.7

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCC----CcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPD----GMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      .++|++.+.||+|+||.||+|++.+    +..||+|+++... ....+.+.+|++++++++||||+++++++.++ ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            4578889999999999999998532    3469999987653 22356789999999999999999999998754 5689


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      ||||+++++|.+++...+..+++..++.++.|+++|++|||   ++||+||||||+||+++.++.+||+|||++......
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE  166 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence            99999999999999877667899999999999999999999   999999999999999999999999999999876544


Q ss_pred             ccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          915 ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       915 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                      .........+++.|+|||++.+..++.++||||+|+++|||++ |+.||......+..... ....              
T Consensus       167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~-~~~~--------------  231 (281)
T 3cc6_A          167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL-EKGD--------------  231 (281)
T ss_dssp             ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH-HHTC--------------
T ss_pred             cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH-hcCC--------------
Confidence            4333344556889999999988899999999999999999998 99999753332211110 0000              


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhh
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~ 1043 (1049)
                            ....+..+++.+.+++.+||+.||++|||++|++++|+++.+.-
T Consensus       232 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          232 ------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence                  00111234567899999999999999999999999999987653

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.4e-39  Score=377.56  Aligned_cols=257  Identities=28%  Similarity=0.434  Sum_probs=207.3

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      .++|++.+.||+|+||.||+|++.++..||||+++... ...+++.+|++++++++||||+++++++.+ +..++||||+
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~  260 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  260 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence            45688889999999999999999888899999997543 346789999999999999999999999876 6789999999


Q ss_pred             CCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          840 SNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       840 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      ++|+|.+++... +..+++.++..++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+++.........
T Consensus       261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  337 (452)
T 1fmk_A          261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  337 (452)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence            999999999753 345899999999999999999999   9999999999999999999999999999998765433222


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE  997 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1049)
                      .....++..|+|||++.+..++.++|||||||++|||++ |+.||......+..  ..+..                   
T Consensus       338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~--~~i~~-------------------  396 (452)
T 1fmk_A          338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL--DQVER-------------------  396 (452)
T ss_dssp             -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH--HHHHT-------------------
T ss_pred             ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH--HHHHc-------------------
Confidence            333456789999999988899999999999999999999 99999764322211  11100                   


Q ss_pred             ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHh
Q 039290          998 ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042 (1049)
Q Consensus       998 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~ 1042 (1049)
                      ..+.+.+..++..+.++|.+||+.||++|||++++++.|+++...
T Consensus       397 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          397 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            001112234677899999999999999999999999999987653

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=8.1e-39  Score=352.20  Aligned_cols=260  Identities=26%  Similarity=0.431  Sum_probs=198.1

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCC--CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDG--SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .++|++.+.||+|+||+||+|+...  .||+|+++.....  ..+.+.+|++++++++||||+++++++ ..+..++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            4579999999999999999998643  5999999765432  346789999999999999999999965 4556799999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc-c
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE-S  916 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~-~  916 (1049)
                      |+++++|.+++......+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....... .
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  176 (289)
T 3og7_A          100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS  176 (289)
T ss_dssp             CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred             ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence            99999999999877777999999999999999999999   9999999999999999999999999999998654322 2


Q ss_pred             ccccccccccCcccccccC---CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGR---EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                      .......||+.|+|||++.   +..++.++||||+|+++|||++|+.||......+..... ..........        
T Consensus       177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~--------  247 (289)
T 3og7_A          177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM-VGRGSLSPDL--------  247 (289)
T ss_dssp             -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHH-HHHTSCCCCT--------
T ss_pred             ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHH-hcccccCcch--------
Confidence            2223456899999999886   567888999999999999999999999764332221111 1111000000        


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~ 1041 (1049)
                             ......++.++.+++.+||+.+|++|||++|+++.|+++.+
T Consensus       248 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          248 -------SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             -------TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             -------hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence                   01112356789999999999999999999999999998754

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=348.63  Aligned_cols=250  Identities=24%  Similarity=0.384  Sum_probs=188.5

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            45789999999999999999996 579999999996542   33457899999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++++|.+++......+++.+++.++.|+++|++|||   +.||+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            9999999999999887677999999999999999999999   9999999999999999999999999999998765332


Q ss_pred             cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                      . ......+++.|+|||++.+..++.++||||+|+++|||++|+.||......+... .             ...     
T Consensus       167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~-------------~~~-----  226 (278)
T 3cok_A          167 E-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN-K-------------VVL-----  226 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------CCS-----
T ss_pred             C-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH-H-------------Hhh-----
Confidence            2 2233568999999999998889999999999999999999999997532211100 0             000     


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                         .....+...+.++.+++.+||+.||++|||++|++++
T Consensus       227 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          227 ---ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             ---SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ---cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence               0011112345678999999999999999999999875

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.8e-39  Score=349.90  Aligned_cols=252  Identities=19%  Similarity=0.316  Sum_probs=207.1

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecC--CeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNN--DFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~lv  835 (1049)
                      .++|+..+.||+|+||.||+|++ +++.||+|+++....  ...+.+.+|++++++++||||+++++++.+.  +..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            35788999999999999999998 488999999976532  2346789999999999999999999999887  788999


Q ss_pred             EeccCCCChhhhhhcCCC-ccCHHHHHHHHHHHHHHHHHhHccCCCC--eEEcCCCCCCeeecCCCceEEecccCceecC
Q 039290          836 LEYMSNGSLEKCLYSDNY-FLDILQRLKIMIDVASALEYLHFGYSTP--IVHCDIKPSNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      |||+++|+|.+++..... .+++.+++.++.|+++|++|||   +.+  |+||||||+||+++.++.++++|||++....
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999987654 5899999999999999999999   888  9999999999999999999999999876432


Q ss_pred             CCccccccccccccCcccccccCCCCcCc---ccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhc
Q 039290          913 KEESMRQTKTLGTIGYMAPEYGREGKVSR---KCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA  989 (1049)
Q Consensus       913 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  989 (1049)
                      .      ....+|+.|+|||++.+..++.   ++||||+||++|||++|+.||......+.........           
T Consensus       165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-----------  227 (271)
T 3kmu_A          165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG-----------  227 (271)
T ss_dssp             C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSC-----------
T ss_pred             c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcC-----------
Confidence            2      2346799999999988765544   7999999999999999999997643322211111100           


Q ss_pred             ccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 039290          990 DANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041 (1049)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~ 1041 (1049)
                               .+...+..++.++.+++.+||+.||++|||++|+++.|+++.+
T Consensus       228 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          228 ---------LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                     0011122356679999999999999999999999999998764

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4.7e-39  Score=362.04  Aligned_cols=264  Identities=23%  Similarity=0.379  Sum_probs=213.4

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEeCC------CcEEEEEEeecccC-CCHHHHHHHHHHHhhc-CCCceeeEEeeeecCC
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVLPD------GMEIAAKVFHMEFD-GSLESFHAECKVMGSI-RHRNLVKIISSCSNND  830 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~  830 (1049)
                      ..++|+..+.||+|+||.||+|....      ...||+|+++.... ...+.+.+|+++++++ +||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            45689999999999999999999542      24799999975432 2356789999999999 8999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhhcC-------------CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCC
Q 039290          831 FKALVLEYMSNGSLEKCLYSD-------------NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES  897 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~  897 (1049)
                      ..++||||+++|+|.+++...             ...+++..++.++.|++.||+|||   +.||+||||||+||+++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCC
Confidence            999999999999999998753             234789999999999999999999   9999999999999999999


Q ss_pred             CceEEecccCceecCCCccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHh
Q 039290          898 MVGHLSDFGIAKILGKEESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRW  975 (1049)
Q Consensus       898 ~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~  975 (1049)
                      +.+||+|||++......... ......+++.|+|||++.+..++.++||||+||++|||++ |..||.......... ..
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~-~~  279 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY-KL  279 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH-HH
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH-HH
Confidence            99999999999866433221 2233456789999999988899999999999999999999 999987643222211 11


Q ss_pred             hhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhh
Q 039290          976 VGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSA 1045 (1049)
Q Consensus       976 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~ 1045 (1049)
                      .....                   ....+..++..+.+++.+||+.||.+|||++|++++|+++..+...
T Consensus       280 ~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~  330 (333)
T 2i1m_A          280 VKDGY-------------------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRR  330 (333)
T ss_dssp             HHHTC-------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             HhcCC-------------------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhc
Confidence            11000                   0011122356789999999999999999999999999998877543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=5.5e-39  Score=361.50  Aligned_cols=257  Identities=22%  Similarity=0.264  Sum_probs=204.0

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCC---CHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDG---SLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      ++|+..+.||+|+||.||+|+.. +++.||+|+++.....   ..+.+.+|..+++++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            46888999999999999999965 6889999999765422   245678899999988 899999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++|+|.+++...+ .+++..++.++.||+.||+|||   ++||+||||||+||+++.++.+||+|||+++......
T Consensus        89 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            99999999999987654 4899999999999999999999   9999999999999999999999999999998643222


Q ss_pred             cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                      . ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+......         ...+.....  
T Consensus       165 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~---------~~~~~~~i~--  232 (345)
T 3a8x_A          165 D-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT---------EDYLFQVIL--  232 (345)
T ss_dssp             C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------C---------HHHHHHHHH--
T ss_pred             C-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccccc---------HHHHHHHHH--
Confidence            1 2344679999999999999999999999999999999999999997532211100000         000000000  


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCH------HHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISM------KDVANR 1035 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~------~ell~~ 1035 (1049)
                        ......+...+.++.+++.+||+.||++||++      +|+++|
T Consensus       233 --~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          233 --EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             --HCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             --cCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence              00111122356678999999999999999996      677665

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-38  Score=350.20  Aligned_cols=259  Identities=26%  Similarity=0.449  Sum_probs=211.7

Q ss_pred             cCCCCCc-eecCCCcEEEEEEEeC---CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          761 DGFSENK-LLGMGSFGSVYKGVLP---DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       761 ~~~~~~~-~lg~G~fg~Vy~a~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      ++|.+.+ .||+|+||.||+|.+.   ++..||+|+++.... ...+.+.+|++++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            3455555 9999999999999853   677899999976432 2356789999999999999999999999 45568999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++++|.+++......+++.+++.++.|+++|++|||   +.||+||||||+||+++.++.+||+|||++.......
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  164 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  164 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence            9999999999999877777999999999999999999999   9999999999999999999999999999998775433


Q ss_pred             cc--cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccc
Q 039290          916 SM--RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       916 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      ..  ......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||......+  ....+...             
T Consensus       165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~i~~~-------------  229 (287)
T 1u59_A          165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQG-------------  229 (287)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHHHTT-------------
T ss_pred             ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHhcC-------------
Confidence            22  1223346789999999988889999999999999999998 999997643222  11111100             


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                            .+...+..++.++.+++.+||+.||++||++.|++++|+++..+..
T Consensus       230 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  275 (287)
T 1u59_A          230 ------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  275 (287)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             ------CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence                  0011123456789999999999999999999999999999987653

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.8e-39  Score=357.76  Aligned_cols=245  Identities=24%  Similarity=0.230  Sum_probs=196.6

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCC--HHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGS--LESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|+..++||+|+||+||+|+.. +++.||||++.......  .....+|+..+.++ +||||+++++++.+++..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            47999999999999999999975 79999999986543322  23445566665555 8999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+ +++|.+++...+..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....... 
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-  211 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-  211 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence            999 66999988877777999999999999999999999   8999999999999999999999999999998765433 


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                       ......||+.|+|||++.+ .++.++||||+||++|||++|..|+...    ..........                 
T Consensus       212 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~~~~-----------------  268 (311)
T 3p1a_A          212 -AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLRQGY-----------------  268 (311)
T ss_dssp             ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHTTTC-----------------
T ss_pred             -CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHhccC-----------------
Confidence             2234568999999998875 7999999999999999999997665431    1111111000                 


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                        .....+..++.++.+++.+||+.||++|||++|++++
T Consensus       269 --~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          269 --LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             --CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             --CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence              0111223456789999999999999999999999875

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=352.83  Aligned_cols=255  Identities=27%  Similarity=0.434  Sum_probs=201.3

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccC
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMS  840 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  840 (1049)
                      ++|++.+.||+|+||+||+|++ .++.||+|++...  ...+.+.+|++++++++||||+++++++.+  ..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            4688889999999999999998 4788999998643  345789999999999999999999998874  4789999999


Q ss_pred             CCChhhhhhcCCC--ccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCc-eEEecccCceecCCCccc
Q 039290          841 NGSLEKCLYSDNY--FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMV-GHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       841 ~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~-~kl~DfGla~~~~~~~~~  917 (1049)
                      +|+|.+++.....  .+++.+++.++.|+++|++|||+.+.+||+||||||+||+++.++. +||+|||++......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999986553  4788999999999999999999222289999999999999998876 799999999765332   


Q ss_pred             cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccccc
Q 039290          918 RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE  997 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1049)
                       .....||+.|+|||++.+..++.++||||+|+++|||++|+.||.................                  
T Consensus       160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------------------  220 (307)
T 2eva_A          160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG------------------  220 (307)
T ss_dssp             ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT------------------
T ss_pred             -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC------------------
Confidence             2234689999999999998999999999999999999999999975432221111111000                  


Q ss_pred             ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhh
Q 039290          998 ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043 (1049)
Q Consensus       998 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~ 1043 (1049)
                       .+......++..+.+++.+||+.||++|||++|++++|+++.+.+
T Consensus       221 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          221 -TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             -CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             -CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence             001111234567899999999999999999999999999987654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.9e-38  Score=359.88  Aligned_cols=254  Identities=23%  Similarity=0.238  Sum_probs=196.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      .++|++.+.||+|+||+||+|+.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            457999999999999999999965 78999999997543 3346789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCc--eEEecccCceecCCCcc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMV--GHLSDFGIAKILGKEES  916 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~--~kl~DfGla~~~~~~~~  916 (1049)
                      +++|+|.+++...+ .+++.+++.++.|+++||+|||   ++||+||||||+||+++.++.  +||+|||+++...... 
T Consensus        98 ~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~-  172 (361)
T 3uc3_A           98 ASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  172 (361)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence            99999999987654 4899999999999999999999   999999999999999987665  9999999997543222 


Q ss_pred             ccccccccccCcccccccCCCCcCcc-cchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRK-CDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                       ......||+.|+|||++.+..++.+ +||||+||++|||++|+.||............... .....            
T Consensus       173 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~-~~~~~------------  238 (361)
T 3uc3_A          173 -QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR-ILSVK------------  238 (361)
T ss_dssp             ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHH-HHTTC------------
T ss_pred             -CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHH-HhcCC------------
Confidence             2234578999999999988777655 89999999999999999999764333222211110 00000            


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                         ...+.....+.++.+++.+||+.||++|||++|+++|-
T Consensus       239 ---~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp  276 (361)
T 3uc3_A          239 ---YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHS  276 (361)
T ss_dssp             ---CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred             ---CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence               00011112356789999999999999999999999873

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=356.95  Aligned_cols=263  Identities=24%  Similarity=0.407  Sum_probs=207.7

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcE----EEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGME----IAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKA  833 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~  833 (1049)
                      .++|++.+.||+|+||+||+|++. +++.    ||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+ .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            357899999999999999999954 4544    5777765432 445678999999999999999999999998765 78


Q ss_pred             EEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          834 LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      +|+||+.+|+|.+++......+++..++.++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++....
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            999999999999999887777999999999999999999999   99999999999999999999999999999987643


Q ss_pred             Ccc-ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccc
Q 039290          914 EES-MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA  991 (1049)
Q Consensus       914 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  991 (1049)
                      ... .......+|+.|+|||++.+..++.++||||+||++|||++ |..||......+...  .....            
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~--~~~~~------------  235 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS--ILEKG------------  235 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH--HHHTT------------
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHcC------------
Confidence            332 12223456778999999999999999999999999999999 999997643332211  11000            


Q ss_pred             ccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhcc
Q 039290          992 NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYI 1047 (1049)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~~ 1047 (1049)
                             .....+..++.++.+++.+||+.||++|||++|+++.|+++.+.-..++
T Consensus       236 -------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~  284 (327)
T 3lzb_A          236 -------ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYL  284 (327)
T ss_dssp             -------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHHHHB
T ss_pred             -------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcCceE
Confidence                   0111122355678999999999999999999999999999987665554

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1e-38  Score=351.67  Aligned_cols=251  Identities=23%  Similarity=0.349  Sum_probs=205.4

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CC-------cEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCee
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DG-------MEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFK  832 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~  832 (1049)
                      ++|++.+.||+|+||+||+|+.. ++       ..||+|++........+.+.+|++++++++||||+++++++.+++..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            46888999999999999999854 33       47999999776666678899999999999999999999999999999


Q ss_pred             EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCc--------eEEec
Q 039290          833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMV--------GHLSD  904 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~--------~kl~D  904 (1049)
                      ++||||+++|+|.+++......+++..++.++.|+++||+|||   +++|+||||||+||+++.++.        +||+|
T Consensus        88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D  164 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD  164 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred             EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence            9999999999999999887777999999999999999999999   999999999999999998876        99999


Q ss_pred             ccCceecCCCccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccC
Q 039290          905 FGIAKILGKEESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSC  983 (1049)
Q Consensus       905 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  983 (1049)
                      ||++......     ....+++.|+|||++.+ ..++.++||||+||++|||++|..|+............+....    
T Consensus       165 fg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~----  235 (289)
T 4fvq_A          165 PGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH----  235 (289)
T ss_dssp             CCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC----
T ss_pred             CcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccC----
Confidence            9998754322     22457889999999887 6789999999999999999996554433222111111111000    


Q ss_pred             CcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 039290          984 SITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041 (1049)
Q Consensus       984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~ 1041 (1049)
                                        ..+...+.++.+++.+||+.||++|||++|++++|+++..
T Consensus       236 ------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          236 ------------------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             ------------------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             ------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                              0001123457899999999999999999999999997754

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=357.32  Aligned_cols=276  Identities=25%  Similarity=0.411  Sum_probs=216.1

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-----CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCC--ee
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-----PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNND--FK  832 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~--~~  832 (1049)
                      .++|++.+.||+|+||.||+|++     .+++.||+|++........+.+.+|++++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            34688899999999999999983     368899999998665555678999999999999999999999986644  78


Q ss_pred             EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecC
Q 039290          833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      ++||||+++++|.+++...+..+++.+++.++.|+++||+|||   +.||+||||||+||+++.++.+||+|||++....
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            9999999999999999887777999999999999999999999   9999999999999999999999999999998775


Q ss_pred             CCccc--cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCc-chhc
Q 039290          913 KEESM--RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSI-TEVA  989 (1049)
Q Consensus       913 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  989 (1049)
                      .....  ......++..|+|||.+.+..++.++||||+|+++|||++|..||......   .....+........ ..+.
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH---HHHHHCTTCCTHHHHHHHH
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH---HHHhhccccchhhhHHHHH
Confidence            44321  122345677899999998888999999999999999999999987642110   00000000000000 0000


Q ss_pred             ccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          990 DANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                      . .+.  ...+...+..++.++.+++.+||+.||++|||+.|+++.|+++++++.
T Consensus       274 ~-~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~  325 (326)
T 2w1i_A          274 E-LLK--NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA  325 (326)
T ss_dssp             H-HHH--TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             H-Hhh--cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            0 000  001112234466789999999999999999999999999999998874

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.3e-38  Score=346.37  Aligned_cols=251  Identities=24%  Similarity=0.308  Sum_probs=208.5

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      .++|++.+.||+|+||.||+|+.. ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            356899999999999999999965 5779999999877667788999999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeee---cCCCceEEecccCceecCCCc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~---~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      +++++|.+++...+ .+++.+++.++.|++.|++|||   ++||+||||||+||++   +.++.+||+|||++.......
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           88 CTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             CCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence            99999999887654 4899999999999999999999   9999999999999999   788999999999998775433


Q ss_pred             cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                      .  .....+|+.|+|||++.+ .++.++||||+|+++|||++|+.||......+..... ....                
T Consensus       164 ~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~----------------  223 (277)
T 3f3z_A          164 M--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI-REGT----------------  223 (277)
T ss_dssp             C--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHCC----------------
T ss_pred             c--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH-HhCC----------------
Confidence            2  234568999999998865 4899999999999999999999999763322211111 0000                


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                       ..........++.++.+++.+|++.||++|||+.|++++
T Consensus       224 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          224 -FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             -CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             -CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             000001112356789999999999999999999999986

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.8e-38  Score=365.16  Aligned_cols=273  Identities=18%  Similarity=0.220  Sum_probs=206.8

Q ss_pred             hcCCCCCceecCC--CcEEEEEEEeC-CCcEEEEEEeecccCC--CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          760 TDGFSENKLLGMG--SFGSVYKGVLP-DGMEIAAKVFHMEFDG--SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       760 ~~~~~~~~~lg~G--~fg~Vy~a~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      .++|++.+.||+|  +||+||+|+.. +++.||||+++.....  ..+.+.+|+++++.++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4578999999999  99999999965 7999999999765422  34678889999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          835 VLEYMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      ||||+++|+|.+++... ...+++..++.++.||+.||+|||   +.||+||||||+||+++.++.+||+|||.+.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            99999999999998764 245899999999999999999999   99999999999999999999999999999875432


Q ss_pred             Ccc------ccccccccccCcccccccCC--CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCc
Q 039290          914 EES------MRQTKTLGTIGYMAPEYGRE--GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSI  985 (1049)
Q Consensus       914 ~~~------~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  985 (1049)
                      ...      .......||+.|+|||++.+  ..++.++||||+||++|||++|+.||.+....+.....+.+........
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  260 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence            211      11223468899999999887  6789999999999999999999999976443333222211111000000


Q ss_pred             chhc-----------------ccccc-------cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          986 TEVA-----------------DANLL-------NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       986 ~~~~-----------------~~~~~-------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ....                 .....       .........+..++.++.+++.+||+.||++|||++|+++|
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            0000                 00000       00000112234456789999999999999999999999977

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.8e-38  Score=357.14  Aligned_cols=261  Identities=24%  Similarity=0.441  Sum_probs=212.5

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe--------CCCcEEEEEEeecccC-CCHHHHHHHHHHHhhc-CCCceeeEEeeeecC
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL--------PDGMEIAAKVFHMEFD-GSLESFHAECKVMGSI-RHRNLVKIISSCSNN  829 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~--------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~  829 (1049)
                      .++|++.+.||+|+||.||+|+.        .++..||+|+++.... ...+.+.+|+++++++ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            45788999999999999999986        3567899999975432 2346788999999999 899999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhhcCCC---------------ccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeee
Q 039290          830 DFKALVLEYMSNGSLEKCLYSDNY---------------FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL  894 (1049)
Q Consensus       830 ~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~  894 (1049)
                      +..++||||+++|+|.+++.....               .+++.+++.++.|+++||+|||   +.||+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence            999999999999999999976542               4889999999999999999999   9999999999999999


Q ss_pred             cCCCceEEecccCceecCCCccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchH
Q 039290          895 NESMVGHLSDFGIAKILGKEESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSL  972 (1049)
Q Consensus       895 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~  972 (1049)
                      +.++.+||+|||++......... ......+++.|+|||++.+..++.++||||+||++|||++ |..||......+.  
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--  268 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--  268 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH--
Confidence            99999999999999876543321 2223456788999999988889999999999999999999 9999976322211  


Q ss_pred             HHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          973 KRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                      ........                   +...+..++.++.+++.+||+.||++|||++|++++|+++.....
T Consensus       269 ~~~~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          269 FKLLKEGH-------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             HHHHHHTC-------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHhcCC-------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            11110000                   011112355678999999999999999999999999999987653

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=359.61  Aligned_cols=251  Identities=23%  Similarity=0.286  Sum_probs=191.9

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++...  ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  129 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL  129 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence            467899999999999999999975 68899999997543  346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC---CCceEEecccCceecCCCc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE---SMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~~~kl~DfGla~~~~~~~  915 (1049)
                      +++|+|.+++...+ .+++.+++.++.|+++||+|||   +.||+||||||+||+++.   ++.+||+|||+++......
T Consensus       130 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  205 (349)
T 2w4o_A          130 VTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV  205 (349)
T ss_dssp             CCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence            99999999987654 4899999999999999999999   999999999999999975   8899999999998664322


Q ss_pred             cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                        ......||+.|+|||++.+..++.++||||+||++|||++|..||......+............              
T Consensus       206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~--------------  269 (349)
T 2w4o_A          206 --LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY--------------  269 (349)
T ss_dssp             ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC--------------
T ss_pred             --ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc--------------
Confidence              2234568999999999999899999999999999999999999997543332222221110000              


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                         ...+.....+.++.+++.+||+.||++|||+.|++++
T Consensus       270 ---~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          270 ---FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             ---CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               0001112345678999999999999999999999986

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=9.9e-39  Score=359.82  Aligned_cols=250  Identities=21%  Similarity=0.282  Sum_probs=206.4

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeE
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKA  833 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~  833 (1049)
                      ..++|+..+.||+|+||+||+|+.. +++.||+|+++...   ....+.+.+|.+++..+ +||+|+++++++.+.+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3568999999999999999999975 57889999997642   44567788999999988 7999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          834 LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      +||||+++|+|.+++...+ .+++.+++.++.||+.||+|||   ++||+||||||+||+++.++.+||+|||+++....
T Consensus        98 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            9999999999999987654 4899999999999999999999   99999999999999999999999999999986432


Q ss_pred             CccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          914 EESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       914 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                      .. .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ......             .  
T Consensus       174 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-~~~i~~-------------~--  236 (353)
T 2i0e_A          174 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-FQSIME-------------H--  236 (353)
T ss_dssp             TT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHH-------------C--
T ss_pred             CC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH-HHHHHh-------------C--
Confidence            22 223446799999999999999999999999999999999999999975322211 111100             0  


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRIS-----MKDVANR 1035 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~ell~~ 1035 (1049)
                            ....+...+.++.+++.+|++.||++||+     ++|+++|
T Consensus       237 ------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          237 ------NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             ------CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                  01111234567899999999999999995     5777765

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.2e-38  Score=356.98  Aligned_cols=249  Identities=22%  Similarity=0.292  Sum_probs=196.3

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe----CCCcEEEEEEeeccc----CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL----PDGMEIAAKVFHMEF----DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDF  831 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~  831 (1049)
                      .++|++.+.||+|+||.||+|+.    .+++.||+|+++...    ......+.+|+++++.++||||+++++++.+.+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            35789999999999999999996    478999999997542    2234567889999999999999999999999999


Q ss_pred             eEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceec
Q 039290          832 KALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL  911 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~  911 (1049)
                      .++||||+++++|.+++...+ .+++.++..++.||+.||+|||   ++||+||||||+||+++.++.+||+|||+++..
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            999999999999999987654 4889999999999999999999   999999999999999999999999999999764


Q ss_pred             CCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccc
Q 039290          912 GKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA  991 (1049)
Q Consensus       912 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  991 (1049)
                      ..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+.. ......             
T Consensus       172 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~i~~~-------------  236 (327)
T 3a62_A          172 IHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI-DKILKC-------------  236 (327)
T ss_dssp             --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHT-------------
T ss_pred             ccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH-HHHHhC-------------
Confidence            33222 223457899999999999889999999999999999999999999753222111 110000             


Q ss_pred             ccccccccCchhhHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 039290          992 NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI-----SMKDVANR 1035 (1049)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~~ 1035 (1049)
                              ....+...+.++.+++.+||+.||++||     +++|+++|
T Consensus       237 --------~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          237 --------KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             --------CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence                    0011123456789999999999999999     78888876

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.5e-38  Score=352.74  Aligned_cols=252  Identities=22%  Similarity=0.277  Sum_probs=208.0

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCC------CHHHHHHHHHHHhhcCCCceeeEEeeeecCCee
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDG------SLESFHAECKVMGSIRHRNLVKIISSCSNNDFK  832 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~  832 (1049)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|+++.....      ..+.+.+|++++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            346889999999999999999965 6899999999765422      357899999999999999999999999999999


Q ss_pred             EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC----ceEEecccCc
Q 039290          833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM----VGHLSDFGIA  908 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~----~~kl~DfGla  908 (1049)
                      ++||||+++++|.+++.... .+++..++.++.|+++||+|||   +.||+||||||+||+++.++    .+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            99999999999999997654 5899999999999999999999   99999999999999999887    7999999999


Q ss_pred             eecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchh
Q 039290          909 KILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEV  988 (1049)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  988 (1049)
                      .......  ......||+.|+|||++.+..++.++||||+||++|||++|..||......+.. ......          
T Consensus       167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~i~~~----------  233 (321)
T 2a2a_A          167 HEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-ANITSV----------  233 (321)
T ss_dssp             EECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-HHHHTT----------
T ss_pred             eecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHHhc----------
Confidence            8765432  223456899999999999889999999999999999999999999753222111 111000          


Q ss_pred             cccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          989 ADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                             ............+..+.+++.+|++.||++|||++|+++|
T Consensus       234 -------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          234 -------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             -------CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             -------ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                   0000111122345678999999999999999999999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.4e-38  Score=369.47  Aligned_cols=248  Identities=25%  Similarity=0.386  Sum_probs=207.5

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      .++|.+.+.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            357899999999999999999965 79999999997542   33457899999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++|+|.+++...+ .+++.+++.++.||+.|++|||   +.||+||||||+||+++.++.+||+|||++.......
T Consensus        95 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           95 MEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            99999999999987654 4899999999999999999999   9999999999999999999999999999998765432


Q ss_pred             cccccccccccCcccccccCCCCc-CcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKV-SRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                        ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||......+.. ......                
T Consensus       171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~-~~i~~~----------------  231 (476)
T 2y94_A          171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF-KKICDG----------------  231 (476)
T ss_dssp             --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHH-HHHHTT----------------
T ss_pred             --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHH-HHHhcC----------------
Confidence              2334578999999999988765 68999999999999999999999753222111 111000                


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                           .+..+...+.++.+++.+||+.||++|||++|+++|
T Consensus       232 -----~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          232 -----IFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             -----CcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence                 001112245678999999999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.3e-38  Score=364.45  Aligned_cols=277  Identities=22%  Similarity=0.244  Sum_probs=215.5

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCC--eeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNND--FKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~--~~~lv~  836 (1049)
                      ++|++.+.||+|+||+||+|+.. +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            46889999999999999999965 58999999997543 344677889999999999999999999988755  779999


Q ss_pred             eccCCCChhhhhhcCCC--ccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeee----cCCCceEEecccCcee
Q 039290          837 EYMSNGSLEKCLYSDNY--FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL----NESMVGHLSDFGIAKI  910 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~----~~~~~~kl~DfGla~~  910 (1049)
                      ||+++|+|.+++.....  .+++.+++.++.|++.||+|||   +.||+||||||+||++    +.++.+||+|||+++.
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            99999999999876433  3899999999999999999999   9999999999999999    7778899999999987


Q ss_pred             cCCCccccccccccccCcccccccCC--------CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhc--c
Q 039290          911 LGKEESMRQTKTLGTIGYMAPEYGRE--------GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDS--L  980 (1049)
Q Consensus       911 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~--~  980 (1049)
                      .....  ......||+.|+|||++.+        ..++.++||||+||++|||++|+.||.................  .
T Consensus       166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  243 (396)
T 4eut_A          166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (396)
T ss_dssp             CCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred             ccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence            65433  2234568999999998764        5678899999999999999999999975433222211111111  0


Q ss_pred             ccCCcchhccc---c--cccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHh
Q 039290          981 LSCSITEVADA---N--LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042 (1049)
Q Consensus       981 ~~~~~~~~~~~---~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~ 1042 (1049)
                      ....+......   .  ...............+..+.+++.+||+.||++||+++|+++.++++..+
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            00111100000   0  00001111223366788899999999999999999999999999998764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-38  Score=356.40  Aligned_cols=262  Identities=26%  Similarity=0.471  Sum_probs=207.4

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCC-----CcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPD-----GMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~-----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      .+|+..+.||+|+||.||+|+...     +..||+|+++.... .....+.+|++++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            457778999999999999998542     24599999975432 234578899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      ||||+++|+|.+++......+++.+++.++.|+++||+|||   +.||+||||||+||+++.++.+||+|||++......
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence            99999999999999887677999999999999999999999   999999999999999999999999999999876533


Q ss_pred             ccc--cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccc
Q 039290          915 ESM--RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA  991 (1049)
Q Consensus       915 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  991 (1049)
                      ...  ......+++.|+|||++.+..++.++||||+||++|||++ |+.||......+.  ...+...            
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~--~~~~~~~------------  266 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV--MKAINDG------------  266 (333)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHHHTT------------
T ss_pred             cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH--HHHHHCC------------
Confidence            211  1222345778999999988899999999999999999999 9999975332211  1111000            


Q ss_pred             ccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhc
Q 039290          992 NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAY 1046 (1049)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~ 1046 (1049)
                             .+...+..++..+.+++.+||+.||++||++.|++++|+++.+.....
T Consensus       267 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~  314 (333)
T 1mqb_A          267 -------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL  314 (333)
T ss_dssp             -------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred             -------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence                   001112235667899999999999999999999999999998876543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.3e-38  Score=355.51  Aligned_cols=269  Identities=23%  Similarity=0.373  Sum_probs=216.7

Q ss_pred             cHHHHHHHhcCCCCCceecCCCcEEEEEEEe------CCCcEEEEEEeecccC-CCHHHHHHHHHHHhhc-CCCceeeEE
Q 039290          752 SYQDLLRATDGFSENKLLGMGSFGSVYKGVL------PDGMEIAAKVFHMEFD-GSLESFHAECKVMGSI-RHRNLVKII  823 (1049)
Q Consensus       752 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~a~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~l~  823 (1049)
                      ...++....++|++.+.||+|+||+||+|++      .+++.||+|+++.... ...+.+.+|++++.++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3344445567899999999999999999983      3568899999975432 2345788999999999 799999999


Q ss_pred             eeeecCC-eeEEEEeccCCCChhhhhhcCCC---------------ccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCC
Q 039290          824 SSCSNND-FKALVLEYMSNGSLEKCLYSDNY---------------FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDI  887 (1049)
Q Consensus       824 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl  887 (1049)
                      +++.+.+ ..++||||+++|+|.+++.....               .+++.+++.++.|+++|++|||   +.||+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccC
Confidence            9987654 58999999999999999976543               2789999999999999999999   999999999


Q ss_pred             CCCCeeecCCCceEEecccCceecCCCcc-ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCcc
Q 039290          888 KPSNVLLNESMVGHLSDFGIAKILGKEES-MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEI  965 (1049)
Q Consensus       888 kp~NIl~~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~  965 (1049)
                      ||+||+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||+||++|||++ |..||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999987644332 22334567889999999988899999999999999999998 99999764


Q ss_pred             ccccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhh
Q 039290          966 FAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043 (1049)
Q Consensus       966 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~ 1043 (1049)
                      ...+..........                    ....+..++.++.+++.+||+.||++|||++|++++|+++.++.
T Consensus       255 ~~~~~~~~~~~~~~--------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          255 KIDEEFCRRLKEGT--------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             CCSHHHHHHHHHTC--------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             chhHHHHHHhccCc--------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            33322221111100                    00111224567899999999999999999999999999998764

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.3e-38  Score=354.18  Aligned_cols=249  Identities=22%  Similarity=0.263  Sum_probs=183.1

Q ss_pred             CceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcC-CCceeeEEeeeecCCeeEEEEeccCCCC
Q 039290          766 NKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIR-HRNLVKIISSCSNNDFKALVLEYMSNGS  843 (1049)
Q Consensus       766 ~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~g~  843 (1049)
                      .+.||+|+||+||+|+.. +++.||||++...   ....+.+|+.+++.+. ||||+++++++.+.+..++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999964 7899999999643   3467889999999997 9999999999999999999999999999


Q ss_pred             hhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC---ceEEecccCceecCCCcccccc
Q 039290          844 LEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM---VGHLSDFGIAKILGKEESMRQT  920 (1049)
Q Consensus       844 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~---~~kl~DfGla~~~~~~~~~~~~  920 (1049)
                      |.+++...+ .+++.+++.++.|+++|++|||   ++||+||||||+||+++.++   .+||+|||+++....... ...
T Consensus        93 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~  167 (325)
T 3kn6_A           93 LFERIKKKK-HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLK  167 (325)
T ss_dssp             HHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-ccc
Confidence            999998764 5899999999999999999999   99999999999999998665   899999999987654332 233


Q ss_pred             ccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccc--hHHHhhhhccccCCcchhcccccccccc
Q 039290          921 KTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEM--SLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       921 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                      ...+|+.|+|||++.+..++.++||||+||++|||++|..||........  .....             ..........
T Consensus       168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-------------~~~i~~~~~~  234 (325)
T 3kn6_A          168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEI-------------MKKIKKGDFS  234 (325)
T ss_dssp             ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHH-------------HHHHTTTCCC
T ss_pred             ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHH-------------HHHHHcCCCC
Confidence            45689999999999999999999999999999999999999976332110  00010             0000000111


Q ss_pred             cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          999 NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       999 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ........++.++.+++.+||+.||++|||++|++++
T Consensus       235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            1112224467789999999999999999999998865

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.5e-38  Score=347.01  Aligned_cols=265  Identities=20%  Similarity=0.255  Sum_probs=209.5

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeee-ecCCeeEEEE
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC-SNNDFKALVL  836 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~-~~~~~~~lv~  836 (1049)
                      ..++|++.+.||+|+||+||+|+. .+++.||+|++.....  .+.+.+|+++++.++|++++..++++ .+.+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            346899999999999999999995 5788999998765432  24688999999999988777666655 6678889999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeee---cCCCceEEecccCceecCC
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~---~~~~~~kl~DfGla~~~~~  913 (1049)
                      ||+ +++|.+++......+++.+++.++.|++.|++|||   ++||+||||||+||++   +.++.+||+|||+++....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            999 89999999876667999999999999999999999   9999999999999999   7889999999999987654


Q ss_pred             Ccc------ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccc--hHHHhhhhccccCCc
Q 039290          914 EES------MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEM--SLKRWVGDSLLSCSI  985 (1049)
Q Consensus       914 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~  985 (1049)
                      ...      .......||+.|+|||++.+..++.++||||+||++|||++|+.||........  ..........     
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-----  235 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-----  235 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH-----
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc-----
Confidence            332      122345789999999999999999999999999999999999999976433221  1111100000     


Q ss_pred             chhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhh
Q 039290          986 TEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSA 1045 (1049)
Q Consensus       986 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~ 1045 (1049)
                                 ..........++.++.+++.+||+.||++|||++++++.|+++.++...
T Consensus       236 -----------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~  284 (296)
T 4hgt_A          236 -----------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             -----------HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred             -----------cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence                       0000001123467899999999999999999999999999999988764

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.6e-38  Score=354.97  Aligned_cols=268  Identities=21%  Similarity=0.271  Sum_probs=200.9

Q ss_pred             cCCCCC-ceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEEEe
Q 039290          761 DGFSEN-KLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       761 ~~~~~~-~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      ++|++. +.||+|+||.||+|+. .+++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            467774 7899999999999995 47899999999876666678899999999985 79999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCc---eEEecccCceecCCC
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMV---GHLSDFGIAKILGKE  914 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~---~kl~DfGla~~~~~~  914 (1049)
                      |+++|+|.+++.... .+++.+++.++.|+++||+|||   +++|+||||||+||+++.++.   +||+|||++......
T Consensus        92 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           92 KMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             cCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            999999999987654 4899999999999999999999   999999999999999987765   999999999765322


Q ss_pred             cc------ccccccccccCcccccccCC-----CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccC
Q 039290          915 ES------MRQTKTLGTIGYMAPEYGRE-----GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSC  983 (1049)
Q Consensus       915 ~~------~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  983 (1049)
                      ..      .......||+.|+|||++.+     ..++.++||||+||++|||++|+.||......+..+..   ......
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~  244 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR---GEACPA  244 (316)
T ss_dssp             --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-------CCHH
T ss_pred             CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc---cccchh
Confidence            11      11223458999999999865     56889999999999999999999999764333211100   000000


Q ss_pred             CcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          984 SITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ....+...................+.++.+++.+||+.||++|||++|+++|
T Consensus       245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            0000000000000000001112356789999999999999999999999986

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=3.4e-37  Score=363.16  Aligned_cols=346  Identities=28%  Similarity=0.439  Sum_probs=197.2

Q ss_pred             cccccceEEeccccccccCccccccccceEEEeeccccCCCccccccccccccceEEeccCccCCCCCCcccCCCCCccE
Q 039290          245 NLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLER  324 (1049)
Q Consensus       245 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~  324 (1049)
                      .+++++.|++++|.+. .+| .+..+++|++|+|++|++.+..|  +.++++|++|++++|++.+..+   ...+++|++
T Consensus        44 ~l~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~---~~~l~~L~~  116 (466)
T 1o6v_A           44 DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP---LANLTNLTG  116 (466)
T ss_dssp             HHHTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG---GTTCTTCCE
T ss_pred             HhccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh---hcCCCCCCE
Confidence            3556666677666665 344 36666677777777666666544  6666666677776666664332   345677777


Q ss_pred             EEcCCCCCCCCCCccccCCCCCceeecccCccccCcccccccccccceeecccccccCCCCCcccccccccCCCCcEEEc
Q 039290          325 LFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYL  404 (1049)
Q Consensus       325 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~L  404 (1049)
                      |++++|++++..+  +.++++|++|++++|.+.+. + .++.+++|++|+++ |.+...       ..+..+++|+.|++
T Consensus       117 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~-------~~~~~l~~L~~L~l  184 (466)
T 1o6v_A          117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDL-------KPLANLTTLERLDI  184 (466)
T ss_dssp             EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCC-------GGGTTCTTCCEEEC
T ss_pred             EECCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCc-------hhhccCCCCCEEEC
Confidence            7777777764432  67777777777777777753 3 36777777777775 333332       22566667777777


Q ss_pred             cCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCC
Q 039290          405 SENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEG  484 (1049)
Q Consensus       405 s~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  484 (1049)
                      ++|.+++..                           .+..+++|++|++++|.+++..|  ++.+++|++|++++|++++
T Consensus       185 ~~n~l~~~~---------------------------~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~  235 (466)
T 1o6v_A          185 SSNKVSDIS---------------------------VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD  235 (466)
T ss_dssp             CSSCCCCCG---------------------------GGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred             cCCcCCCCh---------------------------hhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCccc
Confidence            777665321                           13334444444444444443322  3444445555555555442


Q ss_pred             CCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCC
Q 039290          485 SIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGN  564 (1049)
Q Consensus       485 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  564 (1049)
                      .  ..+..+++|+.|++++|.+++..|  +..+++|++|++++|++++..+  +..+++|+.|++++|++++..+  +..
T Consensus       236 ~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~  307 (466)
T 1o6v_A          236 I--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISN  307 (466)
T ss_dssp             C--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGG
T ss_pred             c--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcC
Confidence            1  234445555555555555543322  4455555555555555554333  4455555555555555554322  455


Q ss_pred             CcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCcccccccccccceee
Q 039290          565 LKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLN  644 (1049)
Q Consensus       565 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~  644 (1049)
                      +++|++|++++|++++..|  +..+++|+.|++++|++++.  ..+.++++|++|++++|++++..|  +..+++|+.|+
T Consensus       308 l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~  381 (466)
T 1o6v_A          308 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLG  381 (466)
T ss_dssp             CTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEE
T ss_pred             CCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEe
Confidence            5556666666666655444  55566666666666666643  345666666666666666665554  55666666666


Q ss_pred             ccCCcccc
Q 039290          645 LSFNQLEG  652 (1049)
Q Consensus       645 l~~N~l~~  652 (1049)
                      +++|++++
T Consensus       382 l~~n~~~~  389 (466)
T 1o6v_A          382 LNDQAWTN  389 (466)
T ss_dssp             CCCEEEEC
T ss_pred             ccCCcccC
Confidence            66666665

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=1.9e-37  Score=365.37  Aligned_cols=345  Identities=26%  Similarity=0.403  Sum_probs=176.1

Q ss_pred             CCccceEEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceEEeccccccccCccccccccceEEEe
Q 039290          198 LPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLG  277 (1049)
Q Consensus       198 l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  277 (1049)
                      ++.++.|++++|.+.. +|. +..+++|++|+|++|.+++..|  ++++++|++|+|++|++++..|  ++++++|++|+
T Consensus        45 l~~l~~L~l~~~~i~~-l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~  118 (466)
T 1o6v_A           45 LDQVTTLQADRLGIKS-IDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT  118 (466)
T ss_dssp             HHTCCEEECCSSCCCC-CTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred             hccccEEecCCCCCcc-Ccc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence            3457778888877763 553 6667777777777777765433  6777777777777777764433  66777777777


Q ss_pred             eccccCCCccccccccccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccc
Q 039290          278 VQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFS  357 (1049)
Q Consensus       278 L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  357 (1049)
                      +++|++.+..+  +.++++|++|++++|.+.+ ++.  ...+++|++|+++ |.+.+..+  +.++++|++|++++|.+.
T Consensus       119 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~--~~~l~~L~~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~l~  190 (466)
T 1o6v_A          119 LFNNQITDIDP--LKNLTNLNRLELSSNTISD-ISA--LSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVS  190 (466)
T ss_dssp             CCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CGG--GTTCTTCSEEEEE-ESCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             CCCCCCCCChH--HcCCCCCCEEECCCCccCC-Chh--hccCCcccEeecC-CcccCchh--hccCCCCCEEECcCCcCC
Confidence            77776665533  5566666666666666552 221  2245555555553 33332211  444555555555555544


Q ss_pred             cCcccccccccccceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccC
Q 039290          358 GLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGG  437 (1049)
Q Consensus       358 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~  437 (1049)
                      +.  ..+..+++|++|++++|.++...+       +..+++|+.|++++|.++                         +.
T Consensus       191 ~~--~~l~~l~~L~~L~l~~n~l~~~~~-------~~~l~~L~~L~l~~n~l~-------------------------~~  236 (466)
T 1o6v_A          191 DI--SVLAKLTNLESLIATNNQISDITP-------LGILTNLDELSLNGNQLK-------------------------DI  236 (466)
T ss_dssp             CC--GGGGGCTTCSEEECCSSCCCCCGG-------GGGCTTCCEEECCSSCCC-------------------------CC
T ss_pred             CC--hhhccCCCCCEEEecCCccccccc-------ccccCCCCEEECCCCCcc-------------------------cc
Confidence            32  124444444444444444433221       222333333333333332                         21


Q ss_pred             CCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCc
Q 039290          438 IPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNL  517 (1049)
Q Consensus       438 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  517 (1049)
                        +.+..+++|+.|++++|.+++..|  +..+++|++|++++|++++..+  +..+++|+.|++++|++++..+  ++.+
T Consensus       237 --~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l  308 (466)
T 1o6v_A          237 --GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNL  308 (466)
T ss_dssp             --GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGC
T ss_pred             --hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCC
Confidence              123444555555555555553322  4445555555555555543222  4444444455554444443222  4444


Q ss_pred             ccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEe
Q 039290          518 TSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSL  597 (1049)
Q Consensus       518 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  597 (1049)
                      ++|+.|++++|++++..|                          +..+++|++|++++|++++.  ..+..+++|+.|++
T Consensus       309 ~~L~~L~L~~n~l~~~~~--------------------------~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l  360 (466)
T 1o6v_A          309 KNLTYLTLYFNNISDISP--------------------------VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSA  360 (466)
T ss_dssp             TTCSEEECCSSCCSCCGG--------------------------GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEEC
T ss_pred             CCCCEEECcCCcCCCchh--------------------------hccCccCCEeECCCCccCCc--hhhccCCCCCEEeC
Confidence            444444444444444332                          34444444455555544433  24555555555555


Q ss_pred             ecccccCCccccccCccCCcEEeccCccccC
Q 039290          598 RYNRLQGPIPESFGGLKSLNFVDMSNNNLSG  628 (1049)
Q Consensus       598 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  628 (1049)
                      ++|++++..|  +..+++|+.|++++|++++
T Consensus       361 ~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~  389 (466)
T 1o6v_A          361 GHNQISDLTP--LANLTRITQLGLNDQAWTN  389 (466)
T ss_dssp             CSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred             CCCccCccch--hhcCCCCCEEeccCCcccC
Confidence            5555555444  5555555555555555553

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.3e-38  Score=355.23  Aligned_cols=262  Identities=24%  Similarity=0.415  Sum_probs=211.0

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEE--EEEEeeccc-CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEI--AAKVFHMEF-DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~v--avK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      ++|++.+.||+|+||.||+|+.. ++..+  |+|.++... ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            46888899999999999999954 56644  899887532 33456789999999999 899999999999999999999


Q ss_pred             EeccCCCChhhhhhcCC---------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCce
Q 039290          836 LEYMSNGSLEKCLYSDN---------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVG  900 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~  900 (1049)
                      |||+++|+|.+++...+               ..+++.+++.++.|+++||+|||   ++||+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence            99999999999997654               36899999999999999999999   9999999999999999999999


Q ss_pred             EEecccCceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhc
Q 039290          901 HLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDS  979 (1049)
Q Consensus       901 kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  979 (1049)
                      ||+|||+++......  ......+++.|+|||++.+..++.++||||+||++|||++ |..||......+.  ...... 
T Consensus       182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~--~~~~~~-  256 (327)
T 1fvr_A          182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--YEKLPQ-  256 (327)
T ss_dssp             EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHGGG-
T ss_pred             EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH--HHHhhc-
Confidence            999999997543211  2233456789999999988889999999999999999998 9999976322211  110000 


Q ss_pred             cccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhccC
Q 039290          980 LLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYID 1048 (1049)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~~~ 1048 (1049)
                         .               .+...+..++.++.+++.+||+.||++|||++|++++|+++.++...+++
T Consensus       257 ---~---------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~  307 (327)
T 1fvr_A          257 ---G---------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN  307 (327)
T ss_dssp             ---T---------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBC
T ss_pred             ---C---------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCccc
Confidence               0               00111123456789999999999999999999999999999998877765

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.7e-38  Score=359.43  Aligned_cols=259  Identities=22%  Similarity=0.269  Sum_probs=204.2

Q ss_pred             HHHHhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc-----CCCHHHHHHHHHHHhhcCCCceeeEEeeeecC
Q 039290          756 LLRATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF-----DGSLESFHAECKVMGSIRHRNLVKIISSCSNN  829 (1049)
Q Consensus       756 ~~~~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~  829 (1049)
                      +....++|++.+.||+|+||+||+|+. .+++.||+|++....     ....+.+.+|++++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            344566799999999999999999996 478899999986542     34467899999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhhcC---------------------------------------CCccCHHHHHHHHHHHHHH
Q 039290          830 DFKALVLEYMSNGSLEKCLYSD---------------------------------------NYFLDILQRLKIMIDVASA  870 (1049)
Q Consensus       830 ~~~~lv~e~~~~g~L~~~l~~~---------------------------------------~~~~~~~~~~~i~~~i~~~  870 (1049)
                      +..++||||+++|+|.+++...                                       ...+++..++.++.|+++|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            9999999999999999988521                                       1234677888999999999


Q ss_pred             HHHhHccCCCCeEEcCCCCCCeeecCCC--ceEEecccCceecCCCc---cccccccccccCcccccccCC--CCcCccc
Q 039290          871 LEYLHFGYSTPIVHCDIKPSNVLLNESM--VGHLSDFGIAKILGKEE---SMRQTKTLGTIGYMAPEYGRE--GKVSRKC  943 (1049)
Q Consensus       871 l~~LH~~~~~~ivH~Dlkp~NIl~~~~~--~~kl~DfGla~~~~~~~---~~~~~~~~~~~~y~aPE~~~~--~~~~~~~  943 (1049)
                      |+|||   +.+|+||||||+||+++.++  .+||+|||++..+....   ........||+.|+|||++.+  ..++.++
T Consensus       181 l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            99999   99999999999999998766  89999999998764322   122345678999999999865  6788999


Q ss_pred             chHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCC
Q 039290          944 DVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLP 1023 (1049)
Q Consensus       944 DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 1023 (1049)
                      ||||+||++|||++|+.||......+..........                  ....+.....+.++.+++.+||+.||
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~li~~~l~~~p  319 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKL------------------CFENPNYNVLSPLARDLLSNLLNRNV  319 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------------CTTSGGGGGSCHHHHHHHHHHSCSCT
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhccc------------------ccCCcccccCCHHHHHHHHHHcCCCh
Confidence            999999999999999999976433322211111000                  00011112345678999999999999


Q ss_pred             CCCCCHHHHHHH
Q 039290         1024 EKRISMKDVANR 1035 (1049)
Q Consensus      1024 ~~Rpt~~ell~~ 1035 (1049)
                      .+|||+.|++++
T Consensus       320 ~~Rps~~~~l~h  331 (345)
T 3hko_A          320 DERFDAMRALQH  331 (345)
T ss_dssp             TTSCCHHHHHHS
T ss_pred             hHCCCHHHHhcC
Confidence            999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.2e-38  Score=350.61  Aligned_cols=260  Identities=25%  Similarity=0.419  Sum_probs=206.9

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCC----CcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeee-ecCCeeEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPD----GMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSC-SNNDFKAL  834 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~-~~~~~~~l  834 (1049)
                      .+|+..+.||+|+||+||+|+..+    ...||+|.+..... ...+.+.+|++++++++||||+++++++ ..++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            458888999999999999998542    23588998865332 2346788999999999999999999985 45668899


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      ||||+++|+|.+++......+++.+++.++.|+++|++|||   ++||+||||||+||+++.++.+||+|||+++.....
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  181 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  181 (298)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred             EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence            99999999999999887777899999999999999999999   999999999999999999999999999999876443


Q ss_pred             cc---ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcc
Q 039290          915 ES---MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD  990 (1049)
Q Consensus       915 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  990 (1049)
                      ..   .......+|+.|+|||.+.+..++.++||||+|+++|||++ |.+||......+..... ....           
T Consensus       182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~-~~~~-----------  249 (298)
T 3f66_A          182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGR-----------  249 (298)
T ss_dssp             GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH-HTTC-----------
T ss_pred             chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-hcCC-----------
Confidence            31   12233457788999999988899999999999999999999 55565543222221111 1000           


Q ss_pred             cccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          991 ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                               +...+..++..+.+++.+||+.||++|||++|+++.|+++.+++.
T Consensus       250 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          250 ---------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             ---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence                     001112245678999999999999999999999999999988653

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5.3e-38  Score=349.16  Aligned_cols=269  Identities=23%  Similarity=0.251  Sum_probs=203.6

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC-----CCHHHHHHHHHHHhhcC---CCceeeEEeeeecCC
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD-----GSLESFHAECKVMGSIR---HRNLVKIISSCSNND  830 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~---hpniv~l~~~~~~~~  830 (1049)
                      .++|++.+.||+|+||+||+|+. .+++.||+|+++....     .....+.+|++++++++   ||||+++++++.+..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            56899999999999999999995 5789999999975431     22456778888877764   999999999997754


Q ss_pred             -----eeEEEEeccCCCChhhhhhcCCC-ccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEec
Q 039290          831 -----FKALVLEYMSNGSLEKCLYSDNY-FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSD  904 (1049)
Q Consensus       831 -----~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D  904 (1049)
                           ..++||||++ ++|.+++..... .+++.+++.++.|+++||+|||   +++|+||||||+||+++.++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred             CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEee
Confidence                 5789999997 599999876543 4899999999999999999999   99999999999999999999999999


Q ss_pred             ccCceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhc--ccc
Q 039290          905 FGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDS--LLS  982 (1049)
Q Consensus       905 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~--~~~  982 (1049)
                      ||+++......  ......+|+.|+|||++.+..++.++||||+||++|||++|+.||......+... ......  ...
T Consensus       164 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~i~~~~~~~~~  240 (308)
T 3g33_A          164 FGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG-KIFDLIGLPPE  240 (308)
T ss_dssp             CSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHH-HHHHHHCCCCT
T ss_pred             CccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCCCh
Confidence            99998664332  2344678999999999988899999999999999999999999997643322211 111100  000


Q ss_pred             CCcchhc---ccccccc-cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          983 CSITEVA---DANLLNC-EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       983 ~~~~~~~---~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ..+....   ....... .........+.++++.+++.+|++.||++|||++|+++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            0000000   0000000 000011112356788999999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.3e-38  Score=353.82  Aligned_cols=260  Identities=22%  Similarity=0.261  Sum_probs=207.7

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeee----cCCeeEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS----NNDFKAL  834 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~----~~~~~~l  834 (1049)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++........+.+.+|+++++.++||||+++++++.    ..+..++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            45799999999999999999996 589999999987655555678899999999999999999999986    3457899


Q ss_pred             EEeccCCCChhhhhhc---CCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceec
Q 039290          835 VLEYMSNGSLEKCLYS---DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL  911 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~  911 (1049)
                      ||||+++|+|.+++..   ....+++.+++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            9999999999998875   3456899999999999999999999   999999999999999999999999999998865


Q ss_pred             CCCccc--------cccccccccCcccccccCCCC---cCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcc
Q 039290          912 GKEESM--------RQTKTLGTIGYMAPEYGREGK---VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSL  980 (1049)
Q Consensus       912 ~~~~~~--------~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  980 (1049)
                      ......        ......|++.|+|||++.+..   ++.++||||+||++|||++|+.||..................
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  264 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL  264 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence            422111        112345789999999987543   688999999999999999999999753322222111111000


Q ss_pred             ccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 039290          981 LSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041 (1049)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~ 1041 (1049)
                                         ..+....++.++.+++.+||+.||.+|||++|++++|+++..
T Consensus       265 -------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          265 -------------------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             --------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             -------------------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence                               001112345679999999999999999999999999998754

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.6e-38  Score=346.38  Aligned_cols=248  Identities=25%  Similarity=0.358  Sum_probs=203.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      .++|++.+.||+|+||.||+|+.. ++..||+|++....   ......+.+|++++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467899999999999999999864 67799999986532   23456789999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++++|.+++.... .+++..++.++.|++.|++|||   +.||+||||||+||+++.++.+||+|||++.......
T Consensus        88 ~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~  163 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  163 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence            99999999999987654 4899999999999999999999   9999999999999999999999999999986543322


Q ss_pred             cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                         .....+++.|+|||.+.+..++.++||||+|+++|+|++|..||......+.. .... .                 
T Consensus       164 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~-~-----------------  221 (279)
T 3fdn_A          164 ---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-KRIS-R-----------------  221 (279)
T ss_dssp             -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHHH-H-----------------
T ss_pred             ---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH-HHHH-h-----------------
Confidence               23456899999999999989999999999999999999999999753222111 1000 0                 


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                         .....+...+..+.+++.+||+.||++|||++|+++|-
T Consensus       222 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~  259 (279)
T 3fdn_A          222 ---VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP  259 (279)
T ss_dssp             ---TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred             ---CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence               00111122456789999999999999999999999874

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.5e-38  Score=351.73  Aligned_cols=261  Identities=21%  Similarity=0.279  Sum_probs=202.0

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCC---HHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGS---LESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.......   .+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            568999999999999999999965 78899999997654322   46788999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++++|.+++.... .+++.+++.++.|+++|++|||   +.||+||||||+||+++.++.+||+|||++.......
T Consensus       113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            99999999999987654 4899999999999999999999   9999999999999999999999999999998765443


Q ss_pred             cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                      ........+++.|+|||++.+..++.++||||+|+++|||++|+.||......  ..........               
T Consensus       189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~---------------  251 (309)
T 2h34_A          189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAI---------------  251 (309)
T ss_dssp             --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCC---------------
T ss_pred             cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCC---------------
Confidence            33334557899999999999989999999999999999999999999763222  1111110000               


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCC-CHHHHHHHHHHHHHhh
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRI-SMKDVANRLVRIRETL 1043 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~ell~~L~~i~~~~ 1043 (1049)
                        ......+..++.++.+++.+||+.||++|| +++++++.|++.....
T Consensus       252 --~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          252 --PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             --CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             --CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence              000111233556789999999999999999 9999999998776543

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.2e-37  Score=344.31  Aligned_cols=264  Identities=20%  Similarity=0.253  Sum_probs=212.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeee-ecCCeeEEEEe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC-SNNDFKALVLE  837 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~-~~~~~~~lv~e  837 (1049)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++....  ..+++.+|+++++.++|++++..++++ .+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46799999999999999999995 589999999987543  335789999999999988766666554 66778899999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec---CCCceEEecccCceecCCC
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~---~~~~~kl~DfGla~~~~~~  914 (1049)
                      |+ +++|.+++......+++.+++.++.|++.|++|||   ++||+||||||+||+++   .++.+||+|||++......
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99 88999999866667999999999999999999999   99999999999999994   8889999999999876543


Q ss_pred             ccc------cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccc--hHHHhhhhccccCCcc
Q 039290          915 ESM------RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEM--SLKRWVGDSLLSCSIT  986 (1049)
Q Consensus       915 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~  986 (1049)
                      ...      ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+.  ...........     
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----  236 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-----  236 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-----
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC-----
Confidence            321      12345789999999999999999999999999999999999999986432211  11111100000     


Q ss_pred             hhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhh
Q 039290          987 EVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSA 1045 (1049)
Q Consensus       987 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~ 1045 (1049)
                                 .........++.++.+++.+||+.||++|||++++++.|+++..+...
T Consensus       237 -----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  284 (296)
T 3uzp_A          237 -----------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             -----------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             -----------CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence                       000011123467899999999999999999999999999999887653

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.9e-38  Score=345.92  Aligned_cols=252  Identities=23%  Similarity=0.363  Sum_probs=206.2

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCC--CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDG--SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      .++|++.+.||+|+||.||+|... +++.||+|++......  ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            467999999999999999999964 6899999999765422  3467889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCc---eEEecccCceecCC
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMV---GHLSDFGIAKILGK  913 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~---~kl~DfGla~~~~~  913 (1049)
                      ||+++++|.+.+.... .+++.+++.++.|++.|++|||   +.||+||||||+||+++.++.   +||+|||++.....
T Consensus        85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            9999999988887654 4899999999999999999999   999999999999999986554   99999999987654


Q ss_pred             CccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          914 EESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       914 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                      ...  .....+++.|+|||++.+..++.++||||+|+++|+|++|+.||......+..... .....             
T Consensus       161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~-~~~~~-------------  224 (284)
T 3kk8_A          161 SEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-KAGAY-------------  224 (284)
T ss_dssp             SCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHTCC-------------
T ss_pred             Ccc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH-Hhccc-------------
Confidence            332  23456899999999999999999999999999999999999999753222111111 10000             


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                          .........++.++.+++.+|++.||++|||++|++++
T Consensus       225 ----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          225 ----DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             ----CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ----cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                00001112345678999999999999999999999986

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=7.3e-39  Score=356.49  Aligned_cols=258  Identities=22%  Similarity=0.384  Sum_probs=198.2

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCC---HHHHHHHHHHHhhcCCCceeeEEeeeecCCe----
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGS---LESFHAECKVMGSIRHRNLVKIISSCSNNDF----  831 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~----  831 (1049)
                      .++|++.+.||+|+||.||+|+. .+++.||+|+++......   ...+.+|++++++++||||+++++++...+.    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            45799999999999999999995 578999999997654333   3578899999999999999999999876543    


Q ss_pred             eEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceec
Q 039290          832 KALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL  911 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~  911 (1049)
                      .++||||+++++|.+++...+ .+++.+++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++...
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            499999999999999987654 4899999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCcc--ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhc
Q 039290          912 GKEES--MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA  989 (1049)
Q Consensus       912 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  989 (1049)
                      .....  .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+.........           
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~-----------  235 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED-----------  235 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-----------
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC-----------
Confidence            54322  12233568999999999998899999999999999999999999997643222211111100           


Q ss_pred             ccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH-HHHHH
Q 039290          990 DANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVAN-RLVRI 1039 (1049)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~-~L~~i 1039 (1049)
                             ..........++.++.+++.+||+.||++||++.++++ .+.++
T Consensus       236 -------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          236 -------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             -------CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -------CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence                   00000111235677999999999999999997666554 45444

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.4e-39  Score=360.46  Aligned_cols=265  Identities=23%  Similarity=0.389  Sum_probs=213.2

Q ss_pred             HHHHHhcCCCCCceecCCCcEEEEEEEeC------CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeee
Q 039290          755 DLLRATDGFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCS  827 (1049)
Q Consensus       755 ~~~~~~~~~~~~~~lg~G~fg~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~  827 (1049)
                      ++....++|++.+.||+|+||.||+|++.      +++.||+|++..... .....+.+|++++++++||||+++++++.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            33445678999999999999999999854      367899999975432 23456889999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhhcCC---------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC
Q 039290          828 NNDFKALVLEYMSNGSLEKCLYSDN---------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM  898 (1049)
Q Consensus       828 ~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~  898 (1049)
                      +.+..++||||+++|+|.+++...+         ..+++.+++.++.|++.||+|||   ++||+||||||+||+++.++
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTC
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCC
Confidence            9999999999999999999987532         34689999999999999999999   99999999999999999999


Q ss_pred             ceEEecccCceecCCCccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhh
Q 039290          899 VGHLSDFGIAKILGKEESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWV  976 (1049)
Q Consensus       899 ~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  976 (1049)
                      .+||+|||++......... ......+++.|+|||++.+..++.++||||+||++|||++ |..||......+.  ...+
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~~~  253 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV--LRFV  253 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH--HHHH
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH--HHHH
Confidence            9999999999865433221 2233456889999999988889999999999999999999 8899876322211  1111


Q ss_pred             hhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhh
Q 039290          977 GDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043 (1049)
Q Consensus       977 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~ 1043 (1049)
                      ..            ...       ...+..++..+.+++.+||+.||++|||+.|++++|+++.+..
T Consensus       254 ~~------------~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~  301 (322)
T 1p4o_A          254 ME------------GGL-------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  301 (322)
T ss_dssp             HT------------TCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             Hc------------CCc-------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence            00            000       0111235567899999999999999999999999998875543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-38  Score=347.08  Aligned_cols=260  Identities=23%  Similarity=0.364  Sum_probs=208.1

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CC---cEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCee-EEE
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DG---MEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFK-ALV  835 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~-~lv  835 (1049)
                      .|...+.||+|+||+||+|++. ++   ..||+|++..... ...+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4556689999999999999843 22   3799999865332 2356788999999999999999999999876655 999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+.+|+|.+++......+++.+++.++.|++.|++|||   +.||+||||||+||+++.++.+||+|||+++......
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            9999999999999887777899999999999999999999   9999999999999999999999999999998654332


Q ss_pred             c---ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccc
Q 039290          916 S---MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       916 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      .   .......+++.|+|||.+.+..++.++||||+||++|||++|..|+........ .........            
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~~~~------------  245 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-LTHFLAQGR------------  245 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-HHHHHHTTC------------
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-HHHHhhcCC------------
Confidence            1   122334578899999999999999999999999999999996655433222211 111111000            


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                             ....+..++..+.+++.+||+.||++|||++|+++.|+++.+++.
T Consensus       246 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          246 -------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             -------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence                   011112345678999999999999999999999999999998764

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.6e-38  Score=343.15  Aligned_cols=253  Identities=25%  Similarity=0.372  Sum_probs=209.0

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            457889999999999999999965 78999999997554 3345788999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc-
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES-  916 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~-  916 (1049)
                      |+++++|.+++.... .+++.+++.++.|+++|++|||   +.||+||||||+||+++.++.+||+|||.+........ 
T Consensus        86 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ecCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence            999999999887543 5899999999999999999999   99999999999999999999999999999986643221 


Q ss_pred             ccccccccccCcccccccCCCCc-CcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKV-SRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                      .......+++.|+|||++.+..+ +.++||||+|+++|||++|+.||............|......              
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------  227 (276)
T 2yex_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------------  227 (276)
T ss_dssp             CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--------------
T ss_pred             hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--------------
Confidence            12234568999999999987665 789999999999999999999998644433333333321100              


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                           .......+..+.+++.+||+.||++|||++|++++
T Consensus       228 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          228 -----LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             -----STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -----cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence                 00112345678899999999999999999999875

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-38  Score=357.69  Aligned_cols=252  Identities=23%  Similarity=0.343  Sum_probs=198.0

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCC--CHHHHHHHHHHHhhcCC--CceeeEEeeeecCCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDG--SLESFHAECKVMGSIRH--RNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h--pniv~l~~~~~~~~~~~lv  835 (1049)
                      .++|++.+.||+|+||.||+|...+++.||+|++......  ..+.+.+|++++++++|  |||+++++++.+++..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            3468999999999999999999888999999999755322  24678899999999976  9999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      || +.+++|.+++.... .+++.++..++.|+++||+|||   +.||+||||||+||+++ ++.+||+|||+++......
T Consensus        88 ~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EC-CCSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             Ee-CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            99 45789999998754 5899999999999999999999   99999999999999997 5789999999998765433


Q ss_pred             cc-cccccccccCcccccccCC-----------CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccC
Q 039290          916 SM-RQTKTLGTIGYMAPEYGRE-----------GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSC  983 (1049)
Q Consensus       916 ~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  983 (1049)
                      .. ......||+.|+|||++.+           ..++.++||||+||++|||++|+.||...............      
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~------  235 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID------  235 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC------
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc------
Confidence            21 2334579999999999854           67889999999999999999999999753322111111110      


Q ss_pred             CcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          984 SITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                             ...      ....+...+.++.+++.+||+.||.+|||++|+++|-
T Consensus       236 -------~~~------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          236 -------PNH------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             -------TTS------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             -------CCc------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence                   000      0011112245688999999999999999999999874

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.7e-38  Score=356.74  Aligned_cols=242  Identities=26%  Similarity=0.359  Sum_probs=203.7

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC--------CCHHHHHHHHHHHhhcCCCceeeEEeeeecCC
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD--------GSLESFHAECKVMGSIRHRNLVKIISSCSNND  830 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~  830 (1049)
                      .++|++.+.||+|+||+||+|+. .+++.||+|+++....        .....+.+|++++++++||||+++++++.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            45799999999999999999995 5788999999976531        13346788999999999999999999999999


Q ss_pred             eeEEEEeccCCC-ChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCce
Q 039290          831 FKALVLEYMSNG-SLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK  909 (1049)
Q Consensus       831 ~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~  909 (1049)
                      ..++||||+.+| +|.+++.... .+++..++.++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++.
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  178 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAA  178 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence            999999999777 9999887654 4899999999999999999999   9999999999999999999999999999998


Q ss_pred             ecCCCccccccccccccCcccccccCCCCc-CcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchh
Q 039290          910 ILGKEESMRQTKTLGTIGYMAPEYGREGKV-SRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEV  988 (1049)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  988 (1049)
                      .......  .....||+.|+|||++.+..+ +.++||||+||++|||++|..||......       .            
T Consensus       179 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~------------  237 (335)
T 3dls_A          179 YLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------V------------  237 (335)
T ss_dssp             ECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------T------------
T ss_pred             ECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------H------------
Confidence            7754332  234568999999999988776 78999999999999999999999752110       0            


Q ss_pred             cccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          989 ADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                       ....        ..+..++.++.+++.+||+.||++|||++|++++
T Consensus       238 -~~~~--------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          238 -EAAI--------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -TTCC--------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -hhcc--------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0000        0011145678999999999999999999999987

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.8e-38  Score=350.93  Aligned_cols=270  Identities=20%  Similarity=0.225  Sum_probs=201.0

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCC--CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDG--SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      ++|++.+.||+|+||+||+|+.. +|+.||+|++......  ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57899999999999999999965 6899999998654322  24567899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      |+++++|.+++...+ .+++..+..++.|+++|++|||   ++||+||||||+||+++.++.+||+|||++........ 
T Consensus        83 ~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  157 (311)
T 4agu_A           83 YCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-  157 (311)
T ss_dssp             CCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             eCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence            999999988876543 4899999999999999999999   99999999999999999999999999999987653322 


Q ss_pred             cccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHh--hhhccccC----Ccchhcc
Q 039290          918 RQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRW--VGDSLLSC----SITEVAD  990 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~--~~~~~~~~----~~~~~~~  990 (1049)
                      ......+|+.|+|||++.+ ..++.++||||+|+++|||++|+.||......+......  .+......    .......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (311)
T 4agu_A          158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS  237 (311)
T ss_dssp             --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred             ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence            2234568999999998865 678999999999999999999999997643322211110  00000000    0000000


Q ss_pred             ccccccccc---CchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          991 ANLLNCEEN---DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       991 ~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .........   ........+..+.+++.+||+.||++|||++|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            000000000   001112356778999999999999999999999976

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-38  Score=355.87  Aligned_cols=270  Identities=20%  Similarity=0.233  Sum_probs=200.6

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCC-CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDG-SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++...... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57889999999999999999965 7899999999754322 223456799999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      ++ |+|.+++...+..+++.+++.++.|++.||+|||   +.||+||||||+||+++.++.+||+|||++........ .
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~  156 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T  156 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-c
Confidence            97 4999998887777999999999999999999999   99999999999999999999999999999986543322 2


Q ss_pred             ccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhh-hccccCCcchhccccc---
Q 039290          919 QTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVG-DSLLSCSITEVADANL---  993 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~---  993 (1049)
                      .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+........ .......+........   
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
T 3mtl_A          157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT  236 (324)
T ss_dssp             ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred             cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence            234568999999998876 56899999999999999999999999764332221111100 0000111111110000   


Q ss_pred             ---cc-ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          994 ---LN-CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       994 ---~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                         .. ............+.++.+++.+|++.||++|||++|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence               00 0000011223356778999999999999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2e-38  Score=359.54  Aligned_cols=265  Identities=13%  Similarity=0.148  Sum_probs=210.5

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCC---------CcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceee----------
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPD---------GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVK----------  821 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~----------  821 (1049)
                      ++|++.+.||+|+||.||+|+...         ++.||+|++...     +.+.+|++++++++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            578999999999999999999753         789999998744     46889999999999999998          


Q ss_pred             -----EEeeeec-CCeeEEEEeccCCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeee
Q 039290          822 -----IISSCSN-NDFKALVLEYMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL  894 (1049)
Q Consensus       822 -----l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~  894 (1049)
                           +++++.. ++..++||||+ +++|.+++... ...+++.+++.++.|+++||+|||   ++||+||||||+||++
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFV  192 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEE
Confidence                 5666665 67889999999 99999999875 356999999999999999999999   9999999999999999


Q ss_pred             cCCC--ceEEecccCceecCCCccc------cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccc
Q 039290          895 NESM--VGHLSDFGIAKILGKEESM------RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIF  966 (1049)
Q Consensus       895 ~~~~--~~kl~DfGla~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~  966 (1049)
                      +.++  .+||+|||+++.+......      ......||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            9988  9999999999876543211      1133478999999999999899999999999999999999999998754


Q ss_pred             cccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhh
Q 039290          967 AGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSA 1045 (1049)
Q Consensus       967 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~ 1045 (1049)
                      .................  ....+.         ......++.++.+++.+||+.||++|||++|+++.|+++.++...
T Consensus       273 ~~~~~~~~~~~~~~~~~--~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  340 (352)
T 2jii_A          273 PNTEDIMKQKQKFVDKP--GPFVGP---------CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV  340 (352)
T ss_dssp             TCHHHHHHHHHHHHHSC--CCEECT---------TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             cCHHHHHHHHHhccCCh--hhhhhh---------ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence            33322222221111000  000000         000012356799999999999999999999999999999987653

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.1e-37  Score=347.11  Aligned_cols=263  Identities=24%  Similarity=0.325  Sum_probs=202.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC---CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD---GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      .++|++.+.||+|+||.||+|+. .+++.||+|+++....   ...+++.+|++++++++||||+++++++.+.+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            45799999999999999999995 5789999999975332   2346788999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhc---CCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecC
Q 039290          836 LEYMSNGSLEKCLYS---DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      |||+++++|.+++..   ....+++..++.++.|+++|++|||   +.||+||||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999998864   3456899999999999999999999   9999999999999999999999999999998664


Q ss_pred             CCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccc
Q 039290          913 KEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       913 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      .... ......+++.|+|||++.+..++.++||||+|+++|||++|..||..................    ..      
T Consensus       188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~------  256 (310)
T 2wqm_A          188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD----YP------  256 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC----SC------
T ss_pred             CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc----CC------
Confidence            3322 223356899999999999889999999999999999999999999753322222211111000    00      


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                              ......++.++.+++.+||+.||++|||+++++++|+++.....
T Consensus       257 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~  300 (310)
T 2wqm_A          257 --------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA  300 (310)
T ss_dssp             --------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             --------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence                    00012345678999999999999999999999999999987653

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.1e-37  Score=348.62  Aligned_cols=271  Identities=21%  Similarity=0.345  Sum_probs=213.7

Q ss_pred             HHHhcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhh--cCCCceeeEEeeeecCC----
Q 039290          757 LRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGS--IRHRNLVKIISSCSNND----  830 (1049)
Q Consensus       757 ~~~~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~hpniv~l~~~~~~~~----  830 (1049)
                      ....++|++.+.||+|+||.||+|+. +++.||+|++...   ....+.+|++++..  ++||||+++++++...+    
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~  113 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT  113 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence            34456899999999999999999998 5899999998643   34677889999887  68999999999998775    


Q ss_pred             eeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHcc-----CCCCeEEcCCCCCCeeecCCCceEEecc
Q 039290          831 FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG-----YSTPIVHCDIKPSNVLLNESMVGHLSDF  905 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlkp~NIl~~~~~~~kl~Df  905 (1049)
                      ..++||||+++|+|.+++...  .+++.+++.++.|++.|++|||..     ++.+|+||||||+||+++.++.+||+||
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  191 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  191 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred             eeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence            789999999999999999764  489999999999999999999921     1478999999999999999999999999


Q ss_pred             cCceecCCCccc---cccccccccCcccccccCCC------CcCcccchHHHHHHHHHHHhC----------CCCCCccc
Q 039290          906 GIAKILGKEESM---RQTKTLGTIGYMAPEYGREG------KVSRKCDVYSYGIMLMETFTK----------KKPTDEIF  966 (1049)
Q Consensus       906 Gla~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg----------~~p~~~~~  966 (1049)
                      |++.........   ......||+.|+|||++.+.      .++.++||||+||++|||++|          ..||....
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~  271 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  271 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence            999876543321   22345789999999998765      344789999999999999999          67776544


Q ss_pred             cccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhh
Q 039290          967 AGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043 (1049)
Q Consensus       967 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~ 1043 (1049)
                      ..+.....+.......         ........++ ...+++..+.+++.+||+.||++|||++|++++|+++.++.
T Consensus       272 ~~~~~~~~~~~~~~~~---------~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~  338 (342)
T 1b6c_B          272 PSDPSVEEMRKVVCEQ---------KLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  338 (342)
T ss_dssp             CSSCCHHHHHHHHTTS---------CCCCCCCGGG-GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             cCcccHHHHHHHHHHH---------HhCCCCcccc-cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence            4333333322211110         0000011111 12457788999999999999999999999999999998764

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.2e-38  Score=356.93  Aligned_cols=278  Identities=21%  Similarity=0.185  Sum_probs=211.5

Q ss_pred             ccccccHHHHHHHhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcC-----CCcee
Q 039290          747 TWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR-----HRNLV  820 (1049)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----hpniv  820 (1049)
                      ....+++++.....++|++.++||+|+||+||+|+. .+++.||||+++.. ......+..|+++++.++     ||||+
T Consensus        21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv   99 (360)
T 3llt_A           21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV   99 (360)
T ss_dssp             GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred             cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence            444555666556678999999999999999999996 47889999998642 223456788999999986     99999


Q ss_pred             eEEeeeecCCeeEEEEeccCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC---
Q 039290          821 KIISSCSNNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE---  896 (1049)
Q Consensus       821 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---  896 (1049)
                      ++++++...+..++||||+ +++|.+++.... ..+++.+++.++.||+.||+|||   ++||+||||||+||+++.   
T Consensus       100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~  175 (360)
T 3llt_A          100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYF  175 (360)
T ss_dssp             CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTC
T ss_pred             cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccc
Confidence            9999999999999999999 889999987654 35899999999999999999999   999999999999999975   


Q ss_pred             ----------------------CCceEEecccCceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHH
Q 039290          897 ----------------------SMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLME  954 (1049)
Q Consensus       897 ----------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~e  954 (1049)
                                            ++.+||+|||++.......    ....||+.|+|||++.+..++.++||||+||++||
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  251 (360)
T 3llt_A          176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE  251 (360)
T ss_dssp             CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             cccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence                                  7899999999998654322    34568999999999999999999999999999999


Q ss_pred             HHhCCCCCCccccccchHHHhhhhccccCCc-----------chhcc-ccccccccc--------------CchhhHHHH
Q 039290          955 TFTKKKPTDEIFAGEMSLKRWVGDSLLSCSI-----------TEVAD-ANLLNCEEN--------------DFSAREQCV 1008 (1049)
Q Consensus       955 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~-~~~~~~~~~--------------~~~~~~~~~ 1008 (1049)
                      |++|+.||......+.. .. ........+.           ....+ .........              .........
T Consensus       252 ll~g~~pf~~~~~~~~~-~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  329 (360)
T 3llt_A          252 LYTGSLLFRTHEHMEHL-AM-MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH  329 (360)
T ss_dssp             HHHSSCSCCCSSHHHHH-HH-HHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCC
T ss_pred             HHHCCCCCCCCcHHHHH-HH-HHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchH
Confidence            99999999763322111 00 0000000000           00000 000000000              000111123


Q ss_pred             HHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290         1009 SSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus      1009 ~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      +.+.+++.+||+.||++|||++|+++|
T Consensus       330 ~~l~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          330 ELFCDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            678899999999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.9e-38  Score=381.18  Aligned_cols=252  Identities=26%  Similarity=0.449  Sum_probs=205.9

Q ss_pred             eecCCCcEEEEEEEeC---CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCCCC
Q 039290          768 LLGMGSFGSVYKGVLP---DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGS  843 (1049)
Q Consensus       768 ~lg~G~fg~Vy~a~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~  843 (1049)
                      .||+|+||.||+|.+.   ++..||||+++... ....+++.+|++++++++|||||++++++.+ +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999853   56679999997653 3456889999999999999999999999976 56899999999999


Q ss_pred             hhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc--cccc
Q 039290          844 LEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM--RQTK  921 (1049)
Q Consensus       844 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~--~~~~  921 (1049)
                      |.+++...+..+++.++..++.||++||+|||   +++|+||||||+||+++.++.+||+|||+++........  ....
T Consensus       422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~  498 (613)
T 2ozo_A          422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA  498 (613)
T ss_dssp             HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence            99999877777999999999999999999999   999999999999999999999999999999876433321  1122


Q ss_pred             cccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccccccccC
Q 039290          922 TLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEND 1000 (1049)
Q Consensus       922 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1049)
                      ..+++.|+|||++.+..++.++|||||||++|||++ |+.||......+.  ...+..                   ..+
T Consensus       499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~--~~~i~~-------------------~~~  557 (613)
T 2ozo_A          499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--MAFIEQ-------------------GKR  557 (613)
T ss_dssp             ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH--HHHHHT-------------------TCC
T ss_pred             CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--HHHHHc-------------------CCC
Confidence            345689999999988899999999999999999998 9999976433221  111110                   001


Q ss_pred             chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290         1001 FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus      1001 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                      ...+..++.++.++|.+||+.||++||+++++++.|+++..+..
T Consensus       558 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~  601 (613)
T 2ozo_A          558 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  601 (613)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence            12223467789999999999999999999999999999887654

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.4e-37  Score=354.34  Aligned_cols=252  Identities=17%  Similarity=0.134  Sum_probs=207.0

Q ss_pred             hcCCCCCceecCCCcEEEEEEE------eCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcC---CCceeeEEeeeecCC
Q 039290          760 TDGFSENKLLGMGSFGSVYKGV------LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR---HRNLVKIISSCSNND  830 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---hpniv~l~~~~~~~~  830 (1049)
                      .++|.+.+.||+|+||+||+|.      ..+++.||+|+++..   ...++.+|+++++.++   |+||+++++++...+
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~  140 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN  140 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence            4678999999999999999994      457889999998643   4567888888888887   899999999999999


Q ss_pred             eeEEEEeccCCCChhhhhhc----CCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC----------
Q 039290          831 FKALVLEYMSNGSLEKCLYS----DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE----------  896 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~----------  896 (1049)
                      ..++||||+++|+|.+++..    ....+++.+++.++.|+++||+|||   ++||+||||||+|||++.          
T Consensus       141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC-----
T ss_pred             CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCcccccc
Confidence            99999999999999999975    3456999999999999999999999   999999999999999998          


Q ss_pred             -CCceEEecccCceecCCC-ccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHH
Q 039290          897 -SMVGHLSDFGIAKILGKE-ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR  974 (1049)
Q Consensus       897 -~~~~kl~DfGla~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~  974 (1049)
                       ++.+||+|||+|+.+... .........||+.|+|||++.+..++.++||||+||++|||++|+.||.....+..... 
T Consensus       218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~-  296 (365)
T 3e7e_A          218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE-  296 (365)
T ss_dssp             -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEEC-
T ss_pred             ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCceeec-
Confidence             899999999999865321 22233456799999999999999999999999999999999999999865322211100 


Q ss_pred             hhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCC-CCHHHHHHHHHHHHHhh
Q 039290          975 WVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKR-ISMKDVANRLVRIRETL 1043 (1049)
Q Consensus       975 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-pt~~ell~~L~~i~~~~ 1043 (1049)
                                      ...     .+.    ...+.+.+++.+|++.+|.+| |+++++.+.|+++..+.
T Consensus       297 ----------------~~~-----~~~----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          297 ----------------GLF-----RRL----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             ----------------SCC-----TTC----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ----------------hhc-----ccc----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence                            000     000    124567889999999999998 58888888888877653

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5.9e-38  Score=344.47  Aligned_cols=250  Identities=27%  Similarity=0.354  Sum_probs=199.3

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      ++|.+.+.||+|+||+||+|+. .++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            4688899999999999999996 478899999997654 34568899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC---CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeee---cCCCceEEecccCceecC
Q 039290          839 MSNGSLEKCLYSD---NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       839 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~---~~~~~~kl~DfGla~~~~  912 (1049)
                      +++|+|.+++...   ...+++..++.++.|+++||+|||   +.||+||||||+||++   +.++.+||+|||++....
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999999988543   346899999999999999999999   9999999999999999   456889999999998664


Q ss_pred             CCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccc
Q 039290          913 KEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       913 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      ...  ......+++.|+|||++. ..++.++||||+||++|||++|+.||......+........    ...        
T Consensus       179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~----~~~--------  243 (285)
T 3is5_A          179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK----EPN--------  243 (285)
T ss_dssp             ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----CCC--------
T ss_pred             Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC----Ccc--------
Confidence            332  223456899999999875 57899999999999999999999999764322221111100    000        


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ..       ......++++.+++.+||+.||++|||++|++++
T Consensus       244 ~~-------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          244 YA-------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             CC-------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             cc-------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00       0001134578899999999999999999999875

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.4e-38  Score=347.72  Aligned_cols=259  Identities=26%  Similarity=0.382  Sum_probs=207.4

Q ss_pred             hcCCCCCc-eecCCCcEEEEEEEe---CCCcEEEEEEeecccCC--CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeE
Q 039290          760 TDGFSENK-LLGMGSFGSVYKGVL---PDGMEIAAKVFHMEFDG--SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKA  833 (1049)
Q Consensus       760 ~~~~~~~~-~lg~G~fg~Vy~a~~---~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~  833 (1049)
                      ..+|.+.+ .||+|+||.||+|.+   .+++.||||+++.....  ..+++.+|+++++.++||||+++++++ +.+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45677777 999999999999963   35678999999765322  256799999999999999999999999 556789


Q ss_pred             EEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          834 LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      +||||+++++|.+++...+ .+++.+++.++.|+++|++|||   +.||+||||||+||+++.++.+||+|||++.....
T Consensus        94 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            9999999999999998754 4899999999999999999999   99999999999999999999999999999987754


Q ss_pred             Ccccc--ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcc
Q 039290          914 EESMR--QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD  990 (1049)
Q Consensus       914 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  990 (1049)
                      .....  .....+++.|+|||++.+..++.++||||+|+++|||++ |+.||......+.  ...+....          
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~~~~~~----------  237 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--TAMLEKGE----------  237 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HHHHHTTC----------
T ss_pred             CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH--HHHHHcCC----------
Confidence            43221  222345688999999988889999999999999999999 9999976332211  11111000          


Q ss_pred             cccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          991 ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                               +...+..++..+.+++.+||+.||++||++.|+++.|+++..+..
T Consensus       238 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  282 (291)
T 1xbb_A          238 ---------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  282 (291)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence                     011122356789999999999999999999999999999887643

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.3e-38  Score=380.05  Aligned_cols=257  Identities=28%  Similarity=0.436  Sum_probs=212.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      .++|++.+.||+|+||.||+|++.++..||||+++... ...+++.+|++++++++||||+++++++.+ +..++||||+
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~  343 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  343 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence            45688889999999999999999888899999997643 346789999999999999999999999876 6789999999


Q ss_pred             CCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          840 SNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       840 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      ++|+|.+++... ...+++.+++.++.||++||+|||   +++|+||||||+|||++.++.+||+|||+++.........
T Consensus       344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  420 (535)
T 2h8h_A          344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  420 (535)
T ss_dssp             TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred             cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence            999999999753 345899999999999999999999   9999999999999999999999999999998764332222


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE  997 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1049)
                      .....++..|+|||++....++.++|||||||++|||++ |+.||......+..  ..+...                  
T Consensus       421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~--~~i~~~------------------  480 (535)
T 2h8h_A          421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL--DQVERG------------------  480 (535)
T ss_dssp             TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH--HHHHTT------------------
T ss_pred             ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH--HHHHcC------------------
Confidence            233456788999999988899999999999999999999 99999764322211  111000                  


Q ss_pred             ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHh
Q 039290          998 ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042 (1049)
Q Consensus       998 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~ 1042 (1049)
                       .+...+..++.++.++|.+||+.||++|||++++++.|+++...
T Consensus       481 -~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          481 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             -CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence             01112234667899999999999999999999999999987543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.1e-37  Score=367.94  Aligned_cols=251  Identities=24%  Similarity=0.328  Sum_probs=209.3

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      .++|+..+.||+|+||.||+|+.. +|+.||+|++....   ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            356888999999999999999964 79999999996542   44567789999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          836 LEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      |||++||+|.+++...+ ..+++..++.++.||+.||+|||   ++||+||||||+||+++.++.+||+|||+++.....
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999987654 35899999999999999999999   999999999999999999999999999999877543


Q ss_pred             ccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccch--HHHhhhhccccCCcchhcccc
Q 039290          915 ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMS--LKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       915 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      ..  ....+||+.|+|||++.+..++.++||||+||++|||++|..||.........  ....+...             
T Consensus       340 ~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-------------  404 (576)
T 2acx_A          340 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-------------  404 (576)
T ss_dssp             CC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-------------
T ss_pred             cc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-------------
Confidence            32  23457999999999999989999999999999999999999999764322111  11111000             


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI-----SMKDVANR 1035 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~~ 1035 (1049)
                             ....+...+.++.+++.+||+.||++||     +++|+++|
T Consensus       405 -------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          405 -------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             -------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence                   0011123456789999999999999999     78999876

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.8e-38  Score=364.94  Aligned_cols=269  Identities=24%  Similarity=0.353  Sum_probs=193.8

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC--CCHHHHHHHHHHHhhcC-CCceeeEEeeeecCC--ee
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIR-HRNLVKIISSCSNND--FK  832 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~--~~  832 (1049)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++.....  ....++.+|+.+++++. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            356899999999999999999995 4789999999865432  23456788999999997 999999999997544  78


Q ss_pred             EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecC
Q 039290          833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      |+||||++ ++|.+++...  .+++..+..++.|+++||+|||   +.||+||||||+||+++.++.+||+|||+|+.+.
T Consensus        87 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             EEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence            99999997 5899988764  4899999999999999999999   9999999999999999999999999999998753


Q ss_pred             CCc--------------------cccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccch
Q 039290          913 KEE--------------------SMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMS  971 (1049)
Q Consensus       913 ~~~--------------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~  971 (1049)
                      ...                    .......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+. 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-  239 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ-  239 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence            211                    112234579999999999876 6789999999999999999999999976332211 


Q ss_pred             HHHhhhhccccCCcchhc---cc-------cc-------ccccccCch----------hhHHHHHHHHHHHhhccccCCC
Q 039290          972 LKRWVGDSLLSCSITEVA---DA-------NL-------LNCEENDFS----------AREQCVSSIFSLAMDCTVDLPE 1024 (1049)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~---~~-------~~-------~~~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~ 1024 (1049)
                      .....+ ....+....+.   .+       .+       .......+.          ....+++++.+++.+||+.||+
T Consensus       240 ~~~i~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~  318 (388)
T 3oz6_A          240 LERIIG-VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN  318 (388)
T ss_dssp             HHHHHH-HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHH-hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence            111111 00000000000   00       00       000000000          0013456799999999999999


Q ss_pred             CCCCHHHHHHH
Q 039290         1025 KRISMKDVANR 1035 (1049)
Q Consensus      1025 ~Rpt~~ell~~ 1035 (1049)
                      +|||++|+++|
T Consensus       319 ~R~t~~e~l~H  329 (388)
T 3oz6_A          319 KRISANDALKH  329 (388)
T ss_dssp             GSCCHHHHTTS
T ss_pred             cCCCHHHHhCC
Confidence            99999999987

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=7.1e-38  Score=349.07  Aligned_cols=263  Identities=23%  Similarity=0.403  Sum_probs=201.4

Q ss_pred             HHhcCCCCCceecCCCcEEEEEEEeC----CCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecCC-
Q 039290          758 RATDGFSENKLLGMGSFGSVYKGVLP----DGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNND-  830 (1049)
Q Consensus       758 ~~~~~~~~~~~lg~G~fg~Vy~a~~~----~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~-  830 (1049)
                      ...++|.+.+.||+|+||.||+|+..    ++..||+|+++....  ...+.+.+|++++++++||||+++++++.+.+ 
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            34567889999999999999999853    345899999975532  23467899999999999999999999997754 


Q ss_pred             ----eeEEEEeccCCCChhhhhhc-----CCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceE
Q 039290          831 ----FKALVLEYMSNGSLEKCLYS-----DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGH  901 (1049)
Q Consensus       831 ----~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~k  901 (1049)
                          ..++||||+++|+|.+++..     ....+++.+++.++.|+++||+|||   +.||+||||||+||+++.++.+|
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEE
Confidence                35999999999999999843     3346899999999999999999999   99999999999999999999999


Q ss_pred             EecccCceecCCCccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhc
Q 039290          902 LSDFGIAKILGKEESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDS  979 (1049)
Q Consensus       902 l~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  979 (1049)
                      |+|||++......... ......+++.|+|||.+.+..++.++||||+|+++|||++ |..||......+.... .....
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-~~~~~  266 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY-LLHGH  266 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-HHTTC
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH-HHcCC
Confidence            9999999876443221 2233456789999999998899999999999999999999 8889876433221111 10000


Q ss_pred             cccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          980 LLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                                          +...+..++.++.+++.+||+.||++|||+++++++|+++.+++.
T Consensus       267 --------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          267 --------------------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             --------------------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             --------------------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence                                011123355679999999999999999999999999999988764

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.7e-38  Score=355.36  Aligned_cols=253  Identities=21%  Similarity=0.318  Sum_probs=202.1

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEEEe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .++|++.+.||+|+||+||+|+.. +++.||+|+++....    ...+|++++.++ +||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            457999999999999999999965 688999999976533    245688888888 79999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCC----CceEEecccCceecCC
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES----MVGHLSDFGIAKILGK  913 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~----~~~kl~DfGla~~~~~  913 (1049)
                      |+++|+|.+++...+ .+++.++..++.||+.|++|||   ++||+||||||+||++..+    +.+||+|||++.....
T Consensus        97 ~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~  172 (342)
T 2qr7_A           97 LMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA  172 (342)
T ss_dssp             CCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred             CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence            999999999987654 4899999999999999999999   9999999999999998532    3599999999987644


Q ss_pred             CccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccc-hHHHhhhhccccCCcchhcccc
Q 039290          914 EESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEM-SLKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       914 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      ... ......+|+.|+|||++.+..++.++||||+||++|||++|..||........ .....+....            
T Consensus       173 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~------------  239 (342)
T 2qr7_A          173 ENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK------------  239 (342)
T ss_dssp             TTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCC------------
T ss_pred             CCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCC------------
Confidence            332 23345789999999999888899999999999999999999999975322111 1111111000            


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                          ...........+.++.+++.+||+.||++|||+.|+++|-.
T Consensus       240 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~  280 (342)
T 2qr7_A          240 ----FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW  280 (342)
T ss_dssp             ----CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred             ----cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence                00000111235667899999999999999999999998743

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.1e-37  Score=342.26  Aligned_cols=258  Identities=24%  Similarity=0.297  Sum_probs=207.8

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC------CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD------GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKA  833 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~  833 (1049)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++....      ...+.+.+|++++++++||||+++++++.+.+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46889999999999999999965 789999999976432      13678999999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC----ceEEecccCce
Q 039290          834 LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM----VGHLSDFGIAK  909 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~----~~kl~DfGla~  909 (1049)
                      +||||+++++|.+++.... .+++.+++.++.|+++||+|||   +.||+||||||+||+++.++    .+||+|||.+.
T Consensus        85 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            9999999999999987643 4899999999999999999999   99999999999999998776    89999999998


Q ss_pred             ecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhc
Q 039290          910 ILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA  989 (1049)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  989 (1049)
                      .......  .....+++.|+|||++.+..++.++||||+|+++|||++|..||......+. ...+...           
T Consensus       161 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~-----------  226 (283)
T 3bhy_A          161 KIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET-LTNISAV-----------  226 (283)
T ss_dssp             ECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTT-----------
T ss_pred             eccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH-HHHhHhc-----------
Confidence            7644322  2345689999999999988999999999999999999999999976322211 1111000           


Q ss_pred             ccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--HHHHHHh
Q 039290          990 DANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR--LVRIRET 1042 (1049)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~--L~~i~~~ 1042 (1049)
                            ............+..+.+++.+||+.||++|||++|++++  ++++..+
T Consensus       227 ------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  275 (283)
T 3bhy_A          227 ------NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR  275 (283)
T ss_dssp             ------CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred             ------ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence                  0000111223346678999999999999999999999986  5555443

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.7e-38  Score=357.22  Aligned_cols=266  Identities=17%  Similarity=0.190  Sum_probs=202.9

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC----CCcEEEEEEeecccCC-----------CHHHHHHHHHHHhhcCCCceeeEEe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP----DGMEIAAKVFHMEFDG-----------SLESFHAECKVMGSIRHRNLVKIIS  824 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~hpniv~l~~  824 (1049)
                      .++|++.+.||+|+||+||+|+..    ++..||+|++......           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            357899999999999999999965    5778999998754321           1234667888899999999999999


Q ss_pred             eeec----CCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC--
Q 039290          825 SCSN----NDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM--  898 (1049)
Q Consensus       825 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~--  898 (1049)
                      ++.+    .+..++||||+ +++|.+++...+ .+++.+++.++.|++.||+|||   +.||+||||||+||+++.++  
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTT
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCC
Confidence            9877    77899999999 999999987665 6899999999999999999999   99999999999999998777  


Q ss_pred             ceEEecccCceecCCCccc------cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchH
Q 039290          899 VGHLSDFGIAKILGKEESM------RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSL  972 (1049)
Q Consensus       899 ~~kl~DfGla~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~  972 (1049)
                      .+||+|||+++.+......      ......||+.|+|||++.+..++.++||||+||++|||++|+.||..........
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            9999999999876533211      1234578999999999998899999999999999999999999997533332222


Q ss_pred             HHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 039290          973 KRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041 (1049)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~ 1041 (1049)
                      ..........  .    .......     .....++.++.+++.+||+.||++|||++++++.|++...
T Consensus       271 ~~~~~~~~~~--~----~~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          271 QTAKTNLLDE--L----PQSVLKW-----APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHHHHHT--T----THHHHHH-----SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHHHhhccc--c----cHHHHhh-----ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            2211111100  0    0000000     0001356689999999999999999999999999987543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.4e-37  Score=357.47  Aligned_cols=250  Identities=22%  Similarity=0.296  Sum_probs=193.7

Q ss_pred             cCCCCC-ceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhh-cCCCceeeEEeeeec----CCeeE
Q 039290          761 DGFSEN-KLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGS-IRHRNLVKIISSCSN----NDFKA  833 (1049)
Q Consensus       761 ~~~~~~-~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~hpniv~l~~~~~~----~~~~~  833 (1049)
                      ++|.+. +.||+|+||+||+|+.. +++.||+|+++..     ..+.+|++++.+ .+||||+++++++..    .+..+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456665 68999999999999964 7889999998632     567888988754 489999999998865    56789


Q ss_pred             EEEeccCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC---CCceEEecccCce
Q 039290          834 LVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE---SMVGHLSDFGIAK  909 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~~~kl~DfGla~  909 (1049)
                      +||||+++|+|.+++.... ..+++.+++.++.||+.||+|||   +.||+||||||+||+++.   ++.+||+|||+++
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            9999999999999998653 36899999999999999999999   999999999999999997   7899999999998


Q ss_pred             ecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccch--HHHhhhhccccCCcch
Q 039290          910 ILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMS--LKRWVGDSLLSCSITE  987 (1049)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~  987 (1049)
                      ......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||.........  ....+....       
T Consensus       213 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~-------  283 (400)
T 1nxk_A          213 ETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ-------  283 (400)
T ss_dssp             ECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC-------
T ss_pred             ccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc-------
Confidence            764332  233467899999999999999999999999999999999999999764322110  111100000       


Q ss_pred             hcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          988 VADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       988 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                               ..........++.++.+++.+||+.||++|||++|+++|-
T Consensus       284 ---------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          284 ---------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             ---------CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             ---------ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence                     0000011123567789999999999999999999999874

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.9e-38  Score=355.24  Aligned_cols=247  Identities=25%  Similarity=0.327  Sum_probs=202.2

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCC---CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDG---SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ..|+..+.||+|+||+||+|+. .+++.||||++......   ..+++.+|++++++++||||+++++++.+.+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            3488889999999999999995 57899999999754322   2357889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+. |++.+++......+++.+++.++.|+++||+|||   +.||+||||||+||+++.++.+||+|||++......  
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence            9997 5888888766667999999999999999999999   999999999999999999999999999999866432  


Q ss_pred             ccccccccccCcccccccC---CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGR---EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                         ....||+.|+|||++.   ...++.++||||+||++|||++|+.||......+.. .......          .+. 
T Consensus       208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-~~~~~~~----------~~~-  272 (348)
T 1u5q_A          208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQNE----------SPA-  272 (348)
T ss_dssp             ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHHHHSC----------CCC-
T ss_pred             ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhcC----------CCC-
Confidence               2356899999999874   567899999999999999999999998753221111 1111000          000 


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                              .....++..+.+++.+||+.||++|||++|++++.
T Consensus       273 --------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          273 --------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             --------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence                    00122456789999999999999999999998763

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.9e-38  Score=371.30  Aligned_cols=249  Identities=24%  Similarity=0.288  Sum_probs=197.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      .++|++.+.||+|+||.||+|+. .+++.||+|+++...   ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            45799999999999999999995 478999999997542   33446778899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCC-CCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS-TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      |||+++|+|.+++...+ .+++..+..++.|+++||+|||   + +||+||||||+||+++.++.+||+|||+++.....
T Consensus       227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            99999999999887654 5899999999999999999999   8 89999999999999999999999999999864332


Q ss_pred             ccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          915 ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       915 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                      . .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+........                 
T Consensus       303 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-----------------  364 (446)
T 4ejn_A          303 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------  364 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------
T ss_pred             C-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC-----------------
Confidence            2 2234467999999999999999999999999999999999999999753222111110000                 


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI-----SMKDVANR 1035 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~~ 1035 (1049)
                           ....+...+.++.+++.+||+.||.+||     +++|+++|
T Consensus       365 -----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          365 -----EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -----CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence                 0011123456789999999999999999     99999876

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.9e-38  Score=360.33  Aligned_cols=251  Identities=23%  Similarity=0.350  Sum_probs=198.2

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccC--CCHHHHHHHHHHHhhcC--CCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIR--HRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~--hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      .+|++.+.||+|+||+||+|...+++.||||++.....  ...+.+.+|++++++++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            35899999999999999999988899999999975532  23467899999999996  599999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      | +.+++|.+++.... .+++.+++.++.||++||+|||   +.+|+||||||+||+++ ++.+||+|||+++.+.....
T Consensus       136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence            9 56789999998765 5889999999999999999999   99999999999999996 57999999999987654332


Q ss_pred             -ccccccccccCcccccccCC-----------CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCC
Q 039290          917 -MRQTKTLGTIGYMAPEYGRE-----------GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCS  984 (1049)
Q Consensus       917 -~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  984 (1049)
                       ......+||+.|+|||++.+           ..++.++||||+||++|||++|+.||..............        
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~--------  281 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII--------  281 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH--------
T ss_pred             cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh--------
Confidence             12334579999999998864           3688999999999999999999999975322211111111        


Q ss_pred             cchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          985 ITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       985 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                           +...      ....+...+.++.+++.+||+.||++|||++|++++-
T Consensus       282 -----~~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  322 (390)
T 2zmd_A          282 -----DPNH------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  322 (390)
T ss_dssp             -----CTTS------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             -----Cccc------cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence                 1000      0000111245689999999999999999999999763

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-38  Score=357.59  Aligned_cols=255  Identities=24%  Similarity=0.300  Sum_probs=206.8

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe----CCCcEEEEEEeeccc----CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCC
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL----PDGMEIAAKVFHMEF----DGSLESFHAECKVMGSI-RHRNLVKIISSCSNND  830 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~  830 (1049)
                      .++|++.+.||+|+||.||+|+.    .+++.||||+++...    ....+.+.+|+++++++ +||||+++++++.+.+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            35789999999999999999996    478999999986532    23456678899999999 6999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCcee
Q 039290          831 FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI  910 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~  910 (1049)
                      ..++||||+++|+|.+++.... .+++.+++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            9999999999999999987654 4899999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCccccccccccccCcccccccCC--CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchh
Q 039290          911 LGKEESMRQTKTLGTIGYMAPEYGRE--GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEV  988 (1049)
Q Consensus       911 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  988 (1049)
                      +............||+.|+|||++.+  ..++.++|||||||++|||++|+.||.......... .+.....        
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~--------  279 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA-EISRRIL--------  279 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH-HHHHHHH--------
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH-HHHHHHh--------
Confidence            75544444445679999999999875  457899999999999999999999997533222211 1111000        


Q ss_pred             cccccccccccCchhhHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHHH
Q 039290          989 ADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI-----SMKDVANRL 1036 (1049)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~~L 1036 (1049)
                               ......+..++..+.+++.+||+.||++||     +++|++++.
T Consensus       280 ---------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          280 ---------KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             ---------HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             ---------ccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                     000111223456789999999999999999     999999874

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-38  Score=353.85  Aligned_cols=273  Identities=21%  Similarity=0.249  Sum_probs=202.7

Q ss_pred             HHhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCC-----CHHHHHHHHHHHhhcCCCceeeEEeeeecCCe
Q 039290          758 RATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDG-----SLESFHAECKVMGSIRHRNLVKIISSCSNNDF  831 (1049)
Q Consensus       758 ~~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~  831 (1049)
                      ...++|++.+.||+|+||.||+|+.. +|+.||+|+++.....     ..+.+.+|++++++++||||+++++++.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34568999999999999999999964 6899999999754321     23578899999999999999999999999999


Q ss_pred             eEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceec
Q 039290          832 KALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL  911 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~  911 (1049)
                      .++||||+++ +|.+++......+++.+++.++.|+++||+|||   +.||+||||||+||+++.++.+||+|||+++..
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            9999999986 899988877777899999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcc-ccCCcchh-
Q 039290          912 GKEESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSL-LSCSITEV-  988 (1049)
Q Consensus       912 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~-  988 (1049)
                      ..... ......+|+.|+|||++.+ ..++.++||||+||++|||++|..||......+.....+..... ....+.+. 
T Consensus       163 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  241 (346)
T 1ua2_A          163 GSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC  241 (346)
T ss_dssp             TSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             cCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence            43332 2334578999999999865 45889999999999999999999998764332221111111000 00000000 


Q ss_pred             --cccccccccccC--chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          989 --ADANLLNCEEND--FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       989 --~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                        .+..........  .......+.++.+++.+|++.||++|||++|+++|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence              000000000000  01112345789999999999999999999999986

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5.8e-38  Score=356.08  Aligned_cols=245  Identities=27%  Similarity=0.294  Sum_probs=193.0

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC---CCHHHHHHHHHH-HhhcCCCceeeEEeeeecCCeeEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD---GSLESFHAECKV-MGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      .++|++.+.||+|+||+||+|+.. +++.||+|+++....   .....+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            357899999999999999999965 688999999976542   234456677776 567899999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      ||||+++|+|.+++...+ .+++..++.++.||+.||+|||   ++||+||||||+||+++.++.+||+|||+++.....
T Consensus       117 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            999999999999987654 4889999999999999999999   999999999999999999999999999999854322


Q ss_pred             ccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          915 ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       915 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                      . .......||+.|+|||++.+..++.++||||+||++|||++|..||......+.. .....             .   
T Consensus       193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~-~~i~~-------------~---  254 (373)
T 2r5t_A          193 N-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY-DNILN-------------K---  254 (373)
T ss_dssp             C-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH-HHHHH-------------S---
T ss_pred             C-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHh-------------c---
Confidence            2 2234567999999999999999999999999999999999999999753222111 11110             0   


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKD 1031 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~e 1031 (1049)
                           ....+...+.++.+++.+|++.||++||++.+
T Consensus       255 -----~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          255 -----PLQLKPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             -----CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             -----ccCCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence                 00011224567899999999999999999853

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=7.8e-38  Score=347.14  Aligned_cols=251  Identities=23%  Similarity=0.291  Sum_probs=203.9

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      .++|.+.+.||+|+||.||+|+.. +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            356889999999999999999965 7899999999866544556789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeee---cCCCceEEecccCceecCCCc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~---~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      +++++|.+++...+ .+++.+++.++.|++.|++|||   +.||+||||||+||++   +.++.+||+|||++...... 
T Consensus        88 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-  162 (304)
T 2jam_A           88 VSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-  162 (304)
T ss_dssp             CCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred             CCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence            99999999887654 4899999999999999999999   9999999999999999   77889999999999764332 


Q ss_pred             cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                        ......|++.|+|||++.+..++.++||||+||++|||++|..||......+. .........               
T Consensus       163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~---------------  224 (304)
T 2jam_A          163 --IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL-FEKIKEGYY---------------  224 (304)
T ss_dssp             --TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHCCC---------------
T ss_pred             --ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHcCCC---------------
Confidence              22335689999999999998999999999999999999999999975322211 111110000               


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                        ..........+.++.+++.+|++.||++|||++|++++
T Consensus       225 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          225 --EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             --CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             --CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence              00001112345678999999999999999999999986

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.5e-37  Score=363.73  Aligned_cols=266  Identities=21%  Similarity=0.211  Sum_probs=197.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecC------C
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNN------D  830 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~------~  830 (1049)
                      .++|++.+.||+|+||+||+|... +++.||+|++....  ....+++.+|+++++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            468999999999999999999954 78899999997643  22356788999999999999999999998654      4


Q ss_pred             eeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCcee
Q 039290          831 FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI  910 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~  910 (1049)
                      ..|+||||+++ ++.+.+..   .+++.++..++.|+++||+|||   +.||+||||||+||+++.++.+||+|||+|+.
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            57999999976 46665543   3889999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcccc--------
Q 039290          911 LGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLS--------  982 (1049)
Q Consensus       911 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------  982 (1049)
                      .....  .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+. +..........        
T Consensus       214 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~-~~~i~~~lg~p~~~~~~~~  290 (464)
T 3ttj_A          214 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKKL  290 (464)
T ss_dssp             ---CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCSCCHHHHTTS
T ss_pred             cCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHc
Confidence            64432  23446789999999999999999999999999999999999999976322111 11110000000        


Q ss_pred             -----------CCcchhccccccc--ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          983 -----------CSITEVADANLLN--CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       983 -----------~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                                 ........+....  ............+.++.+++.+||+.||++|||++|+++|
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                       0000000000000  0001112223346789999999999999999999999987

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.4e-38  Score=343.66  Aligned_cols=252  Identities=30%  Similarity=0.437  Sum_probs=201.3

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecC-CeeEEEEec
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNN-DFKALVLEY  838 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~-~~~~lv~e~  838 (1049)
                      .++|++.+.||+|+||.||+|+. +++.||+|+++..  ...+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            45788999999999999999987 5889999998754  3457899999999999999999999987554 578999999


Q ss_pred             cCCCChhhhhhcCCC-ccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          839 MSNGSLEKCLYSDNY-FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      +++++|.+++..... .+++..++.++.|+++|++|||   ++||+||||||+||+++.++.+||+|||++.......  
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  171 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  171 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence            999999999876433 3789999999999999999999   9999999999999999999999999999998654322  


Q ss_pred             cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          918 RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                        ....+++.|+|||++.+..++.++||||+|+++|||++ |..||......+.. ......                  
T Consensus       172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~-~~~~~~------------------  230 (278)
T 1byg_A          172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-PRVEKG------------------  230 (278)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH-HHHTTT------------------
T ss_pred             --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHhcC------------------
Confidence              22356889999999988899999999999999999998 99999763322111 110000                  


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHh
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~ 1042 (1049)
                        .+...+..++..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus       231 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          231 --YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence              00111233567899999999999999999999999999998765

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.3e-37  Score=341.66  Aligned_cols=247  Identities=25%  Similarity=0.359  Sum_probs=206.5

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            357889999999999999999965 67889999986542   34457899999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++++|.+++...+ .+++.+++.++.|+++|++|||   +.||+||||||+||+++.++.+||+|||++.......
T Consensus        93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR  168 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred             EEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence            99999999999987654 4899999999999999999999   9999999999999999999999999999997654322


Q ss_pred             cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                         .....+++.|+|||++.+..++.++||||+|+++|||++|..||......+.. .....             .    
T Consensus       169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~-------------~----  227 (284)
T 2vgo_A          169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH-RRIVN-------------V----  227 (284)
T ss_dssp             ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHHHT-------------T----
T ss_pred             ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH-HHHhc-------------c----
Confidence               23456899999999999989999999999999999999999999753222111 11000             0    


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                          ....+...+.++.+++.+|++.||++|||++|+++|
T Consensus       228 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          228 ----DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             ----ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence                001112245678999999999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.2e-37  Score=367.19  Aligned_cols=253  Identities=22%  Similarity=0.312  Sum_probs=207.7

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|...+.||+|+||.||+|+.. +|+.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            57888999999999999999964 79999999997543   345678899999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCC---CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          837 EYMSNGSLEKCLYSDN---YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      ||++||+|.+++....   ..+++..++.++.||+.||+|||   ++||+||||||+||+++.++.+||+|||+++....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            9999999999987642   36899999999999999999999   99999999999999999999999999999987654


Q ss_pred             CccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          914 EESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       914 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                      ... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......... ........         .   
T Consensus       342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~-~~~~~~i~---------~---  407 (543)
T 3c4z_A          342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQRVL---------E---  407 (543)
T ss_dssp             TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH-HHHHHHHH---------H---
T ss_pred             CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH-HHHHHHHh---------h---
Confidence            332 223357999999999999999999999999999999999999999764322111 11110000         0   


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCH-----HHHHHH
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISM-----KDVANR 1035 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~ell~~ 1035 (1049)
                           .....+..++.++.+++.+||+.||++||++     +++++|
T Consensus       408 -----~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          408 -----QAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             -----CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             -----cccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence                 0011123356778999999999999999965     677654

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.9e-37  Score=345.88  Aligned_cols=251  Identities=28%  Similarity=0.367  Sum_probs=204.2

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++....  ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  105 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY  105 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence            457999999999999999999965 68999999997543  457889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      +++++|.+++......+++.+++.++.|++.|++|||   +.||+||||||+||+++.++.+||+|||++........ .
T Consensus       106 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~  181 (314)
T 3com_A          106 CGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-K  181 (314)
T ss_dssp             CTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-C
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-c
Confidence            9999999999765667899999999999999999999   99999999999999999999999999999987643322 2


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                      .....+++.|+|||++.+..++.++||||+|+++|+|++|..||......+....  ...                 ...
T Consensus       182 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--~~~-----------------~~~  242 (314)
T 3com_A          182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM--IPT-----------------NPP  242 (314)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--HHH-----------------SCC
T ss_pred             cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH--Hhc-----------------CCC
Confidence            3345689999999999988999999999999999999999999975322111100  000                 000


Q ss_pred             cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          999 NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       999 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .....+..++..+.+++.+||+.||.+|||++|++++
T Consensus       243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          243 PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             CCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            1111123345678999999999999999999999886

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.8e-37  Score=351.17  Aligned_cols=258  Identities=23%  Similarity=0.333  Sum_probs=208.1

Q ss_pred             HHHHHHhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCC--------CHHHHHHHHHHHhhc-CCCceeeEE
Q 039290          754 QDLLRATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDG--------SLESFHAECKVMGSI-RHRNLVKII  823 (1049)
Q Consensus       754 ~~~~~~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l-~hpniv~l~  823 (1049)
                      .......++|++.+.||+|+||.||+|+.. +|+.||||++......        ..+.+.+|+++++++ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            344445678999999999999999999975 7999999999765422        135678899999999 799999999


Q ss_pred             eeeecCCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEe
Q 039290          824 SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLS  903 (1049)
Q Consensus       824 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~  903 (1049)
                      +++...+..++||||+++++|.+++.... .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~  242 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLS  242 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEE
Confidence            99999999999999999999999987643 4899999999999999999999   9999999999999999999999999


Q ss_pred             cccCceecCCCccccccccccccCcccccccCC------CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhh
Q 039290          904 DFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE------GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVG  977 (1049)
Q Consensus       904 DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  977 (1049)
                      |||++........  .....||+.|+|||++.+      ..++.++||||+||++|||++|..||......+  ....+.
T Consensus       243 DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~~i~  318 (365)
T 2y7j_A          243 DFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL--MLRMIM  318 (365)
T ss_dssp             CCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH
T ss_pred             ecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHH
Confidence            9999987754332  234678999999998753      358899999999999999999999997532111  111110


Q ss_pred             hccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          978 DSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       978 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ...                .....+....++.++.+++.+||+.||++|||++|++++
T Consensus       319 ~~~----------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          319 EGQ----------------YQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HTC----------------CCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hCC----------------CCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            000                000011112345678999999999999999999999875

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.4e-37  Score=360.19  Aligned_cols=253  Identities=22%  Similarity=0.287  Sum_probs=195.4

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc--------CCCHHHHHHHHHHHhhcCCCceeeEEeeeecC
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF--------DGSLESFHAECKVMGSIRHRNLVKIISSCSNN  829 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~  829 (1049)
                      ..++|.+.+.||+|+||+||+|.. .+++.||+|++....        ......+.+|++++++++||||+++++++.. 
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            457899999999999999999995 468999999997542        1122357899999999999999999999865 


Q ss_pred             CeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCC---CceEEeccc
Q 039290          830 DFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES---MVGHLSDFG  906 (1049)
Q Consensus       830 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~---~~~kl~DfG  906 (1049)
                      +..++||||+++|+|.+++.... .+++.+++.++.|+++||+|||   +++|+||||||+||+++.+   +.+||+|||
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG  287 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG  287 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred             CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeecc
Confidence            45789999999999999887654 5899999999999999999999   9999999999999999754   459999999


Q ss_pred             CceecCCCccccccccccccCcccccccCC---CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccC
Q 039290          907 IAKILGKEESMRQTKTLGTIGYMAPEYGRE---GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSC  983 (1049)
Q Consensus       907 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  983 (1049)
                      +++......  ......||+.|+|||++.+   ..++.++||||+||++|||++|..||.................    
T Consensus       288 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~----  361 (419)
T 3i6u_A          288 HSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK----  361 (419)
T ss_dssp             TTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC----
T ss_pred             cceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC----
Confidence            998765332  2334678999999999853   5678899999999999999999999976433222221111100    


Q ss_pred             CcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          984 SITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                                   ..........++.++.+++.+||+.||++|||++|+++|
T Consensus       362 -------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          362 -------------YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             -------------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -------------CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence                         000111122356789999999999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.9e-37  Score=348.91  Aligned_cols=272  Identities=22%  Similarity=0.281  Sum_probs=205.3

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeec--------
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSN--------  828 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--------  828 (1049)
                      .++|++.+.||+|+||+||+|+. .+|+.||+|++....  ......+.+|+++++.++||||+++++++.+        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            35799999999999999999996 578999999986554  2335678899999999999999999999876        


Q ss_pred             CCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCc
Q 039290          829 NDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA  908 (1049)
Q Consensus       829 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla  908 (1049)
                      .+..++||||+++ ++.+.+......+++.+++.++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            4468999999975 888887776667999999999999999999999   999999999999999999999999999999


Q ss_pred             eecCCCc---cccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhh-hccccC
Q 039290          909 KILGKEE---SMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVG-DSLLSC  983 (1049)
Q Consensus       909 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~  983 (1049)
                      +.+....   ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+........ ......
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  251 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            8765322   222344578999999998876 55899999999999999999999999864332221111000 000011


Q ss_pred             Ccchhccccccc----ccccCchhh-----HHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          984 SITEVADANLLN----CEENDFSAR-----EQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       984 ~~~~~~~~~~~~----~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ............    .........     ...++.+.+++.+|++.||++|||++|+++|
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            011110000000    000000111     1124568999999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.3e-38  Score=348.97  Aligned_cols=253  Identities=23%  Similarity=0.309  Sum_probs=202.8

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            457899999999999999999975 6889999999877666778999999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      +++++|.+++......+++.+++.++.|++.|++|||   +.||+||||||+||+++.++.+||+|||++....... ..
T Consensus        98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  173 (302)
T 2j7t_A           98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QK  173 (302)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-cc
Confidence            9999999998876667999999999999999999999   9999999999999999999999999999876432111 11


Q ss_pred             ccccccccCccccccc-----CCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          919 QTKTLGTIGYMAPEYG-----REGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~-----~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                      .....+++.|+|||++     ....++.++||||+|+++|||++|..||......+.. .......              
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~--------------  238 (302)
T 2j7t_A          174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL-LKIAKSD--------------  238 (302)
T ss_dssp             -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHHHHSC--------------
T ss_pred             cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH-HHHhccC--------------
Confidence            2234689999999987     4567899999999999999999999999763322111 1111000              


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                          ......+..++.++.+++.+||+.||++|||++|+++|
T Consensus       239 ----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          239 ----PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             ----CCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             ----CcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                00011123345678999999999999999999999874

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.3e-38  Score=362.26  Aligned_cols=251  Identities=16%  Similarity=0.167  Sum_probs=196.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc---CCCHHHHHHHH---HHHhhcCCCceeeEE-------ee
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAEC---KVMGSIRHRNLVKII-------SS  825 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~---~~l~~l~hpniv~l~-------~~  825 (1049)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++....   ....+.+.+|+   +++++++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            35688899999999999999995 579999999997542   33457889999   455556899999998       66


Q ss_pred             eecCC-----------------eeEEEEeccCCCChhhhhhcCCC------ccCHHHHHHHHHHHHHHHHHhHccCCCCe
Q 039290          826 CSNND-----------------FKALVLEYMSNGSLEKCLYSDNY------FLDILQRLKIMIDVASALEYLHFGYSTPI  882 (1049)
Q Consensus       826 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i  882 (1049)
                      +.+.+                 ..++||||+ +|+|.+++...+.      .+++..++.++.||++||+|||   ++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            65543                 278999999 6799999876432      2335888899999999999999   9999


Q ss_pred             EEcCCCCCCeeecCCCceEEecccCceecCCCccccccccccccCcccccccCCC-----------CcCcccchHHHHHH
Q 039290          883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-----------KVSRKCDVYSYGIM  951 (1049)
Q Consensus       883 vH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DvwslG~i  951 (1049)
                      +||||||+|||++.++.+||+|||+++....    ......| +.|+|||++.+.           .++.++|||||||+
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            9999999999999999999999999986432    2234567 999999999877           89999999999999


Q ss_pred             HHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 039290          952 LMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKD 1031 (1049)
Q Consensus       952 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~e 1031 (1049)
                      +|||++|+.||......+....              +..     .       ...++.++.+++.+||+.||++|||+.|
T Consensus       303 l~elltg~~Pf~~~~~~~~~~~--------------~~~-----~-------~~~~~~~~~~li~~~L~~dp~~Rpt~~e  356 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGGSEW--------------IFR-----S-------CKNIPQPVRALLEGFLRYPKEDRLLPLQ  356 (377)
T ss_dssp             HHHHHHSSCCC------CCSGG--------------GGS-----S-------CCCCCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred             HHHHHHCCCCCcccccccchhh--------------hhh-----h-------ccCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence            9999999999965322111100              000     0       0123567899999999999999999999


Q ss_pred             HHHH--HHHHHHhhhh
Q 039290         1032 VANR--LVRIRETLSA 1045 (1049)
Q Consensus      1032 ll~~--L~~i~~~~~~ 1045 (1049)
                      ++++  ++++.+..+.
T Consensus       357 ~l~hp~f~~~~~~~~~  372 (377)
T 3byv_A          357 AMETPEYEQLRTELSA  372 (377)
T ss_dssp             HHTSHHHHHHHHHHHH
T ss_pred             HhhChHHHHHHHHHHH
Confidence            9974  6666665544

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.6e-37  Score=367.67  Aligned_cols=251  Identities=23%  Similarity=0.314  Sum_probs=205.1

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      .++|++.+.||+|+||+||+|+.. +++.||+|++....  ......+.+|++++++++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            356999999999999999999965 78999999996543  345678999999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec---CCCceEEecccCceecCC
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~---~~~~~kl~DfGla~~~~~  913 (1049)
                      ||+++|+|.+.+.... .+++.+++.++.|++.|++|||   ++||+||||||+||+++   .++.+||+|||++.....
T Consensus       101 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            9999999999887654 4899999999999999999999   99999999999999995   456899999999986644


Q ss_pred             CccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          914 EESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       914 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                      ..  ......||+.|+|||++.+ .++.++||||+||++|+|++|..||......+... .....               
T Consensus       177 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~i~~~---------------  237 (486)
T 3mwu_A          177 NT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK-RVETG---------------  237 (486)
T ss_dssp             C------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHHT---------------
T ss_pred             CC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhC---------------
Confidence            32  2334578999999999875 69999999999999999999999997632222111 11000               


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                        ......+....++.++.+++.+||+.||++|||+.|+++|
T Consensus       238 --~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          238 --KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             --CCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             --CCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              0000111223356778999999999999999999999987

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2e-37  Score=342.28  Aligned_cols=252  Identities=28%  Similarity=0.349  Sum_probs=201.4

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      ++|.....||+|+||.||+|+. .+++.||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            3455667999999999999995 578899999998766666788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCC--ccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC-CCceEEecccCceecCCCcc
Q 039290          840 SNGSLEKCLYSDNY--FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE-SMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ++++|.+++.....  ..++..++.++.|++.|++|||   +.||+||||||+||+++. ++.+||+|||++........
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~  178 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP  178 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence            99999999976532  4678899999999999999999   999999999999999987 89999999999987643222


Q ss_pred             ccccccccccCcccccccCCCC--cCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGK--VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                       ......|++.|+|||++.+..  ++.++||||+|+++|||++|+.||.............. ..               
T Consensus       179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~---------------  241 (295)
T 2clq_A          179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG-MF---------------  241 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHH-HH---------------
T ss_pred             -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhc-cc---------------
Confidence             223456899999999986643  78999999999999999999999975322211111100 00               


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                         ......+..++.++.+++.+||+.||++|||++|++++
T Consensus       242 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          242 ---KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             ---CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             ---cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               00011122345678999999999999999999999875

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.1e-37  Score=344.11  Aligned_cols=250  Identities=22%  Similarity=0.296  Sum_probs=207.1

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC---CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD---GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            357889999999999999999965 688999999876532   2346788999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++++|.+++.... .+++.+++.++.|+++|++|||   +.||+||||||+||+++.++.+||+|||++.......
T Consensus        94 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            99999999999887644 4899999999999999999999   9999999999999999999999999999998765332


Q ss_pred             cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                      . ......+++.|+|||++.+..++.++||||+|+++|||++|+.||......+.. ......                 
T Consensus       170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~-----------------  230 (294)
T 2rku_A          170 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-LRIKKN-----------------  230 (294)
T ss_dssp             C-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHHHTT-----------------
T ss_pred             c-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHhhc-----------------
Confidence            2 223456899999999999888999999999999999999999999763322211 111000                 


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                          ....+...+..+.+++.+||+.||++|||++|++++-
T Consensus       231 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~  267 (294)
T 2rku_A          231 ----EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDE  267 (294)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             ----cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence                0011122446789999999999999999999999863

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.7e-37  Score=353.57  Aligned_cols=278  Identities=19%  Similarity=0.246  Sum_probs=206.5

Q ss_pred             cccHHHHHHHhcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCC-----------HHHHHHHHHHHhhcCCCc
Q 039290          750 RISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGS-----------LESFHAECKVMGSIRHRN  818 (1049)
Q Consensus       750 ~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~hpn  818 (1049)
                      +...+++....++|++.+.||+|+||.||+|...+|+.||||++.......           .+.+.+|++++++++|||
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   90 (362)
T 3pg1_A           11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN   90 (362)
T ss_dssp             HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred             HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence            345667888889999999999999999999998889999999986543221           267899999999999999


Q ss_pred             eeeEEeeeec-----CCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCee
Q 039290          819 LVKIISSCSN-----NDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVL  893 (1049)
Q Consensus       819 iv~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl  893 (1049)
                      |+++++++..     ....++||||++ |+|.+.+......+++..++.++.|++.||+|||   +.||+||||||+||+
T Consensus        91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl  166 (362)
T 3pg1_A           91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNIL  166 (362)
T ss_dssp             BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEE
T ss_pred             ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEE
Confidence            9999999843     346899999997 5888888877777999999999999999999999   999999999999999


Q ss_pred             ecCCCceEEecccCceecCCCccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchH
Q 039290          894 LNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSL  972 (1049)
Q Consensus       894 ~~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~  972 (1049)
                      ++.++.+||+|||++.......  ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+.. 
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-  243 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL-  243 (362)
T ss_dssp             ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-
T ss_pred             EcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH-
Confidence            9999999999999997543322  2334568999999998876 67899999999999999999999999763322111 


Q ss_pred             HHhhhhccccCCcc-----------hhcccccccccccC-chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          973 KRWVGDSLLSCSIT-----------EVADANLLNCEEND-FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       973 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ..... ........           +............. .......++.+.+++.+|++.||++|||++|+++|
T Consensus       244 ~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          244 NKIVE-VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHH-HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHH-HcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            11100 00000000           00000010111111 11122345678999999999999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.8e-37  Score=342.49  Aligned_cols=249  Identities=26%  Similarity=0.370  Sum_probs=207.7

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      +.|+..+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            4688899999999999999985 478999999997654 34567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      +++++|.+++...  .+++.++..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||++........ .
T Consensus       102 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  175 (303)
T 3a7i_A          102 LGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K  175 (303)
T ss_dssp             CTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-C
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcccc-c
Confidence            9999999998753  4899999999999999999999   99999999999999999999999999999987644322 2


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                      .....+++.|+|||++.+..++.++||||+|+++|||++|+.||......+..  .......                  
T Consensus       176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~------------------  235 (303)
T 3a7i_A          176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL--FLIPKNN------------------  235 (303)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHHHHSC------------------
T ss_pred             cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH--HHhhcCC------------------
Confidence            33456899999999999989999999999999999999999999753222111  1110000                  


Q ss_pred             cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          999 NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       999 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                       ....+..++..+.+++.+||+.||++|||++|++++.
T Consensus       236 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          236 -PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             -CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             -CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence             0001122456789999999999999999999999874

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=7.9e-38  Score=343.53  Aligned_cols=250  Identities=23%  Similarity=0.378  Sum_probs=205.6

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeec----------
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSN----------  828 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~----------  828 (1049)
                      ..+|++.+.||+|+||.||+|+.. +++.||+|+++...    +.+.+|++++++++||||+++++++..          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            346889999999999999999975 79999999997542    467789999999999999999998854          


Q ss_pred             ------CCeeEEEEeccCCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceE
Q 039290          829 ------NDFKALVLEYMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGH  901 (1049)
Q Consensus       829 ------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~k  901 (1049)
                            ....++||||+++++|.+++... ...+++..++.++.|++.|++|||   +.||+||||||+||+++.++.+|
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~k  162 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVK  162 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEE
Confidence                  44579999999999999999754 346899999999999999999999   99999999999999999999999


Q ss_pred             EecccCceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccc
Q 039290          902 LSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLL  981 (1049)
Q Consensus       902 l~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  981 (1049)
                      |+|||++.......  ......+++.|+|||++.+..++.++||||+|+++|||++|..|+....   .......     
T Consensus       163 l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~-----  232 (284)
T 2a19_B          163 IGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS---KFFTDLR-----  232 (284)
T ss_dssp             ECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH---HHHHHHH-----
T ss_pred             ECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH---HHHHHhh-----
Confidence            99999998765433  2234568999999999988899999999999999999999998864311   0000000     


Q ss_pred             cCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          982 SCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                              ....          +..++..+.+++.+||+.||++|||+.|++++|+.+.+...
T Consensus       233 --------~~~~----------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          233 --------DGII----------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             --------TTCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             --------cccc----------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence                    0000          01234568899999999999999999999999998877654

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.2e-37  Score=367.06  Aligned_cols=250  Identities=25%  Similarity=0.334  Sum_probs=201.1

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      ++|++.+.||+|+||+||+|+.. ++..||+|+++...  ......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            46899999999999999999965 78899999997653  3346789999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC---CCceEEecccCceecCCC
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE---SMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~~~kl~DfGla~~~~~~  914 (1049)
                      |+++|+|.+.+.... .+++.+++.++.||++||+|||   ++||+||||||+||+++.   ++.+||+|||++......
T Consensus       117 ~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          117 CYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            999999999887654 4899999999999999999999   999999999999999975   456999999999876543


Q ss_pred             ccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          915 ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       915 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                      .  ......||+.|+|||++. ..++.++||||+||++|+|++|..||......+.......+...              
T Consensus       193 ~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--------------  255 (494)
T 3lij_A          193 K--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT--------------  255 (494)
T ss_dssp             B--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--------------
T ss_pred             c--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------------
Confidence            3  234467999999999886 57999999999999999999999999764332221111100000              


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                          ...+.....+..+.+++.+||+.||++|||+.|+++|
T Consensus       256 ----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          256 ----FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             ----CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             ----CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence                0011112345678999999999999999999999987

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=8.4e-38  Score=350.70  Aligned_cols=272  Identities=22%  Similarity=0.285  Sum_probs=197.5

Q ss_pred             HHhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          758 RATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       758 ~~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      ...++|++.+.||+|+||+||+|+. .+++.||+|+++....  ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            3456899999999999999999995 4788999999975532  234567899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec-----CCCceEEecccCce
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN-----ESMVGHLSDFGIAK  909 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~-----~~~~~kl~DfGla~  909 (1049)
                      ||||+++ +|.+++..... +++.+++.++.|+++||+|||   ++||+||||||+||+++     ..+.+||+|||+++
T Consensus       111 v~e~~~~-~L~~~~~~~~~-~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMDKNPD-VSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             EEECCSE-EHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             EEecCCC-CHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            9999975 99999877654 899999999999999999999   99999999999999994     55569999999998


Q ss_pred             ecCCCccccccccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcc-ccCCcch
Q 039290          910 ILGKEESMRQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSL-LSCSITE  987 (1049)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~  987 (1049)
                      ....... ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||......+........... .......
T Consensus       186 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (329)
T 3gbz_A          186 AFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG  264 (329)
T ss_dssp             HHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             ccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence            7643322 22345679999999998774 4899999999999999999999999764332221111110000 0000000


Q ss_pred             hcc-----ccccccccc--CchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          988 VAD-----ANLLNCEEN--DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       988 ~~~-----~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ...     .........  +.......+.++.+++.+||+.||++|||++|+++|
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            000     000000000  001112245778999999999999999999999875

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.5e-37  Score=366.27  Aligned_cols=251  Identities=25%  Similarity=0.323  Sum_probs=203.9

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC-------------CCHHHHHHHHHHHhhcCCCceeeEEee
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD-------------GSLESFHAECKVMGSIRHRNLVKIISS  825 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~hpniv~l~~~  825 (1049)
                      .++|++.++||+|+||+||+|+.. +++.||+|+++....             ...+.+.+|++++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            568999999999999999999964 688999999975431             335678999999999999999999999


Q ss_pred             eecCCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC---ceEE
Q 039290          826 CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM---VGHL  902 (1049)
Q Consensus       826 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~---~~kl  902 (1049)
                      +.+.+..++||||+++|+|.+++.... .+++..++.++.|++.||+|||   +.||+||||||+||+++.++   .+||
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEEE
Confidence            999999999999999999999887654 4899999999999999999999   99999999999999998765   6999


Q ss_pred             ecccCceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcccc
Q 039290          903 SDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLS  982 (1049)
Q Consensus       903 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  982 (1049)
                      +|||++.......  ......||+.|+|||++. +.++.++||||+||++|+|++|..||......+.......      
T Consensus       191 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~------  261 (504)
T 3q5i_A          191 VDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK------  261 (504)
T ss_dssp             CCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------
T ss_pred             EECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc------
Confidence            9999998775433  234467899999999986 4699999999999999999999999976332221111100      


Q ss_pred             CCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          983 CSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                                  .............+.++.+++.+|++.||.+|||++|+++|
T Consensus       262 ------------~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          262 ------------GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             ------------CCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ------------CCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                        00000111223456789999999999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.5e-37  Score=376.87  Aligned_cols=252  Identities=27%  Similarity=0.406  Sum_probs=203.4

Q ss_pred             ceecCCCcEEEEEEEe---CCCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCC
Q 039290          767 KLLGMGSFGSVYKGVL---PDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSN  841 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  841 (1049)
                      +.||+|+||+||+|.+   ..++.||||+++....  ...+++.+|++++++++|||||++++++.+ +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            5799999999999964   3567899999976542  335789999999999999999999999975 457899999999


Q ss_pred             CChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc--ccc
Q 039290          842 GSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES--MRQ  919 (1049)
Q Consensus       842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~--~~~  919 (1049)
                      |+|.+++...+ .+++.+++.++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++.+.....  ...
T Consensus       454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            99999997654 4899999999999999999999   99999999999999999999999999999987654332  122


Q ss_pred             cccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccccccc
Q 039290          920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                      ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+..  ..+...                   
T Consensus       530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~--~~i~~~-------------------  588 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT--AMLEKG-------------------  588 (635)
T ss_dssp             -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH--HHHHTT-------------------
T ss_pred             cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH--HHHHcC-------------------
Confidence            23446788999999998899999999999999999998 99999764332211  111000                   


Q ss_pred             cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          999 NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       999 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                      .+...+..++.++.++|.+||+.||++||+++++++.|+++...+.
T Consensus       589 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~  634 (635)
T 4fl3_A          589 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  634 (635)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence            0111223466789999999999999999999999999999887654

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.1e-37  Score=350.81  Aligned_cols=249  Identities=22%  Similarity=0.301  Sum_probs=206.8

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC---CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD---GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      ..+|.+.+.||+|+||.||+|+.. +++.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            357889999999999999999965 678999999876532   2356788999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++++|.+++.... .+++.+++.++.|+++||+|||   ++||+||||||+||+++.++.+||+|||++.......
T Consensus       120 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            99999999999887643 4899999999999999999999   9999999999999999999999999999998765332


Q ss_pred             cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                      . ......|++.|+|||++.+..++.++||||+|+++|||++|+.||......+.. ......                 
T Consensus       196 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~-----------------  256 (335)
T 2owb_A          196 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-LRIKKN-----------------  256 (335)
T ss_dssp             C-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHHHHT-----------------
T ss_pred             c-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH-HHHhcC-----------------
Confidence            2 223456899999999998888999999999999999999999999753222111 111000                 


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                          ....+..++..+.+++.+||+.||++|||++|++++
T Consensus       257 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          257 ----EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ----CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                001112244678899999999999999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.3e-37  Score=348.81  Aligned_cols=260  Identities=21%  Similarity=0.265  Sum_probs=206.4

Q ss_pred             HHHHHHHhcCCCCC-ceecCCCcEEEEEEEeC-CCcEEEEEEeecccC--CCHHHHHHHHHHHhhcC-CCceeeEEeeee
Q 039290          753 YQDLLRATDGFSEN-KLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD--GSLESFHAECKVMGSIR-HRNLVKIISSCS  827 (1049)
Q Consensus       753 ~~~~~~~~~~~~~~-~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-hpniv~l~~~~~  827 (1049)
                      ++......++|.+. +.||+|+||.||+|+.. +++.||+|+++....  .....+.+|+.+++.++ ||||+++++++.
T Consensus        20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~   99 (327)
T 3lm5_A           20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE   99 (327)
T ss_dssp             SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            33444455667777 89999999999999965 689999999976542  33678899999999994 699999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC---CCceEEe
Q 039290          828 NNDFKALVLEYMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE---SMVGHLS  903 (1049)
Q Consensus       828 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~~~kl~  903 (1049)
                      +.+..++||||+++|+|.+++... ...+++.+++.++.|++.||+|||   ++||+||||||+||+++.   ++.+||+
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~  176 (327)
T 3lm5_A          100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIV  176 (327)
T ss_dssp             CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred             eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEe
Confidence            999999999999999999988653 346899999999999999999999   999999999999999987   7899999


Q ss_pred             cccCceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccC
Q 039290          904 DFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSC  983 (1049)
Q Consensus       904 DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  983 (1049)
                      |||+++.......  .....||+.|+|||++.+..++.++||||+||++|||++|+.||......+........  .   
T Consensus       177 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~---  249 (327)
T 3lm5_A          177 DFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV--N---  249 (327)
T ss_dssp             CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--C---
T ss_pred             eCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc--c---
Confidence            9999987654332  23457899999999999999999999999999999999999999763322221111000  0   


Q ss_pred             CcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          984 SITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                                   ..........++..+.+++.+||+.||++|||++|++++
T Consensus       250 -------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          250 -------------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             -------------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             -------------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence                         000011112345678999999999999999999999876

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.3e-37  Score=362.28  Aligned_cols=200  Identities=23%  Similarity=0.371  Sum_probs=168.3

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCC--CHHHHHHHHHHHhhcCCCceeeEEeeeecC-----Ce
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDG--SLESFHAECKVMGSIRHRNLVKIISSCSNN-----DF  831 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~-----~~  831 (1049)
                      .++|++.+.||+|+||.||+|+.. +++.||||+++.....  ..+++.+|++++++++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            467999999999999999999954 6889999999754322  346788999999999999999999998765     57


Q ss_pred             eEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceec
Q 039290          832 KALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL  911 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~  911 (1049)
                      .|+||||++ |+|.+++.... .+++..++.++.||++||+|||   +.||+||||||+||+++.++.+||+|||+|+..
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCC-cCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            899999996 59999987653 5899999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCcc---------------------ccccccccccCccccccc-CCCCcCcccchHHHHHHHHHHHhCCCCCCc
Q 039290          912 GKEES---------------------MRQTKTLGTIGYMAPEYG-REGKVSRKCDVYSYGIMLMETFTKKKPTDE  964 (1049)
Q Consensus       912 ~~~~~---------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg~~p~~~  964 (1049)
                      .....                     ......+||+.|+|||++ ....++.++||||+||++|||++|..||..
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~  254 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN  254 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence            53321                     123456789999999985 556799999999999999999997666543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.8e-38  Score=358.31  Aligned_cols=263  Identities=14%  Similarity=0.136  Sum_probs=189.8

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC---CCHHHHHHHHHHHhhc--CCCceeeEE-------eeee
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD---GSLESFHAECKVMGSI--RHRNLVKII-------SSCS  827 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l--~hpniv~l~-------~~~~  827 (1049)
                      ..|+..+.||+|+||+||+|++. +++.||+|+++....   ...+.+.+|+++++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            34888999999999999999964 789999999987543   2345677785555444  699988855       3443


Q ss_pred             cC-----------------CeeEEEEeccCCCChhhhhhcCCCccCHHHH------HHHHHHHHHHHHHhHccCCCCeEE
Q 039290          828 NN-----------------DFKALVLEYMSNGSLEKCLYSDNYFLDILQR------LKIMIDVASALEYLHFGYSTPIVH  884 (1049)
Q Consensus       828 ~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~------~~i~~~i~~~l~~LH~~~~~~ivH  884 (1049)
                      ..                 ...++||||++ |+|.+++...+..+++..+      ..++.||++||+|||   ++||+|
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ivH  217 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVH  217 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCcc
Confidence            22                 34799999998 7999999875444555666      788899999999999   999999


Q ss_pred             cCCCCCCeeecCCCceEEecccCceecCCCccccccccccccCcccccccCC--CCcCcccchHHHHHHHHHHHhCCCCC
Q 039290          885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE--GKVSRKCDVYSYGIMLMETFTKKKPT  962 (1049)
Q Consensus       885 ~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~  962 (1049)
                      |||||+|||++.++.+||+|||+|+......    ....+|+.|+|||++.+  ..++.++||||+||++|||++|+.||
T Consensus       218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             TTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred             CcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999998764322    13456799999999987  67999999999999999999999999


Q ss_pred             CccccccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--HHHHH
Q 039290          963 DEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR--LVRIR 1040 (1049)
Q Consensus       963 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~--L~~i~ 1040 (1049)
                      ..........  |.....     .      ........+.....++..+.+++.+||+.||++|||++|+++|  ++++.
T Consensus       294 ~~~~~~~~~~--~~~~~~-----~------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  360 (371)
T 3q60_A          294 GLVTPGIKGS--WKRPSL-----R------VPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ  360 (371)
T ss_dssp             TBCCTTCTTC--CCBCCT-----T------SCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred             CCcCcccccc--hhhhhh-----h------hccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence            8643221110  000000     0      0000011111122456789999999999999999999999875  55555


Q ss_pred             Hhhh
Q 039290         1041 ETLS 1044 (1049)
Q Consensus      1041 ~~~~ 1044 (1049)
                      ...+
T Consensus       361 ~~~~  364 (371)
T 3q60_A          361 NEIS  364 (371)
T ss_dssp             HHHH
T ss_pred             HHHh
Confidence            5444

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=6.7e-38  Score=345.40  Aligned_cols=258  Identities=23%  Similarity=0.377  Sum_probs=199.6

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC--CCc--EEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP--DGM--EIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKA  833 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~--~~~--~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~  833 (1049)
                      ++|++.+.||+|+||+||+|++.  +++  .||+|+++...   ....+.+.+|++++++++||||+++++++.+.+ .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            47889999999999999999853  333  68999987543   233567899999999999999999999998765 78


Q ss_pred             EEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          834 LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      +||||+++++|.+++......+++.+++.++.|+++|++|||   +++|+||||||+||+++.++.+||+|||++.....
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence            999999999999999876667899999999999999999999   99999999999999999999999999999987754


Q ss_pred             Cccc--cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcc
Q 039290          914 EESM--RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD  990 (1049)
Q Consensus       914 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  990 (1049)
                      ....  ......++..|+|||++.+..++.++||||+|+++|||++ |..||......+.. .....    ..       
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~~~~----~~-------  241 (291)
T 1u46_A          174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL-HKIDK----EG-------  241 (291)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-HHHHT----SC-------
T ss_pred             cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH-HHHHc----cC-------
Confidence            3321  2223456778999999988889999999999999999999 99999764322111 11000    00       


Q ss_pred             cccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHh
Q 039290          991 ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042 (1049)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~ 1042 (1049)
                              .....+..++.++.+++.+||+.||++|||+++++++|+++...
T Consensus       242 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          242 --------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             --------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence                    00111223567899999999999999999999999999987654

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.4e-37  Score=338.11  Aligned_cols=248  Identities=24%  Similarity=0.387  Sum_probs=198.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            467999999999999999999975 79999999996542   34567889999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++++|.+++.... .+++.+++.++.|+++|++|||   +.||+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            99999999999987654 4899999999999999999999   9999999999999999999999999999998764332


Q ss_pred             cccccccccccCcccccccCCCCc-CcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKV-SRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                        ......+++.|+|||.+.+..+ +.++||||+|+++|+|++|..||......+.  ...+...               
T Consensus       166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~---------------  226 (276)
T 2h6d_A          166 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL--FKKIRGG---------------  226 (276)
T ss_dssp             -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHC---------------
T ss_pred             --ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH--HHHhhcC---------------
Confidence              1234568999999999987665 6899999999999999999999975322111  1111000               


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                           ....+..++..+.+++.+|++.||++|||++|++++
T Consensus       227 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          227 -----VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -----cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                 000112245678999999999999999999999987

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.2e-37  Score=368.91  Aligned_cols=251  Identities=25%  Similarity=0.373  Sum_probs=207.4

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|++.+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            46889999999999999999965 78999999996543   345678999999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeee---cCCCceEEecccCceecCC
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~---~~~~~~kl~DfGla~~~~~  913 (1049)
                      ||+.+|+|.+++.... .+++.+++.++.|++.||+|||   ++||+||||||+||++   +.++.+||+|||++..+..
T Consensus       106 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          106 EVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             CCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            9999999999887654 4899999999999999999999   9999999999999999   4678999999999987654


Q ss_pred             CccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          914 EESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       914 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                      ..  ......||+.|+|||++.+ .++.++||||+||++|+|++|..||......+.  ...+...              
T Consensus       182 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~--------------  242 (484)
T 3nyv_A          182 SK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI--LKKVEKG--------------  242 (484)
T ss_dssp             CC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHC--------------
T ss_pred             cc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHcC--------------
Confidence            33  2334578999999999865 799999999999999999999999976332221  1111100              


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                        ......+....+++++.+++.+||+.||++|||++|+++|-
T Consensus       243 --~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~  283 (484)
T 3nyv_A          243 --KYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHE  283 (484)
T ss_dssp             --CCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred             --CCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence              00001112234567789999999999999999999999873

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=360.07  Aligned_cols=348  Identities=23%  Similarity=0.268  Sum_probs=206.2

Q ss_pred             ceecccccccccccCCCCccccccceEEeccccccccCccccccccceEEEeeccccCCCccccccccccccceEEeccC
Q 039290          226 HVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDN  305 (1049)
Q Consensus       226 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N  305 (1049)
                      +.++.++++++ .+|..+.  ++++.|+|++|++++..|..|.++++|++|+|++|++.+..|..|.++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n   90 (477)
T 2id5_A           14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN   90 (477)
T ss_dssp             TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence            45667777766 5665553  46777777777777666667777777777777777776666666666665555555555


Q ss_pred             ccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCcccccccccccceeecccccccCCCC
Q 039290          306 DLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTP  385 (1049)
Q Consensus       306 ~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~  385 (1049)
                      ++. .+|...+..+++|++|+|++|++++..|..|..+++|++|++++|.+.+..+..|.++++|++|++++|.++.   
T Consensus        91 ~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~---  166 (477)
T 2id5_A           91 RLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTS---  166 (477)
T ss_dssp             CCC-SCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSS---
T ss_pred             cCC-ccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcc---
Confidence            554 3333333344444444444444444444444444444444444444443333333333333333333322221   


Q ss_pred             CcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCcc
Q 039290          386 DLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVT  465 (1049)
Q Consensus       386 ~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  465 (1049)
                                                                         ..+..|.++++|+.|+|++|.+++..+..
T Consensus       167 ---------------------------------------------------~~~~~l~~l~~L~~L~l~~n~i~~~~~~~  195 (477)
T 2id5_A          167 ---------------------------------------------------IPTEALSHLHGLIVLRLRHLNINAIRDYS  195 (477)
T ss_dssp             ---------------------------------------------------CCHHHHTTCTTCCEEEEESCCCCEECTTC
T ss_pred             ---------------------------------------------------cChhHhcccCCCcEEeCCCCcCcEeChhh
Confidence                                                               12223455566777777777776666666


Q ss_pred             ccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccccCcccccccccc
Q 039290          466 LGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDIL  545 (1049)
Q Consensus       466 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  545 (1049)
                      |..+++|++|++++|.+.+.+|.......+|++|++++|++++..+..+.++++|+.|+|++|+++++            
T Consensus       196 ~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~------------  263 (477)
T 2id5_A          196 FKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTI------------  263 (477)
T ss_dssp             SCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEE------------
T ss_pred             cccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCcc------------
Confidence            66666666666666666555555555555566666666665543334555555555555555555544            


Q ss_pred             cccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCcc
Q 039290          546 RFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNN  625 (1049)
Q Consensus       546 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  625 (1049)
                                  .+..|..+++|++|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|+
T Consensus       264 ------------~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  331 (477)
T 2id5_A          264 ------------EGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNP  331 (477)
T ss_dssp             ------------CTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSC
T ss_pred             ------------ChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCC
Confidence                        44445555666666666666666677778888888888888888887777778888888888888888


Q ss_pred             ccCCcccccccccccceeeccCCcccccCCC
Q 039290          626 LSGTIPKSMEALSYLKHLNLSFNQLEGEIPT  656 (1049)
Q Consensus       626 l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~  656 (1049)
                      +++.-+ ..+-...+..+++.++...|..|.
T Consensus       332 l~c~c~-~~~~~~~~~~~~~~~~~~~C~~p~  361 (477)
T 2id5_A          332 LACDCR-LLWVFRRRWRLNFNRQQPTCATPE  361 (477)
T ss_dssp             EECSGG-GHHHHTTTTSSCCTTCCCBEEESG
T ss_pred             ccCccc-hHhHHhhhhccccCccCceeCCch
Confidence            875433 222233344566777777777765

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1e-37  Score=350.49  Aligned_cols=270  Identities=24%  Similarity=0.285  Sum_probs=202.0

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCC--HHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGS--LESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.......  .+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            457899999999999999999965 58999999986554322  356789999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+++++|.++..... .+++..++.++.|++.|++|||   +.||+||||||+||+++.++.+||+|||++........
T Consensus       104 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  179 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  179 (331)
T ss_dssp             ECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             ecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence            9999998888765443 4899999999999999999999   99999999999999999999999999999986643322


Q ss_pred             ccccccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhc----------cccCCc
Q 039290          917 MRQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDS----------LLSCSI  985 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~----------~~~~~~  985 (1049)
                       ......+++.|+|||++.+. .++.++||||+||++|||++|+.||......+..........          ......
T Consensus       180 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (331)
T 4aaa_A          180 -VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF  258 (331)
T ss_dssp             -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred             -ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence             22345689999999998765 789999999999999999999999976433222111100000          000000


Q ss_pred             chhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          986 TEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       986 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .....+.... ..........++.++.+++.+||+.||++|||++|++++
T Consensus       259 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          259 AGVRLPEIKE-REPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             TTCCCCCCSS-CCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ccccCccccc-cchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0000000000 000011112456789999999999999999999999987

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.2e-37  Score=349.33  Aligned_cols=260  Identities=23%  Similarity=0.404  Sum_probs=206.1

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe------CCCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCee
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL------PDGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFK  832 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~  832 (1049)
                      .++|++.+.||+|+||.||+|++      .+++.||+|++.... .....++.+|+.++++++||||+++++++.+.+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            35799999999999999999984      357789999996432 23356788999999999999999999999999999


Q ss_pred             EEEEeccCCCChhhhhhcCC------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC---CCceEEe
Q 039290          833 ALVLEYMSNGSLEKCLYSDN------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE---SMVGHLS  903 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~~~kl~  903 (1049)
                      ++||||+++++|.+++....      ..+++.+++.++.|+++||+|||   +.||+||||||+||+++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999998654      35889999999999999999999   999999999999999984   4569999


Q ss_pred             cccCceecCCCcc-ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccc
Q 039290          904 DFGIAKILGKEES-MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLL  981 (1049)
Q Consensus       904 DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  981 (1049)
                      |||++........ .......+++.|+|||++.+..++.++||||+||++|||++ |..||......+  ....+.... 
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~~-  262 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VLEFVTSGG-  262 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHTTC-
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH--HHHHHhcCC-
Confidence            9999975532221 12233567889999999988899999999999999999998 999987532221  111111000 


Q ss_pred             cCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhh
Q 039290          982 SCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043 (1049)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~ 1043 (1049)
                                        ....+..++..+.+++.+||+.||++|||++|++++|+.+...-
T Consensus       263 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          263 ------------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             ------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             ------------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence                              00111234567899999999999999999999999999887643

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.6e-37  Score=338.50  Aligned_cols=247  Identities=23%  Similarity=0.356  Sum_probs=199.0

Q ss_pred             CCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeec----CCeeEE
Q 039290          762 GFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSN----NDFKAL  834 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~----~~~~~l  834 (1049)
                      .|++.+.||+|+||.||+|.. .++..||+|++.....  ...+.+.+|++++++++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            367778999999999999996 4688999999875432  235678899999999999999999998865    456899


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCC--eEEcCCCCCCeeec-CCCceEEecccCceec
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP--IVHCDIKPSNVLLN-ESMVGHLSDFGIAKIL  911 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIl~~-~~~~~kl~DfGla~~~  911 (1049)
                      ||||+++++|.+++.... .+++..++.++.|+++|++|||   +.+  |+||||||+||+++ .++.+||+|||++...
T Consensus       107 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            999999999999997643 4899999999999999999999   888  99999999999998 7899999999999754


Q ss_pred             CCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccc
Q 039290          912 GKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA  991 (1049)
Q Consensus       912 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  991 (1049)
                      ....   .....|++.|+|||++. +.++.++||||+||++|+|++|+.||..................           
T Consensus       183 ~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----------  247 (290)
T 1t4h_A          183 RASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-----------  247 (290)
T ss_dssp             CTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-----------
T ss_pred             cccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC-----------
Confidence            3322   23456899999999886 46899999999999999999999999763332222211111000           


Q ss_pred             ccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          992 NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                              ....+...+.++.+++.+||+.||++|||++|+++|
T Consensus       248 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          248 --------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             --------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                    001112234578999999999999999999999875

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.4e-37  Score=350.46  Aligned_cols=266  Identities=21%  Similarity=0.269  Sum_probs=207.6

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCC-----------------HHHHHHHHHHHhhcCCCceeeE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGS-----------------LESFHAECKVMGSIRHRNLVKI  822 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~hpniv~l  822 (1049)
                      .++|++.+.||+|+||.||+|+. +++.||+|++.......                 .+.+.+|++++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 99999999997653221                 1789999999999999999999


Q ss_pred             EeeeecCCeeEEEEeccCCCChhhh------hhcC-CCccCHHHHHHHHHHHHHHHHHhHccCC-CCeEEcCCCCCCeee
Q 039290          823 ISSCSNNDFKALVLEYMSNGSLEKC------LYSD-NYFLDILQRLKIMIDVASALEYLHFGYS-TPIVHCDIKPSNVLL  894 (1049)
Q Consensus       823 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~  894 (1049)
                      ++++.+.+..++||||+++++|.++      +... ...+++..++.++.|++.|++|||   + .||+||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence            9999999999999999999999998      5542 456899999999999999999999   8 999999999999999


Q ss_pred             cCCCceEEecccCceecCCCccccccccccccCcccccccCCC-CcCc-ccchHHHHHHHHHHHhCCCCCCccccccchH
Q 039290          895 NESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KVSR-KCDVYSYGIMLMETFTKKKPTDEIFAGEMSL  972 (1049)
Q Consensus       895 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DvwslG~il~elltg~~p~~~~~~~~~~~  972 (1049)
                      +.++.+||+|||.+......   ......+++.|+|||++.+. .++. ++||||+||++|||++|..||..........
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  262 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF  262 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred             cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence            99999999999999876433   23345689999999999876 5666 9999999999999999999997643322222


Q ss_pred             HHhhhhccccCCcchhccccccccc-ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          973 KRWVGDSLLSCSITEVADANLLNCE-ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ...........   ........... .........++.++.+++.+||+.||++|||++|++++
T Consensus       263 ~~i~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          263 NNIRTKNIEYP---LDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             HHHTSCCCCCC---CSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHhccCcCCc---cchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            22111110000   00000000000 00011113456789999999999999999999999985

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.2e-37  Score=349.05  Aligned_cols=256  Identities=22%  Similarity=0.257  Sum_probs=190.5

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcC-CCceeeEEeeee--------cC
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR-HRNLVKIISSCS--------NN  829 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~--------~~  829 (1049)
                      ..+|++.++||+|+||.||+|++ .+++.||+|++........+.+.+|+.+++++. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            34789999999999999999996 478999999987655455677899999999996 999999999983        34


Q ss_pred             CeeEEEEeccCCCChhhhhhc--CCCccCHHHHHHHHHHHHHHHHHhHccCCCC--eEEcCCCCCCeeecCCCceEEecc
Q 039290          830 DFKALVLEYMSNGSLEKCLYS--DNYFLDILQRLKIMIDVASALEYLHFGYSTP--IVHCDIKPSNVLLNESMVGHLSDF  905 (1049)
Q Consensus       830 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIl~~~~~~~kl~Df  905 (1049)
                      ...++||||++ |+|.+++..  ....+++.+++.++.|++.||+|||   +.+  |+||||||+||+++.++.+||+||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecC
Confidence            46799999996 699888865  3446899999999999999999999   888  999999999999999999999999


Q ss_pred             cCceecCCCccc-----------cccccccccCccccccc---CCCCcCcccchHHHHHHHHHHHhCCCCCCccccccch
Q 039290          906 GIAKILGKEESM-----------RQTKTLGTIGYMAPEYG---REGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMS  971 (1049)
Q Consensus       906 Gla~~~~~~~~~-----------~~~~~~~~~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~  971 (1049)
                      |+++........           ......+|+.|+|||++   .+..++.++||||+||++|||++|+.||.........
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~  262 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV  262 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh
Confidence            999876543221           11134589999999998   5667899999999999999999999999652211100


Q ss_pred             HHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhh
Q 039290          972 LKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043 (1049)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~ 1043 (1049)
                           .             ....      .......+..+.+++.+||+.||++|||++|++++|+++....
T Consensus       263 -----~-------------~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          263 -----N-------------GKYS------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             ---------------------CC------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             -----c-------------Cccc------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence                 0             0000      0000112334788999999999999999999999999988753

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.8e-37  Score=363.08  Aligned_cols=194  Identities=25%  Similarity=0.389  Sum_probs=154.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCC--CHHHHHHHHHHHhhcCCCceeeEEeeeec-----CCe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDG--SLESFHAECKVMGSIRHRNLVKIISSCSN-----NDF  831 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~-----~~~  831 (1049)
                      .++|++.+.||+|+||+||+|+.. +++.||||++......  ..+++.+|++++++++||||+++++++..     .+.
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            467999999999999999999954 7899999999654322  34678899999999999999999999843     357


Q ss_pred             eEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceec
Q 039290          832 KALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL  911 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~  911 (1049)
                      .|+||||++ ++|.+++.... .+++..++.++.||++||+|||   +.||+||||||+|||++.++.+||+|||+|+..
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEEeccc-cchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            899999984 68999887654 5899999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCcc--------------------------ccccccccccCccccccc-CCCCcCcccchHHHHHHHHHHHhC
Q 039290          912 GKEES--------------------------MRQTKTLGTIGYMAPEYG-REGKVSRKCDVYSYGIMLMETFTK  958 (1049)
Q Consensus       912 ~~~~~--------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg  958 (1049)
                      .....                          ......+||+.|+|||++ ....++.++||||+||++|||++|
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            43221                          122345789999999976 456799999999999999999994

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.9e-37  Score=345.10  Aligned_cols=264  Identities=18%  Similarity=0.248  Sum_probs=203.3

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcC-CCceeeEEeeeec--CCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR-HRNLVKIISSCSN--NDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~--~~~~~lv  835 (1049)
                      .++|++.+.||+|+||+||+|+. .+++.||+|+++.   ...+.+.+|++++++++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            46799999999999999999985 5789999999863   34578999999999997 9999999999987  6678999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC-ceEEecccCceecCCC
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM-VGHLSDFGIAKILGKE  914 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-~~kl~DfGla~~~~~~  914 (1049)
                      |||+++++|.+++..    +++.+++.++.|+++||+|||   ++||+||||||+||+++.++ .+||+|||+++.....
T Consensus       112 ~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            999999999998753    789999999999999999999   99999999999999999766 8999999999876543


Q ss_pred             ccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcc-------------
Q 039290          915 ESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSL-------------  980 (1049)
Q Consensus       915 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-------------  980 (1049)
                      ..  .....+++.|+|||++.+ ..++.++||||+||++|||++|+.||..................             
T Consensus       185 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  262 (330)
T 3nsz_A          185 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  262 (330)
T ss_dssp             CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             Cc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence            32  234578999999999877 67899999999999999999999999543222111111110000             


Q ss_pred             -ccCCcchhcccccccccc--cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          981 -LSCSITEVADANLLNCEE--NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       981 -~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                       ......+...........  .........+.++.+++.+||+.||++|||++|+++|
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence             000000000000000000  0011122356789999999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.2e-36  Score=355.91  Aligned_cols=264  Identities=19%  Similarity=0.230  Sum_probs=212.6

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCC-CceeeEEeeeecCCeeEEEEe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRH-RNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-pniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .++|++.++||+|+||.||+|+. .+++.||||++.....  ..++.+|+++++.++| +++..+..++.+.+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46799999999999999999995 5789999998865432  3468899999999976 566667677788889999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeee---cCCCceEEecccCceecCCC
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL---NESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~---~~~~~~kl~DfGla~~~~~~  914 (1049)
                      |+ +++|.+++......+++.+++.|+.||+.||+|||   +++|+||||||+|||+   +.++.+||+|||+++.+...
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99 88999999876667999999999999999999999   9999999999999999   58899999999999876543


Q ss_pred             ccc------cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchH-HHhhhhccccCCcch
Q 039290          915 ESM------RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSL-KRWVGDSLLSCSITE  987 (1049)
Q Consensus       915 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~  987 (1049)
                      ...      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ...+.          
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~----------  229 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS----------  229 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHH----------
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHh----------
Confidence            321      1224678999999999999999999999999999999999999998744332211 11000          


Q ss_pred             hcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          988 VADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       988 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                        .....   .........++.++.+++.+||+.+|++||++++|++.|+++..+..
T Consensus       230 --~~~~~---~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~  281 (483)
T 3sv0_A          230 --EKKVA---TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG  281 (483)
T ss_dssp             --HHHHH---SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             --hcccc---ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence              00000   00001112356789999999999999999999999999999987653

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-37  Score=350.85  Aligned_cols=263  Identities=22%  Similarity=0.293  Sum_probs=197.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCC--CHHHHHHHHHHHhhcCCCceeeEEeeeecCC------
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDG--SLESFHAECKVMGSIRHRNLVKIISSCSNND------  830 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~------  830 (1049)
                      .++|+..+.||+|+||.||+|+. .+|+.||+|++......  ..+++.+|++++++++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46799999999999999999996 47999999999654332  2467889999999999999999999997653      


Q ss_pred             eeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCcee
Q 039290          831 FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI  910 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~  910 (1049)
                      ..|+||||+ +++|.+++...  .+++..+..++.|+++||+|||   +.||+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            469999999 78999998763  4899999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhc
Q 039290          911 LGKEESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA  989 (1049)
Q Consensus       911 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  989 (1049)
                      ....    ....++|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+. ...... ...... .+..
T Consensus       178 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~~i~~-~~g~~~-~~~~  250 (367)
T 1cm8_A          178 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMK-VTGTPP-AEFV  250 (367)
T ss_dssp             CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHH-HHCCCC-HHHH
T ss_pred             cccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-hcCCCC-HHHH
Confidence            6432    234578999999998876 6799999999999999999999999975322211 111100 000000 0000


Q ss_pred             c-----------cccccccccCc-hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          990 D-----------ANLLNCEENDF-SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       990 ~-----------~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .           ..+.......+ ......+..+.+++.+|++.||++|||++|+++|
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            0           00000000011 1112346778999999999999999999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.3e-37  Score=354.30  Aligned_cols=268  Identities=25%  Similarity=0.308  Sum_probs=206.1

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .++|++.+.||+|+||+||+|+.. +++.||+|+++.... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            356899999999999999999965 789999999976532 234678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCC-CeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST-PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      |+++++|.+++...+ .+++..+..++.|++.|++|||   +. ||+||||||+||+++.++.+||+|||++......  
T Consensus       112 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence            999999999997654 4899999999999999999999   75 9999999999999999999999999999755322  


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhh---hc--------------
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVG---DS--------------  979 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~---~~--------------  979 (1049)
                       ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+........   ..              
T Consensus       186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (360)
T 3eqc_A          186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  264 (360)
T ss_dssp             -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred             -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence             123357899999999999999999999999999999999999999763322211110000   00              


Q ss_pred             -------cccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          980 -------LLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       980 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                             .......+..+........  ......++.++.+++.+||+.||++|||++|+++|-
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  326 (360)
T 3eqc_A          265 NKFGMDSRPPMAIFELLDYIVNEPPP--KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA  326 (360)
T ss_dssp             ---------CCCHHHHHHHHHHSCCC--CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred             cccccCCCCcccchhhhhHHhccCCC--CCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence                   0000000000000000000  000112456799999999999999999999999874

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.5e-37  Score=375.17  Aligned_cols=250  Identities=21%  Similarity=0.273  Sum_probs=207.7

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecc---cCCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeE
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHME---FDGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKA  833 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~  833 (1049)
                      ..++|++.++||+|+||+||+|+.. +++.||||+++..   .....+.+..|.+++..+ +||+|+++++++.+.+..|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            4568999999999999999999964 6889999999754   244567788999999987 7999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          834 LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      +||||+++|+|.+++...+ .+++.+++.++.||+.||+|||   ++||+||||||+|||++.++.+||+|||+|+....
T Consensus       419 lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            9999999999999998754 4899999999999999999999   99999999999999999999999999999986433


Q ss_pred             CccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          914 EESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       914 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                      ... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+..... .             .   
T Consensus       495 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i-~-------------~---  556 (674)
T 3pfq_A          495 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI-M-------------E---  556 (674)
T ss_dssp             TTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-H-------------S---
T ss_pred             CCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH-H-------------h---
Confidence            222 234567999999999999999999999999999999999999999763222111111 0             0   


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCH-----HHHHHH
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISM-----KDVANR 1035 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~ell~~ 1035 (1049)
                           .....+...+.++.+++.+||+.||++||++     +|+++|
T Consensus       557 -----~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          557 -----HNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             -----SCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             -----CCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence                 0011122356778999999999999999997     777654

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.5e-37  Score=340.27  Aligned_cols=244  Identities=21%  Similarity=0.297  Sum_probs=199.5

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC--CCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD--GSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      .++|++.+.||+|+||+||+|+.. +++.||+|+++....  ....++.+|+..+..+ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            457899999999999999999965 799999999976532  2356788899999999 899999999999999999999


Q ss_pred             EeccCCCChhhhhhcCC---CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC----------------
Q 039290          836 LEYMSNGSLEKCLYSDN---YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE----------------  896 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~----------------  896 (1049)
                      |||+++++|.+++....   ..+++.+++.++.|+++||+|||   ++||+||||||+||+++.                
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            99999999999987642   45899999999999999999999   999999999999999984                


Q ss_pred             ---CCceEEecccCceecCCCccccccccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccchH
Q 039290          897 ---SMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSL  972 (1049)
Q Consensus       897 ---~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~  972 (1049)
                         ...+||+|||.+.......     ...+|+.|+|||++.+. .++.++||||+||++|||++|..|+...    ...
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~  237 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQW  237 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HHH
T ss_pred             cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hHH
Confidence               4489999999998765432     23589999999998765 5668999999999999999998776431    111


Q ss_pred             HHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          973 KRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .......             .       ...+..++.++.+++.+||+.||++|||++|+++|
T Consensus       238 ~~~~~~~-------------~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          238 HEIRQGR-------------L-------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             HHHHTTC-------------C-------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             HHHHcCC-------------C-------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            1111100             0       00112245678999999999999999999999876

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.9e-37  Score=377.38  Aligned_cols=260  Identities=23%  Similarity=0.380  Sum_probs=209.2

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEeC----CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeE
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVLP----DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKA  833 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~  833 (1049)
                      ..++|++.+.||+|+||.||+|++.    .+..||+|+++.... ...+.+.+|+.++++++||||+++++++.+ +..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence            3467889999999999999999864    245799999865432 234678999999999999999999999854 5689


Q ss_pred             EEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          834 LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      +||||+++|+|.+++...+..+++..++.++.|+++||+|||   ++||+||||||+||+++.++.+||+|||+++....
T Consensus       467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            999999999999999877767999999999999999999999   99999999999999999999999999999987754


Q ss_pred             CccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccc
Q 039290          914 EESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       914 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      ..........+++.|+|||++.+..++.++||||+||++|||++ |..||......+.  ...+...             
T Consensus       544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~--~~~i~~~-------------  608 (656)
T 2j0j_A          544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IGRIENG-------------  608 (656)
T ss_dssp             ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHHHHT-------------
T ss_pred             CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHcC-------------
Confidence            44333334556789999999988899999999999999999997 9999976432221  1111000             


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhh
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~ 1043 (1049)
                            .+...+..++..+.+++.+||+.||++|||++|+++.|+++.++.
T Consensus       609 ------~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          609 ------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ------CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence                  011112345678999999999999999999999999999998754

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.8e-37  Score=350.36  Aligned_cols=264  Identities=19%  Similarity=0.186  Sum_probs=195.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecCC------
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNND------  830 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~------  830 (1049)
                      .++|++.+.||+|+||.||+|... +++.||||++.....  ...+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            467999999999999999999954 788999999975432  23457889999999999999999999997654      


Q ss_pred             eeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCcee
Q 039290          831 FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI  910 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~  910 (1049)
                      ..++||||+++ +|.+.+..   .+++.++..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            78999999975 78887753   3789999999999999999999   99999999999999999999999999999986


Q ss_pred             cCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcccc--------
Q 039290          911 LGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLS--------  982 (1049)
Q Consensus       911 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------  982 (1049)
                      .....  ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+. ...........        
T Consensus       177 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~  253 (371)
T 2xrw_A          177 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMKKL  253 (371)
T ss_dssp             ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHC-CCCCCHHHHTTS
T ss_pred             ccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHHh
Confidence            64322  23345789999999999998999999999999999999999999976322211 11110000000        


Q ss_pred             -----------CC-----cchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          983 -----------CS-----ITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       983 -----------~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                                 ..     ........   ............+.++.+++.+|++.||++|||++|+++|-
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  320 (371)
T 2xrw_A          254 QPTVRTYVENRPKYAGYSFEKLFPDV---LFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  320 (371)
T ss_dssp             CHHHHHHHHSSCCCCCCCHHHHSCGG---GSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             hhHHHHHHhhCccccccchhhhcccc---cCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence                       00     00000000   00111122344577899999999999999999999999874

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5.4e-38  Score=343.89  Aligned_cols=253  Identities=22%  Similarity=0.311  Sum_probs=202.7

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeee--cCCeeEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCS--NNDFKAL  834 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~--~~~~~~l  834 (1049)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.....  ...+.+.+|++++++++||||+++++++.  ..+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            457889999999999999999965 789999999975432  23467889999999999999999999874  4678899


Q ss_pred             EEeccCCCChhhhhhcC---CCccCHHHHHHHHHHHHHHHHHhHccCCCC-----eEEcCCCCCCeeecCCCceEEeccc
Q 039290          835 VLEYMSNGSLEKCLYSD---NYFLDILQRLKIMIDVASALEYLHFGYSTP-----IVHCDIKPSNVLLNESMVGHLSDFG  906 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~Dlkp~NIl~~~~~~~kl~DfG  906 (1049)
                      ||||+++++|.+++...   ...+++.+++.++.|++.|++|||   +.+     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999998753   335899999999999999999999   777     9999999999999999999999999


Q ss_pred             CceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcc
Q 039290          907 IAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSIT  986 (1049)
Q Consensus       907 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  986 (1049)
                      .+........ ......+++.|+|||++.+..++.++||||+|+++|||++|+.||......+.  ...+..    ..  
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~i~~----~~--  232 (279)
T 2w5a_A          162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL--AGKIRE----GK--  232 (279)
T ss_dssp             HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH----TC--
T ss_pred             hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH--HHHHhh----cc--
Confidence            9987643322 12235689999999999888899999999999999999999999976432211  111100    00  


Q ss_pred             hhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          987 EVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       987 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                            .       ...+..++.++.+++.+||+.||++|||++|+++++.
T Consensus       233 ------~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          233 ------F-------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             ------C-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             ------c-------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence                  0       0111234567899999999999999999999998754

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3e-37  Score=340.07  Aligned_cols=251  Identities=24%  Similarity=0.278  Sum_probs=188.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCC--CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDG--SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      .++|++.+.||+|+||+||+|+. .+++.||+|+++.....  ..+.+.++...++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            45789999999999999999996 57899999999754321  2233445555678889999999999999999999999


Q ss_pred             eccCCCChhhhhhc---CCCccCHHHHHHHHHHHHHHHHHhHccCCC-CeEEcCCCCCCeeecCCCceEEecccCceecC
Q 039290          837 EYMSNGSLEKCLYS---DNYFLDILQRLKIMIDVASALEYLHFGYST-PIVHCDIKPSNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       837 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      ||+++ +|.+++..   ....+++..++.++.|++.|++|||   ++ ||+||||||+||+++.++.+||+|||++....
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99975 88777654   4556999999999999999999999   87 99999999999999999999999999998764


Q ss_pred             CCccccccccccccCccccccc----CCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchh
Q 039290          913 KEESMRQTKTLGTIGYMAPEYG----REGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEV  988 (1049)
Q Consensus       913 ~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  988 (1049)
                      ...  ......||+.|+|||++    .+..++.++||||+||++|||++|+.||..................        
T Consensus       162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------  231 (290)
T 3fme_A          162 DDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS--------  231 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC--------
T ss_pred             ccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC--------
Confidence            432  22334689999999995    5567899999999999999999999999753322222222111100        


Q ss_pred             cccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          989 ADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                           ..      .....++.++.+++.+||+.||++|||++|+++|
T Consensus       232 -----~~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          232 -----PQ------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             -----CC------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             -----CC------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence                 00      0012245678999999999999999999999985

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-37  Score=347.66  Aligned_cols=260  Identities=24%  Similarity=0.318  Sum_probs=201.1

Q ss_pred             ccHHHHHHHhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhc-CCCceeeEEeeeec
Q 039290          751 ISYQDLLRATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLVKIISSCSN  828 (1049)
Q Consensus       751 ~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~  828 (1049)
                      +.+.++....++|++.+.||+|+||.||+|+. .+++.||+|++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            33444445677899999999999999999996 478999999997543 3457899999999999 79999999999876


Q ss_pred             ------CCeeEEEEeccCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceE
Q 039290          829 ------NDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGH  901 (1049)
Q Consensus       829 ------~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~k  901 (1049)
                            .+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||   +.||+||||||+||+++.++.+|
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~k  169 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVK  169 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEE
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEE
Confidence                  467899999999999999997643 46899999999999999999999   99999999999999999999999


Q ss_pred             EecccCceecCCCccccccccccccCcccccccC-----CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhh
Q 039290          902 LSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR-----EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWV  976 (1049)
Q Consensus       902 l~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~  976 (1049)
                      |+|||++........ ......+++.|+|||++.     +..++.++||||+||++|||++|..||......+... ...
T Consensus       170 l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~  247 (326)
T 2x7f_A          170 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIP  247 (326)
T ss_dssp             ECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHH
T ss_pred             EeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH-Hhh
Confidence            999999987643221 223456899999999986     5678899999999999999999999996532221111 000


Q ss_pred             hhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          977 GDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       977 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      . ..    .     +.         .....++..+.+++.+||+.||++|||++|++++
T Consensus       248 ~-~~----~-----~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          248 R-NP----A-----PR---------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             H-SC----C-----CC---------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             c-Cc----c-----cc---------CCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0 00    0     00         0011235678999999999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.3e-37  Score=351.19  Aligned_cols=272  Identities=23%  Similarity=0.266  Sum_probs=200.9

Q ss_pred             HHhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeec--------
Q 039290          758 RATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSN--------  828 (1049)
Q Consensus       758 ~~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--------  828 (1049)
                      ...++|++.+.||+|+||+||+|+. .+|+.||+|++.....    ...+|+++++.++||||+++++++..        
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            3456899999999999999999995 5799999999865432    23479999999999999999999843        


Q ss_pred             ------------------------------CCeeEEEEeccCCCChhhhhhc---CCCccCHHHHHHHHHHHHHHHHHhH
Q 039290          829 ------------------------------NDFKALVLEYMSNGSLEKCLYS---DNYFLDILQRLKIMIDVASALEYLH  875 (1049)
Q Consensus       829 ------------------------------~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH  875 (1049)
                                                    ....++||||+++ +|.+.+..   ....+++..++.++.|+++||+|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                          3348899999985 87777653   3456899999999999999999999


Q ss_pred             ccCCCCeEEcCCCCCCeeec-CCCceEEecccCceecCCCccccccccccccCcccccccCCC-CcCcccchHHHHHHHH
Q 039290          876 FGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLM  953 (1049)
Q Consensus       876 ~~~~~~ivH~Dlkp~NIl~~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~  953 (1049)
                         +.||+||||||+||+++ .++.+||+|||+|+.......  .....+|+.|+|||++.+. .++.++||||+||++|
T Consensus       159 ---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  233 (383)
T 3eb0_A          159 ---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG  233 (383)
T ss_dssp             ---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred             ---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence               99999999999999998 688999999999987654332  2345689999999988764 5899999999999999


Q ss_pred             HHHhCCCCCCccccccchHHHhhhhccccCCcchhcc------c-ccccccccC--chhhHHHHHHHHHHHhhccccCCC
Q 039290          954 ETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD------A-NLLNCEEND--FSAREQCVSSIFSLAMDCTVDLPE 1024 (1049)
Q Consensus       954 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~-~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~ 1024 (1049)
                      ||++|+.||......+. ....+.. ...+....+..      . .........  ...+..++.++.+++.+||+.||+
T Consensus       234 ell~g~~pf~~~~~~~~-~~~i~~~-~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          234 ELILGKPLFSGETSIDQ-LVRIIQI-MGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             HHHHSSCSSCCSSHHHH-HHHHHHH-HCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             HHHhCCCCCCCCChHHH-HHHHHHH-hCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            99999999976432221 1111110 00000000000      0 000000000  011223567799999999999999


Q ss_pred             CCCCHHHHHHH--HHHHHH
Q 039290         1025 KRISMKDVANR--LVRIRE 1041 (1049)
Q Consensus      1025 ~Rpt~~ell~~--L~~i~~ 1041 (1049)
                      +|||+.|+++|  +++++.
T Consensus       312 ~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          312 LRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             GSCCHHHHHTSGGGHHHHH
T ss_pred             hCCCHHHHhcCHHHHHHHh
Confidence            99999999976  555443

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.1e-37  Score=355.32  Aligned_cols=266  Identities=21%  Similarity=0.252  Sum_probs=202.1

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcC--------CCceeeEEeeee---
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR--------HRNLVKIISSCS---  827 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------hpniv~l~~~~~---  827 (1049)
                      .++|++.+.||+|+||+||+|+. .+++.||+|+++.. ....+.+.+|++++++++        ||||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            36799999999999999999985 47889999999743 223567889999999985        788999999987   


Q ss_pred             -cCCeeEEEEeccCCCChhhhhhc-CCCccCHHHHHHHHHHHHHHHHHhHccCCC-CeEEcCCCCCCeeecCCC------
Q 039290          828 -NNDFKALVLEYMSNGSLEKCLYS-DNYFLDILQRLKIMIDVASALEYLHFGYST-PIVHCDIKPSNVLLNESM------  898 (1049)
Q Consensus       828 -~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIl~~~~~------  898 (1049)
                       +....++||||+. +++.+.+.. ....+++..++.++.||+.||+|||   ++ ||+||||||+|||++.++      
T Consensus       115 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          115 VNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             TTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhh
Confidence             5668899999995 566555544 3456899999999999999999999   88 999999999999998765      


Q ss_pred             -------------------------------------------ceEEecccCceecCCCccccccccccccCcccccccC
Q 039290          899 -------------------------------------------VGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR  935 (1049)
Q Consensus       899 -------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~  935 (1049)
                                                                 .+||+|||++......    .....||+.|+|||++.
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~  266 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLI  266 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHH
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhc
Confidence                                                       8999999999876432    23457899999999999


Q ss_pred             CCCcCcccchHHHHHHHHHHHhCCCCCCccccccch-----HHHhhhhccccCCc---------chhccc----------
Q 039290          936 EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMS-----LKRWVGDSLLSCSI---------TEVADA----------  991 (1049)
Q Consensus       936 ~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~-----~~~~~~~~~~~~~~---------~~~~~~----------  991 (1049)
                      +..++.++||||+||++|||++|+.||......+..     ...... .......         .+....          
T Consensus       267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIE-LLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHH-HHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHH-hcCCCChHHhhcccccccccCCcccccccccc
Confidence            989999999999999999999999999764332211     000000 0000000         000000          


Q ss_pred             ---ccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          992 ---NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       992 ---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                         ............+...+..+.+++.+||+.||++|||++|+++|
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence               00000011122345677889999999999999999999999975

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6.9e-37  Score=338.54  Aligned_cols=253  Identities=23%  Similarity=0.307  Sum_probs=205.3

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC---------CCHHHHHHHHHHHhhcC-CCceeeEEeeee
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD---------GSLESFHAECKVMGSIR-HRNLVKIISSCS  827 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-hpniv~l~~~~~  827 (1049)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|+++....         ...+.+.+|+++++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3568999999999999999999965 788999999975431         12356788999999995 999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccC
Q 039290          828 NNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGI  907 (1049)
Q Consensus       828 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGl  907 (1049)
                      +.+..++||||+++++|.+++.... .+++.+++.++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccc
Confidence            9999999999999999999987643 4899999999999999999999   99999999999999999999999999999


Q ss_pred             ceecCCCccccccccccccCcccccccC------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccc
Q 039290          908 AKILGKEESMRQTKTLGTIGYMAPEYGR------EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLL  981 (1049)
Q Consensus       908 a~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  981 (1049)
                      +........  .....+++.|+|||++.      ...++.++||||+|+++|||++|..||......+.. .......  
T Consensus       171 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~--  245 (298)
T 1phk_A          171 SCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-RMIMSGN--  245 (298)
T ss_dssp             CEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHTC--
T ss_pred             hhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH-HHHhcCC--
Confidence            987654332  23456899999999874      456889999999999999999999999753221111 1100000  


Q ss_pred             cCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          982 SCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                                     .....+....++.++.+++.+||+.||++|||++|++++
T Consensus       246 ---------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          246 ---------------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             ---------------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ---------------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence                           000011112356779999999999999999999999875

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=8e-37  Score=341.92  Aligned_cols=252  Identities=23%  Similarity=0.296  Sum_probs=198.8

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC--------CCHHHHHHHHHHHhhcCCCceeeEEeeeecCC
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD--------GSLESFHAECKVMGSIRHRNLVKIISSCSNND  830 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~  830 (1049)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.....        .....+.+|++++++++||||+++++++...+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            457999999999999999999964 688999999865321        12345889999999999999999999987765


Q ss_pred             eeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC---ceEEecccC
Q 039290          831 FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM---VGHLSDFGI  907 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~---~~kl~DfGl  907 (1049)
                       .++||||+++++|.+++.... .+++.+++.++.|+++||+|||   ++||+||||||+||+++.++   .+||+|||+
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             -eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence             799999999999999887654 5899999999999999999999   99999999999999998655   499999999


Q ss_pred             ceecCCCccccccccccccCcccccccC---CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCC
Q 039290          908 AKILGKEESMRQTKTLGTIGYMAPEYGR---EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCS  984 (1049)
Q Consensus       908 a~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  984 (1049)
                      +.......  ......|++.|+|||++.   ...++.++||||+||++|||++|..||..................    
T Consensus       164 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----  237 (322)
T 2ycf_A          164 SKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY----  237 (322)
T ss_dssp             CEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC----
T ss_pred             ceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc----
Confidence            98765432  123356899999999863   567899999999999999999999999764332221111110000    


Q ss_pred             cchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          985 ITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       985 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                                   .........++.++.+++.+||+.||++|||++|++++
T Consensus       238 -------------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          238 -------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             -------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -------------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence                         00011122356789999999999999999999999865

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.8e-37  Score=344.12  Aligned_cols=262  Identities=25%  Similarity=0.327  Sum_probs=188.6

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+++.+|++++++++||||+++++++...+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            356899999999999999999995 478999999986543 334567889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhc-------CCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCce
Q 039290          837 EYMSNGSLEKCLYS-------DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK  909 (1049)
Q Consensus       837 e~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~  909 (1049)
                      ||+++++|.+++..       ....+++..++.++.|+++|++|||   +.||+||||||+||+++.++.+||+|||++.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            99999999999864       2345899999999999999999999   9999999999999999999999999999997


Q ss_pred             ecCCCcc----ccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCC
Q 039290          910 ILGKEES----MRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCS  984 (1049)
Q Consensus       910 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  984 (1049)
                      .......    .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+...........  ..
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~  247 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP--SL  247 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC--CT
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC--cc
Confidence            6643221    11233568999999998865 56899999999999999999999999764333222111111000  00


Q ss_pred             cchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          985 ITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       985 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .....+          ......++.++.+++.+||+.||++|||++|++++
T Consensus       248 ~~~~~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          248 ETGVQD----------KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             TC---------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             cccccc----------chhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            000000          00112245678999999999999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5.9e-37  Score=355.81  Aligned_cols=197  Identities=21%  Similarity=0.272  Sum_probs=171.3

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhc------CCCceeeEEeeeecCCee
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSI------RHRNLVKIISSCSNNDFK  832 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~hpniv~l~~~~~~~~~~  832 (1049)
                      ..+|++.+.||+|+||+||+|+.. +++.||||+++... .....+.+|+++++.+      .|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            357999999999999999999854 68899999997532 2345677888888877      577999999999999999


Q ss_pred             EEEEeccCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCc--eEEecccCce
Q 039290          833 ALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMV--GHLSDFGIAK  909 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~--~kl~DfGla~  909 (1049)
                      ++||||+. ++|.+++.... ..+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.  +||+|||+++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999996 58999887654 35899999999999999999999   899999999999999998887  9999999998


Q ss_pred             ecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCcc
Q 039290          910 ILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEI  965 (1049)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~  965 (1049)
                      .....    .....+|+.|+|||++.+..++.++||||+||++|||++|..||...
T Consensus       251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            65432    23457899999999999999999999999999999999999999764

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.6e-36  Score=336.85  Aligned_cols=251  Identities=23%  Similarity=0.325  Sum_probs=199.5

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc----CCCHHHHHHHHHHHhhcCCCceeeEEeee--ecCCee
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF----DGSLESFHAECKVMGSIRHRNLVKIISSC--SNNDFK  832 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~hpniv~l~~~~--~~~~~~  832 (1049)
                      .++|++.+.||+|+||.||+|.. .+++.||+|+++...    ....+.+.+|++++++++||||+++++++  .+.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            46899999999999999999996 478899999997542    33457899999999999999999999998  445688


Q ss_pred             EEEEeccCCCChhhhhhc-CCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceec
Q 039290          833 ALVLEYMSNGSLEKCLYS-DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL  911 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~  911 (1049)
                      ++||||++++ +.+++.. ....+++.+++.++.|+++|++|||   ++||+||||||+||+++.++.+||+|||++...
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999876 7666654 3446899999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCc-cccccccccccCcccccccCCCC--cCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchh
Q 039290          912 GKEE-SMRQTKTLGTIGYMAPEYGREGK--VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEV  988 (1049)
Q Consensus       912 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  988 (1049)
                      .... ........+++.|+|||++.+..  ++.++||||+|+++|||++|+.||......+  .......          
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~i~~----------  227 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK--LFENIGK----------  227 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHH----------
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHHhc----------
Confidence            4322 22223456899999999987643  4789999999999999999999997532111  1110000          


Q ss_pred             cccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          989 ADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                                .....+..++..+.+++.+||+.||++|||++|++++-
T Consensus       228 ----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  265 (305)
T 2wtk_C          228 ----------GSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS  265 (305)
T ss_dssp             ----------CCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred             ----------CCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence                      00111123456789999999999999999999999873

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=100.00  E-value=7e-37  Score=341.98  Aligned_cols=270  Identities=22%  Similarity=0.296  Sum_probs=209.0

Q ss_pred             cCChhhHHHHHHHHHhcccCCCCcccccC----CCCCCCceeeeEEEcC--------CCCcEEEEEEeccccccccCCCC
Q 039290           26 TNVTTDQFALLALKEHIKHDPSNLLANNW----STTSSVCSWIGVTCGV--------RNRRVTALNISYLGLTGTIPPQL   93 (1049)
Q Consensus        26 ~~~~~d~~all~~k~~~~~~~~~~l~~~w----~~~~~~c~w~gv~c~~--------~~~~v~~l~l~~~~l~g~~~~~~   93 (1049)
                      ++..+|++||++||+++..||.+++ ++|    ....++|.|.||+|+.        ...+|+.|+|++++++ .+|+.+
T Consensus        23 ~~~~~~~~aLl~~k~~~~~~~~~~~-~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l  100 (328)
T 4fcg_A           23 TALRPYHDVLSQWQRHYNADRNRWH-SAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA  100 (328)
T ss_dssp             CCCCCHHHHHHHHHHHHHHCCTTHH-HHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred             ccCchHHHHHHHHHHhccCCchhhh-hhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence            3567899999999999988998876 488    5677899999999953        3467889999998888 888888


Q ss_pred             CCcchhhhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccC------
Q 039290           94 GNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGY------  167 (1049)
Q Consensus        94 ~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~------  167 (1049)
                      +++++|++|+|++|.++ .+|..++++++|++|+|++|++. .+|..|+++++|++|+|++|.+.+.+|..++.      
T Consensus       101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~  178 (328)
T 4fcg_A          101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE  178 (328)
T ss_dssp             GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCC
T ss_pred             hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhh
Confidence            88888888888888887 78888888888888888888887 77888888888888888888887788877664      


Q ss_pred             ---CCcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccceecccccccccccCCCCc
Q 039290          168 ---LSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIG  244 (1049)
Q Consensus       168 ---l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~  244 (1049)
                         +++|++|+|++|+++ .+|..+++      +++|++|+|++|++++ +|..+..+++|++|+|++|++.+.+|..++
T Consensus       179 ~~~l~~L~~L~L~~n~l~-~lp~~l~~------l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~  250 (328)
T 4fcg_A          179 HQGLVNLQSLRLEWTGIR-SLPASIAN------LQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFG  250 (328)
T ss_dssp             EEESTTCCEEEEEEECCC-CCCGGGGG------CTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTT
T ss_pred             hccCCCCCEEECcCCCcC-cchHhhcC------CCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhc
Confidence               777777777777777 67766543      3457777777777774 566677777777777777777777777777


Q ss_pred             cccccceEEeccccccccCccccccccceEEEeeccccCCCccccccccccccceEEeccCcc
Q 039290          245 NLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDL  307 (1049)
Q Consensus       245 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l  307 (1049)
                      .+++|++|+|++|++.+.+|..++++++|+.|+|++|++.+.+|..+.++++|+.+++..+.+
T Consensus       251 ~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~  313 (328)
T 4fcg_A          251 GRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ  313 (328)
T ss_dssp             CCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred             CCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHH
Confidence            777777777777777777777777777777777777777777777777777777776665544

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.7e-37  Score=347.11  Aligned_cols=262  Identities=22%  Similarity=0.354  Sum_probs=203.0

Q ss_pred             HHhcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          758 RATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       758 ~~~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      ...++|++.+.||+|+||.||+|+..+  .||+|+++...  ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  107 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII  107 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence            345689999999999999999999754  49999987543  23346678899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++++|.+++...+..+++.+++.++.|+++|++|||   ++||+||||||+||+++ ++.+||+|||++.......
T Consensus       108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~  183 (319)
T 2y4i_B          108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ  183 (319)
T ss_dssp             CBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred             eecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence            9999999999999887767999999999999999999999   99999999999999998 6799999999987653211


Q ss_pred             ----cccccccccccCcccccccCC---------CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcccc
Q 039290          916 ----SMRQTKTLGTIGYMAPEYGRE---------GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLS  982 (1049)
Q Consensus       916 ----~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  982 (1049)
                          ........|++.|+|||++..         ..++.++||||+||++|||++|+.||......+.....  ....  
T Consensus       184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~~~~--  259 (319)
T 2y4i_B          184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM--GTGM--  259 (319)
T ss_dssp             ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH--HTTC--
T ss_pred             ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh--ccCC--
Confidence                112233458899999998864         45788999999999999999999999764322211111  0000  


Q ss_pred             CCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhh
Q 039290          983 CSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSA 1045 (1049)
Q Consensus       983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~ 1045 (1049)
                             .+..   .      ...++.++.+++.+||+.||++|||++|+++.|+++.++...
T Consensus       260 -------~~~~---~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~  306 (319)
T 2y4i_B          260 -------KPNL---S------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR  306 (319)
T ss_dssp             -------CCCC---C------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred             -------CCCC---C------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence                   0000   0      012345688999999999999999999999999998876543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.5e-36  Score=333.75  Aligned_cols=251  Identities=24%  Similarity=0.328  Sum_probs=204.5

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            457999999999999999999965 78999999997543  345678999999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC---CCceEEecccCceecCC
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE---SMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~~~kl~DfGla~~~~~  913 (1049)
                      ||+++++|.+++.... .+++.+++.++.|++.|++|||   +.||+||||||+||+++.   ++.+||+|||++.....
T Consensus       101 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~  176 (287)
T 2wei_A          101 ELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (287)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred             EccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence            9999999999887654 4899999999999999999999   999999999999999975   34799999999986643


Q ss_pred             CccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          914 EESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       914 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                      ...  .....+++.|+|||++.+ .++.++||||+|+++|+|++|..||......+. ........              
T Consensus       177 ~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~--------------  238 (287)
T 2wei_A          177 NTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI-LKRVETGK--------------  238 (287)
T ss_dssp             CSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCC--------------
T ss_pred             CCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHcCC--------------
Confidence            322  233468899999998865 589999999999999999999999976322211 11110000              


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                         .....+....++.++.+++.+||+.||++|||++|++++
T Consensus       239 ---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          239 ---YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             ---CCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ---CCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence               000011112345678999999999999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.6e-37  Score=348.99  Aligned_cols=264  Identities=21%  Similarity=0.280  Sum_probs=185.5

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCC--CHHHHHHHHHHHhhcCCCceeeEEeeeecC------C
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDG--SLESFHAECKVMGSIRHRNLVKIISSCSNN------D  830 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~------~  830 (1049)
                      .++|+..+.||+|+||.||+|.. .+|+.||+|++......  ..+.+.+|+++++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            46899999999999999999995 57899999999754322  346788999999999999999999998654      5


Q ss_pred             eeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCcee
Q 039290          831 FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI  910 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~  910 (1049)
                      ..++|+|++ +++|.+++..  ..+++..+..++.||++||+|||   +.||+||||||+||+++.++.+||+|||+++.
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            679999999 6799998865  34899999999999999999999   99999999999999999999999999999986


Q ss_pred             cCCCccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCC---cc
Q 039290          911 LGKEESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCS---IT  986 (1049)
Q Consensus       911 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~  986 (1049)
                      ....    .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+. ...... ....+.   +.
T Consensus       182 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~~i~~-~~g~p~~~~~~  255 (367)
T 2fst_X          182 TADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILR-LVGTPGAELLK  255 (367)
T ss_dssp             -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHH-HHCSCCHHHHT
T ss_pred             cccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-HhCCCCHHHHH
Confidence            5432    234578999999999876 6789999999999999999999999976332211 111111 000000   00


Q ss_pred             hhcc-------cccccccccCc-hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          987 EVAD-------ANLLNCEENDF-SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       987 ~~~~-------~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .+..       ..+...+...+ ......+..+.+++.+|++.||++|||++|+++|
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            0000       00000011111 0112345678999999999999999999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.5e-36  Score=345.64  Aligned_cols=268  Identities=22%  Similarity=0.259  Sum_probs=202.8

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecC-----Cee
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNN-----DFK  832 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~-----~~~  832 (1049)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            457999999999999999999954 788999999974332 2346788999999999999999999998654     468


Q ss_pred             EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecC
Q 039290          833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      ++||||+++ +|.+++...  .+++.+++.++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++....
T Consensus       106 ~iv~e~~~~-~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          106 YIVQDLMET-DLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEEEECCSE-EHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEcccCc-CHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            999999975 999988764  3899999999999999999999   9999999999999999999999999999998775


Q ss_pred             CCccc--cccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchh-
Q 039290          913 KEESM--RQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEV-  988 (1049)
Q Consensus       913 ~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-  988 (1049)
                      .....  ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+.. ....+ .........+ 
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~i~~-~~~~~~~~~~~  257 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL-NHILG-ILGSPSQEDLN  257 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHH-HHHHH-HHCSCCHHHHH
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHH-HHHHH-HhCCCCHHHHH
Confidence            43321  1234578999999998654 45899999999999999999999999764332221 11110 0000000000 


Q ss_pred             --cc----cccccccc-cC---chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          989 --AD----ANLLNCEE-ND---FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       989 --~~----~~~~~~~~-~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                        .+    ......+. ..   .......+.++.+++.+|++.||++|||++|+++|
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence              00    00000000 00   01112345778999999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.1e-36  Score=337.64  Aligned_cols=252  Identities=25%  Similarity=0.335  Sum_probs=195.0

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeec----------
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSN----------  828 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~----------  828 (1049)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++... ....+.+.+|++++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            45789999999999999999996 47899999999653 2345678899999999999999999998754          


Q ss_pred             ---CCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecc
Q 039290          829 ---NDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDF  905 (1049)
Q Consensus       829 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df  905 (1049)
                         .+..++||||+++|+|.+++......+++.+++.++.|+++|++|||   ++||+||||||+||+++.++.+||+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeC
Confidence               45779999999999999999877777899999999999999999999   999999999999999999999999999


Q ss_pred             cCceecCCCc-------------cccccccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccch
Q 039290          906 GIAKILGKEE-------------SMRQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMS  971 (1049)
Q Consensus       906 Gla~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~  971 (1049)
                      |++.......             ........+++.|+|||++.+. .++.++||||+||++|||++   ||.........
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~  237 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI  237 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence            9998664321             1122345689999999998764 68999999999999999998   55432111111


Q ss_pred             HHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          972 LKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ........   ..        .      ........+..+.+++.+||+.||++|||++|++++
T Consensus       238 ~~~~~~~~---~~--------~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          238 LKKLRSVS---IE--------F------PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HHHHHSTT---CC--------C------CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHhccccc---cc--------c------CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            11111000   00        0      001112345678999999999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.1e-36  Score=349.96  Aligned_cols=264  Identities=24%  Similarity=0.281  Sum_probs=195.2

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCC------eeEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNND------FKAL  834 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~------~~~l  834 (1049)
                      .+|+..+.||+|+||+||+|+...+..||+|++.....    ...+|+++++.++||||+++++++...+      ..++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            46889999999999999999988777899998865432    2247999999999999999999985433      3789


Q ss_pred             EEeccCCCChhhhh--hcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec-CCCceEEecccCceec
Q 039290          835 VLEYMSNGSLEKCL--YSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKIL  911 (1049)
Q Consensus       835 v~e~~~~g~L~~~l--~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~-~~~~~kl~DfGla~~~  911 (1049)
                      ||||++++.+....  ......+++..++.++.|+++||+|||   ++||+||||||+||+++ .++.+||+|||+|+..
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            99999875443332  123456899999999999999999999   99999999999999999 7999999999999876


Q ss_pred             CCCccccccccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcc---h
Q 039290          912 GKEESMRQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSIT---E  987 (1049)
Q Consensus       912 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~  987 (1049)
                      .....  .....+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+. ........ ..+...   .
T Consensus       193 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-l~~i~~~~-g~p~~~~~~~  268 (394)
T 4e7w_A          193 IAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ-LVEIIKVL-GTPSREQIKT  268 (394)
T ss_dssp             CTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHH-CCCCHHHHHH
T ss_pred             cCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHh-CCCCHHHHHh
Confidence            44332  2345789999999988664 589999999999999999999999976432221 11111100 000000   0


Q ss_pred             hc----ccccccccccCc--hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          988 VA----DANLLNCEENDF--SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       988 ~~----~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ..    ...........+  ..+...+.++.+++.+||+.||++|||+.|+++|
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            00    000000000000  0112356789999999999999999999999987

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-36  Score=340.71  Aligned_cols=269  Identities=20%  Similarity=0.252  Sum_probs=196.2

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeee-----------
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS-----------  827 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~-----------  827 (1049)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++........+++.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            357899999999999999999975 58999999997665455678899999999999999999999873           


Q ss_pred             ---cCCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec-CCCceEEe
Q 039290          828 ---NNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN-ESMVGHLS  903 (1049)
Q Consensus       828 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~-~~~~~kl~  903 (1049)
                         +.+..++||||++ |+|.+++...  .+++..++.++.|+++||+|||   ++||+||||||+||+++ +++.+||+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence               4467899999997 5999988653  4889999999999999999999   99999999999999997 56799999


Q ss_pred             cccCceecCCCcc--ccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcc
Q 039290          904 DFGIAKILGKEES--MRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSL  980 (1049)
Q Consensus       904 DfGla~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  980 (1049)
                      |||+++.......  .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+. .........
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~  242 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ-MQLILESIP  242 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHSC
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcC
Confidence            9999987643221  12233457889999998765 6789999999999999999999999976432211 111111000


Q ss_pred             cc--CCcchh-------cccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          981 LS--CSITEV-------ADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       981 ~~--~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ..  ....+.       ..................++.++.+++.+||+.||++|||++|+++|
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            00  000000       00000000000011112356789999999999999999999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3e-36  Score=338.08  Aligned_cols=270  Identities=23%  Similarity=0.262  Sum_probs=204.0

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEe--CCCcEEEEEEeecccC--CCHHHHHHHHHHHhhc---CCCceeeEEeeee----
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVL--PDGMEIAAKVFHMEFD--GSLESFHAECKVMGSI---RHRNLVKIISSCS----  827 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~--~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~hpniv~l~~~~~----  827 (1049)
                      ..++|++.+.||+|+||.||+|+.  .+++.||+|+++....  .....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            346899999999999999999997  4688999999975432  2234667788777766   8999999999987    


Q ss_pred             -cCCeeEEEEeccCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecc
Q 039290          828 -NNDFKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDF  905 (1049)
Q Consensus       828 -~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df  905 (1049)
                       .....++||||++ |+|.+++.... ..+++.+++.++.|+++||+|||   +.||+||||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecC
Confidence             5567899999997 59999987653 35899999999999999999999   999999999999999999999999999


Q ss_pred             cCceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccc--cC
Q 039290          906 GIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLL--SC  983 (1049)
Q Consensus       906 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~  983 (1049)
                      |++.......  ......+++.|+|||++.+..++.++||||+||++|||++|+.||......+. ..........  ..
T Consensus       165 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~  241 (326)
T 1blx_A          165 GLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEE  241 (326)
T ss_dssp             CSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCGG
T ss_pred             cccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHcCCCCcc
Confidence            9998764332  23345689999999999988999999999999999999999999976432221 1111110000  00


Q ss_pred             Ccchhcc---cccccc-cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          984 SITEVAD---ANLLNC-EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       984 ~~~~~~~---~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .+.....   ...... ..........++..+.+++.+||+.||++|||+.|+++|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0000000   000000 000011123356778999999999999999999999975

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.2e-36  Score=350.23  Aligned_cols=263  Identities=23%  Similarity=0.295  Sum_probs=194.5

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecC------CeeE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNN------DFKA  833 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~------~~~~  833 (1049)
                      .+|+..+.||+|+||+||+|++. +++.||||++....    ....+|++++++++||||+++++++...      ...+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            35888899999999999999975 68999999986542    2234799999999999999999988431      2467


Q ss_pred             EEEeccCCCChhhhhh---cCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCC-CceEEecccCce
Q 039290          834 LVLEYMSNGSLEKCLY---SDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES-MVGHLSDFGIAK  909 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-~~~kl~DfGla~  909 (1049)
                      +||||+++ ++.+.+.   .....+++..++.++.||++||+|||   +.||+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999986 6665543   24456899999999999999999999   9999999999999999954 678999999998


Q ss_pred             ecCCCccccccccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchh
Q 039290          910 ILGKEESMRQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEV  988 (1049)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  988 (1049)
                      .......  .....+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+ ......... .......+
T Consensus       206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~~~l-g~p~~~~~  281 (420)
T 1j1b_A          206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVL-GTPTREQI  281 (420)
T ss_dssp             ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHH-CSCCHHHH
T ss_pred             hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh-CCCCHHHH
Confidence            7644332  2345789999999998764 78999999999999999999999997643221 111111100 00000000


Q ss_pred             c--cc-----ccccccccCch--hhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          989 A--DA-----NLLNCEENDFS--AREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       989 ~--~~-----~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .  .+     .........+.  .+...+.++.+++.+||+.||++|||+.|+++|
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            0  00     00000000000  112345789999999999999999999999976

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.4e-37  Score=341.30  Aligned_cols=260  Identities=23%  Similarity=0.342  Sum_probs=200.7

Q ss_pred             cHHHHHHHhcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccC--CCHHHHHHHHHHHhhcC--CCceeeEEeeee
Q 039290          752 SYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIR--HRNLVKIISSCS  827 (1049)
Q Consensus       752 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~--hpniv~l~~~~~  827 (1049)
                      .++.+....++|++.+.||+|+||.||+|+..+++.||+|++.....  ...+.+.+|++++++++  ||||+++++++.
T Consensus        19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~   98 (313)
T 3cek_A           19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI   98 (313)
T ss_dssp             -CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred             CeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence            33334444567999999999999999999988899999999975432  23467899999999997  599999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccC
Q 039290          828 NNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGI  907 (1049)
Q Consensus       828 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGl  907 (1049)
                      +.+..++||| +.+++|.+++.... .+++.+++.++.|+++||+|||   +.+|+||||||+||++++ +.+||+|||+
T Consensus        99 ~~~~~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~  172 (313)
T 3cek_A           99 TDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGI  172 (313)
T ss_dssp             CSSEEEEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred             cCCEEEEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccc
Confidence            9999999999 55789999998754 5899999999999999999999   999999999999999975 8999999999


Q ss_pred             ceecCCCcc-ccccccccccCcccccccCC-----------CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHh
Q 039290          908 AKILGKEES-MRQTKTLGTIGYMAPEYGRE-----------GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRW  975 (1049)
Q Consensus       908 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~  975 (1049)
                      +........ .......|++.|+|||++.+           ..++.++||||+||++|||++|+.||.............
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  252 (313)
T 3cek_A          173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI  252 (313)
T ss_dssp             SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred             cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence            987644322 12234568999999999865           468889999999999999999999997543222111111


Q ss_pred             hhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          976 VGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       976 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                      ..             ...      ....+...+.++.+++.+||+.||++|||++|++++-
T Consensus       253 ~~-------------~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          253 ID-------------PNH------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             HC-------------TTS------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             Hh-------------ccc------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence            11             000      0001111245789999999999999999999999874

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.4e-36  Score=344.59  Aligned_cols=264  Identities=19%  Similarity=0.230  Sum_probs=198.3

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCC--CHHHHHHHHHHHhhcCCCceeeEEeeeecCCee----
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDG--SLESFHAECKVMGSIRHRNLVKIISSCSNNDFK----  832 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~----  832 (1049)
                      .++|...+.||+|+||.||+|+.. +|+.||+|++......  ..+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468999999999999999999954 7899999999764332  246788999999999999999999999877654    


Q ss_pred             --EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCcee
Q 039290          833 --ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI  910 (1049)
Q Consensus       833 --~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~  910 (1049)
                        ++||||++ ++|.+.+..   .+++.+++.++.|++.|++|||   +.||+||||||+||+++.++.+||+|||+++.
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence              99999997 588887643   3899999999999999999999   99999999999999999999999999999986


Q ss_pred             cCCCccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcccc--CCcch
Q 039290          911 LGKEESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLS--CSITE  987 (1049)
Q Consensus       911 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~  987 (1049)
                      ....    .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+.. ..........  .....
T Consensus       194 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~  268 (371)
T 4exu_A          194 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL-TQILKVTGVPGTEFVQK  268 (371)
T ss_dssp             ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCCCCHHHHTT
T ss_pred             cccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCcHHHHHH
Confidence            5432    234568999999999877 67899999999999999999999999763322111 1110000000  00000


Q ss_pred             hc-------ccccccccccC-chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          988 VA-------DANLLNCEEND-FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       988 ~~-------~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      +.       ........... ......++.++.+++.+|++.||++|||++|++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            00       00000000001 11112346789999999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.4e-36  Score=341.77  Aligned_cols=276  Identities=21%  Similarity=0.232  Sum_probs=193.1

Q ss_pred             HHHHHHhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCC--
Q 039290          754 QDLLRATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNND--  830 (1049)
Q Consensus       754 ~~~~~~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~--  830 (1049)
                      .......++|++.+.||+|+||+||+|+.. +++.||||++.... .....+.+|++.++.++||||+++++++...+  
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            345567789999999999999999999964 78999999986543 33456778888999999999999999986533  


Q ss_pred             -----eeEEEEeccCCCChhhhhh---cCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC-CCceE
Q 039290          831 -----FKALVLEYMSNGSLEKCLY---SDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE-SMVGH  901 (1049)
Q Consensus       831 -----~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-~~~~k  901 (1049)
                           ..++||||+++ ++.+.+.   .....+++..++.++.|++.|++||| .++.||+||||||+||+++. ++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHT-STTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh-CCCCCeecCcCCHHHEEEeCCCCcEE
Confidence                 27899999986 5544433   24446889999999999999999999 44789999999999999996 89999


Q ss_pred             EecccCceecCCCccccccccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcc
Q 039290          902 LSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSL  980 (1049)
Q Consensus       902 l~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  980 (1049)
                      |+|||+++.......  .....||+.|+|||++.+. .++.++||||+||++|||++|+.||......+. .........
T Consensus       173 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~  249 (360)
T 3e3p_A          173 LCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ-LHEIVRVLG  249 (360)
T ss_dssp             ECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHC
T ss_pred             EeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH-HHHHHHHcC
Confidence            999999987654332  2345689999999988654 489999999999999999999999976432221 111111000


Q ss_pred             cc-----------CCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          981 LS-----------CSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       981 ~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ..           ....+..+.................+.++.+++.+||+.||.+|||++|+++|
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            00           00000000000000000001111246789999999999999999999999986

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=2.8e-35  Score=338.70  Aligned_cols=347  Identities=20%  Similarity=0.227  Sum_probs=201.7

Q ss_pred             ccCCCCCCCce-eeeEEEcCCCCcEEEEEEeccccccccCCCCCCcchhhhhhcccCccccccCcc-cccccCCcEeccc
Q 039290           52 NNWSTTSSVCS-WIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEE-LSHLRGLKYFDFR  129 (1049)
Q Consensus        52 ~~w~~~~~~c~-w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~~-~~~L~~L~~L~l~  129 (1049)
                      ++|..+.+||. |.+..|.....++     ............-..++.+++|++++|.+. .+|.. +.++++|++|+++
T Consensus         4 ~~~~~~~~C~~~~~~~~c~~~~~~i-----~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~   77 (390)
T 3o6n_A            4 KPRQPEYKCIDSNLQYDCVFYDVHI-----DMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLN   77 (390)
T ss_dssp             ---CCEECBCC------EEEESCEE-----CSSCCCCEESCSSGGGCCCSEEEEESCEES-EECTHHHHHCCCCSEEECT
T ss_pred             CCCCCccceehhhhhhccceeeeee-----ecccccccccccccccCCceEEEecCCchh-hCChhHhcccccCcEEECC
Confidence            47988888885 5555553222111     221212122222334567777777777765 45554 4677777777777


Q ss_pred             cCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeecc
Q 039290          130 FNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYN  209 (1049)
Q Consensus       130 ~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N  209 (1049)
                      +|++.+..|..|..+++|++|+|++|.+++..|..++.+++|++|+|++|+++ .+|..++     .++++|++|++++|
T Consensus        78 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~-----~~l~~L~~L~L~~n  151 (390)
T 3o6n_A           78 DLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIF-----HNTPKLTTLSMSNN  151 (390)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTT-----TTCTTCCEEECCSS
T ss_pred             CCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHh-----cCCCCCcEEECCCC
Confidence            77777666667777777777777777777666666777777777777777776 5555432     23445666666666


Q ss_pred             ccCCCCCCCcccccccceecccccccccccCCCCccccccceEEeccccccccCccccccccceEEEeeccccCCCcccc
Q 039290          210 QLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPA  289 (1049)
Q Consensus       210 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~  289 (1049)
                      ++++..|..+..+++|+.|++++|++++.   .++.+++|+.|++++|.++                        +.   
T Consensus       152 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~------------------------~~---  201 (390)
T 3o6n_A          152 NLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS------------------------TL---  201 (390)
T ss_dssp             CCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCS------------------------EE---
T ss_pred             ccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccc------------------------cc---
Confidence            66654455555555555555555555432   2334444555555555443                        22   


Q ss_pred             ccccccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCcccccccccc
Q 039290          290 SIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRS  369 (1049)
Q Consensus       290 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  369 (1049)
                        ...++|++|++++|.+.. +|...   .++|+.|++++|++++.  ..+..+++|++|++++|.+.+..|..|..+++
T Consensus       202 --~~~~~L~~L~l~~n~l~~-~~~~~---~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~  273 (390)
T 3o6n_A          202 --AIPIAVEELDASHNSINV-VRGPV---NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQR  273 (390)
T ss_dssp             --ECCSSCSEEECCSSCCCE-EECCC---CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSS
T ss_pred             --CCCCcceEEECCCCeeee-ccccc---cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHcccccc
Confidence              122355566666665542 23322   35677777777777643  46777777888888888877777777777788


Q ss_pred             cceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCcc
Q 039290          370 LKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLT  449 (1049)
Q Consensus       370 L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~  449 (1049)
                      |++|++++|.+++++..      +..+++|++|++++|+++++ |                         ..+..+++|+
T Consensus       274 L~~L~L~~n~l~~~~~~------~~~l~~L~~L~L~~n~l~~~-~-------------------------~~~~~l~~L~  321 (390)
T 3o6n_A          274 LERLYISNNRLVALNLY------GQPIPTLKVLDLSHNHLLHV-E-------------------------RNQPQFDRLE  321 (390)
T ss_dssp             CCEEECCSSCCCEEECS------SSCCTTCCEEECCSSCCCCC-G-------------------------GGHHHHTTCS
T ss_pred             CCEEECCCCcCcccCcc------cCCCCCCCEEECCCCcceec-C-------------------------ccccccCcCC
Confidence            88888888877765432      34566677777777766532 2                         2233344555


Q ss_pred             EEEccCCcccccCCccccCcCCCcceEeeccccC
Q 039290          450 VIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLE  483 (1049)
Q Consensus       450 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  483 (1049)
                      .|+|++|.+++. +  +..+++|++|++++|++.
T Consensus       322 ~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~  352 (390)
T 3o6n_A          322 NLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWD  352 (390)
T ss_dssp             EEECCSSCCCCC-C--CCTTCCCSEEECCSSCEE
T ss_pred             EEECCCCcccee-C--chhhccCCEEEcCCCCcc
Confidence            555555555532 2  444555555555555554

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.1e-36  Score=343.34  Aligned_cols=269  Identities=22%  Similarity=0.240  Sum_probs=200.6

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecC-----Cee
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNN-----DFK  832 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~-----~~~  832 (1049)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++..... .....+.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            457899999999999999999965 788999999964322 2345678999999999999999999987654     678


Q ss_pred             EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecC
Q 039290          833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      ++||||++ ++|.+++...  .+++.+++.++.|+++||+|||   +.||+||||||+||+++.++.+||+|||++....
T Consensus        90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            99999997 5899988764  4899999999999999999999   9999999999999999999999999999998765


Q ss_pred             CCccc---------cccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccc-
Q 039290          913 KEESM---------RQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLL-  981 (1049)
Q Consensus       913 ~~~~~---------~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-  981 (1049)
                      .....         ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+.. ....+.... 
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~  242 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL-LLIFGIIGTP  242 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCCC
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHHHhCCC
Confidence            32211         1223468999999998754 67899999999999999999999999764322111 111100000 


Q ss_pred             --cCCcchhcccc-------cccccccC-chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          982 --SCSITEVADAN-------LLNCEEND-FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       982 --~~~~~~~~~~~-------~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                        ...........       +....... ......++.++.+++.+||+.||++|||++|+++|
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence              00000000000       00000000 01112456788999999999999999999999986

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.3e-36  Score=347.98  Aligned_cols=267  Identities=19%  Similarity=0.227  Sum_probs=183.0

Q ss_pred             CCC-CceecCCCcEEEEEEEeC---CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeee--cCCeeEEEE
Q 039290          763 FSE-NKLLGMGSFGSVYKGVLP---DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCS--NNDFKALVL  836 (1049)
Q Consensus       763 ~~~-~~~lg~G~fg~Vy~a~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~--~~~~~~lv~  836 (1049)
                      |++ .++||+|+||+||+|+..   +++.||+|++...  .....+.+|++++++++||||+++++++.  .....++||
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~   99 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   99 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence            554 468999999999999965   5788999999644  33467889999999999999999999994  467899999


Q ss_pred             eccCCCChhhhhhcC--------CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeee----cCCCceEEec
Q 039290          837 EYMSNGSLEKCLYSD--------NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL----NESMVGHLSD  904 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~----~~~~~~kl~D  904 (1049)
                      ||+++ +|.+++...        ...+++..++.++.||+.||+|||   +.||+||||||+||++    +.++.+||+|
T Consensus       100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A          100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            99975 787776532        124899999999999999999999   9999999999999999    6778999999


Q ss_pred             ccCceecCCCcc--ccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCcccccc--------chHH
Q 039290          905 FGIAKILGKEES--MRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGE--------MSLK  973 (1049)
Q Consensus       905 fGla~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~--------~~~~  973 (1049)
                      ||+|+.......  .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.......        ....
T Consensus       176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~  255 (405)
T 3rgf_A          176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD  255 (405)
T ss_dssp             TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred             CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence            999987653221  22334678999999999877 458999999999999999999999997533210        0111


Q ss_pred             Hhhhhc--cccCCcchhcc--------cccccccccCchhh-------HHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          974 RWVGDS--LLSCSITEVAD--------ANLLNCEENDFSAR-------EQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       974 ~~~~~~--~~~~~~~~~~~--------~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ......  .....+..+..        ..............       ...+.++.+++.+||+.||++|||++|+++|
T Consensus       256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            111000  00000000000        00000000000000       0114568899999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=5.8e-36  Score=337.66  Aligned_cols=265  Identities=20%  Similarity=0.250  Sum_probs=203.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe--CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCC------ceeeEEeeeecCCe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL--PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHR------NLVKIISSCSNNDF  831 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hp------niv~l~~~~~~~~~  831 (1049)
                      .++|++.+.||+|+||+||+|..  .+++.||+|+++.. ....+.+.+|+++++.++|+      +++++++++.+.+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            35799999999999999999986  36889999999643 23356788999999988765      49999999999999


Q ss_pred             eEEEEeccCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC--------------
Q 039290          832 KALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE--------------  896 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~--------------  896 (1049)
                      .++||||+ +++|.+++...+ ..+++.+++.++.|+++||+|||   ++||+||||||+||+++.              
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999 889999987654 36889999999999999999999   999999999999999987              


Q ss_pred             -----CCceEEecccCceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccch
Q 039290          897 -----SMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMS  971 (1049)
Q Consensus       897 -----~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~  971 (1049)
                           ++.+||+|||++......    .....||+.|+|||++.+..++.++||||+||++|||++|..||......+..
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  243 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL  243 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred             cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                 668999999999875432    23356899999999999989999999999999999999999999764322211


Q ss_pred             HHHhhhhccccCCc--------chhcccc----------------cccccccCchhhHHHHHHHHHHHhhccccCCCCCC
Q 039290          972 LKRWVGDSLLSCSI--------TEVADAN----------------LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI 1027 (1049)
Q Consensus       972 ~~~~~~~~~~~~~~--------~~~~~~~----------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 1027 (1049)
                       .... ......+.        .......                ..............+++++.+++.+||+.||++||
T Consensus       244 -~~~~-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          244 -AMME-RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             -HHHH-HHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             -HHHH-HHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence             1100 00000000        0000000                00000000111234577899999999999999999


Q ss_pred             CHHHHHHH
Q 039290         1028 SMKDVANR 1035 (1049)
Q Consensus      1028 t~~ell~~ 1035 (1049)
                      |++|++++
T Consensus       322 t~~ell~h  329 (339)
T 1z57_A          322 TLREALKH  329 (339)
T ss_dssp             CHHHHTTS
T ss_pred             CHHHHhcC
Confidence            99999976

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-36  Score=337.67  Aligned_cols=245  Identities=22%  Similarity=0.285  Sum_probs=192.9

Q ss_pred             HHHHhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCC------CHHHHHHHHHHHhhc----CCCceeeEEe
Q 039290          756 LLRATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDG------SLESFHAECKVMGSI----RHRNLVKIIS  824 (1049)
Q Consensus       756 ~~~~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~hpniv~l~~  824 (1049)
                      .....++|++.+.||+|+||.||+|+. .+++.||+|+++.....      ....+.+|+.++.++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            334467899999999999999999985 47889999999754321      223456789999988    8999999999


Q ss_pred             eeecCCeeEEEEec-cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec-CCCceEE
Q 039290          825 SCSNNDFKALVLEY-MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN-ESMVGHL  902 (1049)
Q Consensus       825 ~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~-~~~~~kl  902 (1049)
                      ++.+.+..++|||| +.+++|.+++.... .+++.+++.++.|+++||+|||   +.||+||||||+||+++ .++.+||
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEE
Confidence            99999999999999 78999999997654 4899999999999999999999   99999999999999999 8899999


Q ss_pred             ecccCceecCCCccccccccccccCcccccccCCCCc-CcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccc
Q 039290          903 SDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKV-SRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLL  981 (1049)
Q Consensus       903 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  981 (1049)
                      +|||++.......   .....++..|+|||++.+..+ +.++||||+||++|||++|+.||.....       ....   
T Consensus       182 ~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~---  248 (312)
T 2iwi_A          182 IDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-------ILEA---  248 (312)
T ss_dssp             CCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHHT---
T ss_pred             EEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-------Hhhh---
Confidence            9999998765432   234568999999998877666 4589999999999999999999965210       0000   


Q ss_pred             cCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          982 SCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                                        ....+..++.++.+++.+||+.||++|||++|++++
T Consensus       249 ------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          249 ------------------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             ------------------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ------------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                              000112245678999999999999999999999985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=9e-36  Score=334.95  Aligned_cols=253  Identities=22%  Similarity=0.259  Sum_probs=175.1

Q ss_pred             hcCCCCCc-eecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeec----CCeeE
Q 039290          760 TDGFSENK-LLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSN----NDFKA  833 (1049)
Q Consensus       760 ~~~~~~~~-~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~----~~~~~  833 (1049)
                      .++|.+.+ .||+|+||+||+|+.. +++.||+|++...    .....+....++.++||||+++++++..    ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            45788854 6999999999999965 7899999998643    2222333344566799999999999876    45689


Q ss_pred             EEEeccCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC---CCceEEecccCce
Q 039290          834 LVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE---SMVGHLSDFGIAK  909 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~~~kl~DfGla~  909 (1049)
                      +||||+++|+|.+++.... ..+++.+++.++.|+++||+|||   ++||+||||||+||+++.   ++.+||+|||++.
T Consensus       103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~  179 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK  179 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence            9999999999999998654 36899999999999999999999   999999999999999975   4569999999998


Q ss_pred             ecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhc
Q 039290          910 ILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA  989 (1049)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  989 (1049)
                      ......   .....+|+.|+|||++.+..++.++||||+||++|+|++|..||...............          + 
T Consensus       180 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----------~-  245 (336)
T 3fhr_A          180 ETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR----------I-  245 (336)
T ss_dssp             EC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred             eccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHh----------h-
Confidence            664322   23456799999999998889999999999999999999999999764322211000000          0 


Q ss_pred             ccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          990 DANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                         ..............++.++.+++.+||+.||++|||++|++++-
T Consensus       246 ---~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          246 ---RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             --------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             ---hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence               00000000111123567789999999999999999999999864

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=7.9e-36  Score=347.10  Aligned_cols=250  Identities=24%  Similarity=0.323  Sum_probs=189.5

Q ss_pred             CCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEEEeccC
Q 039290          762 GFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALVLEYMS  840 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~  840 (1049)
                      .|...+.||+|+||+||.+...+|+.||||++...   ..+.+.+|+++++++ +||||+++++++.+.+..++||||++
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            45556889999999998777778999999998754   245678999999887 89999999999999999999999996


Q ss_pred             CCChhhhhhcCCCc------cCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCC-------------CceE
Q 039290          841 NGSLEKCLYSDNYF------LDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNES-------------MVGH  901 (1049)
Q Consensus       841 ~g~L~~~l~~~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-------------~~~k  901 (1049)
                       |+|.+++......      .++..++.++.||+.||+|||   +.||+||||||+||+++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             5999999765431      123345789999999999999   9999999999999999754             4899


Q ss_pred             EecccCceecCCCccc---cccccccccCcccccccCC-------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccc
Q 039290          902 LSDFGIAKILGKEESM---RQTKTLGTIGYMAPEYGRE-------GKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEM  970 (1049)
Q Consensus       902 l~DfGla~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~  970 (1049)
                      |+|||++.........   ......||+.|+|||++.+       ..++.++||||+||++|||++ |..||......+.
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~  248 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES  248 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence            9999999987543321   1234578999999999865       578999999999999999999 9999975432221


Q ss_pred             hHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          971 SLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ..   ........              .........++.++.+++.+||+.||++|||+.|+++|
T Consensus       249 ~i---~~~~~~~~--------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          249 NI---IRGIFSLD--------------EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             HH---HHTCCCCC--------------CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HH---hcCCCCcc--------------cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            11   11110000              00111124567889999999999999999999999875

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=9.9e-36  Score=341.10  Aligned_cols=200  Identities=25%  Similarity=0.314  Sum_probs=171.0

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcC-CC-----ceeeEEeeeecCCe
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIR-HR-----NLVKIISSCSNNDF  831 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hp-----niv~l~~~~~~~~~  831 (1049)
                      ..++|++.+.||+|+||+||+|+.. +++.||||+++... .....+.+|+++++.++ |+     +|+++++++...+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            3568999999999999999999965 68899999997432 23456778888888874 44     59999999999999


Q ss_pred             eEEEEeccCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec--CCCceEEecccCc
Q 039290          832 KALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN--ESMVGHLSDFGIA  908 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~--~~~~~kl~DfGla  908 (1049)
                      .++||||+++ +|.+++.... ..+++..+..++.|++.|++||| .++.||+||||||+||+++  .++.+||+|||++
T Consensus       131 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH-~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          131 LCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHT-STTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             eEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhc-cCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            9999999964 9999987654 45899999999999999999999 2247899999999999995  4788999999999


Q ss_pred             eecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCcc
Q 039290          909 KILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEI  965 (1049)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~  965 (1049)
                      +.....    .....+|+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       209 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          209 CQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             EETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            876432    23457899999999999999999999999999999999999999864

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4e-36  Score=343.87  Aligned_cols=267  Identities=17%  Similarity=0.209  Sum_probs=200.5

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcC-----------CCceeeEEeeee
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR-----------HRNLVKIISSCS  827 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------hpniv~l~~~~~  827 (1049)
                      .++|++.+.||+|+||+||+|+. .+++.||+|++.... ...+.+.+|++++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            35799999999999999999995 578999999997432 23467888999998886           899999999987


Q ss_pred             cCC----eeEEEEeccCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCC-CeEEcCCCCCCeeec------
Q 039290          828 NND----FKALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYST-PIVHCDIKPSNVLLN------  895 (1049)
Q Consensus       828 ~~~----~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIl~~------  895 (1049)
                      ..+    ..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||   ++ ||+||||||+||+++      
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCc
Confidence            644    789999999 889999987643 45899999999999999999999   87 999999999999994      


Q ss_pred             CCCceEEecccCceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccc-----
Q 039290          896 ESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEM-----  970 (1049)
Q Consensus       896 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-----  970 (1049)
                      ..+.+||+|||++......    .....+|+.|+|||++.+..++.++||||+||++|||++|+.||........     
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence            3458999999999876432    2335689999999999998999999999999999999999999975432111     


Q ss_pred             hHHHhhhhccc-----------------cC-Ccchhcc---cccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCH
Q 039290          971 SLKRWVGDSLL-----------------SC-SITEVAD---ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISM 1029 (1049)
Q Consensus       971 ~~~~~~~~~~~-----------------~~-~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~ 1029 (1049)
                      ...........                 .. ....+..   .............+...+.++.+++.+||+.||++|||+
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence            11111100000                 00 0000000   000000111223345678899999999999999999999


Q ss_pred             HHHHHH
Q 039290         1030 KDVANR 1035 (1049)
Q Consensus      1030 ~ell~~ 1035 (1049)
                      +|+++|
T Consensus       329 ~ell~h  334 (373)
T 1q8y_A          329 GGLVNH  334 (373)
T ss_dssp             HHHHTC
T ss_pred             HHHhhC
Confidence            999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.8e-36  Score=336.43  Aligned_cols=254  Identities=26%  Similarity=0.270  Sum_probs=179.0

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC-CCHHHHHHHHH-HHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD-GSLESFHAECK-VMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~-~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      .++|+..+.||+|+||.||+|... +++.||+|+++.... ....++..|+. +++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            467889999999999999999964 789999999976532 22344555555 677789999999999999999999999


Q ss_pred             eccCCCChhhhhhc----CCCccCHHHHHHHHHHHHHHHHHhHccCCC-CeEEcCCCCCCeeecCCCceEEecccCceec
Q 039290          837 EYMSNGSLEKCLYS----DNYFLDILQRLKIMIDVASALEYLHFGYST-PIVHCDIKPSNVLLNESMVGHLSDFGIAKIL  911 (1049)
Q Consensus       837 e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~  911 (1049)
                      ||+++ +|.+++..    ....+++..+..++.|+++|++|||   +. ||+||||||+||+++.++.+||+|||++...
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99986 88777653    2456899999999999999999999   87 9999999999999999999999999999876


Q ss_pred             CCCccccccccccccCccccccc----CCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcch
Q 039290          912 GKEESMRQTKTLGTIGYMAPEYG----REGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITE  987 (1049)
Q Consensus       912 ~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  987 (1049)
                      ....  ......|++.|+|||++    .+..++.++||||+||++|||++|+.||.............            
T Consensus       177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~------------  242 (327)
T 3aln_A          177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV------------  242 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC------------
T ss_pred             cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH------------
Confidence            4332  22334689999999998    45678999999999999999999999997532111111000            


Q ss_pred             hcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          988 VADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       988 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                       ........   .......++..+.+++.+||+.||++|||++|++++
T Consensus       243 -~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          243 -VKGDPPQL---SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             -CCSCCCCC---CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             -hcCCCCCC---CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence             00000000   000112245678999999999999999999999886

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=5.5e-35  Score=354.92  Aligned_cols=345  Identities=20%  Similarity=0.231  Sum_probs=207.5

Q ss_pred             ccCCCCCCCce----eeeEEEcCCCCcEEEEEEeccccccccCCCCCCcchhhhhhcccCccccccCc-ccccccCCcEe
Q 039290           52 NNWSTTSSVCS----WIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPE-ELSHLRGLKYF  126 (1049)
Q Consensus        52 ~~w~~~~~~c~----w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~-~~~~L~~L~~L  126 (1049)
                      ++|.++.+||.    |.++.|+..      ++-....+.  .+..-..++.++.|++++|.+. .+|. .++++++|++|
T Consensus        10 ~~~~~~~~C~~~~~~~~c~~~~~~------i~~~~~~~~--~~~~~l~l~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L   80 (597)
T 3oja_B           10 KPRQPEYKCIDSNLQYDCVFYDVH------IDMQTQDVY--FGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELL   80 (597)
T ss_dssp             -CCCSEECCCCC--CCSEEECSCE------ECSSCCCCE--ESCSSGGGCCCSEEEESSCEES-EECTHHHHHCCCCSEE
T ss_pred             cCCCCCCcCcccCcCceeEecCce------ecccccccc--cCcccccCCCceEEEeeCCCCC-CcCHHHHccCCCCcEE
Confidence            48988888884    776666421      111111111  1111223456666666666665 3443 34566666666


Q ss_pred             ccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEe
Q 039290          127 DFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFI  206 (1049)
Q Consensus       127 ~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l  206 (1049)
                      +|++|++.+..|..|+.+++|++|+|++|.+++..|..|+.+++|++|+|++|+++ .+|+.++     .++++|++|+|
T Consensus        81 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~-----~~l~~L~~L~L  154 (597)
T 3oja_B           81 NLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIF-----HNTPKLTTLSM  154 (597)
T ss_dssp             ECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTT-----TTCTTCCEEEC
T ss_pred             ECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCC-CCCHHHh-----ccCCCCCEEEe
Confidence            66666666666666666666666666666666666666666666666666666666 4444331     22344555666


Q ss_pred             eccccCCCCCCCcccccccceecccccccccccCCCCccccccceEEeccccccccCccccccccceEEEeeccccCCCc
Q 039290          207 SYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGL  286 (1049)
Q Consensus       207 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~  286 (1049)
                      ++|.+++..|..+..+++|+.|+|++|++++.   .                        ++.+++|+.|++++|.+.+.
T Consensus       155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~------------------------~~~l~~L~~L~l~~n~l~~l  207 (597)
T 3oja_B          155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---D------------------------LSLIPSLFHANVSYNLLSTL  207 (597)
T ss_dssp             CSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---C------------------------GGGCTTCSEEECCSSCCSEE
T ss_pred             eCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---C------------------------hhhhhhhhhhhcccCccccc
Confidence            65555554444455555555555555544432   1                        33344445555555544432


Q ss_pred             cccccccccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCccccccc
Q 039290          287 IPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGN  366 (1049)
Q Consensus       287 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  366 (1049)
                           ...++|++|++++|.+. .+|..+   .++|+.|+|++|.+++  +..+..+++|+.|+|++|.+.+..|..|+.
T Consensus       208 -----~~~~~L~~L~ls~n~l~-~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~  276 (597)
T 3oja_B          208 -----AIPIAVEELDASHNSIN-VVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVK  276 (597)
T ss_dssp             -----ECCTTCSEEECCSSCCC-EEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTT
T ss_pred             -----cCCchhheeeccCCccc-cccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcC
Confidence                 22335666666666654 233222   2577888888888875  366778888888888888888877888888


Q ss_pred             ccccceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCC
Q 039290          367 LRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNIN  446 (1049)
Q Consensus       367 l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~  446 (1049)
                      +++|+.|+|++|.+++++..      +..+++|+.|+|++|.++.                          +|..+..++
T Consensus       277 l~~L~~L~Ls~N~l~~l~~~------~~~l~~L~~L~Ls~N~l~~--------------------------i~~~~~~l~  324 (597)
T 3oja_B          277 MQRLERLYISNNRLVALNLY------GQPIPTLKVLDLSHNHLLH--------------------------VERNQPQFD  324 (597)
T ss_dssp             CSSCCEEECTTSCCCEEECS------SSCCTTCCEEECCSSCCCC--------------------------CGGGHHHHT
T ss_pred             ccCCCEEECCCCCCCCCCcc------cccCCCCcEEECCCCCCCc--------------------------cCcccccCC
Confidence            88888888888888775432      3456667777777776652                          333445566


Q ss_pred             CccEEEccCCcccccCCccccCcCCCcceEeeccccCC
Q 039290          447 NLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEG  484 (1049)
Q Consensus       447 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  484 (1049)
                      +|+.|+|++|.+++. |  +..+++|+.|+|++|.+.+
T Consensus       325 ~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~  359 (597)
T 3oja_B          325 RLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDC  359 (597)
T ss_dssp             TCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred             CCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCC
Confidence            777777777777643 2  5566777777888777764

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.3e-36  Score=337.52  Aligned_cols=242  Identities=23%  Similarity=0.301  Sum_probs=200.6

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCC------CHHHHHHHHHHHhhcC--CCceeeEEeeeecC
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDG------SLESFHAECKVMGSIR--HRNLVKIISSCSNN  829 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--hpniv~l~~~~~~~  829 (1049)
                      ..++|++.+.||+|+||.||+|+. .+++.||+|++......      ..+.+.+|+.++++++  ||||+++++++.+.
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            456799999999999999999995 57889999999765422      2356778999999996  59999999999999


Q ss_pred             CeeEEEEeccCC-CChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec-CCCceEEecccC
Q 039290          830 DFKALVLEYMSN-GSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGI  907 (1049)
Q Consensus       830 ~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~-~~~~~kl~DfGl  907 (1049)
                      +..++|||++.+ ++|.+++.... .+++..++.++.|+++||+|||   +.||+||||||+||+++ .++.+||+|||+
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~  196 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGS  196 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             CcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence            999999999986 89999987644 4899999999999999999999   99999999999999999 789999999999


Q ss_pred             ceecCCCccccccccccccCcccccccCCCCc-CcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcc
Q 039290          908 AKILGKEESMRQTKTLGTIGYMAPEYGREGKV-SRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSIT  986 (1049)
Q Consensus       908 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  986 (1049)
                      +.......   .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||.....       ......      
T Consensus       197 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------~~~~~~------  260 (320)
T 3a99_A          197 GALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------IIRGQV------  260 (320)
T ss_dssp             CEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHHCCC------
T ss_pred             cccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------hhcccc------
Confidence            98765432   233568999999999877665 6889999999999999999999965210       000000      


Q ss_pred             hhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          987 EVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       987 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                                     ..+..++.++.+++.+||+.||++|||++|++++
T Consensus       261 ---------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          261 ---------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             ---------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                           0011235678999999999999999999999875

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=9.8e-36  Score=337.62  Aligned_cols=264  Identities=20%  Similarity=0.247  Sum_probs=197.6

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCC--CHHHHHHHHHHHhhcCCCceeeEEeeeecCCe-----
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDG--SLESFHAECKVMGSIRHRNLVKIISSCSNNDF-----  831 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~-----  831 (1049)
                      .++|...+.||+|+||.||+|+.. +|+.||||++......  ..+.+.+|+.++++++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            357889999999999999999964 7899999999764322  24678899999999999999999999987654     


Q ss_pred             -eEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCcee
Q 039290          832 -KALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI  910 (1049)
Q Consensus       832 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~  910 (1049)
                       .++||||++ ++|.+++..   .+++.+++.++.|+++||+|||   ++||+||||||+||+++.++.+||+|||++..
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence             499999997 588887643   3899999999999999999999   99999999999999999999999999999986


Q ss_pred             cCCCccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcccc--CCcch
Q 039290          911 LGKEESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLS--CSITE  987 (1049)
Q Consensus       911 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~  987 (1049)
                      ....    .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+. ...........  .....
T Consensus       176 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~  250 (353)
T 3coi_A          176 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGTEFVQK  250 (353)
T ss_dssp             ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH-HHHHHHHHCBCCHHHHTT
T ss_pred             CCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHH
Confidence            5332    233568999999998876 6789999999999999999999999976332211 11111000000  00000


Q ss_pred             hcc-------cccccccccC-chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          988 VAD-------ANLLNCEEND-FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       988 ~~~-------~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      +.+       ..+....... ......++.++.+++.+|++.||++|||++|+++|
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            000       0000000000 11112456789999999999999999999999976

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.4e-36  Score=347.19  Aligned_cols=249  Identities=22%  Similarity=0.333  Sum_probs=190.4

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEEEecc
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      .+|...++||+|+||+||.....+++.||||++....   ...+.+|+++++++ +|||||++++++.+.+..++||||+
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  100 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC  100 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence            4588889999999999765556689999999986432   23467899999999 7999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC-----CCceEEecccCceecCCC
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE-----SMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-----~~~~kl~DfGla~~~~~~  914 (1049)
                      + |+|.+++........+.+++.++.||++||+|||   +.||+||||||+||+++.     ...+||+|||+++.....
T Consensus       101 ~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~  176 (432)
T 3p23_A          101 A-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG  176 (432)
T ss_dssp             S-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred             C-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence            6 5999999877665666677899999999999999   999999999999999953     336889999999876533


Q ss_pred             cc--ccccccccccCcccccccC---CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchh
Q 039290          915 ES--MRQTKTLGTIGYMAPEYGR---EGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEV  988 (1049)
Q Consensus       915 ~~--~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  988 (1049)
                      ..  .......||+.|+|||++.   ...++.++||||+||++|||++ |..||........  .......    .    
T Consensus       177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~--~~~~~~~----~----  246 (432)
T 3p23_A          177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA--NILLGAC----S----  246 (432)
T ss_dssp             ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH--HHHTTCC----C----
T ss_pred             CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH--HHHhccC----C----
Confidence            21  2233467999999999987   4567889999999999999999 8999864322111  1110000    0    


Q ss_pred             cccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          989 ADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                               ..........+..+.+++.+||+.||++|||++|+++|
T Consensus       247 ---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          247 ---------LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             ---------CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ---------ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence                     00001112345668899999999999999999999965

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=4.7e-35  Score=336.85  Aligned_cols=336  Identities=19%  Similarity=0.227  Sum_probs=243.6

Q ss_pred             cccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCcccccccccccce
Q 039290          293 NISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKL  372 (1049)
Q Consensus       293 ~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  372 (1049)
                      .+++++.|++++|.+. .+|..++..+++|++|+|++|++++..+..|..+++|++|++++|.+.+..|..|+++++|++
T Consensus        43 ~l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  121 (390)
T 3o6n_A           43 TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV  121 (390)
T ss_dssp             GGCCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             ccCCceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCE
Confidence            4567778888877765 566666666777888888888777666667777777777888777777776777777777777


Q ss_pred             eecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEE
Q 039290          373 LSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIR  452 (1049)
Q Consensus       373 L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~  452 (1049)
                      |++++|.++.++...     +..+++|++|++++|.+++                         ..|..+.++++|++|+
T Consensus       122 L~L~~n~l~~l~~~~-----~~~l~~L~~L~L~~n~l~~-------------------------~~~~~~~~l~~L~~L~  171 (390)
T 3o6n_A          122 LVLERNDLSSLPRGI-----FHNTPKLTTLSMSNNNLER-------------------------IEDDTFQATTSLQNLQ  171 (390)
T ss_dssp             EECCSSCCCCCCTTT-----TTTCTTCCEEECCSSCCCB-------------------------CCTTTTSSCTTCCEEE
T ss_pred             EECCCCccCcCCHHH-----hcCCCCCcEEECCCCccCc-------------------------cChhhccCCCCCCEEE
Confidence            777777777665542     4555666666666655554                         4455566667777777


Q ss_pred             ccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCccccc
Q 039290          453 LGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTS  532 (1049)
Q Consensus       453 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  532 (1049)
                      +++|.+++.   .++.+++|+.|++++|.+++     +....+|++|++++|.+.. +|..  ..++|+.|++++|++++
T Consensus       172 l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~-----~~~~~~L~~L~l~~n~l~~-~~~~--~~~~L~~L~l~~n~l~~  240 (390)
T 3o6n_A          172 LSSNRLTHV---DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINV-VRGP--VNVELTILKLQHNNLTD  240 (390)
T ss_dssp             CCSSCCSBC---CGGGCTTCSEEECCSSCCSE-----EECCSSCSEEECCSSCCCE-EECC--CCSSCCEEECCSSCCCC
T ss_pred             CCCCcCCcc---ccccccccceeecccccccc-----cCCCCcceEEECCCCeeee-cccc--ccccccEEECCCCCCcc
Confidence            777777643   24556677777777777653     2334567777777777763 3432  24677888888888876


Q ss_pred             ccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccC
Q 039290          533 IIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGG  612 (1049)
Q Consensus       533 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  612 (1049)
                      .  ..+..+++|++|++++|.+++..|..+..+++|++|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..
T Consensus       241 ~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~  316 (390)
T 3o6n_A          241 T--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ  316 (390)
T ss_dssp             C--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHH
T ss_pred             c--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccc
Confidence            3  467777888888888888887777788888888888888888885 5667788899999999999999 56777888


Q ss_pred             ccCCcEEeccCccccCCcccccccccccceeeccCCcccccCCCCCCccccccccccCCccccCCC
Q 039290          613 LKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSP  678 (1049)
Q Consensus       613 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~cg~~  678 (1049)
                      +++|++|+|++|+++. +|  +..+++|+.|++++|+|.|.+.. ..+..+....+.+++..|+.+
T Consensus       317 l~~L~~L~L~~N~i~~-~~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~  378 (390)
T 3o6n_A          317 FDRLENLYLDHNSIVT-LK--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID  378 (390)
T ss_dssp             HTTCSEEECCSSCCCC-CC--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTT
T ss_pred             cCcCCEEECCCCccce-eC--chhhccCCEEEcCCCCccchhHH-HHHHHHHhhcccccCceeccc
Confidence            9999999999999984 44  77888999999999999986543 223344555677787888765

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5.9e-36  Score=334.38  Aligned_cols=252  Identities=23%  Similarity=0.256  Sum_probs=183.2

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCC--CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDG--SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++......  ..+.+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            457888999999999999999965 7899999999765322  1233445556778889999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCC-CeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST-PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      ||+ ++.+..+.......+++..++.++.|+++|++|||   ++ ||+||||||+||+++.++.+||+|||++.......
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            999 55666666554556899999999999999999999   85 99999999999999999999999999997664332


Q ss_pred             cccccccccccCcccccccC-----CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcc
Q 039290          916 SMRQTKTLGTIGYMAPEYGR-----EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD  990 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  990 (1049)
                        ......+++.|+|||++.     ...++.++||||+||++|||++|+.||..................          
T Consensus       180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------  247 (318)
T 2dyl_A          180 --AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP----------  247 (318)
T ss_dssp             ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC----------
T ss_pred             --cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC----------
Confidence              223356899999999984     456889999999999999999999999753222221111111000          


Q ss_pred             cccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          991 ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                              ...+....++.++.+++.+||+.||.+|||++|++++
T Consensus       248 --------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          248 --------PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             --------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             --------CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                    0000111245678999999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.8e-35  Score=335.95  Aligned_cols=265  Identities=19%  Similarity=0.223  Sum_probs=199.8

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CC-cEEEEEEeecccCCCHHHHHHHHHHHhhcCCCc------eeeEEeeeecCCe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DG-MEIAAKVFHMEFDGSLESFHAECKVMGSIRHRN------LVKIISSCSNNDF  831 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn------iv~l~~~~~~~~~  831 (1049)
                      .++|++.+.||+|+||+||+|+.. ++ +.||+|+++.. ....+.+.+|+++++.++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            467999999999999999999964 44 68999999643 233567888999999997665      9999999999999


Q ss_pred             eEEEEeccCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeee----------------
Q 039290          832 KALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL----------------  894 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~----------------  894 (1049)
                      .++||||+ ++++.+++.... ..+++.+++.++.||++||+|||   ++||+||||||+||++                
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999 556666665543 46899999999999999999999   9999999999999999                


Q ss_pred             ---cCCCceEEecccCceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccch
Q 039290          895 ---NESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMS  971 (1049)
Q Consensus       895 ---~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~  971 (1049)
                         +.++.+||+|||++.......    ....||+.|+|||++.+..++.++||||+||++|||++|..||......+..
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  248 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL  248 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence               567899999999998654322    3457899999999999989999999999999999999999999764322111


Q ss_pred             HHHhhhhccccCCc--------chhccc-c------------c---ccccccCchhhHHHHHHHHHHHhhccccCCCCCC
Q 039290          972 LKRWVGDSLLSCSI--------TEVADA-N------------L---LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI 1027 (1049)
Q Consensus       972 ~~~~~~~~~~~~~~--------~~~~~~-~------------~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 1027 (1049)
                       .. ........+.        ...... .            .   ..............+.++.+++.+||+.||++||
T Consensus       249 -~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          249 -VM-MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             -HH-HHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             -HH-HHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence             10 0000000000        000000 0            0   0000000011123456899999999999999999


Q ss_pred             CHHHHHHH
Q 039290         1028 SMKDVANR 1035 (1049)
Q Consensus      1028 t~~ell~~ 1035 (1049)
                      |++|+++|
T Consensus       327 t~~e~l~h  334 (355)
T 2eu9_A          327 TLAEALLH  334 (355)
T ss_dssp             CHHHHTTS
T ss_pred             CHHHHhcC
Confidence            99999875

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=9.2e-35  Score=352.96  Aligned_cols=335  Identities=19%  Similarity=0.228  Sum_probs=246.7

Q ss_pred             ccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCccccccccccccee
Q 039290          294 ISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLL  373 (1049)
Q Consensus       294 l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  373 (1049)
                      +++++.|++++|.+. .+|..++..+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|
T Consensus        50 l~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  128 (597)
T 3oja_B           50 LNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL  128 (597)
T ss_dssp             GCCCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             CCCceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence            566777777777765 5666665567777777777777776666677777777777777777777666667777777777


Q ss_pred             ecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEc
Q 039290          374 SLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRL  453 (1049)
Q Consensus       374 ~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L  453 (1049)
                      +|++|.|+.+++..     |..+++|++|+|++|.++                         +..|..|+++++|++|+|
T Consensus       129 ~L~~n~l~~l~~~~-----~~~l~~L~~L~Ls~N~l~-------------------------~~~~~~~~~l~~L~~L~L  178 (597)
T 3oja_B          129 VLERNDLSSLPRGI-----FHNTPKLTTLSMSNNNLE-------------------------RIEDDTFQATTSLQNLQL  178 (597)
T ss_dssp             ECCSSCCCCCCTTT-----TTTCTTCCEEECCSSCCC-------------------------BCCTTTTTTCTTCCEEEC
T ss_pred             EeeCCCCCCCCHHH-----hccCCCCCEEEeeCCcCC-------------------------CCChhhhhcCCcCcEEEC
Confidence            77777776655432     445555555555555554                         455556667777777777


Q ss_pred             cCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccc
Q 039290          454 GNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSI  533 (1049)
Q Consensus       454 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  533 (1049)
                      ++|.+++.   .++.+++|+.|++++|.+++     +....+|+.|++++|.++. +|..+  .++|+.|+|++|.+++ 
T Consensus       179 ~~N~l~~~---~~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~-~~~~~--~~~L~~L~L~~n~l~~-  246 (597)
T 3oja_B          179 SSNRLTHV---DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNLTD-  246 (597)
T ss_dssp             TTSCCSBC---CGGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCE-EECSC--CSCCCEEECCSSCCCC-
T ss_pred             cCCCCCCc---ChhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCcccc-ccccc--CCCCCEEECCCCCCCC-
Confidence            77777753   24556777777777777763     3344567777888877763 33322  2578888888888876 


Q ss_pred             cCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCc
Q 039290          534 IPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGL  613 (1049)
Q Consensus       534 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  613 (1049)
                       +..+..+++|+.|+|++|.+++..|..|+.+++|++|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+
T Consensus       247 -~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l  323 (597)
T 3oja_B          247 -TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQF  323 (597)
T ss_dssp             -CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHH
T ss_pred             -ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccC
Confidence             3677788888888888888888778888888888888999988886 5777788999999999999999 578888999


Q ss_pred             cCCcEEeccCccccCCcccccccccccceeeccCCcccccCCCCCCccccccccccCCccccCCC
Q 039290          614 KSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSP  678 (1049)
Q Consensus       614 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~cg~~  678 (1049)
                      ++|++|+|++|++++. |  +..+++|+.|++++|+|.|.++. ..+..+....+.++...|+.+
T Consensus       324 ~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~  384 (597)
T 3oja_B          324 DRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID  384 (597)
T ss_dssp             TTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTT
T ss_pred             CCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcc
Confidence            9999999999999854 3  67788999999999999998643 234455566678888899875

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.6e-35  Score=352.55  Aligned_cols=272  Identities=25%  Similarity=0.303  Sum_probs=202.7

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeec------CCe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSN------NDF  831 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~------~~~  831 (1049)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|+++... ....+.+.+|++++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            36899999999999999999996 478999999987543 2235678899999999999999999998765      677


Q ss_pred             eEEEEeccCCCChhhhhhcCCC--ccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCc---eEEeccc
Q 039290          832 KALVLEYMSNGSLEKCLYSDNY--FLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMV---GHLSDFG  906 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~---~kl~DfG  906 (1049)
                      .++||||+++|+|.+++.....  .+++..++.++.|++.|++|||   +.||+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            8999999999999999986442  5888999999999999999999   999999999999999996654   9999999


Q ss_pred             CceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcc
Q 039290          907 IAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSIT  986 (1049)
Q Consensus       907 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  986 (1049)
                      ++.......  ......||+.|+|||++.+..++.++||||+||++|||++|..||.....    ...|...........
T Consensus       170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~~~~i~~~~~~~  243 (676)
T 3qa8_A          170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQWHGKVREKSNEH  243 (676)
T ss_dssp             CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHSSTTCC------
T ss_pred             ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhhhhhhhcccchh
Confidence            998765433  22345789999999999999999999999999999999999999965321    122222111111000


Q ss_pred             hhccccccc------ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHH-----HHHHHHHH
Q 039290          987 EVADANLLN------CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDV-----ANRLVRIR 1040 (1049)
Q Consensus       987 ~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~el-----l~~L~~i~ 1040 (1049)
                      .........      ............+..+.+++.+|+++||++|||++|+     .+.++++.
T Consensus       244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL  308 (676)
T 3qa8_A          244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL  308 (676)
T ss_dssp             CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred             hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence            000000000      0000111223467889999999999999999999984     44455444

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=6.1e-35  Score=324.35  Aligned_cols=255  Identities=33%  Similarity=0.566  Sum_probs=234.8

Q ss_pred             cccEEEccCCcccc--CCCCCCCCCCCccEEEccC-CcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceE
Q 039290          423 SMKSLSMESCNISG--GIPKELGNINNLTVIRLGN-NELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANL  499 (1049)
Q Consensus       423 ~L~~L~L~~n~i~~--~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  499 (1049)
                      +++.|+|++|++++  .+|..|.++++|++|+|++ |.+++.+|..|+.+++|++|+|++|++++.+|..+..+++|++|
T Consensus        51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L  130 (313)
T 1ogq_A           51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence            67778888888887  7888899999999999995 99998899999999999999999999998899999999999999


Q ss_pred             EeeCcccCCcCchhccCcccCCceeecCcccccccCccccccc-ccccccccCCccCCCCccCcCCCcceeEeecccccc
Q 039290          500 YLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLK-DILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNAL  578 (1049)
Q Consensus       500 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  578 (1049)
                      ++++|.+++.+|..++++++|++|++++|++++.+|..+..++ +|++|++++|++++.+|..+..++ |++|++++|++
T Consensus       131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l  209 (313)
T 1ogq_A          131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML  209 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred             eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence            9999999988999999999999999999999988999999988 899999999999988899998887 99999999999


Q ss_pred             cccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCcccccCCCCC
Q 039290          579 SGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRG  658 (1049)
Q Consensus       579 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~  658 (1049)
                      ++..|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..+..+++|+.|++++|+++|.+|...
T Consensus       210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~  288 (313)
T 1ogq_A          210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG  288 (313)
T ss_dssp             EECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred             cCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCc
Confidence            999999999999999999999999977666 8889999999999999999999999999999999999999999999988


Q ss_pred             CccccccccccCCccccCCCC
Q 039290          659 PFITFSAESFLGNQALCGSPK  679 (1049)
Q Consensus       659 ~~~~~~~~~~~~n~~~cg~~~  679 (1049)
                      .+..+....+.+|+++||.|.
T Consensus       289 ~l~~L~~l~l~~N~~lc~~p~  309 (313)
T 1ogq_A          289 NLQRFDVSAYANNKCLCGSPL  309 (313)
T ss_dssp             TGGGSCGGGTCSSSEEESTTS
T ss_pred             cccccChHHhcCCCCccCCCC
Confidence            888888899999999999874

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.2e-34  Score=315.33  Aligned_cols=232  Identities=12%  Similarity=0.047  Sum_probs=186.3

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCC---HHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGS---LESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++.......   .+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            57999999999999999999975 58999999997654332   367899999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+++++|.+++...   ....++.+++.|+++||+|||   ++||+||||||+||+++.++.+||+++|          
T Consensus       111 e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~----------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA----------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred             EecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence            999999999998543   356678899999999999999   9999999999999999999999997543          


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                                 |++       .++.++||||+||++|||++|+.||......+.....               .......
T Consensus       175 -----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---------------~~~~~~~  221 (286)
T 3uqc_A          175 -----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---------------ERDTAGQ  221 (286)
T ss_dssp             -----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---------------CBCTTSC
T ss_pred             -----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---------------HHHhccC
Confidence                       333       3688999999999999999999999763322110000               0000000


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHh
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~ 1042 (1049)
                      ..........++.++.+++.+||+.||++| |++|+++.|+++...
T Consensus       222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence            000011123456789999999999999999 999999999988754

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=1.6e-33  Score=318.69  Aligned_cols=307  Identities=23%  Similarity=0.368  Sum_probs=224.4

Q ss_pred             cccccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCccccccccccc
Q 039290          291 IFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSL  370 (1049)
Q Consensus       291 ~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  370 (1049)
                      +..+++|++|++++|.+. .+|.  ...+++|++|++++|++++. +. +..+++|++|++++|.+...  ..|..+++|
T Consensus        40 ~~~l~~L~~L~l~~~~i~-~~~~--~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L  112 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVA-SIQG--IEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITDI--SALQNLTNL  112 (347)
T ss_dssp             HHHHTTCSEEECCSSCCC-CCTT--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTC
T ss_pred             chhcccccEEEEeCCccc-cchh--hhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccCc--hHHcCCCcC
Confidence            345667777777777765 3443  23466777777777777643 32 66667777777777766643  246666666


Q ss_pred             ceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccE
Q 039290          371 KLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTV  450 (1049)
Q Consensus       371 ~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~  450 (1049)
                      ++|++++|.++.+++       +..+++|+.|++++|...                         ..+ ..+..+++|++
T Consensus       113 ~~L~l~~n~i~~~~~-------~~~l~~L~~L~l~~n~~~-------------------------~~~-~~~~~l~~L~~  159 (347)
T 4fmz_A          113 RELYLNEDNISDISP-------LANLTKMYSLNLGANHNL-------------------------SDL-SPLSNMTGLNY  159 (347)
T ss_dssp             SEEECTTSCCCCCGG-------GTTCTTCCEEECTTCTTC-------------------------CCC-GGGTTCTTCCE
T ss_pred             CEEECcCCcccCchh-------hccCCceeEEECCCCCCc-------------------------ccc-cchhhCCCCcE
Confidence            666666666655332       445555555555555432                         222 23667778888


Q ss_pred             EEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCccc
Q 039290          451 IRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNAL  530 (1049)
Q Consensus       451 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  530 (1049)
                      |++++|.+++..+  +..+++|++|++++|++.+. +. +..+++|+.|++++|.+++..+  +..+++|++|++++|++
T Consensus       160 L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l  233 (347)
T 4fmz_A          160 LTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDI-SP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKI  233 (347)
T ss_dssp             EECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCC-GG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCC
T ss_pred             EEecCCCcCCchh--hccCCCCCEEEccCCccccc-cc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCcc
Confidence            8888888775433  77788888888888888743 33 7778888888888888875443  77888888888888888


Q ss_pred             ccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccc
Q 039290          531 TSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESF  610 (1049)
Q Consensus       531 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~  610 (1049)
                      ++..+  +..+++|++|++++|.+++.  +.+..+++|++|++++|++++.  ..+..+++|+.|++++|++++..|..|
T Consensus       234 ~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l  307 (347)
T 4fmz_A          234 TDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVI  307 (347)
T ss_dssp             CCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHH
T ss_pred             CCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHh
Confidence            87554  77888888888888888763  5688888999999999999865  468889999999999999998889999


Q ss_pred             cCccCCcEEeccCccccCCcccccccccccceeeccCCccc
Q 039290          611 GGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLE  651 (1049)
Q Consensus       611 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~  651 (1049)
                      +++++|++|+|++|++++..|  +..+++|++|++++|+++
T Consensus       308 ~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          308 GGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             HTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             hccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            999999999999999997666  888999999999999875

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=7.4e-34  Score=314.14  Aligned_cols=231  Identities=21%  Similarity=0.300  Sum_probs=181.7

Q ss_pred             cCCCCC-ceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHH-hhcCCCceeeEEeeeec----CCeeE
Q 039290          761 DGFSEN-KLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVM-GSIRHRNLVKIISSCSN----NDFKA  833 (1049)
Q Consensus       761 ~~~~~~-~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~hpniv~l~~~~~~----~~~~~  833 (1049)
                      ++|.+. +.||+|+||.||+|.. .+++.||+|+++..     ..+.+|++++ +..+||||+++++++..    .+..+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            456666 7899999999999996 57899999998642     5678899888 55589999999999876    67789


Q ss_pred             EEEeccCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC---CCceEEecccCce
Q 039290          834 LVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE---SMVGHLSDFGIAK  909 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~~~kl~DfGla~  909 (1049)
                      +||||+++|+|.+++.... ..+++.+++.++.|++.||+|||   +.||+||||||+||+++.   ++.+||+|||++.
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~  168 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  168 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence            9999999999999998754 36899999999999999999999   999999999999999997   7899999999987


Q ss_pred             ecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhc
Q 039290          910 ILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA  989 (1049)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  989 (1049)
                      ...                       +..++.++||||+||++|||++|..||......+....              ..
T Consensus       169 ~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~--------------~~  211 (299)
T 3m2w_A          169 ETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--------------MK  211 (299)
T ss_dssp             ECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC--------------SC
T ss_pred             ccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH--------------HH
Confidence            532                       13567899999999999999999999975322111000              00


Q ss_pred             ccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 039290          990 DANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036 (1049)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L 1036 (1049)
                      .................++.++.+++.+||+.||++|||++|+++|-
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp  258 (299)
T 3m2w_A          212 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  258 (299)
T ss_dssp             CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence            00000000001111134567899999999999999999999999873

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.2e-34  Score=332.64  Aligned_cols=248  Identities=17%  Similarity=0.181  Sum_probs=186.9

Q ss_pred             CCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC---CCHHHHHHHHHHHhhcCC-Cceee---------------
Q 039290          762 GFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD---GSLESFHAECKVMGSIRH-RNLVK---------------  821 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-pniv~---------------  821 (1049)
                      .|...+.||+|+||+||+|++ .+|+.||||+++....   ...+.+.+|+.+++.++| ++...               
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            467778999999999999994 5799999999874332   235789999999999976 22111               


Q ss_pred             ------EEeeeec-----CCeeEEEEeccCCCChhhhhh------cCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEE
Q 039290          822 ------IISSCSN-----NDFKALVLEYMSNGSLEKCLY------SDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH  884 (1049)
Q Consensus       822 ------l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH  884 (1049)
                            ++.++..     ....+++|+++ +++|.+++.      .....+++..++.++.|+++||+|||   ++||+|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iiH  234 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVH  234 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccc
Confidence                  1111111     12356777776 579999884      33456888899999999999999999   999999


Q ss_pred             cCCCCCCeeecCCCceEEecccCceecCCCccccccccccccCccccccc----------CCCCcCcccchHHHHHHHHH
Q 039290          885 CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYG----------REGKVSRKCDVYSYGIMLME  954 (1049)
Q Consensus       885 ~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~DvwslG~il~e  954 (1049)
                      |||||+|||++.++.+||+|||+++.....    .....| +.|+|||++          .+..++.++||||+||++||
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW  309 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence            999999999999999999999999875432    334567 999999998          55678899999999999999


Q ss_pred             HHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 039290          955 TFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVAN 1034 (1049)
Q Consensus       955 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~ 1034 (1049)
                      |++|+.||......+...              .+    ....        ..+++++.+++.+||+.||++|||+.|+++
T Consensus       310 lltg~~Pf~~~~~~~~~~--------------~~----~~~~--------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          310 IWCADLPNTDDAALGGSE--------------WI----FRSC--------KNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHSSCCCCTTGGGSCSG--------------GG----GSSC--------CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHCCCCCCCcchhhhHH--------------HH----Hhhc--------ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            999999997532221100              00    0000        123467899999999999999999999987


Q ss_pred             H--HHHHHHhhh
Q 039290         1035 R--LVRIRETLS 1044 (1049)
Q Consensus      1035 ~--L~~i~~~~~ 1044 (1049)
                      +  ++++.+.+.
T Consensus       364 ~~~~~~~~~~~~  375 (413)
T 3dzo_A          364 TPEYEQLRTELS  375 (413)
T ss_dssp             SHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHH
Confidence            6  565555543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.1e-34  Score=353.09  Aligned_cols=242  Identities=21%  Similarity=0.312  Sum_probs=196.1

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC--CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCe-----e
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP--DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDF-----K  832 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~--~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~-----~  832 (1049)
                      ++|++.+.||+|+||+||+|.+.  +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            67999999999999999999965  689999999865432 234578899999999999999999999987655     6


Q ss_pred             EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecC
Q 039290          833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      |+||||+++++|.+++..   .+++.+++.++.||++||+|||   ++||+||||||+||+++.+ .+||+|||+++...
T Consensus       160 ~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~  232 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN  232 (681)
T ss_dssp             EEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred             EEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence            999999999999987654   5899999999999999999999   9999999999999999986 89999999998764


Q ss_pred             CCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccc
Q 039290          913 KEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       913 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      ..     ....||+.|+|||++.+. ++.++|||||||++|||++|..||........                      
T Consensus       233 ~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------------------  284 (681)
T 2pzi_A          233 SF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------------------  284 (681)
T ss_dssp             CC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------------------
T ss_pred             cC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc----------------------
Confidence            33     335689999999988664 48899999999999999999888764211100                      


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCC-CHHHHHHHHHHHHHhh
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI-SMKDVANRLVRIRETL 1043 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~ell~~L~~i~~~~ 1043 (1049)
                          .  ........+..+.+++.+||+.||++|| +++++.+.+..+.++.
T Consensus       285 ----~--~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~  330 (681)
T 2pzi_A          285 ----P--EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV  330 (681)
T ss_dssp             ----C--TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred             ----c--ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence                0  0011123456789999999999999999 5677777777766543

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=7.8e-33  Score=313.14  Aligned_cols=308  Identities=25%  Similarity=0.402  Sum_probs=249.5

Q ss_pred             ccccccceEEEeeccccCCCccccccccccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCC
Q 039290          266 EIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISE  345 (1049)
Q Consensus       266 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  345 (1049)
                      .+..+++|+.|++++|.+... | .+..+++|++|++++|++.+ +|.  +..+++|++|++++|.+++ +| .+..+++
T Consensus        39 ~~~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~-~~~--~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~  111 (347)
T 4fmz_A           39 TQEELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITD-ISP--LSNLVKLTNLYIGTNKITD-IS-ALQNLTN  111 (347)
T ss_dssp             CHHHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTT
T ss_pred             cchhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCcccc-chh--hhcCCcCCEEEccCCcccC-ch-HHcCCCc
Confidence            467899999999999999865 4 48899999999999999984 554  5589999999999999985 44 6999999


Q ss_pred             CceeecccCccccCcccccccccccceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCcccccccccc
Q 039290          346 LSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMK  425 (1049)
Q Consensus       346 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~  425 (1049)
                      |++|++++|.+.+..+  +..+++|++|++++|......      ..+..+++|++|++++|.+.+..+           
T Consensus       112 L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~------~~~~~l~~L~~L~l~~~~~~~~~~-----------  172 (347)
T 4fmz_A          112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDL------SPLSNMTGLNYLTVTESKVKDVTP-----------  172 (347)
T ss_dssp             CSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCC------GGGTTCTTCCEEECCSSCCCCCGG-----------
T ss_pred             CCEEECcCCcccCchh--hccCCceeEEECCCCCCcccc------cchhhCCCCcEEEecCCCcCCchh-----------
Confidence            9999999999997643  899999999999999654422      236778888888888887764321           


Q ss_pred             EEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcc
Q 039290          426 SLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNK  505 (1049)
Q Consensus       426 ~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  505 (1049)
                                      +..+++|++|++++|.+++..+  +..+++|+.|++++|++++..+  +..+++|++|++++|+
T Consensus       173 ----------------~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~  232 (347)
T 4fmz_A          173 ----------------IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNK  232 (347)
T ss_dssp             ----------------GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSC
T ss_pred             ----------------hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCc
Confidence                            5566777777777777774333  7777888888888888775433  7777888888888888


Q ss_pred             cCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeeccccccccccccc
Q 039290          506 LSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVT  585 (1049)
Q Consensus       506 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  585 (1049)
                      +++..+  +..+++|++|++++|++++.  ..+..+++|++|++++|++++.  +.+..+++|++|++++|++++..|..
T Consensus       233 l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~  306 (347)
T 4fmz_A          233 ITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEV  306 (347)
T ss_dssp             CCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHH
T ss_pred             cCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhH
Confidence            875433  77888888888888888874  4677888888888888888874  46888899999999999999999999


Q ss_pred             ccCCCcccEEEeecccccCCccccccCccCCcEEeccCcccc
Q 039290          586 IGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLS  627 (1049)
Q Consensus       586 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  627 (1049)
                      |+.+++|+.|+|++|++++..|  +..+++|++||+++|+|+
T Consensus       307 l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          307 IGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             HHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             hhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            9999999999999999998777  889999999999999986

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=5.8e-32  Score=303.67  Aligned_cols=288  Identities=24%  Similarity=0.312  Sum_probs=172.2

Q ss_pred             ccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCcccccccccccceeec
Q 039290          296 TLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSL  375 (1049)
Q Consensus       296 ~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  375 (1049)
                      +++.+++++|.+. .+|..++   ++|+.|++++|++++..|..|.++++|++|++++|++++..|..|+++++|++|++
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  109 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI  109 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred             cCCEEECCCCCcc-ccCCCCC---CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence            5677777777765 5666543   56777777777777655666777777777777777777666666666666666666


Q ss_pred             ccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccC
Q 039290          376 AGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGN  455 (1049)
Q Consensus       376 ~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~  455 (1049)
                      ++|.++.++...                              .   .+|++|++++|++++..+..|.++++|+.|++++
T Consensus       110 ~~n~l~~l~~~~------------------------------~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~  156 (332)
T 2ft3_A          110 SKNHLVEIPPNL------------------------------P---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGG  156 (332)
T ss_dssp             CSSCCCSCCSSC------------------------------C---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCS
T ss_pred             CCCcCCccCccc------------------------------c---ccCCEEECCCCccCccCHhHhCCCccCCEEECCC
Confidence            666665544321                              1   1444444444444444444566677777777777


Q ss_pred             Ccccc--cCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccc
Q 039290          456 NELTG--TIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSI  533 (1049)
Q Consensus       456 N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  533 (1049)
                      |.++.  ..|..+..+ +|++|++++|++++ +|..+.  ++                        |++|++++|++++.
T Consensus       157 n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~------------------------L~~L~l~~n~i~~~  208 (332)
T 2ft3_A          157 NPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ET------------------------LNELHLDHNKIQAI  208 (332)
T ss_dssp             CCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SS------------------------CSCCBCCSSCCCCC
T ss_pred             CccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CC------------------------CCEEECCCCcCCcc
Confidence            77752  555666666 66666666666663 343332  34                        44455555555544


Q ss_pred             cCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCc
Q 039290          534 IPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGL  613 (1049)
Q Consensus       534 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  613 (1049)
                      .|..+..+++|++|++++|++++..+..+..+++|++|+|++|+++ .+|..+..+++|+.|++++|+|++..+..|...
T Consensus       209 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~  287 (332)
T 2ft3_A          209 ELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPV  287 (332)
T ss_dssp             CTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCS
T ss_pred             CHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHcccc
Confidence            4445555555555555555555544445555555566666666665 455556666666666666666666555555443


Q ss_pred             ------cCCcEEeccCcccc--CCcccccccccccceeeccCCc
Q 039290          614 ------KSLNFVDMSNNNLS--GTIPKSMEALSYLKHLNLSFNQ  649 (1049)
Q Consensus       614 ------~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~l~l~~N~  649 (1049)
                            .+|+.|++++|++.  +..|..+..+++|+.+++++|+
T Consensus       288 ~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          288 GFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             SCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             ccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence                  45677777777766  4566667777777777777664

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=6.6e-32  Score=303.22  Aligned_cols=297  Identities=25%  Similarity=0.304  Sum_probs=229.3

Q ss_pred             cceEEEeeccccCCCccccccccccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceee
Q 039290          271 RNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLD  350 (1049)
Q Consensus       271 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  350 (1049)
                      .+++.++++++.+.. +|..+.  ++|+.|++++|++.+..|.. +..+++|++|+|++|++++..|..|+++++|++|+
T Consensus        33 c~l~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~i~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  108 (332)
T 2ft3_A           33 CHLRVVQCSDLGLKA-VPKEIS--PDTTLLDLQNNDISELRKDD-FKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLY  108 (332)
T ss_dssp             EETTEEECCSSCCSS-CCSCCC--TTCCEEECCSSCCCEECTTT-TTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEE
T ss_pred             ccCCEEECCCCCccc-cCCCCC--CCCeEEECCCCcCCccCHhH-hhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEE
Confidence            478999999999884 566553  68999999999998544444 45899999999999999988899999999999999


Q ss_pred             cccCccccCcccccccccccceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEcc
Q 039290          351 FGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSME  430 (1049)
Q Consensus       351 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~  430 (1049)
                      +++|++.. +|..+.  ++|++|++++|.++.+++.     .+..+++|+.|++++|.++.                   
T Consensus       109 L~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~-----~~~~l~~L~~L~l~~n~l~~-------------------  161 (332)
T 2ft3_A          109 ISKNHLVE-IPPNLP--SSLVELRIHDNRIRKVPKG-----VFSGLRNMNCIEMGGNPLEN-------------------  161 (332)
T ss_dssp             CCSSCCCS-CCSSCC--TTCCEEECCSSCCCCCCSG-----GGSSCSSCCEEECCSCCCBG-------------------
T ss_pred             CCCCcCCc-cCcccc--ccCCEEECCCCccCccCHh-----HhCCCccCCEEECCCCcccc-------------------
Confidence            99999995 455554  8999999999999887654     26667777777777776642                   


Q ss_pred             CCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcC
Q 039290          431 SCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRL  510 (1049)
Q Consensus       431 ~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  510 (1049)
                          .+..|..+..+ +|++|++++|++++ +|..+.  ++|++|++++|++++..+..+..+++|+.|++++|++++..
T Consensus       162 ----~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~  233 (332)
T 2ft3_A          162 ----SGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIE  233 (332)
T ss_dssp             ----GGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCC
T ss_pred             ----CCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCC
Confidence                13677888888 99999999999995 666554  79999999999999877788888888888888888888777


Q ss_pred             chhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCC
Q 039290          511 PACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQ  590 (1049)
Q Consensus       511 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  590 (1049)
                      +..+..+++|++|++++|+++. +|..+..+++|++|++++|++++..+..|....                +  -....
T Consensus       234 ~~~~~~l~~L~~L~L~~N~l~~-lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~----------------~--~~~~~  294 (332)
T 2ft3_A          234 NGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVG----------------F--GVKRA  294 (332)
T ss_dssp             TTGGGGCTTCCEEECCSSCCCB-CCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSS----------------C--CSSSC
T ss_pred             hhHhhCCCCCCEEECCCCcCee-cChhhhcCccCCEEECCCCCCCccChhHccccc----------------c--ccccc
Confidence            7778888888888888888874 566677777777777777777655444443211                0  01135


Q ss_pred             cccEEEeeccccc--CCccccccCccCCcEEeccCcc
Q 039290          591 GLQLLSLRYNRLQ--GPIPESFGGLKSLNFVDMSNNN  625 (1049)
Q Consensus       591 ~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~Ls~N~  625 (1049)
                      .|+.|++++|.+.  +..|..|..+++|+.+++++|+
T Consensus       295 ~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          295 YYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             CBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             cccceEeecCcccccccCcccccccchhhhhhccccc
Confidence            6777888888776  5677778888888888888774

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1e-33  Score=318.72  Aligned_cols=245  Identities=16%  Similarity=0.171  Sum_probs=186.2

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccC--------CCHHHHHHHHHHHhhcC---------CCceeeE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFD--------GSLESFHAECKVMGSIR---------HRNLVKI  822 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~---------hpniv~l  822 (1049)
                      .++|++.+.||+|+||+||+|+. +|+.||||+++....        ...+.+.+|+++++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35688899999999999999998 789999999976532        23478899999999886         6666655


Q ss_pred             Eee-----------------eec-------------CCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHH
Q 039290          823 ISS-----------------CSN-------------NDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALE  872 (1049)
Q Consensus       823 ~~~-----------------~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~  872 (1049)
                      .++                 +.+             .+..++||||+++|++.+.+..  ..+++.+++.++.||+.||+
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence            554                 333             6789999999999976666643  35799999999999999999


Q ss_pred             HhHccCCCCeEEcCCCCCCeeecCCC--------------------ceEEecccCceecCCCccccccccccccCccccc
Q 039290          873 YLHFGYSTPIVHCDIKPSNVLLNESM--------------------VGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE  932 (1049)
Q Consensus       873 ~LH~~~~~~ivH~Dlkp~NIl~~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE  932 (1049)
                      |||+  ++||+||||||+|||++.++                    .+||+|||+|+.....      ..+||+.|+|||
T Consensus       176 ~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE  247 (336)
T 2vuw_A          176 VAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDED  247 (336)
T ss_dssp             HHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSG
T ss_pred             HHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChh
Confidence            9992  37899999999999999876                    8999999999876432      347899999999


Q ss_pred             ccCCCCcCcccchHHHHHH-HHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHH
Q 039290          933 YGREGKVSRKCDVYSYGIM-LMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSI 1011 (1049)
Q Consensus       933 ~~~~~~~~~~~DvwslG~i-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1011 (1049)
                      ++.+.. +.++||||+|++ .+++++|..||...        .|.....     ..+.... ..............++++
T Consensus       248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~--------~~~~~~~-----~~~~~~~-~~~~~~~~~~~~~~s~~~  312 (336)
T 2vuw_A          248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV--------LWLHYLT-----DKMLKQM-TFKTKCNTPAMKQIKRKI  312 (336)
T ss_dssp             GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--------HHHHHHH-----HHHHHTC-CCSSCCCSHHHHHHHHHH
T ss_pred             hhcCCC-ccceehhhhhCCCCcccccccCCCcch--------hhhhHHH-----Hhhhhhh-ccCcccchhhhhhcCHHH
Confidence            998765 899999998777 77889999998541        1100000     0000000 000111223445688899


Q ss_pred             HHHHhhccccCCCCCCCHHHHH-HH
Q 039290         1012 FSLAMDCTVDLPEKRISMKDVA-NR 1035 (1049)
Q Consensus      1012 ~~li~~cl~~dP~~Rpt~~ell-~~ 1035 (1049)
                      .+++.+||+.|     |++|++ +|
T Consensus       313 ~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          313 QEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHGGGSS-----SHHHHHHHC
T ss_pred             HHHHHHHhccC-----CHHHHHhcC
Confidence            99999999976     999998 64

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.98  E-value=1.1e-31  Score=301.12  Aligned_cols=288  Identities=21%  Similarity=0.282  Sum_probs=173.0

Q ss_pred             ccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCcccccccccccceeec
Q 039290          296 TLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSL  375 (1049)
Q Consensus       296 ~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  375 (1049)
                      +++.++++++.+. .+|..+.   ++|+.|+|++|++++..+..|.++++|++|++++|.+++..|..|+++++|++|++
T Consensus        32 ~l~~l~~~~~~l~-~lp~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  107 (330)
T 1xku_A           32 HLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL  107 (330)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             CCeEEEecCCCcc-ccCccCC---CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence            5667777777665 5665543   57788888888888766667888888888888888888777777888888888887


Q ss_pred             ccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccC
Q 039290          376 AGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGN  455 (1049)
Q Consensus       376 ~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~  455 (1049)
                      ++|.++.++...        .++|++|                         ++++|.+++..+..|.++++|++|++++
T Consensus       108 s~n~l~~l~~~~--------~~~L~~L-------------------------~l~~n~l~~~~~~~~~~l~~L~~L~l~~  154 (330)
T 1xku_A          108 SKNQLKELPEKM--------PKTLQEL-------------------------RVHENEITKVRKSVFNGLNQMIVVELGT  154 (330)
T ss_dssp             CSSCCSBCCSSC--------CTTCCEE-------------------------ECCSSCCCBBCHHHHTTCTTCCEEECCS
T ss_pred             CCCcCCccChhh--------cccccEE-------------------------ECCCCcccccCHhHhcCCccccEEECCC
Confidence            777776654431        0334444                         4444444444444556666777777777


Q ss_pred             Ccccc--cCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccc
Q 039290          456 NELTG--TIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSI  533 (1049)
Q Consensus       456 N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  533 (1049)
                      |.++.  ..+..+..+++|++|++++|+++ .+|..+.  ++|++|++++|++++..|..+.++++|++|++++|++++.
T Consensus       155 n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~  231 (330)
T 1xku_A          155 NPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV  231 (330)
T ss_dssp             SCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEE
T ss_pred             CcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCcee
Confidence            76643  45566666677777777777666 3444333  5566666666666655556666666666666666666655


Q ss_pred             cCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccC-
Q 039290          534 IPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGG-  612 (1049)
Q Consensus       534 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-  612 (1049)
                      .+..+..+++|++|++++|+++                         .+|..+..+++|+.|+|++|+|++..+..|.. 
T Consensus       232 ~~~~~~~l~~L~~L~L~~N~l~-------------------------~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~  286 (330)
T 1xku_A          232 DNGSLANTPHLRELHLNNNKLV-------------------------KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPP  286 (330)
T ss_dssp             CTTTGGGSTTCCEEECCSSCCS-------------------------SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCS
T ss_pred             ChhhccCCCCCCEEECCCCcCc-------------------------cCChhhccCCCcCEEECCCCcCCccChhhcCCc
Confidence            5555555555555555555554                         33344444444444444444444444444432 


Q ss_pred             -----ccCCcEEeccCccccC--CcccccccccccceeeccCC
Q 039290          613 -----LKSLNFVDMSNNNLSG--TIPKSMEALSYLKHLNLSFN  648 (1049)
Q Consensus       613 -----l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~l~l~~N  648 (1049)
                           ...|+.|++++|++..  ..|..+..+.+++.++|++|
T Consensus       287 ~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N  329 (330)
T 1xku_A          287 GYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY  329 (330)
T ss_dssp             SCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC---
T ss_pred             ccccccccccceEeecCcccccccCccccccccceeEEEeccc
Confidence                 2455556666665542  34445555666666666655

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.98  E-value=3.2e-31  Score=297.42  Aligned_cols=289  Identities=24%  Similarity=0.308  Sum_probs=186.1

Q ss_pred             ccceecccccccccccCCCCccccccceEEeccccccccCccccccccceEEEeeccccCCCccccccccccccceEEec
Q 039290          224 ELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVT  303 (1049)
Q Consensus       224 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~  303 (1049)
                      ++++++++++.++ .+|..+.  +++++|+|++|++++..+..|+++++|++|+|++|++++..|..+.++++|++|+++
T Consensus        32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  108 (330)
T 1xku_A           32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS  108 (330)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence            4555555555554 3454443  466677777777776555567777777777777777777667777777777777777


Q ss_pred             cCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCcccc--Ccccccccccccceeeccccccc
Q 039290          304 DNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSG--LIPTTFGNLRSLKLLSLAGNVLT  381 (1049)
Q Consensus       304 ~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~  381 (1049)
                      +|++. .+|..++   ++|++|++++|++++..+..+.++++|++|++++|.+..  ..+..|.++++|++|++++|.++
T Consensus       109 ~n~l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~  184 (330)
T 1xku_A          109 KNQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT  184 (330)
T ss_dssp             SSCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred             CCcCC-ccChhhc---ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc
Confidence            77776 5666554   678888888888887777778888888888888888853  56677777888888888888777


Q ss_pred             CCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCccccc
Q 039290          382 SPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGT  461 (1049)
Q Consensus       382 ~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~  461 (1049)
                      .++...        .++|++|++++|++++                         ..|..|..+++|++|+|++|.+++.
T Consensus       185 ~l~~~~--------~~~L~~L~l~~n~l~~-------------------------~~~~~~~~l~~L~~L~Ls~n~l~~~  231 (330)
T 1xku_A          185 TIPQGL--------PPSLTELHLDGNKITK-------------------------VDAASLKGLNNLAKLGLSFNSISAV  231 (330)
T ss_dssp             SCCSSC--------CTTCSEEECTTSCCCE-------------------------ECTGGGTTCTTCCEEECCSSCCCEE
T ss_pred             cCCccc--------cccCCEEECCCCcCCc-------------------------cCHHHhcCCCCCCEEECCCCcCcee
Confidence            655432        1445555555555544                         4444555555666666666666655


Q ss_pred             CCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccC------cccCCceeecCccccc--c
Q 039290          462 IPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGN------LTSLRDLSLGSNALTS--I  533 (1049)
Q Consensus       462 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~------l~~L~~L~L~~N~l~~--~  533 (1049)
                      .+..+..+++|++|+|++|+++ .+|..+..+++|++|++++|++++..+..|..      .+.|+.|++++|.+..  +
T Consensus       232 ~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i  310 (330)
T 1xku_A          232 DNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEI  310 (330)
T ss_dssp             CTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGS
T ss_pred             ChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCccccccc
Confidence            5555666666666666666665 45555666666666666666666544444432      2556677777776653  4


Q ss_pred             cCcccccccccccccccCCc
Q 039290          534 IPSTLWNLKDILRFNLSSNS  553 (1049)
Q Consensus       534 ~p~~~~~l~~L~~L~Ls~N~  553 (1049)
                      .|..|..+.+++.++|++|+
T Consensus       311 ~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          311 QPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             CGGGGTTCCCGGGEEC----
T ss_pred             CccccccccceeEEEecccC
Confidence            55667777777777777764

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=1.2e-35  Score=350.35  Aligned_cols=385  Identities=20%  Similarity=0.171  Sum_probs=217.0

Q ss_pred             ccceEEeccccccccCccc-cccccceEEEeeccccCCC----ccccccccccccceEEeccCccCCCCCCcccCCCC--
Q 039290          248 SVRNLFLGNNSLIGEIPNE-IGNLRNLEVLGVQSSNLAG----LIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLP--  320 (1049)
Q Consensus       248 ~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~--  320 (1049)
                      +|++|||++|+++...... +..+++|++|+|++|++.+    .++..+..+++|++|++++|.+....+..+...++  
T Consensus         4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~   83 (461)
T 1z7x_W            4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   83 (461)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence            4455555555544322222 4445555555555555543    23444444555555555555554322222222333  


Q ss_pred             --CccEEEcCCCCCCC----CCCccccCCCCCceeecccCccccCcccccc-----cccccceeecccccccCCCCCccc
Q 039290          321 --NLERLFLGENNFSG----TIPSSLTNISELSVLDFGFNSFSGLIPTTFG-----NLRSLKLLSLAGNVLTSPTPDLSF  389 (1049)
Q Consensus       321 --~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~~~~~~~~  389 (1049)
                        +|++|+|++|+++.    .++..+..+++|++|++++|.+.+..+..+.     ..++|++|++++|.++..... ..
T Consensus        84 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~-~l  162 (461)
T 1z7x_W           84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE-PL  162 (461)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH-HH
T ss_pred             CCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHH-HH
Confidence              57777777777773    4577777788888888888887654333332     245677777777776643211 01


Q ss_pred             ccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCccccc----CCcc
Q 039290          390 LSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGT----IPVT  465 (1049)
Q Consensus       390 l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~  465 (1049)
                      ...+..+++|+.|++++|.+....+..+.....                    ...++|++|+|++|.+++.    ++..
T Consensus       163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~--------------------~~~~~L~~L~L~~n~l~~~~~~~l~~~  222 (461)
T 1z7x_W          163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLK--------------------DSPCQLEALKLESCGVTSDNCRDLCGI  222 (461)
T ss_dssp             HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHH--------------------HSCCCCCEEECTTSCCBTTHHHHHHHH
T ss_pred             HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHh--------------------cCCCCceEEEccCCCCcHHHHHHHHHH
Confidence            223455677777777777765432222211000                    0123455555555555432    2444


Q ss_pred             ccCcCCCcceEeeccccCCCC-----CcccccccccceEEeeCcccCCc----CchhccCcccCCceeecCcccccccCc
Q 039290          466 LGRLQKLQGLYLQNNKLEGSI-----PEDLCHLYRLANLYLGDNKLSGR----LPACLGNLTSLRDLSLGSNALTSIIPS  536 (1049)
Q Consensus       466 ~~~l~~L~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~  536 (1049)
                      +..+++|++|++++|++++..     +..+..+++|++|++++|.++..    ++..+..+++|++|++++|++++..+.
T Consensus       223 l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~  302 (461)
T 1z7x_W          223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR  302 (461)
T ss_dssp             HHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred             HHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHH
Confidence            445555555555555554321     11122355666666666666532    455555566666666666666554443


Q ss_pred             ccccc-----cccccccccCCccCCC----CccCcCCCcceeEeecccccccccccccccC-----CCcccEEEeecccc
Q 039290          537 TLWNL-----KDILRFNLSSNSLNGS----LLPDIGNLKVVIEMDLSLNALSGVIPVTIGG-----LQGLQLLSLRYNRL  602 (1049)
Q Consensus       537 ~~~~l-----~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l  602 (1049)
                      .+...     ++|++|++++|.+++.    ++..+..+++|++||+++|++++..+..+..     .++|+.|+|++|++
T Consensus       303 ~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i  382 (461)
T 1z7x_W          303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV  382 (461)
T ss_dssp             HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred             HHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCC
Confidence            33332     4667777777766654    3444556677777788888777655554443     56888888888888


Q ss_pred             cC----CccccccCccCCcEEeccCccccCCcccccc-----cccccceeeccCCccccc
Q 039290          603 QG----PIPESFGGLKSLNFVDMSNNNLSGTIPKSME-----ALSYLKHLNLSFNQLEGE  653 (1049)
Q Consensus       603 ~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~l~l~~N~l~~~  653 (1049)
                      ++    .+|..+..+++|++|||++|++++.-...+.     ...+|+.|++.+|.+...
T Consensus       383 ~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~  442 (461)
T 1z7x_W          383 SDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE  442 (461)
T ss_dssp             CHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred             ChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHH
Confidence            86    6777788888888888888888754222221     123577777777766543

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.97  E-value=5.8e-33  Score=310.25  Aligned_cols=235  Identities=23%  Similarity=0.341  Sum_probs=121.2

Q ss_pred             cCCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCc
Q 039290          121 RGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPV  200 (1049)
Q Consensus       121 ~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~  200 (1049)
                      .++++|+|++|++. .+|..++++++|++|+|++|.++ .+|..++.+++|++|+|++|+++ .+|..+.+      +++
T Consensus        81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~------l~~  151 (328)
T 4fcg_A           81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIAS------LNR  151 (328)
T ss_dssp             TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGG------CTT
T ss_pred             cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhc------CcC
Confidence            34455555555554 44555555555555555555555 45555555555555555555555 44544432      233


Q ss_pred             cceEEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceEEeccccccccCccccccccceEEEeecc
Q 039290          201 LEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQS  280 (1049)
Q Consensus       201 L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~  280 (1049)
                      |++|++++|++.+.+|..+...               .++..|+++++|++|+|++|+++ .+|..++++++|++|+|++
T Consensus       152 L~~L~L~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~  215 (328)
T 4fcg_A          152 LRELSIRACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRN  215 (328)
T ss_dssp             CCEEEEEEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEES
T ss_pred             CCEEECCCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccC
Confidence            5555555555555555444320               11222334444444444444444 4444444444444444444


Q ss_pred             ccCCCccccccccccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCc
Q 039290          281 SNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLI  360 (1049)
Q Consensus       281 n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  360 (1049)
                      |++++ +|..+..+++|++|++++|++.+.+|..+. .+++|++|+|++|++.+.+|..+.++++|++|+|++|++.+.+
T Consensus       216 N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~-~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~i  293 (328)
T 4fcg_A          216 SPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFG-GRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRL  293 (328)
T ss_dssp             SCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTT-CCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCC
T ss_pred             CCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhc-CCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhc
Confidence            44443 233344445555555555555544444433 4555666666666666666666666666666666666666666


Q ss_pred             ccccccccccceeecccccccC
Q 039290          361 PTTFGNLRSLKLLSLAGNVLTS  382 (1049)
Q Consensus       361 p~~~~~l~~L~~L~L~~N~l~~  382 (1049)
                      |..++++++|+.+++..|.+..
T Consensus       294 P~~l~~L~~L~~l~l~~~~~~~  315 (328)
T 4fcg_A          294 PSLIAQLPANCIILVPPHLQAQ  315 (328)
T ss_dssp             CGGGGGSCTTCEEECCGGGSCC
T ss_pred             cHHHhhccCceEEeCCHHHHHH
Confidence            6666666666666666665544

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=1.8e-34  Score=340.24  Aligned_cols=357  Identities=18%  Similarity=0.212  Sum_probs=255.0

Q ss_pred             ccceEEEeeccccCCCccccc-cccccccceEEeccCccCCC----CCCcccCCCCCccEEEcCCCCCCCCCCcccc-CC
Q 039290          270 LRNLEVLGVQSSNLAGLIPAS-IFNISTLKELAVTDNDLLGS----LPSSIDLGLPNLERLFLGENNFSGTIPSSLT-NI  343 (1049)
Q Consensus       270 l~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~----~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l  343 (1049)
                      +++|+.|+|++|+++...... +..+++|++|++++|.+...    ++..+ ..+++|++|+|++|.+++..+..+. .+
T Consensus         2 ~~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l-~~~~~L~~L~Ls~n~l~~~~~~~l~~~l   80 (461)
T 1z7x_W            2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSAL-RVNPALAELNLRSNELGDVGVHCVLQGL   80 (461)
T ss_dssp             CEEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHH-HTCTTCCEEECTTCCCHHHHHHHHHHTT
T ss_pred             CccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHH-HhCCCcCEEeCCCCcCChHHHHHHHHHH
Confidence            357888888888887654433 66777888888888776531    22222 2456677777777776543332222 23


Q ss_pred             C----CCceeecccCcccc----CcccccccccccceeecccccccCCCCCcccccc-cccCCCCcEEEccCCccccCCC
Q 039290          344 S----ELSVLDFGFNSFSG----LIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSS-LTSCRNLEIIYLSENPINGILP  414 (1049)
Q Consensus       344 ~----~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~-l~~l~~L~~L~Ls~N~i~~~~p  414 (1049)
                      +    +|++|++++|+++.    .++..+..+++|++|++++|.++...... .... ....+                 
T Consensus        81 ~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~-l~~~l~~~~~-----------------  142 (461)
T 1z7x_W           81 QTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQL-LCEGLLDPQC-----------------  142 (461)
T ss_dssp             CSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHH-HHHHHTSTTC-----------------
T ss_pred             hhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHH-HHHHHhcCCC-----------------
Confidence            3    46667777666663    33555666666666666666554311100 0000 11123                 


Q ss_pred             CccccccccccEEEccCCccccC----CCCCCCCCCCccEEEccCCcccccCCccccC-----cCCCcceEeeccccCCC
Q 039290          415 SSIGNFSISMKSLSMESCNISGG----IPKELGNINNLTVIRLGNNELTGTIPVTLGR-----LQKLQGLYLQNNKLEGS  485 (1049)
Q Consensus       415 ~~~~~~~~~L~~L~L~~n~i~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~  485 (1049)
                              +|++|++++|++++.    ++..+..+++|++|+|++|.+++..+..+..     .++|++|+|++|++++.
T Consensus       143 --------~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~  214 (461)
T 1z7x_W          143 --------RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSD  214 (461)
T ss_dssp             --------CCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTT
T ss_pred             --------cceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHH
Confidence                    355555555555442    3445666789999999999998655555443     56999999999999864


Q ss_pred             ----CCcccccccccceEEeeCcccCCcC-----chhccCcccCCceeecCcccccc----cCcccccccccccccccCC
Q 039290          486 ----IPEDLCHLYRLANLYLGDNKLSGRL-----PACLGNLTSLRDLSLGSNALTSI----IPSTLWNLKDILRFNLSSN  552 (1049)
Q Consensus       486 ----~~~~~~~l~~L~~L~L~~N~l~~~~-----p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N  552 (1049)
                          ++..+..+++|++|++++|++++..     +..+..+++|++|++++|++++.    ++..+..+++|++|++++|
T Consensus       215 ~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n  294 (461)
T 1z7x_W          215 NCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGN  294 (461)
T ss_dssp             HHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTC
T ss_pred             HHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCC
Confidence                5777888999999999999987543     33344689999999999999975    5777888999999999999


Q ss_pred             ccCCCCccCcCC-----CcceeEeeccccccccc----ccccccCCCcccEEEeecccccCCccccccC-----ccCCcE
Q 039290          553 SLNGSLLPDIGN-----LKVVIEMDLSLNALSGV----IPVTIGGLQGLQLLSLRYNRLQGPIPESFGG-----LKSLNF  618 (1049)
Q Consensus       553 ~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~  618 (1049)
                      .+++..+..+..     .++|++|++++|.+++.    ++..+..+++|+.|+|++|++++..+..+..     .++|++
T Consensus       295 ~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~  374 (461)
T 1z7x_W          295 ELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRV  374 (461)
T ss_dssp             CCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCE
T ss_pred             CCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEE
Confidence            997654444433     36999999999999976    5677888899999999999999766655543     679999


Q ss_pred             EeccCccccC----CcccccccccccceeeccCCccccc
Q 039290          619 VDMSNNNLSG----TIPKSMEALSYLKHLNLSFNQLEGE  653 (1049)
Q Consensus       619 L~Ls~N~l~~----~~p~~~~~l~~L~~l~l~~N~l~~~  653 (1049)
                      |+|++|++++    .+|..+..+++|++|++++|++++.
T Consensus       375 L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~  413 (461)
T 1z7x_W          375 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA  413 (461)
T ss_dssp             EECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred             EECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence            9999999996    7888999999999999999999864

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=1.2e-30  Score=295.50  Aligned_cols=288  Identities=20%  Similarity=0.190  Sum_probs=198.0

Q ss_pred             cCCCCCCCceeeeEEEcCCCCcEEEEEEeccccccccCCCCCCcchhhhhhcccCccccccCcccccccCCcEeccccCC
Q 039290           53 NWSTTSSVCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNN  132 (1049)
Q Consensus        53 ~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~  132 (1049)
                      .|.....+|.|.|+ |+.          ++++++ .+|..+.  +.|++|++++|++++..+..++++++|++|++++|+
T Consensus        22 ~~~~~~~~C~~~~~-c~~----------~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~   87 (353)
T 2z80_A           22 SSNQASLSCDRNGI-CKG----------SSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNG   87 (353)
T ss_dssp             -----CCEECTTSE-EEC----------CSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred             CCCccCCCCCCCeE-eeC----------CCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCc
Confidence            45555678999998 754          455666 7887665  488999999999886555588899999999999999


Q ss_pred             ccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCC-CcccccccCCCCccceEEeeccc-
Q 039290          133 FHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPS-SIFNISSCQNLPVLEGLFISYNQ-  210 (1049)
Q Consensus       133 ~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~-~~~~l~~l~~l~~L~~L~l~~N~-  210 (1049)
                      +++..|..|+++++|++|+|++|++++..+..++.+++|++|+|++|+++ .+|. ..     +..+++|++|++++|+ 
T Consensus        88 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~-----~~~l~~L~~L~l~~n~~  161 (353)
T 2z80_A           88 INTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSL-----FSHLTKLQILRVGNMDT  161 (353)
T ss_dssp             CCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCS-----CTTCTTCCEEEEEESSS
T ss_pred             cCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhh-----hccCCCCcEEECCCCcc
Confidence            98888888999999999999999998655555888999999999999988 5665 22     2345678888888884 


Q ss_pred             cCCCCCCCcccccccceecccccccccccCCCCccccccceEEeccccccccCccccccccceEEEeeccccCCCccccc
Q 039290          211 LTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPAS  290 (1049)
Q Consensus       211 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~  290 (1049)
                      +++..|..+..+++|+.|++++|++++..|..++++++|++|++++|+++...+..++.+++|+.|++++|++++..+..
T Consensus       162 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~  241 (353)
T 2z80_A          162 FTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSE  241 (353)
T ss_dssp             CCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC-
T ss_pred             ccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccc
Confidence            66555666777777777777777777777777777777777777777776333333445777777777777776654433


Q ss_pred             cccccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCC----CCCccccCCCCCceeecccCccccCccccccc
Q 039290          291 IFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSG----TIPSSLTNISELSVLDFGFNSFSGLIPTTFGN  366 (1049)
Q Consensus       291 ~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  366 (1049)
                      +...                      ...+.++.++|+++.+++    .+|..+..+++|++|++++|+++...+..|..
T Consensus       242 l~~~----------------------~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~  299 (353)
T 2z80_A          242 LSTG----------------------ETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDR  299 (353)
T ss_dssp             ---------------------------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred             cccc----------------------cccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhc
Confidence            3210                      112345555555555553    24556666667777777777776443333566


Q ss_pred             ccccceeecccccccC
Q 039290          367 LRSLKLLSLAGNVLTS  382 (1049)
Q Consensus       367 l~~L~~L~L~~N~l~~  382 (1049)
                      +++|++|++++|.++.
T Consensus       300 l~~L~~L~L~~N~~~~  315 (353)
T 2z80_A          300 LTSLQKIWLHTNPWDC  315 (353)
T ss_dssp             CTTCCEEECCSSCBCC
T ss_pred             CCCCCEEEeeCCCccC
Confidence            7777777777776654

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.96  E-value=6.1e-30  Score=289.84  Aligned_cols=281  Identities=19%  Similarity=0.219  Sum_probs=193.6

Q ss_pred             CCCCCceeecccCccccCcccccccccccceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCcccccc
Q 039290          342 NISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFS  421 (1049)
Q Consensus       342 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~  421 (1049)
                      .++.....++++|.++. +|..+.  ++|++|++++|.++.++++     .+..+++                       
T Consensus        29 ~C~~~~~c~~~~~~l~~-iP~~~~--~~L~~L~l~~n~i~~~~~~-----~~~~l~~-----------------------   77 (353)
T 2z80_A           29 SCDRNGICKGSSGSLNS-IPSGLT--EAVKSLDLSNNRITYISNS-----DLQRCVN-----------------------   77 (353)
T ss_dssp             EECTTSEEECCSTTCSS-CCTTCC--TTCCEEECTTSCCCEECTT-----TTTTCTT-----------------------
T ss_pred             CCCCCeEeeCCCCCccc-cccccc--ccCcEEECCCCcCcccCHH-----HhccCCC-----------------------
Confidence            34445556666666663 344333  3555556655555544332     1344444                       


Q ss_pred             ccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCC-cccccccccceEE
Q 039290          422 ISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIP-EDLCHLYRLANLY  500 (1049)
Q Consensus       422 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~  500 (1049)
                        |++|++++|++++..|..|.++++|++|+|++|++++..+..|+.+++|++|+|++|++++..+ ..+..+++|++|+
T Consensus        78 --L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~  155 (353)
T 2z80_A           78 --LQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILR  155 (353)
T ss_dssp             --CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEE
T ss_pred             --CCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEE
Confidence              5555555555555555667777777777777777775444457777777777777777774333 3677777777777


Q ss_pred             eeCc-ccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeeccccccc
Q 039290          501 LGDN-KLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALS  579 (1049)
Q Consensus       501 L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  579 (1049)
                      +++| .+.+..+..++++++|++|++++|++++..|..+..+++|++|++++|.++......+..+++|++|++++|+++
T Consensus       156 l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~  235 (353)
T 2z80_A          156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLD  235 (353)
T ss_dssp             EEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCT
T ss_pred             CCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccc
Confidence            7777 455555667777777777777777777777777777777777777777776543334455777888888888887


Q ss_pred             cccccccc---CCCcccEEEeecccccC----CccccccCccCCcEEeccCccccCCcccc-cccccccceeeccCCccc
Q 039290          580 GVIPVTIG---GLQGLQLLSLRYNRLQG----PIPESFGGLKSLNFVDMSNNNLSGTIPKS-MEALSYLKHLNLSFNQLE  651 (1049)
Q Consensus       580 ~~~p~~~~---~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~l~l~~N~l~  651 (1049)
                      +..+..+.   ....++.++|++|.+++    .+|..+.++++|++|||++|+++ .+|.. +..+++|++|++++|++.
T Consensus       236 ~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~  314 (353)
T 2z80_A          236 TFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD  314 (353)
T ss_dssp             TCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             cccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCcc
Confidence            66554433   35678888999988876    47888999999999999999999 56655 589999999999999999


Q ss_pred             ccCCC
Q 039290          652 GEIPT  656 (1049)
Q Consensus       652 ~~~p~  656 (1049)
                      |.+|.
T Consensus       315 ~~~~~  319 (353)
T 2z80_A          315 CSCPR  319 (353)
T ss_dssp             CCHHH
T ss_pred             CcCCC
Confidence            98873

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=1.1e-29  Score=281.78  Aligned_cols=252  Identities=23%  Similarity=0.252  Sum_probs=157.4

Q ss_pred             CceeeeEEEcCCCCcEEEEEEeccccccccCCCCCCcchhhhhhcccCccccccCcc-cccccCCcEeccccCCcc--cc
Q 039290           60 VCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEE-LSHLRGLKYFDFRFNNFH--IE  136 (1049)
Q Consensus        60 ~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~~-~~~L~~L~~L~l~~n~~~--~~  136 (1049)
                      .|.|.+|.|+..            +++ .+|..+.  +.|++|+|++|+++ .+|.. ++++++|++|+|++|++.  +.
T Consensus         6 ~C~~~~l~c~~~------------~l~-~ip~~~~--~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~   69 (306)
T 2z66_A            6 SCSGTEIRCNSK------------GLT-SVPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGC   69 (306)
T ss_dssp             EEETTEEECCSS------------CCS-SCCSCCC--TTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEE
T ss_pred             eeCCCEEEcCCC------------Ccc-cCCCCCC--CCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccC
Confidence            389999999643            333 5666543  46778888888877 55554 577788888888888776  33


Q ss_pred             CcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCCCCC
Q 039290          137 IPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIP  216 (1049)
Q Consensus       137 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p  216 (1049)
                      +|..+..+++|++|+|++|.++ .+|..+..+++|++|++++|++++ +|.    ...+..+++|++|++++|++++..|
T Consensus        70 ~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~-~~~----~~~~~~l~~L~~L~l~~n~l~~~~~  143 (306)
T 2z66_A           70 CSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MSE----FSVFLSLRNLIYLDISHTHTRVAFN  143 (306)
T ss_dssp             EEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEES-STT----TTTTTTCTTCCEEECTTSCCEECST
T ss_pred             cccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccc-ccc----chhhhhccCCCEEECCCCcCCccch
Confidence            4666667777888888888777 567777777777888877777773 332    0112334556677777776666666


Q ss_pred             CCcccccccceeccccccccc-ccCCCCccccccceEEeccccccccCccccccccceEEEeeccccCCCcccccccccc
Q 039290          217 TNLWKCRELHVVSLAFNKFQG-GIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNIS  295 (1049)
Q Consensus       217 ~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~  295 (1049)
                      ..+..+++|++|++++|++++ .+|..++.+++|++|+|++|++++..|..|+.+++|+.|+|++|++++..+..+..+ 
T Consensus       144 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-  222 (306)
T 2z66_A          144 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL-  222 (306)
T ss_dssp             TTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTC-
T ss_pred             hhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCc-
Confidence            666666666666666666655 455566666666666666666665555556666666666665555555444444444 


Q ss_pred             ccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCC-CCCceeecccCcccc
Q 039290          296 TLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNI-SELSVLDFGFNSFSG  358 (1049)
Q Consensus       296 ~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~  358 (1049)
                                              ++|++|+|++|++++..|..+..+ ++|++|++++|.+.+
T Consensus       223 ------------------------~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~  262 (306)
T 2z66_A          223 ------------------------NSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC  262 (306)
T ss_dssp             ------------------------TTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred             ------------------------ccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeec
Confidence                                    455555555555555555555554 255555555555543

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=1.7e-30  Score=288.69  Aligned_cols=253  Identities=20%  Similarity=0.235  Sum_probs=152.2

Q ss_pred             CcchhhhhhcccCccccccCcccccccCCcEeccccCCc-cccCccccc-------ccCCccEEEeCCCCccCCCcccc-
Q 039290           95 NLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNF-HIEIPSWFV-------SLPRLQHLLLKHNSFVGKIPETI-  165 (1049)
Q Consensus        95 ~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~-~~~~p~~~~-------~l~~L~~L~L~~n~l~~~~p~~~-  165 (1049)
                      ....|+.|++++|.+  .+|..+...  |++|+|++|++ .+.+|..+.       ++++|++|+|++|.+++.+|..+ 
T Consensus        41 ~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  116 (312)
T 1wwl_A           41 GGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLL  116 (312)
T ss_dssp             EEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSS
T ss_pred             cCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHH
Confidence            345566677777776  666666554  66667777666 445665554       56666666666666666666655 


Q ss_pred             -cCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccceecccccccccccCCCCc
Q 039290          166 -GYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIG  244 (1049)
Q Consensus       166 -~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~  244 (1049)
                       +.+++|++|+|++|++++. |..+.++... .+++|++|+|++|++++..                        |..|+
T Consensus       117 ~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~-~~~~L~~L~L~~N~l~~~~------------------------~~~~~  170 (312)
T 1wwl_A          117 EATGPDLNILNLRNVSWATR-DAWLAELQQW-LKPGLKVLSIAQAHSLNFS------------------------CEQVR  170 (312)
T ss_dssp             SCCSCCCSEEEEESCBCSSS-SSHHHHHHTT-CCTTCCEEEEESCSCCCCC------------------------TTTCC
T ss_pred             HhcCCCccEEEccCCCCcch-hHHHHHHHHh-hcCCCcEEEeeCCCCccch------------------------HHHhc
Confidence             6666666666666666643 5444433110 1134555555555555444                        44445


Q ss_pred             cccccceEEecccccccc--Ccccc--ccccceEEEeeccccCCCc--cc-cccccccccceEEeccCccCCCCCCcccC
Q 039290          245 NLTSVRNLFLGNNSLIGE--IPNEI--GNLRNLEVLGVQSSNLAGL--IP-ASIFNISTLKELAVTDNDLLGSLPSSIDL  317 (1049)
Q Consensus       245 ~l~~L~~L~L~~N~l~~~--~p~~l--~~l~~L~~L~L~~n~l~~~--~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~  317 (1049)
                      ++++|++|+|++|++.+.  +|..+  +.+++|++|+|++|++++.  ++ ..+.++++|++|++++|++.+..|...+.
T Consensus       171 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  250 (312)
T 1wwl_A          171 VFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD  250 (312)
T ss_dssp             CCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCC
T ss_pred             cCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhh
Confidence            555555555555554433  22232  5555555555555555521  12 22345566666677777666655544444


Q ss_pred             CCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCcccccccccccceeecccccccC
Q 039290          318 GLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTS  382 (1049)
Q Consensus       318 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  382 (1049)
                      .+++|++|+|++|+++ .+|..+.  ++|++|++++|++++. |. +..+++|++|++++|++++
T Consensus       251 ~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          251 WPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             CCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             hcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            5677777777777777 6666665  6788888888888765 55 7778888888888887765

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=3.2e-30  Score=286.44  Aligned_cols=253  Identities=20%  Similarity=0.243  Sum_probs=192.2

Q ss_pred             cccccCCcEeccccCCccccCcccccccCCccEEEeCCCCc-cCCCccccc-------CCCcccEEcCCCccCccccCCC
Q 039290          117 LSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSF-VGKIPETIG-------YLSLLQELDLSDNQLSGTIPSS  188 (1049)
Q Consensus       117 ~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l-~~~~p~~~~-------~l~~L~~L~Ls~N~l~g~ip~~  188 (1049)
                      ++..++|++|++++|++  .+|..+...  |++|+|++|.+ .+.+|..+.       .+++|++|+|++|+++|.+|..
T Consensus        39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  114 (312)
T 1wwl_A           39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP  114 (312)
T ss_dssp             EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred             EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence            45566677777777777  666655544  66677777766 345565554       5666666666666666666655


Q ss_pred             cccccccCCCCccceEEeeccccCCCCCCCcccccccceecccccccccccCCCCccc-----cccceEEeccccccccC
Q 039290          189 IFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNL-----TSVRNLFLGNNSLIGEI  263 (1049)
Q Consensus       189 ~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~  263 (1049)
                      ++    +..+++|++|+|++|++++                        . |..++.+     ++|++|+|++|++++..
T Consensus       115 ~~----~~~l~~L~~L~Ls~N~l~~------------------------~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~  165 (312)
T 1wwl_A          115 LL----EATGPDLNILNLRNVSWAT------------------------R-DAWLAELQQWLKPGLKVLSIAQAHSLNFS  165 (312)
T ss_dssp             SS----SCCSCCCSEEEEESCBCSS------------------------S-SSHHHHHHTTCCTTCCEEEEESCSCCCCC
T ss_pred             HH----HhcCCCccEEEccCCCCcc------------------------h-hHHHHHHHHhhcCCCcEEEeeCCCCccch
Confidence            42    1223445555555555553                        3 5555555     89999999999999888


Q ss_pred             ccccccccceEEEeeccccCCCc--ccccc--ccccccceEEeccCccCC--CCCCcccCCCCCccEEEcCCCCCCCCCC
Q 039290          264 PNEIGNLRNLEVLGVQSSNLAGL--IPASI--FNISTLKELAVTDNDLLG--SLPSSIDLGLPNLERLFLGENNFSGTIP  337 (1049)
Q Consensus       264 p~~l~~l~~L~~L~L~~n~l~~~--~p~~~--~~l~~L~~L~l~~N~l~~--~~p~~~~~~l~~L~~L~L~~N~l~~~~p  337 (1049)
                      |..|+++++|++|+|++|++.+.  +|..+  ..+++|++|++++|++.+  .++..++..+++|++|+|++|++++..|
T Consensus       166 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  245 (312)
T 1wwl_A          166 CEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG  245 (312)
T ss_dssp             TTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCC
T ss_pred             HHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccc
Confidence            89999999999999999998876  34444  889999999999999983  3444555578999999999999998775


Q ss_pred             -ccccCCCCCceeecccCccccCcccccccccccceeecccccccCCCCCcccccccccCCCCcEEEccCCccccC
Q 039290          338 -SSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGI  412 (1049)
Q Consensus       338 -~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~  412 (1049)
                       ..+..+++|++|+|++|+++ .+|..+.  ++|++|++++|+|++++.       +..+++|++|++++|++++.
T Consensus       246 ~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~p~-------~~~l~~L~~L~L~~N~l~~~  311 (312)
T 1wwl_A          246 APSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRNPS-------PDELPQVGNLSLKGNPFLDS  311 (312)
T ss_dssp             CSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSCCC-------TTTSCEEEEEECTTCTTTCC
T ss_pred             hhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCChh-------HhhCCCCCEEeccCCCCCCC
Confidence             56777899999999999999 5677776  899999999999998732       56789999999999999863

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=1.1e-28  Score=289.33  Aligned_cols=251  Identities=22%  Similarity=0.287  Sum_probs=211.3

Q ss_pred             cEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeec
Q 039290          400 EIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQN  479 (1049)
Q Consensus       400 ~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  479 (1049)
                      ..++.+++.++. +|..+   +.+++.|+|++|+|++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus        57 ~~v~c~~~~l~~-iP~~~---~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~  132 (452)
T 3zyi_A           57 SKVVCTRRGLSE-VPQGI---PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD  132 (452)
T ss_dssp             CEEECCSSCCSS-CCSCC---CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             cEEEECCCCcCc-cCCCC---CCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence            344444444442 23222   23677777777777777788888888999999999999888888888899999999999


Q ss_pred             cccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecC-cccccccCcccccccccccccccCCccCCCC
Q 039290          480 NKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGS-NALTSIIPSTLWNLKDILRFNLSSNSLNGSL  558 (1049)
Q Consensus       480 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  558 (1049)
                      |+|++..+..|..+++|++|+|++|++++..+..|.++++|++|++++ |.+..+.+..|..+++|++|+|++|++++. 
T Consensus       133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-  211 (452)
T 3zyi_A          133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-  211 (452)
T ss_dssp             SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-
T ss_pred             CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-
Confidence            998877677788889999999999998876677888999999999998 566666666788999999999999999864 


Q ss_pred             ccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCccccccccc
Q 039290          559 LPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALS  638 (1049)
Q Consensus       559 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  638 (1049)
                       +.+..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|.++++|++|||++|+|++..+..+..++
T Consensus       212 -~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  290 (452)
T 3zyi_A          212 -PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR  290 (452)
T ss_dssp             -CCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCT
T ss_pred             -ccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcccc
Confidence             4688899999999999999999999999999999999999999998899999999999999999999977778889999


Q ss_pred             ccceeeccCCcccccCCC
Q 039290          639 YLKHLNLSFNQLEGEIPT  656 (1049)
Q Consensus       639 ~L~~l~l~~N~l~~~~p~  656 (1049)
                      +|+.|+|++|+|.|++..
T Consensus       291 ~L~~L~L~~Np~~CdC~~  308 (452)
T 3zyi_A          291 YLVELHLHHNPWNCDCDI  308 (452)
T ss_dssp             TCCEEECCSSCEECSTTT
T ss_pred             CCCEEEccCCCcCCCCCc
Confidence            999999999999998864

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=4.4e-29  Score=276.89  Aligned_cols=233  Identities=20%  Similarity=0.204  Sum_probs=192.8

Q ss_pred             cccEEEccCCccccCCCCCCCCCCCccEEEccCCccccc--CCccccCcCCCcceEeeccccCCCCCcccccccccceEE
Q 039290          423 SMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGT--IPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLY  500 (1049)
Q Consensus       423 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  500 (1049)
                      ++++|+|++|+++...+..|.++++|++|+|++|.++..  .|..+..+++|++|+|++|.++ .+|..+..+++|++|+
T Consensus        29 ~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~  107 (306)
T 2z66_A           29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLD  107 (306)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEE
T ss_pred             CCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEE
Confidence            566667777776654455577888888888888888733  3566777888888888888887 5677788888888888


Q ss_pred             eeCcccCCcCc-hhccCcccCCceeecCcccccccCcccccccccccccccCCccCC-CCccCcCCCcceeEeecccccc
Q 039290          501 LGDNKLSGRLP-ACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNG-SLLPDIGNLKVVIEMDLSLNAL  578 (1049)
Q Consensus       501 L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l  578 (1049)
                      +++|++++..+ ..+..+++|++|++++|++++..|..+..+++|++|++++|.+++ ..|..+..+++|++|++++|++
T Consensus       108 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l  187 (306)
T 2z66_A          108 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL  187 (306)
T ss_dssp             CTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCC
T ss_pred             CCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCc
Confidence            88888886544 578888888899999888888888888888889999999988876 5677888889999999999999


Q ss_pred             cccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCccccccccc-ccceeeccCCcccccCCC
Q 039290          579 SGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALS-YLKHLNLSFNQLEGEIPT  656 (1049)
Q Consensus       579 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~l~l~~N~l~~~~p~  656 (1049)
                      ++..|..|..+++|+.|+|++|++++..+..|..+++|++|||++|++++..|..+..++ +|++|++++|+|+|.++.
T Consensus       188 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~  266 (306)
T 2z66_A          188 EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH  266 (306)
T ss_dssp             CEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGG
T ss_pred             CCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccCh
Confidence            888888899999999999999999987777888899999999999999988888888884 899999999999887753

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=3.3e-31  Score=322.87  Aligned_cols=379  Identities=16%  Similarity=0.091  Sum_probs=228.1

Q ss_pred             cccccceEEeccccccccCccccccc--cceEEEeeccccC-CC-ccccccccccccceEEeccCccCCCCCCc---ccC
Q 039290          245 NLTSVRNLFLGNNSLIGEIPNEIGNL--RNLEVLGVQSSNL-AG-LIPASIFNISTLKELAVTDNDLLGSLPSS---IDL  317 (1049)
Q Consensus       245 ~l~~L~~L~L~~N~l~~~~p~~l~~l--~~L~~L~L~~n~l-~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~---~~~  317 (1049)
                      ++++|++|+|++|.+++..+..++..  .+|++|+|++|.. .. .++....++++|++|+|++|.+.+.-..+   +..
T Consensus       110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~  189 (592)
T 3ogk_B          110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ  189 (592)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred             hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence            66778888888887777666666664  4488888877752 11 12233346788888888888776442211   223


Q ss_pred             CCCCccEEEcCCCCCCC----CCCccccCCCCCceeecccCccccCcccccccccccceeecccccccCCCCCccccccc
Q 039290          318 GLPNLERLFLGENNFSG----TIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSL  393 (1049)
Q Consensus       318 ~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l  393 (1049)
                      .+++|++|++++|.+++    .++..+.++++|++|++++|.+.+ +|..+.++++|++|+++++......  ......+
T Consensus       190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~--~~~~~~l  266 (592)
T 3ogk_B          190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGM--PEKYMNL  266 (592)
T ss_dssp             HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTC--TTSSSCC
T ss_pred             cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccch--HHHHHHh
Confidence            57888888888888873    344455678889999999988886 5678888889999988864322111  1123456


Q ss_pred             ccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCC-CCCCCCCCccEEEccCCccc-ccCCccccCcCC
Q 039290          394 TSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIP-KELGNINNLTVIRLGNNELT-GTIPVTLGRLQK  471 (1049)
Q Consensus       394 ~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p-~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~  471 (1049)
                      ..+++|+.|+++++... .+|..+... .+|++|+|++|.+++... ..+..+++|++|+++ +.+. +.++..+..+++
T Consensus       267 ~~~~~L~~L~l~~~~~~-~l~~~~~~~-~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~  343 (592)
T 3ogk_B          267 VFPRKLCRLGLSYMGPN-EMPILFPFA-AQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQ  343 (592)
T ss_dssp             CCCTTCCEEEETTCCTT-TGGGGGGGG-GGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTT
T ss_pred             hccccccccCccccchh-HHHHHHhhc-CCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCC
Confidence            67778888888775322 333333333 367777777776554333 234566777777777 3333 223333455667


Q ss_pred             CcceEeec-----------cccCCCC-CcccccccccceEEeeCcccCCcCchhccC-cccCCceeec----Ccccccc-
Q 039290          472 LQGLYLQN-----------NKLEGSI-PEDLCHLYRLANLYLGDNKLSGRLPACLGN-LTSLRDLSLG----SNALTSI-  533 (1049)
Q Consensus       472 L~~L~L~~-----------N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~----~N~l~~~-  533 (1049)
                      |++|++++           |.+++.. +..+..+++|++|+++.|.+++..+..++. +++|+.|+++    .|++++. 
T Consensus       344 L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p  423 (592)
T 3ogk_B          344 LKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLP  423 (592)
T ss_dssp             CCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCC
T ss_pred             CCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCch
Confidence            77777772           4444321 112334667777777777776655555554 6667777774    5566542 


Q ss_pred             ----cCcccccccccccccccCCc--cCCCCccCcC-CCcceeEeecccccccc-cccccccCCCcccEEEeecccccCC
Q 039290          534 ----IPSTLWNLKDILRFNLSSNS--LNGSLLPDIG-NLKVVIEMDLSLNALSG-VIPVTIGGLQGLQLLSLRYNRLQGP  605 (1049)
Q Consensus       534 ----~p~~~~~l~~L~~L~Ls~N~--l~~~~~~~~~-~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~  605 (1049)
                          ++..+..+++|++|+++.|.  +++..+..+. .+++|++|++++|++++ .++..+.++++|+.|+|++|++++.
T Consensus       424 ~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~  503 (592)
T 3ogk_B          424 LDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSER  503 (592)
T ss_dssp             CHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHH
T ss_pred             HHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHH
Confidence                23335556666666665432  4433333332 25566666666666654 2334445666666666666666543


Q ss_pred             -ccccccCccCCcEEeccCccccCC
Q 039290          606 -IPESFGGLKSLNFVDMSNNNLSGT  629 (1049)
Q Consensus       606 -~~~~~~~l~~L~~L~Ls~N~l~~~  629 (1049)
                       ++..+..+++|++|+|++|++++.
T Consensus       504 ~~~~~~~~l~~L~~L~ls~n~it~~  528 (592)
T 3ogk_B          504 AIAAAVTKLPSLRYLWVQGYRASMT  528 (592)
T ss_dssp             HHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred             HHHHHHHhcCccCeeECcCCcCCHH
Confidence             333344566666666666666644

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=1.6e-28  Score=286.91  Aligned_cols=232  Identities=23%  Similarity=0.282  Sum_probs=205.8

Q ss_pred             cccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEee
Q 039290          423 SMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLG  502 (1049)
Q Consensus       423 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  502 (1049)
                      +++.|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus        65 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  144 (440)
T 3zyj_A           65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLR  144 (440)
T ss_dssp             TCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECC
T ss_pred             CCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCC
Confidence            66777777777777777888899999999999999998878889999999999999999987767788999999999999


Q ss_pred             CcccCCcCchhccCcccCCceeecC-cccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeeccccccccc
Q 039290          503 DNKLSGRLPACLGNLTSLRDLSLGS-NALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGV  581 (1049)
Q Consensus       503 ~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  581 (1049)
                      +|+++...+..|.++++|++|++++ |.+..+.+..|.++++|++|++++|+++.. | .+..+++|++|+|++|+|++.
T Consensus       145 ~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~  222 (440)
T 3zyj_A          145 NNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI-P-NLTPLIKLDELDLSGNHLSAI  222 (440)
T ss_dssp             SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSC-C-CCTTCSSCCEEECTTSCCCEE
T ss_pred             CCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccc-c-ccCCCcccCEEECCCCccCcc
Confidence            9999877777899999999999998 556666666889999999999999999853 3 588899999999999999999


Q ss_pred             ccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCcccccCCC
Q 039290          582 IPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPT  656 (1049)
Q Consensus       582 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~  656 (1049)
                      .|..|.++++|+.|+|++|+|++..+..|.++++|++|||++|+|++..+..+..+++|+.|+|++|+|.|++..
T Consensus       223 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l  297 (440)
T 3zyj_A          223 RPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDI  297 (440)
T ss_dssp             CTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTT
T ss_pred             ChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCc
Confidence            999999999999999999999999999999999999999999999987778889999999999999999998864

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=2.6e-31  Score=323.70  Aligned_cols=454  Identities=16%  Similarity=0.096  Sum_probs=271.2

Q ss_pred             CceeeeEEEcCCCCcEEEEEEeccccccccCCCCCCcchhhhhhcccCcc---ccccCcccc------------cccCCc
Q 039290           60 VCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSF---FGSLPEELS------------HLRGLK  124 (1049)
Q Consensus        60 ~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~---~g~~p~~~~------------~L~~L~  124 (1049)
                      |++|.+|.+..  ++  .+.+. +.+....+..+..++.|++|+|+++..   .|.+|..++            ++++|+
T Consensus        41 ck~W~~~~~~~--~~--~l~~~-~~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~  115 (592)
T 3ogk_B           41 CRRWFKIDSET--RE--HVTMA-LCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLK  115 (592)
T ss_dssp             CHHHHHHHHHH--CC--EEEES-CGGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred             hHHHHHhhhcc--cc--EEEEe-eccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCC
Confidence            44798885432  11  12222 122222233345566677777766421   134443333            677788


Q ss_pred             EeccccCCccccCccccccc--CCccEEEeCCCC-cc-CCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCc
Q 039290          125 YFDFRFNNFHIEIPSWFVSL--PRLQHLLLKHNS-FV-GKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPV  200 (1049)
Q Consensus       125 ~L~l~~n~~~~~~p~~~~~l--~~L~~L~L~~n~-l~-~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~  200 (1049)
                      +|+|++|.+++..+.++..+  ++|++|+|++|. ++ ..++..+..+++|++|+|++|.+++.-+..+..+  ...+++
T Consensus       116 ~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~--~~~~~~  193 (592)
T 3ogk_B          116 SVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHEL--AQHNTS  193 (592)
T ss_dssp             EEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHH--HHHCCC
T ss_pred             eEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHH--HhcCCC
Confidence            88888777776666666663  348888887775 21 1123333467778888888877764311111111  123456


Q ss_pred             cceEEeeccccCC----CCCCCcccccccceecccccccccccCCCCccccccceEEecccccc---ccCccccccccce
Q 039290          201 LEGLFISYNQLTG----PIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLI---GEIPNEIGNLRNL  273 (1049)
Q Consensus       201 L~~L~l~~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~---~~~p~~l~~l~~L  273 (1049)
                      |++|++++|.+++    .++..+..+++|+.|++++|.+.+ +|..++++++|++|+++.+...   +..+..++.+++|
T Consensus       194 L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L  272 (592)
T 3ogk_B          194 LEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKL  272 (592)
T ss_dssp             CCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTC
T ss_pred             ccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccc
Confidence            7777888777762    334445567778888888777775 6666777777888877754322   2344566777777


Q ss_pred             EEEeeccccCCCccccccccccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecc-
Q 039290          274 EVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFG-  352 (1049)
Q Consensus       274 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls-  352 (1049)
                      +.|+++++ ..+.+|..+..+++|++|++++|.+.+.....+...+++|++|+++++...+.++..+..+++|++|+++ 
T Consensus       273 ~~L~l~~~-~~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~  351 (592)
T 3ogk_B          273 CRLGLSYM-GPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIER  351 (592)
T ss_dssp             CEEEETTC-CTTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEEC
T ss_pred             cccCcccc-chhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeec
Confidence            77777664 3345566677777788888877775543332333467777887777332222333444566777888877 


Q ss_pred             ----------cCccccC-cccccccccccceeecccccccCCCCCcccccccc-cCCCCcEEEcc----CCccccC----
Q 039290          353 ----------FNSFSGL-IPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLT-SCRNLEIIYLS----ENPINGI----  412 (1049)
Q Consensus       353 ----------~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~-~l~~L~~L~Ls----~N~i~~~----  412 (1049)
                                .|.+++. ++..+..+++|++|+++.|.++...     +..+. .+++|+.|+++    .|.+++.    
T Consensus       352 g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~-----~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~  426 (592)
T 3ogk_B          352 GADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNES-----LESIGTYLKNLCDFRLVLLDREERITDLPLDN  426 (592)
T ss_dssp             CCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHH-----HHHHHHHCCSCCEEEEEECSCCSCCSSCCCHH
T ss_pred             CccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHH-----HHHHHhhCCCCcEEEEeecCCCccccCchHHH
Confidence                      3555532 2222445677788877777665421     12233 36777777775    5566643    


Q ss_pred             -CCCccccccccccEEEccCCc--cccCCCCCCC-CCCCccEEEccCCccccc-CCccccCcCCCcceEeeccccCCC-C
Q 039290          413 -LPSSIGNFSISMKSLSMESCN--ISGGIPKELG-NINNLTVIRLGNNELTGT-IPVTLGRLQKLQGLYLQNNKLEGS-I  486 (1049)
Q Consensus       413 -~p~~~~~~~~~L~~L~L~~n~--i~~~~p~~~~-~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~-~  486 (1049)
                       ++..+..+ .+|+.|+++.|.  +++..+..+. .+++|++|+|++|++++. ++..+..+++|++|+|++|.+++. +
T Consensus       427 ~~~~~~~~~-~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~  505 (592)
T 3ogk_B          427 GVRSLLIGC-KKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAI  505 (592)
T ss_dssp             HHHHHHHHC-TTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHH
T ss_pred             HHHHHHHhC-CCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHH
Confidence             11112222 377888886543  5544444443 377888999998888753 445567788899999999987644 3


Q ss_pred             CcccccccccceEEeeCcccCCcCchhc-cCcccCCceeecCc
Q 039290          487 PEDLCHLYRLANLYLGDNKLSGRLPACL-GNLTSLRDLSLGSN  528 (1049)
Q Consensus       487 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N  528 (1049)
                      +..+..+++|++|++++|+++......+ ..++.+....+..+
T Consensus       506 ~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~  548 (592)
T 3ogk_B          506 AAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR  548 (592)
T ss_dssp             HHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred             HHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence            3344568889999999999876533333 24565555555444

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=6.1e-29  Score=272.58  Aligned_cols=252  Identities=21%  Similarity=0.247  Sum_probs=164.2

Q ss_pred             cEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeec
Q 039290          400 EIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQN  479 (1049)
Q Consensus       400 ~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  479 (1049)
                      +.++.+++.++.+ |..+   ..++++|++++|.+++..+..|..+++|++|+|++|.+++..|..|..+++|++|+|++
T Consensus        14 ~~~~c~~~~l~~i-p~~~---~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   89 (285)
T 1ozn_A           14 VTTSCPQQGLQAV-PVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD   89 (285)
T ss_dssp             CEEECCSSCCSSC-CTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             eEEEcCcCCcccC-CcCC---CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence            5677777777743 3322   23677777777777766666777777777777777777766677777777777777777


Q ss_pred             cc-cCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCC
Q 039290          480 NK-LEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSL  558 (1049)
Q Consensus       480 N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  558 (1049)
                      |+ ++...|..+..+++|++|++++|.+++..|..+.++++|++|++++|++++..+..+..+++|++|++++|++++..
T Consensus        90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  169 (285)
T 1ozn_A           90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP  169 (285)
T ss_dssp             CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred             CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccC
Confidence            76 66555666777777777777777777666666677777777777777777666666666666666666666666555


Q ss_pred             ccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCccccccccc
Q 039290          559 LPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALS  638 (1049)
Q Consensus       559 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  638 (1049)
                      +..+..+++|++|++++|++++..|..|..+++|+.|+|++|++++..+..|..+++|++|+|++|++++..+.. ..+.
T Consensus       170 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~  248 (285)
T 1ozn_A          170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWA  248 (285)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHH
T ss_pred             HHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHH
Confidence            555666666666666666666666666666666666666666666655555666666666666666665433321 2223


Q ss_pred             ccceeeccCCcccccCCC
Q 039290          639 YLKHLNLSFNQLEGEIPT  656 (1049)
Q Consensus       639 ~L~~l~l~~N~l~~~~p~  656 (1049)
                      .++.+..+.|.+.|..|.
T Consensus       249 ~l~~~~~~~~~~~c~~p~  266 (285)
T 1ozn_A          249 WLQKFRGSSSEVPCSLPQ  266 (285)
T ss_dssp             HHHHCCSEECCCBEEESG
T ss_pred             HHHhcccccCccccCCch
Confidence            344555556666666554

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.95  E-value=3.6e-28  Score=266.50  Aligned_cols=252  Identities=23%  Similarity=0.230  Sum_probs=210.4

Q ss_pred             ccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeC
Q 039290          424 MKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGD  503 (1049)
Q Consensus       424 L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  503 (1049)
                      -+.+++++++++ .+|..+  .++|++|+|++|.+++..+..|..+++|++|+|++|++++..|..|..+++|++|++++
T Consensus        13 ~~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   89 (285)
T 1ozn_A           13 KVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD   89 (285)
T ss_dssp             SCEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CeEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence            357888888887 455544  46899999999999987778899999999999999999887788899999999999999


Q ss_pred             cc-cCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccc
Q 039290          504 NK-LSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVI  582 (1049)
Q Consensus       504 N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  582 (1049)
                      |+ +....|..+..+++|++|++++|++++..|..+..+++|++|++++|++++..+..+..+++|++|+|++|++++..
T Consensus        90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  169 (285)
T 1ozn_A           90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP  169 (285)
T ss_dssp             CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred             CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccC
Confidence            97 77666888999999999999999999888888999999999999999998877777888999999999999998777


Q ss_pred             cccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCcccccCCCCCCccc
Q 039290          583 PVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFIT  662 (1049)
Q Consensus       583 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~  662 (1049)
                      +..|..+++|+.|+|++|++++..|..|.++++|++|+|++|++++..+..+..+++|++|++++|+|.|.++....+..
T Consensus       170 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~  249 (285)
T 1ozn_A          170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAW  249 (285)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHH
T ss_pred             HHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHH
Confidence            77789999999999999999988888999999999999999999977777788899999999999999988875433333


Q ss_pred             cccccccCCccccCCC
Q 039290          663 FSAESFLGNQALCGSP  678 (1049)
Q Consensus       663 ~~~~~~~~n~~~cg~~  678 (1049)
                      +.......+...|..|
T Consensus       250 l~~~~~~~~~~~c~~p  265 (285)
T 1ozn_A          250 LQKFRGSSSEVPCSLP  265 (285)
T ss_dssp             HHHCCSEECCCBEEES
T ss_pred             HHhcccccCccccCCc
Confidence            3333344555666655

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=2.3e-28  Score=293.43  Aligned_cols=286  Identities=29%  Similarity=0.346  Sum_probs=173.0

Q ss_pred             ccCCCCCCCceeeeEEEcC------CCCcEEEEEEeccccccccCCCCCCcchhhhhhcccCccccccCcccccccCCcE
Q 039290           52 NNWSTTSSVCSWIGVTCGV------RNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKY  125 (1049)
Q Consensus        52 ~~w~~~~~~c~w~gv~c~~------~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~  125 (1049)
                      +.|..+.+||.|+|..|..      ....++.|++++++++ .+|..+.  ++|++|+|++|.++ .||.   .+++|++
T Consensus        13 ~~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~   85 (622)
T 3g06_A           13 SAWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRT   85 (622)
T ss_dssp             HHHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCE
T ss_pred             HHHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCE
Confidence            4788888999998764421      1123667777777777 6776655  56666666666665 4555   4556666


Q ss_pred             eccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEE
Q 039290          126 FDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLF  205 (1049)
Q Consensus       126 L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~  205 (1049)
                      |||++|+++ .+|.   .+++|++|+|++|.+++ +|.   .+++|+.|+|++|+++ .+|..+         ++|++|+
T Consensus        86 L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~-~lp~~l---------~~L~~L~  147 (622)
T 3g06_A           86 LEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLT-SLPVLP---------PGLQELS  147 (622)
T ss_dssp             EEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCS-CCCCCC---------TTCCEEE
T ss_pred             EEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCC-cCCCCC---------CCCCEEE
Confidence            666666665 3444   45666666666666653 443   4455666666666665 344321         3455555


Q ss_pred             eeccccCCCCCCCcccccccceecccccccccccCCCCccccccceEEeccccccccCccccccccceEEEeeccccCCC
Q 039290          206 ISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAG  285 (1049)
Q Consensus       206 l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~  285 (1049)
                      +++|++++ +|..                           ..+|+.|++++|++++ +|   ..+++|+.|++++|++++
T Consensus       148 Ls~N~l~~-l~~~---------------------------~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~  195 (622)
T 3g06_A          148 VSDNQLAS-LPAL---------------------------PSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS  195 (622)
T ss_dssp             CCSSCCSC-CCCC---------------------------CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC
T ss_pred             CcCCcCCC-cCCc---------------------------cCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC
Confidence            55555553 2321                           2344555555555552 33   334555555555555554


Q ss_pred             ccccccccccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCcccccc
Q 039290          286 LIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFG  365 (1049)
Q Consensus       286 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  365 (1049)
                      . |..   +++|+.|++++|.+. .+|.    .+++|++|+|++|++++ +|   ..+++|+.|++++|+|+. +|.   
T Consensus       196 l-~~~---~~~L~~L~L~~N~l~-~l~~----~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---  258 (622)
T 3g06_A          196 L-PTL---PSELYKLWAYNNRLT-SLPA----LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---  258 (622)
T ss_dssp             C-CCC---CTTCCEEECCSSCCS-SCCC----CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---
T ss_pred             C-CCc---cchhhEEECcCCccc-ccCC----CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---
Confidence            2 221   355666666666665 4443    23677777777777774 45   345677788888887774 344   


Q ss_pred             cccccceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCcc
Q 039290          366 NLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSI  417 (1049)
Q Consensus       366 ~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~  417 (1049)
                      .+++|+.|+|++|.|+.++.      .+.++++|+.|+|++|++++..|..+
T Consensus       259 ~~~~L~~L~Ls~N~L~~lp~------~l~~l~~L~~L~L~~N~l~~~~~~~l  304 (622)
T 3g06_A          259 LPSGLLSLSVYRNQLTRLPE------SLIHLSSETTVNLEGNPLSERTLQAL  304 (622)
T ss_dssp             CCTTCCEEECCSSCCCSCCG------GGGGSCTTCEEECCSCCCCHHHHHHH
T ss_pred             ccccCcEEeCCCCCCCcCCH------HHhhccccCEEEecCCCCCCcCHHHH
Confidence            55777888888888776543      25677888888888888887655444

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.95  E-value=4.2e-27  Score=275.79  Aligned_cols=229  Identities=22%  Similarity=0.231  Sum_probs=182.4

Q ss_pred             CCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEe
Q 039290          398 NLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYL  477 (1049)
Q Consensus       398 ~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  477 (1049)
                      +++.|+|++|.|+++.+..+..+. +|++|+|++|+|++..|..|.++++|++|+|++|++++..+..|..+++|++|+|
T Consensus        76 ~l~~L~L~~n~i~~~~~~~~~~l~-~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  154 (452)
T 3zyi_A           76 NTRYLNLMENNIQMIQADTFRHLH-HLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL  154 (452)
T ss_dssp             TCSEEECCSSCCCEECTTTTTTCT-TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred             CccEEECcCCcCceECHHHcCCCC-CCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence            455555555555555555555544 6666666666666666777788888888888888888766677888888888888


Q ss_pred             eccccCCCCCcccccccccceEEeeC-cccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccCC
Q 039290          478 QNNKLEGSIPEDLCHLYRLANLYLGD-NKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNG  556 (1049)
Q Consensus       478 ~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  556 (1049)
                      ++|+|++..+..|..+++|++|++++ |.+....+..|.++++|++|+|++|+++++ | .+..+++|+.|+|++|++++
T Consensus       155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~  232 (452)
T 3zyi_A          155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPE  232 (452)
T ss_dssp             CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSE
T ss_pred             CCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcc
Confidence            88888866666788888888888888 445433445688888888888888888874 3 47788889999999999988


Q ss_pred             CCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCC
Q 039290          557 SLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGT  629 (1049)
Q Consensus       557 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  629 (1049)
                      ..+..|..+++|++|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++...
T Consensus       233 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd  305 (452)
T 3zyi_A          233 IRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCD  305 (452)
T ss_dssp             ECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECS
T ss_pred             cCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCC
Confidence            8888899999999999999999988899999999999999999999988888899999999999999998753

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=1.1e-28  Score=274.77  Aligned_cols=258  Identities=19%  Similarity=0.179  Sum_probs=177.6

Q ss_pred             hhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCc
Q 039290          100 AVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDN  179 (1049)
Q Consensus       100 ~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N  179 (1049)
                      +.++++++.+...++..+..+++|++|||++|++++..|..|.++++|++|+|++|.+++..|  ++.+++|++|+|++|
T Consensus        13 ~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n   90 (317)
T 3o53_A           13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNN   90 (317)
T ss_dssp             EEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSS
T ss_pred             eEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCC
Confidence            344556666654444444566778888888888887777788888888888888888876544  788888888888888


Q ss_pred             cCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceEEeccccc
Q 039290          180 QLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSL  259 (1049)
Q Consensus       180 ~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  259 (1049)
                      ++++ +|.          .+.|++|++++|++++..+..   +++|+.|++++|++++..|..++.+++|++|+|++|++
T Consensus        91 ~l~~-l~~----------~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  156 (317)
T 3o53_A           91 YVQE-LLV----------GPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI  156 (317)
T ss_dssp             EEEE-EEE----------CTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCC
T ss_pred             cccc-ccC----------CCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCC
Confidence            8873 331          245778888888887654443   45677777777777766666777777777777777777


Q ss_pred             cccCccccc-cccceEEEeeccccCCCccccccccccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCc
Q 039290          260 IGEIPNEIG-NLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPS  338 (1049)
Q Consensus       260 ~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~  338 (1049)
                      ++..|..+. .+++|++|+|++|++++. | ....+++|++|++++|++.+ +|..+ ..+++|++|+|++|+++ .+|.
T Consensus       157 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-l~~~~-~~l~~L~~L~L~~N~l~-~l~~  231 (317)
T 3o53_A          157 DTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEF-QSAAGVTWISLRNNKLV-LIEK  231 (317)
T ss_dssp             CEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGG-GGGTTCSEEECTTSCCC-EECT
T ss_pred             CcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCc-chhhh-cccCcccEEECcCCccc-chhh
Confidence            766666653 677777777777777665 2 22236677777777777763 44443 35677777777777777 4566


Q ss_pred             cccCCCCCceeecccCccc-cCcccccccccccceeecccc
Q 039290          339 SLTNISELSVLDFGFNSFS-GLIPTTFGNLRSLKLLSLAGN  378 (1049)
Q Consensus       339 ~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N  378 (1049)
                      .+..+++|+.|++++|.+. +.+|..+..+++|+.|+++++
T Consensus       232 ~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~  272 (317)
T 3o53_A          232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV  272 (317)
T ss_dssp             TCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHH
T ss_pred             HhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCc
Confidence            6777777777777777776 556666777777777777643

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.94  E-value=1.9e-26  Score=269.20  Aligned_cols=245  Identities=23%  Similarity=0.265  Sum_probs=156.9

Q ss_pred             eecccccccccccCCCCccccccceEEeccccccccCccccccccceEEEeeccccCCCccccccccccccceEEeccCc
Q 039290          227 VVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDND  306 (1049)
Q Consensus       227 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~  306 (1049)
                      .++.+++.++ .+|..+.  ++++.|+|++|++++..+..|+++++|++|+|++|++.+..+..|.++++|++|+|++|+
T Consensus        47 ~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~  123 (440)
T 3zyj_A           47 KVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR  123 (440)
T ss_dssp             EEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred             EEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence            3444444443 3444433  355566666666665555566666666666666666665555566666666666666666


Q ss_pred             cCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccC-ccccCcccccccccccceeecccccccCCCC
Q 039290          307 LLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFN-SFSGLIPTTFGNLRSLKLLSLAGNVLTSPTP  385 (1049)
Q Consensus       307 l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~  385 (1049)
                      ++ .+|...+..+++|++|+|++|++++..+..|..+++|++|++++| .+....+..|.++++|++|+|++|.++.++.
T Consensus       124 l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~  202 (440)
T 3zyj_A          124 LT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPN  202 (440)
T ss_dssp             CS-SCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCCC
T ss_pred             CC-eeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccccc
Confidence            65 444444445667777777777777555666777777777777773 4444444567777777777777777765432


Q ss_pred             CcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCcc
Q 039290          386 DLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVT  465 (1049)
Q Consensus       386 ~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  465 (1049)
                             +..+++|+.|+|++|+++                         +..|..|.++++|+.|+|++|++++..+..
T Consensus       203 -------~~~l~~L~~L~Ls~N~l~-------------------------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  250 (440)
T 3zyj_A          203 -------LTPLIKLDELDLSGNHLS-------------------------AIRPGSFQGLMHLQKLWMIQSQIQVIERNA  250 (440)
T ss_dssp             -------CTTCSSCCEEECTTSCCC-------------------------EECTTTTTTCTTCCEEECTTCCCCEECTTS
T ss_pred             -------cCCCcccCEEECCCCccC-------------------------ccChhhhccCccCCEEECCCCceeEEChhh
Confidence                   445555555555555554                         445566667777777777777777777777


Q ss_pred             ccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccC
Q 039290          466 LGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLS  507 (1049)
Q Consensus       466 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  507 (1049)
                      |..+++|++|+|++|+|++..+..|..+++|+.|+|++|++.
T Consensus       251 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          251 FDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             STTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred             hcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence            777777777777777777666666777777888888877765

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.94  E-value=2.8e-26  Score=275.21  Aligned_cols=269  Identities=26%  Similarity=0.349  Sum_probs=165.6

Q ss_pred             cccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCcccccccccccceee
Q 039290          295 STLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLS  374 (1049)
Q Consensus       295 ~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  374 (1049)
                      .+++.|++++|.++ .+|..++   ++|++|+|++|+++ .+|.   .+++|++|+|++|+|++ +|.   .+++|++|+
T Consensus        40 ~~l~~L~ls~n~L~-~lp~~l~---~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~  107 (622)
T 3g06_A           40 NGNAVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELS  107 (622)
T ss_dssp             HCCCEEECCSSCCS-CCCSCCC---TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEE
T ss_pred             CCCcEEEecCCCcC-ccChhhC---CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEE
Confidence            35788888888887 7777664   67888888888887 4554   45778888888888775 343   567777777


Q ss_pred             cccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEcc
Q 039290          375 LAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLG  454 (1049)
Q Consensus       375 L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls  454 (1049)
                      +++|.++.++.         .+++|+.|++++|++++                          +|..   +++|++|+|+
T Consensus       108 Ls~N~l~~l~~---------~l~~L~~L~L~~N~l~~--------------------------lp~~---l~~L~~L~Ls  149 (622)
T 3g06_A          108 IFSNPLTHLPA---------LPSGLCKLWIFGNQLTS--------------------------LPVL---PPGLQELSVS  149 (622)
T ss_dssp             ECSCCCCCCCC---------CCTTCCEEECCSSCCSC--------------------------CCCC---CTTCCEEECC
T ss_pred             CcCCcCCCCCC---------CCCCcCEEECCCCCCCc--------------------------CCCC---CCCCCEEECc
Confidence            77777766543         23556666666666553                          2221   2455555555


Q ss_pred             CCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCccccccc
Q 039290          455 NNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSII  534 (1049)
Q Consensus       455 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  534 (1049)
                      +|++++ +|.   .+++|+.|++++|+|++ +|   ..+++|+.|++++|.+++ +|..   +++|+.|++++|.++.+ 
T Consensus       150 ~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~l-  216 (622)
T 3g06_A          150 DNQLAS-LPA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSL-  216 (622)
T ss_dssp             SSCCSC-CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSSC-
T ss_pred             CCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccccc-
Confidence            555553 232   22445555555555553 33   234555556666665553 3322   34566666666666542 


Q ss_pred             CcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCcc
Q 039290          535 PSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLK  614 (1049)
Q Consensus       535 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  614 (1049)
                      |..   +++|+.|++++|+|++ +|   ..+++|++|+|++|+|+. +|.   .+++|+.|+|++|+|+ .+|..|.+++
T Consensus       217 ~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~  284 (622)
T 3g06_A          217 PAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLS  284 (622)
T ss_dssp             CCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSC
T ss_pred             CCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhcc
Confidence            222   3556666666666665 23   334566777777777763 343   4567777777777777 5677777777


Q ss_pred             CCcEEeccCccccCCccccccccc
Q 039290          615 SLNFVDMSNNNLSGTIPKSMEALS  638 (1049)
Q Consensus       615 ~L~~L~Ls~N~l~~~~p~~~~~l~  638 (1049)
                      +|+.|+|++|++++.+|..+..++
T Consensus       285 ~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          285 SETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             TTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             ccCEEEecCCCCCCcCHHHHHhcc
Confidence            777777777777777776666554

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=2.7e-28  Score=291.06  Aligned_cols=186  Identities=18%  Similarity=0.098  Sum_probs=132.8

Q ss_pred             eecCCCcEEEEEEE-eCCCcEEEEEEeecccC----------CCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEE
Q 039290          768 LLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFD----------GSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       768 ~lg~G~fg~Vy~a~-~~~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      ..+.|++|.+..++ ...|+.||+|++.+...          ...+++.+|+++|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            35667777666665 34688999999975431          1245799999999999 699999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||++|++|.+++...+. ++..   +|+.||++||+|+|   ++|||||||||+|||++++|.+||+|||+|+......
T Consensus       321 MEyv~G~~L~d~i~~~~~-l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEE-IDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             EECCCSEEHHHHHHTTCC-CCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             EecCCCCcHHHHHHhCCC-CCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence            999999999999987654 5553   58899999999999   9999999999999999999999999999998765433


Q ss_pred             cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCC
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPT  962 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~  962 (1049)
                      . .....+||+.|||||++.+ .+..++|+|++|++.+++.++..|+
T Consensus       394 ~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          394 S-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             c-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            2 3345689999999999865 5678899999999998887765443

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.94  E-value=1.4e-28  Score=273.96  Aligned_cols=267  Identities=20%  Similarity=0.224  Sum_probs=194.0

Q ss_pred             CCceeecccCccccCcccccccccccceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccc
Q 039290          345 ELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISM  424 (1049)
Q Consensus       345 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L  424 (1049)
                      +++.++++.+.+.......+..+++|++|+|++|.++.++++     .+..+++|++|+|++|.+++.            
T Consensus        11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~Ls~n~l~~~------------   73 (317)
T 3o53_A           11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAA-----DLAPFTKLELLNLSSNVLYET------------   73 (317)
T ss_dssp             EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHH-----HHTTCTTCCEEECTTSCCEEE------------
T ss_pred             ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHH-----HhhCCCcCCEEECCCCcCCcc------------
Confidence            355667777777655555566666777777777777765432     355666666666666665532            


Q ss_pred             cEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCc
Q 039290          425 KSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDN  504 (1049)
Q Consensus       425 ~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  504 (1049)
                                   .+  +..+++|++|+|++|.+++..     ..++|++|++++|++++..+..   +++|++|++++|
T Consensus        74 -------------~~--~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N  130 (317)
T 3o53_A           74 -------------LD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANN  130 (317)
T ss_dssp             -------------EE--ETTCTTCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSS
T ss_pred             -------------hh--hhhcCCCCEEECcCCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCC
Confidence                         22  556677777777777776432     2367777777777777544333   466777888888


Q ss_pred             ccCCcCchhccCcccCCceeecCcccccccCcccc-cccccccccccCCccCCCCccCcCCCcceeEeeccccccccccc
Q 039290          505 KLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLW-NLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIP  583 (1049)
Q Consensus       505 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  583 (1049)
                      ++++..+..++.+++|++|++++|++++..|..+. .+++|++|++++|.+++.  +....+++|++|+|++|+|++. |
T Consensus       131 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~l~~L~~L~Ls~N~l~~l-~  207 (317)
T 3o53_A          131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV--KGQVVFAKLKTLDLSSNKLAFM-G  207 (317)
T ss_dssp             CCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE--ECCCCCTTCCEEECCSSCCCEE-C
T ss_pred             CCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc--ccccccccCCEEECCCCcCCcc-h
Confidence            88776666777778888888888888877666664 677888888888887764  2333578889999999999864 4


Q ss_pred             ccccCCCcccEEEeecccccCCccccccCccCCcEEeccCcccc-CCcccccccccccceeeccC-CcccccCC
Q 039290          584 VTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLS-GTIPKSMEALSYLKHLNLSF-NQLEGEIP  655 (1049)
Q Consensus       584 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~l~l~~-N~l~~~~p  655 (1049)
                      ..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++ +.+|..+..+++|+.+++++ +.+.|..|
T Consensus       208 ~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~  280 (317)
T 3o53_A          208 PEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE  280 (317)
T ss_dssp             GGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred             hhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCch
Confidence            45889999999999999999 57888999999999999999998 77888899999999999984 45555544

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.94  E-value=2.9e-27  Score=278.52  Aligned_cols=236  Identities=20%  Similarity=0.182  Sum_probs=155.4

Q ss_pred             ccCCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCC
Q 039290          120 LRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLP  199 (1049)
Q Consensus       120 L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~  199 (1049)
                      .++|++|+|++|++.+..|..|+.+++|++|+|++|.+++.+|  ++.+++|++|||++|++++ +|.          .+
T Consensus        33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~~----------~~   99 (487)
T 3oja_A           33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-LLV----------GP   99 (487)
T ss_dssp             GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEE-EEE----------CT
T ss_pred             CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCC-CCC----------CC
Confidence            3378888888888887777788888888888888888876555  7888888888888888873 332          14


Q ss_pred             ccceEEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceEEeccccccccCccccc-cccceEEEee
Q 039290          200 VLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIG-NLRNLEVLGV  278 (1049)
Q Consensus       200 ~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~L  278 (1049)
                      +|++|++++|++++..+..   +++|+.|+|++|++++..|..|+++++|++|+|++|.+++.+|..+. .+++|+.|+|
T Consensus       100 ~L~~L~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~L  176 (487)
T 3oja_A          100 SIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL  176 (487)
T ss_dssp             TCCEEECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEEC
T ss_pred             CcCEEECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEec
Confidence            5777788888777654433   35666677777777666666666777777777777777766666665 5666777777


Q ss_pred             ccccCCCccccccccccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccc-
Q 039290          279 QSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFS-  357 (1049)
Q Consensus       279 ~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-  357 (1049)
                      ++|.+++..+  ...+++|+.|+|++|.+++ +|..+ ..+++|+.|+|++|.+++ +|..+..+++|+.|++++|.+. 
T Consensus       177 s~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~-~~~~~-~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c  251 (487)
T 3oja_A          177 QYNFIYDVKG--QVVFAKLKTLDLSSNKLAF-MGPEF-QSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHC  251 (487)
T ss_dssp             TTSCCCEEEC--CCCCTTCCEEECCSSCCCE-ECGGG-GGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCH
T ss_pred             CCCccccccc--cccCCCCCEEECCCCCCCC-CCHhH-cCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcC
Confidence            7666665522  2235666666666666654 33332 245666666666666663 5555666666666666666665 


Q ss_pred             cCcccccccccccceeecc
Q 039290          358 GLIPTTFGNLRSLKLLSLA  376 (1049)
Q Consensus       358 ~~~p~~~~~l~~L~~L~L~  376 (1049)
                      +.+|..+..+++|+.++++
T Consensus       252 ~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          252 GTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             HHHHHHHTTCHHHHHHHHH
T ss_pred             cchHHHHHhCCCCcEEecc
Confidence            4455555666666665554

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.94  E-value=3.6e-27  Score=277.74  Aligned_cols=234  Identities=21%  Similarity=0.247  Sum_probs=144.6

Q ss_pred             CCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEe
Q 039290          398 NLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYL  477 (1049)
Q Consensus       398 ~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  477 (1049)
                      +|+.|+|++|.+++..|..+..+. +|+.|+|++|.+++..|  +..+++|++|+|++|.|++..+     .++|++|++
T Consensus        35 ~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L  106 (487)
T 3oja_A           35 NVKELDLSGNPLSQISAADLAPFT-KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHA  106 (487)
T ss_dssp             GCCEEECCSSCCCCCCGGGGTTCT-TCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEEC
T ss_pred             CccEEEeeCCcCCCCCHHHHhCCC-CCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEEC
Confidence            344444444444433333333332 44444444444444333  5666677777777777664322     266777777


Q ss_pred             eccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccccCcccc-cccccccccccCCccCC
Q 039290          478 QNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLW-NLKDILRFNLSSNSLNG  556 (1049)
Q Consensus       478 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~  556 (1049)
                      ++|.|++..+.   .+++|+.|+|++|.+++..|..++++++|+.|+|++|++++.+|..+. .+++|+.|+|++|.+++
T Consensus       107 ~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~  183 (487)
T 3oja_A          107 ANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD  183 (487)
T ss_dssp             CSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred             cCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccc
Confidence            77777654443   245677777777777766666677777777777777777776666665 56777777777777665


Q ss_pred             CCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCcccc-CCcccccc
Q 039290          557 SLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLS-GTIPKSME  635 (1049)
Q Consensus       557 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~  635 (1049)
                      .  +....+++|++|+|++|.|++..| .|..+++|+.|+|++|+|++ +|..+..+++|+.|++++|+++ +.+|..+.
T Consensus       184 ~--~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~  259 (487)
T 3oja_A          184 V--KGQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFS  259 (487)
T ss_dssp             E--ECCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHT
T ss_pred             c--cccccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHH
Confidence            4  223346677777777777775433 46677777777777777774 5666777777777777777776 55666666


Q ss_pred             cccccceeecc
Q 039290          636 ALSYLKHLNLS  646 (1049)
Q Consensus       636 ~l~~L~~l~l~  646 (1049)
                      .++.|+.++++
T Consensus       260 ~l~~L~~l~~~  270 (487)
T 3oja_A          260 KNQRVQTVAKQ  270 (487)
T ss_dssp             TCHHHHHHHHH
T ss_pred             hCCCCcEEecc
Confidence            67777766665

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.93  E-value=4.1e-26  Score=248.83  Aligned_cols=211  Identities=20%  Similarity=0.205  Sum_probs=152.8

Q ss_pred             CCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceee
Q 039290          446 NNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSL  525 (1049)
Q Consensus       446 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  525 (1049)
                      ++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|++++|++++..+..+.++++|++|++
T Consensus        28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l  107 (276)
T 2z62_A           28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  107 (276)
T ss_dssp             TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence            35666666666666555556666666666666666666555555666666666666666666555566666666777777


Q ss_pred             cCcccccccCcccccccccccccccCCccCCC-CccCcCCCcceeEeecccccccccccccccCCCccc----EEEeecc
Q 039290          526 GSNALTSIIPSTLWNLKDILRFNLSSNSLNGS-LLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQ----LLSLRYN  600 (1049)
Q Consensus       526 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~Ls~N  600 (1049)
                      ++|++++..+..+..+++|++|++++|.+++. +|..+..+++|++|++++|++++..+..|..+.+|+    .|++++|
T Consensus       108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n  187 (276)
T 2z62_A          108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN  187 (276)
T ss_dssp             TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred             CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence            77777666665666777777777777777653 466777778888888888888877777777777777    8999999


Q ss_pred             cccCCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCcccccCCCC
Q 039290          601 RLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTR  657 (1049)
Q Consensus       601 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~  657 (1049)
                      ++++..+..+.. .+|++|+|++|++++..+..+..+++|+.|++++|+|.|.+|.-
T Consensus       188 ~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l  243 (276)
T 2z62_A          188 PMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  243 (276)
T ss_dssp             CCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred             cccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence            999666665554 48999999999999766667889999999999999999998853

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.93  E-value=2.9e-30  Score=314.69  Aligned_cols=206  Identities=14%  Similarity=0.174  Sum_probs=116.2

Q ss_pred             CceeeeEEEcCCCCcEEEEEEeccccccccCC-CCCCcchhhhhhcccCcccccc---C------------cccccccCC
Q 039290           60 VCSWIGVTCGVRNRRVTALNISYLGLTGTIPP-QLGNLSFLAVLAIRNNSFFGSL---P------------EELSHLRGL  123 (1049)
Q Consensus        60 ~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~-~~~~l~~L~~L~l~~n~~~g~~---p------------~~~~~L~~L  123 (1049)
                      |++|.++..    .....+++.+..  +..|. .+..++.|+.|+++++.....+   |            .-...+++|
T Consensus        34 ck~W~~~~~----~~~~~l~~~~~~--~~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L  107 (594)
T 2p1m_B           34 CKSWYEIER----WCRRKVFIGNCY--AVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWL  107 (594)
T ss_dssp             CHHHHHHHH----HHCCEEEESSTT--SSCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred             HHHHHHhhh----hhceEEeecccc--ccCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCC
Confidence            457888821    122344454321  12221 2345567777888776432211   1            112467788


Q ss_pred             cEeccccCCccccCccccc-ccCCccEEEeCCC-CccCC-CcccccCCCcccEEcCCCccCccccCCCcccccccCCCCc
Q 039290          124 KYFDFRFNNFHIEIPSWFV-SLPRLQHLLLKHN-SFVGK-IPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPV  200 (1049)
Q Consensus       124 ~~L~l~~n~~~~~~p~~~~-~l~~L~~L~L~~n-~l~~~-~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~  200 (1049)
                      ++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+..+++|++|+|++|.+++..+..+..+.  ..+++
T Consensus       108 ~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~--~~~~~  185 (594)
T 2p1m_B          108 EEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFP--DTYTS  185 (594)
T ss_dssp             CEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSC--TTCCC
T ss_pred             CeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHh--hcCCc
Confidence            8888888888777776665 6788888888888 44422 455555788888888888887765544443322  24566


Q ss_pred             cceEEeeccccCCCCCC-C----cccccccceecccccccccccCCCCccccccceEEeccc-------cccccCccccc
Q 039290          201 LEGLFISYNQLTGPIPT-N----LWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNN-------SLIGEIPNEIG  268 (1049)
Q Consensus       201 L~~L~l~~N~l~~~~p~-~----l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-------~l~~~~p~~l~  268 (1049)
                      |++|++++|.  +.++. .    ...+++|+.|++++|...+.+|..+.++++|++|+++.+       .+.+ ++..++
T Consensus       186 L~~L~l~~~~--~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~  262 (594)
T 2p1m_B          186 LVSLNISCLA--SEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALS  262 (594)
T ss_dssp             CCEEECTTCC--SCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHH
T ss_pred             CcEEEecccC--CcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHH-HHHHHh
Confidence            7788887776  22221 1    223466666666666222225555556666666663322       2332 233445


Q ss_pred             cccceEEE
Q 039290          269 NLRNLEVL  276 (1049)
Q Consensus       269 ~l~~L~~L  276 (1049)
                      ++++|+.|
T Consensus       263 ~~~~L~~L  270 (594)
T 2p1m_B          263 GCKELRCL  270 (594)
T ss_dssp             TCTTCCEE
T ss_pred             cCCCcccc
Confidence            55555555

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.93  E-value=6.4e-26  Score=246.17  Aligned_cols=217  Identities=22%  Similarity=0.250  Sum_probs=121.4

Q ss_pred             CCCceeeeEEEcCCCCcEEEEEEeccccccccCCCCCCcchhhhhhcccCccccccCcccccccCCcEeccccCCccccC
Q 039290           58 SSVCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEI  137 (1049)
Q Consensus        58 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~  137 (1049)
                      .++|.|.|+.|.-. ..++.+++++++++ .+|..+.  +.|++|+|++|++++..|..++++++|++|++++|+++...
T Consensus         2 ~~~C~~~~~~C~c~-~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~   77 (270)
T 2o6q_A            2 EALCKKDGGVCSCN-NNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP   77 (270)
T ss_dssp             CCCBGGGTCSBEEE-TTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred             CccCCCCCCCCEeC-CCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence            47899999998542 23456778887777 4665443  34555555555554333334455555555555555554333


Q ss_pred             cccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCCCCCC
Q 039290          138 PSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPT  217 (1049)
Q Consensus       138 p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~  217 (1049)
                      +..|.++++|++|+|++|.+++..+..++.+++|++|                              ++++|++++..|.
T Consensus        78 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L------------------------------~l~~n~l~~~~~~  127 (270)
T 2o6q_A           78 AGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAEL------------------------------RLDRNQLKSLPPR  127 (270)
T ss_dssp             TTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEE------------------------------ECCSSCCCCCCTT
T ss_pred             hhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEE------------------------------ECCCCccCeeCHH
Confidence            3334445555555555555443333344444444444                              4544444444444


Q ss_pred             CcccccccceecccccccccccCCCCccccccceEEeccccccccCccccccccceEEEeeccccCCCcccccccccccc
Q 039290          218 NLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTL  297 (1049)
Q Consensus       218 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L  297 (1049)
                      .+..+++|++|+|++|++++..+..|+.+++|++|+|++|++++..+..|.++++|+.|+|++|++++..+..+..+++|
T Consensus       128 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  207 (270)
T 2o6q_A          128 VFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKL  207 (270)
T ss_dssp             TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTC
T ss_pred             HhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCC
Confidence            44455555555555555554444445566666666666666665555556666666666666666665555556666666


Q ss_pred             ceEEeccCccC
Q 039290          298 KELAVTDNDLL  308 (1049)
Q Consensus       298 ~~L~l~~N~l~  308 (1049)
                      +.|++++|.+.
T Consensus       208 ~~L~l~~N~~~  218 (270)
T 2o6q_A          208 KMLQLQENPWD  218 (270)
T ss_dssp             CEEECCSSCBC
T ss_pred             CEEEecCCCee
Confidence            66666666654

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.93  E-value=7.1e-29  Score=302.39  Aligned_cols=208  Identities=15%  Similarity=0.110  Sum_probs=120.6

Q ss_pred             CCCCCCccEEEccCCccccc-CCccccCcCCCcceEeec---------cccCCCCCcccc-cccccceEEeeCcccCCcC
Q 039290          442 LGNINNLTVIRLGNNELTGT-IPVTLGRLQKLQGLYLQN---------NKLEGSIPEDLC-HLYRLANLYLGDNKLSGRL  510 (1049)
Q Consensus       442 ~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~---------N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~  510 (1049)
                      +..+++|+.|++++| ++.. ++.....+++|++|++++         +.+++.....+. .+++|+.|.++.|.+++..
T Consensus       310 ~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~  388 (594)
T 2p1m_B          310 LCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAA  388 (594)
T ss_dssp             HTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHH
T ss_pred             HhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHH
Confidence            345566666666666 3321 112222456666666633         333322222222 3566777777777766555


Q ss_pred             chhcc-CcccCCceeec--C----cccccc-----cCcccccccccccccccCCccCCCCccCcCC-CcceeEeeccccc
Q 039290          511 PACLG-NLTSLRDLSLG--S----NALTSI-----IPSTLWNLKDILRFNLSSNSLNGSLLPDIGN-LKVVIEMDLSLNA  577 (1049)
Q Consensus       511 p~~~~-~l~~L~~L~L~--~----N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~Ls~N~  577 (1049)
                      +..+. .+++|+.|+++  +    |.+++.     ++..+..+++|++|++++ .+++..+..+.. +++|++|+|++|.
T Consensus       389 ~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~  467 (594)
T 2p1m_B          389 LITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAG  467 (594)
T ss_dssp             HHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCC
T ss_pred             HHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCC
Confidence            44444 46677777777  3    455421     122245566777777766 555444444444 6777788888887


Q ss_pred             ccccccccc-cCCCcccEEEeecccccCCccc-cccCccCCcEEeccCccccCCccccc-ccccccceeeccCCccc
Q 039290          578 LSGVIPVTI-GGLQGLQLLSLRYNRLQGPIPE-SFGGLKSLNFVDMSNNNLSGTIPKSM-EALSYLKHLNLSFNQLE  651 (1049)
Q Consensus       578 l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~l~l~~N~l~  651 (1049)
                      +++..+..+ .++++|+.|+|++|++++.... ....+++|++|++++|+++..-...+ ..+++|+...+..+.-.
T Consensus       468 i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~~  544 (594)
T 2p1m_B          468 DSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAP  544 (594)
T ss_dssp             SSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSCG
T ss_pred             CcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCcc
Confidence            766555544 5678888888888888654433 44557888888888887754433333 45566666666655443

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.93  E-value=5.2e-25  Score=238.99  Aligned_cols=206  Identities=24%  Similarity=0.287  Sum_probs=145.5

Q ss_pred             ccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecC
Q 039290          448 LTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGS  527 (1049)
Q Consensus       448 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  527 (1049)
                      .+.+++++|+++ .+|..+.  ++|++|+|++|++++..+..|..+++|++|++++|.++...+..|.++++|++|++++
T Consensus        18 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~   94 (270)
T 2o6q_A           18 KNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD   94 (270)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred             CCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence            445555555555 2443332  3455555555555544444555566666666666666544444456666666666666


Q ss_pred             cccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCcc
Q 039290          528 NALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIP  607 (1049)
Q Consensus       528 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~  607 (1049)
                      |+++++.+..+..+++|++|++++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++..+
T Consensus        95 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  174 (270)
T 2o6q_A           95 NKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPE  174 (270)
T ss_dssp             SCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             CcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeCh
Confidence            66666666666666777777777777776666667777788888888888887766778888889999999998888777


Q ss_pred             ccccCccCCcEEeccCccccCCcccccccccccceeeccCCcccccCCC
Q 039290          608 ESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPT  656 (1049)
Q Consensus       608 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~  656 (1049)
                      ..|.++++|++|+|++|++++..+..+..+++|+.|++++|+|.|.++.
T Consensus       175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~  223 (270)
T 2o6q_A          175 GAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCNG  223 (270)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSSS
T ss_pred             hHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCcc
Confidence            7888889999999999999866666788889999999999999888764

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.92  E-value=8.3e-25  Score=238.42  Aligned_cols=208  Identities=23%  Similarity=0.275  Sum_probs=133.8

Q ss_pred             cccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEee
Q 039290          423 SMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLG  502 (1049)
Q Consensus       423 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  502 (1049)
                      ++++|++++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..+..+++|++|+++
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  108 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence            44455555555554444455555556666666665555555555555566666666666555555555555666666666


Q ss_pred             CcccCCcCchhccCcccCCceeecCcccccc-cCcccccccccccccccCCccCCCCccCcCCCccee----Eeeccccc
Q 039290          503 DNKLSGRLPACLGNLTSLRDLSLGSNALTSI-IPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVI----EMDLSLNA  577 (1049)
Q Consensus       503 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~----~L~Ls~N~  577 (1049)
                      +|.+++..+..++++++|++|++++|++++. +|..+..+++|++|++++|++++..+..+..+.+|+    +|++++|+
T Consensus       109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~  188 (276)
T 2z62_A          109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP  188 (276)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred             CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence            6665544444555566666666666666553 355566666666666666666555555555554444    78888888


Q ss_pred             ccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCcc
Q 039290          578 LSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIP  631 (1049)
Q Consensus       578 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  631 (1049)
                      +++..+..+.. .+|+.|+|++|++++..+..|.++++|++|+|++|++++..|
T Consensus       189 l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  241 (276)
T 2z62_A          189 MNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  241 (276)
T ss_dssp             CCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred             ccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence            88665555554 489999999999998877888999999999999999986543

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.92  E-value=7.8e-25  Score=239.64  Aligned_cols=207  Identities=26%  Similarity=0.245  Sum_probs=156.9

Q ss_pred             CCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCC
Q 039290          442 LGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLR  521 (1049)
Q Consensus       442 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  521 (1049)
                      +.++++++++++++|+++ .+|..+.  ++++.|+|++|+|++..+..|..+++|++|+|++|.+++ ++.. +.+++|+
T Consensus         6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~-~~l~~L~   80 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLG   80 (290)
T ss_dssp             EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC-SCCTTCC
T ss_pred             ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC-CCCCcCC
Confidence            345566666666666666 3444433  466677777777766666666677777777777777764 3322 6677777


Q ss_pred             ceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeeccc
Q 039290          522 DLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNR  601 (1049)
Q Consensus       522 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  601 (1049)
                      +|++++|+++. +|..+..+++|++|++++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus        81 ~L~Ls~N~l~~-l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  159 (290)
T 1p9a_G           81 TLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (290)
T ss_dssp             EEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             EEECCCCcCCc-CchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence            77777777774 56677777788888888888877777778888888888888888887777788888999999999999


Q ss_pred             ccCCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCcccccCC
Q 039290          602 LQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIP  655 (1049)
Q Consensus       602 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p  655 (1049)
                      |++..+..|.++++|++|+|++|+|+ .+|..+..+.+|+.++|++|+|.|.+.
T Consensus       160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~  212 (290)
T 1p9a_G          160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE  212 (290)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred             CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcCc
Confidence            99777778888999999999999998 788888888899999999999988763

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=2e-24  Score=234.55  Aligned_cols=231  Identities=22%  Similarity=0.232  Sum_probs=130.2

Q ss_pred             CcchhhhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEE
Q 039290           95 NLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQEL  174 (1049)
Q Consensus        95 ~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  174 (1049)
                      .+..+..+++..+.+...  ..+..+++|+.|++++|.+. .++ .+..+++|++|+|++|.+++ + +.++.+++|++|
T Consensus        17 ~~~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L   90 (272)
T 3rfs_A           17 AFAETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYL   90 (272)
T ss_dssp             HHHHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEE
T ss_pred             hHHHHHHHHhcCcccccc--cccccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEE
Confidence            344566667777666533  23556677777777777665 232 46667777777777777664 3 356666777777


Q ss_pred             cCCCccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceEEe
Q 039290          175 DLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFL  254 (1049)
Q Consensus       175 ~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  254 (1049)
                      +|++|++++..|..+.      ++++|++|++++|++++..|..+..+++|++|++++|++++..|..++.+++|++|+|
T Consensus        91 ~L~~n~l~~~~~~~~~------~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l  164 (272)
T 3rfs_A           91 ILTGNQLQSLPNGVFD------KLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDL  164 (272)
T ss_dssp             ECTTSCCCCCCTTTTT------TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             ECCCCccCccChhHhc------CCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEEC
Confidence            7777766633332222      2344556666666655444444444555555555555554444444444444444444


Q ss_pred             ccccccccCccccccccceEEEeeccccCCCccccccccccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCC
Q 039290          255 GNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSG  334 (1049)
Q Consensus       255 ~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~  334 (1049)
                      ++|                        ++++..+..+..+++|++|++++|++.+ +|...+..+++|++|++++|.+.+
T Consensus       165 ~~n------------------------~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~~~~  219 (272)
T 3rfs_A          165 SYN------------------------QLQSLPEGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDNPWDC  219 (272)
T ss_dssp             CSS------------------------CCCCCCTTTTTTCTTCCEEECCSSCCSC-CCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             CCC------------------------CcCccCHHHhcCCccCCEEECCCCcCCc-cCHHHHhCCcCCCEEEccCCCccc
Confidence            444                        4444444444455555555555555553 222333355666666666666553


Q ss_pred             CCCccccCCCCCceeecccCccccCcccccccccc
Q 039290          335 TIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRS  369 (1049)
Q Consensus       335 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  369 (1049)
                      .       +++|+.|+++.|.++|.+|..++.+..
T Consensus       220 ~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~  247 (272)
T 3rfs_A          220 T-------CPGIRYLSEWINKHSGVVRNSAGSVAP  247 (272)
T ss_dssp             C-------TTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred             c-------CcHHHHHHHHHHhCCCcccCcccccCC
Confidence            3       346777777777777777777766654

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=1.4e-24  Score=235.72  Aligned_cols=160  Identities=26%  Similarity=0.294  Sum_probs=99.2

Q ss_pred             cccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCccee
Q 039290          490 LCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVI  569 (1049)
Q Consensus       490 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  569 (1049)
                      +..+++|++|++++|.+++..+..++++++|++|++++|++++..+..+..+++|++|++++|++++..+..++.+++|+
T Consensus        81 l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  160 (272)
T 3rfs_A           81 LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLT  160 (272)
T ss_dssp             GTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             hcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCC
Confidence            33444444444444444433334444444555555555555544444455555555555555555554444555666666


Q ss_pred             EeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCc
Q 039290          570 EMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQ  649 (1049)
Q Consensus       570 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~  649 (1049)
                      +|++++|++++..+..|+.+++|+.|+|++|++++..|..|..+++|++|+|++|++++.       +++|++++++.|.
T Consensus       161 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~  233 (272)
T 3rfs_A          161 ELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINK  233 (272)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHH
T ss_pred             EEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHh
Confidence            666666666666666677777778888888887777777777788888888888877654       3457777888888


Q ss_pred             ccccCCC
Q 039290          650 LEGEIPT  656 (1049)
Q Consensus       650 l~~~~p~  656 (1049)
                      ++|.+|.
T Consensus       234 ~~g~ip~  240 (272)
T 3rfs_A          234 HSGVVRN  240 (272)
T ss_dssp             TGGGBBC
T ss_pred             CCCcccC
Confidence            8888775

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=1.4e-24  Score=257.53  Aligned_cols=185  Identities=15%  Similarity=0.177  Sum_probs=146.2

Q ss_pred             CCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCC--------CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          764 SENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDG--------SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       764 ~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      ...+.||+|+||+||+|+. .++.+++|+.......        ..+++.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4467899999999999954 6788999886543221        134579999999999999999666666677778999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++++|.+++..         +..++.|+++|++|||   +++|+||||||+||+++.  .+||+|||+++......
T Consensus       418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred             EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence            999999999998875         5689999999999999   999999999999999999  99999999999875533


Q ss_pred             ccc------ccccccccCcccccccCC--CCcCcccchHHHHHHHHHHHhCCCCCC
Q 039290          916 SMR------QTKTLGTIGYMAPEYGRE--GKVSRKCDVYSYGIMLMETFTKKKPTD  963 (1049)
Q Consensus       916 ~~~------~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~  963 (1049)
                      ...      .....||+.|||||++..  ..|+..+|+|+..+-..+...++.+|.
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            211      234679999999999976  568888999999998888888777664

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.90  E-value=2.4e-23  Score=227.84  Aligned_cols=205  Identities=24%  Similarity=0.266  Sum_probs=138.9

Q ss_pred             cccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCC
Q 039290          393 LTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKL  472 (1049)
Q Consensus       393 l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  472 (1049)
                      +..+++++.+++++|.++.+ |.                         .+.  ++++.|+|++|.+++..|..|..+++|
T Consensus         6 ~~~l~~l~~l~~~~~~l~~i-p~-------------------------~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L   57 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLTAL-PP-------------------------DLP--KDTTILHLSENLLYTFSLATLMPYTRL   57 (290)
T ss_dssp             EECSTTCCEEECTTSCCSSC-CS-------------------------CCC--TTCCEEECTTSCCSEEEGGGGTTCTTC
T ss_pred             ccccCCccEEECCCCCCCcC-CC-------------------------CCC--CCCCEEEcCCCcCCccCHHHhhcCCCC
Confidence            45566677777777776632 22                         221  345555555555555445555555555


Q ss_pred             cceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCC
Q 039290          473 QGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSN  552 (1049)
Q Consensus       473 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N  552 (1049)
                      ++|+|++|+|++. +.. ..+++|++|++++|+++ .+|..+..+++|++|++++|+++++.|..|..+++|++|+|++|
T Consensus        58 ~~L~L~~n~l~~~-~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N  134 (290)
T 1p9a_G           58 TQLNLDRAELTKL-QVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN  134 (290)
T ss_dssp             CEEECTTSCCCEE-ECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTS
T ss_pred             CEEECCCCccCcc-cCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCC
Confidence            5555555555532 221 45556666666666665 45556666667777777777777666666777777777777777


Q ss_pred             ccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCC
Q 039290          553 SLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGT  629 (1049)
Q Consensus       553 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  629 (1049)
                      ++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|++.+.
T Consensus       135 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~  210 (290)
T 1p9a_G          135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN  210 (290)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred             CCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCc
Confidence            777666666777788888888888888766677788889999999999998 6777777888999999999998753

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.90  E-value=4.6e-26  Score=256.21  Aligned_cols=268  Identities=18%  Similarity=0.212  Sum_probs=156.4

Q ss_pred             CCCceeeeEEEcCCCCcEEEEEEeccccccccCCCCCCc--chhhhhhcccCccccccCcccccccCCcEeccccCCccc
Q 039290           58 SSVCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNL--SFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHI  135 (1049)
Q Consensus        58 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l--~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~  135 (1049)
                      .-|.+|.++.|+..  .+..++++++.+.   |..++.+  +.++.|++++|.+.+..|. +.++++|++|++++|++.+
T Consensus        34 ~vc~~W~~~~~~~~--~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~  107 (336)
T 2ast_B           34 GVCKRWYRLASDES--LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEV  107 (336)
T ss_dssp             SSCHHHHHHHTCST--TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECH
T ss_pred             HHHHHHHHHhcCch--hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCH
Confidence            34558999998643  4567788777665   2334444  5666777777776655443 4566777777777776665


Q ss_pred             c-CcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCc-cCccc-cCCCcccccccCCCCccceEEeecc-cc
Q 039290          136 E-IPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDN-QLSGT-IPSSIFNISSCQNLPVLEGLFISYN-QL  211 (1049)
Q Consensus       136 ~-~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N-~l~g~-ip~~~~~l~~l~~l~~L~~L~l~~N-~l  211 (1049)
                      . +|..+..+++|++|+|++|.+++..|..++.+++|++|+|++| .+++. +|..+.      ++++|++|++++| .+
T Consensus       108 ~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~------~~~~L~~L~l~~~~~l  181 (336)
T 2ast_B          108 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS------SCSRLDELNLSWCFDF  181 (336)
T ss_dssp             HHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHH------HCTTCCEEECCCCTTC
T ss_pred             HHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHh------cCCCCCEEcCCCCCCc
Confidence            4 6666666777777777777666666666666777777777766 45542 333222      2344555555555 55


Q ss_pred             CCCCCCCcccccccceecccccccccccCCCCcccc-ccceEEeccc--ccc-ccCccccccccceEEEeecccc-CCCc
Q 039290          212 TGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLT-SVRNLFLGNN--SLI-GEIPNEIGNLRNLEVLGVQSSN-LAGL  286 (1049)
Q Consensus       212 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N--~l~-~~~p~~l~~l~~L~~L~L~~n~-l~~~  286 (1049)
                      ++.                       .++..+..++ +|++|+|++|  .++ +.+|..++++++|+.|++++|. +++.
T Consensus       182 ~~~-----------------------~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~  238 (336)
T 2ast_B          182 TEK-----------------------HVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKND  238 (336)
T ss_dssp             CHH-----------------------HHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGG
T ss_pred             ChH-----------------------HHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHH
Confidence            432                       1334444455 5555555555  233 3444455555555555555555 4444


Q ss_pred             cccccccccccceEEeccCccCCCCCCc--ccCCCCCccEEEcCCCCCCCCCCccccCC-CCCceeecccCccccCcccc
Q 039290          287 IPASIFNISTLKELAVTDNDLLGSLPSS--IDLGLPNLERLFLGENNFSGTIPSSLTNI-SELSVLDFGFNSFSGLIPTT  363 (1049)
Q Consensus       287 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~  363 (1049)
                      .+..+.++++|++|++++|.  +..+..  ....+++|++|++++| ++   ...+..+ .++..|++++|++++..|..
T Consensus       239 ~~~~l~~l~~L~~L~l~~~~--~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~  312 (336)
T 2ast_B          239 CFQEFFQLNYLQHLSLSRCY--DIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPT  312 (336)
T ss_dssp             GGGGGGGCTTCCEEECTTCT--TCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred             HHHHHhCCCCCCEeeCCCCC--CCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCc
Confidence            45555555666666666654  111111  1224677777777777 32   2233344 34777778888888877777


Q ss_pred             ccc
Q 039290          364 FGN  366 (1049)
Q Consensus       364 ~~~  366 (1049)
                      ++.
T Consensus       313 ~~~  315 (336)
T 2ast_B          313 IGN  315 (336)
T ss_dssp             CSS
T ss_pred             ccc
Confidence            664

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.89  E-value=1.5e-23  Score=224.73  Aligned_cols=190  Identities=21%  Similarity=0.266  Sum_probs=108.8

Q ss_pred             CCceeeeEEEcCCCCcEEEEEEeccccccccCCCCCCcchhhhhhcccCccccccCcccccccCCcEeccccCCccccCc
Q 039290           59 SVCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIP  138 (1049)
Q Consensus        59 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p  138 (1049)
                      +||.|.|.+|...   ...+++++++++ .+|..+.  +.++.|+|++|++.+..|..++++++|++|+|++|++.+..|
T Consensus         3 ~Cp~~~gC~C~~~---~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~   76 (251)
T 3m19_A            3 TCETVTGCTCNEG---KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA   76 (251)
T ss_dssp             -CHHHHSSEEEGG---GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred             cCCCCCceEcCCC---CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCH
Confidence            6889999999532   235788888887 6776554  456666666666665555566666666666666666666555


Q ss_pred             ccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCCCCCCC
Q 039290          139 SWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTN  218 (1049)
Q Consensus       139 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~  218 (1049)
                      ..|..+++|++|+|++|.+++..|..++.+++|++|+|++|+++ .+|...+     .++++|++|+|++|++++..+..
T Consensus        77 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~-----~~l~~L~~L~Ls~N~l~~~~~~~  150 (251)
T 3m19_A           77 GVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVF-----DRLTKLKELRLNTNQLQSIPAGA  150 (251)
T ss_dssp             TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTT-----TTCTTCCEEECCSSCCCCCCTTT
T ss_pred             hHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCC-CcChhHh-----ccCCcccEEECcCCcCCccCHHH
Confidence            55666666666666666666555555566666666666666665 3333221     12344555555555555433334


Q ss_pred             cccccccceecccccccccccCCCCccccccceEEecccccc
Q 039290          219 LWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLI  260 (1049)
Q Consensus       219 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  260 (1049)
                      +..+++|++|+|++|++++..|..|..+++|++|+|++|.+.
T Consensus       151 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  192 (251)
T 3m19_A          151 FDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFD  192 (251)
T ss_dssp             TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred             cCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCcee
Confidence            444444444444444444443444444444444444444444

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.89  E-value=7.1e-24  Score=251.12  Aligned_cols=208  Identities=25%  Similarity=0.369  Sum_probs=171.8

Q ss_pred             cCCCCCCCc-----eeeeE-EEcCCCCcEEEEEEeccccccccCCCCCCcchhhhhhcccCccccccCcccccccCCcEe
Q 039290           53 NWSTTSSVC-----SWIGV-TCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYF  126 (1049)
Q Consensus        53 ~w~~~~~~c-----~w~gv-~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L  126 (1049)
                      +|..+.++|     .|.|+ .|..  ++++.|+|+++++++ +|+.+.  ++|++|+|++|.++ .+|   ..+++|++|
T Consensus        35 ~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L  105 (571)
T 3cvr_A           35 KWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYL  105 (571)
T ss_dssp             HHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEE
T ss_pred             HHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEE
Confidence            566666777     79999 7863  478999999999996 888775  78999999999998 788   567899999


Q ss_pred             ccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEe
Q 039290          127 DFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFI  206 (1049)
Q Consensus       127 ~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l  206 (1049)
                      +|++|++++ +|. +.+  +|++|+|++|.+++ +|.   .+++|++|+|++|++++ +|.         .+++|++|+|
T Consensus       106 ~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---------~l~~L~~L~L  167 (571)
T 3cvr_A          106 DACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---------LPTSLEVLSV  167 (571)
T ss_dssp             ECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---------CCTTCCEEEC
T ss_pred             EccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---------cCCCcCEEEC
Confidence            999999987 787 665  89999999999986 777   68899999999999984 776         1356889999


Q ss_pred             eccccCCCCCCCcccccccceecccccccccccCCCCcccccc-------ceEEeccccccccCccccccccceEEEeec
Q 039290          207 SYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSV-------RNLFLGNNSLIGEIPNEIGNLRNLEVLGVQ  279 (1049)
Q Consensus       207 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-------~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  279 (1049)
                      ++|++++ +|. +.  ++|+.|+|++|+|+ .+|. |..  +|       +.|+|++|+|+ .+|..+..+++|+.|+|+
T Consensus       168 s~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~  238 (571)
T 3cvr_A          168 RNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILE  238 (571)
T ss_dssp             CSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECC
T ss_pred             CCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEee
Confidence            9999986 777 55  88999999999988 6777 655  67       88999999988 678888888899999999


Q ss_pred             cccCCCccccccccccc
Q 039290          280 SSNLAGLIPASIFNIST  296 (1049)
Q Consensus       280 ~n~l~~~~p~~~~~l~~  296 (1049)
                      +|++++.+|..+..++.
T Consensus       239 ~N~l~~~~p~~l~~l~~  255 (571)
T 3cvr_A          239 DNPLSSRIRESLSQQTA  255 (571)
T ss_dssp             SSSCCHHHHHHHHHHHH
T ss_pred             CCcCCCcCHHHHHHhhc
Confidence            99888888887776554

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.89  E-value=5e-23  Score=219.08  Aligned_cols=196  Identities=22%  Similarity=0.254  Sum_probs=104.4

Q ss_pred             cccEEEccCCccccCCCCCCCCCCCccEEEccCCc-ccccCCccccCcCCCcceEeec-cccCCCCCcccccccccceEE
Q 039290          423 SMKSLSMESCNISGGIPKELGNINNLTVIRLGNNE-LTGTIPVTLGRLQKLQGLYLQN-NKLEGSIPEDLCHLYRLANLY  500 (1049)
Q Consensus       423 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~  500 (1049)
                      ++++|++++|++++..+..|.++++|++|++++|+ +++..+..|.++++|++|++++ |++++..+..|..+++|++|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            55555555555555444455555555555555554 5544444555555555555555 555544444555555555555


Q ss_pred             eeCcccCCcCchhccCcccCC---ceeecCc-ccccccCcccccccccccccccCCccCCCCccCcCCCccee-Eeeccc
Q 039290          501 LGDNKLSGRLPACLGNLTSLR---DLSLGSN-ALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVI-EMDLSL  575 (1049)
Q Consensus       501 L~~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~Ls~  575 (1049)
                      +++|++++ +|. +..+++|+   +|++++| +++++.                        +..|..+++|+ +|++++
T Consensus       112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~------------------------~~~~~~l~~L~~~L~l~~  165 (239)
T 2xwt_C          112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIP------------------------VNAFQGLCNETLTLKLYN  165 (239)
T ss_dssp             EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEEC------------------------TTTTTTTBSSEEEEECCS
T ss_pred             CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcC------------------------cccccchhcceeEEEcCC
Confidence            55555553 333 44444444   5555554 444443                        44455555555 555555


Q ss_pred             ccccccccccccCCCcccEEEeeccc-ccCCccccccCc-cCCcEEeccCccccCCcccccccccccceeeccCC
Q 039290          576 NALSGVIPVTIGGLQGLQLLSLRYNR-LQGPIPESFGGL-KSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFN  648 (1049)
Q Consensus       576 N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N  648 (1049)
                      |+++...+..|.. ++|+.|+|++|+ +++..+..|.++ ++|++|||++|+++ .+|..  .+++|+.|+++++
T Consensus       166 n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~--~~~~L~~L~l~~~  236 (239)
T 2xwt_C          166 NGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK--GLEHLKELIARNT  236 (239)
T ss_dssp             CCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCT--TCTTCSEEECTTC
T ss_pred             CCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc-cCChh--HhccCceeeccCc
Confidence            5555332233333 566666666663 665555566666 66666666666666 33332  4555666666554

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.89  E-value=2.7e-23  Score=230.41  Aligned_cols=201  Identities=19%  Similarity=0.193  Sum_probs=133.8

Q ss_pred             CCccEEEccCCcccccCCccc--cCcCCCcceEeeccccCCCCC----cccccccccceEEeeCcccCCcCchhccCccc
Q 039290          446 NNLTVIRLGNNELTGTIPVTL--GRLQKLQGLYLQNNKLEGSIP----EDLCHLYRLANLYLGDNKLSGRLPACLGNLTS  519 (1049)
Q Consensus       446 ~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  519 (1049)
                      ++|++|+|++|.+++..|..+  ..+++|++|+|++|++++..+    ..+..+++|++|++++|++++..|..++++++
T Consensus        91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~  170 (310)
T 4glp_A           91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA  170 (310)
T ss_dssp             SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred             CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence            446666666666666666655  666666666666666665443    23345666666677766666666666666677


Q ss_pred             CCceeecCcccccc---c-CcccccccccccccccCCccCCCCcc----CcCCCcceeEeecccccccccccccccCC--
Q 039290          520 LRDLSLGSNALTSI---I-PSTLWNLKDILRFNLSSNSLNGSLLP----DIGNLKVVIEMDLSLNALSGVIPVTIGGL--  589 (1049)
Q Consensus       520 L~~L~L~~N~l~~~---~-p~~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l--  589 (1049)
                      |++|+|++|++.+.   . +..+..+++|++|+|++|+++. ++.    .+..+++|++|||++|+|++..|..+..+  
T Consensus       171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~  249 (310)
T 4glp_A          171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMW  249 (310)
T ss_dssp             CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCC
T ss_pred             CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccC
Confidence            77777777766542   1 2223566677777777777653 222    24566777777777777777767666666  


Q ss_pred             -CcccEEEeecccccCCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCcccc
Q 039290          590 -QGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEG  652 (1049)
Q Consensus       590 -~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~  652 (1049)
                       ++|+.|+|++|+|+ .+|..+.  ++|++|||++|+|++. |. +..+++|+.|++++|+++.
T Consensus       250 ~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          250 SSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             CTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred             cCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence             58888888888888 5566654  6888888888888853 33 6777888888888888764

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.89  E-value=1.3e-24  Score=246.74  Aligned_cols=111  Identities=19%  Similarity=0.179  Sum_probs=66.6

Q ss_pred             hhcccCccccccCcccccccCCcEeccccCCccccCc----ccccccC-CccEEEeCCCCccCCCcccccCC-----Ccc
Q 039290          102 LAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIP----SWFVSLP-RLQHLLLKHNSFVGKIPETIGYL-----SLL  171 (1049)
Q Consensus       102 L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p----~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l-----~~L  171 (1049)
                      +.++.|+++|.+|..+...++|++|||++|++.+..+    ..|.+++ +|++|+|++|.+++..+..+..+     ++|
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L   82 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV   82 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence            3566677777777666666667777777777665555    5566666 67777777777766656655554     666


Q ss_pred             cEEcCCCccCccccCCCcccccccCCC-CccceEEeeccccCCC
Q 039290          172 QELDLSDNQLSGTIPSSIFNISSCQNL-PVLEGLFISYNQLTGP  214 (1049)
Q Consensus       172 ~~L~Ls~N~l~g~ip~~~~~l~~l~~l-~~L~~L~l~~N~l~~~  214 (1049)
                      ++|||++|++++..+..++..  ++.+ ++|++|+|++|++++.
T Consensus        83 ~~L~Ls~n~l~~~~~~~l~~~--l~~~~~~L~~L~Ls~N~l~~~  124 (362)
T 3goz_A           83 TSLNLSGNFLSYKSSDELVKT--LAAIPFTITVLDLGWNDFSSK  124 (362)
T ss_dssp             CEEECCSSCGGGSCHHHHHHH--HHTSCTTCCEEECCSSCGGGS
T ss_pred             cEEECcCCcCChHHHHHHHHH--HHhCCCCccEEECcCCcCCcH
Confidence            667776666665444433321  1122 3455555555555543

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.88  E-value=1.2e-24  Score=247.06  Aligned_cols=251  Identities=19%  Similarity=0.204  Sum_probs=168.2

Q ss_pred             EEccCCccccCCCCccccccccccEEEccCCccccCCC----CCCCCCC-CccEEEccCCcccccCCccccCc-----CC
Q 039290          402 IYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIP----KELGNIN-NLTVIRLGNNELTGTIPVTLGRL-----QK  471 (1049)
Q Consensus       402 L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~  471 (1049)
                      +++++|.+++.+|..+.. ..+|++|+|++|.+++..+    ..+..++ +|++|+|++|.+++..+..+..+     ++
T Consensus         3 ~~ls~n~~~~~~~~~~~~-~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~   81 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSI-PHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN   81 (362)
T ss_dssp             EECCCCTTCCHHHHHHTS-CTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred             cccccccchHHHHHHHhC-CCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence            345555555544433322 2246666666666665554    5566666 77777887777776666666664     77


Q ss_pred             CcceEeeccccCCCCCcccccc-----cccceEEeeCcccCCcCchhccC-----cccCCceeecCcccccccC----cc
Q 039290          472 LQGLYLQNNKLEGSIPEDLCHL-----YRLANLYLGDNKLSGRLPACLGN-----LTSLRDLSLGSNALTSIIP----ST  537 (1049)
Q Consensus       472 L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~~p----~~  537 (1049)
                      |++|+|++|++++..+..++..     ++|++|++++|++++..+..+..     .++|++|+|++|++++..+    ..
T Consensus        82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~  161 (362)
T 3goz_A           82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI  161 (362)
T ss_dssp             CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred             ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence            8888888888776666554443     67888888888877665554433     2578888888888875333    33


Q ss_pred             ccccc-ccccccccCCccCCCCccCcC----CC-cceeEeeccccccccc----ccccccC-CCcccEEEeecccccCCc
Q 039290          538 LWNLK-DILRFNLSSNSLNGSLLPDIG----NL-KVVIEMDLSLNALSGV----IPVTIGG-LQGLQLLSLRYNRLQGPI  606 (1049)
Q Consensus       538 ~~~l~-~L~~L~Ls~N~l~~~~~~~~~----~l-~~L~~L~Ls~N~l~~~----~p~~~~~-l~~L~~L~Ls~N~l~~~~  606 (1049)
                      +...+ +|++|+|++|++++..+..+.    .+ ++|++|||++|.|++.    ++..+.. .++|+.|+|++|+|++..
T Consensus       162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~  241 (362)
T 3goz_A          162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS  241 (362)
T ss_dssp             HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred             HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence            34444 788888888888766554433    33 5888888888888863    4455555 358888999988888755


Q ss_pred             c----ccccCccCCcEEeccCccccCC-------cccccccccccceeeccCCccccc
Q 039290          607 P----ESFGGLKSLNFVDMSNNNLSGT-------IPKSMEALSYLKHLNLSFNQLEGE  653 (1049)
Q Consensus       607 ~----~~~~~l~~L~~L~Ls~N~l~~~-------~p~~~~~l~~L~~l~l~~N~l~~~  653 (1049)
                      +    ..+..+++|++|+|++|++++.       ++..+..+++|+.||+++|++...
T Consensus       242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~  299 (362)
T 3goz_A          242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS  299 (362)
T ss_dssp             HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred             HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence            4    4456778889999998885533       334566778888899999988765

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.88  E-value=1.3e-22  Score=217.44  Aligned_cols=180  Identities=23%  Similarity=0.253  Sum_probs=102.4

Q ss_pred             CccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeec
Q 039290          447 NLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLG  526 (1049)
Q Consensus       447 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  526 (1049)
                      +.++++++++.++ .+|..+.  ++|+.|+|++|++++..+..|..+++|++|+|++|.+++..|..|.++++|++|+|+
T Consensus        15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~   91 (251)
T 3m19_A           15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA   91 (251)
T ss_dssp             GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred             CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence            4556666666666 4454443  456666666666665555555555666666666666555555555555555555555


Q ss_pred             CcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCc
Q 039290          527 SNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPI  606 (1049)
Q Consensus       527 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  606 (1049)
                      +|+++++.+..|..+                        ++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..
T Consensus        92 ~n~l~~~~~~~~~~l------------------------~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  147 (251)
T 3m19_A           92 NNQLASLPLGVFDHL------------------------TQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIP  147 (251)
T ss_dssp             TSCCCCCCTTTTTTC------------------------TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred             CCcccccChhHhccc------------------------CCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccC
Confidence            555555444444444                        44555555555555444444555555666666666655555


Q ss_pred             cccccCccCCcEEeccCccccCCcccccccccccceeeccCCccccc
Q 039290          607 PESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGE  653 (1049)
Q Consensus       607 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~  653 (1049)
                      +..|+++++|++|+|++|++++..+..+..+++|+.|++++|+|+|.
T Consensus       148 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          148 AGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             HHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            55555566666666666666554444555566666666666666555

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.88  E-value=3.1e-23  Score=229.92  Aligned_cols=201  Identities=21%  Similarity=0.257  Sum_probs=163.7

Q ss_pred             cccEEEccCCccccCCCCCC--CCCCCccEEEccCCcccccCC----ccccCcCCCcceEeeccccCCCCCccccccccc
Q 039290          423 SMKSLSMESCNISGGIPKEL--GNINNLTVIRLGNNELTGTIP----VTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRL  496 (1049)
Q Consensus       423 ~L~~L~L~~n~i~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  496 (1049)
                      +|++|++++|.+.+..|..+  ..+++|++|+|++|.+++..+    ..+..+++|++|+|++|++.+..+..+..+++|
T Consensus        92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L  171 (310)
T 4glp_A           92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL  171 (310)
T ss_dssp             CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred             ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence            47777777777777777777  788889999999998887555    345578899999999999988888888899999


Q ss_pred             ceEEeeCcccCCc--C--chhccCcccCCceeecCcccccccC--c-ccccccccccccccCCccCCCCccCcCCC---c
Q 039290          497 ANLYLGDNKLSGR--L--PACLGNLTSLRDLSLGSNALTSIIP--S-TLWNLKDILRFNLSSNSLNGSLLPDIGNL---K  566 (1049)
Q Consensus       497 ~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~L~~N~l~~~~p--~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l---~  566 (1049)
                      ++|+|++|++.+.  +  +..++.+++|++|+|++|+++...+  . .+..+++|++|+|++|++++..|+.+..+   +
T Consensus       172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~  251 (310)
T 4glp_A          172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSS  251 (310)
T ss_dssp             CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCT
T ss_pred             CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcC
Confidence            9999999987642  2  2334788999999999999975322  1 35678999999999999998878777776   6


Q ss_pred             ceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccC
Q 039290          567 VVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSG  628 (1049)
Q Consensus       567 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  628 (1049)
                      +|++|+|++|+|+ .+|..+.  ++|+.|+|++|+|++. |. +..+++|++|+|++|+++.
T Consensus       252 ~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          252 ALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             TCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred             cCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence            9999999999999 5677765  7999999999999964 43 6888999999999999974

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.88  E-value=1.7e-22  Score=214.84  Aligned_cols=197  Identities=21%  Similarity=0.227  Sum_probs=157.0

Q ss_pred             CCCcEEEccCCccccCCCCccccccccccEEEccCCc-cccCCCCCCCCCCCccEEEccC-CcccccCCccccCcCCCcc
Q 039290          397 RNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCN-ISGGIPKELGNINNLTVIRLGN-NELTGTIPVTLGRLQKLQG  474 (1049)
Q Consensus       397 ~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~-i~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~  474 (1049)
                      ++|++|++++|+++++.+..+..+. +|++|++++|+ +++..+..|.++++|++|+|++ |++++..+..|.++++|++
T Consensus        31 ~~l~~L~l~~n~l~~i~~~~~~~l~-~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~  109 (239)
T 2xwt_C           31 PSTQTLKLIETHLRTIPSHAFSNLP-NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF  109 (239)
T ss_dssp             TTCCEEEEESCCCSEECTTTTTTCT-TCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCE
T ss_pred             CcccEEEEeCCcceEECHHHccCCC-CCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCE
Confidence            4899999999999988887887775 99999999997 8877778999999999999999 9999888889999999999


Q ss_pred             eEeeccccCCCCCcccccccccc---eEEeeCc-ccCCcCchhccCcccCC-ceeecCcccccccCcccccccccccccc
Q 039290          475 LYLQNNKLEGSIPEDLCHLYRLA---NLYLGDN-KLSGRLPACLGNLTSLR-DLSLGSNALTSIIPSTLWNLKDILRFNL  549 (1049)
Q Consensus       475 L~L~~N~l~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~L  549 (1049)
                      |++++|++++ +|. +..+++|+   +|++++| .+++..+..|.++++|+ +|++++|+++.+.+..+.. +       
T Consensus       110 L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~-------  179 (239)
T 2xwt_C          110 LGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-T-------  179 (239)
T ss_dssp             EEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-C-------
T ss_pred             EeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-C-------
Confidence            9999999996 666 88888888   9999999 99977777899999999 9999999998543333322 4       


Q ss_pred             cCCccCCCCccCcCCCcceeEeeccccc-ccccccccccCC-CcccEEEeecccccCCccccccCccCCcEEeccCc
Q 039290          550 SSNSLNGSLLPDIGNLKVVIEMDLSLNA-LSGVIPVTIGGL-QGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNN  624 (1049)
Q Consensus       550 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  624 (1049)
                                       +|++|++++|+ +++..+..|.++ ++|+.|++++|+|++..+.   .+++|+.|+++++
T Consensus       180 -----------------~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~  236 (239)
T 2xwt_C          180 -----------------KLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT  236 (239)
T ss_dssp             -----------------EEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred             -----------------CCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence                             45555555553 554555566666 6777777777777643333   4566777777665

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.88  E-value=3.7e-25  Score=253.74  Aligned_cols=243  Identities=19%  Similarity=0.206  Sum_probs=113.3

Q ss_pred             ccCcccccccCCcEeccccCCccccCc----ccccccCCccEEEeCCC---CccCCCcccc-------cCCCcccEEcCC
Q 039290          112 SLPEELSHLRGLKYFDFRFNNFHIEIP----SWFVSLPRLQHLLLKHN---SFVGKIPETI-------GYLSLLQELDLS  177 (1049)
Q Consensus       112 ~~p~~~~~L~~L~~L~l~~n~~~~~~p----~~~~~l~~L~~L~L~~n---~l~~~~p~~~-------~~l~~L~~L~Ls  177 (1049)
                      .++..+.++++|++|+|++|++....+    ..+..+++|++|+|++|   ++++.+|..+       ..+++|++|+|+
T Consensus        23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls  102 (386)
T 2ca6_A           23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  102 (386)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence            344455555555555555555554322    22445555555555553   3334444433       455555555555


Q ss_pred             CccCcc----ccCCCcccccccCCCCccceEEeeccccCCCCCCCc----ccc---------cccceecccccccc-ccc
Q 039290          178 DNQLSG----TIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNL----WKC---------RELHVVSLAFNKFQ-GGI  239 (1049)
Q Consensus       178 ~N~l~g----~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l----~~l---------~~L~~L~L~~N~l~-~~~  239 (1049)
                      +|++++    .+|..+.      .+++|++|+|++|++++..+..+    ..+         ++|+.|+|++|+++ +.+
T Consensus       103 ~n~l~~~~~~~l~~~l~------~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~  176 (386)
T 2ca6_A          103 DNAFGPTAQEPLIDFLS------KHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSM  176 (386)
T ss_dssp             SCCCCTTTHHHHHHHHH------HCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGH
T ss_pred             CCcCCHHHHHHHHHHHH------hCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHH
Confidence            555553    2333332      22334555555555442222222    122         44445555555444 223


Q ss_pred             C---CCCccccccceEEecccccc--c---cCccccccccceEEEeeccccCC----CccccccccccccceEEeccCcc
Q 039290          240 P---RDIGNLTSVRNLFLGNNSLI--G---EIPNEIGNLRNLEVLGVQSSNLA----GLIPASIFNISTLKELAVTDNDL  307 (1049)
Q Consensus       240 p---~~~~~l~~L~~L~L~~N~l~--~---~~p~~l~~l~~L~~L~L~~n~l~----~~~p~~~~~l~~L~~L~l~~N~l  307 (1049)
                      |   ..+..+++|++|+|++|+++  |   ..|..+..+++|+.|+|++|.++    +.+|..+..+++|++|+|++|.+
T Consensus       177 ~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i  256 (386)
T 2ca6_A          177 KEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLL  256 (386)
T ss_dssp             HHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCC
T ss_pred             HHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCC
Confidence            3   23444455555555555554  1   22334555555555555555553    33444455555555555555554


Q ss_pred             CCC----CCCccc-CCCCCccEEEcCCCCCCC----CCCccc-cCCCCCceeecccCccccCc
Q 039290          308 LGS----LPSSID-LGLPNLERLFLGENNFSG----TIPSSL-TNISELSVLDFGFNSFSGLI  360 (1049)
Q Consensus       308 ~~~----~p~~~~-~~l~~L~~L~L~~N~l~~----~~p~~~-~~l~~L~~L~Ls~N~l~~~~  360 (1049)
                      .+.    +|..+. ..+++|++|+|++|.+++    .+|..+ .++++|++|++++|.+++..
T Consensus       257 ~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~  319 (386)
T 2ca6_A          257 SARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED  319 (386)
T ss_dssp             CHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred             chhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence            432    222211 124555555555555554    244444 44555666666666555443

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.88  E-value=3.4e-25  Score=254.02  Aligned_cols=248  Identities=22%  Similarity=0.278  Sum_probs=205.3

Q ss_pred             ccCCCCCCcchhhhhhcccCccccc----cCcccccccCCcEeccccC---CccccCcccc-------cccCCccEEEeC
Q 039290           88 TIPPQLGNLSFLAVLAIRNNSFFGS----LPEELSHLRGLKYFDFRFN---NFHIEIPSWF-------VSLPRLQHLLLK  153 (1049)
Q Consensus        88 ~~~~~~~~l~~L~~L~l~~n~~~g~----~p~~~~~L~~L~~L~l~~n---~~~~~~p~~~-------~~l~~L~~L~L~  153 (1049)
                      .++..+..++.|++|+|++|.+.+.    ++..+.++++|++|+|++|   ++.+.+|..+       ..+++|++|+|+
T Consensus        23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls  102 (386)
T 2ca6_A           23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  102 (386)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence            4666677788899999999999876    4445778999999999984   6667788766       688999999999


Q ss_pred             CCCccC----CCcccccCCCcccEEcCCCccCccccCCCcccccccCCC---------CccceEEeeccccC-CCCC---
Q 039290          154 HNSFVG----KIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNL---------PVLEGLFISYNQLT-GPIP---  216 (1049)
Q Consensus       154 ~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l---------~~L~~L~l~~N~l~-~~~p---  216 (1049)
                      +|.+++    .+|..+..+++|++|+|++|++++..+..+...  +..+         ++|++|+|++|+++ +.+|   
T Consensus       103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~--l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~  180 (386)
T 2ca6_A          103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA--LQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA  180 (386)
T ss_dssp             SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHH--HHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHH
T ss_pred             CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHH--HHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHH
Confidence            999987    488899999999999999999975444444321  2223         67999999999998 4555   


Q ss_pred             CCcccccccceecccccccc--c---ccCCCCccccccceEEecccccc----ccCccccccccceEEEeeccccCCCc-
Q 039290          217 TNLWKCRELHVVSLAFNKFQ--G---GIPRDIGNLTSVRNLFLGNNSLI----GEIPNEIGNLRNLEVLGVQSSNLAGL-  286 (1049)
Q Consensus       217 ~~l~~l~~L~~L~L~~N~l~--~---~~p~~~~~l~~L~~L~L~~N~l~----~~~p~~l~~l~~L~~L~L~~n~l~~~-  286 (1049)
                      ..+..+++|+.|+|++|+++  |   .+|..+..+++|++|+|++|.++    +.+|..+..+++|+.|+|++|.+++. 
T Consensus       181 ~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~  260 (386)
T 2ca6_A          181 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARG  260 (386)
T ss_dssp             HHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHH
T ss_pred             HHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhh
Confidence            46778899999999999998  3   45668899999999999999996    67899999999999999999999876 


Q ss_pred             ---cccccc--cccccceEEeccCccCC----CCCCcccCCCCCccEEEcCCCCCCCCCC
Q 039290          287 ---IPASIF--NISTLKELAVTDNDLLG----SLPSSIDLGLPNLERLFLGENNFSGTIP  337 (1049)
Q Consensus       287 ---~p~~~~--~l~~L~~L~l~~N~l~~----~~p~~~~~~l~~L~~L~L~~N~l~~~~p  337 (1049)
                         +|..+.  .+++|++|+|++|.+.+    .+|..+...+++|++|+|++|.+++..+
T Consensus       261 ~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~  320 (386)
T 2ca6_A          261 AAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD  320 (386)
T ss_dssp             HHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred             HHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence               566664  48999999999999987    4888776578999999999999997664

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.87  E-value=9.1e-24  Score=237.46  Aligned_cols=249  Identities=17%  Similarity=0.141  Sum_probs=193.7

Q ss_pred             CcEeccccCCccccCccccccc--CCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccc-cCCCcccccccCCCC
Q 039290          123 LKYFDFRFNNFHIEIPSWFVSL--PRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGT-IPSSIFNISSCQNLP  199 (1049)
Q Consensus       123 L~~L~l~~n~~~~~~p~~~~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~-ip~~~~~l~~l~~l~  199 (1049)
                      ++.+|+++|++.   |..+..+  +++++|++++|.+.+.+|. +..+++|++|+|++|++++. +|..+.      .++
T Consensus        49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~------~~~  118 (336)
T 2ast_B           49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILS------QCS  118 (336)
T ss_dssp             SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHT------TBC
T ss_pred             heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHh------hCC
Confidence            667777777665   5566666  7788888888887765554 55678888888888877754 555443      355


Q ss_pred             ccceEEeeccccCCCCCCCcccccccceeccccc-cccc-ccCCCCccccccceEEeccc-ccccc-Ccccccccc-ceE
Q 039290          200 VLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFN-KFQG-GIPRDIGNLTSVRNLFLGNN-SLIGE-IPNEIGNLR-NLE  274 (1049)
Q Consensus       200 ~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N-~l~~-~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~l~~l~-~L~  274 (1049)
                      +|++|++++|++++.+|..+..+++|++|+|++| .+++ .+|..+.++++|++|+|++| .+++. ++..++.++ +|+
T Consensus       119 ~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~  198 (336)
T 2ast_B          119 KLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETIT  198 (336)
T ss_dssp             CCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCC
T ss_pred             CCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCC
Confidence            6788888888877777777778888888888888 6775 36777889999999999999 99864 688899999 999


Q ss_pred             EEeeccc--cCC-CccccccccccccceEEeccCc-cCCCCCCcccCCCCCccEEEcCCCC-CCCCCCccccCCCCCcee
Q 039290          275 VLGVQSS--NLA-GLIPASIFNISTLKELAVTDND-LLGSLPSSIDLGLPNLERLFLGENN-FSGTIPSSLTNISELSVL  349 (1049)
Q Consensus       275 ~L~L~~n--~l~-~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L  349 (1049)
                      +|++++|  .++ +.+|..+.++++|++|++++|. +++..+..+. .+++|++|++++|. +.......++++++|+.|
T Consensus       199 ~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~-~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L  277 (336)
T 2ast_B          199 QLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFF-QLNYLQHLSLSRCYDIIPETLLELGEIPTLKTL  277 (336)
T ss_dssp             EEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGG-GCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred             EEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHh-CCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEE
Confidence            9999999  566 5678888899999999999999 6656666554 68999999999996 332222368889999999


Q ss_pred             ecccCccccCccccccccc-ccceeecccccccCCCCC
Q 039290          350 DFGFNSFSGLIPTTFGNLR-SLKLLSLAGNVLTSPTPD  386 (1049)
Q Consensus       350 ~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~  386 (1049)
                      ++++| +.   ...+..+. +|+.|++++|.+++..+.
T Consensus       278 ~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~  311 (336)
T 2ast_B          278 QVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARP  311 (336)
T ss_dssp             ECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCS
T ss_pred             eccCc-cC---HHHHHHHHhhCcceEEecccCccccCC
Confidence            99999 43   33455563 588999999999987665

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.87  E-value=4.7e-22  Score=219.80  Aligned_cols=190  Identities=25%  Similarity=0.379  Sum_probs=95.6

Q ss_pred             cccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEee
Q 039290          423 SMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLG  502 (1049)
Q Consensus       423 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  502 (1049)
                      +|++|++++|.+.. +| .+..+++|++|+|++|.+++..+  +..+++|++|+|++|++++ + +.+..+++|++|+++
T Consensus        42 ~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~-~~~~~l~~L~~L~l~  115 (308)
T 1h6u_A           42 GITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-V-SAIAGLQSIKTLDLT  115 (308)
T ss_dssp             TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-C-GGGTTCTTCCEEECT
T ss_pred             CcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-c-hhhcCCCCCCEEECC
Confidence            45555555555543 22 34455555555555555553222  5555555555555555543 1 234445555555555


Q ss_pred             CcccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccc
Q 039290          503 DNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVI  582 (1049)
Q Consensus       503 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  582 (1049)
                      +|++++ ++. +..+++|++|++++|++++..+                          +..+++|++|++++|++++..
T Consensus       116 ~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--------------------------l~~l~~L~~L~l~~n~l~~~~  167 (308)
T 1h6u_A          116 STQITD-VTP-LAGLSNLQVLYLDLNQITNISP--------------------------LAGLTNLQYLSIGNAQVSDLT  167 (308)
T ss_dssp             TSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--------------------------GGGCTTCCEEECCSSCCCCCG
T ss_pred             CCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--------------------------ccCCCCccEEEccCCcCCCCh
Confidence            555543 221 4444455555555554444322                          444555555555555555432


Q ss_pred             cccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCcccc
Q 039290          583 PVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEG  652 (1049)
Q Consensus       583 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~  652 (1049)
                      +  +..+++|+.|+|++|++++..+  +..+++|++|+|++|++++..|  +..+++|+.|++++|++++
T Consensus       168 ~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          168 P--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             G--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred             h--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence            2  5555555555555555554333  5555556666666665553332  5555556666666665544

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.87  E-value=1e-21  Score=221.64  Aligned_cols=201  Identities=18%  Similarity=0.141  Sum_probs=110.7

Q ss_pred             EeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccc-e
Q 039290          125 YFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLE-G  203 (1049)
Q Consensus       125 ~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~-~  203 (1049)
                      .++.++++++ .||..+  .+++++|+|++|+|+...+..|+++++|++|||++|++.+.+|...+     .+++++. .
T Consensus        13 ~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f-----~~L~~l~~~   84 (350)
T 4ay9_X           13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF-----SNLPKLHEI   84 (350)
T ss_dssp             EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSB-----CSCTTCCEE
T ss_pred             EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHh-----hcchhhhhh
Confidence            4455555555 455544  24566666666666633334566666666666666666555655432     2233333 3


Q ss_pred             EEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceEEecc-ccccccCcccccccc-ceEEEeeccc
Q 039290          204 LFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGN-NSLIGEIPNEIGNLR-NLEVLGVQSS  281 (1049)
Q Consensus       204 L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~-~L~~L~L~~n  281 (1049)
                      +.++.|++++..|..+..+++|++|++++|++++..+..+....++..|++.+ |++....+..|..+. .++.|+|++|
T Consensus        85 l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N  164 (350)
T 4ay9_X           85 RIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKN  164 (350)
T ss_dssp             EEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSS
T ss_pred             hcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccc
Confidence            55556666655555566666666666666666655454555555666666644 345544444455543 4666666666


Q ss_pred             cCCCccccccccccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCC
Q 039290          282 NLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSG  334 (1049)
Q Consensus       282 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~  334 (1049)
                      +++.+ |...+...+|++|++++|+..+.+|...+.++++|++|+|++|+|+.
T Consensus       165 ~i~~i-~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~  216 (350)
T 4ay9_X          165 GIQEI-HNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS  216 (350)
T ss_dssp             CCCEE-CTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCC
T ss_pred             cccCC-ChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCc
Confidence            66543 33334445566666655444445555555555556666666665553

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.87  E-value=3e-22  Score=221.43  Aligned_cols=211  Identities=25%  Similarity=0.378  Sum_probs=140.9

Q ss_pred             CCceeecccCccccCcccccccccccceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccc
Q 039290          345 ELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISM  424 (1049)
Q Consensus       345 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L  424 (1049)
                      ++..+.+..+.+.+.+  .+..+++|++|++++|.++.++       .+..+++|++|++++|.++              
T Consensus        20 ~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~l~-------~~~~l~~L~~L~L~~n~i~--------------   76 (308)
T 1h6u_A           20 NAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTIE-------GVQYLNNLIGLELKDNQIT--------------   76 (308)
T ss_dssp             HHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCCT-------TGGGCTTCCEEECCSSCCC--------------
T ss_pred             HHHHHHhCCCCcCcee--cHHHcCCcCEEEeeCCCccCch-------hhhccCCCCEEEccCCcCC--------------
Confidence            3444555666655432  2455667777777777666543       1444555555555555544              


Q ss_pred             cEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCc
Q 039290          425 KSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDN  504 (1049)
Q Consensus       425 ~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  504 (1049)
                                 +..+  +..+++|++|+|++|.+++.  ..+..+++|++|+|++|++++ ++ .+..+++|++|++++|
T Consensus        77 -----------~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n  139 (308)
T 1h6u_A           77 -----------DLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITD-VT-PLAGLSNLQVLYLDLN  139 (308)
T ss_dssp             -----------CCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCC-CG-GGTTCTTCCEEECCSS
T ss_pred             -----------CChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCC-ch-hhcCCCCCCEEECCCC
Confidence                       3333  78899999999999999964  479999999999999999986 44 3899999999999999


Q ss_pred             ccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccc
Q 039290          505 KLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPV  584 (1049)
Q Consensus       505 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  584 (1049)
                      .+++..+  ++.+++|+.|++++|++++..+  +..+++|+.|++++|++++..+  +..+++|++|+|++|++++..+ 
T Consensus       140 ~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~-  212 (308)
T 1h6u_A          140 QITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP-  212 (308)
T ss_dssp             CCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG-
T ss_pred             ccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc-
Confidence            9996543  8899999999999999987544  6666777777776666664322  4444444444444444443321 


Q ss_pred             cccCCCcccEEEeeccccc
Q 039290          585 TIGGLQGLQLLSLRYNRLQ  603 (1049)
Q Consensus       585 ~~~~l~~L~~L~Ls~N~l~  603 (1049)
                       +..+++|+.|+|++|+++
T Consensus       213 -l~~l~~L~~L~l~~N~i~  230 (308)
T 1h6u_A          213 -LANTSNLFIVTLTNQTIT  230 (308)
T ss_dssp             -GTTCTTCCEEEEEEEEEE
T ss_pred             -ccCCCCCCEEEccCCeee
Confidence             344444444444444443

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.86  E-value=4.6e-22  Score=235.62  Aligned_cols=192  Identities=24%  Similarity=0.338  Sum_probs=112.1

Q ss_pred             CCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCcc
Q 039290          122 GLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVL  201 (1049)
Q Consensus       122 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L  201 (1049)
                      +|++|+|++|++++ +|..+.  ++|++|+|++|.++ .+|   +.+++|++|+|++|+|++ ||. +.+        +|
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--------~L  122 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--------SL  122 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--------TC
T ss_pred             CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--------CC
Confidence            56666666666654 555442  55666666666665 455   335566666666666653 554 321        35


Q ss_pred             ceEEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceEEeccccccccCccccccccceEEEeeccc
Q 039290          202 EGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSS  281 (1049)
Q Consensus       202 ~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n  281 (1049)
                      ++|+|++|++++ +|.   .++                        +|+.|+|++|++++ +|.   .+++|+.|+|++|
T Consensus       123 ~~L~Ls~N~l~~-lp~---~l~------------------------~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N  170 (571)
T 3cvr_A          123 KHLDVDNNQLTM-LPE---LPA------------------------LLEYINADNNQLTM-LPE---LPTSLEVLSVRNN  170 (571)
T ss_dssp             CEEECCSSCCSC-CCC---CCT------------------------TCCEEECCSSCCSC-CCC---CCTTCCEEECCSS
T ss_pred             CEEECCCCcCCC-CCC---cCc------------------------cccEEeCCCCccCc-CCC---cCCCcCEEECCCC
Confidence            555555555554 443   344                        44455555555443 333   3444555555555


Q ss_pred             cCCCccccccccccccceEEeccCccCCCCCCcccC----CCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccc
Q 039290          282 NLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDL----GLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFS  357 (1049)
Q Consensus       282 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~----~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  357 (1049)
                      ++++ +|. +.  ++|+.|+|++|+++ .+|. +..    ..+.|+.|+|++|+|+ .+|..+..+++|+.|+|++|.++
T Consensus       171 ~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~  243 (571)
T 3cvr_A          171 QLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLS  243 (571)
T ss_dssp             CCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC--------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCC
T ss_pred             CCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHHhhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCC
Confidence            5544 333 33  55555555555555 4554 321    1123388999999988 57888888999999999999998


Q ss_pred             cCcccccccccc
Q 039290          358 GLIPTTFGNLRS  369 (1049)
Q Consensus       358 ~~~p~~~~~l~~  369 (1049)
                      +.+|..++.+.+
T Consensus       244 ~~~p~~l~~l~~  255 (571)
T 3cvr_A          244 SRIRESLSQQTA  255 (571)
T ss_dssp             HHHHHHHHHHHH
T ss_pred             CcCHHHHHHhhc
Confidence            888888777654

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.86  E-value=1.4e-21  Score=202.94  Aligned_cols=185  Identities=23%  Similarity=0.242  Sum_probs=119.6

Q ss_pred             CceeeeEEEcCCCCcEEEEEEeccccccccCCCCCCcchhhhhhcccCccccccCcccccccCCcEeccccCCccccCcc
Q 039290           60 VCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPS  139 (1049)
Q Consensus        60 ~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~  139 (1049)
                      .|.|.+|.|+..            +++ .+|..+  .+.|++|++++|++++..+..++++++|++|++++|++.+..+.
T Consensus         6 ~C~~~~v~c~~~------------~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~   70 (208)
T 2o6s_A            6 SCSGTTVECYSQ------------GRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNG   70 (208)
T ss_dssp             EEETTEEECCSS------------CCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTT
T ss_pred             EECCCEEEecCC------------Ccc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChh
Confidence            489999999643            222 455443  24677777777777754445567777777777777777755555


Q ss_pred             cccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCc
Q 039290          140 WFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNL  219 (1049)
Q Consensus       140 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l  219 (1049)
                      .|..+++|++|+|++|.+++..+..++.+++|++|+|++|++++ +|...     +..+++|++|++++|++++..+..+
T Consensus        71 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~-----~~~l~~L~~L~l~~N~l~~~~~~~~  144 (208)
T 2o6s_A           71 VFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQS-LPDGV-----FDKLTQLKDLRLYQNQLKSVPDGVF  144 (208)
T ss_dssp             TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTT-----TTTCTTCCEEECCSSCCSCCCTTTT
T ss_pred             hcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcc-cCHhH-----hccCCcCCEEECCCCccceeCHHHh
Confidence            66777777777777777775555556777777777777777773 33332     1234557777777777775544456


Q ss_pred             ccccccceecccccccccccCCCCccccccceEEeccccccccCccccccccc
Q 039290          220 WKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRN  272 (1049)
Q Consensus       220 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  272 (1049)
                      ..+++|+.|++++|.+.+       .+++|+.|+++.|+++|.+|++++.++.
T Consensus       145 ~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          145 DRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             TTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             ccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence            666666666666666553       2345666666666666666666665544

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.86  E-value=1.8e-21  Score=219.63  Aligned_cols=223  Identities=17%  Similarity=0.140  Sum_probs=104.6

Q ss_pred             eEEEeeccccCCCccccccccccccceEEeccCccCCCCCCcccCCCCCccE-EEcCCCCCCCCCCccccCCCCCceeec
Q 039290          273 LEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLER-LFLGENNFSGTIPSSLTNISELSVLDF  351 (1049)
Q Consensus       273 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~L  351 (1049)
                      +++|+|++|+++.+.+.+|.++++|++|+|++|++.+.+|...+.+++++.+ +.++.|+++...|..|..+++|++|++
T Consensus        32 l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l  111 (350)
T 4ay9_X           32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLI  111 (350)
T ss_dssp             CSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEE
T ss_pred             CCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccc
Confidence            3344444444333323334444444444444444433444444444444432 444455555555555666666666666


Q ss_pred             ccCccccCcccccccccccceeeccc-ccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEcc
Q 039290          352 GFNSFSGLIPTTFGNLRSLKLLSLAG-NVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSME  430 (1049)
Q Consensus       352 s~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~  430 (1049)
                      ++|++.+..+..+....++..|++.+ |.++.++.                             ..+......++.|+|+
T Consensus       112 ~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~-----------------------------~~f~~~~~~l~~L~L~  162 (350)
T 4ay9_X          112 SNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIER-----------------------------NSFVGLSFESVILWLN  162 (350)
T ss_dssp             EEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECT-----------------------------TSSTTSBSSCEEEECC
T ss_pred             cccccccCCchhhcccchhhhhhhccccccccccc-----------------------------cchhhcchhhhhhccc
Confidence            66666655444444444455555433 33333332                             2222222234444444


Q ss_pred             CCccccCCCCCCCCCCCccEEEccC-CcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCc
Q 039290          431 SCNISGGIPKELGNINNLTVIRLGN-NELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGR  509 (1049)
Q Consensus       431 ~n~i~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  509 (1049)
                      +|+|+. +|.......+|+.|++++ |.++...+..|.++++|++|+|++|+|+...+..+.+   |+.|.+.++.--..
T Consensus       163 ~N~i~~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~---L~~L~~l~~~~l~~  238 (350)
T 4ay9_X          163 KNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN---LKKLRARSTYNLKK  238 (350)
T ss_dssp             SSCCCE-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTT---CCEEECTTCTTCCC
T ss_pred             cccccC-CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhcc---chHhhhccCCCcCc
Confidence            444442 233333344566666653 4455333345666666666666666666333333333   33333333222224


Q ss_pred             CchhccCcccCCceeecCcc
Q 039290          510 LPACLGNLTSLRDLSLGSNA  529 (1049)
Q Consensus       510 ~p~~~~~l~~L~~L~L~~N~  529 (1049)
                      +| .+.++++|+.++++++.
T Consensus       239 lP-~l~~l~~L~~l~l~~~~  257 (350)
T 4ay9_X          239 LP-TLEKLVALMEASLTYPS  257 (350)
T ss_dssp             CC-CTTTCCSCCEEECSCHH
T ss_pred             CC-CchhCcChhhCcCCCCc
Confidence            45 35666666666665543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=5.6e-22  Score=215.40  Aligned_cols=165  Identities=16%  Similarity=0.128  Sum_probs=128.5

Q ss_pred             HHHHHHHhcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCC------------------CHHHHHHHHHHHhhc
Q 039290          753 YQDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDG------------------SLESFHAECKVMGSI  814 (1049)
Q Consensus       753 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~------------------~~~~~~~e~~~l~~l  814 (1049)
                      ...+......|.+.+.||+|+||.||+|+..+|+.||+|+++.....                  ....+.+|+++++++
T Consensus        82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l  161 (282)
T 1zar_A           82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL  161 (282)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence            34444555667788999999999999999978999999999643211                  245688999999999


Q ss_pred             CCCceeeEEeeeecCCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeee
Q 039290          815 RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL  894 (1049)
Q Consensus       815 ~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~  894 (1049)
                      +  | +++.+++.. +..++||||++|++|.+ +..       .+...++.|+++|++|||   +.||+||||||+|||+
T Consensus       162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl  226 (282)
T 1zar_A          162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLV  226 (282)
T ss_dssp             T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEE
T ss_pred             c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEE
Confidence            8  4 555555443 55699999999999998 422       224579999999999999   9999999999999999


Q ss_pred             cCCCceEEecccCceecCCCccccccccccccCcccccccCC----------CCcCcccchHH
Q 039290          895 NESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE----------GKVSRKCDVYS  947 (1049)
Q Consensus       895 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------~~~~~~~Dvws  947 (1049)
                      + ++.+||+|||+|+.              +..|+|||++.+          .++..++|+|.
T Consensus       227 ~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVE--------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             E-TTEEEECCCTTCEE--------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             E-CCcEEEEECCCCeE--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            9 99999999999873              345788988743          34555566654

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.83  E-value=7.3e-22  Score=243.05  Aligned_cols=228  Identities=18%  Similarity=0.144  Sum_probs=108.5

Q ss_pred             CChhhHHHHHHHHHhcccCCCCcccccCC-CCCCCceeeeEEEcCCCCcEEEEEEeccccccccCCCCCCcchhhhhhcc
Q 039290           27 NVTTDQFALLALKEHIKHDPSNLLANNWS-TTSSVCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIR  105 (1049)
Q Consensus        27 ~~~~d~~all~~k~~~~~~~~~~l~~~w~-~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~  105 (1049)
                      ....+++||+++......+.+.. .+.|. ..+..+.|.+++++.  .+++.|+|.++++.+ +|.     ..|+.++|+
T Consensus       129 ~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~-~~~-----~~l~~l~Ls  199 (727)
T 4b8c_D          129 LVDCTKQALMEMADTLTDSKTAK-KQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDE-ANQ-----ALLQHKKLS  199 (727)
T ss_dssp             ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred             ccccchhhhhhhhhhcccccCcc-cCCCcCCCCccccCCCceecC--CccceEEeeCCCCCc-chh-----hHhhcCccC
Confidence            34678899999998875443332 23553 344567899999864  579999999888875 333     245566666


Q ss_pred             cCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCcccc
Q 039290          106 NNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTI  185 (1049)
Q Consensus       106 ~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i  185 (1049)
                      .|.+.              .++++.|++. ..|..|..++.|++|+|++|.+. .+|..+..+++|++|+|++|+|+ .+
T Consensus       200 ~~~i~--------------~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~l  262 (727)
T 4b8c_D          200 QYSID--------------EDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-EL  262 (727)
T ss_dssp             -------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CC
T ss_pred             ccccc--------------Ccccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-cc
Confidence            66553              3455566665 56777888888888888888887 77877778888888888888888 77


Q ss_pred             CCCcccccccCCCCccceEEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceEEeccccccccCcc
Q 039290          186 PSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPN  265 (1049)
Q Consensus       186 p~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  265 (1049)
                      |.++++      +++|++|+|++|+|+ .+|..+..+++|++|+|++|.|+ .+|..|+++++|++|+|++|.+++.+|.
T Consensus       263 p~~~~~------l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~  334 (727)
T 4b8c_D          263 PAEIKN------LSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLK  334 (727)
T ss_dssp             CGGGGG------GTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHH
T ss_pred             ChhhhC------CCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChH
Confidence            776654      344777777777777 66777777777777777777665 5666677777777777777777666666


Q ss_pred             ccccccce-EEEeeccccCCCccc
Q 039290          266 EIGNLRNL-EVLGVQSSNLAGLIP  288 (1049)
Q Consensus       266 ~l~~l~~L-~~L~L~~n~l~~~~p  288 (1049)
                      .++.+... ..|+|++|.+++.+|
T Consensus       335 ~~~~~~~~~~~l~l~~N~l~~~~p  358 (727)
T 4b8c_D          335 ILTEKSVTGLIFYLRDNRPEIPLP  358 (727)
T ss_dssp             HHHHHHHHHHHHHHHHCCCCCCCC
T ss_pred             HHhhcchhhhHHhhccCcccCcCc
Confidence            66544221 224455555554444

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.82  E-value=6.9e-21  Score=199.22  Aligned_cols=157  Identities=24%  Similarity=0.324  Sum_probs=122.7

Q ss_pred             ceEEeeCcccCCcCchhccCcccCCceeecCcccccccC-cccccccccccccccCCccCCCCccCcCCCcceeEeeccc
Q 039290          497 ANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIP-STLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSL  575 (1049)
Q Consensus       497 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  575 (1049)
                      +.+++++|.++ .+|..+.  ..+++|+|++|+++++.| ..|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus        14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence            45666666665 3454442  235677777777776644 4466777777777777777776666778888888888888


Q ss_pred             ccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCcccccCC
Q 039290          576 NALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIP  655 (1049)
Q Consensus       576 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p  655 (1049)
                      |+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..+..+++|+.|++++|+|.|.++
T Consensus        91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A           91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            88887778888888999999999999998888889999999999999999988778889999999999999999998887


Q ss_pred             C
Q 039290          656 T  656 (1049)
Q Consensus       656 ~  656 (1049)
                      .
T Consensus       171 l  171 (220)
T 2v70_A          171 L  171 (220)
T ss_dssp             G
T ss_pred             h
Confidence            4

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.82  E-value=9e-23  Score=243.29  Aligned_cols=216  Identities=21%  Similarity=0.211  Sum_probs=101.7

Q ss_pred             CCcchhhhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccE
Q 039290           94 GNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQE  173 (1049)
Q Consensus        94 ~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~  173 (1049)
                      ..++.|+.|+|++|+++ .||++|++|++|+.|++++|.....+|..+           ..+.+.+.+|..++.+++|+.
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll-----------~~~~~~~~~~~~l~~l~~L~~  413 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLM-----------RALDPLLYEKETLQYFSTLKA  413 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHH-----------HHHCTGGGHHHHHHHHHHHHH
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHH-----------HhcccccCCHHHHHHHHhccc
Confidence            34555556666666554 556666666666666654443111111000           001144556666666666666


Q ss_pred             Ec-CCCccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceE
Q 039290          174 LD-LSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNL  252 (1049)
Q Consensus       174 L~-Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  252 (1049)
                      || ++.|.+.                 .|+.+++++|.+++..+      ..|+.|+|++|++++ +|. |+++++|+.|
T Consensus       414 L~~l~~n~~~-----------------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L  468 (567)
T 1dce_A          414 VDPMRAAYLD-----------------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHL  468 (567)
T ss_dssp             HCGGGHHHHH-----------------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEE
T ss_pred             Ccchhhcccc-----------------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEe
Confidence            66 5555443                 13333344444432111      124444444444443 343 4455555555


Q ss_pred             EeccccccccCccccccccceEEEeeccccCCCccccccccccccceEEeccCccCCCC-CCcccCCCCCccEEEcCCCC
Q 039290          253 FLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSL-PSSIDLGLPNLERLFLGENN  331 (1049)
Q Consensus       253 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~~l~~L~~L~L~~N~  331 (1049)
                      +|++|+++ .+|..|+++++|+.|+|++|++++ +| .+.++++|++|+|++|++++.. |..+. .+++|+.|+|++|.
T Consensus       469 ~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~-~l~~L~~L~L~~N~  544 (567)
T 1dce_A          469 DLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLV-SCPRLVLLNLQGNS  544 (567)
T ss_dssp             ECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGG-GCTTCCEEECTTSG
T ss_pred             ecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHh-cCCCCCEEEecCCc
Confidence            55555554 444455555555555555555544 23 4455555555555555554433 43333 45555555555555


Q ss_pred             CCCCCCcc---ccCCCCCceee
Q 039290          332 FSGTIPSS---LTNISELSVLD  350 (1049)
Q Consensus       332 l~~~~p~~---~~~l~~L~~L~  350 (1049)
                      +++.+|..   +..+++|+.|+
T Consensus       545 l~~~~~~~~~l~~~lp~L~~L~  566 (567)
T 1dce_A          545 LCQEEGIQERLAEMLPSVSSIL  566 (567)
T ss_dssp             GGGSSSCTTHHHHHCTTCSEEE
T ss_pred             CCCCccHHHHHHHHCcccCccC
Confidence            55433321   22355666654

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.82  E-value=2.7e-20  Score=193.28  Aligned_cols=161  Identities=25%  Similarity=0.277  Sum_probs=78.3

Q ss_pred             CccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeec
Q 039290          447 NLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLG  526 (1049)
Q Consensus       447 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  526 (1049)
                      +|++|+|++|++++..+..|+.+++|++|++++|++++..+..|..+++|++|++++|++++..+..+.++++|++|+++
T Consensus        29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~  108 (208)
T 2o6s_A           29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN  108 (208)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence            45555555555554444444445555555555555443333334444444444444444443333333444444444444


Q ss_pred             CcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCc
Q 039290          527 SNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPI  606 (1049)
Q Consensus       527 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  606 (1049)
                      +|+++++                        .+..+..+++|++|++++|++++..+..|..+++|+.|+|++|.+.+  
T Consensus       109 ~N~l~~~------------------------~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~--  162 (208)
T 2o6s_A          109 TNQLQSL------------------------PDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC--  162 (208)
T ss_dssp             SSCCCCC------------------------CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC--
T ss_pred             CCcCccc------------------------CHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec--
Confidence            4444433                        33334444444445555555544444445555556666666665543  


Q ss_pred             cccccCccCCcEEeccCccccCCccccccccc
Q 039290          607 PESFGGLKSLNFVDMSNNNLSGTIPKSMEALS  638 (1049)
Q Consensus       607 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  638 (1049)
                           .+++|++|+++.|+++|.+|..++.++
T Consensus       163 -----~~~~l~~L~~~~n~~~g~ip~~~~~l~  189 (208)
T 2o6s_A          163 -----TCPGIRYLSEWINKHSGVVRNSAGSVA  189 (208)
T ss_dssp             -----CTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred             -----CCCCHHHHHHHHHhCCceeeccCcccc
Confidence                 234566666666666666666655554

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.82  E-value=1.1e-20  Score=197.52  Aligned_cols=157  Identities=20%  Similarity=0.297  Sum_probs=109.0

Q ss_pred             ceEEeeCcccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccc
Q 039290          497 ANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLN  576 (1049)
Q Consensus       497 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  576 (1049)
                      +.+++++|.++ .+|..+.  ++|+.|+|++|+++++.+..|..+++|++|+|++|++++..|..|..+++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            34555555555 3444332  45666666666666655556666666666666666666656666666777777777777


Q ss_pred             cccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCcccccCCC
Q 039290          577 ALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPT  656 (1049)
Q Consensus       577 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~  656 (1049)
                      +|+...+..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..+..+++|++|++++|+|.|.++.
T Consensus        91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~l  170 (220)
T 2v9t_B           91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCHL  170 (220)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred             cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCcc
Confidence            77766566677778888888888888877777888888888888888888866666777788888888888888877653

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.81  E-value=2.5e-20  Score=211.08  Aligned_cols=180  Identities=24%  Similarity=0.189  Sum_probs=107.7

Q ss_pred             cEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccc-cccccceEEeeCcccCCcCchhccCcccCCceeecC
Q 039290          449 TVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLC-HLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGS  527 (1049)
Q Consensus       449 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  527 (1049)
                      +.+++++|+++ .+|..+.  +.++.|+|++|+|++..+..+. .+++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus        21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   97 (361)
T 2xot_A           21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS   97 (361)
T ss_dssp             TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence            46666666666 3454432  2355666666666544444444 555555555555555544444455555555555555


Q ss_pred             cccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCcc
Q 039290          528 NALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIP  607 (1049)
Q Consensus       528 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~  607 (1049)
                      |++++                        ..+..|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+
T Consensus        98 N~l~~------------------------~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~  153 (361)
T 2xot_A           98 NHLHT------------------------LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPV  153 (361)
T ss_dssp             SCCCE------------------------ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCG
T ss_pred             CcCCc------------------------CCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCH
Confidence            55544                        444445555566666666666665666667777777777777777775555


Q ss_pred             ccc---cCccCCcEEeccCccccCCcccccccccc--cceeeccCCcccccCC
Q 039290          608 ESF---GGLKSLNFVDMSNNNLSGTIPKSMEALSY--LKHLNLSFNQLEGEIP  655 (1049)
Q Consensus       608 ~~~---~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~--L~~l~l~~N~l~~~~p  655 (1049)
                      ..|   ..+++|+.|||++|+|++..+..+..++.  ++.|+|++|+|.|.+.
T Consensus       154 ~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~  206 (361)
T 2xot_A          154 ELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCK  206 (361)
T ss_dssp             GGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred             HHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence            555   45777777777777777555566666666  3777888888877664

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.81  E-value=6.1e-20  Score=193.36  Aligned_cols=164  Identities=25%  Similarity=0.333  Sum_probs=95.2

Q ss_pred             CCCCCCCceeeeEEEcCCCCcEEEEEEeccccccccCCCCCCcchhhhhhcccCccccccCcccccccCCcEeccccCCc
Q 039290           54 WSTTSSVCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNF  133 (1049)
Q Consensus        54 w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~  133 (1049)
                      |..+...|+|++|.|+..            ++. .+|..+.                          ++|++|+|++|++
T Consensus        12 ~~~~~~~Cs~~~v~c~~~------------~l~-~ip~~~~--------------------------~~L~~L~Ls~n~i   52 (229)
T 3e6j_A           12 ACPSQCSCSGTTVDCRSK------------RHA-SVPAGIP--------------------------TNAQILYLHDNQI   52 (229)
T ss_dssp             CCCTTCEEETTEEECTTS------------CCS-SCCSCCC--------------------------TTCSEEECCSSCC
T ss_pred             cCCCCCEEeCCEeEccCC------------CcC-ccCCCCC--------------------------CCCCEEEcCCCcc
Confidence            455778899999999642            222 4554332                          3445555555555


Q ss_pred             cccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCC
Q 039290          134 HIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTG  213 (1049)
Q Consensus       134 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~  213 (1049)
                      ++..|..|.++++|++|+|++|++++..+..|+.+++|++|+|++|+++ .+|...+     ..+++|++|+|++|+++ 
T Consensus        53 ~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~-----~~l~~L~~L~Ls~N~l~-  125 (229)
T 3e6j_A           53 TKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVF-----DRLVHLKELFMCCNKLT-  125 (229)
T ss_dssp             CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTT-----TTCTTCCEEECCSSCCC-
T ss_pred             CccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCC-ccChhHh-----CcchhhCeEeccCCccc-
Confidence            5555555555555555555555554333344455555555555555555 3333221     23344555566666555 


Q ss_pred             CCCCCcccccccceecccccccccccCCCCccccccceEEeccccccccC
Q 039290          214 PIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEI  263 (1049)
Q Consensus       214 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  263 (1049)
                      .+|..+..+++|++|+|++|++++..+..|..+++|+.|+|++|.+....
T Consensus       126 ~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c  175 (229)
T 3e6j_A          126 ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC  175 (229)
T ss_dssp             SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred             ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence            55556666666666666666666555556777777777777777776543

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.79  E-value=3.5e-19  Score=213.54  Aligned_cols=192  Identities=19%  Similarity=0.282  Sum_probs=141.9

Q ss_pred             CcchhhhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEE
Q 039290           95 NLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQEL  174 (1049)
Q Consensus        95 ~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  174 (1049)
                      .+..+..+.++.+.+...++  +..|.+|++|++++|.+. .+| .|..+++|++|+|++|.+++..|  ++.+++|++|
T Consensus        19 ~l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L   92 (605)
T 1m9s_A           19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWL   92 (605)
T ss_dssp             HHHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEE
T ss_pred             HHHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEE
Confidence            35567777888887765443  568888999999998887 344 58888999999999999886544  8888999999


Q ss_pred             cCCCccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceEEe
Q 039290          175 DLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFL  254 (1049)
Q Consensus       175 ~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  254 (1049)
                      +|++|++++ +| .+      ..+++|++|+|++|++++ + +.+..+++|+.|+|++|++++.  ..++.+++|+.|+|
T Consensus        93 ~Ls~N~l~~-l~-~l------~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~L  160 (605)
T 1m9s_A           93 FLDENKIKD-LS-SL------KDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSL  160 (605)
T ss_dssp             ECCSSCCCC-CT-TS------TTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEEC
T ss_pred             ECcCCCCCC-Ch-hh------ccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEEC
Confidence            999998873 44 23      456678888888888885 3 4577777777777777777754  56777777777777


Q ss_pred             ccccccccCccccccccceEEEeeccccCCCccccccccccccceEEeccCccC
Q 039290          255 GNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLL  308 (1049)
Q Consensus       255 ~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~  308 (1049)
                      ++|++++..|  +..+++|+.|+|++|++.+.  ..+..+++|+.|+|++|.+.
T Consensus       161 s~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~  210 (605)
T 1m9s_A          161 EDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECL  210 (605)
T ss_dssp             CSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEE
T ss_pred             cCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCc
Confidence            7777776555  77777777777777777764  34666677777777777665

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.79  E-value=3.1e-19  Score=195.32  Aligned_cols=172  Identities=27%  Similarity=0.448  Sum_probs=91.9

Q ss_pred             CCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCc
Q 039290          443 GNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRD  522 (1049)
Q Consensus       443 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  522 (1049)
                      ..+++|+.|++++|.++.. + .+..+++|++|+|++|++++..+  +..+++|++|++++|++++ +| .+..+++|++
T Consensus        43 ~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~  116 (291)
T 1h6t_A           43 NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKS  116 (291)
T ss_dssp             HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCE
T ss_pred             hhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCE
Confidence            3456666666666666633 2 35556666666666666664322  5566666666666666653 22 2555556666


Q ss_pred             eeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccc
Q 039290          523 LSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRL  602 (1049)
Q Consensus       523 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  602 (1049)
                      |++++|+++++  ..+..+++|+.|++++|++++                        .  ..++.+++|+.|+|++|+|
T Consensus       117 L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~------------------------~--~~l~~l~~L~~L~L~~N~l  168 (291)
T 1h6t_A          117 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITD------------------------I--TVLSRLTKLDTLSLEDNQI  168 (291)
T ss_dssp             EECTTSCCCCC--GGGGGCTTCCEEECCSSCCCC------------------------C--GGGGGCTTCSEEECCSSCC
T ss_pred             EECCCCcCCCC--hhhcCCCCCCEEEccCCcCCc------------------------c--hhhccCCCCCEEEccCCcc
Confidence            66666655542  234445555555555555443                        3  3445555555555555555


Q ss_pred             cCCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCcccc
Q 039290          603 QGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEG  652 (1049)
Q Consensus       603 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~  652 (1049)
                      ++..|  +..+++|++|+|++|++++ +| .+..+++|+.|++++|++..
T Consensus       169 ~~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          169 SDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             CCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred             ccchh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccC
Confidence            54333  5555555555555555542 22 24555555555555555543

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.78  E-value=4.4e-19  Score=186.82  Aligned_cols=155  Identities=23%  Similarity=0.274  Sum_probs=106.3

Q ss_pred             ceEEeeCcccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccc
Q 039290          497 ANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLN  576 (1049)
Q Consensus       497 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  576 (1049)
                      +.++.+++.++ .+|..+.  ++|++|+|++|+++++.|..|..+++|++|+|++|+|+...+..|..+++|++|+|++|
T Consensus        22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N   98 (229)
T 3e6j_A           22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN   98 (229)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence            44555555554 3443332  55666666666666655666666666666666666665555555666777777777777


Q ss_pred             cccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCcccccCC
Q 039290          577 ALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIP  655 (1049)
Q Consensus       577 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p  655 (1049)
                      +|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..+..+++|+.|++++|+|.|.++
T Consensus        99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A           99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence            777666666777788888888888887 567777788888888888888876666667778888888888888887776

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.78  E-value=3.8e-19  Score=194.64  Aligned_cols=168  Identities=27%  Similarity=0.390  Sum_probs=127.3

Q ss_pred             ccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEe
Q 039290          422 ISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYL  501 (1049)
Q Consensus       422 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  501 (1049)
                      .+|+.|++++|.+... + .+..+++|++|+|++|++++..+  +..+++|++|+|++|++++ + +.+..+++|++|++
T Consensus        46 ~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L  119 (291)
T 1h6t_A           46 NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-L-SSLKDLKKLKSLSL  119 (291)
T ss_dssp             HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-G-GGGTTCTTCCEEEC
T ss_pred             CcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-C-hhhccCCCCCEEEC
Confidence            3899999999999854 3 48899999999999999997554  9999999999999999985 3 35999999999999


Q ss_pred             eCcccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeeccccccccc
Q 039290          502 GDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGV  581 (1049)
Q Consensus       502 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  581 (1049)
                      ++|++++.  ..+..+++|+.|++++|+++++  ..+..+++|+.|++++|++++..+  +..+++|++|++++|+|++.
T Consensus       120 ~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l  193 (291)
T 1h6t_A          120 EHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL  193 (291)
T ss_dssp             TTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC
T ss_pred             CCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC
Confidence            99999853  4689999999999999999985  567777777777777777765333  44555555555555555432


Q ss_pred             ccccccCCCcccEEEeeccccc
Q 039290          582 IPVTIGGLQGLQLLSLRYNRLQ  603 (1049)
Q Consensus       582 ~p~~~~~l~~L~~L~Ls~N~l~  603 (1049)
                       | .+..+++|+.|++++|+++
T Consensus       194 -~-~l~~l~~L~~L~l~~n~i~  213 (291)
T 1h6t_A          194 -R-ALAGLKNLDVLELFSQECL  213 (291)
T ss_dssp             -G-GGTTCTTCSEEEEEEEEEE
T ss_pred             -h-hhccCCCCCEEECcCCccc
Confidence             1 2444444444444444444

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.78  E-value=3.7e-19  Score=213.34  Aligned_cols=183  Identities=25%  Similarity=0.335  Sum_probs=155.4

Q ss_pred             CCCcchhhhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCccc
Q 039290           93 LGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQ  172 (1049)
Q Consensus        93 ~~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~  172 (1049)
                      +..|+.|+.|++++|.+. .+| .++.|++|++|+|++|++.+..|  +..+++|++|+|++|.+++ +| .++.+++|+
T Consensus        39 ~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~  112 (605)
T 1m9s_A           39 QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLK  112 (605)
T ss_dssp             HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCC
T ss_pred             hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCC
Confidence            456788999999999987 455 68999999999999999997655  8999999999999999984 44 799999999


Q ss_pred             EEcCCCccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceE
Q 039290          173 ELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNL  252 (1049)
Q Consensus       173 ~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  252 (1049)
                      +|+|++|++++ +| .      +..+++|+.|+|++|++++.  ..+..+++|+.|+|++|++++..|  +..+++|+.|
T Consensus       113 ~L~Ls~N~l~~-l~-~------l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L  180 (605)
T 1m9s_A          113 SLSLEHNGISD-IN-G------LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNL  180 (605)
T ss_dssp             EEECTTSCCCC-CG-G------GGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred             EEEecCCCCCC-Cc-c------ccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEE
Confidence            99999999984 43 2      34567899999999999964  678899999999999999998777  9999999999


Q ss_pred             EeccccccccCccccccccceEEEeeccccCCCcccccccccc
Q 039290          253 FLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNIS  295 (1049)
Q Consensus       253 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~  295 (1049)
                      +|++|++++.  ..+..+++|+.|+|++|++.+.....+..+.
T Consensus       181 ~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~~l~  221 (605)
T 1m9s_A          181 YLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLV  221 (605)
T ss_dssp             ECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCSSCE
T ss_pred             ECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcccccccEE
Confidence            9999999864  4699999999999999999876444444433

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.78  E-value=5.6e-19  Score=184.68  Aligned_cols=135  Identities=23%  Similarity=0.273  Sum_probs=97.9

Q ss_pred             ceEEeeCcccCCcCc-hhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeeccc
Q 039290          497 ANLYLGDNKLSGRLP-ACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSL  575 (1049)
Q Consensus       497 ~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  575 (1049)
                      ++|+|++|++++..| ..|.++++|++|+|++|+++++.+..|..+++|++|+|++|++++..+..|..+++|++|+|++
T Consensus        35 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  114 (220)
T 2v70_A           35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRS  114 (220)
T ss_dssp             SEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTT
T ss_pred             CEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCC
Confidence            445555555543322 3355566666666666666665556666666666666666666666666677777777888888


Q ss_pred             ccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCcc
Q 039290          576 NALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIP  631 (1049)
Q Consensus       576 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  631 (1049)
                      |+|++..|..|.++++|+.|+|++|+|++..|..|..+++|++|+|++|++++..+
T Consensus       115 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A          115 NRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             SCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             CcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            88887778888888899999999999998888899999999999999999987554

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.78  E-value=6.3e-19  Score=184.29  Aligned_cols=134  Identities=19%  Similarity=0.277  Sum_probs=95.5

Q ss_pred             ccceEEeeCcccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecc
Q 039290          495 RLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLS  574 (1049)
Q Consensus       495 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  574 (1049)
                      +|+.|++++|+|++..+..|..+++|++|+|++|+++++.|..|..+++|++|+|++|+|+...+..|..+++|++|+|+
T Consensus        33 ~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~  112 (220)
T 2v9t_B           33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLN  112 (220)
T ss_dssp             TCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECC
Confidence            44555555555554444455555566666666666665556666666666666666666665555556777777777777


Q ss_pred             cccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccC
Q 039290          575 LNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSG  628 (1049)
Q Consensus       575 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  628 (1049)
                      +|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|++.+
T Consensus       113 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B          113 ANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             CCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence            888877778888888889999999999988888888889999999999998875

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.78  E-value=5.3e-21  Score=227.99  Aligned_cols=220  Identities=19%  Similarity=0.142  Sum_probs=127.6

Q ss_pred             cccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCccc
Q 039290          142 VSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWK  221 (1049)
Q Consensus       142 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~  221 (1049)
                      ...++|+.|+|++|+++ .+|++|+++++|+.|++++|.....+|..                 +..+.+.+.+|..+..
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~l-----------------l~~~~~~~~~~~~l~~  407 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILL-----------------MRALDPLLYEKETLQY  407 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHH-----------------HHHHCTGGGHHHHHHH
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHH-----------------HHhcccccCCHHHHHH
Confidence            56778888888888887 78888888888888888776521122110                 0112233445555555


Q ss_pred             ccccceec-ccccccccccCCCCccccccceEEeccccccccCccccccccceEEEeeccccCCCccccccccccccceE
Q 039290          222 CRELHVVS-LAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKEL  300 (1049)
Q Consensus       222 l~~L~~L~-L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  300 (1049)
                      +++|+.|+ ++.|.+           .+|+.+.+++|.+++..+      ..|+.|+|++|++++ +|. +..+++|+.|
T Consensus       408 l~~L~~L~~l~~n~~-----------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L  468 (567)
T 1dce_A          408 FSTLKAVDPMRAAYL-----------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHL  468 (567)
T ss_dssp             HHHHHHHCGGGHHHH-----------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEE
T ss_pred             HHhcccCcchhhccc-----------chhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEe
Confidence            56666665 444433           234444455555442211      125555555555554 243 5555555666


Q ss_pred             EeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCc-ccccccccccceeeccccc
Q 039290          301 AVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLI-PTTFGNLRSLKLLSLAGNV  379 (1049)
Q Consensus       301 ~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~  379 (1049)
                      +|++|+++ .+|..+. .+++|+.|+|++|+|++ +| .++.+++|++|+|++|+|++.. |..|+.+++|+.|+|++|.
T Consensus       469 ~Ls~N~l~-~lp~~~~-~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~  544 (567)
T 1dce_A          469 DLSHNRLR-ALPPALA-ALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNS  544 (567)
T ss_dssp             ECCSSCCC-CCCGGGG-GCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSG
T ss_pred             ecCccccc-ccchhhh-cCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCc
Confidence            66666555 5555443 56666666666666664 45 5666667777777777776655 6666777777777777777


Q ss_pred             ccCCCCCcccccccccCCCCcEEEc
Q 039290          380 LTSPTPDLSFLSSLTSCRNLEIIYL  404 (1049)
Q Consensus       380 l~~~~~~~~~l~~l~~l~~L~~L~L  404 (1049)
                      +++.++...  ..+..+++|+.|++
T Consensus       545 l~~~~~~~~--~l~~~lp~L~~L~l  567 (567)
T 1dce_A          545 LCQEEGIQE--RLAEMLPSVSSILT  567 (567)
T ss_dssp             GGGSSSCTT--HHHHHCTTCSEEEC
T ss_pred             CCCCccHHH--HHHHHCcccCccCC
Confidence            766654321  11334666776653

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.77  E-value=3.1e-19  Score=202.01  Aligned_cols=181  Identities=23%  Similarity=0.228  Sum_probs=142.9

Q ss_pred             ccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCcccc-CcCCCcceEeeccccCCCCCcccccccccceEEee
Q 039290          424 MKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLG-RLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLG  502 (1049)
Q Consensus       424 L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  502 (1049)
                      -+.+++++++++. +|..+.  +.++.|+|++|+|++..+..|. .+++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus        20 ~~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls   96 (361)
T 2xot_A           20 SNILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS   96 (361)
T ss_dssp             TTEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence            4689999999984 676654  4689999999999988888888 99999999999999998888899999999999999


Q ss_pred             CcccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccc
Q 039290          503 DNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVI  582 (1049)
Q Consensus       503 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  582 (1049)
                      +|+|++..+..|.++++|++|+|++|+++++.|..|..+++|+.|+|++|+|++..+..|..                  
T Consensus        97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~------------------  158 (361)
T 2xot_A           97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKD------------------  158 (361)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC-------------------
T ss_pred             CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcC------------------
Confidence            99999877788999999999999999999887888877777777777777776533332210                  


Q ss_pred             cccccCCCcccEEEeecccccCCccccccCccC--CcEEeccCccccC
Q 039290          583 PVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKS--LNFVDMSNNNLSG  628 (1049)
Q Consensus       583 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~--L~~L~Ls~N~l~~  628 (1049)
                         +..+++|+.|+|++|+|++..+..|..++.  |+.|+|++|++..
T Consensus       159 ---~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C  203 (361)
T 2xot_A          159 ---GNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC  203 (361)
T ss_dssp             ------CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred             ---cccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccC
Confidence               144566666677777766555566666665  3667777777764

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.75  E-value=4.6e-19  Score=190.76  Aligned_cols=168  Identities=24%  Similarity=0.359  Sum_probs=84.4

Q ss_pred             CCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCcee
Q 039290          445 INNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLS  524 (1049)
Q Consensus       445 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  524 (1049)
                      +.++..+++++|.+++..  .+..+++|++|++++|+|+ .++ .+..+++|++|++++|++++..+  +.++++|++|+
T Consensus        18 l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~   91 (263)
T 1xeu_A           18 LANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS   91 (263)
T ss_dssp             HHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred             HHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence            445555566666665322  4555666666666666665 333 45556666666666666654332  56666666666


Q ss_pred             ecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccC
Q 039290          525 LGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQG  604 (1049)
Q Consensus       525 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  604 (1049)
                      |++|+++++.+ .. . ++|++|++++|++++.  +.+..+++|++|+|++|+|++. + .++.+++|+.|+|++|+|++
T Consensus        92 L~~N~l~~l~~-~~-~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~  164 (263)
T 1xeu_A           92 VNRNRLKNLNG-IP-S-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITN  164 (263)
T ss_dssp             CCSSCCSCCTT-CC-C-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCB
T ss_pred             CCCCccCCcCc-cc-c-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcc
Confidence            66666655321 11 1 4455555555554432  2244444444444444444432 1 34444444444444444443


Q ss_pred             CccccccCccCCcEEeccCcccc
Q 039290          605 PIPESFGGLKSLNFVDMSNNNLS  627 (1049)
Q Consensus       605 ~~~~~~~~l~~L~~L~Ls~N~l~  627 (1049)
                      .  ..+..+++|+.|++++|+++
T Consensus       165 ~--~~l~~l~~L~~L~l~~N~~~  185 (263)
T 1xeu_A          165 T--GGLTRLKKVNWIDLTGQKCV  185 (263)
T ss_dssp             C--TTSTTCCCCCEEEEEEEEEE
T ss_pred             h--HHhccCCCCCEEeCCCCccc
Confidence            3  33444444444444444444

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.74  E-value=2.8e-18  Score=184.60  Aligned_cols=171  Identities=20%  Similarity=0.282  Sum_probs=118.6

Q ss_pred             CcchhhhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEE
Q 039290           95 NLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQEL  174 (1049)
Q Consensus        95 ~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  174 (1049)
                      ++..+..+++++|.++ .++ .+..+++|++|++++|++. .+| .+..+++|++|+|++|.+++. |. ++.+++|++|
T Consensus        17 ~l~~l~~l~l~~~~i~-~~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L   90 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVT-DLV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDL-SP-LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHHTCSCTT-SEE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCSSCCEE
T ss_pred             HHHHHHHHHhcCCCcc-ccc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCC-hh-hccCCCCCEE
Confidence            5778888899998887 455 6788899999999999887 566 688889999999999998854 44 8888999999


Q ss_pred             cCCCccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceEEe
Q 039290          175 DLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFL  254 (1049)
Q Consensus       175 ~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  254 (1049)
                      +|++|+++ .+|...       . ++|++|++++|++++ +| .+..+++|+.|+|++|++++. | .++.+++|++|+|
T Consensus        91 ~L~~N~l~-~l~~~~-------~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L  157 (263)
T 1xeu_A           91 SVNRNRLK-NLNGIP-------S-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDL  157 (263)
T ss_dssp             ECCSSCCS-CCTTCC-------C-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEEC
T ss_pred             ECCCCccC-CcCccc-------c-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEEC
Confidence            99999888 455422       1 457788888888775 22 355566666666666666543 2 4555566666666


Q ss_pred             ccccccccCccccccccceEEEeeccccCCCc
Q 039290          255 GNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGL  286 (1049)
Q Consensus       255 ~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~  286 (1049)
                      ++|++++.  ..+..+++|+.|++++|.+...
T Consensus       158 ~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          158 HGNEITNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             TTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             CCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence            66666543  4455555555555555555443

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.73  E-value=1.7e-18  Score=176.86  Aligned_cols=131  Identities=21%  Similarity=0.292  Sum_probs=80.1

Q ss_pred             ceEEeeCcccCCcCchhccCcccCCceeecCcccccccCc-ccccccccccccccCCccCCCCccCcCCCcceeEeeccc
Q 039290          497 ANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPS-TLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSL  575 (1049)
Q Consensus       497 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  575 (1049)
                      +.+++++|.++ .+|..+..  +|++|++++|+++++.+. .+..+++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            66777777775 55654433  677777777777665553 356666666666666666665555666666666666666


Q ss_pred             ccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCc
Q 039290          576 NALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTI  630 (1049)
Q Consensus       576 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  630 (1049)
                      |+|++..|..|.++++|+.|+|++|+|++.+|..|..+++|++|+|++|++++..
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c  142 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC  142 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence            6666555555555666666666666665555555555555666666665555443

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.73  E-value=6.1e-18  Score=173.70  Aligned_cols=153  Identities=17%  Similarity=0.220  Sum_probs=76.2

Q ss_pred             cCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccccCccccccccccc
Q 039290          467 GRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILR  546 (1049)
Q Consensus       467 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  546 (1049)
                      +.+++|++|++++|.++ .+| .+..+++|++|++++|.++  .+..+..+++|++|++++|++++..|..+        
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l--------  108 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNL--------  108 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCC--------
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhh--------
Confidence            34445555555555554 333 3444555555555555443  12244445555555555555544333334        


Q ss_pred             ccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeeccc-ccCCccccccCccCCcEEeccCcc
Q 039290          547 FNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNR-LQGPIPESFGGLKSLNFVDMSNNN  625 (1049)
Q Consensus       547 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~Ls~N~  625 (1049)
                                      +.+++|++|++++|++++..|..++.+++|+.|+|++|+ ++ .+| .+..+++|++|++++|+
T Consensus       109 ----------------~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~  170 (197)
T 4ezg_A          109 ----------------SGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDG  170 (197)
T ss_dssp             ----------------TTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBC
T ss_pred             ----------------cCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCC
Confidence                            444444444444444444445555555555556665555 44 233 45556666666666666


Q ss_pred             ccCCcccccccccccceeeccCCccc
Q 039290          626 LSGTIPKSMEALSYLKHLNLSFNQLE  651 (1049)
Q Consensus       626 l~~~~p~~~~~l~~L~~l~l~~N~l~  651 (1049)
                      +++ ++ .+..+++|++|++++|++.
T Consensus       171 i~~-~~-~l~~l~~L~~L~l~~N~i~  194 (197)
T 4ezg_A          171 VHD-YR-GIEDFPKLNQLYAFSQTIG  194 (197)
T ss_dssp             CCC-CT-TGGGCSSCCEEEECBC---
T ss_pred             CcC-hH-HhccCCCCCEEEeeCcccC
Confidence            653 32 4555666666666666553

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.73  E-value=8.7e-18  Score=172.53  Aligned_cols=150  Identities=17%  Similarity=0.239  Sum_probs=110.7

Q ss_pred             CcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEE
Q 039290          516 NLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLL  595 (1049)
Q Consensus       516 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  595 (1049)
                      .+++|+.|++++|.++. +| .+..+++|++|++++|.++  .++.+..+++|++|++++|++++..|..|+.+++|+.|
T Consensus        42 ~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L  117 (197)
T 4ezg_A           42 QMNSLTYITLANINVTD-LT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL  117 (197)
T ss_dssp             HHHTCCEEEEESSCCSC-CT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEE
T ss_pred             hcCCccEEeccCCCccC-hH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEE
Confidence            34444444444444443 22 3444555555555555443  23457778888999999999988889999999999999


Q ss_pred             EeecccccCCccccccCccCCcEEeccCcc-ccCCcccccccccccceeeccCCcccccCCCCCCccccccccccCCc
Q 039290          596 SLRYNRLQGPIPESFGGLKSLNFVDMSNNN-LSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQ  672 (1049)
Q Consensus       596 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~  672 (1049)
                      +|++|++++..|..++.+++|++|+|++|+ ++ .+| .+..+++|+.|++++|++++. |.-..+..+....+.+|+
T Consensus       118 ~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~~l~~l~~L~~L~l~~N~  192 (197)
T 4ezg_A          118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-RGIEDFPKLNQLYAFSQT  192 (197)
T ss_dssp             ECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-TTGGGCSSCCEEEECBC-
T ss_pred             EecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-HHhccCCCCCEEEeeCcc
Confidence            999999998899999999999999999998 65 666 699999999999999999873 333344455555666664

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.72  E-value=1.1e-18  Score=214.69  Aligned_cols=198  Identities=20%  Similarity=0.235  Sum_probs=85.6

Q ss_pred             cCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCc
Q 039290          430 ESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGR  509 (1049)
Q Consensus       430 ~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  509 (1049)
                      ..|.+. ..|+.+..+++|+.|+|++|.+. .+|..+..+++|++|+|++|+|+ .+|..|+.+++|++|+|++|+|+ .
T Consensus       209 ~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~  284 (727)
T 4b8c_D          209 IENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-S  284 (727)
T ss_dssp             --------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-S
T ss_pred             ccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-c
Confidence            334433 44556666667777777777766 45555556666777777777666 56666666666666666666666 5


Q ss_pred             CchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcc-eeEeecccccccccccccccC
Q 039290          510 LPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKV-VIEMDLSLNALSGVIPVTIGG  588 (1049)
Q Consensus       510 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~  588 (1049)
                      +|..|+++++|++|+|++|.|+. +|..|..+++|+.|+|++|.|++.+|..+..+.. +..++|++|.+++.+|.    
T Consensus       285 lp~~~~~l~~L~~L~L~~N~l~~-lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~----  359 (727)
T 4b8c_D          285 LPAELGSCFQLKYFYFFDNMVTT-LPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH----  359 (727)
T ss_dssp             CCSSGGGGTTCSEEECCSSCCCC-CCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC----
T ss_pred             cChhhcCCCCCCEEECCCCCCCc-cChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc----
Confidence            56666666666666666666653 4555666666666666666655555544433221 12245555555544443    


Q ss_pred             CCcccEEEeecccccCCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCcccccC
Q 039290          589 LQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEI  654 (1049)
Q Consensus       589 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~  654 (1049)
                        .|+.|++++|...   -..+             +.|.+..+..+..+..+....+++|-+.+..
T Consensus       360 --~l~~l~l~~n~~~---~~~~-------------~~l~~~~~~~~~~l~~~~~~~ls~Nil~~~~  407 (727)
T 4b8c_D          360 --ERRFIEINTDGEP---QREY-------------DSLQQSTEHLATDLAKRTFTVLSYNTLCQHY  407 (727)
T ss_dssp             --C---------------------------------------------------------CCCGGG
T ss_pred             --ccceeEeeccccc---cccc-------------CCccccccchhhcccccceeeeecccccccc
Confidence              2333444444100   0011             1333344444555666666777777765433

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.72  E-value=4.6e-18  Score=182.38  Aligned_cols=138  Identities=18%  Similarity=0.201  Sum_probs=107.2

Q ss_pred             CCCCCceecCCCcEEEEEEEe-CCCcE--EEEEEeecccCCC------------------------HHHHHHHHHHHhhc
Q 039290          762 GFSENKLLGMGSFGSVYKGVL-PDGME--IAAKVFHMEFDGS------------------------LESFHAECKVMGSI  814 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~-~~~~~--vavK~~~~~~~~~------------------------~~~~~~e~~~l~~l  814 (1049)
                      -|.+.+.||+|+||.||+|.. .+|+.  ||||+++......                        ...+.+|++++.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            366788999999999999997 68889  9999975432110                        13678899999999


Q ss_pred             CCCce--eeEEeeeecCCeeEEEEeccCC-C----ChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCC
Q 039290          815 RHRNL--VKIISSCSNNDFKALVLEYMSN-G----SLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDI  887 (1049)
Q Consensus       815 ~hpni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl  887 (1049)
                      +|+++  +.++++    +..++||||+.+ |    +|.+....    .++.++..++.|++.|++|||.  +.||+||||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDl  197 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADL  197 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSC
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCC
Confidence            88754  344432    356899999942 3    66665432    2345678899999999999994  579999999


Q ss_pred             CCCCeeecCCCceEEecccCceec
Q 039290          888 KPSNVLLNESMVGHLSDFGIAKIL  911 (1049)
Q Consensus       888 kp~NIl~~~~~~~kl~DfGla~~~  911 (1049)
                      ||+|||++.  .++|+|||+|...
T Consensus       198 kp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             STTSEEESS--SEEECCCTTCEET
T ss_pred             CHHHEEEcC--cEEEEECcccccC
Confidence            999999998  9999999999864

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.71  E-value=2.3e-17  Score=168.48  Aligned_cols=155  Identities=25%  Similarity=0.342  Sum_probs=103.8

Q ss_pred             CceeecCcccccccCcccccccccccccccCCccCCCCcc-CcCCCcceeEeecccccccccccccccCCCcccEEEeec
Q 039290          521 RDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLP-DIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRY  599 (1049)
Q Consensus       521 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  599 (1049)
                      +.+++++|+++. +|..+..  ++++|++++|++++..+. .++.+++|++|+|++|+|++..|..|.++++|+.|+|++
T Consensus        11 ~~l~~s~~~l~~-ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLKE-IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCSS-CCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcCc-CccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            567777777765 4444432  677777777777765553 367777777777777777777777777777777777777


Q ss_pred             ccccCCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCcccccCCCCCCccccccccccCCccccCCC
Q 039290          600 NRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSP  678 (1049)
Q Consensus       600 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~cg~~  678 (1049)
                      |+|++..+..|.++++|++|+|++|+|++.+|..+..+++|++|++++|+|+|.++...-...+....+.++...|+.|
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P  166 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence            7777766777777777777777777777777777777777777777777777776642111112222344455556655

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.70  E-value=5.6e-18  Score=189.17  Aligned_cols=260  Identities=15%  Similarity=0.111  Sum_probs=118.1

Q ss_pred             ccceEEEeeccccCC--CccccccccccccceEEeccCccCCCCCCcccCC--------CCCccEEEcCCCCCCCCCCcc
Q 039290          270 LRNLEVLGVQSSNLA--GLIPASIFNISTLKELAVTDNDLLGSLPSSIDLG--------LPNLERLFLGENNFSGTIPSS  339 (1049)
Q Consensus       270 l~~L~~L~L~~n~l~--~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~--------l~~L~~L~L~~N~l~~~~p~~  339 (1049)
                      +++|+.|||++|++.  ...+..   ++.++.+.+..|    .+|+..+.+        +++|+.|+|.+ .++...+.+
T Consensus        48 l~~L~~LdLs~n~i~~~~~~~~~---~~~~~~~~~~~~----~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~a  119 (329)
T 3sb4_A           48 FPSLKVLDISNAEIKMYSGKAGT---YPNGKFYIYMAN----FVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAA  119 (329)
T ss_dssp             CTTCCEEEEEEEEECCEEESSSS---SGGGCCEEECTT----EECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTT
T ss_pred             hccCeEEecCcceeEEecCcccc---cccccccccccc----ccCHHHhcccccccccccCCCcEEECCc-cccchhHHH
Confidence            455666666666655  111111   112334444444    345555555        67777777776 666555566


Q ss_pred             ccCCCCCceeecccCccccCcccccccccccceeecccccc----cCCCCCcccccccccCCCCc-EEEccCCccccCCC
Q 039290          340 LTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVL----TSPTPDLSFLSSLTSCRNLE-IIYLSENPINGILP  414 (1049)
Q Consensus       340 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l----~~~~~~~~~l~~l~~l~~L~-~L~Ls~N~i~~~~p  414 (1049)
                      |.++++|+.+++++|.+..+.+..|.++.++..+.+..+..    ..+..     .+|..+..|+ .+.+....   .++
T Consensus       120 F~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~-----~~f~~~~~L~~~i~~~~~~---~l~  191 (329)
T 3sb4_A          120 FKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEH-----FAFIEGEPLETTIQVGAMG---KLE  191 (329)
T ss_dssp             TTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTT-----SCEEESCCCEEEEEECTTC---CHH
T ss_pred             hhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccc-----cccccccccceeEEecCCC---cHH
Confidence            77777777777777777666666677666666666555322    11111     1244455555 33333211   011


Q ss_pred             Cccccc---cccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccc
Q 039290          415 SSIGNF---SISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLC  491 (1049)
Q Consensus       415 ~~~~~~---~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~  491 (1049)
                      ..+...   ..++..+.+.++-...........+++|+.|+|++|+++.+.+.+|.++++|+.|+|.+| ++...+..|.
T Consensus       192 ~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~  270 (329)
T 3sb4_A          192 DEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFS  270 (329)
T ss_dssp             HHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTT
T ss_pred             HHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhh
Confidence            111000   112233333222110000000011344555555555555444444555555555555544 4433334444


Q ss_pred             cccccc-eEEeeCcccCCcCchhccCcccCCceeecCcccccccCcccccccccccc
Q 039290          492 HLYRLA-NLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRF  547 (1049)
Q Consensus       492 ~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  547 (1049)
                      ++.+|+ .+++.+ .++.+.+.+|.++++|+.+++++|+++.+.+.+|.++++|+.+
T Consensus       271 ~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~l  326 (329)
T 3sb4_A          271 NCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLI  326 (329)
T ss_dssp             TCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEE
T ss_pred             CChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhh
Confidence            444444 444444 3333334444444444444444444444444444444444433

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.67  E-value=1.4e-17  Score=185.89  Aligned_cols=101  Identities=13%  Similarity=0.102  Sum_probs=50.2

Q ss_pred             cccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCccc-EEEeecccccCCccccccCccCCcEEe
Q 039290          542 KDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQ-LLSLRYNRLQGPIPESFGGLKSLNFVD  620 (1049)
Q Consensus       542 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~  620 (1049)
                      ++|+.++|++|+++.....+|.++.+|++++|++| ++.+.+.+|.++.+|+ .+++.+ +++.+.+.+|.++++|+.|+
T Consensus       226 ~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~  303 (329)
T 3sb4_A          226 PNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVL  303 (329)
T ss_dssp             TTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEE
T ss_pred             CCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEE
Confidence            34444444444444433444444444455555444 4444444555555555 555555 44444445555555555555


Q ss_pred             ccCccccCCcccccccccccceee
Q 039290          621 MSNNNLSGTIPKSMEALSYLKHLN  644 (1049)
Q Consensus       621 Ls~N~l~~~~p~~~~~l~~L~~l~  644 (1049)
                      +++|+++...+..|.++++|+.++
T Consensus       304 l~~n~i~~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          304 ATGDKITTLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             ECSSCCCEECTTTTCTTCCCCEEE
T ss_pred             eCCCccCccchhhhcCCcchhhhc
Confidence            555555533344555555555544

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.66  E-value=6.9e-17  Score=164.79  Aligned_cols=131  Identities=27%  Similarity=0.389  Sum_probs=93.3

Q ss_pred             ceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeeccc
Q 039290          522 DLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNR  601 (1049)
Q Consensus       522 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  601 (1049)
                      .+++++|.++. +|..+.  ++|++|++++|.|+ .+|..|..+++|++|+|++|+|++..+..|.++++|+.|+|++|+
T Consensus        14 ~l~~~~~~l~~-ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           14 VVRCSNKGLKV-LPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             EEECTTSCCSS-CCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEcCCCCCCc-CCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            34444444443 232221  34555666666665 344566667777777777777777777778888888888888888


Q ss_pred             ccCCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCcccccCCC
Q 039290          602 LQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPT  656 (1049)
Q Consensus       602 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~  656 (1049)
                      |++..|..|.++++|++|+|++|+|++..+..+..+++|+.|++++|+|.|.+..
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l  144 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNM  144 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcC
Confidence            8877778888888888888888888865556688888888888888888887753

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.62  E-value=6.8e-16  Score=153.92  Aligned_cols=133  Identities=19%  Similarity=0.187  Sum_probs=98.7

Q ss_pred             ccCCceeecCcccc-cccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEE
Q 039290          518 TSLRDLSLGSNALT-SIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLS  596 (1049)
Q Consensus       518 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  596 (1049)
                      ++|+.|++++|+++ +.+|..+..+++|++|++++|.+++.  ..+..+++|++|+|++|++++.+|..+..+++|+.|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            45666666666665 44565666666666666666666654  6677777888888888888876777777788888888


Q ss_pred             eecccccCCc-cccccCccCCcEEeccCccccCCcc---cccccccccceeeccCCcccc
Q 039290          597 LRYNRLQGPI-PESFGGLKSLNFVDMSNNNLSGTIP---KSMEALSYLKHLNLSFNQLEG  652 (1049)
Q Consensus       597 Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~l~l~~N~l~~  652 (1049)
                      |++|+|++.. +..+..+++|++|++++|++++..+   ..+..+++|++|++++|.+..
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~  161 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE  161 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence            8888888643 2778888888888888888885544   478888888888888888754

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.62  E-value=4.5e-16  Score=155.23  Aligned_cols=136  Identities=23%  Similarity=0.229  Sum_probs=88.1

Q ss_pred             CCCcceEeeccccC-CCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccccCccccccccccccc
Q 039290          470 QKLQGLYLQNNKLE-GSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFN  548 (1049)
Q Consensus       470 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  548 (1049)
                      ++|++|++++|+++ +.+|..+..+++|+.|++++|.+++.  ..+..+++|++|++++|++++.+|..+..+++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            56777777777776 55666666777777777777776643  5566666666666666666665555554455555555


Q ss_pred             ccCCccCCCCccCcCCCcceeEeecccccccccc-cccccCCCcccEEEeecccccCCcc---ccccCccCCcEEeccCc
Q 039290          549 LSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVI-PVTIGGLQGLQLLSLRYNRLQGPIP---ESFGGLKSLNFVDMSNN  624 (1049)
Q Consensus       549 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~Ls~N  624 (1049)
                      +++|.+                        ++.. +..+..+++|+.|++++|++++..+   ..|..+++|++||+++|
T Consensus       102 Ls~N~l------------------------~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n  157 (168)
T 2ell_A          102 LSGNKL------------------------KDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDR  157 (168)
T ss_dssp             CBSSSC------------------------CSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEET
T ss_pred             ccCCcc------------------------CcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCC
Confidence            555544                        4332 2566677777777777777775544   47777788888888888


Q ss_pred             cccCCccc
Q 039290          625 NLSGTIPK  632 (1049)
Q Consensus       625 ~l~~~~p~  632 (1049)
                      .+. .+|.
T Consensus       158 ~~~-~~~~  164 (168)
T 2ell_A          158 EDQ-EAPD  164 (168)
T ss_dssp             TSC-BCCS
T ss_pred             Chh-hccc
Confidence            776 4444

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.62  E-value=3.4e-16  Score=173.38  Aligned_cols=145  Identities=14%  Similarity=0.148  Sum_probs=104.1

Q ss_pred             HHHHHHhcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccC--------------CCHHH--------HHHHHHHH
Q 039290          754 QDLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFD--------------GSLES--------FHAECKVM  811 (1049)
Q Consensus       754 ~~~~~~~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~e~~~l  811 (1049)
                      ..+.....-|++.+.||+|+||.||+|...+|+.||||+++....              .....        ..+|...+
T Consensus        88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL  167 (397)
T 4gyi_A           88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM  167 (397)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence            334443345899999999999999999998999999999754210              01111        23455666


Q ss_pred             hhcCCCcee--eEEeeeecCCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCC
Q 039290          812 GSIRHRNLV--KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKP  889 (1049)
Q Consensus       812 ~~l~hpniv--~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp  889 (1049)
                      .++.+.++.  ..+++    ...++||||++|++|.++...       .....++.|++.++.++|   +.|||||||||
T Consensus       168 ~rL~~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp  233 (397)
T 4gyi_A          168 KALYEEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLA---KHGLIHGDFNE  233 (397)
T ss_dssp             HHHHHTTCSCCCEEEE----ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCST
T ss_pred             HHHHhcCCCCCeeeec----cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCH
Confidence            666443332  22221    123799999999888765322       234568899999999999   89999999999


Q ss_pred             CCeeecCCC----------ceEEecccCceecC
Q 039290          890 SNVLLNESM----------VGHLSDFGIAKILG  912 (1049)
Q Consensus       890 ~NIl~~~~~----------~~kl~DfGla~~~~  912 (1049)
                      .|||+++++          .+.|+||+-+....
T Consensus       234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          234 FNILIREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             TSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             HHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence            999998766          38999999887543

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.61  E-value=1.2e-15  Score=153.58  Aligned_cols=113  Identities=23%  Similarity=0.270  Sum_probs=70.5

Q ss_pred             ccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEecc
Q 039290          543 DILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMS  622 (1049)
Q Consensus       543 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  622 (1049)
                      +|+.|++++|++++..+..+..+++|++|++++|+|++..+..|+.+++|+.|+|++|+|++..+..|.++++|++|+|+
T Consensus        29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~  108 (177)
T 2o6r_A           29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALD  108 (177)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECc
Confidence            44444444444444444445555555556666666655555556666677777777777776666666677777777777


Q ss_pred             CccccCCcccccccccccceeeccCCcccccCC
Q 039290          623 NNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIP  655 (1049)
Q Consensus       623 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p  655 (1049)
                      +|++++..+..+..+++|++|++++|++.|.+|
T Consensus       109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A          109 TNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             SSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            777765444455667777777777777777665

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.60  E-value=7.7e-16  Score=150.13  Aligned_cols=128  Identities=17%  Similarity=0.199  Sum_probs=98.3

Q ss_pred             ccCCceeecCcccc-cccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEE
Q 039290          518 TSLRDLSLGSNALT-SIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLS  596 (1049)
Q Consensus       518 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  596 (1049)
                      ++|+.|++++|.++ +.+|..+..+++|++|++++|.+++.  ..++.+++|++|++++|++++.+|..+..+++|+.|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            55666666666666 45666666677777777777777654  6677778888888888888877788888888899999


Q ss_pred             eecccccCC-ccccccCccCCcEEeccCccccCCcc---cccccccccceeeccC
Q 039290          597 LRYNRLQGP-IPESFGGLKSLNFVDMSNNNLSGTIP---KSMEALSYLKHLNLSF  647 (1049)
Q Consensus       597 Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~l~l~~  647 (1049)
                      +++|++++. .+..++.+++|++|++++|++++..+   ..+..+++|+.|++++
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            999988864 34788888999999999999986655   4788888899888863

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.58  E-value=4e-15  Score=149.76  Aligned_cols=133  Identities=22%  Similarity=0.225  Sum_probs=104.0

Q ss_pred             cceEEeeCcccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeeccc
Q 039290          496 LANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSL  575 (1049)
Q Consensus       496 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  575 (1049)
                      .+.+++++|.++ .+|..+  .++|+.|++++|+++++.+..+..+++|++|++++|++++..+..+..+++|++|++++
T Consensus         9 ~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   85 (177)
T 2o6r_A            9 GTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE   85 (177)
T ss_dssp             TTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence            456666666665 344333  25677777777777776666677777777777777777776666678888888888888


Q ss_pred             ccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCcc
Q 039290          576 NALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIP  631 (1049)
Q Consensus       576 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  631 (1049)
                      |+|++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|++++..|
T Consensus        86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            88887777788899999999999999997777778999999999999999997665

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.58  E-value=3.6e-15  Score=152.00  Aligned_cols=129  Identities=26%  Similarity=0.362  Sum_probs=94.9

Q ss_pred             ceEEeeCcccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccc
Q 039290          497 ANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLN  576 (1049)
Q Consensus       497 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  576 (1049)
                      +.+++++|.++ .+|..+.  ++|++|+|++|+++. +|..|..+++|++|+|++|.|++..+..|..+++|++|+|++|
T Consensus        13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~~-ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N   88 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN   88 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCS-CCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCch-hHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence            34555555555 3443332  356666666666653 4456666666666777777776666667777788888888888


Q ss_pred             cccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCC
Q 039290          577 ALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGT  629 (1049)
Q Consensus       577 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  629 (1049)
                      +|++..|..|.++++|+.|+|++|+|+...+..|..+++|+.|+|++|++.+.
T Consensus        89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~  141 (193)
T 2wfh_A           89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD  141 (193)
T ss_dssp             CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence            88878788899999999999999999977777899999999999999999753

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.58  E-value=1.5e-14  Score=164.86  Aligned_cols=264  Identities=11%  Similarity=0.113  Sum_probs=166.7

Q ss_pred             CCCceeecccCccccCcccccccccccceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCcccccccc
Q 039290          344 SELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSIS  423 (1049)
Q Consensus       344 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~  423 (1049)
                      ..++.+.+.+ .++.+...+|.+. +|+.+.+..| ++.+...     +|.++ +|+.+.+.+                 
T Consensus       113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~-----aF~~~-~L~~i~lp~-----------------  166 (401)
T 4fdw_A          113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDM-----AFFNS-TVQEIVFPS-----------------  166 (401)
T ss_dssp             SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTT-----TTTTC-CCCEEECCT-----------------
T ss_pred             CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHH-----hcCCC-CceEEEeCC-----------------
Confidence            3444454433 3444445566663 5777776655 5544433     23332 355554443                 


Q ss_pred             ccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeC
Q 039290          424 MKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGD  503 (1049)
Q Consensus       424 L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  503 (1049)
                               .+....+.+|.++++|+.++|++|+++.....+|. ..+|+.+.|..+ ++......|.++++|+.+++.+
T Consensus       167 ---------~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~  235 (401)
T 4fdw_A          167 ---------TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPE  235 (401)
T ss_dssp             ---------TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCT
T ss_pred             ---------CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCC
Confidence                     33334445566666666666666666654445555 466666666633 5545555666666677777665


Q ss_pred             cccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccC-----CCCccCcCCCcceeEeecccccc
Q 039290          504 NKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLN-----GSLLPDIGNLKVVIEMDLSLNAL  578 (1049)
Q Consensus       504 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l  578 (1049)
                      | ++.....+|.+ .+|+.+.+ .+.++.+...+|.++++|+.+++.+|.+.     ......|.++.+|+.++|. |.+
T Consensus       236 ~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i  311 (401)
T 4fdw_A          236 N-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESI  311 (401)
T ss_dssp             T-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTC
T ss_pred             C-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-Cce
Confidence            4 44345556666 56777777 44566666667777777777777666554     3445677778888888887 447


Q ss_pred             cccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCccccccccc-ccceeeccCCcc
Q 039290          579 SGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALS-YLKHLNLSFNQL  650 (1049)
Q Consensus       579 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~l~l~~N~l  650 (1049)
                      +.+...+|.++.+|+.++|..| ++.+.+.+|.++ +|+.+++++|.+....+..|..++ ++..|++..|.+
T Consensus       312 ~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~  382 (401)
T 4fdw_A          312 RILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV  382 (401)
T ss_dssp             CEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred             EEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence            7666778888888888888555 665667788888 888888888888765566677774 677787777654

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.58  E-value=3.7e-14  Score=161.47  Aligned_cols=247  Identities=12%  Similarity=0.161  Sum_probs=135.1

Q ss_pred             CCceeecccCccccCcccccccccccceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccc
Q 039290          345 ELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISM  424 (1049)
Q Consensus       345 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L  424 (1049)
                      +|+.+++..| +..+...+|.+ .+|+.+.+.. .++.+...     +|.+|++|+.+++++|.++.+....|. . .+|
T Consensus       136 ~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~-----aF~~c~~L~~l~l~~n~l~~I~~~aF~-~-~~L  205 (401)
T 4fdw_A          136 QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKED-----IFYYCYNLKKADLSKTKITKLPASTFV-Y-AGI  205 (401)
T ss_dssp             CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSS-----TTTTCTTCCEEECTTSCCSEECTTTTT-T-CCC
T ss_pred             CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHH-----HhhCcccCCeeecCCCcceEechhhEe-e-ccc
Confidence            3444444433 33333444444 2455555543 33333332     355555555555555555533333332 1 244


Q ss_pred             cEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCc
Q 039290          425 KSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDN  504 (1049)
Q Consensus       425 ~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  504 (1049)
                      +.+.+..+ +......+|.++++|+.+++.+| ++.+...+|.+ .+|+.+.+ .|.++......|.++++|+.+++.+|
T Consensus       206 ~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~  281 (401)
T 4fdw_A          206 EEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGS  281 (401)
T ss_dssp             SEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESS
T ss_pred             CEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCc
Confidence            55555422 44444555666666666666653 44344455555 55666666 33344344445555555555555555


Q ss_pred             ccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccc
Q 039290          505 KLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPV  584 (1049)
Q Consensus       505 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  584 (1049)
                      .+.                   .+.+..+.+.+|.++++|+.+++. +.++.....+|.++.+|+.++|..| ++.+.+.
T Consensus       282 ~~~-------------------~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~  340 (401)
T 4fdw_A          282 TFN-------------------DDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFS  340 (401)
T ss_dssp             CCC-------------------CCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTT
T ss_pred             ccc-------------------CCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHH
Confidence            443                   000113444555555566666665 3355445556666677777777444 5556667


Q ss_pred             cccCCCcccEEEeecccccCCccccccCcc-CCcEEeccCcccc
Q 039290          585 TIGGLQGLQLLSLRYNRLQGPIPESFGGLK-SLNFVDMSNNNLS  627 (1049)
Q Consensus       585 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~  627 (1049)
                      +|.++ +|+.+++++|.+....+..|.+++ +++.|++..|.+.
T Consensus       341 aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          341 AFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             SSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             hCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            78888 888888888887766777787774 6778888777654

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.56  E-value=3.2e-15  Score=145.77  Aligned_cols=126  Identities=21%  Similarity=0.248  Sum_probs=90.2

Q ss_pred             cccEEEccCCccc-cCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEe
Q 039290          423 SMKSLSMESCNIS-GGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYL  501 (1049)
Q Consensus       423 ~L~~L~L~~n~i~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  501 (1049)
                      +++.|++++|.++ +.+|..+..+++|++|++++|.+++.  ..++.+++|++|+|++|++++.+|..+..+++|++|++
T Consensus        18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l   95 (149)
T 2je0_A           18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL   95 (149)
T ss_dssp             GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred             cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence            5666666666666 56667777777888888888887754  66777777888888888777667776777777777777


Q ss_pred             eCcccCCc-CchhccCcccCCceeecCcccccccC---ccccccccccccccc
Q 039290          502 GDNKLSGR-LPACLGNLTSLRDLSLGSNALTSIIP---STLWNLKDILRFNLS  550 (1049)
Q Consensus       502 ~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~Ls  550 (1049)
                      ++|++++. .+..++.+++|++|++++|++++..+   ..+..+++|+.|+++
T Consensus        96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             TTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             CCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            77777753 23667777777777777777776554   456667777776665

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.55  E-value=6.3e-17  Score=166.25  Aligned_cols=137  Identities=23%  Similarity=0.296  Sum_probs=71.0

Q ss_pred             cccccCCcEeccccCCccccCcc------cccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcc
Q 039290          117 LSHLRGLKYFDFRFNNFHIEIPS------WFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIF  190 (1049)
Q Consensus       117 ~~~L~~L~~L~l~~n~~~~~~p~------~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~  190 (1049)
                      +.....++.++++.+++.|.+|.      .|..+++|++|+|++|.+++ +| .++.+++|++|+|++|+++ .+|..+.
T Consensus        14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~   90 (198)
T 1ds9_A           14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA   90 (198)
T ss_dssp             HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred             HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence            33445555666666666655554      56666666666666666653 55 5566666666666666665 4554332


Q ss_pred             cccccCCCCccceEEeeccccCCCCCCCcccccccceecccccccccccC-CCCccccccceEEeccccccccCc
Q 039290          191 NISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIP-RDIGNLTSVRNLFLGNNSLIGEIP  264 (1049)
Q Consensus       191 ~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p  264 (1049)
                      .      +++|++|++++|++++ +| .+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++.+|
T Consensus        91 ~------~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~  157 (198)
T 1ds9_A           91 V------ADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK  157 (198)
T ss_dssp             H------HHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHH
T ss_pred             c------CCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccc
Confidence            2      2335555555555553 22 34444445555555554442211 234445555555555555544433

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.54  E-value=1.2e-16  Score=164.11  Aligned_cols=155  Identities=21%  Similarity=0.280  Sum_probs=95.1

Q ss_pred             ccCcCCCcceEeeccccCCCCCc------ccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccccCcccc
Q 039290          466 LGRLQKLQGLYLQNNKLEGSIPE------DLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLW  539 (1049)
Q Consensus       466 ~~~l~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  539 (1049)
                      +.....++.++++.|.+.+.+|.      .+..+++|++|++++|.+++ +| .+.++++|++|++++|+++.       
T Consensus        14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~-------   84 (198)
T 1ds9_A           14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKK-------   84 (198)
T ss_dssp             HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECS-------
T ss_pred             HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCccc-------
Confidence            44556777777777777766554      45555555555555555543 33 44444455555555544442       


Q ss_pred             cccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCcc-ccccCccCCcE
Q 039290          540 NLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIP-ESFGGLKSLNF  618 (1049)
Q Consensus       540 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~  618 (1049)
                                        +|..+..+++|++|++++|++++ +| .+..+++|+.|+|++|+|++..+ ..+..+++|++
T Consensus        85 ------------------l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~  144 (198)
T 1ds9_A           85 ------------------IENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLED  144 (198)
T ss_dssp             ------------------CSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSE
T ss_pred             ------------------ccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCE
Confidence                              33344445566666666666664 33 56677777777777777775332 46777788888


Q ss_pred             EeccCccccCCcccc----------cccccccceeeccCCccc
Q 039290          619 VDMSNNNLSGTIPKS----------MEALSYLKHLNLSFNQLE  651 (1049)
Q Consensus       619 L~Ls~N~l~~~~p~~----------~~~l~~L~~l~l~~N~l~  651 (1049)
                      |++++|++++.+|..          +..+++|+.||  +|+++
T Consensus       145 L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          145 LLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             EEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred             EEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence            888888877665542          67777888776  66654

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.53  E-value=2e-13  Score=156.17  Aligned_cols=310  Identities=14%  Similarity=0.079  Sum_probs=135.4

Q ss_pred             CCCccccccceEEeccccccccCccccccccceEEEeeccccCCCccccccccccccceEEeccCccCCCCCCcccCCCC
Q 039290          241 RDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLP  320 (1049)
Q Consensus       241 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~  320 (1049)
                      .+|.++++|+.+.|..+ ++..-..+|.++++|+.+++..+ +...-..+|.++++|+.+.+..+ +. .+....+.+..
T Consensus        65 ~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~-~i~~~aF~~~~  140 (394)
T 4fs7_A           65 AAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LK-SIGVEAFKGCD  140 (394)
T ss_dssp             TTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CC-EECTTTTTTCC
T ss_pred             HHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-ee-eecceeeeccc
Confidence            34555555555555432 44333445555566666555432 33333345555555555554433 11 23333333333


Q ss_pred             CccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCcccccccccccceeecccccccCCCCCcccccccccCCCCc
Q 039290          321 NLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLE  400 (1049)
Q Consensus       321 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~  400 (1049)
                      .++.......  ...-...|.++++|+.+.+..+- ..+....|.++.+|+.+.+..| ++.+...     +|.++..|+
T Consensus       141 ~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~-----~F~~~~~L~  211 (394)
T 4fs7_A          141 FKEITIPEGV--TVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDY-----CFAECILLE  211 (394)
T ss_dssp             CSEEECCTTC--CEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTT-----TTTTCTTCC
T ss_pred             ccccccCccc--cccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCch-----hhccccccc
Confidence            2222222221  11234456666777777765443 2244556666677777766654 3333322     355556665


Q ss_pred             EEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeecc
Q 039290          401 IIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNN  480 (1049)
Q Consensus       401 ~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  480 (1049)
                      .+.+..+...                           +.+......+|+.+.+..+ ++......|..+.+|+.+.+..+
T Consensus       212 ~i~~~~~~~~---------------------------i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~  263 (394)
T 4fs7_A          212 NMEFPNSLYY---------------------------LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNN  263 (394)
T ss_dssp             BCCCCTTCCE---------------------------ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCT
T ss_pred             eeecCCCceE---------------------------eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCC
Confidence            5554443321                           1111222233444444322 12223334444445555554444


Q ss_pred             ccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCcc
Q 039290          481 KLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLP  560 (1049)
Q Consensus       481 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~  560 (1049)
                      ... .....|..+..++.+....+.+.   ..+|..+.+|+.+.+.++ ++.+...+|.++.+|+.+++.++ ++.....
T Consensus       264 ~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~  337 (394)
T 4fs7_A          264 KLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKR  337 (394)
T ss_dssp             TCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTT
T ss_pred             cce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHH
Confidence            322 33334444444444444433321   233444555555554432 33333344444444444444322 2222233


Q ss_pred             CcCCCcceeEeecccccccccccccccCCCcccEEEee
Q 039290          561 DIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLR  598 (1049)
Q Consensus       561 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  598 (1049)
                      +|.++.+|+.+++..| ++.+...+|.++.+|+.+++.
T Consensus       338 aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp  374 (394)
T 4fs7_A          338 SFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELP  374 (394)
T ss_dssp             TTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEE
T ss_pred             hccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEEC
Confidence            3334444444444333 332333344444444444443

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.52  E-value=6.7e-15  Score=147.86  Aligned_cols=133  Identities=17%  Similarity=0.184  Sum_probs=92.6

Q ss_pred             ccCcccCCceeecCcccccccCcccccc-cccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcc
Q 039290          514 LGNLTSLRDLSLGSNALTSIIPSTLWNL-KDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGL  592 (1049)
Q Consensus       514 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  592 (1049)
                      +.++.+|+.|++++|+++.+ |. +..+ ++|++|++++|.+++.  +.+..+++|++|+|++|+|++..+..|+.+++|
T Consensus        15 ~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L   90 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   90 (176)
T ss_dssp             EECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             cCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence            33445555555555555542 32 2232 2566666666666543  456677777788888888876655556888888


Q ss_pred             cEEEeecccccCCccc--cccCccCCcEEeccCccccCCcccc----cccccccceeeccCCcccc
Q 039290          593 QLLSLRYNRLQGPIPE--SFGGLKSLNFVDMSNNNLSGTIPKS----MEALSYLKHLNLSFNQLEG  652 (1049)
Q Consensus       593 ~~L~Ls~N~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~l~l~~N~l~~  652 (1049)
                      +.|+|++|+|+ .+|.  .+..+++|++|++++|+++ .+|..    +..+++|+.||+++|....
T Consensus        91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~  154 (176)
T 1a9n_A           91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE  154 (176)
T ss_dssp             CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred             CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence            88888888887 4554  7888888999999999987 55654    8888899999998887653

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.49  E-value=3.7e-13  Score=154.04  Aligned_cols=335  Identities=12%  Similarity=0.102  Sum_probs=179.9

Q ss_pred             ccccCccccccccceEEEeeccccCCCccccccccccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCc
Q 039290          259 LIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPS  338 (1049)
Q Consensus       259 l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~  338 (1049)
                      ++..-..+|.++++|+.+.+.. +++..-..+|.++++|+.+++.++ +. .++...+.++.+|+.+.+..+ +...-..
T Consensus        59 VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~c~~L~~i~~p~~-l~~i~~~  134 (394)
T 4fs7_A           59 VVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VK-MIGRCTFSGCYALKSILLPLM-LKSIGVE  134 (394)
T ss_dssp             EEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCCCCCCTT-CCEECTT
T ss_pred             EeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ce-EccchhhcccccchhhcccCc-eeeecce
Confidence            4434455677777888777753 355444556666777777766544 22 455555555555555544433 2223333


Q ss_pred             cccCCCCCceeecccCccccCcccccccccccceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccc
Q 039290          339 SLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIG  418 (1049)
Q Consensus       339 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~  418 (1049)
                      .|.++..+.........  .....+|.++.+|+.+.+.++. +.+...     +|.++.+                    
T Consensus       135 aF~~~~~~~~~~~~~~~--~i~~~aF~~c~~L~~i~l~~~~-~~I~~~-----~F~~c~~--------------------  186 (394)
T 4fs7_A          135 AFKGCDFKEITIPEGVT--VIGDEAFATCESLEYVSLPDSM-ETLHNG-----LFSGCGK--------------------  186 (394)
T ss_dssp             TTTTCCCSEEECCTTCC--EECTTTTTTCTTCCEEECCTTC-CEECTT-----TTTTCTT--------------------
T ss_pred             eeecccccccccCcccc--ccchhhhcccCCCcEEecCCcc-ceeccc-----cccCCCC--------------------
Confidence            44444322222221111  1122344444444444443321 111111     1333333                    


Q ss_pred             cccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccce
Q 039290          419 NFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLAN  498 (1049)
Q Consensus       419 ~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  498 (1049)
                           |+.+.+..+ +.......|.++..|+.+.+..+...  +...+....+|+.+.+..+ ++......+..+..|+.
T Consensus       187 -----L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~  257 (394)
T 4fs7_A          187 -----LKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLES  257 (394)
T ss_dssp             -----CCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCE
T ss_pred             -----ceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCC-ceeccccccccccccee
Confidence                 333333332 22233445666667776666655433  2233334456777776543 33244456667777777


Q ss_pred             EEeeCcccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccc
Q 039290          499 LYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNAL  578 (1049)
Q Consensus       499 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  578 (1049)
                      +.+..+... ....+|..+..++.+....+.+   ....|....+|+.+.+.++ ++.....+|.++.+|+.+++..+ +
T Consensus       258 ~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v  331 (394)
T 4fs7_A          258 ISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-V  331 (394)
T ss_dssp             EEECCTTCE-ECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-C
T ss_pred             EEcCCCcce-eeccccccccccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-c
Confidence            777766543 5556677777777776665543   2345666677777776554 44444556777777777777543 5


Q ss_pred             cccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCccccccccccccee
Q 039290          579 SGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHL  643 (1049)
Q Consensus       579 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l  643 (1049)
                      +.+...+|.++.+|+.+++..| ++.+...+|.++.+|+.+++..+ ++ .+...|.++++|+++
T Consensus       332 ~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          332 EEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI  393 (394)
T ss_dssp             CEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred             cEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence            5455566777777777777655 55455567777777777777544 33 334456666665543

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.48  E-value=5.1e-14  Score=140.30  Aligned_cols=109  Identities=21%  Similarity=0.214  Sum_probs=75.0

Q ss_pred             ccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCc
Q 039290          545 LRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNN  624 (1049)
Q Consensus       545 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  624 (1049)
                      +.+++++|.++. +|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus        12 ~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N   88 (170)
T 3g39_A           12 TTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN   88 (170)
T ss_dssp             TEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence            344455555443 333332  55666777777777666777777777777777777777766677777777888888888


Q ss_pred             cccCCcccccccccccceeeccCCcccccCCC
Q 039290          625 NLSGTIPKSMEALSYLKHLNLSFNQLEGEIPT  656 (1049)
Q Consensus       625 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~  656 (1049)
                      +|++..+..+..+++|++|+|++|+|.|.++.
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~  120 (170)
T 3g39_A           89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACSD  120 (170)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred             ccCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence            77765555677777788888888888777663

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.48  E-value=4.3e-14  Score=141.90  Aligned_cols=133  Identities=18%  Similarity=0.161  Sum_probs=76.4

Q ss_pred             ccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCc
Q 039290          394 TSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQ  473 (1049)
Q Consensus       394 ~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  473 (1049)
                      ..+.+|+.|++++|.++.+ | .+.....+|+.|++++|.+++.  ..+..+++|++|+|++|.+++..+..|..+++|+
T Consensus        16 ~~~~~L~~L~l~~n~l~~i-~-~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   91 (176)
T 1a9n_A           16 TNAVRDRELDLRGYKIPVI-E-NLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   91 (176)
T ss_dssp             ECTTSCEEEECTTSCCCSC-C-CGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             CCcCCceEEEeeCCCCchh-H-HhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence            3444555555555555532 2 2223223455555555555543  4566667777777777777755444556677777


Q ss_pred             ceEeeccccCCCCCc--ccccccccceEEeeCcccCCcCchh----ccCcccCCceeecCccccc
Q 039290          474 GLYLQNNKLEGSIPE--DLCHLYRLANLYLGDNKLSGRLPAC----LGNLTSLRDLSLGSNALTS  532 (1049)
Q Consensus       474 ~L~L~~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~~  532 (1049)
                      +|+|++|+|+ .+|.  .+..+++|+.|++++|+++ .+|..    +..+++|+.||+++|.+..
T Consensus        92 ~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~  154 (176)
T 1a9n_A           92 ELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE  154 (176)
T ss_dssp             EEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred             EEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence            7777777775 3444  5666666666666666665 34442    5666666666666665543

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.44  E-value=1.5e-13  Score=137.27  Aligned_cols=90  Identities=23%  Similarity=0.261  Sum_probs=59.4

Q ss_pred             cceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCcccccccccccceeec
Q 039290          566 KVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNL  645 (1049)
Q Consensus       566 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l  645 (1049)
                      ++|++|+|++|+|++..|..|+++++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..+..+++|++|+|
T Consensus        33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L  112 (174)
T 2r9u_A           33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL  112 (174)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred             CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence            45566666666666666666666667777777777776655556666777777777777776544445666777777777


Q ss_pred             cCCcccccCC
Q 039290          646 SFNQLEGEIP  655 (1049)
Q Consensus       646 ~~N~l~~~~p  655 (1049)
                      ++|+|.|.++
T Consensus       113 ~~N~~~c~~~  122 (174)
T 2r9u_A          113 YNNPWDCECR  122 (174)
T ss_dssp             CSSCBCTTBG
T ss_pred             CCCCcccccc
Confidence            7777766654

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.42  E-value=4.9e-13  Score=133.12  Aligned_cols=109  Identities=22%  Similarity=0.217  Sum_probs=81.5

Q ss_pred             CCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeec
Q 039290          520 LRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRY  599 (1049)
Q Consensus       520 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  599 (1049)
                      .+.+++++|+++. +|..+  .++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|+.|+|++
T Consensus        11 ~~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            3455566666554 33333  25566677777777766677777777788888888888877777788889999999999


Q ss_pred             ccccCCccccccCccCCcEEeccCccccCCcc
Q 039290          600 NRLQGPIPESFGGLKSLNFVDMSNNNLSGTIP  631 (1049)
Q Consensus       600 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  631 (1049)
                      |+|++..+..|.++++|++|+|++|++++..+
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            99998777789999999999999999986543

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.37  E-value=7.1e-13  Score=132.42  Aligned_cols=106  Identities=22%  Similarity=0.214  Sum_probs=75.2

Q ss_pred             CceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecc
Q 039290          521 RDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYN  600 (1049)
Q Consensus       521 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  600 (1049)
                      +.+++++|+++. +|..+.  ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|.++++|+.|+|++|
T Consensus        15 ~~l~~~~n~l~~-iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLAS-VPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCCc-cCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            345555555543 333332  45666666666666666666777777777777777777666666788888888888888


Q ss_pred             cccCCccccccCccCCcEEeccCccccCC
Q 039290          601 RLQGPIPESFGGLKSLNFVDMSNNNLSGT  629 (1049)
Q Consensus       601 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  629 (1049)
                      +|++..+..|.++++|++|+|++|++...
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~  120 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCE  120 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCcccc
Confidence            88877777788899999999999998843

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.29  E-value=4.4e-14  Score=159.33  Aligned_cols=170  Identities=19%  Similarity=0.198  Sum_probs=82.5

Q ss_pred             CCccEEEccCCcccccCCccccCc-----CCCcceEeeccccCCCCCcccc-cccccceEEeeCcccCCcCchhcc----
Q 039290          446 NNLTVIRLGNNELTGTIPVTLGRL-----QKLQGLYLQNNKLEGSIPEDLC-HLYRLANLYLGDNKLSGRLPACLG----  515 (1049)
Q Consensus       446 ~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~----  515 (1049)
                      +.|+.|+|++|.++......+...     ++|++|+|++|.|+......+. .+.+|+.|+|++|.++......+.    
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~  151 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL  151 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence            456666777666664333333222     4566666666655432222221 234455555555555432222221    


Q ss_pred             -CcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeeccccccccc----ccccccCCC
Q 039290          516 -NLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGV----IPVTIGGLQ  590 (1049)
Q Consensus       516 -~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~  590 (1049)
                       ..++|++|+|++|.++.....                    .++..+..+++|++|||++|.|++.    ++..+...+
T Consensus       152 ~~~~~L~~L~Ls~n~l~~~~~~--------------------~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~  211 (372)
T 3un9_A          152 HDQCQITTLRLSNNPLTAAGVA--------------------VLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNR  211 (372)
T ss_dssp             STTCCCCEEECCSSCCHHHHHH--------------------HHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCS
T ss_pred             hcCCccceeeCCCCCCChHHHH--------------------HHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCC
Confidence             223444444444444321111                    1112223344555555555555532    244455566


Q ss_pred             cccEEEeecccccCC----ccccccCccCCcEEeccCccccCCcccccc
Q 039290          591 GLQLLSLRYNRLQGP----IPESFGGLKSLNFVDMSNNNLSGTIPKSME  635 (1049)
Q Consensus       591 ~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  635 (1049)
                      +|+.|+|++|+|++.    ++..+...++|++|||++|.|+..-...+.
T Consensus       212 ~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~  260 (372)
T 3un9_A          212 QLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLR  260 (372)
T ss_dssp             CCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHH
T ss_pred             CcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHH
Confidence            677777777777642    233444556777777777777654443333

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.29  E-value=3.1e-12  Score=143.72  Aligned_cols=92  Identities=21%  Similarity=0.216  Sum_probs=53.9

Q ss_pred             cCcccccccCCcEecccc-CCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCccc
Q 039290          113 LPEELSHLRGLKYFDFRF-NNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFN  191 (1049)
Q Consensus       113 ~p~~~~~L~~L~~L~l~~-n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~  191 (1049)
                      ||. |..+++|++|+|++ |++.+..|..|++|++|++|+|++|+|++..|..|+.|++|++|||++|+|+ .+|+.++.
T Consensus        24 ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~  101 (347)
T 2ifg_A           24 LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQ  101 (347)
T ss_dssp             TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTC
T ss_pred             cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccc-eeCHHHcc
Confidence            444 55555556666654 5555555556666666666666666666666666666666666666666666 44444332


Q ss_pred             ccccCCCCccceEEeeccccC
Q 039290          192 ISSCQNLPVLEGLFISYNQLT  212 (1049)
Q Consensus       192 l~~l~~l~~L~~L~l~~N~l~  212 (1049)
                           .++ |+.|+|.+|.+.
T Consensus       102 -----~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A          102 -----GLS-LQELVLSGNPLH  116 (347)
T ss_dssp             -----SCC-CCEEECCSSCCC
T ss_pred             -----cCC-ceEEEeeCCCcc
Confidence                 122 666666666665

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.26  E-value=2.4e-13  Score=153.23  Aligned_cols=135  Identities=21%  Similarity=0.260  Sum_probs=93.8

Q ss_pred             ccCCceeecCcccccccCcccc-cccccccccccCCccCCCCccCc-----CCCcceeEeeccccccccc----cccccc
Q 039290          518 TSLRDLSLGSNALTSIIPSTLW-NLKDILRFNLSSNSLNGSLLPDI-----GNLKVVIEMDLSLNALSGV----IPVTIG  587 (1049)
Q Consensus       518 ~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~----~p~~~~  587 (1049)
                      ++|++|+|++|.++......+. .+++|+.|+|++|.++......+     ....+|++|+|++|.|++.    ++..+.
T Consensus       101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~  180 (372)
T 3un9_A          101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA  180 (372)
T ss_dssp             SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred             CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence            4555555555555443222222 34556666666666654333332     2356788889999988753    445567


Q ss_pred             CCCcccEEEeecccccCC----ccccccCccCCcEEeccCccccCC----cccccccccccceeeccCCcccc
Q 039290          588 GLQGLQLLSLRYNRLQGP----IPESFGGLKSLNFVDMSNNNLSGT----IPKSMEALSYLKHLNLSFNQLEG  652 (1049)
Q Consensus       588 ~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~~  652 (1049)
                      .+++|++|+|++|+|++.    ++..+...++|++|||++|.|+..    +...+...++|++|+|++|++..
T Consensus       181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~  253 (372)
T 3un9_A          181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS  253 (372)
T ss_dssp             TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred             cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence            889999999999999863    366778889999999999999853    34445567899999999999864

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.26  E-value=9.9e-11  Score=133.78  Aligned_cols=64  Identities=6%  Similarity=0.057  Sum_probs=29.0

Q ss_pred             ccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccc
Q 039290          559 LPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNL  626 (1049)
Q Consensus       559 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  626 (1049)
                      ..+|.++.+|+++.+..+ ++.+...+|.++.+|+.+++.+|...   -..|....+|+.+.+..|.+
T Consensus       327 ~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~---~~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          327 DDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ---WNAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             TTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH---HHTCBCCCCC----------
T ss_pred             HhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee---hhhhhccCCCCEEEeCCCCE
Confidence            334555555555555432 44344556666666666666665443   13455556666666665544

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.25  E-value=1.9e-11  Score=131.45  Aligned_cols=146  Identities=16%  Similarity=0.112  Sum_probs=116.1

Q ss_pred             HHHhcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcC-CCceeeEEeeeecCCeeEEE
Q 039290          757 LRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR-HRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       757 ~~~~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv  835 (1049)
                      ....++|+.....+.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..+.++++++.+.+..|+|
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            344567888888999999999999864 6899999987543334457899999999984 67788999999888899999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHcc--------------------------------------
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG--------------------------------------  877 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~--------------------------------------  877 (1049)
                      |||++|.++.+.+..      ..+...++.+++++++.||..                                      
T Consensus        89 ~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           89 MSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             EEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            999999998875321      122347889999999999941                                      


Q ss_pred             ------------------CCCCeEEcCCCCCCeeecCCCceEEecccCce
Q 039290          878 ------------------YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK  909 (1049)
Q Consensus       878 ------------------~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~  909 (1049)
                                        ....++|||++|.||++++++.+.|+||+.+.
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                              01458999999999999876667799999775

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.24  E-value=2.6e-10  Score=130.27  Aligned_cols=331  Identities=11%  Similarity=0.127  Sum_probs=186.4

Q ss_pred             ccccccc-cccceEEeccCccCCCCCCcccCCCCCccEEEcCCCC---CCCCCCccccCCCCCceeecccCccccCcccc
Q 039290          288 PASIFNI-STLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENN---FSGTIPSSLTNISELSVLDFGFNSFSGLIPTT  363 (1049)
Q Consensus       288 p~~~~~l-~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~---l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  363 (1049)
                      ..+|.++ ..|+.+.+.++ ++ .|.+..|.++.+|+.+.+..|.   ++..-..+|..+.+|+.+.+..+ +..+....
T Consensus        56 ~~aF~~~~~~L~sI~iP~s-vt-~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~a  132 (394)
T 4gt6_A           56 DRVFCNYKYVLTSVQIPDT-VT-EIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEA  132 (394)
T ss_dssp             TTTTTTCCSCCCEEEECTT-CC-EECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTT
T ss_pred             HhhccCCCCcCEEEEECCC-ee-EEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhh
Confidence            3456665 35788877754 33 5666667777777777777653   44334556777777777766544 44344566


Q ss_pred             cccccccceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCC
Q 039290          364 FGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELG  443 (1049)
Q Consensus       364 ~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~  443 (1049)
                      |..+.+|+.+.+..+ ++.+...     +|..+..|+.+.+..+ ++.+....|..  ..|+.+.+..+-.. .....|.
T Consensus       133 F~~c~~L~~i~lp~~-~~~I~~~-----~F~~c~~L~~i~~~~~-~~~I~~~aF~~--~~l~~i~ip~~~~~-i~~~af~  202 (394)
T 4gt6_A          133 FHHCEELDTVTIPEG-VTSVADG-----MFSYCYSLHTVTLPDS-VTAIEERAFTG--TALTQIHIPAKVTR-IGTNAFS  202 (394)
T ss_dssp             TTTCTTCCEEECCTT-CCEECTT-----TTTTCTTCCEEECCTT-CCEECTTTTTT--CCCSEEEECTTCCE-ECTTTTT
T ss_pred             hhhhcccccccccce-eeeeccc-----ceecccccccccccce-eeEeccccccc--cceeEEEECCcccc-cccchhh
Confidence            777777777777543 3333222     3566666776666544 22222222221  13444444433221 2333444


Q ss_pred             CCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCce
Q 039290          444 NINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDL  523 (1049)
Q Consensus       444 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  523 (1049)
                      ++.+++......+.... ....+..........          ...+.....+..+.+.+ .++.....+|.++..|+.+
T Consensus       203 ~c~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i  270 (394)
T 4gt6_A          203 ECFALSTITSDSESYPA-IDNVLYEKSANGDYA----------LIRYPSQREDPAFKIPN-GVARIETHAFDSCAYLASV  270 (394)
T ss_dssp             TCTTCCEEEECCSSSCB-SSSCEEEECTTSCEE----------EEECCTTCCCSEEECCT-TEEEECTTTTTTCSSCCEE
T ss_pred             hccccceeccccccccc-ccceeeccccccccc----------ccccccccccceEEcCC-cceEcccceeeecccccEE
Confidence            44444444444333321 111110000000000          00011122333444432 2333445677888888888


Q ss_pred             eecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeeccccc
Q 039290          524 SLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQ  603 (1049)
Q Consensus       524 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  603 (1049)
                      .+.++.. .+...+|.+++.|+.+.+. +.++.....+|.++.+|+.+++..+ ++.+...+|.++.+|+.+.+..+ ++
T Consensus       271 ~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~  346 (394)
T 4gt6_A          271 KMPDSVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VT  346 (394)
T ss_dssp             ECCTTCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CC
T ss_pred             ecccccc-eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cC
Confidence            8865543 4566778888888888886 4455555677888888888888764 66566778999999999999755 77


Q ss_pred             CCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCcc
Q 039290          604 GPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQL  650 (1049)
Q Consensus       604 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l  650 (1049)
                      .+...+|.++++|+.+++.+|....   ..+....+|+.+.+..|.+
T Consensus       347 ~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          347 KIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             BCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred             EEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence            6777899999999999999886541   3566677788887766644

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.23  E-value=1e-11  Score=139.59  Aligned_cols=103  Identities=22%  Similarity=0.242  Sum_probs=54.9

Q ss_pred             ceeecCc-ccccccCcccccccccccccccC-CccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeec
Q 039290          522 DLSLGSN-ALTSIIPSTLWNLKDILRFNLSS-NSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRY  599 (1049)
Q Consensus       522 ~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  599 (1049)
                      .++++++ +|++ +|. +..+++|+.|+|++ |.|++..+..|..+++|++|+|++|+|++..|..|.++++|+.|+|++
T Consensus        12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            3455555 5654 344 55555555555554 555554445555555555555555555555555555555555555555


Q ss_pred             ccccCCccccccCccCCcEEeccCcccc
Q 039290          600 NRLQGPIPESFGGLKSLNFVDMSNNNLS  627 (1049)
Q Consensus       600 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  627 (1049)
                      |+|++..+..|..++ |+.|+|++|++.
T Consensus        90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           90 NALESLSWKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred             CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence            555544444444443 555555555554

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=99.12  E-value=1.9e-12  Score=136.67  Aligned_cols=149  Identities=20%  Similarity=0.211  Sum_probs=101.0

Q ss_pred             CceeeeEEEcCCCCcEEEEEEec---cccccccCC-CCCCcchhhhhhcccCccccccCcc-cccccCCcE--eccccCC
Q 039290           60 VCSWIGVTCGVRNRRVTALNISY---LGLTGTIPP-QLGNLSFLAVLAIRNNSFFGSLPEE-LSHLRGLKY--FDFRFNN  132 (1049)
Q Consensus        60 ~c~w~gv~c~~~~~~v~~l~l~~---~~l~g~~~~-~~~~l~~L~~L~l~~n~~~g~~p~~-~~~L~~L~~--L~l~~n~  132 (1049)
                      .|+|.|+.|+..+.+|+.+-..+   ..+.|.+++ .+..+..  .|..+.|...+.++-+ +.....|+.  ++++.|+
T Consensus        77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~  154 (267)
T 3rw6_A           77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNR  154 (267)
T ss_dssp             HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTS
T ss_pred             HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCH
Confidence            58999999998777888777766   455666653 2333333  4555666666655532 555556665  6777774


Q ss_pred             c---cccCcccccccCCccEEEeCCCCccC--CCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEee
Q 039290          133 F---HIEIPSWFVSLPRLQHLLLKHNSFVG--KIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFIS  207 (1049)
Q Consensus       133 ~---~~~~p~~~~~l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~  207 (1049)
                      .   .+.++....++++|++|+|++|++++  .+|..++.+++|+.|+|++|+|++.  ..+.   .++.+ .|++|+|+
T Consensus       155 ~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~---~l~~l-~L~~L~L~  228 (267)
T 3rw6_A          155 RSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELD---KIKGL-KLEELWLD  228 (267)
T ss_dssp             HHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGG---GGTTS-CCSEEECT
T ss_pred             HHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhh---hcccC-CcceEEcc
Confidence            3   22233333568899999999999987  5667788899999999999999843  2233   33344 67888888


Q ss_pred             ccccCCCCC
Q 039290          208 YNQLTGPIP  216 (1049)
Q Consensus       208 ~N~l~~~~p  216 (1049)
                      +|.+.+.+|
T Consensus       229 ~Npl~~~~~  237 (267)
T 3rw6_A          229 GNSLCDTFR  237 (267)
T ss_dssp             TSTTGGGCS
T ss_pred             CCcCccccC
Confidence            888877665

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.07  E-value=1.4e-10  Score=124.42  Aligned_cols=137  Identities=14%  Similarity=0.092  Sum_probs=101.5

Q ss_pred             CCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCc--eeeEEeeeecCCeeEEEEecc
Q 039290          762 GFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRN--LVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn--iv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      +|......+.|..+.||++...+|..+++|+....   ....+.+|+++++.+++.+  +.+++++...++..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            44443333466679999998877888999997643   2356788999999885434  566888888888889999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccC-----------------------------------------
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY-----------------------------------------  878 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----------------------------------------  878 (1049)
                      +|.++.  ...    .+   ...++.++++.++.+|...                                         
T Consensus        98 ~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (264)
T 1nd4_A           98 PGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  168 (264)
T ss_dssp             SSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             CCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence            998884  211    11   2357788888888888321                                         


Q ss_pred             --------------CCCeEEcCCCCCCeeecCCCceEEecccCcee
Q 039290          879 --------------STPIVHCDIKPSNVLLNESMVGHLSDFGIAKI  910 (1049)
Q Consensus       879 --------------~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~  910 (1049)
                                    ...++|||++|.||++++++.+.|+|||.+..
T Consensus       169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                          11299999999999998776677999998763

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.92  E-value=8e-11  Score=131.36  Aligned_cols=161  Identities=14%  Similarity=0.227  Sum_probs=96.4

Q ss_pred             CcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCccceEEeec--cccCCC
Q 039290          137 IPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISY--NQLTGP  214 (1049)
Q Consensus       137 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~--N~l~~~  214 (1049)
                      ++..+..+++|+.|+|++|.-. .+|. +. +++|++|+|+.|.++......+.    ...+|+|++|+|+.  |...|.
T Consensus       164 L~~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~----~~~lp~L~~L~L~~~~~~~~~~  236 (362)
T 2ra8_A          164 LSPVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDIL----GSDLPNLEKLVLYVGVEDYGFD  236 (362)
T ss_dssp             CHHHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHH----HSBCTTCCEEEEECBCGGGTCC
T ss_pred             HHHHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHH----HccCCCCcEEEEeccccccccc
Confidence            4455566677777777766311 2333 32 67777777777666532221221    02456677777753  222111


Q ss_pred             -----CCCCc--ccccccceecccccccccccCCCC---ccccccceEEecccccccc----CccccccccceEEEeecc
Q 039290          215 -----IPTNL--WKCRELHVVSLAFNKFQGGIPRDI---GNLTSVRNLFLGNNSLIGE----IPNEIGNLRNLEVLGVQS  280 (1049)
Q Consensus       215 -----~p~~l--~~l~~L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~  280 (1049)
                           +...+  ..+++|++|+|++|.++...+..+   ..+++|++|+|+.|.+.+.    ++..+.++++|+.|+|++
T Consensus       237 ~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~  316 (362)
T 2ra8_A          237 GDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKY  316 (362)
T ss_dssp             SCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCS
T ss_pred             hhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCC
Confidence                 11112  236788888888887765433333   2578899999999998763    455556788999999999


Q ss_pred             ccCCCcccccccc-ccccceEEeccCc
Q 039290          281 SNLAGLIPASIFN-ISTLKELAVTDND  306 (1049)
Q Consensus       281 n~l~~~~p~~~~~-l~~L~~L~l~~N~  306 (1049)
                      |.++...-..+.. +  ..+++++.++
T Consensus       317 n~i~d~~~~~l~~al--g~~~~~~~~~  341 (362)
T 2ra8_A          317 NYLSDEMKKELQKSL--PMKIDVSDSQ  341 (362)
T ss_dssp             BBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred             CcCCHHHHHHHHHHc--CCEEEecCCc
Confidence            9877543333332 2  3668888876

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.91  E-value=4.3e-08  Score=111.27  Aligned_cols=108  Identities=12%  Similarity=0.086  Sum_probs=51.9

Q ss_pred             CCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCccc
Q 039290          440 KELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTS  519 (1049)
Q Consensus       440 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  519 (1049)
                      ..+....+|+.+.+..+ ++.....+|.++.+|+.+.+..+ ++..-...|.++.+|+.+.+..+ +......+|.++++
T Consensus       211 ~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~  287 (379)
T 4h09_A          211 YGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSN  287 (379)
T ss_dssp             TTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTT
T ss_pred             cccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccc
Confidence            34444555555555433 22234445555555555555443 33233344555555555555432 33233344555555


Q ss_pred             CCceeecCcccccccCccccccccccccccc
Q 039290          520 LRDLSLGSNALTSIIPSTLWNLKDILRFNLS  550 (1049)
Q Consensus       520 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  550 (1049)
                      |+.+.+.++.++.+...+|.++.+|+.+.|.
T Consensus       288 L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp  318 (379)
T 4h09_A          288 LTKVVMDNSAIETLEPRVFMDCVKLSSVTLP  318 (379)
T ss_dssp             CCEEEECCTTCCEECTTTTTTCTTCCEEECC
T ss_pred             cccccccccccceehhhhhcCCCCCCEEEcC
Confidence            5555555555554444445444444444443

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.91  E-value=1.6e-08  Score=114.77  Aligned_cols=163  Identities=12%  Similarity=0.077  Sum_probs=85.1

Q ss_pred             CCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCcee
Q 039290          445 INNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLS  524 (1049)
Q Consensus       445 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  524 (1049)
                      ...+..+.+..+.-. .....+....+|+.+.+..+ +.......|.++..|+.+.+..+ ++.....+|.++.+|+.+.
T Consensus       193 ~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~  269 (379)
T 4h09_A          193 AKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLN  269 (379)
T ss_dssp             TCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEE
T ss_pred             cccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccc
Confidence            344444444333222 34445555566666665443 22233344555555555555443 3333344455555555554


Q ss_pred             ecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccC
Q 039290          525 LGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQG  604 (1049)
Q Consensus       525 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  604 (1049)
                      +..+ ++.                        .....|.++.+|+.+++.++.++.+...+|.++.+|+.+.|..+ ++.
T Consensus       270 l~~~-i~~------------------------i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~  323 (379)
T 4h09_A          270 FYAK-VKT------------------------VPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKT  323 (379)
T ss_dssp             ECCC-CSE------------------------ECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCE
T ss_pred             cccc-cee------------------------ccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccE
Confidence            4322 332                        23345555666666666666665555566777777777777544 554


Q ss_pred             CccccccCccCCcEEeccCccccCCcccccccc
Q 039290          605 PIPESFGGLKSLNFVDMSNNNLSGTIPKSMEAL  637 (1049)
Q Consensus       605 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  637 (1049)
                      +...+|.++.+|+.+.+..+ ++..-...|.+.
T Consensus       324 I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c  355 (379)
T 4h09_A          324 IQVYAFKNCKALSTISYPKS-ITLIESGAFEGS  355 (379)
T ss_dssp             ECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred             EHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence            55567777777777776544 442223344443

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.87  E-value=4.6e-09  Score=118.29  Aligned_cols=143  Identities=17%  Similarity=0.187  Sum_probs=107.4

Q ss_pred             CCceecCCCcEEEEEEEeCCCcEEEEEEee--ccc-CCCHHHHHHHHHHHhhcC--CCceeeEEeeeecC---CeeEEEE
Q 039290          765 ENKLLGMGSFGSVYKGVLPDGMEIAAKVFH--MEF-DGSLESFHAECKVMGSIR--HRNLVKIISSCSNN---DFKALVL  836 (1049)
Q Consensus       765 ~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--hpniv~l~~~~~~~---~~~~lv~  836 (1049)
                      ..+.++.|.++.||++... +..+++|+..  ... ......+.+|+++++.+.  +..++++++++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            4578999999999999875 4688888875  322 122457888999999996  45688899888776   4589999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccC--------------------------------------
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY--------------------------------------  878 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------  878 (1049)
                      ||++|..+.+..   ...++..++..++.+++++|+.||...                                      
T Consensus       121 e~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          121 EFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             ECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             EecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            999998775421   123678888899999999999999420                                      


Q ss_pred             -----------------CCCeEEcCCCCCCeeecCCCc--eEEecccCceec
Q 039290          879 -----------------STPIVHCDIKPSNVLLNESMV--GHLSDFGIAKIL  911 (1049)
Q Consensus       879 -----------------~~~ivH~Dlkp~NIl~~~~~~--~kl~DfGla~~~  911 (1049)
                                       ...++|||+++.||+++.++.  +.|+||+.+..-
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                             257999999999999997653  689999998753

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.84  E-value=9.5e-10  Score=122.65  Aligned_cols=84  Identities=18%  Similarity=0.221  Sum_probs=49.1

Q ss_pred             CCcceeEeeccccccccccccccc---CCCcccEEEeecccccCC----ccccccCccCCcEEeccCccccCCccccccc
Q 039290          564 NLKVVIEMDLSLNALSGVIPVTIG---GLQGLQLLSLRYNRLQGP----IPESFGGLKSLNFVDMSNNNLSGTIPKSMEA  636 (1049)
Q Consensus       564 ~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  636 (1049)
                      .+++|++|+|++|.+.+..+..+.   .+++|+.|+|+.|.|++.    ++..+..+++|+.|+|++|.++...-..+..
T Consensus       250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~  329 (362)
T 2ra8_A          250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK  329 (362)
T ss_dssp             TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHH
T ss_pred             CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHH
Confidence            356677777777766643333332   466777777777777753    2333345677777777777776433333332


Q ss_pred             -ccccceeeccCCc
Q 039290          637 -LSYLKHLNLSFNQ  649 (1049)
Q Consensus       637 -l~~L~~l~l~~N~  649 (1049)
                       +  ...+++++|+
T Consensus       330 al--g~~~~~~~~~  341 (362)
T 2ra8_A          330 SL--PMKIDVSDSQ  341 (362)
T ss_dssp             HC--CSEEECCSBC
T ss_pred             Hc--CCEEEecCCc
Confidence             2  2446676665

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.78  E-value=2.7e-09  Score=117.15  Aligned_cols=187  Identities=15%  Similarity=0.133  Sum_probs=123.9

Q ss_pred             CceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcC-CCc--eeeEEeeeecCC---eeEEEEecc
Q 039290          766 NKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR-HRN--LVKIISSCSNND---FKALVLEYM  839 (1049)
Q Consensus       766 ~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpn--iv~l~~~~~~~~---~~~lv~e~~  839 (1049)
                      .+.++.|....||++.    ..+++|+....  .....+.+|+++++.+. +..  +.+++......+   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999863    56888886532  23467889999998883 322  445555544333   358899999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHcc------------------------------------------
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG------------------------------------------  877 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------------------------------------------  877 (1049)
                      +|.++.+...   ..++..++..++.++++.++.||..                                          
T Consensus        99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            9988865332   1357778888899999999998841                                          


Q ss_pred             -------------CCCCeEEcCCCCCCeeecC--CCceEEecccCceecCCCcccccccc----cc---------ccCcc
Q 039290          878 -------------YSTPIVHCDIKPSNVLLNE--SMVGHLSDFGIAKILGKEESMRQTKT----LG---------TIGYM  929 (1049)
Q Consensus       878 -------------~~~~ivH~Dlkp~NIl~~~--~~~~kl~DfGla~~~~~~~~~~~~~~----~~---------~~~y~  929 (1049)
                                   ....++|+|++|.||++++  +..+.|+||+.+..-.+.........    .+         ..++.
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~  255 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK  255 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence                         0135799999999999997  56688999999875433211100000    00         00111


Q ss_pred             c-ccccCCCCcCcccchHHHHHHHHHHHhCCCCCC
Q 039290          930 A-PEYGREGKVSRKCDVYSYGIMLMETFTKKKPTD  963 (1049)
Q Consensus       930 a-PE~~~~~~~~~~~DvwslG~il~elltg~~p~~  963 (1049)
                      . |+...  ......+.|++|.++|++.+|..+|-
T Consensus       256 ~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          256 DIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             CHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             CcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            1 22111  11223689999999999999987754

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.42  E-value=3.3e-08  Score=104.27  Aligned_cols=93  Identities=20%  Similarity=0.191  Sum_probs=73.6

Q ss_pred             CCCcchhhh--hhcccCcc---ccccCcccccccCCcEeccccCCccc--cCcccccccCCccEEEeCCCCccCCCcccc
Q 039290           93 LGNLSFLAV--LAIRNNSF---FGSLPEELSHLRGLKYFDFRFNNFHI--EIPSWFVSLPRLQHLLLKHNSFVGKIPETI  165 (1049)
Q Consensus        93 ~~~l~~L~~--L~l~~n~~---~g~~p~~~~~L~~L~~L~l~~n~~~~--~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~  165 (1049)
                      +...+.|..  ++++.|..   .+.++..-.++.+|+.|+|++|++++  .+|..+..+++|++|+|++|++++.  +.+
T Consensus       137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l  214 (267)
T 3rw6_A          137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL  214 (267)
T ss_dssp             GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred             cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence            566667777  67777743   22233333578899999999999998  6778889999999999999999964  446


Q ss_pred             cCCC--cccEEcCCCccCccccCC
Q 039290          166 GYLS--LLQELDLSDNQLSGTIPS  187 (1049)
Q Consensus       166 ~~l~--~L~~L~Ls~N~l~g~ip~  187 (1049)
                      +.+.  +|++|+|++|.+++.+|.
T Consensus       215 ~~l~~l~L~~L~L~~Npl~~~~~~  238 (267)
T 3rw6_A          215 DKIKGLKLEELWLDGNSLCDTFRD  238 (267)
T ss_dssp             GGGTTSCCSEEECTTSTTGGGCSS
T ss_pred             hhcccCCcceEEccCCcCccccCc
Confidence            6666  999999999999988874

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.32  E-value=5.8e-08  Score=97.57  Aligned_cols=122  Identities=15%  Similarity=0.142  Sum_probs=69.4

Q ss_pred             CchhccCcccCCceeecCc-ccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeeccccccccc----ccc
Q 039290          510 LPACLGNLTSLRDLSLGSN-ALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGV----IPV  584 (1049)
Q Consensus       510 ~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~  584 (1049)
                      +...+...++|++|+|++| .+.......+                    ...+...+.|++|+|++|.|.+.    +..
T Consensus        28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l--------------------~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~   87 (185)
T 1io0_A           28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKAC--------------------AEALKTNTYVKKFSIVGTRSNDPVAFALAE   87 (185)
T ss_dssp             HHHHHTTCTTCCEEECTTCTTCCHHHHHHH--------------------HHHHTTCCSCCEEECTTSCCCHHHHHHHHH
T ss_pred             HHHHHhcCCCCCEEEecCCCCCCHHHHHHH--------------------HHHHHhCCCcCEEECcCCCCChHHHHHHHH
Confidence            3455666777777887777 7764211111                    11222334455555555555432    223


Q ss_pred             cccCCCcccEEEeecccccCC----ccccccCccCCcEEec--cCccccCC----cccccccccccceeeccCCccc
Q 039290          585 TIGGLQGLQLLSLRYNRLQGP----IPESFGGLKSLNFVDM--SNNNLSGT----IPKSMEALSYLKHLNLSFNQLE  651 (1049)
Q Consensus       585 ~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L--s~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~  651 (1049)
                      .+...++|++|+|++|+|++.    +...+...++|++|+|  ++|.|+..    +...+...++|++|+|++|.+.
T Consensus        88 ~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A           88 MLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            344456677777777777642    3455666667777777  66777643    2334445567777777777664

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.32  E-value=2.7e-06  Score=91.31  Aligned_cols=135  Identities=17%  Similarity=0.071  Sum_probs=99.2

Q ss_pred             eecCCCcE-EEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcC-CCceeeEEeeeecCCeeEEEEeccCCCCh
Q 039290          768 LLGMGSFG-SVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIR-HRNLVKIISSCSNNDFKALVLEYMSNGSL  844 (1049)
Q Consensus       768 ~lg~G~fg-~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~g~L  844 (1049)
                      .+..|..+ .||+.... ++..+++|+-...   ....+.+|+..++.+. +--+.++++++.+.+..++|||+++|.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            45555554 68988754 5678999987533   3567888999998884 33477888999988999999999999888


Q ss_pred             hhhhhcCCCccCHHHHHHHHHHHHHHHHHhHcc-----------------------------------------------
Q 039290          845 EKCLYSDNYFLDILQRLKIMIDVASALEYLHFG-----------------------------------------------  877 (1049)
Q Consensus       845 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----------------------------------------------  877 (1049)
                      .+.....     ......++.++++.++.||..                                               
T Consensus       108 ~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (272)
T 4gkh_A          108 FQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE  182 (272)
T ss_dssp             HHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred             cccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence            7754432     123345667777777777730                                               


Q ss_pred             --------CCCCeEEcCCCCCCeeecCCCceEEecccCcee
Q 039290          878 --------YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI  910 (1049)
Q Consensus       878 --------~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~  910 (1049)
                              ....++|+|+.+.||+++.++.+-|+||+.+..
T Consensus       183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                    012378999999999999887778999998763

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.31  E-value=4.6e-08  Score=98.35  Aligned_cols=121  Identities=12%  Similarity=0.054  Sum_probs=77.9

Q ss_pred             CcccccccccceEEeeCc-ccCCc----CchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccC
Q 039290          487 PEDLCHLYRLANLYLGDN-KLSGR----LPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPD  561 (1049)
Q Consensus       487 ~~~~~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~  561 (1049)
                      ...+...+.|++|+|++| .+...    +...+...++|++|+|++|++.......+..                    .
T Consensus        29 ~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~--------------------~   88 (185)
T 1io0_A           29 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAE--------------------M   88 (185)
T ss_dssp             HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHH--------------------H
T ss_pred             HHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHH--------------------H
Confidence            345667789999999999 88743    4455667788999999999887532222211                    1


Q ss_pred             cCCCcceeEeeccccccccc----ccccccCCCcccEEEe--ecccccCC----ccccccCccCCcEEeccCcccc
Q 039290          562 IGNLKVVIEMDLSLNALSGV----IPVTIGGLQGLQLLSL--RYNRLQGP----IPESFGGLKSLNFVDMSNNNLS  627 (1049)
Q Consensus       562 ~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L--s~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~  627 (1049)
                      +...+.|++|+|++|.|++.    +...+...+.|+.|+|  ++|.|+..    +...+...++|++|+|++|.+.
T Consensus        89 L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A           89 LKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            12223344455555555432    3445666677888888  77887753    3345555678888888888875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.27  E-value=3.1e-06  Score=92.53  Aligned_cols=136  Identities=15%  Similarity=0.128  Sum_probs=96.6

Q ss_pred             CceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCC---ceeeEEeeee-cCCeeEEEEeccCC
Q 039290          766 NKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHR---NLVKIISSCS-NNDFKALVLEYMSN  841 (1049)
Q Consensus       766 ~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hp---niv~l~~~~~-~~~~~~lv~e~~~~  841 (1049)
                      .+.++.|....||+.    +..+++|+...  ......+.+|+++++.+.+.   .+.+++.+.. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            457889999999998    57788888532  12346788999999999642   3566777664 45667899999999


Q ss_pred             CChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHcc--------------------------------------------
Q 039290          842 GSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG--------------------------------------------  877 (1049)
Q Consensus       842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~--------------------------------------------  877 (1049)
                      ..+.+....   .++..+...++.++++.++.||..                                            
T Consensus        98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            888663211   134555556666666666666621                                            


Q ss_pred             -------------CCCCeEEcCCCCCCeeecC---CCc-eEEecccCcee
Q 039290          878 -------------YSTPIVHCDIKPSNVLLNE---SMV-GHLSDFGIAKI  910 (1049)
Q Consensus       878 -------------~~~~ivH~Dlkp~NIl~~~---~~~-~kl~DfGla~~  910 (1049)
                                   ....++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                         1335799999999999987   355 58999998864

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.17  E-value=3.5e-06  Score=94.44  Aligned_cols=80  Identities=6%  Similarity=-0.051  Sum_probs=57.2

Q ss_pred             cee-cCCCcEEEEEEEeC-------CCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcC-C--CceeeEEeeeecC---
Q 039290          767 KLL-GMGSFGSVYKGVLP-------DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIR-H--RNLVKIISSCSNN---  829 (1049)
Q Consensus       767 ~~l-g~G~fg~Vy~a~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--pniv~l~~~~~~~---  829 (1049)
                      +.| +.|....+|+....       +++.+++|+.....   ......+.+|+.+++.+. +  -.+.++++++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            567 88999999998764       26789999875432   111256788888888884 2  3567788877655   


Q ss_pred             CeeEEEEeccCCCChhh
Q 039290          830 DFKALVLEYMSNGSLEK  846 (1049)
Q Consensus       830 ~~~~lv~e~~~~g~L~~  846 (1049)
                      +..++||||++|..+.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            45689999999877654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.80  E-value=8.7e-05  Score=84.31  Aligned_cols=75  Identities=12%  Similarity=0.100  Sum_probs=50.4

Q ss_pred             CceecCCCcEEEEEEEeC-CCcEEEEEEeecccC-------CCHHHHHHHHHHHhhcCC--Cc-eeeEEeeeecCCeeEE
Q 039290          766 NKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD-------GSLESFHAECKVMGSIRH--RN-LVKIISSCSNNDFKAL  834 (1049)
Q Consensus       766 ~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--pn-iv~l~~~~~~~~~~~l  834 (1049)
                      .+.+|.|.++.||++... +++.|++|.......       ...+++..|+++++.+..  |. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            468999999999999854 568899998653211       234567889999888742  43 4455544  3344689


Q ss_pred             EEeccCCC
Q 039290          835 VLEYMSNG  842 (1049)
Q Consensus       835 v~e~~~~g  842 (1049)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.80  E-value=1.2e-05  Score=78.51  Aligned_cols=83  Identities=17%  Similarity=0.115  Sum_probs=45.6

Q ss_pred             ceeEeecccccccccccccccCCCcccEEEeeccc-ccCCccccccCc----cCCcEEeccCcc-ccCCccccccccccc
Q 039290          567 VVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNR-LQGPIPESFGGL----KSLNFVDMSNNN-LSGTIPKSMEALSYL  640 (1049)
Q Consensus       567 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~L  640 (1049)
                      .|++||++++.|++..-..+.++++|+.|+|++|. |++.--..++.+    ++|++|+|++|. +|..--..+..+++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            45666666665555444555566666666666663 554433444443    256666666653 554333445556666


Q ss_pred             ceeeccCCc
Q 039290          641 KHLNLSFNQ  649 (1049)
Q Consensus       641 ~~l~l~~N~  649 (1049)
                      +.|++++++
T Consensus       142 ~~L~L~~c~  150 (176)
T 3e4g_A          142 KYLFLSDLP  150 (176)
T ss_dssp             CEEEEESCT
T ss_pred             CEEECCCCC
Confidence            666666554

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.76  E-value=9.8e-05  Score=82.03  Aligned_cols=138  Identities=14%  Similarity=0.107  Sum_probs=80.2

Q ss_pred             ceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCC--CceeeEEe------eeecCCeeEEEEec
Q 039290          767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRH--RNLVKIIS------SCSNNDFKALVLEY  838 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--pniv~l~~------~~~~~~~~~lv~e~  838 (1049)
                      +.++.|..+.||++...+| .+++|+....    ..++..|..+++.+..  -.+.+++.      +....+..++||||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566677899999987555 5899998642    2445556666665531  12333333      12345678899999


Q ss_pred             cCCCChh-----h------h---hhc--C----C-------CccCHHHH-------------------------------
Q 039290          839 MSNGSLE-----K------C---LYS--D----N-------YFLDILQR-------------------------------  860 (1049)
Q Consensus       839 ~~~g~L~-----~------~---l~~--~----~-------~~~~~~~~-------------------------------  860 (1049)
                      ++|..+.     +      .   ++.  .    .       ....|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542     0      0   111  0    0       00112110                               


Q ss_pred             HHHHHHHHHHHHHhHc----------cCCCCeEEcCCCCCCeeecCCCceEEecccCce
Q 039290          861 LKIMIDVASALEYLHF----------GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK  909 (1049)
Q Consensus       861 ~~i~~~i~~~l~~LH~----------~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~  909 (1049)
                      ..+...+.+++++++.          .....++|||+++.||+++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            1111223345556652          125789999999999999888899999999875

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.72  E-value=4.7e-05  Score=87.21  Aligned_cols=80  Identities=10%  Similarity=0.049  Sum_probs=50.1

Q ss_pred             CCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccccccccccCcccccccCCC---CcCcccchHHHHHHHHHH
Q 039290          879 STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG---KVSRKCDVYSYGIMLMET  955 (1049)
Q Consensus       879 ~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~il~el  955 (1049)
                      ...++|||++|.|||++.++ ++++||+.+..-.+.......-......|.+|+.....   ......++......+|+.
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            67899999999999999776 99999999875432221111000012346666654321   122334556778888887


Q ss_pred             HhCC
Q 039290          956 FTKK  959 (1049)
Q Consensus       956 ltg~  959 (1049)
                      +++.
T Consensus       310 y~~~  313 (420)
T 2pyw_A          310 FNKR  313 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7653

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.69  E-value=0.00012  Score=79.08  Aligned_cols=78  Identities=14%  Similarity=0.118  Sum_probs=58.0

Q ss_pred             CCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCC---CceeeEEeeeecCCeeEEEEecc
Q 039290          763 FSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRH---RNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---pniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      ....+.+|.|..+.||+.+..+|+.|++|+...........+.+|++.++.+.-   --+.+++++.    ..++||||+
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l   92 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV   92 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence            344578999999999999999999999998765544445678899999998842   2345555542    237899999


Q ss_pred             CCCCh
Q 039290          840 SNGSL  844 (1049)
Q Consensus       840 ~~g~L  844 (1049)
                      +++..
T Consensus        93 ~~~~~   97 (288)
T 3f7w_A           93 DERPP   97 (288)
T ss_dssp             CCCCC
T ss_pred             cccCC
Confidence            87643

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.67  E-value=0.00028  Score=76.53  Aligned_cols=136  Identities=12%  Similarity=0.073  Sum_probs=92.5

Q ss_pred             CceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcC---CCceeeEEeeeecCCeeEEEEeccCCC
Q 039290          766 NKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR---HRNLVKIISSCSNNDFKALVLEYMSNG  842 (1049)
Q Consensus       766 ~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---hpniv~l~~~~~~~~~~~lv~e~~~~g  842 (1049)
                      .+.++.|....+|+... ++..+++|+....   ....+.+|++.++.+.   ...+++++++....+..++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            46799999999999986 5678999987643   3567889999998883   367888999888888899999999987


Q ss_pred             Chhh-----------hhhcCCC---------------------ccCHHHHH---HHHH----------------HHHHHH
Q 039290          843 SLEK-----------CLYSDNY---------------------FLDILQRL---KIMI----------------DVASAL  871 (1049)
Q Consensus       843 ~L~~-----------~l~~~~~---------------------~~~~~~~~---~i~~----------------~i~~~l  871 (1049)
                      .+..           .++....                     .-+|....   ++..                .+.+.+
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            6421           1121100                     11343322   1111                111111


Q ss_pred             -HHhH-ccCCCCeEEcCCCCCCeeecCCCceEEeccc
Q 039290          872 -EYLH-FGYSTPIVHCDIKPSNVLLNESMVGHLSDFG  906 (1049)
Q Consensus       872 -~~LH-~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfG  906 (1049)
                       ..|. ......++|+|+.+.||+++.++ +.|.|+.
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             2232 12256799999999999999887 8899974

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.67  E-value=1.2e-05  Score=78.47  Aligned_cols=85  Identities=8%  Similarity=0.087  Sum_probs=54.7

Q ss_pred             ccccccccCCccCCCCccCcCCCcceeEeecccc-cccccccccccCC----CcccEEEeeccc-ccCCccccccCccCC
Q 039290          543 DILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLN-ALSGVIPVTIGGL----QGLQLLSLRYNR-LQGPIPESFGGLKSL  616 (1049)
Q Consensus       543 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~~~~~~~l~~L  616 (1049)
                      .|+.||++++.++..-...+..+++|++|+|++| .|++..-..++.+    ++|+.|+|++|. |++.--..+.++++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            4555555555555444455566667777777776 3665444455554    368888888874 776555667778888


Q ss_pred             cEEeccCcc-cc
Q 039290          617 NFVDMSNNN-LS  627 (1049)
Q Consensus       617 ~~L~Ls~N~-l~  627 (1049)
                      ++|+|+++. ++
T Consensus       142 ~~L~L~~c~~It  153 (176)
T 3e4g_A          142 KYLFLSDLPGVK  153 (176)
T ss_dssp             CEEEEESCTTCC
T ss_pred             CEEECCCCCCCC
Confidence            888888874 44

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.32  E-value=0.00052  Score=75.33  Aligned_cols=156  Identities=13%  Similarity=0.143  Sum_probs=88.3

Q ss_pred             ccHHHHHHHhcCCCC-----CceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCc--eeeEE
Q 039290          751 ISYQDLLRATDGFSE-----NKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRN--LVKII  823 (1049)
Q Consensus       751 ~~~~~~~~~~~~~~~-----~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn--iv~l~  823 (1049)
                      ++.+++.....+|..     .+.++.|....+|+....+| .+++|+....  ...+.+..|+.+++.+...+  +.+++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            455556555556654     24567788899999987655 6888988652  12345667888877764212  33333


Q ss_pred             ee------eecCCeeEEEEeccCCCChhh-----h---------hhcC--C--Cc----c---CHHHHHH----------
Q 039290          824 SS------CSNNDFKALVLEYMSNGSLEK-----C---------LYSD--N--YF----L---DILQRLK----------  862 (1049)
Q Consensus       824 ~~------~~~~~~~~lv~e~~~~g~L~~-----~---------l~~~--~--~~----~---~~~~~~~----------  862 (1049)
                      ..      ....+..+++|+|++|..+..     +         ++..  .  ..    .   .|.....          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            21      122356789999999865321     0         1110  0  00    0   1111000          


Q ss_pred             --HHHHHHHHHHHhHc----cCCCCeEEcCCCCCCeeecCCCceEEecccCce
Q 039290          863 --IMIDVASALEYLHF----GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK  909 (1049)
Q Consensus       863 --i~~~i~~~l~~LH~----~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~  909 (1049)
                        +...+.+.+++++.    ....+++|+|+.+.||+++.++.+.++||+.+.
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence              00113344555542    124579999999999999987666899999776

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.28  E-value=0.00028  Score=65.66  Aligned_cols=60  Identities=22%  Similarity=0.309  Sum_probs=41.6

Q ss_pred             EEEeeccccc-CCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCcccccCC
Q 039290          594 LLSLRYNRLQ-GPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIP  655 (1049)
Q Consensus       594 ~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p  655 (1049)
                      .++.++++++ ..+|..+.  ++|++|||++|+|+...+..|..+++|+.|+|++|+|.|.+-
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~   72 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCR   72 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGG
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCc
Confidence            5667777776 23443322  357788888888886556667778888888888888887664

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.13  E-value=0.0013  Score=71.22  Aligned_cols=132  Identities=11%  Similarity=0.103  Sum_probs=77.6

Q ss_pred             CCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCce-eeEEeeeecCCeeEEEEecc-C
Q 039290          763 FSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNL-VKIISSCSNNDFKALVLEYM-S  840 (1049)
Q Consensus       763 ~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~-~  840 (1049)
                      +.-.+.++.|....+|+.     ..+++|+....... .....+|+.+++.+...++ .+++++..  +.-++|+||+ +
T Consensus        20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~   91 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAG   91 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTT
T ss_pred             ccceeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCC
Confidence            333678999999999998     56888887643221 1223567777777642222 46665543  3346899999 6


Q ss_pred             CCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHc--------------------------------------------
Q 039290          841 NGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF--------------------------------------------  876 (1049)
Q Consensus       841 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~--------------------------------------------  876 (1049)
                      |.++...-...        ...++.++++.|+-+|.                                            
T Consensus        92 g~~l~~~~~~~--------~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~  163 (301)
T 3dxq_A           92 AQTMSPEKFKT--------RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVR  163 (301)
T ss_dssp             CEECCHHHHHH--------STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHH
T ss_pred             CccCCHhhHhh--------hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHH
Confidence            54443200000        00122222222222321                                            


Q ss_pred             ------cCCCCeEEcCCCCCCeeecCCCceEEecccCceec
Q 039290          877 ------GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL  911 (1049)
Q Consensus       877 ------~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~  911 (1049)
                            .....++|+|+.+.||+ ..++.+.++||..+..-
T Consensus       164 ~~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          164 SALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             HHHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             HHHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence                  11345799999999999 55667899999988753

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.05  E-value=0.00012  Score=72.90  Aligned_cols=88  Identities=20%  Similarity=0.143  Sum_probs=51.4

Q ss_pred             cCCCcceeEeecccccccccc----cccccCCCcccEEEeecccccCC----ccccccCccCCcEEeccCc---cccC--
Q 039290          562 IGNLKVVIEMDLSLNALSGVI----PVTIGGLQGLQLLSLRYNRLQGP----IPESFGGLKSLNFVDMSNN---NLSG--  628 (1049)
Q Consensus       562 ~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N---~l~~--  628 (1049)
                      +...+.|+.|+|++|+|.+..    ...+..-+.|+.|+|++|+|++.    +-+++..-+.|++|+|++|   .+..  
T Consensus        66 L~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g  145 (197)
T 1pgv_A           66 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQV  145 (197)
T ss_dssp             HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHH
T ss_pred             HhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHH
Confidence            344455666666666665332    23344556777777777777742    3345555567888888765   3332  


Q ss_pred             --CcccccccccccceeeccCCc
Q 039290          629 --TIPKSMEALSYLKHLNLSFNQ  649 (1049)
Q Consensus       629 --~~p~~~~~l~~L~~l~l~~N~  649 (1049)
                        .+-..+..-+.|+.|+++.|.
T Consensus       146 ~~~ia~aL~~N~tL~~L~l~~~~  168 (197)
T 1pgv_A          146 EMDMMMAIEENESLLRVGISFAS  168 (197)
T ss_dssp             HHHHHHHHHHCSSCCEEECCCCC
T ss_pred             HHHHHHHHHhCCCcCeEeccCCC
Confidence              133445555677777776554

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.01  E-value=0.0042  Score=68.33  Aligned_cols=140  Identities=14%  Similarity=0.063  Sum_probs=74.2

Q ss_pred             ceecCCCcEE-EEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcC-C-CceeeEEeeeecCCeeEEEEeccCCCC
Q 039290          767 KLLGMGSFGS-VYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR-H-RNLVKIISSCSNNDFKALVLEYMSNGS  843 (1049)
Q Consensus       767 ~~lg~G~fg~-Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-pniv~l~~~~~~~~~~~lv~e~~~~g~  843 (1049)
                      +.++.|+... +|+....++..+++|.......   +.+..|+.+++.+. + -.+.+++.+..+.+  +++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            3455554444 6677664477888876543321   33455666666663 2 23556666644333  68999997766


Q ss_pred             hhhhhhcCC-------------------------CccCHHHHH-------H-H------------HHHHHHHHHHhH---
Q 039290          844 LEKCLYSDN-------------------------YFLDILQRL-------K-I------------MIDVASALEYLH---  875 (1049)
Q Consensus       844 L~~~l~~~~-------------------------~~~~~~~~~-------~-i------------~~~i~~~l~~LH---  875 (1049)
                      +.+.+....                         ..++.....       . +            ...+.+.++.+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            654332110                         011111100       0 0            001111222221   


Q ss_pred             ccCCCCeEEcCCCCCCeeecCC----CceEEecccCceec
Q 039290          876 FGYSTPIVHCDIKPSNVLLNES----MVGHLSDFGIAKIL  911 (1049)
Q Consensus       876 ~~~~~~ivH~Dlkp~NIl~~~~----~~~kl~DfGla~~~  911 (1049)
                      ......++|||+.+.|||++.+    +.+.|+||+.+..-
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            1125679999999999999874    68899999988754

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.00  E-value=0.0024  Score=71.10  Aligned_cols=140  Identities=13%  Similarity=0.124  Sum_probs=84.0

Q ss_pred             CceecCCCcEEEEEEEeC--------CCcEEEEEEeecccCCCHHHHHHHHHHHhhcC-CCceeeEEeeeecCCeeEEEE
Q 039290          766 NKLLGMGSFGSVYKGVLP--------DGMEIAAKVFHMEFDGSLESFHAECKVMGSIR-HRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       766 ~~~lg~G~fg~Vy~a~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      .+.+..|-...+|++...        +++.|++|+.... ........+|.++++.+. +.-..++++++.+    .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            356777888999999864        3578999986332 234566778999998884 3334667766654    3899


Q ss_pred             eccCCCChhhh-----------------hhcC----CCccC--HHHHHHHHHHHHH-------------------HHHHh
Q 039290          837 EYMSNGSLEKC-----------------LYSD----NYFLD--ILQRLKIMIDVAS-------------------ALEYL  874 (1049)
Q Consensus       837 e~~~~g~L~~~-----------------l~~~----~~~~~--~~~~~~i~~~i~~-------------------~l~~L  874 (1049)
                      ||++|..+..-                 ++.-    .+...  +.++.++..++..                   .++.+
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998655311                 1111    11111  3444444433321                   12222


Q ss_pred             ----Hc-cCCCCeEEcCCCCCCeeecCC----CceEEecccCcee
Q 039290          875 ----HF-GYSTPIVHCDIKPSNVLLNES----MVGHLSDFGIAKI  910 (1049)
Q Consensus       875 ----H~-~~~~~ivH~Dlkp~NIl~~~~----~~~kl~DfGla~~  910 (1049)
                          .. .....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                21 123468899999999999876    7899999998763

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.99  E-value=0.0018  Score=73.97  Aligned_cols=72  Identities=14%  Similarity=0.150  Sum_probs=50.7

Q ss_pred             ceecCCCcEEEEEEEeCC--------CcEEEEEEeecccCCCHHHHHHHHHHHhhcC-CCceeeEEeeeecCCeeEEEEe
Q 039290          767 KLLGMGSFGSVYKGVLPD--------GMEIAAKVFHMEFDGSLESFHAECKVMGSIR-HRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      +.|+.|....||++...+        +..+++|+....  ...+.+.+|..+++.+. +.-..++++.+.+    .+|+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            578889999999998753        578999988432  22256678999988884 3333567766543    38999


Q ss_pred             ccCCCCh
Q 039290          838 YMSNGSL  844 (1049)
Q Consensus       838 ~~~~g~L  844 (1049)
                      |++|.++
T Consensus       153 ~l~G~~l  159 (429)
T 1nw1_A          153 YIPSRPL  159 (429)
T ss_dssp             CCCEEEC
T ss_pred             EeCCccc
Confidence            9987443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.97  E-value=0.0032  Score=69.14  Aligned_cols=157  Identities=11%  Similarity=0.103  Sum_probs=89.9

Q ss_pred             cccHHHHHHHhcCCC-----CCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCC--ceeeE
Q 039290          750 RISYQDLLRATDGFS-----ENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHR--NLVKI  822 (1049)
Q Consensus       750 ~~~~~~~~~~~~~~~-----~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hp--niv~l  822 (1049)
                      .++.+++......|.     ..+.++ |....||+....+|+.+++|..... ....+.+..|..+++.+...  .++++
T Consensus        10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~   87 (328)
T 1zyl_A           10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAP   87 (328)
T ss_dssp             CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred             CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecce
Confidence            344444444443332     234677 8888999988777888999998633 22456777888888877421  23444


Q ss_pred             Eee-----eecCCeeEEEEeccCCCChh-----hh---------hhc----C----CCccCHHHH----HHH--------
Q 039290          823 ISS-----CSNNDFKALVLEYMSNGSLE-----KC---------LYS----D----NYFLDILQR----LKI--------  863 (1049)
Q Consensus       823 ~~~-----~~~~~~~~lv~e~~~~g~L~-----~~---------l~~----~----~~~~~~~~~----~~i--------  863 (1049)
                      +..     ....+..+++|||++|..+.     .+         ++.    .    ....+....    ..+        
T Consensus        88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  167 (328)
T 1zyl_A           88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP  167 (328)
T ss_dssp             CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred             eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence            433     12245667899999875432     11         110    0    011222111    000        


Q ss_pred             -------HHHHHHHHHHhHc----cCCCCeEEcCCCCCCeeecCCCceEEecccCcee
Q 039290          864 -------MIDVASALEYLHF----GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI  910 (1049)
Q Consensus       864 -------~~~i~~~l~~LH~----~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~  910 (1049)
                             ...+.+.++.+..    .....++|||+++.||+++ + .+.++||+.+..
T Consensus       168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                   1111112222221    1245688999999999999 4 899999998764

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.93  E-value=0.0001  Score=73.31  Aligned_cols=116  Identities=15%  Similarity=0.090  Sum_probs=63.5

Q ss_pred             cccccceEEeeCc-ccCCc----CchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCc
Q 039290          492 HLYRLANLYLGDN-KLSGR----LPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLK  566 (1049)
Q Consensus       492 ~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  566 (1049)
                      +-+.|++|+|++| .|...    +..++..-+.|+.|+|++|++.......+                    .+.+...+
T Consensus        39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~al--------------------A~aL~~N~   98 (197)
T 1pgv_A           39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGL--------------------IELIETSP   98 (197)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTH--------------------HHHHHHCS
T ss_pred             cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHH--------------------HHHHhcCC
Confidence            3456666777664 55421    33444555566666666666654322221                    22233345


Q ss_pred             ceeEeeccccccccc----ccccccCCCcccEEEeecc---cccC----CccccccCccCCcEEeccCcccc
Q 039290          567 VVIEMDLSLNALSGV----IPVTIGGLQGLQLLSLRYN---RLQG----PIPESFGGLKSLNFVDMSNNNLS  627 (1049)
Q Consensus       567 ~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N---~l~~----~~~~~~~~l~~L~~L~Ls~N~l~  627 (1049)
                      .|++|+|+.|.|.+.    +...+..-+.|+.|+|++|   .+..    .+.+.+..-+.|+.|+++.|.+.
T Consensus        99 tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g  170 (197)
T 1pgv_A           99 SLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME  170 (197)
T ss_dssp             SCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred             ccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence            566666666666532    2234455566888888765   3332    23445566678888888877653

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.65  E-value=0.0059  Score=69.91  Aligned_cols=73  Identities=15%  Similarity=0.151  Sum_probs=48.0

Q ss_pred             ceecCCCcEEEEEEEeCC-CcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCce-eeEEeeeecCCeeEEEEeccCCCCh
Q 039290          767 KLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNL-VKIISSCSNNDFKALVLEYMSNGSL  844 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~~~g~L  844 (1049)
                      +.|+.|-...+|++...+ +..+++|+....... ..+-.+|..+++.+...++ .++++++.  +  ..||||++|.++
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            578889999999999765 578899987533221 1122578888888864433 56777663  2  359999987544

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.60  E-value=0.0055  Score=60.99  Aligned_cols=102  Identities=15%  Similarity=0.061  Sum_probs=67.6

Q ss_pred             ChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccccccc
Q 039290          843 SLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT  922 (1049)
Q Consensus       843 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~~~  922 (1049)
                      +|.+.+...+.+++++++|.+++|.+++|.-.-.  .+.-..+=+.|..|++..+|.|...+ +.+.             
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------   97 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------   97 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence            7999999988999999999999999999887721  11111222356888888888888753 1110             


Q ss_pred             ccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCC
Q 039290          923 LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKP  961 (1049)
Q Consensus       923 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p  961 (1049)
                      .....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus        98 ~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ---------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence            1123466888764 3556788999999999998874443

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.50  E-value=0.0024  Score=59.23  Aligned_cols=57  Identities=19%  Similarity=0.205  Sum_probs=43.2

Q ss_pred             Eeeccccccc-ccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccC
Q 039290          570 EMDLSLNALS-GVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSG  628 (1049)
Q Consensus       570 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  628 (1049)
                      .+|.+++.++ ..+|..+.  .+|+.|+|++|+|+...+..|..+++|++|+|++|.+..
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C   69 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC   69 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence            5666666665 23454333  468899999999998778888999999999999998864

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.37  E-value=0.0052  Score=68.72  Aligned_cols=73  Identities=14%  Similarity=0.225  Sum_probs=44.4

Q ss_pred             ceecCCCcEEEEEEEeCC---------CcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCc-eeeEEeeeecCCeeEEEE
Q 039290          767 KLLGMGSFGSVYKGVLPD---------GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRN-LVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn-iv~l~~~~~~~~~~~lv~  836 (1049)
                      +.++.|....+|+....+         +..+++|+....... ..+...|.++++.+...+ +.++++..  .  -++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            567888888999998654         268888987543211 122467888888774223 44666544  2  26899


Q ss_pred             eccCCCCh
Q 039290          837 EYMSNGSL  844 (1049)
Q Consensus       837 e~~~~g~L  844 (1049)
                      ||++|..+
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.35  E-value=0.025  Score=62.14  Aligned_cols=67  Identities=9%  Similarity=0.077  Sum_probs=43.6

Q ss_pred             CCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcC---CCceeeEEee------eecCCeeEEEEeccCC
Q 039290          771 MGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR---HRNLVKIISS------CSNNDFKALVLEYMSN  841 (1049)
Q Consensus       771 ~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---hpniv~l~~~------~~~~~~~~lv~e~~~~  841 (1049)
                      .|....||+....+| .+++|+......      .+|+.+++.+.   -|.+++++..      ....+..+++|||++|
T Consensus        33 ~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G  105 (339)
T 3i1a_A           33 ADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA  105 (339)
T ss_dssp             SCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred             CccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence            334689999997777 999998765431      34555555552   2334555432      2335677999999998


Q ss_pred             CCh
Q 039290          842 GSL  844 (1049)
Q Consensus       842 g~L  844 (1049)
                      ..+
T Consensus       106 ~~~  108 (339)
T 3i1a_A          106 PNG  108 (339)
T ss_dssp             CBT
T ss_pred             CcC
Confidence            755

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.42  E-value=0.021  Score=64.50  Aligned_cols=74  Identities=12%  Similarity=0.143  Sum_probs=49.2

Q ss_pred             CceecCCCcEEEEEEEeCC--------CcEEEEEEeecccCCCHHHHHHHHHHHhhcC-CCceeeEEeeeecCCeeEEEE
Q 039290          766 NKLLGMGSFGSVYKGVLPD--------GMEIAAKVFHMEFDGSLESFHAECKVMGSIR-HRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       766 ~~~lg~G~fg~Vy~a~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      .+.+..|-...+|+....+        +..|++|+...... ...+..+|.++++.+. +.-..++++.+.    -+.||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            3577788889999998753        67899998754321 2223467888888774 333455665432    26899


Q ss_pred             eccCCCCh
Q 039290          837 EYMSNGSL  844 (1049)
Q Consensus       837 e~~~~g~L  844 (1049)
                      ||++|..+
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.45  E-value=0.37  Score=54.14  Aligned_cols=30  Identities=30%  Similarity=0.361  Sum_probs=25.1

Q ss_pred             CeEEcCCCCCCeee------cCCCceEEecccCcee
Q 039290          881 PIVHCDIKPSNVLL------NESMVGHLSDFGIAKI  910 (1049)
Q Consensus       881 ~ivH~Dlkp~NIl~------~~~~~~kl~DfGla~~  910 (1049)
                      .++|+|+.+.||++      +++..++++||-+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            35699999999999      4567899999998864

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	1049
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-62
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-58
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-56
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	9e-56
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-56
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-55
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	9e-54
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-53
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-53
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-52
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-52
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-52
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-51
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-51
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-51
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-50
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	8e-50
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-49
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-49
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-49
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-49
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-49
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-49
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-48
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-48
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-48
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-48
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-48
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-48
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	8e-47
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-46
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-45
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-44
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-43
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-41
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-41
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-41
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	7e-40
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	8e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-39
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-39
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-39
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-39
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	9e-39
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-38
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-37
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-36
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-36
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-36
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-35
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-35
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-35
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-34
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-33
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	7e-33
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-32
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-32
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-30
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-29
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	8e-27
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-25
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	7e-21
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-15
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-13
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-12
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	7e-11
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-09
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-25
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-24
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-22
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-18
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-08
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-05
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-22
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-21
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-20
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-18
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-09
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-21
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	8e-19
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-18
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-17
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-15
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-15
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-10
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	7e-11
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-10
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	7e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	9e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	6e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	8e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	6e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	9e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.003
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	6e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-04
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	4e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	3e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	4e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	4e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	6e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	7e-06
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	8e-05
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	7e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	0.002
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	9e-06
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	8e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.002
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	9e-06
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	3e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	7e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	3e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	6e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.002
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.002
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.003
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.002
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.003
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.003

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 3e-62
 Identities = 69/283 (24%), Positives = 127/283 (44%), Gaps = 28/283 (9%)

Query: 767  KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIIS 824
            + +G GSFG+VYKG      ++A K+ ++       L++F  E  V+   RH N++  + 
Sbjct: 14   QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71

Query: 825  SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
              +     A+V ++    SL   L+      ++++ + I    A  ++YLH      I+H
Sbjct: 72   YSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIH 127

Query: 885  CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGYMAPEY---GREGKVS 940
             D+K +N+ L+E +   + DFG+A +  +     Q + L G+I +MAPE      +   S
Sbjct: 128  RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187

Query: 941  RKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEND 1000
             + DVY++GI+L E  T + P   I      +   VG   LS  +++V            
Sbjct: 188  FQSDVYAFGIVLYELMTGQLPYSNI-NNRDQIIFMVGRGYLSPDLSKV------------ 234

Query: 1001 FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043
               R  C  ++  L  +C     ++R     +   +  +  +L
Sbjct: 235  ---RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 6e-58
 Identities = 59/277 (21%), Positives = 116/277 (41%), Gaps = 26/277 (9%)

Query: 761  DGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLV 820
            +     + LG G FG V+ G      ++A K        S ++F AE  +M  ++H+ LV
Sbjct: 13   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV 71

Query: 821  KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYF-LDILQRLKIMIDVASALEYLHFGYS 879
            ++ +  +      ++ EYM NGSL   L + +   L I + L +   +A  + ++     
Sbjct: 72   RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127

Query: 880  TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKV 939
               +H D++ +N+L+++++   ++DFG+A+++   E   +      I + APE    G  
Sbjct: 128  RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187

Query: 940  SRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEN 999
            + K DV+S+GI+L E  T  +           ++                          
Sbjct: 188  TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE--------------------RGY 227

Query: 1000 DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036
                 + C   ++ L   C  + PE R +   + + L
Sbjct: 228  RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 1e-56
 Identities = 60/280 (21%), Positives = 110/280 (39%), Gaps = 24/280 (8%)

Query: 763  FSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKI 822
             +  + +G G FG V+ G   +  ++A K          E F  E +VM  + H  LV++
Sbjct: 7    LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQL 65

Query: 823  ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
               C       LV E+M +G L   L +          L + +DV   + YL       +
Sbjct: 66   YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACV 122

Query: 883  VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRK 942
            +H D+   N L+ E+ V  +SDFG+ + +  ++    T T   + + +PE     + S K
Sbjct: 123  IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182

Query: 943  CDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFS 1002
             DV+S+G+++ E F++ K   E       +   +                          
Sbjct: 183  SDVWSFGVLMWEVFSEGKIPYE-NRSNSEVVEDISTGF-------------------RLY 222

Query: 1003 AREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042
                  + ++ +   C  + PE R +   +  +L  I E+
Sbjct: 223  KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 9e-56
 Identities = 60/277 (21%), Positives = 114/277 (41%), Gaps = 24/277 (8%)

Query: 763  FSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKI 822
             +  K LG G FG V  G      ++A K+         + F  E KVM ++ H  LV++
Sbjct: 6    LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQL 64

Query: 823  ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
               C+      ++ EYM+NG L   L    +     Q L++  DV  A+EYL        
Sbjct: 65   YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 121

Query: 883  VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRK 942
            +H D+   N L+N+  V  +SDFG+++ +  +E      +   + +  PE     K S K
Sbjct: 122  LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181

Query: 943  CDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFS 1002
             D++++G+++ E ++  K   E F    + +       L                     
Sbjct: 182  SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP------------------ 223

Query: 1003 AREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039
                    ++++   C  +  ++R + K + + ++ +
Sbjct: 224  --HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 9e-56
 Identities = 65/304 (21%), Positives = 121/304 (39%), Gaps = 35/304 (11%)

Query: 754  QDLLRATDGFS-ENKLLGMGSFGSVYKGVL---PDGMEIAAKVFHMEFD-GSLESFHAEC 808
            + L    D     +  LG G+FGSV +GV       +++A KV     +    E    E 
Sbjct: 1    KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 809  KVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVA 868
            ++M  + +  +V++I  C       LV+E    G L K L      + +    +++  V+
Sbjct: 61   QIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119

Query: 869  SALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT--LGTI 926
              ++YL        VH D+   NVLL       +SDFG++K LG ++S    ++     +
Sbjct: 120  MGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176

Query: 927  GYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGE--MSLKRWVGDSLLSCS 984
             + APE     K S + DV+SYG+ + E  +  +     +       +  ++        
Sbjct: 177  KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK---PYKKMKGPEVMAFI-------- 225

Query: 985  ITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044
                        +        +C   +++L  DC +   E R     V  R+     +L+
Sbjct: 226  -----------EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274

Query: 1045 AYID 1048
            + ++
Sbjct: 275  SKVE 278

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  193 bits (491), Expect = 1e-55
 Identities = 64/308 (20%), Positives = 129/308 (41%), Gaps = 41/308 (13%)

Query: 752  SYQDLLRATDGFSEN---------KLLGMGSFGSVYKGVLP----DGMEIAAKVFHMEF- 797
            +++D   A   F++          +++G G FG V  G L       + +A K     + 
Sbjct: 8    TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 798  DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDI 857
            +     F +E  +MG   H N++ +    + +    ++ E+M NGSL+  L  ++    +
Sbjct: 68   EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV 127

Query: 858  LQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM 917
            +Q + ++  +A+ ++YL        VH D+   N+L+N ++V  +SDFG+++ L  + S 
Sbjct: 128  IQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184

Query: 918  RQTKT----LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK 973
                +       I + APE  +  K +   DV+SYGI++ E  +  +     +       
Sbjct: 185  PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER---PYWDM---- 237

Query: 974  RWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVA 1033
                      +  +V +A     ++        C S++  L +DC       R     + 
Sbjct: 238  ----------TNQDVINAIE---QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284

Query: 1034 NRLVRIRE 1041
            N L ++  
Sbjct: 285  NTLDKMIR 292

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 9e-54
 Identities = 69/277 (24%), Positives = 113/277 (40%), Gaps = 26/277 (9%)

Query: 761  DGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLV 820
            +       LG G FG V+ G       +A K          E+F  E +VM  +RH  LV
Sbjct: 17   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 75

Query: 821  KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDIL-QRLKIMIDVASALEYLHFGYS 879
            ++ +  S      +V EYMS GSL   L  +      L Q + +   +AS + Y+     
Sbjct: 76   QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--- 131

Query: 880  TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKV 939
               VH D++ +N+L+ E++V  ++DFG+A+++   E   +      I + APE    G+ 
Sbjct: 132  MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191

Query: 940  SRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEN 999
            + K DV+S+GI+L E  TK +           L +                         
Sbjct: 192  TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE--------------------RGY 231

Query: 1000 DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036
                  +C  S+  L   C    PE+R + + +   L
Sbjct: 232  RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (477), Expect = 1e-53
 Identities = 70/298 (23%), Positives = 114/298 (38%), Gaps = 30/298 (10%)

Query: 759  ATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRH 816
              D F +   LG G+ G V+K    P G+ +A K+ H+E           E +V+     
Sbjct: 4    KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 817  RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
              +V    +  ++   ++ +E+M  GSL++ L      +      K+ I V   L YL  
Sbjct: 64   PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE 122

Query: 877  GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
                 I+H D+KPSN+L+N      L DFG++  L    +      +GT  YM+PE  + 
Sbjct: 123  --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQG 177

Query: 937  GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSL----------------KRWVGDSL 980
               S + D++S G+ L+E    + P     A E+ L                 R  G  L
Sbjct: 178  THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237

Query: 981  LSCSITEVADANLLN-----CEENDFSAREQCVSSIF-SLAMDCTVDLPEKRISMKDV 1032
             S  +       +         E          S  F      C +  P +R  +K +
Sbjct: 238  SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 7e-53
 Identities = 58/293 (19%), Positives = 116/293 (39%), Gaps = 22/293 (7%)

Query: 767  KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
            + +G G FG V++G    G E+A K+F    + S     AE      +RH N++  I++ 
Sbjct: 9    ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAAD 66

Query: 827  SNNDFKA----LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH-----FG 877
            + ++       LV +Y  +GSL   L  + Y + +   +K+ +  AS L +LH       
Sbjct: 67   NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124

Query: 878  YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT---LGTIGYMAPEY- 933
                I H D+K  N+L+ ++    ++D G+A                 +GT  YMAPE  
Sbjct: 125  GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184

Query: 934  -----GREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEV 988
                  +  +  ++ D+Y+ G++  E   +          ++     V        + +V
Sbjct: 185  DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244

Query: 989  ADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041
                 L     +     + +  +  +  +C       R++   +   L ++ +
Sbjct: 245  VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 1e-52
 Identities = 76/276 (27%), Positives = 116/276 (42%), Gaps = 32/276 (11%)

Query: 767  KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSC 826
            + +G G FG V  G    G ++A K      D + ++F AE  VM  +RH NLV+++   
Sbjct: 13   QTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVI 69

Query: 827  SNNDFK-ALVLEYMSNGSLEKCLYS-DNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                    +V EYM+ GSL   L S     L     LK  +DV  A+EYL        VH
Sbjct: 70   VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126

Query: 885  CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCD 944
             D+   NVL++E  V  +SDFG+ K      S  Q      + + APE  RE K S K D
Sbjct: 127  RDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFSTKSD 182

Query: 945  VYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAR 1004
            V+S+GI+L E ++  +        +  + R                      +     A 
Sbjct: 183  VWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE--------------------KGYKMDAP 222

Query: 1005 EQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIR 1040
            + C  +++ +  +C       R S   +  +L  I+
Sbjct: 223  DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 1e-52
 Identities = 67/287 (23%), Positives = 123/287 (42%), Gaps = 31/287 (10%)

Query: 763  FSENKLLGMGSFGSVYKGVLPDG-----MEIAAKVFHMEF-DGSLESFHAECKVMGSIRH 816
             +  K++G G FG VYKG+L        + +A K     + +     F  E  +MG   H
Sbjct: 9    VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 817  RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             N++++    S      ++ EYM NG+L+K L   +    +LQ + ++  +A+ ++YL  
Sbjct: 69   HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA- 127

Query: 877  GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT--LGTIGYMAPEYG 934
              +   VH D+   N+L+N ++V  +SDFG++++L  +     T +     I + APE  
Sbjct: 128  --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185

Query: 935  REGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL 994
               K +   DV+S+GI++ E  T  +      +    +K                     
Sbjct: 186  SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI------------------- 226

Query: 995  NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041
              +         C S+I+ L M C      +R    D+ + L ++  
Sbjct: 227  -NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 2e-52
 Identities = 68/279 (24%), Positives = 116/279 (41%), Gaps = 32/279 (11%)

Query: 765  ENKLLGMGSFGSVYKGVLPD---GMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNL 819
            E+K LG G+FG+V KG          +A K+   E +     +   AE  VM  + +  +
Sbjct: 11   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 820  VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            V++I  C    +  LV+E    G L K L  + + +     ++++  V+  ++YL     
Sbjct: 71   VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEE--- 125

Query: 880  TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT--LGTIGYMAPEYGREG 937
            +  VH D+   NVLL       +SDFG++K L  +E+  + +T     + + APE     
Sbjct: 126  SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 938  KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE 997
            K S K DV+S+G+++ E F+  +     + G                 +EV     +  +
Sbjct: 186  KFSSKSDVWSFGVLMWEAFSYGQK---PYRGM--------------KGSEVTA---MLEK 225

Query: 998  ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036
                     C   ++ L   C     E R     V  RL
Sbjct: 226  GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  181 bits (460), Expect = 1e-51
 Identities = 63/295 (21%), Positives = 114/295 (38%), Gaps = 26/295 (8%)

Query: 749  RRISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAE 807
               +Y          +    LG G +G VY+GV     + +A K    +    +E F  E
Sbjct: 5    SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKE 63

Query: 808  CKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYF-LDILQRLKIMID 866
              VM  I+H NLV+++  C+      ++ E+M+ G+L   L   N   +  +  L +   
Sbjct: 64   AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123

Query: 867  VASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTI 926
            ++SA+EYL        +H D+   N L+ E+ +  ++DFG+++++  +           I
Sbjct: 124  ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180

Query: 927  GYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSIT 986
             + APE     K S K DV+++G++L E  T               +    D  +     
Sbjct: 181  KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-- 238

Query: 987  EVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041
                              E C   ++ L   C    P  R S  ++      + +
Sbjct: 239  ------------------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 2e-51
 Identities = 65/295 (22%), Positives = 123/295 (41%), Gaps = 34/295 (11%)

Query: 766  NKLLGMGSFGSVYKGVLPD----GMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLV 820
            N+++G G FG VY G L D     +  A K  +   D G +  F  E  +M    H N++
Sbjct: 32   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 821  KIISSCSNNDFKA-LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
             ++  C  ++    +VL YM +G L   + ++ +   +   +   + VA  +++L     
Sbjct: 92   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS--- 148

Query: 880  TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM---RQTKTLGTIGYMAPEYGRE 936
               VH D+   N +L+E     ++DFG+A+ +  +E      +T     + +MA E  + 
Sbjct: 149  KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208

Query: 937  GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC 996
             K + K DV+S+G++L E  T+  P       +++                     +   
Sbjct: 209  QKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDIT----------------VYLL 248

Query: 997  EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSA--YIDV 1049
            +       E C   ++ + + C     E R S  ++ +R+  I  T     Y+ V
Sbjct: 249  QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHV 303

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 4e-51
 Identities = 62/272 (22%), Positives = 109/272 (40%), Gaps = 29/272 (10%)

Query: 767  KLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISS 825
              LG G+FG VYK    +  +  AAKV   + +  LE +  E  ++ S  H N+VK++ +
Sbjct: 18   GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 826  CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
                +   +++E+ + G+++  +      L   Q   +      AL YLH      I+H 
Sbjct: 78   FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134

Query: 886  DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY-----GREGKVS 940
            D+K  N+L        L+DFG++    +    R +  +GT  +MAPE       ++    
Sbjct: 135  DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVVMCETSKDRPYD 193

Query: 941  RKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEND 1000
             K DV+S GI L+E    + P  E+    + LK                   +   E   
Sbjct: 194  YKADVWSLGITLIEMAEIEPPHHELNPMRVLLK-------------------IAKSEPPT 234

Query: 1001 FSAREQCVSSIFSLAMDCTVDLPEKRISMKDV 1032
             +   +  S+       C     + R +   +
Sbjct: 235  LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 2e-50
 Identities = 61/280 (21%), Positives = 106/280 (37%), Gaps = 29/280 (10%)

Query: 767  KLLGMGSFGSVYKGVLPD----GMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVK 821
            + +G G FG V++G+        + +A K       D   E F  E   M    H ++VK
Sbjct: 13   RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72

Query: 822  IISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP 881
            +I   + N    +++E  + G L   L    Y LD+   +     +++AL YL    S  
Sbjct: 73   LIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKR 128

Query: 882  IVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSR 941
             VH DI   NVL++ +    L DFG+++ +      + +K    I +MAPE     + + 
Sbjct: 129  FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188

Query: 942  KCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDF 1001
              DV+ +G+ + E         +       + R                           
Sbjct: 189  ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE--------------------NGERL 228

Query: 1002 SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041
                 C  +++SL   C    P +R    ++  +L  I E
Sbjct: 229  PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  176 bits (448), Expect = 8e-50
 Identities = 62/280 (22%), Positives = 105/280 (37%), Gaps = 36/280 (12%)

Query: 760  TDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIR 815
               FS+ + +G GSFG+VY    + +   +A K         +   +    E + +  +R
Sbjct: 14   EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 816  HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
            H N ++            LV+EY    + +         L  ++   +       L YLH
Sbjct: 74   HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH 132

Query: 876  FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY-- 933
               S  ++H D+K  N+LL+E  +  L DFG A I+    S       GT  +MAPE   
Sbjct: 133  ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVIL 184

Query: 934  -GREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN 992
               EG+   K DV+S GI  +E   +K P   + A                 +  +A   
Sbjct: 185  AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--------------LYHIAQNE 230

Query: 993  LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDV 1032
                +   +S          +    C   +P+ R + + +
Sbjct: 231  SPALQSGHWS------EYFRNFVDSCLQKIPQDRPTSEVL 264

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  176 bits (446), Expect = 1e-49
 Identities = 68/312 (21%), Positives = 122/312 (39%), Gaps = 54/312 (17%)

Query: 761  DGFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEFDGSLES-FHAECKVMGS 813
            +     + +G G+FG V++   P          +A K+   E    +++ F  E  +M  
Sbjct: 13   NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 814  IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYF------------------- 854
              + N+VK++  C+      L+ EYM+ G L + L S +                     
Sbjct: 73   FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 855  ----LDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI 910
                L   ++L I   VA+ + YL        VH D+   N L+ E+MV  ++DFG+++ 
Sbjct: 133  GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 911  LGKEESMRQTKT-LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGE 969
            +   +  +        I +M PE     + + + DV++YG++L E F+         A E
Sbjct: 190  IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249

Query: 970  MSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISM 1029
              +      ++L+C                     E C   +++L   C   LP  R S 
Sbjct: 250  EVIYYVRDGNILACP--------------------ENCPLELYNLMRLCWSKLPADRPSF 289

Query: 1030 KDVANRLVRIRE 1041
              +   L R+ E
Sbjct: 290  CSIHRILQRMCE 301

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 1e-49
 Identities = 62/285 (21%), Positives = 108/285 (37%), Gaps = 33/285 (11%)

Query: 758  RATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSI 814
            RA D +     +G GS+G   K     DG  +  K        +   +   +E  ++  +
Sbjct: 2    RAED-YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60

Query: 815  RHRNLVKIISSC--SNNDFKALVLEYMSNGSLEKCLYS---DNYFLDILQRLKIMIDVAS 869
            +H N+V+         N    +V+EY   G L   +     +  +LD    L++M  +  
Sbjct: 61   KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 870  ALEYLH--FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIG 927
            AL+  H        ++H D+KP+NV L+      L DFG+A+IL  + S  +    GT  
Sbjct: 121  ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV-GTPY 179

Query: 928  YMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITE 987
            YM+PE       + K D++S G +L E      P    F                 S  E
Sbjct: 180  YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----FTAF--------------SQKE 221

Query: 988  VADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDV 1032
            +A   +   +        +    +  +           R S++++
Sbjct: 222  LAG-KIREGKFRRIP--YRYSDELNEIITRMLNLKDYHRPSVEEI 263

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 2e-49
 Identities = 59/276 (21%), Positives = 105/276 (38%), Gaps = 33/276 (11%)

Query: 761  DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFH---MEFDGSLESFHAECKVMGSIRH 816
            + F   + LG G FG+VY          +A KV     +E  G       E ++   +RH
Sbjct: 6    EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 817  RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             N++++     +     L+LEY   G++ + L   + F D  +    + ++A+AL Y H 
Sbjct: 66   PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYCH- 123

Query: 877  GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
              S  ++H DIKP N+LL  +    ++DFG +               GT+ Y+ PE    
Sbjct: 124  --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC---GTLDYLPPEMIEG 178

Query: 937  GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC 996
                 K D++S G++  E    K P             +  ++                 
Sbjct: 179  RMHDEKVDLWSLGVLCYEFLVGKPP-------------FEANTY---------QETYKRI 216

Query: 997  EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDV 1032
               +F+  +        L        P +R  +++V
Sbjct: 217  SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREV 252

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 4e-49
 Identities = 60/277 (21%), Positives = 111/277 (40%), Gaps = 33/277 (11%)

Query: 766  NKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKI 822
            +  +G GSF +VYKG+  +  +E+A              + F  E +++  ++H N+V+ 
Sbjct: 14   DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 823  ISSC----SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
              S            LV E M++G+L+  L      + I         +   L++LH   
Sbjct: 74   YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHT-R 131

Query: 879  STPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG 937
            + PI+H D+K  N+ +   +    + D G+A +     +      +GT  +MAPE   E 
Sbjct: 132  TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEM-YEE 187

Query: 938  KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE 997
            K     DVY++G+ ++E  T + P  E        +R                   +   
Sbjct: 188  KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR-------------------VTSG 228

Query: 998  ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVAN 1034
                S  +  +  +  +   C     ++R S+KD+ N
Sbjct: 229  VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 6e-49
 Identities = 64/278 (23%), Positives = 109/278 (39%), Gaps = 27/278 (9%)

Query: 761  DGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRN 818
            + +   + LG G++G V   V       +A K+  M+      E+   E  +   + H N
Sbjct: 5    EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 819  LVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGY 878
            +VK        + + L LEY S G L   +  D          +    + + + YLH   
Sbjct: 65   VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM-PEPDAQRFFHQLMAGVVYLH--- 120

Query: 879  STPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGYMAPEYGREG 937
               I H DIKP N+LL+E     +SDFG+A +       R    + GT+ Y+APE  +  
Sbjct: 121  GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 938  KV-SRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC 996
            +  +   DV+S GI+L      + P D+          W                     
Sbjct: 181  EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE------------------- 221

Query: 997  EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVAN 1034
            ++   +  ++  S+  +L     V+ P  RI++ D+  
Sbjct: 222  KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 7e-49
 Identities = 65/301 (21%), Positives = 109/301 (36%), Gaps = 53/301 (17%)

Query: 767  KLLGMGSFGSVYKGVLPD------GMEIAAKVFHMEFD-GSLESFHAECKVMGSI-RHRN 818
            K+LG G+FG V              +++A K+   + D    E+  +E K+M  +  H N
Sbjct: 43   KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102

Query: 819  LVKIISSCSNNDFKALVLEYMSNGSLEKCLYS----------------------DNYFLD 856
            +V ++ +C+ +    L+ EY   G L   L S                      D   L 
Sbjct: 103  IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162

Query: 857  ILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES 916
                L     VA  +E+L        VH D+   NVL+    V  + DFG+A+ +  + +
Sbjct: 163  FEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219

Query: 917  MRQTKTL-GTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRW 975
                      + +MAPE   EG  + K DV+SYGI+L E F+           + +  + 
Sbjct: 220  YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL 279

Query: 976  VGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035
            + +                                I+ +   C      KR S  ++ + 
Sbjct: 280  IQNGF-------------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

Query: 1036 L 1036
            L
Sbjct: 321  L 321

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 1e-48
 Identities = 66/267 (24%), Positives = 110/267 (41%), Gaps = 26/267 (9%)

Query: 767  KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISS 825
            + +G G+ G+VY  + +  G E+A +  +++     E    E  VM   ++ N+V  + S
Sbjct: 26   EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 826  CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
                D   +V+EY++ GSL   +          Q   +  +   ALE+LH   S  ++H 
Sbjct: 86   YLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALEFLH---SNQVIHR 140

Query: 886  DIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDV 945
            DIK  N+LL       L+DFG    +  E+S R +  +GT  +MAPE         K D+
Sbjct: 141  DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKAYGPKVDI 199

Query: 946  YSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSARE 1005
            +S GIM +E    + P    +  E  L+                   +      +    E
Sbjct: 200  WSLGIMAIEMIEGEPP----YLNENPLRAL---------------YLIATNGTPELQNPE 240

Query: 1006 QCVSSIFSLAMDCTVDLPEKRISMKDV 1032
            +  +        C     EKR S K++
Sbjct: 241  KLSAIFRDFLNRCLDMDVEKRGSAKEL 267

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 1e-48
 Identities = 64/319 (20%), Positives = 117/319 (36%), Gaps = 52/319 (16%)

Query: 750  RISYQDLLRATDGFSENKLLGMGSFGSVYKGVLPDG---MEIAAKVFHMEFD-GSLESFH 805
             + + D            ++G G+FG V K  +      M+ A K             F 
Sbjct: 6    VLDWND-------IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 58

Query: 806  AECKVMGSI-RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYF---------- 854
             E +V+  +  H N++ ++ +C +  +  L +EY  +G+L   L                
Sbjct: 59   GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118

Query: 855  -----LDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK 909
                 L   Q L    DVA  ++YL        +H D+   N+L+ E+ V  ++DFG+++
Sbjct: 119  STASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR 175

Query: 910  ILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGE 969
              G+E  +++T     + +MA E       +   DV+SYG++L E  +            
Sbjct: 176  --GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC----G 229

Query: 970  MSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISM 1029
            M+                     L      +      C   ++ L   C  + P +R S 
Sbjct: 230  MTCAELY--------------EKLPQGYRLEKP--LNCDDEVYDLMRQCWREKPYERPSF 273

Query: 1030 KDVANRLVRIRETLSAYID 1048
              +   L R+ E    Y++
Sbjct: 274  AQILVSLNRMLEERKTYVN 292

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  173 bits (440), Expect = 3e-48
 Identities = 64/293 (21%), Positives = 113/293 (38%), Gaps = 31/293 (10%)

Query: 743  YPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL 801
            YPQ     I +  +L   D +  ++ LG G+FG V++      G   AAK      +   
Sbjct: 13   YPQP--VEIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK 67

Query: 802  ESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRL 861
            E+   E + M  +RH  LV +  +  +++   ++ E+MS G L + +  ++  +   + +
Sbjct: 68   ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV 127

Query: 862  KIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQ 919
            + M  V   L ++H       VH D+KP N++          L DFG+   L  ++S++ 
Sbjct: 128  EYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV 184

Query: 920  TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDS 979
            T   GT  + APE      V    D++S G++     +   P    F GE          
Sbjct: 185  TT--GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP----FGGE---------- 228

Query: 980  LLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDV 1032
                +  E            D SA                +  P  R+++   
Sbjct: 229  ----NDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 4e-48
 Identities = 60/283 (21%), Positives = 105/283 (37%), Gaps = 32/283 (11%)

Query: 767  KLLGMGSFGSVYKGVLP----DGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNL 819
            + LG GSFG V +G         + +A K    +      +++ F  E   M S+ HRNL
Sbjct: 14   EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 820  VKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
            +++         K +V E    GSL   L        +    +  + VA  + YL    S
Sbjct: 74   IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---S 129

Query: 880  TPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL--GKEESMRQTKTLGTIGYMAPEYGREG 937
               +H D+   N+LL    +  + DFG+ + L    +  + Q        + APE  +  
Sbjct: 130  KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189

Query: 938  KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE 997
              S   D + +G+ L E FT  +     + G                       + ++ E
Sbjct: 190  TFSHASDTWMFGVTLWEMFTYGQE---PWIGL----------------NGSQILHKIDKE 230

Query: 998  ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIR 1040
                   E C   I+++ + C    PE R +   + + L+  +
Sbjct: 231  GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 4e-48
 Identities = 60/305 (19%), Positives = 110/305 (36%), Gaps = 48/305 (15%)

Query: 761  DGFSENKLLGMGSFGSVYKGVL------PDGMEIAAKVFHMEFD-GSLESFHAECKVMGS 813
            +  S  K LG G+FG V +            M +A K+          E+  +E KV+  
Sbjct: 23   NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 814  I-RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLY-----------------SDNYFL 855
            +  H N+V ++ +C+      ++ EY   G L   L                   D   L
Sbjct: 83   LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 856  DILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE 915
            D+   L     VA  + +L    S   +H D+   N+LL    +  + DFG+A+ +  + 
Sbjct: 143  DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 916  S-MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
            + + +      + +MAPE       + + DV+SYGI L E F+           +    +
Sbjct: 200  NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

Query: 975  WVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVAN 1034
             + +                        + E   + ++ +   C    P KR + K +  
Sbjct: 260  MIKEGF-------------------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

Query: 1035 RLVRI 1039
             + + 
Sbjct: 301  LIEKQ 305

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 5e-48
 Identities = 61/301 (20%), Positives = 124/301 (41%), Gaps = 32/301 (10%)

Query: 756  LLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKV-----FHMEFDGSLESFHAECK 809
            +L+ T+ F + K+LG G+FG+VYKG+ +P+G ++   V            + +    E  
Sbjct: 5    ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63

Query: 810  VMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVAS 869
            VM S+ + ++ +++  C  +  + L+ + M  G L   +      +     L   + +A 
Sbjct: 64   VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 122

Query: 870  ALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGY 928
             + YL       +VH D+   NVL+       ++DFG+AK+LG EE     +     I +
Sbjct: 123  GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179

Query: 929  MAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEV 988
            MA E       + + DV+SYG+ + E  T        + G                 +E+
Sbjct: 180  MALESILHRIYTHQSDVWSYGVTVWELMTFGSK---PYDGI--------------PASEI 222

Query: 989  ADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYID 1048
            +    +  +         C   ++ + + C +   + R   +++     ++      Y+ 
Sbjct: 223  SS---ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLV 279

Query: 1049 V 1049
            +
Sbjct: 280  I 280

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 8e-47
 Identities = 66/282 (23%), Positives = 109/282 (38%), Gaps = 31/282 (10%)

Query: 758  RATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF---DGSLESFHAECKVMGS 813
            +  + F   K+LG GSF +V     L    E A K+        +  +     E  VM  
Sbjct: 5    KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 814  IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
            + H   VK+  +  +++     L Y  NG L K +     F D         ++ SALEY
Sbjct: 65   LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEY 123

Query: 874  LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTL-GTIGYMAPE 932
            LH      I+H D+KP N+LLNE M   ++DFG AK+L  E    +  +  GT  Y++PE
Sbjct: 124  LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180

Query: 933  YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN 992
               E    +  D+++ G ++ +      P    F                 +   +    
Sbjct: 181  LLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAG--------------NEYLI---- 218

Query: 993  LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVAN 1034
                 + ++   E+       L     V    KR+  +++  
Sbjct: 219  FQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  167 bits (425), Expect = 3e-46
 Identities = 59/269 (21%), Positives = 103/269 (38%), Gaps = 26/269 (9%)

Query: 767  KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISS 825
            + LG G+FG V++ V    G    AK  +  +     +   E  +M  + H  L+ +  +
Sbjct: 35   EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94

Query: 826  CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
              +     L+LE++S G L   + +++Y +   + +  M      L+++H      IVH 
Sbjct: 95   FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHL 151

Query: 886  DIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKC 943
            DIKP N++          + DFG+A  L  +E ++ T    T  + APE      V    
Sbjct: 152  DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGFYT 209

Query: 944  DVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSA 1003
            D+++ G++     +   P    FAGE                 E          E D  A
Sbjct: 210  DMWAIGVLGYVLLSGLSP----FAGE--------------DDLETLQNVKRCDWEFDEDA 251

Query: 1004 REQCVSSIFSLAMDCTVDLPEKRISMKDV 1032
                         +     P KR+++ D 
Sbjct: 252  FSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 6e-45
 Identities = 64/322 (19%), Positives = 128/322 (39%), Gaps = 48/322 (14%)

Query: 737  YYDANMYPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGVL------PDGMEIAA 790
            +  A++Y    W  ++ +         + ++ LG GSFG VY+GV            +A 
Sbjct: 4    FSAADVYVPDEWE-VAREK-------ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAI 55

Query: 791  KVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLY 849
            K  +          F  E  VM      ++V+++   S      +++E M+ G L+  L 
Sbjct: 56   KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 115

Query: 850  SDNYF---------LDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVG 900
            S               + + +++  ++A  + YL+   +   VH D+   N ++ E    
Sbjct: 116  SLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTV 172

Query: 901  HLSDFGIAKILGKEESMRQ-TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKK 959
             + DFG+ + + + +  R+  K L  + +M+PE  ++G  +   DV+S+G++L E  T  
Sbjct: 173  KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 232

Query: 960  KPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCT 1019
            +   +  + E  L+  +   LL                       + C   +F L   C 
Sbjct: 233  EQPYQGLSNEQVLRFVMEGGLLDKP--------------------DNCPDMLFELMRMCW 272

Query: 1020 VDLPEKRISMKDVANRLVRIRE 1041
               P+ R S  ++ + +    E
Sbjct: 273  QYNPKMRPSFLEIISSIKEEME 294

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  159 bits (404), Expect = 2e-44
 Identities = 60/292 (20%), Positives = 120/292 (41%), Gaps = 33/292 (11%)

Query: 760  TDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIR 815
            +D +   ++LG G    V+    L    ++A KV   +          F  E +   ++ 
Sbjct: 6    SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 816  HRNLVKIISSCSNNDFKA----LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASAL 871
            H  +V +  +            +V+EY+   +L   ++++   +   + ++++ D   AL
Sbjct: 66   HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 124

Query: 872  EYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT--LGTIGYM 929
             + H      I+H D+KP+N++++ +    + DFGIA+ +    +        +GT  Y+
Sbjct: 125  NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 930  APEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA 989
            +PE  R   V  + DVYS G +L E  T + P    F G+              S   VA
Sbjct: 182  SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD--------------SPVSVA 223

Query: 990  DANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI-SMKDVANRLVRIR 1040
              ++        +  E   + + ++ +      PE R  +  ++   LVR+ 
Sbjct: 224  YQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 1e-43
 Identities = 67/305 (21%), Positives = 125/305 (40%), Gaps = 49/305 (16%)

Query: 761  DGFSENKLLGMGSFGSVYKGVLP--------DGMEIAAKVFHMEF-DGSLESFHAECKVM 811
            D     K LG G+FG V                 ++A K+   +  +  L    +E ++M
Sbjct: 13   DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 812  GSI-RHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCL---------------YSDNYFL 855
              I +H+N++ ++ +C+ +    +++EY S G+L + L               ++    L
Sbjct: 73   KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 856  DILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE 915
                 +     VA  +EYL    S   +H D+   NVL+ E  V  ++DFG+A+ +   +
Sbjct: 133  SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 916  SMRQTKT-LGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKR 974
              ++T      + +MAPE   +   + + DV+S+G++L E FT        + G      
Sbjct: 190  YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS---PYPGV----- 241

Query: 975  WVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVAN 1034
                         V +   L  E +       C + ++ +  DC   +P +R + K +  
Sbjct: 242  ------------PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289

Query: 1035 RLVRI 1039
             L RI
Sbjct: 290  DLDRI 294

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  152 bits (386), Expect = 1e-41
 Identities = 57/289 (19%), Positives = 102/289 (35%), Gaps = 28/289 (9%)

Query: 748  WRRISYQDLLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHME-FDGSLESFH 805
            W++   +D+    D +    +LG G+F  V           +A K    +  +G   S  
Sbjct: 1    WKQA--EDI---RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME 55

Query: 806  AECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMI 865
             E  V+  I+H N+V +     +     L+++ +S G L   +     F       +++ 
Sbjct: 56   NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIF 114

Query: 866  DVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT 925
             V  A++YLH                  L+E     +SDFG++K+      +  +   GT
Sbjct: 115  QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL--STACGT 172

Query: 926  IGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSI 985
             GY+APE   +   S+  D +S G++         P    F  E              + 
Sbjct: 173  PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP----FYDE--------------ND 214

Query: 986  TEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVAN 1034
             ++ +  L    E D    +    S            PEKR + +    
Sbjct: 215  AKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 5e-41
 Identities = 58/306 (18%), Positives = 109/306 (35%), Gaps = 47/306 (15%)

Query: 761  DGFSENKLLGMGSFGSVYKGV------LPDGMEIAAKVFHMEF-DGSLESFHAECKVMGS 813
            D     K LG G+FG V +              +A K+           +  +E K++  
Sbjct: 13   DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 814  IRHRNLVKII--SSCSNNDFKALVLEYMSNGSLEKCLYSDNY---------------FLD 856
            I H   V  +  +         +++E+   G+L   L S                  FL 
Sbjct: 73   IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 857  ILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES 916
            +   +     VA  +E+L    S   +H D+   N+LL+E  V  + DFG+A+ + K+  
Sbjct: 133  LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 917  MRQTKTL-GTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRW 975
              +       + +MAPE   +   + + DV+S+G++L E F+           +    R 
Sbjct: 190  YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249

Query: 976  VGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035
            +                    E     A +     ++   +DC    P +R +  ++   
Sbjct: 250  L-------------------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

Query: 1036 LVRIRE 1041
            L  + +
Sbjct: 291  LGNLLQ 296

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 7e-41
 Identities = 51/269 (18%), Positives = 103/269 (38%), Gaps = 27/269 (10%)

Query: 767  KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISS 825
            + LG G FG V++ V         AK   ++          E  ++   RHRN++ +  S
Sbjct: 11   EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHES 69

Query: 826  CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
              + +   ++ E++S   + + + +  + L+  + +  +  V  AL++LH   S  I H 
Sbjct: 70   FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHF 126

Query: 886  DIKPSNVLLNESMVGH--LSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKC 943
            DI+P N++          + +FG A+ L   ++ R         Y APE  +   VS   
Sbjct: 127  DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVVSTAT 184

Query: 944  DVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSA 1003
            D++S G ++    +   P    F  E              +  ++ +  +      D  A
Sbjct: 185  DMWSLGTLVYVLLSGINP----FLAE--------------TNQQIIENIMNAEYTFDEEA 226

Query: 1004 REQCVSSIFSLAMDCTVDLPEKRISMKDV 1032
             ++             V   + R++  + 
Sbjct: 227  FKEISIEAMDFVDRLLVKERKSRMTASEA 255

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  147 bits (371), Expect = 7e-40
 Identities = 53/275 (19%), Positives = 102/275 (37%), Gaps = 13/275 (4%)

Query: 767  KLLGMGSFGSVYKGVLPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIIS 824
            + +G G++G VYK     G   A K   +E   +G   +   E  ++  ++H N+VK+  
Sbjct: 8    EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 825  SCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVH 884
                     LV E++ +  L+K L      L+ +     ++ + + + Y H      ++H
Sbjct: 68   VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123

Query: 885  CDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCD 944
             D+KP N+L+N      ++DFG+A+  G        + +              K S   D
Sbjct: 124  RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183

Query: 945  VYSYGIMLMETFTKKKP------TDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE 998
            ++S G +  E              D++      L      +  + +     D N    E 
Sbjct: 184  IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243

Query: 999  NDFSAREQCVSSIF-SLAMDCTVDLPEKRISMKDV 1032
              + +  + +      L        P +RI+ K  
Sbjct: 244  LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  146 bits (370), Expect = 8e-40
 Identities = 60/289 (20%), Positives = 109/289 (37%), Gaps = 41/289 (14%)

Query: 761  DGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSL---------ESFHAECKV 810
            + +   ++LG G    V + +  P   E A K+  +   GS          E+   E  +
Sbjct: 3    ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 811  MGSIR-HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVAS 869
            +  +  H N++++  +   N F  LV + M  G L   L ++   L   +  KIM  +  
Sbjct: 63   LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLE 121

Query: 870  ALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYM 929
             +  LH      IVH D+KP N+LL++ M   L+DFG +  L   E +   +  GT  Y+
Sbjct: 122  VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYL 176

Query: 930  APEY------GREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSC 983
            APE              ++ D++S G+++        P    F                 
Sbjct: 177  APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FWHR-------------- 218

Query: 984  SITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDV 1032
                +    +    +      +    ++  L     V  P+KR + ++ 
Sbjct: 219  KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 1e-39
 Identities = 67/283 (23%), Positives = 115/283 (40%), Gaps = 26/283 (9%)

Query: 767  KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF-----DGSLESFHAECKVMGSIRHRNLV 820
              LG G F +VYK         +A K   +       DG   +   E K++  + H N++
Sbjct: 4    DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 821  KIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST 880
             ++ +  +    +LV ++M        +  ++  L        M+     LEYLH     
Sbjct: 64   GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119

Query: 881  PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKV- 939
             I+H D+KP+N+LL+E+ V  L+DFG+AK  G   +   T  + T  Y APE     ++ 
Sbjct: 120  WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPELLFGARMY 178

Query: 940  SRKCDVYSYGIMLMETFTKKKPTDEIFAG--EMSLKRWVGDSLLSCSITEVADANLLNCE 997
                D+++ G +L E   +         G  ++     + ++L + +  +  D   L   
Sbjct: 179  GVGVDMWAVGCILAELLLRVPF----LPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234

Query: 998  ENDFSAREQCVSSIFSLAMDCTVDL--------PEKRISMKDV 1032
                S     +  IFS A D  +DL        P  RI+    
Sbjct: 235  VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 2e-39
 Identities = 62/277 (22%), Positives = 112/277 (40%), Gaps = 34/277 (12%)

Query: 761  DGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF---DGSLESFHAECKVMG-SIR 815
            + F  +K+LG GSFG V+           A K    +    D  +E    E +V+  +  
Sbjct: 2    EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 816  HRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
            H  L  +  +    +    V+EY++ G L   + S + F D+ +      ++   L++LH
Sbjct: 62   HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-DLSRATFYAAEIILGLQFLH 120

Query: 876  FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
               S  IV+ D+K  N+LL++     ++DFG+ K     ++ +     GT  Y+APE   
Sbjct: 121  ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-KTNTFCGTPDYIAPEILL 176

Query: 936  EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN 995
              K +   D +S+G++L E    + P             + G            +  L +
Sbjct: 177  GQKYNHSVDWWSFGVLLYEMLIGQSP-------------FHGQD----------EEELFH 213

Query: 996  CEENDFSAREQCVSSIF-SLAMDCTVDLPEKRISMKD 1031
                D     + +      L +   V  PEKR+ ++ 
Sbjct: 214  SIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRG 250

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 4e-39
 Identities = 59/289 (20%), Positives = 109/289 (37%), Gaps = 19/289 (6%)

Query: 760  TDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFH-MEFDGSLESFHAECKVMGSIRHR 817
               ++    +G G++G V       + + +A K     E     +    E K++   RH 
Sbjct: 7    GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 818  NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYS--DNYFLDILQRLKIMIDVASALEYLH 875
            N++ I         + +   Y+    +   LY       L        +  +   L+Y+H
Sbjct: 67   NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 876  FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKT--LGTIGYMAPEY 933
               S  ++H D+KPSN+LLN +    + DFG+A++   +       T  + T  Y APE 
Sbjct: 127  ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 934  GREGKV-SRKCDVYSYGIMLMETFTKKKP-----TDEIFAGEMSLKRWVGDSLLSCSITE 987
                K  ++  D++S G +L E  + +         +     + +        L+C I  
Sbjct: 184  MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243

Query: 988  VADANLLNCEENDFSAREQCVSSIFSLAMD----CTVDLPEKRISMKDV 1032
             A   LL+    +     +   +  S A+D         P KRI ++  
Sbjct: 244  KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  145 bits (367), Expect = 6e-39
 Identities = 50/199 (25%), Positives = 88/199 (44%), Gaps = 12/199 (6%)

Query: 767 KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKI 822
           + LG GSFG V+      +G   A KV   E       +E  + E  ++  + H  ++++
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 823 ISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPI 882
             +  +     ++++Y+  G L       +             +V  ALEYLH   S  I
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFSL-LRKSQRFPNPVAKFYAAEVCLALEYLH---SKDI 125

Query: 883 VHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRK 942
           ++ D+KP N+LL+++    ++DFG AK +            GT  Y+APE       ++ 
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVSTKPYNKS 181

Query: 943 CDVYSYGIMLMETFTKKKP 961
            D +S+GI++ E      P
Sbjct: 182 IDWWSFGILIYEMLAGYTP 200

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 9e-39
 Identities = 56/282 (19%), Positives = 103/282 (36%), Gaps = 13/282 (4%)

Query: 761  DGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHR 817
            + F + + +G G++G VYK      G  +A K   ++   +G   +   E  ++  + H 
Sbjct: 2    ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 818  NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
            N+VK++      +   LV E++     +    S    + +      +  +   L + H  
Sbjct: 62   NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119

Query: 878  YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG 937
             S  ++H D+KP N+L+N      L+DFG+A+  G        + +              
Sbjct: 120  -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178

Query: 938  KVSRKCDVYSYGIMLMETFTKKKP------TDEIFAGEMSLKRWVGDSLLSCSITEVADA 991
              S   D++S G +  E  T++         D++F    +L           +       
Sbjct: 179  YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238

Query: 992  NLLNCEENDFSAREQCVSSIF-SLAMDCTVDLPEKRISMKDV 1032
            +       DFS     +     SL        P KRIS K  
Sbjct: 239  SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  144 bits (365), Expect = 3e-38
 Identities = 51/212 (24%), Positives = 92/212 (43%), Gaps = 15/212 (7%)

Query: 761 DGFSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHM------EFDGSLESFHAECKVMGS 813
           + FS ++++G G FG VY     D G   A K          + +    +      ++ +
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 814 IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
                +V +  +    D  + +L+ M+ G L   L     F +         ++   LE+
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE-ADMRFYAAEIILGLEH 122

Query: 874 LHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEY 933
           +H   +  +V+ D+KP+N+LL+E     +SD G+A    K++      ++GT GYMAPE 
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEV 176

Query: 934 GREGK-VSRKCDVYSYGIMLMETFTKKKPTDE 964
            ++G       D +S G ML +      P  +
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 208

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 2e-37
 Identities = 62/292 (21%), Positives = 108/292 (36%), Gaps = 22/292 (7%)

Query: 758  RATDGFSENKLLGMGSFGSVYKG--VLPDGMEIAAKVFHMEF--DGSLESFHAECKVM-- 811
            RA   +     +G G++G V+K   +   G  +A K   ++   +G   S   E  V+  
Sbjct: 4    RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 812  -GSIRHRNLVKIISSCSNNDFKA-----LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMI 865
              +  H N+V++   C+ +         LV E++               +       +M 
Sbjct: 64   LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 866  DVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGT 925
             +   L++LH   S  +VH D+KP N+L+  S    L+DFG+A+I      M  T  + T
Sbjct: 124  QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVT 178

Query: 926  IGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTD-----EIFAGEMSLKRWVGDSL 980
            + Y APE   +   +   D++S G +  E F +K         +     + +    G+  
Sbjct: 179  LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 981  LSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDV 1032
                +     A      +               L + C    P KRIS    
Sbjct: 239  WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  138 bits (347), Expect = 2e-36
 Identities = 56/291 (19%), Positives = 100/291 (34%), Gaps = 31/291 (10%)

Query: 757  LRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR 815
            LR  + +   + +G GSFG +Y G  +  G E+A K+  ++        H E K+   ++
Sbjct: 3    LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQ 60

Query: 816  HRNLVKIISSC-SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYL 874
                +  I  C +  D+  +V+E +     +   +    F  +   L +   + S +EY+
Sbjct: 61   GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKF-SLKTVLLLADQMISRIEYI 119

Query: 875  HFGYSTPIVHCDIKPSNVLLNESMVGHL---SDFGIAKILGKEES------MRQTKTLGT 925
            H   S   +H D+KP N L+     G+L    DFG+AK      +             GT
Sbjct: 120  H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176

Query: 926  IGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSI 985
              Y +       + SR+ D+ S G +LM       P   + A     K            
Sbjct: 177  ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK------------ 224

Query: 986  TEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRL 1036
                  +            +   S   +    C     + +     +    
Sbjct: 225  --YERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 273

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 2e-36
 Identities = 59/284 (20%), Positives = 106/284 (37%), Gaps = 37/284 (13%)

Query: 761  DGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF------DGSLESFHAECKVMGS 813
            D +   + LG G F  V K      G++ AAK              S E    E  ++  
Sbjct: 10   DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 814  IRHRNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEY 873
            I+H N++ +     N     L+LE ++ G L   L       +  +  + +  + + + Y
Sbjct: 70   IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 128

Query: 874  LHFGYSTPIVHCDIKPSNVLLNESMVG----HLSDFGIAKILGKEESMRQTKTLGTIGYM 929
            LH   S  I H D+KP N++L +  V      + DFG+A  +  +         GT  ++
Sbjct: 129  LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFV 183

Query: 930  APEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA 989
            APE      +  + D++S G++     +   P    F G+   +                
Sbjct: 184  APEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETL-------------- 225

Query: 990  DANLLNCEENDFSAREQCVSSIF-SLAMDCTVDLPEKRISMKDV 1032
             AN+               S++         V  P+KR++++D 
Sbjct: 226  -ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (342), Expect = 4e-36
 Identities = 55/277 (19%), Positives = 95/277 (34%), Gaps = 45/277 (16%)

Query: 767  KLLGMGSFGSVYKGV-LPDGMEIAAKVFH------MEFDGSLESFHAECKVMGSIR--HR 817
             LLG G FGSVY G+ + D + +A K              +      E  ++  +     
Sbjct: 10   PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69

Query: 818  NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
             +++++      D   L+LE            ++   L           V  A+ + H  
Sbjct: 70   GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 127

Query: 878  YSTPIVHCDIKPSNVLLNES-MVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             +  ++H DIK  N+L++ +     L DFG   +L   +    T   GT  Y  PE+ R 
Sbjct: 128  -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 183

Query: 937  GKV-SRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN 995
             +   R   V+S GI+L +      P    F  +  + R                     
Sbjct: 184  HRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEEIIRG-------------------- 219

Query: 996  CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDV 1032
                    R++  S    L   C    P  R + +++
Sbjct: 220  ----QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 252

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 1e-35
 Identities = 55/280 (19%), Positives = 104/280 (37%), Gaps = 36/280 (12%)

Query: 766  NKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLVKII 823
            +++LG+G  G V +        + A K+              E ++     +  ++V+I+
Sbjct: 17   SQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIV 71

Query: 824  SSC----SNNDFKALVLEYMSNGSLEKCLYS-DNYFLDILQRLKIMIDVASALEYLHFGY 878
                   +      +V+E +  G L   +    +      +  +IM  +  A++YLH   
Sbjct: 72   DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--- 128

Query: 879  STPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
            S  I H D+KP N+L      + +  L+DFG AK      S+       T  Y+APE   
Sbjct: 129  SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLG 186

Query: 936  EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN 995
              K  + CD++S G+++        P    F     L           +I+      +  
Sbjct: 187  PEKYDKSCDMWSLGVIMYILLCGYPP----FYSNHGL-----------AISPGMKTRIRM 231

Query: 996  CEENDFSAREQCVSSIF-SLAMDCTVDLPEKRISMKDVAN 1034
             +    +     VS     L  +     P +R+++ +  N
Sbjct: 232  GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 2e-35
 Identities = 47/277 (16%), Positives = 98/277 (35%), Gaps = 15/277 (5%)

Query: 767  KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKII 823
            + +G G++G+V+K         +A K   ++ D  G   S   E  ++  ++H+N+V++ 
Sbjct: 8    EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 824  SSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIV 883
                ++    LV E+      +     +            +  +   L + H      ++
Sbjct: 68   DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE-IVKSFLFQLLKGLGFCHS---RNVL 123

Query: 884  HCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKC 943
            H D+KP N+L+N +    L++FG+A+  G        + +                S   
Sbjct: 124  HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183

Query: 944  DVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSA 1003
            D++S G +  E     +P       +  LKR              +   L + +      
Sbjct: 184  DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243

Query: 1004 REQCVSSIFSLAMDCTVDL--------PEKRISMKDV 1032
                + ++         DL        P +RIS ++ 
Sbjct: 244  ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  133 bits (336), Expect = 3e-35
 Identities = 45/295 (15%), Positives = 92/295 (31%), Gaps = 33/295 (11%)

Query: 767  KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISS 825
            + +G GSFG +++G  L +  ++A K      D        E +    +     +  +  
Sbjct: 11   RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYY 68

Query: 826  CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHC 885
                    +++  +   SLE  L        +         + + ++ +H      +V+ 
Sbjct: 69   FGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYR 125

Query: 886  DIKPSNVLLNESMVGH-----LSDFGIAKILGKEES------MRQTKTLGTIGYMAPEYG 934
            DIKP N L+      +     + DFG+ K      +        +    GT  YM+    
Sbjct: 126  DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185

Query: 935  REGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK-RWVGDSLLSCSITEVADANL 993
               + SR+ D+ + G + M       P   + A     K   +G+   S  + E+     
Sbjct: 186  LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL----- 240

Query: 994  LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYID 1048
                              +           +       +     ++ E L+   D
Sbjct: 241  ----------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 5e-35
 Identities = 56/287 (19%), Positives = 105/287 (36%), Gaps = 25/287 (8%)

Query: 763  FSENKLLGMGSFGSVYKGVLPD-GMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVK 821
            +++ K++G GSFG VY+  L D G  +A K    +        + E ++M  + H N+V+
Sbjct: 22   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVR 77

Query: 822  IISSC------SNNDFKALVLEYMSNGSLEKCLY--SDNYFLDILQRLKIMIDVASALEY 873
            +           +  +  LVL+Y+         +       L ++     M  +  +L Y
Sbjct: 78   LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 874  LHFGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE 932
            +H   S  I H DIKP N+LL+ ++ V  L DFG AK L + E    +            
Sbjct: 138  IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYYRAPEL 193

Query: 933  YGREGKVSRKCDVYSYGIMLMETFTKKKP-----TDEIFAGEMSLKRWVGDSLLSCSITE 987
                   +   DV+S G +L E    +         +     + +        +      
Sbjct: 194  IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253

Query: 988  VADANLLNCEENDFS--AREQCVSSIFSLAMDCTVDLPEKRISMKDV 1032
              +      + + ++   R +      +L        P  R++  + 
Sbjct: 254  YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 4e-34
 Identities = 59/291 (20%), Positives = 109/291 (37%), Gaps = 29/291 (9%)

Query: 767  KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKII 823
              +G G+FG V+K      G ++A K   ME   +G   +   E K++  ++H N+V +I
Sbjct: 16   AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 824  SSCSNNDFKA--------LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
              C               LV ++  +            F  + +  ++M  + + L Y+H
Sbjct: 76   EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF-TLSEIKRVMQMLLNGLYYIH 134

Query: 876  FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES---MRQTKTLGTIGYMAPE 932
                  I+H D+K +NVL+    V  L+DFG+A+     ++    R T  + T+ Y  PE
Sbjct: 135  ---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191

Query: 933  YGREGK-VSRKCDVYSYGIMLMETFTKKKPTD---------EIFAGEMSLKRWVGDSLLS 982
                 +      D++  G ++ E +T+               I     S+   V  ++ +
Sbjct: 192  LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251

Query: 983  CSITEVADANLLNCEENDFSAREQCVSSIF-SLAMDCTVDLPEKRISMKDV 1032
              + E  +       +     +          L     V  P +RI   D 
Sbjct: 252  YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  129 bits (325), Expect = 4e-33
 Identities = 57/252 (22%), Positives = 97/252 (38%), Gaps = 12/252 (4%)

Query: 761  DGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRH 816
            D F   K LG GSFG V        G   A K+   +       +E    E +++ ++  
Sbjct: 41   DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 817  RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
              LVK+  S  +N    +V+EY++ G +   L     F            +    EYLH 
Sbjct: 101  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF-SEPHARFYAAQIVLTFEYLH- 158

Query: 877  GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
              S  +++ D+KP N+L+++     ++DFG A    K    R     GT   +APE    
Sbjct: 159  --SLDLIYRDLKPENLLIDQQGYIQVTDFGFA----KRVKGRTWTLCGTPEALAPEIILS 212

Query: 937  GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC 996
               ++  D ++ G+++ E      P       ++  K   G        +      L N 
Sbjct: 213  KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNL 272

Query: 997  EENDFSAREQCV 1008
             + D + R   +
Sbjct: 273  LQVDLTKRFGNL 284

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 7e-33
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 9/205 (4%)

Query: 761 DGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRH 816
           + F   KLLG G+FG V        G   A K+   E       +     E +V+ + RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHF 876
             L  +  +   +D    V+EY + G L   L  +  F +  +      ++ SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-RARFYGAEIVSALEYLH- 122

Query: 877 GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGRE 936
             S  +V+ DIK  N++L++     ++DFG+ K    + +  +T   GT  Y+APE   +
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLED 179

Query: 937 GKVSRKCDVYSYGIMLMETFTKKKP 961
               R  D +  G+++ E    + P
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLP 204

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  126 bits (318), Expect = 2e-32
 Identities = 59/321 (18%), Positives = 120/321 (37%), Gaps = 35/321 (10%)

Query: 735  RPYYDANM-YPQATWRRISYQDLLRATDGFSENKLLGMGSFGSVYKGV-LPDGMEIAAKV 792
            R Y D N   P+  W   S+       D +   + LG G +  V++ + + +  ++  K+
Sbjct: 8    RVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI 67

Query: 793  FHMEFDGSLESFHAECKVMGSIR-HRNLVKIISSCSNNDFK--ALVLEYMSNGSLEKCLY 849
                     +    E K++ ++R   N++ +     +   +  ALV E+++N   ++   
Sbjct: 68   LKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ 124

Query: 850  SDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL-NESMVGHLSDFGIA 908
            +    L        M ++  AL+Y H   S  I+H D+KP NV++ +E     L D+G+A
Sbjct: 125  T----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 177

Query: 909  KILGKEESMRQTKTLGTIGYMAPEYGREGK-VSRKCDVYSYGIMLMETFTKKKP----TD 963
            +     +       + +  +  PE   + +      D++S G ML     +K+P     D
Sbjct: 178  EFYHPGQEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235

Query: 964  EIFAGEMSLK----RWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCT 1019
                     K      + D +   +I      N +    +         S    L     
Sbjct: 236  NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEA 295

Query: 1020 VDL--------PEKRISMKDV 1032
            +D          + R++ ++ 
Sbjct: 296  LDFLDKLLRYDHQSRLTAREA 316

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 6e-32
 Identities = 58/286 (20%), Positives = 115/286 (40%), Gaps = 31/286 (10%)

Query: 767  KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKII 823
            + +G G++G+V   V    G ++A K  +  F  +   +  + E +++  +RH N++ ++
Sbjct: 24   QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83

Query: 824  SSCSNNDFKA------LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
               + ++         LV+ +M     +      +  L   +   ++  +   L Y+H  
Sbjct: 84   DVFTPDETLDDFTDFYLVMPFMGTDLGK---LMKHEKLGEDRIQFLVYQMLKGLRYIH-- 138

Query: 878  YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPE-YGRE 936
             +  I+H D+KP N+ +NE     + DFG+A+    E     T  + T  Y APE     
Sbjct: 139  -AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNW 193

Query: 937  GKVSRKCDVYSYGIMLMETFTKKKP---------TDEIFAGEMSLKRWVGDSLLSCSITE 987
             + ++  D++S G ++ E  T K             EI     +        L S     
Sbjct: 194  MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253

Query: 988  VADANLLNCEENDFSAREQCVSSIF-SLAMDCTVDLPEKRISMKDV 1032
                 L   E+ DF++     S +  +L     V   E+R++  + 
Sbjct: 254  YMK-GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 3e-30
 Identities = 61/280 (21%), Positives = 109/280 (38%), Gaps = 33/280 (11%)

Query: 761  DGFSENKLLGMGSFGSVYKGVL----PDGMEIAAKVFH----MEFDGSLESFHAECKVMG 812
            + F   K+LG G++G V+          G   A KV      ++   + E    E +V+ 
Sbjct: 24   ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 813  SIRHR-NLVKIISSCSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASAL 871
             IR    LV +  +        L+L+Y++ G L   L     F +     ++ I V   +
Sbjct: 84   HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE----HEVQIYVGEIV 139

Query: 872  EYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAP 931
              L   +   I++ DIK  N+LL+ +    L+DFG++K    +E+ R     GTI YMAP
Sbjct: 140  LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199

Query: 932  E--YGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA 989
            +   G +    +  D +S G+++ E  T   P    F  +                    
Sbjct: 200  DIVRGGDSGHDKAVDWWSLGVLMYELLTGASP----FTVD--------------GEKNSQ 241

Query: 990  DANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISM 1029
                    +++    ++  +    L     +  P+KR+  
Sbjct: 242  AEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGC 281

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 3e-29
 Identities = 52/282 (18%), Positives = 100/282 (35%), Gaps = 23/282 (8%)

Query: 767  KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKII 823
              +G G++GSV        G+ +A K     F      +  + E +++  ++H N++ ++
Sbjct: 24   SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 824  SSC----SNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS 879
                   S  +F  + L     G+    +       D      ++  +   L+Y+H   S
Sbjct: 84   DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD-HVQFLIYQILRGLKYIH---S 139

Query: 880  TPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKV 939
              I+H D+KPSN+ +NE     + DFG+A+                              
Sbjct: 140  ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHY 196

Query: 940  SRKCDVYSYGIMLMETFTKKKP-----TDEIFAGEMSLKRWVGDSLLSCSITEVADANLL 994
            ++  D++S G ++ E  T +         +     + L    G  LL    +E A   + 
Sbjct: 197  NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256

Query: 995  NCEENDFSAREQCVSSIFSLAMD----CTVDLPEKRISMKDV 1032
            +  +               LA+D      V   +KRI+    
Sbjct: 257  SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 8e-29
 Identities = 57/295 (19%), Positives = 99/295 (33%), Gaps = 38/295 (12%)

Query: 767  KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKII 823
            K +G G+ G V           +A K     F      +  + E  +M  + H+N++ ++
Sbjct: 23   KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 824  SSCSNNDFK------ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG 877
            +  +            LV+E M     +          D  +   ++  +   +++LH  
Sbjct: 83   NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLH-- 136

Query: 878  YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREG 937
             S  I+H D+KPSN+++       + DFG+A+  G    M  T  + T  Y APE     
Sbjct: 137  -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYRAPEVILGM 193

Query: 938  KVSRKCDVYSYGIMLMETFTKK--------------------KPTDEIFAGEMSLKRWVG 977
                  D++S G ++ E    K                     P  E         R   
Sbjct: 194  GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253

Query: 978  DSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDV 1032
            ++    +          +    D    +   S    L     V  P KRIS+ D 
Sbjct: 254  ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  111 bits (277), Expect = 8e-27
 Identities = 52/310 (16%), Positives = 103/310 (33%), Gaps = 47/310 (15%)

Query: 767  KLLGMGSFGSVYKGV-LPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISS 825
            + LG G F +V+    + +   +A K+   +     E+   E K++  +   +  K  S 
Sbjct: 19   RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 826  CSNNDFK---------------ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASA 870
             +N+  K                +V E +    L      ++  + ++   +I   +   
Sbjct: 78   GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 871  LEYLHFGYSTPIVHCDIKPSNVLLN-ESMVGHLSDFGIAKI-LGKEESMRQTKTLGTIGY 928
            L+Y+H      I+H DIKP NVL+       +L    IA +          T ++ T  Y
Sbjct: 138  LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195

Query: 929  MAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTD---------------EIFAGEMSLK 973
             +PE           D++S   ++ E  T     +               +I      L 
Sbjct: 196  RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELP 255

Query: 974  RWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDL----------- 1022
             ++  +         +   L N  +  F   E  ++  +  + D   ++           
Sbjct: 256  SYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315

Query: 1023 PEKRISMKDV 1032
            P KR     +
Sbjct: 316  PRKRADAGGL 325

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  105 bits (261), Expect = 4e-25
 Identities = 76/315 (24%), Positives = 124/315 (39%), Gaps = 19/315 (6%)

Query: 30  TDQFALLALKEHIKHDPSNLLANNWSTTSSVC--SWIGVTC--GVRNRRVTALNISYLGL 85
            D+ ALL +K+ +  +P+ L  ++W  T+  C  +W+GV C    +  RV  L++S L L
Sbjct: 6   QDKQALLQIKKDL-GNPTTL--SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62

Query: 86  TG--TIPPQLGNLSFLAVLAIRNN-SFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFV 142
                IP  L NL +L  L I    +  G +P  ++ L  L Y      N    IP +  
Sbjct: 63  PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122

Query: 143 SLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLE 202
            +  L  L   +N+  G +P +I  L  L  +    N++SG IP S  + S         
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM--- 179

Query: 203 GLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGE 262
              IS N+LTG IP                     G    +              + +  
Sbjct: 180 --TISRNRLTGKIPPTFANLN--LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235

Query: 263 IPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNL 322
              ++G  +NL  L ++++ + G +P  +  +  L  L V+ N+L G +P      L   
Sbjct: 236 DLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG--GNLQRF 293

Query: 323 ERLFLGENNFSGTIP 337
           +      N      P
Sbjct: 294 DVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 92.5 bits (228), Expect = 7e-21
 Identities = 72/306 (23%), Positives = 125/306 (40%), Gaps = 12/306 (3%)

Query: 387 LSFLSSLTSCRNLEIIYLSENPIN----GILPSSIGNFSISMKSLSMESCNISGG--IPK 440
           L     L +   L     + +  N    G+L  +    +  + +L +   N+     IP 
Sbjct: 12  LQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQ-TYRVNNLDLSGLNLPKPYPIPS 70

Query: 441 ELGNINNLTVIRLGNNE-LTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANL 499
            L N+  L  + +G    L G IP  + +L +L  LY+ +  + G+IP+ L  +  L  L
Sbjct: 71  SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130

Query: 500 YLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLL 559
               N LSG LP  + +L +L  ++   N ++  IP + +     L  +++ +    +  
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDS-YGSFSKLFTSMTISRNRLTGK 189

Query: 560 PDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFV 619
                  + +        +       + G                      G  K+LN +
Sbjct: 190 IPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGL 249

Query: 620 DMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSPK 679
           D+ NN + GT+P+ +  L +L  LN+SFN L GEIP  G    F   ++  N+ LCGSP 
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP- 308

Query: 680 LQVSPC 685
             +  C
Sbjct: 309 --LPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 75.9 bits (185), Expect = 3e-15
 Identities = 70/275 (25%), Positives = 110/275 (40%), Gaps = 14/275 (5%)

Query: 244 GNLTSVRNLFLGNNSLIG--EIPNEIGNLRNLEVLGVQSS-NLAGLIPASIFNISTLKEL 300
                V NL L   +L     IP+ + NL  L  L +    NL G IP +I  ++ L  L
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 301 AVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLI 360
            +T  ++           +  L  L    N  SGT+P S++++  L  + F  N  SG I
Sbjct: 107 YITHTNV-SGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165

Query: 361 PTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNF 420
           P ++G+   L           +            +  NL + ++  +       +S+   
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIP-------PTFANLNLAFVDLSRNMLEGDASVLFG 218

Query: 421 SISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNN 480
           S         + N       ++G   NL  + L NN + GT+P  L +L+ L  L +  N
Sbjct: 219 SDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278

Query: 481 KLEGSIPEDLCHLYRLANLYLGDNK-LSGR-LPAC 513
            L G IP+   +L R       +NK L G  LPAC
Sbjct: 279 NLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 72.5 bits (176), Expect = 3e-14
 Identities = 49/268 (18%), Positives = 92/268 (34%), Gaps = 15/268 (5%)

Query: 143 SLPRLQHLLLKHNSFVGK--IPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPV 200
              R+ +L L   +      IP ++  L  L         + G          +   L  
Sbjct: 48  QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN-----FLYIGGINNLVGPIPPAIAKLTQ 102

Query: 201 LEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLI 260
           L  L+I++  ++G IP  L + + L  +  ++N   G +P  I +L ++  +    N + 
Sbjct: 103 LHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162

Query: 261 GEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLP 320
           G IP+  G+   L      S N   L        + L    V  +  +    +S+  G  
Sbjct: 163 GAIPDSYGSFSKLFTSMTISRN--RLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSD 220

Query: 321 NLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVL 380
              +      N        +     L+ LD   N   G +P     L+ L  L+++ N L
Sbjct: 221 KNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280

Query: 381 TSPTPDLSFLSSLTSCRNLEIIYLSENP 408
               P         + +  ++   + N 
Sbjct: 281 CGEIP------QGGNLQRFDVSAYANNK 302

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 70.6 bits (171), Expect = 2e-13
 Identities = 64/283 (22%), Positives = 114/283 (40%), Gaps = 7/283 (2%)

Query: 350 DFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPI 409
           D    ++ G++  T      +  L L+G  L  P P  S L++L     L  +Y+     
Sbjct: 32  DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLP---YLNFLYIGGINN 88

Query: 410 NGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRL 469
                         +  L +   N+SG IP  L  I  L  +    N L+GT+P ++  L
Sbjct: 89  LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL 148

Query: 470 QKLQGLYLQNNKLEGSIPEDLCHLYRLA-NLYLGDNKLSGRLPACLGNLTSLRDLSLGSN 528
             L G+    N++ G+IP+      +L  ++ +  N+L+G++P               S 
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT--FANLNLAFVDLSR 206

Query: 529 ALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGG 588
            +     S L+      +    + +     L  +G  K +  +DL  N + G +P  +  
Sbjct: 207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQ 266

Query: 589 LQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIP 631
           L+ L  L++ +N L G IP+  G L+  +    +NN      P
Sbjct: 267 LKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 67.9 bits (164), Expect = 1e-12
 Identities = 53/283 (18%), Positives = 104/283 (36%), Gaps = 13/283 (4%)

Query: 330 NNFSGTIPSSLTNISELSVLDFGFNSFSGL--IPTTFGNLRSLKLLSLAGNVLTSPTPDL 387
             + G +  + T    ++ LD    +      IP++  NL  L  L + G          
Sbjct: 36  RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP--- 92

Query: 388 SFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINN 447
               ++     L  +Y++   ++G       +   ++ +L      +SG +P  + ++ N
Sbjct: 93  -IPPAIAKLTQLHYLYITHTNVSGA-IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150

Query: 448 LTVIRLGNNELTGTIPVTLGRLQKLQG-LYLQNNKLEGSIPEDLCHLYRLANLYLGDNKL 506
           L  I    N ++G IP + G   KL   + +  N+L G IP    +L         +   
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLE 210

Query: 507 SGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLK 566
                               +    +     +   K++   +L +N + G+L   +  LK
Sbjct: 211 GDASVLF--GSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLK 268

Query: 567 VVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQ--GPIP 607
            +  +++S N L G IP   G LQ   + +   N+     P+P
Sbjct: 269 FLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLP 310

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 62.5 bits (150), Expect = 7e-11
 Identities = 67/267 (25%), Positives = 105/267 (39%), Gaps = 11/267 (4%)

Query: 297 LKELAVTDNDLLGSLPSSIDLG-LPNLERLFLGEN-NFSGTIPSSLTNISELSVLDFGFN 354
           +  L ++  +L    P    L  LP L  L++G   N  G IP ++  +++L  L     
Sbjct: 52  VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111

Query: 355 SFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILP 414
           + SG IP     +++L  L  + N L+   P      S++S  NL  I    N I+G +P
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPP-----SISSLPNLVGITFDGNRISGAIP 166

Query: 415 SSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQG 474
            S G+FS    S+++    ++G IP      N        +  +       L    K   
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPT--FANLNLAFVDLSRNMLEGDASVLFGSDKNTQ 224

Query: 475 LYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSII 534
                          +     L  L L +N++ G LP  L  L  L  L++  N L   I
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284

Query: 535 PSTLWNLKDILRFNLSSNS-LNGSLLP 560
           P    NL+       ++N  L GS LP
Sbjct: 285 PQ-GGNLQRFDVSAYANNKCLCGSPLP 310

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 57.8 bits (138), Expect = 2e-09
 Identities = 23/94 (24%), Positives = 34/94 (36%), Gaps = 9/94 (9%)

Query: 125 YFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGT 184
                  N              L  L L++N   G +P+ +  L  L  L++S N L G 
Sbjct: 224 QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283

Query: 185 IPSSIFNISSCQNLPVLEGLFISYNQ-LTG-PIP 216
           IP          NL   +    + N+ L G P+P
Sbjct: 284 IPQG-------GNLQRFDVSAYANNKCLCGSPLP 310

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  105 bits (262), Expect = 8e-25
 Identities = 87/405 (21%), Positives = 135/405 (33%), Gaps = 44/405 (10%)

Query: 137 IPSWF--VSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISS 194
           I   F   +L      +L   +    + +T   L  +  L      +         +I  
Sbjct: 12  INQIFTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK--------SIDG 61

Query: 195 CQNLPVLEGLFISYNQLTGPIP-TNLWKCRELHV---------VSLAFNKFQGGIPRDIG 244
            + L  L  +  S NQLT   P  NL K  ++ +                  G    +  
Sbjct: 62  VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQ 121

Query: 245 NLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTD 304
                    L N + +    N I ++  L  L        G     +  ++ L  L   D
Sbjct: 122 ITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLD 181

Query: 305 NDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTF 364
                    S+   L NLE L    N  S   P     ++ L  L    N        T 
Sbjct: 182 ISSNKVSDISVLAKLTNLESLIATNNQISDITPL--GILTNLDELSLNGNQLKD--IGTL 237

Query: 365 GNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISM 424
            +L +L  L LA N +++  P       L+    L  + L  N I+ I P      +   
Sbjct: 238 ASLTNLTDLDLANNQISNLAP-------LSGLTKLTELKLGANQISNISP-----LAGLT 285

Query: 425 KSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEG 484
              ++E           + N+ NLT + L  N ++   P  +  L KLQ L+  NNK+  
Sbjct: 286 ALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD 343

Query: 485 SIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNA 529
                L +L  +  L  G N++S   P  L NLT +  L L   A
Sbjct: 344 --VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 384

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  103 bits (256), Expect = 5e-24
 Identities = 88/408 (21%), Positives = 161/408 (39%), Gaps = 38/408 (9%)

Query: 254 LGNNSLIGEIP-NEI---GNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLG 309
           LG+ ++  + P N+I     L       +  +N+   +  +  ++  +  L      +  
Sbjct: 1   LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI-- 56

Query: 310 SLPSSIDL--GLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNL 367
               SID    L NL ++    N  +   P  L N+++L  +    N  + + P      
Sbjct: 57  ---KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTN 111

Query: 368 RSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSL 427
            +   L         P  +L+ L+ L    N      + + +  +   S GN    +K L
Sbjct: 112 LTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPL 171

Query: 428 S-------MESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNN 480
           +       ++  +        L  + NL  +   NN+++   P+ +     L  L L  N
Sbjct: 172 ANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGN 229

Query: 481 KLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWN 540
           +L+      L  L  L +L L +N++S   P  L  LT L +L LG+N +++I P  L  
Sbjct: 230 QLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAG 283

Query: 541 LKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYN 600
           L  +    L+ N L       I NLK +  + L  N +S + P  +  L  LQ L    N
Sbjct: 284 LTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANN 339

Query: 601 RLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFN 648
           ++      S   L ++N++   +N +S   P  +  L+ +  L L+  
Sbjct: 340 KVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 99.3 bits (246), Expect = 1e-22
 Identities = 75/371 (20%), Positives = 136/371 (36%), Gaps = 51/371 (13%)

Query: 316 DLGLPNLERLFLGENNFSGTIP-SSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLS 374
           D  L    +  LG+ N + T+  + L  ++ L     G  S  G+       L +L  ++
Sbjct: 18  DTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGV-----EYLNNLTQIN 72

Query: 375 LAGNVLTSPTPDLSFLSSLTS------------------------------CRNLEIIYL 404
            + N LT  TP L  L+ L                                     +  L
Sbjct: 73  FSNNQLTDITP-LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 131

Query: 405 SENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPV 464
           +      +  ++I + S      S++  +    +       N  T+ RL  +    +   
Sbjct: 132 TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS 191

Query: 465 TLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLS 524
            L +L  L+ L   NN++    P  +     L  L L  N+L       L +LT+L DL 
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLD 247

Query: 525 LGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPV 584
           L +N ++++ P  L  L  +    L +N ++   +  +  L  +  ++L+ N        
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNEN--QLEDIS 301

Query: 585 TIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLN 644
            I  L+ L  L+L +N +    P     L  L  +  +NN +S     S+  L+ +  L+
Sbjct: 302 PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLS 357

Query: 645 LSFNQLEGEIP 655
              NQ+    P
Sbjct: 358 AGHNQISDLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 85.8 bits (211), Expect = 3e-18
 Identities = 66/354 (18%), Positives = 121/354 (34%), Gaps = 64/354 (18%)

Query: 74  RVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLP-EELSHLRGLKYFDFRFNN 132
           +VT L    LG+  +I   +  L+ L  +   NN      P + L+ L  +   + +  +
Sbjct: 45  QVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIAD 102

Query: 133 FHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQEL------------------ 174
                    ++   L +  +     +  +            +                  
Sbjct: 103 ITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFG 162

Query: 175 ----------DLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRE 224
                     +L+  +      + + +IS    L  LE L  + NQ++   P  +     
Sbjct: 163 NQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTN-- 220

Query: 225 LHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLA 284
           L  +SL  N+ +      + +LT++ +L L NN +    P  +  L  L  L + ++ ++
Sbjct: 221 LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 276

Query: 285 GLIPASIFNIST--------------------LKELAVTDNDLLGSLPSSIDLGLPNLER 324
            + P +     T                    L  L +  N++    P S    L  L+R
Sbjct: 277 NISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVS---SLTKLQR 333

Query: 325 LFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGN 378
           LF   N  S    SSL N++ ++ L  G N  S L P    NL  +  L L   
Sbjct: 334 LFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 56.2 bits (134), Expect = 1e-08
 Identities = 37/176 (21%), Positives = 61/176 (34%), Gaps = 18/176 (10%)

Query: 36  LALKEHIKHDPSNL--LANNWSTTSSVCSWIGVTCGVRNRRVTALNISYLGLTGTIPPQL 93
           L+L  +   D   L  L N      +      +       ++T L +    ++   P  L
Sbjct: 224 LSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISP--L 281

Query: 94  GNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLK 153
             L+ L  L +  N      P    +L+ L Y    FNN     P    SL +LQ L   
Sbjct: 282 AGLTALTNLELNENQLEDISPIS--NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFA 337

Query: 154 HNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYN 209
           +N        ++  L+ +  L    NQ+S   P +        NL  +  L ++  
Sbjct: 338 NNKVSD--VSSLANLTNINWLSAGHNQISDLTPLA--------NLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.0 bits (105), Expect = 4e-05
 Identities = 49/266 (18%), Positives = 97/266 (36%), Gaps = 32/266 (12%)

Query: 406 ENPINGILPSSIGNFSISMKSLSMESCNISGGIPK-ELGNINNLTVIRLGNNELTGTIPV 464
           + PIN I   +    +  MK   +   N++  + + +L  +  L   RLG   + G    
Sbjct: 9   DTPINQIFTDT--ALAEKMK-TVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG---- 61

Query: 465 TLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLS 524
            +  L  L  +   NN+L    P  L +L +L ++ + +N+++   P       +   L 
Sbjct: 62  -VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLF 118

Query: 525 LGSNALTSIIPSTLWNLKDILRFNL---------------SSNSLNGSLLPDIGNLKVVI 569
                    + +     +  L  N                 S     + L  + NL  + 
Sbjct: 119 NNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLE 178

Query: 570 EMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGT 629
            +D+S N         +  L  L+ L    N++    P       +L+ + ++ N L   
Sbjct: 179 RLDISSN--KVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD- 233

Query: 630 IPKSMEALSYLKHLNLSFNQLEGEIP 655
              ++ +L+ L  L+L+ NQ+    P
Sbjct: 234 -IGTLASLTNLTDLDLANNQISNLAP 258

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 97.4 bits (241), Expect = 1e-22
 Identities = 67/317 (21%), Positives = 108/317 (34%), Gaps = 36/317 (11%)

Query: 308 LGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNL 367
           L  +P  +    P+   L L  N  +        N+  L  L    N  S + P  F  L
Sbjct: 22  LEKVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPL 78

Query: 368 RSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMK-S 426
             L+ L L+ N L      +         + L+ + + EN I  +  S     +  +   
Sbjct: 79  VKLERLYLSKNQLKELPEKM--------PKTLQELRVHENEITKVRKSVFNGLNQMIVVE 130

Query: 427 LSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSI 486
           L       SG        +  L+ IR+ +  +T    +  G    L  L+L  NK+    
Sbjct: 131 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVD 187

Query: 487 PEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILR 546
              L  L  LA L L  N +S      L N   LR+L L +N L   +P  L + K I  
Sbjct: 188 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQV 246

Query: 547 FNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQ--G 604
             L +N+++                  ++ +     P           +SL  N +Q   
Sbjct: 247 VYLHNNNIS------------------AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 288

Query: 605 PIPESFGGLKSLNFVDM 621
             P +F  +     V +
Sbjct: 289 IQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 93.6 bits (231), Expect = 3e-21
 Identities = 50/261 (19%), Positives = 97/261 (37%), Gaps = 12/261 (4%)

Query: 397 RNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNN 456
            +  ++ L  N I  I      N   ++ +L + +  IS   P     +  L  + L  N
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLK-NLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89

Query: 457 ELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGN 516
           +L          LQ+L+    +  K+  S+   L  +  +  L     K SG        
Sbjct: 90  QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIENGAFQG 148

Query: 517 LTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLN 576
           +  L  + +    +T+I      +L ++   +L  N +       +  L  + ++ LS N
Sbjct: 149 MKKLSYIRIADTNITTIPQGLPPSLTEL---HLDGNKITKVDAASLKGLNNLAKLGLSFN 205

Query: 577 ALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSG------TI 630
           ++S V   ++     L+ L L  N+L   +P      K +  V + NNN+S         
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264

Query: 631 PKSMEALSYLKHLNLSFNQLE 651
           P      +    ++L  N ++
Sbjct: 265 PGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 89.7 bits (221), Expect = 6e-20
 Identities = 57/289 (19%), Positives = 103/289 (35%), Gaps = 32/289 (11%)

Query: 112 SLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLL 171
            +P++L         D + N         F +L  L  L+L +N      P     L  L
Sbjct: 24  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 172 QELDLSDNQLSG-----------------TIPSSIFNISSCQNLPVLEGLFISYNQLTGP 214
           + L LS NQL                    I     ++ +  N  ++  L  +  + +G 
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141

Query: 215 IPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLE 274
                   ++L  + +A       IP+  G   S+  L L  N +       +  L NL 
Sbjct: 142 ENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLA 198

Query: 275 VLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSG 334
            LG+  ++++ +   S+ N   L+EL + +N L+       D     ++ ++L  NN S 
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLAD--HKYIQVVYLHNNNISA 256

Query: 335 ------TIPSSLTNISELSVLDFGFN--SFSGLIPTTFGNLRSLKLLSL 375
                   P   T  +  S +    N   +  + P+TF  +     + L
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 83.9 bits (206), Expect = 5e-18
 Identities = 53/232 (22%), Positives = 88/232 (37%), Gaps = 7/232 (3%)

Query: 447 NLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKL 506
           +L V++  +  L   +P  L        L LQNNK+      D  +L  L  L L +NK+
Sbjct: 11  HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67

Query: 507 SGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLK 566
           S   P     L  L  L L  N L  +       L+++         +  S+   + N  
Sbjct: 68  SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL-NQM 126

Query: 567 VVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNL 626
           +V+E+  +    SG+      G++ L  + +    +   IP+      SL  + +  N +
Sbjct: 127 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKI 183

Query: 627 SGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSP 678
           +     S++ L+ L  L LSFN +               E  L N  L   P
Sbjct: 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP 235

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 57.0 bits (136), Expect = 4e-09
 Identities = 44/296 (14%), Positives = 82/296 (27%), Gaps = 73/296 (24%)

Query: 61  CSWIGVTCGVRN---------RRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFG 111
           C    V C                  L++    +T        NL  L  L + NN    
Sbjct: 10  CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69

Query: 112 SLPEELSHLRGLKYFDFR------------------------------------------ 129
             P   + L  L+                                               
Sbjct: 70  ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV 129

Query: 130 -----FNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGT 184
                           F  + +L ++ +   +    IP+  G    L EL L  N+++  
Sbjct: 130 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQ--GLPPSLTELHLDGNKITKV 186

Query: 185 IPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIG 244
             +S+        L  L  L +S+N ++     +L     L  + L  NK    +P  + 
Sbjct: 187 DAASLK------GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 239

Query: 245 NLTSVRNLFLGNNSLIG------EIPNEIGNLRNLEVLGVQSSNLAGL-IPASIFN 293
           +   ++ ++L NN++          P       +   + + S+ +    I  S F 
Sbjct: 240 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 295

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 90.6 bits (224), Expect = 3e-21
 Identities = 31/199 (15%), Positives = 64/199 (32%), Gaps = 24/199 (12%)

Query: 767 KLLGMGSFGSVYKGVLPDGMEIAAKVFHME----------FDGSLESFHAECKVMGSIRH 816
           KL+G G   +V+        E   K   +            D     F            
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 817 RNLVKIISSCSNNDFKALVLEYMSNGSL-EKCLYSDNYFLDILQRLKIMIDVASALEYLH 875
           R L K+        +      +  N  L E     + Y + +    +++  +   +   +
Sbjct: 66  RALQKLQGLAVPKVY-----AWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 876 FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGR 935
                 IVH D+   NVL++E  +  + DF  +  +G+E      +    +  +   + R
Sbjct: 121 ---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILER--DVRNIITYFSR 174

Query: 936 EGKVSRKCDVYSYGIMLME 954
                 + D+ S    +++
Sbjct: 175 --TYRTEKDINSAIDRILQ 191

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.0 bits (211), Expect = 8e-19
 Identities = 51/292 (17%), Positives = 87/292 (29%), Gaps = 15/292 (5%)

Query: 68  CGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFD 127
           C   N      +    GL   +P  +        + +  N             R L    
Sbjct: 6   CVCYNEPKVTTSCPQQGLQ-AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILW 62

Query: 128 FRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKI-PETIGYLSLLQELDLSDNQLSGTIP 186
              N       + F  L  L+ L L  N+ +  + P T   L  L  L L          
Sbjct: 63  LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG------ 116

Query: 187 SSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNL 246
                    + L  L+ L++  N L             L  + L  N+      R    L
Sbjct: 117 LQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGL 176

Query: 247 TSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDND 306
            S+  L L  N +    P+   +L  L  L + ++NL+ L   ++  +  L+ L + DN 
Sbjct: 177 HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNP 236

Query: 307 LLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSG 358
            +             L++     +    ++P  L       +     N   G
Sbjct: 237 WVCDCR--ARPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.2 bits (209), Expect = 1e-18
 Identities = 53/261 (20%), Positives = 99/261 (37%), Gaps = 9/261 (3%)

Query: 368 RSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSL 427
            + + + L GN ++          S  +CRNL I++L  N +  I  ++    ++  +  
Sbjct: 32  AASQRIFLHGNRISHVPAA-----SFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLD 86

Query: 428 SMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIP 487
             ++  +    P     +  L  + L    L    P     L  LQ LYLQ+N L+    
Sbjct: 87  LSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPD 146

Query: 488 EDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRF 547
           +    L  L +L+L  N++S         L SL  L L  N +  + P    +L  ++  
Sbjct: 147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL 206

Query: 548 NLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIP 607
            L +N+L+      +  L+ +  + L+ N               LQ      + +   +P
Sbjct: 207 YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLP 265

Query: 608 ESFGGLKSLNFVDMSNNNLSG 628
           +   G        ++ N+L G
Sbjct: 266 QRLAGRD---LKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.2 bits (196), Expect = 5e-17
 Identities = 59/270 (21%), Positives = 106/270 (39%), Gaps = 12/270 (4%)

Query: 239 IPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLK 298
           +P  I    + + +FL  N +           RNL +L + S+ LA +  A+   ++ L+
Sbjct: 26  VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 299 ELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSG 358
           +L ++DN  L S+  +   GL  L  L L         P     ++ L  L    N+   
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143

Query: 359 LIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIG 418
           L   TF +L +L  L L GN ++S         +     +L+ + L +N +  + P +  
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPER-----AFRGLHSLDRLLLHQNRVAHVHPHAFR 198

Query: 419 NFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQ 478
           +    M    + + N+S    + L  +  L  +RL +N               LQ     
Sbjct: 199 DLGRLMTL-YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGS 256

Query: 479 NNKLEGSIPEDLCHLYRLANLYLGDNKLSG 508
           ++++  S+P+ L          L  N L G
Sbjct: 257 SSEVPCSLPQRLAGRDL---KRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.2 bits (183), Expect = 3e-15
 Identities = 54/246 (21%), Positives = 95/246 (38%), Gaps = 5/246 (2%)

Query: 413 LPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKL 472
           +P  I     + + + +    IS           NLT++ L +N L          L  L
Sbjct: 26  VPVGIPA---ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 473 QGLYLQNNKLEGSI-PEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALT 531
           + L L +N    S+ P     L RL  L+L    L    P     L +L+ L L  NAL 
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142

Query: 532 SIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQG 591
           ++   T  +L ++    L  N ++         L  +  + L  N ++ V P     L  
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202

Query: 592 LQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLE 651
           L  L L  N L     E+   L++L ++ +++N        +    ++L+    S +++ 
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVP 261

Query: 652 GEIPTR 657
             +P R
Sbjct: 262 CSLPQR 267

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.8 bits (182), Expect = 4e-15
 Identities = 55/243 (22%), Positives = 86/243 (35%), Gaps = 3/243 (1%)

Query: 438 IPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLA 497
           +P  +        I L  N ++     +    + L  L+L +N L          L  L 
Sbjct: 26  VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 498 NLYLGDNKLSGRL-PACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNG 556
            L L DN     + PA    L  L  L L    L  + P     L  +    L  N+L  
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143

Query: 557 SLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSL 616
                  +L  +  + L  N +S V      GL  L  L L  NR+    P +F  L  L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203

Query: 617 NFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCG 676
             + +  NNLS    +++  L  L++L L+ N    +   R  +          ++  C 
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS 263

Query: 677 SPK 679
            P+
Sbjct: 264 LPQ 266

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.6 bits (145), Expect = 2e-10
 Identities = 35/177 (19%), Positives = 50/177 (28%), Gaps = 10/177 (5%)

Query: 61  CSWIGVTCGVRNRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHL 120
              +G         +  L +    L         +L  L  L +  N            L
Sbjct: 117 LQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGL 176

Query: 121 RGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQ 180
             L       N      P  F  L RL  L L  N+      E +  L  LQ L L+DN 
Sbjct: 177 HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNP 236

Query: 181 LSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQG 237
                 +             L+    S +++   +P  L       +  LA N  QG
Sbjct: 237 WVCDCRARPL-------WAWLQKFRGSSSEVPCSLPQRL---AGRDLKRLAANDLQG 283

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.7 bits (148), Expect = 7e-11
 Identities = 50/210 (23%), Positives = 74/210 (35%), Gaps = 7/210 (3%)

Query: 441 ELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLY 500
           E+  + +   +      LT  +P  L +      L+L  N L       L    RL  L 
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 501 LGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLP 560
           L   +L+         L  L  L L  N L S+              ++S N L    L 
Sbjct: 62  LDRAELTKLQVDG--TLPVLGTLDLSHNQLQSLPLLGQTLPALT-VLDVSFNRLTSLPLG 118

Query: 561 DIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVD 620
            +  L  + E+ L  N L  + P  +     L+ LSL  N L         GL++L+ + 
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178

Query: 621 MSNNNLSGTIPKSMEALSYLKHLNLSFNQL 650
           +  N+L  TIPK       L    L  N  
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.3 bits (142), Expect = 4e-10
 Identities = 45/191 (23%), Positives = 70/191 (36%), Gaps = 10/191 (5%)

Query: 438 IPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLA 497
           +P +L    + T++ L  N L      TL    +L  L L   +        L     L 
Sbjct: 25  LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE-----LTKLQVDGTLP 77

Query: 498 NLYL--GDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLN 555
            L      +     LP     L +L  L +  N LTS+    L  L ++    L  N L 
Sbjct: 78  VLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK 137

Query: 556 GSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKS 615
                 +     + ++ L+ N L+ +    + GL+ L  L L+ N L   IP+ F G   
Sbjct: 138 TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHL 196

Query: 616 LNFVDMSNNNL 626
           L F  +  N  
Sbjct: 197 LPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.9 bits (133), Expect = 7e-09
 Identities = 38/196 (19%), Positives = 56/196 (28%), Gaps = 12/196 (6%)

Query: 335 TIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLT 394
            +P  L    + ++L    N        T      L  L+L      +       L  L 
Sbjct: 24  ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL-DRAELTKLQVDGTLPVLG 80

Query: 395 SCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLG 454
           +         S   +             ++  L +    ++      L  +  L  + L 
Sbjct: 81  TLDLSHNQLQSLPLLG--------QTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLK 132

Query: 455 NNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACL 514
            NEL    P  L    KL+ L L NN L       L  L  L  L L +N L   +P   
Sbjct: 133 GNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGF 191

Query: 515 GNLTSLRDLSLGSNAL 530
                L    L  N  
Sbjct: 192 FGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.4 bits (124), Expect = 9e-08
 Identities = 44/219 (20%), Positives = 66/219 (30%), Gaps = 13/219 (5%)

Query: 192 ISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRN 251
           I     +     +      LT  +P +L K  +  ++ L+ N         +   T +  
Sbjct: 3   ICEVSKVASHLEVNCDKRNLTA-LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQ 59

Query: 252 LFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSL 311
           L L             G L  L  L +  + L  L        +          + L SL
Sbjct: 60  LNLDRAE--LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL--DVSFNRLTSL 115

Query: 312 PSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLK 371
           P     GL  L+ L+L  N      P  LT   +L  L    N+ + L       L +L 
Sbjct: 116 PLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD 175

Query: 372 LLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPIN 410
            L L  N L +          L         +L  NP  
Sbjct: 176 TLLLQENSLYTIPKGFFGSHLLPF------AFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.7 bits (117), Expect = 6e-07
 Identities = 45/209 (21%), Positives = 69/209 (33%), Gaps = 21/209 (10%)

Query: 116 ELSHLRGLKYFDFRFNNFHIEIPSWFVSLPR-LQHLLLKHNSFVGKIPETIGYLSLLQEL 174
           E+S +      +    N    +P     LP+    L L  N        T+   + L +L
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPP---DLPKDTTILHLSENLLYTFSLATLMPYTRLTQL 60

Query: 175 DLSDNQ---------------LSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNL 219
           +L   +               L  +           Q LP L  L +S+N+LT      L
Sbjct: 61  NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120

Query: 220 WKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQ 279
               EL  + L  N+ +   P  +     +  L L NN+L       +  L NL+ L + 
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL- 179

Query: 280 SSNLAGLIPASIFNISTLKELAVTDNDLL 308
             N    IP   F    L    +  N  L
Sbjct: 180 QENSLYTIPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.0 bits (97), Expect = 2e-04
 Identities = 19/76 (25%), Positives = 23/76 (30%), Gaps = 1/76 (1%)

Query: 106 NNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETI 165
            N      P  L+    L+      NN           L  L  LLL+ NS    IP+  
Sbjct: 133 GNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGF 191

Query: 166 GYLSLLQELDLSDNQL 181
               LL    L  N  
Sbjct: 192 FGSHLLPFAFLHGNPW 207

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.5 bits (127), Expect = 3e-08
 Identities = 41/219 (18%), Positives = 72/219 (32%), Gaps = 18/219 (8%)

Query: 316 DLGLPNLERLFLGENNFSGTIPSS-LTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLS 374
           D  L N  ++  G++N + T+  + L  I+ LS    G  +  G+       L +L  L 
Sbjct: 15  DPALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEGV-----QYLNNLIGLE 69

Query: 375 LAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSS--------IGNFSISMKS 426
           L  N +T   P  +         +   +             +             ++  S
Sbjct: 70  LKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLS 129

Query: 427 LSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSI 486
                      I           +  L       +    L  L KL  L   +NK+    
Sbjct: 130 NLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDIS 189

Query: 487 PEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSL 525
           P  L  L  L  ++L +N++S   P  L N ++L  ++L
Sbjct: 190 P--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 50.8 bits (120), Expect = 2e-07
 Identities = 41/220 (18%), Positives = 72/220 (32%), Gaps = 23/220 (10%)

Query: 444 NINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGD 503
            + N   I  G + +T    VT   L  +  L      +     E + +L  L  L L D
Sbjct: 17  ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 504 NKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIG 563
           N+++   P       +  +LS       S I          L     ++    + L ++ 
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 564 NLKVVIEMDLSLNAL--------------SGVIPVTIGGLQGLQLLSLRYNRLQGPIPES 609
            L + +    +++ L                     +  L  L  L    N++    P  
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190

Query: 610 FGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQ 649
              L +L  V + NN +S   P  +   S L  + L+ NQ
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT-NQ 227

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.2 bits (108), Expect = 8e-06
 Identities = 38/241 (15%), Positives = 71/241 (29%), Gaps = 27/241 (11%)

Query: 137 IPSWF--VSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISS 194
           I   F   +L     +    ++    + +    L  +  L      ++         I  
Sbjct: 9   INVIFPDPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT--------TIEG 58

Query: 195 CQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFL 254
            Q L  L GL +  NQ+         K                 +    G  +       
Sbjct: 59  VQYLNNLIGLELKDNQI---TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLT 115

Query: 255 GNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSS 314
                       + NL+ L +   Q +N++ L   +     ++    V+D   L +L   
Sbjct: 116 STQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLS-- 173

Query: 315 IDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLS 374
                  L  L   +N  S   P  L ++  L  +    N  S + P    N  +L +++
Sbjct: 174 ------KLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223

Query: 375 L 375
           L
Sbjct: 224 L 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 5e-04
 Identities = 30/212 (14%), Positives = 59/212 (27%), Gaps = 16/212 (7%)

Query: 73  RRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNN 132
                +      +T T+     +L  +  L+        +  E + +L  L   + + N 
Sbjct: 19  ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKDNQ 74

Query: 133 FHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNI 192
                P   ++      L       V  I       +L        +       S++  +
Sbjct: 75  ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134

Query: 193 SSCQNLPVLEGLFI--------SYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIG 244
               N                 S         T L    +L  +    NK     P  + 
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LA 192

Query: 245 NLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVL 276
           +L ++  + L NN +    P  + N  NL ++
Sbjct: 193 SLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 52.1 bits (123), Expect = 2e-07
 Identities = 21/90 (23%), Positives = 34/90 (37%), Gaps = 9/90 (10%)

Query: 432 CNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLC 491
              S  I        +L  + + NN+L   +P    RL++   L    N L   +PE   
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EVPELPQ 324

Query: 492 HLYRLANLYLGDNKLSGRLPACLGNLTSLR 521
           +   L  L++  N L    P    ++  LR
Sbjct: 325 N---LKQLHVEYNPLRE-FPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 51.4 bits (121), Expect = 3e-07
 Identities = 23/90 (25%), Positives = 34/90 (37%), Gaps = 10/90 (11%)

Query: 455 NNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACL 514
            N  +  I         L+ L + NNKL   +P     L R   L    N L+  +P   
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EVPELP 323

Query: 515 GNLTSLRDLSLGSNALTSI--IPSTLWNLK 542
            NL     L +  N L     IP ++ +L+
Sbjct: 324 QNLKQ---LHVEYNPLREFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 49.1 bits (115), Expect = 1e-06
 Identities = 21/94 (22%), Positives = 32/94 (34%), Gaps = 10/94 (10%)

Query: 476 YLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIP 535
               N     I         L  L + +NKL   LPA    L     L    N L   +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLAE-VP 320

Query: 536 STLWNLKDILRFNLSSNSLNG--SLLPDIGNLKV 567
               NLK +   ++  N L     +   + +L++
Sbjct: 321 ELPQNLKQL---HVEYNPLREFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.5 bits (111), Expect = 5e-06
 Identities = 19/82 (23%), Positives = 32/82 (39%), Gaps = 10/82 (12%)

Query: 291 IFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLD 350
                +L+EL V++N L       +    P LERL    N+ +  +P    N   L  L 
Sbjct: 280 CDLPPSLEELNVSNNKL-----IELPALPPRLERLIASFNHLA-EVPELPQN---LKQLH 330

Query: 351 FGFNSFSGLIPTTFGNLRSLKL 372
             +N      P    ++  L++
Sbjct: 331 VEYNPLREF-PDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.1 bits (110), Expect = 6e-06
 Identities = 24/85 (28%), Positives = 36/85 (42%), Gaps = 9/85 (10%)

Query: 571 MDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTI 630
               LNA S  I         L+ L++  N+L   +P     L+ L     S N+L+  +
Sbjct: 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERL---IASFNHLA-EV 319

Query: 631 PKSMEALSYLKHLNLSFNQLEGEIP 655
           P   E    LK L++ +N L  E P
Sbjct: 320 P---ELPQNLKQLHVEYNPLR-EFP 340

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.7 bits (109), Expect = 9e-06
 Identities = 22/104 (21%), Positives = 39/104 (37%), Gaps = 9/104 (8%)

Query: 491 CHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLS 550
             L  L       N  S  + +      SL +L++ +N L   +P+    L+   R   S
Sbjct: 257 SGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE---RLIAS 312

Query: 551 SNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQL 594
            N L   +     NLK   ++ +  N L    P     ++ L++
Sbjct: 313 FNHLA-EVPELPQNLK---QLHVEYNPLRE-FPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 45.6 bits (106), Expect = 2e-05
 Identities = 26/126 (20%), Positives = 47/126 (37%), Gaps = 15/126 (11%)

Query: 125 YFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGT 184
               +   F     + F  L  L   L   N+   +I         L+EL++S+N+L   
Sbjct: 240 PELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-E 298

Query: 185 IPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIG 244
           +P+             LE L  S+N L   +P      ++LH   + +N  +   P    
Sbjct: 299 LPALPPR---------LERLIASFNHLAE-VPELPQNLKQLH---VEYNPLR-EFPDIPE 344

Query: 245 NLTSVR 250
           ++  +R
Sbjct: 345 SVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 42.1 bits (97), Expect = 3e-04
 Identities = 19/94 (20%), Positives = 31/94 (32%), Gaps = 9/94 (9%)

Query: 205 FISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIP 264
               N  +  I +       L  ++++ NK    +P     L     L    N L  E+P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRL---ERLIASFNHL-AEVP 320

Query: 265 NEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLK 298
               NL+ L V      N     P    ++  L+
Sbjct: 321 ELPQNLKQLHV----EYNPLREFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.3 bits (95), Expect = 5e-04
 Identities = 15/74 (20%), Positives = 30/74 (40%), Gaps = 10/74 (13%)

Query: 423 SMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKL 482
           S++ L++ +  +   +P        L  +    N L   +P     L++L   +++ N L
Sbjct: 285 SLEELNVSNNKLIE-LPALPPR---LERLIASFNHLA-EVPELPQNLKQL---HVEYNPL 336

Query: 483 EG--SIPEDLCHLY 494
                IPE +  L 
Sbjct: 337 REFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.4 bits (90), Expect = 0.002
 Identities = 46/331 (13%), Positives = 87/331 (26%), Gaps = 24/331 (7%)

Query: 99  LAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFV 158
              L + N     SLPE   HL  L       N+   E+P    SL  L        +  
Sbjct: 40  AHELELNNLGL-SSLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKALS 94

Query: 159 GKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTN 218
              P          +L+      + +    I   ++           + +          
Sbjct: 95  DLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEE 154

Query: 219 LWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGV 278
           L + + L  ++  +             L+    +   N          +  L  +     
Sbjct: 155 LPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNN 214

Query: 279 ----QSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSG 334
                      L   ++ +        +  +     +  +I  GL  L       N  S 
Sbjct: 215 LLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSN 274

Query: 335 TIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLT 394
            I S       L  L+   N     +P     L     L  + N L              
Sbjct: 275 EIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLER---LIASFNHLAEVPELPQ------ 324

Query: 395 SCRNLEIIYLSENPINGI--LPSSIGNFSIS 423
              NL+ +++  NP+     +P S+ +  ++
Sbjct: 325 ---NLKQLHVEYNPLREFPDIPESVEDLRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 38.7 bits (88), Expect = 0.003
 Identities = 19/98 (19%), Positives = 35/98 (35%), Gaps = 15/98 (15%)

Query: 351 FGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPIN 410
           +  N+ S  I +      SL+ L+++ N L                  LE +  S N + 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPP---------RLERLIASFNHLA 317

Query: 411 GILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNL 448
            + P    N    +K L +E   +    P    ++ +L
Sbjct: 318 EV-PELPQN----LKQLHVEYNPLR-EFPDIPESVEDL 349

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 46.6 bits (110), Expect = 1e-06
 Identities = 27/128 (21%), Positives = 49/128 (38%), Gaps = 12/128 (9%)

Query: 425 KSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEG 484
           + L +   +++  +   L  +  +T + L +N L    P  L  L+ L+ L   +N LE 
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57

Query: 485 SIPEDLCHLYRLANLYLGDNKL-SGRLPACLGNLTSLRDLSLGSNALTSI------IPST 537
                     +   L L +N+L        L +   L  L+L  N+L         +   
Sbjct: 58  VDGVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115

Query: 538 LWNLKDIL 545
           L ++  IL
Sbjct: 116 LPSVSSIL 123

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.5 bits (107), Expect = 2e-06
 Identities = 31/125 (24%), Positives = 45/125 (36%), Gaps = 6/125 (4%)

Query: 521 RDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSG 580
           R L L    LT +    L  L  +   +LS N L     P +  L+ +  +  S NAL  
Sbjct: 1   RVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALP-PALAALRCLEVLQASDNALEN 57

Query: 581 VIPVTIGGLQGLQLLSLRYNRLQG-PIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSY 639
           V  V       LQ L L  NRLQ     +       L  +++  N+L             
Sbjct: 58  VDGVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115

Query: 640 LKHLN 644
           L  ++
Sbjct: 116 LPSVS 120

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 44.3 bits (104), Expect = 5e-06
 Identities = 28/129 (21%), Positives = 47/129 (36%), Gaps = 9/129 (6%)

Query: 78  LNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEI 137
           L++++  LT  +   L  L  +  L + +N      P  L+ LR L+      N      
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALENVD 59

Query: 138 PSWFVSLPRLQHLLLKHNSFVG-KIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQ 196
               +  PRLQ LLL +N        + +     L  L+L  N L          ++   
Sbjct: 60  GVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAE-- 114

Query: 197 NLPVLEGLF 205
            LP +  + 
Sbjct: 115 MLPSVSSIL 123

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.2 bits (101), Expect = 2e-05
 Identities = 26/112 (23%), Positives = 46/112 (41%), Gaps = 6/112 (5%)

Query: 548 NLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIP 607
           +L+   L  ++L  +  L +V  +DLS N L  + P  +  L+   L  L+ +       
Sbjct: 4   HLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALR--CLEVLQASDNALENV 58

Query: 608 ESFGGLKSLNFVDMSNNNLSGT-IPKSMEALSYLKHLNLSFNQLEGEIPTRG 658
           +    L  L  + + NN L  +   + + +   L  LNL  N L  E   + 
Sbjct: 59  DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQE 110

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.2 bits (101), Expect = 2e-05
 Identities = 25/130 (19%), Positives = 47/130 (36%), Gaps = 12/130 (9%)

Query: 172 QELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLA 231
           + L L+   L+         +   + L ++  L +S+N+L    P  L   R L V+   
Sbjct: 1   RVLHLAHKDLT--------VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ-- 49

Query: 232 FNKFQGGIPRDIGNLTSVRNLFLGNNSLIG-EIPNEIGNLRNLEVLGVQSSNLAGLIPAS 290
            +         + NL  ++ L L NN L        + +   L +L +Q ++L       
Sbjct: 50  ASDNALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 109

Query: 291 IFNISTLKEL 300
                 L  +
Sbjct: 110 ERLAEMLPSV 119

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 41.2 bits (96), Expect = 6e-05
 Identities = 18/114 (15%), Positives = 37/114 (32%), Gaps = 12/114 (10%)

Query: 348 VLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSEN 407
           VL       + L       L  +  L L+ N L +  P L+ L  L   +  +    + +
Sbjct: 2   VLHLAHKDLTVLCH--LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59

Query: 408 PINGILPSSIGNFSISMKSLSMESCNISGG-IPKELGNINNLTVIRLGNNELTG 460
            +              ++ L + +  +      + L +   L ++ L  N L  
Sbjct: 60  GV---------ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 39.3 bits (91), Expect = 4e-04
 Identities = 24/113 (21%), Positives = 42/113 (37%), Gaps = 10/113 (8%)

Query: 101 VLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGK 160
           VL + +     ++   L  L  + + D   N      P+   +L  L+ L    N+   +
Sbjct: 2   VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNAL--E 56

Query: 161 IPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTG 213
             + +  L  LQEL L +N+L  +            + P L  L +  N L  
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPL-----VSCPRLVLLNLQGNSLCQ 104

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.6 bits (114), Expect = 2e-06
 Identities = 36/285 (12%), Positives = 92/285 (32%), Gaps = 20/285 (7%)

Query: 324 RLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSP 383
            L L   N    +   L +   +       +     +   F   R ++ + L+ +V+   
Sbjct: 4   TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIE-- 59

Query: 384 TPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKE-- 441
               +    L+ C  L+ + L    ++  + +++   S ++  L++  C+       +  
Sbjct: 60  --VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNS-NLVRLNLSGCSGFSEFALQTL 116

Query: 442 ------LGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYR 495
                 L  +N           +   +      + +L     + N  +  +   +     
Sbjct: 117 LSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPN 176

Query: 496 LANLYLGDN-KLSGRLPACLGNLTSLRDLSL-GSNALTSIIPSTLWNLKDILRFNLSSNS 553
           L +L L D+  L          L  L+ LSL     +       L  +  +    +    
Sbjct: 177 LVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIV 236

Query: 554 LNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLR 598
            +G+L      L     + ++ +  + +   TIG  +  ++  ++
Sbjct: 237 PDGTLQLLKEALP---HLQINCSHFTTIARPTIGNKKNQEIWGIK 278

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.2 bits (113), Expect = 2e-06
 Identities = 42/294 (14%), Positives = 82/294 (27%), Gaps = 32/294 (10%)

Query: 127 DFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIP 186
           D    N H ++    +S   +       +     + E      + Q +DLS++ +  +  
Sbjct: 6   DLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFSPFRV-QHMDLSNSVIEVSTL 63

Query: 187 SSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNL 246
             I +         L+ L +   +L+ PI   L K   L  ++L+               
Sbjct: 64  HGILS-----QCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS 118

Query: 247 TSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDND 306
           +  R   L  +         +          +   NL+G       +  +       +  
Sbjct: 119 SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV 178

Query: 307 LLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDF-GFNSFSGLIPTTFG 365
            L    S                             ++ L  L                G
Sbjct: 179 HLDLSDS----------------VMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELG 222

Query: 366 NLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGN 419
            + +LK L + G V     PD +      +  +L+I   + +    I   +IGN
Sbjct: 223 EIPTLKTLQVFGIV-----PDGTLQLLKEALPHLQI---NCSHFTTIARPTIGN 268

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.2 bits (95), Expect = 4e-04
 Identities = 18/86 (20%), Positives = 38/86 (44%), Gaps = 3/86 (3%)

Query: 571 MDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSG-T 629
           +DL+   L   +   +   QG+       + +  P+ E F   + +  +D+SN+ +   T
Sbjct: 5   LDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVST 62

Query: 630 IPKSMEALSYLKHLNLSFNQLEGEIP 655
           +   +   S L++L+L   +L   I 
Sbjct: 63  LHGILSQCSKLQNLSLEGLRLSDPIV 88

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.2 bits (115), Expect = 2e-06
 Identities = 18/93 (19%), Positives = 35/93 (37%), Gaps = 5/93 (5%)

Query: 421 SISMKSLSMESCNIS-GGIPKELGNINNLTVIRLGNNELTG----TIPVTLGRLQKLQGL 475
           S+ ++SL ++   +S     + L  +    V+RL +  LT      I   L     L  L
Sbjct: 1   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60

Query: 476 YLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSG 508
            L++N+L       +    +  +  +    L  
Sbjct: 61  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 1e-05
 Identities = 21/113 (18%), Positives = 32/113 (28%), Gaps = 9/113 (7%)

Query: 125 YFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSF----VGKIPETIGYLSLLQELDLSDNQ 180
                                 L+ L L            +  T+     L+ELDLS+N 
Sbjct: 349 NNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 408

Query: 181 LSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNL----WKCRELHVVS 229
           L       +   S  Q   +LE L +     +  +   L         L V+S
Sbjct: 409 LGDAGILQLVE-SVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.5 bits (108), Expect = 1e-05
 Identities = 18/90 (20%), Positives = 34/90 (37%), Gaps = 5/90 (5%)

Query: 472 LQGLYLQNNKLEGSIPEDLC-HLYRLANLYLGDNKLSGR----LPACLGNLTSLRDLSLG 526
           +Q L +Q  +L  +   +L   L +   + L D  L+      + + L    +L +L+L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 527 SNALTSIIPSTLWNLKDILRFNLSSNSLNG 556
           SN L  +    +          +   SL  
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (107), Expect = 2e-05
 Identities = 18/96 (18%), Positives = 36/96 (37%), Gaps = 9/96 (9%)

Query: 364 FGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGI----LPSSIGN 419
                 L++L LA   ++  +   S  ++L +  +L  + LS N +       L  S+  
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCS-SLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 423

Query: 420 FSISMKSLSMESCNISGGIPKELGNI----NNLTVI 451
               ++ L +     S  +   L  +     +L VI
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (107), Expect = 2e-05
 Identities = 14/69 (20%), Positives = 24/69 (34%), Gaps = 5/69 (7%)

Query: 592 LQLLSLRYNRLQ-GPIPESFGGLKSLNFVDMSNNNLSG----TIPKSMEALSYLKHLNLS 646
           +Q L ++   L      E    L+    V + +  L+      I  ++     L  LNL 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 647 FNQLEGEIP 655
            N+L     
Sbjct: 64  SNELGDVGV 72

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (104), Expect = 4e-05
 Identities = 11/81 (13%), Positives = 21/81 (25%), Gaps = 5/81 (6%)

Query: 123 LKYFDFRFNNF-HIEIPSWFVSLPRLQHLLLKHNSF----VGKIPETIGYLSLLQELDLS 177
           ++  D +               L + Q + L            I   +     L EL+L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 178 DNQLSGTIPSSIFNISSCQNL 198
            N+L       +       + 
Sbjct: 64  SNELGDVGVHCVLQGLQTPSC 84

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 5e-05
 Identities = 15/93 (16%), Positives = 30/93 (32%), Gaps = 9/93 (9%)

Query: 171 LQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTG----PIPTNLWKCRELH 226
           +Q LD+   +LS    + +        L   + + +    LT      I + L     L 
Sbjct: 4   IQSLDIQCEELSDARWAEL-----LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALA 58

Query: 227 VVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSL 259
            ++L  N+        +       +  +   SL
Sbjct: 59  ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSL 91

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 6e-05
 Identities = 23/94 (24%), Positives = 35/94 (37%), Gaps = 13/94 (13%)

Query: 444 NINNLTVIRLGNNELTGT----IPVTLGRLQKLQGLYLQNNKLEGSIPEDLC-----HLY 494
             + L V+ L + +++ +    +  TL     L+ L L NN L  +    L         
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 495 RLANLYLGDNKLSGRLPACLGNL----TSLRDLS 524
            L  L L D   S  +   L  L     SLR +S
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 7e-05
 Identities = 13/93 (13%), Positives = 29/93 (31%), Gaps = 3/93 (3%)

Query: 345 ELSVLDFGFNSFSGL-IPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIY 403
           ++  LD      S          L+  +++ L    LT         S+L     L  + 
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCK-DISSALRVNPALAELN 61

Query: 404 LSENPINGILPSSIGNFSISMKSLSMESCNISG 436
           L  N +  +    +    +   S  ++  ++  
Sbjct: 62  LRSNELGDVGVHCVLQ-GLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.8 bits (101), Expect = 9e-05
 Identities = 15/96 (15%), Positives = 34/96 (35%), Gaps = 13/96 (13%)

Query: 564 NLKVVIEMDLSLNALSGV-IPVTIGGLQGLQLLSLRYNRLQG----PIPESFGGLKSLNF 618
           +++    +D+    LS       +  LQ  Q++ L    L       I  +     +L  
Sbjct: 3   DIQ---SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59

Query: 619 VDMSNNNLSGTIPKSM-EALSY----LKHLNLSFNQ 649
           +++ +N L       + + L      ++ L+L    
Sbjct: 60  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 1e-04
 Identities = 10/99 (10%), Positives = 32/99 (32%), Gaps = 4/99 (4%)

Query: 398 NLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISG----GIPKELGNINNLTVIRL 453
           +++ + +    ++    + +       + + ++ C ++      I   L     L  + L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 454 GNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCH 492
            +NEL       + +  +     +Q   L+         
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC 101

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 2e-04
 Identities = 15/73 (20%), Positives = 27/73 (36%), Gaps = 9/73 (12%)

Query: 592 LQLLSLRYNRLQG----PIPESFGGLKSLNFVDMSNNNLSGTIPKSM-EAL----SYLKH 642
           L++L L    +       +  +     SL  +D+SNN L       + E++      L+ 
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430

Query: 643 LNLSFNQLEGEIP 655
           L L       E+ 
Sbjct: 431 LVLYDIYWSEEME 443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 0.001
 Identities = 10/83 (12%), Positives = 26/83 (31%), Gaps = 4/83 (4%)

Query: 297 LKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSG----TIPSSLTNISELSVLDFG 352
           ++ L +   +L  +  + +   L   + + L +   +      I S+L     L+ L+  
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 353 FNSFSGLIPTTFGNLRSLKLLSL 375
            N    +               +
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKI 86

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 0.002
 Identities = 15/82 (18%), Positives = 31/82 (37%), Gaps = 9/82 (10%)

Query: 423 SMKSLSMESCNISG----GIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQK-----LQ 473
            ++ L +  C++S      +   L   ++L  + L NN L     + L    +     L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 474 GLYLQNNKLEGSIPEDLCHLYR 495
            L L +      + + L  L +
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEK 451

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.7 bits (112), Expect = 2e-06
 Identities = 43/206 (20%), Positives = 78/206 (37%), Gaps = 17/206 (8%)

Query: 444 NINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGD 503
                    L    +T    VT   L  +  +   N+ ++      + +L  +  L+L  
Sbjct: 22  AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 504 NKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIG 563
           NKL+      L NL +L  L L  N     +             +LS      S +  + 
Sbjct: 78  NKLTD--IKPLANLKNLGWLFLDEN----KVKDLSSLKDLKKLKSLSLEHNGISDINGLV 131

Query: 564 NLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSN 623
           +L  +  + L  N ++ +  ++   L  L  LSL  N++   +P    GL  L  + +S 
Sbjct: 132 HLPQLESLYLGNNKITDITVLSR--LTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187

Query: 624 NNLSGTIPKSMEALSYLKHLNLSFNQ 649
           N++S    +++  L  L  L L  +Q
Sbjct: 188 NHISD--LRALAGLKNLDVLELF-SQ 210

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.8 bits (102), Expect = 3e-05
 Identities = 51/224 (22%), Positives = 91/224 (40%), Gaps = 29/224 (12%)

Query: 310 SLPSSI-----DLGLPNLERLFLGENNFSGTIPSS-LTNISELSVLDFGFNSFSGLIPTT 363
           ++P+ I     D       +  L + + +  +  + L +I ++   +    S  G+    
Sbjct: 9   TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGI---- 64

Query: 364 FGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSIS 423
              L ++  L L GN LT        L++L +             ++      + +    
Sbjct: 65  -QYLPNVTKLFLNGNKLTDIK----PLANLKNLG--------WLFLDENKVKDLSSLKDL 111

Query: 424 MKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLE 483
            K  S+   +        L ++  L  + LGNN++T    ++  RL KL  L L++N++ 
Sbjct: 112 KKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS 169

Query: 484 GSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGS 527
             +P  L  L +L NLYL  N +S  L A L  L +L  L L S
Sbjct: 170 DIVP--LAGLTKLQNLYLSKNHISD-LRA-LAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 4e-04
 Identities = 44/223 (19%), Positives = 76/223 (34%), Gaps = 24/223 (10%)

Query: 184 TIPSSIFNISSCQNLPVLEGLFISYNQLTGPIP-TNLWKCRELHVVSLAFNKFQGGIPRD 242
           T+P+ I  I S           +    +T  +    L    ++   +      QG     
Sbjct: 9   TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQG----- 63

Query: 243 IGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAV 302
           I  L +V  LFL  N L       + NL+NL  L +  + +  L             L  
Sbjct: 64  IQYLPNVTKLFLNGNKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEH 121

Query: 303 TDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPT 362
                +  L           +   L   N   T  + L+ +++L  L    N  S ++P 
Sbjct: 122 NGISDINGLV-------HLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP- 173

Query: 363 TFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLS 405
               L  L+ L L+ N ++        L +L   +NL+++ L 
Sbjct: 174 -LAGLTKLQNLYLSKNHISD-------LRALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 4e-04
 Identities = 37/213 (17%), Positives = 71/213 (33%), Gaps = 22/213 (10%)

Query: 339 SLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRN 398
           S    +E    +    S +  +      L S+  +    + + S       +  +    N
Sbjct: 19  SDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-------VQGIQYLPN 69

Query: 399 LEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNEL 458
           +  ++L+ N +  I P +         +L             +  +           +  
Sbjct: 70  VTKLFLNGNKLTDIKPLA---------NLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLE 120

Query: 459 TGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLT 518
              I    G +   Q   L     + +    L  L +L  L L DN++S  +P  L  LT
Sbjct: 121 HNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLT 178

Query: 519 SLRDLSLGSNALTSIIPSTLWNLKDILRFNLSS 551
            L++L L  N ++ +    L  LK++    L S
Sbjct: 179 KLQNLYLSKNHISDL--RALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 6e-04
 Identities = 35/217 (16%), Positives = 75/217 (34%), Gaps = 25/217 (11%)

Query: 136 EIPSWF--VSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNIS 193
            I   F   +        LK  S    + +    L+ + ++  +++ +         ++ 
Sbjct: 13  PIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK--------SVQ 62

Query: 194 SCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLF 253
             Q LP +  LF++ N+LT   P    K                   +     +      
Sbjct: 63  GIQYLPNVTKLFLNGNKLTDIKPLANLKN---------LGWLFLDENKVKDLSSLKDLKK 113

Query: 254 LGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPS 313
           L + SL     ++I  L +L  L         +   ++ +  T  +    +++ +  +  
Sbjct: 114 LKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP 173

Query: 314 SIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLD 350
               GL  L+ L+L +N+ S     +L  +  L VL+
Sbjct: 174 LA--GLTKLQNLYLSKNHISD--LRALAGLKNLDVLE 206

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 45.6 bits (106), Expect = 7e-06
 Identities = 38/175 (21%), Positives = 71/175 (40%), Gaps = 7/175 (4%)

Query: 438 IPKELGNINNLTVIRLGNNELTGTIPVTL-GRLQKLQGLYLQNNKLEGSIPEDLCHLYRL 496
           IP+++    + T + L +NEL       L GRL  L  L L+ N+L G  P        +
Sbjct: 23  IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80

Query: 497 ANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNG 556
             L LG+NK+          L  L+ L+L  N ++ ++P +  +L   L     +++   
Sbjct: 81  QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS-LTSLNLASNPFN 139

Query: 557 SLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFG 611
                    + + +  L+  A     P     ++ +Q+  L ++  +     S G
Sbjct: 140 CNCHLAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKCSSENSEG 191

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 42.5 bits (98), Expect = 8e-05
 Identities = 40/173 (23%), Positives = 68/173 (39%), Gaps = 12/173 (6%)

Query: 287 IPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISEL 346
           IP  I       EL + DN+L       +   LP+L +L L  N  +G  P++    S +
Sbjct: 23  IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80

Query: 347 SVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSE 406
             L  G N    +    F  L  LK L+L  N ++   P      S     +L  + L+ 
Sbjct: 81  QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPG-----SFEHLNSLTSLNLAS 135

Query: 407 NPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELT 459
           NP N      +  F+  ++  S+       G P ++    ++ +  L ++E  
Sbjct: 136 NPFNCNCH--LAWFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFK 183

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 39.8 bits (91), Expect = 7e-04
 Identities = 39/164 (23%), Positives = 62/164 (37%), Gaps = 8/164 (4%)

Query: 519 SLRDLSLGSNALTSI---IPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSL 575
               +      L  I   IP     L  +L  N      +  L   + +L  +       
Sbjct: 9   EGTTVDCTGRGLKEIPRDIPLHTTEL--LLNDNELGRISSDGLFGRLPHLVKLELKR--- 63

Query: 576 NALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSME 635
           N L+G+ P    G   +Q L L  N+++    + F GL  L  +++ +N +S  +P S E
Sbjct: 64  NQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFE 123

Query: 636 ALSYLKHLNLSFNQLEGEIPTRGPFITFSAESFLGNQALCGSPK 679
            L+ L  LNL+ N                 +S  G  A CG+P 
Sbjct: 124 HLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS 167

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 38.2 bits (87), Expect = 0.002
 Identities = 17/110 (15%), Positives = 31/110 (28%), Gaps = 8/110 (7%)

Query: 86  TGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLP 145
                     L  L  L + +N     +P    HL  L   +   N F+      + +  
Sbjct: 91  KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEW 150

Query: 146 RLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSC 195
             +  L    +     P     +  +Q  DL  ++   +      N   C
Sbjct: 151 LRKKSL-NGGAARCGAPSK---VRDVQIKDLPHSEFKCSSE----NSEGC 192

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (107), Expect = 9e-06
 Identities = 29/219 (13%), Positives = 56/219 (25%), Gaps = 4/219 (1%)

Query: 335 TIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLT 394
            IPS L        L F       +    F     L+ + ++ N +        F +   
Sbjct: 22  EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79

Query: 395 SCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLG 454
                       N +     +     ++    +S         + K       L  I+  
Sbjct: 80  LHEIRIEKA--NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN 137

Query: 455 NNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACL 514
            N  T      +G   +   L+L  N ++                   +N L        
Sbjct: 138 INIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVF 197

Query: 515 GNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNS 553
              +    L +    + S+    L NLK +   +  +  
Sbjct: 198 HGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.0 bits (94), Expect = 4e-04
 Identities = 26/223 (11%), Positives = 60/223 (26%), Gaps = 9/223 (4%)

Query: 438 IPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLA 497
           IP +L    N   +R    +L             L+ + +  N +   I  D+       
Sbjct: 23  IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80

Query: 498 NLYLGDNKLSGRLPACLGNLTSLRDLSLGSNA--LTSIIPSTLWNLKDILRFNLSSNSLN 555
           +    +   +                 L  +   +  +      +    +  ++  N   
Sbjct: 81  HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140

Query: 556 GSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYN-RLQGPIP-ESFGGL 613
            ++  +         + L LN                       +      +P + F G 
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200

Query: 614 KSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPT 656
                +D+S   +       +E L  L+  +     L+ ++PT
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.9 bits (91), Expect = 8e-04
 Identities = 20/225 (8%), Positives = 42/225 (18%), Gaps = 11/225 (4%)

Query: 61  CSWIGVTCGVRN---------RRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFG 111
           CS     C             R    L      L             L  + I  N    
Sbjct: 8   CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67

Query: 112 SLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLL 171
            +  ++                   +        +    L         I        + 
Sbjct: 68  VIEADVFSNL--PKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125

Query: 172 QELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLA 231
               +  +        +I   S          L+++ N +           +   +    
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185

Query: 232 FNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVL 276
            N  +          +    L +    +       + NL+ L   
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR 230

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.1 bits (89), Expect = 0.002
 Identities = 24/226 (10%), Positives = 56/226 (24%), Gaps = 7/226 (3%)

Query: 308 LGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNL 367
           +  +PS +     N   L             + +   +L  ++   N    +I     + 
Sbjct: 20  VTEIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSN 76

Query: 368 RSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSL 427
                         +    ++  +         ++  +    +      I +    +  +
Sbjct: 77  LPKL--HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDI 134

Query: 428 SMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIP 487
                  +      +G      ++ L  N +           Q  +     NN LE    
Sbjct: 135 QDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPN 194

Query: 488 EDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSI 533
           +          L +   ++       L NL  LR  S     L  +
Sbjct: 195 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKL 238

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.9 bits (105), Expect = 9e-06
 Identities = 26/146 (17%), Positives = 48/146 (32%), Gaps = 13/146 (8%)

Query: 135 IEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISS 194
           IE  + + +  R + L L+       I      L     +D SDN+        I  +  
Sbjct: 8   IEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNE--------IRKLDG 58

Query: 195 CQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQG-GIPRDIGNLTSVRNLF 253
              L  L+ L ++ N++            +L  + L  N     G    + +L S+  L 
Sbjct: 59  FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLC 118

Query: 254 LGN---NSLIGEIPNEIGNLRNLEVL 276
           +      +        I  +  + VL
Sbjct: 119 ILRNPVTNKKHYRLYVIYKVPQVRVL 144

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (93), Expect = 3e-04
 Identities = 22/129 (17%), Positives = 44/129 (34%), Gaps = 4/129 (3%)

Query: 516 NLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSL 575
           N    R+L L    +   I +    L      + S N +    L     L+ +  + ++ 
Sbjct: 16  NAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK--LDGFPLLRRLKTLLVNN 72

Query: 576 NALSGVIPVTIGGLQGLQLLSLRYNRLQG-PIPESFGGLKSLNFVDMSNNNLSGTIPKSM 634
           N +  +       L  L  L L  N L      +    LKSL ++ +  N ++      +
Sbjct: 73  NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRL 132

Query: 635 EALSYLKHL 643
             +  +  +
Sbjct: 133 YVIYKVPQV 141

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.1 bits (98), Expect = 7e-05
 Identities = 31/150 (20%), Positives = 49/150 (32%), Gaps = 16/150 (10%)

Query: 72  NRRVTALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFN 131
           +    AL++  L       P L   +   VL  R++    +L     ++  L   +   N
Sbjct: 21  DGSQQALDLKGL----RSDPDLVAQNIDVVLNRRSS-MAATLRIIEENIPELLSLNLSNN 75

Query: 132 NF--HIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSS- 188
                 ++ S     P L+ L L  N    +          L+EL L  N LS T     
Sbjct: 76  RLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQS 135

Query: 189 ---IFNISSCQNLPVLEGLFISYNQLTGPI 215
                       L  L+G     ++L  PI
Sbjct: 136 TYISAIRERFPKLLRLDG-----HELPPPI 160

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.6 bits (94), Expect = 3e-04
 Identities = 28/146 (19%), Positives = 57/146 (39%), Gaps = 8/146 (5%)

Query: 530 LTSIIPSTLWNLKDIL--RFNLSSNSLNGS---LLPDIGNLKVVIEMDLSLNALSGVIPV 584
           L  + P  +  LK I+  R++ S  +L+       PD+    + + ++   ++++  + +
Sbjct: 1   LNELKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRR-SSMAATLRI 59

Query: 585 TIGGLQGLQLLSLRYNRLQG--PIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKH 642
               +  L  L+L  NRL     +        +L  +++S N L             L+ 
Sbjct: 60  IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119

Query: 643 LNLSFNQLEGEIPTRGPFITFSAESF 668
           L L  N L      +  +I+   E F
Sbjct: 120 LWLDGNSLSDTFRDQSTYISAIRERF 145

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 6e-04
 Identities = 39/203 (19%), Positives = 69/203 (33%), Gaps = 21/203 (10%)

Query: 341 TNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLE 400
           T ++E      G  + +  +  +  +L  +  L      + S       +  +    NL 
Sbjct: 15  TALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS-------IDGVEYLNNLT 65

Query: 401 IIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTG 460
            I  S N +            +   +  ++    +  I       N   +  L       
Sbjct: 66  QINFSNNQLTD-------ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQI 118

Query: 461 TIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSL 520
           T    L  L  L  L L +N +       L  L  L  L    N+++   P  L NLT+L
Sbjct: 119 TDIDPLKNLTNLNRLELSSNTIS--DISALSGLTSLQQLNFSSNQVTDLKP--LANLTTL 174

Query: 521 RDLSLGSNALTSI-IPSTLWNLK 542
             L + SN ++ I + + L NL+
Sbjct: 175 ERLDISSNKVSDISVLAKLTNLE 197

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.5 bits (90), Expect = 0.002
 Identities = 44/316 (13%), Positives = 88/316 (27%), Gaps = 36/316 (11%)

Query: 368 RSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSL 427
           +SLKL ++      S        + L    +++ I LS N I       +     S K L
Sbjct: 8   KSLKLDAITTEDEKS------VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDL 61

Query: 428 S------MESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNK 481
                  + +  +   IP+ L  +    +     + +  +        Q+    +L  + 
Sbjct: 62  EIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHT 121

Query: 482 LEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNL 541
               +      L   A   +        +     N   LR +  G N L +         
Sbjct: 122 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 181

Query: 542 KDIL-------------RFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGG 588
                            R     + L   L        + ++ +   +  S  + + +  
Sbjct: 182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 241

Query: 589 LQGLQLLSLRYNRLQGPIPE------SFGGLKSLNFVDMSNNNLSGTIPKSM-----EAL 637
              L+ L L    L            S      L  + +  N +     +++     E +
Sbjct: 242 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301

Query: 638 SYLKHLNLSFNQLEGE 653
             L  L L+ N+   E
Sbjct: 302 PDLLFLELNGNRFSEE 317

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.5 bits (90), Expect = 0.002
 Identities = 15/98 (15%), Positives = 31/98 (31%), Gaps = 20/98 (20%)

Query: 176 LSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKF 235
           L+D  LS    +++ +  S      L+ L + YN++       L    +           
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID----------- 298

Query: 236 QGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNL 273
                     +  +  L L  N    E  + +  +R +
Sbjct: 299 --------EKMPDLLFLELNGNR-FSEEDDVVDEIREV 327

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.7 bits (88), Expect = 0.003
 Identities = 39/353 (11%), Positives = 100/353 (28%), Gaps = 23/353 (6%)

Query: 147 LQHLLLKHNSF----VGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFN-ISSCQNLPVL 201
           ++   LK ++        +   +     ++E+ LS N +       +   I+S ++L + 
Sbjct: 5   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64

Query: 202 EGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIG 261
           E   I   ++   IP  L    +  +     +  +                FL  ++ + 
Sbjct: 65  EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124

Query: 262 EIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPN 321
            +      L       +  +     +     N   L+ +    N L             +
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184

Query: 322 LERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLT 381
              L   +   +G  P  + ++        G      L      +           ++ +
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLL-----LEGLAYCQELKVLDLQDNTF-------THLGS 232

Query: 382 SPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKE 441
           S                L    LS      ++ +     +I +++L ++   I     + 
Sbjct: 233 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRT 292

Query: 442 L-----GNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPED 489
           L       + +L  + L  N  +      +  ++++     +    E    E+
Sbjct: 293 LKTVIDEKMPDLLFLELNGNRFSE-EDDVVDEIREVFSTRGRGELDELDDMEE 344

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (85), Expect = 0.002
 Identities = 20/135 (14%), Positives = 39/135 (28%), Gaps = 5/135 (3%)

Query: 160 KIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNL 219
                +     L EL + + Q    +          + L  L  L I  + L    P   
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELR-----DLRGLGELRNLTIVKSGLRFVAPDAF 76

Query: 220 WKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQ 279
                L  ++L+FN  +    + +  L+    +  GN          +       + GV 
Sbjct: 77  HFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVP 136

Query: 280 SSNLAGLIPASIFNI 294
              L       + ++
Sbjct: 137 EQKLQCHGQGPLAHM 151

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (85), Expect = 0.003
 Identities = 29/145 (20%), Positives = 39/145 (26%), Gaps = 8/145 (5%)

Query: 76  TALNISYLGLTGTIPPQLGNLSFLAVLAIRNNSFFGSLPEEL-SHLRGLKYFDFRFNNFH 134
           + L  +  G        L     L  L I N      L       L  L+      +   
Sbjct: 11  SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69

Query: 135 IEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISS 194
              P  F   PRL  L L  N+    +         LQEL LS N L  +       +  
Sbjct: 70  FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCS-----CALRW 123

Query: 195 CQNLPVLEGLFISYNQLTGPIPTNL 219
            Q         +   +L       L
Sbjct: 124 LQRWEEEGLGGVPEQKLQCHGQGPL 148

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (85), Expect = 0.003
 Identities = 24/110 (21%), Positives = 39/110 (35%), Gaps = 3/110 (2%)

Query: 447 NLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLC-HLYRLANLYLGDNK 505
             + +R   +         L   + L  LY++N +    +       L  L NL +  + 
Sbjct: 9   GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67

Query: 506 LSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLN 555
           L    P        L  L+L  NAL S+   T+     +    LS N L+
Sbjct: 68  LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQG-LSLQELVLSGNPLH 116

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	1049
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.93
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.93
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.93
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.92
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.91
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.88
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.86
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.86
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.84
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.78
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.76
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.75
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.74
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.74
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.74
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.73
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.71
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.71
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.71
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.71
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.68
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.48
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.47
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.47
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.47
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.44
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.44
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.43
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.4
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.33
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.3
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.29
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.22
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.47
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.34
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.3
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.98
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.46
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.38
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.38
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.88
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.84
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.39
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.38
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.34

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-49  Score=423.27  Aligned_cols=257  Identities=24%  Similarity=0.388  Sum_probs=205.6

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccC
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMS  840 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  840 (1049)
                      ++|+..+.||+|+||+||+|++.+++.||||+++.. ....+++.+|++++++++|||||+++|++.+++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            468888999999999999999988999999999754 3456789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccccc
Q 039290          841 NGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT  920 (1049)
Q Consensus       841 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~  920 (1049)
                      +|+|.+++......+++..+..++.||++||+|+|   +++|+||||||+||++++++.+||+|||+|+...........
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~  160 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST  160 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence            99999999887778999999999999999999999   999999999999999999999999999999877654444444


Q ss_pred             ccccccCcccccccCCCCcCcccchHHHHHHHHHHHhC-CCCCCccccccchHHHhhhhccccCCcchhccccccccccc
Q 039290          921 KTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTK-KKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEN  999 (1049)
Q Consensus       921 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1049)
                      ...||+.|+|||++.+..++.++|||||||++|||+|+ .+||... .. ......+...                   .
T Consensus       161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-~~-~~~~~~i~~~-------------------~  219 (263)
T d1sm2a_         161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SN-SEVVEDISTG-------------------F  219 (263)
T ss_dssp             ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-CH-HHHHHHHHHT-------------------C
T ss_pred             ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-CH-HHHHHHHHhc-------------------C
Confidence            56789999999999999999999999999999999995 4444432 11 1111111100                   0


Q ss_pred             CchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHh
Q 039290         1000 DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042 (1049)
Q Consensus      1000 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~ 1042 (1049)
                      +...+..+++++.+++.+||+.||++|||++|++++|+++.++
T Consensus       220 ~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         220 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            1111233567899999999999999999999999999998763

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-49  Score=425.46  Aligned_cols=262  Identities=25%  Similarity=0.400  Sum_probs=209.7

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .++|++.+.||+|+||+||+|++++  .||||+++...  ....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            4679999999999999999998643  69999997543  3346789999999999999999999998765 56799999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc-
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES-  916 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~-  916 (1049)
                      |+++|+|.+++...+..+++.++..++.||++||+|||   +++||||||||+|||++.++.+||+|||+|+....... 
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            99999999999877777999999999999999999999   99999999999999999999999999999987654322 


Q ss_pred             ccccccccccCcccccccCC---CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGRE---GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                      .......||+.|||||++.+   ..++.++|||||||++|||+||+.||.+....+........... .+.         
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-~p~---------  230 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL-SPD---------  230 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSC-CCC---------
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC-CCc---------
Confidence            23344678999999999864   35789999999999999999999999764332222111111110 000         


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhh
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~ 1043 (1049)
                            ....+.++++++.+++.+||+.||++||||+|++++|+.+.+.+
T Consensus       231 ------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         231 ------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             ------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             ------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence                  01122346678999999999999999999999999999988764

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=421.86  Aligned_cols=250  Identities=26%  Similarity=0.339  Sum_probs=212.9

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            4699999999999999999995 579999999998776667788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      ++|+|.+++...  .+++.+++.++.||+.||+|||   ++||+||||||+|||++.++.+||+|||+|+....... ..
T Consensus       100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~  173 (293)
T d1yhwa1         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR  173 (293)
T ss_dssp             TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CB
T ss_pred             CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc-cc
Confidence            999999988764  4899999999999999999999   99999999999999999999999999999998754332 23


Q ss_pred             cccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccccccc
Q 039290          920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEN  999 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1049)
                      ...+||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+..... ...                  ...
T Consensus       174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~-~~~------------------~~~  234 (293)
T d1yhwa1         174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATN------------------GTP  234 (293)
T ss_dssp             CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-HHH------------------CSC
T ss_pred             cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH-HhC------------------CCC
Confidence            4567999999999999999999999999999999999999999753222211111 100                  000


Q ss_pred             CchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290         1000 DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus      1000 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ....+..++.++.+++.+||+.||++|||++|+++|
T Consensus       235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            112223456789999999999999999999999876

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=417.33  Aligned_cols=253  Identities=25%  Similarity=0.367  Sum_probs=207.7

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .++|++.+.||+|+||+||+|++ .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            35789999999999999999996 478999999997653 2334678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc-
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES-  916 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~-  916 (1049)
                      |+++|+|.+++.... .+++.+++.++.|+++||+|||   ++||+||||||+|||+++++.+||+|||+|+....... 
T Consensus        84 y~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          84 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ccCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            999999999987544 5899999999999999999999   99999999999999999999999999999987643332 


Q ss_pred             ccccccccccCcccccccCCCCc-CcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKV-SRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                      ......+||+.|||||++.+..+ +.++||||+||++|||++|+.||............+.....               
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~---------------  224 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---------------  224 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT---------------
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC---------------
Confidence            22345679999999999988776 57899999999999999999999764433333332221111               


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                          ........++++.+++.+||+.||++|||++|+++|
T Consensus       225 ----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         225 ----YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             ----TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ----CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                011112345678899999999999999999999875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-48  Score=413.14  Aligned_cols=254  Identities=24%  Similarity=0.387  Sum_probs=218.3

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccC
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMS  840 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  840 (1049)
                      ++|+..++||+|+||+||+|++++++.||||+++.. ....+++.+|++++++++||||++++|++.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            578999999999999999999988999999999865 3456789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccccc
Q 039290          841 NGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQT  920 (1049)
Q Consensus       841 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~~  920 (1049)
                      +|++.+++......+++..+++++.|+++||+|||   ++||+||||||+||++++++.+||+|||+++...........
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  159 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV  159 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence            99999998887778999999999999999999999   999999999999999999999999999999877655444444


Q ss_pred             ccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccccccccc
Q 039290          921 KTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEEN  999 (1049)
Q Consensus       921 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1049)
                      ...+|+.|+|||++.+..++.++|||||||++|||+| |+.||......+.... ....                    .
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~-i~~~--------------------~  218 (258)
T d1k2pa_         160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-IAQG--------------------L  218 (258)
T ss_dssp             CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH-HHTT--------------------C
T ss_pred             ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH-HHhC--------------------C
Confidence            5678999999999999999999999999999999998 8999986543322211 1100                    0


Q ss_pred             CchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290         1000 DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus      1000 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                      +...+..+++++.+++.+||+.||++|||++|++++|.+|
T Consensus       219 ~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            1112234567899999999999999999999999998653

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-48  Score=414.02  Aligned_cols=246  Identities=25%  Similarity=0.366  Sum_probs=208.9

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecc---cCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHME---FDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++...   .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46899999999999999999964 7889999998643   2455678999999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+++|+|.+++...+ .+++.+++.++.||++||+|||   ++|||||||||+|||++.++.+||+|||+|+...... 
T Consensus        86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-  160 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-  160 (263)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred             eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence            9999999999997654 4899999999999999999999   9999999999999999999999999999998654322 


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                        .....||+.|||||++.+..++.++||||+||++|||++|+.||......+. ......                   
T Consensus       161 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-~~~i~~-------------------  218 (263)
T d2j4za1         161 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-YKRISR-------------------  218 (263)
T ss_dssp             --CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHT-------------------
T ss_pred             --ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH-HHHHHc-------------------
Confidence              2346799999999999999999999999999999999999999975322211 111000                   


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                        ..+..+..+++++.+++.+||+.||++|||++|+++|
T Consensus       219 --~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         219 --VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             --TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             --CCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence              0111122356778999999999999999999999986

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-48  Score=421.04  Aligned_cols=252  Identities=25%  Similarity=0.342  Sum_probs=211.6

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      +.|++.+.||+|+||+||+|+. .+++.||||+++.......+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            4688899999999999999996 478999999998766666788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      ++|+|.+++......+++.++..++.||++||+|||   ++||+||||||+|||++.++.+||+|||+|+...... ...
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~  167 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR  167 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHH
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-ccc
Confidence            999999998776667999999999999999999999   9999999999999999999999999999998653322 123


Q ss_pred             cccccccCcccccccC-----CCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          920 TKTLGTIGYMAPEYGR-----EGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                      ....||+.|+|||++.     ...++.++||||+||++|||++|+.||.+....+..... ...                
T Consensus       168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i-~~~----------------  230 (288)
T d2jfla1         168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI-AKS----------------  230 (288)
T ss_dssp             TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH-HHS----------------
T ss_pred             cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH-HcC----------------
Confidence            3467999999999874     456889999999999999999999999764332221111 100                


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                        .......+..+++++.+++.+||+.||++|||++|+++|
T Consensus       231 --~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         231 --EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             --CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             --CCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              001112223456789999999999999999999999875

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-48  Score=418.36  Aligned_cols=257  Identities=23%  Similarity=0.395  Sum_probs=212.3

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      .++|++.+.||+|+||+||+|++++++.||||+++.. ....+.+.+|++++++++|||||++++++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            3578889999999999999999988899999999754 3456789999999999999999999998865 5579999999


Q ss_pred             CCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          840 SNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       840 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      ++|+|.+++.... ..+++.++.+|+.||++||+|||   +++|+||||||+|||+++++.+||+|||+|+.........
T Consensus        90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~  166 (272)
T d1qpca_          90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA  166 (272)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred             CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence            9999999775433 35899999999999999999999   9999999999999999999999999999999876555444


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                      .....||+.|+|||++.++.++.++|||||||++|||+||..|+........ ....+..                   .
T Consensus       167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~-~~~~i~~-------------------~  226 (272)
T d1qpca_         167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLER-------------------G  226 (272)
T ss_dssp             CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHHHT-------------------T
T ss_pred             ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH-HHHHHHh-------------------c
Confidence            4556789999999999988999999999999999999996665543222111 1111100                   0


Q ss_pred             cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 039290          999 NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041 (1049)
Q Consensus       999 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~ 1041 (1049)
                      .+...+..+++++.+++.+||+.||++|||++||++.|+++..
T Consensus       227 ~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            0111223456789999999999999999999999999998754

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-48  Score=423.63  Aligned_cols=259  Identities=23%  Similarity=0.381  Sum_probs=215.9

Q ss_pred             HhcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          759 ATDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       759 ~~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      ..++|+..+.||+|+||+||+|++. +++.||||+++.. ....+++.+|++++++++|||||++++++.+++..++|||
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            3457888999999999999999965 6889999998754 3456789999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          838 YMSNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      |+++|+|.+++... ...+++..+..++.||++||+|||   ++||+||||||+|||+++++.+||+|||+|+.......
T Consensus        94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            99999999998753 457899999999999999999999   99999999999999999999999999999987765544


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                      .......|++.|+|||++.+..++.++|||||||++|||++|..||....... ...+.+..                  
T Consensus       171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-~~~~~i~~------------------  231 (287)
T d1opja_         171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEK------------------  231 (287)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHHHHT------------------
T ss_pred             eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-HHHHHHhc------------------
Confidence            44445568899999999999999999999999999999999777764322211 11111110                  


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~ 1041 (1049)
                       ..+...+..+++++.+++.+||+.||++|||++|+++.|+.+.+
T Consensus       232 -~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         232 -DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             -CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence             00112223466789999999999999999999999999987654

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.8e-48  Score=420.24  Aligned_cols=258  Identities=24%  Similarity=0.435  Sum_probs=202.9

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CC---cEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DG---MEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      ++|+..++||+|+||+||+|++. ++   ..||||++..... ...++|.+|++++++++|||||+++|++.+++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            45777889999999999999964 33   2588898865432 3356799999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      ||||++|+|.+++......+++.++..++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|+......
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            9999999999999887777999999999999999999999   9999999999999999999999999999998765433


Q ss_pred             cc----cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcc
Q 039290          916 SM----RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD  990 (1049)
Q Consensus       916 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  990 (1049)
                      ..    ......+|+.|||||++.++.++.++|||||||++|||+| |+.||.+....+  ....+..            
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~--~~~~i~~------------  248 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--VINAIEQ------------  248 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHT------------
T ss_pred             CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH--HHHHHHc------------
Confidence            21    1122457899999999999999999999999999999998 899997643221  1111110            


Q ss_pred             cccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHh
Q 039290          991 ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042 (1049)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~ 1042 (1049)
                             ..+.+.+.+++.++.+++.+||+.||++|||++||+++|+++.+.
T Consensus       249 -------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         249 -------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             -------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence                   011122334677899999999999999999999999999998764

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-47  Score=413.29  Aligned_cols=261  Identities=26%  Similarity=0.442  Sum_probs=214.0

Q ss_pred             cCCCCCc-eecCCCcEEEEEEEeC---CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          761 DGFSENK-LLGMGSFGSVYKGVLP---DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       761 ~~~~~~~-~lg~G~fg~Vy~a~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      ++|.+.+ +||+|+||+||+|.+.   ++..||||+++.... ...++|.+|++++++++|||||++++++.+ +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            3455556 4999999999999853   455799999975432 235679999999999999999999999875 457999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++|+|.+++...+..+++.++.+++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+|+......
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            9999999999998877777999999999999999999999   9999999999999999999999999999999876443


Q ss_pred             cc--cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccc
Q 039290          916 SM--RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       916 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+.  ...+..              
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~--~~~i~~--------------  227 (285)
T d1u59a_         164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--MAFIEQ--------------  227 (285)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH--HHHHHT--------------
T ss_pred             cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH--HHHHHc--------------
Confidence            22  2233468899999999998999999999999999999998 8999986432221  111110              


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhc
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAY 1046 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~ 1046 (1049)
                           ..+...+..++.++.+++.+||+.||++||||.+|++.|+.+..++..-
T Consensus       228 -----~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~  276 (285)
T d1u59a_         228 -----GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  276 (285)
T ss_dssp             -----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred             -----CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence                 0112223456778999999999999999999999999999887766543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=411.32  Aligned_cols=250  Identities=22%  Similarity=0.320  Sum_probs=194.4

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeec--CCeeEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSN--NDFKALV  835 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--~~~~~lv  835 (1049)
                      ++|++.+.||+|+||+||+|+. .+|+.||+|+++....  ...+.+.+|++++++++|||||++++++.+  .+..|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5789999999999999999996 4789999999976542  234678899999999999999999999865  4568999


Q ss_pred             EeccCCCChhhhhhc---CCCccCHHHHHHHHHHHHHHHHHhHccCCCC-----eEEcCCCCCCeeecCCCceEEecccC
Q 039290          836 LEYMSNGSLEKCLYS---DNYFLDILQRLKIMIDVASALEYLHFGYSTP-----IVHCDIKPSNVLLNESMVGHLSDFGI  907 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~Dlkp~NIl~~~~~~~kl~DfGl  907 (1049)
                      ||||++|+|.+++..   .+..+++.+++.++.|+++||+|||   +++     |+||||||+|||++.++.+||+|||+
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~  160 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  160 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence            999999999999864   2346999999999999999999999   554     99999999999999999999999999


Q ss_pred             ceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcch
Q 039290          908 AKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITE  987 (1049)
Q Consensus       908 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  987 (1049)
                      |+....... ......||+.|||||++.+..++.++||||+||++|||+||+.||......+. ......          
T Consensus       161 a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~-~~~i~~----------  228 (269)
T d2java1         161 ARILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-AGKIRE----------  228 (269)
T ss_dssp             HHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHH----------
T ss_pred             eeecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH-HHHHHc----------
Confidence            987654332 23446789999999999999999999999999999999999999975322211 111100          


Q ss_pred             hcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          988 VADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       988 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                         ...       ...+..+++++.+++.+||+.||++|||++|+++|
T Consensus       229 ---~~~-------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         229 ---GKF-------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             ---TCC-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---CCC-------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence               000       01112356679999999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-46  Score=408.89  Aligned_cols=259  Identities=25%  Similarity=0.453  Sum_probs=205.0

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCCC-----cEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPDG-----MEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      +.|+..++||+|+||+||+|+++++     ..||||+++.... ....+|.+|++++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4577889999999999999986432     3699999865432 234578999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      ||||+.++++.+++......+++.++.+++.|++.|++|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            99999999999998887778999999999999999999999   999999999999999999999999999999876433


Q ss_pred             cc--ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccc
Q 039290          915 ES--MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       915 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      ..  .......||+.|+|||++.++.++.++|||||||++|||++|..|+........ ....+..              
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-~~~~i~~--------------  228 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-VMKAIND--------------  228 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHT--------------
T ss_pred             CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH-HHHHHhc--------------
Confidence            22  122334578999999999999999999999999999999997666543222211 1111110              


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHh
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRET 1042 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~ 1042 (1049)
                           ..+.+.+.+++.++.+++.+||+.||++||||+||++.|+++.+.
T Consensus       229 -----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         229 -----GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             -----TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -----cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence                 011122234667899999999999999999999999999988763

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-47  Score=411.66  Aligned_cols=249  Identities=26%  Similarity=0.360  Sum_probs=206.2

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++....   ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            4689999999999999999996 478999999997532   455678999999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+++|+|.+++...+ .+++.+++.++.|++.||+|||   ++||+||||||+|||+++++.+||+|||+|+.+.....
T Consensus        88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            9999999999887654 4899999999999999999999   99999999999999999999999999999998754332


Q ss_pred             -ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          917 -MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       917 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                       ......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+.. .....                  
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-~~i~~------------------  224 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF-QKIIK------------------  224 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHT------------------
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH-HHHHc------------------
Confidence             2334567999999999999999999999999999999999999999753221111 11000                  


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                         ..+..+..+++++.+++.+||+.||++|||++|++++
T Consensus       225 ---~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         225 ---LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             ---TCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             ---CCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence               0011122345678999999999999999999997654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.1e-46  Score=419.10  Aligned_cols=253  Identities=22%  Similarity=0.294  Sum_probs=212.0

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            45799999999999999999996 47899999999766555567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec--CCCceEEecccCceecCCCcc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN--ESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~--~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      |++|+|.+++......+++.++..++.||+.||+|||   ++|||||||||+|||++  .++.+||+|||+|+...... 
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  180 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-  180 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence            9999999999776667999999999999999999999   99999999999999996  46789999999999875433 


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                       ......||+.|||||++.+..++.++||||+||++|||++|+.||.+....+.. .......                 
T Consensus       181 -~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-~~i~~~~-----------------  241 (350)
T d1koaa2         181 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL-RNVKSCD-----------------  241 (350)
T ss_dssp             -CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHTC-----------------
T ss_pred             -ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHH-HHHHhCC-----------------
Confidence             234467899999999999999999999999999999999999999753222111 1110000                 


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ..........+++++.+++.+||+.||++|||++|+++|
T Consensus       242 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         242 WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             CCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000111123356678999999999999999999999986

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-47  Score=421.07  Aligned_cols=267  Identities=25%  Similarity=0.312  Sum_probs=207.2

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .++|++.+.||+|+||+||+|+. .+|+.||+|+++... ....+++.+|++++++++|||||++++++.+.+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            45799999999999999999996 478999999997654 3335678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCC-CeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYST-PIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      |+++|+|.+++.+.+ .+++..++.++.|+++||+|||   ++ ||+||||||+|||++.++.+||+|||+|+.....  
T Consensus        85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  158 (322)
T ss_dssp             CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence            999999999997654 4899999999999999999999   74 8999999999999999999999999999865332  


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhh---ccccC----------
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGD---SLLSC----------  983 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~----------  983 (1049)
                       .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||......+.........   .....          
T Consensus       159 -~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (322)
T d1s9ja_         159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  237 (322)
T ss_dssp             -TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred             -ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence             2234689999999999999999999999999999999999999997633222111100000   00000          


Q ss_pred             -----------CcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          984 -----------SITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       984 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                                 ...+..+......+...  .....+.++.+++.+||+.||++|||++|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         238 SSYGMDSRPPMAIFELLDYIVNEPPPKL--PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             --------CCCCHHHHHHHHHTSCCCCC--CBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccchhHHHHHhhhhccCCccC--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                       00000000000000000  001235678999999999999999999999997

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=404.55  Aligned_cols=252  Identities=27%  Similarity=0.402  Sum_probs=203.3

Q ss_pred             ceecCCCcEEEEEEEeC---CCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEeccCC
Q 039290          767 KLLGMGSFGSVYKGVLP---DGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYMSN  841 (1049)
Q Consensus       767 ~~lg~G~fg~Vy~a~~~---~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  841 (1049)
                      ++||+|+||+||+|.+.   .++.||||+++....  ...+++.+|++++++++|||||++++++.++ ..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            57999999999999853   356899999965432  2356799999999999999999999999654 56899999999


Q ss_pred             CChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc--cc
Q 039290          842 GSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM--RQ  919 (1049)
Q Consensus       842 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~--~~  919 (1049)
                      |+|.+++.... .+++.++.+++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+|+........  ..
T Consensus        92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            99999988654 4899999999999999999999   999999999999999999999999999999876543322  22


Q ss_pred             cccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccccccccc
Q 039290          920 TKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                      ....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+.  ...+..                   .
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~--~~~i~~-------------------~  226 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--TAMLEK-------------------G  226 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HHHHHT-------------------T
T ss_pred             cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH--HHHHHc-------------------C
Confidence            33568999999999999999999999999999999998 8999976432221  111100                   0


Q ss_pred             cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          999 NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       999 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                      .+.+.+..++.++.+++.+||+.||++|||++||++.|+....+..
T Consensus       227 ~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~  272 (277)
T d1xbba_         227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  272 (277)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcC
Confidence            1122234467789999999999999999999999999888765443

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.9e-47  Score=413.10  Aligned_cols=252  Identities=23%  Similarity=0.309  Sum_probs=193.3

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .+.|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            456999999999999999999964 78999999997554 3334678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec---CCCceEEecccCceecCCC
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~---~~~~~kl~DfGla~~~~~~  914 (1049)
                      ||+||+|.+++...+ .+++.++..++.||+.||+|||   ++||+||||||+||+++   +++.+||+|||+|+.....
T Consensus        88 ~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          88 LVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             CCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             ccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            999999999997654 5899999999999999999999   99999999999999995   5789999999999866433


Q ss_pred             ccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          915 ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       915 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                      .  .....+||+.|||||++.+..++.++||||+||++|||++|+.||.+....+.......+.                
T Consensus       164 ~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~----------------  225 (307)
T d1a06a_         164 S--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE----------------  225 (307)
T ss_dssp             -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTC----------------
T ss_pred             C--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccC----------------
Confidence            2  2334679999999999999999999999999999999999999997633222211111000                


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                        .....+....+++++.+++.+||+.||++|||++|+++|
T Consensus       226 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         226 --YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             --CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             --CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence              000111223456778999999999999999999999986

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-46  Score=401.25  Aligned_cols=245  Identities=24%  Similarity=0.379  Sum_probs=197.7

Q ss_pred             CCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeec----CCeeEEEE
Q 039290          764 SENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSN----NDFKALVL  836 (1049)
Q Consensus       764 ~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~----~~~~~lv~  836 (1049)
                      +..++||+|+||+||+|++. +++.||+|++.....  ...+.+.+|++++++++|||||++++++.+    .+..++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45578999999999999964 688999999876532  234678999999999999999999999864    45689999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCC--eEEcCCCCCCeeec-CCCceEEecccCceecCC
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTP--IVHCDIKPSNVLLN-ESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIl~~-~~~~~kl~DfGla~~~~~  913 (1049)
                      ||+++|+|.+++.... .+++.+++.++.||++||+|||   +++  |+||||||+|||++ +++.+||+|||+|+....
T Consensus        92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            9999999999997654 4899999999999999999999   888  99999999999997 578999999999986433


Q ss_pred             CccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          914 EESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       914 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                      .   .....+||+.|||||++.+ +++.++||||+||++|||++|+.||.+....+......... .             
T Consensus       168 ~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~-~-------------  229 (270)
T d1t4ha_         168 S---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-V-------------  229 (270)
T ss_dssp             T---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-C-------------
T ss_pred             C---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC-C-------------
Confidence            2   2234679999999999865 69999999999999999999999997532222111111100 0             


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                           .....+..+++++.+++.+||+.||++|||++|+++|
T Consensus       230 -----~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         230 -----KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             -----CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -----CCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence                 0011122345678999999999999999999999875

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.9e-46  Score=417.47  Aligned_cols=253  Identities=23%  Similarity=0.293  Sum_probs=212.2

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      .++|++.+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            35799999999999999999996 57999999999766544566788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec--CCCceEEecccCceecCCCcc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN--ESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~--~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      |++|+|.+.+......+++.+++.|+.||+.||+|||   ++||+||||||+|||++  .++.+||+|||+|+.+.....
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~  184 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  184 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence            9999999988777777999999999999999999999   99999999999999998  678999999999998765432


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                        .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+..........                 
T Consensus       185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-----------------  245 (352)
T d1koba_         185 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW-----------------  245 (352)
T ss_dssp             --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC-----------------
T ss_pred             --eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------------
Confidence              3446789999999999999999999999999999999999999975322221111100000                 


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                       ..........++++.+++.+||+.||++|||++|+++|
T Consensus       246 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         246 -EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             -CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             00011112356678999999999999999999999886

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-46  Score=414.44  Aligned_cols=255  Identities=25%  Similarity=0.380  Sum_probs=207.5

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCC------CcEEEEEEeeccc-CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPD------GMEIAAKVFHMEF-DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDF  831 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~  831 (1049)
                      .++|++.++||+|+||+||+|++..      ...||+|++.... ......+.+|+.++.++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            3578899999999999999998532      2369999986543 34456789999999998 89999999999999999


Q ss_pred             eEEEEeccCCCChhhhhhcCC----------------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCC
Q 039290          832 KALVLEYMSNGSLEKCLYSDN----------------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKP  889 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp  889 (1049)
                      .++|||||++|+|.+++...+                      ..+++.+++.++.||++||+|||   +++||||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCch
Confidence            999999999999999997643                      24788999999999999999999   99999999999


Q ss_pred             CCeeecCCCceEEecccCceecCCCccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCcccc
Q 039290          890 SNVLLNESMVGHLSDFGIAKILGKEESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFA  967 (1049)
Q Consensus       890 ~NIl~~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~  967 (1049)
                      +||+++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||.+...
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999876443322 2334568999999999999999999999999999999998 8999976433


Q ss_pred             ccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 039290          968 GEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLV 1037 (1049)
Q Consensus       968 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~ 1037 (1049)
                      .+.. ...+...                   .+++.+..+++++.++|.+||+.||++|||++||+++|.
T Consensus       273 ~~~~-~~~~~~~-------------------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DANF-YKLIQNG-------------------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SHHH-HHHHHTT-------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHH-HHHHhcC-------------------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            3221 1111100                   011223346678999999999999999999999999985

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-46  Score=404.55  Aligned_cols=260  Identities=23%  Similarity=0.376  Sum_probs=203.7

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCC----CcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPD----GMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      .++|++.+.||+|+||+||+|++..    +..||||+++.... ...+.+.+|++++++++|||||++++++.+ +..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence            3578899999999999999998642    35688898865432 235679999999999999999999999964 67899


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      ||||+++|++.+++......+++.+++.++.||++||+|||   +++|+||||||+||++++++.+||+|||+|+.....
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            99999999999998877778999999999999999999999   999999999999999999999999999999877554


Q ss_pred             ccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccc
Q 039290          915 ESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANL  993 (1049)
Q Consensus       915 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  993 (1049)
                      .........||+.|+|||++.+..++.++|||||||++|||++ |.+||......+.......+                
T Consensus       162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~----------------  225 (273)
T d1mp8a_         162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG----------------  225 (273)
T ss_dssp             ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT----------------
T ss_pred             cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC----------------
Confidence            4444455678999999999999999999999999999999998 88898764433222111100                


Q ss_pred             ccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          994 LNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                           .+.+.+..+++++.+++.+||+.||++|||++||+++|+++.++-.
T Consensus       226 -----~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k  271 (273)
T d1mp8a_         226 -----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK  271 (273)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence                 0112223466789999999999999999999999999999987643

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=403.36  Aligned_cols=251  Identities=22%  Similarity=0.280  Sum_probs=209.1

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc------CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF------DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKA  833 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~  833 (1049)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++...      ....+.+.+|++++++++|||||++++++.+.+..|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            5799999999999999999996 579999999996543      123578999999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC----ceEEecccCce
Q 039290          834 LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM----VGHLSDFGIAK  909 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~----~~kl~DfGla~  909 (1049)
                      +|||||++|+|.+++...+ .+++.+++.++.|++.||+|||   +++|+||||||+||+++.++    .+|++|||+|.
T Consensus        90 iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhhh
Confidence            9999999999999997654 4899999999999999999999   99999999999999998766    59999999998


Q ss_pred             ecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhc
Q 039290          910 ILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA  989 (1049)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  989 (1049)
                      ......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+.. .....            
T Consensus       166 ~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-~~i~~------------  230 (293)
T d1jksa_         166 KIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSA------------  230 (293)
T ss_dssp             ECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHT------------
T ss_pred             hcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHH-HHHHh------------
Confidence            775433  234467899999999999999999999999999999999999999753222211 11100            


Q ss_pred             ccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          990 DANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                           .........+..++.++.+++.+||+.||++|||++|+++|
T Consensus       231 -----~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         231 -----VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             -----TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -----cCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 00011112223456788999999999999999999999875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.1e-46  Score=408.35  Aligned_cols=245  Identities=24%  Similarity=0.305  Sum_probs=201.8

Q ss_pred             CCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCC---CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          762 GFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDG---SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      .|+..+.||+|+||+||+|+. .+++.||||+++.....   ..+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            488899999999999999995 47889999999765422   23568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      ||++|++..++... ..+++.+++.++.||++||+|||   ++|||||||||+|||++.++.+||+|||+|......   
T Consensus        96 ~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---  168 (309)
T d1u5ra_          96 YCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (309)
T ss_dssp             CCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred             ecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence            99999987766554 45899999999999999999999   999999999999999999999999999999865432   


Q ss_pred             cccccccccCcccccccCC---CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccc
Q 039290          918 RQTKTLGTIGYMAPEYGRE---GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLL  994 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  994 (1049)
                        ....||+.|||||++.+   +.|+.++||||+||++|||++|..||.+....+.......+..               
T Consensus       169 --~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~---------------  231 (309)
T d1u5ra_         169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES---------------  231 (309)
T ss_dssp             --CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---------------
T ss_pred             --CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC---------------
Confidence              33579999999999854   4689999999999999999999999975332221111110000               


Q ss_pred             cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          995 NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                           ....+..+++++.+++.+||+.||++|||++|+++|
T Consensus       232 -----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         232 -----PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             -----CCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             -----CCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence                 000112345679999999999999999999999874

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-46  Score=402.99  Aligned_cols=257  Identities=27%  Similarity=0.420  Sum_probs=205.0

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      .++|++.+.||+|+||+||+|++++++.||||+++.. ....+.|.+|+.++++++|||||++++++.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            3578999999999999999999988889999999754 3456789999999999999999999999865 5578999999


Q ss_pred             CCCChhhhhhcC-CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          840 SNGSLEKCLYSD-NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       840 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      ++|+|.+++... ...+++.++..++.||+.|++|||   +.+|+||||||+|||++.++.+||+|||+|+.........
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~  170 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  170 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence            999999887653 345899999999999999999999   9999999999999999999999999999998775544444


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEE  998 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1049)
                      .....||+.|+|||++.++.++.++|||||||++|||++|..|+................                    
T Consensus       171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~--------------------  230 (285)
T d1fmka3         171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG--------------------  230 (285)
T ss_dssp             -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--------------------
T ss_pred             eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc--------------------
Confidence            455678999999999999999999999999999999999766654422222111111100                    


Q ss_pred             cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 039290          999 NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041 (1049)
Q Consensus       999 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~ 1041 (1049)
                      .+.+.+..+++++.+++.+||+.||++|||+++|++.|+++..
T Consensus       231 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         231 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence            0112223466789999999999999999999999998887543

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-45  Score=405.10  Aligned_cols=262  Identities=24%  Similarity=0.409  Sum_probs=211.4

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCc----EEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGM----EIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l  834 (1049)
                      ++|++.++||+|+||+||+|++. +|+    +||+|+++... ....+++.+|++++++++|||||++++++.+++ .++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeE
Confidence            46899999999999999999964 444    58888886543 445678999999999999999999999998754 578


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCC
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKE  914 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~  914 (1049)
                      ++||+.+|+|.+.+......+++.++++++.||++||+|||   +++|+||||||+||+++.++.+||+|||+|+.....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            89999999999998888888999999999999999999999   999999999999999999999999999999877543


Q ss_pred             ccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcccc
Q 039290          915 ESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADAN  992 (1049)
Q Consensus       915 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  992 (1049)
                      ... ......||+.|+|||++.++.++.++|||||||++|||+| |..||+.....+..  ..+..              
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~--~~i~~--------------  228 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--SILEK--------------  228 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH--HHHHH--------------
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH--HHHHc--------------
Confidence            322 2233468999999999999999999999999999999999 78888764333221  11100              


Q ss_pred             cccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhcc
Q 039290          993 LLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYI 1047 (1049)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~~ 1047 (1049)
                           ..+.+.+..++.++.+++.+||+.||++|||++|++++|..+.+...+++
T Consensus       229 -----~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~~~~~  278 (317)
T d1xkka_         229 -----GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYL  278 (317)
T ss_dssp             -----TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSHHHHB
T ss_pred             -----CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhChHhhc
Confidence                 01122234466789999999999999999999999999999877655554

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-45  Score=404.50  Aligned_cols=249  Identities=24%  Similarity=0.299  Sum_probs=210.6

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      .++|++.+.||+|+||+||+|+. .+|+.||+|++++..   ....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            35799999999999999999996 579999999997542   44567899999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++|+|.+++...+ .+++..++.++.||+.||+|||   ++||+||||||+|||++++|.+||+|||+|+......
T Consensus        84 ~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            99999999999988765 4899999999999999999999   9999999999999999999999999999998764333


Q ss_pred             cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                      . .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....+.......                   
T Consensus       160 ~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~-------------------  219 (337)
T d1o6la_         160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-------------------  219 (337)
T ss_dssp             C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------------------
T ss_pred             c-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc-------------------
Confidence            2 33456899999999999999999999999999999999999999976332221111100                   


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRIS-----MKDVANR 1035 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~ell~~ 1035 (1049)
                         .....+..+++++.+++.+||+.||++||+     ++|+++|
T Consensus       220 ---~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         220 ---EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ---CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ---CCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence               011122335677899999999999999994     8899876

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-45  Score=393.02  Aligned_cols=250  Identities=30%  Similarity=0.443  Sum_probs=200.8

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeec-CCeeEEEEecc
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSN-NDFKALVLEYM  839 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~-~~~~~lv~e~~  839 (1049)
                      ++|+..+.||+|+||.||+|++ .|+.||||+++.+  ...+.+.+|++++++++||||++++|++.+ .+..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            4677889999999999999998 5789999999653  445789999999999999999999999855 56789999999


Q ss_pred             CCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          840 SNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       840 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      ++|+|.+++...+ ..+++..+++|+.||++|++|||   +++|+||||||+||+++.++.+|++|||+++......   
T Consensus        84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~---  157 (262)
T d1byga_          84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  157 (262)
T ss_dssp             TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence            9999999997643 35899999999999999999999   9999999999999999999999999999998654322   


Q ss_pred             ccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhccccccccc
Q 039290          919 QTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNCE  997 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1049)
                       ....++..|+|||++.++.++.++|||||||++|||+| |+.||......+  ...++..                   
T Consensus       158 -~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--~~~~i~~-------------------  215 (262)
T d1byga_         158 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEK-------------------  215 (262)
T ss_dssp             -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHHTT-------------------
T ss_pred             -ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHc-------------------
Confidence             23457889999999999999999999999999999998 677776532222  1221110                   


Q ss_pred             ccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 039290          998 ENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041 (1049)
Q Consensus       998 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~ 1041 (1049)
                      ..+++.+..+++++.+++.+||+.||++||||.|++++|++++.
T Consensus       216 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         216 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            01122233456789999999999999999999999999998865

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.2e-45  Score=398.76  Aligned_cols=245  Identities=24%  Similarity=0.307  Sum_probs=207.8

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++...   ....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            4688999999999999999996 479999999997532   455678999999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||++||++.+++..... +++..++.++.||+.|++|||   ++||+||||||+|||++.++.+||+|||+|+.....  
T Consensus        84 E~~~gg~l~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTSS-CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eecCCcccccccccccc-ccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence            99999999998876654 788899999999999999999   999999999999999999999999999999876432  


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                        .....||+.|||||++.+..++.++||||+||++|||++|+.||.+....+.... ...                   
T Consensus       158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~-i~~-------------------  215 (316)
T d1fota_         158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK-ILN-------------------  215 (316)
T ss_dssp             --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-HHH-------------------
T ss_pred             --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHH-HHc-------------------
Confidence              2346799999999999999999999999999999999999999976322211111 100                   


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRI-----SMKDVANR 1035 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~~ 1035 (1049)
                        .....+...++++.+++.+|++.||.+||     |++|+++|
T Consensus       216 --~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         216 --AELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             --CCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --CCCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence              00111223456789999999999999996     99999886

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-45  Score=400.04  Aligned_cols=252  Identities=19%  Similarity=0.251  Sum_probs=209.6

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      .++|++.+.||+|+||+||+|+.. +++.||||+++... .....+.+|++++++++|||||++++++.+++..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            468999999999999999999964 78899999997653 2345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC--CCceEEecccCceecCCCcc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE--SMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~--~~~~kl~DfGla~~~~~~~~  916 (1049)
                      |+||+|.+++...+..+++.+++.++.||++|++|||   +.||+||||||+|||++.  ...+||+|||+++...... 
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~-  158 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence            9999999999887767999999999999999999999   999999999999999984  4589999999998765433 


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                       ......+++.|+|||...+..++.++||||+||++|||++|..||......+..... ..                 ..
T Consensus       159 -~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i-~~-----------------~~  219 (321)
T d1tkia_         159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI-MN-----------------AE  219 (321)
T ss_dssp             -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-HH-----------------TC
T ss_pred             -cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH-Hh-----------------CC
Confidence             233457899999999999999999999999999999999999999763322111110 00                 00


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ..........++.++.+++.+|++.||++|||++|+++|
T Consensus       220 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         220 YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000111122356778999999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-45  Score=402.09  Aligned_cols=261  Identities=26%  Similarity=0.417  Sum_probs=211.8

Q ss_pred             HHHHhcCCCCCceecCCCcEEEEEEEeC------CCcEEEEEEeecccCC-CHHHHHHHHHHHhhcCCCceeeEEeeeec
Q 039290          756 LLRATDGFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEFDG-SLESFHAECKVMGSIRHRNLVKIISSCSN  828 (1049)
Q Consensus       756 ~~~~~~~~~~~~~lg~G~fg~Vy~a~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~l~~~~~~  828 (1049)
                      ++-..++|++.+.||+|+||+||+|++.      +++.||||+++..... ..+++.+|++++++++||||+++++++.+
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            3334568999999999999999999853      4578999998754332 35679999999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhhcCC-----------------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEc
Q 039290          829 NDFKALVLEYMSNGSLEKCLYSDN-----------------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHC  885 (1049)
Q Consensus       829 ~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~  885 (1049)
                      .+..++||||+++|+|.+++....                       ..+++.++..|+.|++.||+|||   +++||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHr  164 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHR  164 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEee
Confidence            999999999999999999986432                       24788999999999999999999   9999999


Q ss_pred             CCCCCCeeecCCCceEEecccCceecCCCccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCC-CCCC
Q 039290          886 DIKPSNVLLNESMVGHLSDFGIAKILGKEESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKK-KPTD  963 (1049)
Q Consensus       886 Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~p~~  963 (1049)
                      ||||+||+++.++.+||+|||+|+........ ......+++.|+|||.+.+..++.++|||||||++|||++|. +||.
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            99999999999999999999999866443322 233456889999999999999999999999999999999986 5666


Q ss_pred             ccccccchHHHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 039290          964 EIFAGEMSLKRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIR 1040 (1049)
Q Consensus       964 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~ 1040 (1049)
                      .....+.  ...+..    +               .+...+..++.++.+++.+||+.+|++||||.||+++|+++.
T Consensus       245 ~~~~~e~--~~~v~~----~---------------~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         245 GMAHEEV--IYYVRD----G---------------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TSCHHHH--HHHHHT----T---------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCHHHH--HHHHHc----C---------------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            5322221  111110    0               011222345678999999999999999999999999999874

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-44  Score=396.18  Aligned_cols=273  Identities=21%  Similarity=0.299  Sum_probs=203.9

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHH--HHHHHhhcCCCceeeEEeeeecCC----eeEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHA--ECKVMGSIRHRNLVKIISSCSNND----FKAL  834 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~--e~~~l~~l~hpniv~l~~~~~~~~----~~~l  834 (1049)
                      .+|...+.||+|+||.||+|++ +|+.||||+++...   ..++.+  |+..+..++|||||++++++.+.+    .+++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            3567778999999999999997 68899999986442   234444  445556789999999999997643    6799


Q ss_pred             EEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHcc-----CCCCeEEcCCCCCCeeecCCCceEEecccCce
Q 039290          835 VLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG-----YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK  909 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~  909 (1049)
                      ||||+++|+|.+++++.  .+++.++.+++.|++.|++|+|..     +++|||||||||+|||++.++.+||+|||+++
T Consensus        79 v~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            99999999999999875  489999999999999999999931     23699999999999999999999999999998


Q ss_pred             ecCCCcc---ccccccccccCcccccccCCC------CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcc
Q 039290          910 ILGKEES---MRQTKTLGTIGYMAPEYGREG------KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSL  980 (1049)
Q Consensus       910 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  980 (1049)
                      .......   .......||+.|+|||++.+.      .++.++|||||||++|||+||..||......+........   
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~---  233 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP---  233 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC---
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc---
Confidence            7644332   223346799999999998754      3677899999999999999999887654333222211100   


Q ss_pred             ccCCcchhc----ccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhh
Q 039290          981 LSCSITEVA----DANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043 (1049)
Q Consensus       981 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~ 1043 (1049)
                      ......++.    +....+... ......+++..+.+++.+||+.||++|||+.||+++|+++.++-
T Consensus       234 ~~~~~~~~~~~~~~~~~~p~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  299 (303)
T d1vjya_         234 SDPSVEEMRKVVCEQKLRPNIP-NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCC-GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ccchHHHHHHHHhccccCCCCC-cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence            000011111    111111111 11123456778999999999999999999999999999998763

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.1e-44  Score=392.22  Aligned_cols=259  Identities=21%  Similarity=0.376  Sum_probs=204.1

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCC---HHHHHHHHHHHhhcCCCceeeEEeeeecCC----e
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGS---LESFHAECKVMGSIRHRNLVKIISSCSNND----F  831 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~----~  831 (1049)
                      .++|++.+.||+|+||+||+|+. .+|+.||||+++......   .+.+.+|++++++++|||||++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            36799999999999999999995 579999999997654332   457899999999999999999999987643    4


Q ss_pred             eEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceec
Q 039290          832 KALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL  911 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~  911 (1049)
                      .|+||||++|++|.+++...+ .+++.+++.++.||+.|++|||   ++||+||||||+||+++.++.++++|||.+...
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhh
Confidence            789999999999999887654 4899999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCc--cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhc
Q 039290          912 GKEE--SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA  989 (1049)
Q Consensus       912 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  989 (1049)
                      ....  .......+||+.|+|||++.+..+++++||||+||++|||+||+.||......+........     .      
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~-----~------  230 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE-----D------  230 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-----C------
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhc-----C------
Confidence            4332  22334567999999999999999999999999999999999999999753322221111110     0      


Q ss_pred             ccccccccccCchhhHHHHHHHHHHHhhccccCCCCCC-CHHHHHHHHHHHH
Q 039290          990 DANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI-SMKDVANRLVRIR 1040 (1049)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~ell~~L~~i~ 1040 (1049)
                             .........++++++.+++.+|++.||++|| |++++++.|.+++
T Consensus       231 -------~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         231 -------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             -------CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -------CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence                   0000011123567899999999999999999 8999999998875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-45  Score=398.81  Aligned_cols=261  Identities=24%  Similarity=0.385  Sum_probs=201.5

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC------CCcEEEEEEeecccC-CCHHHHHHHHHHHhhc-CCCceeeEEeeeec-CC
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEFD-GSLESFHAECKVMGSI-RHRNLVKIISSCSN-ND  830 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~-~~  830 (1049)
                      .++|++.+.||+|+||+||+|++.      +++.||||+++.... ...+.+.+|..++.++ +||||+.+++++.+ ++
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            467999999999999999999853      346899999875432 2345677888888877 68999999998765 45


Q ss_pred             eeEEEEeccCCCChhhhhhcCC---------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec
Q 039290          831 FKALVLEYMSNGSLEKCLYSDN---------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN  895 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~  895 (1049)
                      ..++|||||++|+|.+++...+               ..+++.++..++.||++||+|||   +++||||||||+|||++
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeEC
Confidence            7899999999999999987542               24889999999999999999999   99999999999999999


Q ss_pred             CCCceEEecccCceecCCCcc-ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCC-CCCCccccccchHH
Q 039290          896 ESMVGHLSDFGIAKILGKEES-MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKK-KPTDEIFAGEMSLK  973 (1049)
Q Consensus       896 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~p~~~~~~~~~~~~  973 (1049)
                      +++.+||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||++|. .||......+....
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~  248 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR  248 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999999999999987654332 2334467999999999999999999999999999999999964 56765332222111


Q ss_pred             HhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhh
Q 039290          974 RWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043 (1049)
Q Consensus       974 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~ 1043 (1049)
                      .....                    .++..+..+++++.+++.+||+.||++|||++|++++|++++++.
T Consensus       249 ~~~~~--------------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n  298 (299)
T d1ywna1         249 RLKEG--------------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  298 (299)
T ss_dssp             HHHHT--------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHhcC--------------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence            11110                    011122335678999999999999999999999999999998764

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-45  Score=393.21  Aligned_cols=255  Identities=24%  Similarity=0.387  Sum_probs=199.5

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC--CC--cEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP--DG--MEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKA  833 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~--~~--~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~  833 (1049)
                      ++|++.+.||+|+||.||+|++.  ++  ..||||+++...   +...++|.+|++++++++|||||+++|++.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            46888999999999999999853  22  378999986543   23356899999999999999999999999764 678


Q ss_pred             EEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          834 LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      +||||+++|++.+++......+++..+.+++.||++||+|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            999999999999988877777999999999999999999999   99999999999999999999999999999998754


Q ss_pred             Cccc--cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchHHHhhhhccccCCcchhcc
Q 039290          914 EESM--RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD  990 (1049)
Q Consensus       914 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  990 (1049)
                      ....  ......++..|+|||++.+..++.++|||||||++|||+| |+.||.+....+.  ..++..            
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~--~~~i~~------------  229 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--LHKIDK------------  229 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHHHT------------
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH--HHHHHh------------
Confidence            4322  2233457889999999999999999999999999999998 8999975322221  111110            


Q ss_pred             cccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 039290          991 ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRI 1039 (1049)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i 1039 (1049)
                            ...+++.+..++.++.+++.+||+.||++||||+||++.|++.
T Consensus       230 ------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         230 ------EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                  0011222334567899999999999999999999999988764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.5e-44  Score=387.11  Aligned_cols=251  Identities=24%  Similarity=0.331  Sum_probs=207.4

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCC---------CHHHHHHHHHHHhhcC-CCceeeEEeeeecC
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDG---------SLESFHAECKVMGSIR-HRNLVKIISSCSNN  829 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~  829 (1049)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++.....         ..+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            5789999999999999999996 57899999999765422         1246889999999997 99999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCce
Q 039290          830 DFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK  909 (1049)
Q Consensus       830 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~  909 (1049)
                      +..|+||||+++|+|.+++...+ .+++.+++.++.||++||+|||   ++||+||||||+||+++.++.+||+|||+++
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhee
Confidence            99999999999999999997654 5899999999999999999999   9999999999999999999999999999999


Q ss_pred             ecCCCccccccccccccCcccccccCC------CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccC
Q 039290          910 ILGKEESMRQTKTLGTIGYMAPEYGRE------GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSC  983 (1049)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  983 (1049)
                      ......  ......||+.|+|||.+.+      ..++.++||||+||++|||++|+.||.+....+.. ......     
T Consensus       159 ~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~-~~i~~~-----  230 (277)
T d1phka_         159 QLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-RMIMSG-----  230 (277)
T ss_dssp             ECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHT-----
T ss_pred             EccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH-HHHHhC-----
Confidence            875433  2344679999999998753      45788999999999999999999999764322211 111100     


Q ss_pred             CcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          984 SITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                                  ...........+++++.+++.+||+.||++|||++|+++|
T Consensus       231 ------------~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         231 ------------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             ------------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ------------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                        0000111223466789999999999999999999999876

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-44  Score=394.56  Aligned_cols=256  Identities=25%  Similarity=0.414  Sum_probs=207.2

Q ss_pred             CceecCCCcEEEEEEEeCCC----cEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeec-CCeeEEEEecc
Q 039290          766 NKLLGMGSFGSVYKGVLPDG----MEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSN-NDFKALVLEYM  839 (1049)
Q Consensus       766 ~~~lg~G~fg~Vy~a~~~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~-~~~~~lv~e~~  839 (1049)
                      .++||+|+||+||+|++.++    ..||||+++... ....++|.+|++++++++||||++++|++.+ ++..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999996432    358999986432 3345789999999999999999999999865 56889999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc---
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES---  916 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~---  916 (1049)
                      ++|+|.+++.......++..+.+++.|+++||+|+|   +++|+||||||+|||+++++.+||+|||+++.......   
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            999999999888777889999999999999999999   99999999999999999999999999999987654322   


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                      .......||+.|+|||.+.+..++.++||||||+++|||+||+.||........ ...++...                 
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~-~~~~i~~g-----------------  250 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQG-----------------  250 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTT-----------------
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH-HHHHHHcC-----------------
Confidence            122335689999999999999999999999999999999998888764322211 11111000                 


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                        .+...+..+++++.+++.+||+.||++||++.||+++|+++.+++.
T Consensus       251 --~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~  296 (311)
T d1r0pa_         251 --RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  296 (311)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             --CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence              0111223456789999999999999999999999999999987744

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=397.64  Aligned_cols=262  Identities=24%  Similarity=0.413  Sum_probs=210.5

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCc--EEEEEEeeccc-CCCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCeeEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGM--EIAAKVFHMEF-DGSLESFHAECKVMGSI-RHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      ++|+..++||+|+||+||+|++. +|.  .||||+++... ....+++.+|+++++++ +|||||++++++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            46788899999999999999965 444  47788875432 34567899999999998 799999999999999999999


Q ss_pred             EeccCCCChhhhhhcC---------------CCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCce
Q 039290          836 LEYMSNGSLEKCLYSD---------------NYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVG  900 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~  900 (1049)
                      |||+++|+|.+++...               ...+++.++..++.||++|++|+|   +++|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence            9999999999998653               346899999999999999999999   9999999999999999999999


Q ss_pred             EEecccCceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCC-CCCccccccchHHHhhhhc
Q 039290          901 HLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKK-PTDEIFAGEMSLKRWVGDS  979 (1049)
Q Consensus       901 kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~-p~~~~~~~~~~~~~~~~~~  979 (1049)
                      ||+|||+|+......  ......||..|+|||.+.++.++.++|||||||++|||++|.. ||......+  ....+.. 
T Consensus       167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~--~~~~i~~-  241 (309)
T d1fvra_         167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKLPQ-  241 (309)
T ss_dssp             EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHGGG-
T ss_pred             EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH--HHHHHHh-
Confidence            999999998654322  2234568999999999999999999999999999999999764 565432221  1111110 


Q ss_pred             cccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhhccC
Q 039290          980 LLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSAYID 1048 (1049)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~~~~ 1048 (1049)
                                        ..++..+..+++++.+++.+||+.||++||||+||+++|+++.++...+++
T Consensus       242 ------------------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~~~  292 (309)
T d1fvra_         242 ------------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN  292 (309)
T ss_dssp             ------------------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBC
T ss_pred             ------------------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcCCCC
Confidence                              011222334667899999999999999999999999999999988777664

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.7e-44  Score=399.55  Aligned_cols=276  Identities=30%  Similarity=0.528  Sum_probs=227.1

Q ss_pred             CChhhHHHHHHHHHhcccCCCCcccccCCCCCCCce--eeeEEEcCCC--CcEEEEEEecccccc--ccCCCCCCcchhh
Q 039290           27 NVTTDQFALLALKEHIKHDPSNLLANNWSTTSSVCS--WIGVTCGVRN--RRVTALNISYLGLTG--TIPPQLGNLSFLA  100 (1049)
Q Consensus        27 ~~~~d~~all~~k~~~~~~~~~~l~~~w~~~~~~c~--w~gv~c~~~~--~~v~~l~l~~~~l~g--~~~~~~~~l~~L~  100 (1049)
                      |+++|++||++||+++. ||. .+ ++|..++|||.  |+||+|+..+  +||+.|+|++++++|  ++|+++++|++|+
T Consensus         3 c~~~e~~aLl~~k~~~~-~~~-~l-~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~   79 (313)
T d1ogqa_           3 CNPQDKQALLQIKKDLG-NPT-TL-SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN   79 (313)
T ss_dssp             SCHHHHHHHHHHHHHTT-CCG-GG-TTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred             CCHHHHHHHHHHHHHCC-CCC-cC-CCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccc
Confidence            89999999999999996 664 45 58888899994  9999998754  599999999999998  5899999999999


Q ss_pred             hhhccc-CccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCc
Q 039290          101 VLAIRN-NSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDN  179 (1049)
Q Consensus       101 ~L~l~~-n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N  179 (1049)
                      +|+|++ |++.|.||++|++|++|++|||++|++.+..|..+..+..|+++++++|.+.+.+|.+++.+++|+++++++|
T Consensus        80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n  159 (313)
T d1ogqa_          80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN  159 (313)
T ss_dssp             EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccc
Confidence            999986 8999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceEEeccccc
Q 039290          180 QLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSL  259 (1049)
Q Consensus       180 ~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  259 (1049)
                      .++|.+|..++.+..     .++.+++++|+++|..|..+..+..+ .++++.|.+.|.+|..++.+++++.+++++|.+
T Consensus       160 ~l~~~ip~~~~~l~~-----l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l  233 (313)
T d1ogqa_         160 RISGAIPDSYGSFSK-----LFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL  233 (313)
T ss_dssp             CCEEECCGGGGCCCT-----TCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEE
T ss_pred             ccccccccccccccc-----cccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccc
Confidence            999999988876543     24788888888888888777766544 577777777777777777777777777777777


Q ss_pred             cccCccccccccceEEEeeccccCCCccccccccccccceEEeccCccCCCCC
Q 039290          260 IGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLP  312 (1049)
Q Consensus       260 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  312 (1049)
                      .+.+| .++.+++|+.|+|++|+++|.+|..++++++|++|+|++|+++|.+|
T Consensus       234 ~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP  285 (313)
T d1ogqa_         234 AFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP  285 (313)
T ss_dssp             CCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC
T ss_pred             ccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCC
Confidence            76544 56667777777777777776666666666655555555555555444

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.9e-44  Score=399.92  Aligned_cols=245  Identities=23%  Similarity=0.267  Sum_probs=207.8

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc---CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF---DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      ++|++.+.||+|+||+||+|++ .+|+.||||++....   ....+.+.+|+++++.++|||||++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            4799999999999999999996 479999999986532   455678999999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcc
Q 039290          837 EYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEES  916 (1049)
Q Consensus       837 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~  916 (1049)
                      ||+.+|+|.+++...+ .+++.+++.++.||+.||+|||   +++||||||||+|||++.++.+||+|||+|+.....  
T Consensus       121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            9999999999987655 4899999999999999999999   999999999999999999999999999999976432  


Q ss_pred             ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcccccccc
Q 039290          917 MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLNC  996 (1049)
Q Consensus       917 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1049)
                        .....||+.|||||++.+..++.++||||+||++|||+||+.||.+....+.. .....                   
T Consensus       195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-~~i~~-------------------  252 (350)
T d1rdqe_         195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY-EKIVS-------------------  252 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHH-------------------
T ss_pred             --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHH-HHHhc-------------------
Confidence              23467999999999999999999999999999999999999999753221111 11100                   


Q ss_pred             cccCchhhHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 039290          997 EENDFSAREQCVSSIFSLAMDCTVDLPEKRI-----SMKDVANR 1035 (1049)
Q Consensus       997 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~~ 1035 (1049)
                        .....+..+++++.+++.+||+.||.+|+     |++|+++|
T Consensus       253 --~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         253 --GKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --CCCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence              00111223566789999999999999994     99999876

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.4e-44  Score=401.66  Aligned_cols=250  Identities=21%  Similarity=0.267  Sum_probs=202.5

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHH---HHHHHhhcCCCceeeEEeeeecCCee
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHA---ECKVMGSIRHRNLVKIISSCSNNDFK  832 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~---e~~~l~~l~hpniv~l~~~~~~~~~~  832 (1049)
                      .++|++.++||+|+||+||+|+.. +|+.||||++....   ......+.+   |+++++.++|||||++++++.+.+..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            357999999999999999999964 79999999986432   222333444   46677777899999999999999999


Q ss_pred             EEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecC
Q 039290          833 ALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILG  912 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~  912 (1049)
                      |+||||+++|+|.+++.... .+++.+++.++.||+.||+|||   ++|||||||||+|||++.++.+||+|||+|+.+.
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            99999999999999997654 4789999999999999999999   9999999999999999999999999999999775


Q ss_pred             CCccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccc
Q 039290          913 KEESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADA  991 (1049)
Q Consensus       913 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  991 (1049)
                      ...   .....||+.|+|||++.. ..++.++||||+||++|||+||+.||......+.....  ....           
T Consensus       159 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~--~~~~-----------  222 (364)
T d1omwa3         159 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--RMTL-----------  222 (364)
T ss_dssp             SSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH--HHSS-----------
T ss_pred             CCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH--Hhcc-----------
Confidence            432   234579999999999865 56899999999999999999999999764332221111  0000           


Q ss_pred             ccccccccCchhhHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 039290          992 NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRIS-----MKDVANR 1035 (1049)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~ell~~ 1035 (1049)
                            ......+..+++++.++|.+||+.||++|||     ++|+++|
T Consensus       223 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         223 ------TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             ------SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             ------cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence                  0011112235667899999999999999999     7899876

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-44  Score=394.76  Aligned_cols=252  Identities=22%  Similarity=0.285  Sum_probs=202.2

Q ss_pred             hcCCCCC-ceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhc-CCCceeeEEeeeec----CCee
Q 039290          760 TDGFSEN-KLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSI-RHRNLVKIISSCSN----NDFK  832 (1049)
Q Consensus       760 ~~~~~~~-~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~----~~~~  832 (1049)
                      .++|.+. +.||+|+||+||+|+. .+++.||||+++..     ..+.+|++++.++ +|||||++++++.+    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            3578776 4699999999999995 57899999998642     5788999987655 89999999999865    4678


Q ss_pred             EEEEeccCCCChhhhhhcCC-CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC---CCceEEecccCc
Q 039290          833 ALVLEYMSNGSLEKCLYSDN-YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE---SMVGHLSDFGIA  908 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~~~kl~DfGla  908 (1049)
                      |+|||||+||+|.+++...+ ..+++.+++.++.||+.|++|||   +.||+||||||+||+++.   .+.+||+|||+|
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence            99999999999999997653 46999999999999999999999   999999999999999985   567999999999


Q ss_pred             eecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchh
Q 039290          909 KILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEV  988 (1049)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  988 (1049)
                      +.......  .....||+.|+|||++.+..|+.++||||+||++|||+||+.||.+....+.... .             
T Consensus       162 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~-~-------------  225 (335)
T d2ozaa1         162 KETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-M-------------  225 (335)
T ss_dssp             EECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------------
T ss_pred             eeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH-H-------------
Confidence            87754432  3446799999999999999999999999999999999999999975322211100 0             


Q ss_pred             cccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          989 ADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ..................+++++.+++.+|++.||++|||+.|+++|
T Consensus       226 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         226 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             --CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            00000000011112234567889999999999999999999999886

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-44  Score=394.07  Aligned_cols=262  Identities=23%  Similarity=0.388  Sum_probs=213.1

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe------CCCcEEEEEEeecccC-CCHHHHHHHHHHHhhc-CCCceeeEEeeeecCCe
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL------PDGMEIAAKVFHMEFD-GSLESFHAECKVMGSI-RHRNLVKIISSCSNNDF  831 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~  831 (1049)
                      .++|+..++||+|+||.||+|++      .+++.||||+++.... ....++.+|+.+++++ +|||||++++++.+.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            35788899999999999999984      3466899999976442 2345789999999999 69999999999999999


Q ss_pred             eEEEEeccCCCChhhhhhcCC-----------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeee
Q 039290          832 KALVLEYMSNGSLEKCLYSDN-----------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL  894 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~  894 (1049)
                      .++||||+++|+|.+++....                 ..+++.++.+++.||++|++|||   +++||||||||+||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccc
Confidence            999999999999999987543                 25889999999999999999999   9999999999999999


Q ss_pred             cCCCceEEecccCceecCCCcc-ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCC-CCCCccccccchH
Q 039290          895 NESMVGHLSDFGIAKILGKEES-MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKK-KPTDEIFAGEMSL  972 (1049)
Q Consensus       895 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~p~~~~~~~~~~~  972 (1049)
                      +.++.+|++|||.++....... .......||+.|+|||++.++.++.++|||||||++|||+|+. +||... ......
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~-~~~~~~  257 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-PVDSKF  257 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-CSSHHH
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC-CHHHHH
Confidence            9999999999999997754332 2334467899999999999999999999999999999999954 444432 222222


Q ss_pred             HHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhh
Q 039290          973 KRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLS 1044 (1049)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~ 1044 (1049)
                      ...+....                   +...+..++.++.+++.+||+.||++||||+|++++|+++..+-+
T Consensus       258 ~~~i~~~~-------------------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~~  310 (311)
T d1t46a_         258 YKMIKEGF-------------------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (311)
T ss_dssp             HHHHHHTC-------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             HHHHhcCC-------------------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccCC
Confidence            22221110                   111123356779999999999999999999999999998876643

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-44  Score=396.07  Aligned_cols=248  Identities=24%  Similarity=0.344  Sum_probs=205.7

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeeccc---CCCHHHHHHHHHHHh-hcCCCceeeEEeeeecCCeeEEE
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF---DGSLESFHAECKVMG-SIRHRNLVKIISSCSNNDFKALV  835 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~hpniv~l~~~~~~~~~~~lv  835 (1049)
                      ++|++.++||+|+||+||+|+.. +++.||||+++...   ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57899999999999999999964 78999999997542   445567777777765 68999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCc
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~  915 (1049)
                      |||+++|+|.+++.... .+++.+++.++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+|+......
T Consensus        82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence            99999999999997655 4899999999999999999999   9999999999999999999999999999998664333


Q ss_pred             cccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhccccccc
Q 039290          916 SMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVADANLLN  995 (1049)
Q Consensus       916 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1049)
                      . ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+.......                   
T Consensus       158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-------------------  217 (320)
T d1xjda_         158 A-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-------------------  217 (320)
T ss_dssp             C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------------------
T ss_pred             c-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc-------------------
Confidence            2 33446799999999999999999999999999999999999999975322211111000                   


Q ss_pred             ccccCchhhHHHHHHHHHHHhhccccCCCCCCCHH-HHHHH
Q 039290          996 CEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMK-DVANR 1035 (1049)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~-ell~~ 1035 (1049)
                         ..+..+..+++++.+++.+||+.||++|||+. |+++|
T Consensus       218 ---~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         218 ---DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             ---CCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             ---CCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence               01111223567789999999999999999995 77654

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-44  Score=390.76  Aligned_cols=258  Identities=26%  Similarity=0.437  Sum_probs=206.5

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC--------CCcEEEEEEeecccC-CCHHHHHHHHHHHhhc-CCCceeeEEeeeecC
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP--------DGMEIAAKVFHMEFD-GSLESFHAECKVMGSI-RHRNLVKIISSCSNN  829 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~  829 (1049)
                      .++|++.+.||+|+||.||+|+..        ++..||||+++.... ....++.+|...+.++ +|||||++++++.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            357888999999999999999842        234799999976543 2346788899999888 799999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhhcCC---------------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeee
Q 039290          830 DFKALVLEYMSNGSLEKCLYSDN---------------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLL  894 (1049)
Q Consensus       830 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~  894 (1049)
                      +..++||||+++|+|.+++....               ..+++.++++++.||+.||+|||   +.+||||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence            99999999999999999997543               35899999999999999999999   9999999999999999


Q ss_pred             cCCCceEEecccCceecCCCccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccchH
Q 039290          895 NESMVGHLSDFGIAKILGKEESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFT-KKKPTDEIFAGEMSL  972 (1049)
Q Consensus       895 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~  972 (1049)
                      +.++.+||+|||+++........ ......+++.|+|||.+.++.++.++|||||||++|||++ |..||.+....+  .
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--~  246 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--L  246 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--H
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH--H
Confidence            99999999999999876543322 2334568899999999999999999999999999999998 688886533221  1


Q ss_pred             HHhhhhccccCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 039290          973 KRWVGDSLLSCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041 (1049)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~ 1041 (1049)
                      ..++...                   .++..+..+++++.+++.+||+.||++||||+||++.|+++.+
T Consensus       247 ~~~i~~~-------------------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         247 FKLLKEG-------------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             HHHHHTT-------------------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHcC-------------------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            1111100                   0111223356779999999999999999999999999999865

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-43  Score=387.28  Aligned_cols=271  Identities=22%  Similarity=0.254  Sum_probs=205.0

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++...  +...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5799999999999999999996 579999999996543  2346789999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      |+.++.+..........+++.+++.++.|++.||+|||   ++|||||||||+|||++.++.+||+|||.|+....... 
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-  157 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  157 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCcc-
Confidence            99765454444455567999999999999999999999   99999999999999999999999999999987654332 


Q ss_pred             cccccccccCcccccccCCCC-cCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhcc-ccCCcchhcc-cccc
Q 039290          918 RQTKTLGTIGYMAPEYGREGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSL-LSCSITEVAD-ANLL  994 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~  994 (1049)
                      ......||+.|+|||++.... ++.++||||+||++|+|++|+.||.+....+........... .+........ ....
T Consensus       158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK  237 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence            234467999999999877655 578999999999999999999999764322221111111000 0000000000 0000


Q ss_pred             cc----cccC-chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          995 NC----EEND-FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       995 ~~----~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ..    .... .......++++.+++.+|++.||++|||++|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            00    0000 11112345778999999999999999999999987

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-43  Score=387.68  Aligned_cols=264  Identities=21%  Similarity=0.227  Sum_probs=197.3

Q ss_pred             CceecCCCcEEEEEEEe-CCCcEEEEEEeecccCC-----CHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEecc
Q 039290          766 NKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDG-----SLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEYM  839 (1049)
Q Consensus       766 ~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  839 (1049)
                      .++||+|+||+||+|+. .+|+.||||+++.....     ..+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            47899999999999996 47999999998654321     2356889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccccc
Q 039290          840 SNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMRQ  919 (1049)
Q Consensus       840 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~~  919 (1049)
                      .++++..+.. .+..+++.++..++.||+.||+|||   ++||+||||||+|||++.++.+||+|||+|+....... ..
T Consensus        83 ~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~  157 (299)
T d1ua2a_          83 ETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AY  157 (299)
T ss_dssp             SEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CC
T ss_pred             cchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcc-cc
Confidence            8877666554 4456899999999999999999999   99999999999999999999999999999987654332 22


Q ss_pred             cccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhc--cccCCcchhc---cccc
Q 039290          920 TKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDS--LLSCSITEVA---DANL  993 (1049)
Q Consensus       920 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~---~~~~  993 (1049)
                      ...+||+.|+|||++.. ..++.++||||+||++|||++|..||......+.... .....  ..........   ....
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~-i~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR-IFETLGTPTEEQWPDMCSLPDYVT  236 (299)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred             cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHH-HHHhcCCCChhhccchhccchhhh
Confidence            34578999999998865 4579999999999999999999999975432221111 11000  0000000000   0000


Q ss_pred             ccc-cccC-chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          994 LNC-EEND-FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       994 ~~~-~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ... +... .......++++.+++.+|++.||++|||++|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            000 0000 01112345779999999999999999999999876

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.8e-43  Score=383.54  Aligned_cols=270  Identities=20%  Similarity=0.241  Sum_probs=204.0

Q ss_pred             cCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEec
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      ++|++.++||+|+||+||+|++++|+.||||+++...  ....+.+.+|+.++++++|||||++++++.+.+..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5899999999999999999999999999999996643  33467899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCcccc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESMR  918 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~~  918 (1049)
                      +.++.+..+.. ....+++.+++.++.||+.||+|||   +.+||||||||+|||++.++.+|++|||.|.....+.. .
T Consensus        82 ~~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~  156 (286)
T d1ob3a_          82 LDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K  156 (286)
T ss_dssp             CSEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             ehhhhHHHHHh-hcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc-c
Confidence            98766666544 4456999999999999999999999   99999999999999999999999999999987654332 2


Q ss_pred             ccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhc-cccCCcchhcc-----c
Q 039290          919 QTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDS-LLSCSITEVAD-----A  991 (1049)
Q Consensus       919 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~  991 (1049)
                      .....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+....+.....+.... ...........     .
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence            334568999999998865 4568999999999999999999999976432222111111000 00000000000     0


Q ss_pred             ccc-cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          992 NLL-NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       992 ~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ... .............++++.+++.+|++.||++|||++|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000 00000111122345678999999999999999999999875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-43  Score=389.97  Aligned_cols=258  Identities=23%  Similarity=0.394  Sum_probs=209.7

Q ss_pred             hcCCCCCceecCCCcEEEEEEEeC------CCcEEEEEEeecccC-CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCee
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVLP------DGMEIAAKVFHMEFD-GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFK  832 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~  832 (1049)
                      .++|+..+.||+|+||+||+|.+.      +++.||||+++.... .....+.+|++++++++|||||++++++...+..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            357888999999999999999863      357899999975432 2345689999999999999999999999999999


Q ss_pred             EEEEeccCCCChhhhhhcCC---------CccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEe
Q 039290          833 ALVLEYMSNGSLEKCLYSDN---------YFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLS  903 (1049)
Q Consensus       833 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~  903 (1049)
                      ++||||+++|+|.+++...+         ..+++.++.+++.|+++||+|||   +++|+||||||+|||+++++.+||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEe
Confidence            99999999999999886432         24688999999999999999999   9999999999999999999999999


Q ss_pred             cccCceecCCCccc-cccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCC-CCCCccccccchHHHhhhhccc
Q 039290          904 DFGIAKILGKEESM-RQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKK-KPTDEIFAGEMSLKRWVGDSLL  981 (1049)
Q Consensus       904 DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~  981 (1049)
                      |||+|+........ ......+|+.|+|||.+.+..++.++|||||||++|||+||. .||.+....+.  ...+     
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~--~~~i-----  248 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV--LRFV-----  248 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH--HHHH-----
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH--HHHH-----
Confidence            99999876443322 233346899999999999999999999999999999999985 66654322211  1111     


Q ss_pred             cCCcchhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 039290          982 SCSITEVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRE 1041 (1049)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~ 1041 (1049)
                             .+.       .+...+..++..+.+++.+||+.+|++|||++||+++|++..+
T Consensus       249 -------~~~-------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         249 -------MEG-------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             -------HTT-------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -------HhC-------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                   000       1112223456789999999999999999999999999987655

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-43  Score=382.96  Aligned_cols=240  Identities=24%  Similarity=0.315  Sum_probs=197.9

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCC------CHHHHHHHHHHHhhcC--CCceeeEEeeeecCCe
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDG------SLESFHAECKVMGSIR--HRNLVKIISSCSNNDF  831 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--hpniv~l~~~~~~~~~  831 (1049)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++.....      ...++.+|+.++++++  |||||++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            5799999999999999999996 47899999999754321      2244678999999996  8999999999999999


Q ss_pred             eEEEEeccCC-CChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC-CCceEEecccCce
Q 039290          832 KALVLEYMSN-GSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE-SMVGHLSDFGIAK  909 (1049)
Q Consensus       832 ~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-~~~~kl~DfGla~  909 (1049)
                      .++||||+.+ +++.+++.... .+++.+++.++.||++||+|||   ++||+||||||+||+++. ++.+||+|||+|+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGA  159 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccce
Confidence            9999999976 57777776544 5899999999999999999999   999999999999999985 5799999999998


Q ss_pred             ecCCCccccccccccccCcccccccCCCCc-CcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchh
Q 039290          910 ILGKEESMRQTKTLGTIGYMAPEYGREGKV-SRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEV  988 (1049)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  988 (1049)
                      ......   .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||....    ....  +.          
T Consensus       160 ~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~i~~--~~----------  220 (273)
T d1xwsa_         160 LLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----EIIR--GQ----------  220 (273)
T ss_dssp             ECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HHHH--CC----------
T ss_pred             eccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----HHhh--cc----------
Confidence            764332   344679999999999877665 577999999999999999999997521    1000  00          


Q ss_pred             cccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          989 ADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                                  ...+..+++++.+++.+||+.||++|||++|+++|
T Consensus       221 ------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         221 ------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             ------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                        00111245678999999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-42  Score=382.66  Aligned_cols=270  Identities=21%  Similarity=0.233  Sum_probs=203.1

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CC-CcEEEEEEeeccc--CCCHHHHHHHHHHHhhc---CCCceeeEEeeeec----
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PD-GMEIAAKVFHMEF--DGSLESFHAECKVMGSI---RHRNLVKIISSCSN----  828 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~hpniv~l~~~~~~----  828 (1049)
                      .++|++.+.||+|+||+||+|++ .+ ++.||||+++...  ......+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            36899999999999999999996 34 5679999997643  22344566778777666   79999999999853    


Q ss_pred             -CCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccC
Q 039290          829 -NDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGI  907 (1049)
Q Consensus       829 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGl  907 (1049)
                       ....+++|||++++.+..........+++..++.++.|++.||+|||   +++||||||||+|||+++++.+||+|||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhh
Confidence             35789999999988777666666667899999999999999999999   99999999999999999999999999999


Q ss_pred             ceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhh--ccccCCc
Q 039290          908 AKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGD--SLLSCSI  985 (1049)
Q Consensus       908 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~~~  985 (1049)
                      +.......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+.. ......  ......+
T Consensus       163 ~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~  239 (305)
T d1blxa_         163 ARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL-GKILDVIGLPGEEDW  239 (305)
T ss_dssp             CCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCCCCGGGS
T ss_pred             hhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHH-HHHHHhhCCCchhcc
Confidence            98654332  334567999999999999999999999999999999999999999764322211 111100  0000000


Q ss_pred             chhc---ccccc-cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          986 TEVA---DANLL-NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       986 ~~~~---~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ....   ..... .............++.+.+|+.+||+.||++|||++|+++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0000   00000 00001111123345678999999999999999999999987

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-41  Score=372.54  Aligned_cols=271  Identities=21%  Similarity=0.278  Sum_probs=199.1

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc--CCCHHHHHHHHHHHhhcCCCceeeEEeeeec--------
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF--DGSLESFHAECKVMGSIRHRNLVKIISSCSN--------  828 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--------  828 (1049)
                      .++|++.+.||+|+||+||+|++ .+|+.||||++....  +....++.+|++++++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            36899999999999999999996 589999999986543  3446788999999999999999999998755        


Q ss_pred             CCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCc
Q 039290          829 NDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIA  908 (1049)
Q Consensus       829 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla  908 (1049)
                      .+..++||||++++.+... ......+++.+++.++.|+++|++|||   +.||+||||||+||+++.++.+|++|||++
T Consensus        89 ~~~~~iv~e~~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             --CEEEEEECCCEEHHHHH-TCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCCCccchh-hhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence            3468999999988666544 444456899999999999999999999   999999999999999999999999999999


Q ss_pred             eecCCCcc---ccccccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccchH--HHhhhhcccc
Q 039290          909 KILGKEES---MRQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSL--KRWVGDSLLS  982 (1049)
Q Consensus       909 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--~~~~~~~~~~  982 (1049)
                      ........   ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+...  .+..+. ...
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~-~~~  243 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS-ITP  243 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCT
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC-CCh
Confidence            87653331   122335789999999988754 68999999999999999999999997533222111  111110 000


Q ss_pred             CCcchhccc----ccccccccCchh-----hHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          983 CSITEVADA----NLLNCEENDFSA-----REQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       983 ~~~~~~~~~----~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .........    ........+...     .....+.+.+++.+|+++||++|||++|+++|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            000000000    000000111111     12234567899999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.6e-40  Score=361.79  Aligned_cols=264  Identities=16%  Similarity=0.180  Sum_probs=213.5

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCC-CceeeEEeeeecCCeeEEEEec
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRH-RNLVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-pniv~l~~~~~~~~~~~lv~e~  838 (1049)
                      ++|++.+.||+|+||+||+|++. +|+.||||++....  ..+.+.+|++.++.++| +|++.+++++.++...++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            57999999999999999999954 78999999986543  23467889999999965 8999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecC-----CCceEEecccCceecCC
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNE-----SMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-----~~~~kl~DfGla~~~~~  913 (1049)
                      + +++|.+++......+++.++..++.|++.|++|||   ++||+||||||+||+++.     ++.+||+|||+|+.+..
T Consensus        83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            9 67999999887778999999999999999999999   999999999999999974     57899999999987643


Q ss_pred             Ccc------ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchH-HHhhhhccccCCcc
Q 039290          914 EES------MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSL-KRWVGDSLLSCSIT  986 (1049)
Q Consensus       914 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~  986 (1049)
                      ...      .......||+.|||||++.+..+++++||||+||++|||++|+.||.......... ...+........  
T Consensus       159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~--  236 (293)
T d1csna_         159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP--  236 (293)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC--
T ss_pred             CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC--
Confidence            321      12234579999999999999999999999999999999999999997643332211 111110000000  


Q ss_pred             hhcccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhhhh
Q 039290          987 EVADANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETLSA 1045 (1049)
Q Consensus       987 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~~~ 1045 (1049)
                                   .......+++++.+++..|+..+|++||+++.+.+.|+++.++...
T Consensus       237 -------------~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~  282 (293)
T d1csna_         237 -------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT  282 (293)
T ss_dssp             -------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             -------------hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC
Confidence                         0011123567899999999999999999999999999998876643

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-40  Score=365.11  Aligned_cols=263  Identities=20%  Similarity=0.232  Sum_probs=204.4

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCc-eeeEEeeeecCCeeEEEEec
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRN-LVKIISSCSNNDFKALVLEY  838 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn-iv~l~~~~~~~~~~~lv~e~  838 (1049)
                      ++|++.+.||+|+||+||+|++ .+|+.||||++.....  .+++.+|+++++.++|++ |+.+.+++.+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            5799999999999999999996 5789999999876432  346789999999998766 45555666788889999999


Q ss_pred             cCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeec---CCCceEEecccCceecCCCc
Q 039290          839 MSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLN---ESMVGHLSDFGIAKILGKEE  915 (1049)
Q Consensus       839 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~---~~~~~kl~DfGla~~~~~~~  915 (1049)
                      + ++++.+.+......+++..+..++.|++.||+|||   ++||+||||||+|||++   .+..+|++|||+|+.+....
T Consensus        85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            9 55777777766677999999999999999999999   99999999999999986   45679999999999775432


Q ss_pred             c------ccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhc
Q 039290          916 S------MRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA  989 (1049)
Q Consensus       916 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  989 (1049)
                      .      .......||+.|+|||++.+..+++++|||||||++|||++|+.||......+.........           
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~-----------  229 (299)
T d1ckia_         161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS-----------  229 (299)
T ss_dssp             TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH-----------
T ss_pred             cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh-----------
Confidence            1      12234579999999999999999999999999999999999999997643332221110000           


Q ss_pred             ccccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHhh
Q 039290          990 DANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANRLVRIRETL 1043 (1049)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~i~~~~ 1043 (1049)
                      ....   ..........+++++.+++.+||+.+|++||+++++.+.|+++..+.
T Consensus       230 ~~~~---~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         230 EKKM---STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             HHHH---HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cccC---CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            0000   00001112346678999999999999999999999999998876543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-41  Score=365.57  Aligned_cols=270  Identities=20%  Similarity=0.227  Sum_probs=207.4

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecCCeeEEEEe
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNNDFKALVLE  837 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  837 (1049)
                      ++|++.++||+|+||+||+|++ .+++.||||+++....  ...+++.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5799999999999999999996 5788999999976542  346788999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCCCccc
Q 039290          838 YMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGKEESM  917 (1049)
Q Consensus       838 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~~~~~  917 (1049)
                      ++.++++..++... ..+++..++.++.|+++||+|||   ++||+||||||+|||++.++.+|++|||.|+........
T Consensus        82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~  157 (292)
T d1unla_          82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred             eccccccccccccc-cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence            99998888877654 45889999999999999999999   999999999999999999999999999999987544332


Q ss_pred             cccccccccCcccccccCCCC-cCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccc--cCCcc---hhcc-
Q 039290          918 RQTKTLGTIGYMAPEYGREGK-VSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLL--SCSIT---EVAD-  990 (1049)
Q Consensus       918 ~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~---~~~~-  990 (1049)
                       .....+++.|+|||.+.... ++.++||||+||++|||++|+.||...................  .....   ...+ 
T Consensus       158 -~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (292)
T d1unla_         158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             -CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             -ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence             23345778899999887654 6899999999999999999999975422222111111110000  00000   0000 


Q ss_pred             --cccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          991 --ANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       991 --~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                        .................++.+.+++.+|++.||.+||||+|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              000001111122223455678999999999999999999999876

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-41  Score=370.33  Aligned_cols=253  Identities=25%  Similarity=0.294  Sum_probs=207.8

Q ss_pred             cCCCCCceecCCCcEEEEEEEe----CCCcEEEEEEeeccc----CCCHHHHHHHHHHHhhcCC-CceeeEEeeeecCCe
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL----PDGMEIAAKVFHMEF----DGSLESFHAECKVMGSIRH-RNLVKIISSCSNNDF  831 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-pniv~l~~~~~~~~~  831 (1049)
                      ++|++.+.||+|+||+||+|+.    .+|+.||||+++...    ....+.+.+|++++++++| |||+++++++.+.+.
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5699999999999999999984    258899999986532    2345678899999999976 899999999999999


Q ss_pred             eEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceec
Q 039290          832 KALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL  911 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~  911 (1049)
                      .++||||+.+|+|.+++...+. ..+..+..++.|++.|++|+|   +.+||||||||+||+++.++.+||+|||+|+.+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eeeeeecccccHHHHHHHhccc-ccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            9999999999999999887654 678899999999999999999   999999999999999999999999999999887


Q ss_pred             CCCccccccccccccCcccccccCCC--CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhc
Q 039290          912 GKEESMRQTKTLGTIGYMAPEYGREG--KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVA  989 (1049)
Q Consensus       912 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  989 (1049)
                      ............|++.|+|||.+.+.  .++.++||||+||++|||++|+.||......+...........         
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~---------  250 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK---------  250 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH---------
T ss_pred             cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc---------
Confidence            65554445567799999999988654  4678999999999999999999999765444332222111111         


Q ss_pred             ccccccccccCchhhHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 039290          990 DANLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRI-----SMKDVANR 1035 (1049)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~~ 1035 (1049)
                               .....+..++.++.+++.+||++||++||     |++|+++|
T Consensus       251 ---------~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         251 ---------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             ---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             ---------CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence                     01112234567899999999999999999     58999875

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-41  Score=373.79  Aligned_cols=269  Identities=21%  Similarity=0.227  Sum_probs=198.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeeccc-CCCHHHHHHHHHHHhhcCCCceeeEEeeeecCC----eeE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEF-DGSLESFHAECKVMGSIRHRNLVKIISSCSNND----FKA  833 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~----~~~  833 (1049)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+++.+|++++++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            45799999999999999999985 589999999997543 233567889999999999999999999986543    234


Q ss_pred             EEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceecCC
Q 039290          834 LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKILGK  913 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~~~  913 (1049)
                      ++++|+.+|+|.+++...  .+++..++.++.|++.||+|||   ++|||||||||+|||++.++.+||+|||+|+....
T Consensus        87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            555666789999999764  4899999999999999999999   99999999999999999999999999999987654


Q ss_pred             Ccc--ccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCcchhcc
Q 039290          914 EES--MRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSITEVAD  990 (1049)
Q Consensus       914 ~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  990 (1049)
                      ...  ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||......+.......  ............
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~  239 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG--ILGSPSQEDLNC  239 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--HHCSCCHHHHHT
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhh--hccCCChhhhhh
Confidence            332  12344678999999998854 5678999999999999999999999976432221111100  000000000000


Q ss_pred             -------cccccccc-cCc---hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          991 -------ANLLNCEE-NDF---SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       991 -------~~~~~~~~-~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                             ......+. ...   ......+.++.+++.+|++.||++|||++|+++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                   00000000 000   1112234678999999999999999999999987

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-40  Score=371.82  Aligned_cols=264  Identities=23%  Similarity=0.269  Sum_probs=194.2

Q ss_pred             CCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCceeeEEeeeec------CCeeEE
Q 039290          762 GFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNLVKIISSCSN------NDFKAL  834 (1049)
Q Consensus       762 ~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~------~~~~~l  834 (1049)
                      +|+..++||+|+||+||+|++. +|+.||||+++....    ...+|++++++++||||+++++++..      ..+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            4778899999999999999964 799999999975432    23479999999999999999999843      335789


Q ss_pred             EEeccCCCChhhhhh--cCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC-ceEEecccCceec
Q 039290          835 VLEYMSNGSLEKCLY--SDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM-VGHLSDFGIAKIL  911 (1049)
Q Consensus       835 v~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-~~kl~DfGla~~~  911 (1049)
                      ||||++++.+..+..  .....+++.+++.++.||+.||+|||   ++||+||||||+|||++.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999998764443322  24446899999999999999999999   99999999999999999765 8999999999877


Q ss_pred             CCCccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhc--cccCCcchh
Q 039290          912 GKEESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDS--LLSCSITEV  988 (1049)
Q Consensus       912 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~  988 (1049)
                      .....  .....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+.. .......  .....+...
T Consensus       174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l-~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL-VEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH-HHHHHHHCCCCHHHHHHH
T ss_pred             cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHH-HHHHHHhCCChHHhhhhh
Confidence            54332  334678999999998764 57899999999999999999999999754322211 1110000  000000000


Q ss_pred             c----cccccccccc--CchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          989 A----DANLLNCEEN--DFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       989 ~----~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .    +.........  ........++++.+++.+|++.||++|||++|+++|
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0    0000000000  001112345678999999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-40  Score=373.27  Aligned_cols=264  Identities=21%  Similarity=0.249  Sum_probs=195.5

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccC--CCHHHHHHHHHHHhhcCCCceeeEEeeeecCC------
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFD--GSLESFHAECKVMGSIRHRNLVKIISSCSNND------  830 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~------  830 (1049)
                      .++|++.++||+|+||+||+|+. .+|+.||||+++....  ...+.+.+|++++++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            46899999999999999999996 4799999999975432  23467889999999999999999999997654      


Q ss_pred             eeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCcee
Q 039290          831 FKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI  910 (1049)
Q Consensus       831 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~  910 (1049)
                      +.++||||+ +.+|..+....  .+++..++.++.||+.||+|||   ++||+||||||+|||++.++.+|++|||+|+.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceec
Confidence            569999999 56787776543  4899999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCccccccccccccCcccccccCC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCCc----
Q 039290          911 LGKEESMRQTKTLGTIGYMAPEYGRE-GKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCSI----  985 (1049)
Q Consensus       911 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----  985 (1049)
                      ....    .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+.. ...... ......    
T Consensus       171 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~-~~~~~~-~~~~~~~~~~  244 (346)
T d1cm8a_         171 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL-KEIMKV-TGTPPAEFVQ  244 (346)
T ss_dssp             CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHH-HCCCCHHHHH
T ss_pred             cCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHH-HHHHhc-cCCCcHHHHh
Confidence            6443    234678999999998866 45689999999999999999999999764222111 110000 000000    


Q ss_pred             ------chhcccccccccccC-chhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          986 ------TEVADANLLNCEEND-FSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       986 ------~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                            ............... .......++++.+|+.+|++.||++|||++|+++|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                  000000000000000 11112345678899999999999999999999987

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=7.1e-40  Score=364.04  Aligned_cols=264  Identities=17%  Similarity=0.253  Sum_probs=200.3

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcC-CCceeeEEeeeec--CCeeEEE
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR-HRNLVKIISSCSN--NDFKALV  835 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~--~~~~~lv  835 (1049)
                      .++|++.++||+|+||+||+|+. .+|+.||||+++..   ..+++.+|++++++++ ||||+++++++..  .+..++|
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            35799999999999999999996 57899999998643   4578899999999995 9999999999874  4568999


Q ss_pred             EeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCC-ceEEecccCceecCCC
Q 039290          836 LEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESM-VGHLSDFGIAKILGKE  914 (1049)
Q Consensus       836 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-~~kl~DfGla~~~~~~  914 (1049)
                      |||+++++|.++.    +.+++.+++.++.||+.||+|||   ++|||||||||+|||++.++ .+||+|||+|+.....
T Consensus       111 ~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         111 FEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             EECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             EeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            9999999998764    34899999999999999999999   99999999999999998654 6999999999876543


Q ss_pred             ccccccccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccchHH------------Hhhhhccc
Q 039290          915 ESMRQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK------------RWVGDSLL  981 (1049)
Q Consensus       915 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~------------~~~~~~~~  981 (1049)
                      .  ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||...........            .|......
T Consensus       184 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         184 Q--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             C--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             C--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence            3  23446789999999987764 479999999999999999999999865322211110            11110000


Q ss_pred             c--CCcchhcccccccccc--cCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          982 S--CSITEVADANLLNCEE--NDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       982 ~--~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      .  ................  .........++++.+|+.+|++.||++|||++|+++|
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0  0000010000000000  0111223356778999999999999999999999875

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-39  Score=365.55  Aligned_cols=266  Identities=21%  Similarity=0.184  Sum_probs=192.9

Q ss_pred             cCCCCCceecCCCcEEEEEEEeC-CCcEEEEEEeecccCC--CHHHHHHHHHHHhhcCCCceeeEEeeeec------CCe
Q 039290          761 DGFSENKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEFDG--SLESFHAECKVMGSIRHRNLVKIISSCSN------NDF  831 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~------~~~  831 (1049)
                      ++|++.++||+|+||+||+|++. +|+.||||+++.....  ...++.+|+.++++++|||||++++++..      .++
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999965 7999999999765432  34568899999999999999999999853      468


Q ss_pred             eEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceec
Q 039290          832 KALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL  911 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~  911 (1049)
                      .|+||||+.++.+.. +.   ..+++.+++.++.|++.|++|||   +.||+||||||+|||++.++.+|++|||+++..
T Consensus        97 ~~iv~Ey~~~~l~~~-~~---~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          97 VYLVMELMDANLCQV-IQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEECCSEEHHHH-HT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEeccchHHHHh-hh---cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcc
Confidence            899999997755544 33   24789999999999999999999   999999999999999999999999999998866


Q ss_pred             CCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccchHH-----------Hhhhh--
Q 039290          912 GKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLK-----------RWVGD--  978 (1049)
Q Consensus       912 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~-----------~~~~~--  978 (1049)
                      ....  ......+|+.|+|||++.+..+++++||||+||+++||++|+.||.+.........           .|...  
T Consensus       170 ~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (355)
T d2b1pa1         170 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_dssp             -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred             cccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence            4432  33445789999999999999999999999999999999999999965321111000           00000  


Q ss_pred             -----ccccCCcchhcccccc--cccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          979 -----SLLSCSITEVADANLL--NCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       979 -----~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                           ............+...  .............+.++.+|+.+|++.||++||||+|+++|
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                 0000000000000000  00111223345577889999999999999999999999987

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-39  Score=365.40  Aligned_cols=267  Identities=19%  Similarity=0.225  Sum_probs=196.4

Q ss_pred             hcCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCC--CHHHHHHHHHHHhhcCCCceeeEEeeeecC-----Ce
Q 039290          760 TDGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDG--SLESFHAECKVMGSIRHRNLVKIISSCSNN-----DF  831 (1049)
Q Consensus       760 ~~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~-----~~  831 (1049)
                      .++|++.+.||+|+||+||+|+. .+|+.||||+++.....  ..+++.+|++++++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            56899999999999999999995 57999999999765432  345788999999999999999999998533     33


Q ss_pred             eEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecccCceec
Q 039290          832 KALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKIL  911 (1049)
Q Consensus       832 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~~  911 (1049)
                      .++++||+.+|+|.+++...  .+++.+++.++.||+.||+|||   ++||+||||||+||+++.++.+|++|||.+...
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhccc
Confidence            46677788899999998654  4899999999999999999999   999999999999999999999999999999765


Q ss_pred             CCCccccccccccccCcccccccCCC-CcCcccchHHHHHHHHHHHhCCCCCCccccccchHHHhhhhccccCC-----c
Q 039290          912 GKEESMRQTKTLGTIGYMAPEYGREG-KVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEMSLKRWVGDSLLSCS-----I  985 (1049)
Q Consensus       912 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----~  985 (1049)
                      ..    ......|++.|+|||...+. .++.++||||+||++|+|++|+.||.+....................     .
T Consensus       172 ~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (348)
T d2gfsa1         172 DD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  247 (348)
T ss_dssp             TG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred             Cc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence            33    23346789999999987664 46899999999999999999999997532211111100000000000     0


Q ss_pred             chh---cccccccccccCc-hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 039290          986 TEV---ADANLLNCEENDF-SAREQCVSSIFSLAMDCTVDLPEKRISMKDVANR 1035 (1049)
Q Consensus       986 ~~~---~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~ 1035 (1049)
                      ...   ............+ ......++++.+++.+|++.||++|||++|+++|
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence            000   0000000000000 0112345678999999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-35  Score=335.08  Aligned_cols=267  Identities=16%  Similarity=0.173  Sum_probs=191.1

Q ss_pred             cCCCCCceecCCCcEEEEEEEe-CCCcEEEEEEeecccCCCHHHHHHHHHHHhhcC-----------CCceeeEEeeeec
Q 039290          761 DGFSENKLLGMGSFGSVYKGVL-PDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR-----------HRNLVKIISSCSN  828 (1049)
Q Consensus       761 ~~~~~~~~lg~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------hpniv~l~~~~~~  828 (1049)
                      ++|++.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            3599999999999999999996 579999999997542 23467788999888875           5789999988754


Q ss_pred             --CCeeEEEEeccCCCCh--hhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCC-CCeEEcCCCCCCeeecCCC-----
Q 039290          829 --NDFKALVLEYMSNGSL--EKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYS-TPIVHCDIKPSNVLLNESM-----  898 (1049)
Q Consensus       829 --~~~~~lv~e~~~~g~L--~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~~-----  898 (1049)
                        ....+++++++..+..  ..........+++..++.++.|++.|++|||   + .||+||||||+|||++.++     
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh---~~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHh---hhcCcccccCChhHeeeeccCccccc
Confidence              3456667776655432  2223334457899999999999999999999   6 8999999999999998654     


Q ss_pred             -ceEEecccCceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHHHHHHhCCCCCCccccccc-----hH
Q 039290          899 -VGHLSDFGIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIMLMETFTKKKPTDEIFAGEM-----SL  972 (1049)
Q Consensus       899 -~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-----~~  972 (1049)
                       .++++|||.|......    ....+||+.|+|||++....++.++||||+||+++||++|+.||........     ..
T Consensus       169 ~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             ceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence             4999999999865432    2346789999999999999999999999999999999999999975322110     01


Q ss_pred             HHhhhhccc--------cCCcchhccc-------------ccccccccCchhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 039290          973 KRWVGDSLL--------SCSITEVADA-------------NLLNCEENDFSAREQCVSSIFSLAMDCTVDLPEKRISMKD 1031 (1049)
Q Consensus       973 ~~~~~~~~~--------~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~e 1031 (1049)
                      .........        ........+.             ................++++.+|+.+|++.||++|||++|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence            111000000        0000000000             0000011122233567788999999999999999999999


Q ss_pred             HHHH
Q 039290         1032 VANR 1035 (1049)
Q Consensus      1032 ll~~ 1035 (1049)
                      +++|
T Consensus       325 ~L~H  328 (362)
T d1q8ya_         325 LVNH  328 (362)
T ss_dssp             HHTC
T ss_pred             HhcC
Confidence            9986

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=7.7e-32  Score=297.33  Aligned_cols=258  Identities=33%  Similarity=0.583  Sum_probs=236.2

Q ss_pred             cccEEEccCCcccc--CCCCCCCCCCCccEEEccC-CcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceE
Q 039290          423 SMKSLSMESCNISG--GIPKELGNINNLTVIRLGN-NELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANL  499 (1049)
Q Consensus       423 ~L~~L~L~~n~i~~--~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  499 (1049)
                      .+++|+|++|++++  .+|+.++++++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+.+|+.+
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l  130 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence            46777777777776  4788999999999999987 89999999999999999999999999999889999999999999


Q ss_pred             EeeCcccCCcCchhccCcccCCceeecCcccccccCccccccccc-ccccccCCccCCCCccCcCCCcceeEeecccccc
Q 039290          500 YLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDI-LRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNAL  578 (1049)
Q Consensus       500 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  578 (1049)
                      ++++|.+.+.+|..+++++.|+.+++++|++++.+|..+..+..+ +.+++++|++++..+..+..+..+ .++++.|.+
T Consensus       131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~  209 (313)
T d1ogqa_         131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML  209 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred             ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence            999999999999999999999999999999999999999988886 789999999999888888887665 699999999


Q ss_pred             cccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCcccccCCCCC
Q 039290          579 SGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPTRG  658 (1049)
Q Consensus       579 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~  658 (1049)
                      .+.+|..+..+++|+.|++++|.+++.+| .++.+++|++|||++|+++|.+|..+..+++|++|+|++|+++|.+|..+
T Consensus       210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~  288 (313)
T d1ogqa_         210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG  288 (313)
T ss_dssp             EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred             ccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcc
Confidence            99999999999999999999999997655 68899999999999999999999999999999999999999999999888


Q ss_pred             CccccccccccCCccccCCCCccCCCC
Q 039290          659 PFITFSAESFLGNQALCGSPKLQVSPC  685 (1049)
Q Consensus       659 ~~~~~~~~~~~~n~~~cg~~~~~~~~c  685 (1049)
                      .+..+....+.+|+.+||.|+   ++|
T Consensus       289 ~L~~L~~l~l~~N~~l~g~pl---p~c  312 (313)
T d1ogqa_         289 NLQRFDVSAYANNKCLCGSPL---PAC  312 (313)
T ss_dssp             TGGGSCGGGTCSSSEEESTTS---SCC
T ss_pred             cCCCCCHHHhCCCccccCCCC---CCC
Confidence            888898999999999999984   456

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=3.2e-28  Score=276.60  Aligned_cols=342  Identities=26%  Similarity=0.400  Sum_probs=209.6

Q ss_pred             cccccceEEeccccccccCccccccccceEEEeeccccCCCccccccccccccceEEeccCccCCCCCCcccCCCCCccE
Q 039290          245 NLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLER  324 (1049)
Q Consensus       245 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~  324 (1049)
                      .+.+|++|++++|.++. + +.++.+++|++|+|++|++++..|  +.++++|++|++++|++.+ +++  ...+++|+.
T Consensus        42 ~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~-i~~--l~~l~~L~~  114 (384)
T d2omza2          42 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-ITP--LANLTNLTG  114 (384)
T ss_dssp             HHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CGG--GTTCTTCCE
T ss_pred             HhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCcc--ccCCccccccccccccccc-ccc--ccccccccc
Confidence            45556666666666652 2 345566666666666666655432  5555555555555555542 221  124555555


Q ss_pred             EEcCCCCCCCCCCccccCCCCCceeecccCccccCcccccccccccceeecccccccCCCCCcccccccccCCCCcEEEc
Q 039290          325 LFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYL  404 (1049)
Q Consensus       325 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~L  404 (1049)
                      |++++|.+++..+  ......+..+....|.+....+..................+          ..+...........
T Consensus       115 L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~  182 (384)
T d2omza2         115 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDL----------KPLANLTTLERLDI  182 (384)
T ss_dssp             EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCC----------GGGTTCTTCCEEEC
T ss_pred             ccccccccccccc--ccccccccccccccccccccccccccccccccccccccchh----------hhhccccccccccc
Confidence            5555555553322  22334455555555555433222211111111111111110          11111222222222


Q ss_pred             cCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCC
Q 039290          405 SENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEG  484 (1049)
Q Consensus       405 s~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  484 (1049)
                      .                         .|..  ..+..+..+++++.+++++|.+++..|  +...++|++|++++|++++
T Consensus       183 ~-------------------------~~~~--~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~  233 (384)
T d2omza2         183 S-------------------------SNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD  233 (384)
T ss_dssp             C-------------------------SSCC--CCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred             c-------------------------cccc--ccccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC
Confidence            2                         2222  123345566777777888877775433  4556778888888887764


Q ss_pred             CCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCC
Q 039290          485 SIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGN  564 (1049)
Q Consensus       485 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  564 (1049)
                       + +.+..+++|+.|++++|.+++..+  ++.+++|+.|++++|++++..  .+..++.++.+.++.|.+++  ...+..
T Consensus       234 -~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~  305 (384)
T d2omza2         234 -I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISN  305 (384)
T ss_dssp             -C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGG
T ss_pred             -c-chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--cccccccccccccccccccc--ccccch
Confidence             2 356777788888888888775432  677788888888888887653  36677788888888888875  345777


Q ss_pred             CcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCcccccccccccceee
Q 039290          565 LKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLN  644 (1049)
Q Consensus       565 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~  644 (1049)
                      ++++++|++++|++++..+  +..+++|+.|+|++|+|++ ++ .|+++++|++|+|++|++++..|  +.++++|+.|+
T Consensus       306 ~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~  379 (384)
T d2omza2         306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLG  379 (384)
T ss_dssp             CTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEE
T ss_pred             hcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEee
Confidence            8888888888888887643  7888999999999999885 34 58889999999999999986554  78889999999


Q ss_pred             ccCC
Q 039290          645 LSFN  648 (1049)
Q Consensus       645 l~~N  648 (1049)
                      |++|
T Consensus       380 L~~N  383 (384)
T d2omza2         380 LNDQ  383 (384)
T ss_dssp             CCCE
T ss_pred             CCCC
Confidence            9887

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=9.5e-28  Score=272.66  Aligned_cols=361  Identities=23%  Similarity=0.313  Sum_probs=176.3

Q ss_pred             hhhhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCC
Q 039290           98 FLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLS  177 (1049)
Q Consensus        98 ~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls  177 (1049)
                      ......++.+.+++.++  ...|.+|++|++++|++.. + +.+..|++|++|||++|++++ +|. ++++++|++|+++
T Consensus        23 ~~~~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~-l~~-l~~L~~L~~L~L~   96 (384)
T d2omza2          23 EKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMN   96 (384)
T ss_dssp             HHHHHHTTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECC
T ss_pred             HHHHHHhCCCCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCC-Ccc-ccCCccccccccc
Confidence            33345677777776654  3567788888888888863 4 457788888888888888884 443 8888888888888


Q ss_pred             CccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceEEeccc
Q 039290          178 DNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNN  257 (1049)
Q Consensus       178 ~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  257 (1049)
                      +|++++ +++ +      .++++|+.|++++|.+++..+  ......+.......|.+....+.................
T Consensus        97 ~n~i~~-i~~-l------~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  166 (384)
T d2omza2          97 NNQIAD-ITP-L------ANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVT  166 (384)
T ss_dssp             SSCCCC-CGG-G------TTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCC
T ss_pred             cccccc-ccc-c------ccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccc
Confidence            888874 332 2      345567788888887775322  223344555555555554332222222222222111111


Q ss_pred             cccccCccccccccceEEEeeccccCCCccccccccccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCC
Q 039290          258 SLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIP  337 (1049)
Q Consensus       258 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p  337 (1049)
                      .     ...+...+.........|....  +..+..                         +++++.+++++|.+++..|
T Consensus       167 ~-----~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-------------------------l~~~~~l~l~~n~i~~~~~  214 (384)
T d2omza2         167 D-----LKPLANLTTLERLDISSNKVSD--ISVLAK-------------------------LTNLESLIATNNQISDITP  214 (384)
T ss_dssp             C-----CGGGTTCTTCCEEECCSSCCCC--CGGGGG-------------------------CTTCSEEECCSSCCCCCGG
T ss_pred             h-----hhhhcccccccccccccccccc--cccccc-------------------------ccccceeeccCCccCCCCc
Confidence            1     1122333333333332222221  222333                         4455555555555554332


Q ss_pred             ccccCCCCCceeecccCccccCcccccccccccceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCcc
Q 039290          338 SSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSI  417 (1049)
Q Consensus       338 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~  417 (1049)
                        +..+++|+.|++++|.++..  ..+..+++|+.|++++|.+++++       .+..+++|+.|++++|++++..+  +
T Consensus       215 --~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~-------~~~~~~~L~~L~l~~~~l~~~~~--~  281 (384)
T d2omza2         215 --LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA-------PLSGLTKLTELKLGANQISNISP--L  281 (384)
T ss_dssp             --GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG-------GGTTCTTCSEEECCSSCCCCCGG--G
T ss_pred             --ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCC-------cccccccCCEeeccCcccCCCCc--c
Confidence              23344555555555555532  23455555555555555555432       13445555555555555543211  1


Q ss_pred             ccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccc
Q 039290          418 GNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLA  497 (1049)
Q Consensus       418 ~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  497 (1049)
                      .... .++.+.+..|.+++  ...+..+++++.|++++|++++..  .+..+++|++|++++|+|++ ++ .+.++++|+
T Consensus       282 ~~~~-~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~  354 (384)
T d2omza2         282 AGLT-ALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNIN  354 (384)
T ss_dssp             TTCT-TCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCC
T ss_pred             cccc-cccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCC
Confidence            1111 22223333333221  112333444444444444444321  14444444444444444442 22 344444444


Q ss_pred             eEEeeCcccCCcCchhccCcccCCceeecCc
Q 039290          498 NLYLGDNKLSGRLPACLGNLTSLRDLSLGSN  528 (1049)
Q Consensus       498 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  528 (1049)
                      +|++++|++++..|  +.++++|+.|+|++|
T Consensus       355 ~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         355 WLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             EEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             EEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            44444444443222  344444444444443

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.93  E-value=2.7e-25  Score=243.50  Aligned_cols=280  Identities=24%  Similarity=0.323  Sum_probs=175.3

Q ss_pred             ccceecccccccccccCCCCccccccceEEeccccccccCccccccccceEEEeeccccCCCccccccccccccceEEec
Q 039290          224 ELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVT  303 (1049)
Q Consensus       224 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~  303 (1049)
                      .++.+|.++++++ .+|..+.  +++++|+|++|+++...+.+|.++++|++|++++|.+....|..|.++++|++|+++
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~   87 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS   87 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence            4445555555555 5565553  467777777777774444567777777777777777777777777777777777777


Q ss_pred             cCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccc--cCcccccccccccceeeccccccc
Q 039290          304 DNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFS--GLIPTTFGNLRSLKLLSLAGNVLT  381 (1049)
Q Consensus       304 ~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~  381 (1049)
                      +|+++ .+|....   +.++.|++.+|.+.+..+..+.....+..++...|...  ...+..|..+++|+.+++++|.++
T Consensus        88 ~n~l~-~l~~~~~---~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~  163 (305)
T d1xkua_          88 KNQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT  163 (305)
T ss_dssp             SSCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred             CCccC-cCccchh---hhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc
Confidence            77776 5665443   56778888888887666666666777777777777543  233445666667777777777666


Q ss_pred             CCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCccccc
Q 039290          382 SPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGT  461 (1049)
Q Consensus       382 ~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~  461 (1049)
                      .++...        +++|+.|++++|.                         +.+..+..|.+++.+++|++++|.+++.
T Consensus       164 ~l~~~~--------~~~L~~L~l~~n~-------------------------~~~~~~~~~~~~~~l~~L~~s~n~l~~~  210 (305)
T d1xkua_         164 TIPQGL--------PPSLTELHLDGNK-------------------------ITKVDAASLKGLNNLAKLGLSFNSISAV  210 (305)
T ss_dssp             SCCSSC--------CTTCSEEECTTSC-------------------------CCEECTGGGTTCTTCCEEECCSSCCCEE
T ss_pred             ccCccc--------CCccCEEECCCCc-------------------------CCCCChhHhhcccccccccccccccccc
Confidence            544321        2344444554444                         4444555555566666666666666655


Q ss_pred             CCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchh------ccCcccCCceeecCcccc--cc
Q 039290          462 IPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPAC------LGNLTSLRDLSLGSNALT--SI  533 (1049)
Q Consensus       462 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~------~~~l~~L~~L~L~~N~l~--~~  533 (1049)
                      .+.++.++++|++|+|++|+|+ .+|+++..+++|++|+|++|+|+......      +..+.+|+.|+|++|+++  .+
T Consensus       211 ~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~  289 (305)
T d1xkua_         211 DNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEI  289 (305)
T ss_dssp             CTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGS
T ss_pred             ccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcC
Confidence            5566666666666666666665 44556666666666666666665432222      334566777777777765  34


Q ss_pred             cCccccccccc
Q 039290          534 IPSTLWNLKDI  544 (1049)
Q Consensus       534 ~p~~~~~l~~L  544 (1049)
                      .|.+|..+...
T Consensus       290 ~~~~f~~~~~~  300 (305)
T d1xkua_         290 QPSTFRCVYVR  300 (305)
T ss_dssp             CGGGGTTCCCG
T ss_pred             CHhHhcccccC
Confidence            55555544433

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.93  E-value=2.3e-25  Score=244.02  Aligned_cols=266  Identities=23%  Similarity=0.305  Sum_probs=173.8

Q ss_pred             ccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCCCCCCccccCCCCCceeecccCccccCcccccccccccceeec
Q 039290          296 TLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFSGTIPSSLTNISELSVLDFGFNSFSGLIPTTFGNLRSLKLLSL  375 (1049)
Q Consensus       296 ~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  375 (1049)
                      .++.++.+++.++ ++|..++   +++++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|++|++
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l   86 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL   86 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             cCCEEEecCCCCC-ccCCCCC---CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecc
Confidence            4566777777776 7787765   57899999999998655668899999999999999999887888999999999999


Q ss_pred             ccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccC
Q 039290          376 AGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGN  455 (1049)
Q Consensus       376 ~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~  455 (1049)
                      ++|+++.++...        ...++.|++++|.+.++.+.                         .+.....+..++...
T Consensus        87 ~~n~l~~l~~~~--------~~~l~~L~~~~n~l~~l~~~-------------------------~~~~~~~~~~l~~~~  133 (305)
T d1xkua_          87 SKNQLKELPEKM--------PKTLQELRVHENEITKVRKS-------------------------VFNGLNQMIVVELGT  133 (305)
T ss_dssp             CSSCCSBCCSSC--------CTTCCEEECCSSCCCBBCHH-------------------------HHTTCTTCCEEECCS
T ss_pred             cCCccCcCccch--------hhhhhhhhccccchhhhhhh-------------------------hhhcccccccccccc
Confidence            999888876532        24567777777776644322                         233333444455544


Q ss_pred             Cccc--ccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccc
Q 039290          456 NELT--GTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSI  533 (1049)
Q Consensus       456 N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  533 (1049)
                      |...  ...+..+..+++|+.+++++|.+. .+|..+  +++|+.|++++|.+++..+..+.+++.++.|++++|+++++
T Consensus       134 n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~  210 (305)
T d1xkua_         134 NPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV  210 (305)
T ss_dssp             SCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEE
T ss_pred             ccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhcccccccccccccccccc
Confidence            4322  223445556666666666666665 334332  35666777777777666666777777777777777777777


Q ss_pred             cCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccc------cCCCcccEEEeecccc
Q 039290          534 IPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTI------GGLQGLQLLSLRYNRL  602 (1049)
Q Consensus       534 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~------~~l~~L~~L~Ls~N~l  602 (1049)
                      .+..+..+++|++|+|++|+|+. +|+.+..+++|++|+|++|+|+.+....|      ..+.+|+.|+|++|++
T Consensus       211 ~~~~~~~l~~L~~L~L~~N~L~~-lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~  284 (305)
T d1xkua_         211 DNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV  284 (305)
T ss_dssp             CTTTGGGSTTCCEEECCSSCCSS-CCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSS
T ss_pred             ccccccccccceeeecccccccc-cccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcC
Confidence            67777777777777777777663 34455555555555555555554322222      2334444444444444

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=6.2e-26  Score=245.66  Aligned_cols=227  Identities=25%  Similarity=0.257  Sum_probs=115.3

Q ss_pred             EEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEee-c
Q 039290          401 IIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQ-N  479 (1049)
Q Consensus       401 ~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~-~  479 (1049)
                      .++.+++.++ .+|..+   +.++++|+|++|+|++..+..|.++++|++|++++|++.+..+..+..+..++.++.. .
T Consensus        15 ~v~c~~~~L~-~iP~~i---p~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~   90 (284)
T d1ozna_          15 TTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (284)
T ss_dssp             EEECCSSCCS-SCCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             EEEcCCCCCC-ccCCCC---CCCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence            3455555555 223322   2245555555555554444455555555555555555555555555555555555432 3


Q ss_pred             cccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCc
Q 039290          480 NKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLL  559 (1049)
Q Consensus       480 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~  559 (1049)
                      |.++...+..|.++++|++|++++|.+....+..+...++|+.+++++|+++++.+.                       
T Consensus        91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~-----------------------  147 (284)
T d1ozna_          91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD-----------------------  147 (284)
T ss_dssp             TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT-----------------------
T ss_pred             cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChh-----------------------
Confidence            344434444455555555555555555444444444444555555555555444444                       


Q ss_pred             cCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCcccccccccc
Q 039290          560 PDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSY  639 (1049)
Q Consensus       560 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  639 (1049)
                       .|..+++|++|++++|+|++..+..|.++++|+.+++++|++++..|..|.++++|++||+++|++++..|..+..+++
T Consensus       148 -~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~  226 (284)
T d1ozna_         148 -TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA  226 (284)
T ss_dssp             -TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTT
T ss_pred             -HhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccc
Confidence             4444445555555555555444455555555555555555555555555555555555555555555444445555555


Q ss_pred             cceeeccCCcccccCC
Q 039290          640 LKHLNLSFNQLEGEIP  655 (1049)
Q Consensus       640 L~~l~l~~N~l~~~~p  655 (1049)
                      |++|++++|+|.|+++
T Consensus       227 L~~L~l~~N~l~C~C~  242 (284)
T d1ozna_         227 LQYLRLNDNPWVCDCR  242 (284)
T ss_dssp             CCEEECCSSCEECSGG
T ss_pred             cCEEEecCCCCCCCcc
Confidence            5555555555555544

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=7.3e-25  Score=237.13  Aligned_cols=252  Identities=21%  Similarity=0.232  Sum_probs=190.8

Q ss_pred             ceeecccccccCCCCCcccccccccCCCCcEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccE
Q 039290          371 KLLSLAGNVLTSPTPDLSFLSSLTSCRNLEIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTV  450 (1049)
Q Consensus       371 ~~L~L~~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~  450 (1049)
                      ..++.+++.++++|..+        .+++++|+|++|+|+.+.+..+..+. .|+.|++++|++....+..+..+..+..
T Consensus        14 ~~v~c~~~~L~~iP~~i--------p~~~~~L~Ls~N~i~~i~~~~f~~l~-~L~~L~ls~n~l~~i~~~~~~~~~~~~~   84 (284)
T d1ozna_          14 VTTSCPQQGLQAVPVGI--------PAASQRIFLHGNRISHVPAASFRACR-NLTILWLHSNVLARIDAAAFTGLALLEQ   84 (284)
T ss_dssp             CEEECCSSCCSSCCTTC--------CTTCSEEECTTSCCCEECTTTTTTCT-TCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred             eEEEcCCCCCCccCCCC--------CCCCCEEECcCCcCCCCCHHHhhccc-cccccccccccccccccccccccccccc
Confidence            45678888899887653        15689999999999988777787776 8999999999999999999999999999


Q ss_pred             EEcc-CCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcc
Q 039290          451 IRLG-NNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNA  529 (1049)
Q Consensus       451 L~Ls-~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  529 (1049)
                      +... .|.++...|..|.++++|++|++++|.+....+..+....+|+.+++++|.+++..+..|..+++|+.|++++|+
T Consensus        85 l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~  164 (284)
T d1ozna_          85 LDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR  164 (284)
T ss_dssp             EECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             cccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCc
Confidence            9875 677887778999999999999999999997778889999999999999999998778889999999999999999


Q ss_pred             cccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCcccc
Q 039290          530 LTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPES  609 (1049)
Q Consensus       530 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~  609 (1049)
                      ++++.+..|.++++|+++++++|++++.                        .|..|.++++|++|++++|++++..+..
T Consensus       165 l~~l~~~~f~~l~~L~~l~l~~N~l~~i------------------------~~~~f~~l~~L~~L~l~~N~i~~~~~~~  220 (284)
T d1ozna_         165 ISSVPERAFRGLHSLDRLLLHQNRVAHV------------------------HPHAFRDLGRLMTLYLFANNLSALPTEA  220 (284)
T ss_dssp             CCEECTTTTTTCTTCCEEECCSSCCCEE------------------------CTTTTTTCTTCCEEECCSSCCSCCCHHH
T ss_pred             ccccchhhhccccccchhhhhhcccccc------------------------ChhHhhhhhhcccccccccccccccccc
Confidence            9987777777766666666666666554                        4455555555555555555555555555


Q ss_pred             ccCccCCcEEeccCccccCCcccccccccccceeeccCCcccccCCC
Q 039290          610 FGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPT  656 (1049)
Q Consensus       610 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~  656 (1049)
                      |+++++|++|+|++|++.+.-+ ...-...++.+....+.+.|..|.
T Consensus       221 ~~~~~~L~~L~l~~N~l~C~C~-~~~l~~~l~~~~~~~~~~~C~~p~  266 (284)
T d1ozna_         221 LAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQ  266 (284)
T ss_dssp             HTTCTTCCEEECCSSCEECSGG-GHHHHHHHHHCCSEECCCBEEESG
T ss_pred             cccccccCEEEecCCCCCCCcc-chHHHHHHHhCcCCCCceEeCCch
Confidence            5556666666666666554322 111122344555555555555543

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=3e-24  Score=229.60  Aligned_cols=201  Identities=26%  Similarity=0.246  Sum_probs=136.5

Q ss_pred             ccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecC
Q 039290          448 LTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGS  527 (1049)
Q Consensus       448 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  527 (1049)
                      +.+++.++++|+ .+|..+.  ++|++|+|++|+|++..+..|.++++|++|+|++|+|+ .+| .++.+++|++|+|++
T Consensus        12 ~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~   86 (266)
T d1p9ag_          12 HLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSH   86 (266)
T ss_dssp             CCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCS
T ss_pred             CeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccc
Confidence            333444444444 2333332  24445555555554333344455555555555555554 223 234556666666666


Q ss_pred             cccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCcc
Q 039290          528 NALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIP  607 (1049)
Q Consensus       528 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~  607 (1049)
                      |++++ .+..+..+++|+.|++++|.+....+..+..+.++++|++++|.++...+..+..+++|+.|++++|+|++..+
T Consensus        87 N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~  165 (266)
T d1p9ag_          87 NQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPA  165 (266)
T ss_dssp             SCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCT
T ss_pred             ccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCc
Confidence            66654 34556666666666777776666666667777778888888888887777788888899999999999998888


Q ss_pred             ccccCccCCcEEeccCccccCCcccccccccccceeeccCCcccccCC
Q 039290          608 ESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIP  655 (1049)
Q Consensus       608 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p  655 (1049)
                      ..|..+++|++|||++|+|+ .+|+.+..+++|+.|+|++|+|.|.+.
T Consensus       166 ~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~  212 (266)
T d1p9ag_         166 GLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE  212 (266)
T ss_dssp             TTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred             cccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcc
Confidence            88899999999999999998 788888888999999999999988764

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=1.2e-22  Score=216.89  Aligned_cols=179  Identities=26%  Similarity=0.262  Sum_probs=139.7

Q ss_pred             CCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceee
Q 039290          446 NNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSL  525 (1049)
Q Consensus       446 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  525 (1049)
                      +++++|+|++|+|++..+..|.++++|++|+|++|+|+. +| .++.+++|++|+|++|+++ ..+..+.++++|+.|++
T Consensus        31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l  107 (266)
T d1p9ag_          31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV  107 (266)
T ss_dssp             TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred             cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-ccccccccccccccccccc-ccccccccccccccccc
Confidence            356667777777765555666677777777777777663 33 3456677777777777776 35666777778888888


Q ss_pred             cCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCC
Q 039290          526 GSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGP  605 (1049)
Q Consensus       526 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  605 (1049)
                      ++|++.++.+..+..+.+++.|++++|.++...+..+..++.++.+++++|+|++..+..|..+++|++|+|++|+|+ .
T Consensus       108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~  186 (266)
T d1p9ag_         108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T  186 (266)
T ss_dssp             CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-C
T ss_pred             cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-c
Confidence            888887777777777888888888888888777777888888888999999998888888999999999999999999 6


Q ss_pred             ccccccCccCCcEEeccCccccC
Q 039290          606 IPESFGGLKSLNFVDMSNNNLSG  628 (1049)
Q Consensus       606 ~~~~~~~l~~L~~L~Ls~N~l~~  628 (1049)
                      +|..+..+++|+.|+|++|++..
T Consensus       187 lp~~~~~~~~L~~L~L~~Np~~C  209 (266)
T d1p9ag_         187 IPKGFFGSHLLPFAFLHGNPWLC  209 (266)
T ss_dssp             CCTTTTTTCCCSEEECCSCCBCC
T ss_pred             cChhHCCCCCCCEEEecCCCCCC
Confidence            78888889999999999999875

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.86  E-value=3.6e-20  Score=206.65  Aligned_cols=95  Identities=25%  Similarity=0.390  Sum_probs=59.2

Q ss_pred             CCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEcCCCccCccccCCCcccccccCCCCcc
Q 039290          122 GLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELDLSDNQLSGTIPSSIFNISSCQNLPVL  201 (1049)
Q Consensus       122 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L  201 (1049)
                      +|++|||++|.++ .+|+.   +++|++|+|++|+|+ .+|+.+   .+|+.|++++|+++ .++.-         .+.|
T Consensus        39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---------p~~L  100 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---------PPLL  100 (353)
T ss_dssp             TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---------CTTC
T ss_pred             CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---------cccc
Confidence            5778888888876 57754   456788888888887 677654   46777777777776 44421         1236


Q ss_pred             ceEEeeccccCCCCCCCcccccccceecccccccc
Q 039290          202 EGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQ  236 (1049)
Q Consensus       202 ~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  236 (1049)
                      ++|++++|+++ .+|. +..+++|+.|++++|.+.
T Consensus       101 ~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~  133 (353)
T d1jl5a_         101 EYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK  133 (353)
T ss_dssp             CEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCS
T ss_pred             ccccccccccc-cccc-hhhhccceeecccccccc
Confidence            66666666665 3442 344455555555555443

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.86  E-value=2.3e-22  Score=202.92  Aligned_cols=169  Identities=17%  Similarity=0.168  Sum_probs=122.4

Q ss_pred             CCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCC------------------CHHHHHHHHHHHhhcCCCceeeEEee
Q 039290          764 SENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDG------------------SLESFHAECKVMGSIRHRNLVKIISS  825 (1049)
Q Consensus       764 ~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~------------------~~~~~~~e~~~l~~l~hpniv~l~~~  825 (1049)
                      .+.++||+|+||+||+|+..+|+.||||+++.....                  ......+|+..+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            456899999999999999889999999987532110                  01344568889999999999988866


Q ss_pred             eecCCeeEEEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHccCCCCeEEcCCCCCCeeecCCCceEEecc
Q 039290          826 CSNNDFKALVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFGYSTPIVHCDIKPSNVLLNESMVGHLSDF  905 (1049)
Q Consensus       826 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df  905 (1049)
                      ..    .+++|||+++..+.+        ++...+.+++.|++++++|||   +.||+||||||+|||++++ .++++||
T Consensus        83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred             cC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEEC
Confidence            32    379999998865544        344456789999999999999   9999999999999999965 4899999


Q ss_pred             cCceecCCCccccccccccccCcccccccCCCCcCcccchHHHHHHH
Q 039290          906 GIAKILGKEESMRQTKTLGTIGYMAPEYGREGKVSRKCDVYSYGIML  952 (1049)
Q Consensus       906 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il  952 (1049)
                      |.|+....+.......  .+... -.|. ..+.|+.++|+||..--+
T Consensus       147 G~a~~~~~~~~~~~l~--rd~~~-~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         147 PQSVEVGEEGWREILE--RDVRN-IITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TTCEETTSTTHHHHHH--HHHHH-HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             CCcccCCCCCcHHHHH--HHHHH-HHHH-HcCCCCCcccHHHHHHHH
Confidence            9998764332111000  00000 0111 136788999999975443

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.84  E-value=2.8e-19  Score=199.25  Aligned_cols=59  Identities=27%  Similarity=0.376  Sum_probs=37.5

Q ss_pred             CCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCch
Q 039290          445 INNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPA  512 (1049)
Q Consensus       445 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  512 (1049)
                      +++|++|+|++|+|+ .+|..   +++|+.|+|++|+|+ .+|+.   +.+|++|++++|+++ .+|.
T Consensus       283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~  341 (353)
T d1jl5a_         283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPD  341 (353)
T ss_dssp             CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred             CCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCc
Confidence            456777777777776 44533   456777777777776 45542   346777777777776 4554

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=4.7e-22  Score=230.67  Aligned_cols=383  Identities=19%  Similarity=0.186  Sum_probs=170.6

Q ss_pred             cceEEeccccccccC-ccccccccceEEEeeccccCCC----ccccccccccccceEEeccCccCC----CCCCcccCCC
Q 039290          249 VRNLFLGNNSLIGEI-PNEIGNLRNLEVLGVQSSNLAG----LIPASIFNISTLKELAVTDNDLLG----SLPSSIDLGL  319 (1049)
Q Consensus       249 L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~~l  319 (1049)
                      |+.||+++|++++.. .+.+..++++++|+|++|.++.    .+...+..+++|++|+|++|++..    .+...+....
T Consensus         4 l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~   83 (460)
T d1z7xw1           4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPS   83 (460)
T ss_dssp             EEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTT
T ss_pred             CCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCC
Confidence            444444444444211 2223334444444444444432    123334445555555555554421    0111111123


Q ss_pred             CCccEEEcCCCCCCCC----CCccccCCCCCceeecccCccccCccccccc-----ccccceeecccccccCCCCCcccc
Q 039290          320 PNLERLFLGENNFSGT----IPSSLTNISELSVLDFGFNSFSGLIPTTFGN-----LRSLKLLSLAGNVLTSPTPDLSFL  390 (1049)
Q Consensus       320 ~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~~~~~~~l  390 (1049)
                      .+|++|+|++|+++..    ++..+..+++|++|++++|.++......+..     .............+..... ....
T Consensus        84 ~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~  162 (460)
T d1z7xw1          84 CKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASC-EPLA  162 (460)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGH-HHHH
T ss_pred             CCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhh-cccc
Confidence            4677888888877643    3455677788888888888876432211111     1111222222222111000 0112


Q ss_pred             cccccCCCCcEEEccCCccccCC----CCccccccccccEEEccCCccccC----CCCCCCCCCCccEEEccCCcccc--
Q 039290          391 SSLTSCRNLEIIYLSENPINGIL----PSSIGNFSISMKSLSMESCNISGG----IPKELGNINNLTVIRLGNNELTG--  460 (1049)
Q Consensus       391 ~~l~~l~~L~~L~Ls~N~i~~~~----p~~~~~~~~~L~~L~L~~n~i~~~----~p~~~~~l~~L~~L~Ls~N~l~~--  460 (1049)
                      ..+.....++.++++++.+....    ...+.........+++..+.+...    ....+...+.++.+++++|.+..  
T Consensus       163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~  242 (460)
T d1z7xw1         163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG  242 (460)
T ss_dssp             HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence            23445566777777776654210    001111112344555555544311    01112234556666666665432  


Q ss_pred             ---cCCccccCcCCCcceEeeccccCCCC----CcccccccccceEEeeCcccCCcCchhc-----cCcccCCceeecCc
Q 039290          461 ---TIPVTLGRLQKLQGLYLQNNKLEGSI----PEDLCHLYRLANLYLGDNKLSGRLPACL-----GNLTSLRDLSLGSN  528 (1049)
Q Consensus       461 ---~~p~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~N  528 (1049)
                         ..+........++.+++++|.+....    ...+...+.++.+++++|.++......+     .....|+.+++++|
T Consensus       243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~  322 (460)
T d1z7xw1         243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC  322 (460)
T ss_dssp             HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred             cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccccc
Confidence               11222333445666666666554211    1122334455555555555432211111     11234445555555


Q ss_pred             ccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeeccccccccc----cccccc-CCCcccEEEeeccccc
Q 039290          529 ALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGV----IPVTIG-GLQGLQLLSLRYNRLQ  603 (1049)
Q Consensus       529 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~  603 (1049)
                      .++......+.                    ..+....+|++|||++|+|++.    ++..+. ..+.|+.|+|++|+|+
T Consensus       323 ~l~~~~~~~l~--------------------~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~  382 (460)
T d1z7xw1         323 SFTAACCSHFS--------------------SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS  382 (460)
T ss_dssp             CCBGGGHHHHH--------------------HHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred             chhhhhhhhcc--------------------cccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCC
Confidence            44432211111                    1122234556666666665532    222222 3455666666666665


Q ss_pred             CC----ccccccCccCCcEEeccCccccCCccccc----c-cccccceeeccCCcccc
Q 039290          604 GP----IPESFGGLKSLNFVDMSNNNLSGTIPKSM----E-ALSYLKHLNLSFNQLEG  652 (1049)
Q Consensus       604 ~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~-~l~~L~~l~l~~N~l~~  652 (1049)
                      +.    +++.+...++|++|||++|+|+......+    . ....|+.|++++|.+..
T Consensus       383 ~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~  440 (460)
T d1z7xw1         383 DSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE  440 (460)
T ss_dssp             HHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred             hHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCH
Confidence            32    33445555666667777666654322222    1 22346667777666654

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.76  E-value=2.4e-18  Score=180.61  Aligned_cols=200  Identities=16%  Similarity=0.152  Sum_probs=104.6

Q ss_pred             CccEEEccCCcccccCCccccCcCCCcceEeeccccCCCC-CcccccccccceEEeeC-cccCCcCchhccCcccCCcee
Q 039290          447 NLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSI-PEDLCHLYRLANLYLGD-NKLSGRLPACLGNLTSLRDLS  524 (1049)
Q Consensus       447 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~  524 (1049)
                      ++++|+|++|+|+...+..|.++++|++|++++|.+...+ +..|..+++++++.+.. |.+....+..|.++++|++++
T Consensus        30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~  109 (242)
T d1xwdc1          30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL  109 (242)
T ss_dssp             CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred             CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence            4455555555554333334455555555555555544322 22344455555554432 344444444455555555555


Q ss_pred             ecCcccccccCc-ccccccccccccccCCccCCCCccCcCCCc-ceeEeecccccccccccccccCCCccc-EEEeeccc
Q 039290          525 LGSNALTSIIPS-TLWNLKDILRFNLSSNSLNGSLLPDIGNLK-VVIEMDLSLNALSGVIPVTIGGLQGLQ-LLSLRYNR  601 (1049)
Q Consensus       525 L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~  601 (1049)
                      +++|++....+. .+..+..+..+..+++.+....+..+..+. .++.|++++|+++...+..|. ..+++ .+.+++|+
T Consensus       110 l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~-~~~l~~~~~l~~n~  188 (242)
T d1xwdc1         110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFN-GTQLDELNLSDNNN  188 (242)
T ss_dssp             EESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTT-TCCEEEEECTTCTT
T ss_pred             cchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccccccccc-chhhhccccccccc
Confidence            555555432221 222334444444455555544444444443 566667777777644444443 33433 33456667


Q ss_pred             ccCCccccccCccCCcEEeccCccccCCcccccccccccceeeccC
Q 039290          602 LQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSF  647 (1049)
Q Consensus       602 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~  647 (1049)
                      |+...+..|.++++|++|||++|+|+...+..|.++++|+.+++.+
T Consensus       189 l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~  234 (242)
T d1xwdc1         189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN  234 (242)
T ss_dssp             CCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred             cccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence            7755556677777777777777777744444567777777666543

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=2e-18  Score=179.16  Aligned_cols=188  Identities=21%  Similarity=0.326  Sum_probs=123.2

Q ss_pred             CCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCc
Q 039290          443 GNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRD  522 (1049)
Q Consensus       443 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  522 (1049)
                      ..+.+|+.|++.+|+|+. + ..+..+++|++|++++|++++..  .+..+++|+++++++|.++ .++ .+.++++|+.
T Consensus        38 ~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~  111 (227)
T d1h6ua2          38 ADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSGNPLK-NVS-AIAGLQSIKT  111 (227)
T ss_dssp             HHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCE
T ss_pred             HHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeeccc--ccccccccccccccccccc-ccc-cccccccccc
Confidence            345566666666666663 3 24566666666666666665432  2566666666666666665 233 3566667777


Q ss_pred             eeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccc
Q 039290          523 LSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRL  602 (1049)
Q Consensus       523 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  602 (1049)
                      +++++|...+.  ..+...+.+..+.++++.+...  ..+...++|++|++++|.+++..  .++++++|+.|+|++|++
T Consensus       112 l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l  185 (227)
T d1h6ua2         112 LDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKI  185 (227)
T ss_dssp             EECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred             ccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccch--hhcccccceecccCCCcc
Confidence            77776666543  2345556666677777666542  23566677777888887776443  377788888888888888


Q ss_pred             cCCccccccCccCCcEEeccCccccCCcccccccccccceeecc
Q 039290          603 QGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLS  646 (1049)
Q Consensus       603 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~  646 (1049)
                      ++. + .|+++++|++|+|++|++++ +++ +..+++|+.|+++
T Consensus       186 ~~l-~-~l~~l~~L~~L~Ls~N~lt~-i~~-l~~l~~L~~L~ls  225 (227)
T d1h6ua2         186 SDI-S-PLASLPNLIEVHLKNNQISD-VSP-LANTSNLFIVTLT  225 (227)
T ss_dssp             CCC-G-GGGGCTTCCEEECTTSCCCB-CGG-GTTCTTCCEEEEE
T ss_pred             CCC-h-hhcCCCCCCEEECcCCcCCC-Ccc-cccCCCCCEEEee
Confidence            854 3 37788888888888888874 432 7788888888876

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.74  E-value=5.7e-18  Score=177.70  Aligned_cols=220  Identities=15%  Similarity=0.139  Sum_probs=162.5

Q ss_pred             cEEEccCCccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccC-CccccCcCCCcceEee
Q 039290          400 EIIYLSENPINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTI-PVTLGRLQKLQGLYLQ  478 (1049)
Q Consensus       400 ~~L~Ls~N~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~  478 (1049)
                      +.++.+++.++ .+|..+.   .++++|+|++|+|+...+..|.++++|++|+|++|.+...+ +.+|.++++++++++.
T Consensus        11 ~~i~c~~~~l~-~iP~~l~---~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~   86 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   86 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC---SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred             CEEEEeCCCCC-CcCCCCC---CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence            34555555554 2333332   25677777777777555667888889999999998887544 4578888888888876


Q ss_pred             c-cccCCCCCcccccccccceEEeeCcccCCcCc-hhccCcccCCceeecCcccccccCccccccc-ccccccccCCccC
Q 039290          479 N-NKLEGSIPEDLCHLYRLANLYLGDNKLSGRLP-ACLGNLTSLRDLSLGSNALTSIIPSTLWNLK-DILRFNLSSNSLN  555 (1049)
Q Consensus       479 ~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~  555 (1049)
                      . |.+....+..|.++++|+.+++++|.+....+ ..+..++.+..+..+++++..+.+..+..++ .++.|++++|+++
T Consensus        87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~  166 (242)
T d1xwdc1          87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ  166 (242)
T ss_dssp             CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred             ccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence            4 67777777788888999999999998874332 2344556666777788888887777777765 7888999999998


Q ss_pred             CCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccC
Q 039290          556 GSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSN  623 (1049)
Q Consensus       556 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  623 (1049)
                      ...+..+.....++.+++++|+|+...+..|.++++|+.|+|++|+|+...+..|.++++|+++++.+
T Consensus       167 ~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~  234 (242)
T d1xwdc1         167 EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN  234 (242)
T ss_dssp             EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred             ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence            75555554444445557888999977677899999999999999999977777889988888887754

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.74  E-value=2.3e-18  Score=173.41  Aligned_cols=176  Identities=18%  Similarity=0.236  Sum_probs=103.5

Q ss_pred             ceEEeeCcccCCcCchhccCcccCCceeecCccccc-ccCcccccccccccccccCCccCCCCccCcCCCcceeEeeccc
Q 039290          497 ANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTS-IIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSL  575 (1049)
Q Consensus       497 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  575 (1049)
                      +.++.++|+++ .+|..+.  +++++|+|++|+|++ +.+..|.++++|+.|+|++|.++...+..+..+++|++|+|++
T Consensus        11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~   87 (192)
T d1w8aa_          11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence            34555555555 3444332  355666666666654 2344555666666666666666666666666666666777777


Q ss_pred             ccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCcccccCC
Q 039290          576 NALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIP  655 (1049)
Q Consensus       576 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p  655 (1049)
                      |+|+.+.|..|.++++|++|+|++|+|++..|++|.++++|++|+|++|++.+..+. ..-...++.+.+..|.+.|..|
T Consensus        88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~c~~p  166 (192)
T d1w8aa_          88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCBBCSS
T ss_pred             ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccch-HHHhhhhhhhcccCCCeEeCCC
Confidence            777666666677777777777777777766666777777777777777777643321 1222335566666777776666


Q ss_pred             CCCCccccccccccCCccccCCC
Q 039290          656 TRGPFITFSAESFLGNQALCGSP  678 (1049)
Q Consensus       656 ~~~~~~~~~~~~~~~n~~~cg~~  678 (1049)
                      ..  +....-..+..|...|..+
T Consensus       167 ~~--l~~~~l~~L~~n~l~C~~~  187 (192)
T d1w8aa_         167 SK--VRDVQIKDLPHSEFKCSSE  187 (192)
T ss_dssp             TT--TTTSBGGGSCTTTCCCCCC
T ss_pred             hh--hcCCEeeecCHhhCcCCCC
Confidence            42  2222223344454455443

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.74  E-value=9.6e-19  Score=176.18  Aligned_cols=177  Identities=19%  Similarity=0.202  Sum_probs=104.8

Q ss_pred             cEEEccCCcccccCCccccCcCCCcceEeeccccCCCC-CcccccccccceEEeeCcccCCcCchhccCcccCCceeecC
Q 039290          449 TVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSI-PEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGS  527 (1049)
Q Consensus       449 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  527 (1049)
                      ++++.++++++ .+|..+.  +++++|+|++|+|++.+ +..|.++++|+.|+|++|.+.+..+..+..+++|++|+|++
T Consensus        11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~   87 (192)
T d1w8aa_          11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence            45666666666 4454432  45566666666665422 33445555555555555555544445555555555555555


Q ss_pred             cccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCcc
Q 039290          528 NALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIP  607 (1049)
Q Consensus       528 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~  607 (1049)
                      |++++                        ..+..|.++++|++|+|++|+|+++.|.+|..+++|++|+|++|.+....+
T Consensus        88 N~l~~------------------------l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~  143 (192)
T d1w8aa_          88 NKIKE------------------------ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             CCCCE------------------------ECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             ccccc------------------------cCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence            55554                        444455555566666666666666666667777777777777777764332


Q ss_pred             ccccCccCCcEEeccCccccCCcccccccccccceeeccCCcccccCCC
Q 039290          608 ESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGEIPT  656 (1049)
Q Consensus       608 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~  656 (1049)
                      .. .-...++.+.+..|.+++..|..+   ..++.++|+.|.+.|..+.
T Consensus       144 ~~-~~~~~l~~~~l~~~~~~c~~p~~l---~~~~l~~L~~n~l~C~~~~  188 (192)
T d1w8aa_         144 LA-WFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFKCSSEN  188 (192)
T ss_dssp             GH-HHHHHHHHHCCSGGGCBBCSSTTT---TTSBGGGSCTTTCCCCCC-
T ss_pred             hH-HHhhhhhhhcccCCCeEeCCChhh---cCCEeeecCHhhCcCCCCC
Confidence            21 112346667788888887777654   4566788999999886653

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.73  E-value=8.3e-18  Score=174.43  Aligned_cols=211  Identities=24%  Similarity=0.318  Sum_probs=132.2

Q ss_pred             CCcchhhhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccE
Q 039290           94 GNLSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQE  173 (1049)
Q Consensus        94 ~~l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~  173 (1049)
                      ..|..+..++++.+.+++.+  .+..|++|++|++++|+++ .++ .+..+++|++|++++|.+++..|  +..+++|++
T Consensus        16 ~~l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~   89 (227)
T d1h6ua2          16 PALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITE   89 (227)
T ss_dssp             HHHHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCE
T ss_pred             HHHHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--ccccccccc
Confidence            34556667788888777544  4567888888888888887 454 57888888888888888875433  788888888


Q ss_pred             EcCCCccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceEE
Q 039290          174 LDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLF  253 (1049)
Q Consensus       174 L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  253 (1049)
                      |++++|.++ .++.       +.+++.|+.+++++|+..+.  ..+.....++.+                        .
T Consensus        90 l~~~~n~~~-~i~~-------l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l------------------------~  135 (227)
T d1h6ua2          90 LELSGNPLK-NVSA-------IAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVL------------------------Y  135 (227)
T ss_dssp             EECCSCCCS-CCGG-------GTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEE------------------------E
T ss_pred             ccccccccc-cccc-------cccccccccccccccccccc--chhccccchhhh------------------------h
Confidence            888888876 4431       23455677777777766532  123333444444                        4


Q ss_pred             eccccccccCccccccccceEEEeeccccCCCccccccccccccceEEeccCccCCCCCCcccCCCCCccEEEcCCCCCC
Q 039290          254 LGNNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVTDNDLLGSLPSSIDLGLPNLERLFLGENNFS  333 (1049)
Q Consensus       254 L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~  333 (1049)
                      ++++.+...  ..+.++++|+.|++++|.+.+..  .+.++++|++|++++|++. .++.  +..+++|++|+|++|+++
T Consensus       136 ~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~-~l~~--l~~l~~L~~L~Ls~N~lt  208 (227)
T d1h6ua2         136 LDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKIS-DISP--LASLPNLIEVHLKNNQIS  208 (227)
T ss_dssp             CCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC-CCGG--GGGCTTCCEEECTTSCCC
T ss_pred             chhhhhchh--hhhccccccccccccccccccch--hhcccccceecccCCCccC-CChh--hcCCCCCCEEECcCCcCC
Confidence            444444321  12444445555555555444322  2455556666666666554 2332  235677778888888777


Q ss_pred             CCCCccccCCCCCceeeccc
Q 039290          334 GTIPSSLTNISELSVLDFGF  353 (1049)
Q Consensus       334 ~~~p~~~~~l~~L~~L~Ls~  353 (1049)
                      +. + .++++++|++|++++
T Consensus       209 ~i-~-~l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         209 DV-S-PLANTSNLFIVTLTN  226 (227)
T ss_dssp             BC-G-GGTTCTTCCEEEEEE
T ss_pred             CC-c-ccccCCCCCEEEeeC
Confidence            43 3 377888888888763

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.71  E-value=1.4e-20  Score=218.00  Aligned_cols=359  Identities=18%  Similarity=0.195  Sum_probs=203.2

Q ss_pred             cceEEEeeccccCCCcc-ccccccccccceEEeccCccCC----CCCCcccCCCCCccEEEcCCCCCCCC----CCcccc
Q 039290          271 RNLEVLGVQSSNLAGLI-PASIFNISTLKELAVTDNDLLG----SLPSSIDLGLPNLERLFLGENNFSGT----IPSSLT  341 (1049)
Q Consensus       271 ~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~  341 (1049)
                      .+|+.||+++|++++.. ..-+..+++++.|+|++|.++.    .+...+ ...++|++|+|++|+|+..    +...+.
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L-~~~~~L~~LdLs~N~i~~~~~~~l~~~l~   80 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSAL-RVNPALAELNLRSNELGDVGVHCVLQGLQ   80 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHH-HTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHH-hcCCCCCEEECcCCcCChHHHHHHHHHHh
Confidence            46889999999998642 3345567788888888887652    111111 2456777777777776421    112222


Q ss_pred             -CCCCCceeecccCccccC----cccccccccccceeecccccccCCCCCcccccccc-cCCCCcEEEccCCccccCCCC
Q 039290          342 -NISELSVLDFGFNSFSGL----IPTTFGNLRSLKLLSLAGNVLTSPTPDLSFLSSLT-SCRNLEIIYLSENPINGILPS  415 (1049)
Q Consensus       342 -~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~-~l~~L~~L~Ls~N~i~~~~p~  415 (1049)
                       ...+|++|+|++|+++..    ++..+..+++|++|++++|.++...... ....+. ..............+....  
T Consensus        81 ~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~-l~~~l~~~~~~~~~~~~~~~~~~~~~--  157 (460)
T d1z7xw1          81 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQL-LCEGLLDPQCRLEKLQLEYCSLSAAS--  157 (460)
T ss_dssp             STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHH-HHHHHTSTTCCCCEEECTTSCCBGGG--
T ss_pred             cCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhh-hhhcccccccccccccccccccchhh--
Confidence             123577777777766532    2344555666666666666654321100 000000 0111112222221111000  


Q ss_pred             ccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCC----ccc-cCcCCCcceEeeccccCCCC----
Q 039290          416 SIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIP----VTL-GRLQKLQGLYLQNNKLEGSI----  486 (1049)
Q Consensus       416 ~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p----~~~-~~l~~L~~L~L~~N~l~~~~----  486 (1049)
                       ..                  ..-..+.....++.++++++.+....-    ..+ ........+++..+.+....    
T Consensus       158 -~~------------------~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~  218 (460)
T d1z7xw1         158 -CE------------------PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDL  218 (460)
T ss_dssp             -HH------------------HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHH
T ss_pred             -hc------------------ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcc
Confidence             00                  000112234556667776666542110    011 11224455666666554211    


Q ss_pred             CcccccccccceEEeeCcccCC-----cCchhccCcccCCceeecCcccccc----cCcccccccccccccccCCccCCC
Q 039290          487 PEDLCHLYRLANLYLGDNKLSG-----RLPACLGNLTSLRDLSLGSNALTSI----IPSTLWNLKDILRFNLSSNSLNGS  557 (1049)
Q Consensus       487 ~~~~~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~  557 (1049)
                      ...+.....++.+++++|.+..     ..+........++.+++++|.+...    ....+...+.++.+++++|.++..
T Consensus       219 ~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~  298 (460)
T d1z7xw1         219 CGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE  298 (460)
T ss_dssp             HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHH
T ss_pred             cccccccccccccchhhccccccccchhhccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            1223445677778887776532     2233444566788888888877643    223345567788888888877632


Q ss_pred             CccC-----cCCCcceeEeecccccccccccc----cccCCCcccEEEeecccccCC----cccccc-CccCCcEEeccC
Q 039290          558 LLPD-----IGNLKVVIEMDLSLNALSGVIPV----TIGGLQGLQLLSLRYNRLQGP----IPESFG-GLKSLNFVDMSN  623 (1049)
Q Consensus       558 ~~~~-----~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~----~~~~~~-~l~~L~~L~Ls~  623 (1049)
                      ....     ......|+.+++++|.++.....    .+....+|++|+|++|+|++.    ++..+. ..+.|++|+|++
T Consensus       299 ~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~  378 (460)
T d1z7xw1         299 GARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLAD  378 (460)
T ss_dssp             HHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred             ccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCC
Confidence            2221     12345788999999988855433    344567899999999999753    334443 467799999999


Q ss_pred             ccccCC----cccccccccccceeeccCCcccc
Q 039290          624 NNLSGT----IPKSMEALSYLKHLNLSFNQLEG  652 (1049)
Q Consensus       624 N~l~~~----~p~~~~~l~~L~~l~l~~N~l~~  652 (1049)
                      |+|+..    +...+..+++|++|+|++|+++.
T Consensus       379 n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~  411 (460)
T d1z7xw1         379 CDVSDSSCSSLAATLLANHSLRELDLSNNCLGD  411 (460)
T ss_dssp             SCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred             CCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence            999843    45557778999999999999875

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.71  E-value=1.5e-17  Score=169.86  Aligned_cols=146  Identities=26%  Similarity=0.387  Sum_probs=79.2

Q ss_pred             cccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCccee
Q 039290          490 LCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVI  569 (1049)
Q Consensus       490 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  569 (1049)
                      +..+++|++|++++|++++ ++ .++++++|++|++++|+++++ | .+..+++|+.|++++|.+..  .+.+..++.++
T Consensus        64 l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~  137 (210)
T d1h6ta2          64 IQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKDL-S-SLKDLKKLKSLSLEHNGISD--INGLVHLPQLE  137 (210)
T ss_dssp             GGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCG-G-GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCC
T ss_pred             HhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccccc-c-cccccccccccccccccccc--ccccccccccc
Confidence            3344444444444444442 12 134444444444444444432 1 24444455555555554432  22345555566


Q ss_pred             EeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCccccCCcccccccccccceeeccC
Q 039290          570 EMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSF  647 (1049)
Q Consensus       570 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~  647 (1049)
                      .+++++|.+++  +..+..+++|+.+++++|++++..+  ++++++|++|+|++|+|+ .+| .+..+++|++|+|++
T Consensus       138 ~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~--l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         138 SLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             EEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred             ccccccccccc--ccccccccccccccccccccccccc--ccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEEccC
Confidence            66666666653  2345566777777777777765332  667777777777777776 344 467777777777653

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.71  E-value=2.2e-17  Score=168.55  Aligned_cols=186  Identities=19%  Similarity=0.264  Sum_probs=129.8

Q ss_pred             cchhhhhhcccCccccccCcccccccCCcEeccccCCccccCcccccccCCccEEEeCCCCccCCCcccccCCCcccEEc
Q 039290           96 LSFLAVLAIRNNSFFGSLPEELSHLRGLKYFDFRFNNFHIEIPSWFVSLPRLQHLLLKHNSFVGKIPETIGYLSLLQELD  175 (1049)
Q Consensus        96 l~~L~~L~l~~n~~~g~~p~~~~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  175 (1049)
                      +.......+..+.+.+.++.  ..|.+|++|++++|++.. ++ .+..+++|++|+|++|++++ ++ .++.+++|++|+
T Consensus        23 l~~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~   96 (210)
T d1h6ta2          23 FAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLF   96 (210)
T ss_dssp             HHHHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEE
T ss_pred             HHHHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccC-cc-ccccCccccccc
Confidence            44555667777777766653  467888999999998874 33 37888999999999999885 44 368889999999


Q ss_pred             CCCccCccccCCCcccccccCCCCccceEEeeccccCCCCCCCcccccccceecccccccccccCCCCccccccceEEec
Q 039290          176 LSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGPIPTNLWKCRELHVVSLAFNKFQGGIPRDIGNLTSVRNLFLG  255 (1049)
Q Consensus       176 Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  255 (1049)
                      +++|+++ .+|. +      ..+++|+.|++++|.+..  ...+..+++++.+++++|.+++  +..+..+++|++++++
T Consensus        97 l~~n~i~-~l~~-l------~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~  164 (210)
T d1h6ta2          97 LDENKVK-DLSS-L------KDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLE  164 (210)
T ss_dssp             CCSSCCC-CGGG-G------TTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECC
T ss_pred             ccccccc-cccc-c------cccccccccccccccccc--cccccccccccccccccccccc--cccccccccccccccc
Confidence            9999988 4542 2      346678888888888763  2346667777777777777763  2345666777777777


Q ss_pred             cccccccCccccccccceEEEeeccccCCCccccccccccccceEEec
Q 039290          256 NNSLIGEIPNEIGNLRNLEVLGVQSSNLAGLIPASIFNISTLKELAVT  303 (1049)
Q Consensus       256 ~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~  303 (1049)
                      +|++++ ++ .++++++|+.|+|++|+++.. | .+.++++|++|+|+
T Consensus       165 ~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         165 DNQISD-IV-PLAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELF  208 (210)
T ss_dssp             SSCCCC-CG-GGTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEE
T ss_pred             cccccc-cc-cccCCCCCCEEECCCCCCCCC-h-hhcCCCCCCEEEcc
Confidence            777764 33 266677777777777766543 3 35666666666654

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.71  E-value=4.9e-18  Score=172.02  Aligned_cols=162  Identities=27%  Similarity=0.419  Sum_probs=92.8

Q ss_pred             CcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccccCcccccccccccc
Q 039290          468 RLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRF  547 (1049)
Q Consensus       468 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  547 (1049)
                      .++++++|++++|.|+. + +.+..+++|++|++++|++++..|  ++++++|++|++++|.+..+.  .+.+++.|+.|
T Consensus        38 ~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~--~l~~l~~L~~L  111 (199)
T d2omxa2          38 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT--PLANLTNLTGL  111 (199)
T ss_dssp             HHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEE
T ss_pred             HhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCccccccccccccccccc--ccccccccccc
Confidence            34444555555555442 2 234445555555555555543221  555555555555555554422  24555555555


Q ss_pred             cccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccCcccc
Q 039290          548 NLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSNNNLS  627 (1049)
Q Consensus       548 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  627 (1049)
                      ++++|.+...  ..+..+++|+.|++++|++...  +.+..+++|+.|++++|++++..  .++++++|++|++++|+++
T Consensus       112 ~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~  185 (199)
T d2omxa2         112 TLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVS  185 (199)
T ss_dssp             ECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred             cccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCCc--cccCCCCCCEEECCCCCCC
Confidence            5555555432  2355566666777777766532  34667777777777777777543  3777788888888888877


Q ss_pred             CCccccccccccccee
Q 039290          628 GTIPKSMEALSYLKHL  643 (1049)
Q Consensus       628 ~~~p~~~~~l~~L~~l  643 (1049)
                      + ++ .+..+++|++|
T Consensus       186 ~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         186 D-IS-VLAKLTNLESL  199 (199)
T ss_dssp             C-CG-GGGGCTTCSEE
T ss_pred             C-Cc-cccCCCCCCcC
Confidence            3 43 36677777654

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.68  E-value=5.8e-17  Score=163.94  Aligned_cols=176  Identities=22%  Similarity=0.392  Sum_probs=126.8

Q ss_pred             EccCCccccCCCCCCCCCCCccEEEccCCcccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccC
Q 039290          428 SMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLS  507 (1049)
Q Consensus       428 ~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  507 (1049)
                      .++.+.+++.++  ...++++++|++++|.++. + ..+..+++|++|++++|+|++..  .++++++|++|++++|.+.
T Consensus        24 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~--~l~~l~~L~~L~l~~n~~~   97 (199)
T d2omxa2          24 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIA   97 (199)
T ss_dssp             HTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred             HhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCcc--cccCCcccccccccccccc
Confidence            344444443322  2345677777777777774 2 34667778888888888877533  2777788888888888776


Q ss_pred             CcCchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeeccccccccccccccc
Q 039290          508 GRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIG  587 (1049)
Q Consensus       508 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  587 (1049)
                      . ++ .++++++|+.|++++|.+...  ..+..+++|+.|++++|++..  .+.+..+++|++|++++|++++..  .++
T Consensus        98 ~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~--~~~l~~~~~L~~L~l~~n~l~~l~--~l~  169 (199)
T d2omxa2          98 D-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLNFSSNQVTDLK--PLA  169 (199)
T ss_dssp             C-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC--CGGGTTCTTCSEEECCSSCCCCCG--GGT
T ss_pred             c-cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc--cccccccccccccccccccccCCc--ccc
Confidence            3 34 377788888888888887764  346777888888888888764  335778888888899999888653  488


Q ss_pred             CCCcccEEEeecccccCCccccccCccCCcEE
Q 039290          588 GLQGLQLLSLRYNRLQGPIPESFGGLKSLNFV  619 (1049)
Q Consensus       588 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  619 (1049)
                      ++++|+.|++++|+|++. + .++++++|++|
T Consensus       170 ~l~~L~~L~ls~N~i~~i-~-~l~~L~~L~~L  199 (199)
T d2omxa2         170 NLTTLERLDISSNKVSDI-S-VLAKLTNLESL  199 (199)
T ss_dssp             TCTTCCEEECCSSCCCCC-G-GGGGCTTCSEE
T ss_pred             CCCCCCEEECCCCCCCCC-c-cccCCCCCCcC
Confidence            899999999999999853 3 57888888876

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.48  E-value=1.5e-14  Score=140.00  Aligned_cols=127  Identities=17%  Similarity=0.149  Sum_probs=81.3

Q ss_pred             ccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCCccc
Q 039290          514 LGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQ  593 (1049)
Q Consensus       514 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  593 (1049)
                      +.+..+|++|+|++|+|+.+ +..+..+++|+.|+|++|+|+..  +.+..+++|++|++++|+++...+..+..+++|+
T Consensus        14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~   90 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   90 (162)
T ss_dssp             EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             ccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence            33444555555555555543 34444555555555555555532  3456667777777777777765555567788888


Q ss_pred             EEEeecccccCCcc-ccccCccCCcEEeccCccccCCcc----cccccccccceee
Q 039290          594 LLSLRYNRLQGPIP-ESFGGLKSLNFVDMSNNNLSGTIP----KSMEALSYLKHLN  644 (1049)
Q Consensus       594 ~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~l~  644 (1049)
                      .|+|++|+|+.... ..+..+++|++|++++|+++ ..|    ..+..+++|++||
T Consensus        91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred             cceeccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence            88888888875322 46778888888888888886 333    2467778888776

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.47  E-value=2.9e-15  Score=160.32  Aligned_cols=124  Identities=15%  Similarity=0.173  Sum_probs=58.1

Q ss_pred             cEEEeCCCCccCCCcccccCC--CcccEEcCCCccCccccCCCcccccccCCCCccceEEeeccccCCC-CCCCcccccc
Q 039290          148 QHLLLKHNSFVGKIPETIGYL--SLLQELDLSDNQLSGTIPSSIFNISSCQNLPVLEGLFISYNQLTGP-IPTNLWKCRE  224 (1049)
Q Consensus       148 ~~L~L~~n~l~~~~p~~~~~l--~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~~L~~L~l~~N~l~~~-~p~~l~~l~~  224 (1049)
                      ++|||+++.+.   |+.++.+  ..+..+.++.......+... +      ....|++||+++|.+++. ++..+..|++
T Consensus         3 ~~lDLs~~~l~---~~~l~~l~~~~~~~lrl~~~~~~~~~~~~-~------~~~~L~~LdLs~~~i~~~~l~~l~~~c~~   72 (284)
T d2astb2           3 QTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEH-F------SPFRVQHMDLSNSVIEVSTLHGILSQCSK   72 (284)
T ss_dssp             SEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSC-C------CCBCCCEEECTTCEECHHHHHHHHTTBCC
T ss_pred             CEEECCCCCCC---chHHHHHHhccceEeeccccccccchhhh-c------cCCCCCEEECCCCccCHHHHHHHHHhCCC
Confidence            36777777664   2333322  13445555555443221111 1      123466666666665532 2223344555


Q ss_pred             cceecccccccccccCCCCccccccceEEeccc-ccccc-CccccccccceEEEeeccc
Q 039290          225 LHVVSLAFNKFQGGIPRDIGNLTSVRNLFLGNN-SLIGE-IPNEIGNLRNLEVLGVQSS  281 (1049)
Q Consensus       225 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~l~~l~~L~~L~L~~n  281 (1049)
                      |++|+|+++.++...+..++.+++|++|+|+++ .++.. +...+.++++|+.|+++++
T Consensus        73 L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c  131 (284)
T d2astb2          73 LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC  131 (284)
T ss_dssp             CSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred             cccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccc
Confidence            555555555555444455555555555555553 33311 1112234455555555543

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.47  E-value=1.5e-15  Score=168.09  Aligned_cols=200  Identities=20%  Similarity=0.258  Sum_probs=101.1

Q ss_pred             CCCCCCccEEEccCCccccc----CCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCc
Q 039290          442 LGNINNLTVIRLGNNELTGT----IPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNL  517 (1049)
Q Consensus       442 ~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  517 (1049)
                      +...++|+.|+|++|.++..    +...+...++|++|++++|.+.......++..  +..+         .........
T Consensus        89 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~--l~~~---------~~~~~~~~~  157 (344)
T d2ca6a1          89 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA--LQEL---------AVNKKAKNA  157 (344)
T ss_dssp             HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHH--HHHH---------HHHHHHHTC
T ss_pred             HhhCCCcccccccccccccccccchhhhhcccccchheeccccccccccccccccc--cccc---------ccccccccC
Confidence            34456677777777766543    12233345666666666666532111111000  0000         000001123


Q ss_pred             ccCCceeecCcccccc----cCcccccccccccccccCCccCCC-----CccCcCCCcceeEeeccccccccc----ccc
Q 039290          518 TSLRDLSLGSNALTSI----IPSTLWNLKDILRFNLSSNSLNGS-----LLPDIGNLKVVIEMDLSLNALSGV----IPV  584 (1049)
Q Consensus       518 ~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~  584 (1049)
                      +.|+.+++++|+++..    +...+...+.|+.|+|++|+++..     +...+..+++|+.|+|++|.++..    +..
T Consensus       158 ~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~  237 (344)
T d2ca6a1         158 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI  237 (344)
T ss_dssp             CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred             cccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccc
Confidence            3444455555444321    112233344455555555554421     223345566666777777766532    334


Q ss_pred             cccCCCcccEEEeecccccCCcc----ccccC--ccCCcEEeccCccccCC----cccccc-cccccceeeccCCcccc
Q 039290          585 TIGGLQGLQLLSLRYNRLQGPIP----ESFGG--LKSLNFVDMSNNNLSGT----IPKSME-ALSYLKHLNLSFNQLEG  652 (1049)
Q Consensus       585 ~~~~l~~L~~L~Ls~N~l~~~~~----~~~~~--l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~l~l~~N~l~~  652 (1049)
                      .+..+++|++|+|++|.|++...    ..+..  .+.|++||+++|+|+..    +...+. ..++|+.|++++|++..
T Consensus       238 ~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         238 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             cccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence            56667777888888887775422    22322  35678888888877642    223332 45678888888887754

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.47  E-value=3.2e-15  Score=160.00  Aligned_cols=208  Identities=22%  Similarity=0.193  Sum_probs=127.9

Q ss_pred             CCCCCccEEEccCCccccc-CCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCc-ccCCc-CchhccCccc
Q 039290          443 GNINNLTVIRLGNNELTGT-IPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDN-KLSGR-LPACLGNLTS  519 (1049)
Q Consensus       443 ~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~  519 (1049)
                      ....+|++|+|+++.++.. ++..+..+++|++|+|++|++++..+..+..+++|++|+++++ .++.. +.....++++
T Consensus        43 ~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~  122 (284)
T d2astb2          43 FSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR  122 (284)
T ss_dssp             CCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTT
T ss_pred             ccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHh
Confidence            3445777777777776533 3344667777777777777777666666777777777777774 44422 2223345677


Q ss_pred             CCceeecCc-ccccc-cCccccc-ccccccccccCC--ccCCC-CccCcCCCcceeEeecccc-cccccccccccCCCcc
Q 039290          520 LRDLSLGSN-ALTSI-IPSTLWN-LKDILRFNLSSN--SLNGS-LLPDIGNLKVVIEMDLSLN-ALSGVIPVTIGGLQGL  592 (1049)
Q Consensus       520 L~~L~L~~N-~l~~~-~p~~~~~-l~~L~~L~Ls~N--~l~~~-~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L  592 (1049)
                      |++|+++++ .+++. +...+.. .+.|+.|+++++  .++.. +......+++|++||+++| .+++.....+.++++|
T Consensus       123 L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L  202 (284)
T d2astb2         123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL  202 (284)
T ss_dssp             CCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred             ccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcC
Confidence            888888775 34321 1222222 356777777764  23321 1122345677888888775 5776677778888888


Q ss_pred             cEEEeecc-cccCCccccccCccCCcEEeccCccccCCcccccccccccceeeccCCccccc
Q 039290          593 QLLSLRYN-RLQGPIPESFGGLKSLNFVDMSNNNLSGTIPKSMEALSYLKHLNLSFNQLEGE  653 (1049)
Q Consensus       593 ~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~  653 (1049)
                      ++|+|++| .+++.....++++++|+.|+++++--.+.++.....+++   |.+..++++..
T Consensus       203 ~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~l~~l~~~lp~---L~i~~~~ls~~  261 (284)
T d2astb2         203 QHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPH---LQINCSHFTTI  261 (284)
T ss_dssp             CEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTCHHHHHHHSTT---SEESCCCSCCT
T ss_pred             CEEECCCCCCCChHHHHHHhcCCCCCEEeeeCCCCHHHHHHHHHhCcc---ccccCccCCCC
Confidence            88888884 677666667778888888888877222222222233343   44566666544

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.44  E-value=2.4e-14  Score=138.44  Aligned_cols=128  Identities=19%  Similarity=0.183  Sum_probs=81.1

Q ss_pred             ccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccccCcccccccccc
Q 039290          466 LGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDIL  545 (1049)
Q Consensus       466 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  545 (1049)
                      |.+..+|++|+|++|+|+ .++..+..+++|+.|+|++|+|+ .++ .+..+++|++|++++|+++++.+..+..+++|+
T Consensus        14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~   90 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   90 (162)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence            456667777777777776 44555566677777777777776 332 366666677777777776665444455555555


Q ss_pred             cccccCCccCCCCccCcCCCcceeEeeccccccccccc-ccccCCCcccEEEeecccccCCc---cccccCccCCcEEe
Q 039290          546 RFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIP-VTIGGLQGLQLLSLRYNRLQGPI---PESFGGLKSLNFVD  620 (1049)
Q Consensus       546 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~---~~~~~~l~~L~~L~  620 (1049)
                      .|++++|+++.                        ... ..+..+++|++|++++|.++...   +..++.+++|++||
T Consensus        91 ~L~L~~N~i~~------------------------~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          91 ELILTNNSLVE------------------------LGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             EEECCSCCCCC------------------------GGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             cceeccccccc------------------------cccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            55555555543                        211 34666777777777777776432   23577788888877

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.44  E-value=7.4e-16  Score=170.54  Aligned_cols=252  Identities=16%  Similarity=0.196  Sum_probs=137.8

Q ss_pred             CccccCCCCCceeecccCccccC----cccccccccccceeecccccccCCCCCc-----ccccccccCCCCcEEEccCC
Q 039290          337 PSSLTNISELSVLDFGFNSFSGL----IPTTFGNLRSLKLLSLAGNVLTSPTPDL-----SFLSSLTSCRNLEIIYLSEN  407 (1049)
Q Consensus       337 p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~-----~~l~~l~~l~~L~~L~Ls~N  407 (1049)
                      ...+.....|+.|+|++|.+...    +...+...++|+.|+++++.........     .....+..+++|+.|+|++|
T Consensus        24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n  103 (344)
T d2ca6a1          24 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN  103 (344)
T ss_dssp             SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSC
T ss_pred             HHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccc
Confidence            34455567777777777776532    2234556677777777776554432211     12234556677777777777


Q ss_pred             ccccCCCCccccccccccEEEccCCccccCCCCCCCCCCCccEEEccCCcccccCCccc-------------cCcCCCcc
Q 039290          408 PINGILPSSIGNFSISMKSLSMESCNISGGIPKELGNINNLTVIRLGNNELTGTIPVTL-------------GRLQKLQG  474 (1049)
Q Consensus       408 ~i~~~~p~~~~~~~~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-------------~~l~~L~~  474 (1049)
                      .+......                     .+...+...++|+.|++++|.++......+             ...+.|+.
T Consensus       104 ~i~~~~~~---------------------~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~  162 (344)
T d2ca6a1         104 AFGPTAQE---------------------PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRS  162 (344)
T ss_dssp             CCCTTTHH---------------------HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCE
T ss_pred             cccccccc---------------------chhhhhcccccchheecccccccccccccccccccccccccccccCcccce
Confidence            76532111                     122234456889999999999863211111             23445666


Q ss_pred             eEeeccccCCCC----CcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccccCccccccccccccccc
Q 039290          475 LYLQNNKLEGSI----PEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLS  550 (1049)
Q Consensus       475 L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  550 (1049)
                      +++++|+++...    ...+...+.|+.|++++|.++....                   ...+...+...++|+.|+|+
T Consensus       163 l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~-------------------~~~l~~~l~~~~~L~~L~Ls  223 (344)
T d2ca6a1         163 IICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGI-------------------EHLLLEGLAYCQELKVLDLQ  223 (344)
T ss_dssp             EECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHH-------------------HHHHHTTGGGCTTCCEEECC
T ss_pred             eecccccccccccccccchhhhhhhhccccccccccccccc-------------------ccchhhhhcchhhhcccccc
Confidence            666666554211    1122233445555555554432100                   00112233444455555555


Q ss_pred             CCccCCC----CccCcCCCcceeEeecccccccccccc----cccC--CCcccEEEeecccccCC----cccccc-CccC
Q 039290          551 SNSLNGS----LLPDIGNLKVVIEMDLSLNALSGVIPV----TIGG--LQGLQLLSLRYNRLQGP----IPESFG-GLKS  615 (1049)
Q Consensus       551 ~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~--l~~L~~L~Ls~N~l~~~----~~~~~~-~l~~  615 (1049)
                      +|.++..    +...+..+++|++|+|++|.|++....    .+..  ...|+.|++++|+|+..    +...+. ++++
T Consensus       224 ~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~  303 (344)
T d2ca6a1         224 DNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD  303 (344)
T ss_dssp             SSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTT
T ss_pred             cccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCC
Confidence            5554321    223344556666777777766643222    2222  35789999999988753    233342 5678


Q ss_pred             CcEEeccCccccC
Q 039290          616 LNFVDMSNNNLSG  628 (1049)
Q Consensus       616 L~~L~Ls~N~l~~  628 (1049)
                      |+.|+|++|++..
T Consensus       304 L~~L~l~~N~~~~  316 (344)
T d2ca6a1         304 LLFLELNGNRFSE  316 (344)
T ss_dssp             CCEEECTTSBSCT
T ss_pred             CCEEECCCCcCCC
Confidence            9999999999973

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.43  E-value=1.3e-13  Score=126.60  Aligned_cols=42  Identities=29%  Similarity=0.343  Sum_probs=19.8

Q ss_pred             ccCCCcccEEEeecccccCCc-cccccCccCCcEEeccCcccc
Q 039290          586 IGGLQGLQLLSLRYNRLQGPI-PESFGGLKSLNFVDMSNNNLS  627 (1049)
Q Consensus       586 ~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~  627 (1049)
                      ++.+++|+.|++++|+|++.. ...++.+++|++|++++|+++
T Consensus        61 ~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          61 VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             GTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             cccccccCeEECCCCccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            444445555555555554322 133444555555555555544

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.40  E-value=1.8e-13  Score=125.58  Aligned_cols=117  Identities=27%  Similarity=0.272  Sum_probs=62.4

Q ss_pred             ceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceeecCcccccccCcccccccccccccccCCc
Q 039290          474 GLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNS  553 (1049)
Q Consensus       474 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~  553 (1049)
                      .|+|++|+|+ .++ .+..+++|++|++++|+|+ .+|..++.+++|+.|++++|+++++ |                  
T Consensus         2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~------------------   59 (124)
T d1dcea3           2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D------------------   59 (124)
T ss_dssp             EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G------------------
T ss_pred             EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C------------------
Confidence            4566666665 233 3555555555555555555 3444555555555555555555542 1                  


Q ss_pred             cCCCCccCcCCCcceeEeecccccccccc-cccccCCCcccEEEeecccccCC---ccccccCccCCcEE
Q 039290          554 LNGSLLPDIGNLKVVIEMDLSLNALSGVI-PVTIGGLQGLQLLSLRYNRLQGP---IPESFGGLKSLNFV  619 (1049)
Q Consensus       554 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~---~~~~~~~l~~L~~L  619 (1049)
                             .++.+++|++|++++|+|++.. ...+..+++|+.|++++|++++.   ....+..+++|+.|
T Consensus        60 -------~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          60 -------GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             -------GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             -------ccccccccCeEECCCCccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence                   2444555555555555555332 24566667777777777776532   12233445555544

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.33  E-value=2.8e-14  Score=143.08  Aligned_cols=129  Identities=20%  Similarity=0.281  Sum_probs=74.8

Q ss_pred             chhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeecccccccccccccccCCC
Q 039290          511 PACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQ  590 (1049)
Q Consensus       511 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  590 (1049)
                      +..+..+++|++|+|++|+++.+ + .+..+++|++|+|++|+|+. ++..+..++.|++|++++|+|+..  ..+..++
T Consensus        41 ~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~  115 (198)
T d1m9la_          41 DATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASL--SGIEKLV  115 (198)
T ss_dssp             HHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCCH--HHHHHHH
T ss_pred             hhHHhcccccceeECcccCCCCc-c-cccCCccccChhhccccccc-cccccccccccccccccccccccc--ccccccc
Confidence            34444455555555555555432 1 24445555555555555543 233333345566667777776643  3466777


Q ss_pred             cccEEEeecccccCCcc-ccccCccCCcEEeccCccccCCcccc----------cccccccceee
Q 039290          591 GLQLLSLRYNRLQGPIP-ESFGGLKSLNFVDMSNNNLSGTIPKS----------MEALSYLKHLN  644 (1049)
Q Consensus       591 ~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~----------~~~l~~L~~l~  644 (1049)
                      +|+.|+|++|+|++... ..+..+++|+.|+|++|+++...+..          +..+++|+.||
T Consensus       116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD  180 (198)
T d1m9la_         116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD  180 (198)
T ss_dssp             HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred             cccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence            77788888887774322 46777788888888888776443322          45677777765

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.30  E-value=3.4e-14  Score=142.48  Aligned_cols=148  Identities=22%  Similarity=0.239  Sum_probs=84.6

Q ss_pred             ccEEEccCC--cccccCCccccCcCCCcceEeeccccCCCCCcccccccccceEEeeCcccCCcCchhccCcccCCceee
Q 039290          448 LTVIRLGNN--ELTGTIPVTLGRLQKLQGLYLQNNKLEGSIPEDLCHLYRLANLYLGDNKLSGRLPACLGNLTSLRDLSL  525 (1049)
Q Consensus       448 L~~L~Ls~N--~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  525 (1049)
                      ++.+++.++  .++ .+|..++.+++|++|+|++|+|+. ++ .+..+++|+.|+|++|+++ .+|..+..+++|++|++
T Consensus        25 ~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l  100 (198)
T d1m9la_          25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWI  100 (198)
T ss_dssp             CSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEEC
T ss_pred             cceeeeecccCchh-hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccc
Confidence            444555443  233 344556666666666666666663 32 3556666666666666665 34444444445555555


Q ss_pred             cCcccccccCcccccccccccccccCCccCCCCccCcCCCcceeEeeccccccccccc-ccccCCCcccEEEeecccccC
Q 039290          526 GSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLNALSGVIP-VTIGGLQGLQLLSLRYNRLQG  604 (1049)
Q Consensus       526 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~  604 (1049)
                      ++|+++.+                          +.+..+++|+.|++++|+|++... ..+..+++|+.|+|++|++..
T Consensus       101 ~~N~i~~l--------------------------~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~  154 (198)
T d1m9la_         101 SYNQIASL--------------------------SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN  154 (198)
T ss_dssp             SEEECCCH--------------------------HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred             cccccccc--------------------------ccccccccccccccccchhccccccccccCCCccceeecCCCcccc
Confidence            55555542                          224445556666666666654322 456777788888888887764


Q ss_pred             Cccc----------cccCccCCcEEeccCcccc
Q 039290          605 PIPE----------SFGGLKSLNFVDMSNNNLS  627 (1049)
Q Consensus       605 ~~~~----------~~~~l~~L~~L~Ls~N~l~  627 (1049)
                      ..+.          .+..+++|+.||  +..++
T Consensus       155 ~~~~~~~~~~~r~~vi~~lp~L~~LD--~~~I~  185 (198)
T d1m9la_         155 DYKENNATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             HHCTTTTHHHHHHHHHHHCSSCCEES--SGGGT
T ss_pred             CcccccchhhHHHHHHHHCCCcCEeC--CccCC
Confidence            3332          256788898887  55554

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.29  E-value=2.5e-12  Score=123.16  Aligned_cols=108  Identities=19%  Similarity=0.139  Sum_probs=83.2

Q ss_pred             ccccccCCccCCCCccCcCCCcceeEeecccc-cccccccccccCCCcccEEEeecccccCCccccccCccCCcEEeccC
Q 039290          545 LRFNLSSNSLNGSLLPDIGNLKVVIEMDLSLN-ALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLKSLNFVDMSN  623 (1049)
Q Consensus       545 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  623 (1049)
                      ..++.+++.+.. .|..+..+++|++|++++| .|+.+.+..|.++++|+.|+|++|+|+.+.|.+|.++++|++|||++
T Consensus        11 ~~l~c~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~   89 (156)
T d2ifga3          11 SGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (156)
T ss_dssp             SCEECCSSCCCT-TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             CeEEecCCCCcc-CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence            345555555543 4555667777888888665 47777778899999999999999999988888899999999999999


Q ss_pred             ccccCCcccccccccccceeeccCCcccccC
Q 039290          624 NNLSGTIPKSMEALSYLKHLNLSFNQLEGEI  654 (1049)
Q Consensus       624 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~  654 (1049)
                      |+|+ .+|.......+|+.|+|++|+|.|.+
T Consensus        90 N~l~-~l~~~~~~~~~l~~L~L~~Np~~C~C  119 (156)
T d2ifga3          90 NALE-SLSWKTVQGLSLQELVLSGNPLHCSC  119 (156)
T ss_dssp             SCCS-CCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred             CCCc-ccChhhhccccccccccCCCcccCCc
Confidence            9998 55544444447999999999998766

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.22  E-value=5.3e-12  Score=120.79  Aligned_cols=120  Identities=18%  Similarity=0.135  Sum_probs=68.6

Q ss_pred             cccccccccccccccCC-ccCCCCccCcCCCcceeEeecccccccccccccccCCCcccEEEeecccccCCccccccCcc
Q 039290          536 STLWNLKDILRFNLSSN-SLNGSLLPDIGNLKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIPESFGGLK  614 (1049)
Q Consensus       536 ~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  614 (1049)
                      ..+..+++|++|++++| .++...+.+|.++++|+.|+|++|+|+.+.|.+|..+++|++|+|++|+|+...+..|..+ 
T Consensus        25 ~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~-  103 (156)
T d2ifga3          25 HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL-  103 (156)
T ss_dssp             TTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSC-
T ss_pred             ccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhccc-
Confidence            33334444444444333 2444444555566666666666666666666777777777888888888775555555544 


Q ss_pred             CCcEEeccCccccCC-cccccccccccceeeccCCcccccCCC
Q 039290          615 SLNFVDMSNNNLSGT-IPKSMEALSYLKHLNLSFNQLEGEIPT  656 (1049)
Q Consensus       615 ~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~l~l~~N~l~~~~p~  656 (1049)
                      +|+.|+|++|++... .-.++..+.......+..+++.|.-|.
T Consensus       104 ~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~  146 (156)
T d2ifga3         104 SLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG  146 (156)
T ss_dssp             CCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred             cccccccCCCcccCCchHHHHHHHHHhccCccCcCCcEECcCh
Confidence            688888888877531 111233332333444455666666554

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.47  E-value=4.9e-07  Score=94.05  Aligned_cols=149  Identities=16%  Similarity=0.139  Sum_probs=106.4

Q ss_pred             HHHHHhcCCCCCceecCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcC-CCceeeEEeeeecCCeeE
Q 039290          755 DLLRATDGFSENKLLGMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR-HRNLVKIISSCSNNDFKA  833 (1049)
Q Consensus       755 ~~~~~~~~~~~~~~lg~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~  833 (1049)
                      ++.+..+.|+..+..+-++.+.||+... ++..+++|+...........+.+|...+..+. +--+.+++++..+++..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            4555566777766655555678999865 66678889887665555667888999888774 434677888888888899


Q ss_pred             EEEeccCCCChhhhhhcCCCccCHHHHHHHHHHHHHHHHHhHcc------------------------------------
Q 039290          834 LVLEYMSNGSLEKCLYSDNYFLDILQRLKIMIDVASALEYLHFG------------------------------------  877 (1049)
Q Consensus       834 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------------------------------------  877 (1049)
                      +||++++|.++.+.....      ....+++.++++.++.||..                                    
T Consensus        87 lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred             EEEEeccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence            999999998876543221      12234556666666666630                                    


Q ss_pred             --------------------CCCCeEEcCCCCCCeeecCCCceEEecccCcee
Q 039290          878 --------------------YSTPIVHCDIKPSNVLLNESMVGHLSDFGIAKI  910 (1049)
Q Consensus       878 --------------------~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~~  910 (1049)
                                          ....++|+|+.|.||++++++.+-|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                122478999999999999877677999998763

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.34  E-value=1.7e-08  Score=96.66  Aligned_cols=60  Identities=20%  Similarity=0.042  Sum_probs=28.9

Q ss_pred             CcceeEeecccccccccccccccCCCcccEEEeecccccCCcc-------ccccCccCCcEEeccCccc
Q 039290          565 LKVVIEMDLSLNALSGVIPVTIGGLQGLQLLSLRYNRLQGPIP-------ESFGGLKSLNFVDMSNNNL  626 (1049)
Q Consensus       565 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-------~~~~~l~~L~~L~Ls~N~l  626 (1049)
                      +++|+.|||++|+|+...+-.+.....|+.|+|++|.+.....       ..+..+++|+.||  |+.+
T Consensus        90 l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD--g~~v  156 (162)
T d1koha1          90 APNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD--GHEL  156 (162)
T ss_dssp             STTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET--TEEC
T ss_pred             CCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC--cCCC
Confidence            3344444444444443322222233455666666666654332       2355677777775  4444

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.30  E-value=2.7e-08  Score=95.19  Aligned_cols=63  Identities=24%  Similarity=0.232  Sum_probs=26.0

Q ss_pred             ccccceEEeeCcccCCc--CchhccCcccCCceeecCcccccccCcccccccccccccccCCccC
Q 039290          493 LYRLANLYLGDNKLSGR--LPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLN  555 (1049)
Q Consensus       493 l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  555 (1049)
                      +++|++|+|++|+|+..  ++..+..+++|+.|+|++|+++.+.+-.+.....|+.|++++|++.
T Consensus        64 ~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~  128 (162)
T d1koha1          64 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS  128 (162)
T ss_dssp             CTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred             CCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcC
Confidence            34444444444444322  1223344445555555555554432222222233444444444443

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.98  E-value=6.1e-06  Score=84.99  Aligned_cols=130  Identities=15%  Similarity=0.121  Sum_probs=87.6

Q ss_pred             eecCCCc-EEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcC--CCceeeEEeeeecCCeeEEEEeccCCCCh
Q 039290          768 LLGMGSF-GSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIR--HRNLVKIISSCSNNDFKALVLEYMSNGSL  844 (1049)
Q Consensus       768 ~lg~G~f-g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--hpniv~l~~~~~~~~~~~lv~e~~~~g~L  844 (1049)
                      .+..|.. +.||+....++..+++|......   ...+.+|+..++.+.  .-.+.+++++..+++..++|||+++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4455543 67999998888889999865432   345677888887763  23467788888888889999999988665


Q ss_pred             hhhhhcCCCccCHHHHHHHHHHHHHHHHHhHc------------------------------------------------
Q 039290          845 EKCLYSDNYFLDILQRLKIMIDVASALEYLHF------------------------------------------------  876 (1049)
Q Consensus       845 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~------------------------------------------------  876 (1049)
                      .+..      ...   .+.+.++++.++.||.                                                
T Consensus        94 ~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          94 LSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             TTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cccc------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            4311      111   1122233333333331                                                


Q ss_pred             -------cCCCCeEEcCCCCCCeeecCCCceEEecccCce
Q 039290          877 -------GYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK  909 (1049)
Q Consensus       877 -------~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~  909 (1049)
                             .....++|+|+.|.|||++++..+.|+||+.+.
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                   112347999999999999987777899999775

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.46  E-value=1.5e-05  Score=75.92  Aligned_cols=84  Identities=20%  Similarity=0.142  Sum_probs=46.6

Q ss_pred             CcceeEeeccccccccc----ccccccCCCcccEEEeecccccCC----ccccccCccCCcEEeccCccccCC-------
Q 039290          565 LKVVIEMDLSLNALSGV----IPVTIGGLQGLQLLSLRYNRLQGP----IPESFGGLKSLNFVDMSNNNLSGT-------  629 (1049)
Q Consensus       565 l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~-------  629 (1049)
                      .+.|++|+|++|.+...    +...+...+.|+.|+|++|.|++.    +-..+..-+.|++|+|++|.+...       
T Consensus        43 n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~  122 (167)
T d1pgva_          43 SKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMD  122 (167)
T ss_dssp             CSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHH
T ss_pred             CCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHH
Confidence            34455555555555422    223344456677777777777642    233455566777777777765421       


Q ss_pred             cccccccccccceeeccCC
Q 039290          630 IPKSMEALSYLKHLNLSFN  648 (1049)
Q Consensus       630 ~p~~~~~l~~L~~l~l~~N  648 (1049)
                      +...+..-++|+.|+++.+
T Consensus       123 l~~~L~~n~sL~~l~l~~~  141 (167)
T d1pgva_         123 MMMAIEENESLLRVGISFA  141 (167)
T ss_dssp             HHHHHHHCSSCCEEECCCC
T ss_pred             HHHHHHhCCCccEeeCcCC
Confidence            2333444566777766554

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.38  E-value=0.00032  Score=76.50  Aligned_cols=76  Identities=13%  Similarity=0.107  Sum_probs=50.0

Q ss_pred             CceecCCCcEEEEEEEeC-CCcEEEEEEeeccc-------CCCHHHHHHHHHHHhhcC-C--CceeeEEeeeecCCeeEE
Q 039290          766 NKLLGMGSFGSVYKGVLP-DGMEIAAKVFHMEF-------DGSLESFHAECKVMGSIR-H--RNLVKIISSCSNNDFKAL  834 (1049)
Q Consensus       766 ~~~lg~G~fg~Vy~a~~~-~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~-h--pniv~l~~~~~~~~~~~l  834 (1049)
                      .+.||.|....||++... +++.|+||......       +....+...|.+.++.+. +  ..+++++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            357999999999999865 46789999764321       123355667888887662 3  345566654  3345578


Q ss_pred             EEeccCCCC
Q 039290          835 VLEYMSNGS  843 (1049)
Q Consensus       835 v~e~~~~g~  843 (1049)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.38  E-value=2e-05  Score=75.00  Aligned_cols=114  Identities=15%  Similarity=0.081  Sum_probs=63.8

Q ss_pred             ccccceEEeeCc-ccCCc----CchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCcc
Q 039290          493 LYRLANLYLGDN-KLSGR----LPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLKV  567 (1049)
Q Consensus       493 l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  567 (1049)
                      .++|++|+|+++ .++..    +..++...++|++|+|++|.+.......+                    ...+...+.
T Consensus        14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~l--------------------a~~L~~n~~   73 (167)
T d1pgva_          14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGL--------------------IELIETSPS   73 (167)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTH--------------------HHHHHHCSS
T ss_pred             CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHH--------------------hhhhhhccc
Confidence            356677777653 34321    22334455556666666666653211111                    122233455


Q ss_pred             eeEeeccccccccc----ccccccCCCcccEEEeecccccCC-------ccccccCccCCcEEeccCccc
Q 039290          568 VIEMDLSLNALSGV----IPVTIGGLQGLQLLSLRYNRLQGP-------IPESFGGLKSLNFVDMSNNNL  626 (1049)
Q Consensus       568 L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~-------~~~~~~~l~~L~~L~Ls~N~l  626 (1049)
                      |++|+|++|.|++.    +...+...++|++|+|++|++...       +...+..-++|+.|+++.+..
T Consensus        74 L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~  143 (167)
T d1pgva_          74 LRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  143 (167)
T ss_dssp             CCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             ccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence            66666666666532    223456667788888888765532       344555668888888877754

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.88  E-value=3.7e-05  Score=73.03  Aligned_cols=88  Identities=16%  Similarity=0.161  Sum_probs=52.3

Q ss_pred             CCCcceeEeeccccccccc----ccccccCCCcccEEEeecccccCC----ccccccCccCCcEEec--cCccccC----
Q 039290          563 GNLKVVIEMDLSLNALSGV----IPVTIGGLQGLQLLSLRYNRLQGP----IPESFGGLKSLNFVDM--SNNNLSG----  628 (1049)
Q Consensus       563 ~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L--s~N~l~~----  628 (1049)
                      ...++|++|+|++|.++..    +...+...+.++.|++++|.++..    +...+...++|+.++|  ++|.+..    
T Consensus        43 ~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~  122 (166)
T d1io0a_          43 KTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEM  122 (166)
T ss_dssp             TTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHH
T ss_pred             hcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHH
Confidence            3445555556665555432    223445567777888887777642    3355666777776444  5666653    


Q ss_pred             CcccccccccccceeeccCCcc
Q 039290          629 TIPKSMEALSYLKHLNLSFNQL  650 (1049)
Q Consensus       629 ~~p~~~~~l~~L~~l~l~~N~l  650 (1049)
                      .+...+...++|+.|+++.|+.
T Consensus       123 ~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_         123 EIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             HHHHHHHHCSSCCEEECCCSSH
T ss_pred             HHHHHHHhCCCcCEEeCcCCCC
Confidence            2344455677788888876653

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.84  E-value=0.0011  Score=70.18  Aligned_cols=134  Identities=13%  Similarity=0.134  Sum_probs=79.1

Q ss_pred             cEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCce--eeEEe-----eeecCCeeEEEEeccCCCChh-
Q 039290          774 FGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRNL--VKIIS-----SCSNNDFKALVLEYMSNGSLE-  845 (1049)
Q Consensus       774 fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpni--v~l~~-----~~~~~~~~~lv~e~~~~g~L~-  845 (1049)
                      --.||+++..+|+.|++|+.+.. ....+++..|...+..+....+  +..+.     .+...+..+.++++++|..+. 
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            35899999999999999998643 3345778889988888742221  11111     223456678899999764321 


Q ss_pred             ----hh---------hh----c----CCCccCHH----------------------HHHHHHHHHHHHHHHhH-ccCCCC
Q 039290          846 ----KC---------LY----S----DNYFLDIL----------------------QRLKIMIDVASALEYLH-FGYSTP  881 (1049)
Q Consensus       846 ----~~---------l~----~----~~~~~~~~----------------------~~~~i~~~i~~~l~~LH-~~~~~~  881 (1049)
                          .+         ++    .    .+...+..                      .....+.++...+.-.- .....+
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence                11         00    0    01111111                      11122233333222221 122467


Q ss_pred             eEEcCCCCCCeeecCCCceEEecccCcee
Q 039290          882 IVHCDIKPSNVLLNESMVGHLSDFGIAKI  910 (1049)
Q Consensus       882 ivH~Dlkp~NIl~~~~~~~kl~DfGla~~  910 (1049)
                      +||+|+.+.|||++++  ..++||+-+..
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eecCCCCcccEEEeCC--ceEEechhccc
Confidence            8999999999999753  45899998763

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.39  E-value=0.00012  Score=69.31  Aligned_cols=116  Identities=12%  Similarity=0.076  Sum_probs=63.4

Q ss_pred             cccccceEEeeC-cccCCc----CchhccCcccCCceeecCcccccccCcccccccccccccccCCccCCCCccCcCCCc
Q 039290          492 HLYRLANLYLGD-NKLSGR----LPACLGNLTSLRDLSLGSNALTSIIPSTLWNLKDILRFNLSSNSLNGSLLPDIGNLK  566 (1049)
Q Consensus       492 ~l~~L~~L~L~~-N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  566 (1049)
                      +.+.|++|+|++ +.++..    +..++...++|++|++++|.++......+.                    ..+...+
T Consensus        15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~--------------------~~l~~~~   74 (166)
T d1io0a_          15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALA--------------------EMLKVNN   74 (166)
T ss_dssp             TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHH--------------------HHHHHCS
T ss_pred             cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHH--------------------HHHhhcc
Confidence            446677777765 344422    223344556666666666666542211111                    1122334


Q ss_pred             ceeEeeccccccccc----ccccccCCCcccEEEe--ecccccC----CccccccCccCCcEEeccCcccc
Q 039290          567 VVIEMDLSLNALSGV----IPVTIGGLQGLQLLSL--RYNRLQG----PIPESFGGLKSLNFVDMSNNNLS  627 (1049)
Q Consensus       567 ~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L--s~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~  627 (1049)
                      .++.+++++|.+...    +...+...++|+.++|  ++|.+..    .+...+...++|+.|+++.|...
T Consensus        75 ~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~  145 (166)
T d1io0a_          75 TLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  145 (166)
T ss_dssp             SCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             cchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence            455555555555422    2345566677776555  4566654    34455667788888888777553

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.38  E-value=0.012  Score=61.47  Aligned_cols=156  Identities=12%  Similarity=0.037  Sum_probs=86.8

Q ss_pred             ccHHHHHHHhcCCCCCcee-----cCCCcEEEEEEEeCCCcEEEEEEeecccCCCHHHHHHHHHHHhhcCCCc--eeeEE
Q 039290          751 ISYQDLLRATDGFSENKLL-----GMGSFGSVYKGVLPDGMEIAAKVFHMEFDGSLESFHAECKVMGSIRHRN--LVKII  823 (1049)
Q Consensus       751 ~~~~~~~~~~~~~~~~~~l-----g~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn--iv~l~  823 (1049)
                      ++-+++.....+|.+.+..     ..|---+.|+.+..+| ++++|++....  ..+++..|++++..+...+  +...+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence            5667788888888775443     4566678899987665 58999986432  2345666777777764221  11111


Q ss_pred             e------eeecCCeeEEEEeccCCCChhhh--------------hhc----------CCC----------------ccCH
Q 039290          824 S------SCSNNDFKALVLEYMSNGSLEKC--------------LYS----------DNY----------------FLDI  857 (1049)
Q Consensus       824 ~------~~~~~~~~~lv~e~~~~g~L~~~--------------l~~----------~~~----------------~~~~  857 (1049)
                      .      +....+....++.++.+......              ++.          ...                ....
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            1      11223455667777765432110              000          000                0000


Q ss_pred             HHHHHHHHHHHHHHHHhH-ccCCCCeEEcCCCCCCeeecCCCceEEecccCce
Q 039290          858 LQRLKIMIDVASALEYLH-FGYSTPIVHCDIKPSNVLLNESMVGHLSDFGIAK  909 (1049)
Q Consensus       858 ~~~~~i~~~i~~~l~~LH-~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DfGla~  909 (1049)
                      ......+..+...++..+ .....|+||+|+.++||+++.+...-|.||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            011122222333333333 2346789999999999999988777899999876

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.34  E-value=0.0055  Score=66.45  Aligned_cols=73  Identities=14%  Similarity=0.148  Sum_probs=50.9

Q ss_pred             CceecCCCcEEEEEEEeCC--------CcEEEEEEeecccCCCHHHHHHHHHHHhhcC-CCceeeEEeeeecCCeeEEEE
Q 039290          766 NKLLGMGSFGSVYKGVLPD--------GMEIAAKVFHMEFDGSLESFHAECKVMGSIR-HRNLVKIISSCSNNDFKALVL  836 (1049)
Q Consensus       766 ~~~lg~G~fg~Vy~a~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~  836 (1049)
                      .+.|+-|-.-.+|++...+        .+.|++++.. . ........+|..+++.+. +.-..++++++.+    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            3578889999999998654        3457777664 2 233456678999988884 4444577777653    6899


Q ss_pred             eccCCCCh
Q 039290          837 EYMSNGSL  844 (1049)
Q Consensus       837 e~~~~g~L  844 (1049)
                      ||++|..+
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987544